{"text_format":"3","workbook":"xlsx","n_sheets":6,"sheets":["Recommended Leads","Normalized Full Values","Formulas","Protein+Antibody Info","Gene Ontology Terms","Kinexus Ab Testing Links"],"not_rendered":{"images":2,"comments":4},"read":"whole","date_system":"1900"}

{"sheet":"Recommended Leads","index":0,"n_rows":52,"n_cols":42,"rows_kept":52,"merged":[[0,12,5,26],[7,12,8,26],[13,2,13,3],[15,6,15,7],[15,8,15,11],[15,12,15,15]]}
[{"$nulls":12},"Globally Normalized Values for the signal intensity of samples analyzed with the KAM-1325 antibody microarray data were colourized using the Conditional Formatting feature under Format in the pull down menu of MS-Excel. This feature lets users colourize cells in the spreadsheet according to their desired criteria. In the case of your data, the Globally Normalized intensity signals with a value of 0 was set to blue, the approximate median value of 5000 to white, and 25,000 to red. A colour gradient based on these settings were then generated. In selecting antibody changes to follow up on, it is best to focus on cells that are white to red coloured. These have the best chance of showing up on Western blots to validate the data. "]
[]
[]
[]
[]
[]
[]
[{"$nulls":12},"The Conditional Formatting feature for %CFC (change from control) is set to blue for -100%, white for 0 changes, and orange for +200%. In this case, it is best to focus on orange coloured cells for follow up immunoblotting studies. "]
["Recommended Leads for Order 4047"]
[]
["KAM-1325 ARRAY DETAILS ",{"$nulls":11},"Lead Selection Recommendation for Follow Up Immunoblotting"]
["Sample IDs:",null,"Control ID:  Hec50 CT (Kinexus ID: 20589) vs Treated ID: Hec50 bev (Kineuxs ID: 20590) vs Hec50 cediranib (Kinexus ID: 20591)",{"$nulls":9},"Priority"," lead selection criteria: %CFC ≥75%; Sum of %Error <75% of %CFC; Average Normalized Net Signal ≥1500"]
["Array Barcode:",null,"K01803-1273, -1279",null,"Protocol: Chemical cleavage pre-homogenization: Biotin-labelling",{"$nulls":7},"Possible"," lead selection criteria: %CFC ≥45% + <75%; Sum of %Errors <80% of %CFC; Average Normalized Net Signal ≥750"]
["Date of Report:",null,"2020-02-21",null,"Reviewed by:  Dr. Steven Pelech"]
[]
[{"$nulls":6},"Hec50 CT",null,"Hec50 Bev",{"$nulls":3},"Hec50 Cediranib"]
["Final Sort","Ab Spot ID #","Antibody Codes","Target Name ","P-Site","Full Target Protein Name","Average Normalized Net Signal","% Error in Duplicate from Average","Average Normalized Net Signal","% Error in Duplicate from Average","%CFC ","Lead","Average Normalized Net Signal","% Error in Duplicate from Average","%CFC ","Lead",null,"Preferred Protein Kinase Name ","Protein Kinase","Kinase or Phosphatase Type","Protein Type","Kinase Type","Kinase Group","Kinase Family","Kinase Subfamily","Transcription Factor","Stress Protein","Protein Phosphatase","Adapter","Metabolic Enzyme","Antigen Sequence","Sequence Location in Target","Effect of Phosphorylation","Kinases Known to Target Phosphosite(s) in vitro","Protein Type - Extended","UniProt Link","PhosphoNET Link","KinaseNET Link","OncoNET Link","GO_CelComponent_list","GO_MolFunctin_list","GO_BioProcess_list"]
[35,17,"PK509","Abl2 (Arg)","Y439","Abelson murine leukemia viral oncogene homologue 2",{"v":3312.834270181382,"d":"3313"},{"v":1.0824789157017891,"d":"1"},{"v":1471.529054977892,"d":"1472"},{"v":5.980665246600019,"d":"6"},{"v":-55.580963761965556,"d":"-56"},"Possible",{"v":2192.203738162457,"d":"2192"},{"v":6.294562027845424,"d":"6"},{"v":-33.826942147563855,"d":"-34"},null,null,"ARG","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"GDT(pY)TAH(bA)C","Corresponds to amino acid residues G436 to H442; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y439 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. It is the most predominent phosphorylation site in Abl2 by mass spectrometry (≥1165 reports).","Abl2","EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; Abl family","P42684","P42684","P42684","P42684","GO:0015629; GO:0005829; GO:0031234","GO:0051015; GO:0003785; GO:0005524; GO:0000287; GO:0030145; GO:0004715; GO:0001784; GO:0004672; GO:0004713; GO:0005102","GO:0007155; GO:0006464; GO:0071300; GO:0045087; GO:0038083; GO:0018108; GO:0007204; GO:0010976; GO:0051353; GO:0010863; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0042127; GO:0030100; GO:0007165; GO:0007169"]
[41,20,"PN733","ACC1 (ACACA)","S29","Acetyl-CoA carboxylase 1",{"v":1178.374339068081,"d":"1178"},{"v":4.806014750573356,"d":"5"},{"v":577.6293264843509,"d":"578"},{"v":0.8203266787658835,"d":"1"},{"v":-50.98082949250492,"d":"-51"},"Possible",{"v":798.9013441868744,"d":"799"},{"v":13.284964151412106,"d":"13"},{"v":-32.203093898099766,"d":"-32"},{"$nulls":5},"Fatty acid synthesis",{"$nulls":8},"X","EDN(pS)EDE(bA)C","Corresponds to amino acid residues E26 to E32.","The effect of S29 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in ACC1 (≥78 reports based on mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in fish.","CK2a1 (CSNK2A1)","EC 6.4.1.2; Ligase; Carbohydrate Metabolism - pyruvate; EC 6.3.4.14; Carbohydrate Metabolism - propanoate; Lipid Metabolism - fatty acid biosynthesis","Q13085","Q13085",null,"Q13085","GO:0015629; GO:0005829; GO:0001650","GO:0003989; GO:0005524; GO:0004075; GO:0042802; GO:0046872","GO:0006084; GO:0006853; GO:0071380; GO:0006633; GO:0046949; GO:0055088; GO:2001295; GO:0031325; GO:0051289; GO:0019538; GO:0045540; GO:0001894"]
[43,21,"PN202","ACC1 (ACACA)","S78+S80","Acetyl-CoA carboxylase 1",{"v":954.0130372779294,"d":"954"},{"v":13.798203461568923,"d":"14"},{"v":506.1350300221211,"d":"506"},{"v":4.67100016915158,"d":"5"},{"v":-46.94673864559877,"d":"-47"},"Possible",{"v":660.5609976241955,"d":"661"},{"v":14.838268544921949,"d":"15"},{"v":-30.759751511471592,"d":"-31"},{"$nulls":14},"X","Not precisely defined.","Antibody raised against amino acid residues that encompass the S78 and S80 phosphosites.","The effect of S78 phosphorylation is unclear and it has been rarely observed (3 mass spectrometry reports). S80 phosphorylation produces enzyme inhibition. This is one of the major in vivo phosphorylation sites in ACC1 (≥80 reports based on mass spectrometry studies).","S78: PKACa (PRKACA). S80: AMPKa1 (PRKAA1); AMPKa2 (PRKAA2).","EC 6.4.1.2; Ligase; Carbohydrate Metabolism - pyruvate; EC 6.3.4.14; Carbohydrate Metabolism - propanoate; Lipid Metabolism - fatty acid biosynthesis","Q13085","Q13085",null,"Q13085","GO:0015629; GO:0005829; GO:0001650","GO:0003989; GO:0005524; GO:0004075; GO:0042802; GO:0046872","GO:0006084; GO:0006853; GO:0071380; GO:0006633; GO:0046949; GO:0055088; GO:2001295; GO:0031325; GO:0051289; GO:0019538; GO:0045540; GO:0001894"]
[207,102,"NK193-3","AurKB (Aurora B, AIM-1)","Pan-specific","Aurora Kinase B (serine/threonine protein kinase 12)",{"v":5331.199505682236,"d":"5331"},{"v":63.928716098073544,"d":"64"},{"v":9845.589657839859,"d":"9846"},{"v":6.194593682345497,"d":"6"},{"v":84.67869467923643,"d":"85"},"Possible",{"v":8479.391912766467,"d":"8479"},{"v":5.040282309075168,"d":"5"},{"v":59.05223399966073,"d":"59"},null,null,"AurB","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"CDILTRHFTIDDFEIG","Corresponds to amino acid residues D66 to G80.",null,null,"Protein-serine kinase, Other group, AUR family","Q96GD4","Q96GD4","Q96GD4","Q96GD4","GO:0010369; GO:0032133; GO:0000779; GO:0000780; GO:0005829; GO:0000776; GO:0030496; GO:1990023; GO:0005654; GO:0005634; GO:0005819; GO:0005876; GO:0051233; GO:0031616","GO:0005524; GO:0035174; GO:0019900; GO:0046872; GO:0004712; GO:0004674","GO:0009838; GO:0007568; GO:0031145; GO:0008608; GO:0008283; GO:0034644; GO:0036089; GO:0043988; GO:0016570; GO:0044878; GO:0051256; GO:0002903; GO:0032466; GO:0032091; GO:0000122; GO:0032467; GO:0051973; GO:1904355; GO:0032212; GO:0046777; GO:0034501; GO:0006468; GO:0051983; GO:1901796; GO:0031577; GO:0007051"]
[275,138,"PN116","BRCA1","S1423","Breast cancer type 1 susceptibility protein",{"v":101.07811821417306,"d":"101"},{"v":94.9516723454558,"d":"95"},{"v":981.650114652112,"d":"982"},{"v":31.688016275183013,"d":"32"},{"v":871.1796499536199,"d":"871"},"Possible",{"v":345.6575413283337,"d":"346"},{"v":98.66956708960377,"d":"99"},{"v":241.97069299996718,"d":"242"},{"$nulls":3},"X",null,"Transcription, coactivator/corepressor",{"$nulls":9},"HG(pS)QP","Corresponds to amino acid residues  H1421 to P1425; Surrounds the S1423 phosphosite.","S1423 phosphorylation induces interaction with ATM. This is one of the minor in vivo phosphorylation sites in BRCA1 (≥2 reports from high throughput mass spectrometry studies).","ATM; ATR","Nuclear receptor co-regulator; Transcription, coactivator/corepressor; Ubiquitin conjugating system; Tumor suppressor","P38398","P38398",null,"P38398","GO:0070531; GO:0031436; GO:0005694; GO:0005737; GO:0008274; GO:0000800; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:1990904; GO:0000151","GO:0050681; GO:0003684; GO:0003677; GO:0019899; GO:0042802; GO:0003723; GO:0070063; GO:0003713; GO:0044212; GO:0015631; GO:0031625; GO:0004842; GO:0008270","GO:0030521; GO:0006915; GO:0006974; GO:0071681; GO:0071356; GO:0007098; GO:0043009; GO:0007059; GO:0006978; GO:0000729; GO:0006260; GO:0009048; GO:0006302; GO:0000724; GO:0006303; GO:0006633; GO:0008630; GO:0044818; GO:0046600; GO:1902042; GO:0045717; GO:0070317; GO:0035067; GO:0051572; GO:0051573; GO:0033147; GO:2000378; GO:0045892; GO:0045766; GO:0071158; GO:0045739; GO:0010628; GO:0035066; GO:0051571; GO:2000617; GO:0051574; GO:2000620; GO:0070512; GO:0031398; GO:0045893; GO:0045944; GO:0010575; GO:0006301; GO:0051865; GO:0016579; GO:0085020; GO:0016567; GO:0042981; GO:0042127; GO:0044030; GO:0006349; GO:0006357; GO:0006359; GO:0043627; GO:0010212; GO:0072425; GO:0006351"]
[317,160,"NK302-2","CaMK2a","Pan-specific","Calcium/calmodulin-dependent protein kinase type II subunit alpha",{"v":41.18400901717175,"d":"41"},{"v":37.60559774724806,"d":"38"},{"v":6694.762332686787,"d":"6695"},{"v":15.05586589262767,"d":"15"},{"v":16155.732485624196,"d":"16156"},"Likely Ab spot mis-print",{"v":2611.8833989866434,"d":"2612"},{"v":67.31989839296874,"d":"67"},{"v":6241.984331582711,"d":"6242"},"Likely Ab spot mis-print",null,"CaMK2a","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK2",{"$nulls":6},"Epitope undefined.",{"$nulls":3},"EC 2.7.11.17; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; CAMK2 family","Q9UQM7","Q9UQM7","Q9UQM7",null,"GO:0005954; GO:0030054; GO:0005737; GO:0005829; GO:0043197; GO:0030666; GO:0005739; GO:0043005; GO:0005654; GO:0005634; GO:0005886; GO:0014069; GO:0042734; GO:0098685","GO:0005524; GO:0009931; GO:0005516; GO:0004683; GO:0035254; GO:0042802; GO:0016301; GO:0046872; GO:0042803; GO:0004674; GO:0005088","GO:0038166; GO:0006816; GO:0030154; GO:0048813; GO:0060996; GO:0000082; GO:0060333; GO:0035556; GO:0000165; GO:0007399; GO:0018105; GO:1990443; GO:0018107; GO:0051928; GO:0010666; GO:0051092; GO:0046777; GO:0006468; GO:1902108; GO:0048168; GO:2001222; GO:0046928; GO:0099148; GO:0002931; GO:0007223"]
[353,184,"NN022-1","Caveolin 2","Pan-specific","Caveolin 2",{"v":416.3489291143774,"d":"416"},{"v":36.8818211744448,"d":"37"},{"v":993.235898269528,"d":"993"},{"v":52.304087477219475,"d":"52"},{"v":138.55853319528313,"d":"139"},"Possible",{"v":365.1525790978608,"d":"365"},{"v":21.108817927748316,"d":"21"},{"v":-12.296500948235234,"d":"-12"},{"$nulls":15},"Epitope undefined.",{"$nulls":3},"Adapter/scaffold protein","P51636","P51636",null,null,"GO:0002080; GO:0005901; GO:0031410; GO:0031234; GO:0005925; GO:0005794; GO:0000139; GO:0005887; GO:0005622; GO:0016020; GO:0045121; GO:0005634; GO:0048471; GO:0005886; GO:0032991; GO:0030133","GO:0031748; GO:0030674; GO:0032947; GO:0046982; GO:0042803; GO:0019901; GO:0097110","GO:0070836; GO:0007029; GO:0008286; GO:0007005; GO:0001937; GO:0030512; GO:0044794; GO:0044791; GO:0060161; GO:0001938; GO:0043547; GO:0043410; GO:0051259; GO:0019065; GO:0007088; GO:0048741; GO:0048278; GO:0006906; GO:0016050"]
[361,188,"PN171","Cbl","Y700","E3 ubiquitin-protein ligase CBL",{"v":547.3196303731842,"d":"547"},{"v":65.61855901785657,"d":"66"},{"v":1398.6806667793485,"d":"1399"},{"v":25.588367561085285,"d":"26"},{"v":155.55097773958386,"d":"156"},"Possible",{"v":955.8402476247206,"d":"956"},{"v":11.409424803470943,"d":"11"},{"v":74.64022749795964,"d":"75"},{"$nulls":5},"Ubiquitin protein ligase",{"$nulls":9},"TE(pY)MT","Corresponds to amino acid residues T768 to T772.","Y700 phosphorylation induces interaction with CRK, Src, and VAV1. This is one of the major in vivo phosphorylation sites in Cbl (≥505 reports from high throughput mass spectrometry studies).","Abl1; Fyn; InsR; Lck; Src; Syk; Yes","Ubiquitin conjugating system; EC 6.3.2.-; Ligase; Adaptor/scaffold","P22681","P22681",null,"P22681","GO:0005829; GO:0016600; GO:0005925; GO:0030426; GO:0042629; GO:0045121; GO:0048471; GO:0005886","GO:0045296; GO:0005509; GO:0003700; GO:0046875; GO:0005154; GO:0036312; GO:0001784; GO:0030971; GO:0017124; GO:0061630; GO:0004842","GO:0007166; GO:0006974; GO:0071364; GO:1990090; GO:0090650; GO:0036120; GO:0019221; GO:0035635; GO:0007173; GO:0008543; GO:0070102; GO:0008584; GO:0043303; GO:0061024; GO:0043066; GO:0007175; GO:0042059; GO:1901215; GO:0070997; GO:0045742; GO:0014068; GO:0048260; GO:0006513; GO:0000209; GO:0016567; GO:0014823; GO:0045471; GO:0010332; GO:0042594; GO:0033574; GO:0007179; GO:0006511"]
[661,327,"NN039-3","eIF4E","Pan-specific","Eukaryotic translation initiation factor 4 (mRNA cap binding protein)",{"v":666.8794196703257,"d":"667"},{"v":18.119012236380307,"d":"18"},{"v":490.67741764641926,"d":"491"},{"v":26.231154347408086,"d":"26"},{"v":-26.421868305819444,"d":"-26"},null,{"v":1062.4872572255313,"d":"1062"},{"v":0.6209019825065484,"d":"1"},{"v":59.32224415483924,"d":"59"},"Possible",{"$nulls":14},"Not precisely defined.","Antibody raised against full length human eIF4E.",null,null,"Protein synthesis protein","P06730","P06730",null,"P06730","GO:0033391; GO:0005737; GO:0036464; GO:0010494; GO:0005829; GO:0016281; GO:0070062; GO:0098978; GO:0005845; GO:0000932; GO:0048471; GO:0099524; GO:0016442","GO:0019899; GO:0031370; GO:0070491; GO:0000340; GO:0003723; GO:0000339; GO:0003743; GO:0045182","GO:0001662; GO:0071549; GO:0000082; GO:0030324; GO:0006406; GO:0045665; GO:0017148; GO:0045931; GO:0006417; GO:0099578; GO:0006405; GO:0019827; GO:0006413; GO:0016032"]
[703,347,"PK610","EphB2","Y780","Ephrin type-B receptor 2 protein-tyrosine kinase",{"v":736.3921509920815,"d":"736"},{"v":19.584617880902158,"d":"20"},{"v":636.191610060997,"d":"636"},{"v":38.4835938948279,"d":"38"},{"v":-13.606953957357149,"d":"-14"},null,{"v":1155.0129818987707,"d":"1155"},{"v":5.35405872193438,"d":"5"},{"v":56.84754112910019,"d":"57"},"Possible",null,"EPHB2","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Eph",{"$nulls":6},"DPT(pY)TSA(bA)C","Corresponds to amino acid residues D777 to A783; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII. ","Y780 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation site in EphB2 (≥152reports from high throughput mass spectrometry studies).",null,"EC 2.7.10.1; Receptor tyrosine kinase; TK domain target; TK</A> group; Eph family","P29323","P29323","P29323","P29323","GO:0030424; GO:0005829; GO:0030425; GO:0005576; GO:0098978; GO:0005887; GO:0099055; GO:0099056; GO:0043025; GO:0005634; GO:0005886; GO:0098794","GO:0001540; GO:0005524; GO:0008046; GO:0042802; GO:0044877; GO:0004713; GO:0005102; GO:0005005","GO:0001525; GO:0007413; GO:0007411; GO:0048593; GO:0021952; GO:0071679; GO:0022038; GO:0060996; GO:0060997; GO:0048013; GO:0051389; GO:0042472; GO:0007612; GO:0007611; GO:0050771; GO:0070373; GO:1904782; GO:0001933; GO:0046580; GO:0007399; GO:0106028; GO:0021631; GO:0018108; GO:0016310; GO:0010628; GO:0048170; GO:1900273; GO:1904783; GO:1903078; GO:0051965; GO:0031915; GO:0097104; GO:0050878; GO:0048168; GO:0031290; GO:0060021; GO:0099557; GO:0001655"]
[705,348,"PK611","EphB3","Y600","Ephrin type-B receptor 3 protein-tyrosine kinase",{"v":1080.5153139727518,"d":"1081"},{"v":2.174895841125595,"d":"2"},{"v":921.5843524443716,"d":"922"},{"v":18.07249473418787,"d":"18"},{"v":-14.708811571030452,"d":"-15"},null,{"v":1721.0756547138544,"d":"1721"},{"v":8.312077154462,"d":"8"},{"v":59.28285628696386,"d":"59"},"Possible",null,"EPHB3","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Eph",{"$nulls":6},"LQQ(pY)IAP(bA)C","Corresponds to amino acid residues L597 to P603; In the EphA2_TM region between the transmembrane and kinase catalytic domains. ","The effect of Y600 phosphorylation is unclear. This is the major in vivo phosphorylation site for EphB3 (≥310 reports from high throughput mass spectrometry studies).",null,"Receptor tyrosine kinase; EC 2.7.10.1; TK group; Eph family","P54753","P54753","P54753","P54753","GO:0005829; GO:0030425; GO:0005576; GO:0005887; GO:0005886","GO:0005524; GO:0008046; GO:0005003; GO:0004713","GO:0001525; GO:0007413; GO:0007411; GO:0016477; GO:0021952; GO:0022038; GO:0060996; GO:0060997; GO:0048546; GO:0048013; GO:0051965; GO:0046777; GO:0050770; GO:0022407; GO:0043087; GO:0031290; GO:0060021; GO:0034446; GO:0048538; GO:0001655"]
[815,405,"PK151","FAK (PTK2)","Y576+Y577","Focal adhesion protein-tyrosine kinase",{"v":683.1962857738094,"d":"683"},{"v":1.6794835523777747,"d":"2"},{"v":1039.1579538895771,"d":"1039"},{"v":27.93925525135728,"d":"28"},{"v":52.102400953862684,"d":"52"},"Possible",{"v":771.9863872592571,"d":"772"},{"v":17.158357563293382,"d":"17"},{"v":12.996279888272696,"d":"13"},null,null,"FAK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Fak",{"$nulls":6},"ST(pY)(pY)KA","Corresponds to amino acid residues S574 to A579.","Y576 and Y577 phosphorylation stimulates phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major in vivo phosphorylation sites in FAK (≥2549 and ≥1764 reports, respectively, by mass spectrometry).","Y576: Bmx (Etk); FAK (PTK2); Fgr, Met; Ret; Src. Y577: Bmx (Etk); FAK (PTK2); Fgr, Met; Ret; Src.","Protein-tyrosine kinase, TK group, Fak family","Q05397","Q05397","Q05397","Q05397","GO:0016324; GO:0005938; GO:0005737; GO:0005856; GO:0005829; GO:0031234; GO:0005925; GO:0030027; GO:0005815; GO:0005634; GO:0005886; GO:0001725","GO:0003779; GO:0005524; GO:0008432; GO:0004715; GO:0004672; GO:0019901; GO:0019903; GO:0004713; GO:0005088; GO:0042169; GO:0005102","GO:0001525; GO:0007411; GO:0048870; GO:0021955; GO:0043542; GO:0048013; GO:0007173; GO:0030010; GO:0030198; GO:0038096; GO:0060396; GO:0003007; GO:0045087; GO:0007229; GO:0000165; GO:0000226; GO:2000811; GO:0043066; GO:0010507; GO:0050771; GO:0022408; GO:0046621; GO:0051964; GO:0038007; GO:0001764; GO:0007097; GO:0038083; GO:0018108; GO:0001890; GO:0010613; GO:0030335; GO:0008284; GO:0043552; GO:0014068; GO:0045860; GO:0051897; GO:0001934; GO:2000060; GO:0046777; GO:0033628; GO:0042127; GO:0008360; GO:0051493; GO:0010594; GO:0010632; GO:0051893; GO:0043087; GO:0045667; GO:0001932; GO:1900024; GO:0007172; GO:0007179; GO:0048010; GO:0001570"]
[959,477,"NN260-2","GFAP","Pan-specific","Glial fibrillary acidic protein",{"v":149.3293720588499,"d":"149"},{"v":38.906147039442715,"d":"39"},{"v":1490.9248902873378,"d":"1491"},{"v":32.51331571576734,"d":"33"},{"v":898.4136876299007,"d":"898"},"Possible",{"v":1979.6094530940284,"d":"1980"},{"v":0.1667103103715655,"d":"0"},{"v":1225.6664953455204,"d":"1226"},"Priority",{"$nulls":14},"Epitope undefined.",{"$nulls":3},"Cytoskeletal protein","P14136","P14136",null,null,"GO:0097450; GO:0044297; GO:0005737; GO:0098574; GO:0005829; GO:0005882; GO:0043209","GO:0042802; GO:0005178; GO:0019900; GO:0005200","GO:0014002; GO:0060020; GO:0030198; GO:0045109; GO:0060291; GO:0010977; GO:0031102; GO:0010625; GO:1904714; GO:0051580; GO:0043254; GO:0009611"]
[1005,499,"PK188","GSK3b","S9","Glycogen synthase-serine kinase 3 beta",{"v":629.5136908645334,"d":"630"},{"v":11.91623936872485,"d":"12"},{"v":931.4482555377393,"d":"931"},{"v":14.786688163390101,"d":"15"},{"v":47.963145052262234,"d":"48"},"Possible",{"v":904.0411025130074,"d":"904"},{"v":10.059252222194882,"d":"10"},{"v":43.60944259551462,"d":"44"},null,null,"GSK3B","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","GSK",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S9 phosphosite.","S9 phosphorylation inhibits phosphotransferase activity. Phosphorylation regulates apoptosis, cell adhesion, cell growth, cell motility, cytoskeletal reorganization, transcription, alters intracellular location, and protein degradation. This is one of the less major in vivo phosphorylation sites in GSK3b (≥262reports from high throughput mass spectrometry studies).","Akt1 (PKBa); Akt3 (PKBg); AurA (STK15); GSK3b; ILK; KHS1 (MAP4K5); p70S6K (RPS6KB1); PKACa (PRKACA); PKCa (PRKCA); PKCb1 (PRKCB1); PKCd (PRKCD); PKCg (PRKCG); PKCh (PRKCH); PKCz (PRKCZ); PKG1 (PRKG1); RSK1 (RPS6KA1); RSK2 (RPS6KA3); SGK3","Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.26; CMGC group; GSK family; GSK subfamily","P49841","P49841","P49841","P49841","GO:0030424; GO:0030877; GO:0005813; GO:0005737; GO:0005829; GO:0030425; GO:0098978; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0098794; GO:1990909","GO:0005524; GO:0008013; GO:0034452; GO:0016301; GO:0051059; GO:0002039; GO:0002020; GO:0034236; GO:0004672; GO:0019901; GO:0004674; GO:0001085; GO:0050321; GO:0031625","GO:1904885; GO:1904886; GO:1904646; GO:0036016; GO:0007623; GO:0007212; GO:0001837; GO:0006983; GO:0030010; GO:0060079; GO:0097191; GO:0097192; GO:0005977; GO:0021766; GO:0035556; GO:0030011; GO:0043066; GO:0070885; GO:0090090; GO:1904339; GO:2000466; GO:0045719; GO:1901215; GO:0032515; GO:1901984; GO:0032091; GO:0031333; GO:1900181; GO:2000077; GO:0031175; GO:0106028; GO:0018105; GO:0018107; GO:0001954; GO:0010628; GO:0043547; GO:1901030; GO:0010822; GO:1901216; GO:0032436; GO:0032092; GO:0045732; GO:0031334; GO:0046827; GO:1904781; GO:0046777; GO:0006468; GO:0030516; GO:0050770; GO:1900034; GO:0048814; GO:0032886; GO:0070507; GO:2000300; GO:0071109; GO:0016055"]
[1007,500,"PK883","GSK3b","T275+T277","Glycogen synthase-serine kinase 3 beta",{"v":8110.4787557232185,"d":"8110"},{"v":22.620251839966514,"d":"23"},{"v":11729.19503640522,"d":"11729"},{"v":1.5420641493919254,"d":"2"},{"v":44.6177887850138,"d":"45"},"Possible",{"v":12613.732544806984,"d":"12614"},{"v":0.6202779287827851,"d":"1"},{"v":55.52389599573283,"d":"56"},"Possible",null,"GSK3B","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","GSK",{"$nulls":6},"VLG(pT)P(pT)REQ(bA)C","Corresponds to amino acid residues V272 to Q280. These sites are located in the Gap/Insert 10 (G/I10) region in the protein-serine/threonine kinase catalytic domain of GSK3b, and they are also found in GSK3a at T338 and T340.","The effects of T275 and T277 phosphorylation are unclear. T275 and T277 have not yet been identified as phosphosites in GSK3b by mass spectrometry studies. ",null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.26; CMGC group; GSK family; GSK subfamily","P49841","P49841","P49841","P49841","GO:0030424; GO:0030877; GO:0005813; GO:0005737; GO:0005829; GO:0030425; GO:0098978; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0098794; GO:1990909","GO:0005524; GO:0008013; GO:0034452; GO:0016301; GO:0051059; GO:0002039; GO:0002020; GO:0034236; GO:0004672; GO:0019901; GO:0004674; GO:0001085; GO:0050321; GO:0031625","GO:1904885; GO:1904886; GO:1904646; GO:0036016; GO:0007623; GO:0007212; GO:0001837; GO:0006983; GO:0030010; GO:0060079; GO:0097191; GO:0097192; GO:0005977; GO:0021766; GO:0035556; GO:0030011; GO:0043066; GO:0070885; GO:0090090; GO:1904339; GO:2000466; GO:0045719; GO:1901215; GO:0032515; GO:1901984; GO:0032091; GO:0031333; GO:1900181; GO:2000077; GO:0031175; GO:0106028; GO:0018105; GO:0018107; GO:0001954; GO:0010628; GO:0043547; GO:1901030; GO:0010822; GO:1901216; GO:0032436; GO:0032092; GO:0045732; GO:0031334; GO:0046827; GO:1904781; GO:0046777; GO:0006468; GO:0030516; GO:0050770; GO:1900034; GO:0048814; GO:0032886; GO:0070507; GO:2000300; GO:0071109; GO:0016055"]
[1377,684,"PN759","MAT1A","T341","S-adenosylmethionine synthase isoform type-1",{"v":9338.030365051713,"d":"9338"},{"v":71.40899088762916,"d":"71"},{"v":20289.83637641767,"d":"20290"},{"v":0.968838179533517,"d":"1"},{"v":117.28175625080337,"d":"117"},"Priority",{"v":10350.971996407312,"d":"10351"},{"v":10.256531040260814,"d":"10"},{"v":10.847487015533929,"d":"11"},{"$nulls":14},"X","SQK(pT)ERE(bA)C","Corresponds to amino acid residues S338 to E344.","The effect of T341 phosphorylation is unclear. Phosphorylation at this site in MAT1A has only been reported in one mass spectrometry study. This human phosphosite is highly conserved in vertebrates and also found in yeast.",null,"Enzyme, transferase","Q00266","Q00266",null,null,"GO:0005829","GO:0005524; GO:0042802; GO:0046872; GO:0004478; GO:0098601","GO:0009087; GO:0032259; GO:0006730; GO:0051289; GO:0006556; GO:0001887; GO:0000096"]
[1393,692,"PN622","MEF2A","T108","Myocyte-specific enhancer factor 2A",{"v":7553.675803536498,"d":"7554"},{"v":86.36987273281335,"d":"86"},{"v":17239.79977764765,"d":"17240"},{"v":5.288164121756759,"d":"5"},{"v":128.23060223972388,"d":"128"},"Possible",{"v":10416.427077585402,"d":"10416"},{"v":15.349014746204395,"d":"15"},{"v":37.898783963015916,"d":"38"},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"SYVL(pT)PHTE(bA)C","Corresponds to amino acid residues S104 to E112.","The effect of T108 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in MEF2A (≥26 reports from high throughput mass spectrometry studies).","p38a MAPK (MAPK14)","Transcription protein","Q02078","Q02078",null,null,"GO:0005829; GO:0000790; GO:0005654; GO:0005634; GO:0005667","GO:0033613; GO:0003682; GO:0003700; GO:0035035; GO:0042826; GO:0046982; GO:0019901; GO:0000978; GO:0000977; GO:0000981; GO:0001085; GO:0043565; GO:0046332; GO:0001077; GO:0003713; GO:0003705","GO:0006915; GO:0061337; GO:0071277; GO:0048813; GO:0070375; GO:0007507; GO:0000165; GO:0000002; GO:0048311; GO:0007517; GO:0000122; GO:0010613; GO:0046326; GO:0051149; GO:0045944; GO:0006351; GO:0055005"]
[1397,694,"PN623","MEF2C","S396","Myocyte-specific enhancer factor 2C",{"v":6621.254587352647,"d":"6621"},{"v":12.123900498515876,"d":"12"},{"v":9866.433060895804,"d":"9866"},{"v":0.907180303413449,"d":"1"},{"v":49.01153445665446,"d":"49"},"Possible",{"v":7276.944142171083,"d":"7277"},{"v":0.4784374022847453,"d":"0"},{"v":9.902799328557421,"d":"10"},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"SEPV(pS)PPRD(bA)C","Corresponds to amino acid residues S392 to D400.","S396 phosphorylation induces MEF2C transcriptional activity and facilitates its sumoylation at K391, which in turn recruits co-repressors to inhibit transcription. This is one of the less major in vivo phosphorylation sites in MEF2C (≥8 reports from high throughput mass spectrometry studies).","CDK1 (CDC2)","Transcription protein","Q06413","Q06413",null,"Q06413","GO:0005737; GO:0005829; GO:0043231; GO:0016607; GO:0005654; GO:0005634; GO:0098794; GO:0032991; GO:0016528","GO:0033613; GO:0003680; GO:0003682; GO:0003677; GO:0003700; GO:0042826; GO:0071837; GO:0046982; GO:0000980; GO:0000978; GO:0000977; GO:0000981; GO:0001205; GO:0001077; GO:0000983; GO:0044212","GO:0006915; GO:0001782; GO:0042100; GO:0050853; GO:0001568; GO:0001974; GO:0014898; GO:0003211; GO:0060536; GO:0048667; GO:0071277; GO:0035690; GO:0071498; GO:0071222; GO:0071374; GO:0071560; GO:0035984; GO:0002062; GO:0048703; GO:0001958; GO:2001013; GO:0060079; GO:0002467; GO:0072102; GO:0007507; GO:0001947; GO:0006959; GO:0007611; GO:0000165; GO:0030318; GO:0030224; GO:0007521; GO:0007517; GO:0014902; GO:0043537; GO:0010629; GO:0043524; GO:0030279; GO:0000122; GO:1904753; GO:1905563; GO:1904706; GO:0072160; GO:0007399; GO:0014033; GO:0048666; GO:0030182; GO:0001764; GO:0001649; GO:0003151; GO:0030220; GO:0010694; GO:0030890; GO:2000987; GO:0030501; GO:2000727; GO:0060045; GO:0071864; GO:0010628; GO:2000111; GO:0043406; GO:0051149; GO:0045663; GO:0045666; GO:0045669; GO:0090073; GO:2001016; GO:0048643; GO:0045893; GO:0045944; GO:0003138; GO:2000311; GO:0060998; GO:0002634; GO:0045652; GO:0043523; GO:0046928; GO:2000310; GO:0060297; GO:0051963; GO:0060025; GO:0048167; GO:0051966; GO:0006355; GO:0061333; GO:0002931; GO:0060021; GO:0003139; GO:0003185; GO:0035914; GO:0007519; GO:0051145; GO:0055012"]
[1701,846,"PK737","NuaK1 (ARK5)/Nuak2","T211","NUAK family SNF1-like kinase 1; AMPK-related protein kinase 5",{"v":13268.391948526565,"d":"13268"},{"v":9.250837626306103,"d":"9"},{"v":8529.24038945111,"d":"8529"},{"v":1.3450452923414729,"d":"1"},{"v":-35.71760298806768,"d":"-36"},null,{"v":6300.421532844229,"d":"6300"},{"v":0.21329777917774043,"d":"0"},{"v":-52.515560609860636,"d":"-53"},"Possible",null,"NUAK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","NuaK",{"$nulls":5},"FLQ(pT)FCG(bA)C","Corresponds to amino acid residues F208 to G214; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T211 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is a minor in vivo phosphorylation sites in Nuak1 (≥1 report from high throughput mass spectrometry studies).","LKB1 (STK11); NDR2 (STK38L)","EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); CAMK group; CAMKL family; NuaK subfamily","O60285","O60285","O60285","O60285","GO:0005737; GO:0001650; GO:0015630; GO:0005654; GO:0005634","GO:0005524; GO:0046872; GO:0002039; GO:0004674","GO:0007155; GO:0006974; GO:0035556; GO:0006468; GO:0030155; GO:0042127; GO:2000772; GO:0035507; GO:1901796"]
[1725,860,"PK742","p38d MAPK (MAPK13)","T180+Y182","Mitogen-activated protein-serine kinase p38 delta; Mitogen-activated protein kinase 13",{"v":1121.1256145274222,"d":"1121"},{"v":27.747977195697743,"d":"28"},{"v":511.29630355640654,"d":"511"},{"v":8.503767491926798,"d":"9"},{"v":-54.394378566408136,"d":"-54"},"Possible",{"v":757.7102711848544,"d":"758"},{"v":8.582879399396006,"d":"9"},{"v":-32.41522079537492,"d":"-32"},null,null,"p38d","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","p38",{"$nulls":5},"AEM(pT)G(pY)(bA)C","Corresponds to amino acid residues A177 to Y182; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T180 and Y182 phosphorylation is stimulatory for phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major in vivo phosphorylation sites in p38a (≥382 and >986 reports, respectively, from high throughput mass spectrometry studies).","T180: MKK3 (MAP2K3, MEK3); MKK6 (MAP2K6, MEK6). Y182: MKK3 (MAP2K3, MEK3); MKK6 (MAP2K6, MEK6).","EC 2.7.11.24; EC 2.7.1.37; Protein kinase, Ser/Thr (non-receptor); CMGC group; MAPK family; MAPK/p38 subfamily; p38 subfamily","O15264","O15264","O15264","O15264","GO:0005737; GO:0005829; GO:0005634","GO:0005524; GO:0004707; GO:0004674","GO:0007049; GO:0072740; GO:0070301; GO:0071347; GO:1903936; GO:0072709; GO:0034644; GO:0018105; GO:0050729; GO:0032755; GO:0010468; GO:0006355; GO:0006970; GO:0051403; GO:0006351"]
[1763,879,"NK223-2","p70S6K (S6Ka, RPS6KB1)","Pan-specific","Ribosomal protein S6 kinase beta-1; Ribosomal protein S6 kinase 1",{"v":8055.863115810609,"d":"8056"},{"v":31.328546466266495,"d":"31"},{"v":4312.032624863121,"d":"4312"},{"v":1.5054624371846084,"d":"2"},{"v":-46.473362780951014,"d":"-46"},"Possible",{"v":6370.449693088396,"d":"6370"},{"v":6.311538609245907,"d":"6"},{"v":-20.921574739947914,"d":"-21"},null,null,"p70S6K","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","p70",{"$nulls":5},"MAGVFDIDLDQPEDAC","Corresponds to amino acid residues M24 to A38; Post-N-terminus.",null,null,"Protein-serine kinase, AGC group, RSK family, p70 subfamily","P23443","P23443","P23443","P23443","GO:0030054; GO:0009986; GO:0005737; GO:0005829; GO:0005741; GO:0005739; GO:0043005; GO:0005654; GO:0005634; GO:0048471; GO:0045202","GO:0005524; GO:0042802; GO:0016301; GO:0030165; GO:0042277; GO:0004672; GO:0051721; GO:0004712; GO:0004674; GO:0004711","GO:0007568; GO:0006915; GO:0001662; GO:0016477; GO:0071549; GO:0071363; GO:0032869; GO:0071346; GO:0000082; GO:0007281; GO:0044539; GO:0007616; GO:0043066; GO:2001237; GO:0046627; GO:0018105; GO:0048015; GO:0045931; GO:0048633; GO:0014911; GO:0048661; GO:0045727; GO:0045948; GO:0043491; GO:0046324; GO:0014878; GO:0045471; GO:0033762; GO:0009749; GO:0009408; GO:0043201; GO:0032496; GO:0009612; GO:0007584; GO:0033574; GO:0034612; GO:0009611; GO:0007165; GO:0014732; GO:0003009; GO:0031929"]
[1765,880,"PK145","p70S6K (S6Ka, RPS6KB1)","T252","Ribosomal protein S6 kinase beta-1; Ribosomal protein S6 kinase 1",{"v":379.3293582476748,"d":"379"},{"v":43.91832423869038,"d":"44"},{"v":733.2546529351204,"d":"733"},{"v":3.364186903773314,"d":"3"},{"v":93.30290076212816,"d":"93"},"Possible",{"v":325.2309504157169,"d":"325"},{"v":2.9658074697527703,"d":"3"},{"v":-14.261592638615525,"d":"-14"},null,null,"p70S6K","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","p70",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues that encompass the T229 phosphosite.","T252 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation regulates protein translation and protein conformation. This is one of the minor in vivo phosphorylation sites in p70 S6K (≥18 reports from high throughput mass spectrometry studies).","PDPK1 (PDK1); PIK3CD","Protein-serine kinase, AGC group, RSK family, p70 subfamily","P23443","P23443","P23443","P23443","GO:0030054; GO:0009986; GO:0005737; GO:0005829; GO:0005741; GO:0005739; GO:0043005; GO:0005654; GO:0005634; GO:0048471; GO:0045202","GO:0005524; GO:0042802; GO:0016301; GO:0030165; GO:0042277; GO:0004672; GO:0051721; GO:0004712; GO:0004674; GO:0004711","GO:0007568; GO:0006915; GO:0001662; GO:0016477; GO:0071549; GO:0071363; GO:0032869; GO:0071346; GO:0000082; GO:0007281; GO:0044539; GO:0007616; GO:0043066; GO:2001237; GO:0046627; GO:0018105; GO:0048015; GO:0045931; GO:0048633; GO:0014911; GO:0048661; GO:0045727; GO:0045948; GO:0043491; GO:0046324; GO:0014878; GO:0045471; GO:0033762; GO:0009749; GO:0009408; GO:0043201; GO:0032496; GO:0009612; GO:0007584; GO:0033574; GO:0034612; GO:0009611; GO:0007165; GO:0014732; GO:0003009; GO:0031929"]
[1889,945,"PN524","PFN1","Y129","Profilin 1",{"v":2209.803754419163,"d":"2210"},{"v":14.741068169836568,"d":"15"},{"v":805.5517947558484,"d":"806"},{"v":8.375031721140266,"d":"8"},{"v":-63.546455510137186,"d":"-64"},"Possible",{"v":1678.992377920978,"d":"1679"},{"v":9.983859528991708,"d":"10"},{"v":-24.02074733725422,"d":"-24"},{"$nulls":15},"KKC(pY)EMA(bA)C","Corresponds to amino acid residues K126 to A132; In the end of the Profilin domain.","Y129 phosphorylation induces interaction with VHL. This is the major in vivo phosphorylation site in Profilin 1 (≥666 reports from high throughput mass spectrometry studies).","KDR (VEGFR2); Src","Cytoskeletal protein; Actin binding protein","P07737","P07737",null,"P07737","GO:0072562; GO:0005938; GO:0005737; GO:0005856; GO:0005829; GO:0070062; GO:0005925; GO:0098978; GO:0016020; GO:0043005; GO:0005634; GO:0098688; GO:0098794; GO:0098793; GO:0098685","GO:0003779; GO:0003785; GO:0000774; GO:0045296; GO:0005546; GO:0070064; GO:0017048; GO:0003723; GO:0005102","GO:0030036; GO:0071363; GO:0098885; GO:0032232; GO:0030837; GO:0051497; GO:0001843; GO:0032233; GO:0030838; GO:0032781; GO:0051054; GO:0010634; GO:1900029; GO:0051496; GO:0045944; GO:0050434; GO:0050821; GO:0060074; GO:0060071"]
[2007,1006,"NK139-2","PKD3 (PRKCN)","Pan-specific","Protein-serine kinase C nu; Serine/threonine-protein kinase D3",{"v":1463.5241378267906,"d":"1464"},{"v":9.895809570919846,"d":"10"},{"v":2496.9556450536743,"d":"2497"},{"v":12.036755845962437,"d":"12"},{"v":70.61253589991634,"d":"71"},"Possible",{"v":2418.563453146955,"d":"2419"},{"v":26.900710137946003,"d":"27"},{"v":65.25613692564832,"d":"65"},"Possible",null,"PKD3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","PKD",{"$nulls":6},"TDTMVYFVGENNGDSSHNGC","Corresponds to amino acid residues T490 to N507; Just before kinase catalytic domain.",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.13; CAMK group; PKD family","O94806","O94806","O94806",null,"GO:0005829; GO:0016020; GO:0005654","GO:0005524; GO:0016301; GO:0046872; GO:0004697; GO:0004674","GO:0007205; GO:0089700; GO:0006468; GO:0030148"]
[2113,1057,"PK782","PRKACA/B (PKA, PKACA/B)","T196+T198","cAMP-dependent protein kinase catalytic subunit alpha/beta",{"v":5482.438896420225,"d":"5482"},{"v":37.99646162918901,"d":"38"},{"v":9674.525938379968,"d":"9675"},{"v":8.675858461956329,"d":"9"},{"v":76.46390814673697,"d":"76"},"Priority",{"v":9022.229913556861,"d":"9022"},{"v":5.014200076874019,"d":"5"},{"v":64.56599123152932,"d":"65"},"Possible",null,"PKACa","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKA",{"$nulls":6},"KGR(pT)W(pT)LCG(bA)C","Corresponds to amino acid residues K193 to G201; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T196 and T198 phosphorylation stimulate phosphotransferase activity and regulates stability. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major sites of in vivo phosphorylation of PRKACA.","T198: PDPK1 (PDK1); PKACa (PRKACA)","EC 2.7.11.11; Protein kinase, Ser/Thr (non-receptor); AGC group; PKA family","P17612","P17612","P17612",null,"GO:0001669; GO:0034704; GO:0005952; GO:0005813; GO:0097546; GO:0005737; GO:0005829; GO:0070062; GO:0045171; GO:0016020; GO:0005739; GO:0031514; GO:0016607; GO:0005654; GO:0031588; GO:0005634; GO:0048471; GO:0044853; GO:0097225","GO:0005524; GO:0004691; GO:0004672; GO:0034237; GO:0019901; GO:0004712; GO:0004674; GO:0031625","GO:0034199; GO:0007596; GO:0035584; GO:0086064; GO:0071872; GO:0071377; GO:0071333; GO:0034605; GO:0097711; GO:0019221; GO:0000086; GO:0034380; GO:0006397; GO:0018105; GO:0071158; GO:0010737; GO:0006468; GO:2000810; GO:1903779; GO:0055117; GO:0010881; GO:0051480; GO:0010389; GO:0002027; GO:0016241; GO:0045667; GO:0061136; GO:0043393; GO:0060314; GO:0003091; GO:0048240; GO:0002223"]
[2143,1071,"PP509","PTPN1 (PTP1B)","S50","Tyrosine-protein phosphatase non-receptor type 1",{"v":908.7893475401127,"d":"909"},{"v":2.9474319213605735,"d":"3"},{"v":918.6070978396247,"d":"919"},{"v":29.372806725566086,"d":"29"},{"v":1.080310891196774,"d":"1"},null,{"v":1306.4019158303117,"d":"1306"},{"v":0.8619673599597742,"d":"1"},{"v":43.75189579042123,"d":"44"},"Possible",{"$nulls":3},"PYP","Protein phosphatase, tyrosine (non-receptor)",{"$nulls":6},"X",null,null,"RDV(pS)PFD(bA)C","Corresponds to amino acid residues R47 to D53.","S50 phosphorylation stimulates phosphatase activity and protein interaction inhibition. This is one of the major sites of in vivo phosphorylation of PTPN1 (≥30 reports from high throughput mass spectrometry studies).  This particular human phosphosite is highly conserved in vertebrates and also found in the frog.","Akt3 (PKBg); CLK1; CLK2","Phosphatase; EC 3.1.3.48; Protein phosphatase, tyrosine (non-receptor)","P18031","P18031",null,null,"GO:0098554; GO:0005829; GO:0005769; GO:0005783; GO:0097443","GO:0045296; GO:0019899; GO:0046875; GO:0005158; GO:0019901; GO:0051721; GO:0004725; GO:0030971; GO:0003723; GO:0008270","GO:0031532; GO:0007257; GO:0034620; GO:0030968; GO:0008286; GO:0036498; GO:0060397; GO:1902236; GO:0070373; GO:0046627; GO:0043407; GO:1903898; GO:0009968; GO:0030948; GO:0035335; GO:1990264; GO:0035791; GO:1903896; GO:0061098; GO:2000646; GO:0006470; GO:0030100; GO:1902202; GO:0033157; GO:0009966; GO:0060338"]
[2221,1107,"PK791","Raf1 (RafC)","S296","Raf1 proto-oncogene-encoded protein-serine kinase",{"v":5951.043617161946,"d":"5951"},{"v":7.636874716728205,"d":"8"},{"v":8661.529910443547,"d":"8662"},{"v":10.487157967653797,"d":"10"},{"v":45.54640274295676,"d":"46"},"Possible",{"v":6212.740055599195,"d":"6213"},{"v":1.54476469025879,"d":"2"},{"v":4.39748815959868,"d":"4"},null,null,"RAF1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RAF",{"$nulls":6},"LSS(pS)PNN(bA)C","Corresponds to amino acid residues L293 to N299; In the region between the C1_1 and kinase catalytic domains. ","S296 phosphorylation inhibits phosphotransferase activity and inhibits interaction with H-Ras-1. This is a major in vivo phosphorylation site in Raf1.","ERK1 (MAPK3)","Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; TKL group; RAF family","P04049","P04049","P04049","P04049","GO:0005737; GO:0005829; GO:0005794; GO:0005741; GO:0016607; GO:0005886; GO:0031143","GO:0010856; GO:0008179; GO:0005524; GO:0019899; GO:0042802; GO:0016301; GO:0004709; GO:0046872; GO:0031434; GO:0046982; GO:0004672; GO:0004674","GO:0007190; GO:0000186; GO:0006915; GO:0030154; GO:0008283; GO:0071550; GO:0060324; GO:0007507; GO:0035773; GO:0045104; GO:0034220; GO:0000165; GO:0007275; GO:0043066; GO:0008285; GO:0043154; GO:1902042; GO:0031333; GO:0009968; GO:0048011; GO:0030168; GO:0070374; GO:0033138; GO:0045944; GO:0006468; GO:0042981; GO:0045595; GO:2000145; GO:0035023; GO:0001666; GO:0035994; GO:0007165; GO:0035019; GO:0002223; GO:0048538; GO:0030878; GO:0042060"]
[2225,1109,"PK212","Raf1 (RafC)","S621","Raf1 proto-oncogene-encoded protein-serine kinase",{"v":750.1760898407547,"d":"750"},{"v":0.5789025562828424,"d":"1"},{"v":707.8510183542999,"d":"708"},{"v":9.897786148184158,"d":"10"},{"v":-5.642018195413229,"d":"-6"},null,{"v":1136.9413641752503,"d":"1137"},{"v":18.857694894748487,"d":"19"},{"v":51.55659845365068,"d":"52"},"Possible",null,"RAF1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RAF",{"$nulls":6},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S621 phosphosite.","Phosphorylation of S621 stimulates phosphotransferase activity, but has also been reported to be inhibitory; Phosphorylation regulates protein interactions and cell growth. This is one of the major sites of in vivo phosphorylation of Raf-1.","PKACa (PRKACA); Raf1","Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; TKL group; RAF family","P04049","P04049","P04049","P04049","GO:0005737; GO:0005829; GO:0005794; GO:0005741; GO:0016607; GO:0005886; GO:0031143","GO:0010856; GO:0008179; GO:0005524; GO:0019899; GO:0042802; GO:0016301; GO:0004709; GO:0046872; GO:0031434; GO:0046982; GO:0004672; GO:0004674","GO:0007190; GO:0000186; GO:0006915; GO:0030154; GO:0008283; GO:0071550; GO:0060324; GO:0007507; GO:0035773; GO:0045104; GO:0034220; GO:0000165; GO:0007275; GO:0043066; GO:0008285; GO:0043154; GO:1902042; GO:0031333; GO:0009968; GO:0048011; GO:0030168; GO:0070374; GO:0033138; GO:0045944; GO:0006468; GO:0042981; GO:0045595; GO:2000145; GO:0035023; GO:0001666; GO:0035994; GO:0007165; GO:0035019; GO:0002223; GO:0048538; GO:0030878; GO:0042060"]
[2253,1123,"NN170","RelB","Pan-specific","Transcription factor RelB",{"v":437.21944140644405,"d":"437"},{"v":67.79966522454671,"d":"68"},{"v":846.2496770964412,"d":"846"},{"v":8.710787005876025,"d":"9"},{"v":93.55261842296673,"d":"94"},"Possible",{"v":859.7260331119389,"d":"860"},{"v":1.3176681760698425,"d":"1"},{"v":96.6349049681732,"d":"97"},"Possible",{"$nulls":4},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"LLSPG","Corresponds to amino acid residues  L550 to G554; Surrounds the S552 phosphosite.",null,null,"Transcription protein","Q01201","Q01201",null,"Q01201","GO:0005829; GO:0033256; GO:0005815; GO:0005654; GO:0005634; GO:0032991","GO:0003682; GO:0003700; GO:0042802; GO:0019901; GO:0000980; GO:0000977; GO:0000981; GO:0003714","GO:0019882; GO:0071470; GO:0032922; GO:0007249; GO:0006954; GO:0045087; GO:0030098; GO:0043011; GO:0032688; GO:0000122; GO:0038061; GO:0045944; GO:0034097; GO:0002223; GO:0045063; GO:0006351"]
[2427,1211,"PK107","Src","Y419","Src oncogene-encoded protein-tyrosine kinase",{"v":1184.3556671120464,"d":"1184"},{"v":6.241932755904094,"d":"6"},{"v":133.8969589245765,"d":"134"},{"v":11.910431985593954,"d":"12"},{"v":-88.69453132680378,"d":"-89"},"Possible",{"v":1161.0710713013066,"d":"1161"},{"v":5.127052773500521,"d":"5"},{"v":-1.9660137961358686,"d":"-2"},null,null,"SRC","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues that encompass the Y418 phosphosite.","Y419 phosphorylation stimulates phosphotransferase activity and induces interaction with Cbl-c and SHPS1. This is one of the major sites of in vivo phosphorylation of Src.","EphB2; FAK (PTK2); Met; PDGFRA; PDGFRB; PKACa (PRKACA); PYK2 (PTK2B; FAK2); Src","Protein-tyrosine kinase, TK group, Src family","P12931","P12931","P12931","P12931","GO:0005884; GO:0005901; GO:0005737; GO:0005829; GO:0070062; GO:0031234; GO:0098978; GO:0005770; GO:0005764; GO:0005743; GO:0005739; GO:0043005; GO:0005634; GO:0048471; GO:0005886; GO:0002102; GO:0014069; GO:0099091; GO:0032587","GO:0005524; GO:0045296; GO:0071253; GO:0019899; GO:0046875; GO:0030331; GO:0070851; GO:0020037; GO:0051427; GO:0005158; GO:0005178; GO:0044325; GO:0016301; GO:0019900; GO:0004715; GO:0046934; GO:0051219; GO:0008022; GO:0004672; GO:0005080; GO:0004713; GO:0097110; GO:0042169; GO:0005070; GO:0005102; GO:0031625","GO:0032148; GO:0034332; GO:0086098; GO:0007411; GO:0045453; GO:0060444; GO:0098609; GO:0007049; GO:0008283; GO:0071398; GO:0071498; GO:0071456; GO:0032869; GO:0071222; GO:0071375; GO:0036120; GO:0071393; GO:0034614; GO:0007417; GO:0035635; GO:0048013; GO:0007173; GO:0038096; GO:0030900; GO:0045087; GO:0007229; GO:0030520; GO:0035556; GO:0050900; GO:0016236; GO:2000811; GO:0043066; GO:0043154; GO:2001237; GO:0051895; GO:2001243; GO:0051902; GO:0032463; GO:0051974; GO:0032211; GO:0045892; GO:0048011; GO:0048477; GO:0036035; GO:0018105; GO:0038083; GO:0018108; GO:0030168; GO:0048008; GO:0043065; GO:0090263; GO:0045737; GO:0050715; GO:2000573; GO:0010634; GO:0070374; GO:0010907; GO:0046628; GO:0033625; GO:2000394; GO:0043406; GO:1903997; GO:2000386; GO:0050731; GO:0043552; GO:0014068; GO:0010641; GO:0071803; GO:0031954; GO:0051897; GO:1900182; GO:0010954; GO:0071902; GO:0051057; GO:0014911; GO:0045893; GO:0001545; GO:0050847; GO:0046777; GO:0031648; GO:0045124; GO:2001286; GO:0022407; GO:0051726; GO:0060491; GO:0042127; GO:2000641; GO:0010632; GO:0033146; GO:0071801; GO:0098962; GO:0043393; GO:0043114; GO:0010447; GO:0051602; GO:0042542; GO:0070555; GO:0009612; GO:0051385; GO:0031667; GO:0009615; GO:0007172; GO:0007165; GO:0002223; GO:0043149; GO:0034446; GO:0031295; GO:0045056; GO:0007179; GO:0060065; GO:0048010; GO:0016032"]
[2487,1241,"PK822","Syk","Y352","Spleen protein-tyrosine kinase",{"v":1129.513355249475,"d":"1130"},{"v":29.434001596114555,"d":"29"},{"v":996.2970192011693,"d":"996"},{"v":76.06152011504332,"d":"76"},{"v":-11.794135538918198,"d":"-12"},null,{"v":1954.8569996978445,"d":"1955"},{"v":0.9794080143248576,"d":"1"},{"v":73.07072914300127,"d":"73"},"Possible",null,"SYK","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Syk",{"$nulls":6},"ESP(pY)ADP(bA)C","Corresponds to amino acid residues E349 to P355; In the region between the SH2 and kinase catalytic domains. ","Y352 phosphorylation stimulates phosphotransferase activity and regulates molecular association, including inducing interaction with ITGAM, PLCG1, and CLTC. This is one of the major sites of in vivo phosphorylation of Syk.","Lck; Lyn; Syk","EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; Syk family","P43405","P43405","P43405","P43405","GO:0019815; GO:0005737; GO:0005829; GO:0032009; GO:0031234; GO:0005634; GO:0005886; GO:0032991; GO:0042101","GO:0005524; GO:0005178; GO:0004715; GO:0019902; GO:0001784; GO:0004672; GO:0019901; GO:0004674; GO:0004713; GO:0042169; GO:0035325","GO:0007257; GO:0002250; GO:0001525; GO:0009887; GO:0050853; GO:0043366; GO:0048514; GO:0008283; GO:0071404; GO:0071226; GO:0038063; GO:0042742; GO:0038095; GO:0038096; GO:0006954; GO:0045087; GO:0007229; GO:0038110; GO:0038156; GO:0002366; GO:0007159; GO:0019370; GO:0001945; GO:0002281; GO:0002283; GO:0030593; GO:0018105; GO:0038083; GO:0030168; GO:0046638; GO:0046641; GO:0045579; GO:0045780; GO:0050850; GO:0033630; GO:0120162; GO:0050715; GO:0045588; GO:0045425; GO:0045401; GO:0032753; GO:0043306; GO:1900086; GO:0002092; GO:0032481; GO:0006606; GO:0006468; GO:0031623; GO:0090237; GO:0051090; GO:0070372; GO:0043313; GO:0050764; GO:0010543; GO:0090330; GO:0032928; GO:0010803; GO:0002554; GO:0002223; GO:0007169; GO:0016032"]
[2489,1242,"PK823","Syk","Y525+Y526","Spleen protein-tyrosine kinase",{"v":474.17487641133556,"d":"474"},{"v":7.731188971855264,"d":"8"},{"v":491.2050766197957,"d":"491"},{"v":0.6487963121051723,"d":"1"},{"v":3.5915441866824835,"d":"4"},null,{"v":728.1101486776607,"d":"728"},{"v":1.952601824308138,"d":"2"},{"v":53.55308450505976,"d":"54"},"Possible",null,"SYK","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Syk",{"$nulls":6},"DEN(pY)(pY)KAQ(bA)C","Corresponds to amino acid residues D522 to Q529; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y525 and Y526 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of Syk(≥XXX reports from high throughput mass spectrometry studies).","Y525: Syk. Y526: Syk.","EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; Syk family","P43405","P43405","P43405","P43405","GO:0019815; GO:0005737; GO:0005829; GO:0032009; GO:0031234; GO:0005634; GO:0005886; GO:0032991; GO:0042101","GO:0005524; GO:0005178; GO:0004715; GO:0019902; GO:0001784; GO:0004672; GO:0019901; GO:0004674; GO:0004713; GO:0042169; GO:0035325","GO:0007257; GO:0002250; GO:0001525; GO:0009887; GO:0050853; GO:0043366; GO:0048514; GO:0008283; GO:0071404; GO:0071226; GO:0038063; GO:0042742; GO:0038095; GO:0038096; GO:0006954; GO:0045087; GO:0007229; GO:0038110; GO:0038156; GO:0002366; GO:0007159; GO:0019370; GO:0001945; GO:0002281; GO:0002283; GO:0030593; GO:0018105; GO:0038083; GO:0030168; GO:0046638; GO:0046641; GO:0045579; GO:0045780; GO:0050850; GO:0033630; GO:0120162; GO:0050715; GO:0045588; GO:0045425; GO:0045401; GO:0032753; GO:0043306; GO:1900086; GO:0002092; GO:0032481; GO:0006606; GO:0006468; GO:0031623; GO:0090237; GO:0051090; GO:0070372; GO:0043313; GO:0050764; GO:0010543; GO:0090330; GO:0032928; GO:0010803; GO:0002554; GO:0002223; GO:0007169; GO:0016032"]
[2503,1249,"NK087-2","TAO3 (JIK, TAOK3)","Pan-specific","Serine/threonine-protein kinase TAO3",{"v":622.5553891447621,"d":"623"},{"v":0.8662175168431134,"d":"1"},{"v":695.2431138778599,"d":"695"},{"v":2.1539776082831774,"d":"2"},{"v":11.67570404184481,"d":"12"},null,{"v":911.3566603456093,"d":"911"},{"v":5.5752353598212885,"d":"6"},{"v":46.38965082248973,"d":"46"},"Possible",null,"TAO3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","TAO",{"$nulls":5},"CSEHGTSLNREMDSLGSNHS","Corresponds to amino acid residues S331 to S349; After catalytic domain.",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; STE domain target; STE</A> group; STE20 family; TAO subfamily","Q9H2K8","Q9H2K8","Q9H2K8","Q9H2K8","GO:0005737; GO:0005886","GO:0005524; GO:0004709; GO:0004860; GO:0004674; GO:0016740","GO:0006974; GO:0006281; GO:0000165; GO:0007095; GO:0046329; GO:0007399; GO:0046330; GO:0043507; GO:0032874; GO:0046777; GO:0006468; GO:0042981"]
[2553,1274,"PK833","TRIM28 (TIF1B)","S473","Transcription intermediary factor 1-beta",{"v":1107.4998188996528,"d":"1107"},{"v":0.21307888678576992,"d":"0"},{"v":860.9996673389726,"d":"861"},{"v":2.560148056755085,"d":"3"},{"v":-22.257353667613998,"d":"-22"},null,{"v":1703.708048227031,"d":"1704"},{"v":10.624549057294393,"d":"11"},{"v":53.83370896798303,"d":"54"},"Possible",null,"TIF1b","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","TIF1",null,"X",{"$nulls":4},"RSR(pS)GEG(bA)C","Corresponds to amino acid residues R470 to G476; In the mid-region of the protein kinase between the zf-B_box and PHD domains.","S473 phosphorylation stimulates transcription and induces DNA repair and inhibits interaction with HP1-alpha. This is one of the major sites of in vivo phosphorylation of TRIM28.","Chk1 (CHEK1)","Protein kinase, atypical; Nuclear receptor co-regulator; Transcription, coactivator/corepressor; ATYPICAL domain target; ATYPICAL</A> group; TIF1 family","Q13263","Q13263","Q13263",null,"GO:0005719; GO:0005720; GO:0005654; GO:0005634; GO:0090575","GO:0003682; GO:0070087; GO:0003677; GO:0003700; GO:0035851; GO:1990841; GO:0004672; GO:0003723; GO:0043565; GO:0019789; GO:0003713; GO:0003714; GO:0031625; GO:0004842; GO:0008270","GO:0006325; GO:0060028; GO:0043045; GO:0006281; GO:0007566; GO:0060669; GO:0001837; GO:0045087; GO:1901536; GO:0045869; GO:0045892; GO:0000122; GO:1902187; GO:0043388; GO:0045739; GO:0090309; GO:0042307; GO:0045893; GO:0046777; GO:0051259; GO:0016925; GO:0007265; GO:2000653; GO:0006367; GO:0016032"]
[2673,1335,"PN681","YAP1","S109","Yorkie homologue",{"v":8013.124031787884,"d":"8013"},{"v":9.972668488767399,"d":"10"},{"v":12041.810264333937,"d":"12042"},{"v":9.496485926730717,"d":"9"},{"v":50.276099765389205,"d":"50"},"Possible",{"v":8213.284219502071,"d":"8213"},{"v":1.6829114251005366,"d":"2"},{"v":2.4979045241301208,"d":"2"},{"$nulls":5},"Transcription,  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"SRQA(pS)TDAGC","Corresponds to amino acid residues S105 to G113.","S109 phosphorylation promotes nuclear export. This is one of the major sites of in vivo phosphorylation of YAP1.","LATS1; LATS2 (KPM)","Transcription, coactivator/corepressor","P46937","P46937",null,"P46937","GO:0005737; GO:0005829; GO:0016020; GO:0005654; GO:0005634; GO:0071148; GO:0071149","GO:0033613; GO:0003682; GO:0070064; GO:0008022; GO:0046982; GO:0000978; GO:0003713; GO:0003714; GO:0001076; GO:0044212","GO:0060449; GO:0061026; GO:0000902; GO:0008283; GO:0006974; GO:0071480; GO:0071300; GO:0060242; GO:0003143; GO:0003015; GO:0035329; GO:0030216; GO:0048368; GO:0060487; GO:0030857; GO:2001237; GO:2000737; GO:0030903; GO:0048339; GO:0090263; GO:0060045; GO:0033148; GO:1902459; GO:0045893; GO:0045944; GO:0050847; GO:0065003; GO:1902036; GO:0010837; GO:0072307; GO:0050767; GO:0072091; GO:0032570; GO:0035019; GO:0001894; GO:0006367; GO:0001570"]

{"sheet":"Normalized Full Values","index":1,"n_rows":2724,"n_cols":65,"rows_kept":1125,"cut":true,"merged":[[0,12,5,26],[7,12,8,26],[13,2,13,3],[14,2,14,3],[15,6,15,11],[15,15,15,20],[15,24,15,26],[15,27,15,32],[15,36,15,38]],"bounds":{"rows_first":500,"rows_last":125,"rows_between":500,"halvings":2}}
[{"$nulls":12},"Globally Normalized Values for the signal intensity of samples analyzed with the KAM-1325 antibody microarray data were colourized using the Conditional Formatting feature under Format in the pull down menu of MS-Excel. This feature lets users colourize cells in the spreadsheet according to their desired criteria. In the case of your data, the Globally Normalized intensity signals with a value of 0 was set to blue, the approximate median value of 5000 to white, and 25,000 to red. A colour gradient based on these settings were then generated. In selecting antibody changes to follow up on, it is best to focus on cells that are white to red coloured. These have the best chance of showing up on Western blots to validate the data. "]
[]
[]
[]
[]
[]
[]
[{"$nulls":12},"The Conditional Formatting feature for %CFC (change from control) is set to blue for -100%, white for 0 changes, and orange for +200%. In this case, it is best to focus on orange coloured cells for follow up immunoblotting studies. "]
["Normalized Full Values for Order 4047"]
[]
["KAM-1325 ARRAY DETAILS ",{"$nulls":11},"Lead Selection Recommendation for Follow Up Immunoblotting"]
["Sample IDs:",null,"Control ID:  Hec50 CT (Kinexus ID: 20589) vs Treated ID: Hec50 bev (Kineuxs ID: 20590) vs Hec50 cediranib (Kinexus ID: 20591)",{"$nulls":9},"Priority"," lead selection criteria: %CFC ≥75%; Sum of %Error <75% of %CFC; Average Normalized Net Signal ≥1500"]
["Array Barcode:",null,"K01803-1273, -1279",null,"Protocol: Chemical cleavage pre-homogenization: Biotin-labelling",{"$nulls":7},"Possible"," lead selection criteria: %CFC ≥45% + <75%; Sum of %Errors <80% of %CFC; Average Normalized Net Signal ≥750"]
["Date of Report:",null,"2020-02-21",null,"Reviewed by:  Dr. Steven Pelech"]
[{"$nulls":12},"Globally Normalized Median",{"$nulls":8},"Globally Normalized Median",{"$nulls":11},"Globally Normalized Median"]
[{"$nulls":6},"Sample ID: Hec50 CT (#20589)",{"$nulls":5},{"$f":"MEDIAN(M18:M2716)","v":{"v":4192.274432355355,"d":"4192"}},null,null,"Sample ID: Hec50 Bev (#20590)",{"$nulls":5},{"$f":"MEDIAN(V18:V2716)","v":{"v":4042.847923759638,"d":"4043"}},null,null,"Changes",null,null,"Sample ID: Hec50 Cediranib (#20591)",{"$nulls":5},{"$f":"MEDIAN(AH18:AH2716)","v":{"v":4254.789426937179,"d":"4255"}},null,null,"Changes"]
["Final Sort","Ab Spot ID #","Antibody Codes","Target Name ","P-Site","Full Target Protein Name","Flag","Signal Median","Background Median","Spot Area","Not Normalized Net Signal","Normalized Net Signal","Average Normalized Net Signal","Error in Duplicate from Average","% Error in Duplicate from Average","Flag","Signal Median","Background Median","Spot Area","Not Normalized Net Signal","Normalized Net Signal","Average Normalized Net Signal","Error in Duplicate from Average","% Error in Duplicate from Average","SUM % Error ","%CFC","Lead","Flag","Signal Median","Background Median","Spot Area","Not Normalized Net Signal","Normalized Net Signal","Average Normalized Net Signal","Error in Duplicate from Average","% Error in Duplicate from Average","SUM % Error ","%CFC","Lead",null,"Preferred Protein Kinase Name ","Protein Kinase","Kinase or Phosphatase Type","Protein Type","Kinase Type","Kinase Group","Kinase Family","Kinase Subfamily","Transcription Factor","Stress Protein","Protein Phosphatase","Adapter","Metabolic Enzyme","Antigen Sequence","Sequence Location in Target","Effect of Phosphorylation","Kinases Known to Target Phosphosite(s) in vitro","Protein Type - Extended","UniProt Link","PhosphoNET Link","KinaseNET Link","OncoNET Link","GO_CelComponent_list","GO_MolFunctin_list","GO_BioProcess_list"]
[5,2,"NN166-2","4E-BP1 (PHAS1)","Pan-specific","Eukaryotic translation initiation factor 4E binding protein 1 (PHAS1)",0,598,58,391,{"v":211.14,"d":"211"},{"v":371.0039962405343,"d":"371"},{"v":467.75689736298585,"d":"468"},{"v":96.75290112245153,"d":"97"},{"v":20.684441355734823,"d":"21"},0,310,52,414,{"v":106.812,"d":"107"},{"v":186.62354392149572,"d":"187"},{"v":209.92091064666914,"d":"210"},{"v":23.29736672517342,"d":"23"},{"v":11.098163900587615,"d":"11"},{"v":31.782605256322437,"d":"32"},{"v":-55.121792574280825,"d":"-55"},null,0,602,50,378,{"v":208.656,"d":"209"},{"v":356.97732346103015,"d":"357"},{"v":389.21641882996107,"d":"389"},{"v":32.23909536893092,"d":"32"},{"v":8.283076923076921,"d":"8"},{"v":28.967518278811745,"d":"29"},{"v":-16.790875554332302,"d":"-17"},{"$nulls":15},"Not precisely defined.","Antibody raised against full length human 4E-BP1 protein.",null,null,"Protein synthesis protein, inhibitor","Q13541","Q13541",null,"Q13541","GO:0005829","GO:0008190; GO:0030371","GO:0071549; GO:0000082; GO:0008286; GO:0002192; GO:0045947; GO:0045931; GO:0031929"]
[6,2,"NN166-2","4E-BP1 (PHAS1)","Pan-specific","Eukaryotic translation initiation factor 4E binding protein 1 (PHAS1)",0,715,30,469,{"v":321.265,"d":"321"},{"v":564.5097984854374,"d":"565"},{"$nulls":3},0,516,46,284,{"v":133.48,"d":"133"},{"v":233.21827737184256,"d":"233"},{"$nulls":6},0,708,44,371,{"v":246.344,"d":"246"},{"v":421.455514198892,"d":"421"},{"$nulls":20},"Not precisely defined.","Antibody raised against full length human 4E-BP1 protein.",{"$nulls":3},"Q13541","Q13541",null,"Q13541"]
[7,3,"PN550","4E-BP1 (PHAS1)","T37+T46","4E transcription factor binding protein 1",0,6899,20,586,{"v":4031.094,"d":"4031"},{"v":7083.224321404,"d":"7083"},{"v":6982.207703331289,"d":"6982"},{"v":101.01661807271103,"d":"101"},{"v":1.4467718859826366,"d":"1"},0,7145,18,524,{"v":3734.548,"d":"3735"},{"v":6525.058820216212,"d":"6525"},{"v":6015.818988883859,"d":"6016"},{"v":509.2398313323529,"d":"509"},{"v":8.465012532347394,"d":"8"},{"v":9.911784418330031,"d":"10"},{"v":-13.840732838502575,"d":"-14"},null,0,7224,18,600,{"v":4323.6,"d":"4324"},{"v":7396.993883310856,"d":"7397"},{"v":6393.318510101582,"d":"6393"},{"v":1003.6753732092739,"d":"1004"},{"v":15.698817001271639,"d":"16"},{"v":17.145588887254277,"d":"17"},{"v":-8.434140292743521,"d":"-8"},{"$nulls":15},"DYST(pT)PGG(bA)C     ","Corresponds to amino acid residues D33 to G40; In the N-terminal portion of the translation regulatory protein. ","T37 phosphorylation reduces the rate of ubiquitination by the BCR(KLH25) complex and inhibits interaction with 4E-BP1 and EIF4E. This is one of the major in vivo phosphorylation sites in 4E-BP1 (≥129 reports based on mass spectrometry studies). The effect of T46 phosphorylation - Partly reduces eIF4E and 4E-BP1 binding and reduces the rate of ubiquitination by the BCR(KLH25) complex. This is also one of the major in vivo phosphorylation sites in 4E-BP1 (≥124 reports based on mass spectrometry studies).","ERK1 (MAPK3); ERK2 (MAPK1); FRAP1 (mTOR); GSK3b","Protein synthesis protein, inhibitor","Q13541","Q13541",null,"Q13541","GO:0005829","GO:0008190; GO:0030371","GO:0071549; GO:0000082; GO:0008286; GO:0002192; GO:0045947; GO:0045931; GO:0031929"]
[8,3,"PN550","4E-BP1 (PHAS1)","T37+T46","4E transcription factor binding protein 1",0,6534,18,601,{"v":3916.116,"d":"3916"},{"v":6881.191085258579,"d":"6881"},{"$nulls":3},0,6112,16,517,{"v":3151.632,"d":"3152"},{"v":5506.579157551506,"d":"5507"},{"$nulls":6},0,6312,24,501,{"v":3150.288,"d":"3150"},{"v":5389.6431368923095,"d":"5390"},{"$nulls":20},"DYST(pT)PGG(bA)C     ","Corresponds to amino acid residues D33 to G40; In the N-terminal portion of the translation regulatory protein. ","T37 phosphorylation reduces the rate of ubiquitination by the BCR(KLH25) complex and inhibits interaction with 4E-BP1 and EIF4E. This is one of the major in vivo phosphorylation sites in 4E-BP1 (≥129 reports based on mass spectrometry studies). The effect of T46 phosphorylation - Partly reduces eIF4E and 4E-BP1 binding and reduces the rate of ubiquitination by the BCR(KLH25) complex. This is also one of the major in vivo phosphorylation sites in 4E-BP1 (≥124 reports based on mass spectrometry studies).","ERK1 (MAPK3); ERK2 (MAPK1); FRAP1 (mTOR); GSK3b",null,"Q13541","Q13541",null,"Q13541"]
[9,4,"PK501","A6 (Twinfilin-1)","Y309","Twinfilin, actin-binding protein, 1; Protein tyrosine kinase 9;",0,8468,18,677,{"v":5720.65,"d":"5721"},{"v":10052.022407376207,"d":"10052"},{"v":10171.114795598234,"d":"10171"},{"v":119.09238822202678,"d":"119"},{"v":1.1708882518322037,"d":"1"},0,6864,14,545,{"v":3733.25,"d":"3733"},{"v":6522.790934959779,"d":"6523"},{"v":6739.894647061915,"d":"6740"},{"v":217.10371210213543,"d":"217"},{"v":3.2211736751222997,"d":"3"},{"v":4.392061926954503,"d":"4"},{"v":-33.73494663555712,"d":"-34"},null,0,8778,16,722,{"v":6326.164,"d":"6326"},{"v":10823.06328356493,"d":"10823"},{"v":9066.922223486948,"d":"9067"},{"v":1756.1410600779818,"d":"1756"},{"v":19.36865693552411,"d":"19"},{"v":20.539545187356314,"d":"21"},{"v":-10.856160748368978,"d":"-11"},null,null,"A6","X","PSTK","Protein kinase, dual-specificity","Protein-serine/threonine kinase","ATYPICAL","A6 family",{"$nulls":6},"DFL(pY)EEV(bA)C","Corresponds to amino acid residues D306 to V312; In the end of the Cofilin_ADF domain. ","The effect of Y309 phosphorylation is unclear. The major site of phosphorylation of A6 (≥142 reports based on mass spectrometry studies).",null,"Protein kinase, dual-specificity; ATYPICAL domain target; ATYPICAL</A> group; A6 family","Q12792","Q12792","Q12792",null,"GO:0015629; GO:0005911; GO:0005829; GO:0030175; GO:0005925; GO:0030016; GO:0048471; GO:0032587","GO:0003779; GO:0003785; GO:0005524; GO:0045296; GO:0005546; GO:0044877","GO:0051016; GO:0030837; GO:0018108; GO:0010613; GO:0043538; GO:0042989"]
[10,4,"PK501","A6 (Twinfilin-1)","Y309","Twinfilin, actin-binding protein, 1; Protein tyrosine kinase 9;",0,7966,20,737,{"v":5856.202,"d":"5856"},{"v":10290.20718382026,"d":"10290"},{"$nulls":3},0,6127,20,652,{"v":3981.764,"d":"3982"},{"v":6956.99835916405,"d":"6957"},{"$nulls":6},0,6572,18,652,{"v":4273.208,"d":"4273"},{"v":7310.781163408968,"d":"7311"},{"$nulls":7},"A6","X","PSTK","Protein kinase, dual-specificity","Protein-serine/threonine kinase","ATYPICAL","A6 family",{"$nulls":6},"DFL(pY)EEV(bA)C","Corresponds to amino acid residues D306 to V312; In the end of the Cofilin_ADF domain. ","The effect of Y309 phosphorylation is unclear. The major site of phosphorylation of A6 (≥142 reports based on mass spectrometry studies).",null,null,"Q12792","Q12792","Q12792"]
[11,5,"PK502","A6r (Twinfin-2)","Y309","Twinfilin, actin-binding protein, 2; Protein tyrosine kinase 9-like",0,5234,14,681,{"v":3554.82,"d":"3555"},{"v":6246.340939261989,"d":"6246"},{"v":5687.381967830278,"d":"5687"},{"v":558.9589714317108,"d":"559"},{"v":9.82805400786106,"d":"10"},0,5488,12,514,{"v":2814.664,"d":"2815"},{"v":4917.823565032514,"d":"4918"},{"v":4692.6075330185,"d":"4693"},{"v":225.21603201401376,"d":"225"},{"v":4.799379245533123,"d":"5"},{"v":14.627433253394182,"d":"15"},{"v":-17.490902500281365,"d":"-17"},null,0,5108,14,633,{"v":3224.502,"d":"3225"},{"v":5516.611520659548,"d":"5517"},{"v":4956.895214023144,"d":"4957"},{"v":559.7163066364037,"d":"560"},{"v":11.291671146344921,"d":"11"},{"v":21.11972515420598,"d":"21"},{"v":-12.843989694010531,"d":"-13"},null,null,"A6r","X","PSTK","Protein kinase, dual-specificity","Protein-serine/threonine kinase","ATYPICAL","A6 family",{"$nulls":6},"EFL(pY)DEV(bA)C","Corresponds to amino acid residues E306 to V312; In the end of the Cofilin_ADF domain. ","The effect of Y309 phosphorylation is unclear. This is the major site of phosphorylation of A6r (≥517 reports based on mass spectrometry studies). A similar phosphosite is also the major phosphorylation site in A6.",null,"Protein kinase, atypical; ATYPICAL domain target; ATYPICAL</A> group; A6 family","Q6IBS0","Q6IBS0","Q6IBS0",null,"GO:0005737; GO:0005856; GO:0070062; GO:0030175; GO:0030426; GO:0030027; GO:0030016; GO:0048471; GO:0032420","GO:0003785; GO:0005524; GO:0045296; GO:0005546; GO:0005080; GO:0003723","GO:0051016; GO:0030030; GO:0071363; GO:0071300; GO:0030837; GO:0045773; GO:0010592; GO:0010976; GO:0032956; GO:0032532; GO:0042989"]
[12,5,"PK502","A6r (Twinfin-2)","Y309","Twinfilin, actin-binding protein, 2; Protein tyrosine kinase 9-like",0,4550,18,644,{"v":2918.608,"d":"2919"},{"v":5128.422996398567,"d":"5128"},{"$nulls":3},0,4459,20,576,{"v":2556.864,"d":"2557"},{"v":4467.391501004487,"d":"4467"},{"$nulls":6},0,4567,18,565,{"v":2570.185,"d":"2570"},{"v":4397.17890738674,"d":"4397"},{"$nulls":7},"A6r","X","PSTK","Protein kinase, dual-specificity","Protein-serine/threonine kinase","ATYPICAL","A6 family",{"$nulls":6},"EFL(pY)DEV(bA)C","Corresponds to amino acid residues E306 to V312; In the end of the Cofilin_ADF domain. ","The effect of Y309 phosphorylation is unclear. This is the major site of phosphorylation of A6r (≥517 reports based on mass spectrometry studies). A similar phosphosite is also the major phosphorylation site in A6.",null,null,"Q6IBS0","Q6IBS0","Q6IBS0"]
[13,6,"PK503","AAK1","S637","AP2-associated protein kinase 1",0,7593,12,704,{"v":5337.024,"d":"5337"},{"v":9377.935171126464,"d":"9378"},{"v":8966.073995191959,"d":"8966"},{"v":411.8611759345058,"d":"412"},{"v":4.593550936065949,"d":"5"},0,399,8,917,{"v":358.547,"d":"359"},{"v":626.4587481034016,"d":"626"},{"v":3331.9698551689976,"d":"3332"},{"v":2705.5111070655958,"d":"2706"},{"v":81.19854694568875,"d":"81"},{"v":85.7920978817547,"d":"86"},{"v":-62.838028584687564,"d":"-63"},null,0,7442,12,677,{"v":5030.11,"d":"5030"},{"v":8605.720441849562,"d":"8606"},{"v":5039.880431621195,"d":"5040"},{"v":3565.8400102283667,"d":"3566"},{"v":70.75247237723318,"d":"71"},{"v":75.34602331329913,"d":"75"},{"v":-43.78943967756877,"d":"-44"},null,null,"AAK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","NAK",{"$nulls":6},"RIL(pS)DVT(bA)C","Corresponds to amino acid residues R634 to T640; In the C-terminal half of the kinase after the catalytic domain. ","The effect of S637 phosphorylation is unclear. This is major site of phosphorylation of AAK1 (≥259 reports based on mass spectrometry studies). ",null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; EC 2.7.11.-; Other group; NAK family","Q2M2I8","Q2M2I8","Q2M2I8",null,"GO:0031252; GO:0005905; GO:0030136; GO:0005737; GO:0005829; GO:0019897; GO:0043195","GO:0035612; GO:0005524; GO:0005112; GO:0004674","GO:0006897; GO:0061024; GO:0045747; GO:0046777; GO:0006468; GO:0050821; GO:2000369; GO:0032880"]
[14,6,"PK503","AAK1","S637","AP2-associated protein kinase 1",0,7866,14,620,{"v":4868.24,"d":"4868"},{"v":8554.212819257453,"d":"8554"},{"$nulls":3},0,6370,18,544,{"v":3455.488,"d":"3455"},{"v":6037.480962234594,"d":"6037"},{"$nulls":6},0,1062,10,819,{"v":861.588,"d":"862"},{"v":1474.0404213928284,"d":"1474"},{"$nulls":7},"AAK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","NAK",{"$nulls":6},"RIL(pS)DVT(bA)C","Corresponds to amino acid residues R634 to T640; In the C-terminal half of the kinase after the catalytic domain. ","The effect of S637 phosphorylation is unclear. This is major site of phosphorylation of AAK1 (≥259 reports based on mass spectrometry studies). ",null,null,"Q2M2I8","Q2M2I8","Q2M2I8"]
[15,7,"NK001-2","Abl (Abl1)","Pan-specific","Abelson murine leukemia viral oncogene homologue 1",0,6012,12,654,3924,{"v":6895.044431409759,"d":"6895"},{"v":6926.251360334794,"d":"6926"},{"v":31.206928925034845,"d":"31"},{"v":0.45056015586945714,"d":"0"},0,5519,12,562,{"v":3094.934,"d":"3095"},{"v":5407.515553337926,"d":"5408"},{"v":5498.5664289028155,"d":"5499"},{"v":91.0508755648898,"d":"91"},{"v":1.655902074516868,"d":"2"},{"v":2.106462230386325,"d":"2"},{"v":-20.612664154928524,"d":"-21"},null,0,5742,10,559,{"v":3204.188,"d":"3204"},{"v":5481.857488430485,"d":"5482"},{"v":5514.8091492431195,"d":"5515"},{"v":32.951660812634145,"d":"33"},{"v":0.5975122605495169,"d":"1"},{"v":1.048072416418974,"d":"1"},{"v":-20.378154612965844,"d":"-20"},null,null,"ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"CAATQDFSKLLSSVKE","Corresponds to amino acid residues A1109 to E1123; In the C-terminus of the kinase.",null,null,"Protein-tyrosine kinase; Cytoplasm, nucleolus, nucleus, cytoskeleton protein","P00519","P00519","P00519","P00519","GO:0015629; GO:0031252; GO:0005737; GO:0005829; GO:0030425; GO:0031234; GO:0005739; GO:0043025; GO:0016604; GO:0031965; GO:0005730; GO:0005654; GO:0005634; GO:0048471; GO:0098794; GO:0032991","GO:0051015; GO:0003785; GO:0005524; GO:0003677; GO:0046875; GO:0016301; GO:0000287; GO:0030145; GO:0051019; GO:0038191; GO:0004515; GO:0004715; GO:0001784; GO:0070064; GO:0008022; GO:0004672; GO:0005080; GO:0004713; GO:0042169; GO:0017124; GO:0005102; GO:0019905","GO:0030036; GO:0090135; GO:0050798; GO:1990051; GO:0046632; GO:0006914; GO:0001922; GO:0002322; GO:0050853; GO:0060020; GO:0072358; GO:0007050; GO:0006464; GO:0006974; GO:1903351; GO:0070301; GO:0071222; GO:0034599; GO:0021587; GO:0048668; GO:0006975; GO:0043542; GO:0007173; GO:0045184; GO:0038096; GO:0045087; GO:0007229; GO:0008630; GO:0030035; GO:0006298; GO:0051882; GO:0000278; GO:0030514; GO:0022408; GO:2000773; GO:2000352; GO:0070373; GO:0043124; GO:1900272; GO:0045930; GO:1900275; GO:0071901; GO:0051444; GO:0001843; GO:0060563; GO:0050885; GO:0038189; GO:0038083; GO:0018108; GO:0035791; GO:1905555; GO:2000251; GO:1904531; GO:0043065; GO:0090050; GO:0007204; GO:0010595; GO:0070374; GO:0051894; GO:0043123; GO:1902715; GO:1900042; GO:1904528; GO:0045931; GO:0051149; GO:1901216; GO:0033690; GO:0051353; GO:0050731; GO:0001934; GO:0051281; GO:0051496; GO:1900026; GO:2000096; GO:0009791; GO:0046777; GO:0006468; GO:0032956; GO:2000249; GO:0010506; GO:0030516; GO:0032489; GO:0030155; GO:2000145; GO:0042127; GO:0030100; GO:1903053; GO:1902036; GO:0031113; GO:1905244; GO:2001020; GO:0045580; GO:0006355; GO:0006979; GO:0042770; GO:0048536; GO:0034446; GO:0048538; GO:0002333"]
[16,7,"NK001-2","Abl (Abl1)","Pan-specific","Abelson murine leukemia viral oncogene homologue 1",0,5854,14,678,{"v":3959.52,"d":"3960"},{"v":6957.45828925983,"d":"6957"},{"$nulls":3},0,4798,16,669,{"v":3199.158,"d":"3199"},{"v":5589.617304467704,"d":"5590"},{"$nulls":6},0,5155,16,631,{"v":3242.709,"d":"3243"},{"v":5547.7608100557545,"d":"5548"},{"$nulls":7},"ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"CAATQDFSKLLSSVKE","Corresponds to amino acid residues A1109 to E1123; In the C-terminus of the kinase.",{"$nulls":3},"P00519","P00519","P00519","P00519"]
[17,8,"NK001-6","Abl (Abl1)","Pan-specific","Abelson murine leukemia viral oncogene homologue 1",0,5444,14,569,{"v":3089.67,"d":"3090"},{"v":5429.004059223698,"d":"5429"},{"v":5446.190713042153,"d":"5446"},{"v":17.186653818454943,"d":"17"},{"v":0.3155720158182775,"d":"0"},0,4590,10,481,{"v":2202.98,"d":"2203"},{"v":3849.0800171158357,"d":"3849"},{"v":3511.4079768123115,"d":"3511"},{"v":337.6720403035242,"d":"338"},{"v":9.616428581735638,"d":"10"},{"v":9.932000597553916,"d":"10"},{"v":-35.52543122657384,"d":"-36"},null,0,4756,10,463,{"v":2197.398,"d":"2197"},{"v":3759.3994738642587,"d":"3759"},{"v":3601.9079686537443,"d":"3602"},{"v":157.49150521051433,"d":"157"},{"v":4.3724466749598445,"d":"4"},{"v":4.688018690778122,"d":"5"},{"v":-33.86371946123464,"d":"-34"},null,null,"ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"CISTRVSLRKTRQPP","Corresponds to amino acid residues I1006 to P1019.",null,null,"Protein-tyrosine kinase; Cytoplasm, nucleolus, nucleus, cytoskeleton protein","P00519","P00519","P00519","P00519","GO:0015629; GO:0031252; GO:0005737; GO:0005829; GO:0030425; GO:0031234; GO:0005739; GO:0043025; GO:0016604; GO:0031965; GO:0005730; GO:0005654; GO:0005634; GO:0048471; GO:0098794; GO:0032991","GO:0051015; GO:0003785; GO:0005524; GO:0003677; GO:0046875; GO:0016301; GO:0000287; GO:0030145; GO:0051019; GO:0038191; GO:0004515; GO:0004715; GO:0001784; GO:0070064; GO:0008022; GO:0004672; GO:0005080; GO:0004713; GO:0042169; GO:0017124; GO:0005102; GO:0019905","GO:0030036; GO:0090135; GO:0050798; GO:1990051; GO:0046632; GO:0006914; GO:0001922; GO:0002322; GO:0050853; GO:0060020; GO:0072358; GO:0007050; GO:0006464; GO:0006974; GO:1903351; GO:0070301; GO:0071222; GO:0034599; GO:0021587; GO:0048668; GO:0006975; GO:0043542; GO:0007173; GO:0045184; GO:0038096; GO:0045087; GO:0007229; GO:0008630; GO:0030035; GO:0006298; GO:0051882; GO:0000278; GO:0030514; GO:0022408; GO:2000773; GO:2000352; GO:0070373; GO:0043124; GO:1900272; GO:0045930; GO:1900275; GO:0071901; GO:0051444; GO:0001843; GO:0060563; GO:0050885; GO:0038189; GO:0038083; GO:0018108; GO:0035791; GO:1905555; GO:2000251; GO:1904531; GO:0043065; GO:0090050; GO:0007204; GO:0010595; GO:0070374; GO:0051894; GO:0043123; GO:1902715; GO:1900042; GO:1904528; GO:0045931; GO:0051149; GO:1901216; GO:0033690; GO:0051353; GO:0050731; GO:0001934; GO:0051281; GO:0051496; GO:1900026; GO:2000096; GO:0009791; GO:0046777; GO:0006468; GO:0032956; GO:2000249; GO:0010506; GO:0030516; GO:0032489; GO:0030155; GO:2000145; GO:0042127; GO:0030100; GO:1903053; GO:1902036; GO:0031113; GO:1905244; GO:2001020; GO:0045580; GO:0006355; GO:0006979; GO:0042770; GO:0048536; GO:0034446; GO:0048538; GO:0002333"]
[18,8,"NK001-6","Abl (Abl1)","Pan-specific","Abelson murine leukemia viral oncogene homologue 1",0,5492,18,568,{"v":3109.232,"d":"3109"},{"v":5463.377366860609,"d":"5463"},{"$nulls":3},0,4015,14,454,{"v":1816.454,"d":"1816"},{"v":3173.7359365087873,"d":"3174"},{"$nulls":6},0,4518,14,447,{"v":2013.288,"d":"2013"},{"v":3444.4164634432295,"d":"3444"},{"$nulls":7},"ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"CISTRVSLRKTRQPP","Corresponds to amino acid residues I1006 to P1019.",{"$nulls":3},"P00519","P00519","P00519","P00519"]
[19,9,"PK504","Abl (Abl1)","Y139","Abelson murine leukemia viral oncogene homologue 1",0,5330,14,779,{"v":4141.164,"d":"4141"},{"v":7276.6334805694605,"d":"7277"},{"v":5652.841731237968,"d":"5653"},{"v":1623.7917493314926,"d":"1624"},{"v":28.725229301190492,"d":"29"},0,4917,14,581,{"v":2848.643,"d":"2849"},{"v":4977.192188397946,"d":"4977"},{"v":4543.036307040412,"d":"4543"},{"v":434.1558813575339,"d":"434"},{"v":9.55651357407635,"d":"10"},{"v":38.28174287526684,"d":"38"},{"v":-19.632699391965986,"d":"-20"},null,0,5420,11,658,{"v":3559.122,"d":"3559"},{"v":6089.093270412874,"d":"6089"},{"v":4786.032627839594,"d":"4786"},{"v":1303.0606425732794,"d":"1303"},{"v":27.22632175538424,"d":"27"},{"v":55.95155105657473,"d":"56"},{"v":-15.334041613235527,"d":"-15"},null,null,"ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"AAE(pY)LLS(bA)C","Corresponds to amino acid residues A136 to S142; In the SH2 domain.","Y139 phosphorylation stimulates phosphotransferase activity. This is one of the many in vivo phosphorylation sites in Abl1 (≥57 reports based on mass spectrometry studies).","Fyn; Hck; Lyn","Protein-tyrosine kinase; Cytoplasm, nucleolus, nucleus, cytoskeleton protein","P00519","P00519","P00519","P00519","GO:0015629; GO:0031252; GO:0005737; GO:0005829; GO:0030425; GO:0031234; GO:0005739; GO:0043025; GO:0016604; GO:0031965; GO:0005730; GO:0005654; GO:0005634; GO:0048471; GO:0098794; GO:0032991","GO:0051015; GO:0003785; GO:0005524; GO:0003677; GO:0046875; GO:0016301; GO:0000287; GO:0030145; GO:0051019; GO:0038191; GO:0004515; GO:0004715; GO:0001784; GO:0070064; GO:0008022; GO:0004672; GO:0005080; GO:0004713; GO:0042169; GO:0017124; GO:0005102; GO:0019905","GO:0030036; GO:0090135; GO:0050798; GO:1990051; GO:0046632; GO:0006914; GO:0001922; GO:0002322; GO:0050853; GO:0060020; GO:0072358; GO:0007050; GO:0006464; GO:0006974; GO:1903351; GO:0070301; GO:0071222; GO:0034599; GO:0021587; GO:0048668; GO:0006975; GO:0043542; GO:0007173; GO:0045184; GO:0038096; GO:0045087; GO:0007229; GO:0008630; GO:0030035; GO:0006298; GO:0051882; GO:0000278; GO:0030514; GO:0022408; GO:2000773; GO:2000352; GO:0070373; GO:0043124; GO:1900272; GO:0045930; GO:1900275; GO:0071901; GO:0051444; GO:0001843; GO:0060563; GO:0050885; GO:0038189; GO:0038083; GO:0018108; GO:0035791; GO:1905555; GO:2000251; GO:1904531; GO:0043065; GO:0090050; GO:0007204; GO:0010595; GO:0070374; GO:0051894; GO:0043123; GO:1902715; GO:1900042; GO:1904528; GO:0045931; GO:0051149; GO:1901216; GO:0033690; GO:0051353; GO:0050731; GO:0001934; GO:0051281; GO:0051496; GO:1900026; GO:2000096; GO:0009791; GO:0046777; GO:0006468; GO:0032956; GO:2000249; GO:0010506; GO:0030516; GO:0032489; GO:0030155; GO:2000145; GO:0042127; GO:0030100; GO:1903053; GO:1902036; GO:0031113; GO:1905244; GO:2001020; GO:0045580; GO:0006355; GO:0006979; GO:0042770; GO:0048536; GO:0034446; GO:0048538; GO:0002333"]
[20,9,"PK504","Abl (Abl1)","Y139","Abelson murine leukemia viral oncogene homologue 1",0,3802,12,605,{"v":2292.95,"d":"2293"},{"v":4029.049981906475,"d":"4029"},{"$nulls":3},0,3942,16,599,{"v":2351.674,"d":"2352"},{"v":4108.880425682878,"d":"4109"},{"$nulls":6},0,3502,16,584,{"v":2035.824,"d":"2036"},{"v":3482.971985266315,"d":"3483"},{"$nulls":7},"ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"AAE(pY)LLS(bA)C","Corresponds to amino acid residues A136 to S142; In the SH2 domain.","Y139 phosphorylation stimulates phosphotransferase activity. This is one of the many in vivo phosphorylation sites in Abl1 (≥57 reports based on mass spectrometry studies).","Fyn; Hck; Lyn",null,"P00519","P00519","P00519","P00519"]
[21,10,"PK505","Abl (Abl1)","Y226","Abelson murine leukemia viral oncogene homologue 1",0,8236,20,686,{"v":5636.176,"d":"5636"},{"v":9903.589180235815,"d":"9904"},{"v":10521.571594576106,"d":"10522"},{"v":617.9824143402911,"d":"618"},{"v":5.873480104995555,"d":"6"},0,9316,16,617,{"v":5738.1,"d":"5738"},{"v":10025.69521566804,"d":"10026"},{"v":8679.022154854007,"d":"8679"},{"v":1346.6730608140333,"d":"1347"},{"v":15.516414600472766,"d":"16"},{"v":21.389894705468322,"d":"21"},{"v":-17.51211236040001,"d":"-18"},null,0,8286,14,638,{"v":5277.536,"d":"5278"},{"v":9029.027086444825,"d":"9029"},{"v":8328.86866458406,"d":"8329"},{"v":700.1584218607641,"d":"700"},{"v":8.406404879908495,"d":"8"},{"v":14.27988498490405,"d":"14"},{"v":-20.840070423722523,"d":"-21"},null,null,"ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"PTV(pY)GVS(bA)C","Corresponds to amino acid residues P223 to S229; In the region between the SH2 domain and the protein kinase catalytic domain.","Y226 phosphorylation stimulates phosphotransferase activity. This is one of the major in vivo phosphorylation sites in Abl1 (≥315 reports based on mass spectrometry studies).","Abl1; Fyn; Hck; Lyn","Protein-tyrosine kinase; Cytoplasm, nucleolus, nucleus, cytoskeleton protein","P00519","P00519","P00519","P00519","GO:0015629; GO:0031252; GO:0005737; GO:0005829; GO:0030425; GO:0031234; GO:0005739; GO:0043025; GO:0016604; GO:0031965; GO:0005730; GO:0005654; GO:0005634; GO:0048471; GO:0098794; GO:0032991","GO:0051015; GO:0003785; GO:0005524; GO:0003677; GO:0046875; GO:0016301; GO:0000287; GO:0030145; GO:0051019; GO:0038191; GO:0004515; GO:0004715; GO:0001784; GO:0070064; GO:0008022; GO:0004672; GO:0005080; GO:0004713; GO:0042169; GO:0017124; GO:0005102; GO:0019905","GO:0030036; GO:0090135; GO:0050798; GO:1990051; GO:0046632; GO:0006914; GO:0001922; GO:0002322; GO:0050853; GO:0060020; GO:0072358; GO:0007050; GO:0006464; GO:0006974; GO:1903351; GO:0070301; GO:0071222; GO:0034599; GO:0021587; GO:0048668; GO:0006975; GO:0043542; GO:0007173; GO:0045184; GO:0038096; GO:0045087; GO:0007229; GO:0008630; GO:0030035; GO:0006298; GO:0051882; GO:0000278; GO:0030514; GO:0022408; GO:2000773; GO:2000352; GO:0070373; GO:0043124; GO:1900272; GO:0045930; GO:1900275; GO:0071901; GO:0051444; GO:0001843; GO:0060563; GO:0050885; GO:0038189; GO:0038083; GO:0018108; GO:0035791; GO:1905555; GO:2000251; GO:1904531; GO:0043065; GO:0090050; GO:0007204; GO:0010595; GO:0070374; GO:0051894; GO:0043123; GO:1902715; GO:1900042; GO:1904528; GO:0045931; GO:0051149; GO:1901216; GO:0033690; GO:0051353; GO:0050731; GO:0001934; GO:0051281; GO:0051496; GO:1900026; GO:2000096; GO:0009791; GO:0046777; GO:0006468; GO:0032956; GO:2000249; GO:0010506; GO:0030516; GO:0032489; GO:0030155; GO:2000145; GO:0042127; GO:0030100; GO:1903053; GO:1902036; GO:0031113; GO:1905244; GO:2001020; GO:0045580; GO:0006355; GO:0006979; GO:0042770; GO:0048536; GO:0034446; GO:0048538; GO:0002333"]
[22,10,"PK505","Abl (Abl1)","Y226","Abelson murine leukemia viral oncogene homologue 1",0,7721,18,823,{"v":6339.569,"d":"6340"},{"v":11139.554008916397,"d":"11140"},{"$nulls":3},0,6962,14,604,{"v":4196.592,"d":"4197"},{"v":7332.349094039972,"d":"7332"},{"$nulls":6},0,7208,16,620,{"v":4459.04,"d":"4459"},{"v":7628.710242723295,"d":"7629"},{"$nulls":7},"ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"PTV(pY)GVS(bA)C","Corresponds to amino acid residues P223 to S229; In the region between the SH2 domain and the protein kinase catalytic domain.","Y226 phosphorylation stimulates phosphotransferase activity. This is one of the major in vivo phosphorylation sites in Abl1 (≥315 reports based on mass spectrometry studies).","Abl1; Fyn; Hck; Lyn",null,"P00519","P00519","P00519","P00519"]
[23,11,"PK506","Abl (Abl1)","Y257","Abelson murine leukemia viral oncogene homologue 1",0,5680,18,623,{"v":3527.426,"d":"3527"},{"v":6198.205657112641,"d":"6198"},{"v":6849.355097743726,"d":"6849"},{"v":651.1494406310849,"d":"651"},{"v":9.506726273333129,"d":"10"},0,7338,14,655,{"v":4797.22,"d":"4797"},{"v":8381.77543132867,"d":"8382"},{"v":7043.627033200411,"d":"7044"},{"v":1338.148398128259,"d":"1338"},{"v":18.998001907551952,"d":"19"},{"v":28.50472818088508,"d":"29"},{"v":2.8363536812492214,"d":"3"},null,0,6212,12,653,{"v":4048.6,"d":"4049"},{"v":6926.512497912002,"d":"6927"},{"v":6512.976468560424,"d":"6513"},{"v":413.5360293515778,"d":"414"},{"v":6.349416911727035,"d":"6"},{"v":15.856143185060164,"d":"16"},{"v":-4.911099284283125,"d":"-5"},null,null,"ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"GEV(pY)EGV(bA)C","Corresponds to amino acid residues G254 to V260; In the protein kinase catalytic domain in subdomain I.","Y257 phosphorylation is predicted to be inhibitory for phosphotransferase activity. This phosphosite is located in the kinase subdomain I region, which is involved in binding the phosphates in the ATP substrate. This is one of the major in vivo phosphorylation sites in Abl1 (≥335 reports based on mass spectrometry studies).",null,"Protein-tyrosine kinase; Cytoplasm, nucleolus, nucleus, cytoskeleton protein","P00519","P00519","P00519","P00519","GO:0015629; GO:0031252; GO:0005737; GO:0005829; GO:0030425; GO:0031234; GO:0005739; GO:0043025; GO:0016604; GO:0031965; GO:0005730; GO:0005654; GO:0005634; GO:0048471; GO:0098794; GO:0032991","GO:0051015; GO:0003785; GO:0005524; GO:0003677; GO:0046875; GO:0016301; GO:0000287; GO:0030145; GO:0051019; GO:0038191; GO:0004515; GO:0004715; GO:0001784; GO:0070064; GO:0008022; GO:0004672; GO:0005080; GO:0004713; GO:0042169; GO:0017124; GO:0005102; GO:0019905","GO:0030036; GO:0090135; GO:0050798; GO:1990051; GO:0046632; GO:0006914; GO:0001922; GO:0002322; GO:0050853; GO:0060020; GO:0072358; GO:0007050; GO:0006464; GO:0006974; GO:1903351; GO:0070301; GO:0071222; GO:0034599; GO:0021587; GO:0048668; GO:0006975; GO:0043542; GO:0007173; GO:0045184; GO:0038096; GO:0045087; GO:0007229; GO:0008630; GO:0030035; GO:0006298; GO:0051882; GO:0000278; GO:0030514; GO:0022408; GO:2000773; GO:2000352; GO:0070373; GO:0043124; GO:1900272; GO:0045930; GO:1900275; GO:0071901; GO:0051444; GO:0001843; GO:0060563; GO:0050885; GO:0038189; GO:0038083; GO:0018108; GO:0035791; GO:1905555; GO:2000251; GO:1904531; GO:0043065; GO:0090050; GO:0007204; GO:0010595; GO:0070374; GO:0051894; GO:0043123; GO:1902715; GO:1900042; GO:1904528; GO:0045931; GO:0051149; GO:1901216; GO:0033690; GO:0051353; GO:0050731; GO:0001934; GO:0051281; GO:0051496; GO:1900026; GO:2000096; GO:0009791; GO:0046777; GO:0006468; GO:0032956; GO:2000249; GO:0010506; GO:0030516; GO:0032489; GO:0030155; GO:2000145; GO:0042127; GO:0030100; GO:1903053; GO:1902036; GO:0031113; GO:1905244; GO:2001020; GO:0045580; GO:0006355; GO:0006979; GO:0042770; GO:0048536; GO:0034446; GO:0048538; GO:0002333"]
[24,11,"PK506","Abl (Abl1)","Y257","Abelson murine leukemia viral oncogene homologue 1",0,6401,30,670,{"v":4268.57,"d":"4269"},{"v":7500.50453837481,"d":"7501"},{"$nulls":3},0,5606,24,585,{"v":3265.47,"d":"3265"},{"v":5705.4786350721515,"d":"5705"},{"$nulls":6},0,5677,18,630,{"v":3565.17,"d":"3565"},{"v":6099.440439208845,"d":"6099"},{"$nulls":7},"ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"GEV(pY)EGV(bA)C","Corresponds to amino acid residues G254 to V260; In the protein kinase catalytic domain in subdomain I.","Y257 phosphorylation is predicted to be inhibitory for phosphotransferase activity. This phosphosite is located in the kinase subdomain I region, which is involved in binding the phosphates in the ATP substrate. This is one of the major in vivo phosphorylation sites in Abl1 (≥335 reports based on mass spectrometry studies).",null,null,"P00519","P00519","P00519","P00519"]
[25,12,"PK507","Abl (Abl1)","Y264","Abelson murine leukemia viral oncogene homologue 1",0,6230,18,683,{"v":4242.796,"d":"4243"},{"v":7455.215834201735,"d":"7455"},{"v":7164.975580876819,"d":"7165"},{"v":290.240253324916,"d":"290"},{"v":4.0508198534487905,"d":"4"},0,7626,14,679,{"v":5168.548,"d":"5169"},{"v":9030.565336182815,"d":"9031"},{"v":6984.345770592159,"d":"6984"},{"v":2046.2195655906562,"d":"2046"},{"v":29.297226008001175,"d":"29"},{"v":33.34804586144997,"d":"33"},{"v":-2.5210108289378894,"d":"-3"},null,0,6173,13,684,{"v":4213.44,"d":"4213"},{"v":7208.527594527081,"d":"7209"},{"v":6995.507309949692,"d":"6996"},{"v":213.02028457738925,"d":"213"},{"v":3.0451013077266182,"d":"3"},{"v":7.095921161175409,"d":"7"},{"v":-2.3652316607949615,"d":"-2"},null,null,"ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"WKK(pY)SLT(bA)C","Corresponds to amino acid residues W261 to T267; In the protein kinase catalytic domain in subdomain I.","Y264 phosphorylation is predicted to be inhibitory for phosphotransferase activity. This phosphosite is located in the kinase subdomain I region, which is involved in binding the phosphates in the ATP substrate. This is one of the many in vivo phosphorylation sites in Abl1 (≥60 reports based on mass spectrometry studies).",null,"Protein-tyrosine kinase; Cytoplasm, nucleolus, nucleus, cytoskeleton protein","P00519","P00519","P00519","P00519","GO:0015629; GO:0031252; GO:0005737; GO:0005829; GO:0030425; GO:0031234; GO:0005739; GO:0043025; GO:0016604; GO:0031965; GO:0005730; GO:0005654; GO:0005634; GO:0048471; GO:0098794; GO:0032991","GO:0051015; GO:0003785; GO:0005524; GO:0003677; GO:0046875; GO:0016301; GO:0000287; GO:0030145; GO:0051019; GO:0038191; GO:0004515; GO:0004715; GO:0001784; GO:0070064; GO:0008022; GO:0004672; GO:0005080; GO:0004713; GO:0042169; GO:0017124; GO:0005102; GO:0019905","GO:0030036; GO:0090135; GO:0050798; GO:1990051; GO:0046632; GO:0006914; GO:0001922; GO:0002322; GO:0050853; GO:0060020; GO:0072358; GO:0007050; GO:0006464; GO:0006974; GO:1903351; GO:0070301; GO:0071222; GO:0034599; GO:0021587; GO:0048668; GO:0006975; GO:0043542; GO:0007173; GO:0045184; GO:0038096; GO:0045087; GO:0007229; GO:0008630; GO:0030035; GO:0006298; GO:0051882; GO:0000278; GO:0030514; GO:0022408; GO:2000773; GO:2000352; GO:0070373; GO:0043124; GO:1900272; GO:0045930; GO:1900275; GO:0071901; GO:0051444; GO:0001843; GO:0060563; GO:0050885; GO:0038189; GO:0038083; GO:0018108; GO:0035791; GO:1905555; GO:2000251; GO:1904531; GO:0043065; GO:0090050; GO:0007204; GO:0010595; GO:0070374; GO:0051894; GO:0043123; GO:1902715; GO:1900042; GO:1904528; GO:0045931; GO:0051149; GO:1901216; GO:0033690; GO:0051353; GO:0050731; GO:0001934; GO:0051281; GO:0051496; GO:1900026; GO:2000096; GO:0009791; GO:0046777; GO:0006468; GO:0032956; GO:2000249; GO:0010506; GO:0030516; GO:0032489; GO:0030155; GO:2000145; GO:0042127; GO:0030100; GO:1903053; GO:1902036; GO:0031113; GO:1905244; GO:2001020; GO:0045580; GO:0006355; GO:0006979; GO:0042770; GO:0048536; GO:0034446; GO:0048538; GO:0002333"]
[26,12,"PK507","Abl (Abl1)","Y264","Abelson murine leukemia viral oncogene homologue 1",0,5676,14,691,{"v":3912.442,"d":"3912"},{"v":6874.735327551902,"d":"6875"},{"$nulls":3},0,3038,12,934,{"v":2826.284,"d":"2826"},{"v":4938.126205001504,"d":"4938"},{"$nulls":6},0,5712,16,696,{"v":3964.416,"d":"3964"},{"v":6782.487025372303,"d":"6782"},{"$nulls":7},"ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"WKK(pY)SLT(bA)C","Corresponds to amino acid residues W261 to T267; In the protein kinase catalytic domain in subdomain I.","Y264 phosphorylation is predicted to be inhibitory for phosphotransferase activity. This phosphosite is located in the kinase subdomain I region, which is involved in binding the phosphates in the ATP substrate. This is one of the many in vivo phosphorylation sites in Abl1 (≥60 reports based on mass spectrometry studies).",null,null,"P00519","P00519","P00519","P00519"]
[27,13,"PK873","Abl (Abl1)","Y393+T394","Abelson murine leukemia viral oncogene homologue 1",0,12652,32,822,{"v":10373.64,"d":"10374"},{"v":18228.009356638515,"d":"18228"},{"v":19784.10350739485,"d":"19784"},{"v":1556.0941507563366,"d":"1556"},{"v":7.8653761095351316,"d":"8"},0,16784,44,733,{"v":12270.42,"d":"12270"},{"v":21439.063642710553,"d":"21439"},{"v":21219.148661442316,"d":"21219"},{"v":219.91498126823717,"d":"220"},{"v":1.0363987018378757,"d":"1"},{"v":8.901774811373008,"d":"9"},{"v":7.2535263147560585,"d":"7"},null,0,15314,62,685,{"v":10447.62,"d":"10448"},{"v":17874.220842621,"d":"17874"},{"v":18350.649968152,"d":"18351"},{"v":476.42912553099814,"d":"476"},{"v":2.596252047517949,"d":"3"},{"v":10.461628157053081,"d":"10"},{"v":-7.245481397259468,"d":"-7"},null,null,"ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"GDT(pY)(pT)AHAGC","Corresponds to amino acid residues G390 to G398. Y393 and T394 are located in the Gap/Insert 8 (G/I8) region in the protein-tyrosine kinase catalytic domain of Abl1. The G/I8 region is located in the T-activation loop between kinase subdomains VII and VIII.","Y393 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation regulates cell growth. Y393 is the most frequently detected phosphosite in Abl1 by mass spectrometry (≥1677 reports) and T394 is the third most often observed phosphosite (≥477 reports). No protein kinases have been reported to phosphorylate T394, but it is likely that it becomes collatorally phosphorylated by kinases that target the Y393 site. The effect of this phosphorylation is unclear, but it is likely to be activatory for Abl1 phosphotransferase activity based on its location. ","Y393: Abl1; Fyn; Hck; Lyn.","Protein-tyrosine kinase; Cytoplasm, nucleolus, nucleus, cytoskeleton protein","P00519","P00519","P00519","P00519","GO:0015629; GO:0031252; GO:0005737; GO:0005829; GO:0030425; GO:0031234; GO:0005739; GO:0043025; GO:0016604; GO:0031965; GO:0005730; GO:0005654; GO:0005634; GO:0048471; GO:0098794; GO:0032991","GO:0051015; GO:0003785; GO:0005524; GO:0003677; GO:0046875; GO:0016301; GO:0000287; GO:0030145; GO:0051019; GO:0038191; GO:0004515; GO:0004715; GO:0001784; GO:0070064; GO:0008022; GO:0004672; GO:0005080; GO:0004713; GO:0042169; GO:0017124; GO:0005102; GO:0019905","GO:0030036; GO:0090135; GO:0050798; GO:1990051; GO:0046632; GO:0006914; GO:0001922; GO:0002322; GO:0050853; GO:0060020; GO:0072358; GO:0007050; GO:0006464; GO:0006974; GO:1903351; GO:0070301; GO:0071222; GO:0034599; GO:0021587; GO:0048668; GO:0006975; GO:0043542; GO:0007173; GO:0045184; GO:0038096; GO:0045087; GO:0007229; GO:0008630; GO:0030035; GO:0006298; GO:0051882; GO:0000278; GO:0030514; GO:0022408; GO:2000773; GO:2000352; GO:0070373; GO:0043124; GO:1900272; GO:0045930; GO:1900275; GO:0071901; GO:0051444; GO:0001843; GO:0060563; GO:0050885; GO:0038189; GO:0038083; GO:0018108; GO:0035791; GO:1905555; GO:2000251; GO:1904531; GO:0043065; GO:0090050; GO:0007204; GO:0010595; GO:0070374; GO:0051894; GO:0043123; GO:1902715; GO:1900042; GO:1904528; GO:0045931; GO:0051149; GO:1901216; GO:0033690; GO:0051353; GO:0050731; GO:0001934; GO:0051281; GO:0051496; GO:1900026; GO:2000096; GO:0009791; GO:0046777; GO:0006468; GO:0032956; GO:2000249; GO:0010506; GO:0030516; GO:0032489; GO:0030155; GO:2000145; GO:0042127; GO:0030100; GO:1903053; GO:1902036; GO:0031113; GO:1905244; GO:2001020; GO:0045580; GO:0006355; GO:0006979; GO:0042770; GO:0048536; GO:0034446; GO:0048538; GO:0002333"]
[28,13,"PK873","Abl (Abl1)","Y393+T394","Abelson murine leukemia viral oncogene homologue 1",0,15243,62,800,{"v":12144.8,"d":"12145"},{"v":21340.197658151184,"d":"21340"},{"$nulls":3},0,15528,40,776,{"v":12018.688,"d":"12019"},{"v":20999.23368017408,"d":"20999"},{"$nulls":6},0,14892,81,743,{"v":11004.573,"d":"11005"},{"v":18827.079093682994,"d":"18827"},{"$nulls":7},"ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"GDT(pY)(pT)AHAGC","Corresponds to amino acid residues G390 to G398. Y393 and T394 are located in the Gap/Insert 8 (G/I8) region in the protein-tyrosine kinase catalytic domain of Abl1. The G/I8 region is located in the T-activation loop between kinase subdomains VII and VIII.","Y393 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation regulates cell growth. Y393 is the most frequently detected phosphosite in Abl1 by mass spectrometry (≥1677 reports) and T394 is the third most often observed phosphosite (≥477 reports). No protein kinases have been reported to phosphorylate T394, but it is likely that it becomes collatorally phosphorylated by kinases that target the Y393 site. The effect of this phosphorylation is unclear, but it is likely to be activatory for Abl1 phosphotransferase activity based on its location. ","Y393: Abl1; Fyn; Hck; Lyn.",null,"P00519","P00519","P00519","P00519"]
[29,14,"PK177","Abl (Abl1)","Y413","Abelson murine leukemia viral oncogene homologue 1",0,842,122,442,{"v":318.24,"d":"318"},{"v":559.1944291161677,"d":"559"},{"v":582.3255108937105,"d":"582"},{"v":23.131081777542818,"d":"23"},{"v":3.9721910417496438,"d":"4"},0,330,60,505,{"v":136.35,"d":"136"},{"v":238.23278483406304,"d":"238"},{"v":233.1745969932518,"d":"233"},{"v":5.058187840811229,"d":"5"},{"v":2.169270540631669,"d":"2"},{"v":6.141461582381313,"d":"6"},{"v":-59.9580316109812,"d":"-60"},null,0,457,52,511,{"v":206.955,"d":"207"},{"v":354.0671822371631,"d":"354"},{"v":342.66014719299267,"d":"343"},{"v":11.407035044170414,"d":"11"},{"v":3.3289646133682878,"d":"3"},{"v":7.301155655117931,"d":"7"},{"v":-41.156596992101036,"d":"-41"},null,null,"ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"Not precisely defined.  Original suppliers identified as an antibody for the Y412 site in human Abl1. Likely to include LA(pY)NK.","Antibody raised against amino acid residues surrounding the phosphorylated Tyr-413 of human c-Abl.","The effect of Y413 phosphorylation is unclear. This is one of the many in vivo phosphorylation sites in Abl1 (≥164 reports based on mass spectrometry studies).",null,"Protein-tyrosine kinase; Cytoplasm, nucleolus, nucleus, cytoskeleton protein","P00519","P00519","P00519","P00519","GO:0015629; GO:0031252; GO:0005737; GO:0005829; GO:0030425; GO:0031234; GO:0005739; GO:0043025; GO:0016604; GO:0031965; GO:0005730; GO:0005654; GO:0005634; GO:0048471; GO:0098794; GO:0032991","GO:0051015; GO:0003785; GO:0005524; GO:0003677; GO:0046875; GO:0016301; GO:0000287; GO:0030145; GO:0051019; GO:0038191; GO:0004515; GO:0004715; GO:0001784; GO:0070064; GO:0008022; GO:0004672; GO:0005080; GO:0004713; GO:0042169; GO:0017124; GO:0005102; GO:0019905","GO:0030036; GO:0090135; GO:0050798; GO:1990051; GO:0046632; GO:0006914; GO:0001922; GO:0002322; GO:0050853; GO:0060020; GO:0072358; GO:0007050; GO:0006464; GO:0006974; GO:1903351; GO:0070301; GO:0071222; GO:0034599; GO:0021587; GO:0048668; GO:0006975; GO:0043542; GO:0007173; GO:0045184; GO:0038096; GO:0045087; GO:0007229; GO:0008630; GO:0030035; GO:0006298; GO:0051882; GO:0000278; GO:0030514; GO:0022408; GO:2000773; GO:2000352; GO:0070373; GO:0043124; GO:1900272; GO:0045930; GO:1900275; GO:0071901; GO:0051444; GO:0001843; GO:0060563; GO:0050885; GO:0038189; GO:0038083; GO:0018108; GO:0035791; GO:1905555; GO:2000251; GO:1904531; GO:0043065; GO:0090050; GO:0007204; GO:0010595; GO:0070374; GO:0051894; GO:0043123; GO:1902715; GO:1900042; GO:1904528; GO:0045931; GO:0051149; GO:1901216; GO:0033690; GO:0051353; GO:0050731; GO:0001934; GO:0051281; GO:0051496; GO:1900026; GO:2000096; GO:0009791; GO:0046777; GO:0006468; GO:0032956; GO:2000249; GO:0010506; GO:0030516; GO:0032489; GO:0030155; GO:2000145; GO:0042127; GO:0030100; GO:1903053; GO:1902036; GO:0031113; GO:1905244; GO:2001020; GO:0045580; GO:0006355; GO:0006979; GO:0042770; GO:0048536; GO:0034446; GO:0048538; GO:0002333"]
[30,14,"PK177","Abl (Abl1)","Y413","Abelson murine leukemia viral oncogene homologue 1",0,648,62,588,{"v":344.568,"d":"345"},{"v":605.4565926712534,"d":"605"},{"$nulls":3},0,388,48,384,{"v":130.56,"d":"131"},{"v":228.11640915244058,"d":"228"},{"$nulls":6},0,460,40,461,{"v":193.62,"d":"194"},{"v":331.25311214882225,"d":"331"},{"$nulls":7},"ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"Not precisely defined.  Original suppliers identified as an antibody for the Y412 site in human Abl1. Likely to include LA(pY)NK.","Antibody raised against amino acid residues surrounding the phosphorylated Tyr 413of human c-Abl.","The effect of Y413 phosphorylation is unclear. This is one of the many in vivo phosphorylation sites in Abl1 (≥164 reports based on mass spectrometry studies).",null,null,"P00519","P00519","P00519","P00519"]
[31,15,"PK508","Abl (Abl1)","Y469","Abelson murine leukemia viral oncogene homologue 1",0,9272,22,667,{"v":6169.75,"d":"6170"},{"v":10841.157079686638,"d":"10841"},{"v":11738.55835817477,"d":"11739"},{"v":897.4012784881324,"d":"897"},{"v":7.644901964159673,"d":"8"},0,13265,30,609,{"v":8060.115,"d":"8060"},{"v":14082.75498740597,"d":"14083"},{"v":10862.156119922289,"d":"10862"},{"v":3220.598867483681,"d":"3221"},{"v":29.649719926017067,"d":"30"},{"v":37.29462189017674,"d":"37"},{"v":-7.466012533320608,"d":"-7"},null,0,9464,22,651,{"v":6146.742,"d":"6147"},{"v":10516.100697633901,"d":"10516"},{"v":9680.356383866792,"d":"9680"},{"v":835.7443137671089,"d":"836"},{"v":8.633404397796284,"d":"9"},{"v":16.278306361955956,"d":"16"},{"v":-17.53368609250589,"d":"-18"},null,null,"ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"EKV(pY)ELM(bA)C","Corresponds to amino acid residues E466 to M472; In the protein kinase catalytic domain. ","The effect of Y469 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in Abl1 (≥291 reports based on mass spectrometry studies).",null,"Protein-tyrosine kinase; Cytoplasm, nucleolus, nucleus, cytoskeleton protein","P00519","P00519","P00519","P00519","GO:0015629; GO:0031252; GO:0005737; GO:0005829; GO:0030425; GO:0031234; GO:0005739; GO:0043025; GO:0016604; GO:0031965; GO:0005730; GO:0005654; GO:0005634; GO:0048471; GO:0098794; GO:0032991","GO:0051015; GO:0003785; GO:0005524; GO:0003677; GO:0046875; GO:0016301; GO:0000287; GO:0030145; GO:0051019; GO:0038191; GO:0004515; GO:0004715; GO:0001784; GO:0070064; GO:0008022; GO:0004672; GO:0005080; GO:0004713; GO:0042169; GO:0017124; GO:0005102; GO:0019905","GO:0030036; GO:0090135; GO:0050798; GO:1990051; GO:0046632; GO:0006914; GO:0001922; GO:0002322; GO:0050853; GO:0060020; GO:0072358; GO:0007050; GO:0006464; GO:0006974; GO:1903351; GO:0070301; GO:0071222; GO:0034599; GO:0021587; GO:0048668; GO:0006975; GO:0043542; GO:0007173; GO:0045184; GO:0038096; GO:0045087; GO:0007229; GO:0008630; GO:0030035; GO:0006298; GO:0051882; GO:0000278; GO:0030514; GO:0022408; GO:2000773; GO:2000352; GO:0070373; GO:0043124; GO:1900272; GO:0045930; GO:1900275; GO:0071901; GO:0051444; GO:0001843; GO:0060563; GO:0050885; GO:0038189; GO:0038083; GO:0018108; GO:0035791; GO:1905555; GO:2000251; GO:1904531; GO:0043065; GO:0090050; GO:0007204; GO:0010595; GO:0070374; GO:0051894; GO:0043123; GO:1902715; GO:1900042; GO:1904528; GO:0045931; GO:0051149; GO:1901216; GO:0033690; GO:0051353; GO:0050731; GO:0001934; GO:0051281; GO:0051496; GO:1900026; GO:2000096; GO:0009791; GO:0046777; GO:0006468; GO:0032956; GO:2000249; GO:0010506; GO:0030516; GO:0032489; GO:0030155; GO:2000145; GO:0042127; GO:0030100; GO:1903053; GO:1902036; GO:0031113; GO:1905244; GO:2001020; GO:0045580; GO:0006355; GO:0006979; GO:0042770; GO:0048536; GO:0034446; GO:0048538; GO:0002333"]
[32,15,"PK508","Abl (Abl1)","Y469","Abelson murine leukemia viral oncogene homologue 1",0,6968,20,1035,{"v":7191.18,"d":"7191"},{"v":12635.959636662905,"d":"12636"},{"$nulls":3},0,7870,18,557,{"v":4373.564,"d":"4374"},{"v":7641.557252438608,"d":"7642"},{"$nulls":6},0,7996,18,648,{"v":5169.744,"d":"5170"},{"v":8844.612070099683,"d":"8845"},{"$nulls":7},"ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"EKV(pY)ELM(bA)C","Corresponds to amino acid residues E466 to M472; In the protein kinase catalytic domain. ","The effect of Y469 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in Abl1 (≥291 reports based on mass spectrometry studies).",null,null,"P00519","P00519","P00519","P00519"]
[33,16,"NK238-1","Abl2 (Arg)","Pan-specific","Abelson murine leukemia viral oncogene homologue 2",0,8107,16,732,{"v":5922.612,"d":"5923"},{"v":10406.899309378343,"d":"10407"},{"v":10928.304537286076,"d":"10928"},{"v":521.4052279077332,"d":"521"},{"v":4.771144747373763,"d":"5"},0,6600,16,554,{"v":3647.536,"d":"3648"},{"v":6373.030136138606,"d":"6373"},{"v":7048.05447637437,"d":"7048"},{"v":675.0243402357637,"d":"675"},{"v":9.5774563391713,"d":"10"},{"v":14.348601086545063,"d":"14"},{"v":-35.50642323036253,"d":"-36"},null,0,7084,18,587,{"v":4147.742,"d":"4148"},{"v":7096.128736134596,"d":"7096"},{"v":7649.616724649019,"d":"7650"},{"v":553.4879885144228,"d":"553"},{"v":7.235499613084445,"d":"7"},{"v":12.006644360458209,"d":"12"},{"v":-30.001797638879523,"d":"-30"},null,null,"ARG","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"CDSISEEVAEELGRAA","Corresponds to amino acid residues S547 to A560; Kinase last alpha-chain.",null,null,"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; Abl family","P42684","P42684","P42684","P42684","GO:0015629; GO:0005829; GO:0031234","GO:0051015; GO:0003785; GO:0005524; GO:0000287; GO:0030145; GO:0004715; GO:0001784; GO:0004672; GO:0004713; GO:0005102","GO:0007155; GO:0006464; GO:0071300; GO:0045087; GO:0038083; GO:0018108; GO:0007204; GO:0010976; GO:0051353; GO:0010863; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0042127; GO:0030100; GO:0007165; GO:0007169"]
[34,16,"NK238-1","Abl2 (Arg)","Pan-specific","Abelson murine leukemia viral oncogene homologue 2",0,8681,16,752,{"v":6516.08,"d":"6516"},{"v":11449.70976519381,"d":"11450"},{"$nulls":3},0,7470,16,593,{"v":4420.222,"d":"4420"},{"v":7723.078816610134,"d":"7723"},{"$nulls":6},0,7994,16,601,{"v":4794.778,"d":"4795"},{"v":8203.104713163442,"d":"8203"},{"$nulls":7},"ARG","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"CDSISEEVAEELGRAA","Corresponds to amino acid residues S547 to A560; Kinase last alpha-chain.",{"$nulls":3},"P42684","P42684","P42684","P42684"]
[35,17,"PK509","Abl2 (Arg)","Y439","Abelson murine leukemia viral oncogene homologue 2",0,3079,20,623,{"v":1905.757,"d":"1906"},{"v":3348.695002668239,"d":"3349"},{"v":3312.834270181382,"d":"3313"},{"v":35.860732486856705,"d":"36"},{"v":1.0824789157017891,"d":"1"},0,1764,16,453,{"v":791.844,"d":"792"},{"v":1383.5218281932075,"d":"1384"},{"v":1471.529054977892,"d":"1472"},{"v":88.00722678468446,"d":"88"},{"v":5.980665246600019,"d":"6"},{"v":7.063144162301808,"d":"7"},{"v":-55.580963761965556,"d":"-56"},"Possible",0,2764,18,496,{"v":1362.016,"d":"1362"},{"v":2330.1933622378388,"d":"2330"},{"v":2192.203738162457,"d":"2192"},{"v":137.98962407538193,"d":"138"},{"v":6.294562027845424,"d":"6"},{"v":7.377040943547213,"d":"7"},{"v":-33.826942147563855,"d":"-34"},null,null,"ARG","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"GDT(pY)TAH(bA)C","Corresponds to amino acid residues G436 to H442; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y439 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. It is the most predominent phosphorylation site in Abl2 by mass spectrometry (≥1165 reports).","Abl2","EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; Abl family","P42684","P42684","P42684","P42684","GO:0015629; GO:0005829; GO:0031234","GO:0051015; GO:0003785; GO:0005524; GO:0000287; GO:0030145; GO:0004715; GO:0001784; GO:0004672; GO:0004713; GO:0005102","GO:0007155; GO:0006464; GO:0071300; GO:0045087; GO:0038083; GO:0018108; GO:0007204; GO:0010976; GO:0051353; GO:0010863; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0042127; GO:0030100; GO:0007165; GO:0007169"]
[36,17,"PK509","Abl2 (Arg)","Y439","Abelson murine leukemia viral oncogene homologue 2",0,2707,12,692,{"v":1864.94,"d":"1865"},{"v":3276.9735376945255,"d":"3277"},{"$nulls":3},0,1949,17,462,{"v":892.584,"d":"893"},{"v":1559.5362817625767,"d":"1560"},{"$nulls":6},0,2350,14,514,{"v":1200.704,"d":"1201"},{"v":2054.214114087075,"d":"2054"},{"$nulls":7},"ARG","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"GDT(pY)TAH(bA)C","Corresponds to amino acid residues G436 to H442; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y439 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. It is the most predominent phosphorylation site in Abl2 by mass spectrometry (≥1165 reports).","Abl2",null,"P42684","P42684","P42684","P42684"]
[37,18,"PK510","Abl2 (Arg)","Y439+T440","Abelson murine leukemia viral oncogene homologue 2",0,11844,14,725,{"v":8576.75,"d":"8577"},{"v":15070.609665416325,"d":"15071"},{"v":17764.626876480423,"d":"17765"},{"v":2694.017211064098,"d":"2694"},{"v":15.165064990083508,"d":"15"},0,12652,18,619,{"v":7820.446,"d":"7820"},{"v":13664.001681147114,"d":"13664"},{"v":14054.988244343389,"d":"14055"},{"v":390.9865631962748,"d":"391"},{"v":2.781834864597858,"d":"3"},{"v":17.946899854681366,"d":"18"},{"v":-20.882164640611904,"d":"-21"},null,0,12843,16,752,{"v":9645.904,"d":"9646"},{"v":16502.61191761581,"d":"16503"},{"v":14179.6485711405,"d":"14180"},{"v":2322.9633464753097,"d":"2323"},{"v":16.382376014615634,"d":"16"},{"v":31.54744100469914,"d":"32"},{"v":-20.180431203349812,"d":"-20"},null,null,"ARG","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"DT(pY)(pT)AHA(bA)C","Corresponds to amino acid residues D437 to A443; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T440 phosphorylation is predicted to be stimulatory for phosphotransferase activity. Y439 phosphorylation is also likely to be stimulatory for phosphotransferase activity. Both phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. Y339 is the most predominent phosphorylation site in Abl2 by Mass spectrometry (≥1165 reports), and T440 is the second most phosphorylated site (≥476).","Y439: Abl2.","EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; Abl family","P42684","P42684","P42684","P42684","GO:0015629; GO:0005829; GO:0031234","GO:0051015; GO:0003785; GO:0005524; GO:0000287; GO:0030145; GO:0004715; GO:0001784; GO:0004672; GO:0004713; GO:0005102","GO:0007155; GO:0006464; GO:0071300; GO:0045087; GO:0038083; GO:0018108; GO:0007204; GO:0010976; GO:0051353; GO:0010863; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0042127; GO:0030100; GO:0007165; GO:0007169"]
[38,18,"PK510","Abl2 (Arg)","Y439+T440","Abelson murine leukemia viral oncogene homologue 2",0,15022,18,776,{"v":11643.104,"d":"11643"},{"v":20458.64408754452,"d":"20459"},{"$nulls":3},0,15616,16,530,8268,{"v":14445.974807539664,"d":"14446"},{"$nulls":6},0,11156,14,622,{"v":6930.324,"d":"6930"},{"v":11856.68522466519,"d":"11857"},{"$nulls":7},"ARG","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"DT(pY)(pT)AHA(bA)C","Corresponds to amino acid residues D437 to A443; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T440 phosphorylation is predicted to be stimulatory for phosphotransferase activity. Y439 phosphorylation is also likely to be stimulatory for phosphotransferase activity. Both phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. Y339 is the most predominent phosphorylation site in Abl2 by Mass spectrometry (≥1165 reports), and T440 is the second most phosphorylated site (≥476).","Y439: Abl2.",null,"P42684","P42684","P42684","P42684"]
[39,19,"NN390-1","ACC1 (ACACA)","Pan-specific","Acetyl-CoA carboxylase 1",0,336,12,594,{"v":192.456,"d":"192"},{"v":338.173463580886,"d":"338"},{"v":342.32735884996157,"d":"342"},{"v":4.153895269075576,"d":"4"},{"v":1.213427779488751,"d":"1"},0,202,8,471,{"v":91.374,"d":"91"},{"v":159.65003653412305,"d":"160"},{"v":141.5716014429749,"d":"142"},{"v":18.07843509114815,"d":"18"},{"v":12.769817468251324,"d":"13"},{"v":13.983245247740074,"d":"14"},{"v":-58.64438006983128,"d":"-59"},null,0,309,12,508,{"v":150.876,"d":"151"},{"v":258.12490728522727,"d":"258"},{"v":238.3373156360522,"d":"238"},{"v":19.787591649175056,"d":"20"},{"v":8.302347283037822,"d":"8"},{"v":9.515775062526572,"d":"10"},{"v":-30.377368482396733,"d":"-30"},{"$nulls":14},"X","Not precisely defined.","Antibody raised against amino acid residues 1-76 mapping at the N-terminus of human ACCα.",null,null,"EC 6.4.1.2; Ligase; Carbohydrate Metabolism - pyruvate; EC 6.3.4.14; Carbohydrate Metabolism - propanoate; Lipid Metabolism - fatty acid biosynthesis","Q13085","Q13085",null,"Q13085","GO:0015629; GO:0005829; GO:0001650","GO:0003989; GO:0005524; GO:0004075; GO:0042802; GO:0046872","GO:0006084; GO:0006853; GO:0071380; GO:0006633; GO:0046949; GO:0055088; GO:2001295; GO:0031325; GO:0051289; GO:0019538; GO:0045540; GO:0001894"]
[40,19,"NN390-1","ACC1 (ACACA)","Pan-specific","Acetyl-CoA carboxylase 1",0,330,14,624,{"v":197.184,"d":"197"},{"v":346.4812541190372,"d":"346"},{"$nulls":3},0,164,12,465,{"v":70.68,"d":"71"},{"v":123.49316635182676,"d":"123"},{"$nulls":6},0,266,10,499,{"v":127.744,"d":"128"},{"v":218.54972398687713,"d":"219"},{"$nulls":19},"X","Not precisely defined.","Antibody raised against amino acid residues 1-76 mapping at the N-terminus of human ACCα.",{"$nulls":3},"Q13085","Q13085",null,"Q13085"]
[41,20,"PN733","ACC1 (ACACA)","S29","Acetyl-CoA carboxylase 1",0,1228,12,578,{"v":702.848,"d":"703"},{"v":1235.0071836206644,"d":"1235"},{"v":1178.374339068081,"d":"1178"},{"v":56.632844552583265,"d":"57"},{"v":4.806014750573356,"d":"5"},0,756,12,448,{"v":333.312,"d":"333"},{"v":582.3677739538778,"d":"582"},{"v":577.6293264843509,"d":"578"},{"v":4.738447469526818,"d":"5"},{"v":0.8203266787658835,"d":"1"},{"v":5.626341429339239,"d":"6"},{"v":-50.98082949250492,"d":"-51"},"Possible",0,1072,14,500,529,{"v":905.0351013672501,"d":"905"},{"v":798.9013441868744,"d":"799"},{"v":106.13375718037571,"d":"106"},{"v":13.284964151412106,"d":"13"},{"v":18.090978901985462,"d":"18"},{"v":-32.203093898099766,"d":"-32"},{"$nulls":5},"Fatty acid synthesis",{"$nulls":8},"X","EDN(pS)EDE(bA)C","Corresponds to amino acid residues E26 to E32.","The effect of S29 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in ACC1 (≥78 reports based on mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in fish.","CK2a1 (CSNK2A1)","EC 6.4.1.2; Ligase; Carbohydrate Metabolism - pyruvate; EC 6.3.4.14; Carbohydrate Metabolism - propanoate; Lipid Metabolism - fatty acid biosynthesis","Q13085","Q13085",null,"Q13085","GO:0015629; GO:0005829; GO:0001650","GO:0003989; GO:0005524; GO:0004075; GO:0042802; GO:0046872","GO:0006084; GO:0006853; GO:0071380; GO:0006633; GO:0046949; GO:0055088; GO:2001295; GO:0031325; GO:0051289; GO:0019538; GO:0045540; GO:0001894"]
[42,20,"PN733","ACC1 (ACACA)","S29","Acetyl-CoA carboxylase 1",0,1038,10,621,{"v":638.388,"d":"638"},{"v":1121.741494515498,"d":"1122"},{"$nulls":3},0,804,12,414,{"v":327.888,"d":"328"},{"v":572.890879014824,"d":"573"},{"$nulls":6},0,898,10,456,{"v":404.928,"d":"405"},{"v":692.7675870064988,"d":"693"},{"$nulls":10},"Fatty acid synthesis",{"$nulls":8},"X","EDN(pS)EDE(bA)C","Corresponds to amino acid residues E26 to E32.","The effect of S29 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in ACC1 (≥78 reports based on mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in fish.","CK2a1 (CSNK2A1)",null,"Q13085","Q13085",null,"Q13085"]
[43,21,"PN202","ACC1 (ACACA)","S78+S80","Acetyl-CoA carboxylase 1",0,840,14,748,{"v":617.848,"d":"618"},{"v":1085.6496972114314,"d":"1086"},{"v":954.0130372779294,"d":"954"},{"v":131.63665993350207,"d":"132"},{"v":13.798203461568923,"d":"14"},0,532,7,526,{"v":276.15,"d":"276"},{"v":482.4934619136524,"d":"482"},{"v":506.1350300221211,"d":"506"},{"v":23.641568108468675,"d":"24"},{"v":4.67100016915158,"d":"5"},{"v":18.469203630720504,"d":"18"},{"v":-46.94673864559877,"d":"-47"},"Possible",0,792,10,567,{"v":443.394,"d":"443"},{"v":758.5768123546891,"d":"759"},{"v":660.5609976241955,"d":"661"},{"v":98.01581473049362,"d":"98"},{"v":14.838268544921949,"d":"15"},{"v":28.63647200649087,"d":"29"},{"v":-30.759751511471592,"d":"-31"},{"$nulls":14},"X","Not precisely defined.","Antibody raised against amino acid residues that encompass the S78 and S80 phosphosites.","The effect of S78 phosphorylation is unclear and it has been rarely observed (3 mass spectrometry reports). S80 phosphorylation produces enzyme inhibition. This is one of the major in vivo phosphorylation sites in ACC1 (≥80 reports based on mass spectrometry studies).","S78: PKACa (PRKACA). S80: AMPKa1 (PRKAA1); AMPKa2 (PRKAA2).","EC 6.4.1.2; Ligase; Carbohydrate Metabolism - pyruvate; EC 6.3.4.14; Carbohydrate Metabolism - propanoate; Lipid Metabolism - fatty acid biosynthesis","Q13085","Q13085",null,"Q13085","GO:0015629; GO:0005829; GO:0001650","GO:0003989; GO:0005524; GO:0004075; GO:0042802; GO:0046872","GO:0006084; GO:0006853; GO:0071380; GO:0006633; GO:0046949; GO:0055088; GO:2001295; GO:0031325; GO:0051289; GO:0019538; GO:0045540; GO:0001894"]
[44,21,"PN202","ACC1 (ACACA)","S78+S80","Acetyl-CoA carboxylase 1",0,654,12,729,{"v":468.018,"d":"468"},{"v":822.3763773444273,"d":"822"},{"$nulls":3},0,353,10,884,{"v":303.212,"d":"303"},{"v":529.7765981305898,"d":"530"},{"$nulls":6},0,574,10,583,{"v":328.812,"d":"329"},{"v":562.5451828937018,"d":"563"},{"$nulls":19},"X","Not precisely defined.","Antibody raised against amino acid residues that encompass the S78 and S80 phosphosites.","The effect of S78 phosphorylation is unclear and it has been rarely observed (3 mass spectrometry reports). S80 phosphorylation produces enzyme inhibition. This is one of the major in vivo phosphorylation sites in ACC1 (≥80 reports based on mass spectrometry studies).","S78: PKACa (PRKACA). S80: AMPKa1 (PRKAA1); AMPKa2 (PRKAA2).",null,"Q13085","Q13085",null,"Q13085"]
[45,22,"PN002","ACC1 (ACACA)","S80","Acetyl-CoA carboxylase 1",0,7712,16,428,{"v":3293.888,"d":"3294"},{"v":5787.845084629825,"d":"5788"},{"v":5416.287587116127,"d":"5416"},{"v":371.55749751369785,"d":"372"},{"v":6.860003120911304,"d":"7"},0,9844,16,354,{"v":3479.112,"d":"3479"},{"v":6078.757172787728,"d":"6079"},{"v":5205.706962603133,"d":"5206"},{"v":873.050210184595,"d":"873"},{"v":16.77102104395102,"d":"17"},{"v":23.631024164862325,"d":"24"},{"v":-3.887914390179489,"d":"-4"},null,0,7775,14,346,{"v":2685.306,"d":"2685"},{"v":4594.13268036311,"d":"4594"},{"v":3994.1902152751045,"d":"3994"},{"v":599.9424650880055,"d":"600"},{"v":15.020377917747311,"d":"15"},{"v":21.880381038658616,"d":"22"},{"v":-26.255942820019456,"d":"-26"},{"$nulls":14},"X","Epitope undefined.","Antibody raised against amino acid residues that encompass the S80 phosphosite.","S80 phosphorylation produces enzyme inhibition. This is one of the major in vivo phosphorylation sites in ACC1 (≥80 reports based on mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and found in fish.","AMPKa1 (PRKAA1); AMPKa2 (PRKAA2)","EC 6.4.1.2; Ligase; Carbohydrate Metabolism - pyruvate; EC 6.3.4.14; Carbohydrate Metabolism - propanoate; Lipid Metabolism - fatty acid biosynthesis","Q13085","Q13085",null,"Q13085","GO:0015629; GO:0005829; GO:0001650","GO:0003989; GO:0005524; GO:0004075; GO:0042802; GO:0046872","GO:0006084; GO:0006853; GO:0071380; GO:0006633; GO:0046949; GO:0055088; GO:2001295; GO:0031325; GO:0051289; GO:0019538; GO:0045540; GO:0001894"]
[46,22,"PN002","ACC1 (ACACA)","S80","Acetyl-CoA carboxylase 1",0,7066,12,407,{"v":2870.978,"d":"2871"},{"v":5044.730089602429,"d":"5045"},{"$nulls":3},0,7644,14,325,{"v":2479.75,"d":"2480"},{"v":4332.656752418539,"d":"4333"},{"$nulls":6},0,5746,12,346,{"v":1983.964,"d":"1984"},{"v":3394.2477501870985,"d":"3394"},{"$nulls":19},"X","Epitope undefined.","Antibody raised against amino acid residues that encompass the S80 phosphosite.","S80 phosphorylation produces enzyme inhibition. This is one of the major in vivo phosphorylation sites in ACC1 (≥80 reports based on mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and found in fish.","AMPKa1 (PRKAA1); AMPKa2 (PRKAA2)",null,"Q13085","Q13085",null,"Q13085"]
[47,23,"PN734","ACC2 (ACACB)","T1342","Acetyl CoA carboxylase beta",0,14294,16,781,{"v":11151.118,"d":"11151"},{"v":19594.15241332649,"d":"19594"},{"v":19931.401617638534,"d":"19931"},{"v":337.24920431204373,"d":"337"},{"v":1.6920496148830344,"d":"2"},0,15634,20,655,{"v":10227.17,"d":"10227"},{"v":17869.06630048687,"d":"17869"},{"v":17510.502808710953,"d":"17511"},{"v":358.5634917759162,"d":"359"},{"v":2.0477052868952543,"d":"2"},{"v":3.739754901778289,"d":"4"},{"v":-12.14615437172857,"d":"-12"},null,0,14962,10,702,{"v":10496.304,"d":"10496"},{"v":17957.51144540921,"d":"17958"},{"v":15946.629522338071,"d":"15947"},{"v":2010.8819230711397,"d":"2011"},{"v":12.61007487666464,"d":"13"},{"v":14.302124491547675,"d":"14"},{"v":-19.992432904337704,"d":"-20"},{"$nulls":5},"Fatty acid synthesis",{"$nulls":8},"X","ISI(pT)NPD(bA)C","Corresponds to amino acid residues I1339 to D1335.","The effect of T1342 phosphorylation is unclear. This is the major site of phosphorylation in ACC2 by mass spectrometry (≥29 reports). This human phosphosite is highly conserved in mammals and also found in the platypus.",null,"EC 6.3.4.14; Carbohydrate Metabolism - propanoate; Ligase; EC 6.4.1.2; Lipid Metabolism - fatty acid biosynthesis; Carbohydrate Metabolism - pyruvate; Mitochondrial","O00763","O00763",null,null,"GO:0005829; GO:0012505; GO:0005741; GO:0005739; GO:0005634","GO:0003989; GO:0005524; GO:0009374; GO:0004075; GO:0042802; GO:0046872","GO:0006084; GO:0006853; GO:0097009; GO:0006633; GO:2001295; GO:0043086; GO:0031999; GO:0010629; GO:0031325; GO:0060421; GO:0010884; GO:0051289; GO:0045540; GO:0010906; GO:0042493; GO:0031667; GO:0014070"]
[48,23,"PN734","ACC2 (ACACB)","T1342","Acetyl CoA carboxylase beta",0,14564,18,793,{"v":11534.978,"d":"11535"},{"v":20268.65082195058,"d":"20269"},{"$nulls":3},0,14780,18,665,{"v":9816.73,"d":"9817"},{"v":17151.939316935033,"d":"17152"},{"$nulls":6},0,12433,16,656,{"v":8145.552,"d":"8146"},{"v":13935.747599266932,"d":"13936"},{"$nulls":10},"Fatty acid synthesis",{"$nulls":8},"X","ISI(pT)NPD(bA)C","Corresponds to amino acid residues I1339 to D1335.","The effect of T1342 phosphorylation is unclear. This is the major site of phosphorylation in ACC2 by mass spectrometry (≥29 reports). This human phosphosite is highly conserved in mammals and also found in the platypus.",null,null,"O00763","O00763"]
[49,24,"NK002","ACK1 (TNK2)","Pan-specific","Activated CDC42 kinase 1",0,498,20,683,{"v":326.474,"d":"326"},{"v":573.662776681975,"d":"574"},{"v":505.02686166278625,"d":"505"},{"v":68.6359150191887,"d":"69"},{"v":13.59054740043073,"d":"14"},0,474,14,659,{"v":303.14,"d":"303"},{"v":529.6507986402484,"d":"530"},{"v":423.33275715031266,"d":"423"},{"v":106.3180414899357,"d":"106"},{"v":25.114532172190344,"d":"25"},{"v":38.705079572621074,"d":"39"},{"v":-16.176189964133414,"d":"-16"},null,0,476,12,589,{"v":273.296,"d":"273"},{"v":467.5661116507826,"d":"468"},{"v":424.9182571954276,"d":"425"},{"v":42.647854455355,"d":"43"},{"v":10.036719706242343,"d":"10"},{"v":23.627267106673074,"d":"24"},{"v":-15.862246258268996,"d":"-16"},null,null,"ACK1","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Ack",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues near the C-terminus of human ACK.",null,null,"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK domain target; TK</A> group; Ack family","Q07912","Q07912","Q07912","Q07912","GO:0005912; GO:0005905; GO:0030136; GO:0005737; GO:0030659; GO:0005768; GO:0031234; GO:0070436; GO:0016020; GO:0005634; GO:0048471; GO:0005886","GO:0005524; GO:0005154; GO:0005095; GO:0042802; GO:0046872; GO:0004715; GO:0004712; GO:0004674; GO:0004713; GO:0031625; GO:0050699","GO:0030154; GO:0016477; GO:0007166; GO:0006897; GO:0045087; GO:0038083; GO:0016310; GO:0050731; GO:0042127; GO:2000369; GO:0007264; GO:0007169"]
[50,24,"NK002","ACK1 (TNK2)","Pan-specific","Activated CDC42 kinase 1",0,432,16,597,{"v":248.352,"d":"248"},{"v":436.39094664359754,"d":"436"},{"$nulls":3},0,338,18,567,{"v":181.44,"d":"181"},{"v":317.01471566037696,"d":"317"},{"$nulls":6},0,406,14,570,{"v":223.44,"d":"223"},{"v":382.27040274007254,"d":"382"},{"$nulls":7},"ACK1","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Ack",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues near the C-terminus of human ACK.",{"$nulls":3},"Q07912","Q07912","Q07912","Q07912"]
[51,25,"PK511","ACK1 (TNK2)","Y284","Activated CDC42 kinase 1",0,9222,22,737,{"v":6780.4,"d":"6780"},{"v":11914.158833519556,"d":"11914"},{"v":11839.97209144664,"d":"11840"},{"v":74.18674207291588,"d":"74"},{"v":0.6265786903882097,"d":"1"},0,10218,20,791,{"v":8066.618,"d":"8067"},{"v":14094.117127485002,"d":"14094"},{"v":12698.128919241988,"d":"12698"},{"v":1395.988208243014,"d":"1396"},{"v":10.9936528217761,"d":"11"},{"v":11.62023151216431,"d":"12"},{"v":7.247963265177731,"d":"7"},null,0,9833,18,798,{"v":7832.37,"d":"7832"},{"v":13399.9428674779,"d":"13400"},{"v":12656.498447319038,"d":"12656"},{"v":743.4444201588612,"d":"743"},{"v":5.874013442606958,"d":"6"},{"v":6.500592132995168,"d":"7"},{"v":6.896353720818894,"d":"7"},null,null,"ACK1","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Ack",{"$nulls":6},"DDH(pY)VMQ(bA)C","Corresponds to amino acid residues D281 to Q287; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y284 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII.","ACK1 (TNK2); Src","Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK domain target; TK</A> group; Ack family","Q07912","Q07912","Q07912","Q07912","GO:0005912; GO:0005905; GO:0030136; GO:0005737; GO:0030659; GO:0005768; GO:0031234; GO:0070436; GO:0016020; GO:0005634; GO:0048471; GO:0005886","GO:0005524; GO:0005154; GO:0005095; GO:0042802; GO:0046872; GO:0004715; GO:0004712; GO:0004674; GO:0004713; GO:0031625; GO:0050699","GO:0030154; GO:0016477; GO:0007166; GO:0006897; GO:0045087; GO:0038083; GO:0016310; GO:0050731; GO:0042127; GO:2000369; GO:0007264; GO:0007169"]
[52,25,"PK511","ACK1 (TNK2)","Y284","Activated CDC42 kinase 1",0,9178,18,731,{"v":6695.96,"d":"6696"},{"v":11765.785349373724,"d":"11766"},{"$nulls":3},0,8926,16,726,{"v":6468.66,"d":"6469"},{"v":11302.140710998974,"d":"11302"},{"$nulls":6},0,9292,20,751,{"v":6963.272,"d":"6963"},{"v":11913.054027160179,"d":"11913"},{"$nulls":7},"ACK1","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Ack",{"$nulls":6},"DDH(pY)VMQ(bA)C","Corresponds to amino acid residues D281 to Q287; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y284 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII.","ACK1 (TNK2); Src",null,"Q07912","Q07912","Q07912","Q07912"]
[53,26,"PK512","ACK1 (TNK2)","Y518","Activated CDC42 kinase 1",0,16844,22,858,{"v":14433.276,"d":"14433"},{"v":25361.386164831838,"d":"25361"},{"v":23262.704380301144,"d":"23263"},{"v":2098.681784530694,"d":"2099"},{"v":9.021658661096419,"d":"9"},0,15014,24,674,{"v":10103.26,"d":"10103"},{"v":17652.568872039574,"d":"17653"},{"v":17469.65641308315,"d":"17470"},{"v":182.9124589564235,"d":"183"},{"v":1.0470295158148564,"d":"1"},{"v":10.068688176911275,"d":"10"},{"v":-24.902727870812598,"d":"-25"},null,0,13762,20,792,{"v":10883.664,"d":"10884"},{"v":18620.222970675033,"d":"18620"},{"v":17642.923639351917,"d":"17643"},{"v":977.2993313231163,"d":"977"},{"v":5.539327558745903,"d":"6"},{"v":14.560986219842322,"d":"15"},{"v":-24.157899481833482,"d":"-24"},null,null,"ACK1","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Ack",{"$nulls":6},"KPT(pY)DPV(bA)C","Corresponds to amino acid residues K515 to V521; Just after the GTPase-binding domain. ","Y518 phosphorylation stimulates phosphotransferase activity. This is major site of phosphorylation of ACK1 by mass spectrometry studies (≥757 reports).","ACK1 (TNK2)","Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK domain target; TK</A> group; Ack family","Q07912","Q07912","Q07912","Q07912","GO:0005912; GO:0005905; GO:0030136; GO:0005737; GO:0030659; GO:0005768; GO:0031234; GO:0070436; GO:0016020; GO:0005634; GO:0048471; GO:0005886","GO:0005524; GO:0005154; GO:0005095; GO:0042802; GO:0046872; GO:0004715; GO:0004712; GO:0004674; GO:0004713; GO:0031625; GO:0050699","GO:0030154; GO:0016477; GO:0007166; GO:0006897; GO:0045087; GO:0038083; GO:0016310; GO:0050731; GO:0042127; GO:2000369; GO:0007264; GO:0007169"]
[54,26,"PK512","ACK1 (TNK2)","Y518","Activated CDC42 kinase 1",0,16060,22,751,{"v":12044.538,"d":"12045"},{"v":21164.02259577045,"d":"21164"},{"$nulls":3},0,14034,20,706,{"v":9893.884,"d":"9894"},{"v":17286.743954126727,"d":"17287"},{"$nulls":6},0,13166,20,741,{"v":9741.186,"d":"9741"},{"v":16665.624308028804,"d":"16666"},{"$nulls":7},"ACK1","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Ack",{"$nulls":6},"KPT(pY)DPV(bA)C","Corresponds to amino acid residues K515 to V521; Just after the GTPase-binding domain. ","Y518 phosphorylation stimulates phosphotransferase activity. This is major site of phosphorylation of ACK1 by mass spectrometry studies (≥757 reports).","ACK1 (TNK2)",null,"Q07912","Q07912","Q07912","Q07912"]
[55,27,"PK513","ACK1 (TNK2)","Y859+Y860","Activated CDC42 kinase 1",0,9507,22,702,{"v":6658.47,"d":"6658"},{"v":11699.909912132758,"d":"11700"},{"v":11829.109409317442,"d":"11829"},{"v":129.19949718468342,"d":"129"},{"v":1.0922166049366049,"d":"1"},0,12158,18,594,{"v":7211.16,"d":"7211"},{"v":12599.447955144862,"d":"12599"},{"v":10864.405659419714,"d":"10864"},{"v":1735.0422957251485,"d":"1735"},{"v":15.969969735259498,"d":"16"},{"v":17.062186340196103,"d":"17"},{"v":-8.155337113864718,"d":"-8"},null,0,9380,16,598,{"v":5599.672,"d":"5600"},{"v":9580.150692142442,"d":"9580"},{"v":8755.627787127447,"d":"8756"},{"v":824.5229050149956,"d":"825"},{"v":9.41706208922234,"d":"9"},{"v":10.509278694158944,"d":"11"},{"v":-25.98235856850816,"d":"-26"},null,null,"ACK1","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Ack",{"$nulls":6},"STH(pY)(pY)LL(bA)C","Corresponds to amino acid residues S856 to L862; In the Inhibitor_Mig-6 domain. ","The effects of Y859 and Y860 phosphorylation are unclear. These are two of the main sites of phosphorylation of ACK1 (Y859 >595 reports. Y860 (229 reports).","Bmx (Etk)","Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK domain target; TK</A> group; Ack family","Q07912","Q07912","Q07912","Q07912","GO:0005912; GO:0005905; GO:0030136; GO:0005737; GO:0030659; GO:0005768; GO:0031234; GO:0070436; GO:0016020; GO:0005634; GO:0048471; GO:0005886","GO:0005524; GO:0005154; GO:0005095; GO:0042802; GO:0046872; GO:0004715; GO:0004712; GO:0004674; GO:0004713; GO:0031625; GO:0050699","GO:0030154; GO:0016477; GO:0007166; GO:0006897; GO:0045087; GO:0038083; GO:0016310; GO:0050731; GO:0042127; GO:2000369; GO:0007264; GO:0007169"]
[56,27,"PK513","ACK1 (TNK2)","Y859+Y860","Activated CDC42 kinase 1",0,8604,22,793,{"v":6805.526,"d":"6806"},{"v":11958.308906502125,"d":"11958"},{"$nulls":3},0,8432,18,621,{"v":5225.094,"d":"5225"},{"v":9129.363363694563,"d":"9129"},{"$nulls":6},0,7902,18,588,{"v":4635.792,"d":"4636"},{"v":7931.104882112453,"d":"7931"},{"$nulls":7},"ACK1","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Ack",{"$nulls":6},"STH(pY)(pY)LL(bA)C","Corresponds to amino acid residues S856 to L862; In the Inhibitor_Mig-6 domain. ","The effects of Y859 and Y860 phosphorylation are unclear. These are two of the main sites of phosphorylation of ACK1 (Y859 >595 reports. Y860 (229 reports).","Bmx (Etk)",null,"Q07912","Q07912","Q07912","Q07912"]
[57,28,"PN735","ACLY","S455","ATP-citrate synthase",0,8570,14,645,{"v":5518.62,"d":"5519"},{"v":9697.026019384946,"d":"9697"},{"v":8749.797326283793,"d":"8750"},{"v":947.2286931011531,"d":"947"},{"v":10.825721531351851,"d":"11"},0,8396,14,554,{"v":4643.628,"d":"4644"},{"v":8113.417162988122,"d":"8113"},{"v":7787.188508267808,"d":"7787"},{"v":326.2286547203139,"d":"326"},{"v":4.189299570364204,"d":"4"},{"v":15.015021101716055,"d":"15"},{"v":-11.001498458991435,"d":"-11"},null,0,8192,16,575,{"v":4701.2,"d":"4701"},{"v":8043.007596498518,"d":"8043"},{"v":7579.059058991103,"d":"7579"},{"v":463.9485375074155,"d":"464"},{"v":6.121452991674862,"d":"6"},{"v":16.947174523026714,"d":"17"},{"v":-13.380175833054693,"d":"-13"},{"$nulls":5},"Enzyme - Fatty acid synthesis",{"$nulls":8},"X","RTA(pS)FSE(bA)C","Corresponds to amino acid residues S452 to E458.","The effect of S455 phosphorylation is unclear. This is the second most frequently phosphorylated site in ATP-citrate lysate in mass spectrometry studies (≥202 reports). This human phosphosite is highly conserved in vertebrates and is found in fish.","Akt1 (PKBa); Akt3 (PKBg)","Transferase; Carbohydrate Metabolism - citrate (TCA) cycle; Lyase; EC 2.3.3.8","P53396","P53396",null,null,"GO:0035578; GO:0009346; GO:0005829; GO:0070062; GO:0005576; GO:1904813; GO:0016020; GO:0005654; GO:0005886","GO:0005524; GO:0003878; GO:0048037; GO:0046872","GO:0006085; GO:0006695; GO:0006101; GO:0015936; GO:0006633; GO:0046949; GO:0008610; GO:0043312; GO:0006107; GO:0031325"]
[58,28,"PN735","ACLY","S455","ATP-citrate synthase",0,7822,18,569,{"v":4440.476,"d":"4440"},{"v":7802.568633182641,"d":"7803"},{"$nulls":3},0,7651,12,559,{"v":4270.201,"d":"4270"},{"v":7460.959853547494,"d":"7461"},{"$nulls":6},0,7671,12,543,{"v":4158.837,"d":"4159"},{"v":7115.110521483688,"d":"7115"},{"$nulls":10},"Enzyme - Fatty acid synthesis",{"$nulls":8},"X","RTA(pS)FSE(bA)C","Corresponds to amino acid residues S452 to E458.","The effect of S455 phosphorylation is unclear. This is the second most frequently phosphorylated site in ATP-citrate lysate in mass spectrometry studies (≥202 reports). This human phosphosite is highly conserved in vertebrates and is found in fish.","Akt1 (PKBa); Akt3 (PKBg)",null,"P53396","P53396"]
[59,29,"PN686","ACLY","Y682","ATP-citrate synthase",0,10752,18,812,{"v":8716.008,"d":"8716"},{"v":15315.306428267817,"d":"15315"},{"v":12899.593171644188,"d":"12900"},{"v":2415.7132566236287,"d":"2416"},{"v":18.72704995017855,"d":"19"},0,9916,16,568,{"v":5623.2,"d":"5623"},{"v":9824.940195664858,"d":"9825"},{"v":10717.14163103879,"d":"10717"},{"v":892.2014353739323,"d":"892"},{"v":8.324994351011979,"d":"8"},{"v":27.052044301190527,"d":"27"},{"v":-16.918762565340828,"d":"-17"},null,0,10313,14,604,{"v":6220.596,"d":"6221"},{"v":10642.453178496617,"d":"10642"},{"v":10614.50145167972,"d":"10615"},{"v":27.951726816896553,"d":"28"},{"v":0.2633352771596565,"d":"0"},{"v":18.990385227338205,"d":"19"},{"v":-17.714447964045434,"d":"-18"},{"$nulls":5},"Enzyme - Fatty acid synthesis",{"$nulls":8},"X","DGV(pY)EGVA(bA)C","Corresponds to amino acid residues D679 to A686.","The effect of Y682 phosphorylation is unclear. This is the most frequently phosphorylated site in ATP-citrate lysate in mass spectrometry studies (≥378 reports). This human phosphosite is highly conserved in vertebrates and also found in the nematode worm.",null,"Transferase; Carbohydrate Metabolism - citrate (TCA) cycle; Lyase; EC 2.3.3.8","P53396","P53396",null,null,"GO:0035578; GO:0009346; GO:0005829; GO:0070062; GO:0005576; GO:1904813; GO:0016020; GO:0005654; GO:0005886","GO:0005524; GO:0003878; GO:0048037; GO:0046872","GO:0006085; GO:0006695; GO:0006101; GO:0015936; GO:0006633; GO:0046949; GO:0008610; GO:0043312; GO:0006107; GO:0031325"]
[60,29,"PN686","ACLY","Y682","ATP-citrate synthase",0,9927,16,602,{"v":5966.422,"d":"5966"},{"v":10483.87991502056,"d":"10484"},{"$nulls":3},0,10116,18,658,{"v":6644.484,"d":"6644"},{"v":11609.343066412723,"d":"11609"},{"$nulls":6},0,10504,16,590,{"v":6187.92,"d":"6188"},{"v":10586.549724862825,"d":"10587"},{"$nulls":10},"Enzyme - Fatty acid synthesis",{"$nulls":8},"X","DGV(pY)EGVA(bA)C","Corresponds to amino acid residues D679 to A686.","The effect of Y682 phosphorylation is unclear. This is the most frequently phosphorylated site in ATP-citrate lysate in mass spectrometry studies (≥378 reports). This human phosphosite is highly conserved in vertebrates and also found in the nematode worm.",null,null,"P53396","P53396"]
[61,30,"PN736","ACO1","S711","Cytoplasmic aconitate hydratase",0,8662,14,608,{"v":5257.984,"d":"5258"},{"v":9239.050280234867,"d":"9239"},{"v":8785.84343776849,"d":"8786"},{"v":453.20684246637757,"d":"453"},{"v":5.158376036137144,"d":"5"},0,9735,14,591,{"v":5745.111,"d":"5745"},{"v":10037.944941040036,"d":"10038"},{"v":10642.433332319852,"d":"10642"},{"v":604.4883912798159,"d":"604"},{"v":5.679982879893209,"d":"6"},{"v":10.838358916030352,"d":"11"},{"v":21.13160685939694,"d":"21"},null,0,9072,14,575,{"v":5208.35,"d":"5208"},{"v":8910.660813244078,"d":"8911"},{"v":8335.927596206444,"d":"8336"},{"v":574.733217037634,"d":"575"},{"v":6.894652219618444,"d":"7"},{"v":12.053028255755589,"d":"12"},{"v":-5.120918039899877,"d":"-5"},{"$nulls":5},"Enzyme",{"$nulls":8},"X","SYG(pS)RRG(bA)C","Corresponds to amino acid residues S708 to G714.","S711 phosphorylation inhibits enzyme activity. This is phosphorylation site in ACO1 has not been detected by mass spectrometry. This human phosphosite is highly conserved in vertebrates and also found in yeast.","PKCa (PRKCA)","Enzyme, translation initiation complex","P21399","P21399",null,null,"GO:0005737; GO:0005829; GO:0005783; GO:0070062; GO:0005794; GO:0005739","GO:0051538; GO:0051539; GO:0003994; GO:0030350; GO:0046872; GO:0003723","GO:0006879; GO:0006101; GO:0050892; GO:0009791; GO:0006417; GO:0010040; GO:0006099"]
[62,30,"PN736","ACO1","S711","Cytoplasmic aconitate hydratase",0,7788,14,610,{"v":4742.14,"d":"4742"},{"v":8332.63659530211,"d":"8333"},{"$nulls":3},0,8762,16,736,{"v":6437.056,"d":"6437"},{"v":11246.921723599666,"d":"11247"},{"$nulls":6},0,7714,12,589,{"v":4536.478,"d":"4536"},{"v":7761.194379168809,"d":"7761"},{"$nulls":10},"Enzyme",{"$nulls":8},"X","SYG(pS)RRG(bA)C","Corresponds to amino acid residues S708 to G714.","S711 phosphorylation inhibits enzyme activity. This is phosphorylation site in ACO1 has not been detected by mass spectrometry. This human phosphosite is highly conserved in vertebrates and also found in yeast.","PKCa (PRKCA)",null,"P21399","P21399"]
[63,31,"PN737","ACO1","S806","Cytoplasmic aconitate hydratase",0,5792,18,595,{"v":3435.53,"d":"3436"},{"v":6036.730885688373,"d":"6037"},{"v":5623.479806556812,"d":"5623"},{"v":413.2510791315608,"d":"413"},{"v":7.348671878393201,"d":"7"},0,7258,16,543,{"v":3932.406,"d":"3932"},{"v":6870.759314104719,"d":"6871"},{"v":6294.816050233972,"d":"6295"},{"v":575.9432638707467,"d":"576"},{"v":9.149485215685365,"d":"9"},{"v":16.498157094078564,"d":"16"},{"v":11.938092902803746,"d":"12"},null,0,6320,12,592,{"v":3734.336,"d":"3734"},{"v":6388.8566357266,"d":"6389"},{"v":5425.736757938708,"d":"5426"},{"v":963.1198777878917,"d":"963"},{"v":17.750951082886495,"d":"18"},{"v":25.099622961279696,"d":"25"},{"v":-3.5163823010005473,"d":"-4"},{"$nulls":5},"Enzyme",{"$nulls":8},"X","IHR(pS)NLVGC","Corresponds to amino acid residues I803 to G810.","The effect S806 of phosphorylation is unclear. This is phosphorylation site in ACO1 has only been reported in one mass spectrometry study. This human phosphosite is highly conserved in vertebrates and found in fish.",null,"Enzyme, translation initiation complex","P21399","P21399",null,null,"GO:0005737; GO:0005829; GO:0005783; GO:0070062; GO:0005794; GO:0005739","GO:0051538; GO:0051539; GO:0003994; GO:0030350; GO:0046872; GO:0003723","GO:0006879; GO:0006101; GO:0050892; GO:0009791; GO:0006417; GO:0010040; GO:0006099"]
[64,31,"PN737","ACO1","S806","Cytoplasmic aconitate hydratase",0,4810,12,618,{"v":2965.164,"d":"2965"},{"v":5210.228727425252,"d":"5210"},{"$nulls":3},0,5224,12,628,{"v":3273.136,"d":"3273"},{"v":5718.872786363226,"d":"5719"},{"$nulls":6},0,4744,10,551,{"v":2608.434,"d":"2608"},{"v":4462.6168801508165,"d":"4463"},{"$nulls":10},"Enzyme",{"$nulls":8},"X","IHR(pS)NLVGC","Corresponds to amino acid residues I803 to G810.","The effect S806 of phosphorylation is unclear. This is phosphorylation site in ACO1 has only been reported in one mass spectrometry study. This human phosphosite is highly conserved in vertebrates and found in fish.",null,null,"P21399","P21399"]
[65,32,"PN687","ACP1","Y132+Y133","Low molecular weight phosphotyrosine protein phosphatase",0,1924,16,564,{"v":1076.112,"d":"1076"},{"v":1890.8868637036749,"d":"1891"},{"v":1800.681970500094,"d":"1801"},{"v":90.20489320358092,"d":"90"},{"v":5.009484999648705,"d":"5"},0,1264,10,486,{"v":609.444,"d":"609"},{"v":1064.8297859949446,"d":"1065"},{"v":1410.6447224753604,"d":"1411"},{"v":345.8149364804158,"d":"346"},{"v":24.514672686230256,"d":"25"},{"v":29.52415768587896,"d":"30"},{"v":-21.660529422439353,"d":"-22"},null,0,1884,12,544,{"v":1018.368,"d":"1018"},{"v":1742.266136312219,"d":"1742"},{"v":1682.4944702697471,"d":"1682"},{"v":59.77166604247191,"d":"60"},{"v":3.552562406513524,"d":"4"},{"v":8.562047406162229,"d":"9"},{"v":-6.5634855108547185,"d":"-7"},{"$nulls":5},"Phosphatase",{"$nulls":6},"X",null,null,"EDP(pY)(pY)GND(bA)C","Corresponds to amino acid residues E129 to D136.","Y132 and Y133 phosphorylation stimulates phosphatase activity, and regulates cell adhesion, cell motility, and transcription. These are two major in vivo phosphorylation site in ACP1 (≥205 and >86 reports, respectively, by mass spectrometry). These phosphosites are highly conserved and also found in yeast.","Y132: Lck; Src. Y133: Lck; Src.","EC 3.1.3.48; EC 3.1.3.2; Cofactor and Vitamin Metabolism - riboflavin; Phosphatase (non-protein); Protein phosphatase, tyrosine (non-receptor)","P24666","P24666",null,null,"GO:0005737; GO:0009898; GO:0005829; GO:0070062; GO:0042383","GO:0003993; GO:0004726"]
[66,32,"PN687","ACP1","Y132+Y133","Low molecular weight phosphotyrosine protein phosphatase",0,1702,12,576,{"v":973.44,"d":"973"},{"v":1710.477077296513,"d":"1710"},{"$nulls":3},0,1713,12,591,{"v":1005.291,"d":"1005"},{"v":1756.4596589557761,"d":"1756"},{"$nulls":6},0,1775,12,538,{"v":948.494,"d":"948"},{"v":1622.7228042272752,"d":"1623"},{"$nulls":10},"Phosphatase",{"$nulls":6},"X",null,null,"EDP(pY)(pY)GND(bA)C","Corresponds to amino acid residues E129 to D136.","Y132 and Y133 phosphorylation stimulates phosphatase activity, and regulates cell adhesion, cell motility, and transcription. These are two major in vivo phosphorylation site in ACP1 (≥205 and >86 reports, respectively, by mass spectrometry). These phosphosites are highly conserved and also found in yeast.","Y132: Lck; Src. Y133: Lck; Src.",null,"P24666","P24666"]
[67,33,"PN688","ACS1 (ACSL1)","Y567","Long-chain-fatty-acid--CoA ligase 1",0,6466,12,637,{"v":4111.198,"d":"4111"},{"v":7223.978816596061,"d":"7224"},{"v":8179.2183424094455,"d":"8179"},{"v":955.2395258133847,"d":"955"},{"v":11.678860813146956,"d":"12"},0,6323,14,572,{"v":3608.748,"d":"3609"},{"v":6305.259155147454,"d":"6305"},{"v":6897.239233214017,"d":"6897"},{"v":591.9800780665628,"d":"592"},{"v":8.582855517260466,"d":"9"},{"v":20.261716330407424,"d":"20"},{"v":-15.673613975412977,"d":"-16"},null,0,6867,14,637,{"v":4365.361,"d":"4365"},{"v":7468.440331076825,"d":"7468"},{"v":6958.560834464671,"d":"6959"},{"v":509.87949661215407,"d":"510"},{"v":7.3273699654503295,"d":"7"},{"v":19.006230778597285,"d":"19"},{"v":-14.923889506844873,"d":"-15"},{"$nulls":5},"Enzyme - Fatty acid synthesis",{"$nulls":8},"X","acQGE(pY)IAP(bA)C","Corresponds to amino acid residues Q564 to P570.","The effect of Y567 phosphorylation is unclear. This is the most frequently phosphorylated site in ACS1 from mass spectrometry studies (≥20 reports). This human phosphosite is highly conserved in vertebrates and is found in the fruit fly.",null,"EC 6.2.1.3; Lipid Metabolism - fatty acid; Ligase","P33121","P33121",null,null,"GO:0005789; GO:0016021; GO:0016020; GO:0005741; GO:0005739; GO:0005778; GO:0005886","GO:0005524; GO:0102391; GO:0004467","GO:0033211; GO:0036109; GO:0043651; GO:0008610; GO:0044539; GO:0001676; GO:0035338; GO:0120162; GO:0071902; GO:0019216; GO:0042493; GO:0007584; GO:0034201; GO:0014070; GO:0019432; GO:0042178"]
[68,33,"PN688","ACS1 (ACSL1)","Y567","Long-chain-fatty-acid--CoA ligase 1",0,7548,14,690,{"v":5198.46,"d":"5198"},{"v":9134.45786822283,"d":"9134"},{"$nulls":3},0,6641,16,647,{"v":4286.375,"d":"4286"},{"v":7489.219311280579,"d":"7489"},{"$nulls":6},0,5920,12,638,{"v":3769.304,"d":"3769"},{"v":6448.681337852517,"d":"6449"},{"$nulls":10},"Enzyme - Fatty acid synthesis",{"$nulls":8},"X","acQGE(pY)IAP(bA)C","Corresponds to amino acid residues Q564 to P570.","The effect of Y567 phosphorylation is unclear. This is the most frequently phosphorylated site in ACS1 from mass spectrometry studies (≥20 reports). This human phosphosite is highly conserved in vertebrates and is found in the fruit fly.",null,null,"P33121","P33121"]
[69,34,"NN218-1","ACTB","Pan-specific","Actin, cytoplasmic 1; Beta-actin",0,1804,10,347,{"v":622.518,"d":"623"},{"v":1093.8555732294446,"d":"1094"},{"v":577.1480775560069,"d":"577"},{"v":516.7074956734377,"d":"517"},{"v":89.52771667567342,"d":"90"},0,3244,10,325,{"v":1051.05,"d":"1051"},{"v":1836.410476713179,"d":"1836"},{"v":1404.9758829418502,"d":"1405"},{"v":431.43459377132876,"d":"431"},{"v":30.707615625967666,"d":"31"},{"v":120.23533230164108,"d":"120"},{"v":143.4342134329487,"d":"143"},null,0,1820,10,312,{"v":564.72,"d":"565"},{"v":966.1463562270577,"d":"966"},{"v":510.8315798520612,"d":"511"},{"v":455.3147763749965,"d":"455"},{"v":89.1320729440528,"d":"89"},{"v":178.6597896197262,"d":"179"},{"v":-11.490378341858076,"d":"-11"},{"$nulls":5},"Cytoskeletal/contractile protein",{"$nulls":9},"Epitope undefined.",{"$nulls":3},"Cytoskeletal protein","P60709","P60709",null,"P60709","GO:0015629; GO:0072562; GO:0044305; GO:0030863; GO:0005737; GO:0036464; GO:0005856; GO:0005829; GO:0097433; GO:0070062; GO:0005615; GO:0005925; GO:0098978; GO:0016020; GO:0043209; GO:0035267; GO:0000790; GO:0005654; GO:0005634; GO:0005886; GO:0098871; GO:0098793; GO:0032991; GO:1990904; GO:0098685; GO:0031982","GO:0005524; GO:0042802; GO:0019894; GO:0050998; GO:0019901; GO:0005200; GO:0098973; GO:0030957","GO:0043044; GO:0034329; GO:0048870; GO:0072749; GO:0048013; GO:0038096; GO:0061024; GO:0032091; GO:0070527; GO:0045815; GO:0051623; GO:0098974; GO:0016579; GO:0000079; GO:0051621; GO:1903076; GO:0022898; GO:0001895; GO:0021762; GO:0048488"]
[70,34,"NN218-1","ACTB","Pan-specific","Actin, cytoplasmic 1; Beta-actin",0,63,10,649,{"v":34.397,"d":"34"},{"v":60.44058188256919,"d":"60"},{"$nulls":3},0,1586,12,354,{"v":557.196,"d":"557"},{"v":973.5412891705214,"d":"974"},{"$nulls":6},0,58,8,649,{"v":32.45,"d":"32"},{"v":55.516803477064784,"d":"56"},{"$nulls":10},"Cytoskeletal/contractile protein",{"$nulls":9},"Epitope undefined.",{"$nulls":4},"P60709","P60709",null,"P60709"]
[71,35,"PN501","ACTB","Y53","Actin, cytoplasmic 1; Beta-actin",0,2693,16,688,{"v":1841.776,"d":"1842"},{"v":3236.270986927661,"d":"3236"},{"v":3233.139751153764,"d":"3233"},{"v":3.1312357738970604,"d":"3"},{"v":0.09684814189611388,"d":"0"},0,2476,14,573,{"v":1410.726,"d":"1411"},{"v":2464.84183071374,"d":"2465"},{"v":2724.035955625942,"d":"2724"},{"v":259.1941249122019,"d":"259"},{"v":9.515077228583904,"d":"10"},{"v":9.611925370480018,"d":"10"},{"v":-15.746420962661617,"d":"-16"},null,0,3081,14,644,{"v":1975.148,"d":"1975"},{"v":3379.1649723919118,"d":"3379"},{"v":2998.016881611191,"d":"2998"},{"v":381.14809078072085,"d":"381"},{"v":12.713340379053658,"d":"13"},{"v":12.810188520949772,"d":"13"},{"v":-7.272276722918264,"d":"-7"},{"$nulls":5},"Cytoskeletal/contractile protein",{"$nulls":9},"KDS(pY)VGD(bA)C","Corresponds to amino acid residues K50 to D56; In the Actin domain. ","The effect of Y53 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in actin from mass spectrometry studies (≥1069 reports).",null,"Cytoskeletal protein","P60709","P60709",null,"P60709","GO:0015629; GO:0072562; GO:0044305; GO:0030863; GO:0005737; GO:0036464; GO:0005856; GO:0005829; GO:0097433; GO:0070062; GO:0005615; GO:0005925; GO:0098978; GO:0016020; GO:0043209; GO:0035267; GO:0000790; GO:0005654; GO:0005634; GO:0005886; GO:0098871; GO:0098793; GO:0032991; GO:1990904; GO:0098685; GO:0031982","GO:0005524; GO:0042802; GO:0019894; GO:0050998; GO:0019901; GO:0005200; GO:0098973; GO:0030957","GO:0043044; GO:0034329; GO:0048870; GO:0072749; GO:0048013; GO:0038096; GO:0061024; GO:0032091; GO:0070527; GO:0045815; GO:0051623; GO:0098974; GO:0016579; GO:0000079; GO:0051621; GO:1903076; GO:0022898; GO:0001895; GO:0021762; GO:0048488"]
[72,35,"PN501","ACTB","Y53","Actin, cytoplasmic 1; Beta-actin",0,2560,14,722,{"v":1838.212,"d":"1838"},{"v":3230.008515379867,"d":"3230"},{"$nulls":3},0,2402,14,715,{"v":1707.42,"d":"1707"},{"v":2983.230080538144,"d":"2983"},{"$nulls":6},0,2417,12,636,{"v":1529.58,"d":"1530"},{"v":2616.8687908304696,"d":"2617"},{"$nulls":10},"Cytoskeletal/contractile protein",{"$nulls":9},"KDS(pY)VGD(bA)C","Corresponds to amino acid residues K50 to D56; In the Actin domain. ","The effect of Y53 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in actin from mass spectrometry studies (≥1069 reports).",null,null,"P60709","P60709",null,"P60709"]
[73,36,"PN500","ACTB","Y294","Actin, cytoplasmic 1; Beta-actin",0,7166,14,774,{"v":5535.648,"d":"5536"},{"v":9726.946716779963,"d":"9727"},{"v":9715.38117589119,"d":"9715"},{"v":11.565540888772375,"d":"12"},{"v":0.11904361423792997,"d":"0"},0,7563,18,666,{"v":5024.97,"d":"5025"},{"v":8779.70368029059,"d":"8780"},{"v":9805.49107029353,"d":"9805"},{"v":1025.7873900029408,"d":"1026"},{"v":10.46135662813095,"d":"10"},{"v":10.58040024236888,"d":"11"},{"v":0.9274972620317641,"d":"1"},null,0,7632,16,751,{"v":5719.616,"d":"5720"},{"v":9785.355853198007,"d":"9785"},{"v":9215.330871697164,"d":"9215"},{"v":570.0249815008428,"d":"570"},{"v":6.18561600703397,"d":"6"},{"v":6.304659621271901,"d":"6"},{"v":-5.146996243800558,"d":"-5"},{"$nulls":5},"Cytoskeletal/contractile protein",{"$nulls":9},"KDL(pY)ANT(bA)C","Corresponds to amino acid residues K291 to T297; In the Actin domain. ","The effect of Y294 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in actin from mass spectrometry studies (≥783 reports).",null,"Cytoskeletal protein","P60709","P60709",null,"P60709","GO:0015629; GO:0072562; GO:0044305; GO:0030863; GO:0005737; GO:0036464; GO:0005856; GO:0005829; GO:0097433; GO:0070062; GO:0005615; GO:0005925; GO:0098978; GO:0016020; GO:0043209; GO:0035267; GO:0000790; GO:0005654; GO:0005634; GO:0005886; GO:0098871; GO:0098793; GO:0032991; GO:1990904; GO:0098685; GO:0031982","GO:0005524; GO:0042802; GO:0019894; GO:0050998; GO:0019901; GO:0005200; GO:0098973; GO:0030957","GO:0043044; GO:0034329; GO:0048870; GO:0072749; GO:0048013; GO:0038096; GO:0061024; GO:0032091; GO:0070527; GO:0045815; GO:0051623; GO:0098974; GO:0016579; GO:0000079; GO:0051621; GO:1903076; GO:0022898; GO:0001895; GO:0021762; GO:0048488"]
[74,36,"PN500","ACTB","Y294","Actin, cytoplasmic 1; Beta-actin",0,7078,16,782,{"v":5522.484,"d":"5522"},{"v":9703.81563500242,"d":"9704"},{"$nulls":3},0,6928,17,897,{"v":6199.167,"d":"6199"},{"v":10831.278460296473,"d":"10831"},{"$nulls":6},0,6812,20,744,{"v":5053.248,"d":"5053"},{"v":8645.305890196321,"d":"8645"},{"$nulls":10},"Cytoskeletal/contractile protein",{"$nulls":9},"KDL(pY)ANT(bA)C","Corresponds to amino acid residues K291 to T297; In the Actin domain. ","The effect of Y294 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in actin from mass spectrometry studies (≥783 reports).",null,null,"P60709","P60709",null,"P60709"]
[75,37,"PN502","ACTN1","Y246","Alpha-actinin-1",0,10630,22,814,{"v":8634.912,"d":"8635"},{"v":15172.808843352017,"d":"15173"},{"v":15583.250244592184,"d":"15583"},{"v":410.44140124016667,"d":"410"},{"v":2.6338626075943377,"d":"3"},0,11754,18,744,{"v":8731.584,"d":"8732"},{"v":15255.95579268462,"d":"15256"},{"v":14882.520005606115,"d":"14883"},{"v":373.4357870785043,"d":"373"},{"v":2.509224156512703,"d":"3"},{"v":5.143086764107041,"d":"5"},{"v":-4.496688611088956,"d":"-4"},null,0,10854,16,798,{"v":8648.724,"d":"8649"},{"v":14796.595088917522,"d":"14797"},{"v":14342.056179118084,"d":"14342"},{"v":454.53890979943753,"d":"455"},{"v":3.1692729698077913,"d":"3"},{"v":5.803135577402129,"d":"6"},{"v":-7.964924171739,"d":"-8"},{"$nulls":5},"Cytoskeletal/contractile protein",{"$nulls":9},"SSF(pY)HAF(bA)C","Corresponds to amino acid residues S243 to F249; In the second CH domain.","The effect of Y246 phosphorylation is unclear. This is the major in vivo phosphorylation site in ACTN1 from mass spectrometry studies (≥522 reports).",null,"Cytoskeletal protein","P12814","P12814",null,null,"GO:0005903; GO:0005911; GO:0042995; GO:0005737; GO:0005829; GO:0070062; GO:0005576; GO:0005615; GO:0005916; GO:0005925; GO:0098978; GO:0005622; GO:0005886; GO:0031093; GO:0031143; GO:0001726; GO:0001725; GO:0030018","GO:0051015; GO:0005509; GO:0003725; GO:0005178; GO:0044325; GO:0030374; GO:0042803; GO:0099186; GO:0017166","GO:0051764; GO:0051017; GO:0051639; GO:0007015; GO:0048041; GO:0051271; GO:0002576; GO:0030220; GO:0036344; GO:0042981"]
[76,37,"PN502","ACTN1","Y246","Alpha-actinin-1",0,10956,16,832,{"v":9102.08,"d":"9102"},{"v":15993.69164583235,"d":"15994"},{"$nulls":3},0,10270,18,810,{"v":8304.12,"d":"8304"},{"v":14509.08421852761,"d":"14509"},{"$nulls":6},0,10383,16,783,{"v":8117.361,"d":"8117"},{"v":13887.517269318645,"d":"13888"},{"$nulls":10},"Cytoskeletal/contractile protein",{"$nulls":9},"SSF(pY)HAF(bA)C","Corresponds to amino acid residues S243 to F249; In the second CH domain.","The effect of Y246 phosphorylation is unclear. This is the major in vivo phosphorylation site in ACTN1 from mass spectrometry studies (≥522 reports).",null,null,"P12814","P12814"]
[77,38,"NK357-1","ACTR-I (ALK2","Pan-specific","Activin receptor type-1",0,176,10,564,{"v":93.624,"d":"94"},{"v":164.51112126562367,"d":"165"},{"v":143.47280144470903,"d":"143"},{"v":21.038319820914637,"d":"21"},{"v":14.663629349303742,"d":"15"},0,241,12,483,{"v":110.607,"d":"111"},{"v":193.2542253915747,"d":"193"},{"v":167.5780252483479,"d":"168"},{"v":25.676200143226794,"d":"26"},{"v":15.321937411050811,"d":"15"},{"v":29.98556676035455,"d":"30"},{"v":16.801249826385003,"d":"17"},null,0,186,10,526,{"v":92.576,"d":"93"},{"v":158.3828535806702,"d":"158"},{"v":139.63203182077407,"d":"140"},{"v":18.750821759896127,"d":"19"},{"v":13.428739462850409,"d":"13"},{"v":28.09236881215415,"d":"28"},{"v":-2.677001902283976,"d":"-3"},null,null,"ALK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","STKR","Type 1",{"$nulls":5},"Not precisely defined.","Antibody raised against a peptide mapping at the N-terminus of human ACTR-I. ",null,null,"Protein-serine kinase, TKL group, STKR family, Type 1 subfamily","Q04771","Q04771","Q04771","Q04771","GO:0048179; GO:0045177; GO:0005887","GO:0048185; GO:0016361; GO:0005524; GO:0046872; GO:0017046; GO:0042803; GO:0004672; GO:0004674; GO:0046332; GO:0050431; GO:0005025; GO:0004675","GO:0032924; GO:0002526; GO:0003289; GO:0003181; GO:0030509; GO:0061312; GO:0001569; GO:0060923; GO:0071773; GO:0007368; GO:0003143; GO:0061445; GO:0003274; GO:0003203; GO:0000082; GO:0001702; GO:0007281; GO:0001701; GO:0001707; GO:0003183; GO:0032926; GO:2001237; GO:0009968; GO:0001755; GO:0060389; GO:0018107; GO:0060037; GO:0030501; GO:0030335; GO:2000017; GO:1905007; GO:0045669; GO:0010862; GO:0045893; GO:0045944; GO:0006468; GO:0030278; GO:0051145; GO:0007179; GO:0060412"]
[78,38,"NK357-1","ACTR-I (ALK2","Pan-specific","Activin receptor type-1",0,136,10,553,{"v":69.678,"d":"70"},{"v":122.4344816237944,"d":"122"},{"$nulls":3},0,154,10,564,{"v":81.216,"d":"81"},{"v":141.9018251051211,"d":"142"},{"$nulls":6},0,138,10,552,{"v":70.656,"d":"71"},{"v":120.88121006087795,"d":"121"},{"$nulls":7},"ALK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","STKR","Type 1",{"$nulls":5},"Not precisely defined.","Antibody raised against a peptide mapping at the N-terminus of human ACTR-I. ",{"$nulls":3},"Q04771","Q04771","Q04771","Q04771"]
[79,39,"PN003-PN004","Adducin a/g (ADD3)","S726","Adducin-alpha/gamma",0,956,14,339,{"v":319.338,"d":"319"},{"v":561.1237764111952,"d":"561"},{"v":328.60579871620047,"d":"329"},{"v":232.51797769499473,"d":"233"},{"v":70.75893931373021,"d":"71"},0,1088,18,300,321,{"v":560.856061105495,"d":"561"},{"v":482.3432014113002,"d":"482"},{"v":78.51285969419479,"d":"79"},{"v":16.27738495421352,"d":"16"},{"v":87.03632426794373,"d":"87"},{"v":46.78475038959206,"d":"47"},null,0,838,12,336,{"v":277.536,"d":"278"},{"v":474.8200791929322,"d":"475"},{"v":436.83597839793094,"d":"437"},{"v":37.98410079500127,"d":"38"},{"v":8.695277558022035,"d":"9"},{"v":79.45421687175224,"d":"79"},{"v":32.93617462155717,"d":"33"},{"$nulls":5},"Cytoskeletal/contractile protein",{"$nulls":9},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S726 and S693 phosphosites in ADD1 and ADD3 [TP(pS)FL]. ","Phosphorylation of S726 affects intracellular location of ADD1, and induced cell motility. This is the major in vivo phosphorylation site in ADD1 from mass spectrometry studies (≥208 reports) and ADD3 (≥213 reports).","PKCA; CHK1; PKCz (PRKCZ); PKACa (PRKACA)","Cytoskeletal protein","Q9UEY8","Q9UEY8",null,"Q9UEY8","GO:0005903; GO:0005911; GO:0005938; GO:0000794; GO:0005856; GO:0005829; GO:0016020; GO:0005654; GO:0005886; GO:0014069","GO:0003779; GO:0005516; GO:0005200","GO:0055085"]
[80,39,"PN003-PN004","Adducin a/g (ADD3)","S726","Adducin-alpha/gamma",0,94,10,651,{"v":54.684,"d":"55"},{"v":96.08782102120573,"d":"96"},{"$nulls":3},0,706,14,334,{"v":231.128,"d":"231"},{"v":403.8303417171054,"d":"404"},{"$nulls":6},0,708,10,334,{"v":233.132,"d":"233"},{"v":398.8518776029296,"d":"399"},{"$nulls":10},"Cytoskeletal/contractile protein",{"$nulls":9},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S726 and S693 phosphosites in ADD1 and ADD3 [TP(pS)FL]. ","Phosphorylation of S726 affects intracellular location of ADD1, and induced cell motility. This is the major in vivo phosphorylation site in ADD1 from mass spectrometry studies (≥208 reports) and ADD3 (≥213 reports).","PKCA; CHK1; PKCz (PRKCZ); PKACa (PRKACA)",null,"Q9UEY8","Q9UEY8",null,"Q9UEY8"]
[81,40,"PN689","ADK","S86","Adenosine kinase",0,534,16,585,{"v":303.03,"d":"303"},{"v":532.4682247834096,"d":"532"},{"v":489.1352251088439,"d":"489"},{"v":43.33299967456571,"d":"43"},{"v":8.859104282445232,"d":"9"},0,517,14,532,{"v":267.596,"d":"268"},{"v":467.5477835750344,"d":"468"},{"v":422.65134324429664,"d":"423"},{"v":44.89644033073773,"d":"45"},{"v":10.622571310458879,"d":"11"},{"v":19.48167559290411,"d":"19"},{"v":-13.592127177050699,"d":"-14"},null,0,555,12,487,{"v":264.441,"d":"264"},{"v":452.4166110409395,"d":"452"},{"v":471.353059092893,"d":"471"},{"v":18.936448051953505,"d":"19"},{"v":4.017465822412656,"d":"4"},{"v":12.876570104857887,"d":"13"},{"v":-3.6354294483685834,"d":"-4"},{"$nulls":5},"Enzyme - Nucleotide metabolism",{"$nulls":8},"X","TQN(pS)IKVAC","Corresponds to amino acid residues T83 to A90.","The effect of S86 phosphorylation is unclear. Although this phosphosite has not been easily identified by mass spectrometry (no reports), its surrounding sequence is highly conserved in evolution, including in plants and fungi.",null,"Enzyme, metabolite kinase","P55263","P55263",null,null,"GO:0005829; GO:0005654; GO:0005634","GO:0004001; GO:0005524; GO:0046872; GO:0003723","GO:0006169; GO:0044209; GO:0046835; GO:0006175; GO:0043101; GO:0009156"]
[82,40,"PN689","ADK","S86","Adenosine kinase",0,488,12,533,{"v":253.708,"d":"254"},{"v":445.8022254342781,"d":"446"},{"$nulls":3},0,431,12,516,{"v":216.204,"d":"216"},{"v":377.75490291355896,"d":"378"},{"$nulls":6},0,532,10,549,{"v":286.578,"d":"287"},{"v":490.2895071448465,"d":"490"},{"$nulls":10},"Enzyme - Nucleotide metabolism",{"$nulls":8},"X","TQN(pS)IKVAC","Corresponds to amino acid residues T83 to A90.","The effect of S86 phosphorylation is unclear. Although this phosphosite has not been easily identified by mass spectrometry (no reports), its surrounding sequence is highly conserved in evolution, including in plants and fungi.",null,null,"P55263","P55263"]
[83,41,"NK129-3","Akt1 (PKBa)","Pan-specific","RAC-alpha serine/threonine-protein kinase",0,2106,12,640,{"v":1340.16,"d":"1340"},{"v":2354.857988072911,"d":"2355"},{"v":2195.6323646792753,"d":"2196"},{"v":159.22562339363594,"d":"159"},{"v":7.251925502423292,"d":"7"},0,2618,14,617,{"v":1606.668,"d":"1607"},{"v":2807.194660387051,"d":"2807"},{"v":2351.6694642153407,"d":"2352"},{"v":455.5251961717104,"d":"456"},{"v":19.37029004727504,"d":"19"},{"v":26.622215549698332,"d":"27"},{"v":7.10670429376998,"d":"7"},null,0,2239,10,602,{"v":1341.858,"d":"1342"},{"v":2295.706221267402,"d":"2296"},{"v":2045.5726541683493,"d":"2046"},{"v":250.13356709905247,"d":"250"},{"v":12.228046096986327,"d":"12"},{"v":19.47997159940962,"d":"19"},{"v":-6.834464317656639,"d":"-7"},null,null,"AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"CEMEVSLAKPKHRVTM","Corresponds to amino acid residues E133 to M147; Pre-kinase catalytic domain.",null,null,"EC 2.7.11.1; Nuclear receptor co-regulator; Protein kinase, Ser/Thr (non-receptor); AGC group; AKT family","P31749","P31749","P31749","P31749","GO:0005911; GO:0036064; GO:0005737; GO:0005829; GO:0015630; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0098794; GO:0032991; GO:0005819; GO:0031982","GO:0071889; GO:0005524; GO:0019899; GO:0032794; GO:0042802; GO:0016301; GO:0030235; GO:0005547; GO:0043325; GO:0042803; GO:0004672; GO:0005080; GO:0051721; GO:0004712; GO:0004674","GO:0006924; GO:0032148; GO:0007568; GO:0043276; GO:0008637; GO:0008643; GO:0030154; GO:0002042; GO:0030030; GO:0008283; GO:0006464; GO:0071276; GO:0006974; GO:0071364; GO:0097011; GO:0071456; GO:0032869; GO:0071260; GO:1990090; GO:0071407; GO:0140052; GO:0071380; GO:0034614; GO:0071356; GO:0035924; GO:0051186; GO:0019221; GO:0031018; GO:0007173; GO:0072655; GO:0060079; GO:0097194; GO:0007281; GO:0042593; GO:0006006; GO:0005978; GO:0060709; GO:0007186; GO:0030212; GO:0007249; GO:0006954; GO:0048009; GO:0008286; GO:0035655; GO:0035556; GO:0060716; GO:0031663; GO:0072656; GO:0060644; GO:0001893; GO:0043066; GO:0010507; GO:0045792; GO:0043154; GO:0010951; GO:2001240; GO:0031999; GO:0010629; GO:0046329; GO:1903038; GO:2000402; GO:0016242; GO:1901215; GO:0045746; GO:1902176; GO:0010748; GO:0032091; GO:0006469; GO:0100002; GO:0051898; GO:0071901; GO:0031397; GO:0045861; GO:0090201; GO:0038061; GO:0006809; GO:0001649; GO:0018105; GO:0018107; GO:0032287; GO:0014065; GO:0016310; GO:0043065; GO:0043536; GO:0030307; GO:0008284; GO:0032270; GO:0031659; GO:0051091; GO:0032079; GO:0001938; GO:0045742; GO:0045600; GO:0010763; GO:0010628; GO:0046326; GO:0010907; GO:0045725; GO:1903721; GO:0046889; GO:0010918; GO:0045429; GO:0051000; GO:0046622; GO:0033138; GO:0032436; GO:2000010; GO:1900182; GO:1903078; GO:0001934; GO:0048661; GO:0010765; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0030163; GO:0000060; GO:0043491; GO:0006468; GO:0016567; GO:0042981; GO:0030334; GO:0005979; GO:0043488; GO:0031641; GO:0010975; GO:0050999; GO:1901796; GO:0006417; GO:0034405; GO:0032094; GO:0060416; GO:0009408; GO:1990418; GO:0006979; GO:0070141; GO:0007165; GO:0021510; GO:0051146; GO:0031295; GO:0031929; GO:0006412"]
[84,41,"NK129-3","Akt1 (PKBa)","Pan-specific","RAC-alpha serine/threonine-protein kinase",0,1822,14,641,{"v":1158.928,"d":"1159"},{"v":2036.4067412856398,"d":"2036"},{"$nulls":3},0,1794,12,609,{"v":1085.238,"d":"1085"},{"v":1896.1442680436298,"d":"1896"},{"$nulls":6},0,1807,10,584,{"v":1049.448,"d":"1049"},{"v":1795.4390870692969,"d":"1795"},{"$nulls":7},"AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"CEMEVSLAKPKHRVTM","Corresponds to amino acid residues E133 to M147; Pre-kinase catalytic domain.",{"$nulls":3},"P31749","P31749","P31749","P31749"]
[85,42,"NK129-5","Akt1 (PKBa)","Pan-specific","RAC-alpha serine/threonine-protein kinase",0,7106,14,657,{"v":4659.444,"d":"4659"},{"v":8187.3275753480175,"d":"8187"},{"v":7964.298190907256,"d":"7964"},{"v":223.02938444076153,"d":"223"},{"v":2.8003645656486285,"d":"3"},0,7822,16,611,{"v":4769.466,"d":"4769"},{"v":8333.28322223234,"d":"8333"},{"v":7776.022929892437,"d":"7776"},{"v":557.2602923399027,"d":"557"},{"v":7.1663920922569995,"d":"7"},{"v":9.966756657905627,"d":"10"},{"v":-2.3639906053463733,"d":"-2"},null,0,7158,16,610,{"v":4356.62,"d":"4357"},{"v":7453.485866386747,"d":"7453"},{"v":6902.666790458587,"d":"6903"},{"v":550.8190759281606,"d":"551"},{"v":7.979801034138667,"d":"8"},{"v":10.780165599787296,"d":"11"},{"v":-13.329880109972791,"d":"-13"},null,null,"AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"CDQDDSMEGVDSERRP","Corresponds to amino acid residues D435 to P467; Pre-C-terminus.",null,null,"EC 2.7.11.1; Nuclear receptor co-regulator; Protein kinase, Ser/Thr (non-receptor); AGC group; AKT family","P31749","P31749","P31749","P31749","GO:0005911; GO:0036064; GO:0005737; GO:0005829; GO:0015630; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0098794; GO:0032991; GO:0005819; GO:0031982","GO:0071889; GO:0005524; GO:0019899; GO:0032794; GO:0042802; GO:0016301; GO:0030235; GO:0005547; GO:0043325; GO:0042803; GO:0004672; GO:0005080; GO:0051721; GO:0004712; GO:0004674","GO:0006924; GO:0032148; GO:0007568; GO:0043276; GO:0008637; GO:0008643; GO:0030154; GO:0002042; GO:0030030; GO:0008283; GO:0006464; GO:0071276; GO:0006974; GO:0071364; GO:0097011; GO:0071456; GO:0032869; GO:0071260; GO:1990090; GO:0071407; GO:0140052; GO:0071380; GO:0034614; GO:0071356; GO:0035924; GO:0051186; GO:0019221; GO:0031018; GO:0007173; GO:0072655; GO:0060079; GO:0097194; GO:0007281; GO:0042593; GO:0006006; GO:0005978; GO:0060709; GO:0007186; GO:0030212; GO:0007249; GO:0006954; GO:0048009; GO:0008286; GO:0035655; GO:0035556; GO:0060716; GO:0031663; GO:0072656; GO:0060644; GO:0001893; GO:0043066; GO:0010507; GO:0045792; GO:0043154; GO:0010951; GO:2001240; GO:0031999; GO:0010629; GO:0046329; GO:1903038; GO:2000402; GO:0016242; GO:1901215; GO:0045746; GO:1902176; GO:0010748; GO:0032091; GO:0006469; GO:0100002; GO:0051898; GO:0071901; GO:0031397; GO:0045861; GO:0090201; GO:0038061; GO:0006809; GO:0001649; GO:0018105; GO:0018107; GO:0032287; GO:0014065; GO:0016310; GO:0043065; GO:0043536; GO:0030307; GO:0008284; GO:0032270; GO:0031659; GO:0051091; GO:0032079; GO:0001938; GO:0045742; GO:0045600; GO:0010763; GO:0010628; GO:0046326; GO:0010907; GO:0045725; GO:1903721; GO:0046889; GO:0010918; GO:0045429; GO:0051000; GO:0046622; GO:0033138; GO:0032436; GO:2000010; GO:1900182; GO:1903078; GO:0001934; GO:0048661; GO:0010765; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0030163; GO:0000060; GO:0043491; GO:0006468; GO:0016567; GO:0042981; GO:0030334; GO:0005979; GO:0043488; GO:0031641; GO:0010975; GO:0050999; GO:1901796; GO:0006417; GO:0034405; GO:0032094; GO:0060416; GO:0009408; GO:1990418; GO:0006979; GO:0070141; GO:0007165; GO:0021510; GO:0051146; GO:0031295; GO:0031929; GO:0006412"]
[86,42,"NK129-5","Akt1 (PKBa)","Pan-specific","RAC-alpha serine/threonine-protein kinase",0,6629,14,666,{"v":4405.59,"d":"4406"},{"v":7741.268806466494,"d":"7741"},{"$nulls":3},0,6498,12,637,{"v":4131.582,"d":"4132"},{"v":7218.762637552533,"d":"7219"},{"$nulls":6},0,5864,8,634,{"v":3712.704,"d":"3713"},{"v":6351.847714530426,"d":"6352"},{"$nulls":7},"AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"CDQDDSMEGVDSERRP","Corresponds to amino acid residues D435 to P467; Pre-C-terminus.",{"$nulls":3},"P31749","P31749","P31749","P31749"]
[87,43,"NK129","Akt1 (PKBa)","Pan-specific","RAC-alpha serine/threonine-protein kinase",0,681,12,528,{"v":353.232,"d":"353"},{"v":620.6805134036016,"d":"621"},{"v":619.0639382565839,"d":"619"},{"v":1.6165751470176701,"d":"2"},{"v":0.2611321782965247,"d":"0"},0,517,10,450,{"v":228.15,"d":"228"},{"v":398.6271350193728,"d":"399"},{"v":441.3308203448538,"d":"441"},{"v":42.70368532548099,"d":"43"},{"v":9.676116726249152,"d":"10"},{"v":9.937248904545676,"d":"10"},{"v":-28.709977585233688,"d":"-29"},null,0,649,16,474,{"v":300.042,"d":"300"},{"v":513.3242757739744,"d":"513"},{"v":509.36367792961676,"d":"509"},{"v":3.9605978443576078,"d":"4"},{"v":0.7775579641752308,"d":"1"},{"v":1.0386901424717556,"d":"1"},{"v":-17.720344143434758,"d":"-18"},null,null,"AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 345-480 of human Akt1.",null,null,"EC 2.7.11.1; Nuclear receptor co-regulator; Protein kinase, Ser/Thr (non-receptor); AGC group; AKT family","P31749","P31749","P31749","P31749","GO:0005911; GO:0036064; GO:0005737; GO:0005829; GO:0015630; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0098794; GO:0032991; GO:0005819; GO:0031982","GO:0071889; GO:0005524; GO:0019899; GO:0032794; GO:0042802; GO:0016301; GO:0030235; GO:0005547; GO:0043325; GO:0042803; GO:0004672; GO:0005080; GO:0051721; GO:0004712; GO:0004674","GO:0006924; GO:0032148; GO:0007568; GO:0043276; GO:0008637; GO:0008643; GO:0030154; GO:0002042; GO:0030030; GO:0008283; GO:0006464; GO:0071276; GO:0006974; GO:0071364; GO:0097011; GO:0071456; GO:0032869; GO:0071260; GO:1990090; GO:0071407; GO:0140052; GO:0071380; GO:0034614; GO:0071356; GO:0035924; GO:0051186; GO:0019221; GO:0031018; GO:0007173; GO:0072655; GO:0060079; GO:0097194; GO:0007281; GO:0042593; GO:0006006; GO:0005978; GO:0060709; GO:0007186; GO:0030212; GO:0007249; GO:0006954; GO:0048009; GO:0008286; GO:0035655; GO:0035556; GO:0060716; GO:0031663; GO:0072656; GO:0060644; GO:0001893; GO:0043066; GO:0010507; GO:0045792; GO:0043154; GO:0010951; GO:2001240; GO:0031999; GO:0010629; GO:0046329; GO:1903038; GO:2000402; GO:0016242; GO:1901215; GO:0045746; GO:1902176; GO:0010748; GO:0032091; GO:0006469; GO:0100002; GO:0051898; GO:0071901; GO:0031397; GO:0045861; GO:0090201; GO:0038061; GO:0006809; GO:0001649; GO:0018105; GO:0018107; GO:0032287; GO:0014065; GO:0016310; GO:0043065; GO:0043536; GO:0030307; GO:0008284; GO:0032270; GO:0031659; GO:0051091; GO:0032079; GO:0001938; GO:0045742; GO:0045600; GO:0010763; GO:0010628; GO:0046326; GO:0010907; GO:0045725; GO:1903721; GO:0046889; GO:0010918; GO:0045429; GO:0051000; GO:0046622; GO:0033138; GO:0032436; GO:2000010; GO:1900182; GO:1903078; GO:0001934; GO:0048661; GO:0010765; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0030163; GO:0000060; GO:0043491; GO:0006468; GO:0016567; GO:0042981; GO:0030334; GO:0005979; GO:0043488; GO:0031641; GO:0010975; GO:0050999; GO:1901796; GO:0006417; GO:0034405; GO:0032094; GO:0060416; GO:0009408; GO:1990418; GO:0006979; GO:0070141; GO:0007165; GO:0021510; GO:0051146; GO:0031295; GO:0031929; GO:0006412"]
[88,43,"NK129","Akt1 (PKBa)","Pan-specific","RAC-alpha serine/threonine-protein kinase",0,642,10,556,{"v":351.392,"d":"351"},{"v":617.4473631095664,"d":"617"},{"$nulls":3},0,592,10,476,{"v":277.032,"d":"277"},{"v":484.0345056703348,"d":"484"},{"$nulls":6},0,610,12,494,{"v":295.412,"d":"295"},{"v":505.40308008525915,"d":"505"},{"$nulls":7},"AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 345-480 of human Akt1.",{"$nulls":3},"P31749","P31749","P31749","P31749"]
[89,44,"PK515","Akt1 (PKBa)","T308","RAC-alpha serine/threonine-protein kinase",0,7784,14,694,{"v":5392.38,"d":"5392"},{"v":9475.203794863752,"d":"9475"},{"v":8603.249517765953,"d":"8603"},{"v":871.9542770977987,"d":"872"},{"v":10.135173637556234,"d":"10"},0,8120,16,601,{"v":4870.504,"d":"4871"},{"v":8509.81834591451,"d":"8510"},{"v":8599.37360531645,"d":"8599"},{"v":89.55525940194093,"d":"90"},{"v":1.0414160788010718,"d":"1"},{"v":11.176589716357306,"d":"11"},{"v":-0.04505172657725609,"d":"-0"},null,0,8257,18,653,{"v":5380.067,"d":"5380"},{"v":9204.441366176932,"d":"9204"},{"v":8260.8550200901,"d":"8261"},{"v":943.5863460868313,"d":"944"},{"v":11.422381143260152,"d":"11"},{"v":21.557554780816385,"d":"22"},{"v":-3.9798275868763113,"d":"-4"},null,null,"AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"TMK(pT)FCG(bA)C","Corresponds to amino acid residues T305 to G311; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T308 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of phosphorylation of Akt1 by mass spectrometry studies (≥26 reports).",null,"EC 2.7.11.1; Nuclear receptor co-regulator; Protein kinase, Ser/Thr (non-receptor); AGC group; AKT family","P31749","P31749","P31749","P31749","GO:0005911; GO:0036064; GO:0005737; GO:0005829; GO:0015630; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0098794; GO:0032991; GO:0005819; GO:0031982","GO:0071889; GO:0005524; GO:0019899; GO:0032794; GO:0042802; GO:0016301; GO:0030235; GO:0005547; GO:0043325; GO:0042803; GO:0004672; GO:0005080; GO:0051721; GO:0004712; GO:0004674","GO:0006924; GO:0032148; GO:0007568; GO:0043276; GO:0008637; GO:0008643; GO:0030154; GO:0002042; GO:0030030; GO:0008283; GO:0006464; GO:0071276; GO:0006974; GO:0071364; GO:0097011; GO:0071456; GO:0032869; GO:0071260; GO:1990090; GO:0071407; GO:0140052; GO:0071380; GO:0034614; GO:0071356; GO:0035924; GO:0051186; GO:0019221; GO:0031018; GO:0007173; GO:0072655; GO:0060079; GO:0097194; GO:0007281; GO:0042593; GO:0006006; GO:0005978; GO:0060709; GO:0007186; GO:0030212; GO:0007249; GO:0006954; GO:0048009; GO:0008286; GO:0035655; GO:0035556; GO:0060716; GO:0031663; GO:0072656; GO:0060644; GO:0001893; GO:0043066; GO:0010507; GO:0045792; GO:0043154; GO:0010951; GO:2001240; GO:0031999; GO:0010629; GO:0046329; GO:1903038; GO:2000402; GO:0016242; GO:1901215; GO:0045746; GO:1902176; GO:0010748; GO:0032091; GO:0006469; GO:0100002; GO:0051898; GO:0071901; GO:0031397; GO:0045861; GO:0090201; GO:0038061; GO:0006809; GO:0001649; GO:0018105; GO:0018107; GO:0032287; GO:0014065; GO:0016310; GO:0043065; GO:0043536; GO:0030307; GO:0008284; GO:0032270; GO:0031659; GO:0051091; GO:0032079; GO:0001938; GO:0045742; GO:0045600; GO:0010763; GO:0010628; GO:0046326; GO:0010907; GO:0045725; GO:1903721; GO:0046889; GO:0010918; GO:0045429; GO:0051000; GO:0046622; GO:0033138; GO:0032436; GO:2000010; GO:1900182; GO:1903078; GO:0001934; GO:0048661; GO:0010765; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0030163; GO:0000060; GO:0043491; GO:0006468; GO:0016567; GO:0042981; GO:0030334; GO:0005979; GO:0043488; GO:0031641; GO:0010975; GO:0050999; GO:1901796; GO:0006417; GO:0034405; GO:0032094; GO:0060416; GO:0009408; GO:1990418; GO:0006979; GO:0070141; GO:0007165; GO:0021510; GO:0051146; GO:0031295; GO:0031929; GO:0006412"]
[90,44,"PK515","Akt1 (PKBa)","T308","RAC-alpha serine/threonine-protein kinase",0,6748,10,653,{"v":4399.914,"d":"4400"},{"v":7731.295240668155,"d":"7731"},{"$nulls":3},0,7620,16,654,{"v":4973.016,"d":"4973"},{"v":8688.928864718393,"d":"8689"},{"$nulls":6},0,6596,16,650,4277,{"v":7317.268674003268,"d":"7317"},{"$nulls":7},"AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"TMK(pT)FCG(bA)C","Corresponds to amino acid residues T305 to G311; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T308 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of phosphorylation of Akt1 by mass spectrometry studies (≥26 reports).",null,null,"P31749","P31749","P31749","P31749"]
[91,45,"PK516","Akt1 (PKBa)","Y315","RAC-alpha serine/threonine-protein kinase",0,5830,18,697,{"v":4050.964,"d":"4051"},{"v":7118.138830285781,"d":"7118"},{"v":6959.259364831236,"d":"6959"},{"v":158.87946545454543,"d":"159"},{"v":2.2829938808926444,"d":"2"},0,6460,14,603,{"v":3886.938,"d":"3887"},{"v":6791.316935954113,"d":"6791"},{"v":6558.54594565904,"d":"6559"},{"v":232.77099029507372,"d":"233"},{"v":3.549124946652845,"d":"4"},{"v":5.832118827545489,"d":"6"},{"v":-5.757989437744044,"d":"-6"},null,0,6636,16,725,{"v":4799.5,"d":"4800"},{"v":8211.183306261091,"d":"8211"},{"v":7076.850975223053,"d":"7077"},{"v":1134.3323310380383,"d":"1134"},{"v":16.028772331217354,"d":"16"},{"v":18.311766212109998,"d":"18"},{"v":1.6897144398162283,"d":"2"},null,null,"AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"TPE(pY)LAP(bA)C","Corresponds to amino acid residues T312 to P318; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y315 phosphorylation has been reported to be stimulatory for phosphotransferase activity, although the precise positioning of this phosphosites is predicted to be inhibitory. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. It is one of many sites that have been reported by mass spectrometry studies (≥15 reports).","Brk (PTK6); Ret; Src","EC 2.7.11.1; Nuclear receptor co-regulator; Protein kinase, Ser/Thr (non-receptor); AGC group; AKT family","P31749","P31749","P31749","P31749","GO:0005911; GO:0036064; GO:0005737; GO:0005829; GO:0015630; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0098794; GO:0032991; GO:0005819; GO:0031982","GO:0071889; GO:0005524; GO:0019899; GO:0032794; GO:0042802; GO:0016301; GO:0030235; GO:0005547; GO:0043325; GO:0042803; GO:0004672; GO:0005080; GO:0051721; GO:0004712; GO:0004674","GO:0006924; GO:0032148; GO:0007568; GO:0043276; GO:0008637; GO:0008643; GO:0030154; GO:0002042; GO:0030030; GO:0008283; GO:0006464; GO:0071276; GO:0006974; GO:0071364; GO:0097011; GO:0071456; GO:0032869; GO:0071260; GO:1990090; GO:0071407; GO:0140052; GO:0071380; GO:0034614; GO:0071356; GO:0035924; GO:0051186; GO:0019221; GO:0031018; GO:0007173; GO:0072655; GO:0060079; GO:0097194; GO:0007281; GO:0042593; GO:0006006; GO:0005978; GO:0060709; GO:0007186; GO:0030212; GO:0007249; GO:0006954; GO:0048009; GO:0008286; GO:0035655; GO:0035556; GO:0060716; GO:0031663; GO:0072656; GO:0060644; GO:0001893; GO:0043066; GO:0010507; GO:0045792; GO:0043154; GO:0010951; GO:2001240; GO:0031999; GO:0010629; GO:0046329; GO:1903038; GO:2000402; GO:0016242; GO:1901215; GO:0045746; GO:1902176; GO:0010748; GO:0032091; GO:0006469; GO:0100002; GO:0051898; GO:0071901; GO:0031397; GO:0045861; GO:0090201; GO:0038061; GO:0006809; GO:0001649; GO:0018105; GO:0018107; GO:0032287; GO:0014065; GO:0016310; GO:0043065; GO:0043536; GO:0030307; GO:0008284; GO:0032270; GO:0031659; GO:0051091; GO:0032079; GO:0001938; GO:0045742; GO:0045600; GO:0010763; GO:0010628; GO:0046326; GO:0010907; GO:0045725; GO:1903721; GO:0046889; GO:0010918; GO:0045429; GO:0051000; GO:0046622; GO:0033138; GO:0032436; GO:2000010; GO:1900182; GO:1903078; GO:0001934; GO:0048661; GO:0010765; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0030163; GO:0000060; GO:0043491; GO:0006468; GO:0016567; GO:0042981; GO:0030334; GO:0005979; GO:0043488; GO:0031641; GO:0010975; GO:0050999; GO:1901796; GO:0006417; GO:0034405; GO:0032094; GO:0060416; GO:0009408; GO:1990418; GO:0006979; GO:0070141; GO:0007165; GO:0021510; GO:0051146; GO:0031295; GO:0031929; GO:0006412"]
[92,45,"PK516","Akt1 (PKBa)","Y315","RAC-alpha serine/threonine-protein kinase",0,5526,13,702,{"v":3870.126,"d":"3870"},{"v":6800.3798993766895,"d":"6800"},{"$nulls":3},0,5282,12,687,{"v":3620.49,"d":"3620"},{"v":6325.774955363967,"d":"6326"},{"$nulls":6},0,5366,14,649,{"v":3473.448,"d":"3473"},{"v":5942.518644185014,"d":"5943"},{"$nulls":7},"AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"TPE(pY)LAP(bA)C","Corresponds to amino acid residues T312 to P318; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y315 phosphorylation has been reported to be stimulatory for phosphotransferase activity, although the precise positioning of this phosphosites is predicted to be inhibitory. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. It is one of many sites that have been reported by mass spectrometry studies (≥15 reports).","Brk (PTK6); Ret; Src",null,"P31749","P31749","P31749","P31749"]
[93,46,"PK517","Akt1 (PKBa)","Y326","RAC-alpha serine/threonine-protein kinase",0,2116,14,540,{"v":1135.08,"d":"1135"},{"v":1994.5023020399055,"d":"1995"},{"v":2182.945764068985,"d":"2183"},{"v":188.44346202907968,"d":"188"},{"v":8.632530644179784,"d":"9"},0,1288,16,479,{"v":609.288,"d":"609"},{"v":1064.5572204325383,"d":"1065"},{"v":1376.873674571692,"d":"1377"},{"v":312.3164541391536,"d":"312"},{"v":22.683014419337113,"d":"23"},{"v":31.315545063516897,"d":"31"},{"v":-36.92588715510661,"d":"-37"},null,0,2271,14,539,{"v":1216.523,"d":"1217"},{"v":2081.2779142166182,"d":"2081"},{"v":2046.8190021293058,"d":"2047"},{"v":34.458912087312456,"d":"34"},{"v":1.6835348925070974,"d":"2"},{"v":10.316065536686882,"d":"10"},{"v":-6.235920478662777,"d":"-6"},null,null,"AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"DND(pY)GRA(bA)C","Corresponds to amino acid residues D323 to A329; In the protein kinase catalytic domain.","Y326 phosphorylation stimulates phosphotransferase activity. This is one of the major sites of phosphorylation of Akt1 by mass spectrometry studies (≥28 reports).","Brk (PTK6); Src","EC 2.7.11.1; Nuclear receptor co-regulator; Protein kinase, Ser/Thr (non-receptor); AGC group; AKT family","P31749","P31749","P31749","P31749","GO:0005911; GO:0036064; GO:0005737; GO:0005829; GO:0015630; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0098794; GO:0032991; GO:0005819; GO:0031982","GO:0071889; GO:0005524; GO:0019899; GO:0032794; GO:0042802; GO:0016301; GO:0030235; GO:0005547; GO:0043325; GO:0042803; GO:0004672; GO:0005080; GO:0051721; GO:0004712; GO:0004674","GO:0006924; GO:0032148; GO:0007568; GO:0043276; GO:0008637; GO:0008643; GO:0030154; GO:0002042; GO:0030030; GO:0008283; GO:0006464; GO:0071276; GO:0006974; GO:0071364; GO:0097011; GO:0071456; GO:0032869; GO:0071260; GO:1990090; GO:0071407; GO:0140052; GO:0071380; GO:0034614; GO:0071356; GO:0035924; GO:0051186; GO:0019221; GO:0031018; GO:0007173; GO:0072655; GO:0060079; GO:0097194; GO:0007281; GO:0042593; GO:0006006; GO:0005978; GO:0060709; GO:0007186; GO:0030212; GO:0007249; GO:0006954; GO:0048009; GO:0008286; GO:0035655; GO:0035556; GO:0060716; GO:0031663; GO:0072656; GO:0060644; GO:0001893; GO:0043066; GO:0010507; GO:0045792; GO:0043154; GO:0010951; GO:2001240; GO:0031999; GO:0010629; GO:0046329; GO:1903038; GO:2000402; GO:0016242; GO:1901215; GO:0045746; GO:1902176; GO:0010748; GO:0032091; GO:0006469; GO:0100002; GO:0051898; GO:0071901; GO:0031397; GO:0045861; GO:0090201; GO:0038061; GO:0006809; GO:0001649; GO:0018105; GO:0018107; GO:0032287; GO:0014065; GO:0016310; GO:0043065; GO:0043536; GO:0030307; GO:0008284; GO:0032270; GO:0031659; GO:0051091; GO:0032079; GO:0001938; GO:0045742; GO:0045600; GO:0010763; GO:0010628; GO:0046326; GO:0010907; GO:0045725; GO:1903721; GO:0046889; GO:0010918; GO:0045429; GO:0051000; GO:0046622; GO:0033138; GO:0032436; GO:2000010; GO:1900182; GO:1903078; GO:0001934; GO:0048661; GO:0010765; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0030163; GO:0000060; GO:0043491; GO:0006468; GO:0016567; GO:0042981; GO:0030334; GO:0005979; GO:0043488; GO:0031641; GO:0010975; GO:0050999; GO:1901796; GO:0006417; GO:0034405; GO:0032094; GO:0060416; GO:0009408; GO:1990418; GO:0006979; GO:0070141; GO:0007165; GO:0021510; GO:0051146; GO:0031295; GO:0031929; GO:0006412"]
[94,46,"PK517","Akt1 (PKBa)","Y326","RAC-alpha serine/threonine-protein kinase",0,2288,16,594,{"v":1349.568,"d":"1350"},{"v":2371.3892260980647,"d":"2371"},{"$nulls":3},0,1884,14,517,{"v":966.79,"d":"967"},{"v":1689.1901287108456,"d":"1689"},{"$nulls":6},0,2280,18,520,{"v":1176.24,"d":"1176"},{"v":2012.360090041993,"d":"2012"},{"$nulls":7},"AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"DND(pY)GRA(bA)C","Corresponds to amino acid residues D323 to A329; In the protein kinase catalytic domain.","Y326 phosphorylation stimulates phosphotransferase activity. This is one of the major sites of phosphorylation of Akt1 by mass spectrometry studies (≥28 reports).","Brk (PTK6); Src",null,"P31749","P31749","P31749","P31749"]
[95,47,"PK071-8","Akt1 (PKBa)","T450/T451/T447","RAC-alpha serine/threonine-protein kinase",0,658,10,552,{"v":357.696,"d":"358"},{"v":628.5244171604346,"d":"629"},{"v":578.0134724037309,"d":"578"},{"v":50.51094475670368,"d":"51"},{"v":8.738714090287292,"d":"9"},0,884,12,546,{"v":476.112,"d":"476"},{"v":831.8700964643596,"d":"832"},{"v":703.6087799855643,"d":"704"},{"v":128.26131647879527,"d":"128"},{"v":18.229067079212225,"d":"18"},{"v":26.967781169499517,"d":"27"},{"v":21.728785500367636,"d":"22"},null,0,898,16,478,{"v":421.596,"d":"422"},{"v":721.2838914858737,"d":"721"},{"v":738.1219925589483,"d":"738"},{"v":16.83810107307454,"d":"17"},{"v":2.2812084239218504,"d":"2"},{"v":11.019922514209142,"d":"11"},{"v":27.699790368101446,"d":"28"},null,null,"AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 442-459 with T450 phosphorylated of human Akt1.","T450 phosphorylation stimulates phosphotransferase activity. Phosphorylation regulates apoptosis, carcinogenesis, cell cycle progression, cell differentiation, cell growth, cell motility, cytoskeletal reorganization, gene transcription, intracellular location, and induces interaction with PIN1, ILK, PAK1, PDK1, PIK3R1, PPP2CA, and Rictor. It has been infrequently detetced by mass spectrometry studies (≥5 reports).","mTOR","EC 2.7.11.1; Nuclear receptor co-regulator; Protein kinase, Ser/Thr (non-receptor); AGC group; AKT family","P31749","P31749","P31749","P31749","GO:0005911; GO:0036064; GO:0005737; GO:0005829; GO:0015630; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0098794; GO:0032991; GO:0005819; GO:0031982","GO:0071889; GO:0005524; GO:0019899; GO:0032794; GO:0042802; GO:0016301; GO:0030235; GO:0005547; GO:0043325; GO:0042803; GO:0004672; GO:0005080; GO:0051721; GO:0004712; GO:0004674","GO:0006924; GO:0032148; GO:0007568; GO:0043276; GO:0008637; GO:0008643; GO:0030154; GO:0002042; GO:0030030; GO:0008283; GO:0006464; GO:0071276; GO:0006974; GO:0071364; GO:0097011; GO:0071456; GO:0032869; GO:0071260; GO:1990090; GO:0071407; GO:0140052; GO:0071380; GO:0034614; GO:0071356; GO:0035924; GO:0051186; GO:0019221; GO:0031018; GO:0007173; GO:0072655; GO:0060079; GO:0097194; GO:0007281; GO:0042593; GO:0006006; GO:0005978; GO:0060709; GO:0007186; GO:0030212; GO:0007249; GO:0006954; GO:0048009; GO:0008286; GO:0035655; GO:0035556; GO:0060716; GO:0031663; GO:0072656; GO:0060644; GO:0001893; GO:0043066; GO:0010507; GO:0045792; GO:0043154; GO:0010951; GO:2001240; GO:0031999; GO:0010629; GO:0046329; GO:1903038; GO:2000402; GO:0016242; GO:1901215; GO:0045746; GO:1902176; GO:0010748; GO:0032091; GO:0006469; GO:0100002; GO:0051898; GO:0071901; GO:0031397; GO:0045861; GO:0090201; GO:0038061; GO:0006809; GO:0001649; GO:0018105; GO:0018107; GO:0032287; GO:0014065; GO:0016310; GO:0043065; GO:0043536; GO:0030307; GO:0008284; GO:0032270; GO:0031659; GO:0051091; GO:0032079; GO:0001938; GO:0045742; GO:0045600; GO:0010763; GO:0010628; GO:0046326; GO:0010907; GO:0045725; GO:1903721; GO:0046889; GO:0010918; GO:0045429; GO:0051000; GO:0046622; GO:0033138; GO:0032436; GO:2000010; GO:1900182; GO:1903078; GO:0001934; GO:0048661; GO:0010765; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0030163; GO:0000060; GO:0043491; GO:0006468; GO:0016567; GO:0042981; GO:0030334; GO:0005979; GO:0043488; GO:0031641; GO:0010975; GO:0050999; GO:1901796; GO:0006417; GO:0034405; GO:0032094; GO:0060416; GO:0009408; GO:1990418; GO:0006979; GO:0070141; GO:0007165; GO:0021510; GO:0051146; GO:0031295; GO:0031929; GO:0006412"]
[96,47,"PK071-8","Akt1 (PKBa)","T450/T451/T447","RAC-alpha serine/threonine-protein kinase",0,550,12,558,{"v":300.204,"d":"300"},{"v":527.5025276470274,"d":"528"},{"$nulls":3},0,612,10,547,{"v":329.294,"d":"329"},{"v":575.347463506769,"d":"575"},{"$nulls":6},0,798,10,560,{"v":441.28,"d":"441"},{"v":754.9600936320229,"d":"755"},{"$nulls":7},"AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 442-459 with T450 phosphorylated of human Akt1.","T450 phosphorylation stimulates phosphotransferase activity. Phosphorylation regulates apoptosis, carcinogenesis, cell cycle progression, cell differentiation, cell growth, cell motility, cytoskeletal reorganization, gene transcription, intracellular location, and induces interaction with PIN1, ILK, PAK1, PDK1, PIK3R1, PPP2CA, and Rictor. It has been infrequently detetced by mass spectrometry studies (≥5 reports).","mTOR",null,"P31749","P31749","P31749","P31749"]
[97,48,"PK869","Akt1 (PKBa)","S473","RAC-alpha serine/threonine-protein kinase",0,4670,16,646,{"v":3006.484,"d":"3006"},{"v":5282.834037289128,"d":"5283"},{"v":5157.403620202655,"d":"5157"},{"v":125.43041708647343,"d":"125"},{"v":2.432045779685259,"d":"2"},0,4267,18,602,{"v":2557.898,"d":"2558"},{"v":4469.198121463001,"d":"4469"},{"v":4166.166368597102,"d":"4166"},{"v":303.03175286589976,"d":"303"},{"v":7.273635425364482,"d":"7"},{"v":9.705681205049741,"d":"10"},{"v":-19.219695114081517,"d":"-19"},null,0,4519,20,574,{"v":2582.426,"d":"2582"},{"v":4418.121316981895,"d":"4418"},{"v":4235.2375036910535,"d":"4235"},{"v":182.88381329084132,"d":"183"},{"v":4.318147757509613,"d":"4"},{"v":6.750193537194872,"d":"7"},{"v":-17.880433342453145,"d":"-18"},null,null,"AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"PQF(pS)YSAS(bA)C","Corresponds to amino acid residues P470 to S477; In the C-terminus of the kinase.","S473 phosphorylation stimulates phosphotransferase activity of Akt1, and regulates cell cycle progression, and its intracellular location. This is the major site of phosphorylation of Akt1 identified by mass spectrometry studies (≥66 report) and over 1391 scientific publications involving primarily Western blotting.","S473: ATM; ATR; DNAPK; FRAP1; ILK; MAPKAPK5; p38a MAPK; PDPK1; PKCa; PKCb1; PKCe PKD1","EC 2.7.11.1; Nuclear receptor co-regulator; Protein kinase, Ser/Thr (non-receptor); AGC group; AKT family","P31749","P31749","P31749","P31749","GO:0005911; GO:0036064; GO:0005737; GO:0005829; GO:0015630; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0098794; GO:0032991; GO:0005819; GO:0031982","GO:0071889; GO:0005524; GO:0019899; GO:0032794; GO:0042802; GO:0016301; GO:0030235; GO:0005547; GO:0043325; GO:0042803; GO:0004672; GO:0005080; GO:0051721; GO:0004712; GO:0004674","GO:0006924; GO:0032148; GO:0007568; GO:0043276; GO:0008637; GO:0008643; GO:0030154; GO:0002042; GO:0030030; GO:0008283; GO:0006464; GO:0071276; GO:0006974; GO:0071364; GO:0097011; GO:0071456; GO:0032869; GO:0071260; GO:1990090; GO:0071407; GO:0140052; GO:0071380; GO:0034614; GO:0071356; GO:0035924; GO:0051186; GO:0019221; GO:0031018; GO:0007173; GO:0072655; GO:0060079; GO:0097194; GO:0007281; GO:0042593; GO:0006006; GO:0005978; GO:0060709; GO:0007186; GO:0030212; GO:0007249; GO:0006954; GO:0048009; GO:0008286; GO:0035655; GO:0035556; GO:0060716; GO:0031663; GO:0072656; GO:0060644; GO:0001893; GO:0043066; GO:0010507; GO:0045792; GO:0043154; GO:0010951; GO:2001240; GO:0031999; GO:0010629; GO:0046329; GO:1903038; GO:2000402; GO:0016242; GO:1901215; GO:0045746; GO:1902176; GO:0010748; GO:0032091; GO:0006469; GO:0100002; GO:0051898; GO:0071901; GO:0031397; GO:0045861; GO:0090201; GO:0038061; GO:0006809; GO:0001649; GO:0018105; GO:0018107; GO:0032287; GO:0014065; GO:0016310; GO:0043065; GO:0043536; GO:0030307; GO:0008284; GO:0032270; GO:0031659; GO:0051091; GO:0032079; GO:0001938; GO:0045742; GO:0045600; GO:0010763; GO:0010628; GO:0046326; GO:0010907; GO:0045725; GO:1903721; GO:0046889; GO:0010918; GO:0045429; GO:0051000; GO:0046622; GO:0033138; GO:0032436; GO:2000010; GO:1900182; GO:1903078; GO:0001934; GO:0048661; GO:0010765; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0030163; GO:0000060; GO:0043491; GO:0006468; GO:0016567; GO:0042981; GO:0030334; GO:0005979; GO:0043488; GO:0031641; GO:0010975; GO:0050999; GO:1901796; GO:0006417; GO:0034405; GO:0032094; GO:0060416; GO:0009408; GO:1990418; GO:0006979; GO:0070141; GO:0007165; GO:0021510; GO:0051146; GO:0031295; GO:0031929; GO:0006412"]
[98,48,"PK869","Akt1 (PKBa)","S473","RAC-alpha serine/threonine-protein kinase",0,4447,14,646,{"v":2863.718,"d":"2864"},{"v":5031.973203116181,"d":"5032"},{"$nulls":3},0,3804,18,584,{"v":2211.024,"d":"2211"},{"v":3863.134615731202,"d":"3863"},{"$nulls":6},0,3882,18,613,{"v":2368.632,"d":"2369"},{"v":4052.3536904002126,"d":"4052"},{"$nulls":7},"AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"PQF(pS)YSAS(bA)C","Corresponds to amino acid residues P470 to S477; In the C-terminus of the kinase.","S473 phosphorylation stimulates phosphotransferase activity of Akt1, and regulates cell cycle progression, and its intracellular location. This is the major site of phosphorylation of Akt1 identified by mass spectrometry studies (≥66 report) and over 1391 scientific publications involving primarily Western blotting.","S473: ATM; ATR; DNAPK; FRAP1; ILK; MAPKAPK5; p38a MAPK; PDPK1; PKCa; PKCb1; PKCe PKD1",null,"P31749","P31749","P31749","P31749"]
[99,49,"PK071-6","Akt1 (PKBa)","S473/S474/S472","RAC-alpha serine/threonine-protein kinase",0,278,12,545,{"v":144.97,"d":"145"},{"v":254.7335859381939,"d":"255"},{"v":254.84340761937716,"d":"255"},{"v":0.10982168118326285,"d":"0"},{"v":0.0430937893230841,"d":"0"},0,212,12,534,{"v":106.8,"d":"107"},{"v":186.60257733977215,"d":"187"},{"v":223.10889055079463,"d":"223"},{"v":36.50631321102247,"d":"37"},{"v":16.362554231208986,"d":"16"},{"v":16.40564802053207,"d":"16"},{"v":-12.452555616419872,"d":"-12"},null,0,310,12,483,{"v":143.934,"d":"144"},{"v":246.24824627635874,"d":"246"},{"v":226.44696789597208,"d":"226"},{"v":19.801278380386663,"d":"20"},{"v":8.74433363553943,"d":"9"},{"v":8.787427424862514,"d":"9"},{"v":-11.142701311629281,"d":"-11"},null,null,"AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S473 phosphosite;  In the C-terminus of the kinase.","S473 phosphorylation stimulates phosphotransferase activity of Akt1, and regulates cell cycle progression, and its intracellular location. This is the major site of phosphorylation of Akt1 identified by mass spectrometry studies (≥66 report) and over 1391 scientific publications involving primarily Western blotting.","S473: ATM; ATR; DNAPK; FRAP1; ILK; MAPKAPK5; p38a MAPK; PDPK1; PKCa; PKCb1; PKCe PKD1","EC 2.7.11.1; Nuclear receptor co-regulator; Protein kinase, Ser/Thr (non-receptor); AGC group; AKT family","P31749","P31749","P31749","P31749","GO:0005911; GO:0036064; GO:0005737; GO:0005829; GO:0015630; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0098794; GO:0032991; GO:0005819; GO:0031982","GO:0071889; GO:0005524; GO:0019899; GO:0032794; GO:0042802; GO:0016301; GO:0030235; GO:0005547; GO:0043325; GO:0042803; GO:0004672; GO:0005080; GO:0051721; GO:0004712; GO:0004674","GO:0006924; GO:0032148; GO:0007568; GO:0043276; GO:0008637; GO:0008643; GO:0030154; GO:0002042; GO:0030030; GO:0008283; GO:0006464; GO:0071276; GO:0006974; GO:0071364; GO:0097011; GO:0071456; GO:0032869; GO:0071260; GO:1990090; GO:0071407; GO:0140052; GO:0071380; GO:0034614; GO:0071356; GO:0035924; GO:0051186; GO:0019221; GO:0031018; GO:0007173; GO:0072655; GO:0060079; GO:0097194; GO:0007281; GO:0042593; GO:0006006; GO:0005978; GO:0060709; GO:0007186; GO:0030212; GO:0007249; GO:0006954; GO:0048009; GO:0008286; GO:0035655; GO:0035556; GO:0060716; GO:0031663; GO:0072656; GO:0060644; GO:0001893; GO:0043066; GO:0010507; GO:0045792; GO:0043154; GO:0010951; GO:2001240; GO:0031999; GO:0010629; GO:0046329; GO:1903038; GO:2000402; GO:0016242; GO:1901215; GO:0045746; GO:1902176; GO:0010748; GO:0032091; GO:0006469; GO:0100002; GO:0051898; GO:0071901; GO:0031397; GO:0045861; GO:0090201; GO:0038061; GO:0006809; GO:0001649; GO:0018105; GO:0018107; GO:0032287; GO:0014065; GO:0016310; GO:0043065; GO:0043536; GO:0030307; GO:0008284; GO:0032270; GO:0031659; GO:0051091; GO:0032079; GO:0001938; GO:0045742; GO:0045600; GO:0010763; GO:0010628; GO:0046326; GO:0010907; GO:0045725; GO:1903721; GO:0046889; GO:0010918; GO:0045429; GO:0051000; GO:0046622; GO:0033138; GO:0032436; GO:2000010; GO:1900182; GO:1903078; GO:0001934; GO:0048661; GO:0010765; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0030163; GO:0000060; GO:0043491; GO:0006468; GO:0016567; GO:0042981; GO:0030334; GO:0005979; GO:0043488; GO:0031641; GO:0010975; GO:0050999; GO:1901796; GO:0006417; GO:0034405; GO:0032094; GO:0060416; GO:0009408; GO:1990418; GO:0006979; GO:0070141; GO:0007165; GO:0021510; GO:0051146; GO:0031295; GO:0031929; GO:0006412"]
[100,49,"PK071-6","Akt1 (PKBa)","S473/S474/S472","RAC-alpha serine/threonine-protein kinase",0,269,14,569,{"v":145.095,"d":"145"},{"v":254.95322930056042,"d":"255"},{"$nulls":3},0,260,18,614,{"v":148.588,"d":"149"},{"v":259.6152037618171,"d":"260"},{"$nulls":6},0,258,12,491,{"v":120.786,"d":"121"},{"v":206.6456895155854,"d":"207"},{"$nulls":7},"AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S473 phosphosite;  In the C-terminus of the kinase.","S473 phosphorylation stimulates phosphotransferase activity of Akt1, and regulates cell cycle progression, and its intracellular location. This is the major site of phosphorylation of Akt1 identified by mass spectrometry studies (≥66 report) and over 1391 scientific publications involving primarily Western blotting.","S473: ATM; ATR; DNAPK; FRAP1; ILK; MAPKAPK5; p38a MAPK; PDPK1; PKCa; PKCb1; PKCe PKD1",null,"P31749","P31749","P31749","P31749"]
[101,50,"PK071-7","Akt1 (PKBa)","S473/S474/S472","RAC-alpha serine/threonine-protein kinase",0,108,10,449,{"v":44.002,"d":"44"},{"v":77.31797784681251,"d":"77"},{"v":65.31139308640911,"d":"65"},{"v":12.006584760403399,"d":"12"},{"v":18.38359923592243,"d":"18"},0,94,10,414,{"v":34.776,"d":"35"},{"v":60.76115383490559,"d":"61"},{"v":71.29161950556858,"d":"71"},{"v":10.530465670662984,"d":"11"},{"v":14.770972722593925,"d":"15"},{"v":33.15457195851636,"d":"33"},{"v":9.156482715423692,"d":"9"},null,0,90,12,442,{"v":34.476,"d":"34"},{"v":58.98296815640324,"d":"59"},{"v":63.335348681693006,"d":"63"},{"v":4.352380525289767,"d":"4"},{"v":6.871961102106977,"d":"7"},{"v":25.255560338029404,"d":"25"},{"v":-3.025573810838395,"d":"-3"},null,null,"AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S473 phosphosite;  In the C-terminus of the kinase.","S473 phosphorylation stimulates phosphotransferase activity of Akt1, and regulates cell cycle progression, and its intracellular location. This is the major site of phosphorylation of Akt1 identified by mass spectrometry studies (≥66 report) and over 1391 scientific publications involving primarily Western blotting.","S473: ATM; ATR; DNAPK; FRAP1; ILK; MAPKAPK5; p38a MAPK; PDPK1; PKCa; PKCb1; PKCe PKD1","EC 2.7.11.1; Nuclear receptor co-regulator; Protein kinase, Ser/Thr (non-receptor); AGC group; AKT family","P31749","P31749","P31749","P31749","GO:0005911; GO:0036064; GO:0005737; GO:0005829; GO:0015630; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0098794; GO:0032991; GO:0005819; GO:0031982","GO:0071889; GO:0005524; GO:0019899; GO:0032794; GO:0042802; GO:0016301; GO:0030235; GO:0005547; GO:0043325; GO:0042803; GO:0004672; GO:0005080; GO:0051721; GO:0004712; GO:0004674","GO:0006924; GO:0032148; GO:0007568; GO:0043276; GO:0008637; GO:0008643; GO:0030154; GO:0002042; GO:0030030; GO:0008283; GO:0006464; GO:0071276; GO:0006974; GO:0071364; GO:0097011; GO:0071456; GO:0032869; GO:0071260; GO:1990090; GO:0071407; GO:0140052; GO:0071380; GO:0034614; GO:0071356; GO:0035924; GO:0051186; GO:0019221; GO:0031018; GO:0007173; GO:0072655; GO:0060079; GO:0097194; GO:0007281; GO:0042593; GO:0006006; GO:0005978; GO:0060709; GO:0007186; GO:0030212; GO:0007249; GO:0006954; GO:0048009; GO:0008286; GO:0035655; GO:0035556; GO:0060716; GO:0031663; GO:0072656; GO:0060644; GO:0001893; GO:0043066; GO:0010507; GO:0045792; GO:0043154; GO:0010951; GO:2001240; GO:0031999; GO:0010629; GO:0046329; GO:1903038; GO:2000402; GO:0016242; GO:1901215; GO:0045746; GO:1902176; GO:0010748; GO:0032091; GO:0006469; GO:0100002; GO:0051898; GO:0071901; GO:0031397; GO:0045861; GO:0090201; GO:0038061; GO:0006809; GO:0001649; GO:0018105; GO:0018107; GO:0032287; GO:0014065; GO:0016310; GO:0043065; GO:0043536; GO:0030307; GO:0008284; GO:0032270; GO:0031659; GO:0051091; GO:0032079; GO:0001938; GO:0045742; GO:0045600; GO:0010763; GO:0010628; GO:0046326; GO:0010907; GO:0045725; GO:1903721; GO:0046889; GO:0010918; GO:0045429; GO:0051000; GO:0046622; GO:0033138; GO:0032436; GO:2000010; GO:1900182; GO:1903078; GO:0001934; GO:0048661; GO:0010765; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0030163; GO:0000060; GO:0043491; GO:0006468; GO:0016567; GO:0042981; GO:0030334; GO:0005979; GO:0043488; GO:0031641; GO:0010975; GO:0050999; GO:1901796; GO:0006417; GO:0034405; GO:0032094; GO:0060416; GO:0009408; GO:1990418; GO:0006979; GO:0070141; GO:0007165; GO:0021510; GO:0051146; GO:0031295; GO:0031929; GO:0006412"]
[102,50,"PK071-7","Akt1 (PKBa)","S473/S474/S472","RAC-alpha serine/threonine-protein kinase",0,74,10,474,{"v":30.336,"d":"30"},{"v":53.30480832600573,"d":"53"},{"$nulls":3},0,82,12,669,{"v":46.83,"d":"47"},{"v":81.82208517623155,"d":"82"},{"$nulls":6},0,96,12,471,{"v":39.564,"d":"40"},{"v":67.68772920698277,"d":"68"},{"$nulls":7},"AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S473 phosphosite;  In the C-terminus of the kinase.","S473 phosphorylation stimulates phosphotransferase activity of Akt1, and regulates cell cycle progression, and its intracellular location. This is the major site of phosphorylation of Akt1 identified by mass spectrometry studies (≥66 report) and over 1391 scientific publications involving primarily Western blotting.","S473: ATM; ATR; DNAPK; FRAP1; ILK; MAPKAPK5; p38a MAPK; PDPK1; PKCa; PKCb1; PKCe PKD1",null,"P31749","P31749","P31749","P31749"]
[103,1052,"PN062","AKT1S1 (PRAS40)","T246","Proline-rich AKT1 substrate 1",0,580,10,305,{"v":173.85,"d":"174"},{"v":305.4799883793544,"d":"305"},{"v":273.98313021599563,"d":"274"},{"v":31.496858163358752,"d":"31"},{"v":11.495911495911477,"d":"11"},0,472,12,276,{"v":126.96,"d":"127"},{"v":221.8264346353696,"d":"222"},{"v":247.8931373631979,"d":"248"},{"v":26.0667027278283,"d":"26"},{"v":10.515298247097885,"d":"11"},{"v":22.01120974300936,"d":"22"},{"v":-9.522481487173891,"d":"-10"},null,0,477,12,389,{"v":180.885,"d":"181"},{"v":309.4655469013517,"d":"309"},{"v":283.6634923053778,"d":"284"},{"v":25.802054595973857,"d":"26"},{"v":9.096008226605582,"d":"9"},{"v":20.59191972251706,"d":"21"},{"v":3.533196398533974,"d":"4"},{"$nulls":15},"Not precisely defined.","Antibody raised against amino acid residues that encompass the T246 phosphosite.","T246 phosphorylation inhibits Akt1S1 phosphorylation, induces interaction with 14-3-3-beta and 14-3-3-eta, although one report indicates that it inhibits interaction with 14-3-3-beta. This is the major site of phosphorylation of AKT1S1 from mass spectrometry studies (≥838 reports).","Akt1; Akt3","Inhibitor of mTOR/FRAP","Q96B36","Q96B36",null,null,"GO:0005737; GO:0005829; GO:0005654; GO:0032991",null,"GO:0045792; GO:0006469; GO:0032007; GO:0048011; GO:0042981; GO:1900034; GO:0043523; GO:0038202"]
[104,1052,"PN062","AKT1S1 (PRAS40)","T246","Proline-rich AKT1 substrate 1",0,470,10,300,138,{"v":242.48627205263682,"d":"242"},{"$nulls":3},0,570,12,281,{"v":156.798,"d":"157"},{"v":273.9598400910262,"d":"274"},{"$nulls":6},0,452,10,341,{"v":150.722,"d":"151"},{"v":257.86143770940396,"d":"258"},{"$nulls":20},"Not precisely defined.","Antibody raised against amino acid residues that encompass the T246 phosphosite.","T246 phosphorylation inhibits Akt1S1 phosphorylation, induces interaction with 14-3-3-beta and 14-3-3-eta, although one report indicates that it inhibits interaction with 14-3-3-beta. This is the major site of phosphorylation of AKT1S1 from mass spectrometry studies (≥838 reports).","Akt1; Akt3",null,"Q96B36","Q96B36"]
[105,51,"NK130-8","Akt2 (PKBb)","Pan-specific","RAC-beta serine/threonine-protein kinase",0,6086,10,621,{"v":3773.196,"d":"3773"},{"v":6630.059650463196,"d":"6630"},{"v":6576.582641741094,"d":"6577"},{"v":53.477008722101345,"d":"53"},{"v":0.8131428073706037,"d":"1"},0,6340,16,629,{"v":3977.796,"d":"3978"},{"v":6950.065409474122,"d":"6950"},{"v":6512.699020290167,"d":"6513"},{"v":437.3663891839551,"d":"437"},{"v":6.715593455514372,"d":"7"},{"v":7.528736262884976,"d":"8"},{"v":-0.9713801974518361,"d":"-1"},null,0,6761,10,761,{"v":5137.511,"d":"5138"},{"v":8789.466519206735,"d":"8789"},{"v":8642.752459404657,"d":"8643"},{"v":146.71405980207783,"d":"147"},{"v":1.6975386081135544,"d":"2"},{"v":2.510681415484158,"d":"3"},{"v":31.41707373294045,"d":"31"},null,null,"AKT2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"CHRFFLSINWQDVVQK","Corresponds to amino acid residues H406 to K420; Post-kinase last alpha-chain.",null,null,"Protein-serine kinase, AGC group, AKT family","P31751","P31751","P31751","P31751","GO:0005938; GO:0005829; GO:0005769; GO:0043231; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:0032587","GO:0005524; GO:0046872; GO:0004674","GO:0090630; GO:0008643; GO:0006464; GO:0071486; GO:0032869; GO:0045444; GO:0006006; GO:0005978; GO:0008286; GO:0065002; GO:0035556; GO:0060644; GO:0043066; GO:0010748; GO:0018105; GO:0032287; GO:0030335; GO:2000147; GO:0008284; GO:0032000; GO:0046326; GO:2001275; GO:0010907; GO:0045725; GO:0010918; GO:0001934; GO:0090314; GO:0031340; GO:0043491; GO:0072659; GO:0071156; GO:0030334; GO:0006417; GO:0097473; GO:0007165"]
[106,51,"NK130-8","Akt2 (PKBb)","Pan-specific","RAC-beta serine/threonine-protein kinase",0,6072,16,613,{"v":3712.328,"d":"3712"},{"v":6523.105633018993,"d":"6523"},{"$nulls":3},0,5733,14,608,{"v":3477.152,"d":"3477"},{"v":6075.332631106212,"d":"6075"},{"$nulls":6},0,6512,12,764,4966,{"v":8496.03839960258,"d":"8496"},{"$nulls":7},"AKT2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"CHRFFLSINWQDVVQK","Corresponds to amino acid residues H406 to K420; Post-kinase last alpha-chain.",{"$nulls":3},"P31751","P31751","P31751","P31751"]
[107,52,"NK130-9","Akt2 (PKBb)","Pan-specific","RAC-beta serine/threonine-protein kinase",0,9844,18,692,{"v":6799.592,"d":"6800"},{"v":11947.88199680386,"d":"11948"},{"v":12212.23244771991,"d":"12212"},{"v":264.35045091605025,"d":"264"},{"v":2.164636580966864,"d":"2"},0,10166,20,865,{"v":8776.29,"d":"8776"},{"v":15334.06679289578,"d":"15334"},{"v":13421.50918579288,"d":"13422"},{"v":1912.557607102899,"d":"1913"},{"v":14.249944478132203,"d":"14"},{"v":16.414581059099067,"d":"16"},{"v":9.902175898222026,"d":"10"},null,0,9852,16,680,{"v":6688.48,"d":"6688"},{"v":11442.928496772825,"d":"11443"},{"v":12550.732521039976,"d":"12551"},{"v":1107.8040242671505,"d":"1108"},{"v":8.82660850599783,"d":"9"},{"v":10.991245086964694,"d":"11"},{"v":2.7718115812908906,"d":"3"},null,null,"AKT2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"CDRYDSLGLLELDQRT","Corresponds to amino acid residues D454 to T468; Pre-C-terminus.",null,null,"Protein-serine kinase, AGC group, AKT family","P31751","P31751","P31751","P31751","GO:0005938; GO:0005829; GO:0005769; GO:0043231; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:0032587","GO:0005524; GO:0046872; GO:0004674","GO:0090630; GO:0008643; GO:0006464; GO:0071486; GO:0032869; GO:0045444; GO:0006006; GO:0005978; GO:0008286; GO:0065002; GO:0035556; GO:0060644; GO:0043066; GO:0010748; GO:0018105; GO:0032287; GO:0030335; GO:2000147; GO:0008284; GO:0032000; GO:0046326; GO:2001275; GO:0010907; GO:0045725; GO:0010918; GO:0001934; GO:0090314; GO:0031340; GO:0043491; GO:0072659; GO:0071156; GO:0030334; GO:0006417; GO:0097473; GO:0007165"]
[108,52,"NK130-9","Akt2 (PKBb)","Pan-specific","RAC-beta serine/threonine-protein kinase",0,10262,16,693,{"v":7100.478,"d":"7100"},{"v":12476.582898635961,"d":"12477"},{"$nulls":3},0,9455,18,698,{"v":6587.026,"d":"6587"},{"v":11508.951578689981,"d":"11509"},{"$nulls":6},0,9752,16,820,{"v":7983.52,"d":"7984"},{"v":13658.536545307124,"d":"13659"},{"$nulls":7},"AKT2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"CDRYDSLGLLELDQRT","Corresponds to amino acid residues D454 to T468; Pre-C-terminus.",{"$nulls":3},"P31751","P31751","P31751","P31751"]
[109,53,"NK131-3","Akt3 (PKBg)","Pan-specific","RAC-gamma serine/threonine-protein kinase",0,7936,18,716,{"v":5669.288,"d":"5669"},{"v":9961.771828353254,"d":"9962"},{"v":9332.114930016458,"d":"9332"},{"v":629.6568983367961,"d":"630"},{"v":6.747204712530107,"d":"7"},0,8192,16,661,{"v":5404.336,"d":"5404"},{"v":9442.537700469242,"d":"9443"},{"v":8905.510159492584,"d":"8906"},{"v":537.0275409766582,"d":"537"},{"v":6.030283850771069,"d":"6"},{"v":12.777488563301176,"d":"13"},{"v":-4.5713621587718904,"d":"-5"},null,0,7642,10,641,{"v":4892.112,"d":"4892"},{"v":8369.627750132213,"d":"8370"},{"v":7919.156365764722,"d":"7919"},{"v":450.4713843674908,"d":"450"},{"v":5.6883759274526025,"d":"6"},{"v":12.43558063998271,"d":"12"},{"v":-15.140818290899944,"d":"-15"},null,null,"AKT3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"CHSFFSGVNWQDVYDK","Corresponds to amino acid residues H402 to K416; Post-kinase last alpha-chain.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); AGC domain target; AGC</A> group; AKT family","Q9Y243","Q9Y243","Q9Y243","Q9Y243","GO:0005737; GO:0005622; GO:0016020; GO:0005634","GO:0005524; GO:0004672; GO:0004674","GO:0048854; GO:0048873; GO:0035556; GO:0000002; GO:2000773; GO:0018105; GO:1905653; GO:0043536; GO:0090050; GO:0045793; GO:0001938; GO:0032008; GO:1905564; GO:0006468; GO:0007165"]
[110,53,"NK131-3","Akt3 (PKBg)","Pan-specific","RAC-gamma serine/threonine-protein kinase",0,7373,14,673,{"v":4952.607,"d":"4953"},{"v":8702.458031679662,"d":"8702"},{"$nulls":3},0,7282,14,659,{"v":4789.612,"d":"4790"},{"v":8368.482618515925,"d":"8368"},{"$nulls":6},0,7008,12,624,{"v":4365.504,"d":"4366"},{"v":7468.684981397232,"d":"7469"},{"$nulls":7},"AKT3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"CHSFFSGVNWQDVYDK","Corresponds to amino acid residues H402 to K416; Post-kinase last alpha-chain.",{"$nulls":3},"Q9Y243","Q9Y243","Q9Y243","Q9Y243"]
[111,54,"NK003-2","ALK","Pan-specific","Anaplastic lymphoma receptor-tyrosine kinase",0,2294,14,616,{"v":1404.48,"d":"1404"},{"v":2467.8776766122273,"d":"2468"},{"v":2145.5545566331584,"d":"2146"},{"v":322.3231199790689,"d":"322"},{"v":15.022834958103509,"d":"15"},0,2148,12,622,{"v":1328.592,"d":"1329"},{"v":2321.336062106766,"d":"2321"},{"v":2009.1226936610863,"d":"2009"},{"v":312.21336844567963,"d":"312"},{"v":15.539786068353777,"d":"16"},{"v":30.562621026457286,"d":"31"},{"v":-6.358815838557064,"d":"-6"},null,0,2324,10,577,{"v":1335.178,"d":"1335"},{"v":2284.2778007057136,"d":"2284"},{"v":2147.497741501157,"d":"2147"},{"v":136.78005920455644,"d":"137"},{"v":6.369276044450858,"d":"6"},{"v":21.392111002554365,"d":"21"},{"v":0.09056795419120078,"d":"0"},null,null,"ALK","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Alk",{"$nulls":6},"LLVSQQAKREEERSPAAC","Corresponds to amino acid residues L1424 to A1440; After catalytic domain.",null,null,"EC 2.7.10.1; Receptor tyrosine kinase; TK domain target; TK</A> group; Alk family","Q9UM73","Q9UM73","Q9UM73","Q9UM73","GO:0070062; GO:0005887; GO:0005622; GO:0005886; GO:0032991","GO:0005524; GO:0042802; GO:0004704; GO:0004713; GO:0004714","GO:0000187; GO:0030534; GO:0008283; GO:0021766; GO:0048666; GO:0016310; GO:0051092; GO:0046777; GO:0042981; GO:0042127; GO:0060159; GO:0090648; GO:0007165; GO:0036269; GO:0007169"]
[112,54,"NK003-2","ALK","Pan-specific","Anaplastic lymphoma receptor-tyrosine kinase",0,1855,12,563,{"v":1037.609,"d":"1038"},{"v":1823.23143665409,"d":"1823"},{"$nulls":3},0,1736,14,564,{"v":971.208,"d":"971"},{"v":1696.9093252154066,"d":"1697"},{"$nulls":6},0,2002,10,590,{"v":1175.28,"d":"1175"},{"v":2010.7176822966005,"d":"2011"},{"$nulls":7},"ALK","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Alk",{"$nulls":6},"LLVSQQAKREEERSPAAC","Corresponds to amino acid residues L1424 to A1440; After catalytic domain.",{"$nulls":3},"Q9UM73","Q9UM73","Q9UM73","Q9UM73"]
[113,55,"NK003-3","ALK","Pan-specific","Anaplastic lymphoma receptor-tyrosine kinase",0,3884,12,716,{"v":2772.352,"d":"2772"},{"v":4871.429719548346,"d":"4871"},{"v":4622.206546285203,"d":"4622"},{"v":249.2231732631426,"d":"249"},{"v":5.391865784609721,"d":"5"},0,4065,16,744,{"v":3012.456,"d":"3012"},{"v":5263.408742721542,"d":"5263"},{"v":4876.00921221514,"d":"4876"},{"v":387.3995305064018,"d":"387"},{"v":7.945012276349016,"d":"8"},{"v":13.336878060958737,"d":"13"},{"v":5.490941683121321,"d":"5"},null,0,4291,10,738,{"v":3159.378,"d":"3159"},{"v":5405.194685231494,"d":"5405"},{"v":5065.9947147729345,"d":"5066"},{"v":339.1999704585596,"d":"339"},{"v":6.6956242466937335,"d":"7"},{"v":12.087490031303455,"d":"12"},{"v":9.60121889932411,"d":"10"},null,null,"ALK","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Alk",{"$nulls":6},"LRTSTIMTDYNPNYC","Corresponds to amino acid residues L1083 to C1097; Just before catalytic domain.",null,null,"EC 2.7.10.1; Receptor tyrosine kinase; TK domain target; TK</A> group; Alk family","Q9UM73","Q9UM73","Q9UM73","Q9UM73","GO:0070062; GO:0005887; GO:0005622; GO:0005886; GO:0032991","GO:0005524; GO:0042802; GO:0004704; GO:0004713; GO:0004714","GO:0000187; GO:0030534; GO:0008283; GO:0021766; GO:0048666; GO:0016310; GO:0051092; GO:0046777; GO:0042981; GO:0042127; GO:0060159; GO:0090648; GO:0007165; GO:0036269; GO:0007169"]
[114,55,"NK003-3","ALK","Pan-specific","Anaplastic lymphoma receptor-tyrosine kinase",0,3600,14,694,{"v":2488.684,"d":"2489"},{"v":4372.983373022061,"d":"4373"},{"$nulls":3},0,3598,10,716,{"v":2569.008,"d":"2569"},{"v":4488.609681708739,"d":"4489"},{"$nulls":6},0,3684,10,752,{"v":2762.848,"d":"2763"},{"v":4726.794744314375,"d":"4727"},{"$nulls":7},"ALK","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Alk",{"$nulls":6},"LRTSTIMTDYNPNYC","Corresponds to amino acid residues L1083 to C1097; Just before catalytic domain.",{"$nulls":3},"Q9UM73","Q9UM73","Q9UM73","Q9UM73"]
[115,56,"PK518","ALK","Y1092","Anaplastic lymphoma receptor-tyrosine kinase",0,7502,18,739,{"v":5530.676,"d":"5531"},{"v":9718.210182398472,"d":"9718"},{"v":9315.414127315558,"d":"9315"},{"v":402.7960550829139,"d":"403"},{"v":4.32397368037344,"d":"4"},0,8328,16,714,{"v":5934.768,"d":"5935"},{"v":10369.316523535626,"d":"10369"},{"v":9469.787267849308,"d":"9470"},{"v":899.5292556863187,"d":"900"},{"v":9.498938363064322,"d":"9"},{"v":13.822912043437762,"d":"14"},{"v":1.6571795781046461,"d":"2"},null,0,8095,12,667,{"v":5391.361,"d":"5391"},{"v":9223.763608964913,"d":"9224"},{"v":8527.87801350427,"d":"8528"},{"v":695.8855954606424,"d":"696"},{"v":8.160126051975379,"d":"8"},{"v":12.484099732348819,"d":"12"},{"v":-8.454118121297455,"d":"-8"},null,null,"ALK","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Alk",{"$nulls":6},"MTD(pY)NPN(bA)C","Corresponds to amino acid residues M1089 to N1095; In the region between the Transmembrane and kinase catalytic domains. ","The effect of Y1092 phosphorylation is unclear. One of the major in vivo sites of phosphorylation in ALK (≥38 reports from high throughput mass spectrometry studies).",null,"EC 2.7.10.1; Receptor tyrosine kinase; TK domain target; TK</A> group; Alk family","Q9UM73","Q9UM73","Q9UM73","Q9UM73","GO:0070062; GO:0005887; GO:0005622; GO:0005886; GO:0032991","GO:0005524; GO:0042802; GO:0004704; GO:0004713; GO:0004714","GO:0000187; GO:0030534; GO:0008283; GO:0021766; GO:0048666; GO:0016310; GO:0051092; GO:0046777; GO:0042981; GO:0042127; GO:0060159; GO:0090648; GO:0007165; GO:0036269; GO:0007169"]
[116,56,"PK518","ALK","Y1092","Anaplastic lymphoma receptor-tyrosine kinase",0,7108,14,715,{"v":5072.21,"d":"5072"},{"v":8912.618072232644,"d":"8913"},{"$nulls":3},0,7240,16,679,{"v":4905.096,"d":"4905"},{"v":8570.258012162987,"d":"8570"},{"$nulls":6},0,6898,14,665,{"v":4577.86,"d":"4578"},{"v":7831.992418043628,"d":"7832"},{"$nulls":7},"ALK","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Alk",{"$nulls":6},"MTD(pY)NPN(bA)C","Corresponds to amino acid residues M1089 to N1095; In the region between the Transmembrane and kinase catalytic domains. ","The effect of Y1092 phosphorylation is unclear. One of the major in vivo sites of phosphorylation in ALK (≥38 reports from high throughput mass spectrometry studies).",null,null,"Q9UM73","Q9UM73","Q9UM73","Q9UM73"]
[117,57,"PK519","ALK","Y1096","Anaplastic lymphoma receptor-tyrosine kinase",0,7216,18,695,{"v":5002.61,"d":"5003"},{"v":8790.320648066967,"d":"8790"},{"v":8365.013784061834,"d":"8365"},{"v":425.3068640051333,"d":"425"},{"v":5.084353415119124,"d":"5"},0,7819,18,732,{"v":5710.332,"d":"5710"},{"v":9977.178545559698,"d":"9977"},{"v":9012.914968801857,"d":"9013"},{"v":964.2635767578413,"d":"964"},{"v":10.698687162761804,"d":"11"},{"v":15.783040577880929,"d":"16"},{"v":7.745369003150884,"d":"8"},null,0,7862,20,739,{"v":5795.238,"d":"5795"},{"v":9914.733101658489,"d":"9915"},{"v":9083.508830874012,"d":"9084"},{"v":831.2242707844762,"d":"831"},{"v":9.150916086074814,"d":"9"},{"v":14.235269501193937,"d":"14"},{"v":8.589287063473265,"d":"9"},null,null,"ALK","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Alk",{"$nulls":6},"NPN(pY)CFA(bA)C","Corresponds to amino acid residues N1093 to A1099; In the region between the Transmembrane and kinase catalytic domains. ","Y1096 phosphorylation increases phosphotransferase activity and induces interaction with IRS1 and SNTB1. It is one of the major in vivo sites of phosphorylation in ALK (≥95 reports by mass spectrometry)",null,"EC 2.7.10.1; Receptor tyrosine kinase; TK domain target; TK</A> group; Alk family","Q9UM73","Q9UM73","Q9UM73","Q9UM73","GO:0070062; GO:0005887; GO:0005622; GO:0005886; GO:0032991","GO:0005524; GO:0042802; GO:0004704; GO:0004713; GO:0004714","GO:0000187; GO:0030534; GO:0008283; GO:0021766; GO:0048666; GO:0016310; GO:0051092; GO:0046777; GO:0042981; GO:0042127; GO:0060159; GO:0090648; GO:0007165; GO:0036269; GO:0007169"]
[118,57,"PK519","ALK","Y1096","Anaplastic lymphoma receptor-tyrosine kinase",0,6730,16,673,{"v":4518.522,"d":"4519"},{"v":7939.7069200567,"d":"7940"},{"$nulls":3},0,6871,16,672,{"v":4606.56,"d":"4607"},{"v":8048.651392044016,"d":"8049"},{"$nulls":6},0,6736,18,718,{"v":4823.524,"d":"4824"},{"v":8252.284560089536,"d":"8252"},{"$nulls":7},"ALK","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Alk",{"$nulls":6},"NPN(pY)CFA(bA)C","Corresponds to amino acid residues N1093 to A1099; In the region between the Transmembrane and kinase catalytic domains. ","Y1096 phosphorylation increases phosphotransferase activity and induces interaction with IRS1 and SNTB1. It is one of the major in vivo sites of phosphorylation in ALK (≥95 reports by mass spectrometry)",null,null,"Q9UM73","Q9UM73","Q9UM73","Q9UM73"]
[119,58,"PK520","ALK","Y1507","Anaplastic lymphoma receptor-tyrosine kinase",0,11736,18,731,{"v":8565.858,"d":"8566"},{"v":15051.470821393155,"d":"15051"},{"v":14935.298811317154,"d":"14935"},{"v":116.17201007600124,"d":"116"},{"v":0.7778351912716499,"d":"1"},0,12350,20,678,{"v":8359.74,"d":"8360"},{"v":14606.264324816357,"d":"14606"},{"v":14290.996824299611,"d":"14291"},{"v":315.2675005167457,"d":"315"},{"v":2.206056753022872,"d":"2"},{"v":2.9838919442945215,"d":"3"},{"v":-4.313954445486729,"d":"-4"},null,0,12963,20,758,{"v":9810.794,"d":"9811"},{"v":16784.71255630096,"d":"16785"},{"v":14699.74948970562,"d":"14700"},{"v":2084.963066595341,"d":"2085"},{"v":14.183663932881721,"d":"14"},{"v":14.961499124153372,"d":"15"},{"v":-1.5771316301555771,"d":"-2"},null,null,"ALK","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Alk",{"$nulls":6},"NPT(pY)GSW(bA)C","Corresponds to amino acid residues N1504 to W1510; Near the C-terminus of the kinase after the catalytic domain.","Phosphorylation of Y1507 increases phosphotransferase activity and induces interaction with Shc1 and SNTB1. This is one of the major in vivo phosphorylation sites in ALK (≥95 reports from high throughput mass spectrometry studies).",null,"EC 2.7.10.1; Receptor tyrosine kinase; TK domain target; TK</A> group; Alk family","Q9UM73","Q9UM73","Q9UM73","Q9UM73","GO:0070062; GO:0005887; GO:0005622; GO:0005886; GO:0032991","GO:0005524; GO:0042802; GO:0004704; GO:0004713; GO:0004714","GO:0000187; GO:0030534; GO:0008283; GO:0021766; GO:0048666; GO:0016310; GO:0051092; GO:0046777; GO:0042981; GO:0042127; GO:0060159; GO:0090648; GO:0007165; GO:0036269; GO:0007169"]
[120,58,"PK520","ALK","Y1507","Anaplastic lymphoma receptor-tyrosine kinase",0,11306,16,747,{"v":8433.63,"d":"8434"},{"v":14819.126801241153,"d":"14819"},{"$nulls":3},0,12232,20,655,{"v":7998.86,"d":"7999"},{"v":13975.729323782864,"d":"13976"},{"$nulls":6},0,11258,18,656,{"v":7373.44,"d":"7373"},{"v":12614.786423110278,"d":"12615"},{"$nulls":7},"ALK","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Alk",{"$nulls":6},"NPT(pY)GSW(bA)C","Corresponds to amino acid residues N1504 to W1510; Near the C-terminus of the kinase after the catalytic domain.","Phosphorylation of Y1507 increases phosphotransferase activity and induces interaction with Shc1 and SNTB1. This is one of the major in vivo phosphorylation sites in ALK (≥95 reports from high throughput mass spectrometry studies).",null,null,"Q9UM73","Q9UM73","Q9UM73","Q9UM73"]
[121,59,"PN738","ALOX5 (5-LO)","S272","Arachidonate 5-lipoxygenase",0,8444,18,625,{"v":5266.25,"d":"5266"},{"v":9253.57485650144,"d":"9254"},{"v":10466.96386182454,"d":"10467"},{"v":1213.3890053231007,"d":"1213"},{"v":11.59255942163528,"d":"12"},0,10076,16,653,{"v":6569.18,"d":"6569"},{"v":11477.770777236747,"d":"11478"},{"v":12273.939153063726,"d":"12274"},{"v":796.1683758269792,"d":"796"},{"v":6.486657346905991,"d":"6"},{"v":18.079216768541272,"d":"18"},{"v":17.2636049488013,"d":"17"},null,0,10723,18,618,{"v":6615.69,"d":"6616"},{"v":11318.396351161253,"d":"11318"},{"v":10646.964667272241,"d":"10647"},{"v":671.4316838890118,"d":"671"},{"v":6.3063202036626365,"d":"6"},{"v":17.898879625297916,"d":"18"},{"v":1.7197040882524135,"d":"2"},{"$nulls":14},"X","RQL(pS)LEQ(bA)C","Corresponds to amino acid residues R269 to Q275.","S272 phosphorylation stimulates enzymatic activity and import to the nucleus. This is a minor in vivo phosphorylation sites in ALOX5 (≥2 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and found in fish.","CaMK2a; MAPKAPK2; PKACa","Enzyme","P09917","P09917",null,null,"GO:0005829; GO:0005576; GO:0005615; GO:1904813; GO:0005635; GO:0005641; GO:0016363; GO:0031965; GO:0005654; GO:0034774","GO:0004051; GO:0005506","GO:0019221; GO:0035655; GO:0019370; GO:0006691; GO:0002540; GO:0019372; GO:0042759; GO:0043312"]
[122,59,"PN738","ALOX5 (5-LO)","S272","Arachidonate 5-lipoxygenase",0,10012,16,665,{"v":6647.34,"d":"6647"},{"v":11680.352867147643,"d":"11680"},{"$nulls":3},0,11333,16,661,{"v":7480.537,"d":"7481"},{"v":13070.107528890705,"d":"13070"},{"$nulls":6},0,9072,18,644,{"v":5830.776,"d":"5831"},{"v":9975.532983383231,"d":"9976"},{"$nulls":19},"X","RQL(pS)LEQ(bA)C","Corresponds to amino acid residues R269 to Q275.","S272 phosphorylation stimulates enzymatic activity and import to the nucleus. This is a minor in vivo phosphorylation sites in ALOX5 (≥2 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and found in fish.","CaMK2a; MAPKAPK2; PKACa",null,"P09917","P09917"]
[123,60,"PN568","AML1 (RUNX1)","T273","Runt-related transcription factor 1",0,7252,16,799,{"v":5781.564,"d":"5782"},{"v":10159.057253577763,"d":"10159"},{"v":10030.774987074321,"d":"10031"},{"v":128.28226650344186,"d":"128"},{"v":1.278886892276486,"d":"1"},0,8838,17,799,{"v":7047.979,"d":"7048"},{"v":12314.335640792042,"d":"12314"},{"v":10988.23079664883,"d":"10988"},{"v":1326.1048441432122,"d":"1326"},{"v":12.068410908766543,"d":"12"},{"v":13.347297801043029,"d":"13"},{"v":9.545182807991281,"d":"10"},null,0,8396,18,725,{"v":6074.05,"d":"6074"},{"v":10391.736214479672,"d":"10392"},{"v":9795.76461228443,"d":"9796"},{"v":595.9716021952408,"d":"596"},{"v":6.08397226539988,"d":"6"},{"v":7.3628591576763665,"d":"7"},{"v":-2.3428934961927155,"d":"-2"},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"VHPA(pT)PIS(bA)C","Corresponds to amino acid residues V269 to S276.","T273 phosphorylation induces interaction with CBFB. This is a minor in vivo phosphorylation sites in AML1 (≥6 reports from high throughput mass spectrometry studies).","CDK1; CDK2; CDK6; ERK1; ERK2; HIPK2","Transcription protein","Q01196","Q01196",null,"Q01196","GO:0016513; GO:0005829; GO:0043231; GO:0005654; GO:0005634","GO:0005524; GO:0005509; GO:0003677; GO:0003700; GO:0046982; GO:0042803; GO:0000978; GO:0000977; GO:0000981; GO:0001228; GO:0008134; GO:0044212","GO:0002062; GO:0071425; GO:0030097; GO:0030099; GO:0043371; GO:0010629; GO:0030853; GO:0000122; GO:0001503; GO:0048935; GO:0045766; GO:0043378; GO:0030854; GO:0032743; GO:0045893; GO:0045944; GO:0050855; GO:2000810; GO:0001959; GO:1902036; GO:0033146; GO:0045616; GO:0045652; GO:0045637; GO:0045589; GO:0030111"]
[124,60,"PN568","AML1 (RUNX1)","T273","Runt-related transcription factor 1",0,7006,14,806,{"v":5635.552,"d":"5636"},{"v":9902.49272057088,"d":"9902"},{"$nulls":3},0,7579,14,731,{"v":5530.015,"d":"5530"},{"v":9662.12595250562,"d":"9662"},{"$nulls":6},0,6538,20,825,{"v":5377.35,"d":"5377"},{"v":9199.793010089192,"d":"9200"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"VHPA(pT)PIS(bA)C","Corresponds to amino acid residues V269 to S276.","T273 phosphorylation induces interaction with CBFB. This is a minor in vivo phosphorylation sites in AML1 (≥6 reports from high throughput mass spectrometry studies).","CDK1; CDK2; CDK6; ERK1; ERK2; HIPK2",null,"Q01196","Q01196",null,"Q01196"]
[125,61,"PN569","AML2 (RUNX3)","T231","Runt-related transcription factor 3",0,6276,12,829,{"v":5192.856,"d":"5193"},{"v":9124.610817001212,"d":"9125"},{"v":8656.812626686102,"d":"8657"},{"v":467.79819031511033,"d":"468"},{"v":5.403815589967174,"d":"5"},0,7338,24,885,{"v":6472.89,"d":"6473"},{"v":11309.531431056534,"d":"11310"},{"v":10000.869035692189,"d":"10001"},{"v":1308.6623953643448,"d":"1309"},{"v":13.085486778137462,"d":"13"},{"v":18.489302368104635,"d":"18"},{"v":15.525996310267871,"d":"16"},null,0,7242,16,766,{"v":5535.116,"d":"5535"},{"v":9469.705614630413,"d":"9470"},{"v":9148.622599192513,"d":"9149"},{"v":321.08301543790003,"d":"321"},{"v":3.50963231848956,"d":"4"},{"v":8.913447908456734,"d":"9"},{"v":5.681189991225224,"d":"6"},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"SQPQ(pT)PIQGC","Corresponds to amino acid residues S227 to G235.","T231 phosphorylation induces cell growth. This is a minor in vivo phosphorylation sites in AML2 (≥20 reports from high throughput mass spectrometry studies).",null,"Transcription protein","Q13761","Q13761",null,"Q13761","GO:0016513; GO:0005737; GO:0005829; GO:0043231; GO:0000790; GO:0005730; GO:0005654; GO:0005634","GO:0005524; GO:0003700; GO:0000977; GO:0000981","GO:0002062; GO:0030097; GO:0043371; GO:0045786; GO:0050680; GO:0000122; GO:0001503; GO:0048935; GO:0043378; GO:0045893; GO:0006468; GO:0045595; GO:0006355; GO:0006357; GO:0071559; GO:0006366"]
[126,61,"PN569","AML2 (RUNX3)","T231","Runt-related transcription factor 3",0,6124,16,763,{"v":4660.404,"d":"4660"},{"v":8189.014436370992,"d":"8189"},{"$nulls":3},0,6612,14,754,{"v":4974.892,"d":"4975"},{"v":8692.206640327844,"d":"8692"},{"$nulls":6},0,6349,18,815,{"v":5159.765,"d":"5160"},{"v":8827.539583754611,"d":"8828"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"SQPQ(pT)PIQGC","Corresponds to amino acid residues S227 to G235.","T231 phosphorylation induces cell growth. This is a minor in vivo phosphorylation sites in AML2 (≥20 reports from high throughput mass spectrometry studies).",null,null,"Q13761","Q13761",null,"Q13761"]
[127,62,"NK259-1","AMPKa1 (PRKAA1)","Pan-specific","5'-AMP-activated protein kinase catalytic subunit alpha-1",0,3500,12,636,{"v":2218.368,"d":"2218"},{"v":3897.9984518903175,"d":"3898"},{"v":3632.6516986825736,"d":"3633"},{"v":265.34675320774386,"d":"265"},{"v":7.3044920134780655,"d":"7"},0,3178,16,546,{"v":1726.452,"d":"1726"},{"v":3016.4830791517256,"d":"3016"},{"v":3047.1152550498614,"d":"3047"},{"v":30.632175898135756,"d":"31"},{"v":1.0052844521509412,"d":"1"},{"v":8.309776465629007,"d":"8"},{"v":-16.118705898643242,"d":"-16"},null,0,3777,16,594,{"v":2234.034,"d":"2234"},{"v":3822.0778594477947,"d":"3822"},{"v":3808.07120089412,"d":"3808"},{"v":14.006658553674697,"d":"14"},{"v":0.3678150384999626,"d":"0"},{"v":7.672307051978028,"d":"8"},{"v":4.828965636181536,"d":"5"},null,null,"AMPKa1 ","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","AMPK",{"$nulls":5},"CLYNRNHQDPLAVAY","Corresponds to amino acid residues C321 to Y335; After catalytic domain in region not conserved with AMPKa2.",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; EC 2.7.1.-; CAMK domain target; CAMK</A> group; CAMKL family; AMPK subfamily","Q13131","Q13131","Q13131","Q13131","GO:0016324; GO:0030424; GO:0005737; GO:0005829; GO:0030425; GO:0005622; GO:0043025; GO:0016607; GO:0005654; GO:0031588; GO:0005634","GO:0050405; GO:0047322; GO:0004679; GO:0005524; GO:0004691; GO:0003682; GO:0035174; GO:0046872; GO:0008022; GO:0004672; GO:0050321","GO:0000187; GO:0061762; GO:0007050; GO:0071277; GO:0071361; GO:0042149; GO:0071333; GO:0070301; GO:0071456; GO:0031669; GO:0071417; GO:0034599; GO:0071380; GO:0006695; GO:0009631; GO:0097009; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0008610; GO:0016236; GO:0061744; GO:0043066; GO:0010629; GO:2001274; GO:0046318; GO:0050995; GO:0032007; GO:1904428; GO:0070050; GO:0010508; GO:0008284; GO:1903829; GO:0045542; GO:0010628; GO:0045821; GO:1903109; GO:2000758; GO:1903955; GO:0048643; GO:0051291; GO:0006468; GO:0042752; GO:0070507; GO:0033135; GO:0062028; GO:0060627; GO:0014823; GO:0031000; GO:1901563; GO:0010332; GO:0001666; GO:0009411; GO:0048511; GO:0007165; GO:0006351; GO:0016055"]
[128,62,"NK259-1","AMPKa1 (PRKAA1)","Pan-specific","5'-AMP-activated protein kinase catalytic subunit alpha-1",0,3086,10,623,{"v":1916.348,"d":"1916"},{"v":3367.3049454748293,"d":"3367"},{"$nulls":3},0,3020,14,586,{"v":1761.516,"d":"1762"},{"v":3077.747430947997,"d":"3078"},{"$nulls":6},0,3224,10,690,{"v":2217.66,"d":"2218"},{"v":3794.0645423404458,"d":"3794"},{"$nulls":7},"AMPKa1 ","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","AMPK",{"$nulls":5},"CLYNRNHQDPLAVAY","Corresponds to amino acid residues C321 to Y335; After catalytic domain in region not conserved with AMPKa2.",{"$nulls":3},"Q13131","Q13131","Q13131","Q13131"]
[129,63,"NK259-2","AMPKa1 (PRKAA1)","Pan-specific","5'-AMP-activated protein kinase catalytic subunit alpha-1",0,2568,12,638,{"v":1630.728,"d":"1631"},{"v":2865.4286482018288,"d":"2865"},{"v":2812.777498522226,"d":"2813"},{"v":52.651149679602895,"d":"53"},{"v":1.8718561886699074,"d":"2"},0,2544,18,631,{"v":1593.906,"d":"1594"},{"v":2784.8967007240344,"d":"2785"},{"v":2672.45816458596,"d":"2672"},{"v":112.4385361380746,"d":"112"},{"v":4.207307625168926,"d":"4"},{"v":6.079163813838833,"d":"6"},{"v":-4.988639663463843,"d":"-5"},null,0,2700,16,628,{"v":1685.552,"d":"1686"},{"v":2883.712145897488,"d":"2884"},{"v":2999.4762293266276,"d":"2999"},{"v":115.76408342913965,"d":"116"},{"v":3.859476607858576,"d":"4"},{"v":5.731332796528483,"d":"6"},{"v":6.637522196565101,"d":"7"},null,null,"AMPKa1 ","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","AMPK",{"$nulls":5},"MRRLSSWRKMATAEKQKGC","Corresponds to amino acid residues M1 to K17; N-terminus (not present in AMPKa2).",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; EC 2.7.1.-; CAMK domain target; CAMK</A> group; CAMKL family; AMPK subfamily","Q13131","Q13131","Q13131","Q13131","GO:0016324; GO:0030424; GO:0005737; GO:0005829; GO:0030425; GO:0005622; GO:0043025; GO:0016607; GO:0005654; GO:0031588; GO:0005634","GO:0050405; GO:0047322; GO:0004679; GO:0005524; GO:0004691; GO:0003682; GO:0035174; GO:0046872; GO:0008022; GO:0004672; GO:0050321","GO:0000187; GO:0061762; GO:0007050; GO:0071277; GO:0071361; GO:0042149; GO:0071333; GO:0070301; GO:0071456; GO:0031669; GO:0071417; GO:0034599; GO:0071380; GO:0006695; GO:0009631; GO:0097009; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0008610; GO:0016236; GO:0061744; GO:0043066; GO:0010629; GO:2001274; GO:0046318; GO:0050995; GO:0032007; GO:1904428; GO:0070050; GO:0010508; GO:0008284; GO:1903829; GO:0045542; GO:0010628; GO:0045821; GO:1903109; GO:2000758; GO:1903955; GO:0048643; GO:0051291; GO:0006468; GO:0042752; GO:0070507; GO:0033135; GO:0062028; GO:0060627; GO:0014823; GO:0031000; GO:1901563; GO:0010332; GO:0001666; GO:0009411; GO:0048511; GO:0007165; GO:0006351; GO:0016055"]
[130,63,"NK259-2","AMPKa1 (PRKAA1)","Pan-specific","5'-AMP-activated protein kinase catalytic subunit alpha-1",0,2320,10,680,{"v":1570.8,"d":"1571"},{"v":2760.1263488426225,"d":"2760"},{"$nulls":3},0,2214,14,666,{"v":1465.2,"d":"1465"},{"v":2560.0196284478857,"d":"2560"},{"$nulls":6},0,2318,16,791,{"v":1820.882,"d":"1821"},{"v":3115.2403127557677,"d":"3115"},{"$nulls":7},"AMPKa1 ","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","AMPK",{"$nulls":5},"MRRLSSWRKMATAEKQKGC","Corresponds to amino acid residues M1 to K17; N-terminus (not present in AMPKa2).",{"$nulls":3},"Q13131","Q13131","Q13131","Q13131"]
[131,64,"PK521","AMPKa1 (PRKAA1)","T183+S184","5'-AMP-activated protein kinase catalytic subunit alpha-1",0,15052,18,727,{"v":10929.718,"d":"10930"},{"v":19205.12008990291,"d":"19205"},{"v":18713.123351069153,"d":"18713"},{"v":491.99673883375726,"d":"492"},{"v":2.629153506892518,"d":"3"},0,15954,13,792,{"v":12625.272,"d":"12625"},{"v":22059.066430858238,"d":"22059"},{"v":21653.999060819442,"d":"21654"},{"v":405.06737003879607,"d":"405"},{"v":1.8706353911861084,"d":"2"},{"v":4.499788898078626,"d":"4"},{"v":15.715579139717818,"d":"16"},null,0,15741,18,730,{"v":11477.79,"d":"11478"},{"v":19636.67832915314,"d":"19637"},{"v":20070.76669626034,"d":"20071"},{"v":434.0883671072006,"d":"434"},{"v":2.16278916334612,"d":"2"},{"v":4.791942670238638,"d":"5"},{"v":7.255033378025686,"d":"7"},null,null,"AMPKa1 ","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","AMPK",{"$nulls":5},"FLR(pS)(pT)CG(bA)C","Corresponds to amino acid residues F180 to G186; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T183 and S184 stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in AMPKa1.","T183: AMPKa1; BRSK1; BRSK2; CaMK2b; CAMKK1; CaMKK2; LKB1","Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; EC 2.7.1.-; CAMK domain target; CAMK</A> group; CAMKL family; AMPK subfamily","Q13131","Q13131","Q13131","Q13131","GO:0016324; GO:0030424; GO:0005737; GO:0005829; GO:0030425; GO:0005622; GO:0043025; GO:0016607; GO:0005654; GO:0031588; GO:0005634","GO:0050405; GO:0047322; GO:0004679; GO:0005524; GO:0004691; GO:0003682; GO:0035174; GO:0046872; GO:0008022; GO:0004672; GO:0050321","GO:0000187; GO:0061762; GO:0007050; GO:0071277; GO:0071361; GO:0042149; GO:0071333; GO:0070301; GO:0071456; GO:0031669; GO:0071417; GO:0034599; GO:0071380; GO:0006695; GO:0009631; GO:0097009; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0008610; GO:0016236; GO:0061744; GO:0043066; GO:0010629; GO:2001274; GO:0046318; GO:0050995; GO:0032007; GO:1904428; GO:0070050; GO:0010508; GO:0008284; GO:1903829; GO:0045542; GO:0010628; GO:0045821; GO:1903109; GO:2000758; GO:1903955; GO:0048643; GO:0051291; GO:0006468; GO:0042752; GO:0070507; GO:0033135; GO:0062028; GO:0060627; GO:0014823; GO:0031000; GO:1901563; GO:0010332; GO:0001666; GO:0009411; GO:0048511; GO:0007165; GO:0006351; GO:0016055"]
[132,64,"PK521","AMPKa1 (PRKAA1)","T183+S184","5'-AMP-activated protein kinase catalytic subunit alpha-1",0,10941,14,949,{"v":10369.723,"d":"10370"},{"v":18221.1266122354,"d":"18221"},{"$nulls":3},0,15214,12,800,{"v":12161.6,"d":"12162"},{"v":21248.931690780646,"d":"21249"},{"$nulls":6},0,14760,18,813,{"v":11985.246,"d":"11985"},{"v":20504.85506336754,"d":"20505"},{"$nulls":7},"AMPKa1 ","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","AMPK",{"$nulls":5},"FLR(pS)(pT)CG(bA)C","Corresponds to amino acid residues F180 to G186; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T183 and S184 stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in AMPKa1.","T183: AMPKa1; BRSK1; BRSK2; CaMK2b; CAMKK1; CaMKK2; LKB1",null,"Q13131","Q13131","Q13131","Q13131"]
[133,65,"NK260-2","AMPKa2 (PRKAA2)","Pan-specific","5'-AMP-activated protein kinase catalytic subunit alpha-2",0,5940,18,711,{"v":4210.542,"d":"4211"},{"v":7398.540818123577,"d":"7399"},{"v":7574.68600900703,"d":"7575"},{"v":176.14519088345332,"d":"176"},{"v":2.3254454465043137,"d":"2"},0,5726,20,708,{"v":4039.848,"d":"4040"},{"v":7058.483603566703,"d":"7058"},{"v":6985.344304046745,"d":"6985"},{"v":73.13929951995851,"d":"73"},{"v":1.0470392916436133,"d":"1"},{"v":3.372484738147927,"d":"3"},{"v":-7.780411019803353,"d":"-8"},null,0,6166,12,702,{"v":4320.108,"d":"4320"},{"v":7391.019625136992,"d":"7391"},{"v":7953.4518924981985,"d":"7953"},{"v":562.4322673612069,"d":"562"},{"v":7.071549246330394,"d":"7"},{"v":9.396994692834708,"d":"9"},{"v":5.000416955115753,"d":"5"},null,null,"AMPKa2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","AMPK",{"$nulls":5},"CTESEVMNSLYSGDPQDQL","Corresponds to amino acid residues C302 to L320; After catalytic domain in region not conserved with AMPKa1.",null,null,"Protein-serine kinase, CAMK group, CAMKL family, AMPK subfamily","P54646","P54646","P54646",null,"GO:0030424; GO:0005737; GO:0010494; GO:0005829; GO:0030425; GO:0005794; GO:0043025; GO:0016607; GO:0005654; GO:0031588; GO:0005634","GO:0050405; GO:0047322; GO:0004679; GO:0005524; GO:0003682; GO:0035174; GO:0046872; GO:0004672; GO:0004712; GO:0004674","GO:0007050; GO:0071277; GO:0035690; GO:0042149; GO:0071333; GO:0031669; GO:0034599; GO:0071380; GO:0006695; GO:0097009; GO:0006633; GO:0055089; GO:0042593; GO:0035404; GO:0035556; GO:0008610; GO:0016236; GO:0043066; GO:0010629; GO:0032007; GO:1904428; GO:0010508; GO:1903829; GO:0045821; GO:0016239; GO:2000758; GO:0006468; GO:0042752; GO:0042304; GO:0016241; GO:0070507; GO:0062028; GO:0006355; GO:0014850; GO:0048511; GO:0007165; GO:0006351; GO:0016055"]
[134,65,"NK260-2","AMPKa2 (PRKAA2)","Pan-specific","5'-AMP-activated protein kinase catalytic subunit alpha-2",0,6040,14,732,{"v":4411.032,"d":"4411"},{"v":7750.831199890484,"d":"7751"},{"$nulls":3},0,5507,20,721,{"v":3956.127,"d":"3956"},{"v":6912.205004526786,"d":"6912"},{"$nulls":6},0,6116,16,816,{"v":4977.6,"d":"4978"},{"v":8515.884159859404,"d":"8516"},{"$nulls":7},"AMPKa2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","AMPK",{"$nulls":5},"CTESEVMNSLYSGDPQDQL","Corresponds to amino acid residues C302 to L320; After catalytic domain in region not conserved with AMPKa1.",{"$nulls":3},"P54646","P54646","P54646"]
[135,66,"NK260-1","AMPKa2 (PRKAA2)","Pan-specific","5'-AMP-activated protein kinase catalytic subunit alpha-2",0,9912,16,662,{"v":6551.152,"d":"6551"},{"v":11511.336421233158,"d":"11511"},{"v":11289.162767332176,"d":"11289"},{"v":222.17365390098166,"d":"222"},{"v":1.9680259597628702,"d":"2"},0,11074,14,640,{"v":7078.4,"d":"7078"},{"v":12367.487672676434,"d":"12367"},{"v":12504.460603861373,"d":"12504"},{"v":136.97293118493872,"d":"137"},{"v":1.095392560496704,"d":"1"},{"v":3.0634185202595745,"d":"3"},{"v":10.765172418684088,"d":"11"},null,0,8419,12,670,{"v":5632.69,"d":"5633"},{"v":9636.639253535532,"d":"9637"},{"v":8086.22858282336,"d":"8086"},{"v":1550.4106707121719,"d":"1550"},{"v":19.173470732765704,"d":"19"},{"v":21.141496692528573,"d":"21"},{"v":-28.37176016079114,"d":"-28"},null,null,"AMPKa2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","AMPK",{"$nulls":5},"CGSFMDDSAMHIPPGLKP","Corresponds to amino acid residues G349 to P365; After catalytic domain in region not conserved with AMPKa1.",null,null,"Protein-serine kinase, CAMK group, CAMKL family, AMPK subfamily","P54646","P54646","P54646",null,"GO:0030424; GO:0005737; GO:0010494; GO:0005829; GO:0030425; GO:0005794; GO:0043025; GO:0016607; GO:0005654; GO:0031588; GO:0005634","GO:0050405; GO:0047322; GO:0004679; GO:0005524; GO:0003682; GO:0035174; GO:0046872; GO:0004672; GO:0004712; GO:0004674","GO:0007050; GO:0071277; GO:0035690; GO:0042149; GO:0071333; GO:0031669; GO:0034599; GO:0071380; GO:0006695; GO:0097009; GO:0006633; GO:0055089; GO:0042593; GO:0035404; GO:0035556; GO:0008610; GO:0016236; GO:0043066; GO:0010629; GO:0032007; GO:1904428; GO:0010508; GO:1903829; GO:0045821; GO:0016239; GO:2000758; GO:0006468; GO:0042752; GO:0042304; GO:0016241; GO:0070507; GO:0062028; GO:0006355; GO:0014850; GO:0048511; GO:0007165; GO:0006351; GO:0016055"]
[136,66,"NK260-1","AMPKa2 (PRKAA2)","Pan-specific","5'-AMP-activated protein kinase catalytic subunit alpha-2",0,9224,16,684,{"v":6298.272,"d":"6298"},{"v":11066.989113431195,"d":"11067"},{"$nulls":3},0,11444,14,633,{"v":7235.19,"d":"7235"},{"v":12641.433535046312,"d":"12641"},{"$nulls":6},0,6142,10,623,{"v":3820.236,"d":"3820"},{"v":6535.817912111187,"d":"6536"},{"$nulls":7},"AMPKa2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","AMPK",{"$nulls":5},"CGSFMDDSAMHIPPGLKP","Corresponds to amino acid residues G349 to P365; After catalytic domain in region not conserved with AMPKa1.",{"$nulls":3},"P54646","P54646","P54646"]
[137,67,"PK522","AMPKa2 (PRKAA2)","S377","5'-AMP-activated protein kinase catalytic subunit alpha-2",0,6497,14,765,{"v":4959.495,"d":"4959"},{"v":8714.561259519507,"d":"8715"},{"v":8567.08743458593,"d":"8567"},{"v":147.4738249335769,"d":"147"},{"v":1.7213997879631155,"d":"2"},0,6721,12,691,{"v":4635.919,"d":"4636"},{"v":8099.947881445873,"d":"8100"},{"v":7718.426856290217,"d":"7718"},{"v":381.5210251556555,"d":"382"},{"v":4.94298944926492,"d":"5"},{"v":6.664389237228036,"d":"7"},{"v":-9.90605716091575,"d":"-10"},null,0,6930,12,684,{"v":4731.912,"d":"4732"},{"v":8095.550957619863,"d":"8096"},{"v":7636.001848776277,"d":"7636"},{"v":459.5491088435856,"d":"460"},{"v":6.018190120229365,"d":"6"},{"v":7.73958990819248,"d":"8"},{"v":-10.868169525745657,"d":"-11"},null,null,"AMPKa2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","AMPK",{"$nulls":5},"IAD(pS)PKARC","Corresponds to amino acid residues I374 to C382; In the C-terminal half of the protein after the kinase catalytic domain. ","The effect of S377 phosphorylation is unclear. This is the major in vivo phosphorylation site in AMPKa2.",null,"Protein-serine kinase, CAMK group, CAMKL family, AMPK subfamily","P54646","P54646","P54646",null,"GO:0030424; GO:0005737; GO:0010494; GO:0005829; GO:0030425; GO:0005794; GO:0043025; GO:0016607; GO:0005654; GO:0031588; GO:0005634","GO:0050405; GO:0047322; GO:0004679; GO:0005524; GO:0003682; GO:0035174; GO:0046872; GO:0004672; GO:0004712; GO:0004674","GO:0007050; GO:0071277; GO:0035690; GO:0042149; GO:0071333; GO:0031669; GO:0034599; GO:0071380; GO:0006695; GO:0097009; GO:0006633; GO:0055089; GO:0042593; GO:0035404; GO:0035556; GO:0008610; GO:0016236; GO:0043066; GO:0010629; GO:0032007; GO:1904428; GO:0010508; GO:1903829; GO:0045821; GO:0016239; GO:2000758; GO:0006468; GO:0042752; GO:0042304; GO:0016241; GO:0070507; GO:0062028; GO:0006355; GO:0014850; GO:0048511; GO:0007165; GO:0006351; GO:0016055"]
[138,67,"PK522","AMPKa2 (PRKAA2)","S377","5'-AMP-activated protein kinase catalytic subunit alpha-2",0,6245,14,769,{"v":4791.639,"d":"4792"},{"v":8419.613609652353,"d":"8420"},{"$nulls":3},0,5808,16,725,{"v":4199.2,"d":"4199"},{"v":7336.905831134562,"d":"7337"},{"$nulls":6},0,6206,10,677,{"v":4194.692,"d":"4195"},{"v":7176.452739932691,"d":"7176"},{"$nulls":7},"AMPKa2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","AMPK",{"$nulls":5},"IAD(pS)PKARC","Corresponds to amino acid residues I374 to C382; In the C-terminal half of the protein after the kinase catalytic domain. ","The effect of S377 phosphorylation is unclear. This is the major in vivo phosphorylation site in AMPKa2.",null,null,"P54646","P54646","P54646"]
[139,68,"PK523","ANKRD3 (RIPK4, DIK)","S438","Ankyrin repeat domain protein-serine kinase 3",0,6818,14,705,{"v":4796.82,"d":"4797"},{"v":8428.71738773572,"d":"8429"},{"v":8258.675646605707,"d":"8259"},{"v":170.04174113001318,"d":"170"},{"v":2.0589468385273113,"d":"2"},0,6782,14,679,{"v":4595.472,"d":"4595"},{"v":8029.278270531436,"d":"8029"},{"v":7475.763133851906,"d":"7476"},{"v":553.5151366795299,"d":"554"},{"v":7.404128873119202,"d":"7"},{"v":9.463075711646514,"d":"9"},{"v":-9.479879659344363,"d":"-9"},null,0,7424,12,792,{"v":5870.304,"d":"5870"},{"v":10043.159122299761,"d":"10043"},{"v":9204.800642871236,"d":"9205"},{"v":838.3584794285252,"d":"838"},{"v":9.107839614949203,"d":"9"},{"v":11.166786453476515,"d":"11"},{"v":11.456134575939942,"d":"11"},null,null,"ANKRD3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RIPK",{"$nulls":6},"LSL(pS)FER(bA)C","Corresponds to amino acid residues L435 to R441; In the region between the kinase catalytic and Ank_2 domains.","The effect of S438 phosphorylation is unclear. The major site of phosphorylation in ANKRD3.",null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); TKL group; RIPK family","P57078","P57078","P57078",null,"GO:0005737; GO:0016020","GO:0005524; GO:0004674","GO:0002009; GO:0051092"]
[140,68,"PK523","ANKRD3 (RIPK4, DIK)","S438","Ankyrin repeat domain protein-serine kinase 3",0,6521,10,707,{"v":4603.277,"d":"4603"},{"v":8088.6339054756945,"d":"8089"},{"$nulls":3},0,6353,14,625,{"v":3961.875,"d":"3962"},{"v":6922.247997172376,"d":"6922"},{"$nulls":6},0,6324,14,775,{"v":4890.25,"d":"4890"},{"v":8366.442163442713,"d":"8366"},{"$nulls":7},"ANKRD3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RIPK",{"$nulls":6},"LSL(pS)FER(bA)C","Corresponds to amino acid residues L435 to R441; In the region between the kinase catalytic and Ank_2 domains.","The effect of S438 phosphorylation is unclear. The major site of phosphorylation in ANKRD3.",null,null,"P57078","P57078","P57078"]
[141,69,"PN503","ANXA1","Y207","Annexin A1",0,4732,14,687,{"v":3241.266,"d":"3241"},{"v":5695.380500514217,"d":"5695"},{"v":5554.346618965225,"d":"5554"},{"v":141.0338815489913,"d":"141"},{"v":2.539162411424477,"d":"3"},0,4822,12,628,{"v":3020.68,"d":"3021"},{"v":5277.777840062761,"d":"5278"},{"v":5046.411610743167,"d":"5046"},{"v":231.3662293195939,"d":"231"},{"v":4.584767299342857,"d":"5"},{"v":7.123929710767334,"d":"7"},{"v":-9.144820139379178,"d":"-9"},null,0,5067,12,616,{"v":3113.88,"d":"3114"},{"v":5327.354823148305,"d":"5327"},{"v":4846.916340793009,"d":"4847"},{"v":480.4384823552955,"d":"480"},{"v":9.912250358269862,"d":"10"},{"v":12.45141276969434,"d":"12"},{"v":-12.736516582467274,"d":"-13"},{"$nulls":15},"RAL(pY)EAG(bA)C","Corresponds to amino acid residues R204 to G210; In the beginning of the third Annexin domain. ","The effect of Y207 phosphorylation is unclear. This is the major in vivo phosphorylation site in ANXA1.",null,"Lipid binding protein; Calcium-binding protein","P04083","P04083",null,null,"GO:0016324; GO:0016323; GO:0005913; GO:0009986; GO:0062023; GO:0001533; GO:0005737; GO:0030659; GO:0005829; GO:0031901; GO:0005768; GO:0070062; GO:0005576; GO:0005615; GO:0031313; GO:0031232; GO:0019898; GO:0005925; GO:0016328; GO:0042629; GO:0031966; GO:0031514; GO:0005654; GO:0005634; GO:0001891; GO:0005886; GO:0032991; GO:0042383; GO:0097060; GO:0031982","GO:0098641; GO:0005544; GO:0048306; GO:0005509; GO:1990814; GO:0033676; GO:0019834; GO:0005543; GO:0030674; GO:0042803; GO:0005102; GO:0003697; GO:0003727; GO:0005198","GO:0031532; GO:0002250; GO:0046632; GO:0050482; GO:0007166; GO:0071385; GO:0070301; GO:0035924; GO:0019221; GO:0032508; GO:0031018; GO:0044849; GO:0042063; GO:0007186; GO:0007187; GO:0071621; GO:0070365; GO:0006954; GO:0045087; GO:0030073; GO:0030216; GO:0002548; GO:0014839; GO:0043066; GO:0045920; GO:2000483; GO:1900138; GO:0045629; GO:0097350; GO:0001780; GO:0018149; GO:0006909; GO:0090050; GO:1900087; GO:0032743; GO:0033031; GO:0031394; GO:0042102; GO:0045627; GO:0031340; GO:0090303; GO:0070459; GO:0030850; GO:0008360; GO:0046883; GO:0050727; GO:0032652; GO:0002685; GO:0032355; GO:0070555; GO:0043434; GO:0010165; GO:0007165"]
[142,69,"PN503","ANXA1","Y207","Annexin A1",0,4434,14,697,{"v":3080.74,"d":"3081"},{"v":5413.312737416234,"d":"5413"},{"$nulls":3},0,4322,16,640,{"v":2755.84,"d":"2756"},{"v":4815.045381423574,"d":"4815"},{"$nulls":6},0,4200,16,610,{"v":2552.24,"d":"2552"},{"v":4366.477858437714,"d":"4366"},{"$nulls":20},"RAL(pY)EAG(bA)C","Corresponds to amino acid residues R204 to G210; In the beginning of the third Annexin domain. ","The effect of Y207 phosphorylation is unclear. This is the major in vivo phosphorylation site in ANXA1.",null,null,"P04083","P04083"]
[143,70,"PN504","ANXA2","Y238","Annexin A2",0,5382,14,627,{"v":3365.736,"d":"3366"},{"v":5914.092575024301,"d":"5914"},{"v":5625.299332170656,"d":"5625"},{"v":288.7932428536451,"d":"289"},{"v":5.133828900482835,"d":"5"},0,6076,18,712,{"v":4313.296,"d":"4313"},{"v":7536.2560901622655,"d":"7536"},{"v":6676.248841024875,"d":"6676"},{"v":860.0072491373903,"d":"860"},{"v":12.881593685554869,"d":"13"},{"v":18.015422586037705,"d":"18"},{"v":18.68255263935768,"d":"19"},null,0,6546,14,708,{"v":4624.656,"d":"4625"},{"v":7912.052952265901,"d":"7912"},{"v":7736.207540500627,"d":"7736"},{"v":175.84541176527364,"d":"176"},{"v":2.273018282468341,"d":"2"},{"v":7.406847182951177,"d":"7"},{"v":37.52526014496419,"d":"38"},{"$nulls":15},"YSP(pY)DML(bA)C","Corresponds to amino acid residues Y235 to L241; In the third Annexin domain. ","The effect of Y238 phosphorylation is unclear. The second major in vivo phosphoryation site in Annexin A2.",null,"Lipid binding protein; Calcium-binding protein","P07355","P07355",null,null,"GO:0035578; GO:0005604; GO:0016323; GO:0005913; GO:0005938; GO:0009986; GO:0062023; GO:0005737; GO:0005829; GO:0005769; GO:0005768; GO:0070062; GO:0005576; GO:0005615; GO:0019897; GO:0031902; GO:0005811; GO:0005765; GO:0044354; GO:0042470; GO:0016020; GO:0045121; GO:0030496; GO:0035749; GO:0005634; GO:1990667; GO:0048471; GO:0005886; GO:0001726; GO:0042383; GO:0043220; GO:0031982","GO:0044730; GO:0098641; GO:0005544; GO:0048306; GO:0005509; GO:0008092; GO:0042802; GO:0098772; GO:0005546; GO:0019834; GO:0002020; GO:0017137; GO:0003723; GO:0044548","GO:0001525; GO:0007589; GO:0052362; GO:0030199; GO:0042730; GO:0035722; GO:0001765; GO:0052405; GO:0044147; GO:0032804; GO:0043312; GO:0036035; GO:0048146; GO:1905581; GO:1905597; GO:1905599; GO:0001934; GO:1905602; GO:0001921; GO:0044090; GO:0031340; GO:0051290; GO:0072659; GO:0097066; GO:0006900"]
[144,70,"PN504","ANXA2","Y238","Annexin A2",0,3219,12,947,{"v":3037.029,"d":"3037"},{"v":5336.506089317011,"d":"5337"},{"$nulls":3},0,5420,16,616,{"v":3328.864,"d":"3329"},{"v":5816.241591887484,"d":"5816"},{"$nulls":6},0,6311,16,702,{"v":4419.09,"d":"4419"},{"v":7560.362128735353,"d":"7560"},{"$nulls":20},"YSP(pY)DML(bA)C","Corresponds to amino acid residues Y235 to L241; In the third Annexin domain. ","The effect of Y238 phosphorylation is unclear. The second major in vivo phosphoryation site in Annexin A2.",null,null,"P07355","P07355"]
[145,71,"PN739","APC","S2129","Adenomatous polyposis coli protein",0,8813,14,674,{"v":5930.526,"d":"5931"},{"v":10420.805369936492,"d":"10421"},{"v":11311.96350549272,"d":"11312"},{"v":891.1581355562284,"d":"891"},{"v":7.878014591573877,"d":"8"},0,9029,14,724,{"v":6526.86,"d":"6527"},{"v":11403.828632358289,"d":"11404"},{"v":11429.68042762345,"d":"11430"},{"v":25.851795265161854,"d":"26"},{"v":0.22618126052485937,"d":"0"},{"v":8.104195852098737,"d":"8"},{"v":1.0406409291682195,"d":"1"},null,0,10896,18,731,{"v":7951.818,"d":"7952"},{"v":13604.299451198345,"d":"13604"},{"v":11453.297906507018,"d":"11453"},{"v":2151.0015446913276,"d":"2151"},{"v":18.780630367339597,"d":"19"},{"v":26.658644958913474,"d":"27"},{"v":1.249424124694798,"d":"1"},{"$nulls":15},"RQA(pS)SDS(bA)C","Corresponds to amino acid residues R2126 to S2132.","The effect of S2129 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in APC(≥40 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in mammals, and is found in the chicken.","MAPKAPK2","Tumour suppressor protein","P25054","P25054",null,"P25054","GO:0005912; GO:0030877; GO:0005923; GO:0016342; GO:0005813; GO:0005737; GO:0005829; GO:0000776; GO:0030027; GO:0016328; GO:0005874; GO:0005654; GO:0005634; GO:0048471; GO:0005886; GO:0032587; GO:1990909","GO:0008013; GO:0070840; GO:0045295; GO:0042802; GO:0008017; GO:0051010; GO:0019901; GO:0019887; GO:0031625","GO:1904885; GO:1904886; GO:0070830; GO:0007155; GO:0007050; GO:0016477; GO:0006974; GO:0008286; GO:0000281; GO:0007094; GO:0090090; GO:0008285; GO:0045736; GO:0007026; GO:0043065; GO:0010942; GO:0030335; GO:0120162; GO:0045732; GO:1904781; GO:0031274; GO:0065003; GO:0016579; GO:0051260; GO:0051988; GO:0032886; GO:0016055"]
[146,71,"PN739","APC","S2129","Adenomatous polyposis coli protein",0,10366,16,671,{"v":6944.85,"d":"6945"},{"v":12203.121641048949,"d":"12203"},{"$nulls":3},0,10540,16,623,{"v":6556.452,"d":"6556"},{"v":11455.532222888613,"d":"11456"},{"$nulls":6},0,9046,14,602,{"v":5437.264,"d":"5437"},{"v":9302.29636181569,"d":"9302"},{"$nulls":20},"RQA(pS)SDS(bA)C","Corresponds to amino acid residues R2126 to S2132.","The effect of S2129 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in APC(≥40 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in mammals, and is found in the chicken.","MAPKAPK2",null,"P25054","P25054",null,"P25054"]
[147,72,"PN570","AR","S96","Androgen receptor",0,14214,18,715,{"v":10150.14,"d":"10150"},{"v":17835.28702472718,"d":"17835"},{"v":17929.795170686244,"d":"17930"},{"v":94.50814595906559,"d":"95"},{"v":0.5271010910017461,"d":"1"},0,15992,16,708,{"v":11311.008,"d":"11311"},{"v":19762.764467329416,"d":"19763"},{"v":19531.04180612052,"d":"19531"},{"v":231.72266120889617,"d":"232"},{"v":1.1864326722002116,"d":"1"},{"v":1.7135337632019576,"d":"2"},{"v":8.930646558931059,"d":"9"},null,0,14166,18,678,{"v":9592.344,"d":"9592"},{"v":16410.979252154128,"d":"16411"},{"v":14737.464988400592,"d":"14737"},{"v":1673.5142637535355,"d":"1674"},{"v":11.355509682775887,"d":"11"},{"v":11.882610773777634,"d":"12"},{"v":-17.80461043696056,"d":"-18"},{"$nulls":5},"Receptor (steroid),  Transcription protein",{"$nulls":4},"X",{"$nulls":4},"GEDG(pS)PQAH(bA)C","Corresponds to amino acid residues G92 to H100.","S96 phosphorylation regulates transcription. This is a minor in vivo phosphorylation sites in the androgen receptor (≥8 reports from high throughput mass spectrometry studies).",null,"Receptor (steroid), transcription factor","P10275","P10275",null,"P10275","GO:0005737; GO:0005829; GO:0000790; GO:0016607; GO:0005654; GO:0005634; GO:0005886; GO:0032991","GO:0005497; GO:0004882; GO:0051117; GO:0008013; GO:0003682; GO:0003677; GO:0003700; GO:0019899; GO:0004879; GO:0070974; GO:0046983; GO:0000978; GO:0000981; GO:0001085; GO:0005102; GO:0005496; GO:0001077; GO:0008134; GO:0044212; GO:0008270","GO:0060520; GO:0030521; GO:0048645; GO:0007267; GO:0008283; GO:0071383; GO:0071394; GO:0060742; GO:0003382; GO:0030522; GO:0001701; GO:0060599; GO:0033327; GO:0048808; GO:0019102; GO:0060749; GO:0060571; GO:0035264; GO:0008285; GO:0050680; GO:2001237; GO:0045720; GO:0000122; GO:0045597; GO:0008284; GO:0060769; GO:0010628; GO:0043568; GO:0045726; GO:0033148; GO:0043410; GO:0051092; GO:0042327; GO:0045893; GO:0045944; GO:0045945; GO:0030850; GO:0060740; GO:0060736; GO:0051259; GO:0016579; GO:0050790; GO:0048638; GO:1903076; GO:0003073; GO:0072520; GO:0007548; GO:0007165; GO:0007338; GO:0007283; GO:0060748; GO:0006351; GO:0006367"]
[148,72,"PN570","AR","S96","Androgen receptor",0,13288,18,773,{"v":10257.71,"d":"10258"},{"v":18024.30331664531,"d":"18024"},{"$nulls":3},0,15708,18,704,{"v":11045.76,"d":"11046"},{"v":19299.319144911628,"d":"19299"},{"$nulls":6},0,11396,16,671,{"v":7635.98,"d":"7636"},{"v":13063.950724647058,"d":"13064"},{"$nulls":10},"Receptor (steroid),  Transcription protein",{"$nulls":4},"X",{"$nulls":4},"GEDG(pS)PQAH(bA)C","Corresponds to amino acid residues G92 to H100.","S96 phosphorylation regulates transcription. This is a minor in vivo phosphorylation sites in the androgen receptor (≥8 reports from high throughput mass spectrometry studies).",null,null,"P10275","P10275",null,"P10275"]
[149,73,"PN571","AR","S310","Androgen receptor",0,5969,18,814,{"v":4844.114,"d":"4844"},{"v":8511.819893173815,"d":"8512"},{"v":8219.56946379652,"d":"8220"},{"v":292.2504293772945,"d":"292"},{"v":3.5555442491790505,"d":"4"},0,6398,20,757,{"v":4828.146,"d":"4828"},{"v":8435.809806860594,"d":"8436"},{"v":7936.73702044903,"d":"7937"},{"v":499.07278641156427,"d":"499"},{"v":6.288135604414025,"d":"6"},{"v":9.843679853593075,"d":"10"},{"v":-3.4409642085663847,"d":"-3"},null,0,6403,16,821,{"v":5243.727,"d":"5244"},{"v":8971.185249503187,"d":"8971"},{"v":8417.121562857175,"d":"8417"},{"v":554.0636866460118,"d":"554"},{"v":6.582579121715049,"d":"7"},{"v":10.1381233708941,"d":"10"},{"v":2.403436091522579,"d":"2"},{"$nulls":5},"Receptor (steroid),  Transcription protein",{"$nulls":4},"X",{"$nulls":4},"AEY(pS)PFKGC","Corresponds to amino acid residues A307 to G314.","S310 phosphorylation regulates transcription. This is a minor in vivo phosphorylation sites in the androgen receptor (≥4 reports from high throughput mass spectrometry studies).","CDK1; CDK5","Receptor (steroid), transcription factor","P10275","P10275",null,"P10275","GO:0005737; GO:0005829; GO:0000790; GO:0016607; GO:0005654; GO:0005634; GO:0005886; GO:0032991","GO:0005497; GO:0004882; GO:0051117; GO:0008013; GO:0003682; GO:0003677; GO:0003700; GO:0019899; GO:0004879; GO:0070974; GO:0046983; GO:0000978; GO:0000981; GO:0001085; GO:0005102; GO:0005496; GO:0001077; GO:0008134; GO:0044212; GO:0008270","GO:0060520; GO:0030521; GO:0048645; GO:0007267; GO:0008283; GO:0071383; GO:0071394; GO:0060742; GO:0003382; GO:0030522; GO:0001701; GO:0060599; GO:0033327; GO:0048808; GO:0019102; GO:0060749; GO:0060571; GO:0035264; GO:0008285; GO:0050680; GO:2001237; GO:0045720; GO:0000122; GO:0045597; GO:0008284; GO:0060769; GO:0010628; GO:0043568; GO:0045726; GO:0033148; GO:0043410; GO:0051092; GO:0042327; GO:0045893; GO:0045944; GO:0045945; GO:0030850; GO:0060740; GO:0060736; GO:0051259; GO:0016579; GO:0050790; GO:0048638; GO:1903076; GO:0003073; GO:0072520; GO:0007548; GO:0007165; GO:0007338; GO:0007283; GO:0060748; GO:0006351; GO:0006367"]
[150,73,"PN571","AR","S310","Androgen receptor",0,5570,14,812,{"v":4511.472,"d":"4511"},{"v":7927.319034419228,"d":"7927"},{"$nulls":3},0,5978,16,714,{"v":4256.868,"d":"4257"},{"v":7437.664234037466,"d":"7438"},{"$nulls":6},0,5354,16,861,{"v":4596.018,"d":"4596"},{"v":7863.0578762111645,"d":"7863"},{"$nulls":10},"Receptor (steroid),  Transcription protein",{"$nulls":4},"X",{"$nulls":4},"AEY(pS)PFKGC","Corresponds to amino acid residues A307 to G314.","S310 phosphorylation regulates transcription. This is a minor in vivo phosphorylation sites in the androgen receptor (≥4 reports from high throughput mass spectrometry studies).","CDK1; CDK5",null,"P10275","P10275",null,"P10275"]
[151,74,"PN203","AR","S310","Androgen receptor",0,170,14,491,{"v":76.596,"d":"77"},{"v":134.59042387060703,"d":"135"},{"v":124.03524244872159,"d":"124"},{"v":10.555181421885436,"d":"11"},{"v":8.509824476901505,"d":"9"},0,179,12,457,{"v":76.319,"d":"76"},{"v":133.34571254676098,"d":"133"},{"v":117.55176125591012,"d":"118"},{"v":15.793951290850856,"d":"16"},{"v":13.435741942196369,"d":"13"},{"v":21.945566419097872,"d":"22"},{"v":-5.227128245822428,"d":"-5"},null,0,172,12,534,{"v":85.44,"d":"85"},{"v":146.1742893399203,"d":"146"},{"v":158.09201054242365,"d":"158"},{"v":11.917721202503344,"d":"12"},{"v":7.538471527822875,"d":"8"},{"v":16.048296004724378,"d":"16"},{"v":27.45733182065713,"d":"27"},{"$nulls":5},"Receptor (steroid),  Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S310 phosphosite.","S310 phosphorylation regulates transcription. This is a minor in vivo phosphorylation sites in the androgen receptor (≥4 reports from high throughput mass spectrometry studies).","CDK1; CDK5","Receptor (steroid), transcription factor","P10275","P10275",null,"P10275","GO:0005737; GO:0005829; GO:0000790; GO:0016607; GO:0005654; GO:0005634; GO:0005886; GO:0032991","GO:0005497; GO:0004882; GO:0051117; GO:0008013; GO:0003682; GO:0003677; GO:0003700; GO:0019899; GO:0004879; GO:0070974; GO:0046983; GO:0000978; GO:0000981; GO:0001085; GO:0005102; GO:0005496; GO:0001077; GO:0008134; GO:0044212; GO:0008270","GO:0060520; GO:0030521; GO:0048645; GO:0007267; GO:0008283; GO:0071383; GO:0071394; GO:0060742; GO:0003382; GO:0030522; GO:0001701; GO:0060599; GO:0033327; GO:0048808; GO:0019102; GO:0060749; GO:0060571; GO:0035264; GO:0008285; GO:0050680; GO:2001237; GO:0045720; GO:0000122; GO:0045597; GO:0008284; GO:0060769; GO:0010628; GO:0043568; GO:0045726; GO:0033148; GO:0043410; GO:0051092; GO:0042327; GO:0045893; GO:0045944; GO:0045945; GO:0030850; GO:0060740; GO:0060736; GO:0051259; GO:0016579; GO:0050790; GO:0048638; GO:1903076; GO:0003073; GO:0072520; GO:0007548; GO:0007165; GO:0007338; GO:0007283; GO:0060748; GO:0006351; GO:0006367"]
[152,74,"PN203","AR","S310","Androgen receptor",0,110,12,659,{"v":64.582,"d":"65"},{"v":113.48006102683615,"d":"113"},{"$nulls":3},0,142,12,448,{"v":58.24,"d":"58"},{"v":101.75780996505928,"d":"102"},{"$nulls":6},0,196,14,546,{"v":99.372,"d":"99"},{"v":170.009731744927,"d":"170"},{"$nulls":10},"Receptor (steroid),  Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S310 phosphosite.","S310 phosphorylation regulates transcription. This is a minor in vivo phosphorylation sites in the androgen receptor (≥4 reports from high throughput mass spectrometry studies).","CDK1; CDK5",null,"P10275","P10275",null,"P10275"]
[153,75,"PN740","ARID1A","S363","AT-rich interactive domain-containing protein 1A",0,16854,14,669,{"v":11265.96,"d":"11266"},{"v":19795.94667749365,"d":"19796"},{"v":20131.23490586649,"d":"20131"},{"v":335.2882283728395,"d":"335"},{"v":1.6655124732319941,"d":"2"},0,17982,18,685,{"v":12305.34,"d":"12305"},{"v":21500.076395526143,"d":"21500"},{"v":11444.813057982437,"d":"11445"},{"v":10055.263337543705,"d":"10055"},{"v":87.85869447234387,"d":"88"},{"v":89.52420694557587,"d":"90"},{"v":-43.14897664500812,"d":"-43"},null,0,17822,18,771,{"v":13726.884,"d":"13727"},{"v":23484.521460106775,"d":"23485"},{"v":22823.377065564684,"d":"22823"},{"v":661.1443945420906,"d":"661"},{"v":2.8967860130550442,"d":"3"},{"v":4.562298486287038,"d":"5"},{"v":13.372960835669701,"d":"13"},{"$nulls":5},"Nuclear receptor co-regulator; DNA binding protein",{"$nulls":4},"X",{"$nulls":4},"HAPM(pS)PGS(bA)C","Corresponds to amino acid residues H359-S366.","The effect of S363 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in ARID1A (≥82 reports from high throughput mass spectrometry studies). This human phosphosite is not conserved in mammals, but is found in the mouse.",null,"Nuclear receptor co-regulator; DNA binding protein","O14497","O14497",null,"O14497","GO:0071565; GO:0071564; GO:0000790; GO:0005654; GO:0005634; GO:0016514","GO:0003677; GO:0016922; GO:0031491; GO:0000981; GO:0003713","GO:0030521; GO:0043044; GO:0003205; GO:0055007; GO:0071277; GO:0048096; GO:0006338; GO:0007566; GO:0030900; GO:0001704; GO:0042921; GO:0030520; GO:0006344; GO:0000122; GO:0001843; GO:0006337; GO:0042766; GO:0003408; GO:0060674; GO:0045893; GO:0006357; GO:0019827; GO:1901998; GO:0006351"]
[154,75,"PN740","ARID1A","S363","AT-rich interactive domain-containing protein 1A",0,16512,14,706,{"v":11647.588,"d":"11648"},{"v":20466.52313423933,"d":"20467"},{"$nulls":3},0,794,12,1017,{"v":795.294,"d":"795"},{"v":1389.5497204387336,"d":"1390"},{"$nulls":6},0,16150,18,803,{"v":12953.996,"d":"12954"},{"v":22162.232671022593,"d":"22162"},{"$nulls":10},"Nuclear receptor co-regulator; DNA binding protein",{"$nulls":4},"X",{"$nulls":4},"HAPM(pS)PGS(bA)C","Corresponds to amino acid residues H359-S366.","The effect of S363 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in ARID1A (≥82 reports from high throughput mass spectrometry studies). This human phosphosite is not conserved in mammals, but is found in the mouse.",null,null,"O14497","O14497",null,"O14497"]
[155,77,"NN121","Arrestin b","Pan-specific","Arrestin beta 1",0,441,8,333,{"v":144.189,"d":"144"},{"v":253.36125421012787,"d":"253"},{"v":221.58061682259154,"d":"222"},{"v":31.78063738753633,"d":"32"},{"v":14.342697408853903,"d":"14"},0,1282,10,291,{"v":370.152,"d":"370"},{"v":646.7351798452372,"d":"647"},{"v":422.03981794402586,"d":"422"},{"v":224.69536190121136,"d":"225"},{"v":53.24032291451044,"d":"53"},{"v":67.58302032336435,"d":"68"},{"v":90.4678414547117,"d":"90"},null,0,484,10,312,{"v":147.888,"d":"148"},{"v":253.01291317769355,"d":"253"},{"v":222.4641291133956,"d":"222"},{"v":30.548784064297962,"d":"31"},{"v":13.73200442967885,"d":"14"},{"v":28.074701838532754,"d":"28"},{"v":0.3987317588845798,"d":"0"},{"$nulls":15},"Epitope undefined.",{"$nulls":3},"Adapter/scaffold protein","P49407","P49407",null,null,"GO:0016323; GO:0000785; GO:0005905; GO:0005737; GO:0031410; GO:0030659; GO:0005829; GO:0043197; GO:0005768; GO:0000139; GO:0005765; GO:0016604; GO:0005654; GO:0005634; GO:0005886; GO:0014069; GO:0045211; GO:0031143","GO:0031691; GO:0031692; GO:0031701; GO:0035612; GO:1990763; GO:0035615; GO:0043027; GO:0004857; GO:0030331; GO:0031762; GO:0005096; GO:0005159; GO:0044325; GO:0031434; GO:0045309; GO:0008134; GO:0044212; GO:0031625; GO:0031896","GO:0000187; GO:0042699; GO:0002031; GO:0007186; GO:0016573; GO:0061024; GO:0070373; GO:0034260; GO:0032715; GO:0032717; GO:0043524; GO:0032088; GO:0045746; GO:0031397; GO:0007602; GO:0030168; GO:0008284; GO:0043280; GO:0070374; GO:0035066; GO:0090240; GO:0035774; GO:0033138; GO:0032092; GO:0001934; GO:0031398; GO:0002092; GO:0035025; GO:0034393; GO:0045944; GO:0043161; GO:0015031; GO:0016567; GO:0042493; GO:0043149; GO:0006366; GO:0006511"]
[156,77,"NN121","Arrestin b","Pan-specific","Arrestin beta 1",0,356,12,314,{"v":108.016,"d":"108"},{"v":189.7999794350552,"d":"190"},{"$nulls":3},0,386,12,302,{"v":112.948,"d":"113"},{"v":197.34445604281447,"d":"197"},{"$nulls":6},0,350,8,328,{"v":112.176,"d":"112"},{"v":191.91534504909765,"d":"192"},{"$nulls":20},"Epitope undefined.",{"$nulls":4},"P49407","P49407"]
[157,78,"PN133","Arrestin b","S412","Arrestin beta 1",0,531,14,523,{"v":270.391,"d":"270"},{"v":475.11670714916323,"d":"475"},{"v":466.86602388522726,"d":"467"},{"v":8.250683263935969,"d":"8"},{"v":1.767248598489636,"d":"2"},0,474,16,443,{"v":202.894,"d":"203"},{"v":354.4994693518327,"d":"354"},{"v":469.86983250091976,"d":"470"},{"v":115.37036314908704,"d":"115"},{"v":24.55368597192526,"d":"25"},{"v":26.320934570414895,"d":"26"},{"v":0.6433984188215334,"d":"1"},null,0,626,18,694,{"v":421.952,"d":"422"},{"v":721.89295102479,"d":"722"},{"v":698.7623752771809,"d":"699"},{"v":23.1305757476091,"d":"23"},{"v":3.3102205507893583,"d":"3"},{"v":5.077469149278994,"d":"5"},{"v":49.67085620455478,"d":"50"},{"$nulls":15},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S412 phosphosite.","S412 phosphorylation induces interaction with MEKK1 and inhibits interaction with ADRB2. This is one of the major in vivo phosphorylation sites in beta-arrestin (≥41 reports from high throughput mass spectrometry studies).","ERK1; ERK2","Adapter/scaffold protein","P49407","P49407",null,null,"GO:0016323; GO:0000785; GO:0005905; GO:0005737; GO:0031410; GO:0030659; GO:0005829; GO:0043197; GO:0005768; GO:0000139; GO:0005765; GO:0016604; GO:0005654; GO:0005634; GO:0005886; GO:0014069; GO:0045211; GO:0031143","GO:0031691; GO:0031692; GO:0031701; GO:0035612; GO:1990763; GO:0035615; GO:0043027; GO:0004857; GO:0030331; GO:0031762; GO:0005096; GO:0005159; GO:0044325; GO:0031434; GO:0045309; GO:0008134; GO:0044212; GO:0031625; GO:0031896","GO:0000187; GO:0042699; GO:0002031; GO:0007186; GO:0016573; GO:0061024; GO:0070373; GO:0034260; GO:0032715; GO:0032717; GO:0043524; GO:0032088; GO:0045746; GO:0031397; GO:0007602; GO:0030168; GO:0008284; GO:0043280; GO:0070374; GO:0035066; GO:0090240; GO:0035774; GO:0033138; GO:0032092; GO:0001934; GO:0031398; GO:0002092; GO:0035025; GO:0034393; GO:0045944; GO:0043161; GO:0015031; GO:0016567; GO:0042493; GO:0043149; GO:0006366; GO:0006511"]
[158,78,"PN133","Arrestin b","S412","Arrestin beta 1",0,512,12,522,261,{"v":458.61534062129135,"d":"459"},{"$nulls":3},0,636,18,542,{"v":334.956,"d":"335"},{"v":585.2401956500067,"d":"585"},{"$nulls":6},0,592,18,688,{"v":394.912,"d":"395"},{"v":675.6317995295718,"d":"676"},{"$nulls":20},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S412 phosphosite.","S412 phosphorylation induces interaction with MEKK1 and inhibits interaction with ADRB2. This is one of the major in vivo phosphorylation sites in beta-arrestin (≥41 reports from high throughput mass spectrometry studies).","ERK1; ERK2",null,"P49407","P49407"]
[159,79,"NK007-3","ASK1 (MAP3K5)","Pan-specific","Apoptosis signal regulating protein-serine kinase 1",0,148,12,452,{"v":61.472,"d":"61"},{"v":108.01533417115718,"d":"108"},{"v":98.59702679288085,"d":"99"},{"v":9.418307378276324,"d":"9"},{"v":9.552323923581405,"d":"10"},0,106,8,409,{"v":40.082,"d":"40"},{"v":70.03187738701075,"d":"70"},{"v":58.184011498050126,"d":"58"},{"v":11.847865888960627,"d":"12"},{"v":20.362751869313232,"d":"20"},{"v":29.915075792894637,"d":"30"},{"v":-40.98806689143362,"d":"-41"},null,0,106,8,370,{"v":36.26,"d":"36"},{"v":62.03510921659071,"d":"62"},{"v":72.03668804946963,"d":"72"},{"v":10.00157883287892,"d":"10"},{"v":13.884007029876988,"d":"14"},{"v":23.436330953458395,"d":"23"},{"v":-26.938275531579208,"d":"-27"},null,null,"ASK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 1076-1375 of human ASK 1.",null,null,"EC 2.7.11.25; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE11 family","Q99683","Q99683","Q99683","Q99683","GO:0005829; GO:0009897; GO:1990604; GO:0032991; GO:1902911","GO:0005524; GO:0042802; GO:0000287; GO:0004709; GO:0019904; GO:0042803; GO:0004672; GO:0019901; GO:0019903; GO:0004674","GO:0007257; GO:0000186; GO:0097190; GO:0034198; GO:0070301; GO:1902170; GO:0071356; GO:0072577; GO:0045087; GO:0070059; GO:0008631; GO:0007254; GO:0000165; GO:0038066; GO:0043065; GO:0010666; GO:0043280; GO:0046330; GO:0043507; GO:0045663; GO:1901216; GO:1900745; GO:0045893; GO:1904707; GO:0097300; GO:0006468; GO:0034976; GO:0002931; GO:0051403; GO:0016032; GO:0042060"]
[160,79,"NK007-3","ASK1 (MAP3K5)","Pan-specific","Apoptosis signal regulating protein-serine kinase 1",0,112,8,488,{"v":50.752,"d":"51"},{"v":89.17871941460453,"d":"89"},{"$nulls":3},0,46,6,663,{"v":26.52,"d":"27"},{"v":46.33614560908949,"d":"46"},{"$nulls":6},0,116,8,444,{"v":47.952,"d":"48"},{"v":82.03826688234854,"d":"82"},{"$nulls":7},"ASK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 1076-1375 of human ASK 1.",{"$nulls":3},"Q99683","Q99683","Q99683","Q99683"]
[161,80,"NK007-2","ASK1 (MAP3K5)","Pan-specific","Apoptosis signal regulating protein-serine kinase 1",0,1864,16,694,{"v":1282.512,"d":"1283"},{"v":2253.5619836432707,"d":"2254"},{"v":2217.628329560108,"d":"2218"},{"v":35.933654083162764,"d":"36"},{"v":1.6203641342501525,"d":"2"},0,1598,10,625,{"v":992.5,"d":"993"},{"v":1734.1110300535943,"d":"1734"},{"v":1763.4467723151556,"d":"1763"},{"v":29.335742261561336,"d":"29"},{"v":1.6635456608110526,"d":"2"},{"v":3.283909795061205,"d":"3"},{"v":-20.48050844187422,"d":"-20"},null,0,1934,10,633,{"v":1217.892,"d":"1218"},{"v":2083.6200560952043,"d":"2084"},{"v":2058.2893383053297,"d":"2058"},{"v":25.330717789874598,"d":"25"},{"v":1.230668464266077,"d":"1"},{"v":2.8510325985162295,"d":"3"},{"v":-7.185108033246706,"d":"-7"},null,null,"ASK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues within the last 50 amino acid residues at the C-terminus.",null,null,"EC 2.7.11.25; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE11 family","Q99683","Q99683","Q99683","Q99683","GO:0005829; GO:0009897; GO:1990604; GO:0032991; GO:1902911","GO:0005524; GO:0042802; GO:0000287; GO:0004709; GO:0019904; GO:0042803; GO:0004672; GO:0019901; GO:0019903; GO:0004674","GO:0007257; GO:0000186; GO:0097190; GO:0034198; GO:0070301; GO:1902170; GO:0071356; GO:0072577; GO:0045087; GO:0070059; GO:0008631; GO:0007254; GO:0000165; GO:0038066; GO:0043065; GO:0010666; GO:0043280; GO:0046330; GO:0043507; GO:0045663; GO:1901216; GO:1900745; GO:0045893; GO:1904707; GO:0097300; GO:0006468; GO:0034976; GO:0002931; GO:0051403; GO:0016032; GO:0042060"]
[162,80,"NK007-2","ASK1 (MAP3K5)","Pan-specific","Apoptosis signal regulating protein-serine kinase 1",0,1936,14,646,{"v":1241.612,"d":"1242"},{"v":2181.6946754769456,"d":"2182"},{"$nulls":3},0,1770,10,583,{"v":1026.08,"d":"1026"},{"v":1792.7825145767172,"d":"1793"},{"$nulls":6},0,1968,20,610,{"v":1188.28,"d":"1188"},{"v":2032.9586205154556,"d":"2033"},{"$nulls":7},"ASK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues within the last 50 amino acid residues at the C-terminus.",{"$nulls":3},"Q99683","Q99683","Q99683","Q99683"]
[163,81,"PK175","ASK1 (MAP3K5)","S83","Apoptosis signal regulating protein-serine kinase 1",0,198,10,505,{"v":94.94,"d":"95"},{"v":166.8235265846184,"d":"167"},{"v":160.4169689911118,"d":"160"},{"v":6.406557593506619,"d":"6"},{"v":3.993690713518959,"d":"4"},0,168,10,454,{"v":71.732,"d":"72"},{"v":125.33123668292637,"d":"125"},{"v":118.14843522746006,"d":"118"},{"v":7.182801455466318,"d":"7"},{"v":6.079472353263035,"d":"6"},{"v":10.073163066781994,"d":"10"},{"v":-26.349166194502587,"d":"-26"},null,0,180,10,445,{"v":75.65,"d":"76"},{"v":129.42515201972114,"d":"129"},{"v":134.30447169665763,"d":"134"},{"v":4.87931967693649,"d":"5"},{"v":3.6330284578736918,"d":"4"},{"v":7.626719171392651,"d":"8"},{"v":-16.27788971371288,"d":"-16"},null,null,"ASK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S83 phosphosite.","S83 phosphorylation inhibits phosphotransferase activity and reduces apoptosis. This is one of the less major in vivo phosphorylation sites in ASK1 (≥7 reports from high throughput mass spectrometry studies).","Akt1; Akt2; Akt3; Pim1","EC 2.7.11.25; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE11 family","Q99683","Q99683","Q99683","Q99683","GO:0005829; GO:0009897; GO:1990604; GO:0032991; GO:1902911","GO:0005524; GO:0042802; GO:0000287; GO:0004709; GO:0019904; GO:0042803; GO:0004672; GO:0019901; GO:0019903; GO:0004674","GO:0007257; GO:0000186; GO:0097190; GO:0034198; GO:0070301; GO:1902170; GO:0071356; GO:0072577; GO:0045087; GO:0070059; GO:0008631; GO:0007254; GO:0000165; GO:0038066; GO:0043065; GO:0010666; GO:0043280; GO:0046330; GO:0043507; GO:0045663; GO:1901216; GO:1900745; GO:0045893; GO:1904707; GO:0097300; GO:0006468; GO:0034976; GO:0002931; GO:0051403; GO:0016032; GO:0042060"]
[164,81,"PK175","ASK1 (MAP3K5)","S83","Apoptosis signal regulating protein-serine kinase 1",0,186,10,498,{"v":87.648,"d":"88"},{"v":154.01041139760514,"d":"154"},{"$nulls":3},0,156,10,435,{"v":63.51,"d":"64"},{"v":110.96563377199372,"d":"111"},{"$nulls":6},0,192,10,447,{"v":81.354,"d":"81"},{"v":139.1837913735941,"d":"139"},{"$nulls":7},"ASK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S83 phosphosite.","S83 phosphorylation inhibits phosphotransferase activity and reduces apoptosis. This is one of the less major in vivo phosphorylation sites in ASK1 (≥7 reports from high throughput mass spectrometry studies).","Akt1; Akt2; Akt3; Pim1",null,"Q99683","Q99683","Q99683","Q99683"]
[165,82,"PK525","ASK1 (MAP3K5)","T838","Apoptosis signal regulating protein-serine kinase 1",0,9222,14,776,{"v":7145.408,"d":"7145"},{"v":12555.531508804983,"d":"12556"},{"v":12136.234087194196,"d":"12136"},{"v":419.29742161078684,"d":"419"},{"v":3.454922001325085,"d":"3"},0,8877,16,696,{"v":6167.256,"d":"6167"},{"v":10775.52307784807,"d":"10776"},{"v":11197.056203400443,"d":"11197"},{"v":421.53312555237244,"d":"422"},{"v":3.764678125169692,"d":"4"},{"v":7.219600126494777,"d":"7"},{"v":-7.738626966537723,"d":"-8"},null,0,9356,12,702,{"v":6559.488,"d":"6559"},{"v":11222.24364271694,"d":"11222"},{"v":11469.487598688942,"d":"11469"},{"v":247.24395597200237,"d":"247"},{"v":2.1556669715590817,"d":"2"},{"v":5.610588972884167,"d":"6"},{"v":-5.493849934954582,"d":"-5"},null,null,"ASK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"TE(pT)FTG(bA)C","Corresponds to amino acid residues T836 to G841; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T838 phosphorylation stimulates phosphotransferase activity. Phosphorylation inhibits interactions with 14-3-3-beta and TXN. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the minor in vivo phosphorylation sites in ASK1 (≥2 reports from high throughput mass spectrometry studies).","ASK1; PDPK1","EC 2.7.11.25; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE11 family","Q99683","Q99683","Q99683","Q99683","GO:0005829; GO:0009897; GO:1990604; GO:0032991; GO:1902911","GO:0005524; GO:0042802; GO:0000287; GO:0004709; GO:0019904; GO:0042803; GO:0004672; GO:0019901; GO:0019903; GO:0004674","GO:0007257; GO:0000186; GO:0097190; GO:0034198; GO:0070301; GO:1902170; GO:0071356; GO:0072577; GO:0045087; GO:0070059; GO:0008631; GO:0007254; GO:0000165; GO:0038066; GO:0043065; GO:0010666; GO:0043280; GO:0046330; GO:0043507; GO:0045663; GO:1901216; GO:1900745; GO:0045893; GO:1904707; GO:0097300; GO:0006468; GO:0034976; GO:0002931; GO:0051403; GO:0016032; GO:0042060"]
[166,82,"PK525","ASK1 (MAP3K5)","T838","Apoptosis signal regulating protein-serine kinase 1",0,8850,18,755,{"v":6668.16,"d":"6668"},{"v":11716.936665583411,"d":"11717"},{"$nulls":3},0,9086,14,733,{"v":6649.776,"d":"6650"},{"v":11618.589328952816,"d":"11619"},{"$nulls":6},0,8700,20,789,{"v":6848.52,"d":"6849"},{"v":11716.731554660946,"d":"11717"},{"$nulls":7},"ASK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"TE(pT)FTG(bA)C","Corresponds to amino acid residues T836 to G841; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T838 phosphorylation stimulates phosphotransferase activity. Phosphorylation inhibits interactions with 14-3-3-beta and TXN. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the minor in vivo phosphorylation sites in ASK1 (≥2 reports from high throughput mass spectrometry studies).","ASK1; PDPK1",null,"Q99683","Q99683","Q99683","Q99683"]
[167,83,"PK143","ASK1 (MAP3K5)","S966","Apoptosis signal regulating protein-serine kinase 1",0,804,12,283,{"v":224.136,"d":"224"},{"v":393.83987733905656,"d":"394"},{"v":355.5867893493037,"d":"356"},{"v":38.253087989752885,"d":"38"},{"v":10.757735983317342,"d":"11"},0,1440,14,299,{"v":426.374,"d":"426"},{"v":744.9671096504496,"d":"745"},{"v":561.8939069008117,"d":"562"},{"v":183.07320274963797,"d":"183"},{"v":32.58145363408523,"d":"33"},{"v":43.33918961740257,"d":"43"},{"v":58.01878014901342,"d":"58"},null,0,798,10,250,197,{"v":337.03575608572453,"d":"337"},{"v":283.22979401011014,"d":"283"},{"v":53.80596207561439,"d":"54"},{"v":18.99728178797946,"d":"19"},{"v":29.755017771296803,"d":"30"},{"v":-20.34861741393746,"d":"-20"},null,null,"ASK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"SI(pS)LP","Corresponds to amino acid residues S964 to P968; Surrounds the S966 phosphosite.","S966 phosphorylation induces association of MAP3K5/ASK1 with the 14-3-3 family proteins such as YWHAB, YWHAE, YWHAQ, YWHAH, YWHAZ and SFN, and suppresses MAP3K5/ASK1 phosphotransferase activity. This is one of the major in vivo phosphorylation sites in ASK1 (≥4 reports from high throughput mass spectrometry studies).","ASK1","EC 2.7.11.25; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE11 family","Q99683","Q99683","Q99683","Q99683","GO:0005829; GO:0009897; GO:1990604; GO:0032991; GO:1902911","GO:0005524; GO:0042802; GO:0000287; GO:0004709; GO:0019904; GO:0042803; GO:0004672; GO:0019901; GO:0019903; GO:0004674","GO:0007257; GO:0000186; GO:0097190; GO:0034198; GO:0070301; GO:1902170; GO:0071356; GO:0072577; GO:0045087; GO:0070059; GO:0008631; GO:0007254; GO:0000165; GO:0038066; GO:0043065; GO:0010666; GO:0043280; GO:0046330; GO:0043507; GO:0045663; GO:1901216; GO:1900745; GO:0045893; GO:1904707; GO:0097300; GO:0006468; GO:0034976; GO:0002931; GO:0051403; GO:0016032; GO:0042060"]
[168,83,"PK143","ASK1 (MAP3K5)","S966","Apoptosis signal regulating protein-serine kinase 1",0,610,12,302,{"v":180.596,"d":"181"},{"v":317.33370135955073,"d":"317"},{"$nulls":3},0,816,10,269,{"v":216.814,"d":"217"},{"v":378.82070415117374,"d":"379"},{"$nulls":6},0,464,14,298,{"v":134.1,"d":"134"},{"v":229.42383193449572,"d":"229"},{"$nulls":7},"ASK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"SI(pS)LP","Corresponds to amino acid residues S964 to P968; Surrounds the S966 phosphosite.","S966 phosphorylation induces association of MAP3K5/ASK1 with the 14-3-3 family proteins such as YWHAB, YWHAE, YWHAQ, YWHAH, YWHAZ and SFN, and suppresses MAP3K5/ASK1 phosphotransferase activity. This is one of the major in vivo phosphorylation sites in ASK1 (≥4 reports from high throughput mass spectrometry studies).","ASK1",null,"Q99683","Q99683","Q99683","Q99683"]
[169,84,"PK524","ASK1 (MAP3K5)","S1033","Apoptosis signal regulating protein-serine kinase 1",0,7614,16,780,{"v":5926.44,"d":"5926"},{"v":10413.625667707454,"d":"10414"},{"v":10175.79407779009,"d":"10176"},{"v":237.8315899173649,"d":"238"},{"v":2.337228801007887,"d":"2"},0,7741,20,680,{"v":5250.28,"d":"5250"},{"v":9173.36872430205,"d":"9173"},{"v":9313.732126473205,"d":"9314"},{"v":140.36340217115503,"d":"140"},{"v":1.507058612649899,"d":"2"},{"v":3.8442874136577863,"d":"4"},{"v":-8.471692181728002,"d":"-8"},null,0,8086,18,725,{"v":5849.3,"d":"5849"},{"v":10007.224609503699,"d":"10007"},{"v":9813.660013343604,"d":"9814"},{"v":193.56459616009488,"d":"194"},{"v":1.9723996541240036,"d":"2"},{"v":4.309628455131891,"d":"4"},{"v":-3.5587794100205628,"d":"-4"},null,null,"ASK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"APP(pS)PEE(bA)C","Corresponds to amino acid residues A1030 to E1036; After the kinase catalytic domain. ","S1033 phosphorylation inhibits the enzymatic activity of ASK1. This is the major in vivo phosphorylation site in ASK1 (≥28 reports from high throughput mass spectrometry studies).","ASK1","EC 2.7.11.25; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE11 family","Q99683","Q99683","Q99683","Q99683","GO:0005829; GO:0009897; GO:1990604; GO:0032991; GO:1902911","GO:0005524; GO:0042802; GO:0000287; GO:0004709; GO:0019904; GO:0042803; GO:0004672; GO:0019901; GO:0019903; GO:0004674","GO:0007257; GO:0000186; GO:0097190; GO:0034198; GO:0070301; GO:1902170; GO:0071356; GO:0072577; GO:0045087; GO:0070059; GO:0008631; GO:0007254; GO:0000165; GO:0038066; GO:0043065; GO:0010666; GO:0043280; GO:0046330; GO:0043507; GO:0045663; GO:1901216; GO:1900745; GO:0045893; GO:1904707; GO:0097300; GO:0006468; GO:0034976; GO:0002931; GO:0051403; GO:0016032; GO:0042060"]
[170,84,"PK524","ASK1 (MAP3K5)","S1033","Apoptosis signal regulating protein-serine kinase 1",0,7692,18,737,{"v":5655.738,"d":"5656"},{"v":9937.962487872725,"d":"9938"},{"$nulls":3},0,7989,20,679,{"v":5410.951,"d":"5411"},{"v":9454.095528644359,"d":"9454"},{"$nulls":6},0,7244,35,780,{"v":5623.02,"d":"5623"},{"v":9620.095417183507,"d":"9620"},{"$nulls":7},"ASK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"APP(pS)PEE(bA)C","Corresponds to amino acid residues A1030 to E1036; After the kinase catalytic domain. ","S1033 phosphorylation inhibits the enzymatic activity of ASK1. This is the major in vivo phosphorylation site in ASK1 (≥28 reports from high throughput mass spectrometry studies).","ASK1",null,"Q99683","Q99683","Q99683","Q99683"]
[171,85,"PN741","ASS1","T174+S180","Argininosuccinate synthase",0,5208,18,688,{"v":3570.72,"d":"3571"},{"v":6274.27957495501,"d":"6274"},{"v":6807.7599163522045,"d":"6808"},{"v":533.4803413971949,"d":"533"},{"v":7.836356568858692,"d":"8"},0,6718,18,586,{"v":3926.2,"d":"3926"},{"v":6859.916096923346,"d":"6860"},{"v":7427.254326211712,"d":"7427"},{"v":567.3382292883662,"d":"567"},{"v":7.638599735115551,"d":"8"},{"v":15.474956303974242,"d":"15"},{"v":9.09982751259318,"d":"9"},null,0,7030,16,634,{"v":4446.876,"d":"4447"},{"v":7607.899567916053,"d":"7608"},{"v":7740.651451040894,"d":"7741"},{"v":132.7518831248417,"d":"133"},{"v":1.7149962630986362,"d":"2"},{"v":9.551352831957328,"d":"10"},{"v":13.703355379026931,"d":"14"},{"$nulls":14},"X","IPV(pT)PKNPW(pS)MDE(bA)C","Corresponds to amino acid residues I171 to E183.","The effects of T174 and S180 phosphorylation are unclear. These are two of the minor in vivo phosphorylation sites in arginosuccinate synthase (≥8 and >7 reports, respectively, by mass spectrometry). This human phosphosite is highly conserved in vertebrates and also found in yeast.",null,"Enzyme  - Synthetase","P00966","P00966",null,null,"GO:0070852; GO:0005737; GO:0005829; GO:0005783; GO:0070062; GO:0005764; GO:0005741; GO:0043209; GO:0005634; GO:0043204","GO:0016597; GO:0004055; GO:0005524; GO:0042802; GO:0003723; GO:0015643","GO:0006953; GO:0007568; GO:0006526; GO:0000053; GO:0006531; GO:0071418; GO:0071230; GO:0071242; GO:0071320; GO:0071549; GO:0071377; GO:0071346; GO:0071499; GO:0071222; GO:0071400; GO:0071356; GO:0007623; GO:0000052; GO:0060539; GO:0001822; GO:0001889; GO:0007494; GO:1903038; GO:0045429; GO:0032355; GO:0060416; GO:0010046; GO:0007584; GO:0010043; GO:0000050"]
[172,85,"PN741","ASS1","T174+S180","Argininosuccinate synthase",0,6142,16,682,{"v":4177.932,"d":"4178"},{"v":7341.240257749399,"d":"7341"},{"$nulls":3},0,6872,12,667,{"v":4575.62,"d":"4576"},{"v":7994.592555500078,"d":"7995"},{"$nulls":6},0,6587,22,701,{"v":4602.065,"d":"4602"},{"v":7873.403334165735,"d":"7873"},{"$nulls":19},"X","IPV(pT)PKNPW(pS)MDE(bA)C","Corresponds to amino acid residues I171 to E183.","The effects of T174 and S180 phosphorylation are unclear. These are two of the minor in vivo phosphorylation sites in arginosuccinate synthase (≥8 and >7 reports, respectively, by mass spectrometry). This human phosphosite is highly conserved in vertebrates and also found in yeast.",null,null,"P00966","P00966"]
[173,86,"PN742","ATASE (PPAT)","T356","Glutamine PRPP amidotransferase",0,10968,20,763,{"v":8353.324,"d":"8353"},{"v":14678.01736237551,"d":"14678"},{"v":15187.11904769692,"d":"15187"},{"v":509.1016853214096,"d":"509"},{"v":3.352193946215318,"d":"3"},0,13030,16,673,{"v":8758.422,"d":"8758"},{"v":15302.847552709381,"d":"15303"},{"v":15532.494522327643,"d":"15532"},{"v":229.6469696182612,"d":"230"},{"v":1.478493807212669,"d":"1"},{"v":4.830687753427987,"d":"5"},{"v":2.274134241958791,"d":"2"},null,0,12334,16,827,{"v":10186.986,"d":"10187"},{"v":17428.317404795383,"d":"17428"},{"v":16773.41929220999,"d":"16773"},{"v":654.8981125853934,"d":"655"},{"v":3.904380503321377,"d":"4"},{"v":7.256574449536695,"d":"7"},{"v":10.445037268300268,"d":"10"},{"$nulls":5},"De novo purine synthesis",{"$nulls":8},"X","VGR(pT)FIQ(bA)C","Corresponds to amino acid residues V353 to Q359.","The effect of T356 phosphorylation is unclear. Phosphorylation of this site in ATASE has been reported in only one mass spectrometry study. This human phosphosite is highly conserved in vertebrates and also found in yeast.",null,null,"Q06203","Q06203",null,null,"GO:0005829","GO:0051539; GO:0004044; GO:0046872","GO:0006189; GO:0031100; GO:0035690; GO:0032869; GO:0000082; GO:0006543; GO:0001822; GO:0007595; GO:0060135; GO:0009116; GO:0051289; GO:0009113; GO:0006164; GO:0009168"]
[174,86,"PN742","ATASE (PPAT)","T356","Glutamine PRPP amidotransferase",0,11572,16,773,{"v":8932.788,"d":"8933"},{"v":15696.22073301833,"d":"15696"},{"$nulls":3},0,12922,16,699,{"v":9021.294,"d":"9021"},{"v":15762.141491945904,"d":"15762"},{"$nulls":6},0,11102,18,850,{"v":9421.4,"d":"9421"},{"v":16118.521179624593,"d":"16119"},{"$nulls":10},"De novo purine synthesis",{"$nulls":8},"X","VGR(pT)FIQ(bA)C","Corresponds to amino acid residues V353 to Q359.","The effect of T356 phosphorylation is unclear. Phosphorylation of this site in ATASE has been reported in only one mass spectrometry study. This human phosphosite is highly conserved in vertebrates and also found in yeast.",null,null,"Q06203","Q06203"]
[175,87,"NN160-2","ATF2 (CRE-BP1)","Pan-specific","Cyclic AMP-dependent transcription factor ATF-2",0,140,13,494,{"v":62.738,"d":"63"},{"v":110.23988214520527,"d":"110"},{"v":112.14287223674879,"d":"112"},{"v":1.902990091543515,"d":"2"},{"v":1.696933611193804,"d":"2"},0,122,12,489,{"v":53.79,"d":"54"},{"v":93.9827025759021,"d":"94"},{"v":98.0292528485511,"d":"98"},{"v":4.046550272649,"d":"4"},{"v":4.12790075927709,"d":"4"},{"v":5.824834370470894,"d":"6"},{"v":-12.585391391083618,"d":"-13"},null,0,170,10,503,{"v":80.48,"d":"80"},{"v":137.68851598872646,"d":"138"},{"v":125.40809640911564,"d":"125"},{"v":12.280419579610822,"d":"12"},{"v":9.792365829036047,"d":"10"},{"v":11.489299440229852,"d":"11"},{"v":11.828860727199995,"d":"12"},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against amino acid residues 350-505 mapping within the DNA binding and dimerization domain of human ATF2.",null,null,"Transcription protein","P15336","P15336",null,"P15336","GO:0005737; GO:0005741; GO:0005654; GO:0005634; GO:0035861","GO:0035497; GO:0008140; GO:0003682; GO:0003700; GO:0001158; GO:0004402; GO:0046872; GO:0046982; GO:0019901; GO:0001102; GO:0000980; GO:0000977; GO:0000981; GO:0001077; GO:0001228; GO:0003713; GO:0003705","GO:0060612; GO:0097186; GO:0006974; GO:0045444; GO:0031573; GO:0016525; GO:0050680; GO:0000122; GO:0003151; GO:0110024; GO:0051091; GO:0010628; GO:1902110; GO:0043525; GO:0045944; GO:0032915; GO:0051090; GO:0006355; GO:0006357; GO:0006970; GO:0009414"]
[176,87,"NN160-2","ATF2 (CRE-BP1)","Pan-specific","Cyclic AMP-dependent transcription factor ATF-2",0,134,12,532,{"v":64.904,"d":"65"},{"v":114.04586232829232,"d":"114"},{"$nulls":3},0,119,12,546,{"v":58.422,"d":"58"},{"v":102.07580312120008,"d":"102"},{"$nulls":6},0,134,12,542,{"v":66.124,"d":"66"},{"v":113.12767682950481,"d":"113"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against amino acid residues 350-505 mapping within the DNA binding and dimerization domain of human ATF2.",{"$nulls":3},"P15336","P15336",null,"P15336"]
[177,88,"PN572","ATF2 (CRE-BP1)","T69+T71","Cyclic AMP-dependent transcription factor ATF-2",0,9126,14,755,{"v":6879.56,"d":"6880"},{"v":12088.397520017668,"d":"12088"},{"v":11696.59944737517,"d":"11697"},{"v":391.7980726424976,"d":"392"},{"v":3.3496750436334795,"d":"3"},0,10044,16,750,7521,{"v":13140.805095247439,"d":"13141"},{"v":12653.798576617788,"d":"12654"},{"v":487.0065186296506,"d":"487"},{"v":3.8486982045815186,"d":"4"},{"v":7.198373248214998,"d":"7"},{"v":8.183567656131217,"d":"8"},null,0,10171,20,816,{"v":8283.216,"d":"8283"},{"v":14171.268869956197,"d":"14171"},{"v":12932.482827994007,"d":"12932"},{"v":1238.7860419621902,"d":"1239"},{"v":9.578872506064187,"d":"10"},{"v":12.928547549697665,"d":"13"},{"v":10.566176829250821,"d":"11"},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"CADQ(pT)P(pT)PTR","Corresponds to amino acid residues C66 to R74.","T69 and T71 phosphorylation increases transcriptional activity. These are the major in vivo phosphorylation sites in ATF2 (≥103 and 86 reports by mass spectrometry, respectively).","T69: ERK1; ERK2; JNK1; JNK2; JNK3; p38a. T71: ERK1; ERK2; JNK1; JNK2; JNK3; p38a.","Transcription protein","P15336","P15336",null,"P15336","GO:0005737; GO:0005741; GO:0005654; GO:0005634; GO:0035861","GO:0035497; GO:0008140; GO:0003682; GO:0003700; GO:0001158; GO:0004402; GO:0046872; GO:0046982; GO:0019901; GO:0001102; GO:0000980; GO:0000977; GO:0000981; GO:0001077; GO:0001228; GO:0003713; GO:0003705","GO:0060612; GO:0097186; GO:0006974; GO:0045444; GO:0031573; GO:0016525; GO:0050680; GO:0000122; GO:0003151; GO:0110024; GO:0051091; GO:0010628; GO:1902110; GO:0043525; GO:0045944; GO:0032915; GO:0051090; GO:0006355; GO:0006357; GO:0006970; GO:0009414"]
[178,88,"PN572","ATF2 (CRE-BP1)","T69+T71","Cyclic AMP-dependent transcription factor ATF-2",0,8962,14,719,{"v":6433.612,"d":"6434"},{"v":11304.801374732673,"d":"11305"},{"$nulls":3},0,9812,18,711,{"v":6963.534,"d":"6964"},{"v":12166.792057988136,"d":"12167"},{"$nulls":6},0,8708,12,786,{"v":6835.056,"d":"6835"},{"v":11693.696786031816,"d":"11694"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"CADQ(pT)P(pT)PTR","Corresponds to amino acid residues C66 to R74.","T69 and T71 phosphorylation increases transcriptional activity. These are the major in vivo phosphorylation sites in ATF2 (≥103 and 86 reports by mass spectrometry, respectively).","T69: ERK1; ERK2; JNK1; JNK2; JNK3; p38a. T71: ERK1; ERK2; JNK1; JNK2; JNK3; p38a.",null,"P15336","P15336",null,"P15336"]
[179,89,"PN204","ATF2 (CRE-BP1)","T71","Cyclic AMP-dependent transcription factor ATF-2",0,304,14,548,{"v":158.92,"d":"159"},{"v":279.2457851782974,"d":"279"},{"v":263.50174896386534,"d":"264"},{"v":15.744036214432072,"d":"16"},{"v":5.974926647105895,"d":"6"},0,292,12,507,{"v":141.96,"d":"142"},{"v":248.034661789832,"d":"248"},{"v":246.5844732206184,"d":"247"},{"v":1.4501885692135943,"d":"1"},{"v":0.5881102529582691,"d":"1"},{"v":6.563036900064164,"d":"7"},{"v":-6.420175884892075,"d":"-6"},null,0,332,14,548,{"v":174.264,"d":"174"},{"v":298.13806598234873,"d":"298"},{"v":292.4204340187016,"d":"292"},{"v":5.717631963647136,"d":"6"},{"v":1.9552778460350237,"d":"2"},{"v":7.930204493140919,"d":"8"},{"v":10.974760193641814,"d":"11"},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against amino acid residues that encompass the T71 phosphosite.","T71 phosphorylation increases transcriptional activity. This is one of the major in vivo phosphorylation sites in ATF2 (≥86 reports from high throughput mass spectrometry studies).","T71: ERK1; ERK2; JNK1; JNK2; JNK3; p38a.","Transcription protein","P15336","P15336",null,"P15336","GO:0005737; GO:0005741; GO:0005654; GO:0005634; GO:0035861","GO:0035497; GO:0008140; GO:0003682; GO:0003700; GO:0001158; GO:0004402; GO:0046872; GO:0046982; GO:0019901; GO:0001102; GO:0000980; GO:0000977; GO:0000981; GO:0001077; GO:0001228; GO:0003713; GO:0003705","GO:0060612; GO:0097186; GO:0006974; GO:0045444; GO:0031573; GO:0016525; GO:0050680; GO:0000122; GO:0003151; GO:0110024; GO:0051091; GO:0010628; GO:1902110; GO:0043525; GO:0045944; GO:0032915; GO:0051090; GO:0006355; GO:0006357; GO:0006970; GO:0009414"]
[180,89,"PN204","ATF2 (CRE-BP1)","T71","Cyclic AMP-dependent transcription factor ATF-2",0,260,10,564,141,{"v":247.75771274943327,"d":"248"},{"$nulls":3},0,242,12,610,{"v":140.3,"d":"140"},{"v":245.1342846514048,"d":"245"},{"$nulls":6},0,304,10,570,{"v":167.58,"d":"168"},{"v":286.7028020550544,"d":"287"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against amino acid residues that encompass the T71 phosphosite.","T71 phosphorylation increases transcriptional activity. This is one of the major in vivo phosphorylation sites in ATF2 (≥86 reports from high throughput mass spectrometry studies).","T71: ERK1; ERK2; JNK1; JNK2; JNK3; p38a.",null,"P15336","P15336",null,"P15336"]
[181,90,"PN115","ATF2 (CRE-BP1)","S112","Cyclic AMP-dependent transcription factor ATF-2",0,198,12,258,{"v":47.988,"d":"48"},{"v":84.32196538595605,"d":"84"},{"v":67.00703984387863,"d":"67"},{"v":17.314925542077418,"d":"17"},{"v":25.84045733466199,"d":"26"},0,410,10,205,82,{"v":143.2716417777277,"d":"143"},{"v":105.61566100219613,"d":"106"},{"v":37.65598077553156,"d":"38"},{"v":35.653785071466395,"d":"36"},{"v":61.494242406128386,"d":"61"},{"v":57.6187535642116,"d":"58"},null,0,150,10,228,{"v":31.92,"d":"32"},{"v":54.61005753429608,"d":"55"},{"v":45.63156185948449,"d":"46"},{"v":8.97849567481159,"d":"9"},{"v":19.676064787042602,"d":"20"},{"v":45.5165221217046,"d":"46"},{"v":-31.90034664148334,"d":"-32"},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"DL(pS)PL","Corresponds to amino acid residues D92 to L96 in mouse ATF2; Surrounds the S94 phosphosites. Corresponds to S112 phosphosite in humans.","The effect of S112 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in ATF2 (≥83 reports from high throughput mass spectrometry studies).",null,"Transcription protein","P15336","P15336",null,"P15336","GO:0005737; GO:0005741; GO:0005654; GO:0005634; GO:0035861","GO:0035497; GO:0008140; GO:0003682; GO:0003700; GO:0001158; GO:0004402; GO:0046872; GO:0046982; GO:0019901; GO:0001102; GO:0000980; GO:0000977; GO:0000981; GO:0001077; GO:0001228; GO:0003713; GO:0003705","GO:0060612; GO:0097186; GO:0006974; GO:0045444; GO:0031573; GO:0016525; GO:0050680; GO:0000122; GO:0003151; GO:0110024; GO:0051091; GO:0010628; GO:1902110; GO:0043525; GO:0045944; GO:0032915; GO:0051090; GO:0006355; GO:0006357; GO:0006970; GO:0009414"]
[182,90,"PN115","ATF2 (CRE-BP1)","S112","Cyclic AMP-dependent transcription factor ATF-2",0,80,10,404,{"v":28.28,"d":"28"},{"v":49.692114301801226,"d":"50"},{"$nulls":3},0,186,10,221,{"v":38.896,"d":"39"},{"v":67.95968022666459,"d":"68"},{"$nulls":6},0,58,6,412,{"v":21.424,"d":"21"},{"v":36.6530661846729,"d":"37"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"DL(pS)PL","Corresponds to amino acid residues D92 to L96 in mouse ATF2; Surrounds the S94 phosphosites. Corresponds to S112 phosphosite in humans.","The effect of S112 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in ATF2 (≥83 reports from high throughput mass spectrometry studies).",null,null,"P15336","P15336",null,"P15336"]
[183,91,"NK230-2","ATM","Pan-specific","Ataxia telangiectasia mutated protein-serine kinase",0,9002,16,776,{"v":6973.136,"d":"6973"},{"v":12252.824298232143,"d":"12253"},{"v":12492.246106093042,"d":"12492"},{"v":239.4218078608992,"d":"239"},{"v":1.916563329184831,"d":"2"},0,8842,16,752,{"v":6637.152,"d":"6637"},{"v":11596.53248497962,"d":"11597"},{"v":12256.02582980365,"d":"12256"},{"v":659.4933448240299,"d":"659"},{"v":5.380972217113836,"d":"5"},{"v":7.297535546298667,"d":"7"},{"v":-1.8909351791762816,"d":"-2"},null,0,8878,18,797,{"v":7061.42,"d":"7061"},{"v":12080.969689029731,"d":"12081"},{"v":11602.948625574685,"d":"11603"},{"v":478.0210634550458,"d":"478"},{"v":4.119824010953679,"d":"4"},{"v":6.036387340138511,"d":"6"},{"v":-7.11879571508446,"d":"-7"},null,null,"ATM","X","PSTK","Protein kinase - Atypical protein-serine kinase","Protein-serine/threonine kinase","Atypical","PIKK","ATM",{"$nulls":5},"CDEFLTKPEVARRSRI","Corresponds to amino acid residues D2579 to I2593.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); ATYPICAL domain target; ATYPICAL</A> group; PIKK family","Q13315","Q13315","Q13315","Q13315","GO:0031410; GO:1990391; GO:0005730; GO:0005654; GO:0005634","GO:0016303; GO:0005524; GO:0003677; GO:0004677; GO:0044877; GO:0046983; GO:0047485; GO:0004674","GO:0006915; GO:0007050; GO:0006974; GO:0071480; GO:0071500; GO:0071300; GO:0071481; GO:0006975; GO:0006977; GO:0000729; GO:0006281; GO:0006260; GO:0006303; GO:0097695; GO:0097694; GO:0071044; GO:0016572; GO:0007094; GO:0030889; GO:1904354; GO:1904262; GO:0036289; GO:0018105; GO:0043065; GO:0045785; GO:0030335; GO:1903626; GO:0043517; GO:0010628; GO:0033129; GO:0043525; GO:1904884; GO:0032212; GO:1904358; GO:0045944; GO:0002331; GO:0046777; GO:0006468; GO:0007131; GO:0042981; GO:0010506; GO:1905843; GO:1900034; GO:1903978; GO:1901796; GO:0032210; GO:0090399; GO:0001666; GO:0010212; GO:0007165; GO:0072434; GO:0000723"]
[184,91,"NK230-2","ATM","Pan-specific","Ataxia telangiectasia mutated protein-serine kinase",0,9030,18,804,{"v":7245.648,"d":"7246"},{"v":12731.667913953941,"d":"12732"},{"$nulls":3},0,9146,20,810,{"v":7392.06,"d":"7392"},{"v":12915.51917462768,"d":"12916"},{"$nulls":6},0,8340,14,781,{"v":6502.606,"d":"6503"},{"v":11124.92756211964,"d":"11125"},{"$nulls":7},"ATM","X","PSTK","Protein kinase - Atypical protein-serine kinase","Protein-serine/threonine kinase","Atypical","PIKK","ATM",{"$nulls":5},"CDEFLTKPEVARRSRI","Corresponds to amino acid residues D2579 to I2593.",{"$nulls":3},"Q13315","Q13315","Q13315","Q13315"]
[185,92,"NK230-1","ATM","Pan-specific","Ataxia telangiectasia mutated protein-serine kinase",0,8856,16,752,{"v":6647.68,"d":"6648"},{"v":11680.95029709328,"d":"11681"},{"v":11917.084483106279,"d":"11917"},{"v":236.13418601299782,"d":"236"},{"v":1.9814761433280335,"d":"2"},0,9566,16,719,{"v":6866.45,"d":"6866"},{"v":11997.16542298388,"d":"11997"},{"v":11721.956324065159,"d":"11722"},{"v":275.2090989187218,"d":"275"},{"v":2.3478086021675235,"d":"2"},{"v":4.329284745495557,"d":"4"},{"v":-1.637381687758733,"d":"-2"},null,0,9186,12,708,{"v":6495.192,"d":"6495"},{"v":11112.243383969286,"d":"11112"},{"v":9443.753005991111,"d":"9444"},{"v":1668.4903779781744,"d":"1668"},{"v":17.667662177522907,"d":"18"},{"v":19.64913832085094,"d":"20"},{"v":-20.754501494231874,"d":"-21"},null,null,"ATM","X","PSTK","Protein kinase - Atypical protein-serine kinase","Protein-serine/threonine kinase","Atypical","PIKK","ATM",{"$nulls":5},"CGKERRQLVKGRDDLR","Corresponds to amino acid residues G2719 to R2733.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); ATYPICAL domain target; ATYPICAL</A> group; PIKK family","Q13315","Q13315","Q13315","Q13315","GO:0031410; GO:1990391; GO:0005730; GO:0005654; GO:0005634","GO:0016303; GO:0005524; GO:0003677; GO:0004677; GO:0044877; GO:0046983; GO:0047485; GO:0004674","GO:0006915; GO:0007050; GO:0006974; GO:0071480; GO:0071500; GO:0071300; GO:0071481; GO:0006975; GO:0006977; GO:0000729; GO:0006281; GO:0006260; GO:0006303; GO:0097695; GO:0097694; GO:0071044; GO:0016572; GO:0007094; GO:0030889; GO:1904354; GO:1904262; GO:0036289; GO:0018105; GO:0043065; GO:0045785; GO:0030335; GO:1903626; GO:0043517; GO:0010628; GO:0033129; GO:0043525; GO:1904884; GO:0032212; GO:1904358; GO:0045944; GO:0002331; GO:0046777; GO:0006468; GO:0007131; GO:0042981; GO:0010506; GO:1905843; GO:1900034; GO:1903978; GO:1901796; GO:0032210; GO:0090399; GO:0001666; GO:0010212; GO:0007165; GO:0072434; GO:0000723"]
[186,92,"NK230-1","ATM","Pan-specific","Ataxia telangiectasia mutated protein-serine kinase",0,8767,12,790,{"v":6916.45,"d":"6916"},{"v":12153.218669119275,"d":"12153"},{"$nulls":3},0,9320,14,704,{"v":6551.424,"d":"6551"},{"v":11446.747225146437,"d":"11447"},{"$nulls":6},0,6729,16,677,{"v":4544.701,"d":"4545"},{"v":7775.262628012936,"d":"7775"},{"$nulls":7},"ATM","X","PSTK","Protein kinase - Atypical protein-serine kinase","Protein-serine/threonine kinase","Atypical","PIKK","ATM",{"$nulls":5},"CGKERRQLVKGRDDLR","Corresponds to amino acid residues G2719 to R2733.",{"$nulls":3},"Q13315","Q13315","Q13315","Q13315"]
[187,93,"PK526","ATM","S1981","Ataxia telangiectasia mutated protein-serine kinase",0,4309,14,752,{"v":3229.84,"d":"3230"},{"v":5675.3033400470185,"d":"5675"},{"v":5627.276122431956,"d":"5627"},{"v":48.02721761506291,"d":"48"},{"v":0.8534718497926995,"d":"1"},0,5038,12,734,{"v":3689.084,"d":"3689"},{"v":6445.62343092618,"d":"6446"},{"v":5907.488155548461,"d":"5907"},{"v":538.1352753777192,"d":"538"},{"v":9.109375443644167,"d":"9"},{"v":9.962847293436866,"d":"10"},{"v":4.979532317589658,"d":"5"},null,0,4662,14,777,{"v":3611.496,"d":"3611"},{"v":6178.696877972436,"d":"6179"},{"v":5975.425823121212,"d":"5975"},{"v":203.2710548512241,"d":"203"},{"v":3.4017835861118138,"d":"3"},{"v":4.255255435904513,"d":"4"},{"v":6.186824550894698,"d":"6"},null,null,"ATM","X","PSTK","Protein kinase - Atypical protein-serine kinase","Protein-serine/threonine kinase","Atypical","PIKK","ATM",{"$nulls":5},"EEG(pS)QST(bA)C","Corresponds to amino acid residues E1978 to T1984; In the C-terminal half of the protein kinase before the FAT domain.","S1981 phosphorylation stimulates phosphotransferase activity, although other reports indicate inhibition. Phosphorylation induces interaction with ATM, MDC1, NBS1, PKM and p53, and inhibits interaction with CDCA2. This is one of the major in vivo phosphorylation sites in ATM (≥26 reports from high throughput mass spectrometry studies).","ATR; ATM","EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); ATYPICAL domain target; ATYPICAL</A> group; PIKK family","Q13315","Q13315","Q13315","Q13315","GO:0031410; GO:1990391; GO:0005730; GO:0005654; GO:0005634","GO:0016303; GO:0005524; GO:0003677; GO:0004677; GO:0044877; GO:0046983; GO:0047485; GO:0004674","GO:0006915; GO:0007050; GO:0006974; GO:0071480; GO:0071500; GO:0071300; GO:0071481; GO:0006975; GO:0006977; GO:0000729; GO:0006281; GO:0006260; GO:0006303; GO:0097695; GO:0097694; GO:0071044; GO:0016572; GO:0007094; GO:0030889; GO:1904354; GO:1904262; GO:0036289; GO:0018105; GO:0043065; GO:0045785; GO:0030335; GO:1903626; GO:0043517; GO:0010628; GO:0033129; GO:0043525; GO:1904884; GO:0032212; GO:1904358; GO:0045944; GO:0002331; GO:0046777; GO:0006468; GO:0007131; GO:0042981; GO:0010506; GO:1905843; GO:1900034; GO:1903978; GO:1901796; GO:0032210; GO:0090399; GO:0001666; GO:0010212; GO:0007165; GO:0072434; GO:0000723"]
[188,93,"PK526","ATM","S1981","Ataxia telangiectasia mutated protein-serine kinase",0,4113,16,775,{"v":3175.175,"d":"3175"},{"v":5579.248904816893,"d":"5579"},{"$nulls":3},0,4520,14,682,{"v":3073.092,"d":"3073"},{"v":5369.352880170741,"d":"5369"},{"$nulls":6},0,4301,14,787,{"v":3373.869,"d":"3374"},{"v":5772.154768269987,"d":"5772"},{"$nulls":7},"ATM","X","PSTK","Protein kinase - Atypical protein-serine kinase","Protein-serine/threonine kinase","Atypical","PIKK","ATM",{"$nulls":5},"EEG(pS)QST(bA)C","Corresponds to amino acid residues E1978 to T1984; In the C-terminal half of the protein kinase before the FAT domain.","S1981 phosphorylation stimulates phosphotransferase activity, although other reports indicate inhibition. Phosphorylation induces interaction with ATM, MDC1, NBS1, PKM and p53, and inhibits interaction with CDCA2. This is one of the major in vivo phosphorylation sites in ATM (≥26 reports from high throughput mass spectrometry studies).","ATR; ATM",null,"Q13315","Q13315","Q13315","Q13315"]
[189,94,"PK527","ATM","Y2969","Ataxia telangiectasia mutated protein-serine kinase",0,4542,18,927,{"v":4193.748,"d":"4194"},{"v":7369.031293102909,"d":"7369"},{"v":6517.036447630082,"d":"6517"},{"v":851.9948454728274,"d":"852"},{"v":13.073347867843443,"d":"13"},0,4764,18,929,{"v":4409.034,"d":"4409"},{"v":7703.5309735831925,"d":"7704"},{"v":6588.55960739633,"d":"6589"},{"v":1114.9713661868627,"d":"1115"},{"v":16.922839476707377,"d":"17"},{"v":29.99618734455082,"d":"30"},{"v":1.0974798183345627,"d":"1"},null,0,4482,18,808,{"v":3606.912,"d":"3607"},{"v":6170.854380988187,"d":"6171"},{"v":5582.42416769054,"d":"5582"},{"v":588.4302132976463,"d":"588"},{"v":10.540765008565822,"d":"11"},{"v":23.614112876409266,"d":"24"},{"v":-14.341062650944863,"d":"-14"},null,null,"ATM","X","PSTK","Protein kinase - Atypical protein-serine kinase","Protein-serine/threonine kinase","Atypical","PIKK","ATM",{"$nulls":5},"KAL(pY)LQQ(bA)C","Corresponds to amino acid residues K2966 to Q2972; Near the C-terminus of the kinase. ","The effect of Y2969 phosphorylation is unclear. This is the major in vivo phosphorylation site in ATM (≥80 reports from high throughput mass spectrometry studies).",null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); ATYPICAL domain target; ATYPICAL</A> group; PIKK family","Q13315","Q13315","Q13315","Q13315","GO:0031410; GO:1990391; GO:0005730; GO:0005654; GO:0005634","GO:0016303; GO:0005524; GO:0003677; GO:0004677; GO:0044877; GO:0046983; GO:0047485; GO:0004674","GO:0006915; GO:0007050; GO:0006974; GO:0071480; GO:0071500; GO:0071300; GO:0071481; GO:0006975; GO:0006977; GO:0000729; GO:0006281; GO:0006260; GO:0006303; GO:0097695; GO:0097694; GO:0071044; GO:0016572; GO:0007094; GO:0030889; GO:1904354; GO:1904262; GO:0036289; GO:0018105; GO:0043065; GO:0045785; GO:0030335; GO:1903626; GO:0043517; GO:0010628; GO:0033129; GO:0043525; GO:1904884; GO:0032212; GO:1904358; GO:0045944; GO:0002331; GO:0046777; GO:0006468; GO:0007131; GO:0042981; GO:0010506; GO:1905843; GO:1900034; GO:1903978; GO:1901796; GO:0032210; GO:0090399; GO:0001666; GO:0010212; GO:0007165; GO:0072434; GO:0000723"]
[190,94,"PK527","ATM","Y2969","Ataxia telangiectasia mutated protein-serine kinase",0,4176,16,775,3224,{"v":5665.041602157255,"d":"5665"},{"$nulls":3},0,4193,16,750,{"v":3132.75,"d":"3133"},{"v":5473.588241209468,"d":"5474"},{"$nulls":6},0,3950,16,742,{"v":2919.028,"d":"2919"},{"v":4993.993954392895,"d":"4994"},{"$nulls":7},"ATM","X","PSTK","Protein kinase - Atypical protein-serine kinase","Protein-serine/threonine kinase","Atypical","PIKK","ATM",{"$nulls":5},"KAL(pY)LQQ(bA)C","Corresponds to amino acid residues K2966 to Q2972; Near the C-terminus of the kinase. ","The effect of Y2969 phosphorylation is unclear. This is the major in vivo phosphorylation site in ATM (≥80 reports from high throughput mass spectrometry studies).",null,null,"Q13315","Q13315","Q13315","Q13315"]
[191,95,"NK237-1","ATR","Pan-specific","Ataxia telangiectasia and Rad3 related protein-serine kinase",0,2048,12,603,{"v":1227.708,"d":"1228"},{"v":2157.2633049941933,"d":"2157"},{"v":2263.5144636788227,"d":"2264"},{"v":106.25115868462944,"d":"106"},{"v":4.694079069940759,"d":"5"},0,1790,14,657,{"v":1166.832,"d":"1167"},{"v":2038.7065404730436,"d":"2039"},{"v":2097.7134903037436,"d":"2098"},{"v":59.00694983070002,"d":"59"},{"v":2.8129174981925664,"d":"3"},{"v":7.506996568133326,"d":"8"},{"v":-7.324935450406073,"d":"-7"},null,0,2308,10,562,{"v":1291.476,"d":"1291"},{"v":2209.510609779529,"d":"2210"},{"v":2362.62150558163,"d":"2363"},{"v":153.1108958021009,"d":"153"},{"v":6.480551177595756,"d":"6"},{"v":11.174630247536516,"d":"11"},{"v":4.378458520725843,"d":"4"},null,null,"ATR","X","PSTK","Protein kinase - Atypical protein-serine kinase","Protein-serine/threonine kinase","Atypical","PIKK","ATR",{"$nulls":5},"KISLKGSDGKFYIMMC","Corresponds to amino acid residues K2311 to C2326.",null,null,"Protein-serine kinase,  ATYPICAL group, PIKK family, ATR subfamily","Q13535","Q13535","Q13535","Q13535","GO:0005694; GO:0005794; GO:0005654; GO:0016605","GO:0005524; GO:0003677; GO:0032405; GO:0032407; GO:0004672; GO:0004674","GO:0006974; GO:0071480; GO:0034644; GO:0000077; GO:0006281; GO:0006260; GO:0097695; GO:0097694; GO:0036297; GO:0007275; GO:0008156; GO:0018105; GO:0043517; GO:1904884; GO:0032212; GO:0046777; GO:0070198; GO:1900034; GO:0090399; GO:0042493"]
[192,95,"NK237-1","ATR","Pan-specific","Ataxia telangiectasia and Rad3 related protein-serine kinase",0,2258,14,601,{"v":1348.644,"d":"1349"},{"v":2369.7656223634517,"d":"2370"},{"$nulls":3},0,2172,14,572,{"v":1234.376,"d":"1234"},{"v":2156.720440134444,"d":"2157"},{"$nulls":6},0,2405,14,615,{"v":1470.465,"d":"1470"},{"v":2515.7324013837306,"d":"2516"},{"$nulls":7},"ATR","X","PSTK","Protein kinase - Atypical protein-serine kinase","Protein-serine/threonine kinase","Atypical","PIKK","ATR",{"$nulls":5},"KISLKGSDGKFYIMMC","Corresponds to amino acid residues K2311 to C2326.",{"$nulls":3},"Q13535","Q13535","Q13535","Q13535"]
[193,96,"NK237-3","ATR","Pan-specific","Ataxia telangiectasia and Rad3 related protein-serine kinase",0,10668,14,868,{"v":9247.672,"d":"9248"},{"v":16249.518177141681,"d":"16250"},{"v":16069.498477346082,"d":"16069"},{"v":180.01969979559908,"d":"180"},{"v":1.1202571134959887,"d":"1"},0,9658,22,858,{"v":8267.688,"d":"8268"},{"v":14445.429676414851,"d":"14445"},{"v":14716.904976571635,"d":"14717"},{"v":271.4753001567842,"d":"271"},{"v":1.8446494054895062,"d":"2"},{"v":2.9649065189854946,"d":"3"},{"v":-8.417148193400436,"d":"-8"},null,0,11486,20,866,{"v":9929.556,"d":"9930"},{"v":16987.895502820014,"d":"16988"},{"v":16012.746699138524,"d":"16013"},{"v":975.1488036814899,"d":"975"},{"v":6.08982844732036,"d":"6"},{"v":7.210085560816349,"d":"7"},{"v":-0.35316458872416945,"d":"-0"},null,null,"ATR","X","PSTK","Protein kinase - Atypical protein-serine kinase","Protein-serine/threonine kinase","Atypical","PIKK","ATR",{"$nulls":5},"CGHVHYLIQEATDENL","Corresponds to amino acid residues G2618 to L2632; C-terminus.",null,null,"Protein-serine kinase,  ATYPICAL group, PIKK family, ATR subfamily","Q13535","Q13535","Q13535","Q13535","GO:0005694; GO:0005794; GO:0005654; GO:0016605","GO:0005524; GO:0003677; GO:0032405; GO:0032407; GO:0004672; GO:0004674","GO:0006974; GO:0071480; GO:0034644; GO:0000077; GO:0006281; GO:0006260; GO:0097695; GO:0097694; GO:0036297; GO:0007275; GO:0008156; GO:0018105; GO:0043517; GO:1904884; GO:0032212; GO:0046777; GO:0070198; GO:1900034; GO:0090399; GO:0042493"]
[194,96,"NK237-3","ATR","Pan-specific","Ataxia telangiectasia and Rad3 related protein-serine kinase",0,10462,20,866,{"v":9042.772,"d":"9043"},{"v":15889.478777550485,"d":"15889"},{"$nulls":3},0,10170,18,845,{"v":8578.44,"d":"8578"},{"v":14988.38027672842,"d":"14988"},{"$nulls":6},0,9512,20,926,{"v":8789.592,"d":"8790"},{"v":15037.597895457035,"d":"15038"},{"$nulls":7},"ATR","X","PSTK","Protein kinase - Atypical protein-serine kinase","Protein-serine/threonine kinase","Atypical","PIKK","ATR",{"$nulls":5},"CGHVHYLIQEATDENL","Corresponds to amino acid residues G2618 to L2632; C-terminus.",{"$nulls":3},"Q13535","Q13535","Q13535","Q13535"]
[195,97,"PK528","ATR","S435+S436","Ataxia telangiectasia and Rad3 related protein-serine kinase",0,6944,22,837,{"v":5793.714,"d":"5794"},{"v":10180.406588399786,"d":"10180"},{"v":10176.542622369034,"d":"10177"},{"v":3.8639660307526356,"d":"4"},{"v":0.03796933962875821,"d":"0"},0,7400,38,887,{"v":6530.094,"d":"6530"},{"v":11409.479126132792,"d":"11409"},{"v":10930.922139937738,"d":"10931"},{"v":478.55698619505347,"d":"479"},{"v":4.378011114419842,"d":"4"},{"v":4.415980454048601,"d":"4"},{"v":7.412925445922113,"d":"7"},null,0,7506,24,823,{"v":6157.686,"d":"6158"},{"v":10534.824145931374,"d":"10535"},{"v":10030.820534112501,"d":"10031"},{"v":504.00361181887274,"d":"504"},{"v":5.024550186147514,"d":"5"},{"v":5.062519525776272,"d":"5"},{"v":-1.4319410202854357,"d":"-1"},null,null,"ATR","X","PSTK","Protein kinase - Atypical protein-serine kinase","Protein-serine/threonine kinase","Atypical","PIKK","ATR",{"$nulls":5},"RRL(pS)(pS)SLN(bA)C","Corresponds to amino acid residues R432 to N439; In the N-terminal quarter of the kinase after the transmembrane domain. ","Phosphorylation of S435 induces iteraction with AKAP12. The effects of S436 phosphorylation are unclear. These are the major in vivo phosphorylation sites in ATR (≥97 and ≥53 reports, respectively, by mass spectrometry).","S435: PKACA","Protein-serine kinase,  ATYPICAL group, PIKK family, ATR subfamily","Q13535","Q13535","Q13535","Q13535","GO:0005694; GO:0005794; GO:0005654; GO:0016605","GO:0005524; GO:0003677; GO:0032405; GO:0032407; GO:0004672; GO:0004674","GO:0006974; GO:0071480; GO:0034644; GO:0000077; GO:0006281; GO:0006260; GO:0097695; GO:0097694; GO:0036297; GO:0007275; GO:0008156; GO:0018105; GO:0043517; GO:1904884; GO:0032212; GO:0046777; GO:0070198; GO:1900034; GO:0090399; GO:0042493"]
[196,97,"PK528","ATR","S435+S436","Ataxia telangiectasia and Rad3 related protein-serine kinase",0,6566,17,884,{"v":5789.316,"d":"5789"},{"v":10172.678656338283,"d":"10173"},{"$nulls":3},0,7245,20,828,{"v":5982.3,"d":"5982"},{"v":10452.365153742687,"d":"10452"},{"$nulls":6},0,6236,35,898,{"v":5568.498,"d":"5568"},{"v":9526.816922293629,"d":"9527"},{"$nulls":7},"ATR","X","PSTK","Protein kinase - Atypical protein-serine kinase","Protein-serine/threonine kinase","Atypical","PIKK","ATR",{"$nulls":5},"RRL(pS)(pS)SLN(bA)C","Corresponds to amino acid residues R432 to N439; In the N-terminal quarter of the kinase after the transmembrane domain. ","Phosphorylation of S435 induces iteraction with AKAP12. The effects of S436 phosphorylation are unclear. These are the major in vivo phosphorylation sites in ATR (≥97 and ≥53 reports, respectively, by mass spectrometry).","S435: PKACA",null,"Q13535","Q13535","Q13535","Q13535"]
[197,98,"NK008-3","AurKA (Aurora A, AIK, STK15)","Pan-specific","Aurora Kinase A (serine/threonine protein kinase 6)",0,4492,16,736,{"v":3294.336,"d":"3294"},{"v":5788.632286440546,"d":"5789"},{"v":5783.910832723115,"d":"5784"},{"v":4.72145371743045,"d":"5"},{"v":0.0816308178666639,"d":"0"},0,4430,22,797,{"v":3513.176,"d":"3513"},{"v":6138.274309440369,"d":"6138"},{"v":5701.04595025276,"d":"5701"},{"v":437.2283591876085,"d":"437"},{"v":7.6692656576154,"d":"8"},{"v":7.7508964754820635,"d":"8"},{"v":-1.4326791139576045,"d":"-1"},null,0,4652,14,697,{"v":3232.686,"d":"3233"},{"v":5530.613046689018,"d":"5531"},{"v":5415.697540594998,"d":"5416"},{"v":114.9155060940202,"d":"115"},{"v":2.121896675961615,"d":"2"},{"v":2.203527493828279,"d":"2"},{"v":-6.3661647417679745,"d":"-6"},null,null,"AurA","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"CGPVKATAPVGGPKRV","Corresponds to amino acid residues G11 to V25.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; AUR family","O14965","O14965","O14965","O14965","GO:0043203; GO:0005814; GO:0005813; GO:0032133; GO:0005929; GO:0000780; GO:0005829; GO:0042585; GO:0072687; GO:0005874; GO:0015630; GO:0030496; GO:0097431; GO:0005654; GO:0005634; GO:0048471; GO:0045120; GO:0005819; GO:0051233; GO:0031616","GO:0005524; GO:0035174; GO:0046982; GO:0004672; GO:0019901; GO:0004712; GO:0004674; GO:0031625","GO:0031145; GO:0009948; GO:0051301; GO:0051642; GO:0006977; GO:0000086; GO:0097421; GO:0000278; GO:0007100; GO:0007052; GO:0043066; GO:0010972; GO:0032091; GO:1990138; GO:0045840; GO:1900195; GO:0032436; GO:0046777; GO:0071539; GO:0006468; GO:0046605; GO:0032465; GO:0010389; GO:0031647; GO:1901796; GO:0009611; GO:0007057; GO:0007051"]
[198,98,"NK008-3","AurKA (Aurora A, AIK, STK15)","Pan-specific","Aurora Kinase A (serine/threonine protein kinase 6)",0,4351,12,758,{"v":3288.962,"d":"3289"},{"v":5779.189379005685,"d":"5779"},{"$nulls":3},0,4328,18,699,{"v":3012.69,"d":"3013"},{"v":5263.817591065152,"d":"5264"},{"$nulls":6},0,4222,18,737,{"v":3098.348,"d":"3098"},{"v":5300.782034500977,"d":"5301"},{"$nulls":7},"AurA","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"CGPVKATAPVGGPKRV","Corresponds to amino acid residues G11 to V25.",{"$nulls":3},"O14965","O14965","O14965","O14965"]
[199,99,"NK008-4","AurKA (Aurora A, AIK, STK15)","Pan-specific","Aurora Kinase A (serine/threonine protein kinase 6)",0,6806,16,778,{"v":5282.62,"d":"5283"},{"v":9282.339351236958,"d":"9282"},{"v":8810.27480825124,"d":"8810"},{"v":472.0645429857177,"d":"472"},{"v":5.358113716766325,"d":"5"},0,6802,16,768,{"v":5211.648,"d":"5212"},{"v":9105.870308873304,"d":"9106"},{"v":9293.99471060318,"d":"9294"},{"v":188.1244017298759,"d":"188"},{"v":2.024150083873532,"d":"2"},{"v":7.382263800639857,"d":"7"},{"v":5.490406518295117,"d":"5"},null,0,7053,12,740,{"v":5210.34,"d":"5210"},{"v":8914.065387632965,"d":"8914"},{"v":8752.288224711818,"d":"8752"},{"v":161.77716292114746,"d":"162"},{"v":1.848398484688548,"d":"2"},{"v":7.206512201454872,"d":"7"},{"v":-0.658169975414566,"d":"-1"},null,null,"AurA","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"CESKKRQWALEDFEI","Corresponds to amino acid residues E122 to I135.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; AUR family","O14965","O14965","O14965","O14965","GO:0043203; GO:0005814; GO:0005813; GO:0032133; GO:0005929; GO:0000780; GO:0005829; GO:0042585; GO:0072687; GO:0005874; GO:0015630; GO:0030496; GO:0097431; GO:0005654; GO:0005634; GO:0048471; GO:0045120; GO:0005819; GO:0051233; GO:0031616","GO:0005524; GO:0035174; GO:0046982; GO:0004672; GO:0019901; GO:0004712; GO:0004674; GO:0031625","GO:0031145; GO:0009948; GO:0051301; GO:0051642; GO:0006977; GO:0000086; GO:0097421; GO:0000278; GO:0007100; GO:0007052; GO:0043066; GO:0010972; GO:0032091; GO:1990138; GO:0045840; GO:1900195; GO:0032436; GO:0046777; GO:0071539; GO:0006468; GO:0046605; GO:0032465; GO:0010389; GO:0031647; GO:1901796; GO:0009611; GO:0007057; GO:0007051"]
[200,99,"NK008-4","AurKA (Aurora A, AIK, STK15)","Pan-specific","Aurora Kinase A (serine/threonine protein kinase 6)",0,6360,16,748,{"v":4745.312,"d":"4745"},{"v":8338.210265265523,"d":"8338"},{"$nulls":3},0,6854,19,794,{"v":5426.99,"d":"5427"},{"v":9482.119112333054,"d":"9482"},{"$nulls":6},0,6334,18,795,{"v":5021.22,"d":"5021"},{"v":8590.511061790668,"d":"8591"},{"$nulls":7},"AurA","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"CESKKRQWALEDFEI","Corresponds to amino acid residues E122 to I135.",{"$nulls":3},"O14965","O14965","O14965","O14965"]
[201,100,"PK529","AurKA (Aurora A, AIK, STK15)","T287+T288","Aurora Kinase A (serine/threonine protein kinase 6)",0,10450,16,758,{"v":7908.972,"d":"7909"},{"v":13897.22562354121,"d":"13897"},{"v":14208.693968552125,"d":"14209"},{"v":311.4683450109151,"d":"311"},{"v":2.192096935160142,"d":"2"},0,12753,20,786,{"v":10008.138,"d":"10008"},{"v":17486.370273147124,"d":"17486"},{"v":15984.539265933241,"d":"15985"},{"v":1501.831007213883,"d":"1502"},{"v":9.395522649906043,"d":"9"},{"v":11.587619585066186,"d":"12"},{"v":12.498300697527625,"d":"12"},null,0,11135,18,740,{"v":8226.58,"d":"8227"},{"v":14074.373656343652,"d":"14074"},{"v":15156.749444861045,"d":"15157"},{"v":1082.3757885173927,"d":"1082"},{"v":7.141213176710369,"d":"7"},{"v":9.33331011187051,"d":"9"},{"v":6.672361853997529,"d":"7"},null,null,"AurA","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"RR(pT)(pT)LCG(bA)C","Corresponds to amino acid residues R285 to G291; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T287 and T288 phosphorylation stimulate phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major in vivo phosphorylation sites in AurKA (≥6 and ≥16 reports, respectively, by mass spectrometry).","T287: AurKA. T288: AurKA; PAK1; PKACa","EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; AUR family","O14965","O14965","O14965","O14965","GO:0043203; GO:0005814; GO:0005813; GO:0032133; GO:0005929; GO:0000780; GO:0005829; GO:0042585; GO:0072687; GO:0005874; GO:0015630; GO:0030496; GO:0097431; GO:0005654; GO:0005634; GO:0048471; GO:0045120; GO:0005819; GO:0051233; GO:0031616","GO:0005524; GO:0035174; GO:0046982; GO:0004672; GO:0019901; GO:0004712; GO:0004674; GO:0031625","GO:0031145; GO:0009948; GO:0051301; GO:0051642; GO:0006977; GO:0000086; GO:0097421; GO:0000278; GO:0007100; GO:0007052; GO:0043066; GO:0010972; GO:0032091; GO:1990138; GO:0045840; GO:1900195; GO:0032436; GO:0046777; GO:0071539; GO:0006468; GO:0046605; GO:0032465; GO:0010389; GO:0031647; GO:1901796; GO:0009611; GO:0007057; GO:0007051"]
[202,100,"PK529","AurKA (Aurora A, AIK, STK15)","T287+T288","Aurora Kinase A (serine/threonine protein kinase 6)",0,10718,14,772,{"v":8263.488,"d":"8263"},{"v":14520.16231356304,"d":"14520"},{"$nulls":3},0,12066,18,688,{"v":8289.024,"d":"8289"},{"v":14482.708258719358,"d":"14483"},{"$nulls":6},0,10796,22,881,{"v":9491.894,"d":"9492"},{"v":16239.125233378438,"d":"16239"},{"$nulls":7},"AurA","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"RR(pT)(pT)LCG(bA)C","Corresponds to amino acid residues R285 to G291; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T287 and T288 phosphorylation stimulate phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major in vivo phosphorylation sites in AurKA (≥6 and ≥16 reports, respectively, by mass spectrometry).","T287: AurKA. T288: AurKA; PAK1; PKACa",null,"O14965","O14965","O14965","O14965"]
[203,76,"PK174","AurKA (Aurora A, AIK, STK15)","T288","Aurora Kinase A (serine/threonine protein kinase 6)",0,166,14,520,{"v":79.04,"d":"79"},{"v":138.88489089159722,"d":"139"},{"v":136.60938565748006,"d":"137"},{"v":2.275505234117162,"d":"2"},{"v":1.6657019744035182,"d":"2"},0,180,11,545,{"v":92.105,"d":"92"},{"v":160.9272508041172,"d":"161"},{"v":132.36814567389953,"d":"132"},{"v":28.55910513021766,"d":"29"},{"v":21.575511981995657,"d":"22"},{"v":23.241213956399175,"d":"23"},{"v":-3.104647578325668,"d":"-3"},null,0,190,10,636,{"v":114.48,"d":"114"},{"v":195.85712363803933,"d":"196"},{"v":170.3450566596113,"d":"170"},{"v":25.512066978428038,"d":"26"},{"v":14.976699341153783,"d":"15"},{"v":16.6424013155573,"d":"17"},{"v":24.69498771242297,"d":"25"},{"$nulls":3},"X","PSTK",{"$nulls":10},"Not precisely defined.","Antibody raised against amino acid residues that encompass the T288 phosphosite.","T288 phosphorylation stimulates phosphotransferase activity. This is one of the major in vivo phosphorylation sites in ARK-1 (≥16 reports from high throughput mass spectrometry studies).","AurA; PAK1; PKACa","EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; AUR family","O14965","O14965","O14965","O14965","GO:0043203; GO:0005814; GO:0005813; GO:0032133; GO:0005929; GO:0000780; GO:0005829; GO:0042585; GO:0072687; GO:0005874; GO:0015630; GO:0030496; GO:0097431; GO:0005654; GO:0005634; GO:0048471; GO:0045120; GO:0005819; GO:0051233; GO:0031616","GO:0005524; GO:0035174; GO:0046982; GO:0004672; GO:0019901; GO:0004712; GO:0004674; GO:0031625","GO:0031145; GO:0009948; GO:0051301; GO:0051642; GO:0006977; GO:0000086; GO:0097421; GO:0000278; GO:0007100; GO:0007052; GO:0043066; GO:0010972; GO:0032091; GO:1990138; GO:0045840; GO:1900195; GO:0032436; GO:0046777; GO:0071539; GO:0006468; GO:0046605; GO:0032465; GO:0010389; GO:0031647; GO:1901796; GO:0009611; GO:0007057; GO:0007051"]
[204,76,"PK174","AurKA (Aurora A, AIK, STK15)","T288","Aurora Kinase A (serine/threonine protein kinase 6)",0,149,10,550,{"v":76.45,"d":"76"},{"v":134.33388042336293,"d":"134"},{"$nulls":3},0,130,8,487,{"v":59.414,"d":"59"},{"v":103.80904054368186,"d":"104"},{"$nulls":6},0,160,12,572,{"v":84.656,"d":"85"},{"v":144.83298968118325,"d":"145"},{"$nulls":8},"X","PSTK",{"$nulls":10},"Not precisely defined.","Antibody raised against amino acid residues that encompass the T288 phosphosite.","T288 phosphorylation stimulates phosphotransferase activity. This is one of the major in vivo phosphorylation sites in ARK-1 (≥16 reports from high throughput mass spectrometry studies).","AurA; PAK1; PKACa",null,"O14965","O14965","O14965","O14965"]
[205,101,"NK193-2","AurKB (Aurora B, AIM-1)","Pan-specific","Aurora Kinase B (serine/threonine protein kinase 12)",0,6338,16,748,{"v":4728.856,"d":"4729"},{"v":8309.294655896694,"d":"8309"},{"v":7877.12789039813,"d":"7877"},{"v":432.166765498564,"d":"432"},{"v":5.486349485646363,"d":"5"},0,6557,20,686,{"v":4484.382,"d":"4484"},{"v":7835.180140225488,"d":"7835"},{"v":7740.035539579071,"d":"7740"},{"v":95.14460064641662,"d":"95"},{"v":1.2292527619529625,"d":"1"},{"v":6.715602247599326,"d":"7"},{"v":-1.740384982020771,"d":"-2"},null,0,6694,18,707,{"v":4719.932,"d":"4720"},{"v":8075.055077630487,"d":"8075"},{"v":7311.000151108354,"d":"7311"},{"v":764.0549265221334,"d":"764"},{"v":10.45075790904343,"d":"10"},{"v":15.937107394689793,"d":"16"},{"v":-7.186981691383494,"d":"-7"},null,null,"AurB","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"AQKENSYPWPYGRQTC","Corresponds to amino acid residues A2 to T16; N-terminus.",null,null,"Protein-serine kinase, Other group, AUR family","Q96GD4","Q96GD4","Q96GD4","Q96GD4","GO:0010369; GO:0032133; GO:0000779; GO:0000780; GO:0005829; GO:0000776; GO:0030496; GO:1990023; GO:0005654; GO:0005634; GO:0005819; GO:0005876; GO:0051233; GO:0031616","GO:0005524; GO:0035174; GO:0019900; GO:0046872; GO:0004712; GO:0004674","GO:0009838; GO:0007568; GO:0031145; GO:0008608; GO:0008283; GO:0034644; GO:0036089; GO:0043988; GO:0016570; GO:0044878; GO:0051256; GO:0002903; GO:0032466; GO:0032091; GO:0000122; GO:0032467; GO:0051973; GO:1904355; GO:0032212; GO:0046777; GO:0034501; GO:0006468; GO:0051983; GO:1901796; GO:0031577; GO:0007051"]
[206,101,"NK193-2","AurKB (Aurora B, AIM-1)","Pan-specific","Aurora Kinase B (serine/threonine protein kinase 12)",0,5828,8,728,{"v":4236.96,"d":"4237"},{"v":7444.961124899566,"d":"7445"},{"$nulls":3},0,6240,16,703,{"v":4375.472,"d":"4375"},{"v":7644.8909389326545,"d":"7645"},{"$nulls":6},0,5558,12,690,{"v":3826.74,"d":"3827"},{"v":6546.94522458622,"d":"6547"},{"$nulls":7},"AurB","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"AQKENSYPWPYGRQTC","Corresponds to amino acid residues A2 to T16; N-terminus.",{"$nulls":3},"Q96GD4","Q96GD4","Q96GD4","Q96GD4"]
[207,102,"NK193-3","AurKB (Aurora B, AIM-1)","Pan-specific","Aurora Kinase B (serine/threonine protein kinase 12)",0,7739,16,644,{"v":4973.612,"d":"4974"},{"v":8739.366902291733,"d":"8739"},{"v":5331.199505682236,"d":"5331"},{"v":3408.167396609497,"d":"3408"},{"v":63.928716098073544,"d":"64"},0,7882,16,672,{"v":5285.952,"d":"5286"},{"v":9235.69538290565,"d":"9236"},{"v":9845.589657839859,"d":"9846"},{"v":609.8942749342095,"d":"610"},{"v":6.194593682345497,"d":"6"},{"v":70.12330978041904,"d":"70"},{"v":84.67869467923643,"d":"85"},"Possible",0,7906,18,660,{"v":5206.08,"d":"5206"},{"v":8906.777203262785,"d":"8907"},{"v":8479.391912766467,"d":"8479"},{"v":427.3852904963187,"d":"427"},{"v":5.040282309075168,"d":"5"},{"v":68.96899840714872,"d":"69"},{"v":59.05223399966073,"d":"59"},null,null,"AurB","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"CDILTRHFTIDDFEIG","Corresponds to amino acid residues D66 to G80.",null,null,"Protein-serine kinase, Other group, AUR family","Q96GD4","Q96GD4","Q96GD4","Q96GD4","GO:0010369; GO:0032133; GO:0000779; GO:0000780; GO:0005829; GO:0000776; GO:0030496; GO:1990023; GO:0005654; GO:0005634; GO:0005819; GO:0005876; GO:0051233; GO:0031616","GO:0005524; GO:0035174; GO:0019900; GO:0046872; GO:0004712; GO:0004674","GO:0009838; GO:0007568; GO:0031145; GO:0008608; GO:0008283; GO:0034644; GO:0036089; GO:0043988; GO:0016570; GO:0044878; GO:0051256; GO:0002903; GO:0032466; GO:0032091; GO:0000122; GO:0032467; GO:0051973; GO:1904355; GO:0032212; GO:0046777; GO:0034501; GO:0006468; GO:0051983; GO:1901796; GO:0031577; GO:0007051"]
[208,102,"NK193-3","AurKB (Aurora B, AIM-1)","Pan-specific","Aurora Kinase B (serine/threonine protein kinase 12)",0,1078,4,1019,{"v":1094.406,"d":"1094"},{"v":1923.0321090727393,"d":"1923"},{"$nulls":3},0,7919,14,757,{"v":5984.085,"d":"5984"},{"v":10455.483932774068,"d":"10455"},{"$nulls":6},0,7145,14,660,{"v":4706.46,"d":"4706"},{"v":8052.006622270148,"d":"8052"},{"$nulls":7},"AurB","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"CDILTRHFTIDDFEIG","Corresponds to amino acid residues D66 to G80.",{"$nulls":3},"Q96GD4","Q96GD4","Q96GD4","Q96GD4"]
[209,103,"PK530","AurKB (Aurora B, AIM-1)","S227","Aurora Kinase B (serine/threonine protein kinase 12)",0,11754,14,641,{"v":7525.34,"d":"7525"},{"v":13223.127844410072,"d":"13223"},{"v":13050.997734190678,"d":"13051"},{"v":172.13011021939383,"d":"172"},{"v":1.3189038395773502,"d":"1"},0,11240,14,596,{"v":6690.696,"d":"6691"},{"v":11690.085372630188,"d":"11690"},{"v":12325.061794558791,"d":"12325"},{"v":634.9764219286026,"d":"635"},{"v":5.151912684193834,"d":"5"},{"v":6.470816523771185,"d":"6"},{"v":-5.562302242456894,"d":"-6"},null,0,12332,14,628,{"v":7735.704,"d":"7736"},{"v":13234.562672565296,"d":"13235"},{"v":12913.17769362004,"d":"12913"},{"v":321.3849789452561,"d":"321"},{"v":2.4888140360992743,"d":"2"},{"v":3.807717875676625,"d":"4"},{"v":-1.0560115278357642,"d":"-1"},null,null,"AurB","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"VAHAP(pS)L(bA)C","Corresponds to amino acid residues V222 to L228; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S227 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation induces interaction with INCENP. This is a minor in vivo phosphorylation site in AurKB (≥11 reports from high throughput mass spectrometry studies).","AurKB","Protein-serine kinase, Other group, AUR family","Q96GD4","Q96GD4","Q96GD4","Q96GD4","GO:0010369; GO:0032133; GO:0000779; GO:0000780; GO:0005829; GO:0000776; GO:0030496; GO:1990023; GO:0005654; GO:0005634; GO:0005819; GO:0005876; GO:0051233; GO:0031616","GO:0005524; GO:0035174; GO:0019900; GO:0046872; GO:0004712; GO:0004674","GO:0009838; GO:0007568; GO:0031145; GO:0008608; GO:0008283; GO:0034644; GO:0036089; GO:0043988; GO:0016570; GO:0044878; GO:0051256; GO:0002903; GO:0032466; GO:0032091; GO:0000122; GO:0032467; GO:0051973; GO:1904355; GO:0032212; GO:0046777; GO:0034501; GO:0006468; GO:0051983; GO:1901796; GO:0031577; GO:0007051"]
[210,103,"PK530","AurKB (Aurora B, AIM-1)","S227","Aurora Kinase B (serine/threonine protein kinase 12)",0,11650,16,630,{"v":7329.42,"d":"7329"},{"v":12878.867623971284,"d":"12879"},{"$nulls":3},0,12154,14,611,{"v":7417.54,"d":"7418"},{"v":12960.038216487394,"d":"12960"},{"$nulls":6},0,11792,16,625,7360,{"v":12591.792714674784,"d":"12592"},{"$nulls":7},"AurB","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"VAHAP(pS)L(bA)C","Corresponds to amino acid residues V222 to L228; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S227 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation induces interaction with INCENP. This is a minor in vivo phosphorylation site in AurKB (≥11 reports from high throughput mass spectrometry studies).","AurKB",null,"Q96GD4","Q96GD4","Q96GD4","Q96GD4"]
[211,104,"PK531","AurKB (Aurora B, AIM-1)","T232","Aurora Kinase B (serine/threonine protein kinase 12)",0,1836,18,604,{"v":1098.072,"d":"1098"},{"v":1929.4738096042245,"d":"1929"},{"v":1771.7347324870855,"d":"1772"},{"v":157.739077117139,"d":"158"},{"v":8.903086575252246,"d":"9"},0,1608,16,521,{"v":829.432,"d":"829"},{"v":1449.196151012003,"d":"1449"},{"v":1745.8383380976443,"d":"1746"},{"v":296.64218708564135,"d":"297"},{"v":16.991389214701176,"d":"17"},{"v":25.89447578995342,"d":"26"},{"v":-1.4616406121411245,"d":"-1"},null,0,1892,12,586,{"v":1101.68,"d":"1102"},{"v":1884.799755149853,"d":"1885"},{"v":1896.1255252274545,"d":"1896"},{"v":11.325770077601646,"d":"11"},{"v":0.5973111973292503,"d":"1"},{"v":9.500397772581497,"d":"10"},{"v":7.02084744739156,"d":"7"},null,null,"AurB","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"RRK(pT)MCG(bA)C","Corresponds to amino acid residues R229 to G235; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T232 phosphorylation stimulates or inhibits phosphotransferase activity according to separate reports and regulates cytoskeletal reorganization and intracellular location, and induces binding to INCENP. It is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in AurKB (≥101 reports from high throughput mass spectrometry studies).","AurKB","Protein-serine kinase, Other group, AUR family","Q96GD4","Q96GD4","Q96GD4","Q96GD4","GO:0010369; GO:0032133; GO:0000779; GO:0000780; GO:0005829; GO:0000776; GO:0030496; GO:1990023; GO:0005654; GO:0005634; GO:0005819; GO:0005876; GO:0051233; GO:0031616","GO:0005524; GO:0035174; GO:0019900; GO:0046872; GO:0004712; GO:0004674","GO:0009838; GO:0007568; GO:0031145; GO:0008608; GO:0008283; GO:0034644; GO:0036089; GO:0043988; GO:0016570; GO:0044878; GO:0051256; GO:0002903; GO:0032466; GO:0032091; GO:0000122; GO:0032467; GO:0051973; GO:1904355; GO:0032212; GO:0046777; GO:0034501; GO:0006468; GO:0051983; GO:1901796; GO:0031577; GO:0007051"]
[212,104,"PK531","AurKB (Aurora B, AIM-1)","T232","Aurora Kinase B (serine/threonine protein kinase 12)",0,1674,16,554,{"v":918.532,"d":"919"},{"v":1613.9956553699465,"d":"1614"},{"$nulls":3},0,1818,14,648,{"v":1168.992,"d":"1169"},{"v":2042.4805251832859,"d":"2042"},{"$nulls":6},0,1725,15,652,{"v":1114.92,"d":"1115"},{"v":1907.451295305056,"d":"1907"},{"$nulls":7},"AurB","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"RRK(pT)MCG(bA)C","Corresponds to amino acid residues R229 to G235; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T232 phosphorylation stimulates or inhibits phosphotransferase activity according to separate reports and regulates cytoskeletal reorganization and intracellular location, and induces binding to INCENP. It is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in AurKB (≥101 reports from high throughput mass spectrometry studies).","AurKB",null,"Q96GD4","Q96GD4","Q96GD4","Q96GD4"]
[213,105,"NK009-2","AurKC (Aurora C, AIK3)","Pan-specific","Aurora Kinase C (serine/threonine-protein kinase 13)",0,5532,18,842,{"v":4642.788,"d":"4643"},{"v":8158.0605365994015,"d":"8158"},{"v":7712.810055291389,"d":"7713"},{"v":445.25048130801224,"d":"445"},{"v":5.772869785669714,"d":"6"},0,5768,18,832,4784,{"v":8358.677247129868,"d":"8359"},{"v":7373.931067243242,"d":"7374"},{"v":984.7461798866261,"d":"985"},{"v":13.354426165727304,"d":"13"},{"v":19.127295951397016,"d":"19"},{"v":-4.393716241146876,"d":"-4"},null,0,5820,12,752,{"v":4367.616,"d":"4368"},{"v":7472.298278437095,"d":"7472"},{"v":6488.880978262396,"d":"6489"},{"v":983.4173001746994,"d":"983"},{"v":15.155422074609245,"d":"15"},{"v":20.92829186027896,"d":"21"},{"v":-15.868782820462627,"d":"-16"},null,null,"AurC","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"MSSPRAVVQLGKAQPC","Corresponds to amino acid residues M1 to P15; N-terminus.",null,null,"Protein-serine kinase, Other group, AUR family","Q9UQB9","Q9UQB9","Q9UQB9",null,"GO:0032133; GO:0000793; GO:0000780; GO:0005737; GO:0030496; GO:0005819; GO:0005876; GO:0051233; GO:0031616","GO:0005524; GO:0035174; GO:0004672; GO:0004712","GO:0008608; GO:0000910; GO:0016570; GO:0051321; GO:0051256; GO:0048599; GO:0032467; GO:0006468; GO:0007283"]
[214,105,"NK009-2","AurKC (Aurora C, AIK3)","Pan-specific","Aurora Kinase C (serine/threonine-protein kinase 13)",0,5514,14,752,4136,{"v":7267.559573983376,"d":"7268"},{"$nulls":3},0,5366,12,683,{"v":3656.782,"d":"3657"},{"v":6389.184887356617,"d":"6389"},{"$nulls":6},0,4910,12,657,{"v":3217.986,"d":"3218"},{"v":5505.463678087697,"d":"5505"},{"$nulls":7},"AurC","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"MSSPRAVVQLGKAQPC","Corresponds to amino acid residues M1 to P15; N-terminus.",{"$nulls":3},"Q9UQB9","Q9UQB9","Q9UQB9"]
[215,106,"NK009-3","AurKC (Aurora C, AIK3)","Pan-specific","Aurora Kinase C (serine/threonine-protein kinase 13)",0,2002,12,577,{"v":1148.23,"d":"1148"},{"v":2017.6087837608636,"d":"2018"},{"v":1966.166551147726,"d":"1966"},{"v":51.44223261313755,"d":"51"},{"v":2.61637207606389,"d":"3"},0,2002,12,551,{"v":1096.49,"d":"1096"},{"v":1915.8039328397638,"d":"1916"},{"v":1795.9624461381254,"d":"1796"},{"v":119.84148670163836,"d":"120"},{"v":6.672828096118303,"d":"7"},{"v":9.289200172182193,"d":"9"},{"v":-8.656647368466636,"d":"-9"},null,0,2127,10,522,{"v":1105.074,"d":"1105"},{"v":1890.6063508663756,"d":"1891"},{"v":1889.708159130614,"d":"1890"},{"v":0.8981917357616567,"d":"1"},{"v":0.047530711629825535,"d":"0"},{"v":2.6639027876937154,"d":"3"},{"v":-3.88870373023488,"d":"-4"},null,null,"AurC","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"CSPAMRRLTVDDFEIG","Corresponds to amino acid residues S32 to G46; Pre-kinase catalytic domain.",null,null,"Protein-serine kinase, Other group, AUR family","Q9UQB9","Q9UQB9","Q9UQB9",null,"GO:0032133; GO:0000793; GO:0000780; GO:0005737; GO:0030496; GO:0005819; GO:0005876; GO:0051233; GO:0031616","GO:0005524; GO:0035174; GO:0004672; GO:0004712","GO:0008608; GO:0000910; GO:0016570; GO:0051321; GO:0051256; GO:0048599; GO:0032467; GO:0006468; GO:0007283"]
[216,106,"NK009-3","AurKC (Aurora C, AIK3)","Pan-specific","Aurora Kinase C (serine/threonine-protein kinase 13)",0,1896,14,579,{"v":1089.678,"d":"1090"},{"v":1914.7243185345885,"d":"1915"},{"$nulls":3},0,1893,12,510,{"v":959.31,"d":"959"},{"v":1676.120959436487,"d":"1676"},{"$nulls":6},0,1898,14,586,{"v":1104.024,"d":"1104"},{"v":1888.8099673948523,"d":"1889"},{"$nulls":7},"AurC","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"CSPAMRRLTVDDFEIG","Corresponds to amino acid residues S32 to G46; Pre-kinase catalytic domain.",{"$nulls":3},"Q9UQB9","Q9UQB9","Q9UQB9"]
[217,107,"PK532","AurKC (Aurora C, AIK3)","S193","Aurora Kinase C (serine/threonine-protein kinase 13)",0,7175,16,743,{"v":5319.137,"d":"5319"},{"v":9346.505084545264,"d":"9347"},{"v":9437.949644886041,"d":"9438"},{"v":91.44456034077666,"d":"91"},{"v":0.9689028208613717,"d":"1"},0,7396,20,780,{"v":5753.28,"d":"5753"},{"v":10052.217941548355,"d":"10052"},{"v":9132.920693726996,"d":"9133"},{"v":919.2972478213596,"d":"919"},{"v":10.06575309969334,"d":"10"},{"v":11.034655920554712,"d":"11"},{"v":-3.231940862540256,"d":"-3"},null,0,7106,10,696,{"v":4938.816,"d":"4939"},{"v":8449.530886945551,"d":"8450"},{"v":7901.06935046859,"d":"7901"},{"v":548.4615364769616,"d":"548"},{"v":6.941611472432322,"d":"7"},{"v":7.910514293293693,"d":"8"},{"v":-16.28404846650365,"d":"-16"},null,null,"AurC","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"HTP(pS)LRR(bA)C","Corresponds to amino acid residues H190 to R196; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S193 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation of this site has not apparently been detected by mass spectrometry. ",null,"Protein-serine kinase, Other group, AUR family","Q9UQB9","Q9UQB9","Q9UQB9",null,"GO:0032133; GO:0000793; GO:0000780; GO:0005737; GO:0030496; GO:0005819; GO:0005876; GO:0051233; GO:0031616","GO:0005524; GO:0035174; GO:0004672; GO:0004712","GO:0008608; GO:0000910; GO:0016570; GO:0051321; GO:0051256; GO:0048599; GO:0032467; GO:0006468; GO:0007283"]
[218,107,"PK532","AurKC (Aurora C, AIK3)","S193","Aurora Kinase C (serine/threonine-protein kinase 13)",0,7274,14,747,{"v":5423.22,"d":"5423"},{"v":9529.39420522682,"d":"9529"},{"$nulls":3},0,6782,18,695,{"v":4700.98,"d":"4701"},{"v":8213.623445905638,"d":"8214"},{"$nulls":6},0,6438,14,669,{"v":4297.656,"d":"4298"},{"v":7352.607813991627,"d":"7353"},{"$nulls":7},"AurC","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"HTP(pS)LRR(bA)C","Corresponds to amino acid residues H190 to R196; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S193 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation of this site has not apparently been detected by mass spectrometry. ",null,null,"Q9UQB9","Q9UQB9","Q9UQB9"]
[219,108,"NK010-2","Axl (UFO)","Pan-specific","AXL oncogene-encoded protein-tyrosine kinase UFO",0,4452,10,653,{"v":2900.626,"d":"2901"},{"v":5096.82598086197,"d":"5097"},{"v":4934.267049801059,"d":"4934"},{"v":162.55893106091025,"d":"163"},{"v":3.2944899297143704,"d":"3"},0,4212,14,609,{"v":2556.582,"d":"2557"},{"v":4466.898786333983,"d":"4467"},{"v":4587.821799209529,"d":"4588"},{"v":120.92301287554619,"d":"121"},{"v":2.63573909728536,"d":"3"},{"v":5.93022902699973,"d":"6"},{"v":-7.021209981034531,"d":"-7"},null,0,4570,12,615,{"v":2803.17,"d":"2803"},{"v":4795.779291303657,"d":"4796"},{"v":4523.478352166012,"d":"4523"},{"v":272.3009391376454,"d":"272"},{"v":6.019724599925573,"d":"6"},{"v":9.314214529639944,"d":"9"},{"v":-8.325222236433461,"d":"-8"},null,null,"AXL","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Axl",{"$nulls":6},"CSFTELREDLENTLKAL","Corresponds to amino acid residues S795 to L810; After catalytic domain in a region not as conserved with Tyro3 and MERTK.",null,null,"Receptor tyrosine kinase; EC 2.7.10.1; TK group; Axl family","P30530","P30530","P30530","P30530","GO:0009986; GO:0070062; GO:0005615; GO:0044228; GO:0005887; GO:0005622; GO:0005886","GO:0005524; GO:0032036; GO:0043548; GO:0001786; GO:0046982; GO:0004713; GO:0004714; GO:0001618","GO:0031100; GO:0043277; GO:0001974; GO:0048469; GO:0031668; GO:0070301; GO:0035457; GO:0071222; GO:0097028; GO:0034101; GO:0021885; GO:0006954; GO:0045087; GO:0001779; GO:2000669; GO:0032689; GO:0051250; GO:0043524; GO:0032720; GO:0001764; GO:0097350; GO:0042698; GO:0006909; GO:0030168; GO:0001961; GO:0032825; GO:0048549; GO:0051897; GO:0043491; GO:0032940; GO:0007165; GO:0007283; GO:0034446; GO:0060068; GO:0048010; GO:0046718"]
[220,108,"NK010-2","Axl (UFO)","Pan-specific","AXL oncogene-encoded protein-tyrosine kinase UFO",0,4540,14,600,{"v":2715.6,"d":"2716"},{"v":4771.708118740148,"d":"4772"},{"$nulls":3},0,4391,16,616,2695,{"v":4708.744812085075,"d":"4709"},{"$nulls":6},0,4341,12,574,{"v":2484.846,"d":"2485"},{"v":4251.177413028367,"d":"4251"},{"$nulls":7},"AXL","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Axl",{"$nulls":6},"CSFTELREDLENTLKAL","Corresponds to amino acid residues S795 to L810; After catalytic domain in a region not as conserved with Tyro3 and MERTK.",{"$nulls":3},"P30530","P30530","P30530","P30530"]
[221,109,"NK010-3","Axl (UFO)","Pan-specific","AXL oncogene-encoded protein-tyrosine kinase UFO",0,1686,14,594,{"v":993.168,"d":"993"},{"v":1745.1420713186465,"d":"1745"},{"v":1939.491304075037,"d":"1939"},{"v":194.34923275639062,"d":"194"},{"v":10.02062924170097,"d":"10"},0,1506,14,560,{"v":835.52,"d":"836"},{"v":1459.8331968064272,"d":"1460"},{"v":1641.1382178307108,"d":"1641"},{"v":181.30502102428363,"d":"181"},{"v":11.047516842544573,"d":"11"},{"v":21.06814608424554,"d":"21"},{"v":-15.383058723566378,"d":"-15"},null,0,2301,12,540,{"v":1236.06,"d":"1236"},{"v":2114.7026226767543,"d":"2115"},{"v":2294.920945064136,"d":"2295"},{"v":180.2183223873817,"d":"180"},{"v":7.852920719338555,"d":"8"},{"v":17.873549961039526,"d":"18"},{"v":18.325920835133985,"d":"18"},null,null,"AXL","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Axl",{"$nulls":6},"RKSYSRRTTEATLNSLGC","Corresponds to amino acid residues R501 to G517; Before catalytic domain.",null,null,"Receptor tyrosine kinase; EC 2.7.10.1; TK group; Axl family","P30530","P30530","P30530","P30530","GO:0009986; GO:0070062; GO:0005615; GO:0044228; GO:0005887; GO:0005622; GO:0005886","GO:0005524; GO:0032036; GO:0043548; GO:0001786; GO:0046982; GO:0004713; GO:0004714; GO:0001618","GO:0031100; GO:0043277; GO:0001974; GO:0048469; GO:0031668; GO:0070301; GO:0035457; GO:0071222; GO:0097028; GO:0034101; GO:0021885; GO:0006954; GO:0045087; GO:0001779; GO:2000669; GO:0032689; GO:0051250; GO:0043524; GO:0032720; GO:0001764; GO:0097350; GO:0042698; GO:0006909; GO:0030168; GO:0001961; GO:0032825; GO:0048549; GO:0051897; GO:0043491; GO:0032940; GO:0007165; GO:0007283; GO:0034446; GO:0060068; GO:0048010; GO:0046718"]
[222,109,"NK010-3","Axl (UFO)","Pan-specific","AXL oncogene-encoded protein-tyrosine kinase UFO",0,2115,14,578,{"v":1214.378,"d":"1214"},{"v":2133.8405368314275,"d":"2134"},{"$nulls":3},0,1888,12,556,{"v":1043.056,"d":"1043"},{"v":1822.4432388549942,"d":"1822"},{"$nulls":6},0,2353,12,618,{"v":1446.738,"d":"1447"},{"v":2475.1392674515178,"d":"2475"},{"$nulls":7},"AXL","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Axl",{"$nulls":6},"RKSYSRRTTEATLNSLGC","Corresponds to amino acid residues R501 to G517; Before catalytic domain.",{"$nulls":3},"P30530","P30530","P30530","P30530"]
[223,110,"PK533","Axl (UFO)","Y702+Y703","AXL oncogene-encoded protein-tyrosine kinase UFO",0,4954,18,758,{"v":3741.488,"d":"3741"},{"v":6574.344036591855,"d":"6574"},{"v":6493.52582212237,"d":"6494"},{"v":80.8182144694847,"d":"81"},{"v":1.2445967981547157,"d":"1"},0,5992,18,898,{"v":5364.652,"d":"5365"},{"v":9373.201214709396,"d":"9373"},{"v":7975.4273525895915,"d":"7975"},{"v":1397.773862119804,"d":"1398"},{"v":17.52600582169371,"d":"18"},{"v":18.770602619848425,"d":"19"},{"v":22.821215639408535,"d":"23"},null,0,5532,12,739,{"v":4079.28,"d":"4079"},{"v":6979.0011121085,"d":"6979"},{"v":6389.842080373835,"d":"6390"},{"v":589.1590317346645,"d":"589"},{"v":9.220244011103885,"d":"9"},{"v":10.4648408092586,"d":"10"},{"v":-1.5967248701052625,"d":"-2"},null,null,"AXL","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Axl",{"$nulls":6},"NGD(pY)(pY)RQG(bA)C","Corresponds to amino acid residues N699 to G706; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y702 and Y703 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are the two major in vivo phosphorylation sites in Axl (≥754 and ≥358 reports, respectively, by mass spectrometry).",null,"Receptor tyrosine kinase; EC 2.7.10.1; TK group; Axl family","P30530","P30530","P30530","P30530","GO:0009986; GO:0070062; GO:0005615; GO:0044228; GO:0005887; GO:0005622; GO:0005886","GO:0005524; GO:0032036; GO:0043548; GO:0001786; GO:0046982; GO:0004713; GO:0004714; GO:0001618","GO:0031100; GO:0043277; GO:0001974; GO:0048469; GO:0031668; GO:0070301; GO:0035457; GO:0071222; GO:0097028; GO:0034101; GO:0021885; GO:0006954; GO:0045087; GO:0001779; GO:2000669; GO:0032689; GO:0051250; GO:0043524; GO:0032720; GO:0001764; GO:0097350; GO:0042698; GO:0006909; GO:0030168; GO:0001961; GO:0032825; GO:0048549; GO:0051897; GO:0043491; GO:0032940; GO:0007165; GO:0007283; GO:0034446; GO:0060068; GO:0048010; GO:0046718"]
[224,110,"PK533","Axl (UFO)","Y702+Y703","AXL oncogene-encoded protein-tyrosine kinase UFO",0,4880,14,750,{"v":3649.5,"d":"3650"},{"v":6412.707607652885,"d":"6413"},{"$nulls":3},0,5166,16,731,{"v":3764.65,"d":"3765"},{"v":6577.653490469787,"d":"6578"},{"$nulls":6},0,4776,14,712,{"v":3390.544,"d":"3391"},{"v":5800.683048639171,"d":"5801"},{"$nulls":7},"AXL","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Axl",{"$nulls":6},"NGD(pY)(pY)RQG(bA)C","Corresponds to amino acid residues N699 to G706; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y702 and Y703 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are the two major in vivo phosphorylation sites in Axl (≥754 and ≥358 reports, respectively, by mass spectrometry).",null,null,"P30530","P30530","P30530","P30530"]
[225,111,"PN573","B-Myb (MYBL2)","T487","Myb-related protein B",0,8360,12,710,{"v":5927.08,"d":"5927"},{"v":10414.750241722772,"d":"10415"},{"v":9529.55586274152,"d":"9530"},{"v":885.1943789812522,"d":"885"},{"v":9.288936354758869,"d":"9"},0,10305,18,715,{"v":7355.205,"d":"7355"},{"v":12851.125560509165,"d":"12851"},{"v":11670.688663713172,"d":"11671"},{"v":1180.4368967959927,"d":"1180"},{"v":10.114543629856563,"d":"10"},{"v":19.40347998461543,"d":"19"},{"v":22.46833778836445,"d":"22"},null,0,8812,14,680,{"v":5982.64,"d":"5983"},{"v":10235.348201973093,"d":"10235"},{"v":9722.189877815057,"d":"9722"},{"v":513.1583241580356,"d":"513"},{"v":5.278217465480747,"d":"5"},{"v":14.567153820239616,"d":"15"},{"v":2.0214374924511844,"d":"2"},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"VVVT(pT)PLHR(bA)C","Corresponds to amino acid residues V483 to R491.","T487 phosphorylation stimulates transcriptional activity. This is one of the major in vivo phosphorylation sites in B-Myb (≥42 reports from high throughput mass spectrometry studies).","CDK2","Transcription protein","P10244","P10244",null,null,"GO:0031523; GO:0005654; GO:0005634","GO:0003700; GO:0000978; GO:0000981; GO:0001135; GO:0001077","GO:0030154; GO:1990830; GO:0090307; GO:0043525; GO:0045944; GO:0051726; GO:0006357"]
[226,111,"PN573","B-Myb (MYBL2)","T487","Myb-related protein B",0,7242,18,681,{"v":4919.544,"d":"4920"},{"v":8644.361483760269,"d":"8644"},{"$nulls":3},0,9004,16,668,{"v":6003.984,"d":"6004"},{"v":10490.251766917178,"d":"10490"},{"$nulls":6},0,7193,16,750,{"v":5382.75,"d":"5383"},{"v":9209.031553657023,"d":"9209"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"VVVT(pT)PLHR(bA)C","Corresponds to amino acid residues V483 to R491.","T487 phosphorylation stimulates transcriptional activity. This is one of the major in vivo phosphorylation sites in B-Myb (≥42 reports from high throughput mass spectrometry studies).","CDK2",null,"P10244","P10244"]
[227,112,"PN206","B-Myb (MYBL2)","T487","Myb-related protein B",0,606,10,579,{"v":345.084,"d":"345"},{"v":606.3632804711024,"d":"606"},{"v":523.3591752593454,"d":"523"},{"v":83.00410521175695,"d":"83"},{"v":15.859873894562963,"d":"16"},0,450,16,528,{"v":229.152,"d":"229"},{"v":400.3778445932909,"d":"400"},{"v":441.81829336992683,"d":"442"},{"v":41.44044877663595,"d":"41"},{"v":9.379523075097882,"d":"9"},{"v":25.239396969660845,"d":"25"},{"v":-15.580290887039823,"d":"-16"},null,0,592,10,560,{"v":325.92,"d":"326"},{"v":557.5974295607074,"d":"558"},{"v":469.9937955994407,"d":"470"},{"v":87.60363396126667,"d":"88"},{"v":18.639317110459938,"d":"19"},{"v":34.4991910050229,"d":"34"},{"v":-10.196702796594721,"d":"-10"},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against amino acid residues that encompass the T490 phosphosite of mouse B-Myb, which corresponds to human B-Myb T487.","T487 phosphorylation stimulates transcriptional activity. This is one of the major in vivo phosphorylation sites in B-Myb (≥42 reports from high throughput mass spectrometry studies).","CDK2","Transcription protein","P10244","P10244",null,null,"GO:0031523; GO:0005654; GO:0005634","GO:0003700; GO:0000978; GO:0000981; GO:0001135; GO:0001077","GO:0030154; GO:1990830; GO:0090307; GO:0043525; GO:0045944; GO:0051726; GO:0006357"]
[228,112,"PN206","B-Myb (MYBL2)","T487","Myb-related protein B",0,464,10,552,{"v":250.608,"d":"251"},{"v":440.35507004758847,"d":"440"},{"$nulls":3},0,478,10,591,{"v":276.588,"d":"277"},{"v":483.2587421465628,"d":"483"},{"$nulls":6},0,446,12,515,{"v":223.51,"d":"224"},{"v":382.39016163817405,"d":"382"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against amino acid residues that encompass the T490 phosphosite of mouse B-Myb, which corresponds to human B-Myb T487.","T487 phosphorylation stimulates transcriptional activity. This is one of the major in vivo phosphorylation sites in B-Myb (≥42 reports from high throughput mass spectrometry studies).","CDK2",null,"P10244","P10244"]
[229,113,"NN177-2","B23 (NPM)","Pan-specific","B23 (nucleophosmin, numatrin, nucleolar protein NO38)",0,126,12,494,{"v":56.316,"d":"56"},{"v":98.955484760263,"d":"99"},{"v":96.44627898858789,"d":"96"},{"v":2.509205771675113,"d":"3"},{"v":2.6016615653694815,"d":"3"},0,135,12,571,{"v":70.233,"d":"70"},{"v":122.71216118262377,"d":"123"},{"v":100.57756613553666,"d":"101"},{"v":22.134595047087117,"d":"22"},{"v":22.007487253428767,"d":"22"},{"v":24.60914881879825,"d":"25"},{"v":4.283511183917838,"d":"4"},null,0,132,12,492,{"v":59.04,"d":"59"},{"v":101.00807634163033,"d":"101"},{"v":104.90109595063066,"d":"105"},{"v":3.8930196090003335,"d":"4"},{"v":3.7111334002006,"d":"4"},{"v":6.312794965570081,"d":"6"},{"v":8.76634853174916,"d":"9"},{"$nulls":15},"Not precisely defined.","Antibody raised against amino acid residues 253-294 at the C-terminus of human B23. ",null,null,"RNA binding protein","P06748","P06748",null,"P06748","GO:0005813; GO:0005737; GO:0005829; GO:0005925; GO:0016020; GO:0005730; GO:0005654; GO:0005634; GO:0032991; GO:0032993; GO:1990904; GO:0031616","GO:0033613; GO:0001047; GO:0042393; GO:0051059; GO:0046982; GO:0042803; GO:0019901; GO:0004860; GO:0043023; GO:0043024; GO:0003723; GO:0030957; GO:0003713; GO:0008134; GO:0051082","GO:0007569; GO:0034644; GO:0034080; GO:0007098; GO:0006281; GO:0006886; GO:0043066; GO:0008285; GO:0010826; GO:0044387; GO:0006913; GO:0006334; GO:1902751; GO:0008284; GO:0051092; GO:0045893; GO:0045944; GO:0045727; GO:0051259; GO:0008104; GO:0046599; GO:0060735; GO:0032071; GO:0060699; GO:1902629; GO:0006357; GO:0042255; GO:0007165; GO:0016032"]
[230,113,"NN177-2","B23 (NPM)","Pan-specific","B23 (nucleophosmin, numatrin, nucleolar protein NO38)",0,122,14,495,{"v":53.46,"d":"53"},{"v":93.93707321691278,"d":"94"},{"$nulls":3},0,102,10,488,{"v":44.896,"d":"45"},{"v":78.44297108844954,"d":"78"},{"$nulls":6},0,135,12,517,{"v":63.591,"d":"64"},{"v":108.79411555963101,"d":"109"},{"$nulls":20},"Not precisely defined.","Antibody raised against amino acid residues 253-294 at the C-terminus of human B23. ",{"$nulls":3},"P06748","P06748",null,"P06748"]
[231,114,"PN009","B23 (NPM)","T234+T237","B23 (nucleophosmin, numatrin, nucleolar protein NO38)",0,14,2,731,{"v":8.772,"d":"9"},{"v":15.413692597432828,"d":"15"},{"v":15.044691748657076,"d":"15"},{"v":0.3690008487757517,"d":"0"},{"v":2.452697967764541,"d":"2"},0,18,2,735,{"v":11.76,"d":"12"},{"v":20.547250089098508,"d":"21"},{"v":19.678884162713988,"d":"20"},{"v":0.86836592638452,"d":"1"},{"v":4.412678682411434,"d":"4"},{"v":6.865376650175975,"d":"7"},{"v":30.802840573124882,"d":"31"},null,0,14,2,735,{"v":8.82,"d":"9"},{"v":15.089621160792337,"d":"15"},{"v":12.444660354150052,"d":"12"},{"v":2.6449608066422847,"d":"3"},{"v":21.253780588397028,"d":"21"},{"v":23.70647855616157,"d":"24"},{"v":-17.282051622886257,"d":"-17"},{"$nulls":15},"Not precisely defined.","Antibody raised against amino acid residues that encompass the T234 and T237 phosphosites.","T234 and T237 phosphorylation induces interaction with ROCK2 and inhibits interaction with RNA. These are two of the major in vivo phosphorylation sites in B23 (≥33 and ≥42 reports, respectively, by mass spectrometry).","T234: CDK1; CDK2. T237: CDK1.","RNA binding protein","P06748","P06748",null,"P06748","GO:0005813; GO:0005737; GO:0005829; GO:0005925; GO:0016020; GO:0005730; GO:0005654; GO:0005634; GO:0032991; GO:0032993; GO:1990904; GO:0031616","GO:0033613; GO:0001047; GO:0042393; GO:0051059; GO:0046982; GO:0042803; GO:0019901; GO:0004860; GO:0043023; GO:0043024; GO:0003723; GO:0030957; GO:0003713; GO:0008134; GO:0051082","GO:0007569; GO:0034644; GO:0034080; GO:0007098; GO:0006281; GO:0006886; GO:0043066; GO:0008285; GO:0010826; GO:0044387; GO:0006913; GO:0006334; GO:1902751; GO:0008284; GO:0051092; GO:0045893; GO:0045944; GO:0045727; GO:0051259; GO:0008104; GO:0046599; GO:0060735; GO:0032071; GO:0060699; GO:1902629; GO:0006357; GO:0042255; GO:0007165; GO:0016032"]
[232,114,"PN009","B23 (NPM)","T234+T237","B23 (nucleophosmin, numatrin, nucleolar protein NO38)",0,14,2,696,{"v":8.352,"d":"8"},{"v":14.675690899881324,"d":"15"},{"$nulls":3},0,16,2,769,{"v":10.766,"d":"11"},{"v":18.810518236329468,"d":"19"},{"$nulls":6},0,10,2,716,{"v":5.728,"d":"6"},{"v":9.799699547507768,"d":"10"},{"$nulls":20},"Not precisely defined.","Antibody raised against amino acid residues that encompass the T234 and T237 phosphosites.","T234 and T237 phosphorylation induces interaction with ROCK2 and inhibits interaction with RNA. These are two of the major in vivo phosphorylation sites in B23 (≥33 and ≥42 reports, respectively, by mass spectrometry).","T234: CDK1; CDK2. T237: CDK1.",null,"P06748","P06748",null,"P06748"]
[233,115,"PN207","Bad","S75","Bcl2 antagonist of cell death",0,370,14,510,{"v":181.56,"d":"182"},{"v":319.0275909701213,"d":"319"},{"v":265.41352478990353,"d":"265"},{"v":53.614066180217776,"d":"54"},{"v":20.200201260526452,"d":"20"},0,320,10,477,{"v":147.87,"d":"148"},{"v":258.36070328869016,"d":"258"},{"v":216.59527249533892,"d":"217"},{"v":41.76543079335124,"d":"42"},{"v":19.282706548569763,"d":"19"},{"v":39.48290780909622,"d":"39"},{"v":-18.39327981993692,"d":"-18"},null,0,362,10,501,{"v":176.352,"d":"176"},{"v":301.71030282857714,"d":"302"},{"v":303.17649390962015,"d":"303"},{"v":1.4661910810430072,"d":"1"},{"v":0.48360974894052733,"d":"0"},{"v":20.68381100946698,"d":"21"},{"v":14.227974685769723,"d":"14"},{"$nulls":5},"Apoptosis protein",{"$nulls":9},"Not precisely defined.","Antibody raised against amino acid residues that encompass the mouse S112 phosphosite, which corresponds to the human Bad S75 phosphosite.","S75 phosphorylation Inhibits interaction with Bcl-2 and Bcl-xL, and induces interaction with 14-3-3-beta. This is one of the major sites of Bad phosphorylation by mass spectrometry (≥192 reports).","Akt1; Akt3; JNK1; MSK1; PAK1; PAK5 (PAK7); Pim1; Pim2; Pim3; PKACa, PKCi (PRKCl); Raf1; RSK1; RSK2; RSK3","Apoptosis protein, Bcl family","Q92934","Q92934",null,"Q92934","GO:0005829; GO:0005741; GO:0005739","GO:0071889; GO:0008656; GO:0008289; GO:0005543; GO:0046982; GO:0043422; GO:0019901; GO:0030346","GO:0097202; GO:0006919; GO:0046031; GO:0006915; GO:0046034; GO:0060154; GO:0071247; GO:0071456; GO:0071396; GO:0071260; GO:0071316; GO:0021987; GO:0019221; GO:0097191; GO:0097192; GO:0008625; GO:0006007; GO:0042593; GO:0097193; GO:0008630; GO:0046931; GO:0043065; GO:0060139; GO:0010508; GO:0045579; GO:0043280; GO:0050679; GO:0033133; GO:0032024; GO:0035774; GO:2001244; GO:1902220; GO:0010918; GO:1901216; GO:1900740; GO:0045862; GO:0090200; GO:0045582; GO:2000078; GO:0001844; GO:0046902; GO:0001836; GO:0043200; GO:0051592; GO:0032355; GO:0045471; GO:0051384; GO:0009749; GO:0042542; GO:0034201; GO:0032570; GO:0033574; GO:0007283; GO:0019050; GO:0044342"]
[234,115,"PN207","Bad","S75","Bcl2 antagonist of cell death",0,254,10,494,{"v":120.536,"d":"121"},{"v":211.79945860968573,"d":"212"},{"$nulls":3},0,171,18,654,{"v":100.062,"d":"100"},{"v":174.82984170198765,"d":"175"},{"$nulls":6},0,332,10,553,{"v":178.066,"d":"178"},{"v":304.6426849906631,"d":"305"},{"$nulls":10},"Apoptosis protein",{"$nulls":9},"Not precisely defined.","Antibody raised against amino acid residues that encompass the mouse S112 phosphosite, which corresponds to the human Bad S75 phosphosite.","S75 phosphorylation Inhibits interaction with Bcl-2 and Bcl-xL, and induces interaction with 14-3-3-beta. This is one of the major sites of Bad phosphorylation by mass spectrometry (≥192 reports).","Akt1; Akt3; JNK1; MSK1; PAK1; PAK5 (PAK7); Pim1; Pim2; Pim3; PKACa, PKCi (PRKCl); Raf1; RSK1; RSK2; RSK3",null,"Q92934","Q92934",null,"Q92934"]
[235,116,"PN208","Bad","S99","Bcl2 antagonist of cell death",0,192,10,491,{"v":89.362,"d":"89"},{"v":157.02216118237484,"d":"157"},{"v":161.3904283731202,"d":"161"},{"v":4.3682671907453425,"d":"4"},{"v":2.7066457625642464,"d":"3"},0,198,8,500,95,{"v":165.98543864492842,"d":"166"},{"v":156.40720522754424,"d":"156"},{"v":9.578233417384183,"d":"10"},{"v":6.123908040840947,"d":"6"},{"v":8.830553803405193,"d":"9"},{"v":-3.087681962188725,"d":"-3"},null,0,186,12,459,{"v":79.866,"d":"80"},{"v":136.63805936823593,"d":"137"},{"v":139.74323651186836,"d":"140"},{"v":3.1051771436324316,"d":"3"},{"v":2.222058985565795,"d":"2"},{"v":4.928704748130041,"d":"5"},{"v":-13.41293413708864,"d":"-13"},{"$nulls":5},"Apoptosis protein",{"$nulls":9},"Not precisely defined.","Antibody raised against amino acid residues that encompass the mouse S136 phosphosite, which corresponds to the human Bad S99 phosphosite.","S99 phosphorylation Inhibits interaction with Bcl-2 and Bcl-xL, and induces interaction with 14-3-3-beta and 14-3-3 zeta. This is one of the major sites of Bad phosphorylation by mass spectrometry (≥263 reports).","Akt1; Akt3; A-Raf; B-Raf; p70 S6K; PAK1; Pim1; Pim2; Pim3; PKACa; PKCe; PKCi; PKCt (PKCq); PKD1 (PRKD1); RSK1; RSK2","Apoptosis protein, Bcl family","Q92934","Q92934",null,"Q92934","GO:0005829; GO:0005741; GO:0005739","GO:0071889; GO:0008656; GO:0008289; GO:0005543; GO:0046982; GO:0043422; GO:0019901; GO:0030346","GO:0097202; GO:0006919; GO:0046031; GO:0006915; GO:0046034; GO:0060154; GO:0071247; GO:0071456; GO:0071396; GO:0071260; GO:0071316; GO:0021987; GO:0019221; GO:0097191; GO:0097192; GO:0008625; GO:0006007; GO:0042593; GO:0097193; GO:0008630; GO:0046931; GO:0043065; GO:0060139; GO:0010508; GO:0045579; GO:0043280; GO:0050679; GO:0033133; GO:0032024; GO:0035774; GO:2001244; GO:1902220; GO:0010918; GO:1901216; GO:1900740; GO:0045862; GO:0090200; GO:0045582; GO:2000078; GO:0001844; GO:0046902; GO:0001836; GO:0043200; GO:0051592; GO:0032355; GO:0045471; GO:0051384; GO:0009749; GO:0042542; GO:0034201; GO:0032570; GO:0033574; GO:0007283; GO:0019050; GO:0044342"]
[236,116,"PN208","Bad","S99","Bcl2 antagonist of cell death",0,212,10,467,{"v":94.334,"d":"94"},{"v":165.75869556386553,"d":"166"},{"$nulls":3},0,198,10,447,{"v":84.036,"d":"84"},{"v":146.82897181016006,"d":"147"},{"$nulls":6},0,210,14,426,{"v":83.496,"d":"83"},{"v":142.8484136555008,"d":"143"},{"$nulls":10},"Apoptosis protein",{"$nulls":9},"Not precisely defined.","Antibody raised against amino acid residues that encompass the mouse S136 phosphosite, which corresponds to the human Bad S99 phosphosite.","S99 phosphorylation Inhibits interaction with Bcl-2 and Bcl-xL, and induces interaction with 14-3-3-beta and 14-3-3 zeta. This is one of the major sites of Bad phosphorylation by mass spectrometry (≥263 reports).","Akt1; Akt3; A-Raf; B-Raf; p70 S6K; PAK1; Pim1; Pim2; Pim3; PKACa; PKCe; PKCi; PKCt (PKCq); PKD1 (PRKD1); RSK1; RSK2",null,"Q92934","Q92934",null,"Q92934"]
[237,119,"NK257-1","BCKD (BCKDK)","Pan-specific","[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial",0,3970,10,750,2970,{"v":5218.726289828488,"d":"5219"},{"v":5111.9971871873495,"d":"5112"},{"v":106.72910264113852,"d":"107"},{"v":2.0878161456865256,"d":"2"},0,4240,18,864,{"v":3647.808,"d":"3648"},{"v":6373.505378657674,"d":"6374"},{"v":5660.458142466216,"d":"5660"},{"v":713.0472361914581,"d":"713"},{"v":12.596988057238582,"d":"13"},{"v":14.684804202925108,"d":"15"},{"v":10.72889782986428,"d":"11"},null,0,4172,8,679,{"v":2827.356,"d":"2827"},{"v":4837.157701439136,"d":"4837"},{"v":4520.971114092186,"d":"4521"},{"v":316.18658734694964,"d":"316"},{"v":6.993775880614979,"d":"7"},{"v":9.081592026301504,"d":"9"},{"v":-11.561549262517275,"d":"-12"},null,null,"BCKDK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PDHK",{"$nulls":6},"CQSAIDAAAEKPSVRL","Corresponds to amino acid residues Q56 to L70.",null,null,"Protein-serine kinase, Atypical group, PDHK family","O14874","O14874","O14874",null,"GO:0005947; GO:0005759; GO:0005739","GO:0047323; GO:0005524; GO:0016301; GO:0004674","GO:0009083; GO:0009063; GO:0016310"]
[238,119,"NK257-1","BCKD (BCKDK)","Pan-specific","[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial",0,4024,12,710,{"v":2848.52,"d":"2849"},{"v":5005.26808454621,"d":"5005"},{"$nulls":3},0,4100,14,693,{"v":2831.598,"d":"2832"},{"v":4947.4109062747575,"d":"4947"},{"$nulls":6},0,3621,12,681,{"v":2457.729,"d":"2458"},{"v":4204.784526745237,"d":"4205"},{"$nulls":7},"BCKDK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PDHK",{"$nulls":6},"CQSAIDAAAEKPSVRL","Corresponds to amino acid residues Q56 to L70.",{"$nulls":3},"O14874","O14874","O14874"]
[239,120,"NK257-2","BCKD (BCKDK)","Pan-specific","[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial",0,1262,16,625,{"v":778.75,"d":"779"},{"v":1368.3781475434125,"d":"1368"},{"v":1340.942055863486,"d":"1341"},{"v":27.43609167992645,"d":"27"},{"v":2.046031113720216,"d":"2"},0,1247,18,642,{"v":789.018,"d":"789"},{"v":1378.5841981973067,"d":"1379"},{"v":1416.2925954271473,"d":"1416"},{"v":37.70839722984056,"d":"38"},{"v":2.6624722427831293,"d":"3"},{"v":4.708503356503345,"d":"5"},{"v":5.619224129348368,"d":"6"},null,0,1326,14,577,{"v":757.024,"d":"757"},{"v":1295.1480010915711,"d":"1295"},{"v":1183.1888289392568,"d":"1183"},{"v":111.9591721523143,"d":"112"},{"v":9.462494017348613,"d":"9"},{"v":11.50852513106883,"d":"12"},{"v":-11.764358216257577,"d":"-12"},null,null,"BCKDK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PDHK",{"$nulls":6},"CILHVHELYIRAFQKL","Corresponds to amino acid residues I122 to L136.",null,null,"Protein-serine kinase, Atypical group, PDHK family","O14874","O14874","O14874",null,"GO:0005947; GO:0005759; GO:0005739","GO:0047323; GO:0005524; GO:0016301; GO:0004674","GO:0009083; GO:0009063; GO:0016310"]
[240,120,"NK257-2","BCKD (BCKDK)","Pan-specific","[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial",0,1153,10,654,{"v":747.522,"d":"748"},{"v":1313.5059641835594,"d":"1314"},{"$nulls":3},0,1236,14,681,{"v":832.182,"d":"832"},{"v":1454.0009926569876,"d":"1454"},{"$nulls":6},0,1086,12,583,{"v":626.142,"d":"626"},{"v":1071.2296567869428,"d":"1071"},{"$nulls":7},"BCKDK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PDHK",{"$nulls":6},"CILHVHELYIRAFQKL","Corresponds to amino acid residues I122 to L136.",{"$nulls":3},"O14874","O14874","O14874"]
[241,121,"PN574","BCLAF1","S512","Bcl-2-associated transcription factor 1",0,8252,18,784,{"v":6455.456,"d":"6455"},{"v":11343.184491592947,"d":"11343"},{"v":11031.959511427533,"d":"11032"},{"v":311.2249801654143,"d":"311"},{"v":2.821121486559389,"d":"3"},0,8348,16,783,{"v":6523.956,"d":"6524"},{"v":11398.754719581186,"d":"11399"},{"v":11072.153034427705,"d":"11072"},{"v":326.6016851534805,"d":"327"},{"v":2.949757686133371,"d":"3"},{"v":5.77087917269276,"d":"6"},{"v":0.36433711489367226,"d":"0"},null,0,8020,12,797,{"v":6382.376,"d":"6382"},{"v":10919.23310042326,"d":"10919"},{"v":9949.103905413625,"d":"9949"},{"v":970.1291950096347,"d":"970"},{"v":9.750920326420115,"d":"10"},{"v":12.572041812979503,"d":"13"},{"v":-9.815623461019996,"d":"-10"},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"LFDY(pS)PPL(bA)C","Corresponds to amino acid residues L508 to L515.","The effect of S512 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in BCLAF1 (≥135 reports from high throughput mass spectrometry studies).","PRP4 (PRPF4B)","Transcription protein","Q9NYF8","Q9NYF8",null,null,"GO:0005737; GO:0016607; GO:0005654; GO:0005634","GO:0003677; GO:0003723","GO:0006915; GO:1990830; GO:0045892; GO:0043065; GO:2000144; GO:2001244; GO:2001022; GO:0043620; GO:0006351"]
[242,121,"PN574","BCLAF1","S512","Bcl-2-associated transcription factor 1",0,7631,14,801,{"v":6101.217,"d":"6101"},{"v":10720.73453126212,"d":"10721"},{"$nulls":3},0,8093,22,762,{"v":6150.102,"d":"6150"},{"v":10745.551349274227,"d":"10746"},{"$nulls":6},0,7344,14,716,{"v":5248.28,"d":"5248"},{"v":8978.97471040399,"d":"8979"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"LFDY(pS)PPL(bA)C","Corresponds to amino acid residues L508 to L515.","The effect of S512 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in BCLAF1 (≥135 reports from high throughput mass spectrometry studies).","PRP4 (PRPF4B)",null,"Q9NYF8","Q9NYF8"]
[243,122,"NK362-1","Bcr","Pan-specific","Breakpoint cluster region protein",0,390,8,547,{"v":208.954,"d":"209"},{"v":367.16287311946866,"d":"367"},{"v":363.8234154380481,"d":"364"},{"v":3.3394576814205834,"d":"3"},{"v":0.9178787125066794,"d":"1"},0,530,16,653,{"v":335.642,"d":"336"},{"v":586.4387852385375,"d":"586"},{"v":455.8676503398623,"d":"456"},{"v":130.57113489867527,"d":"131"},{"v":28.6423339759535,"d":"29"},{"v":29.560212688460176,"d":"30"},{"v":25.299150905664433,"d":"25"},null,0,534,10,519,{"v":271.956,"d":"272"},{"v":465.2735841728391,"d":"465"},{"v":432.2149957726134,"d":"432"},{"v":33.05858840022569,"d":"33"},{"v":7.648644476374828,"d":"8"},{"v":8.566523188881508,"d":"9"},{"v":18.798015034909454,"d":"19"},null,null,"BCR","X","PSTK","Protein kinase - Receptor-serine kinase","Protein-serine/threonine kinase","Atypical","BCR",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 1-300 (deletion 17-219) of human Bcr.",null,null,"EC 2.7.11.1; GTPase activating protein, Rac/Rho; Protein kinase, Ser/Thr (non-receptor); ATYPICAL group; BCR family","P11274","P11274","P11274","P11274","GO:0030054; GO:0005829; GO:0070062; GO:0098978; GO:0016020; GO:0014069; GO:0099092; GO:0045211; GO:0032991; GO:0098685","GO:0005524; GO:0005096; GO:0016301; GO:0004674; GO:0004713; GO:0005089","GO:0030036; GO:0007420; GO:0071222; GO:0060216; GO:0048872; GO:0042472; GO:0065002; GO:0035556; GO:0050804; GO:0060313; GO:0002692; GO:0050728; GO:0043314; GO:2000378; GO:0060268; GO:0050885; GO:0048008; GO:0043547; GO:0050766; GO:0046777; GO:0006468; GO:0051726; GO:0051171; GO:0035023; GO:0051056; GO:0043114; GO:0003014; GO:0007165"]
[244,122,"NK362-1","Bcr","Pan-specific","Breakpoint cluster region protein",0,376,9,559,{"v":205.153,"d":"205"},{"v":360.48395775662755,"d":"360"},{"$nulls":3},0,358,10,535,{"v":186.18,"d":"186"},{"v":325.29651544118707,"d":"325"},{"$nulls":6},0,470,8,505,{"v":233.31,"d":"233"},{"v":399.1564073723878,"d":"399"},{"$nulls":7},"BCR","X","PSTK","Protein kinase - Receptor-serine kinase","Protein-serine/threonine kinase","Atypical","BCR",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 1-300 (deletion 17-219) of human Bcr.",{"$nulls":3},"P11274","P11274","P11274","P11274"]
[245,123,"PK164","Bcr","Y177","Breakpoint cluster region protein",0,125,8,434,{"v":50.778,"d":"51"},{"v":89.22440523397675,"d":"89"},{"v":96.69403670133732,"d":"97"},{"v":7.469631467360571,"d":"7"},{"v":7.725017717930544,"d":"8"},0,468,14,327,{"v":148.458,"d":"148"},{"v":259.3880657931451,"d":"259"},{"v":178.26311945922222,"d":"178"},{"v":81.12494633392285,"d":"81"},{"v":45.508541856567376,"d":"46"},{"v":53.23355957449792,"d":"53"},{"v":84.35792479098845,"d":"84"},null,0,84,8,442,{"v":33.592,"d":"34"},{"v":57.470584357521105,"d":"57"},{"v":73.73042103690551,"d":"74"},{"v":16.259836679384406,"d":"16"},{"v":22.053090774085774,"d":"22"},{"v":29.77810849201632,"d":"30"},{"v":-23.748740302734944,"d":"-24"},null,null,"BCR","X","PSTK","Protein kinase - Receptor-serine kinase","Protein-serine/threonine kinase","Atypical","BCR",{"$nulls":6},"PF(pY)VN","Corresponds to amino acid residues P175 to N179.","Y177 phosphorylation stimulates phosphotransferase activity. Phosphorylation induces interaction with Gab2, Grb2 and SOS1, and inhibits interaction with Hck. This is the major site of phosphorylation of Bcr by mass spectrometry stydues (≥1018 reports).","Abl1; Bcr-Abl; Fes; Fyn; Hck; Lyn","EC 2.7.11.1; GTPase activating protein, Rac/Rho; Protein kinase, Ser/Thr (non-receptor); ATYPICAL group; BCR family","P11274","P11274","P11274","P11274","GO:0030054; GO:0005829; GO:0070062; GO:0098978; GO:0016020; GO:0014069; GO:0099092; GO:0045211; GO:0032991; GO:0098685","GO:0005524; GO:0005096; GO:0016301; GO:0004674; GO:0004713; GO:0005089","GO:0030036; GO:0007420; GO:0071222; GO:0060216; GO:0048872; GO:0042472; GO:0065002; GO:0035556; GO:0050804; GO:0060313; GO:0002692; GO:0050728; GO:0043314; GO:2000378; GO:0060268; GO:0050885; GO:0048008; GO:0043547; GO:0050766; GO:0046777; GO:0006468; GO:0051726; GO:0051171; GO:0035023; GO:0051056; GO:0043114; GO:0003014; GO:0007165"]
[246,123,"PK164","Bcr","Y177","Breakpoint cluster region protein",0,234,6,260,{"v":59.28,"d":"59"},{"v":104.1636681686979,"d":"104"},{"$nulls":3},0,256,10,226,{"v":55.596,"d":"56"},{"v":97.13817312529936,"d":"97"},{"$nulls":6},0,210,10,263,{"v":52.6,"d":"53"},{"v":89.9902577162899,"d":"90"},{"$nulls":7},"BCR","X","PSTK","Protein kinase - Receptor-serine kinase","Protein-serine/threonine kinase","Atypical","BCR",{"$nulls":6},"PF(pY)VN","Corresponds to amino acid residues P175 to N179.","Y177 phosphorylation stimulates phosphotransferase activity. Phosphorylation induces interaction with Gab2, Grb2 and SOS1, and inhibits interaction with Hck. This is the major site of phosphorylation of Bcr by mass spectrometry stydues (≥1018 reports).","Abl1; Bcr-Abl; Fes; Fyn; Hck; Lyn",null,"P11274","P11274","P11274","P11274"]
[247,124,"PK538","Bcr","Y177","Breakpoint cluster region protein",0,2503,10,854,{"v":2129.022,"d":"2129"},{"v":3741.0044050583256,"d":"3741"},{"v":3795.3617443767916,"d":"3795"},{"v":54.357339318466074,"d":"54"},{"v":1.4322044374031517,"d":"1"},0,4604,16,747,{"v":3427.236,"d":"3427"},{"v":5988.1186399967355,"d":"5988"},{"v":4436.063933479186,"d":"4436"},{"v":1552.0547065175497,"d":"1552"},{"v":34.98720329082994,"d":"35"},{"v":36.41940772823309,"d":"36"},{"v":16.88118899474229,"d":"17"},null,0,1404,10,850,{"v":1184.9,"d":"1185"},{"v":2027.1759765785534,"d":"2027"},{"v":3156.8565298460485,"d":"3157"},{"v":1129.680553267495,"d":"1130"},{"v":35.784982389509686,"d":"36"},{"v":37.21718682691284,"d":"37"},{"v":-16.823303219429675,"d":"-17"},null,null,"BCR","X","PSTK","Protein kinase - Receptor-serine kinase","Protein-serine/threonine kinase","Atypical","BCR",{"$nulls":6},"KPF(pY)VNV(bA)C","Corresponds to amino acid residues K174 to V180; In the N-terminal portion of the protein kinase.","Y177 phosphorylation stimulates phosphotransferase activity. Phosphorylation induces interaction with Gab2, Grb2 and SOS1, and inhibits interaction with Hck. This is the major site of phosphorylation of Bcr by mass spectrometry stydues (≥1018 reports).","Abl1; Bcr-Abl; Fes; Fyn; Hck; Lyn","EC 2.7.11.1; GTPase activating protein, Rac/Rho; Protein kinase, Ser/Thr (non-receptor); ATYPICAL group; BCR family","P11274","P11274","P11274","P11274","GO:0030054; GO:0005829; GO:0070062; GO:0098978; GO:0016020; GO:0014069; GO:0099092; GO:0045211; GO:0032991; GO:0098685","GO:0005524; GO:0005096; GO:0016301; GO:0004674; GO:0004713; GO:0005089","GO:0030036; GO:0007420; GO:0071222; GO:0060216; GO:0048872; GO:0042472; GO:0065002; GO:0035556; GO:0050804; GO:0060313; GO:0002692; GO:0050728; GO:0043314; GO:2000378; GO:0060268; GO:0050885; GO:0048008; GO:0043547; GO:0050766; GO:0046777; GO:0006468; GO:0051726; GO:0051171; GO:0035023; GO:0051056; GO:0043114; GO:0003014; GO:0007165"]
[248,124,"PK538","Bcr","Y177","Breakpoint cluster region protein",0,3448,14,638,{"v":2190.892,"d":"2191"},{"v":3849.7190836952573,"d":"3850"},{"$nulls":3},0,1842,10,901,{"v":1650.632,"d":"1651"},{"v":2884.0092269616366,"d":"2884"},{"$nulls":6},0,3752,18,671,{"v":2505.514,"d":"2506"},{"v":4286.537083113543,"d":"4287"},{"$nulls":7},"BCR","X","PSTK","Protein kinase - Receptor-serine kinase","Protein-serine/threonine kinase","Atypical","BCR",{"$nulls":6},"KPF(pY)VNV(bA)C","Corresponds to amino acid residues K174 to V180; In the N-terminal portion of the protein kinase.","Y177 phosphorylation stimulates phosphotransferase activity. Phosphorylation induces interaction with Gab2, Grb2 and SOS1, and inhibits interaction with Hck. This is the major site of phosphorylation of Bcr by mass spectrometry stydues (≥1018 reports).","Abl1; Bcr-Abl; Fes; Fyn; Hck; Lyn",null,"P11274","P11274","P11274","P11274"]
[249,125,"PK539","Bcr","Y591","Breakpoint cluster region protein",0,4913,18,673,{"v":3294.335,"d":"3294"},{"v":5788.630529293647,"d":"5789"},{"v":5412.5000569754775,"d":"5413"},{"v":376.13047231816927,"d":"376"},{"v":6.949292717945063,"d":"7"},0,4882,20,630,{"v":3063.06,"d":"3063"},{"v":5351.824817849836,"d":"5352"},{"v":5322.534503182009,"d":"5323"},{"v":29.29031466782726,"d":"29"},{"v":0.5503076523095608,"d":"1"},{"v":7.499600370254624,"d":"7"},{"v":-1.6621811149456533,"d":"-2"},null,0,5256,18,625,{"v":3273.75,"d":"3274"},{"v":5600.867037998176,"d":"5601"},{"v":5962.966620615149,"d":"5963"},{"v":362.09958261697284,"d":"362"},{"v":6.072473747632988,"d":"6"},{"v":13.02176646557805,"d":"13"},{"v":10.17028282392802,"d":"10"},null,null,"BCR","X","PSTK","Protein kinase - Receptor-serine kinase","Protein-serine/threonine kinase","Atypical","BCR",{"$nulls":6},"LGV(pY)RAF(bA)C","Corresponds to amino acid residues L588 to F594; In the Rho-GEF domain. One of the main in vivo phosphorylation sites in Bcr.","The effect of Y591 phosphorylation is unclear. This is one of the major sites of phosphorylation of Bcr by mass spectrometry studies (≥257 reports).",null,"EC 2.7.11.1; GTPase activating protein, Rac/Rho; Protein kinase, Ser/Thr (non-receptor); ATYPICAL group; BCR family","P11274","P11274","P11274","P11274","GO:0030054; GO:0005829; GO:0070062; GO:0098978; GO:0016020; GO:0014069; GO:0099092; GO:0045211; GO:0032991; GO:0098685","GO:0005524; GO:0005096; GO:0016301; GO:0004674; GO:0004713; GO:0005089","GO:0030036; GO:0007420; GO:0071222; GO:0060216; GO:0048872; GO:0042472; GO:0065002; GO:0035556; GO:0050804; GO:0060313; GO:0002692; GO:0050728; GO:0043314; GO:2000378; GO:0060268; GO:0050885; GO:0048008; GO:0043547; GO:0050766; GO:0046777; GO:0006468; GO:0051726; GO:0051171; GO:0035023; GO:0051056; GO:0043114; GO:0003014; GO:0007165"]
[250,125,"PK539","Bcr","Y591","Breakpoint cluster region protein",0,4872,14,590,{"v":2866.22,"d":"2866"},{"v":5036.369584657309,"d":"5036"},{"$nulls":3},0,4682,14,649,{"v":3029.532,"d":"3030"},{"v":5293.2441885141825,"d":"5293"},{"$nulls":6},0,5048,18,735,{"v":3697.05,"d":"3697"},{"v":6325.066203232122,"d":"6325"},{"$nulls":7},"BCR","X","PSTK","Protein kinase - Receptor-serine kinase","Protein-serine/threonine kinase","Atypical","BCR",{"$nulls":6},"LGV(pY)RAF(bA)C","Corresponds to amino acid residues L588 to F594; In the Rho-GEF domain. One of the main in vivo phosphorylation sites in Bcr.","The effect of Y591 phosphorylation is unclear. This is one of the major sites of phosphorylation of Bcr by mass spectrometry studies (≥257 reports).",null,null,"P11274","P11274","P11274","P11274"]
[251,126,"PK540","Bcr","Y644","Breakpoint cluster region protein",0,6252,14,737,{"v":4597.406,"d":"4597"},{"v":8078.317696032063,"d":"8078"},{"v":8520.458905902417,"d":"8520"},{"v":442.1412098703531,"d":"442"},{"v":5.189171319916426,"d":"5"},0,6492,20,772,{"v":4996.384,"d":"4996"},{"v":8729.757788194758,"d":"8730"},{"v":8031.864148944011,"d":"8032"},{"v":697.8936392507476,"d":"698"},{"v":8.689061795728993,"d":"9"},{"v":13.878233115645418,"d":"14"},{"v":-5.734371380160525,"d":"-6"},null,0,6257,16,700,{"v":4368.7,"d":"4369"},{"v":7474.152830516267,"d":"7474"},{"v":6970.421242480225,"d":"6970"},{"v":503.731588036042,"d":"504"},{"v":7.226702239545045,"d":"7"},{"v":12.41587355946147,"d":"12"},{"v":-18.191950463471244,"d":"-18"},null,null,"BCR","X","PSTK","Protein kinase - Receptor-serine kinase","Protein-serine/threonine kinase","Atypical","BCR",{"$nulls":6},"TLL(pY)KPV(bA)C","Corresponds to amino acid residues T641 to V647; In the Rho-GEF domain. One of the main in vivo phosphorylation sites in Bcr.","The effect of Y644 phosphorylation is unclear. This is one of the major sites of phosphorylation of Bcr by mass spectrometry studies (≥320 reports).",null,"EC 2.7.11.1; GTPase activating protein, Rac/Rho; Protein kinase, Ser/Thr (non-receptor); ATYPICAL group; BCR family","P11274","P11274","P11274","P11274","GO:0030054; GO:0005829; GO:0070062; GO:0098978; GO:0016020; GO:0014069; GO:0099092; GO:0045211; GO:0032991; GO:0098685","GO:0005524; GO:0005096; GO:0016301; GO:0004674; GO:0004713; GO:0005089","GO:0030036; GO:0007420; GO:0071222; GO:0060216; GO:0048872; GO:0042472; GO:0065002; GO:0035556; GO:0050804; GO:0060313; GO:0002692; GO:0050728; GO:0043314; GO:2000378; GO:0060268; GO:0050885; GO:0048008; GO:0043547; GO:0050766; GO:0046777; GO:0006468; GO:0051726; GO:0051171; GO:0035023; GO:0051056; GO:0043114; GO:0003014; GO:0007165"]
[252,126,"PK540","Bcr","Y644","Breakpoint cluster region protein",0,5353,12,955,{"v":5100.655,"d":"5101"},{"v":8962.60011577277,"d":"8963"},{"$nulls":3},0,5926,14,710,{"v":4197.52,"d":"4198"},{"v":7333.970509693263,"d":"7334"},{"$nulls":6},0,5532,14,685,{"v":3779.83,"d":"3780"},{"v":6466.689654444183,"d":"6467"},{"$nulls":7},"BCR","X","PSTK","Protein kinase - Receptor-serine kinase","Protein-serine/threonine kinase","Atypical","BCR",{"$nulls":6},"TLL(pY)KPV(bA)C","Corresponds to amino acid residues T641 to V647; In the Rho-GEF domain. One of the main in vivo phosphorylation sites in Bcr.","The effect of Y644 phosphorylation is unclear. This is one of the major sites of phosphorylation of Bcr by mass spectrometry studies (≥320 reports).",null,null,"P11274","P11274","P11274","P11274"]
[253,127,"PK541","BLK","Y187","B lymphoid tyrosine kinase",0,534,12,536,{"v":279.792,"d":"280"},{"v":491.6356451460243,"d":"492"},{"v":454.6055313979282,"d":"455"},{"v":37.030113748096085,"d":"37"},{"v":8.145548434975519,"d":"8"},0,492,12,501,{"v":240.48,"d":"240"},{"v":420.17029774034086,"d":"420"},{"v":377.7155905728273,"d":"378"},{"v":42.45470716751356,"d":"42"},{"v":11.239860950173798,"d":"11"},{"v":19.385409385149316,"d":"19"},{"v":-16.913551533053635,"d":"-17"},null,0,561,10,490,{"v":269.99,"d":"270"},{"v":461.9100699775877,"d":"462"},{"v":472.51557582517853,"d":"473"},{"v":10.605505847590848,"d":"11"},{"v":2.2444775135867006,"d":"2"},{"v":10.390025948562219,"d":"10"},{"v":3.9396890689332906,"d":"4"},null,null,"BLK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"EGG(pY)YIS(bA)C","Corresponds to amino acid residues E184 to S190; In the SH2 domain. One of the two major in vivo phosphorylation sites in BLK.","The effect of Y187 phosphorylation is unclear. This is the major sites of phosphorylation of BLK by mass spectrometry studies (≥146 reports).",null,"Protein-tyrosine kinase, TK group, Src family","P51451","P51451","P51451","P51451","GO:0005829; GO:0031234","GO:0005524; GO:0004715; GO:0004713; GO:0005102","GO:0050853; GO:0030154; GO:0016477; GO:0045087; GO:0035556; GO:0038083; GO:0032024; GO:0050855; GO:0042127; GO:0007169"]
[254,127,"PK541","BLK","Y187","B lymphoid tyrosine kinase",0,505,14,484,{"v":237.644,"d":"238"},{"v":417.57541764983205,"d":"418"},{"$nulls":3},0,395,12,501,{"v":191.883,"d":"192"},{"v":335.2608834053137,"d":"335"},{"$nulls":6},0,466,12,622,{"v":282.388,"d":"282"},{"v":483.1210816727694,"d":"483"},{"$nulls":7},"BLK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"EGG(pY)YIS(bA)C","Corresponds to amino acid residues E184 to S190; In the SH2 domain. One of the two major in vivo phosphorylation sites in BLK.","The effect of Y187 phosphorylation is unclear. This is the major sites of phosphorylation of BLK by mass spectrometry studies (≥146 reports).",null,null,"P51451","P51451","P51451","P51451"]
[255,128,"PK542","BLK","Y188","B lymphoid tyrosine kinase",0,14,2,731,{"v":8.772,"d":"9"},{"v":15.413692597432828,"d":"15"},{"v":13.273487674533467,"d":"13"},{"v":2.140204922899361,"d":"2"},{"v":16.12390786338365,"d":"16"},0,10,2,752,{"v":6.016,"d":"6"},{"v":10.511246304083047,"d":"11"},{"v":8.016223078978229,"d":"8"},{"v":2.495023225104818,"d":"2"},{"v":31.124673060156915,"d":"31"},{"v":47.248580923540565,"d":"47"},{"v":-39.60725865321617,"d":"-40"},null,0,12,2,707,{"v":7.07,"d":"7"},{"v":12.095648708254176,"d":"12"},{"v":9.743241781259906,"d":"10"},{"v":2.35240692699427,"d":"2"},{"v":24.143985952589986,"d":"24"},{"v":40.267893815973636,"d":"40"},{"v":-26.59621931955907,"d":"-27"},null,null,"BLK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"GGY(pY)ISP(bA)C","Corresponds to amino acid residues G185 to P191; In the SH2 domain. One of the two major in vivo phosphorylation sites in BLK.","The effect of Y188 phosphorylation is unclear. This is one of the major sites of phosphorylation of BLK by mass spectrometry studies (≥97 reports).",null,"Protein-tyrosine kinase, TK group, Src family","P51451","P51451","P51451","P51451","GO:0005829; GO:0031234","GO:0005524; GO:0004715; GO:0004713; GO:0005102","GO:0050853; GO:0030154; GO:0016477; GO:0045087; GO:0035556; GO:0038083; GO:0032024; GO:0050855; GO:0042127; GO:0007169"]
[256,128,"PK542","BLK","Y188","B lymphoid tyrosine kinase",0,10,2,792,{"v":6.336,"d":"6"},{"v":11.133282751634107,"d":"11"},{"$nulls":3},0,6,2,790,{"v":3.16,"d":"3"},{"v":5.521199853873409,"d":"6"},{"$nulls":6},0,10,4,720,{"v":4.32,"d":"4"},{"v":7.390834854265635,"d":"7"},{"$nulls":7},"BLK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"GGY(pY)ISP(bA)C","Corresponds to amino acid residues G185 to P191; In the SH2 domain. One of the two major in vivo phosphorylation sites in BLK.","The effect of Y188 phosphorylation is unclear. This is one of the major sites of phosphorylation of BLK by mass spectrometry studies (≥97 reports).",null,null,"P51451","P51451","P51451","P51451"]
[257,129,"PK543","BLK","Y389","B lymphoid tyrosine kinase",0,4159,12,755,{"v":3130.985,"d":"3131"},{"v":5501.600583353081,"d":"5502"},{"v":5401.114623643847,"d":"5401"},{"v":100.48595970923361,"d":"100"},{"v":1.8604670833932615,"d":"2"},0,4118,18,766,{"v":3140.6,"d":"3141"},{"v":5487.30388008697,"d":"5487"},{"v":5445.838970298323,"d":"5446"},{"v":41.464909788646764,"d":"41"},{"v":0.7614053594826604,"d":"1"},{"v":2.621872442875922,"d":"3"},{"v":0.828057720876572,"d":"1"},null,0,4435,14,825,{"v":3647.325,"d":"3647"},{"v":6239.994614545001,"d":"6240"},{"v":5942.5425959646345,"d":"5943"},{"v":297.4520185803667,"d":"297"},{"v":5.005467167914886,"d":"5"},{"v":6.865934251308147,"d":"7"},{"v":10.024374782765008,"d":"10"},null,null,"BLK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"DSE(pY)TAQ(bA)C","Corresponds to amino acid residues D386 to Q392; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y389 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of phosphorylation of BLK by mass spectrometry studies (≥72 reports).",null,"Protein-tyrosine kinase, TK group, Src family","P51451","P51451","P51451","P51451","GO:0005829; GO:0031234","GO:0005524; GO:0004715; GO:0004713; GO:0005102","GO:0050853; GO:0030154; GO:0016477; GO:0045087; GO:0035556; GO:0038083; GO:0032024; GO:0050855; GO:0042127; GO:0007169"]
[258,129,"PK543","BLK","Y389","B lymphoid tyrosine kinase",0,3942,9,767,{"v":3016.611,"d":"3017"},{"v":5300.628663934614,"d":"5301"},{"$nulls":3},0,4000,14,776,{"v":3093.136,"d":"3093"},{"v":5404.374060509676,"d":"5404"},{"$nulls":6},0,4035,16,821,{"v":3299.599,"d":"3300"},{"v":5645.090577384267,"d":"5645"},{"$nulls":7},"BLK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"DSE(pY)TAQ(bA)C","Corresponds to amino acid residues D386 to Q392; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y389 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of phosphorylation of BLK by mass spectrometry studies (≥72 reports).",null,null,"P51451","P51451","P51451","P51451"]
[259,130,"PN013","BLNK","Y84","B-cell linker protein",0,923,14,580,{"v":527.22,"d":"527"},{"v":926.4029880550086,"d":"926"},{"v":897.0147061703683,"d":"897"},{"v":29.388281884640264,"d":"29"},{"v":3.2762318925748586,"d":"3"},0,1151,16,701,{"v":795.635,"d":"796"},{"v":1390.1455208027119,"d":"1390"},{"v":1270.2909299874964,"d":"1270"},{"v":119.85459081521549,"d":"120"},{"v":9.435207950071344,"d":"9"},{"v":12.711439842646204,"d":"13"},{"v":41.613166567888186,"d":"42"},null,0,1034,12,568,{"v":580.496,"d":"580"},{"v":993.1365901763388,"d":"993"},{"v":1142.4759361089423,"d":"1142"},{"v":149.33934593260346,"d":"149"},{"v":13.071552862743449,"d":"13"},{"v":16.347784755318308,"d":"16"},{"v":27.36423697962806,"d":"27"},{"$nulls":13},"X",null,"Not precisely defined.","Antibody raised against amino acid residues that encompass the Y84 phosphosite.","Y84 phosphorylation regulates transcription and molecular association, including inducing interaction with Btk, Nck2, PLCG1, and VAV1. This is one of the major in vivo phosphorylation sites in XXX.","Syk","Adapter/scaffold protein","Q8WV28","Q8WV28",null,"Q8WV28","GO:0005737; GO:0036464; GO:0005829; GO:0005622; GO:0005886","GO:0005070; GO:0005068","GO:0030183; GO:0006959; GO:0006954; GO:0035556"]
[260,130,"PN013","BLNK","Y84","B-cell linker protein",0,918,12,545,{"v":493.77,"d":"494"},{"v":867.626424285728,"d":"868"},{"$nulls":3},0,1130,14,590,{"v":658.44,"d":"658"},{"v":1150.436339172281,"d":"1150"},{"$nulls":6},0,1262,16,606,{"v":755.076,"d":"755"},{"v":1291.815282041546,"d":"1292"},{"$nulls":18},"X",null,"Not precisely defined.","Antibody raised against amino acid residues that encompass the Y84 phosphosite.","Y84 phosphorylation regulates transcription and molecular association, including inducing interaction with Btk, Nck2, PLCG1, and VAV1. This is one of the major in vivo phosphorylation sites in XXX.","Syk",null,"Q8WV28","Q8WV28",null,"Q8WV28"]
[261,131,"NK363-1","BMPR2 (BMPR-II)","Pan-specific","Bone morphogenetic protein receptor type-2",0,104,10,506,{"v":47.564,"d":"48"},{"v":83.57693510080883,"d":"84"},{"v":72.32768065384519,"d":"72"},{"v":11.249254446963633,"d":"11"},{"v":15.553180117584184,"d":"16"},0,84,8,473,{"v":35.948,"d":"36"},{"v":62.80888998324091,"d":"63"},{"v":46.53183370517614,"d":"47"},{"v":16.27705627806477,"d":"16"},{"v":34.9804746170021,"d":"35"},{"v":50.533654734586285,"d":"51"},{"v":-35.66524837444467,"d":"-36"},null,0,32,6,652,{"v":16.952,"d":"17"},{"v":29.002183437386815,"d":"29"},{"v":35.81817558076512,"d":"36"},{"v":6.815992143378306,"d":"7"},{"v":19.02942300343905,"d":"19"},{"v":34.58260312102323,"d":"35"},{"v":-50.477914877171024,"d":"-50"},null,null,"BMPR2","X","PSTK",{"$nulls":10},"Not precisely defined.","Antibody raised against amino acid residues 61-82 within an extracellular domain of human BMPR-II.",null,null,"EC 2.7.11.30; Cell cycle regulation; Receptor Ser/Thr kinase; TKL domain target; TKL</A> group; STKR family; Type2 subfamily","Q13873","Q13873","Q13873","Q13873","GO:0016324; GO:0009925; GO:0005901; GO:0005913; GO:0009986; GO:0005737; GO:0030425; GO:0005615; GO:0005887; GO:0043025; GO:0005654; GO:0005886; GO:0014069; GO:0044214","GO:0016362; GO:0005524; GO:0036122; GO:0098821; GO:0019838; GO:0046872","GO:0009952; GO:0060840; GO:0060413; GO:0001974; GO:0030509; GO:0007420; GO:0071773; GO:0009267; GO:0002063; GO:0003197; GO:0060350; GO:0072577; GO:0001935; GO:0060173; GO:0048286; GO:0001946; GO:0060836; GO:0001893; GO:0001707; GO:0003183; GO:0030308; GO:0003252; GO:1902731; GO:2000279; GO:0003085; GO:0045906; GO:0003151; GO:0003148; GO:0061626; GO:0048842; GO:0030513; GO:0030501; GO:0061036; GO:0010595; GO:0001938; GO:0010634; GO:0045778; GO:0045669; GO:0010862; GO:0045944; GO:0030166; GO:0042127; GO:0014916; GO:0061298; GO:1905314; GO:0006366; GO:0007178; GO:0003186; GO:0060841; GO:0060412"]
[262,131,"NK363-1","BMPR2 (BMPR-II)","Pan-specific","Bone morphogenetic protein receptor type-2",0,98,10,395,{"v":34.76,"d":"35"},{"v":61.07842620688156,"d":"61"},{"$nulls":3},0,34,8,666,{"v":17.316,"d":"17"},{"v":30.25477742711137,"d":"30"},{"$nulls":6},0,78,8,356,{"v":24.92,"d":"25"},{"v":42.63416772414343,"d":"43"},{"$nulls":7},"BMPR2","X","PSTK",{"$nulls":10},"Not precisely defined.","Antibody raised against amino acid residues 61-82 within an extracellular domain of human BMPR-II.",{"$nulls":3},"Q13873","Q13873","Q13873","Q13873"]
[263,132,"PK544","BMPR2 (BMPR-II)","S375","Bone morphogenetic protein receptor type-2",0,4468,12,917,{"v":4086.152,"d":"4086"},{"v":7179.969315365406,"d":"7180"},{"v":6453.975959721205,"d":"6454"},{"v":725.9933556442011,"d":"726"},{"v":11.248776880717761,"d":"11"},0,4712,18,846,{"v":3971.124,"d":"3971"},{"v":6938.407990035817,"d":"6938"},{"v":6135.618542422049,"d":"6136"},{"v":802.7894476137681,"d":"803"},{"v":13.084083406802947,"d":"13"},{"v":24.33286028752071,"d":"24"},{"v":-4.9327332374028146,"d":"-5"},null,0,4381,8,739,{"v":3231.647,"d":"3232"},{"v":5528.83548247291,"d":"5529"},{"v":5043.429572108504,"d":"5043"},{"v":485.40591036440674,"d":"485"},{"v":9.624520446341306,"d":"10"},{"v":20.873297327059067,"d":"21"},{"v":-21.8554639251187,"d":"-22"},null,null,"BMPR2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","STKR","Type2",{"$nulls":5},"AAI(pS)EVG(bA)C","Corresponds to amino acid residues A372 to G378; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S375 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the minor in vivo phosphorylation sites in BMPR2 (≥4 reports from high throughput mass spectrometry studies).",null,"EC 2.7.11.30; Cell cycle regulation; Receptor Ser/Thr kinase; TKL domain target; TKL</A> group; STKR family; Type2 subfamily","Q13873","Q13873","Q13873","Q13873","GO:0016324; GO:0009925; GO:0005901; GO:0005913; GO:0009986; GO:0005737; GO:0030425; GO:0005615; GO:0005887; GO:0043025; GO:0005654; GO:0005886; GO:0014069; GO:0044214","GO:0016362; GO:0005524; GO:0036122; GO:0098821; GO:0019838; GO:0046872","GO:0009952; GO:0060840; GO:0060413; GO:0001974; GO:0030509; GO:0007420; GO:0071773; GO:0009267; GO:0002063; GO:0003197; GO:0060350; GO:0072577; GO:0001935; GO:0060173; GO:0048286; GO:0001946; GO:0060836; GO:0001893; GO:0001707; GO:0003183; GO:0030308; GO:0003252; GO:1902731; GO:2000279; GO:0003085; GO:0045906; GO:0003151; GO:0003148; GO:0061626; GO:0048842; GO:0030513; GO:0030501; GO:0061036; GO:0010595; GO:0001938; GO:0010634; GO:0045778; GO:0045669; GO:0010862; GO:0045944; GO:0030166; GO:0042127; GO:0014916; GO:0061298; GO:1905314; GO:0006366; GO:0007178; GO:0003186; GO:0060841; GO:0060412"]
[264,132,"PK544","BMPR2 (BMPR-II)","S375","Bone morphogenetic protein receptor type-2",0,4204,14,778,{"v":3259.82,"d":"3260"},{"v":5727.982604077004,"d":"5728"},{"$nulls":3},0,4327,16,708,{"v":3052.188,"d":"3052"},{"v":5332.829094808282,"d":"5333"},{"$nulls":6},0,3818,12,700,{"v":2664.2,"d":"2664"},{"v":4558.023661744098,"d":"4558"},{"$nulls":7},"BMPR2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","STKR","Type2",{"$nulls":5},"AAI(pS)EVG(bA)C","Corresponds to amino acid residues A372 to G378; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S375 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the minor in vivo phosphorylation sites in BMPR2 (≥4 reports from high throughput mass spectrometry studies).",null,null,"Q13873","Q13873","Q13873","Q13873"]
[265,133,"NK012","Bmx (Etk)","Pan-specific","Bone marrow X protein-tyrosine kinase",0,139,8,352,{"v":46.112,"d":"46"},{"v":81.02555780355934,"d":"81"},{"v":68.95747290169332,"d":"69"},{"v":12.068084901866015,"d":"12"},{"v":17.5007644480685,"d":"18"},0,254,10,402,{"v":98.088,"d":"98"},{"v":171.38083900846038,"d":"171"},{"v":121.76342335963221,"d":"122"},{"v":49.61741564882817,"d":"50"},{"v":40.749031424881615,"d":"41"},{"v":58.249795872950116,"d":"58"},{"v":76.57756039467941,"d":"77"},null,0,40,5,659,{"v":23.065,"d":"23"},{"v":39.46055692445298,"d":"39"},{"v":52.37313240189971,"d":"52"},{"v":12.91257547744673,"d":"13"},{"v":24.65496120865659,"d":"25"},{"v":42.155725656725096,"d":"42"},{"v":-24.050098998605222,"d":"-24"},null,null,"BMX","X","PYK",{"$nulls":10},"Epitope undefined.",{"$nulls":3},"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; Tec family","P51813","P51813","P51813","P51813","GO:0005829; GO:0031234; GO:0005654; GO:0005886; GO:0032587","GO:0005524; GO:0046872; GO:0004715; GO:0004713","GO:0006915; GO:0007155; GO:0045087; GO:0035556; GO:0007498; GO:0001865; GO:0038083; GO:0006661; GO:0046777; GO:0006468; GO:0042127; GO:0007165; GO:0007169"]
[266,133,"NK012","Bmx (Etk)","Pan-specific","Bone marrow X protein-tyrosine kinase",0,122,8,284,{"v":32.376,"d":"32"},{"v":56.88938799982731,"d":"57"},{"$nulls":3},0,158,10,279,{"v":41.292,"d":"41"},{"v":72.14600771080404,"d":"72"},{"$nulls":6},0,130,10,318,{"v":38.16,"d":"38"},{"v":65.28570787934643,"d":"65"},{"$nulls":7},"BMX","X","PYK",{"$nulls":10},"Epitope undefined.",{"$nulls":4},"P51813","P51813","P51813","P51813"]
[267,134,"PK545","Bmx (Etk)","Y40","Bone marrow X protein-tyrosine kinase",0,2363,14,584,{"v":1371.816,"d":"1372"},{"v":2410.4822303055075,"d":"2410"},{"v":2384.926285807438,"d":"2385"},{"v":25.555944498069493,"d":"26"},{"v":1.0715611903877902,"d":"1"},0,2252,14,530,{"v":1186.14,"d":"1186"},{"v":2072.4417704662674,"d":"2072"},{"v":2085.5563673343604,"d":"2086"},{"v":13.114596868093031,"d":"13"},{"v":0.6288296530127049,"d":"1"},{"v":1.700390843400495,"d":"2"},{"v":-12.552585807561897,"d":"-13"},null,0,2292,10,541,{"v":1234.562,"d":"1235"},{"v":2112.1397822573817,"d":"2112"},{"v":2028.7739024475077,"d":"2029"},{"v":83.36587980987406,"d":"83"},{"v":4.109175483246392,"d":"4"},{"v":5.180736673634182,"d":"5"},{"v":-14.93347553253001,"d":"-15"},null,null,"BMX","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"NLS(pY)YEY(bA)C","Corresponds to amino acid residues N37 to Y43; In the PH domain domain.","Y40 phosphorylation stimulates phosphotransferase activity and regulates cell motility, cytoskeletal reorganization, intracellular location, and induces interaction with FAK. This phosphorylation site has not apparently been detected by mass spectrometry.",null,"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; Tec family","P51813","P51813","P51813","P51813","GO:0005829; GO:0031234; GO:0005654; GO:0005886; GO:0032587","GO:0005524; GO:0046872; GO:0004715; GO:0004713","GO:0006915; GO:0007155; GO:0045087; GO:0035556; GO:0007498; GO:0001865; GO:0038083; GO:0006661; GO:0046777; GO:0006468; GO:0042127; GO:0007165; GO:0007169"]
[268,134,"PK545","Bmx (Etk)","Y40","Bone marrow X protein-tyrosine kinase",0,2204,10,612,{"v":1342.728,"d":"1343"},{"v":2359.370341309369,"d":"2359"},{"$nulls":3},0,2222,14,544,{"v":1201.152,"d":"1201"},{"v":2098.6709642024534,"d":"2099"},{"$nulls":6},0,2250,16,509,{"v":1137.106,"d":"1137"},{"v":1945.4080226376338,"d":"1945"},{"$nulls":7},"BMX","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"NLS(pY)YEY(bA)C","Corresponds to amino acid residues N37 to Y43; In the PH domain domain.","Y40 phosphorylation stimulates phosphotransferase activity and regulates cell motility, cytoskeletal reorganization, intracellular location, and induces interaction with FAK. This phosphorylation site has not apparently been detected by mass spectrometry.",null,null,"P51813","P51813","P51813","P51813"]
[269,135,"NN395-1","BRCA1","Pan-specific","Breast cancer type 1 susceptibility protein homolog",0,164,12,532,{"v":80.864,"d":"81"},{"v":142.08992683524946,"d":"142"},{"v":157.37007626836345,"d":"157"},{"v":15.28014943311399,"d":"15"},{"v":9.709691826708355,"d":"10"},0,226,14,637,{"v":135.044,"d":"135"},{"v":235.95092185648122,"d":"236"},{"v":194.34885567905945,"d":"194"},{"v":41.60206617742176,"d":"42"},{"v":21.405871432616966,"d":"21"},{"v":31.11556325932532,"d":"31"},{"v":23.497973876327066,"d":"23"},null,0,204,10,507,{"v":98.358,"d":"98"},{"v":168.27493856385632,"d":"168"},{"v":156.77295182190542,"d":"157"},{"v":11.501986741950901,"d":"12"},{"v":7.336716320183341,"d":"7"},{"v":17.046408146891697,"d":"17"},{"v":-0.37943963720252327,"d":"-0"},{"$nulls":6},"Transcription, coactivator/corepressor",{"$nulls":3},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against whole mouse BRCA1 protein.",null,null,"Nuclear receptor co-regulator; Transcription, coactivator/corepressor; Ubiquitin conjugating system; Tumor suppressor","P38398","P38398",null,"P38398","GO:0070531; GO:0031436; GO:0005694; GO:0005737; GO:0008274; GO:0000800; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:1990904; GO:0000151","GO:0050681; GO:0003684; GO:0003677; GO:0019899; GO:0042802; GO:0003723; GO:0070063; GO:0003713; GO:0044212; GO:0015631; GO:0031625; GO:0004842; GO:0008270","GO:0030521; GO:0006915; GO:0006974; GO:0071681; GO:0071356; GO:0007098; GO:0043009; GO:0007059; GO:0006978; GO:0000729; GO:0006260; GO:0009048; GO:0006302; GO:0000724; GO:0006303; GO:0006633; GO:0008630; GO:0044818; GO:0046600; GO:1902042; GO:0045717; GO:0070317; GO:0035067; GO:0051572; GO:0051573; GO:0033147; GO:2000378; GO:0045892; GO:0045766; GO:0071158; GO:0045739; GO:0010628; GO:0035066; GO:0051571; GO:2000617; GO:0051574; GO:2000620; GO:0070512; GO:0031398; GO:0045893; GO:0045944; GO:0010575; GO:0006301; GO:0051865; GO:0016579; GO:0085020; GO:0016567; GO:0042981; GO:0042127; GO:0044030; GO:0006349; GO:0006357; GO:0006359; GO:0043627; GO:0010212; GO:0072425; GO:0006351"]
[270,135,"NN395-1","BRCA1","Pan-specific","Breast cancer type 1 susceptibility protein homolog",0,188,10,552,{"v":98.256,"d":"98"},{"v":172.6502257014774,"d":"173"},{"$nulls":3},0,171,10,543,{"v":87.423,"d":"87"},{"v":152.74678950163766,"d":"153"},{"$nulls":6},0,195,12,464,{"v":84.912,"d":"85"},{"v":145.27096507995452,"d":"145"},{"$nulls":11},"Transcription, coactivator/corepressor",{"$nulls":3},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against whole mouse BRCA1 protein.",{"$nulls":3},"P38398","P38398",null,"P38398"]
[271,136,"PN690","BRCA1","T509","Breast cancer type 1 susceptibility protein",0,3802,8,946,{"v":3589.124,"d":"3589"},{"v":6306.618106482956,"d":"6307"},{"v":9346.267869713909,"d":"9346"},{"v":3039.649763230953,"d":"3040"},{"v":32.52260480443513,"d":"33"},0,12062,16,779,{"v":9383.834,"d":"9384"},{"v":16395.576870117824,"d":"16396"},{"v":14494.854898397882,"d":"14495"},{"v":1900.7219717199423,"d":"1901"},{"v":13.11308036570983,"d":"13"},{"v":45.63568517014497,"d":"46"},{"v":55.08709038147407,"d":"55"},null,0,11331,18,746,{"v":8439.498,"d":"8439"},{"v":14438.642585857664,"d":"14439"},{"v":13590.523756233866,"d":"13591"},{"v":848.1188296237979,"d":"848"},{"v":6.240516148134264,"d":"6"},{"v":38.763120952569395,"d":"39"},{"v":45.41123735895957,"d":"45"},{"$nulls":3},"X",null,"Transcription, coactivator/corepressor",{"$nulls":9},"RRP(pT)SGL(bA)C","Corresponds to amino acid residues R506 to L512.","T509 phosphorylation induces transcription. This is the major site of phosphorylation of BRCA1 by mass spectrometry studies (≥79 reports). This human phosphosite is not highly conserved in nature, but is found in the mouse.","Akt1","Nuclear receptor co-regulator; Transcription, coactivator/corepressor; Ubiquitin conjugating system; Tumor suppressor","P38398","P38398",null,"P38398","GO:0070531; GO:0031436; GO:0005694; GO:0005737; GO:0008274; GO:0000800; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:1990904; GO:0000151","GO:0050681; GO:0003684; GO:0003677; GO:0019899; GO:0042802; GO:0003723; GO:0070063; GO:0003713; GO:0044212; GO:0015631; GO:0031625; GO:0004842; GO:0008270","GO:0030521; GO:0006915; GO:0006974; GO:0071681; GO:0071356; GO:0007098; GO:0043009; GO:0007059; GO:0006978; GO:0000729; GO:0006260; GO:0009048; GO:0006302; GO:0000724; GO:0006303; GO:0006633; GO:0008630; GO:0044818; GO:0046600; GO:1902042; GO:0045717; GO:0070317; GO:0035067; GO:0051572; GO:0051573; GO:0033147; GO:2000378; GO:0045892; GO:0045766; GO:0071158; GO:0045739; GO:0010628; GO:0035066; GO:0051571; GO:2000617; GO:0051574; GO:2000620; GO:0070512; GO:0031398; GO:0045893; GO:0045944; GO:0010575; GO:0006301; GO:0051865; GO:0016579; GO:0085020; GO:0016567; GO:0042981; GO:0042127; GO:0044030; GO:0006349; GO:0006357; GO:0006359; GO:0043627; GO:0010212; GO:0072425; GO:0006351"]
[272,136,"PN690","BRCA1","T509","Breast cancer type 1 susceptibility protein",0,10374,8,680,{"v":7048.88,"d":"7049"},{"v":12385.91763294486,"d":"12386"},{"$nulls":3},0,10837,14,666,{"v":7208.118,"d":"7208"},{"v":12594.13292667794,"d":"12594"},{"$nulls":6},0,10271,12,726,{"v":7448.034,"d":"7448"},{"v":12742.404926610066,"d":"12742"},{"$nulls":8},"X",null,"Transcription, coactivator/corepressor",{"$nulls":9},"RRP(pT)SGL(bA)C","Corresponds to amino acid residues R506 to L512.","T509 phosphorylation induces transcription. This is the major site of phosphorylation of BRCA1 by mass spectrometry studies (≥79 reports). This human phosphosite is not highly conserved in nature, but is found in the mouse.","Akt1",null,"P38398","P38398",null,"P38398"]
[273,137,"PN212","BRCA1","S988","Breast cancer type 1 susceptibility protein",0,280,12,558,{"v":149.544,"d":"150"},{"v":262.7707758539096,"d":"263"},{"v":247.22705438595577,"d":"247"},{"v":15.543721467953816,"d":"16"},{"v":6.287225120470799,"d":"6"},0,280,14,667,{"v":177.422,"d":"177"},{"v":309.9944052132683,"d":"310"},{"v":258.4952388547497,"d":"258"},{"v":51.49916635851861,"d":"51"},{"v":19.922675011997555,"d":"20"},{"v":26.209900132468356,"d":"26"},{"v":4.557828226680542,"d":"5"},null,0,293,10,511,{"v":144.613,"d":"145"},{"v":247.40990758794356,"d":"247"},{"v":272.3000837169444,"d":"272"},{"v":24.89017612900085,"d":"25"},{"v":9.140715562494705,"d":"9"},{"v":15.427940682965504,"d":"15"},{"v":10.141701276692046,"d":"10"},{"$nulls":3},"X",null,"Transcription, coactivator/corepressor",{"$nulls":9},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S988 phosphosite.","S988 phosphorylation induces activity. This phosphorylation site has not apparently been detected by mass spectrometry.","Chk2","Nuclear receptor co-regulator; Transcription, coactivator/corepressor; Ubiquitin conjugating system; Tumor suppressor","P38398","P38398",null,"P38398","GO:0070531; GO:0031436; GO:0005694; GO:0005737; GO:0008274; GO:0000800; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:1990904; GO:0000151","GO:0050681; GO:0003684; GO:0003677; GO:0019899; GO:0042802; GO:0003723; GO:0070063; GO:0003713; GO:0044212; GO:0015631; GO:0031625; GO:0004842; GO:0008270","GO:0030521; GO:0006915; GO:0006974; GO:0071681; GO:0071356; GO:0007098; GO:0043009; GO:0007059; GO:0006978; GO:0000729; GO:0006260; GO:0009048; GO:0006302; GO:0000724; GO:0006303; GO:0006633; GO:0008630; GO:0044818; GO:0046600; GO:1902042; GO:0045717; GO:0070317; GO:0035067; GO:0051572; GO:0051573; GO:0033147; GO:2000378; GO:0045892; GO:0045766; GO:0071158; GO:0045739; GO:0010628; GO:0035066; GO:0051571; GO:2000617; GO:0051574; GO:2000620; GO:0070512; GO:0031398; GO:0045893; GO:0045944; GO:0010575; GO:0006301; GO:0051865; GO:0016579; GO:0085020; GO:0016567; GO:0042981; GO:0042127; GO:0044030; GO:0006349; GO:0006357; GO:0006359; GO:0043627; GO:0010212; GO:0072425; GO:0006351"]
[274,137,"PN212","BRCA1","S988","Breast cancer type 1 susceptibility protein",0,250,12,554,{"v":131.852,"d":"132"},{"v":231.68333291800195,"d":"232"},{"$nulls":3},0,246,10,502,{"v":118.472,"d":"118"},{"v":206.99607249623114,"d":"207"},{"$nulls":6},0,302,12,599,{"v":173.71,"d":"174"},{"v":297.1902598459452,"d":"297"},{"$nulls":8},"X",null,"Transcription, coactivator/corepressor",{"$nulls":9},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S988 phosphosite.","S988 phosphorylation induces activity. This phosphorylation site has not apparently been detected by mass spectrometry.","Chk2",null,"P38398","P38398",null,"P38398"]
[275,138,"PN116","BRCA1","S1423","Breast cancer type 1 susceptibility protein",0,184,12,652,{"v":112.144,"d":"112"},{"v":197.05348183384714,"d":"197"},{"v":101.07811821417306,"d":"101"},{"v":95.97536361967408,"d":"96"},{"v":94.9516723454558,"d":"95"},0,2028,12,367,{"v":739.872,"d":"740"},{"v":1292.715562748426,"d":"1293"},{"v":981.650114652112,"d":"982"},{"v":311.06544809631396,"d":"311"},{"v":31.688016275183013,"d":"32"},{"v":126.63968862063882,"d":"127"},{"v":871.1796499536199,"d":"871"},"Possible",0,1307,8,309,{"v":401.391,"d":"401"},{"v":686.7163409695688,"d":"687"},{"v":345.6575413283337,"d":"346"},{"v":341.0587996412351,"d":"341"},{"v":98.66956708960377,"d":"99"},{"v":193.62123943505958,"d":"194"},{"v":241.97069299996718,"d":"242"},{"$nulls":3},"X",null,"Transcription, coactivator/corepressor",{"$nulls":9},"HG(pS)QP","Corresponds to amino acid residues  H1421 to P1425; Surrounds the S1423 phosphosite.","S1423 phosphorylation induces interaction with ATM. This is one of the minor in vivo phosphorylation sites in BRCA1 (≥2 reports from high throughput mass spectrometry studies).","ATM; ATR","Nuclear receptor co-regulator; Transcription, coactivator/corepressor; Ubiquitin conjugating system; Tumor suppressor","P38398","P38398",null,"P38398","GO:0070531; GO:0031436; GO:0005694; GO:0005737; GO:0008274; GO:0000800; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:1990904; GO:0000151","GO:0050681; GO:0003684; GO:0003677; GO:0019899; GO:0042802; GO:0003723; GO:0070063; GO:0003713; GO:0044212; GO:0015631; GO:0031625; GO:0004842; GO:0008270","GO:0030521; GO:0006915; GO:0006974; GO:0071681; GO:0071356; GO:0007098; GO:0043009; GO:0007059; GO:0006978; GO:0000729; GO:0006260; GO:0009048; GO:0006302; GO:0000724; GO:0006303; GO:0006633; GO:0008630; GO:0044818; GO:0046600; GO:1902042; GO:0045717; GO:0070317; GO:0035067; GO:0051572; GO:0051573; GO:0033147; GO:2000378; GO:0045892; GO:0045766; GO:0071158; GO:0045739; GO:0010628; GO:0035066; GO:0051571; GO:2000617; GO:0051574; GO:2000620; GO:0070512; GO:0031398; GO:0045893; GO:0045944; GO:0010575; GO:0006301; GO:0051865; GO:0016579; GO:0085020; GO:0016567; GO:0042981; GO:0042127; GO:0044030; GO:0006349; GO:0006357; GO:0006359; GO:0043627; GO:0010212; GO:0072425; GO:0006351"]
[276,138,"PN116","BRCA1","S1423","Breast cancer type 1 susceptibility protein",1,10,2,363,{"v":2.904,"d":"3"},{"v":5.102754594498966,"d":"5"},{"$nulls":3},1,1373,12,282,{"v":383.802,"d":"384"},{"v":670.5846665557981,"d":"671"},{"$nulls":6},1,9,2,384,{"v":2.688,"d":"3"},{"v":4.5987416870986175,"d":"5"},{"$nulls":8},"X",null,"Transcription, coactivator/corepressor",{"$nulls":9},"HG(pS)QP","Corresponds to amino acid residues  H1421 to P1425; Surrounds the S1423 phosphosite.","S1423 phosphorylation induces interaction with ATM. This is one of the minor in vivo phosphorylation sites in BRCA1 (≥2 reports from high throughput mass spectrometry studies).","ATM; ATR",null,"P38398","P38398",null,"P38398"]
[277,139,"NK013-2","BRD2","Pan-specific","Bromodomain-containing protein 2",0,170,8,523,{"v":84.726,"d":"85"},{"v":148.8760281589254,"d":"149"},{"v":142.90260727600557,"d":"143"},{"v":5.973420882919839,"d":"6"},{"v":4.180064308681667,"d":"4"},0,138,10,496,{"v":63.488,"d":"63"},{"v":110.92719503883384,"d":"111"},{"v":103.16257094053846,"d":"103"},{"v":7.764624098295386,"d":"8"},{"v":7.526590339407896,"d":"8"},{"v":11.706654648089563,"d":"12"},{"v":-27.809175138919784,"d":"-28"},null,0,178,10,513,{"v":86.184,"d":"86"},{"v":147.4471553425994,"d":"147"},{"v":141.6140415843543,"d":"142"},{"v":5.8331137582450765,"d":"6"},{"v":4.119022162622556,"d":"4"},{"v":8.299086471304221,"d":"8"},{"v":-0.9017090144216127,"d":"-1"},null,null,"BRD2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","BRD",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 1-22 at the N-terminus of human BRD2.",null,null,"Protein kinase, Ser/Thr (non-receptor); ATYPICAL group; BRD family","P25440","P25440","P25440","P25440","GO:0005737; GO:0016607; GO:0005654","GO:0003682; GO:0070577","GO:0006334; GO:0006357; GO:0007283; GO:0006351; GO:0016032"]
[278,139,"NK013-2","BRD2","Pan-specific","Bromodomain-containing protein 2",0,161,12,523,{"v":77.927,"d":"78"},{"v":136.92918639308573,"d":"137"},{"$nulls":3},0,128,8,455,{"v":54.6,"d":"55"},{"v":95.39794684224307,"d":"95"},{"$nulls":6},0,175,10,481,{"v":79.365,"d":"79"},{"v":135.78092782610926,"d":"136"},{"$nulls":7},"BRD2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","BRD",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 1-22 at the N-terminus of human BRD2.",{"$nulls":3},"P25440","P25440","P25440","P25440"]
[279,140,"PK546","BRD2","S37","Bromodomain-containing protein-serine kinase 2",0,6528,10,763,{"v":4973.234,"d":"4973"},{"v":8738.702700763937,"d":"8739"},{"v":8262.531705475414,"d":"8263"},{"v":476.17099528852305,"d":"476"},{"v":5.763015650190777,"d":"6"},0,6486,14,743,{"v":4808.696,"d":"4809"},{"v":8401.826472316976,"d":"8402"},{"v":8023.645248908371,"d":"8024"},{"v":378.18122340860464,"d":"378"},{"v":4.713334297276624,"d":"5"},{"v":10.476349947467401,"d":"10"},{"v":-2.891201693165513,"d":"-3"},null,0,6604,16,752,{"v":4954.176,"d":"4954"},{"v":8475.80941087183,"d":"8476"},{"v":7768.239624059983,"d":"7768"},{"v":707.5697868118477,"d":"708"},{"v":9.108495889085928,"d":"9"},{"v":14.871511539276705,"d":"15"},{"v":-5.982332038591437,"d":"-6"},null,null,"BRD2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","BRD",{"$nulls":6},"RKP(pS)LLY(bA)C","Corresponds to amino acid residues R34 to Y40; Near the N-terminus of the protein.","The effect of S37 phosphorylation is unclear. This is a major site of phosphorylation for BRD2 (≥341 reports by mass spectrometry studies).",null,"Protein kinase, Ser/Thr (non-receptor); ATYPICAL group; BRD family","P25440","P25440","P25440","P25440","GO:0005737; GO:0016607; GO:0005654","GO:0003682; GO:0070577","GO:0006334; GO:0006357; GO:0007283; GO:0006351; GO:0016032"]
[280,140,"PK546","BRD2","S37","Bromodomain-containing protein-serine kinase 2",0,5978,14,743,{"v":4431.252,"d":"4431"},{"v":7786.360710186892,"d":"7786"},{"$nulls":3},0,6138,18,715,{"v":4375.8,"d":"4376"},{"v":7645.464025499766,"d":"7645"},{"$nulls":6},0,5652,14,732,{"v":4127.016,"d":"4127"},{"v":7060.669837248134,"d":"7061"},{"$nulls":7},"BRD2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","BRD",{"$nulls":6},"RKP(pS)LLY(bA)C","Corresponds to amino acid residues R34 to Y40; Near the N-terminus of the protein.","The effect of S37 phosphorylation is unclear. This is a major site of phosphorylation for BRD2 (≥341 reports by mass spectrometry studies).",null,null,"P25440","P25440","P25440","P25440"]
[281,141,"PK548","BRK","Y342","Protein-tyrosine kinase 6",0,4072,14,947,{"v":3842.926,"d":"3843"},{"v":6752.585503725734,"d":"6753"},{"v":6016.1107668294035,"d":"6016"},{"v":736.4747368963308,"d":"736"},{"v":12.24170839667678,"d":"12"},0,4768,16,830,{"v":3944.16,"d":"3944"},{"v":6891.296080902956,"d":"6891"},{"v":6467.011091499365,"d":"6467"},{"v":424.2849894035917,"d":"424"},{"v":6.560758647241194,"d":"7"},{"v":18.80246704391797,"d":"19"},{"v":7.494880698607773,"d":"7"},null,0,4984,18,804,{"v":3992.664,"d":"3993"},{"v":6830.814873280474,"d":"6831"},{"v":6362.318063907302,"d":"6362"},{"v":468.49680937317225,"d":"468"},{"v":7.363618176068575,"d":"7"},{"v":19.605326572745355,"d":"20"},{"v":5.7546695946284245,"d":"6"},null,null,"BRK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"EDV(pY)LSH(bA)C","Corresponds to amino acid residues E339 to H345; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y342 phosphorylation stimulates phosphotransferase activity and induces interaction with Brk. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Its phosphorylation is commonly observed by mass spectrometry studies (≥48 reports).","Brk","Protein-tyrosine kinase, TK group, Src family","Q13882","Q13882","Q13882","Q13882","GO:0005737; GO:0005829; GO:0031234; GO:0016604; GO:0005654; GO:0005634; GO:0005886; GO:0001726","GO:0005524; GO:0042802; GO:0004715; GO:0004713; GO:0005102","GO:0016477; GO:0071300; GO:0038128; GO:0045087; GO:0060575; GO:0045926; GO:0061099; GO:0009968; GO:0038083; GO:0045787; GO:0045742; GO:0010976; GO:0042531; GO:0046777; GO:0006468; GO:0042127; GO:0007169; GO:0007260"]
[282,141,"PK548","BRK","Y342","Protein-tyrosine kinase 6",0,4352,10,692,{"v":3004.664,"d":"3005"},{"v":5279.636029933073,"d":"5280"},{"$nulls":3},0,4533,18,766,{"v":3458.49,"d":"3458"},{"v":6042.726102095773,"d":"6043"},{"$nulls":6},0,4443,15,778,{"v":3444.984,"d":"3445"},{"v":5893.82125453413,"d":"5894"},{"$nulls":7},"BRK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"EDV(pY)LSH(bA)C","Corresponds to amino acid residues E339 to H345; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y342 phosphorylation stimulates phosphotransferase activity and induces interaction with Brk. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Its phosphorylation is commonly observed by mass spectrometry studies (≥48 reports).","Brk",null,"Q13882","Q13882","Q13882","Q13882"]
[283,142,"PK547","BRK","S446+Y447","Protein-tyrosine kinase 6",0,3839,18,731,{"v":2793.151,"d":"2793"},{"v":4907.976617899236,"d":"4908"},{"v":4388.705444900256,"d":"4389"},{"v":519.2711729989796,"d":"519"},{"v":11.831989626972591,"d":"12"},0,4081,20,860,{"v":3492.46,"d":"3492"},{"v":6102.079000524913,"d":"6102"},{"v":5228.644403008719,"d":"5229"},{"v":873.4345975161941,"d":"873"},{"v":16.70480013927881,"d":"17"},{"v":28.536789766251403,"d":"29"},{"v":19.138649623535002,"d":"19"},null,0,2955,13,706,{"v":2077.052,"d":"2077"},{"v":3553.5065545653115,"d":"3554"},{"v":3529.6642687946987,"d":"3530"},{"v":23.84228577061276,"d":"24"},{"v":0.6754831041977363,"d":"1"},{"v":12.507472731170328,"d":"13"},{"v":-19.573908226257856,"d":"-20"},null,null,"BRK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"SFT(pS)(pY)ENP(bA)C","Corresponds to amino acid residues S443 to P450; In the C-terminus of the kinase.","S446 phosphorylation probably inhibits phosphotransferase activity and regulates molecular association. Y447 phosphorylation inhibits phosphotransferase activity and inhibits molecular association with Akt1. Y447 is the major phosphosite in BRK by mass spectrometry studies (≥379 reports), where as S446 is also commonly phosphorylated as well (≥87 reports).","Y447: Brk; SRMS","Protein-tyrosine kinase, TK group, Src family","Q13882","Q13882","Q13882","Q13882","GO:0005737; GO:0005829; GO:0031234; GO:0016604; GO:0005654; GO:0005634; GO:0005886; GO:0001726","GO:0005524; GO:0042802; GO:0004715; GO:0004713; GO:0005102","GO:0016477; GO:0071300; GO:0038128; GO:0045087; GO:0060575; GO:0045926; GO:0061099; GO:0009968; GO:0038083; GO:0045787; GO:0045742; GO:0010976; GO:0042531; GO:0046777; GO:0006468; GO:0042127; GO:0007169; GO:0007260"]
[284,142,"PK547","BRK","S446+Y447","Protein-tyrosine kinase 6",0,3140,12,704,{"v":2202.112,"d":"2202"},{"v":3869.4342719012766,"d":"3869"},{"$nulls":3},0,3806,12,657,{"v":2492.658,"d":"2493"},{"v":4355.209805492525,"d":"4355"},{"$nulls":6},0,2956,16,697,{"v":2049.18,"d":"2049"},{"v":3505.821983024086,"d":"3506"},{"$nulls":7},"BRK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"SFT(pS)(pY)ENP(bA)C","Corresponds to amino acid residues S443 to P450; In the C-terminus of the kinase.","S446 phosphorylation probably inhibits phosphotransferase activity and regulates molecular association. Y447 phosphorylation inhibits phosphotransferase activity and inhibits molecular association with Akt1. Y447 is the major phosphosite in BRK by mass spectrometry studies (≥379 reports), where as S446 is also commonly phosphorylated as well (≥87 reports).","Y447: Brk; SRMS",null,"Q13882","Q13882","Q13882","Q13882"]
[285,143,"NK364-1","BRSK1","Pan-specific","Protein-serine/threonine kinase BRSK1",0,162,8,614,{"v":94.556,"d":"95"},{"v":166.14878217542844,"d":"166"},{"v":153.31633837252696,"d":"153"},{"v":12.83244380290148,"d":"13"},{"v":8.369912782368504,"d":"8"},0,154,12,581,{"v":82.502,"d":"83"},{"v":144.14874377983034,"d":"144"},{"v":152.9267526614316,"d":"153"},{"v":8.778008881601266,"d":"9"},{"v":5.740008683134155,"d":"6"},{"v":14.109921465502659,"d":"14"},{"v":-0.2541058019196498,"d":"-0"},null,0,166,12,517,{"v":79.618,"d":"80"},{"v":136.2137707006762,"d":"136"},{"v":135.54996423691347,"d":"136"},{"v":0.6638064637627394,"d":"1"},{"v":0.48971349236399814,"d":"0"},{"v":8.859626274732502,"d":"9"},{"v":-11.588050121862992,"d":"-12"},null,null,"BRSK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","BRSK",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues 462-571 mapping within an internal region of human BRSK1.",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; CAMK domain target; CAMK</A> group; CAMKL family; BRSK subfamily","Q8TDC3","Q8TDC3","Q8TDC3",null,"GO:0030054; GO:0005813; GO:0005737; GO:0150034; GO:0005654; GO:0005634; GO:0048786; GO:0008021","GO:0005524; GO:0043015; GO:0000287; GO:0019901; GO:0004674; GO:0050321","GO:0008306; GO:0007409; GO:0006974; GO:0051298; GO:0030010; GO:0035556; GO:0090176; GO:0007095; GO:0030182; GO:0007269; GO:0006468; GO:0050770; GO:0010975; GO:0048167; GO:2000807; GO:0009411; GO:0099504"]
[286,143,"NK364-1","BRSK1","Pan-specific","Protein-serine/threonine kinase BRSK1",0,142,12,615,{"v":79.95,"d":"80"},{"v":140.48389456962545,"d":"140"},{"$nulls":3},0,162,12,617,{"v":92.55,"d":"93"},{"v":161.70476154303287,"d":"162"},{"$nulls":6},0,168,10,499,{"v":78.842,"d":"79"},{"v":134.88615777315073,"d":"135"},{"$nulls":7},"BRSK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","BRSK",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues 462-571 mapping within an internal region of human BRSK1.",{"$nulls":3},"Q8TDC3","Q8TDC3","Q8TDC3"]
[287,144,"PK549","BRSK1","T189","BR serine/threonine-protein kinase 1",0,9470,18,853,{"v":8062.556,"d":"8063"},{"v":14167.095272866805,"d":"14167"},{"v":14579.283278124512,"d":"14579"},{"v":412.1880052577071,"d":"412"},{"v":2.8272172053627265,"d":"3"},0,9624,18,823,{"v":7905.738,"d":"7906"},{"v":13813.025155177675,"d":"13813"},{"v":13107.442022079807,"d":"13107"},{"v":705.5831330978672,"d":"706"},{"v":5.383072699534319,"d":"5"},{"v":8.210289904897046,"d":"8"},{"v":-10.095429438929486,"d":"-10"},null,0,9762,16,777,{"v":7572.642,"d":"7573"},{"v":12955.589451961996,"d":"12956"},{"v":12760.247291585792,"d":"12760"},{"v":195.34216037620354,"d":"195"},{"v":1.5308650052966741,"d":"2"},{"v":4.358082210659401,"d":"4"},{"v":-12.47685466999667,"d":"-12"},null,null,"BRSK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","BRSK",{"$nulls":5},"LLE(pT)SCG(bA)C","Corresponds to amino acid residues L186 to G192; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T189 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is a minor in vivo phosphorylation site in BRSK1 (≥1 report by mass spectrometry).","BRSK1; CaMK2a; LKB1","Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; CAMK domain target; CAMK</A> group; CAMKL family; BRSK subfamily","Q8TDC3","Q8TDC3","Q8TDC3",null,"GO:0030054; GO:0005813; GO:0005737; GO:0150034; GO:0005654; GO:0005634; GO:0048786; GO:0008021","GO:0005524; GO:0043015; GO:0000287; GO:0019901; GO:0004674; GO:0050321","GO:0008306; GO:0007409; GO:0006974; GO:0051298; GO:0030010; GO:0035556; GO:0090176; GO:0007095; GO:0030182; GO:0007269; GO:0006468; GO:0050770; GO:0010975; GO:0048167; GO:2000807; GO:0009411; GO:0099504"]
[288,144,"PK549","BRSK1","T189","BR serine/threonine-protein kinase 1",0,9542,20,896,{"v":8531.712,"d":"8532"},{"v":14991.471283382218,"d":"14991"},{"$nulls":3},0,9167,20,776,{"v":7098.072,"d":"7098"},{"v":12401.85888898194,"d":"12402"},{"$nulls":6},0,9348,16,787,{"v":7344.284,"d":"7344"},{"v":12564.905131209589,"d":"12565"},{"$nulls":7},"BRSK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","BRSK",{"$nulls":5},"LLE(pT)SCG(bA)C","Corresponds to amino acid residues L186 to G192; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T189 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is a minor in vivo phosphorylation site in BRSK1 (≥1 report by mass spectrometry).","BRSK1; CaMK2a; LKB1",null,"Q8TDC3","Q8TDC3","Q8TDC3"]
[289,145,"NK014","Btk","Pan-specific","Bruton's agammaglobulinemia tyrosine kinase",0,706,12,615,{"v":426.81,"d":"427"},{"v":749.9678679332313,"d":"750"},{"v":776.9840015043131,"d":"777"},{"v":27.01613357108181,"d":"27"},{"v":3.477051460361612,"d":"3"},0,646,14,629,{"v":397.528,"d":"398"},{"v":694.5669416172748,"d":"695"},{"v":652.6669752578639,"d":"653"},{"v":41.89996635941088,"d":"42"},{"v":6.4198079492005125,"d":"6"},{"v":9.896859409562124,"d":"10"},{"v":-15.999946717790834,"d":"-16"},null,0,716,10,562,{"v":396.772,"d":"397"},{"v":678.8139645362695,"d":"679"},{"v":637.6066385409357,"d":"638"},{"v":41.207325995333804,"d":"41"},{"v":6.46281319931524,"d":"6"},{"v":9.939864659676852,"d":"10"},{"v":-17.938253901435544,"d":"-18"},null,null,"BTK","X","PYK","Protein kinase - Non-receptor- tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"Epitope undefined.",{"$nulls":3},"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK domain target; TK</A> group; Tec family","Q06187","Q06187","Q06187","Q06187","GO:0005737; GO:0031410; GO:0005829; GO:0031234; GO:0042629; GO:0045121; GO:0005634; GO:0048471; GO:0005886","GO:0005524; GO:0042802; GO:0046872; GO:0004715; GO:0005547; GO:0004713; GO:0005102","GO:0002250; GO:0097190; GO:0042113; GO:0002344; GO:0050853; GO:0019722; GO:0048469; GO:0098761; GO:0071226; GO:0034614; GO:0038095; GO:0002553; GO:0007249; GO:0045087; GO:0035556; GO:0007498; GO:0002755; GO:0030889; GO:0001818; GO:0038083; GO:0018108; GO:0045579; GO:0051092; GO:0001812; GO:0001805; GO:0006468; GO:0002902; GO:0002721; GO:0042127; GO:0006351; GO:0007169"]
[290,145,"NK014","Btk","Pan-specific","Bruton's agammaglobulinemia tyrosine kinase",0,752,14,620,{"v":457.56,"d":"458"},{"v":804.000135075395,"d":"804"},{"$nulls":3},0,621,12,574,{"v":349.566,"d":"350"},{"v":610.7670088984531,"d":"611"},{"$nulls":6},0,595,14,600,{"v":348.6,"d":"349"},{"v":596.3993125456019,"d":"596"},{"$nulls":7},"BTK","X","PYK","Protein kinase - Non-receptor- tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"Epitope undefined.",{"$nulls":4},"Q06187","Q06187","Q06187","Q06187"]
[291,146,"PK550","Btk","Y223+Y225","Bruton's agammaglobulinemia tyrosine kinase",0,1098,12,549,{"v":596.214,"d":"596"},{"v":1047.6355811999335,"d":"1048"},{"v":1001.420860611119,"d":"1001"},{"v":46.214720588814544,"d":"46"},{"v":4.614914908064919,"d":"5"},0,999,12,616,{"v":607.992,"d":"608"},{"v":1062.2928296063928,"d":"1062"},{"v":1004.4984470853724,"d":"1004"},{"v":57.79438252102045,"d":"58"},{"v":5.753556184055355,"d":"6"},{"v":10.368471092120274,"d":"10"},{"v":0.30732198572090397,"d":"0"},null,0,1084,12,485,{"v":519.92,"d":"520"},{"v":889.5006614420806,"d":"890"},{"v":884.936136583011,"d":"885"},{"v":4.564524859069593,"d":"5"},{"v":0.5158027421836919,"d":"1"},{"v":5.130717650248611,"d":"5"},{"v":-11.631945030286559,"d":"-12"},null,null,"BTK","X","PYK","Protein kinase - Non-receptor- tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"VAL(pY)D(pY)M(bA)C","Corresponds to amino acid residues V220 to M226; In the SH3_1 domain.","Y223 and Y225 phosphorylation stimulate phosphotransferase activity and regulates cell growth. These are two of the major in vivo phosphorylation sites in Btk (≥261 and ≥90 reports, respectively, by mass spectrometry).","Y223: Abl1; Btk; ITK; Lyn; PIK3CD, Tec","EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK domain target; TK</A> group; Tec family","Q06187","Q06187","Q06187","Q06187","GO:0005737; GO:0031410; GO:0005829; GO:0031234; GO:0042629; GO:0045121; GO:0005634; GO:0048471; GO:0005886","GO:0005524; GO:0042802; GO:0046872; GO:0004715; GO:0005547; GO:0004713; GO:0005102","GO:0002250; GO:0097190; GO:0042113; GO:0002344; GO:0050853; GO:0019722; GO:0048469; GO:0098761; GO:0071226; GO:0034614; GO:0038095; GO:0002553; GO:0007249; GO:0045087; GO:0035556; GO:0007498; GO:0002755; GO:0030889; GO:0001818; GO:0038083; GO:0018108; GO:0045579; GO:0051092; GO:0001812; GO:0001805; GO:0006468; GO:0002902; GO:0002721; GO:0042127; GO:0006351; GO:0007169"]
[292,146,"PK550","Btk","Y223+Y225","Bruton's agammaglobulinemia tyrosine kinase",0,1030,12,534,{"v":543.612,"d":"544"},{"v":955.2061400223043,"d":"955"},{"$nulls":3},0,1050,12,522,{"v":541.836,"d":"542"},{"v":946.7040645643519,"d":"947"},{"$nulls":6},0,1033,12,504,{"v":514.584,"d":"515"},{"v":880.3716117239414,"d":"880"},{"$nulls":7},"BTK","X","PYK","Protein kinase - Non-receptor- tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"VAL(pY)D(pY)M(bA)C","Corresponds to amino acid residues V220 to M226; In the SH3_1 domain.","Y223 and Y225 phosphorylation stimulate phosphotransferase activity and regulates cell growth. These are two of the major in vivo phosphorylation sites in Btk (≥261 and ≥90 reports, respectively, by mass spectrometry).","Y223: Abl1; Btk; ITK; Lyn; PIK3CD, Tec",null,"Q06187","Q06187","Q06187","Q06187"]
[293,147,"PK551","Btk","Y551","Bruton's agammaglobulinemia tyrosine kinase",0,4670,14,695,{"v":3235.92,"d":"3236"},{"v":5685.9867931925255,"d":"5686"},{"v":5703.94747021996,"d":"5704"},{"v":17.96067702743494,"d":"18"},{"v":0.314881529347996,"d":"0"},0,4348,16,711,{"v":3080.052,"d":"3080"},{"v":5381.513497570411,"d":"5382"},{"v":5027.831724905798,"d":"5028"},{"v":353.68177266461316,"d":"354"},{"v":7.034479115771118,"d":"7"},{"v":7.3493606451191145,"d":"7"},{"v":-11.853470755895472,"d":"-12"},null,0,4804,12,652,{"v":3124.384,"d":"3124"},{"v":5345.325501229139,"d":"5345"},{"v":5732.119368634647,"d":"5732"},{"v":386.7938674055076,"d":"387"},{"v":6.747833437000447,"d":"7"},{"v":7.062714966348444,"d":"7"},{"v":0.49390178576803123,"d":"0"},null,null,"BTK","X","PYK","Protein kinase - Non-receptor- tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"DDE(pY)TSS(bA)C","Corresponds to amino acid residues D548 to S554; In the protein kinase catalytic domain.","Y551 phosphorylation stimulates phosphotransferase activity, and regulates intracellular location and molecular association, including inducing interaction with BLNK. This is one of the major in vivo phosphorylation sites in Btk (≥148 reports from high throughput mass spectrometry studies).","Btk; Lyn; PIK3CD; Src; Syk","EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK domain target; TK</A> group; Tec family","Q06187","Q06187","Q06187","Q06187","GO:0005737; GO:0031410; GO:0005829; GO:0031234; GO:0042629; GO:0045121; GO:0005634; GO:0048471; GO:0005886","GO:0005524; GO:0042802; GO:0046872; GO:0004715; GO:0005547; GO:0004713; GO:0005102","GO:0002250; GO:0097190; GO:0042113; GO:0002344; GO:0050853; GO:0019722; GO:0048469; GO:0098761; GO:0071226; GO:0034614; GO:0038095; GO:0002553; GO:0007249; GO:0045087; GO:0035556; GO:0007498; GO:0002755; GO:0030889; GO:0001818; GO:0038083; GO:0018108; GO:0045579; GO:0051092; GO:0001812; GO:0001805; GO:0006468; GO:0002902; GO:0002721; GO:0042127; GO:0006351; GO:0007169"]
[294,147,"PK551","Btk","Y551","Bruton's agammaglobulinemia tyrosine kinase",0,4865,12,671,{"v":3256.363,"d":"3256"},{"v":5721.908147247395,"d":"5722"},{"$nulls":3},0,4194,14,640,{"v":2675.2,"d":"2675"},{"v":4674.149952241184,"d":"4674"},{"$nulls":6},0,4898,12,732,{"v":3576.552,"d":"3577"},{"v":6118.913236040154,"d":"6119"},{"$nulls":7},"BTK","X","PYK","Protein kinase - Non-receptor- tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"DDE(pY)TSS(bA)C","Corresponds to amino acid residues D548 to S554; In the protein kinase catalytic domain.","Y551 phosphorylation stimulates phosphotransferase activity, and regulates intracellular location and molecular association, including inducing interaction with BLNK. This is one of the major in vivo phosphorylation sites in Btk (≥148 reports from high throughput mass spectrometry studies).","Btk; Lyn; PIK3CD; Src; Syk",null,"Q06187","Q06187","Q06187","Q06187"]
[295,148,"PK552","BUB1B (Bub1R)","S670","Mitotic checkpoint serine/threonine-protein kinase BUB1 beta",0,4390,14,725,{"v":3172.6,"d":"3173"},{"v":5574.724251552141,"d":"5575"},{"v":5770.463387505587,"d":"5770"},{"v":195.73913595344584,"d":"196"},{"v":3.3920869574749783,"d":"3"},0,4776,22,789,{"v":3750.906,"d":"3751"},{"v":6553.639765535725,"d":"6554"},{"v":6054.063781162794,"d":"6054"},{"v":499.5759843729311,"d":"500"},{"v":8.251911483446221,"d":"8"},{"v":11.6439984409212,"d":"12"},{"v":4.9146901143375885,"d":"5"},null,0,4640,16,698,{"v":3227.552,"d":"3228"},{"v":5521.829586933972,"d":"5522"},{"v":5467.322179883762,"d":"5467"},{"v":54.50740705020962,"d":"55"},{"v":0.9969671670486497,"d":"1"},{"v":4.3890541245236285,"d":"4"},{"v":-5.253325205705266,"d":"-5"},null,null,"BUBR1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","BUB",{"$nulls":6},"KKL(pS)PII(bA)C","Corresponds to amino acid residues K667 to I673; Just before kinase catalytic domain. This is the major in vivo phosphorylation sites.","S670 phosphorylation induces interaction with PPP2R5A and PPP2CA and regulates cell cycle progression. This is the major in vivo phosphorylation site in BUB1B (≥33 reports from high throughput mass spectrometry studies).","CDK1; TTK","Spindle midzone, Anaphase-promoting complex, Cytoplasm, Nucleus, Outer kinetochore of condensed chromosome protein","O60566","O60566","O60566","O60566","GO:0005680; GO:0000777; GO:0000940; GO:0000778; GO:0005737; GO:0005829; GO:0000776; GO:0005815; GO:0048471; GO:0051233","GO:0005524; GO:0004672; GO:0004674","GO:0031145; GO:0006915; GO:0051301; GO:0008283; GO:0051754; GO:0007091; GO:0000278; GO:0007093; GO:0007094; GO:0034501"]
[296,148,"PK552","BUB1B (Bub1R)","S670","Mitotic checkpoint serine/threonine-protein kinase BUB1 beta",0,4676,12,728,{"v":3395.392,"d":"3395"},{"v":5966.202523459033,"d":"5966"},{"$nulls":3},0,4564,16,699,{"v":3179.052,"d":"3179"},{"v":5554.487796789863,"d":"5554"},{"$nulls":6},0,4624,12,686,{"v":3163.832,"d":"3164"},{"v":5412.814772833553,"d":"5413"},{"$nulls":7},"BUBR1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","BUB",{"$nulls":6},"KKL(pS)PII(bA)C","Corresponds to amino acid residues K667 to I673; Just before kinase catalytic domain. This is the major in vivo phosphorylation sites.","S670 phosphorylation induces interaction with PPP2R5A and PPP2CA and regulates cell cycle progression. This is the major in vivo phosphorylation site in BUB1B (≥33 reports from high throughput mass spectrometry studies).","CDK1; TTK",null,"O60566","O60566","O60566","O60566"]
[297,149,"PN575","C-EBPa","T226+T230","CCAAT/enhancer-binding protein alpha",0,3978,12,645,{"v":2558.07,"d":"2558"},{"v":4494.904767751367,"d":"4495"},{"v":4430.085375796659,"d":"4430"},{"v":64.81939195470841,"d":"65"},{"v":1.4631634936166888,"d":"1"},0,4240,18,620,{"v":2617.64,"d":"2618"},{"v":4573.580248573794,"d":"4574"},{"v":4102.108219786165,"d":"4102"},{"v":471.4720287876289,"d":"471"},{"v":11.493407865582975,"d":"11"},{"v":12.956571359199664,"d":"13"},{"v":-7.403404859923583,"d":"-7"},null,0,3653,14,615,{"v":2237.985,"d":"2238"},{"v":3828.837393824925,"d":"3829"},{"v":3682.9496704197477,"d":"3683"},{"v":145.88772340517744,"d":"146"},{"v":3.961165274043795,"d":"4"},{"v":5.424328767660484,"d":"5"},{"v":-16.865040783611406,"d":"-17"},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"CGHP(pT)PPP(pT)PVP","Corresponds to amino acid residues C223 to P233.","The effects of T226 and T230 phosphorylations are unclear.  Their phosphorylation has been reported to both inhibit and activate transcriptional activity. Neither of these two phosphorylation sites have apparently been reported from high throughput mass spectrometry, although there are several literature reports for their phosphorylation.","T226: BARK2 (GRK3, ADRBK2); GSK3a; GSK3b. T230: GSK3a.","Transcription protein","P49715","P49715",null,"P49715","GO:0043231; GO:0005730; GO:0005654; GO:0005634; GO:0090575","GO:0003677; GO:0003700; GO:0019900; GO:0042803; GO:0000978; GO:0000981; GO:0001013; GO:0001077; GO:0001228; GO:0003713; GO:0003705; GO:0008134; GO:0044212","GO:0050873; GO:0048469; GO:0071285; GO:0071407; GO:0071356; GO:0008203; GO:0019221; GO:0001892; GO:0045444; GO:0006091; GO:0042593; GO:0030851; GO:0048839; GO:0055088; GO:0001889; GO:0030324; GO:0030225; GO:0007005; GO:0030099; GO:0008285; GO:0045736; GO:0045892; GO:0000122; GO:0007219; GO:2000144; GO:0045600; GO:0050729; GO:0043032; GO:0045669; GO:0032436; GO:0045944; GO:0045945; GO:0006351; GO:0006360; GO:0006366; GO:0000050; GO:0016032; GO:0050872"]
[298,149,"PN575","C-EBPa","T226+T230","CCAAT/enhancer-binding protein alpha",0,3731,12,668,{"v":2484.292,"d":"2484"},{"v":4365.26598384195,"d":"4365"},{"$nulls":3},0,3530,14,591,{"v":2077.956,"d":"2078"},{"v":3630.6361909985358,"d":"3631"},{"$nulls":6},0,3458,18,601,{"v":2067.44,"d":"2067"},{"v":3537.0619470145703,"d":"3537"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"CGHP(pT)PPP(pT)PVP","Corresponds to amino acid residues C223 to P233.","The effects of T226 and T230 phosphorylations are unclear.  Their phosphorylation has been reported to both inhibit and activate transcriptional activity. Neither of these two phosphorylation sites have apparently been reported from high throughput mass spectrometry, although there are several literature reports for their phosphorylation.","T226: BARK2 (GRK3, ADRBK2); GSK3a; GSK3b. T230: GSK3a.",null,"P49715","P49715",null,"P49715"]
[299,150,"PN216","C3G (RapGEF1)","Y504","Rap guanine nucleotide exchange factor 1",0,126,8,503,{"v":59.354,"d":"59"},{"v":104.29369703921888,"d":"104"},{"v":98.43185498438123,"d":"98"},{"v":5.861842054837652,"d":"6"},{"v":5.955228676496837,"d":"6"},0,108,12,543,{"v":52.128,"d":"52"},{"v":91.07883100718767,"d":"91"},{"v":86.1202344295634,"d":"86"},{"v":4.958596577624277,"d":"5"},{"v":5.757760194765665,"d":"6"},{"v":11.712988871262503,"d":"12"},{"v":-12.50776037571515,"d":"-13"},null,0,118,10,478,{"v":51.624,"d":"52"},{"v":88.32047650847433,"d":"88"},{"v":98.45379012926492,"d":"98"},{"v":10.133313620790588,"d":"10"},{"v":10.292456600691606,"d":"10"},{"v":16.247685277188445,"d":"16"},{"v":0.022284599723505494,"d":"0"},{"$nulls":15},"Not precisely defined.","Antibody raised against amino acid residues that encompass the Y504 phosphosite.","Y504 phosphorylation increases RapGEF1 activity. Its phosphorylation has apparently not been reported from high throughput mass spectrometry, although there are several literature reports for Y504 phosphorylation.","Abl1; Hck; Src","Guanine nucleotide exchange factor for Rap G protein","Q13905","Q13905",null,null,"GO:0005737; GO:0005829; GO:0005769; GO:0005768; GO:0048471; GO:0030670; GO:0032991","GO:0005085; GO:0017034; GO:0017124","GO:0000186; GO:0001568; GO:0098609; GO:0071320; GO:1990090; GO:0019221; GO:0061028; GO:0090090; GO:0070373; GO:2000178; GO:0051898; GO:0046580; GO:0038180; GO:0048008; GO:0070374; GO:1905451; GO:0043547; GO:0010976; GO:0032486; GO:1901888; GO:0046328; GO:0007165; GO:0007169"]
[300,150,"PN216","C3G (RapGEF1)","Y504","Rap guanine nucleotide exchange factor 1",0,116,10,497,{"v":52.682,"d":"53"},{"v":92.57001292954357,"d":"93"},{"$nulls":3},0,106,8,474,{"v":46.452,"d":"46"},{"v":81.1616378519391,"d":"81"},{"$nulls":6},0,120,10,577,{"v":63.47,"d":"63"},{"v":108.5871037500555,"d":"109"},{"$nulls":20},"Not precisely defined.","Antibody raised against amino acid residues that encompass the Y504 phosphosite.","Y504 phosphorylation increases RapGEF1 activity. Its phosphorylation has apparently not been reported from high throughput mass spectrometry, although there are several literature reports for Y504 phosphorylation.","Abl1; Hck; Src",null,"Q13905","Q13905"]
[301,151,"PN691","CAD","S1859","Aspartate carbamoyltransferase",0,2544,14,628,{"v":1588.84,"d":"1589"},{"v":2791.825278899358,"d":"2792"},{"v":2623.7190350785195,"d":"2624"},{"v":168.1062438208387,"d":"168"},{"v":6.407173998941842,"d":"6"},0,2199,14,633,{"v":1383.105,"d":"1383"},{"v":2416.582001231513,"d":"2417"},{"v":2569.41527788276,"d":"2569"},{"v":152.83327665124716,"d":"153"},{"v":5.94817342166597,"d":"6"},{"v":12.355347420607814,"d":"12"},{"v":-2.0697245577644026,"d":"-2"},null,0,2670,16,666,{"v":1767.564,"d":"1768"},{"v":3024.0216709132364,"d":"3024"},{"v":2727.361771901741,"d":"2727"},{"v":296.6598990114953,"d":"297"},{"v":10.877174493966733,"d":"11"},{"v":17.284348492908574,"d":"17"},{"v":3.9502223918621553,"d":"4"},{"$nulls":5},"De novo pyrimidine synthesis",{"$nulls":8},"X","HRA(pS)DPG(bA)C","Corresponds to amino acid residues H1856 to G1862.","S1859 phosphorylation stimulates enzyme activity. This is the major in vivo phosphorylation site in CAD (≥162 reports from high throughput mass spectrometry studies). However, This human phosphosite is not highly conserved in nature, but is found in the rhesus monkey.","PKACa (PRKACA); p70 S6Kb (RPS6KB1)","EC 6.3.5.5; EC 2.1.3.2; Ligase; Nucleotide Metabolism - pyrimidine; EC 3.5.2.3; Transferase; Hydrolase; Amino Acid Metabolism - alanine, aspartate and glutamate","P27708","P27708",null,null,"GO:0042995; GO:0005829; GO:0070062; GO:0016020; GO:0043025; GO:0016363; GO:0005654; GO:0005634; GO:0032991; GO:0043195","GO:0070335; GO:0004070; GO:0005524; GO:0004087; GO:0004088; GO:0004151; GO:0019899; GO:0042802; GO:0004672; GO:0008270","GO:0006207; GO:0044205; GO:0031100; GO:0006526; GO:0035690; GO:0071364; GO:0019240; GO:0017144; GO:0007565; GO:0006541; GO:0007507; GO:0007595; GO:0001889; GO:0018107; GO:0046777; GO:0046134; GO:0014075; GO:0031000; GO:0051414; GO:0032868; GO:0042594; GO:0033574; GO:0000050; GO:0006228"]
[302,151,"PN691","CAD","S1859","Aspartate carbamoyltransferase",0,2248,12,625,{"v":1397.5,"d":"1398"},{"v":2455.612791257681,"d":"2456"},{"$nulls":3},0,2560,10,611,{"v":1558.05,"d":"1558"},{"v":2722.2485545340073,"d":"2722"},{"$nulls":6},0,2374,10,601,{"v":1420.764,"d":"1421"},{"v":2430.7018728902453,"d":"2431"},{"$nulls":10},"De novo pyrimidine synthesis",{"$nulls":8},"X","HRA(pS)DPG(bA)C","Corresponds to amino acid residues H1856 to G1862.","S1859 phosphorylation stimulates enzyme activity. This is the major in vivo phosphorylation site in CAD (≥162 reports from high throughput mass spectrometry studies). However, This human phosphosite is not highly conserved in nature, but is found in the rhesus monkey.","PKACa (PRKACA); p70 S6Kb (RPS6KB1)",null,"P27708","P27708"]
[303,153,"PN015","CALD1","S789","Caldesmon",0,248,8,300,72,{"v":126.51457672311486,"d":"127"},{"v":128.56428858071922,"d":"129"},{"v":2.0497118576043647,"d":"2"},{"v":1.5943088708630397,"d":"2"},0,486,10,333,{"v":158.508,"d":"159"},{"v":276.9475779866349,"d":"277"},{"v":188.03005211211854,"d":"188"},{"v":88.91752587451634,"d":"89"},{"v":47.28899709153759,"d":"47"},{"v":48.88330596240063,"d":"49"},{"v":46.25371803310969,"d":"46"},null,0,208,11,295,{"v":58.115,"d":"58"},{"v":99.42554804528874,"d":"99"},{"v":85.16140786069622,"d":"85"},{"v":14.26414018459252,"d":"14"},{"v":16.749535432675394,"d":"17"},{"v":18.343844303538432,"d":"18"},{"v":-33.75967090019128,"d":"-34"},{"$nulls":15},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S789 phosphosite.","The effect of S789 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in caldesmon (≥18 reports from high throughput mass spectrometry studies).","CDK1 (CDC2); CDK6; ERK1 (MAPK3); ERK2 (MAPK1); p38a MAPK (MAPK14); PKCa (PRKCA)","Cytoskeletal, calcium binding protein","Q05682","Q05682",null,null,"GO:0030478; GO:0015629; GO:0005856; GO:0005829; GO:0043231; GO:0030016; GO:0005886","GO:0003779; GO:0045296; GO:0005516; GO:0017022; GO:0005523","GO:0006936"]
[304,153,"PN015","CALD1","S789","Caldesmon",0,297,10,259,{"v":74.333,"d":"74"},{"v":130.61400043832356,"d":"131"},{"$nulls":3},0,234,8,251,{"v":56.726,"d":"57"},{"v":99.1125262376022,"d":"99"},{"$nulls":6},0,156,8,280,{"v":41.44,"d":"41"},{"v":70.89726767610368,"d":"71"},{"$nulls":20},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S789 phosphosite.","The effect of S789 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in caldesmon (≥18 reports from high throughput mass spectrometry studies).","CDK1 (CDC2); CDK6; ERK1 (MAPK3); ERK2 (MAPK1); p38a MAPK (MAPK14); PKCa (PRKCA)",null,"Q05682","Q05682"]
[305,154,"NK211","CaMK1a (CAMK1)","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase 1 alpha",0,204,12,605,{"v":116.16,"d":"116"},{"v":204.11018377995865,"d":"204"},{"v":174.40034401281383,"d":"174"},{"v":29.709839767144814,"d":"30"},{"v":17.03542497884174,"d":"17"},0,148,12,594,{"v":80.784,"d":"81"},{"v":141.1470281630726,"d":"141"},{"v":136.55709398075442,"d":"137"},{"v":4.5899341823181885,"d":"5"},{"v":3.3611832593369835,"d":"3"},{"v":20.39660823817872,"d":"20"},{"v":-21.699068454405648,"d":"-22"},null,0,180,14,664,{"v":110.224,"d":"110"},{"v":188.5757826334665,"d":"189"},{"v":200.2745161365842,"d":"200"},{"v":11.698733503117694,"d":"12"},{"v":5.841349028719827,"d":"6"},{"v":22.876774007561565,"d":"23"},{"v":14.836078604219566,"d":"15"},null,null,"CaMK1a","X","PSTK","Protein kinase - Non-receptor- tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"Epitope undefined.",{"$nulls":3},"EC 2.7.11.17; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; CAMK1 family","Q14012","Q14012","Q14012",null,"GO:0005737; GO:0098978; GO:0005622; GO:0005634; GO:0014069","GO:0005524; GO:0005516; GO:0004683","GO:0007049; GO:0035556; GO:0032091; GO:0006913; GO:0018107; GO:0060999; GO:0051149; GO:0010976; GO:0033138; GO:1901985; GO:0046827; GO:0071902; GO:0051835; GO:0060143; GO:0045944; GO:0006468; GO:0051147; GO:0043393; GO:0032880; GO:0007165"]
[306,154,"NK211","CaMK1a (CAMK1)","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase 1 alpha",0,156,10,564,{"v":82.344,"d":"82"},{"v":144.69050424566902,"d":"145"},{"$nulls":3},0,144,14,581,{"v":75.53,"d":"76"},{"v":131.96715979843626,"d":"132"},{"$nulls":6},0,196,19,700,{"v":123.9,"d":"124"},{"v":211.9732496397019,"d":"212"},{"$nulls":7},"CaMK1a","X","PSTK","Protein kinase - Non-receptor- tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"Epitope undefined.",{"$nulls":4},"Q14012","Q14012","Q14012"]
[307,155,"PK553","CaMK1a (CAMK1)","T177","Calcium/calmodulin-dependent protein-serine kinase 1 alpha",0,3148,12,666,{"v":2088.576,"d":"2089"},{"v":3669.934841584116,"d":"3670"},{"v":3190.590438996122,"d":"3191"},{"v":479.34440258799395,"d":"479"},{"v":15.023689556933967,"d":"15"},0,2366,14,574,{"v":1350.048,"d":"1350"},{"v":2358.8243102285087,"d":"2359"},{"v":2818.4746813543316,"d":"2818"},{"v":459.65037112582286,"d":"460"},{"v":16.3084796952993,"d":"16"},{"v":31.332169252233268,"d":"31"},{"v":-11.662912077141172,"d":"-12"},null,0,3092,14,628,{"v":1932.984,"d":"1933"},{"v":3307.029055541158,"d":"3307"},{"v":3231.7657206085532,"d":"3232"},{"v":75.26333493260472,"d":"75"},{"v":2.328861106876038,"d":"2"},{"v":17.352550663810003,"d":"17"},{"v":1.2905223155306231,"d":"1"},null,null,"CaMK1a","X","PSTK","Protein kinase - Non-receptor- tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"VLS(pT)ACG(bA)C","Corresponds to amino acid residues V174 to G180; In the protein kinase catalytic domain.","T177 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in CaMK1a (≥12 reports from high throughput mass spectrometry studies).","CAMKK1","EC 2.7.11.17; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; CAMK1 family","Q14012","Q14012","Q14012",null,"GO:0005737; GO:0098978; GO:0005622; GO:0005634; GO:0014069","GO:0005524; GO:0005516; GO:0004683","GO:0007049; GO:0035556; GO:0032091; GO:0006913; GO:0018107; GO:0060999; GO:0051149; GO:0010976; GO:0033138; GO:1901985; GO:0046827; GO:0071902; GO:0051835; GO:0060143; GO:0045944; GO:0006468; GO:0051147; GO:0043393; GO:0032880; GO:0007165"]
[308,155,"PK553","CaMK1a (CAMK1)","T177","Calcium/calmodulin-dependent protein-serine kinase 1 alpha",0,2525,12,614,{"v":1542.982,"d":"1543"},{"v":2711.246036408128,"d":"2711"},{"$nulls":3},0,2962,12,636,{"v":1876.2,"d":"1876"},{"v":3278.125052480155,"d":"3278"},{"$nulls":6},0,2966,14,625,1845,{"v":3156.502385675948,"d":"3157"},{"$nulls":7},"CaMK1a","X","PSTK","Protein kinase - Non-receptor- tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"VLS(pT)ACG(bA)C","Corresponds to amino acid residues V174 to G180; In the protein kinase catalytic domain.","T177 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in CaMK1a (≥12 reports from high throughput mass spectrometry studies).","CAMKK1",null,"Q14012","Q14012","Q14012"]
[309,156,"PK874","CaMK1a (CAMK1)","Y235","Calcium/calmodulin-dependent protein-serine kinase 1 alpha",0,4334,12,866,{"v":3742.852,"d":"3743"},{"v":6576.7407849619985,"d":"6577"},{"v":6033.429206665278,"d":"6033"},{"v":543.3115782967207,"d":"543"},{"v":9.00502118590388,"d":"9"},0,4481,18,795,{"v":3548.085,"d":"3548"},{"v":6199.267842889377,"d":"6199"},{"v":6284.68482322363,"d":"6285"},{"v":85.41698033425291,"d":"85"},{"v":1.359129100931423,"d":"1"},{"v":10.364150286835303,"d":"10"},{"v":4.164391558299613,"d":"4"},null,0,4056,20,953,{"v":3846.308,"d":"3846"},{"v":6580.4229691298015,"d":"6580"},{"v":6371.958655204475,"d":"6372"},{"v":208.46431392532668,"d":"208"},{"v":3.271589242894061,"d":"3"},{"v":12.276610428797941,"d":"12"},{"v":5.610896174354949,"d":"6"},null,null,"CaMK1a","X","PSTK","Protein kinase - Non-receptor- tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"KAE(pY)EFD(bA)C","Corresponds to amino acid residues K232 to D238. Y235 is located in the Gap/Insert 10 (G/I10) region in the protein-serine/threonine kinase catalytic domain of CaMK1a, and has been observed in only a small number of mass spectrometry studies (~2). The effect of its phosphorylation is unknown. However, it has homology with the Y245 phosphosite in VACAMKL.","The effect of Y235 phosphorylation is unclear. This is one of the minor in vivo phosphorylation sites in CaMK1a (≥2 reports from high throughput mass spectrometry studies).",null,"EC 2.7.11.17; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; CAMK1 family","Q14012","Q14012","Q14012",null,"GO:0005737; GO:0098978; GO:0005622; GO:0005634; GO:0014069","GO:0005524; GO:0005516; GO:0004683","GO:0007049; GO:0035556; GO:0032091; GO:0006913; GO:0018107; GO:0060999; GO:0051149; GO:0010976; GO:0033138; GO:1901985; GO:0046827; GO:0071902; GO:0051835; GO:0060143; GO:0045944; GO:0006468; GO:0051147; GO:0043393; GO:0032880; GO:0007165"]
[310,156,"PK874","CaMK1a (CAMK1)","Y235","Calcium/calmodulin-dependent protein-serine kinase 1 alpha",0,3966,16,791,{"v":3124.45,"d":"3124"},{"v":5490.117628368558,"d":"5490"},{"$nulls":3},0,4344,14,842,{"v":3645.86,"d":"3646"},{"v":6370.101803557882,"d":"6370"},{"$nulls":6},0,3659,20,990,{"v":3602.61,"d":"3603"},{"v":6163.494341279148,"d":"6163"},{"$nulls":7},"CaMK1a","X","PSTK","Protein kinase - Non-receptor- tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"KAE(pY)EFD(bA)C","Corresponds to amino acid residues K232 to D238. Y235 is located in the Gap/Insert 10 (G/I10) region in the protein-serine/threonine kinase catalytic domain of CaMK1a, and has been observed in only a small number of mass spectrometry studies (~2). The effect of its phosphorylation is unknown. However, it has homology with the Y245 phosphosite in VACAMKL.","The effect of Y235 phosphorylation is unclear. This is one of the minor in vivo phosphorylation sites in CaMK1a (≥2 reports from high throughput mass spectrometry studies).",null,null,"Q14012","Q14012","Q14012"]
[311,157,"NK016-3","CaMK1d","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase 1 delta",0,50,10,655,{"v":26.2,"d":"26"},{"v":46.03724875202235,"d":"46"},{"v":55.915928617818906,"d":"56"},{"v":9.878679865796556,"d":"10"},{"v":17.667022814405136,"d":"18"},0,88,10,556,{"v":43.368,"d":"43"},{"v":75.77322634898164,"d":"76"},{"v":54.00642008962882,"d":"54"},{"v":21.76680625935282,"d":"22"},{"v":40.304108702685205,"d":"40"},{"v":57.97113151709034,"d":"58"},{"v":-3.4149634556575705,"d":"-3"},null,0,58,8,662,{"v":33.1,"d":"33"},{"v":56.62885038800753,"d":"57"},{"v":56.46460961346829,"d":"56"},{"v":0.16424077453923758,"d":"0"},{"v":0.29087383347473256,"d":"0"},{"v":17.95789664787987,"d":"18"},{"v":0.9812606339770724,"d":"1"},null,null,"CaMK1d","X","PSTK","Protein kinase - Non-receptor- tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 319-385 mapping at the C-terminus of human CaMKIδ.",null,null,"Protein-serine kinase, CAMK group, CAMK1 family","Q8IU85","Q8IU85","Q8IU85",null,"GO:0005737; GO:0005634","GO:0005524; GO:0005516; GO:0004683","GO:0006954; GO:0035556; GO:0043066; GO:0018105; GO:0018107; GO:0043065; GO:0032793; GO:0010976; GO:0090023; GO:0050766; GO:0060267; GO:0050773; GO:0071622"]
[312,157,"NK016-3","CaMK1d","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase 1 delta",0,84,10,506,{"v":37.444,"d":"37"},{"v":65.79460848361546,"d":"66"},{"$nulls":3},0,38,10,659,{"v":18.452,"d":"18"},{"v":32.23961383027599,"d":"32"},{"$nulls":6},0,88,12,433,{"v":32.908,"d":"33"},{"v":56.30036883892905,"d":"56"},{"$nulls":7},"CaMK1d","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK1",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 319-385 mapping at the C-terminus of human CaMKIδ.",{"$nulls":3},"Q8IU85","Q8IU85","Q8IU85"]
[313,158,"NK016-2","CaMK1d","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase 1 delta",0,210,8,594,{"v":119.988,"d":"120"},{"v":210.8365421090709,"d":"211"},{"v":207.75450644834393,"d":"208"},{"v":3.082035660726973,"d":"3"},{"v":1.4834988243652323,"d":"1"},0,212,10,610,{"v":123.22,"d":"123"},{"v":215.29184999819032,"d":"215"},{"v":233.6550811577503,"d":"234"},{"v":18.363231159559973,"d":"18"},{"v":7.859119120616167,"d":"8"},{"v":9.342617944981399,"d":"9"},{"v":12.46691354723815,"d":"12"},null,0,322,8,596,{"v":187.144,"d":"187"},{"v":320.1737032330296,"d":"320"},{"v":266.7099094377053,"d":"267"},{"v":53.46379379532431,"d":"53"},{"v":20.045672059219722,"d":"20"},{"v":21.529170883584953,"d":"22"},{"v":28.37743642591937,"d":"28"},null,null,"CaMK1d","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK1",{"$nulls":6},"Epitope undefined.",{"$nulls":3},"Protein-serine kinase, CAMK group, CAMK1 family","Q8IU85","Q8IU85","Q8IU85",null,"GO:0005737; GO:0005634","GO:0005524; GO:0005516; GO:0004683","GO:0006954; GO:0035556; GO:0043066; GO:0018105; GO:0018107; GO:0043065; GO:0032793; GO:0010976; GO:0090023; GO:0050766; GO:0060267; GO:0050773; GO:0071622"]
[314,158,"NK016-2","CaMK1d","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase 1 delta",0,222,14,560,{"v":116.48,"d":"116"},{"v":204.67247078761693,"d":"205"},{"$nulls":3},0,250,10,601,{"v":144.24,"d":"144"},{"v":252.01831231731026,"d":"252"},{"$nulls":6},0,231,10,564,{"v":124.644,"d":"125"},{"v":213.24611564238097,"d":"213"},{"$nulls":7},"CaMK1d","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK1",{"$nulls":6},"Epitope undefined.",{"$nulls":4},"Q8IU85","Q8IU85","Q8IU85"]
[315,159,"PK554","CaMK1d","T180","Calcium/calmodulin-dependent protein-serine kinase 1 delta",0,3398,16,781,{"v":2641.342,"d":"2641"},{"v":4641.225904319245,"d":"4641"},{"v":4386.771704737981,"d":"4387"},{"v":254.45419958126422,"d":"254"},{"v":5.800488758200892,"d":"6"},0,3614,16,771,{"v":2774.058,"d":"2774"},{"v":4846.87614691024,"d":"4847"},{"v":4744.646588856401,"d":"4745"},{"v":102.22955805383936,"d":"102"},{"v":2.154629562799106,"d":"2"},{"v":7.955118320999998,"d":"8"},{"v":8.15804669597675,"d":"8"},null,0,3608,14,885,{"v":3180.69,"d":"3181"},{"v":5441.656137179204,"d":"5442"},{"v":5045.21740137302,"d":"5045"},{"v":396.438735806184,"d":"396"},{"v":7.85771363783642,"d":"8"},{"v":13.65820239603731,"d":"14"},{"v":15.009800850221524,"d":"15"},null,null,"CaMK1d","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK1",{"$nulls":6},"VMS(pT)ACG(bA)C","Corresponds to amino acid residues V177 to G183; In the protein kinase catalytic domain.","T180 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation site in CaMK1d (≥19 reports from high throughput mass spectrometry studies).","CaMKK1","Protein-serine kinase, CAMK group, CAMK1 family","Q8IU85","Q8IU85","Q8IU85",null,"GO:0005737; GO:0005634","GO:0005524; GO:0005516; GO:0004683","GO:0006954; GO:0035556; GO:0043066; GO:0018105; GO:0018107; GO:0043065; GO:0032793; GO:0010976; GO:0090023; GO:0050766; GO:0060267; GO:0050773; GO:0071622"]
[316,159,"PK554","CaMK1d","T180","Calcium/calmodulin-dependent protein-serine kinase 1 delta",0,3190,12,740,{"v":2351.72,"d":"2352"},{"v":4132.317505156718,"d":"4132"},{"$nulls":3},0,3554,16,751,{"v":2657.038,"d":"2657"},{"v":4642.417030802561,"d":"4642"},{"$nulls":6},0,3679,12,741,{"v":2717.247,"d":"2717"},{"v":4648.778665566836,"d":"4649"},{"$nulls":7},"CaMK1d","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK1",{"$nulls":6},"VMS(pT)ACG(bA)C","Corresponds to amino acid residues V177 to G183; In the protein kinase catalytic domain.","T180 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation site in CaMK1d (≥19 reports from high throughput mass spectrometry studies).","CaMKK1",null,"Q8IU85","Q8IU85","Q8IU85"]
[317,160,"NK302-2","CaMK2a","Pan-specific","Calcium/calmodulin-dependent protein kinase type II subunit alpha",0,26,10,914,{"v":14.624,"d":"15"},{"v":25.696516249983773,"d":"26"},{"v":41.18400901717175,"d":"41"},{"v":15.48749276718798,"d":"15"},{"v":37.60559774724806,"d":"38"},0,7834,10,416,{"v":3254.784,"d":"3255"},{"v":5686.807894047312,"d":"5687"},{"v":6694.762332686787,"d":"6695"},{"v":1007.9544386394746,"d":"1008"},{"v":15.05586589262767,"d":"15"},{"v":52.661463639875734,"d":"53"},{"v":16155.732485624196,"d":"16156"},"Likely Ab spot mis-print",0,1344,10,374,{"v":498.916,"d":"499"},{"v":853.5661486460169,"d":"854"},{"v":2611.8833989866434,"d":"2612"},{"v":1758.3172503406265,"d":"1758"},{"v":67.31989839296874,"d":"67"},{"v":104.92549614021681,"d":"105"},{"v":6241.984331582711,"d":"6242"},"Likely Ab spot mis-print",null,"CaMK2a","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK2",{"$nulls":6},"Epitope undefined.",{"$nulls":3},"EC 2.7.11.17; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; CAMK2 family","Q9UQM7","Q9UQM7","Q9UQM7",null,"GO:0005954; GO:0030054; GO:0005737; GO:0005829; GO:0043197; GO:0030666; GO:0005739; GO:0043005; GO:0005654; GO:0005634; GO:0005886; GO:0014069; GO:0042734; GO:0098685","GO:0005524; GO:0009931; GO:0005516; GO:0004683; GO:0035254; GO:0042802; GO:0016301; GO:0046872; GO:0042803; GO:0004674; GO:0005088","GO:0038166; GO:0006816; GO:0030154; GO:0048813; GO:0060996; GO:0000082; GO:0060333; GO:0035556; GO:0000165; GO:0007399; GO:0018105; GO:1990443; GO:0018107; GO:0051928; GO:0010666; GO:0051092; GO:0046777; GO:0006468; GO:1902108; GO:0048168; GO:2001222; GO:0046928; GO:0099148; GO:0002931; GO:0007223"]
[318,160,"NK302-2","CaMK2a","Pan-specific","Calcium/calmodulin-dependent protein kinase type II subunit alpha",0,54,10,733,{"v":32.252,"d":"32"},{"v":56.671501784359734,"d":"57"},{"$nulls":3},0,12650,18,349,{"v":4408.568,"d":"4409"},{"v":7702.716771326262,"d":"7703"},{"$nulls":6},0,5268,12,486,{"v":2554.416,"d":"2554"},{"v":4370.20064932727,"d":"4370"},{"$nulls":7},"CaMK2a","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK2",{"$nulls":6},"Epitope undefined.",{"$nulls":4},"Q9UQM7","Q9UQM7","Q9UQM7"]
[319,161,"PK875","CaMK2a","Y230","Calcium/calmodulin-dependent protein-serine kinase 2 alpha",0,5614,14,798,{"v":4468.8,"d":"4469"},{"v":7852.338061947996,"d":"7852"},{"v":10590.768918029502,"d":"10591"},{"v":2738.430856081506,"d":"2738"},{"v":25.856770903759962,"d":"26"},0,10746,20,857,{"v":9192.182,"d":"9192"},{"v":16060.71959341069,"d":"16061"},{"v":14875.101330106258,"d":"14875"},{"v":1185.6182633044318,"d":"1186"},{"v":7.970488650755043,"d":"8"},{"v":33.827259554515,"d":"34"},{"v":40.45345947245812,"d":"40"},null,0,8898,16,817,{"v":7256.594,"d":"7257"},{"v":12414.881448716407,"d":"12415"},{"v":11874.521601696013,"d":"11875"},{"v":540.3598470203942,"d":"540"},{"v":4.550582037285745,"d":"5"},{"v":30.40735294104571,"d":"30"},{"v":12.121430404180373,"d":"12"},null,null,"CaMK2a","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK2",{"$nulls":6},"AGA(pY)DFP(bA)C","Corresponds to amino acid residues A227 to P230. Y230 is located in the Gap/Insert 10 (G/I10) region in the protein-serine/threonine kinase catalytic domain of CaMK2a. ","The effect of Y230 phosphorylation is unknown. It appears to be the third most commonly observed phosphosite in CaMK2a by mass spectrometry studies (~28 reports). Phosphorylation of Y230 in rat brain appears to be induced by 15 min ischemia treatment.",null,"EC 2.7.11.17; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; CAMK2 family","Q9UQM7","Q9UQM7","Q9UQM7",null,"GO:0005954; GO:0030054; GO:0005737; GO:0005829; GO:0043197; GO:0030666; GO:0005739; GO:0043005; GO:0005654; GO:0005634; GO:0005886; GO:0014069; GO:0042734; GO:0098685","GO:0005524; GO:0009931; GO:0005516; GO:0004683; GO:0035254; GO:0042802; GO:0016301; GO:0046872; GO:0042803; GO:0004674; GO:0005088","GO:0038166; GO:0006816; GO:0030154; GO:0048813; GO:0060996; GO:0000082; GO:0060333; GO:0035556; GO:0000165; GO:0007399; GO:0018105; GO:1990443; GO:0018107; GO:0051928; GO:0010666; GO:0051092; GO:0046777; GO:0006468; GO:1902108; GO:0048168; GO:2001222; GO:0046928; GO:0099148; GO:0002931; GO:0007223"]
[320,161,"PK875","CaMK2a","Y230","Calcium/calmodulin-dependent protein-serine kinase 2 alpha",0,9508,14,799,{"v":7585.706,"d":"7586"},{"v":13329.19977411101,"d":"13329"},{"$nulls":3},0,9612,22,817,{"v":7835.03,"d":"7835"},{"v":13689.483066801826,"d":"13689"},{"$nulls":6},0,8865,20,749,{"v":6624.905,"d":"6625"},{"v":11334.161754675619,"d":"11334"},{"$nulls":7},"CaMK2a","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK2",{"$nulls":6},"AGA(pY)DFP(bA)C","Corresponds to amino acid residues A227 to P230. Y230 is located in the Gap/Insert 10 (G/I10) region in the protein-serine/threonine kinase catalytic domain of CaMK2a. ","The effect of Y230 phosphorylation is unknown. It appears to be the third most commonly observed phosphosite in CaMK2a by mass spectrometry studies (~28 reports). Phosphorylation of Y230 in rat brain appears to be induced by 15 min ischemia treatment.",null,null,"Q9UQM7","Q9UQM7","Q9UQM7"]
[321,162,"PK555","CaMK2a","T286","Calcium/calmodulin-dependent protein-serine kinase 2 alpha",0,6721,12,857,{"v":5749.613,"d":"5750"},{"v":10102.91465300998,"d":"10103"},{"v":9828.268199839637,"d":"9828"},{"v":274.6464531703441,"d":"275"},{"v":2.794454196669413,"d":"3"},0,8224,24,941,{"v":7716.2,"d":"7716"},{"v":13481.861491284175,"d":"13482"},{"v":11358.778437094912,"d":"11359"},{"v":2123.083054189263,"d":"2123"},{"v":18.691121285153407,"d":"19"},{"v":21.48557548182282,"d":"21"},{"v":15.572532272575216,"d":"16"},null,0,6682,16,806,{"v":5372.796,"d":"5373"},{"v":9192.001838346987,"d":"9192"},{"v":9657.234362326191,"d":"9657"},{"v":465.2325239792044,"d":"465"},{"v":4.817450902860157,"d":"5"},{"v":7.6119050995295705,"d":"8"},{"v":-1.740223547381774,"d":"-2"},null,null,"CaMK2a","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK2",{"$nulls":6},"HRQE(pT)VDC","Corresponds to amino acid residues H282 to C289; In the region between the kinase catalytic domain and the CamKII-AD domains. ","T286 phosphorylation stimulates calcium/calmodulin-independent phosphotransferase activity and regulates cell growth, intracellular location, molecular association, including inducing interaction with GIT1 and MAP2, and inhibiting interaction with MBP and neurogranin. This is a major site of in vivo phosphorylation of CaMK2a (≥88 reports from high throughput mass spectrometry studies).","CaMK2a; CaMK2b; CaMK2d; PKCa (PRKCA)","EC 2.7.11.17; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; CAMK2 family","Q9UQM7","Q9UQM7","Q9UQM7",null,"GO:0005954; GO:0030054; GO:0005737; GO:0005829; GO:0043197; GO:0030666; GO:0005739; GO:0043005; GO:0005654; GO:0005634; GO:0005886; GO:0014069; GO:0042734; GO:0098685","GO:0005524; GO:0009931; GO:0005516; GO:0004683; GO:0035254; GO:0042802; GO:0016301; GO:0046872; GO:0042803; GO:0004674; GO:0005088","GO:0038166; GO:0006816; GO:0030154; GO:0048813; GO:0060996; GO:0000082; GO:0060333; GO:0035556; GO:0000165; GO:0007399; GO:0018105; GO:1990443; GO:0018107; GO:0051928; GO:0010666; GO:0051092; GO:0046777; GO:0006468; GO:1902108; GO:0048168; GO:2001222; GO:0046928; GO:0099148; GO:0002931; GO:0007223"]
[322,162,"PK555","CaMK2a","T286","Calcium/calmodulin-dependent protein-serine kinase 2 alpha",0,6679,16,816,{"v":5437.008,"d":"5437"},{"v":9553.621746669294,"d":"9554"},{"$nulls":3},0,7010,18,756,{"v":5285.952,"d":"5286"},{"v":9235.69538290565,"d":"9236"},{"$nulls":6},0,6386,24,930,{"v":5916.66,"d":"5917"},{"v":10122.466886305396,"d":"10122"},{"$nulls":7},"CaMK2a","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK2",{"$nulls":6},"HRQE(pT)VDC","Corresponds to amino acid residues H282 to C289; In the region between the kinase catalytic domain and the CamKII-AD domains. ","T286 phosphorylation stimulates calcium/calmodulin-independent phosphotransferase activity and regulates cell growth, intracellular location, molecular association, including inducing interaction with GIT1 and MAP2, and inhibiting interaction with MBP and neurogranin. This is a major site of in vivo phosphorylation of CaMK2a (≥88 reports from high throughput mass spectrometry studies).","CaMK2a; CaMK2b; CaMK2d; PKCa (PRKCA)",null,"Q9UQM7","Q9UQM7","Q9UQM7"]
[323,163,"PK178","CaMK2a","T286","Calcium/calmodulin-dependent protein-serine kinase 2 alpha",0,128,10,457,{"v":53.926,"d":"54"},{"v":94.75590367181516,"d":"95"},{"v":87.49888697922538,"d":"87"},{"v":7.2570166925897865,"d":"7"},{"v":8.293838862559246,"d":"8"},0,48,14,786,{"v":26.724,"d":"27"},{"v":46.69257749839018,"d":"47"},{"v":78.30843552238997,"d":"78"},{"v":31.61585802399979,"d":"32"},{"v":40.373502309288476,"d":"40"},{"v":48.667341171847724,"d":"49"},{"v":-10.503506700625195,"d":"-11"},null,0,206,14,457,{"v":87.744,"d":"88"},{"v":150.116067928862,"d":"150"},{"v":133.8151710558428,"d":"134"},{"v":16.300896873019212,"d":"16"},{"v":12.181650813132867,"d":"12"},{"v":20.475489675692113,"d":"20"},{"v":52.93356941513346,"d":"53"},null,null,"CaMK2a","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK2",{"$nulls":6},"Not precisely defined.","Antibody raised against a synthetic peptide corresponding to amino acid residues 281-294 of rat CaMKII.","T286 phosphorylation stimulates calcium/calmodulin-independent phosphotransferase activity and regulates cell growth, intracellular location, molecular association, including inducing interaction with GIT1 and MAP2, and inhibiting interaction with MBP and neurogranin. This is a major site of in vivo phosphorylation of CaMK2a (≥88 reports from high throughput mass spectrometry studies).","CaMK2a; CaMK2b; CaMK2d; PKCa (PRKCA)","EC 2.7.11.17; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; CAMK2 family","Q9UQM7","Q9UQM7","Q9UQM7",null,"GO:0005954; GO:0030054; GO:0005737; GO:0005829; GO:0043197; GO:0030666; GO:0005739; GO:0043005; GO:0005654; GO:0005634; GO:0005886; GO:0014069; GO:0042734; GO:0098685","GO:0005524; GO:0009931; GO:0005516; GO:0004683; GO:0035254; GO:0042802; GO:0016301; GO:0046872; GO:0042803; GO:0004674; GO:0005088","GO:0038166; GO:0006816; GO:0030154; GO:0048813; GO:0060996; GO:0000082; GO:0060333; GO:0035556; GO:0000165; GO:0007399; GO:0018105; GO:1990443; GO:0018107; GO:0051928; GO:0010666; GO:0051092; GO:0046777; GO:0006468; GO:1902108; GO:0048168; GO:2001222; GO:0046928; GO:0099148; GO:0002931; GO:0007223"]
[324,163,"PK178","CaMK2a","T286","Calcium/calmodulin-dependent protein-serine kinase 2 alpha",0,130,12,387,{"v":45.666,"d":"46"},{"v":80.24187028663559,"d":"80"},{"$nulls":3},0,184,18,379,{"v":62.914,"d":"63"},{"v":109.92429354638975,"d":"110"},{"$nulls":6},0,124,18,648,{"v":68.688,"d":"69"},{"v":117.51427418282358,"d":"118"},{"$nulls":7},"CaMK2a","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK2",{"$nulls":6},"Not precisely defined.","Antibody raised against a synthetic peptide corresponding to amino acid residues 281-294 of rat CaMKII.","T286 phosphorylation stimulates calcium/calmodulin-independent phosphotransferase activity and regulates cell growth, intracellular location, molecular association, including inducing interaction with GIT1 and MAP2, and inhibiting interaction with MBP and neurogranin. This is a major site of in vivo phosphorylation of CaMK2a (≥88 reports from high throughput mass spectrometry studies).","CaMK2a; CaMK2b; CaMK2d; PKCa (PRKCA)",null,"Q9UQM7","Q9UQM7","Q9UQM7"]
[325,164,"NK018-3","CaMK2b","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase 2 beta",0,4648,14,859,{"v":3980.606,"d":"3981"},{"v":6994.509488770714,"d":"6995"},{"v":6395.163374440497,"d":"6395"},{"v":599.3461143302166,"d":"599"},{"v":9.371865568370291,"d":"9"},0,4554,20,771,{"v":3495.714,"d":"3496"},{"v":6107.764438602288,"d":"6108"},{"v":6311.648720927712,"d":"6312"},{"v":203.88428232542446,"d":"204"},{"v":3.230285640729649,"d":"3"},{"v":12.60215120909994,"d":"13"},{"v":-1.3059033620089764,"d":"-1"},null,0,4420,18,796,{"v":3503.992,"d":"3504"},{"v":5994.774583950914,"d":"5995"},{"v":6561.663593162899,"d":"6562"},{"v":566.8890092119846,"d":"567"},{"v":8.639409825926915,"d":"9"},{"v":18.011275394297208,"d":"18"},{"v":2.6035334669924453,"d":"3"},null,null,"CAMK2b","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK2",{"$nulls":6},"RISDILNSVRRGSGTPEAEC","Corresponds to amino acid residues R449 to E467; Before CaMAD, repeated 3X.",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.1.123; EC 2.7.11.17; CAMK domain target; CAMK</A> group; CAMK2 family","Q13554","Q13554","Q13554","Q13554","GO:0030054; GO:0005737; GO:0005829; GO:0030666; GO:0005815; GO:0043005; GO:0005654; GO:0005886; GO:0033017; GO:0045202","GO:0003779; GO:0005524; GO:0005516; GO:0004683; GO:0042802; GO:0042803; GO:0004674; GO:0005088","GO:0060333; GO:0035556; GO:0000165; GO:0018105; GO:0018107; GO:0061003; GO:0010976; GO:0090129; GO:0046777; GO:0006468; GO:0051924; GO:0060998; GO:0048169; GO:2001222; GO:0014733; GO:0051823; GO:0007165"]
[326,164,"NK018-3","CaMK2b","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase 2 beta",0,2997,12,1105,{"v":3298.425,"d":"3298"},{"v":5795.81726011028,"d":"5796"},{"$nulls":3},0,4130,14,906,{"v":3729.096,"d":"3729"},{"v":6515.5330032531365,"d":"6516"},{"$nulls":6},0,3960,18,1057,{"v":4166.694,"d":"4167"},{"v":7128.5526023748835,"d":"7129"},{"$nulls":7},"CAMK2b","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK2",{"$nulls":6},"RISDILNSVRRGSGTPEAEC","Corresponds to amino acid residues R449 to E467; Before CaMAD, repeated 3X.",{"$nulls":3},"Q13554","Q13554","Q13554","Q13554"]
[327,165,"NK019-3","CaMK2d","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase 2 delta",0,9056,22,882,{"v":7967.988,"d":"7968"},{"v":14000.925404928592,"d":"14001"},{"v":13158.275066664286,"d":"13158"},{"v":842.6503382643059,"d":"843"},{"v":6.403957463992456,"d":"6"},0,9730,21,925,{"v":8980.825,"d":"8981"},{"v":15691.433442298308,"d":"15691"},{"v":15135.341163281922,"d":"15135"},{"v":556.0922790163859,"d":"556"},{"v":3.6741311148337785,"d":"4"},{"v":10.078088578826234,"d":"10"},{"v":15.02526802792272,"d":"15"},null,0,8256,16,887,{"v":7308.88,"d":"7309"},{"v":12504.334502232641,"d":"12504"},{"v":12820.361125908556,"d":"12820"},{"v":316.0266236759144,"d":"316"},{"v":2.46503683142949,"d":"2"},{"v":8.868994295421945,"d":"9"},{"v":-2.568071719459766,"d":"-3"},null,null,"CAMK2d","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK2",{"$nulls":6},"CTRFTDEYQLFEELGKGAFS","Corresponds to amino acid residues C7 to S26; N-terminus and kinase domain I, highly conserved in all CaMK2 isoforms.",null,null,"EC 2.7.11.17; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; CAMK2 family","Q13557","Q13557","Q13557","Q13557","GO:0005737; GO:0005829; GO:0030666; GO:0016020; GO:0043005; GO:0005654; GO:0005634; GO:0005886; GO:0042383; GO:0033017","GO:0005524; GO:0005516; GO:0004683; GO:0042802; GO:0044325; GO:0042803; GO:0004674; GO:0005088; GO:0019871; GO:0031432","GO:0086003; GO:0030154; GO:0071277; GO:0032469; GO:0060333; GO:0000165; GO:1902306; GO:2000650; GO:0007399; GO:0018105; GO:0018107; GO:0010666; GO:0010613; GO:0046777; GO:0051259; GO:0006468; GO:1902514; GO:0098901; GO:0098909; GO:0010881; GO:0010649; GO:1901844; GO:0001558; GO:0060341; GO:0008016; GO:0086091; GO:1901725; GO:0003254; GO:1901897; GO:0010880; GO:0060314; GO:0002026; GO:0006357; GO:0055119"]
[328,165,"NK019-3","CaMK2d","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase 2 delta",0,8013,12,876,{"v":7008.876,"d":"7009"},{"v":12315.624728399978,"d":"12316"},{"$nulls":3},0,8996,14,929,{"v":8344.278,"d":"8344"},{"v":14579.248884265537,"d":"14579"},{"$nulls":6},0,7198,22,1070,{"v":7678.32,"d":"7678"},{"v":13136.387749584468,"d":"13136"},{"$nulls":7},"CAMK2d","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK2",{"$nulls":6},"CTRFTDEYQLFEELGKGAFS","Corresponds to amino acid residues C7 to S26; N-terminus and kinase domain I, highly conserved in all CaMK2 isoforms.",{"$nulls":3},"Q13557","Q13557","Q13557","Q13557"]
[329,166,"NK020-1","CaMK2g","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase 2 gamma",0,2210,14,869,{"v":1908.324,"d":"1908"},{"v":3353.205598757798,"d":"3353"},{"v":3151.3410487146743,"d":"3151"},{"v":201.86455004312347,"d":"202"},{"v":6.405671329209424,"d":"6"},0,2358,16,888,{"v":2079.696,"d":"2080"},{"v":3633.6763453484527,"d":"3634"},{"v":3493.022031855884,"d":"3493"},{"v":140.6543134925687,"d":"141"},{"v":4.0267227692760175,"d":"4"},{"v":10.432394098485442,"d":"10"},{"v":10.84239940582026,"d":"11"},null,0,2600,16,749,{"v":1935.416,"d":"1935"},{"v":3311.1898218294855,"d":"3311"},{"v":3139.1612972308467,"d":"3139"},{"v":172.0285245986388,"d":"172"},{"v":5.480079177530336,"d":"5"},{"v":11.885750506739761,"d":"12"},{"v":-0.38649423516999093,"d":"-0"},null,null,"CaMK2g","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK2",{"$nulls":6},"CDGIKGSTESSNTTTEDEDL","Corresponds to amino acid residues D376 to L394; Before CaMAD, highly conserved in all CaMK2 isoforms.",null,null,"EC 2.7.11.17; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; CAMK2 family","Q13555","Q13555","Q13555",null,"GO:0005737; GO:0005829; GO:0030666; GO:0016020; GO:0043005; GO:0005654; GO:0005886; GO:0033017","GO:0005524; GO:0004723; GO:0005516; GO:0004683; GO:0042802; GO:0042803; GO:0004674; GO:0005088","GO:0030154; GO:0030073; GO:0060333; GO:0035556; GO:0000165; GO:0007399; GO:0018105; GO:0018107; GO:0051259; GO:0051924; GO:0014733"]
[330,166,"NK020-1","CaMK2g","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase 2 gamma",0,2164,12,780,{"v":1678.56,"d":"1679"},{"v":2949.476498671551,"d":"2949"},{"$nulls":3},0,2694,18,717,{"v":1918.692,"d":"1919"},{"v":3352.367718363316,"d":"3352"},{"$nulls":6},0,2290,14,762,{"v":1734.312,"d":"1734"},{"v":2967.1327726322083,"d":"2967"},{"$nulls":7},"CaMK2g","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK2",{"$nulls":6},"CDGIKGSTESSNTTTEDEDL","Corresponds to amino acid residues D376 to L394; Before CaMAD, highly conserved in all CaMK2 isoforms.",{"$nulls":3},"Q13555","Q13555","Q13555"]
[331,167,"NK021-2 (NK021-3)","CaMK4 (CaMPK4)","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase 4",0,2057,16,801,{"v":1634.841,"d":"1635"},{"v":2872.655793397136,"d":"2873"},{"v":2705.406158689527,"d":"2705"},{"v":167.2496347076094,"d":"167"},{"v":6.182052708441513,"d":"6"},0,2048,16,689,{"v":1400.048,"d":"1400"},{"v":2446.1850674100497,"d":"2446"},{"v":2457.984011274989,"d":"2458"},{"v":11.798943864939247,"d":"12"},{"v":0.4800252487736476,"d":"0"},{"v":6.6620779572151605,"d":"7"},{"v":-9.145471433922765,"d":"-9"},null,0,1994,14,771,{"v":1526.58,"d":"1527"},{"v":2611.7362666261183,"d":"2612"},{"v":2466.7629879500164,"d":"2467"},{"v":144.97327867610193,"d":"145"},{"v":5.877065586936701,"d":"6"},{"v":12.059118295378214,"d":"12"},{"v":-8.820973884938113,"d":"-9"},null,null,"CAMK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK1",{"$nulls":6},"CPQQDAILPEY","Corresponds to amino acid residues Q466 to Y474; C-terminus.",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.17; CAMK domain target; CAMK</A> group; CAMK1 family","Q16566","Q16566","Q16566","Q16566","GO:0005737; GO:0005829; GO:0070062; GO:0001650; GO:0098978; GO:0005654; GO:0005634; GO:0098794","GO:0005524; GO:0009931; GO:0005516; GO:0004683","GO:0002250; GO:0006954; GO:0035556; GO:0007616; GO:0043011; GO:0018105; GO:0045893; GO:0046777; GO:0006468; GO:0045670; GO:0033081; GO:0007165"]
[332,167,"NK021-2 (NK021-3)","CaMK4 (CaMPK4)","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase 4",0,2060,14,706,{"v":1444.476,"d":"1444"},{"v":2538.156523981918,"d":"2538"},{"$nulls":3},0,1984,18,719,{"v":1413.554,"d":"1414"},{"v":2469.782955139928,"d":"2470"},{"$nulls":6},0,1747,16,784,{"v":1357.104,"d":"1357"},{"v":2321.7897092739145,"d":"2322"},{"$nulls":7},"CAMK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK1",{"$nulls":6},"CPQQDAILPEY","Corresponds to amino acid residues Q466 to Y474; C-terminus.",{"$nulls":3},"Q16566","Q16566","Q16566","Q16566"]
[333,168,"NK021 SG-KAP-CA003","CaMK4 (CaMPK4)","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase 4",0,2399,20,856,{"v":2036.424,"d":"2036"},{"v":3578.2961165110064,"d":"3578"},{"v":3333.999983152469,"d":"3334"},{"v":244.2961333585372,"d":"244"},{"v":7.327418554079973,"d":"7"},0,2265,28,838,{"v":1874.606,"d":"1875"},{"v":3275.339991541207,"d":"3275"},{"v":3256.108394455263,"d":"3256"},{"v":19.23159708594403,"d":"19"},{"v":0.5906313536334659,"d":"1"},{"v":7.9180499077134385,"d":"8"},{"v":-2.336280416641017,"d":"-2"},null,0,3030,28,683,{"v":2050.366,"d":"2050"},{"v":3507.851040926206,"d":"3508"},{"v":3412.526379720194,"d":"3413"},{"v":95.32466120601202,"d":"95"},{"v":2.793375071691843,"d":"3"},{"v":10.120793625771816,"d":"10"},{"v":2.355320844767192,"d":"2"},null,null,"CAMK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK1",{"$nulls":6},"CSSVTSSTENLVPDYWID","Corresponds to amino acid residues C14 to D31; N-terminus.",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.17; CAMK domain target; CAMK</A> group; CAMK1 family","Q16566","Q16566","Q16566","Q16566","GO:0005737; GO:0005829; GO:0070062; GO:0001650; GO:0098978; GO:0005654; GO:0005634; GO:0098794","GO:0005524; GO:0009931; GO:0005516; GO:0004683","GO:0002250; GO:0006954; GO:0035556; GO:0007616; GO:0043011; GO:0018105; GO:0045893; GO:0046777; GO:0006468; GO:0045670; GO:0033081; GO:0007165"]
[334,168,"NK021 SG-KAP-CA003","CaMK4 (CaMPK4)","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase 4",0,2233,24,796,{"v":1758.364,"d":"1758"},{"v":3089.7038497939325,"d":"3090"},{"$nulls":3},0,2385,22,784,{"v":1852.592,"d":"1853"},{"v":3236.8767973693184,"d":"3237"},{"$nulls":6},0,2660,22,735,{"v":1938.93,"d":"1939"},{"v":3317.201718514182,"d":"3317"},{"$nulls":7},"CAMK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK1",{"$nulls":6},"CSSVTSSTENLVPDYWID","Corresponds to amino acid residues C14 to D31; N-terminus.",{"$nulls":3},"Q16566","Q16566","Q16566","Q16566"]
[335,169,"PK556","CaMK4 (CaMPK4)","T200","Calcium/calmodulin-dependent protein-serine kinase 4",0,9042,18,1109,{"v":10007.616,"d":"10008"},{"v":17584.851420103776,"d":"17585"},{"v":16653.76563556311,"d":"16654"},{"v":931.0857845406645,"d":"931"},{"v":5.590842365118835,"d":"6"},0,9495,20,1022,{"v":9683.45,"d":"9683"},{"v":16919.070482591917,"d":"16919"},{"v":17208.627712270136,"d":"17209"},{"v":289.5572296782193,"d":"290"},{"v":1.682628240436386,"d":"2"},{"v":7.273470605555221,"d":"7"},{"v":3.3317514419810834,"d":"3"},null,0,9274,19,1118,{"v":10347.09,"d":"10347"},{"v":17702.229956533196,"d":"17702"},{"v":16398.9126877497,"d":"16399"},{"v":1303.3172687834958,"d":"1303"},{"v":7.947583437998902,"d":"8"},{"v":13.538425803117736,"d":"14"},{"v":-1.53030223548474,"d":"-2"},null,null,"CAMK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK1",{"$nulls":6},"LMK(pT)VCG(bA)C","Corresponds to amino acid residues L197 to G203; In the protein kinase catalytic domain.","T200 phosphorylation stimulates phosphotransferase activity and regulates transcription. This is one of the major in vivo phosphorylation sites in CaMK4 (≥13 reports from high throughput mass spectrometry studies).","CaMKK1","Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.17; CAMK domain target; CAMK</A> group; CAMK1 family","Q16566","Q16566","Q16566","Q16566","GO:0005737; GO:0005829; GO:0070062; GO:0001650; GO:0098978; GO:0005654; GO:0005634; GO:0098794","GO:0005524; GO:0009931; GO:0005516; GO:0004683","GO:0002250; GO:0006954; GO:0035556; GO:0007616; GO:0043011; GO:0018105; GO:0045893; GO:0046777; GO:0006468; GO:0045670; GO:0033081; GO:0007165"]
[336,169,"PK556","CaMK4 (CaMPK4)","T200","Calcium/calmodulin-dependent protein-serine kinase 4",0,8680,18,1033,{"v":8947.846,"d":"8948"},{"v":15722.679851022449,"d":"15723"},{"$nulls":3},0,9557,19,1050,{"v":10014.9,"d":"10015"},{"v":17498.18494194835,"d":"17498"},{"$nulls":6},0,8696,20,1017,{"v":8823.492,"d":"8823"},{"v":15095.595418966202,"d":"15096"},{"$nulls":7},"CAMK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK1",{"$nulls":6},"LMK(pT)VCG(bA)C","Corresponds to amino acid residues L197 to G203; In the protein kinase catalytic domain.","T200 phosphorylation stimulates phosphotransferase activity and regulates transcription. This is one of the major in vivo phosphorylation sites in CaMK4 (≥13 reports from high throughput mass spectrometry studies).","CaMKK1",null,"Q16566","Q16566","Q16566","Q16566"]
[337,170,"NK022","CaMKK1 (CaMKK)","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase kinase",0,5711,28,858,{"v":4876.014,"d":"4876"},{"v":8567.872879249753,"d":"8568"},{"v":8705.475931478579,"d":"8705"},{"v":137.60305222882562,"d":"138"},{"v":1.5806493902448187,"d":"2"},0,6522,28,720,{"v":4675.68,"d":"4676"},{"v":8169.418902771778,"d":"8169"},{"v":8103.295545661069,"d":"8103"},{"v":66.12335711070955,"d":"66"},{"v":0.8160057440594707,"d":"1"},{"v":2.3966551343042894,"d":"2"},{"v":-6.917259786338107,"d":"-7"},null,0,6480,26,613,{"v":3956.302,"d":"3956"},{"v":6768.605258240935,"d":"6769"},{"v":6577.757478226342,"d":"6578"},{"v":190.8477800145929,"d":"191"},{"v":2.901411015020487,"d":"3"},{"v":4.4820604052653055,"d":"4"},{"v":-24.441150259901477,"d":"-24"},null,null,"CaMKK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","CAMKK","Meta",{"$nulls":5},"CGKSPELPGVQEDEA","Corresponds to amino acid residues G490 to A503; near the very C-terminus of the kinase.",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.17; Other group; CAMKK family; Meta subfamily","Q8N5S9","Q8N5S9","Q8N5S9",null,"GO:0005737; GO:0005829; GO:0005634","GO:0005524; GO:0005516; GO:0004683","GO:0035556; GO:0018105; GO:0018107; GO:0045860"]
[338,170,"NK022","CaMKK1 (CaMKK)","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase kinase",0,6451,40,785,{"v":5032.635,"d":"5033"},{"v":8843.078983707404,"d":"8843"},{"$nulls":3},0,5721,42,810,{"v":4599.99,"d":"4600"},{"v":8037.17218855036,"d":"8037"},{"$nulls":6},0,6566,28,571,{"v":3733.198,"d":"3733"},{"v":6386.909698211749,"d":"6387"},{"$nulls":7},"CaMKK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","CAMKK","Meta",{"$nulls":5},"CGKSPELPGVQEDEA","Corresponds to amino acid residues G490 to A503; near the very C-terminus of the kinase.",{"$nulls":3},"Q8N5S9","Q8N5S9","Q8N5S9"]
[339,171,"PK557","CaMKK1 (CaMKK)","S74","Calcium/calmodulin-dependent protein-serine kinase kinase",0,920,12,560,{"v":508.48,"d":"508"},{"v":893.4740551690201,"d":"893"},{"v":875.8973147390018,"d":"876"},{"v":17.576740430018276,"d":"18"},{"v":2.0067124461108503,"d":"2"},0,622,16,514,{"v":311.484,"d":"311"},{"v":544.229561798704,"d":"544"},{"v":748.7830275241392,"d":"749"},{"v":204.55346572543522,"d":"205"},{"v":27.318122634509212,"d":"27"},{"v":29.324835080620062,"d":"29"},{"v":-14.512464540748113,"d":"-15"},null,0,1077,10,503,{"v":536.701,"d":"537"},{"v":918.2102909998196,"d":"918"},{"v":1056.0613369216837,"d":"1056"},{"v":137.85104592186417,"d":"138"},{"v":13.053318126737468,"d":"13"},{"v":15.060030572848317,"d":"15"},{"v":20.569080319234317,"d":"21"},null,null,"CaMKK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","CAMKK","Meta",{"$nulls":5},"RKL(pS)LQE(bA)C","Corresponds to amino acid residues R71 to E77; In the N-terminal quarter of the protein located before the kinase catalytic domain.  ","S74 phosphorylation stimulates phosphotransferase activity and inhibits phosphotransferase activity by inducing binding to 14-3-3 eta. This is the major in vivo phosphorylation sites in CaMMK1 (≥75 reports from high throughput mass spectrometry studies).","PKACa (PRKACA)","Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.17; Other group; CAMKK family; Meta subfamily","Q8N5S9","Q8N5S9","Q8N5S9",null,"GO:0005737; GO:0005829; GO:0005634","GO:0005524; GO:0005516; GO:0004683","GO:0035556; GO:0018105; GO:0018107; GO:0045860"]
[340,171,"PK557","CaMKK1 (CaMKK)","S74","Calcium/calmodulin-dependent protein-serine kinase kinase",0,592,18,851,{"v":488.474,"d":"488"},{"v":858.3205743089834,"d":"858"},{"$nulls":3},0,958,14,578,{"v":545.632,"d":"546"},{"v":953.3364932495745,"d":"953"},{"$nulls":6},0,1209,12,583,{"v":697.851,"d":"698"},{"v":1193.912382843548,"d":"1194"},{"$nulls":7},"CaMKK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","CAMKK","Meta",{"$nulls":5},"RKL(pS)LQE(bA)C","Corresponds to amino acid residues R71 to E77; In the N-terminal quarter of the protein located before the kinase catalytic domain.  ","S74 phosphorylation stimulates phosphotransferase activity and inhibits phosphotransferase activity by inducing binding to 14-3-3 eta. This is the major in vivo phosphorylation sites in CaMMK1 (≥75 reports from high throughput mass spectrometry studies).","PKACa (PRKACA)",null,"Q8N5S9","Q8N5S9","Q8N5S9"]
[341,172,"NK366-1","CaMKKb (CaMKK2)","Pan-specific","Calcium/calmodulin-dependent protein kinase kinase 2",0,100,12,436,{"v":38.368,"d":"38"},{"v":67.41821221822876,"d":"67"},{"v":67.8680418243554,"d":"68"},{"v":0.4498296061266416,"d":"0"},{"v":0.6628003314001818,"d":"1"},0,119,10,425,{"v":46.325,"d":"46"},{"v":80.939741528698,"d":"81"},{"v":79.4502406187527,"d":"79"},{"v":1.489500909945292,"d":"1"},{"v":1.8747594700093633,"d":"2"},{"v":2.537559801409545,"d":"3"},{"v":17.065762445853963,"d":"17"},null,0,50,12,654,{"v":24.852,"d":"25"},{"v":42.5178305088448,"d":"43"},{"v":63.925588965193384,"d":"64"},{"v":21.40775845634858,"d":"21"},{"v":33.4885588117222,"d":"33"},{"v":34.151359143122384,"d":"34"},{"v":-5.808997509262468,"d":"-6"},{"$nulls":3},"X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","CAMKK","Meta",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues 1-95 mapping at the N-terminus of human CaMKKβ.",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.17; Other group; CAMKK family; Meta subfamily","Q96RR4","Q96RR4","Q96RR4","Q96RR4","GO:0042995; GO:0005737; GO:0005829; GO:0005622; GO:0005634","GO:0005524; GO:0005509; GO:0005516; GO:0004683; GO:0004713","GO:0019722; GO:0061762; GO:0034614; GO:0000165; GO:0018105; GO:0018107; GO:1903599; GO:0045860; GO:0001934; GO:0045893; GO:0046777; GO:0006468; GO:0045859"]
[342,172,"NK366-1","CaMKKb (CaMKK2)","Pan-specific","Calcium/calmodulin-dependent protein kinase kinase 2",0,88,8,486,{"v":38.88,"d":"39"},{"v":68.31787143048203,"d":"68"},{"$nulls":3},0,102,10,485,{"v":44.62,"d":"45"},{"v":77.96073970880742,"d":"78"},{"$nulls":6},0,114,12,489,{"v":49.878,"d":"50"},{"v":85.33334742154197,"d":"85"},{"$nulls":8},"X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","CAMKK","Meta",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues 1-95 mapping at the N-terminus of human CaMKKβ.",{"$nulls":3},"Q96RR4","Q96RR4","Q96RR4","Q96RR4"]
[343,173,"PN505","Cas-L","Y166","Enhancer of filamentation 1",0,4086,14,968,{"v":3941.696,"d":"3942"},{"v":6926.138902933263,"d":"6926"},{"v":6150.001846234236,"d":"6150"},{"v":776.1370566990272,"d":"776"},{"v":12.620110954507613,"d":"13"},0,4368,14,739,{"v":3217.606,"d":"3218"},{"v":5621.849929437406,"d":"5622"},{"v":5429.087545108763,"d":"5429"},{"v":192.76238432864284,"d":"193"},{"v":3.550548461910668,"d":"4"},{"v":16.17065941641828,"d":"16"},{"v":-11.722180239131191,"d":"-12"},null,0,4457,18,740,{"v":3284.86,"d":"3285"},{"v":5619.87448596829,"d":"5620"},{"v":5748.724795277123,"d":"5749"},{"v":128.85030930883295,"d":"129"},{"v":2.2413720241868282,"d":"2"},{"v":14.861482978694442,"d":"15"},{"v":-6.524828138105718,"d":"-7"},{"$nulls":13},"X",null,"GYV(pY)EYP(bA)C","Corresponds to amino acid residues G163 to P169; In the region between the SH3_9 and Serine_rich domains. ","The effect of Y166 phosphorylation is unclear. This is the second major in vivo phosphorylation site in Cas-L (≥569 reports from high throughput mass spectrometry studies).",null,"Adapter/scaffold protein","Q14511","Q14511",null,"Q14511","GO:0005938; GO:0005737; GO:0005829; GO:0005925; GO:0005794; GO:0030027; GO:0005654; GO:0005634; GO:0005886; GO:0005819; GO:0000922","GO:1990782","GO:0051017; GO:0007155; GO:0007049; GO:0051301; GO:0007010; GO:0007229; GO:0030335; GO:0061098; GO:1900026; GO:0040008; GO:0007165"]
[344,173,"PN505","Cas-L","Y166","Enhancer of filamentation 1",0,4244,14,723,{"v":3058.29,"d":"3058"},{"v":5373.864789535208,"d":"5374"},{"$nulls":3},0,4269,18,705,{"v":2996.955,"d":"2997"},{"v":5236.32516078012,"d":"5236"},{"$nulls":6},0,4398,16,784,{"v":3435.488,"d":"3435"},{"v":5877.575104585957,"d":"5878"},{"$nulls":18},"X",null,"GYV(pY)EYP(bA)C","Corresponds to amino acid residues G163 to P169; In the region between the SH3_9 and Serine_rich domains. ","The effect of Y166 phosphorylation is unclear. This is the second major in vivo phosphorylation site in Cas-L (≥569 reports from high throughput mass spectrometry studies).",null,null,"Q14511","Q14511",null,"Q14511"]
[345,174,"NK023-1","CASK (/Lin2)","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase (Lin2 homolog)",0,450,20,591,{"v":254.13,"d":"254"},{"v":446.5437414256275,"d":"447"},{"v":464.3928396249803,"d":"464"},{"v":17.849098199352795,"d":"18"},{"v":3.8435343261896127,"d":"4"},0,338,12,551,{"v":179.626,"d":"180"},{"v":313.84526738983067,"d":"314"},{"v":365.31735191362293,"d":"365"},{"v":51.47208452379226,"d":"51"},{"v":14.089690581125893,"d":"14"},{"v":17.933224907315505,"d":"18"},{"v":-21.334413293573945,"d":"-21"},null,0,456,12,570,{"v":253.08,"d":"253"},{"v":432.97974187906175,"d":"433"},{"v":524.1059982859147,"d":"524"},{"v":91.12625640685292,"d":"91"},{"v":17.386989789256514,"d":"17"},{"v":21.230524115446126,"d":"21"},{"v":12.858328890074105,"d":"13"},{"$nulls":3},"X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CASK",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 353-459 of human CASK.",null,null,"EC 2.7.11.1; Adaptor/scaffold; Protein kinase, Ser/Thr (non-receptor); CAMK group; CASK family","O14936","O14936","O14936",null,"GO:0015629; GO:0005604; GO:0005911; GO:0060170; GO:0005737; GO:0005829; GO:0005925; GO:0005652; GO:0016363; GO:0005730; GO:0005886; GO:0042734","GO:0005524; GO:0005516; GO:0004385; GO:0004674","GO:0007155; GO:0001953; GO:0090288; GO:0010839; GO:0061045; GO:0007269"]
[346,174,"NK023-1","CASK (/Lin2)","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase (Lin2 homolog)",0,488,14,579,{"v":274.446,"d":"274"},{"v":482.2419378243331,"d":"482"},{"$nulls":3},0,419,14,589,{"v":238.545,"d":"239"},{"v":416.78943643741525,"d":"417"},{"$nulls":6},0,586,17,632,{"v":359.608,"d":"360"},{"v":615.2322546927677,"d":"615"},{"$nulls":8},"X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CASK",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 353-459 of human CASK.",{"$nulls":3},"O14936","O14936","O14936"]
[347,181,"NN147-2","Caveolin 1","Pan-specific","Caveolin 1",0,178,12,491,{"v":81.506,"d":"82"},{"v":143.21801514436387,"d":"143"},{"v":172.50877537611336,"d":"173"},{"v":29.290760231749488,"d":"29"},{"v":16.979287093012005,"d":"17"},0,276,17,553,{"v":143.227,"d":"143"},{"v":250.24838337681223,"d":"250"},{"v":198.70291581698746,"d":"199"},{"v":51.54546755982477,"d":"52"},{"v":25.940971901640335,"d":"26"},{"v":42.92025899465234,"d":"43"},{"v":15.184236502615093,"d":"15"},null,0,230,10,454,{"v":99.88,"d":"100"},{"v":170.87883917686378,"d":"171"},{"v":190.26609393809946,"d":"190"},{"v":19.38725476123568,"d":"19"},{"v":10.18954789051541,"d":"10"},{"v":27.168834983527415,"d":"27"},{"v":10.293574065012393,"d":"10"},{"$nulls":15},"Not precisely defined.","Antibody raised against purified Glut4 vesicles from rat adipocytes.",null,null,"Adapter/scaffold protein","Q03135","Q03135",null,"Q03135","GO:0002080; GO:0016324; GO:0016323; GO:0005901; GO:0005938; GO:0005929; GO:0031410; GO:0031901; GO:0030666; GO:0005783; GO:0005789; GO:0005768; GO:0005925; GO:0000139; GO:0005887; GO:0005622; GO:0005811; GO:0016020; GO:0045121; GO:0048471; GO:0005886; GO:0032991","GO:0051117; GO:0015485; GO:0019899; GO:0042802; GO:0070320; GO:0044325; GO:0050998; GO:0005113; GO:0016504; GO:0030674; GO:0032947; GO:0046982; GO:0019901; GO:0048365; GO:0005102; GO:0005198","GO:0001525; GO:0086098; GO:0097190; GO:1904886; GO:0055074; GO:0006816; GO:0070836; GO:0072584; GO:0006874; GO:0071360; GO:0071455; GO:0071375; GO:0009267; GO:0071560; GO:0042632; GO:0030301; GO:0000188; GO:0007595; GO:0050900; GO:0019915; GO:0032507; GO:0030879; GO:0060056; GO:0051899; GO:2000811; GO:0030514; GO:0090090; GO:0001960; GO:0001937; GO:0030857; GO:1903609; GO:0046426; GO:0043409; GO:0060546; GO:0045019; GO:0051001; GO:0033137; GO:1900085; GO:0048550; GO:1901380; GO:0032091; GO:0061099; GO:0031397; GO:0000122; GO:0030512; GO:0042532; GO:0033484; GO:0010524; GO:0090263; GO:0043085; GO:0060355; GO:0030335; GO:0120162; GO:1903071; GO:2001238; GO:1903598; GO:0010628; GO:2001244; GO:0033138; GO:0032092; GO:0031398; GO:0034141; GO:0045907; GO:0010608; GO:0051260; GO:0008104; GO:1903361; GO:0044860; GO:0031623; GO:2000286; GO:0019065; GO:0030193; GO:0098909; GO:1901844; GO:0051480; GO:2000535; GO:0019217; GO:0086091; GO:0098903; GO:0050999; GO:0052547; GO:1900027; GO:0006940; GO:0003057; GO:0098911; GO:0009617; GO:0051592; GO:0043627; GO:0001666; GO:0002931; GO:0032570; GO:0007519; GO:0031295; GO:0006641; GO:0001570; GO:0042310; GO:0016050"]
[348,181,"NN147-2","Caveolin 1","Pan-specific","Caveolin 1",0,235,12,515,{"v":114.845,"d":"115"},{"v":201.79953560786285,"d":"202"},{"$nulls":3},0,140,12,658,{"v":84.224,"d":"84"},{"v":147.15744825716266,"d":"147"},{"$nulls":6},0,234,12,552,{"v":122.544,"d":"123"},{"v":209.65334869933517,"d":"210"},{"$nulls":20},"Not precisely defined.","Antibody raised against purified Glut4 vesicles from rat adipocytes.",{"$nulls":3},"Q03135","Q03135",null,"Q03135"]
[349,182,"PN147","Caveolin 1","Y14","Caveolin 1",0,14,2,771,{"v":9.252,"d":"9"},{"v":16.25712310892026,"d":"16"},{"v":13.51948824038397,"d":"14"},{"v":2.7376348685362917,"d":"3"},{"v":20.249545100077988,"d":"20"},0,10,2,770,{"v":6.16,"d":"6"},{"v":10.762845284765884,"d":"11"},{"v":11.461731342218215,"d":"11"},{"v":0.6988860574523308,"d":"1"},{"v":6.0975609756097615,"d":"6"},{"v":26.347106075687748,"d":"26"},{"v":-15.220671534141687,"d":"-15"},null,0,14,4,716,{"v":7.16,"d":"7"},{"v":12.249624434384708,"d":"12"},{"v":11.373673636842115,"d":"11"},{"v":0.8759507975425933,"d":"1"},{"v":7.701564380264737,"d":"8"},{"v":27.951109480342726,"d":"28"},{"v":-15.872010577531384,"d":"-16"},{"$nulls":15},"HL(pY)TV","Corresponds to amino acid residues H12 to V16; Surrounds the Y14 phosphosite.","Y14 phosphorylation induces activation and interaction with CSK, Grb7, MMP9 and TRAF2. This is one of the major in vivo phosphorylation sites in caveolin 1 (≥845 reports from high throughput mass spectrometry studies).","Abl1, Fyn; InsR; Src","Adapter/scaffold protein","Q03135","Q03135",null,"Q03135","GO:0002080; GO:0016324; GO:0016323; GO:0005901; GO:0005938; GO:0005929; GO:0031410; GO:0031901; GO:0030666; GO:0005783; GO:0005789; GO:0005768; GO:0005925; GO:0000139; GO:0005887; GO:0005622; GO:0005811; GO:0016020; GO:0045121; GO:0048471; GO:0005886; GO:0032991","GO:0051117; GO:0015485; GO:0019899; GO:0042802; GO:0070320; GO:0044325; GO:0050998; GO:0005113; GO:0016504; GO:0030674; GO:0032947; GO:0046982; GO:0019901; GO:0048365; GO:0005102; GO:0005198","GO:0001525; GO:0086098; GO:0097190; GO:1904886; GO:0055074; GO:0006816; GO:0070836; GO:0072584; GO:0006874; GO:0071360; GO:0071455; GO:0071375; GO:0009267; GO:0071560; GO:0042632; GO:0030301; GO:0000188; GO:0007595; GO:0050900; GO:0019915; GO:0032507; GO:0030879; GO:0060056; GO:0051899; GO:2000811; GO:0030514; GO:0090090; GO:0001960; GO:0001937; GO:0030857; GO:1903609; GO:0046426; GO:0043409; GO:0060546; GO:0045019; GO:0051001; GO:0033137; GO:1900085; GO:0048550; GO:1901380; GO:0032091; GO:0061099; GO:0031397; GO:0000122; GO:0030512; GO:0042532; GO:0033484; GO:0010524; GO:0090263; GO:0043085; GO:0060355; GO:0030335; GO:0120162; GO:1903071; GO:2001238; GO:1903598; GO:0010628; GO:2001244; GO:0033138; GO:0032092; GO:0031398; GO:0034141; GO:0045907; GO:0010608; GO:0051260; GO:0008104; GO:1903361; GO:0044860; GO:0031623; GO:2000286; GO:0019065; GO:0030193; GO:0098909; GO:1901844; GO:0051480; GO:2000535; GO:0019217; GO:0086091; GO:0098903; GO:0050999; GO:0052547; GO:1900027; GO:0006940; GO:0003057; GO:0098911; GO:0009617; GO:0051592; GO:0043627; GO:0001666; GO:0002931; GO:0032570; GO:0007519; GO:0031295; GO:0006641; GO:0001570; GO:0042310; GO:0016050"]
[350,182,"PN147","Caveolin 1","Y14","Caveolin 1",0,12,4,767,{"v":6.136,"d":"6"},{"v":10.781853371847678,"d":"11"},{"$nulls":3},0,16,6,696,{"v":6.96,"d":"7"},{"v":12.160617399670544,"d":"12"},{"$nulls":6},0,14,6,767,{"v":6.136,"d":"6"},{"v":10.497722839299522,"d":"10"},{"$nulls":20},"HL(pY)TV","Corresponds to amino acid residues H12 to V16; Surrounds the Y14 phosphosite.","Y14 phosphorylation induces activation and interaction with CSK, Grb7, MMP9 and TRAF2. This is one of the major in vivo phosphorylation sites in caveolin 1 (≥845 reports from high throughput mass spectrometry studies).","Abl1, Fyn; InsR; Src",null,"Q03135","Q03135",null,"Q03135"]
[351,183,"PN217","Caveolin 1","Y14","Caveolin 1",0,360,18,608,{"v":207.936,"d":"208"},{"v":365.3740975763557,"d":"365"},{"v":385.8554018303089,"d":"386"},{"v":20.48130425395317,"d":"20"},{"v":5.308025793289377,"d":"5"},0,366,18,563,{"v":195.924,"d":"196"},{"v":342.3213798007259,"d":"342"},{"v":333.47173509823574,"d":"333"},{"v":8.849644702490139,"d":"9"},{"v":2.653791542447568,"d":"3"},{"v":7.961817335736946,"d":"8"},{"v":-13.575983771016482,"d":"-14"},null,0,394,14,580,{"v":220.4,"d":"220"},{"v":377.0694448796634,"d":"377"},{"v":408.68750481986785,"d":"409"},{"v":31.618059940204432,"d":"32"},{"v":7.73648804216325,"d":"8"},{"v":13.044513835452626,"d":"13"},{"v":5.917269236417226,"d":"6"},{"$nulls":15},"Not precisely defined.","Antibody raised against amino acid residues that encompass the Y14 phosphosite.","Y14 phosphorylation induces activation and interaction with CSK, Grb7, MMP9 and TRAF2. This is one of the major in vivo phosphorylation sites in caveolin 1 (≥845 reports from high throughput mass spectrometry studies).","Abl1, Fyn; InsR; Src","Adapter/scaffold protein","Q03135","Q03135",null,"Q03135","GO:0002080; GO:0016324; GO:0016323; GO:0005901; GO:0005938; GO:0005929; GO:0031410; GO:0031901; GO:0030666; GO:0005783; GO:0005789; GO:0005768; GO:0005925; GO:0000139; GO:0005887; GO:0005622; GO:0005811; GO:0016020; GO:0045121; GO:0048471; GO:0005886; GO:0032991","GO:0051117; GO:0015485; GO:0019899; GO:0042802; GO:0070320; GO:0044325; GO:0050998; GO:0005113; GO:0016504; GO:0030674; GO:0032947; GO:0046982; GO:0019901; GO:0048365; GO:0005102; GO:0005198","GO:0001525; GO:0086098; GO:0097190; GO:1904886; GO:0055074; GO:0006816; GO:0070836; GO:0072584; GO:0006874; GO:0071360; GO:0071455; GO:0071375; GO:0009267; GO:0071560; GO:0042632; GO:0030301; GO:0000188; GO:0007595; GO:0050900; GO:0019915; GO:0032507; GO:0030879; GO:0060056; GO:0051899; GO:2000811; GO:0030514; GO:0090090; GO:0001960; GO:0001937; GO:0030857; GO:1903609; GO:0046426; GO:0043409; GO:0060546; GO:0045019; GO:0051001; GO:0033137; GO:1900085; GO:0048550; GO:1901380; GO:0032091; GO:0061099; GO:0031397; GO:0000122; GO:0030512; GO:0042532; GO:0033484; GO:0010524; GO:0090263; GO:0043085; GO:0060355; GO:0030335; GO:0120162; GO:1903071; GO:2001238; GO:1903598; GO:0010628; GO:2001244; GO:0033138; GO:0032092; GO:0031398; GO:0034141; GO:0045907; GO:0010608; GO:0051260; GO:0008104; GO:1903361; GO:0044860; GO:0031623; GO:2000286; GO:0019065; GO:0030193; GO:0098909; GO:1901844; GO:0051480; GO:2000535; GO:0019217; GO:0086091; GO:0098903; GO:0050999; GO:0052547; GO:1900027; GO:0006940; GO:0003057; GO:0098911; GO:0009617; GO:0051592; GO:0043627; GO:0001666; GO:0002931; GO:0032570; GO:0007519; GO:0031295; GO:0006641; GO:0001570; GO:0042310; GO:0016050"]
[352,183,"PN217","Caveolin 1","Y14","Caveolin 1",0,406,18,596,{"v":231.248,"d":"231"},{"v":406.336706084262,"d":"406"},{"$nulls":3},0,338,16,577,{"v":185.794,"d":"186"},{"v":324.6220903957456,"d":"325"},{"$nulls":6},0,450,16,593,{"v":257.362,"d":"257"},{"v":440.3055647600723,"d":"440"},{"$nulls":20},"Not precisely defined.","Antibody raised against amino acid residues that encompass the Y14 phosphosite.","Y14 phosphorylation induces activation and interaction with CSK, Grb7, MMP9 and TRAF2. This is one of the major in vivo phosphorylation sites in caveolin 1 (≥845 reports from high throughput mass spectrometry studies).","Abl1, Fyn; InsR; Src",null,"Q03135","Q03135",null,"Q03135"]
[353,184,"NN022-1","Caveolin 2","Pan-specific","Caveolin 2",0,942,10,348,{"v":324.336,"d":"324"},{"v":569.9059966120581,"d":"570"},{"v":416.3489291143774,"d":"416"},{"v":153.55706749768063,"d":"154"},{"v":36.8818211744448,"d":"37"},0,2787,12,312,{"v":865.8,"d":"866"},{"v":1512.7388713555686,"d":"1513"},{"v":993.235898269528,"d":"993"},{"v":519.5029730860406,"d":"520"},{"v":52.304087477219475,"d":"52"},{"v":89.18590865166428,"d":"89"},{"v":138.55853319528313,"d":"139"},"Possible",0,828,10,316,{"v":258.488,"d":"258"},{"v":442.23197217810537,"d":"442"},{"v":365.1525790978608,"d":"365"},{"v":77.07939308024459,"d":"77"},{"v":21.108817927748316,"d":"21"},{"v":57.990639102193114,"d":"58"},{"v":-12.296500948235234,"d":"-12"},{"$nulls":15},"Epitope undefined.",{"$nulls":3},"Adapter/scaffold protein","P51636","P51636",null,null,"GO:0002080; GO:0005901; GO:0031410; GO:0031234; GO:0005925; GO:0005794; GO:0000139; GO:0005887; GO:0005622; GO:0016020; GO:0045121; GO:0005634; GO:0048471; GO:0005886; GO:0032991; GO:0030133","GO:0031748; GO:0030674; GO:0032947; GO:0046982; GO:0042803; GO:0019901; GO:0097110","GO:0070836; GO:0007029; GO:0008286; GO:0007005; GO:0001937; GO:0030512; GO:0044794; GO:0044791; GO:0060161; GO:0001938; GO:0043547; GO:0043410; GO:0051259; GO:0019065; GO:0007088; GO:0048741; GO:0048278; GO:0006906; GO:0016050"]
[354,184,"NN022-1","Caveolin 2","Pan-specific","Caveolin 2",0,422,10,363,{"v":149.556,"d":"150"},{"v":262.7918616166968,"d":"263"},{"$nulls":3},0,928,12,296,{"v":271.136,"d":"271"},{"v":473.7329251834875,"d":"474"},{"$nulls":6},0,485,8,353,{"v":168.381,"d":"168"},{"v":288.07318601761614,"d":"288"},{"$nulls":20},"Epitope undefined.",{"$nulls":4},"P51636","P51636"]
[355,185,"PN018","Caveolin 2","S36","Caveolin 2",0,98,10,350,{"v":30.8,"d":"31"},{"v":54.120124487110246,"d":"54"},{"v":45.50307609474698,"d":"46"},{"v":8.617048392363266,"d":"9"},{"v":18.937287611986402,"d":"19"},0,174,12,319,{"v":51.678,"d":"52"},{"v":90.29258419255379,"d":"90"},{"v":60.114684231762176,"d":"60"},{"v":30.177899960791613,"d":"30"},{"v":50.20054641632273,"d":"50"},{"v":69.13783402830913,"d":"69"},{"v":32.11125354820135,"d":"32"},null,0,110,10,350,35,{"v":59.87944905076324,"d":"60"},{"v":45.723947295162816,"d":"46"},{"v":14.155501755600426,"d":"14"},{"v":30.95861707700365,"d":"31"},{"v":49.89590468899006,"d":"50"},{"v":0.4853983936293389,"d":"0"},{"$nulls":15},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S36 phosphosite.","S36 phosphorylation induces activity. This is one of the minor in vivo phosphorylation sites in caveolin 2 (≥9 reports from high throughput mass spectrometry studies).","CK2a1 (CSNK2A1)","Adapter/scaffold protein","P51636","P51636",null,null,"GO:0002080; GO:0005901; GO:0031410; GO:0031234; GO:0005925; GO:0005794; GO:0000139; GO:0005887; GO:0005622; GO:0016020; GO:0045121; GO:0005634; GO:0048471; GO:0005886; GO:0032991; GO:0030133","GO:0031748; GO:0030674; GO:0032947; GO:0046982; GO:0042803; GO:0019901; GO:0097110","GO:0070836; GO:0007029; GO:0008286; GO:0007005; GO:0001937; GO:0030512; GO:0044794; GO:0044791; GO:0060161; GO:0001938; GO:0043547; GO:0043410; GO:0051259; GO:0019065; GO:0007088; GO:0048741; GO:0048278; GO:0006906; GO:0016050"]
[356,185,"PN018","Caveolin 2","S36","Caveolin 2",0,40,8,656,{"v":20.992,"d":"21"},{"v":36.886027702383714,"d":"37"},{"$nulls":3},0,32,6,659,{"v":17.134,"d":"17"},{"v":29.936784270970563,"d":"30"},{"$nulls":6},0,36,8,659,{"v":18.452,"d":"18"},{"v":31.568445539562383,"d":"32"},{"$nulls":20},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S36 phosphosite.","S36 phosphorylation induces activity. This is one of the minor in vivo phosphorylation sites in caveolin 2 (≥9 reports from high throughput mass spectrometry studies).","CK2a1 (CSNK2A1)",null,"P51636","P51636"]
[357,186,"NN171-2","Cbl","Pan-specific","E3 ubiquitin-protein ligase CBL",0,946,16,579,{"v":538.47,"d":"538"},{"v":946.1708906679953,"d":"946"},{"v":883.5549609245481,"d":"884"},{"v":62.61592974344717,"d":"63"},{"v":7.086817743394946,"d":"7"},0,873,14,556,{"v":477.604,"d":"478"},{"v":834.4769414586567,"d":"834"},{"v":845.9631338128858,"d":"846"},{"v":11.486192354229047,"d":"11"},{"v":1.357765119439545,"d":"1"},{"v":8.44458286283449,"d":"8"},{"v":-4.254611062601754,"d":"-4"},null,0,1013,14,586,{"v":585.414,"d":"585"},{"v":1001.5505081886718,"d":"1002"},{"v":995.0578650701675,"d":"995"},{"v":6.4926431185042475,"d":"6"},{"v":0.6524890005312819,"d":"1"},{"v":7.739306743926228,"d":"8"},{"v":12.619803982419285,"d":"13"},{"$nulls":5},"Ubiquitin protein ligase",{"$nulls":9},"Not precisely defined.","Antibody raised against amino acid residues 892-906 at the C-terminus of human Cbl.",null,null,"Ubiquitin conjugating system; EC 6.3.2.-; Ligase; Adaptor/scaffold","P22681","P22681",null,"P22681","GO:0005829; GO:0016600; GO:0005925; GO:0030426; GO:0042629; GO:0045121; GO:0048471; GO:0005886","GO:0045296; GO:0005509; GO:0003700; GO:0046875; GO:0005154; GO:0036312; GO:0001784; GO:0030971; GO:0017124; GO:0061630; GO:0004842","GO:0007166; GO:0006974; GO:0071364; GO:1990090; GO:0090650; GO:0036120; GO:0019221; GO:0035635; GO:0007173; GO:0008543; GO:0070102; GO:0008584; GO:0043303; GO:0061024; GO:0043066; GO:0007175; GO:0042059; GO:1901215; GO:0070997; GO:0045742; GO:0014068; GO:0048260; GO:0006513; GO:0000209; GO:0016567; GO:0014823; GO:0045471; GO:0010332; GO:0042594; GO:0033574; GO:0007179; GO:0006511"]
[358,186,"NN171-2","Cbl","Pan-specific","E3 ubiquitin-protein ligase CBL",0,812,12,584,{"v":467.2,"d":"467"},{"v":820.9390311811009,"d":"821"},{"$nulls":3},0,880,16,568,{"v":490.752,"d":"491"},{"v":857.4493261671148,"d":"857"},{"$nulls":6},0,940,14,624,{"v":577.824,"d":"578"},{"v":988.5652219516634,"d":"989"},{"$nulls":10},"Ubiquitin protein ligase",{"$nulls":9},"Not precisely defined.","Antibody raised against amino acid residues 892-906 at the C-terminus of human Cbl.",{"$nulls":3},"P22681","P22681",null,"P22681"]
[359,187,"PN743","Cbl","Y674","E3 ubiquitin-protein ligase CBL",0,6424,18,696,{"v":4458.576,"d":"4459"},{"v":7834.372992053313,"d":"7834"},{"v":8463.867354301958,"d":"8464"},{"v":629.4943622486444,"d":"629"},{"v":7.437431801535609,"d":"7"},0,6014,16,721,{"v":4324.558,"d":"4325"},{"v":7555.933227109835,"d":"7556"},{"v":8261.166917178976,"d":"8261"},{"v":705.2336900691416,"d":"705"},{"v":8.536732124400228,"d":"9"},{"v":15.974163925935837,"d":"16"},{"v":-2.394891467905083,"d":"-2"},null,0,5814,14,690,4002,{"v":6846.787288604414,"d":"6847"},{"v":8034.5834134377765,"d":"8035"},{"v":1187.7961248333622,"d":"1188"},{"v":14.783543386291601,"d":"15"},{"v":22.22097518782721,"d":"22"},{"v":-5.071959695185768,"d":"-5"},{"$nulls":5},"Ubiquitin protein ligase",{"$nulls":9},"NAI(pY)SLAAC","Corresponds to amino acid residues N671 to A678.","The effect of Y674 phosphorylation is unclear. This is the major in vivo phosphorylation site in Cbl (≥732 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in fish.",null,"Ubiquitin conjugating system; EC 6.3.2.-; Ligase; Adaptor/scaffold","P22681","P22681",null,"P22681","GO:0005829; GO:0016600; GO:0005925; GO:0030426; GO:0042629; GO:0045121; GO:0048471; GO:0005886","GO:0045296; GO:0005509; GO:0003700; GO:0046875; GO:0005154; GO:0036312; GO:0001784; GO:0030971; GO:0017124; GO:0061630; GO:0004842","GO:0007166; GO:0006974; GO:0071364; GO:1990090; GO:0090650; GO:0036120; GO:0019221; GO:0035635; GO:0007173; GO:0008543; GO:0070102; GO:0008584; GO:0043303; GO:0061024; GO:0043066; GO:0007175; GO:0042059; GO:1901215; GO:0070997; GO:0045742; GO:0014068; GO:0048260; GO:0006513; GO:0000209; GO:0016567; GO:0014823; GO:0045471; GO:0010332; GO:0042594; GO:0033574; GO:0007179; GO:0006511"]
[360,187,"PN743","Cbl","Y674","E3 ubiquitin-protein ligase CBL",0,7264,16,714,{"v":5175.072,"d":"5175"},{"v":9093.361716550604,"d":"9093"},{"$nulls":3},0,7770,18,662,{"v":5131.824,"d":"5132"},{"v":8966.400607248117,"d":"8966"},{"$nulls":6},0,7589,18,712,{"v":5390.552,"d":"5391"},{"v":9222.37953827114,"d":"9222"},{"$nulls":10},"Ubiquitin protein ligase",{"$nulls":9},"NAI(pY)SLAAC","Corresponds to amino acid residues N671 to A678.","The effect of Y674 phosphorylation is unclear. This is the major in vivo phosphorylation site in Cbl (≥732 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in fish.",null,null,"P22681","P22681",null,"P22681"]
[361,188,"PN171","Cbl","Y700","E3 ubiquitin-protein ligase CBL",0,1332,16,392,{"v":515.872,"d":"516"},{"v":906.4628850459264,"d":"906"},{"v":547.3196303731842,"d":"547"},{"v":359.1432546727423,"d":"359"},{"v":65.61855901785657,"d":"66"},0,2848,16,355,{"v":1005.36,"d":"1005"},{"v":1756.5802168006867,"d":"1757"},{"v":1398.6806667793485,"d":"1399"},{"v":357.8995500213382,"d":"358"},{"v":25.588367561085285,"d":"26"},{"v":91.20692657894185,"d":"91"},{"v":155.55097773958386,"d":"156"},"Possible",0,1385,20,456,{"v":622.44,"d":"622"},{"v":1064.8961219187736,"d":"1065"},{"v":955.8402476247206,"d":"956"},{"v":109.05587429405296,"d":"109"},{"v":11.409424803470943,"d":"11"},{"v":77.02798382132751,"d":"77"},{"v":74.64022749795964,"d":"75"},{"$nulls":5},"Ubiquitin protein ligase",{"$nulls":9},"TE(pY)MT","Corresponds to amino acid residues T768 to T772.","Y700 phosphorylation induces interaction with CRK, Src, and VAV1. This is one of the major in vivo phosphorylation sites in Cbl (≥505 reports from high throughput mass spectrometry studies).","Abl1; Fyn; InsR; Lck; Src; Syk; Yes","Ubiquitin conjugating system; EC 6.3.2.-; Ligase; Adaptor/scaffold","P22681","P22681",null,"P22681","GO:0005829; GO:0016600; GO:0005925; GO:0030426; GO:0042629; GO:0045121; GO:0048471; GO:0005886","GO:0045296; GO:0005509; GO:0003700; GO:0046875; GO:0005154; GO:0036312; GO:0001784; GO:0030971; GO:0017124; GO:0061630; GO:0004842","GO:0007166; GO:0006974; GO:0071364; GO:1990090; GO:0090650; GO:0036120; GO:0019221; GO:0035635; GO:0007173; GO:0008543; GO:0070102; GO:0008584; GO:0043303; GO:0061024; GO:0043066; GO:0007175; GO:0042059; GO:1901215; GO:0070997; GO:0045742; GO:0014068; GO:0048260; GO:0006513; GO:0000209; GO:0016567; GO:0014823; GO:0045471; GO:0010332; GO:0042594; GO:0033574; GO:0007179; GO:0006511"]
[362,188,"PN171","Cbl","Y700","E3 ubiquitin-protein ligase CBL",0,178,14,653,{"v":107.092,"d":"107"},{"v":188.1763757004419,"d":"188"},{"$nulls":3},0,1474,14,408,{"v":595.68,"d":"596"},{"v":1040.78111675801,"d":"1041"},{"$nulls":6},0,996,12,503,{"v":494.952,"d":"495"},{"v":846.7843733306677,"d":"847"},{"$nulls":10},"Ubiquitin protein ligase",{"$nulls":9},"TE(pY)MT","Corresponds to amino acid residues T768 to T772.","Y700 phosphorylation induces interaction with CRK, Src, and VAV1. This is one of the major in vivo phosphorylation sites in Cbl (≥505 reports from high throughput mass spectrometry studies).","Abl1; Fyn; InsR; Lck; Src; Syk; Yes",null,"P22681","P22681",null,"P22681"]
[363,189,"PN218","Cbl","Y700","E3 ubiquitin-protein ligase CBL",0,226,10,548,{"v":118.368,"d":"118"},{"v":207.98996413280082,"d":"208"},{"v":194.84650532878834,"d":"195"},{"v":13.143458804012482,"d":"13"},{"v":6.745545054469372,"d":"7"},0,163,12,553,{"v":83.503,"d":"84"},{"v":145.8977061386048,"d":"146"},{"v":162.17738323938502,"d":"162"},{"v":16.27967710078022,"d":"16"},{"v":10.038191994225416,"d":"10"},{"v":16.78373704869479,"d":"17"},{"v":-16.766593803813265,"d":"-17"},null,0,192,10,521,{"v":94.822,"d":"95"},{"v":162.2254033683278,"d":"162"},{"v":172.61705404073737,"d":"173"},{"v":10.391650672409583,"d":"10"},{"v":6.020060260069766,"d":"6"},{"v":12.765605314539137,"d":"13"},{"v":-11.408698991311397,"d":"-11"},{"$nulls":5},"Ubiquitin protein ligase",{"$nulls":9},"Not precisely defined.","Antibody raised against amino acid residues surrounding the phosphorylated Y700 of human Cbl.","Y700 phosphorylation induces interaction with CRK, Src, and VAV1. This is one of the major in vivo phosphorylation sites in Cbl (≥505 reports from high throughput mass spectrometry studies).","Abl1; Fyn; InsR; Lck; Src; Syk; Yes","Ubiquitin conjugating system; EC 6.3.2.-; Ligase; Adaptor/scaffold","P22681","P22681",null,"P22681","GO:0005829; GO:0016600; GO:0005925; GO:0030426; GO:0042629; GO:0045121; GO:0048471; GO:0005886","GO:0045296; GO:0005509; GO:0003700; GO:0046875; GO:0005154; GO:0036312; GO:0001784; GO:0030971; GO:0017124; GO:0061630; GO:0004842","GO:0007166; GO:0006974; GO:0071364; GO:1990090; GO:0090650; GO:0036120; GO:0019221; GO:0035635; GO:0007173; GO:0008543; GO:0070102; GO:0008584; GO:0043303; GO:0061024; GO:0043066; GO:0007175; GO:0042059; GO:1901215; GO:0070997; GO:0045742; GO:0014068; GO:0048260; GO:0006513; GO:0000209; GO:0016567; GO:0014823; GO:0045471; GO:0010332; GO:0042594; GO:0033574; GO:0007179; GO:0006511"]
[364,189,"PN218","Cbl","Y700","E3 ubiquitin-protein ligase CBL",0,194,10,562,{"v":103.408,"d":"103"},{"v":181.70304652477586,"d":"182"},{"$nulls":3},0,182,8,587,{"v":102.138,"d":"102"},{"v":178.45706034016524,"d":"178"},{"$nulls":6},0,198,8,563,{"v":106.97,"d":"107"},{"v":183.00870471314695,"d":"183"},{"$nulls":10},"Ubiquitin protein ligase",{"$nulls":9},"Not precisely defined.","Antibody raised against amino acid residues surrounding the phosphorylated Y700 of human Cbl.","Y700 phosphorylation induces interaction with CRK, Src, and VAV1. This is one of the major in vivo phosphorylation sites in Cbl (≥505 reports from high throughput mass spectrometry studies).","Abl1; Fyn; InsR; Lck; Src; Syk; Yes",null,"P22681","P22681",null,"P22681"]
[365,190,"PN744","CBS","S227","Cystathionine beta-synthase",0,1868,14,643,{"v":1192.122,"d":"1192"},{"v":2094.733475448794,"d":"2095"},{"v":1900.8832724116999,"d":"1901"},{"v":193.85020303709393,"d":"194"},{"v":10.19790146246861,"d":"10"},0,1774,10,663,{"v":1169.532,"d":"1170"},{"v":2043.4240213608464,"d":"2043"},{"v":1733.8629255031985,"d":"1734"},{"v":309.56109585764784,"d":"310"},{"v":17.853839037927845,"d":"18"},{"v":28.051740500396456,"d":"28"},{"v":-8.78645992273887,"d":"-9"},null,0,1860,14,629,{"v":1161.134,"d":"1161"},{"v":1986.5161198316837,"d":"1987"},{"v":1869.3491464533545,"d":"1869"},{"v":117.1669733783292,"d":"117"},{"v":6.267795055868813,"d":"6"},{"v":16.465696518337424,"d":"16"},{"v":-1.6589196409907458,"d":"-2"},{"$nulls":14},"X","RNA(pS)NPLAC","Corresponds to amino acid residues R224 to A 231.","S227 phosphorylation stimulates enzyme activity. This phosphorylation site has not been detected in high throughput mass spectrometry studies.  in CBS. This human phosphosite is highly conserved in vertebrates and also found in sea urchin.","PKG1",null,"P35520","P35520",null,null,"GO:0005737; GO:0005829; GO:0005634","GO:0070025; GO:0004122; GO:0019899; GO:0020037; GO:0042802; GO:0046872; GO:0072341; GO:0070026; GO:0050421; GO:0019825; GO:0042803; GO:0030170; GO:1904047; GO:0031625","GO:0019344; GO:0006535; GO:0019343; GO:0042262; GO:0043418; GO:0050667; GO:0070814; GO:0019448; GO:0006565; GO:0006563; GO:0019346"]
[366,190,"PN744","CBS","S227","Cystathionine beta-synthase",0,1504,14,652,{"v":971.48,"d":"971"},{"v":1707.033069374606,"d":"1707"},{"$nulls":3},0,1346,14,612,{"v":815.184,"d":"815"},{"v":1424.3018296455507,"d":"1424"},{"$nulls":6},0,1578,12,654,{"v":1024.164,"d":"1024"},{"v":1752.1821730750253,"d":"1752"},{"$nulls":19},"X","RNA(pS)NPLAC","Corresponds to amino acid residues R224 to A 231.","S227 phosphorylation stimulates enzyme activity. This phosphorylation site has not been detected in high throughput mass spectrometry studies.  in CBS. This human phosphosite is highly conserved in vertebrates and also found in sea urchin.","PKG1",null,"P35520","P35520"]
[367,191,"NP001","CD45 (PTPRC; Receptor-type tyrosine-protein phosphatase C)","Pan-specific","Receptor protein-tyrosine phosphatase CD45",0,328,12,317,{"v":100.172,"d":"100"},{"v":176.01691915983142,"d":"176"},{"v":147.58013232096295,"d":"148"},{"v":28.43678683886847,"d":"28"},{"v":19.268709406644962,"d":"19"},0,560,12,335,{"v":183.58,"d":"184"},{"v":320.75375606774696,"d":"321"},{"v":196.87270795403418,"d":"197"},{"v":123.88104811371278,"d":"124"},{"v":62.924439553417685,"d":"63"},{"v":82.19314896006264,"d":"82"},{"v":33.40054982866383,"d":"33"},null,0,337,14,380,{"v":122.74,"d":"123"},{"v":209.98867361401943,"d":"210"},{"v":185.8315930255401,"d":"186"},{"v":24.157080588479346,"d":"24"},{"v":12.999447615540419,"d":"13"},{"v":32.26815702218538,"d":"32"},{"v":25.919112622413422,"d":"26"},{"$nulls":4},"PYP","Protein phosphatase - Receptor protein-tyrosine phosphatase",{"$nulls":6},"X",null,null,"Epitope undefined.",{"$nulls":3},"EC 3.1.3.48; Receptor protein phosphatase, tyrosine","P08575","P08575",null,null,"GO:0009986; GO:0009898; GO:0009897; GO:0070062; GO:0005925; GO:0016021; GO:0005887; GO:0016020; GO:0098857; GO:0045121; GO:0005886; GO:0030667","GO:0043395; GO:0008201; GO:0019901; GO:0004725; GO:0005001","GO:0000187; GO:0030183; GO:0042100; GO:0050853; GO:0048539; GO:0044770; GO:0007166; GO:0031668; GO:0051607; GO:0016311; GO:0002244; GO:0034113; GO:0002378; GO:0007159; GO:0006933; GO:0001960; GO:0070373; GO:0045085; GO:1903979; GO:0031953; GO:0006469; GO:0061099; GO:0001915; GO:0045060; GO:0043312; GO:0044855; GO:0046641; GO:0050857; GO:0030890; GO:0070374; GO:2001238; GO:0045588; GO:2000473; GO:0002925; GO:0045086; GO:0048304; GO:0045860; GO:1903615; GO:2000648; GO:0001916; GO:0042102; GO:0045059; GO:0006470; GO:0045577; GO:0050855; GO:0051726; GO:0051209; GO:0010332; GO:0048864; GO:0030217; GO:0042098; GO:0050852"]
[368,191,"NP001","CD45 (PTPRC; Receptor-type tyrosine-protein phosphatase C)","Pan-specific","Receptor protein-tyrosine phosphatase CD45",1,203,12,355,{"v":67.805,"d":"68"},{"v":119.1433454820945,"d":"119"},{"$nulls":3},1,124,12,373,{"v":41.776,"d":"42"},{"v":72.99165984032138,"d":"73"},{"$nulls":6},1,327,12,300,{"v":94.5,"d":"95"},{"v":161.67451243706074,"d":"162"},{"$nulls":9},"PYP","Protein phosphatase - Receptor protein-tyrosine phosphatase",{"$nulls":6},"X",null,null,"Epitope undefined.",{"$nulls":4},"P08575","P08575"]
[369,192,"PP527","CD45 (PTPRC; Receptor-type tyrosine-protein phosphatase C)","Y1216",null,0,9241,16,716,{"v":6605.1,"d":"6605"},{"v":11606.13098213675,"d":"11606"},{"v":11754.648552328294,"d":"11755"},{"v":148.5175701915432,"d":"149"},{"v":1.2634794611713482,"d":"1"},0,9720,16,740,{"v":7180.96,"d":"7181"},{"v":12546.682057807213,"d":"12547"},{"v":11695.12434110442,"d":"11695"},{"v":851.5577167027932,"d":"852"},{"v":7.281305370220434,"d":"7"},{"v":8.544784831391782,"d":"9"},{"v":-0.5063886934508446,"d":"-1"},null,0,4460,12,943,{"v":4194.464,"d":"4194"},{"v":7176.06266809316,"d":"7176"},{"v":9528.189017097593,"d":"9528"},{"v":2352.126349004433,"d":"2352"},{"v":24.6859748981021,"d":"25"},{"v":25.949454359273446,"d":"26"},{"v":-18.941098283960997,"d":"-19"},{"$nulls":4},"PYP","Protein phosphatase - Receptor protein-tyrosine phosphatase",{"$nulls":6},"X",null,null,"FEQ(pY)QFL(bA)C","Corresponds to amino acid residues F1215 to L1221.","Y1216 phosphorylation stimulates phosphatase activity. Phosphorylation at this site has only be reported in a single mass spectrometry study. This human phosphosite is highly conserved in vertebrates and also found in fish.","CSK","EC 3.1.3.48; Receptor protein phosphatase, tyrosine","P08575","P08575",null,null,"GO:0009986; GO:0009898; GO:0009897; GO:0070062; GO:0005925; GO:0016021; GO:0005887; GO:0016020; GO:0098857; GO:0045121; GO:0005886; GO:0030667","GO:0043395; GO:0008201; GO:0019901; GO:0004725; GO:0005001","GO:0000187; GO:0030183; GO:0042100; GO:0050853; GO:0048539; GO:0044770; GO:0007166; GO:0031668; GO:0051607; GO:0016311; GO:0002244; GO:0034113; GO:0002378; GO:0007159; GO:0006933; GO:0001960; GO:0070373; GO:0045085; GO:1903979; GO:0031953; GO:0006469; GO:0061099; GO:0001915; GO:0045060; GO:0043312; GO:0044855; GO:0046641; GO:0050857; GO:0030890; GO:0070374; GO:2001238; GO:0045588; GO:2000473; GO:0002925; GO:0045086; GO:0048304; GO:0045860; GO:1903615; GO:2000648; GO:0001916; GO:0042102; GO:0045059; GO:0006470; GO:0045577; GO:0050855; GO:0051726; GO:0051209; GO:0010332; GO:0048864; GO:0030217; GO:0042098; GO:0050852"]
[370,192,"PP527","CD45 (PTPRC; Receptor-type tyrosine-protein phosphatase C)","Y1216",null,0,9586,18,708,{"v":6774.144,"d":"6774"},{"v":11903.166122519837,"d":"11903"},{"$nulls":3},0,9564,16,650,{"v":6206.2,"d":"6206"},{"v":10843.566624401628,"d":"10844"},{"$nulls":6},0,9767,14,712,{"v":6944.136,"d":"6944"},{"v":11880.315366102024,"d":"11880"},{"$nulls":9},"PYP","Protein phosphatase - Receptor protein-tyrosine phosphatase",{"$nulls":6},"X",null,null,"FEQ(pY)QFL(bA)C","Corresponds to amino acid residues F1215 to L1221.","Y1216 phosphorylation stimulates phosphatase activity. Phosphorylation at this site has only be reported in a single mass spectrometry study. This human phosphosite is highly conserved in vertebrates and also found in fish.","CSK",null,"P08575","P08575"]
[371,193,"NK024","CDC2L5 (CHED, CDK13)","Pan-specific","Cholinesterase-related cell division controller",0,222,16,606,{"v":124.836,"d":"125"},{"v":219.35519027509397,"d":"219"},{"v":224.17855851266273,"d":"224"},{"v":4.823368237568758,"d":"5"},{"v":2.151574293977945,"d":"2"},0,282,16,717,{"v":190.722,"d":"191"},{"v":333.2323666235583,"d":"333"},{"v":298.10810059114783,"d":"298"},{"v":35.124266032410446,"d":"35"},{"v":11.78239234786277,"d":"12"},{"v":13.933966641840716,"d":"14"},{"v":32.977971920677334,"d":"33"},null,0,326,12,654,{"v":205.356,"d":"205"},{"v":351.3315468362439,"d":"351"},{"v":325.82632322342164,"d":"326"},{"v":25.50522361282225,"d":"26"},{"v":7.827858523061416,"d":"8"},{"v":9.979432817039362,"d":"10"},{"v":45.342322381387476,"d":"45"},null,null,"CHED","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CRK7","X",{"$nulls":4},"Epitope undefined.",{"$nulls":3},"EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC domain target; CMGC</A> group; CDK family; CRK7 subfamily; CDK/CRK7 subfamily","Q14004","Q14004","Q14004",null,"GO:0005694; GO:0008024; GO:0002945; GO:0005829; GO:0005576; GO:0005615; GO:1904813; GO:0005794; GO:0019908; GO:0016607; GO:0005654","GO:0005524; GO:0030332; GO:0004693; GO:0004672; GO:0019901; GO:0003723; GO:0008353; GO:0008134; GO:0044212","GO:0000380; GO:0030097; GO:0007275; GO:2000737; GO:0043312; GO:0070816; GO:0008284; GO:0045944; GO:0007088; GO:0006368; GO:0016032"]
[372,193,"NK024","CDC2L5 (CHED, CDK13)","Pan-specific","Cholinesterase-related cell division controller",0,226,12,609,{"v":130.326,"d":"130"},{"v":229.00192675023146,"d":"229"},{"$nulls":3},0,238,12,666,{"v":150.516,"d":"151"},{"v":262.9838345587373,"d":"263"},{"$nulls":6},0,274,12,670,{"v":175.54,"d":"176"},{"v":300.3210996105994,"d":"300"},{"$nulls":7},"CHED","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CRK7","X",{"$nulls":4},"Epitope undefined.",{"$nulls":4},"Q14004","Q14004","Q14004"]
[373,194,"NK024-2","CDC2L5 (CHED, CDK13)","Pan-specific","CDC2-related protein kinase 5",0,1150,20,698,{"v":788.74,"d":"789"},{"v":1385.9320450637447,"d":"1386"},{"v":1321.0142528826964,"d":"1321"},{"v":64.9177921810483,"d":"65"},{"v":4.914238588977047,"d":"5"},0,1196,20,809,{"v":951.384,"d":"951"},{"v":1662.2725322080692,"d":"1662"},{"v":1346.4843615785212,"d":"1346"},{"v":315.78817062954795,"d":"316"},{"v":23.452791554098752,"d":"23"},{"v":28.367030143075798,"d":"28"},{"v":1.928072209686178,"d":"2"},null,0,1408,14,768,{"v":1070.592,"d":"1071"},{"v":1831.6131176615636,"d":"1832"},{"v":1689.1239807003672,"d":"1689"},{"v":142.48913696119644,"d":"142"},{"v":8.435682554344867,"d":"8"},{"v":13.349921143321914,"d":"13"},{"v":27.865689337899838,"d":"28"},null,null,"CHED","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CRK7",{"$nulls":5},"CGPRYGETKEKDIDWGKR ","Corresponds to amino acid residues C683 to R700; Just before kinase catalytic domain.",null,null,"EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC domain target; CMGC</A> group; CDK family; CRK7 subfamily; CDK/CRK7 subfamily","Q14004","Q14004","Q14004",null,"GO:0005694; GO:0008024; GO:0002945; GO:0005829; GO:0005576; GO:0005615; GO:1904813; GO:0005794; GO:0019908; GO:0016607; GO:0005654","GO:0005524; GO:0030332; GO:0004693; GO:0004672; GO:0019901; GO:0003723; GO:0008353; GO:0008134; GO:0044212","GO:0000380; GO:0030097; GO:0007275; GO:2000737; GO:0043312; GO:0070816; GO:0008284; GO:0045944; GO:0007088; GO:0006368; GO:0016032"]
[374,194,"NK024-2","CDC2L5 (CHED, CDK13)","Pan-specific","CDC2-related protein kinase 5",0,1000,14,725,{"v":714.85,"d":"715"},{"v":1256.096460701648,"d":"1256"},{"$nulls":3},0,920,18,654,{"v":589.908,"d":"590"},{"v":1030.696190948973,"d":"1031"},{"$nulls":6},0,1240,20,741,{"v":904.02,"d":"904"},{"v":1546.634843739171,"d":"1547"},{"$nulls":7},"CHED","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CRK7",{"$nulls":5},"CGPRYGETKEKDIDWGKR ","Corresponds to amino acid residues C683 to R700; Just before kinase catalytic domain.",{"$nulls":3},"Q14004","Q14004","Q14004"]
[375,195,"PN576","CDC5L","T385","Cell division cycle 5-like protein",0,13352,20,939,{"v":12518.748,"d":"12519"},{"v":21997.279226713064,"d":"21997"},{"v":22230.361248562614,"d":"22230"},{"v":233.08202184955007,"d":"233"},{"v":1.0484850841756825,"d":"1"},0,13654,20,1004,{"v":13688.536,"d":"13689"},{"v":23916.817393335725,"d":"23917"},{"v":21369.388197212844,"d":"21369"},{"v":2547.429196122881,"d":"2547"},{"v":11.920927134709153,"d":"12"},{"v":12.969412218884836,"d":"13"},{"v":-3.8729602354322594,"d":"-4"},null,0,12924,20,1012,{"v":13058.848,"d":"13059"},{"v":22341.61781364747,"d":"22342"},{"v":21634.862387342713,"d":"21635"},{"v":706.7554263047568,"d":"707"},{"v":3.266743340684422,"d":"3"},{"v":4.315228424860105,"d":"4"},{"v":-2.678763761692821,"d":"-3"},{"$nulls":5},"Transcription protein; RNA processing",{"$nulls":4},"X",{"$nulls":4},"CGGLN(pT)PLHE","Corresponds to amino acid residues C381 to E389.","The effect of T385 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in CDC5L (≥66 reports from high throughput mass spectrometry studies).","ERK1 (MAPK3)","Transcription factor; RNA processing","Q99459","Q99459",null,null,"GO:0071013; GO:0005737; GO:0016020; GO:0016607; GO:0005654; GO:0005634; GO:0048471; GO:0032993; GO:0000974; GO:0071007","GO:0003677; GO:0043522; GO:0019901; GO:0008157; GO:0003723; GO:0000977; GO:0000981; GO:0001135; GO:0043565; GO:0001228; GO:0001222; GO:0044212; GO:0071987","GO:0030154; GO:0044344; GO:0071352; GO:1990090; GO:1990646; GO:1904568; GO:0006281; GO:0000278; GO:0000398; GO:0045944; GO:0006357; GO:0072422"]
[376,195,"PN576","CDC5L","T385","Cell division cycle 5-like protein",0,13258,24,966,{"v":12784.044,"d":"12784"},{"v":22463.44327041217,"d":"22463"},{"$nulls":3},0,12814,20,842,{"v":10772.548,"d":"10773"},{"v":18821.959001089963,"d":"18822"},{"$nulls":6},0,12062,22,1016,{"v":12232.64,"d":"12233"},{"v":20928.106961037956,"d":"20928"},{"$nulls":10},"Transcription protein; RNA processing",{"$nulls":4},"X",{"$nulls":4},"CGGLN(pT)PLHE","Corresponds to amino acid residues C381 to E389.","The effect of T385 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in CDC5L (≥66 reports from high throughput mass spectrometry studies).","ERK1 (MAPK3)",null,"Q99459","Q99459"]
[377,196,"PK558","CDC7","T376","Cell division cycle 7-related protein kinase",0,7705,18,760,{"v":5842.12,"d":"5842"},{"v":10265.463041189496,"d":"10265"},{"v":9990.613637552327,"d":"9991"},{"v":274.8494036371685,"d":"275"},{"v":2.751076296295508,"d":"3"},0,8387,16,707,{"v":5918.297,"d":"5918"},{"v":10340.538142904883,"d":"10341"},{"v":10358.383324774357,"d":"10358"},{"v":17.84518186947389,"d":"18"},{"v":0.17227767413079997,"d":"0"},{"v":2.923353970426308,"d":"3"},{"v":3.68115213503674,"d":"4"},null,0,7877,12,670,{"v":5269.55,"d":"5270"},{"v":9015.364307012842,"d":"9015"},{"v":9366.540167281553,"d":"9367"},{"v":351.1758602687114,"d":"351"},{"v":3.7492591073853583,"d":"4"},{"v":6.500335403680866,"d":"7"},{"v":-6.246597985983868,"d":"-6"},null,null,"CDC7","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","CDC7",{"$nulls":6},"RAG(pT)PGF(bA)C","Corresponds to amino acid residues R373 to F379; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T376 phosphorylation was originally suggested to be stimulatory based on loss of phosphotransferase activity with an alanine substitution. However, it is predicted to be inhibitory for phosphotransferase activity. This phosphosite is located in the kinase activation loop just before the catalytic subdomain VIII. This is one of the major in vivo phosphorylation sites in CDC7 (≥13 reports from high throughput mass spectrometry studies).","CDK1 (CDC2); CDK2","EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; CDC7 family","O00311","O00311","O00311",null,"GO:0005737; GO:0045171; GO:0072686; GO:0005654; GO:0005634","GO:0005524; GO:0016301; GO:0046872; GO:0004672; GO:0004674","GO:0044770; GO:0051301; GO:0006260; GO:0006270; GO:0000727; GO:0000082; GO:0070317; GO:0018105; GO:0006909; GO:0008284; GO:0010971; GO:0010571; GO:0008360"]
[378,196,"PK558","CDC7","T376","Cell division cycle 7-related protein kinase",0,7580,16,731,{"v":5529.284,"d":"5529"},{"v":9715.764233915157,"d":"9716"},{"$nulls":3},0,7618,14,781,{"v":5938.724,"d":"5939"},{"v":10376.22850664383,"d":"10376"},{"$nulls":6},0,7905,16,720,{"v":5680.08,"d":"5680"},{"v":9717.716027550265,"d":"9718"},{"$nulls":7},"CDC7","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","CDC7",{"$nulls":6},"RAG(pT)PGF(bA)C","Corresponds to amino acid residues R373 to F379; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T376 phosphorylation was originally suggested to be stimulatory based on loss of phosphotransferase activity with an alanine substitution. However, it is predicted to be inhibitory for phosphotransferase activity. This phosphosite is located in the kinase activation loop just before the catalytic subdomain VIII. This is one of the major in vivo phosphorylation sites in CDC7 (≥13 reports from high throughput mass spectrometry studies).","CDK1 (CDC2); CDK2",null,"O00311","O00311","O00311"]
[379,197,"NK025-6","CDK1 (CDC2)","Pan-specific","Cyclin-dependent protein-serine kinase 1; Cell division control protein 2 homologue",0,208,14,542,{"v":105.148,"d":"105"},{"v":184.7604821289178,"d":"185"},{"v":166.88678387297995,"d":"167"},{"v":17.873698255937853,"d":"18"},{"v":10.710074123989228,"d":"11"},0,180,10,515,{"v":87.55,"d":"88"},{"v":152.96868582487875,"d":"153"},{"v":168.28302655880293,"d":"168"},{"v":15.314340733924183,"d":"15"},{"v":9.10034781705861,"d":"9"},{"v":19.81042194104784,"d":"20"},{"v":0.8366406574685357,"d":"1"},null,0,174,10,492,{"v":80.688,"d":"81"},{"v":138.04437100022813,"d":"138"},{"v":163.6616547248454,"d":"164"},{"v":25.617283724617266,"d":"26"},{"v":15.652587509081513,"d":"16"},{"v":26.362661633070744,"d":"26"},{"v":-1.932525196596302,"d":"-2"},null,null,"CDK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues at the C-terminus of human Cdc2 p34.",null,null,"EC 2.7.11.23; EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; CDK/CDK1 subfamily; CDK1 subfamily","P06493","P06493","P06493","P06493","GO:0005813; GO:0097125; GO:0000307; GO:0005829; GO:0005789; GO:0070062; GO:0016020; GO:0030496; GO:0005759; GO:0005739; GO:0072686; GO:0000784; GO:0005654; GO:0005634; GO:0005876","GO:0005524; GO:0003682; GO:0030332; GO:0097472; GO:0004693; GO:0035173; GO:0030544; GO:0004672; GO:0004674; GO:0008353; GO:0001618","GO:0000187; GO:0031145; GO:0031100; GO:0006915; GO:0007569; GO:0051301; GO:0016477; GO:0008283; GO:0070301; GO:0007098; GO:0030261; GO:0097711; GO:0006977; GO:0006281; GO:0006260; GO:0030855; GO:0000086; GO:0090166; GO:0000226; GO:0007095; GO:0007077; GO:0043066; GO:0018105; GO:0018107; GO:0060045; GO:0045740; GO:0010971; GO:0010628; GO:1905448; GO:0033160; GO:1900182; GO:0007344; GO:0065003; GO:0016579; GO:0034501; GO:0006468; GO:0045995; GO:0010389; GO:0010468; GO:0051445; GO:0014038; GO:0014823; GO:0014075; GO:0048678; GO:0046686; GO:0046688; GO:0045471; GO:0014070; GO:0055015"]
[380,197,"NK025-6","CDK1 (CDC2)","Pan-specific","Cyclin-dependent protein-serine kinase 1; Cell division control protein 2 homologue",0,158,10,573,{"v":84.804,"d":"85"},{"v":149.01308561704212,"d":"149"},{"$nulls":3},0,195,10,568,{"v":105.08,"d":"105"},{"v":183.59736729272714,"d":"184"},{"$nulls":6},0,213,10,545,{"v":110.635,"d":"111"},{"v":189.27893844946263,"d":"189"},{"$nulls":7},"CDK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues at the C-terminus of human Cdc2 p34.",{"$nulls":3},"P06493","P06493","P06493","P06493"]
[381,198,"NK025-1","CDK1 (CDC2)","Pan-specific","Cyclin-dependent protein-serine kinase 1; Cell division control protein 2 homologue",0,201,12,481,{"v":90.909,"d":"91"},{"v":159.7404674350229,"d":"160"},{"v":155.3045500886687,"d":"155"},{"v":4.435917346354216,"d":"4"},{"v":2.8562700473499323,"d":"3"},0,180,12,444,{"v":74.592,"d":"75"},{"v":130.32827199371053,"d":"130"},{"v":117.12456715329239,"d":"117"},{"v":13.20370484041814,"d":"13"},{"v":11.273215484448414,"d":"11"},{"v":14.129485531798347,"d":"14"},{"v":-24.583943557080616,"d":"-25"},null,0,202,8,470,{"v":91.18,"d":"91"},{"v":155.9945189842455,"d":"156"},{"v":162.1484155052625,"d":"162"},{"v":6.153896521017003,"d":"6"},{"v":3.7952245798031123,"d":"4"},{"v":6.651494627153045,"d":"7"},{"v":4.406738510034899,"d":"4"},null,null,"CDK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"Epitope undefined.",{"$nulls":3},"EC 2.7.11.23; EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; CDK/CDK1 subfamily; CDK1 subfamily","P06493","P06493","P06493","P06493","GO:0005813; GO:0097125; GO:0000307; GO:0005829; GO:0005789; GO:0070062; GO:0016020; GO:0030496; GO:0005759; GO:0005739; GO:0072686; GO:0000784; GO:0005654; GO:0005634; GO:0005876","GO:0005524; GO:0003682; GO:0030332; GO:0097472; GO:0004693; GO:0035173; GO:0030544; GO:0004672; GO:0004674; GO:0008353; GO:0001618","GO:0000187; GO:0031145; GO:0031100; GO:0006915; GO:0007569; GO:0051301; GO:0016477; GO:0008283; GO:0070301; GO:0007098; GO:0030261; GO:0097711; GO:0006977; GO:0006281; GO:0006260; GO:0030855; GO:0000086; GO:0090166; GO:0000226; GO:0007095; GO:0007077; GO:0043066; GO:0018105; GO:0018107; GO:0060045; GO:0045740; GO:0010971; GO:0010628; GO:1905448; GO:0033160; GO:1900182; GO:0007344; GO:0065003; GO:0016579; GO:0034501; GO:0006468; GO:0045995; GO:0010389; GO:0010468; GO:0051445; GO:0014038; GO:0014823; GO:0014075; GO:0048678; GO:0046686; GO:0046688; GO:0045471; GO:0014070; GO:0055015"]
[382,198,"NK025-1","CDK1 (CDC2)","Pan-specific","Cyclin-dependent protein-serine kinase 1; Cell division control protein 2 homologue",0,190,10,477,{"v":85.86,"d":"86"},{"v":150.86863274231447,"d":"151"},{"$nulls":3},0,148,10,431,{"v":59.478,"d":"59"},{"v":103.92086231287423,"d":"104"},{"$nulls":6},0,214,12,487,{"v":98.374,"d":"98"},{"v":168.3023120262795,"d":"168"},{"$nulls":7},"CDK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"Epitope undefined.",{"$nulls":4},"P06493","P06493","P06493","P06493"]
[383,199,"NK204","CDK1 (CDC2)","Pan-specific","Cyclin-dependent protein-serine kinase 1; Cell division control protein 2 homologue",0,10,2,353,{"v":2.824,"d":"3"},{"v":4.962182842584394,"d":"5"},{"v":6.476843469463908,"d":"6"},{"v":1.5146606268795146,"d":"2"},{"v":23.385784047748245,"d":"23"},0,8,2,362,{"v":2.172,"d":"2"},{"v":3.794951291966153,"d":"4"},{"v":7.09019905285389,"d":"7"},{"v":3.295247760887737,"d":"3"},{"v":46.476096599310004,"d":"46"},{"v":69.86188064705826,"d":"70"},{"v":9.469976946050068,"d":"9"},null,0,8,2,423,{"v":2.538,"d":"3"},{"v":4.34211547688106,"d":"4"},{"v":5.794619826712431,"d":"6"},{"v":1.4525043498313712,"d":"1"},{"v":25.066430469441986,"d":"25"},{"v":48.45221451719023,"d":"48"},{"v":-10.53327359180328,"d":"-11"},null,null,"CDK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"EGVPSTAIREISLLKEGGC","Corresponds to amino acid residues E42 to E57; Kinase catalytic subdomain 3.",null,null,"EC 2.7.11.23; EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; CDK/CDK1 subfamily; CDK1 subfamily","P06493","P06493","P06493","P06493","GO:0005813; GO:0097125; GO:0000307; GO:0005829; GO:0005789; GO:0070062; GO:0016020; GO:0030496; GO:0005759; GO:0005739; GO:0072686; GO:0000784; GO:0005654; GO:0005634; GO:0005876","GO:0005524; GO:0003682; GO:0030332; GO:0097472; GO:0004693; GO:0035173; GO:0030544; GO:0004672; GO:0004674; GO:0008353; GO:0001618","GO:0000187; GO:0031145; GO:0031100; GO:0006915; GO:0007569; GO:0051301; GO:0016477; GO:0008283; GO:0070301; GO:0007098; GO:0030261; GO:0097711; GO:0006977; GO:0006281; GO:0006260; GO:0030855; GO:0000086; GO:0090166; GO:0000226; GO:0007095; GO:0007077; GO:0043066; GO:0018105; GO:0018107; GO:0060045; GO:0045740; GO:0010971; GO:0010628; GO:1905448; GO:0033160; GO:1900182; GO:0007344; GO:0065003; GO:0016579; GO:0034501; GO:0006468; GO:0045995; GO:0010389; GO:0010468; GO:0051445; GO:0014038; GO:0014823; GO:0014075; GO:0048678; GO:0046686; GO:0046688; GO:0045471; GO:0014070; GO:0055015"]
[384,199,"NK204","CDK1 (CDC2)","Pan-specific","Cyclin-dependent protein-serine kinase 1; Cell division control protein 2 homologue",0,8,2,758,{"v":4.548,"d":"5"},{"v":7.991504096343422,"d":"8"},{"$nulls":3},0,10,2,743,{"v":5.944,"d":"6"},{"v":10.385446813741627,"d":"10"},{"$nulls":6},0,8,2,706,{"v":4.236,"d":"4"},{"v":7.247124176543802,"d":"7"},{"$nulls":7},"CDK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"EGVPSTAIREISLLKEGGC","Corresponds to amino acid residues E42 to E57; Kinase catalytic subdomain 3.",{"$nulls":3},"P06493","P06493","P06493","P06493"]
[385,200,"PK559","CDK1 (CDC2)","T14","Cyclin-dependent protein-serine kinase 1; Cell division control protein 2 homologue",0,8851,18,742,{"v":6554.086,"d":"6554"},{"v":11516.491890234625,"d":"11516"},{"v":11298.574046122858,"d":"11299"},{"v":217.9178441117674,"d":"218"},{"v":1.928719882900149,"d":"2"},0,8432,14,659,{"v":5547.462,"d":"5547"},{"v":9692.609615116548,"d":"9693"},{"v":9645.183207257833,"d":"9645"},{"v":47.42640785871481,"d":"47"},{"v":0.49171080361674485,"d":"0"},{"v":2.420430686516894,"d":"2"},{"v":-14.633623961002328,"d":"-15"},null,0,8357,18,701,{"v":5845.639,"d":"5846"},{"v":10000.961219132989,"d":"10001"},{"v":10409.387820639135,"d":"10409"},{"v":408.42660150614574,"d":"408"},{"v":3.923637091283514,"d":"4"},{"v":5.852356974183663,"d":"6"},{"v":-7.869897757486044,"d":"-8"},null,null,"CDK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"GEG(pT)YGV(bA)C","Corresponds to amino acid residues G11 to V17; In the protein kinase catalytic domain in subdomain I.","T14 phosphorylation inhibits phosphotransferase activity. This phosphosite is located in the kinase subdomain I region, which is involved in binding the phosphates in the ATP substrate. Phosphorylation regulates cell cycle progression. This is one of the major in vivo phosphorylation sites in CDK1 (≥1823 reports from high throughput mass spectrometry studies).","MYT1 (PKMYT1)","EC 2.7.11.23; EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; CDK/CDK1 subfamily; CDK1 subfamily","P06493","P06493","P06493","P06493","GO:0005813; GO:0097125; GO:0000307; GO:0005829; GO:0005789; GO:0070062; GO:0016020; GO:0030496; GO:0005759; GO:0005739; GO:0072686; GO:0000784; GO:0005654; GO:0005634; GO:0005876","GO:0005524; GO:0003682; GO:0030332; GO:0097472; GO:0004693; GO:0035173; GO:0030544; GO:0004672; GO:0004674; GO:0008353; GO:0001618","GO:0000187; GO:0031145; GO:0031100; GO:0006915; GO:0007569; GO:0051301; GO:0016477; GO:0008283; GO:0070301; GO:0007098; GO:0030261; GO:0097711; GO:0006977; GO:0006281; GO:0006260; GO:0030855; GO:0000086; GO:0090166; GO:0000226; GO:0007095; GO:0007077; GO:0043066; GO:0018105; GO:0018107; GO:0060045; GO:0045740; GO:0010971; GO:0010628; GO:1905448; GO:0033160; GO:1900182; GO:0007344; GO:0065003; GO:0016579; GO:0034501; GO:0006468; GO:0045995; GO:0010389; GO:0010468; GO:0051445; GO:0014038; GO:0014823; GO:0014075; GO:0048678; GO:0046686; GO:0046688; GO:0045471; GO:0014070; GO:0055015"]
[386,200,"PK559","CDK1 (CDC2)","T14","Cyclin-dependent protein-serine kinase 1; Cell division control protein 2 homologue",0,8712,14,725,{"v":6306.05,"d":"6306"},{"v":11080.65620201109,"d":"11081"},{"$nulls":3},0,8694,16,633,{"v":5493.174,"d":"5493"},{"v":9597.756799399116,"d":"9598"},{"$nulls":6},0,8490,14,746,{"v":6323.096,"d":"6323"},{"v":10817.81442214528,"d":"10818"},{"$nulls":7},"CDK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"GEG(pT)YGV(bA)C","Corresponds to amino acid residues G11 to V17; In the protein kinase catalytic domain in subdomain I.","T14 phosphorylation inhibits phosphotransferase activity. This phosphosite is located in the kinase subdomain I region, which is involved in binding the phosphates in the ATP substrate. Phosphorylation regulates cell cycle progression. This is one of the major in vivo phosphorylation sites in CDK1 (≥1823 reports from high throughput mass spectrometry studies).","MYT1 (PKMYT1)",null,"P06493","P06493","P06493","P06493"]
[387,201,"PK560","CDK1 (CDC2)","T14+Y15","Cyclin-dependent protein-serine kinase 1; Cell division control protein 2 homologue",0,9788,18,763,{"v":7454.51,"d":"7455"},{"v":13098.669129558708,"d":"13099"},{"v":12642.213322476204,"d":"12642"},{"v":456.4558070825042,"d":"456"},{"v":3.6105687781030036,"d":"4"},0,9890,16,732,{"v":7227.768,"d":"7228"},{"v":12628.465704250284,"d":"12628"},{"v":12243.012571413889,"d":"12243"},{"v":385.4531328363955,"d":"385"},{"v":3.14835201375507,"d":"3"},{"v":6.758920791858074,"d":"7"},{"v":-3.1576808655220816,"d":"-3"},null,0,10550,20,698,{"v":7349.94,"d":"7350"},{"v":12574.581650176193,"d":"12575"},{"v":12504.476502068961,"d":"12504"},{"v":70.1051481072318,"d":"70"},{"v":0.5606404082220665,"d":"1"},{"v":4.17120918632507,"d":"4"},{"v":-1.0894992585069332,"d":"-1"},null,null,"CDK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"EG(pT)(pY)GVV(bA)C","Corresponds to amino acid residues E12 to V18; In the protein kinase catalytic domain in subdomain I.","T14 and Y15 phosphorylation inhibits phosphotransferase activity. These phosphosites are located in the kinase subdomain I region, which is involved in binding the phosphates in the ATP substrate. Phosphorylation regulates cell cycle progression. These are two of the major in vivo phosphorylation sites in CDK1 (≥1823 and ≥3976 reports, respectively, by mass spectrometry).","T14: MYT1 (PKMYT1). Y15: CDK1 (CDC2); Chk1 (CHEK1); MYT1 (PKMYT1); Src; Wee1.","EC 2.7.11.23; EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; CDK/CDK1 subfamily; CDK1 subfamily","P06493","P06493","P06493","P06493","GO:0005813; GO:0097125; GO:0000307; GO:0005829; GO:0005789; GO:0070062; GO:0016020; GO:0030496; GO:0005759; GO:0005739; GO:0072686; GO:0000784; GO:0005654; GO:0005634; GO:0005876","GO:0005524; GO:0003682; GO:0030332; GO:0097472; GO:0004693; GO:0035173; GO:0030544; GO:0004672; GO:0004674; GO:0008353; GO:0001618","GO:0000187; GO:0031145; GO:0031100; GO:0006915; GO:0007569; GO:0051301; GO:0016477; GO:0008283; GO:0070301; GO:0007098; GO:0030261; GO:0097711; GO:0006977; GO:0006281; GO:0006260; GO:0030855; GO:0000086; GO:0090166; GO:0000226; GO:0007095; GO:0007077; GO:0043066; GO:0018105; GO:0018107; GO:0060045; GO:0045740; GO:0010971; GO:0010628; GO:1905448; GO:0033160; GO:1900182; GO:0007344; GO:0065003; GO:0016579; GO:0034501; GO:0006468; GO:0045995; GO:0010389; GO:0010468; GO:0051445; GO:0014038; GO:0014823; GO:0014075; GO:0048678; GO:0046686; GO:0046688; GO:0045471; GO:0014070; GO:0055015"]
[388,201,"PK560","CDK1 (CDC2)","T14+Y15","Cyclin-dependent protein-serine kinase 1; Cell division control protein 2 homologue",0,9492,18,732,{"v":6934.968,"d":"6935"},{"v":12185.7575153937,"d":"12186"},{"$nulls":3},0,9584,12,709,{"v":6786.548,"d":"6787"},{"v":11857.559438577491,"d":"11858"},{"$nulls":6},0,10027,16,726,{"v":7267.986,"d":"7268"},{"v":12434.37135396173,"d":"12434"},{"$nulls":7},"CDK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"EG(pT)(pY)GVV(bA)C","Corresponds to amino acid residues E12 to V18; In the protein kinase catalytic domain in subdomain I.","T14 and Y15 phosphorylation inhibits phosphotransferase activity. These phosphosites are located in the kinase subdomain I region, which is involved in binding the phosphates in the ATP substrate. Phosphorylation regulates cell cycle progression. These are two of the major in vivo phosphorylation sites in CDK1 (≥1823 and ≥3976 reports, respectively, by mass spectrometry).","T14: MYT1 (PKMYT1). Y15: CDK1 (CDC2); Chk1 (CHEK1); MYT1 (PKMYT1); Src; Wee1.",null,"P06493","P06493","P06493","P06493"]
[389,202,"PK007-1","CDK1 (CDC2)","Y15","Cyclin-dependent protein-serine kinase 1; Cell division control protein 2 homologue",0,543,10,385,{"v":205.205,"d":"205"},{"v":360.575329395372,"d":"361"},{"v":318.0620387491581,"d":"318"},{"v":42.51329064621393,"d":"43"},{"v":13.366351675731522,"d":"13"},0,188,8,319,{"v":57.42,"d":"57"},{"v":100.325093547282,"d":"100"},{"v":211.06708378089098,"d":"211"},{"v":110.74199023360899,"d":"111"},{"v":52.46767437625205,"d":"52"},{"v":65.83402605198357,"d":"66"},{"v":-33.63964948129174,"d":"-34"},null,0,466,10,413,{"v":188.328,"d":"188"},{"v":322.19933945234686,"d":"322"},{"v":287.99106563034655,"d":"288"},{"v":34.20827382200031,"d":"34"},{"v":11.87824134305216,"d":"12"},{"v":25.244593018783682,"d":"25"},{"v":-9.45443638513781,"d":"-9"},null,null,"CDK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"Epitope undefined.","Antibody raised against amino acid residues that encompass the Y15 phosphosite.","The effect of Y15 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in CDK1 (≥3976 reports from high throughput mass spectrometry studies).","CDK1 (CDC2); Chk1 (CHEK1); MYT1 (PKMYT1); Src; Wee1","EC 2.7.11.23; EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; CDK/CDK1 subfamily; CDK1 subfamily","P06493","P06493","P06493","P06493","GO:0005813; GO:0097125; GO:0000307; GO:0005829; GO:0005789; GO:0070062; GO:0016020; GO:0030496; GO:0005759; GO:0005739; GO:0072686; GO:0000784; GO:0005654; GO:0005634; GO:0005876","GO:0005524; GO:0003682; GO:0030332; GO:0097472; GO:0004693; GO:0035173; GO:0030544; GO:0004672; GO:0004674; GO:0008353; GO:0001618","GO:0000187; GO:0031145; GO:0031100; GO:0006915; GO:0007569; GO:0051301; GO:0016477; GO:0008283; GO:0070301; GO:0007098; GO:0030261; GO:0097711; GO:0006977; GO:0006281; GO:0006260; GO:0030855; GO:0000086; GO:0090166; GO:0000226; GO:0007095; GO:0007077; GO:0043066; GO:0018105; GO:0018107; GO:0060045; GO:0045740; GO:0010971; GO:0010628; GO:1905448; GO:0033160; GO:1900182; GO:0007344; GO:0065003; GO:0016579; GO:0034501; GO:0006468; GO:0045995; GO:0010389; GO:0010468; GO:0051445; GO:0014038; GO:0014823; GO:0014075; GO:0048678; GO:0046686; GO:0046688; GO:0045471; GO:0014070; GO:0055015"]
[390,202,"PK007-1","CDK1 (CDC2)","Y15","Cyclin-dependent protein-serine kinase 1; Cell division control protein 2 homologue",0,410,14,396,{"v":156.816,"d":"157"},{"v":275.54874810294416,"d":"276"},{"$nulls":3},0,516,10,364,{"v":184.184,"d":"184"},{"v":321.80907401449997,"d":"322"},{"$nulls":6},0,381,12,402,{"v":148.338,"d":"148"},{"v":253.78279180834622,"d":"254"},{"$nulls":7},"CDK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"Epitope undefined.","Antibody raised against amino acid residues that encompass the Y15 phosphosite.","The effect of Y15 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in CDK1 (≥3976 reports from high throughput mass spectrometry studies).","CDK1 (CDC2); Chk1 (CHEK1); MYT1 (PKMYT1); Src; Wee1",null,"P06493","P06493","P06493","P06493"]
[391,203,"PK008-1","CDK1 (CDC2)","T161","Cyclin-dependent protein-serine kinase 1; Cell division control protein 2 homologue",0,2552,10,370,{"v":940.54,"d":"941"},{"v":1652.6669443216451,"d":"1653"},{"v":1371.5251976394,"d":"1372"},{"v":281.1417466822452,"d":"281"},{"v":20.49847477582856,"d":"20"},0,3593,12,323,{"v":1156.663,"d":"1157"},{"v":2020.9391096774614,"d":"2021"},{"v":1621.2889801914928,"d":"1621"},{"v":399.6501294859686,"d":"400"},{"v":24.65014777555358,"d":"25"},{"v":45.14862255138214,"d":"45"},{"v":18.210659416390868,"d":"18"},null,0,2356,14,375,{"v":878.25,"d":"878"},{"v":1502.5464608237949,"d":"1503"},{"v":1317.993721745839,"d":"1318"},{"v":184.55273907795595,"d":"185"},{"v":14.00255069754763,"d":"14"},{"v":34.50102547337619,"d":"35"},{"v":-3.9030617873952735,"d":"-4"},null,null,"CDK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"TY(pT)HE","Corresponds to amino acid residues T159 to E163.","T161 phosphorylation stimulates phosphotransferase activity and protein interaction. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation regulates cell cycle progression, cell growth and molecular association. This is one of the major in vivo phosphorylation sites in CDK1 (≥122 reports from high throughput mass spectrometry studies).","CDK7","EC 2.7.11.23; EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; CDK/CDK1 subfamily; CDK1 subfamily","P06493","P06493","P06493","P06493","GO:0005813; GO:0097125; GO:0000307; GO:0005829; GO:0005789; GO:0070062; GO:0016020; GO:0030496; GO:0005759; GO:0005739; GO:0072686; GO:0000784; GO:0005654; GO:0005634; GO:0005876","GO:0005524; GO:0003682; GO:0030332; GO:0097472; GO:0004693; GO:0035173; GO:0030544; GO:0004672; GO:0004674; GO:0008353; GO:0001618","GO:0000187; GO:0031145; GO:0031100; GO:0006915; GO:0007569; GO:0051301; GO:0016477; GO:0008283; GO:0070301; GO:0007098; GO:0030261; GO:0097711; GO:0006977; GO:0006281; GO:0006260; GO:0030855; GO:0000086; GO:0090166; GO:0000226; GO:0007095; GO:0007077; GO:0043066; GO:0018105; GO:0018107; GO:0060045; GO:0045740; GO:0010971; GO:0010628; GO:1905448; GO:0033160; GO:1900182; GO:0007344; GO:0065003; GO:0016579; GO:0034501; GO:0006468; GO:0045995; GO:0010389; GO:0010468; GO:0051445; GO:0014038; GO:0014823; GO:0014075; GO:0048678; GO:0046686; GO:0046688; GO:0045471; GO:0014070; GO:0055015"]
[392,203,"PK008-1","CDK1 (CDC2)","T161","Cyclin-dependent protein-serine kinase 1; Cell division control protein 2 homologue",0,1658,12,377,{"v":620.542,"d":"621"},{"v":1090.3834509571548,"d":"1090"},{"$nulls":3},0,2004,12,351,{"v":699.192,"d":"699"},{"v":1221.6388507055242,"d":"1222"},{"$nulls":6},0,1537,14,435,{"v":662.505,"d":"663"},{"v":1133.440982667883,"d":"1133"},{"$nulls":7},"CDK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"TY(pT)HE","Corresponds to amino acid residues T159 to E163.","T161 phosphorylation stimulates phosphotransferase activity and protein interaction. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation regulates cell cycle progression, cell growth and molecular association. This is one of the major in vivo phosphorylation sites in CDK1 (≥122 reports from high throughput mass spectrometry studies).","CDK7",null,"P06493","P06493","P06493","P06493"]
[393,204,"PK561","CDK1 (CDC2)","T161","Cyclin-dependent protein-serine kinase 1; Cell division control protein 2 homologue",0,16316,29,903,{"v":14707.161,"d":"14707"},{"v":25842.64234324587,"d":"25843"},{"v":25709.27489361692,"d":"25709"},{"v":133.36744962894954,"d":"133"},{"v":0.5187522797932428,"d":"1"},0,15768,24,815,{"v":12831.36,"d":"12831"},{"v":22419.14650537883,"d":"22419"},{"v":22764.56395041407,"d":"22765"},{"v":345.41744503524023,"d":"345"},{"v":1.5173470741088249,"d":"2"},{"v":2.0360993539020678,"d":"2"},{"v":-11.453885632278016,"d":"-11"},null,0,14420,26,886,{"v":12753.084,"d":"12753"},{"v":21818.5041033744,"d":"21819"},{"v":22845.14752239814,"d":"22845"},{"v":1026.6434190237414,"d":"1027"},{"v":4.493923350756155,"d":"4"},{"v":5.012675630549398,"d":"5"},{"v":-11.140443995679874,"d":"-11"},null,null,"CDK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"RVY(pT)HEV(bA)C","Corresponds to amino acid residues R158 to V164; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T161 phosphorylation stimulates phosphotransferase activity and protein interaction. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation regulates cell cycle progression, cell growth and molecular association. This is one of the major in vivo phosphorylation sites in CDK1 (≥122 reports from high throughput mass spectrometry studies).","CDK7","EC 2.7.11.23; EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; CDK/CDK1 subfamily; CDK1 subfamily","P06493","P06493","P06493","P06493","GO:0005813; GO:0097125; GO:0000307; GO:0005829; GO:0005789; GO:0070062; GO:0016020; GO:0030496; GO:0005759; GO:0005739; GO:0072686; GO:0000784; GO:0005654; GO:0005634; GO:0005876","GO:0005524; GO:0003682; GO:0030332; GO:0097472; GO:0004693; GO:0035173; GO:0030544; GO:0004672; GO:0004674; GO:0008353; GO:0001618","GO:0000187; GO:0031145; GO:0031100; GO:0006915; GO:0007569; GO:0051301; GO:0016477; GO:0008283; GO:0070301; GO:0007098; GO:0030261; GO:0097711; GO:0006977; GO:0006281; GO:0006260; GO:0030855; GO:0000086; GO:0090166; GO:0000226; GO:0007095; GO:0007077; GO:0043066; GO:0018105; GO:0018107; GO:0060045; GO:0045740; GO:0010971; GO:0010628; GO:1905448; GO:0033160; GO:1900182; GO:0007344; GO:0065003; GO:0016579; GO:0034501; GO:0006468; GO:0045995; GO:0010389; GO:0010468; GO:0051445; GO:0014038; GO:0014823; GO:0014075; GO:0048678; GO:0046686; GO:0046688; GO:0045471; GO:0014070; GO:0055015"]
[394,204,"PK561","CDK1 (CDC2)","T161","Cyclin-dependent protein-serine kinase 1; Cell division control protein 2 homologue",0,16587,28,879,{"v":14555.361,"d":"14555"},{"v":25575.90744398797,"d":"25576"},{"$nulls":3},0,15644,28,847,{"v":13226.752,"d":"13227"},{"v":23109.981395449307,"d":"23110"},{"$nulls":6},0,15902,28,879,{"v":13953.246,"d":"13953"},{"v":23871.790941421885,"d":"23872"},{"$nulls":7},"CDK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"RVY(pT)HEV(bA)C","Corresponds to amino acid residues R158 to V164; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T161 phosphorylation stimulates phosphotransferase activity and protein interaction. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation regulates cell cycle progression, cell growth and molecular association. This is one of the major in vivo phosphorylation sites in CDK1 (≥122 reports from high throughput mass spectrometry studies).","CDK7",null,"P06493","P06493","P06493","P06493"]
[395,205,"NK026-6","CDK2","Pan-specific","Cyclin-dependent protein-serine kinase 2",0,424,14,623,{"v":255.43,"d":"255"},{"v":448.8280323942393,"d":"449"},{"v":525.3632012975776,"d":"525"},{"v":76.53516890333827,"d":"77"},{"v":14.568049059071237,"d":"15"},0,406,14,551,{"v":215.992,"d":"216"},{"v":377.38449330310925,"d":"377"},{"v":355.9566467816208,"d":"356"},{"v":21.427846521488448,"d":"21"},{"v":6.019791094007697,"d":"6"},{"v":20.587840153078936,"d":"21"},{"v":-32.245607248003864,"d":"-32"},null,0,484,14,645,{"v":303.15,"d":"303"},{"v":518.6415708496821,"d":"519"},{"v":542.0253511247059,"d":"542"},{"v":23.38378027502381,"d":"23"},{"v":4.314148817302055,"d":"4"},{"v":18.88219787637329,"d":"19"},{"v":3.171548708774253,"d":"3"},null,null,"CDK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"Epitope undefined.",{"$nulls":3},"EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; CDK1 subfamily; CDK/CDK1 subfamily","P24941","P24941","P24941","P24941","GO:0015030; GO:0005813; GO:0000781; GO:0000793; GO:0097123; GO:0097124; GO:0000307; GO:0097134; GO:0097135; GO:0005737; GO:0005829; GO:0005768; GO:0005654; GO:0005634; GO:0005667; GO:0000805; GO:0000806","GO:0005524; GO:0030332; GO:0097472; GO:0004693; GO:0000287; GO:0019904; GO:0004674","GO:0031145; GO:0051301; GO:0071732; GO:0007099; GO:0051298; GO:0006977; GO:0006281; GO:0006260; GO:0000082; GO:0000086; GO:0016572; GO:0051321; GO:0031571; GO:0007275; GO:0000122; GO:0018105; GO:0008284; GO:0032298; GO:0045893; GO:0006813; GO:0006468; GO:0007265; GO:0010389; GO:0060968; GO:1901796; GO:0010033"]
[396,205,"NK026-6","CDK2","Pan-specific","Cyclin-dependent protein-serine kinase 2",0,523,20,681,{"v":342.543,"d":"343"},{"v":601.8983702009158,"d":"602"},{"$nulls":3},0,376,12,526,{"v":191.464,"d":"191"},{"v":334.52880026013236,"d":"335"},{"$nulls":6},0,506,12,669,{"v":330.486,"d":"330"},{"v":565.4091313997297,"d":"565"},{"$nulls":7},"CDK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"Epitope undefined.",{"$nulls":4},"P24941","P24941","P24941","P24941"]
[397,206,"NK026-3","CDK2","Pan-specific","Cyclin-dependent protein-serine kinase 2",0,715,14,399,{"v":279.699,"d":"280"},{"v":491.4722304844237,"d":"491"},{"v":412.1818552435598,"d":"412"},{"v":79.29037524086385,"d":"79"},{"v":19.23674568207542,"d":"19"},0,872,16,351,{"v":300.456,"d":"300"},{"v":524.9612731947433,"d":"525"},{"v":357.37014383281814,"d":"357"},{"v":167.59112936192514,"d":"168"},{"v":46.89567168776309,"d":"47"},{"v":66.1324173698385,"d":"66"},{"v":-13.297943787058074,"d":"-13"},null,0,710,16,382,{"v":265.108,"d":"265"},{"v":453.5577422557069,"d":"454"},{"v":403.871486274785,"d":"404"},{"v":49.686255980921885,"d":"50"},{"v":12.302491676056695,"d":"12"},{"v":31.539237358132112,"d":"32"},{"v":-2.0161899081812322,"d":"-2"},null,null,"CDK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"Epitope undefined.",{"$nulls":3},"EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; CDK1 subfamily; CDK/CDK1 subfamily","P24941","P24941","P24941","P24941","GO:0015030; GO:0005813; GO:0000781; GO:0000793; GO:0097123; GO:0097124; GO:0000307; GO:0097134; GO:0097135; GO:0005737; GO:0005829; GO:0005768; GO:0005654; GO:0005634; GO:0005667; GO:0000805; GO:0000806","GO:0005524; GO:0030332; GO:0097472; GO:0004693; GO:0000287; GO:0019904; GO:0004674","GO:0031145; GO:0051301; GO:0071732; GO:0007099; GO:0051298; GO:0006977; GO:0006281; GO:0006260; GO:0000082; GO:0000086; GO:0016572; GO:0051321; GO:0031571; GO:0007275; GO:0000122; GO:0018105; GO:0008284; GO:0032298; GO:0045893; GO:0006813; GO:0006468; GO:0007265; GO:0010389; GO:0060968; GO:1901796; GO:0010033"]
[398,206,"NK026-3","CDK2","Pan-specific","Cyclin-dependent protein-serine kinase 2",0,466,16,421,{"v":189.45,"d":"189"},{"v":332.89148000269597,"d":"333"},{"$nulls":3},0,272,14,421,{"v":108.618,"d":"109"},{"v":189.77901447089297,"d":"190"},{"$nulls":6},0,468,14,456,{"v":207.024,"d":"207"},{"v":354.1852302938631,"d":"354"},{"$nulls":7},"CDK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"Epitope undefined.",{"$nulls":4},"P24941","P24941","P24941","P24941"]
[399,207,"PK568","CDK2","T160","Cyclin-dependent protein-serine kinase 2",0,4500,24,987,{"v":4417.812,"d":"4418"},{"v":7762.744655865243,"d":"7763"},{"v":7807.83655958564,"d":"7808"},{"v":45.09190372039757,"d":"45"},{"v":0.5775211017325724,"d":"1"},0,4699,20,907,{"v":4243.853,"d":"4244"},{"v":7414.9242289431095,"d":"7415"},{"v":7198.233733222442,"d":"7198"},{"v":216.69049572066706,"d":"217"},{"v":3.0103286966157037,"d":"3"},{"v":3.587849798348276,"d":"4"},{"v":-7.807576679032707,"d":"-8"},null,0,5218,32,1009,{"v":5232.674,"d":"5233"},{"v":8952.275319492957,"d":"8952"},{"v":8809.692086254681,"d":"8810"},{"v":142.58323323827608,"d":"143"},{"v":1.6184814615795882,"d":"2"},{"v":2.1960025633121605,"d":"2"},{"v":12.831410071450193,"d":"13"},null,null,"CDK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"RTY(pT)HEV(bA)C","Corresponds to amino acid residues R157 to V163; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T160 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in CDK2 (≥267 reports from high throughput mass spectrometry studies).","CCRK (CDK20); CDK2; CDK7; ERK1 (MAPK3); ERK2 (MAPK1)","EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; CDK1 subfamily; CDK/CDK1 subfamily","P24941","P24941","P24941","P24941","GO:0015030; GO:0005813; GO:0000781; GO:0000793; GO:0097123; GO:0097124; GO:0000307; GO:0097134; GO:0097135; GO:0005737; GO:0005829; GO:0005768; GO:0005654; GO:0005634; GO:0005667; GO:0000805; GO:0000806","GO:0005524; GO:0030332; GO:0097472; GO:0004693; GO:0000287; GO:0019904; GO:0004674","GO:0031145; GO:0051301; GO:0071732; GO:0007099; GO:0051298; GO:0006977; GO:0006281; GO:0006260; GO:0000082; GO:0000086; GO:0016572; GO:0051321; GO:0031571; GO:0007275; GO:0000122; GO:0018105; GO:0008284; GO:0032298; GO:0045893; GO:0006813; GO:0006468; GO:0007265; GO:0010389; GO:0060968; GO:1901796; GO:0010033"]
[400,207,"PK568","CDK2","T160","Cyclin-dependent protein-serine kinase 2",0,4550,22,987,{"v":4469.136,"d":"4469"},{"v":7852.928463306038,"d":"7853"},{"$nulls":3},0,4370,22,919,{"v":3995.812,"d":"3996"},{"v":6981.543237501775,"d":"6982"},{"$nulls":6},0,5142,30,991,{"v":5065.992,"d":"5066"},{"v":8667.108853016405,"d":"8667"},{"$nulls":7},"CDK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"RTY(pT)HEV(bA)C","Corresponds to amino acid residues R157 to V163; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T160 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in CDK2 (≥267 reports from high throughput mass spectrometry studies).","CCRK (CDK20); CDK2; CDK7; ERK1 (MAPK3); ERK2 (MAPK1)",null,"P24941","P24941","P24941","P24941"]
[401,208,"NK027-2","CDK4","Pan-specific","Cyclin-dependent protein-serine kinase 4",0,146,18,627,{"v":80.256,"d":"80"},{"v":141.0215815206987,"d":"141"},{"v":126.68326282541236,"d":"127"},{"v":14.338318695286347,"d":"14"},{"v":11.31824234354194,"d":"11"},0,170,18,562,{"v":85.424,"d":"85"},{"v":149.25410642951965,"d":"149"},{"v":126.45644323542464,"d":"126"},{"v":22.79766319409501,"d":"23"},{"v":18.02807560517298,"d":"18"},{"v":29.34631794871492,"d":"29"},{"v":-0.17904463851732544,"d":"-0"},null,0,164,22,633,{"v":89.886,"d":"90"},{"v":153.7806902107687,"d":"154"},{"v":135.52430161589172,"d":"136"},{"v":18.256388594876995,"d":"18"},{"v":13.470933535315288,"d":"13"},{"v":24.78917587885723,"d":"25"},{"v":6.978853080744841,"d":"7"},null,null,"CDK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK4",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues at the C-terminus of human CDK4.",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.22; CMGC group; CDK family; CDK4 subfamily; CDK/CDK4 subfamily","P11802","P11802","P11802","P11802","GO:0005923; GO:0000785; GO:0097129; GO:0000307; GO:0005829; GO:0031965; GO:0005730; GO:0005654; GO:0005634; GO:0048471; GO:0005667","GO:0005524; GO:0030332; GO:0004693; GO:0016538; GO:0044877","GO:0060612; GO:0031100; GO:0051301; GO:0032869; GO:0071353; GO:1904637; GO:0071222; GO:1904628; GO:0007623; GO:0000082; GO:0002088; GO:0007275; GO:0071157; GO:0031658; GO:0043065; GO:0045787; GO:0008284; GO:0045793; GO:0048146; GO:0010971; GO:0045727; GO:0006468; GO:0010468; GO:0046626; GO:0046890; GO:0050994; GO:0040014; GO:0042493; GO:0055093; GO:0010288; GO:0010033; GO:0033574; GO:0009636; GO:0007165; GO:0006367"]
[402,208,"NK027-2","CDK4","Pan-specific","Cyclin-dependent protein-serine kinase 4",0,114,18,666,{"v":63.936,"d":"64"},{"v":112.344944130126,"d":"112"},{"$nulls":3},0,110,14,618,{"v":59.328,"d":"59"},{"v":103.65878004132962,"d":"104"},{"$nulls":6},0,120,18,672,{"v":68.544,"d":"69"},{"v":117.26791302101472,"d":"117"},{"$nulls":7},"CDK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK4",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues at the C-terminus of human CDK4.",{"$nulls":3},"P11802","P11802","P11802","P11802"]
[403,209,"PK569","CDK4","T172","Cyclin-dependent protein-serine kinase 4",0,13620,20,792,{"v":10771.2,"d":"10771"},{"v":18926.580677777984,"d":"18927"},{"v":18671.172347430598,"d":"18671"},{"v":255.40833034738534,"d":"255"},{"v":1.3679287277455447,"d":"1"},0,14844,18,656,{"v":9725.856,"d":"9726"},{"v":16993.162887972725,"d":"16993"},{"v":17958.36297204755,"d":"17958"},{"v":965.200084074826,"d":"965"},{"v":5.374655170836973,"d":"5"},{"v":6.7425838985825175,"d":"7"},{"v":-3.81770015358002,"d":"-4"},null,0,14146,16,708,{"v":10004.04,"d":"10004"},{"v":17115.325813765645,"d":"17115"},{"v":17812.49710653948,"d":"17812"},{"v":697.1712927738336,"d":"697"},{"v":3.913944735563674,"d":"4"},{"v":5.281873463309219,"d":"5"},{"v":-4.598935861728492,"d":"-5"},null,null,"CDK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK4",{"$nulls":5},"MAL(pT)PVV(bA)C","Corresponds to amino acid residues M169 to V175; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T172 stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in CDK4 (≥5 reports from high throughput mass spectrometry studies).","CDK7; JNK1; JNK2","Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.22; CMGC group; CDK family; CDK4 subfamily; CDK/CDK4 subfamily","P11802","P11802","P11802","P11802","GO:0005923; GO:0000785; GO:0097129; GO:0000307; GO:0005829; GO:0031965; GO:0005730; GO:0005654; GO:0005634; GO:0048471; GO:0005667","GO:0005524; GO:0030332; GO:0004693; GO:0016538; GO:0044877","GO:0060612; GO:0031100; GO:0051301; GO:0032869; GO:0071353; GO:1904637; GO:0071222; GO:1904628; GO:0007623; GO:0000082; GO:0002088; GO:0007275; GO:0071157; GO:0031658; GO:0043065; GO:0045787; GO:0008284; GO:0045793; GO:0048146; GO:0010971; GO:0045727; GO:0006468; GO:0010468; GO:0046626; GO:0046890; GO:0050994; GO:0040014; GO:0042493; GO:0055093; GO:0010288; GO:0010033; GO:0033574; GO:0009636; GO:0007165; GO:0006367"]
[404,209,"PK569","CDK4","T172","Cyclin-dependent protein-serine kinase 4",0,13796,24,761,{"v":10480.492,"d":"10480"},{"v":18415.764017083216,"d":"18416"},{"$nulls":3},0,13872,22,782,{"v":10830.7,"d":"10831"},{"v":18923.56305612238,"d":"18924"},{"$nulls":6},0,13652,26,794,{"v":10819.044,"d":"10819"},{"v":18509.66839931331,"d":"18510"},{"$nulls":7},"CDK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK4",{"$nulls":5},"MAL(pT)PVV(bA)C","Corresponds to amino acid residues M169 to V175; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T172 stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in CDK4 (≥5 reports from high throughput mass spectrometry studies).","CDK7; JNK1; JNK2",null,"P11802","P11802","P11802","P11802"]
[405,210,"NK028-4","CDK5","Pan-specific","Cyclin-dependent protein-serine kinase 5",0,311,12,653,{"v":195.247,"d":"195"},{"v":343.0776605758057,"d":"343"},{"v":295.4668867757896,"d":"295"},{"v":47.61077380001609,"d":"48"},{"v":16.113742666583406,"d":"16"},0,332,12,520,{"v":166.4,"d":"166"},{"v":290.7365999001694,"d":"291"},{"v":264.82539932012423,"d":"265"},{"v":25.911200580045147,"d":"26"},{"v":9.78425809856832,"d":"10"},{"v":25.898000765151725,"d":"26"},{"v":-10.37053180139172,"d":"-10"},null,0,352,14,652,{"v":220.376,"d":"220"},{"v":377.0283846860286,"d":"377"},{"v":322.97263976580246,"d":"323"},{"v":54.05574492022612,"d":"54"},{"v":16.736942472719555,"d":"17"},{"v":32.85068513930296,"d":"33"},{"v":9.309250620319148,"d":"9"},null,null,"CDK5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK5",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues 142-171 of human CDK5.",null,null,"Protein-serine kinase, CMGC group, CDK family, CDK5 subfamily","Q00535","Q00535","Q00535","Q00535","GO:0030424; GO:0030054; GO:0005737; GO:0005829; GO:0030425; GO:0030175; GO:0098978; GO:0030426; GO:0030027; GO:0016020; GO:0005874; GO:0031594; GO:0043025; GO:0043005; GO:0005654; GO:0005634; GO:0043204; GO:0005886; GO:0014069; GO:0045211; GO:0098793; GO:0016533; GO:0098685","GO:0030549; GO:0005524; GO:0004693; GO:0008092; GO:0046875; GO:0005176; GO:0043125; GO:0051879; GO:0016301; GO:0002039; GO:0004672; GO:0019901; GO:0004674; GO:0050321","GO:0048675; GO:0048148; GO:0070509; GO:0007049; GO:0051301; GO:0007160; GO:0008283; GO:1904646; GO:0021954; GO:0021697; GO:0007268; GO:0022038; GO:0030866; GO:0048813; GO:0060079; GO:0021766; GO:0006886; GO:0021819; GO:0000226; GO:0007005; GO:0008045; GO:0030517; GO:0045786; GO:1901215; GO:0046826; GO:0031397; GO:0045861; GO:0031914; GO:0045892; GO:0051402; GO:0030182; GO:0001764; GO:0031175; GO:0006913; GO:0048709; GO:0018105; GO:0018107; GO:0016310; GO:2000251; GO:0045956; GO:0034352; GO:0043525; GO:0032092; GO:0045860; GO:0090314; GO:0046777; GO:0035418; GO:0006468; GO:0032801; GO:0043113; GO:0042981; GO:0071156; GO:0030334; GO:0061001; GO:0016241; GO:1903076; GO:0048167; GO:0051966; GO:1903421; GO:0009611; GO:0048511; GO:0014044; GO:0019233; GO:0042501; GO:0007519; GO:0007416; GO:0098883; GO:0001963; GO:0035249; GO:0048488; GO:0016079; GO:0008542"]
[406,210,"NK028-4","CDK5","Pan-specific","Cyclin-dependent protein-serine kinase 5",0,244,12,608,{"v":141.056,"d":"141"},{"v":247.8561129757735,"d":"248"},{"$nulls":3},0,226,14,645,{"v":136.74,"d":"137"},{"v":238.9141987400791,"d":"239"},{"$nulls":6},0,270,14,614,{"v":157.184,"d":"157"},{"v":268.9168948455763,"d":"269"},{"$nulls":7},"CDK5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK5",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues 142-171 of human CDK5.",{"$nulls":3},"Q00535","Q00535","Q00535","Q00535"]
[407,211,"NK028-5","CDK5","Pan-specific","Cyclin-dependent protein-serine kinase 5",0,338,12,656,{"v":213.856,"d":"214"},{"v":375.776407218034,"d":"376"},{"v":323.8913735863655,"d":"324"},{"v":51.885033631668534,"d":"52"},{"v":16.01926999696193,"d":"16"},0,225,16,564,{"v":117.876,"d":"118"},{"v":205.95473227062718,"d":"206"},{"v":221.32498388914755,"d":"221"},{"v":15.37025161852037,"d":"15"},{"v":6.9446527673616325,"d":"7"},{"v":22.963922764323563,"d":"23"},{"v":-31.666909977109555,"d":"-32"},null,0,296,10,567,{"v":162.162,"d":"162"},{"v":277.4334633419963,"d":"277"},{"v":299.83693149398897,"d":"300"},{"v":22.403468151992683,"d":"22"},{"v":7.471884147280843,"d":"7"},{"v":23.491154144242774,"d":"23"},{"v":-7.426700447754413,"d":"-7"},null,null,"CDK5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK5",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues 1-291 representing full length human CDK5.",null,null,"Protein-serine kinase, CMGC group, CDK family, CDK5 subfamily","Q00535","Q00535","Q00535","Q00535","GO:0030424; GO:0030054; GO:0005737; GO:0005829; GO:0030425; GO:0030175; GO:0098978; GO:0030426; GO:0030027; GO:0016020; GO:0005874; GO:0031594; GO:0043025; GO:0043005; GO:0005654; GO:0005634; GO:0043204; GO:0005886; GO:0014069; GO:0045211; GO:0098793; GO:0016533; GO:0098685","GO:0030549; GO:0005524; GO:0004693; GO:0008092; GO:0046875; GO:0005176; GO:0043125; GO:0051879; GO:0016301; GO:0002039; GO:0004672; GO:0019901; GO:0004674; GO:0050321","GO:0048675; GO:0048148; GO:0070509; GO:0007049; GO:0051301; GO:0007160; GO:0008283; GO:1904646; GO:0021954; GO:0021697; GO:0007268; GO:0022038; GO:0030866; GO:0048813; GO:0060079; GO:0021766; GO:0006886; GO:0021819; GO:0000226; GO:0007005; GO:0008045; GO:0030517; GO:0045786; GO:1901215; GO:0046826; GO:0031397; GO:0045861; GO:0031914; GO:0045892; GO:0051402; GO:0030182; GO:0001764; GO:0031175; GO:0006913; GO:0048709; GO:0018105; GO:0018107; GO:0016310; GO:2000251; GO:0045956; GO:0034352; GO:0043525; GO:0032092; GO:0045860; GO:0090314; GO:0046777; GO:0035418; GO:0006468; GO:0032801; GO:0043113; GO:0042981; GO:0071156; GO:0030334; GO:0061001; GO:0016241; GO:1903076; GO:0048167; GO:0051966; GO:1903421; GO:0009611; GO:0048511; GO:0014044; GO:0019233; GO:0042501; GO:0007519; GO:0007416; GO:0098883; GO:0001963; GO:0035249; GO:0048488; GO:0016079; GO:0008542"]
[408,211,"NK028-5","CDK5","Pan-specific","Cyclin-dependent protein-serine kinase 5",0,186,14,900,{"v":154.8,"d":"155"},{"v":272.00633995469695,"d":"272"},{"$nulls":3},0,202,12,713,{"v":135.47,"d":"135"},{"v":236.69523550766792,"d":"237"},{"$nulls":6},0,304,16,654,{"v":188.352,"d":"188"},{"v":322.24039964598165,"d":"322"},{"$nulls":7},"CDK5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK5",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues 1-291 representing full length human CDK5.",{"$nulls":3},"Q00535","Q00535","Q00535","Q00535"]
[409,212,"PK570","CDK5","Y15","Cyclin-dependent protein-serine kinase 5",0,6238,18,682,{"v":4242.04,"d":"4242"},{"v":7453.887431146141,"d":"7454"},{"v":8031.305230751133,"d":"8031"},{"v":577.4177996049921,"d":"577"},{"v":7.189588529073856,"d":"7"},0,6042,20,604,{"v":3637.288,"d":"3637"},{"v":6355.124675346678,"d":"6355"},{"v":7773.358426798399,"d":"7773"},{"v":1418.2337514517212,"d":"1418"},{"v":18.24480068437867,"d":"18"},{"v":25.434389213452526,"d":"25"},{"v":-3.211766911374255,"d":"-3"},null,0,6254,14,692,{"v":4318.08,"d":"4318"},{"v":7387.55003877485,"d":"7388"},{"v":6969.739472181747,"d":"6970"},{"v":417.8105665931025,"d":"418"},{"v":5.9946367903808415,"d":"6"},{"v":13.184225319454697,"d":"13"},{"v":-13.21784850742253,"d":"-13"},null,null,"CDK5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK5",{"$nulls":5},"EGT(pY)GTV(bA)C","Corresponds to amino acid residues E12 to V18; In the protein kinase catalytic domain in subdomain I.","Y15 phosphorylation inhibits phosphotransferase activity. This is the major in vivo phosphorylation site in CDK5 (≥915 reports from high throughput mass spectrometry studies).","Abl1; EphA4; Fyn; TrkA (NTRK1)","Protein-serine kinase, CMGC group, CDK family, CDK5 subfamily","Q00535","Q00535","Q00535","Q00535","GO:0030424; GO:0030054; GO:0005737; GO:0005829; GO:0030425; GO:0030175; GO:0098978; GO:0030426; GO:0030027; GO:0016020; GO:0005874; GO:0031594; GO:0043025; GO:0043005; GO:0005654; GO:0005634; GO:0043204; GO:0005886; GO:0014069; GO:0045211; GO:0098793; GO:0016533; GO:0098685","GO:0030549; GO:0005524; GO:0004693; GO:0008092; GO:0046875; GO:0005176; GO:0043125; GO:0051879; GO:0016301; GO:0002039; GO:0004672; GO:0019901; GO:0004674; GO:0050321","GO:0048675; GO:0048148; GO:0070509; GO:0007049; GO:0051301; GO:0007160; GO:0008283; GO:1904646; GO:0021954; GO:0021697; GO:0007268; GO:0022038; GO:0030866; GO:0048813; GO:0060079; GO:0021766; GO:0006886; GO:0021819; GO:0000226; GO:0007005; GO:0008045; GO:0030517; GO:0045786; GO:1901215; GO:0046826; GO:0031397; GO:0045861; GO:0031914; GO:0045892; GO:0051402; GO:0030182; GO:0001764; GO:0031175; GO:0006913; GO:0048709; GO:0018105; GO:0018107; GO:0016310; GO:2000251; GO:0045956; GO:0034352; GO:0043525; GO:0032092; GO:0045860; GO:0090314; GO:0046777; GO:0035418; GO:0006468; GO:0032801; GO:0043113; GO:0042981; GO:0071156; GO:0030334; GO:0061001; GO:0016241; GO:1903076; GO:0048167; GO:0051966; GO:1903421; GO:0009611; GO:0048511; GO:0014044; GO:0019233; GO:0042501; GO:0007519; GO:0007416; GO:0098883; GO:0001963; GO:0035249; GO:0048488; GO:0016079; GO:0008542"]
[410,212,"PK570","CDK5","Y15","Cyclin-dependent protein-serine kinase 5",0,7035,16,698,{"v":4899.262,"d":"4899"},{"v":8608.723030356126,"d":"8609"},{"$nulls":3},0,7480,18,705,{"v":5260.71,"d":"5261"},{"v":9191.59217825012,"d":"9192"},{"$nulls":6},0,6365,14,603,{"v":3829.653,"d":"3830"},{"v":6551.928905588646,"d":"6552"},{"$nulls":7},"CDK5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK5",{"$nulls":5},"EGT(pY)GTV(bA)C","Corresponds to amino acid residues E12 to V18; In the protein kinase catalytic domain in subdomain I.","Y15 phosphorylation inhibits phosphotransferase activity. This is the major in vivo phosphorylation site in CDK5 (≥915 reports from high throughput mass spectrometry studies).","Abl1; EphA4; Fyn; TrkA (NTRK1)",null,"Q00535","Q00535","Q00535","Q00535"]
[411,213,"PK179","CDK5","S159","Cyclin-dependent protein-serine kinase 5",0,282,10,576,{"v":156.672,"d":"157"},{"v":275.29571894949794,"d":"275"},{"v":281.4527616833562,"d":"281"},{"v":6.157042733858248,"d":"6"},{"v":2.1875936469883097,"d":"2"},0,248,14,591,{"v":138.294,"d":"138"},{"v":241.6293710732814,"d":"242"},{"v":212.36701184775234,"d":"212"},{"v":29.262359225529053,"d":"29"},{"v":13.779145344149532,"d":"14"},{"v":15.966738991137841,"d":"16"},{"v":-24.546126114522778,"d":"-25"},null,0,320,14,560,{"v":171.36,"d":"171"},{"v":293.16978255253684,"d":"293"},{"v":279.85088224224563,"d":"280"},{"v":13.318900310291212,"d":"13"},{"v":4.759284731774422,"d":"5"},{"v":6.946878378762731,"d":"7"},{"v":-0.5691468193560354,"d":"-1"},null,null,"CDK5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK5",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues 142-171 of CDK5 with phosphorylated S159.","S159 phosphorylation stimulates phosphotransferase activity. Phosphorylation of this site in CDK5 has apparently not been detected in high throughput mass spectrometry studies).","CDK7; CK1a1 (CSNK1A1)","Protein-serine kinase, CMGC group, CDK family, CDK5 subfamily","Q00535","Q00535","Q00535","Q00535","GO:0030424; GO:0030054; GO:0005737; GO:0005829; GO:0030425; GO:0030175; GO:0098978; GO:0030426; GO:0030027; GO:0016020; GO:0005874; GO:0031594; GO:0043025; GO:0043005; GO:0005654; GO:0005634; GO:0043204; GO:0005886; GO:0014069; GO:0045211; GO:0098793; GO:0016533; GO:0098685","GO:0030549; GO:0005524; GO:0004693; GO:0008092; GO:0046875; GO:0005176; GO:0043125; GO:0051879; GO:0016301; GO:0002039; GO:0004672; GO:0019901; GO:0004674; GO:0050321","GO:0048675; GO:0048148; GO:0070509; GO:0007049; GO:0051301; GO:0007160; GO:0008283; GO:1904646; GO:0021954; GO:0021697; GO:0007268; GO:0022038; GO:0030866; GO:0048813; GO:0060079; GO:0021766; GO:0006886; GO:0021819; GO:0000226; GO:0007005; GO:0008045; GO:0030517; GO:0045786; GO:1901215; GO:0046826; GO:0031397; GO:0045861; GO:0031914; GO:0045892; GO:0051402; GO:0030182; GO:0001764; GO:0031175; GO:0006913; GO:0048709; GO:0018105; GO:0018107; GO:0016310; GO:2000251; GO:0045956; GO:0034352; GO:0043525; GO:0032092; GO:0045860; GO:0090314; GO:0046777; GO:0035418; GO:0006468; GO:0032801; GO:0043113; GO:0042981; GO:0071156; GO:0030334; GO:0061001; GO:0016241; GO:1903076; GO:0048167; GO:0051966; GO:1903421; GO:0009611; GO:0048511; GO:0014044; GO:0019233; GO:0042501; GO:0007519; GO:0007416; GO:0098883; GO:0001963; GO:0035249; GO:0048488; GO:0016079; GO:0008542"]
[412,213,"PK179","CDK5","S159","Cyclin-dependent protein-serine kinase 5",0,262,14,660,{"v":163.68,"d":"164"},{"v":287.60980441721443,"d":"288"},{"$nulls":3},0,136,14,859,{"v":104.798,"d":"105"},{"v":183.10465262222326,"d":"183"},{"$nulls":6},0,284,14,577,{"v":155.79,"d":"156"},{"v":266.5319819319544,"d":"267"},{"$nulls":7},"CDK5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK5",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues 142-171 of CDK5 with phosphorylated S159.","S159 phosphorylation stimulates phosphotransferase activity. Phosphorylation of this site in CDK5 has apparently not been detected in high throughput mass spectrometry studies).","CDK7; CK1a1 (CSNK1A1)",null,"Q00535","Q00535","Q00535","Q00535"]
[413,214,"NK029-3","CDK6","Pan-specific","Cyclin-dependent protein-serine kinase 6",0,424,12,702,{"v":289.224,"d":"289"},{"v":508.2090546967524,"d":"508"},{"v":430.73469077593495,"d":"431"},{"v":77.47436392081744,"d":"77"},{"v":17.98656239673972,"d":"18"},0,418,16,658,{"v":264.516,"d":"265"},{"v":462.16636093265146,"d":"462"},{"v":432.73277462304657,"d":"433"},{"v":29.43358630960489,"d":"29"},{"v":6.801792708038924,"d":"7"},{"v":24.788355104778645,"d":"25"},{"v":0.4638780878113664,"d":"0"},null,0,502,16,687,{"v":333.882,"d":"334"},{"v":571.2191487990552,"d":"571"},{"v":497.1722221028814,"d":"497"},{"v":74.04692669617384,"d":"74"},{"v":14.893617021276597,"d":"15"},{"v":32.88017941801632,"d":"33"},{"v":15.42423509173696,"d":"15"},null,null,"CDK6","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK4",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues at the C-terminus of human CDK6.",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.22; CMGC domain target; CMGC</A> group; CDK family; CDK4 subfamily; CDK/CDK4 subfamily","Q00534","Q00534","Q00534","Q00534","GO:0005813; GO:0000307; GO:0005737; GO:0005829; GO:0005654; GO:0005634; GO:0001726","GO:0005524; GO:0030332; GO:0004693; GO:0098770","GO:0014002; GO:0007050; GO:0043697; GO:0051301; GO:0021542; GO:0000082; GO:0048699; GO:0042063; GO:0021670; GO:0045786; GO:0045596; GO:0008285; GO:2000773; GO:0031658; GO:0050680; GO:0045656; GO:0045638; GO:0045668; GO:0001954; GO:0048146; GO:0006468; GO:2000145; GO:0045646; GO:0010389; GO:0010468; GO:0009615; GO:0007165; GO:0003323"]
[414,214,"NK029-3","CDK6","Pan-specific","Cyclin-dependent protein-serine kinase 6",0,318,12,657,{"v":201.042,"d":"201"},{"v":353.26032685511746,"d":"353"},{"$nulls":3},0,356,12,671,{"v":230.824,"d":"231"},{"v":403.2991883134417,"d":"403"},{"$nulls":6},0,372,12,687,{"v":247.32,"d":"247"},{"v":423.12529540670755,"d":"423"},{"$nulls":7},"CDK6","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK4",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues at the C-terminus of human CDK6.",{"$nulls":3},"Q00534","Q00534","Q00534","Q00534"]
[415,215,"NK029-4","CDK6","Pan-specific","Cyclin-dependent protein-serine kinase 6",0,52,6,591,{"v":27.186,"d":"27"},{"v":47.769795594369455,"d":"48"},{"v":42.361297439456294,"d":"42"},{"v":5.408498154913161,"d":"5"},{"v":12.767546042807368,"d":"13"},0,46,10,668,{"v":24.048,"d":"24"},{"v":42.017029774034086,"d":"42"},{"v":40.61226879855491,"d":"41"},{"v":1.4047609754791779,"d":"1"},{"v":3.4589571502323038,"d":"3"},{"v":16.226503193039672,"d":"16"},{"v":-4.128836335575272,"d":"-4"},null,0,48,6,666,{"v":27.972,"d":"28"},{"v":47.85565568136998,"d":"48"},{"v":50.75039933262403,"d":"51"},{"v":2.8947436512540463,"d":"3"},{"v":5.703883495145642,"d":"6"},{"v":18.47142953795301,"d":"18"},{"v":19.803694410346196,"d":"20"},null,null,"CDK6","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK4",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues 1-326 representing full length human CDK6.",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.22; CMGC domain target; CMGC</A> group; CDK family; CDK4 subfamily; CDK/CDK4 subfamily","Q00534","Q00534","Q00534","Q00534","GO:0005813; GO:0000307; GO:0005737; GO:0005829; GO:0005654; GO:0005634; GO:0001726","GO:0005524; GO:0030332; GO:0004693; GO:0098770","GO:0014002; GO:0007050; GO:0043697; GO:0051301; GO:0021542; GO:0000082; GO:0048699; GO:0042063; GO:0021670; GO:0045786; GO:0045596; GO:0008285; GO:2000773; GO:0031658; GO:0050680; GO:0045656; GO:0045638; GO:0045668; GO:0001954; GO:0048146; GO:0006468; GO:2000145; GO:0045646; GO:0010389; GO:0010468; GO:0009615; GO:0007165; GO:0003323"]
[416,215,"NK029-4","CDK6","Pan-specific","Cyclin-dependent protein-serine kinase 6",0,38,8,701,{"v":21.03,"d":"21"},{"v":36.95279928454313,"d":"37"},{"$nulls":3},0,54,10,510,{"v":22.44,"d":"22"},{"v":39.20750782307572,"d":"39"},{"$nulls":6},0,60,8,603,{"v":31.356,"d":"31"},{"v":53.64514298387807,"d":"54"},{"$nulls":7},"CDK6","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK4",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues 1-326 representing full length human CDK6.",{"$nulls":3},"Q00534","Q00534","Q00534","Q00534"]
[417,216,"PK571","CDK6","Y13","Cyclin-dependent protein-serine kinase 6",0,8346,15,793,{"v":6606.483,"d":"6606"},{"v":11608.561116297973,"d":"11609"},{"v":11006.798924981724,"d":"11007"},{"v":601.7621913162493,"d":"602"},{"v":5.467186194802305,"d":"5"},0,7949,18,656,{"v":5202.736,"d":"5203"},{"v":9090.299127513266,"d":"9090"},{"v":10040.927437290213,"d":"10041"},{"v":950.6283097769465,"d":"951"},{"v":9.467534903663207,"d":"9"},{"v":14.934721098465513,"d":"15"},{"v":-8.775226060497104,"d":"-9"},null,0,7920,18,783,{"v":6187.266,"d":"6187"},{"v":10585.430834586276,"d":"10585"},{"v":10617.100219768523,"d":"10617"},{"v":31.669385182247424,"d":"32"},{"v":0.29828658039113704,"d":"0"},{"v":5.765472775193442,"d":"6"},{"v":-3.540527158434017,"d":"-4"},null,null,"CDK6","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK4",{"$nulls":5},"DQQ(pY)ECV(bA)C","Corresponds to amino acid residues D10 to V16; In the protein kinase catalytic domain in subdomain I.","Y13 phosphorylation inhibits phosphotransferase activity. This is the major in vivo phosphorylation site in CDK6(≥288 reports from high throughput mass spectrometry studies).",null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.22; CMGC domain target; CMGC</A> group; CDK family; CDK4 subfamily; CDK/CDK4 subfamily","Q00534","Q00534","Q00534","Q00534","GO:0005813; GO:0000307; GO:0005737; GO:0005829; GO:0005654; GO:0005634; GO:0001726","GO:0005524; GO:0030332; GO:0004693; GO:0098770","GO:0014002; GO:0007050; GO:0043697; GO:0051301; GO:0021542; GO:0000082; GO:0048699; GO:0042063; GO:0021670; GO:0045786; GO:0045596; GO:0008285; GO:2000773; GO:0031658; GO:0050680; GO:0045656; GO:0045638; GO:0045668; GO:0001954; GO:0048146; GO:0006468; GO:2000145; GO:0045646; GO:0010389; GO:0010468; GO:0009615; GO:0007165; GO:0003323"]
[418,216,"PK571","CDK6","Y13","Cyclin-dependent protein-serine kinase 6",0,8154,20,728,{"v":5921.552,"d":"5922"},{"v":10405.036733665474,"d":"10405"},{"$nulls":3},0,8198,28,770,{"v":6290.9,"d":"6291"},{"v":10991.55574706716,"d":"10992"},{"$nulls":6},0,8312,24,751,{"v":6224.288,"d":"6224"},{"v":10648.769604950772,"d":"10649"},{"$nulls":7},"CDK6","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK4",{"$nulls":5},"DQQ(pY)ECV(bA)C","Corresponds to amino acid residues D10 to V16; In the protein kinase catalytic domain in subdomain I.","Y13 phosphorylation inhibits phosphotransferase activity. This is the major in vivo phosphorylation site in CDK6(≥288 reports from high throughput mass spectrometry studies).",null,null,"Q00534","Q00534","Q00534","Q00534"]
[419,217,"PK572","CDK6","Y24","Cyclin-dependent protein-serine kinase 6",0,3686,26,930,{"v":3403.8,"d":"3404"},{"v":5980.976614585255,"d":"5981"},{"v":6101.183033941204,"d":"6101"},{"v":120.20641935594813,"d":"120"},{"v":1.9702149351565668,"d":"2"},0,3915,30,899,{"v":3492.615,"d":"3493"},{"v":6102.349818872175,"d":"6102"},{"v":5941.613888126285,"d":"5942"},{"v":160.73593074589007,"d":"161"},{"v":2.7052570862456173,"d":"3"},{"v":4.675472021402184,"d":"5"},{"v":-2.615380409458737,"d":"-3"},null,0,3986,42,956,{"v":3770.464,"d":"3770"},{"v":6450.665913878199,"d":"6451"},{"v":6301.773097551374,"d":"6302"},{"v":148.8928163268247,"d":"149"},{"v":2.3627130653859734,"d":"2"},{"v":4.33292800054254,"d":"4"},{"v":3.2877240773515126,"d":"3"},null,null,"CDK6","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK4",{"$nulls":5},"EGA(pY)GKV(bA)C","Corresponds to amino acid residues E21 to V27; In the protein kinase catalytic domain in subdomain I.","Y24 phosphorylation is predicted to be inhibitory for phosphotransferase activity. This phosphosite is located in the kinase subdomain I region, which is involved in binding the phosphates in the ATP substrate. This is one of the major in vivo phosphorylation sites in CDK6 (≥243 reports from high throughput mass spectrometry studies).",null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.22; CMGC domain target; CMGC</A> group; CDK family; CDK4 subfamily; CDK/CDK4 subfamily","Q00534","Q00534","Q00534","Q00534","GO:0005813; GO:0000307; GO:0005737; GO:0005829; GO:0005654; GO:0005634; GO:0001726","GO:0005524; GO:0030332; GO:0004693; GO:0098770","GO:0014002; GO:0007050; GO:0043697; GO:0051301; GO:0021542; GO:0000082; GO:0048699; GO:0042063; GO:0021670; GO:0045786; GO:0045596; GO:0008285; GO:2000773; GO:0031658; GO:0050680; GO:0045656; GO:0045638; GO:0045668; GO:0001954; GO:0048146; GO:0006468; GO:2000145; GO:0045646; GO:0010389; GO:0010468; GO:0009615; GO:0007165; GO:0003323"]
[420,217,"PK572","CDK6","Y24","Cyclin-dependent protein-serine kinase 6",0,3606,26,989,{"v":3540.62,"d":"3541"},{"v":6221.389453297152,"d":"6221"},{"$nulls":3},0,3456,38,968,{"v":3308.624,"d":"3309"},{"v":5780.877957380396,"d":"5781"},{"$nulls":6},0,3794,36,957,{"v":3596.406,"d":"3596"},{"v":6152.880281224549,"d":"6153"},{"$nulls":7},"CDK6","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK4",{"$nulls":5},"EGA(pY)GKV(bA)C","Corresponds to amino acid residues E21 to V27; In the protein kinase catalytic domain in subdomain I.","Y24 phosphorylation is predicted to be inhibitory for phosphotransferase activity. This phosphosite is located in the kinase subdomain I region, which is involved in binding the phosphates in the ATP substrate. This is one of the major in vivo phosphorylation sites in CDK6 (≥243 reports from high throughput mass spectrometry studies).",null,null,"Q00534","Q00534","Q00534","Q00534"]
[421,218,"NK030-2","CDK7","Pan-specific","Cyclin-dependent protein-serine kinase 7",0,1284,20,843,{"v":1065.552,"d":"1066"},{"v":1872.331392450951,"d":"1872"},{"v":1782.9549940102165,"d":"1783"},{"v":89.37639844073442,"d":"89"},{"v":5.012824145364955,"d":"5"},0,1411,14,703,{"v":982.091,"d":"982"},{"v":1715.924267623541,"d":"1716"},{"v":1371.071173079694,"d":"1371"},{"v":344.85309454384696,"d":"345"},{"v":25.152092853738544,"d":"25"},{"v":30.1649169991035,"d":"30"},{"v":-23.101190008398063,"d":"-23"},null,0,1509,20,902,{"v":1343.078,"d":"1343"},{"v":2297.793447777171,"d":"2298"},{"v":2058.8504942850054,"d":"2059"},{"v":238.94295349216554,"d":"239"},{"v":11.605648596409877,"d":"12"},{"v":16.61847274177483,"d":"17"},{"v":15.474058582614347,"d":"15"},null,null,"CDK7","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK7",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues 1-346 representing full length CDK7.",null,null,"Protein-serine kinase, CMGC group, CDK family, CDK7 subfamily","P50613","P50613","P50613","P50613","GO:0019907; GO:0005737; GO:0005675; GO:0005654; GO:0005634; GO:0048471; GO:0070985","GO:0050681; GO:0005524; GO:0004693; GO:0008094; GO:0016301; GO:0008022; GO:0004672; GO:0004674; GO:0008353; GO:0003713","GO:0006370; GO:0030521; GO:0007050; GO:0051301; GO:0008283; GO:0006294; GO:0045893; GO:0045944; GO:0050821; GO:0000079; GO:0042795; GO:0006363; GO:0006366; GO:0006283; GO:0006368; GO:0006367; GO:0006361"]
[422,218,"NK030-2","CDK7","Pan-specific","Cyclin-dependent protein-serine kinase 7",0,1115,16,877,{"v":963.823,"d":"964"},{"v":1693.5785955694823,"d":"1694"},{"$nulls":3},0,924,19,649,{"v":587.345,"d":"587"},{"v":1026.218078535847,"d":"1026"},{"$nulls":6},0,1274,24,851,{"v":1063.75,"d":"1064"},{"v":1819.9075407928399,"d":"1820"},{"$nulls":7},"CDK7","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK7",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues 1-346 representing full length CDK7.",{"$nulls":3},"P50613","P50613","P50613","P50613"]
[423,219,"NK030-1","CDK7","Pan-specific","Cyclin-dependent protein-serine kinase 7",0,852,14,681,{"v":570.678,"d":"571"},{"v":1002.765077988802,"d":"1003"},{"v":1025.1528866280964,"d":"1025"},{"v":22.387808639294462,"d":"22"},{"v":2.1838507144950645,"d":"2"},0,822,18,614,{"v":493.656,"d":"494"},{"v":862.5232389442187,"d":"863"},{"v":750.7731055727347,"d":"751"},{"v":111.75013337148403,"d":"112"},{"v":14.884674549740872,"d":"15"},{"v":17.068525264235937,"d":"17"},{"v":-26.764766956648174,"d":"-27"},null,0,1078,16,644,{"v":683.928,"d":"684"},{"v":1170.0923380111544,"d":"1170"},{"v":1158.4723032125034,"d":"1158"},{"v":11.620034798650977,"d":"12"},{"v":1.0030481321329843,"d":"1"},{"v":3.186898846628049,"d":"3"},{"v":13.004832578964624,"d":"13"},null,null,"CDK7","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK7",{"$nulls":5},"VATKRKRAEALEQGC","Corresponds to amino acid residues V325 to Q338; Pre-C-terminus.",null,null,"Protein-serine kinase, CMGC group, CDK family, CDK7 subfamily","P50613","P50613","P50613","P50613","GO:0019907; GO:0005737; GO:0005675; GO:0005654; GO:0005634; GO:0048471; GO:0070985","GO:0050681; GO:0005524; GO:0004693; GO:0008094; GO:0016301; GO:0008022; GO:0004672; GO:0004674; GO:0008353; GO:0003713","GO:0006370; GO:0030521; GO:0007050; GO:0051301; GO:0008283; GO:0006294; GO:0045893; GO:0045944; GO:0050821; GO:0000079; GO:0042795; GO:0006363; GO:0006366; GO:0006283; GO:0006368; GO:0006367; GO:0006361"]
[424,219,"NK030-1","CDK7","Pan-specific","Cyclin-dependent protein-serine kinase 7",0,978,18,621,{"v":596.16,"d":"596"},{"v":1047.540695267391,"d":"1048"},{"$nulls":3},0,712,18,527,{"v":365.738,"d":"366"},{"v":639.0229722012508,"d":"639"},{"$nulls":6},0,1074,20,636,{"v":670.344,"d":"670"},{"v":1146.8522684138525,"d":"1147"},{"$nulls":7},"CDK7","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK7",{"$nulls":5},"VATKRKRAEALEQGC","Corresponds to amino acid residues V325 to Q338; Pre-C-terminus.",{"$nulls":3},"P50613","P50613","P50613","P50613"]
[425,220,"PK573","CDK7","T170","Cyclin-dependent protein-serine kinase 7",0,5006,20,867,{"v":4322.862,"d":"4323"},{"v":7595.903557811635,"d":"7596"},{"v":7745.858474166505,"d":"7746"},{"v":149.95491635486997,"d":"150"},{"v":1.9359366925562875,"d":"2"},0,5202,18,739,{"v":3830.976,"d":"3831"},{"v":6693.539282086245,"d":"6694"},{"v":7020.097286861133,"d":"7020"},{"v":326.5580047748881,"d":"327"},{"v":4.651758963313465,"d":"5"},{"v":6.587695655869752,"d":"7"},{"v":-9.369667542027585,"d":"-9"},null,0,5574,16,844,{"v":4690.952,"d":"4691"},{"v":8025.474893816456,"d":"8025"},{"v":7966.038552688668,"d":"7966"},{"v":59.43634112778818,"d":"59"},{"v":0.7461216856366764,"d":"1"},{"v":2.6820583781929637,"d":"3"},{"v":2.8425523040020977,"d":"3"},null,null,"CDK7","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK7",{"$nulls":5},"RAY(pY)HQV(bA)C","Corresponds to amino acid residues R167 to V173; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T170 phosphorylation stimulates phosphotransferase activity and regulates transcription. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation site in CDK7 (≥152 reports from high throughput mass spectrometry studies).","CDK1 (CDC2); CDK2; PKCi","Protein-serine kinase, CMGC group, CDK family, CDK7 subfamily","P50613","P50613","P50613","P50613","GO:0019907; GO:0005737; GO:0005675; GO:0005654; GO:0005634; GO:0048471; GO:0070985","GO:0050681; GO:0005524; GO:0004693; GO:0008094; GO:0016301; GO:0008022; GO:0004672; GO:0004674; GO:0008353; GO:0003713","GO:0006370; GO:0030521; GO:0007050; GO:0051301; GO:0008283; GO:0006294; GO:0045893; GO:0045944; GO:0050821; GO:0000079; GO:0042795; GO:0006363; GO:0006366; GO:0006283; GO:0006368; GO:0006367; GO:0006361"]
[426,220,"PK573","CDK7","T170","Cyclin-dependent protein-serine kinase 7",0,5102,36,887,{"v":4493.542,"d":"4494"},{"v":7895.813390521375,"d":"7896"},{"$nulls":3},0,5092,26,830,{"v":4204.78,"d":"4205"},{"v":7346.6552916360215,"d":"7347"},{"$nulls":6},0,5623,28,826,{"v":4621.47,"d":"4621"},{"v":7906.60221156088,"d":"7907"},{"$nulls":7},"CDK7","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK7",{"$nulls":5},"RAY(pY)HQV(bA)C","Corresponds to amino acid residues R167 to V173; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T170 phosphorylation stimulates phosphotransferase activity and regulates transcription. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation site in CDK7 (≥152 reports from high throughput mass spectrometry studies).","CDK1 (CDC2); CDK2; PKCi",null,"P50613","P50613","P50613","P50613"]
[427,221,"NK031-5","CDK8","Pan-specific","Cyclin-dependent protein-serine kinase 8",0,144,12,966,{"v":127.512,"d":"128"},{"v":224.0573153766364,"d":"224"},{"v":190.7505959073775,"d":"191"},{"v":33.30671946925892,"d":"33"},{"v":17.460873089713242,"d":"17"},0,94,10,967,{"v":81.228,"d":"81"},{"v":141.92279168684468,"d":"142"},{"v":130.01027883756973,"d":"130"},{"v":11.912512849274947,"d":"12"},{"v":9.162746942615223,"d":"9"},{"v":26.623620032328468,"d":"27"},{"v":-31.842792826346596,"d":"-32"},null,0,158,8,963,{"v":144.45,"d":"144"},{"v":247.13104043950713,"d":"247"},{"v":226.5085581864243,"d":"227"},{"v":20.622482253082836,"d":"21"},{"v":9.104504667814727,"d":"9"},{"v":26.56537775752797,"d":"27"},{"v":18.745924283460553,"d":"19"},null,null,"CDK8","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK8",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues at the C-terminus of human CDK8.",null,null,"Protein-serine kinase, CMGC group, CDK family, CDK8 subfamily.","P49336","P49336","P49336",null,"GO:0016592; GO:0005730; GO:0005654; GO:0005634; GO:0032991","GO:0005524; GO:0004693; GO:0004672; GO:0004674; GO:0008353","GO:0045944; GO:0007346; GO:0006367"]
[428,221,"NK031-5","CDK8","Pan-specific","Cyclin-dependent protein-serine kinase 8",0,156,14,631,{"v":89.602,"d":"90"},{"v":157.4438764381186,"d":"157"},{"$nulls":3},0,132,13,568,{"v":67.592,"d":"68"},{"v":118.09776598829475,"d":"118"},{"$nulls":6},0,208,22,647,{"v":120.342,"d":"120"},{"v":205.88607593334143,"d":"206"},{"$nulls":7},"CDK8","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK8",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues at the C-terminus of human CDK8.",{"$nulls":3},"P49336","P49336","P49336"]
[429,222,"NK031-4","CDK8","Pan-specific","Cyclin-dependent protein-serine kinase 8",0,4880,16,837,{"v":4071.168,"d":"4071"},{"v":7153.640226231807,"d":"7154"},{"v":7231.193661763076,"d":"7231"},{"v":77.55343553126932,"d":"78"},{"v":1.072484560071381,"d":"1"},0,4962,16,696,{"v":3442.416,"d":"3442"},{"v":6014.641365877052,"d":"6015"},{"v":6050.850652513656,"d":"6051"},{"v":36.2092866366047,"d":"36"},{"v":0.5984164659817305,"d":"1"},{"v":1.6709010260531114,"d":"2"},{"v":-16.322934559072976,"d":"-16"},null,0,5128,16,732,{"v":3741.984,"d":"3742"},{"v":6401.941150764892,"d":"6402"},{"v":6596.648588981157,"d":"6597"},{"v":194.70743821626547,"d":"195"},{"v":2.951611497715657,"d":"3"},{"v":4.0240960577870375,"d":"4"},{"v":-8.775108266526601,"d":"-9"},null,null,"CDK8","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK8",{"$nulls":5},"MDYDFKVKLSSERERC","Corresponds to amino acid residues M1 to R15; N-terminus.",null,null,"Protein-serine kinase, CMGC group, CDK family, CDK8 subfamily.","P49336","P49336","P49336",null,"GO:0016592; GO:0005730; GO:0005654; GO:0005634; GO:0032991","GO:0005524; GO:0004693; GO:0004672; GO:0004674; GO:0008353","GO:0045944; GO:0007346; GO:0006367"]
[430,222,"NK031-4","CDK8","Pan-specific","Cyclin-dependent protein-serine kinase 8",0,4786,16,872,{"v":4159.44,"d":"4159"},{"v":7308.747097294345,"d":"7309"},{"$nulls":3},0,4588,16,762,{"v":3483.864,"d":"3484"},{"v":6087.059939150262,"d":"6087"},{"$nulls":6},0,4818,18,827,{"v":3969.6,"d":"3970"},{"v":6791.356027197422,"d":"6791"},{"$nulls":7},"CDK8","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK8",{"$nulls":5},"MDYDFKVKLSSERERC","Corresponds to amino acid residues M1 to R15; N-terminus.",{"$nulls":3},"P49336","P49336","P49336"]
[431,223,"NK032","CDK9","Pan-specific","Cyclin-dependent protein-serine kinase 9",0,842,14,719,{"v":595.332,"d":"595"},{"v":1046.0857776350751,"d":"1046"},{"v":970.5846896817586,"d":"971"},{"v":75.50108795331653,"d":"76"},{"v":7.778928387802233,"d":"8"},0,544,12,517,{"v":275.044,"d":"275"},{"v":480.56104196479674,"d":"481"},{"v":607.0410726046604,"d":"607"},{"v":126.48003063986363,"d":"126"},{"v":20.835498016167122,"d":"21"},{"v":28.614426403969354,"d":"29"},{"v":-37.45614586155271,"d":"-37"},null,0,688,12,615,{"v":415.74,"d":"416"},{"v":711.2652042389803,"d":"711"},{"v":775.6492986997623,"d":"776"},{"v":64.38409446078197,"d":"64"},{"v":8.300670750132879,"d":"8"},{"v":16.079599137935112,"d":"16"},{"v":-20.084325773355545,"d":"-20"},null,null,"CDK9","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK9",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues at the C-terminus of human CDK9.",null,null,"EC 2.7.11.23; EC 2.7.11.22; Nuclear receptor co-regulator; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; CDK/CDK9 subfamily; CDK9 subfamily","P50750","P50750","P50750","P50750","GO:0005694; GO:0008024; GO:0036464; GO:0016020; GO:0005654; GO:0016605; GO:0008023","GO:0097322; GO:0005524; GO:0003682; GO:0030332; GO:0004693; GO:0003677; GO:0016301; GO:0004672; GO:0019901; GO:0004674; GO:0008353; GO:0000978; GO:0001223; GO:0044212","GO:0008283; GO:0071345; GO:0006281; GO:0071157; GO:1900364; GO:0070816; GO:0010613; GO:2001168; GO:0033129; GO:1903839; GO:0045944; GO:0050434; GO:0006468; GO:0006282; GO:0031056; GO:0051147; GO:0031297; GO:0042493; GO:0042795; GO:0006366; GO:0006368; GO:0006367"]
[432,223,"NK032","CDK9","Pan-specific","Cyclin-dependent protein-serine kinase 9",0,744,10,694,{"v":509.396,"d":"509"},{"v":895.083601728442,"d":"895"},{"$nulls":3},0,669,12,639,{"v":419.823,"d":"420"},{"v":733.5211032445239,"d":"734"},{"$nulls":6},0,780,14,641,{"v":491.006,"d":"491"},{"v":840.0333931605444,"d":"840"},{"$nulls":7},"CDK9","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK9",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues at the C-terminus of human CDK9.",{"$nulls":3},"P50750","P50750","P50750","P50750"]
[433,224,"PK575","CDK9","T186","Cyclin-dependent protein-serine kinase 9",0,7110,18,809,{"v":5737.428,"d":"5737"},{"v":10081.503818046493,"d":"10082"},{"v":9712.144511303359,"d":"9712"},{"v":369.35930674313386,"d":"369"},{"v":3.8030664217697714,"d":"4"},0,6552,22,706,{"v":4610.18,"d":"4610"},{"v":8054.976310863959,"d":"8055"},{"v":8163.906438993623,"d":"8164"},{"v":108.9301281296639,"d":"109"},{"v":1.3342892761408456,"d":"1"},{"v":5.137355697910617,"d":"5"},{"v":-15.941258601618188,"d":"-16"},null,0,7166,18,741,{"v":5296.668,"d":"5297"},{"v":9061.758904137372,"d":"9062"},{"v":9293.930347362597,"d":"9294"},{"v":232.17144322522472,"d":"232"},{"v":2.498097516849904,"d":"2"},{"v":6.301163938619675,"d":"6"},{"v":-4.306094945910544,"d":"-4"},null,null,"CDK9","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK9",{"$nulls":5},"NRY(pT)NRV(bA)C","Corresponds to amino acid residues N183 to V189; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T186 phosphorylation stimulates phosphotransferase activity by promoting cyclin and substrate binding. Phosphorylation induces binding to EDG-1, RNA and TEAD1. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in CDK9 (≥33 reports from high throughput mass spectrometry studies).","CDK9","EC 2.7.11.23; EC 2.7.11.22; Nuclear receptor co-regulator; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; CDK/CDK9 subfamily; CDK9 subfamily","P50750","P50750","P50750","P50750","GO:0005694; GO:0008024; GO:0036464; GO:0016020; GO:0005654; GO:0016605; GO:0008023","GO:0097322; GO:0005524; GO:0003682; GO:0030332; GO:0004693; GO:0003677; GO:0016301; GO:0004672; GO:0019901; GO:0004674; GO:0008353; GO:0000978; GO:0001223; GO:0044212","GO:0008283; GO:0071345; GO:0006281; GO:0071157; GO:1900364; GO:0070816; GO:0010613; GO:2001168; GO:0033129; GO:1903839; GO:0045944; GO:0050434; GO:0006468; GO:0006282; GO:0031056; GO:0051147; GO:0031297; GO:0042493; GO:0042795; GO:0006366; GO:0006368; GO:0006367"]
[434,224,"PK575","CDK9","T186","Cyclin-dependent protein-serine kinase 9",0,6558,18,813,{"v":5317.02,"d":"5317"},{"v":9342.785204560225,"d":"9343"},{"$nulls":3},0,6456,14,735,{"v":4734.87,"d":"4735"},{"v":8272.836567123286,"d":"8273"},{"$nulls":6},0,6856,24,815,{"v":5568.08,"d":"5568"},{"v":9526.101790587822,"d":"9526"},{"$nulls":7},"CDK9","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK9",{"$nulls":5},"NRY(pT)NRV(bA)C","Corresponds to amino acid residues N183 to V189; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T186 phosphorylation stimulates phosphotransferase activity by promoting cyclin and substrate binding. Phosphorylation induces binding to EDG-1, RNA and TEAD1. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in CDK9 (≥33 reports from high throughput mass spectrometry studies).","CDK9",null,"P50750","P50750","P50750","P50750"]
[435,225,"PK574","CDK9","S347","Cyclin-dependent protein-serine kinase 9",0,7198,18,765,{"v":5492.7,"d":"5493"},{"v":9651.480771764624,"d":"9651"},{"v":9707.578565086482,"d":"9708"},{"v":56.09779332185826,"d":"56"},{"v":0.5778762741474501,"d":"1"},0,6858,26,681,{"v":4652.592,"d":"4653"},{"v":8129.0791995356285,"d":"8129"},{"v":8566.148562145167,"d":"8566"},{"v":437.0693626095381,"d":"437"},{"v":5.102285577219613,"d":"5"},{"v":5.680161851367063,"d":"6"},{"v":-11.758133043048375,"d":"-12"},null,0,7712,24,714,{"v":5489.232,"d":"5489"},{"v":9391.205367766262,"d":"9391"},{"v":9124.329506712616,"d":"9124"},{"v":266.8758610536461,"d":"267"},{"v":2.9248818870176705,"d":"3"},{"v":3.5027581611651204,"d":"4"},{"v":-6.00818272510854,"d":"-6"},null,null,"CDK9","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK9",{"$nulls":5},"RKG(pS)QIT(bA)C","Corresponds to amino acid residues R344 to T350; Near the C-terminus of the kinase after the catalytic domain.","S347 phosphorylation induces interaction with RNA [PubMed: 10958691). This is the major in vivo phosphorylation site in CDK9 (≥93 reports from high throughput mass spectrometry studies).","CDK9","EC 2.7.11.23; EC 2.7.11.22; Nuclear receptor co-regulator; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; CDK/CDK9 subfamily; CDK9 subfamily","P50750","P50750","P50750","P50750","GO:0005694; GO:0008024; GO:0036464; GO:0016020; GO:0005654; GO:0016605; GO:0008023","GO:0097322; GO:0005524; GO:0003682; GO:0030332; GO:0004693; GO:0003677; GO:0016301; GO:0004672; GO:0019901; GO:0004674; GO:0008353; GO:0000978; GO:0001223; GO:0044212","GO:0008283; GO:0071345; GO:0006281; GO:0071157; GO:1900364; GO:0070816; GO:0010613; GO:2001168; GO:0033129; GO:1903839; GO:0045944; GO:0050434; GO:0006468; GO:0006282; GO:0031056; GO:0051147; GO:0031297; GO:0042493; GO:0042795; GO:0006366; GO:0006368; GO:0006367"]
[436,225,"PK574","CDK9","S347","Cyclin-dependent protein-serine kinase 9",0,7029,22,793,{"v":5556.551,"d":"5557"},{"v":9763.676358408342,"d":"9764"},{"$nulls":3},0,6840,24,756,{"v":5152.896,"d":"5153"},{"v":9003.217924754705,"d":"9003"},{"$nulls":6},0,7403,28,702,{"v":5177.25,"d":"5177"},{"v":8857.45364565897,"d":"8857"},{"$nulls":7},"CDK9","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK9",{"$nulls":5},"RKG(pS)QIT(bA)C","Corresponds to amino acid residues R344 to T350; Near the C-terminus of the kinase after the catalytic domain.","S347 phosphorylation induces interaction with RNA [PubMed: 10958691). This is the major in vivo phosphorylation site in CDK9 (≥93 reports from high throughput mass spectrometry studies).","CDK9",null,"P50750","P50750","P50750","P50750"]
[437,226,"NK033-2","CDK10 (PISSLRE)","Pan-specific","Cyclin-dependent protein-serine kinase 10 [PISSLRE]",0,9507,22,845,{"v":8014.825,"d":"8015"},{"v":14083.224894233876,"d":"14083"},{"v":12643.126160290198,"d":"12643"},{"v":1440.0987339436779,"d":"1440"},{"v":11.390369088198858,"d":"11"},0,9940,20,757,{"v":7509.44,"d":"7509"},{"v":13120.607288187064,"d":"13121"},{"v":13568.721671327065,"d":"13569"},{"v":448.1143831400004,"d":"448"},{"v":3.3025541682894093,"d":"3"},{"v":14.692923256488267,"d":"15"},{"v":7.320938661072574,"d":"7"},null,0,11072,18,790,{"v":8732.66,"d":"8733"},{"v":14940.19627278966,"d":"14940"},{"v":13640.134735193125,"d":"13640"},{"v":1300.0615375965353,"d":"1300"},{"v":9.53114879607623,"d":"10"},{"v":20.92151788427509,"d":"21"},{"v":7.885775735073764,"d":"8"},null,null,"CDK10","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK10",{"$nulls":5},"CIRKEGFFTVPPEHRLGR","Corresponds to amino acid residues C15 to R32; Post-N-terminus.",null,null,"Protein-serine kinase, CMGC group, CDK family, CDK10 subfamily","Q15131","Q15131","Q15131","Q15131","GO:0036064; GO:0005737; GO:0016592","GO:0005524; GO:0004693; GO:0004674","GO:0030030; GO:0008285; GO:1902018; GO:0018107; GO:0043410; GO:0006468; GO:0032956; GO:0007089"]
[438,226,"NK033-2","CDK10 (PISSLRE)","Pan-specific","Cyclin-dependent protein-serine kinase 10 [PISSLRE]",0,7506,14,851,{"v":6375.692,"d":"6376"},{"v":11203.027426346522,"d":"11203"},{"$nulls":3},0,9958,17,807,{"v":8022.387,"d":"8022"},{"v":14016.836054467067,"d":"14017"},{"$nulls":6},0,9422,18,767,{"v":7212.868,"d":"7213"},{"v":12340.073197596588,"d":"12340"},{"$nulls":7},"CDK10","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK10",{"$nulls":5},"CIRKEGFFTVPPEHRLGR","Corresponds to amino acid residues C15 to R32; Post-N-terminus.",{"$nulls":3},"Q15131","Q15131","Q15131","Q15131"]
[439,227,"NK033-3","CDK10 (PISSLRE)","Pan-specific","Cyclin-dependent protein-serine kinase 10 [PISSLRE]",0,9385,14,876,{"v":8208.996,"d":"8209"},{"v":14424.41186474643,"d":"14424"},{"v":14494.052867791808,"d":"14494"},{"v":69.64100304537897,"d":"70"},{"v":0.4804798470145837,"d":"0"},0,9014,18,842,{"v":7574.632,"d":"7575"},{"v":13234.511737830646,"d":"13235"},{"v":13913.710175044544,"d":"13914"},{"v":679.1984372138977,"d":"679"},{"v":4.881504851467292,"d":"5"},{"v":5.3619846984818755,"d":"5"},{"v":-4.004005629349422,"d":"-4"},null,0,10541,18,808,{"v":8502.584,"d":"8503"},{"v":14546.572726509565,"d":"14547"},{"v":14284.672847672036,"d":"14285"},{"v":261.8998788375284,"d":"262"},{"v":1.8334328103300597,"d":"2"},{"v":2.3139126573446434,"d":"2"},{"v":-1.444592634162717,"d":"-1"},null,null,"CDK10","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK10",{"$nulls":5},"HRNKRAAPATSEGQSKRC","Corresponds to amino acid residues H341 to C358; C-terminus.",null,null,"Protein-serine kinase, CMGC group, CDK family, CDK10 subfamily","Q15131","Q15131","Q15131","Q15131","GO:0036064; GO:0005737; GO:0016592","GO:0005524; GO:0004693; GO:0004674","GO:0030030; GO:0008285; GO:1902018; GO:0018107; GO:0043410; GO:0006468; GO:0032956; GO:0007089"]
[440,227,"NK033-3","CDK10 (PISSLRE)","Pan-specific","Cyclin-dependent protein-serine kinase 10 [PISSLRE]",0,9136,18,909,{"v":8288.262,"d":"8288"},{"v":14563.693870837187,"d":"14564"},{"$nulls":3},0,9174,16,912,{"v":8352.096,"d":"8352"},{"v":14592.908612258441,"d":"14593"},{"$nulls":6},0,9697,20,847,{"v":8196.419,"d":"8196"},{"v":14022.772968834508,"d":"14023"},{"$nulls":7},"CDK10","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK10",{"$nulls":5},"HRNKRAAPATSEGQSKRC","Corresponds to amino acid residues H341 to C358; C-terminus.",{"$nulls":3},"Q15131","Q15131","Q15131","Q15131"]
[441,228,"PK564","CDK10 (PISSLRE)","T196","Cyclin-dependent protein-serine kinase 10 [PISSLRE]",0,6576,26,682,{"v":4467.1,"d":"4467"},{"v":7849.350912219811,"d":"7849"},{"v":7719.0145409915185,"d":"7719"},{"v":130.3363712282926,"d":"130"},{"v":1.6885105026832956,"d":"2"},0,6056,20,605,{"v":3651.78,"d":"3652"},{"v":6380.445317208176,"d":"6380"},{"v":7026.0911084113595,"d":"7026"},{"v":645.6457912031838,"d":"646"},{"v":9.189260162457074,"d":"9"},{"v":10.87777066514037,"d":"11"},{"v":-8.976838026414086,"d":"-9"},null,0,7440,20,687,{"v":5097.54,"d":"5098"},{"v":8721.082477549362,"d":"8721"},{"v":8452.115968303144,"d":"8452"},{"v":268.96650924621827,"d":"269"},{"v":3.1822387465445092,"d":"3"},{"v":4.870749249227805,"d":"5"},{"v":9.497344815436207,"d":"9"},null,null,"CDK10","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK10",{"$nulls":5},"KPM(pT)PKV(bA)C","Corresponds to amino acid residues K193 to V199; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T196 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation site in CDK10 (≥27 reports from high throughput mass spectrometry studies).",null,"Protein-serine kinase, CMGC group, CDK family, CDK10 subfamily","Q15131","Q15131","Q15131","Q15131","GO:0036064; GO:0005737; GO:0016592","GO:0005524; GO:0004693; GO:0004674","GO:0030030; GO:0008285; GO:1902018; GO:0018107; GO:0043410; GO:0006468; GO:0032956; GO:0007089"]
[442,228,"PK564","CDK10 (PISSLRE)","T196","Cyclin-dependent protein-serine kinase 10 [PISSLRE]",0,6268,18,691,{"v":4318.75,"d":"4319"},{"v":7588.678169763226,"d":"7589"},{"$nulls":3},0,6220,27,709,{"v":4390.837,"d":"4391"},{"v":7671.736899614543,"d":"7672"},{"$nulls":6},0,6656,22,721,{"v":4783.114,"d":"4783"},{"v":8183.149459056925,"d":"8183"},{"$nulls":7},"CDK10","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK10",{"$nulls":5},"KPM(pT)PKV(bA)C","Corresponds to amino acid residues K193 to V199; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T196 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation site in CDK10 (≥27 reports from high throughput mass spectrometry studies).",null,null,"Q15131","Q15131","Q15131","Q15131"]
[443,229,"PK565","CDK11A (Cdc2L2; PITSLRE)","T583(labeledasT580)","Cell division cycle 2-like 2 protein kinase",0,7926,25,934,{"v":7379.534,"d":"7380"},{"v":12966.92528366437,"d":"12967"},{"v":12841.001108299297,"d":"12841"},{"v":125.9241753650731,"d":"126"},{"v":0.9806414180876191,"d":"1"},0,7906,20,833,{"v":6569.038,"d":"6569"},{"v":11477.52267268635,"d":"11478"},{"v":11786.24335805991,"d":"11786"},{"v":308.7206853735606,"d":"309"},{"v":2.619330655195109,"d":"3"},{"v":3.599972073282728,"d":"4"},{"v":-8.213983795684626,"d":"-8"},null,0,6752,30,910,{"v":6117.02,"d":"6117"},{"v":10465.251069499995,"d":"10465"},{"v":11416.504551327427,"d":"11417"},{"v":951.2534818274326,"d":"951"},{"v":8.332265603282467,"d":"8"},{"v":9.312907021370087,"d":"9"},{"v":-11.093345020048318,"d":"-11"},null,null,"CDK11","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK8",{"$nulls":5},"KAY(pT)PVV(bA)C","Corresponds to amino acid residues K580 to V586; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T583 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in CDK11a (≥49 reports from high throughput mass spectrometry studies).",null,"EC 2.7.11.22; RNA processing; Protein kinase, Ser/Thr (non-receptor)","Q9UQ88","Q9UQ88","Q9UQ88","Q9UQ88","GO:0005737; GO:0005634","GO:0005524; GO:0004693; GO:0004672; GO:0004674","GO:0006915; GO:0000278; GO:0006468; GO:0001558; GO:0007346; GO:0050684; GO:0006355"]
[444,229,"PK565","CDK11A (Cdc2L2; PITSLRE)","T583(labeledasT580)","Cell division cycle 2-like 2 protein kinase",0,7912,38,919,{"v":7236.206,"d":"7236"},{"v":12715.076932934224,"d":"12715"},{"$nulls":3},0,8457,56,824,{"v":6922.424,"d":"6922"},{"v":12094.964043433472,"d":"12095"},{"$nulls":6},0,8178,28,887,{"v":7229.05,"d":"7229"},{"v":12367.758033154858,"d":"12368"},{"$nulls":7},"CDK11","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK8",{"$nulls":5},"KAY(pT)PVV(bA)C","Corresponds to amino acid residues K580 to V586; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T583 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in CDK11a (≥49 reports from high throughput mass spectrometry studies).",null,null,"Q9UQ88","Q9UQ88","Q9UQ88","Q9UQ88"]
[445,230,"PK566","CDK12 (Cdc2L7)","S383+S385","Cell division protein kinase 12; Cell division cycle 2-related protein kinase 7",0,7522,30,1015,{"v":7604.38,"d":"7604"},{"v":13362.012735301669,"d":"13362"},{"v":13250.880222531807,"d":"13251"},{"v":111.13251276986193,"d":"111"},{"v":0.8386802303207912,"d":"1"},0,7851,22,908,{"v":7108.732,"d":"7109"},{"v":12420.484202413045,"d":"12420"},{"v":12999.298140764777,"d":"12999"},{"v":578.8139383517318,"d":"579"},{"v":4.45265530557082,"d":"4"},{"v":5.291335535891611,"d":"5"},{"v":-1.8986065645604526,"d":"-2"},null,0,7362,78,982,{"v":7152.888,"d":"7153"},{"v":12237.456930337594,"d":"12237"},{"v":12056.566247279443,"d":"12057"},{"v":180.8906830581509,"d":"181"},{"v":1.5003499283966426,"d":"2"},{"v":2.339030158717434,"d":"2"},{"v":-9.013091622559159,"d":"-9"},null,null,"CRK7","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CRK7",{"$nulls":5},"RHS(pS)I(pS)PVR(bA)C","Corresponds to amino acid residues R380 to R388; In the first quarter of the protein. ","The effects of S383 and S385 phosphorylation are unclear. These are the major in vivo phosphorylation sites in CDK12 (≥163 and ≥174 reports, respectively, from high throughput mass spectrometry studies).",null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.22; CMGC domain target; CMGC</A> group; CDK family; CRK7 subfamily; CDK/CRK7 subfamily","Q9NYV4","Q9NYV4","Q9NYV4",null,"GO:0005694; GO:0008024; GO:0002944; GO:0001650; GO:0019908; GO:0016607; GO:0005654; GO:0005634","GO:0005524; GO:0030332; GO:0004693; GO:0004672; GO:0019901; GO:0008353; GO:0008134; GO:0044212","GO:0006397; GO:2000737; GO:0070816; GO:0045944; GO:0046777; GO:0043405; GO:0043484; GO:0008380; GO:0006368"]
[446,230,"PK566","CDK12 (Cdc2L7)","S383+S385","Cell division protein kinase 12; Cell division cycle 2-related protein kinase 7",0,7264,32,1034,{"v":7477.888,"d":"7478"},{"v":13139.747709761943,"d":"13140"},{"$nulls":3},0,7640,36,1022,{"v":7771.288,"d":"7771"},{"v":13578.112079116509,"d":"13578"},{"$nulls":6},0,6838,46,1022,{"v":6941.424,"d":"6941"},{"v":11875.67556422129,"d":"11876"},{"$nulls":7},"CRK7","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CRK7",{"$nulls":5},"RHS(pS)I(pS)PVR(bA)C","Corresponds to amino acid residues R380 to R388; In the first quarter of the protein. ","The effects of S383 and S385 phosphorylation are unclear. These are the major in vivo phosphorylation sites in CDK12 (≥163 and ≥174 reports, respectively, from high throughput mass spectrometry studies).",null,null,"Q9NYV4","Q9NYV4","Q9NYV4"]
[447,231,"PK567","CDK12 (Cdc2L7)","T893","Cell division protein kinase 12; Cell division cycle 2-related protein kinase 7",0,7819,20,813,{"v":6340.587,"d":"6341"},{"v":11141.34278445951,"d":"11141"},{"v":11801.51429584316,"d":"11802"},{"v":660.1715113836508,"d":"660"},{"v":5.593955952044074,"d":"6"},0,7866,22,831,{"v":6518.364,"d":"6518"},{"v":11388.984292498,"d":"11389"},{"v":11552.292997542887,"d":"11552"},{"v":163.30870504488666,"d":"163"},{"v":1.413647533694147,"d":"1"},{"v":7.007603485738221,"d":"7"},{"v":-2.1117738965757695,"d":"-2"},null,0,8816,28,881,{"v":7742.228,"d":"7742"},{"v":13245.72420186836,"d":"13246"},{"v":12789.394896542304,"d":"12789"},{"v":456.32930532605496,"d":"456"},{"v":3.5680288943883225,"d":"4"},{"v":9.161984846432397,"d":"9"},{"v":8.370795271985585,"d":"8"},null,null,"CRK7","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CRK7",{"$nulls":5},"RPY(pT)NKV(bA)C","Corresponds to amino acid residues R890 to V896; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T893 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in CDK12 (≥73 reports from high throughput mass spectrometry studies).",null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.22; CMGC domain target; CMGC</A> group; CDK family; CRK7 subfamily; CDK/CRK7 subfamily","Q9NYV4","Q9NYV4","Q9NYV4",null,"GO:0005694; GO:0008024; GO:0002944; GO:0001650; GO:0019908; GO:0016607; GO:0005654; GO:0005634","GO:0005524; GO:0030332; GO:0004693; GO:0004672; GO:0019901; GO:0008353; GO:0008134; GO:0044212","GO:0006397; GO:2000737; GO:0070816; GO:0045944; GO:0046777; GO:0043405; GO:0043484; GO:0008380; GO:0006368"]
[448,231,"PK567","CDK12 (Cdc2L7)","T893","Cell division protein kinase 12; Cell division cycle 2-related protein kinase 7",0,7902,22,900,7092,{"v":12461.685807226813,"d":"12462"},{"$nulls":3},0,7751,26,868,{"v":6705.3,"d":"6705"},{"v":11715.601702587774,"d":"11716"},{"$nulls":6},0,8481,20,852,{"v":7208.772,"d":"7209"},{"v":12333.065591216247,"d":"12333"},{"$nulls":7},"CRK7","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CRK7",{"$nulls":5},"RPY(pT)NKV(bA)C","Corresponds to amino acid residues R890 to V896; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T893 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in CDK12 (≥73 reports from high throughput mass spectrometry studies).",null,null,"Q9NYV4","Q9NYV4","Q9NYV4"]
[449,232,"NK199","CDKL1","Pan-specific","Cyclin-dependent kinase-like 1; Serine/threonine protein kinase KKIALRE",0,3536,18,737,{"v":2592.766,"d":"2593"},{"v":4555.870736556717,"d":"4556"},{"v":4702.035487050591,"d":"4702"},{"v":146.16475049387373,"d":"146"},{"v":3.1085420536789132,"d":"3"},0,3324,16,620,{"v":2050.96,"d":"2051"},{"v":3583.468370981078,"d":"3583"},{"v":3690.27563271123,"d":"3690"},{"v":106.80726173015228,"d":"107"},{"v":2.8942895425857778,"d":"3"},{"v":6.002831596264691,"d":"6"},{"v":-21.517486567801285,"d":"-22"},null,0,3927,16,652,{"v":2549.972,"d":"2550"},{"v":4362.597670139225,"d":"4363"},{"v":4624.606187405744,"d":"4625"},{"v":262.00851726651945,"d":"262"},{"v":5.665531434439779,"d":"6"},{"v":8.774073488118692,"d":"9"},{"v":-1.6467187425124052,"d":"-2"},null,null,"CDKL1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDKL",{"$nulls":6},"CLDNKKYYSDTKKLNYR","Corresponds to amino acid residues L338 to R353; C-terminus.",{"$nulls":3},"Q00532","Q00532","Q00532","Q00532","GO:0035869; GO:0005737; GO:0070062; GO:0043231; GO:0005654; GO:0005634","GO:0005524; GO:0004693","GO:0007507; GO:0006468; GO:1902017"]
[450,232,"NK199","CDKL1","Pan-specific","Cyclin-dependent kinase-like 1; Serine/threonine protein kinase KKIALRE",0,3618,16,766,{"v":2759.132,"d":"2759"},{"v":4848.200237544464,"d":"4848"},{"$nulls":3},0,3288,20,665,{"v":2173.22,"d":"2173"},{"v":3797.082894441382,"d":"3797"},{"$nulls":6},0,3922,20,732,{"v":2856.264,"d":"2856"},{"v":4886.6147046722635,"d":"4887"},{"$nulls":7},"CDKL1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDKL",{"$nulls":6},"CLDNKKYYSDTKKLNYR","Corresponds to amino acid residues L338 to R353; C-terminus.",{"$nulls":3},"Q00532","Q00532","Q00532","Q00532"]
[451,233,"NK261-1","CDKL2","Pan-specific","Cyclin-dependent kinase-like 2; Serine/threonine protein kinase KKIAMRE",0,10400,20,778,{"v":8075.64,"d":"8076"},{"v":14190.085782892435,"d":"14190"},{"v":15017.898772742157,"d":"15018"},{"v":827.8129898497227,"d":"828"},{"v":5.5121758534704135,"d":"6"},0,10142,22,681,{"v":6891.72,"d":"6892"},{"v":12041.317549663432,"d":"12041"},{"v":11709.395594397596,"d":"11709"},{"v":331.921955265836,"d":"332"},{"v":2.834663434077206,"d":"3"},{"v":8.34683928754762,"d":"8"},{"v":-22.030400047372623,"d":"-22"},null,0,11038,20,801,{"v":8825.418,"d":"8825"},{"v":15098.890499505394,"d":"15099"},{"v":14614.412720601274,"d":"14614"},{"v":484.47777890412,"d":"484"},{"v":3.3150684065543987,"d":"3"},{"v":8.827244260024813,"d":"9"},{"v":-2.686701104106646,"d":"-3"},null,null,"CDKL2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDKL",{"$nulls":6},"CLSDDSGADLPQMEHQH","Corresponds to amino acid residues L478 to H493; C-terminus.",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.22; CMGC domain target; CMGC</A> group; CDKL family","Q92772","Q92772","Q92772","Q92772","GO:0005813; GO:0005737; GO:0005634","GO:0005524; GO:0004693; GO:0004672","GO:0007548; GO:0007165"]
[452,233,"NK261-1","CDKL2","Pan-specific","Cyclin-dependent kinase-like 2; Serine/threonine protein kinase KKIAMRE",0,11006,22,821,{"v":9017.864,"d":"9018"},{"v":15845.71176259188,"d":"15846"},{"$nulls":3},0,9374,18,696,{"v":6511.776,"d":"6512"},{"v":11377.473639131762,"d":"11377"},{"$nulls":6},0,10790,22,767,{"v":8259.056,"d":"8259"},{"v":14129.934941697156,"d":"14130"},{"$nulls":7},"CDKL2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDKL",{"$nulls":6},"CLSDDSGADLPQMEHQH","Corresponds to amino acid residues L478 to H493; C-terminus.",{"$nulls":3},"Q92772","Q92772","Q92772","Q92772"]
[453,234,"NK262-1","CDKL3","Pan-specific","Cyclin-dependent kinase-like 3; Serine/threonine protein kinase NKIAMRE",0,9432,18,800,{"v":7531.2,"d":"7531"},{"v":13233.424725237814,"d":"13233"},{"v":13220.572074245574,"d":"13221"},{"v":12.852650992239433,"d":"13"},{"v":0.09721705626700623,"d":"0"},0,8684,12,693,{"v":6009.696,"d":"6010"},{"v":10500.231859817597,"d":"10500"},{"v":10361.553646652475,"d":"10362"},{"v":138.67821316512163,"d":"139"},{"v":1.338392078005837,"d":"1"},{"v":1.4356091342728432,"d":"1"},{"v":-21.625527333742454,"d":"-22"},null,0,10333,20,765,{"v":7889.445,"d":"7889"},{"v":13497.58914046568,"d":"13498"},{"v":12448.546530393447,"d":"12449"},{"v":1049.0426100722325,"d":"1049"},{"v":8.427028870486751,"d":"8"},{"v":8.524245926753757,"d":"9"},{"v":-5.839577436713768,"d":"-6"},null,null,"CDKL3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDKL",{"$nulls":6},"CANENKRKLNFSRSDRKEFH","Corresponds to amino acid residues A505 to H523; Pre-C-terminus.",{"$nulls":3},"Q8IVW4","Q8IVW4","Q8IVW4",null,"GO:0005737; GO:0005634","GO:0005524; GO:0004693; GO:0004672","GO:0006464; GO:0097484; GO:0030517; GO:0050775"]
[454,234,"NK262-1","CDKL3","Pan-specific","Cyclin-dependent kinase-like 3; Serine/threonine protein kinase NKIAMRE",0,9671,22,779,{"v":7516.571,"d":"7517"},{"v":13207.719423253335,"d":"13208"},{"$nulls":3},0,8042,16,729,{"v":5850.954,"d":"5851"},{"v":10222.875433487352,"d":"10223"},{"$nulls":6},0,8861,24,754,{"v":6663.098,"d":"6663"},{"v":11399.503920321213,"d":"11400"},{"$nulls":7},"CDKL3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDKL",{"$nulls":6},"CANENKRKLNFSRSDRKEFH","Corresponds to amino acid residues A505 to H523; Pre-C-terminus.",{"$nulls":3},"Q8IVW4","Q8IVW4","Q8IVW4"]
[455,235,"PK576","CDKL5 (STK9)","Y171","Cyclin-dependent kinase-like 5; Serine-threonine-protein kinase 9",0,8548,18,751,{"v":6406.03,"d":"6406"},{"v":11256.335748966325,"d":"11256"},{"v":11236.422003160727,"d":"11236"},{"v":19.9137458055975,"d":"20"},{"v":0.17722497250455618,"d":"0"},0,7450,15,604,{"v":4490.74,"d":"4491"},{"v":7846.288934108693,"d":"7846"},{"v":10465.003634484141,"d":"10465"},{"v":2618.714700375448,"d":"2619"},{"v":25.023543152400773,"d":"25"},{"v":25.20076812490533,"d":"25"},{"v":-6.865338169566712,"d":"-7"},null,0,8304,16,744,{"v":6166.272,"d":"6166"},{"v":10549.513430204228,"d":"10550"},{"v":10487.35171872393,"d":"10487"},{"v":62.16171148029753,"d":"62"},{"v":0.5927303016767819,"d":"1"},{"v":0.769955274181338,"d":"1"},{"v":-6.666448485346038,"d":"-7"},null,null,"CDKL5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDKL",{"$nulls":6},"YTE(pY)VAT(bA)C","Corresponds to amino acid residues Y168 to T174; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y171 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation site in CDKL5 (≥548 reports from high throughput mass spectrometry studies).","CDKL5 (STK9)","EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDKL family","O76039","O76039","O76039",null,"GO:0005813; GO:0036064; GO:0097542; GO:0005829; GO:0032839; GO:0044294; GO:0098978; GO:0005654; GO:0005634; GO:0048471; GO:0099092; GO:0032587","GO:0005524; GO:0016301; GO:0004672; GO:0004674; GO:0048365","GO:0001764; GO:0045773; GO:0050775; GO:0060999; GO:0043547; GO:0046777; GO:0006468; GO:0051726; GO:1902017; GO:0050773; GO:0099175"]
[456,235,"PK576","CDKL5 (STK9)","Y171","Cyclin-dependent kinase-like 5; Serine-threonine-protein kinase 9",0,8484,18,754,{"v":6383.364,"d":"6383"},{"v":11216.50825735513,"d":"11217"},{"$nulls":3},0,8864,23,847,{"v":7488.327,"d":"7488"},{"v":13083.718334859588,"d":"13084"},{"$nulls":6},0,8686,18,703,{"v":6093.604,"d":"6094"},{"v":10425.190007243631,"d":"10425"},{"$nulls":7},"CDKL5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDKL",{"$nulls":6},"YTE(pY)VAT(bA)C","Corresponds to amino acid residues Y168 to T174; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y171 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation site in CDKL5 (≥548 reports from high throughput mass spectrometry studies).","CDKL5 (STK9)",null,"O76039","O76039","O76039"]
[457,255,"PN019","CFL1","S3","Cofilin 1",0,436,10,300,{"v":127.8,"d":"128"},{"v":224.56337368352888,"d":"225"},{"v":201.09491970139106,"d":"201"},{"v":23.468453982137817,"d":"23"},{"v":11.6703365838314,"d":"12"},0,558,10,262,{"v":143.576,"d":"144"},{"v":250.85816146193937,"d":"251"},{"v":246.62990081435277,"d":"247"},{"v":4.228260647586609,"d":"4"},{"v":1.7144152568789188,"d":"2"},{"v":13.384751840710319,"d":"13"},{"v":22.643526340982305,"d":"23"},null,0,426,14,413,{"v":170.156,"d":"170"},{"v":291.10992950519056,"d":"291"},{"v":232.58204516157315,"d":"233"},{"v":58.527884343617416,"d":"59"},{"v":25.164403513159623,"d":"25"},{"v":36.83474009699103,"d":"37"},{"v":15.657842329849899,"d":"16"},{"$nulls":15},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S3 phosphosite.","S3 phosphorylation inhibits activity and induces interaction with 14-3-3 zeta, although one report indicates stimulation of activity. This is one of the major in vivo phosphorylation sites in cofilin 1 (≥67 reports from high throughput mass spectrometry studies).","ILK; LIMK1; LIMK2; PKD1 (PRKCM; PRKD1); TESK1; TESK2","Intracellular, Nuclear matrix, Cortical actin cytoskeleton, Cytoplasm, Nucleus, Cytoskeleton protein","P23528","P23528",null,null,"GO:0005911; GO:0030864; GO:0005737; GO:0005829; GO:0070062; GO:0005615; GO:0005925; GO:0030027; GO:0031258; GO:0016020; GO:0016363; GO:0005634; GO:0032587; GO:0031982","GO:0051015; GO:0005102","GO:0030036; GO:0030042; GO:0030043; GO:0007010; GO:0030010; GO:0035722; GO:0000281; GO:0043066; GO:0001755; GO:0001842; GO:0044794; GO:0030836; GO:0006468; GO:0022604; GO:0061001; GO:0043200; GO:0009615; GO:0007266"]
[458,255,"PN019","CFL1","S3","Cofilin 1",0,334,10,312,{"v":101.088,"d":"101"},{"v":177.62646571925325,"d":"178"},{"$nulls":3},0,472,8,299,{"v":138.736,"d":"139"},{"v":242.40164016676619,"d":"242"},{"$nulls":6},0,326,12,324,{"v":101.736,"d":"102"},{"v":174.0541608179557,"d":"174"},{"$nulls":20},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S3 phosphosite.","S3 phosphorylation inhibits activity and induces interaction with 14-3-3 zeta, although one report indicates stimulation of activity. This is one of the major in vivo phosphorylation sites in cofilin 1 (≥67 reports from high throughput mass spectrometry studies).","ILK; LIMK1; LIMK2; PKD1 (PRKCM; PRKD1); TESK1; TESK2",null,"P23528","P23528"]
[459,256,"PN220","CFL1","S3","Cofilin 1",0,464,14,521,{"v":234.45,"d":"234"},{"v":411.9630904546427,"d":"412"},{"v":386.5811034995678,"d":"387"},{"v":25.38198695507492,"d":"25"},{"v":6.565759869093886,"d":"7"},0,376,16,457,{"v":164.52,"d":"165"},{"v":287.45183543014343,"d":"287"},{"v":294.30790765375076,"d":"294"},{"v":6.8560722236073275,"d":"7"},{"v":2.329557597777292,"d":"2"},{"v":8.895317466871177,"d":"9"},{"v":-23.869039384104354,"d":"-24"},null,0,664,20,634,{"v":408.296,"d":"408"},{"v":698.5297008465836,"d":"699"},{"v":567.2739485273106,"d":"567"},{"v":131.25575231927303,"d":"131"},{"v":23.13798344874177,"d":"23"},{"v":29.703743317835656,"d":"30"},{"v":46.741251290350476,"d":"47"},{"$nulls":15},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S3 phosphosite.","S3 phosphorylation inhibits activity and induces interaction with 14-3-3 zeta, although one report indicates stimulation of activity. This is one of the major in vivo phosphorylation sites in cofilin 1 (≥67 reports from high throughput mass spectrometry studies).","ILK; LIMK1; LIMK2; PKD1 (PRKCM; PRKD1); TESK1; TESK2","Intracellular, Nuclear matrix, Cortical actin cytoskeleton, Cytoplasm, Nucleus, Cytoskeleton protein","P23528","P23528",null,null,"GO:0005911; GO:0030864; GO:0005737; GO:0005829; GO:0070062; GO:0005615; GO:0005925; GO:0030027; GO:0031258; GO:0016020; GO:0016363; GO:0005634; GO:0032587; GO:0031982","GO:0051015; GO:0005102","GO:0030036; GO:0030042; GO:0030043; GO:0007010; GO:0030010; GO:0035722; GO:0000281; GO:0043066; GO:0001755; GO:0001842; GO:0044794; GO:0030836; GO:0006468; GO:0022604; GO:0061001; GO:0043200; GO:0009615; GO:0007266"]
[460,256,"PN220","CFL1","S3","Cofilin 1",0,372,12,571,{"v":205.56,"d":"206"},{"v":361.19911654449294,"d":"361"},{"$nulls":3},0,358,16,504,{"v":172.368,"d":"172"},{"v":301.1639798773581,"d":"301"},{"$nulls":6},0,460,16,574,{"v":254.856,"d":"255"},{"v":436.01819620803764,"d":"436"},{"$nulls":20},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S3 phosphosite.","S3 phosphorylation inhibits activity and induces interaction with 14-3-3 zeta, although one report indicates stimulation of activity. This is one of the major in vivo phosphorylation sites in cofilin 1 (≥67 reports from high throughput mass spectrometry studies).","ILK; LIMK1; LIMK2; PKD1 (PRKCM; PRKD1); TESK1; TESK2",null,"P23528","P23528"]
[461,236,"NK034-2","Chk1 (CHEK1)","Pan-specific","Checkpoint protein-serine kinase 1",0,458,10,682,{"v":305.536,"d":"306"},{"v":536.8716349121337,"d":"537"},{"v":511.11888996138407,"d":"511"},{"v":25.752744950749616,"d":"26"},{"v":5.038503850385041,"d":"5"},0,465,10,615,{"v":279.825,"d":"280"},{"v":488.9144775664957,"d":"489"},{"v":492.77145499606075,"d":"493"},{"v":3.856977429565063,"d":"4"},{"v":0.782711212360281,"d":"1"},{"v":5.821215062745322,"d":"6"},{"v":-3.589660903886667,"d":"-4"},null,0,474,12,635,{"v":293.37,"d":"293"},{"v":501.9095419434975,"d":"502"},{"v":492.26895064632464,"d":"492"},{"v":9.640591297172875,"d":"10"},{"v":1.9583992215058978,"d":"2"},{"v":6.996903071890939,"d":"7"},{"v":-3.68797547601568,"d":"-4"},null,null,"CHK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","CHK1",{"$nulls":5},"Epitope undefined.",{"$nulls":3},"Protein-serine kinase, CAMK group, CAMKL family, CHK1 subfamily","O14757","O14757","O14757","O14757","GO:0005813; GO:0000785; GO:0000794; GO:0005737; GO:0005829; GO:0005615; GO:0043231; GO:0005654; GO:0005634; GO:0032991","GO:0005524; GO:0035402; GO:0016301; GO:0019904; GO:0004672; GO:0004674","GO:0006915; GO:0007049; GO:0006974; GO:0071260; GO:0048096; GO:0000077; GO:0006975; GO:0006281; GO:0006260; GO:0035556; GO:0070317; GO:0045839; GO:0018107; GO:0045787; GO:0010569; GO:2000615; GO:0046602; GO:1901796; GO:0010767; GO:0090399; GO:0072425"]
[462,236,"NK034-2","Chk1 (CHEK1)","Pan-specific","Checkpoint protein-serine kinase 1",0,428,12,664,{"v":276.224,"d":"276"},{"v":485.3661450106344,"d":"485"},{"$nulls":3},0,434,16,680,{"v":284.24,"d":"284"},{"v":496.6284324256258,"d":"497"},{"$nulls":6},0,446,12,650,{"v":282.1,"d":"282"},{"v":482.62835934915176,"d":"483"},{"$nulls":7},"CHK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","CHK1",{"$nulls":5},"Epitope undefined.",{"$nulls":4},"O14757","O14757","O14757","O14757"]
[463,237,"NK034","Chk1 (CHEK1)","Pan-specific","Checkpoint protein-serine kinase 1",0,1012,12,723,723,{"v":1270.4172079279451,"d":"1270"},{"v":1247.9960134975709,"d":"1248"},{"v":22.42119443037427,"d":"22"},{"v":1.7965758053615701,"d":"2"},0,1052,14,573,{"v":594.774,"d":"595"},{"v":1039.1981398378805,"d":"1039"},{"v":1107.522988029564,"d":"1108"},{"v":68.32484819168349,"d":"68"},{"v":6.169158467152253,"d":"6"},{"v":7.965734272513823,"d":"8"},{"v":-11.255887354505589,"d":"-11"},null,0,1276,14,694,{"v":875.828,"d":"876"},{"v":1498.4028029494818,"d":"1498"},{"v":1356.837520345069,"d":"1357"},{"v":141.56528260441291,"d":"142"},{"v":10.433473461760569,"d":"10"},{"v":12.230049267122139,"d":"12"},{"v":8.721302445707678,"d":"9"},null,null,"CHK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","CHK1",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues 1-476 representing full length human Chk1.",null,null,"Protein-serine kinase, CAMK group, CAMKL family, CHK1 subfamily","O14757","O14757","O14757","O14757","GO:0005813; GO:0000785; GO:0000794; GO:0005737; GO:0005829; GO:0005615; GO:0043231; GO:0005654; GO:0005634; GO:0032991","GO:0005524; GO:0035402; GO:0016301; GO:0019904; GO:0004672; GO:0004674","GO:0006915; GO:0007049; GO:0006974; GO:0071260; GO:0048096; GO:0000077; GO:0006975; GO:0006281; GO:0006260; GO:0035556; GO:0070317; GO:0045839; GO:0018107; GO:0045787; GO:0010569; GO:2000615; GO:0046602; GO:1901796; GO:0010767; GO:0090399; GO:0072425"]
[464,237,"NK034","Chk1 (CHEK1)","Pan-specific","Checkpoint protein-serine kinase 1",0,954,14,742,{"v":697.48,"d":"697"},{"v":1225.5748190671966,"d":"1226"},{"$nulls":3},0,954,18,719,{"v":672.984,"d":"673"},{"v":1175.8478362212475,"d":"1176"},{"$nulls":6},0,1026,17,704,{"v":710.336,"d":"710"},{"v":1215.272237740656,"d":"1215"},{"$nulls":7},"CHK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","CHK1",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues 1-476 representing full length human Chk1.",{"$nulls":3},"O14757","O14757","O14757","O14757"]
[465,238,"PK577","Chk1 (CHEK1)","S280","Checkpoint protein-serine kinase 1",0,7520,16,806,{"v":6048.224,"d":"6048"},{"v":10627.618045647008,"d":"10628"},{"v":10437.106421717886,"d":"10437"},{"v":190.51162392912192,"d":"191"},{"v":1.8253298973046672,"d":"2"},0,8589,22,757,{"v":6485.219,"d":"6485"},{"v":11331.072846562358,"d":"11331"},{"v":11360.289778194152,"d":"11360"},{"v":29.21693163179407,"d":"29"},{"v":0.25718473914173723,"d":"0"},{"v":2.0825146364464047,"d":"2"},{"v":8.84520401703746,"d":"9"},null,0,8380,16,748,{"v":6256.272,"d":"6256"},{"v":10703.489156334761,"d":"10703"},{"v":10416.006210600644,"d":"10416"},{"v":287.4829457341166,"d":"287"},{"v":2.760011274201599,"d":"3"},{"v":4.585341171506267,"d":"5"},{"v":-0.20216533457335117,"d":"-0"},null,null,"CHK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","CHK1",{"$nulls":5},"RVT(pS)GGV(bA)C","Corresponds to amino acid residues R277 to V283; After the kinase catalytic domain in the second half of the kinase.","S280 phosphorylation inhibits phosphotransferase activity. Phosphorylation regulates cell cycle progression, intracellular location, protein degradation, and molecular association. This is the major in vivo phosphorylation site in Chk1 (≥168 reports from high throughput mass spectrometry studies).","Akt1 (PKBa); RSK1","Protein-serine kinase, CAMK group, CAMKL family, CHK1 subfamily","O14757","O14757","O14757","O14757","GO:0005813; GO:0000785; GO:0000794; GO:0005737; GO:0005829; GO:0005615; GO:0043231; GO:0005654; GO:0005634; GO:0032991","GO:0005524; GO:0035402; GO:0016301; GO:0019904; GO:0004672; GO:0004674","GO:0006915; GO:0007049; GO:0006974; GO:0071260; GO:0048096; GO:0000077; GO:0006975; GO:0006281; GO:0006260; GO:0035556; GO:0070317; GO:0045839; GO:0018107; GO:0045787; GO:0010569; GO:2000615; GO:0046602; GO:1901796; GO:0010767; GO:0090399; GO:0072425"]
[466,238,"PK577","Chk1 (CHEK1)","S280","Checkpoint protein-serine kinase 1",0,7246,20,807,{"v":5831.382,"d":"5831"},{"v":10246.594797788763,"d":"10247"},{"$nulls":3},0,8198,19,797,{"v":6518.663,"d":"6519"},{"v":11389.506709825946,"d":"11390"},{"$nulls":6},0,7820,20,759,{"v":5920.2,"d":"5920"},{"v":10128.52326486653,"d":"10129"},{"$nulls":7},"CHK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","CHK1",{"$nulls":5},"RVT(pS)GGV(bA)C","Corresponds to amino acid residues R277 to V283; After the kinase catalytic domain in the second half of the kinase.","S280 phosphorylation inhibits phosphotransferase activity. Phosphorylation regulates cell cycle progression, intracellular location, protein degradation, and molecular association. This is the major in vivo phosphorylation site in Chk1 (≥168 reports from high throughput mass spectrometry studies).","Akt1 (PKBa); RSK1",null,"O14757","O14757","O14757","O14757"]
[467,239,"PK578","Chk1 (CHEK1)","S317","Checkpoint protein-serine kinase 1",0,6192,20,851,{"v":5252.372,"d":"5252"},{"v":9229.18917183806,"d":"9229"},{"v":8956.71015936755,"d":"8957"},{"v":272.4790124705087,"d":"272"},{"v":3.0421774024420247,"d":"3"},0,5856,24,800,{"v":4665.6,"d":"4666"},{"v":8151.80697412398,"d":"8152"},{"v":8985.442631490978,"d":"8985"},{"v":833.6356573669982,"d":"834"},{"v":9.27762483781693,"d":"9"},{"v":12.319802240258955,"d":"12"},{"v":0.32079269745462113,"d":"0"},null,0,6736,20,800,{"v":5372.8,"d":"5373"},{"v":9192.008681712594,"d":"9192"},{"v":9084.77998603529,"d":"9085"},{"v":107.22869567730413,"d":"107"},{"v":1.1803114202229574,"d":"1"},{"v":4.222488822664982,"d":"4"},{"v":1.4298757511293871,"d":"1"},null,null,"CHK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","CHK1",{"$nulls":5},"YSS(pS)QPE(bA)C","Corresponds to amino acid residues Y314 to E320; In the C-terminal half of the kinase after the catalytic domain.","S317 phosphorylation stimulates phosphotransferase activity. Phosphorylation regulates cell cycle progression and induces interaction with claspin. This is one of the major in vivo phosphorylation sites in Chk1 (≥26 reports from high throughput mass spectrometry studies).","ATM, ATR","Protein-serine kinase, CAMK group, CAMKL family, CHK1 subfamily","O14757","O14757","O14757","O14757","GO:0005813; GO:0000785; GO:0000794; GO:0005737; GO:0005829; GO:0005615; GO:0043231; GO:0005654; GO:0005634; GO:0032991","GO:0005524; GO:0035402; GO:0016301; GO:0019904; GO:0004672; GO:0004674","GO:0006915; GO:0007049; GO:0006974; GO:0071260; GO:0048096; GO:0000077; GO:0006975; GO:0006281; GO:0006260; GO:0035556; GO:0070317; GO:0045839; GO:0018107; GO:0045787; GO:0010569; GO:2000615; GO:0046602; GO:1901796; GO:0010767; GO:0090399; GO:0072425"]
[468,239,"PK578","Chk1 (CHEK1)","S317","Checkpoint protein-serine kinase 1",0,6108,14,811,{"v":4942.234,"d":"4942"},{"v":8684.23114689704,"d":"8684"},{"$nulls":3},0,6666,31,847,{"v":5619.845,"d":"5620"},{"v":9819.078288857976,"d":"9819"},{"$nulls":6},0,6404,28,823,{"v":5247.448,"d":"5247"},{"v":8977.551290357986,"d":"8978"},{"$nulls":7},"CHK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","CHK1",{"$nulls":5},"YSS(pS)QPE(bA)C","Corresponds to amino acid residues Y314 to E320; In the C-terminal half of the kinase after the catalytic domain.","S317 phosphorylation stimulates phosphotransferase activity. Phosphorylation regulates cell cycle progression and induces interaction with claspin. This is one of the major in vivo phosphorylation sites in Chk1 (≥26 reports from high throughput mass spectrometry studies).","ATM, ATR",null,"O14757","O14757","O14757","O14757"]
[469,240,"PK579","Chk1 (CHEK1)","S345","Checkpoint protein-serine kinase 1",0,3390,20,783,{"v":2638.71,"d":"2639"},{"v":4636.601093681255,"d":"4637"},{"v":4357.478308785883,"d":"4357"},{"v":279.1227848953722,"d":"279"},{"v":6.405603542135445,"d":"6"},0,3187,18,703,{"v":2227.807,"d":"2228"},{"v":3892.458127486758,"d":"3892"},{"v":4124.132740279203,"d":"4124"},{"v":231.67461279244526,"d":"232"},{"v":5.617535306993076,"d":"6"},{"v":12.023138849128522,"d":"12"},{"v":-5.355059783916559,"d":"-5"},null,0,3696,18,793,{"v":2916.654,"d":"2917"},{"v":4989.932416905852,"d":"4990"},{"v":4775.733362602863,"d":"4776"},{"v":214.19905430298877,"d":"214"},{"v":4.48515522202953,"d":"4"},{"v":10.890758764164975,"d":"11"},{"v":9.59855733472412,"d":"10"},null,null,"CHK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","CHK1",{"$nulls":5},"ISF(pS)QPT(bA)C","Corresponds to amino acid residues I342 to T348; In the C-terminal half of the kinase after the catalytic domain.","S345 phosphorylation stimulates phosphotransferase activity. Phosphorylation regulates apoptosis, cell cycle progression, intracellular location, and protein degradation. It induces binding to 14-3-3-sigma, claspin, p21Cip1 and p53. This is one of the major in vivo phosphorylation sites in Chk1 (≥13 reports from high throughput mass spectrometry studies).","ATM, ATR; COT (MAP3K8)","Protein-serine kinase, CAMK group, CAMKL family, CHK1 subfamily","O14757","O14757","O14757","O14757","GO:0005813; GO:0000785; GO:0000794; GO:0005737; GO:0005829; GO:0005615; GO:0043231; GO:0005654; GO:0005634; GO:0032991","GO:0005524; GO:0035402; GO:0016301; GO:0019904; GO:0004672; GO:0004674","GO:0006915; GO:0007049; GO:0006974; GO:0071260; GO:0048096; GO:0000077; GO:0006975; GO:0006281; GO:0006260; GO:0035556; GO:0070317; GO:0045839; GO:0018107; GO:0045787; GO:0010569; GO:2000615; GO:0046602; GO:1901796; GO:0010767; GO:0090399; GO:0072425"]
[470,240,"PK579","Chk1 (CHEK1)","S345","Checkpoint protein-serine kinase 1",0,3050,16,765,{"v":2321.01,"d":"2321"},{"v":4078.355523890512,"d":"4078"},{"$nulls":3},0,3014,14,831,2493,{"v":4355.807353071647,"d":"4356"},{"$nulls":6},0,3372,14,794,{"v":2666.252,"d":"2666"},{"v":4561.534308299874,"d":"4562"},{"$nulls":7},"CHK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","CHK1",{"$nulls":5},"ISF(pS)QPT(bA)C","Corresponds to amino acid residues I342 to T348; In the C-terminal half of the kinase after the catalytic domain.","S345 phosphorylation stimulates phosphotransferase activity. Phosphorylation regulates apoptosis, cell cycle progression, intracellular location, and protein degradation. It induces binding to 14-3-3-sigma, claspin, p21Cip1 and p53. This is one of the major in vivo phosphorylation sites in Chk1 (≥13 reports from high throughput mass spectrometry studies).","ATM, ATR; COT (MAP3K8)",null,"O14757","O14757","O14757","O14757"]
[471,241,"NK035","Chk2 (CHEK2)","Pan-specific","Checkpoint protein-serine kinase 2",0,796,16,760,{"v":592.8,"d":"593"},{"v":1041.6366816869788,"d":"1042"},{"v":918.4325697214522,"d":"918"},{"v":123.20411196552664,"d":"123"},{"v":13.414606148265488,"d":"13"},0,750,14,664,{"v":488.704,"d":"489"},{"v":853.8710295529589,"d":"854"},{"v":862.8534626063649,"d":"863"},{"v":8.982433053405998,"d":"9"},{"v":1.0410148933369694,"d":"1"},{"v":14.455621041602457,"d":"14"},{"v":-6.051517438231059,"d":"-6"},null,0,889,12,711,{"v":623.547,"d":"624"},{"v":1066.7900233501791,"d":"1067"},{"v":989.902244506897,"d":"990"},{"v":76.88777884328215,"d":"77"},{"v":7.767209264343318,"d":"8"},{"v":21.181815412608806,"d":"21"},{"v":7.781700817417715,"d":"8"},null,null,"CHK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","RAD53",{"$nulls":6},"Epitope undefined.",{"$nulls":3},"Protein-serine kinase, CAMK group, RAD53 family","O96017","O96017","O96017","O96017","GO:0005794; GO:0005654; GO:0016605","GO:0005524; GO:0042802; GO:0016301; GO:0046872; GO:0042803; GO:0019901; GO:0004674; GO:0031625","GO:0051301; GO:0044257; GO:1903926; GO:0006974; GO:0071480; GO:0000077; GO:0006975; GO:0006977; GO:0006978; GO:0006302; GO:0000086; GO:0008630; GO:0042771; GO:0090307; GO:0071157; GO:2000002; GO:0018105; GO:0018107; GO:2000210; GO:0001934; GO:0045893; GO:0046777; GO:0006468; GO:0050821; GO:0042981; GO:0042176; GO:1901796; GO:0006355; GO:0001302; GO:0090399; GO:1903416; GO:0042770; GO:0072428; GO:0006351"]
[472,241,"NK035","Chk2 (CHEK2)","Pan-specific","Checkpoint protein-serine kinase 2",0,707,15,654,{"v":452.568,"d":"453"},{"v":795.2284577559255,"d":"795"},{"$nulls":3},0,712,18,719,{"v":498.986,"d":"499"},{"v":871.835895659771,"d":"872"},{"$nulls":6},0,832,16,654,{"v":533.664,"d":"534"},{"v":913.0144656636147,"d":"913"},{"$nulls":7},"CHK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","RAD53",{"$nulls":6},"Epitope undefined.",{"$nulls":4},"O96017","O96017","O96017","O96017"]
[473,242,"NK035-2","Chk2 (CHEK2)","Pan-specific","Checkpoint protein-serine kinase 2",0,136,12,634,{"v":78.616,"d":"79"},{"v":138.13986060644996,"d":"138"},{"v":133.12847765069546,"d":"133"},{"v":5.011382955754499,"d":"5"},{"v":3.764320785597385,"d":"4"},0,352,18,705,{"v":235.47,"d":"235"},{"v":411.41674987075044,"d":"411"},{"v":278.16888137203284,"d":"278"},{"v":133.2478684987176,"d":"133"},{"v":47.90178823795434,"d":"48"},{"v":51.666109023551726,"d":"52"},{"v":108.94769194454145,"d":"109"},null,0,176,16,639,{"v":102.24,"d":"102"},{"v":174.91642488428667,"d":"175"},{"v":154.90642385292307,"d":"155"},{"v":20.0100010313636,"d":"20"},{"v":12.917476585969236,"d":"13"},{"v":16.68179737156662,"d":"17"},{"v":16.35859328262501,"d":"16"},null,null,"CHK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","RAD53",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 1-300 of human Chk2.",null,null,"Protein-serine kinase, CAMK group, RAD53 family","O96017","O96017","O96017","O96017","GO:0005794; GO:0005654; GO:0016605","GO:0005524; GO:0042802; GO:0016301; GO:0046872; GO:0042803; GO:0019901; GO:0004674; GO:0031625","GO:0051301; GO:0044257; GO:1903926; GO:0006974; GO:0071480; GO:0000077; GO:0006975; GO:0006977; GO:0006978; GO:0006302; GO:0000086; GO:0008630; GO:0042771; GO:0090307; GO:0071157; GO:2000002; GO:0018105; GO:0018107; GO:2000210; GO:0001934; GO:0045893; GO:0046777; GO:0006468; GO:0050821; GO:0042981; GO:0042176; GO:1901796; GO:0006355; GO:0001302; GO:0090399; GO:1903416; GO:0042770; GO:0072428; GO:0006351"]
[474,242,"NK035-2","Chk2 (CHEK2)","Pan-specific","Checkpoint protein-serine kinase 2",0,124,12,651,{"v":72.912,"d":"73"},{"v":128.117094694941,"d":"128"},{"$nulls":3},0,142,14,648,{"v":82.944,"d":"83"},{"v":144.9210128733152,"d":"145"},{"$nulls":6},0,144,16,616,{"v":78.848,"d":"79"},{"v":134.89642282155944,"d":"135"},{"$nulls":7},"CHK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","RAD53",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 1-300 of human Chk2.",{"$nulls":3},"O96017","O96017","O96017","O96017"]
[475,243,"PK581","Chk2 (CHEK2)","T68","Checkpoint protein-serine kinase 2",0,9128,24,837,{"v":7620.048,"d":"7620"},{"v":13389.543712914137,"d":"13390"},{"v":13682.116578747386,"d":"13682"},{"v":292.5728658332482,"d":"293"},{"v":2.1383596912754386,"d":"2"},0,9230,30,844,{"v":7764.8,"d":"7765"},{"v":13566.776147264634,"d":"13567"},{"v":14470.016487916026,"d":"14470"},{"v":903.2403406513913,"d":"903"},{"v":6.242151426749868,"d":"6"},{"v":8.380511118025307,"d":"8"},{"v":5.758611283816251,"d":"6"},null,0,9587,36,794,{"v":7583.494,"d":"7583"},{"v":12974.155502850535,"d":"12974"},{"v":13404.622018710867,"d":"13405"},{"v":430.4665158603311,"d":"430"},{"v":3.211329012182989,"d":"3"},{"v":5.349688703458428,"d":"5"},{"v":-2.028155208584863,"d":"-2"},null,null,"CHK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","RAD53",{"$nulls":6},"TVS(pT)QEL(bA)C","Corresponds to amino acid residues T65 to L71; In the N-terminal portion of the kinase before the FHA domain.","T68 phosphorylation stimulates phosphotransferase activity, and induces interactions with Chk2, MDC1, NBS1 and Plk1. This is one of the minor in vivo phosphorylation sites in Chk2 (≥3 reports from high throughput mass spectrometry studies).","ATM; ATR; Chk2 (CHEK2); DNAPK (PRKDC); Plk1 (PLK); TTK; ZAK (MLTK)","Protein-serine kinase, CAMK group, RAD53 family","O96017","O96017","O96017","O96017","GO:0005794; GO:0005654; GO:0016605","GO:0005524; GO:0042802; GO:0016301; GO:0046872; GO:0042803; GO:0019901; GO:0004674; GO:0031625","GO:0051301; GO:0044257; GO:1903926; GO:0006974; GO:0071480; GO:0000077; GO:0006975; GO:0006977; GO:0006978; GO:0006302; GO:0000086; GO:0008630; GO:0042771; GO:0090307; GO:0071157; GO:2000002; GO:0018105; GO:0018107; GO:2000210; GO:0001934; GO:0045893; GO:0046777; GO:0006468; GO:0050821; GO:0042981; GO:0042176; GO:1901796; GO:0006355; GO:0001302; GO:0090399; GO:1903416; GO:0042770; GO:0072428; GO:0006351"]
[476,243,"PK581","Chk2 (CHEK2)","T68","Checkpoint protein-serine kinase 2",0,9257,20,861,{"v":7953.057,"d":"7953"},{"v":13974.689444580634,"d":"13975"},{"$nulls":3},0,9850,30,896,{"v":8798.72,"d":"8799"},{"v":15373.256828567415,"d":"15373"},{"$nulls":6},0,9106,30,891,{"v":8086.716,"d":"8087"},{"v":13835.088534571198,"d":"13835"},{"$nulls":7},"CHK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","RAD53",{"$nulls":6},"TVS(pT)QEL(bA)C","Corresponds to amino acid residues T65 to L71; In the N-terminal portion of the kinase before the FHA domain.","T68 phosphorylation stimulates phosphotransferase activity, and induces interactions with Chk2, MDC1, NBS1 and Plk1. This is one of the minor in vivo phosphorylation sites in Chk2 (≥3 reports from high throughput mass spectrometry studies).","ATM; ATR; Chk2 (CHEK2); DNAPK (PRKDC); Plk1 (PLK); TTK; ZAK (MLTK)",null,"O96017","O96017","O96017","O96017"]
[477,244,"PK580","Chk2 (CHEK2)","T383","Checkpoint protein-serine kinase 2",0,9076,18,813,{"v":7364.154,"d":"7364"},{"v":12939.900364358795,"d":"12940"},{"v":12663.845557948958,"d":"12664"},{"v":276.0548064098366,"d":"276"},{"v":2.1798655483172724,"d":"2"},0,9322,18,749,{"v":6968.696,"d":"6969"},{"v":12175.811182559559,"d":"12176"},{"v":13555.557278827378,"d":"13556"},{"v":1379.7460962678197,"d":"1380"},{"v":10.178453514580807,"d":"10"},{"v":12.35831906289808,"d":"12"},{"v":7.041397629164095,"d":"7"},null,0,10243,54,578,{"v":5889.242,"d":"5889"},{"v":10075.559036760429,"d":"10076"},{"v":11831.52216933266,"d":"11832"},{"v":1755.9631325722312,"d":"1756"},{"v":14.841396630466472,"d":"15"},{"v":17.021262178783743,"d":"17"},{"v":-6.572437928176228,"d":"-7"},null,null,"CHK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","RAD53",{"$nulls":6},"LMR(pT)LCG(bA)C","Corresponds to amino acid residues L380 to G386; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T383 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in XXX.","Chk2 (CHEK2); DNAPK (PRKDC)","Protein-serine kinase, CAMK group, RAD53 family","O96017","O96017","O96017","O96017","GO:0005794; GO:0005654; GO:0016605","GO:0005524; GO:0042802; GO:0016301; GO:0046872; GO:0042803; GO:0019901; GO:0004674; GO:0031625","GO:0051301; GO:0044257; GO:1903926; GO:0006974; GO:0071480; GO:0000077; GO:0006975; GO:0006977; GO:0006978; GO:0006302; GO:0000086; GO:0008630; GO:0042771; GO:0090307; GO:0071157; GO:2000002; GO:0018105; GO:0018107; GO:2000210; GO:0001934; GO:0045893; GO:0046777; GO:0006468; GO:0050821; GO:0042981; GO:0042176; GO:1901796; GO:0006355; GO:0001302; GO:0090399; GO:1903416; GO:0042770; GO:0072428; GO:0006351"]
[478,244,"PK580","Chk2 (CHEK2)","T383","Checkpoint protein-serine kinase 2",0,8978,20,787,{"v":7049.946,"d":"7050"},{"v":12387.790751539122,"d":"12388"},{"$nulls":3},0,9539,20,898,{"v":8548.062,"d":"8548"},{"v":14935.3033750952,"d":"14935"},{"$nulls":6},0,9635,20,826,{"v":7941.99,"d":"7942"},{"v":13587.48530190489,"d":"13587"},{"$nulls":7},"CHK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","RAD53",{"$nulls":6},"LMR(pT)LCG(bA)C","Corresponds to amino acid residues L380 to G386; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T383 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in XXX.","Chk2 (CHEK2); DNAPK (PRKDC)",null,"O96017","O96017","O96017","O96017"]
[479,849,"PN249","Cip (WAF1; p21) p21(WAF1/CIP1)","T145","Cyclin-dependent kinase inhibitor 1",0,42,6,652,{"v":23.472,"d":"23"},{"v":41.243752011735445,"d":"41"},{"v":83.73156402791484,"d":"84"},{"v":42.4878120161794,"d":"42"},{"v":50.74288592294132,"d":"51"},0,108,8,340,34,{"v":59.405314883448064,"d":"59"},{"v":64.61201601146793,"d":"65"},{"v":5.206701128019866,"d":"5"},{"v":8.058409951325048,"d":"8"},{"v":58.801295874266366,"d":"59"},{"v":-22.834337610214405,"d":"-23"},null,0,127,10,368,{"v":43.056,"d":"43"},{"v":73.66198738084748,"d":"74"},{"v":86.17593681175629,"d":"86"},{"v":12.51394943090881,"d":"13"},{"v":14.52139645228856,"d":"15"},{"v":65.26428237522988,"d":"65"},{"v":2.919296697988983,"d":"3"},{"$nulls":15},"Not precisely defined.","Antibody raised against amino acid residues 140-149 with phospho-T145 of human p21.","T145 phosphorylation -reduces binding to PCNA, CDK2 and CDK4. This is one of the major in vivo phosphorylation sites in Cip.","Akt1 (PKBa); Akt3 (PKBg); DAPK3 (ZIPK); Pim1","Inhibitor protein","P38936","P38936",null,"P38936","GO:0000307; GO:0005829; GO:0016604; GO:0005730; GO:0005654; GO:0005634; GO:0070557; GO:0048471; GO:0032991","GO:0030332; GO:0019912; GO:0004693; GO:0004861; GO:0046872; GO:0044877; GO:0019901; GO:0004860; GO:0031625","GO:0031100; GO:0007050; GO:0034198; GO:0006974; GO:0031668; GO:0071480; GO:0034605; GO:0071479; GO:0071493; GO:0090398; GO:0019221; GO:0006977; GO:0006978; GO:0000082; GO:0000086; GO:0060574; GO:0097193; GO:0042771; GO:0071850; GO:0043066; GO:0030308; GO:0008285; GO:1904030; GO:0045736; GO:2000134; GO:0010629; GO:0042326; GO:1904706; GO:0030890; GO:0048146; GO:0043068; GO:0045860; GO:2000379; GO:0050821; GO:0007265; GO:0000079; GO:2000278; GO:0033158; GO:0006357; GO:0090399; GO:0046685; GO:0051412; GO:0042493; GO:0055093; GO:0010243; GO:0009636; GO:0010165; GO:0090400; GO:0006367"]
[480,849,"PN249","Cip (WAF1; p21) p21(WAF1/CIP1)","T145","Cyclin-dependent kinase inhibitor 1",0,156,10,492,{"v":71.832,"d":"72"},{"v":126.21937604409425,"d":"126"},{"$nulls":3},0,128,8,333,{"v":39.96,"d":"40"},{"v":69.81871713948779,"d":"70"},{"$nulls":6},0,147,8,415,{"v":57.685,"d":"58"},{"v":98.68988624266508,"d":"99"},{"$nulls":20},"Not precisely defined.","Antibody raised against amino acid residues 140-149 with phospho-T145 of human p21.","T145 phosphorylation -reduces binding to PCNA, CDK2 and CDK4. This is one of the major in vivo phosphorylation sites in Cip.","Akt1 (PKBa); Akt3 (PKBg); DAPK3 (ZIPK); Pim1",null,"P38936","P38936",null,"P38936"]
[481,850,"PN248","Cip (WAF1; p21) p21(WAF1/CIP1)","S146","Cyclin-dependent kinase inhibitor 1",0,24,8,657,{"v":10.512,"d":"11"},{"v":18.47112820157477,"d":"18"},{"v":58.54110608482353,"d":"59"},{"v":40.06997788324876,"d":"40"},{"v":68.44759274822907,"d":"68"},0,28,6,656,{"v":14.432,"d":"14"},{"v":25.215808952880074,"d":"25"},{"v":27.68986559626132,"d":"28"},{"v":2.474056643381246,"d":"2"},{"v":8.934881373043908,"d":"9"},{"v":77.38247412127298,"d":"77"},{"v":-52.70013252544306,"d":"-53"},null,0,26,6,658,{"v":13.16,"d":"13"},{"v":22.51467284308698,"d":"23"},{"v":39.588870029561754,"d":"40"},{"v":17.074197186474773,"d":"17"},{"v":43.12878133102851,"d":"43"},{"v":111.57637407925759,"d":"112"},{"v":-32.37423636615408,"d":"-32"},{"$nulls":15},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S146 phosphosite.","S146 phosphorylation induces its release from CDK2 and PCNA, cytoplasmic relocalization and subsequent degradation. This is one of the major in vivo phosphorylation sites in Cip.","Akt1 (PKBa); Akt3 (PKBg); Pim1; PKCa (PRKCA)","Inhibitor protein","P38936","P38936",null,"P38936","GO:0000307; GO:0005829; GO:0016604; GO:0005730; GO:0005654; GO:0005634; GO:0070557; GO:0048471; GO:0032991","GO:0030332; GO:0019912; GO:0004693; GO:0004861; GO:0046872; GO:0044877; GO:0019901; GO:0004860; GO:0031625","GO:0031100; GO:0007050; GO:0034198; GO:0006974; GO:0031668; GO:0071480; GO:0034605; GO:0071479; GO:0071493; GO:0090398; GO:0019221; GO:0006977; GO:0006978; GO:0000082; GO:0000086; GO:0060574; GO:0097193; GO:0042771; GO:0071850; GO:0043066; GO:0030308; GO:0008285; GO:1904030; GO:0045736; GO:2000134; GO:0010629; GO:0042326; GO:1904706; GO:0030890; GO:0048146; GO:0043068; GO:0045860; GO:2000379; GO:0050821; GO:0007265; GO:0000079; GO:2000278; GO:0033158; GO:0006357; GO:0090399; GO:0046685; GO:0051412; GO:0042493; GO:0055093; GO:0010243; GO:0009636; GO:0010165; GO:0090400; GO:0006367"]
[482,850,"PN248","Cip (WAF1; p21) p21(WAF1/CIP1)","S146","Cyclin-dependent kinase inhibitor 1",0,130,8,460,{"v":56.12,"d":"56"},{"v":98.6110839680723,"d":"99"},{"$nulls":3},0,36,10,664,{"v":17.264,"d":"17"},{"v":30.16392223964257,"d":"30"},{"$nulls":6},0,102,10,360,{"v":33.12,"d":"33"},{"v":56.663067216036524,"d":"57"},{"$nulls":20},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S146 phosphosite.","S146 phosphorylation induces its release from CDK2 and PCNA, cytoplasmic relocalization and subsequent degradation. This is one of the major in vivo phosphorylation sites in Cip.","Akt1 (PKBa); Akt3 (PKBg); Pim1; PKCa (PRKCA)",null,"P38936","P38936",null,"P38936"]
[483,245,"NK036","CK1 delta (CSNK1D)","Pan-specific","Casein protein-serine kinase 1 delta",0,388,16,660,{"v":245.52,"d":"246"},{"v":431.4147066258217,"d":"431"},{"v":428.7051861076683,"d":"429"},{"v":2.709520518153397,"d":"3"},{"v":0.6320241989031846,"d":"1"},0,367,16,587,{"v":206.037,"d":"206"},{"v":359.9909665482644,"d":"360"},{"v":374.4238372422268,"d":"374"},{"v":14.4328706939624,"d":"14"},{"v":3.8546879921604225,"d":"4"},{"v":4.486712191063607,"d":"4"},{"v":-12.66169634155274,"d":"-13"},null,0,408,16,621,{"v":243.432,"d":"243"},{"v":416.47354403786846,"d":"416"},{"v":425.5786419763874,"d":"426"},{"v":9.105097938518952,"d":"9"},{"v":2.1394630840107185,"d":"2"},{"v":2.771487282913903,"d":"3"},{"v":-0.729299348969306,"d":"-1"},null,null,"CK1d","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CK1","CK1",{"$nulls":6},"Epitope undefined.",{"$nulls":3},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); CK1 group; CK1 family","P48730","P48730","P48730",null,"GO:0005813; GO:0005829; GO:0033116; GO:0005794; GO:0000139; GO:0043005; GO:0005654; GO:0005634; GO:0048471; GO:0005886; GO:0005819; GO:0005876","GO:0005524; GO:0045296; GO:0042277; GO:0004672; GO:0004674; GO:0050321","GO:1990090; GO:0097711; GO:0032922; GO:0048208; GO:0006897; GO:0000086; GO:0007030; GO:0007020; GO:1905515; GO:0018105; GO:0090263; GO:2000052; GO:0032436; GO:0001934; GO:1905426; GO:0071539; GO:0061512; GO:0034067; GO:0006468; GO:0008360; GO:0042752; GO:0010389; GO:0051225; GO:0016055"]
[484,245,"NK036","CK1 delta (CSNK1D)","Pan-specific","Casein protein-serine kinase 1 delta",0,368,12,681,{"v":242.436,"d":"242"},{"v":425.99566558951494,"d":"426"},{"$nulls":3},0,310,16,757,{"v":222.558,"d":"223"},{"v":388.85670793618925,"d":"389"},{"$nulls":6},0,388,16,683,{"v":254.076,"d":"254"},{"v":434.6837399149063,"d":"435"},{"$nulls":7},"CK1d","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CK1","CK1",{"$nulls":6},"Epitope undefined.",{"$nulls":4},"P48730","P48730","P48730"]
[485,246,"NK037-1","CK1 epsilon (CSNK1E)","Pan-specific","Casein protein-serine kinase 1 epsilon",0,3598,14,513,{"v":1838.592,"d":"1839"},{"v":3230.676231201461,"d":"3231"},{"v":3028.2212798002965,"d":"3028"},{"v":202.45495140116464,"d":"202"},{"v":6.685606258420984,"d":"7"},0,3866,16,541,{"v":2082.85,"d":"2083"},{"v":3639.1870619114648,"d":"3639"},{"v":3344.3008260451725,"d":"3344"},{"v":294.8862358662923,"d":"295"},{"v":8.8175750688975,"d":"9"},{"v":15.503181327318485,"d":"16"},{"v":10.437795558510857,"d":"10"},null,0,3904,12,552,{"v":2148.384,"d":"2148"},{"v":3675.5442934135694,"d":"3676"},{"v":3332.51032737436,"d":"3333"},{"v":343.03396603920964,"d":"343"},{"v":10.293560479660433,"d":"10"},{"v":16.979166738081418,"d":"17"},{"v":10.04844162491753,"d":"10"},null,null,"CK1e","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CK1","CK1",{"$nulls":6},"Not precisely defined.","Antibody raised against recombinant full length protein (Human) with a His tag.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); CK1 group; CK1 family","P49674","P49674","P49674",null,"GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0004672; GO:0004674; GO:0003723","GO:0060070; GO:0097711; GO:0032922; GO:0006281; GO:0006897; GO:0000086; GO:0032091; GO:0018105; GO:2000052; GO:0032436; GO:1905426; GO:0006468; GO:0008360; GO:1903827; GO:0042752; GO:0010389; GO:0007165; GO:0016055"]
[486,246,"NK037-1","CK1 epsilon (CSNK1E)","Pan-specific","Casein protein-serine kinase 1 epsilon",0,3085,16,524,{"v":1608.156,"d":"1608"},{"v":2825.766328399132,"d":"2826"},{"$nulls":3},0,3116,16,563,{"v":1745.3,"d":"1745"},{"v":3049.4145901788797,"d":"3049"},{"$nulls":6},0,3336,14,526,{"v":1747.372,"d":"1747"},{"v":2989.4763613351506,"d":"2989"},{"$nulls":7},"CK1e","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CK1","CK1",{"$nulls":6},"Not precisely defined.","Antibody raised against recombinant full length protein (Human) with a His tag.",{"$nulls":3},"P49674","P49674","P49674"]
[487,247,"NK041-3","CK2a1 (CSNK2A1)","Pan-specific","Casein protein-serine kinase 2 alpha/ alpha prime",0,238,14,668,{"v":149.632,"d":"150"},{"v":262.9254047810156,"d":"263"},{"v":262.7092757124469,"d":"263"},{"v":0.2161290685686481,"d":"0"},{"v":0.08226929482505825,"d":"0"},0,252,14,503,{"v":119.714,"d":"120"},{"v":209.16611370462064,"d":"209"},{"v":183.98350183946957,"d":"184"},{"v":25.182611865151074,"d":"25"},{"v":13.687429369141785,"d":"14"},{"v":13.769698663966844,"d":"14"},{"v":-29.96688017942239,"d":"-30"},null,0,242,22,647,{"v":142.34,"d":"142"},{"v":243.52116508244686,"d":"244"},{"v":247.8667022421308,"d":"248"},{"v":4.345537159683943,"d":"4"},{"v":1.7531750414135763,"d":"2"},{"v":1.8354443362386346,"d":"2"},{"v":-5.649809444323665,"d":"-6"},null,null,"CK2a1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","CK2",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 2-27 at the N-terminus of human casein kinase IIα .",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; CK2 family","P68400","P68400","P68400","P68400","GO:0005829; GO:0005654; GO:0005634; GO:0016581; GO:0005886; GO:0005956; GO:0016580","GO:0005524; GO:0051879; GO:0042802; GO:0016301; GO:0047485; GO:0004674","GO:0006915; GO:0007049; GO:0061077; GO:2001234; GO:0043154; GO:2000059; GO:0018105; GO:0018107; GO:0030307; GO:0008284; GO:0045732; GO:0030177; GO:0006468; GO:1905818; GO:1901796; GO:0006355; GO:0048511; GO:0007165; GO:0006351; GO:0016055"]
[489,248,"NK041-2","CK2a1 (CSNK2A1)","Pan-specific","Casein protein-serine kinase 2 alpha/ alpha prime",0,2562,14,1004,{"v":2558.192,"d":"2558"},{"v":4495.119139673036,"d":"4495"},{"v":4656.889111776327,"d":"4657"},{"v":161.76997210329046,"d":"162"},{"v":3.473777627519776,"d":"3"},0,3668,16,642,{"v":2344.584,"d":"2345"},{"v":4096.492670314535,"d":"4096"},{"v":4546.847856876242,"d":"4547"},{"v":450.35518656170734,"d":"450"},{"v":9.904778007485577,"d":"10"},{"v":13.378555635005352,"d":"13"},{"v":-2.362977778917113,"d":"-2"},null,0,3948,16,648,{"v":2547.936,"d":"2548"},{"v":4359.114397045872,"d":"4359"},{"v":4574.950726570049,"d":"4575"},{"v":215.83632952417702,"d":"216"},{"v":4.717784789913896,"d":"5"},{"v":8.191562417433673,"d":"8"},{"v":-1.759509046480673,"d":"-2"},null,null,"CK2a1","X","DSK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","CK2",{"$nulls":6},"CARVYTDVNTHRPREYWDYE","Corresponds to amino acid residues A9 to E27; Post-N-terminus, conserved in both CK2 isoforms.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; CK2 family","P68400","P68400","P68400","P68400","GO:0005829; GO:0005654; GO:0005634; GO:0016581; GO:0005886; GO:0005956; GO:0016580","GO:0005524; GO:0051879; GO:0042802; GO:0016301; GO:0047485; GO:0004674","GO:0006915; GO:0007049; GO:0061077; GO:2001234; GO:0043154; GO:2000059; GO:0018105; GO:0018107; GO:0030307; GO:0008284; GO:0045732; GO:0030177; GO:0006468; GO:1905818; GO:1901796; GO:0006355; GO:0048511; GO:0007165; GO:0006351; GO:0016055"]
[494,250,"PK167","CK2a1 (CSNK2A1)","T360+S362","Casein protein-serine kinase 2 alpha/ alpha prime",0,1790,12,353,{"v":627.634,"d":"628"},{"v":1102.8451367643816,"d":"1103"},{"$nulls":3},0,1702,14,376,{"v":634.688,"d":"635"},{"v":1108.9364850807613,"d":"1109"},{"$nulls":6},0,1466,12,356,{"v":517.624,"d":"518"},{"v":885.5725695843506,"d":"886"},{"$nulls":7},"CK2a1","X","DSK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","CK2",{"$nulls":6},"VP(pT)P(pS)PL","Corresponds to amino acid residues V358 to L364.","Phosphorylation at T360 and S362 stimulates phosphotransferase activity. The effects of T360 and S362 phosphorylation are unclear. T360 phosphorylation has not been reported following high throughput mass spectrometry, and S362 phosphorylation has been described only once from high throughput mass spectrometry studies.","T360: CDK1 (CDC2); ERK2 (MAPK1). S362: CDK1 (CDC2); ERK2 (MAPK1).",null,"P68400","P68400","P68400","P68400"]
[499,253,"NK370-1","CLK1/4","Pan-specific","Dual specificity protein kinase CLK1/4",0,182,14,552,{"v":92.736,"d":"93"},{"v":162.95077481937196,"d":"163"},{"v":147.88411873447822,"d":"148"},{"v":15.066656084893737,"d":"15"},{"v":10.18815016367342,"d":"10"},0,210,14,504,{"v":98.784,"d":"99"},{"v":172.59690074842746,"d":"173"},{"v":163.09903922765028,"d":"163"},{"v":9.497861520777178,"d":"9"},{"v":5.823370613189363,"d":"6"},{"v":16.01152077686278,"d":"16"},{"v":10.288407317414539,"d":"10"},null,0,204,18,612,{"v":113.832,"d":"114"},{"v":194.74849840989947,"d":"195"},{"v":175.46560497415226,"d":"175"},{"v":19.282893435747212,"d":"19"},{"v":10.989557434112381,"d":"11"},{"v":21.1777075977858,"d":"21"},{"v":18.650742537943387,"d":"19"},null,null,"CLK1","X","DSK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CLK",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 202-227 within an internal region of human CLK1.",null,null,"Protein kinase, dual-specificity; EC 2.7.12.1; EC 2.7.1.112; CMGC group; CLK family","P49759/Q9HAZ1","P49759","P49759",null,"GO:0005737; GO:0005634","GO:0005524; GO:0004715; GO:0004712; GO:0004674","GO:0008283; GO:0018105; GO:0018107; GO:0046777; GO:0043484"]
[500,253,"NK370-1","CLK1/4","Pan-specific","Dual specificity protein kinase CLK1/4",0,148,17,577,{"v":75.587,"d":"76"},{"v":132.81746264958448,"d":"133"},{"$nulls":3},0,166,18,594,{"v":87.912,"d":"88"},{"v":153.60117770687313,"d":"154"},{"$nulls":6},0,188,18,537,{"v":91.29,"d":"91"},{"v":156.18271153840504,"d":"156"},{"$nulls":7},"CLK1","X","DSK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CLK",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 202-227 within an internal region of human CLK1.",{"$nulls":3},"P49759/Q9HAZ1","P49759","P49759"]
[505,285,"PN190","CLNB1","S147","Cyclin B1",0,538,12,382,{"v":200.932,"d":"201"},{"v":353.0670406962349,"d":"353"},{"v":323.35368663529226,"d":"323"},{"v":29.713354060942663,"d":"30"},{"v":9.189118692330263,"d":"9"},0,962,14,334,{"v":316.632,"d":"317"},{"v":553.2242253581155,"d":"553"},{"v":484.88190501499577,"d":"485"},{"v":68.34232034311975,"d":"68"},{"v":14.094632040559683,"d":"14"},{"v":23.283750732889946,"d":"23"},{"v":49.95403641767962,"d":"50"},null,0,695,16,390,{"v":264.81,"d":"265"},{"v":453.04791151807467,"d":"453"},{"v":383.10016081977597,"d":"383"},{"v":69.9477506982987,"d":"70"},{"v":18.258345428156748,"d":"18"},{"v":27.447464120487012,"d":"27"},{"v":18.477127880057623,"d":"18"},{"$nulls":15},"AF(pS)DV","Corresponds to amino acid residues A145 to V149."," S147 phosphorylation induces interaction with DNA. This is one of the minor in vivo phosphorylation sites in cyclin B1 (≥1 reports from high throughput mass spectrometry studies).","Plk1 (PLK)","Protein-serine kinase regulatory subunit, activator, cyclin","P14635","P14635",null,"P14635","GO:0005813; GO:0000942; GO:0097125; GO:0005737; GO:0005829; GO:0016020; GO:0005759; GO:0005654; GO:0005634; GO:0000922","GO:0061575; GO:0004693; GO:0035173; GO:0005113; GO:0019901; GO:0044389","GO:0031145; GO:0051301; GO:0071398; GO:0071456; GO:0071283; GO:0071407; GO:0048565; GO:0006977; GO:0000086; GO:2000775; GO:0001701; GO:0007080; GO:0007077; GO:0007052; GO:0010629; GO:0001933; GO:0001556; GO:0051987; GO:0060045; GO:0048146; GO:0010971; GO:0033129; GO:1905448; GO:0045931; GO:0031442; GO:0065003; GO:0051726; GO:0060623; GO:0090266; GO:0046680; GO:0009612; GO:0007283; GO:0042246; GO:0055015"]
[510,257,"PN148","Connexin 43","S368","Gap junction alpha-1 protein",0,1512,10,444,{"v":666.888,"d":"667"},{"v":1171.8201811350643,"d":"1172"},{"$nulls":3},0,1829,14,403,{"v":731.445,"d":"731"},{"v":1277.9917807330492,"d":"1278"},{"$nulls":6},0,1625,12,418,{"v":674.234,"d":"674"},{"v":1153.5074414654944,"d":"1154"},{"$nulls":20},"RA(pS)SR","Corresponds to amino acid residues  R365 to R369; Surrounds the S367 phosphosite.","S368 phosphorylation inhibits activity and induces interaction with CLTA and endocytosis. This is one of the minor in vivo phosphorylation sites in connexin 45 (≥5 reports from high throughput mass spectrometry studies).","PKACa (PRKACA); PKCa (PRKCA); PKCb1 (PRKCB1); PKCe (PRKCE); PKCg (PRKCG)",null,"P17302","P17302"]
[516,260,"NK042-2","COT (MAP3K8, TPL2)","Pan-specific","Osaka thyroid oncogene protein-serine kinase (Tpl2); Mitogen-activated protein kinase kinase kinase 8",0,3102,24,808,{"v":2487.024,"d":"2487"},{"v":4370.066509169833,"d":"4370"},{"$nulls":3},0,3124,18,676,{"v":2099.656,"d":"2100"},{"v":3668.5507596153243,"d":"3669"},{"$nulls":6},0,3386,26,845,{"v":2839.2,"d":"2839"},{"v":4857.420906997914,"d":"4857"},{"$nulls":7},"COT","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE-Unique",{"$nulls":6},"CAGYFNLVRGPPTLEYG","Corresponds to amino acid residues A452 to G467; C-terminus.",{"$nulls":3},"P41279","P41279","P41279","P41279"]
[517,261,"PK585","COT (MAP3K8, TPL2)","S334","Osaka thyroid oncogene protein-serine kinase (Tpl2); Mitogen-activated protein kinase kinase kinase 8",0,9890,18,815,{"v":8045.68,"d":"8046"},{"v":14137.441661800427,"d":"14137"},{"v":13784.78930777234,"d":"13785"},{"v":352.65235402808685,"d":"353"},{"v":2.55827162936215,"d":"3"},0,9806,18,754,{"v":7380.152,"d":"7380"},{"v":12894.713336697323,"d":"12895"},{"v":13481.728702933258,"d":"13482"},{"v":587.0153662359353,"d":"587"},{"v":4.354155013579354,"d":"4"},{"v":6.912426642941504,"d":"7"},{"v":-2.198514595128458,"d":"-2"},null,0,9586,14,800,{"v":7657.6,"d":"7658"},{"v":13100.939115746418,"d":"13101"},{"v":13267.588754978897,"d":"13268"},{"v":166.64963923247888,"d":"167"},{"v":1.2560657577658234,"d":"1"},{"v":3.8143373871279733,"d":"4"},{"v":-3.751965599516467,"d":"-4"},null,null,"COT","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE-Unique",{"$nulls":6},"YPR(pS)AYP(bA)C","Corresponds to amino acid residues Y331 to P337; In the kinase catalytic subdomain X region.","The effect of S334 phosphorylation is unclear. This is one of the minor in vivo phosphorylation sites in COT (≥1 report from high throughput mass spectrometry studies).",null,"Protein-serine kinase, STE group, STE-Unique family","P41279","P41279","P41279","P41279","GO:0005737; GO:0005829","GO:0005524; GO:0000287; GO:0004709; GO:0004674","GO:0032147; GO:0007049; GO:0070498; GO:0006468; GO:0042981; GO:0007346; GO:0023014; GO:0051403; GO:0031098; GO:0031295"]
[522,263,"NN027-2","COX2","Pan-specific","Prostaglandin G/H synthase 2",0,156,10,821,{"v":119.866,"d":"120"},{"v":210.6221701874012,"d":"211"},{"$nulls":3},0,288,13,694,{"v":190.85,"d":"191"},{"v":333.456010161943,"d":"333"},{"$nulls":6},0,240,10,590,{"v":135.7,"d":"136"},{"v":232.16117817681632,"d":"232"},{"$nulls":19},"X","Not precisely defined.","Antibody raised against amino acid residues 169-192 within an internal region of human COX2.",{"$nulls":3},"P00403","P00403"]
[527,267,"PN553","CREB1","S133","cAMP-response element-binding protein 1",0,12822,20,794,{"v":10164.788,"d":"10165"},{"v":17861.025712502742,"d":"17861"},{"v":16654.155722174677,"d":"16654"},{"v":1206.869990328065,"d":"1207"},{"v":7.246659695400479,"d":"7"},0,13402,20,799,{"v":10692.218,"d":"10692"},{"v":18681.605208602097,"d":"18682"},{"v":18594.880437732838,"d":"18595"},{"v":86.72477086925937,"d":"87"},{"v":0.4663905807819929,"d":"0"},{"v":7.7130502761824715,"d":"8"},{"v":11.653095767407322,"d":"12"},null,0,13961,18,793,{"v":11056.799,"d":"11057"},{"v":18916.429496715144,"d":"18916"},{"v":17772.236731259844,"d":"17772"},{"v":1144.1927654553,"d":"1144"},{"v":6.438090954768586,"d":"6"},{"v":13.684750650169065,"d":"14"},{"v":6.713525607284083,"d":"7"},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"RRP(pS)YRK(bA)C     ","Corresponds to amino acid residues R130 to K136; In the PKID domain.","S133 phosphorylation stimulates transcriptional activity and induces interactions with CBP, DNA, MEIS1, Myb, Nur77, RGS13, SOX9 and p300. This is one of the major in vivo phosphorylation sites in CREB1 (≥65 reports from high throughput mass spectrometry studies).","Akt1 (PKBa); Btk; CaMK1a; CaMK2a; CaMK4; DYRK3; MAPKAPK2; MSK1 (RPS6KA5); MSK2 (RPS6KA4); PKACa (PRKACA); PKCa (PRKCA); PKCe (PRKCE); PKD1 (PRKCM; PRKD1); RSK1 (RPS6KA1); RSK2 (RPS6KA3); RSK3 (RPS6KA2); SGK1; TSSK4; VRK1","Transcription protein","P16220","P16220",null,"P16220","GO:1990589; GO:0030424; GO:0005759; GO:0005719; GO:0005654; GO:0005634","GO:1990763; GO:0035497; GO:0003700; GO:0019899; GO:0035035; GO:0030544; GO:0042802; GO:0001102; GO:0000980; GO:0000978; GO:0001225; GO:0000981; GO:0001077; GO:0001190; GO:0001228; GO:0003712; GO:0003705","GO:0007568; GO:0007409; GO:0071398; GO:0035729; GO:1990314; GO:1990830; GO:1990090; GO:0036120; GO:0071300; GO:0071294; GO:0034670; GO:0007623; GO:0007595; GO:0060430; GO:0007613; GO:1901215; GO:0010944; GO:0021983; GO:0043065; GO:0055025; GO:0045600; GO:0046887; GO:0046889; GO:1900273; GO:0040018; GO:0045672; GO:0045899; GO:0045893; GO:0045944; GO:0032916; GO:0006468; GO:0050821; GO:0008361; GO:0042752; GO:0048145; GO:0060251; GO:0014823; GO:0033762; GO:0001666; GO:1902065; GO:0035094; GO:0010033; GO:0033363; GO:0007165; GO:0007179; GO:0060509; GO:0016032; GO:0008542"]
[533,270,"PN025","CRYAB","S19","Crystallin aB",0,856,12,381,{"v":321.564,"d":"322"},{"v":565.0351854082181,"d":"565"},{"v":577.4986283623439,"d":"577"},{"v":12.463442954125753,"d":"12"},{"v":2.1581770660597535,"d":"2"},0,750,12,382,{"v":281.916,"d":"282"},{"v":492.5679044318278,"d":"493"},{"v":498.51891921103436,"d":"499"},{"v":5.9510147792065595,"d":"6"},{"v":1.1937390036520077,"d":"1"},{"v":3.351916069711761,"d":"3"},{"v":-13.676172595470604,"d":"-14"},null,0,959,12,391,{"v":370.277,"d":"370"},{"v":633.4852216048417,"d":"633"},{"v":630.1003218920721,"d":"630"},{"v":3.384899712769652,"d":"3"},{"v":0.5372001243556642,"d":"1"},{"v":2.695377190415418,"d":"3"},{"v":9.108539994093974,"d":"9"},{"$nulls":11},"X",{"$nulls":3},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S19 phosphosite.","S19 phosphorylation appears to induce activity, although one report indicates inhibition. Phosphorylation induces interaction with FBXO4 and inhibits interaction with CRYAB. This is one of the major in vivo phosphorylation sites in crystallin aB (≥16 reports from high throughput mass spectrometry studies).",null,"Chaperone protein","P02511","P02511",null,"P02511","GO:0032432; GO:0030424; GO:0097512; GO:0009986; GO:0005737; GO:0005829; GO:0043197; GO:0070062; GO:0005794; GO:0031430; GO:0015630; GO:0005739; GO:0043209; GO:0005654; GO:0005634; GO:0043204; GO:0014069; GO:0097060; GO:0030018","GO:0001540; GO:0042802; GO:0046872; GO:0008017; GO:0044877; GO:0042803; GO:0005212; GO:0051082","GO:0060561; GO:0071480; GO:0002088; GO:0031109; GO:0010259; GO:0006936; GO:0007517; GO:1905907; GO:0043066; GO:0030308; GO:0043154; GO:0010629; GO:0032387; GO:0032463; GO:2000378; GO:0006457; GO:0051260; GO:0050821; GO:0010941; GO:1900034; GO:0032355; GO:0042542; GO:0001666; GO:0051403; GO:0007021"]
[534,270,"PN025","CRYAB","S19","Crystallin aB",0,798,8,425,{"v":335.75,"d":"336"},{"v":589.9620713164696,"d":"590"},{"$nulls":3},0,762,14,386,{"v":288.728,"d":"289"},{"v":504.469933990241,"d":"504"},{"$nulls":6},0,978,14,380,{"v":366.32,"d":"366"},{"v":626.7154221793025,"d":"627"},{"$nulls":16},"X",{"$nulls":3},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S19 phosphosite.","S19 phosphorylation appears to induce activity, although one report indicates inhibition. Phosphorylation induces interaction with FBXO4 and inhibits interaction with CRYAB. This is one of the major in vivo phosphorylation sites in crystallin aB (≥16 reports from high throughput mass spectrometry studies).",null,null,"P02511","P02511",null,"P02511"]
[539,273,"NK234-4","CSF1R (Fms)","Pan-specific","Macrophage colony-stimulating factor 1 receptor",0,9658,22,889,{"v":8566.404,"d":"8566"},{"v":15052.430223599973,"d":"15052"},{"v":14911.187241570009,"d":"14911"},{"v":141.24298202996397,"d":"141"},{"v":0.9472282772776208,"d":"1"},0,10059,18,752,{"v":7550.832,"d":"7551"},{"v":13192.928017412234,"d":"13193"},{"v":13636.075067898892,"d":"13636"},{"v":443.14705048665746,"d":"443"},{"v":3.2498138084461248,"d":"3"},{"v":4.197042085723746,"d":"4"},{"v":-8.551379263190455,"d":"-9"},null,0,10278,22,857,{"v":8789.392,"d":"8789"},{"v":15037.255727176744,"d":"15037"},{"v":15514.987658434944,"d":"15515"},{"v":477.73193125820035,"d":"478"},{"v":3.0791641074781944,"d":"3"},{"v":4.026392384755815,"d":"4"},{"v":4.049311480588443,"d":"4"},null,null,"Fms","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"CLSSEQNLIQEVTVGE","Corresponds to amino acid residues L303 to E317.",null,null,"Receptor tyrosine kinase; EC 2.7.10.1; TK group; PDGFR family","P07333","P07333","P07333","P07333","GO:0009986; GO:1990682; GO:0005887; GO:0043231; GO:0005654; GO:0005886","GO:0005524; GO:0019955; GO:0005011; GO:0042803; GO:0019903","GO:0007411; GO:0045217; GO:0008283; GO:0071345; GO:0036006; GO:0019221; GO:0021879; GO:0030097; GO:0006954; GO:0045087; GO:0038145; GO:0030225; GO:0060603; GO:0030224; GO:0007275; GO:0043066; GO:0008285; GO:0021772; GO:0030316; GO:0018108; GO:0048015; GO:0046488; GO:0030335; GO:2000147; GO:0008284; GO:0090197; GO:0070374; GO:0001934; GO:0071902; GO:0061098; GO:0042531; GO:0046777; GO:2000249; GO:0045124; GO:0008360; GO:0031529; GO:0007165; GO:0007169"]
[544,275,"PK586","CSF1R (Fms)","S807+Y809","Macrophage colony-stimulating factor 1 receptor",0,5863,14,856,{"v":5006.744,"d":"5007"},{"v":8797.584693347151,"d":"8798"},{"$nulls":3},0,5584,24,908,{"v":5048.48,"d":"5048"},{"v":8820.780708317348,"d":"8821"},{"$nulls":6},0,6032,16,802,{"v":4824.832,"d":"4825"},{"v":8254.522340642632,"d":"8255"},{"$nulls":7},"Fms","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"MND(pS)N(pY)IVKG(bA)C","Corresponds to amino acid residues M804 to G813; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y809 phosphorylation induces interaction with and activation of Src family members, including Fyn, Yes1 and Src as well as binding to PLCG2. S807 and Y809 phosphorylation stimulates receptor activation, transcription, cell cycle progression and cell growth. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. Y809 is one of the major in vivo phosphorylation sites in CSF1R (≥13 reports from high throughput mass spectrometry studies), but phosphorylation of S807 has not been observed in high throughput experiments.","Y809: CSF1R",null,"P07333","P07333","P07333","P07333"]
[549,278,"NK044","Csk","Pan-specific","C-terminus of Src tyrosine kinase",0,28,6,671,{"v":14.762,"d":"15"},{"v":25.93900252203641,"d":"26"},{"v":27.36932009776718,"d":"27"},{"v":1.4303175757307685,"d":"1"},{"v":5.2259887005649635,"d":"5"},0,24,2,696,{"v":15.312,"d":"15"},{"v":26.753358279275197,"d":"27"},{"v":26.18376614245155,"d":"26"},{"v":0.5695921368236476,"d":"1"},{"v":2.175363672761238,"d":"2"},{"v":7.401352373326201,"d":"7"},{"v":-4.3316894649945965,"d":"-4"},null,0,28,8,665,{"v":13.3,"d":"13"},{"v":22.754190639290034,"d":"23"},{"v":23.14768416162362,"d":"23"},{"v":0.3934935223335856,"d":"0"},{"v":1.6999260901699862,"d":"2"},{"v":6.92591479073495,"d":"7"},{"v":-15.42470153099626,"d":"-15"},null,null,"CSK","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Csk",{"$nulls":6},"Epitope undefined.",{"$nulls":3},"Protein-tyrosine kinase, TK group, Csk family","P41240","P41240","P41240","P41240","GO:0005911; GO:0005737; GO:0005829; GO:0070062; GO:0031234; GO:0045121; GO:0005886","GO:0005524; GO:0042802; GO:0016301; GO:0046872; GO:0004715; GO:0070064; GO:0008022; GO:0034236; GO:0019903; GO:0004713; GO:0005102","GO:0002250; GO:0034332; GO:0007420; GO:0030154; GO:0071375; GO:0007417; GO:0045087; GO:0045779; GO:0008285; GO:0070373; GO:0042997; GO:0032715; GO:0033673; GO:0010989; GO:0050765; GO:0048709; GO:0038083; GO:0043406; GO:0006468; GO:0042127; GO:0001817; GO:0060368; GO:0031295; GO:0050852; GO:0007169"]
[551,279,"PK589","Csk","Y184","C-terminus of Src tyrosine kinase",0,2866,12,807,{"v":2303.178,"d":"2303"},{"v":4047.0220803887532,"d":"4047"},{"v":4022.9474107264837,"d":"4023"},{"v":24.07466966226957,"d":"24"},{"v":0.5984336160616638,"d":"1"},0,2804,20,637,{"v":1773.408,"d":"1773"},{"v":3098.5253134360546,"d":"3099"},{"v":3571.6781631918566,"d":"3572"},{"v":473.152849755802,"d":"473"},{"v":13.247353992638727,"d":"13"},{"v":13.845787608700391,"d":"14"},{"v":-11.217378739065708,"d":"-11"},null,0,2949,20,782,{"v":2290.478,"d":"2290"},{"v":3918.64459151126,"d":"3919"},{"v":3925.4075475711934,"d":"3925"},{"v":6.762956059933458,"d":"7"},{"v":0.17228672381083004,"d":"0"},{"v":0.7707203398724938,"d":"1"},{"v":-2.4245870799905873,"d":"-2"},null,null,"CSK","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Csk",{"$nulls":6},"DEF(pY)RSG(bA)C","Corresponds to amino acid residues D181 to G187; In the region between the SH2 domain and the protein kinase catalytic domain.","Y184 phosphorylation stimulates phosphotransferase activity. This is the major in vivo phosphorylation site in Csk (≥40 reports from high throughput mass spectrometry studies).",null,"Protein-tyrosine kinase, TK group, Csk family","P41240","P41240","P41240","P41240","GO:0005911; GO:0005737; GO:0005829; GO:0070062; GO:0031234; GO:0045121; GO:0005886","GO:0005524; GO:0042802; GO:0016301; GO:0046872; GO:0004715; GO:0070064; GO:0008022; GO:0034236; GO:0019903; GO:0004713; GO:0005102","GO:0002250; GO:0034332; GO:0007420; GO:0030154; GO:0071375; GO:0007417; GO:0045087; GO:0045779; GO:0008285; GO:0070373; GO:0042997; GO:0032715; GO:0033673; GO:0010989; GO:0050765; GO:0048709; GO:0038083; GO:0043406; GO:0006468; GO:0042127; GO:0001817; GO:0060368; GO:0031295; GO:0050852; GO:0007169"]
[556,176,"NN021-2","CTNNB1","Pan-specific","Catenin (cadherin-associated protein) beta 1",0,74,8,663,{"v":43.758,"d":"44"},{"v":76.88923400347306,"d":"77"},{"$nulls":3},0,78,8,528,{"v":36.96,"d":"37"},{"v":64.57707170859531,"d":"65"},{"$nulls":6},0,106,8,550,{"v":53.9,"d":"54"},{"v":92.21435153817539,"d":"92"},{"$nulls":10},"Transcription protein; Cytoskeletal protein",{"$nulls":4},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against amino acid residues 680-781 mapping at the C-terminus of human β-catenin ",{"$nulls":3},"P35222","P35222",null,"P35222"]
[561,179,"PN278","CTNNB1","S33+S37","Catenin (cadherin-associated protein) beta 1",0,26,8,684,{"v":12.312,"d":"12"},{"v":21.63399261965264,"d":"22"},{"v":25.324001107410158,"d":"25"},{"v":3.6900084877575168,"d":"4"},{"v":14.571190674437966,"d":"15"},0,26,4,666,{"v":14.652,"d":"15"},{"v":25.60019628447885,"d":"26"},{"v":25.65785438421867,"d":"26"},{"v":0.05765809973981817,"d":"0"},{"v":0.22471910112359914,"d":"0"},{"v":14.795909775561565,"d":"15"},{"v":1.3183275241242143,"d":"1"},null,0,26,10,691,{"v":11.056,"d":"11"},{"v":18.915062534435382,"d":"19"},{"v":21.9346976079953,"d":"22"},{"v":3.0196350735599182,"d":"3"},{"v":13.766476873878794,"d":"14"},{"v":28.33766754831676,"d":"28"},{"v":-13.383759876803595,"d":"-13"},{"$nulls":5},"Transcription protein; Cytoskeletal protein",{"$nulls":4},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against amino acid residues 32-45 of human β-catenin.","S33 and S37 phosphorylation inhibits transcriptional activity and induces binding to CBLL1.  These are two of the minor in vivo phosphorylation sites in CTNNB1 (≥5 and ≥15 reports, respectively, by mass spectrometry).","S33: CDK2; GSK3a; GSK3b; IKKa (CHUK, IKBKA). S37: CDK2; GSK3a; GSK3b; IKKa (CHUK, IKBKA); JNK1. ","Cytoskeletal protein","P35222","P35222",null,"P35222","GO:0005912; GO:0016323; GO:0030877; GO:0070369; GO:1990907; GO:0016342; GO:0005913; GO:0005911; GO:0005938; GO:0030054; GO:0071944; GO:0042995; GO:0005813; GO:0005737; GO:0005829; GO:0070062; GO:0005925; GO:0005622; GO:0016328; GO:0016020; GO:0005719; GO:0005654; GO:0005634; GO:0048471; GO:0005886; GO:0032991; GO:0032993; GO:0000922; GO:0045202; GO:0005667; GO:1990909","GO:0045294; GO:0050681; GO:0045296; GO:0003682; GO:0019899; GO:0030331; GO:0044325; GO:0070411; GO:0019900; GO:0035257; GO:0008022; GO:0019903; GO:0001102; GO:0001085; GO:0046332; GO:0003713; GO:0008134","GO:0034333; GO:0030521; GO:1904886; GO:1904837; GO:0001569; GO:0060070; GO:1904954; GO:0044336; GO:0061324; GO:0044334; GO:0007155; GO:0098609; GO:0071363; GO:0071681; GO:0036023; GO:0061154; GO:0035635; GO:0001837; GO:0035315; GO:1904948; GO:0016525; GO:0043066; GO:0008285; GO:0045976; GO:0033234; GO:0045892; GO:1990138; GO:0043065; GO:1904798; GO:0051091; GO:2000144; GO:0010718; GO:0010909; GO:0051571; GO:0051149; GO:0002052; GO:0043525; GO:0045893; GO:0045944; GO:0032481; GO:0034394; GO:0045765; GO:0090279; GO:0060828; GO:0030997; GO:0070602; GO:0048145; GO:0072182; GO:0050767; GO:2000008; GO:0048660; GO:0042493; GO:0032355; GO:0019827; GO:0061549; GO:0006351; GO:0016032; GO:0016055; GO:0007223"]
[566,180,"PN167","CTNNB1","Y333","Catenin (cadherin-associated protein) beta 1",0,68,8,653,{"v":39.18,"d":"39"},{"v":68.84501550016167,"d":"69"},{"$nulls":3},0,48,8,658,{"v":26.32,"d":"26"},{"v":45.98670258036333,"d":"46"},{"$nulls":6},0,1190,14,342,{"v":402.192,"d":"402"},{"v":688.0867249321306,"d":"688"},{"$nulls":10},"Transcription protein; Cytoskeletal protein",{"$nulls":4},"X",{"$nulls":4},"YT(pY)EK","Corresponds to amino acid residues Y331 to K335.","Y333 phosphorylation induces interaction with PKM and transcription. This is one of the minor in vivo phosphorylation sites in CTNNB1 (≥2 reports from high throughput mass spectrometry studies).","Brk; Src",null,"P35222","P35222",null,"P35222"]
[567,281,"PN745","CTNNB1","Y489","Catenin (cadherin-associated protein) beta 1",0,11719,20,709,{"v":8294.591,"d":"8295"},{"v":14574.814853560529,"d":"14575"},{"v":14676.70038077476,"d":"14677"},{"v":101.88552721423184,"d":"102"},{"v":0.6941991358472732,"d":"1"},0,11634,18,636,{"v":7387.776,"d":"7388"},{"v":12908.034104952365,"d":"12908"},{"v":7468.023844373194,"d":"7468"},{"v":5440.010260579171,"d":"5440"},{"v":72.84403978808884,"d":"73"},{"v":73.5382389239361,"d":"74"},{"v":-49.11646589068701,"d":"-49"},null,0,11146,22,729,{"v":8109.396,"d":"8109"},{"v":13873.890417556091,"d":"13874"},{"v":13604.114680326988,"d":"13604"},{"v":269.77573722910347,"d":"270"},{"v":1.9830451563248597,"d":"2"},{"v":2.6772442921721327,"d":"3"},{"v":-7.30808473717137,"d":"-7"},{"$nulls":5},"Transcription protein; Cytoskeletal protein",{"$nulls":4},"X",{"$nulls":4},"VRLH(pY)GLP(bA)C","Corresponds to amino acid residues V485 to P492.","T489 phosphorylation induces transcription. This is the major in vivo phosphorylation site in CTNNB1 (≥90 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in sea urchin.","Abl1","Cytoskeletal protein","P35222","P35222",null,"P35222","GO:0005912; GO:0016323; GO:0030877; GO:0070369; GO:1990907; GO:0016342; GO:0005913; GO:0005911; GO:0005938; GO:0030054; GO:0071944; GO:0042995; GO:0005813; GO:0005737; GO:0005829; GO:0070062; GO:0005925; GO:0005622; GO:0016328; GO:0016020; GO:0005719; GO:0005654; GO:0005634; GO:0048471; GO:0005886; GO:0032991; GO:0032993; GO:0000922; GO:0045202; GO:0005667; GO:1990909","GO:0045294; GO:0050681; GO:0045296; GO:0003682; GO:0019899; GO:0030331; GO:0044325; GO:0070411; GO:0019900; GO:0035257; GO:0008022; GO:0019903; GO:0001102; GO:0001085; GO:0046332; GO:0003713; GO:0008134","GO:0034333; GO:0030521; GO:1904886; GO:1904837; GO:0001569; GO:0060070; GO:1904954; GO:0044336; GO:0061324; GO:0044334; GO:0007155; GO:0098609; GO:0071363; GO:0071681; GO:0036023; GO:0061154; GO:0035635; GO:0001837; GO:0035315; GO:1904948; GO:0016525; GO:0043066; GO:0008285; GO:0045976; GO:0033234; GO:0045892; GO:1990138; GO:0043065; GO:1904798; GO:0051091; GO:2000144; GO:0010718; GO:0010909; GO:0051571; GO:0051149; GO:0002052; GO:0043525; GO:0045893; GO:0045944; GO:0032481; GO:0034394; GO:0045765; GO:0090279; GO:0060828; GO:0030997; GO:0070602; GO:0048145; GO:0072182; GO:0050767; GO:2000008; GO:0048660; GO:0042493; GO:0032355; GO:0019827; GO:0061549; GO:0006351; GO:0016032; GO:0016055; GO:0007223"]
[574,1351,"NK188-1","DAPK3 (ZIPK)","Pan-specific","ZIP kinase (death associated protein-serine kinase 3 (DAPK3))",0,286,38,973,{"v":241.304,"d":"241"},{"v":424.0065752999237,"d":"424"},{"$nulls":3},0,278,56,851,{"v":188.922,"d":"189"},{"v":330.0873793650228,"d":"330"},{"$nulls":6},0,452,140,607,{"v":189.384,"d":"189"},{"v":324.00598797227843,"d":"324"},{"$nulls":7},"DAPK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","DAPK",{"$nulls":6},"Epitope undefined.",{"$nulls":4},"O43293","O43293","O43293"]
[578,287,"PN696","DCK","S74","Deoxycytidine kinase",0,11466,18,758,{"v":8677.584,"d":"8678"},{"v":15247.789815823251,"d":"15248"},{"$nulls":3},0,12888,18,798,{"v":10270.26,"d":"10270"},{"v":17944.35380102592,"d":"17944"},{"$nulls":6},0,12412,22,748,{"v":9267.72,"d":"9268"},{"v":15855.5990730497,"d":"15856"},{"$nulls":10},"Enzyme - Metabolite kinase",{"$nulls":8},"X","LTM(pS)QKNGGC","Corresponds to amino acid residues L71 to G79.","S74 phosphorylation stimulates enzyme activity. This is the major in vivo phosphorylation sites in DCK (≥115 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and found in fish.","ATR; CK1D",null,"P27707","P27707"]
[583,290,"PK592","DDR1","Y797","Epithelial discoidin domain-containing receptor 1",0,6833,18,840,{"v":5724.6,"d":"5725"},{"v":10058.963137626992,"d":"10059"},{"v":9978.60002420433,"d":"9979"},{"v":80.36311342266163,"d":"80"},{"v":0.8053545911022684,"d":"1"},0,6639,18,851,{"v":5634.471,"d":"5634"},{"v":9844.633057548719,"d":"9845"},{"v":9836.401053399502,"d":"9836"},{"v":8.232004149216664,"d":"8"},{"v":0.0836891877885728,"d":"0"},{"v":0.8890437788908412,"d":"1"},{"v":-1.4250392886768282,"d":"-1"},null,0,6549,20,836,{"v":5458.244,"d":"5458"},{"v":9338.189814418118,"d":"9338"},{"v":9422.700247125562,"d":"9423"},{"v":84.51043270744412,"d":"85"},{"v":0.8968812600530769,"d":"1"},{"v":1.7022358511553453,"d":"2"},{"v":-5.570919525087334,"d":"-6"},null,null,"DDR1","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","DDR",{"$nulls":6},"GDY(pY)RVQ(bA)C","Corresponds to amino acid residues G794 to Q800; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y797 phosphorylation likely stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in DDR1 (≥307 reports from high throughput mass spectrometry studies).",null,"EC 2.7.1.112; EC 2.7.10.1; Receptor tyrosine kinase; TK domain target; TK</A> group; DDR family","Q08345","Q08345","Q08345","Q08345","GO:0070062; GO:0005615; GO:0005887; GO:0005886; GO:0043235","GO:0005524; GO:0005518; GO:0046872; GO:0038062; GO:0004714","GO:0061564; GO:0060444; GO:0007155; GO:0038063; GO:0043583; GO:0007566; GO:0030198; GO:0007595; GO:0060749; GO:0008285; GO:1990138; GO:0038083; GO:0046777; GO:0001558; GO:0001952; GO:0010715; GO:0061302; GO:0014909; GO:0044319"]
[584,290,"PK592","DDR1","Y797","Epithelial discoidin domain-containing receptor 1",0,6308,14,895,{"v":5633.13,"d":"5633"},{"v":9898.236910781667,"d":"9898"},{"$nulls":3},0,6576,20,858,{"v":5625.048,"d":"5625"},{"v":9828.169049250288,"d":"9828"},{"$nulls":6},0,6334,12,879,{"v":5557.038,"d":"5557"},{"v":9507.210679833006,"d":"9507"},{"$nulls":7},"DDR1","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","DDR",{"$nulls":6},"GDY(pY)RVQ(bA)C","Corresponds to amino acid residues G794 to Q800; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y797 phosphorylation likely stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in DDR1 (≥307 reports from high throughput mass spectrometry studies).",null,null,"Q08345","Q08345","Q08345","Q08345"]
[589,292,"PK593","DDR2 (Tyro10)","Y736","Discoidin domain-containing receptor 2",0,7422,16,656,{"v":4858.336,"d":"4858"},{"v":8536.81003637043,"d":"8537"},{"v":8764.124223524237,"d":"8764"},{"v":227.31418715380642,"d":"227"},{"v":2.5936896985515188,"d":"3"},0,7221,20,656,{"v":4723.856,"d":"4724"},{"v":8253.592739531336,"d":"8254"},{"v":8874.587072273032,"d":"8875"},{"v":620.9943327416968,"d":"621"},{"v":6.997444812749384,"d":"7"},{"v":9.591134511300902,"d":"10"},{"v":1.260398026448513,"d":"1"},null,0,7702,18,642,{"v":4933.128,"d":"4933"},{"v":8439.799621054102,"d":"8440"},{"v":8742.012911254706,"d":"8742"},{"v":302.2132902006033,"d":"302"},{"v":3.4570217782625976,"d":"3"},{"v":6.050711476814117,"d":"6"},{"v":-0.25229346031154876,"d":"-0"},null,null,"DDR2","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","DDR",{"$nulls":6},"RNL(pY)SGD(bA)C","Corresponds to amino acid residues R733 to D739; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y736 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in DDR2 (≥412 reports from high throughput mass spectrometry studies).","DDR2; Src","Receptor tyrosine kinase; EC 2.7.1.112; EC 2.7.10.1; TK domain target; TK</A> group; DDR family","Q16832","Q16832","Q16832","Q16832","GO:0015629; GO:0016324; GO:0005925; GO:0005887; GO:0005886","GO:0005524; GO:0005518; GO:0038062; GO:0004714","GO:0031214; GO:0007155; GO:0035988; GO:0038063; GO:0030199; GO:0003416; GO:0030198; GO:0001503; GO:0018108; GO:0051091; GO:0090091; GO:0010763; GO:0048146; GO:0045669; GO:0045860; GO:0046777; GO:0030500; GO:0010715; GO:0007165"]
[592,293,"PK594","DDR2 (Tyro10)","Y740","Discoidin domain-containing receptor 2",0,6158,24,743,{"v":4557.562,"d":"4558"},{"v":8008.305934991011,"d":"8008"},{"$nulls":3},0,6440,44,698,{"v":4464.408,"d":"4464"},{"v":7800.281264946607,"d":"7800"},{"$nulls":6},0,6625,29,711,{"v":4689.756,"d":"4690"},{"v":8023.428727500321,"d":"8023"},{"$nulls":7},"DDR2","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","DDR",{"$nulls":6},"SGD(pY)YRI(bA)C","Corresponds to amino acid residues S737 to I743; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y740 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in DDR2 (≥370 reports from high throughput mass spectrometry studies).","DDR2; Src",null,"Q16832","Q16832","Q16832","Q16832"]
[600,297,"NK048-4","DNAPK (PRKDC)","Pan-specific","DNA-dependent protein kinase catalytic subunit",0,6363,16,853,{"v":5413.991,"d":"5414"},{"v":9513.177496496573,"d":"9513"},{"$nulls":3},0,6530,16,827,{"v":5387.078,"d":"5387"},{"v":9412.384261520461,"d":"9412"},{"$nulls":6},0,6842,16,912,{"v":6225.312,"d":"6225"},{"v":10650.521506545858,"d":"10651"},{"$nulls":7},"DNAPK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PIKK","DNAPK",{"$nulls":5},"CGHDEREHPFLVKGGE","Corresponds to amino acid residues G3742 to E3755.",{"$nulls":3},"P78527","P78527","P78527","P78527"]
[601,298,"NK048-7","DNAPK (PRKDC)","Pan-specific","DNA-dependent protein kinase catalytic subunit",0,6952,20,870,{"v":6030.84,"d":"6031"},{"v":10597.071803955972,"d":"10597"},{"v":10368.691907207962,"d":"10369"},{"v":228.37989674801065,"d":"228"},{"v":2.2025912120047537,"d":"2"},0,7872,20,810,{"v":6360.12,"d":"6360"},{"v":11112.497979309284,"d":"11112"},{"v":10105.088671794623,"d":"10105"},{"v":1007.4093075146611,"d":"1007"},{"v":9.96932674451979,"d":"10"},{"v":12.171917956524544,"d":"12"},{"v":-2.542299817299906,"d":"-3"},null,0,7296,22,852,{"v":6197.448,"d":"6197"},{"v":10602.850621735844,"d":"10603"},{"v":10758.414008686925,"d":"10758"},{"v":155.56338695108025,"d":"156"},{"v":1.4459695158177588,"d":"1"},{"v":3.6485607278225123,"d":"4"},{"v":3.7586428931121247,"d":"4"},null,null,"DNAPK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PIKK","DNAPK",{"$nulls":5},"CLMDQATDPNILGRTW","Corresponds to amino acid residues C4106 to W4121; C-terminus.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); ATYPICAL group; PIKK family; DNAPK subfamily","P78527","P78527","P78527","P78527","GO:0005829; GO:0005958; GO:0016020; GO:0070419; GO:0000784; GO:0005730; GO:0005654; GO:0005634; GO:0032991; GO:0032993; GO:0005667","GO:0005524; GO:0004677; GO:0003690; GO:0019899; GO:0019904; GO:0004672; GO:0004674; GO:0003723; GO:0008134","GO:0002218; GO:0002326; GO:0007420; GO:0008283; GO:0006464; GO:0032869; GO:0006302; GO:0097681; GO:0006303; GO:0035234; GO:0007507; GO:0033152; GO:0045087; GO:0008630; GO:0043066; GO:2000773; GO:0002638; GO:0001933; GO:2001229; GO:0018105; GO:0043065; GO:0048639; GO:0048146; GO:0045944; GO:0032481; GO:0002328; GO:0031648; GO:0006468; GO:0016567; GO:0042752; GO:0048660; GO:0014823; GO:0010332; GO:0048511; GO:0072431; GO:0001756; GO:0048536; GO:0033077; GO:0002360; GO:0033153; GO:0016233; GO:0048538"]
[606,300,"PK595","DNAPK (PRKDC)","T2609","DNA-dependent protein kinase catalytic subunit",0,2508,20,852,{"v":2119.776,"d":"2120"},{"v":3724.7578248307987,"d":"3725"},{"$nulls":3},0,2939,12,837,{"v":2449.899,"d":"2450"},{"v":4280.500633166015,"d":"4281"},{"$nulls":6},0,2764,14,840,2310,{"v":3952.043637350374,"d":"3952"},{"$nulls":7},"DNAPK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PIKK","DNAPK",{"$nulls":5},"FVT(pT)QAS(bA)C","Corresponds to amino acid residues F2606 to S2612; In the mid-region of the protein kinase between the NUC194 and FAT domains.","T2609 phosphorylation stimulates phosphotransferase activity. This is one of the major in vivo phosphorylation sites in DNAPK (≥17 reports from high throughput mass spectrometry studies).","ATM; ATR; DNAPK (PRKDC)",null,"P78527","P78527","P78527","P78527"]
[611,303,"PN747","DPYD","S766+T768","Dihydropyrimidine dehydrogenase [NADP()]",0,14391,18,788,{"v":11325.924,"d":"11326"},{"v":19901.312234141224,"d":"19901"},{"v":18279.31628894044,"d":"18279"},{"v":1621.9959452007824,"d":"1622"},{"v":8.87339504148818,"d":"9"},0,13488,16,664,{"v":8945.408,"d":"8945"},{"v":15629.552323556334,"d":"15630"},{"v":16758.155462293806,"d":"16758"},{"v":1128.6031387374715,"d":"1129"},{"v":6.734650130659378,"d":"7"},{"v":15.608045172147559,"d":"16"},{"v":-8.321759975054349,"d":"-8"},null,0,13544,18,743,{"v":10049.818,"d":"10050"},{"v":17193.644711441237,"d":"17194"},{"v":17290.73838265635,"d":"17291"},{"v":97.09367121511241,"d":"97"},{"v":0.5615357138970027,"d":"1"},{"v":9.434930755385183,"d":"9"},{"v":-5.408177694710673,"d":"-5"},{"$nulls":14},"X","CGGV(pS)G(pT)AIR","Corresponds to amino acid residues G763 to R771.","The effects of S766 and T768 phosphorylation are unclear. These phosphorylation sites have only been detected in a single mass spectrometry study. However, this human phosphosite is highly conserved in vertebrates and also found in sea urchin.",null,"Other Amino Acids Metabolism - beta-alanine; Nucleotide Metabolism - pyrimidine; EC 1.3.1.2; Oxidoreductase; Cofactor and Vitamin Metabolism - pantothenate and CoA biosynthesis; Xenobiotic Metabolism - drug metabolism - other enzymes","Q12882","Q12882",null,null,"GO:0005737; GO:0005829","GO:0051539; GO:0017113; GO:0050660; GO:0046872; GO:0050661; GO:0042803","GO:0019483; GO:0006145; GO:0006208; GO:0046135; GO:0006214; GO:0006210; GO:0006212"]
[615,305,"PK597","DYRK1A","Y321","Dual specificity tyrosine-phosphorylation-regulated kinase 1A",0,2233,14,688,{"v":1526.672,"d":"1527"},{"v":2682.5869704865445,"d":"2683"},{"v":2913.4901301814207,"d":"2913"},{"v":230.9031596948762,"d":"231"},{"v":7.925311203319506,"d":"8"},0,2068,14,603,{"v":1238.562,"d":"1239"},{"v":2164.0342827256823,"d":"2164"},{"v":2462.55123166044,"d":"2463"},{"v":298.5169489347577,"d":"299"},{"v":12.122263492300007,"d":"12"},{"v":20.047574695619513,"d":"20"},{"v":-15.477618882233898,"d":"-15"},null,0,2312,18,655,{"v":1502.57,"d":"1503"},{"v":2570.6589645772947,"d":"2571"},{"v":2764.089259687377,"d":"2764"},{"v":193.43029511008217,"d":"193"},{"v":6.997975714140268,"d":"7"},{"v":14.923286917459773,"d":"15"},{"v":-5.127900346954007,"d":"-5"},null,null,"DYRK1A","X","PSTK","Protein Kinase - Dual specificity kinase","Protein-serine/threonine kinase","CMGC","DYRK","Dyrk1",{"$nulls":5},"IYQ(pY)IQS(bA)C","Corresponds to amino acid residues I318 to S324; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y321 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in DYRK1A (≥3759 reports from high throughput mass spectrometry studies).","DYRK1A","EC 2.7.12.2; Protein kinase, dual-specificity; EC 2.7.12.1; CMGC domain target; CMGC</A> group; DYRK family; Dyrk1 subfamily","Q13627","Q13627","Q13627","Q13627","GO:0030424; GO:0005737; GO:0005856; GO:0030425; GO:0016607; GO:0005654; GO:0005634; GO:1990904","GO:0003779; GO:0005524; GO:0008092; GO:0042802; GO:0004715; GO:0004672; GO:0043621; GO:0004712; GO:0004674; GO:0004713; GO:0048156; GO:0015631","GO:0034205; GO:0007623; GO:0043518; GO:0031115; GO:0048025; GO:0007399; GO:0036289; GO:0018105; GO:0018107; GO:0038083; GO:0018108; GO:0090312; GO:0033120; GO:0046777; GO:0006468; GO:0000381; GO:0016032"]
[618,306,"NK266-1","DYRK2","Pan-specific","Dual specificity tyrosine-phosphorylation-regulated kinase 2",0,2802,20,759,{"v":2111.538,"d":"2112"},{"v":3710.2824486773957,"d":"3710"},{"$nulls":3},0,2864,40,755,{"v":2132.12,"d":"2132"},{"v":3725.272352038155,"d":"3725"},{"$nulls":6},0,2068,32,718,{"v":1461.848,"d":"1462"},{"v":2500.9900810274326,"d":"2501"},{"$nulls":7},"DYRK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","DYRK","Dyrk2",{"$nulls":5},"CGSKHTMNDHLHVGSHAHGQ","Corresponds to amino acid residues G69 to Q87; Post-N-terminus.",{"$nulls":3},"Q92630","Q92630","Q92630"]
[623,309,"NK375-2","DYRK4","Pan-specific","Dual specificity tyrosine-phosphorylation-regulated kinase 4",0,492,12,612,{"v":293.76,"d":"294"},{"v":516.1794730303086,"d":"516"},{"v":493.7231356619557,"d":"494"},{"v":22.456337368352877,"d":"22"},{"v":4.548366431774502,"d":"5"},0,503,12,567,{"v":278.397,"d":"278"},{"v":486.41945434139086,"d":"486"},{"v":506.0205874302133,"d":"506"},{"v":19.60113308882245,"d":"20"},{"v":3.8735841141099217,"d":"4"},{"v":8.421950545884425,"d":"8"},{"v":2.4907586620930573,"d":"2"},null,0,572,16,630,{"v":350.28,"d":"350"},{"v":599.2735261000385,"d":"599"},{"v":621.7497050115928,"d":"622"},{"v":22.47617891155437,"d":"22"},{"v":3.614988271065652,"d":"4"},{"v":8.163354702840154,"d":"8"},{"v":25.930842632680438,"d":"26"},null,null,"DYRK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","DYRK","Dyrk2",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues 119-219 mapping within an internal region of mouse Dyrk4.",null,null,"EC 2.7.12.1; Protein kinase, dual-specificity; EC 2.7.1.-; CMGC domain target; CMGC</A> group; DYRK family; Dyrk2 subfamily","Q9NR20","Q9NR20","Q9NR20",null,"GO:0005737; GO:0043231; GO:0005634","GO:0005524; GO:0046872; GO:0004712; GO:0004674; GO:0004713"]
[628,311,"PN509","EEF1A1","Y141","Eukaryotic elongation factor 1-alpha 1",0,5917,14,932,{"v":5501.596,"d":"5502"},{"v":9667.112350577525,"d":"9667"},{"$nulls":3},0,6409,25,919,{"v":5866.896,"d":"5867"},{"v":10250.729537307114,"d":"10251"},{"$nulls":6},0,6348,22,896,{"v":5668.096,"d":"5668"},{"v":9697.213304195282,"d":"9697"},{"$nulls":7},"EEF1A1",{"$nulls":12},"LLA(pY)TLG(bA)C","Corresponds to amino acid residues L138 to G144; In the middle of the GTP_EFTU domain. ","The effect of Y141 phosphorylation is unclear. This is the second major in vivo phosphorylation site in EEF1A1 (≥1187 reports from high throughput mass spectrometry studies).",null,null,"P68104","P68104"]
[633,314,"NK052-6","EGFR (ErbB1)","Pan-specific","Epidermal growth factor receptor-tyrosine kinase",0,16770,20,971,{"v":16264.25,"d":"16264"},{"v":28578.676450957235,"d":"28579"},{"v":28400.908534912618,"d":"28401"},{"v":177.76791604461687,"d":"178"},{"v":0.6259233426497277,"d":"1"},0,16444,16,937,{"v":15393.036,"d":"15393"},{"v":26894.945605654466,"d":"26895"},{"v":27679.50461045959,"d":"27680"},{"v":784.5590048051235,"d":"785"},{"v":2.8344401962622294,"d":"3"},{"v":3.460363538911957,"d":"3"},{"v":-2.5400734049272415,"d":"-3"},null,0,16612,18,1013,{"v":16809.722,"d":"16810"},{"v":28758.76834447126,"d":"28759"},{"v":27797.995741086157,"d":"27798"},{"v":960.7726033851031,"d":"961"},{"v":3.4562657406449504,"d":"3"},{"v":4.082189083294678,"d":"4"},{"v":-2.1228644607805904,"d":"-2"},null,null,"EGFR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"CVIQGDERMHLPSPT","Corresponds to amino acid residues V980 to T993; Just after the catalytic domain of the kinase.",null,null,"Protein-tyrosine kinase (receptor), TK group, EGFR family","P00533","P00533","P00533","P00533","GO:0016324; GO:0016323; GO:0009986; GO:0030665; GO:0005737; GO:0031901; GO:0030139; GO:0005789; GO:0005768; GO:0010008; GO:0005615; GO:0005925; GO:0000139; GO:0016021; GO:0016020; GO:0045121; GO:0097489; GO:0031965; GO:0005634; GO:0048471; GO:0005886; GO:0032991; GO:0043235; GO:0070435; GO:0045202","GO:0051015; GO:0005524; GO:0045296; GO:0005516; GO:0003682; GO:0003690; GO:0019899; GO:0005006; GO:0048408; GO:0042802; GO:0005178; GO:0004709; GO:0046934; GO:0046982; GO:0019901; GO:0019903; GO:0004713; GO:0005088; GO:0004714; GO:0004888; GO:0031625; GO:0001618","GO:0043006; GO:0007202; GO:0048143; GO:0098609; GO:0008283; GO:0007166; GO:0071230; GO:0071276; GO:0071549; GO:0071364; GO:0071392; GO:0071260; GO:0034614; GO:0021795; GO:0007623; GO:0048546; GO:0016101; GO:0001892; GO:0007173; GO:0038128; GO:0061029; GO:0001942; GO:0042743; GO:0007611; GO:0097421; GO:0030324; GO:0010960; GO:0000165; GO:0061024; GO:0007494; GO:0060571; GO:0043066; GO:1905208; GO:0042059; GO:1901185; GO:0045930; GO:0045746; GO:0042177; GO:0048812; GO:0001503; GO:0042698; GO:0038083; GO:0018108; GO:0097755; GO:0045780; GO:0090263; GO:0030307; GO:0030335; GO:0008284; GO:0031659; GO:0045739; GO:0045740; GO:0050679; GO:0070374; GO:0048146; GO:0050729; GO:0043406; GO:1901224; GO:0010750; GO:0033138; GO:0042327; GO:1903800; GO:1902722; GO:0051897; GO:1900020; GO:1903078; GO:0001934; GO:0048661; GO:0032930; GO:0051968; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0051205; GO:2000145; GO:0070372; GO:0046328; GO:0050999; GO:0050730; GO:0014066; GO:0006357; GO:0051592; GO:0033590; GO:0033594; GO:0006970; GO:0070141; GO:0007435; GO:0007165; GO:0043586; GO:0006412; GO:0042060"]
[638,338,"NK052-5","EGFR (ErbB1)","Pan-specific","Epidermal growth factor receptor-tyrosine kinase",0,13180,28,1113,{"v":14638.176,"d":"14638"},{"v":25721.425564423036,"d":"25721"},{"$nulls":3},0,14368,26,1095,{"v":15704.49,"d":"15704"},{"v":27439.12275099886,"d":"27439"},{"$nulls":6},0,13279,22,1102,{"v":14609.214,"d":"14609"},{"v":24994.048153848486,"d":"24994"},{"$nulls":7},"EGFR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"SNMSMDFQNHLGSC","Corresponds to amino acid residues S174 to C187; In the extracellular domain of the EGF receptor.",{"$nulls":3},"P00533","P00533","P00533","P00533"]
[640,316,"PK602","EGFR (ErbB1)","Y869","Epidermal growth factor receptor-tyrosine kinase",0,6709,20,878,{"v":5872.942,"d":"5873"},{"v":10319.621822908384,"d":"10320"},{"$nulls":3},0,6860,40,935,{"v":6376.7,"d":"6377"},{"v":11141.466806390685,"d":"11141"},{"$nulls":6},0,6964,20,870,{"v":6041.28,"d":"6041"},{"v":10335.67194175414,"d":"10336"},{"$nulls":7},"EGFR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"EKE(pY)HAEG(bA)C","Corresponds to amino acid residues E866 to G873; In the protein kinase catalytic domain.","Y869 phosphorylation stimulates phosphotransferase activity and induces protein interaction with COX2 and PKCE and PKCZ. This is one of the major in vivo phosphorylation sites in EGFR (≥165 reports from high throughput mass spectrometry studies).","Src",null,"P00533","P00533","P00533","P00533"]
[645,319,"PK600","EGFR (ErbB1)","Y1110","Epidermal growth factor receptor-tyrosine kinase",0,666,12,606,{"v":396.324,"d":"396"},{"v":696.3994875723857,"d":"696"},{"v":687.4819670603051,"d":"687"},{"v":8.917520512080614,"d":"9"},{"v":1.2971279159818863,"d":"1"},0,642,14,464,{"v":291.392,"d":"291"},{"v":509.12451513287346,"d":"509"},{"v":556.501127359995,"d":"557"},{"v":47.3766122271216,"d":"47"},{"v":8.513300314749253,"d":"9"},{"v":9.810428230731139,"d":"10"},{"v":-19.0522582374616,"d":"-19"},null,0,730,14,601,{"v":430.316,"d":"430"},{"v":736.202428506521,"d":"736"},{"v":729.4651350676094,"d":"729"},{"v":6.737293438911593,"d":"7"},{"v":0.9235936188077251,"d":"1"},{"v":2.2207215347896114,"d":"2"},{"v":6.106802799035677,"d":"6"},null,null,"EGFR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"NPV(pY)HNQ(bA)C","Corresponds to amino acid residues N1107 to Q1113; In the cytoplasmic region of the EGFR after the kinase catalytic domain. ","Y1110 phosphorylation stimulates phosphotransferase activity, induces binding of CBL, DNA, DOK1, DOK2, GRB2, RASA1, SHC1 and STAT3. Phosphorylation regulates transcription, protein conformation, intracellular location, receptor internalization, molecular association, and ubquitination. One of the major in vivo sites of phosphorylation in EGFR (≥459 reports from high throughput mass spectrometry studies).","EGFR, Src","Protein-tyrosine kinase (receptor), TK group, EGFR family","P00533","P00533","P00533","P00533","GO:0016324; GO:0016323; GO:0009986; GO:0030665; GO:0005737; GO:0031901; GO:0030139; GO:0005789; GO:0005768; GO:0010008; GO:0005615; GO:0005925; GO:0000139; GO:0016021; GO:0016020; GO:0045121; GO:0097489; GO:0031965; GO:0005634; GO:0048471; GO:0005886; GO:0032991; GO:0043235; GO:0070435; GO:0045202","GO:0051015; GO:0005524; GO:0045296; GO:0005516; GO:0003682; GO:0003690; GO:0019899; GO:0005006; GO:0048408; GO:0042802; GO:0005178; GO:0004709; GO:0046934; GO:0046982; GO:0019901; GO:0019903; GO:0004713; GO:0005088; GO:0004714; GO:0004888; GO:0031625; GO:0001618","GO:0043006; GO:0007202; GO:0048143; GO:0098609; GO:0008283; GO:0007166; GO:0071230; GO:0071276; GO:0071549; GO:0071364; GO:0071392; GO:0071260; GO:0034614; GO:0021795; GO:0007623; GO:0048546; GO:0016101; GO:0001892; GO:0007173; GO:0038128; GO:0061029; GO:0001942; GO:0042743; GO:0007611; GO:0097421; GO:0030324; GO:0010960; GO:0000165; GO:0061024; GO:0007494; GO:0060571; GO:0043066; GO:1905208; GO:0042059; GO:1901185; GO:0045930; GO:0045746; GO:0042177; GO:0048812; GO:0001503; GO:0042698; GO:0038083; GO:0018108; GO:0097755; GO:0045780; GO:0090263; GO:0030307; GO:0030335; GO:0008284; GO:0031659; GO:0045739; GO:0045740; GO:0050679; GO:0070374; GO:0048146; GO:0050729; GO:0043406; GO:1901224; GO:0010750; GO:0033138; GO:0042327; GO:1903800; GO:1902722; GO:0051897; GO:1900020; GO:1903078; GO:0001934; GO:0048661; GO:0032930; GO:0051968; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0051205; GO:2000145; GO:0070372; GO:0046328; GO:0050999; GO:0050730; GO:0014066; GO:0006357; GO:0051592; GO:0033590; GO:0033594; GO:0006970; GO:0070141; GO:0007435; GO:0007165; GO:0043586; GO:0006412; GO:0042060"]
[650,321,"PK010","EGFR (ErbB1)","Y1172","Epidermal growth factor receptor-tyrosine kinase",0,861,16,379,{"v":320.255,"d":"320"},{"v":562.735080117516,"d":"563"},{"$nulls":3},0,447,14,357,{"v":154.581,"d":"155"},{"v":270.0862641175966,"d":"270"},{"$nulls":6},0,62,14,655,{"v":31.44,"d":"31"},{"v":53.788853661599894,"d":"54"},{"$nulls":7},"EGFR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues that encompass the Y1172 phosphosite.","Y1172 phosphorylation stimulates phosphotransferase activity. Phosphorylation regulates cell growth, protein degradation, receptor internalization, and induces molecular association with DOK1, DOK2, EGFR, GRB2, RASA1, SHC1, SHP-1 and VAV2. This is one of the major in vivo phosphorylation sites in EGFR (≥995 reports from high throughput mass spectrometry studies).","EGFR",null,"P00533","P00533","P00533","P00533"]
[651,322,"NN038-1","eIF2a","Pan-specific","Eukaryotic translation initiation factor 2 alpha",0,587,8,304,{"v":176.016,"d":"176"},{"v":309.28596856244144,"d":"309"},{"v":323.8720449704772,"d":"324"},{"v":14.586076408035751,"d":"15"},{"v":4.503654030827315,"d":"5"},0,830,10,305,{"v":250.1,"d":"250"},{"v":436.9785074220694,"d":"437"},{"v":414.5634843444296,"d":"415"},{"v":22.41502307763983,"d":"22"},{"v":5.406897598105114,"d":"5"},{"v":9.910551628932428,"d":"10"},{"v":28.00224372011465,"d":"28"},null,0,532,14,329,{"v":170.422,"d":"170"},{"v":291.56501331797637,"d":"292"},{"v":184.94366633818734,"d":"185"},{"v":106.62134697978902,"d":"107"},{"v":57.65071553454639,"d":"58"},{"v":62.154369565373706,"d":"62"},{"v":-42.89606984911401,"d":"-43"},{"$nulls":15},"ELSRR","Corresponds to amino acid residues  E50 to R54; Surrounds the S51 phosphosite.",null,null,"Protein synthesis protein","P05198","P05198",null,null,"GO:0010494; GO:0005829; GO:0033290; GO:0005850; GO:0070062; GO:0097451; GO:0016020; GO:0043614; GO:0005634; GO:0005844; GO:0005840; GO:0045202; GO:0044207","GO:0043022; GO:0003723; GO:0003743","GO:0007568; GO:0034198; GO:0034605; GO:0034599; GO:0034644; GO:1905098; GO:0032057; GO:0036499; GO:1901216; GO:2000676; GO:0046777; GO:0034976; GO:1990737; GO:0034063; GO:0006413; GO:0055085"]
[656,324,"PK604","EIF2AK3 (PERK)","T982","Eukaryotic translation initiation factor 2-alpha kinase 3",0,7615,20,855,{"v":6493.725,"d":"6494"},{"v":11410.428746268182,"d":"11410"},{"$nulls":3},0,8011,22,826,{"v":6598.914,"d":"6599"},{"v":11529.722472317464,"d":"11530"},{"$nulls":6},0,8232,22,805,{"v":6609.05,"d":"6609"},{"v":11307.036364255624,"d":"11307"},{"$nulls":7},"PERK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","PEK","PEK",{"$nulls":5},"ARH(pT)GQV(bA)C","Corresponds to amino acid residues A889 to V895; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T982 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is phosphorylation site in EIF2AK3 has not been reported from high throughput mass spectrometry studies.",null,null,"Q9NZJ5","Q9NZJ5","Q9NZJ5"]
[662,327,"NN039-3","eIF4E","Pan-specific","Eukaryotic translation initiation factor 4 (mRNA cap binding protein)",0,467,14,686,{"v":310.758,"d":"311"},{"v":546.0474560183573,"d":"546"},{"$nulls":3},0,518,18,709,{"v":354.5,"d":"355"},{"v":619.3877684171276,"d":"619"},{"$nulls":6},0,870,14,721,{"v":617.176,"d":"617"},{"v":1055.8902527815387,"d":"1056"},{"$nulls":20},"Not precisely defined.","Antibody raised against full length human eIF4E.",{"$nulls":3},"P06730","P06730",null,"P06730"]
[667,330,"PN031","eIF4G (eIF4G1)","S1106","Eukaryotic translation initiation factor 4 gamma 1",0,312,10,474,{"v":143.148,"d":"143"},{"v":251.5320642883395,"d":"252"},{"v":262.95703342519636,"d":"263"},{"v":11.424969136856845,"d":"11"},{"v":4.344804543935851,"d":"4"},0,324,12,448,{"v":139.776,"d":"140"},{"v":244.21874391614227,"d":"244"},{"v":366.17785537186114,"d":"366"},{"v":121.95911145571887,"d":"122"},{"v":33.305976772371146,"d":"33"},{"v":37.650781316307,"d":"38"},{"v":39.2538737611018,"d":"39"},null,0,368,12,507,{"v":180.492,"d":"180"},{"v":308.7931862305817,"d":"309"},{"v":332.7894477273247,"d":"333"},{"v":23.996261496743045,"d":"24"},{"v":7.2106437450518825,"d":"7"},{"v":11.555448288987733,"d":"12"},{"v":26.556587360495016,"d":"27"},{"$nulls":15},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S1106 phosphosite.","The effect of S1106 phosphorylation is unclear. This phosphosite has been poorly detected by mass spectrometry  (≥1 report).",null,"Protein synthesis protein","Q04637","Q04637",null,"Q04637","GO:0005737; GO:0005829; GO:0016281; GO:0016020; GO:0005634; GO:0005844","GO:0005524; GO:0008190; GO:0042802; GO:0003729; GO:0032947; GO:0003723; GO:0008135; GO:0003743; GO:0031369","GO:0001662; GO:0002191; GO:0034645; GO:0031669; GO:0032502; GO:0097009; GO:0007005; GO:0010507; GO:1901215; GO:0010801; GO:0000184; GO:0010942; GO:0030307; GO:0008284; GO:0032270; GO:1905537; GO:1900087; GO:1905618; GO:1905612; GO:0045666; GO:0033138; GO:0080135; GO:0060964; GO:0043488; GO:1905696; GO:1905606; GO:0006446; GO:0006412; GO:0006413; GO:0016032"]
[668,330,"PN031","eIF4G (eIF4G1)","S1106","Eukaryotic translation initiation factor 4 gamma 1",0,310,12,524,{"v":156.152,"d":"156"},{"v":274.3820025620532,"d":"274"},{"$nulls":3},0,474,16,610,{"v":279.38,"d":"279"},{"v":488.13696682758,"d":"488"},{"$nulls":6},0,404,12,532,{"v":208.544,"d":"209"},{"v":356.7857092240677,"d":"357"},{"$nulls":20},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S1106 phosphosite.","The effect of S1106 phosphorylation is unclear. This phosphosite has been poorly detected by mass spectrometry  (≥1 report).",null,null,"Q04637","Q04637",null,"Q04637"]
[673,333,"PN223","Elk-1","S383","ETS domain-containing protein Elk-1",0,144,15,664,{"v":85.656,"d":"86"},{"v":150.51017477493232,"d":"151"},{"v":173.34078443275774,"d":"173"},{"v":22.83060965782542,"d":"23"},{"v":13.170939391174763,"d":"13"},0,154,18,717,{"v":97.512,"d":"98"},{"v":170.37444308572904,"d":"170"},{"v":179.1175076644577,"d":"179"},{"v":8.74306457872865,"d":"9"},{"v":4.881189277771274,"d":"5"},{"v":18.052128668946036,"d":"18"},{"v":3.3325816833030757,"d":"3"},null,0,172,16,734,{"v":114.504,"d":"115"},{"v":195.89818383167412,"d":"196"},{"v":208.38818148296258,"d":"208"},{"v":12.489997651288462,"d":"12"},{"v":5.99362092533526,"d":"6"},{"v":19.164560316510023,"d":"19"},{"v":20.218782997258458,"d":"20"},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S383 phosphosite.","S383 phosphorylation stimulates DNA binding, transcriptional activity and potentiates ternary complex formation and binding to AurKA. This phosphorylation site in Elk-1 was not reported in high throughput mass spectrometry studies.","ERK1 (MAPK3); ERK2 (MAPK1); JNK1 (MAPK8); JNK2 (MAPK9); JNK3 (MAPK10); p38a MAPK (MAPK14)","Transcription protein","P19419","P19419",null,"P19419","GO:0043679; GO:0030425; GO:0005739; GO:0043025; GO:0005654; GO:0005634","GO:0003682; GO:0003700; GO:0000978; GO:0000981; GO:0001085; GO:0001077","GO:0030154; GO:0071480; GO:0071394; GO:1901216; GO:0045893; GO:0045944; GO:0071774; GO:0009416"]
[679,351,"PN173","ENFB2","Y316","Ephrin-B2",0,1304,12,245,{"v":316.54,"d":"317"},{"v":556.207279387983,"d":"556"},{"v":501.84466862882016,"d":"502"},{"v":54.36261075916286,"d":"54"},{"v":10.832557194977623,"d":"11"},0,1396,12,254,{"v":351.536,"d":"352"},{"v":614.2090227314059,"d":"614"},{"v":521.138366460479,"d":"521"},{"v":93.07065627092686,"d":"93"},{"v":17.85910657529471,"d":"18"},{"v":28.691663770272335,"d":"29"},{"v":3.8445557037348976,"d":"4"},null,0,1240,10,276,{"v":339.48,"d":"339"},{"v":580.7964389643745,"d":"581"},{"v":519.5140999644219,"d":"520"},{"v":61.28233899995257,"d":"61"},{"v":11.79608772969769,"d":"12"},{"v":22.628644924675314,"d":"23"},{"v":3.5208964925102464,"d":"4"},{"$nulls":15},"PV(pY)IV","Corresponds to amino acid residues P314 to V318","The effect of Y316 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in ephrin-B2 (≥125 reports from high throughput mass spectrometry studies).",null,"Ligand, receptor tyrosine kinase","P52799","P52799",null,null,"GO:0005925; GO:0005887; GO:0005886","GO:0046875; GO:0004713; GO:0001618","GO:0009653; GO:0007411; GO:0007155; GO:0007267; GO:0002042; GO:0048013; GO:0010977; GO:2000727; GO:0008284; GO:1901216; GO:0050920"]
[684,336,"PN512","ENO2","Y25","Gamma-enolase",0,6054,22,917,{"v":5531.344,"d":"5531"},{"v":9719.383956526959,"d":"9719"},{"$nulls":3},0,8136,18,866,{"v":7030.188,"d":"7030"},{"v":12283.250936171706,"d":"12283"},{"$nulls":6},0,7108,18,842,{"v":5969.78,"d":"5970"},{"v":10213.34678155044,"d":"10213"},{"$nulls":7},"ENO2",{"$nulls":11},"X","VDL(pY)TAK(bA)C","Corresponds to amino acid residues V22 to K28; In the Enolase_N domain. ","The effect of Y25 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in ENO2 (≥100 reports from high throughput mass spectrometry studies).",null,null,"P09104","P09104"]
[685,337,"PN748","EP300 (p300)","S2279","Histone acetyltransferase p300",0,3763,20,741,{"v":2773.563,"d":"2774"},{"v":4873.557624442953,"d":"4874"},{"v":5242.562866085952,"d":"5243"},{"v":369.00524164299895,"d":"369"},{"v":7.038642188348135,"d":"7"},0,3595,18,708,{"v":2532.516,"d":"2533"},{"v":4424.850306687364,"d":"4425"},{"v":5284.1027588827055,"d":"5284"},{"v":859.2524521953419,"d":"859"},{"v":16.261085209800616,"d":"16"},{"v":23.29972739814875,"d":"23"},{"v":0.7923585059031808,"d":"1"},null,0,4403,19,823,{"v":3608.032,"d":"3608"},{"v":6172.770523357812,"d":"6173"},{"v":6130.7043549789505,"d":"6131"},{"v":42.06616837886122,"d":"42"},{"v":0.6861555531494171,"d":"1"},{"v":7.724797741497552,"d":"8"},{"v":16.940979280160292,"d":"17"},{"$nulls":5},"Histone acetyltransferase and transcriptional co-activator ",{"$nulls":4},"X",{"$nulls":4},"NPM(pS)PQQ(bA)C","Corresponds to amino acid residues N2276 to Q2282.","S2279 phosphorylation stimulates enzyme activity. Phosphorylation at this site in EP300 has only been reported in a single mass spectrometry study. However, this human phosphosite is highly conserved in vertebrates and is found in fish.","ERK2 (MAPK1)","Transcription, coactivator/corepressor; EC 2.3.1.48; Acetyltransferase; Nuclear receptor co-regulator","Q09472","Q09472",null,"Q09472","GO:0005694; GO:0005829; GO:0000123; GO:0005654; GO:0005634; GO:0032993; GO:0005667","GO:0016407; GO:0033613; GO:0050681; GO:0008013; GO:0003682; GO:0031490; GO:0003684; GO:0003677; GO:0004402; GO:0140069; GO:0140068; GO:0004468; GO:0035257; GO:0002039; GO:0140065; GO:0061733; GO:0034212; GO:0097157; GO:0008022; GO:0061920; GO:0001102; GO:0000978; GO:0097677; GO:0001228; GO:0003713; GO:0008134; GO:0016746; GO:0008270","GO:0009887; GO:0006915; GO:0030183; GO:1904837; GO:0034644; GO:0007623; GO:0006977; GO:0045444; GO:0007507; GO:0016573; GO:0043969; GO:0043967; GO:0018393; GO:0006475; GO:0042771; GO:0030324; GO:0010742; GO:0035855; GO:0032460; GO:0000122; GO:0007399; GO:0007219; GO:0018076; GO:0018394; GO:0140067; GO:0140066; GO:0061921; GO:0030220; GO:0043923; GO:0051091; GO:0045815; GO:0010976; GO:0045747; GO:0032092; GO:0045893; GO:0045944; GO:0006990; GO:0007221; GO:0032481; GO:0006473; GO:0031648; GO:0050821; GO:0060765; GO:0010506; GO:0051726; GO:1900034; GO:0045652; GO:1901796; GO:0006355; GO:0061418; GO:0090043; GO:0043627; GO:0001666; GO:0007519; GO:0001756; GO:0002223; GO:0006283; GO:0016032"]
[690,340,"PK606","EphA2","Y588","Ephrin type-A receptor 2 protein-tyrosine kinase",0,5606,18,689,{"v":3850.132,"d":"3850"},{"v":6765.247504279439,"d":"6765"},{"$nulls":3},0,5284,24,733,{"v":3855.58,"d":"3856"},{"v":6736.527763480138,"d":"6737"},{"$nulls":6},0,6831,20,760,{"v":5176.36,"d":"5176"},{"v":8855.93099681168,"d":"8856"},{"$nulls":7},"EPHA2","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Eph",{"$nulls":6},"LKT(pY)VDP(bA)C","Corresponds to amino acid residues L585 to P591; In the EphA2-TM domain located prior to the kinase catalytic domain. ","Y588 phosphorylation stimulates phosphotransferase activity and regulates cell adhesion, cell differentiation, cell motility and molecular association, including inducing interaction with Nck1, VAV2 and VAV3. One of the major in vivo sites of phosphorylation in EphA2 (≥655 reports from high throughput mass spectrometry studies).","EphA2",null,"P29317","P29317","P29317","P29317"]
[695,343,"NK376-1","EphA4","Pan-specific","Ephrin type-A receptor 4 protein-tyrosine kinase",0,347,14,413,{"v":137.529,"d":"138"},{"v":241.65865586323977,"d":"242"},{"v":267.58623693043313,"d":"268"},{"v":25.92758106719336,"d":"26"},{"v":9.689429981383531,"d":"10"},0,398,10,402,{"v":155.976,"d":"156"},{"v":272.52362924296165,"d":"273"},{"v":260.10442400203374,"d":"260"},{"v":12.419205240927909,"d":"12"},{"v":4.77469973399253,"d":"5"},{"v":14.46412971537606,"d":"14"},{"v":-2.796038022816731,"d":"-3"},null,0,490,10,565,{"v":271.2,"d":"271"},{"v":463.98018807334256,"d":"464"},{"v":445.657076663809,"d":"446"},{"v":18.323111409533567,"d":"18"},{"v":4.1114822066106225,"d":"4"},{"v":13.800912187994154,"d":"14"},{"v":66.5470846991546,"d":"67"},null,null,"EPHA4","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Eph",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 889-921 near the C-terminus of human EphA4.",null,null,"Receptor tyrosine kinase; EC 2.7.1.112; EC 2.7.10.1; TK group; Eph family","P54764","P54764","P54764","P54764","GO:0030424; GO:0044295; GO:0043679; GO:0030054; GO:0009986; GO:0005737; GO:0030425; GO:0043198; GO:0043197; GO:0031901; GO:0005783; GO:0030175; GO:0098978; GO:0005794; GO:0005887; GO:0099055; GO:0099056; GO:0005741; GO:0031594; GO:0043204; GO:0005886; GO:0014069; GO:0098685","GO:0005524; GO:0097161; GO:0046875; GO:0005004; GO:0042802; GO:0016301; GO:0042731; GO:0004672; GO:1990782; GO:0005005","GO:0007628; GO:0007155; GO:1904646; GO:0021957; GO:0048013; GO:0097156; GO:0097155; GO:0008347; GO:0008045; GO:0048681; GO:1900272; GO:0010977; GO:1903051; GO:0072178; GO:0106030; GO:0097485; GO:0018108; GO:1902004; GO:1902961; GO:0050775; GO:0043507; GO:0061098; GO:2001108; GO:0046777; GO:0050821; GO:0048710; GO:0050770; GO:0061001; GO:0043087; GO:1905244; GO:0098883"]
[697,344,"PK609","EphB1","Y594","Ephrin type-B receptor 1 protein-tyrosine kinase",0,5484,18,577,{"v":3153.882,"d":"3154"},{"v":5541.83397589793,"d":"5542"},{"v":6098.222241416503,"d":"6098"},{"v":556.3882655185726,"d":"556"},{"v":9.12377810273661,"d":"9"},0,6021,14,574,{"v":3448.018,"d":"3448"},{"v":6024.429265111671,"d":"6024"},{"v":6319.673680082408,"d":"6320"},{"v":295.2444149707371,"d":"295"},{"v":4.671830064600537,"d":"5"},{"v":13.795608167337146,"d":"14"},{"v":3.631409776473916,"d":"4"},null,0,6362,16,633,{"v":4017.018,"d":"4017"},{"v":6872.480704771396,"d":"6872"},{"v":7044.815469980893,"d":"7045"},{"v":172.33476520949716,"d":"172"},{"v":2.4462637232138116,"d":"2"},{"v":11.570041825950423,"d":"12"},{"v":15.522445576606515,"d":"16"},null,null,"EPHB1","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK","Eph",{"$nulls":6},"MKI(pY)IDP(bA)C","Corresponds to amino acid residues M591 to P597; In the region between the transmembrane domain and the kinase catalytic domain. ","Y594 phosphorylation induces binding to Nck1. This is one of the two major in vivo phosphorylation sites in EphB1 (≥127 reports from high throughput mass spectrometry studies).",null,"EC 2.7.10.1; Receptor tyrosine kinase; TK group; Eph family","P54762","P54762","P54762",null,"GO:0030424; GO:0005829; GO:0030425; GO:0031901; GO:0005783; GO:0070062; GO:0005576; GO:0032433; GO:0098978; GO:0005887; GO:0045121; GO:0005886","GO:0005524; GO:0008046; GO:0044877; GO:0004713; GO:0005005","GO:0001525; GO:0007411; GO:0048593; GO:0060326; GO:0031589; GO:0021952; GO:0060996; GO:0060997; GO:0050965; GO:0048013; GO:0030010; GO:0001771; GO:0050804; GO:1902725; GO:1902723; GO:0061351; GO:0022008; GO:0021631; GO:0051965; GO:0046777; GO:0070372; GO:0046328; GO:1901214; GO:0031290; GO:0014719"]
[702,346,"NK267-2","EphB2","Pan-specific","Ephrin type-B receptor 2 protein-tyrosine kinase",0,8408,16,631,{"v":5295.352,"d":"5295"},{"v":9304.711345554162,"d":"9305"},{"$nulls":3},0,8447,20,715,{"v":6025.305,"d":"6025"},{"v":10527.504140994532,"d":"10528"},{"$nulls":6},0,8746,20,743,{"v":6483.418,"d":"6483"},{"v":11092.099937308609,"d":"11092"},{"$nulls":7},"EPHB2","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Eph",{"$nulls":6},"REIQGIFFKEDSHKESNDC","Corresponds to amino acid residues R1033 to C1051; Near C-terminus.",{"$nulls":3},"P29323","P29323","P29323","P29323"]
[707,349,"PK612","EphB4","Y596","Ephrin type-B receptor 4 protein-tyrosine kinase",0,4931,18,764,{"v":3753.532,"d":"3754"},{"v":6595.507113842594,"d":"6596"},{"v":6632.739299484067,"d":"6633"},{"v":37.232185641472824,"d":"37"},{"v":0.5613395003233274,"d":"1"},0,5037,16,743,{"v":3730.603,"d":"3731"},{"v":6518.166056474588,"d":"6518"},{"v":6507.549103654315,"d":"6508"},{"v":10.616952820272672,"d":"11"},{"v":0.16314825522116644,"d":"0"},{"v":0.7244877555444937,"d":"1"},{"v":-1.8874584116322666,"d":"-2"},null,0,5368,16,814,{"v":4356.528,"d":"4357"},{"v":7453.328468977814,"d":"7453"},{"v":7525.840770936888,"d":"7526"},{"v":72.51230195907374,"d":"73"},{"v":0.9635109772598435,"d":"1"},{"v":1.5248504775831708,"d":"2"},{"v":13.465047111414322,"d":"13"},null,null,"EPHB4","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Eph",{"$nulls":6},"PFT(pY)EDP(bA)C","Corresponds to amino acid residues P593 to P599; In the EphA2_TM region between the transmembrane and kinase catalytic domains. ","The effect of Y596 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites for EphB4 (≥216 reports from high throughput mass spectrometry studies).",null,"Receptor tyrosine kinase; EC 2.7.10.1; EC 2.7.1.112; TK group; Eph family","P54760","P54760","P54760",null,"GO:0005829; GO:0070062; GO:0005576; GO:0005887; GO:0005886","GO:0005524; GO:0005003; GO:0004713; GO:0004714","GO:0001525; GO:0007155; GO:0002042; GO:0048013; GO:0003007; GO:0046777"]
[712,353,"PN198","ERa (ESR1)","S104","Estrogen receptor",1,2087,12,400,830,{"v":1458.4319261136852,"d":"1458"},{"$nulls":3},1,2412,14,352,{"v":844.096,"d":"844"},{"v":1474.8173138782051,"d":"1475"},{"$nulls":6},1,12,2,716,{"v":7.16,"d":"7"},{"v":12.249624434384708,"d":"12"},{"$nulls":10},"Transcription protein (receptor)",{"$nulls":4},"X",{"$nulls":4},"SV(pS)PS","Corresponds to amino acid residues S102 to S106.","S104 phosphorylation stimulates transcriptional activity and regulates molecular association, including inducing interactions with CBP, NCoA2, SRC-2, SRC-3 and Src. This is a minor in vivo phosphorylation sites in the estrogen receptor (≥1 report from high throughput mass spectrometry studies).","BARK2 (GRK3, ADRBK2); CDK2; CDK3; ERK1 (MAPK3); ERK2 (MAPK1); GSK3b; mTOR",null,"P03372","P03372",null,"P03372"]
[717,356,"NK054-6","ErbB2 (HER2, Neu)","Pan-specific","ErbB2 (Neu) receptor-tyrosine kinase",0,5036,14,639,{"v":3209.058,"d":"3209"},{"v":5638.78631319341,"d":"5639"},{"v":5626.825414252378,"d":"5627"},{"v":11.9608989410317,"d":"12"},{"v":0.2125692208387261,"d":"0"},0,5969,18,642,{"v":3820.542,"d":"3821"},{"v":6675.308839277601,"d":"6675"},{"v":6055.272854042187,"d":"6055"},{"v":620.035985235414,"d":"620"},{"v":10.23960439406971,"d":"10"},{"v":10.452173614908435,"d":"10"},{"v":7.614372372467429,"d":"8"},null,0,5553,16,668,{"v":3698.716,"d":"3699"},{"v":6327.916465006937,"d":"6328"},{"v":6291.829687326144,"d":"6292"},{"v":36.08677768079269,"d":"36"},{"v":0.5735498173684448,"d":"1"},{"v":0.7861190382071709,"d":"1"},{"v":11.818462882984676,"d":"12"},null,null,"ERBB2","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"CPALVTYNTDTFES","Corresponds to amino acid residues C268 to S281; In the extracellular domain of the receptor.",null,null,"Receptor tyrosine kinase; EC 2.7.10.1; TK group; EGFR family","P04626","P04626","P04626","P04626","GO:0016324; GO:0016323; GO:0005829; GO:0010008; GO:0016021; GO:0043209; GO:0005634; GO:0048471; GO:0005886; GO:0043235","GO:0005524; GO:0043125; GO:0042802; GO:0046934; GO:0008022; GO:0046983; GO:0046982; GO:0019903; GO:0004713; GO:0005088; GO:0001042; GO:0004714; GO:0004888","GO:0008283; GO:0007166; GO:0071364; GO:0071363; GO:0007167; GO:0038128; GO:0007507; GO:0000165; GO:0008045; GO:0042552; GO:1901185; GO:0033088; GO:0007528; GO:0048709; GO:0007422; GO:0014065; GO:0045785; GO:0030307; GO:0050679; GO:0043547; GO:0043406; GO:0051897; GO:0001934; GO:0090314; GO:0045943; GO:0045945; GO:0045727; GO:0046777; GO:0006468; GO:0045765; GO:2000145; GO:0070372; GO:0032886; GO:0006357; GO:0007165; GO:0006351; GO:0007169; GO:0042060"]
[720,357,"PK614","ErbB2 (HER2, Neu)","Y735","ErbB2 (Neu) receptor-tyrosine kinase",0,4314,12,653,{"v":2809.206,"d":"2809"},{"v":4936.187611361592,"d":"4936"},{"$nulls":3},0,4619,18,612,{"v":2815.812,"d":"2816"},{"v":4919.829368017402,"d":"4920"},{"$nulls":6},0,5015,16,715,{"v":3574.285,"d":"3574"},{"v":6115.034758583065,"d":"6115"},{"$nulls":7},"ERBB2","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"GTV(pY)KGIW(bA)C","Corresponds to amino acid residues G732 to W739; In the region between the Transmembrane and kinase catalytic domains. ","Y735 phosphorylation induces interaction with SHC1. This is one of the major in vivo phosphorylation sites in ErbB2 (≥147 reports from high throughput mass spectrometry studies).",null,null,"P04626","P04626","P04626","P04626"]
[724,359,"PK613","ErbB2 (HER2, Neu)","Y1248","ErbB2 (Neu) receptor-tyrosine kinase",0,8614,18,716,{"v":6154.736,"d":"6155"},{"v":10814.77527614607,"d":"10815"},{"$nulls":3},0,9242,16,665,{"v":6135.29,"d":"6135"},{"v":10719.671598566767,"d":"10720"},{"$nulls":6},0,9382,20,720,{"v":6740.64,"d":"6741"},{"v":11532.165984272478,"d":"11532"},{"$nulls":7},"ERBB2","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"NPE(pY)LGL(bA)C","Corresponds to amino acid residues N1245 to L1251; In the C-terminus of the kinase after the catalytic domain.","Y1248 phosphorylation stimulates phosphotransferase activity. Phosphorylation regulates cell motility, cytoskeletal reorganization, transcription, intracellular location and induces molecular association with CPNE3, RACK1 and SHC1. This is the major in vivo phosphorylation site in ErbB2 (≥196 reports from high throughput mass spectrometry studies).","ErbB2",null,"P04626","P04626","P04626","P04626"]
[729,362,"NK231-3","ErbB3 (HER3)","Pan-specific","ErbB3 (HER3) receptor-tyrosine kinase",0,6028,20,805,{"v":4836.44,"d":"4836"},{"v":8498.335547871411,"d":"8498"},{"v":8413.764067625807,"d":"8414"},{"v":84.5714802456041,"d":"85"},{"v":1.0051563077578483,"d":"1"},0,6414,16,806,{"v":5156.788,"d":"5157"},{"v":9010.018086093716,"d":"9010"},{"v":8381.101006283227,"d":"8381"},{"v":628.9170798104897,"d":"629"},{"v":7.50399117417863,"d":"8"},{"v":8.509147481936479,"d":"9"},{"v":-0.3882098556609179,"d":"-0"},null,0,6524,18,830,{"v":5399.98,"d":"5400"},{"v":9238.509351004013,"d":"9239"},{"v":9164.823411843547,"d":"9165"},{"v":73.68593916046666,"d":"74"},{"v":0.8040082808932637,"d":"1"},{"v":1.8091645886511118,"d":"2"},{"v":8.926555798107529,"d":"9"},null,null,"ERBB3","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"CSEKANKVLARIFKET","Corresponds to amino acid residues S693 to T707.",null,null,"Receptor tyrosine kinase; EC 2.7.10.1; TK group; EGFR family","P21860","P21860","P21860","P21860","GO:0016324; GO:0016323; GO:0005615; GO:0005887; GO:0005622; GO:0016328; GO:0005886; GO:0043235","GO:0005524; GO:0019838; GO:0042802; GO:0038132; GO:0046934; GO:0046982; GO:0042803; GO:0030296; GO:0004713; GO:0005088; GO:0004888; GO:0031625","GO:0021545; GO:0003197; GO:0038128; GO:0097192; GO:0007507; GO:0000165; GO:0007162; GO:0043524; GO:0051048; GO:0009968; GO:0051402; GO:0007422; GO:0014065; GO:0070886; GO:0055025; GO:0010628; GO:0014068; GO:0051897; GO:0061098; GO:2000145; GO:0042127; GO:0014037; GO:0007165; GO:0007169; GO:0042060"]
[734,364,"PK617","ErbB3 (HER3)","Y1307","ErbB3 (HER3) receptor-tyrosine kinase",0,4500,18,678,{"v":3038.796,"d":"3039"},{"v":5339.610967887424,"d":"5340"},{"$nulls":3},0,4302,14,690,{"v":2958.72,"d":"2959"},{"v":5169.5203897633955,"d":"5170"},{"$nulls":6},0,4536,18,684,{"v":3090.312,"d":"3090"},{"v":5287.033712998921,"d":"5287"},{"$nulls":7},"ERBB3","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"HVH(pY)ARL(bA)C","Corresponds to amino acid residues H1304 to L1310; In the cytoplasmic region of ErbB3 near the C-terminus after the kinase catalytic domain. ","The effect of Y1307 phosphorylation is unclear. This is a major in vivo phosphorylation site in ErbB3 (≥133 reports from high throughput mass spectrometry studies).",null,null,"P21860","P21860","P21860","P21860"]
[735,365,"PK618","ErbB3 (HER3)","Y1328","ErbB3 (HER3) receptor-tyrosine kinase",0,6388,18,588,{"v":3745.56,"d":"3746"},{"v":6581.499138764307,"d":"6581"},{"v":6624.377037392049,"d":"6624"},{"v":42.87789862774207,"d":"43"},{"v":0.6472744287608163,"d":"1"},0,6780,16,621,{"v":4200.444,"d":"4200"},{"v":7339.07936677324,"d":"7339"},{"v":6882.633388220835,"d":"6883"},{"v":456.445978552405,"d":"456"},{"v":6.63185081648518,"d":"7"},{"v":7.2791252452459965,"d":"7"},{"v":3.898575660337997,"d":"4"},null,0,7294,16,657,{"v":4781.646,"d":"4782"},{"v":8180.637943879596,"d":"8181"},{"v":7787.614902931407,"d":"7788"},{"v":393.0230409481883,"d":"393"},{"v":5.046770363545415,"d":"5"},{"v":5.694044792306231,"d":"6"},{"v":17.55995860400654,"d":"18"},null,null,"ERBB3","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"NPD(pY)WHS(bA)C","Corresponds to amino acid residues N1325 to S1331; In the cytoplasmic region of ErbB3 near the C-terminus after the kinase catalytic domain. ","Y1328 phosphoryation induces interaction with Shc1. This is one of the major in vivo phosphorylation sites in ErbB3 (≥214 reports from high throughput mass spectrometry studies).",null,"Receptor tyrosine kinase; EC 2.7.10.1; TK group; EGFR family","P21860","P21860","P21860","P21860","GO:0016324; GO:0016323; GO:0005615; GO:0005887; GO:0005622; GO:0016328; GO:0005886; GO:0043235","GO:0005524; GO:0019838; GO:0042802; GO:0038132; GO:0046934; GO:0046982; GO:0042803; GO:0030296; GO:0004713; GO:0005088; GO:0004888; GO:0031625","GO:0021545; GO:0003197; GO:0038128; GO:0097192; GO:0007507; GO:0000165; GO:0007162; GO:0043524; GO:0051048; GO:0009968; GO:0051402; GO:0007422; GO:0014065; GO:0070886; GO:0055025; GO:0010628; GO:0014068; GO:0051897; GO:0061098; GO:2000145; GO:0042127; GO:0014037; GO:0007165; GO:0007169; GO:0042060"]
[742,368,"PK619","ErbB4 (HER4)","Y733","ErbB4  receptor-tyrosine kinase",0,378,11,479,{"v":175.793,"d":"176"},{"v":308.8941248039796,"d":"309"},{"$nulls":3},0,376,14,455,{"v":164.71,"d":"165"},{"v":287.7838063074333,"d":"288"},{"$nulls":6},0,452,12,491,{"v":216.04,"d":"216"},{"v":369.61017636933974,"d":"370"},{"$nulls":7},"ERBB4","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"GTV(pY)KGI(bA)C","Corresponds to amino acid residues G730 to I736; In the region between the transmembrane and kinase catalytic domains. ","Y733 phosphorylation induces interaction with SHC1. This is the major in vivo site of phosphorylation in ErbB4 (≥146 reports from high throughput mass spectrometry studies).",null,null,"Q15303","Q15303","Q15303","Q15303"]
[746,370,"PN584","ERF","T526","ETS domain-containing transcription factor ERF",0,8666,14,678,{"v":5866.056,"d":"5866"},{"v":10307.522109362337,"d":"10308"},{"$nulls":3},0,8878,18,614,{"v":5440.04,"d":"5440"},{"v":9504.920269957436,"d":"9505"},{"$nulls":6},0,9614,14,708,{"v":6796.8,"d":"6797"},{"v":11628.246837377932,"d":"11628"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"CGGPL(pT)PRR","Corresponds to amino acid residues C522 to R529.","T526 phosphorylation inhibits ERF transcriptional repression by inducing its export from the nucleus, and regulates cell cycle progression. Phosphorylation induces transcriptional activity. This is the major in vivo phosphorylation site in ERF (≥150 reports from high throughput mass spectrometry studies).","ERK1; ERK2",null,"P50548","P50548"]
[751,373,"NK055-4","ERK1 (MAPK3)","Pan-specific","Extracellular regulated protein-serine kinase 1 (p44 MAP kinase)",0,626,14,502,{"v":307.224,"d":"307"},{"v":539.8376988775311,"d":"540"},{"v":542.1782185469087,"d":"542"},{"v":2.3405196693776134,"d":"2"},{"v":0.4316882510792185,"d":"0"},0,638,14,509,{"v":317.616,"d":"318"},{"v":554.9434850594482,"d":"555"},{"v":524.583874723719,"d":"525"},{"v":30.359610335729258,"d":"30"},{"v":5.7873701039168735,"d":"6"},{"v":6.219058354996092,"d":"6"},{"v":-3.245121847636071,"d":"-3"},null,0,778,12,536,{"v":410.576,"d":"411"},{"v":702.4304192418906,"d":"702"},{"v":685.6966794943044,"d":"686"},{"v":16.73373974758624,"d":"17"},{"v":2.440399705585163,"d":"2"},{"v":2.8720879566643815,"d":"3"},{"v":26.470716830351336,"d":"26"},null,null,"ERK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","ERK",{"$nulls":5},"CGGGGGEPRRTEGVGPGVPGEVEMVKGGC","Corresponds to amino acid residues G8 to K32; N-terminus.",null,null,"EC 2.7.1.123; EC 2.7.11.24; Protein kinase, Ser/Thr (non-receptor); CMGC group; MAPK family; MAPK/ERK subfamily; ERK subfamily","P27361","P27361","P27361","P27361","GO:0005901; GO:0005737; GO:0005856; GO:0005829; GO:0005769; GO:0005925; GO:0005794; GO:0005770; GO:0005739; GO:0005635; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:0031143","GO:0005524; GO:0042802; GO:0016301; GO:0004707; GO:0004708; GO:0019902; GO:0001784; GO:0004674; GO:0097110","GO:0000187; GO:0006915; GO:0019369; GO:0007411; GO:0060020; GO:0030509; GO:0061308; GO:0051216; GO:0072584; GO:0007049; GO:0034198; GO:0071276; GO:1903351; GO:0071260; GO:0034614; GO:0071356; GO:0006975; GO:0070371; GO:0060324; GO:0038095; GO:0038096; GO:0008543; GO:0070498; GO:0031663; GO:0060425; GO:0000165; GO:2000657; GO:0042473; GO:0018105; GO:0038083; GO:0016310; GO:0030168; GO:0031281; GO:0002741; GO:0070374; GO:0010628; GO:0035066; GO:0033129; GO:0010759; GO:1905050; GO:0001934; GO:0051973; GO:1904355; GO:0032212; GO:0045944; GO:0045727; GO:1904417; GO:0065003; GO:0006468; GO:0030641; GO:1900034; GO:0051493; GO:0051090; GO:2000641; GO:0090170; GO:0030278; GO:0014066; GO:0032872; GO:0070849; GO:0043330; GO:0009636; GO:0019233; GO:0051403; GO:0048538; GO:0030878; GO:0060440; GO:0006361; GO:0016032"]
[752,373,"NK055-4","ERK1 (MAPK3)","Pan-specific","Extracellular regulated protein-serine kinase 1 (p44 MAP kinase)",0,590,14,538,{"v":309.888,"d":"310"},{"v":544.5187382162864,"d":"545"},{"$nulls":3},0,580,12,498,{"v":282.864,"d":"283"},{"v":494.22426438798976,"d":"494"},{"$nulls":6},0,714,12,557,{"v":391.014,"d":"391"},{"v":668.9629397467182,"d":"669"},{"$nulls":7},"ERK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","ERK",{"$nulls":5},"CGGGGGEPRRTEGVGPGVPGEVEMVKGGC","Corresponds to amino acid residues G8 to K32; N-terminus.",{"$nulls":3},"P27361","P27361","P27361","P27361"]
[757,376,"PK864","ERK1 (MAPK3)","Y204","Extracellular regulated protein-serine kinase 1 (p44 MAP kinase)",0,7146,12,682,{"v":4865.388,"d":"4865"},{"v":8549.201436301699,"d":"8549"},{"v":8011.73061429703,"d":"8012"},{"v":537.4708220046687,"d":"537"},{"v":6.708548350908671,"d":"7"},0,7682,18,643,{"v":4927.952,"d":"4928"},{"v":8610.192361485813,"d":"8610"},{"v":8061.337921201918,"d":"8061"},{"v":548.8544402838952,"d":"549"},{"v":6.808478265628429,"d":"7"},{"v":13.5170266165371,"d":"14"},{"v":0.6191834110892671,"d":"1"},null,0,7328,14,695,{"v":5083.23,"d":"5083"},{"v":8696.600337094605,"d":"8697"},{"v":8811.366999986702,"d":"8811"},{"v":114.76666289209606,"d":"115"},{"v":1.302484199015536,"d":"1"},{"v":8.011032549924208,"d":"8"},{"v":9.980819677869718,"d":"10"},null,null,"ERK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","ERK",{"$nulls":5},"C(bA)(pY)VATRW","Corresponds to amino acid residues Y204 to W209; In activation T-loop between kinase catalytic subdomains VII and VIII."," Y204 phosphorylation stimulates phosphotransferase activity and induces molecular association with ERK1, GSK3B, KSR and TACE and regulates cell growth, cell motility, cytoskeletal reorganization, transcription, protein conformation, intracellular location, and protein degradation. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the two major in vivo phosphorylation sitesin ERK1 (≥3626 reports, respectively, from high throughput mass spectrometry studies).","ERK1; JAK2; LCK;  MEK1; MEK2; RET","EC 2.7.1.123; EC 2.7.11.24; Protein kinase, Ser/Thr (non-receptor); CMGC group; MAPK family; MAPK/ERK subfamily; ERK subfamily","P27361","P27361","P27361","P27361","GO:0005901; GO:0005737; GO:0005856; GO:0005829; GO:0005769; GO:0005925; GO:0005794; GO:0005770; GO:0005739; GO:0005635; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:0031143","GO:0005524; GO:0042802; GO:0016301; GO:0004707; GO:0004708; GO:0019902; GO:0001784; GO:0004674; GO:0097110","GO:0000187; GO:0006915; GO:0019369; GO:0007411; GO:0060020; GO:0030509; GO:0061308; GO:0051216; GO:0072584; GO:0007049; GO:0034198; GO:0071276; GO:1903351; GO:0071260; GO:0034614; GO:0071356; GO:0006975; GO:0070371; GO:0060324; GO:0038095; GO:0038096; GO:0008543; GO:0070498; GO:0031663; GO:0060425; GO:0000165; GO:2000657; GO:0042473; GO:0018105; GO:0038083; GO:0016310; GO:0030168; GO:0031281; GO:0002741; GO:0070374; GO:0010628; GO:0035066; GO:0033129; GO:0010759; GO:1905050; GO:0001934; GO:0051973; GO:1904355; GO:0032212; GO:0045944; GO:0045727; GO:1904417; GO:0065003; GO:0006468; GO:0030641; GO:1900034; GO:0051493; GO:0051090; GO:2000641; GO:0090170; GO:0030278; GO:0014066; GO:0032872; GO:0070849; GO:0043330; GO:0009636; GO:0019233; GO:0051403; GO:0048538; GO:0030878; GO:0060440; GO:0006361; GO:0016032"]
[760,377,"PK183","ERK1 (MAPK3)","Y204","Extracellular regulated protein-serine kinase 1 (p44 MAP kinase)",0,378,10,474,{"v":174.432,"d":"174"},{"v":306.5026478745329,"d":"307"},{"$nulls":3},0,376,10,511,{"v":187.026,"d":"187"},{"v":326.77465945269876,"d":"327"},{"$nulls":6},0,500,12,570,{"v":278.16,"d":"278"},{"v":475.8876442274373,"d":"476"},{"$nulls":7},"ERK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","ERK",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues surrounding the phosphorylated Tyr-204 of human ERK2."," Y204 phosphorylation stimulates phosphotransferase activity and induces molecular association with ERK1, GSK3B, KSR and TACE and regulates cell growth, cell motility, cytoskeletal reorganization, transcription, protein conformation, intracellular location, and protein degradation. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the two major in vivo phosphorylation sitesin ERK1 (≥3626 reports, respectively, from high throughput mass spectrometry studies).","ERK1; JAK2; LCK;  MEK1; MEK2; RET",null,"P27361","P27361","P27361","P27361"]
[768,381,"PK879","ERK1 (MAPK3)","S283","Extracellular regulated protein-serine kinase 1 (p44 MAP kinase)",0,13228,18,749,{"v":9894.29,"d":"9894"},{"v":17385.720990635393,"d":"17386"},{"$nulls":3},0,13807,24,711,{"v":9799.713,"d":"9800"},{"v":17122.206956835867,"d":"17122"},{"$nulls":6},0,13592,22,712,{"v":9661.84,"d":"9662"},{"v":16529.875886189322,"d":"16530"},{"$nulls":7},"ERK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","ERK",{"$nulls":5},"YLQ(pS)LPS(bA)C","Corresponds to amino acid residues Y280 to S286. S283 is located in the Gap/Insert 10 (G/I10) region in the protein-serine/threonine kinase catalytic domain of ERK1.","The effect of S283 phosphorylation is unknown. Phosphorylation of S283 has not been observed in any mass spectrometry studies with human ERK1, although it was reported to be found in hamster ERK1.",null,null,"P27361","P27361","P27361","P27361"]
[769,382,"NK056-3","ERK2 (MAPK1)","Pan-specific","Extracellular regulated protein-serine kinase 2 (p42 MAP kinase)",0,10300,20,686,{"v":7052.08,"d":"7052"},{"v":12391.540503021442,"d":"12392"},{"v":12146.910511752109,"d":"12147"},{"v":244.6299912693339,"d":"245"},{"v":2.0139276652499825,"d":"2"},0,11666,22,660,{"v":7685.04,"d":"7685"},{"v":13427.418267408639,"d":"13427"},{"v":12584.676998320609,"d":"12585"},{"v":842.7412690880301,"d":"843"},{"v":6.6965665404085595,"d":"7"},{"v":8.710494205658541,"d":"9"},{"v":3.603932754299649,"d":"4"},null,0,9692,20,727,{"v":7031.544,"d":"7032"},{"v":12029.856591319998,"d":"12030"},{"v":12442.719404580106,"d":"12443"},{"v":412.86281326010794,"d":"413"},{"v":3.3181075602181873,"d":"3"},{"v":5.33203522546817,"d":"5"},{"v":2.4352603284744987,"d":"2"},null,null,"ERK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","ERK",{"$nulls":5},"HKNKVPWNRLFPNADC","Corresponds to amino acid residues H269 to D283; Pre-kinase last alpha-chain.",null,null,"EC 2.7.11.24; Protein kinase, Ser/Thr (non-receptor); CMGC domain target; CMGC</A> group; MAPK family; ERK subfamily; MAPK/ERK subfamily","P28482","P28482","P28482","P28482","GO:0030424; GO:0035578; GO:0005901; GO:0005737; GO:0005856; GO:0005829; GO:0032839; GO:0005769; GO:0005576; GO:1904813; GO:0005925; GO:0005794; GO:0005770; GO:0005815; GO:0005739; GO:0072686; GO:0005654; GO:0005634; GO:0043204; GO:0005886; GO:0014069; GO:0032991; GO:0031143","GO:0005524; GO:0003677; GO:0042802; GO:0016301; GO:0004707; GO:0004708; GO:0031435; GO:0019902; GO:0001784; GO:0004674; GO:0008353; GO:0008134","GO:0000187; GO:0006915; GO:0007411; GO:0050853; GO:0060020; GO:0061308; GO:0072584; GO:0007049; GO:0034198; GO:0071276; GO:0006974; GO:1903351; GO:0097011; GO:0034614; GO:0071356; GO:0007268; GO:0006935; GO:0019858; GO:0015966; GO:0038127; GO:0070371; GO:0060324; GO:0038095; GO:0038096; GO:0008543; GO:0060716; GO:0007611; GO:0031663; GO:0060291; GO:0060425; GO:0033598; GO:0000165; GO:0045596; GO:0043312; GO:0042473; GO:0018105; GO:0018107; GO:0030168; GO:0030335; GO:0008284; GO:0010628; GO:0010800; GO:0033160; GO:0051973; GO:1904355; GO:0032212; GO:0045893; GO:0045727; GO:0006468; GO:0030641; GO:1900034; GO:0051493; GO:0051090; GO:2000641; GO:0090170; GO:0030278; GO:0014066; GO:0031647; GO:0032872; GO:0070849; GO:0043627; GO:0043330; GO:0035094; GO:0019233; GO:0007165; GO:0051403; GO:0050852; GO:0048538; GO:0030878; GO:0060440; GO:0006351; GO:0016032"]
[774,384,"PK880","ERK2 (MAPK1)","Y263+S266","Extracellular regulated protein-serine kinase 2 (p42 MAP kinase)",0,8267,12,745,{"v":6149.975,"d":"6150"},{"v":10806.409499760255,"d":"10806"},{"$nulls":3},0,4760,12,965,{"v":4581.82,"d":"4582"},{"v":8005.425289390588,"d":"8005"},{"$nulls":6},0,8634,18,718,{"v":6186.288,"d":"6186"},{"v":10583.757631695657,"d":"10584"},{"$nulls":7},"ERK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","ERK",{"$nulls":5},"ARN(pY)LL(pS)LPH(bA)C","Corresponds to amino acid residues A260 to H269. Y263 and S266 are located in the Gap/Insert 10 (G/I10) region in the protein-serine/threonine kinase catalytic domain of ERK2.","The effects of Y263 and S266 phosphorylation are unknown. Phosphorylation of Y263 has only been observed once in a mass spectrometry studies with human ERK2, and phosphorylation of S266 has not been reported.",null,null,"P28482","P28482","P28482","P28482"]
[779,387,"NK058","ERK4 (MAPK4)","Pan-specific","Extracellular regulated protein-serine kinase 4",0,158,8,409,{"v":61.35,"d":"61"},{"v":107.80096224948745,"d":"108"},{"v":94.2445739242259,"d":"94"},{"v":13.556388325261551,"d":"14"},{"v":14.384264006712044,"d":"14"},0,164,13,401,{"v":60.551,"d":"61"},{"v":105.79562416199012,"d":"106"},{"v":101.95961331414864,"d":"102"},{"v":3.8360108478414787,"d":"4"},{"v":3.7622846175596143,"d":"4"},{"v":18.14654862427166,"d":"18"},{"v":8.18618947349239,"d":"8"},null,0,188,14,464,{"v":80.736,"d":"81"},{"v":138.12649138749777,"d":"138"},{"v":126.78703457868465,"d":"127"},{"v":11.339456808813111,"d":"11"},{"v":8.94370378366708,"d":"9"},{"v":23.327967790379127,"d":"23"},{"v":34.52979763123912,"d":"35"},null,null,"ERK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","ERK",{"$nulls":5},"APVDGGASPQFDLDVFISRALKLCTKPEDLP ","Corresponds to amino acid residues A527 to P557; C-terminus.",null,null,"Protein-serine kinase, CMGC group, MAPK family, ERK subfamily","P31152","P31152","P31152","P31152","GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0004707; GO:0046982; GO:0042803; GO:0019901; GO:0004674","GO:0007049; GO:0071310; GO:0006468; GO:0010468"]
[783,389,"NK206-3","ERK5 (MAPK7)","Pan-specific","Extracellular regulated protein-serine kinase 5 (Big MAP kinase 1 (BMK1))",0,400,12,565,{"v":219.22,"d":"219"},{"v":385.2017431839061,"d":"385"},{"v":338.85172228387387,"d":"339"},{"v":46.350020900032234,"d":"46"},{"v":13.678555501394912,"d":"14"},0,377,12,534,{"v":194.91,"d":"195"},{"v":340.54970364508415,"d":"341"},{"v":327.10488311484494,"d":"327"},{"v":13.444820530239213,"d":"13"},{"v":4.110247576316004,"d":"4"},{"v":17.788803077710917,"d":"18"},{"v":-3.4666606059590777,"d":"-3"},null,0,432,10,578,{"v":243.916,"d":"244"},{"v":417.3015912761705,"d":"417"},{"v":399.647418854604,"d":"400"},{"v":17.6541724215665,"d":"18"},{"v":4.417436867768005,"d":"4"},{"v":18.095992369162918,"d":"18"},{"v":17.941681441358696,"d":"18"},null,null,"ERK5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","ERK",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues at the C-terminus of human ERK5.",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.24; CMGC domain target; CMGC</A> group; MAPK family; MAPK/ERK subfamily; ERK subfamily","Q13164","Q13164","Q13164","Q13164","GO:0005737; GO:0005829; GO:0005654; GO:0005634; GO:0016605","GO:0005524; GO:0004707; GO:0051019; GO:0004674","GO:0007411; GO:0019933; GO:0007049; GO:0071363; GO:0070301; GO:0071499; GO:0071560; GO:0070885; GO:0051344; GO:2000352; GO:0070377; GO:2001240; GO:0034115; GO:0050728; GO:0043407; GO:1902176; GO:0060761; GO:0018105; GO:0051247; GO:0045944; GO:0036003; GO:0045765; GO:0007165"]
[786,390,"NK206-5","ERK5 (MAPK7)","Pan-specific","Extracellular regulated protein-serine kinase 5 (Big MAP kinase 1 (BMK1))",0,5268,12,666,{"v":3500.496,"d":"3500"},{"v":6150.885691124398,"d":"6151"},{"$nulls":3},0,5356,16,646,{"v":3449.64,"d":"3450"},{"v":6027.263248074641,"d":"6027"},{"$nulls":6},0,5572,12,700,3892,{"v":6658.594734444872,"d":"6659"},{"$nulls":7},"ERK5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","ERK",{"$nulls":5},"CADIESLQREIQMDSP","Corresponds to amino acid residues A790 to D802; Pre-C-terminus.",{"$nulls":3},"Q13164","Q13164","Q13164","Q13164"]
[791,393,"PN585","ESRRA (ERR1)","S19+S22","Steroid hormone receptor ERR1",0,7156,21,647,{"v":4616.345,"d":"4616"},{"v":8111.59630115094,"d":"8112"},{"v":7940.744515300519,"d":"7941"},{"v":170.85178585042104,"d":"171"},{"v":2.151583966984677,"d":"2"},0,7431,20,623,{"v":4617.053,"d":"4617"},{"v":8066.984920546133,"d":"8067"},{"v":7811.735133820677,"d":"7812"},{"v":255.24978672545603,"d":"255"},{"v":3.2675171693976104,"d":"3"},{"v":5.419101136382287,"d":"5"},{"v":-1.6246509534623783,"d":"-2"},null,0,7008,20,667,{"v":4660.996,"d":"4661"},{"v":7974.224928794608,"d":"7974"},{"v":7803.5120412336855,"d":"7804"},{"v":170.71288756092235,"d":"171"},{"v":2.187641752314561,"d":"2"},{"v":4.339225719299238,"d":"4"},{"v":-1.7282066411078887,"d":"-2"},{"$nulls":5},"Receptor,  nuclear",{"$nulls":4},"X",{"$nulls":4},"CAEPA(pS)PD(pS)PKG","Corresponds to amino acid residues C15 to G25.","S19 and S22 phosphorylation represses transactivation activity in response to coactivator. Phosphorylation enhanced the sumoylation at Lys-14, and contributes to regulating GRIP-1-dependent activated transcriptional activation by ERRα1. These are two of the major in vivo phosphorylation sites in ESRRA (≥19 and ≥16 reports, respectively, from high throughput mass spectrometry studies).",null,"Receptor, nuclear","P11474","P11474",null,"P11474","GO:0005737; GO:0001650; GO:0045171; GO:0015630; GO:0005654; GO:0005634","GO:0003677; GO:0003700; GO:0004879; GO:0019904; GO:0000978; GO:0000981; GO:0043565; GO:0005496; GO:0003707; GO:0001077; GO:0001078; GO:0008270","GO:0051216; GO:0007005; GO:1900078; GO:0045944; GO:0042127; GO:0045667; GO:0045670; GO:0006355; GO:0032355; GO:0006367"]
[796,395,"PN586","Ets-1","S282","Protein C-ets-1",0,7234,20,671,{"v":4840.594,"d":"4841"},{"v":8505.634736089576,"d":"8506"},{"$nulls":3},0,7252,22,619,{"v":4475.37,"d":"4475"},{"v":7819.434237351087,"d":"7819"},{"$nulls":6},0,7342,26,662,{"v":4843.192,"d":"4843"},{"v":8285.933388773261,"d":"8286"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"RVP(pS)YD(pS)SFDSC","Corresponds to amino acid residues R279 to S289.","S282 phosphorylation inhibits transcriptional activity by inhibiting DNA binding. This is one of the major in vivo phosphorylation sites in Ets-1 (≥95 reports from high throughput mass spectrometry studies).","CaMK2a",null,"P14921","P14921",null,"P14921"]
[801,398,"PN224","EZR","Y146","Ezrin; Cytovilin",0,455,14,477,{"v":210.357,"d":"210"},{"v":369.62815021867044,"d":"370"},{"v":377.487868297594,"d":"377"},{"v":7.8597180789235495,"d":"8"},{"v":2.0821114369501568,"d":"2"},0,526,12,467,{"v":240.038,"d":"240"},{"v":419.3980286468561,"d":"419"},{"v":400.5944992711012,"d":"401"},{"v":18.80352937575492,"d":"19"},{"v":4.69390603464819,"d":"5"},{"v":6.776017471598347,"d":"7"},{"v":6.121158562714669,"d":"6"},null,0,540,10,526,{"v":278.78,"d":"279"},{"v":476.94836589633644,"d":"477"},{"v":472.6421780888858,"d":"473"},{"v":4.306187807450613,"d":"4"},{"v":0.9110883469737194,"d":"1"},{"v":2.993199783923876,"d":"3"},{"v":25.207249764190195,"d":"25"},{"$nulls":15},"Not precisely defined.","Antibody raised against amino acid residues that encompass the Y146 phosphosite.","Y146 phosphorylation induces interaction with EGFR. This is one of the minor in vivo phosphorylation sites in Ezrin (≥1 report from high throughput mass spectrometry studies).","EGFR, Lck, Src","Cytoskeletal protein","P15311","P15311",null,null,"GO:0015629; GO:0005884; GO:0045177; GO:0016324; GO:0097449; GO:0016323; GO:0005903; GO:0044297; GO:0071944; GO:0042995; GO:0051286; GO:0036064; GO:0030863; GO:0005737; GO:0098592; GO:0005829; GO:0005768; GO:0070062; GO:0005615; GO:0019898; GO:0001650; GO:0030175; GO:0005925; GO:0001772; GO:0071437; GO:0016020; GO:0044393; GO:0005902; GO:0031528; GO:0043209; GO:0048471; GO:0005886; GO:0044853; GO:0032991; GO:0001726; GO:0032587; GO:0097454; GO:0030315; GO:0001931; GO:0031982","GO:0003779; GO:0051015; GO:0051117; GO:0045296; GO:0050839; GO:0097718; GO:0042802; GO:0008017; GO:0008022; GO:0019904; GO:0051018; GO:0034236; GO:0034237; GO:0003723; GO:0044548","GO:0031532; GO:0051017; GO:0030953; GO:0007411; GO:0034629; GO:0071320; GO:0043622; GO:0007016; GO:0051660; GO:0061028; GO:0035088; GO:0046847; GO:0001951; GO:0007159; GO:0022614; GO:0030033; GO:0070373; GO:1900041; GO:1903753; GO:0050860; GO:0000122; GO:0048015; GO:1903364; GO:2000643; GO:0010628; GO:0040018; GO:1902966; GO:1903078; GO:0050714; GO:0010737; GO:0072697; GO:0072659; GO:0031623; GO:0008360; GO:0032532; GO:1902115; GO:0003376; GO:1902896"]
[806,400,"PN174","EZR","T567","Ezrin; Cytovilin",0,390,8,273,{"v":104.286,"d":"104"},{"v":183.24582150203827,"d":"183"},{"$nulls":3},0,67,8,488,{"v":28.792,"d":"29"},{"v":50.30581841541873,"d":"50"},{"$nulls":6},0,315,8,310,{"v":95.17,"d":"95"},{"v":162.8207761760325,"d":"163"},{"$nulls":20},"YK(pT)LR","Corresponds to amino acid residues Y565 to R569.","T567 phosphorylation induces activity and binding of ACTA1, and inhibits interaction with ezrin and moesin. This is one of the less major in vivo phosphorylation sites in Ezrin (≥23 reports from high throughput mass spectrometry studies).","Akt1 (PKBa); Akt2 (PKBb); Akt3 (PKBg); BARK1 (GRK2; ADRBK1); Cot; LOK (STK10); LRRK2; MST4; NIK (MAP3K14); PKCa (PRKCA); PKCi (PRKCI); PKCt (PRKCQ; PKCq); ROCK1; ROCK2",null,"P15311","P15311"]
[808,401,"NK060","FAK (PTK2)","Pan-specific","Focal adhesion protein-tyrosine kinase",0,188,12,538,{"v":94.688,"d":"95"},{"v":166.3807255660875,"d":"166"},{"$nulls":3},0,168,12,504,{"v":78.624,"d":"79"},{"v":137.37304345283002,"d":"137"},{"$nulls":6},0,212,10,589,{"v":118.978,"d":"119"},{"v":203.5524882617631,"d":"204"},{"$nulls":7},"FAK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Fak",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues at the C-terminus of human FAK.",{"$nulls":3},"Q05397","Q05397","Q05397","Q05397"]
[813,404,"PK627","FAK (PTK2)","Y397","Focal adhesion protein-tyrosine kinase",0,8686,18,747,{"v":6474.996,"d":"6475"},{"v":11377.51914199808,"d":"11378"},{"v":11385.837475417626,"d":"11386"},{"v":8.318333419545525,"d":"8"},{"v":0.07305859966388123,"d":"0"},0,8782,20,712,{"v":6238.544,"d":"6239"},{"v":10900.078551007224,"d":"10900"},{"v":10978.287395266427,"d":"10978"},{"v":78.20884425920303,"d":"78"},{"v":0.7123956719599526,"d":"1"},{"v":0.7854542716238337,"d":"1"},{"v":-3.5794475464023776,"d":"-4"},null,0,9529,20,778,{"v":7398.002,"d":"7398"},{"v":12656.808109612703,"d":"12657"},{"v":12103.20463930368,"d":"12103"},{"v":553.6034703090227,"d":"554"},{"v":4.574023878859843,"d":"5"},{"v":4.647082478523724,"d":"5"},{"v":6.300521726529752,"d":"6"},null,null,"FAK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Fak",{"$nulls":6},"TDD(pY)AEI(bA)C","Corresponds to amino acid residues T394 to I400; In the region between the FERM_M and kinase catalytic domains. ","Y397 phosphorylation stimulates phosphotransferase activity and induces interaction with Src and other Src family kinases, Bmx, PIK3R1, RASA1 and SHC1, and this leads to phosphorylation at Y576, Y577 and additional tyrosine phosphosites.  Phosphorylation inhibits interaction with PI3KR2. Phosphorylation regulates apoptosis, cell adhesion, cell differentiation, cell growth, cell motility, cytoskeletal reorganization, endocytosis, transcription, alters intracellular location, protein degradation and molecular associations. This is one of the major in vivo phosphorylation sites in FAK (≥485 reports from high throughput mass spectrometry studies).","EphB2; FAK (PTK2); Fgr; Met; Src","Protein-tyrosine kinase, TK group, Fak family","Q05397","Q05397","Q05397","Q05397","GO:0016324; GO:0005938; GO:0005737; GO:0005856; GO:0005829; GO:0031234; GO:0005925; GO:0030027; GO:0005815; GO:0005634; GO:0005886; GO:0001725","GO:0003779; GO:0005524; GO:0008432; GO:0004715; GO:0004672; GO:0019901; GO:0019903; GO:0004713; GO:0005088; GO:0042169; GO:0005102","GO:0001525; GO:0007411; GO:0048870; GO:0021955; GO:0043542; GO:0048013; GO:0007173; GO:0030010; GO:0030198; GO:0038096; GO:0060396; GO:0003007; GO:0045087; GO:0007229; GO:0000165; GO:0000226; GO:2000811; GO:0043066; GO:0010507; GO:0050771; GO:0022408; GO:0046621; GO:0051964; GO:0038007; GO:0001764; GO:0007097; GO:0038083; GO:0018108; GO:0001890; GO:0010613; GO:0030335; GO:0008284; GO:0043552; GO:0014068; GO:0045860; GO:0051897; GO:0001934; GO:2000060; GO:0046777; GO:0033628; GO:0042127; GO:0008360; GO:0051493; GO:0010594; GO:0010632; GO:0051893; GO:0043087; GO:0045667; GO:0001932; GO:1900024; GO:0007172; GO:0007179; GO:0048010; GO:0001570"]
[818,406,"PK628","FAK (PTK2)","Y576+Y577","Focal adhesion protein-tyrosine kinase",0,7705,18,738,{"v":5673.006,"d":"5673"},{"v":9968.304900523486,"d":"9968"},{"$nulls":3},0,8043,18,690,{"v":5537.25,"d":"5537"},{"v":9674.767054069787,"d":"9675"},{"$nulls":6},0,8046,20,749,{"v":6011.474,"d":"6011"},{"v":10284.678602942511,"d":"10285"},{"$nulls":7},"FAK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Fak",{"$nulls":6},"DST(pY)(pY)KAS(bA)C","Corresponds to amino acid residues D573 to S580; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y576 and Y577 phosphorylation stimulates phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major in vivo phosphorylation sites in FAK (≥2549 and ≥1764 reports, respectively, by mass spectrometry).","Y576: FAK (PTK2); Fgr, Met; Src. Y577: FAK (PTK2); Fgr, Met; Src.",null,"Q05397","Q05397","Q05397","Q05397"]
[819,407,"PK629","FAK (PTK2)","Y577","Focal adhesion protein-tyrosine kinase",0,7304,16,701,{"v":5108.888,"d":"5109"},{"v":8977.066706191677,"d":"8977"},{"v":9033.037106363365,"d":"9033"},{"v":55.97040017168729,"d":"56"},{"v":0.6196188448319191,"d":"1"},0,7285,20,693,{"v":5034.645,"d":"5035"},{"v":8796.607986805218,"d":"8797"},{"v":8448.042933688726,"d":"8448"},{"v":348.565053116492,"d":"349"},{"v":4.125985815324161,"d":"4"},{"v":4.74560466015608,"d":"5"},{"v":-6.4761626215676245,"d":"-6"},null,0,7760,18,746,{"v":5775.532,"d":"5776"},{"v":9881.019261001507,"d":"9881"},{"v":9488.289629353669,"d":"9488"},{"v":392.7296316478387,"d":"393"},{"v":4.139098267330094,"d":"4"},{"v":4.758717112162013,"d":"5"},{"v":5.0398610968795765,"d":"5"},null,null,"FAK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Fak",{"$nulls":6},"STY(pY)KAS(bA)C","Corresponds to amino acid residues S574 to S580; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y577 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in FAK (≥1764 reports from high throughput mass spectrometry studies).","FAK (PTK2); Fgr, Met; Src","Protein-tyrosine kinase, TK group, Fak family","Q05397","Q05397","Q05397","Q05397","GO:0016324; GO:0005938; GO:0005737; GO:0005856; GO:0005829; GO:0031234; GO:0005925; GO:0030027; GO:0005815; GO:0005634; GO:0005886; GO:0001725","GO:0003779; GO:0005524; GO:0008432; GO:0004715; GO:0004672; GO:0019901; GO:0019903; GO:0004713; GO:0005088; GO:0042169; GO:0005102","GO:0001525; GO:0007411; GO:0048870; GO:0021955; GO:0043542; GO:0048013; GO:0007173; GO:0030010; GO:0030198; GO:0038096; GO:0060396; GO:0003007; GO:0045087; GO:0007229; GO:0000165; GO:0000226; GO:2000811; GO:0043066; GO:0010507; GO:0050771; GO:0022408; GO:0046621; GO:0051964; GO:0038007; GO:0001764; GO:0007097; GO:0038083; GO:0018108; GO:0001890; GO:0010613; GO:0030335; GO:0008284; GO:0043552; GO:0014068; GO:0045860; GO:0051897; GO:0001934; GO:2000060; GO:0046777; GO:0033628; GO:0042127; GO:0008360; GO:0051493; GO:0010594; GO:0010632; GO:0051893; GO:0043087; GO:0045667; GO:0001932; GO:1900024; GO:0007172; GO:0007179; GO:0048010; GO:0001570"]
[824,409,"PK024","FAK (PTK2)","S910","Focal adhesion protein-tyrosine kinase",0,48,10,674,{"v":25.612,"d":"26"},{"v":45.004046375450244,"d":"45"},{"$nulls":3},0,38,10,661,{"v":18.508,"d":"19"},{"v":32.33745787831931,"d":"32"},{"$nulls":6},0,234,12,390,{"v":86.58,"d":"87"},{"v":148.12464853757376,"d":"148"},{"$nulls":7},"FAK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Fak",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S910 phosphosite.","S910 phosphorylation regulates cell adhesion, cell growth, and cytoskeletal reorganization. This is one of the minor in vivo phosphorylation sites in FAK (≥46 reports from high throughput mass spectrometry studies).","CDK5; ERK1 (MAPK3); ERK2 (MAPK1)",null,"Q05397","Q05397","Q05397","Q05397"]
[830,412,"PN750","FBPase (FBP1)","S88","Fructose-1,6-bisphosphatase isoform 1",0,14728,18,694,{"v":10208.74,"d":"10209"},{"v":17938.255833004605,"d":"17938"},{"$nulls":3},0,15600,18,670,{"v":10439.94,"d":"10440"},{"v":18240.8212665972,"d":"18241"},{"$nulls":6},0,15868,22,722,{"v":11440.812,"d":"11441"},{"v":19573.414835810305,"d":"19573"},{"$nulls":19},"X","MLK(pS)SFATC","Corresponds to amino acid residues M85 to C93.","S88 phosphorylation inhibits enzyme activity. Phosphorylation at this site in fructose-1,6-bisphosphatase isoform 1 has only been reported in a single mass spectrometry study. However, this human phosphosite is highly conserved in vertebrates and found in fish.","ULK1",null,"P09467","P09467"]
[835,415,"PN751","FBPase 2 (FBP2)","Y259","Fructose-1,6-bisphosphatase isoform 2",0,5562,12,648,{"v":3596.4,"d":"3596"},{"v":6319.403107319587,"d":"6319"},{"v":7050.193473997873,"d":"7050"},{"v":730.7903666782859,"d":"731"},{"v":10.365536341286886,"d":"10"},0,5924,16,663,{"v":3917.004,"d":"3917"},{"v":6843.848706462518,"d":"6844"},{"v":6486.6148454109025,"d":"6487"},{"v":357.23386105161535,"d":"357"},{"v":5.507246376811601,"d":"6"},{"v":15.872782718098486,"d":"16"},{"v":-7.993803725607378,"d":"-8"},null,0,5471,12,665,{"v":3630.235,"d":"3630"},{"v":6210.756334994215,"d":"6211"},{"v":6450.073107332597,"d":"6450"},{"v":239.31677233838218,"d":"239"},{"v":3.7102955014001493,"d":"4"},{"v":14.075831842687034,"d":"14"},{"v":-8.512112027543736,"d":"-9"},{"$nulls":14},"X","RTLV(pY)GGI(bA)C","Corresponds to amino acid residues T256 to I262.","The effect of Y259 phosphorylation is unclear. Phosphorylation at this site in fructose-1,6-bisphosphatase isoform 2 has only been reported in a single mass spectrometry study. However, this human phosphosite is highly conserved in vertebrates and found in yeast.",null,"Carbohydrate Metabolism - fructose and mannose; Carbohydrate Metabolism - glycolysis and gluconeogenesis; Phosphatase (non-protein); Carbohydrate Metabolism - pentose phosphate pathway; EC 3.1.3.11","O00757","O00757",null,null,"GO:0030054; GO:0005829; GO:0070062; GO:0005654; GO:0005886; GO:0030018","GO:0042132; GO:0042802; GO:0046872","GO:0030388; GO:0006002; GO:0006000; GO:0006094; GO:0005986"]
[836,415,"PN751","FBPase 2 (FBP2)","Y259","Fructose-1,6-bisphosphatase isoform 2",0,5748,12,772,{"v":4428.192,"d":"4428"},{"v":7780.983840676159,"d":"7781"},{"$nulls":3},0,5556,14,633,{"v":3508.086,"d":"3508"},{"v":6129.380984359287,"d":"6129"},{"$nulls":6},0,5764,14,680,3910,{"v":6689.389879670979,"d":"6689"},{"$nulls":19},"X","RTLV(pY)GGI(bA)C","Corresponds to amino acid residues T256 to I262.","The effect of Y259 phosphorylation is unclear. Phosphorylation at this site in fructose-1,6-bisphosphatase isoform 2 has only been reported in a single mass spectrometry study. However, this human phosphosite is highly conserved in vertebrates and found in yeast.",null,null,"O00757","O00757"]
[841,418,"PK632","Fes","Y713","Fes/Fps protein-tyrosine kinase",0,2566,20,622,{"v":1583.612,"d":"1584"},{"v":2782.6389149117413,"d":"2783"},{"v":2766.8158070868576,"d":"2767"},{"v":15.823107824883664,"d":"16"},{"v":0.5718887316009517,"d":"1"},0,2726,18,582,{"v":1576.056,"d":"1576"},{"v":2753.7089104102242,"d":"2754"},{"v":2775.7185795745418,"d":"2776"},{"v":22.00966916431753,"d":"22"},{"v":0.7929359023021397,"d":"1"},{"v":1.3648246339030914,"d":"1"},{"v":0.32176961201683696,"d":"0"},null,0,3083,22,630,{"v":1928.43,"d":"1928"},{"v":3299.237883798953,"d":"3299"},{"v":3255.752572477588,"d":"3256"},{"v":43.485311321365316,"d":"43"},{"v":1.3356454568743081,"d":"1"},{"v":1.90753418847526,"d":"2"},{"v":17.67146060602873,"d":"18"},null,null,"FES","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Fer",{"$nulls":6},"DGV(pY)AAS(bA)C","Corresponds to amino acid residues D710 to S716; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y713 phosphorylation stimulates phosphotransferase activity, and regulates cell differentiation, cell growth and molecular association, including inducing interaction with Fes. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in Fes (≥120 reports from high throughput mass spectrometry studies).","Fes","Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; Fer family","P07332","P07332","P07332","P07332","GO:0005737; GO:0031410; GO:0005829; GO:0031234; GO:0005925; GO:0005794; GO:0015630","GO:0005524; GO:0034987; GO:0008017; GO:0004715; GO:0035091; GO:0004713","GO:0016477; GO:0008283; GO:0007098; GO:0006935; GO:0007173; GO:0045087; GO:0001578; GO:0007275; GO:0038083; GO:0018108; GO:2000251; GO:0031116; GO:0045639; GO:0010976; GO:0046777; GO:0006468; GO:0030155; GO:0045595; GO:2000145; GO:0042127; GO:0008360; GO:0043304; GO:0060627"]
[847,421,"PK634","FGFR1","Y653+Y654","Fibroblast growth factor receptor-tyrosine kinase 1; Basic fibroblast growth factor receptor 1",0,7252,14,697,{"v":5044.886,"d":"5045"},{"v":8864.605790366224,"d":"8865"},{"v":8628.28534678194,"d":"8628"},{"v":236.32044358428357,"d":"236"},{"v":2.738903896733354,"d":"3"},0,8538,16,698,{"v":5948.356,"d":"5948"},{"v":10393.057682907282,"d":"10393"},{"v":9907.064549060937,"d":"9907"},{"v":485.9931338463448,"d":"486"},{"v":4.905521019265093,"d":"5"},{"v":7.644424915998447,"d":"8"},{"v":14.820780153683003,"d":"15"},null,0,7238,12,734,{"v":5303.884,"d":"5304"},{"v":9074.10433569024,"d":"9074"},{"v":9107.484562273938,"d":"9107"},{"v":33.38022658369846,"d":"33"},{"v":0.3665142263536723,"d":"0"},{"v":3.105418123087026,"d":"3"},{"v":5.553817429910595,"d":"6"},null,null,"FGFR1","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","FGFR",{"$nulls":6},"HID(pY)(pY)KKT(bA)C","Corresponds to amino acid residues H650 to T657; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y653 and Y654 phosphorylation stimulate phosphotransferase activity. Phosphorylation regulates cell differentiation, cell growth, and cell motility. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. They correspond to the two major in vivo phosphorylation sites in FGFR1 (≥332 and ≥186 reports, respectively, from high throughput mass spectrometry studies).","Y653: FGFR1. Y654: FGFR1.","Receptor tyrosine kinase; EC 2.7.10.1; TK group; FGFR family","P11362","P11362","P11362","P11362","GO:0031410; GO:0005829; GO:0005576; GO:0016021; GO:0005887; GO:0005730; GO:0005886; GO:0043235","GO:0016303; GO:0005524; GO:0005007; GO:0017134; GO:0008201; GO:0042802; GO:0046934; GO:0042803; GO:0004713; GO:0005088; GO:0090722","GO:0001525; GO:0060117; GO:0060445; GO:0048469; GO:0016477; GO:0002062; GO:0043009; GO:0030326; GO:0008543; GO:0035607; GO:0042472; GO:0001701; GO:0060484; GO:0000165; GO:0048762; GO:0030901; GO:0042474; GO:0090272; GO:0000122; GO:0001764; GO:0001759; GO:0042473; GO:0048339; GO:0018108; GO:0048015; GO:0043536; GO:0060045; GO:0008284; GO:2000546; GO:0043410; GO:0043406; GO:0090080; GO:0002053; GO:1903465; GO:0045666; GO:0010976; GO:2000830; GO:0014068; GO:0010518; GO:0010863; GO:0051897; GO:1905564; GO:0046777; GO:0006468; GO:0060665; GO:0045595; GO:2001239; GO:0048378; GO:0010966; GO:0007605; GO:0001501; GO:0048705; GO:0006351; GO:0001657; GO:0021847; GO:0070640"]
[852,423,"NK063-2","FGFR2 (BEK)","Pan-specific","Fibroblast growth factor receptor-tyrosine kinase 2 (BEK)",0,9120,12,915,{"v":8333.82,"d":"8334"},{"v":14643.745969258736,"d":"14644"},{"$nulls":3},0,9616,18,878,{"v":8427.044,"d":"8427"},{"v":14723.858892843286,"d":"14724"},{"$nulls":6},0,9878,24,864,{"v":8513.856,"d":"8514"},{"v":14565.857330786712,"d":"14566"},{"$nulls":7},"FGFR2","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","FGFR",{"$nulls":6},"CLPQYPHINGSVKT","Corresponds to amino acid residues C808 to T821; C-terminus.",{"$nulls":3},"P21802","P21802","P21802","P21802"]
[853,424,"PK635","FGFR2 (BEK)","Y656+Y657","Fibroblast growth factor receptor-tyrosine kinase 2 (BEK)",0,6270,21,756,{"v":4724.244,"d":"4724"},{"v":8301.19069439882,"d":"8301"},{"v":8390.573242853701,"d":"8391"},{"v":89.38254845488154,"d":"89"},{"v":1.0652734428009334,"d":"1"},0,6910,17,741,{"v":5107.713,"d":"5108"},{"v":8924.273502920034,"d":"8924"},{"v":8763.027385352205,"d":"8763"},{"v":161.24611756782906,"d":"161"},{"v":1.8400731902009027,"d":"2"},{"v":2.905346633001836,"d":"3"},{"v":4.438959433620653,"d":"4"},null,0,6700,19,785,{"v":5244.585,"d":"5245"},{"v":8972.653151425633,"d":"8973"},{"v":8942.952089275754,"d":"8943"},{"v":29.701062149879363,"d":"30"},{"v":0.33211697718359023,"d":"0"},{"v":1.3973904199845237,"d":"1"},{"v":6.583326674283143,"d":"7"},null,null,"FGFR2","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","FGFR",{"$nulls":6},"DID(pY)(pY)KK(bA)C","Corresponds to amino acid residues D653 to K659; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y656 and Y657 phosphorylation is predicted to be stimulatory for phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. They correspond to two of the major in vivo phosphorylation sites in FGFR2 (≥74 and ≥42 reports, respectively, from high throughput mass spectrometry studies).",null,"EC 2.7.10.1; Receptor tyrosine kinase; TK group; FGFR family","P21802","P21802","P21802","P21802","GO:0005938; GO:0009986; GO:0005737; GO:0031410; GO:0060076; GO:0005576; GO:0005794; GO:0016021; GO:0005887; GO:0043231; GO:0016020; GO:0005654; GO:0005634; GO:0005886","GO:0016303; GO:0005524; GO:0005007; GO:0017134; GO:0008201; GO:0042802; GO:0046934; GO:0042803; GO:0004713; GO:0005088","GO:0001525; GO:0009887; GO:0006915; GO:0007409; GO:0060348; GO:0030282; GO:0060349; GO:0060667; GO:0060670; GO:0060442; GO:0060445; GO:0048755; GO:0060449; GO:0007267; GO:0045165; GO:0071300; GO:0071560; GO:0048565; GO:0048701; GO:0048557; GO:0048568; GO:0048562; GO:0009880; GO:0003416; GO:0048730; GO:0030855; GO:0060664; GO:0001837; GO:0008543; GO:0035603; GO:0060595; GO:0035602; GO:0035607; GO:0035604; GO:0022612; GO:0031069; GO:0042472; GO:0001701; GO:0032808; GO:0060601; GO:0060174; GO:0048286; GO:0060484; GO:0030324; GO:0060463; GO:0060615; GO:0000165; GO:0003149; GO:0048762; GO:0060915; GO:0060916; GO:0048333; GO:0030901; GO:0016331; GO:0035264; GO:0050680; GO:0000122; GO:0042476; GO:0021769; GO:0035265; GO:0030916; GO:0003148; GO:0018108; GO:0090263; GO:0060045; GO:0045787; GO:0051781; GO:0008284; GO:0050679; GO:0060501; GO:0070374; GO:0043410; GO:0002053; GO:0010518; GO:0051897; GO:0048661; GO:0045944; GO:0030177; GO:0009791; GO:0060527; GO:0060523; GO:0060512; GO:0046777; GO:0021860; GO:0060687; GO:0010453; GO:0070372; GO:0040036; GO:0060688; GO:0040014; GO:0045667; GO:0033688; GO:0008589; GO:0051150; GO:0048608; GO:0045471; GO:0032496; GO:0048705; GO:0060529; GO:0001657; GO:0055010; GO:0021847; GO:0042060"]
[858,426,"NK236-3","FGFR3","Pan-specific","Fibroblast growth factor receptor 3",0,4789,16,702,{"v":3350.646,"d":"3351"},{"v":5887.577228319416,"d":"5888"},{"$nulls":3},0,4902,12,654,{"v":3198.06,"d":"3198"},{"v":5587.698862239998,"d":"5588"},{"$nulls":6},0,5202,19,715,{"v":3705.845,"d":"3706"},{"v":6340.113053357877,"d":"6340"},{"$nulls":7},"FGFR3","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","FGFR",{"$nulls":6},"CADPKWELSRARLTLG","Corresponds to amino acid residues A461 to G475.",{"$nulls":3},"P22607","P22607","P22607","P22607"]
[863,429,"NK239-3","FGFR4","Pan-specific","Fibroblast growth factor receptor 4",0,2694,12,608,{"v":1630.656,"d":"1631"},{"v":2865.3021336251054,"d":"2865"},{"v":3170.0652060696957,"d":"3170"},{"v":304.7630724445903,"d":"305"},{"v":9.613779295803226,"d":"10"},0,2779,16,621,{"v":1715.823,"d":"1716"},{"v":2997.911929390074,"d":"2998"},{"v":3136.834752675304,"d":"3137"},{"v":138.92282328523015,"d":"139"},{"v":4.428758102949076,"d":"4"},{"v":14.042537398752302,"d":"14"},{"v":-1.0482577245025055,"d":"-1"},null,0,2960,10,685,{"v":2020.75,"d":"2021"},{"v":3457.182761980852,"d":"3457"},{"v":3453.3761398626248,"d":"3453"},{"v":3.8066221182270965,"d":"4"},{"v":0.11022900385182263,"d":"0"},{"v":9.724008299655049,"d":"10"},{"v":8.937069598772808,"d":"9"},null,null,"FGFR4","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","FGFR",{"$nulls":6},"CSNDDEDPKSHRDPSN ","Corresponds to amino acid residues S124 to N138.",null,null,"Protein-tyrosine kinase (receptor), TK group, FGFR family","P22455","P22455","P22455","P22455","GO:0005783; GO:0005768; GO:0005576; GO:0005794; GO:0005887; GO:0005886; GO:0030133","GO:0016303; GO:0005524; GO:0005007; GO:0017134; GO:0008201; GO:0046934; GO:0004713; GO:0005088","GO:0016477; GO:0042632; GO:0008543; GO:0042593; GO:0000165; GO:0018108; GO:0055062; GO:0043085; GO:0008284; GO:2000573; GO:0070374; GO:0010628; GO:0051897; GO:0045862; GO:0046777; GO:0070857; GO:0010715; GO:0019216"]
[865,430,"NK268-1","Fgr","Pan-specific","Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene",0,11061,18,690,{"v":7619.67,"d":"7620"},{"v":13388.879511386342,"d":"13389"},{"v":13313.403023489609,"d":"13313"},{"v":75.47648789673258,"d":"75"},{"v":0.5669210776806278,"d":"1"},0,11822,18,628,{"v":7412.912,"d":"7413"},{"v":12951.952104802669,"d":"12952"},{"v":12826.15698249911,"d":"12826"},{"v":125.79512230355976,"d":"126"},{"v":0.9807701751600522,"d":"1"},{"v":1.5476912528406799,"d":"2"},{"v":-3.659815902296529,"d":"-4"},null,0,10856,22,734,{"v":7952.156,"d":"7952"},{"v":13604.877715592034,"d":"13605"},{"v":14085.490703770278,"d":"14085"},{"v":480.61298817824354,"d":"481"},{"v":3.4121139141400123,"d":"3"},{"v":3.9790349918206402,"d":"4"},{"v":5.799326279828151,"d":"6"},null,null,"FGR","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"CKKLEPVATAKEDAGLEGDF","Corresponds to amino acid residues C6 to F25; Post-N-terminus.",null,null,"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; Src family","P09769","P09769","P09769","P09769","GO:0015629; GO:0016235; GO:0005829; GO:0070062; GO:0005576; GO:0031234; GO:0005743; GO:0005758; GO:0005886; GO:0032587; GO:0034774","GO:0005524; GO:0034988; GO:0034987; GO:0004715; GO:0001784; GO:0019901; GO:0004713","GO:0030154; GO:0016477; GO:0050830; GO:0038096; GO:0002768; GO:0045087; GO:0007229; GO:0043312; GO:0038083; GO:0018108; GO:0030335; GO:0050715; GO:0043306; GO:0043552; GO:0014068; GO:0046777; GO:0006468; GO:0042127; GO:0008360; GO:0045088; GO:0050764; GO:0045859; GO:0009615; GO:0007169"]
[870,432,"PK639","Fgr","Y412","Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene",0,3640,20,798,{"v":2888.76,"d":"2889"},{"v":5075.97567575924,"d":"5076"},{"$nulls":3},0,3748,18,718,{"v":2678.14,"d":"2678"},{"v":4679.286764763458,"d":"4679"},{"$nulls":6},0,4040,22,803,{"v":3226.454,"d":"3226"},{"v":5519.95108307518,"d":"5520"},{"$nulls":7},"FGR","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"DDE(pY)NPC(bA)C","Corresponds to amino acid residues D409 to C415; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y412 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in Fgr (≥203 reports from high throughput mass spectrometry studies).",null,null,"P09769","P09769","P09769","P09769"]
[875,437,"PK640","Flt3 (STK1)","Y842","Fetal liver fms-related tyrosine kinase 3; Receptor-type tyrosine-protein kinase FLT3",0,94,12,299,{"v":24.518,"d":"25"},{"v":43.08172766801847,"d":"43"},{"v":44.819545951062366,"d":"45"},{"v":1.737818283043893,"d":"2"},{"v":3.877366997294852,"d":"4"},0,91,12,357,{"v":28.203,"d":"28"},{"v":49.27670869582017,"d":"49"},{"v":44.20716395657533,"d":"44"},{"v":5.06954473924484,"d":"5"},{"v":11.467699543505326,"d":"11"},{"v":15.345066540800177,"d":"15"},{"v":-1.3663279747538866,"d":"-1"},null,0,114,16,367,{"v":35.966,"d":"36"},{"v":61.53212184456431,"d":"62"},{"v":59.66559387558195,"d":"60"},{"v":1.8665279689823606,"d":"2"},{"v":3.1283154121863763,"d":"3"},{"v":7.005682409481228,"d":"7"},{"v":33.12404802299807,"d":"33"},null,null,"FLT3","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"DSN(pY)VVR(bA)C","Corresponds to amino acid residues D839 to R845; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y842 phosphorylation has been reported to inhibits phosphotransferase activity and regulate cell growth, inhibit apoptosis and alter conformation. However, this phosphosite is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII.This is one of the major in vivo phosphorylation sites in Flt3.","Flt3","Receptor tyrosine kinase; EC 2.7.10.1; TK group; PDGFR family","P36888","P36888","P36888","P36888","GO:0005829; GO:0005783; GO:0005788; GO:0005887; GO:0005634; GO:0005886; GO:0032991","GO:0016303; GO:0005524; GO:0004896; GO:0035259; GO:0044877; GO:0042803; GO:0043621; GO:0005088; GO:0004714; GO:0005021","GO:0031100; GO:0030183; GO:0071345; GO:0071385; GO:0035726; GO:0019221; GO:0097028; GO:0030097; GO:0001776; GO:0046651; GO:0000165; GO:0002318; GO:0018108; GO:0008284; GO:0043410; GO:0043406; GO:0043552; GO:0014068; GO:0042531; GO:0002328; GO:0046777; GO:0042981; GO:0010243; GO:0007169"]
[880,439,"PN033","Fos","T232","Proto-oncogene c-Fos",0,766,12,383,{"v":288.782,"d":"289"},{"v":507.43239576742434,"d":"507"},{"$nulls":3},0,486,12,345,{"v":163.53,"d":"164"},{"v":285.7220924379489,"d":"286"},{"$nulls":6},0,884,14,392,{"v":341.04,"d":"341"},{"v":583.465351550637,"d":"583"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against amino acid residues that encompass the T232 phosphosite.","T232 phosphorylation stimulates transcriptional activity. This is one of the major in vivo phosphorylation sites in Fos.","ERK1 (MAPK3); ERK2 (MAPK1); ERK5 (MAPK7); Frk",null,"P01100","P01100",null,"P01100"]
[885,442,"PN590","FOXK1","S441+S445","Forkhead box protein K1",0,9240,12,710,{"v":6551.88,"d":"6552"},{"v":11512.61562417558,"d":"11513"},{"v":11619.747113456575,"d":"11620"},{"v":107.13148928099508,"d":"107"},{"v":0.9219778041204395,"d":"1"},0,9806,14,732,{"v":7167.744,"d":"7168"},{"v":12523.590862468987,"d":"12524"},{"v":12158.373975426122,"d":"12158"},{"v":365.216887042865,"d":"365"},{"v":3.0038300169169205,"d":"3"},{"v":3.92580782103736,"d":"4"},{"v":4.635443927568588,"d":"5"},null,0,9209,14,746,{"v":6859.47,"d":"6859"},{"v":11735.465268006827,"d":"11735"},{"v":11349.011858040209,"d":"11349"},{"v":386.453409966618,"d":"386"},{"v":3.4051723163266856,"d":"3"},{"v":4.327150120447125,"d":"4"},{"v":-2.3299582406817905,"d":"-2"},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"CL(pS)REG(pS)PIP","Corresponds to amino acid residues C439 to P448.","The effects of S441 and S445 phosphorylation are unclear. These are two of the major in vivo phosphorylation sites in FOXK1.",null,"Transcription protein","P85037","P85037",null,null,"GO:0005737; GO:0005654; GO:0005634","GO:0000977; GO:0000981","GO:0009653; GO:0030154; GO:0007517; GO:0045892; GO:0045893; GO:0016579; GO:0006351"]
[888,443,"PN591","FOXK2","S424+S428","Forkhead box protein K2",0,4100,18,752,{"v":3069.664,"d":"3070"},{"v":5393.850578363662,"d":"5394"},{"$nulls":3},0,5316,16,711,{"v":3768.3,"d":"3768"},{"v":6584.03082574404,"d":"6584"},{"$nulls":6},0,5374,22,728,{"v":3896.256,"d":"3896"},{"v":6665.876075449445,"d":"6666"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"FAQ(pS)APG(pS)PLS(bA)C","Corresponds to amino acid residues F421 to S431.","The effects of S424 phosphorylation is unclear. S428 phosphorylation regulates transcription and apoptosis, and stabilizes FOXK2. These are two of the major in vivo phosphorylation sites in FOXK2.","S424: ERK1 (MAPK3). ",null,"Q01167","Q01167"]
[892,433,"PN194","FOXO1A (FKHR)","S256","Forkhead box protein O1",0,587,12,333,{"v":191.475,"d":"191"},{"v":336.44970247303354,"d":"336"},{"$nulls":3},0,820,12,318,{"v":256.944,"d":"257"},{"v":448.93644786507883,"d":"449"},{"$nulls":6},0,600,12,369,{"v":216.972,"d":"217"},{"v":371.2046805554915,"d":"371"},{"$nulls":10},"Transcription protein; Nuclear receptor co-regulator",{"$nulls":4},"X",{"$nulls":4},"AA(pS)MD","Corresponds to amino acid residues A254 to D258.","S256 phosphorylation Inhibits transcription by preventing nuclear import, regulates protein degradation and molecular association; phosphorylation induces interaction with 14-3-3 beta, SKP2, and inhibits interaction with DNA. This is one of the major in vivo phosphorylation sites in FOXO1A (≥42 reports from high throughput mass spectrometry studies).","Akt1 (PKBa); Akt3 (PKBg)",null,"Q12778","Q12778",null,"Q12778"]
[897,446,"PN594","FOXO1A (FKHR)","S319","Forkhead box protein O1",0,5162,20,775,{"v":3985.05,"d":"3985"},{"v":7002.318249589568,"d":"7002"},{"v":6682.998093660774,"d":"6683"},{"v":319.3201559287936,"d":"319"},{"v":4.778097366684691,"d":"5"},0,5334,18,795,{"v":4226.22,"d":"4226"},{"v":7384.1155843154675,"d":"7384"},{"v":6821.1244263044555,"d":"6821"},{"v":562.991158011012,"d":"563"},{"v":8.25364152338193,"d":"8"},{"v":13.03173889006662,"d":"13"},{"v":2.0668318426531016,"d":"2"},null,0,5390,20,835,{"v":4483.95,"d":"4484"},{"v":7671.327302033424,"d":"7671"},{"v":7603.489874203814,"d":"7603"},{"v":67.83742782960962,"d":"68"},{"v":0.8921880472250001,"d":"1"},{"v":5.670285413909691,"d":"6"},{"v":13.773635240389808,"d":"14"},{"$nulls":5},"Transcription protein; Nuclear receptor co-regulator",{"$nulls":4},"X",{"$nulls":4},"PRTS(pS)NAS(bA)C","Corresponds to amino acid residues P315 to S322.","S319 phosphorylation increases rate of nuclear exclusion. It also creates the pSer–Xaa–Xaa–Ser recognition motif for CK1, allowing it to phosphorylate S322, induces interaction with IQGAP1, and regulates apoptosis and inhibits transcription. This is one of the major in vivo phosphorylation sites in FOXO1A (≥30 reports from high throughput mass spectrometry studies).","Akt1 (PKBa); Akt3 (PKBg); SGK1","Transcription factor; Nuclear receptor co-regulator","Q12778","Q12778",null,"Q12778","GO:0005737; GO:0005829; GO:0005739; GO:0005654; GO:0005634","GO:0008013; GO:0003682; GO:0051721; GO:0000981; GO:0043565; GO:0001078; GO:0001223; GO:0031625","GO:0009653; GO:0006915; GO:0006914; GO:0001568; GO:0030154; GO:0001678; GO:0070417; GO:0071549; GO:0006974; GO:0070301; GO:0071455; GO:0032869; GO:0071732; GO:0034599; GO:0009267; GO:0019221; GO:0070166; GO:0031018; GO:0097009; GO:0045444; GO:0008286; GO:0043066; GO:0090090; GO:1903243; GO:0045599; GO:0032873; GO:0045892; GO:0097150; GO:0043065; GO:0010508; GO:0045722; GO:0045732; GO:0045893; GO:0045944; GO:0006473; GO:0035947; GO:2000177; GO:2000377; GO:1902617; GO:0001659; GO:0006351"]
[902,448,"PN596","FOXO3 (FKHRL1)","T32","Forkhead box protein O3",0,6829,16,808,{"v":5504.904,"d":"5505"},{"v":9672.924992519194,"d":"9673"},{"$nulls":3},0,7778,18,683,{"v":5300.08,"d":"5300"},{"v":9260.380038454865,"d":"9260"},{"$nulls":6},0,7168,16,735,{"v":5256.72,"d":"5257"},{"v":8993.414211832232,"d":"8993"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"PRSA(pT)WPLC","Corresponds to amino acid residues P28 to L35.","T32 phosphorylation inhibits transcriptional activity and induces 14-3-3-beta binding and nuclear exclusion. This is one of the major in vivo phosphorylation sites in FOXO3 (≥97 reports from high throughput mass spectrometry studies).","Akt1 (PKBa); Akt2 (PKBb); Pim1; SGK1",null,"O43524","O43524",null,"O43524"]
[903,449,"PN597","FOXO3 (FKHRL1)","S294","Forkhead box protein O3",0,13252,14,729,{"v":9650.502,"d":"9651"},{"v":16957.34966243852,"d":"16957"},{"v":17305.013476420536,"d":"17305"},{"v":347.663813982017,"d":"348"},{"v":2.009035210840701,"d":"2"},0,13426,14,776,{"v":10407.712,"d":"10408"},{"v":18184.512016948265,"d":"18185"},{"v":16913.921439563637,"d":"16914"},{"v":1270.590577384628,"d":"1271"},{"v":7.512099319632455,"d":"8"},{"v":9.521134530473155,"d":"10"},{"v":-2.2599926743182976,"d":"-2"},null,0,12842,18,755,{"v":9682.12,"d":"9682"},{"v":16564.571749810737,"d":"16565"},{"v":17057.81673547659,"d":"17058"},{"v":493.24498566585316,"d":"493"},{"v":2.8916067824788483,"d":"3"},{"v":4.9006419933195495,"d":"5"},{"v":-1.428468930583449,"d":"-1"},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"KWPG(pS)PTS(bA)C","Corresponds to amino acid residues K290 to S297.","S294 phosphorylation inhibits FOXO3 dependent transcription, causes degradation of FOXO3, and regulates cell growth, and molecular association, including inducing interaction with MDM2. This is one of the major in vivo phosphorylation sites in FOXO3 (≥77 reports from high throughput mass spectrometry studies).","ERK1 (MAPK3); ERK2 (MAPK1); p38a MAPK (MAPK14)","Transcription protein","O43524","O43524",null,"O43524","GO:0005737; GO:0005829; GO:0005759; GO:0005741; GO:0005654; GO:0005634; GO:0032991","GO:0008013; GO:0031490; GO:0003677; GO:0003700; GO:0034246; GO:0019901; GO:0000978; GO:0000981; GO:0043565; GO:0001228; GO:0001227; GO:0001221","GO:0007568; GO:0009653; GO:0001547; GO:0048854; GO:1904646; GO:0071386; GO:0071333; GO:0071456; GO:1990090; GO:0034599; GO:0019221; GO:0030330; GO:0097192; GO:0001544; GO:0006390; GO:0090090; GO:0030336; GO:0045665; GO:0000122; GO:0097150; GO:0001556; GO:0001542; GO:0043065; GO:2000353; GO:0045648; GO:1901300; GO:0043525; GO:1903428; GO:0045893; GO:0045944; GO:2000177; GO:0006357; GO:0006417; GO:0071548; GO:0031667; GO:1990785; GO:0033209"]
[908,451,"NK269-1","Frk","Pan-specific","Fyn-related kinase; Tyrosine-protein kinase FRK",0,2433,12,674,{"v":1631.754,"d":"1632"},{"v":2867.2314809201325,"d":"2867"},{"$nulls":3},0,2031,16,715,{"v":1440.725,"d":"1441"},{"v":2517.256537807521,"d":"2517"},{"$nulls":6},0,2836,14,699,{"v":1972.578,"d":"1973"},{"v":3374.7681099901843,"d":"3375"},{"$nulls":7},"FRK","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"LSTEADKSTVIENPGALC","Corresponds to amino acid residues L19 to L35; Post-N-terminus.",{"$nulls":3},"P42685","P42685","P42685","P42685"]
[915,455,"NN415-1","FRS2","Pan-specific","Fibroblast growth factor receptor substrate 2",0,374,10,512,{"v":186.368,"d":"186"},{"v":327.47595326018705,"d":"327"},{"v":336.38820233157094,"d":"336"},{"v":8.912249071383883,"d":"9"},{"v":2.649394066025913,"d":"3"},0,504,12,485,{"v":238.62,"d":"239"},{"v":416.92047757318755,"d":"417"},{"v":368.28849126536716,"d":"368"},{"v":48.6319863078204,"d":"49"},{"v":13.204861802966041,"d":"13"},{"v":15.854255868991954,"d":"16"},{"v":9.483177089056397,"d":"9"},null,0,448,12,523,{"v":228.028,"d":"228"},{"v":390.1197430899268,"d":"390"},{"v":415.2417382288242,"d":"415"},{"v":25.121995138897375,"d":"25"},{"v":6.049968687168336,"d":"6"},{"v":8.699362753194249,"d":"9"},{"v":23.441231098684298,"d":"23"},{"$nulls":13},"X",null,"Not precisely defined.","Antibody raised against amino acid residues 258-348 of human FRS2.",null,null,"Adapter/scaffold protein","Q8WU20","Q8WU20",null,null,"GO:0005913; GO:0005829; GO:0005768; GO:0005887; GO:0016020; GO:0005886","GO:0016303; GO:0005104; GO:0005168; GO:0019211; GO:0046934; GO:0005088; GO:0005068","GO:0000187; GO:0000186; GO:0008595; GO:0007411; GO:0008543; GO:0030900; GO:0001702; GO:0007186; GO:0070307; GO:0000165; GO:2000726; GO:0007405; GO:0048011; GO:0046619; GO:0001759; GO:0051897; GO:0060527; GO:0042981; GO:0050678; GO:0070372; GO:0007185; GO:0003281"]
[919,457,"PK643","Fused (STK36)","S159","Serine/threonine-protein kinase 36",0,2561,14,712,{"v":1813.464,"d":"1813"},{"v":3186.5226439250937,"d":"3187"},{"v":3240.2351103316514,"d":"3240"},{"v":53.71246640655772,"d":"54"},{"v":1.657671884218921,"d":"2"},0,2958,16,679,{"v":1997.618,"d":"1998"},{"v":3490.268420789522,"d":"3490"},{"v":3245.817297259277,"d":"3246"},{"v":244.45112353024524,"d":"244"},{"v":7.531265661091164,"d":"8"},{"v":9.188937545310086,"d":"9"},{"v":0.17227721870634127,"d":"0"},null,0,2808,20,767,{"v":2138.396,"d":"2138"},{"v":3658.4564094958837,"d":"3658"},{"v":3661.9704777344623,"d":"3662"},{"v":3.514068238578602,"d":"4"},{"v":0.09596112966898188,"d":"0"},{"v":1.753633013887903,"d":"2"},{"v":13.015579210844507,"d":"13"},null,null,"Fused","X","PYK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","ULK",{"$nulls":6},"VLT(pS)IKG(bA)C","Corresponds to amino acid residues V156 to G162; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S159 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the minor in vivo phosphorylation sites in Fused (≥1 reports from high throughput mass spectrometry studies).",null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; ULK family","Q9NRP7","Q9NRP7","Q9NRP7","Q9NRP7","GO:0005737; GO:0005829; GO:0005634","GO:0005524; GO:0046872; GO:0004674; GO:0008134","GO:0007420; GO:0060271; GO:0003351; GO:0007228; GO:0045880; GO:0009791; GO:0006468; GO:0051090"]
[920,457,"PK643","Fused (STK36)","S159","Serine/threonine-protein kinase 36",0,2618,18,721,{"v":1874.6,"d":"1875"},{"v":3293.9475767382096,"d":"3294"},{"$nulls":3},0,2470,16,700,{"v":1717.8,"d":"1718"},{"v":3001.3661737290317,"d":"3001"},{"$nulls":6},0,2824,16,763,{"v":2142.504,"d":"2143"},{"v":3665.4845459730413,"d":"3665"},{"$nulls":7},"Fused","X","PYK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","ULK",{"$nulls":6},"VLT(pS)IKG(bA)C","Corresponds to amino acid residues V156 to G162; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S159 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the minor in vivo phosphorylation sites in Fused (≥1 reports from high throughput mass spectrometry studies).",null,null,"Q9NRP7","Q9NRP7","Q9NRP7","Q9NRP7"]
[925,460,"PK186","Fyn","T12","Fyn proto-oncogene-encoded protein-tyrosine kinase",0,86,10,668,{"v":50.768,"d":"51"},{"v":89.20683376498744,"d":"89"},{"v":109.59149493949931,"d":"110"},{"v":20.384661174511876,"d":"20"},{"v":18.600586829995667,"d":"19"},0,184,20,485,{"v":79.54,"d":"80"},{"v":138.97349252439585,"d":"139"},{"v":128.61250672266507,"d":"129"},{"v":10.360985801730777,"d":"10"},{"v":8.055970656160834,"d":"8"},{"v":26.6565574861565,"d":"27"},{"v":17.356284621964903,"d":"17"},null,0,126,14,547,{"v":61.264,"d":"61"},{"v":104.81298761845598,"d":"105"},{"v":111.06440209935566,"d":"111"},{"v":6.251414480899683,"d":"6"},{"v":5.628639206383438,"d":"6"},{"v":24.229226036379103,"d":"24"},{"v":1.3439976894826344,"d":"1"},null,null,"FYN","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues that encompass the T12 phosphosite.","The effect of T12 phosphorylation is unclear. This is one of the minor in vivo phosphorylation sites in Fyn (≥2 reports from high throughput mass spectrometry studies).",null,"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; Src family","P06241","P06241","P06241","P06241","GO:0005884; GO:0044297; GO:0005829; GO:0030425; GO:0005768; GO:0031234; GO:0097386; GO:0098978; GO:0045121; GO:0005739; GO:0005634; GO:0097038; GO:0048471; GO:0005886; GO:0014069; GO:0099092; GO:0098685","GO:0043014; GO:0005524; GO:0042609; GO:0042610; GO:0097718; GO:0019899; GO:0046875; GO:0070851; GO:0042802; GO:0044325; GO:0046872; GO:0004715; GO:0051428; GO:0043548; GO:0046934; GO:0004713; GO:0005088; GO:0048156; GO:0042608; GO:0031802","GO:0050798; GO:0002250; GO:0007411; GO:0007596; GO:0006816; GO:0030154; GO:0016477; GO:1905430; GO:1905232; GO:0071375; GO:0036120; GO:0071560; GO:0007417; GO:0019221; GO:0048813; GO:0097062; GO:0050966; GO:0048013; GO:0038096; GO:0007631; GO:0030900; GO:0003015; GO:0045087; GO:0035556; GO:0007612; GO:0050900; GO:0000165; GO:0050804; GO:1902951; GO:2001240; GO:0010629; GO:0010730; GO:0043524; GO:1903202; GO:0042177; GO:0031397; GO:0001764; GO:0038083; GO:0018108; GO:0030168; GO:2001056; GO:0043123; GO:1901216; GO:0010976; GO:1903997; GO:0014068; GO:0051897; GO:1905477; GO:1900182; GO:0090314; GO:0042531; GO:0006468; GO:0042981; GO:1905664; GO:0042127; GO:0008360; GO:0050690; GO:1900449; GO:0050730; GO:1904645; GO:0045471; GO:0042542; GO:0000304; GO:0002223; GO:0042110; GO:0031295; GO:0050852; GO:0007169; GO:0048010"]
[930,462,"PK881","Fyn","Y420","Fyn proto-oncogene-encoded protein-tyrosine kinase",0,10521,18,722,{"v":7583.166,"d":"7583"},{"v":13324.736620987722,"d":"13325"},{"$nulls":3},0,10687,18,669,{"v":7137.561,"d":"7138"},{"v":12470.854667788777,"d":"12471"},{"$nulls":6},0,11536,22,718,{"v":8267.052,"d":"8267"},{"v":14143.614829543152,"d":"14144"},{"$nulls":7},"FYN","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"DNE(pY)TAR(bA)C","Corresponds to amino acid residues D417 to R423. It is located near the C-terminus of the kinase.","Phosphorylation of Y420 - Expected to be stimulatory to Fyn's phosphotransferase activity. Phosphoryation induces binding of the phosphatase STEP. Y420 is the most commonly reported site for phosphorylation of Fyn by mass spectrometry (≥3090 reports).","Fyn",null,"P06241","P06241","P06241","P06241"]
[933,464,"PN515","G6PD","Y401","Glucose-6-phosphate 1-dehydrogenase",0,5902,14,690,{"v":4062.72,"d":"4063"},{"v":7138.7958492296275,"d":"7139"},{"v":7175.003618229023,"d":"7175"},{"v":36.20776899939574,"d":"36"},{"v":0.5046376409818836,"d":"1"},0,6182,14,707,{"v":4360.776,"d":"4361"},{"v":7619.213865181856,"d":"7619"},{"v":6980.987623086101,"d":"6981"},{"v":638.226242095755,"d":"638"},{"v":9.142348855986265,"d":"9"},{"v":9.646986496968148,"d":"10"},{"v":-2.7040543178264045,"d":"-3"},null,0,6214,12,720,{"v":4465.44,"d":"4465"},{"v":7639.659627692577,"d":"7640"},{"v":7554.511051142392,"d":"7555"},{"v":85.14857655018477,"d":"85"},{"v":1.12712227136538,"d":"1"},{"v":1.6317599123472635,"d":"2"},{"v":5.289299533580461,"d":"5"},{"$nulls":5},"Enzyme - Glycolysis",{"$nulls":8},"X","EAV(pY)TKM(bA)C","Corresponds to amino acid residues E398 to M404; In the G6PD_C domain. ","The effect of Y401 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in G6PD (≥571 reports from high throughput mass spectrometry studies).",null,"EC 1.1.1.49; Other Amino Acids Metabolism - glutathione; Oxidoreductase; Carbohydrate Metabolism - pentose phosphate pathway; Cell development/differentiation","P11413","P11413",null,null,"GO:0005737; GO:0009898; GO:0005829; GO:0070062; GO:0016020; GO:0005634","GO:0004345; GO:0005536; GO:0042802; GO:0050661; GO:0042803","GO:0034599; GO:0006695; GO:0043249; GO:0051156; GO:0006006; GO:0006749; GO:0006629; GO:0006740; GO:0006739; GO:0061052; GO:0010734; GO:2000378; GO:0055114; GO:0019322; GO:0006098; GO:0009051; GO:1904879; GO:0043523; GO:0045471; GO:0032094; GO:0010041; GO:0014070; GO:0046390; GO:0021762"]
[937,466,"PN516","Gab1","Y406","GRB2-associated-binding protein 1",0,2010,12,560,{"v":1118.88,"d":"1119"},{"v":1966.036522277205,"d":"1966"},{"v":2198.962158052752,"d":"2199"},{"v":232.92563577554688,"d":"233"},{"v":10.592525884202102,"d":"11"},0,2466,16,570,{"v":1396.5,"d":"1397"},{"v":2439.9859480804475,"d":"2440"},{"v":2083.690341560962,"d":"2084"},{"v":356.2956065194853,"d":"356"},{"v":17.09925891639793,"d":"17"},{"v":27.691784800600033,"d":"28"},{"v":-5.2421009642961,"d":"-5"},null,0,2363,16,583,{"v":1368.301,"d":"1368"},{"v":2340.946000445954,"d":"2341"},{"v":2532.822851563519,"d":"2533"},{"v":191.87685111756537,"d":"192"},{"v":7.57561275946003,"d":"8"},{"v":18.168138643662132,"d":"18"},{"v":15.182648427493234,"d":"15"},{"$nulls":13},"X",null,"QDC(pY)DIP(bA)C","Corresponds to amino acid residues Q403 to P409; In the mid-region of the protein. ","The effect of Y406 phosphorylation is unclear. This is the second major in vivo phosphorylation site of Gab1 (≥1095 reports from high throughput mass spectrometry studies).","EGFR; Met","Adapter/scaffold protein","Q13480","Q13480",null,"Q13480","GO:0005829","GO:0016303; GO:0046934; GO:0005070","GO:0031532; GO:0001525; GO:0007411; GO:0008283; GO:0090668; GO:0007173; GO:0038128; GO:0008286; GO:0045766; GO:0038089; GO:0051897; GO:0035728; GO:0038084"]
[942,468,"PN196","GATA1","S142","Transcription factor GATA-1",0,1426,10,317,{"v":448.872,"d":"449"},{"v":788.7340428174724,"d":"789"},{"$nulls":3},0,1370,12,262,{"v":355.796,"d":"356"},{"v":621.6521592432731,"d":"622"},{"$nulls":6},0,1292,12,278,{"v":355.84,"d":"356"},{"v":608.7858042921026,"d":"609"},{"$nulls":15},"X",{"$nulls":4},"RL(pS)PD","Corresponds to amino acid residues R140 to D144.","The effect of S142 phosphorylation is unclear. Phosphorylation pf this site in GATA1 has not been reported in high throughput mass spectrometry studies.",null,null,"P15976","P15976",null,"P15976"]
[947,471,"PN600","GATAD2B","T120+S122","Transcriptional repressor p66-beta",0,12925,16,768,{"v":9914.112,"d":"9914"},{"v":17420.551156466023,"d":"17421"},{"v":17796.264306395697,"d":"17796"},{"v":375.7131499296738,"d":"376"},{"v":2.1111911098929252,"d":"2"},0,14415,18,770,{"v":11085.69,"d":"11086"},{"v":19369.085445596807,"d":"19369"},{"v":19352.284224775653,"d":"19352"},{"v":16.801220821154857,"d":"17"},{"v":0.08681776593403474,"d":"0"},{"v":2.19800887582696,"d":"2"},{"v":8.743519940984172,"d":"9"},null,0,13772,18,849,{"v":11677.146,"d":"11677"},{"v":19977.744827580682,"d":"19978"},{"v":19761.434594988303,"d":"19761"},{"v":216.31023259237918,"d":"216"},{"v":1.0946079423162811,"d":"1"},{"v":3.2057990522092066,"d":"3"},{"v":11.0426000353701,"d":"11"},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"CGRL(pT)P(pS)PDI","Corresponds to amino acid residues C117 to I125.","The effect of T120 and S122 phosphorylation are unclear. These are two of the major in vivo phosphorylation sites in GATAD2B (≥90 and ≥86 reports, respectively, from high throughput mass spectrometry studies).","S122: PRP4 (PRPF4B).","Transcription protein","Q8WXI9","Q8WXI9",null,null,"GO:0000790; GO:0016607; GO:0005654; GO:0032991","GO:0000981; GO:0043565; GO:0008270","GO:0043044; GO:0006351"]
[952,473,"PK646","GCK (MAP4K2)","S170","Germinal centre protein-serine kinase; Mitogen-activated protein kinase kinase kinase kinase 2",0,7106,16,767,{"v":5438.03,"d":"5438"},{"v":9555.417550800004,"d":"9555"},{"$nulls":3},0,8052,18,677,{"v":5439.018,"d":"5439"},{"v":9503.134616080644,"d":"9503"},{"$nulls":6},0,7976,20,800,{"v":6364.8,"d":"6365"},{"v":10889.163351951369,"d":"10889"},{"$nulls":7},"GCK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","KHS",{"$nulls":5},"KRR(pS)FIG(bA)C","Corresponds to amino acid residues K167 to G173; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S170 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the less major in vivo phosphorylation sites in GCK (≥11 reports from high throughput mass spectrometry studies).",null,null,"Q12851","Q12851","Q12851"]
[956,475,"PN752","GCLC","S5+S8","Glutamate--cysteine ligase catalytic subunit",0,4229,14,592,{"v":2495.28,"d":"2495"},{"v":4384.573513967418,"d":"4385"},{"$nulls":3},0,3974,16,586,{"v":2319.388,"d":"2319"},{"v":4052.4698375556127,"d":"4052"},{"$nulls":6},0,4804,16,644,{"v":3083.472,"d":"3083"},{"v":5275.331557813001,"d":"5275"},{"$nulls":20},"GLL(pS)QG(pS)PLS(bA)C","Corresponds to amino acid residues G2 to S11; N-terminus.","The effects of S5 and S8 phosphorylation are unclear. These are two of the major in vivo phosphorylation sites in GCLC (≥12 and >10 reports, respectively, by mass spectrometry). These human phosphosites are highly conserved in vertebrates and also found in yeast.",null,null,"P48506","P48506"]
[959,477,"NN260-2","GFAP","Pan-specific","Glial fibrillary acidic protein",0,223,6,544,{"v":118.048,"d":"118"},{"v":207.42767712514254,"d":"207"},{"v":149.3293720588499,"d":"149"},{"v":58.098305066292625,"d":"58"},{"v":38.906147039442715,"d":"39"},0,3330,14,341,{"v":1130.756,"d":"1131"},{"v":1975.6740069514178,"d":"1976"},{"v":1490.9248902873378,"d":"1491"},{"v":484.74911666408,"d":"485"},{"v":32.51331571576734,"d":"33"},{"v":71.41946275521005,"d":"71"},{"v":898.4136876299007,"d":"898"},"Possible",0,3111,12,374,{"v":1159.026,"d":"1159"},{"v":1982.9096661574263,"d":"1983"},{"v":1979.6094530940284,"d":"1980"},{"v":3.300213063397905,"d":"3"},{"v":0.1667103103715655,"d":"0"},{"v":39.07285734981428,"d":"39"},{"v":1225.6664953455204,"d":"1226"},"Priority",{"$nulls":14},"Epitope undefined.",{"$nulls":3},"Cytoskeletal protein","P14136","P14136",null,null,"GO:0097450; GO:0044297; GO:0005737; GO:0098574; GO:0005829; GO:0005882; GO:0043209","GO:0042802; GO:0005178; GO:0019900; GO:0005200","GO:0014002; GO:0060020; GO:0030198; GO:0045109; GO:0060291; GO:0010977; GO:0031102; GO:0010625; GO:1904714; GO:0051580; GO:0043254; GO:0009611"]
[964,479,"PN517","GIT1","Y545","ARF GTPase-activating protein GIT1",0,7492,14,704,{"v":5264.512,"d":"5265"},{"v":9250.520935191094,"d":"9251"},{"$nulls":3},0,7503,16,684,{"v":5121.108,"d":"5121"},{"v":8947.67744976897,"d":"8948"},{"$nulls":6},0,8200,16,728,{"v":5957.952,"d":"5958"},{"v":10193.110949454085,"d":"10193"},{"$nulls":20},"DAI(pY)SVH(bA)C","Corresponds to amino acid residues D542 to H548; In the last third of the protein before the GIT1_C domain. ","Y545 phosphorylation inhibits interaction with His-5 and PXN and induces cell motility. This is the major in vivo phosphorylation site in GIT1 (≥749 reports from high throughput mass spectrometry studies).",null,null,"Q9Y2X7","Q9Y2X7"]
[969,483,"PN601","GR","S226","Glucocorticoid receptor",0,7268,14,663,{"v":4809.402,"d":"4809"},{"v":8450.825810018085,"d":"8451"},{"v":8758.092816793653,"d":"8758"},{"v":307.267006775568,"d":"307"},{"v":3.5083780590493765,"d":"4"},0,7258,16,646,{"v":4678.332,"d":"4678"},{"v":8174.052517332687,"d":"8174"},{"v":8131.013366699628,"d":"8131"},{"v":43.03915063305885,"d":"43"},{"v":0.5293208692698093,"d":"1"},{"v":4.037698928319186,"d":"4"},{"v":-7.1600000503716785,"d":"-7"},null,0,8370,18,738,{"v":6163.776,"d":"6164"},{"v":10545.243170066207,"d":"10545"},{"v":10155.87619719292,"d":"10156"},{"v":389.3669728732875,"d":"389"},{"v":3.833908225278567,"d":"4"},{"v":7.342286284327944,"d":"7"},{"v":15.959905993677253,"d":"16"},{"$nulls":5},"Receptor,  nuclear; Transcription protein",{"$nulls":4},"X",{"$nulls":4},"LL(pS)PLAGC","Corresponds to amino acid residues L224 to G230.","S226 phosphorylation inhibits transcriptional activity, and regulates intracellular location and molecular association, including inducing interaction with GRIP1. This is one of the major in vivo phosphorylation sites in the glucocorticoid receptor (≥10 reports from high throughput mass spectrometry studies).","CDK5; ERK2 (MAPK1); JAK1; JNK1 (MAPK8); JNK2 (MAPK9); JNK3 (MAPK10)","Receptor, nuclear; Transcription factor","P04150","P04150",null,"P04150","GO:0005737; GO:0005829; GO:0005815; GO:0005759; GO:0016607; GO:0005654; GO:0005634; GO:0032991; GO:0005819","GO:0001047; GO:0003700; GO:0004883; GO:0051879; GO:0004879; GO:0019901; GO:0003723; GO:0000978; GO:0038050; GO:0000981; GO:0005496; GO:1990239; GO:0032183; GO:0001077; GO:0008270","GO:0006915; GO:0007049; GO:0051301; GO:0071549; GO:0071385; GO:0071383; GO:0071560; GO:0006325; GO:0007059; GO:0000122; GO:0045944; GO:0006355; GO:0007165; GO:0006351; GO:0006366; GO:0006367"]
[970,483,"PN601","GR","S226","Glucocorticoid receptor",0,7064,16,732,{"v":5159.136,"d":"5159"},{"v":9065.35982356922,"d":"9065"},{"$nulls":3},0,7000,18,663,{"v":4629.066,"d":"4629"},{"v":8087.97421606657,"d":"8088"},{"$nulls":6},0,7836,16,730,{"v":5708.6,"d":"5709"},{"v":9766.50922431963,"d":"9767"},{"$nulls":10},"Receptor,  nuclear; Transcription protein",{"$nulls":4},"X",{"$nulls":4},"LL(pS)PLAGC","Corresponds to amino acid residues L224 to G230.","S226 phosphorylation inhibits transcriptional activity, and regulates intracellular location and molecular association, including inducing interaction with GRIP1. This is one of the major in vivo phosphorylation sites in the glucocorticoid receptor (≥10 reports from high throughput mass spectrometry studies).","CDK5; ERK2 (MAPK1); JAK1; JNK1 (MAPK8); JNK2 (MAPK9); JNK3 (MAPK10)",null,"P04150","P04150",null,"P04150"]
[974,485,"NK067-2","GRK2 (BARK1, ADRBK1)","Pan-specific","Beta-adrenergic receptor kinase 1",0,466,10,532,{"v":242.592,"d":"243"},{"v":426.2697805057484,"d":"426"},{"$nulls":3},0,471,10,481,{"v":221.741,"d":"222"},{"v":387.42923316384287,"d":"387"},{"$nulls":6},0,582,14,582,{"v":330.576,"d":"331"},{"v":565.5631071258603,"d":"566"},{"$nulls":7},"BARK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase",{"$nulls":8},"Not precisely defined.","Antibody raised against amino acid residues 468-689 of human GRK2.",{"$nulls":3},"P25098","P25098","P25098"]
[981,487,"PK025","GRK2 (BARK1, ADRBK1)","S670","G protein-coupled receptor-serine kinase 2",0,408,10,504,{"v":200.592,"d":"201"},{"v":352.469610750598,"d":"352"},{"v":412.85659965274976,"d":"413"},{"v":60.38698890215176,"d":"60"},{"v":14.626625553023192,"d":"15"},0,442,14,522,{"v":223.416,"d":"223"},{"v":390.3558185294245,"d":"390"},{"v":394.8339309425503,"d":"395"},{"v":4.478112413125814,"d":"4"},{"v":1.1341761845127225,"d":"1"},{"v":15.760801737535914,"d":"16"},{"v":-4.365358026336068,"d":"-4"},null,0,526,14,567,{"v":290.304,"d":"290"},{"v":496.66410220665057,"d":"497"},{"v":493.512732345179,"d":"494"},{"v":3.151369861471551,"d":"3"},{"v":0.6385589783056254,"d":"1"},{"v":15.265184531328817,"d":"15"},{"v":19.536113207411105,"d":"20"},null,null,"BARK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase",{"$nulls":8},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S670 phosphosite.","S670 phosphorylation may inhibit phosphotransferase activity. Phosphorylation regulates cell cycle progression, cell growth, protein degradation, and molecular association, including inducing binding to PIN1. This is one of the major in vivo phosphorylation sites in GRK2 (≥54 reports from high throughput mass spectrometry studies).","CDK2; ERK1 (MAPK3)","EC 2.7.11.15; Protein kinase, Ser/Thr (non-receptor); AGC group; GRK family; BARK subfamily","P25098","P25098","P25098",null,"GO:0005929; GO:0005737; GO:0005829; GO:0016020; GO:0005886","GO:0031694; GO:0005524; GO:0047696; GO:0031755; GO:0004703; GO:0004672","GO:0060048; GO:0002029; GO:0007213; GO:0007186; GO:0007507; GO:0045988; GO:0003108; GO:0018105; GO:0018107; GO:0033605; GO:0031623; GO:0007217; GO:0046718; GO:0019079"]
[986,489,"NK381-1","GRK7","Pan-specific","Rhodopsin kinase",0,450,12,579,{"v":253.602,"d":"254"},{"v":445.61596786299134,"d":"446"},{"$nulls":3},0,430,10,544,{"v":228.48,"d":"228"},{"v":399.20371601677095,"d":"399"},{"$nulls":6},0,516,14,639,{"v":320.778,"d":"321"},{"v":548.8002830744495,"d":"549"},{"$nulls":7},"GRK7","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase",{"$nulls":8},"Not precisely defined.","Antibody raised against amino acid residues 472-501 near the C-terminus of human GRK7.",{"$nulls":3},"Q8WTQ7","Q8WTQ7","Q8WTQ7"]
[987,490,"NK069-NK070-3","GSK3a","Pan-specific","Glycogen synthase-serine kinase 3 alpha/beta",0,202,10,612,{"v":117.504,"d":"118"},{"v":206.47178921212347,"d":"206"},{"v":209.56963919494086,"d":"210"},{"v":3.0978499828173938,"d":"3"},{"v":1.4781959804472373,"d":"1"},0,201,10,605,{"v":115.555,"d":"116"},{"v":201.89944592226004,"d":"202"},{"v":210.72725043545478,"d":"211"},{"v":8.827804513194735,"d":"9"},{"v":4.189208797131185,"d":"4"},{"v":5.667404777578422,"d":"6"},{"v":0.5523754514064478,"d":"1"},null,0,202,10,634,{"v":121.728,"d":"122"},{"v":208.25730211575166,"d":"208"},{"v":227.96619506046,"d":"228"},{"v":19.70889294470834,"d":"20"},{"v":8.645533141210366,"d":"9"},{"v":10.123729121657604,"d":"10"},{"v":8.778254300665523,"d":"9"},null,null,"GSK3a","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","GSK",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 1-420 representing full length Xenopus laevis glycogen synthase kinase-3 beta. ",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.26; CMGC group; GSK family; GSK subfamily","P49840","P49840","P49840",null,"GO:0097440; GO:0030877; GO:0005829; GO:0005739; GO:0043025; GO:0098794; GO:1990635","GO:0005524; GO:0034236; GO:0004674; GO:0005102; GO:0050321","GO:0003214; GO:0032869; GO:0036016; GO:0007212; GO:0060079; GO:0097191; GO:0097192; GO:0005977; GO:0008286; GO:0036498; GO:0090090; GO:0061052; GO:0046325; GO:2000466; GO:0045719; GO:1904227; GO:0046627; GO:0032007; GO:2000077; GO:0010905; GO:0007399; GO:0018107; GO:0071879; GO:0106071; GO:1902004; GO:0010628; GO:2000467; GO:0045823; GO:1901030; GO:0032436; GO:0045732; GO:1903955; GO:0031398; GO:0043161; GO:0006468; GO:1903146; GO:0003073; GO:0016055"]
[992,492,"PK648","GSK3a","T19+S21","Glycogen synthase-serine kinase 3 alpha",0,10618,20,754,{"v":7990.892,"d":"7991"},{"v":14041.171097501732,"d":"14041"},{"$nulls":3},0,12018,20,729,{"v":8746.542,"d":"8747"},{"v":15282.090636803046,"d":"15282"},{"$nulls":6},0,11222,22,795,8904,{"v":15233.331838514168,"d":"15233"},{"$nulls":7},"GSK3a","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","GSK",{"$nulls":6},"RAR(pT)S(pS)FAE(bA)C","Corresponds to amino acid residues R16 to E24; Near the N-terminus of the protein.","T19+S21 phosphorylation inhibits phosphotransferase activity. These are two of the less major in vivo phosphorylation sites in GSK3a (≥78 and ≥296 reports, respectively, from high throughput mass spectrometry studies).","S21: Akt1 (PKBa); PKACa (PRKACA); PKCb1 (PRKCB1); PKCd (PRKCD); PKCg (PRKCG); PKCh (PRKCH); PKCz (PRKCZ); RSK2 (RPS6KA3)",null,"P49840","P49840","P49840"]
[997,495,"PK649","GSK3a","Y279","Glycogen synthase-serine kinase 3 alpha",0,442,14,609,{"v":260.652,"d":"261"},{"v":458.0038535004629,"d":"458"},{"v":429.16643716863797,"d":"429"},{"v":28.837416331824954,"d":"29"},{"v":6.719401573449112,"d":"7"},0,428,19,561,{"v":229.449,"d":"229"},{"v":400.8967674909493,"d":"401"},{"v":404.8935221320048,"d":"405"},{"v":3.9967546410555315,"d":"4"},{"v":0.9871125178813049,"d":"1"},{"v":7.706514091330416,"d":"8"},{"v":-5.655827887373974,"d":"-6"},null,0,553,20,676,{"v":360.308,"d":"360"},{"v":616.4298436737829,"d":"616"},{"v":644.6835339980352,"d":"645"},{"v":28.25369032425226,"d":"28"},{"v":4.38256738915537,"d":"4"},{"v":11.10196896260448,"d":"11"},{"v":50.21760281424599,"d":"50"},null,null,"GSK3a","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","GSK",{"$nulls":6},"NVS(pY)ICS(bA)C","Corresponds to amino acid residues N276 to S282; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y279 phosphorylation stimulates phosphotransferase activity, promotes nuclear localization, and regulates cell growth, apoptosis, transcription, protein stability, and molecular association. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in GSK3a.","GSK3a; MEK1 (MAP2K1); MEK2 (MAP2K2)","Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.26; CMGC group; GSK family; GSK subfamily","P49840","P49840","P49840",null,"GO:0097440; GO:0030877; GO:0005829; GO:0005739; GO:0043025; GO:0098794; GO:1990635","GO:0005524; GO:0034236; GO:0004674; GO:0005102; GO:0050321","GO:0003214; GO:0032869; GO:0036016; GO:0007212; GO:0060079; GO:0097191; GO:0097192; GO:0005977; GO:0008286; GO:0036498; GO:0090090; GO:0061052; GO:0046325; GO:2000466; GO:0045719; GO:1904227; GO:0046627; GO:0032007; GO:2000077; GO:0010905; GO:0007399; GO:0018107; GO:0071879; GO:0106071; GO:1902004; GO:0010628; GO:2000467; GO:0045823; GO:1901030; GO:0032436; GO:0045732; GO:1903955; GO:0031398; GO:0043161; GO:0006468; GO:1903146; GO:0003073; GO:0016055"]
[1003,498,"NK070","GSK3b","Pan-specific","Glycogen synthase-serine kinase 3 beta",0,10991,14,730,{"v":8013.21,"d":"8013"},{"v":14080.3871019921,"d":"14080"},{"v":14766.944809783568,"d":"14767"},{"v":686.5577077914677,"d":"687"},{"v":4.649287422924486,"d":"5"},0,11601,16,694,{"v":8039.99,"d":"8040"},{"v":14047.5922826404,"d":"14048"},{"v":13687.95425355115,"d":"13688"},{"v":359.63802908925027,"d":"360"},{"v":2.627405253023454,"d":"3"},{"v":7.27669267594794,"d":"7"},{"v":-7.3067961594706645,"d":"-7"},null,0,10205,16,727,{"v":7407.403,"d":"7407"},{"v":12672.891729627738,"d":"12673"},{"v":14012.12212568978,"d":"14012"},{"v":1339.230396062043,"d":"1339"},{"v":9.55765575013582,"d":"10"},{"v":14.206943173060306,"d":"14"},{"v":-5.111569751338777,"d":"-5"},null,null,"GSK3B","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","GSK",{"$nulls":6},"CAHSFFDELRDPNVK","Corresponds to amino acid residues C335 to K349; Kinase catalytic subdomain 11.",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.26; CMGC group; GSK family; GSK subfamily","P49841","P49841","P49841","P49841","GO:0030424; GO:0030877; GO:0005813; GO:0005737; GO:0005829; GO:0030425; GO:0098978; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0098794; GO:1990909","GO:0005524; GO:0008013; GO:0034452; GO:0016301; GO:0051059; GO:0002039; GO:0002020; GO:0034236; GO:0004672; GO:0019901; GO:0004674; GO:0001085; GO:0050321; GO:0031625","GO:1904885; GO:1904886; GO:1904646; GO:0036016; GO:0007623; GO:0007212; GO:0001837; GO:0006983; GO:0030010; GO:0060079; GO:0097191; GO:0097192; GO:0005977; GO:0021766; GO:0035556; GO:0030011; GO:0043066; GO:0070885; GO:0090090; GO:1904339; GO:2000466; GO:0045719; GO:1901215; GO:0032515; GO:1901984; GO:0032091; GO:0031333; GO:1900181; GO:2000077; GO:0031175; GO:0106028; GO:0018105; GO:0018107; GO:0001954; GO:0010628; GO:0043547; GO:1901030; GO:0010822; GO:1901216; GO:0032436; GO:0032092; GO:0045732; GO:0031334; GO:0046827; GO:1904781; GO:0046777; GO:0006468; GO:0030516; GO:0050770; GO:1900034; GO:0048814; GO:0032886; GO:0070507; GO:2000300; GO:0071109; GO:0016055"]
[1004,498,"NK070","GSK3b","Pan-specific","Glycogen synthase-serine kinase 3 beta",0,11246,14,783,{"v":8794.656,"d":"8795"},{"v":15453.502517575036,"d":"15454"},{"$nulls":3},0,10990,14,695,{"v":7628.32,"d":"7628"},{"v":13328.316224461898,"d":"13328"},{"$nulls":6},0,11628,20,773,{"v":8972.984,"d":"8973"},{"v":15351.352521751822,"d":"15351"},{"$nulls":7},"GSK3B","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","GSK",{"$nulls":6},"CAHSFFDELRDPNVK","Corresponds to amino acid residues C335 to K349; Kinase catalytic subdomain 11.",{"$nulls":3},"P49841","P49841","P49841","P49841"]
[1009,501,"PK651","GTF2F1","S385+T389","General transcription factor IIF subunit 1",0,8044,18,812,{"v":6517.112,"d":"6517"},{"v":11451.523140793508,"d":"11452"},{"v":12351.957254829198,"d":"12352"},{"v":900.4341140356901,"d":"900"},{"v":7.289809181323475,"d":"7"},0,8617,16,799,{"v":6872.199,"d":"6872"},{"v":12007.210162844614,"d":"12007"},{"v":12677.275032895182,"d":"12677"},{"v":670.0648700505681,"d":"670"},{"v":5.285559146676819,"d":"5"},{"v":12.575368328000295,"d":"13"},{"v":2.633734649128556,"d":"3"},null,0,10038,16,799,{"v":8007.578,"d":"8008"},{"v":13699.695967743219,"d":"13700"},{"v":14113.740116991028,"d":"14114"},{"v":414.0441492478094,"d":"414"},{"v":2.933624580130652,"d":"3"},{"v":10.223433761454128,"d":"10"},{"v":14.263187815623567,"d":"14"},null,null,"GTF2F1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine; Transcription protein ","Protein-serine/threonine kinase","Atypical",null,null,"X",{"$nulls":4},"RGN(pS)RPG(pT)PSA(bA)C","Corresponds to amino acid residues R382 to A392; in the TFIIF_alpha domain.","S385+T389 phosphorylation inhibits transcriptional activity. These are the two major in vivo phosphorylation sites in GTF2F1 (≥280 and ≥319 reports, respectively, from high throughput mass spectrometry studies).","S385: GTF2F1. T389: GTF2F1","EC 2.7.11.1; Transcription initiation complex","P35269","P35269","P35269",null,"GO:0030054; GO:0043231; GO:0005654; GO:0005634; GO:0032991; GO:0005669; GO:0005674","GO:0003677; GO:0019211; GO:1990841; GO:0019904; GO:0019903; GO:0003723; GO:0003713; GO:0008134","GO:0006370; GO:0008543; GO:0000398; GO:0032091; GO:0045944; GO:0032968; GO:0009615; GO:0016070; GO:0042795; GO:0006366; GO:0006368; GO:0006367"]
[1014,503,"PK652","GUK1","Y53","Guanylate kinase",0,7593,22,938,{"v":7101.598,"d":"7102"},{"v":12478.550903162764,"d":"12479"},{"$nulls":3},0,7512,22,866,{"v":6486.34,"d":"6486"},{"v":11333.031474738369,"d":"11333"},{"$nulls":6},0,8378,24,918,{"v":7668.972,"d":"7669"},{"v":13120.39480416371,"d":"13120"},{"$nulls":7},"GUK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical",{"$nulls":7},"GKD(pY)YFV(bA)C","Corresponds to amino acid residues G50 to V56; In the first third of the Guanylate_kin domain. ","The effect of Y53 phosphorylation is unclear. This Is the major in vivo site of phosphorylation of GUK1 (≥86 reports from high throughput mass spectrometry studies).",null,null,"Q16774","Q16774","Q16774"]
[1020,520,"PN036","H2AFX","S139","Histone H2A.X",0,1472,18,260,{"v":378.04,"d":"378"},{"v":664.2718136723104,"d":"664"},{"$nulls":3},0,718,18,249,{"v":174.3,"d":"174"},{"v":304.53959953485287,"d":"305"},{"$nulls":6},0,33,14,648,{"v":12.312,"d":"12"},{"v":21.063879334657056,"d":"21"},{"$nulls":20},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S139 phosphosite.","S139 phosphorylation regulates DNA damage response mechanism at double strand DNA breaks. This is one of the major in vivo phosphorylation sites in histone H2A.","ATM; JNK2 (MAPK9)",null,"P16104","P16104",null,"P16104"]
[1021,521,"PN037","H2B","S14","Histone H2B",0,1943,10,299,{"v":577.967,"d":"578"},{"v":1015.5729217351184,"d":"1016"},{"v":1072.0432301995504,"d":"1072"},{"v":56.47030846443204,"d":"56"},{"v":5.2675402328617515,"d":"5"},0,1610,10,320,512,{"v":894.5741535389826,"d":"895"},{"v":940.7460609245708,"d":"941"},{"v":46.171907385588156,"d":"46"},{"v":4.908009642922143,"d":"5"},{"v":10.175549875783894,"d":"10"},{"v":-12.247376372176703,"d":"-12"},null,0,1754,10,287,{"v":500.528,"d":"501"},{"v":856.324024985155,"d":"856"},{"v":959.3029906212562,"d":"959"},{"v":102.97896563610118,"d":"103"},{"v":10.734769581966045,"d":"11"},{"v":16.002309814827797,"d":"16"},{"v":-10.516389302445276,"d":"-11"},{"$nulls":15},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S14 phosphosite.","The effect of S14 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in histone H2B.","MST1 (STK4, KRS2); PKCd (PRKCD)","DNA binding protein","P33778","P33778",null,"P33778","GO:0005829; GO:0000784; GO:0005654; GO:0000786; GO:0005634","GO:0003677; GO:0046982","GO:0006334; GO:0016567"]
[1026,523,"PN038","H3F3A","S10","Histone H3",0,4597,10,578,{"v":2651.286,"d":"2651"},{"v":4658.698973082226,"d":"4659"},{"$nulls":3},0,4698,12,572,{"v":2680.392,"d":"2680"},{"v":4683.221493266915,"d":"4683"},{"$nulls":6},0,5332,12,571,{"v":3037.72,"d":"3038"},{"v":5197.057142013843,"d":"5197"},{"$nulls":20},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S10 phosphosite.","S10 phosphorylation induces interaction with DNA and inhibits interaction with HP1-alpha. This is one of the major in vivo phosphorylation sites in histone H3.","Akt1 (PKBa); Akt2 (PKBb); AurA (STK15); AurB (STK12); AurC (STK13); DLK (MAP3K12); Fyn; MSK1 (RPS6KA5); MSK2 (RPS6KA4); p38a MAPK (MAPK14); PAK1; PBK (TOPK); Pim1; PKACa (PRKACA); PKCt (PRKCQ; PKCq); ROCK1; RSK1 (RPS6KA1); TLK1; VRK1",null,"P84243","P84243"]
[1031,506,"PN518","HCA59","Y147","Uncharacterized protein C9orf78",0,10379,22,919,{"v":9518.083,"d":"9518"},{"v":16724.670027228825,"d":"16725"},{"v":17066.20403425392,"d":"17066"},{"v":341.53400702509316,"d":"342"},{"v":2.0012300704924977,"d":"2"},0,12083,28,961,{"v":11584.855,"d":"11585"},{"v":20241.234092767285,"d":"20241"},{"v":18919.95330963564,"d":"18920"},{"v":1321.2807831316459,"d":"1321"},{"v":6.983530886721259,"d":"7"},{"v":8.984760957213757,"d":"9"},{"v":10.862106603560022,"d":"11"},null,0,10512,26,925,{"v":9699.55,"d":"9700"},{"v":16594.391715438014,"d":"16594"},{"v":17089.65549395758,"d":"17090"},{"v":495.2637785195657,"d":"495"},{"v":2.8980325477870337,"d":"3"},{"v":4.899262618279531,"d":"5"},{"v":0.13741462164983886,"d":"0"},{"$nulls":15},"DCL(pY)ELP(bA)C","Corresponds to amino acid residues D144 to P150; In the middle of the Hep_59 domain. ","The effect of Y147 phosphorylation is unclear. This is the major in vivo phosphorylation site in HCA59 (≥518 reports from high throughput mass spectrometry studies).","Syk","Uncharacterized protein","Q9NZ63","Q9NZ63",null,null,"GO:0005829; GO:0005654"]
[1036,508,"NK271-1","Hck","Pan-specific","Tyrosine-protein kinase Hck",0,2432,10,773,{"v":1872.206,"d":"1872"},{"v":3289.740967062166,"d":"3290"},{"$nulls":3},0,3078,10,772,{"v":2368.496,"d":"2368"},{"v":4138.272078829035,"d":"4138"},{"$nulls":6},0,2976,12,766,{"v":2270.424,"d":"2270"},{"v":3884.3353780465736,"d":"3884"},{"$nulls":7},"HCK","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"CMKSKFLQVGGNTFSKTETS","Corresponds to amino acid residues C24 to S43; Post-N-terminus.",{"$nulls":3},"P08631","P08631","P08631","P08631"]
[1038,509,"NN169","HDAC4","Pan-specific","Histone deacetylase 4",0,1149,10,226,{"v":257.414,"d":"257"},{"v":452.31421184172063,"d":"452"},{"$nulls":3},0,1121,10,198,{"v":219.978,"d":"220"},{"v":384.34889286562174,"d":"384"},{"$nulls":6},0,1156,10,213,{"v":244.098,"d":"244"},{"v":417.6129644112345,"d":"418"},{"$nulls":20},"AQSSP","Corresponds to amino acid residues  A630 to P634; Surrounds the S632 phosphosite.",{"$nulls":3},"P56524","P56524",null,"P56524"]
[1043,512,"PP500","HePTP (PTPN7)","S44","Tyrosine-protein phosphatase non-receptor type 7",0,4164,14,539,{"v":2236.85,"d":"2237"},{"v":3930.4740408763814,"d":"3930"},{"v":4796.143003516699,"d":"4796"},{"v":865.6689626403172,"d":"866"},{"v":18.049273385000795,"d":"18"},0,3882,14,539,{"v":2084.852,"d":"2085"},{"v":3642.6849866290136,"d":"3643"},{"v":4411.997792090815,"d":"4412"},{"v":769.3128054618014,"d":"769"},{"v":17.43683568565952,"d":"17"},{"v":35.48610907066032,"d":"35"},{"v":-8.009461167947137,"d":"-8"},null,0,5326,14,620,{"v":3293.44,"d":"3293"},{"v":5634.5535051927345,"d":"5635"},{"v":6617.654299708165,"d":"6618"},{"v":983.1007945154306,"d":"983"},{"v":14.855729084530523,"d":"15"},{"v":32.90500246953132,"d":"33"},{"v":37.97866941948712,"d":"38"},{"$nulls":4},"PYP","Protein phosphatase - Non-receptor protein-tyrosine phosphatase",{"$nulls":6},"X",null,null,"RRG(pS)NVA(bA)C","Corresponds to amino acid residues R41 to A47.","S44 phosphorylation inhibits interaction with ERK2. This is one of the major in vivo phosphorylation sites in HePTP (≥44 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and found in fish.","PKACa (PRKACA); PKCt (PRKCQ; PKCq)","Protein phosphataseProtein-tyrosine phosphatase","P35236","P35236",null,"P35236","GO:0005737; GO:0009898; GO:0005856; GO:0005829; GO:0005654","GO:0004725","GO:0071345; GO:0006470"]
[1048,514,"PP528","HePTP (PTPN7)","S143","Tyrosine-protein phosphatase non-receptor type 7",0,9846,14,594,{"v":5840.208,"d":"5840"},{"v":10262.103376318739,"d":"10262"},{"$nulls":3},0,11635,16,622,{"v":7227.018,"d":"7227"},{"v":12627.155292892561,"d":"12627"},{"$nulls":6},0,10830,14,590,{"v":6381.44,"d":"6381"},{"v":10917.6317528715,"d":"10918"},{"$nulls":9},"PYP","Protein phosphatase - Non-receptor protein-tyrosine phosphatase",{"$nulls":6},"X",null,null,"CGRAQ(pS)QED","Corresponds to amino acid residues G139 to D146.","The effect of S143 phosphorylation is unclear. This is the major in vivo phosphorylation site in HePTP (≥99 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in mammals and also found in the chicken.",null,null,"P35236","P35236",null,"P35236"]
[1053,517,"PN519","HGS (Hrs)","Y216","Hepatocyte growth factor-regulated tyrosine kinase substrate",0,10455,20,555,{"v":5791.425,"d":"5791"},{"v":10176.384479148132,"d":"10176"},{"v":9942.090904511766,"d":"9942"},{"v":234.29357463636552,"d":"234"},{"v":2.356582502479856,"d":"2"},0,11714,18,547,{"v":6397.712,"d":"6398"},{"v":11178.179290988655,"d":"11178"},{"v":10461.723238051974,"d":"10462"},{"v":716.4560529366809,"d":"716"},{"v":6.848356017780572,"d":"7"},{"v":9.204938520260427,"d":"9"},{"v":5.226590045604979,"d":"5"},null,0,10417,17,569,{"v":5917.6,"d":"5918"},{"v":10124.07507722276,"d":"10124"},{"v":9800.146077113546,"d":"9800"},{"v":323.92900010921403,"d":"324"},{"v":3.3053486913393173,"d":"3"},{"v":5.661931193819173,"d":"6"},{"v":-1.4277160484803488,"d":"-1"},{"$nulls":13},"X",null,"EPC(pY)EQL(bA)C","Corresponds to amino acid residues E213 to L219; In the FYVE domain. ","The effect of Y216 phosphorylation is unclear. This is the major in vivo phosphorylation site in HGS (≥1385 reports from high throughput mass spectrometry studies).",null,"Adapter/scaffold protein","O14964","O14964",null,"O14964","GO:0005829; GO:0005769; GO:0031901; GO:0005768; GO:0033565; GO:0070062; GO:0043231; GO:0005764; GO:0032585","GO:0046872; GO:0019904; GO:0044389","GO:0016197; GO:0016236; GO:0010324; GO:0061024; GO:0036258; GO:0016525; GO:0008285; GO:0042059; GO:0046426; GO:0010642; GO:0030948; GO:1903543; GO:0010628; GO:0072657; GO:0006622; GO:0043405; GO:0042176; GO:0007165"]
[1054,517,"PN519","HGS (Hrs)","Y216","Hepatocyte growth factor-regulated tyrosine kinase substrate",0,10269,19,539,{"v":5524.75,"d":"5525"},{"v":9707.7973298754,"d":"9708"},{"$nulls":3},0,9978,18,560,{"v":5577.6,"d":"5578"},{"v":9745.267185115292,"d":"9745"},{"$nulls":6},0,10142,16,547,{"v":5538.922,"d":"5539"},{"v":9476.217077004332,"d":"9476"},{"$nulls":18},"X",null,"EPC(pY)EQL(bA)C","Corresponds to amino acid residues E213 to L219; In the FYVE domain. ","The effect of Y216 phosphorylation is unclear. This is the major in vivo phosphorylation site in HGS (≥1385 reports from high throughput mass spectrometry studies).",null,null,"O14964","O14964",null,"O14964"]
[1060,526,"PN605","HMGA1","S36+T39","High mobility group protein HMG-I/HMG-Y",0,13293,14,598,{"v":7940.842,"d":"7941"},{"v":13953.225895210178,"d":"13953"},{"$nulls":3},0,14196,18,605,{"v":8577.69,"d":"8578"},{"v":14987.069865370695,"d":"14987"},{"$nulls":6},0,11946,14,615,{"v":7338.18,"d":"7338"},{"v":12554.462155295138,"d":"12554"},{"$nulls":10},"DNA binding protein",{"$nulls":4},"X",{"$nulls":4},"PPV(pS)PG(pT)ALVGC","Corresponds to amino acid residues P33 to G43.","S36 and T39 phosphorylation regulates molecular association, including inducing interaction with DNA. These are two of the minor in vivo phosphorylation sites in HMGA1 (≥64 and ≥27 reports, respectively, from high throughput mass spectrometry studies).","S36: ERK1 (MAPK3); CDK1; CDK2; HIPK2",null,"P17096","P17096",null,"P17096"]
[1065,529,"PN705","HMGCR","S872","3-hydroxy-3-methylglutaryl-coenzyme A reductase",0,6745,18,718,{"v":4829.986,"d":"4830"},{"v":8486.994921785703,"d":"8487"},{"v":8274.216732353312,"d":"8274"},{"v":212.77818943239072,"d":"213"},{"v":2.5715810488792137,"d":"3"},0,7615,16,696,{"v":5288.904,"d":"5289"},{"v":9240.853162009647,"d":"9241"},{"v":8988.882898108786,"d":"8989"},{"v":251.97026390086103,"d":"252"},{"v":2.80313212172198,"d":"3"},{"v":5.3747131706011935,"d":"5"},{"v":8.637266690888495,"d":"9"},null,0,7142,20,738,{"v":5256.036,"d":"5256"},{"v":8992.24399631364,"d":"8992"},{"v":8962.773042332257,"d":"8963"},{"v":29.47095398138299,"d":"29"},{"v":0.32881513168065424,"d":"0"},{"v":2.900396180559868,"d":"3"},{"v":8.321709863927012,"d":"8"},{"$nulls":5},"Cholesterol synthesis",{"$nulls":8},"X","HNR(pS)KIN(bA)C","Corresponds to amino acid residues H869 to N875.","The effect of S872 phosphorylation is unclear. This phosphorylation site is not commonly detected by mass spectrometry (≥9 reports), but appears to be the major phosphosite on HMG-CoA reductase.  This phosphosite is not well conserved in vertebrates, but is found in rhesus monkey.","AMPKa1 (PRKAA1); PKACa (PRKACA); PKCa (PRKCA)","Enzyme, cholesterol synthesis","P04035","P04035",null,"P04035","GO:0005783; GO:0005789; GO:0016021; GO:0005778","GO:0050662; GO:0004420; GO:0042282; GO:0070402; GO:0042803; GO:0051721","GO:0007568; GO:0006695; GO:0015936; GO:0008299; GO:0045445; GO:0097756; GO:0061179; GO:0043407; GO:0010664; GO:0061045; GO:0010666; GO:0070374; GO:0048643; GO:0048661; GO:0032874; GO:0051262; GO:0045540; GO:0019216; GO:0045471; GO:0007584; GO:0006743; GO:0008542"]
[1070,531,"PN608","HNF4A","S167","Hepatocyte nuclear factor 4-alpha",0,11212,16,718,{"v":8038.728,"d":"8039"},{"v":14125.225976559052,"d":"14125"},{"$nulls":3},0,12498,18,724,{"v":9035.52,"d":"9036"},{"v":15786.997374579196,"d":"15787"},{"$nulls":6},0,10638,15,711,{"v":7552.953,"d":"7553"},{"v":12921.90469560884,"d":"12922"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"RQIT(pS)PVSGC","Corresponds to amino acid residues R163 to G171.","S167 phosphorylation induces transcription and interaction with PC4. This is one of the major in vivo phosphorylation sites in HNF4A (≥31 reports from high throughput mass spectrometry studies).","p38a MAPK (MAPK14); p38b MAPK (MAPK11)",null,"P41235","P41235"]
[1071,532,"PN229","hnRNP-K","S302","Heterogeneous nuclear ribonucleoprotein K",0,60,12,656,{"v":31.488,"d":"31"},{"v":55.329041553575564,"d":"55"},{"v":63.25904550845637,"d":"63"},{"v":7.930003954880803,"d":"8"},{"v":12.535762895475136,"d":"13"},0,120,10,425,{"v":46.75,"d":"47"},{"v":81.68230796474109,"d":"82"},{"v":81.27171240598784,"d":"81"},{"v":0.4105955587532435,"d":"0"},{"v":0.5052133720305272,"d":"1"},{"v":13.040976267505663,"d":"13"},{"v":28.474452551016697,"d":"28"},null,0,128,8,382,{"v":45.84,"d":"46"},{"v":78.42496984248535,"d":"78"},{"v":89.80890852773616,"d":"90"},{"v":11.383938685250811,"d":"11"},{"v":12.675734369642239,"d":"13"},{"v":25.211497265117373,"d":"25"},{"v":41.9700657919833,"d":"42"},{"$nulls":15},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S302 phosphosite.","S302 phosphorylation induces activity and binding to PKCd. This phosphorylation site in hnRNP-K has not apparently been reported from high throughput mass spectrometry studies.","PKCd (PRKCD)","RNA binding protein","P61978","P61978",null,"P61978","GO:0071013; GO:0042995; GO:0005737; GO:0010494; GO:0070062; GO:0005925; GO:0016020; GO:0000790; GO:0005654; GO:0005634; GO:0002102","GO:0045296; GO:0042802; GO:0019904; GO:0003723; GO:0000978; GO:0003697; GO:0001077","GO:0000398; GO:0043066; GO:0048025; GO:0045716; GO:0048260; GO:0045944; GO:1902165; GO:0072369; GO:0010988; GO:0016070; GO:0006396; GO:0007165; GO:0016032"]
[1076,534,"NN281-3","HRAS","Pan-specific","GTPase HRas",0,5043,12,573,{"v":2882.763,"d":"2883"},{"v":5065.438065806344,"d":"5065"},{"$nulls":3},0,5032,14,582,{"v":2920.476,"d":"2920"},{"v":5102.699893810379,"d":"5103"},{"$nulls":6},0,5538,16,588,{"v":3246.936,"d":"3247"},{"v":5554.992536659686,"d":"5555"},{"$nulls":10},"GTPase",{"$nulls":9},"RQHKLRKLNPPDESGPGC","Corresponds to amino acid residues R164 to C181; C-terminus.",{"$nulls":3},"P01112","P01112",null,"P01112"]
[1083,538,"NN268-2","HSF1","Pan-specific","Heat shock factor protein 1",0,2016,12,283,{"v":567.132,"d":"567"},{"v":996.5342350851885,"d":"997"},{"v":707.7119993077108,"d":"708"},{"v":288.82223577747766,"d":"289"},{"v":40.8107021019858,"d":"41"},0,3842,10,276,{"v":1057.632,"d":"1058"},{"v":1847.9106467885572,"d":"1848"},{"v":1133.217533931799,"d":"1133"},{"v":714.6931128567583,"d":"715"},{"v":63.06760100834894,"d":"63"},{"v":103.87830311033474,"d":"104"},{"v":60.124109106574565,"d":"60"},null,0,1610,10,265,424,{"v":725.3967542149604,"d":"725"},{"v":542.2032786304568,"d":"542"},{"v":183.19347558450363,"d":"183"},{"v":33.78686238254208,"d":"34"},{"v":74.59756448452788,"d":"75"},{"v":-23.386451104284774,"d":"-23"},{"$nulls":5},"Transcription protein",{"$nulls":4},"X","X",{"$nulls":3},"Epitope undefined.",{"$nulls":3},"Transcription protein","Q00613","Q00613",null,null,"GO:0005813; GO:0000777; GO:0005737; GO:0005829; GO:0000791; GO:0000792; GO:0000776; GO:0097431; GO:0097165; GO:0005654; GO:0005634; GO:0048471; GO:0016605; GO:0045120; GO:1990904","GO:0031490; GO:0003677; GO:0003700; GO:0031072; GO:0051879; GO:0042802; GO:1990841; GO:0046982; GO:0019901; GO:0043621; GO:0001162; GO:0000978; GO:0000981; GO:0043565; GO:0098847; GO:0097677; GO:0001078; GO:0061770","GO:0034622; GO:1904385; GO:0071276; GO:0071280; GO:0072738; GO:0071392; GO:0071480; GO:0034605; GO:0070301; GO:1904845; GO:0071222; GO:1904843; GO:0035865; GO:1903936; GO:0034620; GO:0006952; GO:0006281; GO:0001892; GO:0060136; GO:0007143; GO:0000165; GO:0006397; GO:0009299; GO:0051028; GO:0010667; GO:0008285; GO:2001033; GO:0090084; GO:1901215; GO:0000122; GO:0032720; GO:1902512; GO:0008284; GO:0120162; GO:0043280; GO:0090261; GO:1904528; GO:0045931; GO:1900365; GO:0040018; GO:0045944; GO:0061408; GO:0042531; GO:0051260; GO:0070207; GO:1900034; GO:0043497; GO:0014823; GO:1990910; GO:1990911; GO:0033574; GO:0007283"]
[1087,540,"NN152-2","HSP27 (HSP28; HSPB1)","Pan-specific","Heat shock 27 kDa protein beta 1",0,4066,14,292,{"v":1183.184,"d":"1183"},{"v":2079.028096466138,"d":"2079"},{"v":1940.2978345016468,"d":"1940"},{"v":138.7302619644911,"d":"139"},{"v":7.149946750320581,"d":"7"},0,4644,10,295,{"v":1367.03,"d":"1367"},{"v":2388.495517797647,"d":"2388"},{"v":1887.4064451103318,"d":"1887"},{"v":501.08907268731537,"d":"501"},{"v":26.549081358998077,"d":"27"},{"v":33.69902810931866,"d":"34"},{"v":-2.725941783308741,"d":"-3"},null,0,3774,12,310,{"v":1166.22,"d":"1166"},{"v":1995.2174591994603,"d":"1995"},{"v":1857.309955511348,"d":"1857"},{"v":137.90750368811223,"d":"138"},{"v":7.4251205771491176,"d":"7"},{"v":14.575067327469698,"d":"15"},{"v":-4.277069092931995,"d":"-4"},{"$nulls":5},"Chaperone protein",{"$nulls":5},"X",{"$nulls":3},"Epitope undefined.",{"$nulls":3},"Chaperone protein","P04792","P04792",null,"P04792","GO:1904115; GO:0005737; GO:0005856; GO:0005829; GO:0070062; GO:0005615; GO:0005925; GO:0005634; GO:0005886; GO:0000502; GO:0005819; GO:0030018","GO:0042802; GO:0044183; GO:0042803; GO:0019901; GO:0005080; GO:0008426; GO:0003723; GO:0043130","GO:0099641; GO:0035924; GO:0061077; GO:0035556; GO:0043066; GO:1902176; GO:0006469; GO:0070527; GO:0045766; GO:0043536; GO:2001028; GO:0038033; GO:0032731; GO:0042535; GO:0010506; GO:0043122; GO:0043488; GO:0001932; GO:0006446; GO:0006986; GO:0009615; GO:0001895"]
[1088,540,"NN152-2","HSP27 (HSP28; HSPB1)","Pan-specific","Heat shock 27 kDa protein beta 1",0,3570,10,288,{"v":1025.28,"d":"1025"},{"v":1801.5675725371555,"d":"1802"},{"$nulls":3},0,2718,10,293,{"v":793.444,"d":"793"},{"v":1386.3173724230166,"d":"1386"},{"$nulls":6},0,3524,10,286,{"v":1005.004,"d":"1005"},{"v":1719.402451823236,"d":"1719"},{"$nulls":10},"Chaperone protein",{"$nulls":5},"X",{"$nulls":3},"Epitope undefined.",{"$nulls":4},"P04792","P04792",null,"P04792"]
[1093,543,"NN061","HSP90a (HSP90AA1; HSP90; HSP86; HSPC; HSPCA; LAP2)","Pan-specific","Heat shock 90 kDa protein alpha",0,803,12,482,{"v":381.262,"d":"381"},{"v":669.9333409806696,"d":"670"},{"v":711.2245359586763,"d":"711"},{"v":41.291194978006615,"d":"41"},{"v":5.805648271449078,"d":"6"},0,860,11,492,{"v":417.708,"d":"418"},{"v":729.8257432157449,"d":"730"},{"v":762.5021608319286,"d":"763"},{"v":32.6764176161837,"d":"33"},{"v":4.285419674159621,"d":"4"},{"v":10.0910679456087,"d":"10"},{"v":7.209766013504293,"d":"7"},null,0,976,12,514,{"v":495.496,"d":"495"},{"v":847.7150710530566,"d":"848"},{"v":888.3484097582038,"d":"888"},{"v":40.63333870514725,"d":"41"},{"v":4.574031794147871,"d":"5"},{"v":10.379680065596949,"d":"10"},{"v":24.904072461557874,"d":"25"},{"$nulls":5},"Chaperone protein",{"$nulls":5},"X",{"$nulls":3},"Not precisely defined.","Antibody raised against amino acid residues 610-723 of human HSP90β.",null,null,"Chaperone protein","P07900","P07900",null,"P07900","GO:0044295; GO:0005737; GO:0005829; GO:0044294; GO:0071682; GO:0070062; GO:0005576; GO:1904813; GO:0043202; GO:0042470; GO:0016020; GO:0043209; GO:0043025; GO:0005654; GO:0005634; GO:0048471; GO:0005886; GO:0032991; GO:0032587; GO:0034774","GO:0016887; GO:0042623; GO:0005524; GO:0097718; GO:0070182; GO:0051020; GO:0042826; GO:0042802; GO:0023026; GO:0030235; GO:0000166; GO:0042803; GO:0004713; GO:1990782; GO:0003723; GO:0097110; GO:0048156; GO:0030911; GO:0031625; GO:0051082","GO:0048675; GO:0021955; GO:0061684; GO:0051131; GO:0097711; GO:0051186; GO:0019221; GO:0038128; GO:0030010; GO:0038096; GO:0000086; GO:0006839; GO:0043312; GO:1903364; GO:0045429; GO:0033138; GO:0051897; GO:0001934; GO:0032273; GO:1902949; GO:0051973; GO:0045040; GO:0042026; GO:0050821; GO:0043335; GO:0006898; GO:1903827; GO:1900034; GO:0010389; GO:0050999; GO:0043254; GO:0031396; GO:0046677; GO:0009409; GO:0009408; GO:0006986; GO:0007165; GO:1905323; GO:0007004; GO:0048010"]
[1098,545,"PN520","HSP90AB1 (HSP90B; HSP90-beta)","Y484","Heat shock 90 kDa protein beta",0,10676,12,580,{"v":6185.12,"d":"6185"},{"v":10868.164427523225,"d":"10868"},{"$nulls":3},0,10286,12,603,{"v":6195.222,"d":"6195"},{"v":10824.38569655485,"d":"10824"},{"$nulls":6},0,10791,12,568,{"v":6122.472,"d":"6122"},{"v":10474.5785768207,"d":"10475"},{"$nulls":10},"Chaperone protein",{"$nulls":5},"X",{"$nulls":3},"KSI(pY)YIT(bA)C","Corresponds to amino acid residues K481 to T487; In the middle of the HSP90 domain. ","The effect of Y484 phosphorylation is unclear. This is the major in vivo phosphorylation site in HSP90AB1 (≥814 reports from high throughput mass spectrometry studies).",null,null,"P08238","P08238",null,"P08238"]
[1101,547,"PN103","Huntingtin","S419","Huntington's disease protein",0,345,12,229,{"v":76.257,"d":"76"},{"v":133.99475107186905,"d":"134"},{"v":129.4815192619618,"d":"129"},{"v":4.513231809907239,"d":"5"},{"v":3.4856185157792674,"d":"3"},0,353,12,313,{"v":106.733,"d":"107"},{"v":186.4855139251489,"d":"186"},{"v":165.74519656267918,"d":"166"},{"v":20.74031736246971,"d":"21"},{"v":12.513374621162207,"d":"13"},{"v":15.998993136941474,"d":"16"},{"v":28.006836425320415,"d":"28"},null,0,388,10,294,{"v":111.132,"d":"111"},{"v":190.12922662598345,"d":"190"},{"v":187.86578345186462,"d":"188"},{"v":2.2634431741188337,"d":"2"},{"v":1.2048192771084245,"d":"1"},{"v":4.690437792887692,"d":"5"},{"v":45.090808729068215,"d":"45"},{"$nulls":15},"RSG(pS)IVELI","Corresponds to amino acid residues R416-I424.","S419 phosphorylation induces activity and binding to KIF5B and dynactin 1, and inhibits apoptosis. This is one of the major in vivo phosphorylation sites in the huntingtin protein (≥47 reports from high throughput mass spectrometry studies).","Akt1 (PKBa); Akt3 (PKBg); SGK1","Cytoskeletal protein","P42858","P42858",null,"P42858","GO:0005776; GO:0030424; GO:0005814; GO:0005737; GO:0030659; GO:0005829; GO:0030425; GO:0005783; GO:0005794; GO:0016234; GO:0005770; GO:0005654; GO:0005634; GO:0048471; GO:0099524; GO:0099523; GO:0032991","GO:0048487; GO:0034452; GO:0045505; GO:0031072; GO:0042802; GO:0044325; GO:0019900; GO:0002039; GO:0005522; GO:0008134","GO:0048513; GO:0006915; GO:0000132; GO:0007030; GO:2001237; GO:1905337; GO:0043065; GO:1903599; GO:0045724; GO:0031587; GO:1904504; GO:0031648; GO:1905289; GO:2000479; GO:0043666; GO:0006890; GO:0047496; GO:0042297"]
[1105,549,"PK655","ICK","Y156+T157","Intestinal cell (MAK-like) kinase",0,9342,16,611,{"v":5698.186,"d":"5698"},{"v":10012.549859438595,"d":"10013"},{"v":10085.30804108268,"d":"10085"},{"v":72.7581816440852,"d":"73"},{"v":0.72142746010041,"d":"1"},0,10414,16,642,{"v":6675.516,"d":"6676"},{"v":11663.562646749873,"d":"11664"},{"v":11104.871385207338,"d":"11105"},{"v":558.6912615425354,"d":"559"},{"v":5.031046665581027,"d":"5"},{"v":5.752474125681436,"d":"6"},{"v":10.109392196762343,"d":"10"},null,0,8920,12,672,{"v":5986.176,"d":"5986"},{"v":10241.397737168621,"d":"10241"},{"v":9729.476351343836,"d":"9729"},{"v":511.92138582478583,"d":"512"},{"v":5.261551262767386,"d":"5"},{"v":5.982978722867797,"d":"6"},{"v":-3.528218357727482,"d":"-4"},null,null,"ICK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","RCK",{"$nulls":6},"SKPP(pY)(pT)D(bA)C","Corresponds to amino acid residues S152 to D158; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y156 and T157 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major in vivo phosphorylation sites in ICK (≥179 and ≥103 reports, respectively, from high throughput mass spectrometry studies).","T157: CCRK (CDK20).","EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC domain target; CMGC</A> group; RCK family","Q9UPZ9","Q9UPZ9","Q9UPZ9",null,"GO:0036064; GO:0097546; GO:0097542; GO:0005929; GO:0005737; GO:0005829; GO:0001650; GO:0005634","GO:0005524; GO:0000287; GO:0004672; GO:0004674","GO:0060271; GO:0035556; GO:0035720; GO:0035721; GO:0042073; GO:0007275; GO:0006468; GO:0010468; GO:0007165"]
[1110,551,"PN706","IDH1","T75+T77","Isocitrate dehydrogenase [NADP] cytoplasmic",0,17664,16,571,{"v":10077.008,"d":"10077"},{"v":17706.783357714474,"d":"17707"},{"$nulls":3},0,18988,16,634,{"v":12028.248,"d":"12028"},{"v":21015.937056947187,"d":"21016"},{"$nulls":6},0,15776,16,578,{"v":9109.28,"d":"9109"},{"v":15584.533361403903,"d":"15585"},{"$nulls":10},"Carbohydrate Metabolism - citrate (TCA) cycle",{"$nulls":8},"X","CA(pT)I(pT)PDEK","Corresponds to amino acid residues C73 to K81.","The effects of T75 and T77 phosphorylation are unknown. These are two of the main in vivo phosphorylation sites in IDH1 (≥14 and >16 reports, respectively, by mass spectrometry). These phosphosites are almost identical in IDH2 to T115 and T117. These phosphosites are highly conserved in vertebrates and also found in yeast.",null,null,"O75874","O75874",null,"O75874"]
[1115,554,"NK074-2","IGF1R","Pan-specific","Insulin-like growth factor 1 receptor protein-tyrosine kinase",0,606,14,508,{"v":300.736,"d":"301"},{"v":528.4373297972593,"d":"528"},{"v":514.0603538701964,"d":"514"},{"v":14.376975927062858,"d":"14"},{"v":2.7967486344401378,"d":"3"},0,698,12,517,{"v":354.662,"d":"355"},{"v":619.6708172703958,"d":"620"},{"v":616.6446406416271,"d":"617"},{"v":3.026176628768667,"d":"3"},{"v":0.49074887371434694,"d":"0"},{"v":3.287497508154485,"d":"3"},{"v":19.955689249152613,"d":"20"},null,0,774,12,541,{"v":412.242,"d":"412"},{"v":705.2806810167069,"d":"705"},{"v":679.3939397713613,"d":"679"},{"v":25.88674124534566,"d":"26"},{"v":3.810269672711154,"d":"4"},{"v":6.607018307151291,"d":"7"},{"v":32.16229080037411,"d":"32"},null,null,"IGF1R","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","InsR",{"$nulls":6},"VIMLYVFHRKRNNSRLGC","Corresponds to amino acid residues V952 to G968; Just before kinase catalytic domain.",null,null,"EC 2.7.10.1; Receptor tyrosine kinase; TK domain target; TK</A> group; InsR family","P08069","P08069","P08069","P08069","GO:0035867; GO:0005887; GO:0043231; GO:0016020; GO:0005886; GO:0043235","GO:0005524; GO:0042802; GO:0043559; GO:0005010; GO:0005520; GO:0031994; GO:0005158; GO:0043560; GO:0043548; GO:0004713","GO:0097242; GO:1904646; GO:0097062; GO:0006955; GO:0051389; GO:0048009; GO:0008286; GO:0043066; GO:0038083; GO:0014065; GO:0048015; GO:0030335; GO:0008284; GO:0120162; GO:0043243; GO:0046777; GO:0051262; GO:0046328; GO:0007165"]
[1120,556,"PK152","IGF1R","Y1280","Insulin-like growth factor 1 receptor protein-tyrosine kinase",0,2386,14,278,{"v":659.416,"d":"659"},{"v":1158.6907795062432,"d":"1159"},{"$nulls":3},0,1963,14,289,{"v":563.261,"d":"563"},{"v":984.1381490166423,"d":"984"},{"$nulls":6},0,2052,20,284,{"v":577.088,"d":"577"},{"v":987.3060426801959,"d":"987"},{"$nulls":7},"IGF1R","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","InsR",{"$nulls":6},"SF(pY)YS","Corresponds to amino acid residues S1278 to S1282.","Y1280 phosphorylation phosphorylation regulates cell differentiation and cell growth. This is one of the major in vivo phosphorylation sites in IGF1R.","IGF1R",null,"P08069","P08069","P08069","P08069"]
[1124,558,"NN064","IkBa","Pan-specific","Inhibitor of NF-kappa-B alpha (MAD3)",0,2158,10,562,{"v":1207.176,"d":"1207"},{"v":2121.185564865318,"d":"2121"},{"$nulls":3},0,1426,12,587,{"v":830.018,"d":"830"},{"v":1450.2200190861704,"d":"1450"},{"$nulls":6},0,1846,10,597,{"v":1096.092,"d":"1096"},{"v":1875.2395733985481,"d":"1875"},{"$nulls":20},"Epitope undefined.",{"$nulls":4},"P25963","P25963",null,"P25963"]
[1127,560,"PN164","IkBa","Y42","Inhibitor of NF-kappa-B alpha (MAD3)",0,543,8,179,{"v":95.765,"d":"96"},{"v":168.27317277623743,"d":"168"},{"v":156.44493842607568,"d":"156"},{"v":11.82823435016175,"d":"12"},{"v":7.5606372882117245,"d":"8"},0,692,10,178,{"v":121.396,"d":"121"},{"v":212.1049295762077,"d":"212"},{"v":173.74831552808018,"d":"174"},{"v":38.35661404812751,"d":"38"},{"v":22.07596311454803,"d":"22"},{"v":29.636600402759754,"d":"30"},{"v":11.06036237163454,"d":"11"},null,0,561,9,190,{"v":104.88,"d":"105"},{"v":179.43304618411568,"d":"179"},{"v":164.57952113672349,"d":"165"},{"v":14.853525047392196,"d":"15"},{"v":9.02513565770599,"d":"9"},{"v":16.585772945917714,"d":"17"},{"v":5.199645825864536,"d":"5"},{"$nulls":15},"EE(pY)EQ","Corresponds to amino acid residues E40 to Q44.","Y42 phosphorylation inhibits inhibitory action (induces transcription) and binding to NFkB-p65 and facilitates degradation of IkBa. This is one of the major in vivo phosphorylation sites in IkBa (≥27 reports from high throughput mass spectrometry studies).","InsR; Lck; Src","Inhibitor protein","P25963","P25963",null,"P25963","GO:0005737; GO:0005829; GO:0033256; GO:0005622; GO:0005654; GO:0005634; GO:0005886","GO:0019899; GO:0031072; GO:0042802; GO:0051059; GO:0008139; GO:0044877; GO:0008134; GO:0031625","GO:0006915; GO:0070417; GO:0071407; GO:0007253; GO:0042994; GO:0007249; GO:0070498; GO:0031663; GO:0097421; GO:0043066; GO:0043392; GO:0010888; GO:0010745; GO:0045638; GO:0032088; GO:0045746; GO:0070427; GO:0070431; GO:0032270; GO:0010875; GO:0050729; GO:0045944; GO:0016579; GO:0000060; GO:0042127; GO:1901222; GO:0043330; GO:0032495; GO:0035994; GO:0034142; GO:0033209; GO:0016032"]
[1132,562,"PK154","IKKa (IkBKA)","T23","Inhibitor of NF-kappa-B protein-serine kinase alpha (CHUK)",0,2436,12,290,{"v":702.96,"d":"703"},{"v":1235.2039840733448,"d":"1235"},{"$nulls":3},0,1685,10,289,{"v":484.075,"d":"484"},{"v":845.7831706530918,"d":"846"},{"$nulls":6},0,2314,12,305,{"v":702.11,"d":"702"},{"v":1201.198856372325,"d":"1201"},{"$nulls":7},"IKKa","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","IKK",{"$nulls":6},"LG(pT)GG","Corresponds to amino acid residues L21 to G25.","T23 phosphorylation stimulates phosphotransferase activity, and regulates transcription and apoptosis. This is one of the major in vivo phosphorylation sites in IKKa (≥3 reports from high throughput mass spectrometry studies).","Akt1 (PKBa); Akt2 (PKBb); Akt3 (PKBg)",null,"O15111","O15111","O15111"]
[1137,580,"NK076-5","IKKb (IkBKB)","Pan-specific","Inhibitor of nuclear factor kappa B kinase beta subunit",0,8283,14,622,{"v":5143.318,"d":"5143"},{"v":9037.565273921913,"d":"9038"},{"v":9273.622145471356,"d":"9274"},{"v":236.0568715494428,"d":"236"},{"v":2.545465707428223,"d":"3"},0,9144,18,620,{"v":5658.12,"d":"5658"},{"v":9885.952948480446,"d":"9886"},{"v":9345.399527343941,"d":"9345"},{"v":540.5534211365048,"d":"541"},{"v":5.784165990494958,"d":"6"},{"v":8.329631697923181,"d":"8"},{"v":0.7739951094259112,"d":"1"},null,0,8585,18,591,{"v":5063.097,"d":"5063"},{"v":8662.155967159206,"d":"8662"},{"v":8778.957675898326,"d":"8779"},{"v":116.80170873911993,"d":"117"},{"v":1.3304735374198957,"d":"1"},{"v":3.875939244848119,"d":"4"},{"v":-5.334102056493563,"d":"-5"},null,null,"IKKb","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","IKK",{"$nulls":6},"CTLLENAIQDTVREQDQSFT","Corresponds to amino acid residues C716 to T735; Pre-C-terminus.",null,null,"Protein-serine kinase, Other group, IKK family","O14920","O14920","O14920",null,"GO:0035631; GO:0009898; GO:0005829; GO:0008385; GO:0045121; GO:0005634","GO:0005524; GO:0042802; GO:0008384; GO:0046982; GO:0042803; GO:0004672; GO:0019901; GO:0004674; GO:0097110","GO:0009653; GO:0002479; GO:0071356; GO:0030866; GO:0038095; GO:0007249; GO:0006954; GO:0045087; GO:0070498; GO:0002756; GO:0043066; GO:1903347; GO:0035509; GO:0018105; GO:0043123; GO:0051092; GO:0045893; GO:0045944; GO:0072659; GO:0006468; GO:1903140; GO:0042325; GO:0010803; GO:0009615; GO:0002223; GO:0051403; GO:0050852; GO:0035666; GO:0033209; GO:0016032"]
[1138,580,"NK076-5","IKKb (IkBKB)","Pan-specific","Inhibitor of nuclear factor kappa B kinase beta subunit",0,8266,16,656,5412,{"v":9509.6790170208,"d":"9510"},{"$nulls":3},0,8142,14,620,{"v":5039.36,"d":"5039"},{"v":8804.846106207437,"d":"8805"},{"$nulls":6},0,8540,16,610,{"v":5199.64,"d":"5200"},{"v":8895.759384637446,"d":"8896"},{"$nulls":7},"IKKb","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","IKK",{"$nulls":6},"CTLLENAIQDTVREQDQSFT","Corresponds to amino acid residues C716 to T735; Pre-C-terminus.",{"$nulls":3},"O14920","O14920","O14920"]
[1142,566,"NN077-2","IKKg (NEMO)","Pan-specific","I-kappa-B kinase gamma/NF-kappa-B essential modulator",0,360,10,466,{"v":163.1,"d":"163"},{"v":286.5906592158338,"d":"287"},{"$nulls":3},0,404,10,504,{"v":198.576,"d":"199"},{"v":346.95499436163476,"d":"347"},{"$nulls":6},0,466,12,519,{"v":235.626,"d":"236"},{"v":403.11871605814684,"d":"403"},{"$nulls":10},"Regulatory subunit IKK",{"$nulls":7},"X",null,"Not precisely defined.","Antibody raised against full length human IKKg.",{"$nulls":3},"Q9Y6K9","Q9Y6K9",null,"Q9Y6K9"]
[1149,482,"PN227","IL6ST (GP130)","S782","Interleukin-6 receptor subunit beta",0,202,14,421,{"v":79.148,"d":"79"},{"v":139.07466275668187,"d":"139"},{"v":148.51054160394753,"d":"149"},{"v":9.435878847265656,"d":"9"},{"v":6.353676139993851,"d":"6"},0,216,12,419,{"v":85.476,"d":"85"},{"v":149.34496161698843,"d":"149"},{"v":127.57378731977653,"d":"128"},{"v":21.7711742972119,"d":"22"},{"v":17.065554574028802,"d":"17"},{"v":23.419230714022653,"d":"23"},{"v":-14.097823668306177,"d":"-14"},null,0,286,16,488,{"v":131.76,"d":"132"},{"v":225.42046305510183,"d":"225"},{"v":225.4427039933207,"d":"225"},{"v":0.02224093821885731,"d":"0"},{"v":0.009865450433701439,"d":"0"},{"v":6.363541590427553,"d":"6"},{"v":51.80249264361194,"d":"52"},{"$nulls":15},"Not precisely defined.","Antibody raised against amino acid residues 768-789 Ser 782 of human gp130.","S782 phosphorylation phosphorylation induces receptor internalization and protein degradation. This is one of the minor  in vivo phosphorylation sites in IL6ST (≥3 reports from high throughput mass spectrometry studies).","CaMK2a; CaMK4","Receptor, cytokine","P40189","P40189",null,"P40189","GO:0070110; GO:0030425; GO:0009897; GO:0070062; GO:0005576; GO:0005615; GO:0005896; GO:0016020; GO:0043025; GO:0005900; GO:0005886","GO:0004897; GO:0005127; GO:0019838; GO:0019970; GO:0004921; GO:0045509; GO:0042803","GO:0070120; GO:0019221; GO:0005977; GO:0070106; GO:0070757; GO:0070102; GO:0048861; GO:0043066; GO:0070104; GO:0038165; GO:0002675; GO:0002821; GO:0048711; GO:0010613; GO:0008284; GO:0045669; GO:0042102; GO:0042531; GO:0010575; GO:0008593; GO:0034097; GO:0016032"]
[1154,571,"PK661","ILK1 (ILK)","S343","Integrin-linked protein-serine kinase-1",0,2174,16,581,{"v":1253.798,"d":"1254"},{"v":2203.107267587333,"d":"2203"},{"$nulls":3},0,2233,16,566,{"v":1254.822,"d":"1255"},{"v":2192.4440009611194,"d":"2192"},{"$nulls":6},0,2918,14,572,{"v":1661.088,"d":"1661"},{"v":2841.858121852406,"d":"2842"},{"$nulls":7},"ILK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","MLK","ILK",{"$nulls":5},"DVKF(pS)FQC","Corresponds to amino acid residues D339 to C346; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S343 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation regulates molecular association, including inducing interaction with Akt1. This is one of the minor in vivo phosphorylation sites in ILK1 (≥1 reports from high throughput mass spectrometry studies).",null,null,"Q13418","Q13418","Q13418","Q13418"]
[1155,572,"PK662","ILK1 (ILK)","Y351","Integrin-linked protein-serine kinase-1",0,178,8,256,{"v":43.52,"d":"44"},{"v":76.4710330415272,"d":"76"},{"v":58.28456263757944,"d":"58"},{"v":18.186470403947766,"d":"18"},{"v":31.202894181489306,"d":"31"},0,168,12,281,{"v":43.836,"d":"44"},{"v":76.59092303620086,"d":"77"},{"v":67.4494934047244,"d":"67"},{"v":9.14142963147647,"d":"9"},{"v":13.552999689151369,"d":"14"},{"v":44.755893870640676,"d":"45"},{"v":15.724456618356413,"d":"16"},null,0,208,10,285,{"v":56.43,"d":"56"},{"v":96.54278028384485,"d":"97"},{"v":94.09456623836935,"d":"94"},{"v":2.4482140454754955,"d":"2"},{"v":2.601865488463431,"d":"3"},{"v":33.80475966995274,"d":"34"},{"v":61.43994563956997,"d":"61"},null,null,"ILK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","MLK","ILK",{"$nulls":5},"GRM(pY)APA(bA)C","Corresponds to amino acid residues G348 to A354; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y351 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation of this site in ILK1 has apparently not been reported from high throughput mass spectrometry studies.",null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); TKL domain target; TKL</A> group; MLK family; ILK subfamily","Q13418","Q13418","Q13418","Q13418","GO:0005911; GO:0030054; GO:0043034; GO:0005737; GO:0005829; GO:0043198; GO:0005925; GO:0030027; GO:0016020; GO:0043025; GO:0005654; GO:0005886; GO:0032991; GO:0030017; GO:0001725; GO:0043195","GO:0005524; GO:0005178; GO:0019901; GO:0004674; GO:0017124","GO:0001658; GO:0007569; GO:0007050; GO:0034329; GO:0007160; GO:0008283; GO:0045197; GO:0010761; GO:0007229; GO:0000165; GO:0007275; GO:0032288; GO:0022011; GO:0010667; GO:2000178; GO:0043524; GO:0006469; GO:0014912; GO:0048662; GO:0021675; GO:0048812; GO:0003151; GO:0018105; GO:0070527; GO:0045773; GO:0030513; GO:0090263; GO:0001954; GO:0030335; GO:0008284; GO:0050775; GO:0043406; GO:0045663; GO:1901224; GO:0045669; GO:0042327; GO:0051897; GO:0001934; GO:0009967; GO:0045893; GO:0051291; GO:0043491; GO:0006468; GO:0032956; GO:0034446; GO:0097435; GO:0033209"]
[1160,574,"NK079-3","InsR (IR)","Pan-specific","Insulin receptor",0,106,10,500,48,{"v":84.34305114874324,"d":"84"},{"$nulls":3},0,112,10,449,{"v":45.798,"d":"46"},{"v":80.01895914800454,"d":"80"},{"$nulls":6},0,121,10,440,{"v":48.84,"d":"49"},{"v":83.55749404683648,"d":"84"},{"$nulls":7},"INSR","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK","InsR",{"$nulls":6},"Not precisely defined.","Antibody raised against the C-terminus of human insulin receptor.",{"$nulls":3},"P06213","P06213","P06213"]
[1165,579,"PK664","IRAK1","T387","Interleukin 1 receptor-associated kinase 1 (Pelle-like protein kinase)",0,9478,16,646,{"v":6112.452,"d":"6112"},{"v":10740.476076671623,"d":"10740"},{"v":11829.799968048723,"d":"11830"},{"v":1089.3238913771002,"d":"1089"},{"v":9.208303558126687,"d":"9"},0,10722,16,660,{"v":7065.96,"d":"7066"},{"v":12345.752316289667,"d":"12346"},{"v":11754.10246188525,"d":"11754"},{"v":591.649854404417,"d":"592"},{"v":5.033560463871623,"d":"5"},{"v":14.24186402199831,"d":"14"},{"v":-0.6398883021515616,"d":"-1"},null,0,10460,14,719,{"v":7510.674,"d":"7511"},{"v":12849.572031996919,"d":"12850"},{"v":12449.62521589706,"d":"12450"},{"v":399.94681609985855,"d":"400"},{"v":3.212520932671629,"d":"3"},{"v":12.420824490798315,"d":"12"},{"v":5.23952433280725,"d":"5"},null,null,"IRAK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","IRAK",{"$nulls":6},"VRG(pT)LAY(bA)C","Corresponds to amino acid residues V384 to Y390; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T387 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the minor in vivo phosphorylation sites in IRAK1 (≥1 reports from high throughput mass spectrometry studies).","IRAK1; IRAK4","EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); TKL group; IRAK family","P51617","P51617","P51617",null,"GO:0005737; GO:0005829; GO:0010008; GO:0045323; GO:0005811; GO:0005634; GO:0005886","GO:0005524; GO:0031072; GO:0016301; GO:0004704; GO:0046982; GO:0042803; GO:0004672; GO:0004674","GO:0000187; GO:0007250; GO:0007568; GO:0034605; GO:0071456; GO:0070498; GO:0007254; GO:0031663; GO:0002755; GO:0043066; GO:0032088; GO:0070423; GO:0043123; GO:0043406; GO:0051092; GO:0048661; GO:0045893; GO:0032481; GO:0046777; GO:0051259; GO:0006468; GO:0001959; GO:0070555; GO:0032496; GO:0007165; GO:0034134; GO:0034142; GO:0034162; GO:0002224; GO:0007178; GO:0060337; GO:0016032"]
[1171,583,"NK273-1","IRR (INSRR)","Pan-specific","Insulin receptor-related protein",0,2144,12,525,{"v":1119.3,"d":"1119"},{"v":1966.7745239747562,"d":"1967"},{"v":2063.0442097000014,"d":"2063"},{"v":96.26968572524515,"d":"96"},{"v":4.6663898559519605,"d":"5"},0,2217,12,560,{"v":1234.8,"d":"1235"},{"v":2157.4612593553434,"d":"2157"},{"v":2106.8479310746457,"d":"2107"},{"v":50.613328280697715,"d":"51"},{"v":2.4023247019485283,"d":"2"},{"v":7.068714557900488,"d":"7"},{"v":2.1232565530437313,"d":"2"},null,0,2408,10,581,{"v":1393.238,"d":"1393"},{"v":2383.6092524739224,"d":"2384"},{"v":2308.3852668935506,"d":"2308"},{"v":75.22398558037185,"d":"75"},{"v":3.2587275035593417,"d":"3"},{"v":7.925117359511303,"d":"8"},{"v":11.892186121848809,"d":"12"},null,null,"IRR","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK","InsR",{"$nulls":6},"RGSLPTTDAEPDSSPTPRDC","Corresponds to amino acid residues R1269 to C1288; Pre-C-terminus.",null,null,"Membrane, Integral plasma membrane protein","P14616","P14616","P14616",null,"GO:0005887; GO:0043235","GO:0005524; GO:0043560; GO:0043548; GO:0004714","GO:0031532; GO:0071469; GO:0030238; GO:0046777; GO:0007169"]
[1172,583,"NK273-1","IRR (INSRR)","Pan-specific","Insulin receptor-related protein",0,2183,8,565,{"v":1228.875,"d":"1229"},{"v":2159.3138954252468,"d":"2159"},{"$nulls":3},0,2144,12,552,{"v":1176.864,"d":"1177"},{"v":2056.234602793948,"d":"2056"},{"$nulls":6},0,2300,10,570,{"v":1305.3,"d":"1305"},{"v":2233.1612813131787,"d":"2233"},{"$nulls":7},"IRR","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK","InsR",{"$nulls":6},"RGSLPTTDAEPDSSPTPRDC","Corresponds to amino acid residues R1269 to C1288; Pre-C-terminus.",{"$nulls":3},"P14616","P14616","P14616"]
[1177,586,"PN118","IRS1","S639","Insulin receptor substrate 1",0,1480,8,222,{"v":326.784,"d":"327"},{"v":574.207492220644,"d":"574"},{"v":674.9552668178178,"d":"675"},{"v":100.74777459717382,"d":"101"},{"v":14.926585442049362,"d":"15"},0,1774,14,215,{"v":378.4,"d":"378"},{"v":661.1462103499043,"d":"661"},{"v":548.3957963086917,"d":"548"},{"v":112.7504140412126,"d":"113"},{"v":20.56004345769008,"d":"21"},{"v":35.48662889973944,"d":"35"},{"v":-18.750793827539198,"d":"-19"},null,0,1516,12,246,{"v":369.984,"d":"370"},{"v":632.9839450742168,"d":"633"},{"v":620.2065260674847,"d":"620"},{"v":12.777419006732089,"d":"13"},{"v":2.0601877712814938,"d":"2"},{"v":16.986773213330856,"d":"17"},{"v":-8.111462113401174,"d":"-8"},{"$nulls":13},"X",null,"PK(pS)VS","Corresponds to amino acid residues  P637 to S341; Surrounds the S639 phosphosite.","S639 phosphorylation regulates intracellular location and Inhibition of tyrosine phosphorylation. It may also facilitate degradation by the Cul7-RING(FBXW8) complex. This is one of the minor in vivo phosphorylation sites in IRS1 (≥4 reports from high throughput mass spectrometry studies).","BARK1 (GRK2; ADRBK1); ERK2 (MAPK1); FRAP1 (mTOR); p70S6K (RPS6KB1); ROCK1; ROCK2","Adapter/scaffold protein","P35568","P35568",null,null,"GO:0005901; GO:0005737; GO:0005829; GO:0005899; GO:0043231; GO:0005634; GO:0005886","GO:0016303; GO:0005159; GO:0005158; GO:0043548; GO:0046934; GO:0001784; GO:0005080; GO:0005088; GO:0042169; GO:0005068","GO:0032869; GO:0042593; GO:0048009; GO:0008286; GO:0038111; GO:0000165; GO:0046627; GO:0046676; GO:0014065; GO:0048015; GO:0008284; GO:0032000; GO:0046326; GO:2001275; GO:0010907; GO:0045725; GO:0046628; GO:0043552; GO:0051897; GO:0032868; GO:0043434; GO:0007165"]
[1182,577,"PN231","ITGB3","Y785","Integrin beta-3",0,16,2,716,{"v":10.024,"d":"10"},{"v":17.613640514895877,"d":"18"},{"$nulls":3},0,12,2,713,{"v":7.13,"d":"7"},{"v":12.457643974087786,"d":"12"},{"$nulls":6},0,16,2,701,{"v":9.814,"d":"10"},{"v":16.790197513834013,"d":"17"},{"$nulls":20},"Not precisely defined.","Antibody raised against amino acid residues that encompass the Y759 phosphosite.","Y785 phosphorylation induces binding of Grb2 and Shc, and inhibits interaction with kindlin-2. This is one of the minor in vivo phosphorylation sites in ITGB3 (≥7 reports from high throughput mass spectrometry studies).","Src; Syk",null,"P05106","P05106"]
[1188,589,"PN521","ITSN2","Y968","Intersectin-2",0,4934,16,636,{"v":3127.848,"d":"3128"},{"v":5496.08841353113,"d":"5496"},{"$nulls":3},0,5282,16,643,{"v":3386.038,"d":"3386"},{"v":5916.136870509433,"d":"5916"},{"$nulls":6},0,5374,20,669,{"v":3581.826,"d":"3582"},{"v":6127.9362135914025,"d":"6128"},{"$nulls":18},"X",null,"EAL(pY)AAV(bA)C","Corresponds to amino acid residues E965 to V971; In the insert region that separates the SH3_2 and SH3_1 domains. ","The effect of Y968 phosphorylation is unclear. This is the second major in vivo phosphorylation site in ITSN2 (≥765 reports from high throughput mass spectrometry studies).",null,null,"Q9NZM3","Q9NZM3"]
[1189,590,"PN611","IWS1","S720+T721+T725","Protein IWS1 homologue",0,15848,18,695,{"v":11001.85,"d":"11002"},{"v":19331.866610016685,"d":"19332"},{"v":19095.18770846502,"d":"19095"},{"v":236.67890155166606,"d":"237"},{"v":1.2394688398205418,"d":"1"},0,17432,28,724,{"v":12600.496,"d":"12600"},{"v":22015.777428459638,"d":"22016"},{"v":20972.882181377834,"d":"20973"},{"v":1042.895247081804,"d":"1043"},{"v":4.9725890703177065,"d":"5"},{"v":6.212057910138248,"d":"6"},{"v":9.833338648357042,"d":"10"},null,0,14757,16,760,{"v":11203.16,"d":"11203"},{"v":19166.82995507282,"d":"19167"},{"v":17218.30135771894,"d":"17218"},{"v":1948.5285973538776,"d":"1949"},{"v":11.316613392182004,"d":"11"},{"v":12.556082232002547,"d":"13"},{"v":-9.82910657596753,"d":"-10"},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"RMN(pS)(pT)GGQ(pT)PRRC","Corresponds to amino acid residues R717 to R728.","The effects of S720, T721 and T725 phosphorylation are unclear. These are three of the major in vivo phosphorylation sites in ITSN2 (≥790, ≥81 and ≥239 reports, respectively, from high throughput mass spectrometry studies).",null,"Transcription protein","Q96ST2","Q96ST2",null,null,"GO:0005654; GO:0005634",null,"GO:0006397; GO:0051028; GO:0032784; GO:2001253; GO:0090239; GO:0010793; GO:0050684; GO:0008380; GO:0006366; GO:0006368"]
[1194,592,"NK084-5","JAK1","Pan-specific","Janus protein-tyrosine kinase 1",0,10954,14,785,{"v":8587.9,"d":"8588"},{"v":15090.201853339417,"d":"15090"},{"$nulls":3},0,11132,20,812,{"v":9022.944,"d":"9023"},{"v":15765.024396932893,"d":"15765"},{"$nulls":6},0,10372,16,748,{"v":7746.288,"d":"7746"},{"v":13252.670217958248,"d":"13253"},{"$nulls":7},"JAK1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","JakA",{"$nulls":6},"CFQNLIEGFEALLK","Corresponds to amino acid residues F1142 to K1154; Kinase last alpha-chain+C-terminus.",{"$nulls":3},"P23458","P23458","P23458","P23458"]
[1199,595,"PK895","JAK1","T1107","Janus protein-tyrosine kinase 1",0,9082,18,602,{"v":5456.528,"d":"5457"},{"v":9587.921254136452,"d":"9588"},{"v":9643.60699651051,"d":"9644"},{"v":55.685742374058464,"d":"56"},{"v":0.5774368697750547,"d":"1"},0,10755,16,664,{"v":7130.696,"d":"7131"},{"v":12458.860035827753,"d":"12459"},{"v":11693.155229637548,"d":"11693"},{"v":765.7048061902042,"d":"766"},{"v":6.548316439428118,"d":"7"},{"v":7.125753309203173,"d":"7"},{"v":21.252921587002206,"d":"21"},null,0,8668,16,617,{"v":5338.284,"d":"5338"},{"v":9132.95727990013,"d":"9133"},{"v":9435.704352617988,"d":"9436"},{"v":302.747072717857,"d":"303"},{"v":3.208526479889741,"d":"3"},{"v":3.7859633496647955,"d":"4"},{"v":-2.1558597728811577,"d":"-2"},null,null,"JAK1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","JakA",{"$nulls":6},"LVN(pT)LKE(bA)C","Corresponds to amino acid residues L1104 to E1110. T1107 is located in the Gap/Insert 10 (G/I10) region in the second protein-tyrosine kinase catalytic domain of JAK1.","The effect of T1107 phosphorylation is unknown. Its phosphorylation has been observed in only one mass spectrometry study. ",null,"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; JakA family","P23458","P23458","P23458","P23458","GO:0005737; GO:0005856; GO:0005829; GO:0005768; GO:0031234; GO:0005925; GO:0005634","GO:0005524; GO:0031730; GO:0005131; GO:0046872; GO:0004715; GO:0019903; GO:0004713; GO:0005088; GO:0005102; GO:0031625","GO:0030154; GO:0016477; GO:0019221; GO:0045087; GO:0060333; GO:0035722; GO:0035723; GO:0038114; GO:0070106; GO:0038110; GO:0070757; GO:0070102; GO:0038111; GO:0038113; GO:0035556; GO:0000165; GO:0038083; GO:1903672; GO:0006468; GO:0042127; GO:0060334; GO:0046677; GO:0007169; GO:0060337"]
[1204,597,"NK085-4","JAK2","Pan-specific","Janus protein-tyrosine kinase 2",0,7075,12,584,{"v":4124.792,"d":"4125"},{"v":7247.865471540144,"d":"7248"},{"$nulls":3},0,6319,12,587,{"v":3702.209,"d":"3702"},{"v":6468.555629686334,"d":"6469"},{"$nulls":6},0,6601,12,614,{"v":4045.646,"d":"4046"},{"v":6921.458672412117,"d":"6921"},{"$nulls":7},"JAK2","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","JakA",{"$nulls":6},"ELLTENDMLPNMRIGC","Corresponds to amino acid residues E814 to G828; Post-kinase last alpha-chain.",{"$nulls":3},"O60674","O60674","O60674","O60674"]
[1206,598,"PK668","JAK2","Y570","Janus protein-tyrosine kinase 2",0,6306,12,593,{"v":3732.342,"d":"3732"},{"v":6558.273171054222,"d":"6558"},{"$nulls":3},0,7022,14,611,{"v":4281.888,"d":"4282"},{"v":7481.379556931108,"d":"7481"},{"$nulls":6},0,6410,12,569,{"v":3640.462,"d":"3640"},{"v":6228.253110006847,"d":"6228"},{"$nulls":7},"JAK2","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","JakA",{"$nulls":6},"VGD(pY)GQL(bA)C","Corresponds to amino acid residues V567 to L573; In the protein kinase catalytic domain.","Y570 phosphorylation stimulates phosphotransferase activity. This is the major in vivo phosphorylation site in JAK2 (≥847 reports from high throughput mass spectrometry studies).","JAK2",null,"O60674","O60674","O60674","O60674"]
[1211,601,"NK086","JAK3","Pan-specific","Janus protein-tyrosine kinase 3",0,116,10,476,{"v":50.456,"d":"50"},{"v":88.6586039325206,"d":"89"},{"v":102.31514963102128,"d":"102"},{"v":13.656545698500679,"d":"14"},{"v":13.347530397746791,"d":"13"},0,138,14,483,{"v":59.892,"d":"60"},{"v":104.64420938233741,"d":"105"},{"v":103.45260865438118,"d":"103"},{"v":1.191600727956228,"d":"1"},{"v":1.151832460732989,"d":"1"},{"v":14.49936285847978,"d":"14"},{"v":1.1117210183065822,"d":"1"},null,0,146,12,496,{"v":66.464,"d":"66"},{"v":113.70936290599795,"d":"114"},{"v":114.56991613092748,"d":"115"},{"v":0.8605532249295322,"d":"1"},{"v":0.7511162214224846,"d":"1"},{"v":14.098646619169276,"d":"14"},{"v":11.977470144060305,"d":"12"},null,null,"JAK3","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","JakA",{"$nulls":6},"Epitope undefined.",{"$nulls":3},"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; JakA family","P52333","P52333","P52333","P52333","GO:0005856; GO:0005829; GO:0005768; GO:0031234; GO:0005886","GO:0005524; GO:0004715; GO:0019903; GO:0004713; GO:0005088; GO:0005102","GO:0002250; GO:0030183; GO:0016477; GO:0019221; GO:0007167; GO:0030218; GO:0006954; GO:0045087; GO:0035723; GO:0038114; GO:0038110; GO:0035771; GO:0038111; GO:0038113; GO:0035556; GO:0060397; GO:0000165; GO:0002731; GO:0045221; GO:0032693; GO:0032695; GO:0050868; GO:0045626; GO:0070244; GO:0038083; GO:0018108; GO:0042102; GO:0006468; GO:0042981; GO:0046425; GO:0070232; GO:0070672; GO:0070669; GO:0070670; GO:0071104; GO:0043029; GO:0007260"]
[1216,603,"PK669","JAK3","Y980+Y981","Janus protein-tyrosine kinase 3",0,3829,14,749,{"v":2857.435,"d":"2857"},{"v":5020.9330491501905,"d":"5021"},{"$nulls":3},0,4062,14,747,{"v":3023.856,"d":"3024"},{"v":5283.326995358933,"d":"5283"},{"$nulls":6},0,4056,18,752,{"v":3036.576,"d":"3037"},{"v":5195.099939450584,"d":"5195"},{"$nulls":7},"JAK3","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","JakA",{"$nulls":6},"DKD(pY)(pY)VVRE(bA)C","Corresponds to amino acid residues D977 to E985; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y980 phosphorylation stimulates phosphotransferase activity, whereas Y981 phosphorylation inhibits phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major in vivo phosphorylation sites in JAK3 (≥9 and ≥6 reports, respectively, from high throughput mass spectrometry studies).","Y980: JAK3. Y981: JAK3.",null,"P52333","P52333","P52333","P52333"]
[1221,606,"PK035-2","JNK1 (MAPK8)","T183+Y185","Jun N-terminus protein-serine kinase (stress-activated protein kinase (SAPK)) 1",0,963,10,284,{"v":270.652,"d":"271"},{"v":475.57532248978447,"d":"476"},{"v":445.65111080096995,"d":"446"},{"v":29.924211688814523,"d":"30"},{"v":6.7147171775319165,"d":"7"},0,1216,10,268,{"v":323.208,"d":"323"},{"v":564.7139121426319,"d":"565"},{"v":449.3033630452413,"d":"449"},{"v":115.41054909739057,"d":"115"},{"v":25.68655358267809,"d":"26"},{"v":32.40127076021001,"d":"32"},{"v":0.8195317268944109,"d":"1"},null,0,1095,8,282,{"v":306.534,"d":"307"},{"v":524.4310581521903,"d":"524"},{"v":439.8111315950531,"d":"440"},{"v":84.6199265571372,"d":"85"},{"v":19.24006021635879,"d":"19"},{"v":25.954777393890705,"d":"26"},{"v":-1.3104374844753863,"d":"-1"},null,null,"JNK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","JNK",{"$nulls":5},"Epitope undefined.","Antibody raised against amino acid residues that encompass the T183 and Y185 phosphosites.","T183 and Y185 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation regulates apoptosis, cell adhesion and transcription.These are the two  major in vivo phosphorylation sites in JNK1 (≥417 and ≥1286 reports, respectively, from high throughput mass spectrometry studies).","MKK4 (MAP2K4, MEK4); MKK7 (MAP2K7, MEK7)","EC 2.7.11.24; Protein kinase, Ser/Thr (non-receptor); CMGC group; MAPK family; MAPK/JNK subfamily; JNK subfamily","P45983","P45983","P45983","P45983","GO:0030424; GO:0097441; GO:0005737; GO:0005829; GO:0005739; GO:0043005; GO:0005654; GO:0005634","GO:0005524; GO:0019899; GO:0042826; GO:0035033; GO:0004705; GO:0016301; GO:0004674","GO:0034198; GO:0071276; GO:0071345; GO:0071222; GO:0071260; GO:0034614; GO:0038095; GO:0007254; GO:0007258; GO:0043066; GO:0032091; GO:0048666; GO:0018105; GO:0018107; GO:0043065; GO:0031281; GO:0090045; GO:0010628; GO:1900740; GO:0051247; GO:0006468; GO:0042752; GO:1902595; GO:0016241; GO:0032880; GO:0009411; GO:0048511; GO:0051403"]
[1222,606,"PK035-2","JNK1 (MAPK8)","T183+Y185","Jun N-terminus protein-serine kinase (stress-activated protein kinase (SAPK)) 1",0,964,10,248,{"v":236.592,"d":"237"},{"v":415.7268991121554,"d":"416"},{"$nulls":3},0,710,10,273,{"v":191.1,"d":"191"},{"v":333.89281394785075,"d":"334"},{"$nulls":6},0,721,10,292,{"v":207.612,"d":"208"},{"v":355.19120503791595,"d":"355"},{"$nulls":7},"JNK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","JNK",{"$nulls":5},"Epitope undefined.","Antibody raised against amino acid residues that encompass the T183 and Y185 phosphosites.","T183 and Y185 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation regulates apoptosis, cell adhesion and transcription.These are the two  major in vivo phosphorylation sites in JNK1 (≥417 and ≥1286 reports, respectively, from high throughput mass spectrometry studies).","MKK4 (MAP2K4, MEK4); MKK7 (MAP2K7, MEK7)",null,"P45983","P45983","P45983","P45983"]
[1229,610,"NK189-3","JNK2 (MAPK9)","Pan-specific","Jun N-terminus protein-serine kinase (stress-activated protein kinase (SAPK)) 2",0,4716,14,568,{"v":2670.736,"d":"2671"},{"v":4692.875480266456,"d":"4693"},{"v":4717.412279563145,"d":"4717"},{"v":24.536799296688514,"d":"25"},{"v":0.5201326032703832,"d":"1"},0,5544,16,548,{"v":3029.344,"d":"3029"},{"v":5292.915712067179,"d":"5293"},{"v":4365.207370544382,"d":"4365"},{"v":927.7083415227971,"d":"928"},{"v":21.252331510819,"d":"21"},{"v":21.772464114089384,"d":"22"},{"v":-7.466061648768559,"d":"-7"},null,0,4388,14,576,{"v":2519.424,"d":"2519"},{"v":4310.334887007718,"d":"4310"},{"v":4261.263678510618,"d":"4261"},{"v":49.07120849710009,"d":"49"},{"v":1.1515647047274786,"d":"1"},{"v":1.6716973079978619,"d":"2"},{"v":-9.66946652147962,"d":"-10"},null,null,"JNK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","JNK",{"$nulls":5},"CVKDQPSDAAVSSNAT","Corresponds to amino acid residues V372 to T386.",null,null,"EC 2.7.11.24; Protein kinase, Ser/Thr (non-receptor); CMGC group; MAPK family; JNK subfamily; MAPK/JNK subfamily","P45984","P45984","P45984","P45984","GO:0005737; GO:0005829; GO:0005739; GO:0043005; GO:0005654; GO:0005634","GO:0005524; GO:0004705; GO:0004712; GO:0008134","GO:0071276; GO:0071310; GO:0034614; GO:0038095; GO:0007254; GO:0048666; GO:0018105; GO:0043065; GO:2001235; GO:0010628; GO:0010744; GO:0071803; GO:0031398; GO:1901485; GO:0061833; GO:0006468; GO:0042752; GO:0009612; GO:0048511"]
[1233,612,"NN162","Jun (c-Jun)","Pan-specific","Jun proto-oncogene-encoded AP1 transcription factor",0,248,10,263,{"v":62.594,"d":"63"},{"v":109.98685299175905,"d":"110"},{"v":82.87407634123596,"d":"83"},{"v":27.112776650523088,"d":"27"},{"v":32.71563056568569,"d":"33"},0,80,8,443,{"v":31.896,"d":"32"},{"v":55.72917422124881,"d":"56"},{"v":44.585436035171405,"d":"45"},{"v":11.143738186077407,"d":"11"},{"v":24.99412179637903,"d":"25"},{"v":57.70975236206472,"d":"58"},{"v":-46.200985876946824,"d":"-46"},null,0,164,10,230,{"v":35.42,"d":"35"},{"v":60.5980024393724,"d":"61"},{"v":68.03503001147719,"d":"68"},{"v":7.437027572104789,"d":"7"},{"v":10.931174089068818,"d":"11"},{"v":43.64680465475451,"d":"44"},{"v":-17.90553449869975,"d":"-18"},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Epitope undefined.",{"$nulls":3},"Transcription protein","P05412","P05412",null,"P05412","GO:0005829; GO:0000228; GO:0005719; GO:0005654; GO:0005634; GO:0017053; GO:0035976","GO:0035497; GO:0003682; GO:0003677; GO:0003700; GO:0019899; GO:0005096; GO:0071837; GO:0042802; GO:0046982; GO:0042803; GO:0003723; GO:0001102; GO:0000980; GO:0000978; GO:0000981; GO:0070412; GO:0001077; GO:0001190; GO:0003713; GO:0003705; GO:0000982; GO:0008134; GO:0044212; GO:0031625","GO:0007568; GO:0001525; GO:0031103; GO:0071276; GO:0071277; GO:0032870; GO:0051365; GO:0034614; GO:0007623; GO:0061029; GO:0038095; GO:0035026; GO:0007612; GO:0001889; GO:0051899; GO:0001774; GO:0030224; GO:0043922; GO:0008285; GO:0043392; GO:0043524; GO:0031953; GO:0045892; GO:1990441; GO:0003151; GO:0043923; GO:0043065; GO:0045597; GO:0045740; GO:2000144; GO:0001938; GO:0010634; GO:0070374; GO:0048146; GO:0045657; GO:0043525; GO:1902895; GO:0045893; GO:0045944; GO:1904707; GO:0007265; GO:0051726; GO:0042127; GO:0051090; GO:0001836; GO:0051591; GO:0034097; GO:0042493; GO:0042542; GO:0032496; GO:0009612; GO:0035994; GO:0009314; GO:0060395; GO:0007179"]
[1238,614,"PN557","Jun (c-Jun)","S63","Jun proto-oncogene-encoded AP1 transcription factor",0,14270,14,833,{"v":11875.248,"d":"11875"},{"v":20866.555197250225,"d":"20867"},{"$nulls":3},0,15324,22,733,{"v":11216.366,"d":"11216"},{"v":19597.404531705906,"d":"19597"},{"$nulls":6},0,15081,20,736,{"v":11084.896,"d":"11085"},{"v":18964.499007571692,"d":"18964"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"DLLT(pS)PDVGC","Corresponds to amino acid residues D59 to G67; In the N-terminus of the transcription factor. ","S63 phosphorylation stimulates transcriptional activity and binding to PIN1, although it has been reported to decrease binding to DNA and JNK1. This is one of the major in vivo sites of phosphorylation of c-Jun (≥44 reports from high throughput mass spectrometry studies).","CDK1 (CDC2); CDK3; CK2a1 (CSNK2A1); ERK1 (MAPK3); ERK2 (MAPK1); JNK1 (MAPK8); JNK2 (MAPK9); JNK3 (MAPK10); PKD1 (PRKCM; PRKD1); Plk3 (CNK); VRK1",null,"P05412","P05412",null,"P05412"]
[1239,615,"PN612","Jun (c-Jun)","S73","Jun proto-oncogene-encoded AP1 transcription factor",0,7917,18,757,{"v":5979.543,"d":"5980"},{"v":10506.935439481449,"d":"10507"},{"v":9775.60650727864,"d":"9776"},{"v":731.3289322028086,"d":"731"},{"v":7.4811617228893335,"d":"7"},0,8990,18,776,{"v":6962.272,"d":"6962"},{"v":12164.587072476874,"d":"12165"},{"v":11372.231993700869,"d":"11372"},{"v":792.355078776005,"d":"792"},{"v":6.967454403101292,"d":"7"},{"v":14.448616125990625,"d":"14"},{"v":16.332751172353625,"d":"16"},null,0,8030,18,782,{"v":6265.384,"d":"6265"},{"v":10719.078343184778,"d":"10719"},{"v":10506.417335301692,"d":"10506"},{"v":212.6610078830854,"d":"213"},{"v":2.0241058497509115,"d":"2"},{"v":9.505267572640244,"d":"10"},{"v":7.475861753221253,"d":"7"},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"CLKLA(pS)PELE","Corresponds to amino acid residues C69 to E77.","S73 phosphorylation stimulates transcriptional activity and binding to PIN1, although it has been reported to decrease binding to DNA and JNK1. This is the major in vivo phosphorylation site in c-Jun (≥78 reports from high throughput mass spectrometry studies).","CDK1 (CDC2); CDK3; CK2a1 (CSNK2A1); ERK1 (MAPK3); ERK2 (MAPK1); ERK7 (MAPK15); JNK1 (MAPK8); JNK2 (MAPK9); JNK3 (MAPK10); Plk3 (CNK); PBK (TOPK); VRK1","Transcription protein","P05412","P05412",null,"P05412","GO:0005829; GO:0000228; GO:0005719; GO:0005654; GO:0005634; GO:0017053; GO:0035976","GO:0035497; GO:0003682; GO:0003677; GO:0003700; GO:0019899; GO:0005096; GO:0071837; GO:0042802; GO:0046982; GO:0042803; GO:0003723; GO:0001102; GO:0000980; GO:0000978; GO:0000981; GO:0070412; GO:0001077; GO:0001190; GO:0003713; GO:0003705; GO:0000982; GO:0008134; GO:0044212; GO:0031625","GO:0007568; GO:0001525; GO:0031103; GO:0071276; GO:0071277; GO:0032870; GO:0051365; GO:0034614; GO:0007623; GO:0061029; GO:0038095; GO:0035026; GO:0007612; GO:0001889; GO:0051899; GO:0001774; GO:0030224; GO:0043922; GO:0008285; GO:0043392; GO:0043524; GO:0031953; GO:0045892; GO:1990441; GO:0003151; GO:0043923; GO:0043065; GO:0045597; GO:0045740; GO:2000144; GO:0001938; GO:0010634; GO:0070374; GO:0048146; GO:0045657; GO:0043525; GO:1902895; GO:0045893; GO:0045944; GO:1904707; GO:0007265; GO:0051726; GO:0042127; GO:0051090; GO:0001836; GO:0051591; GO:0034097; GO:0042493; GO:0042542; GO:0032496; GO:0009612; GO:0035994; GO:0009314; GO:0060395; GO:0007179"]
[1244,617,"PN214","Jun (c-Jun)","T91+T93","Jun proto-oncogene-encoded AP1 transcription factor",0,178,8,437,{"v":74.29,"d":"74"},{"v":130.5384431216695,"d":"131"},{"$nulls":3},0,190,10,487,{"v":87.66,"d":"88"},{"v":153.16087949067816,"d":"153"},{"$nulls":6},0,177,10,475,{"v":79.325,"d":"79"},{"v":135.71249417005126,"d":"136"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against c-Jun phosphorylated at Thr 91 and Thr-93.","T91 phosphorylation contributes to binding with FBXW7, but reduces binding to DNA. T93 phosphorylation also inhibits DNA binding. These are two of the minor in vivo phosphorylation sites in c-Jun (≥2 and ≥3 reports, respectively, from high throughput mass spectrometry studies).","T91: JNK1 (MAPK8). T93: JNK1 (MAPK8); PAK2",null,"P05412","P05412",null,"P05412"]
[1247,619,"PN613","Jun (c-Jun)","T239","Jun proto-oncogene-encoded AP1 transcription factor",0,4266,14,633,{"v":2691.516,"d":"2692"},{"v":4729.388992826267,"d":"4729"},{"v":4820.967974904813,"d":"4821"},{"v":91.57898207854578,"d":"92"},{"v":1.899597395279398,"d":"2"},0,5404,14,658,{"v":3546.62,"d":"3547"},{"v":6196.708172703958,"d":"6197"},{"v":5391.416713004511,"d":"5391"},{"v":805.2914596994469,"d":"805"},{"v":14.936546413802928,"d":"15"},{"v":16.836143809082326,"d":"17"},{"v":11.8326597701774,"d":"12"},null,0,4622,16,684,{"v":3150.504,"d":"3151"},{"v":5390.012678635023,"d":"5390"},{"v":5134.828707718889,"d":"5135"},{"v":255.18397091613406,"d":"255"},{"v":4.969668618790163,"d":"5"},{"v":6.869266014069561,"d":"7"},{"v":6.510326026803213,"d":"7"},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"MPGE(pT)PPL(bA)C","Corresponds to amino acid residues M235 to L242.","T239 phosphorylation inhibits transcriptional activity by reducing binding of DNA. Its phosphorylation has been separately reported to both induce and inhibit FBXW7 interaction. This is one of the major in vivo phosphorylation sites in c-Jun (≥24 reports from high throughput mass spectrometry studies).","GSK3b","Transcription protein","P05412","P05412",null,"P05412","GO:0005829; GO:0000228; GO:0005719; GO:0005654; GO:0005634; GO:0017053; GO:0035976","GO:0035497; GO:0003682; GO:0003677; GO:0003700; GO:0019899; GO:0005096; GO:0071837; GO:0042802; GO:0046982; GO:0042803; GO:0003723; GO:0001102; GO:0000980; GO:0000978; GO:0000981; GO:0070412; GO:0001077; GO:0001190; GO:0003713; GO:0003705; GO:0000982; GO:0008134; GO:0044212; GO:0031625","GO:0007568; GO:0001525; GO:0031103; GO:0071276; GO:0071277; GO:0032870; GO:0051365; GO:0034614; GO:0007623; GO:0061029; GO:0038095; GO:0035026; GO:0007612; GO:0001889; GO:0051899; GO:0001774; GO:0030224; GO:0043922; GO:0008285; GO:0043392; GO:0043524; GO:0031953; GO:0045892; GO:1990441; GO:0003151; GO:0043923; GO:0043065; GO:0045597; GO:0045740; GO:2000144; GO:0001938; GO:0010634; GO:0070374; GO:0048146; GO:0045657; GO:0043525; GO:1902895; GO:0045893; GO:0045944; GO:1904707; GO:0007265; GO:0051726; GO:0042127; GO:0051090; GO:0001836; GO:0051591; GO:0034097; GO:0042493; GO:0042542; GO:0032496; GO:0009612; GO:0035994; GO:0009314; GO:0060395; GO:0007179"]
[1255,621,"NK089","KHS1 (MAP4K5; KHS)","Pan-specific","Kinase homologous to SPS1/STE20 (MAP kinase kinase kinase protein-serine kinase 5 (MEKKK5)",0,79,8,485,{"v":34.435,"d":"34"},{"v":60.50735346472862,"d":"61"},{"v":57.80574010762044,"d":"58"},{"v":2.7016133571081795,"d":"3"},{"v":4.673607416976969,"d":"5"},0,91,8,523,{"v":43.409,"d":"43"},{"v":75.8448621698705,"d":"76"},{"v":65.7101407292399,"d":"66"},{"v":10.1347214406306,"d":"10"},{"v":15.42337503489902,"d":"15"},{"v":20.096982451875988,"d":"20"},{"v":13.674075631422355,"d":"14"},null,0,65,6,516,{"v":30.444,"d":"30"},{"v":52.08485562575532,"d":"52"},{"v":55.1849002451834,"d":"55"},{"v":3.1000446194280826,"d":"3"},{"v":5.617559523809519,"d":"6"},{"v":10.29116694078649,"d":"10"},{"v":-4.533874763228809,"d":"-5"},null,null,"KHS1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","KHS",{"$nulls":5},"Epitope undefined.",{"$nulls":3},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE20 family; KHS subfamily","Q9Y4K4","Q9Y4K4","Q9Y4K4","Q9Y4K4","GO:0005737","GO:0005524; GO:0008349; GO:0004672; GO:0004674","GO:0007257; GO:0035556; GO:0006468; GO:0042981; GO:0007346"]
[1256,621,"NK089","KHS1 (MAP4K5; KHS)","Pan-specific","Kinase homologous to SPS1/STE20 (MAP kinase kinase kinase protein-serine kinase 5 (MEKKK5)",0,74,10,490,{"v":31.36,"d":"31"},{"v":55.10412675051225,"d":"55"},{"$nulls":3},0,70,6,497,{"v":31.808,"d":"32"},{"v":55.5754192886093,"d":"56"},{"$nulls":6},0,78,10,501,{"v":34.068,"d":"34"},{"v":58.28494486461148,"d":"58"},{"$nulls":7},"KHS1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","KHS",{"$nulls":5},"Epitope undefined.",{"$nulls":4},"Q9Y4K4","Q9Y4K4","Q9Y4K4","Q9Y4K4"]
[1261,624,"NK241-4","Kit","Pan-specific","Mast/stem cell growth factor receptor Kit",0,36,7,657,{"v":19.053,"d":"19"},{"v":33.47891986535427,"d":"33"},{"v":46.7093574408639,"d":"47"},{"v":13.230437575509626,"d":"13"},{"v":28.32502586287971,"d":"28"},0,126,6,393,{"v":47.16,"d":"47"},{"v":82.39866617362972,"d":"82"},{"v":60.56546573881893,"d":"61"},{"v":21.83320043481079,"d":"22"},{"v":36.04892684052619,"d":"36"},{"v":64.3739527034059,"d":"64"},{"v":29.664523464056373,"d":"30"},null,0,59,10,649,{"v":31.801,"d":"32"},{"v":54.40646740752348,"d":"54"},{"v":53.93341976002245,"d":"54"},{"v":0.47304764750102635,"d":"0"},{"v":0.8770955923170806,"d":"1"},{"v":29.20212145519679,"d":"29"},{"v":15.465985222135714,"d":"15"},null,null,"KIT","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 951-981 within the C-terminus of human c-Kit .",null,null,"EC 2.7.10.1; Receptor tyrosine kinase; TK group; PDGFR family","P10721","P10721","P10721","P10721","GO:0001669; GO:0005911; GO:0009898; GO:0009897; GO:0005615; GO:0016021; GO:0042629; GO:0005886","GO:0005524; GO:0019955; GO:0046872; GO:0046934; GO:0002020; GO:0042803; GO:0004713; GO:0005088; GO:0005020; GO:0004714","GO:0031532; GO:0000187; GO:0060326; GO:0097067; GO:0019221; GO:0002371; GO:0050910; GO:0048565; GO:0035234; GO:0035162; GO:0050673; GO:0030218; GO:0038162; GO:0038093; GO:0008354; GO:0006687; GO:0035701; GO:0030097; GO:0002327; GO:0006954; GO:0038109; GO:0030032; GO:0002320; GO:0008584; GO:0000165; GO:0002551; GO:0032762; GO:0043303; GO:0060374; GO:0070662; GO:0035855; GO:0097326; GO:0030318; GO:0097324; GO:0002318; GO:0043069; GO:0001541; GO:0018108; GO:0043473; GO:0030335; GO:0008284; GO:1904343; GO:0051091; GO:0010628; GO:0046427; GO:0048170; GO:0043410; GO:0045747; GO:0043552; GO:0014068; GO:0010863; GO:0051897; GO:0031274; GO:0120072; GO:1904349; GO:0042531; GO:1905065; GO:0046777; GO:1904251; GO:0042127; GO:0008360; GO:0048070; GO:0006357; GO:0046686; GO:0007165; GO:0048103; GO:0035019; GO:0007286; GO:0007283; GO:0048863; GO:0019827; GO:0030217; GO:0043586; GO:0008542"]
[1266,626,"PK036","Kit","Y703","Mast/stem cell growth factor receptor protein-tyrosine Kit",0,3477,12,508,{"v":1760.22,"d":"1760"},{"v":3092.9651144383506,"d":"3093"},{"$nulls":3},0,3600,14,505,{"v":1810.93,"d":"1811"},{"v":3164.084320055371,"d":"3164"},{"$nulls":6},0,3826,14,556,{"v":2119.472,"d":"2119"},{"v":3626.0804468148367,"d":"3626"},{"$nulls":7},"KIT","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues that encompass the Y703 phosphosite.","Y703 phosphorylation induces interaction with Grb2. This is one of the major in vivo phosphorylation sites in Kit (≥26 reports from high throughput mass spectrometry studies).","Kit",null,"P10721","P10721","P10721","P10721"]
[1270,628,"PK037","Kit","Y730","Mast/stem cell growth factor receptor protein-tyrosine Kit",0,706,9,484,{"v":337.348,"d":"337"},{"v":592.7699920609632,"d":"593"},{"$nulls":3},0,758,18,464,{"v":343.36,"d":"343"},{"v":599.9237917170802,"d":"600"},{"$nulls":6},0,870,14,514,{"v":439.984,"d":"440"},{"v":752.7428431757432,"d":"753"},{"$nulls":7},"KIT","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues that encompass the Y730 phosphosite.","The effect of Y730 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in Kit (≥29 reports from high throughput mass spectrometry studies).","Kit",null,"P10721","P10721","P10721","P10721"]
[1273,630,"PK673","Kit","Y936","Mast/stem cell growth factor receptor protein-tyrosine Kit",0,9088,16,628,{"v":5697.216,"d":"5697"},{"v":10010.845426946633,"d":"10011"},{"v":10503.303416841358,"d":"10503"},{"v":492.45798989472496,"d":"492"},{"v":4.688601008184729,"d":"5"},0,10400,16,678,{"v":7040.352,"d":"7040"},{"v":12301.009630891569,"d":"12301"},{"v":11288.002246056714,"d":"11288"},{"v":1013.0073848348547,"d":"1013"},{"v":8.974195457736846,"d":"9"},{"v":13.662796465921573,"d":"14"},{"v":7.47097173216136,"d":"7"},null,0,9952,14,671,{"v":6668.398,"d":"6668"},{"v":11408.5713797489,"d":"11409"},{"v":11437.057744503749,"d":"11437"},{"v":28.486364754848182,"d":"28"},{"v":0.24907074346579858,"d":"0"},{"v":4.9376717516505275,"d":"5"},{"v":8.890101433851541,"d":"9"},null,null,"KIT","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"NHI(pY)SNL(bA)C","Corresponds to amino acid residues N933 to L939; In the C-terminal of the kinase after the catalytic domain.","Y936 phosphorylation stimulates phosphotransferase activity and induces interaction with APS, Cbl, Grb2 and Grb7. Phosphorylation also induces receptor internalization and protein degradation. This is the major in vivo phosphorylation sites in Kit (≥107 reports from high throughput mass spectrometry studies).","Kit","EC 2.7.10.1; Receptor tyrosine kinase; TK group; PDGFR family","P10721","P10721","P10721","P10721","GO:0001669; GO:0005911; GO:0009898; GO:0009897; GO:0005615; GO:0016021; GO:0042629; GO:0005886","GO:0005524; GO:0019955; GO:0046872; GO:0046934; GO:0002020; GO:0042803; GO:0004713; GO:0005088; GO:0005020; GO:0004714","GO:0031532; GO:0000187; GO:0060326; GO:0097067; GO:0019221; GO:0002371; GO:0050910; GO:0048565; GO:0035234; GO:0035162; GO:0050673; GO:0030218; GO:0038162; GO:0038093; GO:0008354; GO:0006687; GO:0035701; GO:0030097; GO:0002327; GO:0006954; GO:0038109; GO:0030032; GO:0002320; GO:0008584; GO:0000165; GO:0002551; GO:0032762; GO:0043303; GO:0060374; GO:0070662; GO:0035855; GO:0097326; GO:0030318; GO:0097324; GO:0002318; GO:0043069; GO:0001541; GO:0018108; GO:0043473; GO:0030335; GO:0008284; GO:1904343; GO:0051091; GO:0010628; GO:0046427; GO:0048170; GO:0043410; GO:0045747; GO:0043552; GO:0014068; GO:0010863; GO:0051897; GO:0031274; GO:0120072; GO:1904349; GO:0042531; GO:1905065; GO:0046777; GO:1904251; GO:0042127; GO:0008360; GO:0048070; GO:0006357; GO:0046686; GO:0007165; GO:0048103; GO:0035019; GO:0007286; GO:0007283; GO:0048863; GO:0019827; GO:0030217; GO:0043586; GO:0008542"]
[1278,632,"NK090-1","Ksr1","Pan-specific","Protein-serine kinase suppressor of Ras 1",0,218,12,488,{"v":100.528,"d":"101"},{"v":176.64246345585127,"d":"177"},{"$nulls":3},0,282,12,482,{"v":130.14,"d":"130"},{"v":227.3825787921156,"d":"227"},{"$nulls":6},0,347,12,526,{"v":176.21,"d":"176"},{"v":301.4673633495712,"d":"301"},{"$nulls":7},"KSR1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RAF",{"$nulls":6},"EKLPKLNRRLSHPGHFWKSC","Corresponds to amino acid residues E829 to S847; C-terminus.",{"$nulls":3},"Q8IVT5","Q8IVT5","Q8IVT5","Q8IVT5"]
[1283,637,"NK091-3","LATS1","Pan-specific","Large tumour suppressor 1 protein-serine kinase (WARTS)",0,24,2,691,{"v":15.202,"d":"15"},{"v":26.712147157566555,"d":"27"},{"v":28.5237656103656,"d":"29"},{"v":1.8116184527990455,"d":"2"},{"v":6.351259779461585,"d":"6"},0,34,6,665,{"v":18.62,"d":"19"},{"v":32.53314597440597,"d":"33"},{"v":30.14645008820626,"d":"30"},{"v":2.386695886199707,"d":"2"},{"v":7.917004752521152,"d":"8"},{"v":14.268264531982737,"d":"14"},{"v":5.688885892579947,"d":"6"},null,0,30,6,669,{"v":16.056,"d":"16"},{"v":27.469269541687275,"d":"27"},{"v":34.47687592202803,"d":"34"},{"v":7.007606380340754,"d":"7"},{"v":20.325526002381906,"d":"20"},{"v":26.676785781843492,"d":"27"},{"v":20.870702672928473,"d":"21"},null,null,"LATS1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","NDR",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 3-28 at the N-terminus of human LATS1.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); AGC group; NDR family","O95835","O95835","O95835","O95835","GO:0005829; GO:0005815; GO:0000922","GO:0005524; GO:0030331; GO:0000287; GO:0019901; GO:0004674","GO:0051301; GO:0034613; GO:0051220; GO:0000082; GO:0000086; GO:0035329; GO:0009755; GO:0001827; GO:0001828; GO:0030216; GO:0060644; GO:0090090; GO:0045736; GO:0043065; GO:0033138; GO:0006468; GO:0030833; GO:0033146; GO:0046620; GO:0043254; GO:2000058; GO:0000819"]
[1288,639,"PK677","LATS1","S464","Large tumour suppressor 1 protein-serine kinase (WARTS)",0,1906,18,797,{"v":1504.736,"d":"1505"},{"v":2644.042196111569,"d":"2644"},{"$nulls":3},0,2184,16,740,{"v":1604.32,"d":"1604"},{"v":2803.092199229806,"d":"2803"},{"$nulls":6},0,2186,20,791,{"v":1713.306,"d":"1713"},{"v":2931.194838153342,"d":"2931"},{"$nulls":7},"LATS1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","NDR",{"$nulls":6},"RSN(pS)FNN(bA)C","Corresponds to amino acid residues R461 to N467; In the N-terminal half of the protein. One of the two major in vivo phosphorylation sites in LATS1.","S464 phosphorylation induces protein degradation. This is the major in vivo phosphorylation site in LATS1 (≥56 reports from high throughput mass spectrometry studies).","NuaK1; NuaK2",null,"O95835","O95835","O95835","O95835"]
[1292,641,"NK092-1","LATS2 (KPM)","Pan-specific","Large tumour suppressor 2 protein-serine kinase",0,4987,16,692,{"v":3439.932,"d":"3440"},{"v":6044.465846337471,"d":"6044"},{"$nulls":3},0,5287,18,642,{"v":3382.698,"d":"3383"},{"v":5910.301171929706,"d":"5910"},{"$nulls":6},0,4987,16,728,{"v":3618.888,"d":"3619"},{"v":6191.343417611956,"d":"6191"},{"$nulls":7},"LATS2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","NDR",{"$nulls":6},"CSDTSLDAKVLGSKDATRQQ","Corresponds to amino acid residues S43 to Q61; Post-N-terminus.",{"$nulls":3},"Q9NRM7","Q9NRM7","Q9NRM7","Q9NRM7"]
[1295,643,"NK353-4","Lck","Pan-specific","Lymphocyte-specific protein-tyrosine kinase",0,114,10,489,{"v":50.856,"d":"51"},{"v":89.36146269209347,"d":"89"},{"v":93.45210067280752,"d":"93"},{"v":4.09063798071405,"d":"4"},{"v":4.377256317689533,"d":"4"},0,122,10,500,56,{"v":97.84404804332623,"d":"98"},{"v":91.69385073774572,"d":"92"},{"v":6.150197305580505,"d":"6"},{"v":6.707317073170731,"d":"7"},{"v":11.084573390860264,"d":"11"},{"v":-1.8814450637313627,"d":"-2"},null,0,122,10,574,{"v":64.288,"d":"64"},{"v":109.98657201644191,"d":"110"},{"v":104.04995235340911,"d":"104"},{"v":5.9366196630328005,"d":"6"},{"v":5.705547699694158,"d":"6"},{"v":10.08280401738369,"d":"10"},{"v":11.340410332461715,"d":"11"},null,null,"LCK","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 1-225 of mouse Lck.",null,null,"Protein-tyrosine kinase, TK group, Src family","P06239","P06239","P06239","P06239","GO:0005829; GO:0070062; GO:0031234; GO:0001772; GO:0045121; GO:0000242; GO:0005886","GO:0051117; GO:0005524; GO:0042609; GO:0042610; GO:0042802; GO:0016301; GO:0004715; GO:0043548; GO:0046934; GO:0001784; GO:0008022; GO:0019901; GO:0019903; GO:0004722; GO:0004713; GO:0042169; GO:0042608","GO:0006919; GO:0050853; GO:0016477; GO:0006882; GO:0030097; GO:0045087; GO:0050900; GO:0038083; GO:0018108; GO:0030168; GO:0034116; GO:2001244; GO:1903039; GO:0051897; GO:0050870; GO:0050862; GO:0006468; GO:0042127; GO:0050690; GO:0051249; GO:0051209; GO:0042493; GO:0031295; GO:0030217; GO:0050852; GO:0007169"]
[1300,645,"PK680","Lck","Y263+Y264","Lymphocyte-specific protein-tyrosine kinase; Proto-oncogene tyrosine-protein kinase LCK",0,5258,14,606,{"v":3177.864,"d":"3178"},{"v":5583.973872828121,"d":"5584"},{"$nulls":3},0,5956,20,597,{"v":3543.792,"d":"3544"},{"v":6191.76704827777,"d":"6192"},{"$nulls":6},0,5636,16,620,{"v":3484.4,"d":"3484"},{"v":5961.255779213699,"d":"5961"},{"$nulls":7},"LCK","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"GEVWMG(pY)(pY)NGHT(bA)C","Corresponds to amino acid residues G257 to T268; In the kinase catalytic domain between subdomains I and II.","The effects of Y263 and Y264 phosphorylation are unclear. These are two of the major in vivo phosphorylation sites in Lck (≥67 and ≥19 reports from high throughput mass spectrometry studies).",null,null,"P06239","P06239","P06239","P06239"]
[1305,648,"PN615","LEDGF","S273+S275","PC4 and SFRS1-interacting protein",0,1922,12,525,{"v":1002.75,"d":"1003"},{"v":1761.9790529042143,"d":"1762"},{"v":1877.1020462815522,"d":"1877"},{"v":115.12299337733793,"d":"115"},{"v":6.133017307470896,"d":"6"},0,2394,12,536,{"v":1276.752,"d":"1277"},{"v":2230.7604290609434,"d":"2231"},{"v":1991.677624059504,"d":"1992"},{"v":239.08280500143928,"d":"239"},{"v":12.004091531345956,"d":"12"},{"v":18.13710883881685,"d":"18"},{"v":6.103854503004811,"d":"6"},null,0,2164,14,564,{"v":1212.6,"d":"1213"},{"v":2074.5662833987285,"d":"2075"},{"v":2106.7061499663755,"d":"2107"},{"v":32.139866567647005,"d":"32"},{"v":1.5255979847099217,"d":"2"},{"v":7.6586152921808175,"d":"8"},{"v":12.231839187414323,"d":"12"},{"$nulls":5},"Nucleus protein; Transcription protein,  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"TST(pS)D(pS)EEEGC","Corresponds to amino acid residues T270 to G279.","The effect of S273 and S275 phosphorylation are unclear. This are two of the major in vivo phosphorylation sites in LEDGF (≥135 and ≥154 reports, respectively, from high throughput mass spectrometry studies).","S275: CK2a1 (CSNK2A1).","Nucleus protein; Transcription protein, coactivator/corepressor","O75475","O75475",null,"O75475","GO:0005829; GO:0005720; GO:0034399; GO:0005654; GO:0005634; GO:0035327","GO:0033613; GO:0003682; GO:0003723; GO:0097100; GO:0003713","GO:0075713; GO:0000395; GO:0051169; GO:0045944; GO:0006355; GO:0009408; GO:0006979; GO:0006351"]
[1306,648,"PN615","LEDGF","S273+S275","PC4 and SFRS1-interacting protein",0,2194,22,522,{"v":1133.784,"d":"1134"},{"v":1992.22503965889,"d":"1992"},{"$nulls":3},0,1873,12,539,{"v":1003.079,"d":"1003"},{"v":1752.5948190580646,"d":"1753"},{"$nulls":6},0,2190,12,574,{"v":1250.172,"d":"1250"},{"v":2138.8460165340225,"d":"2139"},{"$nulls":10},"Nucleus protein; Transcription protein,  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"TST(pS)D(pS)EEEGC","Corresponds to amino acid residues T270 to G279.","The effect of S273 and S275 phosphorylation are unclear. This are two of the major in vivo phosphorylation sites in LEDGF (≥135 and ≥154 reports, respectively, from high throughput mass spectrometry studies).","S275: CK2a1 (CSNK2A1).",null,"O75475","O75475",null,"O75475"]
[1310,650,"NK093","LIMK1","Pan-specific","LIM domain kinase 1",0,1082,8,228,{"v":244.872,"d":"245"},{"v":430.27607543531366,"d":"430"},{"$nulls":3},0,785,6,227,{"v":176.833,"d":"177"},{"v":308.96529549366977,"d":"309"},{"$nulls":6},0,1044,10,226,{"v":233.684,"d":"234"},{"v":399.7962620565302,"d":"400"},{"$nulls":7},"LIMK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","LISK","LIMK",{"$nulls":5},"Epitope undefined.",{"$nulls":4},"P53667","P53667","P53667","P53667"]
[1317,654,"PK682","LKB1 (STK11)","S31","Serine/threonine-protein kinase 11",0,3782,12,668,{"v":2518.36,"d":"2518"},{"v":4425.128464394772,"d":"4425"},{"v":4433.88608453905,"d":"4434"},{"v":8.757620144278008,"d":"9"},{"v":0.19751567760876418,"d":"0"},0,4551,16,655,{"v":2970.425,"d":"2970"},{"v":5189.971543019595,"d":"5190"},{"v":5218.00997803701,"d":"5218"},{"v":28.038435017415395,"d":"28"},{"v":0.5373396205724259,"d":"1"},{"v":0.7348552981811901,"d":"1"},{"v":17.68480016282328,"d":"18"},null,0,3700,16,664,{"v":2446.176,"d":"2446"},{"v":4185.0191760342805,"d":"4185"},{"v":4120.7488525266945,"d":"4121"},{"v":64.270323507586,"d":"64"},{"v":1.5596758212570454,"d":"2"},{"v":1.7571914988658095,"d":"2"},{"v":-7.062365294053535,"d":"-7"},null,null,"LKB1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","LKB",{"$nulls":5},"RID(pS)TEV(bA)C","Corresponds to amino acid residues R28 to V34; In the post-Nterminal region.","The effect of S31 phosphorylation is unclear. This is a major site of phosphorylation for LKB1. This is one of the major in vivo phosphorylation sites in LKB1 (≥309 reports from high throughput mass spectrometry studies).",null,"Protein-serine kinase, CAMK group, CAMKL family, LKB subfamily","Q15831","Q15831","Q15831","Q15831","GO:0005737; GO:0005829; GO:0070062; GO:0016020; GO:0005739; GO:0005654; GO:0005634; GO:0036398","GO:0005524; GO:0030275; GO:0000287; GO:0002039; GO:0030295; GO:0004674","GO:0032147; GO:0043276; GO:0006914; GO:0007409; GO:0060070; GO:0007050; GO:0030154; GO:0006974; GO:0071493; GO:0097484; GO:0030010; GO:0042593; GO:0051645; GO:0072332; GO:0090090; GO:0030308; GO:0008285; GO:0120163; GO:0060770; GO:0051055; GO:1904262; GO:0007399; GO:0018105; GO:0018107; GO:0010508; GO:0050772; GO:0050731; GO:1900182; GO:0071902; GO:0030511; GO:0045059; GO:0046777; GO:0006470; GO:0006468; GO:0001558; GO:0048814; GO:0051896; GO:1901796; GO:0010212; GO:0007283; GO:0050852; GO:0036399; GO:0001894; GO:0001944"]
[1322,656,"PK191","LKB1 (STK11)","S428","Serine/threonine-protein kinase 11",0,622,12,485,{"v":295.85,"d":"296"},{"v":519.8519100490769,"d":"520"},{"$nulls":3},0,652,12,471,{"v":301.44,"d":"301"},{"v":526.680532896076,"d":"527"},{"$nulls":6},0,812,12,552,{"v":441.6,"d":"442"},{"v":755.5075628804871,"d":"756"},{"$nulls":7},"LKB1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","LKB",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues surrounding the phosphorylated Ser-431 of mouse LKB1.","S428 phosphorylation stimulates phosphotransferase activity. Phosphorylation regulates cell growth, intracellular location and molecular association, including inducing interaction with STRAD and exportin 1. This is one of the major in vivo phosphorylation sites in LKB1 (≥5 reports from high throughput mass spectrometry studies).","DNAPK (PRKDC); LKB1 (STK11); MSK1 (RPS6KA5); p70S6K (RPS6KB1); PKACa (PRKACA); PKCz (PRKCZ); RSK1 (RPS6KA1)",null,"Q15831","Q15831","Q15831","Q15831"]
[1323,657,"NK384-1","LMR2 (LMTK2, KPI-2)","Pan-specific","Protein-serine/threonine kinase LMTK2",0,162,10,485,{"v":73.72,"d":"74"},{"v":129.53686938927817,"d":"130"},{"v":129.16083995290668,"d":"129"},{"v":0.376029436371482,"d":"0"},{"v":0.29113269665061486,"d":"0"},0,176,12,491,{"v":80.524,"d":"81"},{"v":140.69275222572858,"d":"141"},{"v":135.14010249926983,"d":"135"},{"v":5.552649726458753,"d":"6"},{"v":4.1088097639179715,"d":"4"},{"v":4.399942460568586,"d":"4"},{"v":4.629315316115338,"d":"5"},null,0,188,10,572,{"v":101.816,"d":"102"},{"v":174.19102813007171,"d":"174"},{"v":161.30839237715037,"d":"161"},{"v":12.882635752921345,"d":"13"},{"v":7.986339435335042,"d":"8"},{"v":8.277472131985657,"d":"8"},{"v":24.889550451952005,"d":"25"},null,null,"LMR2","X","PSTK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Lmr",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 15-148 mapping near the N-terminus of human KPI-2.",null,null,"Receptor tyrosine kinase; EC 2.7.11.1; TK domain target; TK</A> group; Lmr family","Q8IWU2","Q8IWU2","Q8IWU2",null,"GO:0005829; GO:0005769; GO:0005794; GO:0030426; GO:0016021; GO:0043025; GO:0048471; GO:0055037","GO:0005524; GO:0070853; GO:0004864; GO:0004674","GO:0045022; GO:0032456; GO:0018105; GO:0018107; GO:0046777; GO:0006468; GO:0001881; GO:0033572"]
[1328,659,"PK685","LOK","S191","Lymphocyte-oriented protein-serine kinase; Serine-threonine-protein kinase 10",0,9242,18,707,{"v":6521.368,"d":"6521"},{"v":11459.001557995363,"d":"11459"},{"$nulls":3},0,9364,14,685,{"v":6404.75,"d":"6405"},{"v":11190.47619116953,"d":"11190"},{"$nulls":6},0,9135,16,745,{"v":6793.655,"d":"6794"},{"v":11622.86624117037,"d":"11623"},{"$nulls":7},"LOK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","SLK",{"$nulls":5},"KRD(pS)FIG(bA)C","Corresponds to amino acid residues K188 to G194; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S191 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in LOK (≥81 reports from high throughput mass spectrometry studies).",null,null,"O94804","O94804","O94804"]
[1333,662,"PK687","LTK","Y672","Leukocyte tyrosine kinase receptor",0,5087,18,689,{"v":3492.541,"d":"3493"},{"v":6136.907587543394,"d":"6137"},{"v":6245.698702070429,"d":"6246"},{"v":108.79111452703546,"d":"109"},{"v":1.7418565914966655,"d":"2"},0,5576,18,675,{"v":3751.65,"d":"3752"},{"v":6554.939693602586,"d":"6555"},{"v":6245.876554060873,"d":"6246"},{"v":309.0631395417131,"d":"309"},{"v":4.948274863690188,"d":"5"},{"v":6.690131455186854,"d":"7"},{"v":0.002847591581470965,"d":"0"},null,0,5209,20,660,{"v":3424.74,"d":"3425"},{"v":5859.186981203168,"d":"5859"},{"v":6011.794034212542,"d":"6012"},{"v":152.60705300937389,"d":"153"},{"v":2.538461100644863,"d":"3"},{"v":4.280317692141528,"d":"4"},{"v":-3.7450520592731777,"d":"-4"},null,null,"LTK","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Alk",{"$nulls":6},"RDI(pY)RAS(bA)C","Corresponds to amino acid residues R669 to S675; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII. ","Y672 is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation site in LTK (≥24reports from high throughput mass spectrometry studies).",null,"Receptor tyrosine kinase, TK group, Alk family","P29376","P29376","P29376","P29376","GO:0005887; GO:0005622; GO:0016020; GO:0005886","GO:0005524; GO:0004672; GO:0004713; GO:0004714","GO:0008283; GO:0071300; GO:0043066; GO:0014065; GO:0010666; GO:0010976; GO:0006468; GO:0007165; GO:0007169"]
[1338,664,"NK095-2","Lyn","Pan-specific","Yes-related protein-tyrosine kinase; Tyrosine-protein kinase Lyn",0,1371,16,607,{"v":822.485,"d":"822"},{"v":1445.2269671682102,"d":"1445"},{"$nulls":3},0,1520,16,623,{"v":936.992,"d":"937"},{"v":1637.1266118609342,"d":"1637"},{"$nulls":6},0,1928,22,689,{"v":1313.234,"d":"1313"},{"v":2246.735096992286,"d":"2247"},{"$nulls":7},"LYN","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"CGVDLKTQPVRNTERTIYVR","Corresponds to amino acid residues G16 to R34; Post-N-terminus.",{"$nulls":3},"P07948","P07948","P07948","P07948"]
[1340,665,"PK688","Lyn","Y508","Yes-related protein-tyrosine kinase; Tyrosine-protein kinase Lyn",0,8542,20,825,{"v":7030.65,"d":"7031"},{"v":12353.884844977325,"d":"12354"},{"$nulls":3},0,9180,22,803,{"v":7353.874,"d":"7354"},{"v":12848.800017152993,"d":"12849"},{"$nulls":6},0,8768,22,956,{"v":8361.176,"d":"8361"},{"v":14304.646065613268,"d":"14305"},{"$nulls":7},"LYN","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"EGQ(pY)QQQ(bA)C","Corresponds to amino acid residues E505 to Q511; Near the C-terminus of the kinase.","Y508 phosphorylation inhibits phosphotransferase activity. This is one of the major in vivo phosphorylation sites in Lyn (≥1583 reports from high throughput mass spectrometry studies).","CSK; CTK (MATK)",null,"P07948","P07948","P07948","P07948"]
[1345,668,"NK097-2","MAPKAPK2 (RPS6KC1)","Pan-specific","Mitogen-activated protein kinase-activated protein kinase 2",0,485,18,583,{"v":272.261,"d":"272"},{"v":478.40257185016634,"d":"478"},{"v":496.05486959683867,"d":"496"},{"v":17.652297746672332,"d":"18"},{"v":3.5585373370125324,"d":"4"},0,572,14,571,{"v":318.618,"d":"319"},{"v":556.6941946333664,"d":"557"},{"v":520.7627152045984,"d":"521"},{"v":35.93147942876794,"d":"36"},{"v":6.899779569405445,"d":"7"},{"v":10.458316906417977,"d":"10"},{"v":4.980869480797708,"d":"5"},null,0,550,18,628,{"v":334.096,"d":"334"},{"v":571.5852688589656,"d":"572"},{"v":637.2268317498138,"d":"637"},{"v":65.64156289084815,"d":"66"},{"v":10.30112977361571,"d":"10"},{"v":13.859667110628243,"d":"14"},{"v":28.45894089654044,"d":"28"},null,null,"MAPKAPK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","MAPKAPK","MAPKAPK",{"$nulls":5},"SRVLKEDKERWEDVKGC","Corresponds to amino acid residues S339 to K353.",null,null,"Protein-serine kinase, CAMK group, MAPKAPK family, MAPKAPK subfamily","P49137","P49137","P49137","P49137","GO:0005813; GO:0005737; GO:0005829; GO:0070062; GO:0005654; GO:0005634","GO:0005524; GO:0009931; GO:0005516; GO:0004683; GO:0051019; GO:0004672; GO:0004674","GO:0070935; GO:0000187; GO:0006974; GO:0035924; GO:0006954; GO:0048839; GO:0006691; GO:0044351; GO:0000165; GO:0038066; GO:0018105; GO:0042535; GO:0046777; GO:0006468; GO:1900034; GO:0032675; GO:0043488; GO:0032680; GO:0034097; GO:0032496; GO:0002224; GO:0048010"]
[1350,670,"PK690","MAPKAPK2 (RPS6KC1)","T222","Mitogen-activated protein kinase-activated protein kinase 2",0,10995,22,811,{"v":8899.103,"d":"8899"},{"v":15637.0312397278,"d":"15637"},{"$nulls":3},0,12616,26,799,{"v":10059.41,"d":"10059"},{"v":17575.953487991363,"d":"17576"},{"$nulls":6},0,11712,24,864,{"v":10098.432,"d":"10098"},{"v":17276.815555331348,"d":"17277"},{"$nulls":7},"MAPKAPK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","MAPKAPK","MAPKAPK",{"$nulls":5},"SLT(pT)PCYT(bA)C","Corresponds to amino acid residues S219 to T226; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T222 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation sites in MAPKAPK2 (≥44 reports from high throughput mass spectrometry studies).","ERK1 (MAPK3); ERK2 (MAPK1); p38a MAPK (MAPK14)",null,"P49137","P49137","P49137","P49137"]
[1355,673,"PK692","MAPKAPK3","Y76","MAP kinase-activated protein kinase 3",0,5444,24,881,{"v":4775.02,"d":"4775"},{"v":8390.411585339,"d":"8390"},{"v":8454.051053151074,"d":"8454"},{"v":63.639467812074145,"d":"64"},{"v":0.752768908207076,"d":"1"},0,6436,23,898,{"v":5758.874,"d":"5759"},{"v":10061.991863061825,"d":"10062"},{"v":9720.605243362941,"d":"9721"},{"v":341.3866196988838,"d":"341"},{"v":3.5119893376184224,"d":"4"},{"v":4.264758245825498,"d":"4"},{"v":14.981624575590715,"d":"15"},null,0,5633,18,900,{"v":5053.5,"d":"5054"},{"v":8645.737022229487,"d":"8646"},{"v":8458.456346536917,"d":"8458"},{"v":187.28067569256928,"d":"187"},{"v":2.2141235707771454,"d":"2"},{"v":2.9668924789842213,"d":"3"},{"v":0.05210866788178237,"d":"0"},null,null,"MAPKAPK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","MAPKAPK","MAPKAPK",{"$nulls":5},"KLL(pY)DSP(bA)C","Corresponds to amino acid residues K73 to P79; In the protein kinase catalytic domain in subdomain II. ","The effect of Y76 phosphorylation is unclear. This is the major in vivo site of phosphorylation of MAPKAPK3 (≥93 reports from high throughput mass spectrometry studies).",null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; MAPKAPK family; MAPKAPK subfamily","Q16644","Q16644","Q16644","Q16644","GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0009931; GO:0005516; GO:0004683; GO:0004708; GO:0051019; GO:0004674","GO:0000187; GO:0007166; GO:0044351; GO:0018105; GO:0046777; GO:0034097; GO:0032496; GO:0007165; GO:0002224; GO:0048010"]
[1356,673,"PK692","MAPKAPK3","Y76","MAP kinase-activated protein kinase 3",0,5493,28,887,{"v":4847.455,"d":"4847"},{"v":8517.69052096315,"d":"8518"},{"$nulls":3},0,5934,22,908,{"v":5368.096,"d":"5368"},{"v":9379.21862366406,"d":"9379"},{"$nulls":6},0,5457,31,891,{"v":4834.566,"d":"4835"},{"v":8271.17567084435,"d":"8271"},{"$nulls":7},"MAPKAPK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","MAPKAPK","MAPKAPK",{"$nulls":5},"KLL(pY)DSP(bA)C","Corresponds to amino acid residues K73 to P79; In the protein kinase catalytic domain in subdomain II. ","The effect of Y76 phosphorylation is unclear. This is the major in vivo site of phosphorylation of MAPKAPK3 (≥93 reports from high throughput mass spectrometry studies).",null,null,"Q16644","Q16644","Q16644","Q16644"]
[1362,676,"PK695","MARK1","T215","MAP/microtubule affinity-regulating protein-serine kinase 1",0,8182,14,835,{"v":6820.28,"d":"6820"},{"v":11984.233851848969,"d":"11984"},{"$nulls":3},0,7552,12,826,{"v":6228.04,"d":"6228"},{"v":10881.725803138526,"d":"10882"},{"$nulls":6},0,8357,16,853,{"v":7114.873,"d":"7115"},{"v":12172.419294461457,"d":"12172"},{"$nulls":7},"MARK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","MARK",{"$nulls":5},"KLD(pT)FCG(bA)C","Corresponds to amino acid residues N211 to F216; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII. ","T215 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation site in MARK1 (≥75 reports from high throughput mass spectrometry studies).","LKB1 (STK11); TAO1 (TAOK1/MAP3K16)",null,"Q9P0L2","Q9P0L2","Q9P0L2"]
[1367,679,"NK276-1","MARK3","Pan-specific","MAP/microtubule affinity-regulating protein-serine kinase 3",0,320,8,367,{"v":114.504,"d":"115"},{"v":201.200348515327,"d":"201"},{"v":191.14331823928882,"d":"191"},{"v":10.057030276038176,"d":"10"},{"v":5.261512863059102,"d":"5"},0,299,12,476,{"v":136.612,"d":"137"},{"v":238.6905552016943,"d":"239"},{"v":241.858256257097,"d":"242"},{"v":3.167701055402688,"d":"3"},{"v":1.309734513274337,"d":"1"},{"v":6.571247376333439,"d":"7"},{"v":26.532414779113054,"d":"27"},null,0,352,8,352,{"v":121.088,"d":"121"},{"v":207.1623636188234,"d":"207"},{"v":204.77402902239868,"d":"205"},{"v":2.388334596424727,"d":"2"},{"v":1.1663269057246928,"d":"1"},{"v":6.4278397687837945,"d":"6"},{"v":7.131146884269242,"d":"7"},null,null,"MARK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","MARK",{"$nulls":5},"HGDGRQEVTSRTSRSGARC","Corresponds to amino acid residues H21 to C39; Post-N-terminus.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; CAMKL family; MARK subfamily","P27448","P27448","P27448",null,"GO:0005737; GO:0005829; GO:0030425; GO:0070062; GO:0005886","GO:0005524; GO:0004674; GO:0050321","GO:0030010; GO:0000165; GO:0000226; GO:0035331; GO:0036289; GO:0018105; GO:0032092; GO:0006468"]
[1372,681,"PK697","MARK3","T507","MAP/microtubule affinity-regulating protein-serine kinase 3",0,9254,16,560,{"v":5173.28,"d":"5173"},{"v":9090.212909307716,"d":"9090"},{"$nulls":3},0,8816,16,741,{"v":6520.8,"d":"6521"},{"v":11393.240508587887,"d":"11393"},{"$nulls":6},0,8546,13,497,{"v":4240.901,"d":"4241"},{"v":7255.509010252311,"d":"7256"},{"$nulls":7},"MARK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","MARK",{"$nulls":5},"RRN(pT)YVC(bA)C","Corresponds to amino acid residues R504 to C510; In the C-terminal quarter of the protein kinase. This is the major in vivo phosphorylation site in MARK3.","The effect of T507 phosphorylation is unclear. This is the major in vivo phosphorylation site in MARK3 (≥317 reports from high throughput mass spectrometry studies).","PKACa (PRKACA)",null,"P27448","P27448","P27448"]
[1373,682,"NK277-1","MARK4","Pan-specific","MAP/microtubule affinity-regulating protein-serine kinase 4",0,1790,14,654,{"v":1161.504,"d":"1162"},{"v":2040.9331516972886,"d":"2041"},{"v":1723.1232635281274,"d":"1723"},{"v":317.80988816916124,"d":"318"},{"v":18.443827838435624,"d":"18"},0,1252,12,463,{"v":574.12,"d":"574"},{"v":1003.1111582613295,"d":"1003"},{"v":1405.2493221118284,"d":"1405"},{"v":402.1381638504989,"d":"402"},{"v":28.616855210160146,"d":"29"},{"v":47.06068304859577,"d":"47"},{"v":-18.447545114413117,"d":"-18"},null,0,1638,10,480,{"v":781.44,"d":"781"},{"v":1336.9199047493837,"d":"1337"},{"v":1033.0317008167603,"d":"1033"},{"v":303.88820393262336,"d":"304"},{"v":29.417122794233318,"d":"29"},{"v":47.860950632668946,"d":"48"},{"v":-40.04887968945364,"d":"-40"},null,null,"MARK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","MARK",{"$nulls":5},"CGSGRSSDKGPSWSSRSLGA","Corresponds to amino acid residues G22 to C40; Post-N-terminus.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; CAMKL family; MARK subfamily","Q96L34","Q96L34","Q96L34","Q96L34","GO:0005813; GO:0036064; GO:0005737; GO:0005829; GO:0030425; GO:0000930; GO:0015630; GO:0005815; GO:0030496; GO:0043005","GO:0005524; GO:0043015; GO:0008017; GO:0004674; GO:0050321; GO:0043130","GO:0007049; GO:0051301; GO:0097711; GO:0044782; GO:0030010; GO:0001578; GO:0000226; GO:0007399; GO:0045724; GO:0043068; GO:1904781; GO:0006468; GO:0046605"]
[1378,684,"PN759","MAT1A","T341","S-adenosylmethionine synthase isoform type-1",0,1812,16,846,{"v":1519.416,"d":"1519"},{"v":2669.8371125878925,"d":"2670"},{"$nulls":3},0,16404,22,702,{"v":11500.164,"d":"11500"},{"v":20093.26069503805,"d":"20093"},{"$nulls":6},0,12672,14,527,{"v":6670.766,"d":"6671"},{"v":11412.622652187534,"d":"11413"},{"$nulls":19},"X","SQK(pT)ERE(bA)C","Corresponds to amino acid residues S338 to E344.","The effect of T341 phosphorylation is unclear. Phosphorylation at this site in MAT1A has only been reported in one mass spectrometry study. This human phosphosite is highly conserved in vertebrates and also found in yeast.",null,null,"Q00266","Q00266"]
[1384,687,"PN618","MCM2","S40+S41","DNA replication licensing factor MCM2",0,1898,16,628,{"v":1181.896,"d":"1182"},{"v":2076.764891260313,"d":"2077"},{"$nulls":3},0,2387,24,747,{"v":1765.161,"d":"1765"},{"v":3084.1160301465316,"d":"3084"},{"$nulls":6},0,1693,14,472,{"v":792.488,"d":"792"},{"v":1355.8212805526075,"d":"1356"},{"$nulls":10},"DNA binding protein",{"$nulls":4},"X",{"$nulls":4},"DALT(pS)(pS)PGR(bA)C","Corresponds to amino acid residues D36 to R44.","S40 phosphorylation induces binding to DNA. S41 phosphorylation stimulates transcriptional activity and induces binding to DNA. These are two of the major in vivo phosphorylation sites in MCM2 (≥404 and ≥80 reports, respectively, from high throughput mass spectrometry studies).","S40: CDC7 (CDC7L1); CDK2; CDK7; CK2a1 (CSNK2A1). S41: CDC7 (CDC7L1); CDK1; CDK2; CDK7; CK2a1 (CSNK2A1).",null,"P49736","P49736",null,"P49736"]
[1389,690,"PN169","MDM2","S166","E3 ubiquitin-protein ligase double minute 2 protein",0,2868,16,411,{"v":1172.172,"d":"1172"},{"v":2059.678394815097,"d":"2060"},{"v":1954.87161088139,"d":"1955"},{"v":104.80678393370681,"d":"105"},{"v":5.3613129041478444,"d":"5"},0,3626,18,446,{"v":1609.168,"d":"1609"},{"v":2811.562698246128,"d":"2812"},{"v":2483.8410481855813,"d":"2484"},{"v":327.72165006054684,"d":"328"},{"v":13.19414743950479,"d":"13"},{"v":18.555460343652634,"d":"19"},{"v":27.05903724622077,"d":"27"},null,0,1370,10,327,{"v":444.72,"d":"445"},{"v":760.8453880530122,"d":"761"},{"v":1179.6456763968533,"d":"1180"},{"v":418.8002883438411,"d":"419"},{"v":35.50221025884974,"d":"36"},{"v":40.86352316299759,"d":"41"},{"v":-39.6561047881304,"d":"-40"},{"$nulls":5},"DNA binding protein",{"$nulls":9},"AI(pS)ET","Corresponds to amino acid residues A164 to T168.","S166 phosphorylation induces transcriptional activity and binding to ARF1 and p300. This is the major in vivo phosphorylation site in MDM2 (≥24 reports from high throughput mass spectrometry studies).","AKT1; CK1D; DAPK3; MAPKAPK2; PIM1; PKM","Ligase; Ubiquitin ligase; Inhibitor protein; Ubiquitin conjugating system; EC 6.3.2.-","Q00987","Q00987",null,"Q00987","GO:0005737; GO:0005829; GO:0030666; GO:0005730; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:0045202","GO:0008097; GO:0097718; GO:0019899; GO:0042802; GO:0016874; GO:0061663; GO:0002039; GO:0042975; GO:0019904; GO:0047485; GO:0033612; GO:0043021; GO:0097110; GO:0019789; GO:0043130; GO:0061630; GO:0031625; GO:0004842; GO:0008270","GO:1990000; GO:0003283; GO:0003181; GO:0001568; GO:0001974; GO:0060411; GO:0072717; GO:0071312; GO:0071391; GO:0071480; GO:0071363; GO:0070301; GO:0071456; GO:0071375; GO:0071494; GO:0071301; GO:0006977; GO:0003203; GO:0045184; GO:0071157; GO:0043154; GO:0043518; GO:1902254; GO:0010977; GO:0010955; GO:1901797; GO:0045892; GO:0000122; GO:0018205; GO:0008284; GO:0010628; GO:0045931; GO:0032436; GO:0046827; GO:1904754; GO:1904707; GO:0051865; GO:0065003; GO:0031648; GO:0016579; GO:0034504; GO:0016567; GO:0051603; GO:0002027; GO:0042176; GO:1901796; GO:0046677; GO:0042220; GO:0045472; GO:1904404; GO:0010039; GO:0032026; GO:0043278; GO:0048545; GO:1990785; GO:0036369; GO:0007089; GO:0006511; GO:0003281; GO:0016032"]
[1390,690,"PN169","MDM2","S166","E3 ubiquitin-protein ligase double minute 2 protein",0,3290,10,321,{"v":1052.88,"d":"1053"},{"v":1850.064826947683,"d":"1850"},{"$nulls":3},0,3296,14,376,{"v":1234.032,"d":"1234"},{"v":2156.1193981250344,"d":"2156"},{"$nulls":6},0,2730,14,344,{"v":934.304,"d":"934"},{"v":1598.4459647406943,"d":"1598"},{"$nulls":10},"DNA binding protein",{"$nulls":9},"AI(pS)ET","Corresponds to amino acid residues A164 to T168.","S166 phosphorylation induces transcriptional activity and binding to ARF1 and p300. This is the major in vivo phosphorylation site in MDM2 (≥24 reports from high throughput mass spectrometry studies).","AKT1; CK1D; DAPK3; MAPKAPK2; PIM1; PKM",null,"Q00987","Q00987",null,"Q00987"]
[1395,693,"PN236","MEF2A","S387","Myocyte-specific enhancer factor 2A",0,322,10,590,{"v":184.08,"d":"184"},{"v":323.4556011554303,"d":"323"},{"v":235.39442716854666,"d":"235"},{"v":88.06117398688366,"d":"88"},{"v":37.410050461317965,"d":"37"},0,246,12,521,{"v":121.914,"d":"122"},{"v":213.00998702060846,"d":"213"},{"v":246.68231726866173,"d":"247"},{"v":33.67233024805327,"d":"34"},{"v":13.65007861969317,"d":"14"},{"v":51.060129081011134,"d":"51"},{"v":4.795308978165707,"d":"5"},null,0,240,10,417,{"v":95.91,"d":"96"},{"v":164.0867988131058,"d":"164"},{"v":165.3673636020914,"d":"165"},{"v":1.2805647889856004,"d":"1"},{"v":0.7743757662285216,"d":"1"},{"v":38.18442622754649,"d":"38"},{"v":-29.74881963382873,"d":"-30"},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against amino acid residues that encompass the Ser-387 phosphosite.","The effect of S387 phosphorylation is unclear. This phosphorylation site in MEF2C has apparently not been described from high throughput mass spectrometry studies.","ERK5 (MAPK7); p38a MAPK (MAPK14)","Transcription protein","Q02078","Q02078",null,null,"GO:0005829; GO:0000790; GO:0005654; GO:0005634; GO:0005667","GO:0033613; GO:0003682; GO:0003700; GO:0035035; GO:0042826; GO:0046982; GO:0019901; GO:0000978; GO:0000977; GO:0000981; GO:0001085; GO:0043565; GO:0046332; GO:0001077; GO:0003713; GO:0003705","GO:0006915; GO:0061337; GO:0071277; GO:0048813; GO:0070375; GO:0007507; GO:0000165; GO:0000002; GO:0048311; GO:0007517; GO:0000122; GO:0010613; GO:0046326; GO:0051149; GO:0045944; GO:0006351; GO:0055005"]
[1401,696,"PN625","MEF2D","S180","Myocyte-specific enhancer factor 2D",0,8020,18,645,{"v":5161.29,"d":"5161"},{"v":9069.14471798952,"d":"9069"},{"v":7926.920162073171,"d":"7927"},{"v":1142.2245559163493,"d":"1142"},{"v":14.409436862772907,"d":"14"},0,7962,24,659,{"v":5231.142,"d":"5231"},{"v":9139.930520883243,"d":"9140"},{"v":9458.753604217278,"d":"9459"},{"v":318.8230833340349,"d":"319"},{"v":3.370666968128703,"d":"3"},{"v":17.78010383090161,"d":"18"},{"v":19.324446453658723,"d":"19"},null,0,7567,12,543,{"v":4102.365,"d":"4102"},{"v":7018.495885860981,"d":"7018"},{"v":7323.470474083526,"d":"7323"},{"v":304.9745882225452,"d":"305"},{"v":4.164345159877365,"d":"4"},{"v":18.57378202265027,"d":"19"},{"v":-7.612662618666036,"d":"-8"},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"PRLL(pS)PQQ(bA)C","Corresponds to amino acid residues P176 to Q183.","S180 phosphorylation stimulates transcriptional activity. This is the major in vivo phosphorylation site in MEF2D (≥51 reports from high throughput mass spectrometry studies).","ERK5 (MAPK7)","Transcription protein","Q14814","Q14814",null,"Q14814","GO:0005737; GO:0043231; GO:0005654; GO:0005634","GO:0033613; GO:0003700; GO:0042826; GO:0046982; GO:0042803; GO:0000978; GO:0000977; GO:0000981; GO:0001077","GO:0007512; GO:0006915; GO:0002062; GO:0001958; GO:0007517; GO:0007399; GO:0001649; GO:0045944; GO:1904707; GO:0035914"]
[1406,698,"NK099-7","MEK1 (MKK1, MAP2K1)","Pan-specific","MAPK/ERK protein-serine kinase 1 (MKK1); Dual specificity mitogen-activated protein kinase kinase 1",0,7052,16,721,{"v":5072.956,"d":"5073"},{"v":8913.92890381925,"d":"8914"},{"$nulls":3},0,8498,20,819,{"v":6943.482,"d":"6943"},{"v":12131.75689992805,"d":"12132"},{"$nulls":6},0,7242,14,590,{"v":4264.52,"d":"4265"},{"v":7295.917373313168,"d":"7296"},{"$nulls":7},"MEK1","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"CIGLNQPSTPTHAAGV","Corresponds to amino acid residues I379 to V393; C-terminus.",{"$nulls":3},"Q02750","Q02750","Q02750"]
[1407,699,"NK099-3","MEK1 (MKK1, MAP2K1)","Pan-specific","MAPK/ERK protein-serine kinase 1 (MKK1); Dual specificity mitogen-activated protein kinase kinase 1",0,2158,18,774,{"v":1656.36,"d":"1656"},{"v":2910.467837515257,"d":"2910"},{"v":2501.240624782252,"d":"2501"},{"v":409.2272127330052,"d":"409"},{"v":16.360969379690566,"d":"16"},0,1880,19,711,{"v":1323.171,"d":"1323"},{"v":2311.864408813143,"d":"2312"},{"v":2550.1050561153525,"d":"2550"},{"v":238.24064730220925,"d":"238"},{"v":9.342385590385364,"d":"9"},{"v":25.703354970075928,"d":"26"},{"v":1.9536077756355184,"d":"2"},null,0,2210,8,568,{"v":1250.736,"d":"1251"},{"v":2139.8109310844407,"d":"2140"},{"v":2008.8922145212532,"d":"2009"},{"v":130.91871656318744,"d":"131"},{"v":6.516960721777061,"d":"7"},{"v":22.877930101467626,"d":"23"},{"v":-19.68416814371311,"d":"-20"},null,null,"MEK1","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"EFQDFVNKCLIKNPAERADLKC","Corresponds to amino acid residues E333 to K353; Kinase catalytic subdomain 11.",null,null,"Protein kinase, dual-specificity; EC 2.7.12.2; STE domain target; STE</A> group; STE7 family","Q02750","Q02750","Q02750",null,"GO:0005829; GO:0005769; GO:0005783; GO:0005925; GO:0005794; GO:0005770; GO:0005815; GO:0005739; GO:0005634; GO:0005886","GO:0005524; GO:0004708; GO:0008022; GO:0004672; GO:0047485; GO:0004712; GO:0043539; GO:0004674; GO:0004713; GO:0097110","GO:0000187; GO:0060020; GO:0007050; GO:0048870; GO:0090398; GO:0021697; GO:0006935; GO:0060502; GO:0070371; GO:0060324; GO:0007507; GO:0030216; GO:0060711; GO:0000165; GO:0008285; GO:0010629; GO:0030182; GO:0018107; GO:0060674; GO:0050772; GO:0070374; GO:0010628; GO:1903800; GO:0071902; GO:0045893; GO:0006468; GO:0042981; GO:0048679; GO:2000641; GO:0090170; GO:0007346; GO:0032872; GO:0007165; GO:0048538; GO:0030878; GO:0060440"]
[1412,701,"PK698","MEK1 (MKK1, MAP2K1)","S222","MAPK/ERK protein-serine kinase 1 (MKK1); Dual specificity mitogen-activated protein kinase kinase 1",0,3192,18,642,{"v":2037.708,"d":"2038"},{"v":3580.5522931292353,"d":"3581"},{"$nulls":3},0,3679,20,761,{"v":2784.499,"d":"2784"},{"v":4865.1188202248895,"d":"4865"},{"$nulls":6},0,1986,12,830,{"v":1638.42,"d":"1638"},{"v":2803.076768964329,"d":"2803"},{"$nulls":7},"MEK1","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"MAN(pS)YIC(bA)C","Corresponds to amino acid residues M219 to S222; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S222 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation sites in MEK1 (≥213 reports from high throughput mass spectrometry studies).","A-Raf (RafA); B-Raf (RafB); COT (MAP3K8); MEKK1 (MAP3K1); Mos; PDPK1 (PDK1); Plk1; Raf1.",null,"Q02750","Q02750","Q02750"]
[1417,704,"PK046-1","MEK1 (MKK1, MAP2K1)","T292","MAPK/ERK protein-serine kinase 1 (MKK1); Dual specificity mitogen-activated protein kinase kinase 1",0,4176,16,633,{"v":2633.28,"d":"2633"},{"v":4627.059786020054,"d":"4627"},{"v":3544.9964256293433,"d":"3545"},{"v":1082.0633603907108,"d":"1082"},{"v":30.523679870808675,"d":"31"},0,2986,10,551,{"v":1639.776,"d":"1640"},{"v":2865.0414593623805,"d":"2865"},{"v":3681.857550149217,"d":"3682"},{"v":816.8160907868364,"d":"817"},{"v":22.18489117683906,"d":"22"},{"v":52.70857104764774,"d":"53"},{"v":3.8606844150929334,"d":"4"},null,0,3117,10,448,{"v":1391.936,"d":"1392"},{"v":2381.3817369692338,"d":"2381"},{"v":2302.444370127014,"d":"2302"},{"v":78.93736684221994,"d":"79"},{"v":3.428415811751638,"d":"3"},{"v":33.95209568256031,"d":"34"},{"v":-35.050869064888815,"d":"-35"},null,null,"MEK1","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues that encompass the T292 phosphosite.","T292 phosphorylation increases molecular association with ERK2 and Raf1, but reduces interaction with ERK1 and phosphorylation of S298 by PAK isoforms. It promotes dephosphorylation of the activating residues S218 and S222. This is one of the minor in vivo phosphorylation sites in MEK1 (≥5 reports from high throughput mass spectrometry studies).","CDK1 (CDC2); CDK5; ERK1 (MAPK3); ERK2 (MAPK1); MEKK1 (MAP3K1)","Protein kinase, dual-specificity; EC 2.7.12.2; STE domain target; STE</A> group; STE7 family","Q02750","Q02750","Q02750",null,"GO:0005829; GO:0005769; GO:0005783; GO:0005925; GO:0005794; GO:0005770; GO:0005815; GO:0005739; GO:0005634; GO:0005886","GO:0005524; GO:0004708; GO:0008022; GO:0004672; GO:0047485; GO:0004712; GO:0043539; GO:0004674; GO:0004713; GO:0097110","GO:0000187; GO:0060020; GO:0007050; GO:0048870; GO:0090398; GO:0021697; GO:0006935; GO:0060502; GO:0070371; GO:0060324; GO:0007507; GO:0030216; GO:0060711; GO:0000165; GO:0008285; GO:0010629; GO:0030182; GO:0018107; GO:0060674; GO:0050772; GO:0070374; GO:0010628; GO:1903800; GO:0071902; GO:0045893; GO:0006468; GO:0042981; GO:0048679; GO:2000641; GO:0090170; GO:0007346; GO:0032872; GO:0007165; GO:0048538; GO:0030878; GO:0060440"]
[1419,705,"PK194","MEK1 (MKK1, MAP2K1)","S298","MAPK/ERK protein-serine kinase 1 (MKK1); Dual specificity mitogen-activated protein kinase kinase 1",0,1330,14,706,{"v":929.096,"d":"929"},{"v":1632.5581552102656,"d":"1633"},{"v":1528.57195887836,"d":"1529"},{"v":103.9861963319056,"d":"104"},{"v":6.802832913944654,"d":"7"},0,763,12,561,{"v":421.311,"d":"421"},{"v":736.1209593782467,"d":"736"},{"v":1132.5579602150783,"d":"1133"},{"v":396.43700083683166,"d":"396"},{"v":35.00368323414956,"d":"35"},{"v":41.80651614809422,"d":"42"},{"v":-25.907448868411137,"d":"-26"},null,0,1396,12,597,{"v":826.248,"d":"826"},{"v":1413.5792862655724,"d":"1414"},{"v":1350.387648261601,"d":"1350"},{"v":63.19163800397132,"d":"63"},{"v":4.679518365361237,"d":"5"},{"v":11.482351279305892,"d":"11"},{"v":-11.65691347285393,"d":"-12"},null,null,"MEK1","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues surrounding the phosphorylated Ser-298 of human MEK1.","S298 phosphorylation stimulates phosphotransferase activity. Phosphorylation induces interaction with ERK1 and Raf1 and regulates cell growth. MAPK1/ERK2 phosphorylation of Thr-292 in response to cellular adhesion leads to inhibition of S298 phosphorylation by PAK. This is one of the minor in vivo phosphorylation sites in MEK1 (≥3 reports from high throughput mass spectrometry studies).","MEK1 (MAP2K1); PAK1; PAK2; PAK3 (STK4)","Protein kinase, dual-specificity; EC 2.7.12.2; STE domain target; STE</A> group; STE7 family","Q02750","Q02750","Q02750",null,"GO:0005829; GO:0005769; GO:0005783; GO:0005925; GO:0005794; GO:0005770; GO:0005815; GO:0005739; GO:0005634; GO:0005886","GO:0005524; GO:0004708; GO:0008022; GO:0004672; GO:0047485; GO:0004712; GO:0043539; GO:0004674; GO:0004713; GO:0097110","GO:0000187; GO:0060020; GO:0007050; GO:0048870; GO:0090398; GO:0021697; GO:0006935; GO:0060502; GO:0070371; GO:0060324; GO:0007507; GO:0030216; GO:0060711; GO:0000165; GO:0008285; GO:0010629; GO:0030182; GO:0018107; GO:0060674; GO:0050772; GO:0070374; GO:0010628; GO:1903800; GO:0071902; GO:0045893; GO:0006468; GO:0042981; GO:0048679; GO:2000641; GO:0090170; GO:0007346; GO:0032872; GO:0007165; GO:0048538; GO:0030878; GO:0060440"]
[1424,707,"NK100-5","MEK2 (MKK2, MAP2K2)","Pan-specific","MAPK/ERK protein-serine kinase 2 (MKK2); Dual specificity mitogen-activated protein kinase kinase 2",0,7173,16,719,{"v":5145.883,"d":"5146"},{"v":9042.072355717673,"d":"9042"},{"$nulls":3},0,7221,16,682,{"v":4913.81,"d":"4914"},{"v":8585.483244924588,"d":"8585"},{"$nulls":6},0,7211,15,680,{"v":4893.28,"d":"4893"},{"v":8371.626012889106,"d":"8372"},{"$nulls":7},"MEK2","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"PNGVFTPDFQEFVNKC","Corresponds to amino acid residues P334 to C349.",{"$nulls":3},"P36507","P36507","P36507"]
[1429,710,"PK049-2","MEK2 (MKK2, MAP2K2)","T394","MAPK/ERK protein-serine kinase 2 (MKK2); Dual specificity mitogen-activated protein kinase kinase 2",1,246,12,465,{"v":108.81,"d":"109"},{"v":191.19515407280733,"d":"191"},{"v":164.70616457140517,"d":"165"},{"v":26.48898950140216,"d":"26"},{"v":16.082573211713864,"d":"16"},1,870,16,355,{"v":303.17,"d":"303"},{"v":529.7032150945573,"d":"530"},{"v":284.81790860111994,"d":"285"},{"v":244.88530649343738,"d":"245"},{"v":85.97960279119698,"d":"86"},{"v":102.06217600291085,"d":"102"},{"v":72.92486249210341,"d":"73"},null,1,43,8,537,{"v":18.795,"d":"19"},{"v":32.15526414025987,"d":"32"},{"v":35.71809135878028,"d":"36"},{"v":3.562827218520411,"d":"4"},{"v":9.974853310980714,"d":"10"},{"v":26.057426522694577,"d":"26"},{"v":-78.31405311894359,"d":"-78"},null,null,"MEK2","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues that encompass the T394 phosphosite.","The effect of T394 phosphorylation is unclear. However, based on similarity with the T386 phosphosite in MEK1, phosphorylation likely promotes binding to ERK2. This is one of the major in vivo phosphorylation sites in MEK2 (≥111 reports from high throughput mass spectrometry studies).","ERK2 (MAPK1)","Protein kinase, dual-specificity, STE group, STE7 family, N/A subfamily","P36507","P36507","P36507",null,"GO:0005911; GO:0009898; GO:0005829; GO:0005769; GO:0005783; GO:0005576; GO:0005925; GO:0005794; GO:0005770; GO:0005874; GO:0005739; GO:0005634; GO:0048471; GO:0005778","GO:0005524; GO:0004708; GO:0046872; GO:0030165; GO:0004712; GO:0043539; GO:0004674; GO:0004713; GO:0097110","GO:0000187; GO:0070371; GO:0000165; GO:0010629; GO:0036289; GO:1903800; GO:0071902; GO:0045893; GO:0042981; GO:2000641; GO:0090170; GO:0007346; GO:0032872"]
[1434,712,"NK104-2","MEK5 (MAP2K5, MKK5)","Pan-specific","MAPK/ERK protein-serine kinase 5 (MKK5); Dual specificity mitogen-activated protein kinase kinase 5",0,181,10,428,{"v":73.188,"d":"73"},{"v":128.60206723904625,"d":"129"},{"$nulls":3},0,131,12,436,{"v":51.884,"d":"52"},{"v":90.65251051214175,"d":"91"},{"$nulls":6},0,180,14,430,{"v":71.38,"d":"71"},{"v":122.119859235528,"d":"122"},{"$nulls":7},"MEK5","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"AFEYEDEDGDRITVRSC","Corresponds to amino acid residues A59 to S74; Post-N-terminus.",{"$nulls":3},"Q13163","Q13163","Q13163","Q13163"]
[1439,715,"NK107-3","MEKK1 (MAP3K1)","Pan-specific","MAPK/ERK kinase kinase 1; Mitogen-activated protein kinase kinase kinase 1 [Fragment]",0,3678,14,754,{"v":2762.656,"d":"2763"},{"v":4854.3924232163,"d":"4854"},{"v":4660.380562664504,"d":"4660"},{"v":194.0118605517955,"d":"194"},{"v":4.163004671894694,"d":"4"},0,3218,16,768,{"v":2459.136,"d":"2459"},{"v":4296.639659447734,"d":"4297"},{"v":4386.9951433854585,"d":"4387"},{"v":90.35548393772478,"d":"90"},{"v":2.0596212438019057,"d":"2"},{"v":6.222625915696599,"d":"6"},{"v":-5.866160833928589,"d":"-6"},null,0,3782,14,687,{"v":2588.616,"d":"2589"},{"v":4428.711425256873,"d":"4429"},{"v":4623.959489355995,"d":"4624"},{"v":195.24806409912253,"d":"195"},{"v":4.22252972908973,"d":"4"},{"v":8.385534400984422,"d":"8"},{"v":-0.7815042745712191,"d":"-1"},null,null,"MEKK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"CGSTHFTRMRRRLMAIAD","Corresponds to amino acid residues G35 to D51; N-terminus.",null,null,"EC 2.7.11.25; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE11 family","Q13233","Q13233","Q13233","Q13233","GO:0005737; GO:0005829","GO:0005524; GO:0004709; GO:0004672; GO:0019901; GO:0004674; GO:0008270","GO:0032147; GO:0071260; GO:0038095; GO:0002755; GO:0006468; GO:0042981; GO:0007346; GO:0023014; GO:0031098"]
[1442,716,"NK108-3","MEKK2 (MAP3K2)","Pan-specific","MAPK/ERK kinase kinase 2; Mitogen-activated protein kinase kinase kinase 2",0,7602,14,733,{"v":5562.004,"d":"5562"},{"v":9773.258080448219,"d":"9773"},{"$nulls":3},0,8574,16,733,{"v":6273.014,"d":"6273"},{"v":10960.30505700818,"d":"10960"},{"$nulls":6},0,5122,14,654,{"v":3340.632,"d":"3341"},{"v":5715.29153260998,"d":"5715"},{"$nulls":7},"MEKK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"CSSSPKKQNDVRVKFE","Corresponds to amino acid residues S39 to E45.",{"$nulls":3},"Q9Y2U5","Q9Y2U5","Q9Y2U5","Q9Y2U5"]
[1446,718,"PK700","MEKK2 (MAP3K2)","S239","MAPK/ERK kinase kinase 2; Mitogen-activated protein kinase kinase kinase 2",0,6666,20,803,{"v":5336.738,"d":"5337"},{"v":9377.432627113369,"d":"9377"},{"$nulls":3},0,8776,20,816,{"v":7144.896,"d":"7145"},{"v":12483.67049086731,"d":"12484"},{"$nulls":6},0,6432,26,760,{"v":4868.56,"d":"4869"},{"v":8329.334013445254,"d":"8329"},{"$nulls":7},"MEKK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"RAQ(pS)YPD(bA)C","Corresponds to amino acid residues R236 to D242; In the region between the PB1 domain and the protein kinase catalytic domain.","The effect of S239 phosphorylation is unclear. This is a major site of phosphorylation for MEKK2 (≥281 reports from high throughput mass spectrometry studies).",null,null,"Q9Y2U5","Q9Y2U5","Q9Y2U5","Q9Y2U5"]
[1451,721,"NK229-3","MELK","Pan-specific","Maternal embryonic leucine zipper kinase",0,8856,24,995,{"v":8787.84,"d":"8788"},{"v":15441.525804311912,"d":"15442"},{"v":15499.657495169284,"d":"15500"},{"v":58.13169085737172,"d":"58"},{"v":0.37505145436593934,"d":"0"},0,8492,26,965,{"v":8169.69,"d":"8170"},{"v":14274.206086769318,"d":"14274"},{"v":14858.83300990391,"d":"14859"},{"v":584.6269231345923,"d":"585"},{"v":3.934541311184524,"d":"4"},{"v":4.309592765550463,"d":"4"},{"v":-4.13444287698033,"d":"-4"},null,0,8922,22,966,{"v":8597.4,"d":"8597"},{"v":14708.787864829483,"d":"14709"},{"v":14210.986908511568,"d":"14211"},{"v":497.8009563179148,"d":"498"},{"v":3.5029302294252385,"d":"4"},{"v":3.8779816837911776,"d":"4"},{"v":-8.31418750420356,"d":"-8"},null,null,"MELK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","MELK",{"$nulls":5},"CKKRISMKNLLNHPWI","Corresponds to amino acid residues K249 to I263; Kinase last alpha-chain.",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; CAMK domain target; CAMK</A> group; CAMKL family; MELK subfamily","Q14680","Q14680","Q14680",null,"GO:0005938; GO:0016020; GO:0005634; GO:0005886","GO:0005524; GO:0005509; GO:0008289; GO:0004715; GO:0004674","GO:0006915; GO:0008283; GO:0000086; GO:0030097; GO:0035556; GO:0008631; GO:0061351; GO:0043065; GO:0046777"]
[1456,723,"PK702","MERTK (MER)","Y749","Tyrosine-protein kinase Mer; Proto-oncogene tyrosine-protein kinase MER",0,3590,18,788,{"v":2814.736,"d":"2815"},{"v":4945.9046337126865,"d":"4946"},{"$nulls":3},0,4136,22,783,{"v":3221.262,"d":"3221"},{"v":5628.237748002521,"d":"5628"},{"$nulls":6},0,3748,22,747,{"v":2783.322,"d":"2783"},{"v":4761.82251116767,"d":"4762"},{"$nulls":7},"MERTK","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Axl",{"$nulls":6},"KKI(pY)SGD(bA)C","Corresponds to amino acid residues K746 to D752; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y749 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in MERTK (≥445 reports from high throughput mass spectrometry studies).","MER (MERTK)",null,"Q12866","Q12866","Q12866","Q12866"]
[1457,724,"PK703","MERTK (MER)","Y749+Y753","Tyrosine-protein kinase Mer; Proto-oncogene tyrosine-protein kinase MER",0,9294,24,901,{"v":8352.27,"d":"8352"},{"v":14676.165329544036,"d":"14676"},{"v":14290.427656555956,"d":"14290"},{"v":385.7376729880798,"d":"386"},{"v":2.699273123650128,"d":"3"},0,8540,24,826,{"v":7034.216,"d":"7034"},{"v":12290.28871877025,"d":"12290"},{"v":13685.122017803325,"d":"13685"},{"v":1394.8332990330746,"d":"1395"},{"v":10.192333668771827,"d":"10"},{"v":12.891606792421955,"d":"13"},{"v":-4.235741947687174,"d":"-4"},null,0,9452,22,831,{"v":7836.33,"d":"7836"},{"v":13406.717799427643,"d":"13407"},{"v":13363.738041740406,"d":"13364"},{"v":42.979757687237,"d":"43"},{"v":0.3216147873670801,"d":"0"},{"v":3.0208879110172084,"d":"3"},{"v":-6.484687772030512,"d":"-6"},null,null,"MERTK","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Axl",{"$nulls":6},"KI(pY)SGD(pY)Y(bA)C","Corresponds to amino acid residues K747 to Y754; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y749 and Y753 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in MERTK (≥449 and ≥403 reports, respectively, from high throughput mass spectrometry studies).","Y749: MER (MERTK). Y753: MER (MERTK). ","EC 2.7.10.1; Receptor tyrosine kinase; TK domain target; TK</A> group; Axl family","Q12866","Q12866","Q12866","Q12866","GO:0005737; GO:0005615; GO:0005887; GO:0001750; GO:0005886; GO:0016028","GO:0005524; GO:0004714","GO:0043277; GO:0007267; GO:0007166; GO:0050900; GO:0001779; GO:0001818; GO:2000107; GO:0051250; GO:0097350; GO:0006909; GO:0030168; GO:0050766; GO:0043491; GO:0006468; GO:0060041; GO:0032940; GO:0007283; GO:0034446; GO:0060068"]
[1465,728,"PK708","Met","Y1003","Hepatocyte growth factor (HGF) receptor-tyrosine kinase",0,5826,18,780,{"v":4530.24,"d":"4530"},{"v":7960.297167418386,"d":"7960"},{"v":7244.9837506258955,"d":"7245"},{"v":715.3134167924909,"d":"715"},{"v":9.873223203995384,"d":"10"},0,5274,18,734,{"v":3857.904,"d":"3858"},{"v":6740.588291473936,"d":"6741"},{"v":6762.63465215627,"d":"6763"},{"v":22.046360682334125,"d":"22"},{"v":0.32600253919239347,"d":"0"},{"v":10.199225743187776,"d":"10"},{"v":-6.657697450707943,"d":"-7"},null,0,5852,18,779,{"v":4544.686,"d":"4545"},{"v":7775.236965391913,"d":"7775"},{"v":7222.448711010684,"d":"7222"},{"v":552.7882543812293,"d":"553"},{"v":7.653751192978345,"d":"8"},{"v":17.526974396973728,"d":"18"},{"v":-0.31104334241280185,"d":"-0"},null,null,"MET","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Met",{"$nulls":6},"SVD(pY)RAT(bA)C","Corresponds to amino acid residues S1000 to T1006; In the region between the Transmembrane domain and the protein kinase catalytic domain.","Y1003 phosphorylation stimulates phosphotransferase activity and induces interaction with CBL, PTP1B and PTPN2. Phosphorylation regulates cell growth, receptor desensitization, protein stabililzation, and ubquitination. This is one of the major in vivo phosphorylation sites in Met (≥370 reports from high throughput mass spectrometry studies).","Met","Receptor tyrosine kinase; EC 2.7.10.1; TK group; Met family","P08581","P08581","P08581","P08581","GO:0009925; GO:0009986; GO:0005576; GO:0016021; GO:0005887; GO:0005622; GO:0005886","GO:0005524; GO:0005008; GO:0042802; GO:0046934; GO:0019903; GO:0004713; GO:0005088","GO:0048754; GO:0008283; GO:0007166; GO:0001886; GO:0035635; GO:0061436; GO:0000165; GO:0010507; GO:1905098; GO:1901299; GO:0035024; GO:0051497; GO:0070495; GO:0050918; GO:2001028; GO:0031116; GO:0051897; GO:0045944; GO:0071526; GO:0007165"]
[1468,729,"PK055-1","Met","Y1230+Y1234+Y1235","Hepatocyte growth factor (HGF) receptor-tyrosine kinase",0,398,12,314,{"v":121.204,"d":"121"},{"v":212.97323273817238,"d":"213"},{"$nulls":3},0,382,12,291,{"v":107.67,"d":"108"},{"v":188.12265451473098,"d":"188"},{"$nulls":6},0,303,12,396,{"v":115.236,"d":"115"},{"v":197.1505197375358,"d":"197"},{"$nulls":7},"MET","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Met",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues that encompass the Y1230 phosphosite.","Y1230, Y1234 and Y1235 phosphorylation stimulates phosphotransferase activity. Phosphorylation at Y1234 induces binding to Grb2, PTP1B and PTPN2. Phosphorylation at Y1235 induces binding to PTP1B and PTPN2. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are three of the major in vivo phosphorylation sites in Met (≥114, ≥746 and ≥446 reports, respectively, from high throughput mass spectrometry studies).","Y1230: Met. Y1234: Met; Ron (MST1R). Y1235: Met; Ron (MST1R). ",null,"P08581","P08581","P08581","P08581"]
[1473,732,"PK711","Met","Y1234+Y1235","Hepatocyte growth factor (HGF) receptor-tyrosine kinase",0,7032,20,742,{"v":5202.904,"d":"5203"},{"v":9142.266629041684,"d":"9142"},{"v":9068.304801771832,"d":"9068"},{"v":73.96182726985171,"d":"74"},{"v":0.8156080864794102,"d":"1"},0,7436,62,509,{"v":3753.366,"d":"3753"},{"v":6557.937914789057,"d":"6558"},{"v":8112.996084138507,"d":"8113"},{"v":1555.0581693494505,"d":"1555"},{"v":19.167495623345626,"d":"19"},{"v":19.983103709825038,"d":"20"},{"v":-10.53458985461836,"d":"-11"},null,0,7572,14,732,{"v":5532.456,"d":"5532"},{"v":9465.154776502555,"d":"9465"},{"v":9313.680300500942,"d":"9314"},{"v":151.47447600161286,"d":"151"},{"v":1.6263654228443474,"d":"2"},{"v":2.4419735093237573,"d":"2"},{"v":2.705858526956078,"d":"3"},null,null,"MET","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Met",{"$nulls":6},"KE(pY)(pY)SVH(bA)C","Corresponds to amino acid residues K1232 to H1238; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y1234 and Y1235 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. Y1234 and Y1235 phosphorylation induces binding to PTPN1 and PTPN2, and Y1234 phosphorylation also induces interaction with Grb2. These are two of the major in vivo phosphorylation sites in Met (≥746 and ≥446 reports, respectively, from high throughput mass spectrometry studies).","Y1234: Met; Ron (MST1R). Y1235: Met; Ron (MST1R). ","Receptor tyrosine kinase; EC 2.7.10.1; TK group; Met family","P08581","P08581","P08581","P08581","GO:0009925; GO:0009986; GO:0005576; GO:0016021; GO:0005887; GO:0005622; GO:0005886","GO:0005524; GO:0005008; GO:0042802; GO:0046934; GO:0019903; GO:0004713; GO:0005088","GO:0048754; GO:0008283; GO:0007166; GO:0001886; GO:0035635; GO:0061436; GO:0000165; GO:0010507; GO:1905098; GO:1901299; GO:0035024; GO:0051497; GO:0070495; GO:0050918; GO:2001028; GO:0031116; GO:0051897; GO:0045944; GO:0071526; GO:0007165"]
[1474,732,"PK711","Met","Y1234+Y1235","Hepatocyte growth factor (HGF) receptor-tyrosine kinase",0,6898,18,744,{"v":5118.72,"d":"5119"},{"v":8994.34297450198,"d":"8994"},{"$nulls":3},0,7688,24,722,{"v":5533.408,"d":"5533"},{"v":9668.054253487959,"d":"9668"},{"$nulls":6},0,7263,26,740,{"v":5355.38,"d":"5355"},{"v":9162.205824499328,"d":"9162"},{"$nulls":7},"MET","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Met",{"$nulls":6},"KE(pY)(pY)SVH(bA)C","Corresponds to amino acid residues K1232 to H1238; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y1234 and Y1235 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. Y1234 and Y1235 phosphorylation induces binding to PTPN1 and PTPN2, and Y1234 phosphorylation also induces interaction with Grb2. These are two of the major in vivo phosphorylation sites in Met (≥746 and ≥446 reports, respectively, from high throughput mass spectrometry studies).","Y1234: Met; Ron (MST1R). Y1235: Met; Ron (MST1R). ",null,"P08581","P08581","P08581","P08581"]
[1479,735,"PK707","Met","T1355+Y1356","Hepatocyte growth factor (HGF) receptor-tyrosine kinase",0,1572,14,617,{"v":961.286,"d":"961"},{"v":1689.1207138868915,"d":"1689"},{"v":1370.4015021975329,"d":"1370"},{"v":318.71921168935864,"d":"319"},{"v":23.257360064059366,"d":"23"},0,984,18,559,{"v":539.994,"d":"540"},{"v":943.485694269784,"d":"943"},{"v":1014.7816818132117,"d":"1015"},{"v":71.29598754342771,"d":"71"},{"v":7.025746406462133,"d":"7"},{"v":30.2831064705215,"d":"30"},{"v":-25.950046013088894,"d":"-26"},null,0,1586,16,531,{"v":833.67,"d":"834"},{"v":1426.277151147137,"d":"1426"},{"v":1456.6086583534507,"d":"1457"},{"v":30.331507206313745,"d":"30"},{"v":2.082337423464203,"d":"2"},{"v":25.33969748752357,"d":"25"},{"v":6.290649566399239,"d":"6"},null,null,"MET","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Met",{"$nulls":6},"NA(pT)(pY)VNV(bA)C","Corresponds to amino acid residues N1353 to V1359; In the C-terminus of the kinase. ","Y1356 phosphorylation stimulates phosphotransferase activity, and induces binding to FAK, GAB1, Grb2, INPPL1 (SHIP2), Met, PI3R1; PLCG1;  Ron; Shc1 and Src.  Y1356 is one of the major in vivo phosphorylation sites in Met (≥119 reports from high throughput mass spectrometry studies), whereas T1355 is less frequently observed (≥40 reports). The effect of T1355 phosphorylation is unknown.","Abl1; Met; Ron (MST1R)","Receptor tyrosine kinase; EC 2.7.10.1; TK group; Met family","P08581","P08581","P08581","P08581","GO:0009925; GO:0009986; GO:0005576; GO:0016021; GO:0005887; GO:0005622; GO:0005886","GO:0005524; GO:0005008; GO:0042802; GO:0046934; GO:0019903; GO:0004713; GO:0005088","GO:0048754; GO:0008283; GO:0007166; GO:0001886; GO:0035635; GO:0061436; GO:0000165; GO:0010507; GO:1905098; GO:1901299; GO:0035024; GO:0051497; GO:0070495; GO:0050918; GO:2001028; GO:0031116; GO:0051897; GO:0045944; GO:0071526; GO:0007165"]
[1483,737,"NK101-3","MKK3 (MAP2K3, MEK3)","Pan-specific","MAPK/ERK protein-serine kinase 3 beta isoform (MKK3 beta); Dual specificity mitogen-activated protein kinase kinase 3",0,1238,18,681,{"v":830.82,"d":"831"},{"v":1459.8727865708097,"d":"1460"},{"v":1445.0811239755988,"d":"1445"},{"v":14.791662595210937,"d":"15"},{"v":1.0235870048954223,"d":"1"},0,998,16,641,{"v":629.462,"d":"629"},{"v":1099.8055387401466,"d":"1100"},{"v":1285.0120911801578,"d":"1285"},{"v":185.20655244001114,"d":"185"},{"v":14.412825662201906,"d":"14"},{"v":15.436412667097327,"d":"15"},{"v":-11.076819850436564,"d":"-11"},null,0,1137,18,647,{"v":723.993,"d":"724"},{"v":1238.6371987602638,"d":"1239"},{"v":1234.250601406945,"d":"1234"},{"v":4.386597353318848,"d":"4"},{"v":0.3554057294619492,"d":"0"},{"v":1.3789927343573716,"d":"1"},{"v":-14.589528509557496,"d":"-15"},null,null,"MKK3","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"Epitope undefined.",{"$nulls":3},"Protein kinase, dual-specificity, STE group, STE7 family, N/A subfamily","P46734","P46734","P46734",null,"GO:0005737; GO:0005829; GO:0016020; GO:0005654","GO:0005524; GO:0004708; GO:0019901; GO:0004674; GO:0004713","GO:0000187; GO:0032147; GO:0060048; GO:0035924; GO:0006954; GO:0038066; GO:0043536; GO:0045860; GO:0045893; GO:0042981; GO:0042035; GO:0007346; GO:0007165; GO:0023014; GO:0031098"]
[1490,740,"PK051-4","MKK3 (MAP2K3, MEK3)","S218","MAPK/ERK protein-serine kinase 3 beta isoform (MKK3 beta); Dual specificity mitogen-activated protein kinase kinase 3",0,786,14,359,{"v":277.148,"d":"277"},{"v":486.98974874524777,"d":"487"},{"$nulls":3},0,914,14,326,{"v":293.4,"d":"293"},{"v":512.6329231412841,"d":"513"},{"$nulls":6},0,765,14,334,{"v":250.834,"d":"251"},{"v":429.1371920914042,"d":"429"},{"$nulls":7},"MKK3","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"VD(pS)VA","Corresponds to amino acid residues V187 to A199.","S218 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in MKK3 (≥74 reports from high throughput mass spectrometry studies).","ASK1 (MAP3K5); COT (MAP3K8); MEKK3 (MAP3K3); MKK3 (MAP2K3, MEK3); MLK3 (MAP3K11)",null,"P46734","P46734","P46734"]
[1491,741,"PK713","MKK3 (MAP2K3, MEK3)","S218","MAPK/ERK protein-serine kinase 3 beta isoform (MKK3 beta); Dual specificity mitogen-activated protein kinase kinase 3",0,20338,36,1123,{"v":22799.146,"d":"22799"},{"v":40061.44869220135,"d":"40061"},{"v":38219.37185505622,"d":"38219"},{"v":1842.076837145134,"d":"1842"},{"v":4.819746499578949,"d":"5"},0,19844,23,1103,{"v":21862.563,"d":"21863"},{"v":38198.601152182964,"d":"38199"},{"v":38093.8494890693,"d":"38094"},{"v":104.75166311366775,"d":"105"},{"v":0.27498313905956223,"d":"0"},{"v":5.094729638638511,"d":"5"},{"v":-0.3284260308174538,"d":"-0"},null,0,19752,32,1137,{"v":22421.64,"d":"22422"},{"v":38359.87000041586,"d":"38360"},{"v":36176.63791456261,"d":"36177"},{"v":2183.2320858532476,"d":"2183"},{"v":6.034922568010128,"d":"6"},{"v":10.854669067589077,"d":"11"},{"v":-5.344760631442355,"d":"-5"},null,null,"MKK3","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"YLVD(pS)VAK(bA)C","Corresponds to amino acid residues Y214 to K221; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S218 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in MKK3 (≥74 reports from high throughput mass spectrometry studies).","ASK1 (MAP3K5); COT (MAP3K8); MEKK3 (MAP3K3); MKK3 (MAP2K3, MEK3); MLK3 (MAP3K11)","Protein kinase, dual-specificity, STE group, STE7 family, N/A subfamily","P46734","P46734","P46734",null,"GO:0005737; GO:0005829; GO:0016020; GO:0005654","GO:0005524; GO:0004708; GO:0019901; GO:0004674; GO:0004713","GO:0000187; GO:0032147; GO:0060048; GO:0035924; GO:0006954; GO:0038066; GO:0043536; GO:0045860; GO:0045893; GO:0042981; GO:0042035; GO:0007346; GO:0007165; GO:0023014; GO:0031098"]
[1496,743,"NK103-5","MKK4 (MAP2K4, MEK4)","Pan-specific","MAPK/ERK protein-serine kinase 4 (MKK4); Dual specificity mitogen-activated protein kinase kinase 4",0,8888,14,925,{"v":8208.45,"d":"8208"},{"v":14423.452462539615,"d":"14423"},{"$nulls":3},0,9707,22,890,{"v":8619.65,"d":"8620"},{"v":15060.383012797443,"d":"15060"},{"$nulls":6},0,9116,20,814,{"v":7404.144,"d":"7404"},{"v":12667.31609750041,"d":"12667"},{"$nulls":7},"MKK4","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"CGDPPQLSNSEEREFS","Corresponds to amino acid residues G323 to S337.",{"$nulls":3},"P45985","P45985","P45985","P45985"]
[1501,746,"PK715","MKK4 (MAP2K4, MEK4)","S257","MAPK/ERK protein-serine kinase 4 (MKK4); Dual specificity mitogen-activated protein kinase kinase 4",0,7712,23,893,{"v":6866.277,"d":"6866"},{"v":12065.057337759152,"d":"12065"},{"v":11923.632491025148,"d":"11924"},{"v":141.42484673400395,"d":"141"},{"v":1.1860886088233067,"d":"1"},0,7380,20,784,{"v":5770.24,"d":"5770"},{"v":10081.850710384333,"d":"10082"},{"v":10727.313917605006,"d":"10727"},{"v":645.4632072206732,"d":"645"},{"v":6.017006793857116,"d":"6"},{"v":7.2030954026804235,"d":"7"},{"v":-10.033172142135399,"d":"-10"},null,0,7800,20,821,{"v":6387.38,"d":"6387"},{"v":10927.794150796119,"d":"10928"},{"v":10998.764129231784,"d":"10999"},{"v":70.96997843566533,"d":"71"},{"v":0.6452541176607837,"d":"1"},{"v":1.8313427264840905,"d":"2"},{"v":-7.756599027096044,"d":"-8"},null,null,"MKK4","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"LVD(pS)IAK(bA)C","Corresponds to amino acid residues L254 to K260; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S257 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in MKK3 (≥50 reports from high throughput mass spectrometry studies).","ASK1 (MAP3K5); MEKK1 (MAP3K1); MEKK4 (MAP3K4); MLK2 (MAP3K10); MLK3 (MAP3K11)","Protein kinase, dual-specificity; EC 2.7.12.2; STE group; STE7 family","P45985","P45985","P45985","P45985","GO:0030424; GO:0005737; GO:0005829; GO:0032839; GO:0005634; GO:0043204","GO:0005524; GO:0008545; GO:0031435; GO:0004672; GO:0004674; GO:0004713","GO:0032147; GO:0006915; GO:0061049; GO:0071260; GO:0072709; GO:0007254; GO:2000672; GO:0045740; GO:0043525; GO:0051770; GO:0034393; GO:0042981; GO:0007346; GO:0009611; GO:0007165; GO:0023014; GO:0031098"]
[1506,748,"NK105-5","MKK6 (MAP2K6, MEK6)","Pan-specific","MAPK/ERK protein-serine kinase 6 (MKK6); Dual specificity mitogen-activated protein kinase kinase 6",0,3246,12,770,{"v":2490.18,"d":"2490"},{"v":4375.612064782863,"d":"4376"},{"$nulls":3},0,3698,12,736,{"v":2712.896,"d":"2713"},{"v":4740.012974295492,"d":"4740"},{"$nulls":6},0,3490,12,708,{"v":2462.424,"d":"2462"},{"v":4212.816927125046,"d":"4213"},{"$nulls":7},"MKK6","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"HESKGTDVASFVKLC","Corresponds to amino acid residues H317 to L330; C-terminus.",{"$nulls":3},"P52564","P52564","P52564"]
[1508,749,"NK106-4","MKK7 (MEK7, MAP2K7)","Pan-specific","MAPK/ERK protein-serine kinase 7 (MKK7); Dual specificity mitogen-activated protein kinase kinase 7",0,4974,14,844,{"v":4186.24,"d":"4186"},{"v":7355.838634185727,"d":"7356"},{"$nulls":3},0,5149,18,872,{"v":4474.232,"d":"4474"},{"v":7817.445906517635,"d":"7817"},{"$nulls":6},0,5194,14,782,{"v":4050.76,"d":"4051"},{"v":6930.207915339135,"d":"6930"},{"$nulls":7},"MKK7","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"CKYNKLLEHSFIKRYE","Corresponds to amino acid residues K370 to E384; Kinase last alpha-chain.",{"$nulls":3},"O14733","O14733","O14733","O14733"]
[1513,753,"NK278-1","MLK1 (MAP3K9)","Pan-specific","Mixed-lineage protein-serine kinase 1; Mitogen-activated protein kinase kinase kinase 9",0,1386,12,721,{"v":990.654,"d":"991"},{"v":1740.7246040147309,"d":"1741"},{"v":1633.5931147337365,"d":"1634"},{"v":107.1314892809944,"d":"107"},{"v":6.558027719066143,"d":"7"},0,1161,18,705,{"v":805.815,"d":"806"},{"v":1407.9321709648736,"d":"1408"},{"v":1348.7653509485312,"d":"1349"},{"v":59.1668200163424,"d":"59"},{"v":4.3867393223537965,"d":"4"},{"v":10.94476704141994,"d":"11"},{"v":-17.435661378361658,"d":"-17"},null,0,1398,14,652,{"v":902.368,"d":"902"},{"v":1543.808533743975,"d":"1544"},{"v":1536.9925416005967,"d":"1537"},{"v":6.815992143378253,"d":"7"},{"v":0.44346292899249856,"d":"0"},{"v":7.001490648058641,"d":"7"},{"v":-5.913380281899933,"d":"-6"},null,null,"MLK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","MLK","MLK",{"$nulls":5},"CAELNTHRPAPYEIQQEFWS","Corresponds to amino acid residues A1086 to S1104; C-terminus.",null,null,"Protein-serine kinase, TKL group, MLK family, MLK subfamily","P80192","P80192","P80192",null,"GO:0005737","GO:0005524; GO:0004706; GO:0004708; GO:0042803; GO:0004674","GO:0007257; GO:0006915; GO:0043065; GO:0046777; GO:0006468; GO:0006355; GO:0006351"]
[1518,755,"NK208","MLK3 (MAP3K11)","Pan-specific","Mixed-lineage protein-serine kinase 3",0,328,18,593,{"v":183.83,"d":"184"},{"v":323.0163144306973,"d":"323"},{"$nulls":3},0,242,16,600,{"v":135.6,"d":"136"},{"v":236.9223734763399,"d":"237"},{"$nulls":6},0,296,14,554,{"v":156.228,"d":"156"},{"v":267.2813304657897,"d":"267"},{"$nulls":7},"MLK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","MLK","MLK",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues at the C-terminus of human MLK3",{"$nulls":3},"Q16584","Q16584","Q16584","Q16584"]
[1523,758,"NK280-1","MLK4","Pan-specific","Mixed-lineage protein-serine kinase 4",0,2874,14,797,{"v":2279.42,"d":"2279"},{"v":4005.2757843639233,"d":"4005"},{"v":3840.103975864301,"d":"3840"},{"v":165.17180849962233,"d":"165"},{"v":4.301232714993003,"d":"4"},0,2704,14,661,{"v":1778.09,"d":"1778"},{"v":3106.7057747385343,"d":"3107"},{"v":3552.668462429154,"d":"3553"},{"v":445.96268769061953,"d":"446"},{"v":12.552893477307208,"d":"13"},{"v":16.85412619230021,"d":"17"},{"v":-7.485097154705386,"d":"-7"},null,0,2898,14,711,{"v":2050.524,"d":"2051"},{"v":3508.121353867635,"d":"3508"},{"v":3559.498776573891,"d":"3559"},{"v":51.37742270625586,"d":"51"},{"v":1.4433892503176513,"d":"1"},{"v":5.744621965310655,"d":"6"},{"v":-7.3072292066584765,"d":"-7"},null,null,"MLK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","MLK","MLK",{"$nulls":5},"CMRSKTSRPSIYELEKEFLS","Corresponds to amino acid residues M1018 to S1036; C-terminus.",null,null,"EC 2.7.11.25; Protein kinase, Ser/Thr (non-receptor); TKL domain target; TKL</A> group; MLK family; MLK subfamily","Q5TCX8","Q5TCX8","Q5TCX8",null,"GO:0005737","GO:0005524; GO:0004706; GO:0042803","GO:0007257; GO:0046777; GO:0006468"]
[1524,758,"NK280-1","MLK4","Pan-specific","Mixed-lineage protein-serine kinase 4",0,2594,12,810,{"v":2091.42,"d":"2091"},{"v":3674.932167364679,"d":"3675"},{"$nulls":3},0,2770,16,831,{"v":2288.574,"d":"2289"},{"v":3998.631150119773,"d":"3999"},{"$nulls":6},0,2851,18,745,{"v":2110.585,"d":"2111"},{"v":3610.876199280147,"d":"3611"},{"$nulls":7},"MLK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","MLK","MLK",{"$nulls":5},"CMRSKTSRPSIYELEKEFLS","Corresponds to amino acid residues M1018 to S1036; C-terminus.",{"$nulls":3},"Q5TCX8","Q5TCX8","Q5TCX8"]
[1530,761,"NK111","Mnk2","Pan-specific","MAP kinase-interacting serine-threonine kinase 2",0,130,10,661,{"v":79.32,"d":"79"},{"v":139.37689202329818,"d":"139"},{"$nulls":3},0,126,14,624,{"v":69.888,"d":"70"},{"v":122.10937195807114,"d":"122"},{"$nulls":6},0,188,16,626,{"v":107.672,"d":"108"},{"v":184.20971537696514,"d":"184"},{"$nulls":7},"MNK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","MAPKAPK","MNK",{"$nulls":5},"Epitope undefined.",{"$nulls":4},"Q9HBH9","Q9HBH9","Q9HBH9"]
[1535,764,"PK720","MOK (RAGE)","T159+Y161","MAPK-MAK-MRK overlapping kinase; MOK protein kinase",0,10369,16,788,{"v":8158.164,"d":"8158"},{"v":14335.09257357991,"d":"14335"},{"v":13166.226156381952,"d":"13166"},{"v":1168.866417197958,"d":"1169"},{"v":8.877763478423796,"d":"9"},0,10873,22,768,{"v":8333.568,"d":"8334"},{"v":14560.536210077249,"d":"14561"},{"v":14150.241172328711,"d":"14150"},{"v":410.29503774853765,"d":"410"},{"v":2.899562154112849,"d":"3"},{"v":11.777325632536645,"d":"12"},{"v":7.473781813095968,"d":"7"},null,0,8531,16,771,{"v":6565.065,"d":"6565"},{"v":11231.785005212827,"d":"11232"},{"v":11886.464985519537,"d":"11886"},{"v":654.6799803067097,"d":"655"},{"v":5.50777696400285,"d":"6"},{"v":14.385540442426645,"d":"14"},{"v":-9.720030293130634,"d":"-10"},null,null,"MOK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","RCK",{"$nulls":6},"QPY(pT)E(pY)IS(bA)C","Corresponds to amino acid residues Q156 to S163; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T159 and Y161 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major in vivo phosphorylation sites in MOK.",null,"Protein-serine kinase, CMGC group, RCK family","Q9UQ07","Q9UQ07","Q9UQ07",null,"GO:0097546; GO:0005929; GO:0005737; GO:0005634","GO:0005524; GO:0004693; GO:0046872; GO:0004672; GO:0004674","GO:0035556; GO:0006468; GO:0010468; GO:0007165"]
[1540,766,"NK112","Mos","Pan-specific","Moloney sarcoma oncogene-encoded protein-serine kinase",0,364,12,547,{"v":192.544,"d":"193"},{"v":338.32809250799204,"d":"338"},{"$nulls":3},0,324,12,470,{"v":146.64,"d":"147"},{"v":256.2116286620242,"d":"256"},{"$nulls":6},0,392,12,528,{"v":200.64,"d":"201"},{"v":343.2632187870039,"d":"343"},{"$nulls":7},"MOS","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","MOS",{"$nulls":6},"ASQRSFWAELNIARLRHDNIVRVVAASTRC","Corresponds to amino acid residues A148 to R177; Kinase Catalytic Subdomain III.",{"$nulls":3},"P00540","P00540","P00540","P00540"]
[1541,767,"PK722","Mos","Y263","Moloney sarcoma oncogene-encoded protein-serine kinase",0,208,12,477,{"v":93.492,"d":"93"},{"v":164.27917787496466,"d":"164"},{"v":187.04301595063066,"d":"187"},{"v":22.763838075666,"d":"23"},{"v":12.170375867802749,"d":"12"},0,180,14,492,{"v":81.672,"d":"82"},{"v":142.69855521061677,"d":"143"},{"v":141.39513271346817,"d":"141"},{"v":1.3034224971486026,"d":"1"},{"v":0.92182981983541,"d":"1"},{"v":13.09220568763816,"d":"13"},{"v":-24.405018816212348,"d":"-24"},null,0,198,12,415,{"v":77.19,"d":"77"},{"v":132.0598477779547,"d":"132"},{"v":150.66524801872757,"d":"151"},{"v":18.605400240772866,"d":"19"},{"v":12.348833248168967,"d":"12"},{"v":24.519209115971716,"d":"25"},{"v":-19.448877974414657,"d":"-19"},null,null,"MOS","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","MOS",{"$nulls":6},"ADI(pY)SFA(bA)C","Corresponds to amino acid residues A260 to A266; In the protein kinase catalytic domain near subdomain IX.","The effect of Y263 phosphorylation is unclear. This is a minor in vivo phosphorylation sites in Mos (≥1 report from high throughput mass spectrometry studies).",null,"Protein-serine kinase, Other group, MOS family","P00540","P00540","P00540","P00540","GO:0005737; GO:0005829","GO:0005524; GO:0004709; GO:0004674","GO:0000187; GO:0000186; GO:0006325; GO:0051296; GO:0035556; GO:0000212; GO:1902103; GO:0043410; GO:0046777"]
[1547,770,"NK283-1","MRCKb (CDC42BPB)","Pan-specific","Myotonic dystrophy kinase-related CDC42-binding kinase beta",0,272,8,526,{"v":138.864,"d":"139"},{"v":244.0044469733142,"d":"244"},{"v":225.51486872930064,"d":"226"},{"v":18.489578244013558,"d":"18"},{"v":8.198828905693015,"d":"8"},0,196,12,452,{"v":83.168,"d":"83"},{"v":145.3123890654885,"d":"145"},{"v":207.60060893592743,"d":"208"},{"v":62.28821987043892,"d":"62"},{"v":30.003871467286096,"d":"30"},{"v":38.20270037297911,"d":"38"},{"v":-7.943715593705178,"d":"-8"},null,0,317,10,505,{"v":155.035,"d":"155"},{"v":265.2402966738594,"d":"265"},{"v":242.27139543868736,"d":"242"},{"v":22.96890123517204,"d":"23"},{"v":9.48064925022685,"d":"9"},{"v":17.679478155919867,"d":"18"},{"v":7.430342311264894,"d":"7"},null,null,"MRCKb","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","DMPK","GEK",{"$nulls":5},"CFSDRGSLKSIMQSNTLTKD","Corresponds to amino acid residues C408 to D427; Right after kinase catalytic domain.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); AGC domain target; AGC</A> group; DMPK family; GEK subfamily","Q9Y5S2","Q9Y5S2","Q9Y5S2",null,"GO:0042641; GO:0005911; GO:0031252; GO:0005737; GO:0005856; GO:0070062; GO:0030027; GO:0005886","GO:0005524; GO:0000287; GO:0044877; GO:0004672; GO:0004674; GO:0017048","GO:0031532; GO:0031032; GO:0016477; GO:0007010; GO:0007163; GO:0035556; GO:0006468; GO:0007165"]
[1552,771,"PN708","MSH6","S14","DNA mismatch repair protein Msh6",0,6982,12,765,{"v":5332.05,"d":"5332"},{"v":9369.195122451176,"d":"9369"},{"$nulls":3},0,8544,18,754,{"v":6428.604,"d":"6429"},{"v":11232.1542612057,"d":"11232"},{"$nulls":6},0,7200,16,731,{"v":5251.504,"d":"5252"},{"v":8984.490463082268,"d":"8984"},{"$nulls":10},"DNA-binding",{"$nulls":9},"FPK(pS)PAL(bA)C","Corresponds to amino acid residues F11-L17; Near N-terminus.","The effect of S14 phosphorylation is unclear. This is the major in vivo phosphorylation site in MSH6 (≥123 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in fish.",null,null,"P52701","P52701",null,"P52701"]
[1557,774,"PK725","MSK2 (RPS6KA4)","T687","Ribosomal protein S6 kinase alpha-4",0,7745,12,780,{"v":6031.74,"d":"6032"},{"v":10598.653236165012,"d":"10599"},{"v":10196.319310716517,"d":"10196"},{"v":402.3339254484945,"d":"402"},{"v":3.9458741256331016,"d":"4"},0,7361,22,776,{"v":5695.064,"d":"5695"},{"v":9950.502064746745,"d":"9951"},{"v":10628.009197701607,"d":"10628"},{"v":677.5071329548628,"d":"678"},{"v":6.374732279130687,"d":"6"},{"v":10.320606404763788,"d":"10"},{"v":4.233781562052258,"d":"4"},null,0,7378,14,731,{"v":5383.084,"d":"5383"},{"v":9209.602974685107,"d":"9210"},{"v":8834.22726279288,"d":"8834"},{"v":375.3757118922276,"d":"375"},{"v":4.24910635334454,"d":"4"},{"v":8.19498047897764,"d":"8"},{"v":-13.358664106292295,"d":"-13"},null,null,"MSK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","MSK",{"$nulls":5},"PLR(pT)PDC(bA)C","Corresponds to amino acid residues P684 to C690; In the C-terminal part of the kinase after the second catalytic domain.","T687 phosphorylation stimulates phosphotransferase activity. This is one of the major in vivo phosphorylation sites in MSK2 (≥27 reports from high throughput mass spectrometry studies).","ERK1 (MAPK3); ERK2 (MAPK1); p38a MAPK (MAPK14)","EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); AGC group; RSK family; MSK subfamily","O75676","O75676","O75676",null,"GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0000287; GO:0004674; GO:0004711","GO:0043987; GO:0043988; GO:0016572; GO:0006954; GO:0070498; GO:0035556; GO:0001818; GO:0032793; GO:0035066; GO:0033129; GO:0051092; GO:0045944; GO:0006468; GO:0006355"]
[1558,774,"PK725","MSK2 (RPS6KA4)","T687","Ribosomal protein S6 kinase alpha-4",0,7210,18,775,{"v":5573.8,"d":"5574"},{"v":9793.985385268023,"d":"9794"},{"$nulls":3},0,8070,22,804,{"v":6470.592,"d":"6471"},{"v":11305.51633065647,"d":"11306"},{"$nulls":6},0,7192,16,689,{"v":4944.264,"d":"4944"},{"v":8458.851550900654,"d":"8459"},{"$nulls":7},"MSK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","MSK",{"$nulls":5},"PLR(pT)PDC(bA)C","Corresponds to amino acid residues P684 to C690; In the C-terminal part of the kinase after the second catalytic domain.","T687 phosphorylation stimulates phosphotransferase activity. This is one of the major in vivo phosphorylation sites in MSK2 (≥27 reports from high throughput mass spectrometry studies).","ERK1 (MAPK3); ERK2 (MAPK1); p38a MAPK (MAPK14)",null,"O75676","O75676","O75676"]
[1563,777,"PK871","MST1 (STK4, Krs2)","T183","Mammalian STE20-like protein-serine kinase 1 (KRS2); Serine-threonine-protein kinase 4",0,5410,14,676,{"v":3647.696,"d":"3648"},{"v":6409.537714647211,"d":"6410"},{"v":6410.679860131517,"d":"6411"},{"v":1.142145484305729,"d":"1"},{"v":0.017816292643293805,"d":"0"},0,5617,18,606,{"v":3392.994,"d":"3393"},{"v":5928.290499048529,"d":"5928"},{"v":6632.8986860962505,"d":"6633"},{"v":704.608187047721,"d":"705"},{"v":10.622930039994529,"d":"11"},{"v":10.640746332637823,"d":"11"},{"v":3.4663847019834577,"d":"3"},null,0,4554,14,622,{"v":2823.88,"d":"2824"},{"v":4831.210816727695,"d":"4831"},{"v":5477.734360652989,"d":"5478"},{"v":646.5235439252947,"d":"647"},{"v":11.802754594478436,"d":"12"},{"v":11.82057088712173,"d":"12"},{"v":-14.552988447927078,"d":"-15"},null,null,"MST1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","MST",{"$nulls":5},"AKRN(pT)VIGT(bA)C","Corresponds to amino acid residues A179 to T187; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T183 stimulates phosphotransferase activity. Phosphorylation induces protein ubquitination and degradation, and regulates molecular association. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the minor in vivo phosphorylation sites in MST1 (≥6 reports from high throughput mass spectrometry studies).","MST1 (STK4, KRS2)","EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE20 family; MST subfamily","Q13043","Q13043","Q13043","Q13043","GO:0005737; GO:0005829; GO:0016604; GO:0005654; GO:0005634; GO:0032991","GO:0005524; GO:0042802; GO:0000287; GO:0046983; GO:0042803; GO:0004672; GO:0043539; GO:0004674; GO:0008134","GO:0006915; GO:0001569; GO:0060706; GO:0000902; GO:0007417; GO:0003157; GO:0097284; GO:0035329; GO:0035556; GO:0030216; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0018105; GO:0043065; GO:1902043; GO:0045600; GO:0033138; GO:0032092; GO:0001934; GO:1905461; GO:0060215; GO:0046777; GO:0006468; GO:0050821; GO:0060800; GO:0007346; GO:0007165; GO:0023014; GO:0031098"]
[1570,781,"PK727","MST3 (STK24)","T184","Mammalian STE20-like protein-serine kinase 3; Serine-threonine-protein kinase 24",0,6954,16,731,{"v":5071.678,"d":"5072"},{"v":8911.683270082412,"d":"8912"},{"$nulls":3},0,7812,18,754,{"v":5876.676,"d":"5877"},{"v":10267.817301411826,"d":"10268"},{"$nulls":6},0,6183,14,656,{"v":4046.864,"d":"4047"},{"v":6923.542477239084,"d":"6924"},{"$nulls":7},"MST3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","YSK",{"$nulls":5},"LTD(pT)QIK(bA)C","Corresponds to amino acid residues L181 to K187; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T184 phosphorylation is predicted to stimulate phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in MST3 (≥51 reports from high throughput mass spectrometry studies).",null,null,"Q9Y6E0","Q9Y6E0","Q9Y6E0"]
[1574,779,"NK116-4","mTOR (FRAP)","Pan-specific","Mammalian target of rapamycin (FRAP); FKBP12-rapamycin complex-associated protein",0,14634,16,772,{"v":11285.096,"d":"11285"},{"v":19829.57144055162,"d":"19830"},{"$nulls":3},0,15642,16,726,{"v":11344.476,"d":"11344"},{"v":19821.240263756452,"d":"19821"},{"$nulls":6},0,14054,14,770,{"v":10810.8,"d":"10811"},{"v":18495.56422279975,"d":"18496"},{"$nulls":7},"FRAP1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PIKK","FRAP",{"$nulls":5},"FNQAYGRDLMEAQEWC","Corresponds to amino acid residues F2070 to C2085.",{"$nulls":3},"P42345","P42345","P42345","P42345"]
[1575,783,"NK116-6","mTOR (FRAP)","Pan-specific","Mammalian target of rapamycin (FRAP); FKBP12-rapamycin complex-associated protein",0,174,10,572,{"v":93.808,"d":"94"},{"v":164.83443629502722,"d":"165"},{"v":159.6736958528635,"d":"160"},{"v":5.160740442163728,"d":"5"},{"v":3.2320542307226736,"d":"3"},0,107,10,383,{"v":37.151,"d":"37"},{"v":64.9107898010288,"d":"65"},{"v":106.10051320455369,"d":"106"},{"v":41.189723403524894,"d":"41"},{"v":38.821417691085294,"d":"39"},{"v":42.05347192180797,"d":"42"},{"v":-33.55166445052825,"d":"-34"},null,0,174,10,405,{"v":66.42,"d":"66"},{"v":113.63408588433413,"d":"114"},{"v":118.60408015554748,"d":"119"},{"v":4.969994271213352,"d":"5"},{"v":4.190407500901553,"d":"4"},{"v":7.422461731624226,"d":"7"},{"v":-25.720965170845005,"d":"-26"},null,null,"FRAP1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PIKK","FRAP",{"$nulls":5},"Epitope undefined.",{"$nulls":3},"Protein kinase, Ser/Thr (non-receptor); Autophagy; EC 2.7.11.1; ATYPICAL group; PIKK family; FRAP subfamily","P42345","P42345","P42345","P42345","GO:0005737; GO:0005829; GO:0030425; GO:0012505; GO:0005789; GO:0098978; GO:0000139; GO:0005765; GO:0005764; GO:0016020; GO:0005741; GO:0043025; GO:0005654; GO:0005634; GO:0016605; GO:0099524; GO:0031931; GO:0031932","GO:0005524; GO:0042802; GO:0016301; GO:0051219; GO:0019904; GO:0004672; GO:0019901; GO:0004674; GO:0043022; GO:0001030; GO:0001031; GO:0001032; GO:0001156; GO:0045182","GO:0006207; GO:0032148; GO:0043276; GO:0007420; GO:0055013; GO:0060048; GO:0007569; GO:0007050; GO:0034198; GO:0071230; GO:0071456; GO:0071233; GO:1990253; GO:0031669; GO:0009267; GO:0006281; GO:0006112; GO:0007281; GO:0003007; GO:0003179; GO:0007616; GO:0060135; GO:0048255; GO:0035264; GO:0010507; GO:0070885; GO:0045792; GO:1904193; GO:1904213; GO:0016242; GO:0014736; GO:0001933; GO:0031397; GO:0018105; GO:0018107; GO:0016310; GO:0030838; GO:0061051; GO:1904056; GO:1904690; GO:0060999; GO:1904000; GO:0001938; GO:0010718; GO:0010628; GO:0060252; GO:1904197; GO:0051549; GO:0010592; GO:0046889; GO:0010831; GO:1901216; GO:0014042; GO:0045429; GO:0048714; GO:0050731; GO:0032516; GO:0051897; GO:0001934; GO:1904058; GO:1904206; GO:0048661; GO:0051496; GO:0045945; GO:1901838; GO:0045727; GO:1903691; GO:0009791; GO:0046777; GO:0030163; GO:0006468; GO:0032956; GO:0090335; GO:0043610; GO:0001558; GO:0008361; GO:1900034; GO:0031998; GO:0005979; GO:0043087; GO:0016241; GO:0090559; GO:0031641; GO:0045670; GO:0032095; GO:0099547; GO:0014823; GO:0043200; GO:0042220; GO:0032868; GO:0043278; GO:0007584; GO:0031529; GO:0035176; GO:0021510; GO:0002296; GO:0038202; GO:0031929; GO:0008542; GO:0050882; GO:0042060"]
[1580,785,"NK116-3","mTOR (FRAP)","Pan-specific","Mammalian target of rapamycin (FRAP); FKBP12-rapamycin complex-associated protein",0,4060,14,755,{"v":3054.73,"d":"3055"},{"v":5367.609346575009,"d":"5368"},{"$nulls":3},0,3994,18,724,{"v":2878.624,"d":"2879"},{"v":5029.575445619141,"d":"5030"},{"$nulls":6},0,3845,17,705,{"v":2698.74,"d":"2699"},{"v":4617.116123750194,"d":"4617"},{"$nulls":7},"FRAP1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PIKK","FRAP",{"$nulls":5},"CALNKKAIQIINRVRD","Corresponds to amino acid residues A2492 to D2505.",{"$nulls":3},"P42345","P42345","P42345","P42345"]
[1585,788,"PK730","mTOR (FRAP)","S2478+S2481","Mammalian target of rapamycin (FRAP); FKBP12-rapamycin complex-associated protein",0,1750,14,662,{"v":1149.232,"d":"1149"},{"v":2019.3694449535935,"d":"2019"},{"v":2038.2482312357206,"d":"2038"},{"v":18.878786282127066,"d":"19"},{"v":0.9262260598495159,"d":"1"},0,1292,14,611,{"v":780.858,"d":"781"},{"v":1364.326922625279,"d":"1364"},{"v":1880.723347185944,"d":"1881"},{"v":516.3964245606651,"d":"516"},{"v":27.457330464543322,"d":"27"},{"v":28.383556524392837,"d":"28"},{"v":-7.7284445356429785,"d":"-8"},null,0,2082,18,632,{"v":1304.448,"d":"1304"},{"v":2231.7036444391433,"d":"2232"},{"v":2094.377826827524,"d":"2094"},{"v":137.3258176116192,"d":"137"},{"v":6.556878890359272,"d":"7"},{"v":7.483104950208788,"d":"7"},{"v":2.75381549369844,"d":"3"},null,null,"FRAP1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PIKK","FRAP",{"$nulls":5},"VPE(pS)IH(pS)FIG(bA)C","Corresponds to amino acid residues V2475 to G2484; In the C-terminal fifth of the kinase at the end of the PI3_PI4-kinase domain.","S2478 and S2481 phosphorylation stimulate phosphotransferase activity. These are two of the major in vivo phosphorylation sites in mTOR (≥23 and ≥26 reports, respectively, from high throughput mass spectrometry studies).","S2481: mTOR (FRAP1)","Protein kinase, Ser/Thr (non-receptor); Autophagy; EC 2.7.11.1; ATYPICAL group; PIKK family; FRAP subfamily","P42345","P42345","P42345","P42345","GO:0005737; GO:0005829; GO:0030425; GO:0012505; GO:0005789; GO:0098978; GO:0000139; GO:0005765; GO:0005764; GO:0016020; GO:0005741; GO:0043025; GO:0005654; GO:0005634; GO:0016605; GO:0099524; GO:0031931; GO:0031932","GO:0005524; GO:0042802; GO:0016301; GO:0051219; GO:0019904; GO:0004672; GO:0019901; GO:0004674; GO:0043022; GO:0001030; GO:0001031; GO:0001032; GO:0001156; GO:0045182","GO:0006207; GO:0032148; GO:0043276; GO:0007420; GO:0055013; GO:0060048; GO:0007569; GO:0007050; GO:0034198; GO:0071230; GO:0071456; GO:0071233; GO:1990253; GO:0031669; GO:0009267; GO:0006281; GO:0006112; GO:0007281; GO:0003007; GO:0003179; GO:0007616; GO:0060135; GO:0048255; GO:0035264; GO:0010507; GO:0070885; GO:0045792; GO:1904193; GO:1904213; GO:0016242; GO:0014736; GO:0001933; GO:0031397; GO:0018105; GO:0018107; GO:0016310; GO:0030838; GO:0061051; GO:1904056; GO:1904690; GO:0060999; GO:1904000; GO:0001938; GO:0010718; GO:0010628; GO:0060252; GO:1904197; GO:0051549; GO:0010592; GO:0046889; GO:0010831; GO:1901216; GO:0014042; GO:0045429; GO:0048714; GO:0050731; GO:0032516; GO:0051897; GO:0001934; GO:1904058; GO:1904206; GO:0048661; GO:0051496; GO:0045945; GO:1901838; GO:0045727; GO:1903691; GO:0009791; GO:0046777; GO:0030163; GO:0006468; GO:0032956; GO:0090335; GO:0043610; GO:0001558; GO:0008361; GO:1900034; GO:0031998; GO:0005979; GO:0043087; GO:0016241; GO:0090559; GO:0031641; GO:0045670; GO:0032095; GO:0099547; GO:0014823; GO:0043200; GO:0042220; GO:0032868; GO:0043278; GO:0007584; GO:0031529; GO:0035176; GO:0021510; GO:0002296; GO:0038202; GO:0031929; GO:0008542; GO:0050882; GO:0042060"]
[1588,789,"PK872","MUSK","Y756","Muscle, skeletal receptor tyrosine protein kinase",0,2778,16,701,{"v":1936.162,"d":"1936"},{"v":3402.121054130271,"d":"3402"},{"$nulls":3},0,3173,18,621,{"v":1959.255,"d":"1959"},{"v":3423.240006234413,"d":"3423"},{"$nulls":6},0,3054,14,674,{"v":2048.96,"d":"2049"},{"v":3505.4455979157674,"d":"3505"},{"$nulls":7},"MUSK","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK",{"$nulls":7},"SADY(pY)KAN(bA)C","Corresponds to amino acid residues S752 to N759; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y756 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This phosphorylation site in MUSK has ony been reported in one high throughput mass spectrometry study.","MUSK",null,"O15146","O15146","O15146"]
[1592,791,"NN430-1","Myc","Pan-specific","Myc proto-oncogene protein",0,456,12,632,{"v":280.608,"d":"281"},{"v":493.069477015553,"d":"493"},{"$nulls":3},0,447,14,554,{"v":239.882,"d":"240"},{"v":419.1254630844497,"d":"419"},{"$nulls":6},0,484,14,545,{"v":256.15,"d":"256"},{"v":438.23202498151437,"d":"438"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against amino acid residues 408-439 within the C-terminal domain of human c-Myc.",{"$nulls":3},"P01106","P01106",null,"MYC"]
[1597,794,"PN215","Myc","T58+S62","Myc proto-oncogene protein",0,592,12,540,{"v":313.2,"d":"313"},{"v":550.3384087455496,"d":"550"},{"v":465.15192708531896,"d":"465"},{"v":85.18648166023064,"d":"85"},{"v":18.31368993653671,"d":"18"},0,327,10,384,{"v":121.728,"d":"122"},{"v":212.6850050038931,"d":"213"},{"v":358.61765544537053,"d":"359"},{"v":145.93265044147742,"d":"146"},{"v":40.693102591461184,"d":"41"},{"v":59.006792527997895,"d":"59"},{"v":-22.903113033950248,"d":"-23"},null,0,536,12,494,{"v":258.856,"d":"259"},{"v":442.8615618138391,"d":"443"},{"v":332.15472556738655,"d":"332"},{"v":110.70683624645255,"d":"111"},{"v":33.32989950913484,"d":"33"},{"v":51.64358944567155,"d":"52"},{"v":-28.592206927165506,"d":"-29"},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against amino acid residues surrounding the Thr-58 and Ser-62 dually phosphorylated human c-Myc.","T58 phosphorylation induces transcriptional activation and binding to AurA, CDC73, CIP2A, DNA, FWXW7, PIN1, and SH2BP1, and inhibits interaction with DNA, FBXW7 and TUBA4A. S62 phosphorylation induces transcriptional activation and binding to AurA, CDC73, CIP2A, DNA, FWXW7, PIN1, RNF4, SH2BP1 and Axin 1. These are two of the major in vivo phosphorylation sites in mTOR (≥57 and ≥59 reports, respectively, from high throughput mass spectrometry studies).","T58: ERK2 (MAPK1); GSK3a; GSK3b; JNK3 (MAPK10). S62: CDK5; ERK1 (MAPK3); ERK2 (MAPK1); JNK1 (MAPK8); JNK2 (MAPK9); JNK3 (MAPK10); Plk1.","Transcription protein","P01106","P01106",null,"MYC","GO:0000790; GO:0005730; GO:0005654; GO:0005634; GO:0032991","GO:0033613; GO:0003677; GO:0003700; GO:0070888; GO:0044877; GO:0046983; GO:0070491; GO:0000978; GO:0000981; GO:0001077; GO:0008134","GO:1904837; GO:0001658; GO:0007050; GO:0006879; GO:0006974; GO:0035690; GO:0071456; GO:0034644; GO:0006338; GO:0051276; GO:0019221; GO:0006112; GO:0070371; GO:0044346; GO:0000082; GO:0000165; GO:0043066; GO:0051782; GO:0048147; GO:0045656; GO:0032873; GO:0000122; GO:0007219; GO:0015671; GO:0008284; GO:0043280; GO:2000573; GO:0050679; GO:0048146; GO:0010628; GO:0002053; GO:0090096; GO:2001022; GO:0051973; GO:0045893; GO:0045944; GO:0016579; GO:0032986; GO:0010468; GO:0032204; GO:0006357; GO:0042493; GO:0010332; GO:0070848"]
[1602,796,"NN431-1","MyoD","Pan-specific","Myoblast determination protein 1",0,434,8,674,{"v":287.124,"d":"287"},{"v":504.5190462089949,"d":"505"},{"$nulls":3},0,609,12,659,{"v":393.423,"d":"393"},{"v":687.3946234526702,"d":"687"},{"$nulls":6},0,394,14,552,{"v":209.76,"d":"210"},{"v":358.86609236823136,"d":"359"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against amino acid residues 1-318 of mouse MyoD.",{"$nulls":3},"P15172","P15172",null,"P15172"]
[1607,799,"PK197","MYPT1 (MBS)","S695","Protein phosphatase 1 regulatory subunit 12A",0,292,12,592,{"v":165.76,"d":"166"},{"v":291.2646699669933,"d":"291"},{"v":274.24845939773434,"d":"274"},{"v":17.016210569258988,"d":"17"},{"v":6.204669519977462,"d":"6"},0,194,10,481,{"v":88.504,"d":"89"},{"v":154.63552907190257,"d":"155"},{"v":222.02911159203077,"d":"222"},{"v":67.3935825201282,"d":"67"},{"v":30.35348925052725,"d":"30"},{"v":36.55815877050471,"d":"37"},{"v":-19.04089011853715,"d":"-19"},null,0,324,12,574,{"v":179.088,"d":"179"},{"v":306.3911649029453,"d":"306"},{"v":258.0838470915925,"d":"258"},{"v":48.307317811352846,"d":"48"},{"v":18.71768355739399,"d":"19"},{"v":24.92235307737145,"d":"25"},{"v":-5.894148810038999,"d":"-6"},{"$nulls":15},"Not precisely defined.","Antibody raised against amino acid residues that encompass the Ser-695 phosphosite.","The effect of S695 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in MYPT1 (≥66 reports from high throughput mass spectrometry studies).","PKACa (PRKACA); PKG1 (PRKG1)","Protein phosphatase, regulatory subunit","O14974","O14974",null,null,"GO:0031672; GO:0015629; GO:0005813; GO:0043292; GO:0005829; GO:0005925; GO:0000776; GO:0005654; GO:0072357; GO:0030018","GO:0071889; GO:0004857; GO:0019208; GO:0019901","GO:0035690; GO:0007098; GO:0000278; GO:0043086; GO:0035508; GO:0045944; GO:0006470; GO:0030155; GO:0035507; GO:0046822; GO:0007165"]
[1610,800,"PN052","MYPT1 (MBS)","T696","Protein phosphatase 1 regulatory subunit 12A",0,1656,10,383,{"v":630.418,"d":"630"},{"v":1107.7370337310088,"d":"1108"},{"$nulls":3},0,64,10,797,{"v":43.038,"d":"43"},{"v":75.19664535158346,"d":"75"},{"$nulls":6},0,1528,10,389,{"v":590.502,"d":"591"},{"v":1010.2552692392512,"d":"1010"},{"$nulls":20},"Epitope undefined.","Antibody raised against amino acid residues that encompass the T696 phosphosite.","T696 phosphorylation affects the intracellular localization of the protein. This is one of the major in vivo phosphorylation sites in MYPT1 (≥260 reports from high throughput mass spectrometry studies).","DAPK3 (ZIPK); ILK; PAK1; PKG1 (PRKG1); Raf1; ROCK1; ROCK2",null,"O14974","O14974"]
[1614,803,"PK887","MYT1","S143","Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase",0,9664,14,745,{"v":7189.25,"d":"7189"},{"v":12632.568343147965,"d":"12633"},{"$nulls":3},0,10702,20,754,{"v":8054.228,"d":"8054"},{"v":14072.469131855416,"d":"14072"},{"$nulls":6},0,9839,16,692,{"v":6797.516,"d":"6798"},{"v":11629.47179982137,"d":"11629"},{"$nulls":7},"MYT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/tyrosine kinase, dual-specificity","Other ","WEE",{"$nulls":6},"RSM(pS)PFR(bA)C","Corresponds to amino acid residues R140 to R146.Located in the Gap/Insert 2 (G/I2) region in the protein-serine/threonine/tyrosine kinase catalytic domain of MYT1.","The effect of S143 phosphorylation is unknown. S143 is the most common phosphosite in MYT1 by mass spectrometry (≥23 reports).",null,null,"Q99640","Q99640","Q99640"]
[1619,805,"PK731","NDR1 (NDR, STK38)","S281+T282","Serine/threonine-protein kinase 38",0,7861,16,745,{"v":5844.525,"d":"5845"},{"v":10269.688979481429,"d":"10270"},{"v":9508.46219279329,"d":"9508"},{"v":761.2267866881393,"d":"761"},{"v":8.005782336339234,"d":"8"},0,7558,16,709,{"v":5347.278,"d":"5347"},{"v":9342.845098803953,"d":"9343"},{"v":9232.562626153118,"d":"9233"},{"v":110.28247265083519,"d":"110"},{"v":1.1944947152423053,"d":"1"},{"v":9.200277051581539,"d":"9"},{"v":-2.9016213247320195,"d":"-3"},null,0,7640,14,749,{"v":5711.874,"d":"5712"},{"v":9772.110519067977,"d":"9772"},{"v":9996.2572606997,"d":"9996"},{"v":224.14674163172276,"d":"224"},{"v":2.2423066532406684,"d":"2"},{"v":10.248088989579902,"d":"10"},{"v":5.130115238572671,"d":"5"},null,null,"NDR1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","NDR",{"$nulls":6},"LAF(pS)(pT)VGT(bA)C","Corresponds to amino acid residues L278 to T285; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S281 phosphorylation stimulates phosphotransferase activity. T282 phosphorylation is predicted to be stimulatory for phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major in vivo phosphorylation sites in NDR1 (≥15 and ≥12 reports, respectively, from high throughput mass spectrometry studies).","S281: NDR1 (NDR; STK38).","Protein-serine kinase, AGC group, NDR family","Q15208","Q15208","Q15208","Q15208","GO:0005737; GO:0005829; GO:0005634","GO:0005524; GO:0045296; GO:0000287; GO:0031435; GO:0004674","GO:0006464; GO:0035556; GO:0043407; GO:0018105; GO:0006468"]
[1624,807,"NK117-3","Nek2","Pan-specific","NIMA (never-in-mitosis)-related protein-serine kinase 2",0,94,6,602,{"v":52.976,"d":"53"},{"v":93.08661411782963,"d":"93"},{"$nulls":3},0,94,10,613,{"v":51.492,"d":"51"},{"v":89.96760217583845,"d":"90"},{"$nulls":6},0,98,8,533,{"v":47.97,"d":"48"},{"v":82.06906202757465,"d":"82"},{"$nulls":7},"NEK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","NEK",{"$nulls":6},"Epitope undefined.",{"$nulls":4},"P51955","P51955","P51955"]
[1625,808,"PK733","Nek2","T170+S171","NIMA (never-in-mitosis)-related protein-serine kinase 2",0,412,14,583,{"v":232.034,"d":"232"},{"v":407.7178235468227,"d":"408"},{"v":455.3066330106021,"d":"455"},{"v":47.588809463779455,"d":"48"},{"v":10.452035181018617,"d":"10"},0,326,10,409,{"v":129.244,"d":"129"},{"v":225.8170740234224,"d":"226"},{"v":350.96660033141114,"d":"351"},{"v":125.14952630798874,"d":"125"},{"v":35.65852881436935,"d":"36"},{"v":46.11056399538796,"d":"46"},{"v":-22.916431502275387,"d":"-23"},null,0,518,12,583,{"v":294.998,"d":"295"},{"v":504.6947917450587,"d":"505"},{"v":490.9139642563759,"d":"491"},{"v":13.780827488682803,"d":"14"},{"v":2.8071777321628346,"d":"3"},{"v":13.259212913181452,"d":"13"},{"v":7.820516694503027,"d":"8"},null,null,"NEK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","NEK",{"$nulls":6},"HD(pT)(pS)FAK(bA)C","Corresponds to amino acid residues H168 to K174; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T170 and S171 stimulates phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These two in vivo phosphorylation sites in Nek2  have been reported ≥1 and ≥5 times from high throughput mass spectrometry studies.",null,"Protein kinase, tyrosine (non-receptor); Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; Other group; NEK family","P51955","P51955","P51955",null,"GO:0005813; GO:0000777; GO:0000794; GO:0005829; GO:0000776; GO:0005874; GO:0030496; GO:0005730; GO:0005654; GO:0032991; GO:0000922","GO:0005524; GO:0046872; GO:0004672; GO:0019903; GO:0004674","GO:0001824; GO:0051301; GO:0051299; GO:0007059; GO:0097711; GO:0000086; GO:0051321; GO:0000278; GO:0000070; GO:0090307; GO:1903126; GO:0043392; GO:0051973; GO:1904355; GO:0032212; GO:0046777; GO:0006468; GO:0051988; GO:0010389; GO:0046602; GO:0007088; GO:0051225"]
[1633,812,"NK119-2","Nek7","Pan-specific","NIMA (never-in-mitosis)-related protein-serine kinase 7",0,211,12,539,{"v":107.261,"d":"107"},{"v":188.47333352636142,"d":"188"},{"v":158.52012891371453,"d":"159"},{"v":29.953204612646886,"d":"30"},{"v":18.895521229957474,"d":"19"},0,74,8,657,{"v":43.362,"d":"43"},{"v":75.76274305811985,"d":"76"},{"v":116.01683275223044,"d":"116"},{"v":40.25408969411059,"d":"40"},{"v":34.696766614960616,"d":"35"},{"v":53.59228784491809,"d":"54"},{"v":-26.812554628074665,"d":"-27"},null,0,222,10,586,{"v":124.232,"d":"124"},{"v":212.5412489849834,"d":"213"},{"v":160.57957394013252,"d":"161"},{"v":51.96167504485089,"d":"52"},{"v":32.35883230343064,"d":"32"},{"v":51.25435353338811,"d":"51"},{"v":1.299169411815825,"d":"1"},null,null,"NEK7","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","NEK",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 1-26 at the N-terminus of human Nek7.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Protein kinase, tyrosine (non-receptor); Other group; NEK family","Q8TDX7","Q8TDX7","Q8TDX7",null,"GO:0005737; GO:0005874; GO:0005815; GO:0005654; GO:0000922","GO:0005524; GO:0046872; GO:0004674","GO:0051973; GO:1904355; GO:0032212; GO:0006468; GO:0007346; GO:0051225"]
[1636,813,"NK119","Nek7","Pan-specific","NIMA (never-in-mitosis)-related protein-serine kinase 7",0,90,10,514,{"v":41.12,"d":"41"},{"v":72.25388048409003,"d":"72"},{"$nulls":3},0,60,8,667,{"v":34.684,"d":"35"},{"v":60.600410041691546,"d":"61"},{"$nulls":6},0,88,10,429,{"v":33.462,"d":"33"},{"v":57.24817497533257,"d":"57"},{"$nulls":7},"NEK7","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","NEK",{"$nulls":6},"MDEQSQGMQG PPVPQFQPQK ALRPDMGYNT","Corresponds to amino acid residues M1 to T30; N-terminus.",{"$nulls":3},"Q8TDX7","Q8TDX7","Q8TDX7"]
[1641,816,"PN761","NF1","Y2577","Neurofibromin",0,5929,18,714,{"v":4220.454,"d":"4220"},{"v":7415.957658185791,"d":"7416"},{"v":7091.495211857273,"d":"7091"},{"v":324.4624463285181,"d":"324"},{"v":4.575374256560218,"d":"5"},0,5098,16,698,{"v":3547.236,"d":"3547"},{"v":6197.784457232435,"d":"6198"},{"v":6362.47870388622,"d":"6362"},{"v":164.69424665378483,"d":"165"},{"v":2.5885233463050983,"d":"3"},{"v":7.163897602865315,"d":"7"},{"v":-10.280152297813132,"d":"-10"},null,0,4806,12,751,{"v":3600.294,"d":"3600"},{"v":6159.532032593388,"d":"6160"},{"v":6152.842642713717,"d":"6153"},{"v":6.689389879670671,"d":"7"},{"v":0.10872031462713157,"d":"0"},{"v":4.684094571187349,"d":"5"},{"v":-13.236313938054835,"d":"-13"},{"$nulls":5},"GTPase activating protein",{"$nulls":9},"CAETD(pY)EME","Corresponds to amino acid residues A2573 to E2576.","The effect of Y2577 phosphorylation is unclear. This is the major in vivo phosphorylation site in NF1 (≥103 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in fish.",null,"Tumor suppressor; GTPase activating protein, Ras","P21359","P21359",null,"P21359","GO:0030424; GO:0005737; GO:0005829; GO:0030425; GO:0031235; GO:0016020; GO:0005730; GO:0005634; GO:0098793","GO:0005096; GO:0031210; GO:0008429","GO:0030036; GO:0030325; GO:0021764; GO:0048844; GO:0007420; GO:0048593; GO:0007154; GO:0034605; GO:0021987; GO:0050890; GO:0030199; GO:0030198; GO:0008625; GO:0021897; GO:0048853; GO:0061534; GO:0061535; GO:0048820; GO:0007507; GO:0001889; GO:0000165; GO:0001656; GO:0022011; GO:0016525; GO:0048712; GO:0001953; GO:0030336; GO:0001937; GO:0048147; GO:0043409; GO:0043407; GO:0007406; GO:0046929; GO:0048715; GO:0045671; GO:0042308; GO:0006469; GO:0035021; GO:0046580; GO:0021915; GO:0098597; GO:0001649; GO:0007422; GO:0014065; GO:0043473; GO:0045762; GO:0043065; GO:0001938; GO:2001241; GO:1902043; GO:0043547; GO:0043525; GO:0007265; GO:0045765; GO:0043535; GO:0045124; GO:0001952; GO:0010468; GO:0045685; GO:0043087; GO:0048169; GO:1900271; GO:0032228; GO:0001666; GO:0014044; GO:0007519; GO:0048745; GO:0021510; GO:0048485; GO:0008542; GO:0042060"]
[1642,816,"PN761","NF1","Y2577","Neurofibromin",0,5068,14,762,{"v":3851.148,"d":"3851"},{"v":6767.032765528755,"d":"6767"},{"$nulls":3},0,5438,16,689,{"v":3735.758,"d":"3736"},{"v":6527.172950540004,"d":"6527"},{"$nulls":6},0,5358,20,673,{"v":3592.474,"d":"3592"},{"v":6146.153252834047,"d":"6146"},{"$nulls":10},"GTPase activating protein",{"$nulls":9},"CAETD(pY)EME","Corresponds to amino acid residues A2573 to E2576.","The effect of Y2577 phosphorylation is unclear. This is the major in vivo phosphorylation site in NF1 (≥103 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in fish.",null,null,"P21359","P21359",null,"P21359"]
[1647,819,"PN631","NFAT3 (NFATc4)","S213+S217","Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4",0,12268,14,677,{"v":8295.958,"d":"8296"},{"v":14577.21687337137,"d":"14577"},{"v":13494.280210971889,"d":"13494"},{"v":1082.936662399481,"d":"1083"},{"v":8.025153216538145,"d":"8"},0,13472,14,701,{"v":9434.058,"d":"9434"},{"v":16483.32900349154,"d":"16483"},{"v":15193.333854721746,"d":"15193"},{"v":1289.9951487697945,"d":"1290"},{"v":8.490533816374297,"d":"8"},{"v":16.515687032912442,"d":"17"},{"v":12.590917167767103,"d":"13"},null,0,12016,10,674,{"v":8092.044,"d":"8092"},{"v":13844.203897558125,"d":"13844"},{"v":13896.586439587732,"d":"13897"},{"v":52.382542029607066,"d":"52"},{"v":0.37694539056284304,"d":"0"},{"v":8.402098607100989,"d":"8"},{"v":2.981309283089729,"d":"3"},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"CGLG(pS)PLPS(pS)PRA","Corresponds to amino acid residues C210 to A220.","S213 and S217 phosphorylation stimulates transcriptional activity. These are two of the major in vivo phosphorylation sites in NFAT3 (≥12 and ≥16 reports, respectively, from high throughput mass spectrometry studies).","S213: JNK1 (MAPK8); JNK2 (MAPK9). S217: JNK1 (MAPK8); JNK2 (MAPK9).","Transcription protein","Q14934","Q14934",null,null,"GO:0005829; GO:0016607; GO:0005634; GO:0005667","GO:0042975; GO:0000978; GO:0000981; GO:0001078; GO:0001227; GO:0003713; GO:0008134","GO:0001569; GO:0033173; GO:0045333; GO:1904637; GO:0071285; GO:0034644; GO:0007507; GO:0006954; GO:0008630; GO:0055001; GO:0035562; GO:0050774; GO:1902894; GO:0032091; GO:2000297; GO:0030178; GO:2001235; GO:0045944; GO:0032760; GO:0048167; GO:0051145; GO:0006366"]
[1651,821,"PN238","NFAT4 (NFATc3)","S169","Nuclear factor of activated T-cells, cytoplasmic 3",0,662,12,617,{"v":401.05,"d":"401"},{"v":704.7037638167391,"d":"705"},{"v":628.438316962387,"d":"628"},{"v":76.26544685435204,"d":"76"},{"v":12.135709232846894,"d":"12"},0,388,8,457,{"v":173.66,"d":"174"},{"v":303.4213818429291,"d":"303"},{"v":508.7366333709874,"d":"509"},{"v":205.3152515280583,"d":"205"},{"v":40.357866538448334,"d":"40"},{"v":52.49357577129523,"d":"52"},{"v":-19.04748331864748,"d":"-19"},null,0,658,12,547,{"v":353.362,"d":"353"},{"v":604.5463392993087,"d":"605"},{"v":488.3169070089743,"d":"488"},{"v":116.22943229033439,"d":"116"},{"v":23.80204957519489,"d":"24"},{"v":35.937758808041785,"d":"36"},{"v":-22.296764244214472,"d":"-22"},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S169 phosphosite.","The effect of S169 phosphorylation is unclear. This phosphorylation site in NFAT4 has not been reported in high throughput mass spectrometry studies.",null,"Transcription protein","Q12968","Q12968",null,"Q12968","GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0000978; GO:0000981; GO:0001077; GO:0001227","GO:0038095; GO:0006954; GO:1902894; GO:1905064; GO:0045944; GO:0006357; GO:0006366"]
[1658,824,"PN242","NFkB p50","S337","Nuclear factor NF-kappa-B p105 subunit",0,378,12,707,{"v":258.762,"d":"259"},{"v":454.6828458614812,"d":"455"},{"$nulls":3},0,558,10,698,{"v":382.504,"d":"383"},{"v":668.3167812993653,"d":"668"},{"$nulls":6},0,385,12,632,{"v":235.736,"d":"236"},{"v":403.30690861230636,"d":"403"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against amino acid residues surrounding the phosphorylated Ser-337 of human NFκB p50.","The effect of S337 phosphorylation is unclear. This phosphorylation site in NFkB p50 has not been reported in high throughput mass spectrometry studies.","PKACa (PRKACA); PKCa (PRKCA)",null,"P19838","P19838",null,"P19838"]
[1659,825,"NN071","NFKB p65 (Rel A)","Pan-specific","NF-kappa-B p65 nuclear transcription factor",0,1069,14,712,{"v":751.16,"d":"751"},{"v":1319.8984646018744,"d":"1320"},{"v":1970.7149258956117,"d":"1971"},{"v":650.8164612937373,"d":"651"},{"v":33.02438382852188,"d":"33"},0,994,16,640,{"v":625.92,"d":"626"},{"v":1093.6169027014062,"d":"1094"},{"v":1258.5190679572834,"d":"1259"},{"v":164.9021652558772,"d":"165"},{"v":13.102873802582252,"d":"13"},{"v":46.12725763110413,"d":"46"},{"v":-36.138958942256124,"d":"-36"},null,0,1088,12,675,{"v":726.3,"d":"726"},{"v":1242.5841098734097,"d":"1243"},{"v":2168.9328734199285,"d":"2169"},{"v":926.3487635465187,"d":"926"},{"v":42.709886271670136,"d":"43"},{"v":75.73427010019202,"d":"76"},{"v":10.058174570035021,"d":"10"},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Epitope undefined.",{"$nulls":3},"Nuclear receptor co-regulator; Transcription factor","Q04206","Q04206",null,"Q04206","GO:0005737; GO:0005829; GO:0098978; GO:0033256; GO:0035525; GO:0000790; GO:0005654; GO:0005634; GO:0005667","GO:0042805; GO:0033613; GO:0071532; GO:0003682; GO:0031490; GO:0003677; GO:0003700; GO:0042826; GO:0042802; GO:0051059; GO:0042301; GO:0044877; GO:0046982; GO:0042803; GO:0019901; GO:0047485; GO:0070491; GO:0000980; GO:0000978; GO:0000977; GO:0000981; GO:0001205; GO:0001077; GO:0001078; GO:0000983; GO:0003705; GO:0008134; GO:0044212; GO:0031625","GO:0006117; GO:0007568; GO:0009887; GO:0006968; GO:1904385; GO:0035729; GO:0070301; GO:0071347; GO:0071354; GO:0071222; GO:0071223; GO:0071316; GO:0071224; GO:0071356; GO:0035924; GO:0019221; GO:0051607; GO:0038095; GO:0001942; GO:0006954; GO:0070498; GO:0001889; GO:0031293; GO:0043066; GO:2001237; GO:0046627; GO:1901223; GO:1902894; GO:0042177; GO:0033234; GO:0045892; GO:0000122; GO:0070431; GO:0008284; GO:0032332; GO:0043123; GO:0045084; GO:2000630; GO:0051092; GO:1901224; GO:1902895; GO:0014040; GO:0050862; GO:0045893; GO:0045944; GO:1901522; GO:0032481; GO:0099527; GO:0061614; GO:0043620; GO:0050727; GO:1901222; GO:0006355; GO:0043200; GO:0051591; GO:0033590; GO:0032868; GO:0070555; GO:0043278; GO:0032495; GO:0035994; GO:0010033; GO:0032570; GO:0010224; GO:0002223; GO:0050852; GO:0033209; GO:0016032"]
[1664,827,"PN243","NFKB p65 (Rel A)","S311","NF-kappa-B p65 nuclear transcription factor",0,98,8,555,{"v":49.95,"d":"50"},{"v":87.76948760166094,"d":"88"},{"$nulls":3},0,132,12,562,{"v":67.44,"d":"67"},{"v":117.83218928646286,"d":"118"},{"$nulls":6},0,124,10,478,{"v":54.492,"d":"54"},{"v":93.22716964783402,"d":"93"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S311 phosphosite.","The effect of S311 phosphorylation induces transcriptional activity. This is one of the minor in vivo phosphorylation sites in NFKB p65 (≥2 reports from high throughput mass spectrometry studies).","IKKb; PKCz (PRKCZ)",null,"Q04206","Q04206",null,"Q04206"]
[1669,830,"PN633","NFkB-p100","S866","Nuclear factor NF-kappa-B p100 subunit",0,5080,18,743,{"v":3761.066,"d":"3761"},{"v":6608.745458579148,"d":"6609"},{"v":5753.209962104973,"d":"5753"},{"v":855.5354964741755,"d":"856"},{"v":14.87057663651048,"d":"15"},0,4497,18,717,{"v":3211.443,"d":"3211"},{"v":5611.081842507209,"d":"5611"},{"v":5553.840453579148,"d":"5554"},{"v":57.2413889280615,"d":"57"},{"v":1.0306631853490236,"d":"1"},{"v":15.901239821859503,"d":"16"},{"v":-3.465361247703882,"d":"-3"},null,0,4656,18,774,{"v":3589.812,"d":"3590"},{"v":6141.598993023385,"d":"6142"},{"v":5704.323328385282,"d":"5704"},{"v":437.2756646381031,"d":"437"},{"v":7.665688627118588,"d":"8"},{"v":22.53626526362907,"d":"23"},{"v":-0.8497279612893465,"d":"-1"},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"KED(pS)AYG(pS)QSV(bA)C","Corresponds to amino acid residues K863 to V873.","S866 phosphorylation induces interaction with IKKa. This is a minor in vivo phosphorylation site in NFKB p100 (≥1 report from high throughput mass spectrometry studies).","NIK (MAP3K14)","Transcription protein","Q00653","Q00653",null,"Q00653","GO:0033257; GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0003682; GO:0003700; GO:0000978; GO:0000981; GO:0001077; GO:0003713","GO:0007568; GO:0030198; GO:0002268; GO:0002467; GO:0007249; GO:0006954; GO:0045087; GO:0000122; GO:0038061; GO:0051092; GO:0045944; GO:0032481; GO:0006355; GO:0034097; GO:0032496; GO:0048511; GO:0048536"]
[1674,832,"PN241","NFKB1 (NFkB-p105)","S932","Nuclear factor NF-kappa-B p105 subunit",0,392,16,617,{"v":231.992,"d":"232"},{"v":407.6440233770675,"d":"408"},{"$nulls":3},0,428,14,585,{"v":242.19,"d":"242"},{"v":423.1580356359496,"d":"423"},{"$nulls":6},0,478,16,655,{"v":302.61,"d":"303"},{"v":517.7177164928991,"d":"518"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against amino acid residues surrounding the phosphorylated Ser-932 of human NFκB p105.","S932 phosphorylation facilitates protein degradation. This phosphorylation site in NFKB1 has not been reported high throughput mass spectrometry studies.","IKKa (CHUK, IKBKA); IKKb (IKBKB)",null,"P19838","P19838",null,"P19838"]
[1676,833,"NK207-2","NIK (MAP3K14; NLK; LAK1)","Pan-specific","NF-kappa beta-inducing kinase (nemo-like kinase)",0,261,10,575,{"v":144.325,"d":"144"},{"v":253.60022618838263,"d":"254"},{"$nulls":3},0,460,12,603,{"v":270.144,"d":"270"},{"v":471.9996877610057,"d":"472"},{"$nulls":6},0,260,12,524,{"v":129.952,"d":"130"},{"v":222.32726180127955,"d":"222"},{"$nulls":7},"NIK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE-Unique",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 700-9473 mapping at the C-terminus of human NIK.",{"$nulls":3},"Q99558","Q99558","Q99558","Q99558"]
[1681,836,"PN055-1","NMDAR1","S896","Glutamate [NMDA] receptor subunit zeta-1",1,2062,12,563,{"v":1154.15,"d":"1154"},{"v":2028.011093402542,"d":"2028"},{"v":1860.2246503173087,"d":"1860"},{"v":167.78644308523326,"d":"168"},{"v":9.0196871144898,"d":"9"},1,38,12,585,{"v":15.21,"d":"15"},{"v":26.575142334624857,"d":"27"},{"v":479.20345579819553,"d":"479"},{"v":452.6283134635707,"d":"453"},{"v":94.45430912213281,"d":"94"},{"v":103.47399623662261,"d":"103"},{"v":-74.23948469253672,"d":"-74"},null,1,36,14,607,{"v":13.354,"d":"13"},{"v":22.84657607496835,"d":"23"},{"v":920.9245408832205,"d":"921"},{"v":898.0779648082522,"d":"898"},{"v":97.51916958874209,"d":"98"},{"v":106.53885670323189,"d":"107"},{"v":-50.49390724254012,"d":"-50"},{"$nulls":5},"Channel, ligand-gated - Glutamate receptor",{"$nulls":9},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S896 phosphosite.","The effect of S896 phosphorylation is unclear. This phosphorylation site in NMDAR1 has not been reported from high throughput mass spectrometry studies.","PKCa (PRKCA)","Channel protein","Q05586","Q05586",null,null,"GO:0030054; GO:0009986; GO:0030425; GO:0043197; GO:0005783; GO:0060076; GO:0098978; GO:0005887; GO:0099061; GO:0005622; GO:0043005; GO:0017146; GO:0005886; GO:0014069; GO:0045211; GO:0045202; GO:0043083; GO:0097060; GO:0008021; GO:0043195","GO:0005509; GO:0005516; GO:0016595; GO:0022849; GO:0016594; GO:0042165; GO:0004972; GO:0044877; GO:0005088; GO:0005102; GO:1904315","GO:0008344; GO:0007420; GO:0055074; GO:0097553; GO:0006812; GO:0021987; GO:0001661; GO:0048013; GO:0098976; GO:0060079; GO:0035235; GO:0007616; GO:0060179; GO:0000165; GO:0043524; GO:0008355; GO:0021586; GO:0043065; GO:0010524; GO:2001056; GO:2000463; GO:1903428; GO:0045944; GO:0060134; GO:0018964; GO:0051290; GO:1903539; GO:0050770; GO:0048814; GO:0048169; GO:0042391; GO:0043576; GO:0051963; GO:0048167; GO:0007585; GO:0001975; GO:0045471; GO:1905429; GO:0043278; GO:0019233; GO:0035176; GO:0001967; GO:0035249; GO:0008542"]
[1686,838,"PN710","NMDAR2A (GRIN2A)","Y943","Glutamate [NMDA] receptor subunit epsilon-1",0,3977,14,780,{"v":3091.14,"d":"3091"},{"v":5431.5870651651285,"d":"5432"},{"$nulls":3},0,3814,10,782,{"v":2974.728,"d":"2975"},{"v":5197.489809782638,"d":"5197"},{"$nulls":6},0,3830,14,749,{"v":2858.184,"d":"2858"},{"v":4889.899520163049,"d":"4890"},{"$nulls":10},"Channel, ligand-gated - Glutamate receptor",{"$nulls":9},"NLM(pY)SDN(bA)C","Corresponds to amino acid residues N940 to N946.","The effect of Y943 phosphorylation is unclear. This is the major in vivo phosphorylation site in NMDAR2A (≥134 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in fish.","Fyn",null,"Q12879","Q12879"]
[1691,841,"PN762","NOS1","S746","Nitric oxide synthase, brain",0,6923,18,913,{"v":6304.265,"d":"6304"},{"v":11077.519694796496,"d":"11078"},{"v":8947.352473557286,"d":"8947"},{"v":2130.1672212392095,"d":"2130"},{"v":23.807793730431836,"d":"24"},0,7116,20,942,{"v":6684.432,"d":"6684"},{"v":11679.140816970485,"d":"11679"},{"v":10021.397066414707,"d":"10021"},{"v":1657.7437505557773,"d":"1658"},{"v":16.54204238759754,"d":"17"},{"v":40.34983611802937,"d":"40"},{"v":12.004049198146788,"d":"12"},null,0,5726,14,878,{"v":5015.136,"d":"5015"},{"v":8580.102302704245,"d":"8580"},{"v":7794.347063846115,"d":"7794"},{"v":785.7552388581298,"d":"786"},{"v":10.081091237299862,"d":"10"},{"v":33.8888849677317,"d":"34"},{"v":-12.886554018283363,"d":"-13"},{"$nulls":14},"X","CAVKF(pS)AKL","Corresponds to amino acid residues A742 to L749.","S746 phosphorylation inhibits the enzymatic activity of NOS1. Phosphorylation of this site in NOS1 has not been reported by mass spectrometry. This human phosphosite is highly conserved in vertebrates and also found in the fruit fly. ","CaMK1a","Oxidoreductase; Amino Acid Metabolism - arginine and proline; EC 1.14.13.39","P29475","P29475",null,null,"GO:0044305; GO:0005901; GO:0005737; GO:0005856; GO:0005829; GO:0043197; GO:0045121; GO:0005739; GO:0005654; GO:0048471; GO:0001917; GO:0005886; GO:0032991; GO:0042383; GO:0016529; GO:0033017; GO:0045202; GO:0030315; GO:0030018","GO:0034618; GO:0046870; GO:0005516; GO:0050660; GO:0010181; GO:0020037; GO:0044325; GO:0050661; GO:0003958; GO:0004517; GO:0097110; GO:0017080; GO:0034617","GO:0006527; GO:0045454; GO:0071363; GO:0042738; GO:0033555; GO:0007520; GO:0045776; GO:0051926; GO:0010523; GO:0051346; GO:0043267; GO:0051612; GO:0042136; GO:0006809; GO:0007263; GO:0018119; GO:0140196; GO:0031284; GO:0035066; GO:1902307; GO:0098735; GO:0045893; GO:0045944; GO:1902514; GO:1903779; GO:0055117; GO:0050767; GO:0060314; GO:0002028; GO:0009408; GO:0001666; GO:0098924; GO:0006941; GO:0042311"]
[1692,841,"PN762","NOS1","S746","Nitric oxide synthase, brain",0,4927,16,790,{"v":3879.69,"d":"3880"},{"v":6817.185252318076,"d":"6817"},{"$nulls":3},0,6060,16,792,{"v":4786.848,"d":"4787"},{"v":8363.65331585893,"d":"8364"},{"$nulls":6},0,5833,14,704,{"v":4096.576,"d":"4097"},{"v":7008.591824987985,"d":"7009"},{"$nulls":19},"X","CAVKF(pS)AKL","Corresponds to amino acid residues A742 to L749.","S746 phosphorylation inhibits the enzymatic activity of NOS1. Phosphorylation of this site in NOS1 has not been reported by mass spectrometry. This human phosphosite is highly conserved in vertebrates and also found in the fruit fly. ","CaMK1a",null,"P29475","P29475"]
[1698,844,"PN712","NOS3","T1175+S1177","Nitric oxide synthase, endothelial",0,11464,16,821,{"v":9398.808,"d":"9399"},{"v":16515.086330858692,"d":"16515"},{"$nulls":3},0,13947,16,808,{"v":11256.248,"d":"11256"},{"v":19667.08696606419,"d":"19667"},{"$nulls":6},0,13891,18,781,{"v":10834.813,"d":"10835"},{"v":18536.646657372778,"d":"18537"},{"$nulls":19},"X","RIR(pT)Q(pS)FSL(bA)C","Corresponds to amino acid residues R1172 to L1180.","T1175+S1177 phosphorylation stimulates enzyme activity. These are two of the major in vivo phosphorylation sites in NOS3 (≥17 and >22 reports, respectively, by mass spectrometry). These phosphosites are not highly conserved in vertebrates, but are found in the rat.","S1177: Akt1 (PKBa); AMPKa1 (PRKAA1); PKACa (PRKACA); PKCd (PRKCD); PKG2 (PRKG2).",null,"P29474","P29474"]
[1703,847,"PN636","Nur77","S351","Nuclear receptor subfamily 4 group A member 1",0,9350,12,521,{"v":4865.098,"d":"4865"},{"v":8548.69186370101,"d":"8549"},{"v":9650.484469472929,"d":"9650"},{"v":1101.7926057719196,"d":"1102"},{"v":11.416966777752819,"d":"11"},0,9454,16,539,{"v":5087.082,"d":"5087"},{"v":8888.226707291788,"d":"8888"},{"v":8751.09652674392,"d":"8751"},{"v":137.13018054786698,"d":"137"},{"v":1.567005690415918,"d":"2"},{"v":12.983972468168737,"d":"13"},{"v":-9.31961442530698,"d":"-9"},null,0,10082,16,510,{"v":5133.66,"d":"5134"},{"v":8782.878068969749,"d":"8783"},{"v":8978.885746651116,"d":"8979"},{"v":196.00767768136757,"d":"196"},{"v":2.1829844282679858,"d":"2"},{"v":13.599951206020805,"d":"14"},{"v":-6.9592228757660735,"d":"-7"},{"$nulls":5},"Receptor,  nuclear",{"$nulls":4},"X",{"$nulls":4},"CGRLP(pS)KPKQ","Corresponds to amino acid residues C347 to Q355.","S351 phosphorylation inhibits transcriptional activity and regulates apoptosis and cytoskeletal reorganization. This is the major in vivo phosphorylation site in Nur77 (≥4 reports from high throughput mass spectrometry studies).","Akt1 (PKBa); MSK1 (RPS6KA5); PKACa (PRKACA); RSK1 (RPS6KA1); RSK2 (RPS6KA3)","Receptor, nuclear","P22736","P22736",null,null,"GO:0005829; GO:0031965; GO:0005654; GO:0005634","GO:0003677; GO:0004879; GO:0046982; GO:0000981; GO:0043565; GO:0003707; GO:0001077; GO:0008270","GO:0002042; GO:0071376; GO:0044344; GO:0035924; GO:0035767; GO:0045444; GO:0045786; GO:0001938; GO:0045944; GO:0061469; GO:0007165; GO:0006367"]
[1708,851,"NK120-7","p38a MAPK (MAPK14)","Pan-specific","Mitogen-activated protein-serine kinase p38 alpha; Mitogen-activated protein kinase 14",0,1574,18,711,{"v":1106.316,"d":"1106"},{"v":1943.9597286390215,"d":"1944"},{"$nulls":3},0,1306,16,561,{"v":723.69,"d":"724"},{"v":1264.4421272941922,"d":"1264"},{"$nulls":6},0,1846,18,557,{"v":1018.196,"d":"1018"},{"v":1741.9718715911695,"d":"1742"},{"$nulls":7},"p38a","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","p38",{"$nulls":5},"Epitope undefined.",{"$nulls":4},"Q16539","Q16539","Q16539","Q16539"]
[1709,852,"NK120-10","p38a MAPK (MAPK14)","Pan-specific","Mitogen-activated protein-serine kinase p38 alpha; Mitogen-activated protein kinase 14",0,1102,12,448,{"v":488.32,"d":"488"},{"v":858.0499736865479,"d":"858"},{"v":1045.1878755697207,"d":"1045"},{"v":187.13790188317284,"d":"187"},{"v":17.904714191328136,"d":"18"},0,1001,14,458,{"v":452.046,"d":"452"},{"v":789.82161681774,"d":"790"},{"v":757.6955719718001,"d":"758"},{"v":32.12604484593999,"d":"32"},{"v":4.239967347616445,"d":"4"},{"v":22.14468153894458,"d":"22"},{"v":-27.506280001689802,"d":"-28"},null,0,1281,12,478,{"v":606.582,"d":"607"},{"v":1037.7655989745733,"d":"1038"},{"v":978.7056429551048,"d":"979"},{"v":59.05995601946847,"d":"59"},{"v":6.034496321196512,"d":"6"},{"v":23.939210512524646,"d":"24"},{"v":-6.36079255879018,"d":"-6"},null,null,"p38a","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","p38",{"$nulls":5},"MSQERPTFYRQELC","Corresponds to amino acid residues M1 to L13; N-terminus.",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.24; EC 2.7.1.37; CMGC domain target; CMGC</A> group; MAPK family; MAPK/p38 subfamily; p38 subfamily","Q16539","Q16539","Q16539","Q16539","GO:0005737; GO:0005829; GO:0005576; GO:1904813; GO:0098978; GO:0005739; GO:0016607; GO:0005654; GO:0005634; GO:0034774; GO:0000922","GO:0005524; GO:0019899; GO:0004707; GO:0004708; GO:0048273; GO:0051525; GO:0019903; GO:0004674","GO:0070935; GO:0000187; GO:0001525; GO:0006915; GO:0001502; GO:0000902; GO:0007166; GO:0071479; GO:0071222; GO:0071223; GO:0071356; GO:0035924; GO:0098586; GO:0006935; GO:0002062; GO:0000077; GO:0019395; GO:0006006; GO:0035556; GO:0031663; GO:0014835; GO:0090090; GO:0043312; GO:0030316; GO:0038066; GO:0018105; GO:0001890; GO:0090336; GO:0060045; GO:0031281; GO:0002741; GO:0045648; GO:0010628; GO:0046326; GO:2001184; GO:0010759; GO:1905050; GO:0051149; GO:0045663; GO:1901741; GO:0010831; GO:0042307; GO:2000379; GO:0045944; GO:1900015; GO:0030278; GO:1901796; GO:0099179; GO:0006357; GO:0032495; GO:0035994; GO:0007165; GO:0042770; GO:0007519; GO:0090400; GO:0051146; GO:0006351; GO:0007178; GO:0048010"]
[1715,855,"NK248-1","p38b MAPK (MAPK11)","Pan-specific","Mitogen-activated protein-serine kinase p38 beta; Mitogen-activated protein kinase 11",0,1304,14,523,{"v":674.67,"d":"675"},{"v":1185.4942983025542,"d":"1185"},{"v":1473.3132032007416,"d":"1473"},{"v":287.8189048981874,"d":"288"},{"v":19.53548670254953,"d":"20"},0,1250,40,451,{"v":545.71,"d":"546"},{"v":953.4727760307778,"d":"953"},{"v":1084.0613830808893,"d":"1084"},{"v":130.58860705011148,"d":"131"},{"v":12.046237333810401,"d":"12"},{"v":31.58172403635993,"d":"32"},{"v":-26.420167773845435,"d":"-26"},null,0,1572,16,522,{"v":812.232,"d":"812"},{"v":1389.6001331828436,"d":"1390"},{"v":991.6430256328727,"d":"992"},{"v":397.95710754997094,"d":"398"},{"v":40.131085205383485,"d":"40"},{"v":59.66657190793302,"d":"60"},{"v":-32.692992672668026,"d":"-33"},null,null,"p38b","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","p38",{"$nulls":5},"MSGPRAGFYRQELNKC","Corresponds to amino acid residues M1 to K15; N-terminus.",null,null,"Protein-serine kinase, CMGC group, MAPK family, p38 subfamily","Q15759","Q15759","Q15759",null,"GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0004707; GO:0004674","GO:0000187; GO:0071347; GO:0098586; GO:0060044; GO:0010628; GO:2001184; GO:0051149; GO:1901796; GO:0006355; GO:0051403; GO:0006351"]
[1720,857,"PK741","p38b MAPK (MAPK11)","T180+Y182","Mitogen-activated protein-serine kinase p38 beta; Mitogen-activated protein kinase 11",0,10410,18,667,{"v":6931.464,"d":"6931"},{"v":12179.600472659842,"d":"12180"},{"$nulls":3},0,10394,16,632,{"v":6558.896,"d":"6559"},{"v":11459.802416699646,"d":"11460"},{"$nulls":6},0,10454,18,630,{"v":6574.68,"d":"6575"},{"v":11248.234745287775,"d":"11248"},{"$nulls":7},"p38b","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","p38",{"$nulls":5},"EEM(pT)G(pY)(bA)C","Corresponds to amino acid residues E177 to Y182; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T180 and Y182 phosphorylation is stimulatory for phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major in vivo phosphorylation sites in p38a (≥59 and ≥663 reports, respectively, by mass spectrometry).","T180: MKK3 (MAP2K3, MEK3);; MKK6 (MAP2K6, MEK6). Y182: MKK3 (MAP2K3, MEK3); MKK6 (MAP2K6, MEK6).",null,"Q15759","Q15759","Q15759"]
[1725,860,"PK742","p38d MAPK (MAPK13)","T180+Y182","Mitogen-activated protein-serine kinase p38 delta; Mitogen-activated protein kinase 13",0,1107,12,421,{"v":460.995,"d":"461"},{"v":810.0359346732268,"d":"810"},{"v":1121.1256145274222,"d":"1121"},{"v":311.0896798541953,"d":"311"},{"v":27.747977195697743,"d":"28"},0,762,12,357,{"v":267.75,"d":"268"},{"v":467.8168547071535,"d":"468"},{"v":511.29630355640654,"d":"511"},{"v":43.47944884925306,"d":"43"},{"v":8.503767491926798,"d":"9"},{"v":36.25174468762454,"d":"36"},{"v":-54.394378566408136,"d":"-54"},"Possible",0,1037,12,395,{"v":404.875,"d":"405"},{"v":692.6769124122219,"d":"693"},{"v":757.7102711848544,"d":"758"},{"v":65.03335877263248,"d":"65"},{"v":8.582879399396006,"d":"9"},{"v":36.33085659509375,"d":"36"},{"v":-32.41522079537492,"d":"-32"},null,null,"p38d","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","p38",{"$nulls":5},"AEM(pT)G(pY)(bA)C","Corresponds to amino acid residues A177 to Y182; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T180 and Y182 phosphorylation is stimulatory for phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major in vivo phosphorylation sites in p38a (≥382 and >986 reports, respectively, from high throughput mass spectrometry studies).","T180: MKK3 (MAP2K3, MEK3); MKK6 (MAP2K6, MEK6). Y182: MKK3 (MAP2K3, MEK3); MKK6 (MAP2K6, MEK6).","EC 2.7.11.24; EC 2.7.1.37; Protein kinase, Ser/Thr (non-receptor); CMGC group; MAPK family; MAPK/p38 subfamily; p38 subfamily","O15264","O15264","O15264","O15264","GO:0005737; GO:0005829; GO:0005634","GO:0005524; GO:0004707; GO:0004674","GO:0007049; GO:0072740; GO:0070301; GO:0071347; GO:1903936; GO:0072709; GO:0034644; GO:0018105; GO:0050729; GO:0032755; GO:0010468; GO:0006355; GO:0006970; GO:0051403; GO:0006351"]
[1726,860,"PK742","p38d MAPK (MAPK13)","T180+Y182","Mitogen-activated protein-serine kinase p38 delta; Mitogen-activated protein kinase 13",0,1445,10,568,{"v":815.08,"d":"815"},{"v":1432.2152943816175,"d":"1432"},{"$nulls":3},0,794,10,405,{"v":317.52,"d":"318"},{"v":554.7757524056597,"d":"555"},{"$nulls":6},0,1060,10,458,{"v":480.9,"d":"481"},{"v":822.7436299574869,"d":"823"},{"$nulls":7},"p38d","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","p38",{"$nulls":5},"AEM(pT)G(pY)(bA)C","Corresponds to amino acid residues A177 to Y182; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T180 and Y182 phosphorylation is stimulatory for phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major in vivo phosphorylation sites in p38a (≥382 and >986 reports, respectively, from high throughput mass spectrometry studies).","T180: MKK3 (MAP2K3, MEK3); MKK6 (MAP2K6, MEK6). Y182: MKK3 (MAP2K3, MEK3); MKK6 (MAP2K6, MEK6).",null,"O15264","O15264","O15264","O15264"]
[1731,863,"NK059-3","p38g MAPK (MAPK12, ERK6)","Pan-specific","Mitogen-activated protein-serine kinase p38 gamma; Mitogen-activated protein kinase 12",0,3518,10,528,{"v":1852.224,"d":"1852"},{"v":3254.629657727704,"d":"3255"},{"v":3427.757827385691,"d":"3428"},{"v":173.1281696579872,"d":"173"},{"v":5.050770164531429,"d":"5"},0,2870,10,516,{"v":1475.76,"d":"1476"},{"v":2578.470220364627,"d":"2578"},{"v":2874.497387719711,"d":"2874"},{"v":296.02716735508375,"d":"296"},{"v":10.298397508369872,"d":"10"},{"v":15.349167672901302,"d":"15"},{"v":-16.14059299189013,"d":"-16"},null,0,3694,14,539,{"v":1983.52,"d":"1984"},{"v":3393.4881366048544,"d":"3393"},{"v":3594.9140490046148,"d":"3595"},{"v":201.42591239976036,"d":"201"},{"v":5.603080064056958,"d":"6"},{"v":10.653850228588388,"d":"11"},{"v":4.876547003509032,"d":"5"},null,null,"p38g","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","p38",{"$nulls":5},"MSSPPPARSGFYRQEC","Corresponds to amino acid residues M1 to E15; N-terminus.",null,null,"Protein-serine kinase, CMGC group, MAPK family, p38 subfamily","P53778","P53778","P53778","P53778","GO:0005737; GO:0005829; GO:0005739; GO:0005654; GO:0005634","GO:0005524; GO:0000287; GO:0004707; GO:0004674","GO:0007050; GO:0006975; GO:0007517; GO:0045445; GO:0018105; GO:0051149; GO:0010952; GO:0010468; GO:0006355; GO:0007165; GO:0006351"]
[1738,866,"NN082-2","p53 (TP53)","Pan-specific","Cellular tumor antigen p53",0,11258,14,388,{"v":4362.672,"d":"4363"},{"v":7665.855575858123,"d":"7666"},{"$nulls":3},0,8770,12,350,{"v":3065.3,"d":"3065"},{"v":5355.73857977157,"d":"5356"},{"$nulls":6},0,11916,14,354,{"v":4213.308,"d":"4213"},{"v":7208.301763462091,"d":"7208"},{"$nulls":10},"Tumour suppressor; Nuclear receptor co-regulator; Activator protein; Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Epitope undefined.",{"$nulls":4},"P04637","P04637",null,"P04637"]
[1742,868,"PN637","p53 (TP53)","S6+S9","Cellular tumor antigen p53",0,14453,16,739,{"v":10668.943,"d":"10669"},{"v":18746.900107333877,"d":"18747"},{"$nulls":3},0,14787,22,642,{"v":9479.13,"d":"9479"},{"v":16562.079484445265,"d":"16562"},{"$nulls":6},0,14997,18,678,{"v":10155.762,"d":"10156"},{"v":17374.898092876498,"d":"17375"},{"$nulls":10},"Tumour suppressor; Nuclear receptor co-regulator; Activator protein; Transcription protein",{"$nulls":4},"X",{"$nulls":4},"EPQ(pS)DP(pS)VEP(bA)C","Corresponds to amino acid residues E3 to P12.","S6 and S9 phosphorylation stimulates transcriptional activity. This are two of the minor in vivo phosphorylation sites in p53 (≥3 and ≥3 reports, repectively, by mass spectrometry).","S6: ATM; CK1d1 (CSNK1D); CK1e1 (CSNK1E). S9: ATM; CK1d1 (CSNK1D); CK1e1 (CSNK1E); DNAPK (PRKDC); HIPK4",null,"P04637","P04637",null,"P04637"]
[1743,869,"PN638","p53 (TP53)","T18+S20","Cellular tumor antigen p53",0,19466,18,651,{"v":12660.648,"d":"12661"},{"v":22246.618371671535,"d":"22247"},{"v":21877.371522329937,"d":"21877"},{"v":369.24684934159814,"d":"369"},{"v":1.687802618174276,"d":"2"},0,18431,140,597,{"v":10919.727,"d":"10920"},{"v":19079.112378714402,"d":"19079"},{"v":20703.317460980616,"d":"20703"},{"v":1624.2050822662131,"d":"1624"},{"v":7.845144070883037,"d":"8"},{"v":9.532946689057313,"d":"10"},{"v":-5.36652248260711,"d":"-5"},null,0,19775,20,680,{"v":13433.4,"d":"13433"},{"v":22982.416882243513,"d":"22982"},{"v":22859.681120103465,"d":"22860"},{"v":122.73576214004788,"d":"123"},{"v":0.5369093361154128,"d":"1"},{"v":2.2247119542896887,"d":"2"},{"v":4.490071381614101,"d":"4"},{"$nulls":5},"Tumour suppressor; Nuclear receptor co-regulator; Activator protein; Transcription protein",{"$nulls":4},"X",{"$nulls":4},"LSQE(pT)F(pS)DLW(bA)C","Corresponds to amino acid residues L14 to W23.","T18 and S20 phosphorylation stimulates binding of CBP/p300, and inhibits binding to its negative regulatory partner MDM2. T18 phosphorylation has not been reported by mass spectrometry studies, and phosphorylation of the S20 site has only been reported once by mass spectrometry, although ≥117 reports for S20 phosphorylation has been made based on Western blotting data..","T18: AMPKA1; Chk1 (CHEK1); Chk2 (CHEK2);  CK1a1 (CSNK1A1); CK1d1 (CSNK1D); DAPK1; DNAPK (PRKDC); VRK1; VRK2. S20: ATM; Chk1 (CHEK1); Chk2 (CHEK2); CK1a1 (CSNK1A1); CK1d1 (CSNK1D); DAPK1; DAPK3 (ZIPK); DNAPK (PRKDC); DRAK1 (STK17A); JNK1 (MAPK8); JNK2 (MAPK9); MAPKAPK2; Plk3 (CNK).","Tumor suppressor; Nuclear receptor co-regulator; Activator protein; Transcription factor","P04637","P04637",null,"P04637","GO:0005737; GO:0005829; GO:0005783; GO:0005622; GO:0005759; GO:0005739; GO:0000790; GO:0016363; GO:0005730; GO:0005654; GO:0005634; GO:0016605; GO:0032991; GO:0005657","GO:0005524; GO:0051087; GO:0003682; GO:0005507; GO:0001046; GO:0003684; GO:0097718; GO:0003677; GO:0003700; GO:0019899; GO:0035035; GO:0042826; GO:0042802; GO:0003730; GO:0002039; GO:1990841; GO:0002020; GO:0046982; GO:0019901; GO:0047485; GO:0051721; GO:0019903; GO:0043621; GO:0030971; GO:0000980; GO:0000978; GO:0000981; GO:0001085; GO:0001094; GO:0001228; GO:0001074; GO:0008134; GO:0044212; GO:0031625; GO:0008270","GO:0006914; GO:0006284; GO:0007569; GO:0007050; GO:0030154; GO:0008283; GO:0034613; GO:0072717; GO:0006974; GO:0035690; GO:0071480; GO:0042149; GO:0071456; GO:0071479; GO:0034644; GO:0031497; GO:0048512; GO:0019221; GO:0008340; GO:0030330; GO:0006977; GO:0006978; GO:0000733; GO:0043153; GO:0006983; GO:0097193; GO:0072332; GO:0042771; GO:0031571; GO:0009299; GO:0007275; GO:0043066; GO:0030308; GO:0008285; GO:0048147; GO:0051097; GO:0051974; GO:0045892; GO:0000122; GO:0006289; GO:0097252; GO:0090403; GO:0043065; GO:0071158; GO:1900119; GO:0010628; GO:0031065; GO:2001244; GO:0043525; GO:0050731; GO:1902895; GO:1903800; GO:0046827; GO:1900740; GO:0032461; GO:2000379; GO:0090200; GO:0045899; GO:0070245; GO:0045893; GO:0045944; GO:1990440; GO:0065003; GO:0016579; GO:0051289; GO:0008104; GO:0051262; GO:0007265; GO:0042981; GO:1902749; GO:0046902; GO:1901796; GO:0006355; GO:0090399; GO:0046677; GO:0010332; GO:0010165; GO:0072331; GO:0016032"]
[1748,871,"PN159","p53 (TP53)","S37","Cellular tumor antigen p53",0,4752,12,327,{"v":1549.98,"d":"1550"},{"v":2723.5425504068553,"d":"2724"},{"$nulls":3},0,4802,12,306,{"v":1465.74,"d":"1466"},{"v":2560.963124625446,"d":"2561"},{"$nulls":6},0,4656,12,334,{"v":1551.096,"d":"1551"},{"v":2653.679254424076,"d":"2654"},{"$nulls":10},"Tumour suppressor; Nuclear receptor co-regulator; Activator protein; Transcription protein",{"$nulls":4},"X",{"$nulls":4},"LP(pS)QA","Corresponds to amino acid residues L35 to A39.","S37 phosphorylation induces activation, binding to CBP and PPP2CA, and Inhibits binding to MDM2. This is one of the minor vivo phosphorylation sites in p53 (≥3 reports from high throughput mass spectrometry studies).","ATM; ATR; Chk1 (CHEK1); Chk2 (CHEK2); DNAPK (PRKDC); JNK1 (MAPK8); JNK3 (MAPK10); MAPKAPK5 (PRAK)",null,"P04637","P04637",null,"P04637"]
[1753,874,"PN255","p53 (TP53)","T155","Cellular tumor antigen p53",0,26,4,683,{"v":15.026,"d":"15"},{"v":26.4028893033545,"d":"26"},{"v":39.53229093217553,"d":"40"},{"v":13.129401628821029,"d":"13"},{"v":33.211841052538,"d":"33"},0,30,6,663,{"v":15.912,"d":"16"},{"v":27.801687365453695,"d":"28"},{"v":28.493584562331502,"d":"28"},{"v":0.6918971968778074,"d":"1"},{"v":2.4282560706401783,"d":"2"},{"v":35.64009712317818,"d":"36"},{"v":-27.923265031067473,"d":"-28"},null,0,28,8,666,{"v":13.32,"d":"13"},{"v":22.78840746731904,"d":"23"},{"v":23.852550819021175,"d":"24"},{"v":1.0641433517021355,"d":"1"},{"v":4.461339836465357,"d":"4"},{"v":37.673180889003355,"d":"38"},{"v":-39.66312030854892,"d":"-40"},{"$nulls":5},"Tumour suppressor; Nuclear receptor co-regulator; Activator protein; Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against amino acid residues 150-163 Thr-155 of human p53.","T155 phosphorylation induces binding to MDM2 and degradation. This is one of the minor in vivo phosphorylation sites in p53 (≥1 reports from high throughput mass spectrometry studies).","CK2a1 (CSNK2A1)","Tumor suppressor; Nuclear receptor co-regulator; Activator protein; Transcription factor","P04637","P04637",null,"P04637","GO:0005737; GO:0005829; GO:0005783; GO:0005622; GO:0005759; GO:0005739; GO:0000790; GO:0016363; GO:0005730; GO:0005654; GO:0005634; GO:0016605; GO:0032991; GO:0005657","GO:0005524; GO:0051087; GO:0003682; GO:0005507; GO:0001046; GO:0003684; GO:0097718; GO:0003677; GO:0003700; GO:0019899; GO:0035035; GO:0042826; GO:0042802; GO:0003730; GO:0002039; GO:1990841; GO:0002020; GO:0046982; GO:0019901; GO:0047485; GO:0051721; GO:0019903; GO:0043621; GO:0030971; GO:0000980; GO:0000978; GO:0000981; GO:0001085; GO:0001094; GO:0001228; GO:0001074; GO:0008134; GO:0044212; GO:0031625; GO:0008270","GO:0006914; GO:0006284; GO:0007569; GO:0007050; GO:0030154; GO:0008283; GO:0034613; GO:0072717; GO:0006974; GO:0035690; GO:0071480; GO:0042149; GO:0071456; GO:0071479; GO:0034644; GO:0031497; GO:0048512; GO:0019221; GO:0008340; GO:0030330; GO:0006977; GO:0006978; GO:0000733; GO:0043153; GO:0006983; GO:0097193; GO:0072332; GO:0042771; GO:0031571; GO:0009299; GO:0007275; GO:0043066; GO:0030308; GO:0008285; GO:0048147; GO:0051097; GO:0051974; GO:0045892; GO:0000122; GO:0006289; GO:0097252; GO:0090403; GO:0043065; GO:0071158; GO:1900119; GO:0010628; GO:0031065; GO:2001244; GO:0043525; GO:0050731; GO:1902895; GO:1903800; GO:0046827; GO:1900740; GO:0032461; GO:2000379; GO:0090200; GO:0045899; GO:0070245; GO:0045893; GO:0045944; GO:1990440; GO:0065003; GO:0016579; GO:0051289; GO:0008104; GO:0051262; GO:0007265; GO:0042981; GO:1902749; GO:0046902; GO:1901796; GO:0006355; GO:0090399; GO:0046677; GO:0010332; GO:0010165; GO:0072331; GO:0016032"]
[1758,876,"PN640","p53 (TP53)","S392","Cellular tumor antigen p53",0,14606,16,702,{"v":10242.18,"d":"10242"},{"v":17997.014825304897,"d":"17997"},{"$nulls":3},0,7172,14,540,{"v":3865.32,"d":"3865"},{"v":6753.5456389791025,"d":"6754"},{"$nulls":6},0,8789,14,599,{"v":5256.225,"d":"5256"},{"v":8992.567345338515,"d":"8993"},{"$nulls":10},"Tumour suppressor; Nuclear receptor co-regulator; Activator protein; Transcription protein",{"$nulls":4},"X",{"$nulls":4},"CEGPD(pS)D(-cooh)","Corresponds to amino acid residues C388 to D393.","S392 phosphorylation induces activity, stimulates binding to DNA, NFkB-p65, UBE4B and p21Cip1, and inhibits binding of CDK1 and MDM2. This is one of the minor in vivo phosphorylation sites in p53 (≥13 reports by mass spectrometry), althoug there are ≥94 reports with Western blotting.","ATM; CDK7; CDK9; CK2a1 (CSNK2A1); ERK1 (MAPK3); LKB1 (STK11); NuaK1; PKR (EIF2AK2)",null,"P04637","P04637",null,"P04637"]
[1760,877,"PN252","p53 (TP53)","S392","Cellular tumor antigen p53",0,82,10,534,{"v":38.448,"d":"38"},{"v":67.55878397014334,"d":"68"},{"$nulls":3},0,59,8,442,{"v":22.542,"d":"23"},{"v":39.38572376772607,"d":"39"},{"$nulls":6},0,66,6,439,{"v":26.34,"d":"26"},{"v":45.063562514202964,"d":"45"},{"$nulls":10},"Tumour suppressor; Nuclear receptor co-regulator; Activator protein; Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against amino acid residues 78-393; At the C-terminus of human p53.","S392 phosphorylation induces activity, stimulates binding to DNA, NFkB-p65, UBE4B and p21Cip1, and inhibits binding of CDK1 and MDM2. This is one of the minor in vivo phosphorylation sites in p53 (≥13 reports by mass spectrometry), althoug there are ≥94 reports with Western blotting.","ATM; CDK7; CDK9; CK2a1 (CSNK2A1); ERK1 (MAPK3); LKB1 (STK11); NuaK1; PKR (EIF2AK2)",null,"P04637","P04637",null,"P04637"]
[1765,880,"PK145","p70S6K (S6Ka, RPS6KB1)","T252","Ribosomal protein S6 kinase beta-1; Ribosomal protein S6 kinase 1",0,1080,16,292,{"v":310.688,"d":"311"},{"v":545.924455735432,"d":"546"},{"v":379.3293582476748,"d":"379"},{"v":166.59509748775724,"d":"167"},{"v":43.91832423869038,"d":"44"},0,1450,22,284,{"v":405.552,"d":"406"},{"v":708.5865959297686,"d":"709"},{"v":733.2546529351204,"d":"733"},{"v":24.668057005351784,"d":"25"},{"v":3.364186903773314,"d":"3"},{"v":47.2825111424637,"d":"47"},{"v":93.30290076212816,"d":"93"},"Possible",0,631,12,298,{"v":184.462,"d":"184"},{"v":315.58522659433964,"d":"316"},{"v":325.2309504157169,"d":"325"},{"v":9.64572382137726,"d":"10"},{"v":2.9658074697527703,"d":"3"},{"v":46.88413170844315,"d":"47"},{"v":-14.261592638615525,"d":"-14"},null,null,"p70S6K","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","p70",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues that encompass the T229 phosphosite.","T252 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation regulates protein translation and protein conformation. This is one of the minor in vivo phosphorylation sites in p70 S6K (≥18 reports from high throughput mass spectrometry studies).","PDPK1 (PDK1); PIK3CD","Protein-serine kinase, AGC group, RSK family, p70 subfamily","P23443","P23443","P23443","P23443","GO:0030054; GO:0009986; GO:0005737; GO:0005829; GO:0005741; GO:0005739; GO:0043005; GO:0005654; GO:0005634; GO:0048471; GO:0045202","GO:0005524; GO:0042802; GO:0016301; GO:0030165; GO:0042277; GO:0004672; GO:0051721; GO:0004712; GO:0004674; GO:0004711","GO:0007568; GO:0006915; GO:0001662; GO:0016477; GO:0071549; GO:0071363; GO:0032869; GO:0071346; GO:0000082; GO:0007281; GO:0044539; GO:0007616; GO:0043066; GO:2001237; GO:0046627; GO:0018105; GO:0048015; GO:0045931; GO:0048633; GO:0014911; GO:0048661; GO:0045727; GO:0045948; GO:0043491; GO:0046324; GO:0014878; GO:0045471; GO:0033762; GO:0009749; GO:0009408; GO:0043201; GO:0032496; GO:0009612; GO:0007584; GO:0033574; GO:0034612; GO:0009611; GO:0007165; GO:0014732; GO:0003009; GO:0031929"]
[1770,882,"PK199","p70S6K (S6Ka, RPS6KB1)","S434","Ribosomal protein S6 kinase beta-1; Ribosomal protein S6 kinase 1",0,297,14,538,{"v":152.254,"d":"152"},{"v":267.53264395001565,"d":"268"},{"$nulls":3},0,200,12,473,{"v":88.924,"d":"89"},{"v":155.36935943222753,"d":"155"},{"$nulls":6},0,297,14,434,{"v":122.822,"d":"123"},{"v":210.12896260893837,"d":"210"},{"$nulls":7},"p70S6K","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","p70",{"$nulls":5},"Not precisely defined.","Antibody raised against a sequence containing phosphorylated Ser-411 of human p70 S6 kinase α.","S434 phosphorylation stimulates phosphotransferase activity. This is one of the minor in vivo phosphorylation sites in p70 S6K (≥1 reports from high throughput mass spectrometry studies).","CDK5; ERK1 (MAPK3); ERK2 (MAPK1); JNK1 (MAPK8); JNK2 (MAPK9); mTOR (FRAP)",null,"P23443","P23443","P23443","P23443"]
[1775,885,"PK200","p70S6K (S6Ka, RPS6KB1)","T421+S424","Ribosomal protein S6 kinase beta-1; Ribosomal protein S6 kinase 1",0,380,10,457,{"v":169.09,"d":"169"},{"v":297.1159691404374,"d":"297"},{"v":292.49203707589743,"d":"292"},{"v":4.623932064539986,"d":"5"},{"v":1.5808745122658305,"d":"2"},0,430,8,440,{"v":185.68,"d":"186"},{"v":324.42290786937167,"d":"324"},{"v":300.60836546168355,"d":"301"},{"v":23.814542407688123,"d":"24"},{"v":7.922115664051138,"d":"8"},{"v":9.502990176316969,"d":"10"},{"v":2.774888666004969,"d":"3"},null,0,468,12,465,{"v":212.04,"d":"212"},{"v":362.7668107635382,"d":"363"},{"v":358.85411647842125,"d":"359"},{"v":3.91269428511697,"d":"4"},{"v":1.0903300548740535,"d":"1"},{"v":2.671204567139884,"d":"3"},{"v":22.68850805853009,"d":"23"},null,null,"p70S6K","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","p70",{"$nulls":5},"Epitope undefined.","Antibody raised against amino acid residues that encompass the T421 and S424 phosphosites.","T444 and S447 phosphorylation stimulate phosphotransferase activity. Their phosphorylation regulates cell adhesion, cell cycle progression, and molecular association. These are two of the major in vivo phosphorylation sites in p70 S6K.","T444: CDK1 (CDC2); ERK1 (MAPK3); ERK2 (MAPK1). S447: CDK1 (CDC2); CDK5; ERK1 (MAPK3); ERK2 (MAPK1); TBK1","Protein-serine kinase, AGC group, RSK family, p70 subfamily","P23443","P23443","P23443","P23443","GO:0030054; GO:0009986; GO:0005737; GO:0005829; GO:0005741; GO:0005739; GO:0043005; GO:0005654; GO:0005634; GO:0048471; GO:0045202","GO:0005524; GO:0042802; GO:0016301; GO:0030165; GO:0042277; GO:0004672; GO:0051721; GO:0004712; GO:0004674; GO:0004711","GO:0007568; GO:0006915; GO:0001662; GO:0016477; GO:0071549; GO:0071363; GO:0032869; GO:0071346; GO:0000082; GO:0007281; GO:0044539; GO:0007616; GO:0043066; GO:2001237; GO:0046627; GO:0018105; GO:0048015; GO:0045931; GO:0048633; GO:0014911; GO:0048661; GO:0045727; GO:0045948; GO:0043491; GO:0046324; GO:0014878; GO:0045471; GO:0033762; GO:0009749; GO:0009408; GO:0043201; GO:0032496; GO:0009612; GO:0007584; GO:0033574; GO:0034612; GO:0009611; GO:0007165; GO:0014732; GO:0003009; GO:0031929"]
[1776,885,"PK200","p70S6K (S6Ka, RPS6KB1)","T421+S424","Ribosomal protein S6 kinase beta-1; Ribosomal protein S6 kinase 1",0,339,12,501,{"v":163.827,"d":"164"},{"v":287.86810501135744,"d":"288"},{"$nulls":3},0,366,10,445,{"v":158.42,"d":"158"},{"v":276.79382305399537,"d":"277"},{"$nulls":6},0,418,12,511,{"v":207.466,"d":"207"},{"v":354.9414221933042,"d":"355"},{"$nulls":7},"p70S6K","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","p70",{"$nulls":5},"Epitope undefined.","Antibody raised against amino acid residues that encompass the T421 and S424 phosphosites.","T444 and S447 phosphorylation stimulate phosphotransferase activity. Their phosphorylation regulates cell adhesion, cell cycle progression, and molecular association. These are two of the major in vivo phosphorylation sites in p70 S6K.","T444: CDK1 (CDC2); ERK1 (MAPK3); ERK2 (MAPK1). S447: CDK1 (CDC2); CDK5; ERK1 (MAPK3); ERK2 (MAPK1); TBK1",null,"P23443","P23443","P23443","P23443"]
[1783,890,"PN713","PAH","S16","Phenylalanine-4-hydroxylase",0,10301,16,682,{"v":7014.37,"d":"7014"},{"v":12325.27849346271,"d":"12325"},{"v":13796.48927039888,"d":"13796"},{"v":1471.21077693617,"d":"1471"},{"v":10.663660501608426,"d":"11"},0,9880,14,646,{"v":6373.436,"d":"6373"},{"v":11135.763896161872,"d":"11136"},{"v":11785.284136946058,"d":"11785"},{"v":649.5202407841862,"d":"650"},{"v":5.51128197875166,"d":"6"},{"v":16.174942480360087,"d":"16"},{"v":-14.577658808954922,"d":"-15"},null,0,10801,14,684,{"v":7378.308,"d":"7378"},{"v":12623.114799052539,"d":"12623"},{"v":11776.0122092212,"d":"11776"},{"v":847.1025898313383,"d":"847"},{"v":7.193458827836601,"d":"7"},{"v":17.857119329445027,"d":"18"},{"v":-14.644863788012529,"d":"-15"},{"$nulls":14},"X","RKL(pS)DFG(bA)C","Corresponds to amino acid residues R13 to G19; Near N-terminus.","S16 phosphorylation stimulates enzyme activity and inhibits interaction with PAH. This is the major in vivo phosphorylation sites in phenylalanine-4-hydroxylase (≥41 reports from high throughput mass spectrometry studies). This human phosphosite is not highly conserved in vertebrates, but is found in the rat.","PKACa (PRKACA)","Enzyme","P00439","P00439",null,null,"GO:0005829","GO:0005506; GO:0004505","GO:0042423; GO:0008652; GO:0006559; GO:0042136"]
[1787,892,"NK122-2","PAK1 (PAKa)","Pan-specific","p21-activated kinase 1 (alpha) (Protein-serine/threonine kinase PAK 1)",0,4090,14,560,{"v":2282.56,"d":"2283"},{"v":4010.79322562657,"d":"4011"},{"v":5443.21762048916,"d":"5443"},{"v":1432.4243948625904,"d":"1432"},{"v":26.315765687388854,"d":"26"},0,4344,16,655,{"v":2834.84,"d":"2835"},{"v":4953.075377770409,"d":"4953"},{"v":4748.853882922263,"d":"4749"},{"v":204.221494848146,"d":"204"},{"v":4.300437534676807,"d":"4"},{"v":30.61620322206566,"d":"31"},{"v":-12.756494154361903,"d":"-13"},null,0,4018,18,564,2256,{"v":3859.6582016720536,"d":"3860"},{"v":4176.759233748078,"d":"4177"},{"v":317.1010320760247,"d":"317"},{"v":7.592035219886717,"d":"8"},{"v":33.90780090727557,"d":"34"},{"v":-23.266723380192005,"d":"-23"},null,null,"PAK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","PAKA",{"$nulls":5},"MSNNGLDVQDKPC","Corresponds to amino acid residues M1 to P12; N-terminus.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE20 family; PAKA subfamily","Q13153","Q13153","Q13153","Q13153","GO:0030424; GO:0005911; GO:0005737; GO:0005829; GO:0030425; GO:0005925; GO:0014704; GO:0071437; GO:0030027; GO:0031965; GO:0005886; GO:0032991; GO:0001726; GO:0032587; GO:0030018","GO:0005524; GO:0005518; GO:0042802; GO:0004672; GO:0019901; GO:0004674; GO:0048365","GO:0031532; GO:0032147; GO:0006915; GO:0048754; GO:0032869; GO:0021549; GO:0048013; GO:0030010; GO:0006887; GO:0038095; GO:0038096; GO:0048012; GO:0061052; GO:0060244; GO:0048812; GO:0045773; GO:0030335; GO:0008284; GO:0010763; GO:2001275; GO:0033148; GO:0043507; GO:0031116; GO:0033138; GO:0001934; GO:0090314; GO:0051496; GO:1904754; GO:1904707; GO:0046777; GO:0006468; GO:0042981; GO:0050770; GO:0007346; GO:0001666; GO:0007266; GO:0002223; GO:0031295; GO:0050852; GO:0042060"]
[1792,894,"PK748","PAK1 (PAKa)","S144","p21-activated kinase 1 (alpha) (Protein-serine/threonine kinase PAK 1)",0,12812,18,773,{"v":9889.762,"d":"9890"},{"v":17377.764629477027,"d":"17378"},{"$nulls":3},0,12350,18,635,{"v":7830.82,"d":"7831"},{"v":13682.12729104714,"d":"13682"},{"$nulls":6},0,12825,18,663,{"v":8491.041,"d":"8491"},{"v":14526.82448421262,"d":"14527"},{"$nulls":7},"PAK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","PAKA",{"$nulls":5},"KYM(pS)FTD(bA)C","Corresponds to amino acid residues K141 to D147; Just after the PBD. The major site of phosphorylation of PAK1.","S144 phosphorylation stimulates phosphotransferase activity and regulates cytoskeletal reorganization, and intracellular location. This is one of the major in vivo phosphorylation sites in PAK1 (≥163 reports from high throughput mass spectrometry studies).","PAK1",null,"Q13153","Q13153","Q13153","Q13153"]
[1793,895,"PK130","PAK1 (PAKa)","T212","p21-activated kinase 1 (alpha) (Protein-serine/threonine kinase PAK 1)",0,1764,10,296,{"v":519.184,"d":"519"},{"v":912.2825555751897,"d":"912"},{"v":1528.821473738008,"d":"1529"},{"v":616.5389181628184,"d":"617"},{"v":40.32772490141473,"d":"40"},0,3036,16,277,{"v":836.54,"d":"837"},{"v":1461.6153562529307,"d":"1462"},{"v":1531.800988572581,"d":"1532"},{"v":70.18563231965027,"d":"70"},{"v":4.5819027956793015,"d":"5"},{"v":44.90962769709404,"d":"45"},{"v":0.1948896509994711,"d":"0"},null,0,2268,14,316,{"v":712.264,"d":"712"},{"v":1218.5707399626524,"d":"1219"},{"v":1269.8412350813173,"d":"1270"},{"v":51.27049511866494,"d":"51"},{"v":4.037551601116632,"d":"4"},{"v":44.365276502531366,"d":"44"},{"v":-16.939861396862597,"d":"-17"},null,null,"PAK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","PAKA",{"$nulls":5},"PV(pT)PT","Corresponds to amino acid residues P210 to T214; Surrounds the T212 phosphosite.","T212 phosphorylation inhibits phosphotransferase activity. This is one of the major in vivo phosphorylation sites in PAK1 (≥38 reports from high throughput mass spectrometry studies).","CDK1 (CDC2); CDK5","EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE20 family; PAKA subfamily","Q13153","Q13153","Q13153","Q13153","GO:0030424; GO:0005911; GO:0005737; GO:0005829; GO:0030425; GO:0005925; GO:0014704; GO:0071437; GO:0030027; GO:0031965; GO:0005886; GO:0032991; GO:0001726; GO:0032587; GO:0030018","GO:0005524; GO:0005518; GO:0042802; GO:0004672; GO:0019901; GO:0004674; GO:0048365","GO:0031532; GO:0032147; GO:0006915; GO:0048754; GO:0032869; GO:0021549; GO:0048013; GO:0030010; GO:0006887; GO:0038095; GO:0038096; GO:0048012; GO:0061052; GO:0060244; GO:0048812; GO:0045773; GO:0030335; GO:0008284; GO:0010763; GO:2001275; GO:0033148; GO:0043507; GO:0031116; GO:0033138; GO:0001934; GO:0090314; GO:0051496; GO:1904754; GO:1904707; GO:0046777; GO:0006468; GO:0042981; GO:0050770; GO:0007346; GO:0001666; GO:0007266; GO:0002223; GO:0031295; GO:0050852; GO:0042060"]
[1798,897,"NK200-2","PAK2 (PAKg)","Pan-specific","p21-activated kinase 2 (gamma) (Protein-serine/threonine kinase PAK2)",0,146,16,538,{"v":69.94,"d":"70"},{"v":122.89485411131463,"d":"123"},{"$nulls":3},0,116,14,404,{"v":41.208,"d":"41"},{"v":71.99924163873905,"d":"72"},{"$nulls":6},0,164,16,397,{"v":58.756,"d":"59"},{"v":100.52219738361843,"d":"101"},{"$nulls":7},"PAK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","PAKA",{"$nulls":5},"Epitope undefined.",{"$nulls":4},"Q13177","Q13177","Q13177"]
[1801,899,"PK750","PAK2 (PAKg)","S141","p21-activated kinase 2 gamma; Protein-serine/threonine kinase PAK 2",0,13328,16,561,{"v":7468.032,"d":"7468"},{"v":13122.429269926068,"d":"13122"},{"v":14279.961211052465,"d":"14280"},{"v":1157.5319411263972,"d":"1158"},{"v":8.105987992673857,"d":"8"},0,13527,20,550,{"v":7428.85,"d":"7429"},{"v":12979.799219761859,"d":"12980"},{"v":12900.994575138677,"d":"12901"},{"v":78.80464462318196,"d":"79"},{"v":0.6108416228237571,"d":"1"},{"v":8.716829615497614,"d":"9"},{"v":-9.65665533353473,"d":"-10"},null,0,13219,18,607,{"v":8013.007,"d":"8013"},{"v":13708.984125711691,"d":"13709"},{"v":13955.570263164838,"d":"13956"},{"v":246.58613745314688,"d":"247"},{"v":1.7669370208682977,"d":"2"},{"v":9.872925013542154,"d":"10"},{"v":-2.271651463846794,"d":"-2"},null,null,"PAK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","PAKA",{"$nulls":5},"KYL(pS)FTP(bA)C","Corresponds to amino acid residues K138 to P144; In the region between the PBD (p21-binding domain) and the kinase catalytic domain in the N-terminal third of the protein.","S141 phosphorylation stimulates phosphotransferase activity. This is one of the major in vivo phosphorylation sites in PAK2 (≥154 reports from high throughput mass spectrometry studies).","PAK2","EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE20 family; PAKA subfamily","Q13177","Q13177","Q13177",null,"GO:0005737; GO:0005829; GO:0098978; GO:0005634; GO:0048471; GO:0005886; GO:0014069","GO:0005524; GO:0045296; GO:0042802; GO:0004672; GO:0019901; GO:0004674; GO:0030296; GO:0048365; GO:0031267","GO:0030036; GO:0006915; GO:0016477; GO:0071407; GO:0060996; GO:0038095; GO:0035722; GO:0043066; GO:2001271; GO:0006469; GO:0018105; GO:0016310; GO:2001238; GO:0050731; GO:0046777; GO:0006468; GO:0050690; GO:0040008; GO:0043408; GO:0007346; GO:0007266; GO:0007165; GO:0023014; GO:0002223; GO:0031098; GO:0031295; GO:0050852; GO:0048010"]
[1809,903,"NK190-3","PAK5 (PAK7)","Pan-specific","p21-activated kinase 5;  Protein-serine/threonine kinase PAK 7",0,6968,12,590,{"v":4104.04,"d":"4104"},{"v":7211.401159093504,"d":"7211"},{"v":8577.217386458273,"d":"8577"},{"v":1365.8162273647686,"d":"1366"},{"v":15.923768348475367,"d":"16"},0,6586,16,558,{"v":3666.06,"d":"3666"},{"v":6405.395549459224,"d":"6405"},{"v":6908.158454254137,"d":"6908"},{"v":502.7629047949131,"d":"503"},{"v":7.2778137346474,"d":"7"},{"v":23.201582083122766,"d":"23"},{"v":-19.459212201374882,"d":"-19"},null,0,7372,16,571,{"v":4200.276,"d":"4200"},{"v":7186.006078318389,"d":"7186"},{"v":7530.522488431955,"d":"7531"},{"v":344.51641011356605,"d":"345"},{"v":4.574933686776667,"d":"5"},{"v":20.498702035252034,"d":"20"},{"v":-12.203198903164576,"d":"-12"},null,null,"PAK5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","PAKB",{"$nulls":5},"CKETSINGLLEDFDNISV","Corresponds to amino acid residues C77 to V94; Post-PBD.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE20 family; PAKB subfamily","Q9P286","Q9P286","Q9P286","Q9P286","GO:0005737; GO:0005739; GO:0005654; GO:0045202","GO:0005524; GO:0004674; GO:0048365","GO:0030036; GO:0032147; GO:0006915; GO:0016477; GO:0008283; GO:0007010; GO:0007612; GO:0007626; GO:0007613; GO:2001237; GO:0042981; GO:0001558; GO:0043408; GO:0007346; GO:0007266; GO:0007165; GO:0023014; GO:0031098"]
[1810,903,"NK190-3","PAK5 (PAK7)","Pan-specific","p21-activated kinase 5;  Protein-serine/threonine kinase PAK 7",0,7386,18,768,{"v":5658.624,"d":"5659"},{"v":9943.033613823043,"d":"9943"},{"$nulls":3},0,6958,16,611,{"v":4241.562,"d":"4242"},{"v":7410.921359049051,"d":"7411"},{"$nulls":6},0,7193,12,641,{"v":4603.021,"d":"4603"},{"v":7875.038898545521,"d":"7875"},{"$nulls":7},"PAK5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","PAKB",{"$nulls":5},"CKETSINGLLEDFDNISV","Corresponds to amino acid residues C77 to V94; Post-PBD.",{"$nulls":3},"Q9P286","Q9P286","Q9P286","Q9P286"]
[1815,909,"NK284-1","PBK","Pan-specific","Lymphokine-activated killer T-cell-originated protein kinase",0,474,14,443,{"v":203.78,"d":"204"},{"v":358.0713950643937,"d":"358"},{"v":522.333001470369,"d":"522"},{"v":164.26160640597533,"d":"164"},{"v":31.44767915172474,"d":"31"},0,464,16,416,{"v":186.368,"d":"186"},{"v":325.62499188818964,"d":"326"},{"v":331.8171223572173,"d":"332"},{"v":6.1921304690276315,"d":"6"},{"v":1.866127469564847,"d":"2"},{"v":33.31380662128959,"d":"33"},{"v":-36.47402683285355,"d":"-36"},null,0,674,14,412,{"v":271.92,"d":"272"},{"v":465.2119938823869,"d":"465"},{"v":489.25530351766974,"d":"489"},{"v":24.043309635282867,"d":"24"},{"v":4.91426653168912,"d":"5"},{"v":36.36194568341386,"d":"36"},{"v":-6.332683912290719,"d":"-6"},null,null,"PBK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine",null,"Other","TOPK",{"$nulls":6},"GISNFKTPSKLSEKKKSVLC","Corresponds to amino acid residues G3-C22; N-terminus.",null,null,"Protein-serine kinase, Other group, TOPK family","Q96KB5","Q96KB5","Q96KB5","Q96KB5","GO:0005634","GO:0005524; GO:0004674","GO:0034644; GO:0000278; GO:0050728; GO:0032435; GO:0032873"]
[1820,911,"PK889","PBK","Y272","Lymphokine-activated killer T-cell-originated protein kinase",0,5542,14,713,{"v":3941.464,"d":"3941"},{"v":6925.731244852711,"d":"6926"},{"$nulls":3},0,5986,14,605,{"v":3613.06,"d":"3613"},{"v":6312.79314684679,"d":"6313"},{"$nulls":6},0,5766,14,587,{"v":3376.424,"d":"3376"},{"v":5776.525968050692,"d":"5777"},{"$nulls":7},"PBK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","TOPK",{"$nulls":6},"EAY(pY)AAL(bA)C","Corresponds to amino acid residues  E269 to L275. Y272 is located in the Gap/Insert 10 (G/I10) region in the protein-serine/threonine kinase catalytic domain of PBK.","Phosphorylation of Y272 by Src stimulates phosphotransferase activity of PBK and stabilizes the protein. PBK can phosphorylate p38 MAPK, and it is primarly activated during mitosis. Phosphorylation of Y272 has not been observed in reported mass spectrometry studies.","Src",null,"Q96KB5","Q96KB5","Q96KB5","Q96KB5"]
[1824,913,"PK755","PCTK1 (PCTAIRE1, CDK16)","Y176","Cell division protein kinase 16; Protein-serine kinase PCTAIRE-1",0,5701,12,750,{"v":4266.75,"d":"4267"},{"v":7497.306531018755,"d":"7497"},{"$nulls":3},0,6148,12,612,{"v":3755.232,"d":"3755"},{"v":6561.198218247072,"d":"6561"},{"$nulls":6},0,6450,16,637,{"v":4098.458,"d":"4098"},{"v":7011.811628505514,"d":"7012"},{"$nulls":7},"PCTAIRE1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","TAIRE",{"$nulls":5},"EGT(pY)ATV(bA)C","Corresponds to amino acid residues E173 to V179; In the protein kinase catalytic domain in subdomain I. ","Y176 phosphorylation is predicted to be inhibitory for phosphotransferase activity. These phosphosites are located in the kinase subdomain I region, which is involved in binding the phosphates in the ATP substrate. This is the major in vivo phosphorylation site in PCTK1 (≥336 reports from high throughput mass spectrometry studies).",null,null,"Q00536","Q00536","Q00536","Q00536"]
[1827,915,"PK756","PCTK2 (PCTAIRE2, CDK17))","S180","Cell division protein kinase 17; Protein-serine kinase PCTAIRE-2",0,7591,14,599,{"v":4538.623,"d":"4539"},{"v":7975.027329872134,"d":"7975"},{"v":8576.246562796612,"d":"8576"},{"v":601.2192329244781,"d":"601"},{"v":7.010283910592557,"d":"7"},0,7285,14,574,{"v":4173.554,"d":"4174"},{"v":7292.096751561006,"d":"7292"},{"v":7889.5639587861415,"d":"7890"},{"v":597.4672072251351,"d":"597"},{"v":7.572879950605777,"d":"8"},{"v":14.583163861198333,"d":"15"},{"v":-8.006796434576287,"d":"-8"},null,0,8058,18,592,{"v":4759.68,"d":"4760"},{"v":8143.057601655337,"d":"8143"},{"v":8438.68757414316,"d":"8439"},{"v":295.62997248782267,"d":"296"},{"v":3.5032695533563474,"d":"4"},{"v":10.513553463948904,"d":"11"},{"v":-1.6039532870962177,"d":"-2"},null,null,"PCTAIRE2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","TAIRE",{"$nulls":5},"RRA(pS)LSE(bA)C","Corresponds to amino acid residues R177 to E183; Just before kinase catalytic domain. ","The effect of S180 phosphorylation is unclear. One of two major sites of phosphorylation of PCTK2 (≥339 reports from high throughput mass spectrometry studies).",null,"EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC domain target; CMGC</A> group; CDK family; TAIRE subfamily; CDK/TAIRE subfamily","Q00537","Q00537","Q00537",null,"GO:0005737; GO:0005634","GO:0005524; GO:0004672; GO:0004674","GO:0006468; GO:0051726"]
[1832,917,"NN-456-2","PCYT1A (CTPCT; CCTA)","Pan-specific","CTP: phosphocholine cytidylyltransferase isoform A",0,4122,18,723,{"v":2967.192,"d":"2967"},{"v":5213.792221336286,"d":"5214"},{"$nulls":3},0,3464,16,515,{"v":1775.72,"d":"1776"},{"v":3102.5648748481294,"d":"3103"},{"$nulls":6},0,3938,14,578,{"v":2268.072,"d":"2268"},{"v":3880.3114790703626,"d":"3880"},{"$nulls":10},"Metabolic enzyme",{"$nulls":8},"X","Epitope undefined.",{"$nulls":4},"P49585","P49585"]
[1837,920,"PN547","PCYT1A (CTPCT; CCTA)","T342+S343","CTP: phosphocholine cytidylyltransferase isoform A",0,1244,14,423,{"v":520.29,"d":"520"},{"v":914.2259600454087,"d":"914"},{"v":1170.2932204798922,"d":"1170"},{"v":256.0672604344835,"d":"256"},{"v":21.88060700970994,"d":"22"},0,1154,16,399,{"v":454.062,"d":"454"},{"v":793.3440025472999,"d":"793"},{"v":803.5634639223965,"d":"804"},{"v":10.219461375096671,"d":"10"},{"v":1.2717677985523252,"d":"1"},{"v":23.152374808262266,"d":"23"},{"v":-31.33657019794697,"d":"-31"},null,0,1394,16,406,{"v":559.468,"d":"559"},{"v":957.1610171866402,"d":"957"},{"v":1064.9731097818387,"d":"1065"},{"v":107.81209259519858,"d":"108"},{"v":10.123456790123466,"d":"10"},{"v":32.0040637998334,"d":"32"},{"v":-8.99946345539503,"d":"-9"},{"$nulls":5},"Metabolic enzyme",{"$nulls":8},"X","FSGK(pT)(pS)PP(bA)C                                                                                                                                          ","Corresponds to amino acid residues F338 to C346; Near the C-terminus of the protein. ","The effects of T342 and S343 phosphorylation are unclear. These are among the main in vivo phosphorylation sites in PCYT1A (≥33 and ≥50 reports, respectively, from high throughput mass spectrometry studies).",null,"EC 2.7.7.15; Lipid Metabolism - glycerophospholipid; Transferase","P49585","P49585",null,null,"GO:0005829; GO:0005789; GO:0042587; GO:0005635; GO:0005886","GO:0005516; GO:0004105; GO:0031210; GO:0042803","GO:0006657; GO:0006656"]
[1842,922,"PN546","PCYT1B (CCTB)","S315+S319","CTP: phosphocholine cytidylyltransferase isoform B",0,2443,16,491,{"v":1191.657,"d":"1192"},{"v":2093.91640214079,"d":"2094"},{"$nulls":3},0,1878,18,394,{"v":732.84,"d":"733"},{"v":1280.4291458584141,"d":"1280"},{"$nulls":6},0,122,18,660,{"v":68.64,"d":"69"},{"v":117.43215379555397,"d":"117"},{"$nulls":10},"Metabolic enzyme",{"$nulls":8},"X","LQAL(pS)PKQ(pS)PV(bA)C","Corresponds to amino acid residues L311 to V321; Near the C-terminus of the protein. ","S315 phosphorylation inhibits cytidyltransferase activity. S315 and S319 are the main in vivo phosphorylation sites in PCYT1B (≥36 and ≥9 reports, respectively, from high throughput mass spectrometry studies).","S315: ERK1 (MAPK3); ERK2 (MAPK1).",null,"Q9Y5K3","Q9Y5K3"]
[1847,925,"PK063","PDGFRa","Y754","Platelet-derived growth factor receptor kinase alpha",0,1334,12,489,{"v":646.458,"d":"646"},{"v":1135.9216699898802,"d":"1136"},{"v":1068.072956781413,"d":"1068"},{"v":67.84871320846719,"d":"68"},{"v":6.352441823162161,"d":"6"},0,1082,10,457,{"v":489.904,"d":"490"},{"v":855.9676877253158,"d":"856"},{"v":971.2699094838013,"d":"971"},{"v":115.30222175848542,"d":"115"},{"v":11.87128527638263,"d":"12"},{"v":18.223727099544792,"d":"18"},{"v":-9.063336608514376,"d":"-9"},null,0,1287,10,467,{"v":596.359,"d":"596"},{"v":1020.2756673275462,"d":"1020"},{"v":1117.9689884538664,"d":"1118"},{"v":97.69332112632014,"d":"98"},{"v":8.738464316566462,"d":"9"},{"v":15.090906139728624,"d":"15"},{"v":4.671593953919825,"d":"5"},null,null,"PDGFRA","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues that encompass the Y754 phosphosite.","Y574 phosphorylation induces interaction with Src and promotes internalization of the activated receptor. This is one of the minor in vivo phosphorylation sites in PDGFRa (≥16 reports from high throughput mass spectrometry studies).","PDGFRA","Receptor tyrosine kinase; EC 2.7.10.1; TK group; PDGFR family","P16234","P16234","P16234","P16234","GO:0030054; GO:0005737; GO:0005887; GO:0031226; GO:0016020; GO:0005634; GO:0005886; GO:0032991","GO:0005524; GO:0046934; GO:0005018; GO:0048407; GO:0005161; GO:0042803; GO:0004672; GO:0005088; GO:0004714; GO:0005021; GO:0038085","GO:0055003; GO:0001775; GO:0060326; GO:0034614; GO:0048701; GO:0048557; GO:0048704; GO:0001553; GO:0000165; GO:0072277; GO:0010544; GO:0018108; GO:0048015; GO:0070527; GO:0035790; GO:0048008; GO:0030335; GO:0008284; GO:0038091; GO:0007204; GO:0070374; GO:0048146; GO:0043552; GO:0014068; GO:0010863; GO:0051897; GO:0046777; GO:2000249; GO:0050920; GO:2000739; GO:0061298; GO:0016032; GO:0042060"]
[1849,926,"PK758","PDGFRa","Y762","Platelet-derived growth factor receptor kinase alpha",0,4572,16,589,{"v":2683.484,"d":"2683"},{"v":4715.275588934043,"d":"4715"},{"v":4394.5224797091705,"d":"4395"},{"v":320.7531092248728,"d":"321"},{"v":7.298929763265205,"d":"7"},0,4142,16,539,{"v":2223.914,"d":"2224"},{"v":3885.6562189326037,"d":"3886"},{"v":4306.35854368418,"d":"4306"},{"v":420.7023247515767,"d":"421"},{"v":9.769328784027746,"d":"10"},{"v":17.06825854729295,"d":"17"},{"v":-2.0062233480900318,"d":"-2"},null,0,4622,14,581,{"v":2677.248,"d":"2677"},{"v":4580.346720350222,"d":"4580"},{"v":4863.227502714437,"d":"4863"},{"v":282.8807823642146,"d":"283"},{"v":5.816729367612828,"d":"6"},{"v":13.115659130878033,"d":"13"},{"v":10.665664475933795,"d":"11"},null,null,"PDGFRA","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"RSL(pY)DRP(bA)C","Corresponds to amino acid residues R759 to P765; In the protein kinase catalytic domain near subdomain VI. ","Phosphorylation of Y762 induces interaction with CDK6, CRK and CRKL. This is the major in vivo phosphorylation sites in PDGFRa (≥328 reports from high throughput mass spectrometry studies).","PDGFRA","Receptor tyrosine kinase; EC 2.7.10.1; TK group; PDGFR family","P16234","P16234","P16234","P16234","GO:0030054; GO:0005737; GO:0005887; GO:0031226; GO:0016020; GO:0005634; GO:0005886; GO:0032991","GO:0005524; GO:0046934; GO:0005018; GO:0048407; GO:0005161; GO:0042803; GO:0004672; GO:0005088; GO:0004714; GO:0005021; GO:0038085","GO:0055003; GO:0001775; GO:0060326; GO:0034614; GO:0048701; GO:0048557; GO:0048704; GO:0001553; GO:0000165; GO:0072277; GO:0010544; GO:0018108; GO:0048015; GO:0070527; GO:0035790; GO:0048008; GO:0030335; GO:0008284; GO:0038091; GO:0007204; GO:0070374; GO:0048146; GO:0043552; GO:0014068; GO:0010863; GO:0051897; GO:0046777; GO:2000249; GO:0050920; GO:2000739; GO:0061298; GO:0016032; GO:0042060"]
[1854,928,"PK757","PDGFRa","S847+Y849","Platelet-derived growth factor receptor kinase alpha",0,5208,12,906,{"v":4707.576,"d":"4708"},{"v":8271.90256988742,"d":"8272"},{"$nulls":3},0,5216,14,668,{"v":3474.936,"d":"3475"},{"v":6071.460802347926,"d":"6071"},{"$nulls":6},0,5830,16,737,{"v":4284.918,"d":"4285"},{"v":7330.815116219952,"d":"7331"},{"$nulls":7},"PDGFRA","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"D(pS)N(pY)VSKG(bA)C","Corresponds to amino acid residues D846 to G853; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S847 and Y849 phosphorylation is predicted to be stimulatory for phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the less major in vivo phosphorylation sites in PDGFRa (≥16 and ≥67 reports, respectively, from high throughput mass spectrometry studies).",null,null,"P16234","P16234","P16234","P16234"]
[1859,931,"PK203","PDGFRb","Y716","Platelet-derived growth factor receptor kinase beta",0,168,12,341,{"v":53.196,"d":"53"},{"v":93.47318643559468,"d":"93"},{"v":129.79341283652224,"d":"130"},{"v":36.32022640092755,"d":"36"},{"v":27.983104540654697,"d":"28"},0,164,12,316,{"v":48.032,"d":"48"},{"v":83.9222377788758,"d":"84"},{"v":96.01995543337564,"d":"96"},{"v":12.097717654499846,"d":"12"},{"v":12.59917024528715,"d":"13"},{"v":40.58227478594185,"d":"41"},{"v":-26.02093331630398,"d":"-26"},null,0,203,10,350,{"v":67.55,"d":"68"},{"v":115.56733666797305,"d":"116"},{"v":122.94619563242854,"d":"123"},{"v":7.378858964455489,"d":"7"},{"v":6.001697674742223,"d":"6"},{"v":33.98480221539692,"d":"34"},{"v":-5.275473581019028,"d":"-5"},null,null,"PDGFRB","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"Epitope undefined.","Antibody raised against amino acid residues that encompass the Y716 phosphosite.","Y716 phosphorylation stimulates phosphotransferase activity and interaction with Grb2 and Grb7. This is a minor in vivo phosphorylation sites in PDGFRb (≥1 report from high throughput mass spectrometry studies).","PDGFRB","Receptor tyrosine kinase; EC 2.7.10.1; TK group; PDGFR family","P09619","P09619","P09619","P09619","GO:0016324; GO:0009986; GO:0005737; GO:0031410; GO:0005925; GO:0005794; GO:0016021; GO:0043231; GO:0031226; GO:0043202; GO:0016020; GO:0005634; GO:0005886","GO:0005524; GO:0019899; GO:0043548; GO:0046934; GO:0004992; GO:0005017; GO:0005019; GO:0048407; GO:0005161; GO:0019901; GO:0004713; GO:0005088; GO:0005102; GO:0038085","GO:0007568; GO:0035909; GO:0055003; GO:0060326; GO:0016477; GO:0060981; GO:0035441; GO:0006024; GO:0048839; GO:0060437; GO:0008584; GO:0000165; GO:0072278; GO:0072277; GO:0072262; GO:0035789; GO:0072075; GO:0072284; GO:0043066; GO:0018108; GO:0048015; GO:0046488; GO:0035791; GO:0048008; GO:0043065; GO:0090280; GO:0030335; GO:0008284; GO:0038091; GO:0050921; GO:0032967; GO:2000573; GO:0070374; GO:0048146; GO:2000491; GO:0043406; GO:0035793; GO:0045840; GO:0043552; GO:0014068; GO:0010863; GO:0032516; GO:0051897; GO:2000379; GO:0035025; GO:0014911; GO:0048661; GO:0046777; GO:0032956; GO:0032355; GO:0043627; GO:0034405; GO:0042542; GO:0055093; GO:0032526; GO:0061298; GO:0007165; GO:0071670; GO:0042060"]
[1860,931,"PK203","PDGFRb","Y716","Platelet-derived growth factor receptor kinase beta",0,214,12,468,{"v":94.536,"d":"95"},{"v":166.1136392374498,"d":"166"},{"$nulls":3},0,182,12,364,{"v":61.88,"d":"62"},{"v":108.11767308787549,"d":"108"},{"$nulls":6},0,194,10,414,{"v":76.176,"d":"76"},{"v":130.32505459688403,"d":"130"},{"$nulls":7},"PDGFRB","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"Epitope undefined.","Antibody raised against amino acid residues that encompass the Y716 phosphosite.","Y716 phosphorylation stimulates phosphotransferase activity and interaction with Grb2 and Grb7. This is a minor in vivo phosphorylation sites in PDGFRb (≥1 report from high throughput mass spectrometry studies).","PDGFRB",null,"P09619","P09619","P09619","P09619"]
[1865,934,"PK760","PDK1 (PDPK1)","S241","3-phosphoinositide-dependent protein-serine kinase 1",0,15152,20,561,{"v":8489.052,"d":"8489"},{"v":14916.511396673772,"d":"14917"},{"v":18682.713288262785,"d":"18683"},{"v":3766.201891589013,"d":"3766"},{"v":20.158752283347887,"d":"20"},0,15228,20,569,{"v":8653.352,"d":"8653"},{"v":15119.267657568093,"d":"15119"},{"v":15176.059138596669,"d":"15176"},{"v":56.79148102857653,"d":"57"},{"v":0.37421757855529836,"d":"0"},{"v":20.532969861903187,"d":"21"},{"v":-18.76951219857949,"d":"-19"},null,0,15428,22,557,{"v":8581.142,"d":"8581"},{"v":14680.973005324702,"d":"14681"},{"v":15625.107676080701,"d":"15625"},{"v":944.1346707559987,"d":"944"},{"v":6.042420252894022,"d":"6"},{"v":26.20117253624191,"d":"26"},{"v":-16.365961223110943,"d":"-16"},null,null,"PDK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKB",{"$nulls":6},"RAN(pS)FVG(bA)C","Corresponds to amino acid residues R238 to G244; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S241 phosphorylation is stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation induces interaction with 14-3-3 eta and 14-3-3 theta. This is the major in vivo phosphorylation site in PDK1 (≥334 reports from high throughput mass spectrometry studies).","PDPK1 (PDK1)","EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); AGC group; PKB family","O15530","O15530","O15530",null,"GO:0042995; GO:0005737; GO:0031410; GO:0005829; GO:0005925; GO:0005654; GO:0043204; GO:0005886; GO:0014069","GO:0004676; GO:0005524; GO:0005158; GO:0016301; GO:0016004; GO:0043274; GO:0019901; GO:0004674","GO:0030036; GO:0032148; GO:0019722; GO:0016477; GO:1990416; GO:0071364; GO:0032869; GO:0007173; GO:0097191; GO:0038095; GO:0048041; GO:0006972; GO:0035556; GO:0010667; GO:2000352; GO:0043524; GO:0006469; GO:0034122; GO:0030512; GO:0018105; GO:0018107; GO:0030168; GO:0045766; GO:0043536; GO:0010518; GO:1903078; GO:0051281; GO:1903672; GO:1905564; GO:0046777; GO:0006468; GO:0043122; GO:0043304; GO:0006355; GO:0002223; GO:0031295; GO:0050852; GO:0006351; GO:0003323"]
[1871,937,"NN181-2","PDK3 (PDHK3)","Pan-specific","Pyruvate dehydrogenase kinase isoform 3; [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 3, mitochondrial",0,13375,20,674,{"v":9001.27,"d":"9001"},{"v":15816.553666951002,"d":"15817"},{"v":15390.366472349502,"d":"15390"},{"v":426.18719460149987,"d":"426"},{"v":2.7691815875027563,"d":"3"},0,13474,16,615,{"v":8276.67,"d":"8277"},{"v":14461.123162834943,"d":"14461"},{"v":13826.38174134316,"d":"13826"},{"v":634.7414214917826,"d":"635"},{"v":4.590799193644431,"d":"5"},{"v":7.359980781147187,"d":"7"},{"v":-10.162101947450125,"d":"-10"},null,0,12312,18,554,{"v":6810.876,"d":"6811"},{"v":11652.328640944746,"d":"11652"},{"v":11945.075845671126,"d":"11945"},{"v":292.74720472638,"d":"293"},{"v":2.4507772785090443,"d":"2"},{"v":5.219958866011801,"d":"5"},{"v":-22.38602071541456,"d":"-22"},null,null,"PDHK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PDHK",{"$nulls":6},"LEYENKSPEDPQVLDC","Corresponds to amino acid residues L92 to D106.",null,null,"Protein kinase, atypical, ATYPICAL group, PDHK family","Q15120","Q15120","Q15120",null,"GO:0005759; GO:0005739; GO:0005730","GO:0005524; GO:0004672; GO:0004674; GO:0004740","GO:0071398; GO:0071333; GO:0006006; GO:0097411; GO:0018105; GO:0035357; GO:0010510; GO:0010906; GO:2000377"]
[1876,939,"PN522","PDLIM5 (LIM)","Y251","PDZ and LIM domain protein 5",0,5804,18,668,{"v":3865.048,"d":"3865"},{"v":6791.457107423911,"d":"6791"},{"$nulls":3},0,6762,20,634,{"v":4274.428,"d":"4274"},{"v":7468.345331959622,"d":"7468"},{"$nulls":6},0,6467,24,609,{"v":3923.787,"d":"3924"},{"v":6712.977250072775,"d":"6713"},{"$nulls":18},"X",null,"TEF(pY)HVP(bA)C","Corresponds to amino acid residues T248 to P254; In the middle of the protein between the PDZ and first LIM domains. ","The effect of Y251 phosphorylation is unclear. This is the major in vivo phosphorylation site of PDLIM5 (≥970 reports from high throughput mass spectrometry studies).",null,null,"Q96HC4","Q96HC4",null,"Q96HC4"]
[1877,1136,"PN267","PEBP1","S153","Phosphatidylethanolamine-binding protein 1",0,36,10,662,{"v":17.212,"d":"17"},{"v":30.24401242442018,"d":"30"},{"v":34.01484966952858,"d":"34"},{"v":3.7708372451083996,"d":"4"},{"v":11.085855976857124,"d":"11"},0,68,10,449,{"v":26.042,"d":"26"},{"v":45.50097677043396,"d":"46"},{"v":45.70365372709513,"d":"46"},{"v":0.20267695666117191,"d":"0"},{"v":0.4434589800443375,"d":"0"},{"v":11.52931495690146,"d":"12"},{"v":34.36382689069384,"d":"34"},null,0,70,8,451,{"v":27.962,"d":"28"},{"v":47.83854726735548,"d":"48"},{"v":52.18921695124379,"d":"52"},{"v":4.350669683888313,"d":"4"},{"v":8.336338305195872,"d":"8"},{"v":19.422194282052995,"d":"19"},{"v":53.43068529859269,"d":"53"},{"$nulls":15},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S153 phosphosite.","S153 phosphorylation induces interaction with GRK2 and inhibits binding to Raf1. This is one of the less major in vivo phosphorylation sites in PEBP1 (≥15 reports from high throughput mass spectrometry studies).","PKCa (PRKCA); PKCb1 (PRKCB1); PKCd (PRKCD); PKCg (PRKCG)","Lipid binding protein","P30086","P30086",null,"P30086","GO:0005829; GO:0070062; GO:0005634","GO:0005524; GO:0019899; GO:0008429; GO:0019901; GO:0003723; GO:0004867","GO:0000165"]
[1882,941,"PN061","PED15 (PEA15)","S116","Astrocytic phosphoprotein PEA-15",0,1724,8,388,{"v":665.808,"d":"666"},{"v":1169.9224624842175,"d":"1170"},{"$nulls":3},0,1722,10,347,{"v":594.064,"d":"594"},{"v":1037.9576170859027,"d":"1038"},{"$nulls":6},0,2150,8,375,{"v":803.25,"d":"803"},{"v":1374.2333557150164,"d":"1374"},{"$nulls":20},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S116 phosphosite.","S116 phosphorylation stabilizes the protein and inhibits apoptosis. This is the major in vivo phosphorylation site in PED15 (≥1154 reports from high throughput mass spectrometry studies).","Akt1;  CaMK2a; CK2a1 (CSNK2A1); PKCa (PRKCA)",null,"Q15121","Q15121",null,"Q15121"]
[1888,944,"PN716","PFKP","S386","6-phosphofructokinase type C",0,6338,14,693,{"v":4382.532,"d":"4383"},{"v":7700.752513270917,"d":"7701"},{"$nulls":3},0,6628,16,572,{"v":3782.064,"d":"3782"},{"v":6608.079494980974,"d":"6608"},{"$nulls":6},0,6497,15,637,{"v":4129.034,"d":"4129"},{"v":7064.12231519626,"d":"7064"},{"$nulls":10},"Glycolysis",{"$nulls":8},"X","RGR(pS)FAG(bA)C","Corresponds to amino acid residues R383 to G389.","The effect of S386 phosphorylation is unclear. This is the major in vivo phosphorylation site in PFKP (≥231 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in the fruit fly.",null,null,"Q01813","Q01813"]
[1893,947,"NK004-2","PFTAIRE2 (ALS2CR7)","Pan-specific","Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 7 protein",0,3736,14,540,{"v":2009.88,"d":"2010"},{"v":3531.6544092257514,"d":"3532"},{"v":5021.316107174158,"d":"5021"},{"v":1489.6616979484065,"d":"1490"},{"v":29.66675800035904,"d":"30"},0,3394,14,508,{"v":1717.04,"d":"1717"},{"v":3000.0382902198726,"d":"3000"},{"v":3167.575255912345,"d":"3168"},{"v":167.53696569247222,"d":"168"},{"v":5.2891234511243574,"d":"5"},{"v":34.95588145148339,"d":"35"},{"v":-36.91742984699366,"d":"-37"},null,0,3813,14,529,{"v":2009.671,"d":"2010"},{"v":3438.2283500941835,"d":"3438"},{"v":3748.699016318887,"d":"3749"},{"v":310.47066622470356,"d":"310"},{"v":8.282091063410492,"d":"8"},{"v":37.94884906376953,"d":"38"},{"v":-25.3442934818828,"d":"-25"},null,null,"PFTAIRE2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","TAIRE",{"$nulls":5},"PETTEAAFKLTDLKEASC","Corresponds to amino acid residues P33 to C50; Post-N-terminus.",null,null,"EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC domain target; CMGC</A> group; CDK family; CDK/TAIRE subfamily; TAIRE subfamily","Q96Q40","Q96Q40","Q96Q40",null,"GO:0005829; GO:0005634","GO:0005524; GO:0030332; GO:0004693; GO:0046872; GO:0004674"]
[1894,947,"NK004-2","PFTAIRE2 (ALS2CR7)","Pan-specific","Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 7 protein",0,4644,18,801,{"v":3705.426,"d":"3705"},{"v":6510.977805122564,"d":"6511"},{"$nulls":3},0,3510,14,546,{"v":1908.816,"d":"1909"},{"v":3335.1122216048175,"d":"3335"},{"$nulls":6},0,4270,18,558,{"v":2372.616,"d":"2373"},{"v":4059.1696825435906,"d":"4059"},{"$nulls":7},"PFTAIRE2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","TAIRE",{"$nulls":5},"PETTEAAFKLTDLKEASC","Corresponds to amino acid residues P33 to C50; Post-N-terminus.",{"$nulls":3},"Q96Q40","Q96Q40","Q96Q40"]
[1899,951,"PK894","PIK3CA","Y317","Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",0,3496,18,799,{"v":2778.922,"d":"2779"},{"v":4882.97417467433,"d":"4883"},{"v":3983.5416343710313,"d":"3984"},{"v":899.432540303299,"d":"899"},{"v":22.578715697176644,"d":"23"},0,482,12,845,{"v":397.15,"d":"397"},{"v":693.9064942929823,"d":"694"},{"v":1977.1207010903438,"d":"1977"},{"v":1283.2142067973614,"d":"1283"},{"v":64.90317996719642,"d":"65"},{"v":87.48189566437307,"d":"87"},{"v":-50.36776610965396,"d":"-50"},null,0,3282,14,572,{"v":1869.296,"d":"1869"},{"v":3198.0689883655864,"d":"3198"},{"v":3309.8758956331712,"d":"3310"},{"v":111.80690726758485,"d":"112"},{"v":3.3779788364601644,"d":"3"},{"v":25.95669453363681,"d":"26"},{"v":-16.91122625467993,"d":"-17"},{"$nulls":5},"Lipid kinase ",{"$nulls":8},"X","ATP(pY)MNGC","Corresponds to amino acid residues A314 to G320.","The effect of Y317 phosphorylation is unclear. This is the major in vivo phosphorylation site in PIK3CA (≥23 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in fish.",null,"Phosphoinositide 3-kinase complex, Cytoplasm, Lamellipodium, Mitochondrion protein","P42336","P42336",null,"P42336","GO:0005737; GO:0005829; GO:0030027; GO:0005942; GO:0005943; GO:0005886","GO:0016303; GO:0035005; GO:0005524; GO:0043560; GO:0016301; GO:0035004; GO:0046934; GO:0030295; GO:0004674","GO:0002250; GO:0060612; GO:0001525; GO:0043276; GO:0007411; GO:0060048; GO:0060326; GO:0071333; GO:0019221; GO:0043542; GO:0097009; GO:0007173; GO:0038128; GO:0038095; GO:0038096; GO:0006006; GO:0007186; GO:0044029; GO:0006954; GO:0045087; GO:0038028; GO:0050900; GO:0001889; GO:2000811; GO:2000270; GO:0016242; GO:0043524; GO:0014065; GO:0048015; GO:0046854; GO:0016310; GO:0030168; GO:0033138; GO:0051897; GO:0032008; GO:0043491; GO:0006468; GO:0043457; GO:0010468; GO:2000653; GO:0040014; GO:0031295; GO:0050852; GO:0048010; GO:0001944"]
[1904,952,"PN526","PIK3R1","Y467","Phosphatidylinositol 3-kinase regulatory subunit alpha",0,5992,14,829,{"v":4955.762,"d":"4956"},{"v":8708.001830145793,"d":"8708"},{"$nulls":3},0,1693,12,937,{"v":1575.097,"d":"1575"},{"v":2752.033331087482,"d":"2752"},{"$nulls":6},0,6593,24,767,{"v":5038.423,"d":"5038"},{"v":8619.94266641982,"d":"8620"},{"$nulls":20},"DRL(pY)EEY(bA)C","Corresponds to amino acid residues D464 to Y470; In the region between the two SH2 domains in the C-terminus half of the protein. ","The effect of Y467 phosphorylation is unclear. This is the major in vivo phosphorylation site in PI3KR1 (≥2220 reports from high throughput mass spectrometry studies).",null,null,"P27986","P27986",null,"P27986"]
[1906,953,"PN527","PIK3R1","Y580","Phosphatidylinositol 3-kinase regulatory subunit alpha",0,4788,12,790,{"v":3773.04,"d":"3773"},{"v":6629.785535546962,"d":"6630"},{"$nulls":3},0,5576,20,812,{"v":4511.472,"d":"4511"},{"v":7882.5121984664465,"d":"7883"},{"$nulls":6},0,5602,18,875,4886,{"v":8359.17108748655,"d":"8359"},{"$nulls":20},"RDQ(pY)LMW(bA)C","Corresponds to amino acid residues R577 to W583; In the region between the two SH2 domains in the C-terminus half of the protein. ","The effect of Y580 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in PIK3R1 (≥924 reports from high throughput mass spectrometry studies).","InsR",null,"P27986","P27986",null,"P27986"]
[1911,956,"NK288-1","Pim2","Pan-specific","Serine/threonine-protein kinase Pim-2",0,282,12,534,{"v":144.18,"d":"144"},{"v":253.3454398880375,"d":"253"},{"v":300.74008461948495,"d":"301"},{"v":47.39464473144744,"d":"47"},{"v":15.759337432991046,"d":"16"},0,293,12,447,{"v":125.607,"d":"126"},{"v":219.4624525460371,"d":"219"},{"v":255.1606787531303,"d":"255"},{"v":35.6982262070932,"d":"36"},{"v":13.990488809457776,"d":"14"},{"v":29.749826242448822,"d":"30"},{"v":-15.155746838345323,"d":"-15"},null,0,346,10,457,{"v":153.552,"d":"154"},{"v":262.7031188755085,"d":"263"},{"v":284.0133593719744,"d":"284"},{"v":21.310240496465894,"d":"21"},{"v":7.503252855284077,"d":"8"},{"v":23.262590288275124,"d":"23"},{"v":-5.5618542731589145,"d":"-6"},null,null,"PIM2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","PIM",{"$nulls":6},"PGGKDREAFEAEYRLGC","Corresponds to amino acid residues P20 to G35; Just before kinase catalytic domain.",null,null,"Protein-serine kinase, CAMK group, PIM family","Q9P1W9","Q9P1W9","Q9P1W9","Q9P1W9","GO:0005737","GO:0005524; GO:0004674","GO:0008637; GO:0008283; GO:0000082; GO:0007140; GO:0043066; GO:0008285; GO:0032091; GO:0010508; GO:0043123; GO:0016239; GO:0045893; GO:0046777; GO:0006468; GO:0050821; GO:0007346; GO:0009615"]
[1916,958,"PK761","Pim2","T195","Serine/threonine-protein kinase Pim-2",0,8676,16,722,{"v":6252.52,"d":"6253"},{"v":10986.596128511252,"d":"10987"},{"$nulls":3},0,617,12,951,{"v":575.355,"d":"575"},{"v":1005.2689689637136,"d":"1005"},{"$nulls":6},0,8286,18,603,{"v":4985.604,"d":"4986"},{"v":8529.577734436612,"d":"8530"},{"$nulls":7},"PIM2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","PIM",{"$nulls":6},"EPY(pT)DFD(bA)C","Corresponds to amino acid residues E192 to D198; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T195 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the few in vivo phosphorylation sites in Pim2 (≥1 report from high throughput mass spectrometry studies).",null,null,"Q9P1W9","Q9P1W9","Q9P1W9","Q9P1W9"]
[1921,961,"NK213","PITSLRE (CDK11B;  p58/GTA; CLK-1)","Pan-specific","Cell division protein kinase 11B",0,212,10,473,{"v":95.546,"d":"96"},{"v":167.88835760537128,"d":"168"},{"v":214.6759080832377,"d":"215"},{"v":46.787550477866404,"d":"47"},{"v":21.794504514090683,"d":"22"},0,232,12,476,{"v":104.72,"d":"105"},{"v":182.96836984102003,"d":"183"},{"v":186.1168515298428,"d":"186"},{"v":3.1484816888227556,"d":"3"},{"v":1.6916693265241027,"d":"2"},{"v":23.486173840614786,"d":"23"},{"v":-13.303335622701312,"d":"-13"},null,0,244,10,496,{"v":116.064,"d":"116"},{"v":198.5670964179367,"d":"199"},{"v":217.84485732947957,"d":"218"},{"v":19.277760911542856,"d":"19"},{"v":8.849307322589762,"d":"9"},{"v":30.643811836680445,"d":"31"},{"v":1.4761550443812155,"d":"1"},null,null,"PITSLRE","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","PITSLRE",{"$nulls":5},"Epitope undefined.",{"$nulls":3},"EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); Apoptosis; CMGC group; CDK family; CDK/PITSLRE subfamily; PITSLRE subfamily","P21127","P21127","P21127","P21127","GO:0005737; GO:0005634","GO:0005524; GO:0004693; GO:0004672; GO:0004674; GO:0003723","GO:0006915; GO:0008283; GO:0000278; GO:0006468; GO:0001558; GO:0007346; GO:0050684; GO:0006355"]
[1926,964,"NK132","PKCa (PRKCA)","Pan-specific","Protein-serine kinase C alpha",0,2053,10,288,{"v":588.384,"d":"588"},{"v":1033.8771209812946,"d":"1034"},{"$nulls":3},0,1870,12,286,{"v":531.388,"d":"531"},{"v":928.4491607436971,"d":"928"},{"$nulls":6},0,1258,10,350,{"v":436.8,"d":"437"},{"v":747.2955241535253,"d":"747"},{"$nulls":7},"PKCa","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Alpha",{"$nulls":5},"Epitope undefined.",{"$nulls":4},"P17252","P17252","P17252"]
[1929,966,"PK763","PKCa (PRKCA)","T497","Protein-serine kinase C alpha",0,8050,24,893,{"v":7167.218,"d":"7167"},{"v":12593.854882670692,"d":"12594"},{"v":11036.701172334302,"d":"11037"},{"v":1557.1537103363898,"d":"1557"},{"v":14.108869000093133,"d":"14"},0,1172,16,995,{"v":1150.22,"d":"1150"},{"v":2009.6818025070481,"d":"2010"},{"v":5079.203344558831,"d":"5079"},{"v":3069.5215420517834,"d":"3070"},{"v":60.43312964305814,"d":"60"},{"v":74.54199864315127,"d":"75"},{"v":-53.97897192966617,"d":"-54"},null,0,6844,16,720,{"v":4916.16,"d":"4916"},{"v":8410.770064154292,"d":"8411"},{"v":8997.333749482956,"d":"8997"},{"v":586.5636853286633,"d":"587"},{"v":6.5193056260958535,"d":"7"},{"v":20.628174626188986,"d":"21"},{"v":-18.47805237278172,"d":"-18"},null,null,"PKCa","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Alpha",{"$nulls":5},"TTR(pT)FCG(bA)C","Corresponds to amino acid residues T494 to G500; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T497 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in PKCa (≥92 reports from high throughput mass spectrometry studies).","PDPK1 (PDK1); PKCa (PRKCA); PKCb1 (PRKCB1)","EC 2.7.11.13; Protein kinase, Ser/Thr (non-receptor); AGC group; PKC family; Alpha subfamily","P17252","P17252","P17252",null,"GO:0035866; GO:0005737; GO:0005829; GO:0005783; GO:0070062; GO:0031966; GO:0005739; GO:0005654; GO:0048471; GO:0005886","GO:0005524; GO:0004698; GO:0019899; GO:0035403; GO:0005178; GO:0004672; GO:0004697; GO:0004674; GO:0008270","GO:0001525; GO:0097190; GO:0007411; GO:0007155; GO:0002159; GO:0038128; GO:0035408; GO:0035556; GO:0007077; GO:0034351; GO:0018105; GO:0018107; GO:0030168; GO:0106071; GO:0045766; GO:0043536; GO:0045780; GO:0010613; GO:0045785; GO:0030335; GO:2000707; GO:0010595; GO:0001938; GO:0070374; GO:0031666; GO:0045651; GO:0045931; GO:0006468; GO:0050796; GO:0043488; GO:0090330; GO:0070555"]
[1933,968,"NK133-3","PKCb (PRKCB1)","Pan-specific","Protein-serine kinase C beta 1",0,100,8,491,{"v":45.172,"d":"45"},{"v":79.3738397185631,"d":"79"},{"v":83.9810788875632,"d":"84"},{"v":4.607239169000096,"d":"5"},{"v":5.486044273339746,"d":"5"},0,90,8,413,{"v":33.866,"d":"34"},{"v":59.17118805420154,"d":"59"},{"v":46.987856857663786,"d":"47"},{"v":12.18333119653775,"d":"12"},{"v":25.928680325735332,"d":"26"},{"v":31.41472459907508,"d":"31"},{"v":-44.04947223817788,"d":"-44"},null,0,96,10,441,{"v":37.926,"d":"38"},{"v":64.88537099140706,"d":"65"},{"v":62.801566164440494,"d":"63"},{"v":2.0838048269665634,"d":"2"},{"v":3.318077803203665,"d":"3"},{"v":8.804122076543411,"d":"9"},{"v":-25.21938632329143,"d":"-25"},null,null,"PKCb","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Alpha",{"$nulls":5},"Epitope undefined.",{"$nulls":3},"EC 2.7.11.13; Protein kinase, Ser/Thr (non-receptor); AGC group; PKC family; Alpha subfamily","P05771","P05771","P05771",null,"GO:0005737; GO:0005829; GO:0070062; GO:0005654; GO:0005634; GO:0005886","GO:0050681; GO:0005524; GO:0004698; GO:0003682; GO:0042393; GO:0035403; GO:0030374; GO:0004697; GO:0005080; GO:0004674; GO:0008270","GO:0002250; GO:0006915; GO:0042113; GO:0050853; GO:0035408; GO:0035556; GO:0042953; GO:0007077; GO:0010829; GO:0046627; GO:0018105; GO:0030168; GO:0045766; GO:0050861; GO:0043123; GO:0051092; GO:0030949; GO:0006468; GO:0045637; GO:0006357; GO:0007165; GO:0006351"]
[1938,970,"PK765","PKCb (PRKCB1)","S661","Protein-serine kinase C beta 1",0,6907,16,729,{"v":5023.539,"d":"5024"},{"v":8827.095975514718,"d":"8827"},{"$nulls":3},0,7260,12,569,{"v":4124.112,"d":"4124"},{"v":7205.710940429611,"d":"7206"},{"$nulls":6},0,7560,16,638,{"v":4813.072,"d":"4813"},{"v":8234.402845761575,"d":"8234"},{"$nulls":7},"PKCb","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Alpha",{"$nulls":5},"AGF(pS)YTN(bA)C","Corresponds to amino acid residues A658 to N664; In Pkinase_C domain near C-terminus of the kinase.","S661 phosphorylation inhibits phosphotransferase activity. Phosphorylation inhibits membrane binding and causes release into cytoplasm. This is one of the major in vivo phosphorylation sites in PKCb (≥171 reports from high throughput mass spectrometry studies).","PKCb1 (PRKCB1)",null,"P05771","P05771","P05771"]
[1943,973,"PK204","PKCb2/d (PRKCB2/D)","S660","Protein-serine kinase C beta 2 and delta",0,34,8,657,{"v":17.082,"d":"17"},{"v":30.015583327559,"d":"30"},{"v":52.707378380368795,"d":"53"},{"v":22.691795052809795,"d":"23"},{"v":43.052406987598346,"d":"43"},0,34,6,659,{"v":18.452,"d":"18"},{"v":32.23961383027599,"d":"32"},{"v":33.338612155619785,"d":"33"},{"v":1.0989983253437927,"d":"1"},{"v":3.2964729311881027,"d":"3"},{"v":46.34887991878645,"d":"46"},{"v":-36.74773213907947,"d":"-37"},null,0,72,8,435,{"v":27.84,"d":"28"},{"v":47.629824616378535,"d":"48"},{"v":50.92490515557196,"d":"51"},{"v":3.295080539193428,"d":"3"},{"v":6.470469663374319,"d":"6"},{"v":49.52287665097266,"d":"50"},{"v":-3.3818286539190154,"d":"-3"},null,null,"PKCb","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Alpha",{"$nulls":5},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S660 phosphosite.","S660 phosphorylation regulates intracellular localization. This is one of the major in vivo phosphorylation sites in PKCb2 (≥171 reports from high throughput mass spectrometry studies).","PKCb (PRKCB1); PKCb2 (PRKCB2)","EC 2.7.11.13; Protein kinase, Ser/Thr (non-receptor); AGC group; PKC family; Alpha subfamily","P05771","P05771","P05771",null,"GO:0005737; GO:0005829; GO:0070062; GO:0005654; GO:0005634; GO:0005886","GO:0050681; GO:0005524; GO:0004698; GO:0003682; GO:0042393; GO:0035403; GO:0030374; GO:0004697; GO:0005080; GO:0004674; GO:0008270","GO:0002250; GO:0006915; GO:0042113; GO:0050853; GO:0035408; GO:0035556; GO:0042953; GO:0007077; GO:0010829; GO:0046627; GO:0018105; GO:0030168; GO:0045766; GO:0050861; GO:0043123; GO:0051092; GO:0030949; GO:0006468; GO:0045637; GO:0006357; GO:0007165; GO:0006351"]
[1944,973,"PK204","PKCb2/d (PRKCB2/D)","S660","Protein-serine kinase C beta 2 and delta",0,82,12,613,{"v":42.91,"d":"43"},{"v":75.39917343317859,"d":"75"},{"$nulls":3},0,38,8,657,{"v":19.71,"d":"20"},{"v":34.43761048096357,"d":"34"},{"$nulls":6},0,84,8,417,{"v":31.692,"d":"32"},{"v":54.21998569476539,"d":"54"},{"$nulls":7},"PKCb","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Alpha",{"$nulls":5},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S660 phosphosite.","S660 phosphorylation regulates intracellular localization. This is one of the major in vivo phosphorylation sites in PKCb2 (≥171 reports from high throughput mass spectrometry studies).","PKCb (PRKCB1); PKCb2 (PRKCB2)",null,"P05771","P05771","P05771"]
[1951,978,"PK769","PKCd (PRKCD)","Y334","Protein-serine kinase C delta",0,224,14,417,{"v":87.57,"d":"88"},{"v":153.87335393948842,"d":"154"},{"v":131.8738747648579,"d":"132"},{"v":21.999479174630522,"d":"22"},{"v":16.682211858760823,"d":"17"},0,152,10,354,{"v":50.268,"d":"50"},{"v":87.82901084003433,"d":"88"},{"v":106.47878528314976,"d":"106"},{"v":18.649774443115433,"d":"19"},{"v":17.51501427586886,"d":"18"},{"v":34.19722613462969,"d":"34"},{"v":-19.25710420429347,"d":"-19"},null,0,213,10,396,{"v":80.388,"d":"80"},{"v":137.53111857979303,"d":"138"},{"v":154.6018940834649,"d":"155"},{"v":17.070775503671882,"d":"17"},{"v":11.041763495119849,"d":"11"},{"v":27.72397535388067,"d":"28"},{"v":17.234664075149794,"d":"17"},null,null,"PKCd","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Delta",{"$nulls":5},"SGT(pY)GKI(bA)C","Corresponds to amino acid residues S331 to I337; In the region between the C1_1 and kinase catalytic domain. ","Y334 phosphorylation stimulates phosphotransferase activity and regulates apoptosis and molecular association, including inducing interaction with Src. This is one of the major in vivo phosphorylation sites in PKCd (≥545 reports from high throughput mass spectrometry studies).","EGFR; Fyn; Lck; Lyn; PDGFRA; PKCd (PRKCD); Src; Yes","EC 2.7.11.13; Protein kinase, Ser/Thr (non-receptor); AGC domain target; AGC</A> group; PKC family; Delta subfamily","Q05655","Q05655","Q05655","Q05655","GO:0035578; GO:0005911; GO:0005737; GO:0005829; GO:0005783; GO:0070062; GO:0005576; GO:0016363; GO:0005654; GO:0005634; GO:0048471; GO:0005886","GO:0005524; GO:0004699; GO:0008047; GO:0019899; GO:0043560; GO:0019900; GO:0046872; GO:0004715; GO:0004672; GO:0019901; GO:0004697; GO:0004674","GO:0032147; GO:0006915; GO:0042100; GO:0060326; GO:0007049; GO:1904385; GO:0070301; GO:0071447; GO:0090398; GO:0042742; GO:0038096; GO:0016572; GO:0016064; GO:0060333; GO:0032613; GO:0032615; GO:0008631; GO:0030837; GO:0051490; GO:0034351; GO:0050728; GO:0046627; GO:0043407; GO:0050732; GO:0090331; GO:0032091; GO:0042119; GO:0043312; GO:0018105; GO:0018107; GO:0030168; GO:2001235; GO:2000304; GO:0032079; GO:2000753; GO:1900163; GO:0035307; GO:0042307; GO:2001022; GO:2000755; GO:0032930; GO:0006468; GO:0050821; GO:0032956; GO:0043488; GO:0010469; GO:0007165; GO:0002223; GO:0023021"]
[1955,980,"PK767","PKCd (PRKCD)","T507","Protein-serine kinase C delta",0,7595,18,819,{"v":6205.563,"d":"6206"},{"v":10904.085781578095,"d":"10904"},{"v":10552.76270917905,"d":"10553"},{"v":351.3230723990455,"d":"351"},{"v":3.329204702892221,"d":"3"},0,7252,10,593,{"v":4294.506,"d":"4295"},{"v":7503.425917613442,"d":"7503"},{"v":7447.072987585916,"d":"7447"},{"v":56.35293002752587,"d":"56"},{"v":0.7567124710804473,"d":"1"},{"v":4.0859171739726685,"d":"4"},{"v":-29.430110457157625,"d":"-29"},null,0,6486,9,649,{"v":4203.573,"d":"4204"},{"v":7191.646722418972,"d":"7192"},{"v":7823.813740723996,"d":"7824"},{"v":632.1670183050237,"d":"632"},{"v":8.080036658011295,"d":"8"},{"v":11.409241360903517,"d":"11"},{"v":-25.860042944785903,"d":"-26"},null,null,"PKCd","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Delta",{"$nulls":5},"RAS(pT)FCG(bA)C","Corresponds to amino acid residues R504 to G510; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T507 phosphorylation stimulates phosphotransferase activity and degradation. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in PKCd (≥126 reports from high throughput mass spectrometry studies).","PDPK1 (PDK1); PKCe (PRKCE); Src","EC 2.7.11.13; Protein kinase, Ser/Thr (non-receptor); AGC domain target; AGC</A> group; PKC family; Delta subfamily","Q05655","Q05655","Q05655","Q05655","GO:0035578; GO:0005911; GO:0005737; GO:0005829; GO:0005783; GO:0070062; GO:0005576; GO:0016363; GO:0005654; GO:0005634; GO:0048471; GO:0005886","GO:0005524; GO:0004699; GO:0008047; GO:0019899; GO:0043560; GO:0019900; GO:0046872; GO:0004715; GO:0004672; GO:0019901; GO:0004697; GO:0004674","GO:0032147; GO:0006915; GO:0042100; GO:0060326; GO:0007049; GO:1904385; GO:0070301; GO:0071447; GO:0090398; GO:0042742; GO:0038096; GO:0016572; GO:0016064; GO:0060333; GO:0032613; GO:0032615; GO:0008631; GO:0030837; GO:0051490; GO:0034351; GO:0050728; GO:0046627; GO:0043407; GO:0050732; GO:0090331; GO:0032091; GO:0042119; GO:0043312; GO:0018105; GO:0018107; GO:0030168; GO:2001235; GO:2000304; GO:0032079; GO:2000753; GO:1900163; GO:0035307; GO:0042307; GO:2001022; GO:2000755; GO:0032930; GO:0006468; GO:0050821; GO:0032956; GO:0043488; GO:0010469; GO:0007165; GO:0002223; GO:0023021"]
[1960,982,"PK079-1","PKCd (PRKCD)","S645","Protein-serine kinase C delta",0,54,8,651,{"v":29.946,"d":"30"},{"v":52.61952103542219,"d":"53"},{"$nulls":3},0,747,10,310,{"v":228.47,"d":"228"},{"v":399.1862438653347,"d":"399"},{"$nulls":6},0,736,10,346,{"v":251.196,"d":"251"},{"v":429.7565166787292,"d":"430"},{"$nulls":7},"PKCd","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Delta",{"$nulls":5},"RL(pS)YS","Corresponds to amino acid residues R643 to S647.","S645 phosphorylation stimulates phosphotransferase activity. This is one of the major in vivo phosphorylation sites in PKCd (≥127 reports from high throughput mass spectrometry studies).","PKCd (PRKCD)",null,"Q05655","Q05655","Q05655","Q05655"]
[1961,983,"PK080","PKCd (PRKCD)","S664","Protein-serine kinase C delta",0,168,10,285,{"v":45.03,"d":"45"},{"v":79.12432485891475,"d":"79"},{"v":65.74189407664748,"d":"66"},{"v":13.382430782267264,"d":"13"},{"v":20.35601646442509,"d":"20"},0,212,8,251,{"v":51.204,"d":"51"},{"v":89.46440421447278,"d":"89"},{"v":73.8844867787167,"d":"74"},{"v":15.579917435756073,"d":"16"},{"v":21.086858845508083,"d":"21"},{"v":41.44287530993317,"d":"41"},{"v":12.385698368495284,"d":"12"},null,0,134,8,276,{"v":34.776,"d":"35"},{"v":59.49622057683836,"d":"59"},{"v":57.102753456209285,"d":"57"},{"v":2.393467120629076,"d":"2"},{"v":4.1915091230487995,"d":"4"},{"v":24.54752558747389,"d":"25"},{"v":-13.140997444287123,"d":"-13"},null,null,"PKCd","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Delta",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S664 phosphosite.","The effect of S664 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in PKCd (≥128 reports from high throughput mass spectrometry studies).",null,"EC 2.7.11.13; Protein kinase, Ser/Thr (non-receptor); AGC domain target; AGC</A> group; PKC family; Delta subfamily","Q05655","Q05655","Q05655","Q05655","GO:0035578; GO:0005911; GO:0005737; GO:0005829; GO:0005783; GO:0070062; GO:0005576; GO:0016363; GO:0005654; GO:0005634; GO:0048471; GO:0005886","GO:0005524; GO:0004699; GO:0008047; GO:0019899; GO:0043560; GO:0019900; GO:0046872; GO:0004715; GO:0004672; GO:0019901; GO:0004697; GO:0004674","GO:0032147; GO:0006915; GO:0042100; GO:0060326; GO:0007049; GO:1904385; GO:0070301; GO:0071447; GO:0090398; GO:0042742; GO:0038096; GO:0016572; GO:0016064; GO:0060333; GO:0032613; GO:0032615; GO:0008631; GO:0030837; GO:0051490; GO:0034351; GO:0050728; GO:0046627; GO:0043407; GO:0050732; GO:0090331; GO:0032091; GO:0042119; GO:0043312; GO:0018105; GO:0018107; GO:0030168; GO:2001235; GO:2000304; GO:0032079; GO:2000753; GO:1900163; GO:0035307; GO:0042307; GO:2001022; GO:2000755; GO:0032930; GO:0006468; GO:0050821; GO:0032956; GO:0043488; GO:0010469; GO:0007165; GO:0002223; GO:0023021"]
[1966,985,"NK137","PKCg (PRKCG)","Pan-specific","Protein-serine kinase C gamma",0,516,12,745,{"v":375.48,"d":"375"},{"v":659.773517611044,"d":"660"},{"$nulls":3},0,298,10,497,{"v":143.136,"d":"143"},{"v":250.08938679874183,"d":"250"},{"$nulls":6},0,395,10,575,{"v":221.375,"d":"221"},{"v":378.7375152460775,"d":"379"},{"$nulls":7},"PKCg","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Alpha",{"$nulls":5},"Epitope undefined.",{"$nulls":4},"P05129","P05129","P05129"]
[1969,987,"PK082-2","PKCg (PRKCG)","T514","Protein-serine kinase C gamma",0,5066,14,630,{"v":3182.76,"d":"3183"},{"v":5592.5768640452925,"d":"5593"},{"v":7781.358112965632,"d":"7781"},{"v":2188.7812489203397,"d":"2189"},{"v":28.128524830046036,"d":"28"},0,5523,14,598,{"v":3294.382,"d":"3294"},{"v":5755.994119304806,"d":"5756"},{"v":6040.66962987172,"d":"6041"},{"v":284.67551056691354,"d":"285"},{"v":4.71264823289068,"d":"5"},{"v":32.84117306293672,"d":"33"},{"v":-22.36998294929394,"d":"-22"},null,0,5814,12,642,{"v":3724.884,"d":"3725"},{"v":6372.685762800091,"d":"6373"},{"v":6491.544758324455,"d":"6492"},{"v":118.85899552436422,"d":"119"},{"v":1.8309816838579902,"d":"2"},{"v":29.959506513904024,"d":"30"},{"v":-16.575684294648198,"d":"-17"},null,null,"PKCg","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Alpha",{"$nulls":5},"Epitope undefined.","Antibody raised against amino acid residues that encompass the T514 phosphosite.","T514 phosphorylation stimulates phosphotransferase activity. Phosphorylation induces preactivation of PKC. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in PKCg (≥72 reports from high throughput mass spectrometry studies).","PDPK1 (PDK1)","Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.13; AGC group; PKC family; Alpha subfamily","P05129","P05129","P05129",null,"GO:0044305; GO:0005911; GO:0005829; GO:0030425; GO:0005622; GO:0005634; GO:0048471; GO:0005886; GO:0099524; GO:0014069; GO:0099523; GO:0097060","GO:0005524; GO:0004698; GO:0004672; GO:0004697; GO:0004712; GO:0008270","GO:0007268; GO:0007635; GO:0060384; GO:0035556; GO:0007611; GO:0043524; GO:1901799; GO:0042177; GO:0031397; GO:0018105; GO:0016310; GO:0030168; GO:0032425; GO:0099171; GO:0046777; GO:0006468; GO:0042752; GO:0050764; GO:0032095; GO:2000300; GO:0043278; GO:0048265; GO:1990911; GO:0048511"]
[1977,991,"PK087","PKCi (PRKCiota)","T564","Protein-serine kinase C lambda/iota",0,1485,12,320,{"v":471.36,"d":"471"},{"v":828.2487622806586,"d":"828"},{"v":515.2200708234917,"d":"515"},{"v":313.02869145716693,"d":"313"},{"v":60.75630767971515,"d":"61"},0,450,10,255,{"v":112.2,"d":"112"},{"v":196.03753911537862,"d":"196"},{"v":187.4622071904385,"d":"187"},{"v":8.575331924940116,"d":"9"},{"v":4.574432390112976,"d":"5"},{"v":65.33074006982812,"d":"65"},{"v":-63.6151194787866,"d":"-64"},null,0,460,12,260,{"v":116.48,"d":"116"},{"v":199.2788064409401,"d":"199"},{"v":353.84990537917884,"d":"354"},{"v":154.57109893823875,"d":"155"},{"v":43.682673525828214,"d":"44"},{"v":104.43898120554337,"d":"104"},{"v":-31.32062871432592,"d":"-31"},null,null,"PKCi","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Iota",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues that encompass the T555 phosphosite.","The effect of T564 phosphorylation is unclear. This is the major in vivo phosphorylation sites in PKCi (≥27 reports from high throughput mass spectrometry studies).",null,"Adhesion; Motility/polarity/chemotaxis; EC 2.7.11.13; Hydrolase; Protein kinase, Ser/Thr (non-receptor); EC 3.-.-.-; Cell development/differentiation; AGC group; PKC family; Iota subfamily","P41743","P41743","P41743","P41743","GO:0016324; GO:0005923; GO:0031252; GO:0005829; GO:0005768; GO:0070062; GO:0098978; GO:0000139; GO:0045171; GO:0015630; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:0098685; GO:0043220","GO:0005524; GO:0046872; GO:0005543; GO:0019904; GO:0004672; GO:0004697; GO:0004674","GO:0007015; GO:0070830; GO:0045216; GO:0016477; GO:0032869; GO:0007010; GO:0035089; GO:0045197; GO:0042462; GO:0048194; GO:0035556; GO:0061024; GO:0043066; GO:0034351; GO:0043524; GO:0018105; GO:2000353; GO:0060252; GO:0046326; GO:0010976; GO:0051092; GO:0045747; GO:1903078; GO:0006468; GO:0006612; GO:0099072; GO:0070555; GO:0046903; GO:0016192"]
[1978,991,"PK087","PKCi (PRKCiota)","T564","Protein-serine kinase C lambda/iota",0,526,10,223,{"v":115.068,"d":"115"},{"v":202.19137936632472,"d":"202"},{"$nulls":3},0,484,10,216,{"v":102.384,"d":"102"},{"v":178.88687526549842,"d":"179"},{"$nulls":6},0,1236,8,242,{"v":297.176,"d":"297"},{"v":508.4210043174176,"d":"508"},{"$nulls":7},"PKCi","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Iota",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues that encompass the T555 phosphosite.","The effect of T564 phosphorylation is unclear. This is the major in vivo phosphorylation sites in PKCi (≥27 reports from high throughput mass spectrometry studies).",null,null,"P41743","P41743","P41743","P41743"]
[1983,994,"PK773","PKCt (PRKCQ)","Y545","Protein-serine kinase C theta",0,4366,16,866,{"v":3767.1,"d":"3767"},{"v":6619.348082967305,"d":"6619"},{"v":6304.302186870164,"d":"6304"},{"v":315.04589609714094,"d":"315"},{"v":4.997315908385234,"d":"5"},0,4344,12,663,{"v":2872.116,"d":"2872"},{"v":5018.204569464392,"d":"5018"},{"v":5250.902176723433,"d":"5251"},{"v":232.69760725904052,"d":"233"},{"v":4.431573840597503,"d":"4"},{"v":9.428889748982737,"d":"9"},{"v":-16.709224572715215,"d":"-17"},null,0,4352,11,718,{"v":3116.838,"d":"3117"},{"v":5332.415492013794,"d":"5332"},{"v":5823.681034178168,"d":"5824"},{"v":491.265542164374,"d":"491"},{"v":8.435653314136234,"d":"8"},{"v":13.432969222521468,"d":"13"},{"v":-7.623701060729218,"d":"-8"},null,null,"PKCt","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Delta",{"$nulls":5},"TPD(pY)IAP(bA)C","Corresponds to amino acid residues T542 to P548; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y545 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in PKCt.",null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.13; AGC domain target; AGC</A> group; PKC family; Delta subfamily","Q04759","Q04759","Q04759",null,"GO:0016235; GO:0005829; GO:0001772; GO:0005622; GO:0005815; GO:0005886","GO:0005524; GO:0046872; GO:0004672; GO:0004697; GO:0004674","GO:0007411; GO:0060326; GO:0038095; GO:0006954; GO:0035556; GO:0006509; GO:0046627; GO:0070233; GO:0018105; GO:0030168; GO:0032740; GO:0045086; GO:0032753; GO:0051092; GO:0050870; GO:0042102; GO:0051973; GO:1904355; GO:0032212; GO:2000318; GO:2000570; GO:0001558; GO:0045652; GO:0090330; GO:0006355; GO:0050852"]
[1988,996,"PK772","PKCt (PRKCQ)","S695","Protein-serine kinase C theta",0,4058,18,907,{"v":3664.28,"d":"3664"},{"v":6438.678238819102,"d":"6439"},{"$nulls":3},0,4582,16,689,{"v":3145.974,"d":"3146"},{"v":5496.693414268842,"d":"5497"},{"$nulls":6},0,4088,18,694,{"v":2824.58,"d":"2825"},{"v":4832.408405708709,"d":"4832"},{"$nulls":7},"PKCt","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Delta",{"$nulls":5},"RNF(pS)FMN(bA)C","Corresponds to amino acid residues R692 to N698; In Pkinase_C domain near C-terminus of the kinase.","S695 phosphorylation stimulates phosphotransferase activity. This is one of the major in vivo phosphorylation sites in PKCt (≥75 reports from high throughput mass spectrometry studies).","PDK1; PKCt (PRKCQ; PKCq)",null,"Q04759","Q04759","Q04759"]
[1992,998,"PK208","PKCz (PRKCZ)","T410","Protein-serine kinase C zeta",0,156,16,590,{"v":82.6,"d":"83"},{"v":145.14033385179565,"d":"145"},{"$nulls":3},0,178,14,438,{"v":71.832,"d":"72"},{"v":125.50595819728944,"d":"126"},{"$nulls":6},0,180,10,516,{"v":87.72,"d":"88"},{"v":150.0750077352272,"d":"150"},{"$nulls":7},"PKCz","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Iota",{"$nulls":5},"Epitope undefined.","Antibody raised against amino acid residues that encompass the T410 phosphosite.","T410 phosphorylation stimulates phosphotransferase activity, and induces interaction with MYO1C, TNNI1, TPM1 and desmin. In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in PKCz (≥11 reports from high throughput mass spectrometry studies).","PDPK1 (PDK1)",null,"Q05513","Q05513","Q05513"]
[1995,1000,"NK142","PKD1 (PRKCM, PKCm, PRKD1)","Pan-specific","Protein-serine kinase C mu (Protein kinase D)",0,254,12,476,{"v":115.192,"d":"115"},{"v":202.4092655817923,"d":"202"},{"v":267.09950723942893,"d":"267"},{"v":64.69024165763662,"d":"65"},{"v":24.21952864167887,"d":"24"},0,246,14,451,{"v":104.632,"d":"105"},{"v":182.81461490838052,"d":"183"},{"v":192.25569193698968,"d":"192"},{"v":9.441077028609158,"d":"9"},{"v":4.9106879143549085,"d":"5"},{"v":29.13021655603378,"d":"29"},{"v":-28.020948475711336,"d":"-28"},null,0,280,12,508,{"v":136.144,"d":"136"},{"v":232.9207917590603,"d":"233"},{"v":241.9506126759154,"d":"242"},{"v":9.029820916855101,"d":"9"},{"v":3.732092602282532,"d":"4"},{"v":27.9516212439614,"d":"28"},{"v":-9.415552586912838,"d":"-9"},null,null,"PKD1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","PKD",{"$nulls":6},"Epitope undefined.",{"$nulls":3},"EC 2.7.11.13; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; PKD family","Q15139","Q15139","Q15139","Q15139","GO:0000421; GO:0005829; GO:0005794; GO:0005886; GO:0005802","GO:0005524; GO:0042802; GO:0016301; GO:0046872; GO:0004697; GO:0004674","GO:0001525; GO:0006915; GO:0008283; GO:0034198; GO:0071447; GO:0034599; GO:0035924; GO:0007030; GO:0048193; GO:0006954; GO:0045087; GO:0007229; GO:0035556; GO:0060548; GO:0045806; GO:0018105; GO:0018107; GO:0045766; GO:0010508; GO:0043536; GO:0032793; GO:2001028; GO:0038033; GO:0010595; GO:0001938; GO:1901727; GO:0043123; GO:0010976; GO:0051092; GO:0045669; GO:0033138; GO:0043552; GO:0045944; GO:0046777; GO:0089700; GO:0006468; GO:0007265; GO:2001044; GO:0010837; GO:0031647; GO:0007165; GO:0030148; GO:0048010"]
[2000,1002,"PK771","PKD1 (PRKCM, PKCm, PRKD1)","S738+S742","Protein-serine kinase C mu (Protein kinase D)",0,148,12,410,{"v":55.76,"d":"56"},{"v":97.97851108445673,"d":"98"},{"$nulls":3},0,140,14,466,{"v":58.716,"d":"59"},{"v":102.58948437342755,"d":"103"},{"$nulls":6},0,146,13,465,{"v":61.845,"d":"62"},{"v":105.80698647269864,"d":"106"},{"$nulls":7},"PKD1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","PKD",{"$nulls":6},"GEK(pS)FRR(pS)VVG(bA)C","Corresponds to amino acid residues G735 to G745; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S738 and S742 phosphorylation stimulate phosphotransferase activity and induces interaction with ASK1, IKKB, JNK1 and PKCD. These are two of the major in vivo phosphorylation sites in PKD1 (≥32 and ≥79 reports, respectively, from high throughput mass spectrometry studies).","S378: PKCa (PRKCA); PKCd (PRKCD); PKCe (PRKCE); PKCh (PRKCH); PKCz (PRKCZ); PKD1 (PRKCM; PRKD1); PKD3 (PRKCN). S742: p38d MAPK (MAPK13); PKCa (PRKCA); PKCd (PRKCD); PKCe (PRKCE); PKCh (PRKCH); PKCz (PRKCZ); PKD1 (PRKCM; PRKD1); PKD3 (PRKCN).",null,"Q15139","Q15139","Q15139","Q15139"]
[2005,1005,"PK784","PKD2 (PRKD2)","S197+S198","Serine/threonine-protein kinase D2",0,6120,18,1038,{"v":6333.876,"d":"6334"},{"v":11129.550571620775,"d":"11130"},{"v":8122.443168958048,"d":"8122"},{"v":3007.1074026627275,"d":"3007"},{"v":37.02220305037211,"d":"37"},0,5702,14,733,{"v":4169.304,"d":"4169"},{"v":7284.671087200575,"d":"7285"},{"v":5872.537737422841,"d":"5873"},{"v":1412.133349777734,"d":"1412"},{"v":24.046390383818085,"d":"24"},{"v":61.0685934341902,"d":"61"},{"v":-27.699860555919727,"d":"-28"},null,0,5176,10,738,{"v":3812.508,"d":"3813"},{"v":6522.596529760779,"d":"6523"},{"v":5345.431573396028,"d":"5345"},{"v":1177.1649563647507,"d":"1177"},{"v":22.021888040311797,"d":"22"},{"v":59.04409109068391,"d":"59"},{"v":-34.18936319770221,"d":"-34"},null,null,"PKD2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","PKD",{"$nulls":6},"RRL(pS)(pS)TSL(bA)C","Corresponds to amino acid residues R194 to L201; In the C1_1 domain.","The effects of S197 and S198 phosphorylation are unclear. These are the major in vivo sites of phosphorylation of PRKD2 (≥353 and ≥190 reports, respectively, by mass spectrometry).",null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.13; CAMK domain target; CAMK</A> group; PKD family","Q9BZL6","Q9BZL6","Q9BZL6",null,"GO:0005737; GO:0005829; GO:0005794; GO:0005654; GO:0005634; GO:0005886","GO:0005524; GO:0046872; GO:0004672; GO:0004697; GO:0005080; GO:0004674","GO:0002250; GO:0001525; GO:0007155; GO:0008219; GO:0035924; GO:0061154; GO:0035556; GO:0018105; GO:0018107; GO:0045766; GO:0043536; GO:0045785; GO:0032793; GO:0051091; GO:2000573; GO:2001028; GO:0038033; GO:0010595; GO:0001938; GO:0070374; GO:0045743; GO:1901727; GO:0032743; GO:0032757; GO:1902533; GO:0051092; GO:0033138; GO:0050862; GO:0045944; GO:0030949; GO:0046777; GO:0089700; GO:0006468; GO:0030148; GO:0050852; GO:0048010"]
[2010,1007,"NK202","PKG1a (PRKG1A)","Pan-specific","cGMP-dependent protein kinase 1, alpha isozyme",0,114,10,492,{"v":51.168,"d":"51"},{"v":89.90969252456028,"d":"90"},{"$nulls":3},0,130,14,444,{"v":51.504,"d":"52"},{"v":89.98856875756204,"d":"90"},{"$nulls":6},0,140,12,489,{"v":62.592,"d":"63"},{"v":107.08498499958208,"d":"107"},{"$nulls":7},"PKG1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKG",{"$nulls":6},"ELEEDFAKILMLKEEC","Corresponds to amino acid residues E3 to E17; N-terminus.",{"$nulls":3},"Q13976","Q13976","Q13976"]
[2015,1009,"NK290-1","PKG2 (PRKG2)","Pan-specific","cGMP-dependent protein kinase 2",0,4302,35,903,{"v":3853.101,"d":"3853"},{"v":6770.464473422369,"d":"6770"},{"v":6199.420724193253,"d":"6199"},{"v":571.0437492291167,"d":"571"},{"v":9.21124367314864,"d":"9"},0,5940,22,782,{"v":4627.876,"d":"4628"},{"v":8085.89503004565,"d":"8086"},{"v":7293.49452367591,"d":"7293"},{"v":792.4005063697396,"d":"792"},{"v":10.864483462590863,"d":"11"},{"v":20.075727135739506,"d":"20"},{"v":17.64800048515876,"d":"18"},null,0,5620,18,849,{"v":4756.098,"d":"4756"},{"v":8136.929367755341,"d":"8137"},{"v":6639.708756214262,"d":"6640"},{"v":1497.220611541079,"d":"1497"},{"v":22.54949225204787,"d":"23"},{"v":31.76073592519651,"d":"32"},{"v":7.102083430195094,"d":"7"},null,null,"PKG2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKG",{"$nulls":6},"LQKYLEGYVANLNRDDEKRC","Corresponds to amino acid residues L397 to R415; Post-cNMP2.",null,null,"EC 2.7.11.12; Protein kinase, Ser/Thr (non-receptor); AGC domain target; AGC</A> group; PKG family","Q13237","Q13237","Q13237","Q13237","GO:0016324; GO:0005829; GO:0031965","GO:0005524; GO:0030553; GO:0004692; GO:0042803; GO:0004672","GO:0051186; GO:2001226; GO:0036289; GO:0072659; GO:0006468; GO:0007165"]
[2017,1010,"NK290-2","PKG2 (PRKG2)","Pan-specific","cGMP-dependent protein kinase 2",0,302,18,577,{"v":163.868,"d":"164"},{"v":287.9401480342137,"d":"288"},{"v":236.65254434818206,"d":"237"},{"v":51.287603686031616,"d":"51"},{"v":21.672111672111672,"d":"22"},0,260,16,443,{"v":108.092,"d":"108"},{"v":188.8599793053432,"d":"189"},{"v":166.28945407992018,"d":"166"},{"v":22.57052522542301,"d":"23"},{"v":13.573034652321017,"d":"14"},{"v":35.24514632443269,"d":"35"},{"v":-29.732657412184054,"d":"-30"},null,0,316,14,528,{"v":159.456,"d":"159"},{"v":272.8039265096715,"d":"273"},{"v":236.93100400405996,"d":"237"},{"v":35.87292250561154,"d":"36"},{"v":15.14066200681648,"d":"15"},{"v":36.81277367892815,"d":"37"},{"v":0.11766603086600469,"d":"0"},null,null,"PKG2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKG",{"$nulls":6},"CSNWKLSKALSLEMIQLKEK","Corresponds to amino acid residues S422 to K440; Just before kinase catalytic domain.",null,null,"EC 2.7.11.12; Protein kinase, Ser/Thr (non-receptor); AGC domain target; AGC</A> group; PKG family","Q13237","Q13237","Q13237","Q13237","GO:0016324; GO:0005829; GO:0031965","GO:0005524; GO:0030553; GO:0004692; GO:0042803; GO:0004672","GO:0051186; GO:2001226; GO:0036289; GO:0072659; GO:0006468; GO:0007165"]
[2022,1012,"PN717","PKM2","Y148","Pyruvate kinase isozymes M1/M2",0,1084,16,690,{"v":736.92,"d":"737"},{"v":1294.8766927610804,"d":"1295"},{"$nulls":3},0,806,14,464,{"v":367.488,"d":"367"},{"v":642.0805987026048,"d":"642"},{"$nulls":6},0,1088,16,534,{"v":572.448,"d":"572"},{"v":979.3677385774662,"d":"979"},{"$nulls":19},"X","DNA(pY)MEK(bA)C","Corresponds to amino acid residues D145 to C152.","Y148 phosphorylation inhibits enzyme activity. This is one of the major in vivo phosphorylation sites in PKM2 (≥336 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in fish.","EGFR",null,"P14618","P14618","P14618","P14618"]
[2027,1016,"NK149-3","PKN2 (PRK2)","Pan-specific","Serine/threonine-protein kinase N2",0,472,12,374,{"v":172.04,"d":"172"},{"v":302.2995524922872,"d":"302"},{"v":366.5021858854701,"d":"367"},{"v":64.20263339318291,"d":"64"},{"v":17.51766725157974,"d":"18"},0,444,12,444,{"v":191.808,"d":"192"},{"v":335.12984226954137,"d":"335"},{"v":394.3394690569028,"d":"394"},{"v":59.2096267873614,"d":"59"},{"v":15.014887282007653,"d":"15"},{"v":32.532554533587394,"d":"33"},{"v":7.595393491085929,"d":"8"},null,0,609,10,424,{"v":253.976,"d":"254"},{"v":434.5126557747613,"d":"435"},{"v":451.2583714121576,"d":"451"},{"v":16.7457156373963,"d":"17"},{"v":3.7108930710786914,"d":"4"},{"v":21.22856032265843,"d":"21"},{"v":23.12569714200103,"d":"23"},null,null,"PKN2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKN",{"$nulls":6},"CGIQELEDRRSQQRFQFNLQ","Corresponds to amino acid residues G637 to Q655; Just before kinase catalytic domain.",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.13; AGC domain target; AGC</A> group; PKN family","Q16513","Q16513","Q16513",null,"GO:0043296; GO:0005813; GO:0032154; GO:0005737; GO:0005829; GO:0045111; GO:0030027; GO:0030496; GO:0016604; GO:0005654; GO:0005634; GO:0048471; GO:0005886; GO:0032991","GO:0005524; GO:0045296; GO:0017049; GO:0042826; GO:0016301; GO:0004672; GO:0004697; GO:0004674; GO:0003723; GO:0070063","GO:0043297; GO:0006915; GO:0007155; GO:0007049; GO:0051301; GO:0030030; GO:0010631; GO:0035556; GO:0018105; GO:0032467; GO:0045931; GO:0045070; GO:0006468; GO:2000145; GO:0006355; GO:0007165; GO:0006351"]
[2028,1016,"NK149-3","PKN2 (PRK2)","Pan-specific","Serine/threonine-protein kinase N2",0,538,12,466,{"v":245.116,"d":"245"},{"v":430.7048192786531,"d":"431"},{"$nulls":3},0,521,14,512,{"v":259.584,"d":"260"},{"v":453.5490958442642,"d":"454"},{"$nulls":6},0,668,12,417,{"v":273.552,"d":"274"},{"v":468.0040870495539,"d":"468"},{"$nulls":7},"PKN2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKN",{"$nulls":6},"CGIQELEDRRSQQRFQFNLQ","Corresponds to amino acid residues G637 to Q655; Just before kinase catalytic domain.",{"$nulls":3},"Q16513","Q16513","Q16513"]
[2033,1019,"PK777","PKR1 (PRKR; EIF2AK2)","T446","Double-stranded RNA-dependent protein-serine kinase; Interferon-induced, double-stranded RNA-activated protein kinase",0,4079,18,589,{"v":2391.929,"d":"2392"},{"v":4202.970624815881,"d":"4203"},{"v":5023.072375499641,"d":"5023"},{"v":820.1017506837597,"d":"820"},{"v":16.326695882063312,"d":"16"},0,4822,16,570,{"v":2739.42,"d":"2739"},{"v":4786.356108765156,"d":"4786"},{"v":4989.906672998148,"d":"4990"},{"v":203.55056423299175,"d":"204"},{"v":4.079245917252595,"d":"4"},{"v":20.405941799315908,"d":"20"},{"v":-0.6602672631845934,"d":"-1"},null,0,4588,18,593,{"v":2710.01,"d":"2710"},{"v":4636.39730634454,"d":"4636"},{"v":3251.186336777117,"d":"3251"},{"v":1385.210969567423,"d":"1385"},{"v":42.60632354098089,"d":"43"},{"v":58.9330194230442,"d":"59"},{"v":-35.27494541717161,"d":"-35"},null,null,"PKR","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","PEK",{"$nulls":6},"GKR(pT)RSK(bA)C","Corresponds to amino acid residues G443 to K449; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T446 phosphorylation stimulates phosphotransferase activity. Phosphorylation regulates cell cycle progression and cell growth. This is a minor in vivo phosphorylation sites in PKR1 (≥1 report from high throughput mass spectrometry studies).","PKR (EIF2AK2)","EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; PEK family","P19525","P19525","P19525","P19525","GO:0005737; GO:0005829; GO:0016020; GO:0005634; GO:0048471; GO:0005840","GO:0005524; GO:0003725; GO:0004694; GO:0042802; GO:0004715; GO:0004672; GO:0019888; GO:0004674; GO:0003723","GO:0000186; GO:0034198; GO:0051607; GO:0030968; GO:0030683; GO:0045087; GO:0043066; GO:0008285; GO:0033689; GO:0017148; GO:0045071; GO:0032722; GO:0001819; GO:0051092; GO:1901224; GO:0032874; GO:0046777; GO:0006468; GO:1901532; GO:1902036; GO:1902033; GO:1900225; GO:0035455; GO:0009636; GO:0009615; GO:0006351; GO:0006412"]
[2039,1022,"PN721","PLCE1","S1096+T1100","1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase epsilon-1",0,1544,10,550,{"v":843.7,"d":"844"},{"v":1482.5048386290557,"d":"1483"},{"v":1408.1335961317523,"d":"1408"},{"v":74.37124249730346,"d":"74"},{"v":5.281547340508514,"d":"5"},0,1604,14,561,{"v":891.99,"d":"892"},{"v":1558.49843596726,"d":"1558"},{"v":1675.444787175902,"d":"1675"},{"v":116.946351208642,"d":"117"},{"v":6.9800182079270146,"d":"7"},{"v":12.261565548435527,"d":"12"},{"v":18.98336860781346,"d":"19"},null,0,2074,12,548,{"v":1129.976,"d":"1130"},{"v":1933.2097234452929,"d":"1933"},{"v":1886.3052955831292,"d":"1886"},{"v":46.90442786216363,"d":"47"},{"v":2.486576694238865,"d":"2"},{"v":7.768124034747379,"d":"8"},{"v":33.95783615737528,"d":"34"},{"$nulls":5},"Phospholipase",{"$nulls":8},"X","RGE(pS)GEV(pT)DDE(pA)C","Corresponds to amino acid residues R1093 to 1153E.","The effect of S1096 and T1100 phosphorylation is unclear. These are two of the major in vivo phosphorylation sites in PLCE1 (≥19 and >5 reports, respectively, by mass spectrometry). These human phosphosites are conserved in mammals and found in the rat.",null,"Phospholipase; EC 3.1.4.11; Carbohydrate Metabolism - inositol phosphate","Q9P212","Q9P212",null,"Q9P212","GO:0005829; GO:0000139; GO:0005886","GO:0019899; GO:0005085; GO:0046872; GO:0004435; GO:0004629; GO:0017016","GO:0000187; GO:0019722; GO:0008283; GO:0007010; GO:0006651; GO:0007173; GO:0032835; GO:0007507; GO:0048016; GO:0043647; GO:0016042; GO:0007200; GO:0007204; GO:0007265; GO:0001558; GO:0008277; GO:0045859; GO:0046578; GO:0006940"]
[2044,1024,"PN165","PLCG1","Y771","1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2",0,2287,8,292,{"v":665.468,"d":"665"},{"v":1169.3250325385804,"d":"1169"},{"$nulls":3},0,2024,10,302,{"v":608.228,"d":"608"},{"v":1062.7051723802897,"d":"1063"},{"$nulls":6},0,2108,10,324,{"v":679.752,"d":"680"},{"v":1162.9478643186974,"d":"1163"},{"$nulls":10},"Phospholipase",{"$nulls":8},"X","PD(pY)GA","Corresponds to amino acid residues P769 to A773.","The effect of Y771 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in PLCG1 (≥569 reports from high throughput mass spectrometry studies). This human phosphosite is conserved in many mammals and found in the rat.","EGFR; Syk",null,"P19174","P19174"]
[2045,1025,"PN144","PLCG1","Y783","1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2",0,752,14,248,{"v":183.024,"d":"183"},{"v":321.600054030158,"d":"322"},{"v":294.4767344982413,"d":"294"},{"v":27.123319531916707,"d":"27"},{"v":9.210683342482765,"d":"9"},0,712,10,255,{"v":179.01,"d":"179"},{"v":312.76898286135406,"d":"313"},{"v":281.37327394545173,"d":"281"},{"v":31.395708915902333,"d":"31"},{"v":11.158028079805776,"d":"11"},{"v":20.36871142228854,"d":"20"},{"v":-4.449743907652518,"d":"-4"},null,0,576,16,300,168,{"v":287.4213554436636,"d":"287"},{"v":288.0372583481857,"d":"288"},{"v":0.6159029045221018,"d":"1"},{"v":0.21382751247325965,"d":"0"},{"v":9.424510854956026,"d":"9"},{"v":-2.1867520913079375,"d":"-2"},{"$nulls":5},"Phospholipase",{"$nulls":8},"X","GF(pY)VE","Corresponds to amino acid residues G347 to E351; Surrounds the Y349 phosphosite.","Y783 phosphorylation stimulates phospholipase activity, induces interaction with Grb2 and VEGFR-2 and regulates cell motility. This is one of the major sites of in vivo phosphorylation of PLCG1 (≥566 reports from high throughput mass spectrometry studies). ","EGFR; ITK; Ret; Src; Syk; TrkB (NTRK2); ZAP70","EC 3.1.4.11; Phospholipase; Carbohydrate Metabolism - inositol phosphate","P19174","P19174",null,null,"GO:0005911; GO:0042995; GO:0008180; GO:0005737; GO:0005829; GO:0098978; GO:0030027; GO:0005886; GO:0001726; GO:0098685","GO:0005509; GO:0035254; GO:0005168; GO:0004435; GO:0004629; GO:0019901; GO:0030971","GO:0007202; GO:0007411; GO:0019722; GO:0016477; GO:0071364; GO:0007173; GO:0038095; GO:0038096; GO:0043647; GO:0001701; GO:0050900; GO:0050804; GO:0009395; GO:0045766; GO:0043536; GO:2000353; GO:0010634; GO:0010863; GO:0051281; GO:1905564; GO:0007165; GO:0050852; GO:0016032"]
[2050,1027,"PN722","PLCG1","Y977","1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2",0,8013,20,734,{"v":5866.862,"d":"5867"},{"v":10308.938369762876,"d":"10309"},{"$nulls":3},0,8188,20,717,{"v":5856.456,"d":"5856"},{"v":10232.48861120761,"d":"10232"},{"$nulls":6},0,8584,18,661,{"v":5662.126,"d":"5662"},{"v":9686.999581028625,"d":"9687"},{"$nulls":10},"Phospholipase",{"$nulls":8},"X","RAS(pY)RDM(bA)C","Corresponds to amino acid residues R974 to M980 (C976S change).","The effect of Y977 phosphorylation is unclear. This is the major site of in vivo phosphorylation of PLCG1 (≥665 reports from high throughput mass spectrometry studies). This human phosphosite is conserved in mammals and found in the rat.",null,null,"P19174","P19174"]
[2056,1030,"PN531","PLCG2","Y759","1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2",0,5940,20,665,{"v":3936.8,"d":"3937"},{"v":6917.5359117160915,"d":"6918"},{"$nulls":3},0,6107,20,694,{"v":4224.378,"d":"4224"},{"v":7380.897214020899,"d":"7381"},{"$nulls":6},0,6477,18,660,{"v":4262.94,"d":"4263"},{"v":7293.214243898875,"d":"7293"},{"$nulls":10},"Phospholipase",{"$nulls":8},"X","SRM(pY)VDP(bA)C","Corresponds to amino acid residues S756 to P762; Near the end of the second SH2 domain in the protein. ","Y759 phosphorylation stimulates phospholipase activity, and induces interaction with Lyn. This is one of the major in vivo phosphorylation sites in PLCG2 (≥229 reports from high throughput mass spectrometry studies). This human phosphosite is conserved in many mammals and found in the rat.","Btk; Fyn; Lck; Src; Syk",null,"P16885","P16885",null,"P16885"]
[2061,1033,"PK779","Plk1 (PLK)","Y217","Polo-like protein-serine kinase 1",0,4624,16,680,{"v":3133.44,"d":"3133"},{"v":5505.914378989959,"d":"5506"},{"v":6009.373865618898,"d":"6009"},{"v":503.459486628939,"d":"503"},{"v":8.37790255502914,"d":"8"},0,4911,14,731,{"v":3579.707,"d":"3580"},{"v":6254.518280161271,"d":"6255"},{"v":6551.584166919243,"d":"6552"},{"v":297.0658867579723,"d":"297"},{"v":4.534260404650527,"d":"5"},{"v":12.912162959679666,"d":"13"},{"v":9.022742026460733,"d":"9"},null,0,5014,18,714,{"v":3567.144,"d":"3567"},{"v":6102.817640135308,"d":"6103"},{"v":6359.876693227432,"d":"6360"},{"v":257.0590530921245,"d":"257"},{"v":4.041887374418187,"d":"4"},{"v":12.419789929447326,"d":"12"},{"v":5.83260145643203,"d":"6"},null,null,"PLK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","PLK",{"$nulls":6},"TPN(pY)IAP(bA)C","Corresponds to amino acid residues T214 to P220; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y217 phosphorylation is predicted to be inhibitory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major site of in vivo phosphorylation of Plk1 (≥149 reports from high throughput mass spectrometry studies).","Abl1","EC 2.7.11.21; Protein kinase, Ser/Thr (non-receptor); Other group; PLK family","P53350","P53350","P53350","P53350","GO:0034451; GO:0005814; GO:0005813; GO:0000785; GO:0000942; GO:0005829; GO:0000776; GO:0015630; GO:0030496; GO:0005654; GO:0005634; GO:0005819; GO:0051233; GO:0000922; GO:0000795","GO:0010997; GO:0005524; GO:0042802; GO:0016301; GO:0000287; GO:0008017; GO:0004672; GO:0019901; GO:0004674","GO:0031145; GO:0008283; GO:0007098; GO:0097711; GO:0045184; GO:0016321; GO:0000086; GO:0045143; GO:0001578; GO:0000278; GO:0000281; GO:0007077; GO:0000070; GO:0007094; GO:0043066; GO:0045736; GO:0000122; GO:0051081; GO:0018105; GO:0010800; GO:0032436; GO:1900182; GO:0045862; GO:1904668; GO:0051443; GO:0031648; GO:0071168; GO:0090435; GO:0006468; GO:0016567; GO:0051726; GO:1902749; GO:0032465; GO:0010389; GO:0007346; GO:0030071; GO:1901673; GO:0043393; GO:0072425; GO:0007062; GO:0070194"]
[2062,1033,"PK779","Plk1 (PLK)","Y217","Polo-like protein-serine kinase 1",0,4774,16,779,{"v":3706.482,"d":"3706"},{"v":6512.833352247836,"d":"6513"},{"$nulls":3},0,4986,18,789,{"v":3919.752,"d":"3920"},{"v":6848.6500536772155,"d":"6849"},{"$nulls":6},0,5164,14,751,{"v":3867.65,"d":"3868"},{"v":6616.935746319556,"d":"6617"},{"$nulls":7},"PLK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","PLK",{"$nulls":6},"TPN(pY)IAP(bA)C","Corresponds to amino acid residues T214 to P220; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y217 phosphorylation is predicted to be inhibitory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major site of in vivo phosphorylation of Plk1 (≥149 reports from high throughput mass spectrometry studies).","Abl1",null,"P53350","P53350","P53350","P53350"]
[2067,1036,"PK780","Plk4 (SAK; STK18)","T170","Polo-like kinase-serine 4 (SAK)",0,9784,18,647,{"v":6318.602,"d":"6319"},{"v":11102.711909886486,"d":"11103"},{"v":14088.836342855615,"d":"14089"},{"v":2986.124432969129,"d":"2986"},{"v":21.1949685573811,"d":"21"},0,11517,18,736,{"v":8463.264,"d":"8463"},{"v":14787.143025345593,"d":"14787"},{"v":15363.525713824964,"d":"15364"},{"v":576.3826884793707,"d":"576"},{"v":3.7516303172565992,"d":"4"},{"v":24.946598874637697,"d":"25"},{"v":9.047513506079866,"d":"9"},null,0,11247,20,666,{"v":7477.182,"d":"7477"},{"v":12792.272531779543,"d":"12792"},{"v":14104.434850608539,"d":"14104"},{"v":1312.162318828996,"d":"1312"},{"v":9.303189618918921,"d":"9"},{"v":30.49815817630002,"d":"30"},{"v":0.11071537331636705,"d":"0"},null,null,"PLK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","PLK",{"$nulls":6},"KHY(pT)LCG(bA)C","Corresponds to amino acid residues K167 to G173; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T170 stimulates phosphotransferase activity and interaction with STIL. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of Plk4.",null,"EC 2.7.11.21; Protein kinase, Ser/Thr (non-receptor); Other group; PLK family","O00444","O00444","O00444",null,"GO:0005814; GO:0005813; GO:0032154; GO:0005829; GO:0098536; GO:0005730; GO:0001741","GO:0005524; GO:0042802; GO:0004674","GO:0007099; GO:0097711; GO:0098535; GO:0000086; GO:0046601; GO:0006468; GO:0010389; GO:0060707"]
[2072,1037,"PN641","PML","S518","Probable transcription factor PML",0,7389,12,706,{"v":5208.162,"d":"5208"},{"v":9151.505707436268,"d":"9152"},{"$nulls":3},0,8141,15,634,{"v":5151.884,"d":"5152"},{"v":9001.449743029352,"d":"9001"},{"$nulls":6},0,7712,14,669,{"v":5149.962,"d":"5150"},{"v":8810.768205496193,"d":"8811"},{"$nulls":10},"Transcription protein; Tumour suppressor",{"$nulls":4},"X",{"$nulls":4},"SKAV(pS)PPH(bA)C","Corresponds to amino acid residues S14 to H21.","S518 prevents ubiquitination by the BCR(KLHL20) E3 ubiquitin ligase complex. This is one of the major sites of in vivo phosphorylation of PML.",null,null,"P29590","P29590",null,"P29590"]
[2074,1038,"PN643","POU2F1","S385","POU domain, class 2, transcription factor 1",0,16476,18,803,{"v":13215.774,"d":"13216"},{"v":23222.056301088145,"d":"23222"},{"$nulls":3},0,16520,18,810,{"v":13366.62,"d":"13367"},{"v":23354.360883158664,"d":"23354"},{"$nulls":6},0,17280,20,841,{"v":14515.66,"d":"14516"},{"v":24833.9920973772,"d":"24834"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"KKRT(pS)IET(bA)C","Corresponds to amino acid residues K381 to T388.","S385 phosphorylation inhibits transcriptional activity by inhibiting DNA binding. This is one of the major sites of in vivo phosphorylation of POU2F1.","PKACa (PRKACA)",null,"P14859","P14859"]
[2079,1041,"PP502","PP1/Cb (PPP1CB)","T316","Serine/threonine-protein phosphatase PP1-beta catalytic subunit",0,7178,18,710,{"v":5083.6,"d":"5084"},{"v":8932.631975411483,"d":"8933"},{"v":8048.449713044016,"d":"8048"},{"v":884.182262367467,"d":"884"},{"v":10.9857462479325,"d":"11"},0,6754,18,732,{"v":4930.752,"d":"4931"},{"v":8615.08456388798,"d":"8615"},{"v":9201.170411667503,"d":"9201"},{"v":586.0858477795227,"d":"586"},{"v":6.3696880022604425,"d":"6"},{"v":17.355434250192943,"d":"17"},{"v":14.322269998845712,"d":"14"},null,0,7500,16,655,{"v":4902.02,"d":"4902"},{"v":8386.578766737784,"d":"8387"},{"v":8414.568132065513,"d":"8415"},{"v":27.989365327728592,"d":"28"},{"v":0.33262984966595166,"d":"0"},{"v":11.318376097598453,"d":"11"},{"v":4.548930937943666,"d":"5"},{"$nulls":4},"PSTP","Protein phosphatase - Serine/threonine phosphatase",{"$nulls":6},"X",null,null,"CGRPV(pT)PPR","Corresponds to amino acid residues G312 to R319; Near C-terminus.","T316 phosphorylation inhibits phosphatase activity. This is one of the major sites of in vivo phosphorylation of PP1/Cb.",null,"EC 3.1.3.16; Protein phosphatase, Ser/Thr (non-receptor)","P62140","P62140",null,null,"GO:0005829; GO:0070062; GO:0005925; GO:0005730; GO:0005654; GO:0005634; GO:0005886; GO:0000164; GO:0072357","GO:0046872; GO:0050115; GO:0017018; GO:0016791; GO:0019901","GO:0007049; GO:0051301; GO:0032922; GO:0043153; GO:0005977; GO:0006470; GO:0030155; GO:0042752"]
[2084,1043,"PP504","PP2A/Ca (PPP2CA)","Y307","Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform",0,4996,16,705,{"v":3510.9,"d":"3511"},{"v":6169.167047460888,"d":"6169"},{"$nulls":3},0,5444,16,764,{"v":4146.992,"d":"4147"},{"v":7245.687222915884,"d":"7246"},{"$nulls":6},0,5870,14,721,{"v":4222.176,"d":"4222"},{"v":7223.4735050101535,"d":"7223"},{"$nulls":9},"PSTP","Protein phosphatase - Serine/threonine phosphatase",{"$nulls":6},"X",null,null,"C(bA)TPD(pY)Fl-cooh","Corresponds to amino acid residues T304 to L309; At the C-terminus.","The effect of Y307 phosphorylation is unclear. It has been separately report to both stimulate and inhibits phosphatase activity. It regulates cell growth, apoptosis, cytoskeletal reorganization, intracellular location, methylation and molecular association, including inducing interaction with LCMT1. This phosphorylation site has not been reported by mass spectrometry, although other phosphosites in this protein have been reported. This particular human phosphosite is highly conserved in vertebrates and also found in yeast and mould.","EGFR; InsR; Lck; Src",null,"P67775","P67775",null,"P67775"]
[2089,1046,"PN644","PPARg-1","S112","Peroxisome proliferator-activated receptor gamma",0,5807,12,653,{"v":3784.135,"d":"3784"},{"v":6649.281080390615,"d":"6649"},{"v":6683.286265752199,"d":"6683"},{"v":34.005185361584154,"d":"34"},{"v":0.5088093493142762,"d":"1"},0,5944,16,654,{"v":3876.912,"d":"3877"},{"v":6773.799356924071,"d":"6774"},{"v":6893.253835471394,"d":"6893"},{"v":119.45447854732356,"d":"119"},{"v":1.7329186099695497,"d":"2"},{"v":2.2417279592838257,"d":"2"},{"v":3.1416815226836974,"d":"3"},null,0,2385,14,949,{"v":2250.079,"d":"2250"},{"v":3849.528309734066,"d":"3850"},{"v":5666.032131558721,"d":"5666"},{"v":1816.5038218246546,"d":"1817"},{"v":32.0595397210523,"d":"32"},{"v":32.56834907036658,"d":"33"},{"v":-15.220867306048078,"d":"-15"},{"$nulls":5},"Transcription protein (receptor)",{"$nulls":4},"X",{"$nulls":4},"C(bA)EPA(pS)PPYY","Corresponds to amino acid residues C108 to Y116.","S112 phosphorylation inhibits transcriptional activity by inhibiting both ligand-independent and ligand-dependent transactivation functions of peroxisome proliferator-activated receptor gamma and targets PPARG to the ubiquitin-proteasome system to regulate cell growth and differentiation. This is one of the major sites of in vivo phosphorylation of PPARg-1.","CDK9; ERK1 (MAPK3); ERK2 (MAPK1); JNK1 (MAPK8)","Transcription protein (receptor)","P37231","P37231",null,"P37231","GO:0005829; GO:0043231; GO:0005654; GO:0005634; GO:0048471; GO:0032991; GO:0090575","GO:0033613; GO:0051393; GO:0050544; GO:0003682; GO:0050692; GO:0003677; GO:0003700; GO:0003690; GO:0008144; GO:0070888; GO:0019899; GO:0030331; GO:0042802; GO:0050693; GO:0004879; GO:0030374; GO:0042277; GO:0004955; GO:0008022; GO:0046982; GO:0019903; GO:0043621; GO:0046965; GO:0000981; GO:0003707; GO:0008134; GO:0044212; GO:0008270","GO:0006919; GO:0031100; GO:0045165; GO:0048469; GO:0071455; GO:0032869; GO:0071404; GO:0071380; GO:0071300; GO:0071306; GO:0030855; GO:0019395; GO:0042593; GO:0007507; GO:0045087; GO:0055088; GO:0006629; GO:0042953; GO:0015909; GO:0045713; GO:0010742; GO:0030224; GO:0002674; GO:0016525; GO:0043537; GO:0030308; GO:0010887; GO:0032966; GO:0060965; GO:0060336; GO:0010745; GO:2000230; GO:0010871; GO:0010891; GO:0048662; GO:0051974; GO:0045892; GO:0000122; GO:1905563; GO:1904706; GO:0035357; GO:0001890; GO:0043388; GO:0051091; GO:0045600; GO:0046321; GO:0048714; GO:0060100; GO:0045893; GO:0045944; GO:1905461; GO:0061614; GO:0008217; GO:0060694; GO:0042752; GO:0006357; GO:0060850; GO:0031000; GO:0009409; GO:0043627; GO:0035902; GO:0033993; GO:0009612; GO:1901558; GO:0007584; GO:0032526; GO:0042594; GO:0033189; GO:0048511; GO:0007165; GO:0006367; GO:0050872"]
[2094,1048,"PP503","PPP1R12B","T646","Protein phosphatase 1 regulatory subunit 12B",0,4050,16,724,{"v":2920.616,"d":"2921"},{"v":5131.951347371622,"d":"5132"},{"$nulls":3},0,4038,14,595,{"v":2394.28,"d":"2394"},{"v":4183.322274092413,"d":"4183"},{"$nulls":6},0,4444,18,663,{"v":2934.438,"d":"2934"},{"v":5020.358020389245,"d":"5020"},{"$nulls":10},"Protein-serine/threonine phosphatase regulatory subunit",{"$nulls":6},"X",null,null,"RRS(pT)QGV(bA)C","Corresponds to amino acid residues R643 to V649.","T646 phosphorylation inhibits. This is the minor site of in vivo phosphorylation of PPPP1R12B (≥9 reports from high throughput mass spectrometry studies).  This human phosphosite is conserved in mammals and found in the rat.","ROCK1",null,"O60237","O60237"]
[2097,152,"NP049-1","PPP3CC (Calcinerin)","Pan-specific","Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform",0,532,12,296,{"v":153.92,"d":"154"},{"v":270.4600506836366,"d":"270"},{"v":299.96254711670747,"d":"300"},{"v":29.50249643307086,"d":"30"},{"v":9.835393357155425,"d":"10"},0,897,10,325,{"v":288.275,"d":"288"},{"v":503.67844553017613,"d":"504"},{"v":387.0893998184066,"d":"387"},{"v":116.58904571176953,"d":"117"},{"v":30.119410597775186,"d":"30"},{"v":39.95480395493061,"d":"40"},{"v":29.045910410875507,"d":"29"},null,0,458,10,289,{"v":129.472,"d":"129"},{"v":221.5060579285834,"d":"222"},{"v":214.7721861724747,"d":"215"},{"v":6.733871756108698,"d":"7"},{"v":3.1353555952077534,"d":"3"},{"v":12.970748952363179,"d":"13"},{"v":-28.400332562547376,"d":"-28"},{"$nulls":4},"PSTP","Protein phosphatase - Serine/threonine phosphatase",{"$nulls":6},"X",null,null,"Epitope undefined.",{"$nulls":3},"Cytosol protein","P48454","P48454",null,null,"GO:0005737; GO:0005829; GO:0098978; GO:0099523","GO:0005516; GO:0033192; GO:0046872","GO:0007420; GO:0033173; GO:1900244; GO:0006470"]
[2101,1051,"PP507","PPP5C","Y119","Serine/threonine-protein phosphatase 5",0,11167,16,647,{"v":7214.697,"d":"7215"},{"v":12677.282460285092,"d":"12677"},{"v":13611.219215669273,"d":"13611"},{"v":933.9367553841803,"d":"934"},{"v":6.861521665223272,"d":"7"},0,12546,20,625,{"v":7828.75,"d":"7829"},{"v":13678.510555699824,"d":"13679"},{"v":14549.008084559575,"d":"14549"},{"v":870.4975288597507,"d":"870"},{"v":5.983208778223056,"d":"6"},{"v":12.844730443446327,"d":"13"},{"v":6.889822682531758,"d":"7"},null,0,11146,18,637,{"v":7088.536,"d":"7089"},{"v":12127.360864471459,"d":"12127"},{"v":13209.314075162692,"d":"13209"},{"v":1081.9532106912338,"d":"1082"},{"v":8.190835682570505,"d":"8"},{"v":15.052357347793777,"d":"15"},{"v":-2.952749009022696,"d":"-3"},{"$nulls":4},"PSTP","Protein phosphatase - Serine/threonine phosphatase",{"$nulls":6},"X",null,null,"LRD(pY)ETV(bA)C","Corresponds to amino acid residues L116 to V122.","The effect of Y119 phosphorylation is unclear. This is one of the minor sites of in vivo phosphorylation of PPP5C (≥12 reports from high throughput mass spectrometry studies).  This particular human phosphosite is highly conserved in vertebrates and also found in the sea urchin.",null,"Protein phosphatase, Ser/Thr (non-receptor); EC 3.1.3.16","P53041","P53041",null,null,"GO:0101031; GO:0005829; GO:0043231; GO:0005654; GO:0005634; GO:0043204; GO:0005886; GO:0032991; GO:1990635","GO:0043531; GO:0005524; GO:0001965; GO:0051879; GO:0042802; GO:0008289; GO:0046872; GO:0008017; GO:0016791; GO:0004721; GO:0004722; GO:0003723","GO:0071276; GO:0070301; GO:0006281; GO:0016576; GO:0000165; GO:0000278; GO:1901215; GO:0001933; GO:0070262; GO:0035970; GO:2000324; GO:0043123; GO:0006470; GO:0051291; GO:1904550; GO:0010288; GO:0043278; GO:0006351"]
[2106,1015,"NK148","PRK1 (PKN1)","Pan-specific","Protein kinase C-related protein-serine kinase 1; Protein kinase N1",0,176,14,646,{"v":104.652,"d":"105"},{"v":183.88893726704745,"d":"184"},{"$nulls":3},0,172,16,541,{"v":84.396,"d":"84"},{"v":147.45796926186713,"d":"147"},{"$nulls":6},0,244,12,464,{"v":107.648,"d":"108"},{"v":184.16865518333032,"d":"184"},{"$nulls":7},"PKN1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKN",{"$nulls":6},"Epitope undefined.",{"$nulls":4},"Q16512","Q16512","Q16512"]
[2111,1056,"NK127-3","PRKACA (PKA)","Pan-specific","cAMP-dependent protein kinase catalytic subunit alpha",0,478,16,550,{"v":254.1,"d":"254"},{"v":446.4910270186595,"d":"446"},{"v":424.76917705406026,"d":"425"},{"v":21.721849964599244,"d":"22"},{"v":5.113800891874673,"d":"5"},0,420,12,497,{"v":202.776,"d":"203"},{"v":354.2932979648843,"d":"354"},{"v":447.68893625252645,"d":"448"},{"v":93.39563828764216,"d":"93"},{"v":20.861725793232644,"d":"21"},{"v":25.97552668510732,"d":"26"},{"v":5.39581505358359,"d":"5"},null,0,537,16,547,{"v":284.987,"d":"285"},{"v":487.567558475139,"d":"488"},{"v":522.1616270331663,"d":"522"},{"v":34.59406855802729,"d":"35"},{"v":6.62516484686646,"d":"7"},{"v":11.738965738741133,"d":"12"},{"v":22.928323249478822,"d":"23"},null,null,"PKACa","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKA",{"$nulls":6},"Epitope undefined.",{"$nulls":3},"EC 2.7.11.11; Protein kinase, Ser/Thr (non-receptor); AGC group; PKA family","P17612","P17612","P17612",null,"GO:0001669; GO:0034704; GO:0005952; GO:0005813; GO:0097546; GO:0005737; GO:0005829; GO:0070062; GO:0045171; GO:0016020; GO:0005739; GO:0031514; GO:0016607; GO:0005654; GO:0031588; GO:0005634; GO:0048471; GO:0044853; GO:0097225","GO:0005524; GO:0004691; GO:0004672; GO:0034237; GO:0019901; GO:0004712; GO:0004674; GO:0031625","GO:0034199; GO:0007596; GO:0035584; GO:0086064; GO:0071872; GO:0071377; GO:0071333; GO:0034605; GO:0097711; GO:0019221; GO:0000086; GO:0034380; GO:0006397; GO:0018105; GO:0071158; GO:0010737; GO:0006468; GO:2000810; GO:1903779; GO:0055117; GO:0010881; GO:0051480; GO:0010389; GO:0002027; GO:0016241; GO:0045667; GO:0061136; GO:0043393; GO:0060314; GO:0003091; GO:0048240; GO:0002223"]
[2112,1056,"NK127-3","PRKACA (PKA)","Pan-specific","cAMP-dependent protein kinase catalytic subunit alpha",0,462,14,512,{"v":229.376,"d":"229"},{"v":403.047327089461,"d":"403"},{"$nulls":3},0,540,16,591,{"v":309.684,"d":"310"},{"v":541.0845745401685,"d":"541"},{"$nulls":6},0,576,12,577,{"v":325.428,"d":"325"},{"v":556.7556955911937,"d":"557"},{"$nulls":7},"PKACa","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKA",{"$nulls":6},"Epitope undefined.",{"$nulls":4},"P17612","P17612","P17612"]
[2120,962,"PN259","PRKAR2A (PKA2RA)","S99","cAMP-dependent protein kinase type II-alpha regulatory subunit",0,259,24,750,{"v":176.25,"d":"176"},{"v":309.6971409367916,"d":"310"},{"$nulls":3},0,101,10,514,{"v":46.774,"d":"47"},{"v":81.72424112818823,"d":"82"},{"$nulls":6},0,179,12,528,{"v":88.176,"d":"88"},{"v":150.85515141428857,"d":"151"},{"$nulls":20},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S96 phosphosite of mouse PRKAR2A.","The effect of S99 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of PRKAR2A (≥251 reports from high throughput mass spectrometry studies).","PKACa (PRKACA)",null,"P13861","P13861"]
[2123,1061,"PK785","PRKX","T201+T203","Serine/threonine-protein kinase PRKX",0,11491,16,659,{"v":7562.025,"d":"7562"},{"v":13287.588778397398,"d":"13288"},{"v":12962.955010246234,"d":"12963"},{"v":324.63376815116317,"d":"325"},{"v":2.504319176411279,"d":"3"},0,10378,21,633,{"v":6555.981,"d":"6556"},{"v":11454.709284555962,"d":"11455"},{"v":12278.756225214715,"d":"12279"},{"v":824.0469406587526,"d":"824"},{"v":6.71115970986176,"d":"7"},{"v":9.21547888627304,"d":"9"},{"v":-5.2781081511948,"d":"-5"},null,0,11890,18,670,{"v":7954.24,"d":"7954"},{"v":13608.443109072658,"d":"13608"},{"v":14363.15513070147,"d":"14363"},{"v":754.7120216288131,"d":"755"},{"v":5.254500245670982,"d":"5"},{"v":7.7588194220822615,"d":"8"},{"v":10.801550413069265,"d":"11"},null,null,"PRKX","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKA",{"$nulls":6},"VDR(pT)W(pT)LCG(bA)C","Corresponds to amino acid residues V198 to G206; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T201 and T203 phosphorylation are predicted to stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major sites of in vivo phosphorylation of PRKX.",null,"Protein kinase, Ser/Thr, AGC group, PKA family","P51817","P51817","P51817",null,"GO:0005737; GO:0005634","GO:0005524; GO:0004691","GO:0001525; GO:0007155; GO:0031589; GO:0043542; GO:0001935; GO:0060562; GO:0060993; GO:0030099; GO:0018105; GO:0046777; GO:0030155; GO:0030334; GO:2000696"]
[2128,1063,"PN549","PRMT5","T634","Protein arginine N-methyltransferase 5",0,11056,18,642,{"v":7086.396,"d":"7086"},{"v":12451.838756005198,"d":"12452"},{"$nulls":3},0,11542,20,639,{"v":7362.558,"d":"7363"},{"v":12863.972833460282,"d":"12864"},{"$nulls":6},0,12230,24,711,{"v":8678.466,"d":"8678"},{"v":14847.47893387946,"d":"14847"},{"$nulls":20},"GRSY(pT)IGL(bA)C     ","Corresponds to amino acid residues G630 to L637; At the C-terminus of the protein.","The effect of T634 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of PRMT5.",null,null,"O14744","O14744",null,"O14744"]
[2129,1064,"PK786","PRP4K (PRP4, PRPF4B)","Y849","Protein-serine kinase PRP4 homologue",0,3422,14,584,{"v":1990.272,"d":"1990"},{"v":3497.2002728314897,"d":"3497"},{"v":3470.094524768562,"d":"3470"},{"v":27.105748062927432,"d":"27"},{"v":0.7811241990514725,"d":"1"},0,3396,18,555,{"v":1874.79,"d":"1875"},{"v":3275.661479127635,"d":"3276"},{"v":3534.317461775599,"d":"3534"},{"v":258.6559826479638,"d":"259"},{"v":7.318413963810092,"d":"7"},{"v":8.099538162861565,"d":"8"},{"v":1.850754685459762,"d":"2"},null,0,4172,19,607,{"v":2520.871,"d":"2521"},{"v":4312.810474515617,"d":"4313"},{"v":4561.73019964034,"d":"4562"},{"v":248.9197251247233,"d":"249"},{"v":5.456695469283757,"d":"5"},{"v":6.237819668335229,"d":"6"},{"v":31.45838440653384,"d":"31"},null,null,"PRPF4B","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","DYRK","PRP4",{"$nulls":5},"ITP(pY)LVS(bA)C","Corresponds to amino acid residues I846 to S852; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y849 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of PRP4K.",null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; CMGC domain target; CMGC</A> group; DYRK family; PRP4 subfamily","Q13523","Q13523","Q13523","Q13523","GO:0071013; GO:0005694; GO:0016607","GO:0005524; GO:0004672; GO:0004674; GO:0003723","GO:0000398; GO:0006468; GO:0051726; GO:0008380"]
[2134,1066,"NP023-5","PTEN","Pan-specific","Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and protein phosphatase and tensin homolog deleted on chromosome 10",0,5348,16,637,{"v":3396.484,"d":"3396"},{"v":5968.121327872667,"d":"5968"},{"$nulls":3},0,6292,18,744,{"v":4667.856,"d":"4668"},{"v":8155.74869148801,"d":"8156"},{"$nulls":6},0,6545,12,713,{"v":4658.029,"d":"4658"},{"v":7969.148862356505,"d":"7969"},{"$nulls":9},"PIPP","Lipid phosphatase",{"$nulls":8},"X","CNEPFDEDQHTQITKV","Corresponds to amino acid residues N389 to V403; C-terminus.",{"$nulls":3},"P60484","P60484",null,"P60484"]
[2138,1068,"PP003","PTEN","S380+T382+S385","Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and protein phosphatase and tensin homolog deleted on chromosome 10",0,1828,10,325,{"v":590.85,"d":"591"},{"v":1038.2102452340614,"d":"1038"},{"$nulls":3},0,1957,12,294,{"v":571.83,"d":"572"},{"v":999.110035582415,"d":"999"},{"$nulls":6},0,1993,14,338,{"v":668.902,"d":"669"},{"v":1144.385235112961,"d":"1144"},{"$nulls":9},"PIPP","Lipid phosphatase",{"$nulls":8},"X","Not precisely defined.","Antibody raised against amino acid residues that encompass the S380 phosphosite.","S380, T382 and S385 phosphorylation inhibits phosphatase activity, regulates cell differentiation, cell motility, transcription, and induces/inhibits interaction with PTEN. T382 phosphorylation also inhibit interactions with MAGI2 (AIP1). These are major sites of in vivo phosphorylation of PTEN.","S380: CK2a1 (CSNK2A1); LKB1 (STK11); PKCz (PRKCZ). T382: CK2a1 (CSNK2A1); LKB1 (STK11); MAGI2 (AIP1); PKCz (PRKCZ). S385: CK2a1 (CSNK2A1).",null,"P60484","P60484",null,"P60484"]
[2145,1072,"PP510","PTPN1 (PTP1B)","Y66","Tyrosine-protein phosphatase non-receptor type 1",0,2720,16,539,{"v":1457.456,"d":"1457"},{"v":2560.9642907300567,"d":"2561"},{"v":2537.5309796858974,"d":"2538"},{"v":23.43331104415938,"d":"23"},{"v":0.923468963798031,"d":"1"},0,2240,20,531,{"v":1178.82,"d":"1179"},{"v":2059.6521556148896,"d":"2060"},{"v":2858.909607815808,"d":"2859"},{"v":799.2574522009186,"d":"799"},{"v":27.956723431054787,"d":"28"},{"v":28.880192394852816,"d":"29"},{"v":12.665012987139647,"d":"13"},null,0,3134,18,567,{"v":1766.772,"d":"1767"},{"v":3022.6666845232876,"d":"3023"},{"v":3239.8819522170334,"d":"3240"},{"v":217.21526769374577,"d":"217"},{"v":6.704419200986831,"d":"7"},{"v":7.627888164784863,"d":"8"},{"v":27.67851814041991,"d":"28"},{"$nulls":4},"PYP","Protein phosphatase, tyrosine (non-receptor)",{"$nulls":6},"X",null,null,"DND(pY)INA(bA)C","Corresponds to amino acid residues D63 to A69.","Y66 phosphorylation stimulates phosphatase activity and protein interaction. This is one of the major sites of in vivo phosphorylation of PTPN1 (≥46 reports from high throughput mass spectrometry studies).  This particular human phosphosite is highly conserved in vertebrates and also found in the bee.","EGFR","Phosphatase; EC 3.1.3.48; Protein phosphatase, tyrosine (non-receptor)","P18031","P18031",null,null,"GO:0098554; GO:0005829; GO:0005769; GO:0005783; GO:0097443","GO:0045296; GO:0019899; GO:0046875; GO:0005158; GO:0019901; GO:0051721; GO:0004725; GO:0030971; GO:0003723; GO:0008270","GO:0031532; GO:0007257; GO:0034620; GO:0030968; GO:0008286; GO:0036498; GO:0060397; GO:1902236; GO:0070373; GO:0046627; GO:0043407; GO:1903898; GO:0009968; GO:0030948; GO:0035335; GO:1990264; GO:0035791; GO:1903896; GO:0061098; GO:2000646; GO:0006470; GO:0030100; GO:1902202; GO:0033157; GO:0009966; GO:0060338"]
[2146,1072,"PP510","PTPN1 (PTP1B)","Y66","Tyrosine-protein phosphatase non-receptor type 1",0,2502,18,576,{"v":1430.784,"d":"1431"},{"v":2514.0976686417384,"d":"2514"},{"$nulls":3},0,3157,18,667,{"v":2093.713,"d":"2094"},{"v":3658.1670600167267,"d":"3658"},{"$nulls":6},0,3358,18,605,{"v":2020.7,"d":"2021"},{"v":3457.0972199107796,"d":"3457"},{"$nulls":9},"PYP","Protein phosphatase, tyrosine (non-receptor)",{"$nulls":6},"X",null,null,"DND(pY)INA(bA)C","Corresponds to amino acid residues D63 to A69.","Y66 phosphorylation stimulates phosphatase activity and protein interaction. This is one of the major sites of in vivo phosphorylation of PTPN1 (≥46 reports from high throughput mass spectrometry studies).  This particular human phosphosite is highly conserved in vertebrates and also found in the bee.","EGFR",null,"P18031","P18031"]
[2151,1075,"PP512","PTPN11 (PTP1D; PTP2C; SHP2; SHPTP2; Syp)","Y62","Tyrosine-protein phosphatase non-receptor type 11",0,15744,16,621,{"v":9767.088,"d":"9767"},{"v":17162.208390797423,"d":"17162"},{"v":17438.342268817712,"d":"17438"},{"v":276.13387802028956,"d":"276"},{"v":1.5834869723486102,"d":"2"},0,14681,18,618,{"v":9061.734,"d":"9062"},{"v":15832.798872354335,"d":"15833"},{"v":17225.954844849522,"d":"17226"},{"v":1393.1559724951876,"d":"1393"},{"v":8.087539907326152,"d":"8"},{"v":9.671026879674763,"d":"10"},{"v":-1.2179335667012907,"d":"-1"},null,0,14832,14,678,{"v":10046.604,"d":"10047"},{"v":17188.146067176975,"d":"17188"},{"v":18652.889776394324,"d":"18653"},{"v":1464.7437092173495,"d":"1465"},{"v":7.852636919942654,"d":"8"},{"v":9.436123892291263,"d":"9"},{"v":6.964810581498895,"d":"7"},{"$nulls":4},"PYP","Protein phosphatase, tyrosine (non-receptor)",{"$nulls":6},"X",null,null,"TGD(pY)YDL(bA)C","Corresponds to amino acid residues T59 to L65.","The effect of Y62 phosphorylation is unclear. This is the major site of in vivo phosphorylation of PTPN11 (≥2090 reports from high throughput mass spectrometry studies).  This particular human phosphosite is highly conserved in vertebrates and also found in the frog.",null,"EC 3.1.3.48; Protein phosphatase, tyrosine (non-receptor)","Q06124","Q06124",null,"Q06124","GO:0005737; GO:0005829; GO:0005739; GO:0005654; GO:0005634; GO:0032991","GO:0016303; GO:0050839; GO:0031748; GO:0005158; GO:0043560; GO:0004726; GO:0051428; GO:0046934; GO:0043274; GO:0004721; GO:0001784; GO:0019904; GO:0004725; GO:0030971; GO:0005070","GO:0033277; GO:0000187; GO:0036302; GO:0007411; GO:0060020; GO:0007420; GO:0071345; GO:0071364; GO:0071260; GO:0021697; GO:0019221; GO:0000077; GO:0048013; GO:0007173; GO:0038127; GO:0060325; GO:0008543; GO:0048806; GO:0042593; GO:0007507; GO:0048873; GO:0009755; GO:0042445; GO:0048839; GO:0007229; GO:0070102; GO:0061582; GO:0050900; GO:0035855; GO:0032528; GO:0048609; GO:0035264; GO:0033629; GO:0051463; GO:0060125; GO:0046676; GO:0048011; GO:0035265; GO:0035335; GO:0030168; GO:0048008; GO:0030220; GO:0070374; GO:2001275; GO:0046887; GO:0045931; GO:0051897; GO:0033628; GO:0040014; GO:0043254; GO:0046825; GO:0060338; GO:0031295; GO:0006641"]
[2156,1077,"PP004","PTPN11 (PTP1D; PTP2C; SHP2; SHPTP2; Syp)","S580","Tyrosine-protein phosphatase non-receptor type 11",0,20,10,654,{"v":6.54,"d":"7"},{"v":11.491740719016267,"d":"11"},{"$nulls":3},0,30,10,656,{"v":13.12,"d":"13"},{"v":22.923462684436426,"d":"23"},{"$nulls":6},0,1038,12,338,{"v":346.788,"d":"347"},{"v":593.2992679261738,"d":"593"},{"$nulls":9},"PYP","Protein phosphatase, tyrosine (non-receptor)",{"$nulls":6},"X",null,null,"Not precisely defined.","Antibody raised against amino acid residues that encompass the S580 phosphosite.","The effect of S580 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of PTPN11.","PKCa (PRKCA); PKCb1 (PRKCB1); PKCh (PRKCH)",null,"Q06124","Q06124",null,"Q06124"]
[2161,1080,"PP516","PTPN21","S637","Tyrosine-protein phosphatase non-receptor type 21",0,1387,12,517,{"v":710.875,"d":"711"},{"v":1249.1118017783926,"d":"1249"},{"v":1243.4616959248763,"d":"1243"},{"v":5.650105853516379,"d":"6"},{"v":0.4543851951397569,"d":"0"},0,1096,14,496,{"v":536.672,"d":"537"},{"v":937.6814455626424,"d":"938"},{"v":1026.43123878337,"d":"1026"},{"v":88.74979322072761,"d":"89"},{"v":8.646443119358178,"d":"9"},{"v":9.100828314497935,"d":"9"},{"v":-17.453730810749335,"d":"-17"},null,0,1678,12,574,{"v":956.284,"d":"956"},{"v":1636.0502587445735,"d":"1636"},{"v":1639.0716046595348,"d":"1639"},{"v":3.02134591496133,"d":"3"},{"v":0.18433275925055873,"d":"0"},{"v":0.6387179543903156,"d":"1"},{"v":31.815206695241812,"d":"32"},{"$nulls":4},"PYP","Protein phosphatase, tyrosine (non-receptor)",{"$nulls":6},"X",null,null,"KRN(pS)IEVA(bA)C","Corresponds to amino acid residues K634 to A641.","The effect of S637 phosphorylation is unclear. This is the major site of in vivo phosphorylation of PTPN21 (≥27 reports from high throughput mass spectrometry studies). This human phosphosite is conserved in mammals and also found in chicken.",null,"EC 3.1.3.48; Protein phosphatase, tyrosine (non-receptor)","Q16825","Q16825",null,"Q16825","GO:0005737; GO:0005856","GO:0004725","GO:0006470"]
[2163,1081,"PP517","PTPN22","Y499","Protein-tyrosine phosphatase, non-receptor type 22",0,8395,14,641,{"v":5372.221,"d":"5372"},{"v":9439.781470528178,"d":"9440"},{"v":9486.464470765557,"d":"9486"},{"v":46.68300023737902,"d":"47"},{"v":0.49210114454380816,"d":"0"},0,7848,20,635,{"v":4970.78,"d":"4971"},{"v":8685.022091657234,"d":"8685"},{"v":9587.532096378589,"d":"9588"},{"v":902.5100047213546,"d":"903"},{"v":9.41337140412027,"d":"9"},{"v":9.905472548664077,"d":"10"},{"v":1.0653876997536003,"d":"1"},null,0,9404,16,676,{"v":6346.288,"d":"6346"},{"v":10857.492255927718,"d":"10857"},{"v":10679.688786178485,"d":"10680"},{"v":177.80346974923305,"d":"178"},{"v":1.6648750100222396,"d":"2"},{"v":2.1569761545660477,"d":"2"},{"v":12.578177244958738,"d":"13"},{"$nulls":4},"PYP","Protein phosphatase, tyrosine (non-receptor)",{"$nulls":6},"X",null,null,"CAELN(pY)SLP","Corresponds to amino acid residues A495 to P502.","The effect of Y499 phosphorylation is unclear. This is the major site of in vivo phosphorylation of PTPN22 (≥59 reports from high throughput mass spectrometry studies). This human phosphosite is conserved in mammals and found in rat. ",null,"Protein-tyrosine phosphatase","Q9Y2R2","Q9Y2R2",null,null,"GO:0005737; GO:0009898; GO:0005829; GO:0005634; GO:0048471","GO:0019900; GO:0016791; GO:0004725; GO:0017124; GO:0031625","GO:0006914; GO:0071225; GO:0031663; GO:0010507; GO:0010629; GO:1900165; GO:2000483; GO:0043508; GO:0070433; GO:1903753; GO:0050868; GO:0050860; GO:0032720; GO:0035644; GO:0070374; GO:0010628; GO:1902715; GO:1902523; GO:0034141; GO:0034145; GO:0032481; GO:0006470; GO:0050855; GO:0045088; GO:0032817; GO:1901222; GO:0032496; GO:0030217; GO:0050852"]
[2168,1083,"PP522","PTPRB","Y1981","Receptor-type tyrosine-protein phosphatase beta",0,9868,16,662,{"v":6522.024,"d":"6522"},{"v":11460.154246361062,"d":"11460"},{"$nulls":3},0,10873,18,648,{"v":7034.04,"d":"7034"},{"v":12289.981208904972,"d":"12290"},{"$nulls":6},0,11118,16,708,{"v":7860.216,"d":"7860"},{"v":13447.582957142688,"d":"13448"},{"$nulls":9},"PYP","Protein phosphatase, tyrosine (receptor)",{"$nulls":6},"X",null,null,"FPI(pY)ENV(bA)C","Corresponds to amino acid residues F1978 to V1984.","The effect of Y1981 phosphorylation is unclear. This is the major site of in vivo phosphorylation of PTPRB (≥39 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved inmammals and also found in the chicken. ",null,null,"P23467","P23467"]
[2173,1086,"PP526","PTPRM","Y929","Receptor-type tyrosine-protein phosphatase mu",0,8766,20,686,{"v":5999.756,"d":"6000"},{"v":10542.452649749566,"d":"10542"},{"v":10396.489971149069,"d":"10396"},{"v":145.96267860049738,"d":"146"},{"v":1.4039611350133867,"d":"1"},0,8801,16,659,{"v":5789.315,"d":"5789"},{"v":10115.17883924909,"d":"10115"},{"v":11349.548773098682,"d":"11350"},{"v":1234.3699338495917,"d":"1234"},{"v":10.875938405369581,"d":"11"},{"v":12.279899540382967,"d":"12"},{"v":9.167120870547791,"d":"9"},null,0,9552,22,714,{"v":6804.42,"d":"6804"},{"v":11641.283448856984,"d":"11641"},{"v":11790.724589852973,"d":"11791"},{"v":149.44114099598846,"d":"149"},{"v":1.2674466260080115,"d":"1"},{"v":2.671407761021398,"d":"3"},{"v":13.41062822715162,"d":"13"},{"$nulls":4},"PYP","Protein phosphatase, tyrosine (receptor)",{"$nulls":6},"X",null,null,"KNR(pY)GNI(bA)C","Corresponds to amino acid residues K926 to I932.","The effect of Y929 phosphorylation is unclear. This is the major site of in vivo phosphorylation of PTPRM (≥75 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in the nematode worm.",null,"Protein-tyrosine phosphatase (receptor)","P28827","P28827",null,null,"GO:0005913; GO:0005911; GO:0005737; GO:0005887; GO:0030027; GO:0048471; GO:0005886","GO:0045296; GO:0042802; GO:0004725; GO:0005001","GO:0007156; GO:0016525; GO:0010596; GO:0001937; GO:0031175; GO:0097755; GO:0006470; GO:0042493; GO:0010842; GO:0031290; GO:0007165"]
[2178,1088,"PN647","PU.1","S146","Transcription factor PU.1",0,1210,12,626,{"v":749.948,"d":"750"},{"v":1317.7688025603686,"d":"1318"},{"$nulls":3},0,1300,16,602,{"v":772.968,"d":"773"},{"v":1350.541395142032,"d":"1351"},{"$nulls":6},0,1494,14,628,{"v":929.44,"d":"929"},{"v":1590.1244321640397,"d":"1590"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"PLEV(pS)DGEAC","Corresponds to amino acid residues P142 to A150.","S146 phosphorylation induces transcriptional activation and interaction with DNA, IRF2, IRF4 , IRF8, PIP and PU1. This is one of the major sites of in vivo phosphorylation of PU.1.","CK2a1 (CSNK2A1)",null,"P17947","P17947",null,"P17947"]
[2179,906,"NN086","PXN","Pan-specific","Paxillin 1",0,16,2,697,{"v":9.758,"d":"10"},{"v":17.146239439779926,"d":"17"},{"v":14.731919600647151,"d":"15"},{"v":2.4143198391327747,"d":"2"},{"v":16.388358778625953,"d":"16"},0,16,2,709,{"v":9.926,"d":"10"},{"v":17.342857515679572,"d":"17"},{"v":16.41858070469887,"d":"16"},{"v":0.9242768109807038,"d":"1"},{"v":5.629456209428523,"d":"6"},{"v":22.017814988054475,"d":"22"},{"v":11.449024633406395,"d":"11"},null,0,14,2,732,{"v":8.784,"d":"9"},{"v":15.028030870340125,"d":"15"},{"v":15.753427624555083,"d":"16"},{"v":0.7253967542149589,"d":"1"},{"v":4.604691572545603,"d":"5"},{"v":20.993050351171554,"d":"21"},{"v":6.9339777272682,"d":"7"},{"$nulls":15},"Epitope undefined.",{"$nulls":3},"Focal adhesion, Cytoplasm, Lamellipodium, Cell junction, Microtubule associated complex, Cytoskeleton protein","P49023","P49023",null,"P49023","GO:0005938; GO:0005829; GO:0005925; GO:0030027; GO:0005875; GO:0005886; GO:0001725","GO:0008013; GO:0005178; GO:0046872; GO:0038191; GO:0019901; GO:0019903; GO:0031625; GO:0017166","GO:0007155; GO:0007160; GO:0034614; GO:0043542; GO:0060396; GO:0006936; GO:0051496; GO:0007172; GO:0007165; GO:0007179; GO:0048010"]
[2183,908,"PN257","PXN","Y118","Paxillin 1",0,226,10,409,{"v":88.344,"d":"88"},{"v":155.2333856392619,"d":"155"},{"v":192.22484215558157,"d":"192"},{"v":36.99145651631966,"d":"37"},{"v":19.243848038319513,"d":"19"},0,162,12,369,{"v":55.35,"d":"55"},{"v":96.70835819996618,"d":"97"},{"v":107.0256636231062,"d":"107"},{"v":10.317305423140013,"d":"10"},{"v":9.64002938535629,"d":"10"},{"v":28.883877423675802,"d":"29"},{"v":-44.3226679637575,"d":"-44"},null,0,218,10,399,{"v":82.992,"d":"83"},{"v":141.9861495891698,"d":"142"},{"v":167.46399973956883,"d":"167"},{"v":25.477850150399036,"d":"25"},{"v":15.213926688733604,"d":"15"},{"v":34.45777472705312,"d":"34"},{"v":-12.8811875397312,"d":"-13"},{"$nulls":15},"Epitope undefined.","Antibody raised against amino acid residues that encompass the Y118 phosphosite.","Y118 phosphorylation induces activation, and binding to CrkL and Src. This is one of the major sites of in vivo phosphorylation of PXN.","Abl1; Brk (PTK6); FAK (PTK2); Fyn; PYK2 (PTK2B; FAK2); Src","Focal adhesion, Cytoplasm, Lamellipodium, Cell junction, Microtubule associated complex, Cytoskeleton protein","P49023","P49023",null,"P49023","GO:0005938; GO:0005829; GO:0005925; GO:0030027; GO:0005875; GO:0005886; GO:0001725","GO:0008013; GO:0005178; GO:0046872; GO:0038191; GO:0019901; GO:0019903; GO:0031625; GO:0017166","GO:0007155; GO:0007160; GO:0034614; GO:0043542; GO:0060396; GO:0006936; GO:0051496; GO:0007172; GO:0007165; GO:0007179; GO:0048010"]
[2190,1091,"PK788","PYK2 (PTK2B)","Y402","Protein tyrosine kinase 2 beta",0,5824,14,606,{"v":3520.86,"d":"3521"},{"v":6186.668230574252,"d":"6187"},{"$nulls":3},0,6203,20,604,{"v":3734.532,"d":"3735"},{"v":6525.030864773914,"d":"6525"},{"$nulls":6},0,6421,15,628,{"v":4022.968,"d":"4023"},{"v":6882.660211110026,"d":"6883"},{"$nulls":7},"PYK2","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Fak",{"$nulls":6},"SDI(pY)AEI(bA)C","Corresponds to amino acid residues S399 to I405; In the region between the FERM_M domain and the protein kinase catalytic domain.","Y402 phosphorylation stimulates phosphotransferase activity. Its phosphorylation regulates cell cycle progression, cell motility, alters intracellular location, and induces binding to ErbB2, RASA1 and Src. This is one of the major sites of in vivo phosphorylation of PYK2.","PYK2 (PTK2B; FAK2); Src",null,"Q14289","Q14289","Q14289"]
[2195,1094,"PK789","PYK2 (PTK2B)","Y579+Y580","Protein tyrosine kinase 2 beta",0,9666,18,657,{"v":6338.736,"d":"6339"},{"v":11138.090305549586,"d":"11138"},{"v":10526.842156699451,"d":"10527"},{"v":611.2481488501344,"d":"611"},{"v":5.806567057349922,"d":"6"},0,9168,18,654,{"v":5984.1,"d":"5984"},{"v":10455.510141001223,"d":"10456"},{"v":11828.55042554779,"d":"11829"},{"v":1373.040284546567,"d":"1373"},{"v":11.607849103648558,"d":"12"},{"v":17.41441616099848,"d":"17"},{"v":12.365610213124654,"d":"12"},null,0,10022,18,691,{"v":6912.764,"d":"6913"},{"v":11826.642849655724,"d":"11827"},{"v":11836.96007872717,"d":"11837"},{"v":10.31722907144649,"d":"10"},{"v":0.08716113768084874,"d":"0"},{"v":5.893728195030771,"d":"6"},{"v":12.445497923552878,"d":"12"},null,null,"PYK2","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Fak",{"$nulls":6},"ED(pY)(pY)KAS(bA)C","Corresponds to amino acid residues E577 to S583; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y579 and Y580 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major sites of in vivo phosphorylation of PYK2.","Y579: Src. Y580: Src.","Protein kinase, tyrosine (non-receptor); Nuclear receptor co-regulator; EC 2.7.10.2; TK domain target; TK</A> group; Fak family","Q14289","Q14289","Q14289",null,"GO:0097440; GO:0044297; GO:0005938; GO:0005737; GO:0005856; GO:0005829; GO:0030425; GO:0043197; GO:0031234; GO:0005925; GO:0098978; GO:0030426; GO:0030027; GO:0045121; GO:0043025; GO:0017146; GO:0005634; GO:0048471; GO:0014069","GO:0043423; GO:0005524; GO:0004683; GO:0004972; GO:0004715; GO:0044877; GO:0008022; GO:0004713; GO:0005102; GO:0031625","GO:0090630; GO:0042976; GO:0002250; GO:0001525; GO:0006915; GO:0043534; GO:0045453; GO:0007166; GO:0006968; GO:0071498; GO:0071300; GO:0070098; GO:0007173; GO:0048041; GO:0014009; GO:0045087; GO:0007229; GO:0038110; GO:0035235; GO:0060292; GO:0060291; GO:0000165; GO:0002315; GO:0043066; GO:0030502; GO:0008285; GO:0010656; GO:0045638; GO:0043524; GO:0043267; GO:0031175; GO:0001556; GO:0038083; GO:0018108; GO:0030838; GO:0045766; GO:2000538; GO:0030307; GO:0001954; GO:0030335; GO:0008284; GO:0007204; GO:2000573; GO:0010595; GO:0070374; GO:2000463; GO:0046330; GO:0043507; GO:0010976; GO:0045429; GO:0051000; GO:0050731; GO:0043552; GO:0045860; GO:0051968; GO:0045727; GO:2000060; GO:0046777; GO:0065003; GO:0006468; GO:2000249; GO:0050848; GO:0030155; GO:0008360; GO:0010752; GO:2000114; GO:0032960; GO:0010758; GO:2000310; GO:0051279; GO:0048167; GO:2000058; GO:0051592; GO:0051591; GO:0042220; GO:0045471; GO:0009749; GO:0009725; GO:0042542; GO:0001666; GO:0035902; GO:0010226; GO:0009612; GO:0006970; GO:0007172; GO:0007165; GO:0002040; GO:0043149; GO:0033209; GO:0048010"]
[2196,1094,"PK789","PYK2 (PTK2B)","Y579+Y580","Protein tyrosine kinase 2 beta",0,6038,22,938,{"v":5643.008,"d":"5643"},{"v":9915.594007849319,"d":"9916"},{"$nulls":3},0,10168,26,745,{"v":7555.79,"d":"7556"},{"v":13201.590710094355,"d":"13202"},{"$nulls":6},0,10283,24,675,{"v":6924.825,"d":"6925"},{"v":11847.277307798617,"d":"11847"},{"$nulls":7},"PYK2","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Fak",{"$nulls":6},"ED(pY)(pY)KAS(bA)C","Corresponds to amino acid residues E577 to S583; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y579 and Y580 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major sites of in vivo phosphorylation of PYK2.","Y579: Src. Y580: Src.",null,"Q14289","Q14289","Q14289"]
[2201,1097,"NK205-3","Raf-A (ARaf)","Pan-specific","A-Raf proto-oncogene serine/threonine-protein kinase",0,5851,18,673,{"v":3925.609,"d":"3926"},{"v":6897.871680770141,"d":"6898"},{"v":6589.997579740992,"d":"6590"},{"v":307.87410102914964,"d":"308"},{"v":4.671839364184563,"d":"5"},0,5610,14,652,{"v":3648.592,"d":"3649"},{"v":6374.875195330281,"d":"6375"},{"v":6813.036567404588,"d":"6813"},{"v":438.1613720743071,"d":"438"},{"v":6.431220025599008,"d":"6"},{"v":11.10305938978357,"d":"11"},{"v":3.384507884331626,"d":"3"},null,0,6490,16,692,{"v":4480.008,"d":"4480"},{"v":7664.583165228906,"d":"7665"},{"v":8017.403144084412,"d":"8017"},{"v":352.8199788555057,"d":"353"},{"v":4.400676534718497,"d":"4"},{"v":9.07251589890306,"d":"9"},{"v":21.66018343817848,"d":"22"},null,null,"A-RAF","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RAF",{"$nulls":6},"CGRKTVTAWDTAIAPL","Corresponds to amino acid residues G67 to L81.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); TKL group; RAF family","P10398","P10398","P10398",null,"GO:0005829; GO:0005739","GO:0005524; GO:0004709; GO:0046872; GO:0031434; GO:0004672; GO:0004674","GO:0030154; GO:0006464; GO:0000165; GO:0007275; GO:0043066; GO:0009968; GO:0070374; GO:0033138; GO:0032434; GO:0032006"]
[2206,1099,"PK500","Raf-A (ARaf)","Y302","A-Raf proto-oncogene serine/threonine-protein kinase",0,6928,16,731,{"v":5052.672,"d":"5053"},{"v":8878.286936121307,"d":"8878"},{"$nulls":3},0,7238,18,695,{"v":5017.9,"d":"5018"},{"v":8767.350869225118,"d":"8767"},{"$nulls":6},0,8440,14,709,{"v":5974.034,"d":"5974"},{"v":10220.62470087221,"d":"10221"},{"$nulls":7},"A-RAF","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RAF",{"$nulls":6},"SGY(pY)WEV(bA)C","Corresponds to amino acid residues S299 to V305; Just before kinase catalytic domain.","Y302 phosphorylation stimulates phosphotransferase activity. This is one of the major sites of in vivo phosphorylation of Raf-A.","Src",null,"P10398","P10398","P10398"]
[2212,1102,"PK534","Raf-B (BRaf)","S446+S447","B-Raf proto-oncogene serine-threonine-protein kinase; RafB proto-oncogene-encoded protein-serine kinase",0,4623,10,623,{"v":2873.899,"d":"2874"},{"v":5049.862715694209,"d":"5050"},{"$nulls":3},0,4596,18,583,{"v":2668.974,"d":"2669"},{"v":4663.271790756939,"d":"4663"},{"$nulls":6},0,4905,14,609,{"v":2978.619,"d":"2979"},{"v":5095.944704346724,"d":"5096"},{"$nulls":7},"B-RAF","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RAF",{"$nulls":6},"RRD(pS)(pS)DDW(bA)C","Corresponds to amino acid residues R443 to W450; Just before the kinase catalytic domain. ","S446 and S447 phosphorylation stimulate phosphotransferase activity and induces interaction with H-Ras-1. This is the major in vivo phosphorylation sites in B-Raf.","PAK1; PKACa (PRKACA)",null,"P15056","P15056","P15056","P15056"]
[2213,1103,"PK535","Raf-B (BRaf)","S729","B-Raf proto-oncogene serine-threonine-protein kinase; RafB proto-oncogene-encoded protein-serine kinase",0,402,10,907,{"v":355.544,"d":"356"},{"v":624.7430370339326,"d":"625"},{"v":2236.3533654885787,"d":"2236"},{"v":1611.6103284546462,"d":"1612"},{"v":72.06420744257274,"d":"72"},0,2597,14,552,{"v":1425.816,"d":"1426"},{"v":2491.207307231129,"d":"2491"},{"v":2569.5332149049555,"d":"2570"},{"v":78.32590767382635,"d":"78"},{"v":3.0482543373825797,"d":"3"},{"v":75.11246177995531,"d":"75"},{"v":14.898354372703821,"d":"15"},null,0,3015,14,587,{"v":1761.587,"d":"1762"},{"v":3013.7959718567677,"d":"3014"},{"v":3156.7564456240634,"d":"3157"},{"v":142.96047376729575,"d":"143"},{"v":4.528714084530323,"d":"5"},{"v":76.59292152710306,"d":"77"},{"v":41.15642430839205,"d":"41"},null,null,"B-RAF","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RAF",{"$nulls":6},"RSA(pS)EPS(bA)C","Corresponds to amino acid residues R726 to S732; In the C-terminal region after the kinase catalytic domain.","S729 phosphorylation stimulates phosphotransferase activity and regulates cell differentiation, cell growth, and molecular association with 14-3-3 beta. This is one of the major sites of in vivo phosphorylation of Raf-B.",null,"EC 2.7.1.37; Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; TKL domain target; TKL</A> group; RAF family","P15056","P15056","P15056","P15056","GO:0005829; GO:0005622; GO:0043231; GO:0005634; GO:0005886","GO:0005524; GO:0005509; GO:0042802; GO:0004709; GO:0031434; GO:0004672; GO:0004674","GO:0009887; GO:0030154; GO:0071277; GO:0090150; GO:0000165; GO:0043066; GO:0009968; GO:0070374; GO:0010628; GO:0010828; GO:0033138; GO:0006468; GO:0070413"]
[2218,1105,"NK155-8","Raf1 (RafC)","Pan-specific","Raf1 proto-oncogene-encoded protein-serine kinase",0,1908,14,597,{"v":1130.718,"d":"1131"},{"v":1986.8376272667638,"d":"1987"},{"$nulls":3},0,2075,16,569,{"v":1171.571,"d":"1172"},{"v":2046.9865930387095,"d":"2047"},{"$nulls":6},0,2082,16,628,{"v":1297.448,"d":"1297"},{"v":2219.7277546289906,"d":"2220"},{"$nulls":7},"RAF1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RAF",{"$nulls":6},"CLTDPSKTSNTIRVFL","Corresponds to amino acid residues L48 to L62.",{"$nulls":3},"P04049","P04049","P04049","P04049"]
[2223,1108,"PK792","Raf1 (RafC)","S301+T303","Raf1 proto-oncogene-encoded protein-serine kinase",0,1554,14,508,{"v":782.32,"d":"782"},{"v":1374.6511619726002,"d":"1375"},{"v":1908.4548183991983,"d":"1908"},{"v":533.8036564265981,"d":"534"},{"v":27.970463396893503,"d":"28"},0,1492,18,486,{"v":716.364,"d":"716"},{"v":1251.6420291519528,"d":"1252"},{"v":1502.6731649131116,"d":"1503"},{"v":251.0311357611588,"d":"251"},{"v":16.705637767589604,"d":"17"},{"v":44.67610116448311,"d":"45"},{"v":-21.262313866379827,"d":"-21"},null,0,1965,18,532,{"v":1035.804,"d":"1036"},{"v":1772.096366987908,"d":"1772"},{"v":1756.077758946128,"d":"1756"},{"v":16.01860804178,"d":"16"},{"v":0.9121810216076776,"d":"1"},{"v":28.88264441850118,"d":"29"},{"v":-7.98431579223255,"d":"-8"},null,null,"RAF1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RAF",{"$nulls":6},"NNL(pS)P(pT)GW(bA)C","Corresponds to amino acid residues N298 to W305; In the region between the C1_1 and kinase catalytic domains. This is the major in vivo phosphorylation sites in Raf1.","S301+T303 phosphorylation inhibits phosphotransferase activity, inhibits interaction with H-Ras-1, and regulates intracellular location. These two are major in vivo phosphorylation sites in Raf1.","S301: ERK1 (MAPK3).","Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; TKL group; RAF family","P04049","P04049","P04049","P04049","GO:0005737; GO:0005829; GO:0005794; GO:0005741; GO:0016607; GO:0005886; GO:0031143","GO:0010856; GO:0008179; GO:0005524; GO:0019899; GO:0042802; GO:0016301; GO:0004709; GO:0046872; GO:0031434; GO:0046982; GO:0004672; GO:0004674","GO:0007190; GO:0000186; GO:0006915; GO:0030154; GO:0008283; GO:0071550; GO:0060324; GO:0007507; GO:0035773; GO:0045104; GO:0034220; GO:0000165; GO:0007275; GO:0043066; GO:0008285; GO:0043154; GO:1902042; GO:0031333; GO:0009968; GO:0048011; GO:0030168; GO:0070374; GO:0033138; GO:0045944; GO:0006468; GO:0042981; GO:0045595; GO:2000145; GO:0035023; GO:0001666; GO:0035994; GO:0007165; GO:0035019; GO:0002223; GO:0048538; GO:0030878; GO:0042060"]
[2229,1111,"NN093","Rb","Pan-specific","Retinoblastoma-associated protein 1",0,596,12,282,{"v":164.688,"d":"165"},{"v":289.38100849133804,"d":"289"},{"v":301.2118785618482,"d":"301"},{"v":11.830870070510173,"d":"12"},{"v":3.927756809259076,"d":"4"},0,804,12,259,{"v":205.128,"d":"205"},{"v":358.40274798270394,"d":"358"},{"v":326.276703136764,"d":"326"},{"v":32.12604484593993,"d":"32"},{"v":9.846257650971111,"d":"10"},{"v":13.774014460230187,"d":"14"},{"v":8.321326733390833,"d":"8"},null,0,660,10,302,{"v":196.3,"d":"196"},{"v":335.83816710470927,"d":"336"},{"v":380.77940445870854,"d":"381"},{"v":44.94123735399927,"d":"45"},{"v":11.802433857441642,"d":"12"},{"v":15.730190666700718,"d":"16"},{"v":26.415799495278748,"d":"26"},{"$nulls":15},"Epitope undefined.",{"$nulls":3},"Nuclear receptor co-regulator; Transcription, coactivator/corepressor; Tumor suppressor","P06400","P06400",null,"P06400","GO:0000785; GO:0005654; GO:0005634; GO:0016605; GO:0035189; GO:0005819; GO:0016514","GO:0050681; GO:0097718; GO:0003677; GO:0003700; GO:0042802; GO:0061676; GO:0019900; GO:0051219; GO:0000987; GO:0001102; GO:0003713; GO:0008134; GO:0031625","GO:0030521; GO:0003180; GO:0007050; GO:0051301; GO:0048667; GO:0071466; GO:0006338; GO:0048565; GO:0043353; GO:0000082; GO:0034349; GO:0097284; GO:0034088; GO:0007093; GO:0045445; GO:0120163; GO:0043433; GO:0050680; GO:2000134; GO:0010629; GO:0050728; GO:1904761; GO:0006469; GO:0045879; GO:0045892; GO:0000122; GO:0071930; GO:0051402; GO:0042551; GO:0031175; GO:1904028; GO:1903055; GO:0045651; GO:0045842; GO:0045893; GO:0045944; GO:2000679; GO:0071459; GO:0007265; GO:0001558; GO:0090230; GO:0071922; GO:0043550; GO:0007346; GO:0006355; GO:0031134; GO:0035914; GO:0051146; GO:0001894; GO:0006351; GO:0016032"]
[2230,1111,"NN093","Rb","Pan-specific","Retinoblastoma-associated protein 1",0,646,12,281,{"v":178.154,"d":"178"},{"v":313.0427486323584,"d":"313"},{"$nulls":3},0,607,10,282,{"v":168.354,"d":"168"},{"v":294.150658290824,"d":"294"},{"$nulls":6},0,727,14,349,{"v":248.837,"d":"249"},{"v":425.72064181270775,"d":"426"},{"$nulls":20},"Epitope undefined.",{"$nulls":4},"P06400","P06400",null,"P06400"]
[2235,1114,"PN262","Rb","S608","Retinoblastoma-associated protein 1",0,422,12,470,{"v":192.7,"d":"193"},{"v":338.60220742422547,"d":"339"},{"v":342.7385312243117,"d":"343"},{"v":4.136323800086245,"d":"4"},{"v":1.206845283870097,"d":"1"},0,564,10,481,{"v":266.474,"d":"266"},{"v":465.58740818388054,"d":"466"},{"v":492.9977193571609,"d":"493"},{"v":27.410311173280377,"d":"27"},{"v":5.5599265670076035,"d":"6"},{"v":6.7667718508777,"d":"7"},{"v":43.84076327692179,"d":"44"},null,0,536,8,567,{"v":299.376,"d":"299"},{"v":512.1848554006084,"d":"512"},{"v":497.907883905505,"d":"498"},{"v":14.276971495103396,"d":"14"},{"v":2.86739213348406,"d":"3"},{"v":4.074237417354157,"d":"4"},{"v":45.2733902216672,"d":"45"},{"$nulls":15},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S608 phosphosite.","S608 phosphorylation inhibits binding to E2F1. This is one of the major sites of in vivo phosphorylation of Rb.","CDK2; CDK4","Nuclear receptor co-regulator; Transcription, coactivator/corepressor; Tumor suppressor","P06400","P06400",null,"P06400","GO:0000785; GO:0005654; GO:0005634; GO:0016605; GO:0035189; GO:0005819; GO:0016514","GO:0050681; GO:0097718; GO:0003677; GO:0003700; GO:0042802; GO:0061676; GO:0019900; GO:0051219; GO:0000987; GO:0001102; GO:0003713; GO:0008134; GO:0031625","GO:0030521; GO:0003180; GO:0007050; GO:0051301; GO:0048667; GO:0071466; GO:0006338; GO:0048565; GO:0043353; GO:0000082; GO:0034349; GO:0097284; GO:0034088; GO:0007093; GO:0045445; GO:0120163; GO:0043433; GO:0050680; GO:2000134; GO:0010629; GO:0050728; GO:1904761; GO:0006469; GO:0045879; GO:0045892; GO:0000122; GO:0071930; GO:0051402; GO:0042551; GO:0031175; GO:1904028; GO:1903055; GO:0045651; GO:0045842; GO:0045893; GO:0045944; GO:2000679; GO:0071459; GO:0007265; GO:0001558; GO:0090230; GO:0071922; GO:0043550; GO:0007346; GO:0006355; GO:0031134; GO:0035914; GO:0051146; GO:0001894; GO:0006351; GO:0016032"]
[2240,1116,"PN067","Rb","S780","Retinoblastoma-associated protein 1",0,835,10,214,{"v":176.55,"d":"177"},{"v":310.22428500647123,"d":"310"},{"$nulls":3},0,578,14,245,{"v":138.18,"d":"138"},{"v":241.43018854690746,"d":"241"},{"$nulls":6},0,664,10,275,{"v":179.85,"d":"180"},{"v":307.6948260508505,"d":"308"},{"$nulls":20},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S780 phosphosites.","S780 phosphorylation reported to both inhibit and induce interaction with E2F1. This is one of the major sites of in vivo phosphorylation of Rb.","CDK4, CDK6;  PKACa (PRKACA)",null,"P06400","P06400",null,"P06400"]
[2245,1118,"PN265","Rb","T821+T826","Retinoblastoma-associated protein 1",0,105,10,465,{"v":44.175,"d":"44"},{"v":77.62196426032776,"d":"78"},{"v":94.96763987313648,"d":"95"},{"v":17.34567561280872,"d":"17"},{"v":18.26482750964447,"d":"18"},0,110,10,439,{"v":43.9,"d":"44"},{"v":76.70274480539324,"d":"77"},{"v":75.36612522051566,"d":"75"},{"v":1.3366195848775817,"d":"1"},{"v":1.773501796684827,"d":"2"},{"v":20.038329306329295,"d":"20"},{"v":-20.64020405140711,"d":"-21"},null,0,130,10,465,{"v":55.8,"d":"56"},{"v":95.4649502009311,"d":"95"},{"v":91.6001594750547,"d":"92"},{"v":3.8647907258764036,"d":"4"},{"v":4.219196503614052,"d":"4"},{"v":22.48402401325852,"d":"22"},{"v":-3.5459240669561467,"d":"-4"},{"$nulls":15},"Epitope undefined.","Antibody raised against amino acid residues that encompass the T821 and T826 phosphosites.","T821 and T826 phosphorylation inhibits interaction with E2F1, Elf-1 and TFDP1, and induces binding with Rb. These are two of the major sites of in vivo phosphorylation of Rb.","T821: CDK2; CDK6. T826: CDK2; CDK4; CDK6.","Nuclear receptor co-regulator; Transcription, coactivator/corepressor; Tumor suppressor","P06400","P06400",null,"P06400","GO:0000785; GO:0005654; GO:0005634; GO:0016605; GO:0035189; GO:0005819; GO:0016514","GO:0050681; GO:0097718; GO:0003677; GO:0003700; GO:0042802; GO:0061676; GO:0019900; GO:0051219; GO:0000987; GO:0001102; GO:0003713; GO:0008134; GO:0031625","GO:0030521; GO:0003180; GO:0007050; GO:0051301; GO:0048667; GO:0071466; GO:0006338; GO:0048565; GO:0043353; GO:0000082; GO:0034349; GO:0097284; GO:0034088; GO:0007093; GO:0045445; GO:0120163; GO:0043433; GO:0050680; GO:2000134; GO:0010629; GO:0050728; GO:1904761; GO:0006469; GO:0045879; GO:0045892; GO:0000122; GO:0071930; GO:0051402; GO:0042551; GO:0031175; GO:1904028; GO:1903055; GO:0045651; GO:0045842; GO:0045893; GO:0045944; GO:2000679; GO:0071459; GO:0007265; GO:0001558; GO:0090230; GO:0071922; GO:0043550; GO:0007346; GO:0006355; GO:0031134; GO:0035914; GO:0051146; GO:0001894; GO:0006351; GO:0016032"]
[2247,1120,"PN071","Rb","T826","Retinoblastoma-associated protein 1",0,1362,14,514,{"v":692.872,"d":"693"},{"v":1217.477886156917,"d":"1217"},{"v":1354.616173030976,"d":"1355"},{"v":137.13828687405885,"d":"137"},{"v":10.123774512983237,"d":"10"},0,1240,16,494,{"v":604.656,"d":"605"},{"v":1056.4641198872403,"d":"1056"},{"v":1334.8968307459613,"d":"1335"},{"v":278.43271085872107,"d":"278"},{"v":20.857994748787327,"d":"21"},{"v":30.981769261770566,"d":"31"},{"v":-1.4557143696942774,"d":"-1"},null,0,1808,12,556,{"v":998.576,"d":"999"},{"v":1708.405163294713,"d":"1708"},{"v":1514.2315075957008,"d":"1514"},{"v":194.17365569901222,"d":"194"},{"v":12.823247616034713,"d":"13"},{"v":22.947022129017952,"d":"23"},{"v":11.783067243880822,"d":"12"},{"$nulls":15},"Not precisely defined.","Antibody raised against amino acid residues that encompass the T826 phosphosite.","T826 phosphorylation inhibits interaction with E2F1, Elf-1 and TFDP1, and induces binding with Rb. This is one of the major sites of in vivo phosphorylation of Rb.","CDK2; CDK4; CDK6","Nuclear receptor co-regulator; Transcription, coactivator/corepressor; Tumor suppressor","P06400","P06400",null,"P06400","GO:0000785; GO:0005654; GO:0005634; GO:0016605; GO:0035189; GO:0005819; GO:0016514","GO:0050681; GO:0097718; GO:0003677; GO:0003700; GO:0042802; GO:0061676; GO:0019900; GO:0051219; GO:0000987; GO:0001102; GO:0003713; GO:0008134; GO:0031625","GO:0030521; GO:0003180; GO:0007050; GO:0051301; GO:0048667; GO:0071466; GO:0006338; GO:0048565; GO:0043353; GO:0000082; GO:0034349; GO:0097284; GO:0034088; GO:0007093; GO:0045445; GO:0120163; GO:0043433; GO:0050680; GO:2000134; GO:0010629; GO:0050728; GO:1904761; GO:0006469; GO:0045879; GO:0045892; GO:0000122; GO:0071930; GO:0051402; GO:0042551; GO:0031175; GO:1904028; GO:1903055; GO:0045651; GO:0045842; GO:0045893; GO:0045944; GO:2000679; GO:0071459; GO:0007265; GO:0001558; GO:0090230; GO:0071922; GO:0043550; GO:0007346; GO:0006355; GO:0031134; GO:0035914; GO:0051146; GO:0001894; GO:0006351; GO:0016032"]
[2252,1122,"PN650","RDBP","S89+T91","Negative elongation factor E",0,11332,18,682,{"v":7716.148,"d":"7716"},{"v":13558.405529901518,"d":"13558"},{"$nulls":3},0,12082,18,841,{"v":10145.824,"d":"10146"},{"v":17726.937337413077,"d":"17727"},{"$nulls":6},0,12028,20,730,{"v":8765.84,"d":"8766"},{"v":14996.961990489785,"d":"14997"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"CGFKR(pS)R(pT)LEGK","Corresponds to amino acid residues C85 to K95.","The effects of S89 and T91 phosphorylation are unclear. These are two of the major sites of in vivo phosphorylation of RDBP.",null,null,"P18615","P18615"]
[2257,1125,"NK244-2","Ret (GDNF receptor)","Pan-specific","Proto-oncogene tyrosine-protein kinase receptor Ret",0,5082,12,645,{"v":3270.15,"d":"3270"},{"v":5746.133931542973,"d":"5746"},{"v":5975.221958491253,"d":"5975"},{"v":229.08802694827955,"d":"229"},{"v":3.8339668139478524,"d":"4"},0,5216,16,629,{"v":3270.8,"d":"3271"},{"v":5714.791291787704,"d":"5715"},{"v":5877.422077356861,"d":"5877"},{"v":162.63078556915752,"d":"163"},{"v":2.76704281960118,"d":"3"},{"v":6.601009633549032,"d":"7"},{"v":-1.6367572922610947,"d":"-2"},null,0,5624,14,665,{"v":3730.65,"d":"3731"},{"v":6382.550474320854,"d":"6383"},{"v":6673.082139432354,"d":"6673"},{"v":290.53166511149993,"d":"291"},{"v":4.3537852380791175,"d":"4"},{"v":8.187752052026969,"d":"8"},{"v":11.679234441649285,"d":"12"},null,null,"RET","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Ret",{"$nulls":6},"CKRPVFADISKDLEKM","Corresponds to amino acid residues K994 to M1008; Kinase last alpha-chain.",null,null,"Protein-tyrosine kinase (receptor), TK group, Ret family","P07949","P07949","P07949","P07949","GO:0030424; GO:0005829; GO:0030425; GO:0005769; GO:0010008; GO:0005887; GO:0043231; GO:0045121; GO:0043025; GO:0005886; GO:0098797; GO:0043235","GO:0005524; GO:0005509; GO:0004713; GO:0005088; GO:0038023; GO:0004714","GO:0006919; GO:0000187; GO:0007411; GO:0071300; GO:0001838; GO:0048484; GO:0035860; GO:0007156; GO:0060384; GO:0097021; GO:0000165; GO:0033619; GO:0001755; GO:0007158; GO:0042551; GO:0061146; GO:0033630; GO:0030335; GO:0045793; GO:2001241; GO:0043410; GO:0072300; GO:0014042; GO:0010976; GO:0033141; GO:0051897; GO:0045893; GO:0007497; GO:0006468; GO:0050770; GO:0030155; GO:0042493; GO:0048265; GO:0060041; GO:0007165; GO:0001657; GO:0035799"]
[2262,1126,"PK793","Ret (GDNF receptor)","Y905","Proto-oncogene tyrosine-protein kinase receptor Ret",0,9582,10,684,{"v":6547.248,"d":"6547"},{"v":11504.476519739726,"d":"11504"},{"$nulls":3},0,10244,20,760,{"v":7770.24,"d":"7770"},{"v":13576.280997645985,"d":"13576"},{"$nulls":6},0,10673,16,720,{"v":7673.04,"d":"7673"},{"v":13127.354506984811,"d":"13127"},{"$nulls":7},"RET","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Ret",{"$nulls":6},"EDS(pY)VKR(bA)C","Corresponds to amino acid residues E902 to R908; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y905 phosphorylation stimulates phosphotransferase activity, and regulates cell growth. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of Ret.","FAK (PTK2); Ret; Src",null,"P07949","P07949","P07949","P07949"]
[2263,1129,"PK794","RIOK1","Y466","Serine/threonine-protein kinase RIO1",0,2772,16,584,{"v":1609.504,"d":"1610"},{"v":2828.1349624188924,"d":"2828"},{"v":3003.753887806116,"d":"3004"},{"v":175.6189253872235,"d":"176"},{"v":5.846648292330374,"d":"6"},0,3382,16,546,{"v":1837.836,"d":"1838"},{"v":3211.094890709902,"d":"3211"},{"v":3294.6432244480407,"d":"3295"},{"v":83.54833373813881,"d":"84"},{"v":2.5358841017493132,"d":"3"},{"v":8.382532394079687,"d":"8"},{"v":9.684193429521784,"d":"10"},null,0,3282,14,592,{"v":1934.656,"d":"1935"},{"v":3309.889582364383,"d":"3310"},{"v":3601.25442723839,"d":"3601"},{"v":291.36484487400685,"d":"291"},{"v":8.09064871035616,"d":"8"},{"v":13.937297002686535,"d":"14"},{"v":19.89179412660458,"d":"20"},null,null,"RIOK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","RIO","RIO1",{"$nulls":5},"NIL(pY)QTV(bA)C","Corresponds to amino acid residues N463 to V469; In the C-terminal third of the kinase after the catalytic domain. ","The effect of Y466 phosphorylation is unclear. This is a major in vivo phosphorylation site in RIOK1.",null,"EC 2.7.11.1; Protein kinase, atypical; ATYPICAL domain target; ATYPICAL</A> group; RIO family; RIO1 subfamily","Q9BRS2","Q9BRS2","Q9BRS2",null,"GO:0005829; GO:0034708; GO:0005654; GO:0030688","GO:0005524; GO:0016787; GO:0046872; GO:0004674","GO:0030490; GO:2000234; GO:0042274"]
[2269,1133,"PK795","RIPK1 (RIP; RIPK)","Y384","Receptor-interacting protein-serine kinase 1",0,4398,16,735,{"v":3220.77,"d":"3221"},{"v":5659.366017673703,"d":"5659"},{"v":5065.834302432053,"d":"5066"},{"v":593.5317152416501,"d":"594"},{"v":11.716366541177667,"d":"12"},0,3927,18,668,{"v":2611.212,"d":"2611"},{"v":4562.349149630535,"d":"4562"},{"v":5261.137363034822,"d":"5261"},{"v":698.7882134042866,"d":"699"},{"v":13.282075056888445,"d":"13"},{"v":24.998441598066112,"d":"25"},{"v":3.85529902762525,"d":"4"},null,0,968,12,1039,{"v":993.284,"d":"993"},{"v":1699.3513905982377,"d":"1699"},{"v":3248.494327831935,"d":"3248"},{"v":1549.1429372336975,"d":"1549"},{"v":47.68802961917452,"d":"48"},{"v":59.40439616035219,"d":"59"},{"v":-35.87444567082726,"d":"-36"},null,null,"RIPK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RIPK",{"$nulls":6},"EAN(pY)HLY(bA)C","Corresponds to amino acid residues E381 to Y387; In the region between the kinase catalytic and RHIM domains. ","The effect of Y384 phosphorylation is unclear. This is the major site of in vivo phosphorylation of RIPK1.",null,"Protein-serine kinase, TKL group, RIPK family","Q13546","Q13546","Q13546",null,"GO:0005829; GO:0031264; GO:0010008; GO:0045121; GO:0005739; GO:0043235; GO:0097342","GO:0005524; GO:0070513; GO:0005123; GO:0042802; GO:0044877; GO:0004672; GO:0004674; GO:0031625","GO:0006919; GO:0007257; GO:1990000; GO:0006915; GO:0097190; GO:0044257; GO:0071363; GO:0071356; GO:0071550; GO:0097191; GO:0007249; GO:0002756; GO:0070266; GO:0097527; GO:2001237; GO:2001240; GO:1902042; GO:0043124; GO:0036289; GO:0043065; GO:2001238; GO:1905206; GO:0043123; GO:0032757; GO:0046330; GO:0045651; GO:0060545; GO:0010940; GO:0051092; GO:0043068; GO:0001934; GO:2000379; GO:0045944; GO:0032760; GO:0046777; GO:0016579; GO:0051291; GO:0051260; GO:0070926; GO:1902041; GO:0010803; GO:0034612; GO:0097343; GO:1901026; GO:0070231; GO:0034138; GO:0035666; GO:0033209; GO:0016032"]
[2274,1131,"NK157","RIPK2 (RICK; RIP2; CARD3)","Pan-specific","Receptor-interacting serine-threonine-protein kinase 2",0,24,2,681,{"v":14.982,"d":"15"},{"v":26.325574839801483,"d":"26"},{"$nulls":3},0,22,2,714,{"v":14.28,"d":"14"},{"v":24.950232251048185,"d":"25"},{"$nulls":6},0,24,6,669,{"v":12.042,"d":"12"},{"v":20.601952156265455,"d":"21"},{"$nulls":7},"RIPK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RIPK",{"$nulls":6},"Epitope undefined.",{"$nulls":4},"O43353","O43353","O43353"]
[2279,1137,"NK160","ROCK1 (ROKb)","Pan-specific","Rho-associated protein kinase 1",0,22,2,664,{"v":13.28,"d":"13"},{"v":23.33491081781896,"d":"23"},{"v":20.17907498733682,"d":"20"},{"v":3.1558358304821432,"d":"3"},{"v":15.639150121908745,"d":"16"},0,22,3,691,{"v":13.129,"d":"13"},{"v":22.939187620729108,"d":"23"},{"v":25.019247249221607,"d":"25"},{"v":2.0800596284924993,"d":"2"},{"v":8.313837773665288,"d":"8"},{"v":23.952987895574033,"d":"24"},{"v":23.98609581917006,"d":"24"},null,0,24,4,690,{"v":13.8,"d":"14"},{"v":23.60961134001522,"d":"24"},{"v":21.548047451267514,"d":"22"},{"v":2.061563888747706,"d":"2"},{"v":9.567288606589917,"d":"10"},{"v":25.20643872849866,"d":"25"},{"v":6.784119018288905,"d":"7"},null,null,"ROCK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","DMPK","ROCK",{"$nulls":5},"Epitope undefined.",{"$nulls":4},"Q13464","Q13464","Q13464",null,"GO:0032059; GO:0005814; GO:0010494; GO:0005856; GO:0005829; GO:0005576; GO:0000139; GO:0030027; GO:0005886; GO:0001726; GO:0034774","GO:0005524; GO:0017049; GO:0046872; GO:0004672; GO:0004674","GO:0030036; GO:0003383; GO:0006915; GO:0032060; GO:0030866; GO:0048013; GO:0007186; GO:0007249; GO:0007159; GO:0050900; GO:0050901; GO:0022614; GO:0051451; GO:1902430; GO:1902992; GO:0016525; GO:1903347; GO:0070168; GO:0051045; GO:0035509; GO:0043524; GO:0032091; GO:0140058; GO:0031175; GO:0043312; GO:1900223; GO:0010508; GO:0010613; GO:1905205; GO:0051894; GO:0010628; GO:0043410; GO:0072659; GO:0006468; GO:0032956; GO:1902003; GO:0110061; GO:0010506; GO:0030155; GO:2000145; GO:2000114; GO:1903140; GO:0051893; GO:0045616; GO:0045664; GO:0051492; GO:1900242; GO:1990776; GO:0071559; GO:0007266; GO:0007165; GO:0006939; GO:0048010"]
[2280,1137,"NK160","ROCK1 (ROKb)","Pan-specific","Rho-associated protein kinase 1",0,16,2,692,{"v":9.688,"d":"10"},{"v":17.02323915685468,"d":"17"},{"$nulls":3},0,28,6,705,{"v":15.51,"d":"16"},{"v":27.099306877714103,"d":"27"},{"$nulls":6},0,25,8,670,{"v":11.39,"d":"11"},{"v":19.486483562519812,"d":"19"},{"$nulls":7},"ROCK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","DMPK","ROCK",{"$nulls":5},"Epitope undefined.",{"$nulls":4},"Q13464","Q13464","Q13464"]
[2285,1140,"NK159-2","ROCK2 (ROKa)","Pan-specific","Rho-associated protein kinase 2",0,2580,10,317,{"v":814.69,"d":"815"},{"v":1431.5300070910341,"d":"1432"},{"v":1403.6317857766883,"d":"1404"},{"v":27.898221314345847,"d":"28"},{"v":1.9875740630160061,"d":"2"},0,2463,12,290,{"v":710.79,"d":"711"},{"v":1241.9030519413543,"d":"1242"},{"v":1189.2402402971777,"d":"1189"},{"v":52.6628116441766,"d":"53"},{"v":4.428273603575402,"d":"4"},{"v":6.415847666591408,"d":"6"},{"v":-15.274058884387458,"d":"-15"},null,0,2798,10,316,{"v":881.008,"d":"881"},{"v":1507.264961408995,"d":"1507"},{"v":1312.1520537805866,"d":"1312"},{"v":195.1129076284085,"d":"195"},{"v":14.86968732520344,"d":"15"},{"v":16.857261388219445,"d":"17"},{"v":-6.517359675314154,"d":"-7"},null,null,"ROCK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","DMPK","ROCK",{"$nulls":5},"Epitope undefined.",{"$nulls":3},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; AGC domain target; AGC</A> group; DMPK family; ROCK subfamily","O75116","O75116","O75116",null,"GO:0005813; GO:0036464; GO:0005829; GO:0005634; GO:0005886","GO:0005524; GO:0046872; GO:0004674; GO:0072518; GO:0017048; GO:0003723; GO:0005198","GO:0071394; GO:0051298; GO:0030866; GO:0048013; GO:0007186; GO:0007249; GO:0016525; GO:1903347; GO:0070168; GO:0035509; GO:0150033; GO:0018105; GO:0018107; GO:1902004; GO:1902993; GO:1902961; GO:0010613; GO:0030335; GO:0010825; GO:0032723; GO:1905205; GO:0010595; GO:0090271; GO:0010628; GO:0043410; GO:1902966; GO:0001934; GO:0051496; GO:0072659; GO:0006468; GO:0032956; GO:0110061; GO:0030155; GO:2000145; GO:0042752; GO:2000114; GO:1903140; GO:0051893; GO:0045616; GO:0051246; GO:0051492; GO:1990776; GO:0071559; GO:0007266; GO:0048511; GO:0006939; GO:0048010; GO:0039694"]
[2292,1143,"PK800","Ron (RONa)","Y1238","Macrophage-stimulating protein receptor alpha chain",0,7754,32,629,{"v":4857.138,"d":"4857"},{"v":8534.70497438551,"d":"8535"},{"$nulls":3},0,9650,20,712,{"v":6856.56,"d":"6857"},{"v":11979.885465213372,"d":"11980"},{"$nulls":6},0,9318,16,651,{"v":6055.602,"d":"6056"},{"v":10360.174612305713,"d":"10360"},{"$nulls":7},"RON","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK","Met",{"$nulls":6},"DRE(pY)YSV(bA)C","Corresponds to amino acid residues D1235 to V1241; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y1238 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of Ron.",null,null,"Q04912","Q04912","Q04912","Q04912"]
[2296,1145,"PK802","ROR2 (RON2)","Y645+Y646","Neurotrophic tyrosine kinase, receptor-related 2",0,5656,48,612,{"v":3432.096,"d":"3432"},{"v":6030.696843237439,"d":"6031"},{"$nulls":3},0,4449,14,655,{"v":2904.925,"d":"2905"},{"v":5075.528951111776,"d":"5076"},{"$nulls":6},0,4517,14,666,{"v":2998.998,"d":"2999"},{"v":5130.809941266882,"d":"5131"},{"$nulls":7},"ROR2","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Ror",{"$nulls":6},"AAD(pY)(pY)KLL(bA)C","Corresponds to amino acid residues A642 to L649; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y645 and Y646 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major sites of in vivo phosphorylation of ROR2.",null,null,"Q01974","Q01974","Q01974","Q01974"]
[2297,1146,"PN651","RORA","S35","Nuclear receptor ROR-alpha",0,7406,16,667,{"v":4929.13,"d":"4929"},{"v":8661.205493933432,"d":"8661"},{"v":8918.414021278772,"d":"8918"},{"v":257.20852734533946,"d":"257"},{"v":2.8840164487952253,"d":"3"},0,7594,22,725,{"v":5489.7,"d":"5490"},{"v":9591.686973990141,"d":"9592"},{"v":9346.253915549176,"d":"9346"},{"v":245.4330584409654,"d":"245"},{"v":2.62600460739295,"d":"3"},{"v":5.510021056188176,"d":"6"},{"v":4.797264325805074,"d":"5"},null,0,8070,16,746,{"v":6008.284,"d":"6008"},{"v":10279.221018871884,"d":"10279"},{"v":9581.699859031456,"d":"9582"},{"v":697.5211598404276,"d":"698"},{"v":7.2797224929036215,"d":"7"},{"v":10.163738941698847,"d":"10"},{"v":7.437262232613634,"d":"7"},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"LNQE(pS)ARK(bA)C","Corresponds to amino acid residues L31 to K38.","S35 phosphorylation induces interaction with CTNNB1. This is one of the major sites of in vivo phosphorylation of RORA.","PKCa (PRKCA)",null,"P35398","P35398",null,null,"GO:0005654; GO:0005634","GO:0008013; GO:0003677; GO:0003700; GO:0004879; GO:0008142; GO:0000978; GO:0000977; GO:0000981; GO:0043565; GO:0003707; GO:0001228; GO:0001223; GO:0001222; GO:0098531; GO:0008134; GO:0008270","GO:0001525; GO:0071456; GO:0071347; GO:0036315; GO:0071356; GO:0021930; GO:0021702; GO:0046068; GO:0042632; GO:0032922; GO:0019221; GO:0030522; GO:0042692; GO:0045599; GO:0043124; GO:0050728; GO:0006809; GO:0042753; GO:0045893; GO:0045944; GO:0010575; GO:0010906; GO:0043030; GO:0008589; GO:0019218; GO:0006355; GO:0060850; GO:0072539; GO:0006367; GO:0070328; GO:0006805"]
[2302,1148,"NK163-4","Ros","Pan-specific","Orosomucoid 1 receptor-tyrosine kinase; Proto-oncogene tyrosine-protein kinase ROS1",0,3362,16,734,{"v":2455.964,"d":"2456"},{"v":4315.489526489001,"d":"4315"},{"$nulls":3},0,3601,20,619,{"v":2216.639,"d":"2217"},{"v":3872.9452287626896,"d":"3873"},{"$nulls":6},0,3348,18,614,{"v":2044.62,"d":"2045"},{"v":3498.0205462334725,"d":"3498"},{"$nulls":7},"ROS1","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Sev",{"$nulls":6},"CRPTFHRIQDQLQLFR","Corresponds to amino acid residues R2205 to R2219; Kinase last alpha-chain.",{"$nulls":3},"P08922","P08922","P08922","P08922"]
[2307,1151,"PN559","RPS6","S235+S236+S240","40S Ribosomal S6",0,4576,14,654,{"v":2983.548,"d":"2984"},{"v":5242.532116015221,"d":"5243"},{"v":5357.539137697229,"d":"5358"},{"v":115.0070216820086,"d":"115"},{"v":2.146638946093463,"d":"2"},0,4480,18,637,{"v":2842.294,"d":"2842"},{"v":4966.099119451033,"d":"4966"},{"v":5895.05322537124,"d":"5895"},{"v":928.9541059202065,"d":"929"},{"v":15.758197091794804,"d":"16"},{"v":17.904836037888266,"d":"18"},{"v":10.032854149247413,"d":"10"},null,0,4810,14,678,{"v":3251.688,"d":"3252"},{"v":5563.122454999378,"d":"5563"},{"v":5981.777321824095,"d":"5982"},{"v":418.65486682471783,"d":"419"},{"v":6.998837373923715,"d":"7"},{"v":9.145476320017178,"d":"9"},{"v":11.651584208401601,"d":"12"},{"$nulls":5},"Translation protein - 40S ribosomal protein subunit",{"$nulls":9},"RRL(pS)(pS)LRA(pS)TS(bA)C     ","Corresponds to amino acid residues R232 to A239. S235 and S236 are located near the C-terminus of the protein. Phosphorylation appears to induce interaction with mRNA for proteins involved in protein synthesis, which often have a 7-methylGuanylate cap.","S235+S236+S240 phosphorylation is believed to increase the translation of mRNA important for protein synthesis by facilitating the assembly of the preinitiation complex. S235 and S236 are the major sites of phosphorylation of the 40S ribosomal protein S6.","S235: Akt1 (PKBa); Akt2 (PKBb); AurB (STK12); DAPK1; p70S6K (RPS6KB1); PASK; PKACa (PRKACA); PKCd (PRKCD); RSK1 (RPS6KA1); RSK2 (RPS6KA3). S236: Akt1 (PKBa); Akt2 (PKBb); AurB (STK12); DAPK1; p70S6K (RPS6KB1); PASK; PKACa (PRKACA); PKCd (PRKCD); RSK1 (RPS6KA1); RSK2 (RPS6KA3).","Protein synthesis, 40S ribosome","P62753","P62753",null,null,"GO:0044297; GO:0036464; GO:0005829; GO:0022627; GO:0030425; GO:0005783; GO:0016020; GO:0005730; GO:0005654; GO:0005634; GO:1990904; GO:0015935","GO:0019901; GO:0003723; GO:0003735","GO:0042593; GO:0000184; GO:0043065; GO:0042274; GO:0006364; GO:0006614; GO:0031929; GO:0006412; GO:0006413"]
[2310,1152,"PN268","RPS6","S236","40S Ribosomal S6",0,342,48,561,{"v":164.934,"d":"165"},{"v":289.81326662847533,"d":"290"},{"$nulls":3},0,300,12,618,{"v":177.984,"d":"178"},{"v":310.97634012398885,"d":"311"},{"$nulls":6},0,314,12,580,{"v":175.16,"d":"175"},{"v":299.6709798780483,"d":"300"},{"$nulls":20},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S236 phosphosite.","S236 phosphorylation is believed to increase the translation of mRNA important for protein synthesis by facilitating the assembly of the preinitiation complex. S236 is a the major site of phosphorylation of the 40S ribosomal protein S6.","S236: Akt1 (PKBa); Akt2 (PKBb); AurB (STK12); DAPK1; p70S6K (RPS6KB1); PASK; PKACa (PRKACA); PKCd (PRKCD); RSK1 (RPS6KA1); RSK2 (RPS6KA3).",null,"P62753","P62753"]
[2314,1154,"PK807","RSK1 (RPS6KA1, p90RSK)","Y220+S221","Ribosomal S6 protein-serine kinase 1; Ribosomal protein S6 kinase alpha 2",0,6821,22,655,{"v":4453.345,"d":"4453"},{"v":7825.181356624999,"d":"7825"},{"$nulls":3},0,8168,30,742,{"v":6038.396,"d":"6038"},{"v":10550.3769344398,"d":"10550"},{"$nulls":6},0,8104,16,654,{"v":5289.552,"d":"5290"},{"v":9049.58455672465,"d":"9050"},{"$nulls":7},"RSK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","RSK",{"$nulls":5},"KKA(pY)(pS)FCG(bA)C","Corresponds to amino acid residues K217 to G224; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII. ","Y220 and S221 phosphorylation is predicted to stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major in vivo phosphorylation sites in RSK1.","S221: PDPK1 (PDK1); RSK1 (RPS6KA1).",null,"Q15418","Q15418","Q15418","Q15418"]
[2319,1157,"PK158","RSK1 (RPS6KA1, p90RSK)","T348","Ribosomal S6 protein-serine kinase 1; Ribosomal protein S6 kinase alpha 2",0,918,12,257,{"v":232.842,"d":"233"},{"v":409.1375982411599,"d":"409"},{"v":493.3172347283024,"d":"493"},{"v":84.17963648714255,"d":"84"},{"v":17.063996666061144,"d":"17"},0,723,12,253,{"v":179.883,"d":"180"},{"v":314.2943016817438,"d":"314"},{"v":411.1834966490758,"d":"411"},{"v":96.889194967332,"d":"97"},{"v":23.56349312580072,"d":"24"},{"v":40.62748979186186,"d":"41"},{"v":-16.64927399596374,"d":"-17"},null,0,922,12,302,{"v":274.82,"d":"275"},{"v":470.173433946593,"d":"470"},{"v":468.44548413112807,"d":"468"},{"v":1.7279498154649104,"d":"2"},{"v":0.3688689237062257,"d":"0"},{"v":17.43286558976737,"d":"17"},{"v":-5.041735590460888,"d":"-5"},null,null,"RSK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","RSK",{"$nulls":5},"SR(pT)PR","Corresponds to amino acid residues S346 to R350.","The effect of T348 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of RSK1.",null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); AGC domain target; AGC</A> group; RSK family; RSK subfamily","Q15418","Q15418","Q15418","Q15418","GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0043027; GO:0016301; GO:0000287; GO:0004712; GO:0004674","GO:0007049; GO:0072574; GO:0035556; GO:0043066; GO:0043154; GO:0045597; GO:0030307; GO:2000491; GO:0045944; GO:0043620; GO:0043555; GO:0007165"]
[2324,1159,"PK100","RSK1 (RPS6KA1, p90RSK)","S363/S369","Ribosomal S6 protein-serine kinase 1; Ribosomal protein S6 kinase alpha 2",0,826,22,359,{"v":288.636,"d":"289"},{"v":507.1758523201803,"d":"507"},{"$nulls":3},0,580,10,303,{"v":172.71,"d":"173"},{"v":301.7615274564799,"d":"302"},{"$nulls":6},0,661,12,284,{"v":184.316,"d":"184"},{"v":315.3354437497279,"d":"315"},{"$nulls":7},"RSK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","RSK",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S363 phosphosite.","S363 phosphorylation stimulates phosphotransferase activity. This is one of the major sites of in vivo phosphorylation of RSK1.","ERK1 (MAPK3); ERK2 (MAPK1); PDPK1 (PDK1); PKCa (PRKCA)",null,"Q15418","Q15418","Q15418","Q15418"]
[2329,1162,"PK806","RSK1 (RPS6KA1, p90RSK)","T573","Ribosomal S6 protein-serine kinase 1; Ribosomal protein S6 kinase alpha 2",0,10946,18,705,{"v":7704.24,"d":"7704"},{"v":13537.481424629033,"d":"13537"},{"v":13428.19391610305,"d":"13428"},{"v":109.28750852598387,"d":"109"},{"v":0.8138660285127892,"d":"1"},0,11758,18,655,{"v":7689.7,"d":"7690"},{"v":13435.560289977959,"d":"13436"},{"v":15165.830941145852,"d":"15166"},{"v":1730.2706511678934,"d":"1730"},{"v":11.4090065877865,"d":"11"},{"v":12.22287261629929,"d":"12"},{"v":12.940213969944494,"d":"13"},null,0,10768,18,725,{"v":7793.75,"d":"7794"},{"v":13333.870172553887,"d":"13334"},{"v":12598.706224778045,"d":"12599"},{"v":735.1639477758417,"d":"735"},{"v":5.83523367129543,"d":"6"},{"v":6.649099699808219,"d":"7"},{"v":-6.1772096568421375,"d":"-6"},null,null,"RSK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","RSK",{"$nulls":5},"LLM(pT)PCY(bA)C","Corresponds to amino acid residues L570 to Y576; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T573 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of RSK1.","ERK1 (MAPK3); ERK2 (MAPK1)","EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); AGC domain target; AGC</A> group; RSK family; RSK subfamily","Q15418","Q15418","Q15418","Q15418","GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0043027; GO:0016301; GO:0000287; GO:0004712; GO:0004674","GO:0007049; GO:0072574; GO:0035556; GO:0043066; GO:0043154; GO:0045597; GO:0030307; GO:2000491; GO:0045944; GO:0043620; GO:0043555; GO:0007165"]
[2333,1164,"NK165-3","RSK2 (RPS6KA3)","Pan-specific","Ribosomal S6 protein-serine kinase 2; Ribosomal protein S6 kinase alpha-3",0,16608,18,656,{"v":10883.04,"d":"10883"},{"v":19123.099986954556,"d":"19123"},{"v":17689.408689177835,"d":"17689"},{"v":1433.6912977767206,"d":"1434"},{"v":8.104800578516993,"d":"8"},0,16358,16,687,{"v":11226.954,"d":"11227"},{"v":19615.90404564667,"d":"19616"},{"v":20136.483303261186,"d":"20136"},{"v":520.5792576145177,"d":"521"},{"v":2.5852540871931087,"d":"3"},{"v":10.690054665710102,"d":"11"},{"v":13.83355801814021,"d":"14"},null,0,16087,18,690,{"v":11087.61,"d":"11088"},{"v":18969.14223113523,"d":"18969"},{"v":18313.300589516934,"d":"18313"},{"v":655.8416416182954,"d":"656"},{"v":3.5812312390794165,"d":"4"},{"v":11.68603181759641,"d":"12"},{"v":3.526923433685994,"d":"4"},null,null,"RSK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","RSK",{"$nulls":5},"CNRNQSPVLEPVGRS","Corresponds to amino acid residues N711 to S724; Pre-C-terminus.",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; AGC group; RSK family; RSK subfamily","P51812","P51812","P51812",null,"GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0043027; GO:0016301; GO:0000287; GO:0004672; GO:0004674","GO:0007049; GO:0007417; GO:0035556; GO:0043066; GO:0043154; GO:0018105; GO:0045597; GO:0030307; GO:0045944; GO:0043620; GO:0043555; GO:0032496; GO:0007165; GO:0001501; GO:0002224"]
[2336,1165,"PK214","RSK2 (RPS6KA3)","T577","Ribosomal S6 protein-serine kinase 2; Ribosomal protein S6 kinase alpha-3",0,1024,32,644,{"v":638.848,"d":"639"},{"v":1122.5497820890066,"d":"1123"},{"$nulls":3},0,1293,14,597,{"v":763.563,"d":"764"},{"v":1334.108836716184,"d":"1334"},{"$nulls":6},0,1061,12,603,{"v":632.547,"d":"633"},{"v":1082.1875959632325,"d":"1082"},{"$nulls":7},"RSK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","RSK",{"$nulls":5},"Epitope undefined.","Antibody raised against amino acid residues that encompass the T577 phosphosite.","T577 phosphorylation is predicted to be inhibitory for phosphotransferase activity. This phosphosite is located in the kinase activation loop just before catalytic subdomain VIII. This is one of the minor sites of in vivo phosphorylation of RSK2.",null,null,"P51812","P51812","P51812"]
[2341,1168,"PN653","SATB1","S38","DNA-binding protein SATB1",0,840,14,532,{"v":439.432,"d":"439"},{"v":772.1465760915529,"d":"772"},{"v":801.6912440501981,"d":"802"},{"v":29.544667958645164,"d":"30"},{"v":3.6852925833870303,"d":"4"},0,939,18,532,{"v":489.972,"d":"490"},{"v":856.0864983550828,"d":"856"},{"v":862.8901541243812,"d":"863"},{"v":6.803655769298416,"d":"7"},{"v":0.7884729865996019,"d":"1"},{"v":4.473765569986632,"d":"4"},{"v":7.633725642929832,"d":"8"},null,0,1026,12,608,{"v":616.512,"d":"617"},{"v":1054.7542540909756,"d":"1055"},{"v":1033.6664229766982,"d":"1034"},{"v":21.087831114277378,"d":"21"},{"v":2.0401002340338916,"d":"2"},{"v":5.725392817420921,"d":"6"},{"v":28.93572564851101,"d":"29"},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"EQNG(pS)PLGC","Corresponds to amino acid residues E34 to G41.","The effect of S38 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of SATB1.",null,"Transcription protein","Q01826","Q01826",null,"Q01826","GO:0016604; GO:0005720; GO:0016363; GO:0005654; GO:0005634; GO:0016605","GO:0003682; GO:0003690; GO:0000977; GO:0000981; GO:0001227","GO:0050798; GO:0043367; GO:0043374; GO:0006325; GO:0006338; GO:0008544; GO:0016571; GO:0000122; GO:0060004; GO:0006351; GO:0016032"]
[2346,1170,"NK294-1","SGK1","Pan-specific","Serine-threonine-protein kinase Sgk1",0,4308,36,558,{"v":2383.776,"d":"2384"},{"v":4188.644606148887,"d":"4189"},{"$nulls":3},0,4748,18,662,{"v":3131.26,"d":"3131"},{"v":5470.984890645459,"d":"5471"},{"$nulls":6},0,4624,20,620,{"v":2854.48,"d":"2854"},{"v":4883.562563612076,"d":"4884"},{"$nulls":7},"SGK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","SGK",{"$nulls":6},"MTVKTEAAKGTLTYSRMRGC","Corresponds to amino acid residues M1 to G19; N-terminus.",{"$nulls":3},"O00141","O00141","O00141","O00141"]
[2347,1171,"PK810","Sgk223","Y413","Tyrosine-protein kinase SgK223; Homologue of rat pragma of Rnd2",0,14422,22,816,{"v":11750.4,"d":"11750"},{"v":20647.178921212344,"d":"20647"},{"v":17975.117260650404,"d":"17975"},{"v":2672.06166056194,"d":"2672"},{"v":14.865336463820404,"d":"15"},0,14004,22,799,{"v":11171.618,"d":"11172"},{"v":19519.220148458717,"d":"19519"},{"v":17166.24900896137,"d":"17166"},{"v":2352.9711394973456,"d":"2353"},{"v":13.706961481620205,"d":"14"},{"v":28.57229794544061,"d":"29"},{"v":-4.499933101742485,"d":"-4"},null,0,13332,24,812,{"v":10806.096,"d":"10806"},{"v":18487.516424847327,"d":"18488"},{"v":16562.313439160822,"d":"16562"},{"v":1925.2029856865047,"d":"1925"},{"v":11.623998016692834,"d":"12"},{"v":26.489334480513236,"d":"26"},{"v":-7.859775271577078,"d":"-8"},null,null,"SgK223","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","NKF3",{"$nulls":6},"EPI(pY)AES(bA)C","Corresponds to amino acid residues E410 to S416; In the first third of the protein. ","The effect of Y413 phosphorylation is unclear. This is the major in vivo site for phosphorylation of Sgk223.",null,"EC 2.7.10.2; Protein kinase, Ser/Thr (non-receptor); Other group; NKF3 family","Q86YV5","Q86YV5","Q86YV5",null,"GO:0005737; GO:0005925; GO:0005634","GO:0042802; GO:0004672","GO:0016477; GO:0010977; GO:0035025; GO:2000145; GO:0008360; GO:0008593"]
[2351,1173,"NK295-1","SgK288 (ANKK1)","Pan-specific","Protein kinase Sgk288; Protein kinase PKK2",0,10972,20,827,{"v":9057.304,"d":"9057"},{"v":15915.013636285765,"d":"15915"},{"v":14193.552633724026,"d":"14194"},{"v":1721.4610025617385,"d":"1721"},{"v":12.128471616553064,"d":"12"},0,11862,22,900,10656,{"v":18618.324570530076,"d":"18618"},{"v":15888.134923168265,"d":"15888"},{"v":2730.189647361811,"d":"2730"},{"v":17.183827180247672,"d":"17"},{"v":29.312298796800736,"d":"29"},{"v":11.939098921702623,"d":"12"},null,0,11075,24,869,{"v":9603.319,"d":"9603"},{"v":16429.755736535044,"d":"16430"},{"v":13994.44229064719,"d":"13994"},{"v":2435.313445887854,"d":"2435"},{"v":17.402004276479317,"d":"17"},{"v":29.53047589303238,"d":"30"},{"v":-1.4028224519613843,"d":"-1"},null,null,"SgK288","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RIPK",{"$nulls":6},"CGSLPVFTRDDFEGDWRLVA","Corresponds to amino acid residues G11 to A29; Post-N-terminus.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); TKL domain target; TKL</A> group; RIPK family","Q8NFD2","Q8NFD2","Q8NFD2",null,null,"GO:0005524; GO:0004674"]
[2358,1176,"PN074","Shc1 (Shc)","Y349+Y350","SH2 domain-containing transforming protein 1",0,360,20,664,{"v":225.76,"d":"226"},{"v":396.69348390292237,"d":"397"},{"$nulls":3},0,428,10,602,{"v":251.636,"d":"252"},{"v":439.6622298826864,"d":"440"},{"$nulls":6},0,324,10,553,{"v":173.642,"d":"174"},{"v":297.07392263064656,"d":"297"},{"$nulls":18},"X",null,"Not precisely defined.","Antibody raised against amino acid residues that encompass the Y349 and Y350 phosphosites.","Y349 and Y350 phosphorylation regulates apoptosis and molecular association, including inducing interaction with Grb2.  These are two of the major sites of in vivo phosphorylation of Shc1.","Y349: EGFR; Lck; Src; ZAP70. Y350: EGFR; Lck; Src; ZAP70.",null,"P29353","P29353",null,"P29353"]
[2363,1179,"NP045-2","SHIP2 (INPPL1)","Pan-specific","Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 2",0,5136,14,874,{"v":4476.628,"d":"4477"},{"v":7866.093007872836,"d":"7866"},{"v":6446.406170880606,"d":"6446"},{"v":1419.6868369922304,"d":"1420"},{"v":22.022919427652127,"d":"22"},0,5240,20,835,{"v":4358.7,"d":"4359"},{"v":7615.586646543678,"d":"7616"},{"v":6404.486997584536,"d":"6404"},{"v":1211.0996489591425,"d":"1211"},{"v":18.91017421716854,"d":"19"},{"v":40.933093644820666,"d":"41"},{"v":-0.6502719838756832,"d":"-1"},null,0,5680,18,799,{"v":4523.938,"d":"4524"},{"v":7739.740427994622,"d":"7740"},{"v":6900.4272990640875,"d":"6900"},{"v":839.3131289305347,"d":"839"},{"v":12.163205154619506,"d":"12"},{"v":34.18612458227163,"d":"34"},{"v":7.043011503593505,"d":"7"},{"$nulls":5},"Lipid phosphatase",{"$nulls":8},"X","CRRLHSEVDKVLSGLE","Corresponds to amino acid residues C215 to E230.",null,null,"EC 3.1.3.n1; Carbohydrate Metabolism - inositol phosphate; Phosphatase, lipid","O15357","O15357",null,"O15357","GO:0005856; GO:0005829; GO:0030175; GO:0005794; GO:0030027; GO:0005886","GO:0003779; GO:0052659; GO:0034485; GO:0042169; GO:0017124","GO:0007015; GO:0007155; GO:0019221; GO:0001958; GO:0006897; GO:0006006; GO:0002376; GO:0043647; GO:0008285; GO:0010629; GO:0006661; GO:0046856; GO:0009791; GO:0032868; GO:0097178"]
[2364,1179,"NP045-2","SHIP2 (INPPL1)","Pan-specific","Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 2",0,4160,26,692,{"v":2860.728,"d":"2861"},{"v":5026.719333888374,"d":"5027"},{"$nulls":3},0,4510,20,662,{"v":2972.38,"d":"2972"},{"v":5193.387348625393,"d":"5193"},{"$nulls":6},0,4970,22,716,{"v":3542.768,"d":"3543"},{"v":6061.114170133554,"d":"6061"},{"$nulls":10},"Lipid phosphatase",{"$nulls":8},"X","CRRLHSEVDKVLSGLE","Corresponds to amino acid residues C215 to E230.",{"$nulls":3},"O15357","O15357",null,"O15357"]
[2369,1182,"NK251-3","SIK (SNF1LK)","Pan-specific","Salt-inducible serine/threonine-protein kinase SIK1; Serine-threonine-protein kinase SNF1-like kinase 1",0,4418,14,824,{"v":3628.896,"d":"3629"},{"v":6376.503352947287,"d":"6377"},{"v":5849.078139763812,"d":"5849"},{"v":527.4252131834746,"d":"527"},{"v":9.017236572681046,"d":"9"},0,5606,16,953,{"v":5327.27,"d":"5327"},{"v":9307.886818210189,"d":"9308"},{"v":7262.539112976204,"d":"7263"},{"v":2045.347705233985,"d":"2045"},{"v":28.16298368127889,"d":"28"},{"v":37.18022025395994,"d":"37"},{"v":24.16553411388462,"d":"24"},null,0,3433,14,1008,{"v":3446.352,"d":"3446"},{"v":5896.161685571314,"d":"5896"},{"v":5646.902358428402,"d":"5647"},{"v":249.2593271429114,"d":"249"},{"v":4.414089554264635,"d":"4"},{"v":13.431326126945681,"d":"13"},{"v":-3.456540954051505,"d":"-3"},null,null,"SIK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","QIK",{"$nulls":5},"CEDLMPASLGTFVLVQ","Corresponds to amino acid residues E769 to Q783; C-terminus.",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; CAMK group; CAMKL family; QIK subfamily","P57059","P57059","P57059",null,"GO:0005737; GO:0005634","GO:0071889; GO:0005524; GO:0008140; GO:0000287; GO:0019901; GO:0004674","GO:0055007; GO:0007049; GO:0032870; GO:0043153; GO:0035556; GO:0032792; GO:0045721; GO:0010868; GO:2000210; GO:0046777; GO:0006468; GO:0045595; GO:0007346; GO:0010830; GO:0002028; GO:0048511"]
[2374,1184,"NK249-2","SIK2 (QIK)","Pan-specific","Salt-inducible serine/threonine-protein kinase SIK2; Serine-threonine-protein kinase SNF1-like kinase 2",0,2488,18,856,{"v":2114.32,"d":"2114"},{"v":3715.1708313502254,"d":"3715"},{"$nulls":3},0,2325,14,658,{"v":1520.638,"d":"1521"},{"v":2656.881741580491,"d":"2657"},{"$nulls":6},0,2785,18,784,{"v":2169.328,"d":"2169"},{"v":3711.376155725546,"d":"3711"},{"$nulls":7},"SIK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","QIK",{"$nulls":5},"CAQIKEHKWMLIEVPV","Corresponds to amino acid residues A263 to V277; Kinase last alpha-chain.",{"$nulls":3},"Q9H0K1","Q9H0K1","Q9H0K1"]
[2380,1187,"NK250-2","SIK3 (QSK)","Pan-specific","Salt-inducible serine/threonine-protein kinase SIK3",0,18380,26,819,{"v":15031.926,"d":"15032"},{"v":26413.30215587757,"d":"26413"},{"$nulls":3},0,18650,22,712,{"v":13263.136,"d":"13263"},{"v":23173.55207123517,"d":"23174"},{"$nulls":6},0,14675,16,818,{"v":11991.062,"d":"11991"},{"v":20514.805316958376,"d":"20515"},{"$nulls":7},"SIK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","QIK",{"$nulls":5},"CKHKWMKLGDADPNFD","Corresponds to amino acid residues C254 to D269; Kinase last alpha-chain.",{"$nulls":3},"Q9Y2K2","Q9Y2K2","Q9Y2K2","Q9Y2K2"]
[2381,1188,"NK250-3","SIK3 (QSK)","Pan-specific","Salt-inducible serine/threonine-protein kinase SIK3",0,5136,16,730,{"v":3737.6,"d":"3738"},{"v":6567.512249448807,"d":"6568"},{"v":6861.88706942691,"d":"6862"},{"v":294.374819978103,"d":"294"},{"v":4.289998028234653,"d":"4"},0,5313,16,664,{"v":3517.208,"d":"3517"},{"v":6145.319080899489,"d":"6145"},{"v":6243.700397599481,"d":"6244"},{"v":98.38131669999257,"d":"98"},{"v":1.5756892617367946,"d":"2"},{"v":5.865687289971447,"d":"6"},{"v":-9.008989299485194,"d":"-9"},null,0,6141,24,820,{"v":5015.94,"d":"5016"},{"v":8581.47781919101,"d":"8581"},{"v":7709.172824674908,"d":"7709"},{"v":872.3049945161019,"d":"872"},{"v":11.315156818434494,"d":"11"},{"v":15.605154846669146,"d":"16"},{"v":12.347707659356175,"d":"12"},null,null,"SIK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","QIK",{"$nulls":5},"CYKHPEVSFSMEQAGV","Corresponds to amino acid residues Y1249 to V1263; C-terminus.",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; CAMK domain target; CAMK</A> group; CAMKL family; QIK subfamily","Q9Y2K2","Q9Y2K2","Q9Y2K2","Q9Y2K2","GO:0005737","GO:0005524; GO:0000287; GO:0004674","GO:0006468"]
[2386,1190,"PK815","SIK3 (QSK)","T411","Salt-inducible serine/threonine-protein kinase SIK3",0,4998,18,766,{"v":3814.68,"d":"3815"},{"v":6702.953132418496,"d":"6703"},{"$nulls":3},0,4510,22,673,{"v":3020.424,"d":"3020"},{"v":5277.330552985992,"d":"5277"},{"$nulls":6},0,5022,24,697,{"v":3483.606,"d":"3484"},{"v":5959.897371140947,"d":"5960"},{"$nulls":7},"SIK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","QIK",{"$nulls":5},"RRH(pT)VGV(bA)C","Corresponds to amino acid residues R408 to V414; In the first third of the protein. ","The effect of T411 phosphorylation is unclear. This is one of the two major in vivo sites for phosphorylation of SIK3 by ERK1. This is one of the major sites of in vivo phosphorylation of SIK3.",null,null,"Q9Y2K2","Q9Y2K2","Q9Y2K2","Q9Y2K2"]
[2391,1193,"PN536","SIT","Y95","Signaling threshold-regulating transmembrane adapter 1",0,14578,22,715,{"v":10407.54,"d":"10408"},{"v":18287.57663651232,"d":"18288"},{"v":18890.32546581232,"d":"18890"},{"v":602.7488292999988,"d":"603"},{"v":3.190780542086755,"d":"3"},0,15190,24,746,{"v":11313.836,"d":"11314"},{"v":19767.705591755603,"d":"19768"},{"v":19646.63406559285,"d":"19647"},{"v":121.07152616275198,"d":"121"},{"v":0.6162456416632941,"d":"1"},{"v":3.8070261837500494,"d":"4"},{"v":4.00368220838385,"d":"4"},null,0,15454,26,771,{"v":11894.988,"d":"11895"},{"v":20350.437940155432,"d":"20350"},{"v":19643.401935860835,"d":"19643"},{"v":707.0360042945977,"d":"707"},{"v":3.5993561940197254,"d":"4"},{"v":6.790136736106481,"d":"7"},{"v":3.9865722346151813,"d":"4"},{"$nulls":13},"X",null,"NLH(pY)LQT(bA)C","Corresponds to amino acid residues N92 to T98; In the middle of the SIT domain I the protein. ","The effect of phosphorylation is unclear.This is one of the major in vivo phosphorylation sites in SIT.",null,"Adapter/scaffold protein","Q9Y3P8","Q9Y3P8",null,null,"GO:0070062; GO:0005887; GO:0005886","GO:0019900; GO:0042169","GO:0002250; GO:0050863; GO:0007165; GO:0043029"]
[2397,1196,"PN185","Smad2","T220","Mothers against decapentaplegic homologue 2",0,2042,14,281,{"v":569.868,"d":"570"},{"v":1001.3417890006671,"d":"1001"},{"v":965.0215625997395,"d":"965"},{"v":36.320226400927595,"d":"36"},{"v":3.763669933248122,"d":"4"},0,2294,14,285,{"v":649.8,"d":"650"},{"v":1135.3404003313103,"d":"1135"},{"v":945.8287097773929,"d":"946"},{"v":189.51169055391745,"d":"190"},{"v":20.036576242068215,"d":"20"},{"v":23.800246175316335,"d":"24"},{"v":-1.988852225295517,"d":"-2"},null,0,1709,12,302,{"v":512.494,"d":"512"},{"v":876.7959531949102,"d":"877"},{"v":901.4953705076493,"d":"901"},{"v":24.699417312739115,"d":"25"},{"v":2.739827415733749,"d":"3"},{"v":6.503497348981871,"d":"7"},{"v":-6.582877995073233,"d":"-7"},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"PE(pT)PP","Corresponds to amino acid residues P218 to P222.","The effect of T220 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of Smad2.","ERK1 (MAPK3); ERK2 (MAPK1)","Transcription protein","Q15796","Q15796",null,"Q15796","GO:0032444; GO:0005737; GO:0005829; GO:0071144; GO:0000790; GO:0005654; GO:0005634; GO:0032991; GO:0071141; GO:0005667","GO:0033613; GO:0003682; GO:0070410; GO:0097718; GO:0003700; GO:0003690; GO:0035326; GO:0070411; GO:0046872; GO:0019902; GO:0070878; GO:0046982; GO:0042803; GO:0000978; GO:0000981; GO:0070412; GO:0046332; GO:0048156; GO:0001077; GO:0001228; GO:0008134; GO:0030618; GO:0005160; GO:0034713; GO:0031625","GO:0032924; GO:0030325; GO:0009952; GO:0045165; GO:0007182; GO:0048701; GO:0048617; GO:0001706; GO:0007369; GO:0030073; GO:0035556; GO:0001701; GO:0030324; GO:0001707; GO:0008285; GO:0045892; GO:0000122; GO:0030512; GO:0038092; GO:0035265; GO:0031016; GO:0048340; GO:0060039; GO:0030513; GO:0010718; GO:1900224; GO:0045893; GO:0045944; GO:0009791; GO:0031053; GO:0016579; GO:0051098; GO:0017015; GO:0070723; GO:0009749; GO:0062009; GO:0023019; GO:0007183; GO:0060395; GO:0035019; GO:0007179; GO:0001657; GO:0042060; GO:0007352"]
[2398,1196,"PN185","Smad2","T220","Mothers against decapentaplegic homologue 2",0,1950,14,273,{"v":528.528,"d":"529"},{"v":928.7013361988119,"d":"929"},{"$nulls":3},0,1547,12,282,{"v":432.87,"d":"433"},{"v":756.3170192234754,"d":"756"},{"$nulls":6},0,1868,14,292,{"v":541.368,"d":"541"},{"v":926.1947878203885,"d":"926"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"PE(pT)PP","Corresponds to amino acid residues P218 to P222.","The effect of T220 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of Smad2.","ERK1 (MAPK3); ERK2 (MAPK1)",null,"Q15796","Q15796",null,"Q15796"]
[2403,1199,"PN727","SMARCB1","T134","SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1",0,12117,16,698,{"v":8446.498,"d":"8446"},{"v":14841.737767536613,"d":"14842"},{"v":15176.822166869177,"d":"15177"},{"v":335.0843993325634,"d":"335"},{"v":2.207869313142831,"d":"2"},0,12456,18,679,{"v":8445.402,"d":"8445"},{"v":14755.93426845006,"d":"14756"},{"v":15453.081846834477,"d":"15453"},{"v":697.1475783844162,"d":"697"},{"v":4.511382165022474,"d":"5"},{"v":6.7192514781653045,"d":"7"},{"v":1.8202735521825701,"d":"2"},null,0,12159,18,741,{"v":8996.481,"d":"8996"},{"v":15391.5521621617,"d":"15392"},{"v":15524.73688816111,"d":"15525"},{"v":133.18472599940833,"d":"133"},{"v":0.8578871703840125,"d":"1"},{"v":3.0657564835268434,"d":"3"},{"v":2.2924082358388915,"d":"2"},{"$nulls":5},"Transcription protein, coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"WVP(pT)LPNSC","Corresponds to amino acid residues W131 to S138.","The effect of T134 phosphorylation is unclear. In vivo phosphorylation of SMARCB1 is not commonly detected (≥7 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and found in the frog.",null,null,"Q12824","Q12824",null,"Q12824","GO:0001650; GO:0043231; GO:0071565; GO:0071564; GO:0000790; GO:0005730; GO:0005654; GO:0005634; GO:0032991; GO:0016514","GO:0003677; GO:0002039; GO:0001164; GO:0030957; GO:0003713","GO:0043044; GO:0007049; GO:0030154; GO:0006338; GO:0015074; GO:0006281; GO:0008285; GO:1900110; GO:1900113; GO:0007399; GO:0006337; GO:0043923; GO:0051091; GO:1902661; GO:2000617; GO:0090240; GO:0045944; GO:1901838; GO:0006357; GO:0039692"]
[2408,1201,"NK233-2","SMG1","Pan-specific","Serine/threonine-protein kinase SMG1; Lambda/iota protein kinase C-interacting protein",0,6280,16,685,{"v":4290.84,"d":"4291"},{"v":7539.63619981403,"d":"7540"},{"$nulls":3},0,6416,14,673,{"v":4308.546,"d":"4309"},{"v":7527.956818230019,"d":"7528"},{"$nulls":6},0,7146,18,719,{"v":5125.032,"d":"5125"},{"v":8768.116929358035,"d":"8768"},{"$nulls":7},"SMG1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PIKK","SMG1",{"$nulls":5},"CGTKYPRSWNDWQPRT","Corresponds to amino acid residues G18 to T32.",{"$nulls":3},"Q96Q15","Q96Q15","Q96Q15"]
[2413,1204,"PN197","SNCA (a-Synuclein)","S129","Alpha-synuclein",0,534,12,261,{"v":136.242,"d":"136"},{"v":239.39720780431406,"d":"239"},{"v":232.16479116830934,"d":"232"},{"v":7.232416636004729,"d":"7"},{"v":3.1152082103446697,"d":"3"},0,552,12,247,{"v":133.38,"d":"133"},{"v":233.04355585747948,"d":"233"},{"v":221.33546718000932,"d":"221"},{"v":11.708088677470158,"d":"12"},{"v":5.2897481034741345,"d":"5"},{"v":8.404956313818804,"d":"8"},{"v":-4.664498838865384,"d":"-5"},null,0,524,14,266,{"v":135.66,"d":"136"},{"v":232.09274452075832,"d":"232"},{"v":217.73194179698385,"d":"218"},{"v":14.36080272377447,"d":"14"},{"v":6.595634340672289,"d":"7"},{"v":9.71084255101696,"d":"10"},{"v":-6.216640042056284,"d":"-6"},{"$nulls":15},"MP(pS)EE","Corresponds to amino acid residues M127 to E129","The effect of S129 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of SNCA.","BARK1 (GRK2; ADRBK1); CaMK2a; CK1a1 (CSNK1A1); CK2a1 (CSNK2A1); GRK5 (GPRK5); Plk2 (SNK); Plk3 (CNK);","Cytoskeletal protein","P37840","P37840",null,null,"GO:0015629; GO:0030424; GO:0005938; GO:0030054; GO:0005737; GO:0005829; GO:0005576; GO:0005615; GO:0005794; GO:0030426; GO:0016234; GO:0005764; GO:0016020; GO:0005743; GO:0005758; GO:0005759; GO:0005741; GO:0005739; GO:0043025; GO:0005640; GO:0005634; GO:0048471; GO:0005886; GO:0098794; GO:0005840; GO:0005791; GO:0099512; GO:0030672; GO:0043195","GO:0003779; GO:0043014; GO:0048487; GO:0005509; GO:0005507; GO:1903136; GO:0043027; GO:0070840; GO:0008198; GO:0042393; GO:0030544; GO:0042802; GO:0019894; GO:0000287; GO:0008017; GO:0016491; GO:0043274; GO:0005543; GO:0051219; GO:0019904; GO:0047485; GO:0048156; GO:0044212; GO:0008270","GO:0006919; GO:0008344; GO:0007568; GO:0048148; GO:0044267; GO:0071280; GO:0071872; GO:0044344; GO:0034599; GO:0042416; GO:0051583; GO:0060079; GO:0006631; GO:0060291; GO:0001774; GO:0042775; GO:0007006; GO:0043066; GO:1904715; GO:0043154; GO:0045963; GO:0051585; GO:0045920; GO:0035067; GO:0031115; GO:1902957; GO:0032769; GO:0043524; GO:1901215; GO:0051622; GO:0010642; GO:0001933; GO:0051612; GO:0070495; GO:0000122; GO:0032410; GO:0006638; GO:0055114; GO:0006644; GO:0043065; GO:0045807; GO:1903284; GO:1903285; GO:0050729; GO:0060732; GO:1901216; GO:0001956; GO:0033138; GO:0071902; GO:0001921; GO:0051281; GO:0031648; GO:0031623; GO:0050812; GO:0014059; GO:0014048; GO:0040012; GO:0048169; GO:0043030; GO:0051621; GO:0010517; GO:1905606; GO:1903426; GO:1903421; GO:0022898; GO:1904307; GO:0034341; GO:0070555; GO:0010040; GO:0032496; GO:0032026; GO:0097435; GO:0050808; GO:0048488; GO:0048489"]
[2415,1205,"PN661","SND1","Y908","Staphylococcal nuclease domain-containing protein 1",0,1567,16,610,{"v":946.11,"d":"946"},{"v":1662.4542525486972,"d":"1662"},{"v":1734.477946789027,"d":"1734"},{"v":72.02369424032986,"d":"72"},{"v":4.152471028741794,"d":"4"},0,1564,14,649,{"v":1005.95,"d":"1006"},{"v":1757.6110737354288,"d":"1758"},{"v":1618.7895889285287,"d":"1619"},{"v":138.82148480690012,"d":"139"},{"v":8.575634891424375,"d":"9"},{"v":12.728105920166168,"d":"13"},{"v":-6.669923827781602,"d":"-7"},null,0,1848,16,624,{"v":1143.168,"d":"1143"},{"v":1955.779143213226,"d":"1956"},{"v":1987.395492312029,"d":"1987"},{"v":31.616349098803084,"d":"32"},{"v":1.5908433535804352,"d":"2"},{"v":5.743314382322229,"d":"6"},{"v":14.581767729662914,"d":"15"},{"$nulls":5},"Transcription protein, coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"CADEFG(pY)SR(-cooh)","Corresponds to amino acid residues C903 to R910.","The effect of Y908 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of SND1.",null,"Transcription protein, coactivator/corepressor","Q7KZF4","Q7KZF4",null,null,"GO:0005737; GO:0005829; GO:0097433; GO:0070062; GO:0042470; GO:0016020; GO:0005634; GO:0016442","GO:0045296; GO:0004519; GO:0004521; GO:0004518; GO:1905172; GO:0003723; GO:0003712","GO:0031047; GO:0010587; GO:0001649; GO:0010564; GO:0006355; GO:0006401; GO:0006351; GO:0016032"]
[2420,1207,"PN728","SOCS7","Y561","Suppressor of cytokine signaling 7",0,11738,20,759,{"v":8893.962,"d":"8894"},{"v":15627.997747520389,"d":"15628"},{"$nulls":3},0,11734,18,742,{"v":8693.272,"d":"8693"},{"v":15189.016486101835,"d":"15189"},{"$nulls":6},0,12531,24,728,{"v":9105.096,"d":"9105"},{"v":15577.375200980234,"d":"15577"},{"$nulls":10},"Transcription protein",{"$nulls":9},"EEV(pY)LSL(bA)C","Corresponds to amino acid residues E558 to L564.","The effect of Y561 phosphorylation is unclear. This is the major site of in vivo phosphorylation of SOCS7 (≥36 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in fish.",null,null,"O14512","O14512",null,"O14512"]
[2425,1210,"NK172-4","Src","Pan-specific","Src proto-oncogene-encoded protein-tyrosine kinase",0,62,8,501,{"v":27.054,"d":"27"},{"v":47.53785220371041,"d":"48"},{"v":46.85783635382367,"d":"47"},{"v":0.6800158498867361,"d":"1"},{"v":1.4512318596017415,"d":"1"},0,60,8,514,{"v":26.728,"d":"27"},{"v":46.6995663589647,"d":"47"},{"v":47.370496974118936,"d":"47"},{"v":0.6709306151542336,"d":"1"},{"v":1.416347005016222,"d":"1"},{"v":2.8675788646179634,"d":"3"},{"v":1.0940765946258324,"d":"1"},null,0,60,8,559,{"v":29.068,"d":"29"},{"v":49.7307378573596,"d":"50"},{"v":51.85560287796097,"d":"52"},{"v":2.1248650206013693,"d":"2"},{"v":4.097657538766083,"d":"4"},{"v":5.548889398367825,"d":"6"},{"v":10.665807286531859,"d":"11"},null,null,"SRC","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"Epitope undefined.",{"$nulls":3},"Protein-tyrosine kinase, TK group, Src family","P12931","P12931","P12931","P12931","GO:0005884; GO:0005901; GO:0005737; GO:0005829; GO:0070062; GO:0031234; GO:0098978; GO:0005770; GO:0005764; GO:0005743; GO:0005739; GO:0043005; GO:0005634; GO:0048471; GO:0005886; GO:0002102; GO:0014069; GO:0099091; GO:0032587","GO:0005524; GO:0045296; GO:0071253; GO:0019899; GO:0046875; GO:0030331; GO:0070851; GO:0020037; GO:0051427; GO:0005158; GO:0005178; GO:0044325; GO:0016301; GO:0019900; GO:0004715; GO:0046934; GO:0051219; GO:0008022; GO:0004672; GO:0005080; GO:0004713; GO:0097110; GO:0042169; GO:0005070; GO:0005102; GO:0031625","GO:0032148; GO:0034332; GO:0086098; GO:0007411; GO:0045453; GO:0060444; GO:0098609; GO:0007049; GO:0008283; GO:0071398; GO:0071498; GO:0071456; GO:0032869; GO:0071222; GO:0071375; GO:0036120; GO:0071393; GO:0034614; GO:0007417; GO:0035635; GO:0048013; GO:0007173; GO:0038096; GO:0030900; GO:0045087; GO:0007229; GO:0030520; GO:0035556; GO:0050900; GO:0016236; GO:2000811; GO:0043066; GO:0043154; GO:2001237; GO:0051895; GO:2001243; GO:0051902; GO:0032463; GO:0051974; GO:0032211; GO:0045892; GO:0048011; GO:0048477; GO:0036035; GO:0018105; GO:0038083; GO:0018108; GO:0030168; GO:0048008; GO:0043065; GO:0090263; GO:0045737; GO:0050715; GO:2000573; GO:0010634; GO:0070374; GO:0010907; GO:0046628; GO:0033625; GO:2000394; GO:0043406; GO:1903997; GO:2000386; GO:0050731; GO:0043552; GO:0014068; GO:0010641; GO:0071803; GO:0031954; GO:0051897; GO:1900182; GO:0010954; GO:0071902; GO:0051057; GO:0014911; GO:0045893; GO:0001545; GO:0050847; GO:0046777; GO:0031648; GO:0045124; GO:2001286; GO:0022407; GO:0051726; GO:0060491; GO:0042127; GO:2000641; GO:0010632; GO:0033146; GO:0071801; GO:0098962; GO:0043393; GO:0043114; GO:0010447; GO:0051602; GO:0042542; GO:0070555; GO:0009612; GO:0051385; GO:0031667; GO:0009615; GO:0007172; GO:0007165; GO:0002223; GO:0043149; GO:0034446; GO:0031295; GO:0045056; GO:0007179; GO:0060065; GO:0048010; GO:0016032"]
[2430,1212,"PK818","Src","Y419","Src oncogene-encoded protein-tyrosine kinase",0,52,10,652,{"v":27.384,"d":"27"},{"v":48.117710680358016,"d":"48"},{"$nulls":3},0,124,16,407,{"v":43.956,"d":"44"},{"v":76.80058885343657,"d":"77"},{"$nulls":6},0,110,10,396,{"v":39.6,"d":"40"},{"v":67.74931949743498,"d":"68"},{"$nulls":7},"SRC","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"DNE(pY)TAR(bA)C","Corresponds to amino acid residues D416 to R422; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y419 phosphorylation stimulates phosphotransferase activity and induces interaction with Cbl-c and SHPS1. This is one of the major sites of in vivo phosphorylation of Src.","EphB2; FAK (PTK2); Met; PDGFRA; PDGFRB; PKACa (PRKACA); PYK2 (PTK2B; FAK2); Src",null,"P12931","P12931","P12931","P12931"]
[2431,1213,"PK108","Src","Y530","Src oncogene-encoded protein-tyrosine kinase",0,6,2,720,{"v":2.88,"d":"3"},{"v":5.060583068924594,"d":"5"},{"v":3.858694590055003,"d":"4"},{"v":1.2018884788695914,"d":"1"},{"v":31.147540983606564,"d":"31"},0,8,2,696,{"v":4.176,"d":"4"},{"v":7.2963704398023275,"d":"7"},{"v":8.610276227812708,"d":"9"},{"v":1.3139057880103806,"d":"1"},{"v":15.259740259740257,"d":"15"},{"v":46.40728124334682,"d":"46"},{"v":123.13961436605885,"d":"123"},null,0,10,2,730,{"v":5.84,"d":"6"},{"v":9.99131378447021,"d":"10"},{"v":8.978495674811585,"d":"9"},{"v":1.0128181096586246,"d":"1"},{"v":11.280487804878057,"d":"11"},{"v":42.428028788484625,"d":"42"},{"v":132.68220547829372,"d":"133"},null,null,"SRC","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues that encompass the Y529 phosphosite.","Y530 phosphorylation phosphorylation inhibits phosphotransferase activity and induces interaction with Src and AFAP. This is one of the major sites of in vivo phosphorylation of Src.","Akt1 (PKBa); CTK (MATK); Src","Protein-tyrosine kinase, TK group, Src family","P12931","P12931","P12931","P12931","GO:0005884; GO:0005901; GO:0005737; GO:0005829; GO:0070062; GO:0031234; GO:0098978; GO:0005770; GO:0005764; GO:0005743; GO:0005739; GO:0043005; GO:0005634; GO:0048471; GO:0005886; GO:0002102; GO:0014069; GO:0099091; GO:0032587","GO:0005524; GO:0045296; GO:0071253; GO:0019899; GO:0046875; GO:0030331; GO:0070851; GO:0020037; GO:0051427; GO:0005158; GO:0005178; GO:0044325; GO:0016301; GO:0019900; GO:0004715; GO:0046934; GO:0051219; GO:0008022; GO:0004672; GO:0005080; GO:0004713; GO:0097110; GO:0042169; GO:0005070; GO:0005102; GO:0031625","GO:0032148; GO:0034332; GO:0086098; GO:0007411; GO:0045453; GO:0060444; GO:0098609; GO:0007049; GO:0008283; GO:0071398; GO:0071498; GO:0071456; GO:0032869; GO:0071222; GO:0071375; GO:0036120; GO:0071393; GO:0034614; GO:0007417; GO:0035635; GO:0048013; GO:0007173; GO:0038096; GO:0030900; GO:0045087; GO:0007229; GO:0030520; GO:0035556; GO:0050900; GO:0016236; GO:2000811; GO:0043066; GO:0043154; GO:2001237; GO:0051895; GO:2001243; GO:0051902; GO:0032463; GO:0051974; GO:0032211; GO:0045892; GO:0048011; GO:0048477; GO:0036035; GO:0018105; GO:0038083; GO:0018108; GO:0030168; GO:0048008; GO:0043065; GO:0090263; GO:0045737; GO:0050715; GO:2000573; GO:0010634; GO:0070374; GO:0010907; GO:0046628; GO:0033625; GO:2000394; GO:0043406; GO:1903997; GO:2000386; GO:0050731; GO:0043552; GO:0014068; GO:0010641; GO:0071803; GO:0031954; GO:0051897; GO:1900182; GO:0010954; GO:0071902; GO:0051057; GO:0014911; GO:0045893; GO:0001545; GO:0050847; GO:0046777; GO:0031648; GO:0045124; GO:2001286; GO:0022407; GO:0051726; GO:0060491; GO:0042127; GO:2000641; GO:0010632; GO:0033146; GO:0071801; GO:0098962; GO:0043393; GO:0043114; GO:0010447; GO:0051602; GO:0042542; GO:0070555; GO:0009612; GO:0051385; GO:0031667; GO:0009615; GO:0007172; GO:0007165; GO:0002223; GO:0043149; GO:0034446; GO:0031295; GO:0045056; GO:0007179; GO:0060065; GO:0048010; GO:0016032"]
[2438,1216,"PK819","SRPK1","S222","Serine/arginine-rich protein-specific kinase 1; SRPK1a protein kinase",0,1538,18,623,{"v":946.96,"d":"947"},{"v":1663.9478274127896,"d":"1664"},{"$nulls":3},0,1670,15,592,{"v":979.76,"d":"980"},{"v":1711.8515091237375,"d":"1712"},{"$nulls":6},0,1868,16,667,{"v":1235.284,"d":"1235"},{"v":2113.3750097492293,"d":"2113"},{"$nulls":7},"SRPK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","SRPK",{"$nulls":6},"ILG(pS)DDD(bA)C","Corresponds to amino acid residues I219 to D225; Near the N-terminus of the kinase.","S222 phosphorylation stimulates phosphotransferase activity. This is one of the major sites of in vivo phosphorylation of SRPK1.","CK2a1 (CSNK2A1); CK2a2 (CSNK2A2)",null,"Q96SB4","Q96SB4","Q96SB4"]
[2442,1218,"NK296-1","SRPK2","Pan-specific","Serine/arginine-rich protein-specific kinase 2; Serine kinase SRPK2",0,5862,12,700,4095,{"v":7195.516551127158,"d":"7196"},{"$nulls":3},0,6267,18,687,{"v":4293.063,"d":"4293"},{"v":7500.904686161182,"d":"7501"},{"$nulls":6},0,6288,12,704,{"v":4418.304,"d":"4418"},{"v":7559.017407393812,"d":"7559"},{"$nulls":7},"SRPK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","SRPK",{"$nulls":6},"CGEAEDQEEKEDAEKENIEK","Corresponds to amino acid residues G343 to K361; Insert into kinase domain.",{"$nulls":3},"P78362","P78362","P78362","P78362"]
[2447,1221,"PN729","STAG2","Y433","Putative uncharacterized protein DKFZp781H1753",0,3794,16,644,{"v":2433.032,"d":"2433"},{"v":4275.194633802689,"d":"4275"},{"v":4353.942929225233,"d":"4354"},{"v":78.74829542254338,"d":"79"},{"v":1.8086662297283795,"d":"2"},0,4139,16,629,{"v":2593.367,"d":"2593"},{"v":4531.170095392443,"d":"4531"},{"v":4488.598324810306,"d":"4489"},{"v":42.571770582137106,"d":"43"},{"v":0.9484424201387244,"d":"1"},{"v":2.757108649867104,"d":"3"},{"v":3.0927230277001883,"d":"3"},null,0,3827,20,643,{"v":2447.901,"d":"2448"},{"v":4187.970377451782,"d":"4188"},{"v":4474.1676258727075,"d":"4474"},{"v":286.19724842092546,"d":"286"},{"v":6.396659051528078,"d":"6"},{"v":8.205325281256458,"d":"8"},{"v":2.761283246054603,"d":"3"},{"$nulls":5},"Transcription, coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"CGEFL(pY)KKL","Corresponds to amino acid residues G428 to L436.","The effect of Y433 phosphorylation is unclear. This is the major site of in vivo phosphorylation of STAG2 (≥42 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in the frog.",null,null,"Q8N3U4","Q8N3U4",null,null,"GO:0000785; GO:0005694; GO:0000775; GO:0008278; GO:0005829; GO:0016020; GO:0097431; GO:0016363; GO:0005654; GO:0005634",null,"GO:0051301; GO:0051321; GO:0032876; GO:1901673; GO:0007062"]
[2448,1221,"PN729","STAG2","Y433","Putative uncharacterized protein DKFZp781H1753",0,3909,16,648,{"v":2522.664,"d":"2523"},{"v":4432.691224647776,"d":"4433"},{"$nulls":3},0,4013,12,636,{"v":2544.636,"d":"2545"},{"v":4446.026554228169,"d":"4446"},{"$nulls":6},0,4130,20,677,{"v":2782.47,"d":"2782"},{"v":4760.364874293634,"d":"4760"},{"$nulls":10},"Transcription, coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"CGEFL(pY)KKL","Corresponds to amino acid residues G428 to L436.","The effect of Y433 phosphorylation is unclear. This is the major site of in vivo phosphorylation of STAG2 (≥42 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in the frog.",null,null,"Q8N3U4","Q8N3U4"]
[2453,1224,"PN666","STAT1","Y701","Signal transducer and activator of transcription 1-alpha/beta",0,12806,16,705,{"v":9016.95,"d":"9017"},{"v":15844.105730326259,"d":"15844"},{"v":15337.254950182381,"d":"15337"},{"v":506.8507801438773,"d":"507"},{"v":3.3047033630868223,"d":"3"},0,13070,16,722,{"v":9424.988,"d":"9425"},{"v":16467.481762138807,"d":"16467"},{"v":16365.779863058342,"d":"16366"},{"v":101.7018990804645,"d":"102"},{"v":0.6214302033356267,"d":"1"},{"v":3.926133566422449,"d":"4"},{"v":6.706056045992298,"d":"7"},null,0,12844,16,744,{"v":9544.032,"d":"9544"},{"v":16328.325082367255,"d":"16328"},{"v":16522.782737738908,"d":"16523"},{"v":194.45765537165244,"d":"194"},{"v":1.176906205560041,"d":"1"},{"v":4.4816095686468636,"d":"4"},{"v":7.729726025988953,"d":"8"},{"$nulls":5},"Transcription protein, SH2 protein;  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"CGTG(pY)IKTE","Corresponds to amino acid residues C698 to E705.","Y701 phosphorylation regulates transcription and molecular association, and stimulates transcriptional activity. This is one of the major sites of in vivo phosphorylation of STAT1.","FGFR3; JAK1; JAK2; JAK3; Src; Tyk2","Transcription factor; Transcription, coactivator/corepressor","P42224","P42224",null,null,"GO:0030424; GO:0005737; GO:0005829; GO:0030425; GO:0000790; GO:0005730; GO:0005654; GO:0005634; GO:0048471; GO:0032991","GO:0045296; GO:0031730; GO:0003700; GO:0003690; GO:0019899; GO:0035035; GO:0042393; GO:0042802; GO:0035257; GO:1990841; GO:0042803; GO:0051721; GO:0070491; GO:0000979; GO:0000978; GO:0000981; GO:0000983; GO:0000982; GO:0005164; GO:0044389","GO:0008015; GO:0032869; GO:0035458; GO:0071346; GO:0071407; GO:0019221; GO:0051607; GO:0060333; GO:0038114; GO:0070106; GO:0070757; GO:0070102; GO:0038113; GO:0007259; GO:0010742; GO:0072162; GO:0072136; GO:0046725; GO:0016525; GO:0001937; GO:0043124; GO:0003340; GO:0072308; GO:0000122; GO:0002230; GO:0045648; GO:0032727; GO:0002053; GO:0051770; GO:0048661; GO:0045893; GO:0045944; GO:0007221; GO:0042981; GO:0060334; GO:0006355; GO:0061326; GO:0051591; GO:0034097; GO:0042542; GO:0035456; GO:0009612; GO:0007584; GO:0043434; GO:0006351; GO:0033209; GO:0060337; GO:0016032"]
[2456,1225,"PN667","STAT1","S727","Signal transducer and activator of transcription 1-alpha/beta",0,9922,12,716,{"v":7095.56,"d":"7096"},{"v":12467.941250187012,"d":"12468"},{"$nulls":3},0,9765,20,764,{"v":7445.18,"d":"7445"},{"v":13008.33124305735,"d":"13008"},{"$nulls":6},0,10167,15,756,{"v":7674.912,"d":"7675"},{"v":13130.557202088326,"d":"13131"},{"$nulls":10},"Transcription protein, SH2 protein;  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"LLPM(pS)PEE(bA)C","Corresponds to amino acid residues L723 to E730.","S727 phosphorylation regulates cell cycle, cell differentiation, cell growth, transcription, alters intracellular location, molecular association, induces interaction with DNA, PIAS1, STAT2, and inhibits interaction with DNA. This is one of the major sites of in vivo phosphorylation of STAT1.","CaMK2a; CaMK2g; CK2a1 (CSNK2A1); ERK1 (MAPK3); ERK2 (MAPK1); JNK1 (MAPK8); p38a MAPK (MAPK14); PKCd (PRKCD)",null,"P42224","P42224"]
[2464,1229,"PN272","STAT3","S727","Signal transducer and activator of transcription 3",0,88,10,586,{"v":45.708,"d":"46"},{"v":80.31567045639075,"d":"80"},{"$nulls":3},0,108,12,535,{"v":51.36,"d":"51"},{"v":89.73696977687919,"d":"90"},{"$nulls":6},0,118,11,564,{"v":60.348,"d":"60"},{"v":103.24585689472742,"d":"103"},{"$nulls":10},"Transcription protein, SH2 protein;  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S727 phosphosite.","S727 phosphorylation regulates carcinogenesis, cell differentiation, cell growth, cell motility, transcription, activation/inhibition, alters intracellular location, molecular association, induces interaction with DNA, p300, and inhibits interaction with gp130. This is one of the major sites of in vivo phosphorylation of STAT3.","CDK1 (CDC2); CDK5; DYRK1A; DYRK2; ERK1 (MAPK3); ERK2 (MAPK1); FRAP1 (mTOR); HIPK2; IRAK1; JNK1 (MAPK8); MAPKAPK2; MEKK1 (MAP3K1); MSK1 (RPS6KA5); NLK; p38a MAPK (MAPK14); PKCd (PRKCD); PKCe (PRKCE); RSK2 (RPS6KA3)",null,"P40763","P40763",null,"P40763"]
[2465,1230,"PN669","STAT3","S727","Signal transducer and activator of transcription 3",0,13906,20,708,{"v":9831.288,"d":"9831"},{"v":17275.01722170887,"d":"17275"},{"v":17562.542683074935,"d":"17563"},{"v":287.52546136606543,"d":"288"},{"v":1.6371516730499076,"d":"2"},0,17394,20,682,{"v":11849.068,"d":"11849"},{"v":20702.871047511417,"d":"20703"},{"v":21576.249734143013,"d":"21576"},{"v":873.3786866315968,"d":"873"},{"v":4.047870679071404,"d":"4"},{"v":5.685022352121312,"d":"6"},{"v":22.85379243482835,"d":"23"},null,0,15954,22,721,{"v":11486.972,"d":"11487"},{"v":19652.387274901255,"d":"19652"},{"v":16842.231044217726,"d":"16842"},{"v":2810.1562306835294,"d":"2810"},{"v":16.685178010595646,"d":"17"},{"v":18.322329683645552,"d":"18"},{"v":-4.101408616369511,"d":"-4"},{"$nulls":5},"Transcription protein, SH2 protein;  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"DLPM(pS)PRT(bA)C","Corresponds to amino acid residues D723 to T730.","S727 phosphorylation regulates carcinogenesis, cell differentiation, cell growth, cell motility, transcription, activation/inhibition, alters intracellular location, molecular association, induces interaction with DNA, p300, and inhibits interaction with gp130. This is one of the major sites of in vivo phosphorylation of STAT3.","CDK1 (CDC2); CDK5; DYRK1A; DYRK2; ERK1 (MAPK3); ERK2 (MAPK1); FRAP1 (mTOR); HIPK2; IRAK1; JNK1 (MAPK8); MAPKAPK2; MEKK1 (MAP3K1); MSK1 (RPS6KA5); NLK; p38a MAPK (MAPK14); PKCd (PRKCD); PKCe (PRKCE); RSK2 (RPS6KA3)","Nuclear receptor co-regulator; Transcription factor","P40763","P40763",null,"P40763","GO:0005737; GO:0005829; GO:0098978; GO:0005743; GO:0000790; GO:0005654; GO:0005634; GO:0005886; GO:0014069; GO:0090575; GO:0098685","GO:0031730; GO:0031490; GO:0003677; GO:0003700; GO:0035259; GO:0042802; GO:0004879; GO:0046983; GO:0042803; GO:0019901; GO:0019903; GO:0000978; GO:0001103; GO:0000981; GO:0001077; GO:0001228; GO:0008134; GO:0044212","GO:0006953; GO:0007568; GO:0048708; GO:0008283; GO:0071345; GO:0032870; GO:0044320; GO:0071407; GO:0019221; GO:0042755; GO:0097009; GO:0001754; GO:0042593; GO:0060396; GO:0006954; GO:0035723; GO:0038114; GO:0038155; GO:0070106; GO:0070757; GO:0070102; GO:0038111; GO:0038113; GO:0030522; GO:0007259; GO:0060397; GO:0033210; GO:0035278; GO:0050804; GO:0042789; GO:0043066; GO:0008285; GO:0045820; GO:0010730; GO:1901215; GO:2001223; GO:2000737; GO:0000122; GO:0007399; GO:0016310; GO:0045766; GO:2001171; GO:0045648; GO:0010628; GO:2000637; GO:1902728; GO:1904685; GO:0045747; GO:1902895; GO:0045893; GO:0045944; GO:0042531; GO:1905564; GO:0099527; GO:0006606; GO:0060019; GO:0051726; GO:0060259; GO:0046902; GO:0040014; GO:0006355; GO:0006357; GO:0032355; GO:0045471; GO:0044321; GO:0019953; GO:0007165; GO:0035019; GO:0001659; GO:0072540; GO:0016032"]
[2470,1232,"PN670","STAT4","Y693","Signal transducer and activator of transcription 4",0,8011,16,722,{"v":5772.39,"d":"5772"},{"v":10142.937187926958,"d":"10143"},{"$nulls":3},0,7932,12,793,{"v":6280.56,"d":"6281"},{"v":10973.489542482017,"d":"10973"},{"$nulls":6},0,6410,20,1087,{"v":6945.93,"d":"6946"},{"v":11883.384615576228,"d":"11883"},{"$nulls":10},"Transcription protein, SH2 protein;  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"CGDKG(pY)VPSV","Corresponds to amino acid residues C689 to V697.","The effect of Y693 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of STAT4.",null,null,"Q14765","Q14765"]
[2475,1235,"PN671","STAT5A","Y694","Signal transducer and activator of transcription 5A",0,3794,10,683,{"v":2584.472,"d":"2584"},{"v":4541.296960176974,"d":"4541"},{"v":4624.981081238618,"d":"4625"},{"v":83.68412106164396,"d":"84"},{"v":1.8093938027359993,"d":"2"},0,3565,10,664,{"v":2360.52,"d":"2361"},{"v":4124.336290843436,"d":"4124"},{"v":4151.92132353108,"d":"4152"},{"v":27.585032687644343,"d":"28"},{"v":0.6643919895905959,"d":"1"},{"v":2.473785792326595,"d":"2"},{"v":-10.22836092511858,"d":"-10"},null,0,5108,12,721,{"v":3674.216,"d":"3674"},{"v":6286.000850671403,"d":"6286"},{"v":6007.291099643925,"d":"6007"},{"v":278.709751027478,"d":"279"},{"v":4.639524644377532,"d":"5"},{"v":6.448918447113532,"d":"6"},{"v":29.8879064395029,"d":"30"},{"$nulls":5},"Transcription protein, SH2 protein;  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"CAVDG(pY)VKPQ","Corresponds to amino acid residues C690 to Q698.","Y694 phosphorylation stimulates transcriptional activity. This is one of the major sites of in vivo phosphorylation of STAT5A.","Btk; JAK1; JAK2; JAK3; Lck; Lyn; Src; Syk","Transcription protein","P42229","P42229",null,"P42229","GO:0005829; GO:0005654","GO:0003677; GO:0003700; GO:0004713; GO:0000981","GO:0006103; GO:0000255; GO:0006101; GO:0006600; GO:0046449; GO:0019221; GO:0006631; GO:0035723; GO:0038110; GO:0038111; GO:0038113; GO:0006549; GO:0007259; GO:0060397; GO:0007595; GO:0006107; GO:0043536; GO:0001938; GO:0040014; GO:0006357; GO:0006105; GO:0019530; GO:0006351; GO:0006573"]
[2479,1237,"NN107-2","STAT6","Pan-specific","Signal transducer and activator of transcription 6",0,1083,14,588,{"v":628.572,"d":"629"},{"v":1104.4933405555798,"d":"1104"},{"v":1107.3065327407703,"d":"1107"},{"v":2.8131921851904735,"d":"3"},{"v":0.2540572192080678,"d":"0"},0,1239,14,610,{"v":747.25,"d":"747"},{"v":1305.6065160781343,"d":"1306"},{"v":1270.1957067621684,"d":"1270"},{"v":35.410809315965935,"d":"35"},{"v":2.7878230990270745,"d":"3"},{"v":3.041880318235142,"d":"3"},{"v":14.710395830341568,"d":"15"},null,0,1415,14,682,{"v":955.482,"d":"955"},{"v":1634.6781639406104,"d":"1635"},{"v":1588.1278802485472,"d":"1588"},{"v":46.5502836920632,"d":"47"},{"v":2.9311420239519963,"d":"3"},{"v":3.185199243160064,"d":"3"},{"v":43.42260551083925,"d":"43"},{"$nulls":5},"Transcription protein, SH2 protein;  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"Epitope undefined.",{"$nulls":3},"Transcription protein","P42226","P42226",null,null,"GO:0005829; GO:0045121; GO:0000790; GO:0031965; GO:0005654","GO:0003700; GO:0042802; GO:0019903; GO:0000978; GO:0000977; GO:0000981; GO:0001228","GO:0070301; GO:1902170; GO:0019221; GO:0035771; GO:0033598; GO:0060443; GO:0000122; GO:0002829; GO:0120162; GO:0048295; GO:0045944; GO:0032481; GO:0042127; GO:0006357; GO:0007165; GO:0002296"]
[2482,1238,"PN673","STAT6","Y641","Signal transducer and activator of transcription 6",0,5060,14,1093,{"v":5515.278,"d":"5515"},{"v":9691.153634448716,"d":"9691"},{"$nulls":3},0,7590,18,795,{"v":6019.74,"d":"6020"},{"v":10517.780888720225,"d":"10518"},{"$nulls":6},0,7406,20,807,{"v":5960.502,"d":"5961"},{"v":10197.473595027785,"d":"10197"},{"$nulls":10},"Transcription protein, SH2 protein;  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"CGRG(pY)VPAT","Corresponds to amino acid residues C638 to T645.","The effect of Y641 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of STAT6.",null,null,"P42226","P42226"]
[2487,1241,"PK822","Syk","Y352","Spleen protein-tyrosine kinase",0,1408,12,596,{"v":832.016,"d":"832"},{"v":1461.9743342619324,"d":"1462"},{"v":1129.513355249475,"d":"1130"},{"v":332.4609790124575,"d":"332"},{"v":29.434001596114555,"d":"29"},0,1598,12,633,{"v":1003.938,"d":"1004"},{"v":1754.0956768664437,"d":"1754"},{"v":996.2970192011693,"d":"996"},{"v":757.7986576652744,"d":"758"},{"v":76.06152011504332,"d":"76"},{"v":105.49552171115788,"d":"105"},{"v":-11.794135538918198,"d":"-12"},null,0,1752,14,651,{"v":1131.438,"d":"1131"},{"v":1935.7109735742133,"d":"1936"},{"v":1954.8569996978445,"d":"1955"},{"v":19.146026123631145,"d":"19"},{"v":0.9794080143248576,"d":"1"},{"v":30.413409610439412,"d":"30"},{"v":73.07072914300127,"d":"73"},"Possible",null,"SYK","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Syk",{"$nulls":6},"ESP(pY)ADP(bA)C","Corresponds to amino acid residues E349 to P355; In the region between the SH2 and kinase catalytic domains. ","Y352 phosphorylation stimulates phosphotransferase activity and regulates molecular association, including inducing interaction with ITGAM, PLCG1, and CLTC. This is one of the major sites of in vivo phosphorylation of Syk.","Lck; Lyn; Syk","EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; Syk family","P43405","P43405","P43405","P43405","GO:0019815; GO:0005737; GO:0005829; GO:0032009; GO:0031234; GO:0005634; GO:0005886; GO:0032991; GO:0042101","GO:0005524; GO:0005178; GO:0004715; GO:0019902; GO:0001784; GO:0004672; GO:0019901; GO:0004674; GO:0004713; GO:0042169; GO:0035325","GO:0007257; GO:0002250; GO:0001525; GO:0009887; GO:0050853; GO:0043366; GO:0048514; GO:0008283; GO:0071404; GO:0071226; GO:0038063; GO:0042742; GO:0038095; GO:0038096; GO:0006954; GO:0045087; GO:0007229; GO:0038110; GO:0038156; GO:0002366; GO:0007159; GO:0019370; GO:0001945; GO:0002281; GO:0002283; GO:0030593; GO:0018105; GO:0038083; GO:0030168; GO:0046638; GO:0046641; GO:0045579; GO:0045780; GO:0050850; GO:0033630; GO:0120162; GO:0050715; GO:0045588; GO:0045425; GO:0045401; GO:0032753; GO:0043306; GO:1900086; GO:0002092; GO:0032481; GO:0006606; GO:0006468; GO:0031623; GO:0090237; GO:0051090; GO:0070372; GO:0043313; GO:0050764; GO:0010543; GO:0090330; GO:0032928; GO:0010803; GO:0002554; GO:0002223; GO:0007169; GO:0016032"]
[2492,1243,"NK175-5","TAK1 (MAP3K7)","Pan-specific","TGF-beta-activated protein-serine kinase 1; Mitogen-activated protein kinase kinase kinase 7",0,272,14,697,{"v":179.826,"d":"180"},{"v":315.9806982473729,"d":"316"},{"$nulls":3},0,332,12,686,{"v":219.52,"d":"220"},{"v":383.5486683298388,"d":"384"},{"$nulls":6},0,312,18,733,{"v":215.502,"d":"216"},{"v":368.6897436953594,"d":"369"},{"$nulls":7},"TAK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","MLK","TAK1",{"$nulls":5},"Epitope undefined.",{"$nulls":4},"O43318","O43318","O43318","O43318"]
[2497,1246,"PK824","TAK1 (MAP3K7)","S439","TGF-beta-activated protein-serine kinase 1; Mitogen-activated protein kinase kinase kinase 7",0,9778,20,704,{"v":6869.632,"d":"6870"},{"v":12070.952565605068,"d":"12071"},{"v":12352.858671188349,"d":"12353"},{"v":281.9061055832808,"d":"282"},{"v":2.282112287423761,"d":"2"},0,8974,20,695,{"v":6223.03,"d":"6223"},{"v":10872.972255268935,"d":"10873"},{"v":11344.835660248737,"d":"11345"},{"v":471.863404979802,"d":"472"},{"v":4.159279333002311,"d":"4"},{"v":6.441391620426072,"d":"6"},{"v":-8.160240781275292,"d":"-8"},null,0,9712,14,715,{"v":6934.07,"d":"6934"},{"v":11863.094036555025,"d":"11863"},{"v":12330.057932032498,"d":"12330"},{"v":466.96389547747276,"d":"467"},{"v":3.7871995253512813,"d":"4"},{"v":6.069311812775043,"d":"6"},{"v":-0.18457864501462495,"d":"-0"},null,null,"TAK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","MLK","TAK1",{"$nulls":5},"RRR(pS)IQD(bA)C","Corresponds to amino acid residues R436 to D442; In the C-terminal half of the protein. ","The effect of S439 phosphorylation is unclear. This is the major in vivo phosphorylation site in TAK1.",null,"EC 2.7.11.25; Protein kinase, Ser/Thr (non-receptor); TKL group; MLK family; TAK1 subfamily","O43318","O43318","O43318","O43318","GO:0005671; GO:0005829; GO:0010008; GO:0005634; GO:0005886","GO:0005524; GO:0042802; GO:0000287; GO:0004709; GO:0004672; GO:0004674; GO:0030971; GO:0097110","GO:0000187; GO:0000186; GO:0007250; GO:0043276; GO:0038095; GO:0043966; GO:0007249; GO:0007252; GO:0070498; GO:0007254; GO:0002755; GO:0070423; GO:0043123; GO:0032743; GO:0043507; GO:0016239; GO:0051092; GO:0002726; GO:0016579; GO:0002223; GO:0051403; GO:0050852; GO:0006351; GO:0007179; GO:0016032; GO:0007223"]
[2501,1248,"PK827","TAO1 (TAOK1)","Y309","Serine/threonine-protein kinase TAO1",0,2909,16,640,{"v":1851.52,"d":"1852"},{"v":3253.392626310856,"d":"3253"},{"v":3236.7700166469576,"d":"3237"},{"v":16.622609663898402,"d":"17"},{"v":0.5135554759345595,"d":"1"},0,3476,18,620,{"v":2143.96,"d":"2144"},{"v":3745.9593793387444,"d":"3746"},{"v":3680.4589044267404,"d":"3680"},{"v":65.50047491200394,"d":"66"},{"v":1.7796822791098694,"d":"2"},{"v":2.293237755044429,"d":"2"},{"v":13.707766863195616,"d":"14"},null,0,3052,12,634,{"v":1927.36,"d":"1927"},{"v":3297.407283499401,"d":"3297"},{"v":3257.9347506851377,"d":"3258"},{"v":39.472532814263104,"d":"39"},{"v":1.2115814414626354,"d":"1"},{"v":1.7251369173971949,"d":"2"},{"v":0.6538843949161759,"d":"1"},null,null,"TAO1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","TAO",{"$nulls":5},"NLQ(pY)RKM(bA)C","Corresponds to amino acid residues N306 to M312; Just after the kinase catalytic domain.","The effect of Y309 phosphorylation is unclear. This is the major in vivo site of phosphorylation on TAO1.",null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; STE domain target; STE</A> group; STE20 family; TAO subfamily","Q7L7X3","Q7L7X3","Q7L7X3","Q7L7X3","GO:0005737; GO:0005829; GO:0070062; GO:0015630; GO:0048471","GO:0043014; GO:0005524; GO:0048487; GO:0016301; GO:0004709; GO:0004672; GO:0043539; GO:0004674; GO:0016740","GO:0007257; GO:0000187; GO:0006974; GO:0006281; GO:0097194; GO:0000226; GO:0007095; GO:0007026; GO:0007399; GO:0070050; GO:0046330; GO:1901985; GO:0032874; GO:0046777; GO:0006468; GO:0032956; GO:0042981; GO:0051493; GO:0070507; GO:0007346"]
[2504,1249,"NK087-2","TAO3 (JIK, TAOK3)","Pan-specific","Serine/threonine-protein kinase TAO3",0,696,14,515,{"v":351.23,"d":"351"},{"v":617.1627053119394,"d":"617"},{"$nulls":3},0,738,16,563,{"v":406.486,"d":"406"},{"v":710.2184948739197,"d":"710"},{"$nulls":6},0,898,14,569,{"v":502.996,"d":"503"},{"v":860.5463815639345,"d":"861"},{"$nulls":7},"TAO3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","TAO",{"$nulls":5},"CSEHGTSLNREMDSLGSNHS","Corresponds to amino acid residues S331 to S349; After catalytic domain.",{"$nulls":3},"Q9H2K8","Q9H2K8","Q9H2K8","Q9H2K8"]
[2509,1252,"PN275","Tau","S396","Microtubule-associated protein tau",0,74,10,550,{"v":35.2,"d":"35"},{"v":61.85157084241171,"d":"62"},{"v":57.69064698574037,"d":"58"},{"v":4.160923856671339,"d":"4"},{"v":7.212475633528276,"d":"7"},0,80,10,536,{"v":37.52,"d":"38"},{"v":65.55551218902858,"d":"66"},{"v":58.608584777952416,"d":"59"},{"v":6.94692741107616,"d":"7"},{"v":11.85308848080133,"d":"12"},{"v":19.065564114329607,"d":"19"},{"v":1.591137974997821,"d":"2"},null,0,68,10,564,{"v":32.712,"d":"33"},{"v":55.96504392424478,"d":"56"},{"v":57.792222540993784,"d":"58"},{"v":1.827178616749002,"d":"2"},{"v":3.1616341030195345,"d":"3"},{"v":10.37410973654781,"d":"10"},{"v":0.17606936403143436,"d":"0"},{"$nulls":15},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S396 phosphosite.","The effect of S396 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of Tau.",null,"Cytoskeletal protein","P10636","P10636",null,null,"GO:0030673; GO:0030424; GO:1904115; GO:0044297; GO:0005737; GO:0036464; GO:0005829; GO:0030425; GO:0043197; GO:0005576; GO:0097386; GO:0030426; GO:0005622; GO:0044304; GO:0045121; GO:0005874; GO:0005875; GO:0015630; GO:0005739; GO:0097418; GO:0043025; GO:0034399; GO:0016607; GO:0005634; GO:0005886; GO:0036477; GO:0045298","GO:0003779; GO:0034185; GO:0003680; GO:0051087; GO:0003677; GO:0003690; GO:0034452; GO:0019899; GO:0099077; GO:0051879; GO:0042802; GO:0071813; GO:0008017; GO:0099609; GO:0035091; GO:1902936; GO:0030674; GO:0042803; GO:0019901; GO:0051721; GO:0048018; GO:0003723; GO:0043565; GO:0017124; GO:0003697","GO:0006919; GO:1990000; GO:0048143; GO:0098930; GO:0019896; GO:0061564; GO:0007267; GO:1990416; GO:0034605; GO:1990090; GO:0034614; GO:0021954; GO:0031122; GO:0048699; GO:0006475; GO:0048312; GO:0007611; GO:0007613; GO:0001774; GO:0000226; GO:0046785; GO:1903748; GO:0010629; GO:0033673; GO:0090258; GO:0010917; GO:1904428; GO:1902988; GO:0031175; GO:0072386; GO:0045773; GO:1903829; GO:1905689; GO:0031116; GO:1901216; GO:1902474; GO:0032930; GO:0051259; GO:0051260; GO:0010506; GO:0050848; GO:1900034; GO:0033044; GO:1900452; GO:0070507; GO:0031113; GO:0031110; GO:0090140; GO:2001020; GO:0048167; GO:0010288; GO:0016072; GO:0034063; GO:0097435; GO:0007416; GO:0050808"]
[2514,1254,"PN121","Tau","T522","Microtubule-associated protein tau",0,1794,12,318,{"v":566.676,"d":"567"},{"v":995.7329760992756,"d":"996"},{"$nulls":3},0,2098,12,287,{"v":598.682,"d":"599"},{"v":1046.0262566191898,"d":"1046"},{"$nulls":6},0,1472,12,305,{"v":445.3,"d":"445"},{"v":761.8376760658535,"d":"762"},{"$nulls":20},"PG(pT)PG","Corresponds to amino acid residues P203 to G207; Surrounds the T305 phosphosite.","The effect of T522 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of Tau.",null,null,"P10636","P10636"]
[2515,1255,"PN090","Tau","S713","Microtubule-associated protein tau",0,1282,10,373,{"v":474.456,"d":"474"},{"v":833.6888890797526,"d":"834"},{"v":722.5915192478684,"d":"723"},{"v":111.09736983188418,"d":"111"},{"v":15.374851056586339,"d":"15"},0,683,12,357,{"v":239.547,"d":"240"},{"v":418.5401460113333,"d":"419"},{"v":490.48435037304796,"d":"490"},{"v":71.94420436171464,"d":"72"},{"v":14.667991814009152,"d":"15"},{"v":30.042842870595493,"d":"30"},{"v":-32.1214908689236,"d":"-32"},null,0,1106,12,381,{"v":416.814,"d":"417"},{"v":713.102647904138,"d":"713"},{"v":696.6819921330173,"d":"697"},{"v":16.420655771120778,"d":"16"},{"v":2.356980079368204,"d":"2"},{"v":17.731831135954543,"d":"18"},{"v":-3.585639524502014,"d":"-4"},{"$nulls":15},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S713 phosphosite.","The effect of S713 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of Tau.",null,"Cytoskeletal protein","P10636","P10636",null,null,"GO:0030673; GO:0030424; GO:1904115; GO:0044297; GO:0005737; GO:0036464; GO:0005829; GO:0030425; GO:0043197; GO:0005576; GO:0097386; GO:0030426; GO:0005622; GO:0044304; GO:0045121; GO:0005874; GO:0005875; GO:0015630; GO:0005739; GO:0097418; GO:0043025; GO:0034399; GO:0016607; GO:0005634; GO:0005886; GO:0036477; GO:0045298","GO:0003779; GO:0034185; GO:0003680; GO:0051087; GO:0003677; GO:0003690; GO:0034452; GO:0019899; GO:0099077; GO:0051879; GO:0042802; GO:0071813; GO:0008017; GO:0099609; GO:0035091; GO:1902936; GO:0030674; GO:0042803; GO:0019901; GO:0051721; GO:0048018; GO:0003723; GO:0043565; GO:0017124; GO:0003697","GO:0006919; GO:1990000; GO:0048143; GO:0098930; GO:0019896; GO:0061564; GO:0007267; GO:1990416; GO:0034605; GO:1990090; GO:0034614; GO:0021954; GO:0031122; GO:0048699; GO:0006475; GO:0048312; GO:0007611; GO:0007613; GO:0001774; GO:0000226; GO:0046785; GO:1903748; GO:0010629; GO:0033673; GO:0090258; GO:0010917; GO:1904428; GO:1902988; GO:0031175; GO:0072386; GO:0045773; GO:1903829; GO:1905689; GO:0031116; GO:1901216; GO:1902474; GO:0032930; GO:0051259; GO:0051260; GO:0010506; GO:0050848; GO:1900034; GO:0033044; GO:1900452; GO:0070507; GO:0031113; GO:0031110; GO:0090140; GO:2001020; GO:0048167; GO:0010288; GO:0016072; GO:0034063; GO:0097435; GO:0007416; GO:0050808"]
[2519,1257,"PN107","Tau","S739","Microtubule-associated protein tau",0,454,10,307,{"v":136.308,"d":"136"},{"v":239.5131794996436,"d":"240"},{"v":224.13111554639156,"d":"224"},{"v":15.382063953252043,"d":"15"},{"v":6.862975680888092,"d":"7"},0,405,12,306,{"v":120.258,"d":"120"},{"v":210.1165987427558,"d":"210"},{"v":213.27381650729671,"d":"213"},{"v":3.157217764540917,"d":"3"},{"v":1.4803588252160806,"d":"1"},{"v":8.343334506104172,"d":"8"},{"v":-4.844173024627423,"d":"-5"},null,0,358,10,330,{"v":114.84,"d":"115"},{"v":196.47302654256146,"d":"196"},{"v":217.01338840837468,"d":"217"},{"v":20.540361865813225,"d":"21"},{"v":9.465020576131678,"d":"9"},{"v":16.32799625701977,"d":"16"},{"v":-3.175697903731546,"d":"-3"},{"$nulls":15},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S739 phosphosite.","The effect of S739 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of Tau.",null,"Cytoskeletal protein","P10636","P10636",null,null,"GO:0030673; GO:0030424; GO:1904115; GO:0044297; GO:0005737; GO:0036464; GO:0005829; GO:0030425; GO:0043197; GO:0005576; GO:0097386; GO:0030426; GO:0005622; GO:0044304; GO:0045121; GO:0005874; GO:0005875; GO:0015630; GO:0005739; GO:0097418; GO:0043025; GO:0034399; GO:0016607; GO:0005634; GO:0005886; GO:0036477; GO:0045298","GO:0003779; GO:0034185; GO:0003680; GO:0051087; GO:0003677; GO:0003690; GO:0034452; GO:0019899; GO:0099077; GO:0051879; GO:0042802; GO:0071813; GO:0008017; GO:0099609; GO:0035091; GO:1902936; GO:0030674; GO:0042803; GO:0019901; GO:0051721; GO:0048018; GO:0003723; GO:0043565; GO:0017124; GO:0003697","GO:0006919; GO:1990000; GO:0048143; GO:0098930; GO:0019896; GO:0061564; GO:0007267; GO:1990416; GO:0034605; GO:1990090; GO:0034614; GO:0021954; GO:0031122; GO:0048699; GO:0006475; GO:0048312; GO:0007611; GO:0007613; GO:0001774; GO:0000226; GO:0046785; GO:1903748; GO:0010629; GO:0033673; GO:0090258; GO:0010917; GO:1904428; GO:1902988; GO:0031175; GO:0072386; GO:0045773; GO:1903829; GO:1905689; GO:0031116; GO:1901216; GO:1902474; GO:0032930; GO:0051259; GO:0051260; GO:0010506; GO:0050848; GO:1900034; GO:0033044; GO:1900452; GO:0070507; GO:0031113; GO:0031110; GO:0090140; GO:2001020; GO:0048167; GO:0010288; GO:0016072; GO:0034063; GO:0097435; GO:0007416; GO:0050808"]
[2526,1260,"PK829","TEC","Y519","Tyrosine-protein kinase Tec",0,5447,28,664,{"v":3598.216,"d":"3598"},{"v":6322.594086088047,"d":"6323"},{"$nulls":3},0,5000,18,653,{"v":3253.246,"d":"3253"},{"v":5684.120677156408,"d":"5684"},{"$nulls":6},0,5746,22,679,{"v":3886.596,"d":"3887"},{"v":6649.349347511435,"d":"6649"},{"$nulls":7},"Tec","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"DDQ(pY)TSS(bA)C","Corresponds to amino acid residues D516 to S522; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y519 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of TEC.",null,null,"P42680","P42680","P42680"]
[2531,1263,"NN449-1","TH (TY3H)","Pan-specific","Tyrosine 3-monooxygenase",0,90,10,557,{"v":44.56,"d":"45"},{"v":78.29846581641664,"d":"78"},{"v":75.02665829060497,"d":"75"},{"v":3.271807525811667,"d":"3"},{"v":4.360859993442319,"d":"4"},0,106,9,546,{"v":52.962,"d":"53"},{"v":92.53600843697578,"d":"93"},{"v":97.19932565532645,"d":"97"},{"v":4.66331721835067,"d":"5"},{"v":4.797684744117485,"d":"5"},{"v":9.158544737559804,"d":"9"},{"v":29.553052034969795,"d":"30"},null,0,117,8,589,{"v":64.201,"d":"64"},{"v":109.83772881451573,"d":"110"},{"v":110.05928277600356,"d":"110"},{"v":0.22155396148782813,"d":"0"},{"v":0.20130420251669492,"d":"0"},{"v":4.5621641959590145,"d":"5"},{"v":46.693569037427665,"d":"47"},{"$nulls":5},"Metabolic enzyme",{"$nulls":8},"X","Epitope undefined.",{"$nulls":3},"Endoplasmic reticulum; Vesicle protein; EC 1.14.16.2; Amino Acid Metabolism - tyrosine; Mitochondrial; Oxidoreductase","P07101","P07101",null,null,"GO:0005737; GO:0009898; GO:0031410; GO:0005829; GO:0030425; GO:0033162; GO:0005739; GO:0043005; GO:0005634; GO:0043204; GO:0005790; GO:0008021; GO:0043195","GO:0016597; GO:0035240; GO:0019899; GO:0008199; GO:0008198; GO:0019825; GO:0019904; GO:0034617; GO:0004511","GO:0015842; GO:0009653; GO:0009887; GO:0042423; GO:0071312; GO:0071333; GO:0071363; GO:0071287; GO:0071316; GO:0021987; GO:0042745; GO:0042416; GO:0006585; GO:0042755; GO:0048596; GO:0042418; GO:0042462; GO:0006631; GO:0016137; GO:0007507; GO:0003007; GO:0033076; GO:0007612; GO:0007626; GO:0007617; GO:0007613; GO:0010259; GO:0042136; GO:0042421; GO:0018963; GO:0052314; GO:0043473; GO:0008016; GO:0014823; GO:0001975; GO:0051412; GO:0051602; GO:0032355; GO:0045471; GO:0045472; GO:0009635; GO:0001666; GO:0035902; GO:0035900; GO:0009416; GO:0032496; GO:0031667; GO:0043434; GO:0046684; GO:0009651; GO:0009414; GO:0010043; GO:0007605; GO:0035176; GO:0006665; GO:0001963; GO:0042214; GO:0007601"]
[2532,1263,"NN449-1","TH (TY3H)","Pan-specific","Tyrosine 3-monooxygenase",0,94,12,498,{"v":40.836,"d":"41"},{"v":71.7548507647933,"d":"72"},{"$nulls":3},0,124,14,530,{"v":58.3,"d":"58"},{"v":101.86264287367712,"d":"102"},{"$nulls":6},0,122,12,586,{"v":64.46,"d":"64"},{"v":110.28083673749137,"d":"110"},{"$nulls":10},"Metabolic enzyme",{"$nulls":8},"X","Epitope undefined.",{"$nulls":4},"P07101","P07101"]
[2537,1266,"PN676","THRAP3","S253","Thyroid hormone receptor-associated protein 3",0,5648,16,740,{"v":4167.68,"d":"4168"},{"v":7323.225987741547,"d":"7323"},{"v":7529.023032544481,"d":"7529"},{"v":205.79704480293367,"d":"206"},{"v":2.733383121732638,"d":"3"},0,4604,18,736,{"v":3375.296,"d":"3375"},{"v":5897.368285436551,"d":"5897"},{"v":5849.089236587744,"d":"5849"},{"v":48.27904884880627,"d":"48"},{"v":0.8254113913463118,"d":"1"},{"v":3.55879451307895,"d":"4"},{"v":-22.31277270231689,"d":"-22"},null,0,6559,18,781,{"v":5108.521,"d":"5109"},{"v":8739.869226978688,"d":"8740"},{"v":8455.731831605108,"d":"8456"},{"v":284.13739537358015,"d":"284"},{"v":3.360293361144163,"d":"3"},{"v":6.093676482876801,"d":"6"},{"v":12.308486706109065,"d":"12"},{"$nulls":5},"Transcription,  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"PALK(pS)PLQ(bA)C","Corresponds to amino acid residues P249 to Q256.","The effect of S253 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of THRAP3.","ERK1 (MAPK3)","Transcription, coactivator/corepressor","Q9Y2W1","Q9Y2W1",null,"Q9Y2W1","GO:0070062; GO:0016592; GO:0016607; GO:0005654; GO:0005634","GO:0005524; GO:0030374; GO:0051219; GO:0003723; GO:0000980; GO:0038023; GO:0046966; GO:0003713; GO:0003712; GO:0042809","GO:0030521; GO:0007623; GO:0030518; GO:0006397; GO:0048255; GO:0000956; GO:0042753; GO:0048026; GO:0045893; GO:0045944; GO:0000381; GO:0008380; GO:0006367"]
[2542,1268,"PK831","TIE2 (TEK)","Y992","Angiopoietin-1 receptor",0,514,18,589,{"v":292.144,"d":"292"},{"v":513.3399236416343,"d":"513"},{"$nulls":3},0,478,16,550,{"v":254.1,"d":"254"},{"v":443.9673679965927,"d":"444"},{"$nulls":6},0,672,18,576,{"v":376.704,"d":"377"},{"v":644.4807992919633,"d":"644"},{"$nulls":7},"TIE2","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK","Tie",{"$nulls":6},"QEV(pY)VKK(bA)C","Corresponds to amino acid residues Q989 to K995; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y992 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of TIE2.","Tie2",null,"Q02763","Q02763","Q02763","Q02763"]
[2548,1271,"PN677","TORC2","S433","CREB-regulated transcription coactivator 2",0,16789,18,703,{"v":11790.013,"d":"11790"},{"v":20716.784781319744,"d":"20717"},{"$nulls":3},0,16434,22,714,{"v":11718.168,"d":"11718"},{"v":20474.160585210142,"d":"20474"},{"$nulls":6},0,15606,20,726,{"v":11315.436,"d":"11315"},{"v":19358.916384262062,"d":"19359"},{"$nulls":15},"X",{"$nulls":4},"RVPL(pS)PLS(bA)C","Corresponds to amino acid residues R429 to S436.","The effect of S433 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of TORC2.",null,null,"Q53ET0","Q53ET0",null,"Q53ET0"]
[2549,1272,"PN678","TP53BP1","T1056","Tumor suppressor p53-binding protein 1",0,8368,16,716,{"v":5980.032,"d":"5980"},{"v":10507.794684315028,"d":"10508"},{"v":10378.3386436831,"d":"10378"},{"v":129.45604063192695,"d":"129"},{"v":1.2473676671817016,"d":"1"},0,8466,18,707,{"v":5972.736,"d":"5973"},{"v":10435.654788109001,"d":"10436"},{"v":10575.74125667989,"d":"10576"},{"v":140.08646857088934,"d":"140"},{"v":1.324601890032128,"d":"1"},{"v":2.5719695572138295,"d":"3"},{"v":1.902063709560494,"d":"2"},null,0,9142,20,719,{"v":6558.718,"d":"6559"},{"v":11220.926294837822,"d":"11221"},{"v":11048.180927691976,"d":"11048"},{"v":172.7453671458461,"d":"173"},{"v":1.5635638869097843,"d":"2"},{"v":2.8109315540914857,"d":"3"},{"v":6.454234218080586,"d":"6"},{"$nulls":5},"Transcription,  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"DPPT(pT)PIRGC","Corresponds to amino acid residues D1052 to G1060.","The effect of T1056 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of TP53P1.","ERK1 (MAPK3)","Transcription, coactivator/corepressor","Q12888","Q12888",null,"Q12888","GO:0000777; GO:0005737; GO:1990391; GO:0016604; GO:0000784; GO:0005654; GO:0005634; GO:0005657; GO:0035861","GO:0003684; GO:0035064; GO:0002039; GO:0001102; GO:0042162; GO:0003712; GO:0061649","GO:0006974; GO:0071481; GO:0000077; GO:0006303; GO:2000042; GO:0051091; GO:0045830; GO:0045893; GO:0045944; GO:0051260; GO:0006351"]
[2554,1274,"PK833","TRIM28 (TIF1B)","S473","Transcription intermediary factor 1-beta",0,1084,18,590,{"v":628.94,"d":"629"},{"v":1105.139970614387,"d":"1105"},{"$nulls":3},0,966,16,532,{"v":505.4,"d":"505"},{"v":883.0425335910192,"d":"883"},{"$nulls":6},0,1494,18,603,{"v":890.028,"d":"890"},{"v":1522.6967508500773,"d":"1523"},{"$nulls":7},"TIF1b","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","TIF1",null,"X",{"$nulls":4},"RSR(pS)GEG(bA)C","Corresponds to amino acid residues R470 to G476; In the mid-region of the protein kinase between the zf-B_box and PHD domains.","S473 phosphorylation stimulates transcription and induces DNA repair and inhibits interaction with HP1-alpha. This is one of the major sites of in vivo phosphorylation of TRIM28.","Chk1 (CHEK1)",null,"Q13263","Q13263","Q13263"]
[2559,1277,"PK837","TrkA (NGFR; NTRK1)","Y680+Y681","Nerve growth factor (NGF) receptor-tyrosine kinase; High affinity nerve growth factor receptor",0,10057,18,962,{"v":9657.518,"d":"9658"},{"v":16969.67780508143,"d":"16970"},{"v":17289.71926981223,"d":"17290"},{"v":320.04146473080255,"d":"320"},{"v":1.851050672000172,"d":"2"},0,13962,18,824,{"v":11489.856,"d":"11490"},{"v":20075.2504013375,"d":"20075"},{"v":18877.58334240259,"d":"18878"},{"v":1197.6670589349087,"d":"1198"},{"v":6.34438761154731,"d":"6"},{"v":8.195438283547482,"d":"8"},{"v":9.183862663188307,"d":"9"},null,0,11735,14,796,{"v":9329.916,"d":"9330"},{"v":15962.006564854306,"d":"15962"},{"v":17807.23113670581,"d":"17807"},{"v":1845.2245718515042,"d":"1845"},{"v":10.362220592779115,"d":"10"},{"v":12.213271264779287,"d":"12"},{"v":2.9931768053466925,"d":"3"},null,null,"TRKA","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK","Trk",{"$nulls":6},"STD(pY)(pY)RVG(bA)C","Corresponds to amino acid residues S677 to G684; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y680 and Y681 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major sites of in vivo phosphorylation of TrkA.","Y680: TrkA (NTRK1). Y681: TrkA (NTRK1)","Protein-tyrosine kinase (receptor), TK group, Trk family","P04629","P04629","P04629","P04629","GO:0030424; GO:0009986; GO:0030425; GO:0005769; GO:0031901; GO:0005768; GO:0005887; GO:0005770; GO:0031902; GO:0043025; GO:0005886; GO:0032991; GO:0043235","GO:0005524; GO:0005004; GO:0019900; GO:0048406; GO:0010465; GO:0043121; GO:0005166; GO:0042803; GO:0004713; GO:0004714","GO:0000186; GO:0007568; GO:0007411; GO:0060385; GO:0030183; GO:0061368; GO:1990090; GO:0071316; GO:0007623; GO:0050966; GO:0050965; GO:0007611; GO:0042490; GO:0043066; GO:0008285; GO:0043524; GO:0038180; GO:0048666; GO:0031175; GO:0048011; GO:0021553; GO:0038083; GO:0018108; GO:0048015; GO:0045766; GO:0070374; GO:0043547; GO:0010976; GO:0051092; GO:0043068; GO:0001934; GO:0046579; GO:0051965; GO:0051968; GO:0010623; GO:0046777; GO:0006468; GO:0048678; GO:0051602; GO:0051599; GO:0031667; GO:0009314; GO:0060009; GO:0048485"]
[2565,1280,"PK839","TrkB (NTRK2)","Y702","BNDF/NT3/4/5 receptor- tyrosine kinase",0,80,8,694,{"v":49.968,"d":"50"},{"v":87.80111624584171,"d":"88"},{"v":97.92403953058984,"d":"98"},{"v":10.122923284748126,"d":"10"},{"v":10.337526243069142,"d":"10"},0,146,12,498,{"v":66.732,"d":"67"},{"v":116.59516096477223,"d":"117"},{"v":115.53634858773195,"d":"116"},{"v":1.058812377040283,"d":"1"},{"v":0.9164322656746238,"d":"1"},{"v":11.253958508743766,"d":"11"},{"v":17.985684762974174,"d":"18"},null,0,160,12,552,{"v":81.696,"d":"82"},{"v":139.7688991328901,"d":"140"},{"v":143.08793145170384,"d":"143"},{"v":3.3190323188137256,"d":"3"},{"v":2.3195753025013097,"d":"2"},{"v":12.657101545570452,"d":"13"},{"v":46.12135297687098,"d":"46"},null,null,"TRKB","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK","Trk",{"$nulls":6},"RDV(pY)STD(bA)C","Corresponds to amino acid residues R699 to D705; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y702 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of TrkB.","TrkB (NTRK2)","Protein-tyrosine kinase (receptor), TK group, Trk family","Q16620","Q16620","Q16620","Q16620","GO:0030424; GO:0005829; GO:0030425; GO:0005769; GO:0031901; GO:0005887; GO:0048471; GO:0005886; GO:0014069; GO:0045211; GO:0043235; GO:0043195","GO:0005524; GO:0060175; GO:0048403; GO:0043121; GO:0042803","GO:0007202; GO:0031547; GO:0071230; GO:0021954; GO:0021987; GO:0007623; GO:0007631; GO:0014047; GO:0007612; GO:0060291; GO:0042490; GO:2000811; GO:0043524; GO:0007528; GO:0030182; GO:0001764; GO:0048011; GO:0048709; GO:0048935; GO:0050772; GO:0008284; GO:0010628; GO:0043410; GO:0010976; GO:1903997; GO:0033138; GO:0014068; GO:0001934; GO:0051965; GO:0046777; GO:0043087; GO:0051896; GO:0060041; GO:0046548; GO:0099183; GO:0099551; GO:0001570"]
[2566,1280,"PK839","TrkB (NTRK2)","Y702","BNDF/NT3/4/5 receptor- tyrosine kinase",0,146,16,473,{"v":61.49,"d":"61"},{"v":108.04696281533796,"d":"108"},{"$nulls":3},0,154,14,468,{"v":65.52,"d":"66"},{"v":114.47753621069167,"d":"114"},{"$nulls":6},0,170,18,563,{"v":85.576,"d":"86"},{"v":146.40696377051756,"d":"146"},{"$nulls":7},"TRKB","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK","Trk",{"$nulls":6},"RDV(pY)STD(bA)C","Corresponds to amino acid residues R699 to D705; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y702 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of TrkB.","TrkB (NTRK2)",null,"Q16620","Q16620","Q16620","Q16620"]
[2571,1283,"NK232-1","TRRAP","Pan-specific","Transformation/transcription domain-associated protein",0,3329,12,700,{"v":2321.9,"d":"2322"},{"v":4079.919384630561,"d":"4080"},{"v":4426.073809426397,"d":"4426"},{"v":346.1544247958359,"d":"346"},{"v":7.820801001072692,"d":"8"},0,3566,14,726,{"v":2578.752,"d":"2579"},{"v":4505.634546068278,"d":"4506"},{"v":4361.832624494458,"d":"4362"},{"v":143.80192157381953,"d":"144"},{"v":3.2968234674178114,"d":"3"},{"v":11.117624468490503,"d":"11"},{"v":-1.4514259747571714,"d":"-1"},null,0,3682,16,760,{"v":2786.16,"d":"2786"},{"v":4766.677879064986,"d":"4767"},{"v":4765.908000434334,"d":"4766"},{"v":0.7698786306518741,"d":"1"},{"v":0.016153871005938687,"d":"0"},{"v":7.83695487207863,"d":"8"},{"v":7.67800551098307,"d":"8"},null,null,"TRRAP","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PIKK","TRRAP",{"$nulls":5},"CARRLYIRGHNGKIYP","Corresponds to amino acid residues A3513 to P3527.",null,null,"Transcription, coactivator/corepressor; Protein kinase, Ser/Thr (non-receptor); Nuclear receptor co-regulator; ATYPICAL domain target; ATYPICAL</A> group; PIKK family; TRRAP subfamily","Q9Y4A5","Q9Y4A5","Q9Y4A5","Q9Y4A5","GO:0005794; GO:0035267; GO:0005654; GO:0005634; GO:0000125; GO:0030914; GO:0000812; GO:0033276","GO:0016301; GO:0036459; GO:0003712","GO:1904837; GO:0006281; GO:0016573; GO:0016578; GO:0043968; GO:0043967; GO:0016579; GO:0006355; GO:0006351"]
[2576,1285,"NK180","TTK","Pan-specific","Dual specificity protein kinase",0,186,28,465,{"v":73.47,"d":"73"},{"v":129.09758266454511,"d":"129"},{"$nulls":3},0,126,12,429,{"v":48.906,"d":"49"},{"v":85.44930381440915,"d":"85"},{"$nulls":6},0,158,12,522,{"v":76.212,"d":"76"},{"v":130.38664488733625,"d":"130"},{"$nulls":7},"TTK","X","DSK","Protein Kinase - Dual specificity kinase","Protein-serine/threonine kinase","Other","TTK",{"$nulls":6},"SEDLSGRELTIDSIMNKVRDIKNKFKNEDL","Corresponds to amino acid residues S2 to L32; N-terminus.",{"$nulls":3},"P33981","P33981","P33981","P33981"]
[2581,1288,"PK844","TXK","Y420","Tyrosine-protein kinase TXK",0,453,12,549,{"v":242.109,"d":"242"},{"v":425.42107855356414,"d":"425"},{"v":453.3605928200348,"d":"453"},{"v":27.939514266470667,"d":"28"},{"v":6.162757572880069,"d":"6"},0,520,16,570,{"v":287.28,"d":"287"},{"v":501.9399664622635,"d":"502"},{"v":510.26894105195163,"d":"510"},{"v":8.32897458968813,"d":"8"},{"v":1.6322715179406027,"d":"2"},{"v":7.795029090820671,"d":"8"},{"v":12.552557309388177,"d":"13"},null,0,591,14,585,{"v":337.545,"d":"338"},{"v":577.4859608525679,"d":"577"},{"v":568.4997663914498,"d":"568"},{"v":8.986194461118089,"d":"9"},{"v":1.580685691070363,"d":"2"},{"v":7.743443263950432,"d":"8"},{"v":25.396819969555764,"d":"25"},null,null,"TXK","X","DSK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"DDE(pY)VSS(bA)C","Corresponds to amino acid residues D417 to S423.","Y420 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of TXK.","Fyn; TXK","Protein-serine kinase, TK group, Tec family","P42681","P42681","P42681","P42681","GO:0005737; GO:0031234; GO:0005634","GO:0005524; GO:0004715; GO:0000978; GO:0001012; GO:0001077","GO:0007202; GO:0002250; GO:0030154; GO:0001816; GO:0007229; GO:0038083; GO:0060335; GO:0032729; GO:0045944; GO:0046777; GO:0006468; GO:0042127; GO:0010543; GO:0006357; GO:0050852; GO:0042246; GO:0007169"]
[2583,1289,"NK181-3","TYK2","Pan-specific","Protein-tyrosine kinase 2 (Jak-related)",0,3190,16,733,{"v":2326.542,"d":"2327"},{"v":4088.076060535404,"d":"4088"},{"v":4136.951101529202,"d":"4137"},{"v":48.87504099379794,"d":"49"},{"v":1.1814266060754632,"d":"1"},0,3346,12,743,{"v":2477.162,"d":"2477"},{"v":4328.134959626823,"d":"4328"},{"v":4428.011018882191,"d":"4428"},{"v":99.87605925536809,"d":"100"},{"v":2.2555512809130462,"d":"2"},{"v":3.4369778869885095,"d":"3"},{"v":7.035614156652727,"d":"7"},null,0,3864,14,833,{"v":3207.05,"d":"3207"},{"v":5486.753916521436,"d":"5487"},{"v":5507.36613372611,"d":"5507"},{"v":20.61221720467438,"d":"21"},{"v":0.3742663317488355,"d":"0"},{"v":1.5556929378242987,"d":"2"},{"v":33.12620813164412,"d":"33"},null,null,"TYK2","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","JakA",{"$nulls":6},"CSFRTILRDLTRLQPH","Corresponds to amino acid residues S858 to H872; Kinase last alpha-chain.",null,null,"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; JakA family","P29597","P29597","P29597","P29597","GO:0005737; GO:0005856; GO:0005829; GO:0070062; GO:0031234; GO:0005634","GO:0005524; GO:0005131; GO:0004715; GO:0004713; GO:0031702","GO:0030154; GO:0016477; GO:0019221; GO:0045087; GO:0035722; GO:0038155; GO:0070106; GO:0035556; GO:0038083; GO:0006468; GO:0042127; GO:0007169; GO:0060337"]
[2587,1291,"PK846","TYK2","Y292","Protein-tyrosine kinase 2 (Jak-related)",0,1538,18,670,{"v":1018.4,"d":"1018"},{"v":1789.4784018725024,"d":"1789"},{"v":1850.0085982469172,"d":"1850"},{"v":60.5301963744148,"d":"61"},{"v":3.2718872999711297,"d":"3"},0,1637,20,676,{"v":1093.092,"d":"1093"},{"v":1909.8668957817065,"d":"1910"},{"v":1871.6972337539473,"d":"1872"},{"v":38.16966202775916,"d":"38"},{"v":2.0393074979976666,"d":"2"},{"v":5.311194797968796,"d":"5"},{"v":1.1723532273083777,"d":"1"},null,0,1750,16,721,{"v":1250.214,"d":"1250"},{"v":2138.917871872883,"d":"2139"},{"v":2116.4117532368036,"d":"2116"},{"v":22.506118636079464,"d":"23"},{"v":1.0634092634223464,"d":"1"},{"v":4.335296563393476,"d":"4"},{"v":14.400103612617372,"d":"14"},null,null,"TYK2","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","JakA",{"$nulls":6},"EPA(pY)IRD(bA)C","Corresponds to amino acid residues E289 to D295; In the N-terminal half of the kinase. ","The effect of Y292 phosphorylation is unclear. This is the major in vivo site of phosphorylation of Tyk2 by mass spectrometry studies (≥1467 reports).",null,"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; JakA family","P29597","P29597","P29597","P29597","GO:0005737; GO:0005856; GO:0005829; GO:0070062; GO:0031234; GO:0005634","GO:0005524; GO:0005131; GO:0004715; GO:0004713; GO:0031702","GO:0030154; GO:0016477; GO:0019221; GO:0045087; GO:0035722; GO:0038155; GO:0070106; GO:0035556; GO:0038083; GO:0006468; GO:0042127; GO:0007169; GO:0060337"]
[2588,1291,"PK846","TYK2","Y292","Protein-tyrosine kinase 2 (Jak-related)",0,1632,14,672,{"v":1087.296,"d":"1087"},{"v":1910.538794621332,"d":"1911"},{"$nulls":3},0,1606,16,660,{"v":1049.4,"d":"1049"},{"v":1833.5275717261884,"d":"1834"},{"$nulls":6},0,1848,24,671,{"v":1223.904,"d":"1224"},{"v":2093.9056346007237,"d":"2094"},{"$nulls":7},"TYK2","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","JakA",{"$nulls":6},"EPA(pY)IRD(bA)C","Corresponds to amino acid residues E289 to D295; In the N-terminal half of the kinase. ","The effect of Y292 phosphorylation is unclear. This is the major in vivo site of phosphorylation of Tyk2 by mass spectrometry studies (≥1467 reports).",null,null,"P29597","P29597","P29597","P29597"]
[2589,1292,"PK845","TYK2","Y1054+Y1055","Protein-tyrosine kinase 2 (Jak-related)",0,6720,18,722,{"v":4838.844,"d":"4839"},{"v":8502.559729016444,"d":"8503"},{"v":8578.533489485573,"d":"8579"},{"v":75.97376046912905,"d":"76"},{"v":0.8856264367592385,"d":"1"},0,1386,14,1018,{"v":1396.696,"d":"1397"},{"v":2440.328402248599,"d":"2440"},{"v":5476.20207506434,"d":"5476"},{"v":3035.8736728157405,"d":"3036"},{"v":55.43757573591862,"d":"55"},{"v":56.32320217267786,"d":"56"},{"v":-36.16388999615913,"d":"-36"},null,0,7139,20,786,{"v":5595.534,"d":"5596"},{"v":9573.07123042324,"d":"9573"},{"v":9679.336722391528,"d":"9679"},{"v":106.26549196828819,"d":"106"},{"v":1.0978592337061766,"d":"1"},{"v":1.9834856704654151,"d":"2"},{"v":12.832067791717236,"d":"13"},null,null,"TYK2","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","JakA",{"$nulls":6},"GHE(pY)(pY)RVR(bA)C","Corresponds to amino acid residues G1051 to R1058; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y1054 and Y1055 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. The Y1054 site is one of the major in vivo phosphorylation sites in TYK2 (<60).","Y1054: Tyk2. Y1055: Tyk2.","EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; JakA family","P29597","P29597","P29597","P29597","GO:0005737; GO:0005856; GO:0005829; GO:0070062; GO:0031234; GO:0005634","GO:0005524; GO:0005131; GO:0004715; GO:0004713; GO:0031702","GO:0030154; GO:0016477; GO:0019221; GO:0045087; GO:0035722; GO:0038155; GO:0070106; GO:0035556; GO:0038083; GO:0006468; GO:0042127; GO:0007169; GO:0060337"]
[2590,1292,"PK845","TYK2","Y1054+Y1055","Protein-tyrosine kinase 2 (Jak-related)",0,7113,16,694,{"v":4925.318,"d":"4925"},{"v":8654.507249954704,"d":"8655"},{"$nulls":3},0,6753,24,724,{"v":4871.796,"d":"4872"},{"v":8512.07574788008,"d":"8512"},{"$nulls":6},0,7548,22,760,{"v":5719.76,"d":"5720"},{"v":9785.602214359817,"d":"9786"},{"$nulls":7},"TYK2","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","JakA",{"$nulls":6},"GHE(pY)(pY)RVR(bA)C","Corresponds to amino acid residues G1051 to R1058; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y1054 and Y1055 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. The Y1054 site is one of the major in vivo phosphorylation sites in TYK2 (<60).","Y1054: Tyk2. Y1055: Tyk2.",null,"P29597","P29597","P29597","P29597"]
[2591,1294,"PK847","Tyro3","Y681","Tyrosine-protein kinase receptor TYRO3",0,1934,12,681,{"v":1308.882,"d":"1309"},{"v":2299.8979473681115,"d":"2300"},{"v":2609.804188785876,"d":"2610"},{"v":309.90624141776425,"d":"310"},{"v":11.874693233668912,"d":"12"},0,2307,12,649,{"v":1489.455,"d":"1489"},{"v":2602.398331756651,"d":"2602"},{"v":2565.8334868383167,"d":"2566"},{"v":36.564844918334074,"d":"37"},{"v":1.425066946311866,"d":"1"},{"v":13.299760179980778,"d":"13"},{"v":-1.6848276256317405,"d":"-2"},null,0,2357,15,712,{"v":1667.504,"d":"1668"},{"v":2852.8348802841115,"d":"2853"},{"v":3101.673340442266,"d":"3102"},{"v":248.8384601581547,"d":"249"},{"v":8.022716541861012,"d":"8"},{"v":19.897409775529923,"d":"20"},{"v":18.84697533132615,"d":"19"},null,null,"TYRO3","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Axl",{"$nulls":6},"RKI(pY)SGD(bA)C","Corresponds to amino acid residues R678 to D684; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y681 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of Tyro3.",null,"Protein-tyrosine kinase (receptor) TK group, Axl family","Q06418","Q06418","Q06418","Q06418","GO:0009986; GO:0005789; GO:0005887; GO:0005635; GO:0005634","GO:0005524; GO:0043548; GO:0046982; GO:0004713; GO:0004714; GO:0001618","GO:0043277; GO:0007155; GO:0021885; GO:0001779; GO:0050728; GO:0045824; GO:0051250; GO:0043524; GO:0034122; GO:0070050; GO:0007218; GO:0042698; GO:0014065; GO:0030168; GO:0070527; GO:0046777; GO:0043491; GO:0032940; GO:0007165; GO:0007283; GO:0034446; GO:0060068"]
[2592,1294,"PK847","Tyro3","Y681","Tyrosine-protein kinase receptor TYRO3",0,2526,16,662,{"v":1661.62,"d":"1662"},{"v":2919.71043020364,"d":"2920"},{"$nulls":3},0,2214,14,658,{"v":1447.6,"d":"1448"},{"v":2529.2686419199827,"d":"2529"},{"$nulls":6},0,2744,24,720,{"v":1958.4,"d":"1958"},{"v":3350.511800600421,"d":"3351"},{"$nulls":7},"TYRO3","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Axl",{"$nulls":6},"RKI(pY)SGD(bA)C","Corresponds to amino acid residues R678 to D684; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y681 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of Tyro3.",null,null,"Q06418","Q06418","Q06418","Q06418"]
[2593,1295,"PK848","Tyro3","Y685+Y686","Tyrosine-protein kinase receptor TYRO3",0,4722,18,698,{"v":3283.392,"d":"3283"},{"v":5769.402070778632,"d":"5769"},{"v":6166.251940755559,"d":"6166"},{"v":396.84986997692704,"d":"397"},{"v":6.435836125247592,"d":"6"},0,4872,20,662,{"v":3212.024,"d":"3212"},{"v":5612.096974505658,"d":"5612"},{"v":5925.659193042221,"d":"5926"},{"v":313.5622185365628,"d":"314"},{"v":5.2916006189613585,"d":"5"},{"v":11.727436744208951,"d":"12"},{"v":-3.9017664218867054,"d":"-4"},null,0,5171,20,721,{"v":3713.871,"d":"3714"},{"v":6353.844266445918,"d":"6354"},{"v":7164.00722415784,"d":"7164"},{"v":810.162957711922,"d":"810"},{"v":11.308795934487073,"d":"11"},{"v":17.744632059734663,"d":"18"},{"v":16.18090361841466,"d":"16"},null,null,"TYRO3","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Axl",{"$nulls":6},"SGD(pY)(pY)RQG(bA)C","Corresponds to amino acid residues S682 to G689; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y685 and Y686 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII.",null,"Protein-tyrosine kinase (receptor) TK group, Axl family","Q06418","Q06418","Q06418","Q06418","GO:0009986; GO:0005789; GO:0005887; GO:0005635; GO:0005634","GO:0005524; GO:0043548; GO:0046982; GO:0004713; GO:0004714; GO:0001618","GO:0043277; GO:0007155; GO:0021885; GO:0001779; GO:0050728; GO:0045824; GO:0051250; GO:0043524; GO:0034122; GO:0070050; GO:0007218; GO:0042698; GO:0014065; GO:0030168; GO:0070527; GO:0046777; GO:0043491; GO:0032940; GO:0007165; GO:0007283; GO:0034446; GO:0060068"]
[2594,1295,"PK848","Tyro3","Y685+Y686","Tyrosine-protein kinase receptor TYRO3",0,5318,20,705,{"v":3735.09,"d":"3735"},{"v":6563.101810732487,"d":"6563"},{"$nulls":3},0,5254,18,682,{"v":3570.952,"d":"3571"},{"v":6239.221411578784,"d":"6239"},{"$nulls":6},0,5724,26,818,{"v":4660.964,"d":"4661"},{"v":7974.170181869761,"d":"7974"},{"$nulls":7},"TYRO3","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Axl",{"$nulls":6},"SGD(pY)(pY)RQG(bA)C","Corresponds to amino acid residues S682 to G689; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y685 and Y686 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII.",null,null,"Q06418","Q06418","Q06418","Q06418"]
[2595,1296,"PN680","UBF","T201","Nucleolar transcription factor 1",0,12207,16,605,{"v":7375.555,"d":"7376"},{"v":12959.93359615352,"d":"12960"},{"v":12835.247330778744,"d":"12835"},{"v":124.68626537477576,"d":"125"},{"v":0.971436406026862,"d":"1"},0,12514,18,581,{"v":7260.176,"d":"7260"},{"v":12685.089452625072,"d":"12685"},{"v":12541.251713140808,"d":"12541"},{"v":143.8377394842646,"d":"144"},{"v":1.1469169328094295,"d":"1"},{"v":2.1183533388362914,"d":"2"},{"v":-2.2905333264045424,"d":"-2"},null,0,12215,14,632,{"v":7711.032,"d":"7711"},{"v":13192.352793508713,"d":"13192"},{"v":12662.65747636426,"d":"12663"},{"v":529.6953171444529,"d":"530"},{"v":4.183129158576439,"d":"4"},{"v":5.154565564603301,"d":"5"},{"v":-1.3446554629345968,"d":"-1"},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"EKPK(pT)PQQ(bA)C","Corresponds to amino acid residues E197 to Q204.","T201 phosphorylation inhibits transcriptional activity by inhibiting DNA binding. This is one of the major sites of in vivo phosphorylation of UBF.","ERK1 (MAPK3); ERK2 (MAPK1)","Transcription protein","P17480","P17480",null,null,"GO:0001650; GO:0005730; GO:0005654; GO:0005634","GO:0003682; GO:0003723; GO:0001164; GO:0000981; GO:0001165; GO:0097110","GO:0045943; GO:0006356; GO:0006363; GO:0006360; GO:0006361"]
[2596,1296,"PN680","UBF","T201","Nucleolar transcription factor 1",0,12052,16,601,{"v":7233.636,"d":"7234"},{"v":12710.561065403968,"d":"12711"},{"$nulls":3},0,11610,16,612,{"v":7095.528,"d":"7096"},{"v":12397.413973656543,"d":"12397"},{"$nulls":6},0,11738,16,605,{"v":7091.81,"d":"7092"},{"v":12132.96215921981,"d":"12133"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"EKPK(pT)PQQ(bA)C","Corresponds to amino acid residues E197 to Q204.","T201 phosphorylation inhibits transcriptional activity by inhibiting DNA binding. This is one of the major sites of in vivo phosphorylation of UBF.","ERK1 (MAPK3); ERK2 (MAPK1)",null,"P17480","P17480"]
[2597,1297,"PN679","UBF","S484","Nucleolar transcription factor 1",0,494,12,518,{"v":249.676,"d":"250"},{"v":438.71740913778365,"d":"439"},{"v":435.98680285684316,"d":"436"},{"v":2.730606280940492,"d":"3"},{"v":0.6263048016701299,"d":"1"},0,460,12,506,{"v":226.688,"d":"227"},{"v":396.0727064793845,"d":"396"},{"v":377.13638875271363,"d":"377"},{"v":18.936317726670893,"d":"19"},{"v":5.02107945332407,"d":"5"},{"v":5.6473842549942,"d":"6"},{"v":-13.498209972986984,"d":"-13"},null,0,526,12,537,{"v":276.018,"d":"276"},{"v":472.2230219455305,"d":"472"},{"v":481.33496324965523,"d":"481"},{"v":9.111941304124741,"d":"9"},{"v":1.8930561874431355,"d":"2"},{"v":2.5193609891132653,"d":"3"},{"v":10.40126905118781,"d":"10"},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"KLPE(pS)PKRAC","Corresponds to amino acid residues K480 to A488.","S484 phosphorylation stimulates of DNA transcription. This is one of the major sites of in vivo phosphorylation of UBF.","CDK2; CDK4","Transcription protein","P17480","P17480",null,null,"GO:0001650; GO:0005730; GO:0005654; GO:0005634","GO:0003682; GO:0003723; GO:0001164; GO:0000981; GO:0001165; GO:0097110","GO:0045943; GO:0006356; GO:0006363; GO:0006360; GO:0006361"]
[2598,1297,"PN679","UBF","S484","Nucleolar transcription factor 1",0,408,16,629,{"v":246.568,"d":"247"},{"v":433.2561965759026,"d":"433"},{"$nulls":3},0,440,12,479,{"v":205.012,"d":"205"},{"v":358.2000710260428,"d":"358"},{"$nulls":6},0,538,12,545,{"v":286.67,"d":"287"},{"v":490.44690455378,"d":"490"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"KLPE(pS)PKRAC","Corresponds to amino acid residues K480 to A488.","S484 phosphorylation stimulates of DNA transcription. This is one of the major sites of in vivo phosphorylation of UBF.","CDK2; CDK4",null,"P17480","P17480"]
[2599,1298,"NK298-2","ULK1","Pan-specific","Unc-51-like protein-serine/threonine kinase 1",0,806,10,266,{"v":211.736,"d":"212"},{"v":372.05125579229787,"d":"372"},{"v":439.9210547635522,"d":"440"},{"v":67.86979897125434,"d":"68"},{"v":15.427722368899314,"d":"15"},0,936,10,269,{"v":249.094,"d":"249"},{"v":435.2208089875768,"d":"435"},{"v":444.377963555346,"d":"444"},{"v":9.157154567769226,"d":"9"},{"v":2.060668016592305,"d":"2"},{"v":17.48839038549162,"d":"17"},{"v":1.013115590520954,"d":"1"},null,0,718,10,288,{"v":203.904,"d":"204"},{"v":348.84740512133794,"d":"349"},{"v":365.88396379698077,"d":"366"},{"v":17.036558675642823,"d":"17"},{"v":4.656273671807042,"d":"5"},{"v":20.083996040706356,"d":"20"},{"v":-16.82963117243041,"d":"-17"},null,null,"ULK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","ULK",{"$nulls":6},"Epitope undefined.",{"$nulls":3},"Protein-serine kinase, Other group, ULK family","O75385","O75385","O75385",null,"GO:1990316; GO:0005776; GO:0030424; GO:0005737; GO:0005829; GO:0005789; GO:0097635; GO:0097629; GO:0097632; GO:0005741; GO:0034045; GO:0055037","GO:0005524; GO:0051020; GO:0042802; GO:0016301; GO:0044877; GO:0004674; GO:0017137","GO:0006914; GO:0075044; GO:0048675; GO:0031669; GO:0016236; GO:0031333; GO:0031175; GO:0031102; GO:0018105; GO:0018107; GO:2000786; GO:0046777; GO:0008104; GO:0006468; GO:0016241; GO:0042594; GO:0007165"]
[2600,1298,"NK298-2","ULK1","Pan-specific","Unc-51-like protein-serine/threonine kinase 1",0,1123,20,262,{"v":288.986,"d":"289"},{"v":507.7908537348065,"d":"508"},{"$nulls":3},0,926,12,284,{"v":259.576,"d":"260"},{"v":453.5351181231152,"d":"454"},{"$nulls":6},0,732,10,310,{"v":223.82,"d":"224"},{"v":382.92052247262365,"d":"383"},{"$nulls":7},"ULK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","ULK",{"$nulls":6},"Epitope undefined.",{"$nulls":4},"O75385","O75385","O75385"]
[2601,1299,"NK298-1","ULK1","Pan-specific","Unc-51-like kinase 1; Serine-threonine-protein kinase ULK1",0,1708,10,637,{"v":1081.626,"d":"1082"},{"v":1900.5757717043866,"d":"1901"},{"v":1859.5270629984325,"d":"1860"},{"v":41.04870870595414,"d":"41"},{"v":2.207481112953759,"d":"2"},0,1710,12,616,{"v":1045.968,"d":"1046"},{"v":1827.5311293532473,"d":"1828"},{"v":1806.4833021254985,"d":"1806"},{"v":21.047827227748712,"d":"21"},{"v":1.1651271397296588,"d":"1"},{"v":3.372608252683418,"d":"3"},{"v":-2.8525404081725156,"d":"-3"},null,0,1686,14,686,{"v":1146.992,"d":"1147"},{"v":1962.3214007323722,"d":"1962"},{"v":2189.8701504908786,"d":"2190"},{"v":227.54874975850635,"d":"228"},{"v":10.390969971781171,"d":"10"},{"v":12.59845108473493,"d":"13"},{"v":17.764898078965174,"d":"18"},null,null,"ULK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","ULK",{"$nulls":6},"RGGTETVGKFEFSRKDLIGC","Corresponds to amino acid residues R5 to G23; N-terminus.",null,null,"Protein-serine kinase, Other group, ULK family","O75385","O75385","O75385",null,"GO:1990316; GO:0005776; GO:0030424; GO:0005737; GO:0005829; GO:0005789; GO:0097635; GO:0097629; GO:0097632; GO:0005741; GO:0034045; GO:0055037","GO:0005524; GO:0051020; GO:0042802; GO:0016301; GO:0044877; GO:0004674; GO:0017137","GO:0006914; GO:0075044; GO:0048675; GO:0031669; GO:0016236; GO:0031333; GO:0031175; GO:0031102; GO:0018105; GO:0018107; GO:2000786; GO:0046777; GO:0008104; GO:0006468; GO:0016241; GO:0042594; GO:0007165"]
[2602,1299,"NK298-1","ULK1","Pan-specific","Unc-51-like kinase 1; Serine-threonine-protein kinase ULK1",0,1624,12,642,{"v":1034.904,"d":"1035"},{"v":1818.4783542924786,"d":"1818"},{"$nulls":3},0,1648,13,625,{"v":1021.875,"d":"1022"},{"v":1785.4354748977498,"d":"1785"},{"$nulls":6},0,1898,14,750,1413,{"v":2417.4189002493845,"d":"2417"},{"$nulls":7},"ULK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","ULK",{"$nulls":6},"RGGTETVGKFEFSRKDLIGC","Corresponds to amino acid residues R5 to G23; N-terminus.",{"$nulls":3},"O75385","O75385","O75385"]
[2603,1300,"NK354-1","ULK2","Pan-specific","Unc-51-like protein-serine/threonine kinase 2",0,1898,10,281,{"v":530.528,"d":"531"},{"v":932.2156299966762,"d":"932"},{"v":1202.2091581786462,"d":"1202"},{"v":269.9935281819701,"d":"270"},{"v":22.458116072831437,"d":"22"},0,1963,10,296,{"v":578.088,"d":"578"},{"v":1010.0441079512566,"d":"1010"},{"v":1009.7706687812783,"d":"1010"},{"v":0.27343916997824635,"d":"0"},{"v":0.027079333796481538,"d":"0"},{"v":22.48519540662792,"d":"22"},{"v":-16.00707232083586,"d":"-16"},null,0,284,8,441,{"v":121.716,"d":"122"},{"v":208.23677201893423,"d":"208"},{"v":106.7667684989123,"d":"107"},{"v":101.47000352002193,"d":"101"},{"v":95.03893856359966,"d":"95"},{"v":117.4970546364311,"d":"117"},{"v":-91.11911868474995,"d":"-91"},null,null,"ULK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","ULK",{"$nulls":6},"Epitope undefined.",{"$nulls":3},"Protein-serine kinase, Other group, ULK family","Q8IYT8","Q8IYT8","Q8IYT8",null,"GO:0030659; GO:0034045","GO:0005524; GO:0004674","GO:0006914; GO:0075044; GO:0048675; GO:0048671; GO:0046777; GO:0042594; GO:0007165"]
[2604,1300,"NK354-1","ULK2","Pan-specific","Unc-51-like protein-serine/threonine kinase 2",0,2831,10,297,{"v":837.837,"d":"838"},{"v":1472.2026863606163,"d":"1472"},{"$nulls":3},0,2111,10,275,{"v":577.775,"d":"578"},{"v":1009.4972296113001,"d":"1009"},{"$nulls":6},0,8,2,516,{"v":3.096,"d":"3"},{"v":5.296764978890371,"d":"5"},{"$nulls":7},"ULK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","ULK",{"$nulls":6},"Epitope undefined.",{"$nulls":4},"Q8IYT8","Q8IYT8","Q8IYT8"]
[2605,1301,"NK355-1","ULK3","Pan-specific","Unc-51-like protein-serine/threonine kinase 3",0,776,8,341,{"v":261.888,"d":"262"},{"v":460.1756870675431,"d":"460"},{"v":484.7423578615135,"d":"485"},{"v":24.56667079397039,"d":"25"},{"v":5.06798516687268,"d":"5"},0,56,12,650,{"v":28.6,"d":"29"},{"v":49.97035310784161,"d":"50"},{"v":58.48802693304188,"d":"58"},{"v":8.51767382520027,"d":"9"},{"v":14.563106796116498,"d":"15"},{"v":19.631091962989178,"d":"20"},{"v":-87.9342034001181,"d":"-88"},null,0,635,10,353,{"v":220.625,"d":"221"},{"v":377.4543841949897,"d":"377"},{"v":372.0541133113116,"d":"372"},{"v":5.400270883678104,"d":"5"},{"v":1.4514745813761494,"d":"1"},{"v":6.5194597482488295,"d":"7"},{"v":-23.247038911007635,"d":"-23"},null,null,"ULK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","ULK",{"$nulls":6},"Epitope undefined.",{"$nulls":3},"Protein-serine kinase, Other group, ULK family","Q6PHR2","Q6PHR2","Q6PHR2",null,"GO:0097542; GO:0005737; GO:0000407","GO:0005524; GO:0004674","GO:0006914; GO:0090398; GO:0045879; GO:0045880; GO:0046777"]
[2606,1301,"NK355-1","ULK3","Pan-specific","Unc-51-like protein-serine/threonine kinase 3",0,789,14,374,{"v":289.85,"d":"290"},{"v":509.3090286554839,"d":"509"},{"$nulls":3},0,73,14,650,{"v":38.35,"d":"38"},{"v":67.00570075824216,"d":"67"},{"$nulls":6},0,637,14,344,{"v":214.312,"d":"214"},{"v":366.6538424276335,"d":"367"},{"$nulls":7},"ULK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","ULK",{"$nulls":6},"Epitope undefined.",{"$nulls":4},"Q6PHR2","Q6PHR2","Q6PHR2"]
[2607,1302,"PK892","VACAMKL","Y245","CaM kinase-like vesicle-associated protein",0,7258,14,669,{"v":4846.236,"d":"4846"},{"v":8515.54855889335,"d":"8516"},{"v":8257.02304994726,"d":"8257"},{"v":258.52550894608976,"d":"259"},{"v":3.1309771982257093,"d":"3"},0,9306,14,668,{"v":6207.056,"d":"6207"},{"v":10845.062240564575,"d":"10845"},{"v":10178.326688970197,"d":"10178"},{"v":666.7355515943782,"d":"667"},{"v":6.550541871650574,"d":"7"},{"v":9.681519069876284,"d":"10"},{"v":23.268720789573294,"d":"23"},null,0,5839,12,691,{"v":4026.457,"d":"4026"},{"v":6888.629336759685,"d":"6889"},{"v":7426.961836719361,"d":"7427"},{"v":538.3324999596753,"d":"538"},{"v":7.248354196437713,"d":"7"},{"v":10.379331394663422,"d":"10"},{"v":-10.052790312038681,"d":"-10"},null,null,"VACAMKL","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine",null,"CAMK","CAMK-Unique",{"$nulls":6},"CAGD(pY)EFD","Corresponds to amino acid residues A242 to D248. Y245 is located in the Gap/Insert 10 (G/I10) region in the protein-serine/threonine kinase catalytic domain of VACAMKL.","The effect of Y245 phosphorylation is unknown. Y245 phosphorylation has been observed in only a small number of mass spectrometry studies (~6 reports). The effect of its phosphorylation is unknown. However, it has homology with the Y25 phosphosite in CaMK1a. VACAMKL has been suggested to not have detectable phosphotransferase activity. This is one of the major sites of in vivo phosphorylation of VACAMKL.",null,"Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; CAMK-Unique family","Q8NCB2","Q8NCB2","Q8NCB2",null,"GO:0030659; GO:0098978; GO:0005622; GO:0005886","GO:0005524; GO:0005516; GO:0004683","GO:0035556; GO:0018105; GO:0018107; GO:0099159"]
[2608,1302,"PK892","VACAMKL","Y245","CaM kinase-like vesicle-associated protein",0,6814,20,670,{"v":4551.98,"d":"4552"},{"v":7998.497541001171,"d":"7998"},{"$nulls":3},0,8430,16,647,{"v":5443.858,"d":"5444"},{"v":9511.591137375819,"d":"9512"},{"$nulls":6},0,6744,16,692,{"v":4655.776,"d":"4656"},{"v":7965.294336679036,"d":"7965"},{"$nulls":7},"VACAMKL","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine",null,"CAMK","CAMK-Unique",{"$nulls":6},"CAGD(pY)EFD","Corresponds to amino acid residues A242 to D248. Y245 is located in the Gap/Insert 10 (G/I10) region in the protein-serine/threonine kinase catalytic domain of VACAMKL.","The effect of Y245 phosphorylation is unknown. Y245 phosphorylation has been observed in only a small number of mass spectrometry studies (~6 reports). The effect of its phosphorylation is unknown. However, it has homology with the Y25 phosphosite in CaMK1a. VACAMKL has been suggested to not have detectable phosphotransferase activity. This is one of the major sites of in vivo phosphorylation of VACAMKL.",null,null,"Q8NCB2","Q8NCB2","Q8NCB2"]
[2609,1303,"PN276","VASP","S157","Vasodilator-stimulated phosphoprotein",0,262,12,641,{"v":160.25,"d":"160"},{"v":281.58279055387715,"d":"282"},{"v":315.40259691762424,"d":"315"},{"v":33.81980636374709,"d":"34"},{"v":10.72274188426547,"d":"11"},0,290,12,600,{"v":166.8,"d":"167"},{"v":291.4354859576217,"d":"291"},{"v":295.32478686734396,"d":"295"},{"v":3.8893009097222375,"d":"4"},{"v":1.316957154520613,"d":"1"},{"v":12.039699038786084,"d":"12"},{"v":-6.365771951942463,"d":"-6"},null,0,274,14,698,{"v":181.48,"d":"181"},{"v":310.48349753521467,"d":"310"},{"v":365.5879882345299,"d":"366"},{"v":55.10449069931525,"d":"55"},{"v":15.072839500395437,"d":"15"},{"v":25.795581384660906,"d":"26"},{"v":15.911533959250463,"d":"16"},{"$nulls":15},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S157 phosphosite.","S157 phosphorylation induces activity and association with VASP and vinculin, and inhibits interactions with CRKL and SPTAN1. This is one of the major sites of in vivo phosphorylation of VASP (≥3 reports from high throughput mass spectrometry studies).","PKACa (PRKACA); PKG1","Cytoskeletal protein","P50552","P50552",null,null,"GO:0015629; GO:0005923; GO:0005829; GO:0070062; GO:0031527; GO:0005925; GO:0031258; GO:0005886","GO:0003779; GO:0045296; GO:0005522; GO:0017124","GO:0008154; GO:0007411; GO:0034329; GO:0001843; GO:0030838; GO:0051289"]
[2610,1303,"PN276","VASP","S157","Vasodilator-stimulated phosphoprotein",0,336,24,637,{"v":198.744,"d":"199"},{"v":349.2224032813714,"d":"349"},{"$nulls":3},0,296,12,603,{"v":171.252,"d":"171"},{"v":299.21408777706614,"d":"299"},{"$nulls":6},0,358,16,719,{"v":245.898,"d":"246"},{"v":420.6924789338451,"d":"421"},{"$nulls":20},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S157 phosphosite.","S157 phosphorylation induces activity and association with VASP and vinculin, and inhibits interactions with CRKL and SPTAN1. This is one of the major sites of in vivo phosphorylation of VASP (≥3 reports from high throughput mass spectrometry studies).","PKACa (PRKACA); PKG1",null,"P50552","P50552"]
[2611,1304,"PN277","Vav","Y174","Vav 1 guanine nucleotide exchange factor",0,2228,12,705,{"v":1562.28,"d":"1562"},{"v":2745.1554572637206,"d":"2745"},{"v":2822.554263867884,"d":"2823"},{"v":77.39880660416338,"d":"77"},{"v":2.7421547778535893,"d":"3"},0,2276,16,687,{"v":1552.62,"d":"1553"},{"v":2712.761176304092,"d":"2713"},{"v":2627.2227645173575,"d":"2627"},{"v":85.53841178673429,"d":"86"},{"v":3.2558492162140045,"d":"3"},{"v":5.998003994067593,"d":"6"},{"v":-6.9203806584343255,"d":"-7"},null,0,2322,10,750,1734,{"v":2966.598990114956,"d":"2967"},{"v":3155.5212181322163,"d":"3156"},{"v":188.9222280172603,"d":"189"},{"v":5.987037163042282,"d":"6"},{"v":8.729191940895872,"d":"9"},{"v":11.796653780113743,"d":"12"},{"$nulls":15},"Epitope undefined.","Antibody raised against amino acid residues that encompass the Y174 phosphosite.","The effect of Y174 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of Vav.",null,"Guanine nucleotide exchange factor for G protein","P15498","P15498",null,"P15498","GO:0005911; GO:0005829; GO:0005886","GO:0003700; GO:0005085; GO:0046872; GO:0046934; GO:0001784; GO:0030676; GO:0005089","GO:0019221; GO:0038095; GO:0038096; GO:0007186; GO:0006955; GO:0007229; GO:0030593; GO:0030168; GO:0043065; GO:0043547; GO:0045954; GO:0051897; GO:0072593; GO:0008361; GO:0043087; GO:0035023; GO:0051056; GO:0007264; GO:0031295; GO:0030217; GO:0048010"]
[2612,1304,"PN277","Vav","Y174","Vav 1 guanine nucleotide exchange factor",0,2279,12,728,{"v":1650.376,"d":"1650"},{"v":2899.9530704720473,"d":"2900"},{"$nulls":3},0,2146,13,682,{"v":1454.706,"d":"1455"},{"v":2541.6843527306232,"d":"2542"},{"$nulls":6},0,2621,18,751,{"v":1954.853,"d":"1955"},{"v":3344.4434461494766,"d":"3344"},{"$nulls":20},"Epitope undefined.","Antibody raised against amino acid residues that encompass the Y174 phosphosite.","The effect of Y174 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of Vav.",null,null,"P15498","P15498",null,"P15498"]
[2613,1305,"PN543","Vav","Y826","Vav 1 guanine nucleotide exchange factor",0,2437,16,551,{"v":1333.971,"d":"1334"},{"v":2343.98300591542,"d":"2344"},{"v":2434.466406902482,"d":"2434"},{"v":90.48340098706194,"d":"90"},{"v":3.7167652316135023,"d":"4"},0,2477,16,560,{"v":1378.16,"d":"1378"},{"v":2407.9420223462585,"d":"2408"},{"v":2330.0232158008985,"d":"2330"},{"v":77.91880654535998,"d":"78"},{"v":3.3441214669861976,"d":"3"},{"v":7.0608866985997,"d":"7"},{"v":-4.290188223811768,"d":"-4"},null,0,2468,16,606,{"v":1485.912,"d":"1486"},{"v":2542.1597685119345,"d":"2542"},{"v":2659.3147660004533,"d":"2659"},{"v":117.1549974885188,"d":"117"},{"v":4.405458089668609,"d":"4"},{"v":8.12222332128211,"d":"8"},{"v":9.236042791983294,"d":"9"},{"$nulls":15},"GEI(pY)GRV(bA)C","Corresponds to amino acid residues G823 to V829; In the SH3_1 domain.","Y826 phosphorylation regulates carcinogenesis, cell growth, activation and molecular associations, including inducing interaction with Abl, CSK, SH2D1A, and Shc1. This is one of the major sites of in vivo phosphorylation of Vav.",null,"Guanine nucleotide exchange factor for G protein","P15498","P15498",null,"P15498","GO:0005911; GO:0005829; GO:0005886","GO:0003700; GO:0005085; GO:0046872; GO:0046934; GO:0001784; GO:0030676; GO:0005089","GO:0019221; GO:0038095; GO:0038096; GO:0007186; GO:0006955; GO:0007229; GO:0030593; GO:0030168; GO:0043065; GO:0043547; GO:0045954; GO:0051897; GO:0072593; GO:0008361; GO:0043087; GO:0035023; GO:0051056; GO:0007264; GO:0031295; GO:0030217; GO:0048010"]
[2614,1305,"PN543","Vav","Y826","Vav 1 guanine nucleotide exchange factor",0,2578,12,560,{"v":1436.96,"d":"1437"},{"v":2524.9498078895435,"d":"2525"},{"$nulls":3},0,2514,16,516,{"v":1288.968,"d":"1289"},{"v":2252.104409255538,"d":"2252"},{"$nulls":6},0,2698,20,606,{"v":1622.868,"d":"1623"},{"v":2776.4697634889726,"d":"2776"},{"$nulls":20},"GEI(pY)GRV(bA)C","Corresponds to amino acid residues G823 to V829; In the SH3_1 domain.","Y826 phosphorylation regulates carcinogenesis, cell growth, activation and molecular associations, including inducing interaction with Abl, CSK, SH2D1A, and Shc1. This is one of the major sites of in vivo phosphorylation of Vav.",null,null,"P15498","P15498",null,"P15498"]
[2615,1306,"NK226-2","VEGFR1 (Flt1)","Pan-specific","Vascular endothelial growth factor receptor 1",0,12093,18,760,9177,{"v":16125.337091500349,"d":"16125"},{"v":15865.718637183123,"d":"15866"},{"v":259.61845431722577,"d":"260"},{"v":1.6363485339313928,"d":"2"},0,13468,16,806,{"v":10842.312,"d":"10842"},{"v":18943.85171837022,"d":"18944"},{"v":17512.833593712552,"d":"17513"},{"v":1431.0181246576685,"d":"1431"},{"v":8.171254052065176,"d":"8"},{"v":9.80760258599657,"d":"10"},{"v":10.381596914678838,"d":"10"},null,0,11246,16,819,{"v":9197.37,"d":"9197"},{"v":15735.241380457668,"d":"15735"},{"v":15696.88260539575,"d":"15697"},{"v":38.358775061919005,"d":"38"},{"v":0.24437193056876977,"d":"0"},{"v":1.8807204645001625,"d":"2"},{"v":-1.0641562203913537,"d":"-1"},null,null,"FLT1","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"PEIIHMTEGRELVIPC","Corresponds to amino acid residues P143 to C158; Just before and part of the second Ig-like C2-type domain.",null,null,"Receptor tyrosine kinase; EC 2.7.10.1; EC 2.7.1.112; TK group; VEGFR family","P17948","P17948","P17948","P17948","GO:0015629; GO:0005768; GO:0005615; GO:0005925; GO:0005887; GO:0005886; GO:0043235","GO:0005524; GO:0019838; GO:0036332; GO:0004714; GO:0005021; GO:0036326; GO:0036327","GO:0001525; GO:0048514; GO:0030154; GO:0016477; GO:0035924; GO:0048598; GO:0002548; GO:1905563; GO:0018108; GO:0045766; GO:0030335; GO:0008284; GO:0043410; GO:0043406; GO:0043552; GO:0014068; GO:0010863; GO:0030949; GO:0046777; GO:0007169; GO:0036323; GO:0048010"]
[2616,1306,"NK226-2","VEGFR1 (Flt1)","Pan-specific","Vascular endothelial growth factor receptor 1",0,11642,17,764,{"v":8881.5,"d":"8882"},{"v":15606.100182865897,"d":"15606"},{"$nulls":3},0,12272,16,751,{"v":9204.256,"d":"9204"},{"v":16081.815469054885,"d":"16082"},{"$nulls":6},0,11724,20,782,{"v":9152.528,"d":"9153"},{"v":15658.523830333828,"d":"15659"},{"$nulls":7},"FLT1","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"PEIIHMTEGRELVIPC","Corresponds to amino acid residues P143 to C158; Just before and part of the second Ig-like C2-type domain.",{"$nulls":3},"P17948","P17948","P17948","P17948"]
[2617,1307,"PK850","VEGFR1 (Flt1)","Y1048","Vascular endothelial growth factor receptor 1",0,6918,16,684,{"v":4720.968,"d":"4721"},{"v":8295.434281157917,"d":"8295"},{"v":8740.303461588863,"d":"8740"},{"v":444.86918043094556,"d":"445"},{"v":5.0898596643242255,"d":"5"},0,7488,18,668,{"v":4989.96,"d":"4990"},{"v":8718.533678112073,"d":"8719"},{"v":8609.453289480058,"d":"8609"},{"v":109.08038863201546,"d":"109"},{"v":1.2669839183087437,"d":"1"},{"v":6.356843582632969,"d":"6"},{"v":-1.497089576853412,"d":"-1"},null,0,6980,20,733,{"v":5101.68,"d":"5102"},{"v":8728.165360951367,"d":"8728"},{"v":8598.380932237342,"d":"8598"},{"v":129.78442871402513,"d":"130"},{"v":1.5094054303576263,"d":"2"},{"v":6.599265094681852,"d":"7"},{"v":-1.6237711879825412,"d":"-2"},null,null,"FLT1","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"RDI(pY)KNP(bA)C","Corresponds to amino acid residues R1045 to P1051; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y1048 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of VEGFR1.",null,"Receptor tyrosine kinase; EC 2.7.10.1; EC 2.7.1.112; TK group; VEGFR family","P17948","P17948","P17948","P17948","GO:0015629; GO:0005768; GO:0005615; GO:0005925; GO:0005887; GO:0005886; GO:0043235","GO:0005524; GO:0019838; GO:0036332; GO:0004714; GO:0005021; GO:0036326; GO:0036327","GO:0001525; GO:0048514; GO:0030154; GO:0016477; GO:0035924; GO:0048598; GO:0002548; GO:1905563; GO:0018108; GO:0045766; GO:0030335; GO:0008284; GO:0043410; GO:0043406; GO:0043552; GO:0014068; GO:0010863; GO:0030949; GO:0046777; GO:0007169; GO:0036323; GO:0048010"]
[2618,1307,"PK850","VEGFR1 (Flt1)","Y1048","Vascular endothelial growth factor receptor 1",0,7507,18,698,{"v":5227.322,"d":"5227"},{"v":9185.172642019808,"d":"9185"},{"$nulls":3},0,7314,20,667,{"v":4865.098,"d":"4865"},{"v":8500.372900848042,"d":"8500"},{"$nulls":6},0,7412,24,670,{"v":4949.96,"d":"4950"},{"v":8468.596503523315,"d":"8469"},{"$nulls":7},"FLT1","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"RDI(pY)KNP(bA)C","Corresponds to amino acid residues R1045 to P1051; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y1048 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of VEGFR1.",null,null,"P17948","P17948","P17948","P17948"]
[2619,1308,"PK851","VEGFR1 (Flt1)","Y1053","Vascular endothelial growth factor receptor 1",0,3942,16,697,{"v":2736.422,"d":"2736"},{"v":4808.2954314697145,"d":"4808"},{"v":5024.288321153701,"d":"5024"},{"v":215.9928896839865,"d":"216"},{"v":4.298974817480004,"d":"4"},0,4643,14,691,{"v":3198.639,"d":"3199"},{"v":5588.71049980816,"d":"5589"},{"v":5336.385551233143,"d":"5336"},{"v":252.32494857501752,"d":"252"},{"v":4.728386773266593,"d":"5"},{"v":9.027361590746597,"d":"9"},{"v":6.211769909091842,"d":"6"},null,0,4134,18,761,{"v":3132.276,"d":"3132"},{"v":5358.827461569385,"d":"5359"},{"v":5257.822806910557,"d":"5258"},{"v":101.00465465882826,"d":"101"},{"v":1.9210357284401822,"d":"2"},{"v":6.220010545920186,"d":"6"},{"v":4.6481107537879325,"d":"5"},null,null,"FLT1","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"NPD(pY)VRK(bA)C","Corresponds to amino acid residues N1050 to K1056; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y1053 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of VEGFR1.","Flt1 (VEGFR1)","Receptor tyrosine kinase; EC 2.7.10.1; EC 2.7.1.112; TK group; VEGFR family","P17948","P17948","P17948","P17948","GO:0015629; GO:0005768; GO:0005615; GO:0005925; GO:0005887; GO:0005886; GO:0043235","GO:0005524; GO:0019838; GO:0036332; GO:0004714; GO:0005021; GO:0036326; GO:0036327","GO:0001525; GO:0048514; GO:0030154; GO:0016477; GO:0035924; GO:0048598; GO:0002548; GO:1905563; GO:0018108; GO:0045766; GO:0030335; GO:0008284; GO:0043410; GO:0043406; GO:0043552; GO:0014068; GO:0010863; GO:0030949; GO:0046777; GO:0007169; GO:0036323; GO:0048010"]
[2620,1308,"PK851","VEGFR1 (Flt1)","Y1053","Vascular endothelial growth factor receptor 1",0,4357,16,687,{"v":2982.267,"d":"2982"},{"v":5240.281210837688,"d":"5240"},{"$nulls":3},0,4372,16,668,{"v":2909.808,"d":"2910"},{"v":5084.0606026581245,"d":"5084"},{"$nulls":6},0,4324,18,700,{"v":3014.2,"d":"3014"},{"v":5156.81815225173,"d":"5157"},{"$nulls":7},"FLT1","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"NPD(pY)VRK(bA)C","Corresponds to amino acid residues N1050 to K1056; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y1053 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of VEGFR1.","Flt1 (VEGFR1)",null,"P17948","P17948","P17948","P17948"]
[2621,1309,"NK245-2","VEGFR2 (KDR)","Pan-specific","Vascular endothelial growth factor receptor 2 ; Vascular endothelial growth factor receptor-tyrosine kinase 2 (Flk1)",0,4790,12,710,{"v":3392.38,"d":"3392"},{"v":5960.90999699945,"d":"5961"},{"v":6394.519380102038,"d":"6395"},{"v":433.60938310258734,"d":"434"},{"v":6.7809534591741,"d":"7"},0,5222,14,680,{"v":3541.44,"d":"3541"},{"v":6187.657598259951,"d":"6188"},{"v":6113.995007804475,"d":"6114"},{"v":73.66259045547577,"d":"74"},{"v":1.2048192771084365,"d":"1"},{"v":7.985772736282536,"d":"8"},{"v":-4.38695006806104,"d":"-4"},null,0,4968,18,733,{"v":3628.35,"d":"3628"},{"v":6207.53139895248,"d":"6208"},{"v":6461.514359204796,"d":"6462"},{"v":253.98296025231593,"d":"254"},{"v":3.9307033325787275,"d":"4"},{"v":10.711656791752826,"d":"11"},{"v":1.047693737722156,"d":"1"},null,null,"KDR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"CLMTKKNSTFVRVHEK","Corresponds to amino acid residues L313 to K327; In the extracellular domain of the receptor.",null,null,"EC 2.7.10.1; Receptor tyrosine kinase; TK group; VEGFR family","P35968","P35968","P35968","P35968","GO:0030054; GO:0005769; GO:0005783; GO:0005768; GO:0005576; GO:0005794; GO:0005887; GO:0045121; GO:0005634; GO:0005886; GO:0097443","GO:0005524; GO:0019838; GO:0051879; GO:0042802; GO:0005178; GO:0004713; GO:0004714; GO:0005021; GO:0038085","GO:0001525; GO:0035584; GO:0002042; GO:1904881; GO:0035924; GO:0035162; GO:0003158; GO:0070371; GO:0030198; GO:0043066; GO:2000352; GO:0010629; GO:0038083; GO:0018108; GO:0045766; GO:0043536; GO:0030335; GO:0090050; GO:0008284; GO:0038033; GO:0010595; GO:0001938; GO:0070374; GO:0051894; GO:0016239; GO:0043410; GO:0051901; GO:0090141; GO:0051770; GO:0014068; GO:0050927; GO:0001934; GO:2001214; GO:0046777; GO:0043491; GO:0008360; GO:0007169; GO:0048010; GO:0001570; GO:0016032"]
[2622,1309,"NK245-2","VEGFR2 (KDR)","Pan-specific","Vascular endothelial growth factor receptor 2 ; Vascular endothelial growth factor receptor-tyrosine kinase 2 (Flk1)",0,5087,14,766,{"v":3885.918,"d":"3886"},{"v":6828.128763204626,"d":"6828"},{"$nulls":3},0,5102,18,680,{"v":3457.12,"d":"3457"},{"v":6040.332417348999,"d":"6040"},{"$nulls":6},0,4870,24,810,{"v":3925.26,"d":"3925"},{"v":6715.497319457112,"d":"6715"},{"$nulls":7},"KDR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"CLMTKKNSTFVRVHEK","Corresponds to amino acid residues L313 to K327; In the extracellular domain of the receptor.",{"$nulls":3},"P35968","P35968","P35968","P35968"]
[2623,1310,"NK245-3","VEGFR2 (KDR)","Pan-specific","Vascular endothelial growth factor receptor 2 ; Vascular endothelial growth factor receptor-tyrosine kinase 2 (Flk1)",0,6508,12,723,{"v":4696.608,"d":"4697"},{"v":8252.630182699932,"d":"8253"},{"v":8430.140676723855,"d":"8430"},{"v":177.51049402392346,"d":"178"},{"v":2.1056646719317627,"d":"2"},0,6598,14,745,{"v":4905.08,"d":"4905"},{"v":8570.23005672069,"d":"8570"},{"v":8390.371729835333,"d":"8390"},{"v":179.8583268853563,"d":"180"},{"v":2.143627632680419,"d":"2"},{"v":4.249292304612181,"d":"4"},{"v":-0.47174713226704057,"d":"-0"},null,0,6578,16,764,{"v":5013.368,"d":"5013"},{"v":8577.07753510648,"d":"8577"},{"v":8202.17059375825,"d":"8202"},{"v":374.90694134823025,"d":"375"},{"v":4.5708259425075815,"d":"5"},{"v":6.676490614439344,"d":"7"},{"v":-2.704226319675115,"d":"-3"},null,null,"KDR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"CILQPDSGTTLSSPPV","Corresponds to amino acid residues I1342 to V1356; C-terminus.",null,null,"EC 2.7.10.1; Receptor tyrosine kinase; TK group; VEGFR family","P35968","P35968","P35968","P35968","GO:0030054; GO:0005769; GO:0005783; GO:0005768; GO:0005576; GO:0005794; GO:0005887; GO:0045121; GO:0005634; GO:0005886; GO:0097443","GO:0005524; GO:0019838; GO:0051879; GO:0042802; GO:0005178; GO:0004713; GO:0004714; GO:0005021; GO:0038085","GO:0001525; GO:0035584; GO:0002042; GO:1904881; GO:0035924; GO:0035162; GO:0003158; GO:0070371; GO:0030198; GO:0043066; GO:2000352; GO:0010629; GO:0038083; GO:0018108; GO:0045766; GO:0043536; GO:0030335; GO:0090050; GO:0008284; GO:0038033; GO:0010595; GO:0001938; GO:0070374; GO:0051894; GO:0016239; GO:0043410; GO:0051901; GO:0090141; GO:0051770; GO:0014068; GO:0050927; GO:0001934; GO:2001214; GO:0046777; GO:0043491; GO:0008360; GO:0007169; GO:0048010; GO:0001570; GO:0016032"]
[2624,1310,"NK245-3","VEGFR2 (KDR)","Pan-specific","Vascular endothelial growth factor receptor 2 ; Vascular endothelial growth factor receptor-tyrosine kinase 2 (Flk1)",0,6563,14,748,{"v":4898.652,"d":"4899"},{"v":8607.651170747778,"d":"8608"},{"$nulls":3},0,6618,18,712,{"v":4699.2,"d":"4699"},{"v":8210.513402949975,"d":"8211"},{"$nulls":6},0,6392,20,718,{"v":4575.096,"d":"4575"},{"v":7827.263652410019,"d":"7827"},{"$nulls":7},"KDR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"CILQPDSGTTLSSPPV","Corresponds to amino acid residues I1342 to V1356; C-terminus.",{"$nulls":3},"P35968","P35968","P35968","P35968"]
[2625,1311,"PK852","VEGFR2 (KDR)","Y1054","Vascular endothelial growth factor receptor 2 ; Vascular endothelial growth factor receptor-tyrosine kinase 2 (Flk1)",0,7638,14,655,{"v":4993.72,"d":"4994"},{"v":8774.69961213546,"d":"8775"},{"v":8880.641512965878,"d":"8881"},{"v":105.94190083041758,"d":"106"},{"v":1.1929532418997064,"d":"1"},0,8166,12,642,{"v":5234.868,"d":"5235"},{"v":9146.440644508413,"d":"9146"},{"v":9033.095303710794,"d":"9033"},{"v":113.34534079761943,"d":"113"},{"v":1.2547785336777881,"d":"1"},{"v":2.4477317755774948,"d":"2"},{"v":1.7166979493804746,"d":"2"},null,0,7531,16,674,{"v":5065.11,"d":"5065"},{"v":8665.599890900325,"d":"8666"},{"v":9428.621469215981,"d":"9429"},{"v":763.0215783156564,"d":"763"},{"v":8.092610153105488,"d":"8"},{"v":9.285563395005195,"d":"9"},{"v":6.17049968124536,"d":"6"},null,null,"KDR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"RDI(pY)KDP(bA)C","Corresponds to amino acid residues R1051 to P1057; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y1054 phosphorylation stimulates phosphotransferase activity and induces interaction with Cbl and PLCG1. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of VEGFR2.","KDR (VEGFR2)","EC 2.7.10.1; Receptor tyrosine kinase; TK group; VEGFR family","P35968","P35968","P35968","P35968","GO:0030054; GO:0005769; GO:0005783; GO:0005768; GO:0005576; GO:0005794; GO:0005887; GO:0045121; GO:0005634; GO:0005886; GO:0097443","GO:0005524; GO:0019838; GO:0051879; GO:0042802; GO:0005178; GO:0004713; GO:0004714; GO:0005021; GO:0038085","GO:0001525; GO:0035584; GO:0002042; GO:1904881; GO:0035924; GO:0035162; GO:0003158; GO:0070371; GO:0030198; GO:0043066; GO:2000352; GO:0010629; GO:0038083; GO:0018108; GO:0045766; GO:0043536; GO:0030335; GO:0090050; GO:0008284; GO:0038033; GO:0010595; GO:0001938; GO:0070374; GO:0051894; GO:0016239; GO:0043410; GO:0051901; GO:0090141; GO:0051770; GO:0014068; GO:0050927; GO:0001934; GO:2001214; GO:0046777; GO:0043491; GO:0008360; GO:0007169; GO:0048010; GO:0001570; GO:0016032"]
[2626,1311,"PK852","VEGFR2 (KDR)","Y1054","Vascular endothelial growth factor receptor 2 ; Vascular endothelial growth factor receptor-tyrosine kinase 2 (Flk1)",0,7506,18,683,{"v":5114.304,"d":"5114"},{"v":8986.583413796296,"d":"8987"},{"$nulls":3},0,7820,14,654,{"v":5105.124,"d":"5105"},{"v":8919.749962913174,"d":"8920"},{"$nulls":6},0,7595,16,786,{"v":5957.094,"d":"5957"},{"v":10191.64304753164,"d":"10192"},{"$nulls":7},"KDR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"RDI(pY)KDP(bA)C","Corresponds to amino acid residues R1051 to P1057; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y1054 phosphorylation stimulates phosphotransferase activity and induces interaction with Cbl and PLCG1. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of VEGFR2.","KDR (VEGFR2)",null,"P35968","P35968","P35968","P35968"]
[2627,1312,"PK161","VEGFR2 (KDR)","Y1059","Vascular endothelial growth factor receptor 3 ; Vascular endothelial growth factor receptor-protein-tyrosine kinase 3",0,2112,10,324,{"v":681.048,"d":"681"},{"v":1196.7013812239434,"d":"1197"},{"v":1317.5807878421829,"d":"1318"},{"v":120.8794066182395,"d":"121"},{"v":9.174344961131764,"d":"9"},0,2686,10,294,{"v":786.744,"d":"787"},{"v":1374.6110309606902,"d":"1375"},{"v":1405.786590768495,"d":"1406"},{"v":31.175559807804802,"d":"31"},{"v":2.2176594948712807,"d":"2"},{"v":11.392004456003045,"d":"11"},{"v":6.694527101504548,"d":"7"},null,0,2198,10,344,{"v":752.672,"d":"753"},{"v":1287.7024193124591,"d":"1288"},{"v":1402.9010696584196,"d":"1403"},{"v":115.19865034596046,"d":"115"},{"v":8.21145929940799,"d":"8"},{"v":17.385804260539754,"d":"17"},{"v":6.475525645449551,"d":"6"},null,null,"KDR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"PD(pY)VR","Corresponds to amino acid residues P1057 to R1061.","Y1059 phosphorylation stimulates phosphotransferase activity and induces interaction with Cbl, PLCG1 and Src. This is one of the major sites of in vivo phosphorylation of VEGFR2.","KDR (VEGFR2)","EC 2.7.10.1; Receptor tyrosine kinase; TK group; VEGFR family","P35968","P35968","P35968","P35968","GO:0030054; GO:0005769; GO:0005783; GO:0005768; GO:0005576; GO:0005794; GO:0005887; GO:0045121; GO:0005634; GO:0005886; GO:0097443","GO:0005524; GO:0019838; GO:0051879; GO:0042802; GO:0005178; GO:0004713; GO:0004714; GO:0005021; GO:0038085","GO:0001525; GO:0035584; GO:0002042; GO:1904881; GO:0035924; GO:0035162; GO:0003158; GO:0070371; GO:0030198; GO:0043066; GO:2000352; GO:0010629; GO:0038083; GO:0018108; GO:0045766; GO:0043536; GO:0030335; GO:0090050; GO:0008284; GO:0038033; GO:0010595; GO:0001938; GO:0070374; GO:0051894; GO:0016239; GO:0043410; GO:0051901; GO:0090141; GO:0051770; GO:0014068; GO:0050927; GO:0001934; GO:2001214; GO:0046777; GO:0043491; GO:0008360; GO:0007169; GO:0048010; GO:0001570; GO:0016032"]
[2628,1312,"PK161","VEGFR2 (KDR)","Y1059","Vascular endothelial growth factor receptor 3 ; Vascular endothelial growth factor receptor-protein-tyrosine kinase 3",0,2463,12,334,{"v":818.634,"d":"819"},{"v":1438.4601944604224,"d":"1438"},{"$nulls":3},0,2665,12,310,{"v":822.43,"d":"822"},{"v":1436.9621505762996,"d":"1437"},{"$nulls":6},0,2597,10,343,{"v":887.341,"d":"887"},{"v":1518.09972000438,"d":"1518"},{"$nulls":7},"KDR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"PD(pY)VR","Corresponds to amino acid residues P1057 to R1061.","Y1059 phosphorylation stimulates phosphotransferase activity and induces interaction with Cbl, PLCG1 and Src. This is one of the major sites of in vivo phosphorylation of VEGFR2.","KDR (VEGFR2)",null,"P35968","P35968","P35968","P35968"]
[2629,1313,"PK133","VEGFR2 (KDR)","Y1214","Vascular endothelial growth factor receptor 3 ; Vascular endothelial growth factor receptor-protein-tyrosine kinase 3",0,1128,10,251,{"v":280.618,"d":"281"},{"v":493.08704848454227,"d":"493"},{"v":504.39428877917067,"d":"504"},{"v":11.3072402946284,"d":"11"},{"v":2.2417462977220257,"d":"2"},0,1034,8,239,{"v":245.214,"d":"245"},{"v":428.44161423028925,"d":"428"},{"v":452.54095270638925,"d":"453"},{"v":24.0993384761,"d":"24"},{"v":5.325338697409728,"d":"5"},{"v":7.567084995131753,"d":"8"},{"v":-10.280317843861113,"d":"-10"},null,0,887,10,245,{"v":214.865,"d":"215"},{"v":367.59993772263556,"d":"368"},{"v":434.21582479160963,"d":"434"},{"v":66.61588706897408,"d":"67"},{"v":15.341653451010128,"d":"15"},{"v":17.583399748732155,"d":"18"},{"v":-13.913413682264348,"d":"-14"},null,null,"KDR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"FH(pY)DN","Corresponds to amino acid residues F1212 to N1216; Surrounds the Y1214 phosphosite.","Y1214 phosphorylation stimulates phosphotransferase activity and induces interaction with NCK1 and Fyn. This is one of the major sites of in vivo phosphorylation of VEGFR2.","KDR (VEGFR2)","EC 2.7.10.1; Receptor tyrosine kinase; TK group; VEGFR family","P35968","P35968","P35968","P35968","GO:0030054; GO:0005769; GO:0005783; GO:0005768; GO:0005576; GO:0005794; GO:0005887; GO:0045121; GO:0005634; GO:0005886; GO:0097443","GO:0005524; GO:0019838; GO:0051879; GO:0042802; GO:0005178; GO:0004713; GO:0004714; GO:0005021; GO:0038085","GO:0001525; GO:0035584; GO:0002042; GO:1904881; GO:0035924; GO:0035162; GO:0003158; GO:0070371; GO:0030198; GO:0043066; GO:2000352; GO:0010629; GO:0038083; GO:0018108; GO:0045766; GO:0043536; GO:0030335; GO:0090050; GO:0008284; GO:0038033; GO:0010595; GO:0001938; GO:0070374; GO:0051894; GO:0016239; GO:0043410; GO:0051901; GO:0090141; GO:0051770; GO:0014068; GO:0050927; GO:0001934; GO:2001214; GO:0046777; GO:0043491; GO:0008360; GO:0007169; GO:0048010; GO:0001570; GO:0016032"]
[2630,1313,"PK133","VEGFR2 (KDR)","Y1214","Vascular endothelial growth factor receptor 3 ; Vascular endothelial growth factor receptor-protein-tyrosine kinase 3",0,1089,10,272,{"v":293.488,"d":"293"},{"v":515.7015290737991,"d":"516"},{"$nulls":3},0,1110,10,248,{"v":272.8,"d":"273"},{"v":476.6402911824892,"d":"477"},{"$nulls":6},0,1158,10,255,{"v":292.74,"d":"293"},{"v":500.83171186058377,"d":"501"},{"$nulls":7},"KDR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"FH(pY)DN","Corresponds to amino acid residues F1212 to N1216; Surrounds the Y1214 phosphosite.","Y1214 phosphorylation stimulates phosphotransferase activity and induces interaction with NCK1 and Fyn. This is one of the major sites of in vivo phosphorylation of VEGFR2.","KDR (VEGFR2)",null,"P35968","P35968","P35968","P35968"]
[2631,1314,"NK064-2","VEGFR3 (Flt4)","Pan-specific","Vascular endothelial growth factor receptor 3 ; Vascular endothelial growth factor receptor-protein-tyrosine kinase 3",0,3088,16,754,{"v":2316.288,"d":"2316"},{"v":4070.058276233754,"d":"4070"},{"v":4047.7179105607306,"d":"4048"},{"v":22.34036567302337,"d":"22"},{"v":0.551924965293062,"d":"1"},0,3148,14,744,{"v":2331.696,"d":"2332"},{"v":4073.974561543421,"d":"4074"},{"v":4082.990191684556,"d":"4083"},{"v":9.015630141135262,"d":"9"},{"v":0.22080949788947699,"d":"0"},{"v":0.772734463182539,"d":"1"},{"v":0.8714115435711989,"d":"1"},null,0,3123,16,772,{"v":2398.604,"d":"2399"},{"v":4103.631028884483,"d":"4104"},{"v":4263.9197597863695,"d":"4264"},{"v":160.28873090188608,"d":"160"},{"v":3.759187318992064,"d":"4"},{"v":4.311112284285127,"d":"4"},{"v":5.34132698974787,"d":"5"},null,null,"FLT4","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"CNELYDIQLLPRKSLE","Corresponds to amino acid residues N227 to E241.",null,null,"EC 2.7.10.1; EC 2.7.1.112; Receptor tyrosine kinase; TK group; VEGFR family","P35916","P35916","P35916","P35916","GO:0005737; GO:0005576; GO:0005887; GO:0005654; GO:0005886; GO:0043235","GO:0005524; GO:0019838; GO:0042803; GO:0019903; GO:0004714; GO:0005021; GO:0036328","GO:0048514; GO:0035924; GO:0048286; GO:0001946; GO:0001945; GO:0043066; GO:0018108; GO:0008284; GO:0010595; GO:0001938; GO:0070374; GO:0046330; GO:0043410; GO:0090037; GO:0001934; GO:0010575; GO:0046777; GO:0060312; GO:0003016; GO:0002040; GO:0007169; GO:0048010; GO:0038084; GO:0001944"]
[2632,1314,"NK064-2","VEGFR3 (Flt4)","Pan-specific","Vascular endothelial growth factor receptor 3 ; Vascular endothelial growth factor receptor-protein-tyrosine kinase 3",0,3497,26,660,{"v":2290.86,"d":"2291"},{"v":4025.3775448877072,"d":"4025"},{"$nulls":3},0,3442,18,684,{"v":2342.016,"d":"2342"},{"v":4092.0058218256913,"d":"4092"},{"$nulls":6},0,3650,18,712,{"v":2585.984,"d":"2586"},{"v":4424.208490688255,"d":"4424"},{"$nulls":7},"FLT4","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"CNELYDIQLLPRKSLE","Corresponds to amino acid residues N227 to E241.",{"$nulls":3},"P35916","P35916","P35916","P35916"]
[2633,1315,"NK064-3","VEGFR3 (Flt4)","Pan-specific","Vascular endothelial growth factor receptor 3 ; Vascular endothelial growth factor receptor-protein-tyrosine kinase 3",0,10587,20,715,{"v":7555.405,"d":"7555"},{"v":13275.956465926467,"d":"13276"},{"v":13954.877613295175,"d":"13955"},{"v":678.9211473687083,"d":"679"},{"v":4.865117173954162,"d":"5"},0,10726,17,765,{"v":8192.385,"d":"8192"},{"v":14313.85913445402,"d":"14314"},{"v":13493.304003259815,"d":"13493"},{"v":820.5551311942054,"d":"821"},{"v":6.081202431931938,"d":"6"},{"v":10.9463196058861,"d":"11"},{"v":-3.3076148915531007,"d":"-3"},null,0,10786,18,788,{"v":8485.184,"d":"8485"},{"v":14516.804086124326,"d":"14517"},{"v":14340.392385855172,"d":"14340"},{"v":176.4117002691546,"d":"176"},{"v":1.2301734535741193,"d":"1"},{"v":6.095290627528281,"d":"6"},{"v":2.7625808211510616,"d":"3"},null,null,"FLT4","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"CIQRFRESTEVIVHEN","Corresponds to amino acid residues I316 to N330.",null,null,"EC 2.7.10.1; EC 2.7.1.112; Receptor tyrosine kinase; TK group; VEGFR family","P35916","P35916","P35916","P35916","GO:0005737; GO:0005576; GO:0005887; GO:0005654; GO:0005886; GO:0043235","GO:0005524; GO:0019838; GO:0042803; GO:0019903; GO:0004714; GO:0005021; GO:0036328","GO:0048514; GO:0035924; GO:0048286; GO:0001946; GO:0001945; GO:0043066; GO:0018108; GO:0008284; GO:0010595; GO:0001938; GO:0070374; GO:0046330; GO:0043410; GO:0090037; GO:0001934; GO:0010575; GO:0046777; GO:0060312; GO:0003016; GO:0002040; GO:0007169; GO:0048010; GO:0038084; GO:0001944"]
[2634,1315,"NK064-3","VEGFR3 (Flt4)","Pan-specific","Vascular endothelial growth factor receptor 3 ; Vascular endothelial growth factor receptor-protein-tyrosine kinase 3",0,10307,38,811,{"v":8328.159,"d":"8328"},{"v":14633.798760663882,"d":"14634"},{"$nulls":3},0,10279,20,707,{"v":7253.113,"d":"7253"},{"v":12672.748872065607,"d":"12673"},{"$nulls":6},0,10979,28,756,{"v":8278.956,"d":"8279"},{"v":14163.980685586019,"d":"14164"},{"$nulls":7},"FLT4","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"CIQRFRESTEVIVHEN","Corresponds to amino acid residues I316 to N330.",{"$nulls":3},"P35916","P35916","P35916","P35916"]
[2635,1316,"PK853","VEGFR3 (Flt4)","Y1068","Vascular endothelial growth factor receptor 3 ; Vascular endothelial growth factor receptor-protein-tyrosine kinase 3",0,8336,16,774,{"v":6439.68,"d":"6440"},{"v":11315.463742115393,"d":"11315"},{"v":11270.44563856475,"d":"11270"},{"v":45.01810355064299,"d":"45"},{"v":0.3994349912536012,"d":"0"},0,9000,18,783,{"v":7032.906,"d":"7033"},{"v":12287.999866932094,"d":"12288"},{"v":12032.363945659896,"d":"12032"},{"v":255.63592127219817,"d":"256"},{"v":2.124569389911171,"d":"2"},{"v":2.5240043811647723,"d":"3"},{"v":6.760321033695817,"d":"7"},null,0,8110,20,810,{"v":6552.9,"d":"6553"},{"v":11210.972619564183,"d":"11211"},{"v":11583.212359167552,"d":"11583"},{"v":372.23973960336843,"d":"372"},{"v":3.2136140481682416,"d":"3"},{"v":3.613049039421843,"d":"4"},{"v":2.7751051789167036,"d":"3"},null,null,"FLT4","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"DPD(pY)VRK(bA)C","Corresponds to amino acid residues D1065 to K1071; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y1068 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of VEGFR3.","VEGFR3 (FLT4)","EC 2.7.10.1; EC 2.7.1.112; Receptor tyrosine kinase; TK group; VEGFR family","P35916","P35916","P35916","P35916","GO:0005737; GO:0005576; GO:0005887; GO:0005654; GO:0005886; GO:0043235","GO:0005524; GO:0019838; GO:0042803; GO:0019903; GO:0004714; GO:0005021; GO:0036328","GO:0048514; GO:0035924; GO:0048286; GO:0001946; GO:0001945; GO:0043066; GO:0018108; GO:0008284; GO:0010595; GO:0001938; GO:0070374; GO:0046330; GO:0043410; GO:0090037; GO:0001934; GO:0010575; GO:0046777; GO:0060312; GO:0003016; GO:0002040; GO:0007169; GO:0048010; GO:0038084; GO:0001944"]
[2636,1316,"PK853","VEGFR3 (Flt4)","Y1068","Vascular endothelial growth factor receptor 3 ; Vascular endothelial growth factor receptor-protein-tyrosine kinase 3",0,8388,48,766,{"v":6388.44,"d":"6388"},{"v":11225.427535014109,"d":"11225"},{"$nulls":3},0,8783,18,769,{"v":6740.285,"d":"6740"},{"v":11776.728024387698,"d":"11777"},{"$nulls":6},0,8764,18,799,{"v":6988.054,"d":"6988"},{"v":11955.452098770922,"d":"11955"},{"$nulls":7},"FLT4","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"DPD(pY)VRK(bA)C","Corresponds to amino acid residues D1065 to K1071; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y1068 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of VEGFR3.","VEGFR3 (FLT4)",null,"P35916","P35916","P35916","P35916"]
[2637,1317,"NN185-2","VIM","Pan-specific","Vimentin",0,121,12,571,{"v":62.239,"d":"62"},{"v":109.36306584263814,"d":"109"},{"v":109.08280091225845,"d":"109"},{"v":0.2802649303796869,"d":"0"},{"v":0.25692861572661674,"d":"0"},0,142,12,588,{"v":76.44,"d":"76"},{"v":133.5571255791403,"d":"134"},{"v":123.90550912572361,"d":"124"},{"v":9.651616453416679,"d":"10"},{"v":7.789497433583394,"d":"8"},{"v":8.04642604931001,"d":"8"},{"v":13.588492493319748,"d":"14"},null,0,135,8,569,{"v":72.263,"d":"72"},{"v":123.6305321930087,"d":"124"},{"v":148.99118970740838,"d":"149"},{"v":25.360657514399676,"d":"25"},{"v":17.021581990319966,"d":"17"},{"v":17.278510606046584,"d":"17"},{"v":36.5854089383445,"d":"37"},{"$nulls":15},"Epitope undefined.",{"$nulls":3},"Cytoskeletal protein - Microtubule dynamics","P08670","P08670",null,"P08670","GO:0031252; GO:0005737; GO:0005856; GO:0005829; GO:0070062; GO:0005925; GO:0005882; GO:0043005; GO:0016363; GO:0005777; GO:0045335; GO:0005886; GO:0005844; GO:1990904","GO:0003725; GO:0042802; GO:1990254; GO:0008022; GO:0019904; GO:0097110; GO:0005200; GO:0005212","GO:0014002; GO:0060020; GO:0071346; GO:0071222; GO:0071225; GO:0019221; GO:0045109; GO:0070307; GO:0030049; GO:0010977; GO:0032967; GO:0045727; GO:0043488; GO:0060395; GO:0016032"]
[2638,1317,"NN185-2","VIM","Pan-specific","Vimentin",0,148,28,516,{"v":61.92,"d":"62"},{"v":108.80253598187878,"d":"109"},{"$nulls":3},0,132,10,536,{"v":65.392,"d":"65"},{"v":114.25389267230693,"d":"114"},{"$nulls":6},0,178,20,645,{"v":101.91,"d":"102"},{"v":174.35184722180804,"d":"174"},{"$nulls":20},"Epitope undefined.",{"$nulls":4},"P08670","P08670",null,"P08670"]
[2639,1318,"PN094","VIM","S34","Vimentin",0,3089,12,349,{"v":1073.873,"d":"1074"},{"v":1886.9526117969656,"d":"1887"},{"v":1881.1672056322313,"d":"1881"},{"v":5.7854061647342405,"d":"6"},{"v":0.307543430876994,"d":"0"},0,3403,13,330,{"v":1118.7,"d":"1119"},{"v":1954.6095811798045,"d":"1955"},{"v":2086.015884917135,"d":"2086"},{"v":131.4063037373303,"d":"131"},{"v":6.299391327144678,"d":"6"},{"v":6.606934758021673,"d":"7"},{"v":10.889445588440225,"d":"11"},null,0,2317,8,376,{"v":868.184,"d":"868"},{"v":1485.3251312767952,"d":"1485"},{"v":1731.8334254461745,"d":"1732"},{"v":246.50829416937927,"d":"247"},{"v":14.233949440366702,"d":"14"},{"v":14.541492871243696,"d":"15"},{"v":-7.9383576185545905,"d":"-8"},{"$nulls":15},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S34 phosphosite.","The effect of S34 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of vimentin.","PKCa (PRKCA)","Cytoskeletal protein - Microtubule dynamics","P08670","P08670",null,"P08670","GO:0031252; GO:0005737; GO:0005856; GO:0005829; GO:0070062; GO:0005925; GO:0005882; GO:0043005; GO:0016363; GO:0005777; GO:0045335; GO:0005886; GO:0005844; GO:1990904","GO:0003725; GO:0042802; GO:1990254; GO:0008022; GO:0019904; GO:0097110; GO:0005200; GO:0005212","GO:0014002; GO:0060020; GO:0071346; GO:0071222; GO:0071225; GO:0019221; GO:0045109; GO:0070307; GO:0030049; GO:0010977; GO:0032967; GO:0045727; GO:0043488; GO:0060395; GO:0016032"]
[2640,1318,"PN094","VIM","S34","Vimentin",0,3010,12,356,{"v":1067.288,"d":"1067"},{"v":1875.3817994674973,"d":"1875"},{"$nulls":3},0,3905,12,326,{"v":1269.118,"d":"1269"},{"v":2217.4221886544656,"d":"2217"},{"$nulls":6},0,3002,14,387,{"v":1156.356,"d":"1156"},{"v":1978.3417196155538,"d":"1978"},{"$nulls":20},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S34 phosphosite.","The effect of S34 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of vimentin.","PKCa (PRKCA)",null,"P08670","P08670",null,"P08670"]
[2641,1319,"PN544","VIM","Y117","Vimentin",0,4097,14,657,{"v":2682.531,"d":"2683"},{"v":4713.601027939361,"d":"4714"},{"v":5130.455136787182,"d":"5130"},{"v":416.8541088478205,"d":"417"},{"v":8.125090225598676,"d":"8"},0,4732,22,679,{"v":3198.09,"d":"3198"},{"v":5587.751278694307,"d":"5588"},{"v":5435.872855119053,"d":"5436"},{"v":151.8784235752537,"d":"152"},{"v":2.794002501957477,"d":"3"},{"v":10.919092727556153,"d":"11"},{"v":5.9530336040153315,"d":"6"},null,0,4444,20,684,{"v":3026.016,"d":"3026"},{"v":5177.033454251268,"d":"5177"},{"v":5888.089935839272,"d":"5888"},{"v":711.0564815880034,"d":"711"},{"v":12.076182418002613,"d":"12"},{"v":20.20127264360129,"d":"20"},{"v":14.767399360333158,"d":"15"},{"$nulls":15},"FAN(pY)IDK(bA)C","Corresponds to amino acid residues F114 to K120; In the N-terminal part of the Filament domain. ","The effect of Y117 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in vimentin.",null,"Cytoskeletal protein - Microtubule dynamics","P08670","P08670",null,"P08670","GO:0031252; GO:0005737; GO:0005856; GO:0005829; GO:0070062; GO:0005925; GO:0005882; GO:0043005; GO:0016363; GO:0005777; GO:0045335; GO:0005886; GO:0005844; GO:1990904","GO:0003725; GO:0042802; GO:1990254; GO:0008022; GO:0019904; GO:0097110; GO:0005200; GO:0005212","GO:0014002; GO:0060020; GO:0071346; GO:0071222; GO:0071225; GO:0019221; GO:0045109; GO:0070307; GO:0030049; GO:0010977; GO:0032967; GO:0045727; GO:0043488; GO:0060395; GO:0016032"]
[2642,1319,"PN544","VIM","Y117","Vimentin",0,4598,16,689,{"v":3156.998,"d":"3157"},{"v":5547.309245635002,"d":"5547"},{"$nulls":3},0,4507,20,674,{"v":3024.238,"d":"3024"},{"v":5283.9944315438,"d":"5284"},{"$nulls":6},0,4880,22,794,{"v":3857.252,"d":"3857"},{"v":6599.146417427275,"d":"6599"},{"$nulls":20},"FAN(pY)IDK(bA)C","Corresponds to amino acid residues F114 to K120; In the N-terminal part of the Filament domain. ","The effect of Y117 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in vimentin.",null,null,"P08670","P08670",null,"P08670"]
[2643,1320,"PN545","WASP","Y291","Wiskott-Aldrich syndrome protein",0,2126,16,530,{"v":1118.3,"d":"1118"},{"v":1965.0173770758242,"d":"1965"},{"v":2139.375549563064,"d":"2139"},{"v":174.3581724872397,"d":"174"},{"v":8.149956304906345,"d":"8"},0,2384,16,558,{"v":1321.344,"d":"1321"},{"v":2308.6722467457294,"d":"2309"},{"v":2173.8833344903296,"d":"2174"},{"v":134.78891225539974,"d":"135"},{"v":6.200374698902653,"d":"6"},{"v":14.350331003808998,"d":"14"},{"v":1.612983981905984,"d":"2"},null,0,2144,14,544,{"v":1158.72,"d":"1159"},{"v":1982.3861486885824,"d":"1982"},{"v":2284.78164349844,"d":"2285"},{"v":302.39549480985784,"d":"302"},{"v":13.23520327075248,"d":"13"},{"v":21.385159575658825,"d":"21"},{"v":6.79666054728321,"d":"7"},{"$nulls":5},"Adapter/scaffold protein",{"$nulls":7},"X",null,"KLI(pY)DFI(bA)C","Corresponds to amino acid residues K288 to I294; In the PBD domain.","Y291 phosphorylation induces activation of WASP to regulate cell cytoskeleton and cell motility. This is one of the major sites of in vivo phosphorylation of WASP(≥XXX reports from high throughput mass spectrometry studies).","Abl1; Btk; Fyn; Hck; Lck; Lyn","Adapter/scaffold protein","P42768","P42768",null,"P42768","GO:0015629; GO:0005884; GO:0005911; GO:0005829; GO:0070062; GO:0045335; GO:0012506","GO:0003779; GO:0030695; GO:0042802; GO:0043274; GO:0019901; GO:0048365; GO:0017124; GO:0031267","GO:0030048; GO:0030041; GO:0008154; GO:0007596; GO:0032488; GO:0071346; GO:0006952; GO:0016197; GO:0008544; GO:0038096; GO:0006955; GO:2000146; GO:0051497; GO:2000601; GO:0065003; GO:0008064; GO:0010591; GO:0051492; GO:0002625; GO:0042110; GO:0050852"]
[2644,1320,"PN545","WASP","Y291","Wiskott-Aldrich syndrome protein",0,2556,14,518,{"v":1316.756,"d":"1317"},{"v":2313.733722050303,"d":"2314"},{"$nulls":3},0,2267,14,518,{"v":1167.054,"d":"1167"},{"v":2039.0944222349294,"d":"2039"},{"$nulls":6},0,2605,20,585,{"v":1512.225,"d":"1512"},{"v":2587.1771383082983,"d":"2587"},{"$nulls":10},"Adapter/scaffold protein",{"$nulls":7},"X",null,"KLI(pY)DFI(bA)C","Corresponds to amino acid residues K288 to I294; In the PBD domain.","Y291 phosphorylation induces activation of WASP to regulate cell cytoskeleton and cell motility. This is one of the major sites of in vivo phosphorylation of WASP(≥XXX reports from high throughput mass spectrometry studies).","Abl1; Btk; Fyn; Hck; Lck; Lyn",null,"P42768","P42768",null,"P42768"]
[2645,1321,"NK185","Wee1","Pan-specific","Wee1 protein-tyrosine kinase",0,3795,8,676,{"v":2560.012,"d":"2560"},{"v":4498.317147029094,"d":"4498"},{"v":4749.632203675415,"d":"4750"},{"v":251.31505664632186,"d":"251"},{"v":5.291253003797775,"d":"5"},0,4312,18,635,{"v":2726.69,"d":"2727"},{"v":4764.114059986736,"d":"4764"},{"v":4658.902005682718,"d":"4659"},{"v":105.21205430401824,"d":"105"},{"v":2.2583015091471195,"d":"2"},{"v":7.549554512944894,"d":"8"},{"v":-1.9102573441894748,"d":"-2"},null,0,4214,14,712,{"v":2990.4,"d":"2990"},{"v":5116.100126897211,"d":"5116"},{"v":5287.482808866802,"d":"5287"},{"v":171.38268196959052,"d":"171"},{"v":3.2412905755871533,"d":"3"},{"v":8.532543579384928,"d":"9"},{"v":11.324047465721236,"d":"11"},null,null,"WEE1","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","Other","WEE",{"$nulls":6},"LTVVCAAGAEPLPRNGDQWHEIRQGRLPGGC","Corresponds to amino acid residues L361 to P388; Kinase subdomain X.",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.10.2; Other group; WEE family","P30291","P30291","P30291",null,"GO:0005737; GO:0005730; GO:0005654; GO:0005634","GO:0005524; GO:0016301; GO:0000287; GO:0004715; GO:0004713","GO:0051301; GO:0030010; GO:0000086; GO:0000226; GO:2000134; GO:0048812"]
[2646,1321,"NK185","Wee1","Pan-specific","Wee1 protein-tyrosine kinase",0,4185,18,683,{"v":2846.061,"d":"2846"},{"v":5000.947260321736,"d":"5001"},{"$nulls":3},0,4040,18,648,{"v":2606.256,"d":"2606"},{"v":4553.6899513787,"d":"4554"},{"$nulls":6},0,4371,18,733,{"v":3190.749,"d":"3191"},{"v":5458.865490836393,"d":"5459"},{"$nulls":7},"WEE1","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","Other","WEE",{"$nulls":6},"LTVVCAAGAEPLPRNGDQWHEIRQGRLPGGC","Corresponds to amino acid residues L361 to P388; Kinase subdomain X.",{"$nulls":3},"P30291","P30291","P30291"]
[2647,1322,"PK854","Wee1","S642","Wee1 protein-tyrosine kinase",0,7972,16,720,{"v":5728.32,"d":"5728"},{"v":10065.499724091018,"d":"10065"},{"v":10203.115954921586,"d":"10203"},{"v":137.61623083056838,"d":"138"},{"v":1.3487667045887846,"d":"1"},0,8652,20,702,{"v":6059.664,"d":"6060"},{"v":10587.536706114543,"d":"10588"},{"v":10599.166170110548,"d":"10599"},{"v":11.629463996005143,"d":"12"},{"v":0.10972055546029663,"d":"0"},{"v":1.4584872600490812,"d":"1"},{"v":3.8816594551973367,"d":"4"},null,0,8036,19,759,{"v":6084.903,"d":"6085"},{"v":10410.303976209612,"d":"10410"},{"v":10517.588274232463,"d":"10518"},{"v":107.28429802285063,"d":"107"},{"v":1.020046566052519,"d":"1"},{"v":2.3688132706413034,"d":"2"},{"v":3.0821204100810746,"d":"3"},null,null,"WEE1","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","Other","WEE",{"$nulls":6},"RSV(pS)LTI(bA)C","Corresponds to amino acid residues R639 to I645; In the C-terminus of the kinase.","S642 phosphorylation inhibits phosphotransferase activity and induces interaction with 14-3-3. This is one of the major sites of in vivo phosphorylation of Wee1.","Akt1 (PKBa); BRSK1; BRSK2","Protein kinase, Ser/Thr (non-receptor); EC 2.7.10.2; Other group; WEE family","P30291","P30291","P30291",null,"GO:0005737; GO:0005730; GO:0005654; GO:0005634","GO:0005524; GO:0016301; GO:0000287; GO:0004715; GO:0004713","GO:0051301; GO:0030010; GO:0000086; GO:0000226; GO:2000134; GO:0048812"]
[2648,1322,"PK854","Wee1","S642","Wee1 protein-tyrosine kinase",0,8124,18,726,{"v":5884.956,"d":"5885"},{"v":10340.732185752155,"d":"10341"},{"$nulls":3},0,8849,22,688,{"v":6072.976,"d":"6073"},{"v":10610.795634106555,"d":"10611"},{"$nulls":6},0,8366,30,745,{"v":6210.32,"d":"6210"},{"v":10624.872572255314,"d":"10625"},{"$nulls":7},"WEE1","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","Other","WEE",{"$nulls":6},"RSV(pS)LTI(bA)C","Corresponds to amino acid residues R639 to I645; In the C-terminus of the kinase.","S642 phosphorylation inhibits phosphotransferase activity and induces interaction with 14-3-3. This is one of the major sites of in vivo phosphorylation of Wee1.","Akt1 (PKBa); BRSK1; BRSK2",null,"P30291","P30291","P30291"]
[2649,1323,"NK252-1","WNK1","Pan-specific","Serine/threonine-protein kinase WNK1",0,9172,18,730,{"v":6682.42,"d":"6682"},{"v":11741.993580362183,"d":"11742"},{"v":11974.007256897185,"d":"11974"},{"v":232.01367653500165,"d":"232"},{"v":1.9376443621358148,"d":"2"},0,10596,20,731,{"v":7731.056,"d":"7731"},{"v":13507.818119457954,"d":"13508"},{"v":13483.636661870103,"d":"13484"},{"v":24.181457587850673,"d":"24"},{"v":0.17933928504787255,"d":"0"},{"v":2.1169836471836874,"d":"2"},{"v":12.607553783662112,"d":"13"},null,0,9138,22,779,{"v":7101.364,"d":"7101"},{"v":12149.307537969264,"d":"12149"},{"v":11864.868179088327,"d":"11865"},{"v":284.4393588809362,"d":"284"},{"v":2.3973242229716196,"d":"2"},{"v":4.334968585107434,"d":"4"},{"v":-0.9114666081899401,"d":"-1"},null,null,"WNK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"MSGGAAEKQSSTPGSC","Corresponds to amino acid residues M1 to S15; N-terminus.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; Wnk family","Q9H4A3","Q9H4A3","Q9H4A3","Q9H4A3","GO:0005737; GO:0005829; GO:0016020","GO:0005524; GO:0019869; GO:0000287; GO:0019902; GO:0019870; GO:0030295; GO:0004672; GO:0019901; GO:0004674; GO:0030291","GO:0071277; GO:1990869; GO:0038116; GO:0035556; GO:0006811; GO:0097022; GO:0033633; GO:0034260; GO:0034115; GO:1903038; GO:0090188; GO:0010923; GO:0010766; GO:0048666; GO:0018105; GO:0018107; GO:0090263; GO:0003084; GO:0010820; GO:0046777; GO:0006468; GO:0050794; GO:0002028; GO:0023016; GO:0050852"]
[2650,1323,"NK252-1","WNK1","Pan-specific","Serine/threonine-protein kinase WNK1",0,9280,18,750,{"v":6946.5,"d":"6947"},{"v":12206.020933432186,"d":"12206"},{"$nulls":3},0,10376,22,744,{"v":7703.376,"d":"7703"},{"v":13459.455204282254,"d":"13459"},{"$nulls":6},0,8754,20,775,{"v":6768.85,"d":"6769"},{"v":11580.428820207393,"d":"11580"},{"$nulls":7},"WNK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"MSGGAAEKQSSTPGSC","Corresponds to amino acid residues M1 to S15; N-terminus.",{"$nulls":3},"Q9H4A3","Q9H4A3","Q9H4A3","Q9H4A3"]
[2651,1324,"NK252-3","WNK1","Pan-specific","Serine/threonine-protein kinase WNK1",0,5158,18,772,{"v":3968.08,"d":"3968"},{"v":6972.499466714688,"d":"6972"},{"v":6825.883129467789,"d":"6826"},{"v":146.6163372468991,"d":"147"},{"v":2.147946785287704,"d":"2"},0,5690,16,755,{"v":4283.87,"d":"4284"},{"v":7484.842537345784,"d":"7485"},{"v":7479.232229519586,"d":"7479"},{"v":5.610307826197641,"d":"6"},{"v":0.0750118147696292,"d":"0"},{"v":2.222958600057333,"d":"2"},{"v":9.571642052165316,"d":"10"},null,0,5204,19,824,{"v":4272.44,"d":"4272"},{"v":7309.467237212653,"d":"7309"},{"v":7063.639857921052,"d":"7064"},{"v":245.82737929160157,"d":"246"},{"v":3.48017996721527,"d":"3"},{"v":5.628126752502974,"d":"6"},{"v":3.4831643604744897,"d":"3"},null,null,"WNK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"CQKSISNPPGSNLRTT","Corresponds to amino acid residues Q2368 to T2382; C-terminus.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; Wnk family","Q9H4A3","Q9H4A3","Q9H4A3","Q9H4A3","GO:0005737; GO:0005829; GO:0016020","GO:0005524; GO:0019869; GO:0000287; GO:0019902; GO:0019870; GO:0030295; GO:0004672; GO:0019901; GO:0004674; GO:0030291","GO:0071277; GO:1990869; GO:0038116; GO:0035556; GO:0006811; GO:0097022; GO:0033633; GO:0034260; GO:0034115; GO:1903038; GO:0090188; GO:0010923; GO:0010766; GO:0048666; GO:0018105; GO:0018107; GO:0090263; GO:0003084; GO:0010820; GO:0046777; GO:0006468; GO:0050794; GO:0002028; GO:0023016; GO:0050852"]
[2652,1324,"NK252-3","WNK1","Pan-specific","Serine/threonine-protein kinase WNK1",0,5214,14,731,{"v":3801.2,"d":"3801"},{"v":6679.266792220891,"d":"6679"},{"$nulls":3},0,5676,18,756,{"v":4277.448,"d":"4277"},{"v":7473.621921693388,"d":"7474"},{"$nulls":6},0,5176,14,772,{"v":3985.064,"d":"3985"},{"v":6817.81247862945,"d":"6818"},{"$nulls":7},"WNK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"CQKSISNPPGSNLRTT","Corresponds to amino acid residues Q2368 to T2382; C-terminus.",{"$nulls":3},"Q9H4A3","Q9H4A3","Q9H4A3","Q9H4A3"]
[2653,1325,"PK856","WNK1","T60","Serine/threonine-protein kinase WNK1",0,6306,22,730,{"v":4587.32,"d":"4587"},{"v":8060.595112409434,"d":"8061"},{"v":8188.597992555944,"d":"8189"},{"v":128.0028801465105,"d":"128"},{"v":1.563184323651922,"d":"2"},0,6908,18,761,{"v":5243.29,"d":"5243"},{"v":9161.155690448071,"d":"9161"},{"v":8952.387941796198,"d":"8952"},{"v":208.76774865187326,"d":"209"},{"v":2.331978350459937,"d":"2"},{"v":3.895162674111859,"d":"4"},{"v":9.32748133361288,"d":"9"},null,0,6238,18,750,4665,{"v":7981.075137766015,"d":"7981"},{"v":8404.357830581655,"d":"8404"},{"v":423.2826928156401,"d":"423"},{"v":5.036466811008513,"d":"5"},{"v":6.5996511346604345,"d":"7"},{"v":2.6348813096192174,"d":"3"},null,null,"WNK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"RRH(pT)MDK(bA)C","Corresponds to amino acid residues R57 to K63; In the N-terminal portion of the protein kinase.","T60 phosphorylation stimulates phosphotransferase activity. This is one of the major sites of in vivo phosphorylation of WNK1.","Akt1 (PKBa); Akt3 (PKBg); MSK1 (RPS6KA5); SGK1","EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; Wnk family","Q9H4A3","Q9H4A3","Q9H4A3","Q9H4A3","GO:0005737; GO:0005829; GO:0016020","GO:0005524; GO:0019869; GO:0000287; GO:0019902; GO:0019870; GO:0030295; GO:0004672; GO:0019901; GO:0004674; GO:0030291","GO:0071277; GO:1990869; GO:0038116; GO:0035556; GO:0006811; GO:0097022; GO:0033633; GO:0034260; GO:0034115; GO:1903038; GO:0090188; GO:0010923; GO:0010766; GO:0048666; GO:0018105; GO:0018107; GO:0090263; GO:0003084; GO:0010820; GO:0046777; GO:0006468; GO:0050794; GO:0002028; GO:0023016; GO:0050852"]
[2654,1325,"PK856","WNK1","T60","Serine/threonine-protein kinase WNK1",0,6444,22,737,{"v":4733.014,"d":"4733"},{"v":8316.600872702455,"d":"8317"},{"$nulls":3},0,6917,24,726,{"v":5004.318,"d":"5004"},{"v":8743.620193144325,"d":"8744"},{"$nulls":6},0,6570,22,788,{"v":5159.824,"d":"5160"},{"v":8827.640523397296,"d":"8828"},{"$nulls":7},"WNK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"RRH(pT)MDK(bA)C","Corresponds to amino acid residues R57 to K63; In the N-terminal portion of the protein kinase.","T60 phosphorylation stimulates phosphotransferase activity. This is one of the major sites of in vivo phosphorylation of WNK1.","Akt1 (PKBa); Akt3 (PKBg); MSK1 (RPS6KA5); SGK1",null,"Q9H4A3","Q9H4A3","Q9H4A3","Q9H4A3"]
[2655,1326,"PK855","WNK1","S382","Serine/threonine-protein kinase WNK1",0,8590,22,774,{"v":6631.632,"d":"6632"},{"v":11652.751603659217,"d":"11653"},{"v":11733.857990220127,"d":"11734"},{"v":81.10638656091032,"d":"81"},{"v":0.6912167049278288,"d":"1"},0,8891,22,765,{"v":6784.785,"d":"6785"},{"v":11854.47909827927,"d":"11854"},{"v":11936.317781999365,"d":"11936"},{"v":81.83868372009601,"d":"82"},{"v":0.6856275546174996,"d":"1"},{"v":1.3768442595453285,"d":"1"},{"v":1.7254324361858124,"d":"2"},null,0,9180,21,788,{"v":7217.292,"d":"7217"},{"v":12347.641959956605,"d":"12348"},{"v":12775.71757495841,"d":"12776"},{"v":428.0756150018042,"d":"428"},{"v":3.35069723082226,"d":"3"},{"v":4.041913935750088,"d":"4"},{"v":8.879088068107222,"d":"9"},null,null,"WNK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"FAK(pS)VIG(bA)C","Corresponds to amino acid residues F379 to G385; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","S382 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of WNK1.","Wnk1 (PRKWNK1)","EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; Wnk family","Q9H4A3","Q9H4A3","Q9H4A3","Q9H4A3","GO:0005737; GO:0005829; GO:0016020","GO:0005524; GO:0019869; GO:0000287; GO:0019902; GO:0019870; GO:0030295; GO:0004672; GO:0019901; GO:0004674; GO:0030291","GO:0071277; GO:1990869; GO:0038116; GO:0035556; GO:0006811; GO:0097022; GO:0033633; GO:0034260; GO:0034115; GO:1903038; GO:0090188; GO:0010923; GO:0010766; GO:0048666; GO:0018105; GO:0018107; GO:0090263; GO:0003084; GO:0010820; GO:0046777; GO:0006468; GO:0050794; GO:0002028; GO:0023016; GO:0050852"]
[2656,1326,"PK855","WNK1","S382","Serine/threonine-protein kinase WNK1",0,8802,24,766,{"v":6723.948,"d":"6724"},{"v":11814.964376781038,"d":"11815"},{"$nulls":3},0,8890,26,776,{"v":6878.464,"d":"6878"},{"v":12018.156465719461,"d":"12018"},{"$nulls":6},0,9087,18,851,{"v":7717.719,"d":"7718"},{"v":13203.793189960212,"d":"13204"},{"$nulls":7},"WNK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"FAK(pS)VIG(bA)C","Corresponds to amino acid residues F379 to G385; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","S382 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of WNK1.","Wnk1 (PRKWNK1)",null,"Q9H4A3","Q9H4A3","Q9H4A3","Q9H4A3"]
[2657,1327,"PK857","WNK1","T2245","Serine/threonine-protein kinase WNK2",0,8808,18,848,{"v":7453.92,"d":"7454"},{"v":13097.632412888337,"d":"13098"},{"v":13239.982397464628,"d":"13240"},{"v":142.3499845762908,"d":"142"},{"v":1.0751523703199932,"d":"1"},0,8910,18,906,{"v":8056.152,"d":"8056"},{"v":14075.830773791762,"d":"14076"},{"v":13718.610890461296,"d":"13719"},{"v":357.2198833304665,"d":"357"},{"v":2.6039071024227787,"d":"3"},{"v":3.6790594727427717,"d":"4"},{"v":3.615023635441702,"d":"4"},null,0,9094,23,948,{"v":8599.308,"d":"8599"},{"v":14712.052150223451,"d":"14712"},{"v":14845.843369499673,"d":"14846"},{"v":133.79121927622145,"d":"134"},{"v":0.9012032253492003,"d":"1"},{"v":1.9763555956691934,"d":"2"},{"v":12.128875430699651,"d":"12"},null,null,"WNK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"RKG(pT)FTD(bA)C","Corresponds to amino acid residues R2242 to D2248; In the C-terminal region of WNK1. ","The effect of T2245 phosphorylation is unclear. This is the major in vivo phosphorylation sites in WNK1.",null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; Wnk family","Q9H4A3","Q9H4A3","Q9H4A3","Q9H4A3","GO:0005737; GO:0005829; GO:0016020","GO:0005524; GO:0019869; GO:0000287; GO:0019902; GO:0019870; GO:0030295; GO:0004672; GO:0019901; GO:0004674; GO:0030291","GO:0071277; GO:1990869; GO:0038116; GO:0035556; GO:0006811; GO:0097022; GO:0033633; GO:0034260; GO:0034115; GO:1903038; GO:0090188; GO:0010923; GO:0010766; GO:0048666; GO:0018105; GO:0018107; GO:0090263; GO:0003084; GO:0010820; GO:0046777; GO:0006468; GO:0050794; GO:0002028; GO:0023016; GO:0050852"]
[2658,1327,"PK857","WNK1","T2245","Serine/threonine-protein kinase WNK2",0,8748,54,876,{"v":7615.944,"d":"7616"},{"v":13382.33238204092,"d":"13382"},{"$nulls":3},0,9076,26,845,{"v":7647.25,"d":"7647"},{"v":13361.39100713083,"d":"13361"},{"$nulls":6},0,9828,56,896,{"v":8755.712,"d":"8756"},{"v":14979.634588775894,"d":"14980"},{"$nulls":7},"WNK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"RKG(pT)FTD(bA)C","Corresponds to amino acid residues R2242 to D2248; In the C-terminal region of WNK1. ","The effect of T2245 phosphorylation is unclear. This is the major in vivo phosphorylation sites in WNK1.",null,null,"Q9H4A3","Q9H4A3","Q9H4A3","Q9H4A3"]
[2659,1328,"NK253-1","WNK2","Pan-specific","Serine/threonine-protein kinase WNK2",0,7943,20,918,{"v":7273.314,"d":"7273"},{"v":12780.281140059798,"d":"12780"},{"v":11650.026268818974,"d":"11650"},{"v":1130.2548712408243,"d":"1130"},{"v":9.701736675615276,"d":"10"},0,7792,20,815,{"v":6334.18,"d":"6334"},{"v":11067.175218483502,"d":"11067"},{"v":10393.159021385614,"d":"10393"},{"v":674.0161970978879,"d":"674"},{"v":6.485190842466569,"d":"6"},{"v":16.186927518081845,"d":"16"},{"v":-10.788535737445812,"d":"-11"},null,0,7430,22,834,{"v":6178.272,"d":"6178"},{"v":10570.043527021631,"d":"10570"},{"v":10477.5280673968,"d":"10478"},{"v":92.51545962483033,"d":"93"},{"v":0.8829893752583982,"d":"1"},{"v":10.584726050873675,"d":"11"},{"v":-10.064339550549661,"d":"-10"},null,null,"WNK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"MDGDGGRRDVPGTLMC","Corresponds to amino acid residues M1 to M15; N-terminus.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; Wnk family","Q9Y3S1","Q9Y3S1","Q9Y3S1","Q9Y3S1","GO:0005737; GO:0005829; GO:0005886","GO:0005524; GO:0004674","GO:0035556; GO:0050801; GO:0008285; GO:0070373; GO:0090263; GO:2000651; GO:0046777; GO:0006468"]
[2660,1328,"NK253-1","WNK2","Pan-specific","Serine/threonine-protein kinase WNK2",0,7288,40,826,{"v":5986.848,"d":"5987"},{"v":10519.77139757815,"d":"10520"},{"$nulls":3},0,7378,20,756,{"v":5562.648,"d":"5563"},{"v":9719.142824287725,"d":"9719"},{"$nulls":6},0,7470,22,815,{"v":6070.12,"d":"6070"},{"v":10385.01260777197,"d":"10385"},{"$nulls":7},"WNK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"MDGDGGRRDVPGTLMC","Corresponds to amino acid residues M1 to M15; N-terminus.",{"$nulls":3},"Q9Y3S1","Q9Y3S1","Q9Y3S1","Q9Y3S1"]
[2661,1329,"NK253-2","WNK2","Pan-specific","Serine/threonine-protein kinase WNK2",0,2052,15,680,{"v":1385.16,"d":"1385"},{"v":2433.929598524858,"d":"2434"},{"v":2474.974792937014,"d":"2475"},{"v":41.04519441215598,"d":"41"},{"v":1.658408583767768,"d":"2"},0,1788,14,651,{"v":1154.874,"d":"1155"},{"v":2017.8133417855058,"d":"2018"},{"v":2187.4382295746173,"d":"2187"},{"v":169.62488778911143,"d":"170"},{"v":7.754499555495915,"d":"8"},{"v":9.412908139263683,"d":"9"},{"v":-11.617757246779135,"d":"-12"},null,0,2242,14,713,{"v":1588.564,"d":"1589"},{"v":2717.781060053619,"d":"2718"},{"v":3198.6386985522695,"d":"3199"},{"v":480.85763849865043,"d":"481"},{"v":15.033196425601009,"d":"15"},{"v":16.69160500936878,"d":"17"},{"v":29.239243473526244,"d":"29"},null,null,"WNK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"CDEDDLKAVATSLDGR","Corresponds to amino acid residues D179 to R193.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; Wnk family","Q9Y3S1","Q9Y3S1","Q9Y3S1","Q9Y3S1","GO:0005737; GO:0005829; GO:0005886","GO:0005524; GO:0004674","GO:0035556; GO:0050801; GO:0008285; GO:0070373; GO:0090263; GO:2000651; GO:0046777; GO:0006468"]
[2662,1329,"NK253-2","WNK2","Pan-specific","Serine/threonine-protein kinase WNK2",0,1554,16,931,{"v":1431.878,"d":"1432"},{"v":2516.01998734917,"d":"2516"},{"$nulls":3},0,2062,18,660,{"v":1349.04,"d":"1349"},{"v":2357.0631173637285,"d":"2357"},{"$nulls":6},0,2644,18,819,{"v":2150.694,"d":"2151"},{"v":3679.49633705092,"d":"3679"},{"$nulls":7},"WNK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"CDEDDLKAVATSLDGR","Corresponds to amino acid residues D179 to R193.",{"$nulls":3},"Q9Y3S1","Q9Y3S1","Q9Y3S1","Q9Y3S1"]
[2663,1330,"NK254-1","WNK3 (PRKWNK3)","Pan-specific","Serine/threonine-protein kinase WNK3",0,7188,10,770,{"v":5527.06,"d":"5527"},{"v":9711.856339211934,"d":"9712"},{"v":9725.381977466463,"d":"9725"},{"v":13.52563825452853,"d":"14"},{"v":0.13907565055919854,"d":"0"},0,7407,20,798,{"v":5894.826,"d":"5895"},{"v":10299.529256268725,"d":"10300"},{"v":9753.040545289306,"d":"9753"},{"v":546.4887109794181,"d":"546"},{"v":5.603265037623275,"d":"6"},{"v":5.742340688182473,"d":"6"},{"v":0.2843956966104457,"d":"0"},null,0,7370,8,865,{"v":6368.13,"d":"6368"},{"v":10894.860453818197,"d":"10895"},{"v":10964.05800056196,"d":"10964"},{"v":69.19754674376236,"d":"69"},{"v":0.6311307979236853,"d":"1"},{"v":0.7702064484828839,"d":"1"},{"v":12.736528251183216,"d":"13"},null,null,"WNK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"MATDSGDPASTEDSEC","Corresponds to amino acid residues M1 to E15; N-terminus.",null,null,"Protein-serine kinase, Other group, Wnk family","Q9BYP7","Q9BYP7","Q9BYP7","Q9BYP7","GO:0005912; GO:0005923; GO:0005737; GO:0005829","GO:0005524; GO:0019869; GO:0004672; GO:0004674","GO:0035556; GO:0050801; GO:0043066; GO:0090188; GO:0051928; GO:0032414; GO:0010800; GO:1903078; GO:2000651; GO:0010765; GO:0046777; GO:0072659; GO:0006468; GO:0090279"]
[2664,1330,"NK254-1","WNK3 (PRKWNK3)","Pan-specific","Serine/threonine-protein kinase WNK3",0,7357,16,755,{"v":5542.455,"d":"5542"},{"v":9738.907615720993,"d":"9739"},{"$nulls":3},0,7294,16,724,{"v":5269.272,"d":"5269"},{"v":9206.551834309887,"d":"9207"},{"$nulls":6},0,8171,18,791,{"v":6449.023,"d":"6449"},{"v":11033.255547305724,"d":"11033"},{"$nulls":7},"WNK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"MATDSGDPASTEDSEC","Corresponds to amino acid residues M1 to E15; N-terminus.",{"$nulls":3},"Q9BYP7","Q9BYP7","Q9BYP7","Q9BYP7"]
[2665,1331,"NK254-3","WNK3 (PRKWNK3)","Pan-specific","Serine/threonine-protein kinase WNK3",0,3132,14,667,{"v":2079.706,"d":"2080"},{"v":3654.348948590588,"d":"3654"},{"v":3960.686424656621,"d":"3961"},{"v":306.3374760660331,"d":"306"},{"v":7.734454163272761,"d":"8"},0,3509,18,709,{"v":2475.119,"d":"2475"},{"v":4324.565399088386,"d":"4325"},{"v":4018.583473452465,"d":"4019"},{"v":305.98192563592056,"d":"306"},{"v":7.61417369223001,"d":"8"},{"v":15.348627855502771,"d":"15"},{"v":1.4617933001566286,"d":"1"},null,0,3176,15,765,{"v":2418.165,"d":"2418"},{"v":4137.096797538254,"d":"4137"},{"v":4349.27449272543,"d":"4349"},{"v":212.17769518717614,"d":"212"},{"v":4.878461811092017,"d":"5"},{"v":12.612915974364778,"d":"13"},{"v":9.811129344896273,"d":"10"},null,null,"WNK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"CGPFQPGMNMQAFPTS","Corresponds to amino acid residues G1773 to S1787.",null,null,"Protein-serine kinase, Other group, Wnk family","Q9BYP7","Q9BYP7","Q9BYP7","Q9BYP7","GO:0005912; GO:0005923; GO:0005737; GO:0005829","GO:0005524; GO:0019869; GO:0004672; GO:0004674","GO:0035556; GO:0050801; GO:0043066; GO:0090188; GO:0051928; GO:0032414; GO:0010800; GO:1903078; GO:2000651; GO:0010765; GO:0046777; GO:0072659; GO:0006468; GO:0090279"]
[2666,1331,"NK254-3","WNK3 (PRKWNK3)","Pan-specific","Serine/threonine-protein kinase WNK3",0,3338,16,731,{"v":2428.382,"d":"2428"},{"v":4267.023900722655,"d":"4267"},{"$nulls":3},0,3273,14,652,{"v":2124.868,"d":"2125"},{"v":3712.6015478165446,"d":"3713"},{"$nulls":6},0,3588,14,746,{"v":2666.204,"d":"2666"},{"v":4561.452187912605,"d":"4561"},{"$nulls":7},"WNK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"CGPFQPGMNMQAFPTS","Corresponds to amino acid residues G1773 to S1787.",{"$nulls":3},"Q9BYP7","Q9BYP7","Q9BYP7","Q9BYP7"]
[2667,1332,"NK255-1","WNK4 (PRKWNK4)","Pan-specific","Serine/threonine-protein kinase WNK4",0,11360,16,784,{"v":8893.696,"d":"8894"},{"v":15627.530346445274,"d":"15628"},{"v":15508.255214945759,"d":"15508"},{"v":119.27513149951483,"d":"119"},{"v":0.7691073550592971,"d":"1"},0,12303,16,807,{"v":9915.609,"d":"9916"},{"v":17324.702203122106,"d":"17325"},{"v":15774.88218477326,"d":"15775"},{"v":1549.8200183488461,"d":"1550"},{"v":9.824605979275162,"d":"10"},{"v":10.59371333433446,"d":"11"},{"v":1.7192583313340322,"d":"2"},null,0,10634,16,826,{"v":8770.468,"d":"8770"},{"v":15004.879764495698,"d":"15005"},{"v":15000.937985906756,"d":"15001"},{"v":3.9417785889418155,"d":"4"},{"v":0.02627688077002305,"d":"0"},{"v":0.7953842358293202,"d":"1"},{"v":-3.27127211931672,"d":"-3"},null,null,"WNK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"MLASPATETTVLMSQC","Corresponds to amino acid residues M1 to Q15; N-terminus.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; Wnk family","Q96J92","Q96J92","Q96J92","Q96J92","GO:0005923; GO:0005829; GO:0016020","GO:0005524; GO:0019869; GO:0004674","GO:0006821; GO:0072156; GO:0035556; GO:0050801; GO:0006811; GO:0090188; GO:0010766; GO:0008104; GO:0006468; GO:0050794; GO:0070294"]
[2668,1332,"NK255-1","WNK4 (PRKWNK4)","Pan-specific","Serine/threonine-protein kinase WNK4",0,11304,18,776,{"v":8757.936,"d":"8758"},{"v":15388.980083446244,"d":"15389"},{"$nulls":3},0,11035,18,739,{"v":8141.563,"d":"8142"},{"v":14225.062166424414,"d":"14225"},{"$nulls":6},0,10948,18,802,{"v":8765.86,"d":"8766"},{"v":14996.996207317814,"d":"14997"},{"$nulls":7},"WNK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"MLASPATETTVLMSQC","Corresponds to amino acid residues M1 to Q15; N-terminus.",{"$nulls":3},"Q96J92","Q96J92","Q96J92","Q96J92"]
[2669,1333,"NK255-3","WNK4 (PRKWNK4)","Pan-specific","Serine/threonine-protein kinase WNK4",0,9292,12,729,{"v":6765.12,"d":"6765"},{"v":11887.309628903871,"d":"11887"},{"v":11921.468564619114,"d":"11921"},{"v":34.15893571524248,"d":"34"},{"v":0.28653295128941053,"d":"0"},0,10672,18,770,{"v":8203.58,"d":"8204"},{"v":14333.419207986966,"d":"14333"},{"v":13401.33234531423,"d":"13401"},{"v":932.086862672737,"d":"932"},{"v":6.955180564555141,"d":"7"},{"v":7.241713515844551,"d":"7"},{"v":12.413435246451925,"d":"12"},null,0,9786,14,798,{"v":7798.056,"d":"7798"},{"v":13341.237055628531,"d":"13341"},{"v":12882.3414882003,"d":"12882"},{"v":458.8955674282315,"d":"459"},{"v":3.562206201788403,"d":"4"},{"v":3.8487391530778137,"d":"4"},{"v":8.060021450988785,"d":"8"},null,null,"WNK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"CRASKGVTFAGDVGRM","Corresponds to amino acid residues R1229 to M1243; C-terminus.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; Wnk family","Q96J92","Q96J92","Q96J92","Q96J92","GO:0005923; GO:0005829; GO:0016020","GO:0005524; GO:0019869; GO:0004674","GO:0006821; GO:0072156; GO:0035556; GO:0050801; GO:0006811; GO:0090188; GO:0010766; GO:0008104; GO:0006468; GO:0050794; GO:0070294"]
[2670,1333,"NK255-3","WNK4 (PRKWNK4)","Pan-specific","Serine/threonine-protein kinase WNK4",0,9466,16,720,6804,{"v":11955.627500334354,"d":"11956"},{"$nulls":3},0,9932,20,720,{"v":7136.64,"d":"7137"},{"v":12469.245482641494,"d":"12469"},{"$nulls":6},0,10034,18,725,{"v":7261.6,"d":"7262"},{"v":12423.445920772068,"d":"12423"},{"$nulls":7},"WNK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"CRASKGVTFAGDVGRM","Corresponds to amino acid residues R1229 to M1243; C-terminus.",{"$nulls":3},"Q96J92","Q96J92","Q96J92","Q96J92"]
[2671,1334,"PN732","WT1","S365","Wilms tumour protein",0,7086,14,710,{"v":5021.12,"d":"5021"},{"v":8822.845437166201,"d":"8823"},{"v":8630.935124305528,"d":"8631"},{"v":191.910312860673,"d":"192"},{"v":2.2235170360652514,"d":"2"},0,8098,16,728,{"v":5883.696,"d":"5884"},{"v":10280.082751720112,"d":"10280"},{"v":9887.071166172369,"d":"9887"},{"v":393.0115855477434,"d":"393"},{"v":3.975005124797659,"d":"4"},{"v":6.198522160862911,"d":"6"},{"v":14.553881170181015,"d":"15"},null,0,6987,15,728,{"v":5075.616,"d":"5076"},{"v":8683.573990663963,"d":"8684"},{"v":9220.436022439091,"d":"9220"},{"v":536.8620317751283,"d":"537"},{"v":5.822523256694229,"d":"6"},{"v":8.04604029275948,"d":"8"},{"v":6.83009302750375,"d":"7"},{"$nulls":5},"Transcription protein, coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"CERRF(pS)RSD","Corresponds to amino acid residues S360 to D368. Sequence is almost identical to S393.","The effect of S365 phosphorylation is unclear. In vivo phosphorylation of WT1 has not been reported for this phosphosite (0 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in fish. A nearly identical amino acid sequence surrounds S393.","PKACa (PRKACA)","Transcription protein","P19544","P19544",null,"P19544","GO:0005737; GO:0005829; GO:0016607; GO:0005730; GO:0005654; GO:0005634","GO:0070742; GO:0003700; GO:0010385; GO:0044729; GO:0003723; GO:0000981; GO:0043565; GO:0001077; GO:0044212; GO:0008270","GO:0035802; GO:0030325; GO:0001658; GO:0043010; GO:0060923; GO:0071320; GO:0071371; GO:0060539; GO:0030855; GO:0007281; GO:0032836; GO:0072112; GO:0032835; GO:0008406; GO:0007507; GO:0001822; GO:0030539; GO:0008584; GO:0060231; GO:0072207; GO:0072075; GO:0072284; GO:0043066; GO:0030308; GO:0008285; GO:2000195; GO:0072302; GO:0045892; GO:0000122; GO:0017148; GO:0043065; GO:0060421; GO:2000020; GO:2001076; GO:0045893; GO:0072166; GO:0003156; GO:0006355; GO:0006357; GO:0008380; GO:0007530; GO:0007356; GO:0009888; GO:0001657; GO:0001570; GO:0061032"]
[2672,1334,"PN732","WT1","S365","Wilms tumour protein",0,7017,16,686,{"v":4802.686,"d":"4803"},{"v":8439.024811444855,"d":"8439"},{"$nulls":3},0,7920,22,688,{"v":5433.824,"d":"5434"},{"v":9494.059580624626,"d":"9494"},{"$nulls":6},0,7272,16,786,{"v":5703.216,"d":"5703"},{"v":9757.298054214221,"d":"9757"},{"$nulls":10},"Transcription protein, coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"CERRF(pS)RSD","Corresponds to amino acid residues S360 to D368. Sequence is almost identical to S393.","The effect of S365 phosphorylation is unclear. In vivo phosphorylation of WT1 has not been reported for this phosphosite (0 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in fish. A nearly identical amino acid sequence surrounds S393.","PKACa (PRKACA)",null,"P19544","P19544",null,"P19544"]
[2673,1335,"PN681","YAP1","S109","Yorkie homologue",0,6782,14,741,{"v":5015.088,"d":"5015"},{"v":8812.246327071842,"d":"8812"},{"v":8013.124031787884,"d":"8013"},{"v":799.122295283958,"d":"799"},{"v":9.972668488767399,"d":"10"},0,9689,14,780,{"v":7546.5,"d":"7547"},{"v":13185.359081410024,"d":"13185"},{"v":12041.810264333937,"d":"12042"},{"v":1143.5488170760873,"d":"1144"},{"v":9.496485926730717,"d":"9"},{"v":19.469154415498117,"d":"19"},{"v":50.276099765389205,"d":"50"},"Possible",0,6457,17,758,{"v":4881.52,"d":"4882"},{"v":8351.506518008051,"d":"8352"},{"v":8213.284219502071,"d":"8213"},{"v":138.22229850597978,"d":"138"},{"v":1.6829114251005366,"d":"2"},{"v":11.655579913867935,"d":"12"},{"v":2.4979045241301208,"d":"2"},{"$nulls":5},"Transcription,  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"SRQA(pS)TDAGC","Corresponds to amino acid residues S105 to G113.","S109 phosphorylation promotes nuclear export. This is one of the major sites of in vivo phosphorylation of YAP1.","LATS1; LATS2 (KPM)","Transcription, coactivator/corepressor","P46937","P46937",null,"P46937","GO:0005737; GO:0005829; GO:0016020; GO:0005654; GO:0005634; GO:0071148; GO:0071149","GO:0033613; GO:0003682; GO:0070064; GO:0008022; GO:0046982; GO:0000978; GO:0003713; GO:0003714; GO:0001076; GO:0044212","GO:0060449; GO:0061026; GO:0000902; GO:0008283; GO:0006974; GO:0071480; GO:0071300; GO:0060242; GO:0003143; GO:0003015; GO:0035329; GO:0030216; GO:0048368; GO:0060487; GO:0030857; GO:2001237; GO:2000737; GO:0030903; GO:0048339; GO:0090263; GO:0060045; GO:0033148; GO:1902459; GO:0045893; GO:0045944; GO:0050847; GO:0065003; GO:1902036; GO:0010837; GO:0072307; GO:0050767; GO:0072091; GO:0032570; GO:0035019; GO:0001894; GO:0006367; GO:0001570"]
[2674,1335,"PN681","YAP1","S109","Yorkie homologue",0,5564,16,740,{"v":4105.52,"d":"4106"},{"v":7214.001736503925,"d":"7214"},{"$nulls":3},0,8590,22,728,{"v":6237.504,"d":"6238"},{"v":10898.261447257848,"d":"10898"},{"$nulls":6},0,6362,18,744,{"v":4719.936,"d":"4720"},{"v":8075.061920996092,"d":"8075"},{"$nulls":10},"Transcription,  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"SRQA(pS)TDAGC","Corresponds to amino acid residues S105 to G113.","S109 phosphorylation promotes nuclear export. This is one of the major sites of in vivo phosphorylation of YAP1.","LATS1; LATS2 (KPM)",null,"P46937","P46937",null,"P46937"]
[2675,1336,"PN682","YAP1","T119","Yorkie homologue",0,10815,20,737,{"v":7955.915,"d":"7956"},{"v":13979.711370417783,"d":"13980"},{"v":13451.376833714112,"d":"13451"},{"v":528.3345367036709,"d":"528"},{"v":3.9277357495440146,"d":"4"},0,11890,20,766,{"v":9092.42,"d":"9092"},{"v":15886.41391625179,"d":"15886"},{"v":15386.186220630283,"d":"15386"},{"v":500.2276956215064,"d":"500"},{"v":3.251148065209203,"d":"3"},{"v":7.178883814753218,"d":"7"},{"v":14.383727486295868,"d":"14"},null,0,10128,26,823,{"v":8313.946,"d":"8314"},{"v":14223.843026222767,"d":"14224"},{"v":14110.492940011074,"d":"14110"},{"v":113.35008621169254,"d":"113"},{"v":0.8033035181236098,"d":"1"},{"v":4.731039267667624,"d":"5"},{"v":4.899989900253004,"d":"5"},{"$nulls":5},"Transcription,  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"CAGAL(pT)PQHV","Corresponds to amino acid residues C115 to V123.","The effect of T119 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of YAP1.","ERK1 (MAPK3); JNK1 (MAPK8); JNK2 (MAPK9)","Transcription, coactivator/corepressor","P46937","P46937",null,"P46937","GO:0005737; GO:0005829; GO:0016020; GO:0005654; GO:0005634; GO:0071148; GO:0071149","GO:0033613; GO:0003682; GO:0070064; GO:0008022; GO:0046982; GO:0000978; GO:0003713; GO:0003714; GO:0001076; GO:0044212","GO:0060449; GO:0061026; GO:0000902; GO:0008283; GO:0006974; GO:0071480; GO:0071300; GO:0060242; GO:0003143; GO:0003015; GO:0035329; GO:0030216; GO:0048368; GO:0060487; GO:0030857; GO:2001237; GO:2000737; GO:0030903; GO:0048339; GO:0090263; GO:0060045; GO:0033148; GO:1902459; GO:0045893; GO:0045944; GO:0050847; GO:0065003; GO:1902036; GO:0010837; GO:0072307; GO:0050767; GO:0072091; GO:0032570; GO:0035019; GO:0001894; GO:0006367; GO:0001570"]
[2676,1336,"PN682","YAP1","T119","Yorkie homologue",0,9798,18,752,{"v":7354.56,"d":"7355"},{"v":12923.04229701044,"d":"12923"},{"$nulls":3},0,11456,20,745,{"v":8519.82,"d":"8520"},{"v":14885.958525008778,"d":"14886"},{"$nulls":6},0,10032,18,817,{"v":8181.438,"d":"8181"},{"v":13997.14285379938,"d":"13997"},{"$nulls":10},"Transcription,  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"CAGAL(pT)PQHV","Corresponds to amino acid residues C115 to V123.","The effect of T119 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of YAP1.","ERK1 (MAPK3); JNK1 (MAPK8); JNK2 (MAPK9)",null,"P46937","P46937",null,"P46937"]
[2677,1337,"PN683","YAP1","S127","Yorkie homologue",0,9921,18,752,{"v":7447.056,"d":"7447"},{"v":13085.571356574066,"d":"13086"},{"v":12157.30579280619,"d":"12157"},{"v":928.2655637678763,"d":"928"},{"v":7.635454594858973,"d":"8"},0,11068,18,754,{"v":8331.7,"d":"8332"},{"v":14557.27241218895,"d":"14557"},{"v":14296.618489024244,"d":"14297"},{"v":260.6539231647057,"d":"261"},{"v":1.8231858349218322,"d":"2"},{"v":9.458640429780806,"d":"9"},{"v":17.596930871673422,"d":"18"},null,0,9868,18,807,{"v":7948.95,"d":"7949"},{"v":13599.392758058984,"d":"13599"},{"v":12537.790005838004,"d":"12538"},{"v":1061.6027522209806,"d":"1062"},{"v":8.467223902511238,"d":"8"},{"v":16.10267849737021,"d":"16"},{"v":3.12967543562948,"d":"3"},{"$nulls":5},"Transcription,  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"VRAH(pS)SPA(bA)C","Corresponds to amino acid residues V123 to A130.","S127 phosphorylation facilitates cytoplasmic retention with binding to the 14-3-3 protein YWHAB, and increased interaction with and transcriptional coactivity towards ERBB4. This is one of the major sites of in vivo phosphorylation of YAP1.","Akt1 (PKBa); LATS1; LATS2 (KPM); MST2 (CLIK1; STK3)","Transcription, coactivator/corepressor","P46937","P46937",null,"P46937","GO:0005737; GO:0005829; GO:0016020; GO:0005654; GO:0005634; GO:0071148; GO:0071149","GO:0033613; GO:0003682; GO:0070064; GO:0008022; GO:0046982; GO:0000978; GO:0003713; GO:0003714; GO:0001076; GO:0044212","GO:0060449; GO:0061026; GO:0000902; GO:0008283; GO:0006974; GO:0071480; GO:0071300; GO:0060242; GO:0003143; GO:0003015; GO:0035329; GO:0030216; GO:0048368; GO:0060487; GO:0030857; GO:2001237; GO:2000737; GO:0030903; GO:0048339; GO:0090263; GO:0060045; GO:0033148; GO:1902459; GO:0045893; GO:0045944; GO:0050847; GO:0065003; GO:1902036; GO:0010837; GO:0072307; GO:0050767; GO:0072091; GO:0032570; GO:0035019; GO:0001894; GO:0006367; GO:0001570"]
[2678,1337,"PN683","YAP1","S127","Yorkie homologue",0,8514,16,752,{"v":6390.496,"d":"6390"},{"v":11229.040229038314,"d":"11229"},{"$nulls":3},0,10803,20,745,{"v":8033.335,"d":"8033"},{"v":14035.964565859536,"d":"14036"},{"$nulls":6},0,8798,18,764,{"v":6707.92,"d":"6708"},{"v":11476.187253617021,"d":"11476"},{"$nulls":10},"Transcription,  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"VRAH(pS)SPA(bA)C","Corresponds to amino acid residues V123 to A130.","S127 phosphorylation facilitates cytoplasmic retention with binding to the 14-3-3 protein YWHAB, and increased interaction with and transcriptional coactivity towards ERBB4. This is one of the major sites of in vivo phosphorylation of YAP1.","Akt1 (PKBa); LATS1; LATS2 (KPM); MST2 (CLIK1; STK3)",null,"P46937","P46937",null,"P46937"]
[2679,1338,"NK186","Yes","Pan-specific","Yamaguchi sarcoma proto-oncogene-encoded tyrosine kinase",0,348,26,617,{"v":198.674,"d":"199"},{"v":349.0994029984461,"d":"349"},{"v":324.55908940795973,"d":"325"},{"v":24.54031359048639,"d":"25"},{"v":7.561123503042631,"d":"8"},0,390,22,588,{"v":216.384,"d":"216"},{"v":378.0694016394125,"d":"378"},{"v":342.3755434701784,"d":"342"},{"v":35.69385816923409,"d":"36"},{"v":10.42535275956213,"d":"10"},{"v":17.98647626260476,"d":"18"},{"v":5.48943309359116,"d":"5"},null,0,428,26,620,{"v":249.24,"d":"249"},{"v":426.4101108974923,"d":"426"},{"v":414.58990765487164,"d":"415"},{"v":11.820203242620664,"d":"12"},{"v":2.8510590886019536,"d":"3"},{"v":10.412182591644584,"d":"10"},{"v":27.739422861686137,"d":"28"},null,null,"Yes","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"Epitope undefined.",{"$nulls":3},"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; Src family","P07947","P07947","P07947","P07947","GO:0005884; GO:0005829; GO:0070062; GO:0031234; GO:0005925; GO:0098978; GO:0005794; GO:0005815; GO:0005886; GO:0099091","GO:0005524; GO:0019899; GO:0005154; GO:0044325; GO:0004715; GO:0001784; GO:0004713; GO:0005102","GO:0030154; GO:0016477; GO:0006464; GO:0036120; GO:0071300; GO:0071560; GO:0048013; GO:0038096; GO:0045087; GO:0050900; GO:0038083; GO:0050731; GO:0045944; GO:0042127; GO:0010827; GO:0043114; GO:0031295; GO:0007169"]
[2680,1338,"NK186","Yes","Pan-specific","Yamaguchi sarcoma proto-oncogene-encoded tyrosine kinase",0,308,22,597,{"v":170.742,"d":"171"},{"v":300.0187758174733,"d":"300"},{"$nulls":3},0,340,26,559,{"v":175.526,"d":"176"},{"v":306.68168530094425,"d":"307"},{"$nulls":6},0,427,58,638,{"v":235.422,"d":"235"},{"v":402.769704412251,"d":"403"},{"$nulls":7},"Yes","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"Epitope undefined.",{"$nulls":4},"P07947","P07947","P07947","P07947"]
[2681,1339,"PK858","Yes","Y222+Y223","Yamaguchi sarcoma proto-oncogene-encoded tyrosine kinase",0,8263,72,823,{"v":6741.193,"d":"6741"},{"v":11845.266375053123,"d":"11845"},{"v":11289.764590145061,"d":"11290"},{"v":555.5017849080614,"d":"556"},{"v":4.920401842505768,"d":"5"},0,9788,58,803,{"v":7813.19,"d":"7813"},{"v":13651.323888064928,"d":"13651"},{"v":12991.269687179793,"d":"12991"},{"v":660.0542008851353,"d":"660"},{"v":5.080752049482109,"d":"5"},{"v":10.001153891987876,"d":"10"},{"v":15.071218566594297,"d":"15"},null,0,8105,64,861,{"v":6923.301,"d":"6923"},{"v":11844.669985502806,"d":"11845"},{"v":11676.977588436142,"d":"11677"},{"v":167.69239706666303,"d":"168"},{"v":1.4360941930104492,"d":"1"},{"v":6.3564960355162174,"d":"6"},{"v":3.4297703481708055,"d":"3"},null,null,"Yes","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"NGG(pY)(pY)ITT(bA)C","Corresponds to amino acid residues N219 to T226; In the SH2 domain. ","The effects of Y222 and Y223 phosphorylation are unclear. These are two of the major in vivo phosphorylation sites in Yes (Y222 has >1799 reports; Y223 has > 670 reports).",null,"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; Src family","P07947","P07947","P07947","P07947","GO:0005884; GO:0005829; GO:0070062; GO:0031234; GO:0005925; GO:0098978; GO:0005794; GO:0005815; GO:0005886; GO:0099091","GO:0005524; GO:0019899; GO:0005154; GO:0044325; GO:0004715; GO:0001784; GO:0004713; GO:0005102","GO:0030154; GO:0016477; GO:0006464; GO:0036120; GO:0071300; GO:0071560; GO:0048013; GO:0038096; GO:0045087; GO:0050900; GO:0038083; GO:0050731; GO:0045944; GO:0042127; GO:0010827; GO:0043114; GO:0031295; GO:0007169"]
[2682,1339,"PK858","Yes","Y222+Y223","Yamaguchi sarcoma proto-oncogene-encoded tyrosine kinase",0,8232,65,748,{"v":6108.916,"d":"6109"},{"v":10734.262805237,"d":"10734"},{"$nulls":3},0,9760,92,730,{"v":7057.64,"d":"7058"},{"v":12331.215486294659,"d":"12331"},{"$nulls":6},0,8792,134,777,{"v":6727.266,"d":"6727"},{"v":11509.28519136948,"d":"11509"},{"$nulls":7},"Yes","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"NGG(pY)(pY)ITT(bA)C","Corresponds to amino acid residues N219 to T226; In the SH2 domain. ","The effects of Y222 and Y223 phosphorylation are unclear. These are two of the major in vivo phosphorylation sites in Yes (Y222 has >1799 reports; Y223 has > 670 reports).",null,null,"P07947","P07947","P07947","P07947"]
[2683,1340,"NK214","YSK1 (STK25, SOK1)","Pan-specific","Protein-serine/threonine kinase 25",0,470,12,725,{"v":332.05,"d":"332"},{"v":583.4606277904207,"d":"583"},{"v":561.6544347746727,"d":"562"},{"v":21.806193015748022,"d":"22"},{"v":3.8824928044049605,"d":"4"},0,516,14,649,{"v":325.798,"d":"326"},{"v":569.2391993646356,"d":"569"},{"v":556.8706633628731,"d":"557"},{"v":12.36853600176255,"d":"12"},{"v":2.2210787558946796,"d":"2"},{"v":6.10357156029964,"d":"6"},{"v":-0.851728592460745,"d":"-1"},null,0,474,10,738,{"v":342.432,"d":"342"},{"v":585.846842781456,"d":"586"},{"v":626.6264584264272,"d":"627"},{"v":40.77961564497127,"d":"41"},{"v":6.507803029475692,"d":"7"},{"v":10.390295833880653,"d":"10"},{"v":11.56797127006044,"d":"12"},null,null,"YSK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","YSK",{"$nulls":5},"Epitope undefined.",{"$nulls":3},"Protein-serine kinase, STE group, STE20 family, YSK subfamily","O00506","O00506","O00506","O00506","GO:0005737; GO:0070062; GO:0000139","GO:0005524; GO:0008349; GO:0046872; GO:0042803; GO:0004672","GO:0051683; GO:0007163; GO:0051645; GO:0090168; GO:0036481; GO:0048812; GO:0050772; GO:0032874; GO:0046777; GO:0006468; GO:0042981; GO:0007346; GO:0042542; GO:0006979; GO:0007165"]
[2684,1340,"NK214","YSK1 (STK25, SOK1)","Pan-specific","Protein-serine/threonine kinase 25",0,486,24,665,{"v":307.23,"d":"307"},{"v":539.8482417589247,"d":"540"},{"$nulls":3},0,506,16,636,{"v":311.64,"d":"312"},{"v":544.5021273611104,"d":"545"},{"$nulls":6},0,594,22,682,{"v":390.104,"d":"390"},{"v":667.4060740713984,"d":"667"},{"$nulls":7},"YSK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","YSK",{"$nulls":5},"Epitope undefined.",{"$nulls":4},"O00506","O00506","O00506","O00506"]
[2685,1341,"PK859","YSK1 (STK25, SOK1)","T174","Serine/threonine-protein kinase 25",0,12567,20,814,{"v":10213.258,"d":"10213"},{"v":17946.19462269398,"d":"17946"},{"v":15510.948921141822,"d":"15511"},{"v":2435.2457015521577,"d":"2435"},{"v":15.700172271425995,"d":"16"},0,14328,22,779,{"v":11144.374,"d":"11144"},{"v":19471.619019085636,"d":"19472"},{"v":16439.363828832356,"d":"16439"},{"v":3032.2551902532796,"d":"3032"},{"v":18.44508839773426,"d":"18"},{"v":34.14526066916025,"d":"34"},{"v":5.985545516335762,"d":"6"},null,0,10846,20,836,{"v":9050.536,"d":"9051"},{"v":15484.031694117102,"d":"15484"},{"v":14801.648914417407,"d":"14802"},{"v":682.3827796996957,"d":"682"},{"v":4.610180822725955,"d":"5"},{"v":20.31035309415195,"d":"20"},{"v":-4.572898862155512,"d":"-5"},null,null,"YSK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","YSK",{"$nulls":5},"KRN(pT)FVG(bA)C","Corresponds to amino acid residues K171 to G177; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T174 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of YSK1.",null,"Protein-serine kinase, STE group, STE20 family, YSK subfamily","O00506","O00506","O00506","O00506","GO:0005737; GO:0070062; GO:0000139","GO:0005524; GO:0008349; GO:0046872; GO:0042803; GO:0004672","GO:0051683; GO:0007163; GO:0051645; GO:0090168; GO:0036481; GO:0048812; GO:0050772; GO:0032874; GO:0046777; GO:0006468; GO:0042981; GO:0007346; GO:0042542; GO:0006979; GO:0007165"]
[2686,1341,"PK859","YSK1 (STK25, SOK1)","T174","Serine/threonine-protein kinase 25",0,10076,20,740,{"v":7441.44,"d":"7441"},{"v":13075.703219589665,"d":"13076"},{"$nulls":3},0,10650,22,722,{"v":7673.416,"d":"7673"},{"v":13407.108638579075,"d":"13407"},{"$nulls":6},0,10810,22,765,{"v":8252.82,"d":"8253"},{"v":14119.26613471771,"d":"14119"},{"$nulls":7},"YSK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","YSK",{"$nulls":5},"KRN(pT)FVG(bA)C","Corresponds to amino acid residues K171 to G177; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T174 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of YSK1.",null,null,"O00506","O00506","O00506","O00506"]
[2687,1342,"NK256-2","YSK4 (MAP3K19)","Pan-specific","SPS1/STE20-related protein kinase YSK4; Mitogen-activated protein kinase kinase kinase 8",0,4926,14,716,{"v":3516.992,"d":"3517"},{"v":6179.871586369183,"d":"6180"},{"v":6689.479329997486,"d":"6689"},{"v":509.60774362830307,"d":"510"},{"v":7.618047959922385,"d":"8"},0,5022,16,699,{"v":3499.194,"d":"3499"},{"v":6113.844747302122,"d":"6114"},{"v":6269.395817109287,"d":"6269"},{"v":155.55106980716482,"d":"156"},{"v":2.481117389057863,"d":"2"},{"v":10.099165348980248,"d":"10"},{"v":-6.279763972129004,"d":"-6"},null,0,5648,16,790,{"v":4449.28,"d":"4449"},{"v":7612.012430645139,"d":"7612"},{"v":7949.686330573604,"d":"7950"},{"v":337.6738999284653,"d":"338"},{"v":4.247638031073116,"d":"4"},{"v":11.865685990995502,"d":"12"},{"v":18.838641072183293,"d":"19"},null,null,"YSK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"CSALQLLKHSFLERSH","Corresponds to amino acid residues S1314 to H1328; Kinase last alpha-chain + C-terminus.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE11 family","Q56UN5","Q56UN5","Q56UN5",null,"GO:0005737","GO:0005524; GO:0004674","GO:0032147; GO:0042981; GO:0007346; GO:0023014; GO:0031098"]
[2688,1342,"NK256-2","YSK4 (MAP3K19)","Pan-specific","SPS1/STE20-related protein kinase YSK4; Mitogen-activated protein kinase kinase kinase 8",0,5506,14,746,{"v":4097.032,"d":"4097"},{"v":7199.087073625788,"d":"7199"},{"$nulls":3},0,4917,14,750,{"v":3677.25,"d":"3677"},{"v":6424.946886916453,"d":"6425"},{"$nulls":6},0,5771,18,842,{"v":4844.026,"d":"4844"},{"v":8287.36023050207,"d":"8287"},{"$nulls":7},"YSK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"CSALQLLKHSFLERSH","Corresponds to amino acid residues S1314 to H1328; Kinase last alpha-chain + C-terminus.",{"$nulls":3},"Q56UN5","Q56UN5","Q56UN5"]
[2689,1343,"NK256-3","YSK4 (MAP3K19)","Pan-specific","SPS1/STE20-related protein kinase YSK4; Mitogen-activated protein kinase kinase kinase 8",0,4558,14,718,{"v":3262.592,"d":"3263"},{"v":5732.853415280844,"d":"5733"},{"v":5347.061270738897,"d":"5347"},{"v":385.792144541947,"d":"386"},{"v":7.215031304263235,"d":"7"},0,4926,18,719,{"v":3528.852,"d":"3529"},{"v":6165.663654031925,"d":"6166"},{"v":5804.694247003228,"d":"5805"},{"v":360.9694070286969,"d":"361"},{"v":6.218577442128902,"d":"6"},{"v":13.433608746392137,"d":"13"},{"v":8.558588598351548,"d":"9"},null,0,4172,14,738,{"v":3068.604,"d":"3069"},{"v":5249.894767856236,"d":"5250"},{"v":5322.92716560135,"d":"5323"},{"v":73.03239774511349,"d":"73"},{"v":1.3720345117076715,"d":"1"},{"v":8.587065815970906,"d":"9"},{"v":-0.4513526947899038,"d":"-0"},null,null,"YSK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"CHGSKTRKPEEENSQY","Corresponds to amino acid residues C350 to Y366.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE11 family","Q56UN5","Q56UN5","Q56UN5",null,"GO:0005737","GO:0005524; GO:0004674","GO:0032147; GO:0042981; GO:0007346; GO:0023014; GO:0031098"]
[2690,1343,"NK256-3","YSK4 (MAP3K19)","Pan-specific","SPS1/STE20-related protein kinase YSK4; Mitogen-activated protein kinase kinase kinase 8",0,3974,14,713,{"v":2823.48,"d":"2823"},{"v":4961.269126196949,"d":"4961"},{"$nulls":3},0,4532,10,689,{"v":3115.658,"d":"3116"},{"v":5443.72483997453,"d":"5444"},{"$nulls":6},0,4415,10,716,{"v":3153.98,"d":"3154"},{"v":5395.959563346464,"d":"5396"},{"$nulls":7},"YSK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"CHGSKTRKPEEENSQY","Corresponds to amino acid residues C350 to Y366.",{"$nulls":3},"Q56UN5","Q56UN5","Q56UN5"]
[2691,1344,"NK187-2","ZAP70","Pan-specific","Zeta-chain (TCR) associated protein-tyrosine kinase, 70 kDa",0,230,10,623,{"v":137.06,"d":"137"},{"v":240.8345539676406,"d":"241"},{"v":246.91428223794583,"d":"247"},{"v":6.079728270305225,"d":"6"},{"v":2.462282949046392,"d":"2"},0,259,14,673,{"v":164.885,"d":"165"},{"v":288.08956895756864,"d":"288"},{"v":290.6571016111342,"d":"291"},{"v":2.567532653565536,"d":"3"},{"v":0.8833545230216325,"d":"1"},{"v":3.3456374720680246,"d":"3"},{"v":17.715791479017966,"d":"18"},null,0,232,10,632,{"v":140.304,"d":"140"},{"v":240.03789198909388,"d":"240"},{"v":270.8090854355804,"d":"271"},{"v":30.771193446486535,"d":"31"},{"v":11.362688735864563,"d":"11"},{"v":13.824971684910954,"d":"14"},{"v":9.677367781669147,"d":"10"},null,null,"ZAP70","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Syk",{"$nulls":6},"Epitope undefined.",{"$nulls":3},"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; Syk family","P43403","P43403","P43403",null,"GO:0005911; GO:0005737; GO:0005829; GO:0031234; GO:0001772; GO:0005886; GO:0042101","GO:0005524; GO:0004715; GO:0001784; GO:0004713; GO:0005102","GO:0002250; GO:0042113; GO:0043366; GO:0006955; GO:0045087; GO:0035556; GO:0045060; GO:0038083; GO:0018108; GO:0046638; GO:0046641; GO:0050850; GO:0045582; GO:0045059; GO:0006468; GO:0042127; GO:0042110; GO:0070489; GO:0030217; GO:0072678; GO:0050852; GO:0007169"]
[2692,1344,"NK187-2","ZAP70","Pan-specific","Zeta-chain (TCR) associated protein-tyrosine kinase, 70 kDa",0,244,14,626,{"v":143.98,"d":"144"},{"v":252.99401050825105,"d":"253"},{"$nulls":3},0,284,12,617,{"v":167.824,"d":"168"},{"v":293.22463426469966,"d":"293"},{"$nulls":6},0,264,10,694,{"v":176.276,"d":"176"},{"v":301.5802788820669,"d":"302"},{"$nulls":7},"ZAP70","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Syk",{"$nulls":6},"Epitope undefined.",{"$nulls":4},"P43403","P43403","P43403"]
[2693,1345,"NK187","ZAP70","Pan-specific","Zeta-chain (TCR) associated protein-tyrosine kinase, 70 kDa",1,44,10,651,{"v":22.134,"d":"22"},{"v":38.89268946096423,"d":"39"},{"v":37.664443778610654,"d":"38"},{"v":1.228245682353574,"d":"1"},{"v":3.2610216934919536,"d":"3"},1,276,6,400,108,{"v":188.69923551212915,"d":"189"},{"v":170.0022862601357,"d":"170"},{"v":18.69694925199346,"d":"19"},{"v":10.998057533993153,"d":"11"},{"v":14.259079227485106,"d":"14"},{"v":351.3601402410161,"d":"351"},null,1,51,10,667,{"v":27.347,"d":"27"},{"v":46.7863798054635,"d":"47"},{"v":95.90035933760024,"d":"96"},{"v":49.11397953213674,"d":"49"},{"v":51.21355109759252,"d":"51"},{"v":54.474572791084476,"d":"54"},{"v":154.61775010218338,"d":"155"},null,null,"ZAP70","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Syk",{"$nulls":6},"Epitope undefined.",{"$nulls":3},"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; Syk family","P43403","P43403","P43403",null,"GO:0005911; GO:0005737; GO:0005829; GO:0031234; GO:0001772; GO:0005886; GO:0042101","GO:0005524; GO:0004715; GO:0001784; GO:0004713; GO:0005102","GO:0002250; GO:0042113; GO:0043366; GO:0006955; GO:0045087; GO:0035556; GO:0045060; GO:0038083; GO:0018108; GO:0046638; GO:0046641; GO:0050850; GO:0045582; GO:0045059; GO:0006468; GO:0042127; GO:0042110; GO:0070489; GO:0030217; GO:0072678; GO:0050852; GO:0007169"]
[2694,1345,"NK187","ZAP70","Pan-specific","Zeta-chain (TCR) associated protein-tyrosine kinase, 70 kDa",0,46,14,648,{"v":20.736,"d":"21"},{"v":36.43619809625708,"d":"36"},{"$nulls":3},0,316,10,283,{"v":86.598,"d":"87"},{"v":151.30533700814223,"d":"151"},{"$nulls":6},0,287,10,306,{"v":84.762,"d":"85"},{"v":145.01433886973697,"d":"145"},{"$nulls":7},"ZAP70","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Syk",{"$nulls":6},"Epitope undefined.",{"$nulls":4},"P43403","P43403","P43403"]
[2695,1346,"PK860","ZAP70","Y248","Zeta-chain (TCR) associated protein-tyrosine kinase, 70 kDa",0,168,10,572,{"v":90.376,"d":"90"},{"v":158.80390813789208,"d":"159"},{"v":159.65173151662682,"d":"160"},{"v":0.8478233787347449,"d":"1"},{"v":0.5310455268356729,"d":"1"},0,204,12,586,{"v":112.512,"d":"113"},{"v":196.58267024019142,"d":"197"},{"v":185.56473154445544,"d":"186"},{"v":11.017938695735978,"d":"11"},{"v":5.937517654369806,"d":"6"},{"v":6.468563181205479,"d":"6"},{"v":16.230954579487246,"d":"16"},null,0,206,14,618,{"v":118.656,"d":"119"},{"v":203.0015973304961,"d":"203"},{"v":211.30602149313626,"d":"211"},{"v":8.304424162640146,"d":"8"},{"v":3.9300461501093062,"d":"4"},{"v":4.461091676944979,"d":"4"},{"v":32.354356251457205,"d":"32"},null,null,"ZAP70","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Syk",{"$nulls":6},"GLI(pY)CLK(bA)C","Corresponds to amino acid residues G245 to K251; In the intervening region between the SH2 and kinase catalytic domains. ","The effect of Y248 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in ZAP70 (≥344 reports).",null,"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; Syk family","P43403","P43403","P43403",null,"GO:0005911; GO:0005737; GO:0005829; GO:0031234; GO:0001772; GO:0005886; GO:0042101","GO:0005524; GO:0004715; GO:0001784; GO:0004713; GO:0005102","GO:0002250; GO:0042113; GO:0043366; GO:0006955; GO:0045087; GO:0035556; GO:0045060; GO:0038083; GO:0018108; GO:0046638; GO:0046641; GO:0050850; GO:0045582; GO:0045059; GO:0006468; GO:0042127; GO:0042110; GO:0070489; GO:0030217; GO:0072678; GO:0050852; GO:0007169"]
[2696,1346,"PK860","ZAP70","Y248","Zeta-chain (TCR) associated protein-tyrosine kinase, 70 kDa",0,213,14,459,{"v":91.341,"d":"91"},{"v":160.49955489536157,"d":"160"},{"$nulls":3},0,241,16,444,{"v":99.9,"d":"100"},{"v":174.54679284871946,"d":"175"},{"$nulls":6},0,244,16,563,{"v":128.364,"d":"128"},{"v":219.61044565577637,"d":"220"},{"$nulls":7},"ZAP70","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Syk",{"$nulls":6},"GLI(pY)CLK(bA)C","Corresponds to amino acid residues G245 to K251; In the intervening region between the SH2 and kinase catalytic domains. ","The effect of Y248 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in ZAP70 (≥344 reports).",null,null,"P43403","P43403","P43403"]
[2697,1347,"PK861","ZAP70","Y292","Zeta-chain (TCR) associated protein-tyrosine kinase, 70 kDa",0,2297,14,690,{"v":1575.27,"d":"1575"},{"v":2767.9807954808493,"d":"2768"},{"v":2844.3235567987545,"d":"2844"},{"v":76.34276131790511,"d":"76"},{"v":2.684039273078616,"d":"3"},0,2468,16,697,{"v":1709.044,"d":"1709"},{"v":2986.0675579314006,"d":"2986"},{"v":3003.4034265865057,"d":"3003"},{"v":17.33586865510506,"d":"17"},{"v":0.5772074607642038,"d":"1"},{"v":3.2612467338428197,"d":"3"},{"v":5.592889367579318,"d":"6"},null,0,2328,16,684,{"v":1581.408,"d":"1581"},{"v":2705.5382789848395,"d":"2706"},{"v":2940.045020723044,"d":"2940"},{"v":234.5067417382047,"d":"235"},{"v":7.976297644603162,"d":"8"},{"v":10.660336917681779,"d":"11"},{"v":3.3653507420239777,"d":"3"},null,null,"ZAP70","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Syk",{"$nulls":6},"SDG(pY)TPE(bA)C","Corresponds to amino acid residues S289 to E295; In the region between the SH2 domain and the protein kinase catalytic domain.","Phosphorylation of Y292 Inhibits phosphotransferase activity, and regulates cell adhesion, cell growth, intracellular location, protein degradation and molecular association, including inducing interaction with Cbl. This is one of the major in vivo phosphorylation sites of ZAP70 by mass spectrometry studies (≥448 reports).","Lck; ZAP70","Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; Syk family","P43403","P43403","P43403",null,"GO:0005911; GO:0005737; GO:0005829; GO:0031234; GO:0001772; GO:0005886; GO:0042101","GO:0005524; GO:0004715; GO:0001784; GO:0004713; GO:0005102","GO:0002250; GO:0042113; GO:0043366; GO:0006955; GO:0045087; GO:0035556; GO:0045060; GO:0038083; GO:0018108; GO:0046638; GO:0046641; GO:0050850; GO:0045582; GO:0045059; GO:0006468; GO:0042127; GO:0042110; GO:0070489; GO:0030217; GO:0072678; GO:0050852; GO:0007169"]
[2698,1347,"PK861","ZAP70","Y292","Zeta-chain (TCR) associated protein-tyrosine kinase, 70 kDa",0,2684,16,623,{"v":1662.164,"d":"1662"},{"v":2920.6663181166596,"d":"2921"},{"$nulls":3},0,3032,20,574,{"v":1728.888,"d":"1729"},{"v":3020.7392952416103,"d":"3021"},{"$nulls":6},0,2968,18,629,{"v":1855.55,"d":"1856"},{"v":3174.5517624612494,"d":"3175"},{"$nulls":7},"ZAP70","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Syk",{"$nulls":6},"SDG(pY)TPE(bA)C","Corresponds to amino acid residues S289 to E295; In the region between the SH2 domain and the protein kinase catalytic domain.","Phosphorylation of Y292 Inhibits phosphotransferase activity, and regulates cell adhesion, cell growth, intracellular location, protein degradation and molecular association, including inducing interaction with Cbl. This is one of the major in vivo phosphorylation sites of ZAP70 by mass spectrometry studies (≥448 reports).","Lck; ZAP70",null,"P43403","P43403","P43403"]
[2699,1348,"PK862","ZAP70","Y319","Zeta-chain (TCR) associated protein-tyrosine kinase, 70 kDa",0,6120,14,798,{"v":4872.588,"d":"4873"},{"v":8561.85289397401,"d":"8562"},{"v":8504.71750540833,"d":"8505"},{"v":57.13538856567902,"d":"57"},{"v":0.6718081879773833,"d":"1"},0,6888,18,866,{"v":5949.42,"d":"5949"},{"v":10394.916719820105,"d":"10395"},{"v":9406.941686348051,"d":"9407"},{"v":987.9750334720538,"d":"988"},{"v":10.502616752752553,"d":"11"},{"v":11.174424940729937,"d":"11"},{"v":10.608514396462624,"d":"11"},null,0,6208,20,787,{"v":4869.956,"d":"4870"},{"v":8331.72234804168,"d":"8332"},{"v":8601.42451909052,"d":"8601"},{"v":269.7021710488407,"d":"270"},{"v":3.135552377983989,"d":"3"},{"v":3.8073605659613725,"d":"4"},{"v":1.1370984823504386,"d":"1"},null,null,"ZAP70","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Syk",{"$nulls":6},"ESP(pY)SDP(bA)C","Corresponds to amino acid residues E316 to P322; In the region between the SH2 and kinase catalytic domains.","Y319 phosphorylation stimulates phosphotransferase activity and regulates intracellular location, transcription and molecular association, including inducing interaction with Lck and PLCG1. This is one of the major in vivo phosphorylation sites of ZAP70 by mass spectrometry studies (≥259 reports).","Abl1; ZAP70","Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; Syk family","P43403","P43403","P43403",null,"GO:0005911; GO:0005737; GO:0005829; GO:0031234; GO:0001772; GO:0005886; GO:0042101","GO:0005524; GO:0004715; GO:0001784; GO:0004713; GO:0005102","GO:0002250; GO:0042113; GO:0043366; GO:0006955; GO:0045087; GO:0035556; GO:0045060; GO:0038083; GO:0018108; GO:0046638; GO:0046641; GO:0050850; GO:0045582; GO:0045059; GO:0006468; GO:0042127; GO:0042110; GO:0070489; GO:0030217; GO:0072678; GO:0050852; GO:0007169"]
[2700,1348,"PK862","ZAP70","Y319","Zeta-chain (TCR) associated protein-tyrosine kinase, 70 kDa",0,6286,18,767,{"v":4807.556,"d":"4808"},{"v":8447.582116842654,"d":"8448"},{"$nulls":3},0,6558,20,737,{"v":4818.506,"d":"4819"},{"v":8418.966652875995,"d":"8419"},{"$nulls":6},0,6615,18,786,{"v":5185.242,"d":"5185"},{"v":8871.126690139363,"d":"8871"},{"$nulls":7},"ZAP70","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Syk",{"$nulls":6},"ESP(pY)SDP(bA)C","Corresponds to amino acid residues E316 to P322; In the region between the SH2 and kinase catalytic domains.","Y319 phosphorylation stimulates phosphotransferase activity and regulates intracellular location, transcription and molecular association, including inducing interaction with Lck and PLCG1. This is one of the major in vivo phosphorylation sites of ZAP70 by mass spectrometry studies (≥259 reports).","Abl1; ZAP70",null,"P43403","P43403","P43403"]
[2701,1349,"PK863","ZAP70","Y492+Y493","Zeta-chain (TCR) associated protein-tyrosine kinase, 70 kDa",0,8282,18,810,{"v":6693.84,"d":"6694"},{"v":11762.060197947989,"d":"11762"},{"v":11655.492752821552,"d":"11655"},{"v":106.56744512643672,"d":"107"},{"v":0.9143109380822957,"d":"1"},0,9411,22,891,{"v":8365.599,"d":"8366"},{"v":14616.50125834289,"d":"14617"},{"v":13253.157144235904,"d":"13253"},{"v":1363.344114106987,"d":"1363"},{"v":10.28693841980087,"d":"10"},{"v":11.201249357883166,"d":"11"},{"v":13.707394661865237,"d":"14"},null,0,8618,28,578,{"v":4965.02,"d":"4965"},{"v":8494.361775029158,"d":"8494"},{"v":11226.900553011688,"d":"11227"},{"v":2732.5387779825305,"d":"2733"},{"v":24.339208894564486,"d":"24"},{"v":25.25351983264678,"d":"25"},{"v":-3.6771692874684447,"d":"-4"},null,null,"ZAP70","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Syk",{"$nulls":6},"DDS(pY)(pY)TAR(bA)C","Corresponds to amino acid residues D489 to R496; In the protein kinase catalytic domain.","Y492+Y493 phosphorylation inhibits phosphotransferase activity and regulates transcription. This is one of the major sites of in vivo phosphorylation of ZAP70.","Y492: Lck; ZAP70. Y493: Lck; ZAP70.","Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; Syk family","P43403","P43403","P43403",null,"GO:0005911; GO:0005737; GO:0005829; GO:0031234; GO:0001772; GO:0005886; GO:0042101","GO:0005524; GO:0004715; GO:0001784; GO:0004713; GO:0005102","GO:0002250; GO:0042113; GO:0043366; GO:0006955; GO:0045087; GO:0035556; GO:0045060; GO:0038083; GO:0018108; GO:0046638; GO:0046641; GO:0050850; GO:0045582; GO:0045059; GO:0006468; GO:0042127; GO:0042110; GO:0070489; GO:0030217; GO:0072678; GO:0050852; GO:0007169"]
[2702,1349,"PK863","ZAP70","Y492+Y493","Zeta-chain (TCR) associated protein-tyrosine kinase, 70 kDa",0,8584,26,768,{"v":6572.544,"d":"6573"},{"v":11548.925307695114,"d":"11549"},{"$nulls":3},0,8816,24,774,{"v":6805.008,"d":"6805"},{"v":11889.813030128917,"d":"11890"},{"$nulls":6},0,9090,24,900,{"v":8159.4,"d":"8159"},{"v":13959.439330994217,"d":"13959"},{"$nulls":7},"ZAP70","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Syk",{"$nulls":6},"DDS(pY)(pY)TAR(bA)C","Corresponds to amino acid residues D489 to R496; In the protein kinase catalytic domain.","Y492+Y493 phosphorylation inhibits phosphotransferase activity and regulates transcription. This is one of the major sites of in vivo phosphorylation of ZAP70.","Y492: Lck; ZAP70. Y493: Lck; ZAP70.",null,"P43403","P43403","P43403"]
[2703,1350,"NK301-1","ZC2 (TNIK)","Pan-specific","TRAF2 and NCK-interacting kinase",0,1279,16,709,{"v":895.467,"d":"895"},{"v":1573.4670621460762,"d":"1573"},{"v":1404.630723788731,"d":"1405"},{"v":168.83633835734508,"d":"169"},{"v":12.019980447383377,"d":"12"},0,1320,18,744,{"v":968.688,"d":"969"},{"v":1692.506343053457,"d":"1693"},{"v":1471.5832186473444,"d":"1472"},{"v":220.9231244061125,"d":"221"},{"v":15.012615094182813,"d":"15"},{"v":27.032595541566188,"d":"27"},{"v":4.7665549190054435,"d":"5"},null,0,1066,20,674,{"v":705.004,"d":"705"},{"v":1206.1500313881224,"d":"1206"},{"v":1300.7441633157155,"d":"1301"},{"v":94.59413192759303,"d":"95"},{"v":7.272308774883444,"d":"7"},{"v":19.29228922226682,"d":"19"},{"v":-7.396005135983415,"d":"-7"},null,null,"ZC2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","MSN",{"$nulls":5},"CGSSQVFFMTLNRNSMMNW","Corresponds to amino acid residues G1343 to W1360; C-terminus.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE20 family; MSN subfamily","Q9UKE5","Q9UKE5","Q9UKE5",null,"GO:0016324; GO:0005737; GO:0005856; GO:0005829; GO:0070062; GO:0098978; GO:0005654; GO:0005634; GO:0099092; GO:0098793; GO:0055037","GO:0005524; GO:0008349; GO:0004672; GO:0004674","GO:0031532; GO:0007256; GO:0007010; GO:0035556; GO:0030033; GO:0001934; GO:0046777; GO:0072659; GO:0006468; GO:0042981; GO:0048814; GO:0007346; GO:0016055"]
[2704,1350,"NK301-1","ZC2 (TNIK)","Pan-specific","TRAF2 and NCK-interacting kinase",0,1021,22,704,{"v":703.296,"d":"703"},{"v":1235.794385431386,"d":"1236"},{"$nulls":3},0,1154,16,629,{"v":715.802,"d":"716"},{"v":1250.6600942412322,"d":"1251"},{"$nulls":6},0,1102,16,751,{"v":815.586,"d":"816"},{"v":1395.3382952433083,"d":"1395"},{"$nulls":7},"ZC2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","MSN",{"$nulls":5},"CGSSQVFFMTLNRNSMMNW","Corresponds to amino acid residues G1343 to W1360; C-terminus.",{"$nulls":3},"Q9UKE5","Q9UKE5","Q9UKE5"]
[]
[{"$nulls":6},"Heading","Signal Median","Background Median","Spot Area","Not Normalized Net Signal","Normalized Net Signal","Average Normalized Net Signal","Error in Duplicate from Average","% Error in Duplicate from Average","Heading","Signal Median","Background Median","Spot Area","Not Normalized Net Signal","Normalized Net Signal","Average Normalized Net Signal","Error in Duplicate from Average","% Error in Duplicate from Average","SUM % Error ","%CFC",null,"Heading","Signal Median","Background Median","Spot Area","Not Normalized Net Signal","Normalized Net Signal","Average Normalized Net Signal","Error in Duplicate from Average","% Error in Duplicate from Average","SUM % Error ","%CFC"]
[{"$nulls":6},"Average",{"v":4457.432592592592,"d":"4457"},{"v":15.185555555555556,"d":"15"},{"v":635.282962962963,"d":"635"},{"v":3161.691011111117,"d":"3162"},{"v":5555.555558931755,"d":"5556"},{"v":5555.555558931753,"d":"5556"},{"v":342.0394733162652,"d":"342"},{"v":9.610824481606633,"d":"10"},"Average",{"v":4640.1381481481485,"d":"4640"},{"v":15.555555555555555,"d":"16"},{"v":608.4081481481481,"d":"608"},{"v":3179.6631203703705,"d":"3180"},{"v":5555.555416824218,"d":"5556"},{"v":5555.555416824234,"d":"5556"},{"v":392.2883186314219,"d":"392"},{"v":11.29734133295137,"d":"11"},{"v":20.908165814558025,"d":"21"},{"v":13.237855102728998,"d":"13"},null,"Average",{"v":4614.155925925926,"d":"4614"},{"v":15.305185185185184,"d":"15"},{"v":626.1103703703703,"d":"626"},{"v":3247.2650888888897,"d":"3247"},{"v":5555.55555084578,"d":"5556"},{"v":5555.555550845793,"d":"5556"},{"v":288.39332475261756,"d":"288"},{"v":8.17027113734777,"d":"8"},{"$f":"AVERAGE(AK18:AK2717)","v":{"v":17.781095618954367,"d":"18"}},{"v":9.855300157849435,"d":"10"}]
[{"$nulls":6},"Median",{"v":3480.5,"d":"3481"},14,654,{"v":2317.62,"d":"2318"},{"v":4072.398798378,"d":"4072"},{"v":4192.2744349030745,"d":"4192"},{"v":115.34175823634939,"d":"115"},{"v":5.146774293582057,"d":"5"},"Median",3592,16,629,{"v":2231.6634999999997,"d":"2232"},{"v":3899.19616531885,"d":"3899"},{"v":4042.8478228031,"d":"4043"},{"v":162.08958163077477,"d":"162"},{"v":6.568361183031017,"d":"7"},{"v":13.4330288688297,"d":"13"},{"v":-1.3732325526330769,"d":"-1"},null,"Median",3742,14,649,{"v":2452.2105,"d":"2452"},{"v":4195.3432449147,"d":"4195"},{"v":4254.78942333015,"d":"4255"},{"v":110.6837397936998,"d":"111"},{"v":4.607436197635783,"d":"5"},{"$f":"MEDIAN(AK18:AK2717)","v":{"v":10.895699381546919,"d":"11"}},{"v":2.586641783865282,"d":"3"}]
[{"$nulls":6},"Max",20338,466,1123,{"v":22799.146,"d":"22799"},{"v":40061.4487165474,"d":"40061"},{"v":38219.37187828279,"d":"38219"},{"v":7869.454434672899,"d":"7869"},{"v":94.95167234545579,"d":"95"},"Max",20948,198,1124,{"v":21862.563,"d":"21863"},{"v":38198.6001983013,"d":"38199"},{"v":38093.84853780345,"d":"38094"},{"v":10055.263086447301,"d":"10055"},{"v":94.45430912213281,"d":"94"},{"v":182.3858992421243,"d":"182"},{"v":16155.73206981302,"d":"16156"},null,"Max",20100,140,1137,{"v":22421.64,"d":"22422"},{"v":38359.869967896004,"d":"38360"},{"v":36176.63788389361,"d":"36177"},{"v":5604.518824218299,"d":"5605"},{"v":99.38340207468607,"d":"99"},{"$f":"MAX(AK18:AK2717)","v":{"v":193.62123943505958,"d":"194"}},{"v":6241.984331582711,"d":"6242"}]
[{"$nulls":6},"Min",4,2,103,{"v":1.512,"d":"2"},{"v":2.6568061128,"d":"3"},{"v":3.8586945924,"d":"4"},{"v":0.06852872909999963,"d":"0"},{"v":0.01781629264329135,"d":"0"},"Min",6,2,106,{"v":2.172,"d":"2"},{"v":3.7949511972000005,"d":"4"},{"v":7.0901988758000005,"d":"7"},{"v":0.05765809829999924,"d":"0"},{"v":0.021331776487891557,"d":"0"},{"v":0.06910137726611777,"d":"0"},{"v":-98.36960201610962,"d":"-98"},null,"Min",6,2,105,{"v":2.538,"d":"3"},{"v":4.3421154732,"d":"4"},{"v":5.7946198218,"d":"6"},{"v":0.022240938200013716,"d":"0"},{"v":0.004986654138802907,"d":"0"},{"$f":"MIN(AK18:AK2717)","v":{"v":0.25260748451120363,"d":"0"}},{"v":-96.47542081754212,"d":"-96"}]
[{"$nulls":6},"Sum",12035068,41001,1715264,{"v":8536565.730000015,"d":"8536566"},{"v":15000000.009115737,"d":"15000000"},{"v":7500000.004557867,"d":"7500000"},{"v":461753.288976958,"d":"461753"},{"v":12974.613050168953,"d":"12975"},"Sum",12528373,42000,1642702,{"v":8585090.425,"d":"8585090"},{"v":14999999.625425387,"d":"15000000"},{"v":7499999.812712717,"d":"7500000"},{"v":529589.2301524195,"d":"529589"},{"v":15251.41079948435,"d":"15251"},{"v":28226.023849653335,"d":"28226"},{"v":17871.104388684147,"d":"17871"},null,"Sum",12458221,41324,1690498,{"v":8767615.740000002,"d":"8767616"},{"v":14999999.987283606,"d":"15000000"},{"v":7499999.993641821,"d":"7500000"},{"v":389330.9884160337,"d":"389331"},{"v":11029.866035419489,"d":"11030"},{"$f":"SUM(AK18:AK2717)","v":{"v":24004.479085588395,"d":"24004"}},{"$f":"SUM(AL18:AL2717)","v":{"v":13304.655213096737,"d":"13305"}}]

{"sheet":"Formulas","index":2,"n_rows":2727,"n_cols":65,"rows_kept":1125,"cut":true,"merged":[[0,12,5,26],[7,12,8,26],[13,2,13,3],[14,2,14,3],[15,6,15,11],[15,15,15,20],[15,24,15,26],[15,27,15,32],[15,36,15,38]],"bounds":{"rows_first":500,"rows_last":125,"rows_between":500,"halvings":2}}
[{"$nulls":12},"Globally Normalized Values for the signal intensity of samples analyzed with the KAM-1325 antibody microarray data were colourized using the Conditional Formatting feature under Format in the pull down menu of MS-Excel. This feature lets users colourize cells in the spreadsheet according to their desired criteria. In the case of your data, the Globally Normalized intensity signals with a value of 0 was set to blue, the approximate median value of 5000 to white, and 25,000 to red. A colour gradient based on these settings were then generated. In selecting antibody changes to follow up on, it is best to focus on cells that are white to red coloured. These have the best chance of showing up on Western blots to validate the data. "]
[]
[]
[]
[]
[]
[]
[{"$nulls":12},"The Conditional Formatting feature for %CFC (change from control) is set to blue for -100%, white for 0 changes, and orange for +200%. In this case, it is best to focus on orange coloured cells for follow up immunoblotting studies. "]
["Calculations for Order 4047"]
[{"$nulls":28},"Sample 3 Description: K01803-1279-20591(B)-Hec50 cediranib"]
["KAM-1325 ARRAY DETAILS ",{"$nulls":11},"Lead Selection Recommendation for Follow Up Immunoblotting"]
["Sample IDs:",null,"Control ID:  Hec50 CT (Kinexus ID: 20589) vs Treated ID: Hec50 bev (Kineuxs ID: 20590) vs Hec50 cediranib (Kinexus ID: 20591)",{"$nulls":9},"Priority"," lead selection criteria: %CFC ≥75%; Sum of %Error <75% of %CFC; Average Normalized Net Signal ≥1500"]
["Array Barcode:",null,"K01803-1273, -1279",null,"Protocol: Chemical cleavage pre-homogenization: Biotin-labelling",{"$nulls":7},"Possible"," lead selection criteria: %CFC ≥45% + <75%; Sum of %Errors <80% of %CFC; Average Normalized Net Signal ≥750"]
["Date of Report:",null,"2020-02-21",null,"Reviewed by:  Dr. Steven Pelech"]
[{"$nulls":12},"Globally Normalized Median",{"$nulls":8},"Globally Normalized Median",{"$nulls":11},"Globally Normalized Median"]
[{"$nulls":6},"Sample ID: Hec50 CT (#20589)",{"$nulls":5},{"$f":"MEDIAN(M18:M2717)","v":{"v":4192.2744349030745,"d":"4192"}},null,null,"Sample ID: Hec50 Bev (#20590)",{"$nulls":5},{"$f":"MEDIAN(V18:V2717)","v":{"v":4042.8478228031,"d":"4043"}},null,null,"Changes",null,null,"Sample ID: Hec50 Cediranib (#20591)",{"$nulls":5},{"$f":"MEDIAN(AH18:AH2717)","v":{"v":4254.78942333015,"d":"4255"}},null,null,"Changes"]
["Final Sort","Ab Spot ID #","Antibody Codes","Target Name ","P-Site","Full Target Protein Name","Flag","Signal Median","Background Median","Spot Area","Not Normalized Net Signal","Normalized Net Signal","Average Normalized Net Signal","Error in Duplicate from Average","% Error in Duplicate from Average","Flag","Signal Median","Background Median","Spot Area","Not Normalized Net Signal","Normalized Net Signal","Average Normalized Net Signal","Error in Duplicate from Average","% Error in Duplicate from Average","SUM % Error ","%CFC","Lead","Flag","Signal Median","Background Median","Spot Area","Not Normalized Net Signal","Normalized Net Signal","Average Normalized Net Signal","Error in Duplicate from Average","% Error in Duplicate from Average","SUM % Error ","%CFC","Lead",null,"Preferred Protein Kinase Name ","Protein Kinase","Kinase or Phosphatase Type","Protein Type","Kinase Type","Kinase Group","Kinase Family","Kinase Subfamily","Transcription Factor","Stress Protein","Protein Phosphatase","Adapter","Metabolic Enzyme","Antigen Sequence","Sequence Location in Target","Effect of Phosphorylation","Kinases Known to Target Phosphosite(s) in vitro","Protein Type - Extended","UniProt Link","PhosphoNET Link","KinaseNET Link","OncoNET Link","GO_CelComponent_list","GO_MolFunctin_list","GO_BioProcess_list"]
[5,2,"NN166-2","4E-BP1 (PHAS1)","Pan-specific","Eukaryotic translation initiation factor 4E binding protein 1 (PHAS1)",0,598,58,391,{"$f":"(H18-I18)*J18/1000","v":{"v":211.14,"d":"211"}},{"$f":"K18*1.7571469","v":{"v":371.003996466,"d":"371"}},{"$f":"(L18+L19)/2","v":{"v":467.75689764724996,"d":"468"}},{"$f":"SQRT((M18-L18)*(M18-L18))","v":{"v":96.75290118124997,"d":"97"}},{"$f":"N18/M18*100","v":{"v":20.68444135573482,"d":"21"}},0,310,52,414,{"$f":"(Q18-R18)*S18/1000","v":{"v":106.812,"d":"107"}},{"$f":"T18*1.7472151","v":{"v":186.6235392612,"d":"187"}},{"$f":"(U18+U19)/2","v":{"v":209.92090540459998,"d":"210"}},{"$f":"SQRT((V18-U18)*(V18-U18))","v":{"v":23.297366143399984,"d":"23"}},{"$f":"W18/V18*100","v":{"v":11.098163900587611,"d":"11"}},{"$f":"X18+O18","v":{"v":31.78260525632243,"d":"32"}},{"$f":"(V18/M18*100)-100","v":{"v":-55.12179372223649,"d":"-55"}},null,0,602,50,378,{"$f":"(AC18-AD18)*AE18/1000","v":{"v":208.656,"d":"209"}},{"$f":"AF18*1.7108414","v":{"v":356.9773231584,"d":"357"}},{"$f":"(AG18+AG19)/2","v":{"v":389.21641850000003,"d":"389"}},{"$f":"SQRT((AH18-AG18)*(AH18-AG18))","v":{"v":32.239095341600034,"d":"32"}},{"$f":"AI18/AH18*100","v":{"v":8.283076923076932,"d":"8"}},{"$f":"AJ18+O18","v":{"v":28.967518278811752,"d":"29"}},{"$f":"(AH18/M18*100)-100","v":{"v":-16.790875675441086,"d":"-17"}},{"$nulls":15},"Not precisely defined.","Antibody raised against full length human 4E-BP1 protein.",null,null,"Protein synthesis protein, inhibitor","Q13541","Q13541",null,"Q13541","GO:0005829","GO:0008190; GO:0030371","GO:0071549; GO:0000082; GO:0008286; GO:0002192; GO:0045947; GO:0045931; GO:0031929"]
[6,2,"NN166-2","4E-BP1 (PHAS1)","Pan-specific","Eukaryotic translation initiation factor 4E binding protein 1 (PHAS1)",0,715,30,469,{"v":321.265,"d":"321"},{"v":564.5097988284999,"d":"565"},{"$nulls":3},0,516,46,284,{"v":133.48,"d":"133"},{"v":233.218271548,"d":"233"},{"$nulls":6},0,708,44,371,{"v":246.344,"d":"246"},{"$f":"AF19*1.7108414","v":{"v":421.4555138416,"d":"421"}},{"$nulls":20},"Not precisely defined.","Antibody raised against full length human 4E-BP1 protein.",{"$nulls":3},"Q13541","Q13541",null,"Q13541"]
[7,3,"PN550","4E-BP1 (PHAS1)","T37+T46","4E transcription factor binding protein 1",0,6899,20,586,{"v":4031.094,"d":"4031"},{"v":7083.2243257086,"d":"7083"},{"$f":"(L20+L21)/2","v":{"v":6982.2077075745,"d":"6982"}},{"$f":"SQRT((M20-L20)*(M20-L20))","v":{"v":101.0166181341001,"d":"101"}},{"$f":"N20/M20*100","v":{"v":1.4467718859826293,"d":"1"}},0,7145,18,524,{"v":3734.548,"d":"3735"},{"v":6525.0586572748,"d":"6525"},{"$f":"(U20+U21)/2","v":{"v":6015.818838659,"d":"6016"}},{"$f":"SQRT((V20-U20)*(V20-U20))","v":{"v":509.2398186157998,"d":"509"}},{"$f":"W20/V20*100","v":{"v":8.465012532347394,"d":"8"}},{"$f":"X20+O20","v":{"v":9.911784418330024,"d":"10"}},{"$f":"(V20/M20*100)-100","v":{"v":-13.840735042401192,"d":"-14"}},null,0,7224,18,600,{"v":4323.6,"d":"4324"},{"v":7396.993877040001,"d":"7397"},{"$f":"(AG20+AG21)/2","v":{"v":6393.318504681601,"d":"6393"}},{"$f":"SQRT((AH20-AG20)*(AH20-AG20))","v":{"v":1003.6753723584006,"d":"1004"}},{"$f":"AI20/AH20*100","v":{"v":15.698817001271637,"d":"16"}},{"$f":"AJ20+O20","v":{"v":17.145588887254267,"d":"17"}},{"$f":"(AH20/M20*100)-100","v":{"v":-8.434140426015333,"d":"-8"}},{"$nulls":15},"DYST(pT)PGG(bA)C     ","Corresponds to amino acid residues D33 to G40; In the N-terminal portion of the translation regulatory protein. ","T37 phosphorylation reduces the rate of ubiquitination by the BCR(KLH25) complex and inhibits interaction with 4E-BP1 and EIF4E. This is one of the major in vivo phosphorylation sites in 4E-BP1 (≥129 reports based on mass spectrometry studies). The effect of T46 phosphorylation - Partly reduces eIF4E and 4E-BP1 binding and reduces the rate of ubiquitination by the BCR(KLH25) complex. This is also one of the major in vivo phosphorylation sites in 4E-BP1 (≥124 reports based on mass spectrometry studies).","ERK1 (MAPK3); ERK2 (MAPK1); FRAP1 (mTOR); GSK3b","Protein synthesis protein, inhibitor","Q13541","Q13541",null,"Q13541","GO:0005829","GO:0008190; GO:0030371","GO:0071549; GO:0000082; GO:0008286; GO:0002192; GO:0045947; GO:0045931; GO:0031929"]
[8,3,"PN550","4E-BP1 (PHAS1)","T37+T46","4E transcription factor binding protein 1",0,6534,18,601,{"v":3916.116,"d":"3916"},{"v":6881.1910894404,"d":"6881"},{"$nulls":3},0,6112,16,517,{"v":3151.632,"d":"3152"},{"v":5506.5790200432,"d":"5507"},{"$nulls":6},0,6312,24,501,{"v":3150.288,"d":"3150"},{"v":5389.6431323232,"d":"5390"},{"$nulls":20},"DYST(pT)PGG(bA)C     ","Corresponds to amino acid residues D33 to G40; In the N-terminal portion of the translation regulatory protein. ","T37 phosphorylation reduces the rate of ubiquitination by the BCR(KLH25) complex and inhibits interaction with 4E-BP1 and EIF4E. This is one of the major in vivo phosphorylation sites in 4E-BP1 (≥129 reports based on mass spectrometry studies). The effect of T46 phosphorylation - Partly reduces eIF4E and 4E-BP1 binding and reduces the rate of ubiquitination by the BCR(KLH25) complex. This is also one of the major in vivo phosphorylation sites in 4E-BP1 (≥124 reports based on mass spectrometry studies).","ERK1 (MAPK3); ERK2 (MAPK1); FRAP1 (mTOR); GSK3b",null,"Q13541","Q13541",null,"Q13541"]
[9,4,"PK501","A6 (Twinfilin-1)","Y309","Twinfilin, actin-binding protein, 1; Protein tyrosine kinase 9;",0,8468,18,677,{"v":5720.65,"d":"5721"},{"v":10052.022413485,"d":"10052"},{"$f":"(L22+L23)/2","v":{"v":10171.1148017794,"d":"10171"}},{"$f":"SQRT((M22-L22)*(M22-L22))","v":{"v":119.09238829440073,"d":"119"}},{"$f":"N22/M22*100","v":{"v":1.1708882518321977,"d":"1"}},0,6864,14,545,{"v":3733.25,"d":"3733"},{"v":6522.790772075,"d":"6523"},{"$f":"(U22+U23)/2","v":{"v":6739.8944787557,"d":"6740"}},{"$f":"SQRT((V22-U22)*(V22-U22))","v":{"v":217.10370668070027,"d":"217"}},{"$f":"W22/V22*100","v":{"v":3.2211736751223046,"d":"3"}},{"$f":"X22+O22","v":{"v":4.3920619269545025,"d":"4"}},{"$f":"(V22/M22*100)-100","v":{"v":-33.73494833057454,"d":"-34"}},null,0,8778,16,722,{"v":6326.164,"d":"6326"},{"v":10823.0632743896,"d":"10823"},{"$f":"(AG22+AG23)/2","v":{"v":9066.9222158004,"d":"9067"}},{"$f":"SQRT((AH22-AG22)*(AH22-AG22))","v":{"v":1756.1410585892008,"d":"1756"}},{"$f":"AI22/AH22*100","v":{"v":19.368656935524115,"d":"19"}},{"$f":"AJ22+O22","v":{"v":20.539545187356314,"d":"21"}},{"$f":"(AH22/M22*100)-100","v":{"v":-10.856160878115602,"d":"-11"}},null,null,"A6","X","PSTK","Protein kinase, dual-specificity","Protein-serine/threonine kinase","ATYPICAL","A6 family",{"$nulls":6},"DFL(pY)EEV(bA)C","Corresponds to amino acid residues D306 to V312; In the end of the Cofilin_ADF domain. ","The effect of Y309 phosphorylation is unclear. The major site of phosphorylation of A6 (≥142 reports based on mass spectrometry studies).",null,"Protein kinase, dual-specificity; ATYPICAL domain target; ATYPICAL</A> group; A6 family","Q12792","Q12792","Q12792",null,"GO:0015629; GO:0005911; GO:0005829; GO:0030175; GO:0005925; GO:0030016; GO:0048471; GO:0032587","GO:0003779; GO:0003785; GO:0005524; GO:0045296; GO:0005546; GO:0044877","GO:0051016; GO:0030837; GO:0018108; GO:0010613; GO:0043538; GO:0042989"]
[10,4,"PK501","A6 (Twinfilin-1)","Y309","Twinfilin, actin-binding protein, 1; Protein tyrosine kinase 9;",0,7966,20,737,{"v":5856.202,"d":"5856"},{"v":10290.207190073801,"d":"10290"},{"$nulls":3},0,6127,20,652,{"v":3981.764,"d":"3982"},{"v":6956.9981854364005,"d":"6957"},{"$nulls":6},0,6572,18,652,{"v":4273.208,"d":"4273"},{"v":7310.7811572112,"d":"7311"},{"$nulls":7},"A6","X","PSTK","Protein kinase, dual-specificity","Protein-serine/threonine kinase","ATYPICAL","A6 family",{"$nulls":6},"DFL(pY)EEV(bA)C","Corresponds to amino acid residues D306 to V312; In the end of the Cofilin_ADF domain. ","The effect of Y309 phosphorylation is unclear. The major site of phosphorylation of A6 (≥142 reports based on mass spectrometry studies).",null,null,"Q12792","Q12792","Q12792"]
[11,5,"PK502","A6r (Twinfin-2)","Y309","Twinfilin, actin-binding protein, 2; Protein tyrosine kinase 9-like",0,5234,14,681,{"v":3554.82,"d":"3555"},{"v":6246.340943058,"d":"6246"},{"$f":"(L24+L25)/2","v":{"v":5687.381971286601,"d":"5687"}},{"$f":"SQRT((M24-L24)*(M24-L24))","v":{"v":558.9589717713998,"d":"559"}},{"$f":"N24/M24*100","v":{"v":9.828054007861054,"d":"10"}},0,5488,12,514,{"v":2814.664,"d":"2815"},{"v":4917.8234422264,"d":"4918"},{"$f":"(U24+U25)/2","v":{"v":4692.607415836401,"d":"4693"}},{"$f":"SQRT((V24-U24)*(V24-U24))","v":{"v":225.21602638999957,"d":"225"}},{"$f":"W24/V24*100","v":{"v":4.799379245533104,"d":"5"}},{"$f":"X24+O24","v":{"v":14.627433253394159,"d":"15"}},{"$f":"(V24/M24*100)-100","v":{"v":-17.490904610810958,"d":"-17"}},null,0,5108,14,633,{"v":3224.502,"d":"3225"},{"v":5516.6115159828005,"d":"5517"},{"$f":"(AG24+AG25)/2","v":{"v":4956.8952098209,"d":"4957"}},{"$f":"SQRT((AH24-AG24)*(AH24-AG24))","v":{"v":559.7163061619003,"d":"560"}},{"$f":"AI24/AH24*100","v":{"v":11.291671146344925,"d":"11"}},{"$f":"AJ24+O24","v":{"v":21.11972515420598,"d":"21"}},{"$f":"(AH24/M24*100)-100","v":{"v":-12.843989820863925,"d":"-13"}},null,null,"A6r","X","PSTK","Protein kinase, dual-specificity","Protein-serine/threonine kinase","ATYPICAL","A6 family",{"$nulls":6},"EFL(pY)DEV(bA)C","Corresponds to amino acid residues E306 to V312; In the end of the Cofilin_ADF domain. ","The effect of Y309 phosphorylation is unclear. This is the major site of phosphorylation of A6r (≥517 reports based on mass spectrometry studies). A similar phosphosite is also the major phosphorylation site in A6.",null,"Protein kinase, atypical; ATYPICAL domain target; ATYPICAL</A> group; A6 family","Q6IBS0","Q6IBS0","Q6IBS0",null,"GO:0005737; GO:0005856; GO:0070062; GO:0030175; GO:0030426; GO:0030027; GO:0030016; GO:0048471; GO:0032420","GO:0003785; GO:0005524; GO:0045296; GO:0005546; GO:0005080; GO:0003723","GO:0051016; GO:0030030; GO:0071363; GO:0071300; GO:0030837; GO:0045773; GO:0010592; GO:0010976; GO:0032956; GO:0032532; GO:0042989"]
[12,5,"PK502","A6r (Twinfin-2)","Y309","Twinfilin, actin-binding protein, 2; Protein tyrosine kinase 9-like",0,4550,18,644,{"v":2918.608,"d":"2919"},{"v":5128.4229995152,"d":"5128"},{"$nulls":3},0,4459,20,576,{"v":2556.864,"d":"2557"},{"v":4467.3913894464,"d":"4467"},{"$nulls":6},0,4567,18,565,{"v":2570.185,"d":"2570"},{"v":4397.178903659,"d":"4397"},{"$nulls":7},"A6r","X","PSTK","Protein kinase, dual-specificity","Protein-serine/threonine kinase","ATYPICAL","A6 family",{"$nulls":6},"EFL(pY)DEV(bA)C","Corresponds to amino acid residues E306 to V312; In the end of the Cofilin_ADF domain. ","The effect of Y309 phosphorylation is unclear. This is the major site of phosphorylation of A6r (≥517 reports based on mass spectrometry studies). A similar phosphosite is also the major phosphorylation site in A6.",null,null,"Q6IBS0","Q6IBS0","Q6IBS0"]
[13,6,"PK503","AAK1","S637","AP2-associated protein kinase 1",0,7593,12,704,{"v":5337.024,"d":"5337"},{"v":9377.9351768256,"d":"9378"},{"$f":"(L26+L27)/2","v":{"v":8966.0740006408,"d":"8966"}},{"$f":"SQRT((M26-L26)*(M26-L26))","v":{"v":411.86117618480057,"d":"412"}},{"$f":"N26/M26*100","v":{"v":4.593550936065943,"d":"5"}},0,399,8,917,{"v":358.547,"d":"359"},{"v":626.4587324597001,"d":"626"},{"$f":"(U26+U27)/2","v":{"v":3331.96977196425,"d":"3332"}},{"$f":"SQRT((V26-U26)*(V26-U26))","v":{"v":2705.51103950455,"d":"2706"}},{"$f":"W26/V26*100","v":{"v":81.19854694568875,"d":"81"}},{"$f":"X26+O26","v":{"v":85.79209788175469,"d":"86"}},{"$f":"(V26/M26*100)-100","v":{"v":-62.83802953526687,"d":"-63"}},null,0,7442,12,677,{"v":5030.11,"d":"5030"},{"v":8605.720434554,"d":"8606"},{"$f":"(AG26+AG27)/2","v":{"v":5039.880427348599,"d":"5040"}},{"$f":"SQRT((AH26-AG26)*(AH26-AG26))","v":{"v":3565.8400072054,"d":"3566"}},{"$f":"AI26/AH26*100","v":{"v":70.7524723772332,"d":"71"}},{"$f":"AJ26+O26","v":{"v":75.34602331329914,"d":"75"}},{"$f":"(AH26/M26*100)-100","v":{"v":-43.78943975938184,"d":"-44"}},null,null,"AAK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","NAK",{"$nulls":6},"RIL(pS)DVT(bA)C","Corresponds to amino acid residues R634 to T640; In the C-terminal half of the kinase after the catalytic domain. ","The effect of S637 phosphorylation is unclear. This is major site of phosphorylation of AAK1 (≥259 reports based on mass spectrometry studies). ",null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; EC 2.7.11.-; Other group; NAK family","Q2M2I8","Q2M2I8","Q2M2I8",null,"GO:0031252; GO:0005905; GO:0030136; GO:0005737; GO:0005829; GO:0019897; GO:0043195","GO:0035612; GO:0005524; GO:0005112; GO:0004674","GO:0006897; GO:0061024; GO:0045747; GO:0046777; GO:0006468; GO:0050821; GO:2000369; GO:0032880"]
[14,6,"PK503","AAK1","S637","AP2-associated protein kinase 1",0,7866,14,620,{"v":4868.24,"d":"4868"},{"v":8554.212824455999,"d":"8554"},{"$nulls":3},0,6370,18,544,{"v":3455.488,"d":"3455"},{"v":6037.480811468799,"d":"6037"},{"$nulls":6},0,1062,10,819,{"v":861.588,"d":"862"},{"v":1474.0404201432,"d":"1474"},{"$nulls":7},"AAK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","NAK",{"$nulls":6},"RIL(pS)DVT(bA)C","Corresponds to amino acid residues R634 to T640; In the C-terminal half of the kinase after the catalytic domain. ","The effect of S637 phosphorylation is unclear. This is major site of phosphorylation of AAK1 (≥259 reports based on mass spectrometry studies). ",null,null,"Q2M2I8","Q2M2I8","Q2M2I8"]
[15,7,"NK001-2","Abl (Abl1)","Pan-specific","Abelson murine leukemia viral oncogene homologue 1",0,6012,12,654,3924,{"v":6895.0444356,"d":"6895"},{"$f":"(L28+L29)/2","v":{"v":6926.251364543999,"d":"6926"}},{"$f":"SQRT((M28-L28)*(M28-L28))","v":{"v":31.20692894399963,"d":"31"}},{"$f":"N28/M28*100","v":{"v":0.45056015586945397,"d":"0"}},0,5519,12,562,{"v":3094.934,"d":"3095"},{"v":5407.5154183034,"d":"5408"},{"$f":"(U28+U29)/2","v":{"v":5498.5662915945995,"d":"5499"}},{"$f":"SQRT((V28-U28)*(V28-U28))","v":{"v":91.05087329119942,"d":"91"}},{"$f":"W28/V28*100","v":{"v":1.6559020745168538,"d":"2"}},{"$f":"X28+O28","v":{"v":2.106462230386308,"d":"2"}},{"$f":"(V28/M28*100)-100","v":{"v":-20.61266618560549,"d":"-21"}},null,0,5742,10,559,{"v":3204.188,"d":"3204"},{"v":5481.8574837832,"d":"5482"},{"$f":"(AG28+AG29)/2","v":{"v":5514.8091445679,"d":"5515"}},{"$f":"SQRT((AH28-AG28)*(AH28-AG28))","v":{"v":32.951660784699925,"d":"33"}},{"$f":"AI28/AH28*100","v":{"v":0.5975122605495312,"d":"1"}},{"$f":"AJ28+O28","v":{"v":1.0480724164189852,"d":"1"}},{"$f":"(AH28/M28*100)-100","v":{"v":-20.378154728853445,"d":"-20"}},null,null,"ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"CAATQDFSKLLSSVKE","Corresponds to amino acid residues A1109 to E1123; In the C-terminus of the kinase.",null,null,"Protein-tyrosine kinase; Cytoplasm, nucleolus, nucleus, cytoskeleton protein","P00519","P00519","P00519","P00519","GO:0015629; GO:0031252; GO:0005737; GO:0005829; GO:0030425; GO:0031234; GO:0005739; GO:0043025; GO:0016604; GO:0031965; GO:0005730; GO:0005654; GO:0005634; GO:0048471; GO:0098794; GO:0032991","GO:0051015; GO:0003785; GO:0005524; GO:0003677; GO:0046875; GO:0016301; GO:0000287; GO:0030145; GO:0051019; GO:0038191; GO:0004515; GO:0004715; GO:0001784; GO:0070064; GO:0008022; GO:0004672; GO:0005080; GO:0004713; GO:0042169; GO:0017124; GO:0005102; GO:0019905","GO:0030036; GO:0090135; GO:0050798; GO:1990051; GO:0046632; GO:0006914; GO:0001922; GO:0002322; GO:0050853; GO:0060020; GO:0072358; GO:0007050; GO:0006464; GO:0006974; GO:1903351; GO:0070301; GO:0071222; GO:0034599; GO:0021587; GO:0048668; GO:0006975; GO:0043542; GO:0007173; GO:0045184; GO:0038096; GO:0045087; GO:0007229; GO:0008630; GO:0030035; GO:0006298; GO:0051882; GO:0000278; GO:0030514; GO:0022408; GO:2000773; GO:2000352; GO:0070373; GO:0043124; GO:1900272; GO:0045930; GO:1900275; GO:0071901; GO:0051444; GO:0001843; GO:0060563; GO:0050885; GO:0038189; GO:0038083; GO:0018108; GO:0035791; GO:1905555; GO:2000251; GO:1904531; GO:0043065; GO:0090050; GO:0007204; GO:0010595; GO:0070374; GO:0051894; GO:0043123; GO:1902715; GO:1900042; GO:1904528; GO:0045931; GO:0051149; GO:1901216; GO:0033690; GO:0051353; GO:0050731; GO:0001934; GO:0051281; GO:0051496; GO:1900026; GO:2000096; GO:0009791; GO:0046777; GO:0006468; GO:0032956; GO:2000249; GO:0010506; GO:0030516; GO:0032489; GO:0030155; GO:2000145; GO:0042127; GO:0030100; GO:1903053; GO:1902036; GO:0031113; GO:1905244; GO:2001020; GO:0045580; GO:0006355; GO:0006979; GO:0042770; GO:0048536; GO:0034446; GO:0048538; GO:0002333"]
[16,7,"NK001-2","Abl (Abl1)","Pan-specific","Abelson murine leukemia viral oncogene homologue 1",0,5854,14,678,{"v":3959.52,"d":"3960"},{"v":6957.458293488,"d":"6957"},{"$nulls":3},0,4798,16,669,{"v":3199.158,"d":"3199"},{"v":5589.6171648858,"d":"5590"},{"$nulls":6},0,5155,16,631,{"v":3242.709,"d":"3243"},{"v":5547.7608053526,"d":"5548"},{"$nulls":7},"ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"CAATQDFSKLLSSVKE","Corresponds to amino acid residues A1109 to E1123; In the C-terminus of the kinase.",{"$nulls":3},"P00519","P00519","P00519","P00519"]
[17,8,"NK001-6","Abl (Abl1)","Pan-specific","Abelson murine leukemia viral oncogene homologue 1",0,5444,14,569,{"v":3089.67,"d":"3090"},{"v":5429.004062523,"d":"5429"},{"$f":"(L30+L31)/2","v":{"v":5446.1907163519,"d":"5446"}},{"$f":"SQRT((M30-L30)*(M30-L30))","v":{"v":17.18665382889958,"d":"17"}},{"$f":"N30/M30*100","v":{"v":0.31557201581827754,"d":"0"}},0,4590,10,481,{"v":2202.98,"d":"2203"},{"v":3849.079920998,"d":"3849"},{"$f":"(U30+U31)/2","v":{"v":3511.4078891267,"d":"3511"}},{"$f":"SQRT((V30-U30)*(V30-U30))","v":{"v":337.6720318713001,"d":"338"}},{"$f":"W30/V30*100","v":{"v":9.61642858173564,"d":"10"}},{"$f":"X30+O30","v":{"v":9.932000597553918,"d":"10"}},{"$f":"(V30/M30*100)-100","v":{"v":-35.52543287579182,"d":"-36"}},null,0,4756,10,463,{"v":2197.398,"d":"2197"},{"v":3759.3994706772005,"d":"3759"},{"$f":"(AG30+AG31)/2","v":{"v":3601.9079656002004,"d":"3602"}},{"$f":"SQRT((AH30-AG30)*(AH30-AG30))","v":{"v":157.49150507700006,"d":"157"}},{"$f":"AI30/AH30*100","v":{"v":4.372446674959853,"d":"4"}},{"$f":"AJ30+O30","v":{"v":4.688018690778131,"d":"5"}},{"$f":"(AH30/M30*100)-100","v":{"v":-33.86371955749435,"d":"-34"}},null,null,"ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"CISTRVSLRKTRQPP","Corresponds to amino acid residues I1006 to P1019.",null,null,"Protein-tyrosine kinase; Cytoplasm, nucleolus, nucleus, cytoskeleton protein","P00519","P00519","P00519","P00519","GO:0015629; GO:0031252; GO:0005737; GO:0005829; GO:0030425; GO:0031234; GO:0005739; GO:0043025; GO:0016604; GO:0031965; GO:0005730; GO:0005654; GO:0005634; GO:0048471; GO:0098794; GO:0032991","GO:0051015; GO:0003785; GO:0005524; GO:0003677; GO:0046875; GO:0016301; GO:0000287; GO:0030145; GO:0051019; GO:0038191; GO:0004515; GO:0004715; GO:0001784; GO:0070064; GO:0008022; GO:0004672; GO:0005080; GO:0004713; GO:0042169; GO:0017124; GO:0005102; GO:0019905","GO:0030036; GO:0090135; GO:0050798; GO:1990051; GO:0046632; GO:0006914; GO:0001922; GO:0002322; GO:0050853; GO:0060020; GO:0072358; GO:0007050; GO:0006464; GO:0006974; GO:1903351; GO:0070301; GO:0071222; GO:0034599; GO:0021587; GO:0048668; GO:0006975; GO:0043542; GO:0007173; GO:0045184; GO:0038096; GO:0045087; GO:0007229; GO:0008630; GO:0030035; GO:0006298; GO:0051882; GO:0000278; GO:0030514; GO:0022408; GO:2000773; GO:2000352; GO:0070373; GO:0043124; GO:1900272; GO:0045930; GO:1900275; GO:0071901; GO:0051444; GO:0001843; GO:0060563; GO:0050885; GO:0038189; GO:0038083; GO:0018108; GO:0035791; GO:1905555; GO:2000251; GO:1904531; GO:0043065; GO:0090050; GO:0007204; GO:0010595; GO:0070374; GO:0051894; GO:0043123; GO:1902715; GO:1900042; GO:1904528; GO:0045931; GO:0051149; GO:1901216; GO:0033690; GO:0051353; GO:0050731; GO:0001934; GO:0051281; GO:0051496; GO:1900026; GO:2000096; GO:0009791; GO:0046777; GO:0006468; GO:0032956; GO:2000249; GO:0010506; GO:0030516; GO:0032489; GO:0030155; GO:2000145; GO:0042127; GO:0030100; GO:1903053; GO:1902036; GO:0031113; GO:1905244; GO:2001020; GO:0045580; GO:0006355; GO:0006979; GO:0042770; GO:0048536; GO:0034446; GO:0048538; GO:0002333"]
[18,8,"NK001-6","Abl (Abl1)","Pan-specific","Abelson murine leukemia viral oncogene homologue 1",0,5492,18,568,{"v":3109.232,"d":"3109"},{"v":5463.3773701807995,"d":"5463"},{"$nulls":3},0,4015,14,454,{"v":1816.454,"d":"1816"},{"v":3173.7358572554,"d":"3174"},{"$nulls":6},0,4518,14,447,{"v":2013.288,"d":"2013"},{"v":3444.4164605232,"d":"3444"},{"$nulls":7},"ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"CISTRVSLRKTRQPP","Corresponds to amino acid residues I1006 to P1019.",{"$nulls":3},"P00519","P00519","P00519","P00519"]
[19,9,"PK504","Abl (Abl1)","Y139","Abelson murine leukemia viral oncogene homologue 1",0,5330,14,779,{"v":4141.164,"d":"4141"},{"v":7276.633484991599,"d":"7277"},{"$f":"(L32+L33)/2","v":{"v":5652.8417346732995,"d":"5653"}},{"$f":"SQRT((M32-L32)*(M32-L32))","v":{"v":1623.7917503182998,"d":"1624"}},{"$f":"N32/M32*100","v":{"v":28.725229301190495,"d":"29"}},0,4917,14,581,{"v":2848.643,"d":"2849"},{"v":4977.1920641093,"d":"4977"},{"$f":"(U32+U33)/2","v":{"v":4543.036193593351,"d":"4543"}},{"$f":"SQRT((V32-U32)*(V32-U32))","v":{"v":434.1558705159496,"d":"434"}},{"$f":"W32/V32*100","v":{"v":9.55651357407634,"d":"10"}},{"$f":"X32+O32","v":{"v":38.281742875266836,"d":"38"}},{"$f":"(V32/M32*100)-100","v":{"v":-19.632701447709806,"d":"-20"}},null,0,5420,11,658,{"v":3559.122,"d":"3559"},{"v":6089.0932652508,"d":"6089"},{"$f":"(AG32+AG33)/2","v":{"v":4786.0326237822,"d":"4786"}},{"$f":"SQRT((AH32-AG32)*(AH32-AG32))","v":{"v":1303.0606414686,"d":"1303"}},{"$f":"AI32/AH32*100","v":{"v":27.22632175538423,"d":"27"}},{"$f":"AJ32+O32","v":{"v":55.95155105657473,"d":"56"}},{"$f":"(AH32/M32*100)-100","v":{"v":-15.334041736464712,"d":"-15"}},null,null,"ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"AAE(pY)LLS(bA)C","Corresponds to amino acid residues A136 to S142; In the SH2 domain.","Y139 phosphorylation stimulates phosphotransferase activity. This is one of the many in vivo phosphorylation sites in Abl1 (≥57 reports based on mass spectrometry studies).","Fyn; Hck; Lyn","Protein-tyrosine kinase; Cytoplasm, nucleolus, nucleus, cytoskeleton protein","P00519","P00519","P00519","P00519","GO:0015629; GO:0031252; GO:0005737; GO:0005829; GO:0030425; GO:0031234; GO:0005739; GO:0043025; GO:0016604; GO:0031965; GO:0005730; GO:0005654; GO:0005634; GO:0048471; GO:0098794; GO:0032991","GO:0051015; GO:0003785; GO:0005524; GO:0003677; GO:0046875; GO:0016301; GO:0000287; GO:0030145; GO:0051019; GO:0038191; GO:0004515; GO:0004715; GO:0001784; GO:0070064; GO:0008022; GO:0004672; GO:0005080; GO:0004713; GO:0042169; GO:0017124; GO:0005102; GO:0019905","GO:0030036; GO:0090135; GO:0050798; GO:1990051; GO:0046632; GO:0006914; GO:0001922; GO:0002322; GO:0050853; GO:0060020; GO:0072358; GO:0007050; GO:0006464; GO:0006974; GO:1903351; GO:0070301; GO:0071222; GO:0034599; GO:0021587; GO:0048668; GO:0006975; GO:0043542; GO:0007173; GO:0045184; GO:0038096; GO:0045087; GO:0007229; GO:0008630; GO:0030035; GO:0006298; GO:0051882; GO:0000278; GO:0030514; GO:0022408; GO:2000773; GO:2000352; GO:0070373; GO:0043124; GO:1900272; GO:0045930; GO:1900275; GO:0071901; GO:0051444; GO:0001843; GO:0060563; GO:0050885; GO:0038189; GO:0038083; GO:0018108; GO:0035791; GO:1905555; GO:2000251; GO:1904531; GO:0043065; GO:0090050; GO:0007204; GO:0010595; GO:0070374; GO:0051894; GO:0043123; GO:1902715; GO:1900042; GO:1904528; GO:0045931; GO:0051149; GO:1901216; GO:0033690; GO:0051353; GO:0050731; GO:0001934; GO:0051281; GO:0051496; GO:1900026; GO:2000096; GO:0009791; GO:0046777; GO:0006468; GO:0032956; GO:2000249; GO:0010506; GO:0030516; GO:0032489; GO:0030155; GO:2000145; GO:0042127; GO:0030100; GO:1903053; GO:1902036; GO:0031113; GO:1905244; GO:2001020; GO:0045580; GO:0006355; GO:0006979; GO:0042770; GO:0048536; GO:0034446; GO:0048538; GO:0002333"]
[20,9,"PK504","Abl (Abl1)","Y139","Abelson murine leukemia viral oncogene homologue 1",0,3802,12,605,{"v":2292.95,"d":"2293"},{"v":4029.0499843549997,"d":"4029"},{"$nulls":3},0,3942,16,599,{"v":2351.674,"d":"2352"},{"v":4108.8803230774,"d":"4109"},{"$nulls":6},0,3502,16,584,{"v":2035.824,"d":"2036"},{"v":3482.9719823136,"d":"3483"},{"$nulls":7},"ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"AAE(pY)LLS(bA)C","Corresponds to amino acid residues A136 to S142; In the SH2 domain.","Y139 phosphorylation stimulates phosphotransferase activity. This is one of the many in vivo phosphorylation sites in Abl1 (≥57 reports based on mass spectrometry studies).","Fyn; Hck; Lyn",null,"P00519","P00519","P00519","P00519"]
[21,10,"PK505","Abl (Abl1)","Y226","Abelson murine leukemia viral oncogene homologue 1",0,8236,20,686,{"v":5636.176,"d":"5636"},{"v":9903.589186254401,"d":"9904"},{"$f":"(L34+L35)/2","v":{"v":10521.571600970252,"d":"10522"}},{"$f":"SQRT((M34-L34)*(M34-L34))","v":{"v":617.9824147158506,"d":"618"}},{"$f":"N34/M34*100","v":{"v":5.8734801049955605,"d":"6"}},0,9316,16,617,{"v":5738.1,"d":"5738"},{"v":10025.69496531,"d":"10026"},{"$f":"(U34+U35)/2","v":{"v":8679.021938124599,"d":"8679"}},{"$f":"SQRT((V34-U34)*(V34-U34))","v":{"v":1346.6730271854012,"d":"1347"}},{"$f":"W34/V34*100","v":{"v":15.516414600472784,"d":"16"}},{"$f":"X34+O34","v":{"v":21.389894705468343,"d":"21"}},{"$f":"(V34/M34*100)-100","v":{"v":-17.512114470387118,"d":"-18"}},null,0,8286,14,638,{"v":5277.536,"d":"5278"},{"v":9029.027078790401,"d":"9029"},{"$f":"(AG34+AG35)/2","v":{"v":8328.8686575232,"d":"8329"}},{"$f":"SQRT((AH34-AG34)*(AH34-AG34))","v":{"v":700.1584212672005,"d":"700"}},{"$f":"AI34/AH34*100","v":{"v":8.406404879908507,"d":"8"}},{"$f":"AJ34+O34","v":{"v":14.279884984904069,"d":"14"}},{"$f":"(AH34/M34*100)-100","v":{"v":-20.840070538937837,"d":"-21"}},null,null,"ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"PTV(pY)GVS(bA)C","Corresponds to amino acid residues P223 to S229; In the region between the SH2 domain and the protein kinase catalytic domain.","Y226 phosphorylation stimulates phosphotransferase activity. This is one of the major in vivo phosphorylation sites in Abl1 (≥315 reports based on mass spectrometry studies).","Abl1; Fyn; Hck; Lyn","Protein-tyrosine kinase; Cytoplasm, nucleolus, nucleus, cytoskeleton protein","P00519","P00519","P00519","P00519","GO:0015629; GO:0031252; GO:0005737; GO:0005829; GO:0030425; GO:0031234; GO:0005739; GO:0043025; GO:0016604; GO:0031965; GO:0005730; GO:0005654; GO:0005634; GO:0048471; GO:0098794; GO:0032991","GO:0051015; GO:0003785; GO:0005524; GO:0003677; GO:0046875; GO:0016301; GO:0000287; GO:0030145; GO:0051019; GO:0038191; GO:0004515; GO:0004715; GO:0001784; GO:0070064; GO:0008022; GO:0004672; GO:0005080; GO:0004713; GO:0042169; GO:0017124; GO:0005102; GO:0019905","GO:0030036; GO:0090135; GO:0050798; GO:1990051; GO:0046632; GO:0006914; GO:0001922; GO:0002322; GO:0050853; GO:0060020; GO:0072358; GO:0007050; GO:0006464; GO:0006974; GO:1903351; GO:0070301; GO:0071222; GO:0034599; GO:0021587; GO:0048668; GO:0006975; GO:0043542; GO:0007173; GO:0045184; GO:0038096; GO:0045087; GO:0007229; GO:0008630; GO:0030035; GO:0006298; GO:0051882; GO:0000278; GO:0030514; GO:0022408; GO:2000773; GO:2000352; GO:0070373; GO:0043124; GO:1900272; GO:0045930; GO:1900275; GO:0071901; GO:0051444; GO:0001843; GO:0060563; GO:0050885; GO:0038189; GO:0038083; GO:0018108; GO:0035791; GO:1905555; GO:2000251; GO:1904531; GO:0043065; GO:0090050; GO:0007204; GO:0010595; GO:0070374; GO:0051894; GO:0043123; GO:1902715; GO:1900042; GO:1904528; GO:0045931; GO:0051149; GO:1901216; GO:0033690; GO:0051353; GO:0050731; GO:0001934; GO:0051281; GO:0051496; GO:1900026; GO:2000096; GO:0009791; GO:0046777; GO:0006468; GO:0032956; GO:2000249; GO:0010506; GO:0030516; GO:0032489; GO:0030155; GO:2000145; GO:0042127; GO:0030100; GO:1903053; GO:1902036; GO:0031113; GO:1905244; GO:2001020; GO:0045580; GO:0006355; GO:0006979; GO:0042770; GO:0048536; GO:0034446; GO:0048538; GO:0002333"]
[22,10,"PK505","Abl (Abl1)","Y226","Abelson murine leukemia viral oncogene homologue 1",0,7721,18,823,{"v":6339.569,"d":"6340"},{"v":11139.5540156861,"d":"11140"},{"$nulls":3},0,6962,14,604,{"v":4196.592,"d":"4197"},{"v":7332.348910939199,"d":"7332"},{"$nulls":6},0,7208,16,620,{"v":4459.04,"d":"4459"},{"v":7628.710236256,"d":"7629"},{"$nulls":7},"ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"PTV(pY)GVS(bA)C","Corresponds to amino acid residues P223 to S229; In the region between the SH2 domain and the protein kinase catalytic domain.","Y226 phosphorylation stimulates phosphotransferase activity. This is one of the major in vivo phosphorylation sites in Abl1 (≥315 reports based on mass spectrometry studies).","Abl1; Fyn; Hck; Lyn",null,"P00519","P00519","P00519","P00519"]
[23,11,"PK506","Abl (Abl1)","Y257","Abelson murine leukemia viral oncogene homologue 1",0,5680,18,623,{"v":3527.426,"d":"3527"},{"v":6198.2056608794,"d":"6198"},{"$f":"(L36+L37)/2","v":{"v":6849.3551019062,"d":"6849"}},{"$f":"SQRT((M36-L36)*(M36-L36))","v":{"v":651.1494410267996,"d":"651"}},{"$f":"N36/M36*100","v":{"v":9.506726273333127,"d":"10"}},0,7338,14,655,{"v":4797.22,"d":"4797"},{"v":8381.775222022,"d":"8382"},{"$f":"(U36+U37)/2","v":{"v":7043.6268573095,"d":"7044"}},{"$f":"SQRT((V36-U36)*(V36-U36))","v":{"v":1338.1483647125006,"d":"1338"}},{"$f":"W36/V36*100","v":{"v":18.998001907551952,"d":"19"}},{"$f":"X36+O36","v":{"v":28.50472818088508,"d":"29"}},{"$f":"(V36/M36*100)-100","v":{"v":2.836351050761479,"d":"3"}},null,0,6212,12,653,{"v":4048.6,"d":"4049"},{"v":6926.51249204,"d":"6927"},{"$f":"(AG36+AG37)/2","v":{"v":6512.976463039,"d":"6513"}},{"$f":"SQRT((AH36-AG36)*(AH36-AG36))","v":{"v":413.5360290010003,"d":"414"}},{"$f":"AI36/AH36*100","v":{"v":6.349416911727047,"d":"6"}},{"$f":"AJ36+O36","v":{"v":15.856143185060175,"d":"16"}},{"$f":"(AH36/M36*100)-100","v":{"v":-4.911099422682639,"d":"-5"}},null,null,"ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"GEV(pY)EGV(bA)C","Corresponds to amino acid residues G254 to V260; In the protein kinase catalytic domain in subdomain I.","Y257 phosphorylation is predicted to be inhibitory for phosphotransferase activity. This phosphosite is located in the kinase subdomain I region, which is involved in binding the phosphates in the ATP substrate. This is one of the major in vivo phosphorylation sites in Abl1 (≥335 reports based on mass spectrometry studies).",null,"Protein-tyrosine kinase; Cytoplasm, nucleolus, nucleus, cytoskeleton protein","P00519","P00519","P00519","P00519","GO:0015629; GO:0031252; GO:0005737; GO:0005829; GO:0030425; GO:0031234; GO:0005739; GO:0043025; GO:0016604; GO:0031965; GO:0005730; GO:0005654; GO:0005634; GO:0048471; GO:0098794; GO:0032991","GO:0051015; GO:0003785; GO:0005524; GO:0003677; GO:0046875; GO:0016301; GO:0000287; GO:0030145; GO:0051019; GO:0038191; GO:0004515; GO:0004715; GO:0001784; GO:0070064; GO:0008022; GO:0004672; GO:0005080; GO:0004713; GO:0042169; GO:0017124; GO:0005102; GO:0019905","GO:0030036; GO:0090135; GO:0050798; GO:1990051; GO:0046632; GO:0006914; GO:0001922; GO:0002322; GO:0050853; GO:0060020; GO:0072358; GO:0007050; GO:0006464; GO:0006974; GO:1903351; GO:0070301; GO:0071222; GO:0034599; GO:0021587; GO:0048668; GO:0006975; GO:0043542; GO:0007173; GO:0045184; GO:0038096; GO:0045087; GO:0007229; GO:0008630; GO:0030035; GO:0006298; GO:0051882; GO:0000278; GO:0030514; GO:0022408; GO:2000773; GO:2000352; GO:0070373; GO:0043124; GO:1900272; GO:0045930; GO:1900275; GO:0071901; GO:0051444; GO:0001843; GO:0060563; GO:0050885; GO:0038189; GO:0038083; GO:0018108; GO:0035791; GO:1905555; GO:2000251; GO:1904531; GO:0043065; GO:0090050; GO:0007204; GO:0010595; GO:0070374; GO:0051894; GO:0043123; GO:1902715; GO:1900042; GO:1904528; GO:0045931; GO:0051149; GO:1901216; GO:0033690; GO:0051353; GO:0050731; GO:0001934; GO:0051281; GO:0051496; GO:1900026; GO:2000096; GO:0009791; GO:0046777; GO:0006468; GO:0032956; GO:2000249; GO:0010506; GO:0030516; GO:0032489; GO:0030155; GO:2000145; GO:0042127; GO:0030100; GO:1903053; GO:1902036; GO:0031113; GO:1905244; GO:2001020; GO:0045580; GO:0006355; GO:0006979; GO:0042770; GO:0048536; GO:0034446; GO:0048538; GO:0002333"]
[24,11,"PK506","Abl (Abl1)","Y257","Abelson murine leukemia viral oncogene homologue 1",0,6401,30,670,{"v":4268.57,"d":"4269"},{"v":7500.504542932999,"d":"7501"},{"$nulls":3},0,5606,24,585,{"v":3265.47,"d":"3265"},{"v":5705.478492597,"d":"5705"},{"$nulls":6},0,5677,18,630,{"v":3565.17,"d":"3565"},{"v":6099.440434038001,"d":"6099"},{"$nulls":7},"ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"GEV(pY)EGV(bA)C","Corresponds to amino acid residues G254 to V260; In the protein kinase catalytic domain in subdomain I.","Y257 phosphorylation is predicted to be inhibitory for phosphotransferase activity. This phosphosite is located in the kinase subdomain I region, which is involved in binding the phosphates in the ATP substrate. This is one of the major in vivo phosphorylation sites in Abl1 (≥335 reports based on mass spectrometry studies).",null,null,"P00519","P00519","P00519","P00519"]
[25,12,"PK507","Abl (Abl1)","Y264","Abelson murine leukemia viral oncogene homologue 1",0,6230,18,683,{"v":4242.796,"d":"4243"},{"v":7455.215838732401,"d":"7455"},{"$f":"(L38+L39)/2","v":{"v":7164.975585231101,"d":"7165"}},{"$f":"SQRT((M38-L38)*(M38-L38))","v":{"v":290.2402535012998,"d":"290"}},{"$f":"N38/M38*100","v":{"v":4.050819853448786,"d":"4"}},0,7626,14,679,{"v":5168.548,"d":"5169"},{"v":9030.5651106748,"d":"9031"},{"$f":"(U38+U39)/2","v":{"v":6984.3455961816,"d":"6984"}},{"$f":"SQRT((V38-U38)*(V38-U38))","v":{"v":2046.2195144931993,"d":"2046"}},{"$f":"W38/V38*100","v":{"v":29.29722600800116,"d":"29"}},{"$f":"X38+O38","v":{"v":33.34804586144995,"d":"33"}},{"$f":"(V38/M38*100)-100","v":{"v":-2.521013322387688,"d":"-3"}},null,0,6173,13,684,{"v":4213.44,"d":"4213"},{"v":7208.527588415999,"d":"7209"},{"$f":"(AG38+AG39)/2","v":{"v":6995.5073040192,"d":"6996"}},{"$f":"SQRT((AH38-AG38)*(AH38-AG38))","v":{"v":213.02028439679907,"d":"213"}},{"$f":"AI38/AH38*100","v":{"v":3.0451013077266085,"d":"3"}},{"$f":"AJ38+O38","v":{"v":7.0959211611753945,"d":"7"}},{"$f":"(AH38/M38*100)-100","v":{"v":-2.3652318028999275,"d":"-2"}},null,null,"ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"WKK(pY)SLT(bA)C","Corresponds to amino acid residues W261 to T267; In the protein kinase catalytic domain in subdomain I.","Y264 phosphorylation is predicted to be inhibitory for phosphotransferase activity. This phosphosite is located in the kinase subdomain I region, which is involved in binding the phosphates in the ATP substrate. This is one of the many in vivo phosphorylation sites in Abl1 (≥60 reports based on mass spectrometry studies).",null,"Protein-tyrosine kinase; Cytoplasm, nucleolus, nucleus, cytoskeleton protein","P00519","P00519","P00519","P00519","GO:0015629; GO:0031252; GO:0005737; GO:0005829; GO:0030425; GO:0031234; GO:0005739; GO:0043025; GO:0016604; GO:0031965; GO:0005730; GO:0005654; GO:0005634; GO:0048471; GO:0098794; GO:0032991","GO:0051015; GO:0003785; GO:0005524; GO:0003677; GO:0046875; GO:0016301; GO:0000287; GO:0030145; GO:0051019; GO:0038191; GO:0004515; GO:0004715; GO:0001784; GO:0070064; GO:0008022; GO:0004672; GO:0005080; GO:0004713; GO:0042169; GO:0017124; GO:0005102; GO:0019905","GO:0030036; GO:0090135; GO:0050798; GO:1990051; GO:0046632; GO:0006914; GO:0001922; GO:0002322; GO:0050853; GO:0060020; GO:0072358; GO:0007050; GO:0006464; GO:0006974; GO:1903351; GO:0070301; GO:0071222; GO:0034599; GO:0021587; GO:0048668; GO:0006975; GO:0043542; GO:0007173; GO:0045184; GO:0038096; GO:0045087; GO:0007229; GO:0008630; GO:0030035; GO:0006298; GO:0051882; GO:0000278; GO:0030514; GO:0022408; GO:2000773; GO:2000352; GO:0070373; GO:0043124; GO:1900272; GO:0045930; GO:1900275; GO:0071901; GO:0051444; GO:0001843; GO:0060563; GO:0050885; GO:0038189; GO:0038083; GO:0018108; GO:0035791; GO:1905555; GO:2000251; GO:1904531; GO:0043065; GO:0090050; GO:0007204; GO:0010595; GO:0070374; GO:0051894; GO:0043123; GO:1902715; GO:1900042; GO:1904528; GO:0045931; GO:0051149; GO:1901216; GO:0033690; GO:0051353; GO:0050731; GO:0001934; GO:0051281; GO:0051496; GO:1900026; GO:2000096; GO:0009791; GO:0046777; GO:0006468; GO:0032956; GO:2000249; GO:0010506; GO:0030516; GO:0032489; GO:0030155; GO:2000145; GO:0042127; GO:0030100; GO:1903053; GO:1902036; GO:0031113; GO:1905244; GO:2001020; GO:0045580; GO:0006355; GO:0006979; GO:0042770; GO:0048536; GO:0034446; GO:0048538; GO:0002333"]
[26,12,"PK507","Abl (Abl1)","Y264","Abelson murine leukemia viral oncogene homologue 1",0,5676,14,691,{"v":3912.442,"d":"3912"},{"v":6874.7353317298,"d":"6875"},{"$nulls":3},0,3038,12,934,{"v":2826.284,"d":"2826"},{"v":4938.1260816884005,"d":"4938"},{"$nulls":6},0,5712,16,696,{"v":3964.416,"d":"3964"},{"v":6782.4870196224,"d":"6782"},{"$nulls":7},"ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"WKK(pY)SLT(bA)C","Corresponds to amino acid residues W261 to T267; In the protein kinase catalytic domain in subdomain I.","Y264 phosphorylation is predicted to be inhibitory for phosphotransferase activity. This phosphosite is located in the kinase subdomain I region, which is involved in binding the phosphates in the ATP substrate. This is one of the many in vivo phosphorylation sites in Abl1 (≥60 reports based on mass spectrometry studies).",null,null,"P00519","P00519","P00519","P00519"]
[27,13,"PK873","Abl (Abl1)","Y393+T394","Abelson murine leukemia viral oncogene homologue 1",0,12652,32,822,{"v":10373.64,"d":"10374"},{"v":18228.009367716,"d":"18228"},{"$f":"(L40+L41)/2","v":{"v":19784.103519418,"d":"19784"}},{"$f":"SQRT((M40-L40)*(M40-L40))","v":{"v":1556.094151702,"d":"1556"}},{"$f":"N40/M40*100","v":{"v":7.865376109535119,"d":"8"}},0,16784,44,733,{"v":12270.42,"d":"12270"},{"v":21439.063107342,"d":"21439"},{"$f":"(U40+U41)/2","v":{"v":21219.148131565402,"d":"21219"}},{"$f":"SQRT((V40-U40)*(V40-U40))","v":{"v":219.91497577659902,"d":"220"}},{"$f":"W40/V40*100","v":{"v":1.0363987018378726,"d":"1"}},{"$f":"X40+O40","v":{"v":8.901774811372992,"d":"9"}},{"$f":"(V40/M40*100)-100","v":{"v":7.2535235712799135,"d":"7"}},null,0,15314,62,685,{"v":10447.62,"d":"10448"},{"v":17874.220827468,"d":"17874"},{"$f":"(AG40+AG41)/2","v":{"v":18350.6499525951,"d":"18351"}},{"$f":"SQRT((AH40-AG40)*(AH40-AG40))","v":{"v":476.4291251270988,"d":"476"}},{"$f":"AI40/AH40*100","v":{"v":2.5962520475179325,"d":"3"}},{"$f":"AJ40+O40","v":{"v":10.461628157053052,"d":"10"}},{"$f":"(AH40/M40*100)-100","v":{"v":-7.245481532261351,"d":"-7"}},null,null,"ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"GDT(pY)(pT)AHAGC","Corresponds to amino acid residues G390 to G398. Y393 and T394 are located in the Gap/Insert 8 (G/I8) region in the protein-tyrosine kinase catalytic domain of Abl1. The G/I8 region is located in the T-activation loop between kinase subdomains VII and VIII.","Y393 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation regulates cell growth. Y393 is the most frequently detected phosphosite in Abl1 by mass spectrometry (≥1677 reports) and T394 is the third most often observed phosphosite (≥477 reports). No protein kinases have been reported to phosphorylate T394, but it is likely that it becomes collatorally phosphorylated by kinases that target the Y393 site. The effect of this phosphorylation is unclear, but it is likely to be activatory for Abl1 phosphotransferase activity based on its location. ","Y393: Abl1; Fyn; Hck; Lyn.","Protein-tyrosine kinase; Cytoplasm, nucleolus, nucleus, cytoskeleton protein","P00519","P00519","P00519","P00519","GO:0015629; GO:0031252; GO:0005737; GO:0005829; GO:0030425; GO:0031234; GO:0005739; GO:0043025; GO:0016604; GO:0031965; GO:0005730; GO:0005654; GO:0005634; GO:0048471; GO:0098794; GO:0032991","GO:0051015; GO:0003785; GO:0005524; GO:0003677; GO:0046875; GO:0016301; GO:0000287; GO:0030145; GO:0051019; GO:0038191; GO:0004515; GO:0004715; GO:0001784; GO:0070064; GO:0008022; GO:0004672; GO:0005080; GO:0004713; GO:0042169; GO:0017124; GO:0005102; GO:0019905","GO:0030036; GO:0090135; GO:0050798; GO:1990051; GO:0046632; GO:0006914; GO:0001922; GO:0002322; GO:0050853; GO:0060020; GO:0072358; GO:0007050; GO:0006464; GO:0006974; GO:1903351; GO:0070301; GO:0071222; GO:0034599; GO:0021587; GO:0048668; GO:0006975; GO:0043542; GO:0007173; GO:0045184; GO:0038096; GO:0045087; GO:0007229; GO:0008630; GO:0030035; GO:0006298; GO:0051882; GO:0000278; GO:0030514; GO:0022408; GO:2000773; GO:2000352; GO:0070373; GO:0043124; GO:1900272; GO:0045930; GO:1900275; GO:0071901; GO:0051444; GO:0001843; GO:0060563; GO:0050885; GO:0038189; GO:0038083; GO:0018108; GO:0035791; GO:1905555; GO:2000251; GO:1904531; GO:0043065; GO:0090050; GO:0007204; GO:0010595; GO:0070374; GO:0051894; GO:0043123; GO:1902715; GO:1900042; GO:1904528; GO:0045931; GO:0051149; GO:1901216; GO:0033690; GO:0051353; GO:0050731; GO:0001934; GO:0051281; GO:0051496; GO:1900026; GO:2000096; GO:0009791; GO:0046777; GO:0006468; GO:0032956; GO:2000249; GO:0010506; GO:0030516; GO:0032489; GO:0030155; GO:2000145; GO:0042127; GO:0030100; GO:1903053; GO:1902036; GO:0031113; GO:1905244; GO:2001020; GO:0045580; GO:0006355; GO:0006979; GO:0042770; GO:0048536; GO:0034446; GO:0048538; GO:0002333"]
[28,13,"PK873","Abl (Abl1)","Y393+T394","Abelson murine leukemia viral oncogene homologue 1",0,15243,62,800,{"v":12144.8,"d":"12145"},{"v":21340.197671119997,"d":"21340"},{"$nulls":3},0,15528,40,776,{"v":12018.688,"d":"12019"},{"v":20999.2331557888,"d":"20999"},{"$nulls":6},0,14892,81,743,{"v":11004.573,"d":"11005"},{"v":18827.079077722203,"d":"18827"},{"$nulls":7},"ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"GDT(pY)(pT)AHAGC","Corresponds to amino acid residues G390 to G398. Y393 and T394 are located in the Gap/Insert 8 (G/I8) region in the protein-tyrosine kinase catalytic domain of Abl1. The G/I8 region is located in the T-activation loop between kinase subdomains VII and VIII.","Y393 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation regulates cell growth. Y393 is the most frequently detected phosphosite in Abl1 by mass spectrometry (≥1677 reports) and T394 is the third most often observed phosphosite (≥477 reports). No protein kinases have been reported to phosphorylate T394, but it is likely that it becomes collatorally phosphorylated by kinases that target the Y393 site. The effect of this phosphorylation is unclear, but it is likely to be activatory for Abl1 phosphotransferase activity based on its location. ","Y393: Abl1; Fyn; Hck; Lyn.",null,"P00519","P00519","P00519","P00519"]
[29,14,"PK177","Abl (Abl1)","Y413","Abelson murine leukemia viral oncogene homologue 1",0,842,122,442,{"v":318.24,"d":"318"},{"v":559.194429456,"d":"559"},{"$f":"(L42+L43)/2","v":{"v":582.3255112475999,"d":"582"}},{"$f":"SQRT((M42-L42)*(M42-L42))","v":{"v":23.131081791599968,"d":"23"}},{"$f":"N42/M42*100","v":{"v":3.972191041749642,"d":"4"}},0,330,60,505,{"v":136.35,"d":"136"},{"v":238.232778885,"d":"238"},{"$f":"(U42+U43)/2","v":{"v":233.17459117049998,"d":"233"}},{"$f":"SQRT((V42-U42)*(V42-U42))","v":{"v":5.058187714500008,"d":"5"}},{"$f":"W42/V42*100","v":{"v":2.1692705406316772,"d":"2"}},{"$f":"X42+O42","v":{"v":6.14146158238132,"d":"6"}},{"$f":"(V42/M42*100)-100","v":{"v":-59.958032635228975,"d":"-60"}},null,0,457,52,511,{"v":206.955,"d":"207"},{"v":354.06718193700004,"d":"354"},{"$f":"(AG42+AG43)/2","v":{"v":342.66014690250006,"d":"343"}},{"$f":"SQRT((AH42-AG42)*(AH42-AG42))","v":{"v":11.407035034499984,"d":"11"}},{"$f":"AI42/AH42*100","v":{"v":3.328964613368278,"d":"3"}},{"$f":"AJ42+O42","v":{"v":7.30115565511792,"d":"7"}},{"$f":"(AH42/M42*100)-100","v":{"v":-41.15659707774613,"d":"-41"}},null,null,"ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"Not precisely defined.  Original suppliers identified as an antibody for the Y412 site in human Abl1. Likely to include LA(pY)NK.","Antibody raised against amino acid residues surrounding the phosphorylated Tyr-413 of human c-Abl.","The effect of Y413 phosphorylation is unclear. This is one of the many in vivo phosphorylation sites in Abl1 (≥164 reports based on mass spectrometry studies).",null,"Protein-tyrosine kinase; Cytoplasm, nucleolus, nucleus, cytoskeleton protein","P00519","P00519","P00519","P00519","GO:0015629; GO:0031252; GO:0005737; GO:0005829; GO:0030425; GO:0031234; GO:0005739; GO:0043025; GO:0016604; GO:0031965; GO:0005730; GO:0005654; GO:0005634; GO:0048471; GO:0098794; GO:0032991","GO:0051015; GO:0003785; GO:0005524; GO:0003677; GO:0046875; GO:0016301; GO:0000287; GO:0030145; GO:0051019; GO:0038191; GO:0004515; GO:0004715; GO:0001784; GO:0070064; GO:0008022; GO:0004672; GO:0005080; GO:0004713; GO:0042169; GO:0017124; GO:0005102; GO:0019905","GO:0030036; GO:0090135; GO:0050798; GO:1990051; GO:0046632; GO:0006914; GO:0001922; GO:0002322; GO:0050853; GO:0060020; GO:0072358; GO:0007050; GO:0006464; GO:0006974; GO:1903351; GO:0070301; GO:0071222; GO:0034599; GO:0021587; GO:0048668; GO:0006975; GO:0043542; GO:0007173; GO:0045184; GO:0038096; GO:0045087; GO:0007229; GO:0008630; GO:0030035; GO:0006298; GO:0051882; GO:0000278; GO:0030514; GO:0022408; GO:2000773; GO:2000352; GO:0070373; GO:0043124; GO:1900272; GO:0045930; GO:1900275; GO:0071901; GO:0051444; GO:0001843; GO:0060563; GO:0050885; GO:0038189; GO:0038083; GO:0018108; GO:0035791; GO:1905555; GO:2000251; GO:1904531; GO:0043065; GO:0090050; GO:0007204; GO:0010595; GO:0070374; GO:0051894; GO:0043123; GO:1902715; GO:1900042; GO:1904528; GO:0045931; GO:0051149; GO:1901216; GO:0033690; GO:0051353; GO:0050731; GO:0001934; GO:0051281; GO:0051496; GO:1900026; GO:2000096; GO:0009791; GO:0046777; GO:0006468; GO:0032956; GO:2000249; GO:0010506; GO:0030516; GO:0032489; GO:0030155; GO:2000145; GO:0042127; GO:0030100; GO:1903053; GO:1902036; GO:0031113; GO:1905244; GO:2001020; GO:0045580; GO:0006355; GO:0006979; GO:0042770; GO:0048536; GO:0034446; GO:0048538; GO:0002333"]
[30,14,"PK177","Abl (Abl1)","Y413","Abelson murine leukemia viral oncogene homologue 1",0,648,62,588,{"v":344.568,"d":"345"},{"v":605.4565930391999,"d":"605"},{"$nulls":3},0,388,48,384,{"v":130.56,"d":"131"},{"v":228.116403456,"d":"228"},{"$nulls":6},0,460,40,461,{"v":193.62,"d":"194"},{"v":331.253111868,"d":"331"},{"$nulls":7},"ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"Not precisely defined.  Original suppliers identified as an antibody for the Y412 site in human Abl1. Likely to include LA(pY)NK.","Antibody raised against amino acid residues surrounding the phosphorylated Tyr 413of human c-Abl.","The effect of Y413 phosphorylation is unclear. This is one of the many in vivo phosphorylation sites in Abl1 (≥164 reports based on mass spectrometry studies).",null,null,"P00519","P00519","P00519","P00519"]
[31,15,"PK508","Abl (Abl1)","Y469","Abelson murine leukemia viral oncogene homologue 1",0,9272,22,667,{"v":6169.75,"d":"6170"},{"v":10841.157086275,"d":"10841"},{"$f":"(L44+L45)/2","v":{"v":11738.5583653085,"d":"11739"}},{"$f":"SQRT((M44-L44)*(M44-L44))","v":{"v":897.4012790335,"d":"897"}},{"$f":"N44/M44*100","v":{"v":7.644901964159681,"d":"8"}},0,13265,30,609,{"v":8060.115,"d":"8060"},{"v":14082.754635736499,"d":"14083"},{"$f":"(U44+U45)/2","v":{"v":10862.15584867645,"d":"10862"}},{"$f":"SQRT((V44-U44)*(V44-U44))","v":{"v":3220.5987870600493,"d":"3221"}},{"$f":"W44/V44*100","v":{"v":29.649719926017067,"d":"30"}},{"$f":"X44+O44","v":{"v":37.29462189017675,"d":"37"}},{"$f":"(V44/M44*100)-100","v":{"v":-7.466014900280442,"d":"-7"}},null,0,9464,22,651,{"v":6146.742,"d":"6147"},{"v":10516.100688718801,"d":"10516"},{"$f":"(AG44+AG45)/2","v":{"v":9680.356375660202,"d":"9680"}},{"$f":"SQRT((AH44-AG44)*(AH44-AG44))","v":{"v":835.7443130585998,"d":"836"}},{"$f":"AI44/AH44*100","v":{"v":8.633404397796273,"d":"9"}},{"$f":"AJ44+O44","v":{"v":16.278306361955956,"d":"16"}},{"$f":"(AH44/M44*100)-100","v":{"v":-17.533686212533524,"d":"-18"}},null,null,"ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"EKV(pY)ELM(bA)C","Corresponds to amino acid residues E466 to M472; In the protein kinase catalytic domain. ","The effect of Y469 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in Abl1 (≥291 reports based on mass spectrometry studies).",null,"Protein-tyrosine kinase; Cytoplasm, nucleolus, nucleus, cytoskeleton protein","P00519","P00519","P00519","P00519","GO:0015629; GO:0031252; GO:0005737; GO:0005829; GO:0030425; GO:0031234; GO:0005739; GO:0043025; GO:0016604; GO:0031965; GO:0005730; GO:0005654; GO:0005634; GO:0048471; GO:0098794; GO:0032991","GO:0051015; GO:0003785; GO:0005524; GO:0003677; GO:0046875; GO:0016301; GO:0000287; GO:0030145; GO:0051019; GO:0038191; GO:0004515; GO:0004715; GO:0001784; GO:0070064; GO:0008022; GO:0004672; GO:0005080; GO:0004713; GO:0042169; GO:0017124; GO:0005102; GO:0019905","GO:0030036; GO:0090135; GO:0050798; GO:1990051; GO:0046632; GO:0006914; GO:0001922; GO:0002322; GO:0050853; GO:0060020; GO:0072358; GO:0007050; GO:0006464; GO:0006974; GO:1903351; GO:0070301; GO:0071222; GO:0034599; GO:0021587; GO:0048668; GO:0006975; GO:0043542; GO:0007173; GO:0045184; GO:0038096; GO:0045087; GO:0007229; GO:0008630; GO:0030035; GO:0006298; GO:0051882; GO:0000278; GO:0030514; GO:0022408; GO:2000773; GO:2000352; GO:0070373; GO:0043124; GO:1900272; GO:0045930; GO:1900275; GO:0071901; GO:0051444; GO:0001843; GO:0060563; GO:0050885; GO:0038189; GO:0038083; GO:0018108; GO:0035791; GO:1905555; GO:2000251; GO:1904531; GO:0043065; GO:0090050; GO:0007204; GO:0010595; GO:0070374; GO:0051894; GO:0043123; GO:1902715; GO:1900042; GO:1904528; GO:0045931; GO:0051149; GO:1901216; GO:0033690; GO:0051353; GO:0050731; GO:0001934; GO:0051281; GO:0051496; GO:1900026; GO:2000096; GO:0009791; GO:0046777; GO:0006468; GO:0032956; GO:2000249; GO:0010506; GO:0030516; GO:0032489; GO:0030155; GO:2000145; GO:0042127; GO:0030100; GO:1903053; GO:1902036; GO:0031113; GO:1905244; GO:2001020; GO:0045580; GO:0006355; GO:0006979; GO:0042770; GO:0048536; GO:0034446; GO:0048538; GO:0002333"]
[32,15,"PK508","Abl (Abl1)","Y469","Abelson murine leukemia viral oncogene homologue 1",0,6968,20,1035,{"v":7191.18,"d":"7191"},{"v":12635.959644342,"d":"12636"},{"$nulls":3},0,7870,18,557,{"v":4373.564,"d":"4374"},{"v":7641.5570616164005,"d":"7642"},{"$nulls":6},0,7996,18,648,{"v":5169.744,"d":"5170"},{"v":8844.6120626016,"d":"8845"},{"$nulls":7},"ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"EKV(pY)ELM(bA)C","Corresponds to amino acid residues E466 to M472; In the protein kinase catalytic domain. ","The effect of Y469 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in Abl1 (≥291 reports based on mass spectrometry studies).",null,null,"P00519","P00519","P00519","P00519"]
[33,16,"NK238-1","Abl2 (Arg)","Pan-specific","Abelson murine leukemia viral oncogene homologue 2",0,8107,16,732,{"v":5922.612,"d":"5923"},{"v":10406.8993157028,"d":"10407"},{"$f":"(L46+L47)/2","v":{"v":10928.3045439274,"d":"10928"}},{"$f":"SQRT((M46-L46)*(M46-L46))","v":{"v":521.4052282245993,"d":"521"}},{"$f":"N46/M46*100","v":{"v":4.771144747373754,"d":"5"}},0,6600,16,554,{"v":3647.536,"d":"3648"},{"v":6373.0299769936,"d":"6373"},{"$f":"(U46+U47)/2","v":{"v":7048.0543003729,"d":"7048"}},{"$f":"SQRT((V46-U46)*(V46-U46))","v":{"v":675.0243233792999,"d":"675"}},{"$f":"W46/V46*100","v":{"v":9.577456339171302,"d":"10"}},{"$f":"X46+O46","v":{"v":14.348601086545056,"d":"14"}},{"$f":"(V46/M46*100)-100","v":{"v":-35.50642488006672,"d":"-36"}},null,0,7084,18,587,{"v":4147.742,"d":"4148"},{"v":7096.1287301188,"d":"7096"},{"$f":"(AG46+AG47)/2","v":{"v":7649.616718164,"d":"7650"}},{"$f":"SQRT((AH46-AG46)*(AH46-AG46))","v":{"v":553.4879880451999,"d":"553"}},{"$f":"AI46/AH46*100","v":{"v":7.235499613084453,"d":"7"}},{"$f":"AJ46+O46","v":{"v":12.006644360458207,"d":"12"}},{"$f":"(AH46/M46*100)-100","v":{"v":-30.001797740760153,"d":"-30"}},null,null,"ARG","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"CDSISEEVAEELGRAA","Corresponds to amino acid residues S547 to A560; Kinase last alpha-chain.",null,null,"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; Abl family","P42684","P42684","P42684","P42684","GO:0015629; GO:0005829; GO:0031234","GO:0051015; GO:0003785; GO:0005524; GO:0000287; GO:0030145; GO:0004715; GO:0001784; GO:0004672; GO:0004713; GO:0005102","GO:0007155; GO:0006464; GO:0071300; GO:0045087; GO:0038083; GO:0018108; GO:0007204; GO:0010976; GO:0051353; GO:0010863; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0042127; GO:0030100; GO:0007165; GO:0007169"]
[34,16,"NK238-1","Abl2 (Arg)","Pan-specific","Abelson murine leukemia viral oncogene homologue 2",0,8681,16,752,{"v":6516.08,"d":"6516"},{"v":11449.709772152,"d":"11450"},{"$nulls":3},0,7470,16,593,{"v":4420.222,"d":"4420"},{"v":7723.0786237522,"d":"7723"},{"$nulls":6},0,7994,16,601,{"v":4794.778,"d":"4795"},{"v":8203.1047062092,"d":"8203"},{"$nulls":7},"ARG","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"CDSISEEVAEELGRAA","Corresponds to amino acid residues S547 to A560; Kinase last alpha-chain.",{"$nulls":3},"P42684","P42684","P42684","P42684"]
[35,17,"PK509","Abl2 (Arg)","Y439","Abelson murine leukemia viral oncogene homologue 2",0,3079,20,623,{"v":1905.757,"d":"1906"},{"v":3348.6950047033,"d":"3349"},{"$f":"(L48+L49)/2","v":{"v":3312.83427219465,"d":"3313"}},{"$f":"SQRT((M48-L48)*(M48-L48))","v":{"v":35.86073250865002,"d":"36"}},{"$f":"N48/M48*100","v":{"v":1.0824789157017924,"d":"1"}},0,1764,16,453,{"v":791.844,"d":"792"},{"v":1383.5217936444,"d":"1384"},{"$f":"(U48+U49)/2","v":{"v":1471.5290182314,"d":"1472"}},{"$f":"SQRT((V48-U48)*(V48-U48))","v":{"v":88.00722458699988,"d":"88"}},{"$f":"W48/V48*100","v":{"v":5.980665246600025,"d":"6"}},{"$f":"X48+O48","v":{"v":7.063144162301818,"d":"7"}},{"$f":"(V48/M48*100)-100","v":{"v":-55.580964898175914,"d":"-56"}},null,0,2764,18,496,{"v":1362.016,"d":"1362"},{"v":2330.1933602624003,"d":"2330"},{"$f":"(AG48+AG49)/2","v":{"v":2192.203736304,"d":"2192"}},{"$f":"SQRT((AH48-AG48)*(AH48-AG48))","v":{"v":137.98962395840044,"d":"138"}},{"$f":"AI48/AH48*100","v":{"v":6.294562027845435,"d":"6"}},{"$f":"AJ48+O48","v":{"v":7.377040943547228,"d":"7"}},{"$f":"(AH48/M48*100)-100","v":{"v":-33.826942243877085,"d":"-34"}},null,null,"ARG","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"GDT(pY)TAH(bA)C","Corresponds to amino acid residues G436 to H442; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y439 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. It is the most predominent phosphorylation site in Abl2 by mass spectrometry (≥1165 reports).","Abl2","EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; Abl family","P42684","P42684","P42684","P42684","GO:0015629; GO:0005829; GO:0031234","GO:0051015; GO:0003785; GO:0005524; GO:0000287; GO:0030145; GO:0004715; GO:0001784; GO:0004672; GO:0004713; GO:0005102","GO:0007155; GO:0006464; GO:0071300; GO:0045087; GO:0038083; GO:0018108; GO:0007204; GO:0010976; GO:0051353; GO:0010863; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0042127; GO:0030100; GO:0007165; GO:0007169"]
[36,17,"PK509","Abl2 (Arg)","Y439","Abelson murine leukemia viral oncogene homologue 2",0,2707,12,692,{"v":1864.94,"d":"1865"},{"v":3276.973539686,"d":"3277"},{"$nulls":3},0,1949,17,462,{"v":892.584,"d":"893"},{"v":1559.5362428183998,"d":"1560"},{"$nulls":6},0,2350,14,514,{"v":1200.704,"d":"1201"},{"v":2054.2141123456,"d":"2054"},{"$nulls":7},"ARG","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"GDT(pY)TAH(bA)C","Corresponds to amino acid residues G436 to H442; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y439 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. It is the most predominent phosphorylation site in Abl2 by mass spectrometry (≥1165 reports).","Abl2",null,"P42684","P42684","P42684","P42684"]
[37,18,"PK510","Abl2 (Arg)","Y439+T440","Abelson murine leukemia viral oncogene homologue 2",0,11844,14,725,{"v":8576.75,"d":"8577"},{"v":15070.609674575,"d":"15071"},{"$f":"(L50+L51)/2","v":{"v":17764.6268872763,"d":"17765"}},{"$f":"SQRT((M50-L50)*(M50-L50))","v":{"v":2694.0172127012993,"d":"2694"}},{"$f":"N50/M50*100","v":{"v":15.165064990083504,"d":"15"}},0,12652,18,619,{"v":7820.446,"d":"7820"},{"v":13664.0013399346,"d":"13664"},{"$f":"(U50+U51)/2","v":{"v":14054.9878933673,"d":"14055"}},{"$f":"SQRT((V50-U50)*(V50-U50))","v":{"v":390.9865534327,"d":"391"}},{"$f":"W50/V50*100","v":{"v":2.7818348645978612,"d":"3"}},{"$f":"X50+O50","v":{"v":17.946899854681366,"d":"18"}},{"$f":"(V50/M50*100)-100","v":{"v":-20.882166664395214,"d":"-21"}},null,0,12843,16,752,{"v":9645.904,"d":"9646"},{"v":16502.611903625602,"d":"16503"},{"$f":"(AG50+AG51)/2","v":{"v":14179.648559119601,"d":"14180"}},{"$f":"SQRT((AH50-AG50)*(AH50-AG50))","v":{"v":2322.963344506001,"d":"2323"}},{"$f":"AI50/AH50*100","v":{"v":16.382376014615634,"d":"16"}},{"$f":"AJ50+O50","v":{"v":31.547441004699138,"d":"32"}},{"$f":"(AH50/M50*100)-100","v":{"v":-20.180431319525184,"d":"-20"}},null,null,"ARG","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"DT(pY)(pT)AHA(bA)C","Corresponds to amino acid residues D437 to A443; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T440 phosphorylation is predicted to be stimulatory for phosphotransferase activity. Y439 phosphorylation is also likely to be stimulatory for phosphotransferase activity. Both phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. Y339 is the most predominent phosphorylation site in Abl2 by Mass spectrometry (≥1165 reports), and T440 is the second most phosphorylated site (≥476).","Y439: Abl2.","EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; Abl family","P42684","P42684","P42684","P42684","GO:0015629; GO:0005829; GO:0031234","GO:0051015; GO:0003785; GO:0005524; GO:0000287; GO:0030145; GO:0004715; GO:0001784; GO:0004672; GO:0004713; GO:0005102","GO:0007155; GO:0006464; GO:0071300; GO:0045087; GO:0038083; GO:0018108; GO:0007204; GO:0010976; GO:0051353; GO:0010863; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0042127; GO:0030100; GO:0007165; GO:0007169"]
[38,18,"PK510","Abl2 (Arg)","Y439+T440","Abelson murine leukemia viral oncogene homologue 2",0,15022,18,776,{"v":11643.104,"d":"11643"},{"v":20458.6440999776,"d":"20459"},{"$nulls":3},0,15616,16,530,8268,{"v":14445.9744468,"d":"14446"},{"$nulls":6},0,11156,14,622,{"v":6930.324,"d":"6930"},{"v":11856.6852146136,"d":"11857"},{"$nulls":7},"ARG","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"DT(pY)(pT)AHA(bA)C","Corresponds to amino acid residues D437 to A443; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T440 phosphorylation is predicted to be stimulatory for phosphotransferase activity. Y439 phosphorylation is also likely to be stimulatory for phosphotransferase activity. Both phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. Y339 is the most predominent phosphorylation site in Abl2 by Mass spectrometry (≥1165 reports), and T440 is the second most phosphorylated site (≥476).","Y439: Abl2.",null,"P42684","P42684","P42684","P42684"]
[39,19,"NN390-1","ACC1 (ACACA)","Pan-specific","Acetyl-CoA carboxylase 1",0,336,12,594,{"v":192.456,"d":"192"},{"v":338.17346378639996,"d":"338"},{"$f":"(L52+L53)/2","v":{"v":342.32735905799996,"d":"342"}},{"$f":"SQRT((M52-L52)*(M52-L52))","v":{"v":4.153895271599993,"d":"4"}},{"$f":"N52/M52*100","v":{"v":1.2134277794887567,"d":"1"}},0,202,8,471,{"v":91.374,"d":"91"},{"v":159.6500325474,"d":"160"},{"$f":"(U52+U53)/2","v":{"v":141.5715979077,"d":"142"}},{"$f":"SQRT((V52-U52)*(V52-U52))","v":{"v":18.078434639699992,"d":"18"}},{"$f":"W52/V52*100","v":{"v":12.769817468251318,"d":"13"}},{"$f":"X52+O52","v":{"v":13.983245247740076,"d":"14"}},{"$f":"(V52/M52*100)-100","v":{"v":-58.64438112768142,"d":"-59"}},null,0,309,12,508,{"v":150.876,"d":"151"},{"v":258.1249070664,"d":"258"},{"$f":"(AG52+AG53)/2","v":{"v":238.337315434,"d":"238"}},{"$f":"SQRT((AH52-AG52)*(AH52-AG52))","v":{"v":19.787591632399995,"d":"20"}},{"$f":"AI52/AH52*100","v":{"v":8.302347283037827,"d":"8"}},{"$f":"AJ52+O52","v":{"v":9.515775062526584,"d":"10"}},{"$f":"(AH52/M52*100)-100","v":{"v":-30.37736858373073,"d":"-30"}},{"$nulls":14},"X","Not precisely defined.","Antibody raised against amino acid residues 1-76 mapping at the N-terminus of human ACCα.",null,null,"EC 6.4.1.2; Ligase; Carbohydrate Metabolism - pyruvate; EC 6.3.4.14; Carbohydrate Metabolism - propanoate; Lipid Metabolism - fatty acid biosynthesis","Q13085","Q13085",null,"Q13085","GO:0015629; GO:0005829; GO:0001650","GO:0003989; GO:0005524; GO:0004075; GO:0042802; GO:0046872","GO:0006084; GO:0006853; GO:0071380; GO:0006633; GO:0046949; GO:0055088; GO:2001295; GO:0031325; GO:0051289; GO:0019538; GO:0045540; GO:0001894"]
[40,19,"NN390-1","ACC1 (ACACA)","Pan-specific","Acetyl-CoA carboxylase 1",0,330,14,624,{"v":197.184,"d":"197"},{"v":346.4812543296,"d":"346"},{"$nulls":3},0,164,12,465,{"v":70.68,"d":"71"},{"v":123.49316326800002,"d":"123"},{"$nulls":6},0,266,10,499,{"v":127.744,"d":"128"},{"v":218.5497238016,"d":"219"},{"$nulls":19},"X","Not precisely defined.","Antibody raised against amino acid residues 1-76 mapping at the N-terminus of human ACCα.",{"$nulls":3},"Q13085","Q13085",null,"Q13085"]
[41,20,"PN733","ACC1 (ACACA)","S29","Acetyl-CoA carboxylase 1",0,1228,12,578,{"v":702.848,"d":"703"},{"v":1235.0071843711999,"d":"1235"},{"$f":"(L54+L55)/2","v":{"v":1178.3743397842,"d":"1178"}},{"$f":"SQRT((M54-L54)*(M54-L54))","v":{"v":56.63284458699991,"d":"57"}},{"$f":"N54/M54*100","v":{"v":4.806014750573344,"d":"5"}},0,756,12,448,{"v":333.312,"d":"333"},{"v":582.3677594112,"d":"582"},{"$f":"(U54+U55)/2","v":{"v":577.6293120600001,"d":"578"}},{"$f":"SQRT((V54-U54)*(V54-U54))","v":{"v":4.738447351199966,"d":"5"}},{"$f":"W54/V54*100","v":{"v":0.8203266787658743,"d":"1"}},{"$f":"X54+O54","v":{"v":5.626341429339218,"d":"6"}},{"$f":"(V54/M54*100)-100","v":{"v":-50.980830746383745,"d":"-51"}},null,0,1072,14,500,529,{"v":905.0351006000001,"d":"905"},{"$f":"(AG54+AG55)/2","v":{"v":798.9013435096001,"d":"799"}},{"$f":"SQRT((AH54-AG54)*(AH54-AG54))","v":{"v":106.13375709039997,"d":"106"}},{"$f":"AI54/AH54*100","v":{"v":13.284964151412094,"d":"13"}},{"$f":"AJ54+O54","v":{"v":18.090978901985437,"d":"18"}},{"$f":"(AH54/M54*100)-100","v":{"v":-32.20309399677646,"d":"-32"}},{"$nulls":5},"Fatty acid synthesis",{"$nulls":8},"X","EDN(pS)EDE(bA)C","Corresponds to amino acid residues E26 to E32.","The effect of S29 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in ACC1 (≥78 reports based on mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in fish.","CK2a1 (CSNK2A1)","EC 6.4.1.2; Ligase; Carbohydrate Metabolism - pyruvate; EC 6.3.4.14; Carbohydrate Metabolism - propanoate; Lipid Metabolism - fatty acid biosynthesis","Q13085","Q13085",null,"Q13085","GO:0015629; GO:0005829; GO:0001650","GO:0003989; GO:0005524; GO:0004075; GO:0042802; GO:0046872","GO:0006084; GO:0006853; GO:0071380; GO:0006633; GO:0046949; GO:0055088; GO:2001295; GO:0031325; GO:0051289; GO:0019538; GO:0045540; GO:0001894"]
[42,20,"PN733","ACC1 (ACACA)","S29","Acetyl-CoA carboxylase 1",0,1038,10,621,{"v":638.388,"d":"638"},{"v":1121.7414951972,"d":"1122"},{"$nulls":3},0,804,12,414,{"v":327.888,"d":"328"},{"v":572.8908647088,"d":"573"},{"$nulls":6},0,898,10,456,{"v":404.928,"d":"405"},{"v":692.7675864192,"d":"693"},{"$nulls":10},"Fatty acid synthesis",{"$nulls":8},"X","EDN(pS)EDE(bA)C","Corresponds to amino acid residues E26 to E32.","The effect of S29 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in ACC1 (≥78 reports based on mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in fish.","CK2a1 (CSNK2A1)",null,"Q13085","Q13085",null,"Q13085"]
[43,21,"PN202","ACC1 (ACACA)","S78+S80","Acetyl-CoA carboxylase 1",0,840,14,748,{"v":617.848,"d":"618"},{"v":1085.6496978711998,"d":"1086"},{"$f":"(L56+L57)/2","v":{"v":954.0130378576998,"d":"954"}},{"$f":"SQRT((M56-L56)*(M56-L56))","v":{"v":131.63666001349998,"d":"132"}},{"$f":"N56/M56*100","v":{"v":13.798203461568923,"d":"14"}},0,532,7,526,{"v":276.15,"d":"276"},{"v":482.49344986499995,"d":"482"},{"$f":"(U56+U57)/2","v":{"v":506.1350173830999,"d":"506"}},{"$f":"SQRT((V56-U56)*(V56-U56))","v":{"v":23.641567518099976,"d":"24"}},{"$f":"W56/V56*100","v":{"v":4.67100016915158,"d":"5"}},{"$f":"X56+O56","v":{"v":18.469203630720504,"d":"18"}},{"$f":"(V56/M56*100)-100","v":{"v":-46.946740002667056,"d":"-47"}},null,0,792,10,567,{"v":443.394,"d":"443"},{"v":758.5768117116,"d":"759"},{"$f":"(AG56+AG57)/2","v":{"v":660.5609970642,"d":"661"}},{"$f":"SQRT((AH56-AG56)*(AH56-AG56))","v":{"v":98.01581464740002,"d":"98"}},{"$f":"AI56/AH56*100","v":{"v":14.838268544921954,"d":"15"}},{"$f":"AJ56+O56","v":{"v":28.636472006490877,"d":"29"}},{"$f":"(AH56/M56*100)-100","v":{"v":-30.759751612249033,"d":"-31"}},{"$nulls":14},"X","Not precisely defined.","Antibody raised against amino acid residues that encompass the S78 and S80 phosphosites.","The effect of S78 phosphorylation is unclear and it has been rarely observed (3 mass spectrometry reports). S80 phosphorylation produces enzyme inhibition. This is one of the major in vivo phosphorylation sites in ACC1 (≥80 reports based on mass spectrometry studies).","S78: PKACa (PRKACA). S80: AMPKa1 (PRKAA1); AMPKa2 (PRKAA2).","EC 6.4.1.2; Ligase; Carbohydrate Metabolism - pyruvate; EC 6.3.4.14; Carbohydrate Metabolism - propanoate; Lipid Metabolism - fatty acid biosynthesis","Q13085","Q13085",null,"Q13085","GO:0015629; GO:0005829; GO:0001650","GO:0003989; GO:0005524; GO:0004075; GO:0042802; GO:0046872","GO:0006084; GO:0006853; GO:0071380; GO:0006633; GO:0046949; GO:0055088; GO:2001295; GO:0031325; GO:0051289; GO:0019538; GO:0045540; GO:0001894"]
[44,21,"PN202","ACC1 (ACACA)","S78+S80","Acetyl-CoA carboxylase 1",0,654,12,729,{"v":468.018,"d":"468"},{"v":822.3763778442,"d":"822"},{"$nulls":3},0,353,10,884,{"v":303.212,"d":"303"},{"v":529.7765849012,"d":"530"},{"$nulls":6},0,574,10,583,{"v":328.812,"d":"329"},{"v":562.5451824168,"d":"563"},{"$nulls":19},"X","Not precisely defined.","Antibody raised against amino acid residues that encompass the S78 and S80 phosphosites.","The effect of S78 phosphorylation is unclear and it has been rarely observed (3 mass spectrometry reports). S80 phosphorylation produces enzyme inhibition. This is one of the major in vivo phosphorylation sites in ACC1 (≥80 reports based on mass spectrometry studies).","S78: PKACa (PRKACA). S80: AMPKa1 (PRKAA1); AMPKa2 (PRKAA2).",null,"Q13085","Q13085",null,"Q13085"]
[45,22,"PN002","ACC1 (ACACA)","S80","Acetyl-CoA carboxylase 1",0,7712,16,428,{"v":3293.888,"d":"3294"},{"v":5787.8450881472,"d":"5788"},{"$f":"(L58+L59)/2","v":{"v":5416.2875904077,"d":"5416"}},{"$f":"SQRT((M58-L58)*(M58-L58))","v":{"v":371.5574977394999,"d":"372"}},{"$f":"N58/M58*100","v":{"v":6.860003120911305,"d":"7"}},0,9844,16,354,{"v":3479.112,"d":"3479"},{"v":6078.7570209912,"d":"6079"},{"$f":"(U58+U59)/2","v":{"v":5205.706832608101,"d":"5206"}},{"$f":"SQRT((V58-U58)*(V58-U58))","v":{"v":873.0501883830993,"d":"873"}},{"$f":"W58/V58*100","v":{"v":16.771021043950995,"d":"17"}},{"$f":"X58+O58","v":{"v":23.6310241648623,"d":"24"}},{"$f":"(V58/M58*100)-100","v":{"v":-3.8879168486647586,"d":"-4"}},null,0,7775,14,346,{"v":2685.306,"d":"2685"},{"v":4594.1326764684,"d":"4594"},{"$f":"(AG58+AG59)/2","v":{"v":3994.1902118890002,"d":"3994"}},{"$f":"SQRT((AH58-AG58)*(AH58-AG58))","v":{"v":599.9424645793997,"d":"600"}},{"$f":"AI58/AH58*100","v":{"v":15.020377917747304,"d":"15"}},{"$f":"AJ58+O58","v":{"v":21.88038103865861,"d":"22"}},{"$f":"(AH58/M58*100)-100","v":{"v":-26.255942927352095,"d":"-26"}},{"$nulls":14},"X","Epitope undefined.","Antibody raised against amino acid residues that encompass the S80 phosphosite.","S80 phosphorylation produces enzyme inhibition. This is one of the major in vivo phosphorylation sites in ACC1 (≥80 reports based on mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and found in fish.","AMPKa1 (PRKAA1); AMPKa2 (PRKAA2)","EC 6.4.1.2; Ligase; Carbohydrate Metabolism - pyruvate; EC 6.3.4.14; Carbohydrate Metabolism - propanoate; Lipid Metabolism - fatty acid biosynthesis","Q13085","Q13085",null,"Q13085","GO:0015629; GO:0005829; GO:0001650","GO:0003989; GO:0005524; GO:0004075; GO:0042802; GO:0046872","GO:0006084; GO:0006853; GO:0071380; GO:0006633; GO:0046949; GO:0055088; GO:2001295; GO:0031325; GO:0051289; GO:0019538; GO:0045540; GO:0001894"]
[46,22,"PN002","ACC1 (ACACA)","S80","Acetyl-CoA carboxylase 1",0,7066,12,407,{"v":2870.978,"d":"2871"},{"v":5044.7300926682,"d":"5045"},{"$nulls":3},0,7644,14,325,{"v":2479.75,"d":"2480"},{"v":4332.6566442250005,"d":"4333"},{"$nulls":6},0,5746,12,346,{"v":1983.964,"d":"1984"},{"v":3394.2477473096,"d":"3394"},{"$nulls":19},"X","Epitope undefined.","Antibody raised against amino acid residues that encompass the S80 phosphosite.","S80 phosphorylation produces enzyme inhibition. This is one of the major in vivo phosphorylation sites in ACC1 (≥80 reports based on mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and found in fish.","AMPKa1 (PRKAA1); AMPKa2 (PRKAA2)",null,"Q13085","Q13085",null,"Q13085"]
[47,23,"PN734","ACC2 (ACACB)","T1342","Acetyl CoA carboxylase beta",0,14294,16,781,{"v":11151.118,"d":"11151"},{"v":19594.1524252342,"d":"19594"},{"$f":"(L60+L61)/2","v":{"v":19931.4016297512,"d":"19931"}},{"$f":"SQRT((M60-L60)*(M60-L60))","v":{"v":337.2492045170002,"d":"337"}},{"$f":"N60/M60*100","v":{"v":1.6920496148830553,"d":"2"}},0,15634,20,655,{"v":10227.17,"d":"10227"},{"v":17869.065854267,"d":"17869"},{"$f":"(U60+U61)/2","v":{"v":17510.502371445,"d":"17511"}},{"$f":"SQRT((V60-U60)*(V60-U60))","v":{"v":358.56348282199906,"d":"359"}},{"$f":"W60/V60*100","v":{"v":2.0477052868952597,"d":"2"}},{"$f":"X60+O60","v":{"v":3.7397549017783147,"d":"4"}},{"$f":"(V60/M60*100)-100","v":{"v":-12.146156618973407,"d":"-12"}},null,0,14962,10,702,{"v":10496.304,"d":"10496"},{"v":17957.5114301856,"d":"17958"},{"$f":"(AG60+AG61)/2","v":{"v":15946.629508819202,"d":"15947"}},{"$f":"SQRT((AH60-AG60)*(AH60-AG60))","v":{"v":2010.8819213663992,"d":"2011"}},{"$f":"AI60/AH60*100","v":{"v":12.610074876664633,"d":"13"}},{"$f":"AJ60+O60","v":{"v":14.302124491547689,"d":"14"}},{"$f":"(AH60/M60*100)-100","v":{"v":-19.992433020786706,"d":"-20"}},{"$nulls":5},"Fatty acid synthesis",{"$nulls":8},"X","ISI(pT)NPD(bA)C","Corresponds to amino acid residues I1339 to D1335.","The effect of T1342 phosphorylation is unclear. This is the major site of phosphorylation in ACC2 by mass spectrometry (≥29 reports). This human phosphosite is highly conserved in mammals and also found in the platypus.",null,"EC 6.3.4.14; Carbohydrate Metabolism - propanoate; Ligase; EC 6.4.1.2; Lipid Metabolism - fatty acid biosynthesis; Carbohydrate Metabolism - pyruvate; Mitochondrial","O00763","O00763",null,null,"GO:0005829; GO:0012505; GO:0005741; GO:0005739; GO:0005634","GO:0003989; GO:0005524; GO:0009374; GO:0004075; GO:0042802; GO:0046872","GO:0006084; GO:0006853; GO:0097009; GO:0006633; GO:2001295; GO:0043086; GO:0031999; GO:0010629; GO:0031325; GO:0060421; GO:0010884; GO:0051289; GO:0045540; GO:0010906; GO:0042493; GO:0031667; GO:0014070"]
[48,23,"PN734","ACC2 (ACACB)","T1342","Acetyl CoA carboxylase beta",0,14564,18,793,{"v":11534.978,"d":"11535"},{"v":20268.6508342682,"d":"20269"},{"$nulls":3},0,14780,18,665,{"v":9816.73,"d":"9817"},{"v":17151.938888623,"d":"17152"},{"$nulls":6},0,12433,16,656,{"v":8145.552,"d":"8146"},{"v":13935.7475874528,"d":"13936"},{"$nulls":10},"Fatty acid synthesis",{"$nulls":8},"X","ISI(pT)NPD(bA)C","Corresponds to amino acid residues I1339 to D1335.","The effect of T1342 phosphorylation is unclear. This is the major site of phosphorylation in ACC2 by mass spectrometry (≥29 reports). This human phosphosite is highly conserved in mammals and also found in the platypus.",null,null,"O00763","O00763"]
[49,24,"NK002","ACK1 (TNK2)","Pan-specific","Activated CDC42 kinase 1",0,498,20,683,{"v":326.474,"d":"326"},{"v":573.6627770306,"d":"574"},{"$f":"(L62+L63)/2","v":{"v":505.0268619697,"d":"505"}},{"$f":"SQRT((M62-L62)*(M62-L62))","v":{"v":68.63591506089995,"d":"69"}},{"$f":"N62/M62*100","v":{"v":13.590547400430728,"d":"14"}},0,474,14,659,{"v":303.14,"d":"303"},{"v":529.650785414,"d":"530"},{"$f":"(U62+U63)/2","v":{"v":423.332746579,"d":"423"}},{"$f":"SQRT((V62-U62)*(V62-U62))","v":{"v":106.31803883499998,"d":"106"}},{"$f":"W62/V62*100","v":{"v":25.114532172190344,"d":"25"}},{"$f":"X62+O62","v":{"v":38.705079572621074,"d":"39"}},{"$f":"(V62/M62*100)-100","v":{"v":-16.176192108292526,"d":"-16"}},null,0,476,12,589,{"v":273.296,"d":"273"},{"v":467.5661112544,"d":"468"},{"$f":"(AG62+AG63)/2","v":{"v":424.91825683520005,"d":"425"}},{"$f":"SQRT((AH62-AG62)*(AH62-AG62))","v":{"v":42.64785441919997,"d":"43"}},{"$f":"AI62/AH62*100","v":{"v":10.036719706242343,"d":"10"}},{"$f":"AJ62+O62","v":{"v":23.62726710667307,"d":"24"}},{"$f":"(AH62/M62*100)-100","v":{"v":-15.862246380729388,"d":"-16"}},null,null,"ACK1","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Ack",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues near the C-terminus of human ACK.",null,null,"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK domain target; TK</A> group; Ack family","Q07912","Q07912","Q07912","Q07912","GO:0005912; GO:0005905; GO:0030136; GO:0005737; GO:0030659; GO:0005768; GO:0031234; GO:0070436; GO:0016020; GO:0005634; GO:0048471; GO:0005886","GO:0005524; GO:0005154; GO:0005095; GO:0042802; GO:0046872; GO:0004715; GO:0004712; GO:0004674; GO:0004713; GO:0031625; GO:0050699","GO:0030154; GO:0016477; GO:0007166; GO:0006897; GO:0045087; GO:0038083; GO:0016310; GO:0050731; GO:0042127; GO:2000369; GO:0007264; GO:0007169"]
[50,24,"NK002","ACK1 (TNK2)","Pan-specific","Activated CDC42 kinase 1",0,432,16,597,{"v":248.352,"d":"248"},{"v":436.3909469088,"d":"436"},{"$nulls":3},0,338,18,567,{"v":181.44,"d":"181"},{"v":317.014707744,"d":"317"},{"$nulls":6},0,406,14,570,{"v":223.44,"d":"223"},{"v":382.270402416,"d":"382"},{"$nulls":7},"ACK1","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Ack",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues near the C-terminus of human ACK.",{"$nulls":3},"Q07912","Q07912","Q07912","Q07912"]
[51,25,"PK511","ACK1 (TNK2)","Y284","Activated CDC42 kinase 1",0,9222,22,737,{"v":6780.4,"d":"6780"},{"v":11914.15884076,"d":"11914"},{"$f":"(L64+L65)/2","v":{"v":11839.972098642,"d":"11840"}},{"$f":"SQRT((M64-L64)*(M64-L64))","v":{"v":74.18674211799953,"d":"74"}},{"$f":"N64/M64*100","v":{"v":0.6265786903882018,"d":"1"}},0,10218,20,791,{"v":8066.618,"d":"8067"},{"v":14094.1167755318,"d":"14094"},{"$f":"(U64+U65)/2","v":{"v":12698.1286021489,"d":"12698"}},{"$f":"SQRT((V64-U64)*(V64-U64))","v":{"v":1395.9881733829006,"d":"1396"}},{"$f":"W64/V64*100","v":{"v":10.9936528217761,"d":"11"}},{"$f":"X64+O64","v":{"v":11.620231512164303,"d":"12"}},{"$f":"(V64/M64*100)-100","v":{"v":7.247960521843865,"d":"7"}},null,0,9833,18,798,{"v":7832.37,"d":"7832"},{"v":13399.942856118001,"d":"13400"},{"$f":"(AG64+AG65)/2","v":{"v":12656.498436589402,"d":"12656"}},{"$f":"SQRT((AH64-AG64)*(AH64-AG64))","v":{"v":743.4444195285996,"d":"743"}},{"$f":"AI64/AH64*100","v":{"v":5.874013442606948,"d":"6"}},{"$f":"AJ64+O64","v":{"v":6.50059213299515,"d":"7"}},{"$f":"(AH64/M64*100)-100","v":{"v":6.896353565233952,"d":"7"}},null,null,"ACK1","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Ack",{"$nulls":6},"DDH(pY)VMQ(bA)C","Corresponds to amino acid residues D281 to Q287; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y284 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII.","ACK1 (TNK2); Src","Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK domain target; TK</A> group; Ack family","Q07912","Q07912","Q07912","Q07912","GO:0005912; GO:0005905; GO:0030136; GO:0005737; GO:0030659; GO:0005768; GO:0031234; GO:0070436; GO:0016020; GO:0005634; GO:0048471; GO:0005886","GO:0005524; GO:0005154; GO:0005095; GO:0042802; GO:0046872; GO:0004715; GO:0004712; GO:0004674; GO:0004713; GO:0031625; GO:0050699","GO:0030154; GO:0016477; GO:0007166; GO:0006897; GO:0045087; GO:0038083; GO:0016310; GO:0050731; GO:0042127; GO:2000369; GO:0007264; GO:0007169"]
[52,25,"PK511","ACK1 (TNK2)","Y284","Activated CDC42 kinase 1",0,9178,18,731,{"v":6695.96,"d":"6696"},{"v":11765.785356524,"d":"11766"},{"$nulls":3},0,8926,16,726,{"v":6468.66,"d":"6469"},{"v":11302.140428766,"d":"11302"},{"$nulls":6},0,9292,20,751,{"v":6963.272,"d":"6963"},{"v":11913.0540170608,"d":"11913"},{"$nulls":7},"ACK1","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Ack",{"$nulls":6},"DDH(pY)VMQ(bA)C","Corresponds to amino acid residues D281 to Q287; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y284 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII.","ACK1 (TNK2); Src",null,"Q07912","Q07912","Q07912","Q07912"]
[53,26,"PK512","ACK1 (TNK2)","Y518","Activated CDC42 kinase 1",0,16844,22,858,{"v":14433.276,"d":"14433"},{"v":25361.3861802444,"d":"25361"},{"$f":"(L66+L67)/2","v":{"v":23262.7043944383,"d":"23263"}},{"$f":"SQRT((M66-L66)*(M66-L66))","v":{"v":2098.6817858061004,"d":"2099"}},{"$f":"N66/M66*100","v":{"v":9.021658661096419,"d":"9"}},0,15014,24,674,{"v":10103.26,"d":"10103"},{"v":17652.568431226002,"d":"17653"},{"$f":"(U66+U67)/2","v":{"v":17469.655976837203,"d":"17470"}},{"$f":"SQRT((V66-U66)*(V66-U66))","v":{"v":182.91245438879923,"d":"183"}},{"$f":"W66/V66*100","v":{"v":1.047029515814854,"d":"1"}},{"$f":"X66+O66","v":{"v":10.068688176911273,"d":"10"}},{"$f":"(V66/M66*100)-100","v":{"v":-24.902729791752478,"d":"-25"}},null,0,13762,20,792,{"v":10883.664,"d":"10884"},{"v":18620.222954889603,"d":"18620"},{"$f":"(AG66+AG67)/2","v":{"v":17642.923624395,"d":"17643"}},{"$f":"SQRT((AH66-AG66)*(AH66-AG66))","v":{"v":977.299330494603,"d":"977"}},{"$f":"AI66/AH66*100","v":{"v":5.539327558745899,"d":"6"}},{"$f":"AJ66+O66","v":{"v":14.560986219842318,"d":"15"}},{"$f":"(AH66/M66*100)-100","v":{"v":-24.157899592219763,"d":"-24"}},null,null,"ACK1","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Ack",{"$nulls":6},"KPT(pY)DPV(bA)C","Corresponds to amino acid residues K515 to V521; Just after the GTPase-binding domain. ","Y518 phosphorylation stimulates phosphotransferase activity. This is major site of phosphorylation of ACK1 by mass spectrometry studies (≥757 reports).","ACK1 (TNK2)","Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK domain target; TK</A> group; Ack family","Q07912","Q07912","Q07912","Q07912","GO:0005912; GO:0005905; GO:0030136; GO:0005737; GO:0030659; GO:0005768; GO:0031234; GO:0070436; GO:0016020; GO:0005634; GO:0048471; GO:0005886","GO:0005524; GO:0005154; GO:0005095; GO:0042802; GO:0046872; GO:0004715; GO:0004712; GO:0004674; GO:0004713; GO:0031625; GO:0050699","GO:0030154; GO:0016477; GO:0007166; GO:0006897; GO:0045087; GO:0038083; GO:0016310; GO:0050731; GO:0042127; GO:2000369; GO:0007264; GO:0007169"]
[54,26,"PK512","ACK1 (TNK2)","Y518","Activated CDC42 kinase 1",0,16060,22,751,{"v":12044.538,"d":"12045"},{"v":21164.0226086322,"d":"21164"},{"$nulls":3},0,14034,20,706,{"v":9893.884,"d":"9894"},{"v":17286.7435224484,"d":"17287"},{"$nulls":6},0,13166,20,741,{"v":9741.186,"d":"9741"},{"v":16665.6242939004,"d":"16666"},{"$nulls":7},"ACK1","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Ack",{"$nulls":6},"KPT(pY)DPV(bA)C","Corresponds to amino acid residues K515 to V521; Just after the GTPase-binding domain. ","Y518 phosphorylation stimulates phosphotransferase activity. This is major site of phosphorylation of ACK1 by mass spectrometry studies (≥757 reports).","ACK1 (TNK2)",null,"Q07912","Q07912","Q07912","Q07912"]
[55,27,"PK513","ACK1 (TNK2)","Y859+Y860","Activated CDC42 kinase 1",0,9507,22,702,{"v":6658.47,"d":"6658"},{"v":11699.909919243,"d":"11700"},{"$f":"(L68+L69)/2","v":{"v":11829.109416506199,"d":"11829"}},{"$f":"SQRT((M68-L68)*(M68-L68))","v":{"v":129.19949726319828,"d":"129"}},{"$f":"N68/M68*100","v":{"v":1.0922166049365885,"d":"1"}},0,12158,18,594,{"v":7211.16,"d":"7211"},{"v":12599.447640516,"d":"12599"},{"$f":"(U68+U69)/2","v":{"v":10864.4053881177,"d":"10864"}},{"$f":"SQRT((V68-U68)*(V68-U68))","v":{"v":1735.0422523982998,"d":"1735"}},{"$f":"W68/V68*100","v":{"v":15.969969735259504,"d":"16"}},{"$f":"X68+O68","v":{"v":17.062186340196092,"d":"17"}},{"$f":"(V68/M68*100)-100","v":{"v":-8.155339463192064,"d":"-8"}},null,0,9380,16,598,{"v":5599.672,"d":"5600"},{"v":9580.1506840208,"d":"9580"},{"$f":"(AG68+AG69)/2","v":{"v":8755.6277797048,"d":"8756"}},{"$f":"SQRT((AH68-AG68)*(AH68-AG68))","v":{"v":824.5229043159998,"d":"825"}},{"$f":"AI68/AH68*100","v":{"v":9.417062089222332,"d":"9"}},{"$f":"AJ68+O68","v":{"v":10.50927869415892,"d":"11"}},{"$f":"(AH68/M68*100)-100","v":{"v":-25.98235867623896,"d":"-26"}},null,null,"ACK1","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Ack",{"$nulls":6},"STH(pY)(pY)LL(bA)C","Corresponds to amino acid residues S856 to L862; In the Inhibitor_Mig-6 domain. ","The effects of Y859 and Y860 phosphorylation are unclear. These are two of the main sites of phosphorylation of ACK1 (Y859 >595 reports. Y860 (229 reports).","Bmx (Etk)","Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK domain target; TK</A> group; Ack family","Q07912","Q07912","Q07912","Q07912","GO:0005912; GO:0005905; GO:0030136; GO:0005737; GO:0030659; GO:0005768; GO:0031234; GO:0070436; GO:0016020; GO:0005634; GO:0048471; GO:0005886","GO:0005524; GO:0005154; GO:0005095; GO:0042802; GO:0046872; GO:0004715; GO:0004712; GO:0004674; GO:0004713; GO:0031625; GO:0050699","GO:0030154; GO:0016477; GO:0007166; GO:0006897; GO:0045087; GO:0038083; GO:0016310; GO:0050731; GO:0042127; GO:2000369; GO:0007264; GO:0007169"]
[56,27,"PK513","ACK1 (TNK2)","Y859+Y860","Activated CDC42 kinase 1",0,8604,22,793,{"v":6805.526,"d":"6806"},{"v":11958.308913769399,"d":"11958"},{"$nulls":3},0,8432,18,621,{"v":5225.094,"d":"5225"},{"v":9129.3631357194,"d":"9129"},{"$nulls":6},0,7902,18,588,{"v":4635.792,"d":"4636"},{"v":7931.104875388801,"d":"7931"},{"$nulls":7},"ACK1","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Ack",{"$nulls":6},"STH(pY)(pY)LL(bA)C","Corresponds to amino acid residues S856 to L862; In the Inhibitor_Mig-6 domain. ","The effects of Y859 and Y860 phosphorylation are unclear. These are two of the main sites of phosphorylation of ACK1 (Y859 >595 reports. Y860 (229 reports).","Bmx (Etk)",null,"Q07912","Q07912","Q07912","Q07912"]
[57,28,"PN735","ACLY","S455","ATP-citrate synthase",0,8570,14,645,{"v":5518.62,"d":"5519"},{"v":9697.026025277999,"d":"9697"},{"$f":"(L70+L71)/2","v":{"v":8749.7973316012,"d":"8750"}},{"$f":"SQRT((M70-L70)*(M70-L70))","v":{"v":947.2286936767996,"d":"947"}},{"$f":"N70/M70*100","v":{"v":10.825721531351839,"d":"11"}},0,8396,14,554,{"v":4643.628,"d":"4644"},{"v":8113.4169603827995,"d":"8113"},{"$f":"(U70+U71)/2","v":{"v":7787.18831380895,"d":"7787"}},{"$f":"SQRT((V70-U70)*(V70-U70))","v":{"v":326.2286465738498,"d":"326"}},{"$f":"W70/V70*100","v":{"v":4.189299570364204,"d":"4"}},{"$f":"X70+O70","v":{"v":15.015021101716043,"d":"15"}},{"$f":"(V70/M70*100)-100","v":{"v":-11.001500735515819,"d":"-11"}},null,0,8192,16,575,{"v":4701.2,"d":"4701"},{"v":8043.00758968,"d":"8043"},{"$f":"(AG70+AG71)/2","v":{"v":7579.059052565901,"d":"7579"}},{"$f":"SQRT((AH70-AG70)*(AH70-AG70))","v":{"v":463.94853711409905,"d":"464"}},{"$f":"AI70/AH70*100","v":{"v":6.121452991674852,"d":"6"}},{"$f":"AJ70+O70","v":{"v":16.94717452302669,"d":"17"}},{"$f":"(AH70/M70*100)-100","v":{"v":-13.38017595912767,"d":"-13"}},{"$nulls":5},"Enzyme - Fatty acid synthesis",{"$nulls":8},"X","RTA(pS)FSE(bA)C","Corresponds to amino acid residues S452 to E458.","The effect of S455 phosphorylation is unclear. This is the second most frequently phosphorylated site in ATP-citrate lysate in mass spectrometry studies (≥202 reports). This human phosphosite is highly conserved in vertebrates and is found in fish.","Akt1 (PKBa); Akt3 (PKBg)","Transferase; Carbohydrate Metabolism - citrate (TCA) cycle; Lyase; EC 2.3.3.8","P53396","P53396",null,null,"GO:0035578; GO:0009346; GO:0005829; GO:0070062; GO:0005576; GO:1904813; GO:0016020; GO:0005654; GO:0005886","GO:0005524; GO:0003878; GO:0048037; GO:0046872","GO:0006085; GO:0006695; GO:0006101; GO:0015936; GO:0006633; GO:0046949; GO:0008610; GO:0043312; GO:0006107; GO:0031325"]
[58,28,"PN735","ACLY","S455","ATP-citrate synthase",0,7822,18,569,{"v":4440.476,"d":"4440"},{"v":7802.568637924399,"d":"7803"},{"$nulls":3},0,7651,12,559,{"v":4270.201,"d":"4270"},{"v":7460.9596672351,"d":"7461"},{"$nulls":6},0,7671,12,543,{"v":4158.837,"d":"4159"},{"v":7115.110515451801,"d":"7115"},{"$nulls":10},"Enzyme - Fatty acid synthesis",{"$nulls":8},"X","RTA(pS)FSE(bA)C","Corresponds to amino acid residues S452 to E458.","The effect of S455 phosphorylation is unclear. This is the second most frequently phosphorylated site in ATP-citrate lysate in mass spectrometry studies (≥202 reports). This human phosphosite is highly conserved in vertebrates and is found in fish.","Akt1 (PKBa); Akt3 (PKBg)",null,"P53396","P53396"]
[59,29,"PN686","ACLY","Y682","ATP-citrate synthase",0,10752,18,812,{"v":8716.008,"d":"8716"},{"v":15315.3064375752,"d":"15315"},{"$f":"(L72+L73)/2","v":{"v":12899.5931794835,"d":"12900"}},{"$f":"SQRT((M72-L72)*(M72-L72))","v":{"v":2415.7132580917005,"d":"2416"}},{"$f":"N72/M72*100","v":{"v":18.72704995017855,"d":"19"}},0,9916,16,568,{"v":5623.2,"d":"5623"},{"v":9824.93995032,"d":"9825"},{"$f":"(U72+U73)/2","v":{"v":10717.1413634142,"d":"10717"}},{"$f":"SQRT((V72-U72)*(V72-U72))","v":{"v":892.2014130942007,"d":"892"}},{"$f":"W72/V72*100","v":{"v":8.32499435101198,"d":"8"}},{"$f":"X72+O72","v":{"v":27.05204430119053,"d":"27"}},{"$f":"(V72/M72*100)-100","v":{"v":-16.918764690505412,"d":"-17"}},null,0,10313,14,604,{"v":6220.596,"d":"6221"},{"v":10642.4531694744,"d":"10642"},{"$f":"(AG72+AG73)/2","v":{"v":10614.501442681201,"d":"10615"}},{"$f":"SQRT((AH72-AG72)*(AH72-AG72))","v":{"v":27.95172679319876,"d":"28"}},{"$f":"AI72/AH72*100","v":{"v":0.26333527715964217,"d":"0"}},{"$f":"AJ72+O72","v":{"v":18.99038522733819,"d":"19"}},{"$f":"(AH72/M72*100)-100","v":{"v":-17.714448083809984,"d":"-18"}},{"$nulls":5},"Enzyme - Fatty acid synthesis",{"$nulls":8},"X","DGV(pY)EGVA(bA)C","Corresponds to amino acid residues D679 to A686.","The effect of Y682 phosphorylation is unclear. This is the most frequently phosphorylated site in ATP-citrate lysate in mass spectrometry studies (≥378 reports). This human phosphosite is highly conserved in vertebrates and also found in the nematode worm.",null,"Transferase; Carbohydrate Metabolism - citrate (TCA) cycle; Lyase; EC 2.3.3.8","P53396","P53396",null,null,"GO:0035578; GO:0009346; GO:0005829; GO:0070062; GO:0005576; GO:1904813; GO:0016020; GO:0005654; GO:0005886","GO:0005524; GO:0003878; GO:0048037; GO:0046872","GO:0006085; GO:0006695; GO:0006101; GO:0015936; GO:0006633; GO:0046949; GO:0008610; GO:0043312; GO:0006107; GO:0031325"]
[60,29,"PN686","ACLY","Y682","ATP-citrate synthase",0,9927,16,602,{"v":5966.422,"d":"5966"},{"v":10483.8799213918,"d":"10484"},{"$nulls":3},0,10116,18,658,{"v":6644.484,"d":"6644"},{"v":11609.342776508402,"d":"11609"},{"$nulls":6},0,10504,16,590,{"v":6187.92,"d":"6188"},{"v":10586.549715888,"d":"10587"},{"$nulls":10},"Enzyme - Fatty acid synthesis",{"$nulls":8},"X","DGV(pY)EGVA(bA)C","Corresponds to amino acid residues D679 to A686.","The effect of Y682 phosphorylation is unclear. This is the most frequently phosphorylated site in ATP-citrate lysate in mass spectrometry studies (≥378 reports). This human phosphosite is highly conserved in vertebrates and also found in the nematode worm.",null,null,"P53396","P53396"]
[61,30,"PN736","ACO1","S711","Cytoplasmic aconitate hydratase",0,8662,14,608,{"v":5257.984,"d":"5258"},{"v":9239.0502858496,"d":"9239"},{"$f":"(L74+L75)/2","v":{"v":8785.8434431078,"d":"8786"}},{"$f":"SQRT((M74-L74)*(M74-L74))","v":{"v":453.20684274179985,"d":"453"}},{"$f":"N74/M74*100","v":{"v":5.15837603613715,"d":"5"}},0,9735,14,591,{"v":5745.111,"d":"5745"},{"v":10037.9446903761,"d":"10038"},{"$f":"(U74+U75)/2","v":{"v":10642.43306656085,"d":"10642"}},{"$f":"SQRT((V74-U74)*(V74-U74))","v":{"v":604.4883761847505,"d":"604"}},{"$f":"W74/V74*100","v":{"v":5.6799828798932115,"d":"6"}},{"$f":"X74+O74","v":{"v":10.838358916030362,"d":"11"}},{"$f":"(V74/M74*100)-100","v":{"v":21.131603760928414,"d":"21"}},null,0,9072,14,575,{"v":5208.35,"d":"5208"},{"v":8910.66080569,"d":"8911"},{"$f":"(AG74+AG75)/2","v":{"v":8335.927589139601,"d":"8336"}},{"$f":"SQRT((AH74-AG74)*(AH74-AG74))","v":{"v":574.7332165503994,"d":"575"}},{"$f":"AI74/AH74*100","v":{"v":6.89465221961844,"d":"7"}},{"$f":"AJ74+O74","v":{"v":12.053028255755589,"d":"12"}},{"$f":"(AH74/M74*100)-100","v":{"v":-5.120918177993985,"d":"-5"}},{"$nulls":5},"Enzyme",{"$nulls":8},"X","SYG(pS)RRG(bA)C","Corresponds to amino acid residues S708 to G714.","S711 phosphorylation inhibits enzyme activity. This is phosphorylation site in ACO1 has not been detected by mass spectrometry. This human phosphosite is highly conserved in vertebrates and also found in yeast.","PKCa (PRKCA)","Enzyme, translation initiation complex","P21399","P21399",null,null,"GO:0005737; GO:0005829; GO:0005783; GO:0070062; GO:0005794; GO:0005739","GO:0051538; GO:0051539; GO:0003994; GO:0030350; GO:0046872; GO:0003723","GO:0006879; GO:0006101; GO:0050892; GO:0009791; GO:0006417; GO:0010040; GO:0006099"]
[62,30,"PN736","ACO1","S711","Cytoplasmic aconitate hydratase",0,7788,14,610,{"v":4742.14,"d":"4742"},{"v":8332.636600366,"d":"8333"},{"$nulls":3},0,8762,16,736,{"v":6437.056,"d":"6437"},{"v":11246.921442745599,"d":"11247"},{"$nulls":6},0,7714,12,589,{"v":4536.478,"d":"4536"},{"v":7761.194372589201,"d":"7761"},{"$nulls":10},"Enzyme",{"$nulls":8},"X","SYG(pS)RRG(bA)C","Corresponds to amino acid residues S708 to G714.","S711 phosphorylation inhibits enzyme activity. This is phosphorylation site in ACO1 has not been detected by mass spectrometry. This human phosphosite is highly conserved in vertebrates and also found in yeast.","PKCa (PRKCA)",null,"P21399","P21399"]
[63,31,"PN737","ACO1","S806","Cytoplasmic aconitate hydratase",0,5792,18,595,{"v":3435.53,"d":"3436"},{"v":6036.730889357,"d":"6037"},{"$f":"(L76+L77)/2","v":{"v":5623.4798099743,"d":"5623"}},{"$f":"SQRT((M76-L76)*(M76-L76))","v":{"v":413.2510793826996,"d":"413"}},{"$f":"N76/M76*100","v":{"v":7.348671878393179,"d":"7"}},0,7258,16,543,{"v":3932.406,"d":"3932"},{"v":6870.7591425306,"d":"6871"},{"$f":"(U76+U77)/2","v":{"v":6294.8158930421,"d":"6295"}},{"$f":"SQRT((V76-U76)*(V76-U76))","v":{"v":575.9432494885004,"d":"576"}},{"$f":"W76/V76*100","v":{"v":9.149485215685377,"d":"9"}},{"$f":"X76+O76","v":{"v":16.498157094078557,"d":"16"}},{"$f":"(V76/M76*100)-100","v":{"v":11.938090039499343,"d":"12"}},null,0,6320,12,592,{"v":3734.336,"d":"3734"},{"v":6388.8566303104,"d":"6389"},{"$f":"(AG76+AG77)/2","v":{"v":5425.736753339001,"d":"5426"}},{"$f":"SQRT((AH76-AG76)*(AH76-AG76))","v":{"v":963.1198769713992,"d":"963"}},{"$f":"AI76/AH76*100","v":{"v":17.75095108288648,"d":"18"}},{"$f":"AJ76+O76","v":{"v":25.09962296127966,"d":"25"}},{"$f":"(AH76/M76*100)-100","v":{"v":-3.5163824414300393,"d":"-4"}},{"$nulls":5},"Enzyme",{"$nulls":8},"X","IHR(pS)NLVGC","Corresponds to amino acid residues I803 to G810.","The effect S806 of phosphorylation is unclear. This is phosphorylation site in ACO1 has only been reported in one mass spectrometry study. This human phosphosite is highly conserved in vertebrates and found in fish.",null,"Enzyme, translation initiation complex","P21399","P21399",null,null,"GO:0005737; GO:0005829; GO:0005783; GO:0070062; GO:0005794; GO:0005739","GO:0051538; GO:0051539; GO:0003994; GO:0030350; GO:0046872; GO:0003723","GO:0006879; GO:0006101; GO:0050892; GO:0009791; GO:0006417; GO:0010040; GO:0006099"]
[64,31,"PN737","ACO1","S806","Cytoplasmic aconitate hydratase",0,4810,12,618,{"v":2965.164,"d":"2965"},{"v":5210.228730591601,"d":"5210"},{"$nulls":3},0,5224,12,628,{"v":3273.136,"d":"3273"},{"v":5718.8726435536,"d":"5719"},{"$nulls":6},0,4744,10,551,{"v":2608.434,"d":"2608"},{"v":4462.6168763676005,"d":"4463"},{"$nulls":10},"Enzyme",{"$nulls":8},"X","IHR(pS)NLVGC","Corresponds to amino acid residues I803 to G810.","The effect S806 of phosphorylation is unclear. This is phosphorylation site in ACO1 has only been reported in one mass spectrometry study. This human phosphosite is highly conserved in vertebrates and found in fish.",null,null,"P21399","P21399"]
[65,32,"PN687","ACP1","Y132+Y133","Low molecular weight phosphotyrosine protein phosphatase",0,1924,16,564,{"$f":"(H78-I78)*J78/1000","v":{"v":1076.112,"d":"1076"}},{"v":1890.8868648528,"d":"1891"},{"$f":"(L78+L79)/2","v":{"v":1800.6819715944,"d":"1801"}},{"$f":"SQRT((M78-L78)*(M78-L78))","v":{"v":90.20489325840003,"d":"90"}},{"$f":"N78/M78*100","v":{"v":5.009484999648706,"d":"5"}},0,1264,10,486,{"$f":"(Q78-R78)*S78/1000","v":{"v":609.444,"d":"609"}},{"v":1064.8297594044,"d":"1065"},{"$f":"(U78+U79)/2","v":{"v":1410.6446872492502,"d":"1411"}},{"$f":"SQRT((V78-U78)*(V78-U78))","v":{"v":345.8149278448502,"d":"346"}},{"$f":"W78/V78*100","v":{"v":24.51467268623026,"d":"25"}},{"$f":"X78+O78","v":{"v":29.524157685878965,"d":"30"}},{"$f":"(V78/M78*100)-100","v":{"v":-21.660531426312573,"d":"-22"}},null,0,1884,12,544,{"$f":"(AC78-AD78)*AE78/1000","v":{"v":1018.368,"d":"1018"}},{"v":1742.2661348352,"d":"1742"},{"$f":"(AG78+AG79)/2","v":{"v":1682.4944688434002,"d":"1682"}},{"$f":"SQRT((AH78-AG78)*(AH78-AG78))","v":{"v":59.771665991799864,"d":"60"}},{"$f":"AI78/AH78*100","v":{"v":3.552562406513514,"d":"4"}},{"$f":"AJ78+O78","v":{"v":8.56204740616222,"d":"9"}},{"$f":"(AH78/M78*100)-100","v":{"v":-6.563485646849216,"d":"-7"}},{"$nulls":5},"Phosphatase",{"$nulls":6},"X",null,null,"EDP(pY)(pY)GND(bA)C","Corresponds to amino acid residues E129 to D136.","Y132 and Y133 phosphorylation stimulates phosphatase activity, and regulates cell adhesion, cell motility, and transcription. These are two major in vivo phosphorylation site in ACP1 (≥205 and >86 reports, respectively, by mass spectrometry). These phosphosites are highly conserved and also found in yeast.","Y132: Lck; Src. Y133: Lck; Src.","EC 3.1.3.48; EC 3.1.3.2; Cofactor and Vitamin Metabolism - riboflavin; Phosphatase (non-protein); Protein phosphatase, tyrosine (non-receptor)","P24666","P24666",null,null,"GO:0005737; GO:0009898; GO:0005829; GO:0070062; GO:0042383","GO:0003993; GO:0004726"]
[66,32,"PN687","ACP1","Y132+Y133","Low molecular weight phosphotyrosine protein phosphatase",0,1702,12,576,{"v":973.44,"d":"973"},{"v":1710.477078336,"d":"1710"},{"$nulls":3},0,1713,12,591,{"v":1005.291,"d":"1005"},{"v":1756.4596150941002,"d":"1756"},{"$nulls":6},0,1775,12,538,{"v":948.494,"d":"948"},{"v":1622.7228028516001,"d":"1623"},{"$nulls":10},"Phosphatase",{"$nulls":6},"X",null,null,"EDP(pY)(pY)GND(bA)C","Corresponds to amino acid residues E129 to D136.","Y132 and Y133 phosphorylation stimulates phosphatase activity, and regulates cell adhesion, cell motility, and transcription. These are two major in vivo phosphorylation site in ACP1 (≥205 and >86 reports, respectively, by mass spectrometry). These phosphosites are highly conserved and also found in yeast.","Y132: Lck; Src. Y133: Lck; Src.",null,"P24666","P24666"]
[67,33,"PN688","ACS1 (ACSL1)","Y567","Long-chain-fatty-acid--CoA ligase 1",0,6466,12,637,{"v":4111.198,"d":"4111"},{"v":7223.9788209862,"d":"7224"},{"$f":"(L80+L81)/2","v":{"v":8179.2183473801,"d":"8179"}},{"$f":"SQRT((M80-L80)*(M80-L80))","v":{"v":955.2395263938997,"d":"955"}},{"$f":"N80/M80*100","v":{"v":11.678860813146946,"d":"12"}},0,6323,14,572,{"v":3608.748,"d":"3609"},{"v":6305.2589976948,"d":"6305"},{"$f":"(U80+U81)/2","v":{"v":6897.239060978651,"d":"6897"}},{"$f":"SQRT((V80-U80)*(V80-U80))","v":{"v":591.9800632838505,"d":"592"}},{"$f":"W80/V80*100","v":{"v":8.582855517260473,"d":"9"}},{"$f":"X80+O80","v":{"v":20.261716330407417,"d":"20"}},{"$f":"(V80/M80*100)-100","v":{"v":-15.673616132427654,"d":"-16"}},null,0,6867,14,637,{"v":4365.361,"d":"4365"},{"v":7468.4403247454,"d":"7468"},{"$f":"(AG80+AG81)/2","v":{"v":6958.5608285655,"d":"6959"}},{"$f":"SQRT((AH80-AG80)*(AH80-AG80))","v":{"v":509.87949617990034,"d":"510"}},{"$f":"AI80/AH80*100","v":{"v":7.327369965450334,"d":"7"}},{"$f":"AJ80+O80","v":{"v":19.006230778597278,"d":"19"}},{"$f":"(AH80/M80*100)-100","v":{"v":-14.923889630671013,"d":"-15"}},{"$nulls":5},"Enzyme - Fatty acid synthesis",{"$nulls":8},"X","acQGE(pY)IAP(bA)C","Corresponds to amino acid residues Q564 to P570.","The effect of Y567 phosphorylation is unclear. This is the most frequently phosphorylated site in ACS1 from mass spectrometry studies (≥20 reports). This human phosphosite is highly conserved in vertebrates and is found in the fruit fly.",null,"EC 6.2.1.3; Lipid Metabolism - fatty acid; Ligase","P33121","P33121",null,null,"GO:0005789; GO:0016021; GO:0016020; GO:0005741; GO:0005739; GO:0005778; GO:0005886","GO:0005524; GO:0102391; GO:0004467","GO:0033211; GO:0036109; GO:0043651; GO:0008610; GO:0044539; GO:0001676; GO:0035338; GO:0120162; GO:0071902; GO:0019216; GO:0042493; GO:0007584; GO:0034201; GO:0014070; GO:0019432; GO:0042178"]
[68,33,"PN688","ACS1 (ACSL1)","Y567","Long-chain-fatty-acid--CoA ligase 1",0,7548,14,690,{"v":5198.46,"d":"5198"},{"v":9134.457873774,"d":"9134"},{"$nulls":3},0,6641,16,647,{"v":4286.375,"d":"4286"},{"v":7489.2191242625,"d":"7489"},{"$nulls":6},0,5920,12,638,{"v":3769.304,"d":"3769"},{"v":6448.6813323856,"d":"6449"},{"$nulls":10},"Enzyme - Fatty acid synthesis",{"$nulls":8},"X","acQGE(pY)IAP(bA)C","Corresponds to amino acid residues Q564 to P570.","The effect of Y567 phosphorylation is unclear. This is the most frequently phosphorylated site in ACS1 from mass spectrometry studies (≥20 reports). This human phosphosite is highly conserved in vertebrates and is found in the fruit fly.",null,null,"P33121","P33121"]
[69,34,"NN218-1","ACTB","Pan-specific","Actin, cytoplasmic 1; Beta-actin",0,1804,10,347,{"v":622.518,"d":"623"},{"$f":"K82*1.7571469","v":{"v":1093.8555738942,"d":"1094"}},{"$f":"(L82+L83)/2","v":{"v":577.14807790675,"d":"577"}},{"$f":"SQRT((M82-L82)*(M82-L82))","v":{"v":516.70749598745,"d":"517"}},{"$f":"N82/M82*100","v":{"v":89.5277166756734,"d":"90"}},0,3244,10,325,{"v":1051.05,"d":"1051"},{"$f":"T82*1.7472151","v":{"v":1836.410430855,"d":"1836"}},{"$f":"(U82+U83)/2","v":{"v":1404.9758478572999,"d":"1405"}},{"$f":"SQRT((V82-U82)*(V82-U82))","v":{"v":431.4345829977001,"d":"431"}},{"$f":"W82/V82*100","v":{"v":30.707615625967676,"d":"31"}},{"$f":"X82+O82","v":{"v":120.23533230164108,"d":"120"}},{"$f":"(V82/M82*100)-100","v":{"v":143.43420720605815,"d":"143"}},null,0,1820,10,312,{"v":564.72,"d":"565"},{"v":966.1463554080001,"d":"966"},{"$f":"(AG82+AG83)/2","v":{"v":510.83157941900004,"d":"511"}},{"$f":"SQRT((AH82-AG82)*(AH82-AG82))","v":{"v":455.31477598900005,"d":"455"}},{"$f":"AI82/AH82*100","v":{"v":89.1320729440528,"d":"89"}},{"$f":"AJ82+O82","v":{"v":178.6597896197262,"d":"179"}},{"$f":"(AH82/M82*100)-100","v":{"v":-11.49037847068162,"d":"-11"}},{"$nulls":5},"Cytoskeletal/contractile protein",{"$nulls":9},"Epitope undefined.",{"$nulls":3},"Cytoskeletal protein","P60709","P60709",null,"P60709","GO:0015629; GO:0072562; GO:0044305; GO:0030863; GO:0005737; GO:0036464; GO:0005856; GO:0005829; GO:0097433; GO:0070062; GO:0005615; GO:0005925; GO:0098978; GO:0016020; GO:0043209; GO:0035267; GO:0000790; GO:0005654; GO:0005634; GO:0005886; GO:0098871; GO:0098793; GO:0032991; GO:1990904; GO:0098685; GO:0031982","GO:0005524; GO:0042802; GO:0019894; GO:0050998; GO:0019901; GO:0005200; GO:0098973; GO:0030957","GO:0043044; GO:0034329; GO:0048870; GO:0072749; GO:0048013; GO:0038096; GO:0061024; GO:0032091; GO:0070527; GO:0045815; GO:0051623; GO:0098974; GO:0016579; GO:0000079; GO:0051621; GO:1903076; GO:0022898; GO:0001895; GO:0021762; GO:0048488"]
[70,34,"NN218-1","ACTB","Pan-specific","Actin, cytoplasmic 1; Beta-actin",0,63,10,649,{"v":34.397,"d":"34"},{"v":60.440581919299994,"d":"60"},{"$nulls":3},0,1586,12,354,{"v":557.196,"d":"557"},{"v":973.5412648596,"d":"974"},{"$nulls":6},0,58,8,649,{"v":32.45,"d":"32"},{"$f":"AF83*1.7108414","v":{"v":55.51680343000001,"d":"56"}},{"$nulls":10},"Cytoskeletal/contractile protein",{"$nulls":9},"Epitope undefined.",{"$nulls":4},"P60709","P60709",null,"P60709"]
[71,35,"PN501","ACTB","Y53","Actin, cytoplasmic 1; Beta-actin",0,2693,16,688,{"v":1841.776,"d":"1842"},{"v":3236.2709888944,"d":"3236"},{"$f":"(L84+L85)/2","v":{"v":3233.1397531186,"d":"3233"}},{"$f":"SQRT((M84-L84)*(M84-L84))","v":{"v":3.131235775800178,"d":"3"}},{"$f":"N84/M84*100","v":{"v":0.0968481418961204,"d":"0"}},0,2476,14,573,{"v":1410.726,"d":"1411"},{"v":2464.8417691626,"d":"2465"},{"$f":"(U84+U85)/2","v":{"v":2724.0358876023,"d":"2724"}},{"$f":"SQRT((V84-U84)*(V84-U84))","v":{"v":259.1941184397001,"d":"259"}},{"$f":"W84/V84*100","v":{"v":9.515077228583912,"d":"10"}},{"$f":"X84+O84","v":{"v":9.611925370480034,"d":"10"}},{"$f":"(V84/M84*100)-100","v":{"v":-15.746423117813933,"d":"-16"}},null,0,3081,14,644,{"v":1975.148,"d":"1975"},{"v":3379.1649695272,"d":"3379"},{"$f":"(AG84+AG85)/2","v":{"v":2998.0168790696,"d":"2998"}},{"$f":"SQRT((AH84-AG84)*(AH84-AG84))","v":{"v":381.1480904576001,"d":"381"}},{"$f":"AI84/AH84*100","v":{"v":12.713340379053673,"d":"13"}},{"$f":"AJ84+O84","v":{"v":12.810188520949794,"d":"13"}},{"$f":"(AH84/M84*100)-100","v":{"v":-7.272276857881167,"d":"-7"}},{"$nulls":5},"Cytoskeletal/contractile protein",{"$nulls":9},"KDS(pY)VGD(bA)C","Corresponds to amino acid residues K50 to D56; In the Actin domain. ","The effect of Y53 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in actin from mass spectrometry studies (≥1069 reports).",null,"Cytoskeletal protein","P60709","P60709",null,"P60709","GO:0015629; GO:0072562; GO:0044305; GO:0030863; GO:0005737; GO:0036464; GO:0005856; GO:0005829; GO:0097433; GO:0070062; GO:0005615; GO:0005925; GO:0098978; GO:0016020; GO:0043209; GO:0035267; GO:0000790; GO:0005654; GO:0005634; GO:0005886; GO:0098871; GO:0098793; GO:0032991; GO:1990904; GO:0098685; GO:0031982","GO:0005524; GO:0042802; GO:0019894; GO:0050998; GO:0019901; GO:0005200; GO:0098973; GO:0030957","GO:0043044; GO:0034329; GO:0048870; GO:0072749; GO:0048013; GO:0038096; GO:0061024; GO:0032091; GO:0070527; GO:0045815; GO:0051623; GO:0098974; GO:0016579; GO:0000079; GO:0051621; GO:1903076; GO:0022898; GO:0001895; GO:0021762; GO:0048488"]
[72,35,"PN501","ACTB","Y53","Actin, cytoplasmic 1; Beta-actin",0,2560,14,722,{"v":1838.212,"d":"1838"},{"v":3230.0085173427997,"d":"3230"},{"$nulls":3},0,2402,14,715,{"v":1707.42,"d":"1707"},{"v":2983.2300060420002,"d":"2983"},{"$nulls":6},0,2417,12,636,{"v":1529.58,"d":"1530"},{"v":2616.868788612,"d":"2617"},{"$nulls":10},"Cytoskeletal/contractile protein",{"$nulls":9},"KDS(pY)VGD(bA)C","Corresponds to amino acid residues K50 to D56; In the Actin domain. ","The effect of Y53 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in actin from mass spectrometry studies (≥1069 reports).",null,null,"P60709","P60709",null,"P60709"]
[73,36,"PN500","ACTB","Y294","Actin, cytoplasmic 1; Beta-actin",0,7166,14,774,{"v":5535.648,"d":"5536"},{"v":9726.9467226912,"d":"9727"},{"$f":"(L86+L87)/2","v":{"v":9715.381181795401,"d":"9715"}},{"$f":"SQRT((M86-L86)*(M86-L86))","v":{"v":11.565540895799131,"d":"12"}},{"$f":"N86/M86*100","v":{"v":0.11904361423791116,"d":"0"}},0,7563,18,666,{"v":5024.97,"d":"5025"},{"v":8779.703461047,"d":"8780"},{"$f":"(U86+U87)/2","v":{"v":9805.49082543435,"d":"9805"}},{"$f":"SQRT((V86-U86)*(V86-U86))","v":{"v":1025.78736438735,"d":"1026"}},{"$f":"W86/V86*100","v":{"v":10.461356628130964,"d":"10"}},{"$f":"X86+O86","v":{"v":10.580400242368876,"d":"11"}},{"$f":"(V86/M86*100)-100","v":{"v":0.9274946803713249,"d":"1"}},null,0,7632,16,751,{"v":5719.616,"d":"5720"},{"v":9785.3558449024,"d":"9785"},{"$f":"(AG86+AG87)/2","v":{"v":9215.3308638848,"d":"9215"}},{"$f":"SQRT((AH86-AG86)*(AH86-AG86))","v":{"v":570.024981017601,"d":"570"}},{"$f":"AI86/AH86*100","v":{"v":6.185616007033981,"d":"6"}},{"$f":"AJ86+O86","v":{"v":6.304659621271892,"d":"6"}},{"$f":"(AH86/M86*100)-100","v":{"v":-5.146996381856766,"d":"-5"}},{"$nulls":5},"Cytoskeletal/contractile protein",{"$nulls":9},"KDL(pY)ANT(bA)C","Corresponds to amino acid residues K291 to T297; In the Actin domain. ","The effect of Y294 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in actin from mass spectrometry studies (≥783 reports).",null,"Cytoskeletal protein","P60709","P60709",null,"P60709","GO:0015629; GO:0072562; GO:0044305; GO:0030863; GO:0005737; GO:0036464; GO:0005856; GO:0005829; GO:0097433; GO:0070062; GO:0005615; GO:0005925; GO:0098978; GO:0016020; GO:0043209; GO:0035267; GO:0000790; GO:0005654; GO:0005634; GO:0005886; GO:0098871; GO:0098793; GO:0032991; GO:1990904; GO:0098685; GO:0031982","GO:0005524; GO:0042802; GO:0019894; GO:0050998; GO:0019901; GO:0005200; GO:0098973; GO:0030957","GO:0043044; GO:0034329; GO:0048870; GO:0072749; GO:0048013; GO:0038096; GO:0061024; GO:0032091; GO:0070527; GO:0045815; GO:0051623; GO:0098974; GO:0016579; GO:0000079; GO:0051621; GO:1903076; GO:0022898; GO:0001895; GO:0021762; GO:0048488"]
[74,36,"PN500","ACTB","Y294","Actin, cytoplasmic 1; Beta-actin",0,7078,16,782,{"v":5522.484,"d":"5522"},{"v":9703.8156408996,"d":"9704"},{"$nulls":3},0,6928,17,897,{"v":6199.167,"d":"6199"},{"v":10831.2781898217,"d":"10831"},{"$nulls":6},0,6812,20,744,{"v":5053.248,"d":"5053"},{"v":8645.3058828672,"d":"8645"},{"$nulls":10},"Cytoskeletal/contractile protein",{"$nulls":9},"KDL(pY)ANT(bA)C","Corresponds to amino acid residues K291 to T297; In the Actin domain. ","The effect of Y294 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in actin from mass spectrometry studies (≥783 reports).",null,null,"P60709","P60709",null,"P60709"]
[75,37,"PN502","ACTN1","Y246","Alpha-actinin-1",0,10630,22,814,{"v":8634.912,"d":"8635"},{"v":15172.8088525728,"d":"15173"},{"$f":"(L88+L89)/2","v":{"v":15583.250254062401,"d":"15583"}},{"$f":"SQRT((M88-L88)*(M88-L88))","v":{"v":410.44140148960105,"d":"410"}},{"$f":"N88/M88*100","v":{"v":2.6338626075943496,"d":"3"}},0,11754,18,744,{"v":8731.584,"d":"8732"},{"v":15255.955411718402,"d":"15256"},{"$f":"(U88+U89)/2","v":{"v":14882.519633965201,"d":"14883"}},{"$f":"SQRT((V88-U88)*(V88-U88))","v":{"v":373.43577775320045,"d":"373"}},{"$f":"W88/V88*100","v":{"v":2.509224156512701,"d":"3"}},{"$f":"X88+O88","v":{"v":5.143086764107051,"d":"5"}},{"$f":"(V88/M88*100)-100","v":{"v":-4.4966910540021985,"d":"-4"}},null,0,10854,16,798,{"v":8648.724,"d":"8649"},{"v":14796.5950763736,"d":"14797"},{"$f":"(AG88+AG89)/2","v":{"v":14342.0561669595,"d":"14342"}},{"$f":"SQRT((AH88-AG88)*(AH88-AG88))","v":{"v":454.5389094140992,"d":"455"}},{"$f":"AI88/AH88*100","v":{"v":3.169272969807794,"d":"3"}},{"$f":"AJ88+O88","v":{"v":5.803135577402143,"d":"6"}},{"$f":"(AH88/M88*100)-100","v":{"v":-7.964924305693756,"d":"-8"}},{"$nulls":5},"Cytoskeletal/contractile protein",{"$nulls":9},"SSF(pY)HAF(bA)C","Corresponds to amino acid residues S243 to F249; In the second CH domain.","The effect of Y246 phosphorylation is unclear. This is the major in vivo phosphorylation site in ACTN1 from mass spectrometry studies (≥522 reports).",null,"Cytoskeletal protein","P12814","P12814",null,null,"GO:0005903; GO:0005911; GO:0042995; GO:0005737; GO:0005829; GO:0070062; GO:0005576; GO:0005615; GO:0005916; GO:0005925; GO:0098978; GO:0005622; GO:0005886; GO:0031093; GO:0031143; GO:0001726; GO:0001725; GO:0030018","GO:0051015; GO:0005509; GO:0003725; GO:0005178; GO:0044325; GO:0030374; GO:0042803; GO:0099186; GO:0017166","GO:0051764; GO:0051017; GO:0051639; GO:0007015; GO:0048041; GO:0051271; GO:0002576; GO:0030220; GO:0036344; GO:0042981"]
[76,37,"PN502","ACTN1","Y246","Alpha-actinin-1",0,10956,16,832,{"v":9102.08,"d":"9102"},{"v":15993.691655552,"d":"15994"},{"$nulls":3},0,10270,18,810,{"v":8304.12,"d":"8304"},{"v":14509.083856212,"d":"14509"},{"$nulls":6},0,10383,16,783,{"v":8117.361,"d":"8117"},{"v":13887.5172575454,"d":"13888"},{"$nulls":10},"Cytoskeletal/contractile protein",{"$nulls":9},"SSF(pY)HAF(bA)C","Corresponds to amino acid residues S243 to F249; In the second CH domain.","The effect of Y246 phosphorylation is unclear. This is the major in vivo phosphorylation site in ACTN1 from mass spectrometry studies (≥522 reports).",null,null,"P12814","P12814"]
[77,38,"NK357-1","ACTR-I (ALK2","Pan-specific","Activin receptor type-1",0,176,10,564,{"v":93.624,"d":"94"},{"v":164.5111213656,"d":"165"},{"$f":"(L90+L91)/2","v":{"v":143.4728015319,"d":"143"}},{"$f":"SQRT((M90-L90)*(M90-L90))","v":{"v":21.0383198337,"d":"21"}},{"$f":"N90/M90*100","v":{"v":14.663629349303745,"d":"15"}},0,241,12,483,{"v":110.607,"d":"111"},{"v":193.2542205657,"d":"193"},{"$f":"(U90+U91)/2","v":{"v":167.57802106365,"d":"168"}},{"$f":"SQRT((V90-U90)*(V90-U90))","v":{"v":25.676199502049997,"d":"26"}},{"$f":"W90/V90*100","v":{"v":15.32193741105081,"d":"15"}},{"$f":"X90+O90","v":{"v":29.985566760354555,"d":"30"}},{"$f":"(V90/M90*100)-100","v":{"v":16.801246838684207,"d":"17"}},null,0,186,10,526,{"v":92.576,"d":"93"},{"v":158.3828534464,"d":"158"},{"$f":"(AG90+AG91)/2","v":{"v":139.6320317024,"d":"140"}},{"$f":"SQRT((AH90-AG90)*(AH90-AG90))","v":{"v":18.75082174399998,"d":"19"}},{"$f":"AI90/AH90*100","v":{"v":13.428739462850405,"d":"13"}},{"$f":"AJ90+O90","v":{"v":28.09236881215415,"d":"28"}},{"$f":"(AH90/M90*100)-100","v":{"v":-2.6770020439351327,"d":"-3"}},null,null,"ALK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","STKR","Type 1",{"$nulls":5},"Not precisely defined.","Antibody raised against a peptide mapping at the N-terminus of human ACTR-I. ",null,null,"Protein-serine kinase, TKL group, STKR family, Type 1 subfamily","Q04771","Q04771","Q04771","Q04771","GO:0048179; GO:0045177; GO:0005887","GO:0048185; GO:0016361; GO:0005524; GO:0046872; GO:0017046; GO:0042803; GO:0004672; GO:0004674; GO:0046332; GO:0050431; GO:0005025; GO:0004675","GO:0032924; GO:0002526; GO:0003289; GO:0003181; GO:0030509; GO:0061312; GO:0001569; GO:0060923; GO:0071773; GO:0007368; GO:0003143; GO:0061445; GO:0003274; GO:0003203; GO:0000082; GO:0001702; GO:0007281; GO:0001701; GO:0001707; GO:0003183; GO:0032926; GO:2001237; GO:0009968; GO:0001755; GO:0060389; GO:0018107; GO:0060037; GO:0030501; GO:0030335; GO:2000017; GO:1905007; GO:0045669; GO:0010862; GO:0045893; GO:0045944; GO:0006468; GO:0030278; GO:0051145; GO:0007179; GO:0060412"]
[78,38,"NK357-1","ACTR-I (ALK2","Pan-specific","Activin receptor type-1",0,136,10,553,{"v":69.678,"d":"70"},{"v":122.43448169819999,"d":"122"},{"$nulls":3},0,154,10,564,{"v":81.216,"d":"81"},{"v":141.9018215616,"d":"142"},{"$nulls":6},0,138,10,552,{"v":70.656,"d":"71"},{"v":120.88120995840002,"d":"121"},{"$nulls":7},"ALK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","STKR","Type 1",{"$nulls":5},"Not precisely defined.","Antibody raised against a peptide mapping at the N-terminus of human ACTR-I. ",{"$nulls":3},"Q04771","Q04771","Q04771","Q04771"]
[79,39,"PN003-PN004","Adducin a/g (ADD3)","S726","Adducin-alpha/gamma",0,956,14,339,{"v":319.338,"d":"319"},{"v":561.1237767522,"d":"561"},{"$f":"(L92+L93)/2","v":{"v":328.6057989159,"d":"329"}},{"$f":"SQRT((M92-L92)*(M92-L92))","v":{"v":232.51797783630002,"d":"233"}},{"$f":"N92/M92*100","v":{"v":70.75893931373022,"d":"71"}},0,1088,18,300,321,{"v":560.8560471,"d":"561"},{"$f":"(U92+U93)/2","v":{"v":482.3431893664,"d":"482"}},{"$f":"SQRT((V92-U92)*(V92-U92))","v":{"v":78.51285773359996,"d":"79"}},{"$f":"W92/V92*100","v":{"v":16.277384954213506,"d":"16"}},{"$f":"X92+O92","v":{"v":87.03632426794373,"d":"87"}},{"$f":"(V92/M92*100)-100","v":{"v":46.784746634932645,"d":"47"}},null,0,838,12,336,{"v":277.536,"d":"278"},{"v":474.82007879040003,"d":"475"},{"$f":"(AG92+AG93)/2","v":{"v":436.83597802760005,"d":"437"}},{"$f":"SQRT((AH92-AG92)*(AH92-AG92))","v":{"v":37.98410076279998,"d":"38"}},{"$f":"AI92/AH92*100","v":{"v":8.695277558022037,"d":"9"}},{"$f":"AJ92+O92","v":{"v":79.45421687175227,"d":"79"}},{"$f":"(AH92/M92*100)-100","v":{"v":32.936174428071894,"d":"33"}},{"$nulls":5},"Cytoskeletal/contractile protein",{"$nulls":9},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S726 and S693 phosphosites in ADD1 and ADD3 [TP(pS)FL]. ","Phosphorylation of S726 affects intracellular location of ADD1, and induced cell motility. This is the major in vivo phosphorylation site in ADD1 from mass spectrometry studies (≥208 reports) and ADD3 (≥213 reports).","PKCA; CHK1; PKCz (PRKCZ); PKACa (PRKACA)","Cytoskeletal protein","Q9UEY8","Q9UEY8",null,"Q9UEY8","GO:0005903; GO:0005911; GO:0005938; GO:0000794; GO:0005856; GO:0005829; GO:0016020; GO:0005654; GO:0005886; GO:0014069","GO:0003779; GO:0005516; GO:0005200","GO:0055085"]
[80,39,"PN003-PN004","Adducin a/g (ADD3)","S726","Adducin-alpha/gamma",0,94,10,651,{"v":54.684,"d":"55"},{"v":96.08782107959999,"d":"96"},{"$nulls":3},0,706,14,334,{"v":231.128,"d":"231"},{"v":403.8303316328,"d":"404"},{"$nulls":6},0,708,10,334,{"v":233.132,"d":"233"},{"v":398.8518772648,"d":"399"},{"$nulls":10},"Cytoskeletal/contractile protein",{"$nulls":9},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S726 and S693 phosphosites in ADD1 and ADD3 [TP(pS)FL]. ","Phosphorylation of S726 affects intracellular location of ADD1, and induced cell motility. This is the major in vivo phosphorylation site in ADD1 from mass spectrometry studies (≥208 reports) and ADD3 (≥213 reports).","PKCA; CHK1; PKCz (PRKCZ); PKACa (PRKACA)",null,"Q9UEY8","Q9UEY8",null,"Q9UEY8"]
[81,40,"PN689","ADK","S86","Adenosine kinase",0,534,16,585,{"v":303.03,"d":"303"},{"v":532.468225107,"d":"532"},{"$f":"(L94+L95)/2","v":{"v":489.13522540609995,"d":"489"}},{"$f":"SQRT((M94-L94)*(M94-L94))","v":{"v":43.33299970090002,"d":"43"}},{"$f":"N94/M94*100","v":{"v":8.859104282445248,"d":"9"}},0,517,14,532,{"v":267.596,"d":"268"},{"v":467.54777189960004,"d":"468"},{"$f":"(U94+U95)/2","v":{"v":422.65133269,"d":"423"}},{"$f":"SQRT((V94-U94)*(V94-U94))","v":{"v":44.89643920960003,"d":"45"}},{"$f":"W94/V94*100","v":{"v":10.622571310458875,"d":"11"}},{"$f":"X94+O94","v":{"v":19.481675592904125,"d":"19"}},{"$f":"(V94/M94*100)-100","v":{"v":-13.592129387308447,"d":"-14"}},null,0,555,12,487,{"v":264.441,"d":"264"},{"v":452.4166106574,"d":"452"},{"$f":"(AG94+AG95)/2","v":{"v":471.3530586933,"d":"471"}},{"$f":"SQRT((AH94-AG94)*(AH94-AG94))","v":{"v":18.936448035900014,"d":"19"}},{"$f":"AI94/AH94*100","v":{"v":4.01746582241266,"d":"4"}},{"$f":"AJ94+O94","v":{"v":12.876570104857908,"d":"13"}},{"$f":"(AH94/M94*100)-100","v":{"v":-3.6354295886247883,"d":"-4"}},{"$nulls":5},"Enzyme - Nucleotide metabolism",{"$nulls":8},"X","TQN(pS)IKVAC","Corresponds to amino acid residues T83 to A90.","The effect of S86 phosphorylation is unclear. Although this phosphosite has not been easily identified by mass spectrometry (no reports), its surrounding sequence is highly conserved in evolution, including in plants and fungi.",null,"Enzyme, metabolite kinase","P55263","P55263",null,null,"GO:0005829; GO:0005654; GO:0005634","GO:0004001; GO:0005524; GO:0046872; GO:0003723","GO:0006169; GO:0044209; GO:0046835; GO:0006175; GO:0043101; GO:0009156"]
[82,40,"PN689","ADK","S86","Adenosine kinase",0,488,12,533,{"v":253.708,"d":"254"},{"v":445.8022257052,"d":"446"},{"$nulls":3},0,431,12,516,{"v":216.204,"d":"216"},{"v":377.7548934804,"d":"378"},{"$nulls":6},0,532,10,549,{"v":286.578,"d":"287"},{"v":490.28950672919996,"d":"490"},{"$nulls":10},"Enzyme - Nucleotide metabolism",{"$nulls":8},"X","TQN(pS)IKVAC","Corresponds to amino acid residues T83 to A90.","The effect of S86 phosphorylation is unclear. Although this phosphosite has not been easily identified by mass spectrometry (no reports), its surrounding sequence is highly conserved in evolution, including in plants and fungi.",null,null,"P55263","P55263"]
[83,41,"NK129-3","Akt1 (PKBa)","Pan-specific","RAC-alpha serine/threonine-protein kinase",0,2106,12,640,{"v":1340.16,"d":"1340"},{"v":2354.857989504,"d":"2355"},{"$f":"(L96+L97)/2","v":{"v":2195.6323660136004,"d":"2196"}},{"$f":"SQRT((M96-L96)*(M96-L96))","v":{"v":159.2256234903998,"d":"159"}},{"$f":"N96/M96*100","v":{"v":7.2519255024232745,"d":"7"}},0,2618,14,617,{"v":1606.668,"d":"1607"},{"v":2807.1945902867997,"d":"2807"},{"$f":"(U96+U97)/2","v":{"v":2351.6694054903,"d":"2352"}},{"$f":"SQRT((V96-U96)*(V96-U96))","v":{"v":455.5251847964996,"d":"456"}},{"$f":"W96/V96*100","v":{"v":19.370290047275038,"d":"19"}},{"$f":"X96+O96","v":{"v":26.62221554969831,"d":"27"}},{"$f":"(V96/M96*100)-100","v":{"v":7.10670155404938,"d":"7"}},null,0,2239,10,602,{"v":1341.858,"d":"1342"},{"v":2295.7062193212,"d":"2296"},{"$f":"(AG96+AG97)/2","v":{"v":2045.5726524342,"d":"2046"}},{"$f":"SQRT((AH96-AG96)*(AH96-AG96))","v":{"v":250.13356688699992,"d":"250"}},{"$f":"AI96/AH96*100","v":{"v":12.228046096986327,"d":"12"}},{"$f":"AJ96+O96","v":{"v":19.479971599409602,"d":"19"}},{"$f":"(AH96/M96*100)-100","v":{"v":-6.8344644532567855,"d":"-7"}},null,null,"AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"CEMEVSLAKPKHRVTM","Corresponds to amino acid residues E133 to M147; Pre-kinase catalytic domain.",null,null,"EC 2.7.11.1; Nuclear receptor co-regulator; Protein kinase, Ser/Thr (non-receptor); AGC group; AKT family","P31749","P31749","P31749","P31749","GO:0005911; GO:0036064; GO:0005737; GO:0005829; GO:0015630; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0098794; GO:0032991; GO:0005819; GO:0031982","GO:0071889; GO:0005524; GO:0019899; GO:0032794; GO:0042802; GO:0016301; GO:0030235; GO:0005547; GO:0043325; GO:0042803; GO:0004672; GO:0005080; GO:0051721; GO:0004712; GO:0004674","GO:0006924; GO:0032148; GO:0007568; GO:0043276; GO:0008637; GO:0008643; GO:0030154; GO:0002042; GO:0030030; GO:0008283; GO:0006464; GO:0071276; GO:0006974; GO:0071364; GO:0097011; GO:0071456; GO:0032869; GO:0071260; GO:1990090; GO:0071407; GO:0140052; GO:0071380; GO:0034614; GO:0071356; GO:0035924; GO:0051186; GO:0019221; GO:0031018; GO:0007173; GO:0072655; GO:0060079; GO:0097194; GO:0007281; GO:0042593; GO:0006006; GO:0005978; GO:0060709; GO:0007186; GO:0030212; GO:0007249; GO:0006954; GO:0048009; GO:0008286; GO:0035655; GO:0035556; GO:0060716; GO:0031663; GO:0072656; GO:0060644; GO:0001893; GO:0043066; GO:0010507; GO:0045792; GO:0043154; GO:0010951; GO:2001240; GO:0031999; GO:0010629; GO:0046329; GO:1903038; GO:2000402; GO:0016242; GO:1901215; GO:0045746; GO:1902176; GO:0010748; GO:0032091; GO:0006469; GO:0100002; GO:0051898; GO:0071901; GO:0031397; GO:0045861; GO:0090201; GO:0038061; GO:0006809; GO:0001649; GO:0018105; GO:0018107; GO:0032287; GO:0014065; GO:0016310; GO:0043065; GO:0043536; GO:0030307; GO:0008284; GO:0032270; GO:0031659; GO:0051091; GO:0032079; GO:0001938; GO:0045742; GO:0045600; GO:0010763; GO:0010628; GO:0046326; GO:0010907; GO:0045725; GO:1903721; GO:0046889; GO:0010918; GO:0045429; GO:0051000; GO:0046622; GO:0033138; GO:0032436; GO:2000010; GO:1900182; GO:1903078; GO:0001934; GO:0048661; GO:0010765; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0030163; GO:0000060; GO:0043491; GO:0006468; GO:0016567; GO:0042981; GO:0030334; GO:0005979; GO:0043488; GO:0031641; GO:0010975; GO:0050999; GO:1901796; GO:0006417; GO:0034405; GO:0032094; GO:0060416; GO:0009408; GO:1990418; GO:0006979; GO:0070141; GO:0007165; GO:0021510; GO:0051146; GO:0031295; GO:0031929; GO:0006412"]
[84,41,"NK129-3","Akt1 (PKBa)","Pan-specific","RAC-alpha serine/threonine-protein kinase",0,1822,14,641,{"v":1158.928,"d":"1159"},{"v":2036.4067425232001,"d":"2036"},{"$nulls":3},0,1794,12,609,{"v":1085.238,"d":"1085"},{"v":1896.1442206938002,"d":"1896"},{"$nulls":6},0,1807,10,584,{"v":1049.448,"d":"1049"},{"v":1795.4390855472002,"d":"1795"},{"$nulls":7},"AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"CEMEVSLAKPKHRVTM","Corresponds to amino acid residues E133 to M147; Pre-kinase catalytic domain.",{"$nulls":3},"P31749","P31749","P31749","P31749"]
[85,42,"NK129-5","Akt1 (PKBa)","Pan-specific","RAC-alpha serine/threonine-protein kinase",0,7106,14,657,{"v":4659.444,"d":"4659"},{"v":8187.3275803236,"d":"8187"},{"$f":"(L98+L99)/2","v":{"v":7964.2981957473,"d":"7964"}},{"$f":"SQRT((M98-L98)*(M98-L98))","v":{"v":223.0293845762999,"d":"223"}},{"$f":"N98/M98*100","v":{"v":2.800364565648622,"d":"3"}},0,7822,16,611,{"v":4769.466,"d":"4769"},{"v":8333.283014136601,"d":"8333"},{"$f":"(U98+U99)/2","v":{"v":7776.0227357124,"d":"7776"}},{"$f":"SQRT((V98-U98)*(V98-U98))","v":{"v":557.2602784242008,"d":"557"}},{"$f":"W98/V98*100","v":{"v":7.166392092257011,"d":"7"}},{"$f":"X98+O98","v":{"v":9.966756657905632,"d":"10"}},{"$f":"(V98/M98*100)-100","v":{"v":-2.363993102812671,"d":"-2"}},null,0,7158,16,610,{"v":4356.62,"d":"4357"},{"v":7453.485860068,"d":"7453"},{"$f":"(AG98+AG99)/2","v":{"v":6902.6667846068,"d":"6903"}},{"$f":"SQRT((AH98-AG98)*(AH98-AG98))","v":{"v":550.8190754611996,"d":"551"}},{"$f":"AI98/AH98*100","v":{"v":7.979801034138665,"d":"8"}},{"$f":"AJ98+O98","v":{"v":10.780165599787287,"d":"11"}},{"$f":"(AH98/M98*100)-100","v":{"v":-13.329880236118981,"d":"-13"}},null,null,"AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"CDQDDSMEGVDSERRP","Corresponds to amino acid residues D435 to P467; Pre-C-terminus.",null,null,"EC 2.7.11.1; Nuclear receptor co-regulator; Protein kinase, Ser/Thr (non-receptor); AGC group; AKT family","P31749","P31749","P31749","P31749","GO:0005911; GO:0036064; GO:0005737; GO:0005829; GO:0015630; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0098794; GO:0032991; GO:0005819; GO:0031982","GO:0071889; GO:0005524; GO:0019899; GO:0032794; GO:0042802; GO:0016301; GO:0030235; GO:0005547; GO:0043325; GO:0042803; GO:0004672; GO:0005080; GO:0051721; GO:0004712; GO:0004674","GO:0006924; GO:0032148; GO:0007568; GO:0043276; GO:0008637; GO:0008643; GO:0030154; GO:0002042; GO:0030030; GO:0008283; GO:0006464; GO:0071276; GO:0006974; GO:0071364; GO:0097011; GO:0071456; GO:0032869; GO:0071260; GO:1990090; GO:0071407; GO:0140052; GO:0071380; GO:0034614; GO:0071356; GO:0035924; GO:0051186; GO:0019221; GO:0031018; GO:0007173; GO:0072655; GO:0060079; GO:0097194; GO:0007281; GO:0042593; GO:0006006; GO:0005978; GO:0060709; GO:0007186; GO:0030212; GO:0007249; GO:0006954; GO:0048009; GO:0008286; GO:0035655; GO:0035556; GO:0060716; GO:0031663; GO:0072656; GO:0060644; GO:0001893; GO:0043066; GO:0010507; GO:0045792; GO:0043154; GO:0010951; GO:2001240; GO:0031999; GO:0010629; GO:0046329; GO:1903038; GO:2000402; GO:0016242; GO:1901215; GO:0045746; GO:1902176; GO:0010748; GO:0032091; GO:0006469; GO:0100002; GO:0051898; GO:0071901; GO:0031397; GO:0045861; GO:0090201; GO:0038061; GO:0006809; GO:0001649; GO:0018105; GO:0018107; GO:0032287; GO:0014065; GO:0016310; GO:0043065; GO:0043536; GO:0030307; GO:0008284; GO:0032270; GO:0031659; GO:0051091; GO:0032079; GO:0001938; GO:0045742; GO:0045600; GO:0010763; GO:0010628; GO:0046326; GO:0010907; GO:0045725; GO:1903721; GO:0046889; GO:0010918; GO:0045429; GO:0051000; GO:0046622; GO:0033138; GO:0032436; GO:2000010; GO:1900182; GO:1903078; GO:0001934; GO:0048661; GO:0010765; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0030163; GO:0000060; GO:0043491; GO:0006468; GO:0016567; GO:0042981; GO:0030334; GO:0005979; GO:0043488; GO:0031641; GO:0010975; GO:0050999; GO:1901796; GO:0006417; GO:0034405; GO:0032094; GO:0060416; GO:0009408; GO:1990418; GO:0006979; GO:0070141; GO:0007165; GO:0021510; GO:0051146; GO:0031295; GO:0031929; GO:0006412"]
[86,42,"NK129-5","Akt1 (PKBa)","Pan-specific","RAC-alpha serine/threonine-protein kinase",0,6629,14,666,{"v":4405.59,"d":"4406"},{"v":7741.268811171,"d":"7741"},{"$nulls":3},0,6498,12,637,{"v":4131.582,"d":"4132"},{"v":7218.7624572882005,"d":"7219"},{"$nulls":6},0,5864,8,634,{"v":3712.704,"d":"3713"},{"v":6351.847709145601,"d":"6352"},{"$nulls":7},"AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"CDQDDSMEGVDSERRP","Corresponds to amino acid residues D435 to P467; Pre-C-terminus.",{"$nulls":3},"P31749","P31749","P31749","P31749"]
[87,43,"NK129","Akt1 (PKBa)","Pan-specific","RAC-alpha serine/threonine-protein kinase",0,681,12,528,{"v":353.232,"d":"353"},{"v":620.6805137808001,"d":"621"},{"$f":"(L100+L101)/2","v":{"v":619.0639386328,"d":"619"}},{"$f":"SQRT((M100-L100)*(M100-L100))","v":{"v":1.616575148000038,"d":"2"}},{"$f":"N100/M100*100","v":{"v":0.261132178296516,"d":"0"}},0,517,10,450,{"v":228.15,"d":"228"},{"v":398.62712506500003,"d":"399"},{"$f":"(U100+U101)/2","v":{"v":441.33080932409996,"d":"441"}},{"$f":"SQRT((V100-U100)*(V100-U100))","v":{"v":42.70368425909993,"d":"43"}},{"$f":"W100/V100*100","v":{"v":9.676116726249138,"d":"10"}},{"$f":"X100+O100","v":{"v":9.937248904545653,"d":"10"}},{"$f":"(V100/M100*100)-100","v":{"v":-28.70997940878658,"d":"-29"}},null,0,649,16,474,{"v":300.042,"d":"300"},{"v":513.3242753388,"d":"513"},{"$f":"(AG100+AG101)/2","v":{"v":509.36367749780004,"d":"509"}},{"$f":"SQRT((AH100-AG100)*(AH100-AG100))","v":{"v":3.9605978409999807,"d":"4"}},{"$f":"AI100/AH100*100","v":{"v":0.7775579641752305,"d":"1"}},{"$f":"AJ100+O100","v":{"v":1.0386901424717465,"d":"1"}},{"$f":"(AH100/M100*100)-100","v":{"v":-17.72034426319074,"d":"-18"}},null,null,"AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 345-480 of human Akt1.",null,null,"EC 2.7.11.1; Nuclear receptor co-regulator; Protein kinase, Ser/Thr (non-receptor); AGC group; AKT family","P31749","P31749","P31749","P31749","GO:0005911; GO:0036064; GO:0005737; GO:0005829; GO:0015630; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0098794; GO:0032991; GO:0005819; GO:0031982","GO:0071889; GO:0005524; GO:0019899; GO:0032794; GO:0042802; GO:0016301; GO:0030235; GO:0005547; GO:0043325; GO:0042803; GO:0004672; GO:0005080; GO:0051721; GO:0004712; GO:0004674","GO:0006924; GO:0032148; GO:0007568; GO:0043276; GO:0008637; GO:0008643; GO:0030154; GO:0002042; GO:0030030; GO:0008283; GO:0006464; GO:0071276; GO:0006974; GO:0071364; GO:0097011; GO:0071456; GO:0032869; GO:0071260; GO:1990090; GO:0071407; GO:0140052; GO:0071380; GO:0034614; GO:0071356; GO:0035924; GO:0051186; GO:0019221; GO:0031018; GO:0007173; GO:0072655; GO:0060079; GO:0097194; GO:0007281; GO:0042593; GO:0006006; GO:0005978; GO:0060709; GO:0007186; GO:0030212; GO:0007249; GO:0006954; GO:0048009; GO:0008286; GO:0035655; GO:0035556; GO:0060716; GO:0031663; GO:0072656; GO:0060644; GO:0001893; GO:0043066; GO:0010507; GO:0045792; GO:0043154; GO:0010951; GO:2001240; GO:0031999; GO:0010629; GO:0046329; GO:1903038; GO:2000402; GO:0016242; GO:1901215; GO:0045746; GO:1902176; GO:0010748; GO:0032091; GO:0006469; GO:0100002; GO:0051898; GO:0071901; GO:0031397; GO:0045861; GO:0090201; GO:0038061; GO:0006809; GO:0001649; GO:0018105; GO:0018107; GO:0032287; GO:0014065; GO:0016310; GO:0043065; GO:0043536; GO:0030307; GO:0008284; GO:0032270; GO:0031659; GO:0051091; GO:0032079; GO:0001938; GO:0045742; GO:0045600; GO:0010763; GO:0010628; GO:0046326; GO:0010907; GO:0045725; GO:1903721; GO:0046889; GO:0010918; GO:0045429; GO:0051000; GO:0046622; GO:0033138; GO:0032436; GO:2000010; GO:1900182; GO:1903078; GO:0001934; GO:0048661; GO:0010765; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0030163; GO:0000060; GO:0043491; GO:0006468; GO:0016567; GO:0042981; GO:0030334; GO:0005979; GO:0043488; GO:0031641; GO:0010975; GO:0050999; GO:1901796; GO:0006417; GO:0034405; GO:0032094; GO:0060416; GO:0009408; GO:1990418; GO:0006979; GO:0070141; GO:0007165; GO:0021510; GO:0051146; GO:0031295; GO:0031929; GO:0006412"]
[88,43,"NK129","Akt1 (PKBa)","Pan-specific","RAC-alpha serine/threonine-protein kinase",0,642,10,556,{"v":351.392,"d":"351"},{"v":617.4473634848,"d":"617"},{"$nulls":3},0,592,10,476,{"v":277.032,"d":"277"},{"v":484.03449358319995,"d":"484"},{"$nulls":6},0,610,12,494,{"v":295.412,"d":"295"},{"v":505.4030796568,"d":"505"},{"$nulls":7},"AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 345-480 of human Akt1.",{"$nulls":3},"P31749","P31749","P31749","P31749"]
[89,44,"PK515","Akt1 (PKBa)","T308","RAC-alpha serine/threonine-protein kinase",0,7784,14,694,{"v":5392.38,"d":"5392"},{"v":9475.203800622,"d":"9475"},{"$f":"(L102+L103)/2","v":{"v":8603.2495229943,"d":"8603"}},{"$f":"SQRT((M102-L102)*(M102-L102))","v":{"v":871.9542776276994,"d":"872"}},{"$f":"N102/M102*100","v":{"v":10.13517363755622,"d":"10"}},0,8120,16,601,{"v":4870.504,"d":"4871"},{"v":8509.8181334104,"d":"8510"},{"$f":"(U102+U103)/2","v":{"v":8599.373390575998,"d":"8599"}},{"$f":"SQRT((V102-U102)*(V102-U102))","v":{"v":89.55525716559896,"d":"90"}},{"$f":"W102/V102*100","v":{"v":1.0414160788010673,"d":"1"}},{"$f":"X102+O102","v":{"v":11.176589716357286,"d":"11"}},{"$f":"(V102/M102*100)-100","v":{"v":-0.04505428336051409,"d":"-0"}},null,0,8257,18,653,{"v":5380.067,"d":"5380"},{"v":9204.4413583738,"d":"9204"},{"$f":"(AG102+AG103)/2","v":{"v":8260.8550130869,"d":"8261"}},{"$f":"SQRT((AH102-AG102)*(AH102-AG102))","v":{"v":943.5863452868998,"d":"944"}},{"$f":"AI102/AH102*100","v":{"v":11.42238114326016,"d":"11"}},{"$f":"AJ102+O102","v":{"v":21.557554780816382,"d":"22"}},{"$f":"(AH102/M102*100)-100","v":{"v":-3.9798277266312567,"d":"-4"}},null,null,"AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"TMK(pT)FCG(bA)C","Corresponds to amino acid residues T305 to G311; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T308 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of phosphorylation of Akt1 by mass spectrometry studies (≥26 reports).",null,"EC 2.7.11.1; Nuclear receptor co-regulator; Protein kinase, Ser/Thr (non-receptor); AGC group; AKT family","P31749","P31749","P31749","P31749","GO:0005911; GO:0036064; GO:0005737; GO:0005829; GO:0015630; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0098794; GO:0032991; GO:0005819; GO:0031982","GO:0071889; GO:0005524; GO:0019899; GO:0032794; GO:0042802; GO:0016301; GO:0030235; GO:0005547; GO:0043325; GO:0042803; GO:0004672; GO:0005080; GO:0051721; GO:0004712; GO:0004674","GO:0006924; GO:0032148; GO:0007568; GO:0043276; GO:0008637; GO:0008643; GO:0030154; GO:0002042; GO:0030030; GO:0008283; GO:0006464; GO:0071276; GO:0006974; GO:0071364; GO:0097011; GO:0071456; GO:0032869; GO:0071260; GO:1990090; GO:0071407; GO:0140052; GO:0071380; GO:0034614; GO:0071356; GO:0035924; GO:0051186; GO:0019221; GO:0031018; GO:0007173; GO:0072655; GO:0060079; GO:0097194; GO:0007281; GO:0042593; GO:0006006; GO:0005978; GO:0060709; GO:0007186; GO:0030212; GO:0007249; GO:0006954; GO:0048009; GO:0008286; GO:0035655; GO:0035556; GO:0060716; GO:0031663; GO:0072656; GO:0060644; GO:0001893; GO:0043066; GO:0010507; GO:0045792; GO:0043154; GO:0010951; GO:2001240; GO:0031999; GO:0010629; GO:0046329; GO:1903038; GO:2000402; GO:0016242; GO:1901215; GO:0045746; GO:1902176; GO:0010748; GO:0032091; GO:0006469; GO:0100002; GO:0051898; GO:0071901; GO:0031397; GO:0045861; GO:0090201; GO:0038061; GO:0006809; GO:0001649; GO:0018105; GO:0018107; GO:0032287; GO:0014065; GO:0016310; GO:0043065; GO:0043536; GO:0030307; GO:0008284; GO:0032270; GO:0031659; GO:0051091; GO:0032079; GO:0001938; GO:0045742; GO:0045600; GO:0010763; GO:0010628; GO:0046326; GO:0010907; GO:0045725; GO:1903721; GO:0046889; GO:0010918; GO:0045429; GO:0051000; GO:0046622; GO:0033138; GO:0032436; GO:2000010; GO:1900182; GO:1903078; GO:0001934; GO:0048661; GO:0010765; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0030163; GO:0000060; GO:0043491; GO:0006468; GO:0016567; GO:0042981; GO:0030334; GO:0005979; GO:0043488; GO:0031641; GO:0010975; GO:0050999; GO:1901796; GO:0006417; GO:0034405; GO:0032094; GO:0060416; GO:0009408; GO:1990418; GO:0006979; GO:0070141; GO:0007165; GO:0021510; GO:0051146; GO:0031295; GO:0031929; GO:0006412"]
[90,44,"PK515","Akt1 (PKBa)","T308","RAC-alpha serine/threonine-protein kinase",0,6748,10,653,{"v":4399.914,"d":"4400"},{"v":7731.295245366599,"d":"7731"},{"$nulls":3},0,7620,16,654,{"v":4973.016,"d":"4973"},{"v":8688.928647741599,"d":"8689"},{"$nulls":6},0,6596,16,650,4277,{"v":7317.2686678,"d":"7317"},{"$nulls":7},"AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"TMK(pT)FCG(bA)C","Corresponds to amino acid residues T305 to G311; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T308 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of phosphorylation of Akt1 by mass spectrometry studies (≥26 reports).",null,null,"P31749","P31749","P31749","P31749"]
[91,45,"PK516","Akt1 (PKBa)","Y315","RAC-alpha serine/threonine-protein kinase",0,5830,18,697,{"v":4050.964,"d":"4051"},{"v":7118.1388346116,"d":"7118"},{"$f":"(L104+L105)/2","v":{"v":6959.2593690605,"d":"6959"}},{"$f":"SQRT((M104-L104)*(M104-L104))","v":{"v":158.8794655511001,"d":"159"}},{"$f":"N104/M104*100","v":{"v":2.2829938808926564,"d":"2"}},0,6460,14,603,{"v":3886.938,"d":"3887"},{"v":6791.3167663638005,"d":"6791"},{"$f":"(U104+U105)/2","v":{"v":6558.5457818814,"d":"6559"}},{"$f":"SQRT((V104-U104)*(V104-U104))","v":{"v":232.7709844824003,"d":"233"}},{"$f":"W104/V104*100","v":{"v":3.5491249466528396,"d":"4"}},{"$f":"X104+O104","v":{"v":5.8321188275454965,"d":"6"}},{"$f":"(V104/M104*100)-100","v":{"v":-5.757991848393999,"d":"-6"}},null,0,6636,16,725,{"v":4799.5,"d":"4800"},{"v":8211.1832993,"d":"8211"},{"$f":"(AG104+AG105)/2","v":{"v":7076.8509692236,"d":"7077"}},{"$f":"SQRT((AH104-AG104)*(AH104-AG104))","v":{"v":1134.3323300764005,"d":"1134"}},{"$f":"AI104/AH104*100","v":{"v":16.028772331217368,"d":"16"}},{"$f":"AJ104+O104","v":{"v":18.311766212110026,"d":"18"}},{"$f":"(AH104/M104*100)-100","v":{"v":1.6897142918093948,"d":"2"}},null,null,"AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"TPE(pY)LAP(bA)C","Corresponds to amino acid residues T312 to P318; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y315 phosphorylation has been reported to be stimulatory for phosphotransferase activity, although the precise positioning of this phosphosites is predicted to be inhibitory. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. It is one of many sites that have been reported by mass spectrometry studies (≥15 reports).","Brk (PTK6); Ret; Src","EC 2.7.11.1; Nuclear receptor co-regulator; Protein kinase, Ser/Thr (non-receptor); AGC group; AKT family","P31749","P31749","P31749","P31749","GO:0005911; GO:0036064; GO:0005737; GO:0005829; GO:0015630; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0098794; GO:0032991; GO:0005819; GO:0031982","GO:0071889; GO:0005524; GO:0019899; GO:0032794; GO:0042802; GO:0016301; GO:0030235; GO:0005547; GO:0043325; GO:0042803; GO:0004672; GO:0005080; GO:0051721; GO:0004712; GO:0004674","GO:0006924; GO:0032148; GO:0007568; GO:0043276; GO:0008637; GO:0008643; GO:0030154; GO:0002042; GO:0030030; GO:0008283; GO:0006464; GO:0071276; GO:0006974; GO:0071364; GO:0097011; GO:0071456; GO:0032869; GO:0071260; GO:1990090; GO:0071407; GO:0140052; GO:0071380; GO:0034614; GO:0071356; GO:0035924; GO:0051186; GO:0019221; GO:0031018; GO:0007173; GO:0072655; GO:0060079; GO:0097194; GO:0007281; GO:0042593; GO:0006006; GO:0005978; GO:0060709; GO:0007186; GO:0030212; GO:0007249; GO:0006954; GO:0048009; GO:0008286; GO:0035655; GO:0035556; GO:0060716; GO:0031663; GO:0072656; GO:0060644; GO:0001893; GO:0043066; GO:0010507; GO:0045792; GO:0043154; GO:0010951; GO:2001240; GO:0031999; GO:0010629; GO:0046329; GO:1903038; GO:2000402; GO:0016242; GO:1901215; GO:0045746; GO:1902176; GO:0010748; GO:0032091; GO:0006469; GO:0100002; GO:0051898; GO:0071901; GO:0031397; GO:0045861; GO:0090201; GO:0038061; GO:0006809; GO:0001649; GO:0018105; GO:0018107; GO:0032287; GO:0014065; GO:0016310; GO:0043065; GO:0043536; GO:0030307; GO:0008284; GO:0032270; GO:0031659; GO:0051091; GO:0032079; GO:0001938; GO:0045742; GO:0045600; GO:0010763; GO:0010628; GO:0046326; GO:0010907; GO:0045725; GO:1903721; GO:0046889; GO:0010918; GO:0045429; GO:0051000; GO:0046622; GO:0033138; GO:0032436; GO:2000010; GO:1900182; GO:1903078; GO:0001934; GO:0048661; GO:0010765; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0030163; GO:0000060; GO:0043491; GO:0006468; GO:0016567; GO:0042981; GO:0030334; GO:0005979; GO:0043488; GO:0031641; GO:0010975; GO:0050999; GO:1901796; GO:0006417; GO:0034405; GO:0032094; GO:0060416; GO:0009408; GO:1990418; GO:0006979; GO:0070141; GO:0007165; GO:0021510; GO:0051146; GO:0031295; GO:0031929; GO:0006412"]
[92,45,"PK516","Akt1 (PKBa)","Y315","RAC-alpha serine/threonine-protein kinase",0,5526,13,702,{"v":3870.126,"d":"3870"},{"v":6800.3799035094,"d":"6800"},{"$nulls":3},0,5282,12,687,{"v":3620.49,"d":"3620"},{"v":6325.774797399,"d":"6326"},{"$nulls":6},0,5366,14,649,{"v":3473.448,"d":"3473"},{"v":5942.5186391472,"d":"5943"},{"$nulls":7},"AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"TPE(pY)LAP(bA)C","Corresponds to amino acid residues T312 to P318; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y315 phosphorylation has been reported to be stimulatory for phosphotransferase activity, although the precise positioning of this phosphosites is predicted to be inhibitory. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. It is one of many sites that have been reported by mass spectrometry studies (≥15 reports).","Brk (PTK6); Ret; Src",null,"P31749","P31749","P31749","P31749"]
[93,46,"PK517","Akt1 (PKBa)","Y326","RAC-alpha serine/threonine-protein kinase",0,2116,14,540,{"v":1135.08,"d":"1135"},{"v":1994.5023032519998,"d":"1995"},{"$f":"(L106+L107)/2","v":{"v":2182.9457653955997,"d":"2183"}},{"$f":"SQRT((M106-L106)*(M106-L106))","v":{"v":188.44346214359985,"d":"188"}},{"$f":"N106/M106*100","v":{"v":8.632530644179774,"d":"9"}},0,1288,16,479,{"v":609.288,"d":"609"},{"v":1064.5571938488001,"d":"1065"},{"$f":"(U106+U107)/2","v":{"v":1376.8736401889,"d":"1377"}},{"$f":"SQRT((V106-U106)*(V106-U106))","v":{"v":312.3164463400999,"d":"312"}},{"$f":"W106/V106*100","v":{"v":22.683014419337105,"d":"23"}},{"$f":"X106+O106","v":{"v":31.31554506351688,"d":"31"}},{"$f":"(V106/M106*100)-100","v":{"v":-36.925888768501814,"d":"-37"}},null,0,2271,14,539,{"v":1216.523,"d":"1217"},{"v":2081.2779124522,"d":"2081"},{"$f":"(AG106+AG107)/2","v":{"v":2046.8190003941,"d":"2047"}},{"$f":"SQRT((AH106-AG106)*(AH106-AG106))","v":{"v":34.45891205809994,"d":"34"}},{"$f":"AI106/AH106*100","v":{"v":1.6835348925071114,"d":"2"}},{"$f":"AJ106+O106","v":{"v":10.316065536686885,"d":"10"}},{"$f":"(AH106/M106*100)-100","v":{"v":-6.2359206151340345,"d":"-6"}},null,null,"AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"DND(pY)GRA(bA)C","Corresponds to amino acid residues D323 to A329; In the protein kinase catalytic domain.","Y326 phosphorylation stimulates phosphotransferase activity. This is one of the major sites of phosphorylation of Akt1 by mass spectrometry studies (≥28 reports).","Brk (PTK6); Src","EC 2.7.11.1; Nuclear receptor co-regulator; Protein kinase, Ser/Thr (non-receptor); AGC group; AKT family","P31749","P31749","P31749","P31749","GO:0005911; GO:0036064; GO:0005737; GO:0005829; GO:0015630; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0098794; GO:0032991; GO:0005819; GO:0031982","GO:0071889; GO:0005524; GO:0019899; GO:0032794; GO:0042802; GO:0016301; GO:0030235; GO:0005547; GO:0043325; GO:0042803; GO:0004672; GO:0005080; GO:0051721; GO:0004712; GO:0004674","GO:0006924; GO:0032148; GO:0007568; GO:0043276; GO:0008637; GO:0008643; GO:0030154; GO:0002042; GO:0030030; GO:0008283; GO:0006464; GO:0071276; GO:0006974; GO:0071364; GO:0097011; GO:0071456; GO:0032869; GO:0071260; GO:1990090; GO:0071407; GO:0140052; GO:0071380; GO:0034614; GO:0071356; GO:0035924; GO:0051186; GO:0019221; GO:0031018; GO:0007173; GO:0072655; GO:0060079; GO:0097194; GO:0007281; GO:0042593; GO:0006006; GO:0005978; GO:0060709; GO:0007186; GO:0030212; GO:0007249; GO:0006954; GO:0048009; GO:0008286; GO:0035655; GO:0035556; GO:0060716; GO:0031663; GO:0072656; GO:0060644; GO:0001893; GO:0043066; GO:0010507; GO:0045792; GO:0043154; GO:0010951; GO:2001240; GO:0031999; GO:0010629; GO:0046329; GO:1903038; GO:2000402; GO:0016242; GO:1901215; GO:0045746; GO:1902176; GO:0010748; GO:0032091; GO:0006469; GO:0100002; GO:0051898; GO:0071901; GO:0031397; GO:0045861; GO:0090201; GO:0038061; GO:0006809; GO:0001649; GO:0018105; GO:0018107; GO:0032287; GO:0014065; GO:0016310; GO:0043065; GO:0043536; GO:0030307; GO:0008284; GO:0032270; GO:0031659; GO:0051091; GO:0032079; GO:0001938; GO:0045742; GO:0045600; GO:0010763; GO:0010628; GO:0046326; GO:0010907; GO:0045725; GO:1903721; GO:0046889; GO:0010918; GO:0045429; GO:0051000; GO:0046622; GO:0033138; GO:0032436; GO:2000010; GO:1900182; GO:1903078; GO:0001934; GO:0048661; GO:0010765; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0030163; GO:0000060; GO:0043491; GO:0006468; GO:0016567; GO:0042981; GO:0030334; GO:0005979; GO:0043488; GO:0031641; GO:0010975; GO:0050999; GO:1901796; GO:0006417; GO:0034405; GO:0032094; GO:0060416; GO:0009408; GO:1990418; GO:0006979; GO:0070141; GO:0007165; GO:0021510; GO:0051146; GO:0031295; GO:0031929; GO:0006412"]
[94,46,"PK517","Akt1 (PKBa)","Y326","RAC-alpha serine/threonine-protein kinase",0,2288,16,594,{"v":1349.568,"d":"1350"},{"v":2371.3892275392,"d":"2371"},{"$nulls":3},0,1884,14,517,{"v":966.79,"d":"967"},{"v":1689.190086529,"d":"1689"},{"$nulls":6},0,2280,18,520,{"v":1176.24,"d":"1176"},{"v":2012.360088336,"d":"2012"},{"$nulls":7},"AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"DND(pY)GRA(bA)C","Corresponds to amino acid residues D323 to A329; In the protein kinase catalytic domain.","Y326 phosphorylation stimulates phosphotransferase activity. This is one of the major sites of phosphorylation of Akt1 by mass spectrometry studies (≥28 reports).","Brk (PTK6); Src",null,"P31749","P31749","P31749","P31749"]
[95,47,"PK071-8","Akt1 (PKBa)","T450/T451/T447","RAC-alpha serine/threonine-protein kinase",0,658,10,552,{"v":357.696,"d":"358"},{"v":628.5244175424,"d":"629"},{"$f":"(L108+L109)/2","v":{"v":578.0134727550001,"d":"578"}},{"$f":"SQRT((M108-L108)*(M108-L108))","v":{"v":50.51094478739992,"d":"51"}},{"$f":"N108/M108*100","v":{"v":8.738714090287262,"d":"9"}},0,884,12,546,{"v":476.112,"d":"476"},{"v":831.8700756912001,"d":"832"},{"$f":"(U108+U109)/2","v":{"v":703.6087624153,"d":"704"}},{"$f":"SQRT((V108-U108)*(V108-U108))","v":{"v":128.26131327590008,"d":"128"}},{"$f":"W108/V108*100","v":{"v":18.229067079212232,"d":"18"}},{"$f":"X108+O108","v":{"v":26.967781169499496,"d":"27"}},{"$f":"(V108/M108*100)-100","v":{"v":21.728782386623607,"d":"22"}},null,0,898,16,478,{"v":421.596,"d":"422"},{"v":721.2838908744001,"d":"721"},{"$f":"(AG108+AG109)/2","v":{"v":738.1219919332,"d":"738"}},{"$f":"SQRT((AH108-AG108)*(AH108-AG108))","v":{"v":16.838101058799907,"d":"17"}},{"$f":"AI108/AH108*100","v":{"v":2.281208423921849,"d":"2"}},{"$f":"AJ108+O108","v":{"v":11.01992251420911,"d":"11"}},{"$f":"(AH108/M108*100)-100","v":{"v":27.699790182237564,"d":"28"}},null,null,"AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 442-459 with T450 phosphorylated of human Akt1.","T450 phosphorylation stimulates phosphotransferase activity. Phosphorylation regulates apoptosis, carcinogenesis, cell cycle progression, cell differentiation, cell growth, cell motility, cytoskeletal reorganization, gene transcription, intracellular location, and induces interaction with PIN1, ILK, PAK1, PDK1, PIK3R1, PPP2CA, and Rictor. It has been infrequently detetced by mass spectrometry studies (≥5 reports).","mTOR","EC 2.7.11.1; Nuclear receptor co-regulator; Protein kinase, Ser/Thr (non-receptor); AGC group; AKT family","P31749","P31749","P31749","P31749","GO:0005911; GO:0036064; GO:0005737; GO:0005829; GO:0015630; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0098794; GO:0032991; GO:0005819; GO:0031982","GO:0071889; GO:0005524; GO:0019899; GO:0032794; GO:0042802; GO:0016301; GO:0030235; GO:0005547; GO:0043325; GO:0042803; GO:0004672; GO:0005080; GO:0051721; GO:0004712; GO:0004674","GO:0006924; GO:0032148; GO:0007568; GO:0043276; GO:0008637; GO:0008643; GO:0030154; GO:0002042; GO:0030030; GO:0008283; GO:0006464; GO:0071276; GO:0006974; GO:0071364; GO:0097011; GO:0071456; GO:0032869; GO:0071260; GO:1990090; GO:0071407; GO:0140052; GO:0071380; GO:0034614; GO:0071356; GO:0035924; GO:0051186; GO:0019221; GO:0031018; GO:0007173; GO:0072655; GO:0060079; GO:0097194; GO:0007281; GO:0042593; GO:0006006; GO:0005978; GO:0060709; GO:0007186; GO:0030212; GO:0007249; GO:0006954; GO:0048009; GO:0008286; GO:0035655; GO:0035556; GO:0060716; GO:0031663; GO:0072656; GO:0060644; GO:0001893; GO:0043066; GO:0010507; GO:0045792; GO:0043154; GO:0010951; GO:2001240; GO:0031999; GO:0010629; GO:0046329; GO:1903038; GO:2000402; GO:0016242; GO:1901215; GO:0045746; GO:1902176; GO:0010748; GO:0032091; GO:0006469; GO:0100002; GO:0051898; GO:0071901; GO:0031397; GO:0045861; GO:0090201; GO:0038061; GO:0006809; GO:0001649; GO:0018105; GO:0018107; GO:0032287; GO:0014065; GO:0016310; GO:0043065; GO:0043536; GO:0030307; GO:0008284; GO:0032270; GO:0031659; GO:0051091; GO:0032079; GO:0001938; GO:0045742; GO:0045600; GO:0010763; GO:0010628; GO:0046326; GO:0010907; GO:0045725; GO:1903721; GO:0046889; GO:0010918; GO:0045429; GO:0051000; GO:0046622; GO:0033138; GO:0032436; GO:2000010; GO:1900182; GO:1903078; GO:0001934; GO:0048661; GO:0010765; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0030163; GO:0000060; GO:0043491; GO:0006468; GO:0016567; GO:0042981; GO:0030334; GO:0005979; GO:0043488; GO:0031641; GO:0010975; GO:0050999; GO:1901796; GO:0006417; GO:0034405; GO:0032094; GO:0060416; GO:0009408; GO:1990418; GO:0006979; GO:0070141; GO:0007165; GO:0021510; GO:0051146; GO:0031295; GO:0031929; GO:0006412"]
[96,47,"PK071-8","Akt1 (PKBa)","T450/T451/T447","RAC-alpha serine/threonine-protein kinase",0,550,12,558,{"v":300.204,"d":"300"},{"v":527.5025279676,"d":"528"},{"$nulls":3},0,612,10,547,{"v":329.294,"d":"329"},{"v":575.3474491393999,"d":"575"},{"$nulls":6},0,798,10,560,{"v":441.28,"d":"441"},{"v":754.960092992,"d":"755"},{"$nulls":7},"AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 442-459 with T450 phosphorylated of human Akt1.","T450 phosphorylation stimulates phosphotransferase activity. Phosphorylation regulates apoptosis, carcinogenesis, cell cycle progression, cell differentiation, cell growth, cell motility, cytoskeletal reorganization, gene transcription, intracellular location, and induces interaction with PIN1, ILK, PAK1, PDK1, PIK3R1, PPP2CA, and Rictor. It has been infrequently detetced by mass spectrometry studies (≥5 reports).","mTOR",null,"P31749","P31749","P31749","P31749"]
[97,48,"PK869","Akt1 (PKBa)","S473","RAC-alpha serine/threonine-protein kinase",0,4670,16,646,{"v":3006.484,"d":"3006"},{"v":5282.8340404996,"d":"5283"},{"$f":"(L110+L111)/2","v":{"v":5157.4036233369,"d":"5157"}},{"$f":"SQRT((M110-L110)*(M110-L110))","v":{"v":125.4304171627,"d":"125"}},{"$f":"N110/M110*100","v":{"v":2.432045779685265,"d":"2"}},0,4267,18,602,{"v":2557.898,"d":"2558"},{"v":4469.198009859801,"d":"4469"},{"$f":"(U110+U111)/2","v":{"v":4166.1662645611,"d":"4166"}},{"$f":"SQRT((V110-U110)*(V110-U110))","v":{"v":303.0317452987001,"d":"303"}},{"$f":"W110/V110*100","v":{"v":7.273635425364476,"d":"7"}},{"$f":"X110+O110","v":{"v":9.705681205049741,"d":"10"}},{"$f":"(V110/M110*100)-100","v":{"v":-19.219697180389716,"d":"-19"}},null,0,4519,20,574,{"v":2582.426,"d":"2582"},{"v":4418.1213132364,"d":"4418"},{"$f":"(AG110+AG111)/2","v":{"v":4235.2375001006,"d":"4235"}},{"$f":"SQRT((AH110-AG110)*(AH110-AG110))","v":{"v":182.88381313579976,"d":"183"}},{"$f":"AI110/AH110*100","v":{"v":4.318147757509601,"d":"4"}},{"$f":"AJ110+O110","v":{"v":6.750193537194866,"d":"7"}},{"$f":"(AH110/M110*100)-100","v":{"v":-17.88043346197611,"d":"-18"}},null,null,"AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"PQF(pS)YSAS(bA)C","Corresponds to amino acid residues P470 to S477; In the C-terminus of the kinase.","S473 phosphorylation stimulates phosphotransferase activity of Akt1, and regulates cell cycle progression, and its intracellular location. This is the major site of phosphorylation of Akt1 identified by mass spectrometry studies (≥66 report) and over 1391 scientific publications involving primarily Western blotting.","S473: ATM; ATR; DNAPK; FRAP1; ILK; MAPKAPK5; p38a MAPK; PDPK1; PKCa; PKCb1; PKCe PKD1","EC 2.7.11.1; Nuclear receptor co-regulator; Protein kinase, Ser/Thr (non-receptor); AGC group; AKT family","P31749","P31749","P31749","P31749","GO:0005911; GO:0036064; GO:0005737; GO:0005829; GO:0015630; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0098794; GO:0032991; GO:0005819; GO:0031982","GO:0071889; GO:0005524; GO:0019899; GO:0032794; GO:0042802; GO:0016301; GO:0030235; GO:0005547; GO:0043325; GO:0042803; GO:0004672; GO:0005080; GO:0051721; GO:0004712; GO:0004674","GO:0006924; GO:0032148; GO:0007568; GO:0043276; GO:0008637; GO:0008643; GO:0030154; GO:0002042; GO:0030030; GO:0008283; GO:0006464; GO:0071276; GO:0006974; GO:0071364; GO:0097011; GO:0071456; GO:0032869; GO:0071260; GO:1990090; GO:0071407; GO:0140052; GO:0071380; GO:0034614; GO:0071356; GO:0035924; GO:0051186; GO:0019221; GO:0031018; GO:0007173; GO:0072655; GO:0060079; GO:0097194; GO:0007281; GO:0042593; GO:0006006; GO:0005978; GO:0060709; GO:0007186; GO:0030212; GO:0007249; GO:0006954; GO:0048009; GO:0008286; GO:0035655; GO:0035556; GO:0060716; GO:0031663; GO:0072656; GO:0060644; GO:0001893; GO:0043066; GO:0010507; GO:0045792; GO:0043154; GO:0010951; GO:2001240; GO:0031999; GO:0010629; GO:0046329; GO:1903038; GO:2000402; GO:0016242; GO:1901215; GO:0045746; GO:1902176; GO:0010748; GO:0032091; GO:0006469; GO:0100002; GO:0051898; GO:0071901; GO:0031397; GO:0045861; GO:0090201; GO:0038061; GO:0006809; GO:0001649; GO:0018105; GO:0018107; GO:0032287; GO:0014065; GO:0016310; GO:0043065; GO:0043536; GO:0030307; GO:0008284; GO:0032270; GO:0031659; GO:0051091; GO:0032079; GO:0001938; GO:0045742; GO:0045600; GO:0010763; GO:0010628; GO:0046326; GO:0010907; GO:0045725; GO:1903721; GO:0046889; GO:0010918; GO:0045429; GO:0051000; GO:0046622; GO:0033138; GO:0032436; GO:2000010; GO:1900182; GO:1903078; GO:0001934; GO:0048661; GO:0010765; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0030163; GO:0000060; GO:0043491; GO:0006468; GO:0016567; GO:0042981; GO:0030334; GO:0005979; GO:0043488; GO:0031641; GO:0010975; GO:0050999; GO:1901796; GO:0006417; GO:0034405; GO:0032094; GO:0060416; GO:0009408; GO:1990418; GO:0006979; GO:0070141; GO:0007165; GO:0021510; GO:0051146; GO:0031295; GO:0031929; GO:0006412"]
[98,48,"PK869","Akt1 (PKBa)","S473","RAC-alpha serine/threonine-protein kinase",0,4447,14,646,{"v":2863.718,"d":"2864"},{"v":5031.9732061742,"d":"5032"},{"$nulls":3},0,3804,18,584,{"v":2211.024,"d":"2211"},{"v":3863.1345192624,"d":"3863"},{"$nulls":6},0,3882,18,613,{"v":2368.632,"d":"2369"},{"v":4052.3536869648,"d":"4052"},{"$nulls":7},"AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"PQF(pS)YSAS(bA)C","Corresponds to amino acid residues P470 to S477; In the C-terminus of the kinase.","S473 phosphorylation stimulates phosphotransferase activity of Akt1, and regulates cell cycle progression, and its intracellular location. This is the major site of phosphorylation of Akt1 identified by mass spectrometry studies (≥66 report) and over 1391 scientific publications involving primarily Western blotting.","S473: ATM; ATR; DNAPK; FRAP1; ILK; MAPKAPK5; p38a MAPK; PDPK1; PKCa; PKCb1; PKCe PKD1",null,"P31749","P31749","P31749","P31749"]
[99,49,"PK071-6","Akt1 (PKBa)","S473/S474/S472","RAC-alpha serine/threonine-protein kinase",0,278,12,545,{"v":144.97,"d":"145"},{"v":254.73358609299999,"d":"255"},{"$f":"(L112+L113)/2","v":{"v":254.84340777424998,"d":"255"}},{"$f":"SQRT((M112-L112)*(M112-L112))","v":{"v":0.10982168124999703,"d":"0"}},{"$f":"N112/M112*100","v":{"v":0.04309378932308159,"d":"0"}},0,212,12,534,{"v":106.8,"d":"107"},{"v":186.60257268,"d":"187"},{"$f":"(U112+U113)/2","v":{"v":223.1088849794,"d":"223"}},{"$f":"SQRT((V112-U112)*(V112-U112))","v":{"v":36.50631229939998,"d":"37"}},{"$f":"W112/V112*100","v":{"v":16.362554231208975,"d":"16"}},{"$f":"X112+O112","v":{"v":16.405648020532055,"d":"16"}},{"$f":"(V112/M112*100)-100","v":{"v":-12.452557855827152,"d":"-12"}},null,0,310,12,483,{"v":143.934,"d":"144"},{"v":246.2482460676,"d":"246"},{"$f":"(AG112+AG113)/2","v":{"v":226.446967704,"d":"226"}},{"$f":"SQRT((AH112-AG112)*(AH112-AG112))","v":{"v":19.801278363600005,"d":"20"}},{"$f":"AI112/AH112*100","v":{"v":8.74433363553944,"d":"9"}},{"$f":"AJ112+O112","v":{"v":8.787427424862523,"d":"9"}},{"$f":"(AH112/M112*100)-100","v":{"v":-11.142701440958845,"d":"-11"}},null,null,"AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S473 phosphosite;  In the C-terminus of the kinase.","S473 phosphorylation stimulates phosphotransferase activity of Akt1, and regulates cell cycle progression, and its intracellular location. This is the major site of phosphorylation of Akt1 identified by mass spectrometry studies (≥66 report) and over 1391 scientific publications involving primarily Western blotting.","S473: ATM; ATR; DNAPK; FRAP1; ILK; MAPKAPK5; p38a MAPK; PDPK1; PKCa; PKCb1; PKCe PKD1","EC 2.7.11.1; Nuclear receptor co-regulator; Protein kinase, Ser/Thr (non-receptor); AGC group; AKT family","P31749","P31749","P31749","P31749","GO:0005911; GO:0036064; GO:0005737; GO:0005829; GO:0015630; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0098794; GO:0032991; GO:0005819; GO:0031982","GO:0071889; GO:0005524; GO:0019899; GO:0032794; GO:0042802; GO:0016301; GO:0030235; GO:0005547; GO:0043325; GO:0042803; GO:0004672; GO:0005080; GO:0051721; GO:0004712; GO:0004674","GO:0006924; GO:0032148; GO:0007568; GO:0043276; GO:0008637; GO:0008643; GO:0030154; GO:0002042; GO:0030030; GO:0008283; GO:0006464; GO:0071276; GO:0006974; GO:0071364; GO:0097011; GO:0071456; GO:0032869; GO:0071260; GO:1990090; GO:0071407; GO:0140052; GO:0071380; GO:0034614; GO:0071356; GO:0035924; GO:0051186; GO:0019221; GO:0031018; GO:0007173; GO:0072655; GO:0060079; GO:0097194; GO:0007281; GO:0042593; GO:0006006; GO:0005978; GO:0060709; GO:0007186; GO:0030212; GO:0007249; GO:0006954; GO:0048009; GO:0008286; GO:0035655; GO:0035556; GO:0060716; GO:0031663; GO:0072656; GO:0060644; GO:0001893; GO:0043066; GO:0010507; GO:0045792; GO:0043154; GO:0010951; GO:2001240; GO:0031999; GO:0010629; GO:0046329; GO:1903038; GO:2000402; GO:0016242; GO:1901215; GO:0045746; GO:1902176; GO:0010748; GO:0032091; GO:0006469; GO:0100002; GO:0051898; GO:0071901; GO:0031397; GO:0045861; GO:0090201; GO:0038061; GO:0006809; GO:0001649; GO:0018105; GO:0018107; GO:0032287; GO:0014065; GO:0016310; GO:0043065; GO:0043536; GO:0030307; GO:0008284; GO:0032270; GO:0031659; GO:0051091; GO:0032079; GO:0001938; GO:0045742; GO:0045600; GO:0010763; GO:0010628; GO:0046326; GO:0010907; GO:0045725; GO:1903721; GO:0046889; GO:0010918; GO:0045429; GO:0051000; GO:0046622; GO:0033138; GO:0032436; GO:2000010; GO:1900182; GO:1903078; GO:0001934; GO:0048661; GO:0010765; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0030163; GO:0000060; GO:0043491; GO:0006468; GO:0016567; GO:0042981; GO:0030334; GO:0005979; GO:0043488; GO:0031641; GO:0010975; GO:0050999; GO:1901796; GO:0006417; GO:0034405; GO:0032094; GO:0060416; GO:0009408; GO:1990418; GO:0006979; GO:0070141; GO:0007165; GO:0021510; GO:0051146; GO:0031295; GO:0031929; GO:0006412"]
[100,49,"PK071-6","Akt1 (PKBa)","S473/S474/S472","RAC-alpha serine/threonine-protein kinase",0,269,14,569,{"v":145.095,"d":"145"},{"v":254.95322945549998,"d":"255"},{"$nulls":3},0,260,18,614,{"v":148.588,"d":"149"},{"v":259.6151972788,"d":"260"},{"$nulls":6},0,258,12,491,{"v":120.786,"d":"121"},{"v":206.6456893404,"d":"207"},{"$nulls":7},"AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S473 phosphosite;  In the C-terminus of the kinase.","S473 phosphorylation stimulates phosphotransferase activity of Akt1, and regulates cell cycle progression, and its intracellular location. This is the major site of phosphorylation of Akt1 identified by mass spectrometry studies (≥66 report) and over 1391 scientific publications involving primarily Western blotting.","S473: ATM; ATR; DNAPK; FRAP1; ILK; MAPKAPK5; p38a MAPK; PDPK1; PKCa; PKCb1; PKCe PKD1",null,"P31749","P31749","P31749","P31749"]
[101,50,"PK071-7","Akt1 (PKBa)","S473/S474/S472","RAC-alpha serine/threonine-protein kinase",0,108,10,449,{"v":44.002,"d":"44"},{"v":77.3179778938,"d":"77"},{"$f":"(L114+L115)/2","v":{"v":65.3113931261,"d":"65"}},{"$f":"SQRT((M114-L114)*(M114-L114))","v":{"v":12.006584767700005,"d":"12"}},{"$f":"N114/M114*100","v":{"v":18.383599235922414,"d":"18"}},0,94,10,414,{"v":34.776,"d":"35"},{"v":60.76115231760001,"d":"61"},{"$f":"(U114+U115)/2","v":{"v":71.2916177253,"d":"71"}},{"$f":"SQRT((V114-U114)*(V114-U114))","v":{"v":10.530465407699992,"d":"11"}},{"$f":"W114/V114*100","v":{"v":14.770972722593918,"d":"15"}},{"$f":"X114+O114","v":{"v":33.15457195851633,"d":"33"}},{"$f":"(V114/M114*100)-100","v":{"v":9.156479923271093,"d":"9"}},null,0,90,12,442,{"v":34.476,"d":"34"},{"v":58.9829681064,"d":"59"},{"$f":"(AG114+AG115)/2","v":{"v":63.335348628000006,"d":"63"}},{"$f":"SQRT((AH114-AG114)*(AH114-AG114))","v":{"v":4.352380521600004,"d":"4"}},{"$f":"AI114/AH114*100","v":{"v":6.871961102106976,"d":"7"}},{"$f":"AJ114+O114","v":{"v":25.25556033802939,"d":"25"}},{"$f":"(AH114/M114*100)-100","v":{"v":-3.0255739519822242,"d":"-3"}},null,null,"AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S473 phosphosite;  In the C-terminus of the kinase.","S473 phosphorylation stimulates phosphotransferase activity of Akt1, and regulates cell cycle progression, and its intracellular location. This is the major site of phosphorylation of Akt1 identified by mass spectrometry studies (≥66 report) and over 1391 scientific publications involving primarily Western blotting.","S473: ATM; ATR; DNAPK; FRAP1; ILK; MAPKAPK5; p38a MAPK; PDPK1; PKCa; PKCb1; PKCe PKD1","EC 2.7.11.1; Nuclear receptor co-regulator; Protein kinase, Ser/Thr (non-receptor); AGC group; AKT family","P31749","P31749","P31749","P31749","GO:0005911; GO:0036064; GO:0005737; GO:0005829; GO:0015630; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0098794; GO:0032991; GO:0005819; GO:0031982","GO:0071889; GO:0005524; GO:0019899; GO:0032794; GO:0042802; GO:0016301; GO:0030235; GO:0005547; GO:0043325; GO:0042803; GO:0004672; GO:0005080; GO:0051721; GO:0004712; GO:0004674","GO:0006924; GO:0032148; GO:0007568; GO:0043276; GO:0008637; GO:0008643; GO:0030154; GO:0002042; GO:0030030; GO:0008283; GO:0006464; GO:0071276; GO:0006974; GO:0071364; GO:0097011; GO:0071456; GO:0032869; GO:0071260; GO:1990090; GO:0071407; GO:0140052; GO:0071380; GO:0034614; GO:0071356; GO:0035924; GO:0051186; GO:0019221; GO:0031018; GO:0007173; GO:0072655; GO:0060079; GO:0097194; GO:0007281; GO:0042593; GO:0006006; GO:0005978; GO:0060709; GO:0007186; GO:0030212; GO:0007249; GO:0006954; GO:0048009; GO:0008286; GO:0035655; GO:0035556; GO:0060716; GO:0031663; GO:0072656; GO:0060644; GO:0001893; GO:0043066; GO:0010507; GO:0045792; GO:0043154; GO:0010951; GO:2001240; GO:0031999; GO:0010629; GO:0046329; GO:1903038; GO:2000402; GO:0016242; GO:1901215; GO:0045746; GO:1902176; GO:0010748; GO:0032091; GO:0006469; GO:0100002; GO:0051898; GO:0071901; GO:0031397; GO:0045861; GO:0090201; GO:0038061; GO:0006809; GO:0001649; GO:0018105; GO:0018107; GO:0032287; GO:0014065; GO:0016310; GO:0043065; GO:0043536; GO:0030307; GO:0008284; GO:0032270; GO:0031659; GO:0051091; GO:0032079; GO:0001938; GO:0045742; GO:0045600; GO:0010763; GO:0010628; GO:0046326; GO:0010907; GO:0045725; GO:1903721; GO:0046889; GO:0010918; GO:0045429; GO:0051000; GO:0046622; GO:0033138; GO:0032436; GO:2000010; GO:1900182; GO:1903078; GO:0001934; GO:0048661; GO:0010765; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0030163; GO:0000060; GO:0043491; GO:0006468; GO:0016567; GO:0042981; GO:0030334; GO:0005979; GO:0043488; GO:0031641; GO:0010975; GO:0050999; GO:1901796; GO:0006417; GO:0034405; GO:0032094; GO:0060416; GO:0009408; GO:1990418; GO:0006979; GO:0070141; GO:0007165; GO:0021510; GO:0051146; GO:0031295; GO:0031929; GO:0006412"]
[102,50,"PK071-7","Akt1 (PKBa)","S473/S474/S472","RAC-alpha serine/threonine-protein kinase",0,74,10,474,{"v":30.336,"d":"30"},{"v":53.304808358399995,"d":"53"},{"$nulls":3},0,82,12,669,{"v":46.83,"d":"47"},{"v":81.82208313299999,"d":"82"},{"$nulls":6},0,96,12,471,{"v":39.564,"d":"40"},{"v":67.6877291496,"d":"68"},{"$nulls":7},"AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S473 phosphosite;  In the C-terminus of the kinase.","S473 phosphorylation stimulates phosphotransferase activity of Akt1, and regulates cell cycle progression, and its intracellular location. This is the major site of phosphorylation of Akt1 identified by mass spectrometry studies (≥66 report) and over 1391 scientific publications involving primarily Western blotting.","S473: ATM; ATR; DNAPK; FRAP1; ILK; MAPKAPK5; p38a MAPK; PDPK1; PKCa; PKCb1; PKCe PKD1",null,"P31749","P31749","P31749","P31749"]
[103,1052,"PN062","AKT1S1 (PRAS40)","T246","Proline-rich AKT1 substrate 1",0,580,10,305,{"v":173.85,"d":"174"},{"v":305.479988565,"d":"305"},{"$f":"(L116+L117)/2","v":{"v":273.9831303825,"d":"274"}},{"$f":"SQRT((M116-L116)*(M116-L116))","v":{"v":31.496858182499977,"d":"31"}},{"$f":"N116/M116*100","v":{"v":11.495911495911487,"d":"11"}},0,472,12,276,{"v":126.96,"d":"127"},{"v":221.826429096,"d":"222"},{"$f":"(U116+U117)/2","v":{"v":247.89313117289998,"d":"248"}},{"$f":"SQRT((V116-U116)*(V116-U116))","v":{"v":26.066702076899986,"d":"26"}},{"$f":"W116/V116*100","v":{"v":10.515298247097874,"d":"11"}},{"$f":"X116+O116","v":{"v":22.01120974300936,"d":"22"}},{"$f":"(V116/M116*100)-100","v":{"v":-9.522483801530598,"d":"-10"}},null,0,477,12,389,{"v":180.885,"d":"181"},{"v":309.465546639,"d":"309"},{"$f":"(AG116+AG117)/2","v":{"v":283.6634920649,"d":"284"}},{"$f":"SQRT((AH116-AG116)*(AH116-AG116))","v":{"v":25.802054574099998,"d":"26"}},{"$f":"AI116/AH116*100","v":{"v":9.096008226605589,"d":"9"}},{"$f":"AJ116+O116","v":{"v":20.591919722517076,"d":"21"}},{"$f":"(AH116/M116*100)-100","v":{"v":3.5331962478440033,"d":"4"}},{"$nulls":15},"Not precisely defined.","Antibody raised against amino acid residues that encompass the T246 phosphosite.","T246 phosphorylation inhibits Akt1S1 phosphorylation, induces interaction with 14-3-3-beta and 14-3-3-eta, although one report indicates that it inhibits interaction with 14-3-3-beta. This is the major site of phosphorylation of AKT1S1 from mass spectrometry studies (≥838 reports).","Akt1; Akt3","Inhibitor of mTOR/FRAP","Q96B36","Q96B36",null,null,"GO:0005737; GO:0005829; GO:0005654; GO:0032991",null,"GO:0045792; GO:0006469; GO:0032007; GO:0048011; GO:0042981; GO:1900034; GO:0043523; GO:0038202"]
[104,1052,"PN062","AKT1S1 (PRAS40)","T246","Proline-rich AKT1 substrate 1",0,470,10,300,138,{"v":242.4862722,"d":"242"},{"$nulls":3},0,570,12,281,{"v":156.798,"d":"157"},{"v":273.9598332498,"d":"274"},{"$nulls":6},0,452,10,341,{"v":150.722,"d":"151"},{"v":257.86143749080003,"d":"258"},{"$nulls":20},"Not precisely defined.","Antibody raised against amino acid residues that encompass the T246 phosphosite.","T246 phosphorylation inhibits Akt1S1 phosphorylation, induces interaction with 14-3-3-beta and 14-3-3-eta, although one report indicates that it inhibits interaction with 14-3-3-beta. This is the major site of phosphorylation of AKT1S1 from mass spectrometry studies (≥838 reports).","Akt1; Akt3",null,"Q96B36","Q96B36"]
[105,51,"NK130-8","Akt2 (PKBb)","Pan-specific","RAC-beta serine/threonine-protein kinase",0,6086,10,621,{"v":3773.196,"d":"3773"},{"v":6630.0596544924,"d":"6630"},{"$f":"(L118+L119)/2","v":{"v":6576.5826457378,"d":"6577"}},{"$f":"SQRT((M118-L118)*(M118-L118))","v":{"v":53.47700875460032,"d":"53"}},{"$f":"N118/M118*100","v":{"v":0.8131428073706044,"d":"1"}},0,6340,16,629,{"v":3977.796,"d":"3978"},{"v":6950.0652359196,"d":"6950"},{"$f":"(U118+U119)/2","v":{"v":6512.6988576574,"d":"6513"}},{"$f":"SQRT((V118-U118)*(V118-U118))","v":{"v":437.36637826219976,"d":"437"}},{"$f":"W118/V118*100","v":{"v":6.715593455514374,"d":"7"}},{"$f":"X118+O118","v":{"v":7.528736262884978,"d":"8"}},{"$f":"(V118/M118*100)-100","v":{"v":-0.971382730540185,"d":"-1"}},null,0,6761,10,761,{"v":5137.511,"d":"5138"},{"v":8789.466511755401,"d":"8789"},{"$f":"(AG118+AG119)/2","v":{"v":8642.7524520777,"d":"8643"}},{"$f":"SQRT((AH118-AG118)*(AH118-AG118))","v":{"v":146.7140596777008,"d":"147"}},{"$f":"AI118/AH118*100","v":{"v":1.6975386081135648,"d":"2"}},{"$f":"AJ118+O118","v":{"v":2.5106814154841692,"d":"3"}},{"$f":"(AH118/M118*100)-100","v":{"v":31.417073541666184,"d":"31"}},null,null,"AKT2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"CHRFFLSINWQDVVQK","Corresponds to amino acid residues H406 to K420; Post-kinase last alpha-chain.",null,null,"Protein-serine kinase, AGC group, AKT family","P31751","P31751","P31751","P31751","GO:0005938; GO:0005829; GO:0005769; GO:0043231; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:0032587","GO:0005524; GO:0046872; GO:0004674","GO:0090630; GO:0008643; GO:0006464; GO:0071486; GO:0032869; GO:0045444; GO:0006006; GO:0005978; GO:0008286; GO:0065002; GO:0035556; GO:0060644; GO:0043066; GO:0010748; GO:0018105; GO:0032287; GO:0030335; GO:2000147; GO:0008284; GO:0032000; GO:0046326; GO:2001275; GO:0010907; GO:0045725; GO:0010918; GO:0001934; GO:0090314; GO:0031340; GO:0043491; GO:0072659; GO:0071156; GO:0030334; GO:0006417; GO:0097473; GO:0007165"]
[106,51,"NK130-8","Akt2 (PKBb)","Pan-specific","RAC-beta serine/threonine-protein kinase",0,6072,16,613,{"v":3712.328,"d":"3712"},{"v":6523.1056369831995,"d":"6523"},{"$nulls":3},0,5733,14,608,{"v":3477.152,"d":"3477"},{"v":6075.3324793952,"d":"6075"},{"$nulls":6},0,6512,12,764,4966,{"v":8496.0383924,"d":"8496"},{"$nulls":7},"AKT2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"CHRFFLSINWQDVVQK","Corresponds to amino acid residues H406 to K420; Post-kinase last alpha-chain.",{"$nulls":3},"P31751","P31751","P31751","P31751"]
[107,52,"NK130-9","Akt2 (PKBb)","Pan-specific","RAC-beta serine/threonine-protein kinase",0,9844,18,692,{"v":6799.592,"d":"6800"},{"v":11947.882004064799,"d":"11948"},{"$f":"(L120+L121)/2","v":{"v":12212.2324551415,"d":"12212"}},{"$f":"SQRT((M120-L120)*(M120-L120))","v":{"v":264.3504510767016,"d":"264"}},{"$f":"N120/M120*100","v":{"v":2.1646365809668713,"d":"2"}},0,10166,20,865,{"v":8776.29,"d":"8776"},{"v":15334.066409979001,"d":"15334"},{"$f":"(U120+U121)/2","v":{"v":13421.5088506358,"d":"13422"}},{"$f":"SQRT((V120-U120)*(V120-U120))","v":{"v":1912.5575593432004,"d":"1913"}},{"$f":"W120/V120*100","v":{"v":14.249944478132198,"d":"14"}},{"$f":"X120+O120","v":{"v":16.41458105909907,"d":"16"}},{"$f":"(V120/M120*100)-100","v":{"v":9.902173086995077,"d":"10"}},null,0,9852,16,680,{"v":6688.48,"d":"6688"},{"v":11442.928487072,"d":"11443"},{"$f":"(AG120+AG121)/2","v":{"v":12550.732510400001,"d":"12551"}},{"$f":"SQRT((AH120-AG120)*(AH120-AG120))","v":{"v":1107.8040233280008,"d":"1108"}},{"$f":"AI120/AH120*100","v":{"v":8.826608505997823,"d":"9"}},{"$f":"AJ120+O120","v":{"v":10.991245086964694,"d":"11"}},{"$f":"(AH120/M120*100)-100","v":{"v":2.7718114317090965,"d":"3"}},null,null,"AKT2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"CDRYDSLGLLELDQRT","Corresponds to amino acid residues D454 to T468; Pre-C-terminus.",null,null,"Protein-serine kinase, AGC group, AKT family","P31751","P31751","P31751","P31751","GO:0005938; GO:0005829; GO:0005769; GO:0043231; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:0032587","GO:0005524; GO:0046872; GO:0004674","GO:0090630; GO:0008643; GO:0006464; GO:0071486; GO:0032869; GO:0045444; GO:0006006; GO:0005978; GO:0008286; GO:0065002; GO:0035556; GO:0060644; GO:0043066; GO:0010748; GO:0018105; GO:0032287; GO:0030335; GO:2000147; GO:0008284; GO:0032000; GO:0046326; GO:2001275; GO:0010907; GO:0045725; GO:0010918; GO:0001934; GO:0090314; GO:0031340; GO:0043491; GO:0072659; GO:0071156; GO:0030334; GO:0006417; GO:0097473; GO:0007165"]
[108,52,"NK130-9","Akt2 (PKBb)","Pan-specific","RAC-beta serine/threonine-protein kinase",0,10262,16,693,{"v":7100.478,"d":"7100"},{"v":12476.5829062182,"d":"12477"},{"$nulls":3},0,9455,18,698,{"v":6587.026,"d":"6587"},{"v":11508.9512912926,"d":"11509"},{"$nulls":6},0,9752,16,820,{"v":7983.52,"d":"7984"},{"v":13658.536533728002,"d":"13659"},{"$nulls":7},"AKT2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"CDRYDSLGLLELDQRT","Corresponds to amino acid residues D454 to T468; Pre-C-terminus.",{"$nulls":3},"P31751","P31751","P31751","P31751"]
[109,53,"NK131-3","Akt3 (PKBg)","Pan-specific","RAC-gamma serine/threonine-protein kinase",0,7936,18,716,{"v":5669.288,"d":"5669"},{"v":9961.771834407198,"d":"9962"},{"$f":"(L122+L123)/2","v":{"v":9332.114935687749,"d":"9332"}},{"$f":"SQRT((M122-L122)*(M122-L122))","v":{"v":629.6568987194496,"d":"630"}},{"$f":"N122/M122*100","v":{"v":6.747204712530105,"d":"7"}},0,8192,16,661,{"v":5404.336,"d":"5404"},{"v":9442.5374646736,"d":"9443"},{"$f":"(U122+U123)/2","v":{"v":8905.5099371074,"d":"8906"}},{"$f":"SQRT((V122-U122)*(V122-U122))","v":{"v":537.0275275662007,"d":"537"}},{"$f":"W122/V122*100","v":{"v":6.030283850771073,"d":"6"}},{"$f":"X122+O122","v":{"v":12.777488563301178,"d":"13"}},{"$f":"(V122/M122*100)-100","v":{"v":-4.571364599775038,"d":"-5"}},null,0,7642,10,641,{"v":4892.112,"d":"4892"},{"v":8369.6277430368,"d":"8370"},{"$f":"(AG122+AG123)/2","v":{"v":7919.1563590512005,"d":"7919"}},{"$f":"SQRT((AH122-AG122)*(AH122-AG122))","v":{"v":450.47138398560037,"d":"450"}},{"$f":"AI122/AH122*100","v":{"v":5.688375927452602,"d":"6"}},{"$f":"AJ122+O122","v":{"v":12.435580639982707,"d":"12"}},{"$f":"(AH122/M122*100)-100","v":{"v":-15.140818414410333,"d":"-15"}},null,null,"AKT3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"CHSFFSGVNWQDVYDK","Corresponds to amino acid residues H402 to K416; Post-kinase last alpha-chain.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); AGC domain target; AGC</A> group; AKT family","Q9Y243","Q9Y243","Q9Y243","Q9Y243","GO:0005737; GO:0005622; GO:0016020; GO:0005634","GO:0005524; GO:0004672; GO:0004674","GO:0048854; GO:0048873; GO:0035556; GO:0000002; GO:2000773; GO:0018105; GO:1905653; GO:0043536; GO:0090050; GO:0045793; GO:0001938; GO:0032008; GO:1905564; GO:0006468; GO:0007165"]
[110,53,"NK131-3","Akt3 (PKBg)","Pan-specific","RAC-gamma serine/threonine-protein kinase",0,7373,14,673,{"v":4952.607,"d":"4953"},{"v":8702.458036968299,"d":"8702"},{"$nulls":3},0,7282,14,659,{"v":4789.612,"d":"4790"},{"v":8368.4824095412,"d":"8368"},{"$nulls":6},0,7008,12,624,{"v":4365.504,"d":"4366"},{"v":7468.6849750656,"d":"7469"},{"$nulls":7},"AKT3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"CHSFFSGVNWQDVYDK","Corresponds to amino acid residues H402 to K416; Post-kinase last alpha-chain.",{"$nulls":3},"Q9Y243","Q9Y243","Q9Y243","Q9Y243"]
[111,54,"NK003-2","ALK","Pan-specific","Anaplastic lymphoma receptor-tyrosine kinase",0,2294,14,616,{"v":1404.48,"d":"1404"},{"v":2467.877678112,"d":"2468"},{"$f":"(L124+L125)/2","v":{"v":2145.55455793705,"d":"2146"}},{"$f":"SQRT((M124-L124)*(M124-L124))","v":{"v":322.32312017494996,"d":"322"}},{"$f":"N124/M124*100","v":{"v":15.02283495810349,"d":"15"}},0,2148,12,622,{"v":1328.592,"d":"1329"},{"v":2321.3360041392,"d":"2321"},{"$f":"(U124+U125)/2","v":{"v":2009.12264349,"d":"2009"}},{"$f":"SQRT((V124-U124)*(V124-U124))","v":{"v":312.21336064920024,"d":"312"}},{"$f":"W124/V124*100","v":{"v":15.53978606835378,"d":"16"}},{"$f":"X124+O124","v":{"v":30.562621026457272,"d":"31"}},{"$f":"(V124/M124*100)-100","v":{"v":-6.358818233838321,"d":"-6"}},null,0,2324,10,577,{"v":1335.178,"d":"1335"},{"v":2284.2777987692,"d":"2284"},{"$f":"(AG124+AG125)/2","v":{"v":2147.4977396806003,"d":"2147"}},{"$f":"SQRT((AH124-AG124)*(AH124-AG124))","v":{"v":136.78005908859996,"d":"137"}},{"$f":"AI124/AH124*100","v":{"v":6.36927604445085,"d":"6"}},{"$f":"AJ124+O124","v":{"v":21.39211100255434,"d":"21"}},{"$f":"(AH124/M124*100)-100","v":{"v":0.09056780851186375,"d":"0"}},null,null,"ALK","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Alk",{"$nulls":6},"LLVSQQAKREEERSPAAC","Corresponds to amino acid residues L1424 to A1440; After catalytic domain.",null,null,"EC 2.7.10.1; Receptor tyrosine kinase; TK domain target; TK</A> group; Alk family","Q9UM73","Q9UM73","Q9UM73","Q9UM73","GO:0070062; GO:0005887; GO:0005622; GO:0005886; GO:0032991","GO:0005524; GO:0042802; GO:0004704; GO:0004713; GO:0004714","GO:0000187; GO:0030534; GO:0008283; GO:0021766; GO:0048666; GO:0016310; GO:0051092; GO:0046777; GO:0042981; GO:0042127; GO:0060159; GO:0090648; GO:0007165; GO:0036269; GO:0007169"]
[112,54,"NK003-2","ALK","Pan-specific","Anaplastic lymphoma receptor-tyrosine kinase",0,1855,12,563,{"v":1037.609,"d":"1038"},{"v":1823.2314377620999,"d":"1823"},{"$nulls":3},0,1736,14,564,{"v":971.208,"d":"971"},{"v":1696.9092828408,"d":"1697"},{"$nulls":6},0,2002,10,590,{"v":1175.28,"d":"1175"},{"v":2010.717680592,"d":"2011"},{"$nulls":7},"ALK","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Alk",{"$nulls":6},"LLVSQQAKREEERSPAAC","Corresponds to amino acid residues L1424 to A1440; After catalytic domain.",{"$nulls":3},"Q9UM73","Q9UM73","Q9UM73","Q9UM73"]
[113,55,"NK003-3","ALK","Pan-specific","Anaplastic lymphoma receptor-tyrosine kinase",0,3884,12,716,{"v":2772.352,"d":"2772"},{"v":4871.429722508799,"d":"4871"},{"$f":"(L126+L127)/2","v":{"v":4622.2065490942,"d":"4622"}},{"$f":"SQRT((M126-L126)*(M126-L126))","v":{"v":249.22317341459893,"d":"249"}},{"$f":"N126/M126*100","v":{"v":5.391865784609699,"d":"5"}},0,4065,16,744,{"v":3012.456,"d":"3012"},{"v":5263.4086112856,"d":"5263"},{"$f":"(U126+U127)/2","v":{"v":4876.0090904532,"d":"4876"}},{"$f":"SQRT((V126-U126)*(V126-U126))","v":{"v":387.3995208324004,"d":"387"}},{"$f":"W126/V126*100","v":{"v":7.9450122763490105,"d":"8"}},{"$f":"X126+O126","v":{"v":13.33687806095871,"d":"13"}},{"$f":"(V126/M126*100)-100","v":{"v":5.490938984730917,"d":"5"}},null,0,4291,10,738,{"v":3159.378,"d":"3159"},{"v":5405.194680649201,"d":"5405"},{"$f":"(AG126+AG127)/2","v":{"v":5065.9947104782,"d":"5066"}},{"$f":"SQRT((AH126-AG126)*(AH126-AG126))","v":{"v":339.19997017100013,"d":"339"}},{"$f":"AI126/AH126*100","v":{"v":6.695624246693728,"d":"7"}},{"$f":"AJ126+O126","v":{"v":12.087490031303428,"d":"12"}},{"$f":"(AH126/M126*100)-100","v":{"v":9.601218739802263,"d":"10"}},null,null,"ALK","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Alk",{"$nulls":6},"LRTSTIMTDYNPNYC","Corresponds to amino acid residues L1083 to C1097; Just before catalytic domain.",null,null,"EC 2.7.10.1; Receptor tyrosine kinase; TK domain target; TK</A> group; Alk family","Q9UM73","Q9UM73","Q9UM73","Q9UM73","GO:0070062; GO:0005887; GO:0005622; GO:0005886; GO:0032991","GO:0005524; GO:0042802; GO:0004704; GO:0004713; GO:0004714","GO:0000187; GO:0030534; GO:0008283; GO:0021766; GO:0048666; GO:0016310; GO:0051092; GO:0046777; GO:0042981; GO:0042127; GO:0060159; GO:0090648; GO:0007165; GO:0036269; GO:0007169"]
[114,55,"NK003-3","ALK","Pan-specific","Anaplastic lymphoma receptor-tyrosine kinase",0,3600,14,694,{"v":2488.684,"d":"2489"},{"v":4372.983375679601,"d":"4373"},{"$nulls":3},0,3598,10,716,{"v":2569.008,"d":"2569"},{"v":4488.609569620799,"d":"4489"},{"$nulls":6},0,3684,10,752,{"v":2762.848,"d":"2763"},{"v":4726.7947403072,"d":"4727"},{"$nulls":7},"ALK","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Alk",{"$nulls":6},"LRTSTIMTDYNPNYC","Corresponds to amino acid residues L1083 to C1097; Just before catalytic domain.",{"$nulls":3},"Q9UM73","Q9UM73","Q9UM73","Q9UM73"]
[115,56,"PK518","ALK","Y1092","Anaplastic lymphoma receptor-tyrosine kinase",0,7502,18,739,{"v":5530.676,"d":"5531"},{"v":9718.2101883044,"d":"9718"},{"$f":"(L128+L129)/2","v":{"v":9315.4141329767,"d":"9315"}},{"$f":"SQRT((M128-L128)*(M128-L128))","v":{"v":402.7960553276989,"d":"403"}},{"$f":"N128/M128*100","v":{"v":4.323973680373426,"d":"4"}},0,8328,16,714,{"v":5934.768,"d":"5935"},{"v":10369.3162645968,"d":"10369"},{"$f":"(U128+U129)/2","v":{"v":9469.7870313732,"d":"9470"}},{"$f":"SQRT((V128-U128)*(V128-U128))","v":{"v":899.5292332236004,"d":"900"}},{"$f":"W128/V128*100","v":{"v":9.498938363064338,"d":"9"}},{"$f":"X128+O128","v":{"v":13.822912043437764,"d":"14"}},{"$f":"(V128/M128*100)-100","v":{"v":1.6571769777794003,"d":"2"}},null,0,8095,12,667,{"v":5391.361,"d":"5391"},{"v":9223.7636011454,"d":"9224"},{"$f":"(AG128+AG129)/2","v":{"v":8527.8780062747,"d":"8528"}},{"$f":"SQRT((AH128-AG128)*(AH128-AG128))","v":{"v":695.8855948707005,"d":"696"}},{"$f":"AI128/AH128*100","v":{"v":8.160126051975382,"d":"8"}},{"$f":"AJ128+O128","v":{"v":12.484099732348808,"d":"12"}},{"$f":"(AH128/M128*100)-100","v":{"v":-8.454118254540205,"d":"-8"}},null,null,"ALK","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Alk",{"$nulls":6},"MTD(pY)NPN(bA)C","Corresponds to amino acid residues M1089 to N1095; In the region between the Transmembrane and kinase catalytic domains. ","The effect of Y1092 phosphorylation is unclear. One of the major in vivo sites of phosphorylation in ALK (≥38 reports from high throughput mass spectrometry studies).",null,"EC 2.7.10.1; Receptor tyrosine kinase; TK domain target; TK</A> group; Alk family","Q9UM73","Q9UM73","Q9UM73","Q9UM73","GO:0070062; GO:0005887; GO:0005622; GO:0005886; GO:0032991","GO:0005524; GO:0042802; GO:0004704; GO:0004713; GO:0004714","GO:0000187; GO:0030534; GO:0008283; GO:0021766; GO:0048666; GO:0016310; GO:0051092; GO:0046777; GO:0042981; GO:0042127; GO:0060159; GO:0090648; GO:0007165; GO:0036269; GO:0007169"]
[116,56,"PK518","ALK","Y1092","Anaplastic lymphoma receptor-tyrosine kinase",0,7108,14,715,{"v":5072.21,"d":"5072"},{"v":8912.618077649,"d":"8913"},{"$nulls":3},0,7240,16,679,{"v":4905.096,"d":"4905"},{"v":8570.2577981496,"d":"8570"},{"$nulls":6},0,6898,14,665,{"v":4577.86,"d":"4578"},{"v":7831.9924114039995,"d":"7832"},{"$nulls":7},"ALK","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Alk",{"$nulls":6},"MTD(pY)NPN(bA)C","Corresponds to amino acid residues M1089 to N1095; In the region between the Transmembrane and kinase catalytic domains. ","The effect of Y1092 phosphorylation is unclear. One of the major in vivo sites of phosphorylation in ALK (≥38 reports from high throughput mass spectrometry studies).",null,null,"Q9UM73","Q9UM73","Q9UM73","Q9UM73"]
[117,57,"PK519","ALK","Y1096","Anaplastic lymphoma receptor-tyrosine kinase",0,7216,18,695,{"v":5002.61,"d":"5003"},{"v":8790.320653408999,"d":"8790"},{"$f":"(L130+L131)/2","v":{"v":8365.0137891454,"d":"8365"}},{"$f":"SQRT((M130-L130)*(M130-L130))","v":{"v":425.306864263599,"d":"425"}},{"$f":"N130/M130*100","v":{"v":5.084353415119114,"d":"5"}},0,7819,18,732,{"v":5710.332,"d":"5710"},{"v":9977.1782964132,"d":"9977"},{"$f":"(U130+U131)/2","v":{"v":9012.9147437346,"d":"9013"}},{"$f":"SQRT((V130-U130)*(V130-U130))","v":{"v":964.2635526785998,"d":"964"}},{"$f":"W130/V130*100","v":{"v":10.698687162761807,"d":"11"}},{"$f":"X130+O130","v":{"v":15.783040577880922,"d":"16"}},{"$f":"(V130/M130*100)-100","v":{"v":7.745366247093671,"d":"8"}},null,0,7862,20,739,{"v":5795.238,"d":"5795"},{"v":9914.7330932532,"d":"9915"},{"$f":"(AG130+AG131)/2","v":{"v":9083.5088231734,"d":"9084"}},{"$f":"SQRT((AH130-AG130)*(AH130-AG130))","v":{"v":831.2242700797997,"d":"831"}},{"$f":"AI130/AH130*100","v":{"v":9.150916086074814,"d":"9"}},{"$f":"AJ130+O130","v":{"v":14.235269501193928,"d":"14"}},{"$f":"(AH130/M130*100)-100","v":{"v":8.589286905424288,"d":"9"}},null,null,"ALK","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Alk",{"$nulls":6},"NPN(pY)CFA(bA)C","Corresponds to amino acid residues N1093 to A1099; In the region between the Transmembrane and kinase catalytic domains. ","Y1096 phosphorylation increases phosphotransferase activity and induces interaction with IRS1 and SNTB1. It is one of the major in vivo sites of phosphorylation in ALK (≥95 reports by mass spectrometry)",null,"EC 2.7.10.1; Receptor tyrosine kinase; TK domain target; TK</A> group; Alk family","Q9UM73","Q9UM73","Q9UM73","Q9UM73","GO:0070062; GO:0005887; GO:0005622; GO:0005886; GO:0032991","GO:0005524; GO:0042802; GO:0004704; GO:0004713; GO:0004714","GO:0000187; GO:0030534; GO:0008283; GO:0021766; GO:0048666; GO:0016310; GO:0051092; GO:0046777; GO:0042981; GO:0042127; GO:0060159; GO:0090648; GO:0007165; GO:0036269; GO:0007169"]
[118,57,"PK519","ALK","Y1096","Anaplastic lymphoma receptor-tyrosine kinase",0,6730,16,673,{"v":4518.522,"d":"4519"},{"v":7939.7069248818,"d":"7940"},{"$nulls":3},0,6871,16,672,{"v":4606.56,"d":"4607"},{"v":8048.651191056001,"d":"8049"},{"$nulls":6},0,6736,18,718,{"v":4823.524,"d":"4824"},{"v":8252.284553093601,"d":"8252"},{"$nulls":7},"ALK","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Alk",{"$nulls":6},"NPN(pY)CFA(bA)C","Corresponds to amino acid residues N1093 to A1099; In the region between the Transmembrane and kinase catalytic domains. ","Y1096 phosphorylation increases phosphotransferase activity and induces interaction with IRS1 and SNTB1. It is one of the major in vivo sites of phosphorylation in ALK (≥95 reports by mass spectrometry)",null,null,"Q9UM73","Q9UM73","Q9UM73","Q9UM73"]
[119,58,"PK520","ALK","Y1507","Anaplastic lymphoma receptor-tyrosine kinase",0,11736,18,731,{"v":8565.858,"d":"8566"},{"v":15051.4708305402,"d":"15051"},{"$f":"(L132+L133)/2","v":{"v":14935.2988203936,"d":"14935"}},{"$f":"SQRT((M132-L132)*(M132-L132))","v":{"v":116.17201014659986,"d":"116"}},{"$f":"N132/M132*100","v":{"v":0.7778351912716421,"d":"1"}},0,12350,20,678,{"v":8359.74,"d":"8360"},{"v":14606.263960074,"d":"14606"},{"$f":"(U132+U133)/2","v":{"v":14290.996467429999,"d":"14291"}},{"$f":"SQRT((V132-U132)*(V132-U132))","v":{"v":315.2674926440013,"d":"315"}},{"$f":"W132/V132*100","v":{"v":2.2060567530228843,"d":"2"}},{"$f":"X132+O132","v":{"v":2.9838919442945264,"d":"3"}},{"$f":"(V132/M132*100)-100","v":{"v":-4.313956893074206,"d":"-4"}},null,0,12963,20,758,{"v":9810.794,"d":"9811"},{"v":16784.7125420716,"d":"16785"},{"$f":"(AG132+AG133)/2","v":{"v":14699.7494772438,"d":"14700"}},{"$f":"SQRT((AH132-AG132)*(AH132-AG132))","v":{"v":2084.9630648278,"d":"2085"}},{"$f":"AI132/AH132*100","v":{"v":14.183663932881732,"d":"14"}},{"$f":"AJ132+O132","v":{"v":14.961499124153374,"d":"15"}},{"$f":"(AH132/M132*100)-100","v":{"v":-1.577131773407615,"d":"-2"}},null,null,"ALK","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Alk",{"$nulls":6},"NPT(pY)GSW(bA)C","Corresponds to amino acid residues N1504 to W1510; Near the C-terminus of the kinase after the catalytic domain.","Phosphorylation of Y1507 increases phosphotransferase activity and induces interaction with Shc1 and SNTB1. This is one of the major in vivo phosphorylation sites in ALK (≥95 reports from high throughput mass spectrometry studies).",null,"EC 2.7.10.1; Receptor tyrosine kinase; TK domain target; TK</A> group; Alk family","Q9UM73","Q9UM73","Q9UM73","Q9UM73","GO:0070062; GO:0005887; GO:0005622; GO:0005886; GO:0032991","GO:0005524; GO:0042802; GO:0004704; GO:0004713; GO:0004714","GO:0000187; GO:0030534; GO:0008283; GO:0021766; GO:0048666; GO:0016310; GO:0051092; GO:0046777; GO:0042981; GO:0042127; GO:0060159; GO:0090648; GO:0007165; GO:0036269; GO:0007169"]
[120,58,"PK520","ALK","Y1507","Anaplastic lymphoma receptor-tyrosine kinase",0,11306,16,747,{"v":8433.63,"d":"8434"},{"v":14819.126810246999,"d":"14819"},{"$nulls":3},0,12232,20,655,{"v":7998.86,"d":"7999"},{"v":13975.728974786,"d":"13976"},{"$nulls":6},0,11258,18,656,{"v":7373.44,"d":"7373"},{"v":12614.786412416,"d":"12615"},{"$nulls":7},"ALK","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Alk",{"$nulls":6},"NPT(pY)GSW(bA)C","Corresponds to amino acid residues N1504 to W1510; Near the C-terminus of the kinase after the catalytic domain.","Phosphorylation of Y1507 increases phosphotransferase activity and induces interaction with Shc1 and SNTB1. This is one of the major in vivo phosphorylation sites in ALK (≥95 reports from high throughput mass spectrometry studies).",null,null,"Q9UM73","Q9UM73","Q9UM73","Q9UM73"]
[121,59,"PN738","ALOX5 (5-LO)","S272","Arachidonate 5-lipoxygenase",0,8444,18,625,{"v":5266.25,"d":"5266"},{"v":9253.574862125,"d":"9254"},{"$f":"(L134+L135)/2","v":{"v":10466.9638681855,"d":"10467"}},{"$f":"SQRT((M134-L134)*(M134-L134))","v":{"v":1213.389006060499,"d":"1213"}},{"$f":"N134/M134*100","v":{"v":11.592559421635283,"d":"12"}},0,10076,16,653,{"v":6569.18,"d":"6569"},{"v":11477.770490618,"d":"11478"},{"$f":"(U134+U135)/2","v":{"v":12273.938846563351,"d":"12274"}},{"$f":"SQRT((V134-U134)*(V134-U134))","v":{"v":796.1683559453504,"d":"796"}},{"$f":"W134/V134*100","v":{"v":6.486657346905994,"d":"6"}},{"$f":"X134+O134","v":{"v":18.079216768541276,"d":"18"}},{"$f":"(V134/M134*100)-100","v":{"v":17.263601949273763,"d":"17"}},null,0,10723,18,618,{"v":6615.69,"d":"6616"},{"v":11318.396341566,"d":"11318"},{"$f":"(AG134+AG135)/2","v":{"v":10646.964658246201,"d":"10647"}},{"$f":"SQRT((AH134-AG134)*(AH134-AG134))","v":{"v":671.431683319799,"d":"671"}},{"$f":"AI134/AH134*100","v":{"v":6.3063202036626205,"d":"6"}},{"$f":"AJ134+O134","v":{"v":17.8988796252979,"d":"18"}},{"$f":"(AH134/M134*100)-100","v":{"v":1.7197039402019527,"d":"2"}},{"$nulls":14},"X","RQL(pS)LEQ(bA)C","Corresponds to amino acid residues R269 to Q275.","S272 phosphorylation stimulates enzymatic activity and import to the nucleus. This is a minor in vivo phosphorylation sites in ALOX5 (≥2 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and found in fish.","CaMK2a; MAPKAPK2; PKACa","Enzyme","P09917","P09917",null,null,"GO:0005829; GO:0005576; GO:0005615; GO:1904813; GO:0005635; GO:0005641; GO:0016363; GO:0031965; GO:0005654; GO:0034774","GO:0004051; GO:0005506","GO:0019221; GO:0035655; GO:0019370; GO:0006691; GO:0002540; GO:0019372; GO:0042759; GO:0043312"]
[122,59,"PN738","ALOX5 (5-LO)","S272","Arachidonate 5-lipoxygenase",0,10012,16,665,{"v":6647.34,"d":"6647"},{"v":11680.352874246,"d":"11680"},{"$nulls":3},0,11333,16,661,{"v":7480.537,"d":"7481"},{"v":13070.107202508701,"d":"13070"},{"$nulls":6},0,9072,18,644,{"v":5830.776,"d":"5831"},{"v":9975.5329749264,"d":"9976"},{"$nulls":19},"X","RQL(pS)LEQ(bA)C","Corresponds to amino acid residues R269 to Q275.","S272 phosphorylation stimulates enzymatic activity and import to the nucleus. This is a minor in vivo phosphorylation sites in ALOX5 (≥2 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and found in fish.","CaMK2a; MAPKAPK2; PKACa",null,"P09917","P09917"]
[123,60,"PN568","AML1 (RUNX1)","T273","Runt-related transcription factor 1",0,7252,16,799,{"v":5781.564,"d":"5782"},{"v":10159.0572597516,"d":"10159"},{"$f":"(L136+L137)/2","v":{"v":10030.7749931702,"d":"10031"}},{"$f":"SQRT((M136-L136)*(M136-L136))","v":{"v":128.2822665814001,"d":"128"}},{"$f":"N136/M136*100","v":{"v":1.2788868922764742,"d":"1"}},0,8838,17,799,{"v":7047.979,"d":"7048"},{"v":12314.335333282901,"d":"12314"},{"$f":"(U136+U137)/2","v":{"v":10988.2305222547,"d":"10988"}},{"$f":"SQRT((V136-U136)*(V136-U136))","v":{"v":1326.1048110282009,"d":"1326"}},{"$f":"W136/V136*100","v":{"v":12.06841090876654,"d":"12"}},{"$f":"X136+O136","v":{"v":13.347297801043014,"d":"13"}},{"$f":"(V136/M136*100)-100","v":{"v":9.545180005896015,"d":"10"}},null,0,8396,18,725,{"v":6074.05,"d":"6074"},{"v":10391.73620567,"d":"10392"},{"$f":"(AG136+AG137)/2","v":{"v":9795.764603980002,"d":"9796"}},{"$f":"SQRT((AH136-AG136)*(AH136-AG136))","v":{"v":595.9716016899984,"d":"596"}},{"$f":"AI136/AH136*100","v":{"v":6.083972265399846,"d":"6"}},{"$f":"AJ136+O136","v":{"v":7.36285915767632,"d":"7"}},{"$f":"(AH136/M136*100)-100","v":{"v":-2.3428936383301675,"d":"-2"}},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"VHPA(pT)PIS(bA)C","Corresponds to amino acid residues V269 to S276.","T273 phosphorylation induces interaction with CBFB. This is a minor in vivo phosphorylation sites in AML1 (≥6 reports from high throughput mass spectrometry studies).","CDK1; CDK2; CDK6; ERK1; ERK2; HIPK2","Transcription protein","Q01196","Q01196",null,"Q01196","GO:0016513; GO:0005829; GO:0043231; GO:0005654; GO:0005634","GO:0005524; GO:0005509; GO:0003677; GO:0003700; GO:0046982; GO:0042803; GO:0000978; GO:0000977; GO:0000981; GO:0001228; GO:0008134; GO:0044212","GO:0002062; GO:0071425; GO:0030097; GO:0030099; GO:0043371; GO:0010629; GO:0030853; GO:0000122; GO:0001503; GO:0048935; GO:0045766; GO:0043378; GO:0030854; GO:0032743; GO:0045893; GO:0045944; GO:0050855; GO:2000810; GO:0001959; GO:1902036; GO:0033146; GO:0045616; GO:0045652; GO:0045637; GO:0045589; GO:0030111"]
[124,60,"PN568","AML1 (RUNX1)","T273","Runt-related transcription factor 1",0,7006,14,806,{"v":5635.552,"d":"5636"},{"v":9902.4927265888,"d":"9902"},{"$nulls":3},0,7579,14,731,{"v":5530.015,"d":"5530"},{"v":9662.125711226501,"d":"9662"},{"$nulls":6},0,6538,20,825,{"v":5377.35,"d":"5377"},{"v":9199.793002290002,"d":"9200"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"VHPA(pT)PIS(bA)C","Corresponds to amino acid residues V269 to S276.","T273 phosphorylation induces interaction with CBFB. This is a minor in vivo phosphorylation sites in AML1 (≥6 reports from high throughput mass spectrometry studies).","CDK1; CDK2; CDK6; ERK1; ERK2; HIPK2",null,"Q01196","Q01196",null,"Q01196"]
[125,61,"PN569","AML2 (RUNX3)","T231","Runt-related transcription factor 3",0,6276,12,829,{"v":5192.856,"d":"5193"},{"v":9124.6108225464,"d":"9125"},{"$f":"(L138+L139)/2","v":{"v":8656.812631947,"d":"8657"}},{"$f":"SQRT((M138-L138)*(M138-L138))","v":{"v":467.7981905994002,"d":"468"}},{"$f":"N138/M138*100","v":{"v":5.403815589967181,"d":"5"}},0,7338,24,885,{"v":6472.89,"d":"6473"},{"v":11309.531148639,"d":"11310"},{"$f":"(U138+U139)/2","v":{"v":10000.868785954099,"d":"10001"}},{"$f":"SQRT((V138-U138)*(V138-U138))","v":{"v":1308.6623626849014,"d":"1309"}},{"$f":"W138/V138*100","v":{"v":13.085486778137476,"d":"13"}},{"$f":"X138+O138","v":{"v":18.489302368104656,"d":"18"}},{"$f":"(V138/M138*100)-100","v":{"v":15.525993355187225,"d":"16"}},null,0,7242,16,766,{"v":5535.116,"d":"5535"},{"v":9469.7056066024,"d":"9470"},{"$f":"(AG138+AG139)/2","v":{"v":9148.6225914367,"d":"9149"}},{"$f":"SQRT((AH138-AG138)*(AH138-AG138))","v":{"v":321.0830151656992,"d":"321"}},{"$f":"AI138/AH138*100","v":{"v":3.5096323184895564,"d":"4"}},{"$f":"AJ138+O138","v":{"v":8.913447908456737,"d":"9"}},{"$f":"(AH138/M138*100)-100","v":{"v":5.68118983740888,"d":"6"}},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"SQPQ(pT)PIQGC","Corresponds to amino acid residues S227 to G235.","T231 phosphorylation induces cell growth. This is a minor in vivo phosphorylation sites in AML2 (≥20 reports from high throughput mass spectrometry studies).",null,"Transcription protein","Q13761","Q13761",null,"Q13761","GO:0016513; GO:0005737; GO:0005829; GO:0043231; GO:0000790; GO:0005730; GO:0005654; GO:0005634","GO:0005524; GO:0003700; GO:0000977; GO:0000981","GO:0002062; GO:0030097; GO:0043371; GO:0045786; GO:0050680; GO:0000122; GO:0001503; GO:0048935; GO:0043378; GO:0045893; GO:0006468; GO:0045595; GO:0006355; GO:0006357; GO:0071559; GO:0006366"]
[126,61,"PN569","AML2 (RUNX3)","T231","Runt-related transcription factor 3",0,6124,16,763,{"v":4660.404,"d":"4660"},{"v":8189.014441347601,"d":"8189"},{"$nulls":3},0,6612,14,754,{"v":4974.892,"d":"4975"},{"v":8692.2064232692,"d":"8692"},{"$nulls":6},0,6349,18,815,{"v":5159.765,"d":"5160"},{"v":8827.539576271001,"d":"8828"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"SQPQ(pT)PIQGC","Corresponds to amino acid residues S227 to G235.","T231 phosphorylation induces cell growth. This is a minor in vivo phosphorylation sites in AML2 (≥20 reports from high throughput mass spectrometry studies).",null,null,"Q13761","Q13761",null,"Q13761"]
[127,62,"NK259-1","AMPKa1 (PRKAA1)","Pan-specific","5'-AMP-activated protein kinase catalytic subunit alpha-1",0,3500,12,636,{"v":2218.368,"d":"2218"},{"v":3897.9984542591997,"d":"3898"},{"$f":"(L140+L141)/2","v":{"v":3632.6517008901997,"d":"3633"}},{"$f":"SQRT((M140-L140)*(M140-L140))","v":{"v":265.346753369,"d":"265"}},{"$f":"N140/M140*100","v":{"v":7.304492013478073,"d":"7"}},0,3178,16,546,{"v":1726.452,"d":"1726"},{"v":3016.4830038252,"d":"3016"},{"$f":"(U140+U141)/2","v":{"v":3047.1151789584,"d":"3047"}},{"$f":"SQRT((V140-U140)*(V140-U140))","v":{"v":30.632175133200235,"d":"31"}},{"$f":"W140/V140*100","v":{"v":1.0052844521509448,"d":"1"}},{"$f":"X140+O140","v":{"v":8.309776465629017,"d":"8"}},{"$f":"(V140/M140*100)-100","v":{"v":-16.11870804427275,"d":"-16"}},null,0,3777,16,594,{"v":2234.034,"d":"2234"},{"v":3822.0778562076002,"d":"3822"},{"$f":"(AG140+AG141)/2","v":{"v":3808.0711976658004,"d":"3808"}},{"$f":"SQRT((AH140-AG140)*(AH140-AG140))","v":{"v":14.00665854179988,"d":"14"}},{"$f":"AI140/AH140*100","v":{"v":0.3678150384999476,"d":"0"}},{"$f":"AJ140+O140","v":{"v":7.67230705197802,"d":"8"}},{"$f":"(AH140/M140*100)-100","v":{"v":4.828965483605629,"d":"5"}},null,null,"AMPKa1 ","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","AMPK",{"$nulls":5},"CLYNRNHQDPLAVAY","Corresponds to amino acid residues C321 to Y335; After catalytic domain in region not conserved with AMPKa2.",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; EC 2.7.1.-; CAMK domain target; CAMK</A> group; CAMKL family; AMPK subfamily","Q13131","Q13131","Q13131","Q13131","GO:0016324; GO:0030424; GO:0005737; GO:0005829; GO:0030425; GO:0005622; GO:0043025; GO:0016607; GO:0005654; GO:0031588; GO:0005634","GO:0050405; GO:0047322; GO:0004679; GO:0005524; GO:0004691; GO:0003682; GO:0035174; GO:0046872; GO:0008022; GO:0004672; GO:0050321","GO:0000187; GO:0061762; GO:0007050; GO:0071277; GO:0071361; GO:0042149; GO:0071333; GO:0070301; GO:0071456; GO:0031669; GO:0071417; GO:0034599; GO:0071380; GO:0006695; GO:0009631; GO:0097009; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0008610; GO:0016236; GO:0061744; GO:0043066; GO:0010629; GO:2001274; GO:0046318; GO:0050995; GO:0032007; GO:1904428; GO:0070050; GO:0010508; GO:0008284; GO:1903829; GO:0045542; GO:0010628; GO:0045821; GO:1903109; GO:2000758; GO:1903955; GO:0048643; GO:0051291; GO:0006468; GO:0042752; GO:0070507; GO:0033135; GO:0062028; GO:0060627; GO:0014823; GO:0031000; GO:1901563; GO:0010332; GO:0001666; GO:0009411; GO:0048511; GO:0007165; GO:0006351; GO:0016055"]
[128,62,"NK259-1","AMPKa1 (PRKAA1)","Pan-specific","5'-AMP-activated protein kinase catalytic subunit alpha-1",0,3086,10,623,{"v":1916.348,"d":"1916"},{"v":3367.3049475211997,"d":"3367"},{"$nulls":3},0,3020,14,586,{"v":1761.516,"d":"1762"},{"v":3077.7473540916003,"d":"3078"},{"$nulls":6},0,3224,10,690,{"v":2217.66,"d":"2218"},{"v":3794.064539124,"d":"3794"},{"$nulls":7},"AMPKa1 ","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","AMPK",{"$nulls":5},"CLYNRNHQDPLAVAY","Corresponds to amino acid residues C321 to Y335; After catalytic domain in region not conserved with AMPKa2.",{"$nulls":3},"Q13131","Q13131","Q13131","Q13131"]
[129,63,"NK259-2","AMPKa1 (PRKAA1)","Pan-specific","5'-AMP-activated protein kinase catalytic subunit alpha-1",0,2568,12,638,{"$f":"(H142-I142)*J142/1000","v":{"v":1630.728,"d":"1631"}},{"v":2865.4286499432,"d":"2865"},{"$f":"(L142+L143)/2","v":{"v":2812.7775002316002,"d":"2813"}},{"$f":"SQRT((M142-L142)*(M142-L142))","v":{"v":52.65114971159983,"d":"53"}},{"$f":"N142/M142*100","v":{"v":1.8718561886699039,"d":"2"}},0,2544,18,631,{"$f":"(Q142-R142)*S142/1000","v":{"v":1593.906,"d":"1594"}},{"v":2784.8966311806,"d":"2785"},{"$f":"(U142+U143)/2","v":{"v":2672.4580978503,"d":"2672"}},{"$f":"SQRT((V142-U142)*(V142-U142))","v":{"v":112.43853333029983,"d":"112"}},{"$f":"W142/V142*100","v":{"v":4.207307625168916,"d":"4"}},{"$f":"X142+O142","v":{"v":6.07916381383882,"d":"6"}},{"$f":"(V142/M142*100)-100","v":{"v":-4.988642093793288,"d":"-5"}},null,0,2700,16,628,{"$f":"(AC142-AD142)*AE142/1000","v":{"v":1685.552,"d":"1686"}},{"v":2883.7121434528,"d":"2884"},{"$f":"(AG142+AG143)/2","v":{"v":2999.4762267838,"d":"2999"}},{"$f":"SQRT((AH142-AG142)*(AH142-AG142))","v":{"v":115.76408333100017,"d":"116"}},{"$f":"AI142/AH142*100","v":{"v":3.859476607858588,"d":"4"}},{"$f":"AJ142+O142","v":{"v":5.731332796528491,"d":"6"}},{"$f":"(AH142/M142*100)-100","v":{"v":6.637522041356874,"d":"7"}},null,null,"AMPKa1 ","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","AMPK",{"$nulls":5},"MRRLSSWRKMATAEKQKGC","Corresponds to amino acid residues M1 to K17; N-terminus (not present in AMPKa2).",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; EC 2.7.1.-; CAMK domain target; CAMK</A> group; CAMKL family; AMPK subfamily","Q13131","Q13131","Q13131","Q13131","GO:0016324; GO:0030424; GO:0005737; GO:0005829; GO:0030425; GO:0005622; GO:0043025; GO:0016607; GO:0005654; GO:0031588; GO:0005634","GO:0050405; GO:0047322; GO:0004679; GO:0005524; GO:0004691; GO:0003682; GO:0035174; GO:0046872; GO:0008022; GO:0004672; GO:0050321","GO:0000187; GO:0061762; GO:0007050; GO:0071277; GO:0071361; GO:0042149; GO:0071333; GO:0070301; GO:0071456; GO:0031669; GO:0071417; GO:0034599; GO:0071380; GO:0006695; GO:0009631; GO:0097009; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0008610; GO:0016236; GO:0061744; GO:0043066; GO:0010629; GO:2001274; GO:0046318; GO:0050995; GO:0032007; GO:1904428; GO:0070050; GO:0010508; GO:0008284; GO:1903829; GO:0045542; GO:0010628; GO:0045821; GO:1903109; GO:2000758; GO:1903955; GO:0048643; GO:0051291; GO:0006468; GO:0042752; GO:0070507; GO:0033135; GO:0062028; GO:0060627; GO:0014823; GO:0031000; GO:1901563; GO:0010332; GO:0001666; GO:0009411; GO:0048511; GO:0007165; GO:0006351; GO:0016055"]
[130,63,"NK259-2","AMPKa1 (PRKAA1)","Pan-specific","5'-AMP-activated protein kinase catalytic subunit alpha-1",0,2320,10,680,{"v":1570.8,"d":"1571"},{"v":2760.12635052,"d":"2760"},{"$nulls":3},0,2214,14,666,{"v":1465.2,"d":"1465"},{"v":2560.01956452,"d":"2560"},{"$nulls":6},0,2318,16,791,{"v":1820.882,"d":"1821"},{"v":3115.2403101148,"d":"3115"},{"$nulls":7},"AMPKa1 ","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","AMPK",{"$nulls":5},"MRRLSSWRKMATAEKQKGC","Corresponds to amino acid residues M1 to K17; N-terminus (not present in AMPKa2).",{"$nulls":3},"Q13131","Q13131","Q13131","Q13131"]
[131,64,"PK521","AMPKa1 (PRKAA1)","T183+S184","5'-AMP-activated protein kinase catalytic subunit alpha-1",0,15052,18,727,{"v":10929.718,"d":"10930"},{"v":19205.1201015742,"d":"19205"},{"$f":"(L144+L145)/2","v":{"v":18713.123362441453,"d":"18713"}},{"$f":"SQRT((M144-L144)*(M144-L144))","v":{"v":491.9967391327482,"d":"492"}},{"$f":"N144/M144*100","v":{"v":2.6291535068924947,"d":"3"}},0,15954,13,792,{"v":12625.272,"d":"12625"},{"v":22059.0658800072,"d":"22059"},{"$f":"(U144+U145)/2","v":{"v":21653.9985200836,"d":"21654"}},{"$f":"SQRT((V144-U144)*(V144-U144))","v":{"v":405.0673599235997,"d":"405"}},{"$f":"W144/V144*100","v":{"v":1.870635391186107,"d":"2"}},{"$f":"X144+O144","v":{"v":4.499788898078602,"d":"4"}},{"$f":"(V144/M144*100)-100","v":{"v":15.71557617978776,"d":"16"}},null,0,15741,18,730,{"v":11477.79,"d":"11478"},{"v":19636.678312506003,"d":"19637"},{"$f":"(AG144+AG145)/2","v":{"v":20070.7666792452,"d":"20071"}},{"$f":"SQRT((AH144-AG144)*(AH144-AG144))","v":{"v":434.0883667391972,"d":"434"}},{"$f":"AI144/AH144*100","v":{"v":2.1627891633461105,"d":"2"}},{"$f":"AJ144+O144","v":{"v":4.791942670238605,"d":"5"}},{"$f":"(AH144/M144*100)-100","v":{"v":7.2550332219186515,"d":"7"}},null,null,"AMPKa1 ","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","AMPK",{"$nulls":5},"FLR(pS)(pT)CG(bA)C","Corresponds to amino acid residues F180 to G186; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T183 and S184 stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in AMPKa1.","T183: AMPKa1; BRSK1; BRSK2; CaMK2b; CAMKK1; CaMKK2; LKB1","Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; EC 2.7.1.-; CAMK domain target; CAMK</A> group; CAMKL family; AMPK subfamily","Q13131","Q13131","Q13131","Q13131","GO:0016324; GO:0030424; GO:0005737; GO:0005829; GO:0030425; GO:0005622; GO:0043025; GO:0016607; GO:0005654; GO:0031588; GO:0005634","GO:0050405; GO:0047322; GO:0004679; GO:0005524; GO:0004691; GO:0003682; GO:0035174; GO:0046872; GO:0008022; GO:0004672; GO:0050321","GO:0000187; GO:0061762; GO:0007050; GO:0071277; GO:0071361; GO:0042149; GO:0071333; GO:0070301; GO:0071456; GO:0031669; GO:0071417; GO:0034599; GO:0071380; GO:0006695; GO:0009631; GO:0097009; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0008610; GO:0016236; GO:0061744; GO:0043066; GO:0010629; GO:2001274; GO:0046318; GO:0050995; GO:0032007; GO:1904428; GO:0070050; GO:0010508; GO:0008284; GO:1903829; GO:0045542; GO:0010628; GO:0045821; GO:1903109; GO:2000758; GO:1903955; GO:0048643; GO:0051291; GO:0006468; GO:0042752; GO:0070507; GO:0033135; GO:0062028; GO:0060627; GO:0014823; GO:0031000; GO:1901563; GO:0010332; GO:0001666; GO:0009411; GO:0048511; GO:0007165; GO:0006351; GO:0016055"]
[132,64,"PK521","AMPKa1 (PRKAA1)","T183+S184","5'-AMP-activated protein kinase catalytic subunit alpha-1",0,10941,14,949,{"v":10369.723,"d":"10370"},{"v":18221.1266233087,"d":"18221"},{"$nulls":3},0,15214,12,800,{"v":12161.6,"d":"12162"},{"v":21248.931160160002,"d":"21249"},{"$nulls":6},0,14760,18,813,{"v":11985.246,"d":"11985"},{"v":20504.8550459844,"d":"20505"},{"$nulls":7},"AMPKa1 ","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","AMPK",{"$nulls":5},"FLR(pS)(pT)CG(bA)C","Corresponds to amino acid residues F180 to G186; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T183 and S184 stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in AMPKa1.","T183: AMPKa1; BRSK1; BRSK2; CaMK2b; CAMKK1; CaMKK2; LKB1",null,"Q13131","Q13131","Q13131","Q13131"]
[133,65,"NK260-2","AMPKa2 (PRKAA2)","Pan-specific","5'-AMP-activated protein kinase catalytic subunit alpha-2",0,5940,18,711,{"v":4210.542,"d":"4211"},{"$f":"K146*1.7571469","v":{"v":7398.540822619801,"d":"7399"}},{"$f":"(L146+L147)/2","v":{"v":7574.6860136103005,"d":"7575"}},{"$f":"SQRT((M146-L146)*(M146-L146))","v":{"v":176.14519099049994,"d":"176"}},{"$f":"N146/M146*100","v":{"v":2.3254454465043146,"d":"2"}},0,5726,20,708,{"v":4039.848,"d":"4040"},{"$f":"T146*1.7472151","v":{"v":7058.4834273048,"d":"7058"}},{"$f":"(U146+U147)/2","v":{"v":6985.3441296112505,"d":"6985"}},{"$f":"SQRT((V146-U146)*(V146-U146))","v":{"v":73.13929769354945,"d":"73"}},{"$f":"W146/V146*100","v":{"v":1.0470392916436002,"d":"1"}},{"$f":"X146+O146","v":{"v":3.372484738147915,"d":"3"}},{"$f":"(V146/M146*100)-100","v":{"v":-7.780413378721079,"d":"-8"}},null,0,6166,12,702,{"v":4320.108,"d":"4320"},{"v":7391.019618871201,"d":"7391"},{"$f":"(AG146+AG147)/2","v":{"v":7953.451885755601,"d":"7953"}},{"$f":"SQRT((AH146-AG146)*(AH146-AG146))","v":{"v":562.4322668844006,"d":"562"}},{"$f":"AI146/AH146*100","v":{"v":7.071549246330393,"d":"7"}},{"$f":"AJ146+O146","v":{"v":9.396994692834706,"d":"9"}},{"$f":"(AH146/M146*100)-100","v":{"v":5.00041680229026,"d":"5"}},null,null,"AMPKa2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","AMPK",{"$nulls":5},"CTESEVMNSLYSGDPQDQL","Corresponds to amino acid residues C302 to L320; After catalytic domain in region not conserved with AMPKa1.",null,null,"Protein-serine kinase, CAMK group, CAMKL family, AMPK subfamily","P54646","P54646","P54646",null,"GO:0030424; GO:0005737; GO:0010494; GO:0005829; GO:0030425; GO:0005794; GO:0043025; GO:0016607; GO:0005654; GO:0031588; GO:0005634","GO:0050405; GO:0047322; GO:0004679; GO:0005524; GO:0003682; GO:0035174; GO:0046872; GO:0004672; GO:0004712; GO:0004674","GO:0007050; GO:0071277; GO:0035690; GO:0042149; GO:0071333; GO:0031669; GO:0034599; GO:0071380; GO:0006695; GO:0097009; GO:0006633; GO:0055089; GO:0042593; GO:0035404; GO:0035556; GO:0008610; GO:0016236; GO:0043066; GO:0010629; GO:0032007; GO:1904428; GO:0010508; GO:1903829; GO:0045821; GO:0016239; GO:2000758; GO:0006468; GO:0042752; GO:0042304; GO:0016241; GO:0070507; GO:0062028; GO:0006355; GO:0014850; GO:0048511; GO:0007165; GO:0006351; GO:0016055"]
[134,65,"NK260-2","AMPKa2 (PRKAA2)","Pan-specific","5'-AMP-activated protein kinase catalytic subunit alpha-2",0,6040,14,732,{"v":4411.032,"d":"4411"},{"v":7750.8312046008,"d":"7751"},{"$nulls":3},0,5507,20,721,{"v":3956.127,"d":"3956"},{"v":6912.2048319177,"d":"6912"},{"$nulls":6},0,6116,16,816,{"v":4977.6,"d":"4978"},{"$f":"AF147*1.7108414","v":{"v":8515.884152640001,"d":"8516"}},{"$nulls":7},"AMPKa2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","AMPK",{"$nulls":5},"CTESEVMNSLYSGDPQDQL","Corresponds to amino acid residues C302 to L320; After catalytic domain in region not conserved with AMPKa1.",{"$nulls":3},"P54646","P54646","P54646"]
[135,66,"NK260-1","AMPKa2 (PRKAA2)","Pan-specific","5'-AMP-activated protein kinase catalytic subunit alpha-2",0,9912,16,662,{"v":6551.152,"d":"6551"},{"v":11511.3364282288,"d":"11511"},{"$f":"(L148+L149)/2","v":{"v":11289.162774192799,"d":"11289"}},{"$f":"SQRT((M148-L148)*(M148-L148))","v":{"v":222.1736540360016,"d":"222"}},{"$f":"N148/M148*100","v":{"v":1.9680259597628802,"d":"2"}},0,11074,14,640,{"v":7078.4,"d":"7078"},{"v":12367.48736384,"d":"12367"},{"$f":"(U148+U149)/2","v":{"v":12504.4602916045,"d":"12504"}},{"$f":"SQRT((V148-U148)*(V148-U148))","v":{"v":136.97292776450013,"d":"137"}},{"$f":"W148/V148*100","v":{"v":1.0953925604967039,"d":"1"}},{"$f":"X148+O148","v":{"v":3.0634185202595843,"d":"3"}},{"$f":"(V148/M148*100)-100","v":{"v":10.765169585382267,"d":"11"}},null,0,8419,12,670,{"v":5632.69,"d":"5633"},{"v":9636.639245366,"d":"9637"},{"$f":"(AG148+AG149)/2","v":{"v":8086.2285759682,"d":"8086"}},{"$f":"SQRT((AH148-AG148)*(AH148-AG148))","v":{"v":1550.4106693977992,"d":"1550"}},{"$f":"AI148/AH148*100","v":{"v":19.173470732765697,"d":"19"}},{"$f":"AJ148+O148","v":{"v":21.141496692528577,"d":"21"}},{"$f":"(AH148/M148*100)-100","v":{"v":-28.371760265044244,"d":"-28"}},null,null,"AMPKa2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","AMPK",{"$nulls":5},"CGSFMDDSAMHIPPGLKP","Corresponds to amino acid residues G349 to P365; After catalytic domain in region not conserved with AMPKa1.",null,null,"Protein-serine kinase, CAMK group, CAMKL family, AMPK subfamily","P54646","P54646","P54646",null,"GO:0030424; GO:0005737; GO:0010494; GO:0005829; GO:0030425; GO:0005794; GO:0043025; GO:0016607; GO:0005654; GO:0031588; GO:0005634","GO:0050405; GO:0047322; GO:0004679; GO:0005524; GO:0003682; GO:0035174; GO:0046872; GO:0004672; GO:0004712; GO:0004674","GO:0007050; GO:0071277; GO:0035690; GO:0042149; GO:0071333; GO:0031669; GO:0034599; GO:0071380; GO:0006695; GO:0097009; GO:0006633; GO:0055089; GO:0042593; GO:0035404; GO:0035556; GO:0008610; GO:0016236; GO:0043066; GO:0010629; GO:0032007; GO:1904428; GO:0010508; GO:1903829; GO:0045821; GO:0016239; GO:2000758; GO:0006468; GO:0042752; GO:0042304; GO:0016241; GO:0070507; GO:0062028; GO:0006355; GO:0014850; GO:0048511; GO:0007165; GO:0006351; GO:0016055"]
[136,66,"NK260-1","AMPKa2 (PRKAA2)","Pan-specific","5'-AMP-activated protein kinase catalytic subunit alpha-2",0,9224,16,684,{"v":6298.272,"d":"6298"},{"v":11066.989120156799,"d":"11067"},{"$nulls":3},0,11444,14,633,{"v":7235.19,"d":"7235"},{"v":12641.433219368999,"d":"12641"},{"$nulls":6},0,6142,10,623,{"v":3820.236,"d":"3820"},{"v":6535.8179065704,"d":"6536"},{"$nulls":7},"AMPKa2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","AMPK",{"$nulls":5},"CGSFMDDSAMHIPPGLKP","Corresponds to amino acid residues G349 to P365; After catalytic domain in region not conserved with AMPKa1.",{"$nulls":3},"P54646","P54646","P54646"]
[137,67,"PK522","AMPKa2 (PRKAA2)","S377","5'-AMP-activated protein kinase catalytic subunit alpha-2",0,6497,14,765,{"v":4959.495,"d":"4959"},{"v":8714.5612648155,"d":"8715"},{"$f":"(L150+L151)/2","v":{"v":8567.0874397923,"d":"8567"}},{"$f":"SQRT((M150-L150)*(M150-L150))","v":{"v":147.47382502320033,"d":"147"}},{"$f":"N150/M150*100","v":{"v":1.7213997879631269,"d":"2"}},0,6721,12,691,{"v":4635.919,"d":"4636"},{"v":8099.9476791769,"d":"8100"},{"$f":"(U150+U151)/2","v":{"v":7718.42666354845,"d":"7718"}},{"$f":"SQRT((V150-U150)*(V150-U150))","v":{"v":381.5210156284502,"d":"382"}},{"$f":"W150/V150*100","v":{"v":4.9429894492649185,"d":"5"}},{"$f":"X150+O150","v":{"v":6.664389237228045,"d":"7"}},{"$f":"(V150/M150*100)-100","v":{"v":-9.906059465460814,"d":"-10"}},null,0,6930,12,684,{"v":4731.912,"d":"4732"},{"v":8095.5509507568,"d":"8096"},{"$f":"(AG150+AG151)/2","v":{"v":7636.0018423028005,"d":"7636"}},{"$f":"SQRT((AH150-AG150)*(AH150-AG150))","v":{"v":459.5491084539999,"d":"460"}},{"$f":"AI150/AH150*100","v":{"v":6.018190120229371,"d":"6"}},{"$f":"AJ150+O150","v":{"v":7.739589908192498,"d":"8"}},{"$f":"(AH150/M150*100)-100","v":{"v":-10.868169655474802,"d":"-11"}},null,null,"AMPKa2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","AMPK",{"$nulls":5},"IAD(pS)PKARC","Corresponds to amino acid residues I374 to C382; In the C-terminal half of the protein after the kinase catalytic domain. ","The effect of S377 phosphorylation is unclear. This is the major in vivo phosphorylation site in AMPKa2.",null,"Protein-serine kinase, CAMK group, CAMKL family, AMPK subfamily","P54646","P54646","P54646",null,"GO:0030424; GO:0005737; GO:0010494; GO:0005829; GO:0030425; GO:0005794; GO:0043025; GO:0016607; GO:0005654; GO:0031588; GO:0005634","GO:0050405; GO:0047322; GO:0004679; GO:0005524; GO:0003682; GO:0035174; GO:0046872; GO:0004672; GO:0004712; GO:0004674","GO:0007050; GO:0071277; GO:0035690; GO:0042149; GO:0071333; GO:0031669; GO:0034599; GO:0071380; GO:0006695; GO:0097009; GO:0006633; GO:0055089; GO:0042593; GO:0035404; GO:0035556; GO:0008610; GO:0016236; GO:0043066; GO:0010629; GO:0032007; GO:1904428; GO:0010508; GO:1903829; GO:0045821; GO:0016239; GO:2000758; GO:0006468; GO:0042752; GO:0042304; GO:0016241; GO:0070507; GO:0062028; GO:0006355; GO:0014850; GO:0048511; GO:0007165; GO:0006351; GO:0016055"]
[138,67,"PK522","AMPKa2 (PRKAA2)","S377","5'-AMP-activated protein kinase catalytic subunit alpha-2",0,6245,14,769,{"v":4791.639,"d":"4792"},{"v":8419.6136147691,"d":"8420"},{"$nulls":3},0,5808,16,725,{"v":4199.2,"d":"4199"},{"v":7336.90564792,"d":"7337"},{"$nulls":6},0,6206,10,677,{"v":4194.692,"d":"4195"},{"v":7176.452733848801,"d":"7176"},{"$nulls":7},"AMPKa2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","AMPK",{"$nulls":5},"IAD(pS)PKARC","Corresponds to amino acid residues I374 to C382; In the C-terminal half of the protein after the kinase catalytic domain. ","The effect of S377 phosphorylation is unclear. This is the major in vivo phosphorylation site in AMPKa2.",null,null,"P54646","P54646","P54646"]
[139,68,"PK523","ANKRD3 (RIPK4, DIK)","S438","Ankyrin repeat domain protein-serine kinase 3",0,6818,14,705,{"v":4796.82,"d":"4797"},{"v":8428.717392858,"d":"8429"},{"$f":"(L152+L153)/2","v":{"v":8258.67565162465,"d":"8259"}},{"$f":"SQRT((M152-L152)*(M152-L152))","v":{"v":170.04174123334997,"d":"170"}},{"$f":"N152/M152*100","v":{"v":2.058946838527304,"d":"2"}},0,6782,14,679,{"v":4595.472,"d":"4595"},{"v":8029.2780700272,"d":"8029"},{"$f":"(U152+U153)/2","v":{"v":7475.762947169849,"d":"7476"}},{"$f":"SQRT((V152-U152)*(V152-U152))","v":{"v":553.5151228573504,"d":"554"}},{"$f":"W152/V152*100","v":{"v":7.404128873119211,"d":"7"}},{"$f":"X152+O152","v":{"v":9.463075711646514,"d":"9"}},{"$f":"(V152/M152*100)-100","v":{"v":-9.479881974790786,"d":"-9"}},null,0,7424,12,792,{"v":5870.304,"d":"5870"},{"v":10043.159113785601,"d":"10043"},{"$f":"(AG152+AG153)/2","v":{"v":9204.8006350678,"d":"9205"}},{"$f":"SQRT((AH152-AG152)*(AH152-AG152))","v":{"v":838.3584787178006,"d":"838"}},{"$f":"AI152/AH152*100","v":{"v":9.1078396149492,"d":"9"}},{"$f":"AJ152+O152","v":{"v":11.166786453476504,"d":"11"}},{"$f":"(AH152/M152*100)-100","v":{"v":11.45613441371836,"d":"11"}},null,null,"ANKRD3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RIPK",{"$nulls":6},"LSL(pS)FER(bA)C","Corresponds to amino acid residues L435 to R441; In the region between the kinase catalytic and Ank_2 domains.","The effect of S438 phosphorylation is unclear. The major site of phosphorylation in ANKRD3.",null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); TKL group; RIPK family","P57078","P57078","P57078",null,"GO:0005737; GO:0016020","GO:0005524; GO:0004674","GO:0002009; GO:0051092"]
[140,68,"PK523","ANKRD3 (RIPK4, DIK)","S438","Ankyrin repeat domain protein-serine kinase 3",0,6521,10,707,{"v":4603.277,"d":"4603"},{"v":8088.6339103913,"d":"8089"},{"$nulls":3},0,6353,14,625,{"v":3961.875,"d":"3962"},{"v":6922.2478243125,"d":"6922"},{"$nulls":6},0,6324,14,775,{"v":4890.25,"d":"4890"},{"v":8366.44215635,"d":"8366"},{"$nulls":7},"ANKRD3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RIPK",{"$nulls":6},"LSL(pS)FER(bA)C","Corresponds to amino acid residues L435 to R441; In the region between the kinase catalytic and Ank_2 domains.","The effect of S438 phosphorylation is unclear. The major site of phosphorylation in ANKRD3.",null,null,"P57078","P57078","P57078"]
[141,69,"PN503","ANXA1","Y207","Annexin A1",0,4732,14,687,{"v":3241.266,"d":"3241"},{"v":5695.3805039754,"d":"5695"},{"$f":"(L154+L155)/2","v":{"v":5554.3466223406995,"d":"5554"}},{"$f":"SQRT((M154-L154)*(M154-L154))","v":{"v":141.03388163470026,"d":"141"}},{"$f":"N154/M154*100","v":{"v":2.53916241142448,"d":"3"}},0,4822,12,628,{"v":3020.68,"d":"3021"},{"v":5277.7777082679995,"d":"5278"},{"$f":"(U154+U155)/2","v":{"v":5046.411484726,"d":"5046"}},{"$f":"SQRT((V154-U154)*(V154-U154))","v":{"v":231.36622354199972,"d":"231"}},{"$f":"W154/V154*100","v":{"v":4.584767299342851,"d":"5"}},{"$f":"X154+O154","v":{"v":7.123929710767332,"d":"7"}},{"$f":"(V154/M154*100)-100","v":{"v":-9.144822463396181,"d":"-9"}},null,0,5067,12,616,{"v":3113.88,"d":"3114"},{"v":5327.354818632,"d":"5327"},{"$f":"(AG154+AG155)/2","v":{"v":4846.916336684,"d":"4847"}},{"$f":"SQRT((AH154-AG154)*(AH154-AG154))","v":{"v":480.4384819480001,"d":"480"}},{"$f":"AI154/AH154*100","v":{"v":9.912250358269858,"d":"10"}},{"$f":"AJ154+O154","v":{"v":12.451412769694338,"d":"12"}},{"$f":"(AH154/M154*100)-100","v":{"v":-12.736516709477087,"d":"-13"}},{"$nulls":15},"RAL(pY)EAG(bA)C","Corresponds to amino acid residues R204 to G210; In the beginning of the third Annexin domain. ","The effect of Y207 phosphorylation is unclear. This is the major in vivo phosphorylation site in ANXA1.",null,"Lipid binding protein; Calcium-binding protein","P04083","P04083",null,null,"GO:0016324; GO:0016323; GO:0005913; GO:0009986; GO:0062023; GO:0001533; GO:0005737; GO:0030659; GO:0005829; GO:0031901; GO:0005768; GO:0070062; GO:0005576; GO:0005615; GO:0031313; GO:0031232; GO:0019898; GO:0005925; GO:0016328; GO:0042629; GO:0031966; GO:0031514; GO:0005654; GO:0005634; GO:0001891; GO:0005886; GO:0032991; GO:0042383; GO:0097060; GO:0031982","GO:0098641; GO:0005544; GO:0048306; GO:0005509; GO:1990814; GO:0033676; GO:0019834; GO:0005543; GO:0030674; GO:0042803; GO:0005102; GO:0003697; GO:0003727; GO:0005198","GO:0031532; GO:0002250; GO:0046632; GO:0050482; GO:0007166; GO:0071385; GO:0070301; GO:0035924; GO:0019221; GO:0032508; GO:0031018; GO:0044849; GO:0042063; GO:0007186; GO:0007187; GO:0071621; GO:0070365; GO:0006954; GO:0045087; GO:0030073; GO:0030216; GO:0002548; GO:0014839; GO:0043066; GO:0045920; GO:2000483; GO:1900138; GO:0045629; GO:0097350; GO:0001780; GO:0018149; GO:0006909; GO:0090050; GO:1900087; GO:0032743; GO:0033031; GO:0031394; GO:0042102; GO:0045627; GO:0031340; GO:0090303; GO:0070459; GO:0030850; GO:0008360; GO:0046883; GO:0050727; GO:0032652; GO:0002685; GO:0032355; GO:0070555; GO:0043434; GO:0010165; GO:0007165"]
[142,69,"PN503","ANXA1","Y207","Annexin A1",0,4434,14,697,{"v":3080.74,"d":"3081"},{"v":5413.312740705999,"d":"5413"},{"$nulls":3},0,4322,16,640,{"v":2755.84,"d":"2756"},{"v":4815.045261184,"d":"4815"},{"$nulls":6},0,4200,16,610,{"v":2552.24,"d":"2552"},{"v":4366.477854736,"d":"4366"},{"$nulls":20},"RAL(pY)EAG(bA)C","Corresponds to amino acid residues R204 to G210; In the beginning of the third Annexin domain. ","The effect of Y207 phosphorylation is unclear. This is the major in vivo phosphorylation site in ANXA1.",null,null,"P04083","P04083"]
[143,70,"PN504","ANXA2","Y238","Annexin A2",0,5382,14,627,{"v":3365.736,"d":"3366"},{"v":5914.0925786184,"d":"5914"},{"$f":"(L156+L157)/2","v":{"v":5625.29933558925,"d":"5625"}},{"$f":"SQRT((M156-L156)*(M156-L156))","v":{"v":288.7932430291494,"d":"289"}},{"$f":"N156/M156*100","v":{"v":5.133828900482827,"d":"5"}},0,6076,18,712,{"v":4313.296,"d":"4313"},{"v":7536.255901969601,"d":"7536"},{"$f":"(U156+U157)/2","v":{"v":6676.248674308001,"d":"6676"}},{"$f":"SQRT((V156-U156)*(V156-U156))","v":{"v":860.0072276616002,"d":"860"}},{"$f":"W156/V156*100","v":{"v":12.88159368555487,"d":"13"}},{"$f":"X156+O156","v":{"v":18.015422586037698,"d":"18"}},{"$f":"(V156/M156*100)-100","v":{"v":18.682549603534355,"d":"19"}},null,0,6546,14,708,{"v":4624.656,"d":"4625"},{"v":7912.0529455584,"d":"7912"},{"$f":"(AG156+AG157)/2","v":{"v":7736.207533942201,"d":"7736"}},{"$f":"SQRT((AH156-AG156)*(AH156-AG156))","v":{"v":175.84541161619927,"d":"176"}},{"$f":"AI156/AH156*100","v":{"v":2.2730182824683394,"d":"2"}},{"$f":"AJ156+O156","v":{"v":7.406847182951166,"d":"7"}},{"$f":"(AH156/M156*100)-100","v":{"v":37.525259944799586,"d":"38"}},{"$nulls":15},"YSP(pY)DML(bA)C","Corresponds to amino acid residues Y235 to L241; In the third Annexin domain. ","The effect of Y238 phosphorylation is unclear. The second major in vivo phosphoryation site in Annexin A2.",null,"Lipid binding protein; Calcium-binding protein","P07355","P07355",null,null,"GO:0035578; GO:0005604; GO:0016323; GO:0005913; GO:0005938; GO:0009986; GO:0062023; GO:0005737; GO:0005829; GO:0005769; GO:0005768; GO:0070062; GO:0005576; GO:0005615; GO:0019897; GO:0031902; GO:0005811; GO:0005765; GO:0044354; GO:0042470; GO:0016020; GO:0045121; GO:0030496; GO:0035749; GO:0005634; GO:1990667; GO:0048471; GO:0005886; GO:0001726; GO:0042383; GO:0043220; GO:0031982","GO:0044730; GO:0098641; GO:0005544; GO:0048306; GO:0005509; GO:0008092; GO:0042802; GO:0098772; GO:0005546; GO:0019834; GO:0002020; GO:0017137; GO:0003723; GO:0044548","GO:0001525; GO:0007589; GO:0052362; GO:0030199; GO:0042730; GO:0035722; GO:0001765; GO:0052405; GO:0044147; GO:0032804; GO:0043312; GO:0036035; GO:0048146; GO:1905581; GO:1905597; GO:1905599; GO:0001934; GO:1905602; GO:0001921; GO:0044090; GO:0031340; GO:0051290; GO:0072659; GO:0097066; GO:0006900"]
[144,70,"PN504","ANXA2","Y238","Annexin A2",0,3219,12,947,{"v":3037.029,"d":"3037"},{"v":5336.5060925601,"d":"5337"},{"$nulls":3},0,5420,16,616,{"v":3328.864,"d":"3329"},{"v":5816.2414466464,"d":"5816"},{"$nulls":6},0,6311,16,702,{"v":4419.09,"d":"4419"},{"v":7560.362122326001,"d":"7560"},{"$nulls":20},"YSP(pY)DML(bA)C","Corresponds to amino acid residues Y235 to L241; In the third Annexin domain. ","The effect of Y238 phosphorylation is unclear. The second major in vivo phosphoryation site in Annexin A2.",null,null,"P07355","P07355"]
[145,71,"PN739","APC","S2129","Adenomatous polyposis coli protein",0,8813,14,674,{"v":5930.526,"d":"5931"},{"v":10420.8053762694,"d":"10421"},{"$f":"(L158+L159)/2","v":{"v":11311.9635123672,"d":"11312"}},{"$f":"SQRT((M158-L158)*(M158-L158))","v":{"v":891.1581360977998,"d":"891"}},{"$f":"N158/M158*100","v":{"v":7.8780145915738675,"d":"8"}},0,9029,14,724,{"v":6526.86,"d":"6527"},{"v":11403.828347585999,"d":"11404"},{"$f":"(U158+U159)/2","v":{"v":11429.6801422056,"d":"11430"}},{"$f":"SQRT((V158-U158)*(V158-U158))","v":{"v":25.851794619600696,"d":"26"}},{"$f":"W158/V158*100","v":{"v":0.226181260524864,"d":"0"}},{"$f":"X158+O158","v":{"v":8.104195852098732,"d":"8"}},{"$f":"(V158/M158*100)-100","v":{"v":1.0406383446136829,"d":"1"}},null,0,10896,18,731,{"v":7951.818,"d":"7952"},{"v":13604.299439665201,"d":"13604"},{"$f":"(AG158+AG159)/2","v":{"v":11453.297896797401,"d":"11453"}},{"$f":"SQRT((AH158-AG158)*(AH158-AG158))","v":{"v":2151.0015428678,"d":"2151"}},{"$f":"AI158/AH158*100","v":{"v":18.780630367339594,"d":"19"}},{"$f":"AJ158+O158","v":{"v":26.658644958913463,"d":"27"}},{"$f":"(AH158/M158*100)-100","v":{"v":1.2494239773288172,"d":"1"}},{"$nulls":15},"RQA(pS)SDS(bA)C","Corresponds to amino acid residues R2126 to S2132.","The effect of S2129 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in APC(≥40 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in mammals, and is found in the chicken.","MAPKAPK2","Tumour suppressor protein","P25054","P25054",null,"P25054","GO:0005912; GO:0030877; GO:0005923; GO:0016342; GO:0005813; GO:0005737; GO:0005829; GO:0000776; GO:0030027; GO:0016328; GO:0005874; GO:0005654; GO:0005634; GO:0048471; GO:0005886; GO:0032587; GO:1990909","GO:0008013; GO:0070840; GO:0045295; GO:0042802; GO:0008017; GO:0051010; GO:0019901; GO:0019887; GO:0031625","GO:1904885; GO:1904886; GO:0070830; GO:0007155; GO:0007050; GO:0016477; GO:0006974; GO:0008286; GO:0000281; GO:0007094; GO:0090090; GO:0008285; GO:0045736; GO:0007026; GO:0043065; GO:0010942; GO:0030335; GO:0120162; GO:0045732; GO:1904781; GO:0031274; GO:0065003; GO:0016579; GO:0051260; GO:0051988; GO:0032886; GO:0016055"]
[146,71,"PN739","APC","S2129","Adenomatous polyposis coli protein",0,10366,16,671,{"v":6944.85,"d":"6945"},{"v":12203.121648465,"d":"12203"},{"$nulls":3},0,10540,16,623,{"v":6556.452,"d":"6556"},{"v":11455.5319368252,"d":"11456"},{"$nulls":6},0,9046,14,602,{"v":5437.264,"d":"5437"},{"v":9302.2963539296,"d":"9302"},{"$nulls":20},"RQA(pS)SDS(bA)C","Corresponds to amino acid residues R2126 to S2132.","The effect of S2129 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in APC(≥40 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in mammals, and is found in the chicken.","MAPKAPK2",null,"P25054","P25054",null,"P25054"]
[147,72,"PN570","AR","S96","Androgen receptor",0,14214,18,715,{"v":10150.14,"d":"10150"},{"v":17835.287035565998,"d":"17835"},{"$f":"(L160+L161)/2","v":{"v":17929.7951815825,"d":"17930"}},{"$f":"SQRT((M160-L160)*(M160-L160))","v":{"v":94.508146016502,"d":"95"}},{"$f":"N160/M160*100","v":{"v":0.527101091001758,"d":"1"}},0,15992,16,708,{"v":11311.008,"d":"11311"},{"v":19762.763973820798,"d":"19763"},{"$f":"(U160+U161)/2","v":{"v":19531.0413183984,"d":"19531"}},{"$f":"SQRT((V160-U160)*(V160-U160))","v":{"v":231.72265542239984,"d":"232"}},{"$f":"W160/V160*100","v":{"v":1.1864326722002028,"d":"1"}},{"$f":"X160+O160","v":{"v":1.7135337632019607,"d":"2"}},{"$f":"(V160/M160*100)-100","v":{"v":8.930643772555186,"d":"9"}},null,0,14166,18,678,{"v":9592.344,"d":"9592"},{"v":16410.979238241598,"d":"16411"},{"$f":"(AG160+AG161)/2","v":{"v":14737.464975906798,"d":"14737"}},{"$f":"SQRT((AH160-AG160)*(AH160-AG160))","v":{"v":1673.5142623348002,"d":"1674"}},{"$f":"AI160/AH160*100","v":{"v":11.355509682775878,"d":"11"}},{"$f":"AJ160+O160","v":{"v":11.882610773777635,"d":"12"}},{"$f":"(AH160/M160*100)-100","v":{"v":-17.8046105565939,"d":"-18"}},{"$nulls":5},"Receptor (steroid),  Transcription protein",{"$nulls":4},"X",{"$nulls":4},"GEDG(pS)PQAH(bA)C","Corresponds to amino acid residues G92 to H100.","S96 phosphorylation regulates transcription. This is a minor in vivo phosphorylation sites in the androgen receptor (≥8 reports from high throughput mass spectrometry studies).",null,"Receptor (steroid), transcription factor","P10275","P10275",null,"P10275","GO:0005737; GO:0005829; GO:0000790; GO:0016607; GO:0005654; GO:0005634; GO:0005886; GO:0032991","GO:0005497; GO:0004882; GO:0051117; GO:0008013; GO:0003682; GO:0003677; GO:0003700; GO:0019899; GO:0004879; GO:0070974; GO:0046983; GO:0000978; GO:0000981; GO:0001085; GO:0005102; GO:0005496; GO:0001077; GO:0008134; GO:0044212; GO:0008270","GO:0060520; GO:0030521; GO:0048645; GO:0007267; GO:0008283; GO:0071383; GO:0071394; GO:0060742; GO:0003382; GO:0030522; GO:0001701; GO:0060599; GO:0033327; GO:0048808; GO:0019102; GO:0060749; GO:0060571; GO:0035264; GO:0008285; GO:0050680; GO:2001237; GO:0045720; GO:0000122; GO:0045597; GO:0008284; GO:0060769; GO:0010628; GO:0043568; GO:0045726; GO:0033148; GO:0043410; GO:0051092; GO:0042327; GO:0045893; GO:0045944; GO:0045945; GO:0030850; GO:0060740; GO:0060736; GO:0051259; GO:0016579; GO:0050790; GO:0048638; GO:1903076; GO:0003073; GO:0072520; GO:0007548; GO:0007165; GO:0007338; GO:0007283; GO:0060748; GO:0006351; GO:0006367"]
[148,72,"PN570","AR","S96","Androgen receptor",0,13288,18,773,{"v":10257.71,"d":"10258"},{"v":18024.303327599,"d":"18024"},{"$nulls":3},0,15708,18,704,{"v":11045.76,"d":"11046"},{"v":19299.318662976002,"d":"19299"},{"$nulls":6},0,11396,16,671,{"v":7635.98,"d":"7636"},{"v":13063.950713572,"d":"13064"},{"$nulls":10},"Receptor (steroid),  Transcription protein",{"$nulls":4},"X",{"$nulls":4},"GEDG(pS)PQAH(bA)C","Corresponds to amino acid residues G92 to H100.","S96 phosphorylation regulates transcription. This is a minor in vivo phosphorylation sites in the androgen receptor (≥8 reports from high throughput mass spectrometry studies).",null,null,"P10275","P10275",null,"P10275"]
[149,73,"PN571","AR","S310","Androgen receptor",0,5969,18,814,{"v":4844.114,"d":"4844"},{"v":8511.819898346599,"d":"8512"},{"$f":"(L162+L163)/2","v":{"v":8219.569468791698,"d":"8220"}},{"$f":"SQRT((M162-L162)*(M162-L162))","v":{"v":292.2504295549006,"d":"292"}},{"$f":"N162/M162*100","v":{"v":3.5555442491790545,"d":"4"}},0,6398,20,757,{"v":4828.146,"d":"4828"},{"v":8435.809596204599,"d":"8436"},{"$f":"(U162+U163)/2","v":{"v":7936.7368222557,"d":"7937"}},{"$f":"SQRT((V162-U162)*(V162-U162))","v":{"v":499.07277394889934,"d":"499"}},{"$f":"W162/V162*100","v":{"v":6.28813560441403,"d":"6"}},{"$f":"X162+O162","v":{"v":9.843679853593084,"d":"10"}},{"$f":"(V162/M162*100)-100","v":{"v":-3.4409666784843864,"d":"-3"}},null,0,6403,16,821,{"v":5243.727,"d":"5244"},{"v":8971.1852418978,"d":"8971"},{"$f":"(AG162+AG163)/2","v":{"v":8417.1215557215,"d":"8417"}},{"$f":"SQRT((AH162-AG162)*(AH162-AG162))","v":{"v":554.0636861762996,"d":"554"}},{"$f":"AI162/AH162*100","v":{"v":6.582579121715039,"d":"7"}},{"$f":"AJ162+O162","v":{"v":10.138123370894093,"d":"10"}},{"$f":"(AH162/M162*100)-100","v":{"v":2.4034359424769605,"d":"2"}},{"$nulls":5},"Receptor (steroid),  Transcription protein",{"$nulls":4},"X",{"$nulls":4},"AEY(pS)PFKGC","Corresponds to amino acid residues A307 to G314.","S310 phosphorylation regulates transcription. This is a minor in vivo phosphorylation sites in the androgen receptor (≥4 reports from high throughput mass spectrometry studies).","CDK1; CDK5","Receptor (steroid), transcription factor","P10275","P10275",null,"P10275","GO:0005737; GO:0005829; GO:0000790; GO:0016607; GO:0005654; GO:0005634; GO:0005886; GO:0032991","GO:0005497; GO:0004882; GO:0051117; GO:0008013; GO:0003682; GO:0003677; GO:0003700; GO:0019899; GO:0004879; GO:0070974; GO:0046983; GO:0000978; GO:0000981; GO:0001085; GO:0005102; GO:0005496; GO:0001077; GO:0008134; GO:0044212; GO:0008270","GO:0060520; GO:0030521; GO:0048645; GO:0007267; GO:0008283; GO:0071383; GO:0071394; GO:0060742; GO:0003382; GO:0030522; GO:0001701; GO:0060599; GO:0033327; GO:0048808; GO:0019102; GO:0060749; GO:0060571; GO:0035264; GO:0008285; GO:0050680; GO:2001237; GO:0045720; GO:0000122; GO:0045597; GO:0008284; GO:0060769; GO:0010628; GO:0043568; GO:0045726; GO:0033148; GO:0043410; GO:0051092; GO:0042327; GO:0045893; GO:0045944; GO:0045945; GO:0030850; GO:0060740; GO:0060736; GO:0051259; GO:0016579; GO:0050790; GO:0048638; GO:1903076; GO:0003073; GO:0072520; GO:0007548; GO:0007165; GO:0007338; GO:0007283; GO:0060748; GO:0006351; GO:0006367"]
[150,73,"PN571","AR","S310","Androgen receptor",0,5570,14,812,{"v":4511.472,"d":"4511"},{"v":7927.3190392368,"d":"7927"},{"$nulls":3},0,5978,16,714,{"v":4256.868,"d":"4257"},{"v":7437.6640483068,"d":"7438"},{"$nulls":6},0,5354,16,861,{"v":4596.018,"d":"4596"},{"v":7863.0578695452,"d":"7863"},{"$nulls":10},"Receptor (steroid),  Transcription protein",{"$nulls":4},"X",{"$nulls":4},"AEY(pS)PFKGC","Corresponds to amino acid residues A307 to G314.","S310 phosphorylation regulates transcription. This is a minor in vivo phosphorylation sites in the androgen receptor (≥4 reports from high throughput mass spectrometry studies).","CDK1; CDK5",null,"P10275","P10275",null,"P10275"]
[151,74,"PN203","AR","S310","Androgen receptor",0,170,14,491,{"v":76.596,"d":"77"},{"v":134.59042395240002,"d":"135"},{"$f":"(L164+L165)/2","v":{"v":124.0352425241,"d":"124"}},{"$f":"SQRT((M164-L164)*(M164-L164))","v":{"v":10.555181428300017,"d":"11"}},{"$f":"N164/M164*100","v":{"v":8.509824476901514,"d":"9"}},0,179,12,457,{"v":76.319,"d":"76"},{"v":133.34570921690002,"d":"133"},{"$f":"(U164+U165)/2","v":{"v":117.55175832045,"d":"118"}},{"$f":"SQRT((V164-U164)*(V164-U164))","v":{"v":15.793950896450013,"d":"16"}},{"$f":"W164/V164*100","v":{"v":13.435741942196373,"d":"13"}},{"$f":"X164+O164","v":{"v":21.945566419097887,"d":"22"}},{"$f":"(V164/M164*100)-100","v":{"v":-5.227130670051508,"d":"-5"}},null,0,172,12,534,{"v":85.44,"d":"85"},{"v":146.174289216,"d":"146"},{"$f":"(AG164+AG165)/2","v":{"v":158.0920104084,"d":"158"}},{"$f":"SQRT((AH164-AG164)*(AH164-AG164))","v":{"v":11.917721192399995,"d":"12"}},{"$f":"AI164/AH164*100","v":{"v":7.538471527822866,"d":"8"}},{"$f":"AJ164+O164","v":{"v":16.048296004724378,"d":"16"}},{"$f":"(AH164/M164*100)-100","v":{"v":27.45733163514619,"d":"27"}},{"$nulls":5},"Receptor (steroid),  Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S310 phosphosite.","S310 phosphorylation regulates transcription. This is a minor in vivo phosphorylation sites in the androgen receptor (≥4 reports from high throughput mass spectrometry studies).","CDK1; CDK5","Receptor (steroid), transcription factor","P10275","P10275",null,"P10275","GO:0005737; GO:0005829; GO:0000790; GO:0016607; GO:0005654; GO:0005634; GO:0005886; GO:0032991","GO:0005497; GO:0004882; GO:0051117; GO:0008013; GO:0003682; GO:0003677; GO:0003700; GO:0019899; GO:0004879; GO:0070974; GO:0046983; GO:0000978; GO:0000981; GO:0001085; GO:0005102; GO:0005496; GO:0001077; GO:0008134; GO:0044212; GO:0008270","GO:0060520; GO:0030521; GO:0048645; GO:0007267; GO:0008283; GO:0071383; GO:0071394; GO:0060742; GO:0003382; GO:0030522; GO:0001701; GO:0060599; GO:0033327; GO:0048808; GO:0019102; GO:0060749; GO:0060571; GO:0035264; GO:0008285; GO:0050680; GO:2001237; GO:0045720; GO:0000122; GO:0045597; GO:0008284; GO:0060769; GO:0010628; GO:0043568; GO:0045726; GO:0033148; GO:0043410; GO:0051092; GO:0042327; GO:0045893; GO:0045944; GO:0045945; GO:0030850; GO:0060740; GO:0060736; GO:0051259; GO:0016579; GO:0050790; GO:0048638; GO:1903076; GO:0003073; GO:0072520; GO:0007548; GO:0007165; GO:0007338; GO:0007283; GO:0060748; GO:0006351; GO:0006367"]
[152,74,"PN203","AR","S310","Androgen receptor",0,110,12,659,{"v":64.582,"d":"65"},{"v":113.48006109579998,"d":"113"},{"$nulls":3},0,142,12,448,{"v":58.24,"d":"58"},{"v":101.757807424,"d":"102"},{"$nulls":6},0,196,14,546,{"v":99.372,"d":"99"},{"v":170.0097316008,"d":"170"},{"$nulls":10},"Receptor (steroid),  Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S310 phosphosite.","S310 phosphorylation regulates transcription. This is a minor in vivo phosphorylation sites in the androgen receptor (≥4 reports from high throughput mass spectrometry studies).","CDK1; CDK5",null,"P10275","P10275",null,"P10275"]
[153,75,"PN740","ARID1A","S363","AT-rich interactive domain-containing protein 1A",0,16854,14,669,{"v":11265.96,"d":"11266"},{"v":19795.946689523997,"d":"19796"},{"$f":"(L166+L167)/2","v":{"v":20131.2349181006,"d":"20131"}},{"$f":"SQRT((M166-L166)*(M166-L166))","v":{"v":335.2882285766027,"d":"335"}},{"$f":"N166/M166*100","v":{"v":1.665512473232007,"d":"2"}},0,17982,18,685,{"v":12305.34,"d":"12305"},{"v":21500.075858634,"d":"21500"},{"$f":"(U166+U167)/2","v":{"v":11444.8127721867,"d":"11445"}},{"$f":"SQRT((V166-U166)*(V166-U166))","v":{"v":10055.263086447301,"d":"10055"}},{"$f":"W166/V166*100","v":{"v":87.85869447234387,"d":"88"}},{"$f":"X166+O166","v":{"v":89.52420694557588,"d":"90"}},{"$f":"(V166/M166*100)-100","v":{"v":-43.148978099220706,"d":"-43"}},null,0,17822,18,771,{"v":13726.884,"d":"13727"},{"v":23484.5214401976,"d":"23485"},{"$f":"(AG166+AG167)/2","v":{"v":22823.377046216003,"d":"22823"}},{"$f":"SQRT((AH166-AG166)*(AH166-AG166))","v":{"v":661.1443939815981,"d":"661"}},{"$f":"AI166/AH166*100","v":{"v":2.8967860130550327,"d":"3"}},{"$f":"AJ166+O166","v":{"v":4.562298486287039,"d":"5"}},{"$f":"(AH166/M166*100)-100","v":{"v":13.372960670658202,"d":"13"}},{"$nulls":5},"Nuclear receptor co-regulator; DNA binding protein",{"$nulls":4},"X",{"$nulls":4},"HAPM(pS)PGS(bA)C","Corresponds to amino acid residues H359-S366.","The effect of S363 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in ARID1A (≥82 reports from high throughput mass spectrometry studies). This human phosphosite is not conserved in mammals, but is found in the mouse.",null,"Nuclear receptor co-regulator; DNA binding protein","O14497","O14497",null,"O14497","GO:0071565; GO:0071564; GO:0000790; GO:0005654; GO:0005634; GO:0016514","GO:0003677; GO:0016922; GO:0031491; GO:0000981; GO:0003713","GO:0030521; GO:0043044; GO:0003205; GO:0055007; GO:0071277; GO:0048096; GO:0006338; GO:0007566; GO:0030900; GO:0001704; GO:0042921; GO:0030520; GO:0006344; GO:0000122; GO:0001843; GO:0006337; GO:0042766; GO:0003408; GO:0060674; GO:0045893; GO:0006357; GO:0019827; GO:1901998; GO:0006351"]
[154,75,"PN740","ARID1A","S363","AT-rich interactive domain-containing protein 1A",0,16512,14,706,{"v":11647.588,"d":"11648"},{"v":20466.5231466772,"d":"20467"},{"$nulls":3},0,794,12,1017,{"v":795.294,"d":"795"},{"v":1389.5496857394,"d":"1390"},{"$nulls":6},0,16150,18,803,{"v":12953.996,"d":"12954"},{"v":22162.2326522344,"d":"22162"},{"$nulls":10},"Nuclear receptor co-regulator; DNA binding protein",{"$nulls":4},"X",{"$nulls":4},"HAPM(pS)PGS(bA)C","Corresponds to amino acid residues H359-S366.","The effect of S363 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in ARID1A (≥82 reports from high throughput mass spectrometry studies). This human phosphosite is not conserved in mammals, but is found in the mouse.",null,null,"O14497","O14497",null,"O14497"]
[155,77,"NN121","Arrestin b","Pan-specific","Arrestin beta 1",0,441,8,333,{"v":144.189,"d":"144"},{"v":253.36125436409998,"d":"253"},{"$f":"(L168+L169)/2","v":{"v":221.58061695725,"d":"222"}},{"$f":"SQRT((M168-L168)*(M168-L168))","v":{"v":31.78063740684999,"d":"32"}},{"$f":"N168/M168*100","v":{"v":14.342697408853905,"d":"14"}},0,1282,10,291,{"v":370.152,"d":"370"},{"v":646.7351636952,"d":"647"},{"$f":"(U168+U169)/2","v":{"v":422.039807405,"d":"422"}},{"$f":"SQRT((V168-U168)*(V168-U168))","v":{"v":224.69535629019998,"d":"225"}},{"$f":"W168/V168*100","v":{"v":53.24032291451045,"d":"53"}},{"$f":"X168+O168","v":{"v":67.58302032336435,"d":"68"}},{"$f":"(V168/M168*100)-100","v":{"v":90.46783658266688,"d":"90"}},null,0,484,10,312,{"v":147.888,"d":"148"},{"v":253.01291296320002,"d":"253"},{"$f":"(AG168+AG169)/2","v":{"v":222.46412892480004,"d":"222"}},{"$f":"SQRT((AH168-AG168)*(AH168-AG168))","v":{"v":30.548784038399987,"d":"31"}},{"$f":"AI168/AH168*100","v":{"v":13.73200442967884,"d":"14"}},{"$f":"AJ168+O168","v":{"v":28.074701838532746,"d":"28"}},{"$f":"(AH168/M168*100)-100","v":{"v":0.3987316127567624,"d":"0"}},{"$nulls":15},"Epitope undefined.",{"$nulls":3},"Adapter/scaffold protein","P49407","P49407",null,null,"GO:0016323; GO:0000785; GO:0005905; GO:0005737; GO:0031410; GO:0030659; GO:0005829; GO:0043197; GO:0005768; GO:0000139; GO:0005765; GO:0016604; GO:0005654; GO:0005634; GO:0005886; GO:0014069; GO:0045211; GO:0031143","GO:0031691; GO:0031692; GO:0031701; GO:0035612; GO:1990763; GO:0035615; GO:0043027; GO:0004857; GO:0030331; GO:0031762; GO:0005096; GO:0005159; GO:0044325; GO:0031434; GO:0045309; GO:0008134; GO:0044212; GO:0031625; GO:0031896","GO:0000187; GO:0042699; GO:0002031; GO:0007186; GO:0016573; GO:0061024; GO:0070373; GO:0034260; GO:0032715; GO:0032717; GO:0043524; GO:0032088; GO:0045746; GO:0031397; GO:0007602; GO:0030168; GO:0008284; GO:0043280; GO:0070374; GO:0035066; GO:0090240; GO:0035774; GO:0033138; GO:0032092; GO:0001934; GO:0031398; GO:0002092; GO:0035025; GO:0034393; GO:0045944; GO:0043161; GO:0015031; GO:0016567; GO:0042493; GO:0043149; GO:0006366; GO:0006511"]
[156,77,"NN121","Arrestin b","Pan-specific","Arrestin beta 1",0,356,12,314,{"v":108.016,"d":"108"},{"v":189.7999795504,"d":"190"},{"$nulls":3},0,386,12,302,{"v":112.948,"d":"113"},{"v":197.3444511148,"d":"197"},{"$nulls":6},0,350,8,328,{"v":112.176,"d":"112"},{"v":191.91534488640002,"d":"192"},{"$nulls":20},"Epitope undefined.",{"$nulls":4},"P49407","P49407"]
[157,78,"PN133","Arrestin b","S412","Arrestin beta 1",0,531,14,523,{"v":270.391,"d":"270"},{"v":475.1167074379,"d":"475"},{"$f":"(L170+L171)/2","v":{"v":466.86602416895,"d":"467"}},{"$f":"SQRT((M170-L170)*(M170-L170))","v":{"v":8.250683268950013,"d":"8"}},{"$f":"N170/M170*100","v":{"v":1.7672485984896271,"d":"2"}},0,474,16,443,{"v":202.894,"d":"203"},{"v":354.4994604994,"d":"354"},{"$f":"(U170+U171)/2","v":{"v":469.8698207675,"d":"470"}},{"$f":"SQRT((V170-U170)*(V170-U170))","v":{"v":115.3703602681,"d":"115"}},{"$f":"W170/V170*100","v":{"v":24.55368597192526,"d":"25"}},{"$f":"X170+O170","v":{"v":26.320934570414884,"d":"26"}},{"$f":"(V170/M170*100)-100","v":{"v":0.64339584442817,"d":"1"}},null,0,626,18,694,{"v":421.952,"d":"422"},{"v":721.8929504128,"d":"722"},{"$f":"(AG170+AG171)/2","v":{"v":698.7623746848001,"d":"699"}},{"$f":"SQRT((AH170-AG170)*(AH170-AG170))","v":{"v":23.13057572799994,"d":"23"}},{"$f":"AI170/AH170*100","v":{"v":3.3102205507893516,"d":"3"}},{"$f":"AJ170+O170","v":{"v":5.077469149278979,"d":"5"}},{"$f":"(AH170/M170*100)-100","v":{"v":49.67085598671261,"d":"50"}},{"$nulls":15},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S412 phosphosite.","S412 phosphorylation induces interaction with MEKK1 and inhibits interaction with ADRB2. This is one of the major in vivo phosphorylation sites in beta-arrestin (≥41 reports from high throughput mass spectrometry studies).","ERK1; ERK2","Adapter/scaffold protein","P49407","P49407",null,null,"GO:0016323; GO:0000785; GO:0005905; GO:0005737; GO:0031410; GO:0030659; GO:0005829; GO:0043197; GO:0005768; GO:0000139; GO:0005765; GO:0016604; GO:0005654; GO:0005634; GO:0005886; GO:0014069; GO:0045211; GO:0031143","GO:0031691; GO:0031692; GO:0031701; GO:0035612; GO:1990763; GO:0035615; GO:0043027; GO:0004857; GO:0030331; GO:0031762; GO:0005096; GO:0005159; GO:0044325; GO:0031434; GO:0045309; GO:0008134; GO:0044212; GO:0031625; GO:0031896","GO:0000187; GO:0042699; GO:0002031; GO:0007186; GO:0016573; GO:0061024; GO:0070373; GO:0034260; GO:0032715; GO:0032717; GO:0043524; GO:0032088; GO:0045746; GO:0031397; GO:0007602; GO:0030168; GO:0008284; GO:0043280; GO:0070374; GO:0035066; GO:0090240; GO:0035774; GO:0033138; GO:0032092; GO:0001934; GO:0031398; GO:0002092; GO:0035025; GO:0034393; GO:0045944; GO:0043161; GO:0015031; GO:0016567; GO:0042493; GO:0043149; GO:0006366; GO:0006511"]
[158,78,"PN133","Arrestin b","S412","Arrestin beta 1",0,512,12,522,261,{"v":458.6153409,"d":"459"},{"$nulls":3},0,636,18,542,{"v":334.956,"d":"335"},{"v":585.2401810356,"d":"585"},{"$nulls":6},0,592,18,688,{"v":394.912,"d":"395"},{"v":675.6317989568,"d":"676"},{"$nulls":20},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S412 phosphosite.","S412 phosphorylation induces interaction with MEKK1 and inhibits interaction with ADRB2. This is one of the major in vivo phosphorylation sites in beta-arrestin (≥41 reports from high throughput mass spectrometry studies).","ERK1; ERK2",null,"P49407","P49407"]
[159,79,"NK007-3","ASK1 (MAP3K5)","Pan-specific","Apoptosis signal regulating protein-serine kinase 1",0,148,12,452,{"v":61.472,"d":"61"},{"v":108.0153342368,"d":"108"},{"$f":"(L172+L173)/2","v":{"v":98.5970268528,"d":"99"}},{"$f":"SQRT((M172-L172)*(M172-L172))","v":{"v":9.418307384000002,"d":"9"}},{"$f":"N172/M172*100","v":{"v":9.552323923581412,"d":"10"}},0,106,8,409,{"v":40.082,"d":"40"},{"v":70.0318756382,"d":"70"},{"$f":"(U172+U173)/2","v":{"v":58.1840100451,"d":"58"}},{"$f":"SQRT((V172-U172)*(V172-U172))","v":{"v":11.847865593100003,"d":"12"}},{"$f":"W172/V172*100","v":{"v":20.36275186931324,"d":"20"}},{"$f":"X172+O172","v":{"v":29.91507579289465,"d":"30"}},{"$f":"(V172/M172*100)-100","v":{"v":-40.98806840092089,"d":"-41"}},null,0,106,8,370,{"v":36.26,"d":"36"},{"v":62.035109164,"d":"62"},{"$f":"(AG172+AG173)/2","v":{"v":72.0366879884,"d":"72"}},{"$f":"SQRT((AH172-AG172)*(AH172-AG172))","v":{"v":10.001578824400006,"d":"10"}},{"$f":"AI172/AH172*100","v":{"v":13.884007029876985,"d":"14"}},{"$f":"AJ172+O172","v":{"v":23.436330953458395,"d":"23"}},{"$f":"(AH172/M172*100)-100","v":{"v":-26.93827563791872,"d":"-27"}},null,null,"ASK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 1076-1375 of human ASK 1.",null,null,"EC 2.7.11.25; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE11 family","Q99683","Q99683","Q99683","Q99683","GO:0005829; GO:0009897; GO:1990604; GO:0032991; GO:1902911","GO:0005524; GO:0042802; GO:0000287; GO:0004709; GO:0019904; GO:0042803; GO:0004672; GO:0019901; GO:0019903; GO:0004674","GO:0007257; GO:0000186; GO:0097190; GO:0034198; GO:0070301; GO:1902170; GO:0071356; GO:0072577; GO:0045087; GO:0070059; GO:0008631; GO:0007254; GO:0000165; GO:0038066; GO:0043065; GO:0010666; GO:0043280; GO:0046330; GO:0043507; GO:0045663; GO:1901216; GO:1900745; GO:0045893; GO:1904707; GO:0097300; GO:0006468; GO:0034976; GO:0002931; GO:0051403; GO:0016032; GO:0042060"]
[160,79,"NK007-3","ASK1 (MAP3K5)","Pan-specific","Apoptosis signal regulating protein-serine kinase 1",0,112,8,488,{"v":50.752,"d":"51"},{"v":89.1787194688,"d":"89"},{"$nulls":3},0,46,6,663,{"v":26.52,"d":"27"},{"v":46.336144452,"d":"46"},{"$nulls":6},0,116,8,444,{"v":47.952,"d":"48"},{"v":82.0382668128,"d":"82"},{"$nulls":7},"ASK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 1076-1375 of human ASK 1.",{"$nulls":3},"Q99683","Q99683","Q99683","Q99683"]
[161,80,"NK007-2","ASK1 (MAP3K5)","Pan-specific","Apoptosis signal regulating protein-serine kinase 1",0,1864,16,694,{"v":1282.512,"d":"1283"},{"v":2253.5619850128,"d":"2254"},{"$f":"(L174+L175)/2","v":{"v":2217.6283309078,"d":"2218"}},{"$f":"SQRT((M174-L174)*(M174-L174))","v":{"v":35.93365410500019,"d":"36"}},{"$f":"N174/M174*100","v":{"v":1.6203641342501482,"d":"2"}},0,1598,10,625,{"v":992.5,"d":"993"},{"v":1734.11098675,"d":"1734"},{"$f":"(U174+U175)/2","v":{"v":1763.446728279,"d":"1763"}},{"$f":"SQRT((V174-U174)*(V174-U174))","v":{"v":29.33574152899996,"d":"29"}},{"$f":"W174/V174*100","v":{"v":1.663545660811063,"d":"2"}},{"$f":"X174+O174","v":{"v":3.283909795061211,"d":"3"}},{"$f":"(V174/M174*100)-100","v":{"v":-20.480510475931652,"d":"-20"}},null,0,1934,10,633,{"v":1217.892,"d":"1218"},{"v":2083.6200543288,"d":"2084"},{"$f":"(AG174+AG175)/2","v":{"v":2058.2893365604,"d":"2058"}},{"$f":"SQRT((AH174-AG174)*(AH174-AG174))","v":{"v":25.330717768400064,"d":"25"}},{"$f":"AI174/AH174*100","v":{"v":1.2306684642660655,"d":"1"}},{"$f":"AJ174+O174","v":{"v":2.8510325985162135,"d":"3"}},{"$f":"(AH174/M174*100)-100","v":{"v":-7.1851081683364555,"d":"-7"}},null,null,"ASK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues within the last 50 amino acid residues at the C-terminus.",null,null,"EC 2.7.11.25; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE11 family","Q99683","Q99683","Q99683","Q99683","GO:0005829; GO:0009897; GO:1990604; GO:0032991; GO:1902911","GO:0005524; GO:0042802; GO:0000287; GO:0004709; GO:0019904; GO:0042803; GO:0004672; GO:0019901; GO:0019903; GO:0004674","GO:0007257; GO:0000186; GO:0097190; GO:0034198; GO:0070301; GO:1902170; GO:0071356; GO:0072577; GO:0045087; GO:0070059; GO:0008631; GO:0007254; GO:0000165; GO:0038066; GO:0043065; GO:0010666; GO:0043280; GO:0046330; GO:0043507; GO:0045663; GO:1901216; GO:1900745; GO:0045893; GO:1904707; GO:0097300; GO:0006468; GO:0034976; GO:0002931; GO:0051403; GO:0016032; GO:0042060"]
[162,80,"NK007-2","ASK1 (MAP3K5)","Pan-specific","Apoptosis signal regulating protein-serine kinase 1",0,1936,14,646,{"v":1241.612,"d":"1242"},{"v":2181.6946768028,"d":"2182"},{"$nulls":3},0,1770,10,583,{"v":1026.08,"d":"1026"},{"v":1792.7824698079999,"d":"1793"},{"$nulls":6},0,1968,20,610,{"v":1188.28,"d":"1188"},{"v":2032.958618792,"d":"2033"},{"$nulls":7},"ASK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues within the last 50 amino acid residues at the C-terminus.",{"$nulls":3},"Q99683","Q99683","Q99683","Q99683"]
[163,81,"PK175","ASK1 (MAP3K5)","S83","Apoptosis signal regulating protein-serine kinase 1",0,198,10,505,{"v":94.94,"d":"95"},{"v":166.82352668599998,"d":"167"},{"$f":"(L176+L177)/2","v":{"v":160.41696908859998,"d":"160"}},{"$f":"SQRT((M176-L176)*(M176-L176))","v":{"v":6.4065575973999955,"d":"6"}},{"$f":"N176/M176*100","v":{"v":3.993690713518958,"d":"4"}},0,168,10,454,{"v":71.732,"d":"72"},{"v":125.3312335532,"d":"125"},{"$f":"(U176+U177)/2","v":{"v":118.1484322771,"d":"118"}},{"$f":"SQRT((V176-U176)*(V176-U176))","v":{"v":7.182801276099994,"d":"7"}},{"$f":"W176/V176*100","v":{"v":6.079472353263035,"d":"6"}},{"$f":"X176+O176","v":{"v":10.073163066781992,"d":"10"}},{"$f":"(V176/M176*100)-100","v":{"v":-26.349168078443512,"d":"-26"}},null,0,180,10,445,{"v":75.65,"d":"76"},{"v":129.42515191,"d":"129"},{"$f":"(AG176+AG177)/2","v":{"v":134.3044715828,"d":"134"}},{"$f":"SQRT((AH176-AG176)*(AH176-AG176))","v":{"v":4.879319672799994,"d":"5"}},{"$f":"AI176/AH176*100","v":{"v":3.63302845787368,"d":"4"}},{"$f":"AJ176+O176","v":{"v":7.626719171392638,"d":"8"}},{"$f":"(AH176/M176*100)-100","v":{"v":-16.277889835568317,"d":"-16"}},null,null,"ASK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S83 phosphosite.","S83 phosphorylation inhibits phosphotransferase activity and reduces apoptosis. This is one of the less major in vivo phosphorylation sites in ASK1 (≥7 reports from high throughput mass spectrometry studies).","Akt1; Akt2; Akt3; Pim1","EC 2.7.11.25; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE11 family","Q99683","Q99683","Q99683","Q99683","GO:0005829; GO:0009897; GO:1990604; GO:0032991; GO:1902911","GO:0005524; GO:0042802; GO:0000287; GO:0004709; GO:0019904; GO:0042803; GO:0004672; GO:0019901; GO:0019903; GO:0004674","GO:0007257; GO:0000186; GO:0097190; GO:0034198; GO:0070301; GO:1902170; GO:0071356; GO:0072577; GO:0045087; GO:0070059; GO:0008631; GO:0007254; GO:0000165; GO:0038066; GO:0043065; GO:0010666; GO:0043280; GO:0046330; GO:0043507; GO:0045663; GO:1901216; GO:1900745; GO:0045893; GO:1904707; GO:0097300; GO:0006468; GO:0034976; GO:0002931; GO:0051403; GO:0016032; GO:0042060"]
[164,81,"PK175","ASK1 (MAP3K5)","S83","Apoptosis signal regulating protein-serine kinase 1",0,186,10,498,{"v":87.648,"d":"88"},{"v":154.0104114912,"d":"154"},{"$nulls":3},0,156,10,435,{"v":63.51,"d":"64"},{"v":110.96563100099999,"d":"111"},{"$nulls":6},0,192,10,447,{"v":81.354,"d":"81"},{"v":139.1837912556,"d":"139"},{"$nulls":7},"ASK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S83 phosphosite.","S83 phosphorylation inhibits phosphotransferase activity and reduces apoptosis. This is one of the less major in vivo phosphorylation sites in ASK1 (≥7 reports from high throughput mass spectrometry studies).","Akt1; Akt2; Akt3; Pim1",null,"Q99683","Q99683","Q99683","Q99683"]
[165,82,"PK525","ASK1 (MAP3K5)","T838","Apoptosis signal regulating protein-serine kinase 1",0,9222,14,776,{"v":7145.408,"d":"7145"},{"v":12555.5315164352,"d":"12556"},{"$f":"(L178+L179)/2","v":{"v":12136.2340945696,"d":"12136"}},{"$f":"SQRT((M178-L178)*(M178-L178))","v":{"v":419.2974218656,"d":"419"}},{"$f":"N178/M178*100","v":{"v":3.454922001325074,"d":"3"}},0,8877,16,696,{"v":6167.256,"d":"6167"},{"v":10775.522808765601,"d":"10776"},{"$f":"(U178+U179)/2","v":{"v":11197.0559237916,"d":"11197"}},{"$f":"SQRT((V178-U178)*(V178-U178))","v":{"v":421.533115025999,"d":"422"}},{"$f":"W178/V178*100","v":{"v":3.764678125169687,"d":"4"}},{"$f":"X178+O178","v":{"v":7.219600126494761,"d":"7"}},{"$f":"(V178/M178*100)-100","v":{"v":-7.738629326524261,"d":"-8"}},null,0,9356,12,702,{"v":6559.488,"d":"6559"},{"v":11222.243633203201,"d":"11222"},{"$f":"(AG178+AG179)/2","v":{"v":11469.487588965601,"d":"11469"}},{"$f":"SQRT((AH178-AG178)*(AH178-AG178))","v":{"v":247.24395576240022,"d":"247"}},{"$f":"AI178/AH178*100","v":{"v":2.155666971559088,"d":"2"}},{"$f":"AJ178+O178","v":{"v":5.6105889728841625,"d":"6"}},{"$f":"(AH178/M178*100)-100","v":{"v":-5.493850072505907,"d":"-5"}},null,null,"ASK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"TE(pT)FTG(bA)C","Corresponds to amino acid residues T836 to G841; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T838 phosphorylation stimulates phosphotransferase activity. Phosphorylation inhibits interactions with 14-3-3-beta and TXN. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the minor in vivo phosphorylation sites in ASK1 (≥2 reports from high throughput mass spectrometry studies).","ASK1; PDPK1","EC 2.7.11.25; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE11 family","Q99683","Q99683","Q99683","Q99683","GO:0005829; GO:0009897; GO:1990604; GO:0032991; GO:1902911","GO:0005524; GO:0042802; GO:0000287; GO:0004709; GO:0019904; GO:0042803; GO:0004672; GO:0019901; GO:0019903; GO:0004674","GO:0007257; GO:0000186; GO:0097190; GO:0034198; GO:0070301; GO:1902170; GO:0071356; GO:0072577; GO:0045087; GO:0070059; GO:0008631; GO:0007254; GO:0000165; GO:0038066; GO:0043065; GO:0010666; GO:0043280; GO:0046330; GO:0043507; GO:0045663; GO:1901216; GO:1900745; GO:0045893; GO:1904707; GO:0097300; GO:0006468; GO:0034976; GO:0002931; GO:0051403; GO:0016032; GO:0042060"]
[166,82,"PK525","ASK1 (MAP3K5)","T838","Apoptosis signal regulating protein-serine kinase 1",0,8850,18,755,{"v":6668.16,"d":"6668"},{"v":11716.936672704,"d":"11717"},{"$nulls":3},0,9086,14,733,{"v":6649.776,"d":"6650"},{"v":11618.5890388176,"d":"11619"},{"$nulls":6},0,8700,20,789,{"v":6848.52,"d":"6849"},{"v":11716.731544728002,"d":"11717"},{"$nulls":7},"ASK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"TE(pT)FTG(bA)C","Corresponds to amino acid residues T836 to G841; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T838 phosphorylation stimulates phosphotransferase activity. Phosphorylation inhibits interactions with 14-3-3-beta and TXN. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the minor in vivo phosphorylation sites in ASK1 (≥2 reports from high throughput mass spectrometry studies).","ASK1; PDPK1",null,"Q99683","Q99683","Q99683","Q99683"]
[167,83,"PK143","ASK1 (MAP3K5)","S966","Apoptosis signal regulating protein-serine kinase 1",0,804,12,283,{"v":224.136,"d":"224"},{"v":393.8398775784,"d":"394"},{"$f":"(L180+L181)/2","v":{"v":355.58678956539995,"d":"356"}},{"$f":"SQRT((M180-L180)*(M180-L180))","v":{"v":38.253088013000024,"d":"38"}},{"$f":"N180/M180*100","v":{"v":10.757735983317364,"d":"11"}},0,1440,14,299,{"v":426.374,"d":"426"},{"v":744.9670910474,"d":"745"},{"$f":"(U180+U181)/2","v":{"v":561.8938928694,"d":"562"}},{"$f":"SQRT((V180-U180)*(V180-U180))","v":{"v":183.07319817799998,"d":"183"}},{"$f":"W180/V180*100","v":{"v":32.581453634085214,"d":"33"}},{"$f":"X180+O180","v":{"v":43.33918961740258,"d":"43"}},{"$f":"(V180/M180*100)-100","v":{"v":58.01877610699478,"d":"58"}},null,0,798,10,250,197,{"v":337.0357558,"d":"337"},{"$f":"(AG180+AG181)/2","v":{"v":283.22979377,"d":"283"}},{"$f":"SQRT((AH180-AG180)*(AH180-AG180))","v":{"v":53.80596202999999,"d":"54"}},{"$f":"AI180/AH180*100","v":{"v":18.99728178797946,"d":"19"}},{"$f":"AJ180+O180","v":{"v":29.755017771296824,"d":"30"}},{"$f":"(AH180/M180*100)-100","v":{"v":-20.348617529868037,"d":"-20"}},null,null,"ASK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"SI(pS)LP","Corresponds to amino acid residues S964 to P968; Surrounds the S966 phosphosite.","S966 phosphorylation induces association of MAP3K5/ASK1 with the 14-3-3 family proteins such as YWHAB, YWHAE, YWHAQ, YWHAH, YWHAZ and SFN, and suppresses MAP3K5/ASK1 phosphotransferase activity. This is one of the major in vivo phosphorylation sites in ASK1 (≥4 reports from high throughput mass spectrometry studies).","ASK1","EC 2.7.11.25; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE11 family","Q99683","Q99683","Q99683","Q99683","GO:0005829; GO:0009897; GO:1990604; GO:0032991; GO:1902911","GO:0005524; GO:0042802; GO:0000287; GO:0004709; GO:0019904; GO:0042803; GO:0004672; GO:0019901; GO:0019903; GO:0004674","GO:0007257; GO:0000186; GO:0097190; GO:0034198; GO:0070301; GO:1902170; GO:0071356; GO:0072577; GO:0045087; GO:0070059; GO:0008631; GO:0007254; GO:0000165; GO:0038066; GO:0043065; GO:0010666; GO:0043280; GO:0046330; GO:0043507; GO:0045663; GO:1901216; GO:1900745; GO:0045893; GO:1904707; GO:0097300; GO:0006468; GO:0034976; GO:0002931; GO:0051403; GO:0016032; GO:0042060"]
[168,83,"PK143","ASK1 (MAP3K5)","S966","Apoptosis signal regulating protein-serine kinase 1",0,610,12,302,{"v":180.596,"d":"181"},{"v":317.3337015524,"d":"317"},{"$nulls":3},0,816,10,269,{"v":216.814,"d":"217"},{"v":378.8206946914,"d":"379"},{"$nulls":6},0,464,14,298,{"v":134.1,"d":"134"},{"v":229.42383174,"d":"229"},{"$nulls":7},"ASK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"SI(pS)LP","Corresponds to amino acid residues S964 to P968; Surrounds the S966 phosphosite.","S966 phosphorylation induces association of MAP3K5/ASK1 with the 14-3-3 family proteins such as YWHAB, YWHAE, YWHAQ, YWHAH, YWHAZ and SFN, and suppresses MAP3K5/ASK1 phosphotransferase activity. This is one of the major in vivo phosphorylation sites in ASK1 (≥4 reports from high throughput mass spectrometry studies).","ASK1",null,"Q99683","Q99683","Q99683","Q99683"]
[169,84,"PK524","ASK1 (MAP3K5)","S1033","Apoptosis signal regulating protein-serine kinase 1",0,7614,16,780,{"v":5926.44,"d":"5926"},{"v":10413.625674035999,"d":"10414"},{"$f":"(L182+L183)/2","v":{"v":10175.794083974099,"d":"10176"}},{"$f":"SQRT((M182-L182)*(M182-L182))","v":{"v":237.8315900619,"d":"238"}},{"$f":"N182/M182*100","v":{"v":2.3372288010078934,"d":"2"}},0,7741,20,680,{"v":5250.28,"d":"5250"},{"v":9173.368495228,"d":"9173"},{"$f":"(U182+U183)/2","v":{"v":9313.73189389405,"d":"9314"}},{"$f":"SQRT((V182-U182)*(V182-U182))","v":{"v":140.36339866604976,"d":"140"}},{"$f":"W182/V182*100","v":{"v":1.5070586126498875,"d":"2"}},{"$f":"X182+O182","v":{"v":3.844287413657781,"d":"4"}},{"$f":"(V182/M182*100)-100","v":{"v":-8.471694522963219,"d":"-8"}},null,0,8086,18,725,{"v":5849.3,"d":"5849"},{"v":10007.224601020002,"d":"10007"},{"$f":"(AG182+AG183)/2","v":{"v":9813.660005024001,"d":"9814"}},{"$f":"SQRT((AH182-AG182)*(AH182-AG182))","v":{"v":193.5645959960002,"d":"194"}},{"$f":"AI182/AH182*100","v":{"v":1.972399654124015,"d":"2"}},{"$f":"AJ182+O182","v":{"v":4.309628455131908,"d":"4"}},{"$f":"(AH182/M182*100)-100","v":{"v":-3.5587795503883513,"d":"-4"}},null,null,"ASK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"APP(pS)PEE(bA)C","Corresponds to amino acid residues A1030 to E1036; After the kinase catalytic domain. ","S1033 phosphorylation inhibits the enzymatic activity of ASK1. This is the major in vivo phosphorylation site in ASK1 (≥28 reports from high throughput mass spectrometry studies).","ASK1","EC 2.7.11.25; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE11 family","Q99683","Q99683","Q99683","Q99683","GO:0005829; GO:0009897; GO:1990604; GO:0032991; GO:1902911","GO:0005524; GO:0042802; GO:0000287; GO:0004709; GO:0019904; GO:0042803; GO:0004672; GO:0019901; GO:0019903; GO:0004674","GO:0007257; GO:0000186; GO:0097190; GO:0034198; GO:0070301; GO:1902170; GO:0071356; GO:0072577; GO:0045087; GO:0070059; GO:0008631; GO:0007254; GO:0000165; GO:0038066; GO:0043065; GO:0010666; GO:0043280; GO:0046330; GO:0043507; GO:0045663; GO:1901216; GO:1900745; GO:0045893; GO:1904707; GO:0097300; GO:0006468; GO:0034976; GO:0002931; GO:0051403; GO:0016032; GO:0042060"]
[170,84,"PK524","ASK1 (MAP3K5)","S1033","Apoptosis signal regulating protein-serine kinase 1",0,7692,18,737,{"v":5655.738,"d":"5656"},{"v":9937.9624939122,"d":"9938"},{"$nulls":3},0,7989,20,679,{"v":5410.951,"d":"5411"},{"v":9454.0952925601,"d":"9454"},{"$nulls":6},0,7244,35,780,{"v":5623.02,"d":"5623"},{"v":9620.095409028001,"d":"9620"},{"$nulls":7},"ASK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"APP(pS)PEE(bA)C","Corresponds to amino acid residues A1030 to E1036; After the kinase catalytic domain. ","S1033 phosphorylation inhibits the enzymatic activity of ASK1. This is the major in vivo phosphorylation site in ASK1 (≥28 reports from high throughput mass spectrometry studies).","ASK1",null,"Q99683","Q99683","Q99683","Q99683"]
[171,85,"PN741","ASS1","T174+S180","Argininosuccinate synthase",0,5208,18,688,{"v":3570.72,"d":"3571"},{"v":6274.279578768,"d":"6274"},{"$f":"(L184+L185)/2","v":{"v":6807.7599204893995,"d":"6808"}},{"$f":"SQRT((M184-L184)*(M184-L184))","v":{"v":533.4803417213998,"d":"533"}},{"$f":"N184/M184*100","v":{"v":7.836356568858684,"d":"8"}},0,6718,18,586,{"v":3926.2,"d":"3926"},{"v":6859.91592562,"d":"6860"},{"$f":"(U184+U185)/2","v":{"v":7427.254140741,"d":"7427"}},{"$f":"SQRT((V184-U184)*(V184-U184))","v":{"v":567.3382151209998,"d":"567"}},{"$f":"W184/V184*100","v":{"v":7.638599735115538,"d":"8"}},{"$f":"X184+O184","v":{"v":15.474956303974222,"d":"15"}},{"$f":"(V184/M184*100)-100","v":{"v":9.099824721889817,"d":"9"}},null,0,7030,16,634,{"v":4446.876,"d":"4447"},{"v":7607.899561466401,"d":"7608"},{"$f":"(AG184+AG185)/2","v":{"v":7740.651444478701,"d":"7741"}},{"$f":"SQRT((AH184-AG184)*(AH184-AG184))","v":{"v":132.7518830122999,"d":"133"}},{"$f":"AI184/AH184*100","v":{"v":1.714996263098631,"d":"2"}},{"$f":"AJ184+O184","v":{"v":9.551352831957315,"d":"10"}},{"$f":"(AH184/M184*100)-100","v":{"v":13.703355213534564,"d":"14"}},{"$nulls":14},"X","IPV(pT)PKNPW(pS)MDE(bA)C","Corresponds to amino acid residues I171 to E183.","The effects of T174 and S180 phosphorylation are unclear. These are two of the minor in vivo phosphorylation sites in arginosuccinate synthase (≥8 and >7 reports, respectively, by mass spectrometry). This human phosphosite is highly conserved in vertebrates and also found in yeast.",null,"Enzyme  - Synthetase","P00966","P00966",null,null,"GO:0070852; GO:0005737; GO:0005829; GO:0005783; GO:0070062; GO:0005764; GO:0005741; GO:0043209; GO:0005634; GO:0043204","GO:0016597; GO:0004055; GO:0005524; GO:0042802; GO:0003723; GO:0015643","GO:0006953; GO:0007568; GO:0006526; GO:0000053; GO:0006531; GO:0071418; GO:0071230; GO:0071242; GO:0071320; GO:0071549; GO:0071377; GO:0071346; GO:0071499; GO:0071222; GO:0071400; GO:0071356; GO:0007623; GO:0000052; GO:0060539; GO:0001822; GO:0001889; GO:0007494; GO:1903038; GO:0045429; GO:0032355; GO:0060416; GO:0010046; GO:0007584; GO:0010043; GO:0000050"]
[172,85,"PN741","ASS1","T174+S180","Argininosuccinate synthase",0,6142,16,682,{"v":4177.932,"d":"4178"},{"v":7341.240262210799,"d":"7341"},{"$nulls":3},0,6872,12,667,{"v":4575.62,"d":"4576"},{"v":7994.592355862,"d":"7995"},{"$nulls":6},0,6587,22,701,{"v":4602.065,"d":"4602"},{"v":7873.403327491,"d":"7873"},{"$nulls":19},"X","IPV(pT)PKNPW(pS)MDE(bA)C","Corresponds to amino acid residues I171 to E183.","The effects of T174 and S180 phosphorylation are unclear. These are two of the minor in vivo phosphorylation sites in arginosuccinate synthase (≥8 and >7 reports, respectively, by mass spectrometry). This human phosphosite is highly conserved in vertebrates and also found in yeast.",null,null,"P00966","P00966"]
[173,86,"PN742","ATASE (PPAT)","T356","Glutamine PRPP amidotransferase",0,10968,20,763,{"v":8353.324,"d":"8353"},{"v":14678.0173712956,"d":"14678"},{"$f":"(L186+L187)/2","v":{"v":15187.1190569264,"d":"15187"}},{"$f":"SQRT((M186-L186)*(M186-L186))","v":{"v":509.1016856307997,"d":"509"}},{"$f":"N186/M186*100","v":{"v":3.3521939462153183,"d":"3"}},0,13030,16,673,{"v":8758.422,"d":"8758"},{"v":15302.8471705722,"d":"15303"},{"$f":"(U186+U187)/2","v":{"v":15532.4941344558,"d":"15532"}},{"$f":"SQRT((V186-U186)*(V186-U186))","v":{"v":229.6469638835988,"d":"230"}},{"$f":"W186/V186*100","v":{"v":1.478493807212661,"d":"1"}},{"$f":"X186+O186","v":{"v":4.830687753427979,"d":"5"}},{"$f":"(V186/M186*100)-100","v":{"v":2.274131625852263,"d":"2"}},null,0,12334,16,827,{"v":10186.986,"d":"10187"},{"v":17428.317390020402,"d":"17428"},{"$f":"(AG186+AG187)/2","v":{"v":16773.4192779902,"d":"16773"}},{"$f":"SQRT((AH186-AG186)*(AH186-AG186))","v":{"v":654.8981120302014,"d":"655"}},{"$f":"AI186/AH186*100","v":{"v":3.904380503321393,"d":"4"}},{"$f":"AJ186+O186","v":{"v":7.2565744495367115,"d":"7"}},{"$f":"(AH186/M186*100)-100","v":{"v":10.445037107550263,"d":"10"}},{"$nulls":5},"De novo purine synthesis",{"$nulls":8},"X","VGR(pT)FIQ(bA)C","Corresponds to amino acid residues V353 to Q359.","The effect of T356 phosphorylation is unclear. Phosphorylation of this site in ATASE has been reported in only one mass spectrometry study. This human phosphosite is highly conserved in vertebrates and also found in yeast.",null,null,"Q06203","Q06203",null,null,"GO:0005829","GO:0051539; GO:0004044; GO:0046872","GO:0006189; GO:0031100; GO:0035690; GO:0032869; GO:0000082; GO:0006543; GO:0001822; GO:0007595; GO:0060135; GO:0009116; GO:0051289; GO:0009113; GO:0006164; GO:0009168"]
[174,86,"PN742","ATASE (PPAT)","T356","Glutamine PRPP amidotransferase",0,11572,16,773,{"v":8932.788,"d":"8933"},{"v":15696.2207425572,"d":"15696"},{"$nulls":3},0,12922,16,699,{"v":9021.294,"d":"9021"},{"v":15762.1410983394,"d":"15762"},{"$nulls":6},0,11102,18,850,{"v":9421.4,"d":"9421"},{"v":16118.52116596,"d":"16119"},{"$nulls":10},"De novo purine synthesis",{"$nulls":8},"X","VGR(pT)FIQ(bA)C","Corresponds to amino acid residues V353 to Q359.","The effect of T356 phosphorylation is unclear. Phosphorylation of this site in ATASE has been reported in only one mass spectrometry study. This human phosphosite is highly conserved in vertebrates and also found in yeast.",null,null,"Q06203","Q06203"]
[175,87,"NN160-2","ATF2 (CRE-BP1)","Pan-specific","Cyclic AMP-dependent transcription factor ATF-2",0,140,13,494,{"v":62.738,"d":"63"},{"v":110.2398822122,"d":"110"},{"$f":"(L188+L189)/2","v":{"v":112.1428723049,"d":"112"}},{"$f":"SQRT((M188-L188)*(M188-L188))","v":{"v":1.9029900926999943,"d":"2"}},{"$f":"N188/M188*100","v":{"v":1.6969336111938027,"d":"2"}},0,122,12,489,{"v":53.79,"d":"54"},{"v":93.982700229,"d":"94"},{"$f":"(U188+U189)/2","v":{"v":98.0292504006,"d":"98"}},{"$f":"SQRT((V188-U188)*(V188-U188))","v":{"v":4.046550171600003,"d":"4"}},{"$f":"W188/V188*100","v":{"v":4.127900759277086,"d":"4"}},{"$f":"X188+O188","v":{"v":5.824834370470889,"d":"6"}},{"$f":"(V188/M188*100)-100","v":{"v":-12.585393627093055,"d":"-13"}},null,0,170,10,503,{"v":80.48,"d":"80"},{"v":137.688515872,"d":"138"},{"$f":"(AG188+AG189)/2","v":{"v":125.4080963028,"d":"125"}},{"$f":"SQRT((AH188-AG188)*(AH188-AG188))","v":{"v":12.280419569200006,"d":"12"}},{"$f":"AI188/AH188*100","v":{"v":9.792365829036047,"d":"10"}},{"$f":"AJ188+O188","v":{"v":11.48929944022985,"d":"11"}},{"$f":"(AH188/M188*100)-100","v":{"v":11.828860564435885,"d":"12"}},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against amino acid residues 350-505 mapping within the DNA binding and dimerization domain of human ATF2.",null,null,"Transcription protein","P15336","P15336",null,"P15336","GO:0005737; GO:0005741; GO:0005654; GO:0005634; GO:0035861","GO:0035497; GO:0008140; GO:0003682; GO:0003700; GO:0001158; GO:0004402; GO:0046872; GO:0046982; GO:0019901; GO:0001102; GO:0000980; GO:0000977; GO:0000981; GO:0001077; GO:0001228; GO:0003713; GO:0003705","GO:0060612; GO:0097186; GO:0006974; GO:0045444; GO:0031573; GO:0016525; GO:0050680; GO:0000122; GO:0003151; GO:0110024; GO:0051091; GO:0010628; GO:1902110; GO:0043525; GO:0045944; GO:0032915; GO:0051090; GO:0006355; GO:0006357; GO:0006970; GO:0009414"]
[176,87,"NN160-2","ATF2 (CRE-BP1)","Pan-specific","Cyclic AMP-dependent transcription factor ATF-2",0,134,12,532,{"v":64.904,"d":"65"},{"v":114.04586239759999,"d":"114"},{"$nulls":3},0,119,12,546,{"v":58.422,"d":"58"},{"v":102.0758005722,"d":"102"},{"$nulls":6},0,134,12,542,{"v":66.124,"d":"66"},{"v":113.1276767336,"d":"113"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against amino acid residues 350-505 mapping within the DNA binding and dimerization domain of human ATF2.",{"$nulls":3},"P15336","P15336",null,"P15336"]
[177,88,"PN572","ATF2 (CRE-BP1)","T69+T71","Cyclic AMP-dependent transcription factor ATF-2",0,9126,14,755,{"v":6879.56,"d":"6880"},{"v":12088.397527364,"d":"12088"},{"$f":"(L190+L191)/2","v":{"v":11696.5994544834,"d":"11697"}},{"$f":"SQRT((M190-L190)*(M190-L190))","v":{"v":391.79807288060147,"d":"392"}},{"$f":"N190/M190*100","v":{"v":3.349675043633491,"d":"3"}},0,10044,16,750,7521,{"v":13140.8047671,"d":"13141"},{"$f":"(U190+U191)/2","v":{"v":12653.7982606317,"d":"12654"}},{"$f":"SQRT((V190-U190)*(V190-U190))","v":{"v":487.00650646830036,"d":"487"}},{"$f":"W190/V190*100","v":{"v":3.8486982045815243,"d":"4"}},{"$f":"X190+O190","v":{"v":7.198373248215015,"d":"7"}},{"$f":"(V190/M190*100)-100","v":{"v":8.183564888865178,"d":"8"}},null,0,10171,20,816,{"v":8283.216,"d":"8283"},{"v":14171.268857942401,"d":"14171"},{"$f":"(AG190+AG191)/2","v":{"v":12932.4828170304,"d":"12932"}},{"$f":"SQRT((AH190-AG190)*(AH190-AG190))","v":{"v":1238.7860409120003,"d":"1239"}},{"$f":"AI190/AH190*100","v":{"v":9.578872506064187,"d":"10"}},{"$f":"AJ190+O190","v":{"v":12.928547549697678,"d":"13"}},{"$f":"(AH190/M190*100)-100","v":{"v":10.566176668324559,"d":"11"}},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"CADQ(pT)P(pT)PTR","Corresponds to amino acid residues C66 to R74.","T69 and T71 phosphorylation increases transcriptional activity. These are the major in vivo phosphorylation sites in ATF2 (≥103 and 86 reports by mass spectrometry, respectively).","T69: ERK1; ERK2; JNK1; JNK2; JNK3; p38a. T71: ERK1; ERK2; JNK1; JNK2; JNK3; p38a.","Transcription protein","P15336","P15336",null,"P15336","GO:0005737; GO:0005741; GO:0005654; GO:0005634; GO:0035861","GO:0035497; GO:0008140; GO:0003682; GO:0003700; GO:0001158; GO:0004402; GO:0046872; GO:0046982; GO:0019901; GO:0001102; GO:0000980; GO:0000977; GO:0000981; GO:0001077; GO:0001228; GO:0003713; GO:0003705","GO:0060612; GO:0097186; GO:0006974; GO:0045444; GO:0031573; GO:0016525; GO:0050680; GO:0000122; GO:0003151; GO:0110024; GO:0051091; GO:0010628; GO:1902110; GO:0043525; GO:0045944; GO:0032915; GO:0051090; GO:0006355; GO:0006357; GO:0006970; GO:0009414"]
[178,88,"PN572","ATF2 (CRE-BP1)","T69+T71","Cyclic AMP-dependent transcription factor ATF-2",0,8962,14,719,{"v":6433.612,"d":"6434"},{"v":11304.8013816028,"d":"11305"},{"$nulls":3},0,9812,18,711,{"v":6963.534,"d":"6964"},{"v":12166.7917541634,"d":"12167"},{"$nulls":6},0,8708,12,786,{"v":6835.056,"d":"6835"},{"v":11693.6967761184,"d":"11694"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"CADQ(pT)P(pT)PTR","Corresponds to amino acid residues C66 to R74.","T69 and T71 phosphorylation increases transcriptional activity. These are the major in vivo phosphorylation sites in ATF2 (≥103 and 86 reports by mass spectrometry, respectively).","T69: ERK1; ERK2; JNK1; JNK2; JNK3; p38a. T71: ERK1; ERK2; JNK1; JNK2; JNK3; p38a.",null,"P15336","P15336",null,"P15336"]
[179,89,"PN204","ATF2 (CRE-BP1)","T71","Cyclic AMP-dependent transcription factor ATF-2",0,304,14,548,{"v":158.92,"d":"159"},{"v":279.24578534799997,"d":"279"},{"$f":"(L192+L193)/2","v":{"v":263.50174912399996,"d":"264"}},{"$f":"SQRT((M192-L192)*(M192-L192))","v":{"v":15.744036224000013,"d":"16"}},{"$f":"N192/M192*100","v":{"v":5.9749266471059,"d":"6"}},0,292,12,507,{"v":141.96,"d":"142"},{"v":248.03465559600002,"d":"248"},{"$f":"(U192+U193)/2","v":{"v":246.58446706300003,"d":"247"}},{"$f":"SQRT((V192-U192)*(V192-U192))","v":{"v":1.450188532999988,"d":"1"}},{"$f":"W192/V192*100","v":{"v":0.5881102529582605,"d":"1"}},{"$f":"X192+O192","v":{"v":6.56303690006416,"d":"7"}},{"$f":"(V192/M192*100)-100","v":{"v":-6.4201782786037285,"d":"-6"}},null,0,332,14,548,{"v":174.264,"d":"174"},{"v":298.13806572960004,"d":"298"},{"$f":"(AG192+AG193)/2","v":{"v":292.42043377080006,"d":"292"}},{"$f":"SQRT((AH192-AG192)*(AH192-AG192))","v":{"v":5.717631958799984,"d":"6"}},{"$f":"AI192/AH192*100","v":{"v":1.955277846035028,"d":"2"}},{"$f":"AJ192+O192","v":{"v":7.930204493140929,"d":"8"}},{"$f":"(AH192/M192*100)-100","v":{"v":10.974760032120855,"d":"11"}},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against amino acid residues that encompass the T71 phosphosite.","T71 phosphorylation increases transcriptional activity. This is one of the major in vivo phosphorylation sites in ATF2 (≥86 reports from high throughput mass spectrometry studies).","T71: ERK1; ERK2; JNK1; JNK2; JNK3; p38a.","Transcription protein","P15336","P15336",null,"P15336","GO:0005737; GO:0005741; GO:0005654; GO:0005634; GO:0035861","GO:0035497; GO:0008140; GO:0003682; GO:0003700; GO:0001158; GO:0004402; GO:0046872; GO:0046982; GO:0019901; GO:0001102; GO:0000980; GO:0000977; GO:0000981; GO:0001077; GO:0001228; GO:0003713; GO:0003705","GO:0060612; GO:0097186; GO:0006974; GO:0045444; GO:0031573; GO:0016525; GO:0050680; GO:0000122; GO:0003151; GO:0110024; GO:0051091; GO:0010628; GO:1902110; GO:0043525; GO:0045944; GO:0032915; GO:0051090; GO:0006355; GO:0006357; GO:0006970; GO:0009414"]
[180,89,"PN204","ATF2 (CRE-BP1)","T71","Cyclic AMP-dependent transcription factor ATF-2",0,260,10,564,141,{"v":247.7577129,"d":"248"},{"$nulls":3},0,242,12,610,{"v":140.3,"d":"140"},{"v":245.13427853000002,"d":"245"},{"$nulls":6},0,304,10,570,{"v":167.58,"d":"168"},{"v":286.702801812,"d":"287"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against amino acid residues that encompass the T71 phosphosite.","T71 phosphorylation increases transcriptional activity. This is one of the major in vivo phosphorylation sites in ATF2 (≥86 reports from high throughput mass spectrometry studies).","T71: ERK1; ERK2; JNK1; JNK2; JNK3; p38a.",null,"P15336","P15336",null,"P15336"]
[181,90,"PN115","ATF2 (CRE-BP1)","S112","Cyclic AMP-dependent transcription factor ATF-2",0,198,12,258,{"v":47.988,"d":"48"},{"v":84.32196543719999,"d":"84"},{"$f":"(L194+L195)/2","v":{"v":67.0070398846,"d":"67"}},{"$f":"SQRT((M194-L194)*(M194-L194))","v":{"v":17.314925552599988,"d":"17"}},{"$f":"N194/M194*100","v":{"v":25.84045733466196,"d":"26"}},0,410,10,205,82,{"v":143.2716382,"d":"143"},{"$f":"(U194+U195)/2","v":{"v":105.6156583648,"d":"106"}},{"$f":"SQRT((V194-U194)*(V194-U194))","v":{"v":37.655979835200014,"d":"38"}},{"$f":"W194/V194*100","v":{"v":35.6537850714664,"d":"36"}},{"$f":"X194+O194","v":{"v":61.494242406128365,"d":"61"}},{"$f":"(V194/M194*100)-100","v":{"v":57.618749532425284,"d":"58"}},null,0,150,10,228,{"v":31.92,"d":"32"},{"v":54.610057488,"d":"55"},{"$f":"(AG194+AG195)/2","v":{"v":45.6315618208,"d":"46"}},{"$f":"SQRT((AH194-AG194)*(AH194-AG194))","v":{"v":8.9784956672,"d":"9"}},{"$f":"AI194/AH194*100","v":{"v":19.67606478704259,"d":"20"}},{"$f":"AJ194+O194","v":{"v":45.516522121704554,"d":"46"}},{"$f":"(AH194/M194*100)-100","v":{"v":-31.900346740600696,"d":"-32"}},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"DL(pS)PL","Corresponds to amino acid residues D92 to L96 in mouse ATF2; Surrounds the S94 phosphosites. Corresponds to S112 phosphosite in humans.","The effect of S112 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in ATF2 (≥83 reports from high throughput mass spectrometry studies).",null,"Transcription protein","P15336","P15336",null,"P15336","GO:0005737; GO:0005741; GO:0005654; GO:0005634; GO:0035861","GO:0035497; GO:0008140; GO:0003682; GO:0003700; GO:0001158; GO:0004402; GO:0046872; GO:0046982; GO:0019901; GO:0001102; GO:0000980; GO:0000977; GO:0000981; GO:0001077; GO:0001228; GO:0003713; GO:0003705","GO:0060612; GO:0097186; GO:0006974; GO:0045444; GO:0031573; GO:0016525; GO:0050680; GO:0000122; GO:0003151; GO:0110024; GO:0051091; GO:0010628; GO:1902110; GO:0043525; GO:0045944; GO:0032915; GO:0051090; GO:0006355; GO:0006357; GO:0006970; GO:0009414"]
[182,90,"PN115","ATF2 (CRE-BP1)","S112","Cyclic AMP-dependent transcription factor ATF-2",0,80,10,404,{"v":28.28,"d":"28"},{"v":49.692114332,"d":"50"},{"$nulls":3},0,186,10,221,{"v":38.896,"d":"39"},{"v":67.9596785296,"d":"68"},{"$nulls":6},0,58,6,412,{"v":21.424,"d":"21"},{"v":36.6530661536,"d":"37"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"DL(pS)PL","Corresponds to amino acid residues D92 to L96 in mouse ATF2; Surrounds the S94 phosphosites. Corresponds to S112 phosphosite in humans.","The effect of S112 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in ATF2 (≥83 reports from high throughput mass spectrometry studies).",null,null,"P15336","P15336",null,"P15336"]
[183,91,"NK230-2","ATM","Pan-specific","Ataxia telangiectasia mutated protein-serine kinase",0,9002,16,776,{"v":6973.136,"d":"6973"},{"v":12252.824305678401,"d":"12253"},{"$f":"(L196+L197)/2","v":{"v":12492.2461136848,"d":"12492"}},{"$f":"SQRT((M196-L196)*(M196-L196))","v":{"v":239.42180800639835,"d":"239"}},{"$f":"N196/M196*100","v":{"v":1.9165633291848172,"d":"2"}},0,8842,16,752,{"v":6637.152,"d":"6637"},{"v":11596.5321953952,"d":"11597"},{"$f":"(U196+U197)/2","v":{"v":12256.0255237506,"d":"12256"}},{"$f":"SQRT((V196-U196)*(V196-U196))","v":{"v":659.4933283554001,"d":"659"}},{"$f":"W196/V196*100","v":{"v":5.3809722171138334,"d":"5"}},{"$f":"X196+O196","v":{"v":7.297535546298651,"d":"7"}},{"$f":"(V196/M196*100)-100","v":{"v":-1.8909376887429943,"d":"-2"}},null,0,8878,18,797,{"v":7061.42,"d":"7061"},{"v":12080.969678788,"d":"12081"},{"$f":"(AG196+AG197)/2","v":{"v":11602.9486157382,"d":"11603"}},{"$f":"SQRT((AH196-AG196)*(AH196-AG196))","v":{"v":478.02106304980043,"d":"478"}},{"$f":"AI196/AH196*100","v":{"v":4.119824010953684,"d":"4"}},{"$f":"AJ196+O196","v":{"v":6.036387340138501,"d":"6"}},{"$f":"(AH196/M196*100)-100","v":{"v":-7.118795850270729,"d":"-7"}},null,null,"ATM","X","PSTK","Protein kinase - Atypical protein-serine kinase","Protein-serine/threonine kinase","Atypical","PIKK","ATM",{"$nulls":5},"CDEFLTKPEVARRSRI","Corresponds to amino acid residues D2579 to I2593.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); ATYPICAL domain target; ATYPICAL</A> group; PIKK family","Q13315","Q13315","Q13315","Q13315","GO:0031410; GO:1990391; GO:0005730; GO:0005654; GO:0005634","GO:0016303; GO:0005524; GO:0003677; GO:0004677; GO:0044877; GO:0046983; GO:0047485; GO:0004674","GO:0006915; GO:0007050; GO:0006974; GO:0071480; GO:0071500; GO:0071300; GO:0071481; GO:0006975; GO:0006977; GO:0000729; GO:0006281; GO:0006260; GO:0006303; GO:0097695; GO:0097694; GO:0071044; GO:0016572; GO:0007094; GO:0030889; GO:1904354; GO:1904262; GO:0036289; GO:0018105; GO:0043065; GO:0045785; GO:0030335; GO:1903626; GO:0043517; GO:0010628; GO:0033129; GO:0043525; GO:1904884; GO:0032212; GO:1904358; GO:0045944; GO:0002331; GO:0046777; GO:0006468; GO:0007131; GO:0042981; GO:0010506; GO:1905843; GO:1900034; GO:1903978; GO:1901796; GO:0032210; GO:0090399; GO:0001666; GO:0010212; GO:0007165; GO:0072434; GO:0000723"]
[184,91,"NK230-2","ATM","Pan-specific","Ataxia telangiectasia mutated protein-serine kinase",0,9030,18,804,{"v":7245.648,"d":"7246"},{"v":12731.6679216912,"d":"12732"},{"$nulls":3},0,9146,20,810,{"v":7392.06,"d":"7392"},{"v":12915.518852106,"d":"12916"},{"$nulls":6},0,8340,14,781,{"v":6502.606,"d":"6503"},{"v":11124.9275526884,"d":"11125"},{"$nulls":7},"ATM","X","PSTK","Protein kinase - Atypical protein-serine kinase","Protein-serine/threonine kinase","Atypical","PIKK","ATM",{"$nulls":5},"CDEFLTKPEVARRSRI","Corresponds to amino acid residues D2579 to I2593.",{"$nulls":3},"Q13315","Q13315","Q13315","Q13315"]
[185,92,"NK230-1","ATM","Pan-specific","Ataxia telangiectasia mutated protein-serine kinase",0,8856,16,752,{"v":6647.68,"d":"6648"},{"v":11680.950304192,"d":"11681"},{"$f":"(L198+L199)/2","v":{"v":11917.0844903485,"d":"11917"}},{"$f":"SQRT((M198-L198)*(M198-L198))","v":{"v":236.1341861564997,"d":"236"}},{"$f":"N198/M198*100","v":{"v":1.9814761433280252,"d":"2"}},0,9566,16,719,{"v":6866.45,"d":"6866"},{"v":11997.165123395,"d":"11997"},{"$f":"(U198+U199)/2","v":{"v":11721.9560313487,"d":"11722"}},{"$f":"SQRT((V198-U198)*(V198-U198))","v":{"v":275.2090920462997,"d":"275"}},{"$f":"W198/V198*100","v":{"v":2.347808602167524,"d":"2"}},{"$f":"X198+O198","v":{"v":4.329284745495549,"d":"4"}},{"$f":"(V198/M198*100)-100","v":{"v":-1.6373842038111945,"d":"-2"}},null,0,9186,12,708,{"v":6495.192,"d":"6495"},{"v":11112.2433745488,"d":"11112"},{"$f":"(AG198+AG199)/2","v":{"v":9443.7529979851,"d":"9444"}},{"$f":"SQRT((AH198-AG198)*(AH198-AG198))","v":{"v":1668.490376563699,"d":"1668"}},{"$f":"AI198/AH198*100","v":{"v":17.667662177522907,"d":"18"}},{"$f":"AJ198+O198","v":{"v":19.64913832085093,"d":"20"}},{"$f":"(AH198/M198*100)-100","v":{"v":-20.75450160957169,"d":"-21"}},null,null,"ATM","X","PSTK","Protein kinase - Atypical protein-serine kinase","Protein-serine/threonine kinase","Atypical","PIKK","ATM",{"$nulls":5},"CGKERRQLVKGRDDLR","Corresponds to amino acid residues G2719 to R2733.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); ATYPICAL domain target; ATYPICAL</A> group; PIKK family","Q13315","Q13315","Q13315","Q13315","GO:0031410; GO:1990391; GO:0005730; GO:0005654; GO:0005634","GO:0016303; GO:0005524; GO:0003677; GO:0004677; GO:0044877; GO:0046983; GO:0047485; GO:0004674","GO:0006915; GO:0007050; GO:0006974; GO:0071480; GO:0071500; GO:0071300; GO:0071481; GO:0006975; GO:0006977; GO:0000729; GO:0006281; GO:0006260; GO:0006303; GO:0097695; GO:0097694; GO:0071044; GO:0016572; GO:0007094; GO:0030889; GO:1904354; GO:1904262; GO:0036289; GO:0018105; GO:0043065; GO:0045785; GO:0030335; GO:1903626; GO:0043517; GO:0010628; GO:0033129; GO:0043525; GO:1904884; GO:0032212; GO:1904358; GO:0045944; GO:0002331; GO:0046777; GO:0006468; GO:0007131; GO:0042981; GO:0010506; GO:1905843; GO:1900034; GO:1903978; GO:1901796; GO:0032210; GO:0090399; GO:0001666; GO:0010212; GO:0007165; GO:0072434; GO:0000723"]
[186,92,"NK230-1","ATM","Pan-specific","Ataxia telangiectasia mutated protein-serine kinase",0,8767,12,790,{"v":6916.45,"d":"6916"},{"v":12153.218676505,"d":"12153"},{"$nulls":3},0,9320,14,704,{"v":6551.424,"d":"6551"},{"v":11446.7469393024,"d":"11447"},{"$nulls":6},0,6729,16,677,{"v":4544.701,"d":"4545"},{"v":7775.262621421401,"d":"7775"},{"$nulls":7},"ATM","X","PSTK","Protein kinase - Atypical protein-serine kinase","Protein-serine/threonine kinase","Atypical","PIKK","ATM",{"$nulls":5},"CGKERRQLVKGRDDLR","Corresponds to amino acid residues G2719 to R2733.",{"$nulls":3},"Q13315","Q13315","Q13315","Q13315"]
[187,93,"PK526","ATM","S1981","Ataxia telangiectasia mutated protein-serine kinase",0,4309,14,752,{"v":3229.84,"d":"3230"},{"v":5675.303343496,"d":"5675"},{"$f":"(L200+L201)/2","v":{"v":5627.276125851749,"d":"5627"}},{"$f":"SQRT((M200-L200)*(M200-L200))","v":{"v":48.02721764425041,"d":"48"}},{"$f":"N200/M200*100","v":{"v":0.8534718497927088,"d":"1"}},0,5038,12,734,{"v":3689.084,"d":"3689"},{"v":6445.6232699684,"d":"6446"},{"$f":"(U200+U201)/2","v":{"v":5907.4880080288,"d":"5907"}},{"$f":"SQRT((V200-U200)*(V200-U200))","v":{"v":538.1352619395993,"d":"538"}},{"$f":"W200/V200*100","v":{"v":9.109375443644165,"d":"9"}},{"$f":"X200+O200","v":{"v":9.962847293436873,"d":"10"}},{"$f":"(V200/M200*100)-100","v":{"v":4.979529632280816,"d":"5"}},null,0,4662,14,777,{"v":3611.496,"d":"3611"},{"v":6178.6968727344,"d":"6179"},{"$f":"(AG200+AG201)/2","v":{"v":5975.425818055501,"d":"5975"}},{"$f":"SQRT((AH200-AG200)*(AH200-AG200))","v":{"v":203.27105467889942,"d":"203"}},{"$f":"AI200/AH200*100","v":{"v":3.401783586111811,"d":"3"}},{"$f":"AJ200+O200","v":{"v":4.25525543590452,"d":"4"}},{"$f":"(AH200/M200*100)-100","v":{"v":6.186824396342459,"d":"6"}},null,null,"ATM","X","PSTK","Protein kinase - Atypical protein-serine kinase","Protein-serine/threonine kinase","Atypical","PIKK","ATM",{"$nulls":5},"EEG(pS)QST(bA)C","Corresponds to amino acid residues E1978 to T1984; In the C-terminal half of the protein kinase before the FAT domain.","S1981 phosphorylation stimulates phosphotransferase activity, although other reports indicate inhibition. Phosphorylation induces interaction with ATM, MDC1, NBS1, PKM and p53, and inhibits interaction with CDCA2. This is one of the major in vivo phosphorylation sites in ATM (≥26 reports from high throughput mass spectrometry studies).","ATR; ATM","EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); ATYPICAL domain target; ATYPICAL</A> group; PIKK family","Q13315","Q13315","Q13315","Q13315","GO:0031410; GO:1990391; GO:0005730; GO:0005654; GO:0005634","GO:0016303; GO:0005524; GO:0003677; GO:0004677; GO:0044877; GO:0046983; GO:0047485; GO:0004674","GO:0006915; GO:0007050; GO:0006974; GO:0071480; GO:0071500; GO:0071300; GO:0071481; GO:0006975; GO:0006977; GO:0000729; GO:0006281; GO:0006260; GO:0006303; GO:0097695; GO:0097694; GO:0071044; GO:0016572; GO:0007094; GO:0030889; GO:1904354; GO:1904262; GO:0036289; GO:0018105; GO:0043065; GO:0045785; GO:0030335; GO:1903626; GO:0043517; GO:0010628; GO:0033129; GO:0043525; GO:1904884; GO:0032212; GO:1904358; GO:0045944; GO:0002331; GO:0046777; GO:0006468; GO:0007131; GO:0042981; GO:0010506; GO:1905843; GO:1900034; GO:1903978; GO:1901796; GO:0032210; GO:0090399; GO:0001666; GO:0010212; GO:0007165; GO:0072434; GO:0000723"]
[188,93,"PK526","ATM","S1981","Ataxia telangiectasia mutated protein-serine kinase",0,4113,16,775,{"v":3175.175,"d":"3175"},{"v":5579.2489082075,"d":"5579"},{"$nulls":3},0,4520,14,682,{"v":3073.092,"d":"3073"},{"v":5369.3527460892,"d":"5369"},{"$nulls":6},0,4301,14,787,{"v":3373.869,"d":"3374"},{"v":5772.1547633766,"d":"5772"},{"$nulls":7},"ATM","X","PSTK","Protein kinase - Atypical protein-serine kinase","Protein-serine/threonine kinase","Atypical","PIKK","ATM",{"$nulls":5},"EEG(pS)QST(bA)C","Corresponds to amino acid residues E1978 to T1984; In the C-terminal half of the protein kinase before the FAT domain.","S1981 phosphorylation stimulates phosphotransferase activity, although other reports indicate inhibition. Phosphorylation induces interaction with ATM, MDC1, NBS1, PKM and p53, and inhibits interaction with CDCA2. This is one of the major in vivo phosphorylation sites in ATM (≥26 reports from high throughput mass spectrometry studies).","ATR; ATM",null,"Q13315","Q13315","Q13315","Q13315"]
[189,94,"PK527","ATM","Y2969","Ataxia telangiectasia mutated protein-serine kinase",0,4542,18,927,{"v":4193.748,"d":"4194"},{"v":7369.031297581199,"d":"7369"},{"$f":"(L202+L203)/2","v":{"v":6517.036451590599,"d":"6517"}},{"$f":"SQRT((M202-L202)*(M202-L202))","v":{"v":851.9948459906,"d":"852"}},{"$f":"N202/M202*100","v":{"v":13.073347867843449,"d":"13"}},0,4764,18,929,{"v":4409.034,"d":"4409"},{"v":7703.5307812134,"d":"7704"},{"$f":"(U202+U203)/2","v":{"v":6588.5594428692,"d":"6589"}},{"$f":"SQRT((V202-U202)*(V202-U202))","v":{"v":1114.9713383441995,"d":"1115"}},{"$f":"W202/V202*100","v":{"v":16.92283947670736,"d":"17"}},{"$f":"X202+O202","v":{"v":29.99618734455081,"d":"30"}},{"$f":"(V202/M202*100)-100","v":{"v":1.0974772323261135,"d":"1"}},null,0,4482,18,808,{"v":3606.912,"d":"3607"},{"v":6170.8543757567995,"d":"6171"},{"$f":"(AG202+AG203)/2","v":{"v":5582.424162957999,"d":"5582"}},{"$f":"SQRT((AH202-AG202)*(AH202-AG202))","v":{"v":588.4302127988003,"d":"588"}},{"$f":"AI202/AH202*100","v":{"v":10.540765008565822,"d":"11"}},{"$f":"AJ202+O202","v":{"v":23.614112876409273,"d":"24"}},{"$f":"(AH202/M202*100)-100","v":{"v":-14.341062775619292,"d":"-14"}},null,null,"ATM","X","PSTK","Protein kinase - Atypical protein-serine kinase","Protein-serine/threonine kinase","Atypical","PIKK","ATM",{"$nulls":5},"KAL(pY)LQQ(bA)C","Corresponds to amino acid residues K2966 to Q2972; Near the C-terminus of the kinase. ","The effect of Y2969 phosphorylation is unclear. This is the major in vivo phosphorylation site in ATM (≥80 reports from high throughput mass spectrometry studies).",null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); ATYPICAL domain target; ATYPICAL</A> group; PIKK family","Q13315","Q13315","Q13315","Q13315","GO:0031410; GO:1990391; GO:0005730; GO:0005654; GO:0005634","GO:0016303; GO:0005524; GO:0003677; GO:0004677; GO:0044877; GO:0046983; GO:0047485; GO:0004674","GO:0006915; GO:0007050; GO:0006974; GO:0071480; GO:0071500; GO:0071300; GO:0071481; GO:0006975; GO:0006977; GO:0000729; GO:0006281; GO:0006260; GO:0006303; GO:0097695; GO:0097694; GO:0071044; GO:0016572; GO:0007094; GO:0030889; GO:1904354; GO:1904262; GO:0036289; GO:0018105; GO:0043065; GO:0045785; GO:0030335; GO:1903626; GO:0043517; GO:0010628; GO:0033129; GO:0043525; GO:1904884; GO:0032212; GO:1904358; GO:0045944; GO:0002331; GO:0046777; GO:0006468; GO:0007131; GO:0042981; GO:0010506; GO:1905843; GO:1900034; GO:1903978; GO:1901796; GO:0032210; GO:0090399; GO:0001666; GO:0010212; GO:0007165; GO:0072434; GO:0000723"]
[190,94,"PK527","ATM","Y2969","Ataxia telangiectasia mutated protein-serine kinase",0,4176,16,775,3224,{"v":5665.0416055999995,"d":"5665"},{"$nulls":3},0,4193,16,750,{"v":3132.75,"d":"3133"},{"v":5473.588104525,"d":"5474"},{"$nulls":6},0,3950,16,742,{"v":2919.028,"d":"2919"},{"v":4993.9939501592,"d":"4994"},{"$nulls":7},"ATM","X","PSTK","Protein kinase - Atypical protein-serine kinase","Protein-serine/threonine kinase","Atypical","PIKK","ATM",{"$nulls":5},"KAL(pY)LQQ(bA)C","Corresponds to amino acid residues K2966 to Q2972; Near the C-terminus of the kinase. ","The effect of Y2969 phosphorylation is unclear. This is the major in vivo phosphorylation site in ATM (≥80 reports from high throughput mass spectrometry studies).",null,null,"Q13315","Q13315","Q13315","Q13315"]
[191,95,"NK237-1","ATR","Pan-specific","Ataxia telangiectasia and Rad3 related protein-serine kinase",0,2048,12,603,{"v":1227.708,"d":"1228"},{"v":2157.2633063052,"d":"2157"},{"$f":"(L204+L205)/2","v":{"v":2263.5144650544,"d":"2264"}},{"$f":"SQRT((M204-L204)*(M204-L204))","v":{"v":106.25115874919993,"d":"106"}},{"$f":"N204/M204*100","v":{"v":4.69407906994075,"d":"5"}},0,1790,14,657,{"v":1166.832,"d":"1167"},{"v":2038.7064895632002,"d":"2039"},{"$f":"(U204+U205)/2","v":{"v":2097.7134379204,"d":"2098"}},{"$f":"SQRT((V204-U204)*(V204-U204))","v":{"v":59.00694835719969,"d":"59"}},{"$f":"W204/V204*100","v":{"v":2.8129174981925615,"d":"3"}},{"$f":"X204+O204","v":{"v":7.506996568133312,"d":"8"}},{"$f":"(V204/M204*100)-100","v":{"v":-7.324937820974569,"d":"-7"}},null,0,2308,10,562,{"v":1291.476,"d":"1291"},{"v":2209.5106079064003,"d":"2210"},{"$f":"(AG204+AG205)/2","v":{"v":2362.6215035787,"d":"2363"}},{"$f":"SQRT((AH204-AG204)*(AH204-AG204))","v":{"v":153.11089567229965,"d":"153"}},{"$f":"AI204/AH204*100","v":{"v":6.480551177595741,"d":"6"}},{"$f":"AJ204+O204","v":{"v":11.174630247536491,"d":"11"}},{"$f":"(AH204/M204*100)-100","v":{"v":4.37845836880561,"d":"4"}},null,null,"ATR","X","PSTK","Protein kinase - Atypical protein-serine kinase","Protein-serine/threonine kinase","Atypical","PIKK","ATR",{"$nulls":5},"KISLKGSDGKFYIMMC","Corresponds to amino acid residues K2311 to C2326.",null,null,"Protein-serine kinase,  ATYPICAL group, PIKK family, ATR subfamily","Q13535","Q13535","Q13535","Q13535","GO:0005694; GO:0005794; GO:0005654; GO:0016605","GO:0005524; GO:0003677; GO:0032405; GO:0032407; GO:0004672; GO:0004674","GO:0006974; GO:0071480; GO:0034644; GO:0000077; GO:0006281; GO:0006260; GO:0097695; GO:0097694; GO:0036297; GO:0007275; GO:0008156; GO:0018105; GO:0043517; GO:1904884; GO:0032212; GO:0046777; GO:0070198; GO:1900034; GO:0090399; GO:0042493"]
[192,95,"NK237-1","ATR","Pan-specific","Ataxia telangiectasia and Rad3 related protein-serine kinase",0,2258,14,601,{"v":1348.644,"d":"1349"},{"v":2369.7656238035997,"d":"2370"},{"$nulls":3},0,2172,14,572,{"v":1234.376,"d":"1234"},{"v":2156.7203862776,"d":"2157"},{"$nulls":6},0,2405,14,615,{"v":1470.465,"d":"1470"},{"v":2515.732399251,"d":"2516"},{"$nulls":7},"ATR","X","PSTK","Protein kinase - Atypical protein-serine kinase","Protein-serine/threonine kinase","Atypical","PIKK","ATR",{"$nulls":5},"KISLKGSDGKFYIMMC","Corresponds to amino acid residues K2311 to C2326.",{"$nulls":3},"Q13535","Q13535","Q13535","Q13535"]
[193,96,"NK237-3","ATR","Pan-specific","Ataxia telangiectasia and Rad3 related protein-serine kinase",0,10668,14,868,{"$f":"(H206-I206)*J206/1000","v":{"v":9247.672,"d":"9248"}},{"v":16249.5181870168,"d":"16250"},{"$f":"(L206+L207)/2","v":{"v":16069.4984871118,"d":"16069"}},{"$f":"SQRT((M206-L206)*(M206-L206))","v":{"v":180.01969990500038,"d":"180"}},{"$f":"N206/M206*100","v":{"v":1.1202571134959898,"d":"1"}},0,9658,22,858,{"$f":"(Q206-R206)*S206/1000","v":{"v":8267.688,"d":"8268"}},{"v":14445.4293156888,"d":"14445"},{"$f":"(U206+U207)/2","v":{"v":14716.904609066401,"d":"14717"}},{"$f":"SQRT((V206-U206)*(V206-U206))","v":{"v":271.4752933776017,"d":"271"}},{"$f":"W206/V206*100","v":{"v":1.8446494054895104,"d":"2"}},{"$f":"X206+O206","v":{"v":2.9649065189855,"d":"3"}},{"$f":"(V206/M206*100)-100","v":{"v":-8.417150536030832,"d":"-8"}},null,0,11486,20,866,{"$f":"(AC206-AD206)*AE206/1000","v":{"v":9929.556,"d":"9930"}},{"v":16987.895488418402,"d":"16988"},{"$f":"(AG206+AG207)/2","v":{"v":16012.746685563601,"d":"16013"}},{"$f":"SQRT((AH206-AG206)*(AH206-AG206))","v":{"v":975.148802854801,"d":"975"}},{"$f":"AI206/AH206*100","v":{"v":6.0898284473203645,"d":"6"}},{"$f":"AJ206+O206","v":{"v":7.2100855608163545,"d":"7"}},{"$f":"(AH206/M206*100)-100","v":{"v":-0.35316473375765156,"d":"-0"}},null,null,"ATR","X","PSTK","Protein kinase - Atypical protein-serine kinase","Protein-serine/threonine kinase","Atypical","PIKK","ATR",{"$nulls":5},"CGHVHYLIQEATDENL","Corresponds to amino acid residues G2618 to L2632; C-terminus.",null,null,"Protein-serine kinase,  ATYPICAL group, PIKK family, ATR subfamily","Q13535","Q13535","Q13535","Q13535","GO:0005694; GO:0005794; GO:0005654; GO:0016605","GO:0005524; GO:0003677; GO:0032405; GO:0032407; GO:0004672; GO:0004674","GO:0006974; GO:0071480; GO:0034644; GO:0000077; GO:0006281; GO:0006260; GO:0097695; GO:0097694; GO:0036297; GO:0007275; GO:0008156; GO:0018105; GO:0043517; GO:1904884; GO:0032212; GO:0046777; GO:0070198; GO:1900034; GO:0090399; GO:0042493"]
[194,96,"NK237-3","ATR","Pan-specific","Ataxia telangiectasia and Rad3 related protein-serine kinase",0,10462,20,866,{"v":9042.772,"d":"9043"},{"v":15889.478787206801,"d":"15889"},{"$nulls":3},0,10170,18,845,{"v":8578.44,"d":"8578"},{"v":14988.379902444001,"d":"14988"},{"$nulls":6},0,9512,20,926,{"v":8789.592,"d":"8790"},{"v":15037.597882708802,"d":"15038"},{"$nulls":7},"ATR","X","PSTK","Protein kinase - Atypical protein-serine kinase","Protein-serine/threonine kinase","Atypical","PIKK","ATR",{"$nulls":5},"CGHVHYLIQEATDENL","Corresponds to amino acid residues G2618 to L2632; C-terminus.",{"$nulls":3},"Q13535","Q13535","Q13535","Q13535"]
[195,97,"PK528","ATR","S435+S436","Ataxia telangiectasia and Rad3 related protein-serine kinase",0,6944,22,837,{"v":5793.714,"d":"5794"},{"v":10180.4065945866,"d":"10180"},{"$f":"(L208+L209)/2","v":{"v":10176.5426285535,"d":"10177"}},{"$f":"SQRT((M208-L208)*(M208-L208))","v":{"v":3.863966033100951,"d":"4"}},{"$f":"N208/M208*100","v":{"v":0.037969339628759334,"d":"0"}},0,7400,38,887,{"v":6530.094,"d":"6530"},{"v":11409.4788412194,"d":"11409"},{"$f":"(U208+U209)/2","v":{"v":10930.921866974699,"d":"10931"}},{"$f":"SQRT((V208-U208)*(V208-U208))","v":{"v":478.55697424470054,"d":"479"}},{"$f":"W208/V208*100","v":{"v":4.378011114419836,"d":"4"}},{"$f":"X208+O208","v":{"v":4.415980454048595,"d":"4"}},{"$f":"(V208/M208*100)-100","v":{"v":7.41292269836859,"d":"7"}},null,0,7506,24,823,{"v":6157.686,"d":"6158"},{"v":10534.8241370004,"d":"10535"},{"$f":"(AG208+AG209)/2","v":{"v":10030.8205256088,"d":"10031"}},{"$f":"SQRT((AH208-AG208)*(AH208-AG208))","v":{"v":504.0036113915994,"d":"504"}},{"$f":"AI208/AH208*100","v":{"v":5.024550186147508,"d":"5"}},{"$f":"AJ208+O208","v":{"v":5.062519525776267,"d":"5"}},{"$f":"(AH208/M208*100)-100","v":{"v":-1.4319411637487747,"d":"-1"}},null,null,"ATR","X","PSTK","Protein kinase - Atypical protein-serine kinase","Protein-serine/threonine kinase","Atypical","PIKK","ATR",{"$nulls":5},"RRL(pS)(pS)SLN(bA)C","Corresponds to amino acid residues R432 to N439; In the N-terminal quarter of the kinase after the transmembrane domain. ","Phosphorylation of S435 induces iteraction with AKAP12. The effects of S436 phosphorylation are unclear. These are the major in vivo phosphorylation sites in ATR (≥97 and ≥53 reports, respectively, by mass spectrometry).","S435: PKACA","Protein-serine kinase,  ATYPICAL group, PIKK family, ATR subfamily","Q13535","Q13535","Q13535","Q13535","GO:0005694; GO:0005794; GO:0005654; GO:0016605","GO:0005524; GO:0003677; GO:0032405; GO:0032407; GO:0004672; GO:0004674","GO:0006974; GO:0071480; GO:0034644; GO:0000077; GO:0006281; GO:0006260; GO:0097695; GO:0097694; GO:0036297; GO:0007275; GO:0008156; GO:0018105; GO:0043517; GO:1904884; GO:0032212; GO:0046777; GO:0070198; GO:1900034; GO:0090399; GO:0042493"]
[196,97,"PK528","ATR","S435+S436","Ataxia telangiectasia and Rad3 related protein-serine kinase",0,6566,17,884,{"v":5789.316,"d":"5789"},{"v":10172.678662520399,"d":"10173"},{"$nulls":3},0,7245,20,828,{"v":5982.3,"d":"5982"},{"v":10452.36489273,"d":"10452"},{"$nulls":6},0,6236,35,898,{"v":5568.498,"d":"5568"},{"v":9526.8169142172,"d":"9527"},{"$nulls":7},"ATR","X","PSTK","Protein kinase - Atypical protein-serine kinase","Protein-serine/threonine kinase","Atypical","PIKK","ATR",{"$nulls":5},"RRL(pS)(pS)SLN(bA)C","Corresponds to amino acid residues R432 to N439; In the N-terminal quarter of the kinase after the transmembrane domain. ","Phosphorylation of S435 induces iteraction with AKAP12. The effects of S436 phosphorylation are unclear. These are the major in vivo phosphorylation sites in ATR (≥97 and ≥53 reports, respectively, by mass spectrometry).","S435: PKACA",null,"Q13535","Q13535","Q13535","Q13535"]
[197,98,"NK008-3","AurKA (Aurora A, AIK, STK15)","Pan-specific","Aurora Kinase A (serine/threonine protein kinase 6)",0,4492,16,736,{"v":3294.336,"d":"3294"},{"$f":"K210*1.7571469","v":{"v":5788.632289958399,"d":"5789"}},{"$f":"(L210+L211)/2","v":{"v":5783.910836238099,"d":"5784"}},{"$f":"SQRT((M210-L210)*(M210-L210))","v":{"v":4.721453720299905,"d":"5"}},{"$f":"N210/M210*100","v":{"v":0.08163081786666643,"d":"0"}},0,4430,22,797,{"v":3513.176,"d":"3513"},{"$f":"T210*1.7472151","v":{"v":6138.2741561576,"d":"6138"}},{"$f":"(U210+U211)/2","v":{"v":5701.0458078883,"d":"5701"}},{"$f":"SQRT((V210-U210)*(V210-U210))","v":{"v":437.2283482693001,"d":"437"}},{"$f":"W210/V210*100","v":{"v":7.669265657615405,"d":"8"}},{"$f":"X210+O210","v":{"v":7.7508964754820715,"d":"8"}},{"$f":"(V210/M210*100)-100","v":{"v":-1.4326816352462117,"d":"-1"}},null,0,4652,14,697,{"v":3232.686,"d":"3233"},{"v":5530.6130420004,"d":"5531"},{"$f":"(AG210+AG211)/2","v":{"v":5415.6975360037995,"d":"5416"}},{"$f":"SQRT((AH210-AG210)*(AH210-AG210))","v":{"v":114.91550599660059,"d":"115"}},{"$f":"AI210/AH210*100","v":{"v":2.121896675961631,"d":"2"}},{"$f":"AJ210+O210","v":{"v":2.2035274938282976,"d":"2"}},{"$f":"(AH210/M210*100)-100","v":{"v":-6.366164878049688,"d":"-6"}},null,null,"AurA","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"CGPVKATAPVGGPKRV","Corresponds to amino acid residues G11 to V25.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; AUR family","O14965","O14965","O14965","O14965","GO:0043203; GO:0005814; GO:0005813; GO:0032133; GO:0005929; GO:0000780; GO:0005829; GO:0042585; GO:0072687; GO:0005874; GO:0015630; GO:0030496; GO:0097431; GO:0005654; GO:0005634; GO:0048471; GO:0045120; GO:0005819; GO:0051233; GO:0031616","GO:0005524; GO:0035174; GO:0046982; GO:0004672; GO:0019901; GO:0004712; GO:0004674; GO:0031625","GO:0031145; GO:0009948; GO:0051301; GO:0051642; GO:0006977; GO:0000086; GO:0097421; GO:0000278; GO:0007100; GO:0007052; GO:0043066; GO:0010972; GO:0032091; GO:1990138; GO:0045840; GO:1900195; GO:0032436; GO:0046777; GO:0071539; GO:0006468; GO:0046605; GO:0032465; GO:0010389; GO:0031647; GO:1901796; GO:0009611; GO:0007057; GO:0007051"]
[198,98,"NK008-3","AurKA (Aurora A, AIK, STK15)","Pan-specific","Aurora Kinase A (serine/threonine protein kinase 6)",0,4351,12,758,{"v":3288.962,"d":"3289"},{"v":5779.1893825177995,"d":"5779"},{"$nulls":3},0,4328,18,699,{"v":3012.69,"d":"3013"},{"v":5263.817459619,"d":"5264"},{"$nulls":6},0,4222,18,737,{"v":3098.348,"d":"3098"},{"$f":"AF211*1.7108414","v":{"v":5300.7820300072,"d":"5301"}},{"$nulls":7},"AurA","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"CGPVKATAPVGGPKRV","Corresponds to amino acid residues G11 to V25.",{"$nulls":3},"O14965","O14965","O14965","O14965"]
[199,99,"NK008-4","AurKA (Aurora A, AIK, STK15)","Pan-specific","Aurora Kinase A (serine/threonine protein kinase 6)",0,6806,16,778,{"v":5282.62,"d":"5283"},{"v":9282.339356878,"d":"9282"},{"$f":"(L212+L213)/2","v":{"v":8810.2748136054,"d":"8810"}},{"$f":"SQRT((M212-L212)*(M212-L212))","v":{"v":472.0645432725996,"d":"472"}},{"$f":"N212/M212*100","v":{"v":5.358113716766325,"d":"5"}},0,6802,16,768,{"v":5211.648,"d":"5212"},{"v":9105.8700814848,"d":"9106"},{"$f":"(U212+U213)/2","v":{"v":9293.9944785169,"d":"9294"}},{"$f":"SQRT((V212-U212)*(V212-U212))","v":{"v":188.1243970320993,"d":"188"}},{"$f":"W212/V212*100","v":{"v":2.0241500838735114,"d":"2"}},{"$f":"X212+O212","v":{"v":7.382263800639836,"d":"7"}},{"$f":"(V212/M212*100)-100","v":{"v":5.490403819918384,"d":"5"}},null,0,7053,12,740,{"v":5210.34,"d":"5210"},{"v":8914.065380076001,"d":"8914"},{"$f":"(AG212+AG213)/2","v":{"v":8752.288217292,"d":"8752"}},{"$f":"SQRT((AH212-AG212)*(AH212-AG212))","v":{"v":161.77716278400112,"d":"162"}},{"$f":"AI212/AH212*100","v":{"v":1.8483984846885646,"d":"2"}},{"$f":"AJ212+O212","v":{"v":7.206512201454889,"d":"7"}},{"$f":"(AH212/M212*100)-100","v":{"v":-0.6581701200041152,"d":"-1"}},null,null,"AurA","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"CESKKRQWALEDFEI","Corresponds to amino acid residues E122 to I135.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; AUR family","O14965","O14965","O14965","O14965","GO:0043203; GO:0005814; GO:0005813; GO:0032133; GO:0005929; GO:0000780; GO:0005829; GO:0042585; GO:0072687; GO:0005874; GO:0015630; GO:0030496; GO:0097431; GO:0005654; GO:0005634; GO:0048471; GO:0045120; GO:0005819; GO:0051233; GO:0031616","GO:0005524; GO:0035174; GO:0046982; GO:0004672; GO:0019901; GO:0004712; GO:0004674; GO:0031625","GO:0031145; GO:0009948; GO:0051301; GO:0051642; GO:0006977; GO:0000086; GO:0097421; GO:0000278; GO:0007100; GO:0007052; GO:0043066; GO:0010972; GO:0032091; GO:1990138; GO:0045840; GO:1900195; GO:0032436; GO:0046777; GO:0071539; GO:0006468; GO:0046605; GO:0032465; GO:0010389; GO:0031647; GO:1901796; GO:0009611; GO:0007057; GO:0007051"]
[200,99,"NK008-4","AurKA (Aurora A, AIK, STK15)","Pan-specific","Aurora Kinase A (serine/threonine protein kinase 6)",0,6360,16,748,{"v":4745.312,"d":"4745"},{"v":8338.2102703328,"d":"8338"},{"$nulls":3},0,6854,19,794,{"v":5426.99,"d":"5427"},{"v":9482.118875549,"d":"9482"},{"$nulls":6},0,6334,18,795,{"v":5021.22,"d":"5021"},{"v":8590.511054508,"d":"8591"},{"$nulls":7},"AurA","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"CESKKRQWALEDFEI","Corresponds to amino acid residues E122 to I135.",{"$nulls":3},"O14965","O14965","O14965","O14965"]
[201,100,"PK529","AurKA (Aurora A, AIK, STK15)","T287+T288","Aurora Kinase A (serine/threonine protein kinase 6)",0,10450,16,758,{"v":7908.972,"d":"7909"},{"v":13897.2256319868,"d":"13897"},{"$f":"(L214+L215)/2","v":{"v":14208.693977186998,"d":"14209"}},{"$f":"SQRT((M214-L214)*(M214-L214))","v":{"v":311.4683452001991,"d":"311"}},{"$f":"N214/M214*100","v":{"v":2.1920969351601363,"d":"2"}},0,12753,20,786,{"v":10008.138,"d":"10008"},{"v":17486.369836483802,"d":"17486"},{"$f":"(U214+U215)/2","v":{"v":15984.5388667731,"d":"15985"}},{"$f":"SQRT((V214-U214)*(V214-U214))","v":{"v":1501.8309697107015,"d":"1502"}},{"$f":"W214/V214*100","v":{"v":9.395522649906043,"d":"9"}},{"$f":"X214+O214","v":{"v":11.587619585066179,"d":"12"}},{"$f":"(V214/M214*100)-100","v":{"v":12.498297819893509,"d":"12"}},null,0,11135,18,740,{"v":8226.58,"d":"8227"},{"v":14074.373644412,"d":"14074"},{"$f":"(AG214+AG215)/2","v":{"v":15156.7494320118,"d":"15157"}},{"$f":"SQRT((AH214-AG214)*(AH214-AG214))","v":{"v":1082.3757875997999,"d":"1082"}},{"$f":"AI214/AH214*100","v":{"v":7.141213176710363,"d":"7"}},{"$f":"AJ214+O214","v":{"v":9.3333101118705,"d":"9"}},{"$f":"(AH214/M214*100)-100","v":{"v":6.672361698738598,"d":"7"}},null,null,"AurA","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"RR(pT)(pT)LCG(bA)C","Corresponds to amino acid residues R285 to G291; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T287 and T288 phosphorylation stimulate phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major in vivo phosphorylation sites in AurKA (≥6 and ≥16 reports, respectively, by mass spectrometry).","T287: AurKA. T288: AurKA; PAK1; PKACa","EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; AUR family","O14965","O14965","O14965","O14965","GO:0043203; GO:0005814; GO:0005813; GO:0032133; GO:0005929; GO:0000780; GO:0005829; GO:0042585; GO:0072687; GO:0005874; GO:0015630; GO:0030496; GO:0097431; GO:0005654; GO:0005634; GO:0048471; GO:0045120; GO:0005819; GO:0051233; GO:0031616","GO:0005524; GO:0035174; GO:0046982; GO:0004672; GO:0019901; GO:0004712; GO:0004674; GO:0031625","GO:0031145; GO:0009948; GO:0051301; GO:0051642; GO:0006977; GO:0000086; GO:0097421; GO:0000278; GO:0007100; GO:0007052; GO:0043066; GO:0010972; GO:0032091; GO:1990138; GO:0045840; GO:1900195; GO:0032436; GO:0046777; GO:0071539; GO:0006468; GO:0046605; GO:0032465; GO:0010389; GO:0031647; GO:1901796; GO:0009611; GO:0007057; GO:0007051"]
[202,100,"PK529","AurKA (Aurora A, AIK, STK15)","T287+T288","Aurora Kinase A (serine/threonine protein kinase 6)",0,10718,14,772,{"v":8263.488,"d":"8263"},{"v":14520.1623223872,"d":"14520"},{"$nulls":3},0,12066,18,688,{"v":8289.024,"d":"8289"},{"v":14482.707897062399,"d":"14483"},{"$nulls":6},0,10796,22,881,{"v":9491.894,"d":"9492"},{"v":16239.1252196116,"d":"16239"},{"$nulls":7},"AurA","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"RR(pT)(pT)LCG(bA)C","Corresponds to amino acid residues R285 to G291; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T287 and T288 phosphorylation stimulate phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major in vivo phosphorylation sites in AurKA (≥6 and ≥16 reports, respectively, by mass spectrometry).","T287: AurKA. T288: AurKA; PAK1; PKACa",null,"O14965","O14965","O14965","O14965"]
[203,76,"PK174","AurKA (Aurora A, AIK, STK15)","T288","Aurora Kinase A (serine/threonine protein kinase 6)",0,166,14,520,{"v":79.04,"d":"79"},{"v":138.884890976,"d":"139"},{"$f":"(L216+L217)/2","v":{"v":136.6093857405,"d":"137"}},{"$f":"SQRT((M216-L216)*(M216-L216))","v":{"v":2.2755052355000203,"d":"2"}},{"$f":"N216/M216*100","v":{"v":1.6657019744035138,"d":"2"}},0,180,11,545,{"v":92.105,"d":"92"},{"v":160.92724678550002,"d":"161"},{"$f":"(U216+U217)/2","v":{"v":132.36814236845,"d":"132"}},{"$f":"SQRT((V216-U216)*(V216-U216))","v":{"v":28.55910441705001,"d":"29"}},{"$f":"W216/V216*100","v":{"v":21.575511981995664,"d":"22"}},{"$f":"X216+O216","v":{"v":23.24121395639918,"d":"23"}},{"$f":"(V216/M216*100)-100","v":{"v":-3.104650056846424,"d":"-3"}},null,0,190,10,636,{"v":114.48,"d":"114"},{"v":195.857123472,"d":"196"},{"$f":"(AG216+AG217)/2","v":{"v":170.3450565152,"d":"170"}},{"$f":"SQRT((AH216-AG216)*(AH216-AG216))","v":{"v":25.5120669568,"d":"26"}},{"$f":"AI216/AH216*100","v":{"v":14.976699341153783,"d":"15"}},{"$f":"AJ216+O216","v":{"v":16.642401315557297,"d":"17"}},{"$f":"(AH216/M216*100)-100","v":{"v":24.69498753093255,"d":"25"}},{"$nulls":3},"X","PSTK",{"$nulls":10},"Not precisely defined.","Antibody raised against amino acid residues that encompass the T288 phosphosite.","T288 phosphorylation stimulates phosphotransferase activity. This is one of the major in vivo phosphorylation sites in ARK-1 (≥16 reports from high throughput mass spectrometry studies).","AurA; PAK1; PKACa","EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; AUR family","O14965","O14965","O14965","O14965","GO:0043203; GO:0005814; GO:0005813; GO:0032133; GO:0005929; GO:0000780; GO:0005829; GO:0042585; GO:0072687; GO:0005874; GO:0015630; GO:0030496; GO:0097431; GO:0005654; GO:0005634; GO:0048471; GO:0045120; GO:0005819; GO:0051233; GO:0031616","GO:0005524; GO:0035174; GO:0046982; GO:0004672; GO:0019901; GO:0004712; GO:0004674; GO:0031625","GO:0031145; GO:0009948; GO:0051301; GO:0051642; GO:0006977; GO:0000086; GO:0097421; GO:0000278; GO:0007100; GO:0007052; GO:0043066; GO:0010972; GO:0032091; GO:1990138; GO:0045840; GO:1900195; GO:0032436; GO:0046777; GO:0071539; GO:0006468; GO:0046605; GO:0032465; GO:0010389; GO:0031647; GO:1901796; GO:0009611; GO:0007057; GO:0007051"]
[204,76,"PK174","AurKA (Aurora A, AIK, STK15)","T288","Aurora Kinase A (serine/threonine protein kinase 6)",0,149,10,550,{"v":76.45,"d":"76"},{"v":134.333880505,"d":"134"},{"$nulls":3},0,130,8,487,{"v":59.414,"d":"59"},{"v":103.8090379514,"d":"104"},{"$nulls":6},0,160,12,572,{"v":84.656,"d":"85"},{"v":144.83298955840002,"d":"145"},{"$nulls":8},"X","PSTK",{"$nulls":10},"Not precisely defined.","Antibody raised against amino acid residues that encompass the T288 phosphosite.","T288 phosphorylation stimulates phosphotransferase activity. This is one of the major in vivo phosphorylation sites in ARK-1 (≥16 reports from high throughput mass spectrometry studies).","AurA; PAK1; PKACa",null,"O14965","O14965","O14965","O14965"]
[205,101,"NK193-2","AurKB (Aurora B, AIM-1)","Pan-specific","Aurora Kinase B (serine/threonine protein kinase 12)",0,6338,16,748,{"v":4728.856,"d":"4729"},{"v":8309.2946609464,"d":"8309"},{"$f":"(L218+L219)/2","v":{"v":7877.1278951852,"d":"7877"}},{"$f":"SQRT((M218-L218)*(M218-L218))","v":{"v":432.1667657611997,"d":"432"}},{"$f":"N218/M218*100","v":{"v":5.486349485646367,"d":"5"}},0,6557,20,686,{"v":4484.382,"d":"4484"},{"v":7835.179944568199,"d":"7835"},{"$f":"(U218+U219)/2","v":{"v":7740.0353462977,"d":"7740"}},{"$f":"SQRT((V218-U218)*(V218-U218))","v":{"v":95.14459827049905,"d":"95"}},{"$f":"W218/V218*100","v":{"v":1.2292527619529499,"d":"1"}},{"$f":"X218+O218","v":{"v":6.715602247599318,"d":"7"}},{"$f":"(V218/M218*100)-100","v":{"v":-1.7403874954384833,"d":"-2"}},null,0,6694,18,707,{"v":4719.932,"d":"4720"},{"v":8075.0550707848,"d":"8075"},{"$f":"(AG218+AG219)/2","v":{"v":7311.0001449104,"d":"7311"}},{"$f":"SQRT((AH218-AG218)*(AH218-AG218))","v":{"v":764.0549258743995,"d":"764"}},{"$f":"AI218/AH218*100","v":{"v":10.45075790904342,"d":"10"}},{"$f":"AJ218+O218","v":{"v":15.937107394689786,"d":"16"}},{"$f":"(AH218/M218*100)-100","v":{"v":-7.1869818264705145,"d":"-7"}},null,null,"AurB","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"AQKENSYPWPYGRQTC","Corresponds to amino acid residues A2 to T16; N-terminus.",null,null,"Protein-serine kinase, Other group, AUR family","Q96GD4","Q96GD4","Q96GD4","Q96GD4","GO:0010369; GO:0032133; GO:0000779; GO:0000780; GO:0005829; GO:0000776; GO:0030496; GO:1990023; GO:0005654; GO:0005634; GO:0005819; GO:0005876; GO:0051233; GO:0031616","GO:0005524; GO:0035174; GO:0019900; GO:0046872; GO:0004712; GO:0004674","GO:0009838; GO:0007568; GO:0031145; GO:0008608; GO:0008283; GO:0034644; GO:0036089; GO:0043988; GO:0016570; GO:0044878; GO:0051256; GO:0002903; GO:0032466; GO:0032091; GO:0000122; GO:0032467; GO:0051973; GO:1904355; GO:0032212; GO:0046777; GO:0034501; GO:0006468; GO:0051983; GO:1901796; GO:0031577; GO:0007051"]
[206,101,"NK193-2","AurKB (Aurora B, AIM-1)","Pan-specific","Aurora Kinase B (serine/threonine protein kinase 12)",0,5828,8,728,{"v":4236.96,"d":"4237"},{"v":7444.961129424,"d":"7445"},{"$nulls":3},0,6240,16,703,{"v":4375.472,"d":"4375"},{"v":7644.8907480272,"d":"7645"},{"$nulls":6},0,5558,12,690,{"v":3826.74,"d":"3827"},{"v":6546.945219036,"d":"6547"},{"$nulls":7},"AurB","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"AQKENSYPWPYGRQTC","Corresponds to amino acid residues A2 to T16; N-terminus.",{"$nulls":3},"Q96GD4","Q96GD4","Q96GD4","Q96GD4"]
[207,102,"NK193-3","AurKB (Aurora B, AIM-1)","Pan-specific","Aurora Kinase B (serine/threonine protein kinase 12)",0,7739,16,644,{"v":4973.612,"d":"4974"},{"v":8739.3669076028,"d":"8739"},{"$f":"(L220+L221)/2","v":{"v":5331.1995089221,"d":"5331"}},{"$f":"SQRT((M220-L220)*(M220-L220))","v":{"v":3408.1673986807,"d":"3408"}},{"$f":"N220/M220*100","v":{"v":63.92871609807354,"d":"64"}},0,7882,16,672,{"v":5285.952,"d":"5286"},{"v":9235.6951522752,"d":"9236"},{"$f":"(U220+U221)/2","v":{"v":9845.58941197935,"d":"9846"}},{"$f":"SQRT((V220-U220)*(V220-U220))","v":{"v":609.8942597041496,"d":"610"}},{"$f":"W220/V220*100","v":{"v":6.194593682345493,"d":"6"}},{"$f":"X220+O220","v":{"v":70.12330978041904,"d":"70"}},{"$f":"(V220/M220*100)-100","v":{"v":84.67868995527428,"d":"85"}},null,0,7906,18,660,{"v":5206.08,"d":"5206"},{"v":8906.777195712,"d":"8907"},{"$f":"(AG220+AG221)/2","v":{"v":8479.391905578,"d":"8479"}},{"$f":"SQRT((AH220-AG220)*(AH220-AG220))","v":{"v":427.38529013399966,"d":"427"}},{"$f":"AI220/AH220*100","v":{"v":5.040282309075167,"d":"5"}},{"$f":"AJ220+O220","v":{"v":68.9689984071487,"d":"69"}},{"$f":"(AH220/M220*100)-100","v":{"v":59.0522337681642,"d":"59"}},null,null,"AurB","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"CDILTRHFTIDDFEIG","Corresponds to amino acid residues D66 to G80.",null,null,"Protein-serine kinase, Other group, AUR family","Q96GD4","Q96GD4","Q96GD4","Q96GD4","GO:0010369; GO:0032133; GO:0000779; GO:0000780; GO:0005829; GO:0000776; GO:0030496; GO:1990023; GO:0005654; GO:0005634; GO:0005819; GO:0005876; GO:0051233; GO:0031616","GO:0005524; GO:0035174; GO:0019900; GO:0046872; GO:0004712; GO:0004674","GO:0009838; GO:0007568; GO:0031145; GO:0008608; GO:0008283; GO:0034644; GO:0036089; GO:0043988; GO:0016570; GO:0044878; GO:0051256; GO:0002903; GO:0032466; GO:0032091; GO:0000122; GO:0032467; GO:0051973; GO:1904355; GO:0032212; GO:0046777; GO:0034501; GO:0006468; GO:0051983; GO:1901796; GO:0031577; GO:0007051"]
[208,102,"NK193-3","AurKB (Aurora B, AIM-1)","Pan-specific","Aurora Kinase B (serine/threonine protein kinase 12)",0,1078,4,1019,{"v":1094.406,"d":"1094"},{"v":1923.0321102413998,"d":"1923"},{"$nulls":3},0,7919,14,757,{"v":5984.085,"d":"5984"},{"v":10455.4836716835,"d":"10455"},{"$nulls":6},0,7145,14,660,{"v":4706.46,"d":"4706"},{"v":8052.006615444,"d":"8052"},{"$nulls":7},"AurB","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"CDILTRHFTIDDFEIG","Corresponds to amino acid residues D66 to G80.",{"$nulls":3},"Q96GD4","Q96GD4","Q96GD4","Q96GD4"]
[209,103,"PK530","AurKB (Aurora B, AIM-1)","S227","Aurora Kinase B (serine/threonine protein kinase 12)",0,11754,14,641,{"v":7525.34,"d":"7525"},{"v":13223.127852446,"d":"13223"},{"$f":"(L222+L223)/2","v":{"v":13050.997742122,"d":"13051"}},{"$f":"SQRT((M222-L222)*(M222-L222))","v":{"v":172.13011032400027,"d":"172"}},{"$f":"N222/M222*100","v":{"v":1.3189038395773498,"d":"1"}},0,11240,14,596,{"v":6690.696,"d":"6691"},{"v":11690.0850807096,"d":"11690"},{"$f":"(U222+U223)/2","v":{"v":12325.0614867818,"d":"12325"}},{"$f":"SQRT((V222-U222)*(V222-U222))","v":{"v":634.9764060722009,"d":"635"}},{"$f":"W222/V222*100","v":{"v":5.151912684193836,"d":"5"}},{"$f":"X222+O222","v":{"v":6.470816523771186,"d":"6"}},{"$f":"(V222/M222*100)-100","v":{"v":-5.56230465811241,"d":"-6"}},null,0,12332,14,628,{"v":7735.704,"d":"7736"},{"v":13234.5626613456,"d":"13235"},{"$f":"(AG222+AG223)/2","v":{"v":12913.177682672802,"d":"12913"}},{"$f":"SQRT((AH222-AG222)*(AH222-AG222))","v":{"v":321.38497867279875,"d":"321"}},{"$f":"AI222/AH222*100","v":{"v":2.4888140360992668,"d":"2"}},{"$f":"AJ222+O222","v":{"v":3.807717875676617,"d":"4"}},{"$f":"(AH222/M222*100)-100","v":{"v":-1.0560116718462353,"d":"-1"}},null,null,"AurB","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"VAHAP(pS)L(bA)C","Corresponds to amino acid residues V222 to L228; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S227 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation induces interaction with INCENP. This is a minor in vivo phosphorylation site in AurKB (≥11 reports from high throughput mass spectrometry studies).","AurKB","Protein-serine kinase, Other group, AUR family","Q96GD4","Q96GD4","Q96GD4","Q96GD4","GO:0010369; GO:0032133; GO:0000779; GO:0000780; GO:0005829; GO:0000776; GO:0030496; GO:1990023; GO:0005654; GO:0005634; GO:0005819; GO:0005876; GO:0051233; GO:0031616","GO:0005524; GO:0035174; GO:0019900; GO:0046872; GO:0004712; GO:0004674","GO:0009838; GO:0007568; GO:0031145; GO:0008608; GO:0008283; GO:0034644; GO:0036089; GO:0043988; GO:0016570; GO:0044878; GO:0051256; GO:0002903; GO:0032466; GO:0032091; GO:0000122; GO:0032467; GO:0051973; GO:1904355; GO:0032212; GO:0046777; GO:0034501; GO:0006468; GO:0051983; GO:1901796; GO:0031577; GO:0007051"]
[210,103,"PK530","AurKB (Aurora B, AIM-1)","S227","Aurora Kinase B (serine/threonine protein kinase 12)",0,11650,16,630,{"v":7329.42,"d":"7329"},{"v":12878.867631797999,"d":"12879"},{"$nulls":3},0,12154,14,611,{"v":7417.54,"d":"7418"},{"v":12960.037892854,"d":"12960"},{"$nulls":6},0,11792,16,625,7360,{"v":12591.792704000001,"d":"12592"},{"$nulls":7},"AurB","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"VAHAP(pS)L(bA)C","Corresponds to amino acid residues V222 to L228; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S227 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation induces interaction with INCENP. This is a minor in vivo phosphorylation site in AurKB (≥11 reports from high throughput mass spectrometry studies).","AurKB",null,"Q96GD4","Q96GD4","Q96GD4","Q96GD4"]
[211,104,"PK531","AurKB (Aurora B, AIM-1)","T232","Aurora Kinase B (serine/threonine protein kinase 12)",0,1836,18,604,{"v":1098.072,"d":"1098"},{"v":1929.4738107767998,"d":"1929"},{"$f":"(L224+L225)/2","v":{"v":1771.7347335638,"d":"1772"}},{"$f":"SQRT((M224-L224)*(M224-L224))","v":{"v":157.73907721299975,"d":"158"}},{"$f":"N224/M224*100","v":{"v":8.90308657525224,"d":"9"}},0,1608,16,521,{"v":829.432,"d":"829"},{"v":1449.1961148232,"d":"1449"},{"$f":"(U224+U225)/2","v":{"v":1745.8382945012,"d":"1746"}},{"$f":"SQRT((V224-U224)*(V224-U224))","v":{"v":296.6421796779998,"d":"297"}},{"$f":"W224/V224*100","v":{"v":16.991389214701176,"d":"17"}},{"$f":"X224+O224","v":{"v":25.894475789953418,"d":"26"}},{"$f":"(V224/M224*100)-100","v":{"v":-1.4616431326889483,"d":"-1"}},null,0,1892,12,586,{"v":1101.68,"d":"1102"},{"v":1884.799753552,"d":"1885"},{"$f":"(AG224+AG225)/2","v":{"v":1896.1255236200002,"d":"1896"}},{"$f":"SQRT((AH224-AG224)*(AH224-AG224))","v":{"v":11.32577006800011,"d":"11"}},{"$f":"AI224/AH224*100","v":{"v":0.5973111973292488,"d":"1"}},{"$f":"AJ224+O224","v":{"v":9.50039777258149,"d":"10"}},{"$f":"(AH224/M224*100)-100","v":{"v":7.020847291625373,"d":"7"}},null,null,"AurB","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"RRK(pT)MCG(bA)C","Corresponds to amino acid residues R229 to G235; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T232 phosphorylation stimulates or inhibits phosphotransferase activity according to separate reports and regulates cytoskeletal reorganization and intracellular location, and induces binding to INCENP. It is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in AurKB (≥101 reports from high throughput mass spectrometry studies).","AurKB","Protein-serine kinase, Other group, AUR family","Q96GD4","Q96GD4","Q96GD4","Q96GD4","GO:0010369; GO:0032133; GO:0000779; GO:0000780; GO:0005829; GO:0000776; GO:0030496; GO:1990023; GO:0005654; GO:0005634; GO:0005819; GO:0005876; GO:0051233; GO:0031616","GO:0005524; GO:0035174; GO:0019900; GO:0046872; GO:0004712; GO:0004674","GO:0009838; GO:0007568; GO:0031145; GO:0008608; GO:0008283; GO:0034644; GO:0036089; GO:0043988; GO:0016570; GO:0044878; GO:0051256; GO:0002903; GO:0032466; GO:0032091; GO:0000122; GO:0032467; GO:0051973; GO:1904355; GO:0032212; GO:0046777; GO:0034501; GO:0006468; GO:0051983; GO:1901796; GO:0031577; GO:0007051"]
[212,104,"PK531","AurKB (Aurora B, AIM-1)","T232","Aurora Kinase B (serine/threonine protein kinase 12)",0,1674,16,554,{"v":918.532,"d":"919"},{"v":1613.9956563508001,"d":"1614"},{"$nulls":3},0,1818,14,648,{"v":1168.992,"d":"1169"},{"v":2042.4804741792,"d":"2042"},{"$nulls":6},0,1725,15,652,{"v":1114.92,"d":"1115"},{"v":1907.4512936880003,"d":"1907"},{"$nulls":7},"AurB","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"RRK(pT)MCG(bA)C","Corresponds to amino acid residues R229 to G235; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T232 phosphorylation stimulates or inhibits phosphotransferase activity according to separate reports and regulates cytoskeletal reorganization and intracellular location, and induces binding to INCENP. It is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in AurKB (≥101 reports from high throughput mass spectrometry studies).","AurKB",null,"Q96GD4","Q96GD4","Q96GD4","Q96GD4"]
[213,105,"NK009-2","AurKC (Aurora C, AIK3)","Pan-specific","Aurora Kinase C (serine/threonine-protein kinase 13)",0,5532,18,842,{"v":4642.788,"d":"4643"},{"v":8158.060541557199,"d":"8158"},{"$f":"(L226+L227)/2","v":{"v":7712.810059978599,"d":"7713"}},{"$f":"SQRT((M226-L226)*(M226-L226))","v":{"v":445.25048157859965,"d":"445"}},{"$f":"N226/M226*100","v":{"v":5.772869785669727,"d":"6"}},0,5768,18,832,4784,{"v":8358.6770384,"d":"8359"},{"$f":"(U226+U227)/2","v":{"v":7373.9308831041,"d":"7374"}},{"$f":"SQRT((V226-U226)*(V226-U226))","v":{"v":984.7461552958994,"d":"985"}},{"$f":"W226/V226*100","v":{"v":13.35442616572729,"d":"13"}},{"$f":"X226+O226","v":{"v":19.127295951397016,"d":"19"}},{"$f":"(V226/M226*100)-100","v":{"v":-4.393718686694072,"d":"-4"}},null,0,5820,12,752,{"v":4367.616,"d":"4368"},{"v":7472.2982721024,"d":"7472"},{"$f":"(AG226+AG227)/2","v":{"v":6488.8809727614,"d":"6489"}},{"$f":"SQRT((AH226-AG226)*(AH226-AG226))","v":{"v":983.4172993410002,"d":"983"}},{"$f":"AI226/AH226*100","v":{"v":15.155422074609243,"d":"15"}},{"$f":"AJ226+O226","v":{"v":20.928291860278968,"d":"21"}},{"$f":"(AH226/M226*100)-100","v":{"v":-15.868782942913484,"d":"-16"}},null,null,"AurC","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"MSSPRAVVQLGKAQPC","Corresponds to amino acid residues M1 to P15; N-terminus.",null,null,"Protein-serine kinase, Other group, AUR family","Q9UQB9","Q9UQB9","Q9UQB9",null,"GO:0032133; GO:0000793; GO:0000780; GO:0005737; GO:0030496; GO:0005819; GO:0005876; GO:0051233; GO:0031616","GO:0005524; GO:0035174; GO:0004672; GO:0004712","GO:0008608; GO:0000910; GO:0016570; GO:0051321; GO:0051256; GO:0048599; GO:0032467; GO:0006468; GO:0007283"]
[214,105,"NK009-2","AurKC (Aurora C, AIK3)","Pan-specific","Aurora Kinase C (serine/threonine-protein kinase 13)",0,5514,14,752,4136,{"v":7267.5595784,"d":"7268"},{"$nulls":3},0,5366,12,683,{"v":3656.782,"d":"3657"},{"v":6389.1847278082005,"d":"6389"},{"$nulls":6},0,4910,12,657,{"v":3217.986,"d":"3218"},{"v":5505.4636734204,"d":"5505"},{"$nulls":7},"AurC","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"MSSPRAVVQLGKAQPC","Corresponds to amino acid residues M1 to P15; N-terminus.",{"$nulls":3},"Q9UQB9","Q9UQB9","Q9UQB9"]
[215,106,"NK009-3","AurKC (Aurora C, AIK3)","Pan-specific","Aurora Kinase C (serine/threonine-protein kinase 13)",0,2002,12,577,{"v":1148.23,"d":"1148"},{"v":2017.608784987,"d":"2018"},{"$f":"(L228+L229)/2","v":{"v":1966.1665523426,"d":"1966"}},{"$f":"SQRT((M228-L228)*(M228-L228))","v":{"v":51.442232644400065,"d":"51"}},{"$f":"N228/M228*100","v":{"v":2.616372076063899,"d":"3"}},0,2002,12,551,{"v":1096.49,"d":"1096"},{"v":1915.803884999,"d":"1916"},{"$f":"(U228+U229)/2","v":{"v":1795.96240129,"d":"1796"}},{"$f":"SQRT((V228-U228)*(V228-U228))","v":{"v":119.84148370900016,"d":"120"}},{"$f":"W228/V228*100","v":{"v":6.672828096118309,"d":"7"}},{"$f":"X228+O228","v":{"v":9.289200172182207,"d":"9"}},{"$f":"(V228/M228*100)-100","v":{"v":-8.656649704970803,"d":"-9"}},null,0,2127,10,522,{"v":1105.074,"d":"1105"},{"v":1890.6063492636001,"d":"1891"},{"$f":"(AG228+AG229)/2","v":{"v":1889.7081575286002,"d":"1890"}},{"$f":"SQRT((AH228-AG228)*(AH228-AG228))","v":{"v":0.8981917349999549,"d":"1"}},{"$f":"AI228/AH228*100","v":{"v":0.04753071162981213,"d":"0"}},{"$f":"AJ228+O228","v":{"v":2.663902787693711,"d":"3"}},{"$f":"(AH228/M228*100)-100","v":{"v":-3.8887038701224412,"d":"-4"}},null,null,"AurC","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"CSPAMRRLTVDDFEIG","Corresponds to amino acid residues S32 to G46; Pre-kinase catalytic domain.",null,null,"Protein-serine kinase, Other group, AUR family","Q9UQB9","Q9UQB9","Q9UQB9",null,"GO:0032133; GO:0000793; GO:0000780; GO:0005737; GO:0030496; GO:0005819; GO:0005876; GO:0051233; GO:0031616","GO:0005524; GO:0035174; GO:0004672; GO:0004712","GO:0008608; GO:0000910; GO:0016570; GO:0051321; GO:0051256; GO:0048599; GO:0032467; GO:0006468; GO:0007283"]
[216,106,"NK009-3","AurKC (Aurora C, AIK3)","Pan-specific","Aurora Kinase C (serine/threonine-protein kinase 13)",0,1896,14,579,{"v":1089.678,"d":"1090"},{"v":1914.7243196982001,"d":"1915"},{"$nulls":3},0,1893,12,510,{"v":959.31,"d":"959"},{"v":1676.120917581,"d":"1676"},{"$nulls":6},0,1898,14,586,{"v":1104.024,"d":"1104"},{"v":1888.8099657936,"d":"1889"},{"$nulls":7},"AurC","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"CSPAMRRLTVDDFEIG","Corresponds to amino acid residues S32 to G46; Pre-kinase catalytic domain.",{"$nulls":3},"Q9UQB9","Q9UQB9","Q9UQB9"]
[217,107,"PK532","AurKC (Aurora C, AIK3)","S193","Aurora Kinase C (serine/threonine-protein kinase 13)",0,7175,16,743,{"v":5319.137,"d":"5319"},{"v":9346.505090225299,"d":"9347"},{"$f":"(L230+L231)/2","v":{"v":9437.94965062165,"d":"9438"}},{"$f":"SQRT((M230-L230)*(M230-L230))","v":{"v":91.44456039635043,"d":"91"}},{"$f":"N230/M230*100","v":{"v":0.9689028208613855,"d":"1"}},0,7396,20,780,{"v":5753.28,"d":"5753"},{"v":10052.217690528,"d":"10052"},{"$f":"(U230+U231)/2","v":{"v":9132.920465662999,"d":"9133"}},{"$f":"SQRT((V230-U230)*(V230-U230))","v":{"v":919.2972248650003,"d":"919"}},{"$f":"W230/V230*100","v":{"v":10.065753099693335,"d":"10"}},{"$f":"X230+O230","v":{"v":11.034655920554721,"d":"11"}},{"$f":"(V230/M230*100)-100","v":{"v":-3.2319433378049354,"d":"-3"}},null,0,7106,10,696,{"v":4938.816,"d":"4939"},{"v":8449.5308797824,"d":"8450"},{"$f":"(AG230+AG231)/2","v":{"v":7901.069343770399,"d":"7901"}},{"$f":"SQRT((AH230-AG230)*(AH230-AG230))","v":{"v":548.4615360120006,"d":"548"}},{"$f":"AI230/AH230*100","v":{"v":6.9416114724323394,"d":"7"}},{"$f":"AJ230+O230","v":{"v":7.9105142932937245,"d":"8"}},{"$f":"(AH230/M230*100)-100","v":{"v":-16.284048588350117,"d":"-16"}},null,null,"AurC","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"HTP(pS)LRR(bA)C","Corresponds to amino acid residues H190 to R196; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S193 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation of this site has not apparently been detected by mass spectrometry. ",null,"Protein-serine kinase, Other group, AUR family","Q9UQB9","Q9UQB9","Q9UQB9",null,"GO:0032133; GO:0000793; GO:0000780; GO:0005737; GO:0030496; GO:0005819; GO:0005876; GO:0051233; GO:0031616","GO:0005524; GO:0035174; GO:0004672; GO:0004712","GO:0008608; GO:0000910; GO:0016570; GO:0051321; GO:0051256; GO:0048599; GO:0032467; GO:0006468; GO:0007283"]
[218,107,"PK532","AurKC (Aurora C, AIK3)","S193","Aurora Kinase C (serine/threonine-protein kinase 13)",0,7274,14,747,{"v":5423.22,"d":"5423"},{"v":9529.394211018,"d":"9529"},{"$nulls":3},0,6782,18,695,{"v":4700.98,"d":"4701"},{"v":8213.623240797999,"d":"8214"},{"$nulls":6},0,6438,14,669,{"v":4297.656,"d":"4298"},{"v":7352.6078077584,"d":"7353"},{"$nulls":7},"AurC","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"HTP(pS)LRR(bA)C","Corresponds to amino acid residues H190 to R196; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S193 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation of this site has not apparently been detected by mass spectrometry. ",null,null,"Q9UQB9","Q9UQB9","Q9UQB9"]
[219,108,"NK010-2","Axl (UFO)","Pan-specific","AXL oncogene-encoded protein-tyrosine kinase UFO",0,4452,10,653,{"v":2900.626,"d":"2901"},{"v":5096.8259839594,"d":"5097"},{"$f":"(L232+L233)/2","v":{"v":4934.2670527997,"d":"4934"}},{"$f":"SQRT((M232-L232)*(M232-L232))","v":{"v":162.55893115970048,"d":"163"}},{"$f":"N232/M232*100","v":{"v":3.2944899297143766,"d":"3"}},0,4212,14,609,{"v":2556.582,"d":"2557"},{"v":4466.8986747882,"d":"4467"},{"$f":"(U232+U233)/2","v":{"v":4587.8216846441,"d":"4588"}},{"$f":"SQRT((V232-U232)*(V232-U232))","v":{"v":120.92300985590009,"d":"121"}},{"$f":"W232/V232*100","v":{"v":2.635739097285353,"d":"3"}},{"$f":"X232+O232","v":{"v":5.930229026999729,"d":"6"}},{"$f":"(V232/M232*100)-100","v":{"v":-7.021212359372129,"d":"-7"}},null,0,4570,12,615,{"v":2803.17,"d":"2803"},{"v":4795.7792872380005,"d":"4796"},{"$f":"(AG232+AG233)/2","v":{"v":4523.4783483312,"d":"4523"}},{"$f":"SQRT((AH232-AG232)*(AH232-AG232))","v":{"v":272.3009389068002,"d":"272"}},{"$f":"AI232/AH232*100","v":{"v":6.019724599925571,"d":"6"}},{"$f":"AJ232+O232","v":{"v":9.314214529639948,"d":"9"}},{"$f":"(AH232/M232*100)-100","v":{"v":-8.325222369863795,"d":"-8"}},null,null,"AXL","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Axl",{"$nulls":6},"CSFTELREDLENTLKAL","Corresponds to amino acid residues S795 to L810; After catalytic domain in a region not as conserved with Tyro3 and MERTK.",null,null,"Receptor tyrosine kinase; EC 2.7.10.1; TK group; Axl family","P30530","P30530","P30530","P30530","GO:0009986; GO:0070062; GO:0005615; GO:0044228; GO:0005887; GO:0005622; GO:0005886","GO:0005524; GO:0032036; GO:0043548; GO:0001786; GO:0046982; GO:0004713; GO:0004714; GO:0001618","GO:0031100; GO:0043277; GO:0001974; GO:0048469; GO:0031668; GO:0070301; GO:0035457; GO:0071222; GO:0097028; GO:0034101; GO:0021885; GO:0006954; GO:0045087; GO:0001779; GO:2000669; GO:0032689; GO:0051250; GO:0043524; GO:0032720; GO:0001764; GO:0097350; GO:0042698; GO:0006909; GO:0030168; GO:0001961; GO:0032825; GO:0048549; GO:0051897; GO:0043491; GO:0032940; GO:0007165; GO:0007283; GO:0034446; GO:0060068; GO:0048010; GO:0046718"]
[220,108,"NK010-2","Axl (UFO)","Pan-specific","AXL oncogene-encoded protein-tyrosine kinase UFO",0,4540,14,600,{"v":2715.6,"d":"2716"},{"v":4771.70812164,"d":"4772"},{"$nulls":3},0,4391,16,616,2695,{"v":4708.7446945,"d":"4709"},{"$nulls":6},0,4341,12,574,{"v":2484.846,"d":"2485"},{"v":4251.1774094244,"d":"4251"},{"$nulls":7},"AXL","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Axl",{"$nulls":6},"CSFTELREDLENTLKAL","Corresponds to amino acid residues S795 to L810; After catalytic domain in a region not as conserved with Tyro3 and MERTK.",{"$nulls":3},"P30530","P30530","P30530","P30530"]
[221,109,"NK010-3","Axl (UFO)","Pan-specific","AXL oncogene-encoded protein-tyrosine kinase UFO",0,1686,14,594,{"v":993.168,"d":"993"},{"v":1745.1420723792,"d":"1745"},{"$f":"(L234+L235)/2","v":{"v":1939.4913052537,"d":"1939"}},{"$f":"SQRT((M234-L234)*(M234-L234))","v":{"v":194.34923287449988,"d":"194"}},{"$f":"N234/M234*100","v":{"v":10.02062924170096,"d":"10"}},0,1506,14,560,{"v":835.52,"d":"836"},{"v":1459.833160352,"d":"1460"},{"$f":"(U234+U235)/2","v":{"v":1641.1381768488,"d":"1641"}},{"$f":"SQRT((V234-U234)*(V234-U234))","v":{"v":181.3050164967999,"d":"181"}},{"$f":"W234/V234*100","v":{"v":11.04751684254456,"d":"11"}},{"$f":"X234+O234","v":{"v":21.06814608424552,"d":"21"}},{"$f":"(V234/M234*100)-100","v":{"v":-15.383060888013262,"d":"-15"}},null,0,2301,12,540,{"v":1236.06,"d":"1236"},{"v":2114.7026208839998,"d":"2115"},{"$f":"(AG234+AG235)/2","v":{"v":2294.9209431186,"d":"2295"}},{"$f":"SQRT((AH234-AG234)*(AH234-AG234))","v":{"v":180.21832223460024,"d":"180"}},{"$f":"AI234/AH234*100","v":{"v":7.852920719338552,"d":"8"}},{"$f":"AJ234+O234","v":{"v":17.87354996103951,"d":"18"}},{"$f":"(AH234/M234*100)-100","v":{"v":18.32592066291359,"d":"18"}},null,null,"AXL","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Axl",{"$nulls":6},"RKSYSRRTTEATLNSLGC","Corresponds to amino acid residues R501 to G517; Before catalytic domain.",null,null,"Receptor tyrosine kinase; EC 2.7.10.1; TK group; Axl family","P30530","P30530","P30530","P30530","GO:0009986; GO:0070062; GO:0005615; GO:0044228; GO:0005887; GO:0005622; GO:0005886","GO:0005524; GO:0032036; GO:0043548; GO:0001786; GO:0046982; GO:0004713; GO:0004714; GO:0001618","GO:0031100; GO:0043277; GO:0001974; GO:0048469; GO:0031668; GO:0070301; GO:0035457; GO:0071222; GO:0097028; GO:0034101; GO:0021885; GO:0006954; GO:0045087; GO:0001779; GO:2000669; GO:0032689; GO:0051250; GO:0043524; GO:0032720; GO:0001764; GO:0097350; GO:0042698; GO:0006909; GO:0030168; GO:0001961; GO:0032825; GO:0048549; GO:0051897; GO:0043491; GO:0032940; GO:0007165; GO:0007283; GO:0034446; GO:0060068; GO:0048010; GO:0046718"]
[222,109,"NK010-3","Axl (UFO)","Pan-specific","AXL oncogene-encoded protein-tyrosine kinase UFO",0,2115,14,578,{"v":1214.378,"d":"1214"},{"v":2133.8405381282,"d":"2134"},{"$nulls":3},0,1888,12,556,{"v":1043.056,"d":"1043"},{"v":1822.4431933456,"d":"1822"},{"$nulls":6},0,2353,12,618,{"v":1446.738,"d":"1447"},{"v":2475.1392653532002,"d":"2475"},{"$nulls":7},"AXL","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Axl",{"$nulls":6},"RKSYSRRTTEATLNSLGC","Corresponds to amino acid residues R501 to G517; Before catalytic domain.",{"$nulls":3},"P30530","P30530","P30530","P30530"]
[223,110,"PK533","Axl (UFO)","Y702+Y703","AXL oncogene-encoded protein-tyrosine kinase UFO",0,4954,18,758,{"v":3741.488,"d":"3741"},{"v":6574.3440405872,"d":"6574"},{"$f":"(L236+L237)/2","v":{"v":6493.5258260686,"d":"6494"}},{"$f":"SQRT((M236-L236)*(M236-L236))","v":{"v":80.81821451860014,"d":"81"}},{"$f":"N236/M236*100","v":{"v":1.244596798154728,"d":"1"}},0,5992,18,898,{"v":5364.652,"d":"5365"},{"v":9373.2009806452,"d":"9373"},{"$f":"(U236+U237)/2","v":{"v":7975.427153430101,"d":"7975"}},{"$f":"SQRT((V236-U236)*(V236-U236))","v":{"v":1397.7738272151,"d":"1398"}},{"$f":"W236/V236*100","v":{"v":17.526005821693705,"d":"18"}},{"$f":"X236+O236","v":{"v":18.770602619848432,"d":"19"}},{"$f":"(V236/M236*100)-100","v":{"v":22.821212497720893,"d":"23"}},null,0,5532,12,739,{"v":4079.28,"d":"4079"},{"v":6979.001106192,"d":"6979"},{"$f":"(AG236+AG237)/2","v":{"v":6389.8420749568,"d":"6390"}},{"$f":"SQRT((AH236-AG236)*(AH236-AG236))","v":{"v":589.1590312352,"d":"589"}},{"$f":"AI236/AH236*100","v":{"v":9.220244011103876,"d":"9"}},{"$f":"AJ236+O236","v":{"v":10.464840809258604,"d":"10"}},{"$f":"(AH236/M236*100)-100","v":{"v":-1.5967250133287507,"d":"-2"}},null,null,"AXL","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Axl",{"$nulls":6},"NGD(pY)(pY)RQG(bA)C","Corresponds to amino acid residues N699 to G706; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y702 and Y703 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are the two major in vivo phosphorylation sites in Axl (≥754 and ≥358 reports, respectively, by mass spectrometry).",null,"Receptor tyrosine kinase; EC 2.7.10.1; TK group; Axl family","P30530","P30530","P30530","P30530","GO:0009986; GO:0070062; GO:0005615; GO:0044228; GO:0005887; GO:0005622; GO:0005886","GO:0005524; GO:0032036; GO:0043548; GO:0001786; GO:0046982; GO:0004713; GO:0004714; GO:0001618","GO:0031100; GO:0043277; GO:0001974; GO:0048469; GO:0031668; GO:0070301; GO:0035457; GO:0071222; GO:0097028; GO:0034101; GO:0021885; GO:0006954; GO:0045087; GO:0001779; GO:2000669; GO:0032689; GO:0051250; GO:0043524; GO:0032720; GO:0001764; GO:0097350; GO:0042698; GO:0006909; GO:0030168; GO:0001961; GO:0032825; GO:0048549; GO:0051897; GO:0043491; GO:0032940; GO:0007165; GO:0007283; GO:0034446; GO:0060068; GO:0048010; GO:0046718"]
[224,110,"PK533","Axl (UFO)","Y702+Y703","AXL oncogene-encoded protein-tyrosine kinase UFO",0,4880,14,750,{"v":3649.5,"d":"3650"},{"v":6412.7076115499995,"d":"6413"},{"$nulls":3},0,5166,16,731,{"v":3764.65,"d":"3765"},{"v":6577.653326215001,"d":"6578"},{"$nulls":6},0,4776,14,712,{"v":3390.544,"d":"3391"},{"v":5800.6830437216,"d":"5801"},{"$nulls":7},"AXL","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Axl",{"$nulls":6},"NGD(pY)(pY)RQG(bA)C","Corresponds to amino acid residues N699 to G706; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y702 and Y703 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are the two major in vivo phosphorylation sites in Axl (≥754 and ≥358 reports, respectively, by mass spectrometry).",null,null,"P30530","P30530","P30530","P30530"]
[225,111,"PN573","B-Myb (MYBL2)","T487","Myb-related protein B",0,8360,12,710,{"v":5927.08,"d":"5927"},{"v":10414.750248052,"d":"10415"},{"$f":"(L238+L239)/2","v":{"v":9529.5558685328,"d":"9530"}},{"$f":"SQRT((M238-L238)*(M238-L238))","v":{"v":885.1943795192001,"d":"885"}},{"$f":"N238/M238*100","v":{"v":9.288936354758864,"d":"9"}},0,10305,18,715,{"v":7355.205,"d":"7355"},{"v":12851.1252395955,"d":"12851"},{"$f":"(U238+U239)/2","v":{"v":11670.688372276949,"d":"11671"}},{"$f":"SQRT((V238-U238)*(V238-U238))","v":{"v":1180.4368673185509,"d":"1180"}},{"$f":"W238/V238*100","v":{"v":10.114543629856582,"d":"10"}},{"$f":"X238+O238","v":{"v":19.403479984615444,"d":"19"}},{"$f":"(V238/M238*100)-100","v":{"v":22.468334655703174,"d":"22"}},null,0,8812,14,680,{"v":5982.64,"d":"5983"},{"v":10235.348193296,"d":"10235"},{"$f":"(AG238+AG239)/2","v":{"v":9722.189869573001,"d":"9722"}},{"$f":"SQRT((AH238-AG238)*(AH238-AG238))","v":{"v":513.1583237229988,"d":"513"}},{"$f":"AI238/AH238*100","v":{"v":5.278217465480714,"d":"5"}},{"$f":"AJ238+O238","v":{"v":14.567153820239579,"d":"15"}},{"$f":"(AH238/M238*100)-100","v":{"v":2.0214373439615656,"d":"2"}},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"VVVT(pT)PLHR(bA)C","Corresponds to amino acid residues V483 to R491.","T487 phosphorylation stimulates transcriptional activity. This is one of the major in vivo phosphorylation sites in B-Myb (≥42 reports from high throughput mass spectrometry studies).","CDK2","Transcription protein","P10244","P10244",null,null,"GO:0031523; GO:0005654; GO:0005634","GO:0003700; GO:0000978; GO:0000981; GO:0001135; GO:0001077","GO:0030154; GO:1990830; GO:0090307; GO:0043525; GO:0045944; GO:0051726; GO:0006357"]
[226,111,"PN573","B-Myb (MYBL2)","T487","Myb-related protein B",0,7242,18,681,{"v":4919.544,"d":"4920"},{"v":8644.3614890136,"d":"8644"},{"$nulls":3},0,9004,16,668,{"v":6003.984,"d":"6004"},{"v":10490.2515049584,"d":"10490"},{"$nulls":6},0,7193,16,750,{"v":5382.75,"d":"5383"},{"v":9209.03154585,"d":"9209"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"VVVT(pT)PLHR(bA)C","Corresponds to amino acid residues V483 to R491.","T487 phosphorylation stimulates transcriptional activity. This is one of the major in vivo phosphorylation sites in B-Myb (≥42 reports from high throughput mass spectrometry studies).","CDK2",null,"P10244","P10244"]
[227,112,"PN206","B-Myb (MYBL2)","T487","Myb-related protein B",0,606,10,579,{"v":345.084,"d":"345"},{"v":606.3632808396,"d":"606"},{"$f":"(L240+L241)/2","v":{"v":523.3591755774,"d":"523"}},{"$f":"SQRT((M240-L240)*(M240-L240))","v":{"v":83.00410526219991,"d":"83"}},{"$f":"N240/M240*100","v":{"v":15.859873894562945,"d":"16"}},0,450,16,528,{"v":229.152,"d":"229"},{"v":400.3778345952,"d":"400"},{"$f":"(U240+U241)/2","v":{"v":441.818282337,"d":"442"}},{"$f":"SQRT((V240-U240)*(V240-U240))","v":{"v":41.44044774180003,"d":"41"}},{"$f":"W240/V240*100","v":{"v":9.379523075097882,"d":"9"}},{"$f":"X240+O240","v":{"v":25.239396969660827,"d":"25"}},{"$f":"(V240/M240*100)-100","v":{"v":-15.580293046441653,"d":"-16"}},null,0,592,10,560,{"v":325.92,"d":"326"},{"v":557.597429088,"d":"558"},{"$f":"(AG240+AG241)/2","v":{"v":469.993795201,"d":"470"}},{"$f":"SQRT((AH240-AG240)*(AH240-AG240))","v":{"v":87.603633887,"d":"88"}},{"$f":"AI240/AH240*100","v":{"v":18.63931711045993,"d":"19"}},{"$f":"AJ240+O240","v":{"v":34.49919100502288,"d":"34"}},{"$f":"(AH240/M240*100)-100","v":{"v":-10.196702927301175,"d":"-10"}},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against amino acid residues that encompass the T490 phosphosite of mouse B-Myb, which corresponds to human B-Myb T487.","T487 phosphorylation stimulates transcriptional activity. This is one of the major in vivo phosphorylation sites in B-Myb (≥42 reports from high throughput mass spectrometry studies).","CDK2","Transcription protein","P10244","P10244",null,null,"GO:0031523; GO:0005654; GO:0005634","GO:0003700; GO:0000978; GO:0000981; GO:0001135; GO:0001077","GO:0030154; GO:1990830; GO:0090307; GO:0043525; GO:0045944; GO:0051726; GO:0006357"]
[228,112,"PN206","B-Myb (MYBL2)","T487","Myb-related protein B",0,464,10,552,{"v":250.608,"d":"251"},{"v":440.3550703152,"d":"440"},{"$nulls":3},0,478,10,591,{"v":276.588,"d":"277"},{"v":483.25873007880006,"d":"483"},{"$nulls":6},0,446,12,515,{"v":223.51,"d":"224"},{"v":382.390161314,"d":"382"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against amino acid residues that encompass the T490 phosphosite of mouse B-Myb, which corresponds to human B-Myb T487.","T487 phosphorylation stimulates transcriptional activity. This is one of the major in vivo phosphorylation sites in B-Myb (≥42 reports from high throughput mass spectrometry studies).","CDK2",null,"P10244","P10244"]
[229,113,"NN177-2","B23 (NPM)","Pan-specific","B23 (nucleophosmin, numatrin, nucleolar protein NO38)",0,126,12,494,{"v":56.316,"d":"56"},{"v":98.9554848204,"d":"99"},{"$f":"(L242+L243)/2","v":{"v":96.4462790472,"d":"96"}},{"$f":"SQRT((M242-L242)*(M242-L242))","v":{"v":2.5092057732000086,"d":"3"}},{"$f":"N242/M242*100","v":{"v":2.6016615653694886,"d":"3"}},0,135,12,571,{"v":70.233,"d":"70"},{"v":122.71215811830001,"d":"123"},{"$f":"(U242+U243)/2","v":{"v":100.57756362395,"d":"101"}},{"$f":"SQRT((V242-U242)*(V242-U242))","v":{"v":22.13459449435001,"d":"22"}},{"$f":"W242/V242*100","v":{"v":22.007487253428774,"d":"22"}},{"$f":"X242+O242","v":{"v":24.609148818798264,"d":"25"}},{"$f":"(V242/M242*100)-100","v":{"v":4.283508516412724,"d":"4"}},null,0,132,12,492,{"v":59.04,"d":"59"},{"v":101.00807625600001,"d":"101"},{"$f":"(AG242+AG243)/2","v":{"v":104.90109586170001,"d":"105"}},{"$f":"SQRT((AH242-AG242)*(AH242-AG242))","v":{"v":3.8930196057000046,"d":"4"}},{"$f":"AI242/AH242*100","v":{"v":3.711133400200606,"d":"4"}},{"$f":"AJ242+O242","v":{"v":6.312794965570094,"d":"6"}},{"$f":"(AH242/M242*100)-100","v":{"v":8.766348373442483,"d":"9"}},{"$nulls":15},"Not precisely defined.","Antibody raised against amino acid residues 253-294 at the C-terminus of human B23. ",null,null,"RNA binding protein","P06748","P06748",null,"P06748","GO:0005813; GO:0005737; GO:0005829; GO:0005925; GO:0016020; GO:0005730; GO:0005654; GO:0005634; GO:0032991; GO:0032993; GO:1990904; GO:0031616","GO:0033613; GO:0001047; GO:0042393; GO:0051059; GO:0046982; GO:0042803; GO:0019901; GO:0004860; GO:0043023; GO:0043024; GO:0003723; GO:0030957; GO:0003713; GO:0008134; GO:0051082","GO:0007569; GO:0034644; GO:0034080; GO:0007098; GO:0006281; GO:0006886; GO:0043066; GO:0008285; GO:0010826; GO:0044387; GO:0006913; GO:0006334; GO:1902751; GO:0008284; GO:0051092; GO:0045893; GO:0045944; GO:0045727; GO:0051259; GO:0008104; GO:0046599; GO:0060735; GO:0032071; GO:0060699; GO:1902629; GO:0006357; GO:0042255; GO:0007165; GO:0016032"]
[230,113,"NN177-2","B23 (NPM)","Pan-specific","B23 (nucleophosmin, numatrin, nucleolar protein NO38)",0,122,14,495,{"v":53.46,"d":"53"},{"v":93.937073274,"d":"94"},{"$nulls":3},0,102,10,488,{"v":44.896,"d":"45"},{"v":78.4429691296,"d":"78"},{"$nulls":6},0,135,12,517,{"v":63.591,"d":"64"},{"v":108.7941154674,"d":"109"},{"$nulls":20},"Not precisely defined.","Antibody raised against amino acid residues 253-294 at the C-terminus of human B23. ",{"$nulls":3},"P06748","P06748",null,"P06748"]
[231,114,"PN009","B23 (NPM)","T234+T237","B23 (nucleophosmin, numatrin, nucleolar protein NO38)",0,14,2,731,{"v":8.772,"d":"9"},{"v":15.4136926068,"d":"15"},{"$f":"(L244+L245)/2","v":{"v":15.044691757799999,"d":"15"}},{"$f":"SQRT((M244-L244)*(M244-L244))","v":{"v":0.36900084900000074,"d":"0"}},{"$f":"N244/M244*100","v":{"v":2.452697967764546,"d":"2"}},0,18,2,735,{"v":11.76,"d":"12"},{"v":20.547249576,"d":"21"},{"$f":"(U244+U245)/2","v":{"v":19.6788836713,"d":"20"}},{"$f":"SQRT((V244-U244)*(V244-U244))","v":{"v":0.8683659046999992,"d":"1"}},{"$f":"W244/V244*100","v":{"v":4.412678682411432,"d":"4"}},{"$f":"X244+O244","v":{"v":6.865376650175978,"d":"7"}},{"$f":"(V244/M244*100)-100","v":{"v":30.80283722727239,"d":"31"}},null,0,14,2,735,{"v":8.82,"d":"9"},{"v":15.089621148,"d":"15"},{"$f":"(AG244+AG245)/2","v":{"v":12.4446603436,"d":"12"}},{"$f":"SQRT((AH244-AG244)*(AH244-AG244))","v":{"v":2.6449608044,"d":"3"}},{"$f":"AI244/AH244*100","v":{"v":21.25378058839703,"d":"21"}},{"$f":"AJ244+O244","v":{"v":23.706478556161578,"d":"24"}},{"$f":"(AH244/M244*100)-100","v":{"v":-17.282051743280135,"d":"-17"}},{"$nulls":15},"Not precisely defined.","Antibody raised against amino acid residues that encompass the T234 and T237 phosphosites.","T234 and T237 phosphorylation induces interaction with ROCK2 and inhibits interaction with RNA. These are two of the major in vivo phosphorylation sites in B23 (≥33 and ≥42 reports, respectively, by mass spectrometry).","T234: CDK1; CDK2. T237: CDK1.","RNA binding protein","P06748","P06748",null,"P06748","GO:0005813; GO:0005737; GO:0005829; GO:0005925; GO:0016020; GO:0005730; GO:0005654; GO:0005634; GO:0032991; GO:0032993; GO:1990904; GO:0031616","GO:0033613; GO:0001047; GO:0042393; GO:0051059; GO:0046982; GO:0042803; GO:0019901; GO:0004860; GO:0043023; GO:0043024; GO:0003723; GO:0030957; GO:0003713; GO:0008134; GO:0051082","GO:0007569; GO:0034644; GO:0034080; GO:0007098; GO:0006281; GO:0006886; GO:0043066; GO:0008285; GO:0010826; GO:0044387; GO:0006913; GO:0006334; GO:1902751; GO:0008284; GO:0051092; GO:0045893; GO:0045944; GO:0045727; GO:0051259; GO:0008104; GO:0046599; GO:0060735; GO:0032071; GO:0060699; GO:1902629; GO:0006357; GO:0042255; GO:0007165; GO:0016032"]
[232,114,"PN009","B23 (NPM)","T234+T237","B23 (nucleophosmin, numatrin, nucleolar protein NO38)",0,14,2,696,{"v":8.352,"d":"8"},{"v":14.6756909088,"d":"15"},{"$nulls":3},0,16,2,769,{"v":10.766,"d":"11"},{"v":18.8105177666,"d":"19"},{"$nulls":6},0,10,2,716,{"v":5.728,"d":"6"},{"v":9.7996995392,"d":"10"},{"$nulls":20},"Not precisely defined.","Antibody raised against amino acid residues that encompass the T234 and T237 phosphosites.","T234 and T237 phosphorylation induces interaction with ROCK2 and inhibits interaction with RNA. These are two of the major in vivo phosphorylation sites in B23 (≥33 and ≥42 reports, respectively, by mass spectrometry).","T234: CDK1; CDK2. T237: CDK1.",null,"P06748","P06748",null,"P06748"]
[233,115,"PN207","Bad","S75","Bcl2 antagonist of cell death",0,370,14,510,{"v":181.56,"d":"182"},{"v":319.027591164,"d":"319"},{"$f":"(L246+L247)/2","v":{"v":265.4135249512,"d":"265"}},{"$f":"SQRT((M246-L246)*(M246-L246))","v":{"v":53.614066212800026,"d":"54"}},{"$f":"N246/M246*100","v":{"v":20.20020126052647,"d":"20"}},0,320,10,477,{"v":147.87,"d":"148"},{"v":258.36069683700003,"d":"258"},{"$f":"(U246+U247)/2","v":{"v":216.59526708660002,"d":"217"}},{"$f":"SQRT((V246-U246)*(V246-U246))","v":{"v":41.76542975040002,"d":"42"}},{"$f":"W246/V246*100","v":{"v":19.282706548569774,"d":"19"}},{"$f":"X246+O246","v":{"v":39.48290780909625,"d":"39"}},{"$f":"(V246/M246*100)-100","v":{"v":-18.393281907384292,"d":"-18"}},null,0,362,10,501,{"v":176.352,"d":"176"},{"v":301.7103025728,"d":"302"},{"$f":"(AG246+AG247)/2","v":{"v":303.1764936526,"d":"303"}},{"$f":"SQRT((AH246-AG246)*(AH246-AG246))","v":{"v":1.4661910798000122,"d":"1"}},{"$f":"AI246/AH246*100","v":{"v":0.48360974894052056,"d":"0"}},{"$f":"AJ246+O246","v":{"v":20.68381100946699,"d":"21"}},{"$f":"(AH246/M246*100)-100","v":{"v":14.227974519513765,"d":"14"}},{"$nulls":5},"Apoptosis protein",{"$nulls":9},"Not precisely defined.","Antibody raised against amino acid residues that encompass the mouse S112 phosphosite, which corresponds to the human Bad S75 phosphosite.","S75 phosphorylation Inhibits interaction with Bcl-2 and Bcl-xL, and induces interaction with 14-3-3-beta. This is one of the major sites of Bad phosphorylation by mass spectrometry (≥192 reports).","Akt1; Akt3; JNK1; MSK1; PAK1; PAK5 (PAK7); Pim1; Pim2; Pim3; PKACa, PKCi (PRKCl); Raf1; RSK1; RSK2; RSK3","Apoptosis protein, Bcl family","Q92934","Q92934",null,"Q92934","GO:0005829; GO:0005741; GO:0005739","GO:0071889; GO:0008656; GO:0008289; GO:0005543; GO:0046982; GO:0043422; GO:0019901; GO:0030346","GO:0097202; GO:0006919; GO:0046031; GO:0006915; GO:0046034; GO:0060154; GO:0071247; GO:0071456; GO:0071396; GO:0071260; GO:0071316; GO:0021987; GO:0019221; GO:0097191; GO:0097192; GO:0008625; GO:0006007; GO:0042593; GO:0097193; GO:0008630; GO:0046931; GO:0043065; GO:0060139; GO:0010508; GO:0045579; GO:0043280; GO:0050679; GO:0033133; GO:0032024; GO:0035774; GO:2001244; GO:1902220; GO:0010918; GO:1901216; GO:1900740; GO:0045862; GO:0090200; GO:0045582; GO:2000078; GO:0001844; GO:0046902; GO:0001836; GO:0043200; GO:0051592; GO:0032355; GO:0045471; GO:0051384; GO:0009749; GO:0042542; GO:0034201; GO:0032570; GO:0033574; GO:0007283; GO:0019050; GO:0044342"]
[234,115,"PN207","Bad","S75","Bcl2 antagonist of cell death",0,254,10,494,{"v":120.536,"d":"121"},{"v":211.7994587384,"d":"212"},{"$nulls":3},0,171,18,654,{"v":100.062,"d":"100"},{"v":174.8298373362,"d":"175"},{"$nulls":6},0,332,10,553,{"v":178.066,"d":"178"},{"v":304.6426847324,"d":"305"},{"$nulls":10},"Apoptosis protein",{"$nulls":9},"Not precisely defined.","Antibody raised against amino acid residues that encompass the mouse S112 phosphosite, which corresponds to the human Bad S75 phosphosite.","S75 phosphorylation Inhibits interaction with Bcl-2 and Bcl-xL, and induces interaction with 14-3-3-beta. This is one of the major sites of Bad phosphorylation by mass spectrometry (≥192 reports).","Akt1; Akt3; JNK1; MSK1; PAK1; PAK5 (PAK7); Pim1; Pim2; Pim3; PKACa, PKCi (PRKCl); Raf1; RSK1; RSK2; RSK3",null,"Q92934","Q92934",null,"Q92934"]
[235,116,"PN208","Bad","S99","Bcl2 antagonist of cell death",0,192,10,491,{"v":89.362,"d":"89"},{"v":157.0221612778,"d":"157"},{"$f":"(L248+L249)/2","v":{"v":161.39042847119998,"d":"161"}},{"$f":"SQRT((M248-L248)*(M248-L248))","v":{"v":4.368267193399987,"d":"4"}},{"$f":"N248/M248*100","v":{"v":2.7066457625642286,"d":"3"}},0,198,8,500,95,{"v":165.9854345,"d":"166"},{"$f":"(U248+U249)/2","v":{"v":156.40720132180002,"d":"156"}},{"$f":"SQRT((V248-U248)*(V248-U248))","v":{"v":9.57823317819998,"d":"10"}},{"$f":"W248/V248*100","v":{"v":6.123908040840935,"d":"6"}},{"$f":"X248+O248","v":{"v":8.830553803405163,"d":"9"}},{"$f":"(V248/M248*100)-100","v":{"v":-3.0876844411434377,"d":"-3"}},null,0,186,12,459,{"v":79.866,"d":"80"},{"v":136.6380592524,"d":"137"},{"$f":"(AG248+AG249)/2","v":{"v":139.74323639340003,"d":"140"}},{"$f":"SQRT((AH248-AG248)*(AH248-AG248))","v":{"v":3.105177141000013,"d":"3"}},{"$f":"AI248/AH248*100","v":{"v":2.2220589855658073,"d":"2"}},{"$f":"AJ248+O248","v":{"v":4.928704748130036,"d":"5"}},{"$f":"(AH248/M248*100)-100","v":{"v":-13.412934263113925,"d":"-13"}},{"$nulls":5},"Apoptosis protein",{"$nulls":9},"Not precisely defined.","Antibody raised against amino acid residues that encompass the mouse S136 phosphosite, which corresponds to the human Bad S99 phosphosite.","S99 phosphorylation Inhibits interaction with Bcl-2 and Bcl-xL, and induces interaction with 14-3-3-beta and 14-3-3 zeta. This is one of the major sites of Bad phosphorylation by mass spectrometry (≥263 reports).","Akt1; Akt3; A-Raf; B-Raf; p70 S6K; PAK1; Pim1; Pim2; Pim3; PKACa; PKCe; PKCi; PKCt (PKCq); PKD1 (PRKD1); RSK1; RSK2","Apoptosis protein, Bcl family","Q92934","Q92934",null,"Q92934","GO:0005829; GO:0005741; GO:0005739","GO:0071889; GO:0008656; GO:0008289; GO:0005543; GO:0046982; GO:0043422; GO:0019901; GO:0030346","GO:0097202; GO:0006919; GO:0046031; GO:0006915; GO:0046034; GO:0060154; GO:0071247; GO:0071456; GO:0071396; GO:0071260; GO:0071316; GO:0021987; GO:0019221; GO:0097191; GO:0097192; GO:0008625; GO:0006007; GO:0042593; GO:0097193; GO:0008630; GO:0046931; GO:0043065; GO:0060139; GO:0010508; GO:0045579; GO:0043280; GO:0050679; GO:0033133; GO:0032024; GO:0035774; GO:2001244; GO:1902220; GO:0010918; GO:1901216; GO:1900740; GO:0045862; GO:0090200; GO:0045582; GO:2000078; GO:0001844; GO:0046902; GO:0001836; GO:0043200; GO:0051592; GO:0032355; GO:0045471; GO:0051384; GO:0009749; GO:0042542; GO:0034201; GO:0032570; GO:0033574; GO:0007283; GO:0019050; GO:0044342"]
[236,116,"PN208","Bad","S99","Bcl2 antagonist of cell death",0,212,10,467,{"v":94.334,"d":"94"},{"v":165.7586956646,"d":"166"},{"$nulls":3},0,198,10,447,{"v":84.036,"d":"84"},{"v":146.8289681436,"d":"147"},{"$nulls":6},0,210,14,426,{"v":83.496,"d":"83"},{"v":142.8484135344,"d":"143"},{"$nulls":10},"Apoptosis protein",{"$nulls":9},"Not precisely defined.","Antibody raised against amino acid residues that encompass the mouse S136 phosphosite, which corresponds to the human Bad S99 phosphosite.","S99 phosphorylation Inhibits interaction with Bcl-2 and Bcl-xL, and induces interaction with 14-3-3-beta and 14-3-3 zeta. This is one of the major sites of Bad phosphorylation by mass spectrometry (≥263 reports).","Akt1; Akt3; A-Raf; B-Raf; p70 S6K; PAK1; Pim1; Pim2; Pim3; PKACa; PKCe; PKCi; PKCt (PKCq); PKD1 (PRKD1); RSK1; RSK2",null,"Q92934","Q92934",null,"Q92934"]
[237,119,"NK257-1","BCKD (BCKDK)","Pan-specific","[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial",0,3970,10,750,2970,{"v":5218.726293,"d":"5219"},{"$f":"(L250+L251)/2","v":{"v":5111.997190294,"d":"5112"}},{"$f":"SQRT((M250-L250)*(M250-L250))","v":{"v":106.72910270600005,"d":"107"}},{"$f":"N250/M250*100","v":{"v":2.087816145686533,"d":"2"}},0,4240,18,864,{"v":3647.808,"d":"3648"},{"v":6373.5052195008,"d":"6374"},{"$f":"(U250+U251)/2","v":{"v":5660.4580011153,"d":"5660"}},{"$f":"SQRT((V250-U250)*(V250-U250))","v":{"v":713.0472183855,"d":"713"}},{"$f":"W250/V250*100","v":{"v":12.596988057238578,"d":"13"}},{"$f":"X250+O250","v":{"v":14.684804202925111,"d":"15"}},{"$f":"(V250/M250*100)-100","v":{"v":10.728894997490372,"d":"11"}},null,0,4172,8,679,{"v":2827.356,"d":"2827"},{"v":4837.157697338401,"d":"4837"},{"$f":"(AG250+AG251)/2","v":{"v":4520.9711102595,"d":"4521"}},{"$f":"SQRT((AH250-AG250)*(AH250-AG250))","v":{"v":316.18658707890063,"d":"316"}},{"$f":"AI250/AH250*100","v":{"v":6.99377588061499,"d":"7"}},{"$f":"AJ250+O250","v":{"v":9.081592026301523,"d":"9"}},{"$f":"(AH250/M250*100)-100","v":{"v":-11.561549391237207,"d":"-12"}},null,null,"BCKDK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PDHK",{"$nulls":6},"CQSAIDAAAEKPSVRL","Corresponds to amino acid residues Q56 to L70.",null,null,"Protein-serine kinase, Atypical group, PDHK family","O14874","O14874","O14874",null,"GO:0005947; GO:0005759; GO:0005739","GO:0047323; GO:0005524; GO:0016301; GO:0004674","GO:0009083; GO:0009063; GO:0016310"]
[238,119,"NK257-1","BCKD (BCKDK)","Pan-specific","[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial",0,4024,12,710,{"v":2848.52,"d":"2849"},{"v":5005.268087588,"d":"5005"},{"$nulls":3},0,4100,14,693,{"v":2831.598,"d":"2832"},{"v":4947.4107827298,"d":"4947"},{"$nulls":6},0,3621,12,681,{"v":2457.729,"d":"2458"},{"v":4204.7845231805995,"d":"4205"},{"$nulls":7},"BCKDK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PDHK",{"$nulls":6},"CQSAIDAAAEKPSVRL","Corresponds to amino acid residues Q56 to L70.",{"$nulls":3},"O14874","O14874","O14874"]
[239,120,"NK257-2","BCKD (BCKDK)","Pan-specific","[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial",0,1262,16,625,{"v":778.75,"d":"779"},{"v":1368.378148375,"d":"1368"},{"$f":"(L252+L253)/2","v":{"v":1340.9420566784001,"d":"1341"}},{"$f":"SQRT((M252-L252)*(M252-L252))","v":{"v":27.43609169659976,"d":"27"}},{"$f":"N252/M252*100","v":{"v":2.04603111372021,"d":"2"}},0,1247,18,642,{"v":789.018,"d":"789"},{"v":1378.5841637718001,"d":"1379"},{"$f":"(U252+U253)/2","v":{"v":1416.2925600600001,"d":"1416"}},{"$f":"SQRT((V252-U252)*(V252-U252))","v":{"v":37.70839628819999,"d":"38"}},{"$f":"W252/V252*100","v":{"v":2.6624722427831227,"d":"3"}},{"$f":"X252+O252","v":{"v":4.708503356503332,"d":"5"}},{"$f":"(V252/M252*100)-100","v":{"v":5.619221427676607,"d":"6"}},null,0,1326,14,577,{"v":757.024,"d":"757"},{"v":1295.1479999936,"d":"1295"},{"$f":"(AG252+AG253)/2","v":{"v":1183.1888279362001,"d":"1183"}},{"$f":"SQRT((AH252-AG252)*(AH252-AG252))","v":{"v":111.95917205739988,"d":"112"}},{"$f":"AI252/AH252*100","v":{"v":9.462494017348593,"d":"9"}},{"$f":"AJ252+O252","v":{"v":11.508525131068803,"d":"12"}},{"$f":"(AH252/M252*100)-100","v":{"v":-11.764358344682307,"d":"-12"}},null,null,"BCKDK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PDHK",{"$nulls":6},"CILHVHELYIRAFQKL","Corresponds to amino acid residues I122 to L136.",null,null,"Protein-serine kinase, Atypical group, PDHK family","O14874","O14874","O14874",null,"GO:0005947; GO:0005759; GO:0005739","GO:0047323; GO:0005524; GO:0016301; GO:0004674","GO:0009083; GO:0009063; GO:0016310"]
[240,120,"NK257-2","BCKD (BCKDK)","Pan-specific","[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial",0,1153,10,654,{"v":747.522,"d":"748"},{"v":1313.5059649818002,"d":"1314"},{"$nulls":3},0,1236,14,681,{"v":832.182,"d":"832"},{"v":1454.0009563482001,"d":"1454"},{"$nulls":6},0,1086,12,583,{"v":626.142,"d":"626"},{"v":1071.2296558788,"d":"1071"},{"$nulls":7},"BCKDK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PDHK",{"$nulls":6},"CILHVHELYIRAFQKL","Corresponds to amino acid residues I122 to L136.",{"$nulls":3},"O14874","O14874","O14874"]
[241,121,"PN574","BCLAF1","S512","Bcl-2-associated transcription factor 1",0,8252,18,784,{"v":6455.456,"d":"6455"},{"v":11343.1844984864,"d":"11343"},{"$f":"(L254+L255)/2","v":{"v":11031.959518131851,"d":"11032"}},{"$f":"SQRT((M254-L254)*(M254-L254))","v":{"v":311.2249803545492,"d":"311"}},{"$f":"N254/M254*100","v":{"v":2.82112148655937,"d":"3"}},0,8348,16,783,{"v":6523.956,"d":"6524"},{"v":11398.754434935601,"d":"11399"},{"$f":"(U254+U255)/2","v":{"v":11072.1527579379,"d":"11072"}},{"$f":"SQRT((V254-U254)*(V254-U254))","v":{"v":326.60167699770136,"d":"327"}},{"$f":"W254/V254*100","v":{"v":2.9497576861333723,"d":"3"}},{"$f":"X254+O254","v":{"v":5.770879172692743,"d":"6"}},{"$f":"(V254/M254*100)-100","v":{"v":0.3643345476385065,"d":"0"}},null,0,8020,12,797,{"v":6382.376,"d":"6382"},{"v":10919.233091166401,"d":"10919"},{"$f":"(AG254+AG255)/2","v":{"v":9949.1038969792,"d":"9949"}},{"$f":"SQRT((AH254-AG254)*(AH254-AG254))","v":{"v":970.1291941872005,"d":"970"}},{"$f":"AI254/AH254*100","v":{"v":9.750920326420113,"d":"10"}},{"$f":"AJ254+O254","v":{"v":12.572041812979483,"d":"13"}},{"$f":"(AH254/M254*100)-100","v":{"v":-9.8156235922811,"d":"-10"}},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"LFDY(pS)PPL(bA)C","Corresponds to amino acid residues L508 to L515.","The effect of S512 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in BCLAF1 (≥135 reports from high throughput mass spectrometry studies).","PRP4 (PRPF4B)","Transcription protein","Q9NYF8","Q9NYF8",null,null,"GO:0005737; GO:0016607; GO:0005654; GO:0005634","GO:0003677; GO:0003723","GO:0006915; GO:1990830; GO:0045892; GO:0043065; GO:2000144; GO:2001244; GO:2001022; GO:0043620; GO:0006351"]
[242,121,"PN574","BCLAF1","S512","Bcl-2-associated transcription factor 1",0,7631,14,801,{"v":6101.217,"d":"6101"},{"v":10720.7345377773,"d":"10721"},{"$nulls":3},0,8093,22,762,{"v":6150.102,"d":"6150"},{"v":10745.5510809402,"d":"10746"},{"$nulls":6},0,7344,14,716,{"v":5248.28,"d":"5248"},{"v":8978.974702792,"d":"8979"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"LFDY(pS)PPL(bA)C","Corresponds to amino acid residues L508 to L515.","The effect of S512 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in BCLAF1 (≥135 reports from high throughput mass spectrometry studies).","PRP4 (PRPF4B)",null,"Q9NYF8","Q9NYF8"]
[243,122,"NK362-1","Bcr","Pan-specific","Breakpoint cluster region protein",0,390,8,547,{"v":208.954,"d":"209"},{"v":367.1628733426,"d":"367"},{"$f":"(L256+L257)/2","v":{"v":363.82341565915,"d":"364"}},{"$f":"SQRT((M256-L256)*(M256-L256))","v":{"v":3.339457683450007,"d":"3"}},{"$f":"N256/M256*100","v":{"v":0.9178787125066731,"d":"1"}},0,530,16,653,{"v":335.642,"d":"336"},{"v":586.4387705942,"d":"586"},{"$f":"(U256+U257)/2","v":{"v":455.8676389561,"d":"456"}},{"$f":"SQRT((V256-U256)*(V256-U256))","v":{"v":130.57113163810004,"d":"131"}},{"$f":"W256/V256*100","v":{"v":28.642333975953495,"d":"29"}},{"$f":"X256+O256","v":{"v":29.56021268846017,"d":"30"}},{"$f":"(V256/M256*100)-100","v":{"v":25.299147700592783,"d":"25"}},null,0,534,10,519,{"v":271.956,"d":"272"},{"v":465.27358377840005,"d":"465"},{"$f":"(AG256+AG257)/2","v":{"v":432.21499540620005,"d":"432"}},{"$f":"SQRT((AH256-AG256)*(AH256-AG256))","v":{"v":33.058588372200006,"d":"33"}},{"$f":"AI256/AH256*100","v":{"v":7.6486444763748205,"d":"8"}},{"$f":"AJ256+O256","v":{"v":8.566523188881494,"d":"9"}},{"$f":"(AH256/M256*100)-100","v":{"v":18.79801486200192,"d":"19"}},null,null,"BCR","X","PSTK","Protein kinase - Receptor-serine kinase","Protein-serine/threonine kinase","Atypical","BCR",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 1-300 (deletion 17-219) of human Bcr.",null,null,"EC 2.7.11.1; GTPase activating protein, Rac/Rho; Protein kinase, Ser/Thr (non-receptor); ATYPICAL group; BCR family","P11274","P11274","P11274","P11274","GO:0030054; GO:0005829; GO:0070062; GO:0098978; GO:0016020; GO:0014069; GO:0099092; GO:0045211; GO:0032991; GO:0098685","GO:0005524; GO:0005096; GO:0016301; GO:0004674; GO:0004713; GO:0005089","GO:0030036; GO:0007420; GO:0071222; GO:0060216; GO:0048872; GO:0042472; GO:0065002; GO:0035556; GO:0050804; GO:0060313; GO:0002692; GO:0050728; GO:0043314; GO:2000378; GO:0060268; GO:0050885; GO:0048008; GO:0043547; GO:0050766; GO:0046777; GO:0006468; GO:0051726; GO:0051171; GO:0035023; GO:0051056; GO:0043114; GO:0003014; GO:0007165"]
[244,122,"NK362-1","Bcr","Pan-specific","Breakpoint cluster region protein",0,376,9,559,{"v":205.153,"d":"205"},{"v":360.4839579757,"d":"360"},{"$nulls":3},0,358,10,535,{"v":186.18,"d":"186"},{"v":325.296507318,"d":"325"},{"$nulls":6},0,470,8,505,{"v":233.31,"d":"233"},{"v":399.15640703400004,"d":"399"},{"$nulls":7},"BCR","X","PSTK","Protein kinase - Receptor-serine kinase","Protein-serine/threonine kinase","Atypical","BCR",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 1-300 (deletion 17-219) of human Bcr.",{"$nulls":3},"P11274","P11274","P11274","P11274"]
[245,123,"PK164","Bcr","Y177","Breakpoint cluster region protein",0,125,8,434,{"v":50.778,"d":"51"},{"v":89.22440528819999,"d":"89"},{"$f":"(L258+L259)/2","v":{"v":96.6940367601,"d":"97"}},{"$f":"SQRT((M258-L258)*(M258-L258))","v":{"v":7.469631471900016,"d":"7"}},{"$f":"N258/M258*100","v":{"v":7.7250177179305615,"d":"8"}},0,468,14,327,{"v":148.458,"d":"148"},{"v":259.3880593158,"d":"259"},{"$f":"(U258+U259)/2","v":{"v":178.26311500769998,"d":"178"}},{"$f":"SQRT((V258-U258)*(V258-U258))","v":{"v":81.1249443081,"d":"81"}},{"$f":"W258/V258*100","v":{"v":45.50854185656738,"d":"46"}},{"$f":"X258+O258","v":{"v":53.233559574497946,"d":"53"}},{"$f":"(V258/M258*100)-100","v":{"v":84.35792007523136,"d":"84"}},null,0,84,8,442,{"v":33.592,"d":"34"},{"v":57.4705843088,"d":"57"},{"$f":"(AG258+AG259)/2","v":{"v":73.7304209744,"d":"74"}},{"$f":"SQRT((AH258-AG258)*(AH258-AG258))","v":{"v":16.259836665600005,"d":"16"}},{"$f":"AI258/AH258*100","v":{"v":22.053090774085767,"d":"22"}},{"$f":"AJ258+O258","v":{"v":29.77810849201633,"d":"30"}},{"$f":"(AH258/M258*100)-100","v":{"v":-23.748740413716746,"d":"-24"}},null,null,"BCR","X","PSTK","Protein kinase - Receptor-serine kinase","Protein-serine/threonine kinase","Atypical","BCR",{"$nulls":6},"PF(pY)VN","Corresponds to amino acid residues P175 to N179.","Y177 phosphorylation stimulates phosphotransferase activity. Phosphorylation induces interaction with Gab2, Grb2 and SOS1, and inhibits interaction with Hck. This is the major site of phosphorylation of Bcr by mass spectrometry stydues (≥1018 reports).","Abl1; Bcr-Abl; Fes; Fyn; Hck; Lyn","EC 2.7.11.1; GTPase activating protein, Rac/Rho; Protein kinase, Ser/Thr (non-receptor); ATYPICAL group; BCR family","P11274","P11274","P11274","P11274","GO:0030054; GO:0005829; GO:0070062; GO:0098978; GO:0016020; GO:0014069; GO:0099092; GO:0045211; GO:0032991; GO:0098685","GO:0005524; GO:0005096; GO:0016301; GO:0004674; GO:0004713; GO:0005089","GO:0030036; GO:0007420; GO:0071222; GO:0060216; GO:0048872; GO:0042472; GO:0065002; GO:0035556; GO:0050804; GO:0060313; GO:0002692; GO:0050728; GO:0043314; GO:2000378; GO:0060268; GO:0050885; GO:0048008; GO:0043547; GO:0050766; GO:0046777; GO:0006468; GO:0051726; GO:0051171; GO:0035023; GO:0051056; GO:0043114; GO:0003014; GO:0007165"]
[246,123,"PK164","Bcr","Y177","Breakpoint cluster region protein",0,234,6,260,{"v":59.28,"d":"59"},{"v":104.163668232,"d":"104"},{"$nulls":3},0,256,10,226,{"v":55.596,"d":"56"},{"v":97.1381706996,"d":"97"},{"$nulls":6},0,210,10,263,{"v":52.6,"d":"53"},{"v":89.99025764000001,"d":"90"},{"$nulls":7},"BCR","X","PSTK","Protein kinase - Receptor-serine kinase","Protein-serine/threonine kinase","Atypical","BCR",{"$nulls":6},"PF(pY)VN","Corresponds to amino acid residues P175 to N179.","Y177 phosphorylation stimulates phosphotransferase activity. Phosphorylation induces interaction with Gab2, Grb2 and SOS1, and inhibits interaction with Hck. This is the major site of phosphorylation of Bcr by mass spectrometry stydues (≥1018 reports).","Abl1; Bcr-Abl; Fes; Fyn; Hck; Lyn",null,"P11274","P11274","P11274","P11274"]
[247,124,"PK538","Bcr","Y177","Breakpoint cluster region protein",0,2503,10,854,{"v":2129.022,"d":"2129"},{"v":3741.0044073318,"d":"3741"},{"$f":"(L260+L261)/2","v":{"v":3795.3617466832998,"d":"3795"}},{"$f":"SQRT((M260-L260)*(M260-L260))","v":{"v":54.35733935149983,"d":"54"}},{"$f":"N260/M260*100","v":{"v":1.4322044374031477,"d":"1"}},0,4604,16,747,{"v":3427.236,"d":"3427"},{"v":5988.1184904636,"d":"5988"},{"$f":"(U260+U261)/2","v":{"v":4436.0638227034,"d":"4436"}},{"$f":"SQRT((V260-U260)*(V260-U260))","v":{"v":1552.0546677602006,"d":"1552"}},{"$f":"W260/V260*100","v":{"v":34.987203290829946,"d":"35"}},{"$f":"X260+O260","v":{"v":36.4194077282331,"d":"36"}},{"$f":"(V260/M260*100)-100","v":{"v":16.881186004996707,"d":"17"}},null,0,1404,10,850,{"v":1184.9,"d":"1185"},{"v":2027.1759748600002,"d":"2027"},{"$f":"(AG260+AG261)/2","v":{"v":3156.8565271698008,"d":"3157"}},{"$f":"SQRT((AH260-AG260)*(AH260-AG260))","v":{"v":1129.6805523098005,"d":"1130"}},{"$f":"AI260/AH260*100","v":{"v":35.78498238950969,"d":"36"}},{"$f":"AJ260+O260","v":{"v":37.217186826912844,"d":"37"}},{"$f":"(AH260/M260*100)-100","v":{"v":-16.823303340491265,"d":"-17"}},null,null,"BCR","X","PSTK","Protein kinase - Receptor-serine kinase","Protein-serine/threonine kinase","Atypical","BCR",{"$nulls":6},"KPF(pY)VNV(bA)C","Corresponds to amino acid residues K174 to V180; In the N-terminal portion of the protein kinase.","Y177 phosphorylation stimulates phosphotransferase activity. Phosphorylation induces interaction with Gab2, Grb2 and SOS1, and inhibits interaction with Hck. This is the major site of phosphorylation of Bcr by mass spectrometry stydues (≥1018 reports).","Abl1; Bcr-Abl; Fes; Fyn; Hck; Lyn","EC 2.7.11.1; GTPase activating protein, Rac/Rho; Protein kinase, Ser/Thr (non-receptor); ATYPICAL group; BCR family","P11274","P11274","P11274","P11274","GO:0030054; GO:0005829; GO:0070062; GO:0098978; GO:0016020; GO:0014069; GO:0099092; GO:0045211; GO:0032991; GO:0098685","GO:0005524; GO:0005096; GO:0016301; GO:0004674; GO:0004713; GO:0005089","GO:0030036; GO:0007420; GO:0071222; GO:0060216; GO:0048872; GO:0042472; GO:0065002; GO:0035556; GO:0050804; GO:0060313; GO:0002692; GO:0050728; GO:0043314; GO:2000378; GO:0060268; GO:0050885; GO:0048008; GO:0043547; GO:0050766; GO:0046777; GO:0006468; GO:0051726; GO:0051171; GO:0035023; GO:0051056; GO:0043114; GO:0003014; GO:0007165"]
[248,124,"PK538","Bcr","Y177","Breakpoint cluster region protein",0,3448,14,638,{"v":2190.892,"d":"2191"},{"v":3849.7190860347996,"d":"3850"},{"$nulls":3},0,1842,10,901,{"v":1650.632,"d":"1651"},{"v":2884.0091549432,"d":"2884"},{"$nulls":6},0,3752,18,671,{"v":2505.514,"d":"2506"},{"v":4286.537079479601,"d":"4287"},{"$nulls":7},"BCR","X","PSTK","Protein kinase - Receptor-serine kinase","Protein-serine/threonine kinase","Atypical","BCR",{"$nulls":6},"KPF(pY)VNV(bA)C","Corresponds to amino acid residues K174 to V180; In the N-terminal portion of the protein kinase.","Y177 phosphorylation stimulates phosphotransferase activity. Phosphorylation induces interaction with Gab2, Grb2 and SOS1, and inhibits interaction with Hck. This is the major site of phosphorylation of Bcr by mass spectrometry stydues (≥1018 reports).","Abl1; Bcr-Abl; Fes; Fyn; Hck; Lyn",null,"P11274","P11274","P11274","P11274"]
[249,125,"PK539","Bcr","Y591","Breakpoint cluster region protein",0,4913,18,673,{"v":3294.335,"d":"3294"},{"v":5788.6305328114995,"d":"5789"},{"$f":"(L262+L263)/2","v":{"v":5412.50006026475,"d":"5413"}},{"$f":"SQRT((M262-L262)*(M262-L262))","v":{"v":376.13047254674984,"d":"376"}},{"$f":"N262/M262*100","v":{"v":6.949292717945053,"d":"7"}},0,4882,20,630,{"v":3063.06,"d":"3063"},{"v":5351.824684206,"d":"5352"},{"$f":"(U262+U263)/2","v":{"v":5322.5343702696,"d":"5323"}},{"$f":"SQRT((V262-U262)*(V262-U262))","v":{"v":29.290313936399798,"d":"29"}},{"$f":"W262/V262*100","v":{"v":0.5503076523095551,"d":"1"}},{"$f":"X262+O262","v":{"v":7.499600370254608,"d":"7"}},{"$f":"(V262/M262*100)-100","v":{"v":-1.6621836303637707,"d":"-2"}},null,0,5256,18,625,{"v":3273.75,"d":"3274"},{"v":5600.8670332500005,"d":"5601"},{"$f":"(AG262+AG263)/2","v":{"v":5962.966615560001,"d":"5963"}},{"$f":"SQRT((AH262-AG262)*(AH262-AG262))","v":{"v":362.0995823100002,"d":"362"}},{"$f":"AI262/AH262*100","v":{"v":6.072473747632986,"d":"6"}},{"$f":"AJ262+O262","v":{"v":13.02176646557804,"d":"13"}},{"$f":"(AH262/M262*100)-100","v":{"v":10.170282663577936,"d":"10"}},null,null,"BCR","X","PSTK","Protein kinase - Receptor-serine kinase","Protein-serine/threonine kinase","Atypical","BCR",{"$nulls":6},"LGV(pY)RAF(bA)C","Corresponds to amino acid residues L588 to F594; In the Rho-GEF domain. One of the main in vivo phosphorylation sites in Bcr.","The effect of Y591 phosphorylation is unclear. This is one of the major sites of phosphorylation of Bcr by mass spectrometry studies (≥257 reports).",null,"EC 2.7.11.1; GTPase activating protein, Rac/Rho; Protein kinase, Ser/Thr (non-receptor); ATYPICAL group; BCR family","P11274","P11274","P11274","P11274","GO:0030054; GO:0005829; GO:0070062; GO:0098978; GO:0016020; GO:0014069; GO:0099092; GO:0045211; GO:0032991; GO:0098685","GO:0005524; GO:0005096; GO:0016301; GO:0004674; GO:0004713; GO:0005089","GO:0030036; GO:0007420; GO:0071222; GO:0060216; GO:0048872; GO:0042472; GO:0065002; GO:0035556; GO:0050804; GO:0060313; GO:0002692; GO:0050728; GO:0043314; GO:2000378; GO:0060268; GO:0050885; GO:0048008; GO:0043547; GO:0050766; GO:0046777; GO:0006468; GO:0051726; GO:0051171; GO:0035023; GO:0051056; GO:0043114; GO:0003014; GO:0007165"]
[250,125,"PK539","Bcr","Y591","Breakpoint cluster region protein",0,4872,14,590,{"v":2866.22,"d":"2866"},{"v":5036.369587718,"d":"5036"},{"$nulls":3},0,4682,14,649,{"v":3029.532,"d":"3030"},{"v":5293.2440563332,"d":"5293"},{"$nulls":6},0,5048,18,735,{"v":3697.05,"d":"3697"},{"v":6325.066197870001,"d":"6325"},{"$nulls":7},"BCR","X","PSTK","Protein kinase - Receptor-serine kinase","Protein-serine/threonine kinase","Atypical","BCR",{"$nulls":6},"LGV(pY)RAF(bA)C","Corresponds to amino acid residues L588 to F594; In the Rho-GEF domain. One of the main in vivo phosphorylation sites in Bcr.","The effect of Y591 phosphorylation is unclear. This is one of the major sites of phosphorylation of Bcr by mass spectrometry studies (≥257 reports).",null,null,"P11274","P11274","P11274","P11274"]
[251,126,"PK540","Bcr","Y644","Breakpoint cluster region protein",0,6252,14,737,{"v":4597.406,"d":"4597"},{"v":8078.317700941399,"d":"8078"},{"$f":"(L264+L265)/2","v":{"v":8520.458911080448,"d":"8520"}},{"$f":"SQRT((M264-L264)*(M264-L264))","v":{"v":442.1412101390488,"d":"442"}},{"$f":"N264/M264*100","v":{"v":5.189171319916412,"d":"5"}},0,6492,20,772,{"v":4996.384,"d":"4996"},{"v":8729.7575701984,"d":"8730"},{"$f":"(U264+U265)/2","v":{"v":8031.863948375201,"d":"8032"}},{"$f":"SQRT((V264-U264)*(V264-U264))","v":{"v":697.8936218231993,"d":"698"}},{"$f":"W264/V264*100","v":{"v":8.689061795728986,"d":"9"}},{"$f":"X264+O264","v":{"v":13.878233115645397,"d":"14"}},{"$f":"(V264/M264*100)-100","v":{"v":-5.734373791414598,"d":"-6"}},null,0,6257,16,700,{"v":4368.7,"d":"4369"},{"v":7474.15282418,"d":"7474"},{"$f":"(AG264+AG265)/2","v":{"v":6970.421236571,"d":"6970"}},{"$f":"SQRT((AH264-AG264)*(AH264-AG264))","v":{"v":503.7315876089997,"d":"504"}},{"$f":"AI264/AH264*100","v":{"v":7.226702239545042,"d":"7"}},{"$f":"AJ264+O264","v":{"v":12.415873559461453,"d":"12"}},{"$f":"(AH264/M264*100)-100","v":{"v":-18.191950582540784,"d":"-18"}},null,null,"BCR","X","PSTK","Protein kinase - Receptor-serine kinase","Protein-serine/threonine kinase","Atypical","BCR",{"$nulls":6},"TLL(pY)KPV(bA)C","Corresponds to amino acid residues T641 to V647; In the Rho-GEF domain. One of the main in vivo phosphorylation sites in Bcr.","The effect of Y644 phosphorylation is unclear. This is one of the major sites of phosphorylation of Bcr by mass spectrometry studies (≥320 reports).",null,"EC 2.7.11.1; GTPase activating protein, Rac/Rho; Protein kinase, Ser/Thr (non-receptor); ATYPICAL group; BCR family","P11274","P11274","P11274","P11274","GO:0030054; GO:0005829; GO:0070062; GO:0098978; GO:0016020; GO:0014069; GO:0099092; GO:0045211; GO:0032991; GO:0098685","GO:0005524; GO:0005096; GO:0016301; GO:0004674; GO:0004713; GO:0005089","GO:0030036; GO:0007420; GO:0071222; GO:0060216; GO:0048872; GO:0042472; GO:0065002; GO:0035556; GO:0050804; GO:0060313; GO:0002692; GO:0050728; GO:0043314; GO:2000378; GO:0060268; GO:0050885; GO:0048008; GO:0043547; GO:0050766; GO:0046777; GO:0006468; GO:0051726; GO:0051171; GO:0035023; GO:0051056; GO:0043114; GO:0003014; GO:0007165"]
[252,126,"PK540","Bcr","Y644","Breakpoint cluster region protein",0,5353,12,955,{"v":5100.655,"d":"5101"},{"v":8962.600121219499,"d":"8963"},{"$nulls":3},0,5926,14,710,{"v":4197.52,"d":"4198"},{"v":7333.970326552001,"d":"7334"},{"$nulls":6},0,5532,14,685,{"v":3779.83,"d":"3780"},{"v":6466.689648962,"d":"6467"},{"$nulls":7},"BCR","X","PSTK","Protein kinase - Receptor-serine kinase","Protein-serine/threonine kinase","Atypical","BCR",{"$nulls":6},"TLL(pY)KPV(bA)C","Corresponds to amino acid residues T641 to V647; In the Rho-GEF domain. One of the main in vivo phosphorylation sites in Bcr.","The effect of Y644 phosphorylation is unclear. This is one of the major sites of phosphorylation of Bcr by mass spectrometry studies (≥320 reports).",null,null,"P11274","P11274","P11274","P11274"]
[253,127,"PK541","BLK","Y187","B lymphoid tyrosine kinase",0,534,12,536,{"v":279.792,"d":"280"},{"v":491.63564544479993,"d":"492"},{"$f":"(L266+L267)/2","v":{"v":454.60553167419994,"d":"455"}},{"$f":"SQRT((M266-L266)*(M266-L266))","v":{"v":37.030113770599996,"d":"37"}},{"$f":"N266/M266*100","v":{"v":8.145548434975533,"d":"8"}},0,492,12,501,{"v":240.48,"d":"240"},{"v":420.17028724799997,"d":"420"},{"$f":"(U266+U267)/2","v":{"v":377.71558114065,"d":"378"}},{"$f":"SQRT((V266-U266)*(V266-U266))","v":{"v":42.45470610734998,"d":"42"}},{"$f":"W266/V266*100","v":{"v":11.239860950173806,"d":"11"}},{"$f":"X266+O266","v":{"v":19.385409385149337,"d":"19"}},{"$f":"(V266/M266*100)-100","v":{"v":-16.913553658351503,"d":"-17"}},null,0,561,10,490,{"v":269.99,"d":"270"},{"v":461.910069586,"d":"462"},{"$f":"(AG266+AG267)/2","v":{"v":472.5155754246,"d":"473"}},{"$f":"SQRT((AH266-AG266)*(AH266-AG266))","v":{"v":10.605505838599981,"d":"11"}},{"$f":"AI266/AH266*100","v":{"v":2.2444775135867068,"d":"2"}},{"$f":"AJ266+O266","v":{"v":10.39002594856224,"d":"10"}},{"$f":"(AH266/M266*100)-100","v":{"v":3.939688917651708,"d":"4"}},null,null,"BLK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"EGG(pY)YIS(bA)C","Corresponds to amino acid residues E184 to S190; In the SH2 domain. One of the two major in vivo phosphorylation sites in BLK.","The effect of Y187 phosphorylation is unclear. This is the major sites of phosphorylation of BLK by mass spectrometry studies (≥146 reports).",null,"Protein-tyrosine kinase, TK group, Src family","P51451","P51451","P51451","P51451","GO:0005829; GO:0031234","GO:0005524; GO:0004715; GO:0004713; GO:0005102","GO:0050853; GO:0030154; GO:0016477; GO:0045087; GO:0035556; GO:0038083; GO:0032024; GO:0050855; GO:0042127; GO:0007169"]
[254,127,"PK541","BLK","Y187","B lymphoid tyrosine kinase",0,505,14,484,{"v":237.644,"d":"238"},{"v":417.5754179036,"d":"418"},{"$nulls":3},0,395,12,501,{"v":191.883,"d":"192"},{"v":335.2608750333,"d":"335"},{"$nulls":6},0,466,12,622,{"v":282.388,"d":"282"},{"v":483.1210812632,"d":"483"},{"$nulls":7},"BLK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"EGG(pY)YIS(bA)C","Corresponds to amino acid residues E184 to S190; In the SH2 domain. One of the two major in vivo phosphorylation sites in BLK.","The effect of Y187 phosphorylation is unclear. This is the major sites of phosphorylation of BLK by mass spectrometry studies (≥146 reports).",null,null,"P51451","P51451","P51451","P51451"]
[255,128,"PK542","BLK","Y188","B lymphoid tyrosine kinase",0,14,2,731,{"v":8.772,"d":"9"},{"v":15.4136926068,"d":"15"},{"$f":"(L268+L269)/2","v":{"v":13.273487682599999,"d":"13"}},{"$f":"SQRT((M268-L268)*(M268-L268))","v":{"v":2.1402049242000007,"d":"2"}},{"$f":"N268/M268*100","v":{"v":16.123907863383643,"d":"16"}},0,10,2,752,{"v":6.016,"d":"6"},{"v":10.5112460416,"d":"11"},{"$f":"(U268+U269)/2","v":{"v":8.0162228788,"d":"8"}},{"$f":"SQRT((V268-U268)*(V268-U268))","v":{"v":2.495023162799999,"d":"2"}},{"$f":"W268/V268*100","v":{"v":31.124673060156915,"d":"31"}},{"$f":"X268+O268","v":{"v":47.24858092354056,"d":"47"}},{"$f":"(V268/M268*100)-100","v":{"v":-39.60726019802363,"d":"-40"}},null,0,12,2,707,{"v":7.07,"d":"7"},{"v":12.095648698000002,"d":"12"},{"$f":"(AG268+AG269)/2","v":{"v":9.743241773000001,"d":"10"}},{"$f":"SQRT((AH268-AG268)*(AH268-AG268))","v":{"v":2.3524069250000004,"d":"2"}},{"$f":"AI268/AH268*100","v":{"v":24.14398595258999,"d":"24"}},{"$f":"AJ268+O268","v":{"v":40.267893815973636,"d":"40"}},{"$f":"(AH268/M268*100)-100","v":{"v":-26.59621942639643,"d":"-27"}},null,null,"BLK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"GGY(pY)ISP(bA)C","Corresponds to amino acid residues G185 to P191; In the SH2 domain. One of the two major in vivo phosphorylation sites in BLK.","The effect of Y188 phosphorylation is unclear. This is one of the major sites of phosphorylation of BLK by mass spectrometry studies (≥97 reports).",null,"Protein-tyrosine kinase, TK group, Src family","P51451","P51451","P51451","P51451","GO:0005829; GO:0031234","GO:0005524; GO:0004715; GO:0004713; GO:0005102","GO:0050853; GO:0030154; GO:0016477; GO:0045087; GO:0035556; GO:0038083; GO:0032024; GO:0050855; GO:0042127; GO:0007169"]
[256,128,"PK542","BLK","Y188","B lymphoid tyrosine kinase",0,10,2,792,{"v":6.336,"d":"6"},{"v":11.1332827584,"d":"11"},{"$nulls":3},0,6,2,790,{"v":3.16,"d":"3"},{"v":5.521199716,"d":"6"},{"$nulls":6},0,10,4,720,{"v":4.32,"d":"4"},{"v":7.390834848000001,"d":"7"},{"$nulls":7},"BLK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"GGY(pY)ISP(bA)C","Corresponds to amino acid residues G185 to P191; In the SH2 domain. One of the two major in vivo phosphorylation sites in BLK.","The effect of Y188 phosphorylation is unclear. This is one of the major sites of phosphorylation of BLK by mass spectrometry studies (≥97 reports).",null,null,"P51451","P51451","P51451","P51451"]
[257,129,"PK543","BLK","Y389","B lymphoid tyrosine kinase",0,4159,12,755,{"$f":"(H270-I270)*J270/1000","v":{"v":3130.985,"d":"3131"}},{"v":5501.6005866965,"d":"5502"},{"$f":"(L270+L271)/2","v":{"v":5401.1146269262,"d":"5401"}},{"$f":"SQRT((M270-L270)*(M270-L270))","v":{"v":100.48595977029981,"d":"100"}},{"$f":"N270/M270*100","v":{"v":1.860467083393245,"d":"2"}},0,4118,18,766,{"$f":"(Q270-R270)*S270/1000","v":{"v":3140.6,"d":"3141"}},{"v":5487.30374306,"d":"5487"},{"$f":"(U270+U271)/2","v":{"v":5445.8388343068,"d":"5446"}},{"$f":"SQRT((V270-U270)*(V270-U270))","v":{"v":41.46490875319978,"d":"41"}},{"$f":"W270/V270*100","v":{"v":0.7614053594826561,"d":"1"}},{"$f":"X270+O270","v":{"v":2.621872442875901,"d":"3"}},{"$f":"(V270/M270*100)-100","v":{"v":0.8280551417597479,"d":"1"}},null,0,4435,14,825,{"$f":"(AC270-AD270)*AE270/1000","v":{"v":3647.325,"d":"3647"}},{"v":6239.994609255,"d":"6240"},{"$f":"(AG270+AG271)/2","v":{"v":5942.5425909268,"d":"5943"}},{"$f":"SQRT((AH270-AG270)*(AH270-AG270))","v":{"v":297.4520183282002,"d":"297"}},{"$f":"AI270/AH270*100","v":{"v":5.0054671679148965,"d":"5"}},{"$f":"AJ270+O270","v":{"v":6.865934251308142,"d":"7"}},{"$f":"(AH270/M270*100)-100","v":{"v":10.024374622627292,"d":"10"}},null,null,"BLK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"DSE(pY)TAQ(bA)C","Corresponds to amino acid residues D386 to Q392; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y389 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of phosphorylation of BLK by mass spectrometry studies (≥72 reports).",null,"Protein-tyrosine kinase, TK group, Src family","P51451","P51451","P51451","P51451","GO:0005829; GO:0031234","GO:0005524; GO:0004715; GO:0004713; GO:0005102","GO:0050853; GO:0030154; GO:0016477; GO:0045087; GO:0035556; GO:0038083; GO:0032024; GO:0050855; GO:0042127; GO:0007169"]
[258,129,"PK543","BLK","Y389","B lymphoid tyrosine kinase",0,3942,9,767,{"v":3016.611,"d":"3017"},{"v":5300.6286671559,"d":"5301"},{"$nulls":3},0,4000,14,776,{"v":3093.136,"d":"3093"},{"v":5404.3739255536,"d":"5404"},{"$nulls":6},0,4035,16,821,{"v":3299.599,"d":"3300"},{"v":5645.0905725986,"d":"5645"},{"$nulls":7},"BLK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"DSE(pY)TAQ(bA)C","Corresponds to amino acid residues D386 to Q392; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y389 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of phosphorylation of BLK by mass spectrometry studies (≥72 reports).",null,null,"P51451","P51451","P51451","P51451"]
[259,130,"PN013","BLNK","Y84","B-cell linker protein",0,923,14,580,{"v":527.22,"d":"527"},{"v":926.402988618,"d":"926"},{"$f":"(L272+L273)/2","v":{"v":897.0147067155,"d":"897"}},{"$f":"SQRT((M272-L272)*(M272-L272))","v":{"v":29.38828190250001,"d":"29"}},{"$f":"N272/M272*100","v":{"v":3.2762318925748555,"d":"3"}},0,1151,16,701,{"v":795.635,"d":"796"},{"v":1390.1454860885,"d":"1390"},{"$f":"(U272+U273)/2","v":{"v":1270.2908982662502,"d":"1270"}},{"$f":"SQRT((V272-U272)*(V272-U272))","v":{"v":119.85458782224987,"d":"120"}},{"$f":"W272/V272*100","v":{"v":9.435207950071339,"d":"9"}},{"$f":"X272+O272","v":{"v":12.711439842646195,"d":"13"}},{"$f":"(V272/M272*100)-100","v":{"v":41.613162945514546,"d":"42"}},null,0,1034,12,568,{"v":580.496,"d":"580"},{"v":993.1365893344,"d":"993"},{"$f":"(AG272+AG273)/2","v":{"v":1142.4759351404,"d":"1142"}},{"$f":"SQRT((AH272-AG272)*(AH272-AG272))","v":{"v":149.33934580599998,"d":"149"}},{"$f":"AI272/AH272*100","v":{"v":13.071552862743452,"d":"13"}},{"$f":"AJ272+O272","v":{"v":16.347784755318308,"d":"16"}},{"$f":"(AH272/M272*100)-100","v":{"v":27.36423679425262,"d":"27"}},{"$nulls":13},"X",null,"Not precisely defined.","Antibody raised against amino acid residues that encompass the Y84 phosphosite.","Y84 phosphorylation regulates transcription and molecular association, including inducing interaction with Btk, Nck2, PLCG1, and VAV1. This is one of the major in vivo phosphorylation sites in XXX.","Syk","Adapter/scaffold protein","Q8WV28","Q8WV28",null,"Q8WV28","GO:0005737; GO:0036464; GO:0005829; GO:0005622; GO:0005886","GO:0005070; GO:0005068","GO:0030183; GO:0006959; GO:0006954; GO:0035556"]
[260,130,"PN013","BLNK","Y84","B-cell linker protein",0,918,12,545,{"v":493.77,"d":"494"},{"v":867.626424813,"d":"868"},{"$nulls":3},0,1130,14,590,{"v":658.44,"d":"658"},{"v":1150.4363104440001,"d":"1150"},{"$nulls":6},0,1262,16,606,{"v":755.076,"d":"755"},{"v":1291.8152809464,"d":"1292"},{"$nulls":18},"X",null,"Not precisely defined.","Antibody raised against amino acid residues that encompass the Y84 phosphosite.","Y84 phosphorylation regulates transcription and molecular association, including inducing interaction with Btk, Nck2, PLCG1, and VAV1. This is one of the major in vivo phosphorylation sites in XXX.","Syk",null,"Q8WV28","Q8WV28",null,"Q8WV28"]
[261,131,"NK363-1","BMPR2 (BMPR-II)","Pan-specific","Bone morphogenetic protein receptor type-2",0,104,10,506,{"v":47.564,"d":"48"},{"$f":"K274*1.7571469","v":{"v":83.5769351516,"d":"84"}},{"$f":"(L274+L275)/2","v":{"v":72.32768069779999,"d":"72"}},{"$f":"SQRT((M274-L274)*(M274-L274))","v":{"v":11.249254453800006,"d":"11"}},{"$f":"N274/M274*100","v":{"v":15.553180117584189,"d":"16"}},0,84,8,473,{"v":35.948,"d":"36"},{"$f":"T274*1.7472151","v":{"v":62.8088884148,"d":"63"}},{"$f":"(U274+U275)/2","v":{"v":46.5318325432,"d":"47"}},{"$f":"SQRT((V274-U274)*(V274-U274))","v":{"v":16.277055871600005,"d":"16"}},{"$f":"W274/V274*100","v":{"v":34.980474617002116,"d":"35"}},{"$f":"X274+O274","v":{"v":50.53365473458631,"d":"51"}},{"$f":"(V274/M274*100)-100","v":{"v":-35.665250020086205,"d":"-36"}},null,0,32,6,652,{"v":16.952,"d":"17"},{"v":29.002183412800004,"d":"29"},{"$f":"(AG274+AG275)/2","v":{"v":35.81817555040001,"d":"36"}},{"$f":"SQRT((AH274-AG274)*(AH274-AG274))","v":{"v":6.815992137600002,"d":"7"}},{"$f":"AI274/AH274*100","v":{"v":19.029423003439057,"d":"19"}},{"$f":"AJ274+O274","v":{"v":34.58260312102325,"d":"35"}},{"$f":"(AH274/M274*100)-100","v":{"v":-50.47791494924916,"d":"-50"}},null,null,"BMPR2","X","PSTK",{"$nulls":10},"Not precisely defined.","Antibody raised against amino acid residues 61-82 within an extracellular domain of human BMPR-II.",null,null,"EC 2.7.11.30; Cell cycle regulation; Receptor Ser/Thr kinase; TKL domain target; TKL</A> group; STKR family; Type2 subfamily","Q13873","Q13873","Q13873","Q13873","GO:0016324; GO:0009925; GO:0005901; GO:0005913; GO:0009986; GO:0005737; GO:0030425; GO:0005615; GO:0005887; GO:0043025; GO:0005654; GO:0005886; GO:0014069; GO:0044214","GO:0016362; GO:0005524; GO:0036122; GO:0098821; GO:0019838; GO:0046872","GO:0009952; GO:0060840; GO:0060413; GO:0001974; GO:0030509; GO:0007420; GO:0071773; GO:0009267; GO:0002063; GO:0003197; GO:0060350; GO:0072577; GO:0001935; GO:0060173; GO:0048286; GO:0001946; GO:0060836; GO:0001893; GO:0001707; GO:0003183; GO:0030308; GO:0003252; GO:1902731; GO:2000279; GO:0003085; GO:0045906; GO:0003151; GO:0003148; GO:0061626; GO:0048842; GO:0030513; GO:0030501; GO:0061036; GO:0010595; GO:0001938; GO:0010634; GO:0045778; GO:0045669; GO:0010862; GO:0045944; GO:0030166; GO:0042127; GO:0014916; GO:0061298; GO:1905314; GO:0006366; GO:0007178; GO:0003186; GO:0060841; GO:0060412"]
[262,131,"NK363-1","BMPR2 (BMPR-II)","Pan-specific","Bone morphogenetic protein receptor type-2",0,98,10,395,{"v":34.76,"d":"35"},{"v":61.07842624399999,"d":"61"},{"$nulls":3},0,34,8,666,{"v":17.316,"d":"17"},{"v":30.2547766716,"d":"30"},{"$nulls":6},0,78,8,356,{"v":24.92,"d":"25"},{"$f":"AF275*1.7108414","v":{"v":42.634167688000005,"d":"43"}},{"$nulls":7},"BMPR2","X","PSTK",{"$nulls":10},"Not precisely defined.","Antibody raised against amino acid residues 61-82 within an extracellular domain of human BMPR-II.",{"$nulls":3},"Q13873","Q13873","Q13873","Q13873"]
[263,132,"PK544","BMPR2 (BMPR-II)","S375","Bone morphogenetic protein receptor type-2",0,4468,12,917,{"v":4086.152,"d":"4086"},{"v":7179.9693197288,"d":"7180"},{"$f":"(L276+L277)/2","v":{"v":6453.9759636434,"d":"6454"}},{"$f":"SQRT((M276-L276)*(M276-L276))","v":{"v":725.9933560853997,"d":"726"}},{"$f":"N276/M276*100","v":{"v":11.248776880717754,"d":"11"}},0,4712,18,846,{"v":3971.124,"d":"3971"},{"v":6938.4078167724,"d":"6938"},{"$f":"(U276+U277)/2","v":{"v":6135.6183892056,"d":"6136"}},{"$f":"SQRT((V276-U276)*(V276-U276))","v":{"v":802.7894275668004,"d":"803"}},{"$f":"W276/V276*100","v":{"v":13.084083406802952,"d":"13"}},{"$f":"X276+O276","v":{"v":24.332860287520706,"d":"24"}},{"$f":"(V276/M276*100)-100","v":{"v":-4.932735669162312,"d":"-5"}},null,0,4381,8,739,{"v":3231.647,"d":"3232"},{"v":5528.8354777858,"d":"5529"},{"$f":"(AG276+AG277)/2","v":{"v":5043.4295678329,"d":"5043"}},{"$f":"SQRT((AH276-AG276)*(AH276-AG276))","v":{"v":485.4059099529004,"d":"485"}},{"$f":"AI276/AH276*100","v":{"v":9.624520446341306,"d":"10"}},{"$f":"AJ276+O276","v":{"v":20.87329732705906,"d":"21"}},{"$f":"(AH276/M276*100)-100","v":{"v":-21.855464038856113,"d":"-22"}},null,null,"BMPR2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","STKR","Type2",{"$nulls":5},"AAI(pS)EVG(bA)C","Corresponds to amino acid residues A372 to G378; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S375 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the minor in vivo phosphorylation sites in BMPR2 (≥4 reports from high throughput mass spectrometry studies).",null,"EC 2.7.11.30; Cell cycle regulation; Receptor Ser/Thr kinase; TKL domain target; TKL</A> group; STKR family; Type2 subfamily","Q13873","Q13873","Q13873","Q13873","GO:0016324; GO:0009925; GO:0005901; GO:0005913; GO:0009986; GO:0005737; GO:0030425; GO:0005615; GO:0005887; GO:0043025; GO:0005654; GO:0005886; GO:0014069; GO:0044214","GO:0016362; GO:0005524; GO:0036122; GO:0098821; GO:0019838; GO:0046872","GO:0009952; GO:0060840; GO:0060413; GO:0001974; GO:0030509; GO:0007420; GO:0071773; GO:0009267; GO:0002063; GO:0003197; GO:0060350; GO:0072577; GO:0001935; GO:0060173; GO:0048286; GO:0001946; GO:0060836; GO:0001893; GO:0001707; GO:0003183; GO:0030308; GO:0003252; GO:1902731; GO:2000279; GO:0003085; GO:0045906; GO:0003151; GO:0003148; GO:0061626; GO:0048842; GO:0030513; GO:0030501; GO:0061036; GO:0010595; GO:0001938; GO:0010634; GO:0045778; GO:0045669; GO:0010862; GO:0045944; GO:0030166; GO:0042127; GO:0014916; GO:0061298; GO:1905314; GO:0006366; GO:0007178; GO:0003186; GO:0060841; GO:0060412"]
[264,132,"PK544","BMPR2 (BMPR-II)","S375","Bone morphogenetic protein receptor type-2",0,4204,14,778,{"v":3259.82,"d":"3260"},{"v":5727.982607558,"d":"5728"},{"$nulls":3},0,4327,16,708,{"v":3052.188,"d":"3052"},{"v":5332.8289616388,"d":"5333"},{"$nulls":6},0,3818,12,700,{"v":2664.2,"d":"2664"},{"v":4558.0236578799995,"d":"4558"},{"$nulls":7},"BMPR2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","STKR","Type2",{"$nulls":5},"AAI(pS)EVG(bA)C","Corresponds to amino acid residues A372 to G378; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S375 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the minor in vivo phosphorylation sites in BMPR2 (≥4 reports from high throughput mass spectrometry studies).",null,null,"Q13873","Q13873","Q13873","Q13873"]
[265,133,"NK012","Bmx (Etk)","Pan-specific","Bone marrow X protein-tyrosine kinase",0,139,8,352,{"v":46.112,"d":"46"},{"v":81.0255578528,"d":"81"},{"$f":"(L278+L279)/2","v":{"v":68.9574729436,"d":"69"}},{"$f":"SQRT((M278-L278)*(M278-L278))","v":{"v":12.06808490920001,"d":"12"}},{"$f":"N278/M278*100","v":{"v":17.50076444806851,"d":"18"}},0,254,10,402,{"v":98.088,"d":"98"},{"v":171.38083472879998,"d":"171"},{"$f":"(U278+U279)/2","v":{"v":121.76342031899999,"d":"122"}},{"$f":"SQRT((V278-U278)*(V278-U278))","v":{"v":49.61741440979999,"d":"50"}},{"$f":"W278/V278*100","v":{"v":40.749031424881615,"d":"41"}},{"$f":"X278+O278","v":{"v":58.24979587295012,"d":"58"}},{"$f":"(V278/M278*100)-100","v":{"v":76.57755587793906,"d":"77"}},null,0,40,5,659,{"v":23.065,"d":"23"},{"v":39.460556891,"d":"39"},{"$f":"(AG278+AG279)/2","v":{"v":52.3731323575,"d":"52"}},{"$f":"SQRT((AH278-AG278)*(AH278-AG278))","v":{"v":12.912575466499995,"d":"13"}},{"$f":"AI278/AH278*100","v":{"v":24.654961208656584,"d":"25"}},{"$f":"AJ278+O278","v":{"v":42.155725656725096,"d":"42"}},{"$f":"(AH278/M278*100)-100","v":{"v":-24.050099109148405,"d":"-24"}},null,null,"BMX","X","PYK",{"$nulls":10},"Epitope undefined.",{"$nulls":3},"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; Tec family","P51813","P51813","P51813","P51813","GO:0005829; GO:0031234; GO:0005654; GO:0005886; GO:0032587","GO:0005524; GO:0046872; GO:0004715; GO:0004713","GO:0006915; GO:0007155; GO:0045087; GO:0035556; GO:0007498; GO:0001865; GO:0038083; GO:0006661; GO:0046777; GO:0006468; GO:0042127; GO:0007165; GO:0007169"]
[266,133,"NK012","Bmx (Etk)","Pan-specific","Bone marrow X protein-tyrosine kinase",0,122,8,284,{"v":32.376,"d":"32"},{"v":56.88938803439999,"d":"57"},{"$nulls":3},0,158,10,279,{"v":41.292,"d":"41"},{"v":72.1460059092,"d":"72"},{"$nulls":6},0,130,10,318,{"v":38.16,"d":"38"},{"v":65.285707824,"d":"65"},{"$nulls":7},"BMX","X","PYK",{"$nulls":10},"Epitope undefined.",{"$nulls":4},"P51813","P51813","P51813","P51813"]
[267,134,"PK545","Bmx (Etk)","Y40","Bone marrow X protein-tyrosine kinase",0,2363,14,584,{"v":1371.816,"d":"1372"},{"v":2410.4822317704,"d":"2410"},{"$f":"(L280+L281)/2","v":{"v":2384.9262872568,"d":"2385"}},{"$f":"SQRT((M280-L280)*(M280-L280))","v":{"v":25.555944513600025,"d":"26"}},{"$f":"N280/M280*100","v":{"v":1.0715611903877789,"d":"1"}},0,2252,14,530,{"v":1186.14,"d":"1186"},{"v":2072.441718714,"d":"2072"},{"$f":"(U280+U281)/2","v":{"v":2085.5563152546,"d":"2086"}},{"$f":"SQRT((V280-U280)*(V280-U280))","v":{"v":13.114596540599905,"d":"13"}},{"$f":"W280/V280*100","v":{"v":0.6288296530126977,"d":"1"}},{"$f":"X280+O280","v":{"v":1.7003908434004766,"d":"2"}},{"$f":"(V280/M280*100)-100","v":{"v":-12.552588044410484,"d":"-13"}},null,0,2292,10,541,{"v":1234.562,"d":"1235"},{"v":2112.1397804668,"d":"2112"},{"$f":"(AG280+AG281)/2","v":{"v":2028.7739007276,"d":"2029"}},{"$f":"SQRT((AH280-AG280)*(AH280-AG280))","v":{"v":83.36587973919995,"d":"83"}},{"$f":"AI280/AH280*100","v":{"v":4.109175483246388,"d":"4"}},{"$f":"AJ280+O280","v":{"v":5.180736673634167,"d":"5"}},{"$f":"(AH280/M280*100)-100","v":{"v":-14.933475656342196,"d":"-15"}},null,null,"BMX","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"NLS(pY)YEY(bA)C","Corresponds to amino acid residues N37 to Y43; In the PH domain domain.","Y40 phosphorylation stimulates phosphotransferase activity and regulates cell motility, cytoskeletal reorganization, intracellular location, and induces interaction with FAK. This phosphorylation site has not apparently been detected by mass spectrometry.",null,"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; Tec family","P51813","P51813","P51813","P51813","GO:0005829; GO:0031234; GO:0005654; GO:0005886; GO:0032587","GO:0005524; GO:0046872; GO:0004715; GO:0004713","GO:0006915; GO:0007155; GO:0045087; GO:0035556; GO:0007498; GO:0001865; GO:0038083; GO:0006661; GO:0046777; GO:0006468; GO:0042127; GO:0007165; GO:0007169"]
[268,134,"PK545","Bmx (Etk)","Y40","Bone marrow X protein-tyrosine kinase",0,2204,10,612,{"v":1342.728,"d":"1343"},{"v":2359.3703427432,"d":"2359"},{"$nulls":3},0,2222,14,544,{"v":1201.152,"d":"1201"},{"v":2098.6709117952,"d":"2099"},{"$nulls":6},0,2250,16,509,{"v":1137.106,"d":"1137"},{"v":1945.4080209884,"d":"1945"},{"$nulls":7},"BMX","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"NLS(pY)YEY(bA)C","Corresponds to amino acid residues N37 to Y43; In the PH domain domain.","Y40 phosphorylation stimulates phosphotransferase activity and regulates cell motility, cytoskeletal reorganization, intracellular location, and induces interaction with FAK. This phosphorylation site has not apparently been detected by mass spectrometry.",null,null,"P51813","P51813","P51813","P51813"]
[269,135,"NN395-1","BRCA1","Pan-specific","Breast cancer type 1 susceptibility protein homolog",0,164,12,532,{"v":80.864,"d":"81"},{"v":142.0899269216,"d":"142"},{"$f":"(L282+L283)/2","v":{"v":157.370076364,"d":"157"}},{"$f":"SQRT((M282-L282)*(M282-L282))","v":{"v":15.280149442399988,"d":"15"}},{"$f":"N282/M282*100","v":{"v":9.709691826708344,"d":"10"}},0,226,14,637,{"v":135.044,"d":"135"},{"v":235.95091596440002,"d":"236"},{"$f":"(U282+U283)/2","v":{"v":194.34885082585004,"d":"194"}},{"$f":"SQRT((V282-U282)*(V282-U282))","v":{"v":41.60206513854999,"d":"42"}},{"$f":"W282/V282*100","v":{"v":21.405871432616962,"d":"21"}},{"$f":"X282+O282","v":{"v":31.115563259325306,"d":"31"}},{"$f":"(V282/M282*100)-100","v":{"v":23.49797071732837,"d":"23"}},null,0,204,10,507,{"v":98.358,"d":"98"},{"v":168.2749384212,"d":"168"},{"$f":"(AG282+AG283)/2","v":{"v":156.77295168900002,"d":"157"}},{"$f":"SQRT((AH282-AG282)*(AH282-AG282))","v":{"v":11.501986732199981,"d":"12"}},{"$f":"AI282/AH282*100","v":{"v":7.3367163201833225,"d":"7"}},{"$f":"AJ282+O282","v":{"v":17.046408146891665,"d":"17"}},{"$f":"(AH282/M282*100)-100","v":{"v":-0.37943978219773555,"d":"-0"}},{"$nulls":6},"Transcription, coactivator/corepressor",{"$nulls":3},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against whole mouse BRCA1 protein.",null,null,"Nuclear receptor co-regulator; Transcription, coactivator/corepressor; Ubiquitin conjugating system; Tumor suppressor","P38398","P38398",null,"P38398","GO:0070531; GO:0031436; GO:0005694; GO:0005737; GO:0008274; GO:0000800; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:1990904; GO:0000151","GO:0050681; GO:0003684; GO:0003677; GO:0019899; GO:0042802; GO:0003723; GO:0070063; GO:0003713; GO:0044212; GO:0015631; GO:0031625; GO:0004842; GO:0008270","GO:0030521; GO:0006915; GO:0006974; GO:0071681; GO:0071356; GO:0007098; GO:0043009; GO:0007059; GO:0006978; GO:0000729; GO:0006260; GO:0009048; GO:0006302; GO:0000724; GO:0006303; GO:0006633; GO:0008630; GO:0044818; GO:0046600; GO:1902042; GO:0045717; GO:0070317; GO:0035067; GO:0051572; GO:0051573; GO:0033147; GO:2000378; GO:0045892; GO:0045766; GO:0071158; GO:0045739; GO:0010628; GO:0035066; GO:0051571; GO:2000617; GO:0051574; GO:2000620; GO:0070512; GO:0031398; GO:0045893; GO:0045944; GO:0010575; GO:0006301; GO:0051865; GO:0016579; GO:0085020; GO:0016567; GO:0042981; GO:0042127; GO:0044030; GO:0006349; GO:0006357; GO:0006359; GO:0043627; GO:0010212; GO:0072425; GO:0006351"]
[270,135,"NN395-1","BRCA1","Pan-specific","Breast cancer type 1 susceptibility protein homolog",0,188,10,552,{"v":98.256,"d":"98"},{"v":172.6502258064,"d":"173"},{"$nulls":3},0,171,10,543,{"v":87.423,"d":"87"},{"v":152.74678568730002,"d":"153"},{"$nulls":6},0,195,12,464,{"v":84.912,"d":"85"},{"v":145.27096495680001,"d":"145"},{"$nulls":11},"Transcription, coactivator/corepressor",{"$nulls":3},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against whole mouse BRCA1 protein.",{"$nulls":3},"P38398","P38398",null,"P38398"]
[271,136,"PN690","BRCA1","T509","Breast cancer type 1 susceptibility protein",0,3802,8,946,{"v":3589.124,"d":"3589"},{"v":6306.6181103156,"d":"6307"},{"$f":"(L284+L285)/2","v":{"v":9346.2678753938,"d":"9346"}},{"$f":"SQRT((M284-L284)*(M284-L284))","v":{"v":3039.6497650782003,"d":"3040"}},{"$f":"N284/M284*100","v":{"v":32.522604804435126,"d":"33"}},0,12062,16,779,{"v":9383.834,"d":"9384"},{"v":16395.576460693403,"d":"16396"},{"$f":"(U284+U285)/2","v":{"v":14494.8545364376,"d":"14495"}},{"$f":"SQRT((V284-U284)*(V284-U284))","v":{"v":1900.7219242558022,"d":"1901"}},{"$f":"W284/V284*100","v":{"v":13.113080365709848,"d":"13"}},{"$f":"X284+O284","v":{"v":45.635685170144974,"d":"46"}},{"$f":"(V284/M284*100)-100","v":{"v":55.087086414446134,"d":"55"}},null,0,11331,18,746,{"v":8439.498,"d":"8439"},{"v":14438.6425736172,"d":"14439"},{"$f":"(AG284+AG285)/2","v":{"v":13590.5237447124,"d":"13591"}},{"$f":"SQRT((AH284-AG284)*(AH284-AG284))","v":{"v":848.1188289048005,"d":"848"}},{"$f":"AI284/AH284*100","v":{"v":6.240516148134277,"d":"6"}},{"$f":"AJ284+O284","v":{"v":38.7631209525694,"d":"39"}},{"$f":"(AH284/M284*100)-100","v":{"v":45.411237147317166,"d":"45"}},{"$nulls":3},"X",null,"Transcription, coactivator/corepressor",{"$nulls":9},"RRP(pT)SGL(bA)C","Corresponds to amino acid residues R506 to L512.","T509 phosphorylation induces transcription. This is the major site of phosphorylation of BRCA1 by mass spectrometry studies (≥79 reports). This human phosphosite is not highly conserved in nature, but is found in the mouse.","Akt1","Nuclear receptor co-regulator; Transcription, coactivator/corepressor; Ubiquitin conjugating system; Tumor suppressor","P38398","P38398",null,"P38398","GO:0070531; GO:0031436; GO:0005694; GO:0005737; GO:0008274; GO:0000800; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:1990904; GO:0000151","GO:0050681; GO:0003684; GO:0003677; GO:0019899; GO:0042802; GO:0003723; GO:0070063; GO:0003713; GO:0044212; GO:0015631; GO:0031625; GO:0004842; GO:0008270","GO:0030521; GO:0006915; GO:0006974; GO:0071681; GO:0071356; GO:0007098; GO:0043009; GO:0007059; GO:0006978; GO:0000729; GO:0006260; GO:0009048; GO:0006302; GO:0000724; GO:0006303; GO:0006633; GO:0008630; GO:0044818; GO:0046600; GO:1902042; GO:0045717; GO:0070317; GO:0035067; GO:0051572; GO:0051573; GO:0033147; GO:2000378; GO:0045892; GO:0045766; GO:0071158; GO:0045739; GO:0010628; GO:0035066; GO:0051571; GO:2000617; GO:0051574; GO:2000620; GO:0070512; GO:0031398; GO:0045893; GO:0045944; GO:0010575; GO:0006301; GO:0051865; GO:0016579; GO:0085020; GO:0016567; GO:0042981; GO:0042127; GO:0044030; GO:0006349; GO:0006357; GO:0006359; GO:0043627; GO:0010212; GO:0072425; GO:0006351"]
[272,136,"PN690","BRCA1","T509","Breast cancer type 1 susceptibility protein",0,10374,8,680,{"v":7048.88,"d":"7049"},{"v":12385.917640472,"d":"12386"},{"$nulls":3},0,10837,14,666,{"v":7208.118,"d":"7208"},{"v":12594.1326121818,"d":"12594"},{"$nulls":6},0,10271,12,726,{"v":7448.034,"d":"7448"},{"v":12742.4049158076,"d":"12742"},{"$nulls":8},"X",null,"Transcription, coactivator/corepressor",{"$nulls":9},"RRP(pT)SGL(bA)C","Corresponds to amino acid residues R506 to L512.","T509 phosphorylation induces transcription. This is the major site of phosphorylation of BRCA1 by mass spectrometry studies (≥79 reports). This human phosphosite is not highly conserved in nature, but is found in the mouse.","Akt1",null,"P38398","P38398",null,"P38398"]
[273,137,"PN212","BRCA1","S988","Breast cancer type 1 susceptibility protein",0,280,12,558,{"v":149.544,"d":"150"},{"v":262.7707760136,"d":"263"},{"$f":"(L286+L287)/2","v":{"v":247.2270545362,"d":"247"}},{"$f":"SQRT((M286-L286)*(M286-L286))","v":{"v":15.543721477400027,"d":"16"}},{"$f":"N286/M286*100","v":{"v":6.287225120470806,"d":"6"}},0,280,14,667,{"v":177.422,"d":"177"},{"v":309.9943974722,"d":"310"},{"$f":"(U286+U287)/2","v":{"v":258.4952323997,"d":"258"}},{"$f":"SQRT((V286-U286)*(V286-U286))","v":{"v":51.49916507249998,"d":"51"}},{"$f":"W286/V286*100","v":{"v":19.92267501199753,"d":"20"}},{"$f":"X286+O286","v":{"v":26.209900132468334,"d":"26"}},{"$f":"(V286/M286*100)-100","v":{"v":4.557825552158604,"d":"5"}},null,0,293,10,511,{"v":144.613,"d":"145"},{"v":247.40990737820002,"d":"247"},{"$f":"(AG286+AG287)/2","v":{"v":272.30008348610005,"d":"272"}},{"$f":"SQRT((AH286-AG286)*(AH286-AG286))","v":{"v":24.890176107900032,"d":"25"}},{"$f":"AI286/AH286*100","v":{"v":9.140715562494709,"d":"9"}},{"$f":"AJ286+O286","v":{"v":15.427940682965515,"d":"15"}},{"$f":"(AH286/M286*100)-100","v":{"v":10.1417011163836,"d":"10"}},{"$nulls":3},"X",null,"Transcription, coactivator/corepressor",{"$nulls":9},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S988 phosphosite.","S988 phosphorylation induces activity. This phosphorylation site has not apparently been detected by mass spectrometry.","Chk2","Nuclear receptor co-regulator; Transcription, coactivator/corepressor; Ubiquitin conjugating system; Tumor suppressor","P38398","P38398",null,"P38398","GO:0070531; GO:0031436; GO:0005694; GO:0005737; GO:0008274; GO:0000800; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:1990904; GO:0000151","GO:0050681; GO:0003684; GO:0003677; GO:0019899; GO:0042802; GO:0003723; GO:0070063; GO:0003713; GO:0044212; GO:0015631; GO:0031625; GO:0004842; GO:0008270","GO:0030521; GO:0006915; GO:0006974; GO:0071681; GO:0071356; GO:0007098; GO:0043009; GO:0007059; GO:0006978; GO:0000729; GO:0006260; GO:0009048; GO:0006302; GO:0000724; GO:0006303; GO:0006633; GO:0008630; GO:0044818; GO:0046600; GO:1902042; GO:0045717; GO:0070317; GO:0035067; GO:0051572; GO:0051573; GO:0033147; GO:2000378; GO:0045892; GO:0045766; GO:0071158; GO:0045739; GO:0010628; GO:0035066; GO:0051571; GO:2000617; GO:0051574; GO:2000620; GO:0070512; GO:0031398; GO:0045893; GO:0045944; GO:0010575; GO:0006301; GO:0051865; GO:0016579; GO:0085020; GO:0016567; GO:0042981; GO:0042127; GO:0044030; GO:0006349; GO:0006357; GO:0006359; GO:0043627; GO:0010212; GO:0072425; GO:0006351"]
[274,137,"PN212","BRCA1","S988","Breast cancer type 1 susceptibility protein",0,250,12,554,{"v":131.852,"d":"132"},{"v":231.6833330588,"d":"232"},{"$nulls":3},0,246,10,502,{"v":118.472,"d":"118"},{"v":206.9960673272,"d":"207"},{"$nulls":6},0,302,12,599,{"v":173.71,"d":"174"},{"v":297.19025959400005,"d":"297"},{"$nulls":8},"X",null,"Transcription, coactivator/corepressor",{"$nulls":9},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S988 phosphosite.","S988 phosphorylation induces activity. This phosphorylation site has not apparently been detected by mass spectrometry.","Chk2",null,"P38398","P38398",null,"P38398"]
[275,138,"PN116","BRCA1","S1423","Breast cancer type 1 susceptibility protein",0,184,12,652,{"v":112.144,"d":"112"},{"v":197.0534819536,"d":"197"},{"$f":"(L288+L289)/2","v":{"v":101.0781182756,"d":"101"}},{"$f":"SQRT((M288-L288)*(M288-L288))","v":{"v":95.975363678,"d":"96"}},{"$f":"N288/M288*100","v":{"v":94.95167234545579,"d":"95"}},0,2028,12,367,{"v":739.872,"d":"740"},{"v":1292.7155304671999,"d":"1293"},{"$f":"(U288+U289)/2","v":{"v":981.6500901387,"d":"982"}},{"$f":"SQRT((V288-U288)*(V288-U288))","v":{"v":311.0654403284999,"d":"311"}},{"$f":"W288/V288*100","v":{"v":31.688016275183006,"d":"32"}},{"$f":"X288+O288","v":{"v":126.6396886206388,"d":"127"}},{"$f":"(V288/M288*100)-100","v":{"v":871.1796251114697,"d":"871"}},null,0,1307,8,309,{"v":401.391,"d":"401"},{"v":686.7163403874,"d":"687"},{"$f":"(AG288+AG289)/2","v":{"v":345.6575410353,"d":"346"}},{"$f":"SQRT((AH288-AG288)*(AH288-AG288))","v":{"v":341.0587993521,"d":"341"}},{"$f":"AI288/AH288*100","v":{"v":98.66956708960375,"d":"99"}},{"$f":"AJ288+O288","v":{"v":193.62123943505952,"d":"194"}},{"$f":"(AH288/M288*100)-100","v":{"v":241.9706925022375,"d":"242"}},{"$nulls":3},"X",null,"Transcription, coactivator/corepressor",{"$nulls":9},"HG(pS)QP","Corresponds to amino acid residues  H1421 to P1425; Surrounds the S1423 phosphosite.","S1423 phosphorylation induces interaction with ATM. This is one of the minor in vivo phosphorylation sites in BRCA1 (≥2 reports from high throughput mass spectrometry studies).","ATM; ATR","Nuclear receptor co-regulator; Transcription, coactivator/corepressor; Ubiquitin conjugating system; Tumor suppressor","P38398","P38398",null,"P38398","GO:0070531; GO:0031436; GO:0005694; GO:0005737; GO:0008274; GO:0000800; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:1990904; GO:0000151","GO:0050681; GO:0003684; GO:0003677; GO:0019899; GO:0042802; GO:0003723; GO:0070063; GO:0003713; GO:0044212; GO:0015631; GO:0031625; GO:0004842; GO:0008270","GO:0030521; GO:0006915; GO:0006974; GO:0071681; GO:0071356; GO:0007098; GO:0043009; GO:0007059; GO:0006978; GO:0000729; GO:0006260; GO:0009048; GO:0006302; GO:0000724; GO:0006303; GO:0006633; GO:0008630; GO:0044818; GO:0046600; GO:1902042; GO:0045717; GO:0070317; GO:0035067; GO:0051572; GO:0051573; GO:0033147; GO:2000378; GO:0045892; GO:0045766; GO:0071158; GO:0045739; GO:0010628; GO:0035066; GO:0051571; GO:2000617; GO:0051574; GO:2000620; GO:0070512; GO:0031398; GO:0045893; GO:0045944; GO:0010575; GO:0006301; GO:0051865; GO:0016579; GO:0085020; GO:0016567; GO:0042981; GO:0042127; GO:0044030; GO:0006349; GO:0006357; GO:0006359; GO:0043627; GO:0010212; GO:0072425; GO:0006351"]
[276,138,"PN116","BRCA1","S1423","Breast cancer type 1 susceptibility protein",1,10,2,363,{"v":2.904,"d":"3"},{"v":5.1027545976,"d":"5"},{"$nulls":3},1,1373,12,282,{"v":383.802,"d":"384"},{"v":670.5846498102001,"d":"671"},{"$nulls":6},1,9,2,384,{"v":2.688,"d":"3"},{"v":4.5987416832,"d":"5"},{"$nulls":8},"X",null,"Transcription, coactivator/corepressor",{"$nulls":9},"HG(pS)QP","Corresponds to amino acid residues  H1421 to P1425; Surrounds the S1423 phosphosite.","S1423 phosphorylation induces interaction with ATM. This is one of the minor in vivo phosphorylation sites in BRCA1 (≥2 reports from high throughput mass spectrometry studies).","ATM; ATR",null,"P38398","P38398",null,"P38398"]
[277,139,"NK013-2","BRD2","Pan-specific","Bromodomain-containing protein 2",0,170,8,523,{"v":84.726,"d":"85"},{"v":148.8760282494,"d":"149"},{"$f":"(L290+L291)/2","v":{"v":142.90260736285,"d":"143"}},{"$f":"SQRT((M290-L290)*(M290-L290))","v":{"v":5.973420886550002,"d":"6"}},{"$f":"N290/M290*100","v":{"v":4.180064308681673,"d":"4"}},0,138,10,496,{"v":63.488,"d":"63"},{"v":110.9271922688,"d":"111"},{"$f":"(U290+U291)/2","v":{"v":103.1625683644,"d":"103"}},{"$f":"SQRT((V290-U290)*(V290-U290))","v":{"v":7.764623904399997,"d":"8"}},{"$f":"W290/V290*100","v":{"v":7.526590339407896,"d":"8"}},{"$f":"X290+O290","v":{"v":11.706654648089568,"d":"12"}},{"$f":"(V290/M290*100)-100","v":{"v":-27.80917698551461,"d":"-28"}},null,0,178,10,513,{"v":86.184,"d":"86"},{"v":147.4471552176,"d":"147"},{"$f":"(AG290+AG291)/2","v":{"v":141.6140414643,"d":"142"}},{"$f":"SQRT((AH290-AG290)*(AH290-AG290))","v":{"v":5.833113753300012,"d":"6"}},{"$f":"AI290/AH290*100","v":{"v":4.119022162622556,"d":"4"}},{"$f":"AJ290+O290","v":{"v":8.299086471304228,"d":"8"}},{"$f":"(AH290/M290*100)-100","v":{"v":-0.9017091586566863,"d":"-1"}},null,null,"BRD2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","BRD",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 1-22 at the N-terminus of human BRD2.",null,null,"Protein kinase, Ser/Thr (non-receptor); ATYPICAL group; BRD family","P25440","P25440","P25440","P25440","GO:0005737; GO:0016607; GO:0005654","GO:0003682; GO:0070577","GO:0006334; GO:0006357; GO:0007283; GO:0006351; GO:0016032"]
[278,139,"NK013-2","BRD2","Pan-specific","Bromodomain-containing protein 2",0,161,12,523,{"v":77.927,"d":"78"},{"v":136.9291864763,"d":"137"},{"$nulls":3},0,128,8,455,{"v":54.6,"d":"55"},{"v":95.39794446,"d":"95"},{"$nulls":6},0,175,10,481,{"v":79.365,"d":"79"},{"v":135.780927711,"d":"136"},{"$nulls":7},"BRD2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","BRD",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 1-22 at the N-terminus of human BRD2.",{"$nulls":3},"P25440","P25440","P25440","P25440"]
[279,140,"PK546","BRD2","S37","Bromodomain-containing protein-serine kinase 2",0,6528,10,763,{"v":4973.234,"d":"4973"},{"v":8738.7027060746,"d":"8739"},{"$f":"(L292+L293)/2","v":{"v":8262.5317104967,"d":"8263"}},{"$f":"SQRT((M292-L292)*(M292-L292))","v":{"v":476.1709955779006,"d":"476"}},{"$f":"N292/M292*100","v":{"v":5.763015650190778,"d":"6"}},0,6486,14,743,{"v":4808.696,"d":"4809"},{"v":8401.8262625096,"d":"8402"},{"$f":"(U292+U293)/2","v":{"v":8023.6450485448,"d":"8024"}},{"$f":"SQRT((V292-U292)*(V292-U292))","v":{"v":378.1812139647991,"d":"378"}},{"$f":"W292/V292*100","v":{"v":4.713334297276617,"d":"5"}},{"$f":"X292+O292","v":{"v":10.476349947467394,"d":"10"}},{"$f":"(V292/M292*100)-100","v":{"v":-2.891204177146065,"d":"-3"}},null,0,6604,16,752,{"v":4954.176,"d":"4954"},{"v":8475.8094036864,"d":"8476"},{"$f":"(AG292+AG293)/2","v":{"v":7768.2396174744,"d":"7768"}},{"$f":"SQRT((AH292-AG292)*(AH292-AG292))","v":{"v":707.5697862120005,"d":"708"}},{"$f":"AI292/AH292*100","v":{"v":9.108495889085933,"d":"9"}},{"$f":"AJ292+O292","v":{"v":14.87151153927671,"d":"15"}},{"$f":"(AH292/M292*100)-100","v":{"v":-5.982332175431807,"d":"-6"}},null,null,"BRD2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","BRD",{"$nulls":6},"RKP(pS)LLY(bA)C","Corresponds to amino acid residues R34 to Y40; Near the N-terminus of the protein.","The effect of S37 phosphorylation is unclear. This is a major site of phosphorylation for BRD2 (≥341 reports by mass spectrometry studies).",null,"Protein kinase, Ser/Thr (non-receptor); ATYPICAL group; BRD family","P25440","P25440","P25440","P25440","GO:0005737; GO:0016607; GO:0005654","GO:0003682; GO:0070577","GO:0006334; GO:0006357; GO:0007283; GO:0006351; GO:0016032"]
[280,140,"PK546","BRD2","S37","Bromodomain-containing protein-serine kinase 2",0,5978,14,743,{"v":4431.252,"d":"4431"},{"v":7786.3607149188,"d":"7786"},{"$nulls":3},0,6138,18,715,{"v":4375.8,"d":"4376"},{"v":7645.46383458,"d":"7645"},{"$nulls":6},0,5652,14,732,{"v":4127.016,"d":"4127"},{"v":7060.669831262399,"d":"7061"},{"$nulls":7},"BRD2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","BRD",{"$nulls":6},"RKP(pS)LLY(bA)C","Corresponds to amino acid residues R34 to Y40; Near the N-terminus of the protein.","The effect of S37 phosphorylation is unclear. This is a major site of phosphorylation for BRD2 (≥341 reports by mass spectrometry studies).",null,null,"P25440","P25440","P25440","P25440"]
[281,141,"PK548","BRK","Y342","Protein-tyrosine kinase 6",0,4072,14,947,{"v":3842.926,"d":"3843"},{"v":6752.5855078294,"d":"6753"},{"$f":"(L294+L295)/2","v":{"v":6016.1107704855,"d":"6016"}},{"$f":"SQRT((M294-L294)*(M294-L294))","v":{"v":736.4747373438995,"d":"736"}},{"$f":"N294/M294*100","v":{"v":12.24170839667678,"d":"12"}},0,4768,16,830,{"v":3944.16,"d":"3944"},{"v":6891.295908816,"d":"6891"},{"$f":"(U294+U295)/2","v":{"v":6467.0109300075,"d":"6467"}},{"$f":"SQRT((V294-U294)*(V294-U294))","v":{"v":424.28497880849955,"d":"424"}},{"$f":"W294/V294*100","v":{"v":6.560758647241184,"d":"7"}},{"$f":"X294+O294","v":{"v":18.802467043917964,"d":"19"}},{"$f":"(V294/M294*100)-100","v":{"v":7.494877948957907,"d":"7"}},null,0,4984,18,804,{"v":3992.664,"d":"3993"},{"v":6830.814867489601,"d":"6831"},{"$f":"(AG294+AG295)/2","v":{"v":6362.318058513601,"d":"6362"}},{"$f":"SQRT((AH294-AG294)*(AH294-AG294))","v":{"v":468.49680897600047,"d":"468"}},{"$f":"AI294/AH294*100","v":{"v":7.36361817606857,"d":"7"}},{"$f":"AJ294+O294","v":{"v":19.605326572745348,"d":"20"}},{"$f":"(AH294/M294*100)-100","v":{"v":5.7546694407051575,"d":"6"}},null,null,"BRK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"EDV(pY)LSH(bA)C","Corresponds to amino acid residues E339 to H345; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y342 phosphorylation stimulates phosphotransferase activity and induces interaction with Brk. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Its phosphorylation is commonly observed by mass spectrometry studies (≥48 reports).","Brk","Protein-tyrosine kinase, TK group, Src family","Q13882","Q13882","Q13882","Q13882","GO:0005737; GO:0005829; GO:0031234; GO:0016604; GO:0005654; GO:0005634; GO:0005886; GO:0001726","GO:0005524; GO:0042802; GO:0004715; GO:0004713; GO:0005102","GO:0016477; GO:0071300; GO:0038128; GO:0045087; GO:0060575; GO:0045926; GO:0061099; GO:0009968; GO:0038083; GO:0045787; GO:0045742; GO:0010976; GO:0042531; GO:0046777; GO:0006468; GO:0042127; GO:0007169; GO:0007260"]
[282,141,"PK548","BRK","Y342","Protein-tyrosine kinase 6",0,4352,10,692,{"v":3004.664,"d":"3005"},{"v":5279.6360331416,"d":"5280"},{"$nulls":3},0,4533,18,766,{"v":3458.49,"d":"3458"},{"v":6042.725951199,"d":"6043"},{"$nulls":6},0,4443,15,778,{"v":3444.984,"d":"3445"},{"v":5893.8212495376,"d":"5894"},{"$nulls":7},"BRK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"EDV(pY)LSH(bA)C","Corresponds to amino acid residues E339 to H345; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y342 phosphorylation stimulates phosphotransferase activity and induces interaction with Brk. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Its phosphorylation is commonly observed by mass spectrometry studies (≥48 reports).","Brk",null,"Q13882","Q13882","Q13882","Q13882"]
[283,142,"PK547","BRK","S446+Y447","Protein-tyrosine kinase 6",0,3839,18,731,{"v":2793.151,"d":"2793"},{"v":4907.976620881899,"d":"4908"},{"$f":"(L296+L297)/2","v":{"v":4388.705447567349,"d":"4389"}},{"$f":"SQRT((M296-L296)*(M296-L296))","v":{"v":519.2711733145497,"d":"519"}},{"$f":"N296/M296*100","v":{"v":11.83198962697259,"d":"12"}},0,4081,20,860,{"v":3492.46,"d":"3492"},{"v":6102.078848146,"d":"6102"},{"$f":"(U296+U297)/2","v":{"v":5228.644272440901,"d":"5229"}},{"$f":"SQRT((V296-U296)*(V296-U296))","v":{"v":873.4345757050996,"d":"873"}},{"$f":"W296/V296*100","v":{"v":16.70480013927878,"d":"17"}},{"$f":"X296+O296","v":{"v":28.53678976625137,"d":"29"}},{"$f":"(V296/M296*100)-100","v":{"v":19.138646576045048,"d":"19"}},null,0,2955,13,706,{"v":2077.052,"d":"2077"},{"v":3553.5065515528004,"d":"3554"},{"$f":"(AG296+AG297)/2","v":{"v":3529.6642658024,"d":"3530"}},{"$f":"SQRT((AH296-AG296)*(AH296-AG296))","v":{"v":23.84228575040015,"d":"24"}},{"$f":"AI296/AH296*100","v":{"v":0.6754831041977324,"d":"1"}},{"$f":"AJ296+O296","v":{"v":12.507472731170322,"d":"13"}},{"$f":"(AH296/M296*100)-100","v":{"v":-19.573908343316006,"d":"-20"}},null,null,"BRK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"SFT(pS)(pY)ENP(bA)C","Corresponds to amino acid residues S443 to P450; In the C-terminus of the kinase.","S446 phosphorylation probably inhibits phosphotransferase activity and regulates molecular association. Y447 phosphorylation inhibits phosphotransferase activity and inhibits molecular association with Akt1. Y447 is the major phosphosite in BRK by mass spectrometry studies (≥379 reports), where as S446 is also commonly phosphorylated as well (≥87 reports).","Y447: Brk; SRMS","Protein-tyrosine kinase, TK group, Src family","Q13882","Q13882","Q13882","Q13882","GO:0005737; GO:0005829; GO:0031234; GO:0016604; GO:0005654; GO:0005634; GO:0005886; GO:0001726","GO:0005524; GO:0042802; GO:0004715; GO:0004713; GO:0005102","GO:0016477; GO:0071300; GO:0038128; GO:0045087; GO:0060575; GO:0045926; GO:0061099; GO:0009968; GO:0038083; GO:0045787; GO:0045742; GO:0010976; GO:0042531; GO:0046777; GO:0006468; GO:0042127; GO:0007169; GO:0007260"]
[284,142,"PK547","BRK","S446+Y447","Protein-tyrosine kinase 6",0,3140,12,704,{"v":2202.112,"d":"2202"},{"v":3869.4342742528,"d":"3869"},{"$nulls":3},0,3806,12,657,{"v":2492.658,"d":"2493"},{"v":4355.2096967358,"d":"4355"},{"$nulls":6},0,2956,16,697,{"v":2049.18,"d":"2049"},{"v":3505.821980052,"d":"3506"},{"$nulls":7},"BRK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"SFT(pS)(pY)ENP(bA)C","Corresponds to amino acid residues S443 to P450; In the C-terminus of the kinase.","S446 phosphorylation probably inhibits phosphotransferase activity and regulates molecular association. Y447 phosphorylation inhibits phosphotransferase activity and inhibits molecular association with Akt1. Y447 is the major phosphosite in BRK by mass spectrometry studies (≥379 reports), where as S446 is also commonly phosphorylated as well (≥87 reports).","Y447: Brk; SRMS",null,"Q13882","Q13882","Q13882","Q13882"]
[285,143,"NK364-1","BRSK1","Pan-specific","Protein-serine/threonine kinase BRSK1",0,162,8,614,{"v":94.556,"d":"95"},{"v":166.1487822764,"d":"166"},{"$f":"(L298+L299)/2","v":{"v":153.3163384657,"d":"153"}},{"$f":"SQRT((M298-L298)*(M298-L298))","v":{"v":12.8324438107,"d":"13"}},{"$f":"N298/M298*100","v":{"v":8.369912782368514,"d":"8"}},0,154,12,581,{"v":82.502,"d":"83"},{"v":144.14874018019998,"d":"144"},{"$f":"(U298+U299)/2","v":{"v":152.92674884259998,"d":"153"}},{"$f":"SQRT((V298-U298)*(V298-U298))","v":{"v":8.778008662399998,"d":"9"}},{"$f":"W298/V298*100","v":{"v":5.740008683134154,"d":"6"}},{"$f":"X298+O298","v":{"v":14.10992146550267,"d":"14"}},{"$f":"(V298/M298*100)-100","v":{"v":-0.25410835335543425,"d":"-0"}},null,0,166,12,517,{"v":79.618,"d":"80"},{"v":136.2137705852,"d":"136"},{"$f":"(AG298+AG299)/2","v":{"v":135.549964122,"d":"136"}},{"$f":"SQRT((AH298-AG298)*(AH298-AG298))","v":{"v":0.6638064631999896,"d":"1"}},{"$f":"AI298/AH298*100","v":{"v":0.4897134923639958,"d":"0"}},{"$f":"AJ298+O298","v":{"v":8.85962627473251,"d":"9"}},{"$f":"(AH298/M298*100)-100","v":{"v":-11.58805025054437,"d":"-12"}},null,null,"BRSK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","BRSK",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues 462-571 mapping within an internal region of human BRSK1.",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; CAMK domain target; CAMK</A> group; CAMKL family; BRSK subfamily","Q8TDC3","Q8TDC3","Q8TDC3",null,"GO:0030054; GO:0005813; GO:0005737; GO:0150034; GO:0005654; GO:0005634; GO:0048786; GO:0008021","GO:0005524; GO:0043015; GO:0000287; GO:0019901; GO:0004674; GO:0050321","GO:0008306; GO:0007409; GO:0006974; GO:0051298; GO:0030010; GO:0035556; GO:0090176; GO:0007095; GO:0030182; GO:0007269; GO:0006468; GO:0050770; GO:0010975; GO:0048167; GO:2000807; GO:0009411; GO:0099504"]
[286,143,"NK364-1","BRSK1","Pan-specific","Protein-serine/threonine kinase BRSK1",0,142,12,615,{"v":79.95,"d":"80"},{"v":140.483894655,"d":"140"},{"$nulls":3},0,162,12,617,{"v":92.55,"d":"93"},{"v":161.704757505,"d":"162"},{"$nulls":6},0,168,10,499,{"v":78.842,"d":"79"},{"v":134.88615765880002,"d":"135"},{"$nulls":7},"BRSK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","BRSK",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues 462-571 mapping within an internal region of human BRSK1.",{"$nulls":3},"Q8TDC3","Q8TDC3","Q8TDC3"]
[287,144,"PK549","BRSK1","T189","BR serine/threonine-protein kinase 1",0,9470,18,853,{"v":8062.556,"d":"8063"},{"v":14167.095281476399,"d":"14167"},{"$f":"(L300+L301)/2","v":{"v":14579.283286984599,"d":"14579"}},{"$f":"SQRT((M300-L300)*(M300-L300))","v":{"v":412.18800550820015,"d":"412"}},{"$f":"N300/M300*100","v":{"v":2.8272172053627207,"d":"3"}},0,9624,18,823,{"v":7905.738,"d":"7906"},{"v":13813.0248102438,"d":"13813"},{"$f":"(U300+U301)/2","v":{"v":13107.4416947655,"d":"13107"}},{"$f":"SQRT((V300-U300)*(V300-U300))","v":{"v":705.5831154782991,"d":"706"}},{"$f":"W300/V300*100","v":{"v":5.383072699534311,"d":"5"}},{"$f":"X300+O300","v":{"v":8.210289904897031,"d":"8"}},{"$f":"(V300/M300*100)-100","v":{"v":-10.095431738630523,"d":"-10"}},null,0,9762,16,777,{"v":7572.642,"d":"7573"},{"v":12955.5894409788,"d":"12956"},{"$f":"(AG300+AG301)/2","v":{"v":12760.247280768199,"d":"12760"}},{"$f":"SQRT((AH300-AG300)*(AH300-AG300))","v":{"v":195.34216021060092,"d":"195"}},{"$f":"AI300/AH300*100","v":{"v":1.530865005296675,"d":"2"}},{"$f":"AJ300+O300","v":{"v":4.358082210659395,"d":"4"}},{"$f":"(AH300/M300*100)-100","v":{"v":-12.47685479738439,"d":"-12"}},null,null,"BRSK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","BRSK",{"$nulls":5},"LLE(pT)SCG(bA)C","Corresponds to amino acid residues L186 to G192; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T189 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is a minor in vivo phosphorylation site in BRSK1 (≥1 report by mass spectrometry).","BRSK1; CaMK2a; LKB1","Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; CAMK domain target; CAMK</A> group; CAMKL family; BRSK subfamily","Q8TDC3","Q8TDC3","Q8TDC3",null,"GO:0030054; GO:0005813; GO:0005737; GO:0150034; GO:0005654; GO:0005634; GO:0048786; GO:0008021","GO:0005524; GO:0043015; GO:0000287; GO:0019901; GO:0004674; GO:0050321","GO:0008306; GO:0007409; GO:0006974; GO:0051298; GO:0030010; GO:0035556; GO:0090176; GO:0007095; GO:0030182; GO:0007269; GO:0006468; GO:0050770; GO:0010975; GO:0048167; GO:2000807; GO:0009411; GO:0099504"]
[288,144,"PK549","BRSK1","T189","BR serine/threonine-protein kinase 1",0,9542,20,896,{"v":8531.712,"d":"8532"},{"v":14991.471292492799,"d":"14991"},{"$nulls":3},0,9167,20,776,{"v":7098.072,"d":"7098"},{"v":12401.8585792872,"d":"12402"},{"$nulls":6},0,9348,16,787,{"v":7344.284,"d":"7344"},{"v":12564.9051205576,"d":"12565"},{"$nulls":7},"BRSK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","BRSK",{"$nulls":5},"LLE(pT)SCG(bA)C","Corresponds to amino acid residues L186 to G192; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T189 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is a minor in vivo phosphorylation site in BRSK1 (≥1 report by mass spectrometry).","BRSK1; CaMK2a; LKB1",null,"Q8TDC3","Q8TDC3","Q8TDC3"]
[289,145,"NK014","Btk","Pan-specific","Bruton's agammaglobulinemia tyrosine kinase",0,706,12,615,{"v":426.81,"d":"427"},{"v":749.9678683889999,"d":"750"},{"$f":"(L302+L303)/2","v":{"v":776.9840019764999,"d":"777"}},{"$f":"SQRT((M302-L302)*(M302-L302))","v":{"v":27.016133587500008,"d":"27"}},{"$f":"N302/M302*100","v":{"v":3.4770514603616145,"d":"3"}},0,646,14,629,{"v":397.528,"d":"398"},{"v":694.5669242728001,"d":"695"},{"$f":"(U302+U303)/2","v":{"v":652.6669589597,"d":"653"}},{"$f":"SQRT((V302-U302)*(V302-U302))","v":{"v":41.8999653131001,"d":"42"}},{"$f":"W302/V302*100","v":{"v":6.419807949200518,"d":"6"}},{"$f":"X302+O302","v":{"v":9.896859409562133,"d":"10"}},{"$f":"(V302/M302*100)-100","v":{"v":-15.999948866458126,"d":"-16"}},null,0,716,10,562,{"v":396.772,"d":"397"},{"v":678.8139639608,"d":"679"},{"$f":"(AG302+AG303)/2","v":{"v":637.6066380004,"d":"638"}},{"$f":"SQRT((AH302-AG302)*(AH302-AG302))","v":{"v":41.2073259604,"d":"41"}},{"$f":"AI302/AH302*100","v":{"v":6.462813199315241,"d":"6"}},{"$f":"AJ302+O302","v":{"v":9.939864659676855,"d":"10"}},{"$f":"(AH302/M302*100)-100","v":{"v":-17.93825402087434,"d":"-18"}},null,null,"BTK","X","PYK","Protein kinase - Non-receptor- tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"Epitope undefined.",{"$nulls":3},"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK domain target; TK</A> group; Tec family","Q06187","Q06187","Q06187","Q06187","GO:0005737; GO:0031410; GO:0005829; GO:0031234; GO:0042629; GO:0045121; GO:0005634; GO:0048471; GO:0005886","GO:0005524; GO:0042802; GO:0046872; GO:0004715; GO:0005547; GO:0004713; GO:0005102","GO:0002250; GO:0097190; GO:0042113; GO:0002344; GO:0050853; GO:0019722; GO:0048469; GO:0098761; GO:0071226; GO:0034614; GO:0038095; GO:0002553; GO:0007249; GO:0045087; GO:0035556; GO:0007498; GO:0002755; GO:0030889; GO:0001818; GO:0038083; GO:0018108; GO:0045579; GO:0051092; GO:0001812; GO:0001805; GO:0006468; GO:0002902; GO:0002721; GO:0042127; GO:0006351; GO:0007169"]
[290,145,"NK014","Btk","Pan-specific","Bruton's agammaglobulinemia tyrosine kinase",0,752,14,620,{"v":457.56,"d":"458"},{"v":804.000135564,"d":"804"},{"$nulls":3},0,621,12,574,{"v":349.566,"d":"350"},{"v":610.7669936466,"d":"611"},{"$nulls":6},0,595,14,600,{"v":348.6,"d":"349"},{"v":596.39931204,"d":"596"},{"$nulls":7},"BTK","X","PYK","Protein kinase - Non-receptor- tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"Epitope undefined.",{"$nulls":4},"Q06187","Q06187","Q06187","Q06187"]
[291,146,"PK550","Btk","Y223+Y225","Bruton's agammaglobulinemia tyrosine kinase",0,1098,12,549,{"v":596.214,"d":"596"},{"v":1047.6355818366,"d":"1048"},{"$f":"(L304+L305)/2","v":{"v":1001.4208612197,"d":"1001"}},{"$f":"SQRT((M304-L304)*(M304-L304))","v":{"v":46.21472061690008,"d":"46"}},{"$f":"N304/M304*100","v":{"v":4.614914908064923,"d":"5"}},0,999,12,616,{"v":607.992,"d":"608"},{"v":1062.2928030792,"d":"1062"},{"$f":"(U304+U305)/2","v":{"v":1004.4984220014001,"d":"1004"}},{"$f":"SQRT((V304-U304)*(V304-U304))","v":{"v":57.794381077799926,"d":"58"}},{"$f":"W304/V304*100","v":{"v":5.753556184055347,"d":"6"}},{"$f":"X304+O304","v":{"v":10.36847109212027,"d":"10"}},{"$f":"(V304/M304*100)-100","v":{"v":0.3073194199241698,"d":"0"}},null,0,1084,12,485,{"v":519.92,"d":"520"},{"v":889.5006606879999,"d":"890"},{"$f":"(AG304+AG305)/2","v":{"v":884.9361358327999,"d":"885"}},{"$f":"SQRT((AH304-AG304)*(AH304-AG304))","v":{"v":4.564524855200034,"d":"5"}},{"$f":"AI304/AH304*100","v":{"v":0.5158027421836977,"d":"1"}},{"$f":"AJ304+O304","v":{"v":5.130717650248621,"d":"5"}},{"$f":"(AH304/M304*100)-100","v":{"v":-11.631945158904045,"d":"-12"}},null,null,"BTK","X","PYK","Protein kinase - Non-receptor- tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"VAL(pY)D(pY)M(bA)C","Corresponds to amino acid residues V220 to M226; In the SH3_1 domain.","Y223 and Y225 phosphorylation stimulate phosphotransferase activity and regulates cell growth. These are two of the major in vivo phosphorylation sites in Btk (≥261 and ≥90 reports, respectively, by mass spectrometry).","Y223: Abl1; Btk; ITK; Lyn; PIK3CD, Tec","EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK domain target; TK</A> group; Tec family","Q06187","Q06187","Q06187","Q06187","GO:0005737; GO:0031410; GO:0005829; GO:0031234; GO:0042629; GO:0045121; GO:0005634; GO:0048471; GO:0005886","GO:0005524; GO:0042802; GO:0046872; GO:0004715; GO:0005547; GO:0004713; GO:0005102","GO:0002250; GO:0097190; GO:0042113; GO:0002344; GO:0050853; GO:0019722; GO:0048469; GO:0098761; GO:0071226; GO:0034614; GO:0038095; GO:0002553; GO:0007249; GO:0045087; GO:0035556; GO:0007498; GO:0002755; GO:0030889; GO:0001818; GO:0038083; GO:0018108; GO:0045579; GO:0051092; GO:0001812; GO:0001805; GO:0006468; GO:0002902; GO:0002721; GO:0042127; GO:0006351; GO:0007169"]
[292,146,"PK550","Btk","Y223+Y225","Bruton's agammaglobulinemia tyrosine kinase",0,1030,12,534,{"v":543.612,"d":"544"},{"v":955.2061406027999,"d":"955"},{"$nulls":3},0,1050,12,522,{"v":541.836,"d":"542"},{"v":946.7040409236,"d":"947"},{"$nulls":6},0,1033,12,504,{"v":514.584,"d":"515"},{"v":880.3716109776,"d":"880"},{"$nulls":7},"BTK","X","PYK","Protein kinase - Non-receptor- tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"VAL(pY)D(pY)M(bA)C","Corresponds to amino acid residues V220 to M226; In the SH3_1 domain.","Y223 and Y225 phosphorylation stimulate phosphotransferase activity and regulates cell growth. These are two of the major in vivo phosphorylation sites in Btk (≥261 and ≥90 reports, respectively, by mass spectrometry).","Y223: Abl1; Btk; ITK; Lyn; PIK3CD, Tec",null,"Q06187","Q06187","Q06187","Q06187"]
[293,147,"PK551","Btk","Y551","Bruton's agammaglobulinemia tyrosine kinase",0,4670,14,695,{"v":3235.92,"d":"3236"},{"v":5685.986796648,"d":"5686"},{"$f":"(L306+L307)/2","v":{"v":5703.947473686349,"d":"5704"}},{"$f":"SQRT((M306-L306)*(M306-L306))","v":{"v":17.960677038349786,"d":"18"}},{"$f":"N306/M306*100","v":{"v":0.31488152934799296,"d":"0"}},0,4348,16,711,{"v":3080.052,"d":"3080"},{"v":5381.5133631852,"d":"5382"},{"$f":"(U306+U307)/2","v":{"v":5027.8315993526,"d":"5028"}},{"$f":"SQRT((V306-U306)*(V306-U306))","v":{"v":353.68176383260015,"d":"354"}},{"$f":"W306/V306*100","v":{"v":7.034479115771128,"d":"7"}},{"$f":"X306+O306","v":{"v":7.349360645119121,"d":"7"}},{"$f":"(V306/M306*100)-100","v":{"v":-11.853473010626942,"d":"-12"}},null,0,4804,12,652,{"v":3124.384,"d":"3124"},{"v":5345.3254966976,"d":"5345"},{"$f":"(AG306+AG307)/2","v":{"v":5732.1193637752,"d":"5732"}},{"$f":"SQRT((AH306-AG306)*(AH306-AG306))","v":{"v":386.7938670776002,"d":"387"}},{"$f":"AI306/AH306*100","v":{"v":6.747833437000446,"d":"7"}},{"$f":"AJ306+O306","v":{"v":7.062714966348438,"d":"7"}},{"$f":"(AH306/M306*100)-100","v":{"v":0.4939016395016722,"d":"0"}},null,null,"BTK","X","PYK","Protein kinase - Non-receptor- tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"DDE(pY)TSS(bA)C","Corresponds to amino acid residues D548 to S554; In the protein kinase catalytic domain.","Y551 phosphorylation stimulates phosphotransferase activity, and regulates intracellular location and molecular association, including inducing interaction with BLNK. This is one of the major in vivo phosphorylation sites in Btk (≥148 reports from high throughput mass spectrometry studies).","Btk; Lyn; PIK3CD; Src; Syk","EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK domain target; TK</A> group; Tec family","Q06187","Q06187","Q06187","Q06187","GO:0005737; GO:0031410; GO:0005829; GO:0031234; GO:0042629; GO:0045121; GO:0005634; GO:0048471; GO:0005886","GO:0005524; GO:0042802; GO:0046872; GO:0004715; GO:0005547; GO:0004713; GO:0005102","GO:0002250; GO:0097190; GO:0042113; GO:0002344; GO:0050853; GO:0019722; GO:0048469; GO:0098761; GO:0071226; GO:0034614; GO:0038095; GO:0002553; GO:0007249; GO:0045087; GO:0035556; GO:0007498; GO:0002755; GO:0030889; GO:0001818; GO:0038083; GO:0018108; GO:0045579; GO:0051092; GO:0001812; GO:0001805; GO:0006468; GO:0002902; GO:0002721; GO:0042127; GO:0006351; GO:0007169"]
[294,147,"PK551","Btk","Y551","Bruton's agammaglobulinemia tyrosine kinase",0,4865,12,671,{"v":3256.363,"d":"3256"},{"v":5721.908150724699,"d":"5722"},{"$nulls":3},0,4194,14,640,{"v":2675.2,"d":"2675"},{"v":4674.14983552,"d":"4674"},{"$nulls":6},0,4898,12,732,{"v":3576.552,"d":"3577"},{"v":6118.913230852801,"d":"6119"},{"$nulls":7},"BTK","X","PYK","Protein kinase - Non-receptor- tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"DDE(pY)TSS(bA)C","Corresponds to amino acid residues D548 to S554; In the protein kinase catalytic domain.","Y551 phosphorylation stimulates phosphotransferase activity, and regulates intracellular location and molecular association, including inducing interaction with BLNK. This is one of the major in vivo phosphorylation sites in Btk (≥148 reports from high throughput mass spectrometry studies).","Btk; Lyn; PIK3CD; Src; Syk",null,"Q06187","Q06187","Q06187","Q06187"]
[295,148,"PK552","BUB1B (Bub1R)","S670","Mitotic checkpoint serine/threonine-protein kinase BUB1 beta",0,4390,14,725,{"v":3172.6,"d":"3173"},{"v":5574.72425494,"d":"5575"},{"$f":"(L308+L309)/2","v":{"v":5770.463391012399,"d":"5770"}},{"$f":"SQRT((M308-L308)*(M308-L308))","v":{"v":195.73913607239956,"d":"196"}},{"$f":"N308/M308*100","v":{"v":3.3920869574749712,"d":"3"}},0,4776,22,789,{"v":3750.906,"d":"3751"},{"v":6553.6396018806,"d":"6554"},{"$f":"(U308+U309)/2","v":{"v":6054.0636299829,"d":"6054"}},{"$f":"SQRT((V308-U308)*(V308-U308))","v":{"v":499.5759718976997,"d":"500"}},{"$f":"W308/V308*100","v":{"v":8.251911483446214,"d":"8"}},{"$f":"X308+O308","v":{"v":11.643998440921186,"d":"12"}},{"$f":"(V308/M308*100)-100","v":{"v":4.914687430687351,"d":"5"}},null,0,4640,16,698,{"v":3227.552,"d":"3228"},{"v":5521.829582252801,"d":"5522"},{"$f":"(AG308+AG309)/2","v":{"v":5467.322175248801,"d":"5467"}},{"$f":"SQRT((AH308-AG308)*(AH308-AG308))","v":{"v":54.507407004000015,"d":"55"}},{"$f":"AI308/AH308*100","v":{"v":0.9969671670486393,"d":"1"}},{"$f":"AJ308+O308","v":{"v":4.389054124523611,"d":"4"}},{"$f":"(AH308/M308*100)-100","v":{"v":-5.253325343606662,"d":"-5"}},null,null,"BUBR1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","BUB",{"$nulls":6},"KKL(pS)PII(bA)C","Corresponds to amino acid residues K667 to I673; Just before kinase catalytic domain. This is the major in vivo phosphorylation sites.","S670 phosphorylation induces interaction with PPP2R5A and PPP2CA and regulates cell cycle progression. This is the major in vivo phosphorylation site in BUB1B (≥33 reports from high throughput mass spectrometry studies).","CDK1; TTK","Spindle midzone, Anaphase-promoting complex, Cytoplasm, Nucleus, Outer kinetochore of condensed chromosome protein","O60566","O60566","O60566","O60566","GO:0005680; GO:0000777; GO:0000940; GO:0000778; GO:0005737; GO:0005829; GO:0000776; GO:0005815; GO:0048471; GO:0051233","GO:0005524; GO:0004672; GO:0004674","GO:0031145; GO:0006915; GO:0051301; GO:0008283; GO:0051754; GO:0007091; GO:0000278; GO:0007093; GO:0007094; GO:0034501"]
[296,148,"PK552","BUB1B (Bub1R)","S670","Mitotic checkpoint serine/threonine-protein kinase BUB1 beta",0,4676,12,728,{"v":3395.392,"d":"3395"},{"v":5966.2025270848,"d":"5966"},{"$nulls":3},0,4564,16,699,{"v":3179.052,"d":"3179"},{"v":5554.487658085201,"d":"5554"},{"$nulls":6},0,4624,12,686,{"v":3163.832,"d":"3164"},{"v":5412.8147682448,"d":"5413"},{"$nulls":7},"BUBR1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","BUB",{"$nulls":6},"KKL(pS)PII(bA)C","Corresponds to amino acid residues K667 to I673; Just before kinase catalytic domain. This is the major in vivo phosphorylation sites.","S670 phosphorylation induces interaction with PPP2R5A and PPP2CA and regulates cell cycle progression. This is the major in vivo phosphorylation site in BUB1B (≥33 reports from high throughput mass spectrometry studies).","CDK1; TTK",null,"O60566","O60566","O60566","O60566"]
[297,149,"PN575","C-EBPa","T226+T230","CCAAT/enhancer-binding protein alpha",0,3978,12,645,{"v":2558.07,"d":"2558"},{"v":4494.904770483,"d":"4495"},{"$f":"(L310+L311)/2","v":{"v":4430.0853784889005,"d":"4430"}},{"$f":"SQRT((M310-L310)*(M310-L310))","v":{"v":64.81939199409953,"d":"65"}},{"$f":"N310/M310*100","v":{"v":1.4631634936166713,"d":"1"}},0,4240,18,620,{"v":2617.64,"d":"2618"},{"v":4573.580134364,"d":"4574"},{"$f":"(U310+U311)/2","v":{"v":4102.1081173498,"d":"4102"}},{"$f":"SQRT((V310-U310)*(V310-U310))","v":{"v":471.4720170142,"d":"471"}},{"$f":"W310/V310*100","v":{"v":11.493407865582986,"d":"11"}},{"$f":"X310+O310","v":{"v":12.956571359199657,"d":"13"}},{"$f":"(V310/M310*100)-100","v":{"v":-7.403407228484923,"d":"-7"}},null,0,3653,14,615,{"v":2237.985,"d":"2238"},{"v":3828.8373905790004,"d":"3829"},{"$f":"(AG310+AG311)/2","v":{"v":3682.9496672975,"d":"3683"}},{"$f":"SQRT((AH310-AG310)*(AH310-AG310))","v":{"v":145.88772328150026,"d":"146"}},{"$f":"AI310/AH310*100","v":{"v":3.961165274043801,"d":"4"}},{"$f":"AJ310+O310","v":{"v":5.424328767660472,"d":"5"}},{"$f":"(AH310/M310*100)-100","v":{"v":-16.865040904612272,"d":"-17"}},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"CGHP(pT)PPP(pT)PVP","Corresponds to amino acid residues C223 to P233.","The effects of T226 and T230 phosphorylations are unclear.  Their phosphorylation has been reported to both inhibit and activate transcriptional activity. Neither of these two phosphorylation sites have apparently been reported from high throughput mass spectrometry, although there are several literature reports for their phosphorylation.","T226: BARK2 (GRK3, ADRBK2); GSK3a; GSK3b. T230: GSK3a.","Transcription protein","P49715","P49715",null,"P49715","GO:0043231; GO:0005730; GO:0005654; GO:0005634; GO:0090575","GO:0003677; GO:0003700; GO:0019900; GO:0042803; GO:0000978; GO:0000981; GO:0001013; GO:0001077; GO:0001228; GO:0003713; GO:0003705; GO:0008134; GO:0044212","GO:0050873; GO:0048469; GO:0071285; GO:0071407; GO:0071356; GO:0008203; GO:0019221; GO:0001892; GO:0045444; GO:0006091; GO:0042593; GO:0030851; GO:0048839; GO:0055088; GO:0001889; GO:0030324; GO:0030225; GO:0007005; GO:0030099; GO:0008285; GO:0045736; GO:0045892; GO:0000122; GO:0007219; GO:2000144; GO:0045600; GO:0050729; GO:0043032; GO:0045669; GO:0032436; GO:0045944; GO:0045945; GO:0006351; GO:0006360; GO:0006366; GO:0000050; GO:0016032; GO:0050872"]
[298,149,"PN575","C-EBPa","T226+T230","CCAAT/enhancer-binding protein alpha",0,3731,12,668,{"v":2484.292,"d":"2484"},{"v":4365.2659864948,"d":"4365"},{"$nulls":3},0,3530,14,591,{"v":2077.956,"d":"2078"},{"v":3630.6361003356,"d":"3631"},{"$nulls":6},0,3458,18,601,{"v":2067.44,"d":"2067"},{"v":3537.0619440160003,"d":"3537"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"CGHP(pT)PPP(pT)PVP","Corresponds to amino acid residues C223 to P233.","The effects of T226 and T230 phosphorylations are unclear.  Their phosphorylation has been reported to both inhibit and activate transcriptional activity. Neither of these two phosphorylation sites have apparently been reported from high throughput mass spectrometry, although there are several literature reports for their phosphorylation.","T226: BARK2 (GRK3, ADRBK2); GSK3a; GSK3b. T230: GSK3a.",null,"P49715","P49715",null,"P49715"]
[299,150,"PN216","C3G (RapGEF1)","Y504","Rap guanine nucleotide exchange factor 1",0,126,8,503,{"v":59.354,"d":"59"},{"v":104.29369710259999,"d":"104"},{"$f":"(L312+L313)/2","v":{"v":98.4318550442,"d":"98"}},{"$f":"SQRT((M312-L312)*(M312-L312))","v":{"v":5.861842058399986,"d":"6"}},{"$f":"N312/M312*100","v":{"v":5.955228676496826,"d":"6"}},0,108,12,543,{"v":52.128,"d":"52"},{"v":91.0788287328,"d":"91"},{"$f":"(U312+U313)/2","v":{"v":86.12023227899999,"d":"86"}},{"$f":"SQRT((V312-U312)*(V312-U312))","v":{"v":4.958596453800013,"d":"5"}},{"$f":"W312/V312*100","v":{"v":5.757760194765687,"d":"6"}},{"$f":"X312+O312","v":{"v":11.712988871262514,"d":"12"}},{"$f":"(V312/M312*100)-100","v":{"v":-12.507762613710355,"d":"-13"}},null,0,118,10,478,{"v":51.624,"d":"52"},{"v":88.3204764336,"d":"88"},{"$f":"(AG312+AG313)/2","v":{"v":98.4537900458,"d":"98"}},{"$f":"SQRT((AH312-AG312)*(AH312-AG312))","v":{"v":10.133313612199998,"d":"10"}},{"$f":"AI312/AH312*100","v":{"v":10.292456600691606,"d":"10"}},{"$f":"AJ312+O312","v":{"v":16.24768527718843,"d":"16"}},{"$f":"(AH312/M312*100)-100","v":{"v":0.022284454143587595,"d":"0"}},{"$nulls":15},"Not precisely defined.","Antibody raised against amino acid residues that encompass the Y504 phosphosite.","Y504 phosphorylation increases RapGEF1 activity. Its phosphorylation has apparently not been reported from high throughput mass spectrometry, although there are several literature reports for Y504 phosphorylation.","Abl1; Hck; Src","Guanine nucleotide exchange factor for Rap G protein","Q13905","Q13905",null,null,"GO:0005737; GO:0005829; GO:0005769; GO:0005768; GO:0048471; GO:0030670; GO:0032991","GO:0005085; GO:0017034; GO:0017124","GO:0000186; GO:0001568; GO:0098609; GO:0071320; GO:1990090; GO:0019221; GO:0061028; GO:0090090; GO:0070373; GO:2000178; GO:0051898; GO:0046580; GO:0038180; GO:0048008; GO:0070374; GO:1905451; GO:0043547; GO:0010976; GO:0032486; GO:1901888; GO:0046328; GO:0007165; GO:0007169"]
[300,150,"PN216","C3G (RapGEF1)","Y504","Rap guanine nucleotide exchange factor 1",0,116,10,497,{"v":52.682,"d":"53"},{"v":92.5700129858,"d":"93"},{"$nulls":3},0,106,8,474,{"v":46.452,"d":"46"},{"v":81.1616358252,"d":"81"},{"$nulls":6},0,120,10,577,{"v":63.47,"d":"63"},{"v":108.587103658,"d":"109"},{"$nulls":20},"Not precisely defined.","Antibody raised against amino acid residues that encompass the Y504 phosphosite.","Y504 phosphorylation increases RapGEF1 activity. Its phosphorylation has apparently not been reported from high throughput mass spectrometry, although there are several literature reports for Y504 phosphorylation.","Abl1; Hck; Src",null,"Q13905","Q13905"]
[301,151,"PN691","CAD","S1859","Aspartate carbamoyltransferase",0,2544,14,628,{"v":1588.84,"d":"1589"},{"v":2791.8252805959996,"d":"2792"},{"$f":"(L314+L315)/2","v":{"v":2623.719036673,"d":"2624"}},{"$f":"SQRT((M314-L314)*(M314-L314))","v":{"v":168.1062439229995,"d":"168"}},{"$f":"N314/M314*100","v":{"v":6.40717399894183,"d":"6"}},0,2199,14,633,{"v":1383.105,"d":"1383"},{"v":2416.5819408855,"d":"2417"},{"$f":"(U314+U315)/2","v":{"v":2569.41521372025,"d":"2569"}},{"$f":"SQRT((V314-U314)*(V314-U314))","v":{"v":152.83327283475,"d":"153"}},{"$f":"W314/V314*100","v":{"v":5.948173421665978,"d":"6"}},{"$f":"X314+O314","v":{"v":12.355347420607808,"d":"12"}},{"$f":"(V314/M314*100)-100","v":{"v":-2.069727062757835,"d":"-2"}},null,0,2670,16,666,{"v":1767.564,"d":"1768"},{"v":3024.0216683496,"d":"3024"},{"$f":"(AG314+AG315)/2","v":{"v":2727.3617695896,"d":"2727"}},{"$f":"SQRT((AH314-AG314)*(AH314-AG314))","v":{"v":296.65989876000003,"d":"297"}},{"$f":"AI314/AH314*100","v":{"v":10.877174493966745,"d":"11"}},{"$f":"AJ314+O314","v":{"v":17.284348492908574,"d":"17"}},{"$f":"(AH314/M314*100)-100","v":{"v":3.9502222405652105,"d":"4"}},{"$nulls":5},"De novo pyrimidine synthesis",{"$nulls":8},"X","HRA(pS)DPG(bA)C","Corresponds to amino acid residues H1856 to G1862.","S1859 phosphorylation stimulates enzyme activity. This is the major in vivo phosphorylation site in CAD (≥162 reports from high throughput mass spectrometry studies). However, This human phosphosite is not highly conserved in nature, but is found in the rhesus monkey.","PKACa (PRKACA); p70 S6Kb (RPS6KB1)","EC 6.3.5.5; EC 2.1.3.2; Ligase; Nucleotide Metabolism - pyrimidine; EC 3.5.2.3; Transferase; Hydrolase; Amino Acid Metabolism - alanine, aspartate and glutamate","P27708","P27708",null,null,"GO:0042995; GO:0005829; GO:0070062; GO:0016020; GO:0043025; GO:0016363; GO:0005654; GO:0005634; GO:0032991; GO:0043195","GO:0070335; GO:0004070; GO:0005524; GO:0004087; GO:0004088; GO:0004151; GO:0019899; GO:0042802; GO:0004672; GO:0008270","GO:0006207; GO:0044205; GO:0031100; GO:0006526; GO:0035690; GO:0071364; GO:0019240; GO:0017144; GO:0007565; GO:0006541; GO:0007507; GO:0007595; GO:0001889; GO:0018107; GO:0046777; GO:0046134; GO:0014075; GO:0031000; GO:0051414; GO:0032868; GO:0042594; GO:0033574; GO:0000050; GO:0006228"]
[302,151,"PN691","CAD","S1859","Aspartate carbamoyltransferase",0,2248,12,625,{"v":1397.5,"d":"1398"},{"v":2455.61279275,"d":"2456"},{"$nulls":3},0,2560,10,611,{"v":1558.05,"d":"1558"},{"v":2722.248486555,"d":"2722"},{"$nulls":6},0,2374,10,601,{"v":1420.764,"d":"1421"},{"v":2430.7018708296,"d":"2431"},{"$nulls":10},"De novo pyrimidine synthesis",{"$nulls":8},"X","HRA(pS)DPG(bA)C","Corresponds to amino acid residues H1856 to G1862.","S1859 phosphorylation stimulates enzyme activity. This is the major in vivo phosphorylation site in CAD (≥162 reports from high throughput mass spectrometry studies). However, This human phosphosite is not highly conserved in nature, but is found in the rhesus monkey.","PKACa (PRKACA); p70 S6Kb (RPS6KB1)",null,"P27708","P27708"]
[303,153,"PN015","CALD1","S789","Caldesmon",0,248,8,300,72,{"v":126.5145768,"d":"127"},{"$f":"(L316+L317)/2","v":{"v":128.56428865885,"d":"129"}},{"$f":"SQRT((M316-L316)*(M316-L316))","v":{"v":2.0497118588499887,"d":"2"}},{"$f":"N316/M316*100","v":{"v":1.5943088708630229,"d":"2"}},0,486,10,333,{"v":158.508,"d":"159"},{"v":276.9475710708,"d":"277"},{"$f":"(U316+U317)/2","v":{"v":188.0300474167,"d":"188"}},{"$f":"SQRT((V316-U316)*(V316-U316))","v":{"v":88.9175236541,"d":"89"}},{"$f":"W316/V316*100","v":{"v":47.288997091537574,"d":"47"}},{"$f":"X316+O316","v":{"v":48.8833059624006,"d":"49"}},{"$f":"(V316/M316*100)-100","v":{"v":46.25371429203372,"d":"46"}},null,0,208,11,295,{"v":58.115,"d":"58"},{"v":99.425547961,"d":"99"},{"$f":"(AG316+AG317)/2","v":{"v":85.1614077885,"d":"85"}},{"$f":"SQRT((AH316-AG316)*(AH316-AG316))","v":{"v":14.264140172500007,"d":"14"}},{"$f":"AI316/AH316*100","v":{"v":16.749535432675415,"d":"17"}},{"$f":"AJ316+O316","v":{"v":18.34384430353844,"d":"18"}},{"$f":"(AH316/M316*100)-100","v":{"v":-33.75967099660242,"d":"-34"}},{"$nulls":15},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S789 phosphosite.","The effect of S789 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in caldesmon (≥18 reports from high throughput mass spectrometry studies).","CDK1 (CDC2); CDK6; ERK1 (MAPK3); ERK2 (MAPK1); p38a MAPK (MAPK14); PKCa (PRKCA)","Cytoskeletal, calcium binding protein","Q05682","Q05682",null,null,"GO:0030478; GO:0015629; GO:0005856; GO:0005829; GO:0043231; GO:0030016; GO:0005886","GO:0003779; GO:0045296; GO:0005516; GO:0017022; GO:0005523","GO:0006936"]
[304,153,"PN015","CALD1","S789","Caldesmon",0,297,10,259,{"v":74.333,"d":"74"},{"v":130.6140005177,"d":"131"},{"$nulls":3},0,234,8,251,{"v":56.726,"d":"57"},{"v":99.1125237626,"d":"99"},{"$nulls":6},0,156,8,280,{"v":41.44,"d":"41"},{"v":70.897267616,"d":"71"},{"$nulls":20},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S789 phosphosite.","The effect of S789 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in caldesmon (≥18 reports from high throughput mass spectrometry studies).","CDK1 (CDC2); CDK6; ERK1 (MAPK3); ERK2 (MAPK1); p38a MAPK (MAPK14); PKCa (PRKCA)",null,"Q05682","Q05682"]
[305,154,"NK211","CaMK1a (CAMK1)","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase 1 alpha",0,204,12,605,{"v":116.16,"d":"116"},{"v":204.110183904,"d":"204"},{"$f":"(L318+L319)/2","v":{"v":174.40034411879998,"d":"174"}},{"$f":"SQRT((M318-L318)*(M318-L318))","v":{"v":29.709839785200018,"d":"30"}},{"$f":"N318/M318*100","v":{"v":17.03542497884175,"d":"17"}},0,148,12,594,{"v":80.784,"d":"81"},{"v":141.1470246384,"d":"141"},{"$f":"(U318+U319)/2","v":{"v":136.5570905707,"d":"137"}},{"$f":"SQRT((V318-U318)*(V318-U318))","v":{"v":4.5899340677,"d":"5"}},{"$f":"W318/V318*100","v":{"v":3.361183259336975,"d":"3"}},{"$f":"X318+O318","v":{"v":20.396608238178725,"d":"20"}},{"$f":"(V318/M318*100)-100","v":{"v":-21.69907045729306,"d":"-22"}},null,0,180,14,664,{"v":110.224,"d":"110"},{"v":188.57578247360001,"d":"189"},{"$f":"(AG318+AG319)/2","v":{"v":200.2745159668,"d":"200"}},{"$f":"SQRT((AH318-AG318)*(AH318-AG318))","v":{"v":11.698733493199995,"d":"12"}},{"$f":"AI318/AH318*100","v":{"v":5.84134902871982,"d":"6"}},{"$f":"AJ318+O318","v":{"v":22.876774007561572,"d":"23"}},{"$f":"(AH318/M318*100)-100","v":{"v":14.836078437078527,"d":"15"}},null,null,"CaMK1a","X","PSTK","Protein kinase - Non-receptor- tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"Epitope undefined.",{"$nulls":3},"EC 2.7.11.17; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; CAMK1 family","Q14012","Q14012","Q14012",null,"GO:0005737; GO:0098978; GO:0005622; GO:0005634; GO:0014069","GO:0005524; GO:0005516; GO:0004683","GO:0007049; GO:0035556; GO:0032091; GO:0006913; GO:0018107; GO:0060999; GO:0051149; GO:0010976; GO:0033138; GO:1901985; GO:0046827; GO:0071902; GO:0051835; GO:0060143; GO:0045944; GO:0006468; GO:0051147; GO:0043393; GO:0032880; GO:0007165"]
[306,154,"NK211","CaMK1a (CAMK1)","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase 1 alpha",0,156,10,564,{"v":82.344,"d":"82"},{"v":144.6905043336,"d":"145"},{"$nulls":3},0,144,14,581,{"v":75.53,"d":"76"},{"v":131.967156503,"d":"132"},{"$nulls":6},0,196,19,700,{"v":123.9,"d":"124"},{"v":211.97324946,"d":"212"},{"$nulls":7},"CaMK1a","X","PSTK","Protein kinase - Non-receptor- tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"Epitope undefined.",{"$nulls":4},"Q14012","Q14012","Q14012"]
[307,155,"PK553","CaMK1a (CAMK1)","T177","Calcium/calmodulin-dependent protein-serine kinase 1 alpha",0,3148,12,666,{"v":2088.576,"d":"2089"},{"v":3669.9348438143998,"d":"3670"},{"$f":"(L320+L321)/2","v":{"v":3190.5904409350997,"d":"3191"}},{"$f":"SQRT((M320-L320)*(M320-L320))","v":{"v":479.3444028793001,"d":"479"}},{"$f":"N320/M320*100","v":{"v":15.023689556933972,"d":"15"}},0,2366,14,574,{"v":1350.048,"d":"1350"},{"v":2358.8242513248,"d":"2359"},{"$f":"(U320+U321)/2","v":{"v":2818.4746109724,"d":"2818"}},{"$f":"SQRT((V320-U320)*(V320-U320))","v":{"v":459.6503596476,"d":"460"}},{"$f":"W320/V320*100","v":{"v":16.308479695299308,"d":"16"}},{"$f":"X320+O320","v":{"v":31.332169252233278,"d":"31"}},{"$f":"(V320/M320*100)-100","v":{"v":-11.662914336747008,"d":"-12"}},null,0,3092,14,628,{"v":1932.984,"d":"1933"},{"v":3307.0290527376,"d":"3307"},{"$f":"(AG320+AG321)/2","v":{"v":3231.7657178688,"d":"3232"}},{"$f":"SQRT((AH320-AG320)*(AH320-AG320))","v":{"v":75.26333486880003,"d":"75"}},{"$f":"AI320/AH320*100","v":{"v":2.328861106876049,"d":"2"}},{"$f":"AJ320+O320","v":{"v":17.35255066381002,"d":"17"}},{"$f":"(AH320/M320*100)-100","v":{"v":1.2905221681048147,"d":"1"}},null,null,"CaMK1a","X","PSTK","Protein kinase - Non-receptor- tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"VLS(pT)ACG(bA)C","Corresponds to amino acid residues V174 to G180; In the protein kinase catalytic domain.","T177 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in CaMK1a (≥12 reports from high throughput mass spectrometry studies).","CAMKK1","EC 2.7.11.17; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; CAMK1 family","Q14012","Q14012","Q14012",null,"GO:0005737; GO:0098978; GO:0005622; GO:0005634; GO:0014069","GO:0005524; GO:0005516; GO:0004683","GO:0007049; GO:0035556; GO:0032091; GO:0006913; GO:0018107; GO:0060999; GO:0051149; GO:0010976; GO:0033138; GO:1901985; GO:0046827; GO:0071902; GO:0051835; GO:0060143; GO:0045944; GO:0006468; GO:0051147; GO:0043393; GO:0032880; GO:0007165"]
[308,155,"PK553","CaMK1a (CAMK1)","T177","Calcium/calmodulin-dependent protein-serine kinase 1 alpha",0,2525,12,614,{"v":1542.982,"d":"1543"},{"v":2711.2460380558,"d":"2711"},{"$nulls":3},0,2962,12,636,{"v":1876.2,"d":"1876"},{"v":3278.12497062,"d":"3278"},{"$nulls":6},0,2966,14,625,1845,{"v":3156.502383,"d":"3157"},{"$nulls":7},"CaMK1a","X","PSTK","Protein kinase - Non-receptor- tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"VLS(pT)ACG(bA)C","Corresponds to amino acid residues V174 to G180; In the protein kinase catalytic domain.","T177 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in CaMK1a (≥12 reports from high throughput mass spectrometry studies).","CAMKK1",null,"Q14012","Q14012","Q14012"]
[309,156,"PK874","CaMK1a (CAMK1)","Y235","Calcium/calmodulin-dependent protein-serine kinase 1 alpha",0,4334,12,866,{"v":3742.852,"d":"3743"},{"v":6576.740788958799,"d":"6577"},{"$f":"(L322+L323)/2","v":{"v":6033.429210331899,"d":"6033"}},{"$f":"SQRT((M322-L322)*(M322-L322))","v":{"v":543.3115786269,"d":"543"}},{"$f":"N322/M322*100","v":{"v":9.005021185903868,"d":"9"}},0,4481,18,795,{"v":3548.085,"d":"3548"},{"v":6199.2676880835,"d":"6199"},{"$f":"(U322+U323)/2","v":{"v":6284.68466628475,"d":"6285"}},{"$f":"SQRT((V322-U322)*(V322-U322))","v":{"v":85.41697820125046,"d":"85"}},{"$f":"W322/V322*100","v":{"v":1.3591291009314155,"d":"1"}},{"$f":"X322+O322","v":{"v":10.364150286835283,"d":"10"}},{"$f":"(V322/M322*100)-100","v":{"v":4.164388893841505,"d":"4"}},null,0,4056,20,953,{"v":3846.308,"d":"3846"},{"v":6580.4229635512,"d":"6580"},{"$f":"(AG322+AG323)/2","v":{"v":6371.9586498026,"d":"6372"}},{"$f":"SQRT((AH322-AG322)*(AH322-AG322))","v":{"v":208.46431374860003,"d":"208"}},{"$f":"AI322/AH322*100","v":{"v":3.2715892428940694,"d":"3"}},{"$f":"AJ322+O322","v":{"v":12.276610428797937,"d":"12"}},{"$f":"(AH322/M322*100)-100","v":{"v":5.610896020640936,"d":"6"}},null,null,"CaMK1a","X","PSTK","Protein kinase - Non-receptor- tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"KAE(pY)EFD(bA)C","Corresponds to amino acid residues K232 to D238. Y235 is located in the Gap/Insert 10 (G/I10) region in the protein-serine/threonine kinase catalytic domain of CaMK1a, and has been observed in only a small number of mass spectrometry studies (~2). The effect of its phosphorylation is unknown. However, it has homology with the Y245 phosphosite in VACAMKL.","The effect of Y235 phosphorylation is unclear. This is one of the minor in vivo phosphorylation sites in CaMK1a (≥2 reports from high throughput mass spectrometry studies).",null,"EC 2.7.11.17; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; CAMK1 family","Q14012","Q14012","Q14012",null,"GO:0005737; GO:0098978; GO:0005622; GO:0005634; GO:0014069","GO:0005524; GO:0005516; GO:0004683","GO:0007049; GO:0035556; GO:0032091; GO:0006913; GO:0018107; GO:0060999; GO:0051149; GO:0010976; GO:0033138; GO:1901985; GO:0046827; GO:0071902; GO:0051835; GO:0060143; GO:0045944; GO:0006468; GO:0051147; GO:0043393; GO:0032880; GO:0007165"]
[310,156,"PK874","CaMK1a (CAMK1)","Y235","Calcium/calmodulin-dependent protein-serine kinase 1 alpha",0,3966,16,791,{"v":3124.45,"d":"3124"},{"v":5490.117631704999,"d":"5490"},{"$nulls":3},0,4344,14,842,{"v":3645.86,"d":"3646"},{"v":6370.101644486001,"d":"6370"},{"$nulls":6},0,3659,20,990,{"v":3602.61,"d":"3603"},{"v":6163.494336054,"d":"6163"},{"$nulls":7},"CaMK1a","X","PSTK","Protein kinase - Non-receptor- tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"KAE(pY)EFD(bA)C","Corresponds to amino acid residues K232 to D238. Y235 is located in the Gap/Insert 10 (G/I10) region in the protein-serine/threonine kinase catalytic domain of CaMK1a, and has been observed in only a small number of mass spectrometry studies (~2). The effect of its phosphorylation is unknown. However, it has homology with the Y245 phosphosite in VACAMKL.","The effect of Y235 phosphorylation is unclear. This is one of the minor in vivo phosphorylation sites in CaMK1a (≥2 reports from high throughput mass spectrometry studies).",null,null,"Q14012","Q14012","Q14012"]
[311,157,"NK016-3","CaMK1d","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase 1 delta",0,50,10,655,{"v":26.2,"d":"26"},{"v":46.03724878,"d":"46"},{"$f":"(L324+L325)/2","v":{"v":55.9159286518,"d":"56"}},{"$f":"SQRT((M324-L324)*(M324-L324))","v":{"v":9.878679871800003,"d":"10"}},{"$f":"N324/M324*100","v":{"v":17.667022814405133,"d":"18"}},0,88,10,556,{"v":43.368,"d":"43"},{"v":75.77322445680001,"d":"76"},{"$f":"(U324+U325)/2","v":{"v":54.006418741000005,"d":"54"}},{"$f":"SQRT((V324-U324)*(V324-U324))","v":{"v":21.766805715800004,"d":"22"}},{"$f":"W324/V324*100","v":{"v":40.30410870268522,"d":"40"}},{"$f":"X324+O324","v":{"v":57.971131517090356,"d":"58"}},{"$f":"(V324/M324*100)-100","v":{"v":-3.41496592624064,"d":"-3"}},null,0,58,8,662,{"v":33.1,"d":"33"},{"v":56.62885034000001,"d":"57"},{"$f":"(AG324+AG325)/2","v":{"v":56.46460956560001,"d":"56"}},{"$f":"SQRT((AH324-AG324)*(AH324-AG324))","v":{"v":0.16424077439999962,"d":"0"}},{"$f":"AI324/AH324*100","v":{"v":0.2908738334747296,"d":"0"}},{"$f":"AJ324+O324","v":{"v":17.957896647879863,"d":"18"}},{"$f":"(AH324/M324*100)-100","v":{"v":0.981260487001407,"d":"1"}},null,null,"CaMK1d","X","PSTK","Protein kinase - Non-receptor- tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 319-385 mapping at the C-terminus of human CaMKIδ.",null,null,"Protein-serine kinase, CAMK group, CAMK1 family","Q8IU85","Q8IU85","Q8IU85",null,"GO:0005737; GO:0005634","GO:0005524; GO:0005516; GO:0004683","GO:0006954; GO:0035556; GO:0043066; GO:0018105; GO:0018107; GO:0043065; GO:0032793; GO:0010976; GO:0090023; GO:0050766; GO:0060267; GO:0050773; GO:0071622"]
[312,157,"NK016-3","CaMK1d","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase 1 delta",0,84,10,506,{"v":37.444,"d":"37"},{"v":65.7946085236,"d":"66"},{"$nulls":3},0,38,10,659,{"v":18.452,"d":"18"},{"v":32.2396130252,"d":"32"},{"$nulls":6},0,88,12,433,{"v":32.908,"d":"33"},{"v":56.30036879120001,"d":"56"},{"$nulls":7},"CaMK1d","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK1",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 319-385 mapping at the C-terminus of human CaMKIδ.",{"$nulls":3},"Q8IU85","Q8IU85","Q8IU85"]
[313,158,"NK016-2","CaMK1d","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase 1 delta",0,210,8,594,{"v":119.988,"d":"120"},{"v":210.8365422372,"d":"211"},{"$f":"(L326+L327)/2","v":{"v":207.7545065746,"d":"208"}},{"$f":"SQRT((M326-L326)*(M326-L326))","v":{"v":3.0820356626000205,"d":"3"}},{"$f":"N326/M326*100","v":{"v":1.4834988243652516,"d":"1"}},0,212,10,610,{"v":123.22,"d":"123"},{"v":215.291844622,"d":"215"},{"$f":"(U326+U327)/2","v":{"v":233.655075323,"d":"234"}},{"$f":"SQRT((V326-U326)*(V326-U326))","v":{"v":18.363230700999992,"d":"18"}},{"$f":"W326/V326*100","v":{"v":7.859119120616163,"d":"8"}},{"$f":"X326+O326","v":{"v":9.342617944981415,"d":"9"}},{"$f":"(V326/M326*100)-100","v":{"v":12.466910670406904,"d":"12"}},null,0,322,8,596,{"v":187.144,"d":"187"},{"v":320.17370296160004,"d":"320"},{"$f":"(AG326+AG327)/2","v":{"v":266.7099092116,"d":"267"}},{"$f":"SQRT((AH326-AG326)*(AH326-AG326))","v":{"v":53.463793750000036,"d":"53"}},{"$f":"AI326/AH326*100","v":{"v":20.045672059219736,"d":"20"}},{"$f":"AJ326+O326","v":{"v":21.52917088358499,"d":"22"}},{"$f":"(AH326/M326*100)-100","v":{"v":28.377436239069226,"d":"28"}},null,null,"CaMK1d","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK1",{"$nulls":6},"Epitope undefined.",{"$nulls":3},"Protein-serine kinase, CAMK group, CAMK1 family","Q8IU85","Q8IU85","Q8IU85",null,"GO:0005737; GO:0005634","GO:0005524; GO:0005516; GO:0004683","GO:0006954; GO:0035556; GO:0043066; GO:0018105; GO:0018107; GO:0043065; GO:0032793; GO:0010976; GO:0090023; GO:0050766; GO:0060267; GO:0050773; GO:0071622"]
[314,158,"NK016-2","CaMK1d","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase 1 delta",0,222,14,560,{"v":116.48,"d":"116"},{"v":204.672470912,"d":"205"},{"$nulls":3},0,250,10,601,{"v":144.24,"d":"144"},{"v":252.01830602400003,"d":"252"},{"$nulls":6},0,231,10,564,{"v":124.644,"d":"125"},{"v":213.24611546160003,"d":"213"},{"$nulls":7},"CaMK1d","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK1",{"$nulls":6},"Epitope undefined.",{"$nulls":4},"Q8IU85","Q8IU85","Q8IU85"]
[315,159,"PK554","CaMK1d","T180","Calcium/calmodulin-dependent protein-serine kinase 1 delta",0,3398,16,781,{"v":2641.342,"d":"2641"},{"v":4641.2259071398,"d":"4641"},{"$f":"(L328+L329)/2","v":{"v":4386.7717074039,"d":"4387"}},{"$f":"SQRT((M328-L328)*(M328-L328))","v":{"v":254.45419973590015,"d":"254"}},{"$f":"N328/M328*100","v":{"v":5.800488758200883,"d":"6"}},0,3614,16,771,{"v":2774.058,"d":"2774"},{"v":4846.8760258758,"d":"4847"},{"$f":"(U328+U329)/2","v":{"v":4744.646470374801,"d":"4745"}},{"$f":"SQRT((V328-U328)*(V328-U328))","v":{"v":102.2295555009996,"d":"102"}},{"$f":"W328/V328*100","v":{"v":2.154629562799102,"d":"2"}},{"$f":"X328+O328","v":{"v":7.9551183209999845,"d":"8"}},{"$f":"(V328/M328*100)-100","v":{"v":8.15804392936353,"d":"8"}},null,0,3608,14,885,{"v":3180.69,"d":"3181"},{"v":5441.656132566,"d":"5442"},{"$f":"(AG328+AG329)/2","v":{"v":5045.2173970959,"d":"5045"}},{"$f":"SQRT((AH328-AG328)*(AH328-AG328))","v":{"v":396.43873547010026,"d":"396"}},{"$f":"AI328/AH328*100","v":{"v":7.8577136378364205,"d":"8"}},{"$f":"AJ328+O328","v":{"v":13.658202396037304,"d":"14"}},{"$f":"(AH328/M328*100)-100","v":{"v":15.009800682827645,"d":"15"}},null,null,"CaMK1d","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK1",{"$nulls":6},"VMS(pT)ACG(bA)C","Corresponds to amino acid residues V177 to G183; In the protein kinase catalytic domain.","T180 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation site in CaMK1d (≥19 reports from high throughput mass spectrometry studies).","CaMKK1","Protein-serine kinase, CAMK group, CAMK1 family","Q8IU85","Q8IU85","Q8IU85",null,"GO:0005737; GO:0005634","GO:0005524; GO:0005516; GO:0004683","GO:0006954; GO:0035556; GO:0043066; GO:0018105; GO:0018107; GO:0043065; GO:0032793; GO:0010976; GO:0090023; GO:0050766; GO:0060267; GO:0050773; GO:0071622"]
[316,159,"PK554","CaMK1d","T180","Calcium/calmodulin-dependent protein-serine kinase 1 delta",0,3190,12,740,{"v":2351.72,"d":"2352"},{"v":4132.317507668,"d":"4132"},{"$nulls":3},0,3554,16,751,{"v":2657.038,"d":"2657"},{"v":4642.4169148738,"d":"4642"},{"$nulls":6},0,3679,12,741,{"v":2717.247,"d":"2717"},{"v":4648.7786616258,"d":"4649"},{"$nulls":7},"CaMK1d","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK1",{"$nulls":6},"VMS(pT)ACG(bA)C","Corresponds to amino acid residues V177 to G183; In the protein kinase catalytic domain.","T180 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation site in CaMK1d (≥19 reports from high throughput mass spectrometry studies).","CaMKK1",null,"Q8IU85","Q8IU85","Q8IU85"]
[317,160,"NK302-2","CaMK2a","Pan-specific","Calcium/calmodulin-dependent protein kinase type II subunit alpha",0,26,10,914,{"v":14.624,"d":"15"},{"v":25.6965162656,"d":"26"},{"$f":"(L330+L331)/2","v":{"v":41.1840090422,"d":"41"}},{"$f":"SQRT((M330-L330)*(M330-L330))","v":{"v":15.487492776600003,"d":"15"}},{"$f":"N330/M330*100","v":{"v":37.60559774724806,"d":"38"}},0,7834,10,416,{"v":3254.784,"d":"3255"},{"v":5686.8077520384,"d":"5687"},{"$f":"(U330+U331)/2","v":{"v":6694.7621655076,"d":"6695"}},{"$f":"SQRT((V330-U330)*(V330-U330))","v":{"v":1007.9544134691996,"d":"1008"}},{"$f":"W330/V330*100","v":{"v":15.05586589262766,"d":"15"}},{"$f":"X330+O330","v":{"v":52.66146363987572,"d":"53"}},{"$f":"(V330/M330*100)-100","v":{"v":16155.73206981302,"d":"16156"}},null,0,1344,10,374,{"v":498.916,"d":"499"},{"v":853.5661479224,"d":"854"},{"$f":"(AG330+AG331)/2","v":{"v":2611.8833967724004,"d":"2612"}},{"$f":"SQRT((AH330-AG330)*(AH330-AG330))","v":{"v":1758.3172488500004,"d":"1758"}},{"$f":"AI330/AH330*100","v":{"v":67.31989839296874,"d":"67"}},{"$f":"AJ330+O330","v":{"v":104.92549614021681,"d":"105"}},{"$f":"(AH330/M330*100)-100","v":{"v":6241.984322352112,"d":"6242"}},null,null,"CaMK2a","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK2",{"$nulls":6},"Epitope undefined.",{"$nulls":3},"EC 2.7.11.17; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; CAMK2 family","Q9UQM7","Q9UQM7","Q9UQM7",null,"GO:0005954; GO:0030054; GO:0005737; GO:0005829; GO:0043197; GO:0030666; GO:0005739; GO:0043005; GO:0005654; GO:0005634; GO:0005886; GO:0014069; GO:0042734; GO:0098685","GO:0005524; GO:0009931; GO:0005516; GO:0004683; GO:0035254; GO:0042802; GO:0016301; GO:0046872; GO:0042803; GO:0004674; GO:0005088","GO:0038166; GO:0006816; GO:0030154; GO:0048813; GO:0060996; GO:0000082; GO:0060333; GO:0035556; GO:0000165; GO:0007399; GO:0018105; GO:1990443; GO:0018107; GO:0051928; GO:0010666; GO:0051092; GO:0046777; GO:0006468; GO:1902108; GO:0048168; GO:2001222; GO:0046928; GO:0099148; GO:0002931; GO:0007223"]
[318,160,"NK302-2","CaMK2a","Pan-specific","Calcium/calmodulin-dependent protein kinase type II subunit alpha",0,54,10,733,{"v":32.252,"d":"32"},{"v":56.6715018188,"d":"57"},{"$nulls":3},0,12650,18,349,{"v":4408.568,"d":"4409"},{"v":7702.7165789768005,"d":"7703"},{"$nulls":6},0,5268,12,486,{"v":2554.416,"d":"2554"},{"v":4370.200645622401,"d":"4370"},{"$nulls":7},"CaMK2a","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK2",{"$nulls":6},"Epitope undefined.",{"$nulls":4},"Q9UQM7","Q9UQM7","Q9UQM7"]
[319,161,"PK875","CaMK2a","Y230","Calcium/calmodulin-dependent protein-serine kinase 2 alpha",0,5614,14,798,{"v":4468.8,"d":"4469"},{"v":7852.33806672,"d":"7852"},{"$f":"(L332+L333)/2","v":{"v":10590.7689244657,"d":"10591"}},{"$f":"SQRT((M332-L332)*(M332-L332))","v":{"v":2738.4308577456995,"d":"2738"}},{"$f":"N332/M332*100","v":{"v":25.85677090375997,"d":"26"}},0,10746,20,857,{"v":9192.182,"d":"9192"},{"v":16060.7191923482,"d":"16061"},{"$f":"(U332+U333)/2","v":{"v":14875.1009586506,"d":"14875"}},{"$f":"SQRT((V332-U332)*(V332-U332))","v":{"v":1185.6182336975999,"d":"1186"}},{"$f":"W332/V332*100","v":{"v":7.970488650755037,"d":"8"}},{"$f":"X332+O332","v":{"v":33.82725955451501,"d":"34"}},{"$f":"(V332/M332*100)-100","v":{"v":40.453455879749015,"d":"40"}},null,0,8898,16,817,{"v":7256.594,"d":"7257"},{"v":12414.8814381916,"d":"12415"},{"$f":"(AG332+AG333)/2","v":{"v":11874.5215916293,"d":"11875"}},{"$f":"SQRT((AH332-AG332)*(AH332-AG332))","v":{"v":540.3598465622999,"d":"540"}},{"$f":"AI332/AH332*100","v":{"v":4.550582037285742,"d":"5"}},{"$f":"AJ332+O332","v":{"v":30.407352941045712,"d":"30"}},{"$f":"(AH332/M332*100)-100","v":{"v":12.12143024099042,"d":"12"}},null,null,"CaMK2a","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK2",{"$nulls":6},"AGA(pY)DFP(bA)C","Corresponds to amino acid residues A227 to P230. Y230 is located in the Gap/Insert 10 (G/I10) region in the protein-serine/threonine kinase catalytic domain of CaMK2a. ","The effect of Y230 phosphorylation is unknown. It appears to be the third most commonly observed phosphosite in CaMK2a by mass spectrometry studies (~28 reports). Phosphorylation of Y230 in rat brain appears to be induced by 15 min ischemia treatment.",null,"EC 2.7.11.17; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; CAMK2 family","Q9UQM7","Q9UQM7","Q9UQM7",null,"GO:0005954; GO:0030054; GO:0005737; GO:0005829; GO:0043197; GO:0030666; GO:0005739; GO:0043005; GO:0005654; GO:0005634; GO:0005886; GO:0014069; GO:0042734; GO:0098685","GO:0005524; GO:0009931; GO:0005516; GO:0004683; GO:0035254; GO:0042802; GO:0016301; GO:0046872; GO:0042803; GO:0004674; GO:0005088","GO:0038166; GO:0006816; GO:0030154; GO:0048813; GO:0060996; GO:0000082; GO:0060333; GO:0035556; GO:0000165; GO:0007399; GO:0018105; GO:1990443; GO:0018107; GO:0051928; GO:0010666; GO:0051092; GO:0046777; GO:0006468; GO:1902108; GO:0048168; GO:2001222; GO:0046928; GO:0099148; GO:0002931; GO:0007223"]
[320,161,"PK875","CaMK2a","Y230","Calcium/calmodulin-dependent protein-serine kinase 2 alpha",0,9508,14,799,{"v":7585.706,"d":"7586"},{"v":13329.199782211399,"d":"13329"},{"$nulls":3},0,9612,22,817,{"v":7835.03,"d":"7835"},{"v":13689.482724952999,"d":"13689"},{"$nulls":6},0,8865,20,749,{"v":6624.905,"d":"6625"},{"v":11334.161745067,"d":"11334"},{"$nulls":7},"CaMK2a","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK2",{"$nulls":6},"AGA(pY)DFP(bA)C","Corresponds to amino acid residues A227 to P230. Y230 is located in the Gap/Insert 10 (G/I10) region in the protein-serine/threonine kinase catalytic domain of CaMK2a. ","The effect of Y230 phosphorylation is unknown. It appears to be the third most commonly observed phosphosite in CaMK2a by mass spectrometry studies (~28 reports). Phosphorylation of Y230 in rat brain appears to be induced by 15 min ischemia treatment.",null,null,"Q9UQM7","Q9UQM7","Q9UQM7"]
[321,162,"PK555","CaMK2a","T286","Calcium/calmodulin-dependent protein-serine kinase 2 alpha",0,6721,12,857,{"$f":"(H334-I334)*J334/1000","v":{"v":5749.613,"d":"5750"}},{"v":10102.914659149701,"d":"10103"},{"$f":"(L334+L335)/2","v":{"v":9828.26820581245,"d":"9828"}},{"$f":"SQRT((M334-L334)*(M334-L334))","v":{"v":274.64645333725093,"d":"275"}},{"$f":"N334/M334*100","v":{"v":2.7944541966694056,"d":"3"}},0,8224,24,941,{"$f":"(Q334-R334)*S334/1000","v":{"v":7716.2,"d":"7716"}},{"v":13481.861154619999,"d":"13482"},{"$f":"(U334+U335)/2","v":{"v":11358.7781534476,"d":"11359"}},{"$f":"SQRT((V334-U334)*(V334-U334))","v":{"v":2123.0830011723992,"d":"2123"}},{"$f":"W334/V334*100","v":{"v":18.691121285153407,"d":"19"}},{"$f":"X334+O334","v":{"v":21.485575481822814,"d":"21"}},{"$f":"(V334/M334*100)-100","v":{"v":15.572529316304212,"d":"16"}},null,0,6682,16,806,{"$f":"(AC334-AD334)*AE334/1000","v":{"v":5372.796,"d":"5373"}},{"v":9192.0018305544,"d":"9192"},{"$f":"(AG334+AG335)/2","v":{"v":9657.2343541392,"d":"9657"}},{"$f":"SQRT((AH334-AG334)*(AH334-AG334))","v":{"v":465.2325235848002,"d":"465"}},{"$f":"AI334/AH334*100","v":{"v":4.817450902860157,"d":"5"}},{"$f":"AJ334+O334","v":{"v":7.611905099529563,"d":"8"}},{"$f":"(AH334/M334*100)-100","v":{"v":-1.7402236903964479,"d":"-2"}},null,null,"CaMK2a","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK2",{"$nulls":6},"HRQE(pT)VDC","Corresponds to amino acid residues H282 to C289; In the region between the kinase catalytic domain and the CamKII-AD domains. ","T286 phosphorylation stimulates calcium/calmodulin-independent phosphotransferase activity and regulates cell growth, intracellular location, molecular association, including inducing interaction with GIT1 and MAP2, and inhibiting interaction with MBP and neurogranin. This is a major site of in vivo phosphorylation of CaMK2a (≥88 reports from high throughput mass spectrometry studies).","CaMK2a; CaMK2b; CaMK2d; PKCa (PRKCA)","EC 2.7.11.17; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; CAMK2 family","Q9UQM7","Q9UQM7","Q9UQM7",null,"GO:0005954; GO:0030054; GO:0005737; GO:0005829; GO:0043197; GO:0030666; GO:0005739; GO:0043005; GO:0005654; GO:0005634; GO:0005886; GO:0014069; GO:0042734; GO:0098685","GO:0005524; GO:0009931; GO:0005516; GO:0004683; GO:0035254; GO:0042802; GO:0016301; GO:0046872; GO:0042803; GO:0004674; GO:0005088","GO:0038166; GO:0006816; GO:0030154; GO:0048813; GO:0060996; GO:0000082; GO:0060333; GO:0035556; GO:0000165; GO:0007399; GO:0018105; GO:1990443; GO:0018107; GO:0051928; GO:0010666; GO:0051092; GO:0046777; GO:0006468; GO:1902108; GO:0048168; GO:2001222; GO:0046928; GO:0099148; GO:0002931; GO:0007223"]
[322,162,"PK555","CaMK2a","T286","Calcium/calmodulin-dependent protein-serine kinase 2 alpha",0,6679,16,816,{"v":5437.008,"d":"5437"},{"v":9553.6217524752,"d":"9554"},{"$nulls":3},0,7010,18,756,{"v":5285.952,"d":"5286"},{"v":9235.6951522752,"d":"9236"},{"$nulls":6},0,6386,24,930,{"v":5916.66,"d":"5917"},{"v":10122.466877724,"d":"10122"},{"$nulls":7},"CaMK2a","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK2",{"$nulls":6},"HRQE(pT)VDC","Corresponds to amino acid residues H282 to C289; In the region between the kinase catalytic domain and the CamKII-AD domains. ","T286 phosphorylation stimulates calcium/calmodulin-independent phosphotransferase activity and regulates cell growth, intracellular location, molecular association, including inducing interaction with GIT1 and MAP2, and inhibiting interaction with MBP and neurogranin. This is a major site of in vivo phosphorylation of CaMK2a (≥88 reports from high throughput mass spectrometry studies).","CaMK2a; CaMK2b; CaMK2d; PKCa (PRKCA)",null,"Q9UQM7","Q9UQM7","Q9UQM7"]
[323,163,"PK178","CaMK2a","T286","Calcium/calmodulin-dependent protein-serine kinase 2 alpha",0,128,10,457,{"v":53.926,"d":"54"},{"v":94.7559037294,"d":"95"},{"$f":"(L336+L337)/2","v":{"v":87.4988870324,"d":"87"}},{"$f":"SQRT((M336-L336)*(M336-L336))","v":{"v":7.257016696999997,"d":"7"}},{"$f":"N336/M336*100","v":{"v":8.29383886255924,"d":"8"}},0,48,14,786,{"v":26.724,"d":"27"},{"v":46.6925763324,"d":"47"},{"$f":"(U336+U337)/2","v":{"v":78.3084335669,"d":"78"}},{"$f":"SQRT((V336-U336)*(V336-U336))","v":{"v":31.615857234500005,"d":"32"}},{"$f":"W336/V336*100","v":{"v":40.373502309288476,"d":"40"}},{"$f":"X336+O336","v":{"v":48.66734117184772,"d":"49"}},{"$f":"(V336/M336*100)-100","v":{"v":-10.503508989887905,"d":"-11"}},null,0,206,14,457,{"v":87.744,"d":"88"},{"v":150.1160678016,"d":"150"},{"$f":"(AG336+AG337)/2","v":{"v":133.81517094240002,"d":"134"}},{"$f":"SQRT((AH336-AG336)*(AH336-AG336))","v":{"v":16.30089685919998,"d":"16"}},{"$f":"AI336/AH336*100","v":{"v":12.181650813132846,"d":"12"}},{"$f":"AJ336+O336","v":{"v":20.475489675692085,"d":"20"}},{"$f":"(AH336/M336*100)-100","v":{"v":52.93356919254245,"d":"53"}},null,null,"CaMK2a","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK2",{"$nulls":6},"Not precisely defined.","Antibody raised against a synthetic peptide corresponding to amino acid residues 281-294 of rat CaMKII.","T286 phosphorylation stimulates calcium/calmodulin-independent phosphotransferase activity and regulates cell growth, intracellular location, molecular association, including inducing interaction with GIT1 and MAP2, and inhibiting interaction with MBP and neurogranin. This is a major site of in vivo phosphorylation of CaMK2a (≥88 reports from high throughput mass spectrometry studies).","CaMK2a; CaMK2b; CaMK2d; PKCa (PRKCA)","EC 2.7.11.17; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; CAMK2 family","Q9UQM7","Q9UQM7","Q9UQM7",null,"GO:0005954; GO:0030054; GO:0005737; GO:0005829; GO:0043197; GO:0030666; GO:0005739; GO:0043005; GO:0005654; GO:0005634; GO:0005886; GO:0014069; GO:0042734; GO:0098685","GO:0005524; GO:0009931; GO:0005516; GO:0004683; GO:0035254; GO:0042802; GO:0016301; GO:0046872; GO:0042803; GO:0004674; GO:0005088","GO:0038166; GO:0006816; GO:0030154; GO:0048813; GO:0060996; GO:0000082; GO:0060333; GO:0035556; GO:0000165; GO:0007399; GO:0018105; GO:1990443; GO:0018107; GO:0051928; GO:0010666; GO:0051092; GO:0046777; GO:0006468; GO:1902108; GO:0048168; GO:2001222; GO:0046928; GO:0099148; GO:0002931; GO:0007223"]
[324,163,"PK178","CaMK2a","T286","Calcium/calmodulin-dependent protein-serine kinase 2 alpha",0,130,12,387,{"v":45.666,"d":"46"},{"v":80.2418703354,"d":"80"},{"$nulls":3},0,184,18,379,{"v":62.914,"d":"63"},{"v":109.9242908014,"d":"110"},{"$nulls":6},0,124,18,648,{"v":68.688,"d":"69"},{"v":117.51427408320001,"d":"118"},{"$nulls":7},"CaMK2a","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK2",{"$nulls":6},"Not precisely defined.","Antibody raised against a synthetic peptide corresponding to amino acid residues 281-294 of rat CaMKII.","T286 phosphorylation stimulates calcium/calmodulin-independent phosphotransferase activity and regulates cell growth, intracellular location, molecular association, including inducing interaction with GIT1 and MAP2, and inhibiting interaction with MBP and neurogranin. This is a major site of in vivo phosphorylation of CaMK2a (≥88 reports from high throughput mass spectrometry studies).","CaMK2a; CaMK2b; CaMK2d; PKCa (PRKCA)",null,"Q9UQM7","Q9UQM7","Q9UQM7"]
[325,164,"NK018-3","CaMK2b","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase 2 beta",0,4648,14,859,{"v":3980.606,"d":"3981"},{"$f":"K338*1.7571469","v":{"v":6994.5094930214,"d":"6995"}},{"$f":"(L338+L339)/2","v":{"v":6395.16337832695,"d":"6395"}},{"$f":"SQRT((M338-L338)*(M338-L338))","v":{"v":599.3461146944501,"d":"599"}},{"$f":"N338/M338*100","v":{"v":9.371865568370296,"d":"9"}},0,4554,20,771,{"v":3495.714,"d":"3496"},{"$f":"T338*1.7472151","v":{"v":6107.7642860814,"d":"6108"}},{"$f":"(U338+U339)/2","v":{"v":6311.648563315501,"d":"6312"}},{"$f":"SQRT((V338-U338)*(V338-U338))","v":{"v":203.8842772341004,"d":"204"}},{"$f":"W338/V338*100","v":{"v":3.2302856407296585,"d":"3"}},{"$f":"X338+O338","v":{"v":12.602151209099954,"d":"13"}},{"$f":"(V338/M338*100)-100","v":{"v":-1.3059058865404296,"d":"-1"}},null,0,4420,18,796,{"v":3503.992,"d":"3504"},{"v":5994.774578868801,"d":"5995"},{"$f":"(AG338+AG339)/2","v":{"v":6561.663587600201,"d":"6562"}},{"$f":"SQRT((AH338-AG338)*(AH338-AG338))","v":{"v":566.8890087314003,"d":"567"}},{"$f":"AI338/AH338*100","v":{"v":8.639409825926915,"d":"9"}},{"$f":"AJ338+O338","v":{"v":18.01127539429721,"d":"18"}},{"$f":"(AH338/M338*100)-100","v":{"v":2.6035333176555895,"d":"3"}},null,null,"CAMK2b","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK2",{"$nulls":6},"RISDILNSVRRGSGTPEAEC","Corresponds to amino acid residues R449 to E467; Before CaMAD, repeated 3X.",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.1.123; EC 2.7.11.17; CAMK domain target; CAMK</A> group; CAMK2 family","Q13554","Q13554","Q13554","Q13554","GO:0030054; GO:0005737; GO:0005829; GO:0030666; GO:0005815; GO:0043005; GO:0005654; GO:0005886; GO:0033017; GO:0045202","GO:0003779; GO:0005524; GO:0005516; GO:0004683; GO:0042802; GO:0042803; GO:0004674; GO:0005088","GO:0060333; GO:0035556; GO:0000165; GO:0018105; GO:0018107; GO:0061003; GO:0010976; GO:0090129; GO:0046777; GO:0006468; GO:0051924; GO:0060998; GO:0048169; GO:2001222; GO:0014733; GO:0051823; GO:0007165"]
[326,164,"NK018-3","CaMK2b","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase 2 beta",0,2997,12,1105,{"v":3298.425,"d":"3298"},{"v":5795.8172636325,"d":"5796"},{"$nulls":3},0,4130,14,906,{"v":3729.096,"d":"3729"},{"v":6515.5328405496,"d":"6516"},{"$nulls":6},0,3960,18,1057,{"v":4166.694,"d":"4167"},{"$f":"AF339*1.7108414","v":{"v":7128.552596331601,"d":"7129"}},{"$nulls":7},"CAMK2b","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK2",{"$nulls":6},"RISDILNSVRRGSGTPEAEC","Corresponds to amino acid residues R449 to E467; Before CaMAD, repeated 3X.",{"$nulls":3},"Q13554","Q13554","Q13554","Q13554"]
[327,165,"NK019-3","CaMK2d","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase 2 delta",0,9056,22,882,{"v":7967.988,"d":"7968"},{"v":14000.9254134372,"d":"14001"},{"$f":"(L340+L341)/2","v":{"v":13158.2750746608,"d":"13158"}},{"$f":"SQRT((M340-L340)*(M340-L340))","v":{"v":842.6503387764005,"d":"843"}},{"$f":"N340/M340*100","v":{"v":6.403957463992466,"d":"6"}},0,9730,21,925,{"v":8980.825,"d":"8981"},{"v":15691.433050457501,"d":"15691"},{"$f":"(U340+U341)/2","v":{"v":15135.340785327651,"d":"15135"}},{"$f":"SQRT((V340-U340)*(V340-U340))","v":{"v":556.0922651298497,"d":"556"}},{"$f":"W340/V340*100","v":{"v":3.6741311148337736,"d":"4"}},{"$f":"X340+O340","v":{"v":10.07808857882624,"d":"10"}},{"$f":"(V340/M340*100)-100","v":{"v":15.025265085650432,"d":"15"}},null,0,8256,16,887,{"v":7308.88,"d":"7309"},{"v":12504.334491632,"d":"12504"},{"$f":"(AG340+AG341)/2","v":{"v":12820.36111504,"d":"12820"}},{"$f":"SQRT((AH340-AG340)*(AH340-AG340))","v":{"v":316.02662340799907,"d":"316"}},{"$f":"AI340/AH340*100","v":{"v":2.4650368314294795,"d":"2"}},{"$f":"AJ340+O340","v":{"v":8.868994295421945,"d":"9"}},{"$f":"(AH340/M340*100)-100","v":{"v":-2.5680718612694875,"d":"-3"}},null,null,"CAMK2d","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK2",{"$nulls":6},"CTRFTDEYQLFEELGKGAFS","Corresponds to amino acid residues C7 to S26; N-terminus and kinase domain I, highly conserved in all CaMK2 isoforms.",null,null,"EC 2.7.11.17; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; CAMK2 family","Q13557","Q13557","Q13557","Q13557","GO:0005737; GO:0005829; GO:0030666; GO:0016020; GO:0043005; GO:0005654; GO:0005634; GO:0005886; GO:0042383; GO:0033017","GO:0005524; GO:0005516; GO:0004683; GO:0042802; GO:0044325; GO:0042803; GO:0004674; GO:0005088; GO:0019871; GO:0031432","GO:0086003; GO:0030154; GO:0071277; GO:0032469; GO:0060333; GO:0000165; GO:1902306; GO:2000650; GO:0007399; GO:0018105; GO:0018107; GO:0010666; GO:0010613; GO:0046777; GO:0051259; GO:0006468; GO:1902514; GO:0098901; GO:0098909; GO:0010881; GO:0010649; GO:1901844; GO:0001558; GO:0060341; GO:0008016; GO:0086091; GO:1901725; GO:0003254; GO:1901897; GO:0010880; GO:0060314; GO:0002026; GO:0006357; GO:0055119"]
[328,165,"NK019-3","CaMK2d","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase 2 delta",0,8013,12,876,{"v":7008.876,"d":"7009"},{"v":12315.6247358844,"d":"12316"},{"$nulls":3},0,8996,14,929,{"v":8344.278,"d":"8344"},{"v":14579.2485201978,"d":"14579"},{"$nulls":6},0,7198,22,1070,{"v":7678.32,"d":"7678"},{"v":13136.387738448,"d":"13136"},{"$nulls":7},"CAMK2d","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK2",{"$nulls":6},"CTRFTDEYQLFEELGKGAFS","Corresponds to amino acid residues C7 to S26; N-terminus and kinase domain I, highly conserved in all CaMK2 isoforms.",{"$nulls":3},"Q13557","Q13557","Q13557","Q13557"]
[329,166,"NK020-1","CaMK2g","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase 2 gamma",0,2210,14,869,{"v":1908.324,"d":"1908"},{"v":3353.2056007956,"d":"3353"},{"$f":"(L342+L343)/2","v":{"v":3151.3410506297996,"d":"3151"}},{"$f":"SQRT((M342-L342)*(M342-L342))","v":{"v":201.8645501658002,"d":"202"}},{"$f":"N342/M342*100","v":{"v":6.405671329209427,"d":"6"}},0,2358,16,888,{"v":2079.696,"d":"2080"},{"v":3633.6762546095997,"d":"3634"},{"$f":"(U342+U343)/2","v":{"v":3493.0219446294,"d":"3493"}},{"$f":"SQRT((V342-U342)*(V342-U342))","v":{"v":140.65430998019974,"d":"141"}},{"$f":"W342/V342*100","v":{"v":4.026722769276011,"d":"4"}},{"$f":"X342+O342","v":{"v":10.432394098485439,"d":"10"}},{"$f":"(V342/M342*100)-100","v":{"v":10.842396570543045,"d":"11"}},null,0,2600,16,749,{"v":1935.416,"d":"1935"},{"v":3311.1898190224,"d":"3311"},{"$f":"(AG342+AG343)/2","v":{"v":3139.1612945695997,"d":"3139"}},{"$f":"SQRT((AH342-AG342)*(AH342-AG342))","v":{"v":172.0285244528004,"d":"172"}},{"$f":"AI342/AH342*100","v":{"v":5.480079177530337,"d":"5"}},{"$f":"AJ342+O342","v":{"v":11.885750506739765,"d":"12"}},{"$f":"(AH342/M342*100)-100","v":{"v":-0.386494380154943,"d":"-0"}},null,null,"CaMK2g","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK2",{"$nulls":6},"CDGIKGSTESSNTTTEDEDL","Corresponds to amino acid residues D376 to L394; Before CaMAD, highly conserved in all CaMK2 isoforms.",null,null,"EC 2.7.11.17; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; CAMK2 family","Q13555","Q13555","Q13555",null,"GO:0005737; GO:0005829; GO:0030666; GO:0016020; GO:0043005; GO:0005654; GO:0005886; GO:0033017","GO:0005524; GO:0004723; GO:0005516; GO:0004683; GO:0042802; GO:0042803; GO:0004674; GO:0005088","GO:0030154; GO:0030073; GO:0060333; GO:0035556; GO:0000165; GO:0007399; GO:0018105; GO:0018107; GO:0051259; GO:0051924; GO:0014733"]
[330,166,"NK020-1","CaMK2g","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase 2 gamma",0,2164,12,780,{"v":1678.56,"d":"1679"},{"v":2949.476500464,"d":"2949"},{"$nulls":3},0,2694,18,717,{"v":1918.692,"d":"1919"},{"v":3352.3676346492,"d":"3352"},{"$nulls":6},0,2290,14,762,{"v":1734.312,"d":"1734"},{"v":2967.1327701167997,"d":"2967"},{"$nulls":7},"CaMK2g","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK2",{"$nulls":6},"CDGIKGSTESSNTTTEDEDL","Corresponds to amino acid residues D376 to L394; Before CaMAD, highly conserved in all CaMK2 isoforms.",{"$nulls":3},"Q13555","Q13555","Q13555"]
[331,167,"NK021-2 (NK021-3)","CaMK4 (CaMPK4)","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase 4",0,2057,16,801,{"v":1634.841,"d":"1635"},{"v":2872.6557951429,"d":"2873"},{"$f":"(L344+L345)/2","v":{"v":2705.40616033365,"d":"2705"}},{"$f":"SQRT((M344-L344)*(M344-L344))","v":{"v":167.24963480924998,"d":"167"}},{"$f":"N344/M344*100","v":{"v":6.182052708441514,"d":"6"}},0,2048,16,689,{"v":1400.048,"d":"1400"},{"v":2446.1850063248,"d":"2446"},{"$f":"(U344+U345)/2","v":{"v":2457.9839498951,"d":"2458"}},{"$f":"SQRT((V344-U344)*(V344-U344))","v":{"v":11.798943570300253,"d":"12"}},{"$f":"W344/V344*100","v":{"v":0.4800252487736464,"d":"0"}},{"$f":"X344+O344","v":{"v":6.6620779572151605,"d":"7"}},{"$f":"(V344/M344*100)-100","v":{"v":-9.145473757923142,"d":"-9"}},null,0,1994,14,771,{"v":1526.58,"d":"1527"},{"v":2611.736264412,"d":"2612"},{"$f":"(AG344+AG345)/2","v":{"v":2466.7629858587998,"d":"2467"}},{"$f":"SQRT((AH344-AG344)*(AH344-AG344))","v":{"v":144.9732785532001,"d":"145"}},{"$f":"AI344/AH344*100","v":{"v":5.877065586936714,"d":"6"}},{"$f":"AJ344+O344","v":{"v":12.059118295378228,"d":"12"}},{"$f":"(AH344/M344*100)-100","v":{"v":-8.820974017646904,"d":"-9"}},null,null,"CAMK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK1",{"$nulls":6},"CPQQDAILPEY","Corresponds to amino acid residues Q466 to Y474; C-terminus.",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.17; CAMK domain target; CAMK</A> group; CAMK1 family","Q16566","Q16566","Q16566","Q16566","GO:0005737; GO:0005829; GO:0070062; GO:0001650; GO:0098978; GO:0005654; GO:0005634; GO:0098794","GO:0005524; GO:0009931; GO:0005516; GO:0004683","GO:0002250; GO:0006954; GO:0035556; GO:0007616; GO:0043011; GO:0018105; GO:0045893; GO:0046777; GO:0006468; GO:0045670; GO:0033081; GO:0007165"]
[332,167,"NK021-2 (NK021-3)","CaMK4 (CaMPK4)","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase 4",0,2060,14,706,{"v":1444.476,"d":"1444"},{"v":2538.1565255244,"d":"2538"},{"$nulls":3},0,1984,18,719,{"v":1413.554,"d":"1414"},{"v":2469.7828934654003,"d":"2470"},{"$nulls":6},0,1747,16,784,{"v":1357.104,"d":"1357"},{"v":2321.7897073056,"d":"2322"},{"$nulls":7},"CAMK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK1",{"$nulls":6},"CPQQDAILPEY","Corresponds to amino acid residues Q466 to Y474; C-terminus.",{"$nulls":3},"Q16566","Q16566","Q16566","Q16566"]
[333,168,"NK021 SG-KAP-CA003","CaMK4 (CaMPK4)","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase 4",0,2399,20,856,{"v":2036.424,"d":"2036"},{"v":3578.2961186856,"d":"3578"},{"$f":"(L346+L347)/2","v":{"v":3333.9999851786,"d":"3334"}},{"$f":"SQRT((M346-L346)*(M346-L346))","v":{"v":244.29613350699992,"d":"244"}},{"$f":"N346/M346*100","v":{"v":7.327418554079962,"d":"7"}},0,2265,28,838,{"v":1874.606,"d":"1875"},{"v":3275.3399097506,"d":"3275"},{"$f":"(U346+U347)/2","v":{"v":3256.1083131449,"d":"3256"}},{"$f":"SQRT((V346-U346)*(V346-U346))","v":{"v":19.231596605699906,"d":"19"}},{"$f":"W346/V346*100","v":{"v":0.5906313536334773,"d":"1"}},{"$f":"X346+O346","v":{"v":7.918049907713439,"d":"8"}},{"$f":"(V346/M346*100)-100","v":{"v":-2.336282914816138,"d":"-2"}},null,0,3030,28,683,{"v":2050.366,"d":"2050"},{"v":3507.8510379524,"d":"3508"},{"$f":"(AG346+AG347)/2","v":{"v":3412.5263768272002,"d":"3413"}},{"$f":"SQRT((AH346-AG346)*(AH346-AG346))","v":{"v":95.32466112519978,"d":"95"}},{"$f":"AI346/AH346*100","v":{"v":2.7933750716918406,"d":"3"}},{"$f":"AJ346+O346","v":{"v":10.120793625771803,"d":"10"}},{"$f":"(AH346/M346*100)-100","v":{"v":2.3553206957915904,"d":"2"}},null,null,"CAMK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK1",{"$nulls":6},"CSSVTSSTENLVPDYWID","Corresponds to amino acid residues C14 to D31; N-terminus.",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.17; CAMK domain target; CAMK</A> group; CAMK1 family","Q16566","Q16566","Q16566","Q16566","GO:0005737; GO:0005829; GO:0070062; GO:0001650; GO:0098978; GO:0005654; GO:0005634; GO:0098794","GO:0005524; GO:0009931; GO:0005516; GO:0004683","GO:0002250; GO:0006954; GO:0035556; GO:0007616; GO:0043011; GO:0018105; GO:0045893; GO:0046777; GO:0006468; GO:0045670; GO:0033081; GO:0007165"]
[334,168,"NK021 SG-KAP-CA003","CaMK4 (CaMPK4)","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase 4",0,2233,24,796,{"v":1758.364,"d":"1758"},{"v":3089.7038516716,"d":"3090"},{"$nulls":3},0,2385,22,784,{"v":1852.592,"d":"1853"},{"v":3236.8767165392,"d":"3237"},{"$nulls":6},0,2660,22,735,{"v":1938.93,"d":"1939"},{"v":3317.2017157020005,"d":"3317"},{"$nulls":7},"CAMK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK1",{"$nulls":6},"CSSVTSSTENLVPDYWID","Corresponds to amino acid residues C14 to D31; N-terminus.",{"$nulls":3},"Q16566","Q16566","Q16566","Q16566"]
[335,169,"PK556","CaMK4 (CaMPK4)","T200","Calcium/calmodulin-dependent protein-serine kinase 4",0,9042,18,1109,{"v":10007.616,"d":"10008"},{"v":17584.8514307904,"d":"17585"},{"$f":"(L348+L349)/2","v":{"v":16653.7656456839,"d":"16654"}},{"$f":"SQRT((M348-L348)*(M348-L348))","v":{"v":931.0857851065011,"d":"931"}},{"$f":"N348/M348*100","v":{"v":5.5908423651188315,"d":"6"}},0,9495,20,1022,{"v":9683.45,"d":"9683"},{"v":16919.070060095,"d":"16919"},{"$f":"(U348+U349)/2","v":{"v":17208.6272825425,"d":"17209"}},{"$f":"SQRT((V348-U348)*(V348-U348))","v":{"v":289.55722244749995,"d":"290"}},{"$f":"W348/V348*100","v":{"v":1.6826282404363815,"d":"2"}},{"$f":"X348+O348","v":{"v":7.273470605555213,"d":"7"}},{"$f":"(V348/M348*100)-100","v":{"v":3.331748798821394,"d":"3"}},null,0,9274,19,1118,{"v":10347.09,"d":"10347"},{"v":17702.229941526002,"d":"17702"},{"$f":"(AG348+AG349)/2","v":{"v":16398.9126738474,"d":"16399"}},{"$f":"SQRT((AH348-AG348)*(AH348-AG348))","v":{"v":1303.3172676786016,"d":"1303"}},{"$f":"AI348/AH348*100","v":{"v":7.947583437998919,"d":"8"}},{"$f":"AJ348+O348","v":{"v":13.53842580311775,"d":"14"}},{"$f":"(AH348/M348*100)-100","v":{"v":-1.530302378804933,"d":"-2"}},null,null,"CAMK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK1",{"$nulls":6},"LMK(pT)VCG(bA)C","Corresponds to amino acid residues L197 to G203; In the protein kinase catalytic domain.","T200 phosphorylation stimulates phosphotransferase activity and regulates transcription. This is one of the major in vivo phosphorylation sites in CaMK4 (≥13 reports from high throughput mass spectrometry studies).","CaMKK1","Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.17; CAMK domain target; CAMK</A> group; CAMK1 family","Q16566","Q16566","Q16566","Q16566","GO:0005737; GO:0005829; GO:0070062; GO:0001650; GO:0098978; GO:0005654; GO:0005634; GO:0098794","GO:0005524; GO:0009931; GO:0005516; GO:0004683","GO:0002250; GO:0006954; GO:0035556; GO:0007616; GO:0043011; GO:0018105; GO:0045893; GO:0046777; GO:0006468; GO:0045670; GO:0033081; GO:0007165"]
[336,169,"PK556","CaMK4 (CaMPK4)","T200","Calcium/calmodulin-dependent protein-serine kinase 4",0,8680,18,1033,{"v":8947.846,"d":"8948"},{"v":15722.679860577398,"d":"15723"},{"$nulls":3},0,9557,19,1050,{"v":10014.9,"d":"10015"},{"v":17498.18450499,"d":"17498"},{"$nulls":6},0,8696,20,1017,{"v":8823.492,"d":"8823"},{"v":15095.5954061688,"d":"15096"},{"$nulls":7},"CAMK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK1",{"$nulls":6},"LMK(pT)VCG(bA)C","Corresponds to amino acid residues L197 to G203; In the protein kinase catalytic domain.","T200 phosphorylation stimulates phosphotransferase activity and regulates transcription. This is one of the major in vivo phosphorylation sites in CaMK4 (≥13 reports from high throughput mass spectrometry studies).","CaMKK1",null,"Q16566","Q16566","Q16566","Q16566"]
[337,170,"NK022","CaMKK1 (CaMKK)","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase kinase",0,5711,28,858,{"v":4876.014,"d":"4876"},{"v":8567.8728844566,"d":"8568"},{"$f":"(L350+L351)/2","v":{"v":8705.47593676905,"d":"8705"}},{"$f":"SQRT((M350-L350)*(M350-L350))","v":{"v":137.60305231245002,"d":"138"}},{"$f":"N350/M350*100","v":{"v":1.580649390244826,"d":"2"}},0,6522,28,720,{"v":4675.68,"d":"4676"},{"v":8169.4186987680005,"d":"8169"},{"$f":"(U350+U351)/2","v":{"v":8103.2953433085,"d":"8103"}},{"$f":"SQRT((V350-U350)*(V350-U350))","v":{"v":66.12335545950009,"d":"66"}},{"$f":"W350/V350*100","v":{"v":0.8160057440594599,"d":"1"}},{"$f":"X350+O350","v":{"v":2.396655134304286,"d":"2"}},{"$f":"(V350/M350*100)-100","v":{"v":-6.91726216733467,"d":"-7"}},null,0,6480,26,613,{"v":3956.302,"d":"3956"},{"v":6768.605252502801,"d":"6769"},{"$f":"(AG350+AG351)/2","v":{"v":6577.757472650001,"d":"6578"}},{"$f":"SQRT((AH350-AG350)*(AH350-AG350))","v":{"v":190.84777985280016,"d":"191"}},{"$f":"AI350/AH350*100","v":{"v":2.901411015020485,"d":"3"}},{"$f":"AJ350+O350","v":{"v":4.482060405265311,"d":"4"}},{"$f":"(AH350/M350*100)-100","v":{"v":-24.441150369875473,"d":"-24"}},null,null,"CaMKK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","CAMKK","Meta",{"$nulls":5},"CGKSPELPGVQEDEA","Corresponds to amino acid residues G490 to A503; near the very C-terminus of the kinase.",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.17; Other group; CAMKK family; Meta subfamily","Q8N5S9","Q8N5S9","Q8N5S9",null,"GO:0005737; GO:0005829; GO:0005634","GO:0005524; GO:0005516; GO:0004683","GO:0035556; GO:0018105; GO:0018107; GO:0045860"]
[338,170,"NK022","CaMKK1 (CaMKK)","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase kinase",0,6451,40,785,{"v":5032.635,"d":"5033"},{"v":8843.0789890815,"d":"8843"},{"$nulls":3},0,5721,42,810,{"v":4599.99,"d":"4600"},{"v":8037.171987848999,"d":"8037"},{"$nulls":6},0,6566,28,571,{"v":3733.198,"d":"3733"},{"v":6386.9096927972,"d":"6387"},{"$nulls":7},"CaMKK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","CAMKK","Meta",{"$nulls":5},"CGKSPELPGVQEDEA","Corresponds to amino acid residues G490 to A503; near the very C-terminus of the kinase.",{"$nulls":3},"Q8N5S9","Q8N5S9","Q8N5S9"]
[339,171,"PK557","CaMKK1 (CaMKK)","S74","Calcium/calmodulin-dependent protein-serine kinase kinase",0,920,12,560,{"v":508.48,"d":"508"},{"v":893.474055712,"d":"893"},{"$f":"(L352+L353)/2","v":{"v":875.8973152712999,"d":"876"}},{"$f":"SQRT((M352-L352)*(M352-L352))","v":{"v":17.576740440700064,"d":"18"}},{"$f":"N352/M352*100","v":{"v":2.006712446110861,"d":"2"}},0,622,16,514,{"v":311.484,"d":"311"},{"v":544.2295482083999,"d":"544"},{"$f":"(U352+U353)/2","v":{"v":748.7830088257999,"d":"749"}},{"$f":"SQRT((V352-U352)*(V352-U352))","v":{"v":204.5534606174,"d":"205"}},{"$f":"W352/V352*100","v":{"v":27.31812263450922,"d":"27"}},{"$f":"X352+O352","v":{"v":29.32483508062008,"d":"29"}},{"$f":"(V352/M352*100)-100","v":{"v":-14.512466727464243,"d":"-15"}},null,0,1077,10,503,{"v":536.701,"d":"537"},{"v":918.2102902214001,"d":"918"},{"$f":"(AG352+AG353)/2","v":{"v":1056.0613360264,"d":"1056"}},{"$f":"SQRT((AH352-AG352)*(AH352-AG352))","v":{"v":137.851045805,"d":"138"}},{"$f":"AI352/AH352*100","v":{"v":13.053318126737473,"d":"13"}},{"$f":"AJ352+O352","v":{"v":15.060030572848333,"d":"15"}},{"$f":"(AH352/M352*100)-100","v":{"v":20.569080143749076,"d":"21"}},null,null,"CaMKK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","CAMKK","Meta",{"$nulls":5},"RKL(pS)LQE(bA)C","Corresponds to amino acid residues R71 to E77; In the N-terminal quarter of the protein located before the kinase catalytic domain.  ","S74 phosphorylation stimulates phosphotransferase activity and inhibits phosphotransferase activity by inducing binding to 14-3-3 eta. This is the major in vivo phosphorylation sites in CaMMK1 (≥75 reports from high throughput mass spectrometry studies).","PKACa (PRKACA)","Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.17; Other group; CAMKK family; Meta subfamily","Q8N5S9","Q8N5S9","Q8N5S9",null,"GO:0005737; GO:0005829; GO:0005634","GO:0005524; GO:0005516; GO:0004683","GO:0035556; GO:0018105; GO:0018107; GO:0045860"]
[340,171,"PK557","CaMKK1 (CaMKK)","S74","Calcium/calmodulin-dependent protein-serine kinase kinase",0,592,18,851,{"v":488.474,"d":"488"},{"v":858.3205748306,"d":"858"},{"$nulls":3},0,958,14,578,{"v":545.632,"d":"546"},{"v":953.3364694431999,"d":"953"},{"$nulls":6},0,1209,12,583,{"v":697.851,"d":"698"},{"v":1193.9123818314001,"d":"1194"},{"$nulls":7},"CaMKK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","CAMKK","Meta",{"$nulls":5},"RKL(pS)LQE(bA)C","Corresponds to amino acid residues R71 to E77; In the N-terminal quarter of the protein located before the kinase catalytic domain.  ","S74 phosphorylation stimulates phosphotransferase activity and inhibits phosphotransferase activity by inducing binding to 14-3-3 eta. This is the major in vivo phosphorylation sites in CaMMK1 (≥75 reports from high throughput mass spectrometry studies).","PKACa (PRKACA)",null,"Q8N5S9","Q8N5S9","Q8N5S9"]
[341,172,"NK366-1","CaMKKb (CaMKK2)","Pan-specific","Calcium/calmodulin-dependent protein kinase kinase 2",0,100,12,436,{"v":38.368,"d":"38"},{"v":67.4182122592,"d":"67"},{"$f":"(L354+L355)/2","v":{"v":67.8680418656,"d":"68"}},{"$f":"SQRT((M354-L354)*(M354-L354))","v":{"v":0.4498296064000016,"d":"0"}},{"$f":"N354/M354*100","v":{"v":0.662800331400168,"d":"1"}},0,119,10,425,{"v":46.325,"d":"46"},{"v":80.93973950750001,"d":"81"},{"$f":"(U354+U355)/2","v":{"v":79.45023863475001,"d":"79"}},{"$f":"SQRT((V354-U354)*(V354-U354))","v":{"v":1.4895008727499999,"d":"1"}},{"$f":"W354/V354*100","v":{"v":1.8747594700093457,"d":"2"}},{"$f":"X354+O354","v":{"v":2.5375598014095138,"d":"3"}},{"$f":"(V354/M354*100)-100","v":{"v":17.065759451387123,"d":"17"}},null,0,50,12,654,{"v":24.852,"d":"25"},{"v":42.5178304728,"d":"43"},{"$f":"(AG354+AG355)/2","v":{"v":63.925588911,"d":"64"}},{"$f":"SQRT((AH354-AG354)*(AH354-AG354))","v":{"v":21.4077584382,"d":"21"}},{"$f":"AI354/AH354*100","v":{"v":33.4885588117222,"d":"33"}},{"$f":"AJ354+O354","v":{"v":34.15135914312237,"d":"34"}},{"$f":"(AH354/M354*100)-100","v":{"v":-5.808997646355124,"d":"-6"}},{"$nulls":3},"X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","CAMKK","Meta",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues 1-95 mapping at the N-terminus of human CaMKKβ.",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.17; Other group; CAMKK family; Meta subfamily","Q96RR4","Q96RR4","Q96RR4","Q96RR4","GO:0042995; GO:0005737; GO:0005829; GO:0005622; GO:0005634","GO:0005524; GO:0005509; GO:0005516; GO:0004683; GO:0004713","GO:0019722; GO:0061762; GO:0034614; GO:0000165; GO:0018105; GO:0018107; GO:1903599; GO:0045860; GO:0001934; GO:0045893; GO:0046777; GO:0006468; GO:0045859"]
[342,172,"NK366-1","CaMKKb (CaMKK2)","Pan-specific","Calcium/calmodulin-dependent protein kinase kinase 2",0,88,8,486,{"v":38.88,"d":"39"},{"v":68.31787147200001,"d":"68"},{"$nulls":3},0,102,10,485,{"v":44.62,"d":"45"},{"v":77.960737762,"d":"78"},{"$nulls":6},0,114,12,489,{"v":49.878,"d":"50"},{"v":85.3333473492,"d":"85"},{"$nulls":8},"X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","CAMKK","Meta",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues 1-95 mapping at the N-terminus of human CaMKKβ.",{"$nulls":3},"Q96RR4","Q96RR4","Q96RR4","Q96RR4"]
[343,173,"PN505","Cas-L","Y166","Enhancer of filamentation 1",0,4086,14,968,{"v":3941.696,"d":"3942"},{"v":6926.1389071424,"d":"6926"},{"$f":"(L356+L357)/2","v":{"v":6150.0018499717,"d":"6150"}},{"$f":"SQRT((M356-L356)*(M356-L356))","v":{"v":776.1370571707002,"d":"776"}},{"$f":"N356/M356*100","v":{"v":12.620110954507627,"d":"13"}},0,4368,14,739,{"v":3217.606,"d":"3218"},{"v":5621.8497890506005,"d":"5622"},{"$f":"(U356+U357)/2","v":{"v":5429.08740953555,"d":"5429"}},{"$f":"SQRT((V356-U356)*(V356-U356))","v":{"v":192.76237951505027,"d":"193"}},{"$f":"W356/V356*100","v":{"v":3.5505484619106693,"d":"4"}},{"$f":"X356+O356","v":{"v":16.170659416418296,"d":"16"}},{"$f":"(V356/M356*100)-100","v":{"v":-11.722182497220984,"d":"-12"}},null,0,4457,18,740,{"v":3284.86,"d":"3285"},{"v":5619.874481204,"d":"5620"},{"$f":"(AG356+AG357)/2","v":{"v":5748.7247904036,"d":"5749"}},{"$f":"SQRT((AH356-AG356)*(AH356-AG356))","v":{"v":128.8503091995999,"d":"129"}},{"$f":"AI356/AH356*100","v":{"v":2.2413720241868407,"d":"2"}},{"$f":"AJ356+O356","v":{"v":14.861482978694468,"d":"15"}},{"$f":"(AH356/M356*100)-100","v":{"v":-6.524828274156462,"d":"-7"}},{"$nulls":13},"X",null,"GYV(pY)EYP(bA)C","Corresponds to amino acid residues G163 to P169; In the region between the SH3_9 and Serine_rich domains. ","The effect of Y166 phosphorylation is unclear. This is the second major in vivo phosphorylation site in Cas-L (≥569 reports from high throughput mass spectrometry studies).",null,"Adapter/scaffold protein","Q14511","Q14511",null,"Q14511","GO:0005938; GO:0005737; GO:0005829; GO:0005925; GO:0005794; GO:0030027; GO:0005654; GO:0005634; GO:0005886; GO:0005819; GO:0000922","GO:1990782","GO:0051017; GO:0007155; GO:0007049; GO:0051301; GO:0007010; GO:0007229; GO:0030335; GO:0061098; GO:1900026; GO:0040008; GO:0007165"]
[344,173,"PN505","Cas-L","Y166","Enhancer of filamentation 1",0,4244,14,723,{"v":3058.29,"d":"3058"},{"v":5373.864792801,"d":"5374"},{"$nulls":3},0,4269,18,705,{"v":2996.955,"d":"2997"},{"v":5236.3250300205,"d":"5236"},{"$nulls":6},0,4398,16,784,{"v":3435.488,"d":"3435"},{"v":5877.5750996032,"d":"5878"},{"$nulls":18},"X",null,"GYV(pY)EYP(bA)C","Corresponds to amino acid residues G163 to P169; In the region between the SH3_9 and Serine_rich domains. ","The effect of Y166 phosphorylation is unclear. This is the second major in vivo phosphorylation site in Cas-L (≥569 reports from high throughput mass spectrometry studies).",null,null,"Q14511","Q14511",null,"Q14511"]
[345,174,"NK023-1","CASK (/Lin2)","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase (Lin2 homolog)",0,450,20,591,{"v":254.13,"d":"254"},{"v":446.543741697,"d":"447"},{"$f":"(L358+L359)/2","v":{"v":464.3928399072,"d":"464"}},{"$f":"SQRT((M358-L358)*(M358-L358))","v":{"v":17.849098210200054,"d":"18"}},{"$f":"N358/M358*100","v":{"v":3.843534326189623,"d":"4"}},0,338,12,551,{"v":179.626,"d":"180"},{"v":313.8452595526,"d":"314"},{"$f":"(U358+U359)/2","v":{"v":365.31734279105,"d":"365"}},{"$f":"SQRT((V358-U358)*(V358-U358))","v":{"v":51.47208323845001,"d":"51"}},{"$f":"W358/V358*100","v":{"v":14.089690581125906,"d":"14"}},{"$f":"X358+O358","v":{"v":17.933224907315527,"d":"18"}},{"$f":"(V358/M358*100)-100","v":{"v":-21.334415305789022,"d":"-21"}},null,0,456,12,570,{"v":253.08,"d":"253"},{"v":432.97974151200003,"d":"433"},{"$f":"(AG358+AG359)/2","v":{"v":524.1059978416,"d":"524"}},{"$f":"SQRT((AH358-AG358)*(AH358-AG358))","v":{"v":91.12625632959998,"d":"91"}},{"$f":"AI358/AH358*100","v":{"v":17.386989789256518,"d":"17"}},{"$f":"AJ358+O358","v":{"v":21.23052411544614,"d":"21"}},{"$f":"(AH358/M358*100)-100","v":{"v":12.858328725811646,"d":"13"}},{"$nulls":3},"X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CASK",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 353-459 of human CASK.",null,null,"EC 2.7.11.1; Adaptor/scaffold; Protein kinase, Ser/Thr (non-receptor); CAMK group; CASK family","O14936","O14936","O14936",null,"GO:0015629; GO:0005604; GO:0005911; GO:0060170; GO:0005737; GO:0005829; GO:0005925; GO:0005652; GO:0016363; GO:0005730; GO:0005886; GO:0042734","GO:0005524; GO:0005516; GO:0004385; GO:0004674","GO:0007155; GO:0001953; GO:0090288; GO:0010839; GO:0061045; GO:0007269"]
[346,174,"NK023-1","CASK (/Lin2)","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase (Lin2 homolog)",0,488,14,579,{"v":274.446,"d":"274"},{"v":482.2419381174,"d":"482"},{"$nulls":3},0,419,14,589,{"v":238.545,"d":"239"},{"v":416.78942602949996,"d":"417"},{"$nulls":6},0,586,17,632,{"v":359.608,"d":"360"},{"v":615.2322541712,"d":"615"},{"$nulls":8},"X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CASK",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 353-459 of human CASK.",{"$nulls":3},"O14936","O14936","O14936"]
[347,181,"NN147-2","Caveolin 1","Pan-specific","Caveolin 1",0,178,12,491,{"v":81.506,"d":"82"},{"v":143.2180152314,"d":"143"},{"$f":"(L360+L361)/2","v":{"v":172.50877548095,"d":"173"}},{"$f":"SQRT((M360-L360)*(M360-L360))","v":{"v":29.290760249550004,"d":"29"}},{"$f":"N360/M360*100","v":{"v":16.979287093012008,"d":"17"}},0,276,17,553,{"v":143.227,"d":"143"},{"v":250.2483771277,"d":"250"},{"$f":"(U360+U361)/2","v":{"v":198.70291085505,"d":"199"}},{"$f":"SQRT((V360-U360)*(V360-U360))","v":{"v":51.54546627265,"d":"52"}},{"$f":"W360/V360*100","v":{"v":25.94097190164036,"d":"26"}},{"$f":"X360+O360","v":{"v":42.92025899465237,"d":"43"}},{"$f":"(V360/M360*100)-100","v":{"v":15.184233556276453,"d":"15"}},null,0,230,10,454,{"v":99.88,"d":"100"},{"v":170.878839032,"d":"171"},{"$f":"(AG360+AG361)/2","v":{"v":190.2660937768,"d":"190"}},{"$f":"SQRT((AH360-AG360)*(AH360-AG360))","v":{"v":19.387254744800003,"d":"19"}},{"$f":"AI360/AH360*100","v":{"v":10.189547890515414,"d":"10"}},{"$f":"AJ360+O360","v":{"v":27.16883498352742,"d":"27"}},{"$f":"(AH360/M360*100)-100","v":{"v":10.29357390448287,"d":"10"}},{"$nulls":15},"Not precisely defined.","Antibody raised against purified Glut4 vesicles from rat adipocytes.",null,null,"Adapter/scaffold protein","Q03135","Q03135",null,"Q03135","GO:0002080; GO:0016324; GO:0016323; GO:0005901; GO:0005938; GO:0005929; GO:0031410; GO:0031901; GO:0030666; GO:0005783; GO:0005789; GO:0005768; GO:0005925; GO:0000139; GO:0005887; GO:0005622; GO:0005811; GO:0016020; GO:0045121; GO:0048471; GO:0005886; GO:0032991","GO:0051117; GO:0015485; GO:0019899; GO:0042802; GO:0070320; GO:0044325; GO:0050998; GO:0005113; GO:0016504; GO:0030674; GO:0032947; GO:0046982; GO:0019901; GO:0048365; GO:0005102; GO:0005198","GO:0001525; GO:0086098; GO:0097190; GO:1904886; GO:0055074; GO:0006816; GO:0070836; GO:0072584; GO:0006874; GO:0071360; GO:0071455; GO:0071375; GO:0009267; GO:0071560; GO:0042632; GO:0030301; GO:0000188; GO:0007595; GO:0050900; GO:0019915; GO:0032507; GO:0030879; GO:0060056; GO:0051899; GO:2000811; GO:0030514; GO:0090090; GO:0001960; GO:0001937; GO:0030857; GO:1903609; GO:0046426; GO:0043409; GO:0060546; GO:0045019; GO:0051001; GO:0033137; GO:1900085; GO:0048550; GO:1901380; GO:0032091; GO:0061099; GO:0031397; GO:0000122; GO:0030512; GO:0042532; GO:0033484; GO:0010524; GO:0090263; GO:0043085; GO:0060355; GO:0030335; GO:0120162; GO:1903071; GO:2001238; GO:1903598; GO:0010628; GO:2001244; GO:0033138; GO:0032092; GO:0031398; GO:0034141; GO:0045907; GO:0010608; GO:0051260; GO:0008104; GO:1903361; GO:0044860; GO:0031623; GO:2000286; GO:0019065; GO:0030193; GO:0098909; GO:1901844; GO:0051480; GO:2000535; GO:0019217; GO:0086091; GO:0098903; GO:0050999; GO:0052547; GO:1900027; GO:0006940; GO:0003057; GO:0098911; GO:0009617; GO:0051592; GO:0043627; GO:0001666; GO:0002931; GO:0032570; GO:0007519; GO:0031295; GO:0006641; GO:0001570; GO:0042310; GO:0016050"]
[348,181,"NN147-2","Caveolin 1","Pan-specific","Caveolin 1",0,235,12,515,{"v":114.845,"d":"115"},{"v":201.7995357305,"d":"202"},{"$nulls":3},0,140,12,658,{"v":84.224,"d":"84"},{"v":147.15744458240002,"d":"147"},{"$nulls":6},0,234,12,552,{"v":122.544,"d":"123"},{"v":209.6533485216,"d":"210"},{"$nulls":20},"Not precisely defined.","Antibody raised against purified Glut4 vesicles from rat adipocytes.",{"$nulls":3},"Q03135","Q03135",null,"Q03135"]
[349,182,"PN147","Caveolin 1","Y14","Caveolin 1",0,14,2,771,{"v":9.252,"d":"9"},{"v":16.2571231188,"d":"16"},{"$f":"(L362+L363)/2","v":{"v":13.519488248599998,"d":"14"}},{"$f":"SQRT((M362-L362)*(M362-L362))","v":{"v":2.737634870200001,"d":"3"}},{"$f":"N362/M362*100","v":{"v":20.24954510007799,"d":"20"}},0,10,2,770,{"v":6.16,"d":"6"},{"v":10.762845016,"d":"11"},{"$f":"(U362+U363)/2","v":{"v":11.461731056,"d":"11"}},{"$f":"SQRT((V362-U362)*(V362-U362))","v":{"v":0.6988860399999997,"d":"1"}},{"$f":"W362/V362*100","v":{"v":6.0975609756097535,"d":"6"}},{"$f":"X362+O362","v":{"v":26.347106075687744,"d":"26"}},{"$f":"(V362/M362*100)-100","v":{"v":-15.220673702742332,"d":"-15"}},null,0,14,4,716,{"v":7.16,"d":"7"},{"v":12.249624424,"d":"12"},{"$f":"(AG362+AG363)/2","v":{"v":11.3736736272,"d":"11"}},{"$f":"SQRT((AH362-AG362)*(AH362-AG362))","v":{"v":0.8759507967999998,"d":"1"}},{"$f":"AI362/AH362*100","v":{"v":7.701564380264739,"d":"8"}},{"$f":"AJ362+O362","v":{"v":27.95110948034273,"d":"28"}},{"$f":"(AH362/M362*100)-100","v":{"v":-15.872010699977537,"d":"-16"}},{"$nulls":15},"HL(pY)TV","Corresponds to amino acid residues H12 to V16; Surrounds the Y14 phosphosite.","Y14 phosphorylation induces activation and interaction with CSK, Grb7, MMP9 and TRAF2. This is one of the major in vivo phosphorylation sites in caveolin 1 (≥845 reports from high throughput mass spectrometry studies).","Abl1, Fyn; InsR; Src","Adapter/scaffold protein","Q03135","Q03135",null,"Q03135","GO:0002080; GO:0016324; GO:0016323; GO:0005901; GO:0005938; GO:0005929; GO:0031410; GO:0031901; GO:0030666; GO:0005783; GO:0005789; GO:0005768; GO:0005925; GO:0000139; GO:0005887; GO:0005622; GO:0005811; GO:0016020; GO:0045121; GO:0048471; GO:0005886; GO:0032991","GO:0051117; GO:0015485; GO:0019899; GO:0042802; GO:0070320; GO:0044325; GO:0050998; GO:0005113; GO:0016504; GO:0030674; GO:0032947; GO:0046982; GO:0019901; GO:0048365; GO:0005102; GO:0005198","GO:0001525; GO:0086098; GO:0097190; GO:1904886; GO:0055074; GO:0006816; GO:0070836; GO:0072584; GO:0006874; GO:0071360; GO:0071455; GO:0071375; GO:0009267; GO:0071560; GO:0042632; GO:0030301; GO:0000188; GO:0007595; GO:0050900; GO:0019915; GO:0032507; GO:0030879; GO:0060056; GO:0051899; GO:2000811; GO:0030514; GO:0090090; GO:0001960; GO:0001937; GO:0030857; GO:1903609; GO:0046426; GO:0043409; GO:0060546; GO:0045019; GO:0051001; GO:0033137; GO:1900085; GO:0048550; GO:1901380; GO:0032091; GO:0061099; GO:0031397; GO:0000122; GO:0030512; GO:0042532; GO:0033484; GO:0010524; GO:0090263; GO:0043085; GO:0060355; GO:0030335; GO:0120162; GO:1903071; GO:2001238; GO:1903598; GO:0010628; GO:2001244; GO:0033138; GO:0032092; GO:0031398; GO:0034141; GO:0045907; GO:0010608; GO:0051260; GO:0008104; GO:1903361; GO:0044860; GO:0031623; GO:2000286; GO:0019065; GO:0030193; GO:0098909; GO:1901844; GO:0051480; GO:2000535; GO:0019217; GO:0086091; GO:0098903; GO:0050999; GO:0052547; GO:1900027; GO:0006940; GO:0003057; GO:0098911; GO:0009617; GO:0051592; GO:0043627; GO:0001666; GO:0002931; GO:0032570; GO:0007519; GO:0031295; GO:0006641; GO:0001570; GO:0042310; GO:0016050"]
[350,182,"PN147","Caveolin 1","Y14","Caveolin 1",0,12,4,767,{"v":6.136,"d":"6"},{"v":10.7818533784,"d":"11"},{"$nulls":3},0,16,6,696,{"v":6.96,"d":"7"},{"v":12.160617096,"d":"12"},{"$nulls":6},0,14,6,767,{"v":6.136,"d":"6"},{"v":10.4977228304,"d":"10"},{"$nulls":20},"HL(pY)TV","Corresponds to amino acid residues H12 to V16; Surrounds the Y14 phosphosite.","Y14 phosphorylation induces activation and interaction with CSK, Grb7, MMP9 and TRAF2. This is one of the major in vivo phosphorylation sites in caveolin 1 (≥845 reports from high throughput mass spectrometry studies).","Abl1, Fyn; InsR; Src",null,"Q03135","Q03135",null,"Q03135"]
[351,183,"PN217","Caveolin 1","Y14","Caveolin 1",0,360,18,608,{"v":207.936,"d":"208"},{"v":365.3740977984,"d":"365"},{"$f":"(L364+L365)/2","v":{"v":385.8554020648,"d":"386"}},{"$f":"SQRT((M364-L364)*(M364-L364))","v":{"v":20.481304266400002,"d":"20"}},{"$f":"N364/M364*100","v":{"v":5.308025793289374,"d":"5"}},0,366,18,563,{"v":195.924,"d":"196"},{"v":342.3213712524,"d":"342"},{"$f":"(U364+U365)/2","v":{"v":333.4717267709,"d":"333"}},{"$f":"SQRT((V364-U364)*(V364-U364))","v":{"v":8.849644481500036,"d":"9"}},{"$f":"W364/V364*100","v":{"v":2.653791542447577,"d":"3"}},{"$f":"X364+O364","v":{"v":7.961817335736951,"d":"8"}},{"$f":"(V364/M364*100)-100","v":{"v":-13.575985981687197,"d":"-14"}},null,0,394,14,580,{"v":220.4,"d":"220"},{"v":377.06944456,"d":"377"},{"$f":"(AG364+AG365)/2","v":{"v":408.68750447340005,"d":"409"}},{"$f":"SQRT((AH364-AG364)*(AH364-AG364))","v":{"v":31.61805991340003,"d":"32"}},{"$f":"AI364/AH364*100","v":{"v":7.73648804216326,"d":"8"}},{"$f":"AJ364+O364","v":{"v":13.044513835452634,"d":"13"}},{"$f":"(AH364/M364*100)-100","v":{"v":5.91726908225732,"d":"6"}},{"$nulls":15},"Not precisely defined.","Antibody raised against amino acid residues that encompass the Y14 phosphosite.","Y14 phosphorylation induces activation and interaction with CSK, Grb7, MMP9 and TRAF2. This is one of the major in vivo phosphorylation sites in caveolin 1 (≥845 reports from high throughput mass spectrometry studies).","Abl1, Fyn; InsR; Src","Adapter/scaffold protein","Q03135","Q03135",null,"Q03135","GO:0002080; GO:0016324; GO:0016323; GO:0005901; GO:0005938; GO:0005929; GO:0031410; GO:0031901; GO:0030666; GO:0005783; GO:0005789; GO:0005768; GO:0005925; GO:0000139; GO:0005887; GO:0005622; GO:0005811; GO:0016020; GO:0045121; GO:0048471; GO:0005886; GO:0032991","GO:0051117; GO:0015485; GO:0019899; GO:0042802; GO:0070320; GO:0044325; GO:0050998; GO:0005113; GO:0016504; GO:0030674; GO:0032947; GO:0046982; GO:0019901; GO:0048365; GO:0005102; GO:0005198","GO:0001525; GO:0086098; GO:0097190; GO:1904886; GO:0055074; GO:0006816; GO:0070836; GO:0072584; GO:0006874; GO:0071360; GO:0071455; GO:0071375; GO:0009267; GO:0071560; GO:0042632; GO:0030301; GO:0000188; GO:0007595; GO:0050900; GO:0019915; GO:0032507; GO:0030879; GO:0060056; GO:0051899; GO:2000811; GO:0030514; GO:0090090; GO:0001960; GO:0001937; GO:0030857; GO:1903609; GO:0046426; GO:0043409; GO:0060546; GO:0045019; GO:0051001; GO:0033137; GO:1900085; GO:0048550; GO:1901380; GO:0032091; GO:0061099; GO:0031397; GO:0000122; GO:0030512; GO:0042532; GO:0033484; GO:0010524; GO:0090263; GO:0043085; GO:0060355; GO:0030335; GO:0120162; GO:1903071; GO:2001238; GO:1903598; GO:0010628; GO:2001244; GO:0033138; GO:0032092; GO:0031398; GO:0034141; GO:0045907; GO:0010608; GO:0051260; GO:0008104; GO:1903361; GO:0044860; GO:0031623; GO:2000286; GO:0019065; GO:0030193; GO:0098909; GO:1901844; GO:0051480; GO:2000535; GO:0019217; GO:0086091; GO:0098903; GO:0050999; GO:0052547; GO:1900027; GO:0006940; GO:0003057; GO:0098911; GO:0009617; GO:0051592; GO:0043627; GO:0001666; GO:0002931; GO:0032570; GO:0007519; GO:0031295; GO:0006641; GO:0001570; GO:0042310; GO:0016050"]
[352,183,"PN217","Caveolin 1","Y14","Caveolin 1",0,406,18,596,{"v":231.248,"d":"231"},{"v":406.3367063312,"d":"406"},{"$nulls":3},0,338,16,577,{"v":185.794,"d":"186"},{"v":324.6220822894,"d":"325"},{"$nulls":6},0,450,16,593,{"v":257.362,"d":"257"},{"v":440.30556438680003,"d":"440"},{"$nulls":20},"Not precisely defined.","Antibody raised against amino acid residues that encompass the Y14 phosphosite.","Y14 phosphorylation induces activation and interaction with CSK, Grb7, MMP9 and TRAF2. This is one of the major in vivo phosphorylation sites in caveolin 1 (≥845 reports from high throughput mass spectrometry studies).","Abl1, Fyn; InsR; Src",null,"Q03135","Q03135",null,"Q03135"]
[353,184,"NN022-1","Caveolin 2","Pan-specific","Caveolin 2",0,942,10,348,{"v":324.336,"d":"324"},{"v":569.9059969584,"d":"570"},{"$f":"(L366+L367)/2","v":{"v":416.34892936740005,"d":"416"}},{"$f":"SQRT((M366-L366)*(M366-L366))","v":{"v":153.55706759099996,"d":"154"}},{"$f":"N366/M366*100","v":{"v":36.881821174444795,"d":"37"}},0,2787,12,312,{"v":865.8,"d":"866"},{"v":1512.73883358,"d":"1513"},{"$f":"(U366+U367)/2","v":{"v":993.2358734668,"d":"993"}},{"$f":"SQRT((V366-U366)*(V366-U366))","v":{"v":519.5029601132,"d":"520"}},{"$f":"W366/V366*100","v":{"v":52.304087477219475,"d":"52"}},{"$f":"X366+O366","v":{"v":89.18590865166428,"d":"89"}},{"$f":"(V366/M366*100)-100","v":{"v":138.55852709310938,"d":"139"}},null,0,828,10,316,{"v":258.488,"d":"258"},{"v":442.2319718032,"d":"442"},{"$f":"(AG366+AG367)/2","v":{"v":365.1525787883,"d":"365"}},{"$f":"SQRT((AH366-AG366)*(AH366-AG366))","v":{"v":77.0793930149,"d":"77"}},{"$f":"AI366/AH366*100","v":{"v":21.108817927748326,"d":"21"}},{"$f":"AJ366+O366","v":{"v":57.99063910219312,"d":"58"}},{"$f":"(AH366/M366*100)-100","v":{"v":-12.296501075885487,"d":"-12"}},{"$nulls":15},"Epitope undefined.",{"$nulls":3},"Adapter/scaffold protein","P51636","P51636",null,null,"GO:0002080; GO:0005901; GO:0031410; GO:0031234; GO:0005925; GO:0005794; GO:0000139; GO:0005887; GO:0005622; GO:0016020; GO:0045121; GO:0005634; GO:0048471; GO:0005886; GO:0032991; GO:0030133","GO:0031748; GO:0030674; GO:0032947; GO:0046982; GO:0042803; GO:0019901; GO:0097110","GO:0070836; GO:0007029; GO:0008286; GO:0007005; GO:0001937; GO:0030512; GO:0044794; GO:0044791; GO:0060161; GO:0001938; GO:0043547; GO:0043410; GO:0051259; GO:0019065; GO:0007088; GO:0048741; GO:0048278; GO:0006906; GO:0016050"]
[354,184,"NN022-1","Caveolin 2","Pan-specific","Caveolin 2",0,422,10,363,{"v":149.556,"d":"150"},{"v":262.7918617764,"d":"263"},{"$nulls":3},0,928,12,296,{"v":271.136,"d":"271"},{"v":473.73291335360005,"d":"474"},{"$nulls":6},0,485,8,353,{"v":168.381,"d":"168"},{"v":288.0731857734,"d":"288"},{"$nulls":20},"Epitope undefined.",{"$nulls":4},"P51636","P51636"]
[355,185,"PN018","Caveolin 2","S36","Caveolin 2",0,98,10,350,{"v":30.8,"d":"31"},{"v":54.12012452,"d":"54"},{"$f":"(L368+L369)/2","v":{"v":45.5030761224,"d":"46"}},{"$f":"SQRT((M368-L368)*(M368-L368))","v":{"v":8.617048397599994,"d":"9"}},{"$f":"N368/M368*100","v":{"v":18.93728761198639,"d":"19"}},0,174,12,319,{"v":51.678,"d":"52"},{"v":90.2925819378,"d":"90"},{"$f":"(U368+U369)/2","v":{"v":60.114682730599995,"d":"60"}},{"$f":"SQRT((V368-U368)*(V368-U368))","v":{"v":30.1778992072,"d":"30"}},{"$f":"W368/V368*100","v":{"v":50.20054641632273,"d":"50"}},{"$f":"X368+O368","v":{"v":69.13783402830913,"d":"69"}},{"$f":"(V368/M368*100)-100","v":{"v":32.1112501688805,"d":"32"}},null,0,110,10,350,35,{"v":59.879449,"d":"60"},{"$f":"(AG368+AG369)/2","v":{"v":45.7239472564,"d":"46"}},{"$f":"SQRT((AH368-AG368)*(AH368-AG368))","v":{"v":14.155501743599999,"d":"14"}},{"$f":"AI368/AH368*100","v":{"v":30.958617077003662,"d":"31"}},{"$f":"AJ368+O368","v":{"v":49.89590468899006,"d":"50"}},{"$f":"(AH368/M368*100)-100","v":{"v":0.4853982473753433,"d":"0"}},{"$nulls":15},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S36 phosphosite.","S36 phosphorylation induces activity. This is one of the minor in vivo phosphorylation sites in caveolin 2 (≥9 reports from high throughput mass spectrometry studies).","CK2a1 (CSNK2A1)","Adapter/scaffold protein","P51636","P51636",null,null,"GO:0002080; GO:0005901; GO:0031410; GO:0031234; GO:0005925; GO:0005794; GO:0000139; GO:0005887; GO:0005622; GO:0016020; GO:0045121; GO:0005634; GO:0048471; GO:0005886; GO:0032991; GO:0030133","GO:0031748; GO:0030674; GO:0032947; GO:0046982; GO:0042803; GO:0019901; GO:0097110","GO:0070836; GO:0007029; GO:0008286; GO:0007005; GO:0001937; GO:0030512; GO:0044794; GO:0044791; GO:0060161; GO:0001938; GO:0043547; GO:0043410; GO:0051259; GO:0019065; GO:0007088; GO:0048741; GO:0048278; GO:0006906; GO:0016050"]
[356,185,"PN018","Caveolin 2","S36","Caveolin 2",0,40,8,656,{"v":20.992,"d":"21"},{"v":36.8860277248,"d":"37"},{"$nulls":3},0,32,6,659,{"v":17.134,"d":"17"},{"v":29.936783523400003,"d":"30"},{"$nulls":6},0,36,8,659,{"v":18.452,"d":"18"},{"v":31.568445512800004,"d":"32"},{"$nulls":20},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S36 phosphosite.","S36 phosphorylation induces activity. This is one of the minor in vivo phosphorylation sites in caveolin 2 (≥9 reports from high throughput mass spectrometry studies).","CK2a1 (CSNK2A1)",null,"P51636","P51636"]
[357,186,"NN171-2","Cbl","Pan-specific","E3 ubiquitin-protein ligase CBL",0,946,16,579,{"v":538.47,"d":"538"},{"v":946.170891243,"d":"946"},{"$f":"(L370+L371)/2","v":{"v":883.5549614614999,"d":"884"}},{"$f":"SQRT((M370-L370)*(M370-L370))","v":{"v":62.615929781500085,"d":"63"}},{"$f":"N370/M370*100","v":{"v":7.086817743394961,"d":"7"}},0,873,14,556,{"v":477.604,"d":"478"},{"v":834.4769206203999,"d":"834"},{"$f":"(U370+U371)/2","v":{"v":845.9631126878,"d":"846"}},{"$f":"SQRT((V370-U370)*(V370-U370))","v":{"v":11.486192067400111,"d":"11"}},{"$f":"W370/V370*100","v":{"v":1.3577651194395581,"d":"1"}},{"$f":"X370+O370","v":{"v":8.444582862834519,"d":"8"}},{"$f":"(V370/M370*100)-100","v":{"v":-4.254613511707149,"d":"-4"}},null,0,1013,14,586,{"v":585.414,"d":"585"},{"v":1001.5505073396,"d":"1002"},{"$f":"(AG370+AG371)/2","v":{"v":995.0578642266,"d":"995"}},{"$f":"SQRT((AH370-AG370)*(AH370-AG370))","v":{"v":6.4926431129999855,"d":"6"}},{"$f":"AI370/AH370*100","v":{"v":0.6524890005312742,"d":"1"}},{"$f":"AJ370+O370","v":{"v":7.739306743926235,"d":"8"}},{"$f":"(AH370/M370*100)-100","v":{"v":12.619803818504025,"d":"13"}},{"$nulls":5},"Ubiquitin protein ligase",{"$nulls":9},"Not precisely defined.","Antibody raised against amino acid residues 892-906 at the C-terminus of human Cbl.",null,null,"Ubiquitin conjugating system; EC 6.3.2.-; Ligase; Adaptor/scaffold","P22681","P22681",null,"P22681","GO:0005829; GO:0016600; GO:0005925; GO:0030426; GO:0042629; GO:0045121; GO:0048471; GO:0005886","GO:0045296; GO:0005509; GO:0003700; GO:0046875; GO:0005154; GO:0036312; GO:0001784; GO:0030971; GO:0017124; GO:0061630; GO:0004842","GO:0007166; GO:0006974; GO:0071364; GO:1990090; GO:0090650; GO:0036120; GO:0019221; GO:0035635; GO:0007173; GO:0008543; GO:0070102; GO:0008584; GO:0043303; GO:0061024; GO:0043066; GO:0007175; GO:0042059; GO:1901215; GO:0070997; GO:0045742; GO:0014068; GO:0048260; GO:0006513; GO:0000209; GO:0016567; GO:0014823; GO:0045471; GO:0010332; GO:0042594; GO:0033574; GO:0007179; GO:0006511"]
[358,186,"NN171-2","Cbl","Pan-specific","E3 ubiquitin-protein ligase CBL",0,812,12,584,{"v":467.2,"d":"467"},{"v":820.93903168,"d":"821"},{"$nulls":3},0,880,16,568,{"v":490.752,"d":"491"},{"v":857.4493047552,"d":"857"},{"$nulls":6},0,940,14,624,{"v":577.824,"d":"578"},{"v":988.5652211135999,"d":"989"},{"$nulls":10},"Ubiquitin protein ligase",{"$nulls":9},"Not precisely defined.","Antibody raised against amino acid residues 892-906 at the C-terminus of human Cbl.",{"$nulls":3},"P22681","P22681",null,"P22681"]
[359,187,"PN743","Cbl","Y674","E3 ubiquitin-protein ligase CBL",0,6424,18,696,{"v":4458.576,"d":"4459"},{"v":7834.3729968144,"d":"7834"},{"$f":"(L372+L373)/2","v":{"v":8463.8673594456,"d":"8464"}},{"$f":"SQRT((M372-L372)*(M372-L372))","v":{"v":629.4943626311997,"d":"629"}},{"$f":"N372/M372*100","v":{"v":7.437431801535614,"d":"7"}},0,6014,16,721,{"v":4324.558,"d":"4325"},{"v":7555.9330384258,"d":"7556"},{"$f":"(U372+U373)/2","v":{"v":8261.1667108841,"d":"8261"}},{"$f":"SQRT((V372-U372)*(V372-U372))","v":{"v":705.2336724582992,"d":"705"}},{"$f":"W372/V372*100","v":{"v":8.53673212440021,"d":"9"}},{"$f":"X372+O372","v":{"v":15.974163925935823,"d":"16"}},{"$f":"(V372/M372*100)-100","v":{"v":-2.394893964580959,"d":"-2"}},null,0,5814,14,690,4002,{"v":6846.7872828,"d":"6847"},{"$f":"(AG372+AG373)/2","v":{"v":8034.5834066264,"d":"8035"}},{"$f":"SQRT((AH372-AG372)*(AH372-AG372))","v":{"v":1187.7961238263997,"d":"1188"}},{"$f":"AI372/AH372*100","v":{"v":14.783543386291603,"d":"15"}},{"$f":"AJ372+O372","v":{"v":22.220975187827218,"d":"22"}},{"$f":"(AH372/M372*100)-100","v":{"v":-5.071959833351158,"d":"-5"}},{"$nulls":5},"Ubiquitin protein ligase",{"$nulls":9},"NAI(pY)SLAAC","Corresponds to amino acid residues N671 to A678.","The effect of Y674 phosphorylation is unclear. This is the major in vivo phosphorylation site in Cbl (≥732 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in fish.",null,"Ubiquitin conjugating system; EC 6.3.2.-; Ligase; Adaptor/scaffold","P22681","P22681",null,"P22681","GO:0005829; GO:0016600; GO:0005925; GO:0030426; GO:0042629; GO:0045121; GO:0048471; GO:0005886","GO:0045296; GO:0005509; GO:0003700; GO:0046875; GO:0005154; GO:0036312; GO:0001784; GO:0030971; GO:0017124; GO:0061630; GO:0004842","GO:0007166; GO:0006974; GO:0071364; GO:1990090; GO:0090650; GO:0036120; GO:0019221; GO:0035635; GO:0007173; GO:0008543; GO:0070102; GO:0008584; GO:0043303; GO:0061024; GO:0043066; GO:0007175; GO:0042059; GO:1901215; GO:0070997; GO:0045742; GO:0014068; GO:0048260; GO:0006513; GO:0000209; GO:0016567; GO:0014823; GO:0045471; GO:0010332; GO:0042594; GO:0033574; GO:0007179; GO:0006511"]
[360,187,"PN743","Cbl","Y674","E3 ubiquitin-protein ligase CBL",0,7264,16,714,{"v":5175.072,"d":"5175"},{"v":9093.3617220768,"d":"9093"},{"$nulls":3},0,7770,18,662,{"v":5131.824,"d":"5132"},{"v":8966.4003833424,"d":"8966"},{"$nulls":6},0,7589,18,712,{"v":5390.552,"d":"5391"},{"v":9222.3795304528,"d":"9222"},{"$nulls":10},"Ubiquitin protein ligase",{"$nulls":9},"NAI(pY)SLAAC","Corresponds to amino acid residues N671 to A678.","The effect of Y674 phosphorylation is unclear. This is the major in vivo phosphorylation site in Cbl (≥732 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in fish.",null,null,"P22681","P22681",null,"P22681"]
[361,188,"PN171","Cbl","Y700","E3 ubiquitin-protein ligase CBL",0,1332,16,392,{"v":515.872,"d":"516"},{"v":906.4628855967999,"d":"906"},{"$f":"(L374+L375)/2","v":{"v":547.3196307057999,"d":"547"}},{"$f":"SQRT((M374-L374)*(M374-L374))","v":{"v":359.14325489099997,"d":"359"}},{"$f":"N374/M374*100","v":{"v":65.61855901785657,"d":"66"}},0,2848,16,355,{"v":1005.36,"d":"1005"},{"v":1756.580172936,"d":"1757"},{"$f":"(U374+U375)/2","v":{"v":1398.680631852,"d":"1399"}},{"$f":"SQRT((V374-U374)*(V374-U374))","v":{"v":357.899541084,"d":"358"}},{"$f":"W374/V374*100","v":{"v":25.588367561085295,"d":"26"}},{"$f":"X374+O374","v":{"v":91.20692657894186,"d":"91"}},{"$f":"(V374/M374*100)-100","v":{"v":155.55097120275434,"d":"156"}},null,0,1385,20,456,{"v":622.44,"d":"622"},{"v":1064.896121016,"d":"1065"},{"$f":"(AG374+AG375)/2","v":{"v":955.8402468144,"d":"956"}},{"$f":"SQRT((AH374-AG374)*(AH374-AG374))","v":{"v":109.05587420160009,"d":"109"}},{"$f":"AI374/AH374*100","v":{"v":11.40942480347095,"d":"11"}},{"$f":"AJ374+O374","v":{"v":77.02798382132752,"d":"77"}},{"$f":"(AH374/M374*100)-100","v":{"v":74.64022724377514,"d":"75"}},{"$nulls":5},"Ubiquitin protein ligase",{"$nulls":9},"TE(pY)MT","Corresponds to amino acid residues T768 to T772.","Y700 phosphorylation induces interaction with CRK, Src, and VAV1. This is one of the major in vivo phosphorylation sites in Cbl (≥505 reports from high throughput mass spectrometry studies).","Abl1; Fyn; InsR; Lck; Src; Syk; Yes","Ubiquitin conjugating system; EC 6.3.2.-; Ligase; Adaptor/scaffold","P22681","P22681",null,"P22681","GO:0005829; GO:0016600; GO:0005925; GO:0030426; GO:0042629; GO:0045121; GO:0048471; GO:0005886","GO:0045296; GO:0005509; GO:0003700; GO:0046875; GO:0005154; GO:0036312; GO:0001784; GO:0030971; GO:0017124; GO:0061630; GO:0004842","GO:0007166; GO:0006974; GO:0071364; GO:1990090; GO:0090650; GO:0036120; GO:0019221; GO:0035635; GO:0007173; GO:0008543; GO:0070102; GO:0008584; GO:0043303; GO:0061024; GO:0043066; GO:0007175; GO:0042059; GO:1901215; GO:0070997; GO:0045742; GO:0014068; GO:0048260; GO:0006513; GO:0000209; GO:0016567; GO:0014823; GO:0045471; GO:0010332; GO:0042594; GO:0033574; GO:0007179; GO:0006511"]
[362,188,"PN171","Cbl","Y700","E3 ubiquitin-protein ligase CBL",0,178,14,653,{"v":107.092,"d":"107"},{"v":188.1763758148,"d":"188"},{"$nulls":3},0,1474,14,408,{"v":595.68,"d":"596"},{"v":1040.781090768,"d":"1041"},{"$nulls":6},0,996,12,503,{"v":494.952,"d":"495"},{"v":846.7843726128,"d":"847"},{"$nulls":10},"Ubiquitin protein ligase",{"$nulls":9},"TE(pY)MT","Corresponds to amino acid residues T768 to T772.","Y700 phosphorylation induces interaction with CRK, Src, and VAV1. This is one of the major in vivo phosphorylation sites in Cbl (≥505 reports from high throughput mass spectrometry studies).","Abl1; Fyn; InsR; Lck; Src; Syk; Yes",null,"P22681","P22681",null,"P22681"]
[363,189,"PN218","Cbl","Y700","E3 ubiquitin-protein ligase CBL",0,226,10,548,{"v":118.368,"d":"118"},{"v":207.98996425919998,"d":"208"},{"$f":"(L376+L377)/2","v":{"v":194.8465054472,"d":"195"}},{"$f":"SQRT((M376-L376)*(M376-L376))","v":{"v":13.143458811999977,"d":"13"}},{"$f":"N376/M376*100","v":{"v":6.745545054469362,"d":"7"}},0,163,12,553,{"v":83.503,"d":"84"},{"v":145.8977024953,"d":"146"},{"$f":"(U376+U377)/2","v":{"v":162.17737918955,"d":"162"}},{"$f":"SQRT((V376-U376)*(V376-U376))","v":{"v":16.279676694250014,"d":"16"}},{"$f":"W376/V376*100","v":{"v":10.038191994225421,"d":"10"}},{"$f":"X376+O376","v":{"v":16.783737048694782,"d":"17"}},{"$f":"(V376/M376*100)-100","v":{"v":-16.766595932870217,"d":"-17"}},null,0,192,10,521,{"v":94.822,"d":"95"},{"v":162.2254032308,"d":"162"},{"$f":"(AG376+AG377)/2","v":{"v":172.6170538944,"d":"173"}},{"$f":"SQRT((AH376-AG376)*(AH376-AG376))","v":{"v":10.39165066359999,"d":"10"}},{"$f":"AI376/AH376*100","v":{"v":6.020060260069769,"d":"6"}},{"$f":"AJ376+O376","v":{"v":12.765605314539131,"d":"13"}},{"$f":"(AH376/M376*100)-100","v":{"v":-11.408699120253814,"d":"-11"}},{"$nulls":5},"Ubiquitin protein ligase",{"$nulls":9},"Not precisely defined.","Antibody raised against amino acid residues surrounding the phosphorylated Y700 of human Cbl.","Y700 phosphorylation induces interaction with CRK, Src, and VAV1. This is one of the major in vivo phosphorylation sites in Cbl (≥505 reports from high throughput mass spectrometry studies).","Abl1; Fyn; InsR; Lck; Src; Syk; Yes","Ubiquitin conjugating system; EC 6.3.2.-; Ligase; Adaptor/scaffold","P22681","P22681",null,"P22681","GO:0005829; GO:0016600; GO:0005925; GO:0030426; GO:0042629; GO:0045121; GO:0048471; GO:0005886","GO:0045296; GO:0005509; GO:0003700; GO:0046875; GO:0005154; GO:0036312; GO:0001784; GO:0030971; GO:0017124; GO:0061630; GO:0004842","GO:0007166; GO:0006974; GO:0071364; GO:1990090; GO:0090650; GO:0036120; GO:0019221; GO:0035635; GO:0007173; GO:0008543; GO:0070102; GO:0008584; GO:0043303; GO:0061024; GO:0043066; GO:0007175; GO:0042059; GO:1901215; GO:0070997; GO:0045742; GO:0014068; GO:0048260; GO:0006513; GO:0000209; GO:0016567; GO:0014823; GO:0045471; GO:0010332; GO:0042594; GO:0033574; GO:0007179; GO:0006511"]
[364,189,"PN218","Cbl","Y700","E3 ubiquitin-protein ligase CBL",0,194,10,562,{"v":103.408,"d":"103"},{"v":181.7030466352,"d":"182"},{"$nulls":3},0,182,8,587,{"v":102.138,"d":"102"},{"v":178.45705588380002,"d":"178"},{"$nulls":6},0,198,8,563,{"v":106.97,"d":"107"},{"v":183.008704558,"d":"183"},{"$nulls":10},"Ubiquitin protein ligase",{"$nulls":9},"Not precisely defined.","Antibody raised against amino acid residues surrounding the phosphorylated Y700 of human Cbl.","Y700 phosphorylation induces interaction with CRK, Src, and VAV1. This is one of the major in vivo phosphorylation sites in Cbl (≥505 reports from high throughput mass spectrometry studies).","Abl1; Fyn; InsR; Lck; Src; Syk; Yes",null,"P22681","P22681",null,"P22681"]
[365,190,"PN744","CBS","S227","Cystathionine beta-synthase",0,1868,14,643,{"v":1192.122,"d":"1192"},{"v":2094.7334767218,"d":"2095"},{"$f":"(L378+L379)/2","v":{"v":1900.8832735668998,"d":"1901"}},{"$f":"SQRT((M378-L378)*(M378-L378))","v":{"v":193.8502031549001,"d":"194"}},{"$f":"N378/M378*100","v":{"v":10.19790146246861,"d":"10"}},0,1774,10,663,{"v":1169.532,"d":"1170"},{"v":2043.4239703331998,"d":"2043"},{"$f":"(U378+U379)/2","v":{"v":1733.8628822058,"d":"1734"}},{"$f":"SQRT((V378-U378)*(V378-U378))","v":{"v":309.5610881273999,"d":"310"}},{"$f":"W378/V378*100","v":{"v":17.85383903792784,"d":"18"}},{"$f":"X378+O378","v":{"v":28.051740500396452,"d":"28"}},{"$f":"(V378/M378*100)-100","v":{"v":-8.786462255922515,"d":"-9"}},null,0,1860,14,629,{"v":1161.134,"d":"1161"},{"v":1986.5161181476,"d":"1987"},{"$f":"(AG378+AG379)/2","v":{"v":1869.3491448686,"d":"1869"}},{"$f":"SQRT((AH378-AG378)*(AH378-AG378))","v":{"v":117.1669732790001,"d":"117"}},{"$f":"AI378/AH378*100","v":{"v":6.267795055868816,"d":"6"}},{"$f":"AJ378+O378","v":{"v":16.465696518337428,"d":"16"}},{"$f":"(AH378/M378*100)-100","v":{"v":-1.6589197841237109,"d":"-2"}},{"$nulls":14},"X","RNA(pS)NPLAC","Corresponds to amino acid residues R224 to A 231.","S227 phosphorylation stimulates enzyme activity. This phosphorylation site has not been detected in high throughput mass spectrometry studies.  in CBS. This human phosphosite is highly conserved in vertebrates and also found in sea urchin.","PKG1",null,"P35520","P35520",null,null,"GO:0005737; GO:0005829; GO:0005634","GO:0070025; GO:0004122; GO:0019899; GO:0020037; GO:0042802; GO:0046872; GO:0072341; GO:0070026; GO:0050421; GO:0019825; GO:0042803; GO:0030170; GO:1904047; GO:0031625","GO:0019344; GO:0006535; GO:0019343; GO:0042262; GO:0043418; GO:0050667; GO:0070814; GO:0019448; GO:0006565; GO:0006563; GO:0019346"]
[366,190,"PN744","CBS","S227","Cystathionine beta-synthase",0,1504,14,652,{"v":971.48,"d":"971"},{"v":1707.033070412,"d":"1707"},{"$nulls":3},0,1346,14,612,{"v":815.184,"d":"815"},{"v":1424.3017940784,"d":"1424"},{"$nulls":6},0,1578,12,654,{"v":1024.164,"d":"1024"},{"v":1752.1821715896,"d":"1752"},{"$nulls":19},"X","RNA(pS)NPLAC","Corresponds to amino acid residues R224 to A 231.","S227 phosphorylation stimulates enzyme activity. This phosphorylation site has not been detected in high throughput mass spectrometry studies.  in CBS. This human phosphosite is highly conserved in vertebrates and also found in sea urchin.","PKG1",null,"P35520","P35520"]
[367,191,"NP001","CD45 (PTPRC; Receptor-type tyrosine-protein phosphatase C)","Pan-specific","Receptor protein-tyrosine phosphatase CD45",0,328,12,317,{"v":100.172,"d":"100"},{"v":176.0169192668,"d":"176"},{"$f":"(L380+L381)/2","v":{"v":147.58013241065,"d":"148"}},{"$f":"SQRT((M380-L380)*(M380-L380))","v":{"v":28.43678685614998,"d":"28"}},{"$f":"N380/M380*100","v":{"v":19.268709406644945,"d":"19"}},0,560,12,335,{"v":183.58,"d":"184"},{"v":320.75374805800004,"d":"321"},{"$f":"(U380+U381)/2","v":{"v":196.87270303780002,"d":"197"}},{"$f":"SQRT((V380-U380)*(V380-U380))","v":{"v":123.88104502020002,"d":"124"}},{"$f":"W380/V380*100","v":{"v":62.92443955341771,"d":"63"}},{"$f":"X380+O380","v":{"v":82.19314896006266,"d":"82"}},{"$f":"(V380/M380*100)-100","v":{"v":33.400546416363596,"d":"33"}},null,0,337,14,380,{"v":122.74,"d":"123"},{"v":209.988673436,"d":"210"},{"$f":"(AG380+AG381)/2","v":{"v":185.831592868,"d":"186"}},{"$f":"SQRT((AH380-AG380)*(AH380-AG380))","v":{"v":24.157080567999998,"d":"24"}},{"$f":"AI380/AH380*100","v":{"v":12.999447615540415,"d":"13"}},{"$f":"AJ380+O380","v":{"v":32.26815702218536,"d":"32"}},{"$f":"(AH380/M380*100)-100","v":{"v":25.919112439141315,"d":"26"}},{"$nulls":4},"PYP","Protein phosphatase - Receptor protein-tyrosine phosphatase",{"$nulls":6},"X",null,null,"Epitope undefined.",{"$nulls":3},"EC 3.1.3.48; Receptor protein phosphatase, tyrosine","P08575","P08575",null,null,"GO:0009986; GO:0009898; GO:0009897; GO:0070062; GO:0005925; GO:0016021; GO:0005887; GO:0016020; GO:0098857; GO:0045121; GO:0005886; GO:0030667","GO:0043395; GO:0008201; GO:0019901; GO:0004725; GO:0005001","GO:0000187; GO:0030183; GO:0042100; GO:0050853; GO:0048539; GO:0044770; GO:0007166; GO:0031668; GO:0051607; GO:0016311; GO:0002244; GO:0034113; GO:0002378; GO:0007159; GO:0006933; GO:0001960; GO:0070373; GO:0045085; GO:1903979; GO:0031953; GO:0006469; GO:0061099; GO:0001915; GO:0045060; GO:0043312; GO:0044855; GO:0046641; GO:0050857; GO:0030890; GO:0070374; GO:2001238; GO:0045588; GO:2000473; GO:0002925; GO:0045086; GO:0048304; GO:0045860; GO:1903615; GO:2000648; GO:0001916; GO:0042102; GO:0045059; GO:0006470; GO:0045577; GO:0050855; GO:0051726; GO:0051209; GO:0010332; GO:0048864; GO:0030217; GO:0042098; GO:0050852"]
[368,191,"NP001","CD45 (PTPRC; Receptor-type tyrosine-protein phosphatase C)","Pan-specific","Receptor protein-tyrosine phosphatase CD45",1,203,12,355,{"v":67.805,"d":"68"},{"v":119.14334555450002,"d":"119"},{"$nulls":3},1,124,12,373,{"v":41.776,"d":"42"},{"v":72.9916580176,"d":"73"},{"$nulls":6},1,327,12,300,{"v":94.5,"d":"95"},{"v":161.6745123,"d":"162"},{"$nulls":9},"PYP","Protein phosphatase - Receptor protein-tyrosine phosphatase",{"$nulls":6},"X",null,null,"Epitope undefined.",{"$nulls":4},"P08575","P08575"]
[369,192,"PP527","CD45 (PTPRC; Receptor-type tyrosine-protein phosphatase C)","Y1216",null,0,9241,16,716,{"v":6605.1,"d":"6605"},{"v":11606.13098919,"d":"11606"},{"$f":"(L382+L383)/2","v":{"v":11754.6485594718,"d":"11755"}},{"$f":"SQRT((M382-L382)*(M382-L382))","v":{"v":148.51757028179964,"d":"149"}},{"$f":"N382/M382*100","v":{"v":1.2634794611713456,"d":"1"}},0,9720,16,740,{"v":7180.96,"d":"7181"},{"v":12546.681744496,"d":"12547"},{"$f":"(U382+U383)/2","v":{"v":11695.124049057998,"d":"11695"}},{"$f":"SQRT((V382-U382)*(V382-U382))","v":{"v":851.5576954380012,"d":"852"}},{"$f":"W382/V382*100","v":{"v":7.281305370220431,"d":"7"}},{"$f":"X382+O382","v":{"v":8.544784831391777,"d":"9"}},{"$f":"(V382/M382*100)-100","v":{"v":-0.5063912384333804,"d":"-1"}},null,0,4460,12,943,{"v":4194.464,"d":"4194"},{"v":7176.0626620096,"d":"7176"},{"$f":"(AG382+AG383)/2","v":{"v":9528.189009020001,"d":"9528"}},{"$f":"SQRT((AH382-AG382)*(AH382-AG382))","v":{"v":2352.1263470104013,"d":"2352"}},{"$f":"AI382/AH382*100","v":{"v":24.685974898102106,"d":"25"}},{"$f":"AJ382+O382","v":{"v":25.949454359273453,"d":"26"}},{"$f":"(AH382/M382*100)-100","v":{"v":-18.941098401940195,"d":"-19"}},{"$nulls":4},"PYP","Protein phosphatase - Receptor protein-tyrosine phosphatase",{"$nulls":6},"X",null,null,"FEQ(pY)QFL(bA)C","Corresponds to amino acid residues F1215 to L1221.","Y1216 phosphorylation stimulates phosphatase activity. Phosphorylation at this site has only be reported in a single mass spectrometry study. This human phosphosite is highly conserved in vertebrates and also found in fish.","CSK","EC 3.1.3.48; Receptor protein phosphatase, tyrosine","P08575","P08575",null,null,"GO:0009986; GO:0009898; GO:0009897; GO:0070062; GO:0005925; GO:0016021; GO:0005887; GO:0016020; GO:0098857; GO:0045121; GO:0005886; GO:0030667","GO:0043395; GO:0008201; GO:0019901; GO:0004725; GO:0005001","GO:0000187; GO:0030183; GO:0042100; GO:0050853; GO:0048539; GO:0044770; GO:0007166; GO:0031668; GO:0051607; GO:0016311; GO:0002244; GO:0034113; GO:0002378; GO:0007159; GO:0006933; GO:0001960; GO:0070373; GO:0045085; GO:1903979; GO:0031953; GO:0006469; GO:0061099; GO:0001915; GO:0045060; GO:0043312; GO:0044855; GO:0046641; GO:0050857; GO:0030890; GO:0070374; GO:2001238; GO:0045588; GO:2000473; GO:0002925; GO:0045086; GO:0048304; GO:0045860; GO:1903615; GO:2000648; GO:0001916; GO:0042102; GO:0045059; GO:0006470; GO:0045577; GO:0050855; GO:0051726; GO:0051209; GO:0010332; GO:0048864; GO:0030217; GO:0042098; GO:0050852"]
[370,192,"PP527","CD45 (PTPRC; Receptor-type tyrosine-protein phosphatase C)","Y1216",null,0,9586,18,708,{"v":6774.144,"d":"6774"},{"v":11903.1661297536,"d":"11903"},{"$nulls":3},0,9564,16,650,{"v":6206.2,"d":"6206"},{"v":10843.566353619999,"d":"10844"},{"$nulls":6},0,9767,14,712,{"v":6944.136,"d":"6944"},{"v":11880.315356030402,"d":"11880"},{"$nulls":9},"PYP","Protein phosphatase - Receptor protein-tyrosine phosphatase",{"$nulls":6},"X",null,null,"FEQ(pY)QFL(bA)C","Corresponds to amino acid residues F1215 to L1221.","Y1216 phosphorylation stimulates phosphatase activity. Phosphorylation at this site has only be reported in a single mass spectrometry study. This human phosphosite is highly conserved in vertebrates and also found in fish.","CSK",null,"P08575","P08575"]
[371,193,"NK024","CDC2L5 (CHED, CDK13)","Pan-specific","Cholinesterase-related cell division controller",0,222,16,606,{"v":124.836,"d":"125"},{"v":219.3551904084,"d":"219"},{"$f":"(L384+L385)/2","v":{"v":224.17855864889998,"d":"224"}},{"$f":"SQRT((M384-L384)*(M384-L384))","v":{"v":4.823368240499974,"d":"5"}},{"$f":"N384/M384*100","v":{"v":2.1515742939779323,"d":"2"}},0,282,16,717,{"v":190.722,"d":"191"},{"v":333.2323583022,"d":"333"},{"$f":"(U384+U385)/2","v":{"v":298.1080931469,"d":"298"}},{"$f":"SQRT((V384-U384)*(V384-U384))","v":{"v":35.12426515530001,"d":"35"}},{"$f":"W384/V384*100","v":{"v":11.782392347862785,"d":"12"}},{"$f":"X384+O384","v":{"v":13.933966641840717,"d":"14"}},{"$f":"(V384/M384*100)-100","v":{"v":32.97796851918636,"d":"33"}},null,0,326,12,654,{"v":205.356,"d":"205"},{"v":351.3315465384,"d":"351"},{"$f":"(AG384+AG385)/2","v":{"v":325.82632294719997,"d":"326"}},{"$f":"SQRT((AH384-AG384)*(AH384-AG384))","v":{"v":25.505223591200036,"d":"26"}},{"$f":"AI384/AH384*100","v":{"v":7.827858523061424,"d":"8"}},{"$f":"AJ384+O384","v":{"v":9.979432817039356,"d":"10"}},{"$f":"(AH384/M384*100)-100","v":{"v":45.342322169845374,"d":"45"}},null,null,"CHED","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CRK7","X",{"$nulls":4},"Epitope undefined.",{"$nulls":3},"EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC domain target; CMGC</A> group; CDK family; CRK7 subfamily; CDK/CRK7 subfamily","Q14004","Q14004","Q14004",null,"GO:0005694; GO:0008024; GO:0002945; GO:0005829; GO:0005576; GO:0005615; GO:1904813; GO:0005794; GO:0019908; GO:0016607; GO:0005654","GO:0005524; GO:0030332; GO:0004693; GO:0004672; GO:0019901; GO:0003723; GO:0008353; GO:0008134; GO:0044212","GO:0000380; GO:0030097; GO:0007275; GO:2000737; GO:0043312; GO:0070816; GO:0008284; GO:0045944; GO:0007088; GO:0006368; GO:0016032"]
[372,193,"NK024","CDC2L5 (CHED, CDK13)","Pan-specific","Cholinesterase-related cell division controller",0,226,12,609,{"v":130.326,"d":"130"},{"v":229.00192688939998,"d":"229"},{"$nulls":3},0,238,12,666,{"v":150.516,"d":"151"},{"v":262.9838279916,"d":"263"},{"$nulls":6},0,274,12,670,{"v":175.54,"d":"176"},{"v":300.321099356,"d":"300"},{"$nulls":7},"CHED","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CRK7","X",{"$nulls":4},"Epitope undefined.",{"$nulls":4},"Q14004","Q14004","Q14004"]
[373,194,"NK024-2","CDC2L5 (CHED, CDK13)","Pan-specific","CDC2-related protein kinase 5",0,1150,20,698,{"v":788.74,"d":"789"},{"v":1385.932045906,"d":"1386"},{"$f":"(L386+L387)/2","v":{"v":1321.0142536855,"d":"1321"}},{"$f":"SQRT((M386-L386)*(M386-L386))","v":{"v":64.9177922204999,"d":"65"}},{"$f":"N386/M386*100","v":{"v":4.914238588977041,"d":"5"}},0,1196,20,809,{"v":951.384,"d":"951"},{"v":1662.2724906984001,"d":"1662"},{"$f":"(U386+U387)/2","v":{"v":1346.4843279546,"d":"1346"}},{"$f":"SQRT((V386-U386)*(V386-U386))","v":{"v":315.78816274380006,"d":"316"}},{"$f":"W386/V386*100","v":{"v":23.452791554098773,"d":"23"}},{"$f":"X386+O386","v":{"v":28.367030143075816,"d":"28"}},{"$f":"(V386/M386*100)-100","v":{"v":1.9280696024316768,"d":"2"}},null,0,1408,14,768,{"v":1070.592,"d":"1071"},{"v":1831.6131161088003,"d":"1832"},{"$f":"(AG386+AG387)/2","v":{"v":1689.1239792684,"d":"1689"}},{"$f":"SQRT((AH386-AG386)*(AH386-AG386))","v":{"v":142.4891368404003,"d":"142"}},{"$f":"AI386/AH386*100","v":{"v":8.435682554344872,"d":"8"}},{"$f":"AJ386+O386","v":{"v":13.349921143321913,"d":"13"}},{"$f":"(AH386/M386*100)-100","v":{"v":27.865689151794527,"d":"28"}},null,null,"CHED","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CRK7",{"$nulls":5},"CGPRYGETKEKDIDWGKR ","Corresponds to amino acid residues C683 to R700; Just before kinase catalytic domain.",null,null,"EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC domain target; CMGC</A> group; CDK family; CRK7 subfamily; CDK/CRK7 subfamily","Q14004","Q14004","Q14004",null,"GO:0005694; GO:0008024; GO:0002945; GO:0005829; GO:0005576; GO:0005615; GO:1904813; GO:0005794; GO:0019908; GO:0016607; GO:0005654","GO:0005524; GO:0030332; GO:0004693; GO:0004672; GO:0019901; GO:0003723; GO:0008353; GO:0008134; GO:0044212","GO:0000380; GO:0030097; GO:0007275; GO:2000737; GO:0043312; GO:0070816; GO:0008284; GO:0045944; GO:0007088; GO:0006368; GO:0016032"]
[374,194,"NK024-2","CDC2L5 (CHED, CDK13)","Pan-specific","CDC2-related protein kinase 5",0,1000,14,725,{"v":714.85,"d":"715"},{"v":1256.096461465,"d":"1256"},{"$nulls":3},0,920,18,654,{"v":589.908,"d":"590"},{"v":1030.6961652108,"d":"1031"},{"$nulls":6},0,1240,20,741,{"v":904.02,"d":"904"},{"v":1546.634842428,"d":"1547"},{"$nulls":7},"CHED","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CRK7",{"$nulls":5},"CGPRYGETKEKDIDWGKR ","Corresponds to amino acid residues C683 to R700; Just before kinase catalytic domain.",{"$nulls":3},"Q14004","Q14004","Q14004"]
[375,195,"PN576","CDC5L","T385","Cell division cycle 5-like protein",0,13352,20,939,{"v":12518.748,"d":"12519"},{"v":21997.2792400812,"d":"21997"},{"$f":"(L388+L389)/2","v":{"v":22230.3612620724,"d":"22230"}},{"$f":"SQRT((M388-L388)*(M388-L388))","v":{"v":233.08202199120205,"d":"233"}},{"$f":"N388/M388*100","v":{"v":1.0484850841757,"d":"1"}},0,13654,20,1004,{"v":13688.536,"d":"13689"},{"v":23916.8167960936,"d":"23917"},{"$f":"(U388+U389)/2","v":{"v":21369.387663584203,"d":"21369"}},{"$f":"SQRT((V388-U388)*(V388-U388))","v":{"v":2547.429132509398,"d":"2547"}},{"$f":"W388/V388*100","v":{"v":11.920927134709148,"d":"12"}},{"$f":"X388+O388","v":{"v":12.969412218884848,"d":"13"}},{"$f":"(V388/M388*100)-100","v":{"v":-3.872962694300071,"d":"-4"}},null,0,12924,20,1012,{"v":13058.848,"d":"13059"},{"v":22341.6177947072,"d":"22342"},{"$f":"(AG388+AG389)/2","v":{"v":21634.8623690016,"d":"21635"}},{"$f":"SQRT((AH388-AG388)*(AH388-AG388))","v":{"v":706.7554257055999,"d":"707"}},{"$f":"AI388/AH388*100","v":{"v":3.266743340684423,"d":"3"}},{"$f":"AJ388+O388","v":{"v":4.315228424860123,"d":"4"}},{"$f":"(AH388/M388*100)-100","v":{"v":-2.6787639033414763,"d":"-3"}},{"$nulls":5},"Transcription protein; RNA processing",{"$nulls":4},"X",{"$nulls":4},"CGGLN(pT)PLHE","Corresponds to amino acid residues C381 to E389.","The effect of T385 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in CDC5L (≥66 reports from high throughput mass spectrometry studies).","ERK1 (MAPK3)","Transcription factor; RNA processing","Q99459","Q99459",null,null,"GO:0071013; GO:0005737; GO:0016020; GO:0016607; GO:0005654; GO:0005634; GO:0048471; GO:0032993; GO:0000974; GO:0071007","GO:0003677; GO:0043522; GO:0019901; GO:0008157; GO:0003723; GO:0000977; GO:0000981; GO:0001135; GO:0043565; GO:0001228; GO:0001222; GO:0044212; GO:0071987","GO:0030154; GO:0044344; GO:0071352; GO:1990090; GO:1990646; GO:1904568; GO:0006281; GO:0000278; GO:0000398; GO:0045944; GO:0006357; GO:0072422"]
[376,195,"PN576","CDC5L","T385","Cell division cycle 5-like protein",0,13258,24,966,{"v":12784.044,"d":"12784"},{"v":22463.4432840636,"d":"22463"},{"$nulls":3},0,12814,20,842,{"v":10772.548,"d":"10773"},{"v":18821.9585310748,"d":"18822"},{"$nulls":6},0,12062,22,1016,{"v":12232.64,"d":"12233"},{"v":20928.106943296,"d":"20928"},{"$nulls":10},"Transcription protein; RNA processing",{"$nulls":4},"X",{"$nulls":4},"CGGLN(pT)PLHE","Corresponds to amino acid residues C381 to E389.","The effect of T385 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in CDC5L (≥66 reports from high throughput mass spectrometry studies).","ERK1 (MAPK3)",null,"Q99459","Q99459"]
[377,196,"PK558","CDC7","T376","Cell division cycle 7-related protein kinase",0,7705,18,760,{"v":5842.12,"d":"5842"},{"v":10265.463047428,"d":"10265"},{"$f":"(L390+L391)/2","v":{"v":9990.6136436238,"d":"9991"}},{"$f":"SQRT((M390-L390)*(M390-L390))","v":{"v":274.84940380420085,"d":"275"}},{"$f":"N390/M390*100","v":{"v":2.7510762962955235,"d":"3"}},0,8387,16,707,{"v":5918.297,"d":"5918"},{"v":10340.5378846847,"d":"10341"},{"$f":"(U390+U391)/2","v":{"v":10358.38306610855,"d":"10358"}},{"$f":"SQRT((V390-U390)*(V390-U390))","v":{"v":17.84518142385059,"d":"18"}},{"$f":"W390/V390*100","v":{"v":0.17227767413080128,"d":"0"}},{"$f":"X390+O390","v":{"v":2.9233539704263247,"d":"3"}},{"$f":"(V390/M390*100)-100","v":{"v":3.6811494829396025,"d":"4"}},null,0,7877,12,670,{"v":5269.55,"d":"5270"},{"v":9015.364299370001,"d":"9015"},{"$f":"(AG390+AG391)/2","v":{"v":9366.540159341,"d":"9367"}},{"$f":"SQRT((AH390-AG390)*(AH390-AG390))","v":{"v":351.1758599709992,"d":"351"}},{"$f":"AI390/AH390*100","v":{"v":3.749259107385355,"d":"4"}},{"$f":"AJ390+O390","v":{"v":6.500335403680879,"d":"7"}},{"$f":"(AH390/M390*100)-100","v":{"v":-6.246598122439593,"d":"-6"}},null,null,"CDC7","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","CDC7",{"$nulls":6},"RAG(pT)PGF(bA)C","Corresponds to amino acid residues R373 to F379; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T376 phosphorylation was originally suggested to be stimulatory based on loss of phosphotransferase activity with an alanine substitution. However, it is predicted to be inhibitory for phosphotransferase activity. This phosphosite is located in the kinase activation loop just before the catalytic subdomain VIII. This is one of the major in vivo phosphorylation sites in CDC7 (≥13 reports from high throughput mass spectrometry studies).","CDK1 (CDC2); CDK2","EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; CDC7 family","O00311","O00311","O00311",null,"GO:0005737; GO:0045171; GO:0072686; GO:0005654; GO:0005634","GO:0005524; GO:0016301; GO:0046872; GO:0004672; GO:0004674","GO:0044770; GO:0051301; GO:0006260; GO:0006270; GO:0000727; GO:0000082; GO:0070317; GO:0018105; GO:0006909; GO:0008284; GO:0010971; GO:0010571; GO:0008360"]
[378,196,"PK558","CDC7","T376","Cell division cycle 7-related protein kinase",0,7580,16,731,{"v":5529.284,"d":"5529"},{"v":9715.764239819599,"d":"9716"},{"$nulls":3},0,7618,14,781,{"v":5938.724,"d":"5939"},{"v":10376.228247532401,"d":"10376"},{"$nulls":6},0,7905,16,720,{"v":5680.08,"d":"5680"},{"v":9717.716019312,"d":"9718"},{"$nulls":7},"CDC7","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","CDC7",{"$nulls":6},"RAG(pT)PGF(bA)C","Corresponds to amino acid residues R373 to F379; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T376 phosphorylation was originally suggested to be stimulatory based on loss of phosphotransferase activity with an alanine substitution. However, it is predicted to be inhibitory for phosphotransferase activity. This phosphosite is located in the kinase activation loop just before the catalytic subdomain VIII. This is one of the major in vivo phosphorylation sites in CDC7 (≥13 reports from high throughput mass spectrometry studies).","CDK1 (CDC2); CDK2",null,"O00311","O00311","O00311"]
[379,197,"NK025-6","CDK1 (CDC2)","Pan-specific","Cyclin-dependent protein-serine kinase 1; Cell division control protein 2 homologue",0,208,14,542,{"v":105.148,"d":"105"},{"v":184.76048224119998,"d":"185"},{"$f":"(L392+L393)/2","v":{"v":166.88678397439998,"d":"167"}},{"$f":"SQRT((M392-L392)*(M392-L392))","v":{"v":17.873698266800005,"d":"18"}},{"$f":"N392/M392*100","v":{"v":10.710074123989223,"d":"11"}},0,180,10,515,{"v":87.55,"d":"88"},{"v":152.968682005,"d":"153"},{"$f":"(U392+U393)/2","v":{"v":168.2830223565,"d":"168"}},{"$f":"SQRT((V392-U392)*(V392-U392))","v":{"v":15.314340351499993,"d":"15"}},{"$f":"W392/V392*100","v":{"v":9.100347817058605,"d":"9"}},{"$f":"X392+O392","v":{"v":19.810421941047828,"d":"20"}},{"$f":"(V392/M392*100)-100","v":{"v":0.8366380781321965,"d":"1"}},null,0,174,10,492,{"v":80.688,"d":"81"},{"v":138.0443708832,"d":"138"},{"$f":"(AG392+AG393)/2","v":{"v":163.6616545861,"d":"164"}},{"$f":"SQRT((AH392-AG392)*(AH392-AG392))","v":{"v":25.61728370290001,"d":"26"}},{"$f":"AI392/AH392*100","v":{"v":15.652587509081506,"d":"16"}},{"$f":"AJ392+O392","v":{"v":26.36266163307073,"d":"26"}},{"$f":"(AH392/M392*100)-100","v":{"v":-1.9325253393310646,"d":"-2"}},null,null,"CDK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues at the C-terminus of human Cdc2 p34.",null,null,"EC 2.7.11.23; EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; CDK/CDK1 subfamily; CDK1 subfamily","P06493","P06493","P06493","P06493","GO:0005813; GO:0097125; GO:0000307; GO:0005829; GO:0005789; GO:0070062; GO:0016020; GO:0030496; GO:0005759; GO:0005739; GO:0072686; GO:0000784; GO:0005654; GO:0005634; GO:0005876","GO:0005524; GO:0003682; GO:0030332; GO:0097472; GO:0004693; GO:0035173; GO:0030544; GO:0004672; GO:0004674; GO:0008353; GO:0001618","GO:0000187; GO:0031145; GO:0031100; GO:0006915; GO:0007569; GO:0051301; GO:0016477; GO:0008283; GO:0070301; GO:0007098; GO:0030261; GO:0097711; GO:0006977; GO:0006281; GO:0006260; GO:0030855; GO:0000086; GO:0090166; GO:0000226; GO:0007095; GO:0007077; GO:0043066; GO:0018105; GO:0018107; GO:0060045; GO:0045740; GO:0010971; GO:0010628; GO:1905448; GO:0033160; GO:1900182; GO:0007344; GO:0065003; GO:0016579; GO:0034501; GO:0006468; GO:0045995; GO:0010389; GO:0010468; GO:0051445; GO:0014038; GO:0014823; GO:0014075; GO:0048678; GO:0046686; GO:0046688; GO:0045471; GO:0014070; GO:0055015"]
[380,197,"NK025-6","CDK1 (CDC2)","Pan-specific","Cyclin-dependent protein-serine kinase 1; Cell division control protein 2 homologue",0,158,10,573,{"v":84.804,"d":"85"},{"v":149.0130857076,"d":"149"},{"$nulls":3},0,195,10,568,{"v":105.08,"d":"105"},{"v":183.597362708,"d":"184"},{"$nulls":6},0,213,10,545,{"v":110.635,"d":"111"},{"v":189.27893828900002,"d":"189"},{"$nulls":7},"CDK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues at the C-terminus of human Cdc2 p34.",{"$nulls":3},"P06493","P06493","P06493","P06493"]
[381,198,"NK025-1","CDK1 (CDC2)","Pan-specific","Cyclin-dependent protein-serine kinase 1; Cell division control protein 2 homologue",0,201,12,481,{"v":90.909,"d":"91"},{"v":159.7404675321,"d":"160"},{"$f":"(L394+L395)/2","v":{"v":155.30455018305,"d":"155"}},{"$f":"SQRT((M394-L394)*(M394-L394))","v":{"v":4.4359173490500154,"d":"4"}},{"$f":"N394/M394*100","v":{"v":2.856270047349941,"d":"3"}},0,180,12,444,{"v":74.592,"d":"75"},{"v":130.3282687392,"d":"130"},{"$f":"(U394+U395)/2","v":{"v":117.1245642285,"d":"117"}},{"$f":"SQRT((V394-U394)*(V394-U394))","v":{"v":13.203704510700007,"d":"13"}},{"$f":"W394/V394*100","v":{"v":11.273215484448427,"d":"11"}},{"$f":"X394+O394","v":{"v":14.129485531798368,"d":"14"}},{"$f":"(V394/M394*100)-100","v":{"v":-24.583945486174798,"d":"-25"}},null,0,202,8,470,{"v":91.18,"d":"91"},{"v":155.99451885200003,"d":"156"},{"$f":"(AG394+AG395)/2","v":{"v":162.1484153678,"d":"162"}},{"$f":"SQRT((AH394-AG394)*(AH394-AG394))","v":{"v":6.153896515799971,"d":"6"}},{"$f":"AI394/AH394*100","v":{"v":3.795224579803099,"d":"4"}},{"$f":"AJ394+O394","v":{"v":6.65149462715304,"d":"7"}},{"$f":"(AH394/M394*100)-100","v":{"v":4.406738358073525,"d":"4"}},null,null,"CDK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"Epitope undefined.",{"$nulls":3},"EC 2.7.11.23; EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; CDK/CDK1 subfamily; CDK1 subfamily","P06493","P06493","P06493","P06493","GO:0005813; GO:0097125; GO:0000307; GO:0005829; GO:0005789; GO:0070062; GO:0016020; GO:0030496; GO:0005759; GO:0005739; GO:0072686; GO:0000784; GO:0005654; GO:0005634; GO:0005876","GO:0005524; GO:0003682; GO:0030332; GO:0097472; GO:0004693; GO:0035173; GO:0030544; GO:0004672; GO:0004674; GO:0008353; GO:0001618","GO:0000187; GO:0031145; GO:0031100; GO:0006915; GO:0007569; GO:0051301; GO:0016477; GO:0008283; GO:0070301; GO:0007098; GO:0030261; GO:0097711; GO:0006977; GO:0006281; GO:0006260; GO:0030855; GO:0000086; GO:0090166; GO:0000226; GO:0007095; GO:0007077; GO:0043066; GO:0018105; GO:0018107; GO:0060045; GO:0045740; GO:0010971; GO:0010628; GO:1905448; GO:0033160; GO:1900182; GO:0007344; GO:0065003; GO:0016579; GO:0034501; GO:0006468; GO:0045995; GO:0010389; GO:0010468; GO:0051445; GO:0014038; GO:0014823; GO:0014075; GO:0048678; GO:0046686; GO:0046688; GO:0045471; GO:0014070; GO:0055015"]
[382,198,"NK025-1","CDK1 (CDC2)","Pan-specific","Cyclin-dependent protein-serine kinase 1; Cell division control protein 2 homologue",0,190,10,477,{"v":85.86,"d":"86"},{"v":150.86863283399998,"d":"151"},{"$nulls":3},0,148,10,431,{"v":59.478,"d":"59"},{"v":103.9208597178,"d":"104"},{"$nulls":6},0,214,12,487,{"v":98.374,"d":"98"},{"v":168.3023118836,"d":"168"},{"$nulls":7},"CDK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"Epitope undefined.",{"$nulls":4},"P06493","P06493","P06493","P06493"]
[383,199,"NK204","CDK1 (CDC2)","Pan-specific","Cyclin-dependent protein-serine kinase 1; Cell division control protein 2 homologue",0,10,2,353,{"v":2.824,"d":"3"},{"v":4.962182845599999,"d":"5"},{"$f":"(L396+L397)/2","v":{"v":6.476843473399999,"d":"6"}},{"$f":"SQRT((M396-L396)*(M396-L396))","v":{"v":1.5146606277999997,"d":"2"}},{"$f":"N396/M396*100","v":{"v":23.385784047748235,"d":"23"}},0,8,2,362,{"v":2.172,"d":"2"},{"v":3.7949511972000005,"d":"4"},{"$f":"(U396+U397)/2","v":{"v":7.0901988758000005,"d":"7"}},{"$f":"SQRT((V396-U396)*(V396-U396))","v":{"v":3.2952476786,"d":"3"}},{"$f":"W396/V396*100","v":{"v":46.476096599310004,"d":"46"}},{"$f":"X396+O396","v":{"v":69.86188064705824,"d":"70"}},{"$f":"(V396/M396*100)-100","v":{"v":9.469974145878538,"d":"9"}},null,0,8,2,423,{"v":2.538,"d":"3"},{"v":4.3421154732,"d":"4"},{"$f":"(AG396+AG397)/2","v":{"v":5.7946198218,"d":"6"}},{"$f":"SQRT((AH396-AG396)*(AH396-AG396))","v":{"v":1.4525043485999998,"d":"1"}},{"$f":"AI396/AH396*100","v":{"v":25.06643046944198,"d":"25"}},{"$f":"AJ396+O396","v":{"v":48.452214517190214,"d":"48"}},{"$f":"(AH396/M396*100)-100","v":{"v":-10.533273722019842,"d":"-11"}},null,null,"CDK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"EGVPSTAIREISLLKEGGC","Corresponds to amino acid residues E42 to E57; Kinase catalytic subdomain 3.",null,null,"EC 2.7.11.23; EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; CDK/CDK1 subfamily; CDK1 subfamily","P06493","P06493","P06493","P06493","GO:0005813; GO:0097125; GO:0000307; GO:0005829; GO:0005789; GO:0070062; GO:0016020; GO:0030496; GO:0005759; GO:0005739; GO:0072686; GO:0000784; GO:0005654; GO:0005634; GO:0005876","GO:0005524; GO:0003682; GO:0030332; GO:0097472; GO:0004693; GO:0035173; GO:0030544; GO:0004672; GO:0004674; GO:0008353; GO:0001618","GO:0000187; GO:0031145; GO:0031100; GO:0006915; GO:0007569; GO:0051301; GO:0016477; GO:0008283; GO:0070301; GO:0007098; GO:0030261; GO:0097711; GO:0006977; GO:0006281; GO:0006260; GO:0030855; GO:0000086; GO:0090166; GO:0000226; GO:0007095; GO:0007077; GO:0043066; GO:0018105; GO:0018107; GO:0060045; GO:0045740; GO:0010971; GO:0010628; GO:1905448; GO:0033160; GO:1900182; GO:0007344; GO:0065003; GO:0016579; GO:0034501; GO:0006468; GO:0045995; GO:0010389; GO:0010468; GO:0051445; GO:0014038; GO:0014823; GO:0014075; GO:0048678; GO:0046686; GO:0046688; GO:0045471; GO:0014070; GO:0055015"]
[384,199,"NK204","CDK1 (CDC2)","Pan-specific","Cyclin-dependent protein-serine kinase 1; Cell division control protein 2 homologue",0,8,2,758,{"v":4.548,"d":"5"},{"v":7.991504101199999,"d":"8"},{"$nulls":3},0,10,2,743,{"v":5.944,"d":"6"},{"v":10.3854465544,"d":"10"},{"$nulls":6},0,8,2,706,{"v":4.236,"d":"4"},{"v":7.2471241704,"d":"7"},{"$nulls":7},"CDK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"EGVPSTAIREISLLKEGGC","Corresponds to amino acid residues E42 to E57; Kinase catalytic subdomain 3.",{"$nulls":3},"P06493","P06493","P06493","P06493"]
[385,200,"PK559","CDK1 (CDC2)","T14","Cyclin-dependent protein-serine kinase 1; Cell division control protein 2 homologue",0,8851,18,742,{"$f":"(H398-I398)*J398/1000","v":{"v":6554.086,"d":"6554"}},{"v":11516.4918972334,"d":"11516"},{"$f":"(L398+L399)/2","v":{"v":11298.5740529892,"d":"11299"}},{"$f":"SQRT((M398-L398)*(M398-L398))","v":{"v":217.91784424420075,"d":"218"}},{"$f":"N398/M398*100","v":{"v":1.9287198829001564,"d":"2"}},0,8432,14,659,{"$f":"(Q398-R398)*S398/1000","v":{"v":5547.462,"d":"5547"}},{"v":9692.6093730762,"d":"9693"},{"$f":"(U398+U399)/2","v":{"v":9645.1829664018,"d":"9645"}},{"$f":"SQRT((V398-U398)*(V398-U398))","v":{"v":47.426406674399914,"d":"47"}},{"$f":"W398/V398*100","v":{"v":0.49171080361674724,"d":"0"}},{"$f":"X398+O398","v":{"v":2.4204306865169034,"d":"2"}},{"$f":"(V398/M398*100)-100","v":{"v":-14.633626144619285,"d":"-15"}},null,0,8357,18,701,{"$f":"(AC398-AD398)*AE398/1000","v":{"v":5845.639,"d":"5846"}},{"v":10000.961210654601,"d":"10001"},{"$f":"(AG398+AG399)/2","v":{"v":10409.3878118145,"d":"10409"}},{"$f":"SQRT((AH398-AG398)*(AH398-AG398))","v":{"v":408.4266011598993,"d":"408"}},{"$f":"AI398/AH398*100","v":{"v":3.923637091283516,"d":"4"}},{"$f":"AJ398+O398","v":{"v":5.852356974183673,"d":"6"}},{"$f":"(AH398/M398*100)-100","v":{"v":-7.869897891579086,"d":"-8"}},null,null,"CDK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"GEG(pT)YGV(bA)C","Corresponds to amino acid residues G11 to V17; In the protein kinase catalytic domain in subdomain I.","T14 phosphorylation inhibits phosphotransferase activity. This phosphosite is located in the kinase subdomain I region, which is involved in binding the phosphates in the ATP substrate. Phosphorylation regulates cell cycle progression. This is one of the major in vivo phosphorylation sites in CDK1 (≥1823 reports from high throughput mass spectrometry studies).","MYT1 (PKMYT1)","EC 2.7.11.23; EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; CDK/CDK1 subfamily; CDK1 subfamily","P06493","P06493","P06493","P06493","GO:0005813; GO:0097125; GO:0000307; GO:0005829; GO:0005789; GO:0070062; GO:0016020; GO:0030496; GO:0005759; GO:0005739; GO:0072686; GO:0000784; GO:0005654; GO:0005634; GO:0005876","GO:0005524; GO:0003682; GO:0030332; GO:0097472; GO:0004693; GO:0035173; GO:0030544; GO:0004672; GO:0004674; GO:0008353; GO:0001618","GO:0000187; GO:0031145; GO:0031100; GO:0006915; GO:0007569; GO:0051301; GO:0016477; GO:0008283; GO:0070301; GO:0007098; GO:0030261; GO:0097711; GO:0006977; GO:0006281; GO:0006260; GO:0030855; GO:0000086; GO:0090166; GO:0000226; GO:0007095; GO:0007077; GO:0043066; GO:0018105; GO:0018107; GO:0060045; GO:0045740; GO:0010971; GO:0010628; GO:1905448; GO:0033160; GO:1900182; GO:0007344; GO:0065003; GO:0016579; GO:0034501; GO:0006468; GO:0045995; GO:0010389; GO:0010468; GO:0051445; GO:0014038; GO:0014823; GO:0014075; GO:0048678; GO:0046686; GO:0046688; GO:0045471; GO:0014070; GO:0055015"]
[386,200,"PK559","CDK1 (CDC2)","T14","Cyclin-dependent protein-serine kinase 1; Cell division control protein 2 homologue",0,8712,14,725,{"v":6306.05,"d":"6306"},{"v":11080.656208745,"d":"11081"},{"$nulls":3},0,8694,16,633,{"v":5493.174,"d":"5493"},{"v":9597.7565597274,"d":"9598"},{"$nulls":6},0,8490,14,746,{"v":6323.096,"d":"6323"},{"v":10817.8144129744,"d":"10818"},{"$nulls":7},"CDK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"GEG(pT)YGV(bA)C","Corresponds to amino acid residues G11 to V17; In the protein kinase catalytic domain in subdomain I.","T14 phosphorylation inhibits phosphotransferase activity. This phosphosite is located in the kinase subdomain I region, which is involved in binding the phosphates in the ATP substrate. Phosphorylation regulates cell cycle progression. This is one of the major in vivo phosphorylation sites in CDK1 (≥1823 reports from high throughput mass spectrometry studies).","MYT1 (PKMYT1)",null,"P06493","P06493","P06493","P06493"]
[387,201,"PK560","CDK1 (CDC2)","T14+Y15","Cyclin-dependent protein-serine kinase 1; Cell division control protein 2 homologue",0,9788,18,763,{"v":7454.51,"d":"7455"},{"v":13098.669137519,"d":"13099"},{"$f":"(L400+L401)/2","v":{"v":12642.2133301591,"d":"12642"}},{"$f":"SQRT((M400-L400)*(M400-L400))","v":{"v":456.45580735990006,"d":"456"}},{"$f":"N400/M400*100","v":{"v":3.610568778103,"d":"4"}},0,9890,16,732,{"v":7227.768,"d":"7228"},{"v":12628.4653888968,"d":"12628"},{"$f":"(U400+U401)/2","v":{"v":12243.0122656858,"d":"12243"}},{"$f":"SQRT((V400-U400)*(V400-U400))","v":{"v":385.4531232110003,"d":"385"}},{"$f":"W400/V400*100","v":{"v":3.14835201375508,"d":"3"}},{"$f":"X400+O400","v":{"v":6.758920791858079,"d":"7"}},{"$f":"(V400/M400*100)-100","v":{"v":-3.1576833426862834,"d":"-3"}},null,0,10550,20,698,{"v":7349.94,"d":"7350"},{"v":12574.581639516,"d":"12575"},{"$f":"(AG400+AG401)/2","v":{"v":12504.4764914682,"d":"12504"}},{"$f":"SQRT((AH400-AG400)*(AH400-AG400))","v":{"v":70.10514804779996,"d":"70"}},{"$f":"AI400/AH400*100","v":{"v":0.560640408222069,"d":"1"}},{"$f":"AJ400+O400","v":{"v":4.171209186325069,"d":"4"}},{"$f":"(AH400/M400*100)-100","v":{"v":-1.0894994024686895,"d":"-1"}},null,null,"CDK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"EG(pT)(pY)GVV(bA)C","Corresponds to amino acid residues E12 to V18; In the protein kinase catalytic domain in subdomain I.","T14 and Y15 phosphorylation inhibits phosphotransferase activity. These phosphosites are located in the kinase subdomain I region, which is involved in binding the phosphates in the ATP substrate. Phosphorylation regulates cell cycle progression. These are two of the major in vivo phosphorylation sites in CDK1 (≥1823 and ≥3976 reports, respectively, by mass spectrometry).","T14: MYT1 (PKMYT1). Y15: CDK1 (CDC2); Chk1 (CHEK1); MYT1 (PKMYT1); Src; Wee1.","EC 2.7.11.23; EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; CDK/CDK1 subfamily; CDK1 subfamily","P06493","P06493","P06493","P06493","GO:0005813; GO:0097125; GO:0000307; GO:0005829; GO:0005789; GO:0070062; GO:0016020; GO:0030496; GO:0005759; GO:0005739; GO:0072686; GO:0000784; GO:0005654; GO:0005634; GO:0005876","GO:0005524; GO:0003682; GO:0030332; GO:0097472; GO:0004693; GO:0035173; GO:0030544; GO:0004672; GO:0004674; GO:0008353; GO:0001618","GO:0000187; GO:0031145; GO:0031100; GO:0006915; GO:0007569; GO:0051301; GO:0016477; GO:0008283; GO:0070301; GO:0007098; GO:0030261; GO:0097711; GO:0006977; GO:0006281; GO:0006260; GO:0030855; GO:0000086; GO:0090166; GO:0000226; GO:0007095; GO:0007077; GO:0043066; GO:0018105; GO:0018107; GO:0060045; GO:0045740; GO:0010971; GO:0010628; GO:1905448; GO:0033160; GO:1900182; GO:0007344; GO:0065003; GO:0016579; GO:0034501; GO:0006468; GO:0045995; GO:0010389; GO:0010468; GO:0051445; GO:0014038; GO:0014823; GO:0014075; GO:0048678; GO:0046686; GO:0046688; GO:0045471; GO:0014070; GO:0055015"]
[388,201,"PK560","CDK1 (CDC2)","T14+Y15","Cyclin-dependent protein-serine kinase 1; Cell division control protein 2 homologue",0,9492,18,732,{"v":6934.968,"d":"6935"},{"v":12185.7575227992,"d":"12186"},{"$nulls":3},0,9584,12,709,{"v":6786.548,"d":"6787"},{"v":11857.5591424748,"d":"11858"},{"$nulls":6},0,10027,16,726,{"v":7267.986,"d":"7268"},{"v":12434.3713434204,"d":"12434"},{"$nulls":7},"CDK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"EG(pT)(pY)GVV(bA)C","Corresponds to amino acid residues E12 to V18; In the protein kinase catalytic domain in subdomain I.","T14 and Y15 phosphorylation inhibits phosphotransferase activity. These phosphosites are located in the kinase subdomain I region, which is involved in binding the phosphates in the ATP substrate. Phosphorylation regulates cell cycle progression. These are two of the major in vivo phosphorylation sites in CDK1 (≥1823 and ≥3976 reports, respectively, by mass spectrometry).","T14: MYT1 (PKMYT1). Y15: CDK1 (CDC2); Chk1 (CHEK1); MYT1 (PKMYT1); Src; Wee1.",null,"P06493","P06493","P06493","P06493"]
[389,202,"PK007-1","CDK1 (CDC2)","Y15","Cyclin-dependent protein-serine kinase 1; Cell division control protein 2 homologue",0,543,10,385,{"v":205.205,"d":"205"},{"$f":"K402*1.7571469","v":{"v":360.5753296145,"d":"361"}},{"$f":"(L402+L403)/2","v":{"v":318.06203894245,"d":"318"}},{"$f":"SQRT((M402-L402)*(M402-L402))","v":{"v":42.513290672050005,"d":"43"}},{"$f":"N402/M402*100","v":{"v":13.366351675731519,"d":"13"}},0,188,8,319,{"v":57.42,"d":"57"},{"$f":"T402*1.7472151","v":{"v":100.32509104200001,"d":"100"}},{"$f":"(U402+U403)/2","v":{"v":211.0670785102,"d":"211"}},{"$f":"SQRT((V402-U402)*(V402-U402))","v":{"v":110.74198746819998,"d":"111"}},{"$f":"W402/V402*100","v":{"v":52.467674376252035,"d":"52"}},{"$f":"X402+O402","v":{"v":65.83402605198356,"d":"66"}},{"$f":"(V402/M402*100)-100","v":{"v":-33.6396511787468,"d":"-34"}},null,0,466,10,413,{"v":188.328,"d":"188"},{"v":322.1993391792,"d":"322"},{"$f":"(AG402+AG403)/2","v":{"v":287.99106538620003,"d":"288"}},{"$f":"SQRT((AH402-AG402)*(AH402-AG402))","v":{"v":34.20827379299999,"d":"34"}},{"$f":"AI402/AH402*100","v":{"v":11.87824134305216,"d":"12"}},{"$f":"AJ402+O402","v":{"v":25.24459301878368,"d":"25"}},{"$f":"(AH402/M402*100)-100","v":{"v":-9.454436516924602,"d":"-9"}},null,null,"CDK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"Epitope undefined.","Antibody raised against amino acid residues that encompass the Y15 phosphosite.","The effect of Y15 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in CDK1 (≥3976 reports from high throughput mass spectrometry studies).","CDK1 (CDC2); Chk1 (CHEK1); MYT1 (PKMYT1); Src; Wee1","EC 2.7.11.23; EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; CDK/CDK1 subfamily; CDK1 subfamily","P06493","P06493","P06493","P06493","GO:0005813; GO:0097125; GO:0000307; GO:0005829; GO:0005789; GO:0070062; GO:0016020; GO:0030496; GO:0005759; GO:0005739; GO:0072686; GO:0000784; GO:0005654; GO:0005634; GO:0005876","GO:0005524; GO:0003682; GO:0030332; GO:0097472; GO:0004693; GO:0035173; GO:0030544; GO:0004672; GO:0004674; GO:0008353; GO:0001618","GO:0000187; GO:0031145; GO:0031100; GO:0006915; GO:0007569; GO:0051301; GO:0016477; GO:0008283; GO:0070301; GO:0007098; GO:0030261; GO:0097711; GO:0006977; GO:0006281; GO:0006260; GO:0030855; GO:0000086; GO:0090166; GO:0000226; GO:0007095; GO:0007077; GO:0043066; GO:0018105; GO:0018107; GO:0060045; GO:0045740; GO:0010971; GO:0010628; GO:1905448; GO:0033160; GO:1900182; GO:0007344; GO:0065003; GO:0016579; GO:0034501; GO:0006468; GO:0045995; GO:0010389; GO:0010468; GO:0051445; GO:0014038; GO:0014823; GO:0014075; GO:0048678; GO:0046686; GO:0046688; GO:0045471; GO:0014070; GO:0055015"]
[390,202,"PK007-1","CDK1 (CDC2)","Y15","Cyclin-dependent protein-serine kinase 1; Cell division control protein 2 homologue",0,410,14,396,{"v":156.816,"d":"157"},{"v":275.5487482704,"d":"276"},{"$nulls":3},0,516,10,364,{"v":184.184,"d":"184"},{"v":321.8090659784,"d":"322"},{"$nulls":6},0,381,12,402,{"v":148.338,"d":"148"},{"$f":"AF403*1.7108414","v":{"v":253.7827915932,"d":"254"}},{"$nulls":7},"CDK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"Epitope undefined.","Antibody raised against amino acid residues that encompass the Y15 phosphosite.","The effect of Y15 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in CDK1 (≥3976 reports from high throughput mass spectrometry studies).","CDK1 (CDC2); Chk1 (CHEK1); MYT1 (PKMYT1); Src; Wee1",null,"P06493","P06493","P06493","P06493"]
[391,203,"PK008-1","CDK1 (CDC2)","T161","Cyclin-dependent protein-serine kinase 1; Cell division control protein 2 homologue",0,2552,10,370,{"v":940.54,"d":"941"},{"v":1652.666945326,"d":"1653"},{"$f":"(L404+L405)/2","v":{"v":1371.5251984729,"d":"1372"}},{"$f":"SQRT((M404-L404)*(M404-L404))","v":{"v":281.1417468530999,"d":"281"}},{"$f":"N404/M404*100","v":{"v":20.498474775828555,"d":"20"}},0,3593,12,323,{"v":1156.663,"d":"1157"},{"v":2020.9390592113,"d":"2021"},{"$f":"(U404+U405)/2","v":{"v":1621.28893970525,"d":"1621"}},{"$f":"SQRT((V404-U404)*(V404-U404))","v":{"v":399.65011950605003,"d":"400"}},{"$f":"W404/V404*100","v":{"v":24.650147775553588,"d":"25"}},{"$f":"X404+O404","v":{"v":45.14862255138215,"d":"45"}},{"$f":"(V404/M404*100)-100","v":{"v":18.210656392638285,"d":"18"}},null,0,2356,14,375,{"v":878.25,"d":"878"},{"v":1502.54645955,"d":"1503"},{"$f":"(AG404+AG405)/2","v":{"v":1317.9937206285,"d":"1318"}},{"$f":"SQRT((AH404-AG404)*(AH404-AG404))","v":{"v":184.55273892150012,"d":"185"}},{"$f":"AI404/AH404*100","v":{"v":14.002550697547642,"d":"14"}},{"$f":"AJ404+O404","v":{"v":34.501025473376195,"d":"35"}},{"$f":"(AH404/M404*100)-100","v":{"v":-3.9030619272619873,"d":"-4"}},null,null,"CDK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"TY(pT)HE","Corresponds to amino acid residues T159 to E163.","T161 phosphorylation stimulates phosphotransferase activity and protein interaction. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation regulates cell cycle progression, cell growth and molecular association. This is one of the major in vivo phosphorylation sites in CDK1 (≥122 reports from high throughput mass spectrometry studies).","CDK7","EC 2.7.11.23; EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; CDK/CDK1 subfamily; CDK1 subfamily","P06493","P06493","P06493","P06493","GO:0005813; GO:0097125; GO:0000307; GO:0005829; GO:0005789; GO:0070062; GO:0016020; GO:0030496; GO:0005759; GO:0005739; GO:0072686; GO:0000784; GO:0005654; GO:0005634; GO:0005876","GO:0005524; GO:0003682; GO:0030332; GO:0097472; GO:0004693; GO:0035173; GO:0030544; GO:0004672; GO:0004674; GO:0008353; GO:0001618","GO:0000187; GO:0031145; GO:0031100; GO:0006915; GO:0007569; GO:0051301; GO:0016477; GO:0008283; GO:0070301; GO:0007098; GO:0030261; GO:0097711; GO:0006977; GO:0006281; GO:0006260; GO:0030855; GO:0000086; GO:0090166; GO:0000226; GO:0007095; GO:0007077; GO:0043066; GO:0018105; GO:0018107; GO:0060045; GO:0045740; GO:0010971; GO:0010628; GO:1905448; GO:0033160; GO:1900182; GO:0007344; GO:0065003; GO:0016579; GO:0034501; GO:0006468; GO:0045995; GO:0010389; GO:0010468; GO:0051445; GO:0014038; GO:0014823; GO:0014075; GO:0048678; GO:0046686; GO:0046688; GO:0045471; GO:0014070; GO:0055015"]
[392,203,"PK008-1","CDK1 (CDC2)","T161","Cyclin-dependent protein-serine kinase 1; Cell division control protein 2 homologue",0,1658,12,377,{"v":620.542,"d":"621"},{"v":1090.3834516198,"d":"1090"},{"$nulls":3},0,2004,12,351,{"v":699.192,"d":"699"},{"v":1221.6388201992,"d":"1222"},{"$nulls":6},0,1537,14,435,{"v":662.505,"d":"663"},{"v":1133.440981707,"d":"1133"},{"$nulls":7},"CDK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"TY(pT)HE","Corresponds to amino acid residues T159 to E163.","T161 phosphorylation stimulates phosphotransferase activity and protein interaction. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation regulates cell cycle progression, cell growth and molecular association. This is one of the major in vivo phosphorylation sites in CDK1 (≥122 reports from high throughput mass spectrometry studies).","CDK7",null,"P06493","P06493","P06493","P06493"]
[393,204,"PK561","CDK1 (CDC2)","T161","Cyclin-dependent protein-serine kinase 1; Cell division control protein 2 homologue",0,16316,29,903,{"v":14707.161,"d":"14707"},{"v":25842.6423589509,"d":"25843"},{"$f":"(L406+L407)/2","v":{"v":25709.2749092409,"d":"25709"}},{"$f":"SQRT((M406-L406)*(M406-L406))","v":{"v":133.36744971000007,"d":"133"}},{"$f":"N406/M406*100","v":{"v":0.5187522797932457,"d":"1"}},0,15768,24,815,{"v":12831.36,"d":"12831"},{"v":22419.145945536,"d":"22419"},{"$f":"(U406+U407)/2","v":{"v":22764.5633819456,"d":"22765"}},{"$f":"SQRT((V406-U406)*(V406-U406))","v":{"v":345.41743640959976,"d":"345"}},{"$f":"W406/V406*100","v":{"v":1.5173470741088215,"d":"2"}},{"$f":"X406+O406","v":{"v":2.0360993539020673,"d":"2"}},{"$f":"(V406/M406*100)-100","v":{"v":-11.453887897230643,"d":"-11"}},null,0,14420,26,886,{"v":12753.084,"d":"12753"},{"v":21818.5040848776,"d":"21819"},{"$f":"(AG406+AG407)/2","v":{"v":22845.147503031,"d":"22845"}},{"$f":"SQRT((AH406-AG406)*(AH406-AG406))","v":{"v":1026.6434181533987,"d":"1027"}},{"$f":"AI406/AH406*100","v":{"v":4.493923350756163,"d":"4"}},{"$f":"AJ406+O406","v":{"v":5.012675630549409,"d":"5"}},{"$f":"(AH406/M406*100)-100","v":{"v":-11.14044412501272,"d":"-11"}},null,null,"CDK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"RVY(pT)HEV(bA)C","Corresponds to amino acid residues R158 to V164; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T161 phosphorylation stimulates phosphotransferase activity and protein interaction. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation regulates cell cycle progression, cell growth and molecular association. This is one of the major in vivo phosphorylation sites in CDK1 (≥122 reports from high throughput mass spectrometry studies).","CDK7","EC 2.7.11.23; EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; CDK/CDK1 subfamily; CDK1 subfamily","P06493","P06493","P06493","P06493","GO:0005813; GO:0097125; GO:0000307; GO:0005829; GO:0005789; GO:0070062; GO:0016020; GO:0030496; GO:0005759; GO:0005739; GO:0072686; GO:0000784; GO:0005654; GO:0005634; GO:0005876","GO:0005524; GO:0003682; GO:0030332; GO:0097472; GO:0004693; GO:0035173; GO:0030544; GO:0004672; GO:0004674; GO:0008353; GO:0001618","GO:0000187; GO:0031145; GO:0031100; GO:0006915; GO:0007569; GO:0051301; GO:0016477; GO:0008283; GO:0070301; GO:0007098; GO:0030261; GO:0097711; GO:0006977; GO:0006281; GO:0006260; GO:0030855; GO:0000086; GO:0090166; GO:0000226; GO:0007095; GO:0007077; GO:0043066; GO:0018105; GO:0018107; GO:0060045; GO:0045740; GO:0010971; GO:0010628; GO:1905448; GO:0033160; GO:1900182; GO:0007344; GO:0065003; GO:0016579; GO:0034501; GO:0006468; GO:0045995; GO:0010389; GO:0010468; GO:0051445; GO:0014038; GO:0014823; GO:0014075; GO:0048678; GO:0046686; GO:0046688; GO:0045471; GO:0014070; GO:0055015"]
[394,204,"PK561","CDK1 (CDC2)","T161","Cyclin-dependent protein-serine kinase 1; Cell division control protein 2 homologue",0,16587,28,879,{"v":14555.361,"d":"14555"},{"v":25575.9074595309,"d":"25576"},{"$nulls":3},0,15644,28,847,{"v":13226.752,"d":"13227"},{"v":23109.9808183552,"d":"23110"},{"$nulls":6},0,15902,28,879,{"v":13953.246,"d":"13953"},{"v":23871.790921184398,"d":"23872"},{"$nulls":7},"CDK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"RVY(pT)HEV(bA)C","Corresponds to amino acid residues R158 to V164; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T161 phosphorylation stimulates phosphotransferase activity and protein interaction. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation regulates cell cycle progression, cell growth and molecular association. This is one of the major in vivo phosphorylation sites in CDK1 (≥122 reports from high throughput mass spectrometry studies).","CDK7",null,"P06493","P06493","P06493","P06493"]
[395,205,"NK026-6","CDK2","Pan-specific","Cyclin-dependent protein-serine kinase 2",0,424,14,623,{"v":255.43,"d":"255"},{"v":448.828032667,"d":"449"},{"$f":"(L408+L409)/2","v":{"v":525.36320161685,"d":"525"}},{"$f":"SQRT((M408-L408)*(M408-L408))","v":{"v":76.53516894985,"d":"77"}},{"$f":"N408/M408*100","v":{"v":14.568049059071232,"d":"15"}},0,406,14,551,{"v":215.992,"d":"216"},{"v":377.3844838792,"d":"377"},{"$f":"(U408+U409)/2","v":{"v":355.9566378928,"d":"356"}},{"$f":"SQRT((V408-U408)*(V408-U408))","v":{"v":21.427845986399973,"d":"21"}},{"$f":"W408/V408*100","v":{"v":6.019791094007688,"d":"6"}},{"$f":"X408+O408","v":{"v":20.587840153078922,"d":"21"}},{"$f":"(V408/M408*100)-100","v":{"v":-32.24560898111761,"d":"-32"}},null,0,484,14,645,{"v":303.15,"d":"303"},{"v":518.64157041,"d":"519"},{"$f":"(AG408+AG409)/2","v":{"v":542.0253506652,"d":"542"}},{"$f":"SQRT((AH408-AG408)*(AH408-AG408))","v":{"v":23.38378025520001,"d":"23"}},{"$f":"AI408/AH408*100","v":{"v":4.314148817302049,"d":"4"}},{"$f":"AJ408+O408","v":{"v":18.88219787637328,"d":"19"}},{"$f":"(AH408/M408*100)-100","v":{"v":3.1715485586106524,"d":"3"}},null,null,"CDK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"Epitope undefined.",{"$nulls":3},"EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; CDK1 subfamily; CDK/CDK1 subfamily","P24941","P24941","P24941","P24941","GO:0015030; GO:0005813; GO:0000781; GO:0000793; GO:0097123; GO:0097124; GO:0000307; GO:0097134; GO:0097135; GO:0005737; GO:0005829; GO:0005768; GO:0005654; GO:0005634; GO:0005667; GO:0000805; GO:0000806","GO:0005524; GO:0030332; GO:0097472; GO:0004693; GO:0000287; GO:0019904; GO:0004674","GO:0031145; GO:0051301; GO:0071732; GO:0007099; GO:0051298; GO:0006977; GO:0006281; GO:0006260; GO:0000082; GO:0000086; GO:0016572; GO:0051321; GO:0031571; GO:0007275; GO:0000122; GO:0018105; GO:0008284; GO:0032298; GO:0045893; GO:0006813; GO:0006468; GO:0007265; GO:0010389; GO:0060968; GO:1901796; GO:0010033"]
[396,205,"NK026-6","CDK2","Pan-specific","Cyclin-dependent protein-serine kinase 2",0,523,20,681,{"v":342.543,"d":"343"},{"v":601.8983705667,"d":"602"},{"$nulls":3},0,376,12,526,{"v":191.464,"d":"191"},{"v":334.5287919064,"d":"335"},{"$nulls":6},0,506,12,669,{"v":330.486,"d":"330"},{"v":565.4091309204,"d":"565"},{"$nulls":7},"CDK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"Epitope undefined.",{"$nulls":4},"P24941","P24941","P24941","P24941"]
[397,206,"NK026-3","CDK2","Pan-specific","Cyclin-dependent protein-serine kinase 2",0,715,14,399,{"v":279.699,"d":"280"},{"v":491.47223078310003,"d":"491"},{"$f":"(L410+L411)/2","v":{"v":412.18185549405,"d":"412"}},{"$f":"SQRT((M410-L410)*(M410-L410))","v":{"v":79.29037528905002,"d":"79"}},{"$f":"N410/M410*100","v":{"v":19.23674568207542,"d":"19"}},0,872,16,351,{"v":300.456,"d":"300"},{"v":524.9612600856001,"d":"525"},{"$f":"(U410+U411)/2","v":{"v":357.37013490870004,"d":"357"}},{"$f":"SQRT((V410-U410)*(V410-U410))","v":{"v":167.59112517690005,"d":"168"}},{"$f":"W410/V410*100","v":{"v":46.895671687763105,"d":"47"}},{"$f":"X410+O410","v":{"v":66.13241736983852,"d":"66"}},{"$f":"(V410/M410*100)-100","v":{"v":-13.297946004840867,"d":"-13"}},null,0,710,16,382,{"v":265.108,"d":"265"},{"v":453.55774187120005,"d":"454"},{"$f":"(AG410+AG411)/2","v":{"v":403.8714859324,"d":"404"}},{"$f":"SQRT((AH410-AG410)*(AH410-AG410))","v":{"v":49.68625593880006,"d":"50"}},{"$f":"AI410/AH410*100","v":{"v":12.302491676056711,"d":"12"}},{"$f":"AJ410+O410","v":{"v":31.53923735813213,"d":"32"}},{"$f":"(AH410/M410*100)-100","v":{"v":-2.016190050794208,"d":"-2"}},null,null,"CDK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"Epitope undefined.",{"$nulls":3},"EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; CDK1 subfamily; CDK/CDK1 subfamily","P24941","P24941","P24941","P24941","GO:0015030; GO:0005813; GO:0000781; GO:0000793; GO:0097123; GO:0097124; GO:0000307; GO:0097134; GO:0097135; GO:0005737; GO:0005829; GO:0005768; GO:0005654; GO:0005634; GO:0005667; GO:0000805; GO:0000806","GO:0005524; GO:0030332; GO:0097472; GO:0004693; GO:0000287; GO:0019904; GO:0004674","GO:0031145; GO:0051301; GO:0071732; GO:0007099; GO:0051298; GO:0006977; GO:0006281; GO:0006260; GO:0000082; GO:0000086; GO:0016572; GO:0051321; GO:0031571; GO:0007275; GO:0000122; GO:0018105; GO:0008284; GO:0032298; GO:0045893; GO:0006813; GO:0006468; GO:0007265; GO:0010389; GO:0060968; GO:1901796; GO:0010033"]
[398,206,"NK026-3","CDK2","Pan-specific","Cyclin-dependent protein-serine kinase 2",0,466,16,421,{"v":189.45,"d":"189"},{"v":332.891480205,"d":"333"},{"$nulls":3},0,272,14,421,{"v":108.618,"d":"109"},{"v":189.7790097318,"d":"190"},{"$nulls":6},0,468,14,456,{"v":207.024,"d":"207"},{"v":354.1852299936,"d":"354"},{"$nulls":7},"CDK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"Epitope undefined.",{"$nulls":4},"P24941","P24941","P24941","P24941"]
[399,207,"PK568","CDK2","T160","Cyclin-dependent protein-serine kinase 2",0,4500,24,987,{"v":4417.812,"d":"4418"},{"v":7762.7446605828,"d":"7763"},{"$f":"(L412+L413)/2","v":{"v":7807.836564330601,"d":"7808"}},{"$f":"SQRT((M412-L412)*(M412-L412))","v":{"v":45.09190374780064,"d":"45"}},{"$f":"N412/M412*100","v":{"v":0.5775211017325715,"d":"1"}},0,4699,20,907,{"v":4243.853,"d":"4244"},{"v":7414.9240437803,"d":"7415"},{"$f":"(U412+U413)/2","v":{"v":7198.23355347075,"d":"7198"}},{"$f":"SQRT((V412-U412)*(V412-U412))","v":{"v":216.6904903095501,"d":"217"}},{"$f":"W412/V412*100","v":{"v":3.0103286966157015,"d":"3"}},{"$f":"X412+O412","v":{"v":3.587849798348273,"d":"4"}},{"$f":"(V412/M412*100)-100","v":{"v":-7.8075790372555645,"d":"-8"}},null,0,5218,32,1009,{"v":5232.674,"d":"5233"},{"v":8952.2753119036,"d":"8952"},{"$f":"(AG412+AG413)/2","v":{"v":8809.6920787862,"d":"8810"}},{"$f":"SQRT((AH412-AG412)*(AH412-AG412))","v":{"v":142.5832331174006,"d":"143"}},{"$f":"AI412/AH412*100","v":{"v":1.6184814615795937,"d":"2"}},{"$f":"AJ412+O412","v":{"v":2.1960025633121654,"d":"2"}},{"$f":"(AH412/M412*100)-100","v":{"v":12.831409907226885,"d":"13"}},null,null,"CDK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"RTY(pT)HEV(bA)C","Corresponds to amino acid residues R157 to V163; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T160 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in CDK2 (≥267 reports from high throughput mass spectrometry studies).","CCRK (CDK20); CDK2; CDK7; ERK1 (MAPK3); ERK2 (MAPK1)","EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; CDK1 subfamily; CDK/CDK1 subfamily","P24941","P24941","P24941","P24941","GO:0015030; GO:0005813; GO:0000781; GO:0000793; GO:0097123; GO:0097124; GO:0000307; GO:0097134; GO:0097135; GO:0005737; GO:0005829; GO:0005768; GO:0005654; GO:0005634; GO:0005667; GO:0000805; GO:0000806","GO:0005524; GO:0030332; GO:0097472; GO:0004693; GO:0000287; GO:0019904; GO:0004674","GO:0031145; GO:0051301; GO:0071732; GO:0007099; GO:0051298; GO:0006977; GO:0006281; GO:0006260; GO:0000082; GO:0000086; GO:0016572; GO:0051321; GO:0031571; GO:0007275; GO:0000122; GO:0018105; GO:0008284; GO:0032298; GO:0045893; GO:0006813; GO:0006468; GO:0007265; GO:0010389; GO:0060968; GO:1901796; GO:0010033"]
[400,207,"PK568","CDK2","T160","Cyclin-dependent protein-serine kinase 2",0,4550,22,987,{"v":4469.136,"d":"4469"},{"v":7852.9284680784,"d":"7853"},{"$nulls":3},0,4370,22,919,{"v":3995.812,"d":"3996"},{"v":6981.5430631612,"d":"6982"},{"$nulls":6},0,5142,30,991,{"v":5065.992,"d":"5066"},{"v":8667.108845668801,"d":"8667"},{"$nulls":7},"CDK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"RTY(pT)HEV(bA)C","Corresponds to amino acid residues R157 to V163; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T160 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in CDK2 (≥267 reports from high throughput mass spectrometry studies).","CCRK (CDK20); CDK2; CDK7; ERK1 (MAPK3); ERK2 (MAPK1)",null,"P24941","P24941","P24941","P24941"]
[401,208,"NK027-2","CDK4","Pan-specific","Cyclin-dependent protein-serine kinase 4",0,146,18,627,{"v":80.256,"d":"80"},{"v":141.0215816064,"d":"141"},{"$f":"(L414+L415)/2","v":{"v":126.6832629024,"d":"127"}},{"$f":"SQRT((M414-L414)*(M414-L414))","v":{"v":14.338318703999988,"d":"14"}},{"$f":"N414/M414*100","v":{"v":11.318242343541934,"d":"11"}},0,170,18,562,{"v":85.424,"d":"85"},{"v":149.25410270240002,"d":"149"},{"$f":"(U414+U415)/2","v":{"v":126.4564400776,"d":"126"}},{"$f":"SQRT((V414-U414)*(V414-U414))","v":{"v":22.79766262480001,"d":"23"}},{"$f":"W414/V414*100","v":{"v":18.028075605172994,"d":"18"}},{"$f":"X414+O414","v":{"v":29.346317948714926,"d":"29"}},{"$f":"(V414/M414*100)-100","v":{"v":-0.17904719187312423,"d":"-0"}},null,0,164,22,633,{"v":89.886,"d":"90"},{"v":153.7806900804,"d":"154"},{"$f":"(AG414+AG415)/2","v":{"v":135.524301501,"d":"136"}},{"$f":"SQRT((AH414-AG414)*(AH414-AG414))","v":{"v":18.25638857940001,"d":"18"}},{"$f":"AI414/AH414*100","v":{"v":13.470933535315288,"d":"13"}},{"$f":"AJ414+O414","v":{"v":24.789175878857222,"d":"25"}},{"$f":"(AH414/M414*100)-100","v":{"v":6.978852925039789,"d":"7"}},null,null,"CDK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK4",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues at the C-terminus of human CDK4.",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.22; CMGC group; CDK family; CDK4 subfamily; CDK/CDK4 subfamily","P11802","P11802","P11802","P11802","GO:0005923; GO:0000785; GO:0097129; GO:0000307; GO:0005829; GO:0031965; GO:0005730; GO:0005654; GO:0005634; GO:0048471; GO:0005667","GO:0005524; GO:0030332; GO:0004693; GO:0016538; GO:0044877","GO:0060612; GO:0031100; GO:0051301; GO:0032869; GO:0071353; GO:1904637; GO:0071222; GO:1904628; GO:0007623; GO:0000082; GO:0002088; GO:0007275; GO:0071157; GO:0031658; GO:0043065; GO:0045787; GO:0008284; GO:0045793; GO:0048146; GO:0010971; GO:0045727; GO:0006468; GO:0010468; GO:0046626; GO:0046890; GO:0050994; GO:0040014; GO:0042493; GO:0055093; GO:0010288; GO:0010033; GO:0033574; GO:0009636; GO:0007165; GO:0006367"]
[402,208,"NK027-2","CDK4","Pan-specific","Cyclin-dependent protein-serine kinase 4",0,114,18,666,{"v":63.936,"d":"64"},{"v":112.3449441984,"d":"112"},{"$nulls":3},0,110,14,618,{"v":59.328,"d":"59"},{"v":103.65877745280001,"d":"104"},{"$nulls":6},0,120,18,672,{"v":68.544,"d":"69"},{"v":117.2679129216,"d":"117"},{"$nulls":7},"CDK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK4",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues at the C-terminus of human CDK4.",{"$nulls":3},"P11802","P11802","P11802","P11802"]
[403,209,"PK569","CDK4","T172","Cyclin-dependent protein-serine kinase 4",0,13620,20,792,{"v":10771.2,"d":"10771"},{"v":18926.58068928,"d":"18927"},{"$f":"(L416+L417)/2","v":{"v":18671.1723587774,"d":"18671"}},{"$f":"SQRT((M416-L416)*(M416-L416))","v":{"v":255.4083305025997,"d":"255"}},{"$f":"N416/M416*100","v":{"v":1.3679287277455352,"d":"1"}},0,14844,18,656,{"v":9725.856,"d":"9726"},{"v":16993.1624636256,"d":"16993"},{"$f":"(U416+U417)/2","v":{"v":17958.3625235978,"d":"17958"}},{"$f":"SQRT((V416-U416)*(V416-U416))","v":{"v":965.2000599722014,"d":"965"}},{"$f":"W416/V416*100","v":{"v":5.3746551708369905,"d":"5"}},{"$f":"X416+O416","v":{"v":6.7425838985825255,"d":"7"}},{"$f":"(V416/M416*100)-100","v":{"v":-3.8177026138613286,"d":"-4"}},null,0,14146,16,708,{"v":10004.04,"d":"10004"},{"v":17115.325799256003,"d":"17115"},{"$f":"(AG416+AG417)/2","v":{"v":17812.497091438803,"d":"17812"}},{"$f":"SQRT((AH416-AG416)*(AH416-AG416))","v":{"v":697.1712921828002,"d":"697"}},{"$f":"AI416/AH416*100","v":{"v":3.9139447355636667,"d":"4"}},{"$f":"AJ416+O416","v":{"v":5.281873463309202,"d":"5"}},{"$f":"(AH416/M416*100)-100","v":{"v":-4.598936000582356,"d":"-5"}},null,null,"CDK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK4",{"$nulls":5},"MAL(pT)PVV(bA)C","Corresponds to amino acid residues M169 to V175; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T172 stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in CDK4 (≥5 reports from high throughput mass spectrometry studies).","CDK7; JNK1; JNK2","Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.22; CMGC group; CDK family; CDK4 subfamily; CDK/CDK4 subfamily","P11802","P11802","P11802","P11802","GO:0005923; GO:0000785; GO:0097129; GO:0000307; GO:0005829; GO:0031965; GO:0005730; GO:0005654; GO:0005634; GO:0048471; GO:0005667","GO:0005524; GO:0030332; GO:0004693; GO:0016538; GO:0044877","GO:0060612; GO:0031100; GO:0051301; GO:0032869; GO:0071353; GO:1904637; GO:0071222; GO:1904628; GO:0007623; GO:0000082; GO:0002088; GO:0007275; GO:0071157; GO:0031658; GO:0043065; GO:0045787; GO:0008284; GO:0045793; GO:0048146; GO:0010971; GO:0045727; GO:0006468; GO:0010468; GO:0046626; GO:0046890; GO:0050994; GO:0040014; GO:0042493; GO:0055093; GO:0010288; GO:0010033; GO:0033574; GO:0009636; GO:0007165; GO:0006367"]
[404,209,"PK569","CDK4","T172","Cyclin-dependent protein-serine kinase 4",0,13796,24,761,{"v":10480.492,"d":"10480"},{"v":18415.7640282748,"d":"18416"},{"$nulls":3},0,13872,22,782,{"v":10830.7,"d":"10831"},{"v":18923.56258357,"d":"18924"},{"$nulls":6},0,13652,26,794,{"v":10819.044,"d":"10819"},{"v":18509.6683836216,"d":"18510"},{"$nulls":7},"CDK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK4",{"$nulls":5},"MAL(pT)PVV(bA)C","Corresponds to amino acid residues M169 to V175; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T172 stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in CDK4 (≥5 reports from high throughput mass spectrometry studies).","CDK7; JNK1; JNK2",null,"P11802","P11802","P11802","P11802"]
[405,210,"NK028-4","CDK5","Pan-specific","Cyclin-dependent protein-serine kinase 5",0,311,12,653,{"v":195.247,"d":"195"},{"v":343.0776607843,"d":"343"},{"$f":"(L418+L419)/2","v":{"v":295.46688695535,"d":"295"}},{"$f":"SQRT((M418-L418)*(M418-L418))","v":{"v":47.610773828950016,"d":"48"}},{"$f":"N418/M418*100","v":{"v":16.113742666583413,"d":"16"}},0,332,12,520,{"v":166.4,"d":"166"},{"v":290.73659264,"d":"291"},{"$f":"(U418+U419)/2","v":{"v":264.825392707,"d":"265"}},{"$f":"SQRT((V418-U418)*(V418-U418))","v":{"v":25.911199933000034,"d":"26"}},{"$f":"W418/V418*100","v":{"v":9.784258098568332,"d":"10"}},{"$f":"X418+O418","v":{"v":25.898000765151743,"d":"26"}},{"$f":"(V418/M418*100)-100","v":{"v":-10.370534094055841,"d":"-10"}},null,0,352,14,652,{"v":220.376,"d":"220"},{"v":377.0283843664,"d":"377"},{"$f":"(AG418+AG419)/2","v":{"v":322.972639492,"d":"323"}},{"$f":"SQRT((AH418-AG418)*(AH418-AG418))","v":{"v":54.055744874400034,"d":"54"}},{"$f":"AI418/AH418*100","v":{"v":16.73694247271958,"d":"17"}},{"$f":"AJ418+O418","v":{"v":32.850685139302996,"d":"33"}},{"$f":"(AH418/M418*100)-100","v":{"v":9.309250461222263,"d":"9"}},null,null,"CDK5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK5",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues 142-171 of human CDK5.",null,null,"Protein-serine kinase, CMGC group, CDK family, CDK5 subfamily","Q00535","Q00535","Q00535","Q00535","GO:0030424; GO:0030054; GO:0005737; GO:0005829; GO:0030425; GO:0030175; GO:0098978; GO:0030426; GO:0030027; GO:0016020; GO:0005874; GO:0031594; GO:0043025; GO:0043005; GO:0005654; GO:0005634; GO:0043204; GO:0005886; GO:0014069; GO:0045211; GO:0098793; GO:0016533; GO:0098685","GO:0030549; GO:0005524; GO:0004693; GO:0008092; GO:0046875; GO:0005176; GO:0043125; GO:0051879; GO:0016301; GO:0002039; GO:0004672; GO:0019901; GO:0004674; GO:0050321","GO:0048675; GO:0048148; GO:0070509; GO:0007049; GO:0051301; GO:0007160; GO:0008283; GO:1904646; GO:0021954; GO:0021697; GO:0007268; GO:0022038; GO:0030866; GO:0048813; GO:0060079; GO:0021766; GO:0006886; GO:0021819; GO:0000226; GO:0007005; GO:0008045; GO:0030517; GO:0045786; GO:1901215; GO:0046826; GO:0031397; GO:0045861; GO:0031914; GO:0045892; GO:0051402; GO:0030182; GO:0001764; GO:0031175; GO:0006913; GO:0048709; GO:0018105; GO:0018107; GO:0016310; GO:2000251; GO:0045956; GO:0034352; GO:0043525; GO:0032092; GO:0045860; GO:0090314; GO:0046777; GO:0035418; GO:0006468; GO:0032801; GO:0043113; GO:0042981; GO:0071156; GO:0030334; GO:0061001; GO:0016241; GO:1903076; GO:0048167; GO:0051966; GO:1903421; GO:0009611; GO:0048511; GO:0014044; GO:0019233; GO:0042501; GO:0007519; GO:0007416; GO:0098883; GO:0001963; GO:0035249; GO:0048488; GO:0016079; GO:0008542"]
[406,210,"NK028-4","CDK5","Pan-specific","Cyclin-dependent protein-serine kinase 5",0,244,12,608,{"v":141.056,"d":"141"},{"v":247.8561131264,"d":"248"},{"$nulls":3},0,226,14,645,{"v":136.74,"d":"137"},{"v":238.914192774,"d":"239"},{"$nulls":6},0,270,14,614,{"v":157.184,"d":"157"},{"v":268.9168946176,"d":"269"},{"$nulls":7},"CDK5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK5",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues 142-171 of human CDK5.",{"$nulls":3},"Q00535","Q00535","Q00535","Q00535"]
[407,211,"NK028-5","CDK5","Pan-specific","Cyclin-dependent protein-serine kinase 5",0,338,12,656,{"v":213.856,"d":"214"},{"v":375.77640744639996,"d":"376"},{"$f":"(L420+L421)/2","v":{"v":323.8913737832,"d":"324"}},{"$f":"SQRT((M420-L420)*(M420-L420))","v":{"v":51.88503366319998,"d":"52"}},{"$f":"N420/M420*100","v":{"v":16.01926999696193,"d":"16"}},0,225,16,564,{"v":117.876,"d":"118"},{"v":205.95472712760002,"d":"206"},{"$f":"(U420+U421)/2","v":{"v":221.32497836230002,"d":"221"}},{"$f":"SQRT((V420-U420)*(V420-U420))","v":{"v":15.370251234699992,"d":"15"}},{"$f":"W420/V420*100","v":{"v":6.944652767361628,"d":"7"}},{"$f":"X420+O420","v":{"v":22.96392276432356,"d":"23"}},{"$f":"(V420/M420*100)-100","v":{"v":-31.666911725025997,"d":"-32"}},null,0,296,10,567,{"v":162.162,"d":"162"},{"v":277.43346310680005,"d":"277"},{"$f":"(AG420+AG421)/2","v":{"v":299.83693123980004,"d":"300"}},{"$f":"SQRT((AH420-AG420)*(AH420-AG420))","v":{"v":22.40346813299999,"d":"22"}},{"$f":"AI420/AH420*100","v":{"v":7.471884147280846,"d":"7"}},{"$f":"AJ420+O420","v":{"v":23.491154144242778,"d":"23"}},{"$f":"(AH420/M420*100)-100","v":{"v":-7.426700582492515,"d":"-7"}},null,null,"CDK5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK5",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues 1-291 representing full length human CDK5.",null,null,"Protein-serine kinase, CMGC group, CDK family, CDK5 subfamily","Q00535","Q00535","Q00535","Q00535","GO:0030424; GO:0030054; GO:0005737; GO:0005829; GO:0030425; GO:0030175; GO:0098978; GO:0030426; GO:0030027; GO:0016020; GO:0005874; GO:0031594; GO:0043025; GO:0043005; GO:0005654; GO:0005634; GO:0043204; GO:0005886; GO:0014069; GO:0045211; GO:0098793; GO:0016533; GO:0098685","GO:0030549; GO:0005524; GO:0004693; GO:0008092; GO:0046875; GO:0005176; GO:0043125; GO:0051879; GO:0016301; GO:0002039; GO:0004672; GO:0019901; GO:0004674; GO:0050321","GO:0048675; GO:0048148; GO:0070509; GO:0007049; GO:0051301; GO:0007160; GO:0008283; GO:1904646; GO:0021954; GO:0021697; GO:0007268; GO:0022038; GO:0030866; GO:0048813; GO:0060079; GO:0021766; GO:0006886; GO:0021819; GO:0000226; GO:0007005; GO:0008045; GO:0030517; GO:0045786; GO:1901215; GO:0046826; GO:0031397; GO:0045861; GO:0031914; GO:0045892; GO:0051402; GO:0030182; GO:0001764; GO:0031175; GO:0006913; GO:0048709; GO:0018105; GO:0018107; GO:0016310; GO:2000251; GO:0045956; GO:0034352; GO:0043525; GO:0032092; GO:0045860; GO:0090314; GO:0046777; GO:0035418; GO:0006468; GO:0032801; GO:0043113; GO:0042981; GO:0071156; GO:0030334; GO:0061001; GO:0016241; GO:1903076; GO:0048167; GO:0051966; GO:1903421; GO:0009611; GO:0048511; GO:0014044; GO:0019233; GO:0042501; GO:0007519; GO:0007416; GO:0098883; GO:0001963; GO:0035249; GO:0048488; GO:0016079; GO:0008542"]
[408,211,"NK028-5","CDK5","Pan-specific","Cyclin-dependent protein-serine kinase 5",0,186,14,900,{"v":154.8,"d":"155"},{"v":272.00634012,"d":"272"},{"$nulls":3},0,202,12,713,{"v":135.47,"d":"135"},{"v":236.695229597,"d":"237"},{"$nulls":6},0,304,16,654,{"v":188.352,"d":"188"},{"v":322.2403993728,"d":"322"},{"$nulls":7},"CDK5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK5",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues 1-291 representing full length human CDK5.",{"$nulls":3},"Q00535","Q00535","Q00535","Q00535"]
[409,212,"PK570","CDK5","Y15","Cyclin-dependent protein-serine kinase 5",0,6238,18,682,{"v":4242.04,"d":"4242"},{"v":7453.887435676,"d":"7454"},{"$f":"(L422+L423)/2","v":{"v":8031.3052356319,"d":"8031"}},{"$f":"SQRT((M422-L422)*(M422-L422))","v":{"v":577.4177999559006,"d":"577"}},{"$f":"N422/M422*100","v":{"v":7.189588529073874,"d":"7"}},0,6042,20,604,{"v":3637.288,"d":"3637"},{"v":6355.1245166488,"d":"6355"},{"$f":"(U422+U423)/2","v":{"v":7773.358232684899,"d":"7773"}},{"$f":"SQRT((V422-U422)*(V422-U422))","v":{"v":1418.2337160360994,"d":"1418"}},{"$f":"W422/V422*100","v":{"v":18.24480068437866,"d":"18"}},{"$f":"X422+O422","v":{"v":25.434389213452533,"d":"25"}},{"$f":"(V422/M422*100)-100","v":{"v":-3.2117693871549875,"d":"-3"}},null,0,6254,14,692,{"v":4318.08,"d":"4318"},{"v":7387.550032512,"d":"7388"},{"$f":"(AG422+AG423)/2","v":{"v":6969.7394662731,"d":"6970"}},{"$f":"SQRT((AH422-AG422)*(AH422-AG422))","v":{"v":417.8105662388998,"d":"418"}},{"$f":"AI422/AH422*100","v":{"v":5.994636790380831,"d":"6"}},{"$f":"AJ422+O422","v":{"v":13.184225319454704,"d":"13"}},{"$f":"(AH422/M422*100)-100","v":{"v":-13.217848633731776,"d":"-13"}},null,null,"CDK5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK5",{"$nulls":5},"EGT(pY)GTV(bA)C","Corresponds to amino acid residues E12 to V18; In the protein kinase catalytic domain in subdomain I.","Y15 phosphorylation inhibits phosphotransferase activity. This is the major in vivo phosphorylation site in CDK5 (≥915 reports from high throughput mass spectrometry studies).","Abl1; EphA4; Fyn; TrkA (NTRK1)","Protein-serine kinase, CMGC group, CDK family, CDK5 subfamily","Q00535","Q00535","Q00535","Q00535","GO:0030424; GO:0030054; GO:0005737; GO:0005829; GO:0030425; GO:0030175; GO:0098978; GO:0030426; GO:0030027; GO:0016020; GO:0005874; GO:0031594; GO:0043025; GO:0043005; GO:0005654; GO:0005634; GO:0043204; GO:0005886; GO:0014069; GO:0045211; GO:0098793; GO:0016533; GO:0098685","GO:0030549; GO:0005524; GO:0004693; GO:0008092; GO:0046875; GO:0005176; GO:0043125; GO:0051879; GO:0016301; GO:0002039; GO:0004672; GO:0019901; GO:0004674; GO:0050321","GO:0048675; GO:0048148; GO:0070509; GO:0007049; GO:0051301; GO:0007160; GO:0008283; GO:1904646; GO:0021954; GO:0021697; GO:0007268; GO:0022038; GO:0030866; GO:0048813; GO:0060079; GO:0021766; GO:0006886; GO:0021819; GO:0000226; GO:0007005; GO:0008045; GO:0030517; GO:0045786; GO:1901215; GO:0046826; GO:0031397; GO:0045861; GO:0031914; GO:0045892; GO:0051402; GO:0030182; GO:0001764; GO:0031175; GO:0006913; GO:0048709; GO:0018105; GO:0018107; GO:0016310; GO:2000251; GO:0045956; GO:0034352; GO:0043525; GO:0032092; GO:0045860; GO:0090314; GO:0046777; GO:0035418; GO:0006468; GO:0032801; GO:0043113; GO:0042981; GO:0071156; GO:0030334; GO:0061001; GO:0016241; GO:1903076; GO:0048167; GO:0051966; GO:1903421; GO:0009611; GO:0048511; GO:0014044; GO:0019233; GO:0042501; GO:0007519; GO:0007416; GO:0098883; GO:0001963; GO:0035249; GO:0048488; GO:0016079; GO:0008542"]
[410,212,"PK570","CDK5","Y15","Cyclin-dependent protein-serine kinase 5",0,7035,16,698,{"v":4899.262,"d":"4899"},{"v":8608.7230355878,"d":"8609"},{"$nulls":3},0,7480,18,705,{"v":5260.71,"d":"5261"},{"v":9191.591948721,"d":"9192"},{"$nulls":6},0,6365,14,603,{"v":3829.653,"d":"3830"},{"v":6551.9289000342,"d":"6552"},{"$nulls":7},"CDK5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK5",{"$nulls":5},"EGT(pY)GTV(bA)C","Corresponds to amino acid residues E12 to V18; In the protein kinase catalytic domain in subdomain I.","Y15 phosphorylation inhibits phosphotransferase activity. This is the major in vivo phosphorylation site in CDK5 (≥915 reports from high throughput mass spectrometry studies).","Abl1; EphA4; Fyn; TrkA (NTRK1)",null,"Q00535","Q00535","Q00535","Q00535"]
[411,213,"PK179","CDK5","S159","Cyclin-dependent protein-serine kinase 5",0,282,10,576,{"v":156.672,"d":"157"},{"v":275.2957191168,"d":"275"},{"$f":"(L424+L425)/2","v":{"v":281.4527618544,"d":"281"}},{"$f":"SQRT((M424-L424)*(M424-L424))","v":{"v":6.1570427376000225,"d":"6"}},{"$f":"N424/M424*100","v":{"v":2.187593646988321,"d":"2"}},0,248,14,591,{"v":138.294,"d":"138"},{"v":241.62936503940003,"d":"242"},{"$f":"(U424+U425)/2","v":{"v":212.36700654460003,"d":"212"}},{"$f":"SQRT((V424-U424)*(V424-U424))","v":{"v":29.262358494799997,"d":"29"}},{"$f":"W424/V424*100","v":{"v":13.779145344149537,"d":"14"}},{"$f":"X424+O424","v":{"v":15.966738991137857,"d":"16"}},{"$f":"(V424/M424*100)-100","v":{"v":-24.54612804458432,"d":"-25"}},null,0,320,14,560,{"v":171.36,"d":"171"},{"v":293.169782304,"d":"293"},{"$f":"(AG424+AG425)/2","v":{"v":279.850882005,"d":"280"}},{"$f":"SQRT((AH424-AG424)*(AH424-AG424))","v":{"v":13.318900299000006,"d":"13"}},{"$f":"AI424/AH424*100","v":{"v":4.759284731774417,"d":"5"}},{"$f":"AJ424+O424","v":{"v":6.946878378762738,"d":"7"}},{"$f":"(AH424/M424*100)-100","v":{"v":-0.5691469640751592,"d":"-1"}},null,null,"CDK5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK5",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues 142-171 of CDK5 with phosphorylated S159.","S159 phosphorylation stimulates phosphotransferase activity. Phosphorylation of this site in CDK5 has apparently not been detected in high throughput mass spectrometry studies).","CDK7; CK1a1 (CSNK1A1)","Protein-serine kinase, CMGC group, CDK family, CDK5 subfamily","Q00535","Q00535","Q00535","Q00535","GO:0030424; GO:0030054; GO:0005737; GO:0005829; GO:0030425; GO:0030175; GO:0098978; GO:0030426; GO:0030027; GO:0016020; GO:0005874; GO:0031594; GO:0043025; GO:0043005; GO:0005654; GO:0005634; GO:0043204; GO:0005886; GO:0014069; GO:0045211; GO:0098793; GO:0016533; GO:0098685","GO:0030549; GO:0005524; GO:0004693; GO:0008092; GO:0046875; GO:0005176; GO:0043125; GO:0051879; GO:0016301; GO:0002039; GO:0004672; GO:0019901; GO:0004674; GO:0050321","GO:0048675; GO:0048148; GO:0070509; GO:0007049; GO:0051301; GO:0007160; GO:0008283; GO:1904646; GO:0021954; GO:0021697; GO:0007268; GO:0022038; GO:0030866; GO:0048813; GO:0060079; GO:0021766; GO:0006886; GO:0021819; GO:0000226; GO:0007005; GO:0008045; GO:0030517; GO:0045786; GO:1901215; GO:0046826; GO:0031397; GO:0045861; GO:0031914; GO:0045892; GO:0051402; GO:0030182; GO:0001764; GO:0031175; GO:0006913; GO:0048709; GO:0018105; GO:0018107; GO:0016310; GO:2000251; GO:0045956; GO:0034352; GO:0043525; GO:0032092; GO:0045860; GO:0090314; GO:0046777; GO:0035418; GO:0006468; GO:0032801; GO:0043113; GO:0042981; GO:0071156; GO:0030334; GO:0061001; GO:0016241; GO:1903076; GO:0048167; GO:0051966; GO:1903421; GO:0009611; GO:0048511; GO:0014044; GO:0019233; GO:0042501; GO:0007519; GO:0007416; GO:0098883; GO:0001963; GO:0035249; GO:0048488; GO:0016079; GO:0008542"]
[412,213,"PK179","CDK5","S159","Cyclin-dependent protein-serine kinase 5",0,262,14,660,{"v":163.68,"d":"164"},{"v":287.609804592,"d":"288"},{"$nulls":3},0,136,14,859,{"v":104.798,"d":"105"},{"v":183.1046480498,"d":"183"},{"$nulls":6},0,284,14,577,{"v":155.79,"d":"156"},{"v":266.531981706,"d":"267"},{"$nulls":7},"CDK5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK5",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues 142-171 of CDK5 with phosphorylated S159.","S159 phosphorylation stimulates phosphotransferase activity. Phosphorylation of this site in CDK5 has apparently not been detected in high throughput mass spectrometry studies).","CDK7; CK1a1 (CSNK1A1)",null,"Q00535","Q00535","Q00535","Q00535"]
[413,214,"NK029-3","CDK6","Pan-specific","Cyclin-dependent protein-serine kinase 6",0,424,12,702,{"v":289.224,"d":"289"},{"v":508.20905500559996,"d":"508"},{"$f":"(L426+L427)/2","v":{"v":430.7346910377,"d":"431"}},{"$f":"SQRT((M426-L426)*(M426-L426))","v":{"v":77.47436396789999,"d":"77"}},{"$f":"N426/M426*100","v":{"v":17.98656239673973,"d":"18"}},0,418,16,658,{"v":264.516,"d":"265"},{"v":462.1663493916,"d":"462"},{"$f":"(U426+U427)/2","v":{"v":432.73276381700003,"d":"433"}},{"$f":"SQRT((V426-U426)*(V426-U426))","v":{"v":29.433585574599988,"d":"29"}},{"$f":"W426/V426*100","v":{"v":6.80179270803892,"d":"7"}},{"$f":"X426+O426","v":{"v":24.78835510477865,"d":"25"}},{"$f":"(V426/M426*100)-100","v":{"v":0.4638755180100418,"d":"0"}},null,0,502,16,687,{"v":333.882,"d":"334"},{"v":571.2191483148,"d":"571"},{"$f":"(AG426+AG427)/2","v":{"v":497.1722216814,"d":"497"}},{"$f":"SQRT((AH426-AG426)*(AH426-AG426))","v":{"v":74.0469266334,"d":"74"}},{"$f":"AI426/AH426*100","v":{"v":14.893617021276597,"d":"15"}},{"$f":"AJ426+O426","v":{"v":32.880179418016326,"d":"33"}},{"$f":"(AH426/M426*100)-100","v":{"v":15.424234923739903,"d":"15"}},null,null,"CDK6","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK4",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues at the C-terminus of human CDK6.",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.22; CMGC domain target; CMGC</A> group; CDK family; CDK4 subfamily; CDK/CDK4 subfamily","Q00534","Q00534","Q00534","Q00534","GO:0005813; GO:0000307; GO:0005737; GO:0005829; GO:0005654; GO:0005634; GO:0001726","GO:0005524; GO:0030332; GO:0004693; GO:0098770","GO:0014002; GO:0007050; GO:0043697; GO:0051301; GO:0021542; GO:0000082; GO:0048699; GO:0042063; GO:0021670; GO:0045786; GO:0045596; GO:0008285; GO:2000773; GO:0031658; GO:0050680; GO:0045656; GO:0045638; GO:0045668; GO:0001954; GO:0048146; GO:0006468; GO:2000145; GO:0045646; GO:0010389; GO:0010468; GO:0009615; GO:0007165; GO:0003323"]
[414,214,"NK029-3","CDK6","Pan-specific","Cyclin-dependent protein-serine kinase 6",0,318,12,657,{"v":201.042,"d":"201"},{"v":353.2603270698,"d":"353"},{"$nulls":3},0,356,12,671,{"v":230.824,"d":"231"},{"v":403.29917824240005,"d":"403"},{"$nulls":6},0,372,12,687,{"v":247.32,"d":"247"},{"v":423.125295048,"d":"423"},{"$nulls":7},"CDK6","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK4",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues at the C-terminus of human CDK6.",{"$nulls":3},"Q00534","Q00534","Q00534","Q00534"]
[415,215,"NK029-4","CDK6","Pan-specific","Cyclin-dependent protein-serine kinase 6",0,52,6,591,{"v":27.186,"d":"27"},{"v":47.7697956234,"d":"48"},{"$f":"(L428+L429)/2","v":{"v":42.361297465199996,"d":"42"}},{"$f":"SQRT((M428-L428)*(M428-L428))","v":{"v":5.408498158200004,"d":"5"}},{"$f":"N428/M428*100","v":{"v":12.767546042807377,"d":"13"}},0,46,10,668,{"v":24.048,"d":"24"},{"v":42.0170287248,"d":"42"},{"$f":"(U428+U429)/2","v":{"v":40.612267784400004,"d":"41"}},{"$f":"SQRT((V428-U428)*(V428-U428))","v":{"v":1.4047609403999957,"d":"1"}},{"$f":"W428/V428*100","v":{"v":3.4589571502323073,"d":"3"}},{"$f":"X428+O428","v":{"v":16.226503193039683,"d":"16"}},{"$f":"(V428/M428*100)-100","v":{"v":-4.128838787897919,"d":"-4"}},null,0,48,6,666,{"v":27.972,"d":"28"},{"v":47.8556556408,"d":"48"},{"$f":"(AG428+AG429)/2","v":{"v":50.750399289600004,"d":"51"}},{"$f":"SQRT((AH428-AG428)*(AH428-AG428))","v":{"v":2.8947436488000022,"d":"3"}},{"$f":"AI428/AH428*100","v":{"v":5.703883495145635,"d":"6"}},{"$f":"AJ428+O428","v":{"v":18.47142953795301,"d":"18"}},{"$f":"(AH428/M428*100)-100","v":{"v":19.803694235974945,"d":"20"}},null,null,"CDK6","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK4",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues 1-326 representing full length human CDK6.",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.22; CMGC domain target; CMGC</A> group; CDK family; CDK4 subfamily; CDK/CDK4 subfamily","Q00534","Q00534","Q00534","Q00534","GO:0005813; GO:0000307; GO:0005737; GO:0005829; GO:0005654; GO:0005634; GO:0001726","GO:0005524; GO:0030332; GO:0004693; GO:0098770","GO:0014002; GO:0007050; GO:0043697; GO:0051301; GO:0021542; GO:0000082; GO:0048699; GO:0042063; GO:0021670; GO:0045786; GO:0045596; GO:0008285; GO:2000773; GO:0031658; GO:0050680; GO:0045656; GO:0045638; GO:0045668; GO:0001954; GO:0048146; GO:0006468; GO:2000145; GO:0045646; GO:0010389; GO:0010468; GO:0009615; GO:0007165; GO:0003323"]
[416,215,"NK029-4","CDK6","Pan-specific","Cyclin-dependent protein-serine kinase 6",0,38,8,701,{"v":21.03,"d":"21"},{"v":36.952799307,"d":"37"},{"$nulls":3},0,54,10,510,{"v":22.44,"d":"22"},{"v":39.207506844,"d":"39"},{"$nulls":6},0,60,8,603,{"v":31.356,"d":"31"},{"v":53.64514293840001,"d":"54"},{"$nulls":7},"CDK6","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK4",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues 1-326 representing full length human CDK6.",{"$nulls":3},"Q00534","Q00534","Q00534","Q00534"]
[417,216,"PK571","CDK6","Y13","Cyclin-dependent protein-serine kinase 6",0,8346,15,793,{"v":6606.483,"d":"6606"},{"v":11608.5611233527,"d":"11609"},{"$f":"(L430+L431)/2","v":{"v":11006.79893167075,"d":"11007"}},{"$f":"SQRT((M430-L430)*(M430-L430))","v":{"v":601.7621916819498,"d":"602"}},{"$f":"N430/M430*100","v":{"v":5.467186194802296,"d":"5"}},0,7949,18,656,{"v":5202.736,"d":"5203"},{"v":9090.2989005136,"d":"9090"},{"$f":"(U430+U431)/2","v":{"v":10040.9271865518,"d":"10041"}},{"$f":"SQRT((V430-U430)*(V430-U430))","v":{"v":950.6282860381998,"d":"951"}},{"$f":"W430/V430*100","v":{"v":9.467534903663207,"d":"9"}},{"$f":"X430+O430","v":{"v":14.934721098465502,"d":"15"}},{"$f":"(V430/M430*100)-100","v":{"v":-8.775228393968106,"d":"-9"}},null,0,7920,18,783,{"v":6187.266,"d":"6187"},{"v":10585.4308256124,"d":"10585"},{"$f":"(AG430+AG431)/2","v":{"v":10617.1002107678,"d":"10617"}},{"$f":"SQRT((AH430-AG430)*(AH430-AG430))","v":{"v":31.66938515539914,"d":"32"}},{"$f":"AI430/AH430*100","v":{"v":0.2982865803911339,"d":"0"}},{"$f":"AJ430+O430","v":{"v":5.76547277519343,"d":"6"}},{"$f":"(AH430/M430*100)-100","v":{"v":-3.5405272988283514,"d":"-4"}},null,null,"CDK6","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK4",{"$nulls":5},"DQQ(pY)ECV(bA)C","Corresponds to amino acid residues D10 to V16; In the protein kinase catalytic domain in subdomain I.","Y13 phosphorylation inhibits phosphotransferase activity. This is the major in vivo phosphorylation site in CDK6(≥288 reports from high throughput mass spectrometry studies).",null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.22; CMGC domain target; CMGC</A> group; CDK family; CDK4 subfamily; CDK/CDK4 subfamily","Q00534","Q00534","Q00534","Q00534","GO:0005813; GO:0000307; GO:0005737; GO:0005829; GO:0005654; GO:0005634; GO:0001726","GO:0005524; GO:0030332; GO:0004693; GO:0098770","GO:0014002; GO:0007050; GO:0043697; GO:0051301; GO:0021542; GO:0000082; GO:0048699; GO:0042063; GO:0021670; GO:0045786; GO:0045596; GO:0008285; GO:2000773; GO:0031658; GO:0050680; GO:0045656; GO:0045638; GO:0045668; GO:0001954; GO:0048146; GO:0006468; GO:2000145; GO:0045646; GO:0010389; GO:0010468; GO:0009615; GO:0007165; GO:0003323"]
[418,216,"PK571","CDK6","Y13","Cyclin-dependent protein-serine kinase 6",0,8154,20,728,{"v":5921.552,"d":"5922"},{"v":10405.0367399888,"d":"10405"},{"$nulls":3},0,8198,28,770,{"v":6290.9,"d":"6291"},{"v":10991.55547259,"d":"10992"},{"$nulls":6},0,8312,24,751,{"v":6224.288,"d":"6224"},{"v":10648.7695959232,"d":"10649"},{"$nulls":7},"CDK6","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK4",{"$nulls":5},"DQQ(pY)ECV(bA)C","Corresponds to amino acid residues D10 to V16; In the protein kinase catalytic domain in subdomain I.","Y13 phosphorylation inhibits phosphotransferase activity. This is the major in vivo phosphorylation site in CDK6(≥288 reports from high throughput mass spectrometry studies).",null,null,"Q00534","Q00534","Q00534","Q00534"]
[419,217,"PK572","CDK6","Y24","Cyclin-dependent protein-serine kinase 6",0,3686,26,930,{"v":3403.8,"d":"3404"},{"v":5980.97661822,"d":"5981"},{"$f":"(L432+L433)/2","v":{"v":6101.183037649,"d":"6101"}},{"$f":"SQRT((M432-L432)*(M432-L432))","v":{"v":120.20641942899965,"d":"120"}},{"$f":"N432/M432*100","v":{"v":1.970214935156566,"d":"2"}},0,3915,30,899,{"v":3492.615,"d":"3493"},{"v":6102.3496664865,"d":"6102"},{"$f":"(U432+U433)/2","v":{"v":5941.61373975445,"d":"5942"}},{"$f":"SQRT((V432-U432)*(V432-U432))","v":{"v":160.73592673204985,"d":"161"}},{"$f":"W432/V432*100","v":{"v":2.7052570862456067,"d":"3"}},{"$f":"X432+O432","v":{"v":4.6754720214021726,"d":"5"}},{"$f":"(V432/M432*100)-100","v":{"v":-2.615382900494609,"d":"-3"}},null,0,3986,42,956,{"v":3770.464,"d":"3770"},{"v":6450.6659084096,"d":"6451"},{"$f":"(AG432+AG433)/2","v":{"v":6301.7730922089995,"d":"6302"}},{"$f":"SQRT((AH432-AG432)*(AH432-AG432))","v":{"v":148.89281620060046,"d":"149"}},{"$f":"AI432/AH432*100","v":{"v":2.3627130653859854,"d":"2"}},{"$f":"AJ432+O432","v":{"v":4.332928000542552,"d":"4"}},{"$f":"(AH432/M432*100)-100","v":{"v":3.287723927018817,"d":"3"}},null,null,"CDK6","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK4",{"$nulls":5},"EGA(pY)GKV(bA)C","Corresponds to amino acid residues E21 to V27; In the protein kinase catalytic domain in subdomain I.","Y24 phosphorylation is predicted to be inhibitory for phosphotransferase activity. This phosphosite is located in the kinase subdomain I region, which is involved in binding the phosphates in the ATP substrate. This is one of the major in vivo phosphorylation sites in CDK6 (≥243 reports from high throughput mass spectrometry studies).",null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.22; CMGC domain target; CMGC</A> group; CDK family; CDK4 subfamily; CDK/CDK4 subfamily","Q00534","Q00534","Q00534","Q00534","GO:0005813; GO:0000307; GO:0005737; GO:0005829; GO:0005654; GO:0005634; GO:0001726","GO:0005524; GO:0030332; GO:0004693; GO:0098770","GO:0014002; GO:0007050; GO:0043697; GO:0051301; GO:0021542; GO:0000082; GO:0048699; GO:0042063; GO:0021670; GO:0045786; GO:0045596; GO:0008285; GO:2000773; GO:0031658; GO:0050680; GO:0045656; GO:0045638; GO:0045668; GO:0001954; GO:0048146; GO:0006468; GO:2000145; GO:0045646; GO:0010389; GO:0010468; GO:0009615; GO:0007165; GO:0003323"]
[420,217,"PK572","CDK6","Y24","Cyclin-dependent protein-serine kinase 6",0,3606,26,989,{"v":3540.62,"d":"3541"},{"v":6221.389457077999,"d":"6221"},{"$nulls":3},0,3456,38,968,{"v":3308.624,"d":"3309"},{"v":5780.8778130224,"d":"5781"},{"$nulls":6},0,3794,36,957,{"v":3596.406,"d":"3596"},{"v":6152.8802760084,"d":"6153"},{"$nulls":7},"CDK6","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK4",{"$nulls":5},"EGA(pY)GKV(bA)C","Corresponds to amino acid residues E21 to V27; In the protein kinase catalytic domain in subdomain I.","Y24 phosphorylation is predicted to be inhibitory for phosphotransferase activity. This phosphosite is located in the kinase subdomain I region, which is involved in binding the phosphates in the ATP substrate. This is one of the major in vivo phosphorylation sites in CDK6 (≥243 reports from high throughput mass spectrometry studies).",null,null,"Q00534","Q00534","Q00534","Q00534"]
[421,218,"NK030-2","CDK7","Pan-specific","Cyclin-dependent protein-serine kinase 7",0,1284,20,843,{"v":1065.552,"d":"1066"},{"v":1872.3313935887998,"d":"1872"},{"$f":"(L434+L435)/2","v":{"v":1782.9549950937499,"d":"1783"}},{"$f":"SQRT((M434-L434)*(M434-L434))","v":{"v":89.3763984950499,"d":"89"}},{"$f":"N434/M434*100","v":{"v":5.012824145364947,"d":"5"}},0,1411,14,703,{"v":982.091,"d":"982"},{"v":1715.9242247741001,"d":"1716"},{"$f":"(U434+U435)/2","v":{"v":1371.0711388418001,"d":"1371"}},{"$f":"SQRT((V434-U434)*(V434-U434))","v":{"v":344.8530859323,"d":"345"}},{"$f":"W434/V434*100","v":{"v":25.152092853738537,"d":"25"}},{"$f":"X434+O434","v":{"v":30.164916999103482,"d":"30"}},{"$f":"(V434/M434*100)-100","v":{"v":-23.101191975420136,"d":"-23"}},null,0,1509,20,902,{"v":1343.078,"d":"1343"},{"v":2297.7934458292,"d":"2298"},{"$f":"(AG434+AG435)/2","v":{"v":2058.8504925396,"d":"2059"}},{"$f":"SQRT((AH434-AG434)*(AH434-AG434))","v":{"v":238.94295328960015,"d":"239"}},{"$f":"AI434/AH434*100","v":{"v":11.605648596409887,"d":"12"}},{"$f":"AJ434+O434","v":{"v":16.618472741774834,"d":"17"}},{"$f":"(AH434/M434*100)-100","v":{"v":15.474058414544743,"d":"15"}},null,null,"CDK7","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK7",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues 1-346 representing full length CDK7.",null,null,"Protein-serine kinase, CMGC group, CDK family, CDK7 subfamily","P50613","P50613","P50613","P50613","GO:0019907; GO:0005737; GO:0005675; GO:0005654; GO:0005634; GO:0048471; GO:0070985","GO:0050681; GO:0005524; GO:0004693; GO:0008094; GO:0016301; GO:0008022; GO:0004672; GO:0004674; GO:0008353; GO:0003713","GO:0006370; GO:0030521; GO:0007050; GO:0051301; GO:0008283; GO:0006294; GO:0045893; GO:0045944; GO:0050821; GO:0000079; GO:0042795; GO:0006363; GO:0006366; GO:0006283; GO:0006368; GO:0006367; GO:0006361"]
[422,218,"NK030-2","CDK7","Pan-specific","Cyclin-dependent protein-serine kinase 7",0,1115,16,877,{"v":963.823,"d":"964"},{"v":1693.5785965987,"d":"1694"},{"$nulls":3},0,924,19,649,{"v":587.345,"d":"587"},{"v":1026.2180529095,"d":"1026"},{"$nulls":6},0,1274,24,851,{"v":1063.75,"d":"1064"},{"v":1819.9075392500001,"d":"1820"},{"$nulls":7},"CDK7","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK7",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues 1-346 representing full length CDK7.",{"$nulls":3},"P50613","P50613","P50613","P50613"]
[423,219,"NK030-1","CDK7","Pan-specific","Cyclin-dependent protein-serine kinase 7",0,852,14,681,{"v":570.678,"d":"571"},{"v":1002.7650785981999,"d":"1003"},{"$f":"(L436+L437)/2","v":{"v":1025.1528872510999,"d":"1025"}},{"$f":"SQRT((M436-L436)*(M436-L436))","v":{"v":22.387808652899935,"d":"22"}},{"$f":"N436/M436*100","v":{"v":2.1838507144950654,"d":"2"}},0,822,18,614,{"v":493.656,"d":"494"},{"v":862.5232174056,"d":"863"},{"$f":"(U436+U437)/2","v":{"v":750.7730868246999,"d":"751"}},{"$f":"SQRT((V436-U436)*(V436-U436))","v":{"v":111.75013058090008,"d":"112"}},{"$f":"W436/V436*100","v":{"v":14.884674549740875,"d":"15"}},{"$f":"X436+O436","v":{"v":17.06852526423594,"d":"17"}},{"$f":"(V436/M436*100)-100","v":{"v":-26.7647688299583,"d":"-27"}},null,0,1078,16,644,{"v":683.928,"d":"684"},{"v":1170.0923370192,"d":"1170"},{"$f":"(AG436+AG437)/2","v":{"v":1158.4723022304001,"d":"1158"}},{"$f":"SQRT((AH436-AG436)*(AH436-AG436))","v":{"v":11.620034788799785,"d":"12"}},{"$f":"AI436/AH436*100","v":{"v":1.003048132132965,"d":"1"}},{"$f":"AJ436+O436","v":{"v":3.18689884662803,"d":"3"}},{"$f":"(AH436/M436*100)-100","v":{"v":13.00483241448893,"d":"13"}},null,null,"CDK7","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK7",{"$nulls":5},"VATKRKRAEALEQGC","Corresponds to amino acid residues V325 to Q338; Pre-C-terminus.",null,null,"Protein-serine kinase, CMGC group, CDK family, CDK7 subfamily","P50613","P50613","P50613","P50613","GO:0019907; GO:0005737; GO:0005675; GO:0005654; GO:0005634; GO:0048471; GO:0070985","GO:0050681; GO:0005524; GO:0004693; GO:0008094; GO:0016301; GO:0008022; GO:0004672; GO:0004674; GO:0008353; GO:0003713","GO:0006370; GO:0030521; GO:0007050; GO:0051301; GO:0008283; GO:0006294; GO:0045893; GO:0045944; GO:0050821; GO:0000079; GO:0042795; GO:0006363; GO:0006366; GO:0006283; GO:0006368; GO:0006367; GO:0006361"]
[424,219,"NK030-1","CDK7","Pan-specific","Cyclin-dependent protein-serine kinase 7",0,978,18,621,{"v":596.16,"d":"596"},{"v":1047.540695904,"d":"1048"},{"$nulls":3},0,712,18,527,{"v":365.738,"d":"366"},{"v":639.0229562438,"d":"639"},{"$nulls":6},0,1074,20,636,{"v":670.344,"d":"670"},{"v":1146.8522674416001,"d":"1147"},{"$nulls":7},"CDK7","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK7",{"$nulls":5},"VATKRKRAEALEQGC","Corresponds to amino acid residues V325 to Q338; Pre-C-terminus.",{"$nulls":3},"P50613","P50613","P50613","P50613"]
[425,220,"PK573","CDK7","T170","Cyclin-dependent protein-serine kinase 7",0,5006,20,867,{"v":4322.862,"d":"4323"},{"v":7595.9035624278,"d":"7596"},{"$f":"(L438+L439)/2","v":{"v":7745.858478873801,"d":"7746"}},{"$f":"SQRT((M438-L438)*(M438-L438))","v":{"v":149.95491644600042,"d":"150"}},{"$f":"N438/M438*100","v":{"v":1.93593669255629,"d":"2"}},0,5202,18,739,{"v":3830.976,"d":"3831"},{"v":6693.5391149376,"d":"6694"},{"$f":"(U438+U439)/2","v":{"v":7020.0971115577995,"d":"7020"}},{"$f":"SQRT((V438-U438)*(V438-U438))","v":{"v":326.55799662019945,"d":"327"}},{"$f":"W438/V438*100","v":{"v":4.651758963313463,"d":"5"}},{"$f":"X438+O438","v":{"v":6.587695655869753,"d":"7"}},{"$f":"(V438/M438*100)-100","v":{"v":-9.369669860293158,"d":"-9"}},null,0,5574,16,844,{"v":4690.952,"d":"4691"},{"v":8025.4748870128005,"d":"8025"},{"$f":"(AG438+AG439)/2","v":{"v":7966.0385459354,"d":"7966"}},{"$f":"SQRT((AH438-AG438)*(AH438-AG438))","v":{"v":59.43634107740036,"d":"59"}},{"$f":"AI438/AH438*100","v":{"v":0.7461216856366735,"d":"1"}},{"$f":"AJ438+O438","v":{"v":2.6820583781929637,"d":"3"}},{"$f":"(AH438/M438*100)-100","v":{"v":2.842552154317346,"d":"3"}},null,null,"CDK7","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK7",{"$nulls":5},"RAY(pY)HQV(bA)C","Corresponds to amino acid residues R167 to V173; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T170 phosphorylation stimulates phosphotransferase activity and regulates transcription. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation site in CDK7 (≥152 reports from high throughput mass spectrometry studies).","CDK1 (CDC2); CDK2; PKCi","Protein-serine kinase, CMGC group, CDK family, CDK7 subfamily","P50613","P50613","P50613","P50613","GO:0019907; GO:0005737; GO:0005675; GO:0005654; GO:0005634; GO:0048471; GO:0070985","GO:0050681; GO:0005524; GO:0004693; GO:0008094; GO:0016301; GO:0008022; GO:0004672; GO:0004674; GO:0008353; GO:0003713","GO:0006370; GO:0030521; GO:0007050; GO:0051301; GO:0008283; GO:0006294; GO:0045893; GO:0045944; GO:0050821; GO:0000079; GO:0042795; GO:0006363; GO:0006366; GO:0006283; GO:0006368; GO:0006367; GO:0006361"]
[426,220,"PK573","CDK7","T170","Cyclin-dependent protein-serine kinase 7",0,5102,36,887,{"v":4493.542,"d":"4494"},{"v":7895.8133953198,"d":"7896"},{"$nulls":3},0,5092,26,830,{"v":4204.78,"d":"4205"},{"v":7346.655108178,"d":"7347"},{"$nulls":6},0,5623,28,826,{"v":4621.47,"d":"4621"},{"v":7906.602204858001,"d":"7907"},{"$nulls":7},"CDK7","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK7",{"$nulls":5},"RAY(pY)HQV(bA)C","Corresponds to amino acid residues R167 to V173; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T170 phosphorylation stimulates phosphotransferase activity and regulates transcription. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation site in CDK7 (≥152 reports from high throughput mass spectrometry studies).","CDK1 (CDC2); CDK2; PKCi",null,"P50613","P50613","P50613","P50613"]
[427,221,"NK031-5","CDK8","Pan-specific","Cyclin-dependent protein-serine kinase 8",0,144,12,966,{"v":127.512,"d":"128"},{"v":224.0573155128,"d":"224"},{"$f":"(L440+L441)/2","v":{"v":190.75059602329998,"d":"191"}},{"$f":"SQRT((M440-L440)*(M440-L440))","v":{"v":33.30671948950001,"d":"33"}},{"$f":"N440/M440*100","v":{"v":17.460873089713246,"d":"17"}},0,94,10,967,{"v":81.228,"d":"81"},{"v":141.9227881428,"d":"142"},{"$f":"(U440+U441)/2","v":{"v":130.01027559099998,"d":"130"}},{"$f":"SQRT((V440-U440)*(V440-U440))","v":{"v":11.912512551800006,"d":"12"}},{"$f":"W440/V440*100","v":{"v":9.162746942615247,"d":"9"}},{"$f":"X440+O440","v":{"v":26.623620032328493,"d":"27"}},{"$f":"(V440/M440*100)-100","v":{"v":-31.842794569764095,"d":"-32"}},null,0,158,8,963,{"v":144.45,"d":"144"},{"v":247.13104023,"d":"247"},{"$f":"(AG440+AG441)/2","v":{"v":226.5085579944,"d":"227"}},{"$f":"SQRT((AH440-AG440)*(AH440-AG440))","v":{"v":20.62248223559999,"d":"21"}},{"$f":"AI440/AH440*100","v":{"v":9.104504667814732,"d":"9"}},{"$f":"AJ440+O440","v":{"v":26.565377757527976,"d":"27"}},{"$f":"(AH440/M440*100)-100","v":{"v":18.74592411062885,"d":"19"}},null,null,"CDK8","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK8",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues at the C-terminus of human CDK8.",null,null,"Protein-serine kinase, CMGC group, CDK family, CDK8 subfamily.","P49336","P49336","P49336",null,"GO:0016592; GO:0005730; GO:0005654; GO:0005634; GO:0032991","GO:0005524; GO:0004693; GO:0004672; GO:0004674; GO:0008353","GO:0045944; GO:0007346; GO:0006367"]
[428,221,"NK031-5","CDK8","Pan-specific","Cyclin-dependent protein-serine kinase 8",0,156,14,631,{"v":89.602,"d":"90"},{"v":157.4438765338,"d":"157"},{"$nulls":3},0,132,13,568,{"v":67.592,"d":"68"},{"v":118.0977630392,"d":"118"},{"$nulls":6},0,208,22,647,{"v":120.342,"d":"120"},{"v":205.88607575880002,"d":"206"},{"$nulls":7},"CDK8","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK8",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues at the C-terminus of human CDK8.",{"$nulls":3},"P49336","P49336","P49336"]
[429,222,"NK031-4","CDK8","Pan-specific","Cyclin-dependent protein-serine kinase 8",0,4880,16,837,{"v":4071.168,"d":"4071"},{"v":7153.6402305792,"d":"7154"},{"$f":"(L442+L443)/2","v":{"v":7231.1936661576,"d":"7231"}},{"$f":"SQRT((M442-L442)*(M442-L442))","v":{"v":77.55343557840024,"d":"78"}},{"$f":"N442/M442*100","v":{"v":1.0724845600713855,"d":"1"}},0,4962,16,696,{"v":3442.416,"d":"3442"},{"v":6014.6412156816,"d":"6015"},{"$f":"(U442+U443)/2","v":{"v":6050.850501414,"d":"6051"}},{"$f":"SQRT((V442-U442)*(V442-U442))","v":{"v":36.20928573239962,"d":"36"}},{"$f":"W442/V442*100","v":{"v":0.5984164659817328,"d":"1"}},{"$f":"X442+O442","v":{"v":1.6709010260531183,"d":"2"}},{"$f":"(V442/M442*100)-100","v":{"v":-16.322936699478447,"d":"-16"}},null,0,5128,16,732,{"v":3741.984,"d":"3742"},{"v":6401.941145337601,"d":"6402"},{"$f":"(AG442+AG443)/2","v":{"v":6596.6485833888,"d":"6597"}},{"$f":"SQRT((AH442-AG442)*(AH442-AG442))","v":{"v":194.70743805119946,"d":"195"}},{"$f":"AI442/AH442*100","v":{"v":2.951611497715636,"d":"3"}},{"$f":"AJ442+O442","v":{"v":4.0240960577870215,"d":"4"}},{"$f":"(AH442/M442*100)-100","v":{"v":-8.775108399302141,"d":"-9"}},null,null,"CDK8","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK8",{"$nulls":5},"MDYDFKVKLSSERERC","Corresponds to amino acid residues M1 to R15; N-terminus.",null,null,"Protein-serine kinase, CMGC group, CDK family, CDK8 subfamily.","P49336","P49336","P49336",null,"GO:0016592; GO:0005730; GO:0005654; GO:0005634; GO:0032991","GO:0005524; GO:0004693; GO:0004672; GO:0004674; GO:0008353","GO:0045944; GO:0007346; GO:0006367"]
[430,222,"NK031-4","CDK8","Pan-specific","Cyclin-dependent protein-serine kinase 8",0,4786,16,872,{"v":4159.44,"d":"4159"},{"v":7308.747101735999,"d":"7309"},{"$nulls":3},0,4588,16,762,{"v":3483.864,"d":"3484"},{"v":6087.0597871464,"d":"6087"},{"$nulls":6},0,4818,18,827,{"v":3969.6,"d":"3970"},{"v":6791.35602144,"d":"6791"},{"$nulls":7},"CDK8","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK8",{"$nulls":5},"MDYDFKVKLSSERERC","Corresponds to amino acid residues M1 to R15; N-terminus.",{"$nulls":3},"P49336","P49336","P49336"]
[431,223,"NK032","CDK9","Pan-specific","Cyclin-dependent protein-serine kinase 9",0,842,14,719,{"v":595.332,"d":"595"},{"v":1046.0857782708,"d":"1046"},{"$f":"(L444+L445)/2","v":{"v":970.5846902715999,"d":"971"}},{"$f":"SQRT((M444-L444)*(M444-L444))","v":{"v":75.50108799919997,"d":"76"}},{"$f":"N444/M444*100","v":{"v":7.778928387802243,"d":"8"}},0,544,12,517,{"v":275.044,"d":"275"},{"v":480.56102996439995,"d":"481"},{"$f":"(U444+U445)/2","v":{"v":607.0410574458499,"d":"607"}},{"$f":"SQRT((V444-U444)*(V444-U444))","v":{"v":126.48002748144995,"d":"126"}},{"$f":"W444/V444*100","v":{"v":20.83549801616712,"d":"21"}},{"$f":"X444+O444","v":{"v":28.61442640396936,"d":"29"}},{"$f":"(V444/M444*100)-100","v":{"v":-37.45614746138425,"d":"-37"}},null,0,688,12,615,{"v":415.74,"d":"416"},{"v":711.265203636,"d":"711"},{"$f":"(AG444+AG445)/2","v":{"v":775.6492980422,"d":"776"}},{"$f":"SQRT((AH444-AG444)*(AH444-AG444))","v":{"v":64.3840944062,"d":"64"}},{"$f":"AI444/AH444*100","v":{"v":8.300670750132893,"d":"8"}},{"$f":"AJ444+O444","v":{"v":16.079599137935137,"d":"16"}},{"$f":"(AH444/M444*100)-100","v":{"v":-20.08432588967078,"d":"-20"}},null,null,"CDK9","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK9",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues at the C-terminus of human CDK9.",null,null,"EC 2.7.11.23; EC 2.7.11.22; Nuclear receptor co-regulator; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; CDK/CDK9 subfamily; CDK9 subfamily","P50750","P50750","P50750","P50750","GO:0005694; GO:0008024; GO:0036464; GO:0016020; GO:0005654; GO:0016605; GO:0008023","GO:0097322; GO:0005524; GO:0003682; GO:0030332; GO:0004693; GO:0003677; GO:0016301; GO:0004672; GO:0019901; GO:0004674; GO:0008353; GO:0000978; GO:0001223; GO:0044212","GO:0008283; GO:0071345; GO:0006281; GO:0071157; GO:1900364; GO:0070816; GO:0010613; GO:2001168; GO:0033129; GO:1903839; GO:0045944; GO:0050434; GO:0006468; GO:0006282; GO:0031056; GO:0051147; GO:0031297; GO:0042493; GO:0042795; GO:0006366; GO:0006368; GO:0006367"]
[432,223,"NK032","CDK9","Pan-specific","Cyclin-dependent protein-serine kinase 9",0,744,10,694,{"v":509.396,"d":"509"},{"v":895.0836022724,"d":"895"},{"$nulls":3},0,669,12,639,{"v":419.823,"d":"420"},{"v":733.5210849273,"d":"734"},{"$nulls":6},0,780,14,641,{"v":491.006,"d":"491"},{"v":840.0333924484,"d":"840"},{"$nulls":7},"CDK9","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK9",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues at the C-terminus of human CDK9.",{"$nulls":3},"P50750","P50750","P50750","P50750"]
[433,224,"PK575","CDK9","T186","Cyclin-dependent protein-serine kinase 9",0,7110,18,809,{"v":5737.428,"d":"5737"},{"v":10081.5038241732,"d":"10082"},{"$f":"(L446+L447)/2","v":{"v":9712.144517205601,"d":"9712"}},{"$f":"SQRT((M446-L446)*(M446-L446))","v":{"v":369.35930696759897,"d":"369"}},{"$f":"N446/M446*100","v":{"v":3.8030664217697603,"d":"4"}},0,6552,22,706,{"v":4610.18,"d":"4610"},{"v":8054.976109718001,"d":"8055"},{"$f":"(U446+U447)/2","v":{"v":8163.906235127501,"d":"8164"}},{"$f":"SQRT((V446-U446)*(V446-U446))","v":{"v":108.93012540949985,"d":"109"}},{"$f":"W446/V446*100","v":{"v":1.3342892761408427,"d":"1"}},{"$f":"X446+O446","v":{"v":5.137355697910603,"d":"5"}},{"$f":"(V446/M446*100)-100","v":{"v":-15.9412607517867,"d":"-16"}},null,0,7166,18,741,{"v":5296.668,"d":"5297"},{"v":9061.7588964552,"d":"9062"},{"$f":"(AG446+AG447)/2","v":{"v":9293.930339483599,"d":"9294"}},{"$f":"SQRT((AH446-AG446)*(AH446-AG446))","v":{"v":232.17144302839915,"d":"232"}},{"$f":"AI446/AH446*100","v":{"v":2.498097516849899,"d":"2"}},{"$f":"AJ446+O446","v":{"v":6.301163938619659,"d":"6"}},{"$f":"(AH446/M446*100)-100","v":{"v":-4.306095085190634,"d":"-4"}},null,null,"CDK9","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK9",{"$nulls":5},"NRY(pT)NRV(bA)C","Corresponds to amino acid residues N183 to V189; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T186 phosphorylation stimulates phosphotransferase activity by promoting cyclin and substrate binding. Phosphorylation induces binding to EDG-1, RNA and TEAD1. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in CDK9 (≥33 reports from high throughput mass spectrometry studies).","CDK9","EC 2.7.11.23; EC 2.7.11.22; Nuclear receptor co-regulator; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; CDK/CDK9 subfamily; CDK9 subfamily","P50750","P50750","P50750","P50750","GO:0005694; GO:0008024; GO:0036464; GO:0016020; GO:0005654; GO:0016605; GO:0008023","GO:0097322; GO:0005524; GO:0003682; GO:0030332; GO:0004693; GO:0003677; GO:0016301; GO:0004672; GO:0019901; GO:0004674; GO:0008353; GO:0000978; GO:0001223; GO:0044212","GO:0008283; GO:0071345; GO:0006281; GO:0071157; GO:1900364; GO:0070816; GO:0010613; GO:2001168; GO:0033129; GO:1903839; GO:0045944; GO:0050434; GO:0006468; GO:0006282; GO:0031056; GO:0051147; GO:0031297; GO:0042493; GO:0042795; GO:0006366; GO:0006368; GO:0006367"]
[434,224,"PK575","CDK9","T186","Cyclin-dependent protein-serine kinase 9",0,6558,18,813,{"v":5317.02,"d":"5317"},{"v":9342.785210238,"d":"9343"},{"$nulls":3},0,6456,14,735,{"v":4734.87,"d":"4735"},{"v":8272.836360537,"d":"8273"},{"$nulls":6},0,6856,24,815,{"v":5568.08,"d":"5568"},{"v":9526.101782512,"d":"9526"},{"$nulls":7},"CDK9","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK9",{"$nulls":5},"NRY(pT)NRV(bA)C","Corresponds to amino acid residues N183 to V189; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T186 phosphorylation stimulates phosphotransferase activity by promoting cyclin and substrate binding. Phosphorylation induces binding to EDG-1, RNA and TEAD1. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in CDK9 (≥33 reports from high throughput mass spectrometry studies).","CDK9",null,"P50750","P50750","P50750","P50750"]
[435,225,"PK574","CDK9","S347","Cyclin-dependent protein-serine kinase 9",0,7198,18,765,{"v":5492.7,"d":"5493"},{"v":9651.480777629999,"d":"9651"},{"$f":"(L448+L449)/2","v":{"v":9707.578570985948,"d":"9708"}},{"$f":"SQRT((M448-L448)*(M448-L448))","v":{"v":56.09779335594976,"d":"56"}},{"$f":"N448/M448*100","v":{"v":0.5778762741474489,"d":"1"}},0,6858,26,681,{"v":4652.592,"d":"4653"},{"v":8129.0789965392,"d":"8129"},{"$f":"(U448+U449)/2","v":{"v":8566.1483482344,"d":"8566"}},{"$f":"SQRT((V448-U448)*(V448-U448))","v":{"v":437.06935169519966,"d":"437"}},{"$f":"W448/V448*100","v":{"v":5.10228557721961,"d":"5"}},{"$f":"X448+O448","v":{"v":5.680161851367059,"d":"6"}},{"$f":"(V448/M448*100)-100","v":{"v":-11.758135300218541,"d":"-12"}},null,0,7712,24,714,{"v":5489.232,"d":"5489"},{"v":9391.2053598048,"d":"9391"},{"$f":"(AG448+AG449)/2","v":{"v":9124.3294989774,"d":"9124"}},{"$f":"SQRT((AH448-AG448)*(AH448-AG448))","v":{"v":266.8758608274002,"d":"267"}},{"$f":"AI448/AH448*100","v":{"v":2.924881887017671,"d":"3"}},{"$f":"AJ448+O448","v":{"v":3.50275816116512,"d":"4"}},{"$f":"(AH448/M448*100)-100","v":{"v":-6.008182861911266,"d":"-6"}},null,null,"CDK9","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK9",{"$nulls":5},"RKG(pS)QIT(bA)C","Corresponds to amino acid residues R344 to T350; Near the C-terminus of the kinase after the catalytic domain.","S347 phosphorylation induces interaction with RNA [PubMed: 10958691). This is the major in vivo phosphorylation site in CDK9 (≥93 reports from high throughput mass spectrometry studies).","CDK9","EC 2.7.11.23; EC 2.7.11.22; Nuclear receptor co-regulator; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; CDK/CDK9 subfamily; CDK9 subfamily","P50750","P50750","P50750","P50750","GO:0005694; GO:0008024; GO:0036464; GO:0016020; GO:0005654; GO:0016605; GO:0008023","GO:0097322; GO:0005524; GO:0003682; GO:0030332; GO:0004693; GO:0003677; GO:0016301; GO:0004672; GO:0019901; GO:0004674; GO:0008353; GO:0000978; GO:0001223; GO:0044212","GO:0008283; GO:0071345; GO:0006281; GO:0071157; GO:1900364; GO:0070816; GO:0010613; GO:2001168; GO:0033129; GO:1903839; GO:0045944; GO:0050434; GO:0006468; GO:0006282; GO:0031056; GO:0051147; GO:0031297; GO:0042493; GO:0042795; GO:0006366; GO:0006368; GO:0006367"]
[436,225,"PK574","CDK9","S347","Cyclin-dependent protein-serine kinase 9",0,7029,22,793,{"v":5556.551,"d":"5557"},{"v":9763.6763643419,"d":"9764"},{"$nulls":3},0,6840,24,756,{"v":5152.896,"d":"5153"},{"v":9003.217699929599,"d":"9003"},{"$nulls":6},0,7403,28,702,{"v":5177.25,"d":"5177"},{"v":8857.45363815,"d":"8857"},{"$nulls":7},"CDK9","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK9",{"$nulls":5},"RKG(pS)QIT(bA)C","Corresponds to amino acid residues R344 to T350; Near the C-terminus of the kinase after the catalytic domain.","S347 phosphorylation induces interaction with RNA [PubMed: 10958691). This is the major in vivo phosphorylation site in CDK9 (≥93 reports from high throughput mass spectrometry studies).","CDK9",null,"P50750","P50750","P50750","P50750"]
[437,226,"NK033-2","CDK10 (PISSLRE)","Pan-specific","Cyclin-dependent protein-serine kinase 10 [PISSLRE]",0,9507,22,845,{"v":8014.825,"d":"8015"},{"v":14083.224902792499,"d":"14083"},{"$f":"(L450+L451)/2","v":{"v":12643.126167973649,"d":"12643"}},{"$f":"SQRT((M450-L450)*(M450-L450))","v":{"v":1440.09873481885,"d":"1440"}},{"$f":"N450/M450*100","v":{"v":11.390369088198849,"d":"11"}},0,9940,20,757,{"v":7509.44,"d":"7509"},{"v":13120.606960543999,"d":"13121"},{"$f":"(U450+U451)/2","v":{"v":13568.72133249385,"d":"13569"}},{"$f":"SQRT((V450-U450)*(V450-U450))","v":{"v":448.11437194985047,"d":"448"}},{"$f":"W450/V450*100","v":{"v":3.3025541682894137,"d":"3"}},{"$f":"X450+O450","v":{"v":14.692923256488262,"d":"15"}},{"$f":"(V450/M450*100)-100","v":{"v":7.320935915872042,"d":"7"}},null,0,11072,18,790,{"v":8732.66,"d":"8733"},{"v":14940.196260124001,"d":"14940"},{"$f":"(AG450+AG451)/2","v":{"v":13640.134723629602,"d":"13640"}},{"$f":"SQRT((AH450-AG450)*(AH450-AG450))","v":{"v":1300.0615364943988,"d":"1300"}},{"$f":"AI450/AH450*100","v":{"v":9.53114879607623,"d":"10"}},{"$f":"AJ450+O450","v":{"v":20.92151788427508,"d":"21"}},{"$f":"(AH450/M450*100)-100","v":{"v":7.885775578048722,"d":"8"}},null,null,"CDK10","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK10",{"$nulls":5},"CIRKEGFFTVPPEHRLGR","Corresponds to amino acid residues C15 to R32; Post-N-terminus.",null,null,"Protein-serine kinase, CMGC group, CDK family, CDK10 subfamily","Q15131","Q15131","Q15131","Q15131","GO:0036064; GO:0005737; GO:0016592","GO:0005524; GO:0004693; GO:0004674","GO:0030030; GO:0008285; GO:1902018; GO:0018107; GO:0043410; GO:0006468; GO:0032956; GO:0007089"]
[438,226,"NK033-2","CDK10 (PISSLRE)","Pan-specific","Cyclin-dependent protein-serine kinase 10 [PISSLRE]",0,7506,14,851,{"v":6375.692,"d":"6376"},{"v":11203.027433154799,"d":"11203"},{"$nulls":3},0,9958,17,807,{"v":8022.387,"d":"8022"},{"v":14016.8357044437,"d":"14017"},{"$nulls":6},0,9422,18,767,{"v":7212.868,"d":"7213"},{"v":12340.073187135202,"d":"12340"},{"$nulls":7},"CDK10","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK10",{"$nulls":5},"CIRKEGFFTVPPEHRLGR","Corresponds to amino acid residues C15 to R32; Post-N-terminus.",{"$nulls":3},"Q15131","Q15131","Q15131","Q15131"]
[439,227,"NK033-3","CDK10 (PISSLRE)","Pan-specific","Cyclin-dependent protein-serine kinase 10 [PISSLRE]",0,9385,14,876,{"v":8208.996,"d":"8209"},{"v":14424.411873512398,"d":"14424"},{"$f":"(L452+L453)/2","v":{"v":14494.052876600099,"d":"14494"}},{"$f":"SQRT((M452-L452)*(M452-L452))","v":{"v":69.64100308770139,"d":"70"}},{"$f":"N452/M452*100","v":{"v":0.48047984701458624,"d":"0"}},0,9014,18,842,{"v":7574.632,"d":"7575"},{"v":13234.5114073432,"d":"13235"},{"$f":"(U452+U453)/2","v":{"v":13913.7098275964,"d":"13914"}},{"$f":"SQRT((V452-U452)*(V452-U452))","v":{"v":679.1984202532003,"d":"679"}},{"$f":"W452/V452*100","v":{"v":4.881504851467297,"d":"5"}},{"$f":"X452+O452","v":{"v":5.3619846984818835,"d":"5"}},{"$f":"(V452/M452*100)-100","v":{"v":-4.004008084865163,"d":"-4"}},null,0,10541,18,808,{"v":8502.584,"d":"8503"},{"v":14546.572714177602,"d":"14547"},{"$f":"(AG452+AG453)/2","v":{"v":14284.672835562102,"d":"14285"}},{"$f":"SQRT((AH452-AG452)*(AH452-AG452))","v":{"v":261.8998786155007,"d":"262"}},{"$f":"AI452/AH452*100","v":{"v":1.8334328103300588,"d":"2"}},{"$f":"AJ452+O452","v":{"v":2.313912657344645,"d":"2"}},{"$f":"(AH452/M452*100)-100","v":{"v":-1.4445927776076388,"d":"-1"}},null,null,"CDK10","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK10",{"$nulls":5},"HRNKRAAPATSEGQSKRC","Corresponds to amino acid residues H341 to C358; C-terminus.",null,null,"Protein-serine kinase, CMGC group, CDK family, CDK10 subfamily","Q15131","Q15131","Q15131","Q15131","GO:0036064; GO:0005737; GO:0016592","GO:0005524; GO:0004693; GO:0004674","GO:0030030; GO:0008285; GO:1902018; GO:0018107; GO:0043410; GO:0006468; GO:0032956; GO:0007089"]
[440,227,"NK033-3","CDK10 (PISSLRE)","Pan-specific","Cyclin-dependent protein-serine kinase 10 [PISSLRE]",0,9136,18,909,{"v":8288.262,"d":"8288"},{"v":14563.6938796878,"d":"14564"},{"$nulls":3},0,9174,16,912,{"v":8352.096,"d":"8352"},{"v":14592.9082478496,"d":"14593"},{"$nulls":6},0,9697,20,847,{"v":8196.419,"d":"8196"},{"v":14022.772956946601,"d":"14023"},{"$nulls":7},"CDK10","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK10",{"$nulls":5},"HRNKRAAPATSEGQSKRC","Corresponds to amino acid residues H341 to C358; C-terminus.",{"$nulls":3},"Q15131","Q15131","Q15131","Q15131"]
[441,228,"PK564","CDK10 (PISSLRE)","T196","Cyclin-dependent protein-serine kinase 10 [PISSLRE]",0,6576,26,682,{"v":4467.1,"d":"4467"},{"v":7849.350916990001,"d":"7849"},{"$f":"(L454+L455)/2","v":{"v":7719.0145456825,"d":"7719"}},{"$f":"SQRT((M454-L454)*(M454-L454))","v":{"v":130.33637130750049,"d":"130"}},{"$f":"N454/M454*100","v":{"v":1.688510502683298,"d":"2"}},0,6056,20,605,{"v":3651.78,"d":"3652"},{"v":6380.445157878001,"d":"6380"},{"$f":"(U454+U455)/2","v":{"v":7026.090932958351,"d":"7026"}},{"$f":"SQRT((V454-U454)*(V454-U454))","v":{"v":645.6457750803502,"d":"646"}},{"$f":"W454/V454*100","v":{"v":9.189260162457073,"d":"9"}},{"$f":"X454+O454","v":{"v":10.877770665140371,"d":"11"}},{"$f":"(V454/M454*100)-100","v":{"v":-8.976840354727983,"d":"-9"}},null,0,7440,20,687,{"v":5097.54,"d":"5098"},{"v":8721.082470156,"d":"8721"},{"$f":"(AG454+AG455)/2","v":{"v":8452.115961137799,"d":"8452"}},{"$f":"SQRT((AH454-AG454)*(AH454-AG454))","v":{"v":268.96650901820067,"d":"269"}},{"$f":"AI454/AH454*100","v":{"v":3.182238746544518,"d":"3"}},{"$f":"AJ454+O454","v":{"v":4.870749249227816,"d":"5"}},{"$f":"(AH454/M454*100)-100","v":{"v":9.497344656065536,"d":"9"}},null,null,"CDK10","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK10",{"$nulls":5},"KPM(pT)PKV(bA)C","Corresponds to amino acid residues K193 to V199; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T196 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation site in CDK10 (≥27 reports from high throughput mass spectrometry studies).",null,"Protein-serine kinase, CMGC group, CDK family, CDK10 subfamily","Q15131","Q15131","Q15131","Q15131","GO:0036064; GO:0005737; GO:0016592","GO:0005524; GO:0004693; GO:0004674","GO:0030030; GO:0008285; GO:1902018; GO:0018107; GO:0043410; GO:0006468; GO:0032956; GO:0007089"]
[442,228,"PK564","CDK10 (PISSLRE)","T196","Cyclin-dependent protein-serine kinase 10 [PISSLRE]",0,6268,18,691,{"v":4318.75,"d":"4319"},{"v":7588.678174375,"d":"7589"},{"$nulls":3},0,6220,27,709,{"v":4390.837,"d":"4391"},{"v":7671.736708038701,"d":"7672"},{"$nulls":6},0,6656,22,721,{"v":4783.114,"d":"4783"},{"v":8183.1494521196,"d":"8183"},{"$nulls":7},"CDK10","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK10",{"$nulls":5},"KPM(pT)PKV(bA)C","Corresponds to amino acid residues K193 to V199; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T196 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation site in CDK10 (≥27 reports from high throughput mass spectrometry studies).",null,null,"Q15131","Q15131","Q15131","Q15131"]
[443,229,"PK565","CDK11A (Cdc2L2; PITSLRE)","T583(labeledasT580)","Cell division cycle 2-like 2 protein kinase",0,7926,25,934,{"v":7379.534,"d":"7380"},{"v":12966.9252915446,"d":"12967"},{"$f":"(L456+L457)/2","v":{"v":12841.001116103,"d":"12841"}},{"$f":"SQRT((M456-L456)*(M456-L456))","v":{"v":125.9241754415998,"d":"126"}},{"$f":"N456/M456*100","v":{"v":0.9806414180876218,"d":"1"}},0,7906,20,833,{"v":6569.038,"d":"6569"},{"v":11477.522386073799,"d":"11478"},{"$f":"(U456+U457)/2","v":{"v":11786.2430637381,"d":"11786"}},{"$f":"SQRT((V456-U456)*(V456-U456))","v":{"v":308.72067766430155,"d":"309"}},{"$f":"W456/V456*100","v":{"v":2.619330655195128,"d":"3"}},{"$f":"X456+O456","v":{"v":3.59997207328275,"d":"4"}},{"$f":"(V456/M456*100)-100","v":{"v":-8.213986143511832,"d":"-8"}},null,0,6752,30,910,{"v":6117.02,"d":"6117"},{"v":10465.251060628001,"d":"10465"},{"$f":"(AG456+AG457)/2","v":{"v":11416.504541649001,"d":"11417"}},{"$f":"SQRT((AH456-AG456)*(AH456-AG456))","v":{"v":951.253481021,"d":"951"}},{"$f":"AI456/AH456*100","v":{"v":8.332265603282462,"d":"8"}},{"$f":"AJ456+O456","v":{"v":9.312907021370084,"d":"9"}},{"$f":"(AH456/M456*100)-100","v":{"v":-11.093345149449746,"d":"-11"}},null,null,"CDK11","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK8",{"$nulls":5},"KAY(pT)PVV(bA)C","Corresponds to amino acid residues K580 to V586; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T583 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in CDK11a (≥49 reports from high throughput mass spectrometry studies).",null,"EC 2.7.11.22; RNA processing; Protein kinase, Ser/Thr (non-receptor)","Q9UQ88","Q9UQ88","Q9UQ88","Q9UQ88","GO:0005737; GO:0005634","GO:0005524; GO:0004693; GO:0004672; GO:0004674","GO:0006915; GO:0000278; GO:0006468; GO:0001558; GO:0007346; GO:0050684; GO:0006355"]
[444,229,"PK565","CDK11A (Cdc2L2; PITSLRE)","T583(labeledasT580)","Cell division cycle 2-like 2 protein kinase",0,7912,38,919,{"v":7236.206,"d":"7236"},{"v":12715.0769406614,"d":"12715"},{"$nulls":3},0,8457,56,824,{"v":6922.424,"d":"6922"},{"v":12094.9637414024,"d":"12095"},{"$nulls":6},0,8178,28,887,{"v":7229.05,"d":"7229"},{"v":12367.758022670001,"d":"12368"},{"$nulls":7},"CDK11","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK8",{"$nulls":5},"KAY(pT)PVV(bA)C","Corresponds to amino acid residues K580 to V586; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T583 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in CDK11a (≥49 reports from high throughput mass spectrometry studies).",null,null,"Q9UQ88","Q9UQ88","Q9UQ88","Q9UQ88"]
[445,230,"PK566","CDK12 (Cdc2L7)","S383+S385","Cell division protein kinase 12; Cell division cycle 2-related protein kinase 7",0,7522,30,1015,{"v":7604.38,"d":"7604"},{"v":13362.012743422,"d":"13362"},{"$f":"(L458+L459)/2","v":{"v":13250.8802305846,"d":"13251"}},{"$f":"SQRT((M458-L458)*(M458-L458))","v":{"v":111.13251283739919,"d":"111"}},{"$f":"N458/M458*100","v":{"v":0.8386802303207918,"d":"1"}},0,7851,22,908,{"v":7108.732,"d":"7109"},{"v":12420.4838922532,"d":"12420"},{"$f":"(U458+U459)/2","v":{"v":12999.297816151,"d":"12999"}},{"$f":"SQRT((V458-U458)*(V458-U458))","v":{"v":578.8139238978001,"d":"579"}},{"$f":"W458/V458*100","v":{"v":4.4526553055708264,"d":"4"}},{"$f":"X458+O458","v":{"v":5.291335535891618,"d":"5"}},{"$f":"(V458/M458*100)-100","v":{"v":-1.8986090739309418,"d":"-2"}},null,0,7362,78,982,{"v":7152.888,"d":"7153"},{"v":12237.4569199632,"d":"12237"},{"$f":"(AG458+AG459)/2","v":{"v":12056.5662370584,"d":"12057"}},{"$f":"SQRT((AH458-AG458)*(AH458-AG458))","v":{"v":180.890682904801,"d":"181"}},{"$f":"AI458/AH458*100","v":{"v":1.5003499283966553,"d":"2"}},{"$f":"AJ458+O458","v":{"v":2.339030158717447,"d":"2"}},{"$f":"(AH458/M458*100)-100","v":{"v":-9.013091754988352,"d":"-9"}},null,null,"CRK7","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CRK7",{"$nulls":5},"RHS(pS)I(pS)PVR(bA)C","Corresponds to amino acid residues R380 to R388; In the first quarter of the protein. ","The effects of S383 and S385 phosphorylation are unclear. These are the major in vivo phosphorylation sites in CDK12 (≥163 and ≥174 reports, respectively, from high throughput mass spectrometry studies).",null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.22; CMGC domain target; CMGC</A> group; CDK family; CRK7 subfamily; CDK/CRK7 subfamily","Q9NYV4","Q9NYV4","Q9NYV4",null,"GO:0005694; GO:0008024; GO:0002944; GO:0001650; GO:0019908; GO:0016607; GO:0005654; GO:0005634","GO:0005524; GO:0030332; GO:0004693; GO:0004672; GO:0019901; GO:0008353; GO:0008134; GO:0044212","GO:0006397; GO:2000737; GO:0070816; GO:0045944; GO:0046777; GO:0043405; GO:0043484; GO:0008380; GO:0006368"]
[446,230,"PK566","CDK12 (Cdc2L7)","S383+S385","Cell division protein kinase 12; Cell division cycle 2-related protein kinase 7",0,7264,32,1034,{"v":7477.888,"d":"7478"},{"v":13139.7477177472,"d":"13140"},{"$nulls":3},0,7640,36,1022,{"v":7771.288,"d":"7771"},{"v":13578.1117400488,"d":"13578"},{"$nulls":6},0,6838,46,1022,{"v":6941.424,"d":"6941"},{"v":11875.6755541536,"d":"11876"},{"$nulls":7},"CRK7","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CRK7",{"$nulls":5},"RHS(pS)I(pS)PVR(bA)C","Corresponds to amino acid residues R380 to R388; In the first quarter of the protein. ","The effects of S383 and S385 phosphorylation are unclear. These are the major in vivo phosphorylation sites in CDK12 (≥163 and ≥174 reports, respectively, from high throughput mass spectrometry studies).",null,null,"Q9NYV4","Q9NYV4","Q9NYV4"]
[447,231,"PK567","CDK12 (Cdc2L7)","T893","Cell division protein kinase 12; Cell division cycle 2-related protein kinase 7",0,7819,20,813,{"v":6340.587,"d":"6341"},{"v":11141.342791230301,"d":"11141"},{"$f":"(L460+L461)/2","v":{"v":11801.51430301515,"d":"11802"}},{"$f":"SQRT((M460-L460)*(M460-L460))","v":{"v":660.1715117848489,"d":"660"}},{"$f":"N460/M460*100","v":{"v":5.593955952044076,"d":"6"}},0,7866,22,831,{"v":6518.364,"d":"6518"},{"v":11388.984008096399,"d":"11389"},{"$f":"(U460+U461)/2","v":{"v":11552.2927090632,"d":"11552"}},{"$f":"SQRT((V460-U460)*(V460-U460))","v":{"v":163.30870096680155,"d":"163"}},{"$f":"W460/V460*100","v":{"v":1.4136475336941545,"d":"1"}},{"$f":"X460+O460","v":{"v":7.0076034857382306,"d":"7"}},{"$f":"(V460/M460*100)-100","v":{"v":-2.1117764004935964,"d":"-2"}},null,0,8816,28,881,{"v":7742.228,"d":"7742"},{"v":13245.724190639201,"d":"13246"},{"$f":"(AG460+AG461)/2","v":{"v":12789.3948857,"d":"12789"}},{"$f":"SQRT((AH460-AG460)*(AH460-AG460))","v":{"v":456.3293049392014,"d":"456"}},{"$f":"AI460/AH460*100","v":{"v":3.568028894388346,"d":"4"}},{"$f":"AJ460+O460","v":{"v":9.161984846432421,"d":"9"}},{"$f":"(AH460/M460*100)-100","v":{"v":8.370795114254605,"d":"8"}},null,null,"CRK7","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CRK7",{"$nulls":5},"RPY(pT)NKV(bA)C","Corresponds to amino acid residues R890 to V896; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T893 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in CDK12 (≥73 reports from high throughput mass spectrometry studies).",null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.22; CMGC domain target; CMGC</A> group; CDK family; CRK7 subfamily; CDK/CRK7 subfamily","Q9NYV4","Q9NYV4","Q9NYV4",null,"GO:0005694; GO:0008024; GO:0002944; GO:0001650; GO:0019908; GO:0016607; GO:0005654; GO:0005634","GO:0005524; GO:0030332; GO:0004693; GO:0004672; GO:0019901; GO:0008353; GO:0008134; GO:0044212","GO:0006397; GO:2000737; GO:0070816; GO:0045944; GO:0046777; GO:0043405; GO:0043484; GO:0008380; GO:0006368"]
[448,231,"PK567","CDK12 (Cdc2L7)","T893","Cell division protein kinase 12; Cell division cycle 2-related protein kinase 7",0,7902,22,900,7092,{"v":12461.6858148,"d":"12462"},{"$nulls":3},0,7751,26,868,{"v":6705.3,"d":"6705"},{"v":11715.60141003,"d":"11716"},{"$nulls":6},0,8481,20,852,{"v":7208.772,"d":"7209"},{"v":12333.0655807608,"d":"12333"},{"$nulls":7},"CRK7","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CRK7",{"$nulls":5},"RPY(pT)NKV(bA)C","Corresponds to amino acid residues R890 to V896; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T893 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in CDK12 (≥73 reports from high throughput mass spectrometry studies).",null,null,"Q9NYV4","Q9NYV4","Q9NYV4"]
[449,232,"NK199","CDKL1","Pan-specific","Cyclin-dependent kinase-like 1; Serine/threonine protein kinase KKIALRE",0,3536,18,737,{"$f":"(H462-I462)*J462/1000","v":{"v":2592.766,"d":"2593"}},{"v":4555.8707393254,"d":"4556"},{"$f":"(L462+L463)/2","v":{"v":4702.035489908099,"d":"4702"}},{"$f":"SQRT((M462-L462)*(M462-L462))","v":{"v":146.16475058269953,"d":"146"}},{"$f":"N462/M462*100","v":{"v":3.1085420536788906,"d":"3"}},0,3324,16,620,{"$f":"(Q462-R462)*S462/1000","v":{"v":2050.96,"d":"2051"}},{"v":3583.468281496,"d":"3583"},{"$f":"(U462+U463)/2","v":{"v":3690.2755405589996,"d":"3690"}},{"$f":"SQRT((V462-U462)*(V462-U462))","v":{"v":106.80725906299949,"d":"107"}},{"$f":"W462/V462*100","v":{"v":2.8942895425857667,"d":"3"}},{"$f":"X462+O462","v":{"v":6.002831596264658,"d":"6"}},{"$f":"(V462/M462*100)-100","v":{"v":-21.51748857533346,"d":"-22"}},null,0,3927,16,652,{"$f":"(AC462-AD462)*AE462/1000","v":{"v":2549.972,"d":"2550"}},{"v":4362.597666440801,"d":"4363"},{"$f":"(AG462+AG463)/2","v":{"v":4624.606183485201,"d":"4625"}},{"$f":"SQRT((AH462-AG462)*(AH462-AG462))","v":{"v":262.0085170443999,"d":"262"}},{"$f":"AI462/AH462*100","v":{"v":5.665531434439782,"d":"6"}},{"$f":"AJ462+O462","v":{"v":8.774073488118672,"d":"9"}},{"$f":"(AH462/M462*100)-100","v":{"v":-1.6467188856631054,"d":"-2"}},null,null,"CDKL1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDKL",{"$nulls":6},"CLDNKKYYSDTKKLNYR","Corresponds to amino acid residues L338 to R353; C-terminus.",{"$nulls":3},"Q00532","Q00532","Q00532","Q00532","GO:0035869; GO:0005737; GO:0070062; GO:0043231; GO:0005654; GO:0005634","GO:0005524; GO:0004693","GO:0007507; GO:0006468; GO:1902017"]
[450,232,"NK199","CDKL1","Pan-specific","Cyclin-dependent kinase-like 1; Serine/threonine protein kinase KKIALRE",0,3618,16,766,{"v":2759.132,"d":"2759"},{"v":4848.2002404908,"d":"4848"},{"$nulls":3},0,3288,20,665,{"v":2173.22,"d":"2173"},{"v":3797.0827996219996,"d":"3797"},{"$nulls":6},0,3922,20,732,{"v":2856.264,"d":"2856"},{"v":4886.614700529601,"d":"4887"},{"$nulls":7},"CDKL1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDKL",{"$nulls":6},"CLDNKKYYSDTKKLNYR","Corresponds to amino acid residues L338 to R353; C-terminus.",{"$nulls":3},"Q00532","Q00532","Q00532","Q00532"]
[451,233,"NK261-1","CDKL2","Pan-specific","Cyclin-dependent kinase-like 2; Serine/threonine protein kinase KKIAMRE",0,10400,20,778,{"v":8075.64,"d":"8076"},{"v":14190.085791516,"d":"14190"},{"$f":"(L464+L465)/2","v":{"v":15017.8987818688,"d":"15018"}},{"$f":"SQRT((M464-L464)*(M464-L464))","v":{"v":827.8129903528006,"d":"828"}},{"$f":"N464/M464*100","v":{"v":5.5121758534704215,"d":"6"}},0,10142,22,681,{"v":6891.72,"d":"6892"},{"v":12041.317248972,"d":"12041"},{"$f":"(U464+U465)/2","v":{"v":11709.3953019948,"d":"11709"}},{"$f":"SQRT((V464-U464)*(V464-U464))","v":{"v":331.9219469771997,"d":"332"}},{"$f":"W464/V464*100","v":{"v":2.8346634340771963,"d":"3"}},{"$f":"X464+O464","v":{"v":8.346839287547617,"d":"8"}},{"$f":"(V464/M464*100)-100","v":{"v":-22.030402041784797,"d":"-22"}},null,0,11038,20,801,{"v":8825.418,"d":"8825"},{"v":15098.8904867052,"d":"15099"},{"$f":"(AG464+AG465)/2","v":{"v":14614.412708211801,"d":"14614"}},{"$f":"SQRT((AH464-AG464)*(AH464-AG464))","v":{"v":484.47777849339946,"d":"484"}},{"$f":"AI464/AH464*100","v":{"v":3.3150684065543916,"d":"3"}},{"$f":"AJ464+O464","v":{"v":8.827244260024813,"d":"9"}},{"$f":"(AH464/M464*100)-100","v":{"v":-2.68670124574372,"d":"-3"}},null,null,"CDKL2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDKL",{"$nulls":6},"CLSDDSGADLPQMEHQH","Corresponds to amino acid residues L478 to H493; C-terminus.",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.22; CMGC domain target; CMGC</A> group; CDKL family","Q92772","Q92772","Q92772","Q92772","GO:0005813; GO:0005737; GO:0005634","GO:0005524; GO:0004693; GO:0004672","GO:0007548; GO:0007165"]
[452,233,"NK261-1","CDKL2","Pan-specific","Cyclin-dependent kinase-like 2; Serine/threonine protein kinase KKIAMRE",0,11006,22,821,{"v":9017.864,"d":"9018"},{"v":15845.711772221599,"d":"15846"},{"$nulls":3},0,9374,18,696,{"v":6511.776,"d":"6512"},{"v":11377.4733550176,"d":"11377"},{"$nulls":6},0,10790,22,767,{"v":8259.056,"d":"8259"},{"v":14129.934929718402,"d":"14130"},{"$nulls":7},"CDKL2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDKL",{"$nulls":6},"CLSDDSGADLPQMEHQH","Corresponds to amino acid residues L478 to H493; C-terminus.",{"$nulls":3},"Q92772","Q92772","Q92772","Q92772"]
[453,234,"NK262-1","CDKL3","Pan-specific","Cyclin-dependent kinase-like 3; Serine/threonine protein kinase NKIAMRE",0,9432,18,800,{"v":7531.2,"d":"7531"},{"$f":"K466*1.7571469","v":{"v":13233.424733279999,"d":"13233"}},{"$f":"(L466+L467)/2","v":{"v":13220.572082279949,"d":"13221"}},{"$f":"SQRT((M466-L466)*(M466-L466))","v":{"v":12.852651000050173,"d":"13"}},{"$f":"N466/M466*100","v":{"v":0.09721705626700591,"d":"0"}},0,8684,12,693,{"v":6009.696,"d":"6010"},{"$f":"T466*1.7472151","v":{"v":10500.2315976096,"d":"10500"}},{"$f":"(U466+U467)/2","v":{"v":10361.553387907501,"d":"10362"}},{"$f":"SQRT((V466-U466)*(V466-U466))","v":{"v":138.67820970209868,"d":"139"}},{"$f":"W466/V466*100","v":{"v":1.33839207800583,"d":"1"}},{"$f":"X466+O466","v":{"v":1.4356091342728359,"d":"1"}},{"$f":"(V466/M466*100)-100","v":{"v":-21.625529338511015,"d":"-22"}},null,0,10333,20,765,{"v":7889.445,"d":"7889"},{"v":13497.589129023,"d":"13498"},{"$f":"(AG466+AG467)/2","v":{"v":12448.5465198401,"d":"12449"}},{"$f":"SQRT((AH466-AG466)*(AH466-AG466))","v":{"v":1049.0426091828995,"d":"1049"}},{"$f":"AI466/AH466*100","v":{"v":8.427028870486755,"d":"8"}},{"$f":"AJ466+O466","v":{"v":8.52424592675376,"d":"9"}},{"$f":"(AH466/M466*100)-100","v":{"v":-5.839577573761915,"d":"-6"}},null,null,"CDKL3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDKL",{"$nulls":6},"CANENKRKLNFSRSDRKEFH","Corresponds to amino acid residues A505 to H523; Pre-C-terminus.",{"$nulls":3},"Q8IVW4","Q8IVW4","Q8IVW4",null,"GO:0005737; GO:0005634","GO:0005524; GO:0004693; GO:0004672","GO:0006464; GO:0097484; GO:0030517; GO:0050775"]
[454,234,"NK262-1","CDKL3","Pan-specific","Cyclin-dependent kinase-like 3; Serine/threonine protein kinase NKIAMRE",0,9671,22,779,{"v":7516.571,"d":"7517"},{"v":13207.7194312799,"d":"13208"},{"$nulls":3},0,8042,16,729,{"v":5850.954,"d":"5851"},{"v":10222.8751782054,"d":"10223"},{"$nulls":6},0,8861,24,754,{"v":6663.098,"d":"6663"},{"$f":"AF467*1.7108414","v":{"v":11399.5039106572,"d":"11400"}},{"$nulls":7},"CDKL3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDKL",{"$nulls":6},"CANENKRKLNFSRSDRKEFH","Corresponds to amino acid residues A505 to H523; Pre-C-terminus.",{"$nulls":3},"Q8IVW4","Q8IVW4","Q8IVW4"]
[455,235,"PK576","CDKL5 (STK9)","Y171","Cyclin-dependent kinase-like 5; Serine-threonine-protein kinase 9",0,8548,18,751,{"v":6406.03,"d":"6406"},{"v":11256.335755807,"d":"11256"},{"$f":"(L468+L469)/2","v":{"v":11236.4220099893,"d":"11236"}},{"$f":"SQRT((M468-L468)*(M468-L468))","v":{"v":19.913745817701056,"d":"20"}},{"$f":"N468/M468*100","v":{"v":0.17722497250457062,"d":"0"}},0,7450,15,604,{"v":4490.74,"d":"4491"},{"v":7846.288738173999,"d":"7846"},{"$f":"(U468+U469)/2","v":{"v":10465.00337315585,"d":"10465"}},{"$f":"SQRT((V468-U468)*(V468-U468))","v":{"v":2618.7146349818513,"d":"2619"}},{"$f":"W468/V468*100","v":{"v":25.02354315240078,"d":"25"}},{"$f":"X468+O468","v":{"v":25.200768124905352,"d":"25"}},{"$f":"(V468/M468*100)-100","v":{"v":-6.865340551891421,"d":"-7"}},null,0,8304,16,744,{"v":6166.272,"d":"6166"},{"v":10549.5134212608,"d":"10550"},{"$f":"(AG468+AG469)/2","v":{"v":10487.351709833201,"d":"10487"}},{"$f":"SQRT((AH468-AG468)*(AH468-AG468))","v":{"v":62.161711427599585,"d":"62"}},{"$f":"AI468/AH468*100","v":{"v":0.592730301676783,"d":"1"}},{"$f":"AJ468+O468","v":{"v":0.7699552741813536,"d":"1"}},{"$f":"(AH468/M468*100)-100","v":{"v":-6.666448621190682,"d":"-7"}},null,null,"CDKL5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDKL",{"$nulls":6},"YTE(pY)VAT(bA)C","Corresponds to amino acid residues Y168 to T174; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y171 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation site in CDKL5 (≥548 reports from high throughput mass spectrometry studies).","CDKL5 (STK9)","EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDKL family","O76039","O76039","O76039",null,"GO:0005813; GO:0036064; GO:0097542; GO:0005829; GO:0032839; GO:0044294; GO:0098978; GO:0005654; GO:0005634; GO:0048471; GO:0099092; GO:0032587","GO:0005524; GO:0016301; GO:0004672; GO:0004674; GO:0048365","GO:0001764; GO:0045773; GO:0050775; GO:0060999; GO:0043547; GO:0046777; GO:0006468; GO:0051726; GO:1902017; GO:0050773; GO:0099175"]
[456,235,"PK576","CDKL5 (STK9)","Y171","Cyclin-dependent kinase-like 5; Serine-threonine-protein kinase 9",0,8484,18,754,{"v":6383.364,"d":"6383"},{"v":11216.5082641716,"d":"11217"},{"$nulls":3},0,8864,23,847,{"v":7488.327,"d":"7488"},{"v":13083.718008137701,"d":"13084"},{"$nulls":6},0,8686,18,703,{"v":6093.604,"d":"6094"},{"v":10425.189998405602,"d":"10425"},{"$nulls":7},"CDKL5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDKL",{"$nulls":6},"YTE(pY)VAT(bA)C","Corresponds to amino acid residues Y168 to T174; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y171 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation site in CDKL5 (≥548 reports from high throughput mass spectrometry studies).","CDKL5 (STK9)",null,"O76039","O76039","O76039"]
[457,255,"PN019","CFL1","S3","Cofilin 1",0,436,10,300,{"v":127.8,"d":"128"},{"v":224.56337381999998,"d":"225"},{"$f":"(L470+L471)/2","v":{"v":201.09491982359998,"d":"201"}},{"$f":"SQRT((M470-L470)*(M470-L470))","v":{"v":23.4684539964,"d":"23"}},{"$f":"N470/M470*100","v":{"v":11.670336583831395,"d":"12"}},0,558,10,262,{"v":143.576,"d":"144"},{"v":250.85815519759998,"d":"251"},{"$f":"(U470+U471)/2","v":{"v":246.62989465559997,"d":"247"}},{"$f":"SQRT((V470-U470)*(V470-U470))","v":{"v":4.228260542000015,"d":"4"}},{"$f":"W470/V470*100","v":{"v":1.7144152568789206,"d":"2"}},{"$f":"X470+O470","v":{"v":13.384751840710315,"d":"13"}},{"$f":"(V470/M470*100)-100","v":{"v":22.643523203839848,"d":"23"}},null,0,426,14,413,{"v":170.156,"d":"170"},{"v":291.10992925840003,"d":"291"},{"$f":"(AG470+AG471)/2","v":{"v":232.58204496440004,"d":"233"}},{"$f":"SQRT((AH470-AG470)*(AH470-AG470))","v":{"v":58.52788429399999,"d":"59"}},{"$f":"AI470/AH470*100","v":{"v":25.164403513159627,"d":"25"}},{"$f":"AJ470+O470","v":{"v":36.83474009699102,"d":"37"}},{"$f":"(AH470/M470*100)-100","v":{"v":15.657842161512832,"d":"16"}},{"$nulls":15},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S3 phosphosite.","S3 phosphorylation inhibits activity and induces interaction with 14-3-3 zeta, although one report indicates stimulation of activity. This is one of the major in vivo phosphorylation sites in cofilin 1 (≥67 reports from high throughput mass spectrometry studies).","ILK; LIMK1; LIMK2; PKD1 (PRKCM; PRKD1); TESK1; TESK2","Intracellular, Nuclear matrix, Cortical actin cytoskeleton, Cytoplasm, Nucleus, Cytoskeleton protein","P23528","P23528",null,null,"GO:0005911; GO:0030864; GO:0005737; GO:0005829; GO:0070062; GO:0005615; GO:0005925; GO:0030027; GO:0031258; GO:0016020; GO:0016363; GO:0005634; GO:0032587; GO:0031982","GO:0051015; GO:0005102","GO:0030036; GO:0030042; GO:0030043; GO:0007010; GO:0030010; GO:0035722; GO:0000281; GO:0043066; GO:0001755; GO:0001842; GO:0044794; GO:0030836; GO:0006468; GO:0022604; GO:0061001; GO:0043200; GO:0009615; GO:0007266"]
[458,255,"PN019","CFL1","S3","Cofilin 1",0,334,10,312,{"v":101.088,"d":"101"},{"v":177.62646582719998,"d":"178"},{"$nulls":3},0,472,8,299,{"v":138.736,"d":"139"},{"v":242.40163411359998,"d":"242"},{"$nulls":6},0,326,12,324,{"v":101.736,"d":"102"},{"v":174.05416067040002,"d":"174"},{"$nulls":20},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S3 phosphosite.","S3 phosphorylation inhibits activity and induces interaction with 14-3-3 zeta, although one report indicates stimulation of activity. This is one of the major in vivo phosphorylation sites in cofilin 1 (≥67 reports from high throughput mass spectrometry studies).","ILK; LIMK1; LIMK2; PKD1 (PRKCM; PRKD1); TESK1; TESK2",null,"P23528","P23528"]
[459,256,"PN220","CFL1","S3","Cofilin 1",0,464,14,521,{"v":234.45,"d":"234"},{"v":411.96309070499996,"d":"412"},{"$f":"(L472+L473)/2","v":{"v":386.58110373449995,"d":"387"}},{"$f":"SQRT((M472-L472)*(M472-L472))","v":{"v":25.38198697050001,"d":"25"}},{"$f":"N472/M472*100","v":{"v":6.565759869093887,"d":"7"}},0,376,16,457,{"v":164.52,"d":"165"},{"v":287.45182825200004,"d":"287"},{"$f":"(U472+U473)/2","v":{"v":294.30790030440005,"d":"294"}},{"$f":"SQRT((V472-U472)*(V472-U472))","v":{"v":6.856072052400009,"d":"7"}},{"$f":"W472/V472*100","v":{"v":2.3295575977773058,"d":"2"}},{"$f":"X472+O472","v":{"v":8.895317466871193,"d":"9"}},{"$f":"(V472/M472*100)-100","v":{"v":-23.869041331485306,"d":"-24"}},null,0,664,20,634,{"v":408.296,"d":"408"},{"v":698.5297002544,"d":"699"},{"$f":"(AG472+AG473)/2","v":{"v":567.2739480464,"d":"567"}},{"$f":"SQRT((AH472-AG472)*(AH472-AG472))","v":{"v":131.255752208,"d":"131"}},{"$f":"AI472/AH472*100","v":{"v":23.137983448741764,"d":"23"}},{"$f":"AJ472+O472","v":{"v":29.703743317835652,"d":"30"}},{"$f":"(AH472/M472*100)-100","v":{"v":46.74125107677227,"d":"47"}},{"$nulls":15},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S3 phosphosite.","S3 phosphorylation inhibits activity and induces interaction with 14-3-3 zeta, although one report indicates stimulation of activity. This is one of the major in vivo phosphorylation sites in cofilin 1 (≥67 reports from high throughput mass spectrometry studies).","ILK; LIMK1; LIMK2; PKD1 (PRKCM; PRKD1); TESK1; TESK2","Intracellular, Nuclear matrix, Cortical actin cytoskeleton, Cytoplasm, Nucleus, Cytoskeleton protein","P23528","P23528",null,null,"GO:0005911; GO:0030864; GO:0005737; GO:0005829; GO:0070062; GO:0005615; GO:0005925; GO:0030027; GO:0031258; GO:0016020; GO:0016363; GO:0005634; GO:0032587; GO:0031982","GO:0051015; GO:0005102","GO:0030036; GO:0030042; GO:0030043; GO:0007010; GO:0030010; GO:0035722; GO:0000281; GO:0043066; GO:0001755; GO:0001842; GO:0044794; GO:0030836; GO:0006468; GO:0022604; GO:0061001; GO:0043200; GO:0009615; GO:0007266"]
[460,256,"PN220","CFL1","S3","Cofilin 1",0,372,12,571,{"v":205.56,"d":"206"},{"v":361.199116764,"d":"361"},{"$nulls":3},0,358,16,504,{"v":172.368,"d":"172"},{"v":301.1639723568,"d":"301"},{"$nulls":6},0,460,16,574,{"v":254.856,"d":"255"},{"v":436.0181958384,"d":"436"},{"$nulls":20},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S3 phosphosite.","S3 phosphorylation inhibits activity and induces interaction with 14-3-3 zeta, although one report indicates stimulation of activity. This is one of the major in vivo phosphorylation sites in cofilin 1 (≥67 reports from high throughput mass spectrometry studies).","ILK; LIMK1; LIMK2; PKD1 (PRKCM; PRKD1); TESK1; TESK2",null,"P23528","P23528"]
[461,236,"NK034-2","Chk1 (CHEK1)","Pan-specific","Checkpoint protein-serine kinase 1",0,458,10,682,{"v":305.536,"d":"306"},{"v":536.8716352384,"d":"537"},{"$f":"(L474+L475)/2","v":{"v":511.118890272,"d":"511"}},{"$f":"SQRT((M474-L474)*(M474-L474))","v":{"v":25.75274496640003,"d":"26"}},{"$f":"N474/M474*100","v":{"v":5.038503850385045,"d":"5"}},0,465,10,615,{"v":279.825,"d":"280"},{"v":488.9144653575,"d":"489"},{"$f":"(U474+U475)/2","v":{"v":492.77144269075,"d":"493"}},{"$f":"SQRT((V474-U474)*(V474-U474))","v":{"v":3.856977333250029,"d":"4"}},{"$f":"W474/V474*100","v":{"v":0.7827112123602835,"d":"1"}},{"$f":"X474+O474","v":{"v":5.821215062745328,"d":"6"}},{"$f":"(V474/M474*100)-100","v":{"v":-3.5896633700010767,"d":"-4"}},null,0,474,12,635,{"v":293.37,"d":"293"},{"v":501.909541518,"d":"502"},{"$f":"(AG474+AG475)/2","v":{"v":492.26895022900004,"d":"492"}},{"$f":"SQRT((AH474-AG474)*(AH474-AG474))","v":{"v":9.640591288999985,"d":"10"}},{"$f":"AI474/AH474*100","v":{"v":1.9583992215058965,"d":"2"}},{"$f":"AJ474+O474","v":{"v":6.996903071890941,"d":"7"}},{"$f":"(AH474/M474*100)-100","v":{"v":-3.6879756161954163,"d":"-4"}},null,null,"CHK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","CHK1",{"$nulls":5},"Epitope undefined.",{"$nulls":3},"Protein-serine kinase, CAMK group, CAMKL family, CHK1 subfamily","O14757","O14757","O14757","O14757","GO:0005813; GO:0000785; GO:0000794; GO:0005737; GO:0005829; GO:0005615; GO:0043231; GO:0005654; GO:0005634; GO:0032991","GO:0005524; GO:0035402; GO:0016301; GO:0019904; GO:0004672; GO:0004674","GO:0006915; GO:0007049; GO:0006974; GO:0071260; GO:0048096; GO:0000077; GO:0006975; GO:0006281; GO:0006260; GO:0035556; GO:0070317; GO:0045839; GO:0018107; GO:0045787; GO:0010569; GO:2000615; GO:0046602; GO:1901796; GO:0010767; GO:0090399; GO:0072425"]
[462,236,"NK034-2","Chk1 (CHEK1)","Pan-specific","Checkpoint protein-serine kinase 1",0,428,12,664,{"v":276.224,"d":"276"},{"v":485.36614530559996,"d":"485"},{"$nulls":3},0,434,16,680,{"v":284.24,"d":"284"},{"v":496.62842002400004,"d":"497"},{"$nulls":6},0,446,12,650,{"v":282.1,"d":"282"},{"v":482.62835894000006,"d":"483"},{"$nulls":7},"CHK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","CHK1",{"$nulls":5},"Epitope undefined.",{"$nulls":4},"O14757","O14757","O14757","O14757"]
[463,237,"NK034","Chk1 (CHEK1)","Pan-specific","Checkpoint protein-serine kinase 1",0,1012,12,723,723,{"v":1270.4172087,"d":"1270"},{"$f":"(L476+L477)/2","v":{"v":1247.9960142559999,"d":"1248"}},{"$f":"SQRT((M476-L476)*(M476-L476))","v":{"v":22.421194444000093,"d":"22"}},{"$f":"N476/M476*100","v":{"v":1.7965758053615757,"d":"2"}},0,1052,14,573,{"v":594.774,"d":"595"},{"v":1039.1981138874,"d":"1039"},{"$f":"(U476+U477)/2","v":{"v":1107.5229603729001,"d":"1108"}},{"$f":"SQRT((V476-U476)*(V476-U476))","v":{"v":68.32484648550007,"d":"68"}},{"$f":"W476/V476*100","v":{"v":6.169158467152255,"d":"6"}},{"$f":"X476+O476","v":{"v":7.9657342725138305,"d":"8"}},{"$f":"(V476/M476*100)-100","v":{"v":-11.255889624522837,"d":"-11"}},null,0,1276,14,694,{"v":875.828,"d":"876"},{"v":1498.4028016792,"d":"1498"},{"$f":"(AG476+AG477)/2","v":{"v":1356.8375191947998,"d":"1357"}},{"$f":"SQRT((AH476-AG476)*(AH476-AG476))","v":{"v":141.5652824844001,"d":"142"}},{"$f":"AI476/AH476*100","v":{"v":10.433473461760583,"d":"10"}},{"$f":"AJ476+O476","v":{"v":12.230049267122158,"d":"12"}},{"$f":"(AH476/M476*100)-100","v":{"v":8.721302287466543,"d":"9"}},null,null,"CHK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","CHK1",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues 1-476 representing full length human Chk1.",null,null,"Protein-serine kinase, CAMK group, CAMKL family, CHK1 subfamily","O14757","O14757","O14757","O14757","GO:0005813; GO:0000785; GO:0000794; GO:0005737; GO:0005829; GO:0005615; GO:0043231; GO:0005654; GO:0005634; GO:0032991","GO:0005524; GO:0035402; GO:0016301; GO:0019904; GO:0004672; GO:0004674","GO:0006915; GO:0007049; GO:0006974; GO:0071260; GO:0048096; GO:0000077; GO:0006975; GO:0006281; GO:0006260; GO:0035556; GO:0070317; GO:0045839; GO:0018107; GO:0045787; GO:0010569; GO:2000615; GO:0046602; GO:1901796; GO:0010767; GO:0090399; GO:0072425"]
[464,237,"NK034","Chk1 (CHEK1)","Pan-specific","Checkpoint protein-serine kinase 1",0,954,14,742,{"v":697.48,"d":"697"},{"v":1225.574819812,"d":"1226"},{"$nulls":3},0,954,18,719,{"v":672.984,"d":"673"},{"v":1175.8478068584002,"d":"1176"},{"$nulls":6},0,1026,17,704,{"v":710.336,"d":"710"},{"v":1215.2722367104,"d":"1215"},{"$nulls":7},"CHK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","CHK1",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues 1-476 representing full length human Chk1.",{"$nulls":3},"O14757","O14757","O14757","O14757"]
[465,238,"PK577","Chk1 (CHEK1)","S280","Checkpoint protein-serine kinase 1",0,7520,16,806,{"v":6048.224,"d":"6048"},{"v":10627.6180521056,"d":"10628"},{"$f":"(L478+L479)/2","v":{"v":10437.106428060699,"d":"10437"}},{"$f":"SQRT((M478-L478)*(M478-L478))","v":{"v":190.5116240449006,"d":"191"}},{"$f":"N478/M478*100","v":{"v":1.8253298973046808,"d":"2"}},0,8589,22,757,{"v":6485.219,"d":"6485"},{"v":11331.0725636069,"d":"11331"},{"$f":"(U478+U479)/2","v":{"v":11360.2894945091,"d":"11360"}},{"$f":"SQRT((V478-U478)*(V478-U478))","v":{"v":29.216930902199238,"d":"29"}},{"$f":"W478/V478*100","v":{"v":0.2571847391417358,"d":"0"}},{"$f":"X478+O478","v":{"v":2.0825146364464167,"d":"2"}},{"$f":"(V478/M478*100)-100","v":{"v":8.845201232847216,"d":"9"}},null,0,8380,16,748,{"v":6256.272,"d":"6256"},{"v":10703.4891472608,"d":"10703"},{"$f":"(AG478+AG479)/2","v":{"v":10416.0062017704,"d":"10416"}},{"$f":"SQRT((AH478-AG478)*(AH478-AG478))","v":{"v":287.4829454903993,"d":"287"}},{"$f":"AI478/AH478*100","v":{"v":2.7600112742015845,"d":"3"}},{"$f":"AJ478+O478","v":{"v":4.585341171506265,"d":"5"}},{"$f":"(AH478/M478*100)-100","v":{"v":-0.20216547982656152,"d":"-0"}},null,null,"CHK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","CHK1",{"$nulls":5},"RVT(pS)GGV(bA)C","Corresponds to amino acid residues R277 to V283; After the kinase catalytic domain in the second half of the kinase.","S280 phosphorylation inhibits phosphotransferase activity. Phosphorylation regulates cell cycle progression, intracellular location, protein degradation, and molecular association. This is the major in vivo phosphorylation site in Chk1 (≥168 reports from high throughput mass spectrometry studies).","Akt1 (PKBa); RSK1","Protein-serine kinase, CAMK group, CAMKL family, CHK1 subfamily","O14757","O14757","O14757","O14757","GO:0005813; GO:0000785; GO:0000794; GO:0005737; GO:0005829; GO:0005615; GO:0043231; GO:0005654; GO:0005634; GO:0032991","GO:0005524; GO:0035402; GO:0016301; GO:0019904; GO:0004672; GO:0004674","GO:0006915; GO:0007049; GO:0006974; GO:0071260; GO:0048096; GO:0000077; GO:0006975; GO:0006281; GO:0006260; GO:0035556; GO:0070317; GO:0045839; GO:0018107; GO:0045787; GO:0010569; GO:2000615; GO:0046602; GO:1901796; GO:0010767; GO:0090399; GO:0072425"]
[466,238,"PK577","Chk1 (CHEK1)","S280","Checkpoint protein-serine kinase 1",0,7246,20,807,{"v":5831.382,"d":"5831"},{"v":10246.594804015798,"d":"10247"},{"$nulls":3},0,8198,19,797,{"v":6518.663,"d":"6519"},{"v":11389.506425411299,"d":"11390"},{"$nulls":6},0,7820,20,759,{"v":5920.2,"d":"5920"},{"v":10128.52325628,"d":"10129"},{"$nulls":7},"CHK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","CHK1",{"$nulls":5},"RVT(pS)GGV(bA)C","Corresponds to amino acid residues R277 to V283; After the kinase catalytic domain in the second half of the kinase.","S280 phosphorylation inhibits phosphotransferase activity. Phosphorylation regulates cell cycle progression, intracellular location, protein degradation, and molecular association. This is the major in vivo phosphorylation site in Chk1 (≥168 reports from high throughput mass spectrometry studies).","Akt1 (PKBa); RSK1",null,"O14757","O14757","O14757","O14757"]
[467,239,"PK578","Chk1 (CHEK1)","S317","Checkpoint protein-serine kinase 1",0,6192,20,851,{"v":5252.372,"d":"5252"},{"v":9229.1891774468,"d":"9229"},{"$f":"(L480+L481)/2","v":{"v":8956.7101648107,"d":"8957"}},{"$f":"SQRT((M480-L480)*(M480-L480))","v":{"v":272.4790126361004,"d":"272"}},{"$f":"N480/M480*100","v":{"v":3.0421774024420407,"d":"3"}},0,5856,24,800,{"v":4665.6,"d":"4666"},{"v":8151.806770560001,"d":"8152"},{"$f":"(U480+U481)/2","v":{"v":8985.442407109751,"d":"8985"}},{"$f":"SQRT((V480-U480)*(V480-U480))","v":{"v":833.6356365497504,"d":"834"}},{"$f":"W480/V480*100","v":{"v":9.277624837816937,"d":"9"}},{"$f":"X480+O480","v":{"v":12.319802240258978,"d":"12"}},{"$f":"(V480/M480*100)-100","v":{"v":0.3207901313133448,"d":"0"}},null,0,6736,20,800,{"v":5372.8,"d":"5373"},{"v":9192.008673920001,"d":"9192"},{"$f":"(AG480+AG481)/2","v":{"v":9084.779978333601,"d":"9085"}},{"$f":"SQRT((AH480-AG480)*(AH480-AG480))","v":{"v":107.22869558640014,"d":"107"}},{"$f":"AI480/AH480*100","v":{"v":1.1803114202229565,"d":"1"}},{"$f":"AJ480+O480","v":{"v":4.222488822664998,"d":"4"}},{"$f":"(AH480/M480*100)-100","v":{"v":1.4298756035007614,"d":"1"}},null,null,"CHK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","CHK1",{"$nulls":5},"YSS(pS)QPE(bA)C","Corresponds to amino acid residues Y314 to E320; In the C-terminal half of the kinase after the catalytic domain.","S317 phosphorylation stimulates phosphotransferase activity. Phosphorylation regulates cell cycle progression and induces interaction with claspin. This is one of the major in vivo phosphorylation sites in Chk1 (≥26 reports from high throughput mass spectrometry studies).","ATM, ATR","Protein-serine kinase, CAMK group, CAMKL family, CHK1 subfamily","O14757","O14757","O14757","O14757","GO:0005813; GO:0000785; GO:0000794; GO:0005737; GO:0005829; GO:0005615; GO:0043231; GO:0005654; GO:0005634; GO:0032991","GO:0005524; GO:0035402; GO:0016301; GO:0019904; GO:0004672; GO:0004674","GO:0006915; GO:0007049; GO:0006974; GO:0071260; GO:0048096; GO:0000077; GO:0006975; GO:0006281; GO:0006260; GO:0035556; GO:0070317; GO:0045839; GO:0018107; GO:0045787; GO:0010569; GO:2000615; GO:0046602; GO:1901796; GO:0010767; GO:0090399; GO:0072425"]
[468,239,"PK578","Chk1 (CHEK1)","S317","Checkpoint protein-serine kinase 1",0,6108,14,811,{"v":4942.234,"d":"4942"},{"v":8684.2311521746,"d":"8684"},{"$nulls":3},0,6666,31,847,{"v":5619.845,"d":"5620"},{"v":9819.078043659501,"d":"9819"},{"$nulls":6},0,6404,28,823,{"v":5247.448,"d":"5247"},{"v":8977.551282747201,"d":"8978"},{"$nulls":7},"CHK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","CHK1",{"$nulls":5},"YSS(pS)QPE(bA)C","Corresponds to amino acid residues Y314 to E320; In the C-terminal half of the kinase after the catalytic domain.","S317 phosphorylation stimulates phosphotransferase activity. Phosphorylation regulates cell cycle progression and induces interaction with claspin. This is one of the major in vivo phosphorylation sites in Chk1 (≥26 reports from high throughput mass spectrometry studies).","ATM, ATR",null,"O14757","O14757","O14757","O14757"]
[469,240,"PK579","Chk1 (CHEK1)","S345","Checkpoint protein-serine kinase 1",0,3390,20,783,{"v":2638.71,"d":"2639"},{"v":4636.601096499,"d":"4637"},{"$f":"(L482+L483)/2","v":{"v":4357.478311434001,"d":"4357"}},{"$f":"SQRT((M482-L482)*(M482-L482))","v":{"v":279.12278506499933,"d":"279"}},{"$f":"N482/M482*100","v":{"v":6.4056035421354265,"d":"6"}},0,3187,18,703,{"v":2227.807,"d":"2228"},{"v":3892.4580302857,"d":"3892"},{"$f":"(U482+U483)/2","v":{"v":4124.13263729285,"d":"4124"}},{"$f":"SQRT((V482-U482)*(V482-U482))","v":{"v":231.67460700714992,"d":"232"}},{"$f":"W482/V482*100","v":{"v":5.617535306993061,"d":"6"}},{"$f":"X482+O482","v":{"v":12.023138849128488,"d":"12"}},{"$f":"(V482/M482*100)-100","v":{"v":-5.355062204873235,"d":"-5"}},null,0,3696,18,793,{"v":2916.654,"d":"2917"},{"v":4989.9324126756,"d":"4990"},{"$f":"(AG482+AG483)/2","v":{"v":4775.7333585542,"d":"4776"}},{"$f":"SQRT((AH482-AG482)*(AH482-AG482))","v":{"v":214.19905412139997,"d":"214"}},{"$f":"AI482/AH482*100","v":{"v":4.48515522202953,"d":"4"}},{"$f":"AJ482+O482","v":{"v":10.890758764164957,"d":"11"}},{"$f":"(AH482/M482*100)-100","v":{"v":9.598557175206125,"d":"10"}},null,null,"CHK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","CHK1",{"$nulls":5},"ISF(pS)QPT(bA)C","Corresponds to amino acid residues I342 to T348; In the C-terminal half of the kinase after the catalytic domain.","S345 phosphorylation stimulates phosphotransferase activity. Phosphorylation regulates apoptosis, cell cycle progression, intracellular location, and protein degradation. It induces binding to 14-3-3-sigma, claspin, p21Cip1 and p53. This is one of the major in vivo phosphorylation sites in Chk1 (≥13 reports from high throughput mass spectrometry studies).","ATM, ATR; COT (MAP3K8)","Protein-serine kinase, CAMK group, CAMKL family, CHK1 subfamily","O14757","O14757","O14757","O14757","GO:0005813; GO:0000785; GO:0000794; GO:0005737; GO:0005829; GO:0005615; GO:0043231; GO:0005654; GO:0005634; GO:0032991","GO:0005524; GO:0035402; GO:0016301; GO:0019904; GO:0004672; GO:0004674","GO:0006915; GO:0007049; GO:0006974; GO:0071260; GO:0048096; GO:0000077; GO:0006975; GO:0006281; GO:0006260; GO:0035556; GO:0070317; GO:0045839; GO:0018107; GO:0045787; GO:0010569; GO:2000615; GO:0046602; GO:1901796; GO:0010767; GO:0090399; GO:0072425"]
[470,240,"PK579","Chk1 (CHEK1)","S345","Checkpoint protein-serine kinase 1",0,3050,16,765,{"v":2321.01,"d":"2321"},{"v":4078.3555263690005,"d":"4078"},{"$nulls":3},0,3014,14,831,2493,{"v":4355.8072443,"d":"4356"},{"$nulls":6},0,3372,14,794,{"v":2666.252,"d":"2666"},{"v":4561.5343044328,"d":"4562"},{"$nulls":7},"CHK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","CHK1",{"$nulls":5},"ISF(pS)QPT(bA)C","Corresponds to amino acid residues I342 to T348; In the C-terminal half of the kinase after the catalytic domain.","S345 phosphorylation stimulates phosphotransferase activity. Phosphorylation regulates apoptosis, cell cycle progression, intracellular location, and protein degradation. It induces binding to 14-3-3-sigma, claspin, p21Cip1 and p53. This is one of the major in vivo phosphorylation sites in Chk1 (≥13 reports from high throughput mass spectrometry studies).","ATM, ATR; COT (MAP3K8)",null,"O14757","O14757","O14757","O14757"]
[471,241,"NK035","Chk2 (CHEK2)","Pan-specific","Checkpoint protein-serine kinase 2",0,796,16,760,{"v":592.8,"d":"593"},{"v":1041.6366823199999,"d":"1042"},{"$f":"(L484+L485)/2","v":{"v":918.4325702796,"d":"918"}},{"$f":"SQRT((M484-L484)*(M484-L484))","v":{"v":123.20411204039988,"d":"123"}},{"$f":"N484/M484*100","v":{"v":13.414606148265479,"d":"13"}},0,750,14,664,{"v":488.704,"d":"489"},{"v":853.8710082304,"d":"854"},{"$f":"(U484+U485)/2","v":{"v":862.8534410595,"d":"863"}},{"$f":"SQRT((V484-U484)*(V484-U484))","v":{"v":8.982432829100048,"d":"9"}},{"$f":"W484/V484*100","v":{"v":1.0410148933369838,"d":"1"}},{"$f":"X484+O484","v":{"v":14.455621041602463,"d":"14"}},{"$f":"(V484/M484*100)-100","v":{"v":-6.05151984137278,"d":"-6"}},null,0,889,12,711,{"v":623.547,"d":"624"},{"v":1066.7900224458,"d":"1067"},{"$f":"(AG484+AG485)/2","v":{"v":989.9022436677001,"d":"990"}},{"$f":"SQRT((AH484-AG484)*(AH484-AG484))","v":{"v":76.88777877810003,"d":"77"}},{"$f":"AI484/AH484*100","v":{"v":7.7672092643433235,"d":"8"}},{"$f":"AJ484+O484","v":{"v":21.181815412608803,"d":"21"}},{"$f":"(AH484/M484*100)-100","v":{"v":7.781700660544132,"d":"8"}},null,null,"CHK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","RAD53",{"$nulls":6},"Epitope undefined.",{"$nulls":3},"Protein-serine kinase, CAMK group, RAD53 family","O96017","O96017","O96017","O96017","GO:0005794; GO:0005654; GO:0016605","GO:0005524; GO:0042802; GO:0016301; GO:0046872; GO:0042803; GO:0019901; GO:0004674; GO:0031625","GO:0051301; GO:0044257; GO:1903926; GO:0006974; GO:0071480; GO:0000077; GO:0006975; GO:0006977; GO:0006978; GO:0006302; GO:0000086; GO:0008630; GO:0042771; GO:0090307; GO:0071157; GO:2000002; GO:0018105; GO:0018107; GO:2000210; GO:0001934; GO:0045893; GO:0046777; GO:0006468; GO:0050821; GO:0042981; GO:0042176; GO:1901796; GO:0006355; GO:0001302; GO:0090399; GO:1903416; GO:0042770; GO:0072428; GO:0006351"]
[472,241,"NK035","Chk2 (CHEK2)","Pan-specific","Checkpoint protein-serine kinase 2",0,707,15,654,{"v":452.568,"d":"453"},{"v":795.2284582392,"d":"795"},{"$nulls":3},0,712,18,719,{"v":498.986,"d":"499"},{"v":871.8358738886,"d":"872"},{"$nulls":6},0,832,16,654,{"v":533.664,"d":"534"},{"v":913.0144648896,"d":"913"},{"$nulls":7},"CHK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","RAD53",{"$nulls":6},"Epitope undefined.",{"$nulls":4},"O96017","O96017","O96017","O96017"]
[473,242,"NK035-2","Chk2 (CHEK2)","Pan-specific","Checkpoint protein-serine kinase 2",0,136,12,634,{"v":78.616,"d":"79"},{"v":138.13986069039998,"d":"138"},{"$f":"(L486+L487)/2","v":{"v":133.12847773160001,"d":"133"}},{"$f":"SQRT((M486-L486)*(M486-L486))","v":{"v":5.01138295879997,"d":"5"}},{"$f":"N486/M486*100","v":{"v":3.764320785597359,"d":"4"}},0,352,18,705,{"v":235.47,"d":"235"},{"v":411.416739597,"d":"411"},{"$f":"(U486+U487)/2","v":{"v":278.1688744257,"d":"278"}},{"$f":"SQRT((V486-U486)*(V486-U486))","v":{"v":133.24786517130002,"d":"133"}},{"$f":"W486/V486*100","v":{"v":47.90178823795437,"d":"48"}},{"$f":"X486+O486","v":{"v":51.666109023551726,"d":"52"}},{"$f":"(V486/M486*100)-100","v":{"v":108.94768659979385,"d":"109"}},null,0,176,16,639,{"v":102.24,"d":"102"},{"v":174.916424736,"d":"175"},{"$f":"(AG486+AG487)/2","v":{"v":154.9064237216,"d":"155"}},{"$f":"SQRT((AH486-AG486)*(AH486-AG486))","v":{"v":20.010001014400018,"d":"20"}},{"$f":"AI486/AH486*100","v":{"v":12.917476585969265,"d":"13"}},{"$f":"AJ486+O486","v":{"v":16.681797371566624,"d":"17"}},{"$f":"(AH486/M486*100)-100","v":{"v":16.358593113267943,"d":"16"}},null,null,"CHK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","RAD53",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 1-300 of human Chk2.",null,null,"Protein-serine kinase, CAMK group, RAD53 family","O96017","O96017","O96017","O96017","GO:0005794; GO:0005654; GO:0016605","GO:0005524; GO:0042802; GO:0016301; GO:0046872; GO:0042803; GO:0019901; GO:0004674; GO:0031625","GO:0051301; GO:0044257; GO:1903926; GO:0006974; GO:0071480; GO:0000077; GO:0006975; GO:0006977; GO:0006978; GO:0006302; GO:0000086; GO:0008630; GO:0042771; GO:0090307; GO:0071157; GO:2000002; GO:0018105; GO:0018107; GO:2000210; GO:0001934; GO:0045893; GO:0046777; GO:0006468; GO:0050821; GO:0042981; GO:0042176; GO:1901796; GO:0006355; GO:0001302; GO:0090399; GO:1903416; GO:0042770; GO:0072428; GO:0006351"]
[474,242,"NK035-2","Chk2 (CHEK2)","Pan-specific","Checkpoint protein-serine kinase 2",0,124,12,651,{"v":72.912,"d":"73"},{"v":128.11709477280002,"d":"128"},{"$nulls":3},0,142,14,648,{"v":82.944,"d":"83"},{"v":144.92100925440002,"d":"145"},{"$nulls":6},0,144,16,616,{"v":78.848,"d":"79"},{"v":134.8964227072,"d":"135"},{"$nulls":7},"CHK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","RAD53",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 1-300 of human Chk2.",{"$nulls":3},"O96017","O96017","O96017","O96017"]
[475,243,"PK581","Chk2 (CHEK2)","T68","Checkpoint protein-serine kinase 2",0,9128,24,837,{"v":7620.048,"d":"7620"},{"v":13389.5437210512,"d":"13390"},{"$f":"(L488+L489)/2","v":{"v":13682.11658706225,"d":"13682"}},{"$f":"SQRT((M488-L488)*(M488-L488))","v":{"v":292.5728660110508,"d":"293"}},{"$f":"N488/M488*100","v":{"v":2.138359691275445,"d":"2"}},0,9230,30,844,{"v":7764.8,"d":"7765"},{"v":13566.77580848,"d":"13567"},{"$f":"(U488+U489)/2","v":{"v":14470.016126576,"d":"14470"}},{"$f":"SQRT((V488-U488)*(V488-U488))","v":{"v":903.2403180959991,"d":"903"}},{"$f":"W488/V488*100","v":{"v":6.242151426749863,"d":"6"}},{"$f":"X488+O488","v":{"v":8.380511118025307,"d":"8"}},{"$f":"(V488/M488*100)-100","v":{"v":5.758608578579015,"d":"6"}},null,0,9587,36,794,{"v":7583.494,"d":"7583"},{"v":12974.1554918516,"d":"12974"},{"$f":"(AG488+AG489)/2","v":{"v":13404.622007347,"d":"13405"}},{"$f":"SQRT((AH488-AG488)*(AH488-AG488))","v":{"v":430.4665154954,"d":"430"}},{"$f":"AI488/AH488*100","v":{"v":3.21132901218299,"d":"3"}},{"$f":"AJ488+O488","v":{"v":5.349688703458435,"d":"5"}},{"$f":"(AH488/M488*100)-100","v":{"v":-2.0281553511804447,"d":"-2"}},null,null,"CHK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","RAD53",{"$nulls":6},"TVS(pT)QEL(bA)C","Corresponds to amino acid residues T65 to L71; In the N-terminal portion of the kinase before the FHA domain.","T68 phosphorylation stimulates phosphotransferase activity, and induces interactions with Chk2, MDC1, NBS1 and Plk1. This is one of the minor in vivo phosphorylation sites in Chk2 (≥3 reports from high throughput mass spectrometry studies).","ATM; ATR; Chk2 (CHEK2); DNAPK (PRKDC); Plk1 (PLK); TTK; ZAK (MLTK)","Protein-serine kinase, CAMK group, RAD53 family","O96017","O96017","O96017","O96017","GO:0005794; GO:0005654; GO:0016605","GO:0005524; GO:0042802; GO:0016301; GO:0046872; GO:0042803; GO:0019901; GO:0004674; GO:0031625","GO:0051301; GO:0044257; GO:1903926; GO:0006974; GO:0071480; GO:0000077; GO:0006975; GO:0006977; GO:0006978; GO:0006302; GO:0000086; GO:0008630; GO:0042771; GO:0090307; GO:0071157; GO:2000002; GO:0018105; GO:0018107; GO:2000210; GO:0001934; GO:0045893; GO:0046777; GO:0006468; GO:0050821; GO:0042981; GO:0042176; GO:1901796; GO:0006355; GO:0001302; GO:0090399; GO:1903416; GO:0042770; GO:0072428; GO:0006351"]
[476,243,"PK581","Chk2 (CHEK2)","T68","Checkpoint protein-serine kinase 2",0,9257,20,861,{"v":7953.057,"d":"7953"},{"v":13974.689453073299,"d":"13975"},{"$nulls":3},0,9850,30,896,{"v":8798.72,"d":"8799"},{"v":15373.256444671999,"d":"15373"},{"$nulls":6},0,9106,30,891,{"v":8086.716,"d":"8087"},{"v":13835.088522842401,"d":"13835"},{"$nulls":7},"CHK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","RAD53",{"$nulls":6},"TVS(pT)QEL(bA)C","Corresponds to amino acid residues T65 to L71; In the N-terminal portion of the kinase before the FHA domain.","T68 phosphorylation stimulates phosphotransferase activity, and induces interactions with Chk2, MDC1, NBS1 and Plk1. This is one of the minor in vivo phosphorylation sites in Chk2 (≥3 reports from high throughput mass spectrometry studies).","ATM; ATR; Chk2 (CHEK2); DNAPK (PRKDC); Plk1 (PLK); TTK; ZAK (MLTK)",null,"O96017","O96017","O96017","O96017"]
[477,244,"PK580","Chk2 (CHEK2)","T383","Checkpoint protein-serine kinase 2",0,9076,18,813,{"v":7364.154,"d":"7364"},{"v":12939.9003722226,"d":"12940"},{"$f":"(L490+L491)/2","v":{"v":12663.845565645,"d":"12664"}},{"$f":"SQRT((M490-L490)*(M490-L490))","v":{"v":276.0548065776002,"d":"276"}},{"$f":"N490/M490*100","v":{"v":2.1798655483172737,"d":"2"}},0,9322,18,749,{"v":6968.696,"d":"6969"},{"v":12175.8108785096,"d":"12176"},{"$f":"(U490+U491)/2","v":{"v":13555.556940322898,"d":"13556"}},{"$f":"SQRT((V490-U490)*(V490-U490))","v":{"v":1379.746061813299,"d":"1380"}},{"$f":"W490/V490*100","v":{"v":10.178453514580811,"d":"10"}},{"$f":"X490+O490","v":{"v":12.358319062898085,"d":"12"}},{"$f":"(V490/M490*100)-100","v":{"v":7.041394891114038,"d":"7"}},null,0,10243,54,578,{"v":5889.242,"d":"5889"},{"v":10075.5590282188,"d":"10076"},{"$f":"(AG490+AG491)/2","v":{"v":11831.5221593024,"d":"11832"}},{"$f":"SQRT((AH490-AG490)*(AH490-AG490))","v":{"v":1755.9631310835994,"d":"1756"}},{"$f":"AI490/AH490*100","v":{"v":14.841396630466463,"d":"15"}},{"$f":"AJ490+O490","v":{"v":17.021262178783736,"d":"17"}},{"$f":"(AH490/M490*100)-100","v":{"v":-6.5724380641577085,"d":"-7"}},null,null,"CHK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","RAD53",{"$nulls":6},"LMR(pT)LCG(bA)C","Corresponds to amino acid residues L380 to G386; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T383 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in XXX.","Chk2 (CHEK2); DNAPK (PRKDC)","Protein-serine kinase, CAMK group, RAD53 family","O96017","O96017","O96017","O96017","GO:0005794; GO:0005654; GO:0016605","GO:0005524; GO:0042802; GO:0016301; GO:0046872; GO:0042803; GO:0019901; GO:0004674; GO:0031625","GO:0051301; GO:0044257; GO:1903926; GO:0006974; GO:0071480; GO:0000077; GO:0006975; GO:0006977; GO:0006978; GO:0006302; GO:0000086; GO:0008630; GO:0042771; GO:0090307; GO:0071157; GO:2000002; GO:0018105; GO:0018107; GO:2000210; GO:0001934; GO:0045893; GO:0046777; GO:0006468; GO:0050821; GO:0042981; GO:0042176; GO:1901796; GO:0006355; GO:0001302; GO:0090399; GO:1903416; GO:0042770; GO:0072428; GO:0006351"]
[478,244,"PK580","Chk2 (CHEK2)","T383","Checkpoint protein-serine kinase 2",0,8978,20,787,{"v":7049.946,"d":"7050"},{"v":12387.7907590674,"d":"12388"},{"$nulls":3},0,9539,20,898,{"v":8548.062,"d":"8548"},{"v":14935.3030021362,"d":"14935"},{"$nulls":6},0,9635,20,826,{"v":7941.99,"d":"7942"},{"v":13587.485290386001,"d":"13587"},{"$nulls":7},"CHK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","RAD53",{"$nulls":6},"LMR(pT)LCG(bA)C","Corresponds to amino acid residues L380 to G386; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T383 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in XXX.","Chk2 (CHEK2); DNAPK (PRKDC)",null,"O96017","O96017","O96017","O96017"]
[479,849,"PN249","Cip (WAF1; p21) p21(WAF1/CIP1)","T145","Cyclin-dependent kinase inhibitor 1",0,42,6,652,{"v":23.472,"d":"23"},{"v":41.243752036800004,"d":"41"},{"$f":"(L492+L493)/2","v":{"v":83.7315640788,"d":"84"}},{"$f":"SQRT((M492-L492)*(M492-L492))","v":{"v":42.487812042,"d":"42"}},{"$f":"N492/M492*100","v":{"v":50.742885922941326,"d":"51"}},0,108,8,340,34,{"v":59.4053134,"d":"59"},{"$f":"(U492+U493)/2","v":{"v":64.612014398,"d":"65"}},{"$f":"SQRT((V492-U492)*(V492-U492))","v":{"v":5.206700998000002,"d":"5"}},{"$f":"W492/V492*100","v":{"v":8.058409951325045,"d":"8"}},{"$f":"X492+O492","v":{"v":58.80129587426637,"d":"59"}},{"$f":"(V492/M492*100)-100","v":{"v":-22.834339584062405,"d":"-23"}},null,0,127,10,368,{"v":43.056,"d":"43"},{"v":73.6619873184,"d":"74"},{"$f":"(AG492+AG493)/2","v":{"v":86.1759367387,"d":"86"}},{"$f":"SQRT((AH492-AG492)*(AH492-AG492))","v":{"v":12.513949420300008,"d":"13"}},{"$f":"AI492/AH492*100","v":{"v":14.52139645228855,"d":"15"}},{"$f":"AJ492+O492","v":{"v":65.26428237522988,"d":"65"}},{"$f":"(AH492/M492*100)-100","v":{"v":2.9192965481924915,"d":"3"}},{"$nulls":15},"Not precisely defined.","Antibody raised against amino acid residues 140-149 with phospho-T145 of human p21.","T145 phosphorylation -reduces binding to PCNA, CDK2 and CDK4. This is one of the major in vivo phosphorylation sites in Cip.","Akt1 (PKBa); Akt3 (PKBg); DAPK3 (ZIPK); Pim1","Inhibitor protein","P38936","P38936",null,"P38936","GO:0000307; GO:0005829; GO:0016604; GO:0005730; GO:0005654; GO:0005634; GO:0070557; GO:0048471; GO:0032991","GO:0030332; GO:0019912; GO:0004693; GO:0004861; GO:0046872; GO:0044877; GO:0019901; GO:0004860; GO:0031625","GO:0031100; GO:0007050; GO:0034198; GO:0006974; GO:0031668; GO:0071480; GO:0034605; GO:0071479; GO:0071493; GO:0090398; GO:0019221; GO:0006977; GO:0006978; GO:0000082; GO:0000086; GO:0060574; GO:0097193; GO:0042771; GO:0071850; GO:0043066; GO:0030308; GO:0008285; GO:1904030; GO:0045736; GO:2000134; GO:0010629; GO:0042326; GO:1904706; GO:0030890; GO:0048146; GO:0043068; GO:0045860; GO:2000379; GO:0050821; GO:0007265; GO:0000079; GO:2000278; GO:0033158; GO:0006357; GO:0090399; GO:0046685; GO:0051412; GO:0042493; GO:0055093; GO:0010243; GO:0009636; GO:0010165; GO:0090400; GO:0006367"]
[480,849,"PN249","Cip (WAF1; p21) p21(WAF1/CIP1)","T145","Cyclin-dependent kinase inhibitor 1",0,156,10,492,{"v":71.832,"d":"72"},{"v":126.21937612079999,"d":"126"},{"$nulls":3},0,128,8,333,{"v":39.96,"d":"40"},{"v":69.818715396,"d":"70"},{"$nulls":6},0,147,8,415,{"v":57.685,"d":"58"},{"v":98.68988615900001,"d":"99"},{"$nulls":20},"Not precisely defined.","Antibody raised against amino acid residues 140-149 with phospho-T145 of human p21.","T145 phosphorylation -reduces binding to PCNA, CDK2 and CDK4. This is one of the major in vivo phosphorylation sites in Cip.","Akt1 (PKBa); Akt3 (PKBg); DAPK3 (ZIPK); Pim1",null,"P38936","P38936",null,"P38936"]
[481,850,"PN248","Cip (WAF1; p21) p21(WAF1/CIP1)","S146","Cyclin-dependent kinase inhibitor 1",0,24,8,657,{"v":10.512,"d":"11"},{"v":18.4711282128,"d":"18"},{"$f":"(L494+L495)/2","v":{"v":58.541106120399995,"d":"59"}},{"$f":"SQRT((M494-L494)*(M494-L494))","v":{"v":40.06997790759999,"d":"40"}},{"$f":"N494/M494*100","v":{"v":68.44759274822907,"d":"68"}},0,28,6,656,{"v":14.432,"d":"14"},{"v":25.2158083232,"d":"25"},{"$f":"(U494+U495)/2","v":{"v":27.6898649048,"d":"28"}},{"$f":"SQRT((V494-U494)*(V494-U494))","v":{"v":2.4740565815999993,"d":"2"}},{"$f":"W494/V494*100","v":{"v":8.934881373043915,"d":"9"}},{"$f":"X494+O494","v":{"v":77.38247412127299,"d":"77"}},{"$f":"(V494/M494*100)-100","v":{"v":-52.70013373534322,"d":"-53"}},null,0,26,6,658,{"v":13.16,"d":"13"},{"v":22.514672824,"d":"23"},{"$f":"(AG494+AG495)/2","v":{"v":39.588869996,"d":"40"}},{"$f":"SQRT((AH494-AG494)*(AH494-AG494))","v":{"v":17.074197171999998,"d":"17"}},{"$f":"AI494/AH494*100","v":{"v":43.12878133102851,"d":"43"}},{"$f":"AJ494+O494","v":{"v":111.57637407925759,"d":"112"}},{"$f":"(AH494/M494*100)-100","v":{"v":-32.374236464581685,"d":"-32"}},{"$nulls":15},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S146 phosphosite.","S146 phosphorylation induces its release from CDK2 and PCNA, cytoplasmic relocalization and subsequent degradation. This is one of the major in vivo phosphorylation sites in Cip.","Akt1 (PKBa); Akt3 (PKBg); Pim1; PKCa (PRKCA)","Inhibitor protein","P38936","P38936",null,"P38936","GO:0000307; GO:0005829; GO:0016604; GO:0005730; GO:0005654; GO:0005634; GO:0070557; GO:0048471; GO:0032991","GO:0030332; GO:0019912; GO:0004693; GO:0004861; GO:0046872; GO:0044877; GO:0019901; GO:0004860; GO:0031625","GO:0031100; GO:0007050; GO:0034198; GO:0006974; GO:0031668; GO:0071480; GO:0034605; GO:0071479; GO:0071493; GO:0090398; GO:0019221; GO:0006977; GO:0006978; GO:0000082; GO:0000086; GO:0060574; GO:0097193; GO:0042771; GO:0071850; GO:0043066; GO:0030308; GO:0008285; GO:1904030; GO:0045736; GO:2000134; GO:0010629; GO:0042326; GO:1904706; GO:0030890; GO:0048146; GO:0043068; GO:0045860; GO:2000379; GO:0050821; GO:0007265; GO:0000079; GO:2000278; GO:0033158; GO:0006357; GO:0090399; GO:0046685; GO:0051412; GO:0042493; GO:0055093; GO:0010243; GO:0009636; GO:0010165; GO:0090400; GO:0006367"]
[482,850,"PN248","Cip (WAF1; p21) p21(WAF1/CIP1)","S146","Cyclin-dependent kinase inhibitor 1",0,130,8,460,{"v":56.12,"d":"56"},{"v":98.611084028,"d":"99"},{"$nulls":3},0,36,10,664,{"v":17.264,"d":"17"},{"v":30.1639214864,"d":"30"},{"$nulls":6},0,102,10,360,{"v":33.12,"d":"33"},{"v":56.663067168,"d":"57"},{"$nulls":20},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S146 phosphosite.","S146 phosphorylation induces its release from CDK2 and PCNA, cytoplasmic relocalization and subsequent degradation. This is one of the major in vivo phosphorylation sites in Cip.","Akt1 (PKBa); Akt3 (PKBg); Pim1; PKCa (PRKCA)",null,"P38936","P38936",null,"P38936"]
[483,245,"NK036","CK1 delta (CSNK1D)","Pan-specific","Casein protein-serine kinase 1 delta",0,388,16,660,{"v":245.52,"d":"246"},{"v":431.414706888,"d":"431"},{"$f":"(L496+L497)/2","v":{"v":428.7051863682,"d":"429"}},{"$f":"SQRT((M496-L496)*(M496-L496))","v":{"v":2.709520519800037,"d":"3"}},{"$f":"N496/M496*100","v":{"v":0.6320241989031885,"d":"1"}},0,367,16,587,{"v":206.037,"d":"206"},{"v":359.9909575587,"d":"360"},{"$f":"(U496+U497)/2","v":{"v":374.42382789225,"d":"374"}},{"$f":"SQRT((V496-U496)*(V496-U496))","v":{"v":14.43287033355,"d":"14"}},{"$f":"W496/V496*100","v":{"v":3.8546879921604305,"d":"4"}},{"$f":"X496+O496","v":{"v":4.486712191063619,"d":"4"}},{"$f":"(V496/M496*100)-100","v":{"v":-12.66169857561033,"d":"-13"}},null,0,408,16,621,{"v":243.432,"d":"243"},{"v":416.4735436848,"d":"416"},{"$f":"(AG496+AG497)/2","v":{"v":425.5786416156,"d":"426"}},{"$f":"SQRT((AH496-AG496)*(AH496-AG496))","v":{"v":9.105097930800014,"d":"9"}},{"$f":"AI496/AH496*100","v":{"v":2.1394630840107123,"d":"2"}},{"$f":"AJ496+O496","v":{"v":2.771487282913901,"d":"3"}},{"$f":"(AH496/M496*100)-100","v":{"v":-0.729299493455315,"d":"-1"}},null,null,"CK1d","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CK1","CK1",{"$nulls":6},"Epitope undefined.",{"$nulls":3},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); CK1 group; CK1 family","P48730","P48730","P48730",null,"GO:0005813; GO:0005829; GO:0033116; GO:0005794; GO:0000139; GO:0043005; GO:0005654; GO:0005634; GO:0048471; GO:0005886; GO:0005819; GO:0005876","GO:0005524; GO:0045296; GO:0042277; GO:0004672; GO:0004674; GO:0050321","GO:1990090; GO:0097711; GO:0032922; GO:0048208; GO:0006897; GO:0000086; GO:0007030; GO:0007020; GO:1905515; GO:0018105; GO:0090263; GO:2000052; GO:0032436; GO:0001934; GO:1905426; GO:0071539; GO:0061512; GO:0034067; GO:0006468; GO:0008360; GO:0042752; GO:0010389; GO:0051225; GO:0016055"]
[484,245,"NK036","CK1 delta (CSNK1D)","Pan-specific","Casein protein-serine kinase 1 delta",0,368,12,681,{"v":242.436,"d":"242"},{"v":425.9956658484,"d":"426"},{"$nulls":3},0,310,16,757,{"v":222.558,"d":"223"},{"v":388.8566982258,"d":"389"},{"$nulls":6},0,388,16,683,{"v":254.076,"d":"254"},{"v":434.68373954640003,"d":"435"},{"$nulls":7},"CK1d","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CK1","CK1",{"$nulls":6},"Epitope undefined.",{"$nulls":4},"P48730","P48730","P48730"]
[485,246,"NK037-1","CK1 epsilon (CSNK1E)","Pan-specific","Casein protein-serine kinase 1 epsilon",0,3598,14,513,{"v":1838.592,"d":"1839"},{"v":3230.6762331648,"d":"3231"},{"$f":"(L498+L499)/2","v":{"v":3028.2212816406,"d":"3028"}},{"$f":"SQRT((M498-L498)*(M498-L498))","v":{"v":202.45495152420017,"d":"202"}},{"$f":"N498/M498*100","v":{"v":6.685606258420987,"d":"7"}},0,3866,16,541,{"v":2082.85,"d":"2083"},{"v":3639.1869710349997,"d":"3639"},{"$f":"(U498+U499)/2","v":{"v":3344.3007425324995,"d":"3344"}},{"$f":"SQRT((V498-U498)*(V498-U498))","v":{"v":294.8862285025002,"d":"295"}},{"$f":"W498/V498*100","v":{"v":8.817575068897517,"d":"9"}},{"$f":"X498+O498","v":{"v":15.503181327318504,"d":"16"}},{"$f":"(V498/M498*100)-100","v":{"v":10.437792733583095,"d":"10"}},null,0,3904,12,552,{"v":2148.384,"d":"2148"},{"v":3675.5442902976,"d":"3676"},{"$f":"(AG498+AG499)/2","v":{"v":3332.5103245492,"d":"3333"}},{"$f":"SQRT((AH498-AG498)*(AH498-AG498))","v":{"v":343.0339657484001,"d":"343"}},{"$f":"AI498/AH498*100","v":{"v":10.293560479660432,"d":"10"}},{"$f":"AJ498+O498","v":{"v":16.979166738081418,"d":"17"}},{"$f":"(AH498/M498*100)-100","v":{"v":10.048441464744798,"d":"10"}},null,null,"CK1e","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CK1","CK1",{"$nulls":6},"Not precisely defined.","Antibody raised against recombinant full length protein (Human) with a His tag.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); CK1 group; CK1 family","P49674","P49674","P49674",null,"GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0004672; GO:0004674; GO:0003723","GO:0060070; GO:0097711; GO:0032922; GO:0006281; GO:0006897; GO:0000086; GO:0032091; GO:0018105; GO:2000052; GO:0032436; GO:1905426; GO:0006468; GO:0008360; GO:1903827; GO:0042752; GO:0010389; GO:0007165; GO:0016055"]
[486,246,"NK037-1","CK1 epsilon (CSNK1E)","Pan-specific","Casein protein-serine kinase 1 epsilon",0,3085,16,524,{"v":1608.156,"d":"1608"},{"v":2825.7663301164,"d":"2826"},{"$nulls":3},0,3116,16,563,{"v":1745.3,"d":"1745"},{"v":3049.4145140299997,"d":"3049"},{"$nulls":6},0,3336,14,526,{"v":1747.372,"d":"1747"},{"v":2989.4763588008004,"d":"2989"},{"$nulls":7},"CK1e","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CK1","CK1",{"$nulls":6},"Not precisely defined.","Antibody raised against recombinant full length protein (Human) with a His tag.",{"$nulls":3},"P49674","P49674","P49674"]
[487,247,"NK041-3","CK2a1 (CSNK2A1)","Pan-specific","Casein protein-serine kinase 2 alpha/ alpha prime",0,238,14,668,{"v":149.632,"d":"150"},{"v":262.9254049408,"d":"263"},{"$f":"(L500+L501)/2","v":{"v":262.70927587209997,"d":"263"}},{"$f":"SQRT((M500-L500)*(M500-L500))","v":{"v":0.21612906870001325,"d":"0"}},{"$f":"N500/M500*100","v":{"v":0.08226929482506576,"d":"0"}},0,252,14,503,{"v":119.714,"d":"120"},{"v":209.1661084814,"d":"209"},{"$f":"(U500+U501)/2","v":{"v":183.9834972451,"d":"184"}},{"$f":"SQRT((V500-U500)*(V500-U500))","v":{"v":25.182611236299977,"d":"25"}},{"$f":"W500/V500*100","v":{"v":13.687429369141778,"d":"14"}},{"$f":"X500+O500","v":{"v":13.769698663966844,"d":"14"}},{"$f":"(V500/M500*100)-100","v":{"v":-29.966881970824517,"d":"-30"}},null,0,242,22,647,{"v":142.34,"d":"142"},{"v":243.52116487600003,"d":"244"},{"$f":"(AG500+AG501)/2","v":{"v":247.866702032,"d":"248"}},{"$f":"SQRT((AH500-AG500)*(AH500-AG500))","v":{"v":4.345537155999978,"d":"4"}},{"$f":"AI500/AH500*100","v":{"v":1.7531750414135745,"d":"2"}},{"$f":"AJ500+O500","v":{"v":1.8354443362386403,"d":"2"}},{"$f":"(AH500/M500*100)-100","v":{"v":-5.649809581647986,"d":"-6"}},null,null,"CK2a1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","CK2",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 2-27 at the N-terminus of human casein kinase IIα .",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; CK2 family","P68400","P68400","P68400","P68400","GO:0005829; GO:0005654; GO:0005634; GO:0016581; GO:0005886; GO:0005956; GO:0016580","GO:0005524; GO:0051879; GO:0042802; GO:0016301; GO:0047485; GO:0004674","GO:0006915; GO:0007049; GO:0061077; GO:2001234; GO:0043154; GO:2000059; GO:0018105; GO:0018107; GO:0030307; GO:0008284; GO:0045732; GO:0030177; GO:0006468; GO:1905818; GO:1901796; GO:0006355; GO:0048511; GO:0007165; GO:0006351; GO:0016055"]
[489,248,"NK041-2","CK2a1 (CSNK2A1)","Pan-specific","Casein protein-serine kinase 2 alpha/ alpha prime",0,2562,14,1004,{"v":2558.192,"d":"2558"},{"v":4495.1191424048,"d":"4495"},{"$f":"(L502+L503)/2","v":{"v":4656.8891146064,"d":"4657"}},{"$f":"SQRT((M502-L502)*(M502-L502))","v":{"v":161.76997220159956,"d":"162"}},{"$f":"N502/M502*100","v":{"v":3.4737776275197474,"d":"3"}},0,3668,16,642,{"v":2344.584,"d":"2345"},{"v":4096.4925680184,"d":"4096"},{"$f":"(U502+U503)/2","v":{"v":4546.8477433339995,"d":"4547"}},{"$f":"SQRT((V502-U502)*(V502-U502))","v":{"v":450.3551753155998,"d":"450"}},{"$f":"W502/V502*100","v":{"v":9.904778007485568,"d":"10"}},{"$f":"X502+O502","v":{"v":13.378555635005316,"d":"13"}},{"$f":"(V502/M502*100)-100","v":{"v":-2.3629802764092886,"d":"-2"}},null,0,3948,16,648,{"v":2547.936,"d":"2548"},{"v":4359.114393350401,"d":"4359"},{"$f":"(AG502+AG503)/2","v":{"v":4574.9507226916,"d":"4575"}},{"$f":"SQRT((AH502-AG502)*(AH502-AG502))","v":{"v":215.83632934119942,"d":"216"}},{"$f":"AI502/AH502*100","v":{"v":4.717784789913879,"d":"5"}},{"$f":"AJ502+O502","v":{"v":8.191562417433627,"d":"8"}},{"$f":"(AH502/M502*100)-100","v":{"v":-1.759509189467252,"d":"-2"}},null,null,"CK2a1","X","DSK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","CK2",{"$nulls":6},"CARVYTDVNTHRPREYWDYE","Corresponds to amino acid residues A9 to E27; Post-N-terminus, conserved in both CK2 isoforms.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; CK2 family","P68400","P68400","P68400","P68400","GO:0005829; GO:0005654; GO:0005634; GO:0016581; GO:0005886; GO:0005956; GO:0016580","GO:0005524; GO:0051879; GO:0042802; GO:0016301; GO:0047485; GO:0004674","GO:0006915; GO:0007049; GO:0061077; GO:2001234; GO:0043154; GO:2000059; GO:0018105; GO:0018107; GO:0030307; GO:0008284; GO:0045732; GO:0030177; GO:0006468; GO:1905818; GO:1901796; GO:0006355; GO:0048511; GO:0007165; GO:0006351; GO:0016055"]
[494,250,"PK167","CK2a1 (CSNK2A1)","T360+S362","Casein protein-serine kinase 2 alpha/ alpha prime",0,1790,12,353,{"v":627.634,"d":"628"},{"v":1102.8451374346,"d":"1103"},{"$nulls":3},0,1702,14,376,{"v":634.688,"d":"635"},{"v":1108.9364573888,"d":"1109"},{"$nulls":6},0,1466,12,356,{"v":517.624,"d":"518"},{"v":885.5725688336,"d":"886"},{"$nulls":7},"CK2a1","X","DSK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","CK2",{"$nulls":6},"VP(pT)P(pS)PL","Corresponds to amino acid residues V358 to L364.","Phosphorylation at T360 and S362 stimulates phosphotransferase activity. The effects of T360 and S362 phosphorylation are unclear. T360 phosphorylation has not been reported following high throughput mass spectrometry, and S362 phosphorylation has been described only once from high throughput mass spectrometry studies.","T360: CDK1 (CDC2); ERK2 (MAPK1). S362: CDK1 (CDC2); ERK2 (MAPK1).",null,"P68400","P68400","P68400","P68400"]
[499,253,"NK370-1","CLK1/4","Pan-specific","Dual specificity protein kinase CLK1/4",0,182,14,552,{"v":92.736,"d":"93"},{"v":162.95077491840001,"d":"163"},{"$f":"(L512+L513)/2","v":{"v":147.88411882435003,"d":"148"}},{"$f":"SQRT((M512-L512)*(M512-L512))","v":{"v":15.06665609404999,"d":"15"}},{"$f":"N512/M512*100","v":{"v":10.188150163673404,"d":"10"}},0,210,14,504,{"v":98.784,"d":"99"},{"v":172.59689643840002,"d":"173"},{"$f":"(U512+U513)/2","v":{"v":163.09903515480002,"d":"163"}},{"$f":"SQRT((V512-U512)*(V512-U512))","v":{"v":9.497861283600002,"d":"9"}},{"$f":"W512/V512*100","v":{"v":5.823370613189357,"d":"6"}},{"$f":"X512+O512","v":{"v":16.01152077686276,"d":"16"}},{"$f":"(V512/M512*100)-100","v":{"v":10.288404496308075,"d":"10"}},null,0,204,18,612,{"v":113.832,"d":"114"},{"v":194.7484982448,"d":"195"},{"$f":"(AG512+AG513)/2","v":{"v":175.46560482540002,"d":"175"}},{"$f":"SQRT((AH512-AG512)*(AH512-AG512))","v":{"v":19.282893419399983,"d":"19"}},{"$f":"AI512/AH512*100","v":{"v":10.98955743411237,"d":"11"}},{"$f":"AJ512+O512","v":{"v":21.177707597785776,"d":"21"}},{"$f":"(AH512/M512*100)-100","v":{"v":18.650742365250196,"d":"19"}},null,null,"CLK1","X","DSK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CLK",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 202-227 within an internal region of human CLK1.",null,null,"Protein kinase, dual-specificity; EC 2.7.12.1; EC 2.7.1.112; CMGC group; CLK family","P49759/Q9HAZ1","P49759","P49759",null,"GO:0005737; GO:0005634","GO:0005524; GO:0004715; GO:0004712; GO:0004674","GO:0008283; GO:0018105; GO:0018107; GO:0046777; GO:0043484"]
[500,253,"NK370-1","CLK1/4","Pan-specific","Dual specificity protein kinase CLK1/4",0,148,17,577,{"v":75.587,"d":"76"},{"v":132.8174627303,"d":"133"},{"$nulls":3},0,166,18,594,{"v":87.912,"d":"88"},{"v":153.60117387120002,"d":"154"},{"$nulls":6},0,188,18,537,{"v":91.29,"d":"91"},{"v":156.182711406,"d":"156"},{"$nulls":7},"CLK1","X","DSK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CLK",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 202-227 within an internal region of human CLK1.",{"$nulls":3},"P49759/Q9HAZ1","P49759","P49759"]
[506,285,"PN190","CLNB1","S147","Cyclin B1",0,432,10,396,{"v":167.112,"d":"167"},{"v":293.64033275279996,"d":"294"},{"$nulls":3},0,613,14,398,{"v":238.402,"d":"238"},{"v":416.5395742702,"d":"417"},{"$nulls":6},0,534,14,352,{"v":183.04,"d":"183"},{"v":313.152409856,"d":"313"},{"$nulls":20},"AF(pS)DV","Corresponds to amino acid residues A145 to V149."," S147 phosphorylation induces interaction with DNA. This is one of the minor in vivo phosphorylation sites in cyclin B1 (≥1 reports from high throughput mass spectrometry studies).","Plk1 (PLK)",null,"P14635","P14635",null,"P14635"]
[511,258,"NN398-1","Connexin 43","Pan-specific","Gap junction alpha-1 protein",0,308,12,582,{"v":172.272,"d":"172"},{"v":302.70721075679995,"d":"303"},{"$f":"(L524+L525)/2","v":{"v":330.72316093039996,"d":"331"}},{"$f":"SQRT((M524-L524)*(M524-L524))","v":{"v":28.015950173600004,"d":"28"}},{"$f":"N524/M524*100","v":{"v":8.47111828962469,"d":"8"}},0,298,14,583,{"v":165.572,"d":"166"},{"v":289.28989853720003,"d":"289"},{"$f":"(U524+U525)/2","v":{"v":251.44172504100004,"d":"251"}},{"$f":"SQRT((V524-U524)*(V524-U524))","v":{"v":37.84817349619999,"d":"38"}},{"$f":"W524/V524*100","v":{"v":15.052463345146267,"d":"15"}},{"$f":"X524+O524","v":{"v":23.523581634770956,"d":"24"}},{"$f":"(V524/M524*100)-100","v":{"v":-23.972145061253983,"d":"-24"}},null,0,383,16,584,{"v":214.328,"d":"214"},{"v":366.6812155792,"d":"367"},{"$f":"(AG524+AG525)/2","v":{"v":375.8615905316,"d":"376"}},{"$f":"SQRT((AH524-AG524)*(AH524-AG524))","v":{"v":9.180374952399973,"d":"9"}},{"$f":"AI524/AH524*100","v":{"v":2.442488188116191,"d":"2"}},{"$f":"AJ524+O524","v":{"v":10.913606477740881,"d":"11"}},{"$f":"(AH524/M524*100)-100","v":{"v":13.64840293441054,"d":"14"}},{"$nulls":15},"Not precisely defined.","Antibody raised against amino acid residues 357-381 at the C-terminus of human connexin 43.",null,null,"Cytoskeletal protein","P17302","P17302",null,null,"GO:0016324; GO:0030054; GO:0005922; GO:0043292; GO:0005829; GO:0005769; GO:0005789; GO:0005916; GO:0005925; GO:0005921; GO:0005794; GO:0030660; GO:0000139; GO:0005887; GO:0014704; GO:0005882; GO:0043231; GO:0016328; GO:0005764; GO:0045121; GO:0005741; GO:0005739; GO:0005771; GO:0005654; GO:0005886","GO:0048487; GO:0071253; GO:0097718; GO:0005243; GO:0086075; GO:1903763; GO:0015075; GO:0030165; GO:1990782; GO:0097110; GO:0017124; GO:0005102","GO:0007512; GO:0006915; GO:0015867; GO:0086014; GO:0003294; GO:0048514; GO:0007267; GO:0010643; GO:0010644; GO:0086064; GO:0071260; GO:0071374; GO:0071467; GO:0002544; GO:0046697; GO:0042733; GO:0003158; GO:1905867; GO:0002070; GO:0016264; GO:0007507; GO:0001947; GO:0001701; GO:0034220; GO:0002088; GO:0060156; GO:0006936; GO:0060044; GO:0030308; GO:2000279; GO:0001937; GO:0010629; GO:0061045; GO:0001764; GO:0048812; GO:0001649; GO:2000987; GO:0097755; GO:0010652; GO:0120162; GO:0007204; GO:0010628; GO:0003104; GO:0043123; GO:0032024; GO:0045669; GO:0045732; GO:0045844; GO:0045907; GO:0051259; GO:0060371; GO:2000810; GO:0030500; GO:0046850; GO:0051924; GO:0022898; GO:0060373; GO:0060307; GO:0032355; GO:0034405; GO:0009749; GO:0002931; GO:0032496; GO:0043434; GO:0032526; GO:0007165; GO:0043403; GO:0010232"]
[516,260,"NK042-2","COT (MAP3K8, TPL2)","Pan-specific","Osaka thyroid oncogene protein-serine kinase (Tpl2); Mitogen-activated protein kinase kinase kinase 8",0,3102,24,808,{"v":2487.024,"d":"2487"},{"v":4370.066511825599,"d":"4370"},{"$nulls":3},0,3124,18,676,{"v":2099.656,"d":"2100"},{"v":3668.5506680056,"d":"3669"},{"$nulls":6},0,3386,26,845,{"v":2839.2,"d":"2839"},{"v":4857.42090288,"d":"4857"},{"$nulls":7},"COT","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE-Unique",{"$nulls":6},"CAGYFNLVRGPPTLEYG","Corresponds to amino acid residues A452 to G467; C-terminus.",{"$nulls":3},"P41279","P41279","P41279","P41279"]
[517,261,"PK585","COT (MAP3K8, TPL2)","S334","Osaka thyroid oncogene protein-serine kinase (Tpl2); Mitogen-activated protein kinase kinase kinase 8",0,9890,18,815,{"v":8045.68,"d":"8046"},{"$f":"K530*1.7571469","v":{"v":14137.441670392,"d":"14137"}},{"$f":"(L530+L531)/2","v":{"v":13784.7893161496,"d":"13785"}},{"$f":"SQRT((M530-L530)*(M530-L530))","v":{"v":352.6523542424002,"d":"353"}},{"$f":"N530/M530*100","v":{"v":2.5582716293621517,"d":"3"}},0,9806,18,754,{"v":7380.152,"d":"7380"},{"$f":"T530*1.7472151","v":{"v":12894.7130146952,"d":"12895"}},{"$f":"(U530+U531)/2","v":{"v":13481.7283662724,"d":"13482"}},{"$f":"SQRT((V530-U530)*(V530-U530))","v":{"v":587.0153515771999,"d":"587"}},{"$f":"W530/V530*100","v":{"v":4.354155013579356,"d":"4"}},{"$f":"X530+O530","v":{"v":6.912426642941508,"d":"7"}},{"$f":"(V530/M530*100)-100","v":{"v":-2.1985170968275014,"d":"-2"}},null,0,9586,14,800,{"v":7657.6,"d":"7658"},{"v":13100.939104640001,"d":"13101"},{"$f":"(AG530+AG531)/2","v":{"v":13267.588743731201,"d":"13268"}},{"$f":"SQRT((AH530-AG530)*(AH530-AG530))","v":{"v":166.6496390911998,"d":"167"}},{"$f":"AI530/AH530*100","v":{"v":1.2560657577658187,"d":"1"}},{"$f":"AJ530+O530","v":{"v":3.8143373871279707,"d":"4"}},{"$f":"(AH530/M530*100)-100","v":{"v":-3.7519657396030794,"d":"-4"}},null,null,"COT","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE-Unique",{"$nulls":6},"YPR(pS)AYP(bA)C","Corresponds to amino acid residues Y331 to P337; In the kinase catalytic subdomain X region.","The effect of S334 phosphorylation is unclear. This is one of the minor in vivo phosphorylation sites in COT (≥1 report from high throughput mass spectrometry studies).",null,"Protein-serine kinase, STE group, STE-Unique family","P41279","P41279","P41279","P41279","GO:0005737; GO:0005829","GO:0005524; GO:0000287; GO:0004709; GO:0004674","GO:0032147; GO:0007049; GO:0070498; GO:0006468; GO:0042981; GO:0007346; GO:0023014; GO:0051403; GO:0031098; GO:0031295"]
[522,263,"NN027-2","COX2","Pan-specific","Prostaglandin G/H synthase 2",0,156,10,821,{"v":119.866,"d":"120"},{"v":210.62217031539998,"d":"211"},{"$nulls":3},0,288,13,694,{"v":190.85,"d":"191"},{"v":333.456001835,"d":"333"},{"$nulls":6},0,240,10,590,{"v":135.7,"d":"136"},{"v":232.16117798,"d":"232"},{"$nulls":19},"X","Not precisely defined.","Antibody raised against amino acid residues 169-192 within an internal region of human COX2.",{"$nulls":3},"P00403","P00403"]
[529,268,"NN182-2","CrkL","Pan-specific","Crk-like protein",0,1110,16,642,{"v":702.348,"d":"702"},{"v":1234.1286109211999,"d":"1234"},{"$f":"(L542+L543)/2","v":{"v":1239.0442293739497,"d":"1239"}},{"$f":"SQRT((M542-L542)*(M542-L542))","v":{"v":4.915618452749868,"d":"5"}},{"$f":"N542/M542*100","v":{"v":0.396726633014027,"d":"0"}},0,1113,14,536,{"v":589.064,"d":"589"},{"v":1029.2215156664,"d":"1029"},{"$f":"(U542+U543)/2","v":{"v":1200.721161022,"d":"1201"}},{"$f":"SQRT((V542-U542)*(V542-U542))","v":{"v":171.49964535560002,"d":"171"}},{"$f":"W542/V542*100","v":{"v":14.283053461773527,"d":"14"}},{"$f":"X542+O542","v":{"v":14.679780094787553,"d":"15"}},{"$f":"(V542/M542*100)-100","v":{"v":-3.092954024031343,"d":"-3"}},null,0,1312,20,649,{"v":838.508,"d":"839"},{"v":1434.5542006312,"d":"1435"},{"$f":"(AG542+AG543)/2","v":{"v":1367.8502052866002,"d":"1368"}},{"$f":"SQRT((AH542-AG542)*(AH542-AG542))","v":{"v":66.70399534459989,"d":"67"}},{"$f":"AI542/AH542*100","v":{"v":4.876557029914228,"d":"5"}},{"$f":"AJ542+O542","v":{"v":5.273283662928255,"d":"5"}},{"$f":"(AH542/M542*100)-100","v":{"v":10.395591445329757,"d":"10"}},{"$nulls":13},"X",null,"Not precisely defined.","Antibody raised against amino acid residues 181-242 of human Crk-L .",null,null,"Adapter/scaffold protein","P46109","P46109",null,"P46109","GO:0005829; GO:0005768; GO:0098890; GO:0031594; GO:0005654","GO:0045296; GO:0042802; GO:0001784; GO:0003723; GO:0005070","GO:0000186; GO:0009887; GO:0009952; GO:0001568; GO:0071560; GO:0019221; GO:0007507; GO:0035556; GO:0007254; GO:0010629; GO:0001933; GO:0060017; GO:0008284; GO:0070374; GO:1903977; GO:0001934; GO:1900026; GO:0007265; GO:0007416; GO:0048538"]
[533,270,"PN025","CRYAB","S19","Crystallin aB",0,856,12,381,{"v":321.564,"d":"322"},{"v":565.0351857516,"d":"565"},{"$f":"(L546+L547)/2","v":{"v":577.4986287132999,"d":"577"}},{"$f":"SQRT((M546-L546)*(M546-L546))","v":{"v":12.463442961699911,"d":"12"}},{"$f":"N546/M546*100","v":{"v":2.158177066059737,"d":"2"}},0,750,12,382,{"v":281.916,"d":"282"},{"v":492.5678921316,"d":"493"},{"$f":"(U546+U547)/2","v":{"v":498.5189067622,"d":"499"}},{"$f":"SQRT((V546-U546)*(V546-U546))","v":{"v":5.951014630600014,"d":"6"}},{"$f":"W546/V546*100","v":{"v":1.193739003652017,"d":"1"}},{"$f":"X546+O546","v":{"v":3.351916069711754,"d":"3"}},{"$f":"(V546/M546*100)-100","v":{"v":-13.676174803578547,"d":"-14"}},null,0,959,12,391,{"v":370.277,"d":"370"},{"v":633.4852210678,"d":"633"},{"$f":"(AG546+AG547)/2","v":{"v":630.1003213578999,"d":"630"}},{"$f":"SQRT((AH546-AG546)*(AH546-AG546))","v":{"v":3.3848997099000826,"d":"3"}},{"$f":"AI546/AH546*100","v":{"v":0.5372001243556649,"d":"1"}},{"$f":"AJ546+O546","v":{"v":2.695377190415402,"d":"3"}},{"$f":"(AH546/M546*100)-100","v":{"v":9.108539835289235,"d":"9"}},{"$nulls":11},"X",{"$nulls":3},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S19 phosphosite.","S19 phosphorylation appears to induce activity, although one report indicates inhibition. Phosphorylation induces interaction with FBXO4 and inhibits interaction with CRYAB. This is one of the major in vivo phosphorylation sites in crystallin aB (≥16 reports from high throughput mass spectrometry studies).",null,"Chaperone protein","P02511","P02511",null,"P02511","GO:0032432; GO:0030424; GO:0097512; GO:0009986; GO:0005737; GO:0005829; GO:0043197; GO:0070062; GO:0005794; GO:0031430; GO:0015630; GO:0005739; GO:0043209; GO:0005654; GO:0005634; GO:0043204; GO:0014069; GO:0097060; GO:0030018","GO:0001540; GO:0042802; GO:0046872; GO:0008017; GO:0044877; GO:0042803; GO:0005212; GO:0051082","GO:0060561; GO:0071480; GO:0002088; GO:0031109; GO:0010259; GO:0006936; GO:0007517; GO:1905907; GO:0043066; GO:0030308; GO:0043154; GO:0010629; GO:0032387; GO:0032463; GO:2000378; GO:0006457; GO:0051260; GO:0050821; GO:0010941; GO:1900034; GO:0032355; GO:0042542; GO:0001666; GO:0051403; GO:0007021"]
[534,270,"PN025","CRYAB","S19","Crystallin aB",0,798,8,425,{"v":335.75,"d":"336"},{"v":589.962071675,"d":"590"},{"$nulls":3},0,762,14,386,{"v":288.728,"d":"289"},{"v":504.4699213928,"d":"504"},{"$nulls":6},0,978,14,380,{"v":366.32,"d":"366"},{"v":626.715421648,"d":"627"},{"$nulls":16},"X",{"$nulls":3},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S19 phosphosite.","S19 phosphorylation appears to induce activity, although one report indicates inhibition. Phosphorylation induces interaction with FBXO4 and inhibits interaction with CRYAB. This is one of the major in vivo phosphorylation sites in crystallin aB (≥16 reports from high throughput mass spectrometry studies).",null,null,"P02511","P02511",null,"P02511"]
[539,273,"NK234-4","CSF1R (Fms)","Pan-specific","Macrophage colony-stimulating factor 1 receptor",0,9658,22,889,{"v":8566.404,"d":"8566"},{"v":15052.4302327476,"d":"15052"},{"$f":"(L552+L553)/2","v":{"v":14911.1872506318,"d":"14911"}},{"$f":"SQRT((M552-L552)*(M552-L552))","v":{"v":141.24298211580026,"d":"141"}},{"$f":"N552/M552*100","v":{"v":0.9472282772776237,"d":"1"}},0,10059,18,752,{"v":7550.832,"d":"7551"},{"v":13192.927687963202,"d":"13193"},{"$f":"(U552+U553)/2","v":{"v":13636.074727383751,"d":"13636"}},{"$f":"SQRT((V552-U552)*(V552-U552))","v":{"v":443.14703942054985,"d":"443"}},{"$f":"W552/V552*100","v":{"v":3.2498138084461283,"d":"3"}},{"$f":"X552+O552","v":{"v":4.197042085723752,"d":"4"}},{"$f":"(V552/M552*100)-100","v":{"v":-8.551381602387295,"d":"-9"}},null,0,10278,22,857,{"v":8789.392,"d":"8789"},{"v":15037.2557144288,"d":"15037"},{"$f":"(AG552+AG553)/2","v":{"v":15514.987645282,"d":"15515"}},{"$f":"SQRT((AH552-AG552)*(AH552-AG552))","v":{"v":477.73193085320054,"d":"478"}},{"$f":"AI552/AH552*100","v":{"v":3.0791641074782,"d":"3"}},{"$f":"AJ552+O552","v":{"v":4.026392384755824,"d":"4"}},{"$f":"(AH552/M552*100)-100","v":{"v":4.049311329147301,"d":"4"}},null,null,"Fms","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"CLSSEQNLIQEVTVGE","Corresponds to amino acid residues L303 to E317.",null,null,"Receptor tyrosine kinase; EC 2.7.10.1; TK group; PDGFR family","P07333","P07333","P07333","P07333","GO:0009986; GO:1990682; GO:0005887; GO:0043231; GO:0005654; GO:0005886","GO:0005524; GO:0019955; GO:0005011; GO:0042803; GO:0019903","GO:0007411; GO:0045217; GO:0008283; GO:0071345; GO:0036006; GO:0019221; GO:0021879; GO:0030097; GO:0006954; GO:0045087; GO:0038145; GO:0030225; GO:0060603; GO:0030224; GO:0007275; GO:0043066; GO:0008285; GO:0021772; GO:0030316; GO:0018108; GO:0048015; GO:0046488; GO:0030335; GO:2000147; GO:0008284; GO:0090197; GO:0070374; GO:0001934; GO:0071902; GO:0061098; GO:0042531; GO:0046777; GO:2000249; GO:0045124; GO:0008360; GO:0031529; GO:0007165; GO:0007169"]
[544,275,"PK586","CSF1R (Fms)","S807+Y809","Macrophage colony-stimulating factor 1 receptor",0,5863,14,856,{"v":5006.744,"d":"5007"},{"v":8797.5846986936,"d":"8798"},{"$nulls":3},0,5584,24,908,{"v":5048.48,"d":"5048"},{"v":8820.780488048,"d":"8821"},{"$nulls":6},0,6032,16,802,{"v":4824.832,"d":"4825"},{"v":8254.522333644802,"d":"8255"},{"$nulls":7},"Fms","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"MND(pS)N(pY)IVKG(bA)C","Corresponds to amino acid residues M804 to G813; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y809 phosphorylation induces interaction with and activation of Src family members, including Fyn, Yes1 and Src as well as binding to PLCG2. S807 and Y809 phosphorylation stimulates receptor activation, transcription, cell cycle progression and cell growth. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. Y809 is one of the major in vivo phosphorylation sites in CSF1R (≥13 reports from high throughput mass spectrometry studies), but phosphorylation of S807 has not been observed in high throughput experiments.","Y809: CSF1R",null,"P07333","P07333","P07333","P07333"]
[547,277,"NK044-3","Csk","Pan-specific","C-terminus of Src tyrosine kinase",0,2350,10,760,{"v":1778.4,"d":"1778"},{"v":3124.9100469600003,"d":"3125"},{"$f":"(L560+L561)/2","v":{"v":2928.5102236532002,"d":"2929"}},{"$f":"SQRT((M560-L560)*(M560-L560))","v":{"v":196.39982330680004,"d":"196"}},{"$f":"N560/M560*100","v":{"v":6.706475590233694,"d":"7"}},0,2562,14,753,{"v":1918.644,"d":"1919"},{"v":3352.2837683244,"d":"3352"},{"$f":"(U560+U561)/2","v":{"v":3357.4188335033,"d":"3357"}},{"$f":"SQRT((V560-U560)*(V560-U560))","v":{"v":5.135065178899822,"d":"5"}},{"$f":"W560/V560*100","v":{"v":0.15294681520391773,"d":"0"}},{"$f":"X560+O560","v":{"v":6.859422405437612,"d":"7"}},{"$f":"(V560/M560*100)-100","v":{"v":14.645965938102592,"d":"15"}},null,0,2412,13,689,{"v":1652.911,"d":"1653"},{"v":2827.8685693154002,"d":"2828"},{"$f":"(AG560+AG561)/2","v":{"v":2803.5481033937003,"d":"2804"}},{"$f":"SQRT((AH560-AG560)*(AH560-AG560))","v":{"v":24.320465921699906,"d":"24"}},{"$f":"AI560/AH560*100","v":{"v":0.8674888043568767,"d":"1"}},{"$f":"AJ560+O560","v":{"v":7.573964394590571,"d":"8"}},{"$f":"(AH560/M560*100)-100","v":{"v":-4.2670884072794735,"d":"-4"}},null,null,"CSK","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Csk",{"$nulls":6},"Not precisely defined.","Antibody raised against a peptide mapping at the C-terminus of human Csk.",null,null,"Protein-tyrosine kinase, TK group, Csk family","P41240","P41240","P41240","P41240","GO:0005911; GO:0005737; GO:0005829; GO:0070062; GO:0031234; GO:0045121; GO:0005886","GO:0005524; GO:0042802; GO:0016301; GO:0046872; GO:0004715; GO:0070064; GO:0008022; GO:0034236; GO:0019903; GO:0004713; GO:0005102","GO:0002250; GO:0034332; GO:0007420; GO:0030154; GO:0071375; GO:0007417; GO:0045087; GO:0045779; GO:0008285; GO:0070373; GO:0042997; GO:0032715; GO:0033673; GO:0010989; GO:0050765; GO:0048709; GO:0038083; GO:0043406; GO:0006468; GO:0042127; GO:0001817; GO:0060368; GO:0031295; GO:0050852; GO:0007169"]
[551,279,"PK589","Csk","Y184","C-terminus of Src tyrosine kinase",0,2866,12,807,{"v":2303.178,"d":"2303"},{"v":4047.0220828481997,"d":"4047"},{"$f":"(L564+L565)/2","v":{"v":4022.9474131712996,"d":"4023"}},{"$f":"SQRT((M564-L564)*(M564-L564))","v":{"v":24.074669676900157,"d":"24"}},{"$f":"N564/M564*100","v":{"v":0.5984336160616635,"d":"1"}},0,2804,20,637,{"v":1773.408,"d":"1773"},{"v":3098.5252360607997,"d":"3099"},{"$f":"(U564+U565)/2","v":{"v":3571.6780740012,"d":"3572"}},{"$f":"SQRT((V564-U564)*(V564-U564))","v":{"v":473.15283794040033,"d":"473"}},{"$f":"W564/V564*100","v":{"v":13.247353992638738,"d":"13"}},{"$f":"X564+O564","v":{"v":13.845787608700402,"d":"14"}},{"$f":"(V564/M564*100)-100","v":{"v":-11.21738101006801,"d":"-11"}},null,0,2949,20,782,{"v":2290.478,"d":"2290"},{"v":3918.6445881892005,"d":"3919"},{"$f":"(AG564+AG565)/2","v":{"v":3925.4075442434005,"d":"3925"}},{"$f":"SQRT((AH564-AG564)*(AH564-AG564))","v":{"v":6.762956054200004,"d":"7"}},{"$f":"AI564/AH564*100","v":{"v":0.17228672381082724,"d":"0"}},{"$f":"AJ564+O564","v":{"v":0.7707203398724907,"d":"1"}},{"$f":"(AH564/M564*100)-100","v":{"v":-2.4245872220091513,"d":"-2"}},null,null,"CSK","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Csk",{"$nulls":6},"DEF(pY)RSG(bA)C","Corresponds to amino acid residues D181 to G187; In the region between the SH2 domain and the protein kinase catalytic domain.","Y184 phosphorylation stimulates phosphotransferase activity. This is the major in vivo phosphorylation site in Csk (≥40 reports from high throughput mass spectrometry studies).",null,"Protein-tyrosine kinase, TK group, Csk family","P41240","P41240","P41240","P41240","GO:0005911; GO:0005737; GO:0005829; GO:0070062; GO:0031234; GO:0045121; GO:0005886","GO:0005524; GO:0042802; GO:0016301; GO:0046872; GO:0004715; GO:0070064; GO:0008022; GO:0034236; GO:0019903; GO:0004713; GO:0005102","GO:0002250; GO:0034332; GO:0007420; GO:0030154; GO:0071375; GO:0007417; GO:0045087; GO:0045779; GO:0008285; GO:0070373; GO:0042997; GO:0032715; GO:0033673; GO:0010989; GO:0050765; GO:0048709; GO:0038083; GO:0043406; GO:0006468; GO:0042127; GO:0001817; GO:0060368; GO:0031295; GO:0050852; GO:0007169"]
[556,176,"NN021-2","CTNNB1","Pan-specific","Catenin (cadherin-associated protein) beta 1",0,74,8,663,{"v":43.758,"d":"44"},{"v":76.8892340502,"d":"77"},{"$nulls":3},0,78,8,528,{"v":36.96,"d":"37"},{"v":64.577070096,"d":"65"},{"$nulls":6},0,106,8,550,{"v":53.9,"d":"54"},{"v":92.21435146,"d":"92"},{"$nulls":10},"Transcription protein; Cytoskeletal protein",{"$nulls":4},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against amino acid residues 680-781 mapping at the C-terminus of human β-catenin ",{"$nulls":3},"P35222","P35222",null,"P35222"]
[561,179,"PN278","CTNNB1","S33+S37","Catenin (cadherin-associated protein) beta 1",0,26,8,684,{"v":12.312,"d":"12"},{"v":21.6339926328,"d":"22"},{"$f":"(L574+L575)/2","v":{"v":25.3240011228,"d":"25"}},{"$f":"SQRT((M574-L574)*(M574-L574))","v":{"v":3.6900084900000003,"d":"4"}},{"$f":"N574/M574*100","v":{"v":14.57119067443797,"d":"15"}},0,26,4,666,{"v":14.652,"d":"15"},{"v":25.6001956452,"d":"26"},{"$f":"(U574+U575)/2","v":{"v":25.6578537435,"d":"26"}},{"$f":"SQRT((V574-U574)*(V574-U574))","v":{"v":0.05765809829999924,"d":"0"}},{"$f":"W574/V574*100","v":{"v":0.22471910112359253,"d":"0"}},{"$f":"X574+O574","v":{"v":14.795909775561563,"d":"15"}},{"$f":"(V574/M574*100)-100","v":{"v":1.3183249324666235,"d":"1"}},null,0,26,10,691,{"v":11.056,"d":"11"},{"v":18.9150625184,"d":"19"},{"$f":"(AG574+AG575)/2","v":{"v":21.934697589400002,"d":"22"}},{"$f":"SQRT((AH574-AG574)*(AH574-AG574))","v":{"v":3.0196350710000033,"d":"3"}},{"$f":"AI574/AH574*100","v":{"v":13.766476873878805,"d":"14"}},{"$f":"AJ574+O574","v":{"v":28.337667548316773,"d":"28"}},{"$f":"(AH574/M574*100)-100","v":{"v":-13.383760002871341,"d":"-13"}},{"$nulls":5},"Transcription protein; Cytoskeletal protein",{"$nulls":4},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against amino acid residues 32-45 of human β-catenin.","S33 and S37 phosphorylation inhibits transcriptional activity and induces binding to CBLL1.  These are two of the minor in vivo phosphorylation sites in CTNNB1 (≥5 and ≥15 reports, respectively, by mass spectrometry).","S33: CDK2; GSK3a; GSK3b; IKKa (CHUK, IKBKA). S37: CDK2; GSK3a; GSK3b; IKKa (CHUK, IKBKA); JNK1. ","Cytoskeletal protein","P35222","P35222",null,"P35222","GO:0005912; GO:0016323; GO:0030877; GO:0070369; GO:1990907; GO:0016342; GO:0005913; GO:0005911; GO:0005938; GO:0030054; GO:0071944; GO:0042995; GO:0005813; GO:0005737; GO:0005829; GO:0070062; GO:0005925; GO:0005622; GO:0016328; GO:0016020; GO:0005719; GO:0005654; GO:0005634; GO:0048471; GO:0005886; GO:0032991; GO:0032993; GO:0000922; GO:0045202; GO:0005667; GO:1990909","GO:0045294; GO:0050681; GO:0045296; GO:0003682; GO:0019899; GO:0030331; GO:0044325; GO:0070411; GO:0019900; GO:0035257; GO:0008022; GO:0019903; GO:0001102; GO:0001085; GO:0046332; GO:0003713; GO:0008134","GO:0034333; GO:0030521; GO:1904886; GO:1904837; GO:0001569; GO:0060070; GO:1904954; GO:0044336; GO:0061324; GO:0044334; GO:0007155; GO:0098609; GO:0071363; GO:0071681; GO:0036023; GO:0061154; GO:0035635; GO:0001837; GO:0035315; GO:1904948; GO:0016525; GO:0043066; GO:0008285; GO:0045976; GO:0033234; GO:0045892; GO:1990138; GO:0043065; GO:1904798; GO:0051091; GO:2000144; GO:0010718; GO:0010909; GO:0051571; GO:0051149; GO:0002052; GO:0043525; GO:0045893; GO:0045944; GO:0032481; GO:0034394; GO:0045765; GO:0090279; GO:0060828; GO:0030997; GO:0070602; GO:0048145; GO:0072182; GO:0050767; GO:2000008; GO:0048660; GO:0042493; GO:0032355; GO:0019827; GO:0061549; GO:0006351; GO:0016032; GO:0016055; GO:0007223"]
[566,180,"PN167","CTNNB1","Y333","Catenin (cadherin-associated protein) beta 1",0,68,8,653,{"v":39.18,"d":"39"},{"v":68.845015542,"d":"69"},{"$nulls":3},0,48,8,658,{"v":26.32,"d":"26"},{"v":45.986701432000004,"d":"46"},{"$nulls":6},0,1190,14,342,{"v":402.192,"d":"402"},{"v":688.0867243488001,"d":"688"},{"$nulls":10},"Transcription protein; Cytoskeletal protein",{"$nulls":4},"X",{"$nulls":4},"YT(pY)EK","Corresponds to amino acid residues Y331 to K335.","Y333 phosphorylation induces interaction with PKM and transcription. This is one of the minor in vivo phosphorylation sites in CTNNB1 (≥2 reports from high throughput mass spectrometry studies).","Brk; Src",null,"P35222","P35222",null,"P35222"]
[570,282,"PN579","CTNNB1","Y654","Catenin (cadherin-associated protein) beta 1",0,5762,22,826,{"v":4741.24,"d":"4741"},{"v":8331.055168156,"d":"8331"},{"$nulls":3},0,8657,24,861,{"v":7433.013,"d":"7433"},{"v":12987.0725520963,"d":"12987"},{"$nulls":6},0,7674,20,861,{"v":6590.094,"d":"6590"},{"v":11274.6056450916,"d":"11275"},{"$nulls":10},"Transcription protein; Cytoskeletal protein",{"$nulls":4},"X",{"$nulls":4},"GVAT(pY)AAAC","Corresponds to amino acid residues G650 to A657.","Y654 phosphorylation induces activity and binding to Smad2, TBN and TCF4, stabilizes protein, and inhibits binding to CDH1, LEF-1, Met and Axin-1. This is one of the major in vivo phosphorylation sites in CTNNB1 (≥21 reports from high throughput mass spectrometry studies).","Abl1; CSK; EGFR; ErbB2; Met; Src; TrkA (NTRK1).",null,"P35222","P35222",null,"P35222"]
[573,1351,"NK188-1","DAPK3 (ZIPK)","Pan-specific","ZIP kinase (death associated protein-serine kinase 3 (DAPK3))",0,426,42,1028,{"v":394.752,"d":"395"},{"v":693.6372530688,"d":"694"},{"$f":"(L586+L587)/2","v":{"v":558.8219143132,"d":"559"}},{"$f":"SQRT((M586-L586)*(M586-L586))","v":{"v":134.8153387556,"d":"135"}},{"$f":"N586/M586*100","v":{"v":24.124919818380775,"d":"24"}},0,464,44,1021,{"v":428.82,"d":"429"},{"v":749.240779182,"d":"749"},{"$f":"(U586+U587)/2","v":{"v":539.6640751520999,"d":"540"}},{"$f":"SQRT((V586-U586)*(V586-U586))","v":{"v":209.57670402990004,"d":"210"}},{"$f":"W586/V586*100","v":{"v":38.83465912953953,"d":"39"}},{"$f":"X586+O586","v":{"v":62.959578947920306,"d":"63"}},{"$f":"(V586/M586*100)-100","v":{"v":-3.4282548107737085,"d":"-3"}},null,0,530,61,958,{"v":449.302,"d":"449"},{"v":768.6844627028,"d":"769"},{"$f":"(AG586+AG587)/2","v":{"v":546.3452252002,"d":"546"}},{"$f":"SQRT((AH586-AG586)*(AH586-AG586))","v":{"v":222.33923750259999,"d":"222"}},{"$f":"AI586/AH586*100","v":{"v":40.695740943123845,"d":"41"}},{"$f":"AJ586+O586","v":{"v":64.82066076150463,"d":"65"}},{"$f":"(AH586/M586*100)-100","v":{"v":-2.232677136209645,"d":"-2"}},null,null,"DAPK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","DAPK",{"$nulls":6},"Epitope undefined.",{"$nulls":3},"Protein-serine kinase, CAMK group, DAPK family","O43293","O43293","O43293",null,"GO:0005884; GO:0005737; GO:0045121; GO:0005634; GO:0016605","GO:0005524; GO:0008140; GO:0042802; GO:0043522; GO:0008022; GO:0042803; GO:0004674; GO:0017048","GO:0006915; GO:0097190; GO:0071346; GO:0006325; GO:0035556; GO:0017148; GO:0030182; GO:0018105; GO:0018107; GO:0043065; GO:0090263; GO:0030335; GO:2001241; GO:0046777; GO:0006468; GO:2000249; GO:0042981; GO:0010506; GO:2000145; GO:0008360; GO:0051893; GO:0007346; GO:0007088; GO:0043519; GO:0006940; GO:0006355; GO:0006351"]
[578,287,"PN696","DCK","S74","Deoxycytidine kinase",0,11466,18,758,{"v":8677.584,"d":"8678"},{"v":15247.789825089601,"d":"15248"},{"$nulls":3},0,12888,18,798,{"v":10270.26,"d":"10270"},{"v":17944.353352926002,"d":"17944"},{"$nulls":6},0,12412,22,748,{"v":9267.72,"d":"9268"},{"v":15855.599059608,"d":"15856"},{"$nulls":10},"Enzyme - Metabolite kinase",{"$nulls":8},"X","LTM(pS)QKNGGC","Corresponds to amino acid residues L71 to G79.","S74 phosphorylation stimulates enzyme activity. This is the major in vivo phosphorylation sites in DCK (≥115 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and found in fish.","ATR; CK1D",null,"P27707","P27707"]
[583,290,"PK592","DDR1","Y797","Epithelial discoidin domain-containing receptor 1",0,6833,18,840,{"v":5724.6,"d":"5725"},{"v":10058.96314374,"d":"10059"},{"$f":"(L596+L597)/2","v":{"v":9978.600030268499,"d":"9979"}},{"$f":"SQRT((M596-L596)*(M596-L596))","v":{"v":80.36311347150149,"d":"80"}},{"$f":"N596/M596*100","v":{"v":0.8053545911022864,"d":"1"}},0,6639,18,851,{"v":5634.471,"d":"5634"},{"v":9844.6328117121,"d":"9845"},{"$f":"(U596+U597)/2","v":{"v":9836.400807768448,"d":"9836"}},{"$f":"SQRT((V596-U596)*(V596-U596))","v":{"v":8.232003943650852,"d":"8"}},{"$f":"W596/V596*100","v":{"v":0.08368918778858117,"d":"0"}},{"$f":"X596+O596","v":{"v":0.8890437788908675,"d":"1"}},{"$f":"(V596/M596*100)-100","v":{"v":-1.425041810160863,"d":"-1"}},null,0,6549,20,836,{"v":5458.244,"d":"5458"},{"v":9338.1898065016,"d":"9338"},{"$f":"(AG596+AG597)/2","v":{"v":9422.7002391374,"d":"9423"}},{"$f":"SQRT((AH596-AG596)*(AH596-AG596))","v":{"v":84.51043263580141,"d":"85"}},{"$f":"AI596/AH596*100","v":{"v":0.8968812600530939,"d":"1"}},{"$f":"AJ596+O596","v":{"v":1.7022358511553803,"d":"2"}},{"$f":"(AH596/M596*100)-100","v":{"v":-5.57091966252645,"d":"-6"}},null,null,"DDR1","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","DDR",{"$nulls":6},"GDY(pY)RVQ(bA)C","Corresponds to amino acid residues G794 to Q800; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y797 phosphorylation likely stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in DDR1 (≥307 reports from high throughput mass spectrometry studies).",null,"EC 2.7.1.112; EC 2.7.10.1; Receptor tyrosine kinase; TK domain target; TK</A> group; DDR family","Q08345","Q08345","Q08345","Q08345","GO:0070062; GO:0005615; GO:0005887; GO:0005886; GO:0043235","GO:0005524; GO:0005518; GO:0046872; GO:0038062; GO:0004714","GO:0061564; GO:0060444; GO:0007155; GO:0038063; GO:0043583; GO:0007566; GO:0030198; GO:0007595; GO:0060749; GO:0008285; GO:1990138; GO:0038083; GO:0046777; GO:0001558; GO:0001952; GO:0010715; GO:0061302; GO:0014909; GO:0044319"]
[584,290,"PK592","DDR1","Y797","Epithelial discoidin domain-containing receptor 1",0,6308,14,895,{"v":5633.13,"d":"5633"},{"v":9898.236916797,"d":"9898"},{"$nulls":3},0,6576,20,858,{"v":5625.048,"d":"5625"},{"v":9828.1688038248,"d":"9828"},{"$nulls":6},0,6334,12,879,{"v":5557.038,"d":"5557"},{"v":9507.2106717732,"d":"9507"},{"$nulls":7},"DDR1","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","DDR",{"$nulls":6},"GDY(pY)RVQ(bA)C","Corresponds to amino acid residues G794 to Q800; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y797 phosphorylation likely stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in DDR1 (≥307 reports from high throughput mass spectrometry studies).",null,null,"Q08345","Q08345","Q08345","Q08345"]
[588,291,"NK183-3","DDR2 (Tyro10)","Pan-specific","Neurotrophic receptor-tyrosine kinase of discoidin domain receptor family, member 2 precursor",0,116,8,574,{"v":61.992,"d":"62"},{"v":108.9290506248,"d":"109"},{"$nulls":3},0,100,10,529,{"v":47.61,"d":"48"},{"v":83.184910911,"d":"83"},{"$nulls":6},0,150,12,532,{"v":73.416,"d":"73"},{"v":125.6031322224,"d":"126"},{"$nulls":7},"DDR2","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","DDR",{"$nulls":6},"Not precisely defined.","Antibody raised against a recombinant protein corresponding to amino acids 422-639 of human DDR2.",{"$nulls":3},"Q16832","Q16832","Q16832","Q16832"]
[595,295,"NK264-1","DMPK1 (DMPK)","Pan-specific","Myotonic dystrophy protein kinase",0,4175,22,934,{"v":3878.902,"d":"3879"},{"v":6815.8006247038,"d":"6816"},{"$f":"(L608+L609)/2","v":{"v":6941.32856351945,"d":"6941"}},{"$f":"SQRT((M608-L608)*(M608-L608))","v":{"v":125.52793881564958,"d":"126"}},{"$f":"N608/M608*100","v":{"v":1.8084137304113346,"d":"2"}},0,4608,20,861,{"v":3950.268,"d":"3950"},{"v":6901.9678986468,"d":"6902"},{"$f":"(U608+U609)/2","v":{"v":7167.42578322,"d":"7167"}},{"$f":"SQRT((V608-U608)*(V608-U608))","v":{"v":265.4578845732003,"d":"265"}},{"$f":"W608/V608*100","v":{"v":3.7036712008190773,"d":"4"}},{"$f":"X608+O608","v":{"v":5.512084931230412,"d":"6"}},{"$f":"(V608/M608*100)-100","v":{"v":3.25726145407981,"d":"3"}},null,0,4373,18,931,{"v":4054.505,"d":"4055"},{"v":6936.615010507,"d":"6937"},{"$f":"(AG608+AG609)/2","v":{"v":6867.831487440701,"d":"6868"}},{"$f":"SQRT((AH608-AG608)*(AH608-AG608))","v":{"v":68.7835230662995,"d":"69"}},{"$f":"AI608/AH608*100","v":{"v":1.0015318982721821,"d":"1"}},{"$f":"AJ608+O608","v":{"v":2.8099456286835167,"d":"3"}},{"$f":"(AH608/M608*100)-100","v":{"v":-1.0588329799718394,"d":"-1"}},null,null,"DMPK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","DMPK","GEK",{"$nulls":5},"CMALRDSEVPGPTPMELEA","Corresponds to amino acid residues C407 to A425; Just after kinase catalytic domain.",{"$nulls":3},"Q09013","Q09013","Q09013",null,"GO:0005829; GO:0005789; GO:0031307; GO:0031965; GO:0005640; GO:0005886; GO:0033017","GO:0005524; GO:0031072; GO:0046872; GO:0017020; GO:0004674","GO:0006874; GO:0010657; GO:0006998; GO:0018105; GO:0006468; GO:1903779; GO:0014853; GO:0008016; GO:0010830; GO:0014722; GO:0002028; GO:0051823"]
[600,297,"NK048-4","DNAPK (PRKDC)","Pan-specific","DNA-dependent protein kinase catalytic subunit",0,6363,16,853,{"v":5413.991,"d":"5414"},{"v":9513.1775022779,"d":"9513"},{"$nulls":3},0,6530,16,827,{"v":5387.078,"d":"5387"},{"v":9412.384026477801,"d":"9412"},{"$nulls":6},0,6842,16,912,{"v":6225.312,"d":"6225"},{"v":10650.5214975168,"d":"10651"},{"$nulls":7},"DNAPK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PIKK","DNAPK",{"$nulls":5},"CGHDEREHPFLVKGGE","Corresponds to amino acid residues G3742 to E3755.",{"$nulls":3},"P78527","P78527","P78527","P78527"]
[601,298,"NK048-7","DNAPK (PRKDC)","Pan-specific","DNA-dependent protein kinase catalytic subunit",0,6952,20,870,{"v":6030.84,"d":"6031"},{"v":10597.071810396,"d":"10597"},{"$f":"(L614+L615)/2","v":{"v":10368.6919135092,"d":"10369"}},{"$f":"SQRT((M614-L614)*(M614-L614))","v":{"v":228.37989688680136,"d":"228"}},{"$f":"N614/M614*100","v":{"v":2.2025912120047555,"d":"2"}},0,7872,20,810,{"v":6360.12,"d":"6360"},{"v":11112.497701812,"d":"11112"},{"$f":"(U614+U615)/2","v":{"v":10105.088419454001,"d":"10105"}},{"$f":"SQRT((V614-U614)*(V614-U614))","v":{"v":1007.4092823579995,"d":"1007"}},{"$f":"W614/V614*100","v":{"v":9.969326744519785,"d":"10"}},{"$f":"X614+O614","v":{"v":12.17191795652454,"d":"12"}},{"$f":"(V614/M614*100)-100","v":{"v":-2.5423023102051445,"d":"-3"}},null,0,7296,22,852,{"v":6197.448,"d":"6197"},{"v":10602.850612747201,"d":"10603"},{"$f":"(AG614+AG615)/2","v":{"v":10758.4139995664,"d":"10758"}},{"$f":"SQRT((AH614-AG614)*(AH614-AG614))","v":{"v":155.56338681919988,"d":"156"}},{"$f":"AI614/AH614*100","v":{"v":1.4459695158177552,"d":"1"}},{"$f":"AJ614+O614","v":{"v":3.6485607278225105,"d":"4"}},{"$f":"(AH614/M614*100)-100","v":{"v":3.758642742094011,"d":"4"}},null,null,"DNAPK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PIKK","DNAPK",{"$nulls":5},"CLMDQATDPNILGRTW","Corresponds to amino acid residues C4106 to W4121; C-terminus.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); ATYPICAL group; PIKK family; DNAPK subfamily","P78527","P78527","P78527","P78527","GO:0005829; GO:0005958; GO:0016020; GO:0070419; GO:0000784; GO:0005730; GO:0005654; GO:0005634; GO:0032991; GO:0032993; GO:0005667","GO:0005524; GO:0004677; GO:0003690; GO:0019899; GO:0019904; GO:0004672; GO:0004674; GO:0003723; GO:0008134","GO:0002218; GO:0002326; GO:0007420; GO:0008283; GO:0006464; GO:0032869; GO:0006302; GO:0097681; GO:0006303; GO:0035234; GO:0007507; GO:0033152; GO:0045087; GO:0008630; GO:0043066; GO:2000773; GO:0002638; GO:0001933; GO:2001229; GO:0018105; GO:0043065; GO:0048639; GO:0048146; GO:0045944; GO:0032481; GO:0002328; GO:0031648; GO:0006468; GO:0016567; GO:0042752; GO:0048660; GO:0014823; GO:0010332; GO:0048511; GO:0072431; GO:0001756; GO:0048536; GO:0033077; GO:0002360; GO:0033153; GO:0016233; GO:0048538"]
[606,300,"PK595","DNAPK (PRKDC)","T2609","DNA-dependent protein kinase catalytic subunit",0,2508,20,852,{"v":2119.776,"d":"2120"},{"v":3724.7578270943995,"d":"3725"},{"$nulls":3},0,2939,12,837,{"v":2449.899,"d":"2450"},{"v":4280.5005262749,"d":"4281"},{"$nulls":6},0,2764,14,840,2310,{"v":3952.043634,"d":"3952"},{"$nulls":7},"DNAPK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PIKK","DNAPK",{"$nulls":5},"FVT(pT)QAS(bA)C","Corresponds to amino acid residues F2606 to S2612; In the mid-region of the protein kinase between the NUC194 and FAT domains.","T2609 phosphorylation stimulates phosphotransferase activity. This is one of the major in vivo phosphorylation sites in DNAPK (≥17 reports from high throughput mass spectrometry studies).","ATM; ATR; DNAPK (PRKDC)",null,"P78527","P78527","P78527","P78527"]
[611,303,"PN747","DPYD","S766+T768","Dihydropyrimidine dehydrogenase [NADP()]",0,14391,18,788,{"v":11325.924,"d":"11326"},{"v":19901.3122462356,"d":"19901"},{"$f":"(L624+L625)/2","v":{"v":18279.3163000491,"d":"18279"}},{"$f":"SQRT((M624-L624)*(M624-L624))","v":{"v":1621.9959461865,"d":"1622"}},{"$f":"N624/M624*100","v":{"v":8.873395041488195,"d":"9"}},0,13488,16,664,{"v":8945.408,"d":"8945"},{"v":15629.5519332608,"d":"15630"},{"$f":"(U624+U625)/2","v":{"v":16758.1550438152,"d":"16758"}},{"$f":"SQRT((V624-U624)*(V624-U624))","v":{"v":1128.6031105544007,"d":"1129"}},{"$f":"W624/V624*100","v":{"v":6.7346501306593725,"d":"7"}},{"$f":"X624+O624","v":{"v":15.608045172147566,"d":"16"}},{"$f":"(V624/M624*100)-100","v":{"v":-8.321762320124705,"d":"-8"}},null,0,13544,18,743,{"v":10049.818,"d":"10050"},{"v":17193.644696865198,"d":"17194"},{"$f":"(AG624+AG625)/2","v":{"v":17290.738367997998,"d":"17291"}},{"$f":"SQRT((AH624-AG624)*(AH624-AG624))","v":{"v":97.0936711327995,"d":"97"}},{"$f":"AI624/AH624*100","v":{"v":0.5615357138969969,"d":"1"}},{"$f":"AJ624+O624","v":{"v":9.434930755385192,"d":"9"}},{"$f":"(AH624/M624*100)-100","v":{"v":-5.4081778323866985,"d":"-5"}},{"$nulls":14},"X","CGGV(pS)G(pT)AIR","Corresponds to amino acid residues G763 to R771.","The effects of S766 and T768 phosphorylation are unclear. These phosphorylation sites have only been detected in a single mass spectrometry study. However, this human phosphosite is highly conserved in vertebrates and also found in sea urchin.",null,"Other Amino Acids Metabolism - beta-alanine; Nucleotide Metabolism - pyrimidine; EC 1.3.1.2; Oxidoreductase; Cofactor and Vitamin Metabolism - pantothenate and CoA biosynthesis; Xenobiotic Metabolism - drug metabolism - other enzymes","Q12882","Q12882",null,null,"GO:0005737; GO:0005829","GO:0051539; GO:0017113; GO:0050660; GO:0046872; GO:0050661; GO:0042803","GO:0019483; GO:0006145; GO:0006208; GO:0046135; GO:0006214; GO:0006210; GO:0006212"]
[617,306,"NK266-1","DYRK2","Pan-specific","Dual specificity tyrosine-phosphorylation-regulated kinase 2",0,2746,14,812,{"v":2218.384,"d":"2218"},{"v":3898.0265686096,"d":"3898"},{"$f":"(L630+L631)/2","v":{"v":3804.1545097709,"d":"3804"}},{"$f":"SQRT((M630-L630)*(M630-L630))","v":{"v":93.87205883870001,"d":"94"}},{"$f":"N630/M630*100","v":{"v":2.467619509081226,"d":"2"}},0,2899,18,715,{"v":2059.915,"d":"2060"},{"v":3599.1145927165,"d":"3599"},{"$f":"(U630+U631)/2","v":{"v":3662.1934258642495,"d":"3662"}},{"$f":"SQRT((V630-U630)*(V630-U630))","v":{"v":63.07883314774972,"d":"63"}},{"$f":"W630/V630*100","v":{"v":1.7224331380820936,"d":"2"}},{"$f":"X630+O630","v":{"v":4.19005264716332,"d":"4"}},{"$f":"(V630/M630*100)-100","v":{"v":-3.731738117945156,"d":"-4"}},null,0,2170,16,812,{"v":1749.048,"d":"1749"},{"v":2992.3437289872,"d":"2992"},{"$f":"(AG630+AG631)/2","v":{"v":2746.6669039472,"d":"2747"}},{"$f":"SQRT((AH630-AG630)*(AH630-AG630))","v":{"v":245.67682504000004,"d":"246"}},{"$f":"AI630/AH630*100","v":{"v":8.94454382826476,"d":"9"}},{"$f":"AJ630+O630","v":{"v":11.412163337345985,"d":"11"}},{"$f":"(AH630/M630*100)-100","v":{"v":-27.79822962257613,"d":"-28"}},null,null,"DYRK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","DYRK","Dyrk2",{"$nulls":5},"CGSKHTMNDHLHVGSHAHGQ","Corresponds to amino acid residues G69 to Q87; Post-N-terminus.",null,null,"Protein kinase, dual-specificity, CMGC group, DYRK family, Dyrk2 subfamily","Q92630","Q92630","Q92630",null,"GO:0005737; GO:0005829; GO:0005654; GO:0005634; GO:1990904; GO:0000151","GO:0005524; GO:0000287; GO:0030145; GO:0004712; GO:0004674; GO:0004713","GO:0006974; GO:0042771; GO:0070885; GO:0045725; GO:0006468; GO:1901796; GO:0007224"]
[618,306,"NK266-1","DYRK2","Pan-specific","Dual specificity tyrosine-phosphorylation-regulated kinase 2",0,2802,20,759,{"v":2111.538,"d":"2112"},{"v":3710.2824509322,"d":"3710"},{"$nulls":3},0,2864,40,755,{"v":2132.12,"d":"2132"},{"v":3725.2722590119997,"d":"3725"},{"$nulls":6},0,2068,32,718,{"v":1461.848,"d":"1462"},{"v":2500.9900789072,"d":"2501"},{"$nulls":7},"DYRK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","DYRK","Dyrk2",{"$nulls":5},"CGSKHTMNDHLHVGSHAHGQ","Corresponds to amino acid residues G69 to Q87; Post-N-terminus.",{"$nulls":3},"Q92630","Q92630","Q92630"]
[623,309,"NK375-2","DYRK4","Pan-specific","Dual specificity tyrosine-phosphorylation-regulated kinase 4",0,492,12,612,{"v":293.76,"d":"294"},{"v":516.1794733439999,"d":"516"},{"$f":"(L636+L637)/2","v":{"v":493.7231359619999,"d":"494"}},{"$f":"SQRT((M636-L636)*(M636-L636))","v":{"v":22.456337382000015,"d":"22"}},{"$f":"N636/M636*100","v":{"v":4.548366431774507,"d":"5"}},0,503,12,567,{"v":278.397,"d":"278"},{"v":486.41944219469997,"d":"486"},{"$f":"(U636+U637)/2","v":{"v":506.02057479405,"d":"506"}},{"$f":"SQRT((V636-U636)*(V636-U636))","v":{"v":19.601132599350024,"d":"20"}},{"$f":"W636/V636*100","v":{"v":3.8735841141099194,"d":"4"}},{"$f":"X636+O636","v":{"v":8.421950545884426,"d":"8"}},{"$f":"(V636/M636*100)-100","v":{"v":2.4907560404454188,"d":"2"}},null,0,572,16,630,{"v":350.28,"d":"350"},{"v":599.2735255919999,"d":"599"},{"$f":"(AG636+AG637)/2","v":{"v":621.7497044845,"d":"622"}},{"$f":"SQRT((AH636-AG636)*(AH636-AG636))","v":{"v":22.476178892500002,"d":"22"}},{"$f":"AI636/AH636*100","v":{"v":3.614988271065648,"d":"4"}},{"$f":"AJ636+O636","v":{"v":8.163354702840156,"d":"8"}},{"$f":"(AH636/M636*100)-100","v":{"v":25.930842449391278,"d":"26"}},null,null,"DYRK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","DYRK","Dyrk2",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues 119-219 mapping within an internal region of mouse Dyrk4.",null,null,"EC 2.7.12.1; Protein kinase, dual-specificity; EC 2.7.1.-; CMGC domain target; CMGC</A> group; DYRK family; Dyrk2 subfamily","Q9NR20","Q9NR20","Q9NR20",null,"GO:0005737; GO:0043231; GO:0005634","GO:0005524; GO:0046872; GO:0004712; GO:0004674; GO:0004713"]
[628,311,"PN509","EEF1A1","Y141","Eukaryotic elongation factor 1-alpha 1",0,5917,14,932,{"v":5501.596,"d":"5502"},{"v":9667.112356452399,"d":"9667"},{"$nulls":3},0,6409,25,919,{"v":5866.896,"d":"5867"},{"v":10250.729281329599,"d":"10251"},{"$nulls":6},0,6348,22,896,{"v":5668.096,"d":"5668"},{"v":9697.2132959744,"d":"9697"},{"$nulls":7},"EEF1A1",{"$nulls":12},"LLA(pY)TLG(bA)C","Corresponds to amino acid residues L138 to G144; In the middle of the GTP_EFTU domain. ","The effect of Y141 phosphorylation is unclear. This is the second major in vivo phosphorylation site in EEF1A1 (≥1187 reports from high throughput mass spectrometry studies).",null,null,"P68104","P68104"]
[633,314,"NK052-6","EGFR (ErbB1)","Pan-specific","Epidermal growth factor receptor-tyrosine kinase",0,16770,20,971,{"v":16264.25,"d":"16264"},{"v":28578.676468325,"d":"28579"},{"$f":"(L646+L647)/2","v":{"v":28400.90855217235,"d":"28401"}},{"$f":"SQRT((M646-L646)*(M646-L646))","v":{"v":177.7679161526503,"d":"178"}},{"$f":"N646/M646*100","v":{"v":0.6259233426497303,"d":"1"}},0,16444,16,937,{"v":15393.036,"d":"15393"},{"v":26894.9449340436,"d":"26895"},{"$f":"(U646+U647)/2","v":{"v":27679.503919257,"d":"27680"}},{"$f":"SQRT((V646-U646)*(V646-U646))","v":{"v":784.5589852133999,"d":"785"}},{"$f":"W646/V646*100","v":{"v":2.8344401962622303,"d":"3"}},{"$f":"X646+O646","v":{"v":3.4603635389119605,"d":"3"}},{"$f":"(V646/M646*100)-100","v":{"v":-2.5400758978894373,"d":"-3"}},null,0,16612,18,1013,{"v":16809.722,"d":"16810"},{"v":28758.768320090803,"d":"28759"},{"$f":"(AG646+AG647)/2","v":{"v":27797.9957175202,"d":"27798"}},{"$f":"SQRT((AH646-AG646)*(AH646-AG646))","v":{"v":960.7726025706033,"d":"961"}},{"$f":"AI646/AH646*100","v":{"v":3.4562657406449584,"d":"3"}},{"$f":"AJ646+O646","v":{"v":4.082189083294689,"d":"4"}},{"$f":"(AH646/M646*100)-100","v":{"v":-2.1228646032383125,"d":"-2"}},null,null,"EGFR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"CVIQGDERMHLPSPT","Corresponds to amino acid residues V980 to T993; Just after the catalytic domain of the kinase.",null,null,"Protein-tyrosine kinase (receptor), TK group, EGFR family","P00533","P00533","P00533","P00533","GO:0016324; GO:0016323; GO:0009986; GO:0030665; GO:0005737; GO:0031901; GO:0030139; GO:0005789; GO:0005768; GO:0010008; GO:0005615; GO:0005925; GO:0000139; GO:0016021; GO:0016020; GO:0045121; GO:0097489; GO:0031965; GO:0005634; GO:0048471; GO:0005886; GO:0032991; GO:0043235; GO:0070435; GO:0045202","GO:0051015; GO:0005524; GO:0045296; GO:0005516; GO:0003682; GO:0003690; GO:0019899; GO:0005006; GO:0048408; GO:0042802; GO:0005178; GO:0004709; GO:0046934; GO:0046982; GO:0019901; GO:0019903; GO:0004713; GO:0005088; GO:0004714; GO:0004888; GO:0031625; GO:0001618","GO:0043006; GO:0007202; GO:0048143; GO:0098609; GO:0008283; GO:0007166; GO:0071230; GO:0071276; GO:0071549; GO:0071364; GO:0071392; GO:0071260; GO:0034614; GO:0021795; GO:0007623; GO:0048546; GO:0016101; GO:0001892; GO:0007173; GO:0038128; GO:0061029; GO:0001942; GO:0042743; GO:0007611; GO:0097421; GO:0030324; GO:0010960; GO:0000165; GO:0061024; GO:0007494; GO:0060571; GO:0043066; GO:1905208; GO:0042059; GO:1901185; GO:0045930; GO:0045746; GO:0042177; GO:0048812; GO:0001503; GO:0042698; GO:0038083; GO:0018108; GO:0097755; GO:0045780; GO:0090263; GO:0030307; GO:0030335; GO:0008284; GO:0031659; GO:0045739; GO:0045740; GO:0050679; GO:0070374; GO:0048146; GO:0050729; GO:0043406; GO:1901224; GO:0010750; GO:0033138; GO:0042327; GO:1903800; GO:1902722; GO:0051897; GO:1900020; GO:1903078; GO:0001934; GO:0048661; GO:0032930; GO:0051968; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0051205; GO:2000145; GO:0070372; GO:0046328; GO:0050999; GO:0050730; GO:0014066; GO:0006357; GO:0051592; GO:0033590; GO:0033594; GO:0006970; GO:0070141; GO:0007435; GO:0007165; GO:0043586; GO:0006412; GO:0042060"]
[635,315,"NK052-4","EGFR (ErbB1)","Pan-specific","Epidermal growth factor receptor-tyrosine kinase",0,6324,14,924,{"v":5830.44,"d":"5830"},{"v":10244.939571636,"d":"10245"},{"$f":"(L648+L649)/2","v":{"v":9820.4515378278,"d":"9820"}},{"$f":"SQRT((M648-L648)*(M648-L648))","v":{"v":424.48803380820027,"d":"424"}},{"$f":"N648/M648*100","v":{"v":4.322489980965717,"d":"4"}},0,6214,16,802,{"v":4970.796,"d":"4971"},{"v":8685.049830219601,"d":"8685"},{"$f":"(U648+U649)/2","v":{"v":9408.9682209573,"d":"9409"}},{"$f":"SQRT((V648-U648)*(V648-U648))","v":{"v":723.9183907376992,"d":"724"}},{"$f":"W648/V648*100","v":{"v":7.693918968981758,"d":"8"}},{"$f":"X648+O648","v":{"v":12.016408949947476,"d":"12"}},{"$f":"(V648/M648*100)-100","v":{"v":-4.190065144005757,"d":"-4"}},null,0,6392,16,915,{"v":5834.04,"d":"5834"},{"v":9981.117161256001,"d":"9981"},{"$f":"(AG648+AG649)/2","v":{"v":9950.814738379202,"d":"9951"}},{"$f":"SQRT((AH648-AG648)*(AH648-AG648))","v":{"v":30.302422876799028,"d":"30"}},{"$f":"AI648/AH648*100","v":{"v":0.30452202833126724,"d":"0"}},{"$f":"AJ648+O648","v":{"v":4.627012009296984,"d":"5"}},{"$f":"(AH648/M648*100)-100","v":{"v":1.3274664616922394,"d":"1"}},null,null,"EGFR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"CEYLRVAPQSSEFIGA","Corresponds to amino acid residues E1196 to A1210; C-terminus.",null,null,"Protein-tyrosine kinase (receptor), TK group, EGFR family","P00533","P00533","P00533","P00533","GO:0016324; GO:0016323; GO:0009986; GO:0030665; GO:0005737; GO:0031901; GO:0030139; GO:0005789; GO:0005768; GO:0010008; GO:0005615; GO:0005925; GO:0000139; GO:0016021; GO:0016020; GO:0045121; GO:0097489; GO:0031965; GO:0005634; GO:0048471; GO:0005886; GO:0032991; GO:0043235; GO:0070435; GO:0045202","GO:0051015; GO:0005524; GO:0045296; GO:0005516; GO:0003682; GO:0003690; GO:0019899; GO:0005006; GO:0048408; GO:0042802; GO:0005178; GO:0004709; GO:0046934; GO:0046982; GO:0019901; GO:0019903; GO:0004713; GO:0005088; GO:0004714; GO:0004888; GO:0031625; GO:0001618","GO:0043006; GO:0007202; GO:0048143; GO:0098609; GO:0008283; GO:0007166; GO:0071230; GO:0071276; GO:0071549; GO:0071364; GO:0071392; GO:0071260; GO:0034614; GO:0021795; GO:0007623; GO:0048546; GO:0016101; GO:0001892; GO:0007173; GO:0038128; GO:0061029; GO:0001942; GO:0042743; GO:0007611; GO:0097421; GO:0030324; GO:0010960; GO:0000165; GO:0061024; GO:0007494; GO:0060571; GO:0043066; GO:1905208; GO:0042059; GO:1901185; GO:0045930; GO:0045746; GO:0042177; GO:0048812; GO:0001503; GO:0042698; GO:0038083; GO:0018108; GO:0097755; GO:0045780; GO:0090263; GO:0030307; GO:0030335; GO:0008284; GO:0031659; GO:0045739; GO:0045740; GO:0050679; GO:0070374; GO:0048146; GO:0050729; GO:0043406; GO:1901224; GO:0010750; GO:0033138; GO:0042327; GO:1903800; GO:1902722; GO:0051897; GO:1900020; GO:1903078; GO:0001934; GO:0048661; GO:0032930; GO:0051968; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0051205; GO:2000145; GO:0070372; GO:0046328; GO:0050999; GO:0050730; GO:0014066; GO:0006357; GO:0051592; GO:0033590; GO:0033594; GO:0006970; GO:0070141; GO:0007435; GO:0007165; GO:0043586; GO:0006412; GO:0042060"]
[640,316,"PK602","EGFR (ErbB1)","Y869","Epidermal growth factor receptor-tyrosine kinase",0,6709,20,878,{"v":5872.942,"d":"5873"},{"v":10319.6218291798,"d":"10320"},{"$nulls":3},0,6860,40,935,{"v":6376.7,"d":"6377"},{"v":11141.46652817,"d":"11141"},{"$nulls":6},0,6964,20,870,{"v":6041.28,"d":"6041"},{"v":10335.671932992,"d":"10336"},{"$nulls":7},"EGFR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"EKE(pY)HAEG(bA)C","Corresponds to amino acid residues E866 to G873; In the protein kinase catalytic domain.","Y869 phosphorylation stimulates phosphotransferase activity and induces protein interaction with COX2 and PKCE and PKCZ. This is one of the major in vivo phosphorylation sites in EGFR (≥165 reports from high throughput mass spectrometry studies).","Src",null,"P00533","P00533","P00533","P00533"]
[645,319,"PK600","EGFR (ErbB1)","Y1110","Epidermal growth factor receptor-tyrosine kinase",0,666,12,606,{"v":396.324,"d":"396"},{"$f":"K658*1.7571469","v":{"v":696.3994879956,"d":"696"}},{"$f":"(L658+L659)/2","v":{"v":687.4819674780999,"d":"687"}},{"$f":"SQRT((M658-L658)*(M658-L658))","v":{"v":8.917520517500066,"d":"9"}},{"$f":"N658/M658*100","v":{"v":1.2971279159819036,"d":"1"}},0,642,14,464,{"v":291.392,"d":"291"},{"$f":"T658*1.7472151","v":{"v":509.1245024192,"d":"509"}},{"$f":"(U658+U659)/2","v":{"v":556.50111346325,"d":"557"}},{"$f":"SQRT((V658-U658)*(V658-U658))","v":{"v":47.37661104405004,"d":"47"}},{"$f":"W658/V658*100","v":{"v":8.513300314749268,"d":"9"}},{"$f":"X658+O658","v":{"v":9.810428230731171,"d":"10"}},{"$f":"(V658/M658*100)-100","v":{"v":-19.05226030805271,"d":"-19"}},null,0,730,14,601,{"v":430.316,"d":"430"},{"v":736.2024278824,"d":"736"},{"$f":"(AG658+AG659)/2","v":{"v":729.4651344492,"d":"729"}},{"$f":"SQRT((AH658-AG658)*(AH658-AG658))","v":{"v":6.737293433199966,"d":"7"}},{"$f":"AI658/AH658*100","v":{"v":0.9235936188077198,"d":"1"}},{"$f":"AJ658+O658","v":{"v":2.2207215347896234,"d":"2"}},{"$f":"(AH658/M658*100)-100","v":{"v":6.1068026445999095,"d":"6"}},null,null,"EGFR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"NPV(pY)HNQ(bA)C","Corresponds to amino acid residues N1107 to Q1113; In the cytoplasmic region of the EGFR after the kinase catalytic domain. ","Y1110 phosphorylation stimulates phosphotransferase activity, induces binding of CBL, DNA, DOK1, DOK2, GRB2, RASA1, SHC1 and STAT3. Phosphorylation regulates transcription, protein conformation, intracellular location, receptor internalization, molecular association, and ubquitination. One of the major in vivo sites of phosphorylation in EGFR (≥459 reports from high throughput mass spectrometry studies).","EGFR, Src","Protein-tyrosine kinase (receptor), TK group, EGFR family","P00533","P00533","P00533","P00533","GO:0016324; GO:0016323; GO:0009986; GO:0030665; GO:0005737; GO:0031901; GO:0030139; GO:0005789; GO:0005768; GO:0010008; GO:0005615; GO:0005925; GO:0000139; GO:0016021; GO:0016020; GO:0045121; GO:0097489; GO:0031965; GO:0005634; GO:0048471; GO:0005886; GO:0032991; GO:0043235; GO:0070435; GO:0045202","GO:0051015; GO:0005524; GO:0045296; GO:0005516; GO:0003682; GO:0003690; GO:0019899; GO:0005006; GO:0048408; GO:0042802; GO:0005178; GO:0004709; GO:0046934; GO:0046982; GO:0019901; GO:0019903; GO:0004713; GO:0005088; GO:0004714; GO:0004888; GO:0031625; GO:0001618","GO:0043006; GO:0007202; GO:0048143; GO:0098609; GO:0008283; GO:0007166; GO:0071230; GO:0071276; GO:0071549; GO:0071364; GO:0071392; GO:0071260; GO:0034614; GO:0021795; GO:0007623; GO:0048546; GO:0016101; GO:0001892; GO:0007173; GO:0038128; GO:0061029; GO:0001942; GO:0042743; GO:0007611; GO:0097421; GO:0030324; GO:0010960; GO:0000165; GO:0061024; GO:0007494; GO:0060571; GO:0043066; GO:1905208; GO:0042059; GO:1901185; GO:0045930; GO:0045746; GO:0042177; GO:0048812; GO:0001503; GO:0042698; GO:0038083; GO:0018108; GO:0097755; GO:0045780; GO:0090263; GO:0030307; GO:0030335; GO:0008284; GO:0031659; GO:0045739; GO:0045740; GO:0050679; GO:0070374; GO:0048146; GO:0050729; GO:0043406; GO:1901224; GO:0010750; GO:0033138; GO:0042327; GO:1903800; GO:1902722; GO:0051897; GO:1900020; GO:1903078; GO:0001934; GO:0048661; GO:0032930; GO:0051968; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0051205; GO:2000145; GO:0070372; GO:0046328; GO:0050999; GO:0050730; GO:0014066; GO:0006357; GO:0051592; GO:0033590; GO:0033594; GO:0006970; GO:0070141; GO:0007435; GO:0007165; GO:0043586; GO:0006412; GO:0042060"]
[650,321,"PK010","EGFR (ErbB1)","Y1172","Epidermal growth factor receptor-tyrosine kinase",0,861,16,379,{"v":320.255,"d":"320"},{"v":562.7350804595,"d":"563"},{"$nulls":3},0,447,14,357,{"v":154.581,"d":"155"},{"v":270.0862573731,"d":"270"},{"$nulls":6},0,62,14,655,{"v":31.44,"d":"31"},{"v":53.788853616000004,"d":"54"},{"$nulls":7},"EGFR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues that encompass the Y1172 phosphosite.","Y1172 phosphorylation stimulates phosphotransferase activity. Phosphorylation regulates cell growth, protein degradation, receptor internalization, and induces molecular association with DOK1, DOK2, EGFR, GRB2, RASA1, SHC1, SHP-1 and VAV2. This is one of the major in vivo phosphorylation sites in EGFR (≥995 reports from high throughput mass spectrometry studies).","EGFR",null,"P00533","P00533","P00533","P00533"]
[651,322,"NN038-1","eIF2a","Pan-specific","Eukaryotic translation initiation factor 2 alpha",0,587,8,304,{"v":176.016,"d":"176"},{"v":309.2859687504,"d":"309"},{"$f":"(L664+L665)/2","v":{"v":323.87204516730003,"d":"324"}},{"$f":"SQRT((M664-L664)*(M664-L664))","v":{"v":14.586076416900028,"d":"15"}},{"$f":"N664/M664*100","v":{"v":4.503654030827333,"d":"5"}},0,830,10,305,{"v":250.1,"d":"250"},{"v":436.97849651,"d":"437"},{"$f":"(U664+U665)/2","v":{"v":414.56347399210006,"d":"415"}},{"$f":"SQRT((V664-U664)*(V664-U664))","v":{"v":22.415022517899956,"d":"22"}},{"$f":"W664/V664*100","v":{"v":5.406897598105109,"d":"5"}},{"$f":"X664+O664","v":{"v":9.910551628932442,"d":"10"}},{"$f":"(V664/M664*100)-100","v":{"v":28.002240445899616,"d":"28"}},null,0,532,14,329,{"v":170.422,"d":"170"},{"v":291.56501307080003,"d":"292"},{"$f":"(AG664+AG665)/2","v":{"v":184.94366618140003,"d":"185"}},{"$f":"SQRT((AH664-AG664)*(AH664-AG664))","v":{"v":106.6213468894,"d":"107"}},{"$f":"AI664/AH664*100","v":{"v":57.65071553454638,"d":"58"}},{"$f":"AJ664+O664","v":{"v":62.15436956537371,"d":"62"}},{"$f":"(AH664/M664*100)-100","v":{"v":-42.896069932227356,"d":"-43"}},{"$nulls":15},"ELSRR","Corresponds to amino acid residues  E50 to R54; Surrounds the S51 phosphosite.",null,null,"Protein synthesis protein","P05198","P05198",null,null,"GO:0010494; GO:0005829; GO:0033290; GO:0005850; GO:0070062; GO:0097451; GO:0016020; GO:0043614; GO:0005634; GO:0005844; GO:0005840; GO:0045202; GO:0044207","GO:0043022; GO:0003723; GO:0003743","GO:0007568; GO:0034198; GO:0034605; GO:0034599; GO:0034644; GO:1905098; GO:0032057; GO:0036499; GO:1901216; GO:2000676; GO:0046777; GO:0034976; GO:1990737; GO:0034063; GO:0006413; GO:0055085"]
[657,325,"NN407-1","eIF4B","Pan-specific","Eukaryotic translation initiation factor 4B",0,262,18,651,{"v":158.844,"d":"159"},{"v":279.11224218359996,"d":"279"},{"$f":"(L670+L671)/2","v":{"v":341.10087052179995,"d":"341"}},{"$f":"SQRT((M670-L670)*(M670-L670))","v":{"v":61.98862833819999,"d":"62"}},{"$f":"N670/M670*100","v":{"v":18.173107633343978,"d":"18"}},0,300,16,585,{"v":166.14,"d":"166"},{"v":290.282316714,"d":"290"},{"$f":"(U670+U671)/2","v":{"v":304.347398269,"d":"304"}},{"$f":"SQRT((V670-U670)*(V670-U670))","v":{"v":14.065081555000006,"d":"14"}},{"$f":"W670/V670*100","v":{"v":4.6213904357311,"d":"5"}},{"$f":"X670+O670","v":{"v":22.79449806907508,"d":"23"}},{"$f":"(V670/M670*100)-100","v":{"v":-10.774957037364402,"d":"-11"}},null,0,326,22,659,{"v":200.336,"d":"200"},{"v":342.74312271040003,"d":"343"},{"$f":"(AG670+AG671)/2","v":{"v":347.9303938352,"d":"348"}},{"$f":"SQRT((AH670-AG670)*(AH670-AG670))","v":{"v":5.187271124799963,"d":"5"}},{"$f":"AI670/AH670*100","v":{"v":1.4908933558868547,"d":"1"}},{"$f":"AJ670+O670","v":{"v":19.664000989230832,"d":"20"}},{"$f":"(AH670/M670*100)-100","v":{"v":2.0022004936406574,"d":"2"}},{"$nulls":15},"Not precisely defined.","Antibody raised against amino acid residues 581-602 at the C-terminus of human eIF4B.",null,null,"Protein synthesis protein","P23588","P23588",null,null,"GO:0005829; GO:0016281; GO:0005844","GO:0004386; GO:0043024; GO:0003723; GO:0033592; GO:0034057; GO:0003743","GO:0097010; GO:0001731; GO:0006446; GO:0006413"]
[662,327,"NN039-3","eIF4E","Pan-specific","Eukaryotic translation initiation factor 4 (mRNA cap binding protein)",0,467,14,686,{"v":310.758,"d":"311"},{"v":546.0474563501999,"d":"546"},{"$nulls":3},0,518,18,709,{"v":354.5,"d":"355"},{"v":619.38775295,"d":"619"},{"$nulls":6},0,870,14,721,{"v":617.176,"d":"617"},{"v":1055.8902518864002,"d":"1056"},{"$nulls":20},"Not precisely defined.","Antibody raised against full length human eIF4E.",{"$nulls":3},"P06730","P06730",null,"P06730"]
[667,330,"PN031","eIF4G (eIF4G1)","S1106","Eukaryotic translation initiation factor 4 gamma 1",0,312,10,474,{"v":143.148,"d":"143"},{"v":251.5320644412,"d":"252"},{"$f":"(L680+L681)/2","v":{"v":262.957033585,"d":"263"}},{"$f":"SQRT((M680-L680)*(M680-L680))","v":{"v":11.424969143799984,"d":"11"}},{"$f":"N680/M680*100","v":{"v":4.344804543935845,"d":"4"}},0,324,12,448,{"v":139.776,"d":"140"},{"v":244.21873781760002,"d":"244"},{"$f":"(U680+U681)/2","v":{"v":366.17784622780005,"d":"366"}},{"$f":"SQRT((V680-U680)*(V680-U680))","v":{"v":121.95910841020003,"d":"122"}},{"$f":"W680/V680*100","v":{"v":33.305976772371146,"d":"33"}},{"$f":"X680+O680","v":{"v":37.65078131630699,"d":"38"}},{"$f":"(V680/M680*100)-100","v":{"v":39.25387019907734,"d":"39"}},null,0,368,12,507,{"v":180.492,"d":"180"},{"v":308.7931859688,"d":"309"},{"$f":"(AG680+AG681)/2","v":{"v":332.78944744520004,"d":"333"}},{"$f":"SQRT((AH680-AG680)*(AH680-AG680))","v":{"v":23.996261476400036,"d":"24"}},{"$f":"AI680/AH680*100","v":{"v":7.210643745051881,"d":"7"}},{"$f":"AJ680+O680","v":{"v":11.555448288987726,"d":"12"}},{"$f":"(AH680/M680*100)-100","v":{"v":26.556587176295082,"d":"27"}},{"$nulls":15},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S1106 phosphosite.","The effect of S1106 phosphorylation is unclear. This phosphosite has been poorly detected by mass spectrometry  (≥1 report).",null,"Protein synthesis protein","Q04637","Q04637",null,"Q04637","GO:0005737; GO:0005829; GO:0016281; GO:0016020; GO:0005634; GO:0005844","GO:0005524; GO:0008190; GO:0042802; GO:0003729; GO:0032947; GO:0003723; GO:0008135; GO:0003743; GO:0031369","GO:0001662; GO:0002191; GO:0034645; GO:0031669; GO:0032502; GO:0097009; GO:0007005; GO:0010507; GO:1901215; GO:0010801; GO:0000184; GO:0010942; GO:0030307; GO:0008284; GO:0032270; GO:1905537; GO:1900087; GO:1905618; GO:1905612; GO:0045666; GO:0033138; GO:0080135; GO:0060964; GO:0043488; GO:1905696; GO:1905606; GO:0006446; GO:0006412; GO:0006413; GO:0016032"]
[668,330,"PN031","eIF4G (eIF4G1)","S1106","Eukaryotic translation initiation factor 4 gamma 1",0,310,12,524,{"v":156.152,"d":"156"},{"v":274.3820027288,"d":"274"},{"$nulls":3},0,474,16,610,{"v":279.38,"d":"279"},{"v":488.136954638,"d":"488"},{"$nulls":6},0,404,12,532,{"v":208.544,"d":"209"},{"v":356.7857089216,"d":"357"},{"$nulls":20},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S1106 phosphosite.","The effect of S1106 phosphorylation is unclear. This phosphosite has been poorly detected by mass spectrometry  (≥1 report).",null,null,"Q04637","Q04637",null,"Q04637"]
[674,333,"PN223","Elk-1","S383","ETS domain-containing protein Elk-1",0,154,16,809,{"v":111.642,"d":"112"},{"v":196.17139420979998,"d":"196"},{"$nulls":3},0,142,14,840,{"v":107.52,"d":"108"},{"v":187.860567552,"d":"188"},{"$nulls":6},0,187,16,755,{"v":129.105,"d":"129"},{"v":220.87817894699998,"d":"221"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S383 phosphosite.","S383 phosphorylation stimulates DNA binding, transcriptional activity and potentiates ternary complex formation and binding to AurKA. This phosphorylation site in Elk-1 was not reported in high throughput mass spectrometry studies.","ERK1 (MAPK3); ERK2 (MAPK1); JNK1 (MAPK8); JNK2 (MAPK9); JNK3 (MAPK10); p38a MAPK (MAPK14)",null,"P19419","P19419",null,"P19419"]
[679,351,"PN173","ENFB2","Y316","Ephrin-B2",0,1304,12,245,{"v":316.54,"d":"317"},{"v":556.207279726,"d":"556"},{"$f":"(L692+L693)/2","v":{"v":501.8446689338,"d":"502"}},{"$f":"SQRT((M692-L692)*(M692-L692))","v":{"v":54.36261079220003,"d":"54"}},{"$f":"N692/M692*100","v":{"v":10.832557194977632,"d":"11"}},0,1396,12,254,{"v":351.536,"d":"352"},{"v":614.2090073936,"d":"614"},{"$f":"(U692+U693)/2","v":{"v":521.1383534468,"d":"521"}},{"$f":"SQRT((V692-U692)*(V692-U692))","v":{"v":93.07065394680001,"d":"93"}},{"$f":"W692/V692*100","v":{"v":17.859106575294703,"d":"18"}},{"$f":"X692+O692","v":{"v":28.691663770272335,"d":"29"}},{"$f":"(V692/M692*100)-100","v":{"v":3.8445530474580067,"d":"4"}},null,0,1240,10,276,{"v":339.48,"d":"339"},{"v":580.7964384720001,"d":"581"},{"$f":"(AG692+AG693)/2","v":{"v":519.514099524,"d":"520"}},{"$f":"SQRT((AH692-AG692)*(AH692-AG692))","v":{"v":61.282338948000074,"d":"61"}},{"$f":"AI692/AH692*100","v":{"v":11.796087729697701,"d":"12"}},{"$f":"AJ692+O692","v":{"v":22.628644924675335,"d":"23"}},{"$f":"(AH692/M692*100)-100","v":{"v":3.520896341838167,"d":"4"}},{"$nulls":15},"PV(pY)IV","Corresponds to amino acid residues P314 to V318","The effect of Y316 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in ephrin-B2 (≥125 reports from high throughput mass spectrometry studies).",null,"Ligand, receptor tyrosine kinase","P52799","P52799",null,null,"GO:0005925; GO:0005887; GO:0005886","GO:0046875; GO:0004713; GO:0001618","GO:0009653; GO:0007411; GO:0007155; GO:0007267; GO:0002042; GO:0048013; GO:0010977; GO:2000727; GO:0008284; GO:1901216; GO:0050920"]
[684,336,"PN512","ENO2","Y25","Gamma-enolase",0,6054,22,917,{"v":5531.344,"d":"5531"},{"v":9719.3839624336,"d":"9719"},{"$nulls":3},0,8136,18,866,{"v":7030.188,"d":"7030"},{"v":12283.2506294388,"d":"12283"},{"$nulls":6},0,7108,18,842,{"v":5969.78,"d":"5970"},{"v":10213.346772892,"d":"10213"},{"$nulls":7},"ENO2",{"$nulls":11},"X","VDL(pY)TAK(bA)C","Corresponds to amino acid residues V22 to K28; In the Enolase_N domain. ","The effect of Y25 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in ENO2 (≥100 reports from high throughput mass spectrometry studies).",null,null,"P09104","P09104"]
[685,337,"PN748","EP300 (p300)","S2279","Histone acetyltransferase p300",0,3763,20,741,{"v":2773.563,"d":"2774"},{"v":4873.5576274047,"d":"4874"},{"$f":"(L698+L699)/2","v":{"v":5242.56286927195,"d":"5243"}},{"$f":"SQRT((M698-L698)*(M698-L698))","v":{"v":369.00524186725033,"d":"369"}},{"$f":"N698/M698*100","v":{"v":7.038642188348142,"d":"7"}},0,3595,18,708,{"v":2532.516,"d":"2533"},{"v":4424.8501961916,"d":"4425"},{"$f":"(U698+U699)/2","v":{"v":5284.10262693,"d":"5284"}},{"$f":"SQRT((V698-U698)*(V698-U698))","v":{"v":859.2524307384001,"d":"859"}},{"$f":"W698/V698*100","v":{"v":16.261085209800616,"d":"16"}},{"$f":"X698+O698","v":{"v":23.299727398148757,"d":"23"}},{"$f":"(V698/M698*100)-100","v":{"v":0.7923559276995036,"d":"1"}},null,0,4403,19,823,{"v":3608.032,"d":"3608"},{"v":6172.7705181248,"d":"6173"},{"$f":"(AG698+AG699)/2","v":{"v":6130.7043497816,"d":"6131"}},{"$f":"SQRT((AH698-AG698)*(AH698-AG698))","v":{"v":42.066168343199934,"d":"42"}},{"$f":"AI698/AH698*100","v":{"v":0.6861555531494272,"d":"1"}},{"$f":"AJ698+O698","v":{"v":7.724797741497569,"d":"8"}},{"$f":"(AH698/M698*100)-100","v":{"v":16.940979109955606,"d":"17"}},{"$nulls":5},"Histone acetyltransferase and transcriptional co-activator ",{"$nulls":4},"X",{"$nulls":4},"NPM(pS)PQQ(bA)C","Corresponds to amino acid residues N2276 to Q2282.","S2279 phosphorylation stimulates enzyme activity. Phosphorylation at this site in EP300 has only been reported in a single mass spectrometry study. However, this human phosphosite is highly conserved in vertebrates and is found in fish.","ERK2 (MAPK1)","Transcription, coactivator/corepressor; EC 2.3.1.48; Acetyltransferase; Nuclear receptor co-regulator","Q09472","Q09472",null,"Q09472","GO:0005694; GO:0005829; GO:0000123; GO:0005654; GO:0005634; GO:0032993; GO:0005667","GO:0016407; GO:0033613; GO:0050681; GO:0008013; GO:0003682; GO:0031490; GO:0003684; GO:0003677; GO:0004402; GO:0140069; GO:0140068; GO:0004468; GO:0035257; GO:0002039; GO:0140065; GO:0061733; GO:0034212; GO:0097157; GO:0008022; GO:0061920; GO:0001102; GO:0000978; GO:0097677; GO:0001228; GO:0003713; GO:0008134; GO:0016746; GO:0008270","GO:0009887; GO:0006915; GO:0030183; GO:1904837; GO:0034644; GO:0007623; GO:0006977; GO:0045444; GO:0007507; GO:0016573; GO:0043969; GO:0043967; GO:0018393; GO:0006475; GO:0042771; GO:0030324; GO:0010742; GO:0035855; GO:0032460; GO:0000122; GO:0007399; GO:0007219; GO:0018076; GO:0018394; GO:0140067; GO:0140066; GO:0061921; GO:0030220; GO:0043923; GO:0051091; GO:0045815; GO:0010976; GO:0045747; GO:0032092; GO:0045893; GO:0045944; GO:0006990; GO:0007221; GO:0032481; GO:0006473; GO:0031648; GO:0050821; GO:0060765; GO:0010506; GO:0051726; GO:1900034; GO:0045652; GO:1901796; GO:0006355; GO:0061418; GO:0090043; GO:0043627; GO:0001666; GO:0007519; GO:0001756; GO:0002223; GO:0006283; GO:0016032"]
[690,340,"PK606","EphA2","Y588","Ephrin type-A receptor 2 protein-tyrosine kinase",0,5606,18,689,{"v":3850.132,"d":"3850"},{"v":6765.2475083908,"d":"6765"},{"$nulls":3},0,5284,24,733,{"v":3855.58,"d":"3856"},{"v":6736.527595258,"d":"6737"},{"$nulls":6},0,6831,20,760,{"v":5176.36,"d":"5176"},{"v":8855.930989303999,"d":"8856"},{"$nulls":7},"EPHA2","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Eph",{"$nulls":6},"LKT(pY)VDP(bA)C","Corresponds to amino acid residues L585 to P591; In the EphA2-TM domain located prior to the kinase catalytic domain. ","Y588 phosphorylation stimulates phosphotransferase activity and regulates cell adhesion, cell differentiation, cell motility and molecular association, including inducing interaction with Nck1, VAV2 and VAV3. One of the major in vivo sites of phosphorylation in EphA2 (≥655 reports from high throughput mass spectrometry studies).","EphA2",null,"P29317","P29317","P29317","P29317"]
[697,344,"PK609","EphB1","Y594","Ephrin type-B receptor 1 protein-tyrosine kinase",0,5484,18,577,{"v":3153.882,"d":"3154"},{"v":5541.8339792658,"d":"5542"},{"$f":"(L710+L711)/2","v":{"v":6098.2222451225,"d":"6098"}},{"$f":"SQRT((M710-L710)*(M710-L710))","v":{"v":556.3882658567,"d":"556"}},{"$f":"N710/M710*100","v":{"v":9.123778102736617,"d":"9"}},0,6021,14,574,{"v":3448.018,"d":"3448"},{"v":6024.429114671801,"d":"6024"},{"$f":"(U710+U711)/2","v":{"v":6319.673522269801,"d":"6320"}},{"$f":"SQRT((V710-U710)*(V710-U710))","v":{"v":295.2444075980002,"d":"295"}},{"$f":"W710/V710*100","v":{"v":4.6718300646005355,"d":"5"}},{"$f":"X710+O710","v":{"v":13.795608167337154,"d":"14"}},{"$f":"(V710/M710*100)-100","v":{"v":3.6314071256491616,"d":"4"}},null,0,6362,16,633,{"v":4017.018,"d":"4017"},{"v":6872.4806989452,"d":"6872"},{"$f":"(AG710+AG711)/2","v":{"v":7044.8154640085995,"d":"7045"}},{"$f":"SQRT((AH710-AG710)*(AH710-AG710))","v":{"v":172.33476506339957,"d":"172"}},{"$f":"AI710/AH710*100","v":{"v":2.446263723213818,"d":"2"}},{"$f":"AJ710+O710","v":{"v":11.570041825950435,"d":"12"}},{"$f":"(AH710/M710*100)-100","v":{"v":15.522445408466496,"d":"16"}},null,null,"EPHB1","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK","Eph",{"$nulls":6},"MKI(pY)IDP(bA)C","Corresponds to amino acid residues M591 to P597; In the region between the transmembrane domain and the kinase catalytic domain. ","Y594 phosphorylation induces binding to Nck1. This is one of the two major in vivo phosphorylation sites in EphB1 (≥127 reports from high throughput mass spectrometry studies).",null,"EC 2.7.10.1; Receptor tyrosine kinase; TK group; Eph family","P54762","P54762","P54762",null,"GO:0030424; GO:0005829; GO:0030425; GO:0031901; GO:0005783; GO:0070062; GO:0005576; GO:0032433; GO:0098978; GO:0005887; GO:0045121; GO:0005886","GO:0005524; GO:0008046; GO:0044877; GO:0004713; GO:0005005","GO:0001525; GO:0007411; GO:0048593; GO:0060326; GO:0031589; GO:0021952; GO:0060996; GO:0060997; GO:0050965; GO:0048013; GO:0030010; GO:0001771; GO:0050804; GO:1902725; GO:1902723; GO:0061351; GO:0022008; GO:0021631; GO:0051965; GO:0046777; GO:0070372; GO:0046328; GO:1901214; GO:0031290; GO:0014719"]
[701,346,"NK267-2","EphB2","Pan-specific","Ephrin type-B receptor 2 protein-tyrosine kinase",0,8404,16,667,{"v":5594.796,"d":"5595"},{"v":9830.878447532401,"d":"9831"},{"$f":"(L714+L715)/2","v":{"v":9567.794899370601,"d":"9568"}},{"$f":"SQRT((M714-L714)*(M714-L714))","v":{"v":263.0835481617996,"d":"263"}},{"$f":"N714/M714*100","v":{"v":2.749677965809092,"d":"3"}},0,9186,14,644,{"v":5906.768,"d":"5907"},{"v":10320.394241796801,"d":"10320"},{"$f":"(U714+U715)/2","v":{"v":10423.949059951152,"d":"10424"}},{"$f":"SQRT((V714-U714)*(V714-U714))","v":{"v":103.55481815435087,"d":"104"}},{"$f":"W714/V714*100","v":{"v":0.9934317364635715,"d":"1"}},{"$f":"X714+O714","v":{"v":3.7431097022726636,"d":"4"}},{"$f":"(V714/M714*100)-100","v":{"v":8.948291320885971,"d":"9"}},null,0,8545,16,710,{"v":6055.59,"d":"6056"},{"v":10360.154073426002,"d":"10360"},{"$f":"(AG714+AG715)/2","v":{"v":10726.127000665601,"d":"10726"}},{"$f":"SQRT((AH714-AG714)*(AH714-AG714))","v":{"v":365.9729272395998,"d":"366"}},{"$f":"AI714/AH714*100","v":{"v":3.4119764498116574,"d":"3"}},{"$f":"AJ714+O714","v":{"v":6.161654415620749,"d":"6"}},{"$f":"(AH714/M714*100)-100","v":{"v":12.106573285462034,"d":"12"}},null,null,"EPHB2","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Eph",{"$nulls":6},"REIQGIFFKEDSHKESNDC","Corresponds to amino acid residues R1033 to C1051; Near C-terminus.",null,null,"EC 2.7.10.1; Receptor tyrosine kinase; TK domain target; TK</A> group; Eph family","P29323","P29323","P29323","P29323","GO:0030424; GO:0005829; GO:0030425; GO:0005576; GO:0098978; GO:0005887; GO:0099055; GO:0099056; GO:0043025; GO:0005634; GO:0005886; GO:0098794","GO:0001540; GO:0005524; GO:0008046; GO:0042802; GO:0044877; GO:0004713; GO:0005102; GO:0005005","GO:0001525; GO:0007413; GO:0007411; GO:0048593; GO:0021952; GO:0071679; GO:0022038; GO:0060996; GO:0060997; GO:0048013; GO:0051389; GO:0042472; GO:0007612; GO:0007611; GO:0050771; GO:0070373; GO:1904782; GO:0001933; GO:0046580; GO:0007399; GO:0106028; GO:0021631; GO:0018108; GO:0016310; GO:0010628; GO:0048170; GO:1900273; GO:1904783; GO:1903078; GO:0051965; GO:0031915; GO:0097104; GO:0050878; GO:0048168; GO:0031290; GO:0060021; GO:0099557; GO:0001655"]
[702,346,"NK267-2","EphB2","Pan-specific","Ephrin type-B receptor 2 protein-tyrosine kinase",0,8408,16,631,{"v":5295.352,"d":"5295"},{"v":9304.7113512088,"d":"9305"},{"$nulls":3},0,8447,20,715,{"v":6025.305,"d":"6025"},{"v":10527.503878105501,"d":"10528"},{"$nulls":6},0,8746,20,743,{"v":6483.418,"d":"6483"},{"v":11092.0999279052,"d":"11092"},{"$nulls":7},"EPHB2","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Eph",{"$nulls":6},"REIQGIFFKEDSHKESNDC","Corresponds to amino acid residues R1033 to C1051; Near C-terminus.",{"$nulls":3},"P29323","P29323","P29323","P29323"]
[707,349,"PK612","EphB4","Y596","Ephrin type-B receptor 4 protein-tyrosine kinase",0,4931,18,764,{"v":3753.532,"d":"3754"},{"v":6595.5071178508,"d":"6596"},{"$f":"(L720+L721)/2","v":{"v":6632.7393035149,"d":"6633"}},{"$f":"SQRT((M720-L720)*(M720-L720))","v":{"v":37.23218566410014,"d":"37"}},{"$f":"N720/M720*100","v":{"v":0.5613395003233373,"d":"1"}},0,5037,16,743,{"v":3730.603,"d":"3731"},{"v":6518.1658937053,"d":"6518"},{"$f":"(U720+U721)/2","v":{"v":6507.548941150149,"d":"6508"}},{"$f":"SQRT((V720-U720)*(V720-U720))","v":{"v":10.61695255515042,"d":"11"}},{"$f":"W720/V720*100","v":{"v":0.1631482552211735,"d":"0"}},{"$f":"X720+O720","v":{"v":0.7244877555445108,"d":"1"}},{"$f":"(V720/M720*100)-100","v":{"v":-1.8874609212879534,"d":"-2"}},null,0,5368,16,814,{"v":4356.528,"d":"4357"},{"v":7453.3284626592,"d":"7453"},{"$f":"(AG720+AG721)/2","v":{"v":7525.8407645568,"d":"7526"}},{"$f":"SQRT((AH720-AG720)*(AH720-AG720))","v":{"v":72.51230189760008,"d":"73"}},{"$f":"AI720/AH720*100","v":{"v":0.9635109772598325,"d":"1"}},{"$f":"AJ720+O720","v":{"v":1.5248504775831697,"d":"2"}},{"$f":"(AH720/M720*100)-100","v":{"v":13.465046946268757,"d":"13"}},null,null,"EPHB4","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Eph",{"$nulls":6},"PFT(pY)EDP(bA)C","Corresponds to amino acid residues P593 to P599; In the EphA2_TM region between the transmembrane and kinase catalytic domains. ","The effect of Y596 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites for EphB4 (≥216 reports from high throughput mass spectrometry studies).",null,"Receptor tyrosine kinase; EC 2.7.10.1; EC 2.7.1.112; TK group; Eph family","P54760","P54760","P54760",null,"GO:0005829; GO:0070062; GO:0005576; GO:0005887; GO:0005886","GO:0005524; GO:0005003; GO:0004713; GO:0004714","GO:0001525; GO:0007155; GO:0002042; GO:0048013; GO:0003007; GO:0046777"]
[711,353,"PN198","ERa (ESR1)","S104","Estrogen receptor",0,2367,12,401,{"v":944.355,"d":"944"},{"v":1659.3704607495,"d":"1659"},{"$f":"(L724+L725)/2","v":{"v":1558.9011938747499,"d":"1559"}},{"$f":"SQRT((M724-L724)*(M724-L724))","v":{"v":100.46926687475002,"d":"100"}},{"$f":"N724/M724*100","v":{"v":6.444877152542756,"d":"6"}},0,3590,14,330,{"v":1180.08,"d":"1180"},{"v":2061.853595208,"d":"2062"},{"$f":"(U724+U725)/2","v":{"v":1768.3354361288002,"d":"1768"}},{"$f":"SQRT((V724-U724)*(V724-U724))","v":{"v":293.5181590791999,"d":"294"}},{"$f":"W724/V724*100","v":{"v":16.59855664724806,"d":"17"}},{"$f":"X724+O724","v":{"v":23.043433799790815,"d":"23"}},{"$f":"(V724/M724*100)-100","v":{"v":13.434734868185444,"d":"13"}},null,0,2547,16,425,{"v":1075.675,"d":"1076"},{"v":1840.309322945,"d":"1840"},{"$f":"(AG724+AG725)/2","v":{"v":926.2794736845001,"d":"926"}},{"$f":"SQRT((AH724-AG724)*(AH724-AG724))","v":{"v":914.0298492605,"d":"914"}},{"$f":"AI724/AH724*100","v":{"v":98.6775455170917,"d":"99"}},{"$f":"AJ724+O724","v":{"v":105.12242266963446,"d":"105"}},{"$f":"(AH724/M724*100)-100","v":{"v":-40.58125830398702,"d":"-41"}},{"$nulls":5},"Transcription protein (receptor)",{"$nulls":4},"X",{"$nulls":4},"SV(pS)PS","Corresponds to amino acid residues S102 to S106.","S104 phosphorylation stimulates transcriptional activity and regulates molecular association, including inducing interactions with CBP, NCoA2, SRC-2, SRC-3 and Src. This is a minor in vivo phosphorylation sites in the estrogen receptor (≥1 report from high throughput mass spectrometry studies).","BARK2 (GRK3, ADRBK2); CDK2; CDK3; ERK1 (MAPK3); ERK2 (MAPK1); GSK3b; mTOR","Transcription protein (receptor)","P03372","P03372",null,"P03372","GO:0005737; GO:0005829; GO:0005794; GO:0016021; GO:0016020; GO:0000790; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:0035327; GO:0097550","GO:0051117; GO:0008013; GO:0003682; GO:0003700; GO:0019899; GO:0030284; GO:0030331; GO:0034056; GO:0042802; GO:0030235; GO:0046934; GO:0019901; GO:0000978; GO:0038052; GO:0000981; GO:0005496; GO:0003707; GO:0017025; GO:0001093; GO:0001077; GO:0001223; GO:0008134; GO:0008270","GO:0008209; GO:0001547; GO:0071392; GO:0071391; GO:0006338; GO:0002064; GO:0060750; GO:0030520; GO:0030518; GO:0008584; GO:0060749; GO:0060745; GO:0043433; GO:0010629; GO:0043124; GO:1903799; GO:0000122; GO:0007200; GO:0007204; GO:0051091; GO:0048146; GO:0045429; GO:0051000; GO:0010863; GO:0051897; GO:0045899; GO:0045893; GO:0045944; GO:0060527; GO:0060523; GO:0016579; GO:0071168; GO:0042981; GO:0060687; GO:0050727; GO:0033146; GO:0034121; GO:0006355; GO:0006357; GO:0030111; GO:0032355; GO:0043627; GO:0007165; GO:0048863; GO:0006351; GO:0006366; GO:0006367; GO:0060065; GO:0060068"]
[718,356,"NK054-6","ErbB2 (HER2, Neu)","Pan-specific","ErbB2 (Neu) receptor-tyrosine kinase",0,4896,10,654,{"v":3195.444,"d":"3195"},{"v":5614.8645187236,"d":"5615"},{"$nulls":3},0,5070,20,616,{"v":3110.8,"d":"3111"},{"v":5435.236733080001,"d":"5435"},{"$nulls":6},0,5352,14,685,{"v":3656.53,"d":"3657"},{"v":6255.742904342001,"d":"6256"},{"$nulls":7},"ERBB2","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"CPALVTYNTDTFES","Corresponds to amino acid residues C268 to S281; In the extracellular domain of the receptor.",{"$nulls":3},"P04626","P04626","P04626","P04626"]
[719,357,"PK614","ErbB2 (HER2, Neu)","Y735","ErbB2 (Neu) receptor-tyrosine kinase",0,4850,16,643,{"v":3108.262,"d":"3108"},{"v":5461.6729376878,"d":"5462"},{"$f":"(L732+L733)/2","v":{"v":5198.9302760246,"d":"5199"}},{"$f":"SQRT((M732-L732)*(M732-L732))","v":{"v":262.7426616632001,"d":"263"}},{"$f":"N732/M732*100","v":{"v":5.053783138328761,"d":"5"}},0,5241,16,652,{"v":3406.7,"d":"3407"},{"v":5952.23768117,"d":"5952"},{"$f":"(U732+U733)/2","v":{"v":5436.0334631656,"d":"5436"}},{"$f":"SQRT((V732-U732)*(V732-U732))","v":{"v":516.2042180044,"d":"516"}},{"$f":"W732/V732*100","v":{"v":9.495972044730488,"d":"9"}},{"$f":"X732+O732","v":{"v":14.549755183059249,"d":"15"}},{"$f":"(V732/M732*100)-100","v":{"v":4.560614867916684,"d":"5"}},null,0,5189,14,685,{"v":3544.875,"d":"3545"},{"v":6064.718907825,"d":"6065"},{"$f":"(AG732+AG733)/2","v":{"v":6089.876830612,"d":"6090"}},{"$f":"SQRT((AH732-AG732)*(AH732-AG732))","v":{"v":25.157922786999734,"d":"25"}},{"$f":"AI732/AH732*100","v":{"v":0.41311053551261223,"d":"0"}},{"$f":"AJ732+O732","v":{"v":5.466893673841374,"d":"5"}},{"$f":"(AH732/M732*100)-100","v":{"v":17.137112969106184,"d":"17"}},null,null,"ERBB2","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"GTV(pY)KGIW(bA)C","Corresponds to amino acid residues G732 to W739; In the region between the Transmembrane and kinase catalytic domains. ","Y735 phosphorylation induces interaction with SHC1. This is one of the major in vivo phosphorylation sites in ErbB2 (≥147 reports from high throughput mass spectrometry studies).",null,"Receptor tyrosine kinase; EC 2.7.10.1; TK group; EGFR family","P04626","P04626","P04626","P04626","GO:0016324; GO:0016323; GO:0005829; GO:0010008; GO:0016021; GO:0043209; GO:0005634; GO:0048471; GO:0005886; GO:0043235","GO:0005524; GO:0043125; GO:0042802; GO:0046934; GO:0008022; GO:0046983; GO:0046982; GO:0019903; GO:0004713; GO:0005088; GO:0001042; GO:0004714; GO:0004888","GO:0008283; GO:0007166; GO:0071364; GO:0071363; GO:0007167; GO:0038128; GO:0007507; GO:0000165; GO:0008045; GO:0042552; GO:1901185; GO:0033088; GO:0007528; GO:0048709; GO:0007422; GO:0014065; GO:0045785; GO:0030307; GO:0050679; GO:0043547; GO:0043406; GO:0051897; GO:0001934; GO:0090314; GO:0045943; GO:0045945; GO:0045727; GO:0046777; GO:0006468; GO:0045765; GO:2000145; GO:0070372; GO:0032886; GO:0006357; GO:0007165; GO:0006351; GO:0007169; GO:0042060"]
[724,359,"PK613","ErbB2 (HER2, Neu)","Y1248","ErbB2 (Neu) receptor-tyrosine kinase",0,8614,18,716,{"v":6154.736,"d":"6155"},{"v":10814.7752827184,"d":"10815"},{"$nulls":3},0,9242,16,665,{"v":6135.29,"d":"6135"},{"v":10719.671330879,"d":"10720"},{"$nulls":6},0,9382,20,720,{"v":6740.64,"d":"6741"},{"v":11532.165974496002,"d":"11532"},{"$nulls":7},"ERBB2","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"NPE(pY)LGL(bA)C","Corresponds to amino acid residues N1245 to L1251; In the C-terminus of the kinase after the catalytic domain.","Y1248 phosphorylation stimulates phosphotransferase activity. Phosphorylation regulates cell motility, cytoskeletal reorganization, transcription, intracellular location and induces molecular association with CPNE3, RACK1 and SHC1. This is the major in vivo phosphorylation site in ErbB2 (≥196 reports from high throughput mass spectrometry studies).","ErbB2",null,"P04626","P04626","P04626","P04626"]
[729,362,"NK231-3","ErbB3 (HER3)","Pan-specific","ErbB3 (HER3) receptor-tyrosine kinase",0,6028,20,805,{"v":4836.44,"d":"4836"},{"v":8498.335553035999,"d":"8498"},{"$f":"(L742+L743)/2","v":{"v":8413.764072738999,"d":"8414"}},{"$f":"SQRT((M742-L742)*(M742-L742))","v":{"v":84.57148029699965,"d":"85"}},{"$f":"N742/M742*100","v":{"v":1.005156307757848,"d":"1"}},0,6414,16,806,{"v":5156.788,"d":"5157"},{"v":9010.017861098799,"d":"9010"},{"$f":"(U742+U743)/2","v":{"v":8381.1007969934,"d":"8381"}},{"$f":"SQRT((V742-U742)*(V742-U742))","v":{"v":628.9170641053988,"d":"629"}},{"$f":"W742/V742*100","v":{"v":7.503991174178622,"d":"8"}},{"$f":"X742+O742","v":{"v":8.50914748193647,"d":"9"}},{"$f":"(V742/M742*100)-100","v":{"v":-0.38821240366638676,"d":"-0"}},null,0,6524,18,830,{"v":5399.98,"d":"5400"},{"v":9238.509343172,"d":"9239"},{"$f":"(AG742+AG743)/2","v":{"v":9164.823404073999,"d":"9165"}},{"$f":"SQRT((AH742-AG742)*(AH742-AG742))","v":{"v":73.68593909800074,"d":"74"}},{"$f":"AI742/AH742*100","v":{"v":0.8040082808932844,"d":"1"}},{"$f":"AJ742+O742","v":{"v":1.8091645886511323,"d":"2"}},{"$f":"(AH742/M742*100)-100","v":{"v":8.926555639567653,"d":"9"}},null,null,"ERBB3","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"CSEKANKVLARIFKET","Corresponds to amino acid residues S693 to T707.",null,null,"Receptor tyrosine kinase; EC 2.7.10.1; TK group; EGFR family","P21860","P21860","P21860","P21860","GO:0016324; GO:0016323; GO:0005615; GO:0005887; GO:0005622; GO:0016328; GO:0005886; GO:0043235","GO:0005524; GO:0019838; GO:0042802; GO:0038132; GO:0046934; GO:0046982; GO:0042803; GO:0030296; GO:0004713; GO:0005088; GO:0004888; GO:0031625","GO:0021545; GO:0003197; GO:0038128; GO:0097192; GO:0007507; GO:0000165; GO:0007162; GO:0043524; GO:0051048; GO:0009968; GO:0051402; GO:0007422; GO:0014065; GO:0070886; GO:0055025; GO:0010628; GO:0014068; GO:0051897; GO:0061098; GO:2000145; GO:0042127; GO:0014037; GO:0007165; GO:0007169; GO:0042060"]
[734,364,"PK617","ErbB3 (HER3)","Y1307","ErbB3 (HER3) receptor-tyrosine kinase",0,4500,18,678,{"v":3038.796,"d":"3039"},{"v":5339.6109711324,"d":"5340"},{"$nulls":3},0,4302,14,690,{"v":2958.72,"d":"2959"},{"v":5169.5202606719995,"d":"5170"},{"$nulls":6},0,4536,18,684,{"v":3090.312,"d":"3090"},{"v":5287.0337085168,"d":"5287"},{"$nulls":7},"ERBB3","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"HVH(pY)ARL(bA)C","Corresponds to amino acid residues H1304 to L1310; In the cytoplasmic region of ErbB3 near the C-terminus after the kinase catalytic domain. ","The effect of Y1307 phosphorylation is unclear. This is a major in vivo phosphorylation site in ErbB3 (≥133 reports from high throughput mass spectrometry studies).",null,null,"P21860","P21860","P21860","P21860"]
[736,365,"PK618","ErbB3 (HER3)","Y1328","ErbB3 (HER3) receptor-tyrosine kinase",0,6471,18,588,{"v":3794.364,"d":"3794"},{"v":6667.2549400716,"d":"6667"},{"$nulls":3},0,6448,18,572,{"v":3677.96,"d":"3678"},{"v":6426.187249196,"d":"6426"},{"$nulls":6},0,6784,20,639,{"v":4322.196,"d":"4322"},{"v":7394.5918557144005,"d":"7395"},{"$nulls":7},"ERBB3","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"NPD(pY)WHS(bA)C","Corresponds to amino acid residues N1325 to S1331; In the cytoplasmic region of ErbB3 near the C-terminus after the kinase catalytic domain. ","Y1328 phosphoryation induces interaction with Shc1. This is one of the major in vivo phosphorylation sites in ErbB3 (≥214 reports from high throughput mass spectrometry studies).",null,null,"P21860","P21860","P21860","P21860"]
[741,368,"PK619","ErbB4 (HER4)","Y733","ErbB4  receptor-tyrosine kinase",0,406,10,438,{"v":173.448,"d":"173"},{"v":304.7736155112,"d":"305"},{"$f":"(L754+L755)/2","v":{"v":306.83387025145,"d":"307"}},{"$f":"SQRT((M754-L754)*(M754-L754))","v":{"v":2.060254740250002,"d":"2"}},{"$f":"N754/M754*100","v":{"v":0.6714561005151178,"d":"1"}},0,496,16,421,{"v":202.08,"d":"202"},{"v":353.077227408,"d":"353"},{"$f":"(U754+U755)/2","v":{"v":320.4305132645,"d":"320"}},{"$f":"SQRT((V754-U754)*(V754-U754))","v":{"v":32.64671414349999,"d":"33"}},{"$f":"W754/V754*100","v":{"v":10.188391177513017,"d":"10"}},{"$f":"X754+O754","v":{"v":10.859847278028134,"d":"11"}},{"$f":"(V754/M754*100)-100","v":{"v":4.4312718807436795,"d":"4"}},null,0,507,12,502,{"v":248.49,"d":"248"},{"v":425.12697948600004,"d":"425"},{"$f":"(AG754+AG755)/2","v":{"v":397.368577771,"d":"397"}},{"$f":"SQRT((AH754-AG754)*(AH754-AG754))","v":{"v":27.758401715000048,"d":"28"}},{"$f":"AI754/AH754*100","v":{"v":6.985555292446141,"d":"7"}},{"$f":"AJ754+O754","v":{"v":7.657011392961259,"d":"8"}},{"$f":"(AH754/M754*100)-100","v":{"v":29.50609965104468,"d":"30"}},null,null,"ERBB4","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"GTV(pY)KGI(bA)C","Corresponds to amino acid residues G730 to I736; In the region between the transmembrane and kinase catalytic domains. ","Y733 phosphorylation induces interaction with SHC1. This is the major in vivo site of phosphorylation in ErbB4 (≥146 reports from high throughput mass spectrometry studies).",null,"Receptor tyrosine kinase; EC 2.7.10.1; TK domain target; TK</A> group; EGFR family","Q15303","Q15303","Q15303","Q15303","GO:0016323; GO:0005829; GO:0005576; GO:0098982; GO:0098978; GO:0099061; GO:0099056; GO:0005759; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0045211; GO:0043235","GO:0005524; GO:0005154; GO:0046934; GO:0042803; GO:0004713; GO:0005088; GO:0044212; GO:0004714","GO:0061026; GO:0045165; GO:0016477; GO:0008283; GO:0071364; GO:0021551; GO:0009880; GO:0038128; GO:0007507; GO:0007595; GO:0060749; GO:0060644; GO:0000165; GO:0043653; GO:0043066; GO:0008285; GO:2001223; GO:0007399; GO:0001755; GO:0021889; GO:0038083; GO:0018108; GO:0043065; GO:0060045; GO:0008284; GO:0070374; GO:0046427; GO:0043552; GO:0014068; GO:0051897; GO:2000010; GO:0001934; GO:0045893; GO:0042531; GO:0046777; GO:0030334; GO:2000145; GO:0007165; GO:0007416; GO:0006351; GO:0007169"]
[746,370,"PN584","ERF","T526","ETS domain-containing transcription factor ERF",0,8666,14,678,{"v":5866.056,"d":"5866"},{"v":10307.5221156264,"d":"10308"},{"$nulls":3},0,8878,18,614,{"v":5440.04,"d":"5440"},{"v":9504.920032604,"d":"9505"},{"$nulls":6},0,9614,14,708,{"v":6796.8,"d":"6797"},{"v":11628.24682752,"d":"11628"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"CGGPL(pT)PRR","Corresponds to amino acid residues C522 to R529.","T526 phosphorylation inhibits ERF transcriptional repression by inducing its export from the nucleus, and regulates cell cycle progression. Phosphorylation induces transcriptional activity. This is the major in vivo phosphorylation site in ERF (≥150 reports from high throughput mass spectrometry studies).","ERK1; ERK2",null,"P50548","P50548"]
[751,373,"NK055-4","ERK1 (MAPK3)","Pan-specific","Extracellular regulated protein-serine kinase 1 (p44 MAP kinase)",0,626,14,502,{"v":307.224,"d":"307"},{"v":539.8376992056,"d":"540"},{"$f":"(L764+L765)/2","v":{"v":542.1782188764,"d":"542"}},{"$f":"SQRT((M764-L764)*(M764-L764))","v":{"v":2.340519670800063,"d":"2"}},{"$f":"N764/M764*100","v":{"v":0.43168825107923225,"d":"0"}},0,638,14,509,{"v":317.616,"d":"318"},{"v":554.9434712016,"d":"555"},{"$f":"(U764+U765)/2","v":{"v":524.583861624,"d":"525"}},{"$f":"SQRT((V764-U764)*(V764-U764))","v":{"v":30.359609577600054,"d":"30"}},{"$f":"W764/V764*100","v":{"v":5.787370103916877,"d":"6"}},{"$f":"X764+O764","v":{"v":6.219058354996109,"d":"6"}},{"$f":"(V764/M764*100)-100","v":{"v":-3.2451243225635835,"d":"-3"}},null,0,778,12,536,{"v":410.576,"d":"411"},{"v":702.4304186464001,"d":"702"},{"$f":"(AG764+AG765)/2","v":{"v":685.6966789130001,"d":"686"}},{"$f":"SQRT((AH764-AG764)*(AH764-AG764))","v":{"v":16.733739733399943,"d":"17"}},{"$f":"AI764/AH764*100","v":{"v":2.4403997055851407,"d":"2"}},{"$f":"AJ764+O764","v":{"v":2.872087956664373,"d":"3"}},{"$f":"(AH764/M764*100)-100","v":{"v":26.4707166462764,"d":"26"}},null,null,"ERK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","ERK",{"$nulls":5},"CGGGGGEPRRTEGVGPGVPGEVEMVKGGC","Corresponds to amino acid residues G8 to K32; N-terminus.",null,null,"EC 2.7.1.123; EC 2.7.11.24; Protein kinase, Ser/Thr (non-receptor); CMGC group; MAPK family; MAPK/ERK subfamily; ERK subfamily","P27361","P27361","P27361","P27361","GO:0005901; GO:0005737; GO:0005856; GO:0005829; GO:0005769; GO:0005925; GO:0005794; GO:0005770; GO:0005739; GO:0005635; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:0031143","GO:0005524; GO:0042802; GO:0016301; GO:0004707; GO:0004708; GO:0019902; GO:0001784; GO:0004674; GO:0097110","GO:0000187; GO:0006915; GO:0019369; GO:0007411; GO:0060020; GO:0030509; GO:0061308; GO:0051216; GO:0072584; GO:0007049; GO:0034198; GO:0071276; GO:1903351; GO:0071260; GO:0034614; GO:0071356; GO:0006975; GO:0070371; GO:0060324; GO:0038095; GO:0038096; GO:0008543; GO:0070498; GO:0031663; GO:0060425; GO:0000165; GO:2000657; GO:0042473; GO:0018105; GO:0038083; GO:0016310; GO:0030168; GO:0031281; GO:0002741; GO:0070374; GO:0010628; GO:0035066; GO:0033129; GO:0010759; GO:1905050; GO:0001934; GO:0051973; GO:1904355; GO:0032212; GO:0045944; GO:0045727; GO:1904417; GO:0065003; GO:0006468; GO:0030641; GO:1900034; GO:0051493; GO:0051090; GO:2000641; GO:0090170; GO:0030278; GO:0014066; GO:0032872; GO:0070849; GO:0043330; GO:0009636; GO:0019233; GO:0051403; GO:0048538; GO:0030878; GO:0060440; GO:0006361; GO:0016032"]
[752,373,"NK055-4","ERK1 (MAPK3)","Pan-specific","Extracellular regulated protein-serine kinase 1 (p44 MAP kinase)",0,590,14,538,{"v":309.888,"d":"310"},{"v":544.5187385472,"d":"545"},{"$nulls":3},0,580,12,498,{"v":282.864,"d":"283"},{"v":494.22425204639995,"d":"494"},{"$nulls":6},0,714,12,557,{"v":391.014,"d":"391"},{"v":668.9629391796001,"d":"669"},{"$nulls":7},"ERK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","ERK",{"$nulls":5},"CGGGGGEPRRTEGVGPGVPGEVEMVKGGC","Corresponds to amino acid residues G8 to K32; N-terminus.",{"$nulls":3},"P27361","P27361","P27361","P27361"]
[758,376,"PK864","ERK1 (MAPK3)","Y204","Extracellular regulated protein-serine kinase 1 (p44 MAP kinase)",0,6546,12,651,{"v":4253.634,"d":"4254"},{"v":7474.2597968346,"d":"7474"},{"$nulls":3},0,6509,14,662,{"v":4299.69,"d":"4300"},{"v":7512.483293318999,"d":"7512"},{"$nulls":6},0,6854,16,763,{"v":5217.394,"d":"5217"},{"v":8926.133655311602,"d":"8926"},{"$nulls":7},"ERK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","ERK",{"$nulls":5},"C(bA)(pY)VATRW","Corresponds to amino acid residues Y204 to W209; In activation T-loop between kinase catalytic subdomains VII and VIII."," Y204 phosphorylation stimulates phosphotransferase activity and induces molecular association with ERK1, GSK3B, KSR and TACE and regulates cell growth, cell motility, cytoskeletal reorganization, transcription, protein conformation, intracellular location, and protein degradation. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the two major in vivo phosphorylation sitesin ERK1 (≥3626 reports, respectively, from high throughput mass spectrometry studies).","ERK1; JAK2; LCK;  MEK1; MEK2; RET",null,"P27361","P27361","P27361","P27361"]
[763,379,"PK865","ERK1 (MAPK3)","T207","Extracellular regulated protein-serine kinase 1 (p44 MAP kinase)",0,9666,16,643,{"v":6204.95,"d":"6205"},{"v":10903.008657155,"d":"10903"},{"$f":"(L776+L777)/2","v":{"v":11143.140352508999,"d":"11143"}},{"$f":"SQRT((M776-L776)*(M776-L776))","v":{"v":240.13169535399902,"d":"240"}},{"$f":"N776/M776*100","v":{"v":2.154973263887238,"d":"2"}},0,9680,18,618,{"v":5971.116,"d":"5971"},{"v":10432.8240390516,"d":"10433"},{"$f":"(U776+U777)/2","v":{"v":10353.7415891954,"d":"10354"}},{"$f":"SQRT((V776-U776)*(V776-U776))","v":{"v":79.08244985619967,"d":"79"}},{"$f":"W776/V776*100","v":{"v":0.7638055206895041,"d":"1"}},{"$f":"X776+O776","v":{"v":2.918778784576742,"d":"3"}},{"$f":"(V776/M776*100)-100","v":{"v":-7.0841678229051155,"d":"-7"}},null,0,9998,20,653,{"v":6515.634,"d":"6516"},{"v":11147.2163944476,"d":"11147"},{"$f":"(AG776+AG777)/2","v":{"v":11586.7366826318,"d":"11587"}},{"$f":"SQRT((AH776-AG776)*(AH776-AG776))","v":{"v":439.52028818419967,"d":"440"}},{"$f":"AI776/AH776*100","v":{"v":3.793305226682406,"d":"4"}},{"$f":"AJ776+O776","v":{"v":5.948278490569644,"d":"6"}},{"$f":"(AH776/M776*100)-100","v":{"v":3.9808915268927763,"d":"4"}},null,null,"ERK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","ERK",{"$nulls":5},"C(bA)YVA(pT)RW","Corresponds to amino acid residues Y204 to W209; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T207 phosphorylation inhibits phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is a minor in vivo phosphorylation sites in ERK1 (≥43 reports from high throughput mass spectrometry studies).","ERK1","EC 2.7.1.123; EC 2.7.11.24; Protein kinase, Ser/Thr (non-receptor); CMGC group; MAPK family; MAPK/ERK subfamily; ERK subfamily","P27361","P27361","P27361","P27361","GO:0005901; GO:0005737; GO:0005856; GO:0005829; GO:0005769; GO:0005925; GO:0005794; GO:0005770; GO:0005739; GO:0005635; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:0031143","GO:0005524; GO:0042802; GO:0016301; GO:0004707; GO:0004708; GO:0019902; GO:0001784; GO:0004674; GO:0097110","GO:0000187; GO:0006915; GO:0019369; GO:0007411; GO:0060020; GO:0030509; GO:0061308; GO:0051216; GO:0072584; GO:0007049; GO:0034198; GO:0071276; GO:1903351; GO:0071260; GO:0034614; GO:0071356; GO:0006975; GO:0070371; GO:0060324; GO:0038095; GO:0038096; GO:0008543; GO:0070498; GO:0031663; GO:0060425; GO:0000165; GO:2000657; GO:0042473; GO:0018105; GO:0038083; GO:0016310; GO:0030168; GO:0031281; GO:0002741; GO:0070374; GO:0010628; GO:0035066; GO:0033129; GO:0010759; GO:1905050; GO:0001934; GO:0051973; GO:1904355; GO:0032212; GO:0045944; GO:0045727; GO:1904417; GO:0065003; GO:0006468; GO:0030641; GO:1900034; GO:0051493; GO:0051090; GO:2000641; GO:0090170; GO:0030278; GO:0014066; GO:0032872; GO:0070849; GO:0043330; GO:0009636; GO:0019233; GO:0051403; GO:0048538; GO:0030878; GO:0060440; GO:0006361; GO:0016032"]
[768,381,"PK879","ERK1 (MAPK3)","S283","Extracellular regulated protein-serine kinase 1 (p44 MAP kinase)",0,13228,18,749,{"v":9894.29,"d":"9894"},{"v":17385.721001201,"d":"17386"},{"$nulls":3},0,13807,24,711,{"v":9799.713,"d":"9800"},{"v":17122.2065292663,"d":"17122"},{"$nulls":6},0,13592,22,712,{"v":9661.84,"d":"9662"},{"v":16529.875872176002,"d":"16530"},{"$nulls":7},"ERK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","ERK",{"$nulls":5},"YLQ(pS)LPS(bA)C","Corresponds to amino acid residues Y280 to S286. S283 is located in the Gap/Insert 10 (G/I10) region in the protein-serine/threonine kinase catalytic domain of ERK1.","The effect of S283 phosphorylation is unknown. Phosphorylation of S283 has not been observed in any mass spectrometry studies with human ERK1, although it was reported to be found in hamster ERK1.",null,null,"P27361","P27361","P27361","P27361"]
[769,382,"NK056-3","ERK2 (MAPK1)","Pan-specific","Extracellular regulated protein-serine kinase 2 (p42 MAP kinase)",0,10300,20,686,{"$f":"(H782-I782)*J782/1000","v":{"v":7052.08,"d":"7052"}},{"v":12391.540510552,"d":"12392"},{"$f":"(L782+L783)/2","v":{"v":12146.910519134,"d":"12147"}},{"$f":"SQRT((M782-L782)*(M782-L782))","v":{"v":244.62999141799992,"d":"245"}},{"$f":"N782/M782*100","v":{"v":2.0139276652499825,"d":"2"}},0,11666,22,660,{"$f":"(Q782-R782)*S782/1000","v":{"v":7685.04,"d":"7685"}},{"v":13427.417932104,"d":"13427"},{"$f":"(U782+U783)/2","v":{"v":12584.6766840606,"d":"12585"}},{"$f":"SQRT((V782-U782)*(V782-U782))","v":{"v":842.7412480433995,"d":"843"}},{"$f":"W782/V782*100","v":{"v":6.6965665404085595,"d":"7"}},{"$f":"X782+O782","v":{"v":8.710494205658541,"d":"9"}},{"$f":"(V782/M782*100)-100","v":{"v":3.6039301041776923,"d":"4"}},null,0,9692,20,727,{"$f":"(AC782-AD782)*AE782/1000","v":{"v":7031.544,"d":"7032"}},{"v":12029.8565811216,"d":"12030"},{"$f":"(AG782+AG783)/2","v":{"v":12442.719394031701,"d":"12443"}},{"$f":"SQRT((AH782-AG782)*(AH782-AG782))","v":{"v":412.86281291010164,"d":"413"}},{"$f":"AI782/AH782*100","v":{"v":3.318107560218196,"d":"3"}},{"$f":"AJ782+O782","v":{"v":5.332035225468179,"d":"5"}},{"$f":"(AH782/M782*100)-100","v":{"v":2.435260179382553,"d":"2"}},null,null,"ERK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","ERK",{"$nulls":5},"HKNKVPWNRLFPNADC","Corresponds to amino acid residues H269 to D283; Pre-kinase last alpha-chain.",null,null,"EC 2.7.11.24; Protein kinase, Ser/Thr (non-receptor); CMGC domain target; CMGC</A> group; MAPK family; ERK subfamily; MAPK/ERK subfamily","P28482","P28482","P28482","P28482","GO:0030424; GO:0035578; GO:0005901; GO:0005737; GO:0005856; GO:0005829; GO:0032839; GO:0005769; GO:0005576; GO:1904813; GO:0005925; GO:0005794; GO:0005770; GO:0005815; GO:0005739; GO:0072686; GO:0005654; GO:0005634; GO:0043204; GO:0005886; GO:0014069; GO:0032991; GO:0031143","GO:0005524; GO:0003677; GO:0042802; GO:0016301; GO:0004707; GO:0004708; GO:0031435; GO:0019902; GO:0001784; GO:0004674; GO:0008353; GO:0008134","GO:0000187; GO:0006915; GO:0007411; GO:0050853; GO:0060020; GO:0061308; GO:0072584; GO:0007049; GO:0034198; GO:0071276; GO:0006974; GO:1903351; GO:0097011; GO:0034614; GO:0071356; GO:0007268; GO:0006935; GO:0019858; GO:0015966; GO:0038127; GO:0070371; GO:0060324; GO:0038095; GO:0038096; GO:0008543; GO:0060716; GO:0007611; GO:0031663; GO:0060291; GO:0060425; GO:0033598; GO:0000165; GO:0045596; GO:0043312; GO:0042473; GO:0018105; GO:0018107; GO:0030168; GO:0030335; GO:0008284; GO:0010628; GO:0010800; GO:0033160; GO:0051973; GO:1904355; GO:0032212; GO:0045893; GO:0045727; GO:0006468; GO:0030641; GO:1900034; GO:0051493; GO:0051090; GO:2000641; GO:0090170; GO:0030278; GO:0014066; GO:0031647; GO:0032872; GO:0070849; GO:0043627; GO:0043330; GO:0035094; GO:0019233; GO:0007165; GO:0051403; GO:0050852; GO:0048538; GO:0030878; GO:0060440; GO:0006351; GO:0016032"]
[774,384,"PK880","ERK2 (MAPK1)","Y263+S266","Extracellular regulated protein-serine kinase 2 (p42 MAP kinase)",0,8267,12,745,{"v":6149.975,"d":"6150"},{"v":10806.4095063275,"d":"10806"},{"$nulls":3},0,4760,12,965,{"v":4581.82,"d":"4582"},{"v":8005.425089482,"d":"8005"},{"$nulls":6},0,8634,18,718,{"v":6186.288,"d":"6186"},{"$f":"AF787*1.7108414","v":{"v":10583.7576227232,"d":"10584"}},{"$nulls":7},"ERK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","ERK",{"$nulls":5},"ARN(pY)LL(pS)LPH(bA)C","Corresponds to amino acid residues A260 to H269. Y263 and S266 are located in the Gap/Insert 10 (G/I10) region in the protein-serine/threonine kinase catalytic domain of ERK2.","The effects of Y263 and S266 phosphorylation are unknown. Phosphorylation of Y263 has only been observed once in a mass spectrometry studies with human ERK2, and phosphorylation of S266 has not been reported.",null,null,"P28482","P28482","P28482","P28482"]
[780,387,"NK058","ERK4 (MAPK4)","Pan-specific","Extracellular regulated protein-serine kinase 4",0,80,10,656,{"v":45.92,"d":"46"},{"v":80.688185648,"d":"81"},{"$nulls":3},0,140,10,432,{"v":56.16,"d":"56"},{"v":98.123600016,"d":"98"},{"$nulls":6},0,154,14,482,{"v":67.48,"d":"67"},{"v":115.44757767200001,"d":"115"},{"$nulls":7},"ERK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","ERK",{"$nulls":5},"APVDGGASPQFDLDVFISRALKLCTKPEDLP ","Corresponds to amino acid residues A527 to P557; C-terminus.",{"$nulls":3},"P31152","P31152","P31152","P31152"]
[785,390,"NK206-5","ERK5 (MAPK7)","Pan-specific","Extracellular regulated protein-serine kinase 5 (Big MAP kinase 1 (BMK1))",0,5150,12,703,{"v":3612.014,"d":"3612"},{"v":6346.8392028566,"d":"6347"},{"$f":"(L798+L799)/2","v":{"v":6248.8624488595,"d":"6249"}},{"$f":"SQRT((M798-L798)*(M798-L798))","v":{"v":97.97675399710079,"d":"98"}},{"$f":"N798/M798*100","v":{"v":1.5679134370285723,"d":"2"}},0,4242,12,608,{"v":2571.84,"d":"2572"},{"v":4493.5576827840005,"d":"4494"},{"$f":"(U798+U799)/2","v":{"v":5260.410390174,"d":"5260"}},{"$f":"SQRT((V798-U798)*(V798-U798))","v":{"v":766.8527073899995,"d":"767"}},{"$f":"W798/V798*100","v":{"v":14.577811435062468,"d":"15"}},{"$f":"X798+O798","v":{"v":16.14572487209104,"d":"16"}},{"$f":"(V798/M798*100)-100","v":{"v":-15.818111964776975,"d":"-16"}},null,0,5621,10,680,{"v":3815.48,"d":"3815"},{"v":6527.681144872,"d":"6528"},{"$f":"(AG798+AG799)/2","v":{"v":6593.137936836,"d":"6593"}},{"$f":"SQRT((AH798-AG798)*(AH798-AG798))","v":{"v":65.45679196400033,"d":"65"}},{"$f":"AI798/AH798*100","v":{"v":0.9928017977341542,"d":"1"}},{"$f":"AJ798+O798","v":{"v":2.5607152347627267,"d":"3"}},{"$f":"(AH798/M798*100)-100","v":{"v":5.509410565427558,"d":"6"}},null,null,"ERK5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","ERK",{"$nulls":5},"CADIESLQREIQMDSP","Corresponds to amino acid residues A790 to D802; Pre-C-terminus.",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.24; CMGC domain target; CMGC</A> group; MAPK family; MAPK/ERK subfamily; ERK subfamily","Q13164","Q13164","Q13164","Q13164","GO:0005737; GO:0005829; GO:0005654; GO:0005634; GO:0016605","GO:0005524; GO:0004707; GO:0051019; GO:0004674","GO:0007411; GO:0019933; GO:0007049; GO:0071363; GO:0070301; GO:0071499; GO:0071560; GO:0070885; GO:0051344; GO:2000352; GO:0070377; GO:2001240; GO:0034115; GO:0050728; GO:0043407; GO:1902176; GO:0060761; GO:0018105; GO:0051247; GO:0045944; GO:0036003; GO:0045765; GO:0007165"]
[786,390,"NK206-5","ERK5 (MAPK7)","Pan-specific","Extracellular regulated protein-serine kinase 5 (Big MAP kinase 1 (BMK1))",0,5268,12,666,{"v":3500.496,"d":"3500"},{"v":6150.8856948624,"d":"6151"},{"$nulls":3},0,5356,16,646,{"v":3449.64,"d":"3450"},{"v":6027.2630975639995,"d":"6027"},{"$nulls":6},0,5572,12,700,3892,{"v":6658.594728800001,"d":"6659"},{"$nulls":7},"ERK5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","ERK",{"$nulls":5},"CADIESLQREIQMDSP","Corresponds to amino acid residues A790 to D802; Pre-C-terminus.",{"$nulls":3},"Q13164","Q13164","Q13164","Q13164"]
[791,393,"PN585","ESRRA (ERR1)","S19+S22","Steroid hormone receptor ERR1",0,7156,21,647,{"v":4616.345,"d":"4616"},{"v":8111.596306080501,"d":"8112"},{"$f":"(L804+L805)/2","v":{"v":7940.744520126251,"d":"7941"}},{"$f":"SQRT((M804-L804)*(M804-L804))","v":{"v":170.85178595424986,"d":"171"}},{"$f":"N804/M804*100","v":{"v":2.151583966984666,"d":"2"}},0,7431,20,623,{"v":4617.053,"d":"4617"},{"v":8066.9847191003,"d":"8067"},{"$f":"(U804+U805)/2","v":{"v":7811.73493874885,"d":"7812"}},{"$f":"SQRT((V804-U804)*(V804-U804))","v":{"v":255.24978035144977,"d":"255"}},{"$f":"W804/V804*100","v":{"v":3.2675171693975997,"d":"3"}},{"$f":"X804+O804","v":{"v":5.419101136382266,"d":"5"}},{"$f":"(V804/M804*100)-100","v":{"v":-1.6246534698404957,"d":"-2"}},null,0,7008,20,667,{"v":4660.996,"d":"4661"},{"v":7974.2249220344,"d":"7974"},{"$f":"(AG804+AG805)/2","v":{"v":7803.512034618201,"d":"7804"}},{"$f":"SQRT((AH804-AG804)*(AH804-AG804))","v":{"v":170.712887416199,"d":"171"}},{"$f":"AI804/AH804*100","v":{"v":2.187641752314558,"d":"2"}},{"$f":"AJ804+O804","v":{"v":4.339225719299224,"d":"4"}},{"$f":"(AH804/M804*100)-100","v":{"v":-1.7282067841400277,"d":"-2"}},{"$nulls":5},"Receptor,  nuclear",{"$nulls":4},"X",{"$nulls":4},"CAEPA(pS)PD(pS)PKG","Corresponds to amino acid residues C15 to G25.","S19 and S22 phosphorylation represses transactivation activity in response to coactivator. Phosphorylation enhanced the sumoylation at Lys-14, and contributes to regulating GRIP-1-dependent activated transcriptional activation by ERRα1. These are two of the major in vivo phosphorylation sites in ESRRA (≥19 and ≥16 reports, respectively, from high throughput mass spectrometry studies).",null,"Receptor, nuclear","P11474","P11474",null,"P11474","GO:0005737; GO:0001650; GO:0045171; GO:0015630; GO:0005654; GO:0005634","GO:0003677; GO:0003700; GO:0004879; GO:0019904; GO:0000978; GO:0000981; GO:0043565; GO:0005496; GO:0003707; GO:0001077; GO:0001078; GO:0008270","GO:0051216; GO:0007005; GO:1900078; GO:0045944; GO:0042127; GO:0045667; GO:0045670; GO:0006355; GO:0032355; GO:0006367"]
[797,396,"PN587","ETV6 (Tel)","S22","Transcription factor ETV6",0,10834,22,639,{"v":6908.868,"d":"6909"},{"v":12139.8959887092,"d":"12140"},{"$f":"(L810+L811)/2","v":{"v":11902.2172704276,"d":"11902"}},{"$f":"SQRT((M810-L810)*(M810-L810))","v":{"v":237.6787182816006,"d":"238"}},{"$f":"N810/M810*100","v":{"v":1.996928075511948,"d":"2"}},0,13588,22,635,{"v":8614.41,"d":"8614"},{"v":15051.227229591,"d":"15051"},{"$f":"(U810+U811)/2","v":{"v":14180.7943694277,"d":"14181"}},{"$f":"SQRT((V810-U810)*(V810-U810))","v":{"v":870.4328601633006,"d":"870"}},{"$f":"W810/V810*100","v":{"v":6.138110725587151,"d":"6"}},{"$f":"X810+O810","v":{"v":8.1350388010991,"d":"8"}},{"$f":"(V810/M810*100)-100","v":{"v":19.144139677751326,"d":"19"}},null,0,11368,20,652,{"v":7398.896,"d":"7399"},{"v":12658.3375910944,"d":"12658"},{"$f":"(AG810+AG811)/2","v":{"v":12860.4820567114,"d":"12860"}},{"$f":"SQRT((AH810-AG810)*(AH810-AG810))","v":{"v":202.1444656170006,"d":"202"}},{"$f":"AI810/AH810*100","v":{"v":1.571826504835478,"d":"2"}},{"$f":"AJ810+O810","v":{"v":3.5687545803474263,"d":"4"}},{"$f":"(AH810/M810*100)-100","v":{"v":8.051145131291776,"d":"8"}},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"TPPE(pS)PVP(bA)C","Corresponds to amino acid residues T18 to P25.","S22 phosphorylation inhibits transcriptional repression by ETV6, allowing for increased activation of ETV6-repressed genes. This is one of the major in vivo phosphorylation sites in ETV6 (≥149 reports from high throughput mass spectrometry studies).","p38a MAPK (MAPK14)","Transcription protein","P41212","P41212",null,"P41212","GO:0005829; GO:0005730; GO:0005634","GO:0003700; GO:0019904; GO:0000978; GO:0000977; GO:0000981; GO:0001077; GO:0001227","GO:0030154; GO:0071425; GO:0097152; GO:0000122; GO:0022008; GO:0007296"]
[802,398,"PN224","EZR","Y146","Ezrin; Cytovilin",0,425,12,531,{"v":219.303,"d":"219"},{"v":385.3475866107,"d":"385"},{"$nulls":3},0,486,12,461,{"v":218.514,"d":"219"},{"v":381.79096036140004,"d":"382"},{"$nulls":6},0,520,14,541,{"v":273.746,"d":"274"},{"v":468.33598988439996,"d":"468"},{"$nulls":20},"Not precisely defined.","Antibody raised against amino acid residues that encompass the Y146 phosphosite.","Y146 phosphorylation induces interaction with EGFR. This is one of the minor in vivo phosphorylation sites in Ezrin (≥1 report from high throughput mass spectrometry studies).","EGFR, Lck, Src",null,"P15311","P15311"]
[803,399,"PN175","EZR","Y354","Ezrin; Cytovilin",0,968,12,326,{"v":311.656,"d":"312"},{"v":547.6253742664,"d":"548"},{"$f":"(L816+L817)/2","v":{"v":325.78030670069995,"d":"326"}},{"$f":"SQRT((M816-L816)*(M816-L816))","v":{"v":221.8450675657,"d":"222"}},{"$f":"N816/M816*100","v":{"v":68.09652486745091,"d":"68"}},0,60,10,650,{"v":32.5,"d":"33"},{"v":56.78449075,"d":"57"},{"$f":"(U816+U817)/2","v":{"v":204.965803381,"d":"205"}},{"$f":"SQRT((V816-U816)*(V816-U816))","v":{"v":148.181312631,"d":"148"}},{"$f":"W816/V816*100","v":{"v":72.2956269712727,"d":"72"}},{"$f":"X816+O816","v":{"v":140.3921518387236,"d":"140"}},{"$f":"(V816/M816*100)-100","v":{"v":-37.084655160170364,"d":"-37"}},null,0,926,12,363,{"v":331.782,"d":"332"},{"v":567.6263813748,"d":"568"},{"$f":"(AG816+AG817)/2","v":{"v":668.793565881,"d":"669"}},{"$f":"SQRT((AH816-AG816)*(AH816-AG816))","v":{"v":101.16718450619999,"d":"101"}},{"$f":"AI816/AH816*100","v":{"v":15.126817850427843,"d":"15"}},{"$f":"AJ816+O816","v":{"v":83.22334271787875,"d":"83"}},{"$f":"(AH816/M816*100)-100","v":{"v":105.28974653321578,"d":"105"}},{"$nulls":15},"QD(pY)EE","Corresponds to amino acid residues Q351 to E355.","Y354 phosphorylation induces activity and interaction with PIK3R1. This is the major in vivo phosphorylation site in Ezrin (≥245 reports from high throughput mass spectrometry studies).","EGFR","Cytoskeletal protein","P15311","P15311",null,null,"GO:0015629; GO:0005884; GO:0045177; GO:0016324; GO:0097449; GO:0016323; GO:0005903; GO:0044297; GO:0071944; GO:0042995; GO:0051286; GO:0036064; GO:0030863; GO:0005737; GO:0098592; GO:0005829; GO:0005768; GO:0070062; GO:0005615; GO:0019898; GO:0001650; GO:0030175; GO:0005925; GO:0001772; GO:0071437; GO:0016020; GO:0044393; GO:0005902; GO:0031528; GO:0043209; GO:0048471; GO:0005886; GO:0044853; GO:0032991; GO:0001726; GO:0032587; GO:0097454; GO:0030315; GO:0001931; GO:0031982","GO:0003779; GO:0051015; GO:0051117; GO:0045296; GO:0050839; GO:0097718; GO:0042802; GO:0008017; GO:0008022; GO:0019904; GO:0051018; GO:0034236; GO:0034237; GO:0003723; GO:0044548","GO:0031532; GO:0051017; GO:0030953; GO:0007411; GO:0034629; GO:0071320; GO:0043622; GO:0007016; GO:0051660; GO:0061028; GO:0035088; GO:0046847; GO:0001951; GO:0007159; GO:0022614; GO:0030033; GO:0070373; GO:1900041; GO:1903753; GO:0050860; GO:0000122; GO:0048015; GO:1903364; GO:2000643; GO:0010628; GO:0040018; GO:1902966; GO:1903078; GO:0050714; GO:0010737; GO:0072697; GO:0072659; GO:0031623; GO:0008360; GO:0032532; GO:1902115; GO:0003376; GO:1902896"]
[808,401,"NK060","FAK (PTK2)","Pan-specific","Focal adhesion protein-tyrosine kinase",0,188,12,538,{"v":94.688,"d":"95"},{"v":166.3807256672,"d":"166"},{"$nulls":3},0,168,12,504,{"v":78.624,"d":"79"},{"v":137.3730400224,"d":"137"},{"$nulls":6},0,212,10,589,{"v":118.978,"d":"119"},{"v":203.5524880892,"d":"204"},{"$nulls":7},"FAK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Fak",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues at the C-terminus of human FAK.",{"$nulls":3},"Q05397","Q05397","Q05397","Q05397"]
[813,404,"PK627","FAK (PTK2)","Y397","Focal adhesion protein-tyrosine kinase",0,8686,18,747,{"v":6474.996,"d":"6475"},{"v":11377.519148912399,"d":"11378"},{"$f":"(L826+L827)/2","v":{"v":11385.837482337,"d":"11386"}},{"$f":"SQRT((M826-L826)*(M826-L826))","v":{"v":8.318333424600496,"d":"8"}},{"$f":"N826/M826*100","v":{"v":0.07305859966387925,"d":"0"}},0,8782,20,712,{"v":6238.544,"d":"6239"},{"v":10900.0782788144,"d":"10900"},{"$f":"(U826+U827)/2","v":{"v":10978.2871211206,"d":"10978"}},{"$f":"SQRT((V826-U826)*(V826-U826))","v":{"v":78.20884230619959,"d":"78"}},{"$f":"W826/V826*100","v":{"v":0.7123956719599485,"d":"1"}},{"$f":"X826+O826","v":{"v":0.7854542716238277,"d":"1"}},{"$f":"(V826/M826*100)-100","v":{"v":-3.5794500127780537,"d":"-4"}},null,0,9529,20,778,{"v":7398.002,"d":"7398"},{"v":12656.8080988828,"d":"12657"},{"$f":"(AG826+AG827)/2","v":{"v":12103.2046290431,"d":"12103"}},{"$f":"SQRT((AH826-AG826)*(AH826-AG826))","v":{"v":553.6034698396998,"d":"554"}},{"$f":"AI826/AH826*100","v":{"v":4.57402387885983,"d":"5"}},{"$f":"AJ826+O826","v":{"v":4.647082478523709,"d":"5"}},{"$f":"(AH826/M826*100)-100","v":{"v":6.300521571812027,"d":"6"}},null,null,"FAK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Fak",{"$nulls":6},"TDD(pY)AEI(bA)C","Corresponds to amino acid residues T394 to I400; In the region between the FERM_M and kinase catalytic domains. ","Y397 phosphorylation stimulates phosphotransferase activity and induces interaction with Src and other Src family kinases, Bmx, PIK3R1, RASA1 and SHC1, and this leads to phosphorylation at Y576, Y577 and additional tyrosine phosphosites.  Phosphorylation inhibits interaction with PI3KR2. Phosphorylation regulates apoptosis, cell adhesion, cell differentiation, cell growth, cell motility, cytoskeletal reorganization, endocytosis, transcription, alters intracellular location, protein degradation and molecular associations. This is one of the major in vivo phosphorylation sites in FAK (≥485 reports from high throughput mass spectrometry studies).","EphB2; FAK (PTK2); Fgr; Met; Src","Protein-tyrosine kinase, TK group, Fak family","Q05397","Q05397","Q05397","Q05397","GO:0016324; GO:0005938; GO:0005737; GO:0005856; GO:0005829; GO:0031234; GO:0005925; GO:0030027; GO:0005815; GO:0005634; GO:0005886; GO:0001725","GO:0003779; GO:0005524; GO:0008432; GO:0004715; GO:0004672; GO:0019901; GO:0019903; GO:0004713; GO:0005088; GO:0042169; GO:0005102","GO:0001525; GO:0007411; GO:0048870; GO:0021955; GO:0043542; GO:0048013; GO:0007173; GO:0030010; GO:0030198; GO:0038096; GO:0060396; GO:0003007; GO:0045087; GO:0007229; GO:0000165; GO:0000226; GO:2000811; GO:0043066; GO:0010507; GO:0050771; GO:0022408; GO:0046621; GO:0051964; GO:0038007; GO:0001764; GO:0007097; GO:0038083; GO:0018108; GO:0001890; GO:0010613; GO:0030335; GO:0008284; GO:0043552; GO:0014068; GO:0045860; GO:0051897; GO:0001934; GO:2000060; GO:0046777; GO:0033628; GO:0042127; GO:0008360; GO:0051493; GO:0010594; GO:0010632; GO:0051893; GO:0043087; GO:0045667; GO:0001932; GO:1900024; GO:0007172; GO:0007179; GO:0048010; GO:0001570"]
[815,405,"PK151","FAK (PTK2)","Y576+Y577","Focal adhesion protein-tyrosine kinase",0,1212,14,330,{"v":395.34,"d":"395"},{"v":694.6704554459999,"d":"695"},{"$f":"(L828+L829)/2","v":{"v":683.1962861889999,"d":"683"}},{"$f":"SQRT((M828-L828)*(M828-L828))","v":{"v":11.474169256999971,"d":"11"}},{"$f":"N828/M828*100","v":{"v":1.679483552377764,"d":"2"}},0,2254,16,340,{"v":760.92,"d":"761"},{"v":1329.490913892,"d":"1329"},{"$f":"(U828+U829)/2","v":{"v":1039.1579279400999,"d":"1039"}},{"$f":"SQRT((V828-U828)*(V828-U828))","v":{"v":290.3329859519001,"d":"290"}},{"$f":"W828/V828*100","v":{"v":27.93925525135731,"d":"28"}},{"$f":"X828+O828","v":{"v":29.618738803735074,"d":"30"}},{"$f":"(V828/M828*100)-100","v":{"v":52.102397063181115,"d":"52"}},null,0,1424,18,376,{"v":528.656,"d":"529"},{"v":904.4465711583999,"d":"904"},{"$f":"(AG828+AG829)/2","v":{"v":771.9863866047999,"d":"772"}},{"$f":"SQRT((AH828-AG828)*(AH828-AG828))","v":{"v":132.46018455360002,"d":"132"}},{"$f":"AI828/AH828*100","v":{"v":17.158357563293386,"d":"17"}},{"$f":"AJ828+O828","v":{"v":18.83784111567115,"d":"19"}},{"$f":"(AH828/M828*100)-100","v":{"v":12.996279723809437,"d":"13"}},null,null,"FAK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Fak",{"$nulls":6},"ST(pY)(pY)KA","Corresponds to amino acid residues S574 to A579.","Y576 and Y577 phosphorylation stimulates phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major in vivo phosphorylation sites in FAK (≥2549 and ≥1764 reports, respectively, by mass spectrometry).","Y576: Bmx (Etk); FAK (PTK2); Fgr, Met; Ret; Src. Y577: Bmx (Etk); FAK (PTK2); Fgr, Met; Ret; Src.","Protein-tyrosine kinase, TK group, Fak family","Q05397","Q05397","Q05397","Q05397","GO:0016324; GO:0005938; GO:0005737; GO:0005856; GO:0005829; GO:0031234; GO:0005925; GO:0030027; GO:0005815; GO:0005634; GO:0005886; GO:0001725","GO:0003779; GO:0005524; GO:0008432; GO:0004715; GO:0004672; GO:0019901; GO:0019903; GO:0004713; GO:0005088; GO:0042169; GO:0005102","GO:0001525; GO:0007411; GO:0048870; GO:0021955; GO:0043542; GO:0048013; GO:0007173; GO:0030010; GO:0030198; GO:0038096; GO:0060396; GO:0003007; GO:0045087; GO:0007229; GO:0000165; GO:0000226; GO:2000811; GO:0043066; GO:0010507; GO:0050771; GO:0022408; GO:0046621; GO:0051964; GO:0038007; GO:0001764; GO:0007097; GO:0038083; GO:0018108; GO:0001890; GO:0010613; GO:0030335; GO:0008284; GO:0043552; GO:0014068; GO:0045860; GO:0051897; GO:0001934; GO:2000060; GO:0046777; GO:0033628; GO:0042127; GO:0008360; GO:0051493; GO:0010594; GO:0010632; GO:0051893; GO:0043087; GO:0045667; GO:0001932; GO:1900024; GO:0007172; GO:0007179; GO:0048010; GO:0001570"]
[820,407,"PK629","FAK (PTK2)","Y577","Focal adhesion protein-tyrosine kinase",0,6924,18,749,{"v":5172.594,"d":"5173"},{"v":9089.0075120586,"d":"9089"},{"$nulls":3},0,6964,14,667,{"v":4635.65,"d":"4636"},{"v":8099.477678314999,"d":"8099"},{"$nulls":6},0,7349,16,725,{"v":5316.425,"d":"5316"},{"v":9095.559989995001,"d":"9096"},{"$nulls":7},"FAK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Fak",{"$nulls":6},"STY(pY)KAS(bA)C","Corresponds to amino acid residues S574 to S580; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y577 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in FAK (≥1764 reports from high throughput mass spectrometry studies).","FAK (PTK2); Fgr, Met; Src",null,"Q05397","Q05397","Q05397","Q05397"]
[825,410,"PN749","FASN (FAS)","Y45","Fatty acid synthase",0,6948,16,706,{"v":4893.992,"d":"4894"},{"v":8599.4628714248,"d":"8599"},{"$f":"(L838+L839)/2","v":{"v":8433.727018669899,"d":"8434"}},{"$f":"SQRT((M838-L838)*(M838-L838))","v":{"v":165.7358527549004,"d":"166"}},{"$f":"N838/M838*100","v":{"v":1.9651555283685123,"d":"2"}},0,7030,20,710,{"v":4977.1,"d":"4977"},{"v":8696.06427421,"d":"8696"},{"$f":"(U838+U839)/2","v":{"v":8427.9209200281,"d":"8428"}},{"$f":"SQRT((V838-U838)*(V838-U838))","v":{"v":268.1433541819006,"d":"268"}},{"$f":"W838/V838*100","v":{"v":3.1816073824884263,"d":"3"}},{"$f":"X838+O838","v":{"v":5.146762910856939,"d":"5"}},{"$f":"(V838/M838*100)-100","v":{"v":-0.06884380569759685,"d":"-0"}},null,0,6951,20,782,{"v":5420.042,"d":"5420"},{"v":9272.8322433388,"d":"9273"},{"$f":"(AG838+AG839)/2","v":{"v":9177.416907619401,"d":"9177"}},{"$f":"SQRT((AH838-AG838)*(AH838-AG838))","v":{"v":95.41533571939908,"d":"95"}},{"$f":"AI838/AH838*100","v":{"v":1.0396752885899958,"d":"1"}},{"$f":"AJ838+O838","v":{"v":3.004830816958508,"d":"3"}},{"$f":"(AH838/M838*100)-100","v":{"v":8.818045536726316,"d":"9"}},{"$nulls":14},"X","AGL(pY)GLPRC","Corresponds to amino acid residues A42 to R49.","The effect of Y45 phosphorylation is unclear. This is the major in vivo phosphorylation site in fatty acid synthetase (≥90 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in the bee.",null,"Oxidoreductase; Hydrolase; Acetyltransferase; EC 2.3.1.41; EC 2.3.1.85; Lipid Metabolism - fatty acid biosynthesis; EC 1.3.1.10; EC 2.3.1.39; Lyase; EC 4.2.1.61; EC 1.1.1.100; EC 3.1.2.14; EC 2.3.1.38","P49327","P49327",null,null,"GO:0005829; GO:0070062; GO:0042587; GO:0005794; GO:0042470; GO:0016020; GO:0005886","GO:0004313; GO:0004314; GO:0047451; GO:0004316; GO:0004315; GO:0102131; GO:0102132; GO:0045296; GO:0008144; GO:0047117; GO:0004312; GO:0016295; GO:0070402; GO:0004320; GO:0016296; GO:0031177; GO:0042803; GO:0003723","GO:0006084; GO:0071353; GO:0090557; GO:0008611; GO:0006633; GO:0006631; GO:0046949; GO:0030879; GO:0030224; GO:0030223; GO:0001649; GO:0031325; GO:0045540"]
[830,412,"PN750","FBPase (FBP1)","S88","Fructose-1,6-bisphosphatase isoform 1",0,14728,18,694,{"v":10208.74,"d":"10209"},{"v":17938.255843905998,"d":"17938"},{"$nulls":3},0,15600,18,670,{"v":10439.94,"d":"10440"},{"v":18240.820811094,"d":"18241"},{"$nulls":6},0,15868,22,722,{"v":11440.812,"d":"11441"},{"v":19573.4148192168,"d":"19573"},{"$nulls":19},"X","MLK(pS)SFATC","Corresponds to amino acid residues M85 to C93.","S88 phosphorylation inhibits enzyme activity. Phosphorylation at this site in fructose-1,6-bisphosphatase isoform 1 has only been reported in a single mass spectrometry study. However, this human phosphosite is highly conserved in vertebrates and found in fish.","ULK1",null,"P09467","P09467"]
[835,415,"PN751","FBPase 2 (FBP2)","Y259","Fructose-1,6-bisphosphatase isoform 2",0,5562,12,648,{"v":3596.4,"d":"3596"},{"v":6319.40311116,"d":"6319"},{"$f":"(L848+L849)/2","v":{"v":7050.193478282399,"d":"7050"}},{"$f":"SQRT((M848-L848)*(M848-L848))","v":{"v":730.7903671223994,"d":"731"}},{"$f":"N848/M848*100","v":{"v":10.365536341286877,"d":"10"}},0,5924,16,663,{"v":3917.004,"d":"3917"},{"v":6843.8485355604,"d":"6844"},{"$f":"(U848+U849)/2","v":{"v":6486.6146834295,"d":"6487"}},{"$f":"SQRT((V848-U848)*(V848-U848))","v":{"v":357.23385213090023,"d":"357"}},{"$f":"W848/V848*100","v":{"v":5.507246376811598,"d":"6"}},{"$f":"X848+O848","v":{"v":15.872782718098474,"d":"16"}},{"$f":"(V848/M848*100)-100","v":{"v":-7.993806079066658,"d":"-8"}},null,0,5471,12,665,{"v":3630.235,"d":"3630"},{"v":6210.756329729001,"d":"6211"},{"$f":"(AG848+AG849)/2","v":{"v":6450.0731018645,"d":"6450"}},{"$f":"SQRT((AH848-AG848)*(AH848-AG848))","v":{"v":239.31677213549938,"d":"239"}},{"$f":"AI848/AH848*100","v":{"v":3.7102955014001453,"d":"4"}},{"$f":"AJ848+O848","v":{"v":14.075831842687021,"d":"14"}},{"$f":"(AH848/M848*100)-100","v":{"v":-8.51211216070206,"d":"-9"}},{"$nulls":14},"X","RTLV(pY)GGI(bA)C","Corresponds to amino acid residues T256 to I262.","The effect of Y259 phosphorylation is unclear. Phosphorylation at this site in fructose-1,6-bisphosphatase isoform 2 has only been reported in a single mass spectrometry study. However, this human phosphosite is highly conserved in vertebrates and found in yeast.",null,"Carbohydrate Metabolism - fructose and mannose; Carbohydrate Metabolism - glycolysis and gluconeogenesis; Phosphatase (non-protein); Carbohydrate Metabolism - pentose phosphate pathway; EC 3.1.3.11","O00757","O00757",null,null,"GO:0030054; GO:0005829; GO:0070062; GO:0005654; GO:0005886; GO:0030018","GO:0042132; GO:0042802; GO:0046872","GO:0030388; GO:0006002; GO:0006000; GO:0006094; GO:0005986"]
[838,416,"PK630","Fer (TYK3)","Y402","Fer (fps/fes related) protein-tyrosine kinase",0,2620,14,789,{"v":2056.134,"d":"2056"},{"v":3612.9294840846,"d":"3613"},{"$nulls":3},0,2726,14,683,{"v":1852.296,"d":"1852"},{"v":3236.3595408696,"d":"3236"},{"$nulls":6},0,2862,14,743,{"v":2116.064,"d":"2116"},{"$f":"AF851*1.7108414","v":{"v":3620.2498962495997,"d":"3620"}},{"$nulls":7},"FER","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Fer",{"$nulls":6},"VVN(pY)EED(bA)C","Corresponds to amino acid residues V399 to D405; In the region preceding the SH2 domain. ","The effect of Y402 phosphorylation is unclear. One of the two major in vivo phosphorylations sites in Fer (≥627 reports from high throughput mass spectrometry studies).",null,null,"P16591","P16591","P16591","P16591"]
[842,418,"PK632","Fes","Y713","Fes/Fps protein-tyrosine kinase",0,2570,16,613,{"v":1565.602,"d":"1566"},{"v":2750.9927009338003,"d":"2751"},{"$nulls":3},0,2639,14,610,{"v":1601.25,"d":"1601"},{"v":2797.728178875,"d":"2798"},{"$nulls":6},0,2931,20,645,{"v":1877.595,"d":"1878"},{"v":3212.2672584330003,"d":"3212"},{"$nulls":7},"FES","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Fer",{"$nulls":6},"DGV(pY)AAS(bA)C","Corresponds to amino acid residues D710 to S716; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y713 phosphorylation stimulates phosphotransferase activity, and regulates cell differentiation, cell growth and molecular association, including inducing interaction with Fes. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in Fes (≥120 reports from high throughput mass spectrometry studies).","Fes",null,"P07332","P07332","P07332","P07332"]
[847,421,"PK634","FGFR1","Y653+Y654","Fibroblast growth factor receptor-tyrosine kinase 1; Basic fibroblast growth factor receptor 1",0,7252,14,697,{"v":5044.886,"d":"5045"},{"v":8864.605795753401,"d":"8865"},{"$f":"(L860+L861)/2","v":{"v":8628.285352025501,"d":"8628"}},{"$f":"SQRT((M860-L860)*(M860-L860))","v":{"v":236.32044372790006,"d":"236"}},{"$f":"N860/M860*100","v":{"v":2.7389038967333588,"d":"3"}},0,8538,16,698,{"v":5948.356,"d":"5948"},{"v":10393.0574233756,"d":"10393"},{"$f":"(U860+U861)/2","v":{"v":9907.064301665301,"d":"9907"}},{"$f":"SQRT((V860-U860)*(V860-U860))","v":{"v":485.9931217102985,"d":"486"}},{"$f":"W860/V860*100","v":{"v":4.9055210192650796,"d":"5"}},{"$f":"X860+O860","v":{"v":7.644424915998439,"d":"8"}},{"$f":"(V860/M860*100)-100","v":{"v":14.820777216641375,"d":"15"}},null,0,7238,12,734,{"v":5303.884,"d":"5304"},{"v":9074.1043279976,"d":"9074"},{"$f":"(AG860+AG861)/2","v":{"v":9107.484554553,"d":"9107"}},{"$f":"SQRT((AH860-AG860)*(AH860-AG860))","v":{"v":33.38022655540044,"d":"33"}},{"$f":"AI860/AH860*100","v":{"v":0.3665142263536757,"d":"0"}},{"$f":"AJ860+O860","v":{"v":3.1054181230870346,"d":"3"}},{"$f":"(AH860/M860*100)-100","v":{"v":5.553817276279659,"d":"6"}},null,null,"FGFR1","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","FGFR",{"$nulls":6},"HID(pY)(pY)KKT(bA)C","Corresponds to amino acid residues H650 to T657; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y653 and Y654 phosphorylation stimulate phosphotransferase activity. Phosphorylation regulates cell differentiation, cell growth, and cell motility. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. They correspond to the two major in vivo phosphorylation sites in FGFR1 (≥332 and ≥186 reports, respectively, from high throughput mass spectrometry studies).","Y653: FGFR1. Y654: FGFR1.","Receptor tyrosine kinase; EC 2.7.10.1; TK group; FGFR family","P11362","P11362","P11362","P11362","GO:0031410; GO:0005829; GO:0005576; GO:0016021; GO:0005887; GO:0005730; GO:0005886; GO:0043235","GO:0016303; GO:0005524; GO:0005007; GO:0017134; GO:0008201; GO:0042802; GO:0046934; GO:0042803; GO:0004713; GO:0005088; GO:0090722","GO:0001525; GO:0060117; GO:0060445; GO:0048469; GO:0016477; GO:0002062; GO:0043009; GO:0030326; GO:0008543; GO:0035607; GO:0042472; GO:0001701; GO:0060484; GO:0000165; GO:0048762; GO:0030901; GO:0042474; GO:0090272; GO:0000122; GO:0001764; GO:0001759; GO:0042473; GO:0048339; GO:0018108; GO:0048015; GO:0043536; GO:0060045; GO:0008284; GO:2000546; GO:0043410; GO:0043406; GO:0090080; GO:0002053; GO:1903465; GO:0045666; GO:0010976; GO:2000830; GO:0014068; GO:0010518; GO:0010863; GO:0051897; GO:1905564; GO:0046777; GO:0006468; GO:0060665; GO:0045595; GO:2001239; GO:0048378; GO:0010966; GO:0007605; GO:0001501; GO:0048705; GO:0006351; GO:0001657; GO:0021847; GO:0070640"]
[852,423,"NK063-2","FGFR2 (BEK)","Pan-specific","Fibroblast growth factor receptor-tyrosine kinase 2 (BEK)",0,9120,12,915,{"v":8333.82,"d":"8334"},{"v":14643.745978157998,"d":"14644"},{"$nulls":3},0,9616,18,878,{"v":8427.044,"d":"8427"},{"v":14723.8585251644,"d":"14724"},{"$nulls":6},0,9878,24,864,{"v":8513.856,"d":"8514"},{"v":14565.8573184384,"d":"14566"},{"$nulls":7},"FGFR2","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","FGFR",{"$nulls":6},"CLPQYPHINGSVKT","Corresponds to amino acid residues C808 to T821; C-terminus.",{"$nulls":3},"P21802","P21802","P21802","P21802"]
[853,424,"PK635","FGFR2 (BEK)","Y656+Y657","Fibroblast growth factor receptor-tyrosine kinase 2 (BEK)",0,6270,21,756,{"v":4724.244,"d":"4724"},{"v":8301.1906994436,"d":"8301"},{"$f":"(L866+L867)/2","v":{"v":8390.5732479528,"d":"8391"}},{"$f":"SQRT((M866-L866)*(M866-L866))","v":{"v":89.3825485092002,"d":"89"}},{"$f":"N866/M866*100","v":{"v":1.0652734428009254,"d":"1"}},0,6910,17,741,{"v":5107.713,"d":"5108"},{"v":8924.2732800663,"d":"8924"},{"$f":"(U866+U867)/2","v":{"v":8763.027166525051,"d":"8763"}},{"$f":"SQRT((V866-U866)*(V866-U866))","v":{"v":161.24611354124863,"d":"161"}},{"$f":"W866/V866*100","v":{"v":1.8400731902008953,"d":"2"}},{"$f":"X866+O866","v":{"v":2.9053466330018205,"d":"3"}},{"$f":"(V866/M866*100)-100","v":{"v":4.4389567621392985,"d":"4"}},null,0,6700,19,785,{"v":5244.585,"d":"5245"},{"v":8972.653143819,"d":"8973"},{"$f":"(AG866+AG867)/2","v":{"v":8942.9520816943,"d":"8943"}},{"$f":"SQRT((AH866-AG866)*(AH866-AG866))","v":{"v":29.701062124699092,"d":"30"}},{"$f":"AI866/AH866*100","v":{"v":0.33211697718357935,"d":"0"}},{"$f":"AJ866+O866","v":{"v":1.3973904199845046,"d":"1"}},{"$f":"(AH866/M866*100)-100","v":{"v":6.583326519153786,"d":"7"}},null,null,"FGFR2","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","FGFR",{"$nulls":6},"DID(pY)(pY)KK(bA)C","Corresponds to amino acid residues D653 to K659; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y656 and Y657 phosphorylation is predicted to be stimulatory for phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. They correspond to two of the major in vivo phosphorylation sites in FGFR2 (≥74 and ≥42 reports, respectively, from high throughput mass spectrometry studies).",null,"EC 2.7.10.1; Receptor tyrosine kinase; TK group; FGFR family","P21802","P21802","P21802","P21802","GO:0005938; GO:0009986; GO:0005737; GO:0031410; GO:0060076; GO:0005576; GO:0005794; GO:0016021; GO:0005887; GO:0043231; GO:0016020; GO:0005654; GO:0005634; GO:0005886","GO:0016303; GO:0005524; GO:0005007; GO:0017134; GO:0008201; GO:0042802; GO:0046934; GO:0042803; GO:0004713; GO:0005088","GO:0001525; GO:0009887; GO:0006915; GO:0007409; GO:0060348; GO:0030282; GO:0060349; GO:0060667; GO:0060670; GO:0060442; GO:0060445; GO:0048755; GO:0060449; GO:0007267; GO:0045165; GO:0071300; GO:0071560; GO:0048565; GO:0048701; GO:0048557; GO:0048568; GO:0048562; GO:0009880; GO:0003416; GO:0048730; GO:0030855; GO:0060664; GO:0001837; GO:0008543; GO:0035603; GO:0060595; GO:0035602; GO:0035607; GO:0035604; GO:0022612; GO:0031069; GO:0042472; GO:0001701; GO:0032808; GO:0060601; GO:0060174; GO:0048286; GO:0060484; GO:0030324; GO:0060463; GO:0060615; GO:0000165; GO:0003149; GO:0048762; GO:0060915; GO:0060916; GO:0048333; GO:0030901; GO:0016331; GO:0035264; GO:0050680; GO:0000122; GO:0042476; GO:0021769; GO:0035265; GO:0030916; GO:0003148; GO:0018108; GO:0090263; GO:0060045; GO:0045787; GO:0051781; GO:0008284; GO:0050679; GO:0060501; GO:0070374; GO:0043410; GO:0002053; GO:0010518; GO:0051897; GO:0048661; GO:0045944; GO:0030177; GO:0009791; GO:0060527; GO:0060523; GO:0060512; GO:0046777; GO:0021860; GO:0060687; GO:0010453; GO:0070372; GO:0040036; GO:0060688; GO:0040014; GO:0045667; GO:0033688; GO:0008589; GO:0051150; GO:0048608; GO:0045471; GO:0032496; GO:0048705; GO:0060529; GO:0001657; GO:0055010; GO:0021847; GO:0042060"]
[861,428,"PK637","FGFR3","Y647+Y648","Fibroblast growth factor receptor 3",0,5403,20,658,{"v":3542.014,"d":"3542"},{"v":6223.8389198566,"d":"6224"},{"$f":"(L874+L875)/2","v":{"v":6068.7584059033,"d":"6069"}},{"$f":"SQRT((M874-L874)*(M874-L874))","v":{"v":155.0805139533004,"d":"155"}},{"$f":"N874/M874*100","v":{"v":2.555391129138507,"d":"3"}},0,4174,18,853,{"v":3545.068,"d":"3545"},{"v":6193.9963401268005,"d":"6194"},{"$f":"(U874+U875)/2","v":{"v":5931.700914884601,"d":"5932"}},{"$f":"SQRT((V874-U874)*(V874-U874))","v":{"v":262.2954252421996,"d":"262"}},{"$f":"W874/V874*100","v":{"v":4.4219260041249475,"d":"4"}},{"$f":"X874+O874","v":{"v":6.977317133263455,"d":"7"}},{"$f":"(V874/M874*100)-100","v":{"v":-2.258410730032992,"d":"-2"}},null,0,5624,16,702,{"v":3936.816,"d":"3937"},{"v":6735.2677969824,"d":"6735"},{"$f":"(AG874+AG875)/2","v":{"v":6860.145532451201,"d":"6860"}},{"$f":"SQRT((AH874-AG874)*(AH874-AG874))","v":{"v":124.87773546880089,"d":"125"}},{"$f":"AI874/AH874*100","v":{"v":1.8203365348166425,"d":"2"}},{"$f":"AJ874+O874","v":{"v":4.37572766395515,"d":"4"}},{"$f":"(AH874/M874*100)-100","v":{"v":13.040346535760762,"d":"13"}},null,null,"FGFR3","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","FGFR",{"$nulls":6},"NLD(pY)(pY)KKT(bA)C","Corresponds to amino acid residues N644 to T651; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y647 and Y648 phosphorylation is predicted to be stimulatory for phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. They correspond to two of the major in vivo phosphorylation sites in FGFR3.","Y647: FGFR3. Y648: FGFR3.","EC 2.7.10.1; Receptor tyrosine kinase; TK group; FGFR family","P22607","P22607","P22607","P22607","GO:0009986; GO:0005783; GO:0005576; GO:0005794; GO:0005887; GO:0005634; GO:0005886; GO:0030133","GO:0016303; GO:0005524; GO:0005007; GO:0017134; GO:0042802; GO:0046934; GO:0004713; GO:0005088","GO:0070977; GO:0030282; GO:0060349; GO:0007267; GO:0002062; GO:0035988; GO:0003416; GO:0001958; GO:1902178; GO:0008543; GO:0000165; GO:0048640; GO:0018108; GO:0008284; GO:0070374; GO:0043410; GO:0043552; GO:0010518; GO:0051897; GO:0042531; GO:0046777; GO:0001501"]
[864,429,"NK239-3","FGFR4","Pan-specific","Fibroblast growth factor receptor 4",0,2884,18,690,{"v":1977.54,"d":"1978"},{"v":3474.828280626,"d":"3475"},{"$nulls":3},0,2753,16,685,{"v":1874.845,"d":"1875"},{"v":3275.7574941595003,"d":"3276"},{"$nulls":6},0,3067,12,660,{"v":2016.3,"d":"2016"},{"v":3449.56951482,"d":"3450"},{"$nulls":7},"FGFR4","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","FGFR",{"$nulls":6},"CSNDDEDPKSHRDPSN ","Corresponds to amino acid residues S124 to N138.",{"$nulls":3},"P22455","P22455","P22455","P22455"]
[869,432,"PK639","Fgr","Y412","Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene",0,3972,20,737,{"v":2912.624,"d":"2913"},{"v":5117.908232465599,"d":"5118"},{"$f":"(L882+L883)/2","v":{"v":5096.9419556548,"d":"5097"}},{"$f":"SQRT((M882-L882)*(M882-L882))","v":{"v":20.966276810799172,"d":"21"}},{"$f":"N882/M882*100","v":{"v":0.41135011921291637,"d":"0"}},0,4046,20,734,{"v":2955.084,"d":"2955"},{"v":5163.1673865684,"d":"5163"},{"$f":"(U882+U883)/2","v":{"v":4921.2270172412,"d":"4921"}},{"$f":"SQRT((V882-U882)*(V882-U882))","v":{"v":241.94036932719973,"d":"242"}},{"$f":"W882/V882*100","v":{"v":4.916261096665066,"d":"5"}},{"$f":"X882+O882","v":{"v":5.327611215877982,"d":"5"}},{"$f":"(V882/M882*100)-100","v":{"v":-3.44745810217934,"d":"-3"}},null,0,4090,22,800,{"v":3254.4,"d":"3254"},{"v":5567.762252160001,"d":"5568"},{"$f":"(AG882+AG883)/2","v":{"v":5543.856665277801,"d":"5544"}},{"$f":"SQRT((AH882-AG882)*(AH882-AG882))","v":{"v":23.905586882199714,"d":"24"}},{"$f":"AI882/AH882*100","v":{"v":0.43120860306372677,"d":"0"}},{"$f":"AJ882+O882","v":{"v":0.8425587222766431,"d":"1"}},{"$f":"(AH882/M882*100)-100","v":{"v":8.768291134396208,"d":"9"}},null,null,"FGR","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"DDE(pY)NPC(bA)C","Corresponds to amino acid residues D409 to C415; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y412 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in Fgr (≥203 reports from high throughput mass spectrometry studies).",null,"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; Src family","P09769","P09769","P09769","P09769","GO:0015629; GO:0016235; GO:0005829; GO:0070062; GO:0005576; GO:0031234; GO:0005743; GO:0005758; GO:0005886; GO:0032587; GO:0034774","GO:0005524; GO:0034988; GO:0034987; GO:0004715; GO:0001784; GO:0019901; GO:0004713","GO:0030154; GO:0016477; GO:0050830; GO:0038096; GO:0002768; GO:0045087; GO:0007229; GO:0043312; GO:0038083; GO:0018108; GO:0030335; GO:0050715; GO:0043306; GO:0043552; GO:0014068; GO:0046777; GO:0006468; GO:0042127; GO:0008360; GO:0045088; GO:0050764; GO:0045859; GO:0009615; GO:0007169"]
[870,432,"PK639","Fgr","Y412","Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene",0,3640,20,798,{"v":2888.76,"d":"2889"},{"v":5075.975678844,"d":"5076"},{"$nulls":3},0,3748,18,718,{"v":2678.14,"d":"2678"},{"v":4679.286647914,"d":"4679"},{"$nulls":6},0,4040,22,803,{"v":3226.454,"d":"3226"},{"v":5519.9510783956,"d":"5520"},{"$nulls":7},"FGR","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"DDE(pY)NPC(bA)C","Corresponds to amino acid residues D409 to C415; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y412 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in Fgr (≥203 reports from high throughput mass spectrometry studies).",null,null,"P09769","P09769","P09769","P09769"]
[875,437,"PK640","Flt3 (STK1)","Y842","Fetal liver fms-related tyrosine kinase 3; Receptor-type tyrosine-protein kinase FLT3",0,94,12,299,{"v":24.518,"d":"25"},{"v":43.0817276942,"d":"43"},{"$f":"(L888+L889)/2","v":{"v":44.8195459783,"d":"45"}},{"$f":"SQRT((M888-L888)*(M888-L888))","v":{"v":1.7378182841000012,"d":"2"}},{"$f":"N888/M888*100","v":{"v":3.877366997294863,"d":"4"}},0,91,12,357,{"v":28.203,"d":"28"},{"v":49.2767074653,"d":"49"},{"$f":"(U888+U889)/2","v":{"v":44.20716285265,"d":"44"}},{"$f":"SQRT((V888-U888)*(V888-U888))","v":{"v":5.069544612649999,"d":"5"}},{"$f":"W888/V888*100","v":{"v":11.467699543505324,"d":"11"}},{"$f":"X888+O888","v":{"v":15.345066540800186,"d":"15"}},{"$f":"(V888/M888*100)-100","v":{"v":-1.3663304977397388,"d":"-1"}},null,0,114,16,367,{"v":35.966,"d":"36"},{"v":61.532121792400005,"d":"62"},{"$f":"(AG888+AG889)/2","v":{"v":59.665593825,"d":"60"}},{"$f":"SQRT((AH888-AG888)*(AH888-AG888))","v":{"v":1.8665279674000033,"d":"2"}},{"$f":"AI888/AH888*100","v":{"v":3.128315412186385,"d":"3"}},{"$f":"AJ888+O888","v":{"v":7.005682409481248,"d":"7"}},{"$f":"(AH888/M888*100)-100","v":{"v":33.124047829239316,"d":"33"}},null,null,"FLT3","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"DSN(pY)VVR(bA)C","Corresponds to amino acid residues D839 to R845; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y842 phosphorylation has been reported to inhibits phosphotransferase activity and regulate cell growth, inhibit apoptosis and alter conformation. However, this phosphosite is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII.This is one of the major in vivo phosphorylation sites in Flt3.","Flt3","Receptor tyrosine kinase; EC 2.7.10.1; TK group; PDGFR family","P36888","P36888","P36888","P36888","GO:0005829; GO:0005783; GO:0005788; GO:0005887; GO:0005634; GO:0005886; GO:0032991","GO:0016303; GO:0005524; GO:0004896; GO:0035259; GO:0044877; GO:0042803; GO:0043621; GO:0005088; GO:0004714; GO:0005021","GO:0031100; GO:0030183; GO:0071345; GO:0071385; GO:0035726; GO:0019221; GO:0097028; GO:0030097; GO:0001776; GO:0046651; GO:0000165; GO:0002318; GO:0018108; GO:0008284; GO:0043410; GO:0043406; GO:0043552; GO:0014068; GO:0042531; GO:0002328; GO:0046777; GO:0042981; GO:0010243; GO:0007169"]
[879,439,"PN033","Fos","T232","Proto-oncogene c-Fos",0,1004,12,380,{"v":376.96,"d":"377"},{"v":662.374095424,"d":"662"},{"$f":"(L892+L893)/2","v":{"v":584.9032457499,"d":"585"}},{"$f":"SQRT((M892-L892)*(M892-L892))","v":{"v":77.47084967410001,"d":"77"}},{"$f":"N892/M892*100","v":{"v":13.24507091335683,"d":"13"}},0,1186,16,401,{"v":469.17,"d":"469"},{"v":819.740908467,"d":"820"},{"$f":"(U892+U893)/2","v":{"v":552.7314968850001,"d":"553"}},{"$f":"SQRT((V892-U892)*(V892-U892))","v":{"v":267.009411582,"d":"267"}},{"$f":"W892/V892*100","v":{"v":48.30725462304409,"d":"48"}},{"$f":"X892+O892","v":{"v":61.552325536400915,"d":"62"}},{"$f":"(V892/M892*100)-100","v":{"v":-5.500353964295883,"d":"-6"}},null,0,868,12,408,{"v":349.248,"d":"349"},{"v":597.5079372672,"d":"598"},{"$f":"(AG892+AG893)/2","v":{"v":590.4866441616,"d":"590"}},{"$f":"SQRT((AH892-AG892)*(AH892-AG892))","v":{"v":7.021293105599966,"d":"7"}},{"$f":"AI892/AH892*100","v":{"v":1.1890689103678407,"d":"1"}},{"$f":"AJ892+O892","v":{"v":14.43413982372467,"d":"14"}},{"$f":"(AH892/M892*100)-100","v":{"v":0.9545849595246523,"d":"1"}},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against amino acid residues that encompass the T232 phosphosite.","T232 phosphorylation stimulates transcriptional activity. This is one of the major in vivo phosphorylation sites in Fos.","ERK1 (MAPK3); ERK2 (MAPK1); ERK5 (MAPK7); Frk","Transcription protein","P01100","P01100",null,"P01100","GO:0005829; GO:0005783; GO:0016020; GO:0043005; GO:0005654; GO:0005634; GO:0032993; GO:0035976","GO:0003682; GO:0003700; GO:0046982; GO:0001102; GO:0000979; GO:0000978; GO:0000981; GO:0070412; GO:0001077; GO:0008134; GO:0044212","GO:0007568; GO:0071276; GO:0071277; GO:0031668; GO:0032870; GO:0034614; GO:0001661; GO:0019221; GO:0006306; GO:0038095; GO:0007565; GO:0006954; GO:0007399; GO:1901216; GO:0045672; GO:1902895; GO:0045893; GO:0045944; GO:0051090; GO:0006357; GO:0051591; GO:0009409; GO:0051412; GO:0009629; GO:0035902; GO:0009416; GO:0032496; GO:0035994; GO:0032570; GO:0009636; GO:0035914; GO:0030431; GO:0060395; GO:0006366; GO:0007179"]
[886,442,"PN590","FOXK1","S441+S445","Forkhead box protein K1",0,9469,16,706,{"v":6673.818,"d":"6674"},{"v":11726.8786098642,"d":"11727"},{"$nulls":3},0,9784,16,691,{"v":6749.688,"d":"6750"},{"v":11793.1567938888,"d":"11793"},{"$nulls":6},0,9318,18,689,{"v":6407.7,"d":"6408"},{"v":10962.55843878,"d":"10963"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"CL(pS)REG(pS)PIP","Corresponds to amino acid residues C439 to P448.","The effects of S441 and S445 phosphorylation are unclear. These are two of the major in vivo phosphorylation sites in FOXK1.",null,null,"P85037","P85037"]
[887,443,"PN591","FOXK2","S424+S428","Forkhead box protein K2",0,4444,14,687,{"v":3043.41,"d":"3043"},{"v":5347.718446929,"d":"5348"},{"$f":"(L900+L901)/2","v":{"v":5370.7845142853,"d":"5371"}},{"$f":"SQRT((M900-L900)*(M900-L900))","v":{"v":23.066067356300664,"d":"23"}},{"$f":"N900/M900*100","v":{"v":0.42947296237540644,"d":"0"}},0,4948,18,711,{"v":3505.23,"d":"3505"},{"v":6124.390784973,"d":"6124"},{"$f":"(U900+U901)/2","v":{"v":6354.2107231515,"d":"6354"}},{"$f":"SQRT((V900-U900)*(V900-U900))","v":{"v":229.8199381784998,"d":"230"}},{"$f":"W900/V900*100","v":{"v":3.616813294232646,"d":"4"}},{"$f":"X900+O900","v":{"v":4.046286256608052,"d":"4"}},{"$f":"(V900/M900*100)-100","v":{"v":18.310662180738532,"d":"18"}},null,0,5282,16,809,{"v":4260.194,"d":"4260"},{"v":7288.516267231601,"d":"7289"},{"$f":"(AG900+AG901)/2","v":{"v":6977.196168515,"d":"6977"}},{"$f":"SQRT((AH900-AG900)*(AH900-AG900))","v":{"v":311.320098716601,"d":"311"}},{"$f":"AI900/AH900*100","v":{"v":4.46196568360011,"d":"4"}},{"$f":"AJ900+O900","v":{"v":4.891438645975517,"d":"5"}},{"$f":"(AH900/M900*100)-100","v":{"v":29.910186304383274,"d":"30"}},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"FAQ(pS)APG(pS)PLS(bA)C","Corresponds to amino acid residues F421 to S431.","The effects of S424 phosphorylation is unclear. S428 phosphorylation regulates transcription and apoptosis, and stabilizes FOXK2. These are two of the major in vivo phosphorylation sites in FOXK2.","S424: ERK1 (MAPK3). ","Transcription factor","Q01167","Q01167",null,null,"GO:0005654; GO:0005634","GO:0003700; GO:0000287; GO:0000978; GO:0000981; GO:0043565; GO:0001077","GO:0009653; GO:0030154; GO:0045944; GO:0016579; GO:0006355; GO:0006357"]
[892,433,"PN194","FOXO1A (FKHR)","S256","Forkhead box protein O1",0,587,12,333,{"v":191.475,"d":"191"},{"v":336.4497026775,"d":"336"},{"$nulls":3},0,820,12,318,{"v":256.944,"d":"257"},{"v":448.93643665440004,"d":"449"},{"$nulls":6},0,600,12,369,{"v":216.972,"d":"217"},{"v":371.20468024080003,"d":"371"},{"$nulls":10},"Transcription protein; Nuclear receptor co-regulator",{"$nulls":4},"X",{"$nulls":4},"AA(pS)MD","Corresponds to amino acid residues A254 to D258.","S256 phosphorylation Inhibits transcription by preventing nuclear import, regulates protein degradation and molecular association; phosphorylation induces interaction with 14-3-3 beta, SKP2, and inhibits interaction with DNA. This is one of the major in vivo phosphorylation sites in FOXO1A (≥42 reports from high throughput mass spectrometry studies).","Akt1 (PKBa); Akt3 (PKBg)",null,"Q12778","Q12778",null,"Q12778"]
[897,446,"PN594","FOXO1A (FKHR)","S319","Forkhead box protein O1",0,5162,20,775,{"$f":"(H910-I910)*J910/1000","v":{"v":3985.05,"d":"3985"}},{"v":7002.318253845,"d":"7002"},{"$f":"(L910+L911)/2","v":{"v":6682.99809772215,"d":"6683"}},{"$f":"SQRT((M910-L910)*(M910-L910))","v":{"v":319.32015612284977,"d":"319"}},{"$f":"N910/M910*100","v":{"v":4.778097366684687,"d":"5"}},0,5334,18,795,{"$f":"(Q910-R910)*S910/1000","v":{"v":4226.22,"d":"4226"}},{"v":7384.1153999220005,"d":"7384"},{"$f":"(U910+U911)/2","v":{"v":6821.1242559698,"d":"6821"}},{"$f":"SQRT((V910-U910)*(V910-U910))","v":{"v":562.9911439522002,"d":"563"}},{"$f":"W910/V910*100","v":{"v":8.253641523381932,"d":"8"}},{"$f":"X910+O910","v":{"v":13.031738890066618,"d":"13"}},{"$f":"(V910/M910*100)-100","v":{"v":2.0668292318492405,"d":"2"}},null,0,5390,20,835,{"$f":"(AC910-AD910)*AE910/1000","v":{"v":4483.95,"d":"4484"}},{"v":7671.32729553,"d":"7671"},{"$f":"(AG910+AG911)/2","v":{"v":7603.4898677579,"d":"7603"}},{"$f":"SQRT((AH910-AG910)*(AH910-AG910))","v":{"v":67.83742777209955,"d":"68"}},{"$f":"AI910/AH910*100","v":{"v":0.8921880472249948,"d":"1"}},{"$f":"AJ910+O910","v":{"v":5.670285413909681,"d":"6"}},{"$f":"(AH910/M910*100)-100","v":{"v":13.773635074795138,"d":"14"}},{"$nulls":5},"Transcription protein; Nuclear receptor co-regulator",{"$nulls":4},"X",{"$nulls":4},"PRTS(pS)NAS(bA)C","Corresponds to amino acid residues P315 to S322.","S319 phosphorylation increases rate of nuclear exclusion. It also creates the pSer–Xaa–Xaa–Ser recognition motif for CK1, allowing it to phosphorylate S322, induces interaction with IQGAP1, and regulates apoptosis and inhibits transcription. This is one of the major in vivo phosphorylation sites in FOXO1A (≥30 reports from high throughput mass spectrometry studies).","Akt1 (PKBa); Akt3 (PKBg); SGK1","Transcription factor; Nuclear receptor co-regulator","Q12778","Q12778",null,"Q12778","GO:0005737; GO:0005829; GO:0005739; GO:0005654; GO:0005634","GO:0008013; GO:0003682; GO:0051721; GO:0000981; GO:0043565; GO:0001078; GO:0001223; GO:0031625","GO:0009653; GO:0006915; GO:0006914; GO:0001568; GO:0030154; GO:0001678; GO:0070417; GO:0071549; GO:0006974; GO:0070301; GO:0071455; GO:0032869; GO:0071732; GO:0034599; GO:0009267; GO:0019221; GO:0070166; GO:0031018; GO:0097009; GO:0045444; GO:0008286; GO:0043066; GO:0090090; GO:1903243; GO:0045599; GO:0032873; GO:0045892; GO:0097150; GO:0043065; GO:0010508; GO:0045722; GO:0045732; GO:0045893; GO:0045944; GO:0006473; GO:0035947; GO:2000177; GO:2000377; GO:1902617; GO:0001659; GO:0006351"]
[902,448,"PN596","FOXO3 (FKHRL1)","T32","Forkhead box protein O3",0,6829,16,808,{"v":5504.904,"d":"5505"},{"v":9672.9249983976,"d":"9673"},{"$nulls":3},0,7778,18,683,{"v":5300.08,"d":"5300"},{"v":9260.379807208,"d":"9260"},{"$nulls":6},0,7168,16,735,{"v":5256.72,"d":"5257"},{"$f":"AF915*1.7108414","v":{"v":8993.414204208,"d":"8993"}},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"PRSA(pT)WPLC","Corresponds to amino acid residues P28 to L35.","T32 phosphorylation inhibits transcriptional activity and induces 14-3-3-beta binding and nuclear exclusion. This is one of the major in vivo phosphorylation sites in FOXO3 (≥97 reports from high throughput mass spectrometry studies).","Akt1 (PKBa); Akt2 (PKBb); Pim1; SGK1",null,"O43524","O43524",null,"O43524"]
[904,449,"PN597","FOXO3 (FKHRL1)","S294","Forkhead box protein O3",0,13080,16,769,{"v":10046.216,"d":"10046"},{"v":17652.6773011304,"d":"17653"},{"$nulls":3},0,13204,18,679,{"v":8953.294,"d":"8953"},{"v":15643.3304715394,"d":"15643"},{"$nulls":6},0,13225,22,777,{"v":10258.731,"d":"10259"},{"v":17551.0617062634,"d":"17551"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"KWPG(pS)PTS(bA)C","Corresponds to amino acid residues K290 to S297.","S294 phosphorylation inhibits FOXO3 dependent transcription, causes degradation of FOXO3, and regulates cell growth, and molecular association, including inducing interaction with MDM2. This is one of the major in vivo phosphorylation sites in FOXO3 (≥77 reports from high throughput mass spectrometry studies).","ERK1 (MAPK3); ERK2 (MAPK1); p38a MAPK (MAPK14)",null,"O43524","O43524",null,"O43524"]
[909,452,"NK269-2","Frk","Pan-specific","Fyn-related kinase; Tyrosine-protein kinase FRK",0,5502,14,686,{"v":3764.768,"d":"3765"},{"v":6615.2504204192,"d":"6615"},{"$f":"(L922+L923)/2","v":{"v":6324.1333506148,"d":"6324"}},{"$f":"SQRT((M922-L922)*(M922-L922))","v":{"v":291.11706980439976,"d":"291"}},{"$f":"N922/M922*100","v":{"v":4.6032721586444545,"d":"5"}},0,5902,16,656,{"v":3861.216,"d":"3861"},{"v":6746.3748995616,"d":"6746"},{"$f":"(U922+U923)/2","v":{"v":6310.3451408509,"d":"6310"}},{"$f":"SQRT((V922-U922)*(V922-U922))","v":{"v":436.02975871069975,"d":"436"}},{"$f":"W922/V922*100","v":{"v":6.909760860590655,"d":"7"}},{"$f":"X922+O922","v":{"v":11.51303301923511,"d":"12"}},{"$f":"(V922/M922*100)-100","v":{"v":-0.21802528503862106,"d":"-0"}},null,0,5860,14,728,{"v":4255.888,"d":"4256"},{"v":7281.1493841632,"d":"7281"},{"$f":"(AG922+AG923)/2","v":{"v":7127.4191639041,"d":"7127"}},{"$f":"SQRT((AH922-AG922)*(AH922-AG922))","v":{"v":153.73022025909995,"d":"154"}},{"$f":"AI922/AH922*100","v":{"v":2.1568847955182284,"d":"2"}},{"$f":"AJ922+O922","v":{"v":6.760156954162683,"d":"7"}},{"$f":"(AH922/M922*100)-100","v":{"v":12.701911372744988,"d":"13"}},null,null,"FRK","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"MSNISQRLWEYLEPYLGC","Corresponds to amino acid residues M1 to L16; N-terminus.",null,null,"Protein-tyrosine kinase, TK group, Src family","P42685","P42685","P42685","P42685","GO:0035578; GO:0005829; GO:0070062; GO:0005576; GO:0031234; GO:0005622; GO:0005634; GO:0035580","GO:0005524; GO:0004715; GO:0004713; GO:0005102","GO:0030154; GO:0016477; GO:0045087; GO:0008285; GO:0000122; GO:0043312; GO:0038083; GO:0006468; GO:0007169"]
[914,454,"PK642","Frk","Y497","Fyn-related kinase; Tyrosine-protein kinase FRK",0,4278,14,636,{"v":2711.904,"d":"2712"},{"v":4765.2137066976,"d":"4765"},{"$nulls":3},0,4372,16,636,{"v":2770.416,"d":"2770"},{"v":4840.5126684816005,"d":"4841"},{"$nulls":6},0,4584,18,662,{"v":3022.692,"d":"3023"},{"v":5171.3466130488005,"d":"5171"},{"$nulls":7},"FRK","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"DSS(pY)SDA(bA)C","Corresponds to amino acid residues D494 to A500; In the C-terminus of the kinase. ","By analogy with other Src family kinases, this is likely inhibitory to the phosphotransferase activity of Frk. It is one of the two major in vivo phosphorylation sites in Frk (≥508 reports from high throughput mass spectrometry studies).",null,null,"P42685","P42685","P42685","P42685"]
[920,457,"PK643","Fused (STK36)","S159","Serine/threonine-protein kinase 36",0,2618,18,721,{"v":1874.6,"d":"1875"},{"v":3293.9475787399997,"d":"3294"},{"$nulls":3},0,2470,16,700,{"v":1717.8,"d":"1718"},{"v":3001.36609878,"d":"3001"},{"$nulls":6},0,2824,16,763,{"v":2142.504,"d":"2143"},{"v":3665.4845428656,"d":"3665"},{"$nulls":7},"Fused","X","PYK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","ULK",{"$nulls":6},"VLT(pS)IKG(bA)C","Corresponds to amino acid residues V156 to G162; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S159 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the minor in vivo phosphorylation sites in Fused (≥1 reports from high throughput mass spectrometry studies).",null,null,"Q9NRP7","Q9NRP7","Q9NRP7","Q9NRP7"]
[921,458,"NK065","Fyn","Pan-specific","Fyn proto-oncogene-encoded protein-tyrosine kinase",0,160,10,519,{"v":77.85,"d":"78"},{"v":136.79388616499998,"d":"137"},{"$f":"(L934+L935)/2","v":{"v":139.4594780123,"d":"139"}},{"$f":"SQRT((M934-L934)*(M934-L934))","v":{"v":2.6655918473000213,"d":"3"}},{"$f":"N934/M934*100","v":{"v":1.9113737447553922,"d":"2"}},0,120,12,515,{"v":55.62,"d":"56"},{"v":97.180103862,"d":"97"},{"$f":"(U934+U935)/2","v":{"v":101.5760970536,"d":"102"}},{"$f":"SQRT((V934-U934)*(V934-U934))","v":{"v":4.395993191599999,"d":"4"}},{"$f":"W934/V934*100","v":{"v":4.3277831292142555,"d":"4"}},{"$f":"X934+O934","v":{"v":6.239156873969648,"d":"6"}},{"$f":"(V934/M934*100)-100","v":{"v":-27.16443622093493,"d":"-27"}},null,0,194,12,576,{"v":104.832,"d":"105"},{"v":179.3509256448,"d":"179"},{"$f":"(AG934+AG935)/2","v":{"v":188.1686022204,"d":"188"}},{"$f":"SQRT((AH934-AG934)*(AH934-AG934))","v":{"v":8.817676575600018,"d":"9"}},{"$f":"AI934/AH934*100","v":{"v":4.686050951939348,"d":"5"}},{"$f":"AJ934+O934","v":{"v":6.597424696694739,"d":"7"}},{"$f":"(AH934/M934*100)-100","v":{"v":34.92708054149176,"d":"35"}},null,null,"FYN","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 85-206 of human Fyn.",null,null,"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; Src family","P06241","P06241","P06241","P06241","GO:0005884; GO:0044297; GO:0005829; GO:0030425; GO:0005768; GO:0031234; GO:0097386; GO:0098978; GO:0045121; GO:0005739; GO:0005634; GO:0097038; GO:0048471; GO:0005886; GO:0014069; GO:0099092; GO:0098685","GO:0043014; GO:0005524; GO:0042609; GO:0042610; GO:0097718; GO:0019899; GO:0046875; GO:0070851; GO:0042802; GO:0044325; GO:0046872; GO:0004715; GO:0051428; GO:0043548; GO:0046934; GO:0004713; GO:0005088; GO:0048156; GO:0042608; GO:0031802","GO:0050798; GO:0002250; GO:0007411; GO:0007596; GO:0006816; GO:0030154; GO:0016477; GO:1905430; GO:1905232; GO:0071375; GO:0036120; GO:0071560; GO:0007417; GO:0019221; GO:0048813; GO:0097062; GO:0050966; GO:0048013; GO:0038096; GO:0007631; GO:0030900; GO:0003015; GO:0045087; GO:0035556; GO:0007612; GO:0050900; GO:0000165; GO:0050804; GO:1902951; GO:2001240; GO:0010629; GO:0010730; GO:0043524; GO:1903202; GO:0042177; GO:0031397; GO:0001764; GO:0038083; GO:0018108; GO:0030168; GO:2001056; GO:0043123; GO:1901216; GO:0010976; GO:1903997; GO:0014068; GO:0051897; GO:1905477; GO:1900182; GO:0090314; GO:0042531; GO:0006468; GO:0042981; GO:1905664; GO:0042127; GO:0008360; GO:0050690; GO:1900449; GO:0050730; GO:1904645; GO:0045471; GO:0042542; GO:0000304; GO:0002223; GO:0042110; GO:0031295; GO:0050852; GO:0007169; GO:0048010"]
[926,460,"PK186","Fyn","T12","Fyn proto-oncogene-encoded protein-tyrosine kinase",0,144,14,569,{"v":73.97,"d":"74"},{"v":129.976156193,"d":"130"},{"$nulls":3},0,160,16,470,{"v":67.68,"d":"68"},{"v":118.25151796800002,"d":"118"},{"$nulls":6},0,138,14,553,{"v":68.572,"d":"69"},{"v":117.31581648080001,"d":"117"},{"$nulls":7},"FYN","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues that encompass the T12 phosphosite.","The effect of T12 phosphorylation is unclear. This is one of the minor in vivo phosphorylation sites in Fyn (≥2 reports from high throughput mass spectrometry studies).",null,null,"P06241","P06241","P06241","P06241"]
[931,463,"PK645","Fyn","Y531","Fyn proto-oncogene-encoded protein-tyrosine kinase",0,1760,16,598,{"v":1042.912,"d":"1043"},{"v":1832.5495877728001,"d":"1833"},{"$f":"(L944+L945)/2","v":{"v":1868.3936273859001,"d":"1868"}},{"$f":"SQRT((M944-L944)*(M944-L944))","v":{"v":35.844039613099994,"d":"36"}},{"$f":"N944/M944*100","v":{"v":1.9184415472049094,"d":"2"}},0,1794,16,558,{"v":992.124,"d":"992"},{"v":1733.4540338724,"d":"1733"},{"$f":"(U944+U945)/2","v":{"v":1620.2589564038,"d":"1620"}},{"$f":"SQRT((V944-U944)*(V944-U944))","v":{"v":113.19507746859995,"d":"113"}},{"$f":"W944/V944*100","v":{"v":6.98623371413659,"d":"7"}},{"$f":"X944+O944","v":{"v":8.904675261341499,"d":"9"}},{"$f":"(V944/M944*100)-100","v":{"v":-13.280642116579543,"d":"-13"}},null,0,1940,20,607,{"v":1165.44,"d":"1165"},{"v":1993.8830012160001,"d":"1994"},{"$f":"(AG944+AG945)/2","v":{"v":2073.4063311708,"d":"2073"}},{"$f":"SQRT((AH944-AG944)*(AH944-AG944))","v":{"v":79.52332995479992,"d":"80"}},{"$f":"AI944/AH944*100","v":{"v":3.835395347225312,"d":"4"}},{"$f":"AJ944+O944","v":{"v":5.753836894430222,"d":"6"}},{"$f":"(AH944/M944*100)-100","v":{"v":10.972671966973934,"d":"11"}},null,null,"FYN","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"EPQ(pY)QPG(bA)C","Corresponds to amino acid residues E528 to G534; In the C-terminus of the kinase.","Y531 phosphorylation inhibits phosphotransferase activity of Fyn. This is the major in vivo phosphorylation sites in Fyn (≥1037 reports from high throughput mass spectrometry studies).","CSK","EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; Src family","P06241","P06241","P06241","P06241","GO:0005884; GO:0044297; GO:0005829; GO:0030425; GO:0005768; GO:0031234; GO:0097386; GO:0098978; GO:0045121; GO:0005739; GO:0005634; GO:0097038; GO:0048471; GO:0005886; GO:0014069; GO:0099092; GO:0098685","GO:0043014; GO:0005524; GO:0042609; GO:0042610; GO:0097718; GO:0019899; GO:0046875; GO:0070851; GO:0042802; GO:0044325; GO:0046872; GO:0004715; GO:0051428; GO:0043548; GO:0046934; GO:0004713; GO:0005088; GO:0048156; GO:0042608; GO:0031802","GO:0050798; GO:0002250; GO:0007411; GO:0007596; GO:0006816; GO:0030154; GO:0016477; GO:1905430; GO:1905232; GO:0071375; GO:0036120; GO:0071560; GO:0007417; GO:0019221; GO:0048813; GO:0097062; GO:0050966; GO:0048013; GO:0038096; GO:0007631; GO:0030900; GO:0003015; GO:0045087; GO:0035556; GO:0007612; GO:0050900; GO:0000165; GO:0050804; GO:1902951; GO:2001240; GO:0010629; GO:0010730; GO:0043524; GO:1903202; GO:0042177; GO:0031397; GO:0001764; GO:0038083; GO:0018108; GO:0030168; GO:2001056; GO:0043123; GO:1901216; GO:0010976; GO:1903997; GO:0014068; GO:0051897; GO:1905477; GO:1900182; GO:0090314; GO:0042531; GO:0006468; GO:0042981; GO:1905664; GO:0042127; GO:0008360; GO:0050690; GO:1900449; GO:0050730; GO:1904645; GO:0045471; GO:0042542; GO:0000304; GO:0002223; GO:0042110; GO:0031295; GO:0050852; GO:0007169; GO:0048010"]
[936,465,"PN701","G6PD","Y503+Y507","Glucose-6-phosphate 1-dehydrogenase",0,7233,18,839,{"v":6053.385,"d":"6053"},{"v":10636.6866872565,"d":"10637"},{"$nulls":3},0,7090,18,744,{"v":5261.568,"d":"5262"},{"v":9193.091059276801,"d":"9193"},{"$nulls":6},0,7746,18,831,{"v":6421.968,"d":"6422"},{"v":10986.9687238752,"d":"10987"},{"$nulls":10},"Enzyme - Glycolysis",{"$nulls":8},"X","GFQ(pY)EGT(pY)KWV(bA)C","Corresponds to amino acid residues G500 to V510.","The effects of Y503 and Y507 phosphorylation are unclear. These are two of the major in vivo phosphorylation sites in G6PD (≥961 and >771 reports, respectively, by mass spectrometry). These phosphosites are highly conserved in vertebrates and also found in the nematode worm.","Y507: Src",null,"P11413","P11413"]
[938,466,"PN516","Gab1","Y406","GRB2-associated-binding protein 1",0,2315,16,602,{"v":1383.998,"d":"1384"},{"v":2431.8877953062,"d":"2432"},{"$nulls":3},0,1934,18,516,{"v":988.656,"d":"989"},{"v":1727.3946919056,"d":"1727"},{"$nulls":6},0,2554,18,628,{"v":1592.608,"d":"1593"},{"v":2724.6997003712,"d":"2725"},{"$nulls":18},"X",null,"QDC(pY)DIP(bA)C","Corresponds to amino acid residues Q403 to P409; In the mid-region of the protein. ","The effect of Y406 phosphorylation is unclear. This is the second major in vivo phosphorylation site of Gab1 (≥1095 reports from high throughput mass spectrometry studies).","EGFR; Met",null,"Q13480","Q13480",null,"Q13480"]
[943,469,"PN702","GATA3","S369","Trans-acting T-cell-specific transcription factor GATA-3",0,1600,16,600,{"v":950.4,"d":"950"},{"v":1669.9924137599999,"d":"1670"},{"$f":"(L956+L957)/2","v":{"v":1747.9974360917,"d":"1748"}},{"$f":"SQRT((M956-L956)*(M956-L956))","v":{"v":78.00502233170005,"d":"78"}},{"$f":"N956/M956*100","v":{"v":4.4625364271763095,"d":"4"}},0,1636,14,610,{"v":989.42,"d":"989"},{"v":1728.729564242,"d":"1729"},{"$f":"(U956+U957)/2","v":{"v":1644.47448408225,"d":"1644"}},{"$f":"SQRT((V956-U956)*(V956-U956))","v":{"v":84.25508015974992,"d":"84"}},{"$f":"W956/V956*100","v":{"v":5.123526146212666,"d":"5"}},{"$f":"X956+O956","v":{"v":9.586062573388975,"d":"10"}},{"$f":"(V956/M956*100)-100","v":{"v":-5.922374362339696,"d":"-6"}},null,0,1825,20,657,{"v":1185.885,"d":"1186"},{"v":2028.8611536390001,"d":"2029"},{"$f":"(AG956+AG957)/2","v":{"v":1981.3211482365,"d":"1981"}},{"$f":"SQRT((AH956-AG956)*(AH956-AG956))","v":{"v":47.54000540250013,"d":"48"}},{"$f":"AI956/AH956*100","v":{"v":2.3994093761535686,"d":"2"}},{"$f":"AJ956+O956","v":{"v":6.861945803329878,"d":"7"}},{"$f":"(AH956/M956*100)-100","v":{"v":13.348058030707534,"d":"13"}},{"$nulls":5},"DNA-binding; Transcription protein",{"$nulls":4},"X",{"$nulls":4},"RKM(pS)SKSC","Corresponds to amino acid residues R366 to S372.","The effect of S369 phosphorylation is unclear. This is the major in vivo phosphorylation site in GATA3 (≥28 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in the fruit fly.","Pim","Transcription protein","P23771","P23771",null,"P23771","GO:0000790; GO:0005654; GO:0005634; GO:0005667","GO:0003682; GO:0003677; GO:0003700; GO:0070888; GO:0001158; GO:0071837; GO:0005134; GO:0046983; GO:0000987; GO:0000978; GO:0000977; GO:0000981; GO:0001085; GO:0001077; GO:0001228; GO:0001078; GO:0003713; GO:0008134; GO:0044212; GO:0000976; GO:0008270","GO:0048646; GO:0009653; GO:0003180; GO:0007411; GO:0007596; GO:0061290; GO:0003215; GO:0001709; GO:0048469; GO:0071773; GO:0035457; GO:0071353; GO:0071356; GO:0006338; GO:0090102; GO:0019221; GO:0006952; GO:0048589; GO:0043583; GO:0035162; GO:0030218; GO:0006959; GO:0045087; GO:0042472; GO:0072643; GO:0072602; GO:0001701; GO:0001822; GO:0002088; GO:0072676; GO:0008584; GO:0060374; GO:0060231; GO:0001823; GO:0045786; GO:2000146; GO:0008285; GO:2000607; GO:1901536; GO:2000352; GO:0045599; GO:2000703; GO:2000734; GO:0050728; GO:0032689; GO:0032703; GO:0033600; GO:0045892; GO:0072179; GO:0072178; GO:0001764; GO:0042421; GO:0071599; GO:0060017; GO:0035898; GO:0060037; GO:0014065; GO:0010595; GO:0071442; GO:2000617; GO:2000667; GO:0032753; GO:2000664; GO:0051897; GO:0009967; GO:0045582; GO:2000553; GO:2000611; GO:0045893; GO:0045944; GO:2000679; GO:0072107; GO:0009791; GO:0002572; GO:0016579; GO:0043370; GO:2000683; GO:0042035; GO:2000114; GO:1902036; GO:0061085; GO:0051569; GO:0072182; GO:0043523; GO:0010975; GO:0043627; GO:0045471; GO:0010332; GO:0009615; GO:0007165; GO:0048485; GO:0050852; GO:0045064; GO:0045061; GO:0048538; GO:0031929; GO:0006366; GO:0001806; GO:0060676; GO:0035799; GO:0060065; GO:0003281"]
[948,471,"PN600","GATAD2B","T120+S122","Transcriptional repressor p66-beta",0,13343,16,776,{"v":10341.752,"d":"10342"},{"v":18171.9774673688,"d":"18172"},{"$nulls":3},0,14699,22,754,{"v":11066.458,"d":"11066"},{"v":19335.482521115802,"d":"19335"},{"$nulls":6},0,14070,18,813,{"v":11424.276,"d":"11424"},{"v":19545.1243458264,"d":"19545"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"CGRL(pT)P(pS)PDI","Corresponds to amino acid residues C117 to I125.","The effect of T120 and S122 phosphorylation are unclear. These are two of the major in vivo phosphorylation sites in GATAD2B (≥90 and ≥86 reports, respectively, from high throughput mass spectrometry studies).","S122: PRP4 (PRPF4B).",null,"Q8WXI9","Q8WXI9"]
[953,474,"PK893","GCK (MAP4K2)","S411","Glucokinase",0,11787,18,679,{"v":7991.151,"d":"7991"},{"v":14041.6262070819,"d":"14042"},{"$f":"(L966+L967)/2","v":{"v":15292.5179994291,"d":"15293"}},{"$f":"SQRT((M966-L966)*(M966-L966))","v":{"v":1250.8917923472,"d":"1251"}},{"$f":"N966/M966*100","v":{"v":8.179763413676532,"d":"8"}},0,12376,18,684,{"v":8452.872,"d":"8453"},{"v":14768.9855967672,"d":"14769"},{"$f":"(U966+U967)/2","v":{"v":14926.2594167786,"d":"14926"}},{"$f":"SQRT((V966-U966)*(V966-U966))","v":{"v":157.27382001139995,"d":"157"}},{"$f":"W966/V966*100","v":{"v":1.0536720260577044,"d":"1"}},{"$f":"X966+O966","v":{"v":9.233435439734237,"d":"9"}},{"$f":"(V966/M966*100)-100","v":{"v":-2.3950181563570823,"d":"-2"}},null,0,13805,28,705,{"v":9712.785,"d":"9713"},{"v":16617.034687299,"d":"16617"},{"$f":"(AG966+AG967)/2","v":{"v":17411.8522523868,"d":"17412"}},{"$f":"SQRT((AH966-AG966)*(AH966-AG966))","v":{"v":794.8175650878002,"d":"795"}},{"$f":"AI966/AH966*100","v":{"v":4.564807658408928,"d":"5"}},{"$f":"AJ966+O966","v":{"v":12.74457107208546,"d":"13"}},{"$f":"(AH966/M966*100)-100","v":{"v":13.858635007242242,"d":"14"}},null,null,"GCK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","KHS",{"$nulls":4},"X","GVDG(pS)VYK(bA)C","Corresponds to amino acid residues G407 to Y413.","S411 phosphorylation stimulates enzyme activity. This phosphorylation site in glucokinase is poorly detected by mass spectrometry (≥1 report by mass spectrometry). This human phosphosite is highly conserved in vertebrates and also found in yeast.",null,null,"P35557","P35557",null,null,"GO:0005829; GO:0005739; GO:0005654","GO:0005524; GO:0004340; GO:0005536","GO:0070509; GO:0061621; GO:0001678; GO:0032869; GO:0044320; GO:0051594; GO:0051156; GO:0042593; GO:0006096; GO:0006739; GO:0045721; GO:0045725; GO:0032024; GO:0006110; GO:0050796; GO:0043266"]
[954,474,"PK893","GCK (MAP4K2)","S411","Glucokinase",0,13145,14,717,{"v":9414.927,"d":"9415"},{"v":16543.4097917763,"d":"16543"},{"$nulls":3},0,13120,20,659,{"v":8632.9,"d":"8633"},{"v":15083.53323679,"d":"15084"},{"$nulls":6},0,14036,15,759,{"v":10641.939,"d":"10642"},{"v":18206.6698174746,"d":"18207"},{"$nulls":7},"GCK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","KHS",{"$nulls":4},"X","GVDG(pS)VYK(bA)C","Corresponds to amino acid residues G407 to Y413.","S411 phosphorylation stimulates enzyme activity. This phosphorylation site in glucokinase is poorly detected by mass spectrometry (≥1 report by mass spectrometry). This human phosphosite is highly conserved in vertebrates and also found in yeast.",null,null,"P35557","P35557"]
[961,478,"PN034","GFAP","S8","Glial fibrillary acidic protein",0,73,10,648,{"$f":"(H974-I974)*J974/1000","v":{"v":40.824,"d":"41"}},{"v":71.7337650456,"d":"72"},{"$f":"(L974+L975)/2","v":{"v":1068.93132369115,"d":"1069"}},{"$f":"SQRT((M974-L974)*(M974-L974))","v":{"v":997.1975586455501,"d":"997"}},{"$f":"N974/M974*100","v":{"v":93.28920731802539,"d":"93"}},0,3872,10,336,{"$f":"(Q974-R974)*S974/1000","v":{"v":1297.632,"d":"1298"}},{"v":2267.2422246432,"d":"2267"},{"$f":"(U974+U975)/2","v":{"v":2032.0233918057002,"d":"2032"}},{"$f":"SQRT((V974-U974)*(V974-U974))","v":{"v":235.21883283750003,"d":"235"}},{"$f":"W974/V974*100","v":{"v":11.575596707500472,"d":"12"}},{"$f":"X974+O974","v":{"v":104.86480402552586,"d":"105"}},{"$f":"(V974/M974*100)-100","v":{"v":90.09859162783965,"d":"90"}},null,0,3561,12,392,{"$f":"(AC974-AD974)*AE974/1000","v":{"v":1391.208,"d":"1391"}},{"v":2380.1362424112003,"d":"2380"},{"$f":"(AG974+AG975)/2","v":{"v":2240.6342346552,"d":"2241"}},{"$f":"SQRT((AH974-AG974)*(AH974-AG974))","v":{"v":139.50200775600024,"d":"140"}},{"$f":"AI974/AH974*100","v":{"v":6.226005369299711,"d":"6"}},{"$f":"AJ974+O974","v":{"v":99.5152126873251,"d":"100"}},{"$f":"(AH974/M974*100)-100","v":{"v":109.61442377027714,"d":"110"}},{"$nulls":15},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S8 phosphosite.","S8 phosphorylation induces interaction with fascin. Phosphorylation of this site in GFAP has not been reported from high throughput mass spectrometry studies.","PKACa (PRKACA); PKCa (PRKCA)","Cytoskeletal protein","P14136","P14136",null,null,"GO:0097450; GO:0044297; GO:0005737; GO:0098574; GO:0005829; GO:0005882; GO:0043209","GO:0042802; GO:0005178; GO:0019900; GO:0005200","GO:0014002; GO:0060020; GO:0030198; GO:0045109; GO:0060291; GO:0010977; GO:0031102; GO:0010625; GO:1904714; GO:0051580; GO:0043254; GO:0009611"]
[965,480,"PN178","GluR1","S849","Glutamate receptor 1",0,2672,14,345,{"v":917.01,"d":"917"},{"$f":"K978*1.7571469","v":{"v":1611.321278769,"d":"1611"}},{"$f":"(L978+L979)/2","v":{"v":873.2545663337,"d":"873"}},{"$f":"SQRT((M978-L978)*(M978-L978))","v":{"v":738.0667124352999,"d":"738"}},{"$f":"N978/M978*100","v":{"v":84.51907850124654,"d":"85"}},0,2774,10,330,{"v":912.12,"d":"912"},{"$f":"T978*1.7472151","v":{"v":1593.669837012,"d":"1594"}},{"$f":"(U978+U979)/2","v":{"v":827.498543511,"d":"827"}},{"$f":"SQRT((V978-U978)*(V978-U978))","v":{"v":766.171293501,"d":"766"}},{"$f":"W978/V978*100","v":{"v":92.58883891809717,"d":"93"}},{"$f":"X978+O978","v":{"v":177.10791741934372,"d":"177"}},{"$f":"(V978/M978*100)-100","v":{"v":-5.239711830515077,"d":"-5"}},null,0,1966,8,333,{"v":652.014,"d":"652"},{"v":1115.4925445796,"d":"1115"},{"$f":"(AG978+AG979)/2","v":{"v":1119.3676003506,"d":"1119"}},{"$f":"SQRT((AH978-AG978)*(AH978-AG978))","v":{"v":3.8750557710000066,"d":"4"}},{"$f":"AI978/AH978*100","v":{"v":0.3461825918300914,"d":"0"}},{"$f":"AJ978+O978","v":{"v":84.86526109307663,"d":"85"}},{"$f":"(AH978/M978*100)-100","v":{"v":28.183423655050433,"d":"28"}},{"$nulls":15},"QQ(pS)IN","Corresponds to amino acid residues Q847 to N851.","S849 phosphorylation induces activity. This is one of the major in vivo phosphorylation sites in GluR1 (≥6 reports from high throughput mass spectrometry studies).","CaMK2a; PKACa (PRKACA); PKCa (PRKCA)","Channel, calcium; Channel, ligand-gated","P42261","P42261",null,null,"GO:0032281; GO:0044308; GO:0030054; GO:0009986; GO:0030425; GO:0043197; GO:0032591; GO:0031901; GO:0030666; GO:0033116; GO:0005789; GO:0012507; GO:0098978; GO:0000139; GO:0099061; GO:0043025; GO:0044309; GO:0005886; GO:0014069; GO:0055037; GO:0055038; GO:0008021","GO:0004971; GO:0001540; GO:0005231; GO:0008066; GO:0099583; GO:0030165; GO:1904315","GO:0007268; GO:0048208; GO:0006888; GO:0007616; GO:0060292; GO:0031623; GO:0007165"]
[970,483,"PN601","GR","S226","Glucocorticoid receptor",0,7064,16,732,{"v":5159.136,"d":"5159"},{"v":9065.359829078401,"d":"9065"},{"$nulls":3},0,7000,18,663,{"v":4629.066,"d":"4629"},{"v":8087.9740140966,"d":"8088"},{"$nulls":6},0,7836,16,730,{"v":5708.6,"d":"5709"},{"v":9766.509216040002,"d":"9767"},{"$nulls":10},"Receptor,  nuclear; Transcription protein",{"$nulls":4},"X",{"$nulls":4},"LL(pS)PLAGC","Corresponds to amino acid residues L224 to G230.","S226 phosphorylation inhibits transcriptional activity, and regulates intracellular location and molecular association, including inducing interaction with GRIP1. This is one of the major in vivo phosphorylation sites in the glucocorticoid receptor (≥10 reports from high throughput mass spectrometry studies).","CDK5; ERK2 (MAPK1); JAK1; JNK1 (MAPK8); JNK2 (MAPK9); JNK3 (MAPK10)",null,"P04150","P04150",null,"P04150"]
[971,484,"NK382-1","GRK1 (Rhodopsin kinase)","Pan-specific","Rhodopsin kinase",0,216,12,539,{"v":109.956,"d":"110"},{"v":193.2088445364,"d":"193"},{"$f":"(L984+L985)/2","v":{"v":191.44818334259998,"d":"191"}},{"$f":"SQRT((M984-L984)*(M984-L984))","v":{"v":1.7606611938000185,"d":"2"}},{"$f":"N984/M984*100","v":{"v":0.9196541659783125,"d":"1"}},0,222,14,517,{"v":107.536,"d":"108"},{"v":187.8885229936,"d":"188"},{"$f":"(U984+U985)/2","v":{"v":192.5396095898,"d":"193"}},{"$f":"SQRT((V984-U984)*(V984-U984))","v":{"v":4.6510865962000025,"d":"5"}},{"$f":"W984/V984*100","v":{"v":2.41565182671192,"d":"2"}},{"$f":"X984+O984","v":{"v":3.335305992690232,"d":"3"}},{"$f":"(V984/M984*100)-100","v":{"v":0.5700896337297081,"d":"1"}},null,0,254,18,585,{"v":138.06,"d":"138"},{"v":236.198763684,"d":"236"},{"$f":"(AG984+AG985)/2","v":{"v":237.9044725598,"d":"238"}},{"$f":"SQRT((AH984-AG984)*(AH984-AG984))","v":{"v":1.7057088758000134,"d":"2"}},{"$f":"AI984/AH984*100","v":{"v":0.7169721768771136,"d":"1"}},{"$f":"AJ984+O984","v":{"v":1.636626342855426,"d":"2"}},{"$f":"(AH984/M984*100)-100","v":{"v":24.265724754392508,"d":"24"}},null,null,"GRK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase",{"$nulls":8},"Not precisely defined.","Antibody raised against full length human GRK1.",null,null,"Protein-serine kinase, AGC group, GRK family, GRK subfamily","Q15835","Q15835","Q15835","Q15835","GO:0097381","GO:0005524; GO:0004703; GO:0004672; GO:0050254","GO:0046777; GO:0008277; GO:0022400; GO:0016056; GO:0007601"]
[976,486,"NK067","GRK2 (BARK1, ADRBK1)","Pan-specific","G protein-coupled receptor-serine kinase 2",0,502,12,632,{"v":309.68,"d":"310"},{"v":544.153251992,"d":"544"},{"$nulls":3},0,433,14,548,{"v":229.612,"d":"230"},{"v":401.1815535412,"d":"401"},{"$nulls":6},0,500,18,620,{"v":298.84,"d":"299"},{"v":511.267843976,"d":"511"},{"$nulls":7},"BARK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase",{"$nulls":8},"Not precisely defined.","Antibody raised against amino acid residues at the C-terminus of human GRK2.",{"$nulls":3},"P25098","P25098","P25098"]
[979,118,"PK536","GRK2 (BARK1, ADRBK1)","S670","Beta-adrenergic receptor kinase 1",0,3190,14,616,{"v":1956.416,"d":"1956"},{"v":3437.7103095104,"d":"3438"},{"$f":"(L992+L993)/2","v":{"v":3742.38991766245,"d":"3742"}},{"$f":"SQRT((M992-L992)*(M992-L992))","v":{"v":304.67960815205015,"d":"305"}},{"$f":"N992/M992*100","v":{"v":8.141311163598832,"d":"8"}},0,3197,20,678,{"v":2154.006,"d":"2154"},{"v":3763.5118086906,"d":"3764"},{"$f":"(U992+U993)/2","v":{"v":3290.1685243043003,"d":"3290"}},{"$f":"SQRT((V992-U992)*(V992-U992))","v":{"v":473.34328438629973,"d":"473"}},{"$f":"W992/V992*100","v":{"v":14.38659694449503,"d":"14"}},{"$f":"X992+O992","v":{"v":22.52790810809386,"d":"23"}},{"$f":"(V992/M992*100)-100","v":{"v":-12.083759397273425,"d":"-12"}},null,0,3438,12,540,{"v":1850.04,"d":"1850"},{"v":3165.125023656,"d":"3165"},{"$f":"(AG992+AG993)/2","v":{"v":3023.6675241798002,"d":"3024"}},{"$f":"SQRT((AH992-AG992)*(AH992-AG992))","v":{"v":141.4574994761997,"d":"141"}},{"$f":"AI992/AH992*100","v":{"v":4.678341727223182,"d":"5"}},{"$f":"AJ992+O992","v":{"v":12.819652890822013,"d":"13"}},{"$f":"(AH992/M992*100)-100","v":{"v":-19.20490406653228,"d":"-19"}},null,null,"BARK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","GRK","BARK",{"$nulls":5},"KPR(pS)PVV(bA)C","Corresponds to amino acid residues K667 to V673; Near the C-terminus of the kinase.","S670 phosphorylation inhibits phosphotransferase activity. Phosphorylation regulates cell cycle progression, cell growth, protein degradation, and induces molecular association with PIN1. This is one of the major in vivo phosphorylation sites in BARK1 (≥54reports from high throughput mass spectrometry studies).","ERK1","EC 2.7.11.15; Protein kinase, Ser/Thr (non-receptor); AGC group; GRK family; BARK subfamily","P25098","P25098","P25098",null,"GO:0005929; GO:0005737; GO:0005829; GO:0016020; GO:0005886","GO:0031694; GO:0005524; GO:0047696; GO:0031755; GO:0004703; GO:0004672","GO:0060048; GO:0002029; GO:0007213; GO:0007186; GO:0007507; GO:0045988; GO:0003108; GO:0018105; GO:0018107; GO:0033605; GO:0031623; GO:0007217; GO:0046718; GO:0019079"]
[987,490,"NK069-NK070-3","GSK3a","Pan-specific","Glycogen synthase-serine kinase 3 alpha/beta",0,202,10,612,{"v":117.504,"d":"118"},{"v":206.4717893376,"d":"206"},{"$f":"(L1000+L1001)/2","v":{"v":209.5696393223,"d":"210"}},{"$f":"SQRT((M1000-L1000)*(M1000-L1000))","v":{"v":3.097849984699991,"d":"3"}},{"$f":"N1000/M1000*100","v":{"v":1.4781959804472276,"d":"1"}},0,201,10,605,{"v":115.555,"d":"116"},{"v":201.8994408805,"d":"202"},{"$f":"(U1000+U1001)/2","v":{"v":210.72724517325,"d":"211"}},{"$f":"SQRT((V1000-U1000)*(V1000-U1000))","v":{"v":8.827804292749988,"d":"9"}},{"$f":"W1000/V1000*100","v":{"v":4.189208797131185,"d":"4"}},{"$f":"X1000+O1000","v":{"v":5.667404777578413,"d":"6"}},{"$f":"(V1000/M1000*100)-100","v":{"v":0.5523728793414193,"d":"1"}},null,0,202,10,634,{"v":121.728,"d":"122"},{"v":208.2573019392,"d":"208"},{"$f":"(AG1000+AG1001)/2","v":{"v":227.9661948672,"d":"228"}},{"$f":"SQRT((AH1000-AG1000)*(AH1000-AG1000))","v":{"v":19.708892927999983,"d":"20"}},{"$f":"AI1000/AH1000*100","v":{"v":8.645533141210368,"d":"9"}},{"$f":"AJ1000+O1000","v":{"v":10.123729121657595,"d":"10"}},{"$f":"(AH1000/M1000*100)-100","v":{"v":8.778254142341524,"d":"9"}},null,null,"GSK3a","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","GSK",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 1-420 representing full length Xenopus laevis glycogen synthase kinase-3 beta. ",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.26; CMGC group; GSK family; GSK subfamily","P49840","P49840","P49840",null,"GO:0097440; GO:0030877; GO:0005829; GO:0005739; GO:0043025; GO:0098794; GO:1990635","GO:0005524; GO:0034236; GO:0004674; GO:0005102; GO:0050321","GO:0003214; GO:0032869; GO:0036016; GO:0007212; GO:0060079; GO:0097191; GO:0097192; GO:0005977; GO:0008286; GO:0036498; GO:0090090; GO:0061052; GO:0046325; GO:2000466; GO:0045719; GO:1904227; GO:0046627; GO:0032007; GO:2000077; GO:0010905; GO:0007399; GO:0018107; GO:0071879; GO:0106071; GO:1902004; GO:0010628; GO:2000467; GO:0045823; GO:1901030; GO:0032436; GO:0045732; GO:1903955; GO:0031398; GO:0043161; GO:0006468; GO:1903146; GO:0003073; GO:0016055"]
[988,490,"NK069-NK070-3","GSK3a","Pan-specific","Glycogen synthase-serine kinase 3 alpha/beta",0,204,14,637,{"v":121.03,"d":"121"},{"v":212.66748930699998,"d":"213"},{"$nulls":3},0,216,10,610,{"v":125.66,"d":"126"},{"v":219.55504946599999,"d":"220"},{"$nulls":6},0,220,12,696,{"v":144.768,"d":"145"},{"v":247.6750877952,"d":"248"},{"$nulls":7},"GSK3a","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","GSK",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 1-420 representing full length Xenopus laevis glycogen synthase kinase-3 beta. ",{"$nulls":3},"P49840","P49840","P49840"]
[993,493,"PK187","GSK3a","S21","Glycogen synthase-serine kinase 3 alpha",0,24,3,721,{"v":15.141,"d":"15"},{"v":26.6049612129,"d":"27"},{"$f":"(L1006+L1007)/2","v":{"v":25.18079365045,"d":"25"}},{"$f":"SQRT((M1006-L1006)*(M1006-L1006))","v":{"v":1.4241675624500019,"d":"1"}},{"$f":"N1006/M1006*100","v":{"v":5.655769163671896,"d":"6"}},0,30,6,686,{"v":16.464,"d":"16"},{"v":28.766149406399997,"d":"29"},{"$f":"(U1006+U1007)/2","v":{"v":26.246665232199998,"d":"26"}},{"$f":"SQRT((V1006-U1006)*(V1006-U1006))","v":{"v":2.5194841741999987,"d":"3"}},{"$f":"W1006/V1006*100","v":{"v":9.599254426840629,"d":"10"}},{"$f":"X1006+O1006","v":{"v":15.255023590512526,"d":"15"}},{"$f":"(V1006/M1006*100)-100","v":{"v":4.23287524827856,"d":"4"}},null,0,32,6,707,{"v":18.382,"d":"18"},{"v":31.448686614800003,"d":"31"},{"$f":"(AG1006+AG1007)/2","v":{"v":30.218591648200004,"d":"30"}},{"$f":"SQRT((AH1006-AG1006)*(AH1006-AG1006))","v":{"v":1.2300949665999994,"d":"1"}},{"$f":"AI1006/AH1006*100","v":{"v":4.070656173922887,"d":"4"}},{"$f":"AJ1006+O1006","v":{"v":9.726425337594783,"d":"10"}},{"$f":"(AH1006/M1006*100)-100","v":{"v":20.006509992031056,"d":"20"}},null,null,"GSK3a","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","GSK",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S21 phosphosite.","S21 phosphorylation inhibits phosphotransferase activity. This is one of the less major in vivo phosphorylation sites in GSK3a (≥296 reports from high throughput mass spectrometry studies).","Akt1 (PKBa); PKACa (PRKACA); PKCb1 (PRKCB1); PKCd (PRKCD); PKCg (PRKCG); PKCh (PRKCH); PKCz (PRKCZ); RSK2 (RPS6KA3)","Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.26; CMGC group; GSK family; GSK subfamily","P49840","P49840","P49840",null,"GO:0097440; GO:0030877; GO:0005829; GO:0005739; GO:0043025; GO:0098794; GO:1990635","GO:0005524; GO:0034236; GO:0004674; GO:0005102; GO:0050321","GO:0003214; GO:0032869; GO:0036016; GO:0007212; GO:0060079; GO:0097191; GO:0097192; GO:0005977; GO:0008286; GO:0036498; GO:0090090; GO:0061052; GO:0046325; GO:2000466; GO:0045719; GO:1904227; GO:0046627; GO:0032007; GO:2000077; GO:0010905; GO:0007399; GO:0018107; GO:0071879; GO:0106071; GO:1902004; GO:0010628; GO:2000467; GO:0045823; GO:1901030; GO:0032436; GO:0045732; GO:1903955; GO:0031398; GO:0043161; GO:0006468; GO:1903146; GO:0003073; GO:0016055"]
[998,495,"PK649","GSK3a","Y279","Glycogen synthase-serine kinase 3 alpha",0,415,16,571,{"v":227.829,"d":"228"},{"v":400.3290210801,"d":"400"},{"$nulls":3},0,410,18,597,{"v":234.024,"d":"234"},{"v":408.89026656240003,"d":"409"},{"$nulls":6},0,604,23,677,{"v":393.337,"d":"393"},{"v":672.9372237518,"d":"673"},{"$nulls":7},"GSK3a","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","GSK",{"$nulls":6},"NVS(pY)ICS(bA)C","Corresponds to amino acid residues N276 to S282; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y279 phosphorylation stimulates phosphotransferase activity, promotes nuclear localization, and regulates cell growth, apoptosis, transcription, protein stability, and molecular association. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in GSK3a.","GSK3a; MEK1 (MAP2K1); MEK2 (MAP2K2)",null,"P49840","P49840","P49840"]
[1002,497,"NK270-3","GSK3b","Pan-specific","Glycogen synthase-serine kinase 3 beta",0,7697,14,799,{"v":6138.717,"d":"6139"},{"v":10786.6275465273,"d":"10787"},{"$nulls":3},0,8758,18,775,{"v":6773.5,"d":"6774"},{"v":11834.76147985,"d":"11835"},{"$nulls":6},0,8350,18,857,{"v":7140.524,"d":"7141"},{"v":12216.3040768936,"d":"12216"},{"$nulls":7},"GSK3B","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","GSK",{"$nulls":6},"CKPVQQPSAFGSMKVSRDKD","Corresponds to amino acid residues C14 to D33; Near N-terminus.",{"$nulls":3},"P49841","P49841","P49841","P49841"]
[1005,499,"PK188","GSK3b","S9","Glycogen synthase-serine kinase 3 beta",0,500,16,652,{"v":315.568,"d":"316"},{"v":554.4993329391999,"d":"554"},{"$f":"(L1018+L1019)/2","v":{"v":629.5136912470999,"d":"630"}},{"$f":"SQRT((M1018-L1018)*(M1018-L1018))","v":{"v":75.01435830790001,"d":"75"}},{"$f":"N1018/M1018*100","v":{"v":11.916239368724863,"d":"12"}},0,688,14,674,{"v":454.276,"d":"454"},{"v":793.7178867676,"d":"794"},{"$f":"(U1018+U1019)/2","v":{"v":931.44823227795,"d":"931"}},{"$f":"SQRT((V1018-U1018)*(V1018-U1018))","v":{"v":137.73034551034993,"d":"138"}},{"$f":"W1018/V1018*100","v":{"v":14.7866881633901,"d":"15"}},{"$f":"X1018+O1018","v":{"v":26.702927532114963,"d":"27"}},{"$f":"(V1018/M1018*100)-100","v":{"v":47.96314126746023,"d":"48"}},null,0,650,18,752,{"v":475.264,"d":"475"},{"v":813.1013271296,"d":"813"},{"$f":"(AG1018+AG1019)/2","v":{"v":904.0411017465999,"d":"904"}},{"$f":"SQRT((AH1018-AG1018)*(AH1018-AG1018))","v":{"v":90.9397746169999,"d":"91"}},{"$f":"AI1018/AH1018*100","v":{"v":10.059252222194877,"d":"10"}},{"$f":"AJ1018+O1018","v":{"v":21.975491590919738,"d":"22"}},{"$f":"(AH1018/M1018*100)-100","v":{"v":43.60944238649466,"d":"44"}},null,null,"GSK3B","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","GSK",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S9 phosphosite.","S9 phosphorylation inhibits phosphotransferase activity. Phosphorylation regulates apoptosis, cell adhesion, cell growth, cell motility, cytoskeletal reorganization, transcription, alters intracellular location, and protein degradation. This is one of the less major in vivo phosphorylation sites in GSK3b (≥262reports from high throughput mass spectrometry studies).","Akt1 (PKBa); Akt3 (PKBg); AurA (STK15); GSK3b; ILK; KHS1 (MAP4K5); p70S6K (RPS6KB1); PKACa (PRKACA); PKCa (PRKCA); PKCb1 (PRKCB1); PKCd (PRKCD); PKCg (PRKCG); PKCh (PRKCH); PKCz (PRKCZ); PKG1 (PRKG1); RSK1 (RPS6KA1); RSK2 (RPS6KA3); SGK3","Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.26; CMGC group; GSK family; GSK subfamily","P49841","P49841","P49841","P49841","GO:0030424; GO:0030877; GO:0005813; GO:0005737; GO:0005829; GO:0030425; GO:0098978; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0098794; GO:1990909","GO:0005524; GO:0008013; GO:0034452; GO:0016301; GO:0051059; GO:0002039; GO:0002020; GO:0034236; GO:0004672; GO:0019901; GO:0004674; GO:0001085; GO:0050321; GO:0031625","GO:1904885; GO:1904886; GO:1904646; GO:0036016; GO:0007623; GO:0007212; GO:0001837; GO:0006983; GO:0030010; GO:0060079; GO:0097191; GO:0097192; GO:0005977; GO:0021766; GO:0035556; GO:0030011; GO:0043066; GO:0070885; GO:0090090; GO:1904339; GO:2000466; GO:0045719; GO:1901215; GO:0032515; GO:1901984; GO:0032091; GO:0031333; GO:1900181; GO:2000077; GO:0031175; GO:0106028; GO:0018105; GO:0018107; GO:0001954; GO:0010628; GO:0043547; GO:1901030; GO:0010822; GO:1901216; GO:0032436; GO:0032092; GO:0045732; GO:0031334; GO:0046827; GO:1904781; GO:0046777; GO:0006468; GO:0030516; GO:0050770; GO:1900034; GO:0048814; GO:0032886; GO:0070507; GO:2000300; GO:0071109; GO:0016055"]
[1010,501,"PK651","GTF2F1","S385+T389","General transcription factor IIF subunit 1",0,8721,12,866,{"v":7541.994,"d":"7542"},{"v":13252.391376918598,"d":"13252"},{"$nulls":3},0,9136,20,838,{"v":7639.208,"d":"7639"},{"v":13347.339569640799,"d":"13347"},{"$nulls":6},0,10210,16,833,{"v":8491.602,"d":"8492"},{"v":14527.784253922802,"d":"14528"},{"$nulls":7},"GTF2F1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine; Transcription protein ","Protein-serine/threonine kinase","Atypical",null,null,"X",{"$nulls":4},"RGN(pS)RPG(pT)PSA(bA)C","Corresponds to amino acid residues R382 to A392; in the TFIIF_alpha domain.","S385+T389 phosphorylation inhibits transcriptional activity. These are the two major in vivo phosphorylation sites in GTF2F1 (≥280 and ≥319 reports, respectively, from high throughput mass spectrometry studies).","S385: GTF2F1. T389: GTF2F1",null,"P35269","P35269","P35269"]
[1015,504,"PN703","GYS1","S641+S645","Glycogen [starch] synthase, muscle",0,6494,18,800,{"v":5180.8,"d":"5181"},{"v":9103.42665952,"d":"9103"},{"$f":"(L1028+L1029)/2","v":{"v":9314.7499314485,"d":"9315"}},{"$f":"SQRT((M1028-L1028)*(M1028-L1028))","v":{"v":211.3232719284988,"d":"211"}},{"$f":"N1028/M1028*100","v":{"v":2.2686950641050303,"d":"2"}},0,7146,22,770,{"v":5485.48,"d":"5485"},{"v":9584.313486747998,"d":"9584"},{"$f":"(U1028+U1029)/2","v":{"v":8811.188277148998,"d":"8811"}},{"$f":"SQRT((V1028-U1028)*(V1028-U1028))","v":{"v":773.1252095990003,"d":"773"}},{"$f":"W1028/V1028*100","v":{"v":8.774358069319991,"d":"9"}},{"$f":"X1028+O1028","v":{"v":11.04305313342502,"d":"11"}},{"$f":"(V1028/M1028*100)-100","v":{"v":-5.406067344861015,"d":"-5"}},null,0,6530,20,781,{"v":5084.31,"d":"5084"},{"v":8698.448038434,"d":"8698"},{"$f":"(AG1028+AG1029)/2","v":{"v":9305.239001137601,"d":"9305"}},{"$f":"SQRT((AH1028-AG1028)*(AH1028-AG1028))","v":{"v":606.7909627036006,"d":"607"}},{"$f":"AI1028/AH1028*100","v":{"v":6.520960532334722,"d":"7"}},{"$f":"AJ1028+O1028","v":{"v":8.789655596439752,"d":"9"}},{"$f":"(AH1028/M1028*100)-100","v":{"v":-0.10210612609992609,"d":"-0"}},{"$nulls":5},"Glycogen synthesis",{"$nulls":8},"X","RPA(pS)VPP(pS)PSL(bA)C","Corresponds to amino acid residues R638 to L648","S641+S645 phosphorylation inhibits enzyme activity. These are two of the major in vivo phosphorylation sites in glycogen synthase isoform 1 (≥26 and >35 reports, respectively, by mass spectrometry). These phosphosites are highly conserved in mammals and found in the platypus.","S641: BARK2 (GRK3, ADRBK2); DYRK1A; DYRK1B; DYRK2; GSK3b; PASK (PASKIN). S645: BARK2 (GRK3, ADRBK2); GSK3b; p38b MAPK (MAPK11).","EC 2.4.1.11; Carbohydrate Metabolism - starch and sucrose; Transferase","P13807","P13807",null,null,"GO:0005829; GO:0016234; GO:0016020","GO:0005536; GO:0004373; GO:0061547; GO:0019901","GO:0005978; GO:0007507"]
[1020,520,"PN036","H2AFX","S139","Histone H2A.X",0,1472,18,260,{"v":378.04,"d":"378"},{"v":664.271814076,"d":"664"},{"$nulls":3},0,718,18,249,{"v":174.3,"d":"174"},{"v":304.53959193000003,"d":"305"},{"$nulls":6},0,33,14,648,{"v":12.312,"d":"12"},{"v":21.0638793168,"d":"21"},{"$nulls":20},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S139 phosphosite.","S139 phosphorylation regulates DNA damage response mechanism at double strand DNA breaks. This is one of the major in vivo phosphorylation sites in histone H2A.","ATM; JNK2 (MAPK9)",null,"P16104","P16104",null,"P16104"]
[1025,523,"PN038","H3F3A","S10","Histone H3",0,4564,10,566,{"$f":"(H1038-I1038)*J1038/1000","v":{"v":2577.564,"d":"2578"}},{"v":4529.1585921516,"d":"4529"},{"$f":"(L1038+L1039)/2","v":{"v":4593.9287840325,"d":"4594"}},{"$f":"SQRT((M1038-L1038)*(M1038-L1038))","v":{"v":64.7701918808998,"d":"65"}},{"$f":"N1038/M1038*100","v":{"v":1.4099084884821669,"d":"1"}},0,5204,14,544,{"$f":"(Q1038-R1038)*S1038/1000","v":{"v":2823.36,"d":"2823"}},{"v":4933.017224736001,"d":"4933"},{"$f":"(U1038+U1039)/2","v":{"v":4808.1193005276,"d":"4808"}},{"$f":"SQRT((V1038-U1038)*(V1038-U1038))","v":{"v":124.89792420840058,"d":"125"}},{"$f":"W1038/V1038*100","v":{"v":2.59764611486856,"d":"3"}},{"$f":"X1038+O1038","v":{"v":4.0075546033507266,"d":"4"}},{"$f":"(V1038/M1038*100)-100","v":{"v":4.662469240698286,"d":"5"}},null,0,5318,14,569,{"$f":"(AC1038-AD1038)*AE1038/1000","v":{"v":3017.976,"d":"3018"}},{"v":5163.2782850064,"d":"5163"},{"$f":"(AG1038+AG1039)/2","v":{"v":5180.1677113072,"d":"5180"}},{"$f":"SQRT((AH1038-AG1038)*(AH1038-AG1038))","v":{"v":16.88942630079964,"d":"17"}},{"$f":"AI1038/AH1038*100","v":{"v":0.3260401446836099,"d":"0"}},{"$f":"AJ1038+O1038","v":{"v":1.7359486331657767,"d":"2"}},{"$f":"(AH1038/M1038*100)-100","v":{"v":12.761167071469188,"d":"13"}},{"$nulls":15},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S10 phosphosite.","S10 phosphorylation induces interaction with DNA and inhibits interaction with HP1-alpha. This is one of the major in vivo phosphorylation sites in histone H3.","Akt1 (PKBa); Akt2 (PKBb); AurA (STK15); AurB (STK12); AurC (STK13); DLK (MAP3K12); Fyn; MSK1 (RPS6KA5); MSK2 (RPS6KA4); p38a MAPK (MAPK14); PAK1; PBK (TOPK); Pim1; PKACa (PRKACA); PKCt (PRKCQ; PKCq); ROCK1; RSK1 (RPS6KA1); TLK1; VRK1","DNA binding protein","P84243","P84243",null,null,"GO:0070062; GO:0005576; GO:0000228; GO:0000784; GO:0000788; GO:0005654; GO:0000786; GO:0005634; GO:0032991","GO:0031492; GO:0046982; GO:0000979; GO:0000980","GO:0007596; GO:0044267; GO:0000183; GO:0006336; GO:0045814; GO:0006334; GO:0030307; GO:0060964; GO:0045652; GO:0032200"]
[1027,524,"PN039","H3F3A","S28","Histone H3",0,2600,8,295,{"v":764.64,"d":"765"},{"v":1343.584805616,"d":"1344"},{"$f":"(L1040+L1041)/2","v":{"v":1225.8164275107501,"d":"1226"}},{"$f":"SQRT((M1040-L1040)*(M1040-L1040))","v":{"v":117.7683781052499,"d":"118"}},{"$f":"N1040/M1040*100","v":{"v":9.607342132328952,"d":"10"}},0,2440,8,320,{"v":778.24,"d":"778"},{"v":1359.752679424,"d":"1360"},{"$f":"(U1040+U1041)/2","v":{"v":1296.293826992,"d":"1296"}},{"$f":"SQRT((V1040-U1040)*(V1040-U1040))","v":{"v":63.45885243199996,"d":"63"}},{"$f":"W1040/V1040*100","v":{"v":4.895406512831569,"d":"5"}},{"$f":"X1040+O1040","v":{"v":14.502748645160521,"d":"15"}},{"$f":"(V1040/M1040*100)-100","v":{"v":5.74942527278472,"d":"6"}},null,0,2616,10,312,{"v":813.072,"d":"813"},{"v":1391.0372387808,"d":"1391"},{"$f":"(AG1040+AG1041)/2","v":{"v":1298.8673691971999,"d":"1299"}},{"$f":"SQRT((AH1040-AG1040)*(AH1040-AG1040))","v":{"v":92.16986958360008,"d":"92"}},{"$f":"AI1040/AH1040*100","v":{"v":7.096172539969817,"d":"7"}},{"$f":"AJ1040+O1040","v":{"v":16.70351467229877,"d":"17"}},{"$f":"(AH1040/M1040*100)-100","v":{"v":5.959370428310649,"d":"6"}},{"$nulls":15},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S28 phosphosite.","S28 phosphorylation induces transcription. This is one of the major in vivo phosphorylation sites in histone H3.","Akt2 (PKBb); AurB (STK12); AurC (STK13); MSK1 (RPS6KA5); MSK2 (RPS6KA4); ROCK1; TGM2; ZAK (MLTK)","DNA binding protein","P84243","P84243",null,null,"GO:0070062; GO:0005576; GO:0000228; GO:0000784; GO:0000788; GO:0005654; GO:0000786; GO:0005634; GO:0032991","GO:0031492; GO:0046982; GO:0000979; GO:0000980","GO:0007596; GO:0044267; GO:0000183; GO:0006336; GO:0045814; GO:0006334; GO:0030307; GO:0060964; GO:0045652; GO:0032200"]
[1032,506,"PN518","HCA59","Y147","Uncharacterized protein C9orf78",0,10804,24,919,{"v":9906.82,"d":"9907"},{"v":17407.738051858,"d":"17408"},{"$nulls":3},0,11253,24,897,{"v":10072.413,"d":"10072"},{"v":17598.672087036302,"d":"17599"},{"$nulls":6},0,10524,25,979,{"v":10278.521,"d":"10279"},{"v":17584.919257569403,"d":"17585"},{"$nulls":20},"DCL(pY)ELP(bA)C","Corresponds to amino acid residues D144 to P150; In the middle of the Hep_59 domain. ","The effect of Y147 phosphorylation is unclear. This is the major in vivo phosphorylation site in HCA59 (≥518 reports from high throughput mass spectrometry studies).","Syk",null,"Q9NZ63","Q9NZ63"]
[1037,509,"NN169","HDAC4","Pan-specific","Histone deacetylase 4",0,1246,12,193,{"v":238.162,"d":"238"},{"v":418.4856199978,"d":"418"},{"$f":"(L1050+L1051)/2","v":{"v":435.39991605719996,"d":"435"}},{"$f":"SQRT((M1050-L1050)*(M1050-L1050))","v":{"v":16.914296059399987,"d":"17"}},{"$f":"N1050/M1050*100","v":{"v":3.884772466786121,"d":"4"}},0,1420,10,175,{"v":246.75,"d":"247"},{"v":431.125325925,"d":"431"},{"$f":"(U1050+U1051)/2","v":{"v":407.73710459640006,"d":"408"}},{"$f":"SQRT((V1050-U1050)*(V1050-U1050))","v":{"v":23.38822132859997,"d":"23"}},{"$f":"W1050/V1050*100","v":{"v":5.736103255000763,"d":"6"}},{"$f":"X1050+O1050","v":{"v":9.620875721786884,"d":"10"}},{"$f":"(V1050/M1050*100)-100","v":{"v":-6.353425997713273,"d":"-6"}},null,0,1484,10,197,{"v":290.378,"d":"290"},{"v":496.7907040492,"d":"497"},{"$f":"(AG1050+AG1051)/2","v":{"v":457.2018340532,"d":"457"}},{"$f":"SQRT((AH1050-AG1050)*(AH1050-AG1050))","v":{"v":39.58886999599997,"d":"40"}},{"$f":"AI1050/AH1050*100","v":{"v":8.65894820347405,"d":"9"}},{"$f":"AJ1050+O1050","v":{"v":12.543720670260171,"d":"13"}},{"$f":"(AH1050/M1050*100)-100","v":{"v":5.00733169483108,"d":"5"}},{"$nulls":15},"AQSSP","Corresponds to amino acid residues  A630 to P634; Surrounds the S632 phosphosite.",null,null,"Enzyme, hydrolase; Nuclear receptor co-regulator","P56524","P56524",null,"P56524","GO:0031672; GO:0042641; GO:0005737; GO:0005829; GO:0000118; GO:0031594; GO:0005654; GO:0005634; GO:0017053; GO:0030018","GO:0033613; GO:0004407; GO:0042826; GO:0042802; GO:0032041; GO:0030955; GO:1990841; GO:0033558; GO:0019901; GO:0070491; GO:0000978; GO:0001085; GO:0019789; GO:0003714; GO:0008134; GO:0008270","GO:0042113; GO:0030183; GO:0014898; GO:0071260; GO:0071374; GO:0071356; GO:0006338; GO:0016575; GO:0070932; GO:0070933; GO:0006954; GO:0008285; GO:0043433; GO:0045820; GO:0010832; GO:0045668; GO:1902894; GO:0045892; GO:0000122; GO:0007399; GO:0002076; GO:0034983; GO:0008284; GO:0051091; GO:0010592; GO:0043525; GO:0033235; GO:1903428; GO:0014911; GO:0048661; GO:0045893; GO:0045944; GO:0006476; GO:0010882; GO:0040029; GO:0043393; GO:0048742; GO:0014894; GO:0042493; GO:0070555; GO:0001501; GO:0006351"]
[1038,509,"NN169","HDAC4","Pan-specific","Histone deacetylase 4",0,1149,10,226,{"v":257.414,"d":"257"},{"v":452.31421211659995,"d":"452"},{"$nulls":3},0,1121,10,198,{"v":219.978,"d":"220"},{"v":384.34888326780003,"d":"384"},{"$nulls":6},0,1156,10,213,{"v":244.098,"d":"244"},{"v":417.61296405720003,"d":"418"},{"$nulls":20},"AQSSP","Corresponds to amino acid residues  A630 to P634; Surrounds the S632 phosphosite.",{"$nulls":3},"P56524","P56524",null,"P56524"]
[1043,512,"PP500","HePTP (PTPN7)","S44","Tyrosine-protein phosphatase non-receptor type 7",0,4164,14,539,{"v":2236.85,"d":"2237"},{"v":3930.4740432649996,"d":"3930"},{"$f":"(L1056+L1057)/2","v":{"v":4796.143006431399,"d":"4796"}},{"$f":"SQRT((M1056-L1056)*(M1056-L1056))","v":{"v":865.6689631663994,"d":"866"}},{"$f":"N1056/M1056*100","v":{"v":18.049273385000795,"d":"18"}},0,3882,14,539,{"v":2084.852,"d":"2085"},{"v":3642.6848956651997,"d":"3643"},{"$f":"(U1056+U1057)/2","v":{"v":4411.997681916,"d":"4412"}},{"$f":"SQRT((V1056-U1056)*(V1056-U1056))","v":{"v":769.3127862508004,"d":"769"}},{"$f":"W1056/V1056*100","v":{"v":17.43683568565953,"d":"17"}},{"$f":"X1056+O1056","v":{"v":35.486109070660326,"d":"35"}},{"$f":"(V1056/M1056*100)-100","v":{"v":-8.009463521005912,"d":"-8"}},null,0,5326,14,620,{"v":3293.44,"d":"3293"},{"v":5634.553500416,"d":"5635"},{"$f":"(AG1056+AG1057)/2","v":{"v":6617.654294098,"d":"6618"}},{"$f":"SQRT((AH1056-AG1056)*(AH1056-AG1056))","v":{"v":983.1007936819997,"d":"983"}},{"$f":"AI1056/AH1056*100","v":{"v":14.855729084530523,"d":"15"}},{"$f":"AJ1056+O1056","v":{"v":32.90500246953132,"d":"33"}},{"$f":"(AH1056/M1056*100)-100","v":{"v":37.97866921866259,"d":"38"}},{"$nulls":4},"PYP","Protein phosphatase - Non-receptor protein-tyrosine phosphatase",{"$nulls":6},"X",null,null,"RRG(pS)NVA(bA)C","Corresponds to amino acid residues R41 to A47.","S44 phosphorylation inhibits interaction with ERK2. This is one of the major in vivo phosphorylation sites in HePTP (≥44 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and found in fish.","PKACa (PRKACA); PKCt (PRKCQ; PKCq)","Protein phosphataseProtein-tyrosine phosphatase","P35236","P35236",null,"P35236","GO:0005737; GO:0009898; GO:0005856; GO:0005829; GO:0005654","GO:0004725","GO:0071345; GO:0006470"]
[1049,515,"NK300-1","HGK (ZC1)","Pan-specific","Mitogen-activated protein kinase kinase kinase kinase 4",0,8774,20,622,{"v":5444.988,"d":"5445"},{"v":9567.6437847372,"d":"9568"},{"$f":"(L1062+L1063)/2","v":{"v":10066.1006744478,"d":"10066"}},{"$f":"SQRT((M1062-L1062)*(M1062-L1062))","v":{"v":498.4568897106001,"d":"498"}},{"$f":"N1062/M1062*100","v":{"v":4.951836921082096,"d":"5"}},0,9003,16,649,{"v":5832.563,"d":"5833"},{"v":10190.742145301301,"d":"10191"},{"$f":"(U1062+U1063)/2","v":{"v":10223.07348711925,"d":"10223"}},{"$f":"SQRT((V1062-U1062)*(V1062-U1062))","v":{"v":32.33134181794958,"d":"32"}},{"$f":"W1062/V1062*100","v":{"v":0.3162585288923732,"d":"0"}},{"$f":"X1062+O1062","v":{"v":5.268095449974469,"d":"5"}},{"$f":"(V1062/M1062*100)-100","v":{"v":1.559420253663049,"d":"2"}},null,0,7204,16,651,{"v":4679.388,"d":"4679"},{"v":8005.6907170632,"d":"8006"},{"$f":"(AG1062+AG1063)/2","v":{"v":9361.8849598916,"d":"9362"}},{"$f":"SQRT((AH1062-AG1062)*(AH1062-AG1062))","v":{"v":1356.1942428284,"d":"1356"}},{"$f":"AI1062/AH1062*100","v":{"v":14.48633740575363,"d":"14"}},{"$f":"AJ1062+O1062","v":{"v":19.43817432683573,"d":"19"}},{"$f":"(AH1062/M1062*100)-100","v":{"v":-6.995913684271102,"d":"-7"}},null,null,"ZC1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","MSN",{"$nulls":5},"ANDSPAKSLVDIDLSSLRDC","Corresponds to amino acid residues A2 to D20; N-terminus.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE group; STE20 family; MSN subfamily","O95819","O95819","O95819",null,"GO:0005737; GO:0005925","GO:0005524; GO:0004111; GO:0008349; GO:0008017; GO:0004674","GO:0035556; GO:0043066; GO:0001953; GO:0061179; GO:0070571; GO:0048812; GO:1903393; GO:0032014; GO:0030335; GO:0051894; GO:0043547; GO:0051549; GO:0006468; GO:0046328; GO:0007346"]
[1054,517,"PN519","HGS (Hrs)","Y216","Hepatocyte growth factor-regulated tyrosine kinase substrate",0,10269,19,539,{"v":5524.75,"d":"5525"},{"v":9707.797335775,"d":"9708"},{"$nulls":3},0,9978,18,560,{"v":5577.6,"d":"5578"},{"v":9745.266941760001,"d":"9745"},{"$nulls":6},0,10142,16,547,{"v":5538.922,"d":"5539"},{"v":9476.2170689708,"d":"9476"},{"$nulls":18},"X",null,"EPC(pY)EQL(bA)C","Corresponds to amino acid residues E213 to L219; In the FYVE domain. ","The effect of Y216 phosphorylation is unclear. This is the major in vivo phosphorylation site in HGS (≥1385 reports from high throughput mass spectrometry studies).",null,null,"O14964","O14964",null,"O14964"]
[1055,518,"PK654","HIPK1","Y352","Homeodomain-interacting protein-serine kinase 1",0,6396,16,682,{"v":4351.16,"d":"4351"},{"v":7645.627305403999,"d":"7646"},{"$f":"(L1068+L1069)/2","v":{"v":7394.5714277727,"d":"7395"}},{"$f":"SQRT((M1068-L1068)*(M1068-L1068))","v":{"v":251.05587763129915,"d":"251"}},{"$f":"N1068/M1068*100","v":{"v":3.3951376368937054,"d":"3"}},0,7228,16,697,{"v":5026.764,"d":"5027"},{"v":8782.8379649364,"d":"8783"},{"$f":"(U1068+U1069)/2","v":{"v":7945.5602585107,"d":"7946"}},{"$f":"SQRT((V1068-U1068)*(V1068-U1068))","v":{"v":837.2777064256998,"d":"837"}},{"$f":"W1068/V1068*100","v":{"v":10.53767990153834,"d":"11"}},{"$f":"X1068+O1068","v":{"v":13.932817538432046,"d":"14"}},{"$f":"(V1068/M1068*100)-100","v":{"v":7.451261186937529,"d":"7"}},null,0,6501,16,720,{"v":4669.2,"d":"4669"},{"v":7988.26066488,"d":"7988"},{"$f":"(AG1068+AG1069)/2","v":{"v":7506.051462083,"d":"7506"}},{"$f":"SQRT((AH1068-AG1068)*(AH1068-AG1068))","v":{"v":482.2092027970002,"d":"482"}},{"$f":"AI1068/AH1068*100","v":{"v":6.42427253840307,"d":"6"}},{"$f":"AJ1068+O1068","v":{"v":9.819410175296776,"d":"10"}},{"$f":"(AH1068/M1068*100)-100","v":{"v":1.5075929064881421,"d":"2"}},null,null,"HIPK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","DYRK","HIPK",{"$nulls":5},"CST(pY)LQS(bA)C","Corresponds to amino acid residues C349 to S355; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII. ","Y352 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation site in HIPK1 (≥3356 reports from high throughput mass spectrometry studies).",null,"EC 2.7.1.; Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; CMGC domain target; CMGC</A> group; DYRK family; HIPK subfamily","Q86Z02","Q86Z02","Q86Z02",null,"GO:0005813; GO:0005737; GO:0005829; GO:0016607; GO:0005654; GO:0005634; GO:0016605","GO:0005524; GO:0004674","GO:0034333; GO:0009952; GO:0060216; GO:0048596; GO:0060059; GO:0072577; GO:0097191; GO:0001654; GO:0042771; GO:0061072; GO:0060235; GO:0030182; GO:0045766; GO:0008284; GO:1901796; GO:0006355; GO:0010803; GO:0010842; GO:0007224; GO:0006351"]
[1060,526,"PN605","HMGA1","S36+T39","High mobility group protein HMG-I/HMG-Y",0,13293,14,598,{"v":7940.842,"d":"7941"},{"v":13953.2259036898,"d":"13953"},{"$nulls":3},0,14196,18,605,{"v":8577.69,"d":"8578"},{"v":14987.069491119,"d":"14987"},{"$nulls":6},0,11946,14,615,{"v":7338.18,"d":"7338"},{"v":12554.462144652001,"d":"12554"},{"$nulls":10},"DNA binding protein",{"$nulls":4},"X",{"$nulls":4},"PPV(pS)PG(pT)ALVGC","Corresponds to amino acid residues P33 to G43.","S36 and T39 phosphorylation regulates molecular association, including inducing interaction with DNA. These are two of the minor in vivo phosphorylation sites in HMGA1 (≥64 and ≥27 reports, respectively, from high throughput mass spectrometry studies).","S36: ERK1 (MAPK3); CDK1; CDK2; HIPK2",null,"P17096","P17096",null,"P17096"]
[1066,529,"PN705","HMGCR","S872","3-hydroxy-3-methylglutaryl-coenzyme A reductase",0,6340,12,725,{"v":4587.8,"d":"4588"},{"v":8061.43854782,"d":"8061"},{"$nulls":3},0,5499,10,911,{"v":5000.479,"d":"5000"},{"v":8736.912416032901,"d":"8737"},{"$nulls":6},0,7364,20,711,{"v":5221.584,"d":"5222"},{"v":8933.3020807776,"d":"8933"},{"$nulls":10},"Cholesterol synthesis",{"$nulls":8},"X","HNR(pS)KIN(bA)C","Corresponds to amino acid residues H869 to N875.","The effect of S872 phosphorylation is unclear. This phosphorylation site is not commonly detected by mass spectrometry (≥9 reports), but appears to be the major phosphosite on HMG-CoA reductase.  This phosphosite is not well conserved in vertebrates, but is found in rhesus monkey.","AMPKa1 (PRKAA1); PKACa (PRKACA); PKCa (PRKCA)",null,"P04035","P04035",null,"P04035"]
[1071,532,"PN229","hnRNP-K","S302","Heterogeneous nuclear ribonucleoprotein K",0,60,12,656,{"v":31.488,"d":"31"},{"v":55.329041587199995,"d":"55"},{"$f":"(L1084+L1085)/2","v":{"v":63.2590455469,"d":"63"}},{"$f":"SQRT((M1084-L1084)*(M1084-L1084))","v":{"v":7.930003959700002,"d":"8"}},{"$f":"N1084/M1084*100","v":{"v":12.53576289547513,"d":"13"}},0,120,10,425,{"v":46.75,"d":"47"},{"v":81.682305925,"d":"82"},{"$f":"(U1084+U1085)/2","v":{"v":81.2717103765,"d":"81"}},{"$f":"SQRT((V1084-U1084)*(V1084-U1084))","v":{"v":0.41059554849999813,"d":"0"}},{"$f":"W1084/V1084*100","v":{"v":0.5052133720305255,"d":"1"}},{"$f":"X1084+O1084","v":{"v":13.040976267505656,"d":"13"}},{"$f":"(V1084/M1084*100)-100","v":{"v":28.47444926472292,"d":"28"}},null,0,128,8,382,{"v":45.84,"d":"46"},{"v":78.42496977600001,"d":"78"},{"$f":"(AG1084+AG1085)/2","v":{"v":89.80890845160002,"d":"90"}},{"$f":"SQRT((AH1084-AG1084)*(AH1084-AG1084))","v":{"v":11.383938675600007,"d":"11"}},{"$f":"AI1084/AH1084*100","v":{"v":12.67573436964225,"d":"13"}},{"$f":"AJ1084+O1084","v":{"v":25.21149726511738,"d":"25"}},{"$f":"(AH1084/M1084*100)-100","v":{"v":41.97006558534946,"d":"42"}},{"$nulls":15},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S302 phosphosite.","S302 phosphorylation induces activity and binding to PKCd. This phosphorylation site in hnRNP-K has not apparently been reported from high throughput mass spectrometry studies.","PKCd (PRKCD)","RNA binding protein","P61978","P61978",null,"P61978","GO:0071013; GO:0042995; GO:0005737; GO:0010494; GO:0070062; GO:0005925; GO:0016020; GO:0000790; GO:0005654; GO:0005634; GO:0002102","GO:0045296; GO:0042802; GO:0019904; GO:0003723; GO:0000978; GO:0003697; GO:0001077","GO:0000398; GO:0043066; GO:0048025; GO:0045716; GO:0048260; GO:0045944; GO:1902165; GO:0072369; GO:0010988; GO:0016070; GO:0006396; GO:0007165; GO:0016032"]
[1072,532,"PN229","hnRNP-K","S302","Heterogeneous nuclear ribonucleoprotein K",0,102,8,431,{"v":40.514,"d":"41"},{"v":71.1890495066,"d":"71"},{"$nulls":3},0,114,10,445,{"v":46.28,"d":"46"},{"v":80.861114828,"d":"81"},{"$nulls":6},0,132,8,477,{"v":59.148,"d":"59"},{"v":101.19284712720001,"d":"101"},{"$nulls":20},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S302 phosphosite.","S302 phosphorylation induces activity and binding to PKCd. This phosphorylation site in hnRNP-K has not apparently been reported from high throughput mass spectrometry studies.","PKCd (PRKCD)",null,"P61978","P61978",null,"P61978"]
[1077,535,"PN755","HRAS","Y157","GTPase HRas",0,8688,15,574,{"v":4978.302,"d":"4978"},{"v":8747.6079265638,"d":"8748"},{"$f":"(L1090+L1091)/2","v":{"v":8595.4934765777,"d":"8595"}},{"$f":"SQRT((M1090-L1090)*(M1090-L1090))","v":{"v":152.11444998610023,"d":"152"}},{"$f":"N1090/M1090*100","v":{"v":1.7697000224664785,"d":"2"}},0,9307,14,585,{"v":5436.405,"d":"5436"},{"v":9498.5689057155,"d":"9499"},{"$f":"(U1090+U1091)/2","v":{"v":9020.79730465825,"d":"9021"}},{"$f":"SQRT((V1090-U1090)*(V1090-U1090))","v":{"v":477.7716010572494,"d":"478"}},{"$f":"W1090/V1090*100","v":{"v":5.296334513696842,"d":"5"}},{"$f":"X1090+O1090","v":{"v":7.066034536163321,"d":"7"}},{"$f":"(V1090/M1090*100)-100","v":{"v":4.947986165535269,"d":"5"}},null,0,8408,14,539,{"v":4524.366,"d":"4524"},{"v":7740.4726615524005,"d":"7740"},{"$f":"(AG1090+AG1091)/2","v":{"v":8308.268416225801,"d":"8308"}},{"$f":"SQRT((AH1090-AG1090)*(AH1090-AG1090))","v":{"v":567.7957546734006,"d":"568"}},{"$f":"AI1090/AH1090*100","v":{"v":6.834104607941076,"d":"7"}},{"$f":"AJ1090+O1090","v":{"v":8.603804630407554,"d":"9"}},{"$f":"(AH1090/M1090*100)-100","v":{"v":-3.3415773176324706,"d":"-3"}},{"$nulls":5},"GTPase",{"$nulls":9},"DAF(pY)TLV(bA)C","Corresponds to amino acid residues D154 to V160.","The effect of Y157 phosphorylation is unknown. This phosphosite is found in K- and N-Ras. This is the major in vivo phosphorylation site in HRAS (16 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in red bread mould.","Src","G protein; G protein, monomeric (non-Rab)","P01112","P01112",null,"P01112","GO:0005737; GO:0005829; GO:0098978; GO:0005794; GO:0000139; GO:0005634; GO:0048471; GO:0005886","GO:0019003; GO:0003924; GO:0005525; GO:0008022","GO:0009887; GO:0007050; GO:0008283; GO:0007166; GO:0071480; GO:0090398; GO:0006935; GO:0042832; GO:0006897; GO:0048013; GO:0097193; GO:0000165; GO:0007093; GO:0008285; GO:0010629; GO:0034260; GO:0043524; GO:2000251; GO:0030335; GO:0008284; GO:0045740; GO:0050679; GO:0070374; GO:0043547; GO:0032729; GO:0046330; GO:0043410; GO:0043406; GO:2000630; GO:0010863; GO:0001934; GO:0090314; GO:0046579; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0007265; GO:0048169; GO:0098696; GO:0035900; GO:0007165; GO:0002223; GO:0050852; GO:0042088"]
[1082,537,"PK876","HRI (HCR; EIF2AK1)","S258","Eukaryotic translation initiation factor 2-alpha kinase 1",0,2518,12,500,1253,{"v":2201.7050657,"d":"2202"},{"$nulls":3},0,2718,12,496,{"v":1342.176,"d":"1342"},{"v":2345.0701740576,"d":"2345"},{"$nulls":6},0,2687,10,496,{"v":1327.792,"d":"1328"},{"v":2271.6415241888,"d":"2272"},{"$nulls":7},"HRI","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","PEK",{"$nulls":6},"EVL(pS)DQE(bA)C","Corresponds to amino acid residues E255 to E261. S258 is located in the Gap/Insert 4 (G/I4) region in the protein-serine/threonine kinase catalytic domain of HRI. ","The effect of S258 phosphorylation is unknown. S258 appears to be the most commonly observed phosphosite in HRI from high throughput mass spectrometry studies (~12 reports).",null,null,"Q9BQI3","Q9BQI3","Q9BQI3"]
[1084,538,"NN268-2","HSF1","Pan-specific","Heat shock factor protein 1",0,958,12,252,{"v":238.392,"d":"238"},{"v":418.8897637848,"d":"419"},{"$nulls":3},0,974,12,249,{"v":239.538,"d":"240"},{"v":418.5244106238,"d":"419"},{"$nulls":6},0,816,12,261,{"v":209.844,"d":"210"},{"v":359.0098027416,"d":"359"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X","X",{"$nulls":3},"Epitope undefined.",{"$nulls":4},"Q00613","Q00613"]
[1089,541,"PN041","HSP27 (HSP28; HSPB1)","S78","Heat shock 27 kDa protein beta 1",0,2680,12,274,{"$f":"(H1102-I1102)*J1102/1000","v":{"v":731.032,"d":"731"}},{"v":1284.5306126008,"d":"1285"},{"$f":"(L1102+L1103)/2","v":{"v":1134.8814397154001,"d":"1135"}},{"$f":"SQRT((M1102-L1102)*(M1102-L1102))","v":{"v":149.64917288539982,"d":"150"}},{"$f":"N1102/M1102*100","v":{"v":13.186326575481585,"d":"13"}},0,3270,8,267,{"$f":"(Q1102-R1102)*S1102/1000","v":{"v":870.954,"d":"871"}},{"v":1521.7439802054,"d":"1522"},{"$f":"(U1102+U1103)/2","v":{"v":1237.5891468471,"d":"1238"}},{"$f":"SQRT((V1102-U1102)*(V1102-U1102))","v":{"v":284.15483335830004,"d":"284"}},{"$f":"W1102/V1102*100","v":{"v":22.960352721435623,"d":"23"}},{"$f":"X1102+O1102","v":{"v":36.146679296917206,"d":"36"}},{"$f":"(V1102/M1102*100)-100","v":{"v":9.050082549368014,"d":"9"}},null,0,2640,12,271,{"$f":"(AC1102-AD1102)*AE1102/1000","v":{"v":712.188,"d":"712"}},{"v":1218.4407149832,"d":"1218"},{"$f":"(AG1102+AG1103)/2","v":{"v":1111.8116693075,"d":"1112"}},{"$f":"SQRT((AH1102-AG1102)*(AH1102-AG1102))","v":{"v":106.6290456756999,"d":"107"}},{"$f":"AI1102/AH1102*100","v":{"v":9.590567235376705,"d":"10"}},{"$f":"AJ1102+O1102","v":{"v":22.77689381085829,"d":"23"}},{"$f":"(AH1102/M1102*100)-100","v":{"v":-2.0327912326846445,"d":"-2"}},{"$nulls":5},"Chaperone protein",{"$nulls":5},"X",{"$nulls":3},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S78 phosphosite.","S78 phosphorylation inhibits interaction with HSF1, TRAF6, and hnRNP D0, and induces interaction with TPM1. It regulates apoptosis, cell cycle progression, cell growth, cytoskeletal reorganization, transcription, alters conformation, alters intracellular location, induces enzymatic activation, phosphorylation, molecular association, sumoylation, and ubiquitination. This is one of the major in vivo phosphorylation sites in HSP27 (≥51 reports from high throughput mass spectrometry studies).","MAPKAPK2; MAPKAPK5 (PRAK); p70S6K (RPS6KB1); PKACa (PRKACA); PKG1 (PRKG1); RSK2 (RPS6KA3)","Chaperone protein","P04792","P04792",null,"P04792","GO:1904115; GO:0005737; GO:0005856; GO:0005829; GO:0070062; GO:0005615; GO:0005925; GO:0005634; GO:0005886; GO:0000502; GO:0005819; GO:0030018","GO:0042802; GO:0044183; GO:0042803; GO:0019901; GO:0005080; GO:0008426; GO:0003723; GO:0043130","GO:0099641; GO:0035924; GO:0061077; GO:0035556; GO:0043066; GO:1902176; GO:0006469; GO:0070527; GO:0045766; GO:0043536; GO:2001028; GO:0038033; GO:0032731; GO:0042535; GO:0010506; GO:0043122; GO:0043488; GO:0001932; GO:0006446; GO:0006986; GO:0009615; GO:0001895"]
[1094,543,"NN061","HSP90a (HSP90AA1; HSP90; HSP86; HSPC; HSPCA; LAP2)","Pan-specific","Heat shock 90 kDa protein alpha",0,886,12,490,{"v":428.26,"d":"428"},{"v":752.515731394,"d":"753"},{"$nulls":3},0,915,12,504,{"v":455.112,"d":"455"},{"v":795.1785585912,"d":"795"},{"$nulls":6},0,1084,13,507,{"v":542.997,"d":"543"},{"$f":"AF1107*1.7108414","v":{"v":928.9817476758,"d":"929"}},{"$nulls":10},"Chaperone protein",{"$nulls":5},"X",{"$nulls":3},"Not precisely defined.","Antibody raised against amino acid residues 610-723 of human HSP90β.",{"$nulls":3},"P07900","P07900",null,"P07900"]
[1099,546,"NN422-1","Huntingtin","Pan-specific","Huntington's disease protein",0,80,8,322,{"v":23.184,"d":"23"},{"v":40.737693729600004,"d":"41"},{"$f":"(L1112+L1113)/2","v":{"v":38.7837463768,"d":"39"}},{"$f":"SQRT((M1112-L1112)*(M1112-L1112))","v":{"v":1.9539473528000002,"d":"2"}},{"$f":"N1112/M1112*100","v":{"v":5.03805726712577,"d":"5"}},0,112,6,392,{"v":41.552,"d":"42"},{"v":72.6002818352,"d":"73"},{"$f":"(U1112+U1113)/2","v":{"v":66.3295268413,"d":"66"}},{"$f":"SQRT((V1112-U1112)*(V1112-U1112))","v":{"v":6.270754993899999,"d":"6"}},{"$f":"W1112/V1112*100","v":{"v":9.45394199615415,"d":"9"}},{"$f":"X1112+O1112","v":{"v":14.491999263279919,"d":"14"}},{"$f":"(V1112/M1112*100)-100","v":{"v":71.02403206972693,"d":"71"}},null,0,146,10,308,{"v":41.888,"d":"42"},{"v":71.6637245632,"d":"72"},{"$f":"(AG1112+AG1113)/2","v":{"v":93.8020122792,"d":"94"}},{"$f":"SQRT((AH1112-AG1112)*(AH1112-AG1112))","v":{"v":22.138287715999994,"d":"22"}},{"$f":"AI1112/AH1112*100","v":{"v":23.60107974027868,"d":"24"}},{"$f":"AJ1112+O1112","v":{"v":28.63913700740445,"d":"29"}},{"$f":"(AH1112/M1112*100)-100","v":{"v":141.85908026490011,"d":"142"}},{"$nulls":15},"Not precisely defined.","Antibody raised against amino acid residues 997-1276 of mouse Huntingtin.",null,null,"Cytoskeletal protein","P42858","P42858",null,"P42858","GO:0005776; GO:0030424; GO:0005814; GO:0005737; GO:0030659; GO:0005829; GO:0030425; GO:0005783; GO:0005794; GO:0016234; GO:0005770; GO:0005654; GO:0005634; GO:0048471; GO:0099524; GO:0099523; GO:0032991","GO:0048487; GO:0034452; GO:0045505; GO:0031072; GO:0042802; GO:0044325; GO:0019900; GO:0002039; GO:0005522; GO:0008134","GO:0048513; GO:0006915; GO:0000132; GO:0007030; GO:2001237; GO:1905337; GO:0043065; GO:1903599; GO:0045724; GO:0031587; GO:1904504; GO:0031648; GO:1905289; GO:2000479; GO:0043666; GO:0006890; GO:0047496; GO:0042297"]
[1104,548,"NK073-2","ICK","Pan-specific","Intestinal cell (MAK-like) kinase",0,464,10,434,{"v":197.036,"d":"197"},{"v":346.2211965884,"d":"346"},{"$nulls":3},0,429,6,438,{"v":185.274,"d":"185"},{"v":323.7135304374,"d":"324"},{"$nulls":6},0,519,12,494,{"v":250.458,"d":"250"},{"v":428.49391536120004,"d":"428"},{"$nulls":7},"ICK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","RCK",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 579-611 near the C-terminus of mouse ICK.",{"$nulls":3},"Q9UPZ9","Q9UPZ9","Q9UPZ9"]
[1107,550,"PK656","ICK","Y159","Intestinal cell (MAK-like) kinase",0,4342,20,576,{"v":2489.472,"d":"2489"},{"v":4374.3680074368,"d":"4374"},{"$f":"(L1120+L1121)/2","v":{"v":4532.9751152184,"d":"4533"}},{"$f":"SQRT((M1120-L1120)*(M1120-L1120))","v":{"v":158.60710778159955,"d":"159"}},{"$f":"N1120/M1120*100","v":{"v":3.4989626845537587,"d":"3"}},0,5285,18,608,{"v":3202.336,"d":"3202"},{"v":5595.1698144736,"d":"5595"},{"$f":"(U1120+U1121)/2","v":{"v":5209.6223416472,"d":"5210"}},{"$f":"SQRT((V1120-U1120)*(V1120-U1120))","v":{"v":385.5474728263998,"d":"386"}},{"$f":"W1120/V1120*100","v":{"v":7.400679886989578,"d":"7"}},{"$f":"X1120+O1120","v":{"v":10.899642571543337,"d":"11"}},{"$f":"(V1120/M1120*100)-100","v":{"v":14.927221289106924,"d":"15"}},null,0,4848,12,603,{"v":2916.108,"d":"2916"},{"v":4988.9982932712,"d":"4989"},{"$f":"(AG1120+AG1121)/2","v":{"v":4748.785895662801,"d":"4749"}},{"$f":"SQRT((AH1120-AG1120)*(AH1120-AG1120))","v":{"v":240.21239760839944,"d":"240"}},{"$f":"AI1120/AH1120*100","v":{"v":5.0583960381914075,"d":"5"}},{"$f":"AJ1120+O1120","v":{"v":8.557358722745166,"d":"9"}},{"$f":"(AH1120/M1120*100)-100","v":{"v":4.76090812234699,"d":"5"}},null,null,"ICK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","RCK",{"$nulls":6},"YTD(pY)VST(bA)C","Corresponds to amino acid residues Y156 to T162; In the protein kinase catalytic domain in subdomain I.","Y159 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in ICK (≥448 reports from high throughput mass spectrometry studies).","ICK","EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC domain target; CMGC</A> group; RCK family","Q9UPZ9","Q9UPZ9","Q9UPZ9",null,"GO:0036064; GO:0097546; GO:0097542; GO:0005929; GO:0005737; GO:0005829; GO:0001650; GO:0005634","GO:0005524; GO:0000287; GO:0004672; GO:0004674","GO:0060271; GO:0035556; GO:0035720; GO:0035721; GO:0042073; GO:0007275; GO:0006468; GO:0010468; GO:0007165"]
[1111,552,"PN757","IDH1","Y391","Isocitrate dehydrogenase [NADP] cytoplasmic",0,6744,18,605,{"v":4069.23,"d":"4069"},{"v":7150.234879887,"d":"7150"},{"$f":"(L1124+L1125)/2","v":{"v":7299.7909239867,"d":"7300"}},{"$f":"SQRT((M1124-L1124)*(M1124-L1124))","v":{"v":149.55604409970056,"d":"150"}},{"$f":"N1124/M1124*100","v":{"v":2.0487716108178913,"d":"2"}},0,7854,18,608,{"v":4764.288,"d":"4764"},{"v":8324.235934348799,"d":"8324"},{"$f":"(U1124+U1125)/2","v":{"v":7983.9413326123995,"d":"7984"}},{"$f":"SQRT((V1124-U1124)*(V1124-U1124))","v":{"v":340.2946017363993,"d":"340"}},{"$f":"W1124/V1124*100","v":{"v":4.262238255012986,"d":"4"}},{"$f":"X1124+O1124","v":{"v":6.3110098658308775,"d":"6"}},{"$f":"(V1124/M1124*100)-100","v":{"v":9.372191830558037,"d":"9"}},null,0,7710,18,671,{"v":5161.332,"d":"5161"},{"v":8830.220464744802,"d":"8830"},{"$f":"(AG1124+AG1125)/2","v":{"v":8164.080413875201,"d":"8164"}},{"$f":"SQRT((AH1124-AG1124)*(AH1124-AG1124))","v":{"v":666.1400508696006,"d":"666"}},{"$f":"AI1124/AH1124*100","v":{"v":8.159400901263385,"d":"8"}},{"$f":"AJ1124+O1124","v":{"v":10.208172512081276,"d":"10"}},{"$f":"(AH1124/M1124*100)-100","v":{"v":11.839921155118205,"d":"12"}},{"$nulls":5},"Carbohydrate Metabolism - citrate (TCA) cycle",{"$nulls":8},"X","RSD(pY)LNT(bA)C","Corresponds to amino acid residues R388 to T394.","The effect of Y391 phosphorylation is unclear. This is the major in vivo phosphorylation site in IDH1 (≥34 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in sea urchin.",null,"Carbohydrate Metabolism - citrate (TCA) cycle; EC 1.1.1.42; Other Amino Acids Metabolism - glutathione; Oxidoreductase","O75874","O75874",null,"O75874","GO:0005737; GO:0005829; GO:0070062; GO:0005576; GO:1904813; GO:0005739; GO:0005782; GO:0005777; GO:0034774; GO:1904724","GO:0051990; GO:0045296; GO:0042802; GO:0004450; GO:0000287; GO:0051287; GO:0050661; GO:0042803; GO:0005102","GO:0006103; GO:0008585; GO:0006749; GO:0006097; GO:0006102; GO:0006740; GO:0043312; GO:0006625; GO:0071071; GO:0060696; GO:0006979; GO:0048545; GO:0006099"]
[1116,554,"NK074-2","IGF1R","Pan-specific","Insulin-like growth factor 1 receptor protein-tyrosine kinase",0,574,12,506,{"v":284.372,"d":"284"},{"v":499.68337824680003,"d":"500"},{"$nulls":3},0,662,8,537,{"v":351.198,"d":"351"},{"v":613.6184486898,"d":"614"},{"$nulls":6},0,724,14,538,{"v":381.98,"d":"382"},{"v":653.5071979720001,"d":"654"},{"$nulls":7},"IGF1R","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","InsR",{"$nulls":6},"VIMLYVFHRKRNNSRLGC","Corresponds to amino acid residues V952 to G968; Just before kinase catalytic domain.",{"$nulls":3},"P08069","P08069","P08069","P08069"]
[1121,557,"PK658","IGF1R","Y1346","Insulin-like growth factor 1 receptor",0,2554,12,593,{"v":1507.406,"d":"1507"},{"v":2648.7337799414,"d":"2649"},{"$f":"(L1134+L1135)/2","v":{"v":2625.5411980083,"d":"2626"}},{"$f":"SQRT((M1134-L1134)*(M1134-L1134))","v":{"v":23.192581933099973,"d":"23"}},{"$f":"N1134/M1134*100","v":{"v":0.8833448109933887,"d":"1"}},0,2937,16,618,{"v":1805.178,"d":"1805"},{"v":3154.0342597878002,"d":"3154"},{"$f":"(U1134+U1135)/2","v":{"v":2839.5407834331,"d":"2840"}},{"$f":"SQRT((V1134-U1134)*(V1134-U1134))","v":{"v":314.4934763547003,"d":"314"}},{"$f":"W1134/V1134*100","v":{"v":11.07550482069383,"d":"11"}},{"$f":"X1134+O1134","v":{"v":11.958849631687219,"d":"12"}},{"$f":"(V1134/M1134*100)-100","v":{"v":8.150684726910299,"d":"8"}},null,0,2432,12,647,{"v":1565.74,"d":"1566"},{"v":2678.732813636,"d":"2679"},{"$f":"(AG1134+AG1135)/2","v":{"v":2508.77782896,"d":"2509"}},{"$f":"SQRT((AH1134-AG1134)*(AH1134-AG1134))","v":{"v":169.9549846760001,"d":"170"}},{"$f":"AI1134/AH1134*100","v":{"v":6.774413529732683,"d":"7"}},{"$f":"AJ1134+O1134","v":{"v":7.657758340726072,"d":"8"}},{"$f":"(AH1134/M1134*100)-100","v":{"v":-4.447211460131527,"d":"-4"}},null,null,"IGF1R","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","InsR",{"$nulls":6},"RQP(pY)AHM(bA)C","Corresponds to amino acid residues R1343 to M1349; In the C-terminal of the kinase after the catalytic domain.","Y1346 phosphorylation stimulates phosphotransferase activity and induces binding to Grb10. Phosphorylation regulates cell differentiation, cell growth, molecular association and protein interaction. This is one of the major in vivo phosphorylation sites in IGF1R.","IGF1R; Src","EC 2.7.10.1; Receptor tyrosine kinase; TK domain target; TK</A> group; InsR family","P08069","P08069","P08069","P08069","GO:0035867; GO:0005887; GO:0043231; GO:0016020; GO:0005886; GO:0043235","GO:0005524; GO:0042802; GO:0043559; GO:0005010; GO:0005520; GO:0031994; GO:0005158; GO:0043560; GO:0043548; GO:0004713","GO:0097242; GO:1904646; GO:0097062; GO:0006955; GO:0051389; GO:0048009; GO:0008286; GO:0043066; GO:0038083; GO:0014065; GO:0048015; GO:0030335; GO:0008284; GO:0120162; GO:0043243; GO:0046777; GO:0051262; GO:0046328; GO:0007165"]
[1125,559,"PN232","IkBa","S32","Inhibitor of NF-kappa-B alpha (MAD3)",0,34,4,655,{"v":19.65,"d":"20"},{"v":34.527936585,"d":"35"},{"$f":"(L1138+L1139)/2","v":{"v":62.4050721535,"d":"62"}},{"$f":"SQRT((M1138-L1138)*(M1138-L1138))","v":{"v":27.8771355685,"d":"28"}},{"$f":"N1138/M1138*100","v":{"v":44.67126566239617,"d":"45"}},0,146,8,428,{"v":59.064,"d":"59"},{"v":103.1975126664,"d":"103"},{"$f":"(U1138+U1139)/2","v":{"v":88.2902734332,"d":"88"}},{"$f":"SQRT((V1138-U1138)*(V1138-U1138))","v":{"v":14.907239233200002,"d":"15"}},{"$f":"W1138/V1138*100","v":{"v":16.884350510567565,"d":"17"}},{"$f":"X1138+O1138","v":{"v":61.55561617296374,"d":"62"}},{"$f":"(V1138/M1138*100)-100","v":{"v":41.479322732019654,"d":"41"}},null,0,52,8,660,{"v":29.04,"d":"29"},{"v":49.682834256,"d":"50"},{"$f":"(AG1138+AG1139)/2","v":{"v":83.326530387,"d":"83"}},{"$f":"SQRT((AH1138-AG1138)*(AH1138-AG1138))","v":{"v":33.643696131000006,"d":"34"}},{"$f":"AI1138/AH1138*100","v":{"v":40.37573144441023,"d":"40"}},{"$f":"AJ1138+O1138","v":{"v":85.0469971068064,"d":"85"}},{"$f":"(AH1138/M1138*100)-100","v":{"v":33.525252854509546,"d":"34"}},{"$nulls":15},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S32 phosphosite.","S32 phosphorylation induces release of the inhibitory protein and facilitates it degradation. It also induces interaction with AurC. This is one of the major in vivo phosphorylation sites in IkBa (≥19 reports from high throughput mass spectrometry studies).","AUKC, CK2a1 (CSNK2A1); ERK7 (MAPK15); IKKa (CHUK, IKBKA); IKKb (IKBKB); IKKe (IKBKE); NIK (MAP3K14); PKR (EIF2AK2); RSK1 (RPS6KA1); RSK2 (RPS6KA3); SGK1","Inhibitor protein","P25963","P25963",null,"P25963","GO:0005737; GO:0005829; GO:0033256; GO:0005622; GO:0005654; GO:0005634; GO:0005886","GO:0019899; GO:0031072; GO:0042802; GO:0051059; GO:0008139; GO:0044877; GO:0008134; GO:0031625","GO:0006915; GO:0070417; GO:0071407; GO:0007253; GO:0042994; GO:0007249; GO:0070498; GO:0031663; GO:0097421; GO:0043066; GO:0043392; GO:0010888; GO:0010745; GO:0045638; GO:0032088; GO:0045746; GO:0070427; GO:0070431; GO:0032270; GO:0010875; GO:0050729; GO:0045944; GO:0016579; GO:0000060; GO:0042127; GO:1901222; GO:0043330; GO:0032495; GO:0035994; GO:0034142; GO:0033209; GO:0016032"]
[1128,560,"PN164","IkBa","Y42","Inhibitor of NF-kappa-B alpha (MAD3)",0,483,10,174,{"v":82.302,"d":"82"},{"v":144.6167041638,"d":"145"},{"$nulls":3},0,420,10,189,{"v":77.49,"d":"77"},{"v":135.391698099,"d":"135"},{"$nulls":6},0,452,10,198,{"v":87.516,"d":"88"},{"v":149.72599596240002,"d":"150"},{"$nulls":20},"EE(pY)EQ","Corresponds to amino acid residues E40 to Q44.","Y42 phosphorylation inhibits inhibitory action (induces transcription) and binding to NFkB-p65 and facilitates degradation of IkBa. This is one of the major in vivo phosphorylation sites in IkBa (≥27 reports from high throughput mass spectrometry studies).","InsR; Lck; Src",null,"P25963","P25963",null,"P25963"]
[1133,563,"PK659","IKKa (IkBKA)","T179+S180","Inhibitor of NF-kappa-B protein-serine kinase alpha (CHUK)",0,13032,18,650,{"v":8459.1,"d":"8459"},{"v":14863.88134179,"d":"14864"},{"$f":"(L1146+L1147)/2","v":{"v":16159.6998660764,"d":"16160"}},{"$f":"SQRT((M1146-L1146)*(M1146-L1146))","v":{"v":1295.8185242864001,"d":"1296"}},{"$f":"N1146/M1146*100","v":{"v":8.0188279177553,"d":"8"}},0,16563,15,685,{"v":11335.38,"d":"11335"},{"v":19805.347100238,"d":"19805"},{"$f":"(U1146+U1147)/2","v":{"v":19173.667689059497,"d":"19174"}},{"$f":"SQRT((V1146-U1146)*(V1146-U1146))","v":{"v":631.679411178502,"d":"632"}},{"$f":"W1146/V1146*100","v":{"v":3.2945152770063837,"d":"3"}},{"$f":"X1146+O1146","v":{"v":11.313343194761682,"d":"11"}},{"$f":"(V1146/M1146*100)-100","v":{"v":18.651137384737154,"d":"19"}},null,0,11665,18,679,{"v":7908.313,"d":"7908"},{"v":13529.8692845582,"d":"13530"},{"$f":"(AG1146+AG1147)/2","v":{"v":13699.464137119501,"d":"13699"}},{"$f":"SQRT((AH1146-AG1146)*(AH1146-AG1146))","v":{"v":169.59485256130029,"d":"170"}},{"$f":"AI1146/AH1146*100","v":{"v":1.2379670537752867,"d":"1"}},{"$f":"AJ1146+O1146","v":{"v":9.256794971530585,"d":"9"}},{"$f":"(AH1146/M1146*100)-100","v":{"v":-15.22451375549123,"d":"-15"}},null,null,"IKKa","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","IKK",{"$nulls":6},"CC(pT)(pS)FVGT","Corresponds to amino acid residues C177 to T184; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T179 and S180 phosphorylation stimulate phosphotransferase activity and regulates chromatin organization, transcription, molecular association and ubiquitination. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. However, these two phosphorylation sites in IKKa have apparently not been reported in high throughput mass spectrometry studies.","S180: NIK (MAP3K14)","Protein-serine kinase, Other group, IKK family","O15111","O15111","O15111",null,"GO:0035631; GO:0005737; GO:0009898; GO:0005829; GO:0008385; GO:0043231; GO:0005654","GO:0005524; GO:0008384; GO:0046982; GO:0042803; GO:0004672; GO:0097110","GO:0009653; GO:0002479; GO:0071276; GO:0034614; GO:0071356; GO:0098586; GO:0038095; GO:0007249; GO:0007252; GO:0006955; GO:0006954; GO:0045087; GO:0070498; GO:0002756; GO:0032088; GO:0038061; GO:0018105; GO:0043123; GO:1902741; GO:0051092; GO:0045893; GO:0045944; GO:0006468; GO:0010803; GO:0010034; GO:0043200; GO:0042493; GO:0033194; GO:0032496; GO:0009636; GO:0009615; GO:0007266; GO:0003009; GO:0002223; GO:0051403; GO:0051146; GO:0050852; GO:0035666; GO:0033209"]
[1138,580,"NK076-5","IKKb (IkBKB)","Pan-specific","Inhibitor of nuclear factor kappa B kinase beta subunit",0,8266,16,656,5412,{"v":9509.679022799999,"d":"9510"},{"$nulls":3},0,8142,14,620,{"v":5039.36,"d":"5039"},{"v":8804.845886336,"d":"8805"},{"$nulls":6},0,8540,16,610,{"v":5199.64,"d":"5200"},{"v":8895.759377096001,"d":"8896"},{"$nulls":7},"IKKb","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","IKK",{"$nulls":6},"CTLLENAIQDTVREQDQSFT","Corresponds to amino acid residues C716 to T735; Pre-C-terminus.",{"$nulls":3},"O14920","O14920","O14920"]
[1139,565,"PK660","IKKe (IkBKE)","S172","Inhibitor of nuclear factor kappa-B kinase subunit epsilon",0,7173,16,603,{"v":4315.671,"d":"4316"},{"v":7583.2679190699,"d":"7583"},{"$f":"(L1152+L1153)/2","v":{"v":7893.939398150949,"d":"7894"}},{"$f":"SQRT((M1152-L1152)*(M1152-L1152))","v":{"v":310.67147908104926,"d":"311"}},{"$f":"N1152/M1152*100","v":{"v":3.935569598543155,"d":"4"}},0,7495,16,621,{"v":4644.459,"d":"4644"},{"v":8114.8688961309,"d":"8115"},{"$f":"(U1152+U1153)/2","v":{"v":7986.38306571465,"d":"7986"}},{"$f":"SQRT((V1152-U1152)*(V1152-U1152))","v":{"v":128.48583041624988,"d":"128"}},{"$f":"W1152/V1152*100","v":{"v":1.608811264862018,"d":"2"}},{"$f":"X1152+O1152","v":{"v":5.544380863405173,"d":"6"}},{"$f":"(V1152/M1152*100)-100","v":{"v":1.1710714118904377,"d":"1"}},null,0,7942,14,617,{"v":4891.576,"d":"4892"},{"v":8368.7107320464,"d":"8369"},{"$f":"(AG1152+AG1153)/2","v":{"v":8299.531149196,"d":"8300"}},{"$f":"SQRT((AH1152-AG1152)*(AH1152-AG1152))","v":{"v":69.17958285040004,"d":"69"}},{"$f":"AI1152/AH1152*100","v":{"v":0.8335360348289272,"d":"1"}},{"$f":"AJ1152+O1152","v":{"v":4.7691056333720825,"d":"5"}},{"$f":"(AH1152/M1152*100)-100","v":{"v":5.138014501860198,"d":"5"}},null,null,"IKKe","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","IKK",{"$nulls":6},"KFV(pS)VYG(bA)C","Corresponds to amino acid residues K169 to G175; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S172 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the less major in vivo phosphorylation sites in IKKe (≥4 reports from high throughput mass spectrometry studies).","IKKe (IKBKE)","Protein-serine kinase, Other group, IKK family","Q14164","Q14164","Q14164","Q14164","GO:0005737; GO:0005829; GO:0010008; GO:0031966; GO:0005654; GO:0005634; GO:0016605","GO:0005524; GO:0008384; GO:0036435; GO:0004704; GO:0004672; GO:0031625","GO:0098586; GO:0006955; GO:0045087; GO:0008630; GO:0032480; GO:0018105; GO:0043123; GO:0010884; GO:0051260; GO:0006468; GO:0035456; GO:0034340; GO:0035666"]
[1143,567,"PK189","IKKg (NEMO)","S376","I-kappa-B kinase gamma/NF-kappa-B essential modulator",0,210,10,465,93,{"v":163.41466169999998,"d":"163"},{"$f":"(L1156+L1157)/2","v":{"v":159.41803107594998,"d":"159"}},{"$f":"SQRT((M1156-L1156)*(M1156-L1156))","v":{"v":3.996630624049999,"d":"4"}},{"$f":"N1156/M1156*100","v":{"v":2.5070129125769487,"d":"3"}},0,215,10,472,{"v":96.76,"d":"97"},{"v":169.060533076,"d":"169"},{"$f":"(U1156+U1157)/2","v":{"v":158.2732270486,"d":"158"}},{"$f":"SQRT((V1156-U1156)*(V1156-U1156))","v":{"v":10.787306027400007,"d":"11"}},{"$f":"W1156/V1156*100","v":{"v":6.815622723158107,"d":"7"}},{"$f":"X1156+O1156","v":{"v":9.322635635735056,"d":"9"}},{"$f":"(V1156/M1156*100)-100","v":{"v":-0.7181145191816825,"d":"-1"}},null,0,222,12,456,{"v":95.76,"d":"96"},{"v":163.83017246400001,"d":"164"},{"$f":"(AG1156+AG1157)/2","v":{"v":180.86673112520003,"d":"181"}},{"$f":"SQRT((AH1156-AG1156)*(AH1156-AG1156))","v":{"v":17.03655866120002,"d":"17"}},{"$f":"AI1156/AH1156*100","v":{"v":9.419398777880787,"d":"9"}},{"$f":"AJ1156+O1156","v":{"v":11.926411690457735,"d":"12"}},{"$f":"(AH1156/M1156*100)-100","v":{"v":13.454375207426466,"d":"13"}},{"$nulls":5},"Regulatory subunit IKK",{"$nulls":7},"X",null,"Not precisely defined.","Antibody raised against amino acid residues that encompass the S376 phosphosite.","The effect of S376 phosphorylation is unclear. This is one of the minor in vivo phosphorylation sites in IKKg (≥8 reports from high throughput mass spectrometry studies). This human phosphosite is not conserved in vertebrates, but is found in the chimpanzee.","IKKb (IKBKB)","Adaptor/scaffold, Protein kinase, regulatory subunit","Q9Y6K9","Q9Y6K9",null,"Q9Y6K9","GO:0005737; GO:0005829; GO:0008385; GO:0005622; GO:0072686; GO:0005654; GO:0005634; GO:0000922; GO:0000151","GO:0042802; GO:0070530; GO:1990450; GO:0046872; GO:0042975; GO:0019904; GO:0046982; GO:0042803; GO:0031625","GO:0000187; GO:0043276; GO:0002479; GO:0006915; GO:0006974; GO:0051650; GO:0038095; GO:0007249; GO:0006955; GO:0006954; GO:0045087; GO:0070498; GO:0007254; GO:0002756; GO:1901215; GO:0070423; GO:0043123; GO:0016239; GO:0051092; GO:0045944; GO:0016579; GO:0010803; GO:0009615; GO:0002223; GO:0051403; GO:0050852; GO:0006351; GO:0035666; GO:0016032"]
[1150,482,"PN227","IL6ST (GP130)","S782","Interleukin-6 receptor subunit beta",0,228,16,424,{"v":89.888,"d":"90"},{"v":157.9464205472,"d":"158"},{"$nulls":3},0,181,16,367,{"v":60.555,"d":"61"},{"v":105.8026103805,"d":"106"},{"$nulls":6},0,276,14,503,{"v":131.786,"d":"132"},{"v":225.4649447404,"d":"225"},{"$nulls":20},"Not precisely defined.","Antibody raised against amino acid residues 768-789 Ser 782 of human gp130.","S782 phosphorylation phosphorylation induces receptor internalization and protein degradation. This is one of the minor  in vivo phosphorylation sites in IL6ST (≥3 reports from high throughput mass spectrometry studies).","CaMK2a; CaMK4",null,"P40189","P40189",null,"P40189"]
[1155,572,"PK662","ILK1 (ILK)","Y351","Integrin-linked protein-serine kinase-1",0,178,8,256,{"v":43.52,"d":"44"},{"v":76.471033088,"d":"76"},{"$f":"(L1168+L1169)/2","v":{"v":58.284562672999996,"d":"58"}},{"$f":"SQRT((M1168-L1168)*(M1168-L1168))","v":{"v":18.186470415000002,"d":"18"}},{"$f":"N1168/M1168*100","v":{"v":31.202894181489306,"d":"31"}},0,168,12,281,{"v":43.836,"d":"44"},{"v":76.5909211236,"d":"77"},{"$f":"(U1168+U1169)/2","v":{"v":67.4494917204,"d":"67"}},{"$f":"SQRT((V1168-U1168)*(V1168-U1168))","v":{"v":9.141429403199993,"d":"9"}},{"$f":"W1168/V1168*100","v":{"v":13.55299968915137,"d":"14"}},{"$f":"X1168+O1168","v":{"v":44.755893870640676,"d":"45"}},{"$f":"(V1168/M1168*100)-100","v":{"v":15.724453658199295,"d":"16"}},null,0,208,10,285,{"v":56.43,"d":"56"},{"v":96.542780202,"d":"97"},{"$f":"(AG1168+AG1169)/2","v":{"v":94.0945661586,"d":"94"}},{"$f":"SQRT((AH1168-AG1168)*(AH1168-AG1168))","v":{"v":2.4482140434,"d":"2"}},{"$f":"AI1168/AH1168*100","v":{"v":2.6018654884634267,"d":"3"}},{"$f":"AJ1168+O1168","v":{"v":33.80475966995273,"d":"34"}},{"$f":"(AH1168/M1168*100)-100","v":{"v":61.43994540459818,"d":"61"}},null,null,"ILK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","MLK","ILK",{"$nulls":5},"GRM(pY)APA(bA)C","Corresponds to amino acid residues G348 to A354; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y351 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation of this site in ILK1 has apparently not been reported from high throughput mass spectrometry studies.",null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); TKL domain target; TKL</A> group; MLK family; ILK subfamily","Q13418","Q13418","Q13418","Q13418","GO:0005911; GO:0030054; GO:0043034; GO:0005737; GO:0005829; GO:0043198; GO:0005925; GO:0030027; GO:0016020; GO:0043025; GO:0005654; GO:0005886; GO:0032991; GO:0030017; GO:0001725; GO:0043195","GO:0005524; GO:0005178; GO:0019901; GO:0004674; GO:0017124","GO:0001658; GO:0007569; GO:0007050; GO:0034329; GO:0007160; GO:0008283; GO:0045197; GO:0010761; GO:0007229; GO:0000165; GO:0007275; GO:0032288; GO:0022011; GO:0010667; GO:2000178; GO:0043524; GO:0006469; GO:0014912; GO:0048662; GO:0021675; GO:0048812; GO:0003151; GO:0018105; GO:0070527; GO:0045773; GO:0030513; GO:0090263; GO:0001954; GO:0030335; GO:0008284; GO:0050775; GO:0043406; GO:0045663; GO:1901224; GO:0045669; GO:0042327; GO:0051897; GO:0001934; GO:0009967; GO:0045893; GO:0051291; GO:0043491; GO:0006468; GO:0032956; GO:0034446; GO:0097435; GO:0033209"]
[1156,572,"PK662","ILK1 (ILK)","Y351","Integrin-linked protein-serine kinase-1",0,40,5,652,{"v":22.82,"d":"23"},{"v":40.098092258,"d":"40"},{"$nulls":3},0,116,8,309,{"v":33.372,"d":"33"},{"v":58.3080623172,"d":"58"},{"$nulls":6},0,152,8,372,{"v":53.568,"d":"54"},{"v":91.6463521152,"d":"92"},{"$nulls":7},"ILK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","MLK","ILK",{"$nulls":5},"GRM(pY)APA(bA)C","Corresponds to amino acid residues G348 to A354; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y351 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation of this site in ILK1 has apparently not been reported from high throughput mass spectrometry studies.",null,null,"Q13418","Q13418","Q13418","Q13418"]
[1161,575,"PK663","InsR (IR)","Y1189","Insulin receptor",0,3736,12,668,{"v":2487.632,"d":"2488"},{"v":4371.1348571408,"d":"4371"},{"$f":"(L1174+L1175)/2","v":{"v":4464.1476711454,"d":"4464"}},{"$f":"SQRT((M1174-L1174)*(M1174-L1174))","v":{"v":93.01281400459993,"d":"93"}},{"$f":"N1174/M1174*100","v":{"v":2.0835514605800425,"d":"2"}},0,4249,16,683,{"v":2891.139,"d":"2891"},{"v":5051.4417169989,"d":"5051"},{"$f":"(U1174+U1175)/2","v":{"v":4813.3688082955505,"d":"4813"}},{"$f":"SQRT((V1174-U1174)*(V1174-U1174))","v":{"v":238.07290870334964,"d":"238"}},{"$f":"W1174/V1174*100","v":{"v":4.946076608404604,"d":"5"}},{"$f":"X1174+O1174","v":{"v":7.029628068984646,"d":"7"}},{"$f":"(V1174/M1174*100)-100","v":{"v":7.822795366008762,"d":"8"}},null,0,4192,16,693,{"v":2893.968,"d":"2894"},{"v":4951.1202646752,"d":"4951"},{"$f":"(AG1174+AG1175)/2","v":{"v":4716.4518486235,"d":"4716"}},{"$f":"SQRT((AH1174-AG1174)*(AH1174-AG1174))","v":{"v":234.66841605169975,"d":"235"}},{"$f":"AI1174/AH1174*100","v":{"v":4.975528714878917,"d":"5"}},{"$f":"AJ1174+O1174","v":{"v":7.059080175458959,"d":"7"}},{"$f":"(AH1174/M1174*100)-100","v":{"v":5.651788338206231,"d":"6"}},null,null,"INSR","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK","InsR",{"$nulls":6},"ETD(pY)YRK(bA)C","Corresponds to amino acid residues E1186 to K1192; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y1189 phosphorylation stimulates phosphotransferase activity, receptor internalization and induces interaction with APS, GRB7, SOCS1, IRS2 and PTP1B. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation site in the insulin receptor (≥719 reports from high throughput mass spectrometry studies).","InsR","Receptor tyrosine kinase; EC 2.7.10.1; TK group; InsR family","P06213","P06213","P06213",null,"GO:0005901; GO:0032590; GO:0010008; GO:0009897; GO:0070062; GO:0005899; GO:0005887; GO:0005622; GO:0016020; GO:0032809; GO:0005886; GO:0043235","GO:0001540; GO:0005524; GO:0005525; GO:0042802; GO:0005009; GO:0043559; GO:0031994; GO:0031995; GO:0005159; GO:0043560; GO:0043548; GO:0044877; GO:0019904; GO:0004713; GO:0051425","GO:0000187; GO:0032147; GO:0032148; GO:0030325; GO:0097242; GO:0005975; GO:0071363; GO:0032869; GO:0097062; GO:0008544; GO:0031017; GO:0042593; GO:0007186; GO:0003007; GO:0008286; GO:0007612; GO:0008584; GO:0030238; GO:0007613; GO:1990535; GO:0038083; GO:0018108; GO:0030335; GO:0008284; GO:0048639; GO:0046326; GO:0045725; GO:0045821; GO:0043410; GO:0051446; GO:0045840; GO:0045429; GO:0043243; GO:0051897; GO:0001934; GO:0060267; GO:0045893; GO:0046777; GO:0051290; GO:0006468; GO:0045995; GO:2000194; GO:0006355; GO:0019087"]
[1166,579,"PK664","IRAK1","T387","Interleukin 1 receptor-associated kinase 1 (Pelle-like protein kinase)",0,10382,12,709,{"v":7352.33,"d":"7352"},{"v":12919.123867277,"d":"12919"},{"$nulls":3},0,9421,12,679,{"v":6388.711,"d":"6389"},{"v":11162.4523287361,"d":"11162"},{"$nulls":6},0,10146,12,695,{"v":7043.13,"d":"7043"},{"v":12049.678389582,"d":"12050"},{"$nulls":7},"IRAK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","IRAK",{"$nulls":6},"VRG(pT)LAY(bA)C","Corresponds to amino acid residues V384 to Y390; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T387 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the minor in vivo phosphorylation sites in IRAK1 (≥1 reports from high throughput mass spectrometry studies).","IRAK1; IRAK4",null,"P51617","P51617","P51617"]
[1172,583,"NK273-1","IRR (INSRR)","Pan-specific","Insulin receptor-related protein",0,2183,8,565,{"v":1228.875,"d":"1229"},{"v":2159.3138967375,"d":"2159"},{"$nulls":3},0,2144,12,552,{"v":1176.864,"d":"1177"},{"v":2056.2345514464,"d":"2056"},{"$nulls":6},0,2300,10,570,{"v":1305.3,"d":"1305"},{"v":2233.16127942,"d":"2233"},{"$nulls":7},"IRR","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK","InsR",{"$nulls":6},"RGSLPTTDAEPDSSPTPRDC","Corresponds to amino acid residues R1269 to C1288; Pre-C-terminus.",{"$nulls":3},"P14616","P14616","P14616"]
[1173,584,"NN383-2","IRS1","Pan-specific","Insulin receptor substrate 1",0,130,10,406,{"v":48.72,"d":"49"},{"v":85.608196968,"d":"86"},{"$f":"(L1186+L1187)/2","v":{"v":93.9054446298,"d":"94"}},{"$f":"SQRT((M1186-L1186)*(M1186-L1186))","v":{"v":8.2972476618,"d":"8"}},{"$f":"N1186/M1186*100","v":{"v":8.835747165151005,"d":"9"}},0,132,10,398,{"v":48.556,"d":"49"},{"v":84.8377763956,"d":"85"},{"$f":"(U1186+U1187)/2","v":{"v":97.7549376299,"d":"98"}},{"$f":"SQRT((V1186-U1186)*(V1186-U1186))","v":{"v":12.917161234299996,"d":"13"}},{"$f":"W1186/V1186*100","v":{"v":13.213819728681475,"d":"13"}},{"$f":"X1186+O1186","v":{"v":22.04956689383248,"d":"22"}},{"$f":"(V1186/M1186*100)-100","v":{"v":4.099328867751723,"d":"4"}},null,0,136,10,444,{"v":55.944,"d":"56"},{"v":95.7113112816,"d":"96"},{"$f":"(AG1186+AG1187)/2","v":{"v":109.6512470088,"d":"110"}},{"$f":"SQRT((AH1186-AG1186)*(AH1186-AG1186))","v":{"v":13.939935727199995,"d":"14"}},{"$f":"AI1186/AH1186*100","v":{"v":12.712975098296194,"d":"13"}},{"$f":"AJ1186+O1186","v":{"v":21.5487222634472,"d":"22"}},{"$f":"(AH1186/M1186*100)-100","v":{"v":16.767720382001386,"d":"17"}},{"$nulls":13},"X",null,"Not precisely defined.","Antibody raised against amino acid residues 2-25 at the N-terminus of  human IRS1.",null,null,"Adapter/scaffold protein","P35568","P35568",null,null,"GO:0005901; GO:0005737; GO:0005829; GO:0005899; GO:0043231; GO:0005634; GO:0005886","GO:0016303; GO:0005159; GO:0005158; GO:0043548; GO:0046934; GO:0001784; GO:0005080; GO:0005088; GO:0042169; GO:0005068","GO:0032869; GO:0042593; GO:0048009; GO:0008286; GO:0038111; GO:0000165; GO:0046627; GO:0046676; GO:0014065; GO:0048015; GO:0008284; GO:0032000; GO:0046326; GO:2001275; GO:0010907; GO:0045725; GO:0046628; GO:0043552; GO:0051897; GO:0032868; GO:0043434; GO:0007165"]
[1178,586,"PN118","IRS1","S639","Insulin receptor substrate 1",0,1633,10,272,{"v":441.456,"d":"441"},{"v":775.7030418864,"d":"776"},{"$nulls":3},0,1201,8,209,{"v":249.337,"d":"249"},{"v":435.64537138869997,"d":"436"},{"$nulls":6},0,1547,10,231,{"v":355.047,"d":"355"},{"v":607.4291065458001,"d":"607"},{"$nulls":18},"X",null,"PK(pS)VS","Corresponds to amino acid residues  P637 to S341; Surrounds the S639 phosphosite.","S639 phosphorylation regulates intracellular location and Inhibition of tyrosine phosphorylation. It may also facilitate degradation by the Cul7-RING(FBXW8) complex. This is one of the minor in vivo phosphorylation sites in IRS1 (≥4 reports from high throughput mass spectrometry studies).","BARK1 (GRK2; ADRBK1); ERK2 (MAPK1); FRAP1 (mTOR); p70S6K (RPS6KB1); ROCK1; ROCK2",null,"P35568","P35568"]
[1183,587,"NK274-1","ITK","Pan-specific","Tyrosine-protein kinase ITK/TSK",0,2090,14,845,{"v":1754.22,"d":"1754"},{"v":3082.422234918,"d":"3082"},{"$f":"(L1196+L1197)/2","v":{"v":3849.7384146506997,"d":"3850"}},{"$f":"SQRT((M1196-L1196)*(M1196-L1196))","v":{"v":767.3161797326998,"d":"767"}},{"$f":"N1196/M1196*100","v":{"v":19.93164462324438,"d":"20"}},0,5252,18,584,{"v":3056.656,"d":"3057"},{"v":5340.6355187056,"d":"5341"},{"$f":"(U1196+U1197)/2","v":{"v":4822.7994017978,"d":"4823"}},{"$f":"SQRT((V1196-U1196)*(V1196-U1196))","v":{"v":517.8361169077998,"d":"518"}},{"$f":"W1196/V1196*100","v":{"v":10.73725182753331,"d":"11"}},{"$f":"X1196+O1196","v":{"v":30.66889645077769,"d":"31"}},{"$f":"(V1196/M1196*100)-100","v":{"v":25.276028715197512,"d":"25"}},null,0,4427,14,584,{"v":2577.192,"d":"2577"},{"v":4409.1667693488,"d":"4409"},{"$f":"(AG1196+AG1197)/2","v":{"v":4606.78263778,"d":"4607"}},{"$f":"SQRT((AH1196-AG1196)*(AH1196-AG1196))","v":{"v":197.6158684312004,"d":"198"}},{"$f":"AI1196/AH1196*100","v":{"v":4.289672076354597,"d":"4"}},{"$f":"AJ1196+O1196","v":{"v":24.22131669959898,"d":"24"}},{"$f":"(AH1196/M1196*100)-100","v":{"v":19.66482242659052,"d":"20"}},null,null,"ITK","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"CWKERPEDRPAFSRLLRQLA","Corresponds to amino acid residues C594 to A613; Pre-C-terminus.",null,null,"Protein-tyrosine kinase, TK group, Tec family","Q08881","Q08881","Q08881","Q08881","GO:0005911; GO:0005829; GO:0031234; GO:0005634","GO:0005524; GO:0046872; GO:0004715","GO:0007202; GO:0002250; GO:0006968; GO:0001816; GO:0038095; GO:0045087; GO:0032609; GO:0032633; GO:0035556; GO:0001865; GO:0038083; GO:0042127; GO:0007165; GO:0042110; GO:0050852; GO:0007169"]
[1189,590,"PN611","IWS1","S720+T721+T725","Protein IWS1 homologue",0,15848,18,695,{"v":11001.85,"d":"11002"},{"v":19331.866621765,"d":"19332"},{"$f":"(L1202+L1203)/2","v":{"v":19095.187720069498,"d":"19095"}},{"$f":"SQRT((M1202-L1202)*(M1202-L1202))","v":{"v":236.67890169550083,"d":"237"}},{"$f":"N1202/M1202*100","v":{"v":1.2394688398205462,"d":"1"}},0,17432,28,724,{"v":12600.496,"d":"12600"},{"v":22015.776878689598,"d":"22016"},{"$f":"(U1202+U1203)/2","v":{"v":20972.8816576506,"d":"20973"}},{"$f":"SQRT((V1202-U1202)*(V1202-U1202))","v":{"v":1042.895221038998,"d":"1043"}},{"$f":"W1202/V1202*100","v":{"v":4.972589070317693,"d":"5"}},{"$f":"X1202+O1202","v":{"v":6.212057910138239,"d":"6"}},{"$f":"(V1202/M1202*100)-100","v":{"v":9.83333583889096,"d":"10"}},null,0,14757,16,760,{"v":11203.16,"d":"11203"},{"v":19166.829938824,"d":"19167"},{"$f":"(AG1202+AG1203)/2","v":{"v":17218.301343122002,"d":"17218"}},{"$f":"SQRT((AH1202-AG1202)*(AH1202-AG1202))","v":{"v":1948.5285957019987,"d":"1949"}},{"$f":"AI1202/AH1202*100","v":{"v":11.316613392182004,"d":"11"}},{"$f":"AJ1202+O1202","v":{"v":12.55608223200255,"d":"13"}},{"$f":"(AH1202/M1202*100)-100","v":{"v":-9.829106707208979,"d":"-10"}},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"RMN(pS)(pT)GGQ(pT)PRRC","Corresponds to amino acid residues R717 to R728.","The effects of S720, T721 and T725 phosphorylation are unclear. These are three of the major in vivo phosphorylation sites in ITSN2 (≥790, ≥81 and ≥239 reports, respectively, from high throughput mass spectrometry studies).",null,"Transcription protein","Q96ST2","Q96ST2",null,null,"GO:0005654; GO:0005634",null,"GO:0006397; GO:0051028; GO:0032784; GO:2001253; GO:0090239; GO:0010793; GO:0050684; GO:0008380; GO:0006366; GO:0006368"]
[1190,590,"PN611","IWS1","S720+T721+T725","Protein IWS1 homologue",0,14718,16,730,{"v":10732.46,"d":"10732"},{"v":18858.508818373997,"d":"18859"},{"$nulls":3},0,16362,20,698,{"v":11406.716,"d":"11407"},{"v":19929.9864366116,"d":"19930"},{"$nulls":6},0,12680,20,705,{"v":8925.3,"d":"8925"},{"v":15269.77274742,"d":"15270"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"RMN(pS)(pT)GGQ(pT)PRRC","Corresponds to amino acid residues R717 to R728.","The effects of S720, T721 and T725 phosphorylation are unclear. These are three of the major in vivo phosphorylation sites in ITSN2 (≥790, ≥81 and ≥239 reports, respectively, from high throughput mass spectrometry studies).",null,null,"Q96ST2","Q96ST2"]
[1195,593,"PK126","JAK1","Y1022","Janus protein-tyrosine kinase 1",0,2172,12,233,{"v":503.28,"d":"503"},{"v":884.3368918319999,"d":"884"},{"$f":"(L1208+L1209)/2","v":{"v":771.4156034503999,"d":"771"}},{"$f":"SQRT((M1208-L1208)*(M1208-L1208))","v":{"v":112.9212883816,"d":"113"}},{"$f":"N1208/M1208*100","v":{"v":14.638190863203166,"d":"15"}},0,1722,12,223,{"v":381.33,"d":"381"},{"v":666.265534083,"d":"666"},{"$f":"(U1208+U1209)/2","v":{"v":644.2663487589,"d":"644"}},{"$f":"SQRT((V1208-U1208)*(V1208-U1208))","v":{"v":21.99918532410004,"d":"22"}},{"$f":"W1208/V1208*100","v":{"v":3.4146103341387875,"d":"3"}},{"$f":"X1208+O1208","v":{"v":18.052801197341953,"d":"18"}},{"$f":"(V1208/M1208*100)-100","v":{"v":-16.48258787128296,"d":"-16"}},null,0,2194,14,221,{"v":481.78,"d":"482"},{"v":824.249169692,"d":"824"},{"$f":"(AG1208+AG1209)/2","v":{"v":801.341003346,"d":"801"}},{"$f":"SQRT((AH1208-AG1208)*(AH1208-AG1208))","v":{"v":22.90816634600003,"d":"23"}},{"$f":"AI1208/AH1208*100","v":{"v":2.8587288370802146,"d":"3"}},{"$f":"AJ1208+O1208","v":{"v":17.49691970028338,"d":"17"}},{"$f":"(AH1208/M1208*100)-100","v":{"v":3.8792837170714876,"d":"4"}},null,null,"JAK1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","JakA",{"$nulls":6},"KE(pY)YT","Corresponds to amino acid residues K1020 to T1024; Surrounds the Y1022 phosphosite.","The effect of Y1022 phosphorylation is unclear. Phosphorylation of this site in JAK1 from high throughput mass spectrometry studies has not been reported.","JAK1; JAK3","Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; JakA family","P23458","P23458","P23458","P23458","GO:0005737; GO:0005856; GO:0005829; GO:0005768; GO:0031234; GO:0005925; GO:0005634","GO:0005524; GO:0031730; GO:0005131; GO:0046872; GO:0004715; GO:0019903; GO:0004713; GO:0005088; GO:0005102; GO:0031625","GO:0030154; GO:0016477; GO:0019221; GO:0045087; GO:0060333; GO:0035722; GO:0035723; GO:0038114; GO:0070106; GO:0038110; GO:0070757; GO:0070102; GO:0038111; GO:0038113; GO:0035556; GO:0000165; GO:0038083; GO:1903672; GO:0006468; GO:0042127; GO:0060334; GO:0046677; GO:0007169; GO:0060337"]
[1200,595,"PK895","JAK1","T1107","Janus protein-tyrosine kinase 1",0,8570,12,645,{"v":5519.91,"d":"5520"},{"v":9699.292744778999,"d":"9699"},{"$nulls":3},0,10069,14,622,{"v":6254.21,"d":"6254"},{"v":10927.450150571,"d":"10927"},{"$nulls":6},0,8964,14,636,{"v":5692.2,"d":"5692"},{"v":9738.45141708,"d":"9738"},{"$nulls":7},"JAK1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","JakA",{"$nulls":6},"LVN(pT)LKE(bA)C","Corresponds to amino acid residues L1104 to E1110. T1107 is located in the Gap/Insert 10 (G/I10) region in the second protein-tyrosine kinase catalytic domain of JAK1.","The effect of T1107 phosphorylation is unknown. Its phosphorylation has been observed in only one mass spectrometry study. ",null,null,"P23458","P23458","P23458","P23458"]
[1205,598,"PK668","JAK2","Y570","Janus protein-tyrosine kinase 2",0,6088,15,571,{"v":3467.683,"d":"3468"},{"v":6093.2284336327,"d":"6093"},{"$f":"(L1218+L1219)/2","v":{"v":6325.75080433625,"d":"6326"}},{"$f":"SQRT((M1218-L1218)*(M1218-L1218))","v":{"v":232.52237070355022,"d":"233"}},{"$f":"N1218/M1218*100","v":{"v":3.6758066812268044,"d":"4"}},0,7568,12,586,{"v":4427.816,"d":"4428"},{"v":7736.3469752216,"d":"7736"},{"$f":"(U1218+U1219)/2","v":{"v":7608.8631726652,"d":"7609"}},{"$f":"SQRT((V1218-U1218)*(V1218-U1218))","v":{"v":127.4838025563995,"d":"127"}},{"$f":"W1218/V1218*100","v":{"v":1.675464516360136,"d":"2"}},{"$f":"X1218+O1218","v":{"v":5.35127119758694,"d":"5"}},{"$f":"(V1218/M1218*100)-100","v":{"v":20.28395376323371,"d":"20"}},null,0,5954,12,589,{"v":3499.838,"d":"3500"},{"v":5987.6677436932005,"d":"5988"},{"$f":"(AG1218+AG1219)/2","v":{"v":6107.96042421,"d":"6108"}},{"$f":"SQRT((AH1218-AG1218)*(AH1218-AG1218))","v":{"v":120.29268051679992,"d":"120"}},{"$f":"AI1218/AH1218*100","v":{"v":1.9694410598994425,"d":"2"}},{"$f":"AJ1218+O1218","v":{"v":5.645247741126247,"d":"6"}},{"$f":"(AH1218/M1218*100)-100","v":{"v":-3.442917479091278,"d":"-3"}},null,null,"JAK2","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","JakA",{"$nulls":6},"VGD(pY)GQL(bA)C","Corresponds to amino acid residues V567 to L573; In the protein kinase catalytic domain.","Y570 phosphorylation stimulates phosphotransferase activity. This is the major in vivo phosphorylation site in JAK2 (≥847 reports from high throughput mass spectrometry studies).","JAK2","Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; JakA family","O60674","O60674","O60674","O60674","GO:0005901; GO:0005737; GO:0005856; GO:0005829; GO:0031904; GO:0031234; GO:0005925; GO:0098978; GO:0045121; GO:0016363; GO:0005654; GO:0005634; GO:0005886; GO:0098794","GO:0033130; GO:0005524; GO:0005131; GO:0020037; GO:0042393; GO:0035401; GO:0042802; GO:0043560; GO:0005143; GO:0046872; GO:0004715; GO:0051428; GO:0043548; GO:0008022; GO:0004672; GO:0019901; GO:0004713; GO:0005088; GO:0042169; GO:0005102; GO:0031702","GO:0030041; GO:0006919; GO:0097296; GO:0042976; GO:0000186; GO:0002250; GO:0006915; GO:0031103; GO:0007596; GO:0030154; GO:0016477; GO:0019221; GO:0007167; GO:0030218; GO:0097191; GO:0007186; GO:0060396; GO:0035409; GO:0045087; GO:0060333; GO:0035722; GO:0038155; GO:0070106; GO:0070757; GO:0070102; GO:0035556; GO:0008631; GO:0007259; GO:0060397; GO:0061180; GO:0000165; GO:0007498; GO:0031959; GO:0050804; GO:0010667; GO:0022408; GO:0008285; GO:0043392; GO:0045822; GO:0043524; GO:0038083; GO:0018108; GO:0048008; GO:0050867; GO:0045597; GO:0030335; GO:0010811; GO:0120162; GO:0007204; GO:0043388; GO:0051091; GO:1904037; GO:1902728; GO:0060399; GO:0050729; GO:0032024; GO:0032731; GO:0045429; GO:0051770; GO:0050731; GO:0014068; GO:0032516; GO:0033160; GO:0032760; GO:0042531; GO:1904707; GO:0099527; GO:0046777; GO:0006468; GO:0042981; GO:0042127; GO:0050727; GO:0060334; GO:0046425; GO:0046677; GO:0033194; GO:0070671; GO:0032496; GO:0034612; GO:0007165; GO:0033209; GO:0007260"]
[1207,599,"PK034-1","JAK2","Y1007+Y1008","Janus protein-tyrosine kinase 2",0,412,10,346,{"v":139.092,"d":"139"},{"v":244.4050766148,"d":"244"},{"$f":"(L1220+L1221)/2","v":{"v":249.3584737259,"d":"249"}},{"$f":"SQRT((M1220-L1220)*(M1220-L1220))","v":{"v":4.953397111100003,"d":"5"}},{"$f":"N1220/M1220*100","v":{"v":1.9864563000754003,"d":"2"}},0,392,12,354,{"v":134.52,"d":"135"},{"v":235.03537525200002,"d":"235"},{"$f":"(U1220+U1221)/2","v":{"v":231.83272997370003,"d":"232"}},{"$f":"SQRT((V1220-U1220)*(V1220-U1220))","v":{"v":3.202645278299997,"d":"3"}},{"$f":"W1220/V1220*100","v":{"v":1.381446562210313,"d":"1"}},{"$f":"X1220+O1220","v":{"v":3.367902862285713,"d":"3"}},{"$f":"(V1220/M1220*100)-100","v":{"v":-7.028332941861308,"d":"-7"}},null,0,420,10,406,{"v":166.46,"d":"166"},{"v":284.786659444,"d":"285"},{"$f":"(AG1220+AG1221)/2","v":{"v":271.2658798598,"d":"271"}},{"$f":"SQRT((AH1220-AG1220)*(AH1220-AG1220))","v":{"v":13.5207795842,"d":"14"}},{"$f":"AI1220/AH1220*100","v":{"v":4.984327402763674,"d":"5"}},{"$f":"AJ1220+O1220","v":{"v":6.970783702839075,"d":"7"}},{"$f":"(AH1220/M1220*100)-100","v":{"v":8.785506987815879,"d":"9"}},null,null,"JAK2","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","JakA",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues that encompass the Y1007+Y1008 phosphosite.","T1007 and Y1008 phosphorylation stimulate phosphotransferase activity and induce interactions with SOCS1. These are two of the major in vivo phosphorylation sites in JAK2 (≥19 and ≥18 reports, respectively, from high throughput mass spectrometry studies).","Y1007: JAK2; PYK2 (PTK2B; FAK2). Y1008 JAK2; PYK2 (PTK2B; FAK2). ","Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; JakA family","O60674","O60674","O60674","O60674","GO:0005901; GO:0005737; GO:0005856; GO:0005829; GO:0031904; GO:0031234; GO:0005925; GO:0098978; GO:0045121; GO:0016363; GO:0005654; GO:0005634; GO:0005886; GO:0098794","GO:0033130; GO:0005524; GO:0005131; GO:0020037; GO:0042393; GO:0035401; GO:0042802; GO:0043560; GO:0005143; GO:0046872; GO:0004715; GO:0051428; GO:0043548; GO:0008022; GO:0004672; GO:0019901; GO:0004713; GO:0005088; GO:0042169; GO:0005102; GO:0031702","GO:0030041; GO:0006919; GO:0097296; GO:0042976; GO:0000186; GO:0002250; GO:0006915; GO:0031103; GO:0007596; GO:0030154; GO:0016477; GO:0019221; GO:0007167; GO:0030218; GO:0097191; GO:0007186; GO:0060396; GO:0035409; GO:0045087; GO:0060333; GO:0035722; GO:0038155; GO:0070106; GO:0070757; GO:0070102; GO:0035556; GO:0008631; GO:0007259; GO:0060397; GO:0061180; GO:0000165; GO:0007498; GO:0031959; GO:0050804; GO:0010667; GO:0022408; GO:0008285; GO:0043392; GO:0045822; GO:0043524; GO:0038083; GO:0018108; GO:0048008; GO:0050867; GO:0045597; GO:0030335; GO:0010811; GO:0120162; GO:0007204; GO:0043388; GO:0051091; GO:1904037; GO:1902728; GO:0060399; GO:0050729; GO:0032024; GO:0032731; GO:0045429; GO:0051770; GO:0050731; GO:0014068; GO:0032516; GO:0033160; GO:0032760; GO:0042531; GO:1904707; GO:0099527; GO:0046777; GO:0006468; GO:0042981; GO:0042127; GO:0050727; GO:0060334; GO:0046425; GO:0046677; GO:0033194; GO:0070671; GO:0032496; GO:0034612; GO:0007165; GO:0033209; GO:0007260"]
[1212,601,"NK086","JAK3","Pan-specific","Janus protein-tyrosine kinase 3",0,135,10,528,66,{"v":115.9716954,"d":"116"},{"$nulls":3},0,130,12,496,{"v":58.528,"d":"59"},{"v":102.2610053728,"d":"102"},{"$nulls":6},0,140,10,519,{"v":67.47,"d":"67"},{"v":115.430469258,"d":"115"},{"$nulls":7},"JAK3","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","JakA",{"$nulls":6},"Epitope undefined.",{"$nulls":4},"P52333","P52333","P52333","P52333"]
[1217,604,"NK189-5","JNK1 (MAPK8)","Pan-specific","Jun N-terminus protein-serine kinase 2 (Stress-activated protein kinase-alpha)",0,364,12,522,{"$f":"(H1230-I1230)*J1230/1000","v":{"v":183.744,"d":"184"}},{"v":322.8651999936,"d":"323"},{"$f":"(L1230+L1231)/2","v":{"v":285.8069718726,"d":"286"}},{"$f":"SQRT((M1230-L1230)*(M1230-L1230))","v":{"v":37.05822812100001,"d":"37"}},{"$f":"N1230/M1230*100","v":{"v":12.966173595484898,"d":"13"}},0,595,10,539,{"$f":"(Q1230-R1230)*S1230/1000","v":{"v":315.315,"d":"315"}},{"v":550.9231292565,"d":"551"},{"$f":"(U1230+U1231)/2","v":{"v":435.48899563725,"d":"435"}},{"$f":"SQRT((V1230-U1230)*(V1230-U1230))","v":{"v":115.43413361925002,"d":"115"}},{"$f":"W1230/V1230*100","v":{"v":26.506785424126623,"d":"27"}},{"$f":"X1230+O1230","v":{"v":39.47295901961152,"d":"39"}},{"$f":"(V1230/M1230*100)-100","v":{"v":52.37171885064146,"d":"52"}},null,0,386,10,522,{"$f":"(AC1230-AD1230)*AE1230/1000","v":{"v":196.272,"d":"196"}},{"v":335.7902632608,"d":"336"},{"$f":"(AG1230+AG1231)/2","v":{"v":293.2886857813,"d":"293"}},{"$f":"SQRT((AH1230-AG1230)*(AH1230-AG1230))","v":{"v":42.501577479499986,"d":"43"}},{"$f":"AI1230/AH1230*100","v":{"v":14.491379838359206,"d":"14"}},{"$f":"AJ1230+O1230","v":{"v":27.457553433844105,"d":"27"}},{"$f":"(AH1230/M1230*100)-100","v":{"v":2.6177506656608074,"d":"3"}},null,null,"JNK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","JNK",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues 1-424 representing full length human JNK2 p54.",null,null,"EC 2.7.11.24; Protein kinase, Ser/Thr (non-receptor); CMGC group; MAPK family; MAPK/JNK subfamily; JNK subfamily","P45983","P45983","P45983","P45983","GO:0030424; GO:0097441; GO:0005737; GO:0005829; GO:0005739; GO:0043005; GO:0005654; GO:0005634","GO:0005524; GO:0019899; GO:0042826; GO:0035033; GO:0004705; GO:0016301; GO:0004674","GO:0034198; GO:0071276; GO:0071345; GO:0071222; GO:0071260; GO:0034614; GO:0038095; GO:0007254; GO:0007258; GO:0043066; GO:0032091; GO:0048666; GO:0018105; GO:0018107; GO:0043065; GO:0031281; GO:0090045; GO:0010628; GO:1900740; GO:0051247; GO:0006468; GO:0042752; GO:1902595; GO:0016241; GO:0032880; GO:0009411; GO:0048511; GO:0051403"]
[1222,606,"PK035-2","JNK1 (MAPK8)","T183+Y185","Jun N-terminus protein-serine kinase (stress-activated protein kinase (SAPK)) 1",0,964,10,248,{"v":236.592,"d":"237"},{"v":415.72689936480003,"d":"416"},{"$nulls":3},0,710,10,273,{"v":191.1,"d":"191"},{"v":333.89280561,"d":"334"},{"$nulls":6},0,721,10,292,{"v":207.612,"d":"208"},{"$f":"AF1235*1.7108414","v":{"v":355.1912047368,"d":"355"}},{"$nulls":7},"JNK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","JNK",{"$nulls":5},"Epitope undefined.","Antibody raised against amino acid residues that encompass the T183 and Y185 phosphosites.","T183 and Y185 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation regulates apoptosis, cell adhesion and transcription.These are the two  major in vivo phosphorylation sites in JNK1 (≥417 and ≥1286 reports, respectively, from high throughput mass spectrometry studies).","MKK4 (MAP2K4, MEK4); MKK7 (MAP2K7, MEK7)",null,"P45983","P45983","P45983","P45983"]
[1223,607,"PK190","JNK1 (MAPK8)","T183+Y185","Jun N-terminus protein-serine kinase (stress-activated protein kinase (SAPK)) 1",0,28,2,692,{"v":17.992,"d":"18"},{"v":31.614587024800002,"d":"32"},{"$f":"(L1236+L1237)/2","v":{"v":28.6994803177,"d":"29"}},{"$f":"SQRT((M1236-L1236)*(M1236-L1236))","v":{"v":2.9151067071000014,"d":"3"}},{"$f":"N1236/M1236*100","v":{"v":10.157350150003065,"d":"10"}},0,36,10,668,{"v":17.368,"d":"17"},{"v":30.345631856799997,"d":"30"},{"$f":"(U1236+U1237)/2","v":{"v":28.684030296699998,"d":"29"}},{"$f":"SQRT((V1236-U1236)*(V1236-U1236))","v":{"v":1.6616015600999994,"d":"2"}},{"$f":"W1236/V1236*100","v":{"v":5.79277578120241,"d":"6"}},{"$f":"X1236+O1236","v":{"v":15.950125931205475,"d":"16"}},{"$f":"(V1236/M1236*100)-100","v":{"v":-0.053833800573983126,"d":"-0"}},null,0,32,8,665,{"v":15.96,"d":"16"},{"v":27.305028744,"d":"27"},{"$f":"(AG1236+AG1237)/2","v":{"v":46.663199185,"d":"47"}},{"$f":"SQRT((AH1236-AG1236)*(AH1236-AG1236))","v":{"v":19.358170441000002,"d":"19"}},{"$f":"AI1236/AH1236*100","v":{"v":41.484876260311644,"d":"41"}},{"$f":"AJ1236+O1236","v":{"v":51.642226410314706,"d":"52"}},{"$f":"(AH1236/M1236*100)-100","v":{"v":62.592488325376166,"d":"63"}},null,null,"JNK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","JNK",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues that encompass the Thr-183  and Tyr-185 phosphosites.","T183 and Y185 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation regulates apoptosis, cell adhesion and transcription.These are the two  major in vivo phosphorylation sites in JNK1 (≥417 and ≥1286 reports, respectively, from high throughput mass spectrometry studies).","MKK4 (MAP2K4, MEK4); MKK7 (MAP2K7, MEK7)","EC 2.7.11.24; Protein kinase, Ser/Thr (non-receptor); CMGC group; MAPK family; MAPK/JNK subfamily; JNK subfamily","P45983","P45983","P45983","P45983","GO:0030424; GO:0097441; GO:0005737; GO:0005829; GO:0005739; GO:0043005; GO:0005654; GO:0005634","GO:0005524; GO:0019899; GO:0042826; GO:0035033; GO:0004705; GO:0016301; GO:0004674","GO:0034198; GO:0071276; GO:0071345; GO:0071222; GO:0071260; GO:0034614; GO:0038095; GO:0007254; GO:0007258; GO:0043066; GO:0032091; GO:0048666; GO:0018105; GO:0018107; GO:0043065; GO:0031281; GO:0090045; GO:0010628; GO:1900740; GO:0051247; GO:0006468; GO:0042752; GO:1902595; GO:0016241; GO:0032880; GO:0009411; GO:0048511; GO:0051403"]
[1230,610,"NK189-3","JNK2 (MAPK9)","Pan-specific","Jun N-terminus protein-serine kinase (stress-activated protein kinase (SAPK)) 2",0,4637,16,584,{"v":2698.664,"d":"2699"},{"v":4741.9490817416,"d":"4742"},{"$nulls":3},0,3490,14,566,{"v":1967.416,"d":"1967"},{"v":3437.4989431815998,"d":"3437"},{"$nulls":6},0,4281,14,577,{"v":2462.059,"d":"2462"},{"v":4212.192466442601,"d":"4212"},{"$nulls":7},"JNK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","JNK",{"$nulls":5},"CVKDQPSDAAVSSNAT","Corresponds to amino acid residues V372 to T386.",{"$nulls":3},"P45984","P45984","P45984","P45984"]
[1234,612,"NN162","Jun (c-Jun)","Pan-specific","Jun proto-oncogene-encoded AP1 transcription factor",0,137,8,246,{"v":31.734,"d":"32"},{"v":55.7612997246,"d":"56"},{"$nulls":3},0,54,10,435,{"v":19.14,"d":"19"},{"v":33.441697014,"d":"33"},{"$nulls":6},0,169,8,274,{"v":44.114,"d":"44"},{"v":75.4720575196,"d":"75"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Epitope undefined.",{"$nulls":4},"P05412","P05412",null,"P05412"]
[1239,615,"PN612","Jun (c-Jun)","S73","Jun proto-oncogene-encoded AP1 transcription factor",0,7917,18,757,{"v":5979.543,"d":"5980"},{"v":10506.935445866699,"d":"10507"},{"$f":"(L1252+L1253)/2","v":{"v":9775.606513219449,"d":"9776"}},{"$f":"SQRT((M1252-L1252)*(M1252-L1252))","v":{"v":731.3289326472495,"d":"731"}},{"$f":"N1252/M1252*100","v":{"v":7.481161722889329,"d":"7"}},0,8990,18,776,{"v":6962.272,"d":"6962"},{"v":12164.5867687072,"d":"12165"},{"$f":"(U1252+U1253)/2","v":{"v":11372.2317097176,"d":"11372"}},{"$f":"SQRT((V1252-U1252)*(V1252-U1252))","v":{"v":792.3550589896004,"d":"792"}},{"$f":"W1252/V1252*100","v":{"v":6.967454403101294,"d":"7"}},{"$f":"X1252+O1252","v":{"v":14.448616125990622,"d":"14"}},{"$f":"(V1252/M1252*100)-100","v":{"v":16.33274819663673,"d":"16"}},null,0,8030,18,782,{"v":6265.384,"d":"6265"},{"v":10719.078334097601,"d":"10719"},{"$f":"(AG1252+AG1253)/2","v":{"v":10506.4173263948,"d":"10506"}},{"$f":"SQRT((AH1252-AG1252)*(AH1252-AG1252))","v":{"v":212.66100770280173,"d":"213"}},{"$f":"AI1252/AH1252*100","v":{"v":2.0241058497509234,"d":"2"}},{"$f":"AJ1252+O1252","v":{"v":9.505267572640253,"d":"10"}},{"$f":"(AH1252/M1252*100)-100","v":{"v":7.475861596792839,"d":"7"}},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"CLKLA(pS)PELE","Corresponds to amino acid residues C69 to E77.","S73 phosphorylation stimulates transcriptional activity and binding to PIN1, although it has been reported to decrease binding to DNA and JNK1. This is the major in vivo phosphorylation site in c-Jun (≥78 reports from high throughput mass spectrometry studies).","CDK1 (CDC2); CDK3; CK2a1 (CSNK2A1); ERK1 (MAPK3); ERK2 (MAPK1); ERK7 (MAPK15); JNK1 (MAPK8); JNK2 (MAPK9); JNK3 (MAPK10); Plk3 (CNK); PBK (TOPK); VRK1","Transcription protein","P05412","P05412",null,"P05412","GO:0005829; GO:0000228; GO:0005719; GO:0005654; GO:0005634; GO:0017053; GO:0035976","GO:0035497; GO:0003682; GO:0003677; GO:0003700; GO:0019899; GO:0005096; GO:0071837; GO:0042802; GO:0046982; GO:0042803; GO:0003723; GO:0001102; GO:0000980; GO:0000978; GO:0000981; GO:0070412; GO:0001077; GO:0001190; GO:0003713; GO:0003705; GO:0000982; GO:0008134; GO:0044212; GO:0031625","GO:0007568; GO:0001525; GO:0031103; GO:0071276; GO:0071277; GO:0032870; GO:0051365; GO:0034614; GO:0007623; GO:0061029; GO:0038095; GO:0035026; GO:0007612; GO:0001889; GO:0051899; GO:0001774; GO:0030224; GO:0043922; GO:0008285; GO:0043392; GO:0043524; GO:0031953; GO:0045892; GO:1990441; GO:0003151; GO:0043923; GO:0043065; GO:0045597; GO:0045740; GO:2000144; GO:0001938; GO:0010634; GO:0070374; GO:0048146; GO:0045657; GO:0043525; GO:1902895; GO:0045893; GO:0045944; GO:1904707; GO:0007265; GO:0051726; GO:0042127; GO:0051090; GO:0001836; GO:0051591; GO:0034097; GO:0042493; GO:0042542; GO:0032496; GO:0009612; GO:0035994; GO:0009314; GO:0060395; GO:0007179"]
[1240,615,"PN612","Jun (c-Jun)","S73","Jun proto-oncogene-encoded AP1 transcription factor",0,7149,20,722,{"v":5147.138,"d":"5147"},{"v":9044.2775805722,"d":"9044"},{"$nulls":3},0,7882,18,770,{"v":6055.28,"d":"6055"},{"v":10579.876650728,"d":"10580"},{"$nulls":6},0,7840,26,770,{"v":6016.78,"d":"6017"},{"v":10293.756318692,"d":"10294"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"CLKLA(pS)PELE","Corresponds to amino acid residues C69 to E77.","S73 phosphorylation stimulates transcriptional activity and binding to PIN1, although it has been reported to decrease binding to DNA and JNK1. This is the major in vivo phosphorylation site in c-Jun (≥78 reports from high throughput mass spectrometry studies).","CDK1 (CDC2); CDK3; CK2a1 (CSNK2A1); ERK1 (MAPK3); ERK2 (MAPK1); ERK7 (MAPK15); JNK1 (MAPK8); JNK2 (MAPK9); JNK3 (MAPK10); Plk3 (CNK); PBK (TOPK); VRK1",null,"P05412","P05412",null,"P05412"]
[1245,618,"PN155","Jun (c-Jun)","Y170","Jun proto-oncogene-encoded AP1 transcription factor",0,1382,10,358,{"v":491.176,"d":"491"},{"v":863.0683857544,"d":"863"},{"$f":"(L1258+L1259)/2","v":{"v":822.116320103,"d":"822"}},{"$f":"SQRT((M1258-L1258)*(M1258-L1258))","v":{"v":40.95206565139995,"d":"41"}},{"$f":"N1258/M1258*100","v":{"v":4.981298223865598,"d":"5"}},0,84,10,563,{"v":41.662,"d":"42"},{"v":72.7924754962,"d":"73"},{"$f":"(U1258+U1259)/2","v":{"v":352.31019997910005,"d":"352"}},{"$f":"SQRT((V1258-U1258)*(V1258-U1258))","v":{"v":279.51772448290006,"d":"280"}},{"$f":"W1258/V1258*100","v":{"v":79.33852738282394,"d":"79"}},{"$f":"X1258+O1258","v":{"v":84.31982560668953,"d":"84"}},{"$f":"(V1258/M1258*100)-100","v":{"v":-57.145942567475075,"d":"-57"}},null,0,1388,10,357,{"v":491.946,"d":"492"},{"v":841.6415833644,"d":"842"},{"$f":"(AG1258+AG1259)/2","v":{"v":736.9842824022,"d":"737"}},{"$f":"SQRT((AH1258-AG1258)*(AH1258-AG1258))","v":{"v":104.6573009622,"d":"105"}},{"$f":"AI1258/AH1258*100","v":{"v":14.200750743430993,"d":"14"}},{"$f":"AJ1258+O1258","v":{"v":19.18204896729659,"d":"19"}},{"$f":"(AH1258/M1258*100)-100","v":{"v":-10.355230229480668,"d":"-10"}},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"PV(pY)AN","Corresponds to amino acid residues P168 to N172.","Y170 phosphorylation induces interaction with Abl1. This is one of the minor in vivo phosphorylation sites in c-Jun (≥1 reports from high throughput mass spectrometry studies).","Abl1","Transcription protein","P05412","P05412",null,"P05412","GO:0005829; GO:0000228; GO:0005719; GO:0005654; GO:0005634; GO:0017053; GO:0035976","GO:0035497; GO:0003682; GO:0003677; GO:0003700; GO:0019899; GO:0005096; GO:0071837; GO:0042802; GO:0046982; GO:0042803; GO:0003723; GO:0001102; GO:0000980; GO:0000978; GO:0000981; GO:0070412; GO:0001077; GO:0001190; GO:0003713; GO:0003705; GO:0000982; GO:0008134; GO:0044212; GO:0031625","GO:0007568; GO:0001525; GO:0031103; GO:0071276; GO:0071277; GO:0032870; GO:0051365; GO:0034614; GO:0007623; GO:0061029; GO:0038095; GO:0035026; GO:0007612; GO:0001889; GO:0051899; GO:0001774; GO:0030224; GO:0043922; GO:0008285; GO:0043392; GO:0043524; GO:0031953; GO:0045892; GO:1990441; GO:0003151; GO:0043923; GO:0043065; GO:0045597; GO:0045740; GO:2000144; GO:0001938; GO:0010634; GO:0070374; GO:0048146; GO:0045657; GO:0043525; GO:1902895; GO:0045893; GO:0045944; GO:1904707; GO:0007265; GO:0051726; GO:0042127; GO:0051090; GO:0001836; GO:0051591; GO:0034097; GO:0042493; GO:0042542; GO:0032496; GO:0009612; GO:0035994; GO:0009314; GO:0060395; GO:0007179"]
[1248,619,"PN613","Jun (c-Jun)","T239","Jun proto-oncogene-encoded AP1 transcription factor",0,4160,12,674,{"v":2795.752,"d":"2796"},{"v":4912.5469599687995,"d":"4913"},{"$nulls":3},0,4280,12,615,{"v":2624.82,"d":"2625"},{"v":4586.125138782,"d":"4586"},{"$nulls":6},0,4434,12,645,{"v":2852.19,"d":"2852"},{"v":4879.644732666,"d":"4880"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"MPGE(pT)PPL(bA)C","Corresponds to amino acid residues M235 to L242.","T239 phosphorylation inhibits transcriptional activity by reducing binding of DNA. Its phosphorylation has been separately reported to both induce and inhibit FBXW7 interaction. This is one of the major in vivo phosphorylation sites in c-Jun (≥24 reports from high throughput mass spectrometry studies).","GSK3b",null,"P05412","P05412",null,"P05412"]
[1256,621,"NK089","KHS1 (MAP4K5; KHS)","Pan-specific","Kinase homologous to SPS1/STE20 (MAP kinase kinase kinase protein-serine kinase 5 (MEKKK5)",0,74,10,490,{"v":31.36,"d":"31"},{"v":55.104126783999995,"d":"55"},{"$nulls":3},0,70,6,497,{"v":31.808,"d":"32"},{"v":55.5754179008,"d":"56"},{"$nulls":6},0,78,10,501,{"v":34.068,"d":"34"},{"v":58.2849448152,"d":"58"},{"$nulls":7},"KHS1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","KHS",{"$nulls":5},"Epitope undefined.",{"$nulls":4},"Q9Y4K4","Q9Y4K4","Q9Y4K4","Q9Y4K4"]
[1257,622,"PK672","KHS1 (MAP4K5; KHS)","Y31","Kinase homologous to SPS1/STE20 (MAP kinase kinase kinase protein-serine kinase 5 (MEKKK5)",0,4586,16,659,{"v":3011.63,"d":"3012"},{"v":5291.876318447,"d":"5292"},{"$f":"(L1270+L1271)/2","v":{"v":5613.922687985199,"d":"5614"}},{"$f":"SQRT((M1270-L1270)*(M1270-L1270))","v":{"v":322.04636953819954,"d":"322"}},{"$f":"N1270/M1270*100","v":{"v":5.736565810345705,"d":"6"}},0,5156,18,656,{"v":3370.528,"d":"3371"},{"v":5889.0374165728,"d":"5889"},{"$f":"(U1270+U1271)/2","v":{"v":5507.1276455846,"d":"5507"}},{"$f":"SQRT((V1270-U1270)*(V1270-U1270))","v":{"v":381.90977098819985,"d":"382"}},{"$f":"W1270/V1270*100","v":{"v":6.93482692914155,"d":"7"}},{"$f":"X1270+O1270","v":{"v":12.671392739487255,"d":"13"}},{"$f":"(V1270/M1270*100)-100","v":{"v":-1.9023247795905718,"d":"-2"}},null,0,4798,18,667,{"v":3188.26,"d":"3188"},{"v":5454.6072019640005,"d":"5455"},{"$f":"(AG1270+AG1271)/2","v":{"v":5767.727961254101,"d":"5768"}},{"$f":"SQRT((AH1270-AG1270)*(AH1270-AG1270))","v":{"v":313.12075929010007,"d":"313"}},{"$f":"AI1270/AH1270*100","v":{"v":5.428840635230254,"d":"5"}},{"$f":"AJ1270+O1270","v":{"v":11.16540644557596,"d":"11"}},{"$f":"(AH1270/M1270*100)-100","v":{"v":2.739711282417062,"d":"3"}},null,null,"KHS1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","KHS",{"$nulls":5},"SGT(pY)GDV(bA)C","Corresponds to amino acid residues S28 to V34; In the protein kinase catalytic domain in subdomain I.","Y31 phosphorylation is predicted to be inhibitory for phosphotransferase activity. This phosphosite is located in the kinase subdomain I region, which is involved in binding the phosphates in the ATP substrate. This is one of the major in vivo phosphorylation sites in KHS1 (≥161 reports from high throughput mass spectrometry studies).",null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE20 family; KHS subfamily","Q9Y4K4","Q9Y4K4","Q9Y4K4","Q9Y4K4","GO:0005737","GO:0005524; GO:0008349; GO:0004672; GO:0004674","GO:0007257; GO:0035556; GO:0006468; GO:0042981; GO:0007346"]
[1262,624,"NK241-4","Kit","Pan-specific","Mast/stem cell growth factor receptor Kit",0,62,10,656,{"v":34.112,"d":"34"},{"v":59.9397950528,"d":"60"},{"$nulls":3},0,40,6,652,{"v":22.168,"d":"22"},{"v":38.7322643368,"d":"39"},{"$nulls":6},0,54,6,651,{"v":31.248,"d":"31"},{"v":53.460372067200005,"d":"53"},{"$nulls":7},"KIT","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 951-981 within the C-terminus of human c-Kit .",{"$nulls":3},"P10721","P10721","P10721","P10721"]
[1267,627,"PK885","Kit","Y721","Mast/stem cell growth factor receptor protein-tyrosine Kit",0,9440,18,624,{"v":5879.328,"d":"5879"},{"v":10330.8429692832,"d":"10331"},{"$f":"(L1280+L1281)/2","v":{"v":10229.6418507246,"d":"10230"}},{"$f":"SQRT((M1280-L1280)*(M1280-L1280))","v":{"v":101.20111855859977,"d":"101"}},{"$f":"N1280/M1280*100","v":{"v":0.9892928807808785,"d":"1"}},0,10594,18,611,{"v":6461.936,"d":"6462"},{"v":11290.392154433599,"d":"11290"},{"$f":"(U1280+U1281)/2","v":{"v":10808.290080751,"d":"10808"}},{"$f":"SQRT((V1280-U1280)*(V1280-U1280))","v":{"v":482.10207368259944,"d":"482"}},{"$f":"W1280/V1280*100","v":{"v":4.460484221654988,"d":"4"}},{"$f":"X1280+O1280","v":{"v":5.449777102435866,"d":"5"}},{"$f":"(V1280/M1280*100)-100","v":{"v":5.6565834705680516,"d":"6"}},null,0,9773,20,647,{"v":6310.191,"d":"6310"},{"v":10795.7360047074,"d":"10796"},{"$f":"(AG1280+AG1281)/2","v":{"v":11339.332763198501,"d":"11339"}},{"$f":"SQRT((AH1280-AG1280)*(AH1280-AG1280))","v":{"v":543.5967584911014,"d":"544"}},{"$f":"AI1280/AH1280*100","v":{"v":4.793904278524482,"d":"5"}},{"$f":"AJ1280+O1280","v":{"v":5.78319715930536,"d":"6"}},{"$f":"(AH1280/M1280*100)-100","v":{"v":10.847798277466552,"d":"11"}},null,null,"KIT","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"TNE(pY)MDM(bA)C","Corresponds to amino acid residues T718 to M724; The phosphosite located in the Gap/Insert 5(G/5) region in the protein-tyrosine kinase catalytic domain of Kit. ","Y721 phosphorylation stimulates phosphotransferase activity and induces interaction with PIK3R1. Phosphorylation regulates cell adhesion. Y721 is the second most observed phosphosite in Kit by mass spectrometry (≥53 reports).","Kit","EC 2.7.10.1; Receptor tyrosine kinase; TK group; PDGFR family","P10721","P10721","P10721","P10721","GO:0001669; GO:0005911; GO:0009898; GO:0009897; GO:0005615; GO:0016021; GO:0042629; GO:0005886","GO:0005524; GO:0019955; GO:0046872; GO:0046934; GO:0002020; GO:0042803; GO:0004713; GO:0005088; GO:0005020; GO:0004714","GO:0031532; GO:0000187; GO:0060326; GO:0097067; GO:0019221; GO:0002371; GO:0050910; GO:0048565; GO:0035234; GO:0035162; GO:0050673; GO:0030218; GO:0038162; GO:0038093; GO:0008354; GO:0006687; GO:0035701; GO:0030097; GO:0002327; GO:0006954; GO:0038109; GO:0030032; GO:0002320; GO:0008584; GO:0000165; GO:0002551; GO:0032762; GO:0043303; GO:0060374; GO:0070662; GO:0035855; GO:0097326; GO:0030318; GO:0097324; GO:0002318; GO:0043069; GO:0001541; GO:0018108; GO:0043473; GO:0030335; GO:0008284; GO:1904343; GO:0051091; GO:0010628; GO:0046427; GO:0048170; GO:0043410; GO:0045747; GO:0043552; GO:0014068; GO:0010863; GO:0051897; GO:0031274; GO:0120072; GO:1904349; GO:0042531; GO:1905065; GO:0046777; GO:1904251; GO:0042127; GO:0008360; GO:0048070; GO:0006357; GO:0046686; GO:0007165; GO:0048103; GO:0035019; GO:0007286; GO:0007283; GO:0048863; GO:0019827; GO:0030217; GO:0043586; GO:0008542"]
[1271,629,"PK674","Kit","S821+Y823","Mast/stem cell growth factor receptor protein-tyrosine Kit",0,5532,16,630,{"v":3475.08,"d":"3475"},{"v":6106.226049252,"d":"6106"},{"$f":"(L1284+L1285)/2","v":{"v":6054.688930675,"d":"6055"}},{"$f":"SQRT((M1284-L1284)*(M1284-L1284))","v":{"v":51.537118577,"d":"52"}},{"$f":"N1284/M1284*100","v":{"v":0.851193499238192,"d":"1"}},0,5972,14,674,{"v":4015.692,"d":"4016"},{"v":7016.2776993492,"d":"7016"},{"$f":"(U1284+U1285)/2","v":{"v":6433.6373743824,"d":"6434"}},{"$f":"SQRT((V1284-U1284)*(V1284-U1284))","v":{"v":582.6403249668001,"d":"583"}},{"$f":"W1284/V1284*100","v":{"v":9.056157365765909,"d":"9"}},{"$f":"X1284+O1284","v":{"v":9.907350865004101,"d":"10"}},{"$f":"(V1284/M1284*100)-100","v":{"v":6.258759913949092,"d":"6"}},null,0,5979,14,639,{"v":3811.635,"d":"3812"},{"v":6521.102959689,"d":"6521"},{"$f":"(AG1284+AG1285)/2","v":{"v":6331.7410455921,"d":"6332"}},{"$f":"SQRT((AH1284-AG1284)*(AH1284-AG1284))","v":{"v":189.36191409690036,"d":"189"}},{"$f":"AI1284/AH1284*100","v":{"v":2.9906768570190723,"d":"3"}},{"$f":"AJ1284+O1284","v":{"v":3.8418703562572643,"d":"4"}},{"$f":"(AH1284/M1284*100)-100","v":{"v":4.575827397398811,"d":"5"}},null,null,"KIT","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"KND(pS)N(pY)VVKG(bA)C","Corresponds to amino acid residues K818 to G827; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","S821 and Y823 phosphorylation stimulate phosphotransferase activity. Y823 phosphorylation also induces interaction with Grb2 and Grb7. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. S821 phosphorylation is not frequently observed (≥1 reports) in high throughput mass spectrometry studies, where as Y283 appears to be more commonly observed (13 reports). ","Y823: Kit.","EC 2.7.10.1; Receptor tyrosine kinase; TK group; PDGFR family","P10721","P10721","P10721","P10721","GO:0001669; GO:0005911; GO:0009898; GO:0009897; GO:0005615; GO:0016021; GO:0042629; GO:0005886","GO:0005524; GO:0019955; GO:0046872; GO:0046934; GO:0002020; GO:0042803; GO:0004713; GO:0005088; GO:0005020; GO:0004714","GO:0031532; GO:0000187; GO:0060326; GO:0097067; GO:0019221; GO:0002371; GO:0050910; GO:0048565; GO:0035234; GO:0035162; GO:0050673; GO:0030218; GO:0038162; GO:0038093; GO:0008354; GO:0006687; GO:0035701; GO:0030097; GO:0002327; GO:0006954; GO:0038109; GO:0030032; GO:0002320; GO:0008584; GO:0000165; GO:0002551; GO:0032762; GO:0043303; GO:0060374; GO:0070662; GO:0035855; GO:0097326; GO:0030318; GO:0097324; GO:0002318; GO:0043069; GO:0001541; GO:0018108; GO:0043473; GO:0030335; GO:0008284; GO:1904343; GO:0051091; GO:0010628; GO:0046427; GO:0048170; GO:0043410; GO:0045747; GO:0043552; GO:0014068; GO:0010863; GO:0051897; GO:0031274; GO:0120072; GO:1904349; GO:0042531; GO:1905065; GO:0046777; GO:1904251; GO:0042127; GO:0008360; GO:0048070; GO:0006357; GO:0046686; GO:0007165; GO:0048103; GO:0035019; GO:0007286; GO:0007283; GO:0048863; GO:0019827; GO:0030217; GO:0043586; GO:0008542"]
[1274,630,"PK673","Kit","Y936","Mast/stem cell growth factor receptor protein-tyrosine Kit",0,9410,14,666,{"v":6257.736,"d":"6258"},{"v":10995.761413418399,"d":"10996"},{"$nulls":3},0,9246,14,637,{"v":5880.784,"d":"5881"},{"v":10274.9946046384,"d":"10275"},{"$nulls":6},0,9547,14,703,{"v":6701.699,"d":"6702"},{"v":11465.5440995386,"d":"11466"},{"$nulls":7},"KIT","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"NHI(pY)SNL(bA)C","Corresponds to amino acid residues N933 to L939; In the C-terminal of the kinase after the catalytic domain.","Y936 phosphorylation stimulates phosphotransferase activity and induces interaction with APS, Cbl, Grb2 and Grb7. Phosphorylation also induces receptor internalization and protein degradation. This is the major in vivo phosphorylation sites in Kit (≥107 reports from high throughput mass spectrometry studies).","Kit",null,"P10721","P10721","P10721","P10721"]
[1279,633,"PK675","Ksr1","S406","Protein-serine kinase suppressor of Ras 1",0,7710,14,630,{"v":4848.48,"d":"4848"},{"v":8519.491601712,"d":"8519"},{"$f":"(L1292+L1293)/2","v":{"v":9238.02411206,"d":"9238"}},{"$f":"SQRT((M1292-L1292)*(M1292-L1292))","v":{"v":718.5325103480009,"d":"719"}},{"$f":"N1292/M1292*100","v":{"v":7.777989120097397,"d":"8"}},0,8468,14,628,{"v":5309.112,"d":"5309"},{"v":9276.1606539912,"d":"9276"},{"$f":"(U1292+U1293)/2","v":{"v":8473.172043903001,"d":"8473"}},{"$f":"SQRT((V1292-U1292)*(V1292-U1292))","v":{"v":802.9886100881995,"d":"803"}},{"$f":"W1292/V1292*100","v":{"v":9.476835899561394,"d":"9"}},{"$f":"X1292+O1292","v":{"v":17.25482501965879,"d":"17"}},{"$f":"(V1292/M1292*100)-100","v":{"v":-8.279390255742072,"d":"-8"}},null,0,8112,12,681,{"v":5516.1,"d":"5516"},{"v":9437.172246540002,"d":"9437"},{"$f":"(AG1292+AG1293)/2","v":{"v":9485.590769001401,"d":"9486"}},{"$f":"SQRT((AH1292-AG1292)*(AH1292-AG1292))","v":{"v":48.418522461399334,"d":"48"}},{"$f":"AI1292/AH1292*100","v":{"v":0.5104428774181307,"d":"1"}},{"$f":"AJ1292+O1292","v":{"v":8.288431997515527,"d":"8"}},{"$f":"(AH1292/M1292*100)-100","v":{"v":2.679865888401494,"d":"3"}},null,null,"KSR1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RAF",{"$nulls":6},"RTE(pS)VPS(bA)C","Corresponds to amino acid residues R401 to S407; In the region between the KSR1-SAM and kinase catalytic domains. ","The effect of S406 phosphorylation is unclear. This is the major in vivo phosphorylation site in Krs1.","MARK3; NM23 (NME1); TAK1 (MAP3K7)","Protein kinase, Ser/Thr (non-receptor); TKL domain target; TKL</A> group; RAF family","Q8IVT5","Q8IVT5","Q8IVT5","Q8IVT5","GO:0005829; GO:0005783; GO:0005789; GO:0016020; GO:0032991; GO:0032587","GO:0071889; GO:0005524; GO:0051087; GO:0051879; GO:0005078; GO:0046872; GO:0031434; GO:0008022; GO:0004672","GO:0019933; GO:0000165; GO:0043410; GO:0006468; GO:0007265; GO:0042127; GO:0043405"]
[1284,637,"NK091-3","LATS1","Pan-specific","Large tumour suppressor 1 protein-serine kinase (WARTS)",0,30,4,664,{"v":17.264,"d":"17"},{"v":30.335384081599997,"d":"30"},{"$nulls":3},0,28,4,662,{"v":15.888,"d":"16"},{"v":27.7597535088,"d":"28"},{"$nulls":6},0,62,6,433,{"v":24.248,"d":"24"},{"v":41.4844822672,"d":"41"},{"$nulls":7},"LATS1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","NDR",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 3-28 at the N-terminus of human LATS1.",{"$nulls":3},"O95835","O95835","O95835","O95835"]
[1289,640,"PK678","LATS1","S909","Large tumour suppressor 1 protein-serine kinase (WARTS)",0,7497,16,772,{"v":5775.332,"d":"5775"},{"v":10148.1067202708,"d":"10148"},{"$f":"(L1302+L1303)/2","v":{"v":9897.4725578955,"d":"9897"}},{"$f":"SQRT((M1302-L1302)*(M1302-L1302))","v":{"v":250.63416237529964,"d":"251"}},{"$f":"N1302/M1302*100","v":{"v":2.5323046960646685,"d":"3"}},0,8962,20,755,{"v":6751.21,"d":"6751"},{"v":11795.816055271,"d":"11796"},{"$f":"(U1302+U1303)/2","v":{"v":10844.338622694198,"d":"10844"}},{"$f":"SQRT((V1302-U1302)*(V1302-U1302))","v":{"v":951.4774325768012,"d":"951"}},{"$f":"W1302/V1302*100","v":{"v":8.773955385214755,"d":"9"}},{"$f":"X1302+O1302","v":{"v":11.306260081279424,"d":"11"}},{"$f":"(V1302/M1302*100)-100","v":{"v":9.566746048144935,"d":"10"}},null,0,7670,18,784,{"v":5999.168,"d":"5999"},{"v":10263.6249799552,"d":"10264"},{"$f":"(AG1302+AG1303)/2","v":{"v":10902.499351433002,"d":"10902"}},{"$f":"SQRT((AH1302-AG1302)*(AH1302-AG1302))","v":{"v":638.8743714778011,"d":"639"}},{"$f":"AI1302/AH1302*100","v":{"v":5.85988910326171,"d":"6"}},{"$f":"AJ1302+O1302","v":{"v":8.392193799326378,"d":"8"}},{"$f":"(AH1302/M1302*100)-100","v":{"v":10.154378177444528,"d":"10"}},null,null,"LATS1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","NDR",{"$nulls":6},"LAH(pS)LVG(bA)C","Corresponds to amino acid residues L906 to G912; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","S909 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in LATS1 (≥13 reports from high throughput mass spectrometry studies).","LATS1; MST2 (CLIK1; STK3)","EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); AGC group; NDR family","O95835","O95835","O95835","O95835","GO:0005829; GO:0005815; GO:0000922","GO:0005524; GO:0030331; GO:0000287; GO:0019901; GO:0004674","GO:0051301; GO:0034613; GO:0051220; GO:0000082; GO:0000086; GO:0035329; GO:0009755; GO:0001827; GO:0001828; GO:0030216; GO:0060644; GO:0090090; GO:0045736; GO:0043065; GO:0033138; GO:0006468; GO:0030833; GO:0033146; GO:0046620; GO:0043254; GO:2000058; GO:0000819"]
[1293,642,"NK092-2","LATS2 (KPM)","Pan-specific","Large tumour suppressor 2 protein-serine kinase",0,5740,14,560,{"v":3206.56,"d":"3207"},{"v":5634.3969636639995,"d":"5634"},{"$f":"(L1306+L1307)/2","v":{"v":5578.0558054624,"d":"5578"}},{"$f":"SQRT((M1306-L1306)*(M1306-L1306))","v":{"v":56.34115820159968,"d":"56"}},{"$f":"N1306/M1306*100","v":{"v":1.0100500992913466,"d":"1"}},0,5634,14,589,{"v":3310.18,"d":"3310"},{"v":5783.5964797179995,"d":"5784"},{"$f":"(U1306+U1307)/2","v":{"v":5736.50990638055,"d":"5737"}},{"$f":"SQRT((V1306-U1306)*(V1306-U1306))","v":{"v":47.08657333744941,"d":"47"}},{"$f":"W1306/V1306*100","v":{"v":0.8208226623138297,"d":"1"}},{"$f":"X1306+O1306","v":{"v":1.8308727616051763,"d":"2"}},{"$f":"(V1306/M1306*100)-100","v":{"v":2.840668979377753,"d":"3"}},null,0,6118,16,562,{"v":3429.324,"d":"3429"},{"v":5867.029473213601,"d":"5867"},{"$f":"(AG1306+AG1307)/2","v":{"v":5866.7369193342,"d":"5867"}},{"$f":"SQRT((AH1306-AG1306)*(AH1306-AG1306))","v":{"v":0.292553879400657,"d":"0"}},{"$f":"AI1306/AH1306*100","v":{"v":0.004986654138802907,"d":"0"}},{"$f":"AJ1306+O1306","v":{"v":1.0150367534301494,"d":"1"}},{"$f":"(AH1306/M1306*100)-100","v":{"v":5.1752998524881235,"d":"5"}},null,null,"LATS2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","NDR",{"$nulls":6},"SQAESSDLESSDLVDQTEGC","Corresponds to amino acid residues S1064 to C1083; C-terminus.",null,null,"Protein-serine kinase, AGC group, NDR family","Q9NRM7","Q9NRM7","Q9NRM7","Q9NRM7","GO:0005829; GO:0005815; GO:0005634; GO:0000922","GO:0005524; GO:0046872; GO:0004674","GO:0051301; GO:0034613; GO:0000082; GO:0035329; GO:0009755; GO:0001827; GO:0001828; GO:0035556; GO:0030216; GO:0090090; GO:0045736; GO:0018105; GO:0043065; GO:0006468; GO:0046620"]
[1296,643,"NK353-4","Lck","Pan-specific","Lymphocyte-specific protein-tyrosine kinase",0,116,8,514,{"v":55.512,"d":"56"},{"v":97.5427387128,"d":"98"},{"$nulls":3},0,112,10,480,{"v":48.96,"d":"49"},{"v":85.54365129600001,"d":"86"},{"$nulls":6},0,118,10,531,{"v":57.348,"d":"57"},{"v":98.11333260720001,"d":"98"},{"$nulls":7},"LCK","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 1-225 of mouse Lck.",{"$nulls":3},"P06239","P06239","P06239","P06239"]
[1301,646,"PK149","Lck","Y394","Lymphocyte-specific protein-tyrosine kinase; Proto-oncogene tyrosine-protein kinase LCK",0,284,10,337,{"v":92.338,"d":"92"},{"v":162.2514304522,"d":"162"},{"$f":"(L1314+L1315)/2","v":{"v":183.4619506821,"d":"183"}},{"$f":"SQRT((M1314-L1314)*(M1314-L1314))","v":{"v":21.2105202299,"d":"21"}},{"$f":"N1314/M1314*100","v":{"v":11.561263875719526,"d":"12"}},0,367,12,383,{"v":135.965,"d":"136"},{"v":237.56010107150001,"d":"238"},{"$f":"(U1314+U1315)/2","v":{"v":162.33462854855,"d":"162"}},{"$f":"SQRT((V1314-U1314)*(V1314-U1314))","v":{"v":75.22547252295001,"d":"75"}},{"$f":"W1314/V1314*100","v":{"v":46.33975707804824,"d":"46"}},{"$f":"X1314+O1314","v":{"v":57.90102095376776,"d":"58"}},{"$f":"(V1314/M1314*100)-100","v":{"v":-11.515914910421444,"d":"-12"}},null,0,348,10,357,{"v":120.666,"d":"121"},{"v":206.4403883724,"d":"206"},{"$f":"(AG1314+AG1315)/2","v":{"v":224.73099377980003,"d":"225"}},{"$f":"SQRT((AH1314-AG1314)*(AH1314-AG1314))","v":{"v":18.290605407400022,"d":"18"}},{"$f":"AI1314/AH1314*100","v":{"v":8.138888677421082,"d":"8"}},{"$f":"AJ1314+O1314","v":{"v":19.700152553140608,"d":"20"}},{"$f":"(AH1314/M1314*100)-100","v":{"v":22.494606071866315,"d":"22"}},null,null,"LCK","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues that encompass the Y394 phosphosite.","Y394 phosphorylation stimulates phosphotransferase activity and induces interaction with Lck. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation regulates cell growth and molecular association.This is the major in vivo phosphorylation sites in Lck (≥2998 reports from high throughput mass spectrometry studies).","Lck","Protein-tyrosine kinase, TK group, Src family","P06239","P06239","P06239","P06239","GO:0005829; GO:0070062; GO:0031234; GO:0001772; GO:0045121; GO:0000242; GO:0005886","GO:0051117; GO:0005524; GO:0042609; GO:0042610; GO:0042802; GO:0016301; GO:0004715; GO:0043548; GO:0046934; GO:0001784; GO:0008022; GO:0019901; GO:0019903; GO:0004722; GO:0004713; GO:0042169; GO:0042608","GO:0006919; GO:0050853; GO:0016477; GO:0006882; GO:0030097; GO:0045087; GO:0050900; GO:0038083; GO:0018108; GO:0030168; GO:0034116; GO:2001244; GO:1903039; GO:0051897; GO:0050870; GO:0050862; GO:0006468; GO:0042127; GO:0050690; GO:0051249; GO:0051209; GO:0042493; GO:0031295; GO:0030217; GO:0050852; GO:0007169"]
[1306,648,"PN615","LEDGF","S273+S275","PC4 and SFRS1-interacting protein",0,2194,22,522,{"v":1133.784,"d":"1134"},{"v":1992.2250408696002,"d":"1992"},{"$nulls":3},0,1873,12,539,{"v":1003.079,"d":"1003"},{"v":1752.5947752928998,"d":"1753"},{"$nulls":6},0,2190,12,574,{"v":1250.172,"d":"1250"},{"v":2138.8460147208,"d":"2139"},{"$nulls":10},"Nucleus protein; Transcription protein,  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"TST(pS)D(pS)EEEGC","Corresponds to amino acid residues T270 to G279.","The effect of S273 and S275 phosphorylation are unclear. This are two of the major in vivo phosphorylation sites in LEDGF (≥135 and ≥154 reports, respectively, from high throughput mass spectrometry studies).","S275: CK2a1 (CSNK2A1).",null,"O75475","O75475",null,"O75475"]
[1307,649,"PN616","LEF1","T155","Lymphoid enhancer-binding factor 1",0,10254,16,662,{"v":6777.556,"d":"6778"},{"v":11909.161514976398,"d":"11909"},{"$f":"(L1320+L1321)/2","v":{"v":11990.73969552925,"d":"11991"}},{"$f":"SQRT((M1320-L1320)*(M1320-L1320))","v":{"v":81.57818055285134,"d":"82"}},{"$f":"N1320/M1320*100","v":{"v":0.6803431866948774,"d":"1"}},0,11749,14,678,{"v":7956.33,"d":"7956"},{"v":13901.419916583,"d":"13901"},{"$f":"(U1320+U1321)/2","v":{"v":11790.614595918301,"d":"11791"}},{"$f":"SQRT((V1320-U1320)*(V1320-U1320))","v":{"v":2110.8053206646982,"d":"2111"}},{"$f":"W1320/V1320*100","v":{"v":17.902419789002526,"d":"18"}},{"$f":"X1320+O1320","v":{"v":18.582762975697403,"d":"19"}},{"$f":"(V1320/M1320*100)-100","v":{"v":-1.66899711521188,"d":"-2"}},null,0,8486,16,657,{"v":5564.79,"d":"5565"},{"v":9520.473114306,"d":"9520"},{"$f":"(AG1320+AG1321)/2","v":{"v":10010.616344095499,"d":"10011"}},{"$f":"SQRT((AH1320-AG1320)*(AH1320-AG1320))","v":{"v":490.14322978949895,"d":"490"}},{"$f":"AI1320/AH1320*100","v":{"v":4.896234287098588,"d":"5"}},{"$f":"AJ1320+O1320","v":{"v":5.576577473793465,"d":"6"}},{"$f":"(AH1320/M1320*100)-100","v":{"v":-16.513771474599196,"d":"-17"}},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"VHPL(pT)PLIT(bA)C","Corresponds to amino acid residues V151 to T159.","T155 phosphorylation regulates transcription, although one report indicates inhibition, wheras another describes induction. This is one of the major in vivo phosphorylation sites in LEF1 (≥11 reports from high throughput mass spectrometry studies).","NLK","Transcription protein","Q9UJU2","Q9UJU2",null,"Q9UJU2","GO:1990907; GO:0005737; GO:0005654; GO:0005634; GO:0032993; GO:0005667","GO:0070016; GO:0008013; GO:0070742; GO:0003682; GO:0043027; GO:0003677; GO:0008301; GO:0003700; GO:0035326; GO:0030284; GO:0030331; GO:0045295; GO:0042393; GO:0042826; GO:0000978; GO:0000977; GO:0000981; GO:0043565; GO:0001077; GO:0001228; GO:0003705; GO:0044212","GO:0046632; GO:0060033; GO:1902262; GO:0060561; GO:0042100; GO:1904837; GO:0030509; GO:0001569; GO:0060070; GO:0060326; GO:0071345; GO:0071353; GO:0060710; GO:0021542; GO:0030326; GO:0001837; GO:0048069; GO:0060325; GO:0021873; GO:0021879; GO:0021861; GO:0021943; GO:0043966; GO:0043967; GO:0021854; GO:0030879; GO:0048747; GO:0043066; GO:0071866; GO:0022408; GO:0043154; GO:0043392; GO:0071899; GO:0032696; GO:0032713; GO:0032714; GO:0045843; GO:0045892; GO:0000122; GO:0001755; GO:0030223; GO:0071895; GO:0042475; GO:0001649; GO:0048341; GO:0043923; GO:0022409; GO:0090068; GO:0030307; GO:0030335; GO:0008284; GO:0071864; GO:0010718; GO:0010628; GO:0030854; GO:0045893; GO:0045944; GO:0022407; GO:0016202; GO:0030111; GO:0062009; GO:0050909; GO:0001756; GO:0002040; GO:0033153; GO:0045063; GO:0043586; GO:0061153; GO:0006366; GO:0007223"]
[1311,651,"PK681","LIMK1","T508","LIM domain kinase 1",0,12068,18,739,{"v":8904.95,"d":"8905"},{"v":15647.305287155,"d":"15647"},{"$f":"(L1324+L1325)/2","v":{"v":15971.1386750905,"d":"15971"}},{"$f":"SQRT((M1324-L1324)*(M1324-L1324))","v":{"v":323.83338793549956,"d":"324"}},{"$f":"N1324/M1324*100","v":{"v":2.0276161551371947,"d":"2"}},0,13636,16,760,{"v":10351.2,"d":"10351"},{"v":18085.772943120002,"d":"18086"},{"$f":"(U1324+U1325)/2","v":{"v":17894.2012906956,"d":"17894"}},{"$f":"SQRT((V1324-U1324)*(V1324-U1324))","v":{"v":191.5716524244017,"d":"192"}},{"$f":"W1324/V1324*100","v":{"v":1.070579509597965,"d":"1"}},{"$f":"X1324+O1324","v":{"v":3.09819566473516,"d":"3"}},{"$f":"(V1324/M1324*100)-100","v":{"v":12.040861047712383,"d":"12"}},null,0,12140,18,805,{"v":9758.21,"d":"9758"},{"v":16694.749657894,"d":"16695"},{"$f":"(AG1324+AG1325)/2","v":{"v":16802.927870457403,"d":"16803"}},{"$f":"SQRT((AH1324-AG1324)*(AH1324-AG1324))","v":{"v":108.17821256340176,"d":"108"}},{"$f":"AI1324/AH1324*100","v":{"v":0.6438057307476674,"d":"1"}},{"$f":"AJ1324+O1324","v":{"v":2.671421885884862,"d":"3"}},{"$f":"(AH1324/M1324*100)-100","v":{"v":5.208076971144251,"d":"5"}},null,null,"LIMK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","LISK","LIMK",{"$nulls":5},"KRY(pT)VVG(bA)C","Corresponds to amino acid residues K505 to G511; In the protein kinase catalytic domain.","T508 phosphorylation stimulates phosphotransferase activity and induced interaction with NISCH. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the minor in vivo phosphorylation sites in LIMK1 (≥2 reports from high throughput mass spectrometry studies).","MRCKa (CDC42BPA, PK428); PAK1; PAK4; ROCK1","EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); TKL group; LISK family; LIMK subfamily","P53667","P53667","P53667","P53667","GO:0005737; GO:0005829; GO:0005925; GO:0005794; GO:0030027; GO:0016020; GO:0043005; GO:0016607; GO:0005634","GO:0005524; GO:0031072; GO:0046872; GO:0046982; GO:0004672; GO:0004674","GO:0030036; GO:0038096; GO:0051444; GO:0007399; GO:0032233; GO:0045773; GO:0051496; GO:0006468; GO:0007266; GO:0007165"]
[1318,654,"PK682","LKB1 (STK11)","S31","Serine/threonine-protein kinase 11",0,3784,16,671,{"v":2528.328,"d":"2528"},{"v":4442.643707383199,"d":"4443"},{"$nulls":3},0,4598,14,655,{"v":3002.52,"d":"3003"},{"v":5246.048282052,"d":"5246"},{"$nulls":6},0,3649,18,653,{"v":2371.043,"d":"2371"},{"v":4056.4785255802003,"d":"4056"},{"$nulls":7},"LKB1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","LKB",{"$nulls":5},"RID(pS)TEV(bA)C","Corresponds to amino acid residues R28 to V34; In the post-Nterminal region.","The effect of S31 phosphorylation is unclear. This is a major site of phosphorylation for LKB1. This is one of the major in vivo phosphorylation sites in LKB1 (≥309 reports from high throughput mass spectrometry studies).",null,null,"Q15831","Q15831","Q15831","Q15831"]
[1323,657,"NK384-1","LMR2 (LMTK2, KPI-2)","Pan-specific","Protein-serine/threonine kinase LMTK2",0,162,10,485,{"v":73.72,"d":"74"},{"v":129.536869468,"d":"130"},{"$f":"(L1336+L1337)/2","v":{"v":129.1608400314,"d":"129"}},{"$f":"SQRT((M1336-L1336)*(M1336-L1336))","v":{"v":0.37602943659999255,"d":"0"}},{"$f":"N1336/M1336*100","v":{"v":0.2911326966506078,"d":"0"}},0,176,12,491,{"v":80.524,"d":"81"},{"v":140.6927487124,"d":"141"},{"$f":"(U1336+U1337)/2","v":{"v":135.1400991246,"d":"135"}},{"$f":"SQRT((V1336-U1336)*(V1336-U1336))","v":{"v":5.552649587800005,"d":"6"}},{"$f":"W1336/V1336*100","v":{"v":4.108809763917982,"d":"4"}},{"$f":"X1336+O1336","v":{"v":4.39994246056859,"d":"4"}},{"$f":"(V1336/M1336*100)-100","v":{"v":4.629312639764805,"d":"5"}},null,0,188,10,572,{"v":101.816,"d":"102"},{"v":174.19102798240002,"d":"174"},{"$f":"(AG1336+AG1337)/2","v":{"v":161.3083922404,"d":"161"}},{"$f":"SQRT((AH1336-AG1336)*(AH1336-AG1336))","v":{"v":12.88263574200002,"d":"13"}},{"$f":"AI1336/AH1336*100","v":{"v":7.986339435335056,"d":"8"}},{"$f":"AJ1336+O1336","v":{"v":8.277472131985665,"d":"8"}},{"$f":"(AH1336/M1336*100)-100","v":{"v":24.88955027017839,"d":"25"}},null,null,"LMR2","X","PSTK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Lmr",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 15-148 mapping near the N-terminus of human KPI-2.",null,null,"Receptor tyrosine kinase; EC 2.7.11.1; TK domain target; TK</A> group; Lmr family","Q8IWU2","Q8IWU2","Q8IWU2",null,"GO:0005829; GO:0005769; GO:0005794; GO:0030426; GO:0016021; GO:0043025; GO:0048471; GO:0055037","GO:0005524; GO:0070853; GO:0004864; GO:0004674","GO:0045022; GO:0032456; GO:0018105; GO:0018107; GO:0046777; GO:0006468; GO:0001881; GO:0033572"]
[1324,657,"NK384-1","LMR2 (LMTK2, KPI-2)","Pan-specific","Protein-serine/threonine kinase LMTK2",0,156,10,502,{"v":73.292,"d":"73"},{"v":128.7848105948,"d":"129"},{"$nulls":3},0,156,10,508,{"v":74.168,"d":"74"},{"v":129.58744953680002,"d":"130"},{"$nulls":6},0,174,10,529,{"v":86.756,"d":"87"},{"v":148.4257564984,"d":"148"},{"$nulls":7},"LMR2","X","PSTK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Lmr",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 15-148 mapping near the N-terminus of human KPI-2.",{"$nulls":3},"Q8IWU2","Q8IWU2","Q8IWU2"]
[1330,660,"PK686","LOK","T952","Lymphocyte-oriented protein-serine kinase; Serine-threonine-protein kinase 10",0,2064,14,613,{"v":1256.65,"d":"1257"},{"v":2208.118651885,"d":"2208"},{"$nulls":3},0,1772,12,564,{"v":992.64,"d":"993"},{"v":1734.355596864,"d":"1734"},{"$nulls":6},0,2153,16,611,{"v":1305.707,"d":"1306"},{"v":2233.8575918698,"d":"2234"},{"$nulls":7},"LOK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","SLK",{"$nulls":5},"NPS(pT)PSK(bA)C","Corresponds to amino acid residues N949 to K955; In the C-terminus of the kinase. This is the major in vivo site of phosphorylation in LOK.","The effect of T952 phosphorylation is unclear. This is the major in vivo phosphorylation site in LOK (≥109 reports from high throughput mass spectrometry studies).","ERK1 (MAPK3)",null,"O94804","O94804","O94804"]
[1335,663,"NK095","Lyn","Pan-specific","Yes-related protein-tyrosine kinase",0,148,12,455,{"v":61.88,"d":"62"},{"v":108.73225017200001,"d":"109"},{"$f":"(L1348+L1349)/2","v":{"v":122.52409619010001,"d":"123"}},{"$f":"SQRT((M1348-L1348)*(M1348-L1348))","v":{"v":13.791846018100003,"d":"14"}},{"$f":"N1348/M1348*100","v":{"v":11.256435629365114,"d":"11"}},0,183,8,478,{"v":83.65,"d":"84"},{"v":146.15454311500002,"d":"146"},{"$f":"(U1348+U1349)/2","v":{"v":132.03529789190003,"d":"132"}},{"$f":"SQRT((V1348-U1348)*(V1348-U1348))","v":{"v":14.119245223099995,"d":"14"}},{"$f":"W1348/V1348*100","v":{"v":10.693538355674939,"d":"11"}},{"$f":"X1348+O1348","v":{"v":21.949973985040053,"d":"22"}},{"$f":"(V1348/M1348*100)-100","v":{"v":7.762719332402241,"d":"8"}},null,0,206,8,513,{"v":101.574,"d":"102"},{"v":173.7770043636,"d":"174"},{"$f":"(AG1348+AG1349)/2","v":{"v":175.9480621002,"d":"176"}},{"$f":"SQRT((AH1348-AG1348)*(AH1348-AG1348))","v":{"v":2.171057736599977,"d":"2"}},{"$f":"AI1348/AH1348*100","v":{"v":1.2339196639537804,"d":"1"}},{"$f":"AJ1348+O1348","v":{"v":12.490355293318895,"d":"12"}},{"$f":"(AH1348/M1348*100)-100","v":{"v":43.60282391082569,"d":"44"}},null,null,"LYN","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 44-63 near the N-terminus of human Lyn.",null,null,"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; Src family","P07948","P07948","P07948","P07948","GO:0005913; GO:0005737; GO:0005829; GO:0070062; GO:0031234; GO:0098978; GO:0005794; GO:0034666; GO:0043231; GO:0042629; GO:0045121; GO:0030061; GO:0005758; GO:0005634; GO:0048471; GO:0005886; GO:0014069; GO:0099091","GO:0005524; GO:0019899; GO:0046875; GO:0043015; GO:0043208; GO:0005178; GO:0044325; GO:0016301; GO:0004715; GO:0051219; GO:0140031; GO:0005161; GO:0004713; GO:0017124; GO:0005102; GO:0031625","GO:0002250; GO:0001782; GO:0050853; GO:0007596; GO:0006974; GO:0031668; GO:0034605; GO:0071300; GO:0007417; GO:0050663; GO:0097028; GO:0048013; GO:0030218; GO:0038095; GO:0038096; GO:0002774; GO:0002431; GO:0002553; GO:0002768; GO:0006954; GO:0045087; GO:0060397; GO:0050900; GO:0031663; GO:0030889; GO:0008285; GO:0070373; GO:0050777; GO:1902532; GO:0043407; GO:0070667; GO:0002762; GO:0001933; GO:0034136; GO:0034144; GO:0031175; GO:0014003; GO:0038083; GO:0018108; GO:0030168; GO:0002576; GO:1902961; GO:0050861; GO:0030335; GO:0008284; GO:0051272; GO:2000670; GO:0060369; GO:0060252; GO:0070668; GO:0010976; GO:0070447; GO:0043552; GO:0001934; GO:0070304; GO:0042531; GO:0046777; GO:0006468; GO:0002902; GO:0050855; GO:0033628; GO:0001817; GO:0050707; GO:0070372; GO:0045646; GO:0050727; GO:0033003; GO:0043304; GO:0090025; GO:0090330; GO:0001932; GO:0051279; GO:0043200; GO:0048678; GO:0009743; GO:0042493; GO:0009725; GO:0032868; GO:0014070; GO:0006991; GO:0009636; GO:0007165; GO:0002223; GO:0031295; GO:0002513; GO:0007169; GO:0016032"]
[1340,665,"PK688","Lyn","Y508","Yes-related protein-tyrosine kinase; Tyrosine-protein kinase Lyn",0,8542,20,825,{"v":7030.65,"d":"7031"},{"v":12353.884852484998,"d":"12354"},{"$nulls":3},0,9180,22,803,{"v":7353.874,"d":"7354"},{"v":12848.7996962974,"d":"12849"},{"$nulls":6},0,8768,22,956,{"v":8361.176,"d":"8361"},{"v":14304.6460534864,"d":"14305"},{"$nulls":7},"LYN","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"EGQ(pY)QQQ(bA)C","Corresponds to amino acid residues E505 to Q511; Near the C-terminus of the kinase.","Y508 phosphorylation inhibits phosphotransferase activity. This is one of the major in vivo phosphorylation sites in Lyn (≥1583 reports from high throughput mass spectrometry studies).","CSK; CTK (MATK)",null,"P07948","P07948","P07948","P07948"]
[1341,666,"PN617","MAFG","S124","Transcription factor MafG",0,6436,20,775,{"v":4972.4,"d":"4972"},{"v":8737.23724556,"d":"8737"},{"$f":"(L1354+L1355)/2","v":{"v":12373.4172974254,"d":"12373"}},{"$f":"SQRT((M1354-L1354)*(M1354-L1354))","v":{"v":3636.1800518654,"d":"3636"}},{"$f":"N1354/M1354*100","v":{"v":29.38703160542398,"d":"29"}},0,15557,22,785,{"v":12194.975,"d":"12195"},{"v":21307.2444641225,"d":"21307"},{"$f":"(U1354+U1355)/2","v":{"v":18818.97166686135,"d":"18819"}},{"$f":"SQRT((V1354-U1354)*(V1354-U1354))","v":{"v":2488.27279726115,"d":"2488"}},{"$f":"W1354/V1354*100","v":{"v":13.222150717420933,"d":"13"}},{"$f":"X1354+O1354","v":{"v":42.609182322844916,"d":"43"}},{"$f":"(V1354/M1354*100)-100","v":{"v":52.09195014199602,"d":"52"}},null,0,12612,24,786,{"v":9894.168,"d":"9894"},{"v":16927.3522329552,"d":"16927"},{"$f":"(AG1354+AG1355)/2","v":{"v":11322.8334087369,"d":"11323"}},{"$f":"SQRT((AH1354-AG1354)*(AH1354-AG1354))","v":{"v":5604.518824218299,"d":"5605"}},{"$f":"AI1354/AH1354*100","v":{"v":49.497494327645526,"d":"49"}},{"$f":"AJ1354+O1354","v":{"v":78.88452593306951,"d":"79"}},{"$f":"(AH1354/M1354*100)-100","v":{"v":-8.490652690644325,"d":"-8"}},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"TVAR(pS)PVAC","Corresponds to amino acid residues T120 to A127.","S124 phosphorylation stabilizes protein. This is the major in vivo phosphorylation site in MAFG (≥10 reports from high throughput mass spectrometry studies).",null,null,"O15525","O15525",null,"O15525","GO:0005654","GO:0003700; GO:0046982; GO:0000978; GO:0000981; GO:0001077","GO:0030534; GO:0007596; GO:0001701; GO:0042127; GO:0030641; GO:0045604"]
[1346,668,"NK097-2","MAPKAPK2 (RPS6KC1)","Pan-specific","Mitogen-activated protein kinase-activated protein kinase 2",0,455,18,669,{"v":292.353,"d":"292"},{"v":513.7071676557,"d":"514"},{"$nulls":3},0,508,16,564,{"v":277.488,"d":"277"},{"v":484.8312236688,"d":"485"},{"$nulls":6},0,648,14,648,{"v":410.832,"d":"411"},{"v":702.8683940448,"d":"703"},{"$nulls":7},"MAPKAPK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","MAPKAPK","MAPKAPK",{"$nulls":5},"SRVLKEDKERWEDVKGC","Corresponds to amino acid residues S339 to K353.",{"$nulls":3},"P49137","P49137","P49137","P49137"]
[1353,672,"PK192","MAPKAPK2 (RPS6KC1)","T334","Mitogen-activated protein kinase-activated protein kinase 2",0,309,18,610,{"v":177.51,"d":"178"},{"v":311.911146219,"d":"312"},{"$f":"(L1366+L1367)/2","v":{"v":335.43758606309996,"d":"335"}},{"$f":"SQRT((M1366-L1366)*(M1366-L1366))","v":{"v":23.52643984409997,"d":"24"}},{"$f":"N1366/M1366*100","v":{"v":7.013656436125901,"d":"7"}},0,326,16,557,{"v":172.67,"d":"173"},{"v":301.691631317,"d":"302"},{"$f":"(U1366+U1367)/2","v":{"v":325.6249837568,"d":"326"}},{"$f":"SQRT((V1366-U1366)*(V1366-U1366))","v":{"v":23.933352439800046,"d":"24"}},{"$f":"W1366/V1366*100","v":{"v":7.349974244505509,"d":"7"}},{"$f":"X1366+O1366","v":{"v":14.36363068063141,"d":"14"}},{"$f":"(V1366/M1366*100)-100","v":{"v":-2.925313892657826,"d":"-3"}},null,0,364,16,654,{"v":227.592,"d":"228"},{"v":389.37381590880005,"d":"389"},{"$f":"(AG1366+AG1367)/2","v":{"v":470.3479393708001,"d":"470"}},{"$f":"SQRT((AH1366-AG1366)*(AH1366-AG1366))","v":{"v":80.97412346200002,"d":"81"}},{"$f":"AI1366/AH1366*100","v":{"v":17.215792115581877,"d":"17"}},{"$f":"AJ1366+O1366","v":{"v":24.229448551707776,"d":"24"}},{"$f":"(AH1366/M1366*100)-100","v":{"v":40.21921183344131,"d":"40"}},null,null,"MAPKAPK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","MAPKAPK","MAPKAPK",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues that encompass the Thr-334 phosphosite.","T334 phosphorylation stimulates phosphotransferase activity. This is one of the major in vivo phosphorylation sites in MAPKAPK2 (≥36 reports from high throughput mass spectrometry studies).","ERK1 (MAPK3); ERK2 (MAPK1); p38a MAPK (MAPK14)","Protein-serine kinase, CAMK group, MAPKAPK family, MAPKAPK subfamily","P49137","P49137","P49137","P49137","GO:0005813; GO:0005737; GO:0005829; GO:0070062; GO:0005654; GO:0005634","GO:0005524; GO:0009931; GO:0005516; GO:0004683; GO:0051019; GO:0004672; GO:0004674","GO:0070935; GO:0000187; GO:0006974; GO:0035924; GO:0006954; GO:0048839; GO:0006691; GO:0044351; GO:0000165; GO:0038066; GO:0018105; GO:0042535; GO:0046777; GO:0006468; GO:1900034; GO:0032675; GO:0043488; GO:0032680; GO:0034097; GO:0032496; GO:0002224; GO:0048010"]
[1357,674,"PK693","MAPKAPK5 (PRAK)","T186","MAP kinase-activated protein kinase 5",0,6986,22,770,{"v":5362.28,"d":"5362"},{"v":9422.313678932,"d":"9422"},{"$f":"(L1370+L1371)/2","v":{"v":9614.914550640999,"d":"9615"}},{"$f":"SQRT((M1370-L1370)*(M1370-L1370))","v":{"v":192.60087170899897,"d":"193"}},{"$f":"N1370/M1370*100","v":{"v":2.003146993086473,"d":"2"}},0,8372,20,730,{"v":6096.96,"d":"6097"},{"v":10652.700576096,"d":"10653"},{"$f":"(U1370+U1371)/2","v":{"v":10264.670310612499,"d":"10265"}},{"$f":"SQRT((V1370-U1370)*(V1370-U1370))","v":{"v":388.03026548350135,"d":"388"}},{"$f":"W1370/V1370*100","v":{"v":3.780250643630729,"d":"4"}},{"$f":"X1370+O1370","v":{"v":5.783397636717202,"d":"6"}},{"$f":"(V1370/M1370*100)-100","v":{"v":6.757790269994473,"d":"7"}},null,0,7433,20,773,{"v":5730.249,"d":"5730"},{"v":9803.5472215086,"d":"9804"},{"$f":"(AG1370+AG1371)/2","v":{"v":10273.1654870223,"d":"10273"}},{"$f":"SQRT((AH1370-AG1370)*(AH1370-AG1370))","v":{"v":469.61826551369995,"d":"470"}},{"$f":"AI1370/AH1370*100","v":{"v":4.571310236430542,"d":"5"}},{"$f":"AJ1370+O1370","v":{"v":6.574457229517016,"d":"7"}},{"$f":"(AH1370/M1370*100)-100","v":{"v":6.846144424002347,"d":"7"}},null,null,"MAPKAPK5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","MAPKAPK","MAPKAPK",{"$nulls":5},"PQF(pT)PYYV(bA)C","Corresponds to amino acid residues P183 to V190; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T186 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the less major in vivo phosphorylation sites in MAPKAPK5 (≥11 reports from high throughput mass spectrometry studies).",null,"Protein-serine kinase, CAMK group, MAPKAPK family, MAPKAPK subfamily","Q8IW41","Q8IW41","Q8IW41",null,"GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0009931; GO:0005516; GO:0004683; GO:0004708; GO:0051019; GO:0002039; GO:0004674","GO:0007166; GO:0032007; GO:0018105; GO:0051973; GO:1904355; GO:0032212; GO:0046777; GO:0007265; GO:1901796; GO:0006417; GO:0007165; GO:0090400"]
[1358,674,"PK693","MAPKAPK5 (PRAK)","T186","MAP kinase-activated protein kinase 5",0,7460,18,750,{"v":5581.5,"d":"5582"},{"v":9807.51542235,"d":"9808"},{"$nulls":3},0,7390,20,767,{"v":5652.79,"d":"5653"},{"v":9876.640045129,"d":"9877"},{"$nulls":6},0,7832,22,804,{"v":6279.24,"d":"6279"},{"v":10742.783752536,"d":"10743"},{"$nulls":7},"MAPKAPK5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","MAPKAPK","MAPKAPK",{"$nulls":5},"PQF(pT)PYYV(bA)C","Corresponds to amino acid residues P183 to V190; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T186 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the less major in vivo phosphorylation sites in MAPKAPK5 (≥11 reports from high throughput mass spectrometry studies).",null,null,"Q8IW41","Q8IW41","Q8IW41"]
[1363,677,"NK275-1","MARK2","Pan-specific","MAP/microtubule affinity-regulating protein-serine kinase 2",0,820,8,559,{"v":453.908,"d":"454"},{"v":797.5830350852,"d":"798"},{"$f":"(L1376+L1377)/2","v":{"v":700.9294127037999,"d":"701"}},{"$f":"SQRT((M1376-L1376)*(M1376-L1376))","v":{"v":96.65362238140006,"d":"97"}},{"$f":"N1376/M1376*100","v":{"v":13.789351770610333,"d":"14"}},0,680,11,536,{"v":358.584,"d":"359"},{"v":626.5233794184,"d":"627"},{"$f":"(U1376+U1377)/2","v":{"v":619.1728454927,"d":"619"}},{"$f":"SQRT((V1376-U1376)*(V1376-U1376))","v":{"v":7.350533925700006,"d":"7"}},{"$f":"W1376/V1376*100","v":{"v":1.1871537938410233,"d":"1"}},{"$f":"X1376+O1376","v":{"v":14.976505564451356,"d":"15"}},{"$f":"(V1376/M1376*100)-100","v":{"v":-11.664022900070364,"d":"-12"}},null,0,927,8,418,{"v":384.142,"d":"384"},{"v":657.2060370788,"d":"657"},{"$f":"(AG1376+AG1377)/2","v":{"v":492.6299377644,"d":"493"}},{"$f":"SQRT((AH1376-AG1376)*(AH1376-AG1376))","v":{"v":164.57609931440004,"d":"165"}},{"$f":"AI1376/AH1376*100","v":{"v":33.40765282379336,"d":"33"}},{"$f":"AJ1376+O1376","v":{"v":47.197004594403694,"d":"47"}},{"$f":"(AH1376/M1376*100)-100","v":{"v":-29.71761081274863,"d":"-30"}},null,null,"MARK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","MARK",{"$nulls":5},"PTLGHLDSKPSSKSNMIRGC","Corresponds to amino acid residues P19 to G37; Post-N-terminus.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; CAMKL family; MARK subfamily","Q7KZI7","Q7KZI7","Q7KZI7",null,"GO:0005884; GO:0005737; GO:0030425; GO:0016328; GO:0016020; GO:0097427; GO:0005739; GO:0005654; GO:0005886","GO:0005524; GO:0045296; GO:0008289; GO:0000287; GO:0030295; GO:0004674; GO:0003723; GO:0048156; GO:0050321","GO:0032147; GO:0000422; GO:0061564; GO:0030010; GO:0071963; GO:0045197; GO:0035556; GO:0000226; GO:0051646; GO:0001764; GO:0018105; GO:0018107; GO:0010976; GO:0046777; GO:0006468; GO:0050770; GO:0051493; GO:1904526; GO:0070507; GO:0016055"]
[1368,679,"NK276-1","MARK3","Pan-specific","MAP/microtubule affinity-regulating protein-serine kinase 3",0,265,8,401,{"v":103.057,"d":"103"},{"v":181.0862880733,"d":"181"},{"$nulls":3},0,306,12,477,{"v":140.238,"d":"140"},{"v":245.0259511938,"d":"245"},{"$nulls":6},0,326,8,372,{"v":118.296,"d":"118"},{"v":202.38569425440002,"d":"202"},{"$nulls":7},"MARK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","MARK",{"$nulls":5},"HGDGRQEVTSRTSRSGARC","Corresponds to amino acid residues H21 to C39; Post-N-terminus.",{"$nulls":3},"P27448","P27448","P27448"]
[1371,681,"PK697","MARK3","T507","MAP/microtubule affinity-regulating protein-serine kinase 3",0,8097,16,652,{"v":5268.812,"d":"5269"},{"v":9258.076672482799,"d":"9258"},{"$f":"(L1384+L1385)/2","v":{"v":9174.1447936574,"d":"9174"}},{"$f":"SQRT((M1384-L1384)*(M1384-L1384))","v":{"v":83.9318788253986,"d":"84"}},{"$f":"N1384/M1384*100","v":{"v":0.9148741459086781,"d":"1"}},0,9511,16,660,{"v":6266.7,"d":"6267"},{"v":10949.27286717,"d":"10949"},{"$f":"(U1384+U1385)/2","v":{"v":11171.256545625001,"d":"11171"}},{"$f":"SQRT((V1384-U1384)*(V1384-U1384))","v":{"v":221.9836784550007,"d":"222"}},{"$f":"W1384/V1384*100","v":{"v":1.9870967741935543,"d":"2"}},{"$f":"X1384+O1384","v":{"v":2.9019709201022326,"d":"3"}},{"$f":"(V1384/M1384*100)-100","v":{"v":21.76891467146143,"d":"22"}},null,0,8394,16,511,{"v":4281.158,"d":"4281"},{"v":7324.382346341201,"d":"7324"},{"$f":"(AG1384+AG1385)/2","v":{"v":7289.945675221301,"d":"7290"}},{"$f":"SQRT((AH1384-AG1384)*(AH1384-AG1384))","v":{"v":34.436671119899984,"d":"34"}},{"$f":"AI1384/AH1384*100","v":{"v":0.472385840088645,"d":"0"}},{"$f":"AJ1384+O1384","v":{"v":1.3872599859973231,"d":"1"}},{"$f":"(AH1384/M1384*100)-100","v":{"v":-20.53814454442393,"d":"-21"}},null,null,"MARK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","MARK",{"$nulls":5},"RRN(pT)YVC(bA)C","Corresponds to amino acid residues R504 to C510; In the C-terminal quarter of the protein kinase. This is the major in vivo phosphorylation site in MARK3.","The effect of T507 phosphorylation is unclear. This is the major in vivo phosphorylation site in MARK3 (≥317 reports from high throughput mass spectrometry studies).","PKACa (PRKACA)","EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; CAMKL family; MARK subfamily","P27448","P27448","P27448",null,"GO:0005737; GO:0005829; GO:0030425; GO:0070062; GO:0005886","GO:0005524; GO:0004674; GO:0050321","GO:0030010; GO:0000165; GO:0000226; GO:0035331; GO:0036289; GO:0018105; GO:0032092; GO:0006468"]
[1375,683,"NK277-2","MARK4","Pan-specific","MAP/microtubule affinity-regulating protein-serine kinase 4",0,1336,16,577,{"v":761.64,"d":"762"},{"v":1338.313364916,"d":"1338"},{"$f":"(L1388+L1389)/2","v":{"v":1115.4913236738998,"d":"1115"}},{"$f":"SQRT((M1388-L1388)*(M1388-L1388))","v":{"v":222.8220412421001,"d":"223"}},{"$f":"N1388/M1388*100","v":{"v":19.97523750415466,"d":"20"}},0,1052,16,585,{"v":606.06,"d":"606"},{"v":1058.917183506,"d":"1059"},{"$f":"(U1388+U1389)/2","v":{"v":1157.8252831019,"d":"1158"}},{"$f":"SQRT((V1388-U1388)*(V1388-U1388))","v":{"v":98.90809959590001,"d":"99"}},{"$f":"W1388/V1388*100","v":{"v":8.54257555431143,"d":"9"}},{"$f":"X1388+O1388","v":{"v":28.51781305846609,"d":"29"}},{"$f":"(V1388/M1388*100)-100","v":{"v":3.795095356597855,"d":"4"}},null,0,1282,12,440,{"v":558.8,"d":"559"},{"v":956.01817432,"d":"956"},{"$f":"(AG1388+AG1389)/2","v":{"v":768.6938723305,"d":"769"}},{"$f":"SQRT((AH1388-AG1388)*(AH1388-AG1388))","v":{"v":187.3243019895,"d":"187"}},{"$f":"AI1388/AH1388*100","v":{"v":24.369168108700613,"d":"24"}},{"$f":"AJ1388+O1388","v":{"v":44.34440561285527,"d":"44"}},{"$f":"(AH1388/M1388*100)-100","v":{"v":-31.089211003561502,"d":"-31"}},null,null,"MARK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","MARK",{"$nulls":5},"CSSRTVLAPGNDRNSDTHGT","Corresponds to amino acid residues S2 to T20; N-terminus.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; CAMKL family; MARK subfamily","Q96L34","Q96L34","Q96L34","Q96L34","GO:0005813; GO:0036064; GO:0005737; GO:0005829; GO:0030425; GO:0000930; GO:0015630; GO:0005815; GO:0030496; GO:0043005","GO:0005524; GO:0043015; GO:0008017; GO:0004674; GO:0050321; GO:0043130","GO:0007049; GO:0051301; GO:0097711; GO:0044782; GO:0030010; GO:0001578; GO:0000226; GO:0007399; GO:0045724; GO:0043068; GO:1904781; GO:0006468; GO:0046605"]
[1380,685,"PN235","MBP","T232","Myelin basic protein",0,24,4,695,{"v":13.9,"d":"14"},{"v":24.42434191,"d":"24"},{"$nulls":3},0,44,11,672,{"v":22.176,"d":"22"},{"v":38.7462420576,"d":"39"},{"$nulls":6},0,28,6,671,{"v":14.762,"d":"15"},{"v":25.2554407468,"d":"25"},{"$nulls":20},"Not precisely defined.","Antibody raised against amino acid residues that encompass the Thr-125 phosphosite.","The effect of T232 phosphorylation is unclear. This is the main phosphosite targeted by the ERK1 and ERK2 MAP kinases. This is one of the less major in vivo phosphorylation sites in myelin basic protein (≥19 reports from high throughput mass spectrometry studies).","CDK9; ERK1 (MAPK3); ERK2 (MAPK1)",null,"P02686","P02686"]
[1385,688,"PN620","MCM2","Y137+S139","DNA replication licensing factor MCM2",0,16484,24,841,{"v":13842.86,"d":"13843"},{"v":24323.938536134,"d":"24324"},{"$f":"(L1398+L1399)/2","v":{"v":22952.5943237918,"d":"22953"}},{"$f":"SQRT((M1398-L1398)*(M1398-L1398))","v":{"v":1371.3442123421992,"d":"1371"}},{"$f":"N1398/M1398*100","v":{"v":5.9746806526385345,"d":"6"}},0,17159,20,755,{"v":12939.945,"d":"12940"},{"v":22608.8672971695,"d":"22609"},{"$f":"(U1398+U1399)/2","v":{"v":24839.30705655385,"d":"24839"}},{"$f":"SQRT((V1398-U1398)*(V1398-U1398))","v":{"v":2230.4397593843496,"d":"2230"}},{"$f":"W1398/V1398*100","v":{"v":8.979476578417062,"d":"9"}},{"$f":"X1398+O1398","v":{"v":14.954157231055596,"d":"15"}},{"$f":"(V1398/M1398*100)-100","v":{"v":8.220041299672843,"d":"8"}},null,0,11637,16,658,{"v":7646.618,"d":"7647"},{"v":13082.150644385201,"d":"13082"},{"$f":"(AG1398+AG1399)/2","v":{"v":14547.772013999002,"d":"14548"}},{"$f":"SQRT((AH1398-AG1398)*(AH1398-AG1398))","v":{"v":1465.6213696138002,"d":"1466"}},{"$f":"AI1398/AH1398*100","v":{"v":10.074541780029717,"d":"10"}},{"$f":"AJ1398+O1398","v":{"v":16.04922243266825,"d":"16"}},{"$f":"(AH1398/M1398*100)-100","v":{"v":-36.61818002455903,"d":"-37"}},{"$nulls":5},"DNA binding protein",{"$nulls":4},"X",{"$nulls":4},"CGLL(pY)D(pS)DEE","Corresponds to amino acid residues C134 to E142.","Y137 and S139 phosphorylation stimulates transcriptional activty and induces interaction with DNA. These are two of the major in vivo phosphorylation sites in MCM2.","S139: CDC7 (CDC7L1); CDK2; CDK7; CK2a1 (CSNK2A1); CK2a1 (CSNK2A1)","DNA binding protein","P49736","P49736",null,"P49736","GO:0000785; GO:0005737; GO:0042555; GO:0015630; GO:0000784; GO:0005664; GO:0005654; GO:0005634","GO:0005524; GO:0003677; GO:0003688; GO:0019899; GO:0004386; GO:0042393; GO:0046872","GO:0006915; GO:0071353; GO:0090102; GO:0006260; GO:0006270; GO:0006268; GO:0000082; GO:1905775; GO:0006334"]
[1390,690,"PN169","MDM2","S166","E3 ubiquitin-protein ligase double minute 2 protein",0,3290,10,321,{"v":1052.88,"d":"1053"},{"v":1850.0648280720002,"d":"1850"},{"$nulls":3},0,3296,14,376,{"v":1234.032,"d":"1234"},{"v":2156.1193442832,"d":"2156"},{"$nulls":6},0,2730,14,344,{"v":934.304,"d":"934"},{"v":1598.4459633856,"d":"1598"},{"$nulls":10},"DNA binding protein",{"$nulls":9},"AI(pS)ET","Corresponds to amino acid residues A164 to T168.","S166 phosphorylation induces transcriptional activity and binding to ARF1 and p300. This is the major in vivo phosphorylation site in MDM2 (≥24 reports from high throughput mass spectrometry studies).","AKT1; CK1D; DAPK3; MAPKAPK2; PIM1; PKM",null,"Q00987","Q00987",null,"Q00987"]
[1394,692,"PN622","MEF2A","T108","Myocyte-specific enhancer factor 2A",0,638,12,936,{"v":585.936,"d":"586"},{"v":1029.5756259984,"d":"1030"},{"$nulls":3},0,13772,12,755,{"v":10388.8,"d":"10389"},{"v":18151.46823088,"d":"18151"},{"$nulls":6},0,9334,14,553,{"v":5153.96,"d":"5154"},{"v":8817.608141944,"d":"8818"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"SYVL(pT)PHTE(bA)C","Corresponds to amino acid residues S104 to E112.","The effect of T108 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in MEF2A (≥26 reports from high throughput mass spectrometry studies).","p38a MAPK (MAPK14)",null,"Q02078","Q02078"]
[1397,694,"PN623","MEF2C","S396","Myocyte-specific enhancer factor 2C",0,6954,12,477,{"v":3311.334,"d":"3311"},{"v":5818.500272964599,"d":"5819"},{"$f":"(L1410+L1411)/2","v":{"v":6621.2545913765,"d":"6621"}},{"$f":"SQRT((M1410-L1410)*(M1410-L1410))","v":{"v":802.7543184119004,"d":"803"}},{"$f":"N1410/M1410*100","v":{"v":12.12390049851587,"d":"12"}},0,10068,36,568,{"v":5698.176,"d":"5698"},{"v":9955.9391496576,"d":"9956"},{"$f":"(U1410+U1411)/2","v":{"v":9866.432814514801,"d":"9866"}},{"$f":"SQRT((V1410-U1410)*(V1410-U1410))","v":{"v":89.5063351427998,"d":"90"}},{"$f":"W1410/V1410*100","v":{"v":0.9071803034134523,"d":"1"}},{"$f":"X1410+O1410","v":{"v":13.031080801929322,"d":"13"}},{"$f":"(V1410/M1410*100)-100","v":{"v":49.01153064503532,"d":"49"}},null,0,9620,16,445,{"v":4273.78,"d":"4274"},{"v":7311.7597584919995,"d":"7312"},{"$f":"(AG1410+AG1411)/2","v":{"v":7276.944136002,"d":"7277"}},{"$f":"SQRT((AH1410-AG1410)*(AH1410-AG1410))","v":{"v":34.81562248999944,"d":"35"}},{"$f":"AI1410/AH1410*100","v":{"v":0.47843740228473663,"d":"0"}},{"$f":"AJ1410+O1410","v":{"v":12.602337900800606,"d":"13"}},{"$f":"(AH1410/M1410*100)-100","v":{"v":9.902799168596658,"d":"10"}},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"SEPV(pS)PPRD(bA)C","Corresponds to amino acid residues S392 to D400.","S396 phosphorylation induces MEF2C transcriptional activity and facilitates its sumoylation at K391, which in turn recruits co-repressors to inhibit transcription. This is one of the less major in vivo phosphorylation sites in MEF2C (≥8 reports from high throughput mass spectrometry studies).","CDK1 (CDC2)","Transcription protein","Q06413","Q06413",null,"Q06413","GO:0005737; GO:0005829; GO:0043231; GO:0016607; GO:0005654; GO:0005634; GO:0098794; GO:0032991; GO:0016528","GO:0033613; GO:0003680; GO:0003682; GO:0003677; GO:0003700; GO:0042826; GO:0071837; GO:0046982; GO:0000980; GO:0000978; GO:0000977; GO:0000981; GO:0001205; GO:0001077; GO:0000983; GO:0044212","GO:0006915; GO:0001782; GO:0042100; GO:0050853; GO:0001568; GO:0001974; GO:0014898; GO:0003211; GO:0060536; GO:0048667; GO:0071277; GO:0035690; GO:0071498; GO:0071222; GO:0071374; GO:0071560; GO:0035984; GO:0002062; GO:0048703; GO:0001958; GO:2001013; GO:0060079; GO:0002467; GO:0072102; GO:0007507; GO:0001947; GO:0006959; GO:0007611; GO:0000165; GO:0030318; GO:0030224; GO:0007521; GO:0007517; GO:0014902; GO:0043537; GO:0010629; GO:0043524; GO:0030279; GO:0000122; GO:1904753; GO:1905563; GO:1904706; GO:0072160; GO:0007399; GO:0014033; GO:0048666; GO:0030182; GO:0001764; GO:0001649; GO:0003151; GO:0030220; GO:0010694; GO:0030890; GO:2000987; GO:0030501; GO:2000727; GO:0060045; GO:0071864; GO:0010628; GO:2000111; GO:0043406; GO:0051149; GO:0045663; GO:0045666; GO:0045669; GO:0090073; GO:2001016; GO:0048643; GO:0045893; GO:0045944; GO:0003138; GO:2000311; GO:0060998; GO:0002634; GO:0045652; GO:0043523; GO:0046928; GO:2000310; GO:0060297; GO:0051963; GO:0060025; GO:0048167; GO:0051966; GO:0006355; GO:0061333; GO:0002931; GO:0060021; GO:0003139; GO:0003185; GO:0035914; GO:0007519; GO:0051145; GO:0055012"]
[1402,696,"PN625","MEF2D","S180","Myocyte-specific enhancer factor 2D",0,6907,12,560,{"v":3861.2,"d":"3861"},{"v":6784.6956102799995,"d":"6785"},{"$nulls":3},0,7810,16,718,{"v":5596.092,"d":"5596"},{"v":9777.5764433892,"d":"9778"},{"$nulls":6},0,6931,18,645,{"v":4458.885,"d":"4459"},{"v":7628.445055839001,"d":"7628"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"PRLL(pS)PQQ(bA)C","Corresponds to amino acid residues P176 to Q183.","S180 phosphorylation stimulates transcriptional activity. This is the major in vivo phosphorylation site in MEF2D (≥51 reports from high throughput mass spectrometry studies).","ERK5 (MAPK7)",null,"Q14814","Q14814",null,"Q14814"]
[1407,699,"NK099-3","MEK1 (MKK1, MAP2K1)","Pan-specific","MAPK/ERK protein-serine kinase 1 (MKK1); Dual specificity mitogen-activated protein kinase kinase 1",0,2158,18,774,{"v":1656.36,"d":"1656"},{"v":2910.4678392839996,"d":"2910"},{"$f":"(L1420+L1421)/2","v":{"v":2501.2406263023,"d":"2501"}},{"$f":"SQRT((M1420-L1420)*(M1420-L1420))","v":{"v":409.2272129816997,"d":"409"}},{"$f":"N1420/M1420*100","v":{"v":16.360969379690562,"d":"16"}},0,1880,19,711,{"v":1323.171,"d":"1323"},{"v":2311.8643510821003,"d":"2312"},{"$f":"(U1420+U1421)/2","v":{"v":2550.10499243505,"d":"2550"}},{"$f":"SQRT((V1420-U1420)*(V1420-U1420))","v":{"v":238.24064135294975,"d":"238"}},{"$f":"W1420/V1420*100","v":{"v":9.342385590385359,"d":"9"}},{"$f":"X1420+O1420","v":{"v":25.70335497007592,"d":"26"}},{"$f":"(V1420/M1420*100)-100","v":{"v":1.9536051677278437,"d":"2"}},null,0,2210,8,568,{"v":1250.736,"d":"1251"},{"v":2139.8109292704003,"d":"2140"},{"$f":"(AG1420+AG1421)/2","v":{"v":2008.8922128182003,"d":"2009"}},{"$f":"SQRT((AH1420-AG1420)*(AH1420-AG1420))","v":{"v":130.9187164522,"d":"131"}},{"$f":"AI1420/AH1420*100","v":{"v":6.516960721777052,"d":"7"}},{"$f":"AJ1420+O1420","v":{"v":22.877930101467616,"d":"23"}},{"$f":"(AH1420/M1420*100)-100","v":{"v":-19.684168260610775,"d":"-20"}},null,null,"MEK1","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"EFQDFVNKCLIKNPAERADLKC","Corresponds to amino acid residues E333 to K353; Kinase catalytic subdomain 11.",null,null,"Protein kinase, dual-specificity; EC 2.7.12.2; STE domain target; STE</A> group; STE7 family","Q02750","Q02750","Q02750",null,"GO:0005829; GO:0005769; GO:0005783; GO:0005925; GO:0005794; GO:0005770; GO:0005815; GO:0005739; GO:0005634; GO:0005886","GO:0005524; GO:0004708; GO:0008022; GO:0004672; GO:0047485; GO:0004712; GO:0043539; GO:0004674; GO:0004713; GO:0097110","GO:0000187; GO:0060020; GO:0007050; GO:0048870; GO:0090398; GO:0021697; GO:0006935; GO:0060502; GO:0070371; GO:0060324; GO:0007507; GO:0030216; GO:0060711; GO:0000165; GO:0008285; GO:0010629; GO:0030182; GO:0018107; GO:0060674; GO:0050772; GO:0070374; GO:0010628; GO:1903800; GO:0071902; GO:0045893; GO:0006468; GO:0042981; GO:0048679; GO:2000641; GO:0090170; GO:0007346; GO:0032872; GO:0007165; GO:0048538; GO:0030878; GO:0060440"]
[1408,699,"NK099-3","MEK1 (MKK1, MAP2K1)","Pan-specific","MAPK/ERK protein-serine kinase 1 (MKK1); Dual specificity mitogen-activated protein kinase kinase 1",0,1726,8,693,{"v":1190.574,"d":"1191"},{"v":2092.0134133206,"d":"2092"},{"$nulls":3},0,2060,14,780,{"v":1595.88,"d":"1596"},{"v":2788.345633788,"d":"2788"},{"$nulls":6},0,1884,14,587,{"v":1097.69,"d":"1098"},{"v":1877.973496366,"d":"1878"},{"$nulls":7},"MEK1","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"EFQDFVNKCLIKNPAERADLKC","Corresponds to amino acid residues E333 to K353; Kinase catalytic subdomain 11.",{"$nulls":3},"Q02750","Q02750","Q02750"]
[1412,701,"PK698","MEK1 (MKK1, MAP2K1)","S222","MAPK/ERK protein-serine kinase 1 (MKK1); Dual specificity mitogen-activated protein kinase kinase 1",0,3192,18,642,{"v":2037.708,"d":"2038"},{"v":3580.5522953052,"d":"3581"},{"$nulls":3},0,3679,20,761,{"v":2784.499,"d":"2784"},{"v":4865.1186987349,"d":"4865"},{"$nulls":6},0,1986,12,830,{"v":1638.42,"d":"1638"},{"v":2803.0767665880003,"d":"2803"},{"$nulls":7},"MEK1","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"MAN(pS)YIC(bA)C","Corresponds to amino acid residues M219 to S222; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S222 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation sites in MEK1 (≥213 reports from high throughput mass spectrometry studies).","A-Raf (RafA); B-Raf (RafB); COT (MAP3K8); MEKK1 (MAP3K1); Mos; PDPK1 (PDK1); Plk1; Raf1.",null,"Q02750","Q02750","Q02750"]
[1419,705,"PK194","MEK1 (MKK1, MAP2K1)","S298","MAPK/ERK protein-serine kinase 1 (MKK1); Dual specificity mitogen-activated protein kinase kinase 1",0,1330,14,706,{"v":929.096,"d":"929"},{"v":1632.5581562024,"d":"1633"},{"$f":"(L1432+L1433)/2","v":{"v":1528.5719598073001,"d":"1529"}},{"$f":"SQRT((M1432-L1432)*(M1432-L1432))","v":{"v":103.9861963950998,"d":"104"}},{"$f":"N1432/M1432*100","v":{"v":6.802832913944649,"d":"7"}},0,763,12,561,{"v":421.311,"d":"421"},{"v":736.1209409961,"d":"736"},{"$f":"(U1432+U1433)/2","v":{"v":1132.55793193325,"d":"1133"}},{"$f":"SQRT((V1432-U1432)*(V1432-U1432))","v":{"v":396.4369909371501,"d":"396"}},{"$f":"W1432/V1432*100","v":{"v":35.00368323414956,"d":"35"}},{"$f":"X1432+O1432","v":{"v":41.80651614809421,"d":"42"}},{"$f":"(V1432/M1432*100)-100","v":{"v":-25.907450763650914,"d":"-26"}},null,0,1396,12,597,{"v":826.248,"d":"826"},{"v":1413.5792850672,"d":"1414"},{"$f":"(AG1432+AG1433)/2","v":{"v":1350.3876471168,"d":"1350"}},{"$f":"SQRT((AH1432-AG1432)*(AH1432-AG1432))","v":{"v":63.191637950400036,"d":"63"}},{"$f":"AI1432/AH1432*100","v":{"v":4.679518365361228,"d":"5"}},{"$f":"AJ1432+O1432","v":{"v":11.482351279305878,"d":"11"}},{"$f":"(AH1432/M1432*100)-100","v":{"v":-11.656913601435093,"d":"-12"}},null,null,"MEK1","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues surrounding the phosphorylated Ser-298 of human MEK1.","S298 phosphorylation stimulates phosphotransferase activity. Phosphorylation induces interaction with ERK1 and Raf1 and regulates cell growth. MAPK1/ERK2 phosphorylation of Thr-292 in response to cellular adhesion leads to inhibition of S298 phosphorylation by PAK. This is one of the minor in vivo phosphorylation sites in MEK1 (≥3 reports from high throughput mass spectrometry studies).","MEK1 (MAP2K1); PAK1; PAK2; PAK3 (STK4)","Protein kinase, dual-specificity; EC 2.7.12.2; STE domain target; STE</A> group; STE7 family","Q02750","Q02750","Q02750",null,"GO:0005829; GO:0005769; GO:0005783; GO:0005925; GO:0005794; GO:0005770; GO:0005815; GO:0005739; GO:0005634; GO:0005886","GO:0005524; GO:0004708; GO:0008022; GO:0004672; GO:0047485; GO:0004712; GO:0043539; GO:0004674; GO:0004713; GO:0097110","GO:0000187; GO:0060020; GO:0007050; GO:0048870; GO:0090398; GO:0021697; GO:0006935; GO:0060502; GO:0070371; GO:0060324; GO:0007507; GO:0030216; GO:0060711; GO:0000165; GO:0008285; GO:0010629; GO:0030182; GO:0018107; GO:0060674; GO:0050772; GO:0070374; GO:0010628; GO:1903800; GO:0071902; GO:0045893; GO:0006468; GO:0042981; GO:0048679; GO:2000641; GO:0090170; GO:0007346; GO:0032872; GO:0007165; GO:0048538; GO:0030878; GO:0060440"]
[1424,707,"NK100-5","MEK2 (MKK2, MAP2K2)","Pan-specific","MAPK/ERK protein-serine kinase 2 (MKK2); Dual specificity mitogen-activated protein kinase kinase 2",0,7173,16,719,{"v":5145.883,"d":"5146"},{"v":9042.0723612127,"d":"9042"},{"$nulls":3},0,7221,16,682,{"v":4913.81,"d":"4914"},{"v":8585.483030531,"d":"8585"},{"$nulls":6},0,7211,15,680,{"v":4893.28,"d":"4893"},{"v":8371.626005792,"d":"8372"},{"$nulls":7},"MEK2","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"PNGVFTPDFQEFVNKC","Corresponds to amino acid residues P334 to C349.",{"$nulls":3},"P36507","P36507","P36507"]
[1425,708,"NK100-4","MEK2 (MKK2, MAP2K2)","Pan-specific","MAPK/ERK protein-serine kinase 2 (MKK2); Dual specificity mitogen-activated protein kinase kinase 2",0,6381,18,781,{"v":4969.503,"d":"4970"},{"v":8732.146790990699,"d":"8732"},{"$f":"(L1438+L1439)/2","v":{"v":8221.84409545375,"d":"8222"}},{"$f":"SQRT((M1438-L1438)*(M1438-L1438))","v":{"v":510.3026955369496,"d":"510"}},{"$f":"N1438/M1438*100","v":{"v":6.206669569654336,"d":"6"}},0,6071,14,771,{"v":4669.947,"d":"4670"},{"v":8159.4019145997,"d":"8159"},{"$f":"(U1438+U1439)/2","v":{"v":7582.902177101851,"d":"7583"}},{"$f":"SQRT((V1438-U1438)*(V1438-U1438))","v":{"v":576.4997374978493,"d":"576"}},{"$f":"W1438/V1438*100","v":{"v":7.602626593795581,"d":"8"}},{"$f":"X1438+O1438","v":{"v":13.809296163449917,"d":"14"}},{"$f":"(V1438/M1438*100)-100","v":{"v":-7.771272611520331,"d":"-8"}},null,0,5164,14,564,{"v":2904.6,"d":"2905"},{"v":4969.30993044,"d":"4969"},{"$f":"(AG1438+AG1439)/2","v":{"v":5301.373981131601,"d":"5301"}},{"$f":"SQRT((AH1438-AG1438)*(AH1438-AG1438))","v":{"v":332.06405069160064,"d":"332"}},{"$f":"AI1438/AH1438*100","v":{"v":6.263735625395743,"d":"6"}},{"$f":"AJ1438+O1438","v":{"v":12.470405195050079,"d":"12"}},{"$f":"(AH1438/M1438*100)-100","v":{"v":-35.5208646675387,"d":"-36"}},null,null,"MEK2","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"CLKMLTNHTFIKRSEV","Corresponds to amino acid residues L360 to V374; Kinase last alpha-chain.",null,null,"Protein kinase, dual-specificity, STE group, STE7 family, N/A subfamily","P36507","P36507","P36507",null,"GO:0005911; GO:0009898; GO:0005829; GO:0005769; GO:0005783; GO:0005576; GO:0005925; GO:0005794; GO:0005770; GO:0005874; GO:0005739; GO:0005634; GO:0048471; GO:0005778","GO:0005524; GO:0004708; GO:0046872; GO:0030165; GO:0004712; GO:0043539; GO:0004674; GO:0004713; GO:0097110","GO:0000187; GO:0070371; GO:0000165; GO:0010629; GO:0036289; GO:1903800; GO:0071902; GO:0045893; GO:0042981; GO:2000641; GO:0090170; GO:0007346; GO:0032872"]
[1430,710,"PK049-2","MEK2 (MKK2, MAP2K2)","T394","MAPK/ERK protein-serine kinase 2 (MKK2); Dual specificity mitogen-activated protein kinase kinase 2",0,188,8,437,{"v":78.66,"d":"79"},{"v":138.217175154,"d":"138"},{"$nulls":3},0,43,8,653,{"v":22.855,"d":"23"},{"v":39.9326011105,"d":"40"},{"$nulls":6},0,43,8,656,{"v":22.96,"d":"23"},{"v":39.280918544,"d":"39"},{"$nulls":7},"MEK2","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues that encompass the T394 phosphosite.","The effect of T394 phosphorylation is unclear. However, based on similarity with the T386 phosphosite in MEK1, phosphorylation likely promotes binding to ERK2. This is one of the major in vivo phosphorylation sites in MEK2 (≥111 reports from high throughput mass spectrometry studies).","ERK2 (MAPK1)",null,"P36507","P36507","P36507"]
[1434,712,"NK104-2","MEK5 (MAP2K5, MKK5)","Pan-specific","MAPK/ERK protein-serine kinase 5 (MKK5); Dual specificity mitogen-activated protein kinase kinase 5",0,181,10,428,{"v":73.188,"d":"73"},{"v":128.6020673172,"d":"129"},{"$nulls":3},0,131,12,436,{"v":51.884,"d":"52"},{"v":90.6525082484,"d":"91"},{"$nulls":6},0,180,14,430,{"v":71.38,"d":"71"},{"v":122.119859132,"d":"122"},{"$nulls":7},"MEK5","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"AFEYEDEDGDRITVRSC","Corresponds to amino acid residues A59 to S74; Post-N-terminus.",{"$nulls":3},"Q13163","Q13163","Q13163","Q13163"]
[1441,716,"NK108-3","MEKK2 (MAP3K2)","Pan-specific","MAPK/ERK kinase kinase 2; Mitogen-activated protein kinase kinase kinase 2",0,5916,12,709,{"v":4185.936,"d":"4186"},{"v":7355.304465998399,"d":"7355"},{"$f":"(L1454+L1455)/2","v":{"v":8564.281276193,"d":"8564"}},{"$f":"SQRT((M1454-L1454)*(M1454-L1454))","v":{"v":1208.976810194601,"d":"1209"}},{"$f":"N1454/M1454*100","v":{"v":14.116500511903041,"d":"14"}},0,2501,18,799,{"v":1983.917,"d":"1984"},{"v":3466.3297395467,"d":"3466"},{"$f":"(U1454+U1455)/2","v":{"v":7213.31726142905,"d":"7213"}},{"$f":"SQRT((V1454-U1454)*(V1454-U1454))","v":{"v":3746.98752188235,"d":"3747"}},{"$f":"W1454/V1454*100","v":{"v":51.94541410119571,"d":"52"}},{"$f":"X1454+O1454","v":{"v":66.06191461309875,"d":"66"}},{"$f":"(V1454/M1454*100)-100","v":{"v":-15.774400340158863,"d":"-16"}},null,0,6676,12,644,{"v":4291.616,"d":"4292"},{"v":7342.2743257024,"d":"7342"},{"$f":"(AG1454+AG1455)/2","v":{"v":6528.7829267336,"d":"6529"}},{"$f":"SQRT((AH1454-AG1454)*(AH1454-AG1454))","v":{"v":813.4913989688002,"d":"813"}},{"$f":"AI1454/AH1454*100","v":{"v":12.460077293085869,"d":"12"}},{"$f":"AJ1454+O1454","v":{"v":26.576577804988908,"d":"27"}},{"$f":"(AH1454/M1454*100)-100","v":{"v":-23.767299132475728,"d":"-24"}},null,null,"MEKK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"CSSSPKKQNDVRVKFE","Corresponds to amino acid residues S39 to E45.",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.25; STE domain target; STE</A> group; STE11 family","Q9Y2U5","Q9Y2U5","Q9Y2U5","Q9Y2U5","GO:0005737; GO:0005829; GO:0005654","GO:0005524; GO:0004709; GO:0046872; GO:0004672; GO:0019901; GO:0004674","GO:0007257; GO:0000187; GO:0071260; GO:0045893; GO:0006468; GO:0042981; GO:0007346"]
[1442,716,"NK108-3","MEKK2 (MAP3K2)","Pan-specific","MAPK/ERK kinase kinase 2; Mitogen-activated protein kinase kinase kinase 2",0,7602,14,733,{"v":5562.004,"d":"5562"},{"v":9773.2580863876,"d":"9773"},{"$nulls":3},0,8574,16,733,{"v":6273.014,"d":"6273"},{"v":10960.3047833114,"d":"10960"},{"$nulls":6},0,5122,14,654,{"v":3340.632,"d":"3341"},{"v":5715.291527764801,"d":"5715"},{"$nulls":7},"MEKK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"CSSSPKKQNDVRVKFE","Corresponds to amino acid residues S39 to E45.",{"$nulls":3},"Q9Y2U5","Q9Y2U5","Q9Y2U5","Q9Y2U5"]
[1447,719,"NK225-2","MEKK6 (MAP3K6)","Pan-specific","Mitogen-activated protein kinase kinase kinase 6",0,5390,16,753,{"v":4046.622,"d":"4047"},{"v":7110.509302771799,"d":"7111"},{"$f":"(L1460+L1461)/2","v":{"v":6898.591236617649,"d":"6899"}},{"$f":"SQRT((M1460-L1460)*(M1460-L1460))","v":{"v":211.91806615415044,"d":"212"}},{"$f":"N1460/M1460*100","v":{"v":3.071903507331926,"d":"3"}},0,5411,24,690,{"v":3717.03,"d":"3717"},{"v":6494.4509431530005,"d":"6494"},{"$f":"(U1460+U1461)/2","v":{"v":6837.3261815921,"d":"6837"}},{"$f":"SQRT((V1460-U1460)*(V1460-U1460))","v":{"v":342.8752384390991,"d":"343"}},{"$f":"W1460/V1460*100","v":{"v":5.014756197564633,"d":"5"}},{"$f":"X1460+O1460","v":{"v":8.08665970489656,"d":"8"}},{"$f":"(V1460/M1460*100)-100","v":{"v":-0.8880806663881629,"d":"-1"}},null,0,5800,10,680,{"v":3937.2,"d":"3937"},{"v":6735.92476008,"d":"6736"},{"$f":"(AG1460+AG1461)/2","v":{"v":6612.9049983715995,"d":"6613"}},{"$f":"SQRT((AH1460-AG1460)*(AH1460-AG1460))","v":{"v":123.01976170840044,"d":"123"}},{"$f":"AI1460/AH1460*100","v":{"v":1.8602983369441046,"d":"2"}},{"$f":"AJ1460+O1460","v":{"v":4.9322018442760305,"d":"5"}},{"$f":"(AH1460/M1460*100)-100","v":{"v":-4.141225772729214,"d":"-4"}},null,null,"ASK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"CGKRSRSPSSPRHAPR","Corresponds to amino acid residues G909 to R923; Post-kinase last alpha-chain.",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.25; STE group; STE11 family","O95382","O95382","O95382","O95382","GO:0005622","GO:0005524; GO:0000287; GO:0004709","GO:0007257; GO:0006468; GO:0007165"]
[1452,721,"NK229-3","MELK","Pan-specific","Maternal embryonic leucine zipper kinase",0,8207,24,1082,{"v":8854.006,"d":"8854"},{"v":15557.789195481399,"d":"15558"},{"$nulls":3},0,8440,22,1050,{"v":8838.9,"d":"8839"},{"v":15443.459547389999,"d":"15443"},{"$nulls":6},0,8310,21,967,{"v":8015.463,"d":"8015"},{"v":13713.1859405682,"d":"13713"},{"$nulls":7},"MELK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","MELK",{"$nulls":5},"CKKRISMKNLLNHPWI","Corresponds to amino acid residues K249 to I263; Kinase last alpha-chain.",{"$nulls":3},"Q14680","Q14680","Q14680"]
[1457,724,"PK703","MERTK (MER)","Y749+Y753","Tyrosine-protein kinase Mer; Proto-oncogene tyrosine-protein kinase MER",0,9294,24,901,{"v":8352.27,"d":"8352"},{"v":14676.165338463,"d":"14676"},{"$f":"(L1470+L1471)/2","v":{"v":14290.4276652405,"d":"14290"}},{"$f":"SQRT((M1470-L1470)*(M1470-L1470))","v":{"v":385.73767322250023,"d":"386"}},{"$f":"N1470/M1470*100","v":{"v":2.6992731236501344,"d":"3"}},0,8540,24,826,{"v":7034.216,"d":"7034"},{"v":12290.2884118616,"d":"12290"},{"$f":"(U1470+U1471)/2","v":{"v":13685.121676063402,"d":"13685"}},{"$f":"SQRT((V1470-U1470)*(V1470-U1470))","v":{"v":1394.8332642018013,"d":"1395"}},{"$f":"W1470/V1470*100","v":{"v":10.192333668771827,"d":"10"}},{"$f":"X1470+O1470","v":{"v":12.89160679242196,"d":"13"}},{"$f":"(V1470/M1470*100)-100","v":{"v":-4.235744397275269,"d":"-4"}},null,0,9452,22,831,{"v":7836.33,"d":"7836"},{"v":13406.717788062,"d":"13407"},{"$f":"(AG1470+AG1471)/2","v":{"v":13363.738030411201,"d":"13364"}},{"$f":"SQRT((AH1470-AG1470)*(AH1470-AG1470))","v":{"v":42.979757650799,"d":"43"}},{"$f":"AI1470/AH1470*100","v":{"v":0.3216147873670681,"d":"0"}},{"$f":"AJ1470+O1470","v":{"v":3.0208879110172027,"d":"3"}},{"$f":"(AH1470/M1470*100)-100","v":{"v":-6.484687908139691,"d":"-6"}},null,null,"MERTK","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Axl",{"$nulls":6},"KI(pY)SGD(pY)Y(bA)C","Corresponds to amino acid residues K747 to Y754; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y749 and Y753 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in MERTK (≥449 and ≥403 reports, respectively, from high throughput mass spectrometry studies).","Y749: MER (MERTK). Y753: MER (MERTK). ","EC 2.7.10.1; Receptor tyrosine kinase; TK domain target; TK</A> group; Axl family","Q12866","Q12866","Q12866","Q12866","GO:0005737; GO:0005615; GO:0005887; GO:0001750; GO:0005886; GO:0016028","GO:0005524; GO:0004714","GO:0043277; GO:0007267; GO:0007166; GO:0050900; GO:0001779; GO:0001818; GO:2000107; GO:0051250; GO:0097350; GO:0006909; GO:0030168; GO:0050766; GO:0043491; GO:0006468; GO:0060041; GO:0032940; GO:0007283; GO:0034446; GO:0060068"]
[1459,725,"PK704","MERTK (MER)","Y753","Tyrosine-protein kinase Mer; Proto-oncogene tyrosine-protein kinase MER",0,4878,14,751,{"v":3652.864,"d":"3653"},{"v":6418.6186537216,"d":"6419"},{"$f":"(L1472+L1473)/2","v":{"v":5969.2634769846,"d":"5969"}},{"$f":"SQRT((M1472-L1472)*(M1472-L1472))","v":{"v":449.35517673699997,"d":"449"}},{"$f":"N1472/M1472*100","v":{"v":7.527816094390154,"d":"8"}},0,4242,20,722,{"v":3048.284,"d":"3048"},{"v":5326.0078338884005,"d":"5326"},{"$f":"(U1472+U1473)/2","v":{"v":5886.8796059243,"d":"5887"}},{"$f":"SQRT((V1472-U1472)*(V1472-U1472))","v":{"v":560.8717720359,"d":"561"}},{"$f":"W1472/V1472*100","v":{"v":9.527488407805434,"d":"10"}},{"$f":"X1472+O1472","v":{"v":17.05530450219559,"d":"17"}},{"$f":"(V1472/M1472*100)-100","v":{"v":-1.380134607526415,"d":"-1"}},null,0,4980,14,712,{"v":3535.792,"d":"3536"},{"v":6049.1793353888,"d":"6049"},{"$f":"(AG1472+AG1473)/2","v":{"v":5819.1207814894005,"d":"5819"}},{"$f":"SQRT((AH1472-AG1472)*(AH1472-AG1472))","v":{"v":230.05855389939916,"d":"230"}},{"$f":"AI1472/AH1472*100","v":{"v":3.9534933633138274,"d":"4"}},{"$f":"AJ1472+O1472","v":{"v":11.481309457703981,"d":"11"}},{"$f":"(AH1472/M1472*100)-100","v":{"v":-2.515263333141476,"d":"-3"}},null,null,"MERTK","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Axl",{"$nulls":6},"SGD(pY)YRQG(bA)C","Corresponds to amino acid residues S750 to G757; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y753 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in MERTK (≥403 reports from high throughput mass spectrometry studies).","MER (MERTK)","EC 2.7.10.1; Receptor tyrosine kinase; TK domain target; TK</A> group; Axl family","Q12866","Q12866","Q12866","Q12866","GO:0005737; GO:0005615; GO:0005887; GO:0001750; GO:0005886; GO:0016028","GO:0005524; GO:0004714","GO:0043277; GO:0007267; GO:0007166; GO:0050900; GO:0001779; GO:0001818; GO:2000107; GO:0051250; GO:0097350; GO:0006909; GO:0030168; GO:0050766; GO:0043491; GO:0006468; GO:0060041; GO:0032940; GO:0007283; GO:0034446; GO:0060068"]
[1464,727,"NK110-3","Met","Pan-specific","Hepatocyte growth factor (HGF) receptor-tyrosine kinase",0,5696,12,817,{"v":4643.828,"d":"4644"},{"v":8159.887974333201,"d":"8160"},{"$nulls":3},0,6411,12,776,{"v":4965.624,"d":"4966"},{"v":8676.0132337224,"d":"8676"},{"$nulls":6},0,6712,20,798,{"v":5340.216,"d":"5340"},{"v":9136.2626177424,"d":"9136"},{"$nulls":7},"MET","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Met",{"$nulls":6},"CEMRPSFSELVSRISA","Corresponds to amino acid residues E1325 to A1349; In the C-terminal part of the cytoplasmic portion immediately after the kinase catalytic domain.",{"$nulls":3},"P08581","P08581","P08581","P08581"]
[1469,730,"PK709","Met","Y1230","Hepatocyte growth factor (HGF) receptor-tyrosine kinase",0,6264,18,763,{"v":4765.698,"d":"4766"},{"v":8374.0314670362,"d":"8374"},{"$f":"(L1482+L1483)/2","v":{"v":8489.591990061599,"d":"8490"}},{"$f":"SQRT((M1482-L1482)*(M1482-L1482))","v":{"v":115.56052302539865,"d":"116"}},{"$f":"N1482/M1482*100","v":{"v":1.3612023188002487,"d":"1"}},0,3901,16,767,{"v":2979.795,"d":"2980"},{"v":5206.3428189045,"d":"5206"},{"$f":"(U1482+U1483)/2","v":{"v":6902.19416300225,"d":"6902"}},{"$f":"SQRT((V1482-U1482)*(V1482-U1482))","v":{"v":1695.8513440977504,"d":"1696"}},{"$f":"W1482/V1482*100","v":{"v":24.569742665136868,"d":"25"}},{"$f":"X1482+O1482","v":{"v":25.930944983937117,"d":"26"}},{"$f":"(V1482/M1482*100)-100","v":{"v":-18.698163927284696,"d":"-19"}},null,0,6243,16,672,{"v":4184.544,"d":"4185"},{"v":7159.0911153216,"d":"7159"},{"$f":"(AG1482+AG1483)/2","v":{"v":7226.999543011801,"d":"7227"}},{"$f":"SQRT((AH1482-AG1482)*(AH1482-AG1482))","v":{"v":67.90842769020037,"d":"68"}},{"$f":"AI1482/AH1482*100","v":{"v":0.939648982763046,"d":"1"}},{"$f":"AJ1482+O1482","v":{"v":2.3008513015632945,"d":"2"}},{"$f":"(AH1482/M1482*100)-100","v":{"v":-14.87223942596843,"d":"-15"}},null,null,"MET","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Met",{"$nulls":6},"M(pY)DKEYY(bA)C","Corresponds to amino acid residues M1229 to Y1235; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y1230 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major in vivo phosphorylation sites in MEK1 (≥114 reports from high throughput mass spectrometry studies).","Met","Receptor tyrosine kinase; EC 2.7.10.1; TK group; Met family","P08581","P08581","P08581","P08581","GO:0009925; GO:0009986; GO:0005576; GO:0016021; GO:0005887; GO:0005622; GO:0005886","GO:0005524; GO:0005008; GO:0042802; GO:0046934; GO:0019903; GO:0004713; GO:0005088","GO:0048754; GO:0008283; GO:0007166; GO:0001886; GO:0035635; GO:0061436; GO:0000165; GO:0010507; GO:1905098; GO:1901299; GO:0035024; GO:0051497; GO:0070495; GO:0050918; GO:2001028; GO:0031116; GO:0051897; GO:0045944; GO:0071526; GO:0007165"]
[1474,732,"PK711","Met","Y1234+Y1235","Hepatocyte growth factor (HGF) receptor-tyrosine kinase",0,6898,18,744,{"v":5118.72,"d":"5119"},{"v":8994.342979968,"d":"8994"},{"$nulls":3},0,7688,24,722,{"v":5533.408,"d":"5533"},{"v":9668.0540120608,"d":"9668"},{"$nulls":6},0,7263,26,740,{"v":5355.38,"d":"5355"},{"v":9162.205816732001,"d":"9162"},{"$nulls":7},"MET","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Met",{"$nulls":6},"KE(pY)(pY)SVH(bA)C","Corresponds to amino acid residues K1232 to H1238; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y1234 and Y1235 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. Y1234 and Y1235 phosphorylation induces binding to PTPN1 and PTPN2, and Y1234 phosphorylation also induces interaction with Grb2. These are two of the major in vivo phosphorylation sites in Met (≥746 and ≥446 reports, respectively, from high throughput mass spectrometry studies).","Y1234: Met; Ron (MST1R). Y1235: Met; Ron (MST1R). ",null,"P08581","P08581","P08581","P08581"]
[1475,733,"PK705","Met","S1236","Hepatocyte growth factor (HGF) receptor-tyrosine kinase",0,8994,22,829,{"v":7437.788,"d":"7438"},{"v":13069.2861270572,"d":"13069"},{"$f":"(L1488+L1489)/2","v":{"v":13188.5190871036,"d":"13189"}},{"$f":"SQRT((M1488-L1488)*(M1488-L1488))","v":{"v":119.23296004639997,"d":"119"}},{"$f":"N1488/M1488*100","v":{"v":0.9040663266203404,"d":"1"}},0,9446,22,767,{"v":7228.208,"d":"7228"},{"v":12629.2341635408,"d":"12629"},{"$f":"(U1488+U1489)/2","v":{"v":13540.225127820398,"d":"13540"}},{"$f":"SQRT((V1488-U1488)*(V1488-U1488))","v":{"v":910.9909642795992,"d":"911"}},{"$f":"W1488/V1488*100","v":{"v":6.728034103419988,"d":"7"}},{"$f":"X1488+O1488","v":{"v":7.632100430040328,"d":"8"}},{"$f":"(V1488/M1488*100)-100","v":{"v":2.666759159189567,"d":"3"}},null,0,9346,24,782,{"v":7289.804,"d":"7290"},{"v":12471.698481085601,"d":"12472"},{"$f":"(AG1488+AG1489)/2","v":{"v":12598.752406815202,"d":"12599"}},{"$f":"SQRT((AH1488-AG1488)*(AH1488-AG1488))","v":{"v":127.05392572960045,"d":"127"}},{"$f":"AI1488/AH1488*100","v":{"v":1.0084643433493587,"d":"1"}},{"$f":"AJ1488+O1488","v":{"v":1.9125306699696991,"d":"2"}},{"$f":"(AH1488/M1488*100)-100","v":{"v":-4.471818832677741,"d":"-4"}},null,null,"MET","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Met",{"$nulls":6},"EYY(pS)VHN(bA)C","Corresponds to amino acid residues E1233 to N1239; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Phosphorylation of S1236 is likely to stimulate phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in Met (≥178 reports from high throughput mass spectrometry studies).",null,"Receptor tyrosine kinase; EC 2.7.10.1; TK group; Met family","P08581","P08581","P08581","P08581","GO:0009925; GO:0009986; GO:0005576; GO:0016021; GO:0005887; GO:0005622; GO:0005886","GO:0005524; GO:0005008; GO:0042802; GO:0046934; GO:0019903; GO:0004713; GO:0005088","GO:0048754; GO:0008283; GO:0007166; GO:0001886; GO:0035635; GO:0061436; GO:0000165; GO:0010507; GO:1905098; GO:1901299; GO:0035024; GO:0051497; GO:0070495; GO:0050918; GO:2001028; GO:0031116; GO:0051897; GO:0045944; GO:0071526; GO:0007165"]
[1481,736,"PN626","MITF","S414","Microphthalmia-associated transcription factor",0,11060,18,881,{"v":9728.002,"d":"9728"},{"v":17093.5285574938,"d":"17094"},{"$f":"(L1494+L1495)/2","v":{"v":16870.2479009108,"d":"16870"}},{"$f":"SQRT((M1494-L1494)*(M1494-L1494))","v":{"v":223.28065658299965,"d":"223"}},{"$f":"N1494/M1494*100","v":{"v":1.3235173418580592,"d":"1"}},0,11896,30,865,{"v":10264.09,"d":"10264"},{"v":17933.573035759,"d":"17934"},{"$f":"(U1494+U1495)/2","v":{"v":17597.1030878765,"d":"17597"}},{"$f":"SQRT((V1494-U1494)*(V1494-U1494))","v":{"v":336.4699478824987,"d":"336"}},{"$f":"W1494/V1494*100","v":{"v":1.9120757899878937,"d":"2"}},{"$f":"X1494+O1494","v":{"v":3.235593131845953,"d":"3"}},{"$f":"(V1494/M1494*100)-100","v":{"v":4.308503296661456,"d":"4"}},null,0,9706,20,823,{"v":7971.578,"d":"7972"},{"v":13638.105665729201,"d":"13638"},{"$f":"(AG1494+AG1495)/2","v":{"v":14810.132964371802,"d":"14810"}},{"$f":"SQRT((AH1494-AG1494)*(AH1494-AG1494))","v":{"v":1172.0272986426007,"d":"1172"}},{"$f":"AI1494/AH1494*100","v":{"v":7.913685187446353,"d":"8"}},{"$f":"AJ1494+O1494","v":{"v":9.237202529304412,"d":"9"}},{"$f":"(AH1494/M1494*100)-100","v":{"v":-12.21152735063113,"d":"-12"}},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"TGLA(pS)PDL(bA)C","Corresponds to amino acid residues T410 to D417.","The effect of S414 phosphorylation is unclear. This is the major in vivo phosphorylation sites in MITF (≥24 reports from high throughput mass spectrometry studies).","p38a MAPK (MAPK14)","Transcription protein","O75030","O75030",null,"O75030","GO:0005654; GO:0005634; GO:0032991","GO:0003682; GO:0070888; GO:0046983; GO:0000978; GO:0000981; GO:0001077; GO:0001227; GO:0003705","GO:0046849; GO:0043010; GO:0044336; GO:0045165; GO:0030318; GO:0030336; GO:0000122; GO:0030316; GO:2000144; GO:0010628; GO:0045893; GO:0045944; GO:0065003; GO:0042127; GO:0045670; GO:2001141; GO:0006355"]
[1486,738,"NK101-4","MKK3 (MAP2K3, MEK3)","Pan-specific","MAPK/ERK protein-serine kinase 3 beta isoform (MKK3 beta); Dual specificity mitogen-activated protein kinase kinase 3",0,4730,16,823,{"v":3879.622,"d":"3880"},{"v":6817.0657704718,"d":"6817"},{"$nulls":3},0,5188,12,856,{"v":4430.656,"d":"4431"},{"v":7741.3090661056,"d":"7741"},{"$nulls":6},0,5132,16,812,{"v":4154.192,"d":"4154"},{"v":7107.163657148801,"d":"7107"},{"$nulls":7},"MKK3","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"SRTFITIGDRNFEVEA","Corresponds to amino acid residues S46 to A61.",{"$nulls":3},"P46734","P46734","P46734"]
[1491,741,"PK713","MKK3 (MAP2K3, MEK3)","S218","MAPK/ERK protein-serine kinase 3 beta isoform (MKK3 beta); Dual specificity mitogen-activated protein kinase kinase 3",0,20338,36,1123,{"v":22799.146,"d":"22799"},{"v":40061.4487165474,"d":"40061"},{"$f":"(L1504+L1505)/2","v":{"v":38219.37187828279,"d":"38219"}},{"$f":"SQRT((M1504-L1504)*(M1504-L1504))","v":{"v":1842.0768382646056,"d":"1842"}},{"$f":"N1504/M1504*100","v":{"v":4.819746499578974,"d":"5"}},0,19844,23,1103,{"v":21862.563,"d":"21863"},{"v":38198.6001983013,"d":"38199"},{"$f":"(U1504+U1505)/2","v":{"v":38093.84853780345,"d":"38094"}},{"$f":"SQRT((V1504-U1504)*(V1504-U1504))","v":{"v":104.75166049784457,"d":"105"}},{"$f":"W1504/V1504*100","v":{"v":0.2749831390595556,"d":"0"}},{"$f":"X1504+O1504","v":{"v":5.09472963863853,"d":"5"}},{"$f":"(V1504/M1504*100)-100","v":{"v":-0.3284285803521101,"d":"-0"}},null,0,19752,32,1137,{"v":22421.64,"d":"22422"},{"v":38359.869967896004,"d":"38360"},{"$f":"(AG1504+AG1505)/2","v":{"v":36176.63788389361,"d":"36177"}},{"$f":"SQRT((AH1504-AG1504)*(AH1504-AG1504))","v":{"v":2183.2320840023967,"d":"2183"}},{"$f":"AI1504/AH1504*100","v":{"v":6.034922568010128,"d":"6"}},{"$f":"AJ1504+O1504","v":{"v":10.854669067589102,"d":"11"}},{"$f":"(AH1504/M1504*100)-100","v":{"v":-5.344760769210637,"d":"-5"}},null,null,"MKK3","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"YLVD(pS)VAK(bA)C","Corresponds to amino acid residues Y214 to K221; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S218 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in MKK3 (≥74 reports from high throughput mass spectrometry studies).","ASK1 (MAP3K5); COT (MAP3K8); MEKK3 (MAP3K3); MKK3 (MAP2K3, MEK3); MLK3 (MAP3K11)","Protein kinase, dual-specificity, STE group, STE7 family, N/A subfamily","P46734","P46734","P46734",null,"GO:0005737; GO:0005829; GO:0016020; GO:0005654","GO:0005524; GO:0004708; GO:0019901; GO:0004674; GO:0004713","GO:0000187; GO:0032147; GO:0060048; GO:0035924; GO:0006954; GO:0038066; GO:0043536; GO:0045860; GO:0045893; GO:0042981; GO:0042035; GO:0007346; GO:0007165; GO:0023014; GO:0031098"]
[1492,741,"PK713","MKK3 (MAP2K3, MEK3)","S218","MAPK/ERK protein-serine kinase 3 beta isoform (MKK3 beta); Dual specificity mitogen-activated protein kinase kinase 3",0,18554,20,1117,{"v":20702.478,"d":"20702"},{"v":36377.295040018194,"d":"36377"},{"$nulls":3},0,19360,16,1124,{"v":21742.656,"d":"21743"},{"v":37989.0968773056,"d":"37989"},{"$nulls":6},0,18126,30,1098,{"v":19869.408,"d":"19869"},{"v":33993.4057998912,"d":"33993"},{"$nulls":7},"MKK3","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"YLVD(pS)VAK(bA)C","Corresponds to amino acid residues Y214 to K221; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S218 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in MKK3 (≥74 reports from high throughput mass spectrometry studies).","ASK1 (MAP3K5); COT (MAP3K8); MEKK3 (MAP3K3); MKK3 (MAP2K3, MEK3); MLK3 (MAP3K11)",null,"P46734","P46734","P46734"]
[1498,744,"NK103-6","MKK4 (MAP2K4, MEK4)","Pan-specific","MAPK/ERK protein-serine kinase 4 (MKK4); Dual specificity mitogen-activated protein kinase kinase 4",0,9024,16,776,{"v":6990.208,"d":"6990"},{"v":12282.8223175552,"d":"12283"},{"$nulls":3},0,11275,20,792,{"v":8913.96,"d":"8914"},{"v":15574.605512795999,"d":"15575"},{"$nulls":6},0,9086,14,751,{"v":6813.072,"d":"6813"},{"v":11656.0856387808,"d":"11656"},{"$nulls":7},"MKK4","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"CLDQMPATPSSPMYVD","Corresponds to amino acid residues L385 to D399; C-terminus.",{"$nulls":3},"P45985","P45985","P45985","P45985"]
[1503,747,"NK105-4","MKK6 (MAP2K6, MEK6)","Pan-specific","MAPK/ERK protein-serine kinase 6 (MKK6); Dual specificity mitogen-activated protein kinase kinase 6",0,3368,14,778,{"v":2609.412,"d":"2609"},{"v":4585.1202066228,"d":"4585"},{"$f":"(L1516+L1517)/2","v":{"v":4544.498484588599,"d":"4544"}},{"$f":"SQRT((M1516-L1516)*(M1516-L1516))","v":{"v":40.6217220342005,"d":"41"}},{"$f":"N1516/M1516*100","v":{"v":0.8938658945966812,"d":"1"}},0,3041,14,758,{"v":2294.466,"d":"2294"},{"v":4008.9256416365997,"d":"4009"},{"$f":"(U1516+U1517)/2","v":{"v":4410.1858198573,"d":"4410"}},{"$f":"SQRT((V1516-U1516)*(V1516-U1516))","v":{"v":401.26017822070025,"d":"401"}},{"$f":"W1516/V1516*100","v":{"v":9.098486880393711,"d":"9"}},{"$f":"X1516+O1516","v":{"v":9.992352774990392,"d":"10"}},{"$f":"(V1516/M1516*100)-100","v":{"v":-2.9555002644798662,"d":"-3"}},null,0,3422,14,737,{"v":2511.696,"d":"2512"},{"v":4297.1135010144,"d":"4297"},{"$f":"(AG1516+AG1517)/2","v":{"v":4361.0023068353,"d":"4361"}},{"$f":"SQRT((AH1516-AG1516)*(AH1516-AG1516))","v":{"v":63.888805820900416,"d":"64"}},{"$f":"AI1516/AH1516*100","v":{"v":1.4650027981127889,"d":"1"}},{"$f":"AJ1516+O1516","v":{"v":2.35886869270947,"d":"2"}},{"$f":"(AH1516/M1516*100)-100","v":{"v":-4.0377651874145215,"d":"-4"}},null,null,"MKK6","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"CSKERPTYPELMQHPF","Corresponds to amino acid residues S299 to F313; Kinase last alpha-chain.",null,null,"Protein kinase, dual-specificity, STE group, STE7 family, N/A subfamily","P52564","P52564","P52564",null,"GO:0005737; GO:0005856; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0042802; GO:0004708; GO:0019901; GO:0004674; GO:0004713","GO:0000187; GO:0032147; GO:0006915; GO:0060048; GO:0007050; GO:0072709; GO:0006975; GO:0120163; GO:0070423; GO:0022602; GO:0043065; GO:0051770; GO:0032308; GO:0042981; GO:0007346; GO:0006355; GO:0042493; GO:0002931; GO:0007165; GO:0023014; GO:0031098; GO:0006351"]
[1508,749,"NK106-4","MKK7 (MEK7, MAP2K7)","Pan-specific","MAPK/ERK protein-serine kinase 7 (MKK7); Dual specificity mitogen-activated protein kinase kinase 7",0,4974,14,844,{"v":4186.24,"d":"4186"},{"v":7355.838638656,"d":"7356"},{"$nulls":3},0,5149,18,872,{"v":4474.232,"d":"4474"},{"v":7817.4457113032,"d":"7817"},{"$nulls":6},0,5194,14,782,{"v":4050.76,"d":"4051"},{"v":6930.207909464,"d":"6930"},{"$nulls":7},"MKK7","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"CKYNKLLEHSFIKRYE","Corresponds to amino acid residues K370 to E384; Kinase last alpha-chain.",{"$nulls":3},"O14733","O14733","O14733","O14733"]
[1509,750,"NK106-5","MKK7 (MEK7, MAP2K7)","Pan-specific","MAPK/ERK protein-serine kinase 7 (MKK7); Dual specificity mitogen-activated protein kinase kinase 7",0,7766,16,771,{"v":5975.25,"d":"5975"},{"v":10499.392014224999,"d":"10499"},{"$f":"(L1522+L1523)/2","v":{"v":10041.2598887225,"d":"10041"}},{"$f":"SQRT((M1522-L1522)*(M1522-L1522))","v":{"v":458.13212550249955,"d":"458"}},{"$f":"N1522/M1522*100","v":{"v":4.562496445461342,"d":"5"}},0,7046,16,796,{"v":5595.88,"d":"5596"},{"v":9777.206033788001,"d":"9777"},{"$f":"(U1522+U1523)/2","v":{"v":9691.077065433501,"d":"9691"}},{"$f":"SQRT((V1522-U1522)*(V1522-U1522))","v":{"v":86.1289683545001,"d":"86"}},{"$f":"W1522/V1522*100","v":{"v":0.8887450566429623,"d":"1"}},{"$f":"X1522+O1522","v":{"v":5.451241502104304,"d":"5"}},{"$f":"(V1522/M1522*100)-100","v":{"v":-3.4874390979790775,"d":"-3"}},null,0,7382,16,652,{"v":4802.632,"d":"4803"},{"v":8216.5416545648,"d":"8217"},{"$f":"(AG1522+AG1523)/2","v":{"v":8981.5272781608,"d":"8982"}},{"$f":"SQRT((AH1522-AG1522)*(AH1522-AG1522))","v":{"v":764.9856235959996,"d":"765"}},{"$f":"AI1522/AH1522*100","v":{"v":8.517322276091225,"d":"9"}},{"$f":"AJ1522+O1522","v":{"v":13.079818721552567,"d":"13"}},{"$f":"(AH1522/M1522*100)-100","v":{"v":-10.553781321325047,"d":"-11"}},null,null,"MKK7","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"EVDVASWFKDVMAKTE","Corresponds to amino acid residues E387 to E402.",null,null,"Protein kinase, dual-specificity, STE group, STE7 family, N/A subfamily","O14733","O14733","O14733","O14733","GO:0005737; GO:0005829; GO:0005634","GO:0005524; GO:0019899; GO:0000287; GO:0004708; GO:0019901; GO:0019903; GO:0004674; GO:0004713","GO:0007257; GO:0006915; GO:0051973; GO:1904355; GO:0032212; GO:0042981; GO:0007346; GO:0009408; GO:0006970; GO:0034612; GO:0009411; GO:0007165; GO:0051403"]
[1514,753,"NK278-1","MLK1 (MAP3K9)","Pan-specific","Mixed-lineage protein-serine kinase 1; Mitogen-activated protein kinase kinase kinase 9",0,1237,10,708,{"v":868.716,"d":"869"},{"v":1526.4616263804,"d":"1526"},{"$nulls":3},0,1234,12,604,{"v":738.088,"d":"738"},{"v":1289.5984987288,"d":"1290"},{"$nulls":6},0,1388,12,650,{"v":894.4,"d":"894"},{"v":1530.17654816,"d":"1530"},{"$nulls":7},"MLK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","MLK","MLK",{"$nulls":5},"CAELNTHRPAPYEIQQEFWS","Corresponds to amino acid residues A1086 to S1104; C-terminus.",{"$nulls":3},"P80192","P80192","P80192"]
[1521,757,"PK718","MLK3 (MAP3K11)","S281","Mixed-lineage protein-serine kinase 3; Mitogen-activated protein kinase kinase kinase 11",0,655,10,582,{"v":375.39,"d":"375"},{"v":659.6153747909999,"d":"660"},{"$f":"(L1534+L1535)/2","v":{"v":687.3695100765,"d":"687"}},{"$f":"SQRT((M1534-L1534)*(M1534-L1534))","v":{"v":27.75413528550007,"d":"28"}},{"$f":"N1534/M1534*100","v":{"v":4.037731508109984,"d":"4"}},0,345,14,520,{"v":172.12,"d":"172"},{"v":300.73066301200004,"d":"301"},{"$f":"(U1534+U1535)/2","v":{"v":499.1583874888,"d":"499"}},{"$f":"SQRT((V1534-U1534)*(V1534-U1534))","v":{"v":198.42772447679994,"d":"198"}},{"$f":"W1534/V1534*100","v":{"v":39.752457226064784,"d":"40"}},{"$f":"X1534+O1534","v":{"v":43.79018873417477,"d":"44"}},{"$f":"(V1534/M1534*100)-100","v":{"v":-27.38136036420255,"d":"-27"}},null,0,710,12,512,{"v":357.376,"d":"357"},{"v":611.4136561664,"d":"611"},{"$f":"(AG1534+AG1535)/2","v":{"v":604.1939054584,"d":"604"}},{"$f":"SQRT((AH1534-AG1534)*(AH1534-AG1534))","v":{"v":7.219750707999992,"d":"7"}},{"$f":"AI1534/AH1534*100","v":{"v":1.1949393469175082,"d":"1"}},{"$f":"AJ1534+O1534","v":{"v":5.232670855027493,"d":"5"}},{"$f":"(AH1534/M1534*100)-100","v":{"v":-12.100566492808667,"d":"-12"}},null,null,"MLK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","MLK","MLK",{"$nulls":5},"TQM(pS)AAG(bA)C","Corresponds to amino acid residues T278 to G284; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S281 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in MLK3.","HPK1 (MAP4K1); MLK3 (MAP3K11)","Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.25; TKL domain target; TKL</A> group; MLK family; MLK subfamily","Q16584","Q16584","Q16584","Q16584","GO:0005813; GO:0005737; GO:0016020; GO:0005874","GO:0005524; GO:0042802; GO:0004706; GO:0031434; GO:0031435; GO:0042803; GO:0004672; GO:0004674; GO:0048365","GO:0007257; GO:0000187; GO:0008219; GO:0008283; GO:0007254; GO:0007017; GO:0043065; GO:0046330; GO:0043507; GO:0043525; GO:0046777; GO:0006468"]
[1525,759,"PK719","MLTK (ZAK)","T161+T162","Mitogen-activated protein kinase kinase kinase MLT",0,12074,20,826,{"v":9956.604,"d":"9957"},{"v":17495.2158531276,"d":"17495"},{"$f":"(L1538+L1539)/2","v":{"v":16273.552442314998,"d":"16274"}},{"$f":"SQRT((M1538-L1538)*(M1538-L1538))","v":{"v":1221.6634108126018,"d":"1222"}},{"$f":"N1538/M1538*100","v":{"v":7.507048108537104,"d":"8"}},0,11294,16,739,{"v":8334.442,"d":"8334"},{"v":14562.062912474199,"d":"14562"},{"$f":"(U1538+U1539)/2","v":{"v":14765.5680440316,"d":"14766"}},{"$f":"SQRT((V1538-U1538)*(V1538-U1538))","v":{"v":203.5051315574001,"d":"204"}},{"$f":"W1538/V1538*100","v":{"v":1.378241127944001,"d":"1"}},{"$f":"X1538+O1538","v":{"v":8.885289236481105,"d":"9"}},{"$f":"(V1538/M1538*100)-100","v":{"v":-9.266473338435262,"d":"-9"}},null,0,12108,20,777,{"v":9392.376,"d":"9392"},{"v":16068.865705166401,"d":"16069"},{"$f":"(AG1538+AG1539)/2","v":{"v":14667.279418313201,"d":"14667"}},{"$f":"SQRT((AH1538-AG1538)*(AH1538-AG1538))","v":{"v":1401.5862868532004,"d":"1402"}},{"$f":"AI1538/AH1538*100","v":{"v":9.555870907478688,"d":"10"}},{"$f":"AJ1538+O1538","v":{"v":17.06291901601579,"d":"17"}},{"$f":"(AH1538/M1538*100)-100","v":{"v":-9.87045102595495,"d":"-10"}},null,null,"ZAK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","MLK","MLK",{"$nulls":5},"HNH(pT)(pT)HMS(bA)C","Corresponds to amino acid residues H158 to S165; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T161 and T162 phosphorylation stimulates phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These phosphorylation sites in MLTK have apparently not been reported in high throughput mass spectrometry studies.","T161: ZAK (MLTK). T162: ZAK (MLTK).","Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.25; TKL domain target; TKL</A> group; MLK family; MLK subfamily","Q9NYL2","Q9NYL2","Q9NYL2","Q9NYL2","GO:0005737; GO:0005829; GO:0005634","GO:0005524; GO:0000287; GO:0004709; GO:0004674; GO:0003723","GO:0007257; GO:0000186; GO:0007050; GO:0008219; GO:0030154; GO:0008283; GO:0071480; GO:0007010; GO:0000077; GO:0042733; GO:0060173; GO:0007093; GO:0043065; GO:0006468; GO:0051403"]
[1526,759,"PK719","MLTK (ZAK)","T161+T162","Mitogen-activated protein kinase kinase kinase MLT",0,10492,20,818,{"v":8566.096,"d":"8566"},{"v":15051.889031502398,"d":"15052"},{"$nulls":3},0,11192,22,767,{"v":8567.39,"d":"8567"},{"v":14969.073175589,"d":"14969"},{"$nulls":6},0,10090,20,770,{"v":7753.9,"d":"7754"},{"v":13265.69313146,"d":"13266"},{"$nulls":7},"ZAK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","MLK","MLK",{"$nulls":5},"HNH(pT)(pT)HMS(bA)C","Corresponds to amino acid residues H158 to S165; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T161 and T162 phosphorylation stimulates phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These phosphorylation sites in MLTK have apparently not been reported in high throughput mass spectrometry studies.","T161: ZAK (MLTK). T162: ZAK (MLTK).",null,"Q9NYL2","Q9NYL2","Q9NYL2","Q9NYL2"]
[1531,762,"NK281-2","MOK (RAGE)","Pan-specific","MAPK-MAK-MRK overlapping kinase; MOK protein kinase",0,482,14,569,{"v":266.292,"d":"266"},{"v":467.91416229479995,"d":"468"},{"$f":"(L1544+L1545)/2","v":{"v":483.2171546469,"d":"483"}},{"$f":"SQRT((M1544-L1544)*(M1544-L1544))","v":{"v":15.302992352100034,"d":"15"}},{"$f":"N1544/M1544*100","v":{"v":3.1668975749179165,"d":"3"}},0,360,16,630,{"v":216.72,"d":"217"},{"v":378.656456472,"d":"379"},{"$f":"(U1544+U1545)/2","v":{"v":431.89584778409994,"d":"432"}},{"$f":"SQRT((V1544-U1544)*(V1544-U1544))","v":{"v":53.23939131209994,"d":"53"}},{"$f":"W1544/V1544*100","v":{"v":12.326905105768402,"d":"12"}},{"$f":"X1544+O1544","v":{"v":15.493802680686318,"d":"15"}},{"$f":"(V1544/M1544*100)-100","v":{"v":-10.620754327379359,"d":"-11"}},null,0,572,10,541,{"v":304.042,"d":"304"},{"v":520.1676409388,"d":"520"},{"$f":"(AG1544+AG1545)/2","v":{"v":559.6008243674,"d":"560"}},{"$f":"SQRT((AH1544-AG1544)*(AH1544-AG1544))","v":{"v":39.433183428600046,"d":"39"}},{"$f":"AI1544/AH1544*100","v":{"v":7.046662855291043,"d":"7"}},{"$f":"AJ1544+O1544","v":{"v":10.21356043020896,"d":"10"}},{"$f":"(AH1544/M1544*100)-100","v":{"v":15.807317473303641,"d":"16"}},null,null,"MOK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","RCK",{"$nulls":6},"CIPASKKTDPQKDLKPAPQQ","Corresponds to amino acid residues C388 to Q407; C-terminus.",null,null,"Protein-serine kinase, CMGC group, RCK family","Q9UQ07","Q9UQ07","Q9UQ07",null,"GO:0097546; GO:0005929; GO:0005737; GO:0005634","GO:0005524; GO:0004693; GO:0046872; GO:0004672; GO:0004674","GO:0035556; GO:0006468; GO:0010468; GO:0007165"]
[1535,764,"PK720","MOK (RAGE)","T159+Y161","MAPK-MAK-MRK overlapping kinase; MOK protein kinase",0,10369,16,788,{"v":8158.164,"d":"8158"},{"v":14335.0925822916,"d":"14335"},{"$f":"(L1548+L1549)/2","v":{"v":13166.2261643833,"d":"13166"}},{"$f":"SQRT((M1548-L1548)*(M1548-L1548))","v":{"v":1168.866417908299,"d":"1169"}},{"$f":"N1548/M1548*100","v":{"v":8.877763478423796,"d":"9"}},0,10873,22,768,{"v":8333.568,"d":"8334"},{"v":14560.5358464768,"d":"14561"},{"$f":"(U1548+U1549)/2","v":{"v":14150.240818974,"d":"14150"}},{"$f":"SQRT((V1548-U1548)*(V1548-U1548))","v":{"v":410.2950275027997,"d":"410"}},{"$f":"W1548/V1548*100","v":{"v":2.89956215411286,"d":"3"}},{"$f":"X1548+O1548","v":{"v":11.777325632536655,"d":"12"}},{"$f":"(V1548/M1548*100)-100","v":{"v":7.473779063985788,"d":"7"}},null,0,8531,16,771,{"v":6565.065,"d":"6565"},{"v":11231.784995691,"d":"11232"},{"$f":"(AG1548+AG1549)/2","v":{"v":11886.464975442701,"d":"11886"}},{"$f":"SQRT((AH1548-AG1548)*(AH1548-AG1548))","v":{"v":654.6799797517015,"d":"655"}},{"$f":"AI1548/AH1548*100","v":{"v":5.507776964002861,"d":"6"}},{"$f":"AJ1548+O1548","v":{"v":14.385540442426658,"d":"14"}},{"$f":"(AH1548/M1548*100)-100","v":{"v":-9.720030424530862,"d":"-10"}},null,null,"MOK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","RCK",{"$nulls":6},"QPY(pT)E(pY)IS(bA)C","Corresponds to amino acid residues Q156 to S163; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T159 and Y161 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major in vivo phosphorylation sites in MOK.",null,"Protein-serine kinase, CMGC group, RCK family","Q9UQ07","Q9UQ07","Q9UQ07",null,"GO:0097546; GO:0005929; GO:0005737; GO:0005634","GO:0005524; GO:0004693; GO:0046872; GO:0004672; GO:0004674","GO:0035556; GO:0006468; GO:0010468; GO:0007165"]
[1542,767,"PK722","Mos","Y263","Moloney sarcoma oncogene-encoded protein-serine kinase",0,239,12,526,{"v":119.402,"d":"119"},{"v":209.8068541538,"d":"210"},{"$nulls":3},0,200,10,422,{"v":80.18,"d":"80"},{"v":140.091706718,"d":"140"},{"$nulls":6},0,216,12,485,{"v":98.94,"d":"99"},{"$f":"AF1555*1.7108414","v":{"v":169.270648116,"d":"169"}},{"$nulls":7},"MOS","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","MOS",{"$nulls":6},"ADI(pY)SFA(bA)C","Corresponds to amino acid residues A260 to A266; In the protein kinase catalytic domain near subdomain IX.","The effect of Y263 phosphorylation is unclear. This is a minor in vivo phosphorylation sites in Mos (≥1 report from high throughput mass spectrometry studies).",null,null,"P00540","P00540","P00540","P00540"]
[1543,768,"PN760","MPL","Y591","Thrombopoietin receptor",0,8270,12,670,{"v":5532.86,"d":"5533"},{"v":9722.047797133999,"d":"9722"},{"$f":"(L1556+L1557)/2","v":{"v":8956.5379644145,"d":"8957"}},{"$f":"SQRT((M1556-L1556)*(M1556-L1556))","v":{"v":765.5098327194992,"d":"766"}},{"$f":"N1556/M1556*100","v":{"v":8.54693895968476,"d":"9"}},0,4822,16,598,{"v":2873.988,"d":"2874"},{"v":5021.4752308188,"d":"5021"},{"$f":"(U1556+U1557)/2","v":{"v":7117.4938700922,"d":"7117"}},{"$f":"SQRT((V1556-U1556)*(V1556-U1556))","v":{"v":2096.0186392734004,"d":"2096"}},{"$f":"W1556/V1556*100","v":{"v":29.448829567397272,"d":"29"}},{"$f":"X1556+O1556","v":{"v":37.995768527082035,"d":"38"}},{"$f":"(V1556/M1556*100)-100","v":{"v":-20.532979390352196,"d":"-21"}},null,0,6542,12,632,{"v":4126.96,"d":"4127"},{"v":7060.574024144001,"d":"7061"},{"$f":"(AG1556+AG1557)/2","v":{"v":6996.610796722201,"d":"6997"}},{"$f":"SQRT((AH1556-AG1556)*(AH1556-AG1556))","v":{"v":63.963227421800184,"d":"64"}},{"$f":"AI1556/AH1556*100","v":{"v":0.9142030231518083,"d":"1"}},{"$f":"AJ1556+O1556","v":{"v":9.461141982836567,"d":"9"}},{"$f":"(AH1556/M1556*100)-100","v":{"v":-21.882642327642074,"d":"-22"}},{"$nulls":5},"Thrombopoietin receptor",{"$nulls":9},"CAQMD(pY)RRL","Corresponds to amino acid residues A587 to L594.","The effect of Y591 phosphorylation is unclear. This is the major in vivo phosphorylation site in MPL (≥17 reports from high throughput mass spectrometry studies). This human phosphosite is conserved in mammals, and found in the mouse.",null,"Receptor, cytokine","P40238","P40238",null,"P40238","GO:0009986; GO:0005794; GO:0005887; GO:0043025; GO:0043005; GO:0005886","GO:0038164; GO:0004888","GO:1990960; GO:0008283; GO:0007166; GO:0071456; GO:1990959; GO:0035702; GO:0001780; GO:0070527; GO:0050671; GO:1905221"]
[1548,770,"NK283-1","MRCKb (CDC42BPB)","Pan-specific","Myotonic dystrophy kinase-related CDC42-binding kinase beta",0,257,10,477,{"v":117.819,"d":"118"},{"v":207.0252906111,"d":"207"},{"$nulls":3},0,306,14,529,{"v":154.468,"d":"154"},{"v":269.8888220668,"d":"270"},{"$nulls":6},0,306,12,436,{"v":128.184,"d":"128"},{"v":219.3024940176,"d":"219"},{"$nulls":7},"MRCKb","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","DMPK","GEK",{"$nulls":5},"CFSDRGSLKSIMQSNTLTKD","Corresponds to amino acid residues C408 to D427; Right after kinase catalytic domain.",{"$nulls":3},"Q9Y5S2","Q9Y5S2","Q9Y5S2"]
[1553,772,"PK723","MSK1 (RPS6KA5)","S212","Mitogen & stress-activated protein-serine kinase 1; Ribosomal protein S6 kinase alpha 5",0,7326,20,810,{"v":5917.86,"d":"5918"},{"v":10398.549353634,"d":"10399"},{"$f":"(L1566+L1567)/2","v":{"v":10028.7121027096,"d":"10029"}},{"$f":"SQRT((M1566-L1566)*(M1566-L1566))","v":{"v":369.8372509244,"d":"370"}},{"$f":"N1566/M1566*100","v":{"v":3.6877841056427956,"d":"4"}},0,7150,18,639,{"v":4557.348,"d":"4557"},{"v":7962.6672415548,"d":"7963"},{"$f":"(U1566+U1567)/2","v":{"v":9312.3629508632,"d":"9312"}},{"$f":"SQRT((V1566-U1566)*(V1566-U1566))","v":{"v":1349.6957093084002,"d":"1350"}},{"$f":"W1566/V1566*100","v":{"v":14.493590041862484,"d":"14"}},{"$f":"X1566+O1566","v":{"v":18.18137414750528,"d":"18"}},{"$f":"(V1566/M1566*100)-100","v":{"v":-7.142982513705348,"d":"-7"}},null,0,7262,18,742,{"v":5375.048,"d":"5375"},{"v":9195.8546453872,"d":"9196"},{"$f":"(AG1566+AG1567)/2","v":{"v":9286.5258179044,"d":"9287"}},{"$f":"SQRT((AH1566-AG1566)*(AH1566-AG1566))","v":{"v":90.67117251719901,"d":"91"}},{"$f":"AI1566/AH1566*100","v":{"v":0.9763734500407591,"d":"1"}},{"$f":"AJ1566+O1566","v":{"v":4.664157555683555,"d":"5"}},{"$f":"(AH1566/M1566*100)-100","v":{"v":-7.400614128754114,"d":"-7"}},null,null,"MSK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","MSK",{"$nulls":5},"RAY(pS)FCG(bA)C","Corresponds to amino acid residues R209 to G215; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S212 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in MSK1 (≥13 reports from high throughput mass spectrometry studies).","MSK1 (RPS6KA5)","EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); AGC group; RSK family; MSK subfamily","O75582","O75582","O75582",null,"GO:0005737; GO:0005654; GO:0005634","GO:0005524; GO:0000287; GO:0004672; GO:0004674","GO:0007411; GO:0007173; GO:0043990; GO:0043987; GO:0043988; GO:0016572; GO:0006954; GO:0070498; GO:0035556; GO:0001818; GO:0045892; GO:0032793; GO:0035066; GO:0033129; GO:0051092; GO:0045944; GO:0006468; GO:0006355; GO:0002223"]
[1558,774,"PK725","MSK2 (RPS6KA4)","T687","Ribosomal protein S6 kinase alpha-4",0,7210,18,775,{"v":5573.8,"d":"5574"},{"v":9793.98539122,"d":"9794"},{"$nulls":3},0,8070,22,804,{"v":6470.592,"d":"6471"},{"v":11305.5160483392,"d":"11306"},{"$nulls":6},0,7192,16,689,{"v":4944.264,"d":"4944"},{"v":8458.851543729601,"d":"8459"},{"$nulls":7},"MSK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","MSK",{"$nulls":5},"PLR(pT)PDC(bA)C","Corresponds to amino acid residues P684 to C690; In the C-terminal part of the kinase after the second catalytic domain.","T687 phosphorylation stimulates phosphotransferase activity. This is one of the major in vivo phosphorylation sites in MSK2 (≥27 reports from high throughput mass spectrometry studies).","ERK1 (MAPK3); ERK2 (MAPK1); p38a MAPK (MAPK14)",null,"O75676","O75676","O75676"]
[1560,775,"NK113-3","MST1 (STK4, Krs2)","Pan-specific","Mammalian STE20-like protein-serine kinase 1",0,102,10,584,{"v":53.728,"d":"54"},{"v":94.4079886432,"d":"94"},{"$nulls":3},0,114,14,600,60,{"v":104.83290600000001,"d":"105"},{"$nulls":6},0,126,10,540,{"v":62.64,"d":"63"},{"v":107.167105296,"d":"107"},{"$nulls":7},"MST1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","MST",{"$nulls":5},"Epitope undefined.",{"$nulls":4},"Q13043","Q13043","Q13043","Q13043"]
[1565,778,"PK726","MST1 (STK4, Krs2)","T187","Mammalian STE20-like protein-serine kinase 1 (KRS2); Serine-threonine-protein kinase 4",0,2447,18,633,{"v":1537.557,"d":"1538"},{"v":2701.7135161233,"d":"2702"},{"$f":"(L1578+L1579)/2","v":{"v":2653.11346858965,"d":"2653"}},{"$f":"SQRT((M1578-L1578)*(M1578-L1578))","v":{"v":48.60004753365001,"d":"49"}},{"$f":"N1578/M1578*100","v":{"v":1.8318118734471227,"d":"2"}},0,2074,16,613,{"v":1261.554,"d":"1262"},{"v":2204.2061982654,"d":"2204"},{"$f":"(U1578+U1579)/2","v":{"v":2457.0946174092,"d":"2457"}},{"$f":"SQRT((V1578-U1578)*(V1578-U1578))","v":{"v":252.8884191438001,"d":"253"}},{"$f":"W1578/V1578*100","v":{"v":10.292172607111471,"d":"10"}},{"$f":"X1578+O1578","v":{"v":12.123984480558594,"d":"12"}},{"$f":"(V1578/M1578*100)-100","v":{"v":-7.388257362571466,"d":"-7"}},null,0,2632,16,610,{"v":1595.76,"d":"1596"},{"v":2730.092272464,"d":"2730"},{"$f":"(AG1578+AG1579)/2","v":{"v":2537.0067120599997,"d":"2537"}},{"$f":"SQRT((AH1578-AG1578)*(AH1578-AG1578))","v":{"v":193.08556040400026,"d":"193"}},{"$f":"AI1578/AH1578*100","v":{"v":7.610762694719816,"d":"8"}},{"$f":"AJ1578+O1578","v":{"v":9.44257456816694,"d":"9"}},{"$f":"(AH1578/M1578*100)-100","v":{"v":-4.376245415216658,"d":"-4"}},null,null,"MST1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","MST",{"$nulls":5},"VIG(pT)PFW(bA)C","Corresponds to amino acid residues V184 to W190; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T187 phosphorylation is predicted to be inhibitory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This phosphorylation site in MST1 has not apparently been reported in high throughput mass spectrometry studies.","MST1 (STK4, KRS2)","EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE20 family; MST subfamily","Q13043","Q13043","Q13043","Q13043","GO:0005737; GO:0005829; GO:0016604; GO:0005654; GO:0005634; GO:0032991","GO:0005524; GO:0042802; GO:0000287; GO:0046983; GO:0042803; GO:0004672; GO:0043539; GO:0004674; GO:0008134","GO:0006915; GO:0001569; GO:0060706; GO:0000902; GO:0007417; GO:0003157; GO:0097284; GO:0035329; GO:0035556; GO:0030216; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0018105; GO:0043065; GO:1902043; GO:0045600; GO:0033138; GO:0032092; GO:0001934; GO:1905461; GO:0060215; GO:0046777; GO:0006468; GO:0050821; GO:0060800; GO:0007346; GO:0007165; GO:0023014; GO:0031098"]
[1570,781,"PK727","MST3 (STK24)","T184","Mammalian STE20-like protein-serine kinase 3; Serine-threonine-protein kinase 24",0,6954,16,731,{"v":5071.678,"d":"5072"},{"v":8911.683275498199,"d":"8912"},{"$nulls":3},0,7812,18,754,{"v":5876.676,"d":"5877"},{"v":10267.817045007601,"d":"10268"},{"$nulls":6},0,6183,14,656,{"v":4046.864,"d":"4047"},{"v":6923.5424713696,"d":"6924"},{"$nulls":7},"MST3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","YSK",{"$nulls":5},"LTD(pT)QIK(bA)C","Corresponds to amino acid residues L181 to K187; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T184 phosphorylation is predicted to stimulate phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in MST3 (≥51 reports from high throughput mass spectrometry studies).",null,null,"Q9Y6E0","Q9Y6E0","Q9Y6E0"]
[1575,783,"NK116-6","mTOR (FRAP)","Pan-specific","Mammalian target of rapamycin (FRAP); FKBP12-rapamycin complex-associated protein",0,174,10,572,{"v":93.808,"d":"94"},{"v":164.83443639520002,"d":"165"},{"$f":"(L1588+L1589)/2","v":{"v":159.6736959499,"d":"160"}},{"$f":"SQRT((M1588-L1588)*(M1588-L1588))","v":{"v":5.160740445300007,"d":"5"}},{"$f":"N1588/M1588*100","v":{"v":3.232054230722677,"d":"3"}},0,107,10,383,{"v":37.151,"d":"37"},{"v":64.91078818010001,"d":"65"},{"$f":"(U1588+U1589)/2","v":{"v":106.10051055505001,"d":"106"}},{"$f":"SQRT((V1588-U1588)*(V1588-U1588))","v":{"v":41.189722374949994,"d":"41"}},{"$f":"W1588/V1588*100","v":{"v":38.82141769108529,"d":"39"}},{"$f":"X1588+O1588","v":{"v":42.05347192180796,"d":"42"}},{"$f":"(V1588/M1588*100)-100","v":{"v":-33.5516661502339,"d":"-34"}},null,0,174,10,405,{"v":66.42,"d":"66"},{"v":113.63408578800001,"d":"114"},{"$f":"(AG1588+AG1589)/2","v":{"v":118.60408005500001,"d":"119"}},{"$f":"SQRT((AH1588-AG1588)*(AH1588-AG1588))","v":{"v":4.969994267000004,"d":"5"}},{"$f":"AI1588/AH1588*100","v":{"v":4.190407500901554,"d":"4"}},{"$f":"AJ1588+O1588","v":{"v":7.422461731624231,"d":"7"}},{"$f":"(AH1588/M1588*100)-100","v":{"v":-25.72096527895627,"d":"-26"}},null,null,"FRAP1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PIKK","FRAP",{"$nulls":5},"Epitope undefined.",{"$nulls":3},"Protein kinase, Ser/Thr (non-receptor); Autophagy; EC 2.7.11.1; ATYPICAL group; PIKK family; FRAP subfamily","P42345","P42345","P42345","P42345","GO:0005737; GO:0005829; GO:0030425; GO:0012505; GO:0005789; GO:0098978; GO:0000139; GO:0005765; GO:0005764; GO:0016020; GO:0005741; GO:0043025; GO:0005654; GO:0005634; GO:0016605; GO:0099524; GO:0031931; GO:0031932","GO:0005524; GO:0042802; GO:0016301; GO:0051219; GO:0019904; GO:0004672; GO:0019901; GO:0004674; GO:0043022; GO:0001030; GO:0001031; GO:0001032; GO:0001156; GO:0045182","GO:0006207; GO:0032148; GO:0043276; GO:0007420; GO:0055013; GO:0060048; GO:0007569; GO:0007050; GO:0034198; GO:0071230; GO:0071456; GO:0071233; GO:1990253; GO:0031669; GO:0009267; GO:0006281; GO:0006112; GO:0007281; GO:0003007; GO:0003179; GO:0007616; GO:0060135; GO:0048255; GO:0035264; GO:0010507; GO:0070885; GO:0045792; GO:1904193; GO:1904213; GO:0016242; GO:0014736; GO:0001933; GO:0031397; GO:0018105; GO:0018107; GO:0016310; GO:0030838; GO:0061051; GO:1904056; GO:1904690; GO:0060999; GO:1904000; GO:0001938; GO:0010718; GO:0010628; GO:0060252; GO:1904197; GO:0051549; GO:0010592; GO:0046889; GO:0010831; GO:1901216; GO:0014042; GO:0045429; GO:0048714; GO:0050731; GO:0032516; GO:0051897; GO:0001934; GO:1904058; GO:1904206; GO:0048661; GO:0051496; GO:0045945; GO:1901838; GO:0045727; GO:1903691; GO:0009791; GO:0046777; GO:0030163; GO:0006468; GO:0032956; GO:0090335; GO:0043610; GO:0001558; GO:0008361; GO:1900034; GO:0031998; GO:0005979; GO:0043087; GO:0016241; GO:0090559; GO:0031641; GO:0045670; GO:0032095; GO:0099547; GO:0014823; GO:0043200; GO:0042220; GO:0032868; GO:0043278; GO:0007584; GO:0031529; GO:0035176; GO:0021510; GO:0002296; GO:0038202; GO:0031929; GO:0008542; GO:0050882; GO:0042060"]
[1580,785,"NK116-3","mTOR (FRAP)","Pan-specific","Mammalian target of rapamycin (FRAP); FKBP12-rapamycin complex-associated protein",0,4060,14,755,{"v":3054.73,"d":"3055"},{"v":5367.609349837,"d":"5368"},{"$nulls":3},0,3994,18,724,{"v":2878.624,"d":"2879"},{"v":5029.5753200224,"d":"5030"},{"$nulls":6},0,3845,17,705,{"v":2698.74,"d":"2699"},{"v":4617.116119836,"d":"4617"},{"$nulls":7},"FRAP1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PIKK","FRAP",{"$nulls":5},"CALNKKAIQIINRVRD","Corresponds to amino acid residues A2492 to D2505.",{"$nulls":3},"P42345","P42345","P42345","P42345"]
[1582,786,"PK729","mTOR (FRAP)","S2448","Mammalian target of rapamycin (FRAP); FKBP12-rapamycin complex-associated protein",0,5912,12,752,{"v":4436.8,"d":"4437"},{"v":7796.1093659200005,"d":"7796"},{"$nulls":3},0,6928,20,721,{"v":4980.668,"d":"4981"},{"v":8702.2983376868,"d":"8702"},{"$nulls":6},0,6456,16,649,{"v":4179.56,"d":"4180"},{"v":7150.564281784001,"d":"7151"},{"$nulls":7},"FRAP1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PIKK","FRAP",{"$nulls":5},"RTD(pS)YSA(bA)C","Corresponds to amino acid residues R2445 to A2451; In the C-terminal fifth of the kinase in the PI3_PI4-kinase domain.","S2448 phosphorylation stimulates phosphotransferase activity. This is the major in vivo phosphorylation site in mTOR (≥114 reports from high throughput mass spectrometry studies).","Akt1 (PKBa); p70S6K (RPS6KB1)",null,"P42345","P42345","P42345","P42345"]
[1587,789,"PK872","MUSK","Y756","Muscle, skeletal receptor tyrosine protein kinase",0,3082,16,652,{"v":1999.032,"d":"1999"},{"v":3512.5928818007997,"d":"3513"},{"$f":"(L1600+L1601)/2","v":{"v":3457.3569689993,"d":"3457"}},{"$f":"SQRT((M1600-L1600)*(M1600-L1600))","v":{"v":55.23591280149958,"d":"55"}},{"$f":"N1600/M1600*100","v":{"v":1.5976340683584982,"d":"2"}},0,2827,14,660,{"v":1856.58,"d":"1857"},{"v":3243.844610358,"d":"3244"},{"$f":"(U1600+U1601)/2","v":{"v":3333.5422655542498,"d":"3334"}},{"$f":"SQRT((V1600-U1600)*(V1600-U1600))","v":{"v":89.6976551962498,"d":"90"}},{"$f":"W1600/V1600*100","v":{"v":2.6907609998859954,"d":"3"}},{"$f":"X1600+O1600","v":{"v":4.288395068244494,"d":"4"}},{"$f":"(V1600/M1600*100)-100","v":{"v":-3.5811952469833557,"d":"-4"}},null,0,3140,14,646,{"v":2019.396,"d":"2019"},{"v":3454.8662797944003,"d":"3455"},{"$f":"(AG1600+AG1601)/2","v":{"v":3480.1559373692003,"d":"3480"}},{"$f":"SQRT((AH1600-AG1600)*(AH1600-AG1600))","v":{"v":25.289657574800003,"d":"25"}},{"$f":"AI1600/AH1600*100","v":{"v":0.7266817358166296,"d":"1"}},{"$f":"AJ1600+O1600","v":{"v":2.3243158041751277,"d":"2"}},{"$f":"(AH1600/M1600*100)-100","v":{"v":0.6594334508796464,"d":"1"}},null,null,"MUSK","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK",{"$nulls":7},"SADY(pY)KAN(bA)C","Corresponds to amino acid residues S752 to N759; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y756 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This phosphorylation site in MUSK has ony been reported in one high throughput mass spectrometry study.","MUSK","Receptor tyrosine kinase, TK group, Musk family","O15146","O15146","O15146",null,"GO:0030054; GO:0005887; GO:0031594; GO:0045211; GO:0043235","GO:0005524; GO:0046872; GO:0004713; GO:0004714","GO:0030154; GO:0007613; GO:0007275; GO:0007528; GO:0010628; GO:2000541; GO:0001934; GO:0046777; GO:0008582; GO:0071340; GO:0007169"]
[1592,791,"NN430-1","Myc","Pan-specific","Myc proto-oncogene protein",0,456,12,632,{"v":280.608,"d":"281"},{"v":493.0694773152,"d":"493"},{"$nulls":3},0,447,14,554,{"v":239.882,"d":"240"},{"v":419.12545261820003,"d":"419"},{"$nulls":6},0,484,14,545,{"v":256.15,"d":"256"},{"v":438.23202461,"d":"438"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against amino acid residues 408-439 within the C-terminal domain of human c-Myc.",{"$nulls":3},"P01106","P01106",null,"MYC"]
[1593,792,"PN199","Myc","T58","Myc proto-oncogene protein",0,2241,14,377,{"v":839.579,"d":"840"},{"v":1475.2636371550998,"d":"1475"},{"$f":"(L1606+L1607)/2","v":{"v":1358.5794186871499,"d":"1359"}},{"$f":"SQRT((M1606-L1606)*(M1606-L1606))","v":{"v":116.6842184679499,"d":"117"}},{"$f":"N1606/M1606*100","v":{"v":8.588693223448548,"d":"9"}},0,2514,10,356,{"v":891.424,"d":"891"},{"v":1557.5094733024,"d":"1558"},{"$f":"(U1606+U1607)/2","v":{"v":1311.5749702566,"d":"1312"}},{"$f":"SQRT((V1606-U1606)*(V1606-U1606))","v":{"v":245.93450304580006,"d":"246"}},{"$f":"W1606/V1606*100","v":{"v":18.751082372186836,"d":"19"}},{"$f":"X1606+O1606","v":{"v":27.339775595635384,"d":"27"}},{"$f":"(V1606/M1606*100)-100","v":{"v":-3.459823384927489,"d":"-3"}},null,0,2028,14,324,{"v":652.536,"d":"653"},{"v":1116.3856037904,"d":"1116"},{"$f":"(AG1606+AG1607)/2","v":{"v":1016.6298634391999,"d":"1017"}},{"$f":"SQRT((AH1606-AG1606)*(AH1606-AG1606))","v":{"v":99.75574035120007,"d":"100"}},{"$f":"AI1606/AH1606*100","v":{"v":9.812395242230263,"d":"10"}},{"$f":"AJ1606+O1606","v":{"v":18.40108846567881,"d":"18"}},{"$f":"(AH1606/M1606*100)-100","v":{"v":-25.169640474782824,"d":"-25"}},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"LP(pT)PP","Corresponds to amino acid residues L56 to P60.","T58 phosphorylation induces transcriptional activation and binding to AurA, CDC73, CIP2A, DNA, FWXW7, PIN1, and SH2BP1, and inhibits interaction with DNA, FBXW7 and TUBA4A. This is one of the major in vivo phosphorylation sites in c-Myc (≥57 reports from high throughput mass spectrometry studies).","ERK2 (MAPK1); GSK3a; GSK3b; JNK3 (MAPK10)","Transcription protein","P01106","P01106",null,"MYC","GO:0000790; GO:0005730; GO:0005654; GO:0005634; GO:0032991","GO:0033613; GO:0003677; GO:0003700; GO:0070888; GO:0044877; GO:0046983; GO:0070491; GO:0000978; GO:0000981; GO:0001077; GO:0008134","GO:1904837; GO:0001658; GO:0007050; GO:0006879; GO:0006974; GO:0035690; GO:0071456; GO:0034644; GO:0006338; GO:0051276; GO:0019221; GO:0006112; GO:0070371; GO:0044346; GO:0000082; GO:0000165; GO:0043066; GO:0051782; GO:0048147; GO:0045656; GO:0032873; GO:0000122; GO:0007219; GO:0015671; GO:0008284; GO:0043280; GO:2000573; GO:0050679; GO:0048146; GO:0010628; GO:0002053; GO:0090096; GO:2001022; GO:0051973; GO:0045893; GO:0045944; GO:0016579; GO:0032986; GO:0010468; GO:0032204; GO:0006357; GO:0042493; GO:0010332; GO:0070848"]
[1598,794,"PN215","Myc","T58+S62","Myc proto-oncogene protein",0,420,12,530,{"v":216.24,"d":"216"},{"v":379.965445656,"d":"380"},{"$nulls":3},0,538,12,549,{"v":288.774,"d":"289"},{"v":504.5502932874,"d":"505"},{"$nulls":6},0,316,10,423,{"v":129.438,"d":"129"},{"v":221.4478891332,"d":"221"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against amino acid residues surrounding the Thr-58 and Ser-62 dually phosphorylated human c-Myc.","T58 phosphorylation induces transcriptional activation and binding to AurA, CDC73, CIP2A, DNA, FWXW7, PIN1, and SH2BP1, and inhibits interaction with DNA, FBXW7 and TUBA4A. S62 phosphorylation induces transcriptional activation and binding to AurA, CDC73, CIP2A, DNA, FWXW7, PIN1, RNF4, SH2BP1 and Axin 1. These are two of the major in vivo phosphorylation sites in mTOR (≥57 and ≥59 reports, respectively, from high throughput mass spectrometry studies).","T58: ERK2 (MAPK1); GSK3a; GSK3b; JNK3 (MAPK10). S62: CDK5; ERK1 (MAPK3); ERK2 (MAPK1); JNK1 (MAPK8); JNK2 (MAPK9); JNK3 (MAPK10); Plk1.",null,"P01106","P01106",null,"MYC"]
[1604,797,"PN182","MyoD","S200","Myoblast determination protein 1",0,704,8,299,{"v":208.104,"d":"208"},{"v":365.6692984776,"d":"366"},{"$nulls":3},0,630,8,268,{"v":166.696,"d":"167"},{"v":291.2537683096,"d":"291"},{"$nulls":6},0,134,10,465,{"v":57.66,"d":"58"},{"v":98.647115124,"d":"99"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"AS(pS)PR","Corresponds to amino acid residues A198 to R202.","The effect of S200 phosphorylation is unclear. Phosphorylation of this site in MyoD has not been reported in high throughput mass spectrometry studies.","CDK1 (CDC2); CDK2; CDK9",null,"P15172","P15172",null,"P15172"]
[1609,800,"PN052","MYPT1 (MBS)","T696","Protein phosphatase 1 regulatory subunit 12A",0,2078,10,387,{"v":800.316,"d":"800"},{"v":1406.2727784204,"d":"1406"},{"$f":"(L1622+L1623)/2","v":{"v":1257.0049064123,"d":"1257"}},{"$f":"SQRT((M1622-L1622)*(M1622-L1622))","v":{"v":149.26787200810008,"d":"149"}},{"$f":"N1622/M1622*100","v":{"v":11.874883800902202,"d":"12"}},0,2582,10,382,{"v":982.504,"d":"983"},{"v":1716.6458246104,"d":"1717"},{"$f":"(U1622+U1623)/2","v":{"v":895.9212340421,"d":"896"}},{"$f":"SQRT((V1622-U1622)*(V1622-U1622))","v":{"v":820.7245905683001,"d":"821"}},{"$f":"W1622/V1622*100","v":{"v":91.60677963457373,"d":"92"}},{"$f":"X1622+O1622","v":{"v":103.48166343547592,"d":"103"}},{"$f":"(V1622/M1622*100)-100","v":{"v":-28.72571702212305,"d":"-29"}},null,0,1388,10,364,{"v":501.592,"d":"502"},{"v":858.1443595088,"d":"858"},{"$f":"(AG1622+AG1623)/2","v":{"v":934.1998139458,"d":"934"}},{"$f":"SQRT((AH1622-AG1622)*(AH1622-AG1622))","v":{"v":76.05545443699998,"d":"76"}},{"$f":"AI1622/AH1622*100","v":{"v":8.14124058918005,"d":"8"}},{"$f":"AJ1622+O1622","v":{"v":20.016124390082254,"d":"20"}},{"$f":"(AH1622/M1622*100)-100","v":{"v":-25.680495821439493,"d":"-26"}},{"$nulls":15},"Epitope undefined.","Antibody raised against amino acid residues that encompass the T696 phosphosite.","T696 phosphorylation affects the intracellular localization of the protein. This is one of the major in vivo phosphorylation sites in MYPT1 (≥260 reports from high throughput mass spectrometry studies).","DAPK3 (ZIPK); ILK; PAK1; PKG1 (PRKG1); Raf1; ROCK1; ROCK2","Protein phosphatase, regulatory subunit","O14974","O14974",null,null,"GO:0031672; GO:0015629; GO:0005813; GO:0043292; GO:0005829; GO:0005925; GO:0000776; GO:0005654; GO:0072357; GO:0030018","GO:0071889; GO:0004857; GO:0019208; GO:0019901","GO:0035690; GO:0007098; GO:0000278; GO:0043086; GO:0035508; GO:0045944; GO:0006470; GO:0030155; GO:0035507; GO:0046822; GO:0007165"]
[1610,800,"PN052","MYPT1 (MBS)","T696","Protein phosphatase 1 regulatory subunit 12A",0,1656,10,383,{"v":630.418,"d":"630"},{"v":1107.7370344042,"d":"1108"},{"$nulls":3},0,64,10,797,{"v":43.038,"d":"43"},{"v":75.1966434738,"d":"75"},{"$nulls":6},0,1528,10,389,{"v":590.502,"d":"591"},{"v":1010.2552683828,"d":"1010"},{"$nulls":20},"Epitope undefined.","Antibody raised against amino acid residues that encompass the T696 phosphosite.","T696 phosphorylation affects the intracellular localization of the protein. This is one of the major in vivo phosphorylation sites in MYPT1 (≥260 reports from high throughput mass spectrometry studies).","DAPK3 (ZIPK); ILK; PAK1; PKG1 (PRKG1); Raf1; ROCK1; ROCK2",null,"O14974","O14974"]
[1615,889,"PN187","NBN (p95NBS1)","S343","Nibrin",0,856,10,225,{"v":190.35,"d":"190"},{"v":334.472912415,"d":"334"},{"$f":"(L1628+L1629)/2","v":{"v":412.55612778375,"d":"413"}},{"$f":"SQRT((M1628-L1628)*(M1628-L1628))","v":{"v":78.08321536875002,"d":"78"}},{"$f":"N1628/M1628*100","v":{"v":18.926689027311934,"d":"19"}},0,1202,12,209,{"v":248.71,"d":"249"},{"v":434.549867521,"d":"435"},{"$f":"(U1628+U1629)/2","v":{"v":389.2218661817,"d":"389"}},{"$f":"SQRT((V1628-U1628)*(V1628-U1628))","v":{"v":45.32800133929999,"d":"45"}},{"$f":"W1628/V1628*100","v":{"v":11.645800320514256,"d":"12"}},{"$f":"X1628+O1628","v":{"v":30.572489347826192,"d":"31"}},{"$f":"(V1628/M1628*100)-100","v":{"v":-5.656021091578879,"d":"-6"}},null,0,1029,12,214,{"v":217.638,"d":"218"},{"v":372.3441006132,"d":"372"},{"$f":"(AG1628+AG1629)/2","v":{"v":347.3718041181,"d":"347"}},{"$f":"SQRT((AH1628-AG1628)*(AH1628-AG1628))","v":{"v":24.97229649510001,"d":"25"}},{"$f":"AI1628/AH1628*100","v":{"v":7.1889244317048515,"d":"7"}},{"$f":"AJ1628+O1628","v":{"v":26.115613459016785,"d":"26"}},{"$f":"(AH1628/M1628*100)-100","v":{"v":-15.80011040335772,"d":"-16"}},{"$nulls":10},"X",{"$nulls":4},"SL(pS)QG","Corresponds to amino acid residues S341 to G345.","S343 phosphorylation induces activity. This is one of the major in vivo phosphorylation sites in nibrin (≥73 reports from high throughput mass spectrometry studies).","ATM; ATR","DNA binding protein","O60934","O60934",null,"O60934","GO:0005829; GO:0030870; GO:0000784; GO:0042405; GO:0005730; GO:0005654; GO:0005634; GO:0016605; GO:0005657; GO:0035861","GO:0003684; GO:0047485; GO:0008134","GO:0001832; GO:0007050; GO:0008283; GO:0000077; GO:0030330; GO:0000729; GO:0032508; GO:0006260; GO:0006302; GO:0000724; GO:0006303; GO:0097193; GO:0045190; GO:0051321; GO:0007093; GO:0007095; GO:1904354; GO:0050885; GO:0033674; GO:0031954; GO:0032206; GO:0030174; GO:0090656; GO:0000723; GO:0090737; GO:0031860"]
[1621,806,"NK117-4","Nek2","Pan-specific","NIMA (never-in-mitosis)-related protein-serine kinase 2",0,184,12,695,{"v":119.54,"d":"120"},{"v":210.04934042600001,"d":"210"},{"$f":"(L1634+L1635)/2","v":{"v":211.0386141307,"d":"211"}},{"$f":"SQRT((M1634-L1634)*(M1634-L1634))","v":{"v":0.9892737046999969,"d":"1"}},{"$f":"N1634/M1634*100","v":{"v":0.46876431063337154,"d":"0"}},0,171,14,656,{"v":102.992,"d":"103"},{"v":179.9491775792,"d":"180"},{"$f":"(U1634+U1635)/2","v":{"v":191.7009463418,"d":"192"}},{"$f":"SQRT((V1634-U1634)*(V1634-U1634))","v":{"v":11.751768762599994,"d":"12"}},{"$f":"W1634/V1634*100","v":{"v":6.13026121511511,"d":"6"}},{"$f":"X1634+O1634","v":{"v":6.599025525748481,"d":"7"}},{"$f":"(V1634/M1634*100)-100","v":{"v":-9.163094568524727,"d":"-9"}},null,0,260,14,706,{"v":173.676,"d":"174"},{"v":297.1320909864,"d":"297"},{"$f":"(AG1634+AG1635)/2","v":{"v":270.1452787428,"d":"270"}},{"$f":"SQRT((AH1634-AG1634)*(AH1634-AG1634))","v":{"v":26.986812243600014,"d":"27"}},{"$f":"AI1634/AH1634*100","v":{"v":9.989740471938296,"d":"10"}},{"$f":"AJ1634+O1634","v":{"v":10.458504782571667,"d":"10"}},{"$f":"(AH1634/M1634*100)-100","v":{"v":28.007511732186686,"d":"28"}},null,null,"NEK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","NEK",{"$nulls":6},"Epitope undefined.",{"$nulls":3},"Protein kinase, tyrosine (non-receptor); Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; Other group; NEK family","P51955","P51955","P51955",null,"GO:0005813; GO:0000777; GO:0000794; GO:0005829; GO:0000776; GO:0005874; GO:0030496; GO:0005730; GO:0005654; GO:0032991; GO:0000922","GO:0005524; GO:0046872; GO:0004672; GO:0019903; GO:0004674","GO:0001824; GO:0051301; GO:0051299; GO:0007059; GO:0097711; GO:0000086; GO:0051321; GO:0000278; GO:0000070; GO:0090307; GO:1903126; GO:0043392; GO:0051973; GO:1904355; GO:0032212; GO:0046777; GO:0006468; GO:0051988; GO:0010389; GO:0046602; GO:0007088; GO:0051225"]
[1626,808,"PK733","Nek2","T170+S171","NIMA (never-in-mitosis)-related protein-serine kinase 2",0,460,10,636,{"v":286.2,"d":"286"},{"v":502.89544277999994,"d":"503"},{"$nulls":3},0,450,14,625,{"v":272.5,"d":"273"},{"v":476.11611475,"d":"476"},{"$nulls":6},0,505,14,568,{"v":278.888,"d":"279"},{"v":477.1331363632,"d":"477"},{"$nulls":7},"NEK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","NEK",{"$nulls":6},"HD(pT)(pS)FAK(bA)C","Corresponds to amino acid residues H168 to K174; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T170 and S171 stimulates phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These two in vivo phosphorylation sites in Nek2  have been reported ≥1 and ≥5 times from high throughput mass spectrometry studies.",null,null,"P51955","P51955","P51955"]
[1627,809,"PK732","Nek2","S171","NIMA (never-in-mitosis)-related protein-serine kinase 2",0,10662,14,744,{"v":7922.112,"d":"7922"},{"v":13920.3145422528,"d":"13920"},{"$f":"(L1640+L1641)/2","v":{"v":13977.0194298627,"d":"13977"}},{"$f":"SQRT((M1640-L1640)*(M1640-L1640))","v":{"v":56.70488760989974,"d":"57"}},{"$f":"N1640/M1640*100","v":{"v":0.4057008569992148,"d":"0"}},0,9977,16,637,{"v":6345.157,"d":"6345"},{"v":11086.3541222707,"d":"11086"},{"$f":"(U1640+U1641)/2","v":{"v":13905.488306943349,"d":"13905"}},{"$f":"SQRT((V1640-U1640)*(V1640-U1640))","v":{"v":2819.134184672648,"d":"2819"}},{"$f":"W1640/V1640*100","v":{"v":20.273536048820276,"d":"20"}},{"$f":"X1640+O1640","v":{"v":20.67923690581949,"d":"21"}},{"$f":"(V1640/M1640*100)-100","v":{"v":-0.5117766579512733,"d":"-1"}},null,0,11922,14,718,{"v":8549.944,"d":"8550"},{"v":14627.598162881599,"d":"14628"},{"$f":"(AG1640+AG1641)/2","v":{"v":13448.2176679018,"d":"13448"}},{"$f":"SQRT((AH1640-AG1640)*(AH1640-AG1640))","v":{"v":1179.3804949797996,"d":"1179"}},{"$f":"AI1640/AH1640*100","v":{"v":8.769790347718304,"d":"9"}},{"$f":"AJ1640+O1640","v":{"v":9.175491204717519,"d":"9"}},{"$f":"(AH1640/M1640*100)-100","v":{"v":-3.783365721243001,"d":"-4"}},null,null,"NEK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","NEK",{"$nulls":6},"HDT(pS)FAK(bA)C","Corresponds to amino acid residues H168 to K174; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S171 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in Nek2 (≥5 reports from high throughput mass spectrometry studies).",null,"Protein kinase, tyrosine (non-receptor); Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; Other group; NEK family","P51955","P51955","P51955",null,"GO:0005813; GO:0000777; GO:0000794; GO:0005829; GO:0000776; GO:0005874; GO:0030496; GO:0005730; GO:0005654; GO:0032991; GO:0000922","GO:0005524; GO:0046872; GO:0004672; GO:0019903; GO:0004674","GO:0001824; GO:0051301; GO:0051299; GO:0007059; GO:0097711; GO:0000086; GO:0051321; GO:0000278; GO:0000070; GO:0090307; GO:1903126; GO:0043392; GO:0051973; GO:1904355; GO:0032212; GO:0046777; GO:0006468; GO:0051988; GO:0010389; GO:0046602; GO:0007088; GO:0051225"]
[1632,811,"PK734","Nek6","S206","NIMA (never-in-mitosis)-related protein-serine kinase 6",0,7558,12,652,{"v":4919.992,"d":"4920"},{"v":8645.1486908248,"d":"8645"},{"$nulls":3},0,8822,14,655,{"v":5769.24,"d":"5769"},{"v":10080.103243524,"d":"10080"},{"$nulls":6},0,7993,14,571,{"v":4556.009,"d":"4556"},{"v":7794.6088159726005,"d":"7795"},{"$nulls":7},"NEK6","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","NEK",{"$nulls":6},"AAH(pS)LVG(bA)C","Corresponds to amino acid residues A203 to G209; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S206 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation site in Nek6 (≥60 reports from high throughput mass spectrometry studies).","NEK9",null,"Q9HC98","Q9HC98","Q9HC98"]
[1637,814,"PK735","Nek7","T191+S195","NIMA (never-in-mitosis)-related protein-serine kinase 7",0,5557,14,732,{"v":4057.476,"d":"4057"},{"v":7129.5813752244,"d":"7130"},{"$f":"(L1650+L1651)/2","v":{"v":6531.6752424145,"d":"6532"}},{"$f":"SQRT((M1650-L1650)*(M1650-L1650))","v":{"v":597.9061328099006,"d":"598"}},{"$f":"N1650/M1650*100","v":{"v":9.153947656908896,"d":"9"}},0,4420,14,579,{"v":2551.074,"d":"2551"},{"v":4457.2750140174,"d":"4457"},{"$f":"(U1650+U1651)/2","v":{"v":5566.0664525529,"d":"5566"}},{"$f":"SQRT((V1650-U1650)*(V1650-U1650))","v":{"v":1108.7914385354998,"d":"1109"}},{"$f":"W1650/V1650*100","v":{"v":19.920556967604075,"d":"20"}},{"$f":"X1650+O1650","v":{"v":29.07450462451297,"d":"29"}},{"$f":"(V1650/M1650*100)-100","v":{"v":-14.783478265901238,"d":"-15"}},null,0,5291,14,719,{"v":3794.163,"d":"3794"},{"v":6491.2111387482,"d":"6491"},{"$f":"(AG1650+AG1651)/2","v":{"v":6399.2679556501,"d":"6399"}},{"$f":"SQRT((AH1650-AG1650)*(AH1650-AG1650))","v":{"v":91.94318309810023,"d":"92"}},{"$f":"AI1650/AH1650*100","v":{"v":1.4367765771852221,"d":"1"}},{"$f":"AJ1650+O1650","v":{"v":10.590724234094118,"d":"11"}},{"$f":"(AH1650/M1650*100)-100","v":{"v":-2.0271566152675717,"d":"-2"}},null,null,"NEK7","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","NEK",{"$nulls":6},"(pT)AAH(pS)LVG(bA)C","Corresponds to amino acid residues T191 to G198; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T191 and S195 phosphorylation is predicted to be stimulatory for phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. T191 is a minor phosphosite (≥1 report) and S195 is a major phosphosite (≥80 reports) from high throughput mass spectrometry studies.","NEK9","EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Protein kinase, tyrosine (non-receptor); Other group; NEK family","Q8TDX7","Q8TDX7","Q8TDX7",null,"GO:0005737; GO:0005874; GO:0005815; GO:0005654; GO:0000922","GO:0005524; GO:0046872; GO:0004674","GO:0051973; GO:1904355; GO:0032212; GO:0006468; GO:0007346; GO:0051225"]
[1639,815,"PN237","NES","T315","Nestin",0,132,10,545,{"v":66.49,"d":"66"},{"v":116.83269738099999,"d":"117"},{"$f":"(L1652+L1653)/2","v":{"v":129.5421409087,"d":"130"}},{"$f":"SQRT((M1652-L1652)*(M1652-L1652))","v":{"v":12.709443527700003,"d":"13"}},{"$f":"N1652/M1652*100","v":{"v":9.81104946895813,"d":"10"}},0,102,10,544,{"v":50.048,"d":"50"},{"v":87.44462132480001,"d":"87"},{"$f":"(U1652+U1653)/2","v":{"v":110.27023939120001,"d":"110"}},{"$f":"SQRT((V1652-U1652)*(V1652-U1652))","v":{"v":22.825618066399997,"d":"23"}},{"$f":"W1652/V1652*100","v":{"v":20.69970845481049,"d":"21"}},{"$f":"X1652+O1652","v":{"v":30.510757923768622,"d":"31"}},{"$f":"(V1652/M1652*100)-100","v":{"v":-14.876936093778653,"d":"-15"}},null,0,122,8,532,{"v":60.648,"d":"61"},{"v":103.75910922720001,"d":"104"},{"$f":"(AG1652+AG1653)/2","v":{"v":103.19110988240001,"d":"103"}},{"$f":"SQRT((AH1652-AG1652)*(AH1652-AG1652))","v":{"v":0.5679993448000005,"d":"1"}},{"$f":"AI1652/AH1652*100","v":{"v":0.5504343789375957,"d":"1"}},{"$f":"AJ1652+O1652","v":{"v":10.361483847895725,"d":"10"}},{"$f":"(AH1652/M1652*100)-100","v":{"v":-20.341667075636735,"d":"-20"}},{"$nulls":15},"Epitope undefined.","Antibody raised against amino acid residues that encompass the T316 phosphosite.","The effect of T315 phosphorylation is unclear. This is the minor in vivo phosphorylation site in NES (≥7 reports from high throughput mass spectrometry studies). ","CDK5","Cytoskeletal protein","P48681","P48681",null,null,"GO:0005737; GO:0005882; GO:0045111","GO:0019215; GO:0005198","GO:0007420; GO:0007417; GO:0031076; GO:0000086; GO:0043086; GO:0032091; GO:0030844; GO:2000179; GO:0072089"]
[1644,817,"PN709","NF2","S518","Merlin",0,15704,21,784,{"v":12295.472,"d":"12295"},{"v":21604.9505088368,"d":"21605"},{"$nulls":3},0,18320,20,746,{"v":13651.8,"d":"13652"},{"v":23852.63110218,"d":"23853"},{"$nulls":6},0,17107,20,735,{"v":12558.945,"d":"12559"},{"v":21486.363046323,"d":"21486"},{"$nulls":10},"Cytoskeletal protein",{"$nulls":9},"MKRL(pS)MEI(bA)C","Corresponds to amino acid residues M514 to I521.","S518 phosphorylation inhibits activity. Phosphorylation induces binding of Ezrin, Merlin and SPTAN1, and inhibits interaction with CD44, DDB1, Hrs, LIN28B, LRP6, Merlin, PIK3R2, SRc, TUBA4A and VPRBP. This is the major in vivo phosphorylation site in NF2 (≥37 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in fish.","PAK1; PAK2; PKACa (PRKACA)",null,"P35240","P35240"]
[1649,823,"PN240","NFAT3 (NFATc4)","S168+S170","Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4",0,98,8,621,{"v":55.89,"d":"56"},{"v":98.206940241,"d":"98"},{"$f":"(L1662+L1663)/2","v":{"v":80.5880282747,"d":"81"}},{"$f":"SQRT((M1662-L1662)*(M1662-L1662))","v":{"v":17.618911966300004,"d":"18"}},{"$f":"N1662/M1662*100","v":{"v":21.862939624533944,"d":"22"}},0,79,6,523,{"v":38.179,"d":"38"},{"v":66.7069253029,"d":"67"},{"$f":"(U1662+U1663)/2","v":{"v":82.78567226065,"d":"83"}},{"$f":"SQRT((V1662-U1662)*(V1662-U1662))","v":{"v":16.07874695775,"d":"16"}},{"$f":"W1662/V1662*100","v":{"v":19.422137332081086,"d":"19"}},{"$f":"X1662+O1662","v":{"v":41.28507695661503,"d":"41"}},{"$f":"(V1662/M1662*100)-100","v":{"v":2.727010491507386,"d":"3"}},null,0,108,8,591,{"v":59.1,"d":"59"},{"v":101.11072674,"d":"101"},{"$f":"(AG1662+AG1663)/2","v":{"v":75.68420185320001,"d":"76"}},{"$f":"SQRT((AH1662-AG1662)*(AH1662-AG1662))","v":{"v":25.426524886799996,"d":"25"}},{"$f":"AI1662/AH1662*100","v":{"v":33.595551335955506,"d":"34"}},{"$f":"AJ1662+O1662","v":{"v":55.45849096048945,"d":"55"}},{"$f":"(AH1662/M1662*100)-100","v":{"v":-6.085055716693219,"d":"-6"}},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against amino acid residues surrounding the dually phosphorylated Ser-168 and Ser-170 of human NFATc4.","S168 and S170 phosphorylation inhibits nuclear translocation and transcriptional activity. These are two of the minor in vivo phosphorylation sites in NFAT3 (≥1 and ≥1 reports, respectively, from high throughput mass spectrometry studies).","S168: ERK5 (MAPK7); FRAP1 (mTOR); p38a MAPK (MAPK14). S170: ERK5 (MAPK7); FRAP1 (mTOR); p38a MAPK (MAPK14).","Transcription protein","Q14934","Q14934",null,null,"GO:0005829; GO:0016607; GO:0005634; GO:0005667","GO:0042975; GO:0000978; GO:0000981; GO:0001078; GO:0001227; GO:0003713; GO:0008134","GO:0001569; GO:0033173; GO:0045333; GO:1904637; GO:0071285; GO:0034644; GO:0007507; GO:0006954; GO:0008630; GO:0055001; GO:0035562; GO:0050774; GO:1902894; GO:0032091; GO:2000297; GO:0030178; GO:2001235; GO:0045944; GO:0032760; GO:0048167; GO:0051145; GO:0006366"]
[1654,822,"PN239","NFAT4 (NFATc3)","S240","Nuclear factor of activated T-cells, cytoplasmic 3",0,372,12,597,{"v":214.92,"d":"215"},{"v":377.646011748,"d":"378"},{"$nulls":3},0,430,16,623,{"v":257.922,"d":"258"},{"v":450.64521302220004,"d":"451"},{"$nulls":6},0,315,14,529,{"v":159.229,"d":"159"},{"v":272.41556528060005,"d":"272"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S240 phosphosite.","The effect of S240 phosphorylation is unclear. This phosphorylation site in NFAT4 has only been reported once in high throughput mass spectrometry studies.",null,null,"Q12968","Q12968",null,"Q12968"]
[1659,825,"NN071","NFKB p65 (Rel A)","Pan-specific","NF-kappa-B p65 nuclear transcription factor",0,1069,14,712,{"v":751.16,"d":"751"},{"v":1319.8984654039998,"d":"1320"},{"$f":"(L1672+L1673)/2","v":{"v":1970.71492709325,"d":"1971"}},{"$f":"SQRT((M1672-L1672)*(M1672-L1672))","v":{"v":650.8164616892502,"d":"651"}},{"$f":"N1672/M1672*100","v":{"v":33.02438382852189,"d":"33"}},0,994,16,640,{"v":625.92,"d":"626"},{"v":1093.6168753919999,"d":"1094"},{"$f":"(U1672+U1673)/2","v":{"v":1258.51903653,"d":"1259"}},{"$f":"SQRT((V1672-U1672)*(V1672-U1672))","v":{"v":164.9021611380001,"d":"165"}},{"$f":"W1672/V1672*100","v":{"v":13.102873802582266,"d":"13"}},{"$f":"X1672+O1672","v":{"v":46.12725763110416,"d":"46"}},{"$f":"(V1672/M1672*100)-100","v":{"v":-36.138960575780445,"d":"-36"}},null,0,1088,12,675,{"v":726.3,"d":"726"},{"v":1242.58410882,"d":"1243"},{"$f":"(AG1672+AG1673)/2","v":{"v":2168.9328715812,"d":"2169"}},{"$f":"SQRT((AH1672-AG1672)*(AH1672-AG1672))","v":{"v":926.3487627611999,"d":"926"}},{"$f":"AI1672/AH1672*100","v":{"v":42.70988627167014,"d":"43"}},{"$f":"AJ1672+O1672","v":{"v":75.73427010019203,"d":"76"}},{"$f":"(AH1672/M1672*100)-100","v":{"v":10.058174409848093,"d":"10"}},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Epitope undefined.",{"$nulls":3},"Nuclear receptor co-regulator; Transcription factor","Q04206","Q04206",null,"Q04206","GO:0005737; GO:0005829; GO:0098978; GO:0033256; GO:0035525; GO:0000790; GO:0005654; GO:0005634; GO:0005667","GO:0042805; GO:0033613; GO:0071532; GO:0003682; GO:0031490; GO:0003677; GO:0003700; GO:0042826; GO:0042802; GO:0051059; GO:0042301; GO:0044877; GO:0046982; GO:0042803; GO:0019901; GO:0047485; GO:0070491; GO:0000980; GO:0000978; GO:0000977; GO:0000981; GO:0001205; GO:0001077; GO:0001078; GO:0000983; GO:0003705; GO:0008134; GO:0044212; GO:0031625","GO:0006117; GO:0007568; GO:0009887; GO:0006968; GO:1904385; GO:0035729; GO:0070301; GO:0071347; GO:0071354; GO:0071222; GO:0071223; GO:0071316; GO:0071224; GO:0071356; GO:0035924; GO:0019221; GO:0051607; GO:0038095; GO:0001942; GO:0006954; GO:0070498; GO:0001889; GO:0031293; GO:0043066; GO:2001237; GO:0046627; GO:1901223; GO:1902894; GO:0042177; GO:0033234; GO:0045892; GO:0000122; GO:0070431; GO:0008284; GO:0032332; GO:0043123; GO:0045084; GO:2000630; GO:0051092; GO:1901224; GO:1902895; GO:0014040; GO:0050862; GO:0045893; GO:0045944; GO:1901522; GO:0032481; GO:0099527; GO:0061614; GO:0043620; GO:0050727; GO:1901222; GO:0006355; GO:0043200; GO:0051591; GO:0033590; GO:0032868; GO:0070555; GO:0043278; GO:0032495; GO:0035994; GO:0010033; GO:0032570; GO:0010224; GO:0002223; GO:0050852; GO:0033209; GO:0016032"]
[1662,826,"PN053-1","NFKB p65 (Rel A)","S276","NF-kappa-B p65 nuclear transcription factor",0,6158,12,748,{"v":4597.208,"d":"4597"},{"v":8077.969785855199,"d":"8078"},{"$nulls":3},0,7548,18,803,{"v":6046.59,"d":"6047"},{"v":10564.693351509,"d":"10565"},{"$nulls":6},0,7378,16,752,{"v":5536.224,"d":"5536"},{"v":9471.6012188736,"d":"9472"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S276 phosphosite.","S276 phosphorylation induces transcriptional activity and binding to CBP, DNA, DNMT1, PKACA, eEF1B and p300, and inhibits interaction with HDAC1. This phosphorylation site in NFKB p65 has not been detected in high throughput mass spectrometry studies, although it is commonly reported by Western blotting.","MSK1; MSK2; Pim1; PKACa (PRKACA); PKCa (PRKCA)",null,"Q04206","Q04206",null,"Q04206"]
[1666,828,"PN156","NFKB p65 (Rel A)","S529","NF-kappa-B p65 nuclear transcription factor",0,1368,10,371,{"v":503.818,"d":"504"},{"v":885.2822368642,"d":"885"},{"$nulls":3},0,1512,12,353,{"v":529.5,"d":"530"},{"v":925.15039545,"d":"925"},{"$nulls":6},0,1880,14,309,{"v":576.594,"d":"577"},{"v":986.4608861916001,"d":"986"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"LL(pS)GD","Corresponds to amino acid residues L527 to D531.","S529 phosphorylation induces transcriptional activity. This is one of the minor in vivo phosphorylation sites in NFKB p65 (≥3 reports from high throughput mass spectrometry studies).","CK2a1 (CSNK2A1)",null,"Q04206","Q04206",null,"Q04206"]
[1671,831,"PN634","NFKB1 (NFkB-p105)","S903","Nuclear factor NF-kappa-B p105 subunit",0,15486,20,771,{"v":11924.286,"d":"11924"},{"v":20952.7221796134,"d":"20953"},{"$f":"(L1684+L1685)/2","v":{"v":19230.5442600703,"d":"19231"}},{"$f":"SQRT((M1684-L1684)*(M1684-L1684))","v":{"v":1722.1779195431009,"d":"1722"}},{"$f":"N1684/M1684*100","v":{"v":8.955429946509508,"d":"9"}},0,16402,20,770,{"v":12614.14,"d":"12614"},{"v":22039.615881514,"d":"22040"},{"$f":"(U1684+U1685)/2","v":{"v":18786.3625178425,"d":"18786"}},{"$f":"SQRT((V1684-U1684)*(V1684-U1684))","v":{"v":3253.2533636715016,"d":"3253"}},{"$f":"W1684/V1684*100","v":{"v":17.317100958643262,"d":"17"}},{"$f":"X1684+O1684","v":{"v":26.27253090515277,"d":"26"}},{"$f":"(V1684/M1684*100)-100","v":{"v":-2.309772080398602,"d":"-2"}},null,0,15009,20,823,{"v":12335.947,"d":"12336"},{"v":21104.848835805802,"d":"21105"},{"$f":"(AG1684+AG1685)/2","v":{"v":18969.0361428872,"d":"18969"}},{"$f":"SQRT((AH1684-AG1684)*(AH1684-AG1684))","v":{"v":2135.8126929186037,"d":"2136"}},{"$f":"AI1684/AH1684*100","v":{"v":11.259468730146668,"d":"11"}},{"$f":"AJ1684+O1684","v":{"v":20.214898676656176,"d":"20"}},{"$f":"(AH1684/M1684*100)-100","v":{"v":-1.3598581176201492,"d":"-1"}},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"CSQAH(pS)LPL(pS)PAS","Corresponds to amino acid residues C899 to S910.","S903 phosphorylation promotes protein proteolysis. This is one of the major in vivo phosphorylation sites in NFKB1 (≥30 reports from high throughput mass spectrometry studies).","GSK3b","Transcription protein","P19838","P19838",null,"P19838","GO:0005737; GO:0005829; GO:0005576; GO:0033256; GO:0005739; GO:0005654; GO:0005634; GO:0034774; GO:0035580","GO:0042805; GO:0003682; GO:0003700; GO:0042802; GO:0046982; GO:0042803; GO:0000980; GO:0000977; GO:0000981; GO:0001205; GO:0001227; GO:0008134; GO:0044212; GO:0000976","GO:0006915; GO:1904385; GO:0071359; GO:0071347; GO:0071354; GO:0071222; GO:0071260; GO:0071316; GO:0071356; GO:0038095; GO:0007249; GO:0006954; GO:0045087; GO:0070498; GO:0031293; GO:0043066; GO:0010956; GO:0032269; GO:0032375; GO:0010629; GO:0050728; GO:0045083; GO:0000122; GO:0010957; GO:0043312; GO:0038061; GO:0090263; GO:1900127; GO:0010884; GO:0010744; GO:2000630; GO:0051092; GO:0045893; GO:0045944; GO:0032481; GO:0035994; GO:0002223; GO:0051403; GO:0050852; GO:0006366"]
[1676,833,"NK207-2","NIK (MAP3K14; NLK; LAK1)","Pan-specific","NF-kappa beta-inducing kinase (nemo-like kinase)",0,261,10,575,{"v":144.325,"d":"144"},{"v":253.60022634249998,"d":"254"},{"$nulls":3},0,460,12,603,{"v":270.144,"d":"270"},{"v":471.9996759744,"d":"472"},{"$nulls":6},0,260,12,524,{"v":129.952,"d":"130"},{"v":222.32726161280002,"d":"222"},{"$nulls":7},"NIK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE-Unique",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues 700-9473 mapping at the C-terminus of human NIK.",{"$nulls":3},"Q99558","Q99558","Q99558","Q99558"]
[1677,834,"NK207","NIK (MAP3K14; NLK; LAK1)","Pan-specific","Serine/threonine protein kinase NLK",0,232,18,736,{"v":157.504,"d":"158"},{"v":276.7576653376,"d":"277"},{"$f":"(L1690+L1691)/2","v":{"v":194.7551338084,"d":"195"}},{"$f":"SQRT((M1690-L1690)*(M1690-L1690))","v":{"v":82.00253152919998,"d":"82"}},{"$f":"N1690/M1690*100","v":{"v":42.10545310188025,"d":"42"}},0,194,18,558,{"v":98.208,"d":"98"},{"v":171.5905005408,"d":"172"},{"$f":"(U1690+U1691)/2","v":{"v":185.4284441328,"d":"185"}},{"$f":"SQRT((V1690-U1690)*(V1690-U1690))","v":{"v":13.837943591999988,"d":"14"}},{"$f":"W1690/V1690*100","v":{"v":7.462686567164173,"d":"7"}},{"$f":"X1690+O1690","v":{"v":49.56813966904443,"d":"50"}},{"$f":"(V1690/M1690*100)-100","v":{"v":-4.7889313586853035,"d":"-5"}},null,0,312,26,783,{"v":223.938,"d":"224"},{"v":383.12240143319997,"d":"383"},{"$f":"(AG1690+AG1691)/2","v":{"v":253.03344305999997,"d":"253"}},{"$f":"SQRT((AH1690-AG1690)*(AH1690-AG1690))","v":{"v":130.0889583732,"d":"130"}},{"$f":"AI1690/AH1690*100","v":{"v":51.411764705882355,"d":"51"}},{"$f":"AJ1690+O1690","v":{"v":93.5172178077626,"d":"94"}},{"$f":"(AH1690/M1690*100)-100","v":{"v":29.92388858356574,"d":"30"}},null,null,"NIK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE-Unique",{"$nulls":6},"Epitope undefined.",{"$nulls":3},"Protein-serine kinase, STE group, STE-Unique family","Q99558","Q99558","Q99558","Q99558","GO:0005737; GO:0005829; GO:0001650; GO:0043231; GO:0005634","GO:0005524; GO:0016301; GO:0004709; GO:0004704; GO:0004672; GO:0004674","GO:0032147; GO:0071260; GO:0051607; GO:0007249; GO:0006955; GO:0038061; GO:0043123; GO:0042981; GO:0007346; GO:0023014; GO:0031098; GO:0033209"]
[1685,838,"PN710","NMDAR2A (GRIN2A)","Y943","Glutamate [NMDA] receptor subunit epsilon-1",0,4186,12,962,{"v":4015.388,"d":"4015"},{"v":7055.6265764971995,"d":"7056"},{"$f":"(L1698+L1699)/2","v":{"v":6243.606822481599,"d":"6244"}},{"$f":"SQRT((M1698-L1698)*(M1698-L1698))","v":{"v":812.0197540156005,"d":"812"}},{"$f":"N1698/M1698*100","v":{"v":13.00561962184629,"d":"13"}},0,4282,18,943,{"v":4020.952,"d":"4021"},{"v":7025.4680507752,"d":"7025"},{"$f":"(U1698+U1699)/2","v":{"v":6111.4788653840005,"d":"6111"}},{"$f":"SQRT((V1698-U1698)*(V1698-U1698))","v":{"v":913.9891853911995,"d":"914"}},{"$f":"W1698/V1698*100","v":{"v":14.955286691215141,"d":"15"}},{"$f":"X1698+O1698","v":{"v":27.96090631306143,"d":"28"}},{"$f":"(V1698/M1698*100)-100","v":{"v":-2.116212004603497,"d":"-2"}},null,0,3988,22,916,{"v":3632.856,"d":"3633"},{"v":6215.240445038401,"d":"6215"},{"$f":"(AG1698+AG1699)/2","v":{"v":5552.569980528001,"d":"5553"}},{"$f":"SQRT((AH1698-AG1698)*(AH1698-AG1698))","v":{"v":662.6704645104,"d":"663"}},{"$f":"AI1698/AH1698*100","v":{"v":11.934481993640462,"d":"12"}},{"$f":"AJ1698+O1698","v":{"v":24.940101615486753,"d":"25"}},{"$f":"(AH1698/M1698*100)-100","v":{"v":-11.06791093035126,"d":"-11"}},{"$nulls":5},"Channel, ligand-gated - Glutamate receptor",{"$nulls":9},"NLM(pY)SDN(bA)C","Corresponds to amino acid residues N940 to N946.","The effect of Y943 phosphorylation is unclear. This is the major in vivo phosphorylation site in NMDAR2A (≥134 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in fish.","Fyn","Channel, ligand-gated","Q12879","Q12879",null,null,"GO:0030054; GO:0009986; GO:0005783; GO:0098978; GO:0005887; GO:0099061; GO:0043005; GO:0017146; GO:0005886; GO:0014069; GO:0042734; GO:0097060; GO:0008021","GO:0022849; GO:0004972; GO:0005088; GO:0008270","GO:0097202; GO:0007420; GO:0097553; GO:0007268; GO:0033058; GO:0042417; GO:0098976; GO:0060079; GO:0007215; GO:0007611; GO:0060291; GO:0000165; GO:0007613; GO:0042177; GO:0022008; GO:0043065; GO:1900273; GO:1903539; GO:0051930; GO:0048167; GO:0001975; GO:0045471; GO:0009611; GO:0019233; GO:0042428; GO:0030431; GO:0001964; GO:0008542"]
[1688,839,"PN054","NMDAR2B (GRIN2B)","Y1474","Glutamate [NMDA] receptor subunit epsilon-2",0,278,12,235,{"v":62.51,"d":"63"},{"v":109.83925271899999,"d":"110"},{"$nulls":3},0,208,12,245,{"v":48.02,"d":"48"},{"v":83.901269102,"d":"84"},{"$nulls":6},0,135,10,354,{"v":44.25,"d":"44"},{"v":75.70473195000001,"d":"76"},{"$nulls":10},"Channel, ligand-gated - Glutamate receptor",{"$nulls":9},"Epitope undefined.","Antibody raised against amino acid residues that encompass the Y1474 phosphosite.","The effect of Y1474 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in NMDAR2B (≥105 reports from high throughput mass spectrometry studies).","Fyn",null,"Q13224","Q13224",null,"Q13224"]
[1693,842,"PN711","NOS2","S745","Nitric oxide synthase, inducible",0,6225,20,962,{"v":5969.21,"d":"5969"},{"v":10488.778846949,"d":"10489"},{"$f":"(L1706+L1707)/2","v":{"v":8336.72987406955,"d":"8337"}},{"$f":"SQRT((M1706-L1706)*(M1706-L1706))","v":{"v":2152.048972879451,"d":"2152"}},{"$f":"N1706/M1706*100","v":{"v":25.814066251242647,"d":"26"}},0,6309,22,995,{"v":6255.565,"d":"6256"},{"v":10929.8176270315,"d":"10930"},{"$f":"(U1706+U1707)/2","v":{"v":9419.15361138275,"d":"9419"}},{"$f":"SQRT((V1706-U1706)*(V1706-U1706))","v":{"v":1510.6640156487501,"d":"1511"}},{"$f":"W1706/V1706*100","v":{"v":16.03821402618554,"d":"16"}},{"$f":"X1706+O1706","v":{"v":41.852280277428186,"d":"42"}},{"$f":"(V1706/M1706*100)-100","v":{"v":12.983792849999332,"d":"13"}},null,0,5808,20,894,{"v":5174.472,"d":"5174"},{"v":8852.7009207408,"d":"8853"},{"$f":"(AG1706+AG1707)/2","v":{"v":7759.812012738,"d":"7760"}},{"$f":"SQRT((AH1706-AG1706)*(AH1706-AG1706))","v":{"v":1092.8889080027993,"d":"1093"}},{"$f":"AI1706/AH1706*100","v":{"v":14.08396113473863,"d":"14"}},{"$f":"AJ1706+O1706","v":{"v":39.89802738598128,"d":"40"}},{"$f":"(AH1706/M1706*100)-100","v":{"v":-6.920193769573686,"d":"-7"}},{"$nulls":14},"X","NLQ(pS)PTS(bA)C","Corresponds to amino acid residues N742 to S748.","S745 phosphorylation stimulates enzyme activity. This phosphorylation site appears to be poorly detected by mass spectrometry (≥1 report ). This human phosphosite is highly conserved in vertebrates and found in the frog.","ERK1 (MAPK3); ERK2 (MAPK1)","Oxidoreductase, Amino Acid Metabolism group, Arginine and proline metabolism family","P35228","P35228",null,null,"GO:0030863; GO:0005737; GO:0005829; GO:0005622; GO:0005634; GO:0048471; GO:0005782; GO:0005777","GO:0034618; GO:0005516; GO:0050660; GO:0010181; GO:0020037; GO:0046872; GO:0050661; GO:0003958; GO:0004517; GO:0042803; GO:0005102; GO:0034617","GO:0006527; GO:0045454; GO:0035690; GO:0071346; GO:0071222; GO:0007623; GO:0019221; GO:0042742; GO:0050829; GO:0002227; GO:0072604; GO:0072606; GO:0045776; GO:0010629; GO:0042177; GO:0006809; GO:0007263; GO:0018119; GO:0097755; GO:0031284; GO:0051712; GO:0001912; GO:0032310; GO:0006625; GO:0042127; GO:0043457; GO:1900015; GO:0050796; GO:0009617; GO:0001666; GO:0006801"]
[1694,842,"PN711","NOS2","S745","Nitric oxide synthase, inducible",0,4475,14,789,{"v":3519.729,"d":"3520"},{"v":6184.6809011901,"d":"6185"},{"$nulls":3},0,5817,14,780,{"v":4526.34,"d":"4526"},{"v":7908.489595734,"d":"7908"},{"$nulls":6},0,5126,12,762,{"v":3896.868,"d":"3897"},{"v":6666.9231047352005,"d":"6667"},{"$nulls":19},"X","NLQ(pS)PTS(bA)C","Corresponds to amino acid residues N742 to S748.","S745 phosphorylation stimulates enzyme activity. This phosphorylation site appears to be poorly detected by mass spectrometry (≥1 report ). This human phosphosite is highly conserved in vertebrates and found in the frog.","ERK1 (MAPK3); ERK2 (MAPK1)",null,"P35228","P35228"]
[1699,845,"NK361-1","NuaK1 (ARK5)/Nuak2","Pan-specific","NUAK family SNF1-like kinase 1/2",0,916,14,1000,902,{"v":1584.9465038,"d":"1585"},{"$f":"(L1712+L1713)/2","v":{"v":948.8804117628,"d":"949"}},{"$f":"SQRT((M1712-L1712)*(M1712-L1712))","v":{"v":636.0660920372001,"d":"636"}},{"$f":"N1712/M1712*100","v":{"v":67.03332518536625,"d":"67"}},0,1259,22,974,{"v":1204.838,"d":"1205"},{"v":2105.1111466538,"d":"2105"},{"$f":"(U1712+U1713)/2","v":{"v":1226.3947397013999,"d":"1226"}},{"$f":"SQRT((V1712-U1712)*(V1712-U1712))","v":{"v":878.7164069524001,"d":"879"}},{"$f":"W1712/V1712*100","v":{"v":71.65037312263327,"d":"72"}},{"$f":"X1712+O1712","v":{"v":138.68369830799952,"d":"139"}},{"$f":"(V1712/M1712*100)-100","v":{"v":29.24650192989469,"d":"29"}},null,0,1458,24,1012,{"v":1451.208,"d":"1451"},{"v":2482.7867264112,"d":"2483"},{"$f":"(AG1712+AG1713)/2","v":{"v":1401.3433473744,"d":"1401"}},{"$f":"SQRT((AH1712-AG1712)*(AH1712-AG1712))","v":{"v":1081.4433790368,"d":"1081"}},{"$f":"AI1712/AH1712*100","v":{"v":77.17190658970377,"d":"77"}},{"$f":"AJ1712+O1712","v":{"v":144.20523177507002,"d":"144"}},{"$f":"(AH1712/M1712*100)-100","v":{"v":47.68387354219155,"d":"48"}},null,null,"NUAK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","NuaK",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues 526-661 mapping at the C-terminus of human ARK5.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); CAMK group; CAMKL family; NuaK subfamily","O60285","O60285","O60285","O60285","GO:0005737; GO:0001650; GO:0015630; GO:0005654; GO:0005634","GO:0005524; GO:0046872; GO:0002039; GO:0004674","GO:0007155; GO:0006974; GO:0035556; GO:0006468; GO:0030155; GO:0042127; GO:2000772; GO:0035507; GO:1901796"]
[1703,847,"PN636","Nur77","S351","Nuclear receptor subfamily 4 group A member 1",0,9350,12,521,{"v":4865.098,"d":"4865"},{"v":8548.6918688962,"d":"8549"},{"$f":"(L1716+L1717)/2","v":{"v":9650.4844753377,"d":"9650"}},{"$f":"SQRT((M1716-L1716)*(M1716-L1716))","v":{"v":1101.7926064415005,"d":"1102"}},{"$f":"N1716/M1716*100","v":{"v":11.416966777752839,"d":"11"}},0,9454,16,539,{"v":5087.082,"d":"5087"},{"v":8888.2264853382,"d":"8888"},{"$f":"(U1716+U1717)/2","v":{"v":8751.0963082147,"d":"8751"}},{"$f":"SQRT((V1716-U1716)*(V1716-U1716))","v":{"v":137.1301771235012,"d":"137"}},{"$f":"W1716/V1716*100","v":{"v":1.5670056904159129,"d":"2"}},{"$f":"X1716+O1716","v":{"v":12.983972468168751,"d":"13"}},{"$f":"(V1716/M1716*100)-100","v":{"v":-9.319616744852894,"d":"-9"}},null,0,10082,16,510,{"v":5133.66,"d":"5134"},{"v":8782.878061524,"d":"8783"},{"$f":"(AG1716+AG1717)/2","v":{"v":8978.8857390392,"d":"8979"}},{"$f":"SQRT((AH1716-AG1716)*(AH1716-AG1716))","v":{"v":196.00767751520107,"d":"196"}},{"$f":"AI1716/AH1716*100","v":{"v":2.1829844282679907,"d":"2"}},{"$f":"AJ1716+O1716","v":{"v":13.59995120602083,"d":"14"}},{"$f":"(AH1716/M1716*100)-100","v":{"v":-6.959223011184605,"d":"-7"}},{"$nulls":5},"Receptor,  nuclear",{"$nulls":4},"X",{"$nulls":4},"CGRLP(pS)KPKQ","Corresponds to amino acid residues C347 to Q355.","S351 phosphorylation inhibits transcriptional activity and regulates apoptosis and cytoskeletal reorganization. This is the major in vivo phosphorylation site in Nur77 (≥4 reports from high throughput mass spectrometry studies).","Akt1 (PKBa); MSK1 (RPS6KA5); PKACa (PRKACA); RSK1 (RPS6KA1); RSK2 (RPS6KA3)","Receptor, nuclear","P22736","P22736",null,null,"GO:0005829; GO:0031965; GO:0005654; GO:0005634","GO:0003677; GO:0004879; GO:0046982; GO:0000981; GO:0043565; GO:0003707; GO:0001077; GO:0008270","GO:0002042; GO:0071376; GO:0044344; GO:0035924; GO:0035767; GO:0045444; GO:0045786; GO:0001938; GO:0045944; GO:0061469; GO:0007165; GO:0006367"]
[1710,852,"NK120-10","p38a MAPK (MAPK14)","Pan-specific","Mitogen-activated protein-serine kinase p38 alpha; Mitogen-activated protein kinase 14",0,1092,18,653,{"v":701.322,"d":"701"},{"v":1232.3257782018,"d":"1232"},{"$nulls":3},0,872,14,484,{"v":415.272,"d":"415"},{"v":725.5695090071999,"d":"726"},{"$nulls":6},0,1068,14,510,{"v":537.54,"d":"538"},{"v":919.645686156,"d":"920"},{"$nulls":7},"p38a","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","p38",{"$nulls":5},"MSQERPTFYRQELC","Corresponds to amino acid residues M1 to L13; N-terminus.",{"$nulls":3},"Q16539","Q16539","Q16539","Q16539"]
[1711,853,"PK739","p38a MAPK (MAPK14)","T180+Y182","Mitogen-activated protein-serine kinase p38 alpha; Mitogen-activated protein kinase 14",0,9542,14,565,{"v":5383.32,"d":"5383"},{"v":9459.284049708,"d":"9459"},{"$f":"(L1724+L1725)/2","v":{"v":13381.763074577999,"d":"13382"}},{"$f":"SQRT((M1724-L1724)*(M1724-L1724))","v":{"v":3922.479024869999,"d":"3922"}},{"$f":"N1724/M1724*100","v":{"v":29.31212429191582,"d":"29"}},0,8595,16,537,{"v":4606.923,"d":"4607"},{"v":8049.2854301373,"d":"8049"},{"$f":"(U1724+U1725)/2","v":{"v":8596.0973622635,"d":"8596"}},{"$f":"SQRT((V1724-U1724)*(V1724-U1724))","v":{"v":546.8119321261993,"d":"547"}},{"$f":"W1724/V1724*100","v":{"v":6.361164945928606,"d":"6"}},{"$f":"X1724+O1724","v":{"v":35.67328923784442,"d":"36"}},{"$f":"(V1724/M1724*100)-100","v":{"v":-35.7625948512425,"d":"-36"}},null,0,8958,14,560,{"v":5008.64,"d":"5009"},{"v":8568.988669696,"d":"8569"},{"$f":"(AG1724+AG1725)/2","v":{"v":9419.4000260768,"d":"9419"}},{"$f":"SQRT((AH1724-AG1724)*(AH1724-AG1724))","v":{"v":850.4113563808005,"d":"850"}},{"$f":"AI1724/AH1724*100","v":{"v":9.028296431051974,"d":"9"}},{"$f":"AJ1724+O1724","v":{"v":38.34042072296779,"d":"38"}},{"$f":"(AH1724/M1724*100)-100","v":{"v":-29.610171891540176,"d":"-30"}},null,null,"p38a","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","p38",{"$nulls":5},"DEM(pT)G(pY)(bA)C","Corresponds to amino acid residues D177 to Y182; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T180 and Y182 phosphorylation is stimulatory for phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major in vivo phosphorylation sites in p38a (≥1578 and ≥3744 reports, respectively, by mass spectrometry).","T180: MKK3 (MAP2K3, MEK3); MKK4 (MAP2K4, MEK4); MKK6 (MAP2K6, MEK6); p38a MAPK (MAPK14); PBK (TOPK).","Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.24; EC 2.7.1.37; CMGC domain target; CMGC</A> group; MAPK family; MAPK/p38 subfamily; p38 subfamily","Q16539","Q16539","Q16539","Q16539","GO:0005737; GO:0005829; GO:0005576; GO:1904813; GO:0098978; GO:0005739; GO:0016607; GO:0005654; GO:0005634; GO:0034774; GO:0000922","GO:0005524; GO:0019899; GO:0004707; GO:0004708; GO:0048273; GO:0051525; GO:0019903; GO:0004674","GO:0070935; GO:0000187; GO:0001525; GO:0006915; GO:0001502; GO:0000902; GO:0007166; GO:0071479; GO:0071222; GO:0071223; GO:0071356; GO:0035924; GO:0098586; GO:0006935; GO:0002062; GO:0000077; GO:0019395; GO:0006006; GO:0035556; GO:0031663; GO:0014835; GO:0090090; GO:0043312; GO:0030316; GO:0038066; GO:0018105; GO:0001890; GO:0090336; GO:0060045; GO:0031281; GO:0002741; GO:0045648; GO:0010628; GO:0046326; GO:2001184; GO:0010759; GO:1905050; GO:0051149; GO:0045663; GO:1901741; GO:0010831; GO:0042307; GO:2000379; GO:0045944; GO:1900015; GO:0030278; GO:1901796; GO:0099179; GO:0006357; GO:0032495; GO:0035994; GO:0007165; GO:0042770; GO:0007519; GO:0090400; GO:0051146; GO:0006351; GO:0007178; GO:0048010"]
[1716,855,"NK248-1","p38b MAPK (MAPK11)","Pan-specific","Mitogen-activated protein-serine kinase p38 beta; Mitogen-activated protein kinase 11",0,1338,14,757,{"v":1002.268,"d":"1002"},{"v":1761.1321091692,"d":"1761"},{"$nulls":3},0,1311,14,536,{"v":695.192,"d":"695"},{"v":1214.6499597992001,"d":"1215"},{"$nulls":6},0,404,18,899,{"v":347.014,"d":"347"},{"v":593.6859175796001,"d":"594"},{"$nulls":7},"p38b","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","p38",{"$nulls":5},"MSGPRAGFYRQELNKC","Corresponds to amino acid residues M1 to K15; N-terminus.",{"$nulls":3},"Q15759","Q15759","Q15759"]
[1721,858,"NK121-2","p38d MAPK (MAPK13)","Pan-specific","Mitogen-activated protein-serine kinase p38 delta; Mitogen-activated protein kinase 13",0,2635,14,565,{"v":1480.865,"d":"1481"},{"v":2602.0973440684998,"d":"2602"},{"$f":"(L1734+L1735)/2","v":{"v":2904.8107048394495,"d":"2905"}},{"$f":"SQRT((M1734-L1734)*(M1734-L1734))","v":{"v":302.71336077094975,"d":"303"}},{"$f":"N1734/M1734*100","v":{"v":10.421104558263492,"d":"10"}},0,2580,12,536,{"v":1376.448,"d":"1376"},{"v":2404.9507299648003,"d":"2405"},{"$f":"(U1734+U1735)/2","v":{"v":2656.1443504616,"d":"2656"}},{"$f":"SQRT((V1734-U1734)*(V1734-U1734))","v":{"v":251.19362049679967,"d":"251"}},{"$f":"W1734/V1734*100","v":{"v":9.457077152194149,"d":"9"}},{"$f":"X1734+O1734","v":{"v":19.87818171045764,"d":"20"}},{"$f":"(V1734/M1734*100)-100","v":{"v":-8.560501170130237,"d":"-9"}},null,0,3446,14,640,{"v":2196.48,"d":"2196"},{"v":3757.828918272,"d":"3758"},{"$f":"(AG1734+AG1735)/2","v":{"v":3553.622888768,"d":"3554"}},{"$f":"SQRT((AH1734-AG1734)*(AH1734-AG1734))","v":{"v":204.20602950400007,"d":"204"}},{"$f":"AI1734/AH1734*100","v":{"v":5.746418117393317,"d":"6"}},{"$f":"AJ1734+O1734","v":{"v":16.16752267565681,"d":"16"}},{"$f":"(AH1734/M1734*100)-100","v":{"v":22.33578190990626,"d":"22"}},null,null,"p38d","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","p38",{"$nulls":5},"MSLIRKKGFYKQDVNC","Corresponds to amino acid residues M1 to N15; N-terminus.",null,null,"EC 2.7.11.24; EC 2.7.1.37; Protein kinase, Ser/Thr (non-receptor); CMGC group; MAPK family; MAPK/p38 subfamily; p38 subfamily","O15264","O15264","O15264","O15264","GO:0005737; GO:0005829; GO:0005634","GO:0005524; GO:0004707; GO:0004674","GO:0007049; GO:0072740; GO:0070301; GO:0071347; GO:1903936; GO:0072709; GO:0034644; GO:0018105; GO:0050729; GO:0032755; GO:0010468; GO:0006355; GO:0006970; GO:0051403; GO:0006351"]
[1726,860,"PK742","p38d MAPK (MAPK13)","T180+Y182","Mitogen-activated protein-serine kinase p38 delta; Mitogen-activated protein kinase 13",0,1445,10,568,{"v":815.08,"d":"815"},{"v":1432.215295252,"d":"1432"},{"$nulls":3},0,794,10,405,{"v":317.52,"d":"318"},{"v":554.775738552,"d":"555"},{"$nulls":6},0,1060,10,458,{"v":480.9,"d":"481"},{"v":822.74362926,"d":"823"},{"$nulls":7},"p38d","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","p38",{"$nulls":5},"AEM(pT)G(pY)(bA)C","Corresponds to amino acid residues A177 to Y182; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T180 and Y182 phosphorylation is stimulatory for phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major in vivo phosphorylation sites in p38a (≥382 and >986 reports, respectively, from high throughput mass spectrometry studies).","T180: MKK3 (MAP2K3, MEK3); MKK6 (MAP2K6, MEK6). Y182: MKK3 (MAP2K3, MEK3); MKK6 (MAP2K6, MEK6).",null,"O15264","O15264","O15264","O15264"]
[1728,861,"PK743","p38d MAPK (MAPK13)","Y182","Mitogen-activated protein-serine kinase p38 delta; Mitogen-activated protein kinase 13",0,7650,16,667,{"v":5091.878,"d":"5092"},{"v":8947.1776428782,"d":"8947"},{"$nulls":3},0,8168,14,588,{"v":4794.552,"d":"4795"},{"v":8377.1136521352,"d":"8377"},{"$nulls":6},0,8200,16,616,{"v":5041.344,"d":"5041"},{"v":8624.940026841601,"d":"8625"},{"$nulls":7},"p38d","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","p38",{"$nulls":5},"MTG(pY)VVT(bA)C","Corresponds to amino acid residues M179 to T185; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y182 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in p38d (≥986 reports from high throughput mass spectrometry studies).","MKK3 (MAP2K3, MEK3); MKK6 (MAP2K6, MEK6)",null,"O15264","O15264","O15264","O15264"]
[1733,864,"NK059-4","p38g MAPK (MAPK12, ERK6)","Pan-specific","Mitogen-activated protein-serine kinase p38 gamma; Mitogen-activated protein kinase 12",0,6586,14,576,{"v":3785.472,"d":"3785"},{"$f":"K1746*1.7571469","v":{"v":6651.6303898368005,"d":"6652"}},{"$f":"(L1746+L1747)/2","v":{"v":8055.98348526895,"d":"8056"}},{"$f":"SQRT((M1746-L1746)*(M1746-L1746))","v":{"v":1404.3530954321495,"d":"1404"}},{"$f":"N1746/M1746*100","v":{"v":17.432422720331147,"d":"17"}},0,5858,12,553,{"v":3232.838,"d":"3233"},{"$f":"T1746*1.7472151","v":{"v":5648.463369453801,"d":"5648"}},{"$f":"(U1746+U1747)/2","v":{"v":6240.8793629051,"d":"6241"}},{"$f":"SQRT((V1746-U1746)*(V1746-U1746))","v":{"v":592.4159934512991,"d":"592"}},{"$f":"W1746/V1746*100","v":{"v":9.492508330997962,"d":"9"}},{"$f":"X1746+O1746","v":{"v":26.92493105132911,"d":"27"}},{"$f":"(V1746/M1746*100)-100","v":{"v":-22.531130130578376,"d":"-23"}},null,0,7096,16,596,{"v":4219.68,"d":"4220"},{"v":7219.203238752001,"d":"7219"},{"$f":"(AG1746+AG1747)/2","v":{"v":7167.739418598601,"d":"7168"}},{"$f":"SQRT((AH1746-AG1746)*(AH1746-AG1746))","v":{"v":51.463820153399865,"d":"51"}},{"$f":"AI1746/AH1746*100","v":{"v":0.7179923424652316,"d":"1"}},{"$f":"AJ1746+O1746","v":{"v":18.150415062796377,"d":"18"}},{"$f":"(AH1746/M1746*100)-100","v":{"v":-11.025892348148162,"d":"-11"}},null,null,"p38g","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","p38",{"$nulls":5},"CVQKYDDSFDDVDRTL","Corresponds to amino acid residues V323 to L337; Post-kinase last alpha-chain.",null,null,"Protein-serine kinase, CMGC group, MAPK family, p38 subfamily","P53778","P53778","P53778","P53778","GO:0005737; GO:0005829; GO:0005739; GO:0005654; GO:0005634","GO:0005524; GO:0000287; GO:0004707; GO:0004674","GO:0007050; GO:0006975; GO:0007517; GO:0045445; GO:0018105; GO:0051149; GO:0010952; GO:0010468; GO:0006355; GO:0007165; GO:0006351"]
[1738,866,"NN082-2","p53 (TP53)","Pan-specific","Cellular tumor antigen p53",0,11258,14,388,{"v":4362.672,"d":"4363"},{"v":7665.855580516799,"d":"7666"},{"$nulls":3},0,8770,12,350,{"v":3065.3,"d":"3065"},{"v":5355.73844603,"d":"5356"},{"$nulls":6},0,11916,14,354,{"v":4213.308,"d":"4213"},{"v":7208.301757351201,"d":"7208"},{"$nulls":10},"Tumour suppressor; Nuclear receptor co-regulator; Activator protein; Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Epitope undefined.",{"$nulls":4},"P04637","P04637",null,"P04637"]
[1743,869,"PN638","p53 (TP53)","T18+S20","Cellular tumor antigen p53",0,19466,18,651,{"v":12660.648,"d":"12661"},{"v":22246.6183851912,"d":"22247"},{"$f":"(L1756+L1757)/2","v":{"v":21877.3715356252,"d":"21877"}},{"$f":"SQRT((M1756-L1756)*(M1756-L1756))","v":{"v":369.2468495659996,"d":"369"}},{"$f":"N1756/M1756*100","v":{"v":1.6878026181742927,"d":"2"}},0,18431,140,597,{"v":10919.727,"d":"10920"},{"v":19079.111902277702,"d":"19079"},{"$f":"(U1756+U1757)/2","v":{"v":20703.31694398485,"d":"20703"}},{"$f":"SQRT((V1756-U1756)*(V1756-U1756))","v":{"v":1624.2050417071478,"d":"1624"}},{"$f":"W1756/V1756*100","v":{"v":7.8451440708830225,"d":"8"}},{"$f":"X1756+O1756","v":{"v":9.532946689057315,"d":"10"}},{"$f":"(V1756/M1756*100)-100","v":{"v":-5.366524903270559,"d":"-5"}},null,0,19775,20,680,{"v":13433.4,"d":"13433"},{"v":22982.41686276,"d":"22982"},{"$f":"(AG1756+AG1757)/2","v":{"v":22859.681100724003,"d":"22860"}},{"$f":"SQRT((AH1756-AG1756)*(AH1756-AG1756))","v":{"v":122.73576203599805,"d":"123"}},{"$f":"AI1756/AH1756*100","v":{"v":0.5369093361154141,"d":"1"}},{"$f":"AJ1756+O1756","v":{"v":2.224711954289707,"d":"2"}},{"$f":"(AH1756/M1756*100)-100","v":{"v":4.490071229531424,"d":"4"}},{"$nulls":5},"Tumour suppressor; Nuclear receptor co-regulator; Activator protein; Transcription protein",{"$nulls":4},"X",{"$nulls":4},"LSQE(pT)F(pS)DLW(bA)C","Corresponds to amino acid residues L14 to W23.","T18 and S20 phosphorylation stimulates binding of CBP/p300, and inhibits binding to its negative regulatory partner MDM2. T18 phosphorylation has not been reported by mass spectrometry studies, and phosphorylation of the S20 site has only been reported once by mass spectrometry, although ≥117 reports for S20 phosphorylation has been made based on Western blotting data..","T18: AMPKA1; Chk1 (CHEK1); Chk2 (CHEK2);  CK1a1 (CSNK1A1); CK1d1 (CSNK1D); DAPK1; DNAPK (PRKDC); VRK1; VRK2. S20: ATM; Chk1 (CHEK1); Chk2 (CHEK2); CK1a1 (CSNK1A1); CK1d1 (CSNK1D); DAPK1; DAPK3 (ZIPK); DNAPK (PRKDC); DRAK1 (STK17A); JNK1 (MAPK8); JNK2 (MAPK9); MAPKAPK2; Plk3 (CNK).","Tumor suppressor; Nuclear receptor co-regulator; Activator protein; Transcription factor","P04637","P04637",null,"P04637","GO:0005737; GO:0005829; GO:0005783; GO:0005622; GO:0005759; GO:0005739; GO:0000790; GO:0016363; GO:0005730; GO:0005654; GO:0005634; GO:0016605; GO:0032991; GO:0005657","GO:0005524; GO:0051087; GO:0003682; GO:0005507; GO:0001046; GO:0003684; GO:0097718; GO:0003677; GO:0003700; GO:0019899; GO:0035035; GO:0042826; GO:0042802; GO:0003730; GO:0002039; GO:1990841; GO:0002020; GO:0046982; GO:0019901; GO:0047485; GO:0051721; GO:0019903; GO:0043621; GO:0030971; GO:0000980; GO:0000978; GO:0000981; GO:0001085; GO:0001094; GO:0001228; GO:0001074; GO:0008134; GO:0044212; GO:0031625; GO:0008270","GO:0006914; GO:0006284; GO:0007569; GO:0007050; GO:0030154; GO:0008283; GO:0034613; GO:0072717; GO:0006974; GO:0035690; GO:0071480; GO:0042149; GO:0071456; GO:0071479; GO:0034644; GO:0031497; GO:0048512; GO:0019221; GO:0008340; GO:0030330; GO:0006977; GO:0006978; GO:0000733; GO:0043153; GO:0006983; GO:0097193; GO:0072332; GO:0042771; GO:0031571; GO:0009299; GO:0007275; GO:0043066; GO:0030308; GO:0008285; GO:0048147; GO:0051097; GO:0051974; GO:0045892; GO:0000122; GO:0006289; GO:0097252; GO:0090403; GO:0043065; GO:0071158; GO:1900119; GO:0010628; GO:0031065; GO:2001244; GO:0043525; GO:0050731; GO:1902895; GO:1903800; GO:0046827; GO:1900740; GO:0032461; GO:2000379; GO:0090200; GO:0045899; GO:0070245; GO:0045893; GO:0045944; GO:1990440; GO:0065003; GO:0016579; GO:0051289; GO:0008104; GO:0051262; GO:0007265; GO:0042981; GO:1902749; GO:0046902; GO:1901796; GO:0006355; GO:0090399; GO:0046677; GO:0010332; GO:0010165; GO:0072331; GO:0016032"]
[1744,869,"PN638","p53 (TP53)","T18+S20","Cellular tumor antigen p53",0,16424,16,746,{"v":12240.368,"d":"12240"},{"v":21508.1246860592,"d":"21508"},{"$nulls":3},0,19380,18,660,{"v":12778.92,"d":"12779"},{"v":22327.521985692,"d":"22328"},{"$nulls":6},0,19560,16,680,{"v":13289.92,"d":"13290"},{"v":22736.945338688,"d":"22737"},{"$nulls":10},"Tumour suppressor; Nuclear receptor co-regulator; Activator protein; Transcription protein",{"$nulls":4},"X",{"$nulls":4},"LSQE(pT)F(pS)DLW(bA)C","Corresponds to amino acid residues L14 to W23.","T18 and S20 phosphorylation stimulates binding of CBP/p300, and inhibits binding to its negative regulatory partner MDM2. T18 phosphorylation has not been reported by mass spectrometry studies, and phosphorylation of the S20 site has only been reported once by mass spectrometry, although ≥117 reports for S20 phosphorylation has been made based on Western blotting data..","T18: AMPKA1; Chk1 (CHEK1); Chk2 (CHEK2);  CK1a1 (CSNK1A1); CK1d1 (CSNK1D); DAPK1; DNAPK (PRKDC); VRK1; VRK2. S20: ATM; Chk1 (CHEK1); Chk2 (CHEK2); CK1a1 (CSNK1A1); CK1d1 (CSNK1D); DAPK1; DAPK3 (ZIPK); DNAPK (PRKDC); DRAK1 (STK17A); JNK1 (MAPK8); JNK2 (MAPK9); MAPKAPK2; Plk3 (CNK).",null,"P04637","P04637",null,"P04637"]
[1750,872,"PN254","p53 (TP53)","S46","Cellular tumor antigen p53",0,122,8,506,{"v":57.684,"d":"58"},{"v":101.35926177959999,"d":"101"},{"$nulls":3},0,46,10,660,{"v":23.76,"d":"24"},{"v":41.513830776000006,"d":"42"},{"$nulls":6},0,122,10,461,{"v":51.632,"d":"52"},{"v":88.3341631648,"d":"88"},{"$nulls":10},"Tumour suppressor; Nuclear receptor co-regulator; Activator protein; Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against amino acid residues 42-51 Ser-46 of human p53.","S46 phosphorylation induces activation, and binding to CBP, GTF2H1, Pin1, and TFB1M. This is one of the minor in vivo phosphorylation sites in p53 (≥3 reports from high throughput mass spectrometry studies).","ATM; CDK5; DNAPK (PRKDC); DYRK2; HIPK2; p38a MAPK (MAPK14); PKCd (PRKCD)",null,"P04637","P04637",null,"P04637"]
[1755,875,"PN253","p53 (TP53)","S315","Cellular tumor antigen p53",0,8,2,740,{"v":4.44,"d":"4"},{"v":7.801732236,"d":"8"},{"$f":"(L1768+L1769)/2","v":{"v":7.8702609651,"d":"8"}},{"$f":"SQRT((M1768-L1768)*(M1768-L1768))","v":{"v":0.06852872909999963,"d":"0"}},{"$f":"N1768/M1768*100","v":{"v":0.8707300736771555,"d":"1"}},0,10,2,734,{"v":5.872,"d":"6"},{"v":10.2596470672,"d":"10"},{"$f":"(U1768+U1769)/2","v":{"v":8.9142914402,"d":"9"}},{"$f":"SQRT((V1768-U1768)*(V1768-U1768))","v":{"v":1.345355627,"d":"1"}},{"$f":"W1768/V1768*100","v":{"v":15.092120736965898,"d":"15"}},{"$f":"X1768+O1768","v":{"v":15.962850810643053,"d":"16"}},{"$f":"(V1768/M1768*100)-100","v":{"v":13.265512792138196,"d":"13"}},null,0,10,2,730,{"v":5.84,"d":"6"},{"v":9.991313776,"d":"10"},{"$f":"(AG1768+AG1769)/2","v":{"v":7.4626901868,"d":"7"}},{"$f":"SQRT((AH1768-AG1768)*(AH1768-AG1768))","v":{"v":2.5286235892000004,"d":"3"}},{"$f":"AI1768/AH1768*100","v":{"v":33.883539660706106,"d":"34"}},{"$f":"AJ1768+O1768","v":{"v":34.754269734383264,"d":"35"}},{"$f":"(AH1768/M1768*100)-100","v":{"v":-5.178618347057835,"d":"-5"}},{"$nulls":5},"Tumour suppressor; Nuclear receptor co-regulator; Activator protein; Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against amino acid residues surrounding the phosphorylated human Ser-315 of human p53.","S315 phosphorylation induces activation and binding to DNA and Pin1. This is one of the major in vivo phosphorylation sites in p53 (≥31 reports from high throughput mass spectrometry studies).","AurA (STK15); CDK1 (CDC2); CDK2; CDK5; CDK9","Tumor suppressor; Nuclear receptor co-regulator; Activator protein; Transcription factor","P04637","P04637",null,"P04637","GO:0005737; GO:0005829; GO:0005783; GO:0005622; GO:0005759; GO:0005739; GO:0000790; GO:0016363; GO:0005730; GO:0005654; GO:0005634; GO:0016605; GO:0032991; GO:0005657","GO:0005524; GO:0051087; GO:0003682; GO:0005507; GO:0001046; GO:0003684; GO:0097718; GO:0003677; GO:0003700; GO:0019899; GO:0035035; GO:0042826; GO:0042802; GO:0003730; GO:0002039; GO:1990841; GO:0002020; GO:0046982; GO:0019901; GO:0047485; GO:0051721; GO:0019903; GO:0043621; GO:0030971; GO:0000980; GO:0000978; GO:0000981; GO:0001085; GO:0001094; GO:0001228; GO:0001074; GO:0008134; GO:0044212; GO:0031625; GO:0008270","GO:0006914; GO:0006284; GO:0007569; GO:0007050; GO:0030154; GO:0008283; GO:0034613; GO:0072717; GO:0006974; GO:0035690; GO:0071480; GO:0042149; GO:0071456; GO:0071479; GO:0034644; GO:0031497; GO:0048512; GO:0019221; GO:0008340; GO:0030330; GO:0006977; GO:0006978; GO:0000733; GO:0043153; GO:0006983; GO:0097193; GO:0072332; GO:0042771; GO:0031571; GO:0009299; GO:0007275; GO:0043066; GO:0030308; GO:0008285; GO:0048147; GO:0051097; GO:0051974; GO:0045892; GO:0000122; GO:0006289; GO:0097252; GO:0090403; GO:0043065; GO:0071158; GO:1900119; GO:0010628; GO:0031065; GO:2001244; GO:0043525; GO:0050731; GO:1902895; GO:1903800; GO:0046827; GO:1900740; GO:0032461; GO:2000379; GO:0090200; GO:0045899; GO:0070245; GO:0045893; GO:0045944; GO:1990440; GO:0065003; GO:0016579; GO:0051289; GO:0008104; GO:0051262; GO:0007265; GO:0042981; GO:1902749; GO:0046902; GO:1901796; GO:0006355; GO:0090399; GO:0046677; GO:0010332; GO:0010165; GO:0072331; GO:0016032"]
[1760,877,"PN252","p53 (TP53)","S392","Cellular tumor antigen p53",0,82,10,534,{"v":38.448,"d":"38"},{"v":67.5587840112,"d":"68"},{"$nulls":3},0,59,8,442,{"v":22.542,"d":"23"},{"v":39.385722784200006,"d":"39"},{"$nulls":6},0,66,6,439,{"v":26.34,"d":"26"},{"v":45.063562476,"d":"45"},{"$nulls":10},"Tumour suppressor; Nuclear receptor co-regulator; Activator protein; Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against amino acid residues 78-393; At the C-terminus of human p53.","S392 phosphorylation induces activity, stimulates binding to DNA, NFkB-p65, UBE4B and p21Cip1, and inhibits binding of CDK1 and MDM2. This is one of the minor in vivo phosphorylation sites in p53 (≥13 reports by mass spectrometry), althoug there are ≥94 reports with Western blotting.","ATM; CDK7; CDK9; CK2a1 (CSNK2A1); ERK1 (MAPK3); LKB1 (STK11); NuaK1; PKR (EIF2AK2)",null,"P04637","P04637",null,"P04637"]
[1762,878,"NK223-4","p70S6K (S6Ka, RPS6KB1)","Pan-specific","Ribosomal protein S6 kinase beta-1; Ribosomal protein S6 kinase 1",0,2692,18,704,{"v":1882.496,"d":"1882"},{"v":3307.8220106624,"d":"3308"},{"$nulls":3},0,2730,12,591,{"v":1606.338,"d":"1606"},{"v":2806.6180093038,"d":"2807"},{"$nulls":6},0,2927,13,584,{"v":1701.776,"d":"1702"},{"v":2911.4688343264,"d":"2911"},{"$nulls":7},"p70S6K","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","p70",{"$nulls":5},"AMIVRNAKDTAHTKAERNILEEVKHP-GGC","Corresponds to amino acid residues A128 to P153; Kinase subdomain III region.",{"$nulls":3},"P23443","P23443","P23443","P23443"]
[1767,881,"PK744","p70S6K (S6Ka, RPS6KB1)","T252","Ribosomal protein S6 kinase beta-1; Ribosomal protein S6 kinase 1",0,15310,20,622,{"v":9510.38,"d":"9510"},{"v":16711.134734821997,"d":"16711"},{"$f":"(L1780+L1781)/2","v":{"v":21032.960535655,"d":"21033"}},{"$f":"SQRT((M1780-L1780)*(M1780-L1780))","v":{"v":4321.825800833001,"d":"4322"}},{"$f":"N1780/M1780*100","v":{"v":20.54787196270662,"d":"21"}},0,15096,50,569,{"v":8561.174,"d":"8561"},{"v":14958.212486527402,"d":"14958"},{"$f":"(U1780+U1781)/2","v":{"v":17371.86085326,"d":"17372"}},{"$f":"SQRT((V1780-U1780)*(V1780-U1780))","v":{"v":2413.6483667325992,"d":"2414"}},{"$f":"W1780/V1780*100","v":{"v":13.894011626737468,"d":"14"}},{"$f":"X1780+O1780","v":{"v":34.44188358944409,"d":"34"}},{"$f":"(V1780/M1780*100)-100","v":{"v":-17.406487670571693,"d":"-17"}},null,0,15888,24,640,{"v":10152.96,"d":"10153"},{"v":17370.104300544,"d":"17370"},{"$f":"(AG1780+AG1781)/2","v":{"v":17726.429793129,"d":"17726"}},{"$f":"SQRT((AH1780-AG1780)*(AH1780-AG1780))","v":{"v":356.32549258499785,"d":"356"}},{"$f":"AI1780/AH1780*100","v":{"v":2.0101368224926737,"d":"2"}},{"$f":"AJ1780+O1780","v":{"v":22.55800878519929,"d":"23"}},{"$f":"(AH1780/M1780*100)-100","v":{"v":-15.720710058485494,"d":"-16"}},null,null,"p70S6K","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","p70",{"$nulls":5},"VTH(pT)FCG(bA)C","Corresponds to amino acid residues V249 to G255; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T252 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation regulates protein translation and protein conformation. This is one of the minor in vivo phosphorylation sites in p70 S6K (≥18 reports from high throughput mass spectrometry studies).","PDPK1 (PDK1); PIK3CD","Protein-serine kinase, AGC group, RSK family, p70 subfamily","P23443","P23443","P23443","P23443","GO:0030054; GO:0009986; GO:0005737; GO:0005829; GO:0005741; GO:0005739; GO:0043005; GO:0005654; GO:0005634; GO:0048471; GO:0045202","GO:0005524; GO:0042802; GO:0016301; GO:0030165; GO:0042277; GO:0004672; GO:0051721; GO:0004712; GO:0004674; GO:0004711","GO:0007568; GO:0006915; GO:0001662; GO:0016477; GO:0071549; GO:0071363; GO:0032869; GO:0071346; GO:0000082; GO:0007281; GO:0044539; GO:0007616; GO:0043066; GO:2001237; GO:0046627; GO:0018105; GO:0048015; GO:0045931; GO:0048633; GO:0014911; GO:0048661; GO:0045727; GO:0045948; GO:0043491; GO:0046324; GO:0014878; GO:0045471; GO:0033762; GO:0009749; GO:0009408; GO:0043201; GO:0032496; GO:0009612; GO:0007584; GO:0033574; GO:0034612; GO:0009611; GO:0007165; GO:0014732; GO:0003009; GO:0031929"]
[1772,883,"PK166","p70S6K (S6Ka, RPS6KB1)","S434","Ribosomal protein S6 kinase beta-1; Ribosomal protein S6 kinase 1",0,1658,12,364,{"v":599.144,"d":"599"},{"v":1052.7840222536,"d":"1053"},{"$nulls":3},0,1912,10,280,{"v":532.56,"d":"533"},{"v":930.4968736559999,"d":"930"},{"$nulls":6},0,1940,12,319,{"v":615.032,"d":"615"},{"v":1052.2222079248002,"d":"1052"},{"$nulls":7},"p70S6K","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","p70",{"$nulls":5},"IR(pS)PR","Corresponds to amino acid residues I409 to R413.","S434 phosphorylation stimulates phosphotransferase activity. This is one of the minor in vivo phosphorylation sites in p70 S6K (≥1 reports from high throughput mass spectrometry studies).","CDK5; ERK1 (MAPK3); ERK2 (MAPK1); JNK1 (MAPK8); JNK2 (MAPK9); mTOR (FRAP)",null,"P23443","P23443","P23443","P23443"]
[1777,886,"PK156","p70S6K (S6Ka, RPS6KB1)","S447","Ribosomal protein S6 kinase beta-1; Ribosomal protein S6 kinase 1",0,1138,12,277,{"v":311.902,"d":"312"},{"v":548.0576324038,"d":"548"},{"$f":"(L1790+L1791)/2","v":{"v":560.8900762144999,"d":"561"}},{"$f":"SQRT((M1790-L1790)*(M1790-L1790))","v":{"v":12.832443810699942,"d":"13"}},{"$f":"N1790/M1790*100","v":{"v":2.287871430585351,"d":"2"}},0,1214,12,257,{"v":308.914,"d":"309"},{"v":539.7392054014,"d":"540"},{"$f":"(U1790+U1791)/2","v":{"v":521.85383803025,"d":"522"}},{"$f":"SQRT((V1790-U1790)*(V1790-U1790))","v":{"v":17.885367371149982,"d":"18"}},{"$f":"W1790/V1790*100","v":{"v":3.427275238342356,"d":"3"}},{"$f":"X1790+O1790","v":{"v":5.715146668927707,"d":"6"}},{"$f":"(V1790/M1790*100)-100","v":{"v":-6.95969492769585,"d":"-7"}},null,0,1062,12,275,{"v":288.75,"d":"289"},{"v":494.00545425,"d":"494"},{"$f":"(AG1790+AG1791)/2","v":{"v":376.8487460194,"d":"377"}},{"$f":"SQRT((AH1790-AG1790)*(AH1790-AG1790))","v":{"v":117.15670823060003,"d":"117"}},{"$f":"AI1790/AH1790*100","v":{"v":31.08852277421904,"d":"31"}},{"$f":"AJ1790+O1790","v":{"v":33.37639420480439,"d":"33"}},{"$f":"(AH1790/M1790*100)-100","v":{"v":-32.81237055167962,"d":"-33"}},null,null,"p70S6K","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","p70",{"$nulls":5},"PV(pS)PV","Corresponds to amino acid residues P422 to V426.","S447 phosphorylation stimulates phosphotransferase activity. This is one of the major in vivo phosphorylation sites in p70 S6K (≥280 reports from high throughput mass spectrometry studies).","S447: CDK1 (CDC2); CDK5; ERK1 (MAPK3); ERK2 (MAPK1); TBK","Protein-serine kinase, AGC group, RSK family, p70 subfamily","P23443","P23443","P23443","P23443","GO:0030054; GO:0009986; GO:0005737; GO:0005829; GO:0005741; GO:0005739; GO:0043005; GO:0005654; GO:0005634; GO:0048471; GO:0045202","GO:0005524; GO:0042802; GO:0016301; GO:0030165; GO:0042277; GO:0004672; GO:0051721; GO:0004712; GO:0004674; GO:0004711","GO:0007568; GO:0006915; GO:0001662; GO:0016477; GO:0071549; GO:0071363; GO:0032869; GO:0071346; GO:0000082; GO:0007281; GO:0044539; GO:0007616; GO:0043066; GO:2001237; GO:0046627; GO:0018105; GO:0048015; GO:0045931; GO:0048633; GO:0014911; GO:0048661; GO:0045727; GO:0045948; GO:0043491; GO:0046324; GO:0014878; GO:0045471; GO:0033762; GO:0009749; GO:0009408; GO:0043201; GO:0032496; GO:0009612; GO:0007584; GO:0033574; GO:0034612; GO:0009611; GO:0007165; GO:0014732; GO:0003009; GO:0031929"]
[1778,886,"PK156","p70S6K (S6Ka, RPS6KB1)","S447","Ribosomal protein S6 kinase beta-1; Ribosomal protein S6 kinase 1",0,1102,10,299,{"v":326.508,"d":"327"},{"v":573.7225200252,"d":"574"},{"$nulls":3},0,1200,13,243,{"v":288.441,"d":"288"},{"v":503.9684706591,"d":"504"},{"$nulls":6},0,370,12,424,{"v":151.792,"d":"152"},{"v":259.6920377888,"d":"260"},{"$nulls":7},"p70S6K","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","p70",{"$nulls":5},"PV(pS)PV","Corresponds to amino acid residues P422 to V426.","S447 phosphorylation stimulates phosphotransferase activity. This is one of the major in vivo phosphorylation sites in p70 S6K (≥280 reports from high throughput mass spectrometry studies).","S447: CDK1 (CDC2); CDK5; ERK1 (MAPK3); ERK2 (MAPK1); TBK",null,"P23443","P23443","P23443","P23443"]
[1785,891,"NK122","PAK1 (PAKa)","Pan-specific","p21-activated kinase 1 (alpha) (Protein-serine/threonine kinase PAK 1)",0,154,10,478,{"v":68.832,"d":"69"},{"v":120.94793542079998,"d":"121"},{"$f":"(L1798+L1799)/2","v":{"v":175.8640474865,"d":"176"}},{"$f":"SQRT((M1798-L1798)*(M1798-L1798))","v":{"v":54.91611206570002,"d":"55"}},{"$f":"N1798/M1798*100","v":{"v":31.226457511115562,"d":"31"}},0,151,9,492,{"v":69.864,"d":"70"},{"v":122.06743574640001,"d":"122"},{"$f":"(U1798+U1799)/2","v":{"v":119.9602943358,"d":"120"}},{"$f":"SQRT((V1798-U1798)*(V1798-U1798))","v":{"v":2.1071414106000077,"d":"2"}},{"$f":"W1798/V1798*100","v":{"v":1.7565323778729418,"d":"2"}},{"$f":"X1798+O1798","v":{"v":32.982989888988506,"d":"33"}},{"$f":"(V1798/M1798*100)-100","v":{"v":-31.788051025603394,"d":"-32"}},null,0,166,10,489,{"v":76.284,"d":"76"},{"v":130.50982535760002,"d":"131"},{"$f":"(AG1798+AG1799)/2","v":{"v":135.09145862680003,"d":"135"}},{"$f":"SQRT((AH1798-AG1798)*(AH1798-AG1798))","v":{"v":4.581633269200012,"d":"5"}},{"$f":"AI1798/AH1798*100","v":{"v":3.3915047744484768,"d":"3"}},{"$f":"AJ1798+O1798","v":{"v":34.61796228556404,"d":"35"}},{"$f":"(AH1798/M1798*100)-100","v":{"v":-23.184152441862693,"d":"-23"}},null,null,"PAK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","PAKA",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues at the C-terminus of rat αPAK.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE20 family; PAKA subfamily","Q13153","Q13153","Q13153","Q13153","GO:0030424; GO:0005911; GO:0005737; GO:0005829; GO:0030425; GO:0005925; GO:0014704; GO:0071437; GO:0030027; GO:0031965; GO:0005886; GO:0032991; GO:0001726; GO:0032587; GO:0030018","GO:0005524; GO:0005518; GO:0042802; GO:0004672; GO:0019901; GO:0004674; GO:0048365","GO:0031532; GO:0032147; GO:0006915; GO:0048754; GO:0032869; GO:0021549; GO:0048013; GO:0030010; GO:0006887; GO:0038095; GO:0038096; GO:0048012; GO:0061052; GO:0060244; GO:0048812; GO:0045773; GO:0030335; GO:0008284; GO:0010763; GO:2001275; GO:0033148; GO:0043507; GO:0031116; GO:0033138; GO:0001934; GO:0090314; GO:0051496; GO:1904754; GO:1904707; GO:0046777; GO:0006468; GO:0042981; GO:0050770; GO:0007346; GO:0001666; GO:0007266; GO:0002223; GO:0031295; GO:0050852; GO:0042060"]
[1789,893,"PK061","PAK1 (PAKa)","S141","p21-activated kinase 1 (alpha) (Protein-serine/threonine kinase PAK 1)",0,523,14,254,{"v":129.286,"d":"129"},{"v":227.1744941134,"d":"227"},{"$f":"(L1802+L1803)/2","v":{"v":227.35548024409997,"d":"227"}},{"$f":"SQRT((M1802-L1802)*(M1802-L1802))","v":{"v":0.18098613069997782,"d":"0"}},{"$f":"N1802/M1802*100","v":{"v":0.07960491231865723,"d":"0"}},0,762,14,229,{"v":171.292,"d":"171"},{"v":299.2839689092,"d":"299"},{"$f":"(U1802+U1803)/2","v":{"v":295.2374187376,"d":"295"}},{"$f":"SQRT((V1802-U1802)*(V1802-U1802))","v":{"v":4.046550171599961,"d":"4"}},{"$f":"W1802/V1802*100","v":{"v":1.3706088438594695,"d":"1"}},{"$f":"X1802+O1802","v":{"v":1.4502137561781268,"d":"1"}},{"$f":"(V1802/M1802*100)-100","v":{"v":29.857181546984776,"d":"30"}},null,0,601,14,252,{"v":147.924,"d":"148"},{"v":253.07450325360003,"d":"253"},{"$f":"(AG1802+AG1803)/2","v":{"v":262.2026975433,"d":"262"}},{"$f":"SQRT((AH1802-AG1802)*(AH1802-AG1802))","v":{"v":9.12819428969999,"d":"9"}},{"$f":"AI1802/AH1802*100","v":{"v":3.48135025887465,"d":"3"}},{"$f":"AJ1802+O1802","v":{"v":3.5609551711933074,"d":"4"}},{"$f":"(AH1802/M1802*100)-100","v":{"v":15.327194779640394,"d":"15"}},null,null,"PAK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","PAKA",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S141 phosphosite.","S141 phosphorylation stimulates phosphotransferase activity. This is one of the major in vivo phosphorylation sites in PAK2 (≥154 reports from high throughput mass spectrometry studies).","PAK2","EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE20 family; PAKA subfamily","Q13153","Q13153","Q13153","Q13153","GO:0030424; GO:0005911; GO:0005737; GO:0005829; GO:0030425; GO:0005925; GO:0014704; GO:0071437; GO:0030027; GO:0031965; GO:0005886; GO:0032991; GO:0001726; GO:0032587; GO:0030018","GO:0005524; GO:0005518; GO:0042802; GO:0004672; GO:0019901; GO:0004674; GO:0048365","GO:0031532; GO:0032147; GO:0006915; GO:0048754; GO:0032869; GO:0021549; GO:0048013; GO:0030010; GO:0006887; GO:0038095; GO:0038096; GO:0048012; GO:0061052; GO:0060244; GO:0048812; GO:0045773; GO:0030335; GO:0008284; GO:0010763; GO:2001275; GO:0033148; GO:0043507; GO:0031116; GO:0033138; GO:0001934; GO:0090314; GO:0051496; GO:1904754; GO:1904707; GO:0046777; GO:0006468; GO:0042981; GO:0050770; GO:0007346; GO:0001666; GO:0007266; GO:0002223; GO:0031295; GO:0050852; GO:0042060"]
[1794,895,"PK130","PAK1 (PAKa)","T212","p21-activated kinase 1 (alpha) (Protein-serine/threonine kinase PAK 1)",0,2860,14,429,{"v":1220.934,"d":"1221"},{"v":2145.3603932046,"d":"2145"},{"$nulls":3},0,3154,14,292,{"v":916.88,"d":"917"},{"v":1601.986580888,"d":"1602"},{"$nulls":6},0,2216,16,351,{"v":772.2,"d":"772"},{"v":1321.11172908,"d":"1321"},{"$nulls":7},"PAK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","PAKA",{"$nulls":5},"PV(pT)PT","Corresponds to amino acid residues P210 to T214; Surrounds the T212 phosphosite.","T212 phosphorylation inhibits phosphotransferase activity. This is one of the major in vivo phosphorylation sites in PAK1 (≥38 reports from high throughput mass spectrometry studies).","CDK1 (CDC2); CDK5",null,"Q13153","Q13153","Q13153","Q13153"]
[1795,896,"PK749","PAK1 (PAKa)","T423","p21-activated kinase 1 (alpha) (Protein-serine/threonine kinase PAK 1)",0,6912,16,555,{"v":3827.28,"d":"3827"},{"v":6725.093187432,"d":"6725"},{"$f":"(L1808+L1809)/2","v":{"v":8545.95159830565,"d":"8546"}},{"$f":"SQRT((M1808-L1808)*(M1808-L1808))","v":{"v":1820.8584108736495,"d":"1821"}},{"$f":"N1808/M1808*100","v":{"v":21.306678254937218,"d":"21"}},0,7192,16,564,{"v":4047.264,"d":"4047"},{"v":7071.4407744864,"d":"7071"},{"$f":"(U1808+U1809)/2","v":{"v":7486.5336546538,"d":"7487"}},{"$f":"SQRT((V1808-U1808)*(V1808-U1808))","v":{"v":415.0928801673999,"d":"415"}},{"$f":"W1808/V1808*100","v":{"v":5.544527004288143,"d":"6"}},{"$f":"X1808+O1808","v":{"v":26.85120525922536,"d":"27"}},{"$f":"(V1808/M1808*100)-100","v":{"v":-12.396722956655807,"d":"-12"}},null,0,8373,14,546,{"v":4564.014,"d":"4564"},{"v":7808.3041013796,"d":"7808"},{"$f":"(AG1808+AG1809)/2","v":{"v":8090.6784744496,"d":"8091"}},{"$f":"SQRT((AH1808-AG1808)*(AH1808-AG1808))","v":{"v":282.3743730699998,"d":"282"}},{"$f":"AI1808/AH1808*100","v":{"v":3.490119820750996,"d":"3"}},{"$f":"AJ1808+O1808","v":{"v":24.796798075688216,"d":"25"}},{"$f":"(AH1808/M1808*100)-100","v":{"v":-5.32735434572686,"d":"-5"}},null,null,"PAK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","PAKA",{"$nulls":5},"KRS(pT)MVG(bA)C","Corresponds to amino acid residues K420 to G426; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T423 phosphorylation stimulates phosphotransferase activty and interaction with CDC42 and PAK1, and induces cell motility. This is one of the minor in vivo phosphorylation sites in PAK1 (≥12 reports from high throughput mass spectrometry studies).","PAK1; PDPK1 (PDK1); PKACa (PRKACA)","EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE20 family; PAKA subfamily","Q13153","Q13153","Q13153","Q13153","GO:0030424; GO:0005911; GO:0005737; GO:0005829; GO:0030425; GO:0005925; GO:0014704; GO:0071437; GO:0030027; GO:0031965; GO:0005886; GO:0032991; GO:0001726; GO:0032587; GO:0030018","GO:0005524; GO:0005518; GO:0042802; GO:0004672; GO:0019901; GO:0004674; GO:0048365","GO:0031532; GO:0032147; GO:0006915; GO:0048754; GO:0032869; GO:0021549; GO:0048013; GO:0030010; GO:0006887; GO:0038095; GO:0038096; GO:0048012; GO:0061052; GO:0060244; GO:0048812; GO:0045773; GO:0030335; GO:0008284; GO:0010763; GO:2001275; GO:0033148; GO:0043507; GO:0031116; GO:0033138; GO:0001934; GO:0090314; GO:0051496; GO:1904754; GO:1904707; GO:0046777; GO:0006468; GO:0042981; GO:0050770; GO:0007346; GO:0001666; GO:0007266; GO:0002223; GO:0031295; GO:0050852; GO:0042060"]
[1800,898,"PK751","PAK2 (PAKg)","Y130","p21-activated kinase 2 gamma; Protein-serine/threonine kinase PAK 2",0,4068,16,612,{"v":2479.824,"d":"2480"},{"v":4357.4150541456,"d":"4357"},{"$nulls":3},0,4434,18,616,{"v":2720.256,"d":"2720"},{"v":4752.8723590656,"d":"4753"},{"$nulls":6},0,4532,18,563,{"v":2541.382,"d":"2541"},{"v":4347.9015388148,"d":"4348"},{"$nulls":7},"PAK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","PAKA",{"$nulls":5},"LKF(pY)DSN(bA)C","Corresponds to amino acid residues L127 to N133; At the end of the PBD (p21-binding domain) in the N-terminal third of the protein.","Y130 phosphorylation stimulates phosphotransferase activity. This is one of the major in vivo phosphorylation sites in PAK2 (≥126 reports from high throughput mass spectrometry studies).","Src",null,"Q13177","Q13177","Q13177"]
[1803,900,"NK123","PAK3","Pan-specific","p21-activated kinase 3 (beta) (Protein-serine/threonine kinase PAK3)",0,272,14,565,{"v":145.77,"d":"146"},{"v":256.13930361300004,"d":"256"},{"$f":"(L1816+L1817)/2","v":{"v":248.77246523475,"d":"249"}},{"$f":"SQRT((M1816-L1816)*(M1816-L1816))","v":{"v":7.366838378250037,"d":"7"}},{"$f":"N1816/M1816*100","v":{"v":2.961275626423705,"d":"3"}},0,258,12,522,{"v":128.412,"d":"128"},{"v":224.3633854212,"d":"224"},{"$f":"(U1816+U1817)/2","v":{"v":231.8886408569,"d":"232"}},{"$f":"SQRT((V1816-U1816)*(V1816-U1816))","v":{"v":7.5252554356999894,"d":"8"}},{"$f":"W1816/V1816*100","v":{"v":3.2452022694565166,"d":"3"}},{"$f":"X1816+O1816","v":{"v":6.206477895880221,"d":"6"}},{"$f":"(V1816/M1816*100)-100","v":{"v":-6.7868541487973175,"d":"-7"}},null,0,306,14,533,{"v":155.636,"d":"156"},{"v":266.2685121304,"d":"266"},{"$f":"(AG1816+AG1817)/2","v":{"v":285.05697238519997,"d":"285"}},{"$f":"SQRT((AH1816-AG1816)*(AH1816-AG1816))","v":{"v":18.788460254799986,"d":"19"}},{"$f":"AI1816/AH1816*100","v":{"v":6.591124608385644,"d":"7"}},{"$f":"AJ1816+O1816","v":{"v":9.55240023480935,"d":"10"}},{"$f":"(AH1816/M1816*100)-100","v":{"v":14.585419297192189,"d":"15"}},null,null,"PAK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","PAKA",{"$nulls":5},"Epitope undefined.",{"$nulls":3},"Protein-serine kinase, STE group, STE20 family, PAKA subfamily","O75914","O75914","O75914",null,"GO:0005737; GO:0005829; GO:0005768; GO:0098978; GO:0005886; GO:0014069","GO:0005524; GO:0004708; GO:0046872; GO:0004674; GO:0048365; GO:0017124","GO:0007409; GO:0016477; GO:0071407; GO:0016358; GO:0060997; GO:0048013; GO:0061003; GO:2000573; GO:0010763; GO:0043525; GO:0030833; GO:0042981; GO:0050770; GO:0007346; GO:0007266; GO:0002223; GO:0031098; GO:0050808; GO:0031295; GO:0050852"]
[1811,904,"PK753","PAK5 (PAK7)","S602","p21-activated kinase 5;  Protein-serine/threonine kinase PAK 7",0,3976,12,567,{"v":2247.588,"d":"2248"},{"v":3949.3422866772003,"d":"3949"},{"$f":"(L1824+L1825)/2","v":{"v":4858.7114932466,"d":"4859"}},{"$f":"SQRT((M1824-L1824)*(M1824-L1824))","v":{"v":909.3692065693999,"d":"909"}},{"$f":"N1824/M1824*100","v":{"v":18.716262692966726,"d":"19"}},0,3719,16,580,{"v":2147.74,"d":"2148"},{"v":3752.5637588739996,"d":"3753"},{"$f":"(U1824+U1825)/2","v":{"v":4073.3559456641997,"d":"4073"}},{"$f":"SQRT((V1824-U1824)*(V1824-U1824))","v":{"v":320.79218679020005,"d":"321"}},{"$f":"W1824/V1824*100","v":{"v":7.875378215637176,"d":"8"}},{"$f":"X1824+O1824","v":{"v":26.591640908603903,"d":"27"}},{"$f":"(V1824/M1824*100)-100","v":{"v":-16.1638646104839,"d":"-16"}},null,0,4465,14,643,{"v":2861.993,"d":"2862"},{"v":4896.4161109102,"d":"4896"},{"$f":"(AG1824+AG1825)/2","v":{"v":4947.028787467099,"d":"4947"}},{"$f":"SQRT((AH1824-AG1824)*(AH1824-AG1824))","v":{"v":50.612676556899714,"d":"51"}},{"$f":"AI1824/AH1824*100","v":{"v":1.0230924203457816,"d":"1"}},{"$f":"AJ1824+O1824","v":{"v":19.73935511331251,"d":"20"}},{"$f":"(AH1824/M1824*100)-100","v":{"v":1.8177101962784974,"d":"2"}},null,null,"PAK5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","PAKB",{"$nulls":5},"KRK(pS)LVG(bA)C","Corresponds to amino acid residues K599 to G605; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S602 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation site in PAK5 (≥42 reports from high throughput mass spectrometry studies).",null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE20 family; PAKB subfamily","Q9P286","Q9P286","Q9P286","Q9P286","GO:0005737; GO:0005739; GO:0005654; GO:0045202","GO:0005524; GO:0004674; GO:0048365","GO:0030036; GO:0032147; GO:0006915; GO:0016477; GO:0008283; GO:0007010; GO:0007612; GO:0007626; GO:0007613; GO:2001237; GO:0042981; GO:0001558; GO:0043408; GO:0007346; GO:0007266; GO:0007165; GO:0023014; GO:0031098"]
[1812,904,"PK753","PAK5 (PAK7)","S602","p21-activated kinase 5;  Protein-serine/threonine kinase PAK 7",0,4462,26,740,{"v":3282.64,"d":"3283"},{"v":5768.080699816,"d":"5768"},{"$nulls":3},0,4112,16,614,{"v":2514.944,"d":"2515"},{"v":4394.1481324544,"d":"4394"},{"$nulls":6},0,4446,20,660,{"v":2921.16,"d":"2921"},{"v":4997.641464024,"d":"4998"},{"$nulls":7},"PAK5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","PAKB",{"$nulls":5},"KRK(pS)LVG(bA)C","Corresponds to amino acid residues K599 to G605; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S602 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation site in PAK5 (≥42 reports from high throughput mass spectrometry studies).",null,null,"Q9P286","Q9P286","Q9P286","Q9P286"]
[1817,910,"PK754","PBK","Y74","Lymphokine-activated killer T-cell-originated protein kinase",0,7466,14,608,{"v":4530.816,"d":"4531"},{"v":7961.3092888703995,"d":"7961"},{"$f":"(L1830+L1831)/2","v":{"v":9159.2213450357,"d":"9159"}},{"$f":"SQRT((M1830-L1830)*(M1830-L1830))","v":{"v":1197.9120561652999,"d":"1198"}},{"$f":"N1830/M1830*100","v":{"v":13.07875430715045,"d":"13"}},0,8714,16,581,{"v":5053.538,"d":"5054"},{"v":8829.6179020238,"d":"8830"},{"$f":"(U1830+U1831)/2","v":{"v":9603.72941454675,"d":"9604"}},{"$f":"SQRT((V1830-U1830)*(V1830-U1830))","v":{"v":774.1115125229499,"d":"774"}},{"$f":"W1830/V1830*100","v":{"v":8.060530228500657,"d":"8"}},{"$f":"X1830+O1830","v":{"v":21.139284535651107,"d":"21"}},{"$f":"(V1830/M1830*100)-100","v":{"v":4.853120726817821,"d":"5"}},null,0,8974,14,572,{"v":5125.12,"d":"5125"},{"v":8768.267475968,"d":"8768"},{"$f":"(AG1830+AG1831)/2","v":{"v":9602.037478051,"d":"9602"}},{"$f":"SQRT((AH1830-AG1830)*(AH1830-AG1830))","v":{"v":833.7700020829998,"d":"834"}},{"$f":"AI1830/AH1830*100","v":{"v":8.683261276462302,"d":"9"}},{"$f":"AJ1830+O1830","v":{"v":21.76201558361275,"d":"22"}},{"$f":"(AH1830/M1830*100)-100","v":{"v":4.834648234102417,"d":"5"}},null,null,"PBK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","TOPK",{"$nulls":6},"NDH(pY)RSV(bA)C","Corresponds to amino acid residues N71 to V77; In the protein kinase catalytic domain between subdomains II and III. ","Y74 phosphorylation stimulates phosphotransferase activity. This is the major in vivo phosphorylation site in PBK (≥166 reports from high throughput mass spectrometry studies).","Src","Protein-serine kinase, Other group, TOPK family","Q96KB5","Q96KB5","Q96KB5","Q96KB5","GO:0005634","GO:0005524; GO:0004674","GO:0034644; GO:0000278; GO:0050728; GO:0032435; GO:0032873"]
[1822,912,"PN714","PBRM1","S948","Protein polybromo-1",0,150,10,507,{"v":70.98,"d":"71"},{"v":124.722286962,"d":"125"},{"$nulls":3},0,156,10,377,{"v":55.042,"d":"55"},{"v":96.1702135342,"d":"96"},{"$nulls":6},0,188,10,403,{"v":71.734,"d":"72"},{"v":122.7254969876,"d":"123"},{"$nulls":10},"DNA-binding",{"$nulls":4},"X",{"$nulls":4},"HRTY(pS)QDC","Corresponds to amino acid residues H944 to C951.","S948 phosphorylation inhibits this protein. It is possibly targeted by ATM. This is one of the major in vivo phosphorylation sites in PBRM1 (≥47 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in fish.",null,null,"Q86U86","Q86U86",null,"Q86U86"]
[1826,914,"NK285-1","PCTK2 (PCTAIRE2, CDK17)","Pan-specific","Cell division protein kinase 17; Protein-serine kinase PCTAIRE-2",0,1044,10,752,{"v":777.568,"d":"778"},{"v":1366.3012007391999,"d":"1366"},{"$nulls":3},0,1214,10,609,{"v":733.236,"d":"733"},{"v":1281.1210110636,"d":"1281"},{"$nulls":6},0,1212,14,647,{"v":775.106,"d":"775"},{"v":1326.0834341884001,"d":"1326"},{"$nulls":7},"PCTAIRE2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","TAIRE",{"$nulls":5},"CGSQTIDESLSELAEQMTIE","Corresponds to amino acid residues G14 to E32; Post-N-terminus.",{"$nulls":3},"Q00537","Q00537","Q00537"]
[1829,916,"NK286-1","PCTK3 (PCTAIRE3, CDK18)","Pan-specific","Cell division protein kinase 18; Protein-serine kinase PCTAIRE-3",0,8038,15,591,{"v":4741.593,"d":"4742"},{"v":8331.6754410117,"d":"8332"},{"$f":"(L1842+L1843)/2","v":{"v":9274.215188185848,"d":"9274"}},{"$f":"SQRT((M1842-L1842)*(M1842-L1842))","v":{"v":942.5397471741489,"d":"943"}},{"$f":"N1842/M1842*100","v":{"v":10.163013560164345,"d":"10"}},0,7975,18,580,{"v":4615.06,"d":"4615"},{"v":8063.502519406001,"d":"8064"},{"$f":"(U1842+U1843)/2","v":{"v":7998.596972871201,"d":"7999"}},{"$f":"SQRT((V1842-U1842)*(V1842-U1842))","v":{"v":64.90554653480012,"d":"65"}},{"$f":"W1842/V1842*100","v":{"v":0.8114616445226572,"d":"1"}},{"$f":"X1842+O1842","v":{"v":10.974475204687002,"d":"11"}},{"$f":"(V1842/M1842*100)-100","v":{"v":-13.754459967023621,"d":"-14"}},null,0,8174,18,627,{"v":5113.812,"d":"5114"},{"v":8748.9212814168,"d":"8749"},{"$f":"(AG1842+AG1843)/2","v":{"v":8694.2445011142,"d":"8694"}},{"$f":"SQRT((AH1842-AG1842)*(AH1842-AG1842))","v":{"v":54.67678030259958,"d":"55"}},{"$f":"AI1842/AH1842*100","v":{"v":0.6288847788395246,"d":"1"}},{"$f":"AJ1842+O1842","v":{"v":10.791898339003868,"d":"11"}},{"$f":"(AH1842/M1842*100)-100","v":{"v":-6.253582381940575,"d":"-6"}},null,null,"PCTAIRE3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","TAIRE",{"$nulls":5},"CIEESLAEFTEQFNQLHNRR","Corresponds to amino acid residues I21 to R39; Post-N-terminus.",null,null,"EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC domain target; CMGC</A> group; CDK family; CDK/TAIRE subfamily; TAIRE subfamily","Q07002","Q07002","Q07002","Q07002","GO:0005737; GO:0005634","GO:0005524; GO:0004674","GO:0006468; GO:0051726"]
[1834,918,"NN-456-1","PCYT1A (CTPCT; CCTA)","Pan-specific","CTP: phosphocholine cytidylyltransferase isoform A",0,220,12,584,{"v":121.472,"d":"121"},{"v":213.44414823679998,"d":"213"},{"$nulls":3},0,246,10,435,{"v":102.66,"d":"103"},{"v":179.369102166,"d":"179"},{"$nulls":6},0,294,14,438,{"v":122.64,"d":"123"},{"v":209.81758929600002,"d":"210"},{"$nulls":10},"Metabolic enzyme",{"$nulls":8},"X","Epitope undefined.",{"$nulls":4},"P49585","P49585"]
[1839,921,"PN548","PCYT1A (CTPCT; CCTA)","Y359+S362","CTP: phosphocholine cytidylyltransferase isoform A",0,1184,14,351,{"v":410.67,"d":"411"},{"v":721.607517423,"d":"722"},{"$f":"(L1852+L1853)/2","v":{"v":823.4640517753,"d":"823"}},{"$f":"SQRT((M1852-L1852)*(M1852-L1852))","v":{"v":101.85653435230006,"d":"102"}},{"$f":"N1852/M1852*100","v":{"v":12.36927515326362,"d":"12"}},0,78,14,652,{"v":41.728,"d":"42"},{"v":72.9077916928,"d":"73"},{"$f":"(U1852+U1853)/2","v":{"v":392.2428010896,"d":"392"}},{"$f":"SQRT((V1852-U1852)*(V1852-U1852))","v":{"v":319.3350093968,"d":"319"}},{"$f":"W1852/V1852*100","v":{"v":81.4125864157936,"d":"81"}},{"$f":"X1852+O1852","v":{"v":93.78186156905721,"d":"94"}},{"$f":"(V1852/M1852*100)-100","v":{"v":-52.366736563184915,"d":"-52"}},null,0,1225,14,350,{"v":423.85,"d":"424"},{"v":725.1401273900001,"d":"725"},{"$f":"(AG1852+AG1853)/2","v":{"v":775.0556360764001,"d":"775"}},{"$f":"SQRT((AH1852-AG1852)*(AH1852-AG1852))","v":{"v":49.91550868640002,"d":"50"}},{"$f":"AI1852/AH1852*100","v":{"v":6.44024846256065,"d":"6"}},{"$f":"AJ1852+O1852","v":{"v":18.80952361582427,"d":"19"}},{"$f":"(AH1852/M1852*100)-100","v":{"v":-5.878631325136368,"d":"-6"}},{"$nulls":5},"Metabolic enzyme",{"$nulls":8},"X","KAAA(pY)DI(pS)EDE(bA)C     ","Corresponds to amino acid residues K355 to E365; in the C-terminus of the protein. ","The effects of Y359 and S362 phosphorylation are unclear. These are among the main in vivo phosphorylation sites in PCYT1A (≥32 and ≥98 reports, respectively, from high throughput mass spectrometry studies).",null,"EC 2.7.7.15; Lipid Metabolism - glycerophospholipid; Transferase","P49585","P49585",null,null,"GO:0005829; GO:0005789; GO:0042587; GO:0005635; GO:0005886","GO:0005516; GO:0004105; GO:0031210; GO:0042803","GO:0006657; GO:0006656"]
[1844,923,"NK242-1","PDGFRa","Pan-specific","Platelet-derived growth factor receptor kinase alpha",0,10202,16,620,{"v":6315.32,"d":"6315"},{"v":11096.944960507999,"d":"11097"},{"$nulls":3},0,10228,14,649,{"v":6628.886,"d":"6629"},{"v":11582.0897153786,"d":"11582"},{"$nulls":6},0,10654,20,661,{"v":7029.074,"d":"7029"},{"v":12025.6308028636,"d":"12026"},{"$nulls":7},"PDGFRA","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"CPSILPNENEKVVQLN","Corresponds to amino acid residues P28 to N42.",{"$nulls":3},"P16234","P16234","P16234","P16234"]
[1849,926,"PK758","PDGFRa","Y762","Platelet-derived growth factor receptor kinase alpha",0,4572,16,589,{"v":2683.484,"d":"2683"},{"v":4715.2755917996,"d":"4715"},{"$f":"(L1862+L1863)/2","v":{"v":4394.5224823798,"d":"4395"}},{"$f":"SQRT((M1862-L1862)*(M1862-L1862))","v":{"v":320.75310941980024,"d":"321"}},{"$f":"N1862/M1862*100","v":{"v":7.298929763265208,"d":"7"}},0,4142,16,539,{"v":2223.914,"d":"2224"},{"v":3885.6561219014006,"d":"3886"},{"$f":"(U1862+U1863)/2","v":{"v":4306.35843614735,"d":"4306"}},{"$f":"SQRT((V1862-U1862)*(V1862-U1862))","v":{"v":420.70231424594976,"d":"421"}},{"$f":"W1862/V1862*100","v":{"v":9.769328784027735,"d":"10"}},{"$f":"X1862+O1862","v":{"v":17.068258547292942,"d":"17"}},{"$f":"(V1862/M1862*100)-100","v":{"v":-2.006225854707779,"d":"-2"}},null,0,4622,14,581,{"v":2677.248,"d":"2677"},{"v":4580.3467164672,"d":"4580"},{"$f":"(AG1862+AG1863)/2","v":{"v":4863.2274985916,"d":"4863"}},{"$f":"SQRT((AH1862-AG1862)*(AH1862-AG1862))","v":{"v":282.88078212439996,"d":"283"}},{"$f":"AI1862/AH1862*100","v":{"v":5.816729367612821,"d":"6"}},{"$f":"AJ1862+O1862","v":{"v":13.11565913087803,"d":"13"}},{"$f":"(AH1862/M1862*100)-100","v":{"v":10.665664314862681,"d":"11"}},null,null,"PDGFRA","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"RSL(pY)DRP(bA)C","Corresponds to amino acid residues R759 to P765; In the protein kinase catalytic domain near subdomain VI. ","Phosphorylation of Y762 induces interaction with CDK6, CRK and CRKL. This is the major in vivo phosphorylation sites in PDGFRa (≥328 reports from high throughput mass spectrometry studies).","PDGFRA","Receptor tyrosine kinase; EC 2.7.10.1; TK group; PDGFR family","P16234","P16234","P16234","P16234","GO:0030054; GO:0005737; GO:0005887; GO:0031226; GO:0016020; GO:0005634; GO:0005886; GO:0032991","GO:0005524; GO:0046934; GO:0005018; GO:0048407; GO:0005161; GO:0042803; GO:0004672; GO:0005088; GO:0004714; GO:0005021; GO:0038085","GO:0055003; GO:0001775; GO:0060326; GO:0034614; GO:0048701; GO:0048557; GO:0048704; GO:0001553; GO:0000165; GO:0072277; GO:0010544; GO:0018108; GO:0048015; GO:0070527; GO:0035790; GO:0048008; GO:0030335; GO:0008284; GO:0038091; GO:0007204; GO:0070374; GO:0048146; GO:0043552; GO:0014068; GO:0010863; GO:0051897; GO:0046777; GO:2000249; GO:0050920; GO:2000739; GO:0061298; GO:0016032; GO:0042060"]
[1851,927,"PK759","PDGFRa","Y768","Platelet-derived growth factor receptor kinase alpha",0,3336,15,604,{"v":2005.884,"d":"2006"},{"v":3524.6328523596,"d":"3525"},{"$f":"(L1864+L1865)/2","v":{"v":3009.746639134,"d":"3010"}},{"$f":"SQRT((M1864-L1864)*(M1864-L1864))","v":{"v":514.8862132255999,"d":"515"}},{"$f":"N1864/M1864*100","v":{"v":17.10729423303714,"d":"17"}},0,2874,12,493,{"v":1410.966,"d":"1411"},{"v":2465.2611007866,"d":"2465"},{"$f":"(U1864+U1865)/2","v":{"v":2563.1208713224996,"d":"2563"}},{"$f":"SQRT((V1864-U1864)*(V1864-U1864))","v":{"v":97.85977053589977,"d":"98"}},{"$f":"W1864/V1864*100","v":{"v":3.8179928083300583,"d":"4"}},{"$f":"X1864+O1864","v":{"v":20.9252870413672,"d":"21"}},{"$f":"(V1864/M1864*100)-100","v":{"v":-14.83931444608271,"d":"-15"}},null,0,3290,14,497,{"v":1628.172,"d":"1628"},{"v":2785.5440639208,"d":"2786"},{"$f":"(AG1864+AG1865)/2","v":{"v":2825.2390060836,"d":"2825"}},{"$f":"SQRT((AH1864-AG1864)*(AH1864-AG1864))","v":{"v":39.69494216280009,"d":"40"}},{"$f":"AI1864/AH1864*100","v":{"v":1.4050118265153777,"d":"1"}},{"$f":"AJ1864+O1864","v":{"v":18.512306059552518,"d":"19"}},{"$f":"(AH1864/M1864*100)-100","v":{"v":-6.130337705219219,"d":"-6"}},null,null,"PDGFRA","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"PAS(pY)KKK(bA)C","Corresponds to amino acid residues P765 to K771; In the protein kinase catalytic domain near subdomain VI. ","The effect of Y768 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in PDGFRa (≥268 reports from high throughput mass spectrometry studies).",null,"Receptor tyrosine kinase; EC 2.7.10.1; TK group; PDGFR family","P16234","P16234","P16234","P16234","GO:0030054; GO:0005737; GO:0005887; GO:0031226; GO:0016020; GO:0005634; GO:0005886; GO:0032991","GO:0005524; GO:0046934; GO:0005018; GO:0048407; GO:0005161; GO:0042803; GO:0004672; GO:0005088; GO:0004714; GO:0005021; GO:0038085","GO:0055003; GO:0001775; GO:0060326; GO:0034614; GO:0048701; GO:0048557; GO:0048704; GO:0001553; GO:0000165; GO:0072277; GO:0010544; GO:0018108; GO:0048015; GO:0070527; GO:0035790; GO:0048008; GO:0030335; GO:0008284; GO:0038091; GO:0007204; GO:0070374; GO:0048146; GO:0043552; GO:0014068; GO:0010863; GO:0051897; GO:0046777; GO:2000249; GO:0050920; GO:2000739; GO:0061298; GO:0016032; GO:0042060"]
[1856,929,"NK243-1","PDGFRb","Pan-specific","Platelet-derived growth factor receptor kinase beta",0,6532,20,885,{"v":5763.12,"d":"5763"},{"v":10126.648442328,"d":"10127"},{"$nulls":3},0,6477,14,700,{"v":4524.1,"d":"4524"},{"v":7904.575833910001,"d":"7905"},{"$nulls":6},0,7257,14,754,{"v":5461.222,"d":"5461"},{"v":9343.2846921908,"d":"9343"},{"$nulls":7},"PDGFRB","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"CKGDVALPVPYDHQRG","Corresponds to amino acid residues K164 to G178.",{"$nulls":3},"P09619","P09619","P09619","P09619"]
[1861,932,"PK202","PDGFRb","Y1009","Platelet-derived growth factor receptor kinase beta",0,294,14,363,{"v":101.64,"d":"102"},{"$f":"K1874*1.7571469","v":{"v":178.596410916,"d":"179"}},{"$f":"(L1874+L1875)/2","v":{"v":299.3932317034,"d":"299"}},{"$f":"SQRT((M1874-L1874)*(M1874-L1874))","v":{"v":120.79682078739998,"d":"121"}},{"$f":"N1874/M1874*100","v":{"v":40.34721162536828,"d":"40"}},0,304,16,374,{"v":107.712,"d":"108"},{"$f":"T1874*1.7472151","v":{"v":188.19603285120002,"d":"188"}},{"$f":"(U1874+U1875)/2","v":{"v":207.2808633885,"d":"207"}},{"$f":"SQRT((V1874-U1874)*(V1874-U1874))","v":{"v":19.08483053729998,"d":"19"}},{"$f":"W1874/V1874*100","v":{"v":9.207232267037542,"d":"9"}},{"$f":"X1874+O1874","v":{"v":49.55444389240582,"d":"50"}},{"$f":"(V1874/M1874*100)-100","v":{"v":-30.76634959007791,"d":"-31"}},null,0,376,12,390,{"v":141.96,"d":"142"},{"v":242.87104514400002,"d":"243"},{"$f":"(AG1874+AG1875)/2","v":{"v":195.1180399872,"d":"195"}},{"$f":"SQRT((AH1874-AG1874)*(AH1874-AG1874))","v":{"v":47.753005156800015,"d":"48"}},{"$f":"AI1874/AH1874*100","v":{"v":24.47390572390573,"d":"24"}},{"$f":"AJ1874+O1874","v":{"v":64.821117349274,"d":"65"}},{"$f":"(AH1874/M1874*100)-100","v":{"v":-34.82884069319988,"d":"-35"}},null,null,"PDGFRB","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"Epitope undefined.","Antibody raised against amino acid residues that encompass the Y1009 phosphosite.","Y1009 phosphorylation induces molecular association with PLCG1 and upregulates cell growth. This is a minor in vivo phosphorylation sites in PDGFRb (≥0 reports from high throughput mass spectrometry studies, but ≥16 reports from low throughput Western studies).","PDGFRB","Receptor tyrosine kinase; EC 2.7.10.1; TK group; PDGFR family","P09619","P09619","P09619","P09619","GO:0016324; GO:0009986; GO:0005737; GO:0031410; GO:0005925; GO:0005794; GO:0016021; GO:0043231; GO:0031226; GO:0043202; GO:0016020; GO:0005634; GO:0005886","GO:0005524; GO:0019899; GO:0043548; GO:0046934; GO:0004992; GO:0005017; GO:0005019; GO:0048407; GO:0005161; GO:0019901; GO:0004713; GO:0005088; GO:0005102; GO:0038085","GO:0007568; GO:0035909; GO:0055003; GO:0060326; GO:0016477; GO:0060981; GO:0035441; GO:0006024; GO:0048839; GO:0060437; GO:0008584; GO:0000165; GO:0072278; GO:0072277; GO:0072262; GO:0035789; GO:0072075; GO:0072284; GO:0043066; GO:0018108; GO:0048015; GO:0046488; GO:0035791; GO:0048008; GO:0043065; GO:0090280; GO:0030335; GO:0008284; GO:0038091; GO:0050921; GO:0032967; GO:2000573; GO:0070374; GO:0048146; GO:2000491; GO:0043406; GO:0035793; GO:0045840; GO:0043552; GO:0014068; GO:0010863; GO:0032516; GO:0051897; GO:2000379; GO:0035025; GO:0014911; GO:0048661; GO:0046777; GO:0032956; GO:0032355; GO:0043627; GO:0034405; GO:0042542; GO:0055093; GO:0032526; GO:0061298; GO:0007165; GO:0071670; GO:0042060"]
[1862,932,"PK202","PDGFRb","Y1009","Platelet-derived growth factor receptor kinase beta",0,394,12,626,{"v":239.132,"d":"239"},{"v":420.1900524908,"d":"420"},{"$nulls":3},0,300,14,453,{"v":129.558,"d":"130"},{"v":226.3656939258,"d":"226"},{"$nulls":6},0,125,14,776,{"v":86.136,"d":"86"},{"$f":"AF1875*1.7108414","v":{"v":147.3650348304,"d":"147"}},{"$nulls":7},"PDGFRB","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"Epitope undefined.","Antibody raised against amino acid residues that encompass the Y1009 phosphosite.","Y1009 phosphorylation induces molecular association with PLCG1 and upregulates cell growth. This is a minor in vivo phosphorylation sites in PDGFRb (≥0 reports from high throughput mass spectrometry studies, but ≥16 reports from low throughput Western studies).","PDGFRB",null,"P09619","P09619","P09619","P09619"]
[1867,935,"NN179-1","PDK1 (PDHK1)","Pan-specific","Pyruvate dehydrogenase kinase isoform 1; [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 1, mitochondrial",0,9937,16,638,{"v":6329.598,"d":"6330"},{"v":11122.033503946199,"d":"11122"},{"$f":"(L1880+L1881)/2","v":{"v":12738.891552597099,"d":"12739"}},{"$f":"SQRT((M1880-L1880)*(M1880-L1880))","v":{"v":1616.8580486509,"d":"1617"}},{"$f":"N1880/M1880*100","v":{"v":12.692297771553509,"d":"13"}},0,10058,20,590,{"v":5922.42,"d":"5922"},{"v":10347.741652542,"d":"10348"},{"$f":"(U1880+U1881)/2","v":{"v":11071.4189275959,"d":"11071"}},{"$f":"SQRT((V1880-U1880)*(V1880-U1880))","v":{"v":723.6772750539003,"d":"724"}},{"$f":"W1880/V1880*100","v":{"v":6.536445597321851,"d":"7"}},{"$f":"X1880+O1880","v":{"v":19.22874336887536,"d":"19"}},{"$f":"(V1880/M1880*100)-100","v":{"v":-13.089621009146981,"d":"-13"}},null,0,9866,14,637,{"v":6275.724,"d":"6276"},{"v":10736.7684341736,"d":"10737"},{"$f":"(AG1880+AG1881)/2","v":{"v":11130.8949674916,"d":"11131"}},{"$f":"SQRT((AH1880-AG1880)*(AH1880-AG1880))","v":{"v":394.12653331799993,"d":"394"}},{"$f":"AI1880/AH1880*100","v":{"v":3.5408341779261097,"d":"4"}},{"$f":"AJ1880+O1880","v":{"v":16.23313194947962,"d":"16"}},{"$f":"(AH1880/M1880*100)-100","v":{"v":-12.622735490496211,"d":"-13"}},null,null,"PDHK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PDHK",{"$nulls":6},"CNVLEVIKDGYENARR","Corresponds to amino acid residues C223 to R238.",null,null,"Protein kinase, atypical; EC 2.7.11.2; ATYPICAL domain target; ATYPICAL</A> group; PDHK family","Q15118","Q15118","Q15118",null,"GO:0005759; GO:0005967; GO:0005739; GO:0005730; GO:0005634","GO:0005524; GO:0004672; GO:0004740","GO:0008283; GO:0006006; GO:0097411; GO:0008631; GO:0010510; GO:0010906"]
[1873,938,"NN178-2","PDK4 (PDHK4)","Pan-specific","Pyruvate dehydrogenase kinase isoform 4; [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 4, mitochondrial",0,8850,20,798,{"v":7046.34,"d":"7046"},{"v":12381.454487346,"d":"12381"},{"$f":"(L1886+L1887)/2","v":{"v":10810.9025309508,"d":"10811"}},{"$f":"SQRT((M1886-L1886)*(M1886-L1886))","v":{"v":1570.5519563952002,"d":"1571"}},{"$f":"N1886/M1886*100","v":{"v":14.527482343854533,"d":"15"}},0,7648,14,607,{"v":4633.838,"d":"4634"},{"v":8096.3117245538,"d":"8096"},{"$f":"(U1886+U1887)/2","v":{"v":8024.1936740862,"d":"8024"}},{"$f":"SQRT((V1886-U1886)*(V1886-U1886))","v":{"v":72.11805046759946,"d":"72"}},{"$f":"W1886/V1886*100","v":{"v":0.8987575997885208,"d":"1"}},{"$f":"X1886+O1886","v":{"v":15.426239943643054,"d":"15"}},{"$f":"(V1886/M1886*100)-100","v":{"v":-25.776838232390517,"d":"-26"}},null,0,7822,18,605,{"v":4721.42,"d":"4721"},{"v":8077.600802788001,"d":"8078"},{"$f":"(AG1886+AG1887)/2","v":{"v":8252.702853815901,"d":"8253"}},{"$f":"SQRT((AH1886-AG1886)*(AH1886-AG1886))","v":{"v":175.10205102790042,"d":"175"}},{"$f":"AI1886/AH1886*100","v":{"v":2.1217539772068297,"d":"2"}},{"$f":"AJ1886+O1886","v":{"v":16.649236321061363,"d":"17"}},{"$f":"(AH1886/M1886*100)-100","v":{"v":-23.663146252692286,"d":"-24"}},null,null,"PDHK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PDHK",{"$nulls":6},"CREVEHFSRYSPSPLS","Corresponds to amino acid residues R22 to S36.",{"$nulls":3},"Q16654","Q16654","Q16654","Q16654","GO:0005759; GO:0005739","GO:0005524; GO:0004672; GO:0004740","GO:0071398; GO:0009267; GO:0042593; GO:0006006; GO:0008286; GO:2000811; GO:0072593; GO:0010510; GO:0045124; GO:0010565; GO:0042304; GO:0046320; GO:0010906; GO:0006885; GO:0042594"]
[1878,1136,"PN267","PEBP1","S153","Phosphatidylethanolamine-binding protein 1",0,58,10,448,{"v":21.504,"d":"22"},{"v":37.785686937600005,"d":"38"},{"$nulls":3},0,68,10,453,{"v":26.274,"d":"26"},{"v":45.906329537400005,"d":"46"},{"$nulls":6},0,80,12,486,{"v":33.048,"d":"33"},{"v":56.53988658720001,"d":"57"},{"$nulls":20},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S153 phosphosite.","S153 phosphorylation induces interaction with GRK2 and inhibits binding to Raf1. This is one of the less major in vivo phosphorylation sites in PEBP1 (≥15 reports from high throughput mass spectrometry studies).","PKCa (PRKCA); PKCb1 (PRKCB1); PKCd (PRKCD); PKCg (PRKCG)",null,"P30086","P30086",null,"P30086"]
[1879,940,"PN523","PECAM-1","Y713","Platelet endothelial cell adhesion molecule",0,9690,26,911,{"v":8803.904,"d":"8804"},{"v":15469.7526214976,"d":"15470"},{"$f":"(L1892+L1893)/2","v":{"v":13165.8677064157,"d":"13166"}},{"$f":"SQRT((M1892-L1892)*(M1892-L1892))","v":{"v":2303.8849150819005,"d":"2304"}},{"$f":"N1892/M1892*100","v":{"v":17.498921958324267,"d":"17"}},0,8914,16,687,{"v":6112.926,"d":"6113"},{"v":10680.5966123826,"d":"10681"},{"$f":"(U1892+U1893)/2","v":{"v":10839.6403612903,"d":"10840"}},{"$f":"SQRT((V1892-U1892)*(V1892-U1892))","v":{"v":159.0437489076994,"d":"159"}},{"$f":"W1892/V1892*100","v":{"v":1.4672419342957572,"d":"1"}},{"$f":"X1892+O1892","v":{"v":18.966163892620024,"d":"19"}},{"$f":"(V1892/M1892*100)-100","v":{"v":-17.668621597890095,"d":"-18"}},null,0,9398,18,715,{"v":6706.7,"d":"6707"},{"v":11474.10001738,"d":"11474"},{"$f":"(AG1892+AG1893)/2","v":{"v":12075.5950705299,"d":"12076"}},{"$f":"SQRT((AH1892-AG1892)*(AH1892-AG1892))","v":{"v":601.4950531498998,"d":"601"}},{"$f":"AI1892/AH1892*100","v":{"v":4.981080018307579,"d":"5"}},{"$f":"AJ1892+O1892","v":{"v":22.480001976631847,"d":"22"}},{"$f":"(AH1892/M1892*100)-100","v":{"v":-8.281054163672877,"d":"-8"}},{"$nulls":15},"ETV(pY)SEV(bA)C","Corresponds to amino acid residues E710 to V716; In the C-terminal region of the protein after the transmembrane domain. ","Y713 phosphorylation induces activity and interaction with SHP-2 and STAT5A. This is the major in vivo phosphorylation site in PECAM-1 (≥791 reports from high throughput mass spectrometry studies).","CSK; Fer; Fes; Fyn; Lck","Cell surface protein","P16284","P16284",null,null,"GO:0030054; GO:0009897; GO:0070062; GO:0005615; GO:0016021; GO:0045121; GO:0005886; GO:0031092; GO:0030667; GO:0030485","GO:0042803","GO:0001525; GO:0098742; GO:0008037; GO:0050904; GO:0090673; GO:0043542; GO:0001886; GO:0030198; GO:0072011; GO:0007156; GO:0007159; GO:0050900; GO:0043312; GO:0072672; GO:0006909; GO:0002576; GO:0042531; GO:0030334; GO:0007266; GO:0007165; GO:0042060"]
[1884,942,"PN258","PFKFB2 (PFK2)","S483","6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2",0,304,12,694,{"v":202.648,"d":"203"},{"v":356.0823049912,"d":"356"},{"$nulls":3},0,196,10,490,{"v":91.14,"d":"91"},{"v":159.24118421400001,"d":"159"},{"$nulls":6},0,234,8,523,{"v":118.198,"d":"118"},{"v":202.21803179719998,"d":"202"},{"$nulls":10},"Gluconeogenesis",{"$nulls":8},"X","Epitope undefined.","Antibody raised against amino acid residues that encompass the S483 phosphosite.","S483 phosphorylation induces interaction with 14-3-3 beta. This is one of the major in vivo phosphorylation sites in PFKFB2 (≥134 reports from high throughput mass spectrometry studies).","Akt1 (PKBa); Akt3 (PKBg); p70S6K (RPS6KB1); PKACa (PRKACA); RSK2 (RPS6KA3)",null,"O60825","O60825"]
[1890,945,"PN524","PFN1","Y129","Profilin 1",0,2211,18,658,{"v":1442.994,"d":"1443"},{"v":2535.5524338185996,"d":"2536"},{"$nulls":3},0,1040,14,487,{"v":499.662,"d":"500"},{"v":873.0169912962,"d":"873"},{"$nulls":6},0,1948,24,561,{"v":1079.364,"d":"1079"},{"v":1846.6206168696,"d":"1847"},{"$nulls":20},"KKC(pY)EMA(bA)C","Corresponds to amino acid residues K126 to A132; In the end of the Profilin domain.","Y129 phosphorylation induces interaction with VHL. This is the major in vivo phosphorylation site in Profilin 1 (≥666 reports from high throughput mass spectrometry studies).","KDR (VEGFR2); Src",null,"P07737","P07737",null,"P07737"]
[1895,948,"NK004-3","PFTAIRE2 (ALS2CR7)","Pan-specific","Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 7 protein",0,1836,12,536,{"v":977.664,"d":"978"},{"v":1717.8992668416,"d":"1718"},{"$f":"(L1908+L1909)/2","v":{"v":2578.3881609468,"d":"2578"}},{"$f":"SQRT((M1908-L1908)*(M1908-L1908))","v":{"v":860.4888941052,"d":"860"}},{"$f":"N1908/M1908*100","v":{"v":33.37313237543036,"d":"33"}},0,1516,14,475,{"v":713.45,"d":"713"},{"v":1246.550613095,"d":"1247"},{"$f":"(U1908+U1909)/2","v":{"v":1475.6926318147,"d":"1476"}},{"$f":"SQRT((V1908-U1908)*(V1908-U1908))","v":{"v":229.1420187197,"d":"229"}},{"$f":"W1908/V1908*100","v":{"v":15.527760576937876,"d":"16"}},{"$f":"X1908+O1908","v":{"v":48.90089295236824,"d":"49"}},{"$f":"(V1908/M1908*100)-100","v":{"v":-42.766855116460945,"d":"-43"}},null,0,1884,14,489,{"v":914.43,"d":"914"},{"v":1564.444701402,"d":"1564"},{"$f":"(AG1908+AG1909)/2","v":{"v":1839.5223359010001,"d":"1840"}},{"$f":"SQRT((AH1908-AG1908)*(AH1908-AG1908))","v":{"v":275.07763449900017,"d":"275"}},{"$f":"AI1908/AH1908*100","v":{"v":14.953753435359449,"d":"15"}},{"$f":"AJ1908+O1908","v":{"v":48.326885810789804,"d":"48"}},{"$f":"(AH1908/M1908*100)-100","v":{"v":-28.65611300256994,"d":"-29"}},null,null,"PFTAIRE2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","TAIRE",{"$nulls":5},"CDLLASYQKGHHPAQFSK","Corresponds to amino acid residues C416 to K433; C-terminus.",null,null,"EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC domain target; CMGC</A> group; CDK family; CDK/TAIRE subfamily; TAIRE subfamily","Q96Q40","Q96Q40","Q96Q40",null,"GO:0005829; GO:0005634","GO:0005524; GO:0030332; GO:0004693; GO:0046872; GO:0004674"]
[1896,948,"NK004-3","PFTAIRE2 (ALS2CR7)","Pan-specific","Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 7 protein",0,2792,16,705,{"v":1957.08,"d":"1957"},{"v":3438.877055052,"d":"3439"},{"$nulls":3},0,1950,14,504,{"v":975.744,"d":"976"},{"v":1704.8346505344,"d":"1705"},{"$nulls":6},0,2414,14,515,1236,{"v":2114.5999704,"d":"2115"},{"$nulls":7},"PFTAIRE2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","TAIRE",{"$nulls":5},"CDLLASYQKGHHPAQFSK","Corresponds to amino acid residues C416 to K433; C-terminus.",{"$nulls":3},"Q96Q40","Q96Q40","Q96Q40"]
[1901,950,"NN089","PIK3R1","Pan-specific","Phosphatidylinositol 3-kinase regulatory subunit alpha",0,310,22,638,{"v":183.744,"d":"184"},{"v":322.8651999936,"d":"323"},{"$f":"(L1914+L1915)/2","v":{"v":380.0989888204,"d":"380"}},{"$f":"SQRT((M1914-L1914)*(M1914-L1914))","v":{"v":57.23378882679998,"d":"57"}},{"$f":"N1914/M1914*100","v":{"v":15.057600917176718,"d":"15"}},0,272,14,483,{"v":124.614,"d":"125"},{"v":217.7274624714,"d":"218"},{"$f":"(U1914+U1915)/2","v":{"v":224.8718250153,"d":"225"}},{"$f":"SQRT((V1914-U1914)*(V1914-U1914))","v":{"v":7.144362543900002,"d":"7"}},{"$f":"W1914/V1914*100","v":{"v":3.1770821192979195,"d":"3"}},{"$f":"X1914+O1914","v":{"v":18.234683036474635,"d":"18"}},{"$f":"(V1914/M1914*100)-100","v":{"v":-40.83861530040696,"d":"-41"}},null,0,341,14,502,{"v":164.154,"d":"164"},{"v":280.8414591756,"d":"281"},{"$f":"(AG1914+AG1915)/2","v":{"v":327.80148934349995,"d":"328"}},{"$f":"SQRT((AH1914-AG1914)*(AH1914-AG1914))","v":{"v":46.96003016789996,"d":"47"}},{"$f":"AI1914/AH1914*100","v":{"v":14.325752534544161,"d":"14"}},{"$f":"AJ1914+O1914","v":{"v":29.38335345172088,"d":"29"}},{"$f":"(AH1914/M1914*100)-100","v":{"v":-13.75891570751088,"d":"-14"}},{"$nulls":15},"Epitope undefined.",{"$nulls":3},"Regulator, inositol phosphate metabolism","P27986","P27986",null,"P27986","GO:0005911; GO:0005801; GO:0005737; GO:0005829; GO:0016020; GO:0005634; GO:1990578; GO:0005942; GO:0005943; GO:0005886","GO:0016303; GO:0046935; GO:0043125; GO:0043559; GO:0005159; GO:0005158; GO:0043560; GO:0005168; GO:0043548; GO:0035014; GO:0036312; GO:0046934; GO:0001784; GO:0046982; GO:0019903; GO:0008134; GO:0005068","GO:0007411; GO:0030183; GO:0001678; GO:0032869; GO:0034644; GO:0019221; GO:0007173; GO:0038128; GO:0008625; GO:0038095; GO:0038096; GO:0007186; GO:0060396; GO:0048009; GO:0008286; GO:0008630; GO:0050900; GO:0043066; GO:0001953; GO:0045671; GO:0014065; GO:0048015; GO:0046854; GO:0030168; GO:0030335; GO:1900103; GO:0046326; GO:2001275; GO:0042307; GO:0051897; GO:1903078; GO:0033120; GO:0045944; GO:0032760; GO:0006606; GO:0006468; GO:0050821; GO:0046626; GO:0043551; GO:0051492; GO:0034976; GO:0031295; GO:0050852; GO:0048010; GO:0016032"]
[1906,953,"PN527","PIK3R1","Y580","Phosphatidylinositol 3-kinase regulatory subunit alpha",0,4788,12,790,{"v":3773.04,"d":"3773"},{"v":6629.785539576,"d":"6630"},{"$nulls":3},0,5576,20,812,{"v":4511.472,"d":"4511"},{"v":7882.512001627199,"d":"7883"},{"$nulls":6},0,5602,18,875,4886,{"v":8359.1710804,"d":"8359"},{"$nulls":20},"RDQ(pY)LMW(bA)C","Corresponds to amino acid residues R577 to W583; In the region between the two SH2 domains in the C-terminus half of the protein. ","The effect of Y580 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in PIK3R1 (≥924 reports from high throughput mass spectrometry studies).","InsR",null,"P27986","P27986",null,"P27986"]
[1908,954,"PN528","PIK3R2","Y464","Phosphatidylinositol 3-kinase regulatory subunit beta",0,3462,10,544,{"v":1877.888,"d":"1878"},{"v":3299.7250777472,"d":"3300"},{"$nulls":3},0,4004,12,560,{"v":2235.52,"d":"2236"},{"v":3905.934300352,"d":"3906"},{"$nulls":6},0,4276,14,603,{"v":2569.986,"d":"2570"},{"v":4396.8384462204,"d":"4397"},{"$nulls":20},"DQL(pY)EEY(bA)C","Corresponds to amino acid residues D461 to Y467; In the region between the two SH2 domains in the protein. ","The effect of Y464 phosphorylation is unclear. This is the major in vivo phosphorylation site in PIK3R2 (≥1687 reports from high throughput mass spectrometry studies).",null,null,"O00459","O00459",null,"O00459"]
[1913,957,"NK288-2","Pim2","Pan-specific","Serine/threonine-protein kinase Pim-2",0,6574,14,555,{"v":3640.8,"d":"3641"},{"v":6397.42043352,"d":"6397"},{"$f":"(L1926+L1927)/2","v":{"v":8598.28470442835,"d":"8598"}},{"$f":"SQRT((M1926-L1926)*(M1926-L1926))","v":{"v":2200.8642709083497,"d":"2201"}},{"$f":"N1926/M1926*100","v":{"v":25.59655031863326,"d":"26"}},0,5802,14,561,{"v":3247.068,"d":"3247"},{"v":5673.326240326801,"d":"5673"},{"$f":"(U1926+U1927)/2","v":{"v":5687.628943135401,"d":"5688"}},{"$f":"SQRT((V1926-U1926)*(V1926-U1926))","v":{"v":14.30270280859986,"d":"14"}},{"$f":"W1926/V1926*100","v":{"v":0.2514703921721598,"d":"0"}},{"$f":"X1926+O1926","v":{"v":25.848020710805418,"d":"26"}},{"$f":"(V1926/M1926*100)-100","v":{"v":-33.85158623316907,"d":"-34"}},null,0,6797,14,635,{"v":4307.205,"d":"4307"},{"v":7368.944632287,"d":"7369"},{"$f":"(AG1926+AG1927)/2","v":{"v":6762.210982770301,"d":"6762"}},{"$f":"SQRT((AH1926-AG1926)*(AH1926-AG1926))","v":{"v":606.7336495166992,"d":"607"}},{"$f":"AI1926/AH1926*100","v":{"v":8.972415250908607,"d":"9"}},{"$f":"AJ1926+O1926","v":{"v":34.56896556954187,"d":"35"}},{"$f":"(AH1926/M1926*100)-100","v":{"v":-21.35395354741418,"d":"-21"}},null,null,"PIM2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","PIM",{"$nulls":6},"LDPWMQTPAEDVPLNPSKGC","Corresponds to amino acid residues L282 to G300; C-terminus.",null,null,"Protein-serine kinase, CAMK group, PIM family","Q9P1W9","Q9P1W9","Q9P1W9","Q9P1W9","GO:0005737","GO:0005524; GO:0004674","GO:0008637; GO:0008283; GO:0000082; GO:0007140; GO:0043066; GO:0008285; GO:0032091; GO:0010508; GO:0043123; GO:0016239; GO:0045893; GO:0046777; GO:0006468; GO:0050821; GO:0007346; GO:0009615"]
[1918,959,"NK289-1","Pim3","Pan-specific","Serine/threonine-protein kinase Pim-3",0,582,12,609,{"v":347.13,"d":"347"},{"v":609.958403397,"d":"610"},{"$nulls":3},0,510,12,491,{"v":244.518,"d":"245"},{"v":427.2255418218,"d":"427"},{"$nulls":6},0,590,12,513,{"v":296.514,"d":"297"},{"v":507.2884268796,"d":"507"},{"$nulls":7},"PIM3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","PIM",{"$nulls":6},"CVKILQPAKADKESFEKAYQ","Corresponds to amino acid residues V23 to Q41; Post-N-terminus.",{"$nulls":3},"Q86V86","Q86V86","Q86V86","Q86V86"]
[1923,963,"NK201","PKCa (PRKCA)","Pan-specific","Protein-serine kinase C alpha",0,2934,18,686,{"v":2000.376,"d":"2000"},{"v":3514.9544872344,"d":"3515"},{"$f":"(L1936+L1937)/2","v":{"v":2762.2050553026997,"d":"2762"}},{"$f":"SQRT((M1936-L1936)*(M1936-L1936))","v":{"v":752.7494319317002,"d":"753"}},{"$f":"N1936/M1936*100","v":{"v":27.251757811630288,"d":"27"}},0,2454,12,506,{"v":1235.652,"d":"1236"},{"v":2158.9498327452,"d":"2159"},{"$f":"(U1936+U1937)/2","v":{"v":2299.89854846975,"d":"2300"}},{"$f":"SQRT((V1936-U1936)*(V1936-U1936))","v":{"v":140.94871572454986,"d":"141"}},{"$f":"W1936/V1936*100","v":{"v":6.1284753546338315,"d":"6"}},{"$f":"X1936+O1936","v":{"v":33.38023316626412,"d":"33"}},{"$f":"(V1936/M1936*100)-100","v":{"v":-16.736864120404235,"d":"-17"}},null,0,2642,14,512,{"v":1345.536,"d":"1346"},{"v":2301.9986939904,"d":"2302"},{"$f":"(AG1936+AG1937)/2","v":{"v":2347.6490750666,"d":"2348"}},{"$f":"SQRT((AH1936-AG1936)*(AH1936-AG1936))","v":{"v":45.650381076199665,"d":"46"}},{"$f":"AI1936/AH1936*100","v":{"v":1.9445146875243533,"d":"2"}},{"$f":"AJ1936+O1936","v":{"v":29.19627249915464,"d":"29"}},{"$f":"(AH1936/M1936*100)-100","v":{"v":-15.008153700981126,"d":"-15"}},null,null,"PKCa","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Alpha",{"$nulls":5},"KKDVVIQDDDVESTMVEKC","Corresponds to amino acid residues K371 to K388; Kinase catalytic subdomain 3.",null,null,"EC 2.7.11.13; Protein kinase, Ser/Thr (non-receptor); AGC group; PKC family; Alpha subfamily","P17252","P17252","P17252",null,"GO:0035866; GO:0005737; GO:0005829; GO:0005783; GO:0070062; GO:0031966; GO:0005739; GO:0005654; GO:0048471; GO:0005886","GO:0005524; GO:0004698; GO:0019899; GO:0035403; GO:0005178; GO:0004672; GO:0004697; GO:0004674; GO:0008270","GO:0001525; GO:0097190; GO:0007411; GO:0007155; GO:0002159; GO:0038128; GO:0035408; GO:0035556; GO:0007077; GO:0034351; GO:0018105; GO:0018107; GO:0030168; GO:0106071; GO:0045766; GO:0043536; GO:0045780; GO:0010613; GO:0045785; GO:0030335; GO:2000707; GO:0010595; GO:0001938; GO:0070374; GO:0031666; GO:0045651; GO:0045931; GO:0006468; GO:0050796; GO:0043488; GO:0090330; GO:0070555"]
[1928,965,"PK764","PKCa (PRKCA)","Y195","Protein-serine kinase C alpha",0,2642,14,647,{"v":1700.316,"d":"1700"},{"v":2987.7049884204,"d":"2988"},{"$nulls":3},0,2750,16,536,{"v":1465.424,"d":"1465"},{"v":2560.4109407024,"d":"2560"},{"$nulls":6},0,2765,20,622,{"v":1707.39,"d":"1707"},{"v":2921.0734979460003,"d":"2921"},{"$nulls":7},"PKCa","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Alpha",{"$nulls":5},"SDP(pY)VKL(bA)C","Corresponds to amino acid residues S192 to L198; In the C2 domain.","The effect of Y195 phosphorylation is unclear. This is the major in vivo site of phosphorylation of PKCa (≥124 reports from high throughput mass spectrometry studies).",null,null,"P17252","P17252","P17252"]
[1931,967,"PK210","PKCa (PRKCA)","S657","Protein-serine kinase C alpha",0,83,12,527,{"v":37.417,"d":"37"},{"v":65.74716555730001,"d":"66"},{"$f":"(L1944+L1945)/2","v":{"v":52.06689836735001,"d":"52"}},{"$f":"SQRT((M1944-L1944)*(M1944-L1944))","v":{"v":13.680267189950001,"d":"14"}},{"$f":"N1944/M1944*100","v":{"v":26.274403928252028,"d":"26"}},0,48,10,658,{"v":25.004,"d":"25"},{"v":43.687366360400006,"d":"44"},{"$f":"(U1944+U1945)/2","v":{"v":43.5161392806,"d":"44"}},{"$f":"SQRT((V1944-U1944)*(V1944-U1944))","v":{"v":0.17122707980000484,"d":"0"}},{"$f":"W1944/V1944*100","v":{"v":0.39347948285554796,"d":"0"}},{"$f":"X1944+O1944","v":{"v":26.667883411107574,"d":"27"}},{"$f":"(V1944/M1944*100)-100","v":{"v":-16.422639632615414,"d":"-16"}},null,0,38,8,655,{"v":19.65,"d":"20"},{"v":33.61803351,"d":"34"},{"$f":"(AG1944+AG1945)/2","v":{"v":39.333954627400004,"d":"39"}},{"$f":"SQRT((AH1944-AG1944)*(AH1944-AG1944))","v":{"v":5.715921117400008,"d":"6"}},{"$f":"AI1944/AH1944*100","v":{"v":14.531773302596687,"d":"15"}},{"$f":"AJ1944+O1944","v":{"v":40.80617723084872,"d":"41"}},{"$f":"(AH1944/M1944*100)-100","v":{"v":-24.45496877904013,"d":"-24"}},null,null,"PKCa","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Alpha",{"$nulls":5},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S657 phosphosite.","S657 phosphorylation regulates intracellular localization. This is one of the minor in vivo phosphorylation sites in PKCa (≥6 reports from high throughput mass spectrometry studies).","PKCa (PRKCA)","EC 2.7.11.13; Protein kinase, Ser/Thr (non-receptor); AGC group; PKC family; Alpha subfamily","P17252","P17252","P17252",null,"GO:0035866; GO:0005737; GO:0005829; GO:0005783; GO:0070062; GO:0031966; GO:0005739; GO:0005654; GO:0048471; GO:0005886","GO:0005524; GO:0004698; GO:0019899; GO:0035403; GO:0005178; GO:0004672; GO:0004697; GO:0004674; GO:0008270","GO:0001525; GO:0097190; GO:0007411; GO:0007155; GO:0002159; GO:0038128; GO:0035408; GO:0035556; GO:0007077; GO:0034351; GO:0018105; GO:0018107; GO:0030168; GO:0106071; GO:0045766; GO:0043536; GO:0045780; GO:0010613; GO:0045785; GO:0030335; GO:2000707; GO:0010595; GO:0001938; GO:0070374; GO:0031666; GO:0045651; GO:0045931; GO:0006468; GO:0050796; GO:0043488; GO:0090330; GO:0070555"]
[1935,969,"PK766","PKCb (PRKCB1)","T500","Protein-serine kinase C beta 1",0,2313,16,659,{"v":1513.723,"d":"1514"},{"v":2659.8336769087,"d":"2660"},{"$f":"(L1948+L1949)/2","v":{"v":2716.44280001255,"d":"2716"}},{"$f":"SQRT((M1948-L1948)*(M1948-L1948))","v":{"v":56.609123103849925,"d":"57"}},{"$f":"N1948/M1948*100","v":{"v":2.083943129727907,"d":"2"}},0,2394,10,516,{"v":1230.144,"d":"1230"},{"v":2149.3261719744,"d":"2149"},{"$f":"(U1948+U1949)/2","v":{"v":2248.9663546972,"d":"2249"}},{"$f":"SQRT((V1948-U1948)*(V1948-U1948))","v":{"v":99.64018272280009,"d":"100"}},{"$f":"W1948/V1948*100","v":{"v":4.43048792236003,"d":"4"}},{"$f":"X1948+O1948","v":{"v":6.514431052087938,"d":"7"}},{"$f":"(V1948/M1948*100)-100","v":{"v":-17.20914003096955,"d":"-17"}},null,0,2381,12,619,{"v":1466.411,"d":"1466"},{"v":2508.7966482154,"d":"2509"},{"$f":"(AG1948+AG1949)/2","v":{"v":2476.1247099996003,"d":"2476"}},{"$f":"SQRT((AH1948-AG1948)*(AH1948-AG1948))","v":{"v":32.671938215799855,"d":"33"}},{"$f":"AI1948/AH1948*100","v":{"v":1.3194787033083293,"d":"1"}},{"$f":"AJ1948+O1948","v":{"v":3.4034218330362362,"d":"3"}},{"$f":"(AH1948/M1948*100)-100","v":{"v":-8.846793682231763,"d":"-9"}},null,null,"PKCb","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Alpha",{"$nulls":5},"TTK(pT)FCG(bA)C","Corresponds to amino acid residues T497 to G503; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T500 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in PKCb (≥82 reports from high throughput mass spectrometry studies).","BLVRA; PKCa (PRKCA); PKCb1 (PRKCB1)","EC 2.7.11.13; Protein kinase, Ser/Thr (non-receptor); AGC group; PKC family; Alpha subfamily","P05771","P05771","P05771",null,"GO:0005737; GO:0005829; GO:0070062; GO:0005654; GO:0005634; GO:0005886","GO:0050681; GO:0005524; GO:0004698; GO:0003682; GO:0042393; GO:0035403; GO:0030374; GO:0004697; GO:0005080; GO:0004674; GO:0008270","GO:0002250; GO:0006915; GO:0042113; GO:0050853; GO:0035408; GO:0035556; GO:0042953; GO:0007077; GO:0010829; GO:0046627; GO:0018105; GO:0030168; GO:0045766; GO:0050861; GO:0043123; GO:0051092; GO:0030949; GO:0006468; GO:0045637; GO:0006357; GO:0007165; GO:0006351"]
[1940,971,"NK134-3","PKCb2 (PRKCB2)","Pan-specific","Protein-serine kinase C beta 2",0,92,12,659,{"v":52.72,"d":"53"},{"v":92.636784568,"d":"93"},{"$nulls":3},0,98,10,426,{"v":37.488,"d":"37"},{"v":65.4995996688,"d":"65"},{"$nulls":6},0,60,12,656,{"v":31.488,"d":"31"},{"v":53.870974003200004,"d":"54"},{"$nulls":7},"PKCb","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Alpha",{"$nulls":5},"Epitope undefined.",{"$nulls":4},"P05771-2","P05771-2","P05771-2"]
[1945,974,"NK135","PKCd (PRKCD)","Pan-specific","Protein-serine kinase C delta",0,210,10,504,{"v":100.8,"d":"101"},{"v":177.12040752,"d":"177"},{"$f":"(L1958+L1959)/2","v":{"v":260.8467001581,"d":"261"}},{"$f":"SQRT((M1958-L1958)*(M1958-L1958))","v":{"v":83.72629263810003,"d":"84"}},{"$f":"N1958/M1958*100","v":{"v":32.09789220540389,"d":"32"}},0,224,10,466,{"v":99.724,"d":"100"},{"v":174.23927863240002,"d":"174"},{"$f":"(U1958+U1959)/2","v":{"v":171.6900918015,"d":"172"}},{"$f":"SQRT((V1958-U1958)*(V1958-U1958))","v":{"v":2.5491868309000267,"d":"3"}},{"$f":"W1958/V1958*100","v":{"v":1.4847605963466295,"d":"1"}},{"$f":"X1958+O1958","v":{"v":33.58265280175052,"d":"34"}},{"$f":"(V1958/M1958*100)-100","v":{"v":-34.179695699643474,"d":"-34"}},null,0,254,10,515,{"v":125.66,"d":"126"},{"v":214.984330324,"d":"215"},{"$f":"(AG1958+AG1959)/2","v":{"v":229.7249398264,"d":"230"}},{"$f":"SQRT((AH1958-AG1958)*(AH1958-AG1958))","v":{"v":14.740609502399991,"d":"15"}},{"$f":"AI1958/AH1958*100","v":{"v":6.416634394828558,"d":"6"}},{"$f":"AJ1958+O1958","v":{"v":38.51452660023244,"d":"39"}},{"$f":"(AH1958/M1958*100)-100","v":{"v":-11.931053876793158,"d":"-12"}},null,null,"PKCd","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Alpha",{"$nulls":5},"Epitope undefined.",{"$nulls":3},"EC 2.7.11.13; Protein kinase, Ser/Thr (non-receptor); AGC domain target; AGC</A> group; PKC family; Delta subfamily","Q05655","Q05655","Q05655","Q05655","GO:0035578; GO:0005911; GO:0005737; GO:0005829; GO:0005783; GO:0070062; GO:0005576; GO:0016363; GO:0005654; GO:0005634; GO:0048471; GO:0005886","GO:0005524; GO:0004699; GO:0008047; GO:0019899; GO:0043560; GO:0019900; GO:0046872; GO:0004715; GO:0004672; GO:0019901; GO:0004697; GO:0004674","GO:0032147; GO:0006915; GO:0042100; GO:0060326; GO:0007049; GO:1904385; GO:0070301; GO:0071447; GO:0090398; GO:0042742; GO:0038096; GO:0016572; GO:0016064; GO:0060333; GO:0032613; GO:0032615; GO:0008631; GO:0030837; GO:0051490; GO:0034351; GO:0050728; GO:0046627; GO:0043407; GO:0050732; GO:0090331; GO:0032091; GO:0042119; GO:0043312; GO:0018105; GO:0018107; GO:0030168; GO:2001235; GO:2000304; GO:0032079; GO:2000753; GO:1900163; GO:0035307; GO:0042307; GO:2001022; GO:2000755; GO:0032930; GO:0006468; GO:0050821; GO:0032956; GO:0043488; GO:0010469; GO:0007165; GO:0002223; GO:0023021"]
[1946,974,"NK135","PKCd (PRKCD)","Pan-specific","Protein-serine kinase C delta",0,306,12,667,{"v":196.098,"d":"196"},{"v":344.5729927962,"d":"345"},{"$nulls":3},0,204,10,499,{"v":96.806,"d":"97"},{"v":169.1409049706,"d":"169"},{"$nulls":6},0,288,10,514,{"v":142.892,"d":"143"},{"v":244.4655493288,"d":"244"},{"$nulls":7},"PKCd","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Alpha",{"$nulls":5},"Epitope undefined.",{"$nulls":4},"Q05655","Q05655","Q05655","Q05655"]
[1953,979,"PK206","PKCd (PRKCD)","T507","Protein-serine kinase C delta",0,156,12,563,{"v":81.072,"d":"81"},{"v":142.4554134768,"d":"142"},{"$f":"(L1966+L1967)/2","v":{"v":148.2610268344,"d":"148"}},{"$f":"SQRT((M1966-L1966)*(M1966-L1966))","v":{"v":5.805613357600009,"d":"6"}},{"$f":"N1966/M1966*100","v":{"v":3.9158054423058744,"d":"4"}},0,152,10,445,{"v":63.19,"d":"63"},{"v":110.406522169,"d":"110"},{"$f":"(U1966+U1967)/2","v":{"v":103.155579504,"d":"103"}},{"$f":"SQRT((V1966-U1966)*(V1966-U1966))","v":{"v":7.250942664999997,"d":"7"}},{"$f":"W1966/V1966*100","v":{"v":7.02913279132791,"d":"7"}},{"$f":"X1966+O1966","v":{"v":10.944938233633785,"d":"11"}},{"$f":"(V1966/M1966*100)-100","v":{"v":-30.422996719684463,"d":"-30"}},null,0,178,10,494,{"v":82.992,"d":"83"},{"v":141.98614946880002,"d":"142"},{"$f":"(AG1966+AG1967)/2","v":{"v":125.66985503700002,"d":"126"}},{"$f":"SQRT((AH1966-AG1966)*(AH1966-AG1966))","v":{"v":16.316294431800003,"d":"16"}},{"$f":"AI1966/AH1966*100","v":{"v":12.983459260771902,"d":"13"}},{"$f":"AJ1966+O1966","v":{"v":16.899264703077776,"d":"17"}},{"$f":"(AH1966/M1966*100)-100","v":{"v":-15.237431090122683,"d":"-15"}},null,null,"PKCd","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Delta",{"$nulls":5},"Epitope undefined.","Antibody raised against amino acid residues that encompass the T507 phosphosite.","T507 phosphorylation stimulates phosphotransferase activity and degradation. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in PKCd (≥126 reports from high throughput mass spectrometry studies).","PDPK1 (PDK1); PKCe (PRKCE); Src","EC 2.7.11.13; Protein kinase, Ser/Thr (non-receptor); AGC domain target; AGC</A> group; PKC family; Delta subfamily","Q05655","Q05655","Q05655","Q05655","GO:0035578; GO:0005911; GO:0005737; GO:0005829; GO:0005783; GO:0070062; GO:0005576; GO:0016363; GO:0005654; GO:0005634; GO:0048471; GO:0005886","GO:0005524; GO:0004699; GO:0008047; GO:0019899; GO:0043560; GO:0019900; GO:0046872; GO:0004715; GO:0004672; GO:0019901; GO:0004697; GO:0004674","GO:0032147; GO:0006915; GO:0042100; GO:0060326; GO:0007049; GO:1904385; GO:0070301; GO:0071447; GO:0090398; GO:0042742; GO:0038096; GO:0016572; GO:0016064; GO:0060333; GO:0032613; GO:0032615; GO:0008631; GO:0030837; GO:0051490; GO:0034351; GO:0050728; GO:0046627; GO:0043407; GO:0050732; GO:0090331; GO:0032091; GO:0042119; GO:0043312; GO:0018105; GO:0018107; GO:0030168; GO:2001235; GO:2000304; GO:0032079; GO:2000753; GO:1900163; GO:0035307; GO:0042307; GO:2001022; GO:2000755; GO:0032930; GO:0006468; GO:0050821; GO:0032956; GO:0043488; GO:0010469; GO:0007165; GO:0002223; GO:0023021"]
[1957,981,"PK205","PKCd (PRKCD)","S645","Protein-serine kinase C delta",0,114,12,581,{"v":59.262,"d":"59"},{"v":104.1320395878,"d":"104"},{"$f":"(L1970+L1971)/2","v":{"v":88.2386458773,"d":"88"}},{"$f":"SQRT((M1970-L1970)*(M1970-L1970))","v":{"v":15.893393710499993,"d":"16"}},{"$f":"N1970/M1970*100","v":{"v":18.011828663599967,"d":"18"}},0,36,6,653,{"v":19.59,"d":"20"},{"v":34.227943809,"d":"34"},{"$f":"(U1970+U1971)/2","v":{"v":35.368875269300005,"d":"35"}},{"$f":"SQRT((V1970-U1970)*(V1970-U1970))","v":{"v":1.1409314603000027,"d":"1"}},{"$f":"W1970/V1970*100","v":{"v":3.22580645161291,"d":"3"}},{"$f":"X1970+O1970","v":{"v":21.23763511521288,"d":"21"}},{"$f":"(V1970/M1970*100)-100","v":{"v":-59.916797319757045,"d":"-60"}},null,0,92,10,438,{"v":35.916,"d":"36"},{"v":61.446579722399996,"d":"61"},{"$f":"(AG1970+AG1971)/2","v":{"v":70.49350904559999,"d":"70"}},{"$f":"SQRT((AH1970-AG1970)*(AH1970-AG1970))","v":{"v":9.046929323199997,"d":"9"}},{"$f":"AI1970/AH1970*100","v":{"v":12.833705465488784,"d":"13"}},{"$f":"AJ1970+O1970","v":{"v":30.84553412908875,"d":"31"}},{"$f":"(AH1970/M1970*100)-100","v":{"v":-20.110391150353166,"d":"-20"}},null,null,"PKCd","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Delta",{"$nulls":5},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S645 phosphosite.","S645 phosphorylation stimulates phosphotransferase activity. This is one of the major in vivo phosphorylation sites in PKCd (≥127 reports from high throughput mass spectrometry studies).","PKCd (PRKCD)","EC 2.7.11.13; Protein kinase, Ser/Thr (non-receptor); AGC domain target; AGC</A> group; PKC family; Delta subfamily","Q05655","Q05655","Q05655","Q05655","GO:0035578; GO:0005911; GO:0005737; GO:0005829; GO:0005783; GO:0070062; GO:0005576; GO:0016363; GO:0005654; GO:0005634; GO:0048471; GO:0005886","GO:0005524; GO:0004699; GO:0008047; GO:0019899; GO:0043560; GO:0019900; GO:0046872; GO:0004715; GO:0004672; GO:0019901; GO:0004697; GO:0004674","GO:0032147; GO:0006915; GO:0042100; GO:0060326; GO:0007049; GO:1904385; GO:0070301; GO:0071447; GO:0090398; GO:0042742; GO:0038096; GO:0016572; GO:0016064; GO:0060333; GO:0032613; GO:0032615; GO:0008631; GO:0030837; GO:0051490; GO:0034351; GO:0050728; GO:0046627; GO:0043407; GO:0050732; GO:0090331; GO:0032091; GO:0042119; GO:0043312; GO:0018105; GO:0018107; GO:0030168; GO:2001235; GO:2000304; GO:0032079; GO:2000753; GO:1900163; GO:0035307; GO:0042307; GO:2001022; GO:2000755; GO:0032930; GO:0006468; GO:0050821; GO:0032956; GO:0043488; GO:0010469; GO:0007165; GO:0002223; GO:0023021"]
[1962,983,"PK080","PKCd (PRKCD)","S664","Protein-serine kinase C delta",0,102,8,317,{"v":29.798,"d":"30"},{"v":52.35946332619999,"d":"52"},{"$nulls":3},0,150,8,235,{"v":33.37,"d":"33"},{"v":58.304567887,"d":"58"},{"$nulls":6},0,128,10,271,{"v":31.978,"d":"32"},{"v":54.7092862892,"d":"55"},{"$nulls":7},"PKCd","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Delta",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S664 phosphosite.","The effect of S664 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in PKCd (≥128 reports from high throughput mass spectrometry studies).",null,null,"Q05655","Q05655","Q05655","Q05655"]
[1963,984,"PK081-1","PKCe (PRKCE)","S729","Protein-serine kinase C epsilon",0,1022,12,279,{"v":281.79,"d":"282"},{"v":495.14642495100003,"d":"495"},{"$f":"(L1976+L1977)/2","v":{"v":521.2136992125,"d":"521"}},{"$f":"SQRT((M1976-L1976)*(M1976-L1976))","v":{"v":26.067274261500017,"d":"26"}},{"$f":"N1976/M1976*100","v":{"v":5.001264222503163,"d":"5"}},0,1130,12,257,{"v":287.326,"d":"287"},{"v":502.02032582260006,"d":"502"},{"$f":"(U1976+U1977)/2","v":{"v":494.92313808640006,"d":"495"}},{"$f":"SQRT((V1976-U1976)*(V1976-U1976))","v":{"v":7.097187736199999,"d":"7"}},{"$f":"W1976/V1976*100","v":{"v":1.4339979665612286,"d":"1"}},{"$f":"X1976+O1976","v":{"v":6.435262189064392,"d":"6"}},{"$f":"(V1976/M1976*100)-100","v":{"v":-5.044104014499666,"d":"-5"}},null,0,990,12,286,{"v":279.708,"d":"280"},{"v":478.5360263112001,"d":"479"},{"$f":"(AG1976+AG1977)/2","v":{"v":426.3793153908,"d":"426"}},{"$f":"SQRT((AH1976-AG1976)*(AH1976-AG1976))","v":{"v":52.15671092040009,"d":"52"}},{"$f":"AI1976/AH1976*100","v":{"v":12.23246743866916,"d":"12"}},{"$f":"AJ1976+O1976","v":{"v":17.23373166117232,"d":"17"}},{"$f":"(AH1976/M1976*100)-100","v":{"v":-18.19491390287419,"d":"-18"}},null,null,"PKCe","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Eta",{"$nulls":5},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S729 phosphosite.","S729 phosphorylation stimulates phosphotransferase activity. This is one of the major in vivo phosphorylation sites in PKCe (≥23 reports from high throughput mass spectrometry studies).","PKCe (PRKCE)","Protein-serine kinase, AGC group, PKC family, Eta subfamily","Q02156","Q02156","Q02156",null,"GO:0071944; GO:0005737; GO:0005856; GO:0005829; GO:0005783; GO:0005794; GO:0005739; GO:0005634; GO:0048471; GO:0005886","GO:0071889; GO:0003785; GO:0005524; GO:0004699; GO:0008047; GO:0019899; GO:0035276; GO:0046872; GO:0004697; GO:0004674; GO:0030546","GO:0006915; GO:0007155; GO:0007049; GO:0051301; GO:0071361; GO:0071456; GO:0071380; GO:0038096; GO:0035556; GO:0031663; GO:0035641; GO:0002281; GO:0031397; GO:2000650; GO:0018105; GO:0030168; GO:0030838; GO:0010811; GO:2001031; GO:0032467; GO:0010634; GO:0010763; GO:0043123; GO:0032024; GO:0050996; GO:0043410; GO:0070257; GO:1903078; GO:0032230; GO:0090303; GO:0006468; GO:0061178; GO:0050730; GO:0051279; GO:0051209; GO:0043278; GO:0007165; GO:0035669"]
[1967,986,"NK137-2","PKCg (PRKCG)","Pan-specific","Protein-serine kinase C gamma",0,805,12,566,{"v":448.838,"d":"449"},{"v":788.6743003022,"d":"789"},{"$f":"(L1980+L1981)/2","v":{"v":771.8320472657,"d":"772"}},{"$f":"SQRT((M1980-L1980)*(M1980-L1980))","v":{"v":16.842253036499983,"d":"17"}},{"$f":"N1980/M1980*100","v":{"v":2.1821137248920306,"d":"2"}},0,692,10,468,{"v":319.176,"d":"319"},{"v":557.6691267576,"d":"558"},{"$f":"(U1980+U1981)/2","v":{"v":571.3725347869,"d":"571"}},{"$f":"SQRT((V1980-U1980)*(V1980-U1980))","v":{"v":13.703408029300022,"d":"14"}},{"$f":"W1980/V1980*100","v":{"v":2.398331595411891,"d":"2"}},{"$f":"X1980+O1980","v":{"v":4.580445320303921,"d":"5"}},{"$f":"(V1980/M1980*100)-100","v":{"v":-25.97190842087342,"d":"-26"}},null,0,902,10,552,{"v":492.384,"d":"492"},{"v":842.3909318976,"d":"842"},{"$f":"(AG1980+AG1981)/2","v":{"v":799.8662580592,"d":"800"}},{"$f":"SQRT((AH1980-AG1980)*(AH1980-AG1980))","v":{"v":42.52467383839996,"d":"43"}},{"$f":"AI1980/AH1980*100","v":{"v":5.316473024075559,"d":"5"}},{"$f":"AJ1980+O1980","v":{"v":7.49858674896759,"d":"7"}},{"$f":"(AH1980/M1980*100)-100","v":{"v":3.632164651987992,"d":"4"}},null,null,"PKCg","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Alpha",{"$nulls":5},"Epitope undefined.",{"$nulls":3},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.13; AGC group; PKC family; Alpha subfamily","P05129","P05129","P05129",null,"GO:0044305; GO:0005911; GO:0005829; GO:0030425; GO:0005622; GO:0005634; GO:0048471; GO:0005886; GO:0099524; GO:0014069; GO:0099523; GO:0097060","GO:0005524; GO:0004698; GO:0004672; GO:0004697; GO:0004712; GO:0008270","GO:0007268; GO:0007635; GO:0060384; GO:0035556; GO:0007611; GO:0043524; GO:1901799; GO:0042177; GO:0031397; GO:0018105; GO:0016310; GO:0030168; GO:0032425; GO:0099171; GO:0046777; GO:0006468; GO:0042752; GO:0050764; GO:0032095; GO:2000300; GO:0043278; GO:0048265; GO:1990911; GO:0048511"]
[1974,989,"PK085","PKCh (PRKCeta)","T656","Protein-serine kinase C eta",0,6650,16,579,{"v":3841.086,"d":"3841"},{"v":6749.352357533399,"d":"6749"},{"$nulls":3},0,6074,14,479,{"v":2902.74,"d":"2903"},{"v":5071.711159374,"d":"5072"},{"$nulls":6},0,7396,14,597,{"v":4407.054,"d":"4407"},{"v":7539.7704352356,"d":"7540"},{"$nulls":7},"PKCh","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Eta",{"$nulls":5},"Not precisely defined.","Antibody raised against amino acid residues that encompass the T655 phosphosite.","The effect of T656 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in PKCh (≥14 reports from high throughput mass spectrometry studies).","PKCg (PRKCG)",null,"P24723","P24723","P24723"]
[1979,992,"NK140","PKCt (PRKCQ)","Pan-specific","Protein-serine kinase C theta",0,39,10,652,{"v":18.908,"d":"19"},{"v":33.2241335852,"d":"33"},{"$f":"(L1992+L1993)/2","v":{"v":64.4960769645,"d":"64"}},{"$f":"SQRT((M1992-L1992)*(M1992-L1992))","v":{"v":31.271943379300005,"d":"31"}},{"$f":"N1992/M1992*100","v":{"v":48.48658220950824,"d":"48"}},0,29,4,655,{"v":16.375,"d":"16"},{"v":28.6106472625,"d":"29"},{"$f":"(U1992+U1993)/2","v":{"v":43.96255273865,"d":"44"}},{"$f":"SQRT((V1992-U1992)*(V1992-U1992))","v":{"v":15.351905476149998,"d":"15"}},{"$f":"W1992/V1992*100","v":{"v":34.92041412475408,"d":"35"}},{"$f":"X1992+O1992","v":{"v":83.40699633426232,"d":"83"}},{"$f":"(V1992/M1992*100)-100","v":{"v":-31.836857669889113,"d":"-32"}},null,0,36,8,653,{"v":18.284,"d":"18"},{"v":31.2810241576,"d":"31"},{"$f":"(AG1992+AG1993)/2","v":{"v":60.635640898800006,"d":"61"}},{"$f":"SQRT((AH1992-AG1992)*(AH1992-AG1992))","v":{"v":29.354616741200005,"d":"29"}},{"$f":"AI1992/AH1992*100","v":{"v":48.4114891936121,"d":"48"}},{"$f":"AJ1992+O1992","v":{"v":96.89807140312034,"d":"97"}},{"$f":"(AH1992/M1992*100)-100","v":{"v":-5.985536248700612,"d":"-6"}},null,null,"PKCt","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Delta",{"$nulls":5},"Epitope undefined.",{"$nulls":3},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.13; AGC domain target; AGC</A> group; PKC family; Delta subfamily","Q04759","Q04759","Q04759",null,"GO:0016235; GO:0005829; GO:0001772; GO:0005622; GO:0005815; GO:0005886","GO:0005524; GO:0046872; GO:0004672; GO:0004697; GO:0004674","GO:0007411; GO:0060326; GO:0038095; GO:0006954; GO:0035556; GO:0006509; GO:0046627; GO:0070233; GO:0018105; GO:0030168; GO:0032740; GO:0045086; GO:0032753; GO:0051092; GO:0050870; GO:0042102; GO:0051973; GO:1904355; GO:0032212; GO:2000318; GO:2000570; GO:0001558; GO:0045652; GO:0090330; GO:0006355; GO:0050852"]
[1980,992,"NK140","PKCt (PRKCQ)","Pan-specific","Protein-serine kinase C theta",0,246,8,229,{"v":54.502,"d":"55"},{"v":95.7680203438,"d":"96"},{"$nulls":3},0,172,8,207,{"v":33.948,"d":"34"},{"v":59.3144582148,"d":"59"},{"$nulls":6},0,208,8,263,{"v":52.6,"d":"53"},{"v":89.99025764000001,"d":"90"},{"$nulls":7},"PKCt","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Delta",{"$nulls":5},"Epitope undefined.",{"$nulls":4},"Q04759","Q04759","Q04759"]
[1985,995,"PK089-1","PKCt (PRKCQ)","S676","Protein-serine kinase C theta",0,96,8,650,{"$f":"(H1998-I1998)*J1998/1000","v":{"v":57.2,"d":"57"}},{"v":100.50880268,"d":"101"},{"$f":"(L1998+L1999)/2","v":{"v":469.2706797016,"d":"469"}},{"$f":"SQRT((M1998-L1998)*(M1998-L1998))","v":{"v":368.76187702159996,"d":"369"}},{"$f":"N1998/M1998*100","v":{"v":78.58191294970493,"d":"79"}},0,1324,10,307,{"$f":"(Q1998-R1998)*S1998/1000","v":{"v":403.398,"d":"403"}},{"v":704.8230769098001,"d":"705"},{"$f":"(U1998+U1999)/2","v":{"v":683.2903980174001,"d":"683"}},{"$f":"SQRT((V1998-U1998)*(V1998-U1998))","v":{"v":21.532678892399986,"d":"22"}},{"$f":"W1998/V1998*100","v":{"v":3.151321744733731,"d":"3"}},{"$f":"X1998+O1998","v":{"v":81.73323469443866,"d":"82"}},{"$f":"(V1998/M1998*100)-100","v":{"v":45.60688054320613,"d":"46"}},null,0,1020,10,351,{"$f":"(AC1998-AD1998)*AE1998/1000","v":{"v":354.51,"d":"355"}},{"v":606.510384714,"d":"607"},{"$f":"(AG1998+AG1999)/2","v":{"v":701.4826125108,"d":"701"}},{"$f":"SQRT((AH1998-AG1998)*(AH1998-AG1998))","v":{"v":94.97222779679998,"d":"95"}},{"$f":"AI1998/AH1998*100","v":{"v":13.538785723692873,"d":"14"}},{"$f":"AJ1998+O1998","v":{"v":92.1206986733978,"d":"92"}},{"$f":"(AH1998/M1998*100)-100","v":{"v":49.483580128393925,"d":"49"}},null,null,"PKCt","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Delta",{"$nulls":5},"RL(pS)FA","Corresponds to amino acid residues R674 to A678.","S676 phosphorylation stimulates phosphotransferase activity. This is one of the major in vivo phosphorylation sites in PKCt (≥25 reports from high throughput mass spectrometry studies).","PKCt (PRKCQ; PKCq)","Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.13; AGC domain target; AGC</A> group; PKC family; Delta subfamily","Q04759","Q04759","Q04759",null,"GO:0016235; GO:0005829; GO:0001772; GO:0005622; GO:0005815; GO:0005886","GO:0005524; GO:0046872; GO:0004672; GO:0004697; GO:0004674","GO:0007411; GO:0060326; GO:0038095; GO:0006954; GO:0035556; GO:0006509; GO:0046627; GO:0070233; GO:0018105; GO:0030168; GO:0032740; GO:0045086; GO:0032753; GO:0051092; GO:0050870; GO:0042102; GO:0051973; GO:1904355; GO:0032212; GO:2000318; GO:2000570; GO:0001558; GO:0045652; GO:0090330; GO:0006355; GO:0050852"]
[1990,997,"PK774","PKCz (PRKCZ)","S262+Y263","Protein-serine kinase C zeta",0,6759,14,836,{"v":5638.82,"d":"5639"},{"v":9908.235082657999,"d":"9908"},{"$nulls":3},0,8150,14,704,{"v":5727.744,"d":"5728"},{"v":10007.600805734399,"d":"10008"},{"$nulls":6},0,7514,14,794,5955,{"$f":"AF2003*1.7108414","v":{"v":10188.060537000001,"d":"10188"}},{"$nulls":7},"PKCz","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Iota",{"$nulls":5},"IGRG(pS)(pY)AKVL(bA)C","Corresponds to amino acid residues I258 to L267; In the kinase catalytic subdomain I region.","S262 and Y263 phosphorylation is predicted to be inhibitory for phosphotransferase activity. These phosphosites are located in the kinase subdomain I region, which is involved in binding the phosphates in the ATP substrate. Phosphorylation of S262 induces interaction with 14-3-3 proteins. These are minor in vivo phosphorylation sites in PKCz (≥1 and ≥0 reports, respectively, from high throughput mass spectrometry studies).",null,null,"Q05513","Q05513","Q05513"]
[1996,1000,"NK142","PKD1 (PRKCM, PKCm, PRKD1)","Pan-specific","Protein-serine kinase C mu (Protein kinase D)",0,357,18,557,{"v":188.823,"d":"189"},{"v":331.7897490987,"d":"332"},{"$nulls":3},0,253,12,479,{"v":115.439,"d":"115"},{"v":201.6967639289,"d":"202"},{"$nulls":6},0,314,14,489,{"v":146.7,"d":"147"},{"v":250.98043338,"d":"251"},{"$nulls":7},"PKD1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","PKD",{"$nulls":6},"Epitope undefined.",{"$nulls":4},"Q15139","Q15139","Q15139","Q15139"]
[1997,1001,"PK770","PKD1 (PRKCM, PKCm, PRKD1)","S205","Protein-serine kinase C mu (Protein kinase D)",0,5189,18,657,{"v":3397.347,"d":"3397"},{"v":5969.6377492743,"d":"5970"},{"$f":"(L2010+L2011)/2","v":{"v":6455.90091807235,"d":"6456"}},{"$f":"SQRT((M2010-L2010)*(M2010-L2010))","v":{"v":486.26316879804926,"d":"486"}},{"$f":"N2010/M2010*100","v":{"v":7.53207298205006,"d":"8"}},0,5098,18,587,{"v":2981.96,"d":"2982"},{"v":5210.125539596,"d":"5210"},{"$f":"(U2010+U2011)/2","v":{"v":5388.1929665125,"d":"5388"}},{"$f":"SQRT((V2010-U2010)*(V2010-U2010))","v":{"v":178.06742691650015,"d":"178"}},{"$f":"W2010/V2010*100","v":{"v":3.304770783511008,"d":"3"}},{"$f":"X2010+O2010","v":{"v":10.836843765561069,"d":"11"}},{"$f":"(V2010/M2010*100)-100","v":{"v":-16.538481075057348,"d":"-17"}},null,0,5139,18,670,{"v":3431.07,"d":"3431"},{"v":5870.016602298,"d":"5870"},{"$f":"(AG2010+AG2011)/2","v":{"v":5788.8765272202,"d":"5789"}},{"$f":"SQRT((AH2010-AG2010)*(AH2010-AG2010))","v":{"v":81.14007507780025,"d":"81"}},{"$f":"AI2010/AH2010*100","v":{"v":1.401654961826651,"d":"1"}},{"$f":"AJ2010+O2010","v":{"v":8.933727943876711,"d":"9"}},{"$f":"(AH2010/M2010*100)-100","v":{"v":-10.332010966663262,"d":"-10"}},null,null,"PKD1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","PKD",{"$nulls":6},"RRL(pS)NVS(bA)C","Corresponds to amino acid residues R202 to S208; In the region between the two C1_1 domains in the N-terminal quarter of the protein kinase.","S205 phosphorylation inhibits phosphotransferase activity and induces binding to 14-3-3-beta. This is one of the major in vivo phosphorylation sites in PKD1 (≥112 reports from high throughput mass spectrometry studies).","p38d MAPK (MAPK13); PKD1 (PRKCM; PRKD1)","EC 2.7.11.13; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; PKD family","Q15139","Q15139","Q15139","Q15139","GO:0000421; GO:0005829; GO:0005794; GO:0005886; GO:0005802","GO:0005524; GO:0042802; GO:0016301; GO:0046872; GO:0004697; GO:0004674","GO:0001525; GO:0006915; GO:0008283; GO:0034198; GO:0071447; GO:0034599; GO:0035924; GO:0007030; GO:0048193; GO:0006954; GO:0045087; GO:0007229; GO:0035556; GO:0060548; GO:0045806; GO:0018105; GO:0018107; GO:0045766; GO:0010508; GO:0043536; GO:0032793; GO:2001028; GO:0038033; GO:0010595; GO:0001938; GO:1901727; GO:0043123; GO:0010976; GO:0051092; GO:0045669; GO:0033138; GO:0043552; GO:0045944; GO:0046777; GO:0089700; GO:0006468; GO:0007265; GO:2001044; GO:0010837; GO:0031647; GO:0007165; GO:0030148; GO:0048010"]
[2002,1003,"PK092","PKD1 (PRKCM, PKCm, PRKD1)","S738+S742","Protein-serine kinase C mu (Protein kinase D)",0,102,6,298,{"v":28.608,"d":"29"},{"v":50.2684585152,"d":"50"},{"$nulls":3},0,138,8,191,{"v":24.83,"d":"25"},{"v":43.383350932999996,"d":"43"},{"$nulls":6},0,184,8,211,{"v":37.136,"d":"37"},{"v":63.53380623040001,"d":"64"},{"$nulls":7},"PKD1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","PKD",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S738 phosphosite.","S738 and S742 phosphorylation stimulate phosphotransferase activity and induces interaction with ASK1, IKKB, JNK1 and PKCD. These are two of the major in vivo phosphorylation sites in PKD1.","S378: PKCa (PRKCA); PKCd (PRKCD); PKCe (PRKCE); PKCh (PRKCH); PKCz (PRKCZ); PKD1 (PRKCM; PRKD1); PKD3 (PRKCN). S742: p38d MAPK (MAPK13); PKCa (PRKCA); PKCd (PRKCD); PKCe (PRKCE); PKCh (PRKCH); PKCz (PRKCZ); PKD1 (PRKCM; PRKD1); PKD3 (PRKCN).",null,"Q15139","Q15139","Q15139","Q15139"]
[2007,1006,"NK139-2","PKD3 (PRKCN)","Pan-specific","Protein-serine kinase C nu; Serine/threonine-protein kinase D3",0,952,18,980,{"v":915.32,"d":"915"},{"v":1608.351700508,"d":"1608"},{"$f":"(L2020+L2021)/2","v":{"v":1463.5241387162,"d":"1464"}},{"$f":"SQRT((M2020-L2020)*(M2020-L2020))","v":{"v":144.8275617918,"d":"145"}},{"$f":"N2020/M2020*100","v":{"v":9.895809570919848,"d":"10"}},0,2072,14,778,{"v":1601.124,"d":"1601"},{"v":2797.5080297724003,"d":"2798"},{"$f":"(U2020+U2021)/2","v":{"v":2496.9555827006,"d":"2497"}},{"$f":"SQRT((V2020-U2020)*(V2020-U2020))","v":{"v":300.5524470718001,"d":"301"}},{"$f":"W2020/V2020*100","v":{"v":12.036755845962443,"d":"12"}},{"$f":"X2020+O2020","v":{"v":21.93256541688229,"d":"22"}},{"$f":"(V2020/M2020*100)-100","v":{"v":70.61253153575751,"d":"71"}},null,0,2182,18,829,{"v":1793.956,"d":"1794"},{"v":3069.1741945784,"d":"3069"},{"$f":"(AG2020+AG2021)/2","v":{"v":2418.5634510966,"d":"2419"}},{"$f":"SQRT((AH2020-AG2020)*(AH2020-AG2020))","v":{"v":650.6107434818,"d":"651"}},{"$f":"AI2020/AH2020*100","v":{"v":26.90071013794601,"d":"27"}},{"$f":"AJ2020+O2020","v":{"v":36.79651970886586,"d":"37"}},{"$f":"(AH2020/M2020*100)-100","v":{"v":65.25613668512216,"d":"65"}},null,null,"PKD3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","PKD",{"$nulls":6},"TDTMVYFVGENNGDSSHNGC","Corresponds to amino acid residues T490 to N507; Just before kinase catalytic domain.",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.13; CAMK group; PKD family","O94806","O94806","O94806",null,"GO:0005829; GO:0016020; GO:0005654","GO:0005524; GO:0016301; GO:0046872; GO:0004697; GO:0004674","GO:0007205; GO:0089700; GO:0006468; GO:0030148"]
[2013,975,"PK776","PKG1a (PRKG1A)","T515+T517","cGMP-dependent protein kinase 1, alpha isozyme",0,3546,14,573,{"v":2023.836,"d":"2024"},{"v":3556.1771535084,"d":"3556"},{"$f":"(L2026+L2027)/2","v":{"v":5358.3070141484,"d":"5358"}},{"$f":"SQRT((M2026-L2026)*(M2026-L2026))","v":{"v":1802.1298606400005,"d":"1802"}},{"$f":"N2026/M2026*100","v":{"v":33.63244875445821,"d":"34"}},0,3670,14,524,{"v":1915.744,"d":"1916"},{"v":3347.2168445344,"d":"3347"},{"$f":"(U2026+U2027)/2","v":{"v":3531.4746545502,"d":"3531"}},{"$f":"SQRT((V2026-U2026)*(V2026-U2026))","v":{"v":184.2578100157998,"d":"184"}},{"$f":"W2026/V2026*100","v":{"v":5.217588345944636,"d":"5"}},{"$f":"X2026+O2026","v":{"v":38.850037100402844,"d":"39"}},{"$f":"(V2026/M2026*100)-100","v":{"v":-34.09346188590018,"d":"-34"}},null,0,4022,14,604,{"v":2420.832,"d":"2421"},{"v":4141.6596080448,"d":"4142"},{"$f":"(AG2026+AG2027)/2","v":{"v":4494.286261523001,"d":"4494"}},{"$f":"SQRT((AH2026-AG2026)*(AH2026-AG2026))","v":{"v":352.62665347820075,"d":"353"}},{"$f":"AI2026/AH2026*100","v":{"v":7.846110215478452,"d":"8"}},{"$f":"AJ2026+O2026","v":{"v":41.478558969936664,"d":"41"}},{"$f":"(AH2026/M2026*100)-100","v":{"v":-16.12488329511517,"d":"-16"}},null,null,"PKG1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKG",{"$nulls":6},"FGKK(pT)W(pT)FCG(bA)C","Corresponds to amino acid residues F511 to G521; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T515 and T517 phosphorylation stimulates phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major in vivo phosphorylation sites in PKG1a (≥4 and ≥13 reports, respectively, from high throughput mass spectrometry studies).","T517: PKG1 (PRKG1).","Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.12","Q13976","Q13976","Q13976",null,"GO:0005737; GO:0005829; GO:0005794; GO:0005886","GO:0005524; GO:0005246; GO:0030553; GO:0004692; GO:0042802; GO:0004672; GO:0004674","GO:0030036; GO:0019934; GO:0016358; GO:0030900; GO:0090331; GO:1904753; GO:1904706; GO:0001764; GO:0006468; GO:0043087; GO:0060087; GO:0007165"]
[2014,975,"PK776","PKG1a (PRKG1A)","T515+T517","cGMP-dependent protein kinase 1, alpha isozyme",0,4926,34,833,{"v":4075.036,"d":"4075"},{"v":7160.4368747884,"d":"7160"},{"$nulls":3},0,3782,18,565,{"v":2126.66,"d":"2127"},{"v":3715.7324645659996,"d":"3716"},{"$nulls":6},0,4426,20,643,{"v":2833.058,"d":"2833"},{"v":4846.9129150012,"d":"4847"},{"$nulls":7},"PKG1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKG",{"$nulls":6},"FGKK(pT)W(pT)FCG(bA)C","Corresponds to amino acid residues F511 to G521; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T515 and T517 phosphorylation stimulates phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major in vivo phosphorylation sites in PKG1a (≥4 and ≥13 reports, respectively, from high throughput mass spectrometry studies).","T517: PKG1 (PRKG1).",null,"Q13976","Q13976","Q13976"]
[2019,1011,"NN115-2","PKM2","Pan-specific","Pyruvate kinase isozymes M1/M2",0,237,12,545,{"v":122.625,"d":"123"},{"v":215.4701386125,"d":"215"},{"$f":"(L2032+L2033)/2","v":{"v":234.90330475305,"d":"235"}},{"$f":"SQRT((M2032-L2032)*(M2032-L2032))","v":{"v":19.433166140550014,"d":"19"}},{"$f":"N2032/M2032*100","v":{"v":8.272836417086504,"d":"8"}},0,198,12,499,{"v":92.814,"d":"93"},{"v":162.1660222914,"d":"162"},{"$f":"(U2032+U2033)/2","v":{"v":146.6874437205,"d":"147"}},{"$f":"SQRT((V2032-U2032)*(V2032-U2032))","v":{"v":15.478578570899998,"d":"15"}},{"$f":"W2032/V2032*100","v":{"v":10.552081472217258,"d":"11"}},{"$f":"X2032+O2032","v":{"v":18.824917889303762,"d":"19"}},{"$f":"(V2032/M2032*100)-100","v":{"v":-37.554116629091226,"d":"-38"}},null,0,310,12,598,{"v":178.204,"d":"178"},{"v":304.87878084560003,"d":"305"},{"$f":"(AG2032+AG2033)/2","v":{"v":223.03897163520003,"d":"223"}},{"$f":"SQRT((AH2032-AG2032)*(AH2032-AG2032))","v":{"v":81.8398092104,"d":"82"}},{"$f":"AI2032/AH2032*100","v":{"v":36.69305351006382,"d":"37"}},{"$f":"AJ2032+O2032","v":{"v":44.96588992715032,"d":"45"}},{"$f":"(AH2032/M2032*100)-100","v":{"v":-5.050730610334654,"d":"-5"}},{"$nulls":14},"X","Epitope undefined.",{"$nulls":3},"Nucleotide Metabolism - purine; Mitochondrial; Carbohydrate Metabolism - glycolysis and gluconeogenesis; Kinase (non-protein); Carbohydrate Metabolism - pyruvate; EC 2.7.1.40","P14618","P14618","P14618","P14618","GO:0005929; GO:0005737; GO:0005829; GO:0070062; GO:0031012; GO:0005576; GO:1903561; GO:1904813; GO:0005739; GO:0043209; GO:0005634; GO:0001917; GO:1902912; GO:0034774; GO:0031982","GO:0043531; GO:0005524; GO:0045296; GO:0042802; GO:0016301; GO:0000287; GO:0023026; GO:0030955; GO:0004743; GO:0003723; GO:0070324","GO:0031100; GO:0061621; GO:0032869; GO:0001889; GO:0043312; GO:0012501; GO:0051289; GO:0009629; GO:0001666; GO:0014870; GO:0007584; GO:0043403"]
[2024,1013,"PN718","PKM2","S37","Pyruvate kinase isozymes M1/M2",0,4774,30,831,{"v":3942.264,"d":"3942"},{"v":6927.1369665816,"d":"6927"},{"$nulls":3},0,4774,16,633,{"v":3011.814,"d":"3012"},{"v":5262.2868991914,"d":"5262"},{"$nulls":6},0,4814,14,636,{"v":3052.8,"d":"3053"},{"v":5222.856625920001,"d":"5223"},{"$nulls":19},"X","DID(pS)API(bA)C","Corresponds to amino acid residues D34 to I40.","S37 phosphorylation stimulates enzyme activity, induces interaction with ERK1 and ERK2, and inhibit interaction with CTNNB1. This is one of the major in vivo phosphorylation sites in PKM2 (≥62 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in the fruit fly.","Akt1",null,"P14618","P14618","P14618","P14618"]
[2029,1017,"NK144-1","PKR1 (PRKR; EIF2AK2)","Pan-specific","Double stranded RNA dependent protein-serine kinase",0,84,10,470,{"v":34.78,"d":"35"},{"v":61.113569182,"d":"61"},{"$f":"(L2042+L2043)/2","v":{"v":60.076852511,"d":"60"}},{"$f":"SQRT((M2042-L2042)*(M2042-L2042))","v":{"v":1.0367166710000006,"d":"1"}},{"$f":"N2042/M2042*100","v":{"v":1.725650775080434,"d":"2"}},0,88,10,466,{"v":36.348,"d":"36"},{"v":63.5077744548,"d":"64"},{"$f":"(U2042+U2043)/2","v":{"v":61.190967232199995,"d":"61"}},{"$f":"SQRT((V2042-U2042)*(V2042-U2042))","v":{"v":2.316807222600005,"d":"2"}},{"$f":"W2042/V2042*100","v":{"v":3.786191536748338,"d":"4"}},{"$f":"X2042+O2042","v":{"v":5.511842311828772,"d":"6"}},{"$f":"(V2042/M2042*100)-100","v":{"v":1.8544825080441854,"d":"2"}},null,0,136,14,395,{"v":48.19,"d":"48"},{"v":82.445447066,"d":"82"},{"$f":"(AG2042+AG2043)/2","v":{"v":78.77398142160001,"d":"79"}},{"$f":"SQRT((AH2042-AG2042)*(AH2042-AG2042))","v":{"v":3.671465644399987,"d":"4"}},{"$f":"AI2042/AH2042*100","v":{"v":4.6607592737381465,"d":"5"}},{"$f":"AJ2042+O2042","v":{"v":6.386410048818581,"d":"6"}},{"$f":"(AH2042/M2042*100)-100","v":{"v":31.122018097030946,"d":"31"}},null,null,"PKR","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","PEK",{"$nulls":6},"Epitope undefined.",{"$nulls":3},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; PEK family","P19525","P19525","P19525","P19525","GO:0005737; GO:0005829; GO:0016020; GO:0005634; GO:0048471; GO:0005840","GO:0005524; GO:0003725; GO:0004694; GO:0042802; GO:0004715; GO:0004672; GO:0019888; GO:0004674; GO:0003723","GO:0000186; GO:0034198; GO:0051607; GO:0030968; GO:0030683; GO:0045087; GO:0043066; GO:0008285; GO:0033689; GO:0017148; GO:0045071; GO:0032722; GO:0001819; GO:0051092; GO:1901224; GO:0032874; GO:0046777; GO:0006468; GO:1901532; GO:1902036; GO:1902033; GO:1900225; GO:0035455; GO:0009636; GO:0009615; GO:0006351; GO:0006412"]
[2031,1018,"PK132","PKR1 (PRKR; EIF2AK2)","T446","Double-stranded RNA-dependent protein-serine kinase; Interferon-induced, double-stranded RNA-activated protein kinase",0,2152,14,334,{"v":714.092,"d":"714"},{"v":1254.7645441148,"d":"1255"},{"$f":"(L2044+L2045)/2","v":{"v":1076.9992636825,"d":"1077"}},{"$f":"SQRT((M2044-L2044)*(M2044-L2044))","v":{"v":177.76528043229996,"d":"178"}},{"$f":"N2044/M2044*100","v":{"v":16.50560835338744,"d":"17"}},0,141,12,407,{"v":52.503,"d":"53"},{"v":91.7340343953,"d":"92"},{"$f":"(U2044+U2045)/2","v":{"v":462.12004819145,"d":"462"}},{"$f":"SQRT((V2044-U2044)*(V2044-U2044))","v":{"v":370.38601379615,"d":"370"}},{"$f":"W2044/V2044*100","v":{"v":80.14930649420864,"d":"80"}},{"$f":"X2044+O2044","v":{"v":96.65491484759609,"d":"97"}},{"$f":"(V2044/M2044*100)-100","v":{"v":-57.09188819578587,"d":"-57"}},null,0,2267,18,246,{"v":553.254,"d":"553"},{"v":946.5298479156,"d":"947"},{"$f":"(AG2044+AG2045)/2","v":{"v":977.9836670546001,"d":"978"}},{"$f":"SQRT((AH2044-AG2044)*(AH2044-AG2044))","v":{"v":31.453819139000075,"d":"31"}},{"$f":"AI2044/AH2044*100","v":{"v":3.2161906377976384,"d":"3"}},{"$f":"AJ2044+O2044","v":{"v":19.72179899118508,"d":"20"}},{"$f":"(AH2044/M2044*100)-100","v":{"v":-9.19365499743644,"d":"-9"}},null,null,"PKR","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","PEK",{"$nulls":6},"KR(pT)RS","Corresponds to amino acid residues K444 to S448; Surrounds the T446 phosphosite.","T446 phosphorylation stimulates phosphotransferase activity. Phosphorylation regulates cell cycle progression and cell growth. This is a minor in vivo phosphorylation sites in PKR1 (≥1 report from high throughput mass spectrometry studies).","PKR (EIF2AK2)","EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; PEK family","P19525","P19525","P19525","P19525","GO:0005737; GO:0005829; GO:0016020; GO:0005634; GO:0048471; GO:0005840","GO:0005524; GO:0003725; GO:0004694; GO:0042802; GO:0004715; GO:0004672; GO:0019888; GO:0004674; GO:0003723","GO:0000186; GO:0034198; GO:0051607; GO:0030968; GO:0030683; GO:0045087; GO:0043066; GO:0008285; GO:0033689; GO:0017148; GO:0045071; GO:0032722; GO:0001819; GO:0051092; GO:1901224; GO:0032874; GO:0046777; GO:0006468; GO:1901532; GO:1902036; GO:1902033; GO:1900225; GO:0035455; GO:0009636; GO:0009615; GO:0006351; GO:0006412"]
[2036,1020,"PN719","PLCB3","S1105","1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta-3",0,2021,18,595,{"v":1191.785,"d":"1192"},{"v":2094.1413182165,"d":"2094"},{"$nulls":3},0,2098,21,629,{"v":1306.433,"d":"1306"},{"v":2282.6194647383,"d":"2283"},{"$nulls":6},0,2294,16,528,{"v":1202.784,"d":"1203"},{"v":2057.7726624576003,"d":"2058"},{"$nulls":10},"Phospholipase",{"$nulls":8},"X","RHN(pS)ISEAC","Corresponds to amino acid residues R1102 to A1109.","S1105 phosphorylation inhibits enzyme activity. This is the major in vivo phosphorylation site in PLCB3 (≥232 reports from high throughput mass spectrometry studies). This human phosphosite is conserved in mammals and also found in the rat.","PKACa (PRKACA); PKCa (PRKCA); PKCb1 (PRKCB1); PKCd (PRKCD); PKCe (PRKCE); PKG1 (PRKG1); PKG2 (PRKG2)",null,"Q01970","Q01970",null,"Q01970"]
[2041,1023,"NN144-2","PLCG1","Pan-specific","1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1",0,670,10,456,{"v":300.96,"d":"301"},{"v":528.8309310239999,"d":"529"},{"$f":"(L2054+L2055)/2","v":{"v":640.3465018856,"d":"640"}},{"$f":"SQRT((M2054-L2054)*(M2054-L2054))","v":{"v":111.51557086160005,"d":"112"}},{"$f":"N2054/M2054*100","v":{"v":17.414879371281813,"d":"17"}},0,840,14,545,{"v":450.17,"d":"450"},{"v":786.543821567,"d":"787"},{"$f":"(U2054+U2055)/2","v":{"v":916.5741901316501,"d":"917"}},{"$f":"SQRT((V2054-U2054)*(V2054-U2054))","v":{"v":130.03036856465008,"d":"130"}},{"$f":"W2054/V2054*100","v":{"v":14.186562306099134,"d":"14"}},{"$f":"X2054+O2054","v":{"v":31.601441677380947,"d":"32"}},{"$f":"(V2054/M2054*100)-100","v":{"v":43.13722140007866,"d":"43"}},null,0,919,14,547,{"v":495.035,"d":"495"},{"v":846.926372449,"d":"847"},{"$f":"(AG2054+AG2055)/2","v":{"v":819.2500911212001,"d":"819"}},{"$f":"SQRT((AH2054-AG2054)*(AH2054-AG2054))","v":{"v":27.676281327799984,"d":"28"}},{"$f":"AI2054/AH2054*100","v":{"v":3.378245742996878,"d":"3"}},{"$f":"AJ2054+O2054","v":{"v":20.79312511427869,"d":"21"}},{"$f":"(AH2054/M2054*100)-100","v":{"v":27.93855962495158,"d":"28"}},{"$nulls":5},"Phospholipase",{"$nulls":8},"X","Epitope undefined.",{"$nulls":3},"EC 3.1.4.11; Phospholipase; Carbohydrate Metabolism - inositol phosphate","P19174","P19174",null,null,"GO:0005911; GO:0042995; GO:0008180; GO:0005737; GO:0005829; GO:0098978; GO:0030027; GO:0005886; GO:0001726; GO:0098685","GO:0005509; GO:0035254; GO:0005168; GO:0004435; GO:0004629; GO:0019901; GO:0030971","GO:0007202; GO:0007411; GO:0019722; GO:0016477; GO:0071364; GO:0007173; GO:0038095; GO:0038096; GO:0043647; GO:0001701; GO:0050900; GO:0050804; GO:0009395; GO:0045766; GO:0043536; GO:2000353; GO:0010634; GO:0010863; GO:0051281; GO:1905564; GO:0007165; GO:0050852; GO:0016032"]
[2046,1025,"PN144","PLCG1","Y783","1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2",0,506,12,308,{"v":152.152,"d":"152"},{"v":267.35341512879995,"d":"267"},{"$nulls":3},0,540,14,272,{"v":143.072,"d":"143"},{"v":249.9775587872,"d":"250"},{"$nulls":6},0,582,12,296,{"v":168.72,"d":"169"},{"v":288.653161008,"d":"289"},{"$nulls":10},"Phospholipase",{"$nulls":8},"X","GF(pY)VE","Corresponds to amino acid residues G347 to E351; Surrounds the Y349 phosphosite.","Y783 phosphorylation stimulates phospholipase activity, induces interaction with Grb2 and VEGFR-2 and regulates cell motility. This is one of the major sites of in vivo phosphorylation of PLCG1 (≥566 reports from high throughput mass spectrometry studies). ","EGFR; ITK; Ret; Src; Syk; TrkB (NTRK2); ZAP70",null,"P19174","P19174"]
[2047,1026,"PN530","PLCG1","Y783","1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2",0,7148,14,939,{"v":6698.826,"d":"6699"},{"v":11770.8213395394,"d":"11771"},{"$f":"(L2060+L2061)/2","v":{"v":9693.7700320723,"d":"9694"}},{"$f":"SQRT((M2060-L2060)*(M2060-L2060))","v":{"v":2077.0513074671,"d":"2077"}},{"$f":"N2060/M2060*100","v":{"v":21.426661666153382,"d":"21"}},0,9714,20,771,{"v":7474.074,"d":"7474"},{"v":13058.8149513174,"d":"13059"},{"$f":"(U2060+U2061)/2","v":{"v":14004.273227874699,"d":"14004"}},{"$f":"SQRT((V2060-U2060)*(V2060-U2060))","v":{"v":945.4582765572995,"d":"945"}},{"$f":"W2060/V2060*100","v":{"v":6.751212727522478,"d":"7"}},{"$f":"X2060+O2060","v":{"v":28.17787439367586,"d":"28"}},{"$f":"(V2060/M2060*100)-100","v":{"v":44.46673669316371,"d":"44"}},null,0,9850,16,794,{"v":7808.196,"d":"7808"},{"v":13358.5849761144,"d":"13359"},{"$f":"(AG2060+AG2061)/2","v":{"v":12816.580155546,"d":"12817"}},{"$f":"SQRT((AH2060-AG2060)*(AH2060-AG2060))","v":{"v":542.0048205683997,"d":"542"}},{"$f":"AI2060/AH2060*100","v":{"v":4.228934817170109,"d":"4"}},{"$f":"AJ2060+O2060","v":{"v":25.655596483323492,"d":"26"}},{"$f":"(AH2060/M2060*100)-100","v":{"v":32.2146091060726,"d":"32"}},{"$nulls":5},"Phospholipase",{"$nulls":8},"X","PGF(pY)VEA(bA)C","Corresponds to amino acid residues P780 to A786; In the intervening region between the second SH2 domain and the SH3 domain in PLCG1. ","Y783 phosphorylation stimulates phospholipase activity, induces interaction with Grb2 and VEGFR-2 and regulates cell motility. This is one of the major sites of in vivo phosphorylation of PLCG1 (≥566 reports from high throughput mass spectrometry studies). ","EGFR; ITK; Ret; Src; Syk; TrkB (NTRK2); ZAP70","EC 3.1.4.11; Phospholipase; Carbohydrate Metabolism - inositol phosphate","P19174","P19174",null,null,"GO:0005911; GO:0042995; GO:0008180; GO:0005737; GO:0005829; GO:0098978; GO:0030027; GO:0005886; GO:0001726; GO:0098685","GO:0005509; GO:0035254; GO:0005168; GO:0004435; GO:0004629; GO:0019901; GO:0030971","GO:0007202; GO:0007411; GO:0019722; GO:0016477; GO:0071364; GO:0007173; GO:0038095; GO:0038096; GO:0043647; GO:0001701; GO:0050900; GO:0050804; GO:0009395; GO:0045766; GO:0043536; GO:2000353; GO:0010634; GO:0010863; GO:0051281; GO:1905564; GO:0007165; GO:0050852; GO:0016032"]
[2054,1029,"PN723","PLCG2","Y753","1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2",0,6021,18,709,{"v":4256.127,"d":"4256"},{"v":7478.6403640563,"d":"7479"},{"$nulls":3},0,6776,20,598,{"v":4040.088,"d":"4040"},{"v":7058.902758928801,"d":"7059"},{"$nulls":6},0,7207,18,648,{"v":4658.472,"d":"4658"},{"$f":"AF2067*1.7108414","v":{"v":7969.9067583408,"d":"7970"}},{"$nulls":10},"Phospholipase",{"$nulls":8},"X","NSL(pY)DVS(bA)C","Corresponds to amino acid residues N750 to S756.","Y753 phosphorylation stimulates phospholipase activity, and regulates molecular association, including inducing interaction with Lyn. This is one of the major sites of in vivo phosphorylation of PLCG2 (≥276 reports from high throughput mass spectrometry studies). This human phosphosite is conserved in mammals and found in the rat.","Btk; Fyn; Lck; Src",null,"P16885","P16885",null,"P16885"]
[2058,1031,"NK145-2","Plk1 (PLK)","Pan-specific","Polo-like protein-serine kinase 1",0,11178,14,653,{"v":7290.092,"d":"7290"},{"v":12809.7625585148,"d":"12810"},{"$nulls":3},0,11444,16,543,{"v":6205.404,"d":"6205"},{"v":10842.1755704004,"d":"10842"},{"$nulls":6},0,12311,12,618,{"v":7600.782,"d":"7601"},{"v":13003.7325179748,"d":"13004"},{"$nulls":7},"PLK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","PLK",{"$nulls":6},"CAKEIPEVLVDPRSRRRYVR","Corresponds to amino acid residues A37 to R55; Just before kinase catalytic domain.",{"$nulls":3},"P53350","P53350","P53350","P53350"]
[2063,1034,"NK147-2","Plk3 (CNK)","Pan-specific","Polo-like protein-serine kinase 3 (cytokine- inducible kinase (CNK))",0,3116,14,582,{"v":1805.364,"d":"1805"},{"v":3172.2897559716,"d":"3172"},{"$f":"(L2076+L2077)/2","v":{"v":3292.1236602578,"d":"3292"}},{"$f":"SQRT((M2076-L2076)*(M2076-L2076))","v":{"v":119.83390428620032,"d":"120"}},{"$f":"N2076/M2076*100","v":{"v":3.6400183180487313,"d":"4"}},0,2766,12,556,{"v":1531.224,"d":"1531"},{"v":2675.3776942823997,"d":"2675"},{"$f":"(U2076+U2077)/2","v":{"v":4028.5267742359497,"d":"4029"}},{"$f":"SQRT((V2076-U2076)*(V2076-U2076))","v":{"v":1353.14907995355,"d":"1353"}},{"$f":"W2076/V2076*100","v":{"v":33.58917926541988,"d":"34"}},{"$f":"X2076+O2076","v":{"v":37.22919758346861,"d":"37"}},{"$f":"(V2076/M2076*100)-100","v":{"v":22.368634655737168,"d":"22"}},null,0,3190,12,571,{"v":1814.638,"d":"1815"},{"v":3104.5578164132,"d":"3105"},{"$f":"(AG2076+AG2077)/2","v":{"v":3355.9163457426002,"d":"3356"}},{"$f":"SQRT((AH2076-AG2076)*(AH2076-AG2076))","v":{"v":251.35852932940043,"d":"251"}},{"$f":"AI2076/AH2076*100","v":{"v":7.49001177124931,"d":"7"}},{"$f":"AJ2076+O2076","v":{"v":11.13003008929804,"d":"11"}},{"$f":"(AH2076/M2076*100)-100","v":{"v":1.937736612232996,"d":"2"}},null,null,"PLK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","PLK",{"$nulls":6},"KSKNHAQERDEVSGLVSGC","Corresponds to amino acid residues K357 to G374; After catalytic domain.",null,null,"Membrane, Dendrite protein","Q9H4B4","Q9H4B4","Q9H4B4","Q9H4B4","GO:0005813; GO:0005737; GO:0030425; GO:0005795; GO:0043025; GO:0005730; GO:0005654; GO:0005634","GO:0005524; GO:0002039; GO:0004674","GO:0006915; GO:0006974; GO:0031122; GO:0006977; GO:0007113; GO:0000082; GO:0000086; GO:0090166; GO:0007093; GO:0044819; GO:0043066; GO:0000122; GO:1904716; GO:0090316; GO:2000777; GO:0043491; GO:0006468; GO:0051302; GO:0032465; GO:1901796; GO:0006970; GO:0009314; GO:0000302"]
[2064,1034,"NK147-2","Plk3 (CNK)","Pan-specific","Polo-like protein-serine kinase 3 (cytokine- inducible kinase (CNK))",0,3292,12,592,{"v":1941.76,"d":"1942"},{"v":3411.957564544,"d":"3412"},{"$nulls":3},0,4013,18,771,{"v":3080.145,"d":"3080"},{"v":5381.6758541895,"d":"5382"},{"$nulls":6},0,3534,14,599,{"v":2108.48,"d":"2108"},{"v":3607.274875072,"d":"3607"},{"$nulls":7},"PLK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","PLK",{"$nulls":6},"KSKNHAQERDEVSGLVSGC","Corresponds to amino acid residues K357 to G374; After catalytic domain.",{"$nulls":3},"Q9H4B4","Q9H4B4","Q9H4B4","Q9H4B4"]
[2069,802,"NN432-1","PLPB1 (MYT1)","Pan-specific","Myelin transcription factor 1",0,496,16,612,{"v":293.76,"d":"294"},{"v":516.1794733439999,"d":"516"},{"$f":"(L2082+L2083)/2","v":{"v":490.63407171179995,"d":"491"}},{"$f":"SQRT((M2082-L2082)*(M2082-L2082))","v":{"v":25.54540163219997,"d":"26"}},{"$f":"N2082/M2082*100","v":{"v":5.206609794357172,"d":"5"}},0,422,14,577,{"v":235.416,"d":"235"},{"v":411.3223899816,"d":"411"},{"$f":"(U2082+U2083)/2","v":{"v":516.861170882,"d":"517"}},{"$f":"SQRT((V2082-U2082)*(V2082-U2082))","v":{"v":105.53878090040001,"d":"106"}},{"$f":"W2082/V2082*100","v":{"v":20.419173821918736,"d":"20"}},{"$f":"X2082+O2082","v":{"v":25.62578361627591,"d":"26"}},{"$f":"(V2082/M2082*100)-100","v":{"v":5.345551946422077,"d":"5"}},null,0,526,16,592,{"v":301.92,"d":"302"},{"v":516.5372354880001,"d":"517"},{"$f":"(AG2082+AG2083)/2","v":{"v":425.36136475780006,"d":"425"}},{"$f":"SQRT((AH2082-AG2082)*(AH2082-AG2082))","v":{"v":91.17587073020002,"d":"91"}},{"$f":"AI2082/AH2082*100","v":{"v":21.434920583846488,"d":"21"}},{"$f":"AJ2082+O2082","v":{"v":26.64153037820366,"d":"27"}},{"$f":"(AH2082/M2082*100)-100","v":{"v":-13.303745238537218,"d":"-13"}},{"$nulls":10},"X",{"$nulls":4},"Epitope undefined.",{"$nulls":3},"Transcription factor","Q01538","Q01538",null,null,"GO:0005829; GO:0005654; GO:0005634","GO:0003677; GO:0003700; GO:0000981; GO:0008270","GO:0030154; GO:0007399; GO:0006355; GO:0006351"]
[2072,1037,"PN641","PML","S518","Probable transcription factor PML",0,7389,12,706,{"v":5208.162,"d":"5208"},{"v":9151.5057129978,"d":"9152"},{"$nulls":3},0,8141,15,634,{"v":5151.884,"d":"5152"},{"v":9001.4495182484,"d":"9001"},{"$nulls":6},0,7712,14,669,{"v":5149.962,"d":"5150"},{"v":8810.7681980268,"d":"8811"},{"$nulls":10},"Transcription protein; Tumour suppressor",{"$nulls":4},"X",{"$nulls":4},"SKAV(pS)PPH(bA)C","Corresponds to amino acid residues S14 to H21.","S518 prevents ubiquitination by the BCR(KLHL20) E3 ubiquitin ligase complex. This is one of the major sites of in vivo phosphorylation of PML.",null,null,"P29590","P29590",null,"P29590"]
[2080,1041,"PP502","PP1/Cb (PPP1CB)","T316","Serine/threonine-protein phosphatase PP1-beta catalytic subunit",0,6878,14,594,{"v":4077.216,"d":"4077"},{"v":7164.2674550304,"d":"7164"},{"$nulls":3},0,7278,22,772,{"v":5601.632,"d":"5602"},{"v":9787.2560150432,"d":"9787"},{"$nulls":6},0,7216,12,685,{"v":4934.74,"d":"4935"},{"v":8442.557490236,"d":"8443"},{"$nulls":9},"PSTP","Protein phosphatase - Serine/threonine phosphatase",{"$nulls":6},"X",null,null,"CGRPV(pT)PPR","Corresponds to amino acid residues G312 to R319; Near C-terminus.","T316 phosphorylation inhibits phosphatase activity. This is one of the major sites of in vivo phosphorylation of PP1/Cb.",null,null,"P62140","P62140"]
[2081,1042,"NP013-NP014-2","PP2A/Ca (PPP2CA)","Pan-specific","Protein-serine phosphatase 2A - catalytic subunit - alpha and beta isoform",0,122,10,471,{"v":52.752,"d":"53"},{"v":92.6930132688,"d":"93"},{"$f":"(L2094+L2095)/2","v":{"v":82.40403959585,"d":"82"}},{"$f":"SQRT((M2094-L2094)*(M2094-L2094))","v":{"v":10.288973672950007,"d":"10"}},{"$f":"N2094/M2094*100","v":{"v":12.486006418389442,"d":"12"}},0,104,10,463,{"v":43.522,"d":"44"},{"v":76.0422955822,"d":"76"},{"$f":"(U2094+U2095)/2","v":{"v":96.6017756639,"d":"97"}},{"$f":"SQRT((V2094-U2094)*(V2094-U2094))","v":{"v":20.559480081700002,"d":"21"}},{"$f":"W2094/V2094*100","v":{"v":21.282714463998264,"d":"21"}},{"$f":"X2094+O2094","v":{"v":33.768720882387704,"d":"34"}},{"$f":"(V2094/M2094*100)-100","v":{"v":17.229417559724865,"d":"17"}},null,0,150,12,492,{"v":67.896,"d":"68"},{"v":116.1592876944,"d":"116"},{"$f":"(AG2094+AG2095)/2","v":{"v":111.84112400080001,"d":"112"}},{"$f":"SQRT((AH2094-AG2094)*(AH2094-AG2094))","v":{"v":4.318163693599999,"d":"4"}},{"$f":"AI2094/AH2094*100","v":{"v":3.8609802361867454,"d":"4"}},{"$f":"AJ2094+O2094","v":{"v":16.346986654576188,"d":"16"}},{"$f":"(AH2094/M2094*100)-100","v":{"v":35.72286571061804,"d":"36"}},{"$nulls":4},"PSTP","Protein phosphatase - Serine/threonine phosphatase",{"$nulls":6},"X",null,null,"Epitope undefined.",{"$nulls":3},"Protein phosphatase, Ser/Thr (non-receptor); EC 3.1.3.16","P67775","P67775",null,"P67775","GO:0000775; GO:0005829; GO:0070062; GO:0016020; GO:0015630; GO:0005739; GO:0005634; GO:0005886; GO:0000159; GO:0000922; GO:0045202","GO:0050811; GO:0046872; GO:0004721; GO:0008022; GO:0046982; GO:0004722","GO:0006915; GO:0006672; GO:0000188; GO:0051321; GO:0007498; GO:0030308; GO:0010719; GO:0042532; GO:0000184; GO:0070262; GO:0035970; GO:1904528; GO:0071902; GO:0006470; GO:0030155; GO:0045595; GO:0006275; GO:0040008; GO:1904526; GO:0001932; GO:0006355; GO:0030111; GO:0010288; GO:0010033; GO:0008380; GO:0019932"]
[2086,1044,"PP007","PP2A/Ca (PPP2CA)","Y307","Protein-serine phosphatase 2A - catalytic subunit - alpha and beta isoform",0,10,2,722,{"v":5.776,"d":"6"},{"v":10.1492804944,"d":"10"},{"$nulls":3},0,10,2,699,{"v":5.592,"d":"6"},{"v":9.770426839199999,"d":"10"},{"$nulls":6},0,8,2,728,{"v":4.368,"d":"4"},{"v":7.472955235200001,"d":"7"},{"$nulls":9},"PSTP","Protein phosphatase - Serine/threonine phosphatase",{"$nulls":6},"X",null,null,"Epitope undefined.","Antibody raised against amino acid residues that encompass the Y307 phosphosite.","The effect of Y307 phosphorylation is unclear. It has been separately report to both stimulate and inhibits phosphatase activity. It regulates cell growth, apoptosis, cytoskeletal reorganization, intracellular location, methylation and molecular association, including inducing interaction with LCMT1. This phosphorylation site has not been reported by mass spectrometry, although other phosphosites in this protein have been reported. This particular human phosphosite is highly conserved in vertebrates and also found in yeast and mould.","EGFR; InsR; Lck; Src",null,"P67775","P67775",null,"P67775"]
[2091,1047,"PN532","PPP1R11 (HCG V)","Y64","Protein phosphatase 1 regulatory subunit 11",0,3506,14,597,{"v":2084.724,"d":"2085"},{"v":3663.1663139556003,"d":"3663"},{"$f":"(L2104+L2105)/2","v":{"v":4019.9057918874,"d":"4020"}},{"$f":"SQRT((M2104-L2104)*(M2104-L2104))","v":{"v":356.7394779317997,"d":"357"}},{"$f":"N2104/M2104*100","v":{"v":8.874324334956757,"d":"9"}},0,3424,12,617,{"v":2105.204,"d":"2105"},{"v":3678.2442173804,"d":"3678"},{"$f":"(U2104+U2105)/2","v":{"v":3966.9942264517003,"d":"3967"}},{"$f":"SQRT((V2104-U2104)*(V2104-U2104))","v":{"v":288.75000907130016,"d":"289"}},{"$f":"W2104/V2104*100","v":{"v":7.278810923039185,"d":"7"}},{"$f":"X2104+O2104","v":{"v":16.15313525799594,"d":"16"}},{"$f":"(V2104/M2104*100)-100","v":{"v":-1.316238941282677,"d":"-1"}},null,0,4018,14,633,{"v":2534.532,"d":"2535"},{"v":4336.182275224801,"d":"4336"},{"$f":"(AG2104+AG2105)/2","v":{"v":4487.7097871814,"d":"4488"}},{"$f":"SQRT((AH2104-AG2104)*(AH2104-AG2104))","v":{"v":151.52751195659948,"d":"152"}},{"$f":"AI2104/AH2104*100","v":{"v":3.376499799283356,"d":"3"}},{"$f":"AJ2104+O2104","v":{"v":12.250824134240112,"d":"12"}},{"$f":"(AH2104/M2104*100)-100","v":{"v":11.637188021621768,"d":"12"}},{"$nulls":5},"Protein-serine/threonine phosphatase regulatory subunit",{"$nulls":6},"X",null,null,"CCI(pY)EKP(bA)C","Corresponds to amino acid residues C61 to P67; In the PPI_Ypi1 domain. ","The effect of Y64 phosphorylation is unclear. This is the major in vivo phosphorylation site in PPP1R11.",null,"Protein phosphatase, regulatory subunit","O60927","O60927",null,null,"GO:0005737; GO:0005634; GO:0000164","GO:0008157; GO:0004865; GO:0061630","GO:0050830; GO:0050710; GO:0032515; GO:0006511"]
[2094,1048,"PP503","PPP1R12B","T646","Protein phosphatase 1 regulatory subunit 12B",0,4050,16,724,{"v":2920.616,"d":"2921"},{"v":5131.9513504904,"d":"5132"},{"$nulls":3},0,4038,14,595,{"v":2394.28,"d":"2394"},{"v":4183.322169628001,"d":"4183"},{"$nulls":6},0,4444,18,663,{"v":2934.438,"d":"2934"},{"v":5020.3580161332,"d":"5020"},{"$nulls":10},"Protein-serine/threonine phosphatase regulatory subunit",{"$nulls":6},"X",null,null,"RRS(pT)QGV(bA)C","Corresponds to amino acid residues R643 to V649.","T646 phosphorylation inhibits. This is the minor site of in vivo phosphorylation of PPPP1R12B (≥9 reports from high throughput mass spectrometry studies).  This human phosphosite is conserved in mammals and found in the rat.","ROCK1",null,"O60237","O60237"]
[2098,152,"NP049-1","PPP3CC (Calcinerin)","Pan-specific","Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform",0,635,10,300,{"v":187.5,"d":"188"},{"v":329.46504375,"d":"329"},{"$nulls":3},0,559,10,282,{"v":154.818,"d":"155"},{"v":270.50034735180003,"d":"271"},{"$nulls":6},0,412,12,304,{"v":121.6,"d":"122"},{"v":208.03831424,"d":"208"},{"$nulls":9},"PSTP","Protein phosphatase - Serine/threonine phosphatase",{"$nulls":6},"X",null,null,"Epitope undefined.",{"$nulls":4},"P48454","P48454"]
[2103,1053,"PN260","PRC1","T481","Protein regulator of cytokinesis 1",0,229,10,643,{"v":140.817,"d":"141"},{"v":247.4361550173,"d":"247"},{"$f":"(L2116+L2117)/2","v":{"v":258.24524417265,"d":"258"}},{"$f":"SQRT((M2116-L2116)*(M2116-L2116))","v":{"v":10.809089155350023,"d":"11"}},{"$f":"N2116/M2116*100","v":{"v":4.185590789863142,"d":"4"}},0,260,12,672,{"v":166.656,"d":"167"},{"v":291.1838797056,"d":"291"},{"$f":"(U2116+U2117)/2","v":{"v":297.9071634104,"d":"298"}},{"$f":"SQRT((V2116-U2116)*(V2116-U2116))","v":{"v":6.7232837047999965,"d":"7"}},{"$f":"W2116/V2116*100","v":{"v":2.256838549242245,"d":"2"}},{"$f":"X2116+O2116","v":{"v":6.442429339105388,"d":"6"}},{"$f":"(V2116/M2116*100)-100","v":{"v":15.358238005434103,"d":"15"}},null,0,296,10,661,{"v":189.046,"d":"189"},{"v":323.4277233044,"d":"323"},{"$f":"(AG2116+AG2117)/2","v":{"v":311.090845969,"d":"311"}},{"$f":"SQRT((AH2116-AG2116)*(AH2116-AG2116))","v":{"v":12.336877335400004,"d":"12"}},{"$f":"AI2116/AH2116*100","v":{"v":3.965683174306378,"d":"4"}},{"$f":"AJ2116+O2116","v":{"v":8.15127396416952,"d":"8"}},{"$f":"(AH2116/M2116*100)-100","v":{"v":20.463339786044628,"d":"20"}},{"$nulls":15},"Epitope undefined.","Antibody raised against amino acid residues that encompass the T481 phosphosite.","The effect of T481 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of PRC1.","CDK1 (CDC2)","Cytoskeletal protein; Cell cycle regulation; Microtubule binding protein","O43663","O43663",null,null,"GO:0070938; GO:0005829; GO:0030496; GO:0005634; GO:0005819; GO:0005876; GO:0000922","GO:0042802; GO:0019894; GO:0008017; GO:0019901","GO:0000910; GO:0001578; GO:0000022; GO:0008284; GO:0032465"]
[2108,1054,"PK781","PRK1 (PKN1)","T774","Protein kinase C-related protein-serine kinase 1; Protein kinase N1",0,10212,18,718,{"v":7319.292,"d":"7319"},{"v":12861.0712479948,"d":"12861"},{"$nulls":3},0,10196,20,685,{"v":6970.56,"d":"6971"},{"v":12179.067687456001,"d":"12179"},{"$nulls":6},0,10252,16,692,{"v":7083.312,"d":"7083"},{"v":12118.4234187168,"d":"12118"},{"$nulls":7},"PKN1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKN",{"$nulls":6},"RTS(pT)FCG(bA)C","Corresponds to amino acid residues R771 to G777; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T774 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of PPRK1.","PDPK1 (PDK1); PKN1 (PRKCL1)",null,"Q16512","Q16512","Q16512"]
[2113,1057,"PK782","PRKACA/B (PKA, PKACA/B)","T196+T198","cAMP-dependent protein kinase catalytic subunit alpha/beta",0,2272,12,856,{"$f":"(H2126-I2126)*J2126/1000","v":{"v":1934.56,"d":"1935"}},{"v":3399.306106864,"d":"3399"},{"$f":"(L2126+L2127)/2","v":{"v":5482.438899752,"d":"5482"}},{"$f":"SQRT((M2126-L2126)*(M2126-L2126))","v":{"v":2083.132792888,"d":"2083"}},{"$f":"N2126/M2126*100","v":{"v":37.99646162918899,"d":"38"}},0,8018,16,752,{"$f":"(Q2126-R2126)*S2126/1000","v":{"v":6017.504,"d":"6018"}},{"v":10513.873853110399,"d":"10514"},{"$f":"(U2126+U2127)/2","v":{"v":9674.5256967912,"d":"9675"}},{"$f":"SQRT((V2126-U2126)*(V2126-U2126))","v":{"v":839.3481563191999,"d":"839"}},{"$f":"W2126/V2126*100","v":{"v":8.675858461956341,"d":"9"}},{"$f":"X2126+O2126","v":{"v":46.67232009114534,"d":"47"}},{"$f":"(V2126/M2126*100)-100","v":{"v":76.46390363290377,"d":"76"}},null,0,7890,14,636,{"$f":"(AC2126-AD2126)*AE2126/1000","v":{"v":5009.136,"d":"5009"}},{"v":8569.8372470304,"d":"8570"},{"$f":"(AG2126+AG2127)/2","v":{"v":9022.2299059082,"d":"9022"}},{"$f":"SQRT((AH2126-AG2126)*(AH2126-AG2126))","v":{"v":452.3926588777995,"d":"452"}},{"$f":"AI2126/AH2126*100","v":{"v":5.014200076874017,"d":"5"}},{"$f":"AJ2126+O2126","v":{"v":43.01066170606301,"d":"43"}},{"$f":"(AH2126/M2126*100)-100","v":{"v":64.56599099200767,"d":"65"}},null,null,"PKACa","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKA",{"$nulls":6},"KGR(pT)W(pT)LCG(bA)C","Corresponds to amino acid residues K193 to G201; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T196 and T198 phosphorylation stimulate phosphotransferase activity and regulates stability. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major sites of in vivo phosphorylation of PRKACA.","T198: PDPK1 (PDK1); PKACa (PRKACA)","EC 2.7.11.11; Protein kinase, Ser/Thr (non-receptor); AGC group; PKA family","P17612","P17612","P17612",null,"GO:0001669; GO:0034704; GO:0005952; GO:0005813; GO:0097546; GO:0005737; GO:0005829; GO:0070062; GO:0045171; GO:0016020; GO:0005739; GO:0031514; GO:0016607; GO:0005654; GO:0031588; GO:0005634; GO:0048471; GO:0044853; GO:0097225","GO:0005524; GO:0004691; GO:0004672; GO:0034237; GO:0019901; GO:0004712; GO:0004674; GO:0031625","GO:0034199; GO:0007596; GO:0035584; GO:0086064; GO:0071872; GO:0071377; GO:0071333; GO:0034605; GO:0097711; GO:0019221; GO:0000086; GO:0034380; GO:0006397; GO:0018105; GO:0071158; GO:0010737; GO:0006468; GO:2000810; GO:1903779; GO:0055117; GO:0010881; GO:0051480; GO:0010389; GO:0002027; GO:0016241; GO:0045667; GO:0061136; GO:0043393; GO:0060314; GO:0003091; GO:0048240; GO:0002223"]
[2117,1058,"PK068","PRKACB (PKA)","S339","cAMP-dependent protein-serine kinase catalytic subunit beta",0,885,12,358,{"v":312.534,"d":"313"},{"$f":"K2130*1.7571469","v":{"v":549.1681492445999,"d":"549"}},{"$f":"(L2130+L2131)/2","v":{"v":554.0828891239,"d":"554"}},{"$f":"SQRT((M2130-L2130)*(M2130-L2130))","v":{"v":4.9147398793001,"d":"5"}},{"$f":"N2130/M2130*100","v":{"v":0.8870044492929833,"d":"1"}},0,1104,14,320,{"v":348.8,"d":"349"},{"$f":"T2130*1.7472151","v":{"v":609.42862688,"d":"609"}},{"$f":"(U2130+U2131)/2","v":{"v":506.68888456980005,"d":"507"}},{"$f":"SQRT((V2130-U2130)*(V2130-U2130))","v":{"v":102.73974231019997,"d":"103"}},{"$f":"W2130/V2130*100","v":{"v":20.276691563390084,"d":"20"}},{"$f":"X2130+O2130","v":{"v":21.16369601268307,"d":"21"}},{"$f":"(V2130/M2130*100)-100","v":{"v":-8.553594684910422,"d":"-9"}},null,0,1104,14,359,{"v":391.31,"d":"391"},{"v":669.469348234,"d":"669"},{"$f":"(AG2130+AG2131)/2","v":{"v":674.1245476834,"d":"674"}},{"$f":"SQRT((AH2130-AG2130)*(AH2130-AG2130))","v":{"v":4.6551994494000155,"d":"5"}},{"$f":"AI2130/AH2130*100","v":{"v":0.690554804063642,"d":"1"}},{"$f":"AJ2130+O2130","v":{"v":1.5775592533566254,"d":"2"}},{"$f":"(AH2130/M2130*100)-100","v":{"v":21.664927922482207,"d":"22"}},null,null,"PKACb","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKA",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S339 phosphosite.","The effect of S339 phosphorylation is unclear. This is one of the minor sites of in vivo phosphorylation of PRKACB (≥13 reports from high throughput mass spectrometry studies).",null,"Protein-serine kinase, AGC group, PKA family","P22694","P22694","P22694","P22694","GO:0005952; GO:0005813; GO:0097546; GO:0005829; GO:0070062; GO:0045171; GO:0005654; GO:0048471; GO:0005886","GO:0005524; GO:0004691; GO:0016301; GO:0000287; GO:0034237; GO:0004674; GO:0031625","GO:0034199; GO:0007188; GO:0007596; GO:0071377; GO:0034380; GO:0051447; GO:1901621; GO:0001843; GO:0006468; GO:0070613; GO:0003091; GO:0097338; GO:0007165; GO:0002223"]
[2120,962,"PN259","PRKAR2A (PKA2RA)","S99","cAMP-dependent protein kinase type II-alpha regulatory subunit",0,259,24,750,{"v":176.25,"d":"176"},{"v":309.697141125,"d":"310"},{"$nulls":3},0,101,10,514,{"v":46.774,"d":"47"},{"v":81.72423908740001,"d":"82"},{"$nulls":6},0,179,12,528,{"v":88.176,"d":"88"},{"v":150.8551512864,"d":"151"},{"$nulls":20},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S96 phosphosite of mouse PRKAR2A.","The effect of S99 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of PRKAR2A (≥251 reports from high throughput mass spectrometry studies).","PKACa (PRKACA)",null,"P13861","P13861"]
[2125,1062,"NK293-1","PRKY","Pan-specific","Serine/threonine-protein kinase PRKY",0,18108,19,723,{"v":13078.347,"d":"13078"},{"v":22980.5768881743,"d":"22981"},{"$f":"(L2138+L2139)/2","v":{"v":23305.6033788549,"d":"23306"}},{"$f":"SQRT((M2138-L2138)*(M2138-L2138))","v":{"v":325.02649068060055,"d":"325"}},{"$f":"N2138/M2138*100","v":{"v":1.3946280874903074,"d":"1"}},0,17646,22,691,{"v":12178.184,"d":"12178"},{"v":21277.9069753784,"d":"21278"},{"$f":"(U2138+U2139)/2","v":{"v":22330.8137389404,"d":"22331"}},{"$f":"SQRT((V2138-U2138)*(V2138-U2138))","v":{"v":1052.9067635620013,"d":"1053"}},{"$f":"W2138/V2138*100","v":{"v":4.715039836304514,"d":"5"}},{"$f":"X2138+O2138","v":{"v":6.109667923794821,"d":"6"}},{"$f":"(V2138/M2138*100)-100","v":{"v":-4.1826406468365604,"d":"-4"}},null,0,19315,22,722,{"v":13929.546,"d":"13930"},{"v":23831.2439800044,"d":"23831"},{"$f":"(AG2138+AG2139)/2","v":{"v":24378.0742287415,"d":"24378"}},{"$f":"SQRT((AH2138-AG2138)*(AH2138-AG2138))","v":{"v":546.8302487371002,"d":"547"}},{"$f":"AI2138/AH2138*100","v":{"v":2.243123241016277,"d":"2"}},{"$f":"AJ2138+O2138","v":{"v":3.6377513285065843,"d":"4"}},{"$f":"(AH2138/M2138*100)-100","v":{"v":4.601772511325123,"d":"5"}},null,null,"PRKY","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKA",{"$nulls":6},"CAESNSREVTEDAADWAPAL","Corresponds to amino acid residues A12 to L30; Post-N-terminus.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); AGC group; PKA family","O43930","O43930","O43930",null,null,"GO:0005524; GO:0004674","GO:0006468"]
[2130,1064,"PK786","PRP4K (PRP4, PRPF4B)","Y849","Protein-serine kinase PRP4 homologue",0,3406,16,578,{"v":1959.42,"d":"1959"},{"v":3442.988778798,"d":"3443"},{"$nulls":3},0,3798,16,574,{"v":2170.868,"d":"2171"},{"v":3792.9733497068,"d":"3793"},{"$nulls":6},0,4364,18,647,{"v":2811.862,"d":"2812"},{"v":4810.6499206868,"d":"4811"},{"$nulls":7},"PRPF4B","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","DYRK","PRP4",{"$nulls":5},"ITP(pY)LVS(bA)C","Corresponds to amino acid residues I846 to S852; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y849 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of PRP4K.",null,null,"Q13523","Q13523","Q13523","Q13523"]
[2131,1065,"NP023","PTEN","Pan-specific","Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and protein phosphatase and tensin homolog deleted on chromosome 10",0,1910,14,564,{"v":1069.344,"d":"1069"},{"v":1878.9944946336,"d":"1879"},{"$f":"(L2144+L2145)/2","v":{"v":1950.3170873046,"d":"1950"}},{"$f":"SQRT((M2144-L2144)*(M2144-L2144))","v":{"v":71.32259267099994,"d":"71"}},{"$f":"N2144/M2144*100","v":{"v":3.6569741984658517,"d":"4"}},0,2062,8,571,{"v":1172.834,"d":"1173"},{"v":2049.1932745934,"d":"2049"},{"$f":"(U2144+U2145)/2","v":{"v":2067.8150931292002,"d":"2068"}},{"$f":"SQRT((V2144-U2144)*(V2144-U2144))","v":{"v":18.62181853580023,"d":"19"}},{"$f":"W2144/V2144*100","v":{"v":0.9005553058237935,"d":"1"}},{"$f":"X2144+O2144","v":{"v":4.557529504289645,"d":"5"}},{"$f":"(V2144/M2144*100)-100","v":{"v":6.024559113461208,"d":"6"}},null,0,2236,12,603,{"v":1341.072,"d":"1341"},{"v":2294.3614979808,"d":"2294"},{"$f":"(AG2144+AG2145)/2","v":{"v":2307.0970013624,"d":"2307"}},{"$f":"SQRT((AH2144-AG2144)*(AH2144-AG2144))","v":{"v":12.73550338160021,"d":"13"}},{"$f":"AI2144/AH2144*100","v":{"v":0.5520142141435566,"d":"1"}},{"$f":"AJ2144+O2144","v":{"v":4.208988412609409,"d":"4"}},{"$f":"(AH2144/M2144*100)-100","v":{"v":18.293431174870207,"d":"18"}},{"$nulls":4},"PIPP","Lipid phosphatase",{"$nulls":8},"X","Epitope undefined.",{"$nulls":3},"Nuclear receptor co-regulator; Phosphatase, lipid; Tumor suppressor; EC 3.1.3.16; Carbohydrate Metabolism - inositol phosphate; EC 3.1.3.48; EC 3.1.3.67","P60484","P60484",null,"P60484","GO:0016324; GO:0042995; GO:0005737; GO:0009898; GO:0005829; GO:0043197; GO:0005576; GO:0005739; GO:0035749; GO:0043005; GO:0005654; GO:0005634; GO:0005886; GO:0016605; GO:0099524; GO:0045211; GO:0043220","GO:0010997; GO:0019899; GO:0042802; GO:0051717; GO:0035255; GO:0008289; GO:0030165; GO:0016314; GO:0051800; GO:0004438; GO:0004721; GO:0005161; GO:0004722; GO:0008138; GO:1990782; GO:0004725; GO:1990381","GO:0030534; GO:0007568; GO:0001525; GO:0006915; GO:0048854; GO:0060070; GO:0048738; GO:0016477; GO:0008283; GO:0071257; GO:0071361; GO:0071456; GO:1990314; GO:0032869; GO:0044320; GO:1990090; GO:0007417; GO:0032286; GO:0021955; GO:0060997; GO:0021542; GO:0043542; GO:0048853; GO:0007507; GO:0046855; GO:0043647; GO:0007611; GO:0045475; GO:0007626; GO:0060292; GO:0060291; GO:0060179; GO:0042711; GO:0007613; GO:0033555; GO:0043066; GO:0050771; GO:0048681; GO:0060044; GO:0090344; GO:0030336; GO:0008285; GO:0045792; GO:0031658; GO:0061002; GO:0050680; GO:0010719; GO:0070373; GO:0090394; GO:0051895; GO:2000134; GO:0051548; GO:0031642; GO:0046621; GO:0050765; GO:0014067; GO:1901017; GO:0051898; GO:0001933; GO:0090071; GO:2000272; GO:2000808; GO:1904706; GO:1903690; GO:0007270; GO:0006661; GO:0046856; GO:0048008; GO:0010666; GO:0008284; GO:0051091; GO:0070374; GO:2000463; GO:0010628; GO:0045666; GO:1903984; GO:2000060; GO:1904668; GO:0097107; GO:0060134; GO:0097105; GO:0060736; GO:0006470; GO:0016579; GO:0043491; GO:0050821; GO:0002902; GO:0032535; GO:0000079; GO:0033032; GO:0010975; GO:0031647; GO:0032228; GO:0014823; GO:0046685; GO:0033198; GO:0032355; GO:0009749; GO:0010043; GO:0060024; GO:0035176; GO:0007416; GO:0060074"]
[2135,1067,"PP006-2","PTEN","S380","Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and protein phosphatase and tensin homolog deleted on chromosome 10",0,330,12,471,{"v":149.778,"d":"150"},{"v":263.1819483882,"d":"263"},{"$f":"(L2148+L2149)/2","v":{"v":326.58420140745,"d":"327"}},{"$f":"SQRT((M2148-L2148)*(M2148-L2148))","v":{"v":63.40225301925,"d":"63"}},{"$f":"N2148/M2148*100","v":{"v":19.413753863784937,"d":"19"}},0,368,12,535,{"v":190.46,"d":"190"},{"v":332.774587946,"d":"333"},{"$f":"(U2148+U2149)/2","v":{"v":297.0999500342,"d":"297"}},{"$f":"SQRT((V2148-U2148)*(V2148-U2148))","v":{"v":35.674637911800005,"d":"36"}},{"$f":"W2148/V2148*100","v":{"v":12.00762164641677,"d":"12"}},{"$f":"X2148+O2148","v":{"v":31.421375510201706,"d":"31"}},{"$f":"(V2148/M2148*100)-100","v":{"v":-9.028070324952779,"d":"-9"}},null,0,375,12,484,{"v":175.692,"d":"176"},{"v":300.58114724880005,"d":"301"},{"$f":"(AG2148+AG2149)/2","v":{"v":333.596964586,"d":"334"}},{"$f":"SQRT((AH2148-AG2148)*(AH2148-AG2148))","v":{"v":33.01581733719996,"d":"33"}},{"$f":"AI2148/AH2148*100","v":{"v":9.89691779065592,"d":"10"}},{"$f":"AJ2148+O2148","v":{"v":29.310671654440856,"d":"29"}},{"$f":"(AH2148/M2148*100)-100","v":{"v":2.147306314367853,"d":"2"}},{"$nulls":4},"PIPP","Lipid phosphatase",{"$nulls":8},"X","Epitope undefined.","Antibody raised against amino acid residues that encompass the S380 phosphosite.","S380 phosphorylation inhibits phosphatase activity, regulates cell differentiation, cell motility, transcription, and induces/inhibits interaction with PTEN.  This is one of the major sites of in vivo phosphorylation of PTEN.","CK2a1 (CSNK2A1); LKB1 (STK11); PKCz (PRKCZ)","Nuclear receptor co-regulator; Phosphatase, lipid; Tumor suppressor; EC 3.1.3.16; Carbohydrate Metabolism - inositol phosphate; EC 3.1.3.48; EC 3.1.3.67","P60484","P60484",null,"P60484","GO:0016324; GO:0042995; GO:0005737; GO:0009898; GO:0005829; GO:0043197; GO:0005576; GO:0005739; GO:0035749; GO:0043005; GO:0005654; GO:0005634; GO:0005886; GO:0016605; GO:0099524; GO:0045211; GO:0043220","GO:0010997; GO:0019899; GO:0042802; GO:0051717; GO:0035255; GO:0008289; GO:0030165; GO:0016314; GO:0051800; GO:0004438; GO:0004721; GO:0005161; GO:0004722; GO:0008138; GO:1990782; GO:0004725; GO:1990381","GO:0030534; GO:0007568; GO:0001525; GO:0006915; GO:0048854; GO:0060070; GO:0048738; GO:0016477; GO:0008283; GO:0071257; GO:0071361; GO:0071456; GO:1990314; GO:0032869; GO:0044320; GO:1990090; GO:0007417; GO:0032286; GO:0021955; GO:0060997; GO:0021542; GO:0043542; GO:0048853; GO:0007507; GO:0046855; GO:0043647; GO:0007611; GO:0045475; GO:0007626; GO:0060292; GO:0060291; GO:0060179; GO:0042711; GO:0007613; GO:0033555; GO:0043066; GO:0050771; GO:0048681; GO:0060044; GO:0090344; GO:0030336; GO:0008285; GO:0045792; GO:0031658; GO:0061002; GO:0050680; GO:0010719; GO:0070373; GO:0090394; GO:0051895; GO:2000134; GO:0051548; GO:0031642; GO:0046621; GO:0050765; GO:0014067; GO:1901017; GO:0051898; GO:0001933; GO:0090071; GO:2000272; GO:2000808; GO:1904706; GO:1903690; GO:0007270; GO:0006661; GO:0046856; GO:0048008; GO:0010666; GO:0008284; GO:0051091; GO:0070374; GO:2000463; GO:0010628; GO:0045666; GO:1903984; GO:2000060; GO:1904668; GO:0097107; GO:0060134; GO:0097105; GO:0060736; GO:0006470; GO:0016579; GO:0043491; GO:0050821; GO:0002902; GO:0032535; GO:0000079; GO:0033032; GO:0010975; GO:0031647; GO:0032228; GO:0014823; GO:0046685; GO:0033198; GO:0032355; GO:0009749; GO:0010043; GO:0060024; GO:0035176; GO:0007416; GO:0060074"]
[2142,1070,"NP024-2","PTPN1 (PTP1B)","Pan-specific","Protein-tyrosine phosphatase, non-receptor type 1",0,234,10,484,{"v":108.416,"d":"108"},{"v":190.5028383104,"d":"191"},{"$nulls":3},0,292,16,568,{"v":156.768,"d":"157"},{"v":273.9074167968,"d":"274"},{"$nulls":6},0,316,14,477,{"v":144.054,"d":"144"},{"v":246.45354703560002,"d":"246"},{"$nulls":9},"PYP","Protein phosphatase, tyrosine (non-receptor)",{"$nulls":6},"X",null,null,"Epitope undefined.",{"$nulls":4},"P18031","P18031"]
[2147,1073,"PP515","PTPN2","S304","Tyrosine-protein phosphatase non-receptor type 2",0,15558,14,676,{"v":10507.744,"d":"10508"},{"v":18463.6497955936,"d":"18464"},{"$f":"(L2160+L2161)/2","v":{"v":17671.3592869712,"d":"17671"}},{"$f":"SQRT((M2160-L2160)*(M2160-L2160))","v":{"v":792.2905086223982,"d":"792"}},{"$f":"N2160/M2160*100","v":{"v":4.483472356348619,"d":"4"}},0,15970,18,713,{"v":11373.776,"d":"11374"},{"v":19872.4331712176,"d":"19872"},{"$f":"(U2160+U2161)/2","v":{"v":21435.296111586402,"d":"21435"}},{"$f":"SQRT((V2160-U2160)*(V2160-U2160))","v":{"v":1562.8629403688028,"d":"1563"}},{"$f":"W2160/V2160*100","v":{"v":7.291072314713815,"d":"7"}},{"$f":"X2160+O2160","v":{"v":11.774544671062433,"d":"12"}},{"$f":"(V2160/M2160*100)-100","v":{"v":21.299645168723885,"d":"21"}},null,0,16718,20,693,{"v":11571.714,"d":"11572"},{"v":19797.3673801596,"d":"19797"},{"$f":"(AG2160+AG2161)/2","v":{"v":19944.159283121,"d":"19944"}},{"$f":"SQRT((AH2160-AG2160)*(AH2160-AG2160))","v":{"v":146.7919029613986,"d":"147"}},{"$f":"AI2160/AH2160*100","v":{"v":0.7360144936549443,"d":"1"}},{"$f":"AJ2160+O2160","v":{"v":5.219486850003563,"d":"5"}},{"$f":"(AH2160/M2160*100)-100","v":{"v":12.861489369555713,"d":"13"}},{"$nulls":4},"PYP","Protein phosphatase, tyrosine (non-receptor)",{"$nulls":6},"X",null,null,"FDH(pS)PNK(bA)C","Corresponds to amino acid residues F301 to K307.","The effect of S304 phosphorylation is unclear. This is the major site of in vivo phosphorylation of PTPN2 (≥40 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in fish.","CDK1 (CDC2); CDK2","Protein phosphatase, tyrosine (non-receptor); EC 3.1.3.48","P17706","P17706",null,null,"GO:0005829; GO:0005783; GO:0005793; GO:0005654; GO:0005634; GO:0005886","GO:0005178; GO:0004726; GO:0019901; GO:0004725; GO:0030971; GO:0097677; GO:0019905","GO:0030183; GO:0071345; GO:0030218; GO:0042593; GO:0008286; GO:0008285; GO:0050922; GO:0042059; GO:0070373; GO:0050728; GO:0046627; GO:0060336; GO:1902206; GO:1902215; GO:0070104; GO:0010888; GO:1902227; GO:0045650; GO:2000587; GO:1902233; GO:0061099; GO:0050860; GO:0000122; GO:0010804; GO:0060339; GO:0042532; GO:0035335; GO:1902237; GO:0045722; GO:1903899; GO:1902202; GO:0060334; GO:0030217"]
[2148,1073,"PP515","PTPN2","S304","Tyrosine-protein phosphatase non-receptor type 2",0,14702,14,654,{"v":9605.952,"d":"9606"},{"v":16879.0687783488,"d":"16879"},{"$nulls":3},0,16724,20,788,{"v":13162.752,"d":"13163"},{"v":22998.1590519552,"d":"22998"},{"$nulls":6},0,17066,22,689,{"v":11743.316,"d":"11743"},{"v":20090.951186082402,"d":"20091"},{"$nulls":9},"PYP","Protein phosphatase, tyrosine (non-receptor)",{"$nulls":6},"X",null,null,"FDH(pS)PNK(bA)C","Corresponds to amino acid residues F301 to K307.","The effect of S304 phosphorylation is unclear. This is the major site of in vivo phosphorylation of PTPN2 (≥40 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in fish.","CDK1 (CDC2); CDK2",null,"P17706","P17706"]
[2153,1076,"PP008","PTPN11 (PTP1D; PTP2C; SHP2; SHPTP2; Syp)","T542","Tyrosine-protein phosphatase non-receptor type 11",0,316,10,481,{"v":147.186,"d":"147"},{"v":258.62742362340003,"d":"259"},{"$f":"(L2166+L2167)/2","v":{"v":266.91939984450005,"d":"267"}},{"$f":"SQRT((M2166-L2166)*(M2166-L2166))","v":{"v":8.291976221100015,"d":"8"}},{"$f":"N2166/M2166*100","v":{"v":3.1065468549422386,"d":"3"}},0,333,12,445,{"v":142.845,"d":"143"},{"v":249.5809409595,"d":"250"},{"$f":"(U2166+U2167)/2","v":{"v":263.16990639975,"d":"263"}},{"$f":"SQRT((V2166-U2166)*(V2166-U2166))","v":{"v":13.588965440250007,"d":"14"}},{"$f":"W2166/V2166*100","v":{"v":5.163571179604643,"d":"5"}},{"$f":"X2166+O2166","v":{"v":8.270118034546883,"d":"8"}},{"$f":"(V2166/M2166*100)-100","v":{"v":-1.4047287109645907,"d":"-1"}},null,0,341,14,475,{"v":155.325,"d":"155"},{"v":265.736440455,"d":"266"},{"$f":"(AG2166+AG2167)/2","v":{"v":300.08585866349995,"d":"300"}},{"$f":"SQRT((AH2166-AG2166)*(AH2166-AG2166))","v":{"v":34.34941820849997,"d":"34"}},{"$f":"AI2166/AH2166*100","v":{"v":11.446530123572916,"d":"11"}},{"$f":"AJ2166+O2166","v":{"v":14.553076978515154,"d":"15"}},{"$f":"(AH2166/M2166*100)-100","v":{"v":12.425645658697633,"d":"12"}},{"$nulls":4},"PYP","Protein phosphatase, tyrosine (non-receptor)",{"$nulls":6},"X",null,null,"Epitope undefined.","Antibody raised against amino acid residues that encompass the T542 phosphosite.","The effect of T542 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of PTPN11.",null,"EC 3.1.3.48; Protein phosphatase, tyrosine (non-receptor)","Q06124","Q06124",null,"Q06124","GO:0005737; GO:0005829; GO:0005739; GO:0005654; GO:0005634; GO:0032991","GO:0016303; GO:0050839; GO:0031748; GO:0005158; GO:0043560; GO:0004726; GO:0051428; GO:0046934; GO:0043274; GO:0004721; GO:0001784; GO:0019904; GO:0004725; GO:0030971; GO:0005070","GO:0033277; GO:0000187; GO:0036302; GO:0007411; GO:0060020; GO:0007420; GO:0071345; GO:0071364; GO:0071260; GO:0021697; GO:0019221; GO:0000077; GO:0048013; GO:0007173; GO:0038127; GO:0060325; GO:0008543; GO:0048806; GO:0042593; GO:0007507; GO:0048873; GO:0009755; GO:0042445; GO:0048839; GO:0007229; GO:0070102; GO:0061582; GO:0050900; GO:0035855; GO:0032528; GO:0048609; GO:0035264; GO:0033629; GO:0051463; GO:0060125; GO:0046676; GO:0048011; GO:0035265; GO:0035335; GO:0030168; GO:0048008; GO:0030220; GO:0070374; GO:2001275; GO:0046887; GO:0045931; GO:0051897; GO:0033628; GO:0040014; GO:0043254; GO:0046825; GO:0060338; GO:0031295; GO:0006641"]
[2158,1078,"PP513","PTPN12 (PTP-PEST, PTPG1)","S39","Protein-tyrosine phosphatase, non-receptor type 12",0,4969,16,618,{"v":3060.954,"d":"3061"},{"v":5378.5458321426,"d":"5379"},{"$nulls":3},0,5940,16,633,{"v":3749.892,"d":"3750"},{"v":6551.8679257692,"d":"6552"},{"$nulls":6},0,6314,12,674,{"v":4247.548,"d":"4248"},{"v":7266.8809668872,"d":"7267"},{"$nulls":9},"PYP","Protein phosphatase, tyrosine (non-receptor)",{"$nulls":6},"X",null,null,"RRL(pS)TKY(bA)C","Corresponds to amino acid residues R36 to Y42.","S39 phosphorylation inhibits phosphatase activity. This is one of the minor sites of in vivo phosphorylation of PTPN11 (≥15 reports from high throughput mass spectrometry studies).  This particular human phosphosite is highly conserved in vertebrates and also found in the sea urchin.","PKACa (PRKACA); PKCa (PRKCA)",null,"Q05209","Q05209"]
[2164,1081,"PP517","PTPN22","Y499","Protein-tyrosine phosphatase, non-receptor type 22",0,8022,20,678,{"v":5425.356,"d":"5425"},{"v":9533.1474767964,"d":"9533"},{"$nulls":3},0,8222,20,732,{"v":6003.864,"d":"6004"},{"v":10490.041839146399,"d":"10490"},{"$nulls":6},0,9139,18,673,{"v":6138.433,"d":"6138"},{"v":10501.8853075262,"d":"10502"},{"$nulls":9},"PYP","Protein phosphatase, tyrosine (non-receptor)",{"$nulls":6},"X",null,null,"CAELN(pY)SLP","Corresponds to amino acid residues A495 to P502.","The effect of Y499 phosphorylation is unclear. This is the major site of in vivo phosphorylation of PTPN22 (≥59 reports from high throughput mass spectrometry studies). This human phosphosite is conserved in mammals and found in rat. ",null,null,"Q9Y2R2","Q9Y2R2"]
[2165,1082,"PP521","PTPRA","Y798","Receptor-type tyrosine-protein phosphatase alpha",0,7032,20,619,{"v":4340.428,"d":"4340"},{"v":7626.7696048732,"d":"7627"},{"$f":"(L2178+L2179)/2","v":{"v":8310.1995915999,"d":"8310"}},{"$f":"SQRT((M2178-L2178)*(M2178-L2178))","v":{"v":683.4299867267,"d":"683"}},{"$f":"N2178/M2178*100","v":{"v":8.223990040113158,"d":"8"}},0,7260,18,672,{"v":4866.624,"d":"4867"},{"v":8503.0389388224,"d":"8503"},{"$f":"(U2178+U2179)/2","v":{"v":8442.73118882325,"d":"8443"}},{"$f":"SQRT((V2178-U2178)*(V2178-U2178))","v":{"v":60.307749999148655,"d":"60"}},{"$f":"W2178/V2178*100","v":{"v":0.7143156479858783,"d":"1"}},{"$f":"X2178+O2178","v":{"v":8.938305688099035,"d":"9"}},{"$f":"(V2178/M2178*100)-100","v":{"v":1.5948064274812026,"d":"2"}},null,0,7598,18,669,{"v":5071.02,"d":"5071"},{"v":8675.710956228,"d":"8676"},{"$f":"(AG2178+AG2179)/2","v":{"v":8850.8908505396,"d":"8851"}},{"$f":"SQRT((AH2178-AG2178)*(AH2178-AG2178))","v":{"v":175.17989431159913,"d":"175"}},{"$f":"AI2178/AH2178*100","v":{"v":1.979234602140859,"d":"2"}},{"$f":"AJ2178+O2178","v":{"v":10.203224642254018,"d":"10"}},{"$f":"(AH2178/M2178*100)-100","v":{"v":6.5063570733757246,"d":"7"}},{"$nulls":4},"PYP","Protein phosphatase, tyrosine (receptor)",{"$nulls":6},"X",null,null,"CAFSD(pY)ANF","Corresponds to amino acid residues A794 to F801; At the C-terminus.","Y798 phosphorylation stimulates phosphatase activity and regulates cytoskeletal reorganization. This is the major site of in vivo phosphorylation of PTPRA (≥2372 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in the frog.","Src","EC 3.1.3.48; Receptor protein phosphatase, tyrosine","P18433","P18433",null,null,"GO:0070062; GO:0005887; GO:0099699; GO:0005622; GO:0005886; GO:0043235; GO:0098685","GO:0004725; GO:0005088; GO:0005001","GO:0007411; GO:0008286; GO:0000165; GO:0050804"]
[2170,1084,"PP523","PTPRF","Y1621","Receptor-type tyrosine-protein phosphatase F",0,5718,17,651,{"v":3711.351,"d":"3711"},{"v":6521.3889044619,"d":"6521"},{"$nulls":3},0,6690,22,687,{"v":4580.916,"d":"4581"},{"v":8003.845607031601,"d":"8004"},{"$nulls":6},0,7444,24,684,{"v":5075.28,"d":"5075"},{"v":8682.999140592,"d":"8683"},{"$nulls":9},"PYP","Protein phosphatase, tyrosine (receptor)",{"$nulls":6},"X",null,null,"CARNL(pY)AHI","Corresponds to amino acid residues A1617 to I1624.","The effect of Y1621 phosphorylation is unclear. This is the major site of in vivo phosphorylation of PTPRF (≥143 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in fish.",null,null,"P10586","P10586"]
[2177,1088,"PN647","PU.1","S146","Transcription factor PU.1",0,1156,14,577,{"$f":"(H2190-I2190)*J2190/1000","v":{"v":658.934,"d":"659"}},{"v":1157.8438354046,"d":"1158"},{"$f":"(L2190+L2191)/2","v":{"v":1237.8063193828998,"d":"1238"}},{"$f":"SQRT((M2190-L2190)*(M2190-L2190))","v":{"v":79.96248397829982,"d":"80"}},{"$f":"N2190/M2190*100","v":{"v":6.460015813957436,"d":"6"}},0,1166,14,615,{"$f":"(Q2190-R2190)*S2190/1000","v":{"v":708.48,"d":"708"}},{"v":1237.866954048,"d":"1238"},{"$f":"(U2190+U2191)/2","v":{"v":1294.2041577323998,"d":"1294"}},{"$f":"SQRT((V2190-U2190)*(V2190-U2190))","v":{"v":56.33720368439981,"d":"56"}},{"$f":"W2190/V2190*100","v":{"v":4.353038378667344,"d":"4"}},{"$f":"X2190+O2190","v":{"v":10.81305419262478,"d":"11"}},{"$f":"(V2190/M2190*100)-100","v":{"v":4.556273260716324,"d":"5"}},null,0,1464,16,636,{"$f":"(AC2190-AD2190)*AE2190/1000","v":{"v":920.928,"d":"921"}},{"v":1575.5617488192001,"d":"1576"},{"$f":"(AG2190+AG2191)/2","v":{"v":1582.8430898176002,"d":"1583"}},{"$f":"SQRT((AH2190-AG2190)*(AH2190-AG2190))","v":{"v":7.281340998400083,"d":"7"}},{"$f":"AI2190/AH2190*100","v":{"v":0.46001660210293827,"d":"0"}},{"$f":"AJ2190+O2190","v":{"v":6.920032416060375,"d":"7"}},{"$f":"(AH2190/M2190*100)-100","v":{"v":27.87485934041088,"d":"28"}},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"PLEV(pS)DGEAC","Corresponds to amino acid residues P142 to A150.","S146 phosphorylation induces transcriptional activation and interaction with DNA, IRF2, IRF4 , IRF8, PIP and PU1. This is one of the major sites of in vivo phosphorylation of PU.1.","CK2a1 (CSNK2A1)","Transcription protein","P17947","P17947",null,"P17947","GO:0000790; GO:0005654; GO:0005634","GO:0003700; GO:0051525; GO:0003723; GO:0000980; GO:0000978; GO:0000981; GO:0001085; GO:0001205; GO:0001077; GO:0001078; GO:0003705","GO:0060033; GO:1902262; GO:0071361; GO:0030218; GO:0030851; GO:0043966; GO:0044027; GO:0030098; GO:0002320; GO:0030225; GO:0043011; GO:0045814; GO:0090241; GO:0045347; GO:0045892; GO:0000122; GO:1902895; GO:0045893; GO:0045944; GO:0061614; GO:0045646; GO:0006357; GO:0035019"]
[2181,907,"PN059","PXN","Y31","Paxillin 1",0,1012,10,274,{"v":274.548,"d":"275"},{"$f":"K2194*1.7571469","v":{"v":482.4211671012,"d":"482"}},{"$f":"(L2194+L2195)/2","v":{"v":486.20254722999994,"d":"486"}},{"$f":"SQRT((M2194-L2194)*(M2194-L2194))","v":{"v":3.781380128799924,"d":"4"}},{"$f":"N2194/M2194*100","v":{"v":0.7777376219732407,"d":"1"}},0,1636,12,252,{"v":409.248,"d":"409"},{"$f":"T2194*1.7472151","v":{"v":715.0442852448,"d":"715"}},{"$f":"(U2194+U2195)/2","v":{"v":668.414608656,"d":"668"}},{"$f":"SQRT((V2194-U2194)*(V2194-U2194))","v":{"v":46.62967658879995,"d":"47"}},{"$f":"W2194/V2194*100","v":{"v":6.976160602258462,"d":"7"}},{"$f":"X2194+O2194","v":{"v":7.753898224231703,"d":"8"}},{"$f":"(V2194/M2194*100)-100","v":{"v":37.476574827528424,"d":"37"}},null,0,1104,10,280,{"v":306.32,"d":"306"},{"v":524.064937648,"d":"524"},{"$f":"(AG2194+AG2195)/2","v":{"v":522.696264528,"d":"523"}},{"$f":"SQRT((AH2194-AG2194)*(AH2194-AG2194))","v":{"v":1.3686731199999258,"d":"1"}},{"$f":"AI2194/AH2194*100","v":{"v":0.26184865147943065,"d":"0"}},{"$f":"AJ2194+O2194","v":{"v":1.0395862734526713,"d":"1"}},{"$f":"(AH2194/M2194*100)-100","v":{"v":7.505867154730609,"d":"8"}},{"$nulls":15},"Not precisely defined.","Antibody raised against amino acid residues that encompass the Y31 phosphosite.","The effect of Y31 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of PXN.","Abl1; Brk (PTK6); FAK (PTK2); PYK2 (PTK2B; FAK2); Src","Focal adhesion, Cytoplasm, Lamellipodium, Cell junction, Microtubule associated complex, Cytoskeleton protein","P49023","P49023",null,"P49023","GO:0005938; GO:0005829; GO:0005925; GO:0030027; GO:0005875; GO:0005886; GO:0001725","GO:0008013; GO:0005178; GO:0046872; GO:0038191; GO:0019901; GO:0019903; GO:0031625; GO:0017166","GO:0007155; GO:0007160; GO:0034614; GO:0043542; GO:0060396; GO:0006936; GO:0051496; GO:0007172; GO:0007165; GO:0007179; GO:0048010"]
[2182,907,"PN059","PXN","Y31","Paxillin 1",0,882,16,322,{"v":278.852,"d":"279"},{"v":489.9839273587999,"d":"490"},{"$nulls":3},0,1360,12,264,{"v":355.872,"d":"356"},{"v":621.7849320672001,"d":"622"},{"$nulls":6},0,1054,14,293,{"v":304.72,"d":"305"},{"$f":"AF2195*1.7108414","v":{"v":521.3275914080001,"d":"521"}},{"$nulls":20},"Not precisely defined.","Antibody raised against amino acid residues that encompass the Y31 phosphosite.","The effect of Y31 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of PXN.","Abl1; Brk (PTK6); FAK (PTK2); PYK2 (PTK2B; FAK2); Src",null,"P49023","P49023",null,"P49023"]
[2187,1090,"NK154-3","PYK2 (PTK2B)","Pan-specific","Protein-tyrosine kinase 2",0,58,10,652,{"v":31.296,"d":"31"},{"v":54.9916693824,"d":"55"},{"$f":"(L2200+L2201)/2","v":{"v":59.2878935529,"d":"59"}},{"$f":"SQRT((M2200-L2200)*(M2200-L2200))","v":{"v":4.296224170500004,"d":"4"}},{"$f":"N2200/M2200*100","v":{"v":7.246376811594208,"d":"7"}},0,124,8,456,{"v":52.896,"d":"53"},{"v":92.4206899296,"d":"92"},{"$f":"(U2200+U2201)/2","v":{"v":91.0875648083,"d":"91"}},{"$f":"SQRT((V2200-U2200)*(V2200-U2200))","v":{"v":1.3331251213000002,"d":"1"}},{"$f":"W2200/V2200*100","v":{"v":1.4635643450405693,"d":"1"}},{"$f":"X2200+O2200","v":{"v":8.709941156634777,"d":"9"}},{"$f":"(V2200/M2200*100)-100","v":{"v":53.63602811597033,"d":"54"}},null,0,78,10,655,{"v":44.54,"d":"45"},{"v":76.200875956,"d":"76"},{"$f":"(AG2200+AG2201)/2","v":{"v":76.979308793,"d":"77"}},{"$f":"SQRT((AH2200-AG2200)*(AH2200-AG2200))","v":{"v":0.7784328369999969,"d":"1"}},{"$f":"AI2200/AH2200*100","v":{"v":1.0112234692743598,"d":"1"}},{"$f":"AJ2200+O2200","v":{"v":8.257600280868568,"d":"8"}},{"$f":"(AH2200/M2200*100)-100","v":{"v":29.839844494246904,"d":"30"}},null,null,"PYK2","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Fak",{"$nulls":6},"Epitope undefined.",{"$nulls":3},"Protein kinase, tyrosine (non-receptor); Nuclear receptor co-regulator; EC 2.7.10.2; TK domain target; TK</A> group; Fak family","Q14289","Q14289","Q14289",null,"GO:0097440; GO:0044297; GO:0005938; GO:0005737; GO:0005856; GO:0005829; GO:0030425; GO:0043197; GO:0031234; GO:0005925; GO:0098978; GO:0030426; GO:0030027; GO:0045121; GO:0043025; GO:0017146; GO:0005634; GO:0048471; GO:0014069","GO:0043423; GO:0005524; GO:0004683; GO:0004972; GO:0004715; GO:0044877; GO:0008022; GO:0004713; GO:0005102; GO:0031625","GO:0090630; GO:0042976; GO:0002250; GO:0001525; GO:0006915; GO:0043534; GO:0045453; GO:0007166; GO:0006968; GO:0071498; GO:0071300; GO:0070098; GO:0007173; GO:0048041; GO:0014009; GO:0045087; GO:0007229; GO:0038110; GO:0035235; GO:0060292; GO:0060291; GO:0000165; GO:0002315; GO:0043066; GO:0030502; GO:0008285; GO:0010656; GO:0045638; GO:0043524; GO:0043267; GO:0031175; GO:0001556; GO:0038083; GO:0018108; GO:0030838; GO:0045766; GO:2000538; GO:0030307; GO:0001954; GO:0030335; GO:0008284; GO:0007204; GO:2000573; GO:0010595; GO:0070374; GO:2000463; GO:0046330; GO:0043507; GO:0010976; GO:0045429; GO:0051000; GO:0050731; GO:0043552; GO:0045860; GO:0051968; GO:0045727; GO:2000060; GO:0046777; GO:0065003; GO:0006468; GO:2000249; GO:0050848; GO:0030155; GO:0008360; GO:0010752; GO:2000114; GO:0032960; GO:0010758; GO:2000310; GO:0051279; GO:0048167; GO:2000058; GO:0051592; GO:0051591; GO:0042220; GO:0045471; GO:0009749; GO:0009725; GO:0042542; GO:0001666; GO:0035902; GO:0010226; GO:0009612; GO:0006970; GO:0007172; GO:0007165; GO:0002040; GO:0043149; GO:0033209; GO:0048010"]
[2192,1092,"PK787","PYK2 (PTK2B)","Y402","Protein tyrosine kinase 2 beta",0,5294,14,627,{"v":3310.56,"d":"3311"},{"v":5817.140241264,"d":"5817"},{"$nulls":3},0,5455,14,618,{"v":3362.538,"d":"3363"},{"v":5875.0771679238005,"d":"5875"},{"$nulls":6},0,6278,18,659,{"v":4125.34,"d":"4125"},{"v":7057.802461076,"d":"7058"},{"$nulls":7},"PYK2","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Fak",{"$nulls":6},"SDI(pY)AEI(bA)C","Corresponds to amino acid residues S399 to I405; In the region between the FERM_M domain and the protein kinase catalytic domain.","Y402 phosphorylation stimulates phosphotransferase activity. Its phosphorylation regulates cell cycle progression, cell motility, alters intracellular location, and induces binding to ErbB2, RASA1 and Src. This is one of the major sites of in vivo phosphorylation of PYK2.","PYK2 (PTK2B; FAK2); Src",null,"Q14289","Q14289","Q14289"]
[2195,1094,"PK789","PYK2 (PTK2B)","Y579+Y580","Protein tyrosine kinase 2 beta",0,9666,18,657,{"v":6338.736,"d":"6339"},{"v":11138.0903123184,"d":"11138"},{"$f":"(L2208+L2209)/2","v":{"v":10526.8421630968,"d":"10527"}},{"$f":"SQRT((M2208-L2208)*(M2208-L2208))","v":{"v":611.2481492215993,"d":"611"}},{"$f":"N2208/M2208*100","v":{"v":5.806567057349908,"d":"6"}},0,9168,18,654,{"v":5984.1,"d":"5984"},{"v":10455.509879910001,"d":"10456"},{"$f":"(U2208+U2209)/2","v":{"v":11828.5501301695,"d":"11829"}},{"$f":"SQRT((V2208-U2208)*(V2208-U2208))","v":{"v":1373.0402502594989,"d":"1373"}},{"$f":"W2208/V2208*100","v":{"v":11.607849103648544,"d":"12"}},{"$f":"X2208+O2208","v":{"v":17.414416160998453,"d":"17"}},{"$f":"(V2208/M2208*100)-100","v":{"v":12.36560733888463,"d":"12"}},null,0,10022,18,691,{"v":6912.764,"d":"6913"},{"v":11826.642839629601,"d":"11827"},{"$f":"(AG2208+AG2209)/2","v":{"v":11836.9600686923,"d":"11837"}},{"$f":"SQRT((AH2208-AG2208)*(AH2208-AG2208))","v":{"v":10.31722906269897,"d":"10"}},{"$f":"AI2208/AH2208*100","v":{"v":0.08716113768084019,"d":"0"}},{"$f":"AJ2208+O2208","v":{"v":5.893728195030748,"d":"6"}},{"$f":"(AH2208/M2208*100)-100","v":{"v":12.445497759891254,"d":"12"}},null,null,"PYK2","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Fak",{"$nulls":6},"ED(pY)(pY)KAS(bA)C","Corresponds to amino acid residues E577 to S583; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y579 and Y580 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major sites of in vivo phosphorylation of PYK2.","Y579: Src. Y580: Src.","Protein kinase, tyrosine (non-receptor); Nuclear receptor co-regulator; EC 2.7.10.2; TK domain target; TK</A> group; Fak family","Q14289","Q14289","Q14289",null,"GO:0097440; GO:0044297; GO:0005938; GO:0005737; GO:0005856; GO:0005829; GO:0030425; GO:0043197; GO:0031234; GO:0005925; GO:0098978; GO:0030426; GO:0030027; GO:0045121; GO:0043025; GO:0017146; GO:0005634; GO:0048471; GO:0014069","GO:0043423; GO:0005524; GO:0004683; GO:0004972; GO:0004715; GO:0044877; GO:0008022; GO:0004713; GO:0005102; GO:0031625","GO:0090630; GO:0042976; GO:0002250; GO:0001525; GO:0006915; GO:0043534; GO:0045453; GO:0007166; GO:0006968; GO:0071498; GO:0071300; GO:0070098; GO:0007173; GO:0048041; GO:0014009; GO:0045087; GO:0007229; GO:0038110; GO:0035235; GO:0060292; GO:0060291; GO:0000165; GO:0002315; GO:0043066; GO:0030502; GO:0008285; GO:0010656; GO:0045638; GO:0043524; GO:0043267; GO:0031175; GO:0001556; GO:0038083; GO:0018108; GO:0030838; GO:0045766; GO:2000538; GO:0030307; GO:0001954; GO:0030335; GO:0008284; GO:0007204; GO:2000573; GO:0010595; GO:0070374; GO:2000463; GO:0046330; GO:0043507; GO:0010976; GO:0045429; GO:0051000; GO:0050731; GO:0043552; GO:0045860; GO:0051968; GO:0045727; GO:2000060; GO:0046777; GO:0065003; GO:0006468; GO:2000249; GO:0050848; GO:0030155; GO:0008360; GO:0010752; GO:2000114; GO:0032960; GO:0010758; GO:2000310; GO:0051279; GO:0048167; GO:2000058; GO:0051592; GO:0051591; GO:0042220; GO:0045471; GO:0009749; GO:0009725; GO:0042542; GO:0001666; GO:0035902; GO:0010226; GO:0009612; GO:0006970; GO:0007172; GO:0007165; GO:0002040; GO:0043149; GO:0033209; GO:0048010"]
[2199,1096,"PN063","Rac1/cdc42","S71","Ras-related C3 botulinum toxin substrate 1",0,430,8,260,{"v":109.72,"d":"110"},{"v":192.79415786799999,"d":"193"},{"$f":"(L2212+L2213)/2","v":{"v":232.189391366,"d":"232"}},{"$f":"SQRT((M2212-L2212)*(M2212-L2212))","v":{"v":39.39523349800001,"d":"39"}},{"$f":"N2212/M2212*100","v":{"v":16.96685333736946,"d":"17"}},0,716,12,234,{"v":164.736,"d":"165"},{"v":287.8292267136,"d":"288"},{"$f":"(U2212+U2213)/2","v":{"v":248.85235226280003,"d":"249"}},{"$f":"SQRT((V2212-U2212)*(V2212-U2212))","v":{"v":38.97687445079998,"d":"39"}},{"$f":"W2212/V2212*100","v":{"v":15.66265060240963,"d":"16"}},{"$f":"X2212+O2212","v":{"v":32.62950393977909,"d":"33"}},{"$f":"(V2212/M2212*100)-100","v":{"v":7.1764522912824305,"d":"7"}},null,0,573,12,271,{"v":152.031,"d":"152"},{"v":260.1009288834,"d":"260"},{"$f":"(AG2212+AG2213)/2","v":{"v":290.6702430186,"d":"291"}},{"$f":"SQRT((AH2212-AG2212)*(AH2212-AG2212))","v":{"v":30.56931413519999,"d":"31"}},{"$f":"AI2212/AH2212*100","v":{"v":10.516836473434212,"d":"11"}},{"$f":"AJ2212+O2212","v":{"v":27.483689810803675,"d":"27"}},{"$f":"(AH2212/M2212*100)-100","v":{"v":25.18670267773632,"d":"25"}},{"$nulls":5},"Small G protein",{"$nulls":9},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S71 phosphosite.","S71 phosphorylation induces inhibition of Rac1 function. This is one of the major sites of in vivo phosphorylation of Rac1.","Akt1 (PKBa)","G protein; G protein, monomeric (non-Rab)","P63000","P63000",null,"P63000","GO:0005737; GO:0036464; GO:0005829; GO:0043197; GO:0005789; GO:0070062; GO:0101003; GO:0005925; GO:0098978; GO:0000139; GO:0030027; GO:0042470; GO:0016020; GO:0005886; GO:0098794; GO:0055038; GO:0032587; GO:0030667; GO:0005802","GO:0051117; GO:0019899; GO:0003924; GO:0005525; GO:0042826; GO:0019901; GO:0004674; GO:0017137; GO:0051022; GO:0031996","GO:0030036; GO:0030041; GO:0009653; GO:0007596; GO:0045453; GO:0007155; GO:0007160; GO:0048870; GO:0008283; GO:0071260; GO:0048013; GO:0038095; GO:0038096; GO:0007186; GO:0048012; GO:0006954; GO:0035556; GO:0030032; GO:0051668; GO:0002551; GO:0032707; GO:0048261; GO:0001764; GO:0043312; GO:0010811; GO:0045740; GO:0051894; GO:0010592; GO:0031116; GO:0090023; GO:0001934; GO:0035025; GO:0051496; GO:1900026; GO:0016601; GO:0030334; GO:0008361; GO:0050690; GO:0010310; GO:0010591; GO:0060263; GO:0051056; GO:0051492; GO:0009611; GO:0097178; GO:0031529; GO:0071526; GO:0034446; GO:0031295; GO:0048010; GO:0060071"]
[2204,1098,"NK205-4","Raf-A (ARaf)","Pan-specific","A-Raf proto-oncogene serine/threonine-protein kinase",0,9444,16,718,{"v":6769.304,"d":"6769"},{"v":11894.6615387576,"d":"11895"},{"$nulls":3},0,9658,18,798,{"v":7692.72,"d":"7693"},{"v":13440.836544072,"d":"13441"},{"$nulls":6},0,10382,18,724,{"v":7503.536,"d":"7504"},{"v":12837.3600351904,"d":"12837"},{"$nulls":7},"A-RAF","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RAF",{"$nulls":6},"CGYYWEVPPSEVQLLK","Corresponds to amino acid residues G300 to K314.",{"$nulls":3},"P10398","P10398","P10398"]
[2209,1101,"NK156-4","Raf-B (BRaf)","Pan-specific","B-Raf proto-oncogene serine-threonine-protein kinase; RafB proto-oncogene-encoded protein-serine kinase",0,8895,20,679,{"v":6026.125,"d":"6026"},{"v":10588.7868627625,"d":"10589"},{"$f":"(L2222+L2223)/2","v":{"v":10210.61282837105,"d":"10211"}},{"$f":"SQRT((M2222-L2222)*(M2222-L2222))","v":{"v":378.1740343914498,"d":"378"}},{"$f":"N2222/M2222*100","v":{"v":3.703734934896967,"d":"4"}},0,7288,14,617,{"v":4488.058,"d":"4488"},{"v":7841.6027072758,"d":"7842"},{"$f":"(U2222+U2223)/2","v":{"v":8013.1635051599,"d":"8013"}},{"$f":"SQRT((V2222-U2222)*(V2222-U2222))","v":{"v":171.56079788409988,"d":"172"}},{"$f":"W2222/V2222*100","v":{"v":2.1409871116897476,"d":"2"}},{"$f":"X2222+O2222","v":{"v":5.844722046586714,"d":"6"}},{"$f":"(V2222/M2222*100)-100","v":{"v":-21.521228550605215,"d":"-22"}},null,0,9646,12,648,{"v":6242.832,"d":"6243"},{"v":10680.4954388448,"d":"10680"},{"$f":"(AG2222+AG2223)/2","v":{"v":10583.2546353516,"d":"10583"}},{"$f":"SQRT((AH2222-AG2222)*(AH2222-AG2222))","v":{"v":97.24080349319956,"d":"97"}},{"$f":"AI2222/AH2222*100","v":{"v":0.9188175740228611,"d":"1"}},{"$f":"AJ2222+O2222","v":{"v":4.622552508919828,"d":"5"}},{"$f":"(AH2222/M2222*100)-100","v":{"v":3.6495537853040076,"d":"4"}},null,null,"B-RAF","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RAF",{"$nulls":6},"CSDDWEIPDGQITVGQ","Corresponds to amino acid residues S447 to Q461.",null,null,"EC 2.7.1.37; Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; TKL domain target; TKL</A> group; RAF family","P15056","P15056","P15056","P15056","GO:0005829; GO:0005622; GO:0043231; GO:0005634; GO:0005886","GO:0005524; GO:0005509; GO:0042802; GO:0004709; GO:0031434; GO:0004672; GO:0004674","GO:0009887; GO:0030154; GO:0071277; GO:0090150; GO:0000165; GO:0043066; GO:0009968; GO:0070374; GO:0010628; GO:0010828; GO:0033138; GO:0006468; GO:0070413"]
[2214,1103,"PK535","Raf-B (BRaf)","S729","B-Raf proto-oncogene serine-threonine-protein kinase; RafB proto-oncogene-encoded protein-serine kinase",0,3327,14,661,{"v":2189.893,"d":"2190"},{"v":3847.9636962817,"d":"3848"},{"$nulls":3},0,2872,18,531,{"v":1515.474,"d":"1515"},{"v":2647.8590564574,"d":"2648"},{"$nulls":6},0,3285,16,590,{"v":1928.71,"d":"1929"},{"v":3299.7169165940004,"d":"3300"},{"$nulls":7},"B-RAF","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RAF",{"$nulls":6},"RSA(pS)EPS(bA)C","Corresponds to amino acid residues R726 to S732; In the C-terminal region after the kinase catalytic domain.","S729 phosphorylation stimulates phosphotransferase activity and regulates cell differentiation, cell growth, and molecular association with 14-3-3 beta. This is one of the major sites of in vivo phosphorylation of Raf-B.",null,null,"P15056","P15056","P15056","P15056"]
[2217,1105,"NK155-8","Raf1 (RafC)","Pan-specific","Raf1 proto-oncogene-encoded protein-serine kinase",0,1682,14,579,{"v":965.772,"d":"966"},{"v":1697.0032759068001,"d":"1697"},{"$f":"(L2230+L2231)/2","v":{"v":1841.9204521905,"d":"1842"}},{"$f":"SQRT((M2230-L2230)*(M2230-L2230))","v":{"v":144.91717628369997,"d":"145"}},{"$f":"N2230/M2230*100","v":{"v":7.867721763519023,"d":"8"}},0,1788,14,547,{"v":970.378,"d":"970"},{"v":1695.4590943078001,"d":"1695"},{"$f":"(U2230+U2231)/2","v":{"v":1871.2228181149499,"d":"1871"}},{"$f":"SQRT((V2230-U2230)*(V2230-U2230))","v":{"v":175.76372380714974,"d":"176"}},{"$f":"W2230/V2230*100","v":{"v":9.392987414733017,"d":"9"}},{"$f":"X2230+O2230","v":{"v":17.26070917825204,"d":"17"}},{"$f":"(V2230/M2230*100)-100","v":{"v":1.5908594689636004,"d":"2"}},null,0,1989,16,591,{"v":1166.043,"d":"1166"},{"v":1994.9146385801998,"d":"1995"},{"$f":"(AG2230+AG2231)/2","v":{"v":2107.3211956637,"d":"2107"}},{"$f":"SQRT((AH2230-AG2230)*(AH2230-AG2230))","v":{"v":112.40655708350027,"d":"112"}},{"$f":"AI2230/AH2230*100","v":{"v":5.3340970192300405,"d":"5"}},{"$f":"AJ2230+O2230","v":{"v":13.201818782749063,"d":"13"}},{"$f":"(AH2230/M2230*100)-100","v":{"v":14.40891451949365,"d":"14"}},null,null,"RAF1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RAF",{"$nulls":6},"CLTDPSKTSNTIRVFL","Corresponds to amino acid residues L48 to L62.",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; TKL group; RAF family","P04049","P04049","P04049","P04049","GO:0005737; GO:0005829; GO:0005794; GO:0005741; GO:0016607; GO:0005886; GO:0031143","GO:0010856; GO:0008179; GO:0005524; GO:0019899; GO:0042802; GO:0016301; GO:0004709; GO:0046872; GO:0031434; GO:0046982; GO:0004672; GO:0004674","GO:0007190; GO:0000186; GO:0006915; GO:0030154; GO:0008283; GO:0071550; GO:0060324; GO:0007507; GO:0035773; GO:0045104; GO:0034220; GO:0000165; GO:0007275; GO:0043066; GO:0008285; GO:0043154; GO:1902042; GO:0031333; GO:0009968; GO:0048011; GO:0030168; GO:0070374; GO:0033138; GO:0045944; GO:0006468; GO:0042981; GO:0045595; GO:2000145; GO:0035023; GO:0001666; GO:0035994; GO:0007165; GO:0035019; GO:0002223; GO:0048538; GO:0030878; GO:0042060"]
[2221,1107,"PK791","Raf1 (RafC)","S296","Raf1 proto-oncogene-encoded protein-serine kinase",0,5013,16,626,{"v":3128.122,"d":"3128"},{"v":5496.5698751218,"d":"5497"},{"$f":"(L2234+L2235)/2","v":{"v":5951.0436207785,"d":"5951"}},{"$f":"SQRT((M2234-L2234)*(M2234-L2234))","v":{"v":454.4737456567,"d":"454"}},{"$f":"N2234/M2234*100","v":{"v":7.636874716728205,"d":"8"}},0,6519,22,683,{"v":4437.451,"d":"4437"},{"v":7753.1813927101,"d":"7753"},{"$f":"(U2234+U2235)/2","v":{"v":8661.52969415095,"d":"8662"}},{"$f":"SQRT((V2234-U2234)*(V2234-U2234))","v":{"v":908.3483014408494,"d":"908"}},{"$f":"W2234/V2234*100","v":{"v":10.48715796765378,"d":"10"}},{"$f":"X2234+O2234","v":{"v":18.124032684381984,"d":"18"}},{"$f":"(V2234/M2234*100)-100","v":{"v":45.54639901997345,"d":"46"}},null,0,5587,18,642,{"v":3575.298,"d":"3575"},{"v":6116.7678357372,"d":"6117"},{"$f":"(AG2234+AG2235)/2","v":{"v":6212.740050332301,"d":"6213"}},{"$f":"SQRT((AH2234-AG2234)*(AH2234-AG2234))","v":{"v":95.97221459510092,"d":"96"}},{"$f":"AI2234/AH2234*100","v":{"v":1.544764690258812,"d":"2"}},{"$f":"AJ2234+O2234","v":{"v":9.181639406987017,"d":"9"}},{"$f":"(AH2234/M2234*100)-100","v":{"v":4.397488007650779,"d":"4"}},null,null,"RAF1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RAF",{"$nulls":6},"LSS(pS)PNN(bA)C","Corresponds to amino acid residues L293 to N299; In the region between the C1_1 and kinase catalytic domains. ","S296 phosphorylation inhibits phosphotransferase activity and inhibits interaction with H-Ras-1. This is a major in vivo phosphorylation site in Raf1.","ERK1 (MAPK3)","Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; TKL group; RAF family","P04049","P04049","P04049","P04049","GO:0005737; GO:0005829; GO:0005794; GO:0005741; GO:0016607; GO:0005886; GO:0031143","GO:0010856; GO:0008179; GO:0005524; GO:0019899; GO:0042802; GO:0016301; GO:0004709; GO:0046872; GO:0031434; GO:0046982; GO:0004672; GO:0004674","GO:0007190; GO:0000186; GO:0006915; GO:0030154; GO:0008283; GO:0071550; GO:0060324; GO:0007507; GO:0035773; GO:0045104; GO:0034220; GO:0000165; GO:0007275; GO:0043066; GO:0008285; GO:0043154; GO:1902042; GO:0031333; GO:0009968; GO:0048011; GO:0030168; GO:0070374; GO:0033138; GO:0045944; GO:0006468; GO:0042981; GO:0045595; GO:2000145; GO:0035023; GO:0001666; GO:0035994; GO:0007165; GO:0035019; GO:0002223; GO:0048538; GO:0030878; GO:0042060"]
[2226,1109,"PK212","Raf1 (RafC)","S621","Raf1 proto-oncogene-encoded protein-serine kinase",0,835,14,517,{"v":424.457,"d":"424"},{"v":745.8333017333,"d":"746"},{"$nulls":3},0,932,14,485,{"v":445.23,"d":"445"},{"v":777.912578973,"d":"778"},{"$nulls":6},0,1002,18,548,{"v":539.232,"d":"539"},{"v":922.5404298047999,"d":"923"},{"$nulls":7},"RAF1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RAF",{"$nulls":6},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S621 phosphosite.","Phosphorylation of S621 stimulates phosphotransferase activity, but has also been reported to be inhibitory; Phosphorylation regulates protein interactions and cell growth. This is one of the major sites of in vivo phosphorylation of Raf-1.","PKACa (PRKACA); Raf1",null,"P04049","P04049","P04049","P04049"]
[2231,1112,"PN261","Rb","S249+T252","Retinoblastoma-associated protein 1",0,1488,10,524,{"v":774.472,"d":"774"},{"v":1360.8610739368,"d":"1361"},{"$f":"(L2244+L2245)/2","v":{"v":1315.9290705569001,"d":"1316"}},{"$f":"SQRT((M2244-L2244)*(M2244-L2244))","v":{"v":44.932003379899925,"d":"45"}},{"$f":"N2244/M2244*100","v":{"v":3.4144700033782773,"d":"3"}},0,1813,16,569,{"v":1022.493,"d":"1022"},{"v":1786.5152092443002,"d":"1787"},{"$f":"(U2244+U2245)/2","v":{"v":1831.95066431225,"d":"1832"}},{"$f":"SQRT((V2244-U2244)*(V2244-U2244))","v":{"v":45.43545506794976,"d":"45"}},{"$f":"W2244/V2244*100","v":{"v":2.480168049995337,"d":"2"}},{"$f":"X2244+O2244","v":{"v":5.8946380533736145,"d":"6"}},{"$f":"(V2244/M2244*100)-100","v":{"v":39.21348082514584,"d":"39"}},null,0,1708,14,549,{"v":930.006,"d":"930"},{"v":1591.0927670484,"d":"1591"},{"$f":"(AG2244+AG2245)/2","v":{"v":1576.0493386182,"d":"1576"}},{"$f":"SQRT((AH2244-AG2244)*(AH2244-AG2244))","v":{"v":15.043428430200038,"d":"15"}},{"$f":"AI2244/AH2244*100","v":{"v":0.9545023789286541,"d":"1"}},{"$f":"AJ2244+O2244","v":{"v":4.368972382306931,"d":"4"}},{"$f":"(AH2244/M2244*100)-100","v":{"v":19.767043215423243,"d":"20"}},{"$nulls":15},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S249 and T252 phosphosites.","The effects of S249 and T252 phosphorylation are unclear. These are two of the major sites of in vivo phosphorylation of Rb (≥114 and >76 reports, respectively, by mass spectrometry). These human phosphosites are highly conserved in mammals and also found in the chicken.","S249: CDK1 (CDC2); CDK2; CDK4; CDK6. T252: CDK1 (CDC2); CDK2; CDK4; CDK6. ","Nuclear receptor co-regulator; Transcription, coactivator/corepressor; Tumor suppressor","P06400","P06400",null,"P06400","GO:0000785; GO:0005654; GO:0005634; GO:0016605; GO:0035189; GO:0005819; GO:0016514","GO:0050681; GO:0097718; GO:0003677; GO:0003700; GO:0042802; GO:0061676; GO:0019900; GO:0051219; GO:0000987; GO:0001102; GO:0003713; GO:0008134; GO:0031625","GO:0030521; GO:0003180; GO:0007050; GO:0051301; GO:0048667; GO:0071466; GO:0006338; GO:0048565; GO:0043353; GO:0000082; GO:0034349; GO:0097284; GO:0034088; GO:0007093; GO:0045445; GO:0120163; GO:0043433; GO:0050680; GO:2000134; GO:0010629; GO:0050728; GO:1904761; GO:0006469; GO:0045879; GO:0045892; GO:0000122; GO:0071930; GO:0051402; GO:0042551; GO:0031175; GO:1904028; GO:1903055; GO:0045651; GO:0045842; GO:0045893; GO:0045944; GO:2000679; GO:0071459; GO:0007265; GO:0001558; GO:0090230; GO:0071922; GO:0043550; GO:0007346; GO:0006355; GO:0031134; GO:0035914; GO:0051146; GO:0001894; GO:0006351; GO:0016032"]
[2232,1112,"PN261","Rb","S249+T252","Retinoblastoma-associated protein 1",0,1420,10,513,{"v":723.33,"d":"723"},{"v":1270.997067177,"d":"1271"},{"$nulls":3},0,1873,14,578,{"v":1074.502,"d":"1075"},{"v":1877.3861193802,"d":"1877"},{"$nulls":6},0,1656,12,555,{"v":912.42,"d":"912"},{"v":1561.005910188,"d":"1561"},{"$nulls":20},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S249 and T252 phosphosites.","The effects of S249 and T252 phosphorylation are unclear. These are two of the major sites of in vivo phosphorylation of Rb (≥114 and >76 reports, respectively, by mass spectrometry). These human phosphosites are highly conserved in mammals and also found in the chicken.","S249: CDK1 (CDC2); CDK2; CDK4; CDK6. T252: CDK1 (CDC2); CDK2; CDK4; CDK6. ",null,"P06400","P06400",null,"P06400"]
[2240,1116,"PN067","Rb","S780","Retinoblastoma-associated protein 1",0,835,10,214,{"v":176.55,"d":"177"},{"v":310.224285195,"d":"310"},{"$nulls":3},0,578,14,245,{"v":138.18,"d":"138"},{"v":241.430182518,"d":"241"},{"$nulls":6},0,664,10,275,{"v":179.85,"d":"180"},{"v":307.69482579,"d":"308"},{"$nulls":20},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S780 phosphosites.","S780 phosphorylation reported to both inhibit and induce interaction with E2F1. This is one of the major sites of in vivo phosphorylation of Rb.","CDK4, CDK6;  PKACa (PRKACA)",null,"P06400","P06400",null,"P06400"]
[2243,1119,"PN070","Rb","T821","Retinoblastoma-associated protein 1",0,1830,10,332,{"v":604.24,"d":"604"},{"v":1061.738442856,"d":"1062"},{"$f":"(L2256+L2257)/2","v":{"v":1316.41492167475,"d":"1316"}},{"$f":"SQRT((M2256-L2256)*(M2256-L2256))","v":{"v":254.67647881875018,"d":"255"}},{"$f":"N2256/M2256*100","v":{"v":19.346216350597835,"d":"19"}},0,2911,14,301,{"v":871.997,"d":"872"},{"v":1523.5663255547,"d":"1524"},{"$f":"(U2256+U2257)/2","v":{"v":1669.09099762615,"d":"1669"}},{"$f":"SQRT((V2256-U2256)*(V2256-U2256))","v":{"v":145.52467207145014,"d":"146"}},{"$f":"W2256/V2256*100","v":{"v":8.718797973173501,"d":"9"}},{"$f":"X2256+O2256","v":{"v":28.065014323771337,"d":"28"}},{"$f":"(V2256/M2256*100)-100","v":{"v":26.79064709345012,"d":"27"}},null,0,2242,10,375,837,{"v":1431.9742518,"d":"1432"},{"$f":"(AG2256+AG2257)/2","v":{"v":1512.546327533,"d":"1513"}},{"$f":"SQRT((AH2256-AG2256)*(AH2256-AG2256))","v":{"v":80.57207573300002,"d":"81"}},{"$f":"AI2256/AH2256*100","v":{"v":5.326916225066312,"d":"5"}},{"$f":"AJ2256+O2256","v":{"v":24.673132575664148,"d":"25"}},{"$f":"(AH2256/M2256*100)-100","v":{"v":14.898904792778438,"d":"15"}},{"$nulls":15},"Not precisely defined.","Antibody raised against amino acid residues that encompass the T821 phosphosite.","T821 phosphorylation inhibits interaction with E2F1, Elf-1 and TFDP1, and induces binding with Rb. This is one of the major sites of in vivo phosphorylation of Rb.","CDK2; CDK6","Nuclear receptor co-regulator; Transcription, coactivator/corepressor; Tumor suppressor","P06400","P06400",null,"P06400","GO:0000785; GO:0005654; GO:0005634; GO:0016605; GO:0035189; GO:0005819; GO:0016514","GO:0050681; GO:0097718; GO:0003677; GO:0003700; GO:0042802; GO:0061676; GO:0019900; GO:0051219; GO:0000987; GO:0001102; GO:0003713; GO:0008134; GO:0031625","GO:0030521; GO:0003180; GO:0007050; GO:0051301; GO:0048667; GO:0071466; GO:0006338; GO:0048565; GO:0043353; GO:0000082; GO:0034349; GO:0097284; GO:0034088; GO:0007093; GO:0045445; GO:0120163; GO:0043433; GO:0050680; GO:2000134; GO:0010629; GO:0050728; GO:1904761; GO:0006469; GO:0045879; GO:0045892; GO:0000122; GO:0071930; GO:0051402; GO:0042551; GO:0031175; GO:1904028; GO:1903055; GO:0045651; GO:0045842; GO:0045893; GO:0045944; GO:2000679; GO:0071459; GO:0007265; GO:0001558; GO:0090230; GO:0071922; GO:0043550; GO:0007346; GO:0006355; GO:0031134; GO:0035914; GO:0051146; GO:0001894; GO:0006351; GO:0016032"]
[2248,1120,"PN071","Rb","T826","Retinoblastoma-associated protein 1",0,1632,18,526,{"v":848.964,"d":"849"},{"v":1491.7544608116,"d":"1492"},{"$nulls":3},0,1484,16,629,{"v":923.372,"d":"923"},{"v":1613.3295013171999,"d":"1613"},{"$nulls":6},0,1428,20,548,{"v":771.584,"d":"772"},{"v":1320.0578507776,"d":"1320"},{"$nulls":20},"Not precisely defined.","Antibody raised against amino acid residues that encompass the T826 phosphosite.","T826 phosphorylation inhibits interaction with E2F1, Elf-1 and TFDP1, and induces binding with Rb. This is one of the major sites of in vivo phosphorylation of Rb.","CDK2; CDK4; CDK6",null,"P06400","P06400",null,"P06400"]
[2249,1121,"PN649","RBM9 iso6","T7","RNA-binding protein 9",0,13642,22,704,{"v":9588.48,"d":"9588"},{"v":16848.367907712,"d":"16848"},{"$f":"(L2262+L2263)/2","v":{"v":18049.360242393,"d":"18049"}},{"$f":"SQRT((M2262-L2262)*(M2262-L2262))","v":{"v":1200.9923346809992,"d":"1201"}},{"$f":"N2262/M2262*100","v":{"v":6.653932984617357,"d":"7"}},0,14273,22,745,{"v":10616.995,"d":"10617"},{"v":18550.173980624502,"d":"18550"},{"$f":"(U2262+U2263)/2","v":{"v":18056.1506583146,"d":"18056"}},{"$f":"SQRT((V2262-U2262)*(V2262-U2262))","v":{"v":494.02332230990214,"d":"494"}},{"$f":"W2262/V2262*100","v":{"v":2.736038991136859,"d":"3"}},{"$f":"X2262+O2262","v":{"v":9.389971975754216,"d":"9"}},{"$f":"(V2262/M2262*100)-100","v":{"v":0.03762136624460766,"d":"0"}},null,0,13232,22,730,{"v":9643.3,"d":"9643"},{"v":16498.15687262,"d":"16498"},{"$f":"(AG2262+AG2263)/2","v":{"v":17140.047457485998,"d":"17140"}},{"$f":"SQRT((AH2262-AG2262)*(AH2262-AG2262))","v":{"v":641.8905848659997,"d":"642"}},{"$f":"AI2262/AH2262*100","v":{"v":3.7449755402261204,"d":"4"}},{"$f":"AJ2262+O2262","v":{"v":10.398908524843478,"d":"10"}},{"$f":"(AH2262/M2262*100)-100","v":{"v":-5.037922522989348,"d":"-5"}},{"$nulls":10},"X",{"$nulls":4},"NEPL(pT)PGYHGC","Corresponds to amino acid residues N3 to G12.","The effect of T7 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of RBM9 isoform 6.","ERK1 (MAPK3)",null,"O43251","O43251",null,null,"GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0003729; GO:0003723; GO:0003714; GO:0008134","GO:0048813; GO:0008543; GO:0030520; GO:0006397; GO:0045892; GO:0007399; GO:0050885; GO:0021942; GO:0000381; GO:0042127; GO:0010724; GO:0016070; GO:0008380"]
[2254,1123,"NN170","RelB","Pan-specific","Transcription factor RelB",0,204,10,413,{"v":80.122,"d":"80"},{"v":140.7861239218,"d":"141"},{"$nulls":3},0,1616,14,276,{"v":442.152,"d":"442"},{"v":772.5346508952,"d":"773"},{"$nulls":6},0,1693,12,295,{"v":495.895,"d":"496"},{"v":848.397696053,"d":"848"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"LLSPG","Corresponds to amino acid residues  L550 to G554; Surrounds the S552 phosphosite.",{"$nulls":3},"Q01201","Q01201",null,"Q01201"]
[2258,1125,"NK244-2","Ret (GDNF receptor)","Pan-specific","Proto-oncogene tyrosine-protein kinase receptor Ret",0,5282,12,670,{"v":3530.9,"d":"3531"},{"v":6204.30998921,"d":"6204"},{"$nulls":3},0,5556,16,624,{"v":3456.96,"d":"3457"},{"v":6040.0527120960005,"d":"6040"},{"$nulls":6},0,6082,16,671,{"v":4070.286,"d":"4070"},{"v":6963.6137986404,"d":"6964"},{"$nulls":7},"RET","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Ret",{"$nulls":6},"CKRPVFADISKDLEKM","Corresponds to amino acid residues K994 to M1008; Kinase last alpha-chain.",{"$nulls":3},"P07949","P07949","P07949","P07949"]
[2265,1130,"PK890","RIOK2","S332+S335+S337","Serine/threonine-protein kinase RIO2",0,10674,12,580,{"v":6183.96,"d":"6184"},{"v":10866.126143724,"d":"10866"},{"$f":"(L2278+L2279)/2","v":{"v":11151.170513842,"d":"11151"}},{"$f":"SQRT((M2278-L2278)*(M2278-L2278))","v":{"v":285.0443701180011,"d":"285"}},{"$f":"N2278/M2278*100","v":{"v":2.556183404819917,"d":"3"}},0,12107,15,573,{"v":6928.716,"d":"6929"},{"v":12105.9572188116,"d":"12106"},{"$f":"(U2278+U2279)/2","v":{"v":12029.268453642399,"d":"12029"}},{"$f":"SQRT((V2278-U2278)*(V2278-U2278))","v":{"v":76.68876516920136,"d":"77"}},{"$f":"W2278/V2278*100","v":{"v":0.6375181123003403,"d":"1"}},{"$f":"X2278+O2278","v":{"v":3.193701517120257,"d":"3"}},{"$f":"(V2278/M2278*100)-100","v":{"v":7.874491190950877,"d":"8"}},null,0,11644,12,616,{"v":7165.312,"d":"7165"},{"v":12258.7124135168,"d":"12259"},{"$f":"(AG2278+AG2279)/2","v":{"v":12805.3459154929,"d":"12805"}},{"$f":"SQRT((AH2278-AG2278)*(AH2278-AG2278))","v":{"v":546.6335019761009,"d":"547"}},{"$f":"AI2278/AH2278*100","v":{"v":4.268791374973644,"d":"4"}},{"$f":"AJ2278+O2278","v":{"v":6.824974779793561,"d":"7"}},{"$f":"(AH2278/M2278*100)-100","v":{"v":14.834096560514112,"d":"15"}},null,null,"RIOK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","RIO","RIO2",{"$nulls":5},"KEG(pS)EF(pS)F(pS)DGC","Corresponds to amino acid residues K329 to G339. S332, S335 and S337 are located in RIOK2 after the RIO domain.","The effect of their phosphoryation on RIOK2 is unknown. S332+S335+S337 are major sites of phosphorylation of RIOK2 from mass spectrometry studies (≥40-, >37-, and >50-times, respectively). ",null,"EC 2.7.11.1; Protein kinase, atypical; ATYPICAL domain target; ATYPICAL</A> group; RIO family; RIO2 subfamily","Q9BVS4","Q9BVS4","Q9BVS4",null,"GO:0005737; GO:0005829; GO:0005654; GO:0030688","GO:0005524; GO:0046872; GO:0004674","GO:0007049; GO:0030490; GO:2000208; GO:2000234; GO:0046777; GO:0030071; GO:0042274"]
[2266,1130,"PK890","RIOK2","S332+S335+S337","Serine/threonine-protein kinase RIO2",0,10614,14,614,{"v":6508.4,"d":"6508"},{"v":11436.21488396,"d":"11436"},{"$nulls":3},0,11934,16,574,{"v":6840.932,"d":"6841"},{"v":11952.579688473199,"d":"11953"},{"$nulls":6},0,12830,15,609,{"v":7804.335,"d":"7804"},{"v":13351.979417469001,"d":"13352"},{"$nulls":7},"RIOK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","RIO","RIO2",{"$nulls":5},"KEG(pS)EF(pS)F(pS)DGC","Corresponds to amino acid residues K329 to G339. S332, S335 and S337 are located in RIOK2 after the RIO domain.","The effect of their phosphoryation on RIOK2 is unknown. S332+S335+S337 are major sites of phosphorylation of RIOK2 from mass spectrometry studies (≥40-, >37-, and >50-times, respectively). ",null,null,"Q9BVS4","Q9BVS4","Q9BVS4"]
[2271,1128,"NK157-3","RIPK2 (RICK; RIP2; CARD3)","Pan-specific","Receptor-interacting serine-threonine-protein kinase 2",0,298,8,510,{"v":147.9,"d":"148"},{"v":259.88202651,"d":"260"},{"$f":"(L2284+L2285)/2","v":{"v":268.7081753887,"d":"269"}},{"$f":"SQRT((M2284-L2284)*(M2284-L2284))","v":{"v":8.826148878699996,"d":"9"}},{"$f":"N2284/M2284*100","v":{"v":3.284659599929375,"d":"3"}},0,376,14,572,{"v":207.064,"d":"207"},{"v":361.78534746639997,"d":"362"},{"$f":"(U2284+U2285)/2","v":{"v":316.6932201656,"d":"317"}},{"$f":"SQRT((V2284-U2284)*(V2284-U2284))","v":{"v":45.09212730079997,"d":"45"}},{"$f":"W2284/V2284*100","v":{"v":14.238425210751634,"d":"14"}},{"$f":"X2284+O2284","v":{"v":17.52308481068101,"d":"18"}},{"$f":"(V2284/M2284*100)-100","v":{"v":17.85767950955983,"d":"18"}},null,0,304,10,524,{"v":154.056,"d":"154"},{"v":263.56538271840003,"d":"264"},{"$f":"(AG2284+AG2285)/2","v":{"v":291.3426036888,"d":"291"}},{"$f":"SQRT((AH2284-AG2284)*(AH2284-AG2284))","v":{"v":27.77722097039998,"d":"28"}},{"$f":"AI2284/AH2284*100","v":{"v":9.534211824395737,"d":"10"}},{"$f":"AJ2284+O2284","v":{"v":12.818871424325112,"d":"13"}},{"$f":"(AH2284/M2284*100)-100","v":{"v":8.423423763478041,"d":"8"}},null,null,"RIPK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RIPK",{"$nulls":6},"Epitope undefined.",{"$nulls":3},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; TKL group; RIPK family","O43353","O43353","O43353",null,"GO:0005737; GO:0005856; GO:0005829; GO:0032991; GO:0031982","GO:0005524; GO:0050700; GO:0089720; GO:0042802; GO:0030274; GO:0004715; GO:0042803; GO:0004674; GO:0005102","GO:0097202; GO:0000187; GO:0002250; GO:0006915; GO:0071223; GO:0071225; GO:0071224; GO:0050830; GO:0007249; GO:0006954; GO:0045087; GO:0070498; GO:0007254; GO:0031663; GO:0000165; GO:0043066; GO:0070427; GO:0070431; GO:0070423; GO:0046641; GO:0043065; GO:0010942; GO:0032722; GO:0001961; GO:0070374; GO:0043123; GO:0033091; GO:0032727; GO:0032728; GO:0032729; GO:0032735; GO:0050718; GO:0032743; GO:0032755; GO:0046330; GO:0051092; GO:0033138; GO:0010800; GO:0050731; GO:0032092; GO:0031398; GO:0045627; GO:0045944; GO:0032760; GO:1904417; GO:0043330; GO:0070671; GO:0070673; GO:0007165; GO:0042098; GO:0050852; GO:0034134; GO:0034142"]
[2276,1134,"PK796","RIPK2 (RICK; RIP2; CARD3)","S176","Receptor-interacting serine/threonine-protein kinase 2 (RIPK2)",0,9287,38,717,{"v":6631.533,"d":"6632"},{"v":11652.5776531977,"d":"11653"},{"$nulls":3},0,11682,26,690,{"v":8042.64,"d":"8043"},{"v":14052.222051864,"d":"14052"},{"$nulls":6},0,9944,24,662,{"v":6567.04,"d":"6567"},{"v":11235.163907456,"d":"11235"},{"$nulls":7},"RIPK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RIPK",{"$nulls":6},"MSL(pS)QSR(bA)C","Corresponds to amino acid residues M173 to R179; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S176 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of RIPK2.","RIPK2",null,"O43353","O43353","O43353"]
[2281,1138,"PK798","ROCK1 (ROKb)","Y913","Rho-associated protein kinase 1",0,9426,16,646,{"v":6078.86,"d":"6079"},{"v":10681.450004534,"d":"10681"},{"$f":"(L2294+L2295)/2","v":{"v":11073.6328925857,"d":"11074"}},{"$f":"SQRT((M2294-L2294)*(M2294-L2294))","v":{"v":392.1828880517005,"d":"392"}},{"$f":"N2294/M2294*100","v":{"v":3.541591922505258,"d":"4"}},0,9184,18,634,{"v":5811.244,"d":"5811"},{"v":10153.493266584399,"d":"10153"},{"$f":"(U2294+U2295)/2","v":{"v":10930.1181480287,"d":"10930"}},{"$f":"SQRT((V2294-U2294)*(V2294-U2294))","v":{"v":776.6248814443006,"d":"777"}},{"$f":"W2294/V2294*100","v":{"v":7.10536584258578,"d":"7"}},{"$f":"X2294+O2294","v":{"v":10.646957765091038,"d":"11"}},{"$f":"(V2294/M2294*100)-100","v":{"v":-1.2960041745025563,"d":"-1"}},null,0,9708,18,663,{"v":6424.47,"d":"6424"},{"v":10991.249249058,"d":"10991"},{"$f":"(AG2294+AG2295)/2","v":{"v":11786.1078743394,"d":"11786"}},{"$f":"SQRT((AH2294-AG2294)*(AH2294-AG2294))","v":{"v":794.8586252813984,"d":"795"}},{"$f":"AI2294/AH2294*100","v":{"v":6.744029782825567,"d":"7"}},{"$f":"AJ2294+O2294","v":{"v":10.285621705330826,"d":"10"}},{"$f":"(AH2294/M2294*100)-100","v":{"v":6.433976895068767,"d":"6"}},null,null,"ROCK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","DMPK","ROCK",{"$nulls":5},"EEQ(pY)FEL(bA)C","Corresponds to amino acid residues E910 to L916; Just before Rho-Binding domain.","The effect of Y913 phosphorylation is unclear. This is the major in vivo phosphorylation site in ROCK1.",null,null,"Q13464","Q13464","Q13464",null,"GO:0032059; GO:0005814; GO:0010494; GO:0005856; GO:0005829; GO:0005576; GO:0000139; GO:0030027; GO:0005886; GO:0001726; GO:0034774","GO:0005524; GO:0017049; GO:0046872; GO:0004672; GO:0004674","GO:0030036; GO:0003383; GO:0006915; GO:0032060; GO:0030866; GO:0048013; GO:0007186; GO:0007249; GO:0007159; GO:0050900; GO:0050901; GO:0022614; GO:0051451; GO:1902430; GO:1902992; GO:0016525; GO:1903347; GO:0070168; GO:0051045; GO:0035509; GO:0043524; GO:0032091; GO:0140058; GO:0031175; GO:0043312; GO:1900223; GO:0010508; GO:0010613; GO:1905205; GO:0051894; GO:0010628; GO:0043410; GO:0072659; GO:0006468; GO:0032956; GO:1902003; GO:0110061; GO:0010506; GO:0030155; GO:2000145; GO:2000114; GO:1903140; GO:0051893; GO:0045616; GO:0045664; GO:0051492; GO:1900242; GO:1990776; GO:0071559; GO:0007266; GO:0007165; GO:0006939; GO:0048010"]
[2283,1139,"NK159-1","ROCK2 (ROKa)","Pan-specific","Rho-associated protein kinase 2",0,1020,10,293,{"v":295.93,"d":"296"},{"v":519.992482117,"d":"520"},{"$f":"(L2296+L2297)/2","v":{"v":558.7270283805999,"d":"559"}},{"$f":"SQRT((M2296-L2296)*(M2296-L2296))","v":{"v":38.734546263599896,"d":"39"}},{"$f":"N2296/M2296*100","v":{"v":6.932642291508093,"d":"7"}},0,1190,13,278,{"v":327.206,"d":"327"},{"v":571.6992640106,"d":"572"},{"$f":"(U2296+U2297)/2","v":{"v":548.3442397689,"d":"548"}},{"$f":"SQRT((V2296-U2296)*(V2296-U2296))","v":{"v":23.355024241699994,"d":"23"}},{"$f":"W2296/V2296*100","v":{"v":4.259190221737896,"d":"4"}},{"$f":"X2296+O2296","v":{"v":11.191832513245988,"d":"11"}},{"$f":"(V2296/M2296*100)-100","v":{"v":-1.858293600328068,"d":"-2"}},null,0,1010,12,304,{"v":303.392,"d":"303"},{"v":519.0555940288,"d":"519"},{"$f":"(AG2296+AG2297)/2","v":{"v":436.076364446,"d":"436"}},{"$f":"SQRT((AH2296-AG2296)*(AH2296-AG2296))","v":{"v":82.97922958279997,"d":"83"}},{"$f":"AI2296/AH2296*100","v":{"v":19.0286005727961,"d":"19"}},{"$f":"AJ2296+O2296","v":{"v":25.961242864304193,"d":"26"}},{"$f":"(AH2296/M2296*100)-100","v":{"v":-21.951804316696013,"d":"-22"}},null,null,"ROCK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","DMPK","ROCK",{"$nulls":5},"Epitope undefined.",{"$nulls":3},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; AGC domain target; AGC</A> group; DMPK family; ROCK subfamily","O75116","O75116","O75116",null,"GO:0005813; GO:0036464; GO:0005829; GO:0005634; GO:0005886","GO:0005524; GO:0046872; GO:0004674; GO:0072518; GO:0017048; GO:0003723; GO:0005198","GO:0071394; GO:0051298; GO:0030866; GO:0048013; GO:0007186; GO:0007249; GO:0016525; GO:1903347; GO:0070168; GO:0035509; GO:0150033; GO:0018105; GO:0018107; GO:1902004; GO:1902993; GO:1902961; GO:0010613; GO:0030335; GO:0010825; GO:0032723; GO:1905205; GO:0010595; GO:0090271; GO:0010628; GO:0043410; GO:1902966; GO:0001934; GO:0051496; GO:0072659; GO:0006468; GO:0032956; GO:0110061; GO:0030155; GO:2000145; GO:0042752; GO:2000114; GO:1903140; GO:0051893; GO:0045616; GO:0051246; GO:0051492; GO:1990776; GO:0071559; GO:0007266; GO:0048511; GO:0006939; GO:0048010; GO:0039694"]
[2288,1141,"PK799","ROCK2 (ROKa)","Y722","Rho-associated protein kinase 2",0,2809,16,540,{"v":1508.22,"d":"1508"},{"v":2650.164097518,"d":"2650"},{"$nulls":3},0,2990,16,525,{"v":1561.35,"d":"1561"},{"v":2728.014296385,"d":"2728"},{"$nulls":6},0,3396,16,605,{"v":2044.9,"d":"2045"},{"v":3498.4995788600004,"d":"3498"},{"$nulls":7},"ROCK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","DMPK","ROCK",{"$nulls":5},"NKI(pY)ESI(bA)C","Corresponds to amino acid residues N719 to I725; In the region between the kinase catalytic and Rho_Binding domains. ","Y722 phosphorylation inhibits phosphotransferase activity and inhibits interaction with RhoA. This is the major site of in vivo phosphorylation of ROCK2.",null,null,"O75116","O75116","O75116"]
[2293,1144,"PK801","Ron (RONa)","Y1238+Y1239","Macrophage-stimulating protein receptor alpha chain",0,7822,14,669,{"v":5223.552,"d":"5224"},{"v":9178.5482037888,"d":"9179"},{"$f":"(L2306+L2307)/2","v":{"v":9229.76552163,"d":"9230"}},{"$f":"SQRT((M2306-L2306)*(M2306-L2306))","v":{"v":51.21731784120129,"d":"51"}},{"$f":"N2306/M2306*100","v":{"v":0.5549146153406959,"d":"1"}},0,9338,16,621,{"v":5788.962,"d":"5789"},{"v":10114.561819726201,"d":"10115"},{"$f":"(U2306+U2307)/2","v":{"v":10380.187436949,"d":"10380"}},{"$f":"SQRT((V2306-U2306)*(V2306-U2306))","v":{"v":265.6256172227986,"d":"266"}},{"$f":"W2306/V2306*100","v":{"v":2.5589674448197894,"d":"3"}},{"$f":"X2306+O2306","v":{"v":3.1138820601604853,"d":"3"}},{"$f":"(V2306/M2306*100)-100","v":{"v":12.464259385820583,"d":"12"}},null,0,8866,16,704,{"v":6230.4,"d":"6230"},{"v":10659.22625856,"d":"10659"},{"$f":"(AG2306+AG2307)/2","v":{"v":10797.71886989,"d":"10798"}},{"$f":"SQRT((AH2306-AG2306)*(AH2306-AG2306))","v":{"v":138.49261133000073,"d":"138"}},{"$f":"AI2306/AH2306*100","v":{"v":1.282609901209732,"d":"1"}},{"$f":"AJ2306+O2306","v":{"v":1.837524516550428,"d":"2"}},{"$f":"(AH2306/M2306*100)-100","v":{"v":16.988008466580155,"d":"17"}},null,null,"RON","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK","Met",{"$nulls":6},"DRE(pY)(pY)SV(bA)C","Corresponds to amino acid residues D1235 to V1241; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y1238 and Y1239 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major sites of in vivo phosphorylation of Ron.",null,"EC 2.7.10.1; Receptor tyrosine kinase; TK domain target; TK</A> group; Met family","Q04912","Q04912","Q04912","Q04912","GO:0009986; GO:0005887; GO:0005886; GO:0001725; GO:0005773","GO:0005524; GO:0019899; GO:0005011","GO:0006952; GO:0048012; GO:0045087; GO:0008284; GO:0043406; GO:0051897; GO:0009615; GO:0007165; GO:0007338"]
[2298,1146,"PN651","RORA","S35","Nuclear receptor ROR-alpha",0,7581,24,691,{"v":5221.887,"d":"5222"},{"v":9175.6225542003,"d":"9176"},{"$nulls":3},0,7556,18,691,{"v":5208.758,"d":"5209"},{"v":9100.820629845799,"d":"9101"},{"$nulls":6},0,7445,16,699,{"v":5192.871,"d":"5193"},{"v":8884.178691659401,"d":"8884"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"LNQE(pS)ARK(bA)C","Corresponds to amino acid residues L31 to K38.","S35 phosphorylation induces interaction with CTNNB1. This is one of the major sites of in vivo phosphorylation of RORA.","PKCa (PRKCA)",null,"P35398","P35398"]
[2299,1147,"NK163-3","Ros","Pan-specific","Orosomucoid 1 receptor-tyrosine kinase; Proto-oncogene tyrosine-protein kinase ROS1",0,6159,20,658,{"v":4039.462,"d":"4039"},{"v":7097.9281309678,"d":"7098"},{"$f":"(L2312+L2313)/2","v":{"v":8365.9573770307,"d":"8366"}},{"$f":"SQRT((M2312-L2312)*(M2312-L2312))","v":{"v":1268.0292460628998,"d":"1268"}},{"$f":"N2312/M2312*100","v":{"v":15.157012986276497,"d":"15"}},0,6762,18,662,{"v":4464.528,"d":"4465"},{"v":7800.4907359728,"d":"7800"},{"$f":"(U2312+U2313)/2","v":{"v":7936.8434023768,"d":"7937"}},{"$f":"SQRT((V2312-U2312)*(V2312-U2312))","v":{"v":136.35266640400005,"d":"136"}},{"$f":"W2312/V2312*100","v":{"v":1.7179709802913248,"d":"2"}},{"$f":"X2312+O2312","v":{"v":16.87498396656782,"d":"17"}},{"$f":"(V2312/M2312*100)-100","v":{"v":-5.129287125369061,"d":"-5"}},null,0,6576,18,683,{"v":4479.114,"d":"4479"},{"v":7663.0536665196,"d":"7663"},{"$f":"(AG2312+AG2313)/2","v":{"v":7577.891403310399,"d":"7578"}},{"$f":"SQRT((AH2312-AG2312)*(AH2312-AG2312))","v":{"v":85.16226320920032,"d":"85"}},{"$f":"AI2312/AH2312*100","v":{"v":1.1238253318330376,"d":"1"}},{"$f":"AJ2312+O2312","v":{"v":16.280838318109534,"d":"16"}},{"$f":"(AH2312/M2312*100)-100","v":{"v":-9.419913803099078,"d":"-9"}},null,null,"ROS1","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Sev",{"$nulls":6},"CAIHTLPTQEEIENLP","Corresponds to amino acid residues A1924 to P1938.",null,null,"EC 2.7.10.1; Receptor tyrosine kinase; TK group; Sev family","P08922","P08922","P08922","P08922","GO:0009986; GO:0016021; GO:0016020; GO:0048471; GO:0005886","GO:0005524; GO:0019903; GO:0004713; GO:0004714","GO:0030154; GO:0008283; GO:0002066; GO:0010629; GO:0038083; GO:0006468; GO:0001558; GO:0070372; GO:0010966; GO:0032006; GO:0023014; GO:0007283; GO:0007169"]
[2305,1150,"PN685","RPS6","S235+S236","40S Ribosomal S6",0,10060,16,605,{"$f":"(H2318-I2318)*J2318/1000","v":{"v":6076.62,"d":"6077"}},{"v":10677.513995477999,"d":"10678"},{"$f":"(L2318+L2319)/2","v":{"v":10770.2526945662,"d":"10770"}},{"$f":"SQRT((M2318-L2318)*(M2318-L2318))","v":{"v":92.73869908820052,"d":"93"}},{"$f":"N2318/M2318*100","v":{"v":0.8610633540194371,"d":"1"}},0,10084,22,760,{"$f":"(Q2318-R2318)*S2318/1000","v":{"v":7647.12,"d":"7647"}},{"v":13361.163535512,"d":"13361"},{"$f":"(U2318+U2319)/2","v":{"v":13234.2318529272,"d":"13234"}},{"$f":"SQRT((V2318-U2318)*(V2318-U2318))","v":{"v":126.9316825848,"d":"127"}},{"$f":"W2318/V2318*100","v":{"v":0.9591163582095228,"d":"1"}},{"$f":"X2318+O2318","v":{"v":1.8201797122289598,"d":"2"}},{"$f":"(V2318/M2318*100)-100","v":{"v":22.877635541495934,"d":"23"}},null,0,9772,18,635,{"$f":"(AC2318-AD2318)*AE2318/1000","v":{"v":6193.79,"d":"6194"}},{"v":10596.592354906,"d":"10597"},{"$f":"(AG2318+AG2319)/2","v":{"v":10964.876628877,"d":"10965"}},{"$f":"SQRT((AH2318-AG2318)*(AH2318-AG2318))","v":{"v":368.2842739709995,"d":"368"}},{"$f":"AI2318/AH2318*100","v":{"v":3.3587634994550633,"d":"3"}},{"$f":"AJ2318+O2318","v":{"v":4.2198268534745,"d":"4"}},{"$f":"(AH2318/M2318*100)-100","v":{"v":1.8070507705821228,"d":"2"}},{"$nulls":5},"Translation protein - 40S ribosomal protein subunit",{"$nulls":9},"RRL(pS)(pS)LRA(bA)C     ","Corresponds to amino acid residues R232 to A239. S235 and S236 are located near the C-terminus of the protein. Phosphorylation appears to induce interaction with mRNA for proteins involved in protein synthesis, which often have a 7-methylGuanylate cap.","S235+S236 phosphorylation is believed to increase the translation of mRNA important for protein synthesis by facilitating the assembly of the preinitiation complex. S235 and S236 are the major sites of phosphorylation of the 40S ribosomal protein S6.","S235: Akt1 (PKBa); Akt2 (PKBb); AurB (STK12); DAPK1; p70S6K (RPS6KB1); PASK; PKACa (PRKACA); PKCd (PRKCD); RSK1 (RPS6KA1); RSK2 (RPS6KA3). S236: Akt1 (PKBa); Akt2 (PKBb); AurB (STK12); DAPK1; p70S6K (RPS6KB1); PASK; PKACa (PRKACA); PKCd (PRKCD); RSK1 (RPS6KA1); RSK2 (RPS6KA3).","Protein synthesis, 40S ribosome","P62753","P62753",null,null,"GO:0044297; GO:0036464; GO:0005829; GO:0022627; GO:0030425; GO:0005783; GO:0016020; GO:0005730; GO:0005654; GO:0005634; GO:1990904; GO:0015935","GO:0019901; GO:0003723; GO:0003735","GO:0042593; GO:0000184; GO:0043065; GO:0042274; GO:0006364; GO:0006614; GO:0031929; GO:0006412; GO:0006413"]
[2310,1152,"PN268","RPS6","S236","40S Ribosomal S6",0,342,48,561,{"v":164.934,"d":"165"},{"v":289.8132668046,"d":"290"},{"$nulls":3},0,300,12,618,{"v":177.984,"d":"178"},{"v":310.97633235840004,"d":"311"},{"$nulls":6},0,314,12,580,{"v":175.16,"d":"175"},{"$f":"AF2323*1.7108414","v":{"v":299.670979624,"d":"300"}},{"$nulls":20},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S236 phosphosite.","S236 phosphorylation is believed to increase the translation of mRNA important for protein synthesis by facilitating the assembly of the preinitiation complex. S236 is a the major site of phosphorylation of the 40S ribosomal protein S6.","S236: Akt1 (PKBa); Akt2 (PKBb); AurB (STK12); DAPK1; p70S6K (RPS6KB1); PASK; PKACa (PRKACA); PKCd (PRKCD); RSK1 (RPS6KA1); RSK2 (RPS6KA3).",null,"P62753","P62753"]
[2315,1155,"PK804","RSK1 (RPS6KA1, p90RSK)","S221","Ribosomal S6 protein-serine kinase 1; Ribosomal protein S6 kinase alpha 2",0,5604,12,671,{"v":3752.232,"d":"3752"},{"v":6593.222826880799,"d":"6593"},{"$f":"(L2328+L2329)/2","v":{"v":6770.886192792899,"d":"6771"}},{"$f":"SQRT((M2328-L2328)*(M2328-L2328))","v":{"v":177.66336591209983,"d":"178"}},{"$f":"N2328/M2328*100","v":{"v":2.623930765535672,"d":"3"}},0,6752,16,819,{"v":5516.784,"d":"5517"},{"v":9639.008308238399,"d":"9639"},{"$f":"(U2328+U2329)/2","v":{"v":8663.0628754012,"d":"8663"}},{"$f":"SQRT((V2328-U2328)*(V2328-U2328))","v":{"v":975.9454328371994,"d":"976"}},{"$f":"W2328/V2328*100","v":{"v":11.265593322754244,"d":"11"}},{"$f":"X2328+O2328","v":{"v":13.889524088289916,"d":"14"}},{"$f":"(V2328/M2328*100)-100","v":{"v":27.94577591072762,"d":"28"}},null,0,6491,14,722,{"v":4676.394,"d":"4676"},{"v":8000.5684579116005,"d":"8001"},{"$f":"(AG2328+AG2329)/2","v":{"v":8373.610581816,"d":"8374"}},{"$f":"SQRT((AH2328-AG2328)*(AH2328-AG2328))","v":{"v":373.042123904399,"d":"373"}},{"$f":"AI2328/AH2328*100","v":{"v":4.454973398386729,"d":"4"}},{"$f":"AJ2328+O2328","v":{"v":7.078904163922401,"d":"7"}},{"$f":"(AH2328/M2328*100)-100","v":{"v":23.67082156437779,"d":"24"}},null,null,"RSK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","RSK",{"$nulls":5},"KAY(pS)FCG(bA)C","Corresponds to amino acid residues K218 to G224; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S221 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of RSK1.","S221: PDPK1 (PDK1); RSK1 (RPS6KA1).","EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); AGC domain target; AGC</A> group; RSK family; RSK subfamily","Q15418","Q15418","Q15418","Q15418","GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0043027; GO:0016301; GO:0000287; GO:0004712; GO:0004674","GO:0007049; GO:0072574; GO:0035556; GO:0043066; GO:0043154; GO:0045597; GO:0030307; GO:2000491; GO:0045944; GO:0043620; GO:0043555; GO:0007165"]
[2316,1155,"PK804","RSK1 (RPS6KA1, p90RSK)","S221","Ribosomal S6 protein-serine kinase 1; Ribosomal protein S6 kinase alpha 2",0,6480,50,615,{"v":3954.45,"d":"3954"},{"v":6948.549558704999,"d":"6949"},{"$nulls":3},0,6636,20,665,{"v":4399.64,"d":"4400"},{"v":7687.117442564001,"d":"7687"},{"$nulls":6},0,7328,14,699,{"v":5112.486,"d":"5112"},{"v":8746.6527057204,"d":"8747"},{"$nulls":7},"RSK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","RSK",{"$nulls":5},"KAY(pS)FCG(bA)C","Corresponds to amino acid residues K218 to G224; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S221 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of RSK1.","S221: PDPK1 (PDK1); RSK1 (RPS6KA1).",null,"Q15418","Q15418","Q15418","Q15418"]
[2322,1158,"PK157","RSK1 (RPS6KA1, p90RSK)","S352","Ribosomal S6 protein-serine kinase 1; Ribosomal protein S6 kinase alpha 2",0,2748,32,526,{"v":1428.616,"d":"1429"},{"v":2510.2881756904,"d":"2510"},{"$nulls":3},0,1834,12,367,{"v":668.674,"d":"669"},{"v":1168.3173097774,"d":"1168"},{"$nulls":6},0,2056,12,349,{"v":713.356,"d":"713"},{"v":1220.4389777384001,"d":"1220"},{"$nulls":7},"RSK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","RSK",{"$nulls":5},"RD(pS)PG","Corresponds to amino acid residues D350 to G354.","The effect of S352 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of RSK1.",null,null,"Q15418","Q15418","Q15418","Q15418"]
[2327,1161,"PK805","RSK1 (RPS6KA1, p90RSK)","S380","Ribosomal S6 protein-serine kinase 1; Ribosomal protein S6 kinase alpha 2",0,7312,18,667,{"v":4865.098,"d":"4865"},{"v":8548.6918688962,"d":"8549"},{"$f":"(L2340+L2341)/2","v":{"v":8048.8248687983505,"d":"8049"}},{"$f":"SQRT((M2340-L2340)*(M2340-L2340))","v":{"v":499.8670000978491,"d":"500"}},{"$f":"N2340/M2340*100","v":{"v":6.210434544744626,"d":"6"}},0,8026,18,670,{"v":5365.36,"d":"5365"},{"v":9374.438008936,"d":"9374"},{"$f":"(U2340+U2341)/2","v":{"v":9813.023943338001,"d":"9813"}},{"$f":"SQRT((V2340-U2340)*(V2340-U2340))","v":{"v":438.58593440200093,"d":"439"}},{"$f":"W2340/V2340*100","v":{"v":4.469426926240755,"d":"4"}},{"$f":"X2340+O2340","v":{"v":10.67986147098538,"d":"11"}},{"$f":"(V2340/M2340*100)-100","v":{"v":21.918716126855387,"d":"22"}},null,0,7420,18,725,{"v":5366.45,"d":"5366"},{"v":9181.14483103,"d":"9181"},{"$f":"(AG2340+AG2341)/2","v":{"v":8736.231970753,"d":"8736"}},{"$f":"SQRT((AH2340-AG2340)*(AH2340-AG2340))","v":{"v":444.9128602769997,"d":"445"}},{"$f":"AI2340/AH2340*100","v":{"v":5.092731760860643,"d":"5"}},{"$f":"AJ2340+O2340","v":{"v":11.303166305605268,"d":"11"}},{"$f":"(AH2340/M2340*100)-100","v":{"v":8.540465386685398,"d":"9"}},null,null,"RSK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","RSK",{"$nulls":5},"RGF(pS)FVA(bA)C","Corresponds to amino acid residues R377 to A383; In Pkinase_C domain that follows the first kinase catalytic domain .","S380 phosphorylation stimulates phosphotransferase activity. This is one of the major sites of in vivo phosphorylation of RSK1.","JNK1 (MAPK8); JNK2 (MAPK9); p70S6K (RPS6KB1); RSK1 (RPS6KA1)","EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); AGC domain target; AGC</A> group; RSK family; RSK subfamily","Q15418","Q15418","Q15418","Q15418","GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0043027; GO:0016301; GO:0000287; GO:0004712; GO:0004674","GO:0007049; GO:0072574; GO:0035556; GO:0043066; GO:0043154; GO:0045597; GO:0030307; GO:2000491; GO:0045944; GO:0043620; GO:0043555; GO:0007165"]
[2332,1163,"NK165-2","RSK2 (RPS6KA3)","Pan-specific","Ribosomal S6 protein-serine kinase 2; Ribosomal protein S6 kinase alpha-3",0,396,30,541,{"v":198.006,"d":"198"},{"v":347.9256290814,"d":"348"},{"$nulls":3},0,481,14,540,{"v":252.18,"d":"252"},{"v":440.612703918,"d":"441"},{"$nulls":6},0,521,12,567,{"v":288.603,"d":"289"},{"v":493.75396056420004,"d":"494"},{"$nulls":7},"RSK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","RSK",{"$nulls":5},"CTSDDESQAMQTVGVHSIVQ","Corresponds to amino acid residues T391 to Q409; Just before kinase catalytic domain 2.",{"$nulls":3},"P51812","P51812","P51812"]
[2333,1164,"NK165-3","RSK2 (RPS6KA3)","Pan-specific","Ribosomal S6 protein-serine kinase 2; Ribosomal protein S6 kinase alpha-3",0,16608,18,656,{"v":10883.04,"d":"10883"},{"v":19123.099998576003,"d":"19123"},{"$f":"(L2346+L2347)/2","v":{"v":17689.408699928,"d":"17689"}},{"$f":"SQRT((M2346-L2346)*(M2346-L2346))","v":{"v":1433.691298648002,"d":"1434"}},{"$f":"N2346/M2346*100","v":{"v":8.104800578517004,"d":"8"}},0,16358,16,687,{"v":11226.954,"d":"11227"},{"v":19615.9035558054,"d":"19616"},{"$f":"(U2346+U2347)/2","v":{"v":20136.4828004202,"d":"20136"}},{"$f":"SQRT((V2346-U2346)*(V2346-U2346))","v":{"v":520.5792446148007,"d":"521"}},{"$f":"W2346/V2346*100","v":{"v":2.5852540871931096,"d":"3"}},{"$f":"X2346+O2346","v":{"v":10.690054665710115,"d":"11"}},{"$f":"(V2346/M2346*100)-100","v":{"v":13.833555106351042,"d":"14"}},null,0,16087,18,690,{"v":11087.61,"d":"11088"},{"v":18969.142215054002,"d":"18969"},{"$f":"(AG2346+AG2347)/2","v":{"v":18313.3005739917,"d":"18313"}},{"$f":"SQRT((AH2346-AG2346)*(AH2346-AG2346))","v":{"v":655.8416410623031,"d":"656"}},{"$f":"AI2346/AH2346*100","v":{"v":3.581231239079429,"d":"4"}},{"$f":"AJ2346+O2346","v":{"v":11.686031817596433,"d":"12"}},{"$f":"(AH2346/M2346*100)-100","v":{"v":3.5269232830051465,"d":"4"}},null,null,"RSK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","RSK",{"$nulls":5},"CNRNQSPVLEPVGRS","Corresponds to amino acid residues N711 to S724; Pre-C-terminus.",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; AGC group; RSK family; RSK subfamily","P51812","P51812","P51812",null,"GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0043027; GO:0016301; GO:0000287; GO:0004672; GO:0004674","GO:0007049; GO:0007417; GO:0035556; GO:0043066; GO:0043154; GO:0018105; GO:0045597; GO:0030307; GO:0045944; GO:0043620; GO:0043555; GO:0032496; GO:0007165; GO:0001501; GO:0002224"]
[2338,1166,"PK808","RSK3 (RPS6KA2)","Y217+S218","Ribosomal S6 protein-serine kinase 3; Ribosomal protein S6 kinase alpha-3",0,9827,22,728,{"v":7138.04,"d":"7138"},{"v":12542.584858076,"d":"12543"},{"$nulls":3},0,11350,24,742,{"v":8403.892,"d":"8404"},{"v":14683.4070011692,"d":"14683"},{"$nulls":6},0,10907,22,686,{"v":7467.11,"d":"7467"},{"v":12775.040926354,"d":"12775"},{"$nulls":7},"RSK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","RSK",{"$nulls":5},"KRA(pY)(pS)FCG(bA)C","Corresponds to amino acid residues K214 to G221; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y217 and S218 phosphorylation are predicted to be stimulatory for phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major sites of in vivo phosphorylation of RSK2.",null,null,"Q15349","Q15349","Q15349"]
[2345,1170,"NK294-1","SGK1","Pan-specific","Serine-threonine-protein kinase Sgk1",0,4384,12,609,{"v":2662.548,"d":"2663"},{"v":4678.487964301199,"d":"4678"},{"$f":"(L2358+L2359)/2","v":{"v":4433.566286497799,"d":"4434"}},{"$f":"SQRT((M2358-L2358)*(M2358-L2358))","v":{"v":244.9216778033997,"d":"245"}},{"$f":"N2358/M2358*100","v":{"v":5.5242588466376645,"d":"6"}},0,4217,14,583,{"v":2450.349,"d":"2450"},{"v":4281.2867730699,"d":"4281"},{"$f":"(U2358+U2359)/2","v":{"v":4876.135763547951,"d":"4876"}},{"$f":"SQRT((V2358-U2358)*(V2358-U2358))","v":{"v":594.8489904780508,"d":"595"}},{"$f":"W2358/V2358*100","v":{"v":12.199188441899118,"d":"12"}},{"$f":"X2358+O2358","v":{"v":17.723447288536782,"d":"18"}},{"$f":"(V2358/M2358*100)-100","v":{"v":9.982245633678104,"d":"10"}},null,0,4478,18,611,{"v":2725.06,"d":"2725"},{"v":4662.145465484,"d":"4662"},{"$f":"(AG2358+AG2359)/2","v":{"v":4772.854012478,"d":"4773"}},{"$f":"SQRT((AH2358-AG2358)*(AH2358-AG2358))","v":{"v":110.70854699400024,"d":"111"}},{"$f":"AI2358/AH2358*100","v":{"v":2.3195460557680434,"d":"2"}},{"$f":"AJ2358+O2358","v":{"v":7.843804902405708,"d":"8"}},{"$f":"(AH2358/M2358*100)-100","v":{"v":7.652704483374578,"d":"8"}},null,null,"SGK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","SGK",{"$nulls":6},"MTVKTEAAKGTLTYSRMRGC","Corresponds to amino acid residues M1 to G19; N-terminus.",null,null,"Protein-serine kinase, AGC group, SGK family","O00141","O00141","O00141","O00141","GO:0005737; GO:0005829; GO:0005789; GO:0005739; GO:0016607; GO:0005634; GO:0005886","GO:0005524; GO:0005246; GO:0017081; GO:0015459; GO:0004712; GO:0004674; GO:0017080","GO:0006915; GO:0006974; GO:0035556; GO:0034220; GO:0007616; GO:0048812; GO:0018105; GO:0032411; GO:0006468; GO:0042981; GO:0008217; GO:0050790; GO:0001558; GO:0030334; GO:0042127; GO:0051090; GO:0060453; GO:0070294; GO:0006814"]
[2349,1172,"PK811","SgK269 (PEAK1)","Y635","Tyrosine-protein kinase SgK269; Pseudopodium-enriched atypical kinase 1",0,6030,20,796,{"v":4783.96,"d":"4784"},{"v":8406.120483724,"d":"8406"},{"$f":"(L2362+L2363)/2","v":{"v":8867.6368741559,"d":"8868"}},{"$f":"SQRT((M2362-L2362)*(M2362-L2362))","v":{"v":461.5163904318997,"d":"462"}},{"$f":"N2362/M2362*100","v":{"v":5.204502585992854,"d":"5"}},0,8349,20,873,{"v":7271.217,"d":"7271"},{"v":12704.3801377767,"d":"12704"},{"$f":"(U2362+U2363)/2","v":{"v":10237.90035445785,"d":"10238"}},{"$f":"SQRT((V2362-U2362)*(V2362-U2362))","v":{"v":2466.4797833188495,"d":"2466"}},{"$f":"W2362/V2362*100","v":{"v":24.091656471777238,"d":"24"}},{"$f":"X2362+O2362","v":{"v":29.29615905777009,"d":"29"}},{"$f":"(V2362/M2362*100)-100","v":{"v":15.452408570038372,"d":"15"}},null,0,7704,20,724,{"v":5563.216,"d":"5563"},{"v":9517.780249942401,"d":"9518"},{"$f":"(AG2362+AG2363)/2","v":{"v":7934.816545806101,"d":"7935"}},{"$f":"SQRT((AH2362-AG2362)*(AH2362-AG2362))","v":{"v":1582.9637041363003,"d":"1583"}},{"$f":"AI2362/AH2362*100","v":{"v":19.94959423444977,"d":"20"}},{"$f":"AJ2362+O2362","v":{"v":25.154096820442625,"d":"25"}},{"$f":"(AH2362/M2362*100)-100","v":{"v":-10.519378968577726,"d":"-11"}},null,null,"SgK269","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","NKF3",{"$nulls":6},"PNA(pY)DNL(bA)C","Corresponds to amino acid residues P632 to L638; In the N-terminal half of the protein. ","Y635 phosphorylation induces interaction with Grb2 and stimulates cells growth and motility. This is the major in vivo phosphorylation site in SgK269.",null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.10.2; Other group; NKF3 family","Q9H792","Q9H792","Q9H792",null,"GO:0015629; GO:0005737; GO:0005925","GO:0042802; GO:0004715","GO:0016477; GO:0048041; GO:0046777; GO:0051893; GO:0034446"]
[2350,1172,"PK811","SgK269 (PEAK1)","Y635","Tyrosine-protein kinase SgK269; Pseudopodium-enriched atypical kinase 1",0,9184,466,609,{"v":5309.262,"d":"5309"},{"v":9329.1532645878,"d":"9329"},{"$nulls":3},0,6590,20,677,{"v":4447.89,"d":"4448"},{"v":7771.4205711390005,"d":"7771"},{"$nulls":6},0,5671,20,657,{"v":3712.707,"d":"3713"},{"v":6351.8528416698,"d":"6352"},{"$nulls":7},"SgK269","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","NKF3",{"$nulls":6},"PNA(pY)DNL(bA)C","Corresponds to amino acid residues P632 to L638; In the N-terminal half of the protein. ","Y635 phosphorylation induces interaction with Grb2 and stimulates cells growth and motility. This is the major in vivo phosphorylation site in SgK269.",null,null,"Q9H792","Q9H792","Q9H792"]
[2355,1175,"PN161","Shc1 (Shc)","Y349","SH2 domain-containing transforming protein 1",0,62,18,556,{"v":24.464,"d":"24"},{"v":42.9868417616,"d":"43"},{"$f":"(L2368+L2369)/2","v":{"v":421.4762840216,"d":"421"}},{"$f":"SQRT((M2368-L2368)*(M2368-L2368))","v":{"v":378.48944226000003,"d":"378"}},{"$f":"N2368/M2368*100","v":{"v":89.80088716939599,"d":"90"}},0,114,19,549,{"v":52.155,"d":"52"},{"v":91.12600354050001,"d":"91"},{"$f":"(U2368+U2369)/2","v":{"v":315.28933283275,"d":"315"}},{"$f":"SQRT((V2368-U2368)*(V2368-U2368))","v":{"v":224.16332929225,"d":"224"}},{"$f":"W2368/V2368*100","v":{"v":71.09765727823113,"d":"71"}},{"$f":"X2368+O2368","v":{"v":160.8985444476271,"d":"161"}},{"$f":"(V2368/M2368*100)-100","v":{"v":-25.194051294095615,"d":"-25"}},null,0,1357,18,345,{"v":461.955,"d":"462"},{"v":790.331738937,"d":"790"},{"$f":"(AG2368+AG2369)/2","v":{"v":640.0043822225,"d":"640"}},{"$f":"SQRT((AH2368-AG2368)*(AH2368-AG2368))","v":{"v":150.32735671449996,"d":"150"}},{"$f":"AI2368/AH2368*100","v":{"v":23.488488655728933,"d":"23"}},{"$f":"AJ2368+O2368","v":{"v":113.28937582512492,"d":"113"}},{"$f":"(AH2368/M2368*100)-100","v":{"v":51.84825492807582,"d":"52"}},{"$nulls":13},"X",null,"HQ(pY)YN","Corresponds to amino acid residues H347 to N351.","Y349 phosphorylation regulates apoptosis and molecular association, including inducing interaction with Grb2. This is one of the major sites of in vivo phosphorylation of Shc1.","EGFR; Lck; Src; ZAP70","Adapter/scaffold protein","P29353","P29353",null,"P29353","GO:0005829; GO:0005759; GO:0005886; GO:0070435","GO:0046875; GO:0048408; GO:0005154; GO:0005159; GO:0005158; GO:0005168; GO:0005543; GO:0001784; GO:0005088; GO:0005068","GO:0031532; GO:0000187; GO:0001525; GO:0007411; GO:0098609; GO:0071363; GO:0019221; GO:0042742; GO:0007173; GO:0038128; GO:0038095; GO:0007507; GO:0008286; GO:0035723; GO:0038110; GO:0036498; GO:0050900; GO:0000165; GO:0016525; GO:0043066; GO:0045892; GO:0008284; GO:0071864; GO:0070374; GO:0043410; GO:0045893; GO:0007265; GO:0007176; GO:0040008; GO:0090322; GO:0016032"]
[2360,1177,"NP044-3","SHIP1 (INPP5D)","Pan-specific","Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 1",0,2260,16,673,{"v":1510.212,"d":"1510"},{"v":2653.6643341428,"d":"2654"},{"$nulls":3},0,2632,12,684,{"v":1792.08,"d":"1792"},{"v":3131.149236408,"d":"3131"},{"$nulls":6},0,2450,12,643,{"v":1567.634,"d":"1568"},{"v":2681.9731472476,"d":"2682"},{"$nulls":10},"Lipid phosphatase",{"$nulls":8},"X","CGRDYRDNTELPHHGK","Corresponds to amino acid residues R1159 to K1172.",{"$nulls":3},"Q92835","Q92835"]
[2363,1179,"NP045-2","SHIP2 (INPPL1)","Pan-specific","Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 2",0,5136,14,874,{"v":4476.628,"d":"4477"},{"v":7866.093012653199,"d":"7866"},{"$f":"(L2376+L2377)/2","v":{"v":6446.4061747982,"d":"6446"}},{"$f":"SQRT((M2376-L2376)*(M2376-L2376))","v":{"v":1419.6868378549998,"d":"1420"}},{"$f":"N2376/M2376*100","v":{"v":22.022919427652138,"d":"22"}},0,5240,20,835,{"v":4358.7,"d":"4359"},{"v":7615.58645637,"d":"7616"},{"$f":"(U2376+U2377)/2","v":{"v":6404.486837654,"d":"6404"}},{"$f":"SQRT((V2376-U2376)*(V2376-U2376))","v":{"v":1211.099618716,"d":"1211"}},{"$f":"W2376/V2376*100","v":{"v":18.910174217168546,"d":"19"}},{"$f":"X2376+O2376","v":{"v":40.93309364482069,"d":"41"}},{"$f":"(V2376/M2376*100)-100","v":{"v":-0.6502745251777782,"d":"-1"}},null,0,5680,18,799,{"v":4523.938,"d":"4524"},{"v":7739.7404214332,"d":"7740"},{"$f":"(AG2376+AG2377)/2","v":{"v":6900.4272932142,"d":"6900"}},{"$f":"SQRT((AH2376-AG2376)*(AH2376-AG2376))","v":{"v":839.3131282189997,"d":"839"}},{"$f":"AI2376/AH2376*100","v":{"v":12.16320515461949,"d":"12"}},{"$f":"AJ2376+O2376","v":{"v":34.18612458227163,"d":"34"}},{"$f":"(AH2376/M2376*100)-100","v":{"v":7.043011347795101,"d":"7"}},{"$nulls":5},"Lipid phosphatase",{"$nulls":8},"X","CRRLHSEVDKVLSGLE","Corresponds to amino acid residues C215 to E230.",null,null,"EC 3.1.3.n1; Carbohydrate Metabolism - inositol phosphate; Phosphatase, lipid","O15357","O15357",null,"O15357","GO:0005856; GO:0005829; GO:0030175; GO:0005794; GO:0030027; GO:0005886","GO:0003779; GO:0052659; GO:0034485; GO:0042169; GO:0017124","GO:0007015; GO:0007155; GO:0019221; GO:0001958; GO:0006897; GO:0006006; GO:0002376; GO:0043647; GO:0008285; GO:0010629; GO:0006661; GO:0046856; GO:0009791; GO:0032868; GO:0097178"]
[2367,1181,"NK251-2","SIK (SNF1LK)","Pan-specific","Salt-inducible serine/threonine-protein kinase SIK1; Serine-threonine-protein kinase SNF1-like kinase 1",0,4074,18,783,{"v":3175.848,"d":"3176"},{"v":5580.4314680712,"d":"5580"},{"$f":"(L2380+L2381)/2","v":{"v":5196.285769940099,"d":"5196"}},{"$f":"SQRT((M2380-L2380)*(M2380-L2380))","v":{"v":384.1456981311003,"d":"384"}},{"$f":"N2380/M2380*100","v":{"v":7.392697690980313,"d":"7"}},0,4557,16,902,{"v":4095.982,"d":"4096"},{"v":7156.5615997282,"d":"7157"},{"$f":"(U2380+U2381)/2","v":{"v":6129.70668691475,"d":"6130"}},{"$f":"SQRT((V2380-U2380)*(V2380-U2380))","v":{"v":1026.85491281345,"d":"1027"}},{"$f":"W2380/V2380*100","v":{"v":16.7521052027743,"d":"17"}},{"$f":"X2380+O2380","v":{"v":24.144802893754612,"d":"24"}},{"$f":"(V2380/M2380*100)-100","v":{"v":17.963232937926193,"d":"18"}},null,0,4530,14,702,{"v":3170.232,"d":"3170"},{"v":5423.7641532048,"d":"5424"},{"$f":"(AG2380+AG2381)/2","v":{"v":5172.2259855284,"d":"5172"}},{"$f":"SQRT((AH2380-AG2380)*(AH2380-AG2380))","v":{"v":251.5381676764,"d":"252"}},{"$f":"AI2380/AH2380*100","v":{"v":4.863247823667987,"d":"5"}},{"$f":"AJ2380+O2380","v":{"v":12.2559455146483,"d":"12"}},{"$f":"(AH2380/M2380*100)-100","v":{"v":-0.4630188845825671,"d":"-0"}},null,null,"SIK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","QIK",{"$nulls":5},"CARRITIAQIRQHRWM","Corresponds to amino acid residues A264 to M278; Kinase last alpha-chain.",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; CAMK group; CAMKL family; QIK subfamily","P57059","P57059","P57059",null,"GO:0005737; GO:0005634","GO:0071889; GO:0005524; GO:0008140; GO:0000287; GO:0019901; GO:0004674","GO:0055007; GO:0007049; GO:0032870; GO:0043153; GO:0035556; GO:0032792; GO:0045721; GO:0010868; GO:2000210; GO:0046777; GO:0006468; GO:0045595; GO:0007346; GO:0010830; GO:0002028; GO:0048511"]
[2372,1183,"PK812","SIK (SNF1LK)","T182","Salt-inducible serine/threonine-protein kinase SIK1; Serine-threonine-protein kinase SNF1-like kinase 1",0,5904,31,492,{"v":2889.516,"d":"2890"},{"v":5077.3040819004,"d":"5077"},{"$nulls":3},0,5822,22,680,3944,{"v":6891.0163544,"d":"6891"},{"$nulls":6},0,5996,26,774,{"v":4620.78,"d":"4621"},{"v":7905.421724291999,"d":"7905"},{"$nulls":7},"SIK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","QIK",{"$nulls":5},"PLS(pT)WCG(bA)C","Corresponds to amino acid residues P179 to G185; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T182 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of SIK.","GSK3b; LKB1 (STK11)",null,"P57059","P57059","P57059"]
[2377,1186,"PK813","SIK2 (QIK)","S358","Salt-inducible serine/threonine-protein kinase SIK2; Serine-threonine-protein kinase SNF1-like kinase 2",0,6652,30,768,{"v":5085.696,"d":"5086"},{"v":8936.3149607424,"d":"8936"},{"$f":"(L2390+L2391)/2","v":{"v":9374.5772690997,"d":"9375"}},{"$f":"SQRT((M2390-L2390)*(M2390-L2390))","v":{"v":438.26230835729984,"d":"438"}},{"$f":"N2390/M2390*100","v":{"v":4.675008758015058,"d":"5"}},0,6551,26,607,{"v":3960.675,"d":"3961"},{"v":6920.151166192501,"d":"6920"},{"$f":"(U2390+U2391)/2","v":{"v":7617.03052965015,"d":"7617"}},{"$f":"SQRT((V2390-U2390)*(V2390-U2390))","v":{"v":696.8793634576496,"d":"697"}},{"$f":"W2390/V2390*100","v":{"v":9.148963769345128,"d":"9"}},{"$f":"X2390+O2390","v":{"v":13.823972527360187,"d":"14"}},{"$f":"(V2390/M2390*100)-100","v":{"v":-18.74801059289085,"d":"-19"}},null,0,7690,26,764,{"v":5855.296,"d":"5855"},{"v":10017.4828060544,"d":"10017"},{"$f":"(AG2390+AG2391)/2","v":{"v":9612.5129599432,"d":"9613"}},{"$f":"SQRT((AH2390-AG2390)*(AH2390-AG2390))","v":{"v":404.96984611120024,"d":"405"}},{"$f":"AI2390/AH2390*100","v":{"v":4.21294460458749,"d":"4"}},{"$f":"AJ2390+O2390","v":{"v":8.887953362602548,"d":"9"}},{"$f":"(AH2390/M2390*100)-100","v":{"v":2.5380951483303704,"d":"3"}},null,null,"SIK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","QIK",{"$nulls":5},"RRP(pS)TIA(bA)C","Corresponds to amino acid residues R355 to A361; After the kinase catalytic domain.","S358 phosphorylation stimulates phosphotransferase activity. This is one of the major sites of in vivo phosphorylation of SIK2.","Akt1 (PKBa); Akt2 (PKBb)","Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; CAMK domain target; CAMK</A> group; CAMKL family; QIK subfamily","Q9H0K1","Q9H0K1","Q9H0K1",null,"GO:0005737; GO:0005634","GO:0005524; GO:0000287; GO:0004674","GO:0032870; GO:0035556; GO:0046777; GO:0006468; GO:0046626"]
[2381,1188,"NK250-3","SIK3 (QSK)","Pan-specific","Salt-inducible serine/threonine-protein kinase SIK3",0,5136,16,730,{"v":3737.6,"d":"3738"},{"v":6567.51225344,"d":"6568"},{"$f":"(L2394+L2395)/2","v":{"v":6861.8870735969995,"d":"6862"}},{"$f":"SQRT((M2394-L2394)*(M2394-L2394))","v":{"v":294.3748201569997,"d":"294"}},{"$f":"N2394/M2394*100","v":{"v":4.289998028234651,"d":"4"}},0,5313,16,664,{"v":3517.208,"d":"3517"},{"v":6145.3189274408005,"d":"6145"},{"$f":"(U2394+U2395)/2","v":{"v":6243.70024168405,"d":"6244"}},{"$f":"SQRT((V2394-U2394)*(V2394-U2394))","v":{"v":98.38131424324911,"d":"98"}},{"$f":"W2394/V2394*100","v":{"v":1.5756892617367826,"d":"2"}},{"$f":"X2394+O2394","v":{"v":5.865687289971433,"d":"6"}},{"$f":"(V2394/M2394*100)-100","v":{"v":-9.008991626976695,"d":"-9"}},null,0,6141,24,820,{"v":5015.94,"d":"5016"},{"v":8581.477811916,"d":"8581"},{"$f":"(AG2394+AG2395)/2","v":{"v":7709.172818139401,"d":"7709"}},{"$f":"SQRT((AH2394-AG2394)*(AH2394-AG2394))","v":{"v":872.3049937765991,"d":"872"}},{"$f":"AI2394/AH2394*100","v":{"v":11.315156818434494,"d":"11"}},{"$f":"AJ2394+O2394","v":{"v":15.605154846669144,"d":"16"}},{"$f":"(AH2394/M2394*100)-100","v":{"v":12.347707495836914,"d":"12"}},null,null,"SIK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","QIK",{"$nulls":5},"CYKHPEVSFSMEQAGV","Corresponds to amino acid residues Y1249 to V1263; C-terminus.",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; CAMK domain target; CAMK</A> group; CAMKL family; QIK subfamily","Q9Y2K2","Q9Y2K2","Q9Y2K2","Q9Y2K2","GO:0005737","GO:0005524; GO:0000287; GO:0004674","GO:0006468"]
[2384,1189,"PK814","SIK3 (QSK)","T163","Salt-inducible serine/threonine-protein kinase SIK3",0,9726,18,776,{"v":7533.408,"d":"7533"},{"v":13237.304513635201,"d":"13237"},{"$nulls":3},0,9313,18,740,{"v":6878.3,"d":"6878"},{"v":12017.869622330001,"d":"12018"},{"$nulls":6},0,9428,18,734,{"v":6906.94,"d":"6907"},{"v":11816.678899315999,"d":"11817"},{"$nulls":7},"SIK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","QIK",{"$nulls":5},"LLK(pT)WCG(bA)C","Corresponds to amino acid residues L160 to G166; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T163 phosphorylation is predicted to stimulate phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII.",null,null,"Q9Y2K2","Q9Y2K2","Q9Y2K2","Q9Y2K2"]
[2389,1192,"PN535","SIT","Y90","Signaling threshold-regulating transmembrane adapter 1",0,8592,20,769,{"v":6591.868,"d":"6592"},{"v":11582.8804214092,"d":"11583"},{"$f":"(L2402+L2403)/2","v":{"v":11517.331813451601,"d":"11517"}},{"$f":"SQRT((M2402-L2402)*(M2402-L2402))","v":{"v":65.5486079575985,"d":"66"}},{"$f":"N2402/M2402*100","v":{"v":0.569130151143526,"d":"1"}},0,8590,20,666,{"v":5707.62,"d":"5708"},{"v":9972.439849062,"d":"9972"},{"$f":"(U2402+U2403)/2","v":{"v":10432.1426251626,"d":"10432"}},{"$f":"SQRT((V2402-U2402)*(V2402-U2402))","v":{"v":459.7027761005993,"d":"460"}},{"$f":"W2402/V2402*100","v":{"v":4.406599800426273,"d":"4"}},{"$f":"X2402+O2402","v":{"v":4.975729951569798,"d":"5"}},{"$f":"(V2402/M2402*100)-100","v":{"v":-9.422227351490918,"d":"-9"}},null,0,9636,21,869,{"v":8355.435,"d":"8355"},{"v":14294.824113009,"d":"14295"},{"$f":"(AG2402+AG2403)/2","v":{"v":12925.335777081898,"d":"12925"}},{"$f":"SQRT((AH2402-AG2402)*(AH2402-AG2402))","v":{"v":1369.4883359271007,"d":"1369"}},{"$f":"AI2402/AH2402*100","v":{"v":10.595379180441567,"d":"11"}},{"$f":"AJ2402+O2402","v":{"v":11.164509331585093,"d":"11"}},{"$f":"(AH2402/M2402*100)-100","v":{"v":12.225088123152176,"d":"12"}},{"$nulls":13},"X",null,"VPL(pY)GNL(bA)C","Corresponds to amino acid residues V87 to L93; In the Sit domain. ","Y90 phosphorylation induces interaction with Grb2. This is the major in vivo phosphorylation site of SIT.",null,"Adapter/scaffold protein","Q9Y3P8","Q9Y3P8",null,null,"GO:0070062; GO:0005887; GO:0005886","GO:0019900; GO:0042169","GO:0002250; GO:0050863; GO:0007165; GO:0043029"]
[2394,1194,"PK816","SLK","S189","STE20-like serine/threonine-protein kinase; CTCL tumour antigen se20-9",0,6766,18,707,{"v":4770.836,"d":"4771"},{"v":8383.0596878084,"d":"8383"},{"$nulls":3},0,6251,20,701,{"v":4367.931,"d":"4368"},{"v":7631.714998958099,"d":"7632"},{"$nulls":6},0,7122,24,790,{"v":5607.42,"d":"5607"},{"v":9593.406283188,"d":"9593"},{"$nulls":7},"SLK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","SLK",{"$nulls":5},"RRD(pS)FIG(bA)C","Corresponds to amino acid residues R186 to G192; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S189 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. It is one of the major in vivo phosphorylation sites in SIT.",null,null,"Q9H2G2","Q9H2G2","Q9H2G2"]
[2399,1197,"NN096-2","Smad2/3","Pan-specific","Mothers against decapentaplegic homologue 2/3",0,256,14,575,{"v":139.15,"d":"139"},{"v":244.506991135,"d":"245"},{"$f":"(L2412+L2413)/2","v":{"v":288.9505076767,"d":"289"}},{"$f":"SQRT((M2412-L2412)*(M2412-L2412))","v":{"v":44.443516541700006,"d":"44"}},{"$f":"N2412/M2412*100","v":{"v":15.381013481875181,"d":"15"}},0,314,12,588,{"v":177.576,"d":"178"},{"v":310.26346859759997,"d":"310"},{"$f":"(U2412+U2413)/2","v":{"v":280.4944177238,"d":"280"}},{"$f":"SQRT((V2412-U2412)*(V2412-U2412))","v":{"v":29.769050873799983,"d":"30"}},{"$f":"W2412/V2412*100","v":{"v":10.613063573733317,"d":"11"}},{"$f":"X2412+O2412","v":{"v":25.9940770556085,"d":"26"}},{"$f":"(V2412/M2412*100)-100","v":{"v":-2.926483853892833,"d":"-3"}},null,0,320,10,635,{"v":196.85,"d":"197"},{"v":336.77912959,"d":"337"},{"$f":"(AG2412+AG2413)/2","v":{"v":353.52997773740003,"d":"354"}},{"$f":"SQRT((AH2412-AG2412)*(AH2412-AG2412))","v":{"v":16.750848147400006,"d":"17"}},{"$f":"AI2412/AH2412*100","v":{"v":4.738169095194082,"d":"5"}},{"$f":"AJ2412+O2412","v":{"v":20.119182577069264,"d":"20"}},{"$f":"(AH2412/M2412*100)-100","v":{"v":22.349664854355098,"d":"22"}},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Epitope undefined.",{"$nulls":3},"Transcription protein","Q15796","Q15796",null,"Q15796","GO:0032444; GO:0005737; GO:0005829; GO:0071144; GO:0000790; GO:0005654; GO:0005634; GO:0032991; GO:0071141; GO:0005667","GO:0033613; GO:0003682; GO:0070410; GO:0097718; GO:0003700; GO:0003690; GO:0035326; GO:0070411; GO:0046872; GO:0019902; GO:0070878; GO:0046982; GO:0042803; GO:0000978; GO:0000981; GO:0070412; GO:0046332; GO:0048156; GO:0001077; GO:0001228; GO:0008134; GO:0030618; GO:0005160; GO:0034713; GO:0031625","GO:0032924; GO:0030325; GO:0009952; GO:0045165; GO:0007182; GO:0048701; GO:0048617; GO:0001706; GO:0007369; GO:0030073; GO:0035556; GO:0001701; GO:0030324; GO:0001707; GO:0008285; GO:0045892; GO:0000122; GO:0030512; GO:0038092; GO:0035265; GO:0031016; GO:0048340; GO:0060039; GO:0030513; GO:0010718; GO:1900224; GO:0045893; GO:0045944; GO:0009791; GO:0031053; GO:0016579; GO:0051098; GO:0017015; GO:0070723; GO:0009749; GO:0062009; GO:0023019; GO:0007183; GO:0060395; GO:0035019; GO:0007179; GO:0001657; GO:0042060; GO:0007352"]
[2404,1199,"PN727","SMARCB1","T134","SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1",0,12249,22,722,{"v":8827.894,"d":"8828"},{"v":15511.9065756286,"d":"15512"},{"$nulls":3},0,12520,12,739,{"v":9243.412,"d":"9243"},{"v":16150.229021921201,"d":"16150"},{"$nulls":6},0,13130,18,698,{"v":9152.176,"d":"9152"},{"v":15657.9216008864,"d":"15658"},{"$nulls":10},"Transcription protein, coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"WVP(pT)LPNSC","Corresponds to amino acid residues W131 to S138.","The effect of T134 phosphorylation is unclear. In vivo phosphorylation of SMARCB1 is not commonly detected (≥7 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and found in the frog.",null,null,"Q12824","Q12824",null,"Q12824"]
[2406,1200,"PN270","SMC1A","S957","Structural maintenance of chromosomes protein 1A",0,436,12,598,{"v":253.552,"d":"254"},{"v":445.52811078879995,"d":"446"},{"$nulls":3},0,497,12,575,{"v":278.875,"d":"279"},{"v":487.2546110125,"d":"487"},{"$nulls":6},0,491,14,637,{"v":303.849,"d":"304"},{"v":519.8374485486,"d":"520"},{"$nulls":20},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S957 phosphosite.","The effect of S957 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of SMC1A.","ATM; ATR",null,"Q14683","Q14683"]
[2411,1203,"PK817","SMG1","T3550","Serine/threonine-protein kinase SMG1; Lambda/iota protein kinase C-interacting protein",0,8,2,762,{"v":4.572,"d":"5"},{"v":8.0336756268,"d":"8"},{"$f":"(L2424+L2425)/2","v":{"v":9.288278513399998,"d":"9"}},{"$f":"SQRT((M2424-L2424)*(M2424-L2424))","v":{"v":1.254602886599999,"d":"1"}},{"$f":"N2424/M2424*100","v":{"v":13.507377979568663,"d":"14"}},0,10,2,722,{"v":5.776,"d":"6"},{"v":10.0919144176,"d":"10"},{"$f":"(U2424+U2425)/2","v":{"v":7.5933968246,"d":"8"}},{"$f":"SQRT((V2424-U2424)*(V2424-U2424))","v":{"v":2.498517593,"d":"2"}},{"$f":"W2424/V2424*100","v":{"v":32.903819604233774,"d":"33"}},{"$f":"X2424+O2424","v":{"v":46.41119758380243,"d":"46"}},{"$f":"(V2424/M2424*100)-100","v":{"v":-18.247533020837267,"d":"-18"}},null,0,10,2,726,{"v":5.808,"d":"6"},{"v":9.9365668512,"d":"10"},{"$f":"(AG2424+AG2425)/2","v":{"v":8.6072430834,"d":"9"}},{"$f":"SQRT((AH2424-AG2424)*(AH2424-AG2424))","v":{"v":1.3293237678,"d":"1"}},{"$f":"AI2424/AH2424*100","v":{"v":15.444245676803817,"d":"15"}},{"$f":"AJ2424+O2424","v":{"v":28.95162365637248,"d":"29"}},{"$f":"(AH2424/M2424*100)-100","v":{"v":-7.332202937470953,"d":"-7"}},null,null,"SMG1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PIKK","SMG1",{"$nulls":5},"GQK(pT)QPD(bA)C","Corresponds to amino acid residues G3547 to D3553; In the C-terminus of SMG1. ","The effect of T3550 phosphorylation is unclear. This is one of the two major in vivo sites for phosphorylation of SMG1.",null,"Protein-serine kinase, Atypical group, PIKK family, SMG1 subfamily","Q96Q15","Q96Q15","Q96Q15",null,"GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0046872; GO:0004672; GO:0004674; GO:0003723; GO:0042162","GO:0006281; GO:0006406; GO:0000184; GO:0018105; GO:0046854; GO:0046777; GO:2001020; GO:0032204"]
[2416,1205,"PN661","SND1","Y908","Staphylococcal nuclease domain-containing protein 1",0,1584,12,654,{"v":1028.088,"d":"1028"},{"v":1806.5016421271998,"d":"1807"},{"$nulls":3},0,1438,12,594,{"v":847.044,"d":"847"},{"v":1479.9680671644,"d":"1480"},{"$nulls":6},0,1836,12,647,{"v":1180.128,"d":"1180"},{"v":2019.0118396992,"d":"2019"},{"$nulls":10},"Transcription protein, coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"CADEFG(pY)SR(-cooh)","Corresponds to amino acid residues C903 to R910.","The effect of Y908 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of SND1.",null,null,"Q7KZF4","Q7KZF4"]
[2417,1206,"PN537","snRNP 70","Y126","U1 small nuclear ribonucleoprotein 70 kDa",0,5606,18,667,{"v":3727.196,"d":"3727"},{"v":6549.2308970924,"d":"6549"},{"$f":"(L2430+L2431)/2","v":{"v":7067.7860330452,"d":"7068"}},{"$f":"SQRT((M2430-L2430)*(M2430-L2430))","v":{"v":518.5551359528008,"d":"519"}},{"$f":"N2430/M2430*100","v":{"v":7.336882207926405,"d":"7"}},0,5708,20,679,{"v":3862.152,"d":"3862"},{"v":6748.0102928952,"d":"6748"},{"$f":"(U2430+U2431)/2","v":{"v":6560.3838521666,"d":"6560"}},{"$f":"SQRT((V2430-U2430)*(V2430-U2430))","v":{"v":187.62644072859985,"d":"188"}},{"$f":"W2430/V2430*100","v":{"v":2.8599918077451405,"d":"3"}},{"$f":"X2430+O2430","v":{"v":10.196874015671545,"d":"10"}},{"$f":"(V2430/M2430*100)-100","v":{"v":-7.179082367607876,"d":"-7"}},null,0,5932,26,697,{"v":4116.482,"d":"4116"},{"v":7042.6478279548,"d":"7043"},{"$f":"(AG2430+AG2431)/2","v":{"v":7308.0592085438,"d":"7308"}},{"$f":"SQRT((AH2430-AG2430)*(AH2430-AG2430))","v":{"v":265.41138058900015,"d":"265"}},{"$f":"AI2430/AH2430*100","v":{"v":3.6317628663805785,"d":"4"}},{"$f":"AJ2430+O2430","v":{"v":10.968645074306984,"d":"11"}},{"$f":"(AH2430/M2430*100)-100","v":{"v":3.3995536137513227,"d":"3"}},{"$nulls":15},"FEV(pY)GPI(bA)C","Corresponds to amino acid residues F123 to I129; In the RRM_1 domain. This is the major in vivo phosphorylation site in snRNP70.","The effect of Y126 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of snRNP 70.",null,"RNA binding protein","P08621","P08621",null,null,"GO:0000243; GO:0005737; GO:0016607; GO:0005654; GO:0005634; GO:0071011; GO:0005681; GO:0005685; GO:0071004","GO:0003729; GO:0003723; GO:0030619; GO:1990446","GO:0071300; GO:0071560; GO:0071356; GO:0006397; GO:0000398; GO:1904715; GO:0061084; GO:0048026; GO:0043462; GO:0043484; GO:0008380"]
[2422,1208,"PN663","SPT5","T791","Transcription elongation factor SPT5",0,9281,16,753,{"v":6976.545,"d":"6977"},{"v":12258.8144194605,"d":"12259"},{"$nulls":3},0,7907,14,762,{"v":6014.466,"d":"6014"},{"v":10508.5658136366,"d":"10509"},{"$nulls":6},0,9114,18,774,{"v":7040.304,"d":"7040"},{"v":12044.843551785601,"d":"12045"},{"$nulls":10},"Transcription elongation factor",{"$nulls":4},"X",{"$nulls":4},"CGSQ(pT)PLQD","Corresponds to amino acid residues C785 to D795.","The effect of T791 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of SPT5.","CDK9",null,"O00267","O00267",null,"O00267"]
[2428,1211,"PK107","Src","Y419","Src oncogene-encoded protein-tyrosine kinase",0,1660,10,383,{"v":631.95,"d":"632"},{"v":1110.428983455,"d":"1110"},{"$nulls":3},0,282,8,313,{"v":85.762,"d":"86"},{"v":149.8446614062,"d":"150"},{"$nulls":6},0,1512,10,475,{"v":713.45,"d":"713"},{"v":1220.59979683,"d":"1221"},{"$nulls":7},"SRC","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"Not precisely defined.","Antibody raised against amino acid residues that encompass the Y418 phosphosite.","Y419 phosphorylation stimulates phosphotransferase activity and induces interaction with Cbl-c and SHPS1. This is one of the major sites of in vivo phosphorylation of Src.","EphB2; FAK (PTK2); Met; PDGFRA; PDGFRB; PKACa (PRKACA); PYK2 (PTK2B; FAK2); Src",null,"P12931","P12931","P12931","P12931"]
[2433,1214,"PK215","Src","Y530","Src oncogene-encoded protein-tyrosine kinase",0,352,10,545,{"$f":"(H2446-I2446)*J2446/1000","v":{"v":186.39,"d":"186"}},{"v":327.514610691,"d":"328"},{"$f":"(L2446+L2447)/2","v":{"v":350.7669356187,"d":"351"}},{"$f":"SQRT((M2446-L2446)*(M2446-L2446))","v":{"v":23.252324927700045,"d":"23"}},{"$f":"N2446/M2446*100","v":{"v":6.628995656813105,"d":"7"}},0,434,12,543,{"$f":"(Q2446-R2446)*S2446/1000","v":{"v":229.146,"d":"229"}},{"v":400.3673513046,"d":"400"},{"$f":"(U2446+U2447)/2","v":{"v":345.1885512315,"d":"345"}},{"$f":"SQRT((V2446-U2446)*(V2446-U2446))","v":{"v":55.17880007309998,"d":"55"}},{"$f":"W2446/V2446*100","v":{"v":15.985118821653627,"d":"16"}},{"$f":"X2446+O2446","v":{"v":22.614114478466732,"d":"23"}},{"$f":"(V2446/M2446*100)-100","v":{"v":-1.590339288211581,"d":"-2"}},null,0,476,10,658,{"$f":"(AC2446-AD2446)*AE2446/1000","v":{"v":306.628,"d":"307"}},{"v":524.5918767992,"d":"525"},{"$f":"(AG2446+AG2447)/2","v":{"v":528.2975592716,"d":"528"}},{"$f":"SQRT((AH2446-AG2446)*(AH2446-AG2446))","v":{"v":3.7056824723999853,"d":"4"}},{"$f":"AI2446/AH2446*100","v":{"v":0.7014384994527068,"d":"1"}},{"$f":"AJ2446+O2446","v":{"v":7.330434156265811,"d":"7"}},{"$f":"(AH2446/M2446*100)-100","v":{"v":50.61213176771142,"d":"51"}},null,null,"SRC","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"Epitope undefined.","Antibody raised against amino acid residues that encompass the Y530 phosphosite.","Y530 phosphorylation phosphorylation inhibits phosphotransferase activity and induces interaction with Src and AFAP. This is one of the major sites of in vivo phosphorylation of Src.","Akt1 (PKBa); CTK (MATK); Src","Protein-tyrosine kinase, TK group, Src family","P12931","P12931","P12931","P12931","GO:0005884; GO:0005901; GO:0005737; GO:0005829; GO:0070062; GO:0031234; GO:0098978; GO:0005770; GO:0005764; GO:0005743; GO:0005739; GO:0043005; GO:0005634; GO:0048471; GO:0005886; GO:0002102; GO:0014069; GO:0099091; GO:0032587","GO:0005524; GO:0045296; GO:0071253; GO:0019899; GO:0046875; GO:0030331; GO:0070851; GO:0020037; GO:0051427; GO:0005158; GO:0005178; GO:0044325; GO:0016301; GO:0019900; GO:0004715; GO:0046934; GO:0051219; GO:0008022; GO:0004672; GO:0005080; GO:0004713; GO:0097110; GO:0042169; GO:0005070; GO:0005102; GO:0031625","GO:0032148; GO:0034332; GO:0086098; GO:0007411; GO:0045453; GO:0060444; GO:0098609; GO:0007049; GO:0008283; GO:0071398; GO:0071498; GO:0071456; GO:0032869; GO:0071222; GO:0071375; GO:0036120; GO:0071393; GO:0034614; GO:0007417; GO:0035635; GO:0048013; GO:0007173; GO:0038096; GO:0030900; GO:0045087; GO:0007229; GO:0030520; GO:0035556; GO:0050900; GO:0016236; GO:2000811; GO:0043066; GO:0043154; GO:2001237; GO:0051895; GO:2001243; GO:0051902; GO:0032463; GO:0051974; GO:0032211; GO:0045892; GO:0048011; GO:0048477; GO:0036035; GO:0018105; GO:0038083; GO:0018108; GO:0030168; GO:0048008; GO:0043065; GO:0090263; GO:0045737; GO:0050715; GO:2000573; GO:0010634; GO:0070374; GO:0010907; GO:0046628; GO:0033625; GO:2000394; GO:0043406; GO:1903997; GO:2000386; GO:0050731; GO:0043552; GO:0014068; GO:0010641; GO:0071803; GO:0031954; GO:0051897; GO:1900182; GO:0010954; GO:0071902; GO:0051057; GO:0014911; GO:0045893; GO:0001545; GO:0050847; GO:0046777; GO:0031648; GO:0045124; GO:2001286; GO:0022407; GO:0051726; GO:0060491; GO:0042127; GO:2000641; GO:0010632; GO:0033146; GO:0071801; GO:0098962; GO:0043393; GO:0043114; GO:0010447; GO:0051602; GO:0042542; GO:0070555; GO:0009612; GO:0051385; GO:0031667; GO:0009615; GO:0007172; GO:0007165; GO:0002223; GO:0043149; GO:0034446; GO:0031295; GO:0045056; GO:0007179; GO:0060065; GO:0048010; GO:0016032"]
[2434,1214,"PK215","Src","Y530","Src oncogene-encoded protein-tyrosine kinase",0,402,10,543,{"v":212.856,"d":"213"},{"v":374.0192605464,"d":"374"},{"$nulls":3},0,262,15,672,{"v":165.984,"d":"166"},{"v":290.00975115840004,"d":"290"},{"$nulls":6},0,532,12,598,{"v":310.96,"d":"311"},{"v":532.003241744,"d":"532"},{"$nulls":7},"SRC","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"Epitope undefined.","Antibody raised against amino acid residues that encompass the Y530 phosphosite.","Y530 phosphorylation phosphorylation inhibits phosphotransferase activity and induces interaction with Src and AFAP. This is one of the major sites of in vivo phosphorylation of Src.","Akt1 (PKBa); CTK (MATK); Src",null,"P12931","P12931","P12931","P12931"]
[2439,1217,"PK891","SRPK1","S587","Serine/arginine-rich protein-specific kinase 1; SRPK1a protein kinase",0,4182,16,932,{"v":3882.712,"d":"3883"},{"v":6822.4953543927995,"d":"6822"},{"$f":"(L2452+L2453)/2","v":{"v":6788.635133629799,"d":"6789"}},{"$f":"SQRT((M2452-L2452)*(M2452-L2452))","v":{"v":33.86022076300014,"d":"34"}},{"$f":"N2452/M2452*100","v":{"v":0.4987780326455032,"d":"0"}},0,5922,18,743,{"v":4386.672,"d":"4387"},{"v":7664.459557147199,"d":"7664"},{"$f":"(U2452+U2453)/2","v":{"v":7392.030284324999,"d":"7392"}},{"$f":"SQRT((V2452-U2452)*(V2452-U2452))","v":{"v":272.4292728221999,"d":"272"}},{"$f":"W2452/V2452*100","v":{"v":3.685445842935649,"d":"4"}},{"$f":"X2452+O2452","v":{"v":4.184223875581152,"d":"4"}},{"$f":"(V2452/M2452*100)-100","v":{"v":8.888313170729688,"d":"9"}},null,0,6035,14,680,{"v":4094.28,"d":"4094"},{"v":7004.663727192001,"d":"7005"},{"$f":"(AG2452+AG2453)/2","v":{"v":6898.908066051001,"d":"6899"}},{"$f":"SQRT((AH2452-AG2452)*(AH2452-AG2452))","v":{"v":105.75566114100002,"d":"106"}},{"$f":"AI2452/AH2452*100","v":{"v":1.5329333298615115,"d":"2"}},{"$f":"AJ2452+O2452","v":{"v":2.0317113625070147,"d":"2"}},{"$f":"(AH2452/M2452*100)-100","v":{"v":1.6243755961331061,"d":"2"}},null,null,"SRPK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","SRPK",{"$nulls":6},"GKY(pS)KEF(bA)C","Corresponds to amino acid residues G584 to F590. S587 is located in the Gap/Insert 10 (G/I10) region in the protein-serine/threonine kinase catalytic domain of SRPK1. ","S587 phosphorylation appears to induce RNA splicing. It has been observed in only one mass spectrometry study. ",null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; CMGC domain target; CMGC</A> group; SRPK family","Q96SB4","Q96SB4","Q96SB4",null,"GO:0005737; GO:0005829; GO:0005783; GO:0016363; GO:0005634; GO:0005886","GO:0005524; GO:0000287; GO:0004672; GO:0004674; GO:0003723","GO:0007059; GO:0045087; GO:0035556; GO:0045071; GO:0045070; GO:0006468; GO:0050684; GO:0048024; GO:0008380; GO:0035092; GO:0000245; GO:0016032"]
[2445,1220,"PN665","SSRP1","Y441+S444","FACT complex subunit SSRP1",0,1676,14,631,{"v":1048.722,"d":"1049"},{"v":1842.7586112617998,"d":"1843"},{"$f":"(L2458+L2459)/2","v":{"v":1857.9140032742998,"d":"1858"}},{"$f":"SQRT((M2458-L2458)*(M2458-L2458))","v":{"v":15.155392012499988,"d":"15"}},{"$f":"N2458/M2458*100","v":{"v":0.8157208560671184,"d":"1"}},0,1562,18,555,{"v":856.92,"d":"857"},{"v":1497.223563492,"d":"1497"},{"$f":"(U2458+U2459)/2","v":{"v":1616.8798424004,"d":"1617"}},{"$f":"SQRT((V2458-U2458)*(V2458-U2458))","v":{"v":119.65627890840005,"d":"120"}},{"$f":"W2458/V2458*100","v":{"v":7.4004434819819265,"d":"7"}},{"$f":"X2458+O2458","v":{"v":8.216164338049046,"d":"8"}},{"$f":"(V2458/M2458*100)-100","v":{"v":-12.973375541016026,"d":"-13"}},null,0,1764,16,649,{"v":1134.452,"d":"1134"},{"v":1940.8674479128001,"d":"1941"},{"$f":"(AG2458+AG2459)/2","v":{"v":1982.1568942604001,"d":"1982"}},{"$f":"SQRT((AH2458-AG2458)*(AH2458-AG2458))","v":{"v":41.289446347600006,"d":"41"}},{"$f":"AI2458/AH2458*100","v":{"v":2.0830564153200544,"d":"2"}},{"$f":"AJ2458+O2458","v":{"v":2.8987772713871727,"d":"3"}},{"$f":"(AH2458/M2458*100)-100","v":{"v":6.687225068928939,"d":"7"}},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"YDE(pY)AD(pS)DED(bA)C","Corresponds to amino acid residues Y438 to D447.","The effects of Y441 and S444 phosphorylation are unclear. This is one of the major sites of in vivo phosphorylation of SSRP1.",null,"Transcription initiation complex; Transcription, coactivator/corepressor","Q08945","Q08945",null,null,"GO:0005694; GO:0005730; GO:0005654","GO:0003682; GO:0003677; GO:0003723; GO:0000981","GO:0006281; GO:0006260; GO:1901796; GO:0006366; GO:0006368"]
[2450,1222,"PN538","STAM2","Y374","Signal transducing adapter molecule 2",0,914,14,551,{"v":495.9,"d":"496"},{"v":871.36914771,"d":"871"},{"$nulls":3},0,844,12,557,{"v":463.424,"d":"463"},{"v":809.7014105024,"d":"810"},{"$nulls":6},0,1019,12,585,{"v":589.095,"d":"589"},{"v":1007.8481145330001,"d":"1008"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",null,null,"X",null,"YSV(pY)SKL(bA)C","Corresponds to amino acid residues Y371 to L377; In the C-terminal half of the protein. ","The effect of Y374 phosphorylation is unclear. This is the second major in vivo phosphorylation site in STAM2.",null,null,"O75886","O75886",null,"O75886"]
[2451,1223,"NN139-2","STAT1","Pan-specific","Signal transducer and activator of transcription 1 alpha",0,226,12,564,{"v":120.696,"d":"121"},{"v":212.0806022424,"d":"212"},{"$f":"(L2464+L2465)/2","v":{"v":214.4843792016,"d":"214"}},{"$f":"SQRT((M2464-L2464)*(M2464-L2464))","v":{"v":2.403776959200002,"d":"2"}},{"$f":"N2464/M2464*100","v":{"v":1.1207235548564696,"d":"1"}},0,241,12,501,{"v":114.729,"d":"115"},{"v":200.4562412079,"d":"200"},{"$f":"(U2464+U2465)/2","v":{"v":210.88973617755,"d":"211"}},{"$f":"SQRT((V2464-U2464)*(V2464-U2464))","v":{"v":10.433494969649985,"d":"10"}},{"$f":"W2464/V2464*100","v":{"v":4.947369729205755,"d":"5"}},{"$f":"X2464+O2464","v":{"v":6.068093284062224,"d":"6"}},{"$f":"(V2464/M2464*100)-100","v":{"v":-1.675946303143732,"d":"-2"}},null,0,261,12,575,{"v":143.175,"d":"143"},{"v":244.94971744500003,"d":"245"},{"$f":"(AG2464+AG2465)/2","v":{"v":247.58013609750003,"d":"248"}},{"$f":"SQRT((AH2464-AG2464)*(AH2464-AG2464))","v":{"v":2.6304186524999977,"d":"3"}},{"$f":"AI2464/AH2464*100","v":{"v":1.0624514122829738,"d":"1"}},{"$f":"AJ2464+O2464","v":{"v":2.1831749671394434,"d":"2"}},{"$f":"(AH2464/M2464*100)-100","v":{"v":15.430380999817416,"d":"15"}},{"$nulls":5},"Transcription protein, SH2 protein;  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"Epitope undefined.",{"$nulls":3},"Transcription factor; Transcription, coactivator/corepressor","P42224","P42224",null,null,"GO:0030424; GO:0005737; GO:0005829; GO:0030425; GO:0000790; GO:0005730; GO:0005654; GO:0005634; GO:0048471; GO:0032991","GO:0045296; GO:0031730; GO:0003700; GO:0003690; GO:0019899; GO:0035035; GO:0042393; GO:0042802; GO:0035257; GO:1990841; GO:0042803; GO:0051721; GO:0070491; GO:0000979; GO:0000978; GO:0000981; GO:0000983; GO:0000982; GO:0005164; GO:0044389","GO:0008015; GO:0032869; GO:0035458; GO:0071346; GO:0071407; GO:0019221; GO:0051607; GO:0060333; GO:0038114; GO:0070106; GO:0070757; GO:0070102; GO:0038113; GO:0007259; GO:0010742; GO:0072162; GO:0072136; GO:0046725; GO:0016525; GO:0001937; GO:0043124; GO:0003340; GO:0072308; GO:0000122; GO:0002230; GO:0045648; GO:0032727; GO:0002053; GO:0051770; GO:0048661; GO:0045893; GO:0045944; GO:0007221; GO:0042981; GO:0060334; GO:0006355; GO:0061326; GO:0051591; GO:0034097; GO:0042542; GO:0035456; GO:0009612; GO:0007584; GO:0043434; GO:0006351; GO:0033209; GO:0060337; GO:0016032"]
[2456,1225,"PN667","STAT1","S727","Signal transducer and activator of transcription 1-alpha/beta",0,9922,12,716,{"v":7095.56,"d":"7096"},{"v":12467.941257764,"d":"12468"},{"$nulls":3},0,9765,20,764,{"v":7445.18,"d":"7445"},{"v":13008.330918218,"d":"13008"},{"$nulls":6},0,10167,15,756,{"v":7674.912,"d":"7675"},{"v":13130.5571909568,"d":"13131"},{"$nulls":10},"Transcription protein, SH2 protein;  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"LLPM(pS)PEE(bA)C","Corresponds to amino acid residues L723 to E730.","S727 phosphorylation regulates cell cycle, cell differentiation, cell growth, transcription, alters intracellular location, molecular association, induces interaction with DNA, PIAS1, STAT2, and inhibits interaction with DNA. This is one of the major sites of in vivo phosphorylation of STAT1.","CaMK2a; CaMK2g; CK2a1 (CSNK2A1); ERK1 (MAPK3); ERK2 (MAPK1); JNK1 (MAPK8); p38a MAPK (MAPK14); PKCd (PRKCD)",null,"P42224","P42224"]
[2461,1228,"PN539","STAT3","Y705+T708","Signal transducer and activator of transcription 3",0,5181,22,640,{"v":3301.76,"d":"3302"},{"v":5801.677348544,"d":"5802"},{"$f":"(L2474+L2475)/2","v":{"v":6042.5751599464,"d":"6043"}},{"$f":"SQRT((M2474-L2474)*(M2474-L2474))","v":{"v":240.8978114024003,"d":"241"}},{"$f":"N2474/M2474*100","v":{"v":3.9866746383099545,"d":"4"}},0,5515,20,637,{"v":3500.315,"d":"3500"},{"v":6115.8032227565,"d":"6116"},{"$f":"(U2474+U2475)/2","v":{"v":6053.18565439515,"d":"6053"}},{"$f":"SQRT((V2474-U2474)*(V2474-U2474))","v":{"v":62.617568361350095,"d":"63"}},{"$f":"W2474/V2474*100","v":{"v":1.0344564323065852,"d":"1"}},{"$f":"X2474+O2474","v":{"v":5.02113107061654,"d":"5"}},{"$f":"(V2474/M2474*100)-100","v":{"v":0.17559557254797653,"d":"0"}},null,0,5982,20,676,{"v":4030.312,"d":"4030"},{"v":6895.2246245168,"d":"6895"},{"$f":"(AG2474+AG2475)/2","v":{"v":6778.045675348,"d":"6778"}},{"$f":"SQRT((AH2474-AG2474)*(AH2474-AG2474))","v":{"v":117.17894916879959,"d":"117"}},{"$f":"AI2474/AH2474*100","v":{"v":1.7288014094532251,"d":"2"}},{"$f":"AJ2474+O2474","v":{"v":5.71547604776318,"d":"6"}},{"$f":"(AH2474/M2474*100)-100","v":{"v":12.171474841996414,"d":"12"}},{"$nulls":5},"Transcription protein, SH2 protein;  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"AAP(pY)LK(pT)(bA)C","Corresponds to amino acid residues A702 to T708; In the C-terminus of the transcription factor. ","Phosphorylation of Y705 and T708 induces transcriptional activity and interaction with DNA, PKCD and STAT1. Y705 is the major in vivo phosphorylation site in STAT3.","Y705: EphB1; Fer; JAK1; JAK2; MAPKAPK2; MEKK1 (MAP3K1); PKM2","Nuclear receptor co-regulator; Transcription factor","P40763","P40763",null,"P40763","GO:0005737; GO:0005829; GO:0098978; GO:0005743; GO:0000790; GO:0005654; GO:0005634; GO:0005886; GO:0014069; GO:0090575; GO:0098685","GO:0031730; GO:0031490; GO:0003677; GO:0003700; GO:0035259; GO:0042802; GO:0004879; GO:0046983; GO:0042803; GO:0019901; GO:0019903; GO:0000978; GO:0001103; GO:0000981; GO:0001077; GO:0001228; GO:0008134; GO:0044212","GO:0006953; GO:0007568; GO:0048708; GO:0008283; GO:0071345; GO:0032870; GO:0044320; GO:0071407; GO:0019221; GO:0042755; GO:0097009; GO:0001754; GO:0042593; GO:0060396; GO:0006954; GO:0035723; GO:0038114; GO:0038155; GO:0070106; GO:0070757; GO:0070102; GO:0038111; GO:0038113; GO:0030522; GO:0007259; GO:0060397; GO:0033210; GO:0035278; GO:0050804; GO:0042789; GO:0043066; GO:0008285; GO:0045820; GO:0010730; GO:1901215; GO:2001223; GO:2000737; GO:0000122; GO:0007399; GO:0016310; GO:0045766; GO:2001171; GO:0045648; GO:0010628; GO:2000637; GO:1902728; GO:1904685; GO:0045747; GO:1902895; GO:0045893; GO:0045944; GO:0042531; GO:1905564; GO:0099527; GO:0006606; GO:0060019; GO:0051726; GO:0060259; GO:0046902; GO:0040014; GO:0006355; GO:0006357; GO:0032355; GO:0045471; GO:0044321; GO:0019953; GO:0007165; GO:0035019; GO:0001659; GO:0072540; GO:0016032"]
[2463,1229,"PN272","STAT3","S727","Signal transducer and activator of transcription 3",0,115,10,494,{"v":51.87,"d":"52"},{"v":91.143209703,"d":"91"},{"$f":"(L2476+L2477)/2","v":{"v":85.7294401041,"d":"86"}},{"$f":"SQRT((M2476-L2476)*(M2476-L2476))","v":{"v":5.413769598900004,"d":"5"}},{"$f":"N2476/M2476*100","v":{"v":6.314948041566751,"d":"6"}},0,132,12,504,{"v":60.48,"d":"60"},{"v":105.671569248,"d":"106"},{"$f":"(U2476+U2477)/2","v":{"v":97.70426839199999,"d":"98"}},{"$f":"SQRT((V2476-U2476)*(V2476-U2476))","v":{"v":7.9673008560000085,"d":"8"}},{"$f":"W2476/V2476*100","v":{"v":8.15450643776825,"d":"8"}},{"$f":"X2476+O2476","v":{"v":14.469454479335,"d":"14"}},{"$f":"(V2476/M2476*100)-100","v":{"v":13.968163414294011,"d":"14"}},null,0,116,12,595,{"v":61.88,"d":"62"},{"v":105.866865832,"d":"106"},{"$f":"(AG2476+AG2477)/2","v":{"v":104.5563613196,"d":"105"}},{"$f":"SQRT((AH2476-AG2476)*(AH2476-AG2476))","v":{"v":1.3105045124000014,"d":"1"}},{"$f":"AI2476/AH2476*100","v":{"v":1.2533952940406468,"d":"1"}},{"$f":"AJ2476+O2476","v":{"v":7.568343335607398,"d":"8"}},{"$f":"(AH2476/M2476*100)-100","v":{"v":21.960858711591683,"d":"22"}},{"$nulls":5},"Transcription protein, SH2 protein;  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S727 phosphosite.","S727 phosphorylation regulates carcinogenesis, cell differentiation, cell growth, cell motility, transcription, activation/inhibition, alters intracellular location, molecular association, induces interaction with DNA, p300, and inhibits interaction with gp130. This is one of the major sites of in vivo phosphorylation of STAT3.","CDK1 (CDC2); CDK5; DYRK1A; DYRK2; ERK1 (MAPK3); ERK2 (MAPK1); FRAP1 (mTOR); HIPK2; IRAK1; JNK1 (MAPK8); MAPKAPK2; MEKK1 (MAP3K1); MSK1 (RPS6KA5); NLK; p38a MAPK (MAPK14); PKCd (PRKCD); PKCe (PRKCE); RSK2 (RPS6KA3)","Nuclear receptor co-regulator; Transcription factor","P40763","P40763",null,"P40763","GO:0005737; GO:0005829; GO:0098978; GO:0005743; GO:0000790; GO:0005654; GO:0005634; GO:0005886; GO:0014069; GO:0090575; GO:0098685","GO:0031730; GO:0031490; GO:0003677; GO:0003700; GO:0035259; GO:0042802; GO:0004879; GO:0046983; GO:0042803; GO:0019901; GO:0019903; GO:0000978; GO:0001103; GO:0000981; GO:0001077; GO:0001228; GO:0008134; GO:0044212","GO:0006953; GO:0007568; GO:0048708; GO:0008283; GO:0071345; GO:0032870; GO:0044320; GO:0071407; GO:0019221; GO:0042755; GO:0097009; GO:0001754; GO:0042593; GO:0060396; GO:0006954; GO:0035723; GO:0038114; GO:0038155; GO:0070106; GO:0070757; GO:0070102; GO:0038111; GO:0038113; GO:0030522; GO:0007259; GO:0060397; GO:0033210; GO:0035278; GO:0050804; GO:0042789; GO:0043066; GO:0008285; GO:0045820; GO:0010730; GO:1901215; GO:2001223; GO:2000737; GO:0000122; GO:0007399; GO:0016310; GO:0045766; GO:2001171; GO:0045648; GO:0010628; GO:2000637; GO:1902728; GO:1904685; GO:0045747; GO:1902895; GO:0045893; GO:0045944; GO:0042531; GO:1905564; GO:0099527; GO:0006606; GO:0060019; GO:0051726; GO:0060259; GO:0046902; GO:0040014; GO:0006355; GO:0006357; GO:0032355; GO:0045471; GO:0044321; GO:0019953; GO:0007165; GO:0035019; GO:0001659; GO:0072540; GO:0016032"]
[2468,1231,"NN117","STAT4","Pan-specific","Signal transducer and activator of transcription 4",0,628,18,611,{"v":372.71,"d":"373"},{"v":654.9062210989999,"d":"655"},{"$nulls":3},0,598,16,614,{"v":357.348,"d":"357"},{"v":624.3638215548,"d":"624"},{"$nulls":6},0,700,20,643,{"v":437.24,"d":"437"},{"v":748.048293736,"d":"748"},{"$nulls":10},"Transcription protein, SH2 protein;  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":5},"Likely to correspond to the C-terminal 20 amino acids.",{"$nulls":3},"Q14765","Q14765"]
[2473,1234,"PN083-1","STAT5","Y694","Signal transducer and activator of transcription 5",0,2740,12,333,{"v":908.424,"d":"908"},{"v":1596.2344154855998,"d":"1596"},{"$f":"(L2486+L2487)/2","v":{"v":1577.3978007176,"d":"1577"}},{"$f":"SQRT((M2486-L2486)*(M2486-L2486))","v":{"v":18.83661476799989,"d":"19"}},{"$f":"N2486/M2486*100","v":{"v":1.1941575396789965,"d":"1"}},0,84,10,649,{"v":48.026,"d":"48"},{"v":83.91175239260001,"d":"84"},{"$f":"(U2486+U2487)/2","v":{"v":723.0971996407,"d":"723"}},{"$f":"SQRT((V2486-U2486)*(V2486-U2486))","v":{"v":639.1854472481,"d":"639"}},{"$f":"W2486/V2486*100","v":{"v":88.39550859354802,"d":"88"}},{"$f":"X2486+O2486","v":{"v":89.58966613322701,"d":"90"}},{"$f":"(V2486/M2486*100)-100","v":{"v":-54.15885585032869,"d":"-54"}},null,0,2788,16,344,{"v":953.568,"d":"954"},{"v":1631.4036121152,"d":"1631"},{"$f":"(AG2486+AG2487)/2","v":{"v":820.3467404586,"d":"820"}},{"$f":"SQRT((AH2486-AG2486)*(AH2486-AG2486))","v":{"v":811.0568716566,"d":"811"}},{"$f":"AI2486/AH2486*100","v":{"v":98.86756802412519,"d":"99"}},{"$f":"AJ2486+O2486","v":{"v":100.06172556380419,"d":"100"}},{"$f":"(AH2486/M2486*100)-100","v":{"v":-47.993667793539295,"d":"-48"}},{"$nulls":5},"Transcription protein, SH2 protein;  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"Not precisely defined.","Antibody raised against amino acid residues that encompass the Y694 phosphosite.","Y694 phosphorylation stimulates transcriptional activity. This is one of the major sites of in vivo phosphorylation of STAT5A.","Btk; JAK1; JAK2; JAK3; Lck; Lyn; Src; Syk","Transcription protein","P42229","P42229",null,"P42229","GO:0005829; GO:0005654","GO:0003677; GO:0003700; GO:0004713; GO:0000981","GO:0006103; GO:0000255; GO:0006101; GO:0006600; GO:0046449; GO:0019221; GO:0006631; GO:0035723; GO:0038110; GO:0038111; GO:0038113; GO:0006549; GO:0007259; GO:0060397; GO:0007595; GO:0006107; GO:0043536; GO:0001938; GO:0040014; GO:0006357; GO:0006105; GO:0019530; GO:0006351; GO:0006573"]
[2478,1236,"PN672","STAT5A","S780","Signal transducer and activator of transcription 5A",0,16898,18,781,{"v":13183.28,"d":"13183"},{"v":23164.959583832002,"d":"23165"},{"$nulls":3},0,17465,22,793,{"v":13832.299,"d":"13832"},{"v":24168.001680514903,"d":"24168"},{"$nulls":6},0,16908,20,832,{"v":14050.816,"d":"14051"},{"v":24038.717716582403,"d":"24039"},{"$nulls":10},"Transcription protein, SH2 protein;  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"DSRL(pS)PPAGC","Corresponds to amino acid residues D776 to G784.","S780 phosphorylation regulates molecular association, including inhibiting interaction with ERK1. This is one of the major sites of in vivo phosphorylation of STAT5A.","ERK1 (MAPK3); ERK2 (MAPK1); PAK1",null,"P42229","P42229",null,"P42229"]
[2483,1239,"NK174","Syk","Pan-specific","Spleen protein-tyrosine kinase",0,436,12,636,{"v":269.664,"d":"270"},{"v":473.8392616416,"d":"474"},{"$f":"(L2496+L2497)/2","v":{"v":484.49460044319994,"d":"484"}},{"$f":"SQRT((M2496-L2496)*(M2496-L2496))","v":{"v":10.655338801599953,"d":"11"}},{"$f":"N2496/M2496*100","v":{"v":2.1992688446584947,"d":"2"}},0,433,12,663,{"v":279.123,"d":"279"},{"v":487.6879203573,"d":"488"},{"$f":"(U2496+U2497)/2","v":{"v":503.16387810555,"d":"503"}},{"$f":"SQRT((V2496-U2496)*(V2496-U2496))","v":{"v":15.475957748249982,"d":"15"}},{"$f":"W2496/V2496*100","v":{"v":3.075729085823516,"d":"3"}},{"$f":"X2496+O2496","v":{"v":5.2749979304820105,"d":"5"}},{"$f":"(V2496/M2496*100)-100","v":{"v":3.8533510270851252,"d":"4"}},null,0,496,8,719,{"v":350.872,"d":"351"},{"v":600.2863437008001,"d":"600"},{"$f":"(AG2496+AG2497)/2","v":{"v":596.5823720698,"d":"597"}},{"$f":"SQRT((AH2496-AG2496)*(AH2496-AG2496))","v":{"v":3.7039716310000586,"d":"4"}},{"$f":"AI2496/AH2496*100","v":{"v":0.6208650815727915,"d":"1"}},{"$f":"AJ2496+O2496","v":{"v":2.820133926231286,"d":"3"}},{"$f":"(AH2496/M2496*100)-100","v":{"v":23.13498881598801,"d":"23"}},null,null,"SYK","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Syk",{"$nulls":6},"Epitope undefined.",{"$nulls":3},"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; Syk family","P43405","P43405","P43405","P43405","GO:0019815; GO:0005737; GO:0005829; GO:0032009; GO:0031234; GO:0005634; GO:0005886; GO:0032991; GO:0042101","GO:0005524; GO:0005178; GO:0004715; GO:0019902; GO:0001784; GO:0004672; GO:0019901; GO:0004674; GO:0004713; GO:0042169; GO:0035325","GO:0007257; GO:0002250; GO:0001525; GO:0009887; GO:0050853; GO:0043366; GO:0048514; GO:0008283; GO:0071404; GO:0071226; GO:0038063; GO:0042742; GO:0038095; GO:0038096; GO:0006954; GO:0045087; GO:0007229; GO:0038110; GO:0038156; GO:0002366; GO:0007159; GO:0019370; GO:0001945; GO:0002281; GO:0002283; GO:0030593; GO:0018105; GO:0038083; GO:0030168; GO:0046638; GO:0046641; GO:0045579; GO:0045780; GO:0050850; GO:0033630; GO:0120162; GO:0050715; GO:0045588; GO:0045425; GO:0045401; GO:0032753; GO:0043306; GO:1900086; GO:0002092; GO:0032481; GO:0006606; GO:0006468; GO:0031623; GO:0090237; GO:0051090; GO:0070372; GO:0043313; GO:0050764; GO:0010543; GO:0090330; GO:0032928; GO:0010803; GO:0002554; GO:0002223; GO:0007169; GO:0016032"]
[2486,1240,"PK821","Syk","Y323","Spleen protein-tyrosine kinase",0,3484,14,656,{"v":2276.32,"d":"2276"},{"v":3999.828631408,"d":"4000"},{"$nulls":3},0,3578,14,699,{"v":2491.236,"d":"2491"},{"v":4352.7251568636,"d":"4353"},{"$nulls":6},0,3881,18,720,{"v":2781.36,"d":"2781"},{"v":4758.465836304001,"d":"4758"},{"$nulls":7},"SYK","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Syk",{"$nulls":6},"FNP(pY)EPE(bA)C","Corresponds to amino acid residues F320 to E326; In the region between the SH2 and kinase catalytic domains. ","Y323 phosphorylation stimulates phosphotransferase activity and regulates molecular association, including inducing interaction with Cbl, and Fyn. This is the major site of phosphorylation in Syk.","Lck; Lyn; Syk",null,"P43405","P43405","P43405","P43405"]
[2490,1242,"PK823","Syk","Y525+Y526","Spleen protein-tyrosine kinase",0,572,14,521,{"v":290.718,"d":"291"},{"v":510.8342324742,"d":"511"},{"$nulls":3},0,542,14,529,{"v":279.312,"d":"279"},{"v":488.01814401120004,"d":"488"},{"$nulls":6},0,730,14,606,{"v":433.896,"d":"434"},{"v":742.3272400944,"d":"742"},{"$nulls":7},"SYK","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Syk",{"$nulls":6},"DEN(pY)(pY)KAQ(bA)C","Corresponds to amino acid residues D522 to Q529; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y525 and Y526 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of Syk(≥XXX reports from high throughput mass spectrometry studies).","Y525: Syk. Y526: Syk.",null,"P43405","P43405","P43405","P43405"]
[2495,1245,"PK825","TAK1 (MAP3K7)","T184+T187","TGF-beta-activated protein-serine kinase 1; Mitogen-activated protein kinase kinase kinase 7",0,4273,18,620,{"v":2638.1,"d":"2638"},{"v":4635.52923689,"d":"4636"},{"$f":"(L2508+L2509)/2","v":{"v":4834.84328833045,"d":"4835"}},{"$f":"SQRT((M2508-L2508)*(M2508-L2508))","v":{"v":199.31405144045038,"d":"199"}},{"$f":"N2508/M2508*100","v":{"v":4.122451123111309,"d":"4"}},0,4006,18,644,{"v":2568.272,"d":"2568"},{"v":4487.3236193072,"d":"4487"},{"$f":"(U2508+U2509)/2","v":{"v":4255.8420795686,"d":"4256"}},{"$f":"SQRT((V2508-U2508)*(V2508-U2508))","v":{"v":231.48153973860008,"d":"231"}},{"$f":"W2508/V2508*100","v":{"v":5.43914777406554,"d":"5"}},{"$f":"X2508+O2508","v":{"v":9.561598897176848,"d":"10"}},{"$f":"(V2508/M2508*100)-100","v":{"v":-11.975594124412439,"d":"-12"}},null,0,4510,18,675,{"v":3032.1,"d":"3032"},{"v":5187.4422089400005,"d":"5187"},{"$f":"(AG2508+AG2509)/2","v":{"v":4990.1787738372,"d":"4990"}},{"$f":"SQRT((AH2508-AG2508)*(AH2508-AG2508))","v":{"v":197.26343510280003,"d":"197"}},{"$f":"AI2508/AH2508*100","v":{"v":3.953033429123306,"d":"4"}},{"$f":"AJ2508+O2508","v":{"v":8.075484552234615,"d":"8"}},{"$f":"(AH2508/M2508*100)-100","v":{"v":3.212833927454753,"d":"3"}},null,null,"TAK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","MLK","TAK1",{"$nulls":5},"DIQ(pT)HM(pT)NNK(bA)C","Corresponds to amino acid residues D181 to K190; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T184 and T187 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major sites of in vivo phosphorylation of TAK1.","T184: TAK1 (MAP3K7). T187: TAK1 (MAP3K7). ","EC 2.7.11.25; Protein kinase, Ser/Thr (non-receptor); TKL group; MLK family; TAK1 subfamily","O43318","O43318","O43318","O43318","GO:0005671; GO:0005829; GO:0010008; GO:0005634; GO:0005886","GO:0005524; GO:0042802; GO:0000287; GO:0004709; GO:0004672; GO:0004674; GO:0030971; GO:0097110","GO:0000187; GO:0000186; GO:0007250; GO:0043276; GO:0038095; GO:0043966; GO:0007249; GO:0007252; GO:0070498; GO:0007254; GO:0002755; GO:0070423; GO:0043123; GO:0032743; GO:0043507; GO:0016239; GO:0051092; GO:0002726; GO:0016579; GO:0002223; GO:0051403; GO:0050852; GO:0006351; GO:0007179; GO:0016032; GO:0007223"]
[2500,1247,"PK826","TAO1 (TAOK1)","S181","Serine/threonine-protein kinase TAO1",0,3192,38,617,{"v":1946.018,"d":"1946"},{"v":3419.4394960442,"d":"3419"},{"$nulls":3},0,3022,16,617,{"v":1854.702,"d":"1855"},{"v":3240.5633404002,"d":"3241"},{"$nulls":6},0,3235,20,643,{"v":2067.245,"d":"2067"},{"v":3536.728329943,"d":"3537"},{"$nulls":7},"TAO1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","TAO",{"$nulls":5},"PAN(pS)FVG(bA)C","Corresponds to amino acid residues P178 to G184; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S181 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of TAO1.",null,null,"Q7L7X3","Q7L7X3","Q7L7X3","Q7L7X3"]
[2501,1248,"PK827","TAO1 (TAOK1)","Y309","Serine/threonine-protein kinase TAO1",0,2909,16,640,{"v":1851.52,"d":"1852"},{"$f":"K2514*1.7571469","v":{"v":3253.3926282879997,"d":"3253"}},{"$f":"(L2514+L2515)/2","v":{"v":3236.770018614,"d":"3237"}},{"$f":"SQRT((M2514-L2514)*(M2514-L2514))","v":{"v":16.622609673999705,"d":"17"}},{"$f":"N2514/M2514*100","v":{"v":0.5135554759345424,"d":"1"}},0,3476,18,620,{"v":2143.96,"d":"2144"},{"$f":"T2514*1.7472151","v":{"v":3745.959285796,"d":"3746"}},{"$f":"(U2514+U2515)/2","v":{"v":3680.4588125196506,"d":"3680"}},{"$f":"SQRT((V2514-U2514)*(V2514-U2514))","v":{"v":65.50047327634957,"d":"66"}},{"$f":"W2514/V2514*100","v":{"v":1.779682279109864,"d":"2"}},{"$f":"X2514+O2514","v":{"v":2.2932377550444065,"d":"2"}},{"$f":"(V2514/M2514*100)-100","v":{"v":13.707763954624113,"d":"14"}},null,0,3052,12,634,{"v":1927.36,"d":"1927"},{"v":3297.407280704,"d":"3297"},{"$f":"(AG2514+AG2515)/2","v":{"v":3257.9347479232,"d":"3258"}},{"$f":"SQRT((AH2514-AG2514)*(AH2514-AG2514))","v":{"v":39.472532780800066,"d":"39"}},{"$f":"AI2514/AH2514*100","v":{"v":1.211581441462638,"d":"1"}},{"$f":"AJ2514+O2514","v":{"v":1.7251369173971804,"d":"2"}},{"$f":"(AH2514/M2514*100)-100","v":{"v":0.653884248416972,"d":"1"}},null,null,"TAO1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","TAO",{"$nulls":5},"NLQ(pY)RKM(bA)C","Corresponds to amino acid residues N306 to M312; Just after the kinase catalytic domain.","The effect of Y309 phosphorylation is unclear. This is the major in vivo site of phosphorylation on TAO1.",null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; STE domain target; STE</A> group; STE20 family; TAO subfamily","Q7L7X3","Q7L7X3","Q7L7X3","Q7L7X3","GO:0005737; GO:0005829; GO:0070062; GO:0015630; GO:0048471","GO:0043014; GO:0005524; GO:0048487; GO:0016301; GO:0004709; GO:0004672; GO:0043539; GO:0004674; GO:0016740","GO:0007257; GO:0000187; GO:0006974; GO:0006281; GO:0097194; GO:0000226; GO:0007095; GO:0007026; GO:0007399; GO:0070050; GO:0046330; GO:1901985; GO:0032874; GO:0046777; GO:0006468; GO:0032956; GO:0042981; GO:0051493; GO:0070507; GO:0007346"]
[2509,1252,"PN275","Tau","S396","Microtubule-associated protein tau",0,74,10,550,{"v":35.2,"d":"35"},{"v":61.851570880000004,"d":"62"},{"$f":"(L2522+L2523)/2","v":{"v":57.6906470208,"d":"58"}},{"$f":"SQRT((M2522-L2522)*(M2522-L2522))","v":{"v":4.160923859200004,"d":"4"}},{"$f":"N2522/M2522*100","v":{"v":7.212475633528272,"d":"7"}},0,80,10,536,{"v":37.52,"d":"38"},{"v":65.555510552,"d":"66"},{"$f":"(U2522+U2523)/2","v":{"v":58.6085833144,"d":"59"}},{"$f":"SQRT((V2522-U2522)*(V2522-U2522))","v":{"v":6.946927237600001,"d":"7"}},{"$f":"W2522/V2522*100","v":{"v":11.853088480801336,"d":"12"}},{"$f":"X2522+O2522","v":{"v":19.065564114329607,"d":"19"}},{"$f":"(V2522/M2522*100)-100","v":{"v":1.591135376361862,"d":"2"}},null,0,68,10,564,{"v":32.712,"d":"33"},{"v":55.96504387680001,"d":"56"},{"$f":"(AG2522+AG2523)/2","v":{"v":57.79222249200001,"d":"58"}},{"$f":"SQRT((AH2522-AG2522)*(AH2522-AG2522))","v":{"v":1.8271786151999976,"d":"2"}},{"$f":"AI2522/AH2522*100","v":{"v":3.1616341030195336,"d":"3"}},{"$f":"AJ2522+O2522","v":{"v":10.374109736547805,"d":"10"}},{"$f":"(AH2522/M2522*100)-100","v":{"v":0.1760692182276813,"d":"0"}},{"$nulls":15},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S396 phosphosite.","The effect of S396 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of Tau.",null,"Cytoskeletal protein","P10636","P10636",null,null,"GO:0030673; GO:0030424; GO:1904115; GO:0044297; GO:0005737; GO:0036464; GO:0005829; GO:0030425; GO:0043197; GO:0005576; GO:0097386; GO:0030426; GO:0005622; GO:0044304; GO:0045121; GO:0005874; GO:0005875; GO:0015630; GO:0005739; GO:0097418; GO:0043025; GO:0034399; GO:0016607; GO:0005634; GO:0005886; GO:0036477; GO:0045298","GO:0003779; GO:0034185; GO:0003680; GO:0051087; GO:0003677; GO:0003690; GO:0034452; GO:0019899; GO:0099077; GO:0051879; GO:0042802; GO:0071813; GO:0008017; GO:0099609; GO:0035091; GO:1902936; GO:0030674; GO:0042803; GO:0019901; GO:0051721; GO:0048018; GO:0003723; GO:0043565; GO:0017124; GO:0003697","GO:0006919; GO:1990000; GO:0048143; GO:0098930; GO:0019896; GO:0061564; GO:0007267; GO:1990416; GO:0034605; GO:1990090; GO:0034614; GO:0021954; GO:0031122; GO:0048699; GO:0006475; GO:0048312; GO:0007611; GO:0007613; GO:0001774; GO:0000226; GO:0046785; GO:1903748; GO:0010629; GO:0033673; GO:0090258; GO:0010917; GO:1904428; GO:1902988; GO:0031175; GO:0072386; GO:0045773; GO:1903829; GO:1905689; GO:0031116; GO:1901216; GO:1902474; GO:0032930; GO:0051259; GO:0051260; GO:0010506; GO:0050848; GO:1900034; GO:0033044; GO:1900452; GO:0070507; GO:0031113; GO:0031110; GO:0090140; GO:2001020; GO:0048167; GO:0010288; GO:0016072; GO:0034063; GO:0097435; GO:0007416; GO:0050808"]
[2512,1253,"PN085","Tau","S516","Microtubule-associated protein tau",0,776,12,294,{"v":224.616,"d":"225"},{"v":394.68330809040003,"d":"395"},{"$nulls":3},0,735,12,309,{"v":223.407,"d":"223"},{"v":390.3400838457,"d":"390"},{"$nulls":6},0,631,11,359,{"v":222.58,"d":"223"},{"v":380.79907881200006,"d":"381"},{"$nulls":20},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S516 phosphosite.","The effect of S516 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of Tau.",null,null,"P10636","P10636"]
[2517,1256,"PN092","Tau","S721","Microtubule-associated protein tau",0,300,8,260,{"v":75.92,"d":"76"},{"v":133.402592648,"d":"133"},{"$f":"(L2530+L2531)/2","v":{"v":142.55381370319998,"d":"143"}},{"$f":"SQRT((M2530-L2530)*(M2530-L2530))","v":{"v":9.151221055199983,"d":"9"}},{"$f":"N2530/M2530*100","v":{"v":6.419485257864105,"d":"6"}},0,332,10,263,{"v":84.686,"d":"85"},{"v":147.96465795860001,"d":"148"},{"$f":"(U2530+U2531)/2","v":{"v":103.86756965725002,"d":"104"}},{"$f":"SQRT((V2530-U2530)*(V2530-U2530))","v":{"v":44.09708830135,"d":"44"}},{"$f":"W2530/V2530*100","v":{"v":42.455107447748006,"d":"42"}},{"$f":"X2530+O2530","v":{"v":48.87459270561211,"d":"49"}},{"$f":"(V2530/M2530*100)-100","v":{"v":-27.137993043452028,"d":"-27"}},null,0,286,12,280,{"v":76.72,"d":"77"},{"v":131.255752208,"d":"131"},{"$f":"(AG2530+AG2531)/2","v":{"v":128.48418914,"d":"128"}},{"$f":"SQRT((AH2530-AG2530)*(AH2530-AG2530))","v":{"v":2.7715630679999776,"d":"3"}},{"$f":"AI2530/AH2530*100","v":{"v":2.1571238348868,"d":"2"}},{"$f":"AJ2530+O2530","v":{"v":8.576609092750905,"d":"9"}},{"$f":"(AH2530/M2530*100)-100","v":{"v":-9.869693554809572,"d":"-10"}},{"$nulls":15},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S721 phosphosite.","The effect of S721 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of Tau.",null,"Cytoskeletal protein","P10636","P10636",null,null,"GO:0030673; GO:0030424; GO:1904115; GO:0044297; GO:0005737; GO:0036464; GO:0005829; GO:0030425; GO:0043197; GO:0005576; GO:0097386; GO:0030426; GO:0005622; GO:0044304; GO:0045121; GO:0005874; GO:0005875; GO:0015630; GO:0005739; GO:0097418; GO:0043025; GO:0034399; GO:0016607; GO:0005634; GO:0005886; GO:0036477; GO:0045298","GO:0003779; GO:0034185; GO:0003680; GO:0051087; GO:0003677; GO:0003690; GO:0034452; GO:0019899; GO:0099077; GO:0051879; GO:0042802; GO:0071813; GO:0008017; GO:0099609; GO:0035091; GO:1902936; GO:0030674; GO:0042803; GO:0019901; GO:0051721; GO:0048018; GO:0003723; GO:0043565; GO:0017124; GO:0003697","GO:0006919; GO:1990000; GO:0048143; GO:0098930; GO:0019896; GO:0061564; GO:0007267; GO:1990416; GO:0034605; GO:1990090; GO:0034614; GO:0021954; GO:0031122; GO:0048699; GO:0006475; GO:0048312; GO:0007611; GO:0007613; GO:0001774; GO:0000226; GO:0046785; GO:1903748; GO:0010629; GO:0033673; GO:0090258; GO:0010917; GO:1904428; GO:1902988; GO:0031175; GO:0072386; GO:0045773; GO:1903829; GO:1905689; GO:0031116; GO:1901216; GO:1902474; GO:0032930; GO:0051259; GO:0051260; GO:0010506; GO:0050848; GO:1900034; GO:0033044; GO:1900452; GO:0070507; GO:0031113; GO:0031110; GO:0090140; GO:2001020; GO:0048167; GO:0010288; GO:0016072; GO:0034063; GO:0097435; GO:0007416; GO:0050808"]
[2518,1256,"PN092","Tau","S721","Microtubule-associated protein tau",0,318,14,284,{"v":86.336,"d":"86"},{"v":151.7050347584,"d":"152"},{"$nulls":3},0,73,10,543,{"v":34.209,"d":"34"},{"v":59.7704813559,"d":"60"},{"$nulls":6},0,232,12,334,{"v":73.48,"d":"73"},{"v":125.712626072,"d":"126"},{"$nulls":20},"Not precisely defined.","Antibody raised against amino acid residues that encompass the S721 phosphosite.","The effect of S721 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of Tau.",null,null,"P10636","P10636"]
[2523,1259,"PK828","TBK1","S172","TANK binding kinase TBK1; Serine/threonine-protein kinase TBK1",0,13945,18,676,{"v":9414.652,"d":"9415"},{"v":16542.9265763788,"d":"16543"},{"$f":"(L2536+L2537)/2","v":{"v":16614.809698910896,"d":"16615"}},{"$f":"SQRT((M2536-L2536)*(M2536-L2536))","v":{"v":71.88312253209733,"d":"72"}},{"$f":"N2536/M2536*100","v":{"v":0.432644874270268,"d":"0"}},0,13710,20,660,{"v":9035.4,"d":"9035"},{"v":15786.787314539999,"d":"15787"},{"$f":"(U2536+U2537)/2","v":{"v":15981.9582300704,"d":"15982"}},{"$f":"SQRT((V2536-U2536)*(V2536-U2536))","v":{"v":195.17091553040154,"d":"195"}},{"$f":"W2536/V2536*100","v":{"v":1.2211952548041531,"d":"1"}},{"$f":"X2536+O2536","v":{"v":1.6538401290744211,"d":"2"}},{"$f":"(V2536/M2536*100)-100","v":{"v":-3.808960080246834,"d":"-4"}},null,0,14013,24,693,{"v":9694.377,"d":"9694"},{"v":16585.5415188078,"d":"16586"},{"$f":"(AG2536+AG2537)/2","v":{"v":16516.540718883698,"d":"16517"}},{"$f":"SQRT((AH2536-AG2536)*(AH2536-AG2536))","v":{"v":69.00079992410247,"d":"69"}},{"$f":"AI2536/AH2536*100","v":{"v":0.4177678673671203,"d":"0"}},{"$f":"AJ2536+O2536","v":{"v":0.8504127416373883,"d":"1"}},{"$f":"(AH2536/M2536*100)-100","v":{"v":-0.5914541412631422,"d":"-1"}},null,null,"TBK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","IKK",{"$nulls":6},"QFV(pS)LYG(bA)C","Corresponds to amino acid residues Q169 to G175; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S172 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of TBK1.",null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; IKK family","Q9UHD2","Q9UHD2","Q9UHD2","Q9UHD2","GO:0016235; GO:0005737; GO:0005829; GO:0010008; GO:0005654","GO:0005524; GO:0042802; GO:0003676; GO:0051219; GO:0004672; GO:0004674","GO:0071345; GO:0050830; GO:0051607; GO:0044565; GO:0007249; GO:0006954; GO:0045087; GO:0010629; GO:0032480; GO:0018105; GO:0018107; GO:0043123; GO:0032727; GO:0045359; GO:0032728; GO:0016239; GO:0033138; GO:0045944; GO:0032481; GO:1904417; GO:0006468; GO:1901214; GO:0032479; GO:0009615; GO:0035666; GO:0032606; GO:0016032"]
[2527,1261,"PN675","TERF1","T371","Telomeric repeat-binding factor 1",0,9682,16,679,{"v":6563.214,"d":"6563"},{"v":11532.5311341366,"d":"11533"},{"$f":"(L2540+L2541)/2","v":{"v":11764.3743675633,"d":"11764"}},{"$f":"SQRT((M2540-L2540)*(M2540-L2540))","v":{"v":231.84323342669995,"d":"232"}},{"$f":"N2540/M2540*100","v":{"v":1.9707230166521859,"d":"2"}},0,9697,16,691,{"v":6689.571,"d":"6690"},{"v":11688.1194637221,"d":"11688"},{"$f":"(U2540+U2541)/2","v":{"v":11889.26323407185,"d":"11889"}},{"$f":"SQRT((V2540-U2540)*(V2540-U2540))","v":{"v":201.1437703497504,"d":"201"}},{"$f":"W2540/V2540*100","v":{"v":1.6918102189319804,"d":"2"}},{"$f":"X2540+O2540","v":{"v":3.662533235584166,"d":"4"}},{"$f":"(V2540/M2540*100)-100","v":{"v":1.0615852794764464,"d":"1"}},null,0,9762,16,703,{"v":6851.438,"d":"6851"},{"v":11721.723779933202,"d":"11722"},{"$f":"(AG2540+AG2541)/2","v":{"v":11331.5629769804,"d":"11332"}},{"$f":"SQRT((AH2540-AG2540)*(AH2540-AG2540))","v":{"v":390.16080295280153,"d":"390"}},{"$f":"AI2540/AH2540*100","v":{"v":3.443133164819337,"d":"3"}},{"$f":"AJ2540+O2540","v":{"v":5.413856181471523,"d":"5"}},{"$f":"(AH2540/M2540*100)-100","v":{"v":-3.6790004896158877,"d":"-4"}},{"$nulls":5},"DNA binding protein",{"$nulls":4},"X",{"$nulls":4},"SQPV(pT)PEKH(bA)C","Corresponds to amino acid residues S367 to H375.","T371 phosphoryation generates a docking site for Plk1 at S435. This is one of the major sites of in vivo phosphorylation of TERF1.","CDK1 (CDC2)","DNA binding protein","P54274","P54274",null,null,"GO:0000781; GO:0005737; GO:0001650; GO:0016604; GO:0000784; GO:0000783; GO:0005730; GO:0005654; GO:0005634; GO:0070187; GO:0005819","GO:0071532; GO:0003677; GO:0008301; GO:0003691; GO:0098505; GO:0008017; GO:0008022; GO:0046982; GO:0042803; GO:0000981; GO:0042162","GO:0051301; GO:0000086; GO:0045141; GO:0007094; GO:0008156; GO:1904914; GO:1904850; GO:1904911; GO:1905778; GO:0051974; GO:0032214; GO:0032211; GO:1904357; GO:1905839; GO:0043065; GO:0031116; GO:0045931; GO:0045840; GO:1904792; GO:0051260; GO:0042493; GO:0090656; GO:0016233; GO:0000723; GO:0007004; GO:0061820; GO:0031627"]
[2534,1264,"PN731","TH (TY3H)","S19","Tyrosine 3-monooxygenase",0,3284,10,697,{"v":2281.978,"d":"2282"},{"v":4009.7705685682,"d":"4010"},{"$nulls":3},0,3561,16,695,{"v":2463.775,"d":"2464"},{"v":4304.7448830025005,"d":"4305"},{"$nulls":6},0,3862,20,710,{"v":2727.82,"d":"2728"},{"v":4666.8673877480005,"d":"4667"},{"$nulls":10},"Metabolic enzyme",{"$nulls":8},"X","RAV(pS)ELDAC","Corresponds to amino acid residues R16 to A23.","S19 phosphorylation stimulates enzyme activity. This is one of the major sites of in vivo phosphorylation of tyrosine hydroxylase (≥11 reports from high throughput mass spectrometry studies). This human phosphosite is conserved in mammals and found in the rat.","CaMK1a; CaMK2a; MAPKAPK2; MAPKAPK5 (PRAK)",null,"P07101","P07101"]
[2535,1265,"PN730","TH (TY3H)","S71","Tyrosine 3-monooxygenase",0,12962,18,807,{"v":10445.808,"d":"10446"},{"v":18354.8191451952,"d":"18355"},{"$f":"(L2548+L2549)/2","v":{"v":18033.0556763079,"d":"18033"}},{"$f":"SQRT((M2548-L2548)*(M2548-L2548))","v":{"v":321.7634688873004,"d":"322"}},{"$f":"N2548/M2548*100","v":{"v":1.784298094914874,"d":"2"}},0,12050,20,776,{"v":9335.28,"d":"9335"},{"v":16310.742178728002,"d":"16311"},{"$f":"(U2548+U2549)/2","v":{"v":17822.294653255103,"d":"17822"}},{"$f":"SQRT((V2548-U2548)*(V2548-U2548))","v":{"v":1511.5524745271014,"d":"1512"}},{"$f":"W2548/V2548*100","v":{"v":8.481245002034731,"d":"8"}},{"$f":"X2548+O2548","v":{"v":10.265543096949605,"d":"10"}},{"$f":"(V2548/M2548*100)-100","v":{"v":-1.1687482522981298,"d":"-1"}},null,0,12628,14,828,{"v":10444.392,"d":"10444"},{"v":17868.6982314288,"d":"17869"},{"$f":"(AG2548+AG2549)/2","v":{"v":18467.3746733722,"d":"18467"}},{"$f":"SQRT((AH2548-AG2548)*(AH2548-AG2548))","v":{"v":598.6764419434003,"d":"599"}},{"$f":"AI2548/AH2548*100","v":{"v":3.2418059011204328,"d":"3"}},{"$f":"AJ2548+O2548","v":{"v":5.026103996035307,"d":"5"}},{"$f":"(AH2548/M2548*100)-100","v":{"v":2.4084603566932685,"d":"2"}},{"$nulls":5},"Metabolic enzyme",{"$nulls":8},"X","CGRRQ(pS)LIE","Corresponds to amino acid residues G67 to E74.","S71 phosphorylation stimulates enzyme activity. This is one of the major sites of in vivo phosphorylation of tyrosine hydroxylase.","CaMK1a; CaMK2a; MAPKAPK2; MSK1 (RPS6KA5); PKACa (PRKACA); PKACa (PRKACA); RSK2 (RPS6KA3)","Endoplasmic reticulum; Vesicle protein; EC 1.14.16.2; Amino Acid Metabolism - tyrosine; Mitochondrial; Oxidoreductase","P07101","P07101",null,null,"GO:0005737; GO:0009898; GO:0031410; GO:0005829; GO:0030425; GO:0033162; GO:0005739; GO:0043005; GO:0005634; GO:0043204; GO:0005790; GO:0008021; GO:0043195","GO:0016597; GO:0035240; GO:0019899; GO:0008199; GO:0008198; GO:0019825; GO:0019904; GO:0034617; GO:0004511","GO:0015842; GO:0009653; GO:0009887; GO:0042423; GO:0071312; GO:0071333; GO:0071363; GO:0071287; GO:0071316; GO:0021987; GO:0042745; GO:0042416; GO:0006585; GO:0042755; GO:0048596; GO:0042418; GO:0042462; GO:0006631; GO:0016137; GO:0007507; GO:0003007; GO:0033076; GO:0007612; GO:0007626; GO:0007617; GO:0007613; GO:0010259; GO:0042136; GO:0042421; GO:0018963; GO:0052314; GO:0043473; GO:0008016; GO:0014823; GO:0001975; GO:0051412; GO:0051602; GO:0032355; GO:0045471; GO:0045472; GO:0009635; GO:0001666; GO:0035902; GO:0035900; GO:0009416; GO:0032496; GO:0031667; GO:0043434; GO:0046684; GO:0009651; GO:0009414; GO:0010043; GO:0007605; GO:0035176; GO:0006665; GO:0001963; GO:0042214; GO:0007601"]
[2540,1267,"PK830","TIE2 (TEK)","Y897","Angiopoietin-1 receptor",0,6506,14,749,{"v":4862.508,"d":"4863"},{"v":8544.1408584252,"d":"8544"},{"$nulls":3},0,6677,14,704,{"v":4690.752,"d":"4691"},{"v":8195.7527247552,"d":"8196"},{"$nulls":6},0,6912,16,776,{"v":5351.296,"d":"5351"},{"v":9155.2187404544,"d":"9155"},{"$nulls":7},"TIE2","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK","Tie",{"$nulls":6},"HRG(pY)LYL(bA)C","Corresponds to amino acid residues H894 to L900; In the protein kinase catalytic domain.","Y897 phosphorylation inhibits phosphotransferase activity. This is one of the major sites of in vivo phosphorylation of TIE2.",null,null,"Q02763","Q02763","Q02763","Q02763"]
[2545,1270,"PK832","TNK1","Y277","Non-receptor tyrosine-protein kinase TNK1",0,6274,14,669,{"v":4187.94,"d":"4188"},{"v":7358.825788385999,"d":"7359"},{"$f":"(L2558+L2559)/2","v":{"v":7867.654237673849,"d":"7868"}},{"$f":"SQRT((M2558-L2558)*(M2558-L2558))","v":{"v":508.82844928785016,"d":"509"}},{"$f":"N2558/M2558*100","v":{"v":6.467346351487485,"d":"6"}},0,6841,18,656,{"v":4475.888,"d":"4476"},{"v":7820.3390995088,"d":"7820"},{"$f":"(U2558+U2559)/2","v":{"v":7721.0029322134005,"d":"7721"}},{"$f":"SQRT((V2558-U2558)*(V2558-U2558))","v":{"v":99.33616729539972,"d":"99"}},{"$f":"W2558/V2558*100","v":{"v":1.2865707754228601,"d":"1"}},{"$f":"X2558+O2558","v":{"v":7.753917126910346,"d":"8"}},{"$f":"(V2558/M2558*100)-100","v":{"v":-1.8639775088007298,"d":"-2"}},null,0,6836,18,682,{"v":4649.876,"d":"4650"},{"v":7955.200365666401,"d":"7955"},{"$f":"(AG2558+AG2559)/2","v":{"v":7776.160813156401,"d":"7776"}},{"$f":"SQRT((AH2558-AG2558)*(AH2558-AG2558))","v":{"v":179.03955251000025,"d":"179"}},{"$f":"AI2558/AH2558*100","v":{"v":2.3024157654646906,"d":"2"}},{"$f":"AJ2558+O2558","v":{"v":8.769762116952176,"d":"9"}},{"$f":"(AH2558/M2558*100)-100","v":{"v":-1.1629060168828573,"d":"-1"}},null,null,"TNK1","X","PSTK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Ack",{"$nulls":6},"RGR(pY)VMG(bA)C","Corresponds to amino acid residues R274 to G280; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y277 phosphorylation is predicted to stimulate phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of TNK1.",null,"Protein-serine kinase, TK group, Ack family","Q13470","Q13470","Q13470","Q13470","GO:0005737; GO:0005829; GO:0031234; GO:0016020","GO:0005524; GO:0004715; GO:0004713; GO:0005102","GO:0030154; GO:0016477; GO:0045087; GO:0030308; GO:0046580; GO:0038083; GO:0046777; GO:0006468; GO:0042127; GO:0007169"]
[2550,1272,"PN678","TP53BP1","T1056","Tumor suppressor p53-binding protein 1",0,8058,24,726,{"v":5832.684,"d":"5833"},{"v":10248.8826092796,"d":"10249"},{"$nulls":3},0,8410,20,731,{"v":6133.09,"d":"6133"},{"v":10715.827457659001,"d":"10716"},{"$nulls":6},0,8714,18,731,{"v":6356.776,"d":"6357"},{"v":10875.4355513264,"d":"10875"},{"$nulls":10},"Transcription,  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"DPPT(pT)PIRGC","Corresponds to amino acid residues D1052 to G1060.","The effect of T1056 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of TP53P1.","ERK1 (MAPK3)",null,"Q12888","Q12888",null,"Q12888"]
[2552,1273,"PK834","TRIM28 (TIF1B)","Y458","Transcription intermediary factor 1-beta",0,34,14,699,{"v":13.98,"d":"14"},{"v":24.564913662,"d":"25"},{"$nulls":3},0,20,2,724,{"v":13.032,"d":"13"},{"v":22.7697071832,"d":"23"},{"$nulls":6},0,20,8,769,{"v":9.228,"d":"9"},{"v":15.787644439200001,"d":"16"},{"$nulls":7},"TIF1b","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","TIF1",null,"X",{"$nulls":4},"DDP(pY)SSA(bA)C","Corresponds to amino acid residues D455 to A461; In the region between the zf-B_box and PHD domains. ","Y458 phosphorylation stimulates interaction with HP1 alpha and induces DNA repair. This is one of the major in vivo sites of phosphorylation in TRIM28.",null,null,"Q13263","Q13263","Q13263"]
[2557,1276,"PK836","TRIM33 (TIF1G)","S1119","Transcription intermediary factor 1-gamma",0,3594,18,705,{"v":2521.08,"d":"2521"},{"v":4429.907906652,"d":"4430"},{"$f":"(L2570+L2571)/2","v":{"v":4370.6779989468,"d":"4371"}},{"$f":"SQRT((M2570-L2570)*(M2570-L2570))","v":{"v":59.229907705200276,"d":"59"}},{"$f":"N2570/M2570*100","v":{"v":1.3551652105113414,"d":"1"}},0,4068,17,717,{"v":2904.567,"d":"2905"},{"v":5074.9033213617,"d":"5075"},{"$f":"(U2570+U2571)/2","v":{"v":5133.97404307005,"d":"5134"}},{"$f":"SQRT((V2570-U2570)*(V2570-U2570))","v":{"v":59.07072170834999,"d":"59"}},{"$f":"W2570/V2570*100","v":{"v":1.1505847363619794,"d":"1"}},{"$f":"X2570+O2570","v":{"v":2.505749946873321,"d":"3"}},{"$f":"(V2570/M2570*100)-100","v":{"v":17.464019182085295,"d":"17"}},null,0,4352,14,744,{"v":3227.472,"d":"3227"},{"v":5521.6927149408,"d":"5522"},{"$f":"(AG2570+AG2571)/2","v":{"v":5584.1794862344,"d":"5584"}},{"$f":"SQRT((AH2570-AG2570)*(AH2570-AG2570))","v":{"v":62.48677129360021,"d":"62"}},{"$f":"AI2570/AH2570*100","v":{"v":1.1189964693584222,"d":"1"}},{"$f":"AJ2570+O2570","v":{"v":2.4741616798697637,"d":"2"}},{"$f":"(AH2570/M2570*100)-100","v":{"v":27.764605115728443,"d":"28"}},null,null,"TIF1g","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine; Ligase","Protein-serine/threonine kinase","Atypical","TIF1",null,"X",{"$nulls":4},"RLK(pS)DER(bA)C","Corresponds to amino acid residues R1116 to R1122; In C-terminus of kinase.","The effect of S1119 phosphorylation is unclear. This is a major site of phosphorylation for TRIM33.",null,"Ligase; Protein kinase, atypical; EC 6.3.2.-; Transcription, coactivator/corepressor; ATYPICAL domain target; ATYPICAL</A> group; TIF1 family","Q9UPN9","Q9UPN9","Q9UPN9",null,"GO:0005654; GO:0005634","GO:0070410; GO:0003677; GO:0070412; GO:0004842; GO:0008270","GO:0030514; GO:0045892; GO:0000122; GO:0016567; GO:0017015; GO:0006351"]
[2562,1278,"NK179-2","TrkB (NTRK2)","Pan-specific","BNDF/NT3/4/5 receptor- tyrosine kinase",0,214,10,594,{"v":121.176,"d":"121"},{"v":212.9240327544,"d":"213"},{"$nulls":3},0,366,12,592,{"v":209.568,"d":"210"},{"v":366.16037407680005,"d":"366"},{"$nulls":6},0,440,18,653,{"v":275.566,"d":"276"},{"v":471.44972123239995,"d":"471"},{"$nulls":7},"TRKB","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK","Trk",{"$nulls":6},"Epitope undefined.",{"$nulls":4},"Q16620","Q16620","Q16620","Q16620"]
[2567,1281,"PK840","TrkC (NTRK3)","Y709+Y710","NT-3 growth factor receptor",0,439,16,518,{"v":219.114,"d":"219"},{"v":385.0154858466,"d":"385"},{"$f":"(L2580+L2581)/2","v":{"v":421.8681277803,"d":"422"}},{"$f":"SQRT((M2580-L2580)*(M2580-L2580))","v":{"v":36.8526419337,"d":"37"}},{"$f":"N2580/M2580*100","v":{"v":8.73558335103525,"d":"9"}},0,483,16,563,{"v":262.921,"d":"263"},{"v":459.3795413071,"d":"459"},{"$f":"(U2580+U2581)/2","v":{"v":446.6039044959,"d":"447"}},{"$f":"SQRT((V2580-U2580)*(V2580-U2580))","v":{"v":12.775636811200002,"d":"13"}},{"$f":"W2580/V2580*100","v":{"v":2.860619148778017,"d":"3"}},{"$f":"X2580+O2580","v":{"v":11.596202499813268,"d":"12"}},{"$f":"(V2580/M2580*100)-100","v":{"v":5.8633907343865275,"d":"6"}},null,0,526,14,637,{"v":326.144,"d":"326"},{"v":557.9806575616001,"d":"558"},{"$f":"(AG2580+AG2581)/2","v":{"v":573.1635195659001,"d":"573"}},{"$f":"SQRT((AH2580-AG2580)*(AH2580-AG2580))","v":{"v":15.182862004299977,"d":"15"}},{"$f":"AI2580/AH2580*100","v":{"v":2.648958191861042,"d":"3"}},{"$f":"AJ2580+O2580","v":{"v":11.384541542896294,"d":"11"}},{"$f":"(AH2580/M2580*100)-100","v":{"v":35.86319558712705,"d":"36"}},null,null,"TRKC","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK","Trk",{"$nulls":6},"STD(pY)(pY)RLF(bA)C","Corresponds to amino acid residues S706 to F713; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y709 and Y710 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major sites of in vivo phosphorylation of TrkC.","Y709: TrkC (NTRK3). Y710: TrkC (NTRK3).","Receptor tyrosine kinase; EC 2.7.10.1; TK domain target; TK</A> group; Trk family","Q16288","Q16288","Q16288","Q16288","GO:0005737; GO:0098978; GO:0005887; GO:0099055; GO:0005886; GO:0043235","GO:0005524; GO:0005004; GO:0043121; GO:0005030; GO:0002039","GO:0090630; GO:0000187; GO:0032148; GO:0071300; GO:0007623; GO:0090102; GO:0007507; GO:0070306; GO:0042490; GO:0019056; GO:0048712; GO:0060548; GO:0001933; GO:0048665; GO:0001764; GO:2000251; GO:0043065; GO:0048691; GO:0030335; GO:0008284; GO:0010628; GO:0033138; GO:0014068; GO:0010863; GO:0050927; GO:0001934; GO:0051965; GO:0046777; GO:0099151; GO:1905606; GO:0048678; GO:0051412; GO:0045471; GO:0007169"]
[2568,1281,"PK840","TrkC (NTRK3)","Y709+Y710","NT-3 growth factor receptor",0,476,18,570,{"v":261.06,"d":"261"},{"v":458.72076971399997,"d":"459"},{"$nulls":3},0,465,16,553,{"v":248.297,"d":"248"},{"v":433.8282676847,"d":"434"},{"$nulls":6},0,577,16,613,{"v":343.893,"d":"344"},{"v":588.3463815701999,"d":"588"},{"$nulls":7},"TRKC","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK","Trk",{"$nulls":6},"STD(pY)(pY)RLF(bA)C","Corresponds to amino acid residues S706 to F713; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y709 and Y710 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major sites of in vivo phosphorylation of TrkC.","Y709: TrkC (NTRK3). Y710: TrkC (NTRK3).",null,"Q16288","Q16288","Q16288","Q16288"]
[2574,1284,"PK841","TSSK3","T168","Testis-specific serine/threonine-protein kinase 3",0,970,24,652,{"v":616.792,"d":"617"},{"v":1083.7941507448,"d":"1084"},{"$nulls":3},0,886,16,588,{"v":511.56,"d":"512"},{"v":893.805356556,"d":"894"},{"$nulls":6},0,1050,20,637,{"v":656.11,"d":"656"},{"v":1122.500150954,"d":"1123"},{"$nulls":7},"TSSK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","TSSK",{"$nulls":6},"LSQ(pT)FCG(bA)C","Corresponds to amino acid residues L165 to G171; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T168 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of TSSK3.","PDPK1 (PDK1); TSSK3 (STK22C)",null,"Q96PN8","Q96PN8","Q96PN8"]
[2579,1287,"PK843","TTK","Y833+Y836","Dual specificity protein kinase TTK",0,6670,14,739,{"v":4918.784,"d":"4919"},{"v":8643.0260573696,"d":"8643"},{"$f":"(L2592+L2593)/2","v":{"v":7963.036564273099,"d":"7963"}},{"$f":"SQRT((M2592-L2592)*(M2592-L2592))","v":{"v":679.9894930965002,"d":"680"}},{"$f":"N2592/M2592*100","v":{"v":8.53932400797123,"d":"9"}},0,6744,17,732,{"v":4924.164,"d":"4924"},{"v":8603.5736956764,"d":"8604"},{"$f":"(U2592+U2593)/2","v":{"v":8732.143392417449,"d":"8732"}},{"$f":"SQRT((V2592-U2592)*(V2592-U2592))","v":{"v":128.56969674104948,"d":"129"}},{"$f":"W2592/V2592*100","v":{"v":1.4723727149589974,"d":"1"}},{"$f":"X2592+O2592","v":{"v":10.011696722930226,"d":"10"}},{"$f":"(V2592/M2592*100)-100","v":{"v":9.658461592340515,"d":"10"}},null,0,6569,22,777,{"v":5087.019,"d":"5087"},{"v":8703.082707786602,"d":"8703"},{"$f":"(AG2592+AG2593)/2","v":{"v":9363.7694516937,"d":"9364"}},{"$f":"SQRT((AH2592-AG2592)*(AH2592-AG2592))","v":{"v":660.6867439070993,"d":"661"}},{"$f":"AI2592/AH2592*100","v":{"v":7.055777561755278,"d":"7"}},{"$f":"AJ2592+O2592","v":{"v":15.595101569726507,"d":"16"}},{"$f":"(AH2592/M2592*100)-100","v":{"v":17.59043646371184,"d":"18"}},null,null,"TTK","X","DSK","Protein Kinase - Dual specificity kinase","Protein-serine/threonine kinase","Other","TTK",{"$nulls":6},"KTL(pY)EH(pY)SGG(bA)C","Corresponds to amino acid residues K830 to G839; In the C-terminal region after the kinase catalytic domain. ","The effect of Y833 and Y836 phosphorylation is unclear. These are two of the major sites of in vivo phosphorylation of TTK.",null,"Protein kinase, dual-specificity; EC 2.7.12.1; Other group; TTK family","P33981","P33981","P33981","P33981","GO:0005737; GO:0000776; GO:0016020; GO:0005819","GO:0005524; GO:0043515; GO:0042803; GO:0004712; GO:0004674; GO:0004713","GO:0051304; GO:0016321; GO:0033316; GO:0007094; GO:0007052; GO:0018105; GO:0018107; GO:0008284; GO:0010862; GO:0046777; GO:0034501; GO:1903096; GO:0007051"]
[2584,1289,"NK181-3","TYK2","Pan-specific","Protein-tyrosine kinase 2 (Jak-related)",0,3186,14,751,{"v":2382.172,"d":"2382"},{"v":4185.8261450668,"d":"4186"},{"$nulls":3},0,3410,18,764,{"v":2591.488,"d":"2591"},{"v":4527.886965068799,"d":"4528"},{"$nulls":6},0,4012,18,809,{"v":3231.146,"d":"3231"},{"v":5527.9783462444,"d":"5528"},{"$nulls":7},"TYK2","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","JakA",{"$nulls":6},"CSFRTILRDLTRLQPH","Corresponds to amino acid residues S858 to H872; Kinase last alpha-chain.",{"$nulls":3},"P29597","P29597","P29597","P29597"]
[2586,1290,"NK181-5","TYK2","Pan-specific","Protein-tyrosine kinase 2 (Jak-related)",0,6168,20,774,{"v":4758.552,"d":"4759"},{"v":8361.474895288799,"d":"8361"},{"$nulls":3},0,5874,14,723,{"v":4236.78,"d":"4237"},{"v":7402.565991378,"d":"7403"},{"$nulls":6},0,7216,26,780,{"v":5608.2,"d":"5608"},{"v":9594.74073948,"d":"9595"},{"$nulls":7},"TYK2","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","JakA",{"$nulls":6},"CWETEASFRPTFENLI","Corresponds to amino acid residues C1151 t oI 1166: Near C-terminus.",{"$nulls":3},"P29597","P29597","P29597","P29597"]
[2590,1292,"PK845","TYK2","Y1054+Y1055","Protein-tyrosine kinase 2 (Jak-related)",0,7113,16,694,{"v":4925.318,"d":"4925"},{"v":8654.507255214201,"d":"8655"},{"$nulls":3},0,6753,24,724,{"v":4871.796,"d":"4872"},{"v":8512.0755353196,"d":"8512"},{"$nulls":6},0,7548,22,760,{"v":5719.76,"d":"5720"},{"v":9785.602206064,"d":"9786"},{"$nulls":7},"TYK2","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","JakA",{"$nulls":6},"GHE(pY)(pY)RVR(bA)C","Corresponds to amino acid residues G1051 to R1058; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y1054 and Y1055 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. The Y1054 site is one of the major in vivo phosphorylation sites in TYK2 (<60).","Y1054: Tyk2. Y1055: Tyk2.",null,"P29597","P29597","P29597","P29597"]
[2591,1294,"PK847","Tyro3","Y681","Tyrosine-protein kinase receptor TYRO3",0,1934,12,681,{"v":1308.882,"d":"1309"},{"v":2299.8979487658003,"d":"2300"},{"$f":"(L2604+L2605)/2","v":{"v":2609.8041903719,"d":"2610"}},{"$f":"SQRT((M2604-L2604)*(M2604-L2604))","v":{"v":309.9062416060997,"d":"310"}},{"$f":"N2604/M2604*100","v":{"v":11.87469323366891,"d":"12"}},0,2307,12,649,{"v":1489.455,"d":"1489"},{"v":2602.3982667705,"d":"2602"},{"$f":"(U2604+U2605)/2","v":{"v":2565.83342276525,"d":"2566"}},{"$f":"SQRT((V2604-U2604)*(V2604-U2604))","v":{"v":36.56484400525005,"d":"37"}},{"$f":"W2604/V2604*100","v":{"v":1.425066946311869,"d":"1"}},{"$f":"X2604+O2604","v":{"v":13.29976017998078,"d":"13"}},{"$f":"(V2604/M2604*100)-100","v":{"v":-1.6848301404705808,"d":"-2"}},null,0,2357,15,712,{"v":1667.504,"d":"1668"},{"v":2852.8348778656,"d":"2853"},{"$f":"(AG2604+AG2605)/2","v":{"v":3101.6733378128,"d":"3102"}},{"$f":"SQRT((AH2604-AG2604)*(AH2604-AG2604))","v":{"v":248.83845994720014,"d":"249"}},{"$f":"AI2604/AH2604*100","v":{"v":8.022716541861014,"d":"8"}},{"$f":"AJ2604+O2604","v":{"v":19.897409775529923,"d":"20"}},{"$f":"(AH2604/M2604*100)-100","v":{"v":18.846975158347348,"d":"19"}},null,null,"TYRO3","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Axl",{"$nulls":6},"RKI(pY)SGD(bA)C","Corresponds to amino acid residues R678 to D684; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y681 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of Tyro3.",null,"Protein-tyrosine kinase (receptor) TK group, Axl family","Q06418","Q06418","Q06418","Q06418","GO:0009986; GO:0005789; GO:0005887; GO:0005635; GO:0005634","GO:0005524; GO:0043548; GO:0046982; GO:0004713; GO:0004714; GO:0001618","GO:0043277; GO:0007155; GO:0021885; GO:0001779; GO:0050728; GO:0045824; GO:0051250; GO:0043524; GO:0034122; GO:0070050; GO:0007218; GO:0042698; GO:0014065; GO:0030168; GO:0070527; GO:0046777; GO:0043491; GO:0032940; GO:0007165; GO:0007283; GO:0034446; GO:0060068"]
[2592,1294,"PK847","Tyro3","Y681","Tyrosine-protein kinase receptor TYRO3",0,2526,16,662,{"v":1661.62,"d":"1662"},{"v":2919.7104319779996,"d":"2920"},{"$nulls":3},0,2214,14,658,{"v":1447.6,"d":"1448"},{"v":2529.26857876,"d":"2529"},{"$nulls":6},0,2744,24,720,{"v":1958.4,"d":"1958"},{"v":3350.5117977600003,"d":"3351"},{"$nulls":7},"TYRO3","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Axl",{"$nulls":6},"RKI(pY)SGD(bA)C","Corresponds to amino acid residues R678 to D684; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y681 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of Tyro3.",null,null,"Q06418","Q06418","Q06418","Q06418"]
[2593,1295,"PK848","Tyro3","Y685+Y686","Tyrosine-protein kinase receptor TYRO3",0,4722,18,698,{"v":3283.392,"d":"3283"},{"v":5769.4020742848,"d":"5769"},{"$f":"(L2606+L2607)/2","v":{"v":6166.251944502899,"d":"6166"}},{"$f":"SQRT((M2606-L2606)*(M2606-L2606))","v":{"v":396.84987021809957,"d":"397"}},{"$f":"N2606/M2606*100","v":{"v":6.43583612524759,"d":"6"}},0,4872,20,662,{"v":3212.024,"d":"3212"},{"v":5612.0968343624,"d":"5612"},{"$f":"(U2606+U2607)/2","v":{"v":5925.6590450688,"d":"5926"}},{"$f":"SQRT((V2606-U2606)*(V2606-U2606))","v":{"v":313.56221070640004,"d":"314"}},{"$f":"W2606/V2606*100","v":{"v":5.291600618961353,"d":"5"}},{"$f":"X2606+O2606","v":{"v":11.727436744208944,"d":"12"}},{"$f":"(V2606/M2606*100)-100","v":{"v":-3.901768880017684,"d":"-4"}},null,0,5171,20,721,{"v":3713.871,"d":"3714"},{"v":6353.8442610594,"d":"6354"},{"$f":"(AG2606+AG2607)/2","v":{"v":7164.0072180845,"d":"7164"}},{"$f":"SQRT((AH2606-AG2606)*(AH2606-AG2606))","v":{"v":810.1629570250998,"d":"810"}},{"$f":"AI2606/AH2606*100","v":{"v":11.308795934487065,"d":"11"}},{"$f":"AJ2606+O2606","v":{"v":17.744632059734656,"d":"18"}},{"$f":"(AH2606/M2606*100)-100","v":{"v":16.18090344931626,"d":"16"}},null,null,"TYRO3","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Axl",{"$nulls":6},"SGD(pY)(pY)RQG(bA)C","Corresponds to amino acid residues S682 to G689; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y685 and Y686 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII.",null,"Protein-tyrosine kinase (receptor) TK group, Axl family","Q06418","Q06418","Q06418","Q06418","GO:0009986; GO:0005789; GO:0005887; GO:0005635; GO:0005634","GO:0005524; GO:0043548; GO:0046982; GO:0004713; GO:0004714; GO:0001618","GO:0043277; GO:0007155; GO:0021885; GO:0001779; GO:0050728; GO:0045824; GO:0051250; GO:0043524; GO:0034122; GO:0070050; GO:0007218; GO:0042698; GO:0014065; GO:0030168; GO:0070527; GO:0046777; GO:0043491; GO:0032940; GO:0007165; GO:0007283; GO:0034446; GO:0060068"]
[2594,1295,"PK848","Tyro3","Y685+Y686","Tyrosine-protein kinase receptor TYRO3",0,5318,20,705,{"v":3735.09,"d":"3735"},{"v":6563.101814721,"d":"6563"},{"$nulls":3},0,5254,18,682,{"v":3570.952,"d":"3571"},{"v":6239.221255775201,"d":"6239"},{"$nulls":6},0,5724,26,818,{"v":4660.964,"d":"4661"},{"v":7974.1701751096,"d":"7974"},{"$nulls":7},"TYRO3","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Axl",{"$nulls":6},"SGD(pY)(pY)RQG(bA)C","Corresponds to amino acid residues S682 to G689; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y685 and Y686 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII.",null,null,"Q06418","Q06418","Q06418","Q06418"]
[2595,1296,"PN680","UBF","T201","Nucleolar transcription factor 1",0,12207,16,605,{"v":7375.555,"d":"7376"},{"v":12959.9336040295,"d":"12960"},{"$f":"(L2608+L2609)/2","v":{"v":12835.247338578949,"d":"12835"}},{"$f":"SQRT((M2608-L2608)*(M2608-L2608))","v":{"v":124.68626545055122,"d":"125"}},{"$f":"N2608/M2608*100","v":{"v":0.9714364060268731,"d":"1"}},0,12514,18,581,{"v":7260.176,"d":"7260"},{"v":12685.089135857601,"d":"12685"},{"$f":"(U2608+U2609)/2","v":{"v":12541.2513999652,"d":"12541"}},{"$f":"SQRT((V2608-U2608)*(V2608-U2608))","v":{"v":143.83773589240081,"d":"144"}},{"$f":"W2608/V2608*100","v":{"v":1.146916932809432,"d":"1"}},{"$f":"X2608+O2608","v":{"v":2.118353338836305,"d":"2"}},{"$f":"(V2608/M2608*100)-100","v":{"v":-2.2905358257497994,"d":"-2"}},null,0,12215,14,632,{"v":7711.032,"d":"7711"},{"v":13192.3527823248,"d":"13192"},{"$f":"(AG2608+AG2609)/2","v":{"v":12662.6574656294,"d":"12663"}},{"$f":"SQRT((AH2608-AG2608)*(AH2608-AG2608))","v":{"v":529.6953166954008,"d":"530"}},{"$f":"AI2608/AH2608*100","v":{"v":4.183129158576448,"d":"4"}},{"$f":"AJ2608+O2608","v":{"v":5.154565564603321,"d":"5"}},{"$f":"(AH2608/M2608*100)-100","v":{"v":-1.3446556065249666,"d":"-1"}},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"EKPK(pT)PQQ(bA)C","Corresponds to amino acid residues E197 to Q204.","T201 phosphorylation inhibits transcriptional activity by inhibiting DNA binding. This is one of the major sites of in vivo phosphorylation of UBF.","ERK1 (MAPK3); ERK2 (MAPK1)","Transcription protein","P17480","P17480",null,null,"GO:0001650; GO:0005730; GO:0005654; GO:0005634","GO:0003682; GO:0003723; GO:0001164; GO:0000981; GO:0001165; GO:0097110","GO:0045943; GO:0006356; GO:0006363; GO:0006360; GO:0006361"]
[2596,1296,"PN680","UBF","T201","Nucleolar transcription factor 1",0,12052,16,601,{"v":7233.636,"d":"7234"},{"v":12710.5610731284,"d":"12711"},{"$nulls":3},0,11610,16,612,{"v":7095.528,"d":"7096"},{"v":12397.413664072801,"d":"12397"},{"$nulls":6},0,11738,16,605,{"v":7091.81,"d":"7092"},{"v":12132.962148934,"d":"12133"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"EKPK(pT)PQQ(bA)C","Corresponds to amino acid residues E197 to Q204.","T201 phosphorylation inhibits transcriptional activity by inhibiting DNA binding. This is one of the major sites of in vivo phosphorylation of UBF.","ERK1 (MAPK3); ERK2 (MAPK1)",null,"P17480","P17480"]
[2597,1297,"PN679","UBF","S484","Nucleolar transcription factor 1",0,494,12,518,{"v":249.676,"d":"250"},{"v":438.7174094044,"d":"439"},{"$f":"(L2610+L2611)/2","v":{"v":435.9868031218,"d":"436"}},{"$f":"SQRT((M2610-L2610)*(M2610-L2610))","v":{"v":2.730606282599979,"d":"3"}},{"$f":"N2610/M2610*100","v":{"v":0.6263048016701414,"d":"1"}},0,460,12,506,{"v":226.688,"d":"227"},{"v":396.0726965888,"d":"396"},{"$f":"(U2610+U2611)/2","v":{"v":377.136379335,"d":"377"}},{"$f":"SQRT((V2610-U2610)*(V2610-U2610))","v":{"v":18.936317253799984,"d":"19"}},{"$f":"W2610/V2610*100","v":{"v":5.021079453324064,"d":"5"}},{"$f":"X2610+O2610","v":{"v":5.647384254994205,"d":"6"}},{"$f":"(V2610/M2610*100)-100","v":{"v":-13.498212185647091,"d":"-13"}},null,0,526,12,537,{"v":276.018,"d":"276"},{"v":472.22302154519997,"d":"472"},{"$f":"(AG2610+AG2611)/2","v":{"v":481.33496284160003,"d":"481"}},{"$f":"SQRT((AH2610-AG2610)*(AH2610-AG2610))","v":{"v":9.111941296400062,"d":"9"}},{"$f":"AI2610/AH2610*100","v":{"v":1.8930561874431429,"d":"2"}},{"$f":"AJ2610+O2610","v":{"v":2.5193609891132844,"d":"3"}},{"$f":"(AH2610/M2610*100)-100","v":{"v":10.401268890501541,"d":"10"}},{"$nulls":5},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"KLPE(pS)PKRAC","Corresponds to amino acid residues K480 to A488.","S484 phosphorylation stimulates of DNA transcription. This is one of the major sites of in vivo phosphorylation of UBF.","CDK2; CDK4","Transcription protein","P17480","P17480",null,null,"GO:0001650; GO:0005730; GO:0005654; GO:0005634","GO:0003682; GO:0003723; GO:0001164; GO:0000981; GO:0001165; GO:0097110","GO:0045943; GO:0006356; GO:0006363; GO:0006360; GO:0006361"]
[2598,1297,"PN679","UBF","S484","Nucleolar transcription factor 1",0,408,16,629,{"v":246.568,"d":"247"},{"v":433.2561968392,"d":"433"},{"$nulls":3},0,440,12,479,{"v":205.012,"d":"205"},{"v":358.20006208120003,"d":"358"},{"$nulls":6},0,538,12,545,{"v":286.67,"d":"287"},{"v":490.44690413800004,"d":"490"},{"$nulls":10},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"KLPE(pS)PKRAC","Corresponds to amino acid residues K480 to A488.","S484 phosphorylation stimulates of DNA transcription. This is one of the major sites of in vivo phosphorylation of UBF.","CDK2; CDK4",null,"P17480","P17480"]
[2599,1298,"NK298-2","ULK1","Pan-specific","Unc-51-like protein-serine/threonine kinase 1",0,806,10,266,{"v":211.736,"d":"212"},{"v":372.05125601839995,"d":"372"},{"$f":"(L2612+L2613)/2","v":{"v":439.9210550309,"d":"440"}},{"$f":"SQRT((M2612-L2612)*(M2612-L2612))","v":{"v":67.86979901250004,"d":"68"}},{"$f":"N2612/M2612*100","v":{"v":15.42772236889932,"d":"15"}},0,936,10,269,{"v":249.094,"d":"249"},{"v":435.2207981194,"d":"435"},{"$f":"(U2612+U2613)/2","v":{"v":444.37795245850003,"d":"444"}},{"$f":"SQRT((V2612-U2612)*(V2612-U2612))","v":{"v":9.157154339100032,"d":"9"}},{"$f":"W2612/V2612*100","v":{"v":2.060668016592297,"d":"2"}},{"$f":"X2612+O2612","v":{"v":17.488390385491616,"d":"17"}},{"$f":"(V2612/M2612*100)-100","v":{"v":1.0131130066704799,"d":"1"}},null,0,718,10,288,{"v":203.904,"d":"204"},{"v":348.8474048256,"d":"349"},{"$f":"(AG2612+AG2613)/2","v":{"v":365.8839634868,"d":"366"}},{"$f":"SQRT((AH2612-AG2612)*(AH2612-AG2612))","v":{"v":17.03655866119999,"d":"17"}},{"$f":"AI2612/AH2612*100","v":{"v":4.6562736718070505,"d":"5"}},{"$f":"AJ2612+O2612","v":{"v":20.08399604070637,"d":"20"}},{"$f":"(AH2612/M2612*100)-100","v":{"v":-16.82963129348279,"d":"-17"}},null,null,"ULK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","ULK",{"$nulls":6},"Epitope undefined.",{"$nulls":3},"Protein-serine kinase, Other group, ULK family","O75385","O75385","O75385",null,"GO:1990316; GO:0005776; GO:0030424; GO:0005737; GO:0005829; GO:0005789; GO:0097635; GO:0097629; GO:0097632; GO:0005741; GO:0034045; GO:0055037","GO:0005524; GO:0051020; GO:0042802; GO:0016301; GO:0044877; GO:0004674; GO:0017137","GO:0006914; GO:0075044; GO:0048675; GO:0031669; GO:0016236; GO:0031333; GO:0031175; GO:0031102; GO:0018105; GO:0018107; GO:2000786; GO:0046777; GO:0008104; GO:0006468; GO:0016241; GO:0042594; GO:0007165"]
[2600,1298,"NK298-2","ULK1","Pan-specific","Unc-51-like protein-serine/threonine kinase 1",0,1123,20,262,{"v":288.986,"d":"289"},{"v":507.7908540434,"d":"508"},{"$nulls":3},0,926,12,284,{"v":259.576,"d":"260"},{"v":453.53510679760006,"d":"454"},{"$nulls":6},0,732,10,310,{"v":223.82,"d":"224"},{"v":382.92052214800003,"d":"383"},{"$nulls":7},"ULK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","ULK",{"$nulls":6},"Epitope undefined.",{"$nulls":4},"O75385","O75385","O75385"]
[2601,1299,"NK298-1","ULK1","Pan-specific","Unc-51-like kinase 1; Serine-threonine-protein kinase ULK1",0,1708,10,637,{"v":1081.626,"d":"1082"},{"v":1900.5757728593999,"d":"1901"},{"$f":"(L2614+L2615)/2","v":{"v":1859.5270641285,"d":"1860"}},{"$f":"SQRT((M2614-L2614)*(M2614-L2614))","v":{"v":41.04870873089999,"d":"41"}},{"$f":"N2614/M2614*100","v":{"v":2.207481112953749,"d":"2"}},0,1710,12,616,{"v":1045.968,"d":"1046"},{"v":1827.5310837168001,"d":"1828"},{"$f":"(U2614+U2615)/2","v":{"v":1806.48325701465,"d":"1806"}},{"$f":"SQRT((V2614-U2614)*(V2614-U2614))","v":{"v":21.047826702150132,"d":"21"}},{"$f":"W2614/V2614*100","v":{"v":1.1651271397296676,"d":"1"}},{"$f":"X2614+O2614","v":{"v":3.372608252683417,"d":"3"}},{"$f":"(V2614/M2614*100)-100","v":{"v":-2.852542893142015,"d":"-3"}},null,0,1686,14,686,{"v":1146.992,"d":"1147"},{"v":1962.3213990688,"d":"1962"},{"$f":"(AG2614+AG2615)/2","v":{"v":2189.8701486344,"d":"2190"}},{"$f":"SQRT((AH2614-AG2614)*(AH2614-AG2614))","v":{"v":227.5487495655998,"d":"228"}},{"$f":"AI2614/AH2614*100","v":{"v":10.390969971781153,"d":"10"}},{"$f":"AJ2614+O2614","v":{"v":12.598451084734902,"d":"13"}},{"$f":"(AH2614/M2614*100)-100","v":{"v":17.764897907561306,"d":"18"}},null,null,"ULK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","ULK",{"$nulls":6},"RGGTETVGKFEFSRKDLIGC","Corresponds to amino acid residues R5 to G23; N-terminus.",null,null,"Protein-serine kinase, Other group, ULK family","O75385","O75385","O75385",null,"GO:1990316; GO:0005776; GO:0030424; GO:0005737; GO:0005829; GO:0005789; GO:0097635; GO:0097629; GO:0097632; GO:0005741; GO:0034045; GO:0055037","GO:0005524; GO:0051020; GO:0042802; GO:0016301; GO:0044877; GO:0004674; GO:0017137","GO:0006914; GO:0075044; GO:0048675; GO:0031669; GO:0016236; GO:0031333; GO:0031175; GO:0031102; GO:0018105; GO:0018107; GO:2000786; GO:0046777; GO:0008104; GO:0006468; GO:0016241; GO:0042594; GO:0007165"]
[2602,1299,"NK298-1","ULK1","Pan-specific","Unc-51-like kinase 1; Serine-threonine-protein kinase ULK1",0,1624,12,642,{"v":1034.904,"d":"1035"},{"v":1818.4783553976,"d":"1818"},{"$nulls":3},0,1648,13,625,{"v":1021.875,"d":"1022"},{"v":1785.4354303125,"d":"1785"},{"$nulls":6},0,1898,14,750,1413,{"v":2417.4188982,"d":"2417"},{"$nulls":7},"ULK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","ULK",{"$nulls":6},"RGGTETVGKFEFSRKDLIGC","Corresponds to amino acid residues R5 to G23; N-terminus.",{"$nulls":3},"O75385","O75385","O75385"]
[2603,1300,"NK354-1","ULK2","Pan-specific","Unc-51-like protein-serine/threonine kinase 2",0,1898,10,281,{"v":530.528,"d":"531"},{"v":932.2156305632,"d":"932"},{"$f":"(L2616+L2617)/2","v":{"v":1202.20915890925,"d":"1202"}},{"$f":"SQRT((M2616-L2616)*(M2616-L2616))","v":{"v":269.99352834604997,"d":"270"}},{"$f":"N2616/M2616*100","v":{"v":22.458116072831444,"d":"22"}},0,1963,10,296,{"v":578.088,"d":"578"},{"v":1010.0440827287999,"d":"1010"},{"$f":"(U2616+U2617)/2","v":{"v":1009.77064356565,"d":"1010"}},{"$f":"SQRT((V2616-U2616)*(V2616-U2616))","v":{"v":0.2734391631499875,"d":"0"}},{"$f":"W2616/V2616*100","v":{"v":0.027079333796478106,"d":"0"}},{"$f":"X2616+O2616","v":{"v":22.485195406627923,"d":"22"}},{"$f":"(V2616/M2616*100)-100","v":{"v":-16.007074469320898,"d":"-16"}},null,0,284,8,441,{"v":121.716,"d":"122"},{"v":208.2367718424,"d":"208"},{"$f":"(AG2616+AG2617)/2","v":{"v":106.7667684084,"d":"107"}},{"$f":"SQRT((AH2616-AG2616)*(AH2616-AG2616))","v":{"v":101.470003434,"d":"101"}},{"$f":"AI2616/AH2616*100","v":{"v":95.03893856359966,"d":"95"}},{"$f":"AJ2616+O2616","v":{"v":117.4970546364311,"d":"117"}},{"$f":"(AH2616/M2616*100)-100","v":{"v":-91.11911869767584,"d":"-91"}},null,null,"ULK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","ULK",{"$nulls":6},"Epitope undefined.",{"$nulls":3},"Protein-serine kinase, Other group, ULK family","Q8IYT8","Q8IYT8","Q8IYT8",null,"GO:0030659; GO:0034045","GO:0005524; GO:0004674","GO:0006914; GO:0075044; GO:0048675; GO:0048671; GO:0046777; GO:0042594; GO:0007165"]
[2604,1300,"NK354-1","ULK2","Pan-specific","Unc-51-like protein-serine/threonine kinase 2",0,2831,10,297,{"v":837.837,"d":"838"},{"v":1472.2026872553,"d":"1472"},{"$nulls":3},0,2111,10,275,{"v":577.775,"d":"578"},{"v":1009.4972044025,"d":"1009"},{"$nulls":6},0,8,2,516,{"v":3.096,"d":"3"},{"v":5.2967649744,"d":"5"},{"$nulls":7},"ULK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","ULK",{"$nulls":6},"Epitope undefined.",{"$nulls":4},"Q8IYT8","Q8IYT8","Q8IYT8"]
[2605,1301,"NK355-1","ULK3","Pan-specific","Unc-51-like protein-serine/threonine kinase 3",0,776,8,341,{"v":261.888,"d":"262"},{"v":460.1756873471999,"d":"460"},{"$f":"(L2618+L2619)/2","v":{"v":484.74235815609995,"d":"485"}},{"$f":"SQRT((M2618-L2618)*(M2618-L2618))","v":{"v":24.566670808900028,"d":"25"}},{"$f":"N2618/M2618*100","v":{"v":5.067985166872688,"d":"5"}},0,56,12,650,{"v":28.6,"d":"29"},{"v":49.97035186,"d":"50"},{"$f":"(U2618+U2619)/2","v":{"v":58.4880254725,"d":"58"}},{"$f":"SQRT((V2618-U2618)*(V2618-U2618))","v":{"v":8.517673612499998,"d":"9"}},{"$f":"W2618/V2618*100","v":{"v":14.563106796116502,"d":"15"}},{"$f":"X2618+O2618","v":{"v":19.63109196298919,"d":"20"}},{"$f":"(V2618/M2618*100)-100","v":{"v":-87.9342037087534,"d":"-88"}},null,0,635,10,353,{"v":220.625,"d":"221"},{"v":377.454383875,"d":"377"},{"$f":"(AG2618+AG2619)/2","v":{"v":372.0541129959,"d":"372"}},{"$f":"SQRT((AH2618-AG2618)*(AH2618-AG2618))","v":{"v":5.400270879099992,"d":"5"}},{"$f":"AI2618/AH2618*100","v":{"v":1.451474581376151,"d":"1"}},{"$f":"AJ2618+O2618","v":{"v":6.519459748248839,"d":"7"}},{"$f":"(AH2618/M2618*100)-100","v":{"v":-23.247039022719633,"d":"-23"}},null,null,"ULK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","ULK",{"$nulls":6},"Epitope undefined.",{"$nulls":3},"Protein-serine kinase, Other group, ULK family","Q6PHR2","Q6PHR2","Q6PHR2",null,"GO:0097542; GO:0005737; GO:0000407","GO:0005524; GO:0004674","GO:0006914; GO:0090398; GO:0045879; GO:0045880; GO:0046777"]
[2606,1301,"NK355-1","ULK3","Pan-specific","Unc-51-like protein-serine/threonine kinase 3",0,789,14,374,{"v":289.85,"d":"290"},{"v":509.30902896500004,"d":"509"},{"$nulls":3},0,73,14,650,{"v":38.35,"d":"38"},{"v":67.005699085,"d":"67"},{"$nulls":6},0,637,14,344,{"v":214.312,"d":"214"},{"v":366.65384211680004,"d":"367"},{"$nulls":7},"ULK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","ULK",{"$nulls":6},"Epitope undefined.",{"$nulls":4},"Q6PHR2","Q6PHR2","Q6PHR2"]
[2607,1302,"PK892","VACAMKL","Y245","CaM kinase-like vesicle-associated protein",0,7258,14,669,{"v":4846.236,"d":"4846"},{"v":8515.5485640684,"d":"8516"},{"$f":"(L2620+L2621)/2","v":{"v":8257.0230549652,"d":"8257"}},{"$f":"SQRT((M2620-L2620)*(M2620-L2620))","v":{"v":258.5255091031995,"d":"259"}},{"$f":"N2620/M2620*100","v":{"v":3.1309771982257,"d":"3"}},0,9306,14,668,{"v":6207.056,"d":"6207"},{"v":10845.061969745599,"d":"10845"},{"$f":"(U2620+U2621)/2","v":{"v":10178.3264348007,"d":"10178"}},{"$f":"SQRT((V2620-U2620)*(V2620-U2620))","v":{"v":666.735534944899,"d":"667"}},{"$f":"W2620/V2620*100","v":{"v":6.550541871650576,"d":"7"}},{"$f":"X2620+O2620","v":{"v":9.681519069876275,"d":"10"}},{"$f":"(V2620/M2620*100)-100","v":{"v":23.268717636438723,"d":"23"}},null,0,5839,12,691,{"v":4026.457,"d":"4026"},{"v":6888.6293309198,"d":"6889"},{"$f":"(AG2620+AG2621)/2","v":{"v":7426.9618304231,"d":"7427"}},{"$f":"SQRT((AH2620-AG2620)*(AH2620-AG2620))","v":{"v":538.3324995032999,"d":"538"}},{"$f":"AI2620/AH2620*100","v":{"v":7.248354196437713,"d":"7"}},{"$f":"AJ2620+O2620","v":{"v":10.379331394663414,"d":"10"}},{"$f":"(AH2620/M2620*100)-100","v":{"v":-10.052790442954617,"d":"-10"}},null,null,"VACAMKL","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine",null,"CAMK","CAMK-Unique",{"$nulls":6},"CAGD(pY)EFD","Corresponds to amino acid residues A242 to D248. Y245 is located in the Gap/Insert 10 (G/I10) region in the protein-serine/threonine kinase catalytic domain of VACAMKL.","The effect of Y245 phosphorylation is unknown. Y245 phosphorylation has been observed in only a small number of mass spectrometry studies (~6 reports). The effect of its phosphorylation is unknown. However, it has homology with the Y25 phosphosite in CaMK1a. VACAMKL has been suggested to not have detectable phosphotransferase activity. This is one of the major sites of in vivo phosphorylation of VACAMKL.",null,"Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; CAMK-Unique family","Q8NCB2","Q8NCB2","Q8NCB2",null,"GO:0030659; GO:0098978; GO:0005622; GO:0005886","GO:0005524; GO:0005516; GO:0004683","GO:0035556; GO:0018105; GO:0018107; GO:0099159"]
[2608,1302,"PK892","VACAMKL","Y245","CaM kinase-like vesicle-associated protein",0,6814,20,670,{"v":4551.98,"d":"4552"},{"v":7998.497545861999,"d":"7998"},{"$nulls":3},0,8430,16,647,{"v":5443.858,"d":"5444"},{"v":9511.5908998558,"d":"9512"},{"$nulls":6},0,6744,16,692,{"v":4655.776,"d":"4656"},{"v":7965.2943299264,"d":"7965"},{"$nulls":7},"VACAMKL","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine",null,"CAMK","CAMK-Unique",{"$nulls":6},"CAGD(pY)EFD","Corresponds to amino acid residues A242 to D248. Y245 is located in the Gap/Insert 10 (G/I10) region in the protein-serine/threonine kinase catalytic domain of VACAMKL.","The effect of Y245 phosphorylation is unknown. Y245 phosphorylation has been observed in only a small number of mass spectrometry studies (~6 reports). The effect of its phosphorylation is unknown. However, it has homology with the Y25 phosphosite in CaMK1a. VACAMKL has been suggested to not have detectable phosphotransferase activity. This is one of the major sites of in vivo phosphorylation of VACAMKL.",null,null,"Q8NCB2","Q8NCB2","Q8NCB2"]
[2609,1303,"PN276","VASP","S157","Vasodilator-stimulated phosphoprotein",0,262,12,641,{"v":160.25,"d":"160"},{"v":281.582790725,"d":"282"},{"$f":"(L2622+L2623)/2","v":{"v":315.4025971093,"d":"315"}},{"$f":"SQRT((M2622-L2622)*(M2622-L2622))","v":{"v":33.81980638430002,"d":"34"}},{"$f":"N2622/M2622*100","v":{"v":10.722741884265481,"d":"11"}},0,290,12,600,{"v":166.8,"d":"167"},{"v":291.43547868,"d":"291"},{"$f":"(U2622+U2623)/2","v":{"v":295.3247794926,"d":"295"}},{"$f":"SQRT((V2622-U2622)*(V2622-U2622))","v":{"v":3.88930081259997,"d":"4"}},{"$f":"W2622/V2622*100","v":{"v":1.3169571545205963,"d":"1"}},{"$f":"X2622+O2622","v":{"v":12.039699038786077,"d":"12"}},{"$f":"(V2622/M2622*100)-100","v":{"v":-6.3657743470458,"d":"-6"}},null,0,274,14,698,{"v":181.48,"d":"181"},{"v":310.483497272,"d":"310"},{"$f":"(AG2622+AG2623)/2","v":{"v":365.58798792460004,"d":"366"}},{"$f":"SQRT((AH2622-AG2622)*(AH2622-AG2622))","v":{"v":55.10449065260002,"d":"55"}},{"$f":"AI2622/AH2622*100","v":{"v":15.072839500395437,"d":"15"}},{"$f":"AJ2622+O2622","v":{"v":25.79558138466092,"d":"26"}},{"$f":"(AH2622/M2622*100)-100","v":{"v":15.911533790544127,"d":"16"}},{"$nulls":15},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S157 phosphosite.","S157 phosphorylation induces activity and association with VASP and vinculin, and inhibits interactions with CRKL and SPTAN1. This is one of the major sites of in vivo phosphorylation of VASP (≥3 reports from high throughput mass spectrometry studies).","PKACa (PRKACA); PKG1","Cytoskeletal protein","P50552","P50552",null,null,"GO:0015629; GO:0005923; GO:0005829; GO:0070062; GO:0031527; GO:0005925; GO:0031258; GO:0005886","GO:0003779; GO:0045296; GO:0005522; GO:0017124","GO:0008154; GO:0007411; GO:0034329; GO:0001843; GO:0030838; GO:0051289"]
[2610,1303,"PN276","VASP","S157","Vasodilator-stimulated phosphoprotein",0,336,24,637,{"v":198.744,"d":"199"},{"v":349.2224034936,"d":"349"},{"$nulls":3},0,296,12,603,{"v":171.252,"d":"171"},{"v":299.2140803052,"d":"299"},{"$nulls":6},0,358,16,719,{"v":245.898,"d":"246"},{"v":420.6924785772,"d":"421"},{"$nulls":20},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S157 phosphosite.","S157 phosphorylation induces activity and association with VASP and vinculin, and inhibits interactions with CRKL and SPTAN1. This is one of the major sites of in vivo phosphorylation of VASP (≥3 reports from high throughput mass spectrometry studies).","PKACa (PRKACA); PKG1",null,"P50552","P50552"]
[2611,1304,"PN277","Vav","Y174","Vav 1 guanine nucleotide exchange factor",0,2228,12,705,{"v":1562.28,"d":"1562"},{"v":2745.155458932,"d":"2745"},{"$f":"(L2624+L2625)/2","v":{"v":2822.5542655831996,"d":"2823"}},{"$f":"SQRT((M2624-L2624)*(M2624-L2624))","v":{"v":77.39880665119972,"d":"77"}},{"$f":"N2624/M2624*100","v":{"v":2.7421547778535795,"d":"3"}},0,2276,16,687,{"v":1552.62,"d":"1553"},{"v":2712.7611085619997,"d":"2713"},{"$f":"(U2624+U2625)/2","v":{"v":2627.2226989112996,"d":"2627"}},{"$f":"SQRT((V2624-U2624)*(V2624-U2624))","v":{"v":85.53840965070003,"d":"86"}},{"$f":"W2624/V2624*100","v":{"v":3.255849216214007,"d":"3"}},{"$f":"X2624+O2624","v":{"v":5.998003994067586,"d":"6"}},{"$f":"(V2624/M2624*100)-100","v":{"v":-6.92038303935108,"d":"-7"}},null,0,2322,10,750,1734,{"v":2966.5989876000003,"d":"2967"},{"$f":"(AG2624+AG2625)/2","v":{"v":3155.5212154571,"d":"3156"}},{"$f":"SQRT((AH2624-AG2624)*(AH2624-AG2624))","v":{"v":188.92222785709964,"d":"189"}},{"$f":"AI2624/AH2624*100","v":{"v":5.987037163042268,"d":"6"}},{"$f":"AJ2624+O2624","v":{"v":8.729191940895847,"d":"9"}},{"$f":"(AH2624/M2624*100)-100","v":{"v":11.79665361739653,"d":"12"}},{"$nulls":15},"Epitope undefined.","Antibody raised against amino acid residues that encompass the Y174 phosphosite.","The effect of Y174 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of Vav.",null,"Guanine nucleotide exchange factor for G protein","P15498","P15498",null,"P15498","GO:0005911; GO:0005829; GO:0005886","GO:0003700; GO:0005085; GO:0046872; GO:0046934; GO:0001784; GO:0030676; GO:0005089","GO:0019221; GO:0038095; GO:0038096; GO:0007186; GO:0006955; GO:0007229; GO:0030593; GO:0030168; GO:0043065; GO:0043547; GO:0045954; GO:0051897; GO:0072593; GO:0008361; GO:0043087; GO:0035023; GO:0051056; GO:0007264; GO:0031295; GO:0030217; GO:0048010"]
[2612,1304,"PN277","Vav","Y174","Vav 1 guanine nucleotide exchange factor",0,2279,12,728,{"v":1650.376,"d":"1650"},{"v":2899.9530722343998,"d":"2900"},{"$nulls":3},0,2146,13,682,{"v":1454.706,"d":"1455"},{"v":2541.6842892606,"d":"2542"},{"$nulls":6},0,2621,18,751,{"v":1954.853,"d":"1955"},{"v":3344.4434433142,"d":"3344"},{"$nulls":20},"Epitope undefined.","Antibody raised against amino acid residues that encompass the Y174 phosphosite.","The effect of Y174 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of Vav.",null,null,"P15498","P15498",null,"P15498"]
[2613,1305,"PN543","Vav","Y826","Vav 1 guanine nucleotide exchange factor",0,2437,16,551,{"v":1333.971,"d":"1334"},{"v":2343.9830073399,"d":"2344"},{"$f":"(L2626+L2627)/2","v":{"v":2434.46640838195,"d":"2434"}},{"$f":"SQRT((M2626-L2626)*(M2626-L2626))","v":{"v":90.48340104204999,"d":"90"}},{"$f":"N2626/M2626*100","v":{"v":3.71676523161349,"d":"4"}},0,2477,16,560,{"v":1378.16,"d":"1378"},{"v":2407.9419622160003,"d":"2408"},{"$f":"(U2626+U2627)/2","v":{"v":2330.0231576164006,"d":"2330"}},{"$f":"SQRT((V2626-U2626)*(V2626-U2626))","v":{"v":77.91880459959975,"d":"78"}},{"$f":"W2626/V2626*100","v":{"v":3.3441214669862003,"d":"3"}},{"$f":"X2626+O2626","v":{"v":7.06088669859969,"d":"7"}},{"$f":"(V2626/M2626*100)-100","v":{"v":-4.290190672007128,"d":"-4"}},null,0,2468,16,606,{"v":1485.912,"d":"1486"},{"v":2542.1597663568,"d":"2542"},{"$f":"(AG2626+AG2627)/2","v":{"v":2659.3147637459997,"d":"2659"}},{"$f":"SQRT((AH2626-AG2626)*(AH2626-AG2626))","v":{"v":117.1549973891997,"d":"117"}},{"$f":"AI2626/AH2626*100","v":{"v":4.405458089668605,"d":"4"}},{"$f":"AJ2626+O2626","v":{"v":8.122223321282096,"d":"8"}},{"$f":"(AH2626/M2626*100)-100","v":{"v":9.236042632992977,"d":"9"}},{"$nulls":15},"GEI(pY)GRV(bA)C","Corresponds to amino acid residues G823 to V829; In the SH3_1 domain.","Y826 phosphorylation regulates carcinogenesis, cell growth, activation and molecular associations, including inducing interaction with Abl, CSK, SH2D1A, and Shc1. This is one of the major sites of in vivo phosphorylation of Vav.",null,"Guanine nucleotide exchange factor for G protein","P15498","P15498",null,"P15498","GO:0005911; GO:0005829; GO:0005886","GO:0003700; GO:0005085; GO:0046872; GO:0046934; GO:0001784; GO:0030676; GO:0005089","GO:0019221; GO:0038095; GO:0038096; GO:0007186; GO:0006955; GO:0007229; GO:0030593; GO:0030168; GO:0043065; GO:0043547; GO:0045954; GO:0051897; GO:0072593; GO:0008361; GO:0043087; GO:0035023; GO:0051056; GO:0007264; GO:0031295; GO:0030217; GO:0048010"]
[2614,1305,"PN543","Vav","Y826","Vav 1 guanine nucleotide exchange factor",0,2578,12,560,{"v":1436.96,"d":"1437"},{"v":2524.949809424,"d":"2525"},{"$nulls":3},0,2514,16,516,{"v":1288.968,"d":"1289"},{"v":2252.1043530168004,"d":"2252"},{"$nulls":6},0,2698,20,606,{"v":1622.868,"d":"1623"},{"v":2776.4697611352,"d":"2776"},{"$nulls":20},"GEI(pY)GRV(bA)C","Corresponds to amino acid residues G823 to V829; In the SH3_1 domain.","Y826 phosphorylation regulates carcinogenesis, cell growth, activation and molecular associations, including inducing interaction with Abl, CSK, SH2D1A, and Shc1. This is one of the major sites of in vivo phosphorylation of Vav.",null,null,"P15498","P15498",null,"P15498"]
[2615,1306,"NK226-2","VEGFR1 (Flt1)","Pan-specific","Vascular endothelial growth factor receptor 1",0,12093,18,760,9177,{"v":16125.3371013,"d":"16125"},{"$f":"(L2628+L2629)/2","v":{"v":15865.718646825,"d":"15866"}},{"$f":"SQRT((M2628-L2628)*(M2628-L2628))","v":{"v":259.61845447499945,"d":"260"}},{"$f":"N2628/M2628*100","v":{"v":1.6363485339313861,"d":"2"}},0,13468,16,806,{"v":10842.312,"d":"10842"},{"v":18943.8512453112,"d":"18944"},{"$f":"(U2628+U2629)/2","v":{"v":17512.8331563884,"d":"17513"}},{"$f":"SQRT((V2628-U2628)*(V2628-U2628))","v":{"v":1431.0180889228031,"d":"1431"}},{"$f":"W2628/V2628*100","v":{"v":8.171254052065189,"d":"8"}},{"$f":"X2628+O2628","v":{"v":9.807602585996575,"d":"10"}},{"$f":"(V2628/M2628*100)-100","v":{"v":10.381594091188646,"d":"10"}},null,0,11246,16,819,{"v":9197.37,"d":"9197"},{"v":15735.241367118002,"d":"15735"},{"$f":"(AG2628+AG2629)/2","v":{"v":15696.882592088601,"d":"15697"}},{"$f":"SQRT((AH2628-AG2628)*(AH2628-AG2628))","v":{"v":38.35877502940093,"d":"38"}},{"$f":"AI2628/AH2628*100","v":{"v":0.2443719305687753,"d":"0"}},{"$f":"AJ2628+O2628","v":{"v":1.8807204645001614,"d":"2"}},{"$f":"(AH2628/M2628*100)-100","v":{"v":-1.0641563643900014,"d":"-1"}},null,null,"FLT1","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"PEIIHMTEGRELVIPC","Corresponds to amino acid residues P143 to C158; Just before and part of the second Ig-like C2-type domain.",null,null,"Receptor tyrosine kinase; EC 2.7.10.1; EC 2.7.1.112; TK group; VEGFR family","P17948","P17948","P17948","P17948","GO:0015629; GO:0005768; GO:0005615; GO:0005925; GO:0005887; GO:0005886; GO:0043235","GO:0005524; GO:0019838; GO:0036332; GO:0004714; GO:0005021; GO:0036326; GO:0036327","GO:0001525; GO:0048514; GO:0030154; GO:0016477; GO:0035924; GO:0048598; GO:0002548; GO:1905563; GO:0018108; GO:0045766; GO:0030335; GO:0008284; GO:0043410; GO:0043406; GO:0043552; GO:0014068; GO:0010863; GO:0030949; GO:0046777; GO:0007169; GO:0036323; GO:0048010"]
[2616,1306,"NK226-2","VEGFR1 (Flt1)","Pan-specific","Vascular endothelial growth factor receptor 1",0,11642,17,764,{"v":8881.5,"d":"8882"},{"v":15606.100192349999,"d":"15606"},{"$nulls":3},0,12272,16,751,{"v":9204.256,"d":"9204"},{"v":16081.815067465599,"d":"16082"},{"$nulls":6},0,11724,20,782,{"v":9152.528,"d":"9153"},{"v":15658.5238170592,"d":"15659"},{"$nulls":7},"FLT1","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"PEIIHMTEGRELVIPC","Corresponds to amino acid residues P143 to C158; Just before and part of the second Ig-like C2-type domain.",{"$nulls":3},"P17948","P17948","P17948","P17948"]
[2617,1307,"PK850","VEGFR1 (Flt1)","Y1048","Vascular endothelial growth factor receptor 1",0,6918,16,684,{"v":4720.968,"d":"4721"},{"v":8295.434286199199,"d":"8295"},{"$f":"(L2630+L2631)/2","v":{"v":8740.3034669005,"d":"8740"}},{"$f":"SQRT((M2630-L2630)*(M2630-L2630))","v":{"v":444.86918070130014,"d":"445"}},{"$f":"N2630/M2630*100","v":{"v":5.089859664324223,"d":"5"}},0,7488,18,668,{"v":4989.96,"d":"4990"},{"v":8718.533460396,"d":"8719"},{"$f":"(U2630+U2631)/2","v":{"v":8609.453074487901,"d":"8609"}},{"$f":"SQRT((V2630-U2630)*(V2630-U2630))","v":{"v":109.08038590809883,"d":"109"}},{"$f":"W2630/V2630*100","v":{"v":1.266983918308737,"d":"1"}},{"$f":"X2630+O2630","v":{"v":6.35684358263296,"d":"6"}},{"$f":"(V2630/M2630*100)-100","v":{"v":-1.4970920964944554,"d":"-1"}},null,0,6980,20,733,{"v":5101.68,"d":"5102"},{"v":8728.165353552,"d":"8728"},{"$f":"(AG2630+AG2631)/2","v":{"v":8598.380924948,"d":"8598"}},{"$f":"SQRT((AH2630-AG2630)*(AH2630-AG2630))","v":{"v":129.7844286039999,"d":"130"}},{"$f":"AI2630/AH2630*100","v":{"v":1.509405430357632,"d":"2"}},{"$f":"AJ2630+O2630","v":{"v":6.599265094681855,"d":"7"}},{"$f":"(AH2630/M2630*100)-100","v":{"v":-1.623771331166708,"d":"-2"}},null,null,"FLT1","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"RDI(pY)KNP(bA)C","Corresponds to amino acid residues R1045 to P1051; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y1048 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of VEGFR1.",null,"Receptor tyrosine kinase; EC 2.7.10.1; EC 2.7.1.112; TK group; VEGFR family","P17948","P17948","P17948","P17948","GO:0015629; GO:0005768; GO:0005615; GO:0005925; GO:0005887; GO:0005886; GO:0043235","GO:0005524; GO:0019838; GO:0036332; GO:0004714; GO:0005021; GO:0036326; GO:0036327","GO:0001525; GO:0048514; GO:0030154; GO:0016477; GO:0035924; GO:0048598; GO:0002548; GO:1905563; GO:0018108; GO:0045766; GO:0030335; GO:0008284; GO:0043410; GO:0043406; GO:0043552; GO:0014068; GO:0010863; GO:0030949; GO:0046777; GO:0007169; GO:0036323; GO:0048010"]
[2618,1307,"PK850","VEGFR1 (Flt1)","Y1048","Vascular endothelial growth factor receptor 1",0,7507,18,698,{"v":5227.322,"d":"5227"},{"v":9185.1726476018,"d":"9185"},{"$nulls":3},0,7314,20,667,{"v":4865.098,"d":"4865"},{"v":8500.3726885798,"d":"8500"},{"$nulls":6},0,7412,24,670,{"v":4949.96,"d":"4950"},{"v":8468.596496344,"d":"8469"},{"$nulls":7},"FLT1","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"RDI(pY)KNP(bA)C","Corresponds to amino acid residues R1045 to P1051; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y1048 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of VEGFR1.",null,null,"P17948","P17948","P17948","P17948"]
[2619,1308,"PK851","VEGFR1 (Flt1)","Y1053","Vascular endothelial growth factor receptor 1",0,3942,16,697,{"v":2736.422,"d":"2736"},{"v":4808.2954343918,"d":"4808"},{"$f":"(L2632+L2633)/2","v":{"v":5024.288324207049,"d":"5024"}},{"$f":"SQRT((M2632-L2632)*(M2632-L2632))","v":{"v":215.99288981524933,"d":"216"}},{"$f":"N2632/M2632*100","v":{"v":4.2989748174800075,"d":"4"}},0,4643,14,691,{"v":3198.639,"d":"3199"},{"v":5588.7103602489005,"d":"5589"},{"$f":"(U2632+U2633)/2","v":{"v":5336.3854179748505,"d":"5336"}},{"$f":"SQRT((V2632-U2632)*(V2632-U2632))","v":{"v":252.32494227405004,"d":"252"}},{"$f":"W2632/V2632*100","v":{"v":4.728386773266593,"d":"5"}},{"$f":"X2632+O2632","v":{"v":9.027361590746601,"d":"9"}},{"$f":"(V2632/M2632*100)-100","v":{"v":6.211767192263153,"d":"6"}},null,0,4134,18,761,{"v":3132.276,"d":"3132"},{"v":5358.8274570264,"d":"5359"},{"$f":"(AG2632+AG2633)/2","v":{"v":5257.8228024532,"d":"5258"}},{"$f":"SQRT((AH2632-AG2632)*(AH2632-AG2632))","v":{"v":101.00465457320024,"d":"101"}},{"$f":"AI2632/AH2632*100","v":{"v":1.9210357284401711,"d":"2"}},{"$f":"AJ2632+O2632","v":{"v":6.220010545920179,"d":"6"}},{"$f":"(AH2632/M2632*100)-100","v":{"v":4.648110601475253,"d":"5"}},null,null,"FLT1","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"NPD(pY)VRK(bA)C","Corresponds to amino acid residues N1050 to K1056; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y1053 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of VEGFR1.","Flt1 (VEGFR1)","Receptor tyrosine kinase; EC 2.7.10.1; EC 2.7.1.112; TK group; VEGFR family","P17948","P17948","P17948","P17948","GO:0015629; GO:0005768; GO:0005615; GO:0005925; GO:0005887; GO:0005886; GO:0043235","GO:0005524; GO:0019838; GO:0036332; GO:0004714; GO:0005021; GO:0036326; GO:0036327","GO:0001525; GO:0048514; GO:0030154; GO:0016477; GO:0035924; GO:0048598; GO:0002548; GO:1905563; GO:0018108; GO:0045766; GO:0030335; GO:0008284; GO:0043410; GO:0043406; GO:0043552; GO:0014068; GO:0010863; GO:0030949; GO:0046777; GO:0007169; GO:0036323; GO:0048010"]
[2620,1308,"PK851","VEGFR1 (Flt1)","Y1053","Vascular endothelial growth factor receptor 1",0,4357,16,687,{"v":2982.267,"d":"2982"},{"v":5240.2812140222995,"d":"5240"},{"$nulls":3},0,4372,16,668,{"v":2909.808,"d":"2910"},{"v":5084.0604757008,"d":"5084"},{"$nulls":6},0,4324,18,700,{"v":3014.2,"d":"3014"},{"v":5156.81814788,"d":"5157"},{"$nulls":7},"FLT1","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"NPD(pY)VRK(bA)C","Corresponds to amino acid residues N1050 to K1056; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y1053 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of VEGFR1.","Flt1 (VEGFR1)",null,"P17948","P17948","P17948","P17948"]
[2621,1309,"NK245-2","VEGFR2 (KDR)","Pan-specific","Vascular endothelial growth factor receptor 2 ; Vascular endothelial growth factor receptor-tyrosine kinase 2 (Flk1)",0,4790,12,710,{"v":3392.38,"d":"3392"},{"v":5960.910000622,"d":"5961"},{"$f":"(L2634+L2635)/2","v":{"v":6394.519383988099,"d":"6395"}},{"$f":"SQRT((M2634-L2634)*(M2634-L2634))","v":{"v":433.6093833660998,"d":"434"}},{"$f":"N2634/M2634*100","v":{"v":6.780953459174106,"d":"7"}},0,5222,14,680,{"v":3541.44,"d":"3541"},{"v":6187.657443744,"d":"6188"},{"$f":"(U2634+U2635)/2","v":{"v":6113.9948551279995,"d":"6114"}},{"$f":"SQRT((V2634-U2634)*(V2634-U2634))","v":{"v":73.6625886160009,"d":"74"}},{"$f":"W2634/V2634*100","v":{"v":1.2048192771084485,"d":"1"}},{"$f":"X2634+O2634","v":{"v":7.985772736282555,"d":"8"}},{"$f":"(V2634/M2634*100)-100","v":{"v":-4.386952513781324,"d":"-4"}},null,0,4968,18,733,{"v":3628.35,"d":"3628"},{"v":6207.53139369,"d":"6208"},{"$f":"(AG2634+AG2635)/2","v":{"v":6461.5143537270005,"d":"6462"}},{"$f":"SQRT((AH2634-AG2634)*(AH2634-AG2634))","v":{"v":253.98296003700034,"d":"254"}},{"$f":"AI2634/AH2634*100","v":{"v":3.930703332578732,"d":"4"}},{"$f":"AJ2634+O2634","v":{"v":10.711656791752837,"d":"11"}},{"$f":"(AH2634/M2634*100)-100","v":{"v":1.0476935906497715,"d":"1"}},null,null,"KDR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"CLMTKKNSTFVRVHEK","Corresponds to amino acid residues L313 to K327; In the extracellular domain of the receptor.",null,null,"EC 2.7.10.1; Receptor tyrosine kinase; TK group; VEGFR family","P35968","P35968","P35968","P35968","GO:0030054; GO:0005769; GO:0005783; GO:0005768; GO:0005576; GO:0005794; GO:0005887; GO:0045121; GO:0005634; GO:0005886; GO:0097443","GO:0005524; GO:0019838; GO:0051879; GO:0042802; GO:0005178; GO:0004713; GO:0004714; GO:0005021; GO:0038085","GO:0001525; GO:0035584; GO:0002042; GO:1904881; GO:0035924; GO:0035162; GO:0003158; GO:0070371; GO:0030198; GO:0043066; GO:2000352; GO:0010629; GO:0038083; GO:0018108; GO:0045766; GO:0043536; GO:0030335; GO:0090050; GO:0008284; GO:0038033; GO:0010595; GO:0001938; GO:0070374; GO:0051894; GO:0016239; GO:0043410; GO:0051901; GO:0090141; GO:0051770; GO:0014068; GO:0050927; GO:0001934; GO:2001214; GO:0046777; GO:0043491; GO:0008360; GO:0007169; GO:0048010; GO:0001570; GO:0016032"]
[2622,1309,"NK245-2","VEGFR2 (KDR)","Pan-specific","Vascular endothelial growth factor receptor 2 ; Vascular endothelial growth factor receptor-tyrosine kinase 2 (Flk1)",0,5087,14,766,{"v":3885.918,"d":"3886"},{"v":6828.1287673542,"d":"6828"},{"$nulls":3},0,5102,18,680,{"v":3457.12,"d":"3457"},{"v":6040.3322665119995,"d":"6040"},{"$nulls":6},0,4870,24,810,{"v":3925.26,"d":"3925"},{"v":6715.497313764001,"d":"6715"},{"$nulls":7},"KDR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"CLMTKKNSTFVRVHEK","Corresponds to amino acid residues L313 to K327; In the extracellular domain of the receptor.",{"$nulls":3},"P35968","P35968","P35968","P35968"]
[2623,1310,"NK245-3","VEGFR2 (KDR)","Pan-specific","Vascular endothelial growth factor receptor 2 ; Vascular endothelial growth factor receptor-tyrosine kinase 2 (Flk1)",0,6508,12,723,{"v":4696.608,"d":"4697"},{"v":8252.6301877152,"d":"8253"},{"$f":"(L2636+L2637)/2","v":{"v":8430.140681846999,"d":"8430"}},{"$f":"SQRT((M2636-L2636)*(M2636-L2636))","v":{"v":177.51049413179862,"d":"178"}},{"$f":"N2636/M2636*100","v":{"v":2.10566467193175,"d":"2"}},0,6598,14,745,{"v":4905.08,"d":"4905"},{"v":8570.229842708,"d":"8570"},{"$f":"(U2636+U2637)/2","v":{"v":8390.371520314,"d":"8390"}},{"$f":"SQRT((V2636-U2636)*(V2636-U2636))","v":{"v":179.85832239400042,"d":"180"}},{"$f":"W2636/V2636*100","v":{"v":2.143627632680435,"d":"2"}},{"$f":"X2636+O2636","v":{"v":4.249292304612185,"d":"4"}},{"$f":"(V2636/M2636*100)-100","v":{"v":-0.47174967813568003,"d":"-0"}},null,0,6578,16,764,{"v":5013.368,"d":"5013"},{"v":8577.077527835201,"d":"8577"},{"$f":"(AG2636+AG2637)/2","v":{"v":8202.170586804801,"d":"8202"}},{"$f":"SQRT((AH2636-AG2636)*(AH2636-AG2636))","v":{"v":374.90694103040005,"d":"375"}},{"$f":"AI2636/AH2636*100","v":{"v":4.570825942507581,"d":"5"}},{"$f":"AJ2636+O2636","v":{"v":6.676490614439331,"d":"7"}},{"$f":"(AH2636/M2636*100)-100","v":{"v":-2.704226461286652,"d":"-3"}},null,null,"KDR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"CILQPDSGTTLSSPPV","Corresponds to amino acid residues I1342 to V1356; C-terminus.",null,null,"EC 2.7.10.1; Receptor tyrosine kinase; TK group; VEGFR family","P35968","P35968","P35968","P35968","GO:0030054; GO:0005769; GO:0005783; GO:0005768; GO:0005576; GO:0005794; GO:0005887; GO:0045121; GO:0005634; GO:0005886; GO:0097443","GO:0005524; GO:0019838; GO:0051879; GO:0042802; GO:0005178; GO:0004713; GO:0004714; GO:0005021; GO:0038085","GO:0001525; GO:0035584; GO:0002042; GO:1904881; GO:0035924; GO:0035162; GO:0003158; GO:0070371; GO:0030198; GO:0043066; GO:2000352; GO:0010629; GO:0038083; GO:0018108; GO:0045766; GO:0043536; GO:0030335; GO:0090050; GO:0008284; GO:0038033; GO:0010595; GO:0001938; GO:0070374; GO:0051894; GO:0016239; GO:0043410; GO:0051901; GO:0090141; GO:0051770; GO:0014068; GO:0050927; GO:0001934; GO:2001214; GO:0046777; GO:0043491; GO:0008360; GO:0007169; GO:0048010; GO:0001570; GO:0016032"]
[2624,1310,"NK245-3","VEGFR2 (KDR)","Pan-specific","Vascular endothelial growth factor receptor 2 ; Vascular endothelial growth factor receptor-tyrosine kinase 2 (Flk1)",0,6563,14,748,{"v":4898.652,"d":"4899"},{"v":8607.651175978799,"d":"8608"},{"$nulls":3},0,6618,18,712,{"v":4699.2,"d":"4699"},{"v":8210.51319792,"d":"8211"},{"$nulls":6},0,6392,20,718,{"v":4575.096,"d":"4575"},{"v":7827.263645774399,"d":"7827"},{"$nulls":7},"KDR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"CILQPDSGTTLSSPPV","Corresponds to amino acid residues I1342 to V1356; C-terminus.",{"$nulls":3},"P35968","P35968","P35968","P35968"]
[2625,1311,"PK852","VEGFR2 (KDR)","Y1054","Vascular endothelial growth factor receptor 2 ; Vascular endothelial growth factor receptor-tyrosine kinase 2 (Flk1)",0,7638,14,655,{"$f":"(H2638-I2638)*J2638/1000","v":{"v":4993.72,"d":"4994"}},{"v":8774.699617468,"d":"8775"},{"$f":"(L2638+L2639)/2","v":{"v":8880.641518362801,"d":"8881"}},{"$f":"SQRT((M2638-L2638)*(M2638-L2638))","v":{"v":105.94190089480071,"d":"106"}},{"$f":"N2638/M2638*100","v":{"v":1.1929532418997104,"d":"1"}},0,8166,12,642,{"$f":"(Q2638-R2638)*S2638/1000","v":{"v":5234.868,"d":"5235"}},{"v":9146.440416106801,"d":"9146"},{"$f":"(U2638+U2639)/2","v":{"v":9033.0950781396,"d":"9033"}},{"$f":"SQRT((V2638-U2638)*(V2638-U2638))","v":{"v":113.34533796720098,"d":"113"}},{"$f":"W2638/V2638*100","v":{"v":1.254778533677793,"d":"1"}},{"$f":"X2638+O2638","v":{"v":2.4477317755775037,"d":"2"}},{"$f":"(V2638/M2638*100)-100","v":{"v":1.7166953475327773,"d":"2"}},null,0,7531,16,674,{"$f":"(AC2638-AD2638)*AE2638/1000","v":{"v":5065.11,"d":"5065"}},{"v":8665.599883554,"d":"8666"},{"$f":"(AG2638+AG2639)/2","v":{"v":9428.6214612228,"d":"9429"}},{"$f":"SQRT((AH2638-AG2638)*(AH2638-AG2638))","v":{"v":763.0215776688001,"d":"763"}},{"$f":"AI2638/AH2638*100","v":{"v":8.092610153105497,"d":"8"}},{"$f":"AJ2638+O2638","v":{"v":9.285563395005207,"d":"9"}},{"$f":"(AH2638/M2638*100)-100","v":{"v":6.170499526716867,"d":"6"}},null,null,"KDR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"RDI(pY)KDP(bA)C","Corresponds to amino acid residues R1051 to P1057; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y1054 phosphorylation stimulates phosphotransferase activity and induces interaction with Cbl and PLCG1. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of VEGFR2.","KDR (VEGFR2)","EC 2.7.10.1; Receptor tyrosine kinase; TK group; VEGFR family","P35968","P35968","P35968","P35968","GO:0030054; GO:0005769; GO:0005783; GO:0005768; GO:0005576; GO:0005794; GO:0005887; GO:0045121; GO:0005634; GO:0005886; GO:0097443","GO:0005524; GO:0019838; GO:0051879; GO:0042802; GO:0005178; GO:0004713; GO:0004714; GO:0005021; GO:0038085","GO:0001525; GO:0035584; GO:0002042; GO:1904881; GO:0035924; GO:0035162; GO:0003158; GO:0070371; GO:0030198; GO:0043066; GO:2000352; GO:0010629; GO:0038083; GO:0018108; GO:0045766; GO:0043536; GO:0030335; GO:0090050; GO:0008284; GO:0038033; GO:0010595; GO:0001938; GO:0070374; GO:0051894; GO:0016239; GO:0043410; GO:0051901; GO:0090141; GO:0051770; GO:0014068; GO:0050927; GO:0001934; GO:2001214; GO:0046777; GO:0043491; GO:0008360; GO:0007169; GO:0048010; GO:0001570; GO:0016032"]
[2626,1311,"PK852","VEGFR2 (KDR)","Y1054","Vascular endothelial growth factor receptor 2 ; Vascular endothelial growth factor receptor-tyrosine kinase 2 (Flk1)",0,7506,18,683,{"v":5114.304,"d":"5114"},{"v":8986.5834192576,"d":"8987"},{"$nulls":3},0,7820,14,654,{"v":5105.124,"d":"5105"},{"v":8919.7497401724,"d":"8920"},{"$nulls":6},0,7595,16,786,{"v":5957.094,"d":"5957"},{"v":10191.6430388916,"d":"10192"},{"$nulls":7},"KDR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"RDI(pY)KDP(bA)C","Corresponds to amino acid residues R1051 to P1057; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y1054 phosphorylation stimulates phosphotransferase activity and induces interaction with Cbl and PLCG1. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of VEGFR2.","KDR (VEGFR2)",null,"P35968","P35968","P35968","P35968"]
[2627,1312,"PK161","VEGFR2 (KDR)","Y1059","Vascular endothelial growth factor receptor 3 ; Vascular endothelial growth factor receptor-protein-tyrosine kinase 3",0,2112,10,324,{"v":681.048,"d":"681"},{"v":1196.7013819512,"d":"1197"},{"$f":"(L2640+L2641)/2","v":{"v":1317.5807886429,"d":"1318"}},{"$f":"SQRT((M2640-L2640)*(M2640-L2640))","v":{"v":120.87940669170007,"d":"121"}},{"$f":"N2640/M2640*100","v":{"v":9.174344961131766,"d":"9"}},0,2686,10,294,{"v":786.744,"d":"787"},{"v":1374.6109966344,"d":"1375"},{"$f":"(U2640+U2641)/2","v":{"v":1405.7865556636998,"d":"1406"}},{"$f":"SQRT((V2640-U2640)*(V2640-U2640))","v":{"v":31.175559029299848,"d":"31"}},{"$f":"W2640/V2640*100","v":{"v":2.2176594948712713,"d":"2"}},{"$f":"X2640+O2640","v":{"v":11.392004456003036,"d":"11"}},{"$f":"(V2640/M2640*100)-100","v":{"v":6.6945243723272085,"d":"7"}},null,0,2198,10,344,{"v":752.672,"d":"753"},{"v":1287.7024182208002,"d":"1288"},{"$f":"(AG2640+AG2641)/2","v":{"v":1402.9010684691002,"d":"1403"}},{"$f":"SQRT((AH2640-AG2640)*(AH2640-AG2640))","v":{"v":115.19865024830005,"d":"115"}},{"$f":"AI2640/AH2640*100","v":{"v":8.211459299407995,"d":"8"}},{"$f":"AJ2640+O2640","v":{"v":17.38580426053976,"d":"17"}},{"$f":"(AH2640/M2640*100)-100","v":{"v":6.4755254904770965,"d":"6"}},null,null,"KDR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"PD(pY)VR","Corresponds to amino acid residues P1057 to R1061.","Y1059 phosphorylation stimulates phosphotransferase activity and induces interaction with Cbl, PLCG1 and Src. This is one of the major sites of in vivo phosphorylation of VEGFR2.","KDR (VEGFR2)","EC 2.7.10.1; Receptor tyrosine kinase; TK group; VEGFR family","P35968","P35968","P35968","P35968","GO:0030054; GO:0005769; GO:0005783; GO:0005768; GO:0005576; GO:0005794; GO:0005887; GO:0045121; GO:0005634; GO:0005886; GO:0097443","GO:0005524; GO:0019838; GO:0051879; GO:0042802; GO:0005178; GO:0004713; GO:0004714; GO:0005021; GO:0038085","GO:0001525; GO:0035584; GO:0002042; GO:1904881; GO:0035924; GO:0035162; GO:0003158; GO:0070371; GO:0030198; GO:0043066; GO:2000352; GO:0010629; GO:0038083; GO:0018108; GO:0045766; GO:0043536; GO:0030335; GO:0090050; GO:0008284; GO:0038033; GO:0010595; GO:0001938; GO:0070374; GO:0051894; GO:0016239; GO:0043410; GO:0051901; GO:0090141; GO:0051770; GO:0014068; GO:0050927; GO:0001934; GO:2001214; GO:0046777; GO:0043491; GO:0008360; GO:0007169; GO:0048010; GO:0001570; GO:0016032"]
[2628,1312,"PK161","VEGFR2 (KDR)","Y1059","Vascular endothelial growth factor receptor 3 ; Vascular endothelial growth factor receptor-protein-tyrosine kinase 3",0,2463,12,334,{"v":818.634,"d":"819"},{"v":1438.4601953346,"d":"1438"},{"$nulls":3},0,2665,12,310,{"v":822.43,"d":"822"},{"v":1436.9621146929999,"d":"1437"},{"$nulls":6},0,2597,10,343,{"v":887.341,"d":"887"},{"v":1518.0997187174,"d":"1518"},{"$nulls":7},"KDR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"PD(pY)VR","Corresponds to amino acid residues P1057 to R1061.","Y1059 phosphorylation stimulates phosphotransferase activity and induces interaction with Cbl, PLCG1 and Src. This is one of the major sites of in vivo phosphorylation of VEGFR2.","KDR (VEGFR2)",null,"P35968","P35968","P35968","P35968"]
[2629,1313,"PK133","VEGFR2 (KDR)","Y1214","Vascular endothelial growth factor receptor 3 ; Vascular endothelial growth factor receptor-protein-tyrosine kinase 3",0,1128,10,251,{"v":280.618,"d":"281"},{"$f":"K2642*1.7571469","v":{"v":493.08704878419996,"d":"493"}},{"$f":"(L2642+L2643)/2","v":{"v":504.3942890857,"d":"504"}},{"$f":"SQRT((M2642-L2642)*(M2642-L2642))","v":{"v":11.30724030150003,"d":"11"}},{"$f":"N2642/M2642*100","v":{"v":2.2417462977220297,"d":"2"}},0,1034,8,239,{"v":245.214,"d":"245"},{"$f":"T2642*1.7472151","v":{"v":428.4416035314,"d":"428"}},{"$f":"(U2642+U2643)/2","v":{"v":452.5409414057,"d":"453"}},{"$f":"SQRT((V2642-U2642)*(V2642-U2642))","v":{"v":24.099337874299977,"d":"24"}},{"$f":"W2642/V2642*100","v":{"v":5.325338697409718,"d":"5"}},{"$f":"X2642+O2642","v":{"v":7.567084995131747,"d":"8"}},{"$f":"(V2642/M2642*100)-100","v":{"v":-10.280320138832849,"d":"-10"}},null,0,887,10,245,{"v":214.865,"d":"215"},{"v":367.59993741100004,"d":"368"},{"$f":"(AG2642+AG2643)/2","v":{"v":434.21582442350007,"d":"434"}},{"$f":"SQRT((AH2642-AG2642)*(AH2642-AG2642))","v":{"v":66.61588701250002,"d":"67"}},{"$f":"AI2642/AH2642*100","v":{"v":15.34165345101014,"d":"15"}},{"$f":"AJ2642+O2642","v":{"v":17.58339974873217,"d":"18"}},{"$f":"(AH2642/M2642*100)-100","v":{"v":-13.913413807561199,"d":"-14"}},null,null,"KDR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"FH(pY)DN","Corresponds to amino acid residues F1212 to N1216; Surrounds the Y1214 phosphosite.","Y1214 phosphorylation stimulates phosphotransferase activity and induces interaction with NCK1 and Fyn. This is one of the major sites of in vivo phosphorylation of VEGFR2.","KDR (VEGFR2)","EC 2.7.10.1; Receptor tyrosine kinase; TK group; VEGFR family","P35968","P35968","P35968","P35968","GO:0030054; GO:0005769; GO:0005783; GO:0005768; GO:0005576; GO:0005794; GO:0005887; GO:0045121; GO:0005634; GO:0005886; GO:0097443","GO:0005524; GO:0019838; GO:0051879; GO:0042802; GO:0005178; GO:0004713; GO:0004714; GO:0005021; GO:0038085","GO:0001525; GO:0035584; GO:0002042; GO:1904881; GO:0035924; GO:0035162; GO:0003158; GO:0070371; GO:0030198; GO:0043066; GO:2000352; GO:0010629; GO:0038083; GO:0018108; GO:0045766; GO:0043536; GO:0030335; GO:0090050; GO:0008284; GO:0038033; GO:0010595; GO:0001938; GO:0070374; GO:0051894; GO:0016239; GO:0043410; GO:0051901; GO:0090141; GO:0051770; GO:0014068; GO:0050927; GO:0001934; GO:2001214; GO:0046777; GO:0043491; GO:0008360; GO:0007169; GO:0048010; GO:0001570; GO:0016032"]
[2630,1313,"PK133","VEGFR2 (KDR)","Y1214","Vascular endothelial growth factor receptor 3 ; Vascular endothelial growth factor receptor-protein-tyrosine kinase 3",0,1089,10,272,{"v":293.488,"d":"293"},{"v":515.7015293872,"d":"516"},{"$nulls":3},0,1110,10,248,{"v":272.8,"d":"273"},{"v":476.64027928,"d":"477"},{"$nulls":6},0,1158,10,255,{"v":292.74,"d":"293"},{"$f":"AF2643*1.7108414","v":{"v":500.83171143600003,"d":"501"}},{"$nulls":7},"KDR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"FH(pY)DN","Corresponds to amino acid residues F1212 to N1216; Surrounds the Y1214 phosphosite.","Y1214 phosphorylation stimulates phosphotransferase activity and induces interaction with NCK1 and Fyn. This is one of the major sites of in vivo phosphorylation of VEGFR2.","KDR (VEGFR2)",null,"P35968","P35968","P35968","P35968"]
[2631,1314,"NK064-2","VEGFR3 (Flt4)","Pan-specific","Vascular endothelial growth factor receptor 3 ; Vascular endothelial growth factor receptor-protein-tyrosine kinase 3",0,3088,16,754,{"v":2316.288,"d":"2316"},{"v":4070.0582787072,"d":"4070"},{"$f":"(L2644+L2645)/2","v":{"v":4047.7179130206,"d":"4048"}},{"$f":"SQRT((M2644-L2644)*(M2644-L2644))","v":{"v":22.340365686599853,"d":"22"}},{"$f":"N2644/M2644*100","v":{"v":0.5519249652930583,"d":"1"}},0,3148,14,744,{"v":2331.696,"d":"2332"},{"v":4073.9744598096,"d":"4074"},{"$f":"(U2644+U2645)/2","v":{"v":4082.9900897256002,"d":"4083"}},{"$f":"SQRT((V2644-U2644)*(V2644-U2644))","v":{"v":9.015629916000307,"d":"9"}},{"$f":"W2644/V2644*100","v":{"v":0.22080949788947954,"d":"0"}},{"$f":"X2644+O2644","v":{"v":0.7727344631825379,"d":"1"}},{"$f":"(V2644/M2644*100)-100","v":{"v":0.8714089633454307,"d":"1"}},null,0,3123,16,772,{"v":2398.604,"d":"2399"},{"v":4103.6310254056,"d":"4104"},{"$f":"(AG2644+AG2645)/2","v":{"v":4263.9197561716,"d":"4264"}},{"$f":"SQRT((AH2644-AG2644)*(AH2644-AG2644))","v":{"v":160.2887307660003,"d":"160"}},{"$f":"AI2644/AH2644*100","v":{"v":3.759187318992068,"d":"4"}},{"$f":"AJ2644+O2644","v":{"v":4.311112284285127,"d":"4"}},{"$f":"(AH2644/M2644*100)-100","v":{"v":5.341326836426205,"d":"5"}},null,null,"FLT4","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"CNELYDIQLLPRKSLE","Corresponds to amino acid residues N227 to E241.",null,null,"EC 2.7.10.1; EC 2.7.1.112; Receptor tyrosine kinase; TK group; VEGFR family","P35916","P35916","P35916","P35916","GO:0005737; GO:0005576; GO:0005887; GO:0005654; GO:0005886; GO:0043235","GO:0005524; GO:0019838; GO:0042803; GO:0019903; GO:0004714; GO:0005021; GO:0036328","GO:0048514; GO:0035924; GO:0048286; GO:0001946; GO:0001945; GO:0043066; GO:0018108; GO:0008284; GO:0010595; GO:0001938; GO:0070374; GO:0046330; GO:0043410; GO:0090037; GO:0001934; GO:0010575; GO:0046777; GO:0060312; GO:0003016; GO:0002040; GO:0007169; GO:0048010; GO:0038084; GO:0001944"]
[2632,1314,"NK064-2","VEGFR3 (Flt4)","Pan-specific","Vascular endothelial growth factor receptor 3 ; Vascular endothelial growth factor receptor-protein-tyrosine kinase 3",0,3497,26,660,{"v":2290.86,"d":"2291"},{"v":4025.377547334,"d":"4025"},{"$nulls":3},0,3442,18,684,{"v":2342.016,"d":"2342"},{"v":4092.0057196416,"d":"4092"},{"$nulls":6},0,3650,18,712,{"v":2585.984,"d":"2586"},{"v":4424.2084869376,"d":"4424"},{"$nulls":7},"FLT4","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"CNELYDIQLLPRKSLE","Corresponds to amino acid residues N227 to E241.",{"$nulls":3},"P35916","P35916","P35916","P35916"]
[2633,1315,"NK064-3","VEGFR3 (Flt4)","Pan-specific","Vascular endothelial growth factor receptor 3 ; Vascular endothelial growth factor receptor-protein-tyrosine kinase 3",0,10587,20,715,{"v":7555.405,"d":"7555"},{"v":13275.9564739945,"d":"13276"},{"$f":"(L2646+L2647)/2","v":{"v":13954.877621775799,"d":"13955"}},{"$f":"SQRT((M2646-L2646)*(M2646-L2646))","v":{"v":678.9211477812987,"d":"679"}},{"$f":"N2646/M2646*100","v":{"v":4.865117173954149,"d":"5"}},0,10726,17,765,{"v":8192.385,"d":"8192"},{"v":14313.8587770135,"d":"14314"},{"$f":"(U2646+U2647)/2","v":{"v":13493.303666309901,"d":"13493"}},{"$f":"SQRT((V2646-U2646)*(V2646-U2646))","v":{"v":820.555110703599,"d":"821"}},{"$f":"W2646/V2646*100","v":{"v":6.0812024319319375,"d":"6"}},{"$f":"X2646+O2646","v":{"v":10.946319605886087,"d":"11"}},{"$f":"(V2646/M2646*100)-100","v":{"v":-3.307617364882063,"d":"-3"}},null,0,10786,18,788,{"v":8485.184,"d":"8485"},{"v":14516.804073817599,"d":"14517"},{"$f":"(AG2646+AG2647)/2","v":{"v":14340.392373698,"d":"14340"}},{"$f":"SQRT((AH2646-AG2646)*(AH2646-AG2646))","v":{"v":176.41170011959912,"d":"176"}},{"$f":"AI2646/AH2646*100","v":{"v":1.230173453574111,"d":"1"}},{"$f":"AJ2646+O2646","v":{"v":6.095290627528261,"d":"6"}},{"$f":"(AH2646/M2646*100)-100","v":{"v":2.7625806715827252,"d":"3"}},null,null,"FLT4","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"CIQRFRESTEVIVHEN","Corresponds to amino acid residues I316 to N330.",null,null,"EC 2.7.10.1; EC 2.7.1.112; Receptor tyrosine kinase; TK group; VEGFR family","P35916","P35916","P35916","P35916","GO:0005737; GO:0005576; GO:0005887; GO:0005654; GO:0005886; GO:0043235","GO:0005524; GO:0019838; GO:0042803; GO:0019903; GO:0004714; GO:0005021; GO:0036328","GO:0048514; GO:0035924; GO:0048286; GO:0001946; GO:0001945; GO:0043066; GO:0018108; GO:0008284; GO:0010595; GO:0001938; GO:0070374; GO:0046330; GO:0043410; GO:0090037; GO:0001934; GO:0010575; GO:0046777; GO:0060312; GO:0003016; GO:0002040; GO:0007169; GO:0048010; GO:0038084; GO:0001944"]
[2634,1315,"NK064-3","VEGFR3 (Flt4)","Pan-specific","Vascular endothelial growth factor receptor 3 ; Vascular endothelial growth factor receptor-protein-tyrosine kinase 3",0,10307,38,811,{"v":8328.159,"d":"8328"},{"v":14633.7987695571,"d":"14634"},{"$nulls":3},0,10279,20,707,{"v":7253.113,"d":"7253"},{"v":12672.7485556063,"d":"12673"},{"$nulls":6},0,10979,28,756,{"v":8278.956,"d":"8279"},{"v":14163.9806735784,"d":"14164"},{"$nulls":7},"FLT4","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"CIQRFRESTEVIVHEN","Corresponds to amino acid residues I316 to N330.",{"$nulls":3},"P35916","P35916","P35916","P35916"]
[2635,1316,"PK853","VEGFR3 (Flt4)","Y1068","Vascular endothelial growth factor receptor 3 ; Vascular endothelial growth factor receptor-protein-tyrosine kinase 3",0,8336,16,774,{"v":6439.68,"d":"6440"},{"v":11315.463748992,"d":"11315"},{"$f":"(L2648+L2649)/2","v":{"v":11270.445645414,"d":"11270"}},{"$f":"SQRT((M2648-L2648)*(M2648-L2648))","v":{"v":45.01810357800059,"d":"45"}},{"$f":"N2648/M2648*100","v":{"v":0.399434991253595,"d":"0"}},0,9000,18,783,{"v":7032.906,"d":"7033"},{"v":12287.9995600806,"d":"12288"},{"$f":"(U2648+U2649)/2","v":{"v":12032.36364519205,"d":"12032"}},{"$f":"SQRT((V2648-U2648)*(V2648-U2648))","v":{"v":255.63591488854945,"d":"256"}},{"$f":"W2648/V2648*100","v":{"v":2.1245693899111644,"d":"2"}},{"$f":"X2648+O2648","v":{"v":2.5240043811647594,"d":"3"}},{"$f":"(V2648/M2648*100)-100","v":{"v":6.7603183028355005,"d":"7"}},null,0,8110,20,810,{"v":6552.9,"d":"6553"},{"v":11210.97261006,"d":"11211"},{"$f":"(AG2648+AG2649)/2","v":{"v":11583.2123493478,"d":"11583"}},{"$f":"SQRT((AH2648-AG2648)*(AH2648-AG2648))","v":{"v":372.23973928779924,"d":"372"}},{"$f":"AI2648/AH2648*100","v":{"v":3.21361404816824,"d":"3"}},{"$f":"AJ2648+O2648","v":{"v":3.613049039421835,"d":"4"}},{"$f":"(AH2648/M2648*100)-100","v":{"v":2.775105029330092,"d":"3"}},null,null,"FLT4","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"DPD(pY)VRK(bA)C","Corresponds to amino acid residues D1065 to K1071; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y1068 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of VEGFR3.","VEGFR3 (FLT4)","EC 2.7.10.1; EC 2.7.1.112; Receptor tyrosine kinase; TK group; VEGFR family","P35916","P35916","P35916","P35916","GO:0005737; GO:0005576; GO:0005887; GO:0005654; GO:0005886; GO:0043235","GO:0005524; GO:0019838; GO:0042803; GO:0019903; GO:0004714; GO:0005021; GO:0036328","GO:0048514; GO:0035924; GO:0048286; GO:0001946; GO:0001945; GO:0043066; GO:0018108; GO:0008284; GO:0010595; GO:0001938; GO:0070374; GO:0046330; GO:0043410; GO:0090037; GO:0001934; GO:0010575; GO:0046777; GO:0060312; GO:0003016; GO:0002040; GO:0007169; GO:0048010; GO:0038084; GO:0001944"]
[2636,1316,"PK853","VEGFR3 (Flt4)","Y1068","Vascular endothelial growth factor receptor 3 ; Vascular endothelial growth factor receptor-protein-tyrosine kinase 3",0,8388,48,766,{"v":6388.44,"d":"6388"},{"v":11225.427541836,"d":"11225"},{"$nulls":3},0,8783,18,769,{"v":6740.285,"d":"6740"},{"v":11776.7277303035,"d":"11777"},{"$nulls":6},0,8764,18,799,{"v":6988.054,"d":"6988"},{"v":11955.4520886356,"d":"11955"},{"$nulls":7},"FLT4","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"DPD(pY)VRK(bA)C","Corresponds to amino acid residues D1065 to K1071; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y1068 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of VEGFR3.","VEGFR3 (FLT4)",null,"P35916","P35916","P35916","P35916"]
[2637,1317,"NN185-2","VIM","Pan-specific","Vimentin",0,121,12,571,{"v":62.239,"d":"62"},{"v":109.36306590909999,"d":"109"},{"$f":"(L2650+L2651)/2","v":{"v":109.08280097854998,"d":"109"}},{"$f":"SQRT((M2650-L2650)*(M2650-L2650))","v":{"v":0.280264930550004,"d":"0"}},{"$f":"N2650/M2650*100","v":{"v":0.25692861572661235,"d":"0"}},0,142,12,588,{"v":76.44,"d":"76"},{"v":133.557122244,"d":"134"},{"$f":"(U2650+U2651)/2","v":{"v":123.9055060316,"d":"124"}},{"$f":"SQRT((V2650-U2650)*(V2650-U2650))","v":{"v":9.6516162124,"d":"10"}},{"$f":"W2650/V2650*100","v":{"v":7.789497433583395,"d":"8"}},{"$f":"X2650+O2650","v":{"v":8.046426049310007,"d":"8"}},{"$f":"(V2650/M2650*100)-100","v":{"v":13.58848958779923,"d":"14"}},null,0,135,8,569,{"v":72.263,"d":"72"},{"v":123.63053208820001,"d":"124"},{"$f":"(AG2650+AG2651)/2","v":{"v":148.9911895811,"d":"149"}},{"$f":"SQRT((AH2650-AG2650)*(AH2650-AG2650))","v":{"v":25.36065749289999,"d":"25"}},{"$f":"AI2650/AH2650*100","v":{"v":17.021581990319962,"d":"17"}},{"$f":"AJ2650+O2650","v":{"v":17.278510606046574,"d":"17"}},{"$f":"(AH2650/M2650*100)-100","v":{"v":36.58540873954786,"d":"37"}},{"$nulls":15},"Epitope undefined.",{"$nulls":3},"Cytoskeletal protein - Microtubule dynamics","P08670","P08670",null,"P08670","GO:0031252; GO:0005737; GO:0005856; GO:0005829; GO:0070062; GO:0005925; GO:0005882; GO:0043005; GO:0016363; GO:0005777; GO:0045335; GO:0005886; GO:0005844; GO:1990904","GO:0003725; GO:0042802; GO:1990254; GO:0008022; GO:0019904; GO:0097110; GO:0005200; GO:0005212","GO:0014002; GO:0060020; GO:0071346; GO:0071222; GO:0071225; GO:0019221; GO:0045109; GO:0070307; GO:0030049; GO:0010977; GO:0032967; GO:0045727; GO:0043488; GO:0060395; GO:0016032"]
[2638,1317,"NN185-2","VIM","Pan-specific","Vimentin",0,148,28,516,{"v":61.92,"d":"62"},{"v":108.802536048,"d":"109"},{"$nulls":3},0,132,10,536,{"v":65.392,"d":"65"},{"v":114.2538898192,"d":"114"},{"$nulls":6},0,178,20,645,{"v":101.91,"d":"102"},{"v":174.351847074,"d":"174"},{"$nulls":20},"Epitope undefined.",{"$nulls":4},"P08670","P08670",null,"P08670"]
[2639,1318,"PN094","VIM","S34","Vimentin",0,3089,12,349,{"v":1073.873,"d":"1074"},{"v":1886.9526129437,"d":"1887"},{"$f":"(L2652+L2653)/2","v":{"v":1881.1672067754498,"d":"1881"}},{"$f":"SQRT((M2652-L2652)*(M2652-L2652))","v":{"v":5.78540616825012,"d":"6"}},{"$f":"N2652/M2652*100","v":{"v":0.3075434308769932,"d":"0"}},0,3403,13,330,{"v":1118.7,"d":"1119"},{"v":1954.6095323700001,"d":"1955"},{"$f":"(U2652+U2653)/2","v":{"v":2086.0158328259004,"d":"2086"}},{"$f":"SQRT((V2652-U2652)*(V2652-U2652))","v":{"v":131.40630045590024,"d":"131"}},{"$f":"W2652/V2652*100","v":{"v":6.299391327144709,"d":"6"}},{"$f":"X2652+O2652","v":{"v":6.606934758021702,"d":"7"}},{"$f":"(V2652/M2652*100)-100","v":{"v":10.88944275195962,"d":"11"}},null,0,2317,8,376,{"v":868.184,"d":"868"},{"v":1485.3251300176,"d":"1485"},{"$f":"(AG2652+AG2653)/2","v":{"v":1731.8334239780002,"d":"1732"}},{"$f":"SQRT((AH2652-AG2652)*(AH2652-AG2652))","v":{"v":246.50829396040012,"d":"247"}},{"$f":"AI2652/AH2652*100","v":{"v":14.233949440366706,"d":"14"}},{"$f":"AJ2652+O2652","v":{"v":14.5414928712437,"d":"15"}},{"$f":"(AH2652/M2652*100)-100","v":{"v":-7.938357752548015,"d":"-8"}},{"$nulls":15},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S34 phosphosite.","The effect of S34 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of vimentin.","PKCa (PRKCA)","Cytoskeletal protein - Microtubule dynamics","P08670","P08670",null,"P08670","GO:0031252; GO:0005737; GO:0005856; GO:0005829; GO:0070062; GO:0005925; GO:0005882; GO:0043005; GO:0016363; GO:0005777; GO:0045335; GO:0005886; GO:0005844; GO:1990904","GO:0003725; GO:0042802; GO:1990254; GO:0008022; GO:0019904; GO:0097110; GO:0005200; GO:0005212","GO:0014002; GO:0060020; GO:0071346; GO:0071222; GO:0071225; GO:0019221; GO:0045109; GO:0070307; GO:0030049; GO:0010977; GO:0032967; GO:0045727; GO:0043488; GO:0060395; GO:0016032"]
[2640,1318,"PN094","VIM","S34","Vimentin",0,3010,12,356,{"v":1067.288,"d":"1067"},{"v":1875.3818006072,"d":"1875"},{"$nulls":3},0,3905,12,326,{"v":1269.118,"d":"1269"},{"v":2217.4221332818,"d":"2217"},{"$nulls":6},0,3002,14,387,{"v":1156.356,"d":"1156"},{"v":1978.3417179384,"d":"1978"},{"$nulls":20},"Epitope undefined.","Antibody raised against amino acid residues that encompass the S34 phosphosite.","The effect of S34 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of vimentin.","PKCa (PRKCA)",null,"P08670","P08670",null,"P08670"]
[2641,1319,"PN544","VIM","Y117","Vimentin",0,4097,14,657,{"v":2682.531,"d":"2683"},{"v":4713.601030803899,"d":"4714"},{"$f":"(L2654+L2655)/2","v":{"v":5130.45513990505,"d":"5130"}},{"$f":"SQRT((M2654-L2654)*(M2654-L2654))","v":{"v":416.85410910115024,"d":"417"}},{"$f":"N2654/M2654*100","v":{"v":8.12509022559868,"d":"8"}},0,4732,22,679,{"v":3198.09,"d":"3198"},{"v":5587.751139159001,"d":"5588"},{"$f":"(U2654+U2655)/2","v":{"v":5435.872719376401,"d":"5436"}},{"$f":"SQRT((V2654-U2654)*(V2654-U2654))","v":{"v":151.87841978259985,"d":"152"}},{"$f":"W2654/V2654*100","v":{"v":2.794002501957464,"d":"3"}},{"$f":"X2654+O2654","v":{"v":10.919092727556144,"d":"11"}},{"$f":"(V2654/M2654*100)-100","v":{"v":5.95303089380495,"d":"6"}},null,0,4444,20,684,{"v":3026.016,"d":"3026"},{"v":5177.033449862401,"d":"5177"},{"$f":"(AG2654+AG2655)/2","v":{"v":5888.0899308476,"d":"5888"}},{"$f":"SQRT((AH2654-AG2654)*(AH2654-AG2654))","v":{"v":711.0564809851994,"d":"711"}},{"$f":"AI2654/AH2654*100","v":{"v":12.0761824180026,"d":"12"}},{"$f":"AJ2654+O2654","v":{"v":20.20127264360128,"d":"20"}},{"$f":"(AH2654/M2654*100)-100","v":{"v":14.767399193292079,"d":"15"}},{"$nulls":15},"FAN(pY)IDK(bA)C","Corresponds to amino acid residues F114 to K120; In the N-terminal part of the Filament domain. ","The effect of Y117 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in vimentin.",null,"Cytoskeletal protein - Microtubule dynamics","P08670","P08670",null,"P08670","GO:0031252; GO:0005737; GO:0005856; GO:0005829; GO:0070062; GO:0005925; GO:0005882; GO:0043005; GO:0016363; GO:0005777; GO:0045335; GO:0005886; GO:0005844; GO:1990904","GO:0003725; GO:0042802; GO:1990254; GO:0008022; GO:0019904; GO:0097110; GO:0005200; GO:0005212","GO:0014002; GO:0060020; GO:0071346; GO:0071222; GO:0071225; GO:0019221; GO:0045109; GO:0070307; GO:0030049; GO:0010977; GO:0032967; GO:0045727; GO:0043488; GO:0060395; GO:0016032"]
[2642,1319,"PN544","VIM","Y117","Vimentin",0,4598,16,689,{"v":3156.998,"d":"3157"},{"v":5547.3092490062,"d":"5547"},{"$nulls":3},0,4507,20,674,{"v":3024.238,"d":"3024"},{"v":5283.9942995938,"d":"5284"},{"$nulls":6},0,4880,22,794,{"v":3857.252,"d":"3857"},{"v":6599.1464118328,"d":"6599"},{"$nulls":20},"FAN(pY)IDK(bA)C","Corresponds to amino acid residues F114 to K120; In the N-terminal part of the Filament domain. ","The effect of Y117 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in vimentin.",null,null,"P08670","P08670",null,"P08670"]
[2643,1320,"PN545","WASP","Y291","Wiskott-Aldrich syndrome protein",0,2126,16,530,{"v":1118.3,"d":"1118"},{"v":1965.0173782699999,"d":"1965"},{"$f":"(L2656+L2657)/2","v":{"v":2139.3755508632003,"d":"2139"}},{"$f":"SQRT((M2656-L2656)*(M2656-L2656))","v":{"v":174.35817259320038,"d":"174"}},{"$f":"N2656/M2656*100","v":{"v":8.149956304906352,"d":"8"}},0,2384,16,558,{"v":1321.344,"d":"1321"},{"v":2308.6721890944,"d":"2309"},{"$f":"(U2656+U2657)/2","v":{"v":2173.8832802049,"d":"2174"}},{"$f":"SQRT((V2656-U2656)*(V2656-U2656))","v":{"v":134.7889088894999,"d":"135"}},{"$f":"W2656/V2656*100","v":{"v":6.200374698902663,"d":"6"}},{"$f":"X2656+O2656","v":{"v":14.350331003809014,"d":"14"}},{"$f":"(V2656/M2656*100)-100","v":{"v":1.6129813827112685,"d":"2"}},null,0,2144,14,544,{"v":1158.72,"d":"1159"},{"v":1982.386147008,"d":"1982"},{"$f":"(AG2656+AG2657)/2","v":{"v":2284.7816415615,"d":"2285"}},{"$f":"SQRT((AH2656-AG2656)*(AH2656-AG2656))","v":{"v":302.3954945534997,"d":"302"}},{"$f":"AI2656/AH2656*100","v":{"v":13.235203270752475,"d":"13"}},{"$f":"AJ2656+O2656","v":{"v":21.385159575658825,"d":"21"}},{"$f":"(AH2656/M2656*100)-100","v":{"v":6.796660391843346,"d":"7"}},{"$nulls":5},"Adapter/scaffold protein",{"$nulls":7},"X",null,"KLI(pY)DFI(bA)C","Corresponds to amino acid residues K288 to I294; In the PBD domain.","Y291 phosphorylation induces activation of WASP to regulate cell cytoskeleton and cell motility. This is one of the major sites of in vivo phosphorylation of WASP(≥XXX reports from high throughput mass spectrometry studies).","Abl1; Btk; Fyn; Hck; Lck; Lyn","Adapter/scaffold protein","P42768","P42768",null,"P42768","GO:0015629; GO:0005884; GO:0005911; GO:0005829; GO:0070062; GO:0045335; GO:0012506","GO:0003779; GO:0030695; GO:0042802; GO:0043274; GO:0019901; GO:0048365; GO:0017124; GO:0031267","GO:0030048; GO:0030041; GO:0008154; GO:0007596; GO:0032488; GO:0071346; GO:0006952; GO:0016197; GO:0008544; GO:0038096; GO:0006955; GO:2000146; GO:0051497; GO:2000601; GO:0065003; GO:0008064; GO:0010591; GO:0051492; GO:0002625; GO:0042110; GO:0050852"]
[2644,1320,"PN545","WASP","Y291","Wiskott-Aldrich syndrome protein",0,2556,14,518,{"v":1316.756,"d":"1317"},{"v":2313.7337234564,"d":"2314"},{"$nulls":3},0,2267,14,518,{"v":1167.054,"d":"1167"},{"v":2039.0943713154002,"d":"2039"},{"$nulls":6},0,2605,20,585,{"v":1512.225,"d":"1512"},{"v":2587.177136115,"d":"2587"},{"$nulls":10},"Adapter/scaffold protein",{"$nulls":7},"X",null,"KLI(pY)DFI(bA)C","Corresponds to amino acid residues K288 to I294; In the PBD domain.","Y291 phosphorylation induces activation of WASP to regulate cell cytoskeleton and cell motility. This is one of the major sites of in vivo phosphorylation of WASP(≥XXX reports from high throughput mass spectrometry studies).","Abl1; Btk; Fyn; Hck; Lck; Lyn",null,"P42768","P42768",null,"P42768"]
[2645,1321,"NK185","Wee1","Pan-specific","Wee1 protein-tyrosine kinase",0,3795,8,676,{"v":2560.012,"d":"2560"},{"v":4498.3171497628,"d":"4498"},{"$f":"(L2658+L2659)/2","v":{"v":4749.63220656185,"d":"4750"}},{"$f":"SQRT((M2658-L2658)*(M2658-L2658))","v":{"v":251.31505679904967,"d":"251"}},{"$f":"N2658/M2658*100","v":{"v":5.29125300379776,"d":"5"}},0,4312,18,635,{"v":2726.69,"d":"2727"},{"v":4764.113941019,"d":"4764"},{"$f":"(U2658+U2659)/2","v":{"v":4658.9018893423,"d":"4659"}},{"$f":"SQRT((V2658-U2658)*(V2658-U2658))","v":{"v":105.21205167669996,"d":"105"}},{"$f":"W2658/V2658*100","v":{"v":2.258301509147101,"d":"2"}},{"$f":"X2658+O2658","v":{"v":7.5495545129448605,"d":"8"}},{"$f":"(V2658/M2658*100)-100","v":{"v":-1.910259853261934,"d":"-2"}},null,0,4214,14,712,{"v":2990.4,"d":"2990"},{"v":5116.10012256,"d":"5116"},{"$f":"(AG2658+AG2659)/2","v":{"v":5287.4828043843,"d":"5287"}},{"$f":"SQRT((AH2658-AG2658)*(AH2658-AG2658))","v":{"v":171.38268182429965,"d":"171"}},{"$f":"AI2658/AH2658*100","v":{"v":3.2412905755871537,"d":"3"}},{"$f":"AJ2658+O2658","v":{"v":8.532543579384914,"d":"9"}},{"$f":"(AH2658/M2658*100)-100","v":{"v":11.324047303691913,"d":"11"}},null,null,"WEE1","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","Other","WEE",{"$nulls":6},"LTVVCAAGAEPLPRNGDQWHEIRQGRLPGGC","Corresponds to amino acid residues L361 to P388; Kinase subdomain X.",null,null,"Protein kinase, Ser/Thr (non-receptor); EC 2.7.10.2; Other group; WEE family","P30291","P30291","P30291",null,"GO:0005737; GO:0005730; GO:0005654; GO:0005634","GO:0005524; GO:0016301; GO:0000287; GO:0004715; GO:0004713","GO:0051301; GO:0030010; GO:0000086; GO:0000226; GO:2000134; GO:0048812"]
[2646,1321,"NK185","Wee1","Pan-specific","Wee1 protein-tyrosine kinase",0,4185,18,683,{"v":2846.061,"d":"2846"},{"v":5000.9472633609,"d":"5001"},{"$nulls":3},0,4040,18,648,{"v":2606.256,"d":"2606"},{"v":4553.6898376656,"d":"4554"},{"$nulls":6},0,4371,18,733,{"v":3190.749,"d":"3191"},{"v":5458.8654862086,"d":"5459"},{"$nulls":7},"WEE1","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","Other","WEE",{"$nulls":6},"LTVVCAAGAEPLPRNGDQWHEIRQGRLPGGC","Corresponds to amino acid residues L361 to P388; Kinase subdomain X.",{"$nulls":3},"P30291","P30291","P30291"]
[2647,1322,"PK854","Wee1","S642","Wee1 protein-tyrosine kinase",0,7972,16,720,{"v":5728.32,"d":"5728"},{"v":10065.499730208,"d":"10065"},{"$f":"(L2660+L2661)/2","v":{"v":10203.1159611222,"d":"10203"}},{"$f":"SQRT((M2660-L2660)*(M2660-L2660))","v":{"v":137.61623091420006,"d":"138"}},{"$f":"N2660/M2660*100","v":{"v":1.3487667045887834,"d":"1"}},0,8652,20,702,{"v":6059.664,"d":"6060"},{"v":10587.536441726399,"d":"10588"},{"$f":"(U2660+U2661)/2","v":{"v":10599.165905431999,"d":"10599"}},{"$f":"SQRT((V2660-U2660)*(V2660-U2660))","v":{"v":11.629463705599846,"d":"12"}},{"$f":"W2660/V2660*100","v":{"v":0.10972055546031058,"d":"0"}},{"$f":"X2660+O2660","v":{"v":1.4584872600490941,"d":"1"}},{"$f":"(V2660/M2660*100)-100","v":{"v":3.8816567979713454,"d":"4"}},null,0,8036,19,759,{"v":6084.903,"d":"6085"},{"v":10410.303967384201,"d":"10410"},{"$f":"(AG2660+AG2661)/2","v":{"v":10517.5882653161,"d":"10518"}},{"$f":"SQRT((AH2660-AG2660)*(AH2660-AG2660))","v":{"v":107.28429793189935,"d":"107"}},{"$f":"AI2660/AH2660*100","v":{"v":1.0200465660525166,"d":"1"}},{"$f":"AJ2660+O2660","v":{"v":2.3688132706413,"d":"2"}},{"$f":"(AH2660/M2660*100)-100","v":{"v":3.0821202600476454,"d":"3"}},null,null,"WEE1","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","Other","WEE",{"$nulls":6},"RSV(pS)LTI(bA)C","Corresponds to amino acid residues R639 to I645; In the C-terminus of the kinase.","S642 phosphorylation inhibits phosphotransferase activity and induces interaction with 14-3-3. This is one of the major sites of in vivo phosphorylation of Wee1.","Akt1 (PKBa); BRSK1; BRSK2","Protein kinase, Ser/Thr (non-receptor); EC 2.7.10.2; Other group; WEE family","P30291","P30291","P30291",null,"GO:0005737; GO:0005730; GO:0005654; GO:0005634","GO:0005524; GO:0016301; GO:0000287; GO:0004715; GO:0004713","GO:0051301; GO:0030010; GO:0000086; GO:0000226; GO:2000134; GO:0048812"]
[2648,1322,"PK854","Wee1","S642","Wee1 protein-tyrosine kinase",0,8124,18,726,{"v":5884.956,"d":"5885"},{"v":10340.7321920364,"d":"10341"},{"$nulls":3},0,8849,22,688,{"v":6072.976,"d":"6073"},{"v":10610.795369137599,"d":"10611"},{"$nulls":6},0,8366,30,745,{"v":6210.32,"d":"6210"},{"v":10624.872563248,"d":"10625"},{"$nulls":7},"WEE1","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","Other","WEE",{"$nulls":6},"RSV(pS)LTI(bA)C","Corresponds to amino acid residues R639 to I645; In the C-terminus of the kinase.","S642 phosphorylation inhibits phosphotransferase activity and induces interaction with 14-3-3. This is one of the major sites of in vivo phosphorylation of Wee1.","Akt1 (PKBa); BRSK1; BRSK2",null,"P30291","P30291","P30291"]
[2649,1323,"NK252-1","WNK1","Pan-specific","Serine/threonine-protein kinase WNK1",0,9172,18,730,{"v":6682.42,"d":"6682"},{"v":11741.993587498,"d":"11742"},{"$f":"(L2662+L2663)/2","v":{"v":11974.007264174,"d":"11974"}},{"$f":"SQRT((M2662-L2662)*(M2662-L2662))","v":{"v":232.0136766760006,"d":"232"}},{"$f":"N2662/M2662*100","v":{"v":1.9376443621358164,"d":"2"}},0,10596,20,731,{"v":7731.056,"d":"7731"},{"v":13507.8177821456,"d":"13508"},{"$f":"(U2662+U2663)/2","v":{"v":13483.6363251616,"d":"13484"}},{"$f":"SQRT((V2662-U2662)*(V2662-U2662))","v":{"v":24.18145698399894,"d":"24"}},{"$f":"W2662/V2662*100","v":{"v":0.1793392850478643,"d":"0"}},{"$f":"X2662+O2662","v":{"v":2.1169836471836807,"d":"2"}},{"$f":"(V2662/M2662*100)-100","v":{"v":12.607550903233374,"d":"13"}},null,0,9138,22,779,{"v":7101.364,"d":"7101"},{"v":12149.3075276696,"d":"12149"},{"$f":"(AG2662+AG2663)/2","v":{"v":11864.8681690298,"d":"11865"}},{"$f":"SQRT((AH2662-AG2662)*(AH2662-AG2662))","v":{"v":284.43935863980005,"d":"284"}},{"$f":"AI2662/AH2662*100","v":{"v":2.3973242229716143,"d":"2"}},{"$f":"AJ2662+O2662","v":{"v":4.334968585107431,"d":"4"}},{"$f":"(AH2662/M2662*100)-100","v":{"v":-0.9114667524108029,"d":"-1"}},null,null,"WNK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"MSGGAAEKQSSTPGSC","Corresponds to amino acid residues M1 to S15; N-terminus.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; Wnk family","Q9H4A3","Q9H4A3","Q9H4A3","Q9H4A3","GO:0005737; GO:0005829; GO:0016020","GO:0005524; GO:0019869; GO:0000287; GO:0019902; GO:0019870; GO:0030295; GO:0004672; GO:0019901; GO:0004674; GO:0030291","GO:0071277; GO:1990869; GO:0038116; GO:0035556; GO:0006811; GO:0097022; GO:0033633; GO:0034260; GO:0034115; GO:1903038; GO:0090188; GO:0010923; GO:0010766; GO:0048666; GO:0018105; GO:0018107; GO:0090263; GO:0003084; GO:0010820; GO:0046777; GO:0006468; GO:0050794; GO:0002028; GO:0023016; GO:0050852"]
[2650,1323,"NK252-1","WNK1","Pan-specific","Serine/threonine-protein kinase WNK1",0,9280,18,750,{"v":6946.5,"d":"6947"},{"v":12206.02094085,"d":"12206"},{"$nulls":3},0,10376,22,744,{"v":7703.376,"d":"7703"},{"v":13459.454868177601,"d":"13459"},{"$nulls":6},0,8754,20,775,{"v":6768.85,"d":"6769"},{"v":11580.428810390002,"d":"11580"},{"$nulls":7},"WNK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"MSGGAAEKQSSTPGSC","Corresponds to amino acid residues M1 to S15; N-terminus.",{"$nulls":3},"Q9H4A3","Q9H4A3","Q9H4A3","Q9H4A3"]
[2651,1324,"NK252-3","WNK1","Pan-specific","Serine/threonine-protein kinase WNK1",0,5158,18,772,{"v":3968.08,"d":"3968"},{"v":6972.499470952,"d":"6972"},{"$f":"(L2664+L2665)/2","v":{"v":6825.883133616,"d":"6826"}},{"$f":"SQRT((M2664-L2664)*(M2664-L2664))","v":{"v":146.61633733599956,"d":"147"}},{"$f":"N2664/M2664*100","v":{"v":2.1479467852876906,"d":"2"}},0,5690,16,755,{"v":4283.87,"d":"4284"},{"v":7484.842350437,"d":"7485"},{"$f":"(U2664+U2665)/2","v":{"v":7479.2320427509,"d":"7479"}},{"$f":"SQRT((V2664-U2664)*(V2664-U2664))","v":{"v":5.610307686099986,"d":"6"}},{"$f":"W2664/V2664*100","v":{"v":0.07501181476964158,"d":"0"}},{"$f":"X2664+O2664","v":{"v":2.222958600057332,"d":"2"}},{"$f":"(V2664/M2664*100)-100","v":{"v":9.571639249393215,"d":"10"}},null,0,5204,19,824,{"v":4272.44,"d":"4272"},{"v":7309.4672310159995,"d":"7309"},{"$f":"(AG2664+AG2665)/2","v":{"v":7063.6398519327995,"d":"7064"}},{"$f":"SQRT((AH2664-AG2664)*(AH2664-AG2664))","v":{"v":245.82737908319996,"d":"246"}},{"$f":"AI2664/AH2664*100","v":{"v":3.4801799672152747,"d":"3"}},{"$f":"AJ2664+O2664","v":{"v":5.628126752502965,"d":"6"}},{"$f":"(AH2664/M2664*100)-100","v":{"v":3.483164209857307,"d":"3"}},null,null,"WNK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"CQKSISNPPGSNLRTT","Corresponds to amino acid residues Q2368 to T2382; C-terminus.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; Wnk family","Q9H4A3","Q9H4A3","Q9H4A3","Q9H4A3","GO:0005737; GO:0005829; GO:0016020","GO:0005524; GO:0019869; GO:0000287; GO:0019902; GO:0019870; GO:0030295; GO:0004672; GO:0019901; GO:0004674; GO:0030291","GO:0071277; GO:1990869; GO:0038116; GO:0035556; GO:0006811; GO:0097022; GO:0033633; GO:0034260; GO:0034115; GO:1903038; GO:0090188; GO:0010923; GO:0010766; GO:0048666; GO:0018105; GO:0018107; GO:0090263; GO:0003084; GO:0010820; GO:0046777; GO:0006468; GO:0050794; GO:0002028; GO:0023016; GO:0050852"]
[2652,1324,"NK252-3","WNK1","Pan-specific","Serine/threonine-protein kinase WNK1",0,5214,14,731,{"v":3801.2,"d":"3801"},{"v":6679.26679628,"d":"6679"},{"$nulls":3},0,5676,18,756,{"v":4277.448,"d":"4277"},{"v":7473.6217350648,"d":"7474"},{"$nulls":6},0,5176,14,772,{"v":3985.064,"d":"3985"},{"v":6817.8124728496,"d":"6818"},{"$nulls":7},"WNK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"CQKSISNPPGSNLRTT","Corresponds to amino acid residues Q2368 to T2382; C-terminus.",{"$nulls":3},"Q9H4A3","Q9H4A3","Q9H4A3","Q9H4A3"]
[2653,1325,"PK856","WNK1","T60","Serine/threonine-protein kinase WNK1",0,6306,22,730,{"v":4587.32,"d":"4587"},{"v":8060.595117307999,"d":"8061"},{"$f":"(L2666+L2667)/2","v":{"v":8188.5979975323,"d":"8189"}},{"$f":"SQRT((M2666-L2666)*(M2666-L2666))","v":{"v":128.0028802243005,"d":"128"}},{"$f":"N2666/M2666*100","v":{"v":1.563184323651927,"d":"2"}},0,6908,18,761,{"v":5243.29,"d":"5243"},{"v":9161.155461679,"d":"9161"},{"$f":"(U2666+U2667)/2","v":{"v":8952.3877182404,"d":"8952"}},{"$f":"SQRT((V2666-U2666)*(V2666-U2666))","v":{"v":208.76774343860052,"d":"209"}},{"$f":"W2666/V2666*100","v":{"v":2.331978350459938,"d":"2"}},{"$f":"X2666+O2666","v":{"v":3.895162674111865,"d":"4"}},{"$f":"(V2666/M2666*100)-100","v":{"v":9.327478537086236,"d":"9"}},null,0,6238,18,750,4665,{"v":7981.0751310000005,"d":"7981"},{"$f":"(AG2666+AG2667)/2","v":{"v":8404.3578234568,"d":"8404"}},{"$f":"SQRT((AH2666-AG2666)*(AH2666-AG2666))","v":{"v":423.28269245679894,"d":"423"}},{"$f":"AI2666/AH2666*100","v":{"v":5.036466811008511,"d":"5"}},{"$f":"AJ2666+O2666","v":{"v":6.599651134660438,"d":"7"}},{"$f":"(AH2666/M2666*100)-100","v":{"v":2.6348811602367164,"d":"3"}},null,null,"WNK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"RRH(pT)MDK(bA)C","Corresponds to amino acid residues R57 to K63; In the N-terminal portion of the protein kinase.","T60 phosphorylation stimulates phosphotransferase activity. This is one of the major sites of in vivo phosphorylation of WNK1.","Akt1 (PKBa); Akt3 (PKBg); MSK1 (RPS6KA5); SGK1","EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; Wnk family","Q9H4A3","Q9H4A3","Q9H4A3","Q9H4A3","GO:0005737; GO:0005829; GO:0016020","GO:0005524; GO:0019869; GO:0000287; GO:0019902; GO:0019870; GO:0030295; GO:0004672; GO:0019901; GO:0004674; GO:0030291","GO:0071277; GO:1990869; GO:0038116; GO:0035556; GO:0006811; GO:0097022; GO:0033633; GO:0034260; GO:0034115; GO:1903038; GO:0090188; GO:0010923; GO:0010766; GO:0048666; GO:0018105; GO:0018107; GO:0090263; GO:0003084; GO:0010820; GO:0046777; GO:0006468; GO:0050794; GO:0002028; GO:0023016; GO:0050852"]
[2654,1325,"PK856","WNK1","T60","Serine/threonine-protein kinase WNK1",0,6444,22,737,{"v":4733.014,"d":"4733"},{"v":8316.6008777566,"d":"8317"},{"$nulls":3},0,6917,24,726,{"v":5004.318,"d":"5004"},{"v":8743.6199748018,"d":"8744"},{"$nulls":6},0,6570,22,788,{"v":5159.824,"d":"5160"},{"v":8827.6405159136,"d":"8828"},{"$nulls":7},"WNK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"RRH(pT)MDK(bA)C","Corresponds to amino acid residues R57 to K63; In the N-terminal portion of the protein kinase.","T60 phosphorylation stimulates phosphotransferase activity. This is one of the major sites of in vivo phosphorylation of WNK1.","Akt1 (PKBa); Akt3 (PKBg); MSK1 (RPS6KA5); SGK1",null,"Q9H4A3","Q9H4A3","Q9H4A3","Q9H4A3"]
[2655,1326,"PK855","WNK1","S382","Serine/threonine-protein kinase WNK1",0,8590,22,774,{"v":6631.632,"d":"6632"},{"v":11652.7516107408,"d":"11653"},{"$f":"(L2668+L2669)/2","v":{"v":11733.857997350999,"d":"11734"}},{"$f":"SQRT((M2668-L2668)*(M2668-L2668))","v":{"v":81.10638661019948,"d":"81"}},{"$f":"N2668/M2668*100","v":{"v":0.6912167049278235,"d":"1"}},0,8891,22,765,{"v":6784.785,"d":"6785"},{"v":11854.4788022535,"d":"11854"},{"$f":"(U2668+U2669)/2","v":{"v":11936.31748392995,"d":"11936"}},{"$f":"SQRT((V2668-U2668)*(V2668-U2668))","v":{"v":81.8386816764505,"d":"82"}},{"$f":"W2668/V2668*100","v":{"v":0.685627554617504,"d":"1"}},{"$f":"X2668+O2668","v":{"v":1.3768442595453276,"d":"1"}},{"$f":"(V2668/M2668*100)-100","v":{"v":1.7254298341147205,"d":"2"}},null,0,9180,21,788,{"v":7217.292,"d":"7217"},{"v":12347.641949488801,"d":"12348"},{"$f":"(AG2668+AG2669)/2","v":{"v":12775.7175641277,"d":"12776"}},{"$f":"SQRT((AH2668-AG2668)*(AH2668-AG2668))","v":{"v":428.0756146388994,"d":"428"}},{"$f":"AI2668/AH2668*100","v":{"v":3.3506972308222553,"d":"3"}},{"$f":"AJ2668+O2668","v":{"v":4.041913935750079,"d":"4"}},{"$f":"(AH2668/M2668*100)-100","v":{"v":8.879087909636453,"d":"9"}},null,null,"WNK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"FAK(pS)VIG(bA)C","Corresponds to amino acid residues F379 to G385; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","S382 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of WNK1.","Wnk1 (PRKWNK1)","EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; Wnk family","Q9H4A3","Q9H4A3","Q9H4A3","Q9H4A3","GO:0005737; GO:0005829; GO:0016020","GO:0005524; GO:0019869; GO:0000287; GO:0019902; GO:0019870; GO:0030295; GO:0004672; GO:0019901; GO:0004674; GO:0030291","GO:0071277; GO:1990869; GO:0038116; GO:0035556; GO:0006811; GO:0097022; GO:0033633; GO:0034260; GO:0034115; GO:1903038; GO:0090188; GO:0010923; GO:0010766; GO:0048666; GO:0018105; GO:0018107; GO:0090263; GO:0003084; GO:0010820; GO:0046777; GO:0006468; GO:0050794; GO:0002028; GO:0023016; GO:0050852"]
[2656,1326,"PK855","WNK1","S382","Serine/threonine-protein kinase WNK1",0,8802,24,766,{"v":6723.948,"d":"6724"},{"v":11814.9643839612,"d":"11815"},{"$nulls":3},0,8890,26,776,{"v":6878.464,"d":"6878"},{"v":12018.1561656064,"d":"12018"},{"$nulls":6},0,9087,18,851,{"v":7717.719,"d":"7718"},{"v":13203.7931787666,"d":"13204"},{"$nulls":7},"WNK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"FAK(pS)VIG(bA)C","Corresponds to amino acid residues F379 to G385; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","S382 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of WNK1.","Wnk1 (PRKWNK1)",null,"Q9H4A3","Q9H4A3","Q9H4A3","Q9H4A3"]
[2657,1327,"PK857","WNK1","T2245","Serine/threonine-protein kinase WNK2",0,8808,18,848,{"v":7453.92,"d":"7454"},{"v":13097.632420848,"d":"13098"},{"$f":"(L2670+L2671)/2","v":{"v":13239.9824055108,"d":"13240"}},{"$f":"SQRT((M2670-L2670)*(M2670-L2670))","v":{"v":142.34998466280013,"d":"142"}},{"$f":"N2670/M2670*100","v":{"v":1.0751523703199986,"d":"1"}},0,8910,18,906,{"v":8056.152,"d":"8056"},{"v":14075.830422295201,"d":"14076"},{"$f":"(U2670+U2671)/2","v":{"v":13718.6105478851,"d":"13719"}},{"$f":"SQRT((V2670-U2670)*(V2670-U2670))","v":{"v":357.2198744101006,"d":"357"}},{"$f":"W2670/V2670*100","v":{"v":2.6039071024227787,"d":"3"}},{"$f":"X2670+O2670","v":{"v":3.679059472742777,"d":"4"}},{"$f":"(V2670/M2670*100)-100","v":{"v":3.6150209850360824,"d":"4"}},null,0,9094,23,948,{"v":8599.308,"d":"8599"},{"v":14712.052137751201,"d":"14712"},{"$f":"(AG2670+AG2671)/2","v":{"v":14845.843356914,"d":"14846"}},{"$f":"SQRT((AH2670-AG2670)*(AH2670-AG2670))","v":{"v":133.79121916279837,"d":"134"}},{"$f":"AI2670/AH2670*100","v":{"v":0.9012032253491963,"d":"1"}},{"$f":"AJ2670+O2670","v":{"v":1.9763555956691947,"d":"2"}},{"$f":"(AH2670/M2670*100)-100","v":{"v":12.128875267498856,"d":"12"}},null,null,"WNK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"RKG(pT)FTD(bA)C","Corresponds to amino acid residues R2242 to D2248; In the C-terminal region of WNK1. ","The effect of T2245 phosphorylation is unclear. This is the major in vivo phosphorylation sites in WNK1.",null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; Wnk family","Q9H4A3","Q9H4A3","Q9H4A3","Q9H4A3","GO:0005737; GO:0005829; GO:0016020","GO:0005524; GO:0019869; GO:0000287; GO:0019902; GO:0019870; GO:0030295; GO:0004672; GO:0019901; GO:0004674; GO:0030291","GO:0071277; GO:1990869; GO:0038116; GO:0035556; GO:0006811; GO:0097022; GO:0033633; GO:0034260; GO:0034115; GO:1903038; GO:0090188; GO:0010923; GO:0010766; GO:0048666; GO:0018105; GO:0018107; GO:0090263; GO:0003084; GO:0010820; GO:0046777; GO:0006468; GO:0050794; GO:0002028; GO:0023016; GO:0050852"]
[2658,1327,"PK857","WNK1","T2245","Serine/threonine-protein kinase WNK2",0,8748,54,876,{"v":7615.944,"d":"7616"},{"v":13382.3323901736,"d":"13382"},{"$nulls":3},0,9076,26,845,{"v":7647.25,"d":"7647"},{"v":13361.390673475,"d":"13361"},{"$nulls":6},0,9828,56,896,{"v":8755.712,"d":"8756"},{"v":14979.6345760768,"d":"14980"},{"$nulls":7},"WNK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"RKG(pT)FTD(bA)C","Corresponds to amino acid residues R2242 to D2248; In the C-terminal region of WNK1. ","The effect of T2245 phosphorylation is unclear. This is the major in vivo phosphorylation sites in WNK1.",null,null,"Q9H4A3","Q9H4A3","Q9H4A3","Q9H4A3"]
[2659,1328,"NK253-1","WNK2","Pan-specific","Serine/threonine-protein kinase WNK2",0,7943,20,918,{"v":7273.314,"d":"7273"},{"v":12780.2811478266,"d":"12780"},{"$f":"(L2672+L2673)/2","v":{"v":11650.0262758989,"d":"11650"}},{"$f":"SQRT((M2672-L2672)*(M2672-L2672))","v":{"v":1130.2548719277002,"d":"1130"}},{"$f":"N2672/M2672*100","v":{"v":9.701736675615278,"d":"10"}},0,7792,20,815,{"v":6334.18,"d":"6334"},{"v":11067.174942118001,"d":"11067"},{"$f":"(U2672+U2673)/2","v":{"v":10393.1587618514,"d":"10393"}},{"$f":"SQRT((V2672-U2672)*(V2672-U2672))","v":{"v":674.0161802666007,"d":"674"}},{"$f":"W2672/V2672*100","v":{"v":6.485190842466587,"d":"6"}},{"$f":"X2672+O2672","v":{"v":16.186927518081866,"d":"16"}},{"$f":"(V2672/M2672*100)-100","v":{"v":-10.788538019417643,"d":"-11"}},null,0,7430,22,834,{"v":6178.272,"d":"6178"},{"v":10570.0435180608,"d":"10570"},{"$f":"(AG2672+AG2673)/2","v":{"v":10477.5280585144,"d":"10478"}},{"$f":"SQRT((AH2672-AG2672)*(AH2672-AG2672))","v":{"v":92.51545954640096,"d":"93"}},{"$f":"AI2672/AH2672*100","v":{"v":0.8829893752584105,"d":"1"}},{"$f":"AJ2672+O2672","v":{"v":10.58472605087369,"d":"11"}},{"$f":"(AH2672/M2672*100)-100","v":{"v":-10.064339681448757,"d":"-10"}},null,null,"WNK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"MDGDGGRRDVPGTLMC","Corresponds to amino acid residues M1 to M15; N-terminus.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; Wnk family","Q9Y3S1","Q9Y3S1","Q9Y3S1","Q9Y3S1","GO:0005737; GO:0005829; GO:0005886","GO:0005524; GO:0004674","GO:0035556; GO:0050801; GO:0008285; GO:0070373; GO:0090263; GO:2000651; GO:0046777; GO:0006468"]
[2660,1328,"NK253-1","WNK2","Pan-specific","Serine/threonine-protein kinase WNK2",0,7288,40,826,{"v":5986.848,"d":"5987"},{"v":10519.7714039712,"d":"10520"},{"$nulls":3},0,7378,20,756,{"v":5562.648,"d":"5563"},{"v":9719.1425815848,"d":"9719"},{"$nulls":6},0,7470,22,815,{"v":6070.12,"d":"6070"},{"v":10385.012598968,"d":"10385"},{"$nulls":7},"WNK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"MDGDGGRRDVPGTLMC","Corresponds to amino acid residues M1 to M15; N-terminus.",{"$nulls":3},"Q9Y3S1","Q9Y3S1","Q9Y3S1","Q9Y3S1"]
[2661,1329,"NK253-2","WNK2","Pan-specific","Serine/threonine-protein kinase WNK2",0,2052,15,680,{"v":1385.16,"d":"1385"},{"v":2433.929600004,"d":"2434"},{"$f":"(L2674+L2675)/2","v":{"v":2474.9747944411,"d":"2475"}},{"$f":"SQRT((M2674-L2674)*(M2674-L2674))","v":{"v":41.045194437100236,"d":"41"}},{"$f":"N2674/M2674*100","v":{"v":1.6584085837677824,"d":"2"}},0,1788,14,651,{"v":1154.874,"d":"1155"},{"v":2017.8132913974,"d":"2018"},{"$f":"(U2674+U2675)/2","v":{"v":2187.4381749507,"d":"2187"}},{"$f":"SQRT((V2674-U2674)*(V2674-U2674))","v":{"v":169.62488355330015,"d":"170"}},{"$f":"W2674/V2674*100","v":{"v":7.754499555495922,"d":"8"}},{"$f":"X2674+O2674","v":{"v":9.412908139263704,"d":"9"}},{"$f":"(V2674/M2674*100)-100","v":{"v":-11.617759507540015,"d":"-12"}},null,0,2242,14,713,{"v":1588.564,"d":"1589"},{"v":2717.7810577496,"d":"2718"},{"$f":"(AG2674+AG2675)/2","v":{"v":3198.6386958406,"d":"3199"}},{"$f":"SQRT((AH2674-AG2674)*(AH2674-AG2674))","v":{"v":480.8576380909999,"d":"481"}},{"$f":"AI2674/AH2674*100","v":{"v":15.03319642560101,"d":"15"}},{"$f":"AJ2674+O2674","v":{"v":16.691605009368793,"d":"17"}},{"$f":"(AH2674/M2674*100)-100","v":{"v":29.239243285421736,"d":"29"}},null,null,"WNK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"CDEDDLKAVATSLDGR","Corresponds to amino acid residues D179 to R193.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; Wnk family","Q9Y3S1","Q9Y3S1","Q9Y3S1","Q9Y3S1","GO:0005737; GO:0005829; GO:0005886","GO:0005524; GO:0004674","GO:0035556; GO:0050801; GO:0008285; GO:0070373; GO:0090263; GO:2000651; GO:0046777; GO:0006468"]
[2662,1329,"NK253-2","WNK2","Pan-specific","Serine/threonine-protein kinase WNK2",0,1554,16,931,{"v":1431.878,"d":"1432"},{"v":2516.0199888782,"d":"2516"},{"$nulls":3},0,2062,18,660,{"v":1349.04,"d":"1349"},{"v":2357.063058504,"d":"2357"},{"$nulls":6},0,2644,18,819,{"v":2150.694,"d":"2151"},{"v":3679.4963339316,"d":"3679"},{"$nulls":7},"WNK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"CDEDDLKAVATSLDGR","Corresponds to amino acid residues D179 to R193.",{"$nulls":3},"Q9Y3S1","Q9Y3S1","Q9Y3S1","Q9Y3S1"]
[2663,1330,"NK254-1","WNK3 (PRKWNK3)","Pan-specific","Serine/threonine-protein kinase WNK3",0,7188,10,770,{"v":5527.06,"d":"5527"},{"v":9711.856345114,"d":"9712"},{"$f":"(L2676+L2677)/2","v":{"v":9725.381983376748,"d":"9725"}},{"$f":"SQRT((M2676-L2676)*(M2676-L2676))","v":{"v":13.525638262748544,"d":"14"}},{"$f":"N2676/M2676*100","v":{"v":0.13907565055920104,"d":"0"}},0,7407,20,798,{"v":5894.826,"d":"5895"},{"v":10299.5289990726,"d":"10300"},{"$f":"(U2676+U2677)/2","v":{"v":9753.0403017399,"d":"9753"}},{"$f":"SQRT((V2676-U2676)*(V2676-U2676))","v":{"v":546.4886973326993,"d":"546"}},{"$f":"W2676/V2676*100","v":{"v":5.603265037623275,"d":"6"}},{"$f":"X2676+O2676","v":{"v":5.742340688182476,"d":"6"}},{"$f":"(V2676/M2676*100)-100","v":{"v":0.2843931314001651,"d":"0"}},null,0,7370,8,865,{"v":6368.13,"d":"6368"},{"v":10894.860444582,"d":"10895"},{"$f":"(AG2676+AG2677)/2","v":{"v":10964.0579912671,"d":"10964"}},{"$f":"SQRT((AH2676-AG2676)*(AH2676-AG2676))","v":{"v":69.19754668509995,"d":"69"}},{"$f":"AI2676/AH2676*100","v":{"v":0.6311307979236882,"d":"1"}},{"$f":"AJ2676+O2676","v":{"v":0.7702064484828892,"d":"1"}},{"$f":"(AH2676/M2676*100)-100","v":{"v":12.736528087098037,"d":"13"}},null,null,"WNK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"MATDSGDPASTEDSEC","Corresponds to amino acid residues M1 to E15; N-terminus.",null,null,"Protein-serine kinase, Other group, Wnk family","Q9BYP7","Q9BYP7","Q9BYP7","Q9BYP7","GO:0005912; GO:0005923; GO:0005737; GO:0005829","GO:0005524; GO:0019869; GO:0004672; GO:0004674","GO:0035556; GO:0050801; GO:0043066; GO:0090188; GO:0051928; GO:0032414; GO:0010800; GO:1903078; GO:2000651; GO:0010765; GO:0046777; GO:0072659; GO:0006468; GO:0090279"]
[2664,1330,"NK254-1","WNK3 (PRKWNK3)","Pan-specific","Serine/threonine-protein kinase WNK3",0,7357,16,755,{"v":5542.455,"d":"5542"},{"v":9738.907621639499,"d":"9739"},{"$nulls":3},0,7294,16,724,{"v":5269.272,"d":"5269"},{"v":9206.5516044072,"d":"9207"},{"$nulls":6},0,8171,18,791,{"v":6449.023,"d":"6449"},{"v":11033.2555379522,"d":"11033"},{"$nulls":7},"WNK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"MATDSGDPASTEDSEC","Corresponds to amino acid residues M1 to E15; N-terminus.",{"$nulls":3},"Q9BYP7","Q9BYP7","Q9BYP7","Q9BYP7"]
[2665,1331,"NK254-3","WNK3 (PRKWNK3)","Pan-specific","Serine/threonine-protein kinase WNK3",0,3132,14,667,{"v":2079.706,"d":"2080"},{"v":3654.3489508114003,"d":"3654"},{"$f":"(L2678+L2679)/2","v":{"v":3960.6864270636006,"d":"3961"}},{"$f":"SQRT((M2678-L2678)*(M2678-L2678))","v":{"v":306.3374762522003,"d":"306"}},{"$f":"N2678/M2678*100","v":{"v":7.7344541632727735,"d":"8"}},0,3509,18,709,{"v":2475.119,"d":"2475"},{"v":4324.5652910969,"d":"4325"},{"$f":"(U2678+U2679)/2","v":{"v":4018.58337310185,"d":"4019"}},{"$f":"SQRT((V2678-U2678)*(V2678-U2678))","v":{"v":305.98191799505,"d":"306"}},{"$f":"W2678/V2678*100","v":{"v":7.6141736922300005,"d":"8"}},{"$f":"X2678+O2678","v":{"v":15.348627855502773,"d":"15"}},{"$f":"(V2678/M2678*100)-100","v":{"v":1.461790704829255,"d":"1"}},null,0,3176,15,765,{"v":2418.165,"d":"2418"},{"v":4137.096794031,"d":"4137"},{"$f":"(AG2678+AG2679)/2","v":{"v":4349.2744890383,"d":"4349"}},{"$f":"SQRT((AH2678-AG2678)*(AH2678-AG2678))","v":{"v":212.17769500729992,"d":"212"}},{"$f":"AI2678/AH2678*100","v":{"v":4.878461811091994,"d":"5"}},{"$f":"AJ2678+O2678","v":{"v":12.612915974364768,"d":"13"}},{"$f":"(AH2678/M2678*100)-100","v":{"v":9.811129185068907,"d":"10"}},null,null,"WNK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"CGPFQPGMNMQAFPTS","Corresponds to amino acid residues G1773 to S1787.",null,null,"Protein-serine kinase, Other group, Wnk family","Q9BYP7","Q9BYP7","Q9BYP7","Q9BYP7","GO:0005912; GO:0005923; GO:0005737; GO:0005829","GO:0005524; GO:0019869; GO:0004672; GO:0004674","GO:0035556; GO:0050801; GO:0043066; GO:0090188; GO:0051928; GO:0032414; GO:0010800; GO:1903078; GO:2000651; GO:0010765; GO:0046777; GO:0072659; GO:0006468; GO:0090279"]
[2666,1331,"NK254-3","WNK3 (PRKWNK3)","Pan-specific","Serine/threonine-protein kinase WNK3",0,3338,16,731,{"v":2428.382,"d":"2428"},{"v":4267.0239033158,"d":"4267"},{"$nulls":3},0,3273,14,652,{"v":2124.868,"d":"2125"},{"v":3712.6014551068,"d":"3713"},{"$nulls":6},0,3588,14,746,{"v":2666.204,"d":"2666"},{"v":4561.452184045601,"d":"4561"},{"$nulls":7},"WNK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"CGPFQPGMNMQAFPTS","Corresponds to amino acid residues G1773 to S1787.",{"$nulls":3},"Q9BYP7","Q9BYP7","Q9BYP7","Q9BYP7"]
[2667,1332,"NK255-1","WNK4 (PRKWNK4)","Pan-specific","Serine/threonine-protein kinase WNK4",0,11360,16,784,{"v":8893.696,"d":"8894"},{"v":15627.5303559424,"d":"15628"},{"$f":"(L2680+L2681)/2","v":{"v":15508.2552243704,"d":"15508"}},{"$f":"SQRT((M2680-L2680)*(M2680-L2680))","v":{"v":119.27513157199974,"d":"119"}},{"$f":"N2680/M2680*100","v":{"v":0.7691073550592926,"d":"1"}},0,12303,16,807,{"v":9915.609,"d":"9916"},{"v":17324.7017704959,"d":"17325"},{"$f":"(U2680+U2681)/2","v":{"v":15774.8817908486,"d":"15775"}},{"$f":"SQRT((V2680-U2680)*(V2680-U2680))","v":{"v":1549.8199796473,"d":"1550"}},{"$f":"W2680/V2680*100","v":{"v":9.82460597927516,"d":"10"}},{"$f":"X2680+O2680","v":{"v":10.593713334334453,"d":"11"}},{"$f":"(V2680/M2680*100)-100","v":{"v":1.7192557294208655,"d":"2"}},null,0,10634,16,826,{"v":8770.468,"d":"8770"},{"v":15004.879751775203,"d":"15005"},{"$f":"(AG2680+AG2681)/2","v":{"v":15000.937973189602,"d":"15001"}},{"$f":"SQRT((AH2680-AG2680)*(AH2680-AG2680))","v":{"v":3.941778585600332,"d":"4"}},{"$f":"AI2680/AH2680*100","v":{"v":0.026276880770024304,"d":"0"}},{"$f":"AJ2680+O2680","v":{"v":0.7953842358293169,"d":"1"}},{"$f":"(AH2680/M2680*100)-100","v":{"v":-3.271272260102961,"d":"-3"}},null,null,"WNK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"MLASPATETTVLMSQC","Corresponds to amino acid residues M1 to Q15; N-terminus.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; Wnk family","Q96J92","Q96J92","Q96J92","Q96J92","GO:0005923; GO:0005829; GO:0016020","GO:0005524; GO:0019869; GO:0004674","GO:0006821; GO:0072156; GO:0035556; GO:0050801; GO:0006811; GO:0090188; GO:0010766; GO:0008104; GO:0006468; GO:0050794; GO:0070294"]
[2668,1332,"NK255-1","WNK4 (PRKWNK4)","Pan-specific","Serine/threonine-protein kinase WNK4",0,11304,18,776,{"v":8757.936,"d":"8758"},{"v":15388.9800927984,"d":"15389"},{"$nulls":3},0,11035,18,739,{"v":8141.563,"d":"8142"},{"v":14225.0618112013,"d":"14225"},{"$nulls":6},0,10948,18,802,{"v":8765.86,"d":"8766"},{"v":14996.996194604002,"d":"14997"},{"$nulls":7},"WNK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"MLASPATETTVLMSQC","Corresponds to amino acid residues M1 to Q15; N-terminus.",{"$nulls":3},"Q96J92","Q96J92","Q96J92","Q96J92"]
[2669,1333,"NK255-3","WNK4 (PRKWNK4)","Pan-specific","Serine/threonine-protein kinase WNK4",0,9292,12,729,{"v":6765.12,"d":"6765"},{"v":11887.309636128,"d":"11887"},{"$f":"(L2682+L2683)/2","v":{"v":11921.468571864,"d":"11921"}},{"$f":"SQRT((M2682-L2682)*(M2682-L2682))","v":{"v":34.158935735998966,"d":"34"}},{"$f":"N2682/M2682*100","v":{"v":0.28653295128938966,"d":"0"}},0,10672,18,770,{"v":8203.58,"d":"8204"},{"v":14333.418850058,"d":"14333"},{"$f":"(U2682+U2683)/2","v":{"v":13401.332010661,"d":"13401"}},{"$f":"SQRT((V2682-U2682)*(V2682-U2682))","v":{"v":932.0868393969995,"d":"932"}},{"$f":"W2682/V2682*100","v":{"v":6.955180564555133,"d":"7"}},{"$f":"X2682+O2682","v":{"v":7.2417135158445225,"d":"7"}},{"$f":"(V2682/M2682*100)-100","v":{"v":12.413432370988616,"d":"12"}},null,0,9786,14,798,{"v":7798.056,"d":"7798"},{"v":13341.237044318399,"d":"13341"},{"$f":"(AG2682+AG2683)/2","v":{"v":12882.3414772792,"d":"12882"}},{"$f":"SQRT((AH2682-AG2682)*(AH2682-AG2682))","v":{"v":458.8955670391988,"d":"459"}},{"$f":"AI2682/AH2682*100","v":{"v":3.562206201788398,"d":"4"}},{"$f":"AJ2682+O2682","v":{"v":3.848739153077788,"d":"4"}},{"$f":"(AH2682/M2682*100)-100","v":{"v":8.06002129371015,"d":"8"}},null,null,"WNK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"CRASKGVTFAGDVGRM","Corresponds to amino acid residues R1229 to M1243; C-terminus.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; Wnk family","Q96J92","Q96J92","Q96J92","Q96J92","GO:0005923; GO:0005829; GO:0016020","GO:0005524; GO:0019869; GO:0004674","GO:0006821; GO:0072156; GO:0035556; GO:0050801; GO:0006811; GO:0090188; GO:0010766; GO:0008104; GO:0006468; GO:0050794; GO:0070294"]
[2670,1333,"NK255-3","WNK4 (PRKWNK4)","Pan-specific","Serine/threonine-protein kinase WNK4",0,9466,16,720,6804,{"v":11955.6275076,"d":"11956"},{"$nulls":3},0,9932,20,720,{"v":7136.64,"d":"7137"},{"v":12469.245171264001,"d":"12469"},{"$nulls":6},0,10034,18,725,{"v":7261.6,"d":"7262"},{"v":12423.445910240001,"d":"12423"},{"$nulls":7},"WNK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"CRASKGVTFAGDVGRM","Corresponds to amino acid residues R1229 to M1243; C-terminus.",{"$nulls":3},"Q96J92","Q96J92","Q96J92","Q96J92"]
[2671,1334,"PN732","WT1","S365","Wilms tumour protein",0,7086,14,710,{"v":5021.12,"d":"5021"},{"v":8822.845442528,"d":"8823"},{"$f":"(L2684+L2685)/2","v":{"v":8630.9351295507,"d":"8631"}},{"$f":"SQRT((M2684-L2684)*(M2684-L2684))","v":{"v":191.91031297729933,"d":"192"}},{"$f":"N2684/M2684*100","v":{"v":2.2235170360652403,"d":"2"}},0,8098,16,728,{"v":5883.696,"d":"5884"},{"v":10280.0824950096,"d":"10280"},{"$f":"(U2684+U2685)/2","v":{"v":9887.070919276,"d":"9887"}},{"$f":"SQRT((V2684-U2684)*(V2684-U2684))","v":{"v":393.0115757335989,"d":"393"}},{"$f":"W2684/V2684*100","v":{"v":3.9750051247976472,"d":"4"}},{"$f":"X2684+O2684","v":{"v":6.198522160862888,"d":"6"}},{"$f":"(V2684/M2684*100)-100","v":{"v":14.553878239966451,"d":"15"}},null,0,6987,15,728,{"v":5075.616,"d":"5076"},{"v":8683.5739833024,"d":"8684"},{"$f":"(AG2684+AG2685)/2","v":{"v":9220.4360146224,"d":"9220"}},{"$f":"SQRT((AH2684-AG2684)*(AH2684-AG2684))","v":{"v":536.8620313200008,"d":"537"}},{"$f":"AI2684/AH2684*100","v":{"v":5.82252325669424,"d":"6"}},{"$f":"AJ2684+O2684","v":{"v":8.04604029275948,"d":"8"}},{"$f":"(AH2684/M2684*100)-100","v":{"v":6.830092872015214,"d":"7"}},{"$nulls":5},"Transcription protein, coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"CERRF(pS)RSD","Corresponds to amino acid residues S360 to D368. Sequence is almost identical to S393.","The effect of S365 phosphorylation is unclear. In vivo phosphorylation of WT1 has not been reported for this phosphosite (0 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in fish. A nearly identical amino acid sequence surrounds S393.","PKACa (PRKACA)","Transcription protein","P19544","P19544",null,"P19544","GO:0005737; GO:0005829; GO:0016607; GO:0005730; GO:0005654; GO:0005634","GO:0070742; GO:0003700; GO:0010385; GO:0044729; GO:0003723; GO:0000981; GO:0043565; GO:0001077; GO:0044212; GO:0008270","GO:0035802; GO:0030325; GO:0001658; GO:0043010; GO:0060923; GO:0071320; GO:0071371; GO:0060539; GO:0030855; GO:0007281; GO:0032836; GO:0072112; GO:0032835; GO:0008406; GO:0007507; GO:0001822; GO:0030539; GO:0008584; GO:0060231; GO:0072207; GO:0072075; GO:0072284; GO:0043066; GO:0030308; GO:0008285; GO:2000195; GO:0072302; GO:0045892; GO:0000122; GO:0017148; GO:0043065; GO:0060421; GO:2000020; GO:2001076; GO:0045893; GO:0072166; GO:0003156; GO:0006355; GO:0006357; GO:0008380; GO:0007530; GO:0007356; GO:0009888; GO:0001657; GO:0001570; GO:0061032"]
[2672,1334,"PN732","WT1","S365","Wilms tumour protein",0,7017,16,686,{"v":4802.686,"d":"4803"},{"v":8439.0248165734,"d":"8439"},{"$nulls":3},0,7920,22,688,{"v":5433.824,"d":"5434"},{"v":9494.0593435424,"d":"9494"},{"$nulls":6},0,7272,16,786,{"v":5703.216,"d":"5703"},{"v":9757.298045942402,"d":"9757"},{"$nulls":10},"Transcription protein, coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"CERRF(pS)RSD","Corresponds to amino acid residues S360 to D368. Sequence is almost identical to S393.","The effect of S365 phosphorylation is unclear. In vivo phosphorylation of WT1 has not been reported for this phosphosite (0 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in fish. A nearly identical amino acid sequence surrounds S393.","PKACa (PRKACA)",null,"P19544","P19544",null,"P19544"]
[2673,1335,"PN681","YAP1","S109","Yorkie homologue",0,6782,14,741,{"v":5015.088,"d":"5015"},{"v":8812.2463324272,"d":"8812"},{"$f":"(L2686+L2687)/2","v":{"v":8013.1240366576,"d":"8013"}},{"$f":"SQRT((M2686-L2686)*(M2686-L2686))","v":{"v":799.1222957695991,"d":"799"}},{"$f":"N2686/M2686*100","v":{"v":9.972668488767404,"d":"10"}},0,9689,14,780,{"v":7546.5,"d":"7547"},{"v":13185.35875215,"d":"13185"},{"$f":"(U2686+U2687)/2","v":{"v":12041.8099636302,"d":"12042"}},{"$f":"SQRT((V2686-U2686)*(V2686-U2686))","v":{"v":1143.5487885198,"d":"1144"}},{"$f":"W2686/V2686*100","v":{"v":9.496485926730722,"d":"9"}},{"$f":"X2686+O2686","v":{"v":19.469154415498124,"d":"19"}},{"$f":"(V2686/M2686*100)-100","v":{"v":50.27609592142326,"d":"50"}},null,0,6457,17,758,{"v":4881.52,"d":"4882"},{"v":8351.506510928,"d":"8352"},{"$f":"(AG2686+AG2687)/2","v":{"v":8213.2842125392,"d":"8213"}},{"$f":"SQRT((AH2686-AG2686)*(AH2686-AG2686))","v":{"v":138.22229838880048,"d":"138"}},{"$f":"AI2686/AH2686*100","v":{"v":1.6829114251005324,"d":"2"}},{"$f":"AJ2686+O2686","v":{"v":11.655579913867935,"d":"12"}},{"$f":"(AH2686/M2686*100)-100","v":{"v":2.497904374946984,"d":"2"}},{"$nulls":5},"Transcription,  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"SRQA(pS)TDAGC","Corresponds to amino acid residues S105 to G113.","S109 phosphorylation promotes nuclear export. This is one of the major sites of in vivo phosphorylation of YAP1.","LATS1; LATS2 (KPM)","Transcription, coactivator/corepressor","P46937","P46937",null,"P46937","GO:0005737; GO:0005829; GO:0016020; GO:0005654; GO:0005634; GO:0071148; GO:0071149","GO:0033613; GO:0003682; GO:0070064; GO:0008022; GO:0046982; GO:0000978; GO:0003713; GO:0003714; GO:0001076; GO:0044212","GO:0060449; GO:0061026; GO:0000902; GO:0008283; GO:0006974; GO:0071480; GO:0071300; GO:0060242; GO:0003143; GO:0003015; GO:0035329; GO:0030216; GO:0048368; GO:0060487; GO:0030857; GO:2001237; GO:2000737; GO:0030903; GO:0048339; GO:0090263; GO:0060045; GO:0033148; GO:1902459; GO:0045893; GO:0045944; GO:0050847; GO:0065003; GO:1902036; GO:0010837; GO:0072307; GO:0050767; GO:0072091; GO:0032570; GO:0035019; GO:0001894; GO:0006367; GO:0001570"]
[2674,1335,"PN681","YAP1","S109","Yorkie homologue",0,5564,16,740,{"v":4105.52,"d":"4106"},{"v":7214.001740888,"d":"7214"},{"$nulls":3},0,8590,22,728,{"v":6237.504,"d":"6238"},{"v":10898.2611751104,"d":"10898"},{"$nulls":6},0,6362,18,744,{"v":4719.936,"d":"4720"},{"v":8075.061914150399,"d":"8075"},{"$nulls":10},"Transcription,  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"SRQA(pS)TDAGC","Corresponds to amino acid residues S105 to G113.","S109 phosphorylation promotes nuclear export. This is one of the major sites of in vivo phosphorylation of YAP1.","LATS1; LATS2 (KPM)",null,"P46937","P46937",null,"P46937"]
[2675,1336,"PN682","YAP1","T119","Yorkie homologue",0,10815,20,737,{"v":7955.915,"d":"7956"},{"v":13979.7113789135,"d":"13980"},{"$f":"(L2688+L2689)/2","v":{"v":13451.37684188875,"d":"13451"}},{"$f":"SQRT((M2688-L2688)*(M2688-L2688))","v":{"v":528.3345370247498,"d":"528"}},{"$f":"N2688/M2688*100","v":{"v":3.92773574954402,"d":"4"}},0,11890,20,766,{"v":9092.42,"d":"9092"},{"v":15886.413519542,"d":"15886"},{"$f":"(U2688+U2689)/2","v":{"v":15386.185836412,"d":"15386"}},{"$f":"SQRT((V2688-U2688)*(V2688-U2688))","v":{"v":500.2276831300005,"d":"500"}},{"$f":"W2688/V2688*100","v":{"v":3.2511480652091986,"d":"3"}},{"$f":"X2688+O2688","v":{"v":7.178883814753219,"d":"7"}},{"$f":"(V2688/M2688*100)-100","v":{"v":14.383724560433748,"d":"14"}},null,0,10128,26,823,{"v":8313.946,"d":"8314"},{"v":14223.8430141644,"d":"14224"},{"$f":"(AG2688+AG2689)/2","v":{"v":14110.4929280488,"d":"14110"}},{"$f":"SQRT((AH2688-AG2688)*(AH2688-AG2688))","v":{"v":113.35008611560079,"d":"113"}},{"$f":"AI2688/AH2688*100","v":{"v":0.8033035181236212,"d":"1"}},{"$f":"AJ2688+O2688","v":{"v":4.731039267667641,"d":"5"}},{"$f":"(AH2688/M2688*100)-100","v":{"v":4.899989747573684,"d":"5"}},{"$nulls":5},"Transcription,  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"CAGAL(pT)PQHV","Corresponds to amino acid residues C115 to V123.","The effect of T119 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of YAP1.","ERK1 (MAPK3); JNK1 (MAPK8); JNK2 (MAPK9)","Transcription, coactivator/corepressor","P46937","P46937",null,"P46937","GO:0005737; GO:0005829; GO:0016020; GO:0005654; GO:0005634; GO:0071148; GO:0071149","GO:0033613; GO:0003682; GO:0070064; GO:0008022; GO:0046982; GO:0000978; GO:0003713; GO:0003714; GO:0001076; GO:0044212","GO:0060449; GO:0061026; GO:0000902; GO:0008283; GO:0006974; GO:0071480; GO:0071300; GO:0060242; GO:0003143; GO:0003015; GO:0035329; GO:0030216; GO:0048368; GO:0060487; GO:0030857; GO:2001237; GO:2000737; GO:0030903; GO:0048339; GO:0090263; GO:0060045; GO:0033148; GO:1902459; GO:0045893; GO:0045944; GO:0050847; GO:0065003; GO:1902036; GO:0010837; GO:0072307; GO:0050767; GO:0072091; GO:0032570; GO:0035019; GO:0001894; GO:0006367; GO:0001570"]
[2676,1336,"PN682","YAP1","T119","Yorkie homologue",0,9798,18,752,{"v":7354.56,"d":"7355"},{"v":12923.042304864,"d":"12923"},{"$nulls":3},0,11456,20,745,{"v":8519.82,"d":"8520"},{"v":14885.958153282,"d":"14886"},{"$nulls":6},0,10032,18,817,{"v":8181.438,"d":"8181"},{"v":13997.1428419332,"d":"13997"},{"$nulls":10},"Transcription,  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"CAGAL(pT)PQHV","Corresponds to amino acid residues C115 to V123.","The effect of T119 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of YAP1.","ERK1 (MAPK3); JNK1 (MAPK8); JNK2 (MAPK9)",null,"P46937","P46937",null,"P46937"]
[2677,1337,"PN683","YAP1","S127","Yorkie homologue",0,9921,18,752,{"v":7447.056,"d":"7447"},{"v":13085.571364526399,"d":"13086"},{"$f":"(L2690+L2691)/2","v":{"v":12157.3058001944,"d":"12157"}},{"$f":"SQRT((M2690-L2690)*(M2690-L2690))","v":{"v":928.2655643319995,"d":"928"}},{"$f":"N2690/M2690*100","v":{"v":7.635454594858972,"d":"8"}},0,11068,18,754,{"v":8331.7,"d":"8332"},{"v":14557.272048670002,"d":"14557"},{"$f":"(U2690+U2691)/2","v":{"v":14296.618132014251,"d":"14297"}},{"$f":"SQRT((V2690-U2690)*(V2690-U2690))","v":{"v":260.65391665575044,"d":"261"}},{"$f":"W2690/V2690*100","v":{"v":1.8231858349218346,"d":"2"}},{"$f":"X2690+O2690","v":{"v":9.458640429780807,"d":"9"}},{"$f":"(V2690/M2690*100)-100","v":{"v":17.596927863619612,"d":"18"}},null,0,9868,18,807,{"v":7948.95,"d":"7949"},{"v":13599.39274653,"d":"13599"},{"$f":"(AG2690+AG2691)/2","v":{"v":12537.789995209001,"d":"12538"}},{"$f":"SQRT((AH2690-AG2690)*(AH2690-AG2690))","v":{"v":1061.6027513209992,"d":"1062"}},{"$f":"AI2690/AH2690*100","v":{"v":8.467223902511238,"d":"8"}},{"$f":"AJ2690+O2690","v":{"v":16.10267849737021,"d":"16"}},{"$f":"(AH2690/M2690*100)-100","v":{"v":3.1296752855268153,"d":"3"}},{"$nulls":5},"Transcription,  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"VRAH(pS)SPA(bA)C","Corresponds to amino acid residues V123 to A130.","S127 phosphorylation facilitates cytoplasmic retention with binding to the 14-3-3 protein YWHAB, and increased interaction with and transcriptional coactivity towards ERBB4. This is one of the major sites of in vivo phosphorylation of YAP1.","Akt1 (PKBa); LATS1; LATS2 (KPM); MST2 (CLIK1; STK3)","Transcription, coactivator/corepressor","P46937","P46937",null,"P46937","GO:0005737; GO:0005829; GO:0016020; GO:0005654; GO:0005634; GO:0071148; GO:0071149","GO:0033613; GO:0003682; GO:0070064; GO:0008022; GO:0046982; GO:0000978; GO:0003713; GO:0003714; GO:0001076; GO:0044212","GO:0060449; GO:0061026; GO:0000902; GO:0008283; GO:0006974; GO:0071480; GO:0071300; GO:0060242; GO:0003143; GO:0003015; GO:0035329; GO:0030216; GO:0048368; GO:0060487; GO:0030857; GO:2001237; GO:2000737; GO:0030903; GO:0048339; GO:0090263; GO:0060045; GO:0033148; GO:1902459; GO:0045893; GO:0045944; GO:0050847; GO:0065003; GO:1902036; GO:0010837; GO:0072307; GO:0050767; GO:0072091; GO:0032570; GO:0035019; GO:0001894; GO:0006367; GO:0001570"]
[2678,1337,"PN683","YAP1","S127","Yorkie homologue",0,8514,16,752,{"v":6390.496,"d":"6390"},{"v":11229.0402358624,"d":"11229"},{"$nulls":3},0,10803,20,745,{"v":8033.335,"d":"8033"},{"v":14035.964215358501,"d":"14036"},{"$nulls":6},0,8798,18,764,{"v":6707.92,"d":"6708"},{"v":11476.187243888,"d":"11476"},{"$nulls":10},"Transcription,  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"VRAH(pS)SPA(bA)C","Corresponds to amino acid residues V123 to A130.","S127 phosphorylation facilitates cytoplasmic retention with binding to the 14-3-3 protein YWHAB, and increased interaction with and transcriptional coactivity towards ERBB4. This is one of the major sites of in vivo phosphorylation of YAP1.","Akt1 (PKBa); LATS1; LATS2 (KPM); MST2 (CLIK1; STK3)",null,"P46937","P46937",null,"P46937"]
[2679,1338,"NK186","Yes","Pan-specific","Yamaguchi sarcoma proto-oncogene-encoded tyrosine kinase",0,348,26,617,{"v":198.674,"d":"199"},{"v":349.09940321060003,"d":"349"},{"$f":"(L2692+L2693)/2","v":{"v":324.55908960520003,"d":"325"}},{"$f":"SQRT((M2692-L2692)*(M2692-L2692))","v":{"v":24.5403136054,"d":"25"}},{"$f":"N2692/M2692*100","v":{"v":7.56112350304264,"d":"8"}},0,390,22,588,{"v":216.384,"d":"216"},{"v":378.06939219839995,"d":"378"},{"$f":"(U2692+U2693)/2","v":{"v":342.3755349205,"d":"342"}},{"$f":"SQRT((V2692-U2692)*(V2692-U2692))","v":{"v":35.69385727789995,"d":"36"}},{"$f":"W2692/V2692*100","v":{"v":10.42535275956213,"d":"10"}},{"$f":"X2692+O2692","v":{"v":17.98647626260477,"d":"18"}},{"$f":"(V2692/M2692*100)-100","v":{"v":5.489430395239353,"d":"5"}},null,0,428,26,620,{"v":249.24,"d":"249"},{"v":426.41011053600005,"d":"426"},{"$f":"(AG2692+AG2693)/2","v":{"v":414.5899073034,"d":"415"}},{"$f":"SQRT((AH2692-AG2692)*(AH2692-AG2692))","v":{"v":11.820203232600022,"d":"12"}},{"$f":"AI2692/AH2692*100","v":{"v":2.8510590886019584,"d":"3"}},{"$f":"AJ2692+O2692","v":{"v":10.412182591644598,"d":"10"}},{"$f":"(AH2692/M2692*100)-100","v":{"v":27.739422675764587,"d":"28"}},null,null,"Yes","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"Epitope undefined.",{"$nulls":3},"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; Src family","P07947","P07947","P07947","P07947","GO:0005884; GO:0005829; GO:0070062; GO:0031234; GO:0005925; GO:0098978; GO:0005794; GO:0005815; GO:0005886; GO:0099091","GO:0005524; GO:0019899; GO:0005154; GO:0044325; GO:0004715; GO:0001784; GO:0004713; GO:0005102","GO:0030154; GO:0016477; GO:0006464; GO:0036120; GO:0071300; GO:0071560; GO:0048013; GO:0038096; GO:0045087; GO:0050900; GO:0038083; GO:0050731; GO:0045944; GO:0042127; GO:0010827; GO:0043114; GO:0031295; GO:0007169"]
[2680,1338,"NK186","Yes","Pan-specific","Yamaguchi sarcoma proto-oncogene-encoded tyrosine kinase",0,308,22,597,{"v":170.742,"d":"171"},{"v":300.01877599979997,"d":"300"},{"$nulls":3},0,340,26,559,{"v":175.526,"d":"176"},{"v":306.68167764260005,"d":"307"},{"$nulls":6},0,427,58,638,{"v":235.422,"d":"235"},{"v":402.7697040708,"d":"403"},{"$nulls":7},"Yes","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"Epitope undefined.",{"$nulls":4},"P07947","P07947","P07947","P07947"]
[2681,1339,"PK858","Yes","Y222+Y223","Yamaguchi sarcoma proto-oncogene-encoded tyrosine kinase",0,8263,72,823,{"v":6741.193,"d":"6741"},{"v":11845.2663822517,"d":"11845"},{"$f":"(L2694+L2695)/2","v":{"v":11289.764597006051,"d":"11290"}},{"$f":"SQRT((M2694-L2694)*(M2694-L2694))","v":{"v":555.5017852456494,"d":"556"}},{"$f":"N2694/M2694*100","v":{"v":4.9204018425057665,"d":"5"}},0,9788,58,803,{"v":7813.19,"d":"7813"},{"v":13651.323547168999,"d":"13651"},{"$f":"(U2694+U2695)/2","v":{"v":12991.2693627665,"d":"12991"}},{"$f":"SQRT((V2694-U2694)*(V2694-U2694))","v":{"v":660.0541844024992,"d":"660"}},{"$f":"W2694/V2694*100","v":{"v":5.0807520494821015,"d":"5"}},{"$f":"X2694+O2694","v":{"v":10.001153891987869,"d":"10"}},{"$f":"(V2694/M2694*100)-100","v":{"v":15.0712156231466,"d":"15"}},null,0,8105,64,861,{"v":6923.301,"d":"6923"},{"v":11844.669975461402,"d":"11845"},{"$f":"(AG2694+AG2695)/2","v":{"v":11676.977578536902,"d":"11677"}},{"$f":"SQRT((AH2694-AG2694)*(AH2694-AG2694))","v":{"v":167.69239692449992,"d":"168"}},{"$f":"AI2694/AH2694*100","v":{"v":1.4360941930104434,"d":"1"}},{"$f":"AJ2694+O2694","v":{"v":6.35649603551621,"d":"6"}},{"$f":"(AH2694/M2694*100)-100","v":{"v":3.4297701976313704,"d":"3"}},null,null,"Yes","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"NGG(pY)(pY)ITT(bA)C","Corresponds to amino acid residues N219 to T226; In the SH2 domain. ","The effects of Y222 and Y223 phosphorylation are unclear. These are two of the major in vivo phosphorylation sites in Yes (Y222 has >1799 reports; Y223 has > 670 reports).",null,"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; Src family","P07947","P07947","P07947","P07947","GO:0005884; GO:0005829; GO:0070062; GO:0031234; GO:0005925; GO:0098978; GO:0005794; GO:0005815; GO:0005886; GO:0099091","GO:0005524; GO:0019899; GO:0005154; GO:0044325; GO:0004715; GO:0001784; GO:0004713; GO:0005102","GO:0030154; GO:0016477; GO:0006464; GO:0036120; GO:0071300; GO:0071560; GO:0048013; GO:0038096; GO:0045087; GO:0050900; GO:0038083; GO:0050731; GO:0045944; GO:0042127; GO:0010827; GO:0043114; GO:0031295; GO:0007169"]
[2682,1339,"PK858","Yes","Y222+Y223","Yamaguchi sarcoma proto-oncogene-encoded tyrosine kinase",0,8232,65,748,{"v":6108.916,"d":"6109"},{"v":10734.2628117604,"d":"10734"},{"$nulls":3},0,9760,92,730,{"v":7057.64,"d":"7058"},{"v":12331.215178364,"d":"12331"},{"$nulls":6},0,8792,134,777,{"v":6727.266,"d":"6727"},{"v":11509.2851816124,"d":"11509"},{"$nulls":7},"Yes","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"NGG(pY)(pY)ITT(bA)C","Corresponds to amino acid residues N219 to T226; In the SH2 domain. ","The effects of Y222 and Y223 phosphorylation are unclear. These are two of the major in vivo phosphorylation sites in Yes (Y222 has >1799 reports; Y223 has > 670 reports).",null,null,"P07947","P07947","P07947","P07947"]
[2683,1340,"NK214","YSK1 (STK25, SOK1)","Pan-specific","Protein-serine/threonine kinase 25",0,470,12,725,{"v":332.05,"d":"332"},{"v":583.460628145,"d":"583"},{"$f":"(L2696+L2697)/2","v":{"v":561.6544351160001,"d":"562"}},{"$f":"SQRT((M2696-L2696)*(M2696-L2696))","v":{"v":21.806193028999928,"d":"22"}},{"$f":"N2696/M2696*100","v":{"v":3.8824928044049427,"d":"4"}},0,516,14,649,{"v":325.798,"d":"326"},{"v":569.2391851498,"d":"569"},{"$f":"(U2696+U2697)/2","v":{"v":556.8706494569001,"d":"557"}},{"$f":"SQRT((V2696-U2696)*(V2696-U2696))","v":{"v":12.368535692899968,"d":"12"}},{"$f":"W2696/V2696*100","v":{"v":2.221078755894685,"d":"2"}},{"$f":"X2696+O2696","v":{"v":6.103571560299628,"d":"6"}},{"$f":"(V2696/M2696*100)-100","v":{"v":-0.8517311286096998,"d":"-1"}},null,0,474,10,738,{"v":342.432,"d":"342"},{"v":585.8468422848,"d":"586"},{"$f":"(AG2696+AG2697)/2","v":{"v":626.6264578952,"d":"627"}},{"$f":"SQRT((AH2696-AG2696)*(AH2696-AG2696))","v":{"v":40.779615610400015,"d":"41"}},{"$f":"AI2696/AH2696*100","v":{"v":6.507803029475687,"d":"7"}},{"$f":"AJ2696+O2696","v":{"v":10.390295833880629,"d":"10"}},{"$f":"(AH2696/M2696*100)-100","v":{"v":11.567971107676044,"d":"12"}},null,null,"YSK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","YSK",{"$nulls":5},"Epitope undefined.",{"$nulls":3},"Protein-serine kinase, STE group, STE20 family, YSK subfamily","O00506","O00506","O00506","O00506","GO:0005737; GO:0070062; GO:0000139","GO:0005524; GO:0008349; GO:0046872; GO:0042803; GO:0004672","GO:0051683; GO:0007163; GO:0051645; GO:0090168; GO:0036481; GO:0048812; GO:0050772; GO:0032874; GO:0046777; GO:0006468; GO:0042981; GO:0007346; GO:0042542; GO:0006979; GO:0007165"]
[2684,1340,"NK214","YSK1 (STK25, SOK1)","Pan-specific","Protein-serine/threonine kinase 25",0,486,24,665,{"v":307.23,"d":"307"},{"v":539.848242087,"d":"540"},{"$nulls":3},0,506,16,636,{"v":311.64,"d":"312"},{"v":544.502113764,"d":"545"},{"$nulls":6},0,594,22,682,{"v":390.104,"d":"390"},{"v":667.4060735056,"d":"667"},{"$nulls":7},"YSK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","YSK",{"$nulls":5},"Epitope undefined.",{"$nulls":4},"O00506","O00506","O00506","O00506"]
[2685,1341,"PK859","YSK1 (STK25, SOK1)","T174","Serine/threonine-protein kinase 25",0,12567,20,814,{"v":10213.258,"d":"10213"},{"v":17946.1946336002,"d":"17946"},{"$f":"(L2698+L2699)/2","v":{"v":15510.9489305681,"d":"15511"}},{"$f":"SQRT((M2698-L2698)*(M2698-L2698))","v":{"v":2435.2457030321,"d":"2435"}},{"$f":"N2698/M2698*100","v":{"v":15.700172271425997,"d":"16"}},0,14328,22,779,{"v":11144.374,"d":"11144"},{"v":19471.6185328474,"d":"19472"},{"$f":"(U2698+U2699)/2","v":{"v":16439.3634183145,"d":"16439"}},{"$f":"SQRT((V2698-U2698)*(V2698-U2698))","v":{"v":3032.255114532898,"d":"3032"}},{"$f":"W2698/V2698*100","v":{"v":18.445088397734256,"d":"18"}},{"$f":"X2698+O2698","v":{"v":34.14526066916025,"d":"34"}},{"$f":"(V2698/M2698*100)-100","v":{"v":5.985542805293704,"d":"6"}},null,0,10846,20,836,{"v":9050.536,"d":"9051"},{"v":15484.031680990402,"d":"15484"},{"$f":"(AG2698+AG2699)/2","v":{"v":14801.648901869201,"d":"14802"}},{"$f":"SQRT((AH2698-AG2698)*(AH2698-AG2698))","v":{"v":682.3827791212007,"d":"682"}},{"$f":"AI2698/AH2698*100","v":{"v":4.610180822725954,"d":"5"}},{"$f":"AJ2698+O2698","v":{"v":20.31035309415195,"d":"20"}},{"$f":"(AH2698/M2698*100)-100","v":{"v":-4.572899001047261,"d":"-5"}},null,null,"YSK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","YSK",{"$nulls":5},"KRN(pT)FVG(bA)C","Corresponds to amino acid residues K171 to G177; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T174 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of YSK1.",null,"Protein-serine kinase, STE group, STE20 family, YSK subfamily","O00506","O00506","O00506","O00506","GO:0005737; GO:0070062; GO:0000139","GO:0005524; GO:0008349; GO:0046872; GO:0042803; GO:0004672","GO:0051683; GO:0007163; GO:0051645; GO:0090168; GO:0036481; GO:0048812; GO:0050772; GO:0032874; GO:0046777; GO:0006468; GO:0042981; GO:0007346; GO:0042542; GO:0006979; GO:0007165"]
[2686,1341,"PK859","YSK1 (STK25, SOK1)","T174","Serine/threonine-protein kinase 25",0,10076,20,740,{"v":7441.44,"d":"7441"},{"v":13075.703227536,"d":"13076"},{"$nulls":3},0,10650,22,722,{"v":7673.416,"d":"7673"},{"v":13407.1083037816,"d":"13407"},{"$nulls":6},0,10810,22,765,{"v":8252.82,"d":"8253"},{"v":14119.266122748,"d":"14119"},{"$nulls":7},"YSK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","YSK",{"$nulls":5},"KRN(pT)FVG(bA)C","Corresponds to amino acid residues K171 to G177; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T174 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of YSK1.",null,null,"O00506","O00506","O00506","O00506"]
[2687,1342,"NK256-2","YSK4 (MAP3K19)","Pan-specific","SPS1/STE20-related protein kinase YSK4; Mitogen-activated protein kinase kinase kinase 8",0,4926,14,716,{"v":3516.992,"d":"3517"},{"v":6179.871590124801,"d":"6180"},{"$f":"(L2700+L2701)/2","v":{"v":6689.4793340628,"d":"6689"}},{"$f":"SQRT((M2700-L2700)*(M2700-L2700))","v":{"v":509.60774393799966,"d":"510"}},{"$f":"N2700/M2700*100","v":{"v":7.61804795992237,"d":"8"}},0,5022,16,699,{"v":3499.194,"d":"3499"},{"v":6113.8445946294,"d":"6114"},{"$f":"(U2700+U2701)/2","v":{"v":6269.3956605522,"d":"6269"}},{"$f":"SQRT((V2700-U2700)*(V2700-U2700))","v":{"v":155.55106592280026,"d":"156"}},{"$f":"W2700/V2700*100","v":{"v":2.481117389057872,"d":"2"}},{"$f":"X2700+O2700","v":{"v":10.099165348980241,"d":"10"}},{"$f":"(V2700/M2700*100)-100","v":{"v":-6.279766369432309,"d":"-6"}},null,0,5648,16,790,{"v":4449.28,"d":"4449"},{"v":7612.012424192,"d":"7612"},{"$f":"(AG2700+AG2701)/2","v":{"v":7949.6863238342,"d":"7950"}},{"$f":"SQRT((AH2700-AG2700)*(AH2700-AG2700))","v":{"v":337.6738996422,"d":"338"}},{"$f":"AI2700/AH2700*100","v":{"v":4.2476380310731185,"d":"4"}},{"$f":"AJ2700+O2700","v":{"v":11.865685990995487,"d":"12"}},{"$f":"(AH2700/M2700*100)-100","v":{"v":18.838640899216657,"d":"19"}},null,null,"YSK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"CSALQLLKHSFLERSH","Corresponds to amino acid residues S1314 to H1328; Kinase last alpha-chain + C-terminus.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE11 family","Q56UN5","Q56UN5","Q56UN5",null,"GO:0005737","GO:0005524; GO:0004674","GO:0032147; GO:0042981; GO:0007346; GO:0023014; GO:0031098"]
[2688,1342,"NK256-2","YSK4 (MAP3K19)","Pan-specific","SPS1/STE20-related protein kinase YSK4; Mitogen-activated protein kinase kinase kinase 8",0,5506,14,746,{"v":4097.032,"d":"4097"},{"v":7199.0870780008,"d":"7199"},{"$nulls":3},0,4917,14,750,{"v":3677.25,"d":"3677"},{"v":6424.946726475,"d":"6425"},{"$nulls":6},0,5771,18,842,{"v":4844.026,"d":"4844"},{"v":8287.3602234764,"d":"8287"},{"$nulls":7},"YSK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"CSALQLLKHSFLERSH","Corresponds to amino acid residues S1314 to H1328; Kinase last alpha-chain + C-terminus.",{"$nulls":3},"Q56UN5","Q56UN5","Q56UN5"]
[2689,1343,"NK256-3","YSK4 (MAP3K19)","Pan-specific","SPS1/STE20-related protein kinase YSK4; Mitogen-activated protein kinase kinase kinase 8",0,4558,14,718,{"$f":"(H2702-I2702)*J2702/1000","v":{"v":3262.592,"d":"3263"}},{"v":5732.8534187648,"d":"5733"},{"$f":"(L2702+L2703)/2","v":{"v":5347.0612739884,"d":"5347"}},{"$f":"SQRT((M2702-L2702)*(M2702-L2702))","v":{"v":385.79214477640016,"d":"386"}},{"$f":"N2702/M2702*100","v":{"v":7.215031304263246,"d":"7"}},0,4926,18,719,{"$f":"(Q2702-R2702)*S2702/1000","v":{"v":3528.852,"d":"3529"}},{"v":6165.6635000651995,"d":"6166"},{"$f":"(U2702+U2703)/2","v":{"v":5804.6941020505,"d":"5805"}},{"$f":"SQRT((V2702-U2702)*(V2702-U2702))","v":{"v":360.96939801469944,"d":"361"}},{"$f":"W2702/V2702*100","v":{"v":6.218577442128906,"d":"6"}},{"$f":"X2702+O2702","v":{"v":13.433608746392153,"d":"13"}},{"$f":"(V2702/M2702*100)-100","v":{"v":8.558585821492741,"d":"9"}},null,0,4172,14,738,{"$f":"(AC2702-AD2702)*AE2702/1000","v":{"v":3068.604,"d":"3069"}},{"v":5249.8947634056,"d":"5250"},{"$f":"(AG2702+AG2703)/2","v":{"v":5322.927161088801,"d":"5323"}},{"$f":"SQRT((AH2702-AG2702)*(AH2702-AG2702))","v":{"v":73.03239768320054,"d":"73"}},{"$f":"AI2702/AH2702*100","v":{"v":1.3720345117076864,"d":"1"}},{"$f":"AJ2702+O2702","v":{"v":8.587065815970933,"d":"9"}},{"$f":"(AH2702/M2702*100)-100","v":{"v":-0.4513528396804247,"d":"-0"}},null,null,"YSK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"CHGSKTRKPEEENSQY","Corresponds to amino acid residues C350 to Y366.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE11 family","Q56UN5","Q56UN5","Q56UN5",null,"GO:0005737","GO:0005524; GO:0004674","GO:0032147; GO:0042981; GO:0007346; GO:0023014; GO:0031098"]
[2690,1343,"NK256-3","YSK4 (MAP3K19)","Pan-specific","SPS1/STE20-related protein kinase YSK4; Mitogen-activated protein kinase kinase kinase 8",0,3974,14,713,{"v":2823.48,"d":"2823"},{"v":4961.269129212,"d":"4961"},{"$nulls":3},0,4532,10,689,{"v":3115.658,"d":"3116"},{"v":5443.7247040358,"d":"5444"},{"$nulls":6},0,4415,10,716,{"v":3153.98,"d":"3154"},{"v":5395.9595587720005,"d":"5396"},{"$nulls":7},"YSK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"CHGSKTRKPEEENSQY","Corresponds to amino acid residues C350 to Y366.",{"$nulls":3},"Q56UN5","Q56UN5","Q56UN5"]
[2691,1344,"NK187-2","ZAP70","Pan-specific","Zeta-chain (TCR) associated protein-tyrosine kinase, 70 kDa",0,230,10,623,{"v":137.06,"d":"137"},{"v":240.83455411399999,"d":"241"},{"$f":"(L2704+L2705)/2","v":{"v":246.91428238799998,"d":"247"}},{"$f":"SQRT((M2704-L2704)*(M2704-L2704))","v":{"v":6.07972827399999,"d":"6"}},{"$f":"N2704/M2704*100","v":{"v":2.4622829490463953,"d":"2"}},0,259,14,673,{"v":164.885,"d":"165"},{"v":288.0895617635,"d":"288"},{"$f":"(U2704+U2705)/2","v":{"v":290.65709435295,"d":"291"}},{"$f":"SQRT((V2704-U2704)*(V2704-U2704))","v":{"v":2.5675325894500247,"d":"3"}},{"$f":"W2704/V2704*100","v":{"v":0.883354523021628,"d":"1"}},{"$f":"X2704+O2704","v":{"v":3.3456374720680233,"d":"3"}},{"$f":"(V2704/M2704*100)-100","v":{"v":17.715788467923787,"d":"18"}},null,0,232,10,632,{"v":140.304,"d":"140"},{"v":240.0378917856,"d":"240"},{"$f":"(AG2704+AG2705)/2","v":{"v":270.809085206,"d":"271"}},{"$f":"SQRT((AH2704-AG2704)*(AH2704-AG2704))","v":{"v":30.77119342040001,"d":"31"}},{"$f":"AI2704/AH2704*100","v":{"v":11.362688735864555,"d":"11"}},{"$f":"AJ2704+O2704","v":{"v":13.82497168491095,"d":"14"}},{"$f":"(AH2704/M2704*100)-100","v":{"v":9.677367622036485,"d":"10"}},null,null,"ZAP70","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Syk",{"$nulls":6},"Epitope undefined.",{"$nulls":3},"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; Syk family","P43403","P43403","P43403",null,"GO:0005911; GO:0005737; GO:0005829; GO:0031234; GO:0001772; GO:0005886; GO:0042101","GO:0005524; GO:0004715; GO:0001784; GO:0004713; GO:0005102","GO:0002250; GO:0042113; GO:0043366; GO:0006955; GO:0045087; GO:0035556; GO:0045060; GO:0038083; GO:0018108; GO:0046638; GO:0046641; GO:0050850; GO:0045582; GO:0045059; GO:0006468; GO:0042127; GO:0042110; GO:0070489; GO:0030217; GO:0072678; GO:0050852; GO:0007169"]
[2692,1344,"NK187-2","ZAP70","Pan-specific","Zeta-chain (TCR) associated protein-tyrosine kinase, 70 kDa",0,244,14,626,{"v":143.98,"d":"144"},{"v":252.99401066199997,"d":"253"},{"$nulls":3},0,284,12,617,{"v":167.824,"d":"168"},{"v":293.22462694240005,"d":"293"},{"$nulls":6},0,264,10,694,{"v":176.276,"d":"176"},{"v":301.5802786264,"d":"302"},{"$nulls":7},"ZAP70","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Syk",{"$nulls":6},"Epitope undefined.",{"$nulls":4},"P43403","P43403","P43403"]
[2693,1345,"NK187","ZAP70","Pan-specific","Zeta-chain (TCR) associated protein-tyrosine kinase, 70 kDa",1,44,10,651,{"v":22.134,"d":"22"},{"$f":"K2706*1.7571469","v":{"v":38.8926894846,"d":"39"}},{"$f":"(L2706+L2707)/2","v":{"v":37.6644438015,"d":"38"}},{"$f":"SQRT((M2706-L2706)*(M2706-L2706))","v":{"v":1.228245683099999,"d":"1"}},{"$f":"N2706/M2706*100","v":{"v":3.26102169349195,"d":"3"}},1,276,6,400,108,{"$f":"T2706*1.7472151","v":{"v":188.6992308,"d":"189"}},{"$f":"(U2706+U2707)/2","v":{"v":170.0022820149,"d":"170"}},{"$f":"SQRT((V2706-U2706)*(V2706-U2706))","v":{"v":18.696948785100005,"d":"19"}},{"$f":"W2706/V2706*100","v":{"v":10.998057533993158,"d":"11"}},{"$f":"X2706+O2706","v":{"v":14.259079227485108,"d":"14"}},{"$f":"(V2706/M2706*100)-100","v":{"v":351.36012869551416,"d":"351"}},null,1,51,10,667,{"v":27.347,"d":"27"},{"v":46.78637976580001,"d":"47"},{"$f":"(AG2706+AG2707)/2","v":{"v":95.9003592563,"d":"96"}},{"$f":"SQRT((AH2706-AG2706)*(AH2706-AG2706))","v":{"v":49.1139794905,"d":"49"}},{"$f":"AI2706/AH2706*100","v":{"v":51.213551097592514,"d":"51"}},{"$f":"AJ2706+O2706","v":{"v":54.47457279108446,"d":"54"}},{"$f":"(AH2706/M2706*100)-100","v":{"v":154.61774973159365,"d":"155"}},null,null,"ZAP70","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Syk",{"$nulls":6},"Epitope undefined.",{"$nulls":3},"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; Syk family","P43403","P43403","P43403",null,"GO:0005911; GO:0005737; GO:0005829; GO:0031234; GO:0001772; GO:0005886; GO:0042101","GO:0005524; GO:0004715; GO:0001784; GO:0004713; GO:0005102","GO:0002250; GO:0042113; GO:0043366; GO:0006955; GO:0045087; GO:0035556; GO:0045060; GO:0038083; GO:0018108; GO:0046638; GO:0046641; GO:0050850; GO:0045582; GO:0045059; GO:0006468; GO:0042127; GO:0042110; GO:0070489; GO:0030217; GO:0072678; GO:0050852; GO:0007169"]
[2694,1345,"NK187","ZAP70","Pan-specific","Zeta-chain (TCR) associated protein-tyrosine kinase, 70 kDa",0,46,14,648,{"v":20.736,"d":"21"},{"v":36.4361981184,"d":"36"},{"$nulls":3},0,316,10,283,{"v":86.598,"d":"87"},{"v":151.3053332298,"d":"151"},{"$nulls":6},0,287,10,306,{"v":84.762,"d":"85"},{"$f":"AF2707*1.7108414","v":{"v":145.0143387468,"d":"145"}},{"$nulls":7},"ZAP70","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Syk",{"$nulls":6},"Epitope undefined.",{"$nulls":4},"P43403","P43403","P43403"]
[2695,1346,"PK860","ZAP70","Y248","Zeta-chain (TCR) associated protein-tyrosine kinase, 70 kDa",0,168,10,572,{"v":90.376,"d":"90"},{"v":158.8039082344,"d":"159"},{"$f":"(L2708+L2709)/2","v":{"v":159.65173161364999,"d":"160"}},{"$f":"SQRT((M2708-L2708)*(M2708-L2708))","v":{"v":0.8478233792499736,"d":"1"}},{"$f":"N2708/M2708*100","v":{"v":0.5310455268356675,"d":"1"}},0,204,12,586,{"v":112.512,"d":"113"},{"v":196.5826653312,"d":"197"},{"$f":"(U2708+U2709)/2","v":{"v":185.5647269106,"d":"186"}},{"$f":"SQRT((V2708-U2708)*(V2708-U2708))","v":{"v":11.01793842059999,"d":"11"}},{"$f":"W2708/V2708*100","v":{"v":5.937517654369804,"d":"6"}},{"$f":"X2708+O2708","v":{"v":6.468563181205472,"d":"6"}},{"$f":"(V2708/M2708*100)-100","v":{"v":16.230951606374248,"d":"16"}},null,0,206,14,618,{"v":118.656,"d":"119"},{"v":203.00159715840002,"d":"203"},{"$f":"(AG2708+AG2709)/2","v":{"v":211.30602131400002,"d":"211"}},{"$f":"SQRT((AH2708-AG2708)*(AH2708-AG2708))","v":{"v":8.304424155600003,"d":"8"}},{"$f":"AI2708/AH2708*100","v":{"v":3.9300461501093036,"d":"4"}},{"$f":"AJ2708+O2708","v":{"v":4.461091676944971,"d":"4"}},{"$f":"(AH2708/M2708*100)-100","v":{"v":32.35435605881875,"d":"32"}},null,null,"ZAP70","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Syk",{"$nulls":6},"GLI(pY)CLK(bA)C","Corresponds to amino acid residues G245 to K251; In the intervening region between the SH2 and kinase catalytic domains. ","The effect of Y248 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in ZAP70 (≥344 reports).",null,"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; Syk family","P43403","P43403","P43403",null,"GO:0005911; GO:0005737; GO:0005829; GO:0031234; GO:0001772; GO:0005886; GO:0042101","GO:0005524; GO:0004715; GO:0001784; GO:0004713; GO:0005102","GO:0002250; GO:0042113; GO:0043366; GO:0006955; GO:0045087; GO:0035556; GO:0045060; GO:0038083; GO:0018108; GO:0046638; GO:0046641; GO:0050850; GO:0045582; GO:0045059; GO:0006468; GO:0042127; GO:0042110; GO:0070489; GO:0030217; GO:0072678; GO:0050852; GO:0007169"]
[2696,1346,"PK860","ZAP70","Y248","Zeta-chain (TCR) associated protein-tyrosine kinase, 70 kDa",0,213,14,459,{"v":91.341,"d":"91"},{"v":160.4995549929,"d":"160"},{"$nulls":3},0,241,16,444,{"v":99.9,"d":"100"},{"v":174.54678849,"d":"175"},{"$nulls":6},0,244,16,563,{"v":128.364,"d":"128"},{"v":219.61044546960002,"d":"220"},{"$nulls":7},"ZAP70","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Syk",{"$nulls":6},"GLI(pY)CLK(bA)C","Corresponds to amino acid residues G245 to K251; In the intervening region between the SH2 and kinase catalytic domains. ","The effect of Y248 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in ZAP70 (≥344 reports).",null,null,"P43403","P43403","P43403"]
[2697,1347,"PK861","ZAP70","Y292","Zeta-chain (TCR) associated protein-tyrosine kinase, 70 kDa",0,2297,14,690,{"v":1575.27,"d":"1575"},{"v":2767.980797163,"d":"2768"},{"$f":"(L2710+L2711)/2","v":{"v":2844.3235585272996,"d":"2844"}},{"$f":"SQRT((M2710-L2710)*(M2710-L2710))","v":{"v":76.3427613642998,"d":"76"}},{"$f":"N2710/M2710*100","v":{"v":2.6840392730786107,"d":"3"}},0,2468,16,697,{"v":1709.044,"d":"1709"},{"v":2986.0674833644002,"d":"2986"},{"$f":"(U2710+U2711)/2","v":{"v":3003.4033515866004,"d":"3003"}},{"$f":"SQRT((V2710-U2710)*(V2710-U2710))","v":{"v":17.335868222200133,"d":"17"}},{"$f":"W2710/V2710*100","v":{"v":0.5772074607642079,"d":"1"}},{"$f":"X2710+O2710","v":{"v":3.2612467338428184,"d":"3"}},{"$f":"(V2710/M2710*100)-100","v":{"v":5.59288666658118,"d":"6"}},null,0,2328,16,684,{"v":1581.408,"d":"1581"},{"v":2705.5382766912,"d":"2706"},{"$f":"(AG2710+AG2711)/2","v":{"v":2940.0450182306,"d":"2940"}},{"$f":"SQRT((AH2710-AG2710)*(AH2710-AG2710))","v":{"v":234.50674153940008,"d":"235"}},{"$f":"AI2710/AH2710*100","v":{"v":7.976297644603167,"d":"8"}},{"$f":"AJ2710+O2710","v":{"v":10.660336917681779,"d":"11"}},{"$f":"(AH2710/M2710*100)-100","v":{"v":3.36535059157832,"d":"3"}},null,null,"ZAP70","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Syk",{"$nulls":6},"SDG(pY)TPE(bA)C","Corresponds to amino acid residues S289 to E295; In the region between the SH2 domain and the protein kinase catalytic domain.","Phosphorylation of Y292 Inhibits phosphotransferase activity, and regulates cell adhesion, cell growth, intracellular location, protein degradation and molecular association, including inducing interaction with Cbl. This is one of the major in vivo phosphorylation sites of ZAP70 by mass spectrometry studies (≥448 reports).","Lck; ZAP70","Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; Syk family","P43403","P43403","P43403",null,"GO:0005911; GO:0005737; GO:0005829; GO:0031234; GO:0001772; GO:0005886; GO:0042101","GO:0005524; GO:0004715; GO:0001784; GO:0004713; GO:0005102","GO:0002250; GO:0042113; GO:0043366; GO:0006955; GO:0045087; GO:0035556; GO:0045060; GO:0038083; GO:0018108; GO:0046638; GO:0046641; GO:0050850; GO:0045582; GO:0045059; GO:0006468; GO:0042127; GO:0042110; GO:0070489; GO:0030217; GO:0072678; GO:0050852; GO:0007169"]
[2698,1347,"PK861","ZAP70","Y292","Zeta-chain (TCR) associated protein-tyrosine kinase, 70 kDa",0,2684,16,623,{"v":1662.164,"d":"1662"},{"v":2920.6663198916,"d":"2921"},{"$nulls":3},0,3032,20,574,{"v":1728.888,"d":"1729"},{"v":3020.7392198088,"d":"3021"},{"$nulls":6},0,2968,18,629,{"v":1855.55,"d":"1856"},{"v":3174.55175977,"d":"3175"},{"$nulls":7},"ZAP70","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Syk",{"$nulls":6},"SDG(pY)TPE(bA)C","Corresponds to amino acid residues S289 to E295; In the region between the SH2 domain and the protein kinase catalytic domain.","Phosphorylation of Y292 Inhibits phosphotransferase activity, and regulates cell adhesion, cell growth, intracellular location, protein degradation and molecular association, including inducing interaction with Cbl. This is one of the major in vivo phosphorylation sites of ZAP70 by mass spectrometry studies (≥448 reports).","Lck; ZAP70",null,"P43403","P43403","P43403"]
[2699,1348,"PK862","ZAP70","Y319","Zeta-chain (TCR) associated protein-tyrosine kinase, 70 kDa",0,6120,14,798,{"v":4872.588,"d":"4873"},{"v":8561.8528991772,"d":"8562"},{"$f":"(L2712+L2713)/2","v":{"v":8504.7175105768,"d":"8505"}},{"$f":"SQRT((M2712-L2712)*(M2712-L2712))","v":{"v":57.13538860039989,"d":"57"}},{"$f":"N2712/M2712*100","v":{"v":0.6718081879773676,"d":"1"}},0,6888,18,866,{"v":5949.42,"d":"5949"},{"v":10394.916460242,"d":"10395"},{"$f":"(U2712+U2713)/2","v":{"v":9406.9414514413,"d":"9407"}},{"$f":"SQRT((V2712-U2712)*(V2712-U2712))","v":{"v":987.9750088007004,"d":"988"}},{"$f":"W2712/V2712*100","v":{"v":10.502616752752576,"d":"11"}},{"$f":"X2712+O2712","v":{"v":11.174424940729944,"d":"11"}},{"$f":"(V2712/M2712*100)-100","v":{"v":10.60851156716798,"d":"11"}},null,0,6208,20,787,{"v":4869.956,"d":"4870"},{"v":8331.7223409784,"d":"8332"},{"$f":"(AG2712+AG2713)/2","v":{"v":8601.4245117986,"d":"8601"}},{"$f":"SQRT((AH2712-AG2712)*(AH2712-AG2712))","v":{"v":269.70217082019917,"d":"270"}},{"$f":"AI2712/AH2712*100","v":{"v":3.1355523779839944,"d":"3"}},{"$f":"AJ2712+O2712","v":{"v":3.8073605659613623,"d":"4"}},{"$f":"(AH2712/M2712*100)-100","v":{"v":1.1370983351478827,"d":"1"}},null,null,"ZAP70","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Syk",{"$nulls":6},"ESP(pY)SDP(bA)C","Corresponds to amino acid residues E316 to P322; In the region between the SH2 and kinase catalytic domains.","Y319 phosphorylation stimulates phosphotransferase activity and regulates intracellular location, transcription and molecular association, including inducing interaction with Lck and PLCG1. This is one of the major in vivo phosphorylation sites of ZAP70 by mass spectrometry studies (≥259 reports).","Abl1; ZAP70","Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; Syk family","P43403","P43403","P43403",null,"GO:0005911; GO:0005737; GO:0005829; GO:0031234; GO:0001772; GO:0005886; GO:0042101","GO:0005524; GO:0004715; GO:0001784; GO:0004713; GO:0005102","GO:0002250; GO:0042113; GO:0043366; GO:0006955; GO:0045087; GO:0035556; GO:0045060; GO:0038083; GO:0018108; GO:0046638; GO:0046641; GO:0050850; GO:0045582; GO:0045059; GO:0006468; GO:0042127; GO:0042110; GO:0070489; GO:0030217; GO:0072678; GO:0050852; GO:0007169"]
[2700,1348,"PK862","ZAP70","Y319","Zeta-chain (TCR) associated protein-tyrosine kinase, 70 kDa",0,6286,18,767,{"v":4807.556,"d":"4808"},{"v":8447.582121976398,"d":"8448"},{"$nulls":3},0,6558,20,737,{"v":4818.506,"d":"4819"},{"v":8418.9664426406,"d":"8419"},{"$nulls":6},0,6615,18,786,{"v":5185.242,"d":"5185"},{"v":8871.1266826188,"d":"8871"},{"$nulls":7},"ZAP70","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Syk",{"$nulls":6},"ESP(pY)SDP(bA)C","Corresponds to amino acid residues E316 to P322; In the region between the SH2 and kinase catalytic domains.","Y319 phosphorylation stimulates phosphotransferase activity and regulates intracellular location, transcription and molecular association, including inducing interaction with Lck and PLCG1. This is one of the major in vivo phosphorylation sites of ZAP70 by mass spectrometry studies (≥259 reports).","Abl1; ZAP70",null,"P43403","P43403","P43403"]
[2701,1349,"PK863","ZAP70","Y492+Y493","Zeta-chain (TCR) associated protein-tyrosine kinase, 70 kDa",0,8282,18,810,{"v":6693.84,"d":"6694"},{"v":11762.060205096,"d":"11762"},{"$f":"(L2714+L2715)/2","v":{"v":11655.492759904799,"d":"11655"}},{"$f":"SQRT((M2714-L2714)*(M2714-L2714))","v":{"v":106.56744519120184,"d":"107"}},{"$f":"N2714/M2714*100","v":{"v":0.9143109380823147,"d":"1"}},0,9411,22,891,{"v":8365.599,"d":"8366"},{"v":14616.5008933449,"d":"14617"},{"$f":"(U2714+U2715)/2","v":{"v":13253.15681328285,"d":"13253"}},{"$f":"SQRT((V2714-U2714)*(V2714-U2714))","v":{"v":1363.3440800620501,"d":"1363"}},{"$f":"W2714/V2714*100","v":{"v":10.286938419800869,"d":"10"}},{"$f":"X2714+O2714","v":{"v":11.201249357883183,"d":"11"}},{"$f":"(V2714/M2714*100)-100","v":{"v":13.707391753303284,"d":"14"}},null,0,8618,28,578,{"v":4965.02,"d":"4965"},{"v":8494.361767828,"d":"8494"},{"$f":"(AG2714+AG2715)/2","v":{"v":11226.900543494,"d":"11227"}},{"$f":"SQRT((AH2714-AG2714)*(AH2714-AG2714))","v":{"v":2732.538775666,"d":"2733"}},{"$f":"AI2714/AH2714*100","v":{"v":24.339208894564486,"d":"24"}},{"$f":"AJ2714+O2714","v":{"v":25.253519832646802,"d":"25"}},{"$f":"(AH2714/M2714*100)-100","v":{"v":-3.677169427663898,"d":"-4"}},null,null,"ZAP70","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Syk",{"$nulls":6},"DDS(pY)(pY)TAR(bA)C","Corresponds to amino acid residues D489 to R496; In the protein kinase catalytic domain.","Y492+Y493 phosphorylation inhibits phosphotransferase activity and regulates transcription. This is one of the major sites of in vivo phosphorylation of ZAP70.","Y492: Lck; ZAP70. Y493: Lck; ZAP70.","Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; Syk family","P43403","P43403","P43403",null,"GO:0005911; GO:0005737; GO:0005829; GO:0031234; GO:0001772; GO:0005886; GO:0042101","GO:0005524; GO:0004715; GO:0001784; GO:0004713; GO:0005102","GO:0002250; GO:0042113; GO:0043366; GO:0006955; GO:0045087; GO:0035556; GO:0045060; GO:0038083; GO:0018108; GO:0046638; GO:0046641; GO:0050850; GO:0045582; GO:0045059; GO:0006468; GO:0042127; GO:0042110; GO:0070489; GO:0030217; GO:0072678; GO:0050852; GO:0007169"]
[2702,1349,"PK863","ZAP70","Y492+Y493","Zeta-chain (TCR) associated protein-tyrosine kinase, 70 kDa",0,8584,26,768,{"v":6572.544,"d":"6573"},{"v":11548.925314713599,"d":"11549"},{"$nulls":3},0,8816,24,774,{"v":6805.008,"d":"6805"},{"v":11889.8127332208,"d":"11890"},{"$nulls":6},0,9090,24,900,{"v":8159.4,"d":"8159"},{"v":13959.43931916,"d":"13959"},{"$nulls":7},"ZAP70","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Syk",{"$nulls":6},"DDS(pY)(pY)TAR(bA)C","Corresponds to amino acid residues D489 to R496; In the protein kinase catalytic domain.","Y492+Y493 phosphorylation inhibits phosphotransferase activity and regulates transcription. This is one of the major sites of in vivo phosphorylation of ZAP70.","Y492: Lck; ZAP70. Y493: Lck; ZAP70.",null,"P43403","P43403","P43403"]
[2703,1350,"NK301-1","ZC2 (TNIK)","Pan-specific","TRAF2 and NCK-interacting kinase",0,1279,16,709,{"v":895.467,"d":"895"},{"v":1573.4670631023,"d":"1573"},{"$f":"(L2716+L2717)/2","v":{"v":1404.63072464235,"d":"1405"}},{"$f":"SQRT((M2716-L2716)*(M2716-L2716))","v":{"v":168.83633845994996,"d":"169"}},{"$f":"N2716/M2716*100","v":{"v":12.01998044738338,"d":"12"}},0,1320,18,744,{"v":968.688,"d":"969"},{"v":1692.5063007888,"d":"1693"},{"$f":"(U2716+U2717)/2","v":{"v":1471.5831818995,"d":"1472"}},{"$f":"SQRT((V2716-U2716)*(V2716-U2716))","v":{"v":220.92311888929999,"d":"221"}},{"$f":"W2716/V2716*100","v":{"v":15.012615094182808,"d":"15"}},{"$f":"X2716+O2716","v":{"v":27.032595541566188,"d":"27"}},{"$f":"(V2716/M2716*100)-100","v":{"v":4.766552239144389,"d":"5"}},null,0,1066,20,674,{"v":705.004,"d":"705"},{"v":1206.1500303656,"d":"1206"},{"$f":"(AG2716+AG2717)/2","v":{"v":1300.744162213,"d":"1301"}},{"$f":"SQRT((AH2716-AG2716)*(AH2716-AG2716))","v":{"v":94.59413184739992,"d":"95"}},{"$f":"AI2716/AH2716*100","v":{"v":7.272308774883427,"d":"7"}},{"$f":"AJ2716+O2716","v":{"v":19.29228922226681,"d":"19"}},{"$f":"(AH2716/M2716*100)-100","v":{"v":-7.396005270766224,"d":"-7"}},null,null,"ZC2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","MSN",{"$nulls":5},"CGSSQVFFMTLNRNSMMNW","Corresponds to amino acid residues G1343 to W1360; C-terminus.",null,null,"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE20 family; MSN subfamily","Q9UKE5","Q9UKE5","Q9UKE5",null,"GO:0016324; GO:0005737; GO:0005856; GO:0005829; GO:0070062; GO:0098978; GO:0005654; GO:0005634; GO:0099092; GO:0098793; GO:0055037","GO:0005524; GO:0008349; GO:0004672; GO:0004674","GO:0031532; GO:0007256; GO:0007010; GO:0035556; GO:0030033; GO:0001934; GO:0046777; GO:0072659; GO:0006468; GO:0042981; GO:0048814; GO:0007346; GO:0016055"]
[2704,1350,"NK301-1","ZC2 (TNIK)","Pan-specific","TRAF2 and NCK-interacting kinase",0,1021,22,704,{"v":703.296,"d":"703"},{"v":1235.7943861824,"d":"1236"},{"$nulls":3},0,1154,16,629,{"v":715.802,"d":"716"},{"v":1250.6600630102,"d":"1251"},{"$nulls":6},0,1102,16,751,{"v":815.586,"d":"816"},{"v":1395.3382940604001,"d":"1395"},{"$nulls":7},"ZC2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","MSN",{"$nulls":5},"CGSSQVFFMTLNRNSMMNW","Corresponds to amino acid residues G1343 to W1360; C-terminus.",{"$nulls":3},"Q9UKE5","Q9UKE5","Q9UKE5"]
[]
[{"$nulls":6},"Heading","Signal Median","Background Median","Spot Area","Not Normalized Net Signal","Normalized Net Signal","Average Normalized Net Signal","Error in Duplicate from Average","% Error in Duplicate from Average","Heading","Signal Median","Background Median","Spot Area","Not Normalized Net Signal","Normalized Net Signal","Average Normalized Net Signal","Error in Duplicate from Average","% Error in Duplicate from Average","SUM % Error ","%CFC",null,"Heading","Signal Median","Background Median","Spot Area","Not Normalized Net Signal","Normalized Net Signal","Average Normalized Net Signal","Error in Duplicate from Average","% Error in Duplicate from Average","SUM % Error ","%CFC"]
[{"$nulls":6},"Average",{"$f":"AVERAGE(H18:H2717)","v":{"v":4457.432592592592,"d":"4457"}},{"v":15.185555555555556,"d":"15"},{"v":635.282962962963,"d":"635"},{"v":3161.691011111117,"d":"3162"},{"v":5555.555558931755,"d":"5556"},{"$f":"AVERAGE(M18:M2717)","v":{"v":5555.555558931753,"d":"5556"}},{"v":342.0394733162652,"d":"342"},{"v":9.610824481606633,"d":"10"},"Average",{"$f":"AVERAGE(Q18:Q2717)","v":{"v":4640.1381481481485,"d":"4640"}},{"v":15.555555555555555,"d":"16"},{"v":608.4081481481481,"d":"608"},{"v":3179.6631203703705,"d":"3180"},{"v":5555.555416824218,"d":"5556"},{"v":5555.555416824234,"d":"5556"},{"v":392.2883186314219,"d":"392"},{"v":11.29734133295137,"d":"11"},{"v":20.908165814558025,"d":"21"},{"v":13.237855102728998,"d":"13"},null,"Average",{"$f":"AVERAGE(AC18:AC2717)","v":{"v":4614.155925925926,"d":"4614"}},{"v":15.305185185185184,"d":"15"},{"v":626.1103703703703,"d":"626"},{"v":3247.2650888888897,"d":"3247"},{"v":5555.55555084578,"d":"5556"},{"$f":"AVERAGE(AH18:AH2717)","v":{"v":5555.555550845793,"d":"5556"}},{"$f":"AVERAGE(AI18:AI2717)","v":{"v":288.39332475261756,"d":"288"}},{"v":8.17027113734777,"d":"8"},{"v":17.78109561895437,"d":"18"},{"v":9.855299997957799,"d":"10"}]
[{"$nulls":6},"Median",{"$f":"MEDIAN(H18:H2717)","v":{"v":3480.5,"d":"3481"}},14,654,{"v":2317.62,"d":"2318"},{"v":4072.398798378,"d":"4072"},{"v":4192.2744349030745,"d":"4192"},{"v":115.34175823634939,"d":"115"},{"v":5.146774293582057,"d":"5"},"Median",{"$f":"MEDIAN(Q18:Q2717)","v":3592},16,629,{"v":2231.6634999999997,"d":"2232"},{"v":3899.19616531885,"d":"3899"},{"v":4042.8478228031,"d":"4043"},{"v":162.08958163077477,"d":"162"},{"v":6.568361183031017,"d":"7"},{"v":13.4330288688297,"d":"13"},{"v":-1.3732325526330769,"d":"-1"},null,"Median",{"$f":"MEDIAN(AC18:AC2717)","v":3742},14,649,{"v":2452.2105,"d":"2452"},{"v":4195.3432449147,"d":"4195"},{"v":4254.78942333015,"d":"4255"},{"v":110.6837397936998,"d":"111"},{"v":4.607436197635783,"d":"5"},{"v":10.895699381546912,"d":"11"},{"v":2.586641634552997,"d":"3"}]
[{"$nulls":6},"Max",{"$f":"MAX(H18:H2717)","v":20338},466,1123,{"v":22799.146,"d":"22799"},{"v":40061.4487165474,"d":"40061"},{"v":38219.37187828279,"d":"38219"},{"v":7869.454434672899,"d":"7869"},{"v":94.95167234545579,"d":"95"},"Max",{"$f":"MAX(Q18:Q2717)","v":20948},198,1124,{"v":21862.563,"d":"21863"},{"v":38198.6001983013,"d":"38199"},{"v":38093.84853780345,"d":"38094"},{"v":10055.263086447301,"d":"10055"},{"v":94.45430912213281,"d":"94"},{"v":182.3858992421243,"d":"182"},{"v":16155.73206981302,"d":"16156"},null,"Max",{"$f":"MAX(AC18:AC2717)","v":20100},140,1137,{"v":22421.64,"d":"22422"},{"v":38359.869967896004,"d":"38360"},{"v":36176.63788389361,"d":"36177"},{"v":5604.518824218299,"d":"5605"},{"v":99.38340207468607,"d":"99"},{"v":193.62123943505952,"d":"194"},{"v":6241.984322352112,"d":"6242"}]
[{"$nulls":6},"Min",{"$f":"MIN(H18:H2717)","v":4},2,103,{"v":1.512,"d":"2"},{"v":2.6568061128,"d":"3"},{"v":3.8586945924,"d":"4"},{"v":0.06852872909999963,"d":"0"},{"v":0.01781629264329135,"d":"0"},"Min",{"$f":"MIN(Q18:Q2717)","v":6},2,106,{"v":2.172,"d":"2"},{"v":3.7949511972000005,"d":"4"},{"v":7.0901988758000005,"d":"7"},{"v":0.05765809829999924,"d":"0"},{"v":0.021331776487891557,"d":"0"},{"v":0.06910137726611777,"d":"0"},{"v":-98.36960201610962,"d":"-98"},null,"Min",{"$f":"MIN(AC18:AC2717)","v":6},2,105,{"v":2.538,"d":"3"},{"v":4.3421154732,"d":"4"},{"v":5.7946198218,"d":"6"},{"v":0.022240938200013716,"d":"0"},{"v":0.004986654138802907,"d":"0"},{"v":0.25260748451120096,"d":"0"},{"v":-96.47542082267205,"d":"-96"}]
[{"$nulls":6},"Sum",{"$f":"SUM(H18:H2717)","v":12035068},41001,1715264,{"v":8536565.730000015,"d":"8536566"},{"v":15000000.009115737,"d":"15000000"},{"$f":"SUM(M18:M2717)","v":{"v":7500000.004557867,"d":"7500000"}},{"v":461753.288976958,"d":"461753"},{"v":12974.613050168953,"d":"12975"},"Sum",{"$f":"SUM(Q18:Q2717)","v":12528373},42000,{"$f":"SUM(S18:S2717)","v":1642702},{"v":8585090.425,"d":"8585090"},{"v":14999999.625425387,"d":"15000000"},{"v":7499999.812712717,"d":"7500000"},{"v":529589.2301524195,"d":"529589"},{"v":15251.41079948435,"d":"15251"},{"v":28226.023849653335,"d":"28226"},{"v":17871.104388684147,"d":"17871"},null,"Sum",{"$f":"SUM(AC18:AC2717)","v":12458221},41324,1690498,{"v":8767615.740000002,"d":"8767616"},{"v":14999999.987283606,"d":"15000000"},{"$f":"SUM(AH18:AH2717)","v":{"v":7499999.993641821,"d":"7500000"}},{"$f":"SUM(AI18:AI2717)","v":{"v":389330.9884160337,"d":"389331"}},{"v":11029.866035419489,"d":"11030"},{"v":24004.4790855884,"d":"24004"},{"$f":"SUM(AL18:AL2717)","v":{"v":13304.65499724303,"d":"13305"}}]
[]
[{"$nulls":9},"Desired Sum",15000000,{"$nulls":7},"Desired Sum",15000000,{"$nulls":10},"Desired Sum",15000000]
[{"$nulls":9},"Scalar",{"$f":"K2726/K2724","v":{"v":1.7571468989321508,"d":"1.7571469"}},{"$nulls":7},"Scalar",{"$f":"T2726/T2724","v":{"v":1.7472151436308254,"d":"1.7472151"}},{"$nulls":10},"Scalar",{"$f":"AF2726/AF2724","v":{"v":1.7108414014503783,"d":"1.7108414"}}]

{"sheet":"Protein+Antibody Info","index":3,"n_rows":1354,"n_cols":45,"rows_kept":1354}
["Antibody and Protein Target Information",{"$nulls":5},"All Data","All Data","All Data","All Data","All Data","All Data"]
[]
[{"$nulls":9},"Meta-Analysis of 278 Different Cell/Tissue Lysates with KAM-1325 Chips.               "]
["Final Sort","Ab Spot ID #","Antibody Codes","Target Name","P-Site","Full Target Protein Name","Average Normalized Net Signal","Median Normalized Net Signal","S.Dev. Normalized Net Signal","%S.Dev. Normalized Net Signal","Minimum Recorded Normalized Net Signal","Maximum Recorded  Normalized Net Signal","Antibody Source","Type","Antigen Sequence","Sequence Location in Target","Effect of Phosphorylation","Kinases Known to Target Phosphosite(s) in vitro","UniProt Link","PhosphoNETLink","PhosphoSIte Plus Link","KinaseNETLink","OncoNETLink","RefSeq Link","Field-Block","Row","Column","Field Positions","Preferred Protein Kinase Name ","Protein Kinase","Kinase or Phosphatase Type","Protein Type - Simple","Kinase Type","Kinase Group","Kinase Family","Kinase Subfamily","Transcription Factor","Stress Protein","Protein Phosphatase","Adapter","Metabolic Enzyme","Protein Type - Extended","GO_CelComponent_list","GO_MolFunctin_list","GO_BioProcess_list"]
[5,2,"NN166-2","4E-BP1 (PHAS1)","Pan-specific","Eukaryotic translation initiation factor 4E binding protein 1 (PHAS1)",{"v":338.7251844219655,"d":"339"},{"v":287.95486243575596,"d":"288"},{"v":204.39388795642648,"d":"204"},{"v":60.3420995416165,"d":"60"},{"v":26.51946791687036,"d":"27"},{"v":1543.3531255113417,"d":"1543"},"External","MmAb","Not precisely defined.","Antibody raised against full length human 4E-BP1 protein.",null,null,"Q13541","Q13541",555,null,"Q13541","NP_004086","Block1",1,2,"1, 9, 17, 25",{"$nulls":13},"Protein synthesis protein, inhibitor","GO:0005829","GO:0008190; GO:0030371","GO:0071549; GO:0000082; GO:0008286; GO:0002192; GO:0045947; GO:0045931; GO:0031929"]
[7,3,"PN550","4E-BP1 (PHAS1)","T37+T46","4E transcription factor binding protein 1",{"v":7609.104659280873,"d":"7609"},{"v":7673.231322434089,"d":"7673"},{"v":1699.595957445443,"d":"1700"},{"v":22.336346174085474,"d":"22"},{"v":3217.046068217602,"d":"3217"},{"v":14544.644275496586,"d":"14545"},"Kinexus","RpAb","DYST(pT)PGG(bA)C     ","Corresponds to amino acid residues D33 to G40; In the N-terminal portion of the translation regulatory protein. ","T37 phosphorylation reduces the rate of ubiquitination by the BCR(KLH25) complex and inhibits interaction with 4E-BP1 and EIF4E. This is one of the major in vivo phosphorylation sites in 4E-BP1 (≥129 reports based on mass spectrometry studies). The effect of T46 phosphorylation - Partly reduces eIF4E and 4E-BP1 binding and reduces the rate of ubiquitination by the BCR(KLH25) complex. This is also one of the major in vivo phosphorylation sites in 4E-BP1 (≥124 reports based on mass spectrometry studies).","ERK1 (MAPK3); ERK2 (MAPK1); FRAP1 (mTOR); GSK3b","Q13541","Q13541",555,null,"Q13541","NP_004086","Block1",1,3,"1, 9, 17, 25",{"$nulls":13},"Protein synthesis protein, inhibitor","GO:0005829","GO:0008190; GO:0030371","GO:0071549; GO:0000082; GO:0008286; GO:0002192; GO:0045947; GO:0045931; GO:0031929"]
[9,4,"PK501","A6 (Twinfilin-1)","Y309","Twinfilin, actin-binding protein, 1; Protein tyrosine kinase 9;",{"v":8195.008454738934,"d":"8195"},{"v":8058.0058087702455,"d":"8058"},{"v":2395.585293576093,"d":"2396"},{"v":29.232249201534334,"d":"29"},{"v":249.97264177779417,"d":"250"},{"v":14624.120838824716,"d":"14624"},"Kinexus","RpAb","DFL(pY)EEV(bA)C","Corresponds to amino acid residues D306 to V312; In the end of the Cofilin_ADF domain. ","The effect of Y309 phosphorylation is unclear. The major site of phosphorylation of A6 (≥142 reports based on mass spectrometry studies).",null,"Q12792","Q12792",2314,"Q12792",null,"NP_001229326.1","Block1",1,4,"1, 9, 17, 25","A6","X","PSTK","Protein kinase, dual-specificity","Protein-serine/threonine kinase","ATYPICAL group","A6 family",{"$nulls":6},"Protein kinase, dual-specificity; ATYPICAL domain target; ATYPICAL</A> group; A6 family","GO:0015629; GO:0005911; GO:0005829; GO:0030175; GO:0005925; GO:0030016; GO:0048471; GO:0032587","GO:0003779; GO:0003785; GO:0005524; GO:0045296; GO:0005546; GO:0044877","GO:0051016; GO:0030837; GO:0018108; GO:0010613; GO:0043538; GO:0042989"]
[11,5,"PK502","A6r (Twinfin-2)","Y309","Twinfilin, actin-binding protein, 2; Protein tyrosine kinase 9-like",{"v":5556.441043346117,"d":"5556"},{"v":5410.598228923023,"d":"5411"},{"v":1368.6865210603726,"d":"1369"},{"v":24.63243127000125,"d":"25"},{"v":544.3233691878755,"d":"544"},{"v":10793.415116349053,"d":"10793"},"Kinexus","RpAb","EFL(pY)DEV(bA)C","Corresponds to amino acid residues E306 to V312; In the end of the Cofilin_ADF domain. ","The effect of Y309 phosphorylation is unclear. This is the major site of phosphorylation of A6r (≥517 reports based on mass spectrometry studies). A similar phosphosite is also the major phosphorylation site in A6.",null,"Q6IBS0","Q6IBS0",2316,"Q6IBS0",null,"NP_009215.1","Block1",1,5,"1, 9, 17, 25","A6r","X","PSTK","Protein kinase, dual-specificity","Protein-serine/threonine kinase","ATYPICAL group","A6 family",{"$nulls":6},"Protein kinase, atypical; ATYPICAL domain target; ATYPICAL</A> group; A6 family","GO:0005737; GO:0005856; GO:0070062; GO:0030175; GO:0030426; GO:0030027; GO:0030016; GO:0048471; GO:0032420","GO:0003785; GO:0005524; GO:0045296; GO:0005546; GO:0005080; GO:0003723","GO:0051016; GO:0030030; GO:0071363; GO:0071300; GO:0030837; GO:0045773; GO:0010592; GO:0010976; GO:0032956; GO:0032532; GO:0042989"]
[13,6,"PK503","AAK1","S637","AP2-associated protein kinase 1",{"v":8887.96907786677,"d":"8888"},{"v":8882.808734313281,"d":"8883"},{"v":2144.9256266401894,"d":"2145"},{"v":24.132910542877358,"d":"24"},{"v":1068.1251357670103,"d":"1068"},{"v":16694.87269394865,"d":"16695"},"Kinexus","RpAb","RIL(pS)DVT(bA)C","Corresponds to amino acid residues R634 to T640; In the C-terminal half of the kinase after the catalytic domain. ","The effect of S637 phosphorylation is unclear. This is major site of phosphorylation of AAK1 (≥259 reports based on mass spectrometry studies). ",null,"Q2M2I8","Q2M2I8",2190,"Q2M2I8",null,"NP_055726.3","Block1",1,6,"1, 9, 17, 25","AAK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","NAK",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; EC 2.7.11.-; Other group; NAK family","GO:0031252; GO:0005905; GO:0030136; GO:0005737; GO:0005829; GO:0019897; GO:0043195","GO:0035612; GO:0005524; GO:0005112; GO:0004674","GO:0006897; GO:0061024; GO:0045747; GO:0046777; GO:0006468; GO:0050821; GO:2000369; GO:0032880"]
[15,7,"NK001-2","Abl (Abl1)","Pan-specific","Abelson murine leukemia viral oncogene homologue 1",{"v":6478.2725038497,"d":"6478"},{"v":6176.110828748451,"d":"6176"},{"v":1486.7111212223258,"d":"1487"},{"v":22.9491908581933,"d":"23"},{"v":3084.118496188942,"d":"3084"},{"v":12306.63888811081,"d":"12307"},"Kinexus","RpAb","CAATQDFSKLLSSVKE","Corresponds to amino acid residues A1109 to E1123; In the C-terminus of the kinase.",null,null,"P00519","P00519",4577,"P00519","P00519","NP_005148","Block1",1,7,"1, 9, 17, 25","ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"Protein-tyrosine kinase; Cytoplasm, nucleolus, nucleus, cytoskeleton protein","GO:0015629; GO:0031252; GO:0005737; GO:0005829; GO:0030425; GO:0031234; GO:0005739; GO:0043025; GO:0016604; GO:0031965; GO:0005730; GO:0005654; GO:0005634; GO:0048471; GO:0098794; GO:0032991","GO:0051015; GO:0003785; GO:0005524; GO:0003677; GO:0046875; GO:0016301; GO:0000287; GO:0030145; GO:0051019; GO:0038191; GO:0004515; GO:0004715; GO:0001784; GO:0070064; GO:0008022; GO:0004672; GO:0005080; GO:0004713; GO:0042169; GO:0017124; GO:0005102; GO:0019905","GO:0030036; GO:0090135; GO:0050798; GO:1990051; GO:0046632; GO:0006914; GO:0001922; GO:0002322; GO:0050853; GO:0060020; GO:0072358; GO:0007050; GO:0006464; GO:0006974; GO:1903351; GO:0070301; GO:0071222; GO:0034599; GO:0021587; GO:0048668; GO:0006975; GO:0043542; GO:0007173; GO:0045184; GO:0038096; GO:0045087; GO:0007229; GO:0008630; GO:0030035; GO:0006298; GO:0051882; GO:0000278; GO:0030514; GO:0022408; GO:2000773; GO:2000352; GO:0070373; GO:0043124; GO:1900272; GO:0045930; GO:1900275; GO:0071901; GO:0051444; GO:0001843; GO:0060563; GO:0050885; GO:0038189; GO:0038083; GO:0018108; GO:0035791; GO:1905555; GO:2000251; GO:1904531; GO:0043065; GO:0090050; GO:0007204; GO:0010595; GO:0070374; GO:0051894; GO:0043123; GO:1902715; GO:1900042; GO:1904528; GO:0045931; GO:0051149; GO:1901216; GO:0033690; GO:0051353; GO:0050731; GO:0001934; GO:0051281; GO:0051496; GO:1900026; GO:2000096; GO:0009791; GO:0046777; GO:0006468; GO:0032956; GO:2000249; GO:0010506; GO:0030516; GO:0032489; GO:0030155; GO:2000145; GO:0042127; GO:0030100; GO:1903053; GO:1902036; GO:0031113; GO:1905244; GO:2001020; GO:0045580; GO:0006355; GO:0006979; GO:0042770; GO:0048536; GO:0034446; GO:0048538; GO:0002333"]
[17,8,"NK001-6","Abl (Abl1)","Pan-specific","Abelson murine leukemia viral oncogene homologue 1",{"v":3687.799394983422,"d":"3688"},{"v":3576.3786497755946,"d":"3576"},{"v":1223.5099514544527,"d":"1224"},{"v":33.17723716530825,"d":"33"},{"v":179.26760310824977,"d":"179"},{"v":7483.378883541519,"d":"7483"},"Kinexus","RpAb","CISTRVSLRKTRQPP","Corresponds to amino acid residues I1006 to P1019.",null,null,"P00519","P00519",4577,"P00519","P00519","NP_005148","Block1",1,8,"1, 9, 17, 25","ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"Protein-tyrosine kinase; Cytoplasm, nucleolus, nucleus, cytoskeleton protein","GO:0015629; GO:0031252; GO:0005737; GO:0005829; GO:0030425; GO:0031234; GO:0005739; GO:0043025; GO:0016604; GO:0031965; GO:0005730; GO:0005654; GO:0005634; GO:0048471; GO:0098794; GO:0032991","GO:0051015; GO:0003785; GO:0005524; GO:0003677; GO:0046875; GO:0016301; GO:0000287; GO:0030145; GO:0051019; GO:0038191; GO:0004515; GO:0004715; GO:0001784; GO:0070064; GO:0008022; GO:0004672; GO:0005080; GO:0004713; GO:0042169; GO:0017124; GO:0005102; GO:0019905","GO:0030036; GO:0090135; GO:0050798; GO:1990051; GO:0046632; GO:0006914; GO:0001922; GO:0002322; GO:0050853; GO:0060020; GO:0072358; GO:0007050; GO:0006464; GO:0006974; GO:1903351; GO:0070301; GO:0071222; GO:0034599; GO:0021587; GO:0048668; GO:0006975; GO:0043542; GO:0007173; GO:0045184; GO:0038096; GO:0045087; GO:0007229; GO:0008630; GO:0030035; GO:0006298; GO:0051882; GO:0000278; GO:0030514; GO:0022408; GO:2000773; GO:2000352; GO:0070373; GO:0043124; GO:1900272; GO:0045930; GO:1900275; GO:0071901; GO:0051444; GO:0001843; GO:0060563; GO:0050885; GO:0038189; GO:0038083; GO:0018108; GO:0035791; GO:1905555; GO:2000251; GO:1904531; GO:0043065; GO:0090050; GO:0007204; GO:0010595; GO:0070374; GO:0051894; GO:0043123; GO:1902715; GO:1900042; GO:1904528; GO:0045931; GO:0051149; GO:1901216; GO:0033690; GO:0051353; GO:0050731; GO:0001934; GO:0051281; GO:0051496; GO:1900026; GO:2000096; GO:0009791; GO:0046777; GO:0006468; GO:0032956; GO:2000249; GO:0010506; GO:0030516; GO:0032489; GO:0030155; GO:2000145; GO:0042127; GO:0030100; GO:1903053; GO:1902036; GO:0031113; GO:1905244; GO:2001020; GO:0045580; GO:0006355; GO:0006979; GO:0042770; GO:0048536; GO:0034446; GO:0048538; GO:0002333"]
[19,9,"PK504","Abl (Abl1)","Y139","Abelson murine leukemia viral oncogene homologue 1",{"v":4670.4327806361725,"d":"4670"},{"v":4791.2429648970065,"d":"4791"},{"v":1452.0837198467657,"d":"1452"},{"v":31.090988523958018,"d":"31"},{"v":198.84330890268194,"d":"199"},{"v":8531.234754128478,"d":"8531"},"Kinexus","RpAb","AAE(pY)LLS(bA)C","Corresponds to amino acid residues A136 to S142; In the SH2 domain.","Y139 phosphorylation stimulates phosphotransferase activity. This is one of the many in vivo phosphorylation sites in Abl1 (≥57 reports based on mass spectrometry studies).","Fyn; Hck; Lyn","P00519","P00519",4577,"P00519","P00519","NP_005148","Block1",1,9,"1, 9, 17, 25","ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"Protein-tyrosine kinase; Cytoplasm, nucleolus, nucleus, cytoskeleton protein","GO:0015629; GO:0031252; GO:0005737; GO:0005829; GO:0030425; GO:0031234; GO:0005739; GO:0043025; GO:0016604; GO:0031965; GO:0005730; GO:0005654; GO:0005634; GO:0048471; GO:0098794; GO:0032991","GO:0051015; GO:0003785; GO:0005524; GO:0003677; GO:0046875; GO:0016301; GO:0000287; GO:0030145; GO:0051019; GO:0038191; GO:0004515; GO:0004715; GO:0001784; GO:0070064; GO:0008022; GO:0004672; GO:0005080; GO:0004713; GO:0042169; GO:0017124; GO:0005102; GO:0019905","GO:0030036; GO:0090135; GO:0050798; GO:1990051; GO:0046632; GO:0006914; GO:0001922; GO:0002322; GO:0050853; GO:0060020; GO:0072358; GO:0007050; GO:0006464; GO:0006974; GO:1903351; GO:0070301; GO:0071222; GO:0034599; GO:0021587; GO:0048668; GO:0006975; GO:0043542; GO:0007173; GO:0045184; GO:0038096; GO:0045087; GO:0007229; GO:0008630; GO:0030035; GO:0006298; GO:0051882; GO:0000278; GO:0030514; GO:0022408; GO:2000773; GO:2000352; GO:0070373; GO:0043124; GO:1900272; GO:0045930; GO:1900275; GO:0071901; GO:0051444; GO:0001843; GO:0060563; GO:0050885; GO:0038189; GO:0038083; GO:0018108; GO:0035791; GO:1905555; GO:2000251; GO:1904531; GO:0043065; GO:0090050; GO:0007204; GO:0010595; GO:0070374; GO:0051894; GO:0043123; GO:1902715; GO:1900042; GO:1904528; GO:0045931; GO:0051149; GO:1901216; GO:0033690; GO:0051353; GO:0050731; GO:0001934; GO:0051281; GO:0051496; GO:1900026; GO:2000096; GO:0009791; GO:0046777; GO:0006468; GO:0032956; GO:2000249; GO:0010506; GO:0030516; GO:0032489; GO:0030155; GO:2000145; GO:0042127; GO:0030100; GO:1903053; GO:1902036; GO:0031113; GO:1905244; GO:2001020; GO:0045580; GO:0006355; GO:0006979; GO:0042770; GO:0048536; GO:0034446; GO:0048538; GO:0002333"]
[21,10,"PK505","Abl (Abl1)","Y226","Abelson murine leukemia viral oncogene homologue 1",{"v":9817.029520052867,"d":"9817"},{"v":9652.803048884376,"d":"9653"},{"v":1895.205093683216,"d":"1895"},{"v":19.30528058219601,"d":"19"},{"v":4740.889481621755,"d":"4741"},{"v":17532.373598546466,"d":"17532"},"Kinexus","RpAb","PTV(pY)GVS(bA)C","Corresponds to amino acid residues P223 to S229; In the region between the SH2 domain and the protein kinase catalytic domain.","Y226 phosphorylation stimulates phosphotransferase activity. This is one of the major in vivo phosphorylation sites in Abl1 (≥315 reports based on mass spectrometry studies).","Abl1; Fyn; Hck; Lyn","P00519","P00519",4577,"P00519","P00519","NP_005148","Block1",1,10,"1, 9, 17, 25","ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"Protein-tyrosine kinase; Cytoplasm, nucleolus, nucleus, cytoskeleton protein","GO:0015629; GO:0031252; GO:0005737; GO:0005829; GO:0030425; GO:0031234; GO:0005739; GO:0043025; GO:0016604; GO:0031965; GO:0005730; GO:0005654; GO:0005634; GO:0048471; GO:0098794; GO:0032991","GO:0051015; GO:0003785; GO:0005524; GO:0003677; GO:0046875; GO:0016301; GO:0000287; GO:0030145; GO:0051019; GO:0038191; GO:0004515; GO:0004715; GO:0001784; GO:0070064; GO:0008022; GO:0004672; GO:0005080; GO:0004713; GO:0042169; GO:0017124; GO:0005102; GO:0019905","GO:0030036; GO:0090135; GO:0050798; GO:1990051; GO:0046632; GO:0006914; GO:0001922; GO:0002322; GO:0050853; GO:0060020; GO:0072358; GO:0007050; GO:0006464; GO:0006974; GO:1903351; GO:0070301; GO:0071222; GO:0034599; GO:0021587; GO:0048668; GO:0006975; GO:0043542; GO:0007173; GO:0045184; GO:0038096; GO:0045087; GO:0007229; GO:0008630; GO:0030035; GO:0006298; GO:0051882; GO:0000278; GO:0030514; GO:0022408; GO:2000773; GO:2000352; GO:0070373; GO:0043124; GO:1900272; GO:0045930; GO:1900275; GO:0071901; GO:0051444; GO:0001843; GO:0060563; GO:0050885; GO:0038189; GO:0038083; GO:0018108; GO:0035791; GO:1905555; GO:2000251; GO:1904531; GO:0043065; GO:0090050; GO:0007204; GO:0010595; GO:0070374; GO:0051894; GO:0043123; GO:1902715; GO:1900042; GO:1904528; GO:0045931; GO:0051149; GO:1901216; GO:0033690; GO:0051353; GO:0050731; GO:0001934; GO:0051281; GO:0051496; GO:1900026; GO:2000096; GO:0009791; GO:0046777; GO:0006468; GO:0032956; GO:2000249; GO:0010506; GO:0030516; GO:0032489; GO:0030155; GO:2000145; GO:0042127; GO:0030100; GO:1903053; GO:1902036; GO:0031113; GO:1905244; GO:2001020; GO:0045580; GO:0006355; GO:0006979; GO:0042770; GO:0048536; GO:0034446; GO:0048538; GO:0002333"]
[23,11,"PK506","Abl (Abl1)","Y257","Abelson murine leukemia viral oncogene homologue 1",{"v":7125.557964257642,"d":"7126"},{"v":7117.470863482686,"d":"7117"},{"v":1555.2023564608953,"d":"1555"},{"v":21.825692307352103,"d":"22"},{"v":635.6419347567632,"d":"636"},{"v":12080.13940843067,"d":"12080"},"Kinexus","RpAb","GEV(pY)EGV(bA)C","Corresponds to amino acid residues G254 to V260; In the protein kinase catalytic domain in subdomain I.","Y257 phosphorylation is predicted to be inhibitory for phosphotransferase activity. This phosphosite is located in the kinase subdomain I region, which is involved in binding the phosphates in the ATP substrate. This is one of the major in vivo phosphorylation sites in Abl1 (≥335 reports based on mass spectrometry studies).",null,"P00519","P00519",4577,"P00519","P00519","NP_005148","Block1",1,11,"1, 9, 17, 25","ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"Protein-tyrosine kinase; Cytoplasm, nucleolus, nucleus, cytoskeleton protein","GO:0015629; GO:0031252; GO:0005737; GO:0005829; GO:0030425; GO:0031234; GO:0005739; GO:0043025; GO:0016604; GO:0031965; GO:0005730; GO:0005654; GO:0005634; GO:0048471; GO:0098794; GO:0032991","GO:0051015; GO:0003785; GO:0005524; GO:0003677; GO:0046875; GO:0016301; GO:0000287; GO:0030145; GO:0051019; GO:0038191; GO:0004515; GO:0004715; GO:0001784; GO:0070064; GO:0008022; GO:0004672; GO:0005080; GO:0004713; GO:0042169; GO:0017124; GO:0005102; GO:0019905","GO:0030036; GO:0090135; GO:0050798; GO:1990051; GO:0046632; GO:0006914; GO:0001922; GO:0002322; GO:0050853; GO:0060020; GO:0072358; GO:0007050; GO:0006464; GO:0006974; GO:1903351; GO:0070301; GO:0071222; GO:0034599; GO:0021587; GO:0048668; GO:0006975; GO:0043542; GO:0007173; GO:0045184; GO:0038096; GO:0045087; GO:0007229; GO:0008630; GO:0030035; GO:0006298; GO:0051882; GO:0000278; GO:0030514; GO:0022408; GO:2000773; GO:2000352; GO:0070373; GO:0043124; GO:1900272; GO:0045930; GO:1900275; GO:0071901; GO:0051444; GO:0001843; GO:0060563; GO:0050885; GO:0038189; GO:0038083; GO:0018108; GO:0035791; GO:1905555; GO:2000251; GO:1904531; GO:0043065; GO:0090050; GO:0007204; GO:0010595; GO:0070374; GO:0051894; GO:0043123; GO:1902715; GO:1900042; GO:1904528; GO:0045931; GO:0051149; GO:1901216; GO:0033690; GO:0051353; GO:0050731; GO:0001934; GO:0051281; GO:0051496; GO:1900026; GO:2000096; GO:0009791; GO:0046777; GO:0006468; GO:0032956; GO:2000249; GO:0010506; GO:0030516; GO:0032489; GO:0030155; GO:2000145; GO:0042127; GO:0030100; GO:1903053; GO:1902036; GO:0031113; GO:1905244; GO:2001020; GO:0045580; GO:0006355; GO:0006979; GO:0042770; GO:0048536; GO:0034446; GO:0048538; GO:0002333"]
[25,12,"PK507","Abl (Abl1)","Y264","Abelson murine leukemia viral oncogene homologue 1",{"v":9162.14531704129,"d":"9162"},{"v":9125.5011140783,"d":"9126"},{"v":2284.1877532301583,"d":"2284"},{"v":24.930708629797042,"d":"25"},{"v":4367.903726918933,"d":"4368"},{"v":16732.995012083156,"d":"16733"},"Kinexus","RpAb","WKK(pY)SLT(bA)C","Corresponds to amino acid residues W261 to T267; In the protein kinase catalytic domain in subdomain I.","Y264 phosphorylation is predicted to be inhibitory for phosphotransferase activity. This phosphosite is located in the kinase subdomain I region, which is involved in binding the phosphates in the ATP substrate. This is one of the many in vivo phosphorylation sites in Abl1 (≥60 reports based on mass spectrometry studies).",null,"P00519","P00519",4577,"P00519","P00519","NP_005148","Block1",1,12,"1, 9, 17, 25","ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"Protein-tyrosine kinase; Cytoplasm, nucleolus, nucleus, cytoskeleton protein","GO:0015629; GO:0031252; GO:0005737; GO:0005829; GO:0030425; GO:0031234; GO:0005739; GO:0043025; GO:0016604; GO:0031965; GO:0005730; GO:0005654; GO:0005634; GO:0048471; GO:0098794; GO:0032991","GO:0051015; GO:0003785; GO:0005524; GO:0003677; GO:0046875; GO:0016301; GO:0000287; GO:0030145; GO:0051019; GO:0038191; GO:0004515; GO:0004715; GO:0001784; GO:0070064; GO:0008022; GO:0004672; GO:0005080; GO:0004713; GO:0042169; GO:0017124; GO:0005102; GO:0019905","GO:0030036; GO:0090135; GO:0050798; GO:1990051; GO:0046632; GO:0006914; GO:0001922; GO:0002322; GO:0050853; GO:0060020; GO:0072358; GO:0007050; GO:0006464; GO:0006974; GO:1903351; GO:0070301; GO:0071222; GO:0034599; GO:0021587; GO:0048668; GO:0006975; GO:0043542; GO:0007173; GO:0045184; GO:0038096; GO:0045087; GO:0007229; GO:0008630; GO:0030035; GO:0006298; GO:0051882; GO:0000278; GO:0030514; GO:0022408; GO:2000773; GO:2000352; GO:0070373; GO:0043124; GO:1900272; GO:0045930; GO:1900275; GO:0071901; GO:0051444; GO:0001843; GO:0060563; GO:0050885; GO:0038189; GO:0038083; GO:0018108; GO:0035791; GO:1905555; GO:2000251; GO:1904531; GO:0043065; GO:0090050; GO:0007204; GO:0010595; GO:0070374; GO:0051894; GO:0043123; GO:1902715; GO:1900042; GO:1904528; GO:0045931; GO:0051149; GO:1901216; GO:0033690; GO:0051353; GO:0050731; GO:0001934; GO:0051281; GO:0051496; GO:1900026; GO:2000096; GO:0009791; GO:0046777; GO:0006468; GO:0032956; GO:2000249; GO:0010506; GO:0030516; GO:0032489; GO:0030155; GO:2000145; GO:0042127; GO:0030100; GO:1903053; GO:1902036; GO:0031113; GO:1905244; GO:2001020; GO:0045580; GO:0006355; GO:0006979; GO:0042770; GO:0048536; GO:0034446; GO:0048538; GO:0002333"]
[27,13,"PK873","Abl (Abl1)","Y393+T394","Abelson murine leukemia viral oncogene homologue 1",{"v":17241.72615327022,"d":"17242"},{"v":17059.214756663507,"d":"17059"},{"v":4817.644816322085,"d":"4818"},{"v":27.941777833006164,"d":"28"},{"v":9107.022444436807,"d":"9107"},{"v":31015.977781941736,"d":"31016"},"Kinexus","RpAb","GDT(pY)(pT)AHAGC","Corresponds to amino acid residues G390 to G398. Y393 and T394 are located in the Gap/Insert 8 (G/I8) region in the protein-tyrosine kinase catalytic domain of Abl1. The G/I8 region is located in the T-activation loop between kinase subdomains VII and VIII.","Y393 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation regulates cell growth. Y393 is the most frequently detected phosphosite in Abl1 by mass spectrometry (≥1677 reports) and T394 is the third most often observed phosphosite (≥477 reports). No protein kinases have been reported to phosphorylate T394, but it is likely that it becomes collatorally phosphorylated by kinases that target the Y393 site. The effect of this phosphorylation is unclear, but it is likely to be activatory for Abl1 phosphotransferase activity based on its location. ","Y393: Abl1; Fyn; Hck; Lyn.","P00519","P00519",4577,"P00519","P00519","NP_005148","Block1",1,13,"1, 9, 17, 25","ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"Protein-tyrosine kinase; Cytoplasm, nucleolus, nucleus, cytoskeleton protein","GO:0015629; GO:0031252; GO:0005737; GO:0005829; GO:0030425; GO:0031234; GO:0005739; GO:0043025; GO:0016604; GO:0031965; GO:0005730; GO:0005654; GO:0005634; GO:0048471; GO:0098794; GO:0032991","GO:0051015; GO:0003785; GO:0005524; GO:0003677; GO:0046875; GO:0016301; GO:0000287; GO:0030145; GO:0051019; GO:0038191; GO:0004515; GO:0004715; GO:0001784; GO:0070064; GO:0008022; GO:0004672; GO:0005080; GO:0004713; GO:0042169; GO:0017124; GO:0005102; GO:0019905","GO:0030036; GO:0090135; GO:0050798; GO:1990051; GO:0046632; GO:0006914; GO:0001922; GO:0002322; GO:0050853; GO:0060020; GO:0072358; GO:0007050; GO:0006464; GO:0006974; GO:1903351; GO:0070301; GO:0071222; GO:0034599; GO:0021587; GO:0048668; GO:0006975; GO:0043542; GO:0007173; GO:0045184; GO:0038096; GO:0045087; GO:0007229; GO:0008630; GO:0030035; GO:0006298; GO:0051882; GO:0000278; GO:0030514; GO:0022408; GO:2000773; GO:2000352; GO:0070373; GO:0043124; GO:1900272; GO:0045930; GO:1900275; GO:0071901; GO:0051444; GO:0001843; GO:0060563; GO:0050885; GO:0038189; GO:0038083; GO:0018108; GO:0035791; GO:1905555; GO:2000251; GO:1904531; GO:0043065; GO:0090050; GO:0007204; GO:0010595; GO:0070374; GO:0051894; GO:0043123; GO:1902715; GO:1900042; GO:1904528; GO:0045931; GO:0051149; GO:1901216; GO:0033690; GO:0051353; GO:0050731; GO:0001934; GO:0051281; GO:0051496; GO:1900026; GO:2000096; GO:0009791; GO:0046777; GO:0006468; GO:0032956; GO:2000249; GO:0010506; GO:0030516; GO:0032489; GO:0030155; GO:2000145; GO:0042127; GO:0030100; GO:1903053; GO:1902036; GO:0031113; GO:1905244; GO:2001020; GO:0045580; GO:0006355; GO:0006979; GO:0042770; GO:0048536; GO:0034446; GO:0048538; GO:0002333"]
[29,14,"PK177","Abl (Abl1)","Y413","Abelson murine leukemia viral oncogene homologue 1",{"v":321.9841089970197,"d":"322"},{"v":271.469681178139,"d":"271"},{"v":230.52006358902779,"d":"231"},{"v":71.5936150722151,"d":"72"},{"v":37.57919648868538,"d":"38"},{"v":2199.6636520103684,"d":"2200"},"External","MmAb","Not precisely defined.  Original suppliers identified as an antibody for the Y412 site in human Abl1. Likely to include LA(pY)NK.","Antibody raised against amino acid residues surrounding the phosphorylated Tyr-413 of human c-Abl.","The effect of Y413 phosphorylation is unclear. This is one of the many in vivo phosphorylation sites in Abl1 (≥164 reports based on mass spectrometry studies).",null,"P00519","P00519",4577,"P00519","P00519","NP_005148","Block1",2,1,"1, 9, 17, 25","ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"Protein-tyrosine kinase; Cytoplasm, nucleolus, nucleus, cytoskeleton protein","GO:0015629; GO:0031252; GO:0005737; GO:0005829; GO:0030425; GO:0031234; GO:0005739; GO:0043025; GO:0016604; GO:0031965; GO:0005730; GO:0005654; GO:0005634; GO:0048471; GO:0098794; GO:0032991","GO:0051015; GO:0003785; GO:0005524; GO:0003677; GO:0046875; GO:0016301; GO:0000287; GO:0030145; GO:0051019; GO:0038191; GO:0004515; GO:0004715; GO:0001784; GO:0070064; GO:0008022; GO:0004672; GO:0005080; GO:0004713; GO:0042169; GO:0017124; GO:0005102; GO:0019905","GO:0030036; GO:0090135; GO:0050798; GO:1990051; GO:0046632; GO:0006914; GO:0001922; GO:0002322; GO:0050853; GO:0060020; GO:0072358; GO:0007050; GO:0006464; GO:0006974; GO:1903351; GO:0070301; GO:0071222; GO:0034599; GO:0021587; GO:0048668; GO:0006975; GO:0043542; GO:0007173; GO:0045184; GO:0038096; GO:0045087; GO:0007229; GO:0008630; GO:0030035; GO:0006298; GO:0051882; GO:0000278; GO:0030514; GO:0022408; GO:2000773; GO:2000352; GO:0070373; GO:0043124; GO:1900272; GO:0045930; GO:1900275; GO:0071901; GO:0051444; GO:0001843; GO:0060563; GO:0050885; GO:0038189; GO:0038083; GO:0018108; GO:0035791; GO:1905555; GO:2000251; GO:1904531; GO:0043065; GO:0090050; GO:0007204; GO:0010595; GO:0070374; GO:0051894; GO:0043123; GO:1902715; GO:1900042; GO:1904528; GO:0045931; GO:0051149; GO:1901216; GO:0033690; GO:0051353; GO:0050731; GO:0001934; GO:0051281; GO:0051496; GO:1900026; GO:2000096; GO:0009791; GO:0046777; GO:0006468; GO:0032956; GO:2000249; GO:0010506; GO:0030516; GO:0032489; GO:0030155; GO:2000145; GO:0042127; GO:0030100; GO:1903053; GO:1902036; GO:0031113; GO:1905244; GO:2001020; GO:0045580; GO:0006355; GO:0006979; GO:0042770; GO:0048536; GO:0034446; GO:0048538; GO:0002333"]
[31,15,"PK508","Abl (Abl1)","Y469","Abelson murine leukemia viral oncogene homologue 1",{"v":14316.925630040032,"d":"14317"},{"v":14112.382942783011,"d":"14112"},{"v":3079.612858986757,"d":"3080"},{"v":21.510294448446793,"d":"22"},{"v":5981.1987780410445,"d":"5981"},{"v":24341.855299852075,"d":"24342"},"Kinexus","RpAb","EKV(pY)ELM(bA)C","Corresponds to amino acid residues E466 to M472; In the protein kinase catalytic domain. ","The effect of Y469 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in Abl1 (≥291 reports based on mass spectrometry studies).",null,"P00519","P00519",4577,"P00519","P00519","NP_005148","Block1",2,2,"1, 9, 17, 25","ABL1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"Protein-tyrosine kinase; Cytoplasm, nucleolus, nucleus, cytoskeleton protein","GO:0015629; GO:0031252; GO:0005737; GO:0005829; GO:0030425; GO:0031234; GO:0005739; GO:0043025; GO:0016604; GO:0031965; GO:0005730; GO:0005654; GO:0005634; GO:0048471; GO:0098794; GO:0032991","GO:0051015; GO:0003785; GO:0005524; GO:0003677; GO:0046875; GO:0016301; GO:0000287; GO:0030145; GO:0051019; GO:0038191; GO:0004515; GO:0004715; GO:0001784; GO:0070064; GO:0008022; GO:0004672; GO:0005080; GO:0004713; GO:0042169; GO:0017124; GO:0005102; GO:0019905","GO:0030036; GO:0090135; GO:0050798; GO:1990051; GO:0046632; GO:0006914; GO:0001922; GO:0002322; GO:0050853; GO:0060020; GO:0072358; GO:0007050; GO:0006464; GO:0006974; GO:1903351; GO:0070301; GO:0071222; GO:0034599; GO:0021587; GO:0048668; GO:0006975; GO:0043542; GO:0007173; GO:0045184; GO:0038096; GO:0045087; GO:0007229; GO:0008630; GO:0030035; GO:0006298; GO:0051882; GO:0000278; GO:0030514; GO:0022408; GO:2000773; GO:2000352; GO:0070373; GO:0043124; GO:1900272; GO:0045930; GO:1900275; GO:0071901; GO:0051444; GO:0001843; GO:0060563; GO:0050885; GO:0038189; GO:0038083; GO:0018108; GO:0035791; GO:1905555; GO:2000251; GO:1904531; GO:0043065; GO:0090050; GO:0007204; GO:0010595; GO:0070374; GO:0051894; GO:0043123; GO:1902715; GO:1900042; GO:1904528; GO:0045931; GO:0051149; GO:1901216; GO:0033690; GO:0051353; GO:0050731; GO:0001934; GO:0051281; GO:0051496; GO:1900026; GO:2000096; GO:0009791; GO:0046777; GO:0006468; GO:0032956; GO:2000249; GO:0010506; GO:0030516; GO:0032489; GO:0030155; GO:2000145; GO:0042127; GO:0030100; GO:1903053; GO:1902036; GO:0031113; GO:1905244; GO:2001020; GO:0045580; GO:0006355; GO:0006979; GO:0042770; GO:0048536; GO:0034446; GO:0048538; GO:0002333"]
[33,16,"NK238-1","Abl2 (Arg)","Pan-specific","Abelson murine leukemia viral oncogene homologue 2",{"v":7108.826300767528,"d":"7109"},{"v":6766.599906839965,"d":"6767"},{"v":2252.5040048563337,"d":"2253"},{"v":31.686018332071708,"d":"32"},{"v":386.2853058163099,"d":"386"},{"v":15048.405655725743,"d":"15048"},"Kinexus","RpAb","CDSISEEVAEELGRAA","Corresponds to amino acid residues S547 to A560; Kinase last alpha-chain.",null,null,"P42684","P42684",838,"P42684","P42684","NP_009298.1","Block1",2,3,"1, 9, 17, 25","ARG","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; Abl family","GO:0015629; GO:0005829; GO:0031234","GO:0051015; GO:0003785; GO:0005524; GO:0000287; GO:0030145; GO:0004715; GO:0001784; GO:0004672; GO:0004713; GO:0005102","GO:0007155; GO:0006464; GO:0071300; GO:0045087; GO:0038083; GO:0018108; GO:0007204; GO:0010976; GO:0051353; GO:0010863; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0042127; GO:0030100; GO:0007165; GO:0007169"]
[35,17,"PK509","Abl2 (Arg)","Y439","Abelson murine leukemia viral oncogene homologue 2",{"v":1332.362316577787,"d":"1332"},{"v":1274.378345725499,"d":"1274"},{"v":725.5921939299739,"d":"726"},{"v":54.45907505052225,"d":"54"},{"v":128.9795146259595,"d":"129"},{"v":3545.6619769903627,"d":"3546"},"Kinexus","RpAb","GDT(pY)TAH(bA)C","Corresponds to amino acid residues G436 to H442; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y439 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. It is the most predominent phosphorylation site in Abl2 by mass spectrometry (≥1165 reports).","Abl2","P42684","P42684",838,"P42684","P42684","NP_009298.1","Block1",2,4,"1, 9, 17, 25","ARG","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; Abl family","GO:0015629; GO:0005829; GO:0031234","GO:0051015; GO:0003785; GO:0005524; GO:0000287; GO:0030145; GO:0004715; GO:0001784; GO:0004672; GO:0004713; GO:0005102","GO:0007155; GO:0006464; GO:0071300; GO:0045087; GO:0038083; GO:0018108; GO:0007204; GO:0010976; GO:0051353; GO:0010863; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0042127; GO:0030100; GO:0007165; GO:0007169"]
[37,18,"PK510","Abl2 (Arg)","Y439+T440","Abelson murine leukemia viral oncogene homologue 2",{"v":15422.614150658179,"d":"15423"},{"v":15005.407776264288,"d":"15005"},{"v":3432.4836926071685,"d":"3432"},{"v":22.256173039644402,"d":"22"},{"v":753.523486761437,"d":"754"},{"v":27583.39508056232,"d":"27583"},"Kinexus","RpAb","DT(pY)(pT)AHA(bA)C","Corresponds to amino acid residues D437 to A443; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T440 phosphorylation is predicted to be stimulatory for phosphotransferase activity. Y439 phosphorylation is also likely to be stimulatory for phosphotransferase activity. Both phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. Y339 is the most predominent phosphorylation site in Abl2 by Mass spectrometry (≥1165 reports), and T440 is the second most phosphorylated site (≥476).","Y439: Abl2.","P42684","P42684",838,"P42684","P42684","NP_009298.1","Block1",2,5,"1, 9, 17, 25","ARG","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Abl",{"$nulls":6},"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; Abl family","GO:0015629; GO:0005829; GO:0031234","GO:0051015; GO:0003785; GO:0005524; GO:0000287; GO:0030145; GO:0004715; GO:0001784; GO:0004672; GO:0004713; GO:0005102","GO:0007155; GO:0006464; GO:0071300; GO:0045087; GO:0038083; GO:0018108; GO:0007204; GO:0010976; GO:0051353; GO:0010863; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0042127; GO:0030100; GO:0007165; GO:0007169"]
[39,19,"NN390-1","ACC1 (ACACA)","Pan-specific","Acetyl-CoA carboxylase 1",{"v":277.5593737531021,"d":"278"},{"v":220.0366421191269,"d":"220"},{"v":265.622496801735,"d":"266"},{"v":95.69934288654747,"d":"96"},{"v":23.349702447008653,"d":"23"},{"v":2663.646892282973,"d":"2664"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 1-76 mapping at the N-terminus of human ACCα.",null,null,"Q13085","Q13085",1109,null,"Q13085","NP_000655","Block1",2,6,"1, 9, 17, 25",{"$nulls":3},"Fatty acid synthesis",{"$nulls":8},"X","EC 6.4.1.2; Ligase; Carbohydrate Metabolism - pyruvate; EC 6.3.4.14; Carbohydrate Metabolism - propanoate; Lipid Metabolism - fatty acid biosynthesis","GO:0015629; GO:0005829; GO:0001650","GO:0003989; GO:0005524; GO:0004075; GO:0042802; GO:0046872","GO:0006084; GO:0006853; GO:0071380; GO:0006633; GO:0046949; GO:0055088; GO:2001295; GO:0031325; GO:0051289; GO:0019538; GO:0045540; GO:0001894"]
[41,20,"PN733","ACC1 (ACACA)","S29","Acetyl-CoA carboxylase 1",{"v":505.3347146984521,"d":"505"},{"v":473.4392194489646,"d":"473"},{"v":267.9859632988765,"d":"268"},{"v":53.03137811515513,"d":"53"},{"v":36.46244988711348,"d":"36"},{"v":1604.293385501491,"d":"1604"},"Kinexus","RpAb","EDN(pS)EDE(bA)C","Corresponds to amino acid residues E26 to E32.","The effect of S29 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in ACC1 (≥78 reports based on mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in fish.","CK2a1 (CSNK2A1)","Q13085","Q13085",1109,null,"Q13085","NP_000655","Block1",2,7,"1, 9, 17, 25",{"$nulls":3},"Fatty acid synthesis",{"$nulls":8},"X","EC 6.4.1.2; Ligase; Carbohydrate Metabolism - pyruvate; EC 6.3.4.14; Carbohydrate Metabolism - propanoate; Lipid Metabolism - fatty acid biosynthesis","GO:0015629; GO:0005829; GO:0001650","GO:0003989; GO:0005524; GO:0004075; GO:0042802; GO:0046872","GO:0006084; GO:0006853; GO:0071380; GO:0006633; GO:0046949; GO:0055088; GO:2001295; GO:0031325; GO:0051289; GO:0019538; GO:0045540; GO:0001894"]
[43,21,"PN202","ACC1 (ACACA)","S78+S80","Acetyl-CoA carboxylase 1",{"v":546.4868416040774,"d":"546"},{"v":425.41914593623886,"d":"425"},{"v":549.8132122778973,"d":"550"},{"v":100.60868266545195,"d":"101"},{"v":36.67017921213886,"d":"37"},{"v":5341.362954171844,"d":"5341"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S78 and S80 phosphosites.","The effect of S78 phosphorylation is unclear and it has been rarely observed (3 mass spectrometry reports). S80 phosphorylation produces enzyme inhibition. This is one of the major in vivo phosphorylation sites in ACC1 (≥80 reports based on mass spectrometry studies).","S78: PKACa (PRKACA). S80: AMPKa1 (PRKAA1); AMPKa2 (PRKAA2).","Q13085","Q13085",1109,null,"Q13085","NP_000655","Block1",2,8,"1, 9, 17, 25",{"$nulls":3},"Fatty acid synthesis",{"$nulls":8},"X","EC 6.4.1.2; Ligase; Carbohydrate Metabolism - pyruvate; EC 6.3.4.14; Carbohydrate Metabolism - propanoate; Lipid Metabolism - fatty acid biosynthesis","GO:0015629; GO:0005829; GO:0001650","GO:0003989; GO:0005524; GO:0004075; GO:0042802; GO:0046872","GO:0006084; GO:0006853; GO:0071380; GO:0006633; GO:0046949; GO:0055088; GO:2001295; GO:0031325; GO:0051289; GO:0019538; GO:0045540; GO:0001894"]
[45,22,"PN002","ACC1 (ACACA)","S80","Acetyl-CoA carboxylase 1",{"v":5409.967379424663,"d":"5410"},{"v":5363.917137036411,"d":"5364"},{"v":1333.8877906900461,"d":"1334"},{"v":24.65611522470773,"d":"25"},{"v":92.01019018577873,"d":"92"},{"v":9359.011017710047,"d":"9359"},"External","RpAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the S80 phosphosite.","S80 phosphorylation produces enzyme inhibition. This is one of the major in vivo phosphorylation sites in ACC1 (≥80 reports based on mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and found in fish.","AMPKa1 (PRKAA1); AMPKa2 (PRKAA2)","Q13085","Q13085",1109,null,"Q13085","NP_000655","Block1",2,9,"1, 9, 17, 25",{"$nulls":3},"Fatty acid synthesis",{"$nulls":8},"X","EC 6.4.1.2; Ligase; Carbohydrate Metabolism - pyruvate; EC 6.3.4.14; Carbohydrate Metabolism - propanoate; Lipid Metabolism - fatty acid biosynthesis","GO:0015629; GO:0005829; GO:0001650","GO:0003989; GO:0005524; GO:0004075; GO:0042802; GO:0046872","GO:0006084; GO:0006853; GO:0071380; GO:0006633; GO:0046949; GO:0055088; GO:2001295; GO:0031325; GO:0051289; GO:0019538; GO:0045540; GO:0001894"]
[47,23,"PN734","ACC2 (ACACB)","T1342","Acetyl CoA carboxylase beta",{"v":15678.890727891154,"d":"15679"},{"v":15325.964966891497,"d":"15326"},{"v":3375.7420966037475,"d":"3376"},{"v":21.53049061435606,"d":"22"},{"v":8293.690358674687,"d":"8294"},{"v":27703.19019156909,"d":"27703"},"Kinexus","RpAb","ISI(pT)NPD(bA)C","Corresponds to amino acid residues I1339 to D1335.","The effect of T1342 phosphorylation is unclear. This is the major site of phosphorylation in ACC2 by mass spectrometry (≥29 reports). This human phosphosite is highly conserved in mammals and also found in the platypus.",null,"O00763","O00763",4652000,null,null,"NP_001084.3","Block1",2,10,"1, 9, 17, 25",{"$nulls":3},"Fatty acid synthesis",{"$nulls":8},"X","EC 6.3.4.14; Carbohydrate Metabolism - propanoate; Ligase; EC 6.4.1.2; Lipid Metabolism - fatty acid biosynthesis; Carbohydrate Metabolism - pyruvate; Mitochondrial","GO:0005829; GO:0012505; GO:0005741; GO:0005739; GO:0005634","GO:0003989; GO:0005524; GO:0009374; GO:0004075; GO:0042802; GO:0046872","GO:0006084; GO:0006853; GO:0097009; GO:0006633; GO:2001295; GO:0043086; GO:0031999; GO:0010629; GO:0031325; GO:0060421; GO:0010884; GO:0051289; GO:0045540; GO:0010906; GO:0042493; GO:0031667; GO:0014070"]
[49,24,"NK002","ACK1 (TNK2)","Pan-specific","Activated CDC42 kinase 1",{"v":565.8217298361484,"d":"566"},{"v":467.321396931191,"d":"467"},{"v":347.4262215036066,"d":"347"},{"v":61.40206414557724,"d":"61"},{"v":163.81711263382203,"d":"164"},{"v":3094.723553604507,"d":"3095"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues near the C-terminus of human ACK.",null,null,"Q07912","Q07912",1883,"Q07912","Q07912","NP_005772","Block1",2,11,"1, 9, 17, 25","ACK1","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Ack",{"$nulls":6},"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK domain target; TK</A> group; Ack family","GO:0005912; GO:0005905; GO:0030136; GO:0005737; GO:0030659; GO:0005768; GO:0031234; GO:0070436; GO:0016020; GO:0005634; GO:0048471; GO:0005886","GO:0005524; GO:0005154; GO:0005095; GO:0042802; GO:0046872; GO:0004715; GO:0004712; GO:0004674; GO:0004713; GO:0031625; GO:0050699","GO:0030154; GO:0016477; GO:0007166; GO:0006897; GO:0045087; GO:0038083; GO:0016310; GO:0050731; GO:0042127; GO:2000369; GO:0007264; GO:0007169"]
[51,25,"PK511","ACK1 (TNK2)","Y284","Activated CDC42 kinase 1",{"v":15254.31899753053,"d":"15254"},{"v":14723.251937964282,"d":"14723"},{"v":3453.5092319788405,"d":"3454"},{"v":22.639550363001568,"d":"23"},{"v":2422.633794100895,"d":"2423"},{"v":28271.010803971774,"d":"28271"},"Kinexus","RpAb","DDH(pY)VMQ(bA)C","Corresponds to amino acid residues D281 to Q287; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y284 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII.","ACK1 (TNK2); Src","Q07912","Q07912",1883,"Q07912","Q07912","NP_005772","Block1",2,12,"1, 9, 17, 25","ACK1","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Ack",{"$nulls":6},"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK domain target; TK</A> group; Ack family","GO:0005912; GO:0005905; GO:0030136; GO:0005737; GO:0030659; GO:0005768; GO:0031234; GO:0070436; GO:0016020; GO:0005634; GO:0048471; GO:0005886","GO:0005524; GO:0005154; GO:0005095; GO:0042802; GO:0046872; GO:0004715; GO:0004712; GO:0004674; GO:0004713; GO:0031625; GO:0050699","GO:0030154; GO:0016477; GO:0007166; GO:0006897; GO:0045087; GO:0038083; GO:0016310; GO:0050731; GO:0042127; GO:2000369; GO:0007264; GO:0007169"]
[53,26,"PK512","ACK1 (TNK2)","Y518","Activated CDC42 kinase 1",{"v":17206.02995845622,"d":"17206"},{"v":16089.071579385072,"d":"16089"},{"v":4975.076935323895,"d":"4975"},{"v":28.914729006843338,"d":"29"},{"v":7299.661898229493,"d":"7300"},{"v":35704.63475843728,"d":"35705"},"Kinexus","RpAb","KPT(pY)DPV(bA)C","Corresponds to amino acid residues K515 to V521; Just after the GTPase-binding domain. ","Y518 phosphorylation stimulates phosphotransferase activity. This is major site of phosphorylation of ACK1 by mass spectrometry studies (≥757 reports).","ACK1 (TNK2)","Q07912","Q07912",1883,"Q07912","Q07912","NP_005772","Block1",2,13,"1, 9, 17, 25","ACK1","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Ack",{"$nulls":6},"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK domain target; TK</A> group; Ack family","GO:0005912; GO:0005905; GO:0030136; GO:0005737; GO:0030659; GO:0005768; GO:0031234; GO:0070436; GO:0016020; GO:0005634; GO:0048471; GO:0005886","GO:0005524; GO:0005154; GO:0005095; GO:0042802; GO:0046872; GO:0004715; GO:0004712; GO:0004674; GO:0004713; GO:0031625; GO:0050699","GO:0030154; GO:0016477; GO:0007166; GO:0006897; GO:0045087; GO:0038083; GO:0016310; GO:0050731; GO:0042127; GO:2000369; GO:0007264; GO:0007169"]
[55,27,"PK513","ACK1 (TNK2)","Y859+Y860","Activated CDC42 kinase 1",{"v":14111.670199158798,"d":"14112"},{"v":13788.84293963117,"d":"13789"},{"v":3702.7723796929968,"d":"3703"},{"v":26.239079623003946,"d":"26"},{"v":3182.816057171012,"d":"3183"},{"v":26703.477120814372,"d":"26703"},"Kinexus","RpAb","STH(pY)(pY)LL(bA)C","Corresponds to amino acid residues S856 to L862; In the Inhibitor_Mig-6 domain. ","The effects of Y859 and Y860 phosphorylation are unclear. These are two of the main sites of phosphorylation of ACK1 (Y859 >595 reports. Y860 (229 reports).","Bmx (Etk)","Q07912","Q07912",1883,"Q07912","Q07912","NP_005772","Block1",3,1,"1, 9, 17, 25","ACK1","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Ack",{"$nulls":6},"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK domain target; TK</A> group; Ack family","GO:0005912; GO:0005905; GO:0030136; GO:0005737; GO:0030659; GO:0005768; GO:0031234; GO:0070436; GO:0016020; GO:0005634; GO:0048471; GO:0005886","GO:0005524; GO:0005154; GO:0005095; GO:0042802; GO:0046872; GO:0004715; GO:0004712; GO:0004674; GO:0004713; GO:0031625; GO:0050699","GO:0030154; GO:0016477; GO:0007166; GO:0006897; GO:0045087; GO:0038083; GO:0016310; GO:0050731; GO:0042127; GO:2000369; GO:0007264; GO:0007169"]
[57,28,"PN735","ACLY","S455","ATP-citrate synthase",{"v":8355.865827170699,"d":"8356"},{"v":8392.097275990503,"d":"8392"},{"v":1708.2840697157535,"d":"1708"},{"v":20.444129968685477,"d":"20"},{"v":960.7812650796523,"d":"961"},{"v":17779.99346693043,"d":"17780"},"Kinexus","RpAb","RTA(pS)FSE(bA)C","Corresponds to amino acid residues S452 to E458.","The effect of S455 phosphorylation is unclear. This is the second most frequently phosphorylated site in ATP-citrate lysate in mass spectrometry studies (≥202 reports). This human phosphosite is highly conserved in vertebrates and is found in fish.","Akt1 (PKBa); Akt3 (PKBg)","P53396","P53396",1862,null,null,"NP_001087.2","Block1",3,2,"1, 9, 17, 25",{"$nulls":3},"Enzyme - Fatty acid synthesis",{"$nulls":8},"X","Transferase; Carbohydrate Metabolism - citrate (TCA) cycle; Lyase; EC 2.3.3.8","GO:0035578; GO:0009346; GO:0005829; GO:0070062; GO:0005576; GO:1904813; GO:0016020; GO:0005654; GO:0005886","GO:0005524; GO:0003878; GO:0048037; GO:0046872","GO:0006085; GO:0006695; GO:0006101; GO:0015936; GO:0006633; GO:0046949; GO:0008610; GO:0043312; GO:0006107; GO:0031325"]
[59,29,"PN686","ACLY","Y682","ATP-citrate synthase",{"v":11718.39018950931,"d":"11718"},{"v":11718.795111495052,"d":"11719"},{"v":2296.422977441922,"d":"2296"},{"v":19.596744435918815,"d":"20"},{"v":1212.214543560647,"d":"1212"},{"v":19329.464659252004,"d":"19329"},"Kinexus","RpAb","DGV(pY)EGVA(bA)C","Corresponds to amino acid residues D679 to A686.","The effect of Y682 phosphorylation is unclear. This is the most frequently phosphorylated site in ATP-citrate lysate in mass spectrometry studies (≥378 reports). This human phosphosite is highly conserved in vertebrates and also found in the nematode worm.",null,"P53396","P53396",1862,null,null,"NP_001087.2","Block1",3,3,"1, 9, 17, 25",{"$nulls":3},"Enzyme - Fatty acid synthesis",{"$nulls":8},"X","Transferase; Carbohydrate Metabolism - citrate (TCA) cycle; Lyase; EC 2.3.3.8","GO:0035578; GO:0009346; GO:0005829; GO:0070062; GO:0005576; GO:1904813; GO:0016020; GO:0005654; GO:0005886","GO:0005524; GO:0003878; GO:0048037; GO:0046872","GO:0006085; GO:0006695; GO:0006101; GO:0015936; GO:0006633; GO:0046949; GO:0008610; GO:0043312; GO:0006107; GO:0031325"]
[61,30,"PN736","ACO1","S711","Cytoplasmic aconitate hydratase",{"v":10757.630952574575,"d":"10758"},{"v":10873.637769763754,"d":"10874"},{"v":2243.630166924765,"d":"2244"},{"v":20.856173416023417,"d":"21"},{"v":956.3443717587429,"d":"956"},{"v":18333.38167057828,"d":"18333"},"Kinexus","RpAb","SYG(pS)RRG(bA)C","Corresponds to amino acid residues S708 to G714.","S711 phosphorylation inhibits enzyme activity. This is phosphorylation site in ACO1 has not been detected by mass spectrometry. This human phosphosite is highly conserved in vertebrates and also found in yeast.","PKCa (PRKCA)","P21399","P21399",5108,null,null,"NP_001265281.1","Block1",3,4,"1, 9, 17, 25",{"$nulls":3},"Enzyme",{"$nulls":8},"X","Enzyme, translation initiation complex","GO:0005737; GO:0005829; GO:0005783; GO:0070062; GO:0005794; GO:0005739","GO:0051538; GO:0051539; GO:0003994; GO:0030350; GO:0046872; GO:0003723","GO:0006879; GO:0006101; GO:0050892; GO:0009791; GO:0006417; GO:0010040; GO:0006099"]
[63,31,"PN737","ACO1","S806","Cytoplasmic aconitate hydratase",{"v":6919.287250186141,"d":"6919"},{"v":6704.149287813923,"d":"6704"},{"v":1891.7908050042474,"d":"1892"},{"v":27.34083347895919,"d":"27"},{"v":2777.071113322557,"d":"2777"},{"v":13210.799740258233,"d":"13211"},"Kinexus","RpAb","IHR(pS)NLVGC","Corresponds to amino acid residues I803 to G810.","The effect S806 of phosphorylation is unclear. This is phosphorylation site in ACO1 has only been reported in one mass spectrometry study. This human phosphosite is highly conserved in vertebrates and found in fish.",null,"P21399","P21399",5108,null,null,"NP_001265281.1","Block1",3,5,"1, 9, 17, 25",{"$nulls":3},"Enzyme",{"$nulls":8},"X","Enzyme, translation initiation complex","GO:0005737; GO:0005829; GO:0005783; GO:0070062; GO:0005794; GO:0005739","GO:0051538; GO:0051539; GO:0003994; GO:0030350; GO:0046872; GO:0003723","GO:0006879; GO:0006101; GO:0050892; GO:0009791; GO:0006417; GO:0010040; GO:0006099"]
[65,32,"PN687","ACP1","Y132+Y133","Low molecular weight phosphotyrosine protein phosphatase",{"v":1091.1487711514471,"d":"1091"},{"v":1072.5846058157067,"d":"1073"},{"v":469.14695956601435,"d":"469"},{"v":42.99569151060324,"d":"43"},{"v":153.68890145720889,"d":"154"},{"v":2464.6015005815516,"d":"2465"},"Kinexus","RpAb","EDP(pY)(pY)GND(bA)C","Corresponds to amino acid residues E129 to D136.","Y132 and Y133 phosphorylation stimulates phosphatase activity, and regulates cell adhesion, cell motility, and transcription. These are two major in vivo phosphorylation site in ACP1 (≥205 and >86 reports, respectively, by mass spectrometry). These phosphosites are highly conserved and also found in yeast.","Y132: Lck; Src. Y133: Lck; Src.","P24666","P24666",5205,null,null,"NP_004291.1","Block1",3,6,"1, 9, 17, 25",{"$nulls":3},"Phosphatase",{"$nulls":6},"X",null,null,"EC 3.1.3.48; EC 3.1.3.2; Cofactor and Vitamin Metabolism - riboflavin; Phosphatase (non-protein); Protein phosphatase, tyrosine (non-receptor)","GO:0005737; GO:0009898; GO:0005829; GO:0070062; GO:0042383","GO:0003993; GO:0004726"]
[67,33,"PN688","ACS1 (ACSL1)","Y567","Long-chain-fatty-acid--CoA ligase 1",{"v":6576.816762540648,"d":"6577"},{"v":6623.9702759123675,"d":"6624"},{"v":1549.2664239686949,"d":"1549"},{"v":23.556478459196235,"d":"24"},{"v":1078.8226574879452,"d":"1079"},{"v":11665.18164938431,"d":"11665"},"Kinexus","RpAb","acQGE(pY)IAP(bA)C","Corresponds to amino acid residues Q564 to P570.","The effect of Y567 phosphorylation is unclear. This is the most frequently phosphorylated site in ACS1 from mass spectrometry studies (≥20 reports). This human phosphosite is highly conserved in vertebrates and is found in the fruit fly.",null,"P33121","P33121",15691,null,null,"NP_001273637.1","Block1",3,7,"1, 9, 17, 25",{"$nulls":3},"Enzyme - Fatty acid synthesis",{"$nulls":8},"X","EC 6.2.1.3; Lipid Metabolism - fatty acid; Ligase","GO:0005789; GO:0016021; GO:0016020; GO:0005741; GO:0005739; GO:0005778; GO:0005886","GO:0005524; GO:0102391; GO:0004467","GO:0033211; GO:0036109; GO:0043651; GO:0008610; GO:0044539; GO:0001676; GO:0035338; GO:0120162; GO:0071902; GO:0019216; GO:0042493; GO:0007584; GO:0034201; GO:0014070; GO:0019432; GO:0042178"]
[69,34,"NN218-1","ACTB","Pan-specific","Actin, cytoplasmic 1; Beta-actin",{"v":1314.3733976555568,"d":"1314"},{"v":1261.378220025671,"d":"1261"},{"v":713.1528504766314,"d":"713"},{"v":54.258010071466735,"d":"54"},{"v":21.97277119992664,"d":"22"},{"v":3678.5019855897835,"d":"3679"},"External","RpAb","Epitope undefined.",{"$nulls":3},"P60709","P60709",4107,null,"P60709","NP_001092.1","Block1",3,8,"1, 9, 17, 25",{"$nulls":3},"Cytoskeletal/contractile protein",{"$nulls":9},"Cytoskeletal protein","GO:0015629; GO:0072562; GO:0044305; GO:0030863; GO:0005737; GO:0036464; GO:0005856; GO:0005829; GO:0097433; GO:0070062; GO:0005615; GO:0005925; GO:0098978; GO:0016020; GO:0043209; GO:0035267; GO:0000790; GO:0005654; GO:0005634; GO:0005886; GO:0098871; GO:0098793; GO:0032991; GO:1990904; GO:0098685; GO:0031982","GO:0005524; GO:0042802; GO:0019894; GO:0050998; GO:0019901; GO:0005200; GO:0098973; GO:0030957","GO:0043044; GO:0034329; GO:0048870; GO:0072749; GO:0048013; GO:0038096; GO:0061024; GO:0032091; GO:0070527; GO:0045815; GO:0051623; GO:0098974; GO:0016579; GO:0000079; GO:0051621; GO:1903076; GO:0022898; GO:0001895; GO:0021762; GO:0048488"]
[71,35,"PN501","ACTB","Y53","Actin, cytoplasmic 1; Beta-actin",{"v":2327.287398679857,"d":"2327"},{"v":2227.53208644091,"d":"2228"},{"v":1348.0200900243292,"d":"1348"},{"v":57.92237309362769,"d":"58"},{"v":230.987548533802,"d":"231"},{"v":12487.439797315119,"d":"12487"},"Kinexus","RpAb","KDS(pY)VGD(bA)C","Corresponds to amino acid residues K50 to D56; In the Actin domain. ","The effect of Y53 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in actin from mass spectrometry studies (≥1069 reports).",null,"P60709","P60709",4107,null,"P60709","NP_001092.1","Block1",3,9,"1, 9, 17, 25",{"$nulls":3},"Cytoskeletal/contractile protein",{"$nulls":9},"Cytoskeletal protein","GO:0015629; GO:0072562; GO:0044305; GO:0030863; GO:0005737; GO:0036464; GO:0005856; GO:0005829; GO:0097433; GO:0070062; GO:0005615; GO:0005925; GO:0098978; GO:0016020; GO:0043209; GO:0035267; GO:0000790; GO:0005654; GO:0005634; GO:0005886; GO:0098871; GO:0098793; GO:0032991; GO:1990904; GO:0098685; GO:0031982","GO:0005524; GO:0042802; GO:0019894; GO:0050998; GO:0019901; GO:0005200; GO:0098973; GO:0030957","GO:0043044; GO:0034329; GO:0048870; GO:0072749; GO:0048013; GO:0038096; GO:0061024; GO:0032091; GO:0070527; GO:0045815; GO:0051623; GO:0098974; GO:0016579; GO:0000079; GO:0051621; GO:1903076; GO:0022898; GO:0001895; GO:0021762; GO:0048488"]
[73,36,"PN500","ACTB","Y294","Actin, cytoplasmic 1; Beta-actin",{"v":12096.837558098234,"d":"12097"},{"v":11832.329179760045,"d":"11832"},{"v":3005.0498270848743,"d":"3005"},{"v":24.84161511347354,"d":"25"},{"v":1667.1693518709938,"d":"1667"},{"v":25498.98066700907,"d":"25499"},"Kinexus","RpAb","KDL(pY)ANT(bA)C","Corresponds to amino acid residues K291 to T297; In the Actin domain. ","The effect of Y294 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in actin from mass spectrometry studies (≥783 reports).",null,"P60709","P60709",4107,null,"P60709","NP_001092.1","Block1",3,10,"1, 9, 17, 25",{"$nulls":3},"Cytoskeletal/contractile protein",{"$nulls":9},"Cytoskeletal protein","GO:0015629; GO:0072562; GO:0044305; GO:0030863; GO:0005737; GO:0036464; GO:0005856; GO:0005829; GO:0097433; GO:0070062; GO:0005615; GO:0005925; GO:0098978; GO:0016020; GO:0043209; GO:0035267; GO:0000790; GO:0005654; GO:0005634; GO:0005886; GO:0098871; GO:0098793; GO:0032991; GO:1990904; GO:0098685; GO:0031982","GO:0005524; GO:0042802; GO:0019894; GO:0050998; GO:0019901; GO:0005200; GO:0098973; GO:0030957","GO:0043044; GO:0034329; GO:0048870; GO:0072749; GO:0048013; GO:0038096; GO:0061024; GO:0032091; GO:0070527; GO:0045815; GO:0051623; GO:0098974; GO:0016579; GO:0000079; GO:0051621; GO:1903076; GO:0022898; GO:0001895; GO:0021762; GO:0048488"]
[75,37,"PN502","ACTN1","Y246","Alpha-actinin-1",{"v":15163.16507740308,"d":"15163"},{"v":15080.452356835722,"d":"15080"},{"v":2696.858292870954,"d":"2697"},{"v":17.785589480193348,"d":"18"},{"v":1705.300129152642,"d":"1705"},{"v":23736.15734881332,"d":"23736"},"Kinexus","RpAb","SSF(pY)HAF(bA)C","Corresponds to amino acid residues S243 to F249; In the second CH domain.","The effect of Y246 phosphorylation is unclear. This is the major in vivo phosphorylation site in ACTN1 from mass spectrometry studies (≥522 reports).",null,"P12814","P12814",3911,null,null,"NP_1093.1","Block1",3,11,"1, 9, 17, 25",{"$nulls":3},"Cytoskeletal/contractile protein",{"$nulls":9},"Cytoskeletal protein","GO:0005903; GO:0005911; GO:0042995; GO:0005737; GO:0005829; GO:0070062; GO:0005576; GO:0005615; GO:0005916; GO:0005925; GO:0098978; GO:0005622; GO:0005886; GO:0031093; GO:0031143; GO:0001726; GO:0001725; GO:0030018","GO:0051015; GO:0005509; GO:0003725; GO:0005178; GO:0044325; GO:0030374; GO:0042803; GO:0099186; GO:0017166","GO:0051764; GO:0051017; GO:0051639; GO:0007015; GO:0048041; GO:0051271; GO:0002576; GO:0030220; GO:0036344; GO:0042981"]
[77,38,"NK357-1","ACTR-I (ALK2","Pan-specific","Activin receptor type-1",{"v":346.5035119206985,"d":"347"},{"v":249.37947503126986,"d":"249"},{"v":334.24784751760495,"d":"334"},{"v":96.46304756475358,"d":"96"},{"v":48.58388122854203,"d":"49"},{"v":3323.0313567086205,"d":"3323"},"External","MmAb","Not precisely defined.","Antibody raised against a peptide mapping at the N-terminus of human ACTR-I. ",null,null,"Q04771","Q04771",12612,"Q04771","Q04771","NP_001096.1","Block1",3,12,"1, 9, 17, 25","ALK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","STKR","Type 1",{"$nulls":5},"Protein-serine kinase, TKL group, STKR family, Type 1 subfamily","GO:0048179; GO:0045177; GO:0005887","GO:0048185; GO:0016361; GO:0005524; GO:0046872; GO:0017046; GO:0042803; GO:0004672; GO:0004674; GO:0046332; GO:0050431; GO:0005025; GO:0004675","GO:0032924; GO:0002526; GO:0003289; GO:0003181; GO:0030509; GO:0061312; GO:0001569; GO:0060923; GO:0071773; GO:0007368; GO:0003143; GO:0061445; GO:0003274; GO:0003203; GO:0000082; GO:0001702; GO:0007281; GO:0001701; GO:0001707; GO:0003183; GO:0032926; GO:2001237; GO:0009968; GO:0001755; GO:0060389; GO:0018107; GO:0060037; GO:0030501; GO:0030335; GO:2000017; GO:1905007; GO:0045669; GO:0010862; GO:0045893; GO:0045944; GO:0006468; GO:0030278; GO:0051145; GO:0007179; GO:0060412"]
[79,39,"PN003-PN004","Adducin a/g (ADD3)","S726","Adducin-alpha/gamma",{"v":556.4971139974679,"d":"556"},{"v":454.37407098581957,"d":"454"},{"v":414.3034414988976,"d":"414"},{"v":74.44844386035444,"d":"74"},{"v":32.39343351881627,"d":"32"},{"v":2673.4968628219362,"d":"2673"},"External","RpAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the S726 and S693 phosphosites in ADD1 and ADD3 [TP(pS)FL]. ","Phosphorylation of S726 affects intracellular location of ADD1, and induced cell motility. This is the major in vivo phosphorylation site in ADD1 from mass spectrometry studies (≥208 reports) and ADD3 (≥213 reports).","PKCA; CHK1; PKCz (PRKCZ); PKACa (PRKACA)","Q9UEY8","Q9UEY8",3233,null,"Q9UEY8","NP_058432.1","Block1",3,13,"1, 9, 17, 25",{"$nulls":3},"Cytoskeletal/contractile protein",{"$nulls":9},"Cytoskeletal protein","GO:0005903; GO:0005911; GO:0005938; GO:0000794; GO:0005856; GO:0005829; GO:0016020; GO:0005654; GO:0005886; GO:0014069","GO:0003779; GO:0005516; GO:0005200","GO:0055085"]
[81,40,"PN689","ADK","S86","Adenosine kinase",{"v":683.0396301598194,"d":"683"},{"v":556.4929558550928,"d":"556"},{"v":484.7149748392833,"d":"485"},{"v":70.96439993179729,"d":"71"},{"v":68.88658734844427,"d":"69"},{"v":4544.784992267261,"d":"4545"},"Kinexus","RpAb","TQN(pS)IKVAC","Corresponds to amino acid residues T83 to A90.","The effect of S86 phosphorylation is unclear. Although this phosphosite has not been easily identified by mass spectrometry (no reports), its surrounding sequence is highly conserved in evolution, including in plants and fungi.",null,"P55263","P55263",19736,null,null,"NP_001114.2","Block1",4,1,"1, 9, 17, 25",{"$nulls":3},"Enzyme - Nucleotide metabolism",{"$nulls":8},"X","Enzyme, metabolite kinase","GO:0005829; GO:0005654; GO:0005634","GO:0004001; GO:0005524; GO:0046872; GO:0003723","GO:0006169; GO:0044209; GO:0046835; GO:0006175; GO:0043101; GO:0009156"]
[83,41,"NK129-3","Akt1 (PKBa)","Pan-specific","RAC-alpha serine/threonine-protein kinase",{"v":3825.8233468284775,"d":"3826"},{"v":3953.008008633719,"d":"3953"},{"v":1697.7407661542773,"d":"1698"},{"v":44.37582742971305,"d":"44"},{"v":320.40675465164304,"d":"320"},{"v":8109.329570551356,"d":"8109"},"Kinexus","RpAb","CEMEVSLAKPKHRVTM","Corresponds to amino acid residues E133 to M147; Pre-kinase catalytic domain.",null,null,"P31749","P31749",570,"P31749","P31749","NP_005154","Block1",4,2,"1, 9, 17, 25","AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"EC 2.7.11.1; Nuclear receptor co-regulator; Protein kinase, Ser/Thr (non-receptor); AGC group; AKT family","GO:0005911; GO:0036064; GO:0005737; GO:0005829; GO:0015630; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0098794; GO:0032991; GO:0005819; GO:0031982","GO:0071889; GO:0005524; GO:0019899; GO:0032794; GO:0042802; GO:0016301; GO:0030235; GO:0005547; GO:0043325; GO:0042803; GO:0004672; GO:0005080; GO:0051721; GO:0004712; GO:0004674","GO:0006924; GO:0032148; GO:0007568; GO:0043276; GO:0008637; GO:0008643; GO:0030154; GO:0002042; GO:0030030; GO:0008283; GO:0006464; GO:0071276; GO:0006974; GO:0071364; GO:0097011; GO:0071456; GO:0032869; GO:0071260; GO:1990090; GO:0071407; GO:0140052; GO:0071380; GO:0034614; GO:0071356; GO:0035924; GO:0051186; GO:0019221; GO:0031018; GO:0007173; GO:0072655; GO:0060079; GO:0097194; GO:0007281; GO:0042593; GO:0006006; GO:0005978; GO:0060709; GO:0007186; GO:0030212; GO:0007249; GO:0006954; GO:0048009; GO:0008286; GO:0035655; GO:0035556; GO:0060716; GO:0031663; GO:0072656; GO:0060644; GO:0001893; GO:0043066; GO:0010507; GO:0045792; GO:0043154; GO:0010951; GO:2001240; GO:0031999; GO:0010629; GO:0046329; GO:1903038; GO:2000402; GO:0016242; GO:1901215; GO:0045746; GO:1902176; GO:0010748; GO:0032091; GO:0006469; GO:0100002; GO:0051898; GO:0071901; GO:0031397; GO:0045861; GO:0090201; GO:0038061; GO:0006809; GO:0001649; GO:0018105; GO:0018107; GO:0032287; GO:0014065; GO:0016310; GO:0043065; GO:0043536; GO:0030307; GO:0008284; GO:0032270; GO:0031659; GO:0051091; GO:0032079; GO:0001938; GO:0045742; GO:0045600; GO:0010763; GO:0010628; GO:0046326; GO:0010907; GO:0045725; GO:1903721; GO:0046889; GO:0010918; GO:0045429; GO:0051000; GO:0046622; GO:0033138; GO:0032436; GO:2000010; GO:1900182; GO:1903078; GO:0001934; GO:0048661; GO:0010765; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0030163; GO:0000060; GO:0043491; GO:0006468; GO:0016567; GO:0042981; GO:0030334; GO:0005979; GO:0043488; GO:0031641; GO:0010975; GO:0050999; GO:1901796; GO:0006417; GO:0034405; GO:0032094; GO:0060416; GO:0009408; GO:1990418; GO:0006979; GO:0070141; GO:0007165; GO:0021510; GO:0051146; GO:0031295; GO:0031929; GO:0006412"]
[85,42,"NK129-5","Akt1 (PKBa)","Pan-specific","RAC-alpha serine/threonine-protein kinase",{"v":9491.539392646,"d":"9492"},{"v":9177.47676376986,"d":"9177"},{"v":2070.909916291297,"d":"2071"},{"v":21.818483078686143,"d":"22"},{"v":4400.25988234588,"d":"4400"},{"v":19004.724664791516,"d":"19005"},"Kinexus","RpAb","CDQDDSMEGVDSERRP","Corresponds to amino acid residues D435 to P467; Pre-C-terminus.",null,null,"P31749","P31749",570,"P31749","P31749","NP_005154","Block1",4,3,"1, 9, 17, 25","AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"EC 2.7.11.1; Nuclear receptor co-regulator; Protein kinase, Ser/Thr (non-receptor); AGC group; AKT family","GO:0005911; GO:0036064; GO:0005737; GO:0005829; GO:0015630; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0098794; GO:0032991; GO:0005819; GO:0031982","GO:0071889; GO:0005524; GO:0019899; GO:0032794; GO:0042802; GO:0016301; GO:0030235; GO:0005547; GO:0043325; GO:0042803; GO:0004672; GO:0005080; GO:0051721; GO:0004712; GO:0004674","GO:0006924; GO:0032148; GO:0007568; GO:0043276; GO:0008637; GO:0008643; GO:0030154; GO:0002042; GO:0030030; GO:0008283; GO:0006464; GO:0071276; GO:0006974; GO:0071364; GO:0097011; GO:0071456; GO:0032869; GO:0071260; GO:1990090; GO:0071407; GO:0140052; GO:0071380; GO:0034614; GO:0071356; GO:0035924; GO:0051186; GO:0019221; GO:0031018; GO:0007173; GO:0072655; GO:0060079; GO:0097194; GO:0007281; GO:0042593; GO:0006006; GO:0005978; GO:0060709; GO:0007186; GO:0030212; GO:0007249; GO:0006954; GO:0048009; GO:0008286; GO:0035655; GO:0035556; GO:0060716; GO:0031663; GO:0072656; GO:0060644; GO:0001893; GO:0043066; GO:0010507; GO:0045792; GO:0043154; GO:0010951; GO:2001240; GO:0031999; GO:0010629; GO:0046329; GO:1903038; GO:2000402; GO:0016242; GO:1901215; GO:0045746; GO:1902176; GO:0010748; GO:0032091; GO:0006469; GO:0100002; GO:0051898; GO:0071901; GO:0031397; GO:0045861; GO:0090201; GO:0038061; GO:0006809; GO:0001649; GO:0018105; GO:0018107; GO:0032287; GO:0014065; GO:0016310; GO:0043065; GO:0043536; GO:0030307; GO:0008284; GO:0032270; GO:0031659; GO:0051091; GO:0032079; GO:0001938; GO:0045742; GO:0045600; GO:0010763; GO:0010628; GO:0046326; GO:0010907; GO:0045725; GO:1903721; GO:0046889; GO:0010918; GO:0045429; GO:0051000; GO:0046622; GO:0033138; GO:0032436; GO:2000010; GO:1900182; GO:1903078; GO:0001934; GO:0048661; GO:0010765; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0030163; GO:0000060; GO:0043491; GO:0006468; GO:0016567; GO:0042981; GO:0030334; GO:0005979; GO:0043488; GO:0031641; GO:0010975; GO:0050999; GO:1901796; GO:0006417; GO:0034405; GO:0032094; GO:0060416; GO:0009408; GO:1990418; GO:0006979; GO:0070141; GO:0007165; GO:0021510; GO:0051146; GO:0031295; GO:0031929; GO:0006412"]
[87,43,"NK129","Akt1 (PKBa)","Pan-specific","RAC-alpha serine/threonine-protein kinase",{"v":465.65987924315,"d":"466"},{"v":398.7929995461794,"d":"399"},{"v":249.5391237596101,"d":"250"},{"v":53.58828082101319,"d":"54"},{"v":74.2982787933041,"d":"74"},{"v":1407.0805740912087,"d":"1407"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 345-480 of human Akt1.",null,null,"P31749","P31749",570,"P31749","P31749","NP_005154","Block1",4,4,"1, 9, 17, 25","AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"EC 2.7.11.1; Nuclear receptor co-regulator; Protein kinase, Ser/Thr (non-receptor); AGC group; AKT family","GO:0005911; GO:0036064; GO:0005737; GO:0005829; GO:0015630; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0098794; GO:0032991; GO:0005819; GO:0031982","GO:0071889; GO:0005524; GO:0019899; GO:0032794; GO:0042802; GO:0016301; GO:0030235; GO:0005547; GO:0043325; GO:0042803; GO:0004672; GO:0005080; GO:0051721; GO:0004712; GO:0004674","GO:0006924; GO:0032148; GO:0007568; GO:0043276; GO:0008637; GO:0008643; GO:0030154; GO:0002042; GO:0030030; GO:0008283; GO:0006464; GO:0071276; GO:0006974; GO:0071364; GO:0097011; GO:0071456; GO:0032869; GO:0071260; GO:1990090; GO:0071407; GO:0140052; GO:0071380; GO:0034614; GO:0071356; GO:0035924; GO:0051186; GO:0019221; GO:0031018; GO:0007173; GO:0072655; GO:0060079; GO:0097194; GO:0007281; GO:0042593; GO:0006006; GO:0005978; GO:0060709; GO:0007186; GO:0030212; GO:0007249; GO:0006954; GO:0048009; GO:0008286; GO:0035655; GO:0035556; GO:0060716; GO:0031663; GO:0072656; GO:0060644; GO:0001893; GO:0043066; GO:0010507; GO:0045792; GO:0043154; GO:0010951; GO:2001240; GO:0031999; GO:0010629; GO:0046329; GO:1903038; GO:2000402; GO:0016242; GO:1901215; GO:0045746; GO:1902176; GO:0010748; GO:0032091; GO:0006469; GO:0100002; GO:0051898; GO:0071901; GO:0031397; GO:0045861; GO:0090201; GO:0038061; GO:0006809; GO:0001649; GO:0018105; GO:0018107; GO:0032287; GO:0014065; GO:0016310; GO:0043065; GO:0043536; GO:0030307; GO:0008284; GO:0032270; GO:0031659; GO:0051091; GO:0032079; GO:0001938; GO:0045742; GO:0045600; GO:0010763; GO:0010628; GO:0046326; GO:0010907; GO:0045725; GO:1903721; GO:0046889; GO:0010918; GO:0045429; GO:0051000; GO:0046622; GO:0033138; GO:0032436; GO:2000010; GO:1900182; GO:1903078; GO:0001934; GO:0048661; GO:0010765; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0030163; GO:0000060; GO:0043491; GO:0006468; GO:0016567; GO:0042981; GO:0030334; GO:0005979; GO:0043488; GO:0031641; GO:0010975; GO:0050999; GO:1901796; GO:0006417; GO:0034405; GO:0032094; GO:0060416; GO:0009408; GO:1990418; GO:0006979; GO:0070141; GO:0007165; GO:0021510; GO:0051146; GO:0031295; GO:0031929; GO:0006412"]
[89,44,"PK515","Akt1 (PKBa)","T308","RAC-alpha serine/threonine-protein kinase",{"v":9871.175816591664,"d":"9871"},{"v":10001.582389555777,"d":"10002"},{"v":2209.886531162907,"d":"2210"},{"v":22.38726745651199,"d":"22"},{"v":1693.3474296716622,"d":"1693"},{"v":18807.74322915744,"d":"18808"},"Kinexus","RpAb","TMK(pT)FCG(bA)C","Corresponds to amino acid residues T305 to G311; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T308 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of phosphorylation of Akt1 by mass spectrometry studies (≥26 reports).",null,"P31749","P31749",570,"P31749","P31749","NP_005154","Block1",4,5,"1, 9, 17, 25","AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"EC 2.7.11.1; Nuclear receptor co-regulator; Protein kinase, Ser/Thr (non-receptor); AGC group; AKT family","GO:0005911; GO:0036064; GO:0005737; GO:0005829; GO:0015630; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0098794; GO:0032991; GO:0005819; GO:0031982","GO:0071889; GO:0005524; GO:0019899; GO:0032794; GO:0042802; GO:0016301; GO:0030235; GO:0005547; GO:0043325; GO:0042803; GO:0004672; GO:0005080; GO:0051721; GO:0004712; GO:0004674","GO:0006924; GO:0032148; GO:0007568; GO:0043276; GO:0008637; GO:0008643; GO:0030154; GO:0002042; GO:0030030; GO:0008283; GO:0006464; GO:0071276; GO:0006974; GO:0071364; GO:0097011; GO:0071456; GO:0032869; GO:0071260; GO:1990090; GO:0071407; GO:0140052; GO:0071380; GO:0034614; GO:0071356; GO:0035924; GO:0051186; GO:0019221; GO:0031018; GO:0007173; GO:0072655; GO:0060079; GO:0097194; GO:0007281; GO:0042593; GO:0006006; GO:0005978; GO:0060709; GO:0007186; GO:0030212; GO:0007249; GO:0006954; GO:0048009; GO:0008286; GO:0035655; GO:0035556; GO:0060716; GO:0031663; GO:0072656; GO:0060644; GO:0001893; GO:0043066; GO:0010507; GO:0045792; GO:0043154; GO:0010951; GO:2001240; GO:0031999; GO:0010629; GO:0046329; GO:1903038; GO:2000402; GO:0016242; GO:1901215; GO:0045746; GO:1902176; GO:0010748; GO:0032091; GO:0006469; GO:0100002; GO:0051898; GO:0071901; GO:0031397; GO:0045861; GO:0090201; GO:0038061; GO:0006809; GO:0001649; GO:0018105; GO:0018107; GO:0032287; GO:0014065; GO:0016310; GO:0043065; GO:0043536; GO:0030307; GO:0008284; GO:0032270; GO:0031659; GO:0051091; GO:0032079; GO:0001938; GO:0045742; GO:0045600; GO:0010763; GO:0010628; GO:0046326; GO:0010907; GO:0045725; GO:1903721; GO:0046889; GO:0010918; GO:0045429; GO:0051000; GO:0046622; GO:0033138; GO:0032436; GO:2000010; GO:1900182; GO:1903078; GO:0001934; GO:0048661; GO:0010765; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0030163; GO:0000060; GO:0043491; GO:0006468; GO:0016567; GO:0042981; GO:0030334; GO:0005979; GO:0043488; GO:0031641; GO:0010975; GO:0050999; GO:1901796; GO:0006417; GO:0034405; GO:0032094; GO:0060416; GO:0009408; GO:1990418; GO:0006979; GO:0070141; GO:0007165; GO:0021510; GO:0051146; GO:0031295; GO:0031929; GO:0006412"]
[91,45,"PK516","Akt1 (PKBa)","Y315","RAC-alpha serine/threonine-protein kinase",{"v":7996.379471857099,"d":"7996"},{"v":8065.971780389777,"d":"8066"},{"v":1776.8948279369015,"d":"1777"},{"v":22.22124192818267,"d":"22"},{"v":107.80412890861098,"d":"108"},{"v":14286.469891606475,"d":"14286"},"Kinexus","RpAb","TPE(pY)LAP(bA)C","Corresponds to amino acid residues T312 to P318; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y315 phosphorylation has been reported to be stimulatory for phosphotransferase activity, although the precise positioning of this phosphosites is predicted to be inhibitory. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. It is one of many sites that have been reported by mass spectrometry studies (≥15 reports).","Brk (PTK6); Ret; Src","P31749","P31749",570,"P31749","P31749","NP_005154","Block1",4,6,"1, 9, 17, 25","AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"EC 2.7.11.1; Nuclear receptor co-regulator; Protein kinase, Ser/Thr (non-receptor); AGC group; AKT family","GO:0005911; GO:0036064; GO:0005737; GO:0005829; GO:0015630; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0098794; GO:0032991; GO:0005819; GO:0031982","GO:0071889; GO:0005524; GO:0019899; GO:0032794; GO:0042802; GO:0016301; GO:0030235; GO:0005547; GO:0043325; GO:0042803; GO:0004672; GO:0005080; GO:0051721; GO:0004712; GO:0004674","GO:0006924; GO:0032148; GO:0007568; GO:0043276; GO:0008637; GO:0008643; GO:0030154; GO:0002042; GO:0030030; GO:0008283; GO:0006464; GO:0071276; GO:0006974; GO:0071364; GO:0097011; GO:0071456; GO:0032869; GO:0071260; GO:1990090; GO:0071407; GO:0140052; GO:0071380; GO:0034614; GO:0071356; GO:0035924; GO:0051186; GO:0019221; GO:0031018; GO:0007173; GO:0072655; GO:0060079; GO:0097194; GO:0007281; GO:0042593; GO:0006006; GO:0005978; GO:0060709; GO:0007186; GO:0030212; GO:0007249; GO:0006954; GO:0048009; GO:0008286; GO:0035655; GO:0035556; GO:0060716; GO:0031663; GO:0072656; GO:0060644; GO:0001893; GO:0043066; GO:0010507; GO:0045792; GO:0043154; GO:0010951; GO:2001240; GO:0031999; GO:0010629; GO:0046329; GO:1903038; GO:2000402; GO:0016242; GO:1901215; GO:0045746; GO:1902176; GO:0010748; GO:0032091; GO:0006469; GO:0100002; GO:0051898; GO:0071901; GO:0031397; GO:0045861; GO:0090201; GO:0038061; GO:0006809; GO:0001649; GO:0018105; GO:0018107; GO:0032287; GO:0014065; GO:0016310; GO:0043065; GO:0043536; GO:0030307; GO:0008284; GO:0032270; GO:0031659; GO:0051091; GO:0032079; GO:0001938; GO:0045742; GO:0045600; GO:0010763; GO:0010628; GO:0046326; GO:0010907; GO:0045725; GO:1903721; GO:0046889; GO:0010918; GO:0045429; GO:0051000; GO:0046622; GO:0033138; GO:0032436; GO:2000010; GO:1900182; GO:1903078; GO:0001934; GO:0048661; GO:0010765; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0030163; GO:0000060; GO:0043491; GO:0006468; GO:0016567; GO:0042981; GO:0030334; GO:0005979; GO:0043488; GO:0031641; GO:0010975; GO:0050999; GO:1901796; GO:0006417; GO:0034405; GO:0032094; GO:0060416; GO:0009408; GO:1990418; GO:0006979; GO:0070141; GO:0007165; GO:0021510; GO:0051146; GO:0031295; GO:0031929; GO:0006412"]
[93,46,"PK517","Akt1 (PKBa)","Y326","RAC-alpha serine/threonine-protein kinase",{"v":1343.5953294827143,"d":"1344"},{"v":1308.9765722808415,"d":"1309"},{"v":700.6874292426032,"d":"701"},{"v":52.150183456827634,"d":"52"},{"v":55.70218191158258,"d":"56"},{"v":4185.2130429618,"d":"4185"},"Kinexus","RpAb","DND(pY)GRA(bA)C","Corresponds to amino acid residues D323 to A329; In the protein kinase catalytic domain.","Y326 phosphorylation stimulates phosphotransferase activity. This is one of the major sites of phosphorylation of Akt1 by mass spectrometry studies (≥28 reports).","Brk (PTK6); Src","P31749","P31749",570,"P31749","P31749","NP_005154","Block1",4,7,"1, 9, 17, 25","AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"EC 2.7.11.1; Nuclear receptor co-regulator; Protein kinase, Ser/Thr (non-receptor); AGC group; AKT family","GO:0005911; GO:0036064; GO:0005737; GO:0005829; GO:0015630; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0098794; GO:0032991; GO:0005819; GO:0031982","GO:0071889; GO:0005524; GO:0019899; GO:0032794; GO:0042802; GO:0016301; GO:0030235; GO:0005547; GO:0043325; GO:0042803; GO:0004672; GO:0005080; GO:0051721; GO:0004712; GO:0004674","GO:0006924; GO:0032148; GO:0007568; GO:0043276; GO:0008637; GO:0008643; GO:0030154; GO:0002042; GO:0030030; GO:0008283; GO:0006464; GO:0071276; GO:0006974; GO:0071364; GO:0097011; GO:0071456; GO:0032869; GO:0071260; GO:1990090; GO:0071407; GO:0140052; GO:0071380; GO:0034614; GO:0071356; GO:0035924; GO:0051186; GO:0019221; GO:0031018; GO:0007173; GO:0072655; GO:0060079; GO:0097194; GO:0007281; GO:0042593; GO:0006006; GO:0005978; GO:0060709; GO:0007186; GO:0030212; GO:0007249; GO:0006954; GO:0048009; GO:0008286; GO:0035655; GO:0035556; GO:0060716; GO:0031663; GO:0072656; GO:0060644; GO:0001893; GO:0043066; GO:0010507; GO:0045792; GO:0043154; GO:0010951; GO:2001240; GO:0031999; GO:0010629; GO:0046329; GO:1903038; GO:2000402; GO:0016242; GO:1901215; GO:0045746; GO:1902176; GO:0010748; GO:0032091; GO:0006469; GO:0100002; GO:0051898; GO:0071901; GO:0031397; GO:0045861; GO:0090201; GO:0038061; GO:0006809; GO:0001649; GO:0018105; GO:0018107; GO:0032287; GO:0014065; GO:0016310; GO:0043065; GO:0043536; GO:0030307; GO:0008284; GO:0032270; GO:0031659; GO:0051091; GO:0032079; GO:0001938; GO:0045742; GO:0045600; GO:0010763; GO:0010628; GO:0046326; GO:0010907; GO:0045725; GO:1903721; GO:0046889; GO:0010918; GO:0045429; GO:0051000; GO:0046622; GO:0033138; GO:0032436; GO:2000010; GO:1900182; GO:1903078; GO:0001934; GO:0048661; GO:0010765; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0030163; GO:0000060; GO:0043491; GO:0006468; GO:0016567; GO:0042981; GO:0030334; GO:0005979; GO:0043488; GO:0031641; GO:0010975; GO:0050999; GO:1901796; GO:0006417; GO:0034405; GO:0032094; GO:0060416; GO:0009408; GO:1990418; GO:0006979; GO:0070141; GO:0007165; GO:0021510; GO:0051146; GO:0031295; GO:0031929; GO:0006412"]
[95,47,"PK071-8","Akt1 (PKBa)","T450/T451/T447","RAC-alpha serine/threonine-protein kinase",{"v":810.8508004237282,"d":"811"},{"v":643.699336641951,"d":"644"},{"v":1071.6099401069687,"d":"1072"},{"v":132.15870780999106,"d":"132"},{"v":111.8387309918811,"d":"112"},{"v":9256.892094488681,"d":"9257"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 442-459 with T450 phosphorylated of human Akt1.","T450 phosphorylation stimulates phosphotransferase activity. Phosphorylation regulates apoptosis, carcinogenesis, cell cycle progression, cell differentiation, cell growth, cell motility, cytoskeletal reorganization, gene transcription, intracellular location, and induces interaction with PIN1, ILK, PAK1, PDK1, PIK3R1, PPP2CA, and Rictor. It has been infrequently detetced by mass spectrometry studies (≥5 reports).","mTOR","P31749","P31749",570,"P31749","P31749","NP_005154","Block1",4,8,"1, 9, 17, 25","AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"EC 2.7.11.1; Nuclear receptor co-regulator; Protein kinase, Ser/Thr (non-receptor); AGC group; AKT family","GO:0005911; GO:0036064; GO:0005737; GO:0005829; GO:0015630; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0098794; GO:0032991; GO:0005819; GO:0031982","GO:0071889; GO:0005524; GO:0019899; GO:0032794; GO:0042802; GO:0016301; GO:0030235; GO:0005547; GO:0043325; GO:0042803; GO:0004672; GO:0005080; GO:0051721; GO:0004712; GO:0004674","GO:0006924; GO:0032148; GO:0007568; GO:0043276; GO:0008637; GO:0008643; GO:0030154; GO:0002042; GO:0030030; GO:0008283; GO:0006464; GO:0071276; GO:0006974; GO:0071364; GO:0097011; GO:0071456; GO:0032869; GO:0071260; GO:1990090; GO:0071407; GO:0140052; GO:0071380; GO:0034614; GO:0071356; GO:0035924; GO:0051186; GO:0019221; GO:0031018; GO:0007173; GO:0072655; GO:0060079; GO:0097194; GO:0007281; GO:0042593; GO:0006006; GO:0005978; GO:0060709; GO:0007186; GO:0030212; GO:0007249; GO:0006954; GO:0048009; GO:0008286; GO:0035655; GO:0035556; GO:0060716; GO:0031663; GO:0072656; GO:0060644; GO:0001893; GO:0043066; GO:0010507; GO:0045792; GO:0043154; GO:0010951; GO:2001240; GO:0031999; GO:0010629; GO:0046329; GO:1903038; GO:2000402; GO:0016242; GO:1901215; GO:0045746; GO:1902176; GO:0010748; GO:0032091; GO:0006469; GO:0100002; GO:0051898; GO:0071901; GO:0031397; GO:0045861; GO:0090201; GO:0038061; GO:0006809; GO:0001649; GO:0018105; GO:0018107; GO:0032287; GO:0014065; GO:0016310; GO:0043065; GO:0043536; GO:0030307; GO:0008284; GO:0032270; GO:0031659; GO:0051091; GO:0032079; GO:0001938; GO:0045742; GO:0045600; GO:0010763; GO:0010628; GO:0046326; GO:0010907; GO:0045725; GO:1903721; GO:0046889; GO:0010918; GO:0045429; GO:0051000; GO:0046622; GO:0033138; GO:0032436; GO:2000010; GO:1900182; GO:1903078; GO:0001934; GO:0048661; GO:0010765; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0030163; GO:0000060; GO:0043491; GO:0006468; GO:0016567; GO:0042981; GO:0030334; GO:0005979; GO:0043488; GO:0031641; GO:0010975; GO:0050999; GO:1901796; GO:0006417; GO:0034405; GO:0032094; GO:0060416; GO:0009408; GO:1990418; GO:0006979; GO:0070141; GO:0007165; GO:0021510; GO:0051146; GO:0031295; GO:0031929; GO:0006412"]
[97,48,"PK869","Akt1 (PKBa)","S473","RAC-alpha serine/threonine-protein kinase",{"v":4784.793729572974,"d":"4785"},{"v":4558.938739050827,"d":"4559"},{"v":1943.3363273169603,"d":"1943"},{"v":40.61484020316161,"d":"41"},{"v":405.6879769444854,"d":"406"},{"v":10555.609904088953,"d":"10556"},"Kinexus","RpAb","PQF(pS)YSAS(bA)C","Corresponds to amino acid residues P470 to S477; In the C-terminus of the kinase.","S473 phosphorylation stimulates phosphotransferase activity of Akt1, and regulates cell cycle progression, and its intracellular location. This is the major site of phosphorylation of Akt1 identified by mass spectrometry studies (≥66 report) and over 1391 scientific publications involving primarily Western blotting.","S473: ATM; ATR; DNAPK; FRAP1; ILK; MAPKAPK5; p38a MAPK; PDPK1; PKCa; PKCb1; PKCe PKD1","P31749","P31749",570,"P31749","P31749","NP_005154","Block1",4,9,"1, 9, 17, 25","AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"EC 2.7.11.1; Nuclear receptor co-regulator; Protein kinase, Ser/Thr (non-receptor); AGC group; AKT family","GO:0005911; GO:0036064; GO:0005737; GO:0005829; GO:0015630; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0098794; GO:0032991; GO:0005819; GO:0031982","GO:0071889; GO:0005524; GO:0019899; GO:0032794; GO:0042802; GO:0016301; GO:0030235; GO:0005547; GO:0043325; GO:0042803; GO:0004672; GO:0005080; GO:0051721; GO:0004712; GO:0004674","GO:0006924; GO:0032148; GO:0007568; GO:0043276; GO:0008637; GO:0008643; GO:0030154; GO:0002042; GO:0030030; GO:0008283; GO:0006464; GO:0071276; GO:0006974; GO:0071364; GO:0097011; GO:0071456; GO:0032869; GO:0071260; GO:1990090; GO:0071407; GO:0140052; GO:0071380; GO:0034614; GO:0071356; GO:0035924; GO:0051186; GO:0019221; GO:0031018; GO:0007173; GO:0072655; GO:0060079; GO:0097194; GO:0007281; GO:0042593; GO:0006006; GO:0005978; GO:0060709; GO:0007186; GO:0030212; GO:0007249; GO:0006954; GO:0048009; GO:0008286; GO:0035655; GO:0035556; GO:0060716; GO:0031663; GO:0072656; GO:0060644; GO:0001893; GO:0043066; GO:0010507; GO:0045792; GO:0043154; GO:0010951; GO:2001240; GO:0031999; GO:0010629; GO:0046329; GO:1903038; GO:2000402; GO:0016242; GO:1901215; GO:0045746; GO:1902176; GO:0010748; GO:0032091; GO:0006469; GO:0100002; GO:0051898; GO:0071901; GO:0031397; GO:0045861; GO:0090201; GO:0038061; GO:0006809; GO:0001649; GO:0018105; GO:0018107; GO:0032287; GO:0014065; GO:0016310; GO:0043065; GO:0043536; GO:0030307; GO:0008284; GO:0032270; GO:0031659; GO:0051091; GO:0032079; GO:0001938; GO:0045742; GO:0045600; GO:0010763; GO:0010628; GO:0046326; GO:0010907; GO:0045725; GO:1903721; GO:0046889; GO:0010918; GO:0045429; GO:0051000; GO:0046622; GO:0033138; GO:0032436; GO:2000010; GO:1900182; GO:1903078; GO:0001934; GO:0048661; GO:0010765; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0030163; GO:0000060; GO:0043491; GO:0006468; GO:0016567; GO:0042981; GO:0030334; GO:0005979; GO:0043488; GO:0031641; GO:0010975; GO:0050999; GO:1901796; GO:0006417; GO:0034405; GO:0032094; GO:0060416; GO:0009408; GO:1990418; GO:0006979; GO:0070141; GO:0007165; GO:0021510; GO:0051146; GO:0031295; GO:0031929; GO:0006412"]
[99,49,"PK071-6","Akt1 (PKBa)","S473/S474/S472","RAC-alpha serine/threonine-protein kinase",{"v":366.0825750575235,"d":"366"},{"v":196.7279071975641,"d":"197"},{"v":899.6014844577956,"d":"900"},{"v":245.73731331419935,"d":"246"},{"v":42.73891061456454,"d":"43"},{"v":8093.93492121981,"d":"8094"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S473 phosphosite;  In the C-terminus of the kinase.","S473 phosphorylation stimulates phosphotransferase activity of Akt1, and regulates cell cycle progression, and its intracellular location. This is the major site of phosphorylation of Akt1 identified by mass spectrometry studies (≥66 report) and over 1391 scientific publications involving primarily Western blotting.","S473: ATM; ATR; DNAPK; FRAP1; ILK; MAPKAPK5; p38a MAPK; PDPK1; PKCa; PKCb1; PKCe PKD1","P31749","P31749",570,"P31749","P31749","NP_005154","Block1",4,10,"1, 9, 17, 25","AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"EC 2.7.11.1; Nuclear receptor co-regulator; Protein kinase, Ser/Thr (non-receptor); AGC group; AKT family","GO:0005911; GO:0036064; GO:0005737; GO:0005829; GO:0015630; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0098794; GO:0032991; GO:0005819; GO:0031982","GO:0071889; GO:0005524; GO:0019899; GO:0032794; GO:0042802; GO:0016301; GO:0030235; GO:0005547; GO:0043325; GO:0042803; GO:0004672; GO:0005080; GO:0051721; GO:0004712; GO:0004674","GO:0006924; GO:0032148; GO:0007568; GO:0043276; GO:0008637; GO:0008643; GO:0030154; GO:0002042; GO:0030030; GO:0008283; GO:0006464; GO:0071276; GO:0006974; GO:0071364; GO:0097011; GO:0071456; GO:0032869; GO:0071260; GO:1990090; GO:0071407; GO:0140052; GO:0071380; GO:0034614; GO:0071356; GO:0035924; GO:0051186; GO:0019221; GO:0031018; GO:0007173; GO:0072655; GO:0060079; GO:0097194; GO:0007281; GO:0042593; GO:0006006; GO:0005978; GO:0060709; GO:0007186; GO:0030212; GO:0007249; GO:0006954; GO:0048009; GO:0008286; GO:0035655; GO:0035556; GO:0060716; GO:0031663; GO:0072656; GO:0060644; GO:0001893; GO:0043066; GO:0010507; GO:0045792; GO:0043154; GO:0010951; GO:2001240; GO:0031999; GO:0010629; GO:0046329; GO:1903038; GO:2000402; GO:0016242; GO:1901215; GO:0045746; GO:1902176; GO:0010748; GO:0032091; GO:0006469; GO:0100002; GO:0051898; GO:0071901; GO:0031397; GO:0045861; GO:0090201; GO:0038061; GO:0006809; GO:0001649; GO:0018105; GO:0018107; GO:0032287; GO:0014065; GO:0016310; GO:0043065; GO:0043536; GO:0030307; GO:0008284; GO:0032270; GO:0031659; GO:0051091; GO:0032079; GO:0001938; GO:0045742; GO:0045600; GO:0010763; GO:0010628; GO:0046326; GO:0010907; GO:0045725; GO:1903721; GO:0046889; GO:0010918; GO:0045429; GO:0051000; GO:0046622; GO:0033138; GO:0032436; GO:2000010; GO:1900182; GO:1903078; GO:0001934; GO:0048661; GO:0010765; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0030163; GO:0000060; GO:0043491; GO:0006468; GO:0016567; GO:0042981; GO:0030334; GO:0005979; GO:0043488; GO:0031641; GO:0010975; GO:0050999; GO:1901796; GO:0006417; GO:0034405; GO:0032094; GO:0060416; GO:0009408; GO:1990418; GO:0006979; GO:0070141; GO:0007165; GO:0021510; GO:0051146; GO:0031295; GO:0031929; GO:0006412"]
[101,50,"PK071-7","Akt1 (PKBa)","S473/S474/S472","RAC-alpha serine/threonine-protein kinase",{"v":207.63791861260526,"d":"208"},{"v":134.61217657519333,"d":"135"},{"v":256.44209958244795,"d":"256"},{"v":123.5044645486443,"d":"124"},{"v":30.027494168684434,"d":"30"},{"v":2489.835942237837,"d":"2490"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S473 phosphosite;  In the C-terminus of the kinase.","S473 phosphorylation stimulates phosphotransferase activity of Akt1, and regulates cell cycle progression, and its intracellular location. This is the major site of phosphorylation of Akt1 identified by mass spectrometry studies (≥66 report) and over 1391 scientific publications involving primarily Western blotting.","S473: ATM; ATR; DNAPK; FRAP1; ILK; MAPKAPK5; p38a MAPK; PDPK1; PKCa; PKCb1; PKCe PKD1","P31749","P31749",570,"P31749","P31749","NP_005154","Block1",4,11,"1, 9, 17, 25","AKT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"EC 2.7.11.1; Nuclear receptor co-regulator; Protein kinase, Ser/Thr (non-receptor); AGC group; AKT family","GO:0005911; GO:0036064; GO:0005737; GO:0005829; GO:0015630; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0098794; GO:0032991; GO:0005819; GO:0031982","GO:0071889; GO:0005524; GO:0019899; GO:0032794; GO:0042802; GO:0016301; GO:0030235; GO:0005547; GO:0043325; GO:0042803; GO:0004672; GO:0005080; GO:0051721; GO:0004712; GO:0004674","GO:0006924; GO:0032148; GO:0007568; GO:0043276; GO:0008637; GO:0008643; GO:0030154; GO:0002042; GO:0030030; GO:0008283; GO:0006464; GO:0071276; GO:0006974; GO:0071364; GO:0097011; GO:0071456; GO:0032869; GO:0071260; GO:1990090; GO:0071407; GO:0140052; GO:0071380; GO:0034614; GO:0071356; GO:0035924; GO:0051186; GO:0019221; GO:0031018; GO:0007173; GO:0072655; GO:0060079; GO:0097194; GO:0007281; GO:0042593; GO:0006006; GO:0005978; GO:0060709; GO:0007186; GO:0030212; GO:0007249; GO:0006954; GO:0048009; GO:0008286; GO:0035655; GO:0035556; GO:0060716; GO:0031663; GO:0072656; GO:0060644; GO:0001893; GO:0043066; GO:0010507; GO:0045792; GO:0043154; GO:0010951; GO:2001240; GO:0031999; GO:0010629; GO:0046329; GO:1903038; GO:2000402; GO:0016242; GO:1901215; GO:0045746; GO:1902176; GO:0010748; GO:0032091; GO:0006469; GO:0100002; GO:0051898; GO:0071901; GO:0031397; GO:0045861; GO:0090201; GO:0038061; GO:0006809; GO:0001649; GO:0018105; GO:0018107; GO:0032287; GO:0014065; GO:0016310; GO:0043065; GO:0043536; GO:0030307; GO:0008284; GO:0032270; GO:0031659; GO:0051091; GO:0032079; GO:0001938; GO:0045742; GO:0045600; GO:0010763; GO:0010628; GO:0046326; GO:0010907; GO:0045725; GO:1903721; GO:0046889; GO:0010918; GO:0045429; GO:0051000; GO:0046622; GO:0033138; GO:0032436; GO:2000010; GO:1900182; GO:1903078; GO:0001934; GO:0048661; GO:0010765; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0030163; GO:0000060; GO:0043491; GO:0006468; GO:0016567; GO:0042981; GO:0030334; GO:0005979; GO:0043488; GO:0031641; GO:0010975; GO:0050999; GO:1901796; GO:0006417; GO:0034405; GO:0032094; GO:0060416; GO:0009408; GO:1990418; GO:0006979; GO:0070141; GO:0007165; GO:0021510; GO:0051146; GO:0031295; GO:0031929; GO:0006412"]
[103,1052,"PN062","AKT1S1 (PRAS40)","T246","Proline-rich AKT1 substrate 1",{"v":304.0003847694193,"d":"304"},{"v":256.2536331741792,"d":"256"},{"v":241.25758353345145,"d":"241"},{"v":79.36094676868335,"d":"79"},{"v":8.41859652183824,"d":"8"},{"v":1148.1251037931065,"d":"1148"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the T246 phosphosite.","T246 phosphorylation inhibits Akt1S1 phosphorylation, induces interaction with 14-3-3-beta and 14-3-3-eta, although one report indicates that it inhibits interaction with 14-3-3-beta. This is the major site of phosphorylation of AKT1S1 from mass spectrometry studies (≥838 reports).","Akt1; Akt3","Q96B36","Q96B36",6306,null,null,"NP_115751.3","Block7",3,12,"7, 15, 23, 31",{"$nulls":13},"Inhibitor of mTOR/FRAP","GO:0005737; GO:0005829; GO:0005654; GO:0032991",null,"GO:0045792; GO:0006469; GO:0032007; GO:0048011; GO:0042981; GO:1900034; GO:0043523; GO:0038202"]
[105,51,"NK130-8","Akt2 (PKBb)","Pan-specific","RAC-beta serine/threonine-protein kinase",{"v":5838.411323977585,"d":"5838"},{"v":5929.568675032345,"d":"5930"},{"v":1255.2298735803088,"d":"1255"},{"v":21.499510807421967,"d":"21"},{"v":628.015775701454,"d":"628"},{"v":11013.525524613975,"d":"11014"},"Kinexus","RpAb","CHRFFLSINWQDVVQK","Corresponds to amino acid residues H406 to K420; Post-kinase last alpha-chain.",null,null,"P31751","P31751",669,"P31751","P31751","NP_001617","Block1",4,12,"1, 9, 17, 25","AKT2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"Protein-serine kinase, AGC group, AKT family","GO:0005938; GO:0005829; GO:0005769; GO:0043231; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:0032587","GO:0005524; GO:0046872; GO:0004674","GO:0090630; GO:0008643; GO:0006464; GO:0071486; GO:0032869; GO:0045444; GO:0006006; GO:0005978; GO:0008286; GO:0065002; GO:0035556; GO:0060644; GO:0043066; GO:0010748; GO:0018105; GO:0032287; GO:0030335; GO:2000147; GO:0008284; GO:0032000; GO:0046326; GO:2001275; GO:0010907; GO:0045725; GO:0010918; GO:0001934; GO:0090314; GO:0031340; GO:0043491; GO:0072659; GO:0071156; GO:0030334; GO:0006417; GO:0097473; GO:0007165"]
[107,52,"NK130-9","Akt2 (PKBb)","Pan-specific","RAC-beta serine/threonine-protein kinase",{"v":14171.401543517853,"d":"14171"},{"v":13826.269883937937,"d":"13826"},{"v":2576.482511722165,"d":"2576"},{"v":18.180858850200845,"d":"18"},{"v":8893.924184836025,"d":"8894"},{"v":25776.011108486986,"d":"25776"},"Kinexus","RpAb","CDRYDSLGLLELDQRT","Corresponds to amino acid residues D454 to T468; Pre-C-terminus.",null,null,"P31751","P31751",669,"P31751","P31751","NP_001617","Block1",4,13,"1, 9, 17, 25","AKT2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"Protein-serine kinase, AGC group, AKT family","GO:0005938; GO:0005829; GO:0005769; GO:0043231; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:0032587","GO:0005524; GO:0046872; GO:0004674","GO:0090630; GO:0008643; GO:0006464; GO:0071486; GO:0032869; GO:0045444; GO:0006006; GO:0005978; GO:0008286; GO:0065002; GO:0035556; GO:0060644; GO:0043066; GO:0010748; GO:0018105; GO:0032287; GO:0030335; GO:2000147; GO:0008284; GO:0032000; GO:0046326; GO:2001275; GO:0010907; GO:0045725; GO:0010918; GO:0001934; GO:0090314; GO:0031340; GO:0043491; GO:0072659; GO:0071156; GO:0030334; GO:0006417; GO:0097473; GO:0007165"]
[109,53,"NK131-3","Akt3 (PKBg)","Pan-specific","RAC-gamma serine/threonine-protein kinase",{"v":9837.777022966351,"d":"9838"},{"v":9695.406843289493,"d":"9695"},{"v":2411.2786828115604,"d":"2411"},{"v":24.510401863982235,"d":"25"},{"v":815.9551005604894,"d":"816"},{"v":25005.026602753438,"d":"25005"},"Kinexus","RpAb","CHSFFSGVNWQDVYDK","Corresponds to amino acid residues H402 to K416; Post-kinase last alpha-chain.",null,null,"Q9Y243","Q9Y243",670,"Q9Y243","Q9Y243","NP_005456.1","Block1",5,1,"1, 9, 17, 25","AKT3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","AKT",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); AGC domain target; AGC</A> group; AKT family","GO:0005737; GO:0005622; GO:0016020; GO:0005634","GO:0005524; GO:0004672; GO:0004674","GO:0048854; GO:0048873; GO:0035556; GO:0000002; GO:2000773; GO:0018105; GO:1905653; GO:0043536; GO:0090050; GO:0045793; GO:0001938; GO:0032008; GO:1905564; GO:0006468; GO:0007165"]
[111,54,"NK003-2","ALK","Pan-specific","Anaplastic lymphoma receptor-tyrosine kinase",{"v":1956.1184719538735,"d":"1956"},{"v":1819.5867574841714,"d":"1820"},{"v":847.1205464245196,"d":"847"},{"v":43.30619840108004,"d":"43"},{"v":463.29990760763377,"d":"463"},{"v":4944.771242004183,"d":"4945"},"Kinexus","RpAb","LLVSQQAKREEERSPAAC","Corresponds to amino acid residues L1424 to A1440; After catalytic domain.",null,null,"Q9UM73","Q9UM73",837,"Q9UM73","Q9UM73","NP_004295.2","Block1",5,2,"1, 9, 17, 25","ALK","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Alk",{"$nulls":6},"EC 2.7.10.1; Receptor tyrosine kinase; TK domain target; TK</A> group; Alk family","GO:0070062; GO:0005887; GO:0005622; GO:0005886; GO:0032991","GO:0005524; GO:0042802; GO:0004704; GO:0004713; GO:0004714","GO:0000187; GO:0030534; GO:0008283; GO:0021766; GO:0048666; GO:0016310; GO:0051092; GO:0046777; GO:0042981; GO:0042127; GO:0060159; GO:0090648; GO:0007165; GO:0036269; GO:0007169"]
[113,55,"NK003-3","ALK","Pan-specific","Anaplastic lymphoma receptor-tyrosine kinase",{"v":4687.243198138261,"d":"4687"},{"v":4492.841712725128,"d":"4493"},{"v":1416.268983860562,"d":"1416"},{"v":30.215393654485307,"d":"30"},{"v":744.4482927584559,"d":"744"},{"v":9508.190918758235,"d":"9508"},"Kinexus","RpAb","LRTSTIMTDYNPNYC","Corresponds to amino acid residues L1083 to C1097; Just before catalytic domain.",null,null,"Q9UM73","Q9UM73",837,"Q9UM73","Q9UM73","NP_004295.2","Block1",5,3,"1, 9, 17, 25","ALK","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Alk",{"$nulls":6},"EC 2.7.10.1; Receptor tyrosine kinase; TK domain target; TK</A> group; Alk family","GO:0070062; GO:0005887; GO:0005622; GO:0005886; GO:0032991","GO:0005524; GO:0042802; GO:0004704; GO:0004713; GO:0004714","GO:0000187; GO:0030534; GO:0008283; GO:0021766; GO:0048666; GO:0016310; GO:0051092; GO:0046777; GO:0042981; GO:0042127; GO:0060159; GO:0090648; GO:0007165; GO:0036269; GO:0007169"]
[115,56,"PK518","ALK","Y1092","Anaplastic lymphoma receptor-tyrosine kinase",{"v":12369.839433719013,"d":"12370"},{"v":12293.809544973145,"d":"12294"},{"v":2540.35473020641,"d":"2540"},{"v":20.536683146279515,"d":"21"},{"v":6171.769800949045,"d":"6172"},{"v":20635.027062021487,"d":"20635"},"Kinexus","RpAb","MTD(pY)NPN(bA)C","Corresponds to amino acid residues M1089 to N1095; In the region between the Transmembrane and kinase catalytic domains. ","The effect of Y1092 phosphorylation is unclear. One of the major in vivo sites of phosphorylation in ALK (≥38 reports from high throughput mass spectrometry studies).",null,"Q9UM73","Q9UM73",837,"Q9UM73","Q9UM73","NP_004295.2","Block1",5,4,"1, 9, 17, 25","ALK","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Alk",{"$nulls":6},"EC 2.7.10.1; Receptor tyrosine kinase; TK domain target; TK</A> group; Alk family","GO:0070062; GO:0005887; GO:0005622; GO:0005886; GO:0032991","GO:0005524; GO:0042802; GO:0004704; GO:0004713; GO:0004714","GO:0000187; GO:0030534; GO:0008283; GO:0021766; GO:0048666; GO:0016310; GO:0051092; GO:0046777; GO:0042981; GO:0042127; GO:0060159; GO:0090648; GO:0007165; GO:0036269; GO:0007169"]
[117,57,"PK519","ALK","Y1096","Anaplastic lymphoma receptor-tyrosine kinase",{"v":10661.18931643294,"d":"10661"},{"v":10410.177489834601,"d":"10410"},{"v":2013.706213286594,"d":"2014"},{"v":18.888194867552986,"d":"19"},{"v":5188.966227883968,"d":"5189"},{"v":16970.725679814157,"d":"16971"},"Kinexus","RpAb","NPN(pY)CFA(bA)C","Corresponds to amino acid residues N1093 to A1099; In the region between the Transmembrane and kinase catalytic domains. ","Y1096 phosphorylation increases phosphotransferase activity and induces interaction with IRS1 and SNTB1. It is one of the major in vivo sites of phosphorylation in ALK (≥95 reports by mass spectrometry)",null,"Q9UM73","Q9UM73",837,"Q9UM73","Q9UM73","NP_004295.2","Block1",5,5,"1, 9, 17, 25","ALK","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Alk",{"$nulls":6},"EC 2.7.10.1; Receptor tyrosine kinase; TK domain target; TK</A> group; Alk family","GO:0070062; GO:0005887; GO:0005622; GO:0005886; GO:0032991","GO:0005524; GO:0042802; GO:0004704; GO:0004713; GO:0004714","GO:0000187; GO:0030534; GO:0008283; GO:0021766; GO:0048666; GO:0016310; GO:0051092; GO:0046777; GO:0042981; GO:0042127; GO:0060159; GO:0090648; GO:0007165; GO:0036269; GO:0007169"]
[119,58,"PK520","ALK","Y1507","Anaplastic lymphoma receptor-tyrosine kinase",{"v":15464.622150952513,"d":"15465"},{"v":15069.502305340637,"d":"15070"},{"v":2846.595355995602,"d":"2847"},{"v":18.407144566543913,"d":"18"},{"v":7760.780105552234,"d":"7761"},{"v":25834.282157554935,"d":"25834"},"Kinexus","RpAb","NPT(pY)GSW(bA)C","Corresponds to amino acid residues N1504 to W1510; Near the C-terminus of the kinase after the catalytic domain.","Phosphorylation of Y1507 increases phosphotransferase activity and induces interaction with Shc1 and SNTB1. This is one of the major in vivo phosphorylation sites in ALK (≥95 reports from high throughput mass spectrometry studies).",null,"Q9UM73","Q9UM73",837,"Q9UM73","Q9UM73","NP_004295.2","Block1",5,6,"1, 9, 17, 25","ALK","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Alk",{"$nulls":6},"EC 2.7.10.1; Receptor tyrosine kinase; TK domain target; TK</A> group; Alk family","GO:0070062; GO:0005887; GO:0005622; GO:0005886; GO:0032991","GO:0005524; GO:0042802; GO:0004704; GO:0004713; GO:0004714","GO:0000187; GO:0030534; GO:0008283; GO:0021766; GO:0048666; GO:0016310; GO:0051092; GO:0046777; GO:0042981; GO:0042127; GO:0060159; GO:0090648; GO:0007165; GO:0036269; GO:0007169"]
[121,59,"PN738","ALOX5 (5-LO)","S272","Arachidonate 5-lipoxygenase",{"v":10417.196778640173,"d":"10417"},{"v":10132.489166940464,"d":"10132"},{"v":2742.7137466352337,"d":"2743"},{"v":26.328712079808277,"d":"26"},{"v":4319.6388509419985,"d":"4320"},{"v":22271.98609188598,"d":"22272"},"Kinexus","RpAb","RQL(pS)LEQ(bA)C","Corresponds to amino acid residues R269 to Q275.","S272 phosphorylation stimulates enzymatic activity and import to the nucleus. This is a minor in vivo phosphorylation sites in ALOX5 (≥2 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and found in fish.","CaMK2a; MAPKAPK2; PKACa","P09917","P09917",3884,null,null,"NP_000689.1","Block1",5,7,"1, 9, 17, 25",{"$nulls":12},"X","Enzyme","GO:0005829; GO:0005576; GO:0005615; GO:1904813; GO:0005635; GO:0005641; GO:0016363; GO:0031965; GO:0005654; GO:0034774","GO:0004051; GO:0005506","GO:0019221; GO:0035655; GO:0019370; GO:0006691; GO:0002540; GO:0019372; GO:0042759; GO:0043312"]
[123,60,"PN568","AML1 (RUNX1)","T273","Runt-related transcription factor 1",{"v":10381.371237328585,"d":"10381"},{"v":10295.839647024499,"d":"10296"},{"v":1967.2094099840228,"d":"1967"},{"v":18.949417808222417,"d":"19"},{"v":1842.0675139967004,"d":"1842"},{"v":19648.418069864972,"d":"19648"},"Kinexus","RpAb","VHPA(pT)PIS(bA)C","Corresponds to amino acid residues V269 to S276.","T273 phosphorylation induces interaction with CBFB. This is a minor in vivo phosphorylation sites in AML1 (≥6 reports from high throughput mass spectrometry studies).","CDK1; CDK2; CDK6; ERK1; ERK2; HIPK2","Q01196","Q01196",5862,null,"Q01196","NP_001001890.1","Block1",5,8,"1, 9, 17, 25",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0016513; GO:0005829; GO:0043231; GO:0005654; GO:0005634","GO:0005524; GO:0005509; GO:0003677; GO:0003700; GO:0046982; GO:0042803; GO:0000978; GO:0000977; GO:0000981; GO:0001228; GO:0008134; GO:0044212","GO:0002062; GO:0071425; GO:0030097; GO:0030099; GO:0043371; GO:0010629; GO:0030853; GO:0000122; GO:0001503; GO:0048935; GO:0045766; GO:0043378; GO:0030854; GO:0032743; GO:0045893; GO:0045944; GO:0050855; GO:2000810; GO:0001959; GO:1902036; GO:0033146; GO:0045616; GO:0045652; GO:0045637; GO:0045589; GO:0030111"]
[125,61,"PN569","AML2 (RUNX3)","T231","Runt-related transcription factor 3",{"v":8008.2104052025525,"d":"8008"},{"v":8089.045834188133,"d":"8089"},{"v":1647.7870624785317,"d":"1648"},{"v":20.576220892098977,"d":"21"},{"v":3991.9912139364314,"d":"3992"},{"v":14027.951656633999,"d":"14028"},"Kinexus","RpAb","SQPQ(pT)PIQGC","Corresponds to amino acid residues S227 to G235.","T231 phosphorylation induces cell growth. This is a minor in vivo phosphorylation sites in AML2 (≥20 reports from high throughput mass spectrometry studies).",null,"Q13761","Q13761",9489,null,"Q13761","NP_001026850.1","Block1",5,9,"1, 9, 17, 25",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0016513; GO:0005737; GO:0005829; GO:0043231; GO:0000790; GO:0005730; GO:0005654; GO:0005634","GO:0005524; GO:0003700; GO:0000977; GO:0000981","GO:0002062; GO:0030097; GO:0043371; GO:0045786; GO:0050680; GO:0000122; GO:0001503; GO:0048935; GO:0043378; GO:0045893; GO:0006468; GO:0045595; GO:0006355; GO:0006357; GO:0071559; GO:0006366"]
[127,62,"NK259-1","AMPKa1 (PRKAA1)","Pan-specific","5'-AMP-activated protein kinase catalytic subunit alpha-1",{"v":3733.8936837230012,"d":"3734"},{"v":3649.7414498810017,"d":"3650"},{"v":1281.9735668099115,"d":"1282"},{"v":34.33342444639928,"d":"34"},{"v":524.7696238180201,"d":"525"},{"v":7850.595113277985,"d":"7851"},"Kinexus","RpAb","CLYNRNHQDPLAVAY","Corresponds to amino acid residues C321 to Y335; After catalytic domain in region not conserved with AMPKa2.",null,null,"Q13131","Q13131",742,"Q13131","Q13131","NP_006242.5","Block1",5,10,"1, 9, 17, 25","AMPKa1 ","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","AMPK",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; EC 2.7.1.-; CAMK domain target; CAMK</A> group; CAMKL family; AMPK subfamily","GO:0016324; GO:0030424; GO:0005737; GO:0005829; GO:0030425; GO:0005622; GO:0043025; GO:0016607; GO:0005654; GO:0031588; GO:0005634","GO:0050405; GO:0047322; GO:0004679; GO:0005524; GO:0004691; GO:0003682; GO:0035174; GO:0046872; GO:0008022; GO:0004672; GO:0050321","GO:0000187; GO:0061762; GO:0007050; GO:0071277; GO:0071361; GO:0042149; GO:0071333; GO:0070301; GO:0071456; GO:0031669; GO:0071417; GO:0034599; GO:0071380; GO:0006695; GO:0009631; GO:0097009; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0008610; GO:0016236; GO:0061744; GO:0043066; GO:0010629; GO:2001274; GO:0046318; GO:0050995; GO:0032007; GO:1904428; GO:0070050; GO:0010508; GO:0008284; GO:1903829; GO:0045542; GO:0010628; GO:0045821; GO:1903109; GO:2000758; GO:1903955; GO:0048643; GO:0051291; GO:0006468; GO:0042752; GO:0070507; GO:0033135; GO:0062028; GO:0060627; GO:0014823; GO:0031000; GO:1901563; GO:0010332; GO:0001666; GO:0009411; GO:0048511; GO:0007165; GO:0006351; GO:0016055"]
[129,63,"NK259-2","AMPKa1 (PRKAA1)","Pan-specific","5'-AMP-activated protein kinase catalytic subunit alpha-1",{"v":3499.461485673217,"d":"3499"},{"v":3409.700356232688,"d":"3410"},{"v":1234.5360857615092,"d":"1235"},{"v":35.27788749256695,"d":"35"},{"v":885.3035625871362,"d":"885"},{"v":8113.975371478863,"d":"8114"},"Kinexus","RpAb","MRRLSSWRKMATAEKQKGC","Corresponds to amino acid residues M1 to K17; N-terminus (not present in AMPKa2).",null,null,"Q13131","Q13131",742,"Q13131","Q13131","NP_006242.5","Block1",5,11,"1, 9, 17, 25","AMPKa1 ","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","AMPK",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; EC 2.7.1.-; CAMK domain target; CAMK</A> group; CAMKL family; AMPK subfamily","GO:0016324; GO:0030424; GO:0005737; GO:0005829; GO:0030425; GO:0005622; GO:0043025; GO:0016607; GO:0005654; GO:0031588; GO:0005634","GO:0050405; GO:0047322; GO:0004679; GO:0005524; GO:0004691; GO:0003682; GO:0035174; GO:0046872; GO:0008022; GO:0004672; GO:0050321","GO:0000187; GO:0061762; GO:0007050; GO:0071277; GO:0071361; GO:0042149; GO:0071333; GO:0070301; GO:0071456; GO:0031669; GO:0071417; GO:0034599; GO:0071380; GO:0006695; GO:0009631; GO:0097009; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0008610; GO:0016236; GO:0061744; GO:0043066; GO:0010629; GO:2001274; GO:0046318; GO:0050995; GO:0032007; GO:1904428; GO:0070050; GO:0010508; GO:0008284; GO:1903829; GO:0045542; GO:0010628; GO:0045821; GO:1903109; GO:2000758; GO:1903955; GO:0048643; GO:0051291; GO:0006468; GO:0042752; GO:0070507; GO:0033135; GO:0062028; GO:0060627; GO:0014823; GO:0031000; GO:1901563; GO:0010332; GO:0001666; GO:0009411; GO:0048511; GO:0007165; GO:0006351; GO:0016055"]
[131,64,"PK521","AMPKa1 (PRKAA1)","T183+S184","5'-AMP-activated protein kinase catalytic subunit alpha-1",{"v":20843.457880400325,"d":"20843"},{"v":19881.47522182205,"d":"19881"},{"v":6416.461076602072,"d":"6416"},{"v":30.784052787304773,"d":"31"},{"v":10052.410930811206,"d":"10052"},{"v":46415.53439317629,"d":"46416"},"Kinexus","RpAb","FLR(pS)(pT)CG(bA)C","Corresponds to amino acid residues F180 to G186; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T183 and S184 stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in AMPKa1.","T183: AMPKa1; BRSK1; BRSK2; CaMK2b; CAMKK1; CaMKK2; LKB1","Q13131","Q13131",742,"Q13131","Q13131","NP_006242.5","Block1",5,12,"1, 9, 17, 25","AMPKa1 ","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","AMPK",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; EC 2.7.1.-; CAMK domain target; CAMK</A> group; CAMKL family; AMPK subfamily","GO:0016324; GO:0030424; GO:0005737; GO:0005829; GO:0030425; GO:0005622; GO:0043025; GO:0016607; GO:0005654; GO:0031588; GO:0005634","GO:0050405; GO:0047322; GO:0004679; GO:0005524; GO:0004691; GO:0003682; GO:0035174; GO:0046872; GO:0008022; GO:0004672; GO:0050321","GO:0000187; GO:0061762; GO:0007050; GO:0071277; GO:0071361; GO:0042149; GO:0071333; GO:0070301; GO:0071456; GO:0031669; GO:0071417; GO:0034599; GO:0071380; GO:0006695; GO:0009631; GO:0097009; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0008610; GO:0016236; GO:0061744; GO:0043066; GO:0010629; GO:2001274; GO:0046318; GO:0050995; GO:0032007; GO:1904428; GO:0070050; GO:0010508; GO:0008284; GO:1903829; GO:0045542; GO:0010628; GO:0045821; GO:1903109; GO:2000758; GO:1903955; GO:0048643; GO:0051291; GO:0006468; GO:0042752; GO:0070507; GO:0033135; GO:0062028; GO:0060627; GO:0014823; GO:0031000; GO:1901563; GO:0010332; GO:0001666; GO:0009411; GO:0048511; GO:0007165; GO:0006351; GO:0016055"]
[133,65,"NK260-2","AMPKa2 (PRKAA2)","Pan-specific","5'-AMP-activated protein kinase catalytic subunit alpha-2",{"v":5901.781371609069,"d":"5902"},{"v":5667.8071736339725,"d":"5668"},{"v":1873.355212373722,"d":"1873"},{"v":31.74219942110408,"d":"32"},{"v":1602.2759628029967,"d":"1602"},{"v":13230.365124939537,"d":"13230"},"Kinexus","RpAb","CTESEVMNSLYSGDPQDQL","Corresponds to amino acid residues C302 to L320; After catalytic domain in region not conserved with AMPKa1.",null,null,"P54646","P54646",572,"P54646",null,"NP_006243.2","Block1",5,13,"1, 9, 17, 25","AMPKa2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","AMPK",{"$nulls":5},"Protein-serine kinase, CAMK group, CAMKL family, AMPK subfamily","GO:0030424; GO:0005737; GO:0010494; GO:0005829; GO:0030425; GO:0005794; GO:0043025; GO:0016607; GO:0005654; GO:0031588; GO:0005634","GO:0050405; GO:0047322; GO:0004679; GO:0005524; GO:0003682; GO:0035174; GO:0046872; GO:0004672; GO:0004712; GO:0004674","GO:0007050; GO:0071277; GO:0035690; GO:0042149; GO:0071333; GO:0031669; GO:0034599; GO:0071380; GO:0006695; GO:0097009; GO:0006633; GO:0055089; GO:0042593; GO:0035404; GO:0035556; GO:0008610; GO:0016236; GO:0043066; GO:0010629; GO:0032007; GO:1904428; GO:0010508; GO:1903829; GO:0045821; GO:0016239; GO:2000758; GO:0006468; GO:0042752; GO:0042304; GO:0016241; GO:0070507; GO:0062028; GO:0006355; GO:0014850; GO:0048511; GO:0007165; GO:0006351; GO:0016055"]
[135,66,"NK260-1","AMPKa2 (PRKAA2)","Pan-specific","5'-AMP-activated protein kinase catalytic subunit alpha-2",{"v":11851.732833753691,"d":"11852"},{"v":11379.846426031676,"d":"11380"},{"v":3217.4753249529203,"d":"3217"},{"v":27.147720675828623,"d":"27"},{"v":5080.941531764125,"d":"5081"},{"v":29998.339872368022,"d":"29998"},"Kinexus","RpAb","CGSFMDDSAMHIPPGLKP","Corresponds to amino acid residues G349 to P365; After catalytic domain in region not conserved with AMPKa1.",null,null,"P54646","P54646",572,"P54646",null,"NP_006243.2","Block1",6,1,"1, 9, 17, 25","AMPKa2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","AMPK",{"$nulls":5},"Protein-serine kinase, CAMK group, CAMKL family, AMPK subfamily","GO:0030424; GO:0005737; GO:0010494; GO:0005829; GO:0030425; GO:0005794; GO:0043025; GO:0016607; GO:0005654; GO:0031588; GO:0005634","GO:0050405; GO:0047322; GO:0004679; GO:0005524; GO:0003682; GO:0035174; GO:0046872; GO:0004672; GO:0004712; GO:0004674","GO:0007050; GO:0071277; GO:0035690; GO:0042149; GO:0071333; GO:0031669; GO:0034599; GO:0071380; GO:0006695; GO:0097009; GO:0006633; GO:0055089; GO:0042593; GO:0035404; GO:0035556; GO:0008610; GO:0016236; GO:0043066; GO:0010629; GO:0032007; GO:1904428; GO:0010508; GO:1903829; GO:0045821; GO:0016239; GO:2000758; GO:0006468; GO:0042752; GO:0042304; GO:0016241; GO:0070507; GO:0062028; GO:0006355; GO:0014850; GO:0048511; GO:0007165; GO:0006351; GO:0016055"]
[137,67,"PK522","AMPKa2 (PRKAA2)","S377","5'-AMP-activated protein kinase catalytic subunit alpha-2",{"v":11332.21328847063,"d":"11332"},{"v":10957.54122323293,"d":"10958"},{"v":2749.78758783633,"d":"2750"},{"v":24.265229729076477,"d":"24"},{"v":6225.04434321137,"d":"6225"},{"v":22806.61008001243,"d":"22807"},"Kinexus","RpAb","IAD(pS)PKARC","Corresponds to amino acid residues I374 to C382; In the C-terminal half of the protein after the kinase catalytic domain. ","The effect of S377 phosphorylation is unclear. This is the major in vivo phosphorylation site in AMPKa2.",null,"P54646","P54646",572,"P54646",null,"NP_006243.2","Block1",6,2,"1, 9, 17, 25","AMPKa2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","AMPK",{"$nulls":5},"Protein-serine kinase, CAMK group, CAMKL family, AMPK subfamily","GO:0030424; GO:0005737; GO:0010494; GO:0005829; GO:0030425; GO:0005794; GO:0043025; GO:0016607; GO:0005654; GO:0031588; GO:0005634","GO:0050405; GO:0047322; GO:0004679; GO:0005524; GO:0003682; GO:0035174; GO:0046872; GO:0004672; GO:0004712; GO:0004674","GO:0007050; GO:0071277; GO:0035690; GO:0042149; GO:0071333; GO:0031669; GO:0034599; GO:0071380; GO:0006695; GO:0097009; GO:0006633; GO:0055089; GO:0042593; GO:0035404; GO:0035556; GO:0008610; GO:0016236; GO:0043066; GO:0010629; GO:0032007; GO:1904428; GO:0010508; GO:1903829; GO:0045821; GO:0016239; GO:2000758; GO:0006468; GO:0042752; GO:0042304; GO:0016241; GO:0070507; GO:0062028; GO:0006355; GO:0014850; GO:0048511; GO:0007165; GO:0006351; GO:0016055"]
[139,68,"PK523","ANKRD3 (RIPK4, DIK)","S438","Ankyrin repeat domain protein-serine kinase 3",{"v":9560.012530691445,"d":"9560"},{"v":9471.660692502386,"d":"9472"},{"v":1916.8047582090996,"d":"1917"},{"v":20.05023269640488,"d":"20"},{"v":4549.853393325969,"d":"4550"},{"v":16550.550378277774,"d":"16551"},"Kinexus","RpAb","LSL(pS)FER(bA)C","Corresponds to amino acid residues L435 to R441; In the region between the kinase catalytic and Ank_2 domains.","The effect of S438 phosphorylation is unclear. The major site of phosphorylation in ANKRD3.",null,"P57078","P57078",573,"P57078",null,"NP_065690.2","Block1",6,3,"1, 9, 17, 25","ANKRD3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RIPK",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); TKL group; RIPK family","GO:0005737; GO:0016020","GO:0005524; GO:0004674","GO:0002009; GO:0051092"]
[141,69,"PN503","ANXA1","Y207","Annexin A1",{"v":6116.375850980738,"d":"6116"},{"v":6059.184386665494,"d":"6059"},{"v":1552.7364020824882,"d":"1553"},{"v":25.38654327191997,"d":"25"},{"v":782.1747250541032,"d":"782"},{"v":11355.561031746995,"d":"11356"},"Kinexus","RpAb","RAL(pY)EAG(bA)C","Corresponds to amino acid residues R204 to G210; In the beginning of the third Annexin domain. ","The effect of Y207 phosphorylation is unclear. This is the major in vivo phosphorylation site in ANXA1.",null,"P04083","P04083",1264,null,null,"NP_000691.1","Block1",6,4,"1, 9, 17, 25",{"$nulls":13},"Lipid binding protein; Calcium-binding protein","GO:0016324; GO:0016323; GO:0005913; GO:0009986; GO:0062023; GO:0001533; GO:0005737; GO:0030659; GO:0005829; GO:0031901; GO:0005768; GO:0070062; GO:0005576; GO:0005615; GO:0031313; GO:0031232; GO:0019898; GO:0005925; GO:0016328; GO:0042629; GO:0031966; GO:0031514; GO:0005654; GO:0005634; GO:0001891; GO:0005886; GO:0032991; GO:0042383; GO:0097060; GO:0031982","GO:0098641; GO:0005544; GO:0048306; GO:0005509; GO:1990814; GO:0033676; GO:0019834; GO:0005543; GO:0030674; GO:0042803; GO:0005102; GO:0003697; GO:0003727; GO:0005198","GO:0031532; GO:0002250; GO:0046632; GO:0050482; GO:0007166; GO:0071385; GO:0070301; GO:0035924; GO:0019221; GO:0032508; GO:0031018; GO:0044849; GO:0042063; GO:0007186; GO:0007187; GO:0071621; GO:0070365; GO:0006954; GO:0045087; GO:0030073; GO:0030216; GO:0002548; GO:0014839; GO:0043066; GO:0045920; GO:2000483; GO:1900138; GO:0045629; GO:0097350; GO:0001780; GO:0018149; GO:0006909; GO:0090050; GO:1900087; GO:0032743; GO:0033031; GO:0031394; GO:0042102; GO:0045627; GO:0031340; GO:0090303; GO:0070459; GO:0030850; GO:0008360; GO:0046883; GO:0050727; GO:0032652; GO:0002685; GO:0032355; GO:0070555; GO:0043434; GO:0010165; GO:0007165"]
[143,70,"PN504","ANXA2","Y238","Annexin A2",{"v":5816.411958831437,"d":"5816"},{"v":5832.934870376035,"d":"5833"},{"v":1937.122986531844,"d":"1937"},{"v":33.30443235869124,"d":"33"},{"v":580.489051947734,"d":"580"},{"v":11944.124093851105,"d":"11944"},"Kinexus","RpAb","YSP(pY)DML(bA)C","Corresponds to amino acid residues Y235 to L241; In the third Annexin domain. ","The effect of Y238 phosphorylation is unclear. The second major in vivo phosphoryation site in Annexin A2.",null,"P07355","P07355",3235,null,null,"NP_001002857.1","Block1",6,5,"1, 9, 17, 25",{"$nulls":13},"Lipid binding protein; Calcium-binding protein","GO:0035578; GO:0005604; GO:0016323; GO:0005913; GO:0005938; GO:0009986; GO:0062023; GO:0005737; GO:0005829; GO:0005769; GO:0005768; GO:0070062; GO:0005576; GO:0005615; GO:0019897; GO:0031902; GO:0005811; GO:0005765; GO:0044354; GO:0042470; GO:0016020; GO:0045121; GO:0030496; GO:0035749; GO:0005634; GO:1990667; GO:0048471; GO:0005886; GO:0001726; GO:0042383; GO:0043220; GO:0031982","GO:0044730; GO:0098641; GO:0005544; GO:0048306; GO:0005509; GO:0008092; GO:0042802; GO:0098772; GO:0005546; GO:0019834; GO:0002020; GO:0017137; GO:0003723; GO:0044548","GO:0001525; GO:0007589; GO:0052362; GO:0030199; GO:0042730; GO:0035722; GO:0001765; GO:0052405; GO:0044147; GO:0032804; GO:0043312; GO:0036035; GO:0048146; GO:1905581; GO:1905597; GO:1905599; GO:0001934; GO:1905602; GO:0001921; GO:0044090; GO:0031340; GO:0051290; GO:0072659; GO:0097066; GO:0006900"]
[145,71,"PN739","APC","S2129","Adenomatous polyposis coli protein",{"v":10089.429821159636,"d":"10089"},{"v":9892.86774838814,"d":"9893"},{"v":2178.1954505551107,"d":"2178"},{"v":21.588885488721882,"d":"22"},{"v":1913.296168080526,"d":"1913"},{"v":19838.12706722488,"d":"19838"},"Kinexus","RpAb","RQA(pS)SDS(bA)C","Corresponds to amino acid residues R2126 to S2132.","The effect of S2129 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in APC(≥40 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in mammals, and is found in the chicken.","MAPKAPK2","P25054","P25054",3867,null,"P25054","NP_000029.2","Block1",6,6,"1, 9, 17, 25",{"$nulls":13},"Tumour suppressor protein","GO:0005912; GO:0030877; GO:0005923; GO:0016342; GO:0005813; GO:0005737; GO:0005829; GO:0000776; GO:0030027; GO:0016328; GO:0005874; GO:0005654; GO:0005634; GO:0048471; GO:0005886; GO:0032587; GO:1990909","GO:0008013; GO:0070840; GO:0045295; GO:0042802; GO:0008017; GO:0051010; GO:0019901; GO:0019887; GO:0031625","GO:1904885; GO:1904886; GO:0070830; GO:0007155; GO:0007050; GO:0016477; GO:0006974; GO:0008286; GO:0000281; GO:0007094; GO:0090090; GO:0008285; GO:0045736; GO:0007026; GO:0043065; GO:0010942; GO:0030335; GO:0120162; GO:0045732; GO:1904781; GO:0031274; GO:0065003; GO:0016579; GO:0051260; GO:0051988; GO:0032886; GO:0016055"]
[147,72,"PN570","AR","S96","Androgen receptor",{"v":16242.435728904262,"d":"16242"},{"v":16234.736074584143,"d":"16235"},{"v":3298.6074715159475,"d":"3299"},{"v":20.308576414102124,"d":"20"},{"v":3235.8368724165402,"d":"3236"},{"v":25198.693571239735,"d":"25199"},"Kinexus","RpAb","GEDG(pS)PQAH(bA)C","Corresponds to amino acid residues G92 to H100.","S96 phosphorylation regulates transcription. This is a minor in vivo phosphorylation sites in the androgen receptor (≥8 reports from high throughput mass spectrometry studies).",null,"P10275","P10275",920,null,"P10275","NP_000029.2","Block1",6,7,"1, 9, 17, 25",{"$nulls":3},"Receptor (steroid),  Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Receptor (steroid), transcription factor","GO:0005737; GO:0005829; GO:0000790; GO:0016607; GO:0005654; GO:0005634; GO:0005886; GO:0032991","GO:0005497; GO:0004882; GO:0051117; GO:0008013; GO:0003682; GO:0003677; GO:0003700; GO:0019899; GO:0004879; GO:0070974; GO:0046983; GO:0000978; GO:0000981; GO:0001085; GO:0005102; GO:0005496; GO:0001077; GO:0008134; GO:0044212; GO:0008270","GO:0060520; GO:0030521; GO:0048645; GO:0007267; GO:0008283; GO:0071383; GO:0071394; GO:0060742; GO:0003382; GO:0030522; GO:0001701; GO:0060599; GO:0033327; GO:0048808; GO:0019102; GO:0060749; GO:0060571; GO:0035264; GO:0008285; GO:0050680; GO:2001237; GO:0045720; GO:0000122; GO:0045597; GO:0008284; GO:0060769; GO:0010628; GO:0043568; GO:0045726; GO:0033148; GO:0043410; GO:0051092; GO:0042327; GO:0045893; GO:0045944; GO:0045945; GO:0030850; GO:0060740; GO:0060736; GO:0051259; GO:0016579; GO:0050790; GO:0048638; GO:1903076; GO:0003073; GO:0072520; GO:0007548; GO:0007165; GO:0007338; GO:0007283; GO:0060748; GO:0006351; GO:0006367"]
[149,73,"PN571","AR","S310","Androgen receptor",{"v":7959.053136143023,"d":"7959"},{"v":7881.884241640192,"d":"7882"},{"v":2104.1987248740706,"d":"2104"},{"v":26.43780219682979,"d":"26"},{"v":116.96893376663643,"d":"117"},{"v":14272.994046276657,"d":"14273"},"Kinexus","RpAb","AEY(pS)PFKGC","Corresponds to amino acid residues A307 to G314.","S310 phosphorylation regulates transcription. This is a minor in vivo phosphorylation sites in the androgen receptor (≥4 reports from high throughput mass spectrometry studies).","CDK1; CDK5","P10275","P10275",920,null,"P10275","NP_000029.2","Block1",6,8,"1, 9, 17, 25",{"$nulls":3},"Receptor (steroid),  Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Receptor (steroid), transcription factor","GO:0005737; GO:0005829; GO:0000790; GO:0016607; GO:0005654; GO:0005634; GO:0005886; GO:0032991","GO:0005497; GO:0004882; GO:0051117; GO:0008013; GO:0003682; GO:0003677; GO:0003700; GO:0019899; GO:0004879; GO:0070974; GO:0046983; GO:0000978; GO:0000981; GO:0001085; GO:0005102; GO:0005496; GO:0001077; GO:0008134; GO:0044212; GO:0008270","GO:0060520; GO:0030521; GO:0048645; GO:0007267; GO:0008283; GO:0071383; GO:0071394; GO:0060742; GO:0003382; GO:0030522; GO:0001701; GO:0060599; GO:0033327; GO:0048808; GO:0019102; GO:0060749; GO:0060571; GO:0035264; GO:0008285; GO:0050680; GO:2001237; GO:0045720; GO:0000122; GO:0045597; GO:0008284; GO:0060769; GO:0010628; GO:0043568; GO:0045726; GO:0033148; GO:0043410; GO:0051092; GO:0042327; GO:0045893; GO:0045944; GO:0045945; GO:0030850; GO:0060740; GO:0060736; GO:0051259; GO:0016579; GO:0050790; GO:0048638; GO:1903076; GO:0003073; GO:0072520; GO:0007548; GO:0007165; GO:0007338; GO:0007283; GO:0060748; GO:0006351; GO:0006367"]
[151,74,"PN203","AR","S310","Androgen receptor",{"v":529.4827552682965,"d":"529"},{"v":197.54862518514346,"d":"198"},{"v":2267.9267986312825,"d":"2268"},{"v":428.328737067573,"d":"428"},{"v":33.456664344948656,"d":"33"},{"v":21302.38827855428,"d":"21302"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S310 phosphosite.","S310 phosphorylation regulates transcription. This is a minor in vivo phosphorylation sites in the androgen receptor (≥4 reports from high throughput mass spectrometry studies).","CDK1; CDK5","P10275","P10275",920,null,"P10275","NP_000029.2","Block1",6,9,"1, 9, 17, 25",{"$nulls":3},"Receptor (steroid),  Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Receptor (steroid), transcription factor","GO:0005737; GO:0005829; GO:0000790; GO:0016607; GO:0005654; GO:0005634; GO:0005886; GO:0032991","GO:0005497; GO:0004882; GO:0051117; GO:0008013; GO:0003682; GO:0003677; GO:0003700; GO:0019899; GO:0004879; GO:0070974; GO:0046983; GO:0000978; GO:0000981; GO:0001085; GO:0005102; GO:0005496; GO:0001077; GO:0008134; GO:0044212; GO:0008270","GO:0060520; GO:0030521; GO:0048645; GO:0007267; GO:0008283; GO:0071383; GO:0071394; GO:0060742; GO:0003382; GO:0030522; GO:0001701; GO:0060599; GO:0033327; GO:0048808; GO:0019102; GO:0060749; GO:0060571; GO:0035264; GO:0008285; GO:0050680; GO:2001237; GO:0045720; GO:0000122; GO:0045597; GO:0008284; GO:0060769; GO:0010628; GO:0043568; GO:0045726; GO:0033148; GO:0043410; GO:0051092; GO:0042327; GO:0045893; GO:0045944; GO:0045945; GO:0030850; GO:0060740; GO:0060736; GO:0051259; GO:0016579; GO:0050790; GO:0048638; GO:1903076; GO:0003073; GO:0072520; GO:0007548; GO:0007165; GO:0007338; GO:0007283; GO:0060748; GO:0006351; GO:0006367"]
[153,75,"PN740","ARID1A","S363","AT-rich interactive domain-containing protein 1A",{"v":18494.281127334376,"d":"18494"},{"v":18338.733703390993,"d":"18339"},{"v":4436.989298529838,"d":"4437"},{"v":23.99114227787967,"d":"24"},{"v":5675.919473269518,"d":"5676"},{"v":31177.74506696542,"d":"31178"},"Kinexus","RpAb","HAPM(pS)PGS(bA)C","Corresponds to amino acid residues H359-S366.","The effect of S363 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in ARID1A (≥82 reports from high throughput mass spectrometry studies). This human phosphosite is not conserved in mammals, but is found in the mouse.",null,"O14497","O14497",5747,null,"O14497","NP_006006.3","Block1",6,10,"1, 9, 17, 25",{"$nulls":3},"Nuclear receptor co-regulator; DNA binding protein",{"$nulls":4},"X",{"$nulls":4},"Nuclear receptor co-regulator; DNA binding protein","GO:0071565; GO:0071564; GO:0000790; GO:0005654; GO:0005634; GO:0016514","GO:0003677; GO:0016922; GO:0031491; GO:0000981; GO:0003713","GO:0030521; GO:0043044; GO:0003205; GO:0055007; GO:0071277; GO:0048096; GO:0006338; GO:0007566; GO:0030900; GO:0001704; GO:0042921; GO:0030520; GO:0006344; GO:0000122; GO:0001843; GO:0006337; GO:0042766; GO:0003408; GO:0060674; GO:0045893; GO:0006357; GO:0019827; GO:1901998; GO:0006351"]
[155,77,"NN121","Arrestin b","Pan-specific","Arrestin beta 1",{"v":339.5560703102256,"d":"340"},{"v":258.48698606075817,"d":"258"},{"v":296.09790654291436,"d":"296"},{"v":87.20147640782656,"d":"87"},{"v":9.720919323647943,"d":"10"},{"v":1429.460564112644,"d":"1429"},"External","MmAb","Epitope undefined.",{"$nulls":3},"P49407","P49407",524,null,null,"NP_004032","Block1",6,12,"1, 9, 17, 25",{"$nulls":13},"Adapter/scaffold protein","GO:0016323; GO:0000785; GO:0005905; GO:0005737; GO:0031410; GO:0030659; GO:0005829; GO:0043197; GO:0005768; GO:0000139; GO:0005765; GO:0016604; GO:0005654; GO:0005634; GO:0005886; GO:0014069; GO:0045211; GO:0031143","GO:0031691; GO:0031692; GO:0031701; GO:0035612; GO:1990763; GO:0035615; GO:0043027; GO:0004857; GO:0030331; GO:0031762; GO:0005096; GO:0005159; GO:0044325; GO:0031434; GO:0045309; GO:0008134; GO:0044212; GO:0031625; GO:0031896","GO:0000187; GO:0042699; GO:0002031; GO:0007186; GO:0016573; GO:0061024; GO:0070373; GO:0034260; GO:0032715; GO:0032717; GO:0043524; GO:0032088; GO:0045746; GO:0031397; GO:0007602; GO:0030168; GO:0008284; GO:0043280; GO:0070374; GO:0035066; GO:0090240; GO:0035774; GO:0033138; GO:0032092; GO:0001934; GO:0031398; GO:0002092; GO:0035025; GO:0034393; GO:0045944; GO:0043161; GO:0015031; GO:0016567; GO:0042493; GO:0043149; GO:0006366; GO:0006511"]
[157,78,"PN133","Arrestin b","S412","Arrestin beta 1",{"v":876.0347571896673,"d":"876"},{"v":701.6283021256836,"d":"702"},{"v":568.6363665315946,"d":"569"},{"v":64.91025177537347,"d":"65"},{"v":151.66240918484942,"d":"152"},{"v":4442.4048628009095,"d":"4442"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S412 phosphosite.","S412 phosphorylation induces interaction with MEKK1 and inhibits interaction with ADRB2. This is one of the major in vivo phosphorylation sites in beta-arrestin (≥41 reports from high throughput mass spectrometry studies).","ERK1; ERK2","P49407","P49407",524,null,null,"NP_004032","Block1",6,13,"1, 9, 17, 25",{"$nulls":13},"Adapter/scaffold protein","GO:0016323; GO:0000785; GO:0005905; GO:0005737; GO:0031410; GO:0030659; GO:0005829; GO:0043197; GO:0005768; GO:0000139; GO:0005765; GO:0016604; GO:0005654; GO:0005634; GO:0005886; GO:0014069; GO:0045211; GO:0031143","GO:0031691; GO:0031692; GO:0031701; GO:0035612; GO:1990763; GO:0035615; GO:0043027; GO:0004857; GO:0030331; GO:0031762; GO:0005096; GO:0005159; GO:0044325; GO:0031434; GO:0045309; GO:0008134; GO:0044212; GO:0031625; GO:0031896","GO:0000187; GO:0042699; GO:0002031; GO:0007186; GO:0016573; GO:0061024; GO:0070373; GO:0034260; GO:0032715; GO:0032717; GO:0043524; GO:0032088; GO:0045746; GO:0031397; GO:0007602; GO:0030168; GO:0008284; GO:0043280; GO:0070374; GO:0035066; GO:0090240; GO:0035774; GO:0033138; GO:0032092; GO:0001934; GO:0031398; GO:0002092; GO:0035025; GO:0034393; GO:0045944; GO:0043161; GO:0015031; GO:0016567; GO:0042493; GO:0043149; GO:0006366; GO:0006511"]
[159,79,"NK007-3","ASK1 (MAP3K5)","Pan-specific","Apoptosis signal regulating protein-serine kinase 1",{"v":149.37627393366006,"d":"149"},{"v":130.97785373069433,"d":"131"},{"v":85.8731227681446,"d":"86"},{"v":57.487792744302865,"d":"57"},{"v":26.225895442954233,"d":"26"},{"v":634.6450407069292,"d":"635"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 1076-1375 of human ASK 1.",null,null,"Q99683","Q99683",575,"Q99683","Q99683","NP_005914","Block1",7,1,"1, 9, 17, 25","ASK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"EC 2.7.11.25; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE11 family","GO:0005829; GO:0009897; GO:1990604; GO:0032991; GO:1902911","GO:0005524; GO:0042802; GO:0000287; GO:0004709; GO:0019904; GO:0042803; GO:0004672; GO:0019901; GO:0019903; GO:0004674","GO:0007257; GO:0000186; GO:0097190; GO:0034198; GO:0070301; GO:1902170; GO:0071356; GO:0072577; GO:0045087; GO:0070059; GO:0008631; GO:0007254; GO:0000165; GO:0038066; GO:0043065; GO:0010666; GO:0043280; GO:0046330; GO:0043507; GO:0045663; GO:1901216; GO:1900745; GO:0045893; GO:1904707; GO:0097300; GO:0006468; GO:0034976; GO:0002931; GO:0051403; GO:0016032; GO:0042060"]
[161,80,"NK007-2","ASK1 (MAP3K5)","Pan-specific","Apoptosis signal regulating protein-serine kinase 1",{"v":2167.46124808212,"d":"2167"},{"v":1811.1068751818284,"d":"1811"},{"v":1146.918335580183,"d":"1147"},{"v":52.91528679440219,"d":"53"},{"v":636.8866463894303,"d":"637"},{"v":7890.519563878668,"d":"7891"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues within the last 50 amino acid residues at the C-terminus.",null,null,"Q99683","Q99683",575,"Q99683","Q99683","NP_005914","Block1",7,2,"1, 9, 17, 25","ASK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"EC 2.7.11.25; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE11 family","GO:0005829; GO:0009897; GO:1990604; GO:0032991; GO:1902911","GO:0005524; GO:0042802; GO:0000287; GO:0004709; GO:0019904; GO:0042803; GO:0004672; GO:0019901; GO:0019903; GO:0004674","GO:0007257; GO:0000186; GO:0097190; GO:0034198; GO:0070301; GO:1902170; GO:0071356; GO:0072577; GO:0045087; GO:0070059; GO:0008631; GO:0007254; GO:0000165; GO:0038066; GO:0043065; GO:0010666; GO:0043280; GO:0046330; GO:0043507; GO:0045663; GO:1901216; GO:1900745; GO:0045893; GO:1904707; GO:0097300; GO:0006468; GO:0034976; GO:0002931; GO:0051403; GO:0016032; GO:0042060"]
[163,81,"PK175","ASK1 (MAP3K5)","S83","Apoptosis signal regulating protein-serine kinase 1",{"v":314.69832888162904,"d":"315"},{"v":160.65394548330934,"d":"161"},{"v":1023.5938195808457,"d":"1024"},{"v":325.26191772879145,"d":"325"},{"v":28.414081723517302,"d":"28"},{"v":9517.145725831728,"d":"9517"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S83 phosphosite.","S83 phosphorylation inhibits phosphotransferase activity and reduces apoptosis. This is one of the less major in vivo phosphorylation sites in ASK1 (≥7 reports from high throughput mass spectrometry studies).","Akt1; Akt2; Akt3; Pim1","Q99683","Q99683",575,"Q99683","Q99683","NP_005914","Block1",7,3,"1, 9, 17, 25","ASK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"EC 2.7.11.25; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE11 family","GO:0005829; GO:0009897; GO:1990604; GO:0032991; GO:1902911","GO:0005524; GO:0042802; GO:0000287; GO:0004709; GO:0019904; GO:0042803; GO:0004672; GO:0019901; GO:0019903; GO:0004674","GO:0007257; GO:0000186; GO:0097190; GO:0034198; GO:0070301; GO:1902170; GO:0071356; GO:0072577; GO:0045087; GO:0070059; GO:0008631; GO:0007254; GO:0000165; GO:0038066; GO:0043065; GO:0010666; GO:0043280; GO:0046330; GO:0043507; GO:0045663; GO:1901216; GO:1900745; GO:0045893; GO:1904707; GO:0097300; GO:0006468; GO:0034976; GO:0002931; GO:0051403; GO:0016032; GO:0042060"]
[165,82,"PK525","ASK1 (MAP3K5)","T838","Apoptosis signal regulating protein-serine kinase 1",{"v":13126.622986090615,"d":"13127"},{"v":13096.976480217952,"d":"13097"},{"v":2994.6591954472406,"d":"2995"},{"v":22.813629968808247,"d":"23"},{"v":68.90862178118188,"d":"69"},{"v":22917.812959274976,"d":"22918"},"Kinexus","RpAb","TE(pT)FTG(bA)C","Corresponds to amino acid residues T836 to G841; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T838 phosphorylation stimulates phosphotransferase activity. Phosphorylation inhibits interactions with 14-3-3-beta and TXN. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the minor in vivo phosphorylation sites in ASK1 (≥2 reports from high throughput mass spectrometry studies).","ASK1; PDPK1","Q99683","Q99683",575,"Q99683","Q99683","NP_005914","Block1",7,4,"1, 9, 17, 25","ASK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"EC 2.7.11.25; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE11 family","GO:0005829; GO:0009897; GO:1990604; GO:0032991; GO:1902911","GO:0005524; GO:0042802; GO:0000287; GO:0004709; GO:0019904; GO:0042803; GO:0004672; GO:0019901; GO:0019903; GO:0004674","GO:0007257; GO:0000186; GO:0097190; GO:0034198; GO:0070301; GO:1902170; GO:0071356; GO:0072577; GO:0045087; GO:0070059; GO:0008631; GO:0007254; GO:0000165; GO:0038066; GO:0043065; GO:0010666; GO:0043280; GO:0046330; GO:0043507; GO:0045663; GO:1901216; GO:1900745; GO:0045893; GO:1904707; GO:0097300; GO:0006468; GO:0034976; GO:0002931; GO:0051403; GO:0016032; GO:0042060"]
[167,83,"PK143","ASK1 (MAP3K5)","S966","Apoptosis signal regulating protein-serine kinase 1",{"v":313.11857120999645,"d":"313"},{"v":246.31977407721575,"d":"246"},{"v":290.15522575058924,"d":"290"},{"v":92.66624608988569,"d":"93"},{"v":7.697139200031472,"d":"8"},{"v":1949.3219575243631,"d":"1949"},"External","RpAb","SI(pS)LP","Corresponds to amino acid residues S964 to P968; Surrounds the S966 phosphosite.","S966 phosphorylation induces association of MAP3K5/ASK1 with the 14-3-3 family proteins such as YWHAB, YWHAE, YWHAQ, YWHAH, YWHAZ and SFN, and suppresses MAP3K5/ASK1 phosphotransferase activity. This is one of the major in vivo phosphorylation sites in ASK1 (≥4 reports from high throughput mass spectrometry studies).","ASK1","Q99683","Q99683",575,"Q99683","Q99683","NP_005914","Block1",7,5,"1, 9, 17, 25","ASK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"EC 2.7.11.25; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE11 family","GO:0005829; GO:0009897; GO:1990604; GO:0032991; GO:1902911","GO:0005524; GO:0042802; GO:0000287; GO:0004709; GO:0019904; GO:0042803; GO:0004672; GO:0019901; GO:0019903; GO:0004674","GO:0007257; GO:0000186; GO:0097190; GO:0034198; GO:0070301; GO:1902170; GO:0071356; GO:0072577; GO:0045087; GO:0070059; GO:0008631; GO:0007254; GO:0000165; GO:0038066; GO:0043065; GO:0010666; GO:0043280; GO:0046330; GO:0043507; GO:0045663; GO:1901216; GO:1900745; GO:0045893; GO:1904707; GO:0097300; GO:0006468; GO:0034976; GO:0002931; GO:0051403; GO:0016032; GO:0042060"]
[169,84,"PK524","ASK1 (MAP3K5)","S1033","Apoptosis signal regulating protein-serine kinase 1",{"v":8532.052607820047,"d":"8532"},{"v":8305.932736669869,"d":"8306"},{"v":1873.1888873824596,"d":"1873"},{"v":21.95472734973047,"d":"22"},{"v":3788.1531783254713,"d":"3788"},{"v":17048.854921363134,"d":"17049"},"Kinexus","RpAb","APP(pS)PEE(bA)C","Corresponds to amino acid residues A1030 to E1036; After the kinase catalytic domain. ","S1033 phosphorylation inhibits the enzymatic activity of ASK1. This is the major in vivo phosphorylation site in ASK1 (≥28 reports from high throughput mass spectrometry studies).","ASK1","Q99683","Q99683",575,"Q99683","Q99683","NP_005914","Block1",7,6,"1, 9, 17, 25","ASK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"EC 2.7.11.25; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE11 family","GO:0005829; GO:0009897; GO:1990604; GO:0032991; GO:1902911","GO:0005524; GO:0042802; GO:0000287; GO:0004709; GO:0019904; GO:0042803; GO:0004672; GO:0019901; GO:0019903; GO:0004674","GO:0007257; GO:0000186; GO:0097190; GO:0034198; GO:0070301; GO:1902170; GO:0071356; GO:0072577; GO:0045087; GO:0070059; GO:0008631; GO:0007254; GO:0000165; GO:0038066; GO:0043065; GO:0010666; GO:0043280; GO:0046330; GO:0043507; GO:0045663; GO:1901216; GO:1900745; GO:0045893; GO:1904707; GO:0097300; GO:0006468; GO:0034976; GO:0002931; GO:0051403; GO:0016032; GO:0042060"]
[171,85,"PN741","ASS1","T174+S180","Argininosuccinate synthase",{"v":5443.384491019786,"d":"5443"},{"v":5413.979047651624,"d":"5414"},{"v":1659.0399404564698,"d":"1659"},{"v":30.478095809573404,"d":"30"},{"v":738.1471109529606,"d":"738"},{"v":11821.742269128148,"d":"11822"},"Kinexus","RpAb","IPV(pT)PKNPW(pS)MDE(bA)C","Corresponds to amino acid residues I171 to E183.","The effects of T174 and S180 phosphorylation are unclear. These are two of the minor in vivo phosphorylation sites in arginosuccinate synthase (≥8 and >7 reports, respectively, by mass spectrometry). This human phosphosite is highly conserved in vertebrates and also found in yeast.",null,"P00966","P00966",13326,null,null,"NP_000041.2","Block1",7,7,"1, 9, 17, 25",{"$nulls":12},"X","Enzyme  - Synthetase","GO:0070852; GO:0005737; GO:0005829; GO:0005783; GO:0070062; GO:0005764; GO:0005741; GO:0043209; GO:0005634; GO:0043204","GO:0016597; GO:0004055; GO:0005524; GO:0042802; GO:0003723; GO:0015643","GO:0006953; GO:0007568; GO:0006526; GO:0000053; GO:0006531; GO:0071418; GO:0071230; GO:0071242; GO:0071320; GO:0071549; GO:0071377; GO:0071346; GO:0071499; GO:0071222; GO:0071400; GO:0071356; GO:0007623; GO:0000052; GO:0060539; GO:0001822; GO:0001889; GO:0007494; GO:1903038; GO:0045429; GO:0032355; GO:0060416; GO:0010046; GO:0007584; GO:0010043; GO:0000050"]
[173,86,"PN742","ATASE (PPAT)","T356","Glutamine PRPP amidotransferase",{"v":13221.869565610832,"d":"13222"},{"v":12993.275864603842,"d":"12993"},{"v":2781.8379000507957,"d":"2782"},{"v":21.039671328222475,"d":"21"},{"v":3313.6165049435504,"d":"3314"},{"v":21343.893038461523,"d":"21344"},"Kinexus","RpAb","VGR(pT)FIQ(bA)C","Corresponds to amino acid residues V353 to Q359.","The effect of T356 phosphorylation is unclear. Phosphorylation of this site in ATASE has been reported in only one mass spectrometry study. This human phosphosite is highly conserved in vertebrates and also found in yeast.",null,"Q06203","Q06203",9663,null,null,"NP_002694.3","Block1",7,8,"1, 9, 17, 25",{"$nulls":3},"De novo purine synthesis",{"$nulls":8},"X",null,"GO:0005829","GO:0051539; GO:0004044; GO:0046872","GO:0006189; GO:0031100; GO:0035690; GO:0032869; GO:0000082; GO:0006543; GO:0001822; GO:0007595; GO:0060135; GO:0009116; GO:0051289; GO:0009113; GO:0006164; GO:0009168"]
[175,87,"NN160-2","ATF2 (CRE-BP1)","Pan-specific","Cyclic AMP-dependent transcription factor ATF-2",{"v":255.20499913843645,"d":"255"},{"v":155.79124291523408,"d":"156"},{"v":432.33010367707624,"d":"432"},{"v":169.40502934370733,"d":"169"},{"v":29.362974902351695,"d":"29"},{"v":4795.78771363826,"d":"4796"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 350-505 mapping within the DNA binding and dimerization domain of human ATF2.",null,null,"P15336","P15336",922,null,"P15336","NP_001871","Block1",7,9,"1, 9, 17, 25",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005737; GO:0005741; GO:0005654; GO:0005634; GO:0035861","GO:0035497; GO:0008140; GO:0003682; GO:0003700; GO:0001158; GO:0004402; GO:0046872; GO:0046982; GO:0019901; GO:0001102; GO:0000980; GO:0000977; GO:0000981; GO:0001077; GO:0001228; GO:0003713; GO:0003705","GO:0060612; GO:0097186; GO:0006974; GO:0045444; GO:0031573; GO:0016525; GO:0050680; GO:0000122; GO:0003151; GO:0110024; GO:0051091; GO:0010628; GO:1902110; GO:0043525; GO:0045944; GO:0032915; GO:0051090; GO:0006355; GO:0006357; GO:0006970; GO:0009414"]
[177,88,"PN572","ATF2 (CRE-BP1)","T69+T71","Cyclic AMP-dependent transcription factor ATF-2",{"v":12708.591268701537,"d":"12709"},{"v":12805.434621757766,"d":"12805"},{"v":2731.820740989932,"d":"2732"},{"v":21.49585806349603,"d":"21"},{"v":34.761129283464044,"d":"35"},{"v":20467.188358147177,"d":"20467"},"Kinexus","RpAb","CADQ(pT)P(pT)PTR","Corresponds to amino acid residues C66 to R74.","T69 and T71 phosphorylation increases transcriptional activity. These are the major in vivo phosphorylation sites in ATF2 (≥103 and 86 reports by mass spectrometry, respectively).","T69: ERK1; ERK2; JNK1; JNK2; JNK3; p38a. T71: ERK1; ERK2; JNK1; JNK2; JNK3; p38a.","P15336","P15336",922,null,"P15336","NP_001871","Block1",7,10,"1, 9, 17, 25",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005737; GO:0005741; GO:0005654; GO:0005634; GO:0035861","GO:0035497; GO:0008140; GO:0003682; GO:0003700; GO:0001158; GO:0004402; GO:0046872; GO:0046982; GO:0019901; GO:0001102; GO:0000980; GO:0000977; GO:0000981; GO:0001077; GO:0001228; GO:0003713; GO:0003705","GO:0060612; GO:0097186; GO:0006974; GO:0045444; GO:0031573; GO:0016525; GO:0050680; GO:0000122; GO:0003151; GO:0110024; GO:0051091; GO:0010628; GO:1902110; GO:0043525; GO:0045944; GO:0032915; GO:0051090; GO:0006355; GO:0006357; GO:0006970; GO:0009414"]
[179,89,"PN204","ATF2 (CRE-BP1)","T71","Cyclic AMP-dependent transcription factor ATF-2",{"v":602.5399666882197,"d":"603"},{"v":295.61366572135375,"d":"296"},{"v":1710.0054735900205,"d":"1710"},{"v":283.7995100953779,"d":"284"},{"v":53.16998767375867,"d":"53"},{"v":15768.939037430537,"d":"15769"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the T71 phosphosite.","T71 phosphorylation increases transcriptional activity. This is one of the major in vivo phosphorylation sites in ATF2 (≥86 reports from high throughput mass spectrometry studies).","T71: ERK1; ERK2; JNK1; JNK2; JNK3; p38a.","P15336","P15336",922,null,"P15336","NP_001871","Block1",7,11,"1, 9, 17, 25",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005737; GO:0005741; GO:0005654; GO:0005634; GO:0035861","GO:0035497; GO:0008140; GO:0003682; GO:0003700; GO:0001158; GO:0004402; GO:0046872; GO:0046982; GO:0019901; GO:0001102; GO:0000980; GO:0000977; GO:0000981; GO:0001077; GO:0001228; GO:0003713; GO:0003705","GO:0060612; GO:0097186; GO:0006974; GO:0045444; GO:0031573; GO:0016525; GO:0050680; GO:0000122; GO:0003151; GO:0110024; GO:0051091; GO:0010628; GO:1902110; GO:0043525; GO:0045944; GO:0032915; GO:0051090; GO:0006355; GO:0006357; GO:0006970; GO:0009414"]
[181,90,"PN115","ATF2 (CRE-BP1)","S112","Cyclic AMP-dependent transcription factor ATF-2",{"v":88.43274943090648,"d":"88"},{"v":51.80360437487985,"d":"52"},{"v":125.80669832137316,"d":"126"},{"v":142.26256577001192,"d":"142"},{"v":5.656730268175296,"d":"6"},{"v":1419.2700879463334,"d":"1419"},"External","RpAb","DL(pS)PL","Corresponds to amino acid residues D92 to L96 in mouse ATF2; Surrounds the S94 phosphosites. Corresponds to S112 phosphosite in humans.","The effect of S112 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in ATF2 (≥83 reports from high throughput mass spectrometry studies).",null,"P15336","P15336",922,null,"P15336","NP_001871","Block1",7,12,"1, 9, 17, 25",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005737; GO:0005741; GO:0005654; GO:0005634; GO:0035861","GO:0035497; GO:0008140; GO:0003682; GO:0003700; GO:0001158; GO:0004402; GO:0046872; GO:0046982; GO:0019901; GO:0001102; GO:0000980; GO:0000977; GO:0000981; GO:0001077; GO:0001228; GO:0003713; GO:0003705","GO:0060612; GO:0097186; GO:0006974; GO:0045444; GO:0031573; GO:0016525; GO:0050680; GO:0000122; GO:0003151; GO:0110024; GO:0051091; GO:0010628; GO:1902110; GO:0043525; GO:0045944; GO:0032915; GO:0051090; GO:0006355; GO:0006357; GO:0006970; GO:0009414"]
[183,91,"NK230-2","ATM","Pan-specific","Ataxia telangiectasia mutated protein-serine kinase",{"v":10547.874762068031,"d":"10548"},{"v":10077.194140621581,"d":"10077"},{"v":2710.159816940971,"d":"2710"},{"v":25.69389453396973,"d":"26"},{"v":2744.271670343931,"d":"2744"},{"v":20118.714712759123,"d":"20119"},"Kinexus","RpAb","CDEFLTKPEVARRSRI","Corresponds to amino acid residues D2579 to I2593.",null,null,"Q13315","Q13315",1393,"Q13315","Q13315","NP_000042","Block1",7,13,"1, 9, 17, 25","ATM","X","PSTK","Protein kinase - Atypical protein-serine kinase","Protein-serine/threonine kinase","Atypical","PIKK","ATM",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); ATYPICAL domain target; ATYPICAL</A> group; PIKK family","GO:0031410; GO:1990391; GO:0005730; GO:0005654; GO:0005634","GO:0016303; GO:0005524; GO:0003677; GO:0004677; GO:0044877; GO:0046983; GO:0047485; GO:0004674","GO:0006915; GO:0007050; GO:0006974; GO:0071480; GO:0071500; GO:0071300; GO:0071481; GO:0006975; GO:0006977; GO:0000729; GO:0006281; GO:0006260; GO:0006303; GO:0097695; GO:0097694; GO:0071044; GO:0016572; GO:0007094; GO:0030889; GO:1904354; GO:1904262; GO:0036289; GO:0018105; GO:0043065; GO:0045785; GO:0030335; GO:1903626; GO:0043517; GO:0010628; GO:0033129; GO:0043525; GO:1904884; GO:0032212; GO:1904358; GO:0045944; GO:0002331; GO:0046777; GO:0006468; GO:0007131; GO:0042981; GO:0010506; GO:1905843; GO:1900034; GO:1903978; GO:1901796; GO:0032210; GO:0090399; GO:0001666; GO:0010212; GO:0007165; GO:0072434; GO:0000723"]
[185,92,"NK230-1","ATM","Pan-specific","Ataxia telangiectasia mutated protein-serine kinase",{"v":11844.80798139828,"d":"11845"},{"v":11417.621413894816,"d":"11418"},{"v":3154.3693517901847,"d":"3154"},{"v":26.630818808915897,"d":"27"},{"v":4552.829195549214,"d":"4553"},{"v":25242.54577985601,"d":"25243"},"Kinexus","RpAb","CGKERRQLVKGRDDLR","Corresponds to amino acid residues G2719 to R2733.",null,null,"Q13315","Q13315",1393,"Q13315","Q13315","NP_000042","Block1",8,1,"1, 9, 17, 25","ATM","X","PSTK","Protein kinase - Atypical protein-serine kinase","Protein-serine/threonine kinase","Atypical","PIKK","ATM",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); ATYPICAL domain target; ATYPICAL</A> group; PIKK family","GO:0031410; GO:1990391; GO:0005730; GO:0005654; GO:0005634","GO:0016303; GO:0005524; GO:0003677; GO:0004677; GO:0044877; GO:0046983; GO:0047485; GO:0004674","GO:0006915; GO:0007050; GO:0006974; GO:0071480; GO:0071500; GO:0071300; GO:0071481; GO:0006975; GO:0006977; GO:0000729; GO:0006281; GO:0006260; GO:0006303; GO:0097695; GO:0097694; GO:0071044; GO:0016572; GO:0007094; GO:0030889; GO:1904354; GO:1904262; GO:0036289; GO:0018105; GO:0043065; GO:0045785; GO:0030335; GO:1903626; GO:0043517; GO:0010628; GO:0033129; GO:0043525; GO:1904884; GO:0032212; GO:1904358; GO:0045944; GO:0002331; GO:0046777; GO:0006468; GO:0007131; GO:0042981; GO:0010506; GO:1905843; GO:1900034; GO:1903978; GO:1901796; GO:0032210; GO:0090399; GO:0001666; GO:0010212; GO:0007165; GO:0072434; GO:0000723"]
[187,93,"PK526","ATM","S1981","Ataxia telangiectasia mutated protein-serine kinase",{"v":6971.659520047267,"d":"6972"},{"v":6850.60035390851,"d":"6851"},{"v":1662.4623790785688,"d":"1662"},{"v":23.84600645367285,"d":"24"},{"v":2779.6140938000713,"d":"2780"},{"v":14402.57809329209,"d":"14403"},"Kinexus","RpAb","EEG(pS)QST(bA)C","Corresponds to amino acid residues E1978 to T1984; In the C-terminal half of the protein kinase before the FAT domain.","S1981 phosphorylation stimulates phosphotransferase activity, although other reports indicate inhibition. Phosphorylation induces interaction with ATM, MDC1, NBS1, PKM and p53, and inhibits interaction with CDCA2. This is one of the major in vivo phosphorylation sites in ATM (≥26 reports from high throughput mass spectrometry studies).","ATR; ATM","Q13315","Q13315",1393,"Q13315","Q13315","NP_000042","Block1",8,2,"1, 9, 17, 25","ATM","X","PSTK","Protein kinase - Atypical protein-serine kinase","Protein-serine/threonine kinase","Atypical","PIKK","ATM",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); ATYPICAL domain target; ATYPICAL</A> group; PIKK family","GO:0031410; GO:1990391; GO:0005730; GO:0005654; GO:0005634","GO:0016303; GO:0005524; GO:0003677; GO:0004677; GO:0044877; GO:0046983; GO:0047485; GO:0004674","GO:0006915; GO:0007050; GO:0006974; GO:0071480; GO:0071500; GO:0071300; GO:0071481; GO:0006975; GO:0006977; GO:0000729; GO:0006281; GO:0006260; GO:0006303; GO:0097695; GO:0097694; GO:0071044; GO:0016572; GO:0007094; GO:0030889; GO:1904354; GO:1904262; GO:0036289; GO:0018105; GO:0043065; GO:0045785; GO:0030335; GO:1903626; GO:0043517; GO:0010628; GO:0033129; GO:0043525; GO:1904884; GO:0032212; GO:1904358; GO:0045944; GO:0002331; GO:0046777; GO:0006468; GO:0007131; GO:0042981; GO:0010506; GO:1905843; GO:1900034; GO:1903978; GO:1901796; GO:0032210; GO:0090399; GO:0001666; GO:0010212; GO:0007165; GO:0072434; GO:0000723"]
[189,94,"PK527","ATM","Y2969","Ataxia telangiectasia mutated protein-serine kinase",{"v":6543.87600214183,"d":"6544"},{"v":6517.83913659927,"d":"6518"},{"v":1557.4980862285252,"d":"1557"},{"v":23.80084961449073,"d":"24"},{"v":3206.028061181176,"d":"3206"},{"v":12661.600914485027,"d":"12662"},"Kinexus","RpAb","KAL(pY)LQQ(bA)C","Corresponds to amino acid residues K2966 to Q2972; Near the C-terminus of the kinase. ","The effect of Y2969 phosphorylation is unclear. This is the major in vivo phosphorylation site in ATM (≥80 reports from high throughput mass spectrometry studies).",null,"Q13315","Q13315",1393,"Q13315","Q13315","NP_000042","Block1",8,3,"1, 9, 17, 25","ATM","X","PSTK","Protein kinase - Atypical protein-serine kinase","Protein-serine/threonine kinase","Atypical","PIKK","ATM",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); ATYPICAL domain target; ATYPICAL</A> group; PIKK family","GO:0031410; GO:1990391; GO:0005730; GO:0005654; GO:0005634","GO:0016303; GO:0005524; GO:0003677; GO:0004677; GO:0044877; GO:0046983; GO:0047485; GO:0004674","GO:0006915; GO:0007050; GO:0006974; GO:0071480; GO:0071500; GO:0071300; GO:0071481; GO:0006975; GO:0006977; GO:0000729; GO:0006281; GO:0006260; GO:0006303; GO:0097695; GO:0097694; GO:0071044; GO:0016572; GO:0007094; GO:0030889; GO:1904354; GO:1904262; GO:0036289; GO:0018105; GO:0043065; GO:0045785; GO:0030335; GO:1903626; GO:0043517; GO:0010628; GO:0033129; GO:0043525; GO:1904884; GO:0032212; GO:1904358; GO:0045944; GO:0002331; GO:0046777; GO:0006468; GO:0007131; GO:0042981; GO:0010506; GO:1905843; GO:1900034; GO:1903978; GO:1901796; GO:0032210; GO:0090399; GO:0001666; GO:0010212; GO:0007165; GO:0072434; GO:0000723"]
[191,95,"NK237-1","ATR","Pan-specific","Ataxia telangiectasia and Rad3 related protein-serine kinase",{"v":1535.8164528278223,"d":"1536"},{"v":1423.0511085710348,"d":"1423"},{"v":609.3535371606004,"d":"609"},{"v":39.67619542287284,"d":"40"},{"v":400.2075582469365,"d":"400"},{"v":3942.3871487863603,"d":"3942"},"Kinexus","RpAb","KISLKGSDGKFYIMMC","Corresponds to amino acid residues K2311 to C2326.",null,null,"Q13535","Q13535",576,"Q13535","Q13535","NP_001175.2","Block1",8,4,"1, 9, 17, 25","ATR","X","PSTK","Protein kinase - Atypical protein-serine kinase","Protein-serine/threonine kinase","Atypical","PIKK","ATR",{"$nulls":5},"Protein-serine kinase,  ATYPICAL group, PIKK family, ATR subfamily","GO:0005694; GO:0005794; GO:0005654; GO:0016605","GO:0005524; GO:0003677; GO:0032405; GO:0032407; GO:0004672; GO:0004674","GO:0006974; GO:0071480; GO:0034644; GO:0000077; GO:0006281; GO:0006260; GO:0097695; GO:0097694; GO:0036297; GO:0007275; GO:0008156; GO:0018105; GO:0043517; GO:1904884; GO:0032212; GO:0046777; GO:0070198; GO:1900034; GO:0090399; GO:0042493"]
[193,96,"NK237-3","ATR","Pan-specific","Ataxia telangiectasia and Rad3 related protein-serine kinase",{"v":16587.92062426187,"d":"16588"},{"v":16473.70841664,"d":"16474"},{"v":3452.2483973190597,"d":"3452"},{"v":20.811821297659954,"d":"21"},{"v":7652.176147044495,"d":"7652"},{"v":30471.98656682911,"d":"30472"},"Kinexus","RpAb","CGHVHYLIQEATDENL","Corresponds to amino acid residues G2618 to L2632; C-terminus.",null,null,"Q13535","Q13535",576,"Q13535","Q13535","NP_001175.2","Block1",8,5,"1, 9, 17, 25","ATR","X","PSTK","Protein kinase - Atypical protein-serine kinase","Protein-serine/threonine kinase","Atypical","PIKK","ATR",{"$nulls":5},"Protein-serine kinase,  ATYPICAL group, PIKK family, ATR subfamily","GO:0005694; GO:0005794; GO:0005654; GO:0016605","GO:0005524; GO:0003677; GO:0032405; GO:0032407; GO:0004672; GO:0004674","GO:0006974; GO:0071480; GO:0034644; GO:0000077; GO:0006281; GO:0006260; GO:0097695; GO:0097694; GO:0036297; GO:0007275; GO:0008156; GO:0018105; GO:0043517; GO:1904884; GO:0032212; GO:0046777; GO:0070198; GO:1900034; GO:0090399; GO:0042493"]
[195,97,"PK528","ATR","S435+S436","Ataxia telangiectasia and Rad3 related protein-serine kinase",{"v":8884.520803585527,"d":"8885"},{"v":8734.865723911822,"d":"8735"},{"v":1884.543597839954,"d":"1885"},{"v":21.211539029537853,"d":"21"},{"v":2884.3811198051585,"d":"2884"},{"v":14877.26278926808,"d":"14877"},"Kinexus","RpAb","RRL(pS)(pS)SLN(bA)C","Corresponds to amino acid residues R432 to N439; In the N-terminal quarter of the kinase after the transmembrane domain. ","Phosphorylation of S435 induces iteraction with AKAP12. The effects of S436 phosphorylation are unclear. These are the major in vivo phosphorylation sites in ATR (≥97 and ≥53 reports, respectively, by mass spectrometry).","S435: PKACA","Q13535","Q13535",576,"Q13535","Q13535","NP_001175.2","Block1",8,6,"1, 9, 17, 25","ATR","X","PSTK","Protein kinase - Atypical protein-serine kinase","Protein-serine/threonine kinase","Atypical","PIKK","ATR",{"$nulls":5},"Protein-serine kinase,  ATYPICAL group, PIKK family, ATR subfamily","GO:0005694; GO:0005794; GO:0005654; GO:0016605","GO:0005524; GO:0003677; GO:0032405; GO:0032407; GO:0004672; GO:0004674","GO:0006974; GO:0071480; GO:0034644; GO:0000077; GO:0006281; GO:0006260; GO:0097695; GO:0097694; GO:0036297; GO:0007275; GO:0008156; GO:0018105; GO:0043517; GO:1904884; GO:0032212; GO:0046777; GO:0070198; GO:1900034; GO:0090399; GO:0042493"]
[197,98,"NK008-3","AurKA (Aurora A, AIK, STK15)","Pan-specific","Aurora Kinase A (serine/threonine protein kinase 6)",{"v":5938.493304319862,"d":"5938"},{"v":5793.997264777959,"d":"5794"},{"v":1672.8699320631931,"d":"1673"},{"v":28.169938843684317,"d":"28"},{"v":2114.5134117077214,"d":"2115"},{"v":11441.896035310332,"d":"11442"},"Kinexus","RpAb","CGPVKATAPVGGPKRV","Corresponds to amino acid residues G11 to V25.",null,null,"O14965","O14965",2173,"O14965","O14965","NP_940835","Block1",8,7,"1, 9, 17, 25","AurA","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; AUR family","GO:0043203; GO:0005814; GO:0005813; GO:0032133; GO:0005929; GO:0000780; GO:0005829; GO:0042585; GO:0072687; GO:0005874; GO:0015630; GO:0030496; GO:0097431; GO:0005654; GO:0005634; GO:0048471; GO:0045120; GO:0005819; GO:0051233; GO:0031616","GO:0005524; GO:0035174; GO:0046982; GO:0004672; GO:0019901; GO:0004712; GO:0004674; GO:0031625","GO:0031145; GO:0009948; GO:0051301; GO:0051642; GO:0006977; GO:0000086; GO:0097421; GO:0000278; GO:0007100; GO:0007052; GO:0043066; GO:0010972; GO:0032091; GO:1990138; GO:0045840; GO:1900195; GO:0032436; GO:0046777; GO:0071539; GO:0006468; GO:0046605; GO:0032465; GO:0010389; GO:0031647; GO:1901796; GO:0009611; GO:0007057; GO:0007051"]
[199,99,"NK008-4","AurKA (Aurora A, AIK, STK15)","Pan-specific","Aurora Kinase A (serine/threonine protein kinase 6)",{"v":11547.363722006081,"d":"11547"},{"v":11409.785925954642,"d":"11410"},{"v":1945.4388796573817,"d":"1945"},{"v":16.847472085337657,"d":"17"},{"v":6345.925221736577,"d":"6346"},{"v":17624.30893629672,"d":"17624"},"Kinexus","RpAb","CESKKRQWALEDFEI","Corresponds to amino acid residues E122 to I135.",null,null,"O14965","O14965",2173,"O14965","O14965","NP_940835","Block1",8,8,"1, 9, 17, 25","AurA","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; AUR family","GO:0043203; GO:0005814; GO:0005813; GO:0032133; GO:0005929; GO:0000780; GO:0005829; GO:0042585; GO:0072687; GO:0005874; GO:0015630; GO:0030496; GO:0097431; GO:0005654; GO:0005634; GO:0048471; GO:0045120; GO:0005819; GO:0051233; GO:0031616","GO:0005524; GO:0035174; GO:0046982; GO:0004672; GO:0019901; GO:0004712; GO:0004674; GO:0031625","GO:0031145; GO:0009948; GO:0051301; GO:0051642; GO:0006977; GO:0000086; GO:0097421; GO:0000278; GO:0007100; GO:0007052; GO:0043066; GO:0010972; GO:0032091; GO:1990138; GO:0045840; GO:1900195; GO:0032436; GO:0046777; GO:0071539; GO:0006468; GO:0046605; GO:0032465; GO:0010389; GO:0031647; GO:1901796; GO:0009611; GO:0007057; GO:0007051"]
[201,100,"PK529","AurKA (Aurora A, AIK, STK15)","T287+T288","Aurora Kinase A (serine/threonine protein kinase 6)",{"v":14740.62748704818,"d":"14741"},{"v":14808.322815871383,"d":"14808"},{"v":2868.013902503693,"d":"2868"},{"v":19.45652520575306,"d":"19"},{"v":7812.851692950735,"d":"7813"},{"v":23830.2438541112,"d":"23830"},"Kinexus","RpAb","RR(pT)(pT)LCG(bA)C","Corresponds to amino acid residues R285 to G291; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T287 and T288 phosphorylation stimulate phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major in vivo phosphorylation sites in AurKA (≥6 and ≥16 reports, respectively, by mass spectrometry).","T287: AurKA. T288: AurKA; PAK1; PKACa","O14965","O14965",2173,"O14965","O14965","NP_004208","Block1",8,9,"1, 9, 17, 25","AurA","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; AUR family","GO:0043203; GO:0005814; GO:0005813; GO:0032133; GO:0005929; GO:0000780; GO:0005829; GO:0042585; GO:0072687; GO:0005874; GO:0015630; GO:0030496; GO:0097431; GO:0005654; GO:0005634; GO:0048471; GO:0045120; GO:0005819; GO:0051233; GO:0031616","GO:0005524; GO:0035174; GO:0046982; GO:0004672; GO:0019901; GO:0004712; GO:0004674; GO:0031625","GO:0031145; GO:0009948; GO:0051301; GO:0051642; GO:0006977; GO:0000086; GO:0097421; GO:0000278; GO:0007100; GO:0007052; GO:0043066; GO:0010972; GO:0032091; GO:1990138; GO:0045840; GO:1900195; GO:0032436; GO:0046777; GO:0071539; GO:0006468; GO:0046605; GO:0032465; GO:0010389; GO:0031647; GO:1901796; GO:0009611; GO:0007057; GO:0007051"]
[203,76,"PK174","AurKA (Aurora A, AIK, STK15)","T288","Aurora Kinase A (serine/threonine protein kinase 6)",{"v":314.95285003989505,"d":"315"},{"v":252.0001745405007,"d":"252"},{"v":198.5635863047943,"d":"199"},{"v":63.045495946343166,"d":"63"},{"v":39.14896145655362,"d":"39"},{"v":1583.3194910055909,"d":"1583"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the T288 phosphosite.","T288 phosphorylation stimulates phosphotransferase activity. This is one of the major in vivo phosphorylation sites in ARK-1 (≥16 reports from high throughput mass spectrometry studies).","AurA; PAK1; PKACa","O14965","O14965",2173,"O14965","O14965","NP_001310232.1","Block1",6,11,"1, 9, 17, 25",null,"X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; AUR family","GO:0043203; GO:0005814; GO:0005813; GO:0032133; GO:0005929; GO:0000780; GO:0005829; GO:0042585; GO:0072687; GO:0005874; GO:0015630; GO:0030496; GO:0097431; GO:0005654; GO:0005634; GO:0048471; GO:0045120; GO:0005819; GO:0051233; GO:0031616","GO:0005524; GO:0035174; GO:0046982; GO:0004672; GO:0019901; GO:0004712; GO:0004674; GO:0031625","GO:0031145; GO:0009948; GO:0051301; GO:0051642; GO:0006977; GO:0000086; GO:0097421; GO:0000278; GO:0007100; GO:0007052; GO:0043066; GO:0010972; GO:0032091; GO:1990138; GO:0045840; GO:1900195; GO:0032436; GO:0046777; GO:0071539; GO:0006468; GO:0046605; GO:0032465; GO:0010389; GO:0031647; GO:1901796; GO:0009611; GO:0007057; GO:0007051"]
[205,101,"NK193-2","AurKB (Aurora B, AIM-1)","Pan-specific","Aurora Kinase B (serine/threonine protein kinase 12)",{"v":10311.987274602283,"d":"10312"},{"v":10168.978598059333,"d":"10169"},{"v":2261.6974016627046,"d":"2262"},{"v":21.932701635824454,"d":"22"},{"v":5583.532744484726,"d":"5584"},{"v":16260.983097911556,"d":"16261"},"Kinexus","RpAb","AQKENSYPWPYGRQTC","Corresponds to amino acid residues A2 to T16; N-terminus.",null,null,"Q96GD4","Q96GD4",2170,"Q96GD4","Q96GD4","NP_004208","Block1",8,10,"1, 9, 17, 25","AurB","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"Protein-serine kinase, Other group, AUR family","GO:0010369; GO:0032133; GO:0000779; GO:0000780; GO:0005829; GO:0000776; GO:0030496; GO:1990023; GO:0005654; GO:0005634; GO:0005819; GO:0005876; GO:0051233; GO:0031616","GO:0005524; GO:0035174; GO:0019900; GO:0046872; GO:0004712; GO:0004674","GO:0009838; GO:0007568; GO:0031145; GO:0008608; GO:0008283; GO:0034644; GO:0036089; GO:0043988; GO:0016570; GO:0044878; GO:0051256; GO:0002903; GO:0032466; GO:0032091; GO:0000122; GO:0032467; GO:0051973; GO:1904355; GO:0032212; GO:0046777; GO:0034501; GO:0006468; GO:0051983; GO:1901796; GO:0031577; GO:0007051"]
[207,102,"NK193-3","AurKB (Aurora B, AIM-1)","Pan-specific","Aurora Kinase B (serine/threonine protein kinase 12)",{"v":11596.909256636889,"d":"11597"},{"v":11357.969895013233,"d":"11358"},{"v":1909.1223518920071,"d":"1909"},{"v":16.462337590504298,"d":"16"},{"v":6219.808538190307,"d":"6220"},{"v":17758.95771574785,"d":"17759"},"Kinexus","RpAb","CDILTRHFTIDDFEIG","Corresponds to amino acid residues D66 to G80.",null,null,"Q96GD4","Q96GD4",2170,"Q96GD4","Q96GD4","NP_004208","Block1",8,11,"1, 9, 17, 25","AurB","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"Protein-serine kinase, Other group, AUR family","GO:0010369; GO:0032133; GO:0000779; GO:0000780; GO:0005829; GO:0000776; GO:0030496; GO:1990023; GO:0005654; GO:0005634; GO:0005819; GO:0005876; GO:0051233; GO:0031616","GO:0005524; GO:0035174; GO:0019900; GO:0046872; GO:0004712; GO:0004674","GO:0009838; GO:0007568; GO:0031145; GO:0008608; GO:0008283; GO:0034644; GO:0036089; GO:0043988; GO:0016570; GO:0044878; GO:0051256; GO:0002903; GO:0032466; GO:0032091; GO:0000122; GO:0032467; GO:0051973; GO:1904355; GO:0032212; GO:0046777; GO:0034501; GO:0006468; GO:0051983; GO:1901796; GO:0031577; GO:0007051"]
[209,103,"PK530","AurKB (Aurora B, AIM-1)","S227","Aurora Kinase B (serine/threonine protein kinase 12)",{"v":6925.763541983056,"d":"6926"},{"v":6908.253920918595,"d":"6908"},{"v":6904.834381066605,"d":"6905"},{"v":99.69780716899182,"d":"100"},{"v":2.364586692412378,"d":"2"},{"v":23848.617827864604,"d":"23849"},"Kinexus","RpAb","VAHAP(pS)L(bA)C","Corresponds to amino acid residues V222 to L228; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S227 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation induces interaction with INCENP. This is a minor in vivo phosphorylation site in AurKB (≥11 reports from high throughput mass spectrometry studies).","AurKB","Q96GD4","Q96GD4",2170,"Q96GD4","Q96GD4","NP_004208","Block1",8,12,"1, 9, 17, 25","AurB","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"Protein-serine kinase, Other group, AUR family","GO:0010369; GO:0032133; GO:0000779; GO:0000780; GO:0005829; GO:0000776; GO:0030496; GO:1990023; GO:0005654; GO:0005634; GO:0005819; GO:0005876; GO:0051233; GO:0031616","GO:0005524; GO:0035174; GO:0019900; GO:0046872; GO:0004712; GO:0004674","GO:0009838; GO:0007568; GO:0031145; GO:0008608; GO:0008283; GO:0034644; GO:0036089; GO:0043988; GO:0016570; GO:0044878; GO:0051256; GO:0002903; GO:0032466; GO:0032091; GO:0000122; GO:0032467; GO:0051973; GO:1904355; GO:0032212; GO:0046777; GO:0034501; GO:0006468; GO:0051983; GO:1901796; GO:0031577; GO:0007051"]
[211,104,"PK531","AurKB (Aurora B, AIM-1)","T232","Aurora Kinase B (serine/threonine protein kinase 12)",{"v":1499.5486515046457,"d":"1500"},{"v":1398.8114468617441,"d":"1399"},{"v":638.8791045384868,"d":"639"},{"v":42.60476003212274,"d":"43"},{"v":149.39053299349285,"d":"149"},{"v":3695.576628269062,"d":"3696"},"Kinexus","RpAb","RRK(pT)MCG(bA)C","Corresponds to amino acid residues R229 to G235; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T232 phosphorylation stimulates or inhibits phosphotransferase activity according to separate reports and regulates cytoskeletal reorganization and intracellular location, and induces binding to INCENP. It is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in AurKB (≥101 reports from high throughput mass spectrometry studies).","AurKB","Q96GD4","Q96GD4",2170,"Q96GD4","Q96GD4","NP_004208","Block1",8,13,"1, 9, 17, 25","AurB","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"Protein-serine kinase, Other group, AUR family","GO:0010369; GO:0032133; GO:0000779; GO:0000780; GO:0005829; GO:0000776; GO:0030496; GO:1990023; GO:0005654; GO:0005634; GO:0005819; GO:0005876; GO:0051233; GO:0031616","GO:0005524; GO:0035174; GO:0019900; GO:0046872; GO:0004712; GO:0004674","GO:0009838; GO:0007568; GO:0031145; GO:0008608; GO:0008283; GO:0034644; GO:0036089; GO:0043988; GO:0016570; GO:0044878; GO:0051256; GO:0002903; GO:0032466; GO:0032091; GO:0000122; GO:0032467; GO:0051973; GO:1904355; GO:0032212; GO:0046777; GO:0034501; GO:0006468; GO:0051983; GO:1901796; GO:0031577; GO:0007051"]
[213,105,"NK009-2","AurKC (Aurora C, AIK3)","Pan-specific","Aurora Kinase C (serine/threonine-protein kinase 13)",{"v":9191.820477157344,"d":"9192"},{"v":8855.93153627404,"d":"8856"},{"v":3004.509128489913,"d":"3005"},{"v":32.686769024225825,"d":"33"},{"v":1161.7628460499982,"d":"1162"},{"v":18842.157047073513,"d":"18842"},"Kinexus","RpAb","MSSPRAVVQLGKAQPC","Corresponds to amino acid residues M1 to P15; N-terminus.",null,null,"Q9UQB9","Q9UQB9",2168,"Q9UQB9",null,"NP_003151","Block1",9,1,"1, 9, 17, 25","AurC","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"Protein-serine kinase, Other group, AUR family","GO:0032133; GO:0000793; GO:0000780; GO:0005737; GO:0030496; GO:0005819; GO:0005876; GO:0051233; GO:0031616","GO:0005524; GO:0035174; GO:0004672; GO:0004712","GO:0008608; GO:0000910; GO:0016570; GO:0051321; GO:0051256; GO:0048599; GO:0032467; GO:0006468; GO:0007283"]
[215,106,"NK009-3","AurKC (Aurora C, AIK3)","Pan-specific","Aurora Kinase C (serine/threonine-protein kinase 13)",{"v":2360.013874862248,"d":"2360"},{"v":2238.9133968924157,"d":"2239"},{"v":1035.1912508222142,"d":"1035"},{"v":43.86377816878883,"d":"44"},{"v":437.44865164671774,"d":"437"},{"v":6438.503871517109,"d":"6439"},"Kinexus","RpAb","CSPAMRRLTVDDFEIG","Corresponds to amino acid residues S32 to G46; Pre-kinase catalytic domain.",null,null,"Q9UQB9","Q9UQB9",2168,"Q9UQB9",null,"NP_003151","Block1",9,2,"1, 9, 17, 25","AurC","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"Protein-serine kinase, Other group, AUR family","GO:0032133; GO:0000793; GO:0000780; GO:0005737; GO:0030496; GO:0005819; GO:0005876; GO:0051233; GO:0031616","GO:0005524; GO:0035174; GO:0004672; GO:0004712","GO:0008608; GO:0000910; GO:0016570; GO:0051321; GO:0051256; GO:0048599; GO:0032467; GO:0006468; GO:0007283"]
[217,107,"PK532","AurKC (Aurora C, AIK3)","S193","Aurora Kinase C (serine/threonine-protein kinase 13)",{"v":10017.64123117542,"d":"10018"},{"v":9906.89414998299,"d":"9907"},{"v":2310.8781566696866,"d":"2311"},{"v":23.068086621809872,"d":"23"},{"v":5282.31275264999,"d":"5282"},{"v":19800.496550809192,"d":"19800"},"Kinexus","RpAb","HTP(pS)LRR(bA)C","Corresponds to amino acid residues H190 to R196; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S193 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation of this site has not apparently been detected by mass spectrometry. ",null,"Q9UQB9","Q9UQB9",2168,"Q9UQB9",null,"NP_003151","Block1",9,3,"1, 9, 17, 25","AurC","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","AUR",{"$nulls":6},"Protein-serine kinase, Other group, AUR family","GO:0032133; GO:0000793; GO:0000780; GO:0005737; GO:0030496; GO:0005819; GO:0005876; GO:0051233; GO:0031616","GO:0005524; GO:0035174; GO:0004672; GO:0004712","GO:0008608; GO:0000910; GO:0016570; GO:0051321; GO:0051256; GO:0048599; GO:0032467; GO:0006468; GO:0007283"]
[219,108,"NK010-2","Axl (UFO)","Pan-specific","AXL oncogene-encoded protein-tyrosine kinase UFO",{"v":4764.304974313743,"d":"4764"},{"v":4454.402597325869,"d":"4454"},{"v":1660.5321287835393,"d":"1661"},{"v":34.85360693188464,"d":"35"},{"v":1767.2537926705158,"d":"1767"},{"v":12046.142181036885,"d":"12046"},"Kinexus","RpAb","CSFTELREDLENTLKAL","Corresponds to amino acid residues S795 to L810; After catalytic domain in a region not as conserved with Tyro3 and MERTK.",null,null,"P30530","P30530",1889,"P30530","P30530","NP_001690.2","Block1",9,4,"1, 9, 17, 25","AXL","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Axl",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; Axl family","GO:0009986; GO:0070062; GO:0005615; GO:0044228; GO:0005887; GO:0005622; GO:0005886","GO:0005524; GO:0032036; GO:0043548; GO:0001786; GO:0046982; GO:0004713; GO:0004714; GO:0001618","GO:0031100; GO:0043277; GO:0001974; GO:0048469; GO:0031668; GO:0070301; GO:0035457; GO:0071222; GO:0097028; GO:0034101; GO:0021885; GO:0006954; GO:0045087; GO:0001779; GO:2000669; GO:0032689; GO:0051250; GO:0043524; GO:0032720; GO:0001764; GO:0097350; GO:0042698; GO:0006909; GO:0030168; GO:0001961; GO:0032825; GO:0048549; GO:0051897; GO:0043491; GO:0032940; GO:0007165; GO:0007283; GO:0034446; GO:0060068; GO:0048010; GO:0046718"]
[221,109,"NK010-3","Axl (UFO)","Pan-specific","AXL oncogene-encoded protein-tyrosine kinase UFO",{"v":1834.331693264542,"d":"1834"},{"v":1693.3145156345995,"d":"1693"},{"v":757.4155626101674,"d":"757"},{"v":41.29109066758817,"d":"41"},{"v":158.04325874461892,"d":"158"},{"v":4823.2090541787775,"d":"4823"},"Kinexus","RpAb","RKSYSRRTTEATLNSLGC","Corresponds to amino acid residues R501 to G517; Before catalytic domain.",null,null,"P30530","P30530",1889,"P30530","P30530","NP_001690.2","Block1",9,5,"1, 9, 17, 25","AXL","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Axl",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; Axl family","GO:0009986; GO:0070062; GO:0005615; GO:0044228; GO:0005887; GO:0005622; GO:0005886","GO:0005524; GO:0032036; GO:0043548; GO:0001786; GO:0046982; GO:0004713; GO:0004714; GO:0001618","GO:0031100; GO:0043277; GO:0001974; GO:0048469; GO:0031668; GO:0070301; GO:0035457; GO:0071222; GO:0097028; GO:0034101; GO:0021885; GO:0006954; GO:0045087; GO:0001779; GO:2000669; GO:0032689; GO:0051250; GO:0043524; GO:0032720; GO:0001764; GO:0097350; GO:0042698; GO:0006909; GO:0030168; GO:0001961; GO:0032825; GO:0048549; GO:0051897; GO:0043491; GO:0032940; GO:0007165; GO:0007283; GO:0034446; GO:0060068; GO:0048010; GO:0046718"]
[223,110,"PK533","Axl (UFO)","Y702+Y703","AXL oncogene-encoded protein-tyrosine kinase UFO",{"v":7009.493113241858,"d":"7009"},{"v":6912.64529517414,"d":"6913"},{"v":1929.7243302298964,"d":"1930"},{"v":27.530155163208487,"d":"28"},{"v":1315.9897622094595,"d":"1316"},{"v":13320.834729639882,"d":"13321"},"Kinexus","RpAb","NGD(pY)(pY)RQG(bA)C","Corresponds to amino acid residues N699 to G706; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y702 and Y703 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are the two major in vivo phosphorylation sites in Axl (≥754 and ≥358 reports, respectively, by mass spectrometry).",null,"P30530","P30530",1889,"P30530","P30530","NP_001690.2","Block1",9,6,"1, 9, 17, 25","AXL","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Axl",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; Axl family","GO:0009986; GO:0070062; GO:0005615; GO:0044228; GO:0005887; GO:0005622; GO:0005886","GO:0005524; GO:0032036; GO:0043548; GO:0001786; GO:0046982; GO:0004713; GO:0004714; GO:0001618","GO:0031100; GO:0043277; GO:0001974; GO:0048469; GO:0031668; GO:0070301; GO:0035457; GO:0071222; GO:0097028; GO:0034101; GO:0021885; GO:0006954; GO:0045087; GO:0001779; GO:2000669; GO:0032689; GO:0051250; GO:0043524; GO:0032720; GO:0001764; GO:0097350; GO:0042698; GO:0006909; GO:0030168; GO:0001961; GO:0032825; GO:0048549; GO:0051897; GO:0043491; GO:0032940; GO:0007165; GO:0007283; GO:0034446; GO:0060068; GO:0048010; GO:0046718"]
[225,111,"PN573","B-Myb (MYBL2)","T487","Myb-related protein B",{"v":10842.369892527578,"d":"10842"},{"v":10581.628983875977,"d":"10582"},{"v":2410.5233450473033,"d":"2411"},{"v":22.232439669011892,"d":"22"},{"v":4494.927634245205,"d":"4495"},{"v":19070.659466591525,"d":"19071"},"Kinexus","RpAb","VVVT(pT)PLHR(bA)C","Corresponds to amino acid residues V483 to R491.","T487 phosphorylation stimulates transcriptional activity. This is one of the major in vivo phosphorylation sites in B-Myb (≥42 reports from high throughput mass spectrometry studies).","CDK2","P10244","P10244",2985,null,null,"NP_001265539.1","Block1",9,7,"1, 9, 17, 25",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0031523; GO:0005654; GO:0005634","GO:0003700; GO:0000978; GO:0000981; GO:0001135; GO:0001077","GO:0030154; GO:1990830; GO:0090307; GO:0043525; GO:0045944; GO:0051726; GO:0006357"]
[227,112,"PN206","B-Myb (MYBL2)","T487","Myb-related protein B",{"v":192.41320589561536,"d":"192"},{"v":36.3275117228008,"d":"36"},{"v":300.9975049990299,"d":"301"},{"v":156.43287247254838,"d":"156"},{"v":3.1616115821241677,"d":"3"},{"v":2841.2051434092373,"d":"2841"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the T490 phosphosite of mouse B-Myb, which corresponds to human B-Myb T487.","T487 phosphorylation stimulates transcriptional activity. This is one of the major in vivo phosphorylation sites in B-Myb (≥42 reports from high throughput mass spectrometry studies).","CDK2","P10244","P10244",2985,null,null,"NP_001265539.1","Block1",9,8,"1, 9, 17, 25",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0031523; GO:0005654; GO:0005634","GO:0003700; GO:0000978; GO:0000981; GO:0001135; GO:0001077","GO:0030154; GO:1990830; GO:0090307; GO:0043525; GO:0045944; GO:0051726; GO:0006357"]
[229,113,"NN177-2","B23 (NPM)","Pan-specific","B23 (nucleophosmin, numatrin, nucleolar protein NO38)",{"v":271.80174955541867,"d":"272"},{"v":225.20486672069467,"d":"225"},{"v":178.83933792048867,"d":"179"},{"v":65.79771403716606,"d":"66"},{"v":51.2863685708486,"d":"51"},{"v":1223.3206481273555,"d":"1223"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 253-294 at the C-terminus of human B23. ",null,null,"P06748","P06748",1183,null,"P06748","NP_002511","Block1",9,9,"1, 9, 17, 25",{"$nulls":13},"RNA binding protein","GO:0005813; GO:0005737; GO:0005829; GO:0005925; GO:0016020; GO:0005730; GO:0005654; GO:0005634; GO:0032991; GO:0032993; GO:1990904; GO:0031616","GO:0033613; GO:0001047; GO:0042393; GO:0051059; GO:0046982; GO:0042803; GO:0019901; GO:0004860; GO:0043023; GO:0043024; GO:0003723; GO:0030957; GO:0003713; GO:0008134; GO:0051082","GO:0007569; GO:0034644; GO:0034080; GO:0007098; GO:0006281; GO:0006886; GO:0043066; GO:0008285; GO:0010826; GO:0044387; GO:0006913; GO:0006334; GO:1902751; GO:0008284; GO:0051092; GO:0045893; GO:0045944; GO:0045727; GO:0051259; GO:0008104; GO:0046599; GO:0060735; GO:0032071; GO:0060699; GO:1902629; GO:0006357; GO:0042255; GO:0007165; GO:0016032"]
[231,114,"PN009","B23 (NPM)","T234+T237","B23 (nucleophosmin, numatrin, nucleolar protein NO38)",{"v":30.492800597038833,"d":"30"},{"v":23.83067191927081,"d":"24"},{"v":30.538542192534752,"d":"31"},{"v":100.15000785300239,"d":"100"},{"v":7.912870774320696,"d":"8"},{"v":309.65795435559596,"d":"310"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the T234 and T237 phosphosites.","T234 and T237 phosphorylation induces interaction with ROCK2 and inhibits interaction with RNA. These are two of the major in vivo phosphorylation sites in B23 (≥33 and ≥42 reports, respectively, by mass spectrometry).","T234: CDK1; CDK2. T237: CDK1.","P06748","P06748",1183,null,"P06748","NP_002511","Block1",9,10,"1, 9, 17, 25",{"$nulls":13},"RNA binding protein","GO:0005813; GO:0005737; GO:0005829; GO:0005925; GO:0016020; GO:0005730; GO:0005654; GO:0005634; GO:0032991; GO:0032993; GO:1990904; GO:0031616","GO:0033613; GO:0001047; GO:0042393; GO:0051059; GO:0046982; GO:0042803; GO:0019901; GO:0004860; GO:0043023; GO:0043024; GO:0003723; GO:0030957; GO:0003713; GO:0008134; GO:0051082","GO:0007569; GO:0034644; GO:0034080; GO:0007098; GO:0006281; GO:0006886; GO:0043066; GO:0008285; GO:0010826; GO:0044387; GO:0006913; GO:0006334; GO:1902751; GO:0008284; GO:0051092; GO:0045893; GO:0045944; GO:0045727; GO:0051259; GO:0008104; GO:0046599; GO:0060735; GO:0032071; GO:0060699; GO:1902629; GO:0006357; GO:0042255; GO:0007165; GO:0016032"]
[233,115,"PN207","Bad","S75","Bcl2 antagonist of cell death",{"v":447.6734172098111,"d":"448"},{"v":373.2213563367279,"d":"373"},{"v":255.0770999981495,"d":"255"},{"v":56.97838875221901,"d":"57"},{"v":92.39208742896383,"d":"92"},{"v":1486.450037524267,"d":"1486"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the mouse S112 phosphosite, which corresponds to the human Bad S75 phosphosite.","S75 phosphorylation Inhibits interaction with Bcl-2 and Bcl-xL, and induces interaction with 14-3-3-beta. This is one of the major sites of Bad phosphorylation by mass spectrometry (≥192 reports).","Akt1; Akt3; JNK1; MSK1; PAK1; PAK5 (PAK7); Pim1; Pim2; Pim3; PKACa, PKCi (PRKCl); Raf1; RSK1; RSK2; RSK3","Q92934","Q92934",1156,null,"Q92934","NP_004313.1","Block1",9,11,"1, 9, 17, 25",{"$nulls":3},"Apoptosis protein",{"$nulls":9},"Apoptosis protein, Bcl family","GO:0005829; GO:0005741; GO:0005739","GO:0071889; GO:0008656; GO:0008289; GO:0005543; GO:0046982; GO:0043422; GO:0019901; GO:0030346","GO:0097202; GO:0006919; GO:0046031; GO:0006915; GO:0046034; GO:0060154; GO:0071247; GO:0071456; GO:0071396; GO:0071260; GO:0071316; GO:0021987; GO:0019221; GO:0097191; GO:0097192; GO:0008625; GO:0006007; GO:0042593; GO:0097193; GO:0008630; GO:0046931; GO:0043065; GO:0060139; GO:0010508; GO:0045579; GO:0043280; GO:0050679; GO:0033133; GO:0032024; GO:0035774; GO:2001244; GO:1902220; GO:0010918; GO:1901216; GO:1900740; GO:0045862; GO:0090200; GO:0045582; GO:2000078; GO:0001844; GO:0046902; GO:0001836; GO:0043200; GO:0051592; GO:0032355; GO:0045471; GO:0051384; GO:0009749; GO:0042542; GO:0034201; GO:0032570; GO:0033574; GO:0007283; GO:0019050; GO:0044342"]
[235,116,"PN208","Bad","S99","Bcl2 antagonist of cell death",{"v":273.597615398763,"d":"274"},{"v":213.63985767161535,"d":"214"},{"v":202.00767572605022,"d":"202"},{"v":73.83385832205741,"d":"74"},{"v":28.419562400877737,"d":"28"},{"v":1470.980491754106,"d":"1471"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the mouse S136 phosphosite, which corresponds to the human Bad S99 phosphosite.","S99 phosphorylation Inhibits interaction with Bcl-2 and Bcl-xL, and induces interaction with 14-3-3-beta and 14-3-3 zeta. This is one of the major sites of Bad phosphorylation by mass spectrometry (≥263 reports).","Akt1; Akt3; A-Raf; B-Raf; p70 S6K; PAK1; Pim1; Pim2; Pim3; PKACa; PKCe; PKCi; PKCt (PKCq); PKD1 (PRKD1); RSK1; RSK2","Q92934","Q92934",1156,null,"Q92934","NP_004313.1","Block1",9,12,"1, 9, 17, 25",{"$nulls":3},"Apoptosis protein",{"$nulls":9},"Apoptosis protein, Bcl family","GO:0005829; GO:0005741; GO:0005739","GO:0071889; GO:0008656; GO:0008289; GO:0005543; GO:0046982; GO:0043422; GO:0019901; GO:0030346","GO:0097202; GO:0006919; GO:0046031; GO:0006915; GO:0046034; GO:0060154; GO:0071247; GO:0071456; GO:0071396; GO:0071260; GO:0071316; GO:0021987; GO:0019221; GO:0097191; GO:0097192; GO:0008625; GO:0006007; GO:0042593; GO:0097193; GO:0008630; GO:0046931; GO:0043065; GO:0060139; GO:0010508; GO:0045579; GO:0043280; GO:0050679; GO:0033133; GO:0032024; GO:0035774; GO:2001244; GO:1902220; GO:0010918; GO:1901216; GO:1900740; GO:0045862; GO:0090200; GO:0045582; GO:2000078; GO:0001844; GO:0046902; GO:0001836; GO:0043200; GO:0051592; GO:0032355; GO:0045471; GO:0051384; GO:0009749; GO:0042542; GO:0034201; GO:0032570; GO:0033574; GO:0007283; GO:0019050; GO:0044342"]
[237,119,"NK257-1","BCKD (BCKDK)","Pan-specific","[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial",{"v":6105.060757585167,"d":"6105"},{"v":5708.369742077817,"d":"5708"},{"v":2038.1025273118785,"d":"2038"},{"v":33.38382054232073,"d":"33"},{"v":2538.4521308670655,"d":"2538"},{"v":12116.03563575014,"d":"12116"},"Kinexus","RpAb","CQSAIDAAAEKPSVRL","Corresponds to amino acid residues Q56 to L70.",null,null,"O14874","O14874",2349,"O14874",null,"NP_005872.2","Block1",10,2,"1, 9, 17, 25","BCKDK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PDHK",{"$nulls":6},"Protein-serine kinase, Atypical group, PDHK family","GO:0005947; GO:0005759; GO:0005739","GO:0047323; GO:0005524; GO:0016301; GO:0004674","GO:0009083; GO:0009063; GO:0016310"]
[239,120,"NK257-2","BCKD (BCKDK)","Pan-specific","[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial",{"v":1113.24238359447,"d":"1113"},{"v":1045.2771809568317,"d":"1045"},{"v":504.50609292471995,"d":"505"},{"v":45.31862066693469,"d":"45"},{"v":129.38581902309502,"d":"129"},{"v":2955.4994929629283,"d":"2955"},"Kinexus","RpAb","CILHVHELYIRAFQKL","Corresponds to amino acid residues I122 to L136.",null,null,"O14874","O14874",2349,"O14874",null,"NP_005872.2","Block1",10,3,"1, 9, 17, 25","BCKDK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PDHK",{"$nulls":6},"Protein-serine kinase, Atypical group, PDHK family","GO:0005947; GO:0005759; GO:0005739","GO:0047323; GO:0005524; GO:0016301; GO:0004674","GO:0009083; GO:0009063; GO:0016310"]
[241,121,"PN574","BCLAF1","S512","Bcl-2-associated transcription factor 1",{"v":12226.059773672852,"d":"12226"},{"v":12011.184720542995,"d":"12011"},{"v":2795.457958180744,"d":"2795"},{"v":22.86474964076636,"d":"23"},{"v":6615.105054521467,"d":"6615"},{"v":24011.68321563887,"d":"24012"},"Kinexus","RpAb","LFDY(pS)PPL(bA)C","Corresponds to amino acid residues L508 to L515.","The effect of S512 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in BCLAF1 (≥135 reports from high throughput mass spectrometry studies).","PRP4 (PRPF4B)","Q9NYF8","Q9NYF8",2879,null,null,"NP_001070908.1","Block1",10,4,"1, 9, 17, 25",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005737; GO:0016607; GO:0005654; GO:0005634","GO:0003677; GO:0003723","GO:0006915; GO:1990830; GO:0045892; GO:0043065; GO:2000144; GO:2001244; GO:2001022; GO:0043620; GO:0006351"]
[243,122,"NK362-1","Bcr","Pan-specific","Breakpoint cluster region protein",{"v":903.6087036713387,"d":"904"},{"v":736.7393026703148,"d":"737"},{"v":539.6653307460836,"d":"540"},{"v":59.72334358372571,"d":"60"},{"v":166.18976473150644,"d":"166"},{"v":3276.5957513677986,"d":"3277"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 1-300 (deletion 17-219) of human Bcr.",null,null,"P11274","P11274",927,"P11274","P11274","NP_004318.3","Block1",10,5,"1, 9, 17, 25","BCR","X","PSTK","Protein kinase - Receptor-serine kinase","Protein-serine/threonine kinase","Atypical","BCR",{"$nulls":6},"EC 2.7.11.1; GTPase activating protein, Rac/Rho; Protein kinase, Ser/Thr (non-receptor); ATYPICAL group; BCR family","GO:0030054; GO:0005829; GO:0070062; GO:0098978; GO:0016020; GO:0014069; GO:0099092; GO:0045211; GO:0032991; GO:0098685","GO:0005524; GO:0005096; GO:0016301; GO:0004674; GO:0004713; GO:0005089","GO:0030036; GO:0007420; GO:0071222; GO:0060216; GO:0048872; GO:0042472; GO:0065002; GO:0035556; GO:0050804; GO:0060313; GO:0002692; GO:0050728; GO:0043314; GO:2000378; GO:0060268; GO:0050885; GO:0048008; GO:0043547; GO:0050766; GO:0046777; GO:0006468; GO:0051726; GO:0051171; GO:0035023; GO:0051056; GO:0043114; GO:0003014; GO:0007165"]
[245,123,"PK164","Bcr","Y177","Breakpoint cluster region protein",{"v":142.71165365563334,"d":"143"},{"v":82.37690267662074,"d":"82"},{"v":171.41370287204606,"d":"171"},{"v":120.11191691862211,"d":"120"},{"v":12.986313026023009,"d":"13"},{"v":1457.176141711544,"d":"1457"},"External","RpAb","PF(pY)VN","Corresponds to amino acid residues P175 to N179.","Y177 phosphorylation stimulates phosphotransferase activity. Phosphorylation induces interaction with Gab2, Grb2 and SOS1, and inhibits interaction with Hck. This is the major site of phosphorylation of Bcr by mass spectrometry stydues (≥1018 reports).","Abl1; Bcr-Abl; Fes; Fyn; Hck; Lyn","P11274","P11274",927,"P11274","P11274","NP_004318.3","Block1",10,6,"1, 9, 17, 25","BCR","X","PSTK","Protein kinase - Receptor-serine kinase","Protein-serine/threonine kinase","Atypical","BCR",{"$nulls":6},"EC 2.7.11.1; GTPase activating protein, Rac/Rho; Protein kinase, Ser/Thr (non-receptor); ATYPICAL group; BCR family","GO:0030054; GO:0005829; GO:0070062; GO:0098978; GO:0016020; GO:0014069; GO:0099092; GO:0045211; GO:0032991; GO:0098685","GO:0005524; GO:0005096; GO:0016301; GO:0004674; GO:0004713; GO:0005089","GO:0030036; GO:0007420; GO:0071222; GO:0060216; GO:0048872; GO:0042472; GO:0065002; GO:0035556; GO:0050804; GO:0060313; GO:0002692; GO:0050728; GO:0043314; GO:2000378; GO:0060268; GO:0050885; GO:0048008; GO:0043547; GO:0050766; GO:0046777; GO:0006468; GO:0051726; GO:0051171; GO:0035023; GO:0051056; GO:0043114; GO:0003014; GO:0007165"]
[247,124,"PK538","Bcr","Y177","Breakpoint cluster region protein",{"v":4613.6765232342095,"d":"4614"},{"v":4426.8629234433765,"d":"4427"},{"v":1398.0868931774573,"d":"1398"},{"v":30.30309745680635,"d":"30"},{"v":651.4999587609577,"d":"651"},{"v":9708.296341759455,"d":"9708"},"Kinexus","RpAb","KPF(pY)VNV(bA)C","Corresponds to amino acid residues K174 to V180; In the N-terminal portion of the protein kinase.","Y177 phosphorylation stimulates phosphotransferase activity. Phosphorylation induces interaction with Gab2, Grb2 and SOS1, and inhibits interaction with Hck. This is the major site of phosphorylation of Bcr by mass spectrometry stydues (≥1018 reports).","Abl1; Bcr-Abl; Fes; Fyn; Hck; Lyn","P11274","P11274",927,"P11274","P11274","NP_004318.3","Block1",10,7,"1, 9, 17, 25","BCR","X","PSTK","Protein kinase - Receptor-serine kinase","Protein-serine/threonine kinase","Atypical","BCR",{"$nulls":6},"EC 2.7.11.1; GTPase activating protein, Rac/Rho; Protein kinase, Ser/Thr (non-receptor); ATYPICAL group; BCR family","GO:0030054; GO:0005829; GO:0070062; GO:0098978; GO:0016020; GO:0014069; GO:0099092; GO:0045211; GO:0032991; GO:0098685","GO:0005524; GO:0005096; GO:0016301; GO:0004674; GO:0004713; GO:0005089","GO:0030036; GO:0007420; GO:0071222; GO:0060216; GO:0048872; GO:0042472; GO:0065002; GO:0035556; GO:0050804; GO:0060313; GO:0002692; GO:0050728; GO:0043314; GO:2000378; GO:0060268; GO:0050885; GO:0048008; GO:0043547; GO:0050766; GO:0046777; GO:0006468; GO:0051726; GO:0051171; GO:0035023; GO:0051056; GO:0043114; GO:0003014; GO:0007165"]
[249,125,"PK539","Bcr","Y591","Breakpoint cluster region protein",{"v":9199.442046467319,"d":"9199"},{"v":9121.804351393035,"d":"9122"},{"v":2045.1556277517477,"d":"2045"},{"v":22.231300739995515,"d":"22"},{"v":3956.3500951889127,"d":"3956"},{"v":15833.207461238273,"d":"15833"},"Kinexus","RpAb","LGV(pY)RAF(bA)C","Corresponds to amino acid residues L588 to F594; In the Rho-GEF domain. One of the main in vivo phosphorylation sites in Bcr.","The effect of Y591 phosphorylation is unclear. This is one of the major sites of phosphorylation of Bcr by mass spectrometry studies (≥257 reports).",null,"P11274","P11274",927,"P11274","P11274","NP_004318.3","Block1",10,8,"1, 9, 17, 25","BCR","X","PSTK","Protein kinase - Receptor-serine kinase","Protein-serine/threonine kinase","Atypical","BCR",{"$nulls":6},"EC 2.7.11.1; GTPase activating protein, Rac/Rho; Protein kinase, Ser/Thr (non-receptor); ATYPICAL group; BCR family","GO:0030054; GO:0005829; GO:0070062; GO:0098978; GO:0016020; GO:0014069; GO:0099092; GO:0045211; GO:0032991; GO:0098685","GO:0005524; GO:0005096; GO:0016301; GO:0004674; GO:0004713; GO:0005089","GO:0030036; GO:0007420; GO:0071222; GO:0060216; GO:0048872; GO:0042472; GO:0065002; GO:0035556; GO:0050804; GO:0060313; GO:0002692; GO:0050728; GO:0043314; GO:2000378; GO:0060268; GO:0050885; GO:0048008; GO:0043547; GO:0050766; GO:0046777; GO:0006468; GO:0051726; GO:0051171; GO:0035023; GO:0051056; GO:0043114; GO:0003014; GO:0007165"]
[251,126,"PK540","Bcr","Y644","Breakpoint cluster region protein",{"v":9412.681299512311,"d":"9413"},{"v":9241.141395597431,"d":"9241"},{"v":1628.5266007759362,"d":"1629"},{"v":17.301410182243323,"d":"17"},{"v":4555.405333015475,"d":"4555"},{"v":13898.332961479886,"d":"13898"},"Kinexus","RpAb","TLL(pY)KPV(bA)C","Corresponds to amino acid residues T641 to V647; In the Rho-GEF domain. One of the main in vivo phosphorylation sites in Bcr.","The effect of Y644 phosphorylation is unclear. This is one of the major sites of phosphorylation of Bcr by mass spectrometry studies (≥320 reports).",null,"P11274","P11274",927,"P11274","P11274","NP_004318.3","Block1",10,9,"1, 9, 17, 25","BCR","X","PSTK","Protein kinase - Receptor-serine kinase","Protein-serine/threonine kinase","Atypical","BCR",{"$nulls":6},"EC 2.7.11.1; GTPase activating protein, Rac/Rho; Protein kinase, Ser/Thr (non-receptor); ATYPICAL group; BCR family","GO:0030054; GO:0005829; GO:0070062; GO:0098978; GO:0016020; GO:0014069; GO:0099092; GO:0045211; GO:0032991; GO:0098685","GO:0005524; GO:0005096; GO:0016301; GO:0004674; GO:0004713; GO:0005089","GO:0030036; GO:0007420; GO:0071222; GO:0060216; GO:0048872; GO:0042472; GO:0065002; GO:0035556; GO:0050804; GO:0060313; GO:0002692; GO:0050728; GO:0043314; GO:2000378; GO:0060268; GO:0050885; GO:0048008; GO:0043547; GO:0050766; GO:0046777; GO:0006468; GO:0051726; GO:0051171; GO:0035023; GO:0051056; GO:0043114; GO:0003014; GO:0007165"]
[253,127,"PK541","BLK","Y187","B lymphoid tyrosine kinase",{"v":487.28526282588825,"d":"487"},{"v":448.6624931017718,"d":"449"},{"v":233.9469666416336,"d":"234"},{"v":48.01026923837529,"d":"48"},{"v":91.92621397503328,"d":"92"},{"v":1537.2309833761797,"d":"1537"},"Kinexus","RpAb","EGG(pY)YIS(bA)C","Corresponds to amino acid residues E184 to S190; In the SH2 domain. One of the two major in vivo phosphorylation sites in BLK.","The effect of Y187 phosphorylation is unclear. This is the major sites of phosphorylation of BLK by mass spectrometry studies (≥146 reports).",null,"P51451","P51451",1248,"P51451","P51451","NP_001706.2","Block1",10,10,"1, 9, 17, 25","BLK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"Protein-tyrosine kinase, TK group, Src family","GO:0005829; GO:0031234","GO:0005524; GO:0004715; GO:0004713; GO:0005102","GO:0050853; GO:0030154; GO:0016477; GO:0045087; GO:0035556; GO:0038083; GO:0032024; GO:0050855; GO:0042127; GO:0007169"]
[255,128,"PK542","BLK","Y188","B lymphoid tyrosine kinase",{"v":5581.566321066491,"d":"5582"},{"v":6496.011426325815,"d":"6496"},{"v":2959.7704322976533,"d":"2960"},{"v":53.02759587620772,"d":"53"},{"v":-4.3375390948412615,"d":"-4"},{"v":10140.616710639968,"d":"10141"},"Kinexus","RpAb","GGY(pY)ISP(bA)C","Corresponds to amino acid residues G185 to P191; In the SH2 domain. One of the two major in vivo phosphorylation sites in BLK.","The effect of Y188 phosphorylation is unclear. This is one of the major sites of phosphorylation of BLK by mass spectrometry studies (≥97 reports).",null,"P51451","P51451",1248,"P51451","P51451","NP_001706.2","Block1",10,11,"1, 9, 17, 25","BLK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"Protein-tyrosine kinase, TK group, Src family","GO:0005829; GO:0031234","GO:0005524; GO:0004715; GO:0004713; GO:0005102","GO:0050853; GO:0030154; GO:0016477; GO:0045087; GO:0035556; GO:0038083; GO:0032024; GO:0050855; GO:0042127; GO:0007169"]
[257,129,"PK543","BLK","Y389","B lymphoid tyrosine kinase",{"v":5931.540786184947,"d":"5932"},{"v":5626.413891135868,"d":"5626"},{"v":1624.9954319781316,"d":"1625"},{"v":27.395840146001888,"d":"27"},{"v":1917.736476129713,"d":"1918"},{"v":12953.883955843039,"d":"12954"},"Kinexus","RpAb","DSE(pY)TAQ(bA)C","Corresponds to amino acid residues D386 to Q392; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y389 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of phosphorylation of BLK by mass spectrometry studies (≥72 reports).",null,"P51451","P51451",1248,"P51451","P51451","NP_001706.2","Block1",10,12,"1, 9, 17, 25","BLK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"Protein-tyrosine kinase, TK group, Src family","GO:0005829; GO:0031234","GO:0005524; GO:0004715; GO:0004713; GO:0005102","GO:0050853; GO:0030154; GO:0016477; GO:0045087; GO:0035556; GO:0038083; GO:0032024; GO:0050855; GO:0042127; GO:0007169"]
[259,130,"PN013","BLNK","Y84","B-cell linker protein",{"v":1795.2222638951266,"d":"1795"},{"v":1622.9479289970157,"d":"1623"},{"v":826.0206781623557,"d":"826"},{"v":46.01216767277181,"d":"46"},{"v":404.01945598621626,"d":"404"},{"v":5383.560982056821,"d":"5384"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the Y84 phosphosite.","Y84 phosphorylation regulates transcription and molecular association, including inducing interaction with Btk, Nck2, PLCG1, and VAV1. This is one of the major in vivo phosphorylation sites in XXX.","Syk","Q8WV28","Q8WV28",1117,null,"Q8WV28","NP_037446","Block1",10,13,"1, 9, 17, 25",{"$nulls":11},"X",null,"Adapter/scaffold protein","GO:0005737; GO:0036464; GO:0005829; GO:0005622; GO:0005886","GO:0005070; GO:0005068","GO:0030183; GO:0006959; GO:0006954; GO:0035556"]
[261,131,"NK363-1","BMPR2 (BMPR-II)","Pan-specific","Bone morphogenetic protein receptor type-2",{"v":153.7879909305862,"d":"154"},{"v":115.84235368518586,"d":"116"},{"v":113.07215127153282,"d":"113"},{"v":73.5246949955729,"d":"74"},{"v":23.80152569630945,"d":"24"},{"v":1054.0738395742783,"d":"1054"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 61-82 within an extracellular domain of human BMPR-II.",null,null,"Q13873","Q13873",672,"Q13873","Q13873","NP_001195.2","Block1",11,1,"1, 9, 17, 25","BMPR2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","STKR","Type2",{"$nulls":5},"EC 2.7.11.30; Cell cycle regulation; Receptor Ser/Thr kinase; TKL domain target; TKL</A> group; STKR family; Type2 subfamily","GO:0016324; GO:0009925; GO:0005901; GO:0005913; GO:0009986; GO:0005737; GO:0030425; GO:0005615; GO:0005887; GO:0043025; GO:0005654; GO:0005886; GO:0014069; GO:0044214","GO:0016362; GO:0005524; GO:0036122; GO:0098821; GO:0019838; GO:0046872","GO:0009952; GO:0060840; GO:0060413; GO:0001974; GO:0030509; GO:0007420; GO:0071773; GO:0009267; GO:0002063; GO:0003197; GO:0060350; GO:0072577; GO:0001935; GO:0060173; GO:0048286; GO:0001946; GO:0060836; GO:0001893; GO:0001707; GO:0003183; GO:0030308; GO:0003252; GO:1902731; GO:2000279; GO:0003085; GO:0045906; GO:0003151; GO:0003148; GO:0061626; GO:0048842; GO:0030513; GO:0030501; GO:0061036; GO:0010595; GO:0001938; GO:0010634; GO:0045778; GO:0045669; GO:0010862; GO:0045944; GO:0030166; GO:0042127; GO:0014916; GO:0061298; GO:1905314; GO:0006366; GO:0007178; GO:0003186; GO:0060841; GO:0060412"]
[263,132,"PK544","BMPR2 (BMPR-II)","S375","Bone morphogenetic protein receptor type-2",{"v":7224.343305131388,"d":"7224"},{"v":6885.8592526799985,"d":"6886"},{"v":1778.2774693066474,"d":"1778"},{"v":24.615074259324754,"d":"25"},{"v":1166.4650754844906,"d":"1166"},{"v":13446.347862299473,"d":"13446"},"Kinexus","RpAb","AAI(pS)EVG(bA)C","Corresponds to amino acid residues A372 to G378; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S375 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the minor in vivo phosphorylation sites in BMPR2 (≥4 reports from high throughput mass spectrometry studies).",null,"Q13873","Q13873",672,"Q13873","Q13873","NP_001195.2","Block1",11,2,"1, 9, 17, 25","BMPR2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","STKR","Type2",{"$nulls":5},"EC 2.7.11.30; Cell cycle regulation; Receptor Ser/Thr kinase; TKL domain target; TKL</A> group; STKR family; Type2 subfamily","GO:0016324; GO:0009925; GO:0005901; GO:0005913; GO:0009986; GO:0005737; GO:0030425; GO:0005615; GO:0005887; GO:0043025; GO:0005654; GO:0005886; GO:0014069; GO:0044214","GO:0016362; GO:0005524; GO:0036122; GO:0098821; GO:0019838; GO:0046872","GO:0009952; GO:0060840; GO:0060413; GO:0001974; GO:0030509; GO:0007420; GO:0071773; GO:0009267; GO:0002063; GO:0003197; GO:0060350; GO:0072577; GO:0001935; GO:0060173; GO:0048286; GO:0001946; GO:0060836; GO:0001893; GO:0001707; GO:0003183; GO:0030308; GO:0003252; GO:1902731; GO:2000279; GO:0003085; GO:0045906; GO:0003151; GO:0003148; GO:0061626; GO:0048842; GO:0030513; GO:0030501; GO:0061036; GO:0010595; GO:0001938; GO:0010634; GO:0045778; GO:0045669; GO:0010862; GO:0045944; GO:0030166; GO:0042127; GO:0014916; GO:0061298; GO:1905314; GO:0006366; GO:0007178; GO:0003186; GO:0060841; GO:0060412"]
[265,133,"NK012","Bmx (Etk)","Pan-specific","Bone marrow X protein-tyrosine kinase",{"v":139.63974889181625,"d":"140"},{"v":84.2712791506197,"d":"84"},{"v":150.11557938388938,"d":"150"},{"v":107.50204048289224,"d":"108"},{"v":18.377979576158513,"d":"18"},{"v":965.2140089006994,"d":"965"},"External","MmAb","Epitope undefined.",{"$nulls":3},"P51813","P51813",843,"P51813","P51813","NP_001712","Block1",11,3,"1, 9, 17, 25","BMX","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; Tec family","GO:0005829; GO:0031234; GO:0005654; GO:0005886; GO:0032587","GO:0005524; GO:0046872; GO:0004715; GO:0004713","GO:0006915; GO:0007155; GO:0045087; GO:0035556; GO:0007498; GO:0001865; GO:0038083; GO:0006661; GO:0046777; GO:0006468; GO:0042127; GO:0007165; GO:0007169"]
[267,134,"PK545","Bmx (Etk)","Y40","Bone marrow X protein-tyrosine kinase",{"v":1745.4978697409756,"d":"1745"},{"v":1676.5775200825074,"d":"1677"},{"v":732.4124657737051,"d":"732"},{"v":41.96008935160671,"d":"42"},{"v":168.6347602032647,"d":"169"},{"v":4649.438633447144,"d":"4649"},"Kinexus","RpAb","NLS(pY)YEY(bA)C","Corresponds to amino acid residues N37 to Y43; In the PH domain domain.","Y40 phosphorylation stimulates phosphotransferase activity and regulates cell motility, cytoskeletal reorganization, intracellular location, and induces interaction with FAK. This phosphorylation site has not apparently been detected by mass spectrometry.",null,"P51813","P51813",843,"P51813","P51813","NP_001712","Block1",11,4,"1, 9, 17, 25","BMX","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; Tec family","GO:0005829; GO:0031234; GO:0005654; GO:0005886; GO:0032587","GO:0005524; GO:0046872; GO:0004715; GO:0004713","GO:0006915; GO:0007155; GO:0045087; GO:0035556; GO:0007498; GO:0001865; GO:0038083; GO:0006661; GO:0046777; GO:0006468; GO:0042127; GO:0007165; GO:0007169"]
[269,135,"NN395-1","BRCA1","Pan-specific","Breast cancer type 1 susceptibility protein homolog",{"v":249.10217459882253,"d":"249"},{"v":196.84271470420398,"d":"197"},{"v":173.093632690535,"d":"173"},{"v":69.4870018574913,"d":"69"},{"v":40.68242304313098,"d":"41"},{"v":1704.617150141628,"d":"1705"},"External","MmAb","Not precisely defined.","Antibody raised against whole mouse BRCA1 protein.",null,null,"P38398","P38398",929,null,"P38398","NP_009225.1","Block1",11,5,"1, 9, 17, 25",{"$nulls":4},"Transcription, coactivator/corepressor",{"$nulls":3},"X",{"$nulls":4},"Nuclear receptor co-regulator; Transcription, coactivator/corepressor; Ubiquitin conjugating system; Tumor suppressor","GO:0070531; GO:0031436; GO:0005694; GO:0005737; GO:0008274; GO:0000800; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:1990904; GO:0000151","GO:0050681; GO:0003684; GO:0003677; GO:0019899; GO:0042802; GO:0003723; GO:0070063; GO:0003713; GO:0044212; GO:0015631; GO:0031625; GO:0004842; GO:0008270","GO:0030521; GO:0006915; GO:0006974; GO:0071681; GO:0071356; GO:0007098; GO:0043009; GO:0007059; GO:0006978; GO:0000729; GO:0006260; GO:0009048; GO:0006302; GO:0000724; GO:0006303; GO:0006633; GO:0008630; GO:0044818; GO:0046600; GO:1902042; GO:0045717; GO:0070317; GO:0035067; GO:0051572; GO:0051573; GO:0033147; GO:2000378; GO:0045892; GO:0045766; GO:0071158; GO:0045739; GO:0010628; GO:0035066; GO:0051571; GO:2000617; GO:0051574; GO:2000620; GO:0070512; GO:0031398; GO:0045893; GO:0045944; GO:0010575; GO:0006301; GO:0051865; GO:0016579; GO:0085020; GO:0016567; GO:0042981; GO:0042127; GO:0044030; GO:0006349; GO:0006357; GO:0006359; GO:0043627; GO:0010212; GO:0072425; GO:0006351"]
[271,136,"PN690","BRCA1","T509","Breast cancer type 1 susceptibility protein",{"v":16498.517786839526,"d":"16499"},{"v":16385.072128456235,"d":"16385"},{"v":4215.457870343923,"d":"4215"},{"v":25.550524748995894,"d":"26"},{"v":15.05392434672291,"d":"15"},{"v":26662.045747106342,"d":"26662"},"Kinexus","RpAb","RRP(pT)SGL(bA)C","Corresponds to amino acid residues R506 to L512.","T509 phosphorylation induces transcription. This is the major site of phosphorylation of BRCA1 by mass spectrometry studies (≥79 reports). This human phosphosite is not highly conserved in nature, but is found in the mouse.","Akt1","P38398","P38398",929,null,"P38398","NP_009225.1","Block1",11,6,"1, 9, 17, 25",null,"X",null,"Transcription, coactivator/corepressor",{"$nulls":9},"Nuclear receptor co-regulator; Transcription, coactivator/corepressor; Ubiquitin conjugating system; Tumor suppressor","GO:0070531; GO:0031436; GO:0005694; GO:0005737; GO:0008274; GO:0000800; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:1990904; GO:0000151","GO:0050681; GO:0003684; GO:0003677; GO:0019899; GO:0042802; GO:0003723; GO:0070063; GO:0003713; GO:0044212; GO:0015631; GO:0031625; GO:0004842; GO:0008270","GO:0030521; GO:0006915; GO:0006974; GO:0071681; GO:0071356; GO:0007098; GO:0043009; GO:0007059; GO:0006978; GO:0000729; GO:0006260; GO:0009048; GO:0006302; GO:0000724; GO:0006303; GO:0006633; GO:0008630; GO:0044818; GO:0046600; GO:1902042; GO:0045717; GO:0070317; GO:0035067; GO:0051572; GO:0051573; GO:0033147; GO:2000378; GO:0045892; GO:0045766; GO:0071158; GO:0045739; GO:0010628; GO:0035066; GO:0051571; GO:2000617; GO:0051574; GO:2000620; GO:0070512; GO:0031398; GO:0045893; GO:0045944; GO:0010575; GO:0006301; GO:0051865; GO:0016579; GO:0085020; GO:0016567; GO:0042981; GO:0042127; GO:0044030; GO:0006349; GO:0006357; GO:0006359; GO:0043627; GO:0010212; GO:0072425; GO:0006351"]
[273,137,"PN212","BRCA1","S988","Breast cancer type 1 susceptibility protein",{"v":423.9348301019198,"d":"424"},{"v":363.0112366222394,"d":"363"},{"v":248.0553575802155,"d":"248"},{"v":58.512615611361674,"d":"59"},{"v":108.14997180254166,"d":"108"},{"v":1829.6158079921502,"d":"1830"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S988 phosphosite.","S988 phosphorylation induces activity. This phosphorylation site has not apparently been detected by mass spectrometry.","Chk2","P38398","P38398",929,null,"P38398","NP_009225.1","Block1",11,7,"1, 9, 17, 25",null,"X",null,"Transcription, coactivator/corepressor",{"$nulls":9},"Nuclear receptor co-regulator; Transcription, coactivator/corepressor; Ubiquitin conjugating system; Tumor suppressor","GO:0070531; GO:0031436; GO:0005694; GO:0005737; GO:0008274; GO:0000800; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:1990904; GO:0000151","GO:0050681; GO:0003684; GO:0003677; GO:0019899; GO:0042802; GO:0003723; GO:0070063; GO:0003713; GO:0044212; GO:0015631; GO:0031625; GO:0004842; GO:0008270","GO:0030521; GO:0006915; GO:0006974; GO:0071681; GO:0071356; GO:0007098; GO:0043009; GO:0007059; GO:0006978; GO:0000729; GO:0006260; GO:0009048; GO:0006302; GO:0000724; GO:0006303; GO:0006633; GO:0008630; GO:0044818; GO:0046600; GO:1902042; GO:0045717; GO:0070317; GO:0035067; GO:0051572; GO:0051573; GO:0033147; GO:2000378; GO:0045892; GO:0045766; GO:0071158; GO:0045739; GO:0010628; GO:0035066; GO:0051571; GO:2000617; GO:0051574; GO:2000620; GO:0070512; GO:0031398; GO:0045893; GO:0045944; GO:0010575; GO:0006301; GO:0051865; GO:0016579; GO:0085020; GO:0016567; GO:0042981; GO:0042127; GO:0044030; GO:0006349; GO:0006357; GO:0006359; GO:0043627; GO:0010212; GO:0072425; GO:0006351"]
[275,138,"PN116","BRCA1","S1423","Breast cancer type 1 susceptibility protein",{"v":794.0550533673958,"d":"794"},{"v":486.96850541473276,"d":"487"},{"v":2049.858865654837,"d":"2050"},{"v":258.1507235501972,"d":"258"},{"v":5.008471355710203,"d":"5"},{"v":18541.619381651057,"d":"18542"},"External","RpAb","HG(pS)QP","Corresponds to amino acid residues  H1421 to P1425; Surrounds the S1423 phosphosite.","S1423 phosphorylation induces interaction with ATM. This is one of the minor in vivo phosphorylation sites in BRCA1 (≥2 reports from high throughput mass spectrometry studies).","ATM; ATR","P38398","P38398",929,null,"P38398","NP_009225.1","Block1",11,8,"1, 9, 17, 25",null,"X",null,"Transcription, coactivator/corepressor",{"$nulls":9},"Nuclear receptor co-regulator; Transcription, coactivator/corepressor; Ubiquitin conjugating system; Tumor suppressor","GO:0070531; GO:0031436; GO:0005694; GO:0005737; GO:0008274; GO:0000800; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:1990904; GO:0000151","GO:0050681; GO:0003684; GO:0003677; GO:0019899; GO:0042802; GO:0003723; GO:0070063; GO:0003713; GO:0044212; GO:0015631; GO:0031625; GO:0004842; GO:0008270","GO:0030521; GO:0006915; GO:0006974; GO:0071681; GO:0071356; GO:0007098; GO:0043009; GO:0007059; GO:0006978; GO:0000729; GO:0006260; GO:0009048; GO:0006302; GO:0000724; GO:0006303; GO:0006633; GO:0008630; GO:0044818; GO:0046600; GO:1902042; GO:0045717; GO:0070317; GO:0035067; GO:0051572; GO:0051573; GO:0033147; GO:2000378; GO:0045892; GO:0045766; GO:0071158; GO:0045739; GO:0010628; GO:0035066; GO:0051571; GO:2000617; GO:0051574; GO:2000620; GO:0070512; GO:0031398; GO:0045893; GO:0045944; GO:0010575; GO:0006301; GO:0051865; GO:0016579; GO:0085020; GO:0016567; GO:0042981; GO:0042127; GO:0044030; GO:0006349; GO:0006357; GO:0006359; GO:0043627; GO:0010212; GO:0072425; GO:0006351"]
[277,139,"NK013-2","BRD2","Pan-specific","Bromodomain-containing protein 2",{"v":300.3434684298457,"d":"300"},{"v":229.02453816275445,"d":"229"},{"v":216.800003854659,"d":"217"},{"v":72.18402483931466,"d":"72"},{"v":73.30426733282394,"d":"73"},{"v":1374.077453725246,"d":"1374"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 1-22 at the N-terminus of human BRD2.",null,null,"P25440","P25440",2331,"P25440","P25440","NP_001106653.1","Block1",11,9,"1, 9, 17, 25","BRD2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","BRD",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); ATYPICAL group; BRD family","GO:0005737; GO:0016607; GO:0005654","GO:0003682; GO:0070577","GO:0006334; GO:0006357; GO:0007283; GO:0006351; GO:0016032"]
[279,140,"PK546","BRD2","S37","Bromodomain-containing protein-serine kinase 2",{"v":10199.199746856635,"d":"10199"},{"v":10156.403942859788,"d":"10156"},{"v":1950.0791968365365,"d":"1950"},{"v":19.119923574764243,"d":"19"},{"v":1746.9285710446388,"d":"1747"},{"v":17560.965278617627,"d":"17561"},"Kinexus","RpAb","RKP(pS)LLY(bA)C","Corresponds to amino acid residues R34 to Y40; Near the N-terminus of the protein.","The effect of S37 phosphorylation is unclear. This is a major site of phosphorylation for BRD2 (≥341 reports by mass spectrometry studies).",null,"P25440","P25440",2331,"P25440","P25440","NP_001106653.1","Block1",11,10,"1, 9, 17, 25","BRD2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","BRD",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); ATYPICAL group; BRD family","GO:0005737; GO:0016607; GO:0005654","GO:0003682; GO:0070577","GO:0006334; GO:0006357; GO:0007283; GO:0006351; GO:0016032"]
[281,141,"PK548","BRK","Y342","Protein-tyrosine kinase 6",{"v":6319.542286135059,"d":"6320"},{"v":6130.842761705819,"d":"6131"},{"v":1421.8790821407129,"d":"1422"},{"v":22.499716241479785,"d":"22"},{"v":857.3271495570093,"d":"857"},{"v":10271.168827043368,"d":"10271"},"Kinexus","RpAb","EDV(pY)LSH(bA)C","Corresponds to amino acid residues E339 to H345; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y342 phosphorylation stimulates phosphotransferase activity and induces interaction with Brk. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Its phosphorylation is commonly observed by mass spectrometry studies (≥48 reports).","Brk","Q13882","Q13882",1961,"Q13882","Q13882","NP_005966.1","Block1",11,11,"1, 9, 17, 25","BRK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"Protein-tyrosine kinase, TK group, Src family","GO:0005737; GO:0005829; GO:0031234; GO:0016604; GO:0005654; GO:0005634; GO:0005886; GO:0001726","GO:0005524; GO:0042802; GO:0004715; GO:0004713; GO:0005102","GO:0016477; GO:0071300; GO:0038128; GO:0045087; GO:0060575; GO:0045926; GO:0061099; GO:0009968; GO:0038083; GO:0045787; GO:0045742; GO:0010976; GO:0042531; GO:0046777; GO:0006468; GO:0042127; GO:0007169; GO:0007260"]
[283,142,"PK547","BRK","S446+Y447","Protein-tyrosine kinase 6",{"v":4488.54991338391,"d":"4489"},{"v":4569.754937008645,"d":"4570"},{"v":1316.8185982083994,"d":"1317"},{"v":29.337283167597704,"d":"29"},{"v":989.9227552260456,"d":"990"},{"v":8516.724488525528,"d":"8517"},"Kinexus","RpAb","SFT(pS)(pY)ENP(bA)C","Corresponds to amino acid residues S443 to P450; In the C-terminus of the kinase.","S446 phosphorylation probably inhibits phosphotransferase activity and regulates molecular association. Y447 phosphorylation inhibits phosphotransferase activity and inhibits molecular association with Akt1. Y447 is the major phosphosite in BRK by mass spectrometry studies (≥379 reports), where as S446 is also commonly phosphorylated as well (≥87 reports).","Y447: Brk; SRMS","Q13882","Q13882",1961,"Q13882","Q13882","NP_005966.1","Block1",11,12,"1, 9, 17, 25","BRK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"Protein-tyrosine kinase, TK group, Src family","GO:0005737; GO:0005829; GO:0031234; GO:0016604; GO:0005654; GO:0005634; GO:0005886; GO:0001726","GO:0005524; GO:0042802; GO:0004715; GO:0004713; GO:0005102","GO:0016477; GO:0071300; GO:0038128; GO:0045087; GO:0060575; GO:0045926; GO:0061099; GO:0009968; GO:0038083; GO:0045787; GO:0045742; GO:0010976; GO:0042531; GO:0046777; GO:0006468; GO:0042127; GO:0007169; GO:0007260"]
[285,143,"NK364-1","BRSK1","Pan-specific","Protein-serine/threonine kinase BRSK1",{"v":89.71424220018724,"d":"90"},{"v":23.951110634404618,"d":"24"},{"v":223.286358339277,"d":"223"},{"v":248.88618892977837,"d":"249"},{"v":3.7618068721367335,"d":"4"},{"v":2149.9179592826977,"d":"2150"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 462-571 mapping within an internal region of human BRSK1.",null,null,"Q8TDC3","Q8TDC3",2097,"Q8TDC3",null,"NP_115806.1","Block1",11,13,"1, 9, 17, 25","BRSK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","BRSK",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; CAMK domain target; CAMK</A> group; CAMKL family; BRSK subfamily","GO:0030054; GO:0005813; GO:0005737; GO:0150034; GO:0005654; GO:0005634; GO:0048786; GO:0008021","GO:0005524; GO:0043015; GO:0000287; GO:0019901; GO:0004674; GO:0050321","GO:0008306; GO:0007409; GO:0006974; GO:0051298; GO:0030010; GO:0035556; GO:0090176; GO:0007095; GO:0030182; GO:0007269; GO:0006468; GO:0050770; GO:0010975; GO:0048167; GO:2000807; GO:0009411; GO:0099504"]
[287,144,"PK549","BRSK1","T189","BR serine/threonine-protein kinase 1",{"v":19735.230131377826,"d":"19735"},{"v":18645.17867809518,"d":"18645"},{"v":7371.966234613504,"d":"7372"},{"v":37.35434644307756,"d":"37"},{"v":5554.362006941248,"d":"5554"},{"v":44445.60162330011,"d":"44446"},"Kinexus","RpAb","LLE(pT)SCG(bA)C","Corresponds to amino acid residues L186 to G192; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T189 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is a minor in vivo phosphorylation site in BRSK1 (≥1 report by mass spectrometry).","BRSK1; CaMK2a; LKB1","Q8TDC3","Q8TDC3",2097,"Q8TDC3",null,"NP_115806.1","Block1",12,1,"1, 9, 17, 25","BRSK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","BRSK",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; CAMK domain target; CAMK</A> group; CAMKL family; BRSK subfamily","GO:0030054; GO:0005813; GO:0005737; GO:0150034; GO:0005654; GO:0005634; GO:0048786; GO:0008021","GO:0005524; GO:0043015; GO:0000287; GO:0019901; GO:0004674; GO:0050321","GO:0008306; GO:0007409; GO:0006974; GO:0051298; GO:0030010; GO:0035556; GO:0090176; GO:0007095; GO:0030182; GO:0007269; GO:0006468; GO:0050770; GO:0010975; GO:0048167; GO:2000807; GO:0009411; GO:0099504"]
[289,145,"NK014","Btk","Pan-specific","Bruton's agammaglobulinemia tyrosine kinase",{"v":947.8478967698801,"d":"948"},{"v":825.955614844118,"d":"826"},{"v":584.3789791502996,"d":"584"},{"v":61.6532442749278,"d":"62"},{"v":192.67716665473927,"d":"193"},{"v":4958.949298880513,"d":"4959"},"External","RpAb","Epitope undefined.",{"$nulls":3},"Q06187","Q06187",450,"Q06187","Q06187","NP_000052","Block1",12,2,"1, 9, 17, 25","BTK","X","PYK","Protein kinase - Non-receptor- tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK domain target; TK</A> group; Tec family","GO:0005737; GO:0031410; GO:0005829; GO:0031234; GO:0042629; GO:0045121; GO:0005634; GO:0048471; GO:0005886","GO:0005524; GO:0042802; GO:0046872; GO:0004715; GO:0005547; GO:0004713; GO:0005102","GO:0002250; GO:0097190; GO:0042113; GO:0002344; GO:0050853; GO:0019722; GO:0048469; GO:0098761; GO:0071226; GO:0034614; GO:0038095; GO:0002553; GO:0007249; GO:0045087; GO:0035556; GO:0007498; GO:0002755; GO:0030889; GO:0001818; GO:0038083; GO:0018108; GO:0045579; GO:0051092; GO:0001812; GO:0001805; GO:0006468; GO:0002902; GO:0002721; GO:0042127; GO:0006351; GO:0007169"]
[291,146,"PK550","Btk","Y223+Y225","Bruton's agammaglobulinemia tyrosine kinase",{"v":1028.9402114513514,"d":"1029"},{"v":956.0326167934847,"d":"956"},{"v":504.80084218136375,"d":"505"},{"v":49.0602696408693,"d":"49"},{"v":124.19602328111453,"d":"124"},{"v":2919.693283402932,"d":"2920"},"Kinexus","RpAb","VAL(pY)D(pY)M(bA)C","Corresponds to amino acid residues V220 to M226; In the SH3_1 domain.","Y223 and Y225 phosphorylation stimulate phosphotransferase activity and regulates cell growth. These are two of the major in vivo phosphorylation sites in Btk (≥261 and ≥90 reports, respectively, by mass spectrometry).","Y223: Abl1; Btk; ITK; Lyn; PIK3CD, Tec","Q06187","Q06187",450,"Q06187","Q06187","NP_000052","Block1",12,3,"1, 9, 17, 25","BTK","X","PYK","Protein kinase - Non-receptor- tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK domain target; TK</A> group; Tec family","GO:0005737; GO:0031410; GO:0005829; GO:0031234; GO:0042629; GO:0045121; GO:0005634; GO:0048471; GO:0005886","GO:0005524; GO:0042802; GO:0046872; GO:0004715; GO:0005547; GO:0004713; GO:0005102","GO:0002250; GO:0097190; GO:0042113; GO:0002344; GO:0050853; GO:0019722; GO:0048469; GO:0098761; GO:0071226; GO:0034614; GO:0038095; GO:0002553; GO:0007249; GO:0045087; GO:0035556; GO:0007498; GO:0002755; GO:0030889; GO:0001818; GO:0038083; GO:0018108; GO:0045579; GO:0051092; GO:0001812; GO:0001805; GO:0006468; GO:0002902; GO:0002721; GO:0042127; GO:0006351; GO:0007169"]
[293,147,"PK551","Btk","Y551","Bruton's agammaglobulinemia tyrosine kinase",{"v":5555.693891415507,"d":"5556"},{"v":5435.500137615262,"d":"5436"},{"v":1660.761027882086,"d":"1661"},{"v":29.892954153724066,"d":"30"},{"v":755.170700022127,"d":"755"},{"v":11912.622832866648,"d":"11913"},"Kinexus","RpAb","DDE(pY)TSS(bA)C","Corresponds to amino acid residues D548 to S554; In the protein kinase catalytic domain.","Y551 phosphorylation stimulates phosphotransferase activity, and regulates intracellular location and molecular association, including inducing interaction with BLNK. This is one of the major in vivo phosphorylation sites in Btk (≥148 reports from high throughput mass spectrometry studies).","Btk; Lyn; PIK3CD; Src; Syk","Q06187","Q06187",450,"Q06187","Q06187","NP_000052","Block1",12,4,"1, 9, 17, 25","BTK","X","PYK","Protein kinase - Non-receptor- tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK domain target; TK</A> group; Tec family","GO:0005737; GO:0031410; GO:0005829; GO:0031234; GO:0042629; GO:0045121; GO:0005634; GO:0048471; GO:0005886","GO:0005524; GO:0042802; GO:0046872; GO:0004715; GO:0005547; GO:0004713; GO:0005102","GO:0002250; GO:0097190; GO:0042113; GO:0002344; GO:0050853; GO:0019722; GO:0048469; GO:0098761; GO:0071226; GO:0034614; GO:0038095; GO:0002553; GO:0007249; GO:0045087; GO:0035556; GO:0007498; GO:0002755; GO:0030889; GO:0001818; GO:0038083; GO:0018108; GO:0045579; GO:0051092; GO:0001812; GO:0001805; GO:0006468; GO:0002902; GO:0002721; GO:0042127; GO:0006351; GO:0007169"]
[295,148,"PK552","BUB1B (Bub1R)","S670","Mitotic checkpoint serine/threonine-protein kinase BUB1 beta",{"v":7368.008302963713,"d":"7368"},{"v":7261.983173400762,"d":"7262"},{"v":1747.6966272287596,"d":"1748"},{"v":23.720068644952054,"d":"24"},{"v":652.4014434675767,"d":"652"},{"v":12709.096507870197,"d":"12709"},"Kinexus","RpAb","KKL(pS)PII(bA)C","Corresponds to amino acid residues K667 to I673; Just before kinase catalytic domain. This is the major in vivo phosphorylation sites.","S670 phosphorylation induces interaction with PPP2R5A and PPP2CA and regulates cell cycle progression. This is the major in vivo phosphorylation site in BUB1B (≥33 reports from high throughput mass spectrometry studies).","CDK1; TTK","O60566","O60566",2176,"O60566","O60566","NP_001202.4","Block1",12,5,"1, 9, 17, 25","BUBR1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","BUB",{"$nulls":6},"Spindle midzone, Anaphase-promoting complex, Cytoplasm, Nucleus, Outer kinetochore of condensed chromosome protein","GO:0005680; GO:0000777; GO:0000940; GO:0000778; GO:0005737; GO:0005829; GO:0000776; GO:0005815; GO:0048471; GO:0051233","GO:0005524; GO:0004672; GO:0004674","GO:0031145; GO:0006915; GO:0051301; GO:0008283; GO:0051754; GO:0007091; GO:0000278; GO:0007093; GO:0007094; GO:0034501"]
[297,149,"PN575","C-EBPa","T226+T230","CCAAT/enhancer-binding protein alpha",{"v":789.3426332678549,"d":"789"},{"v":22.308545011591967,"d":"22"},{"v":1582.8075153085795,"d":"1583"},{"v":200.5222382016544,"d":"201"},{"v":3.890547844572718,"d":"4"},{"v":6509.918810866413,"d":"6510"},"Kinexus","RpAb","CGHP(pT)PPP(pT)PVP","Corresponds to amino acid residues C223 to P233.","The effects of T226 and T230 phosphorylations are unclear.  Their phosphorylation has been reported to both inhibit and activate transcriptional activity. Neither of these two phosphorylation sites have apparently been reported from high throughput mass spectrometry, although there are several literature reports for their phosphorylation.","T226: BARK2 (GRK3, ADRBK2); GSK3a; GSK3b. T230: GSK3a.","P49715","P49715",930,null,"P49715","NP_001272758.1","Block1",12,6,"1, 9, 17, 25",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0043231; GO:0005730; GO:0005654; GO:0005634; GO:0090575","GO:0003677; GO:0003700; GO:0019900; GO:0042803; GO:0000978; GO:0000981; GO:0001013; GO:0001077; GO:0001228; GO:0003713; GO:0003705; GO:0008134; GO:0044212","GO:0050873; GO:0048469; GO:0071285; GO:0071407; GO:0071356; GO:0008203; GO:0019221; GO:0001892; GO:0045444; GO:0006091; GO:0042593; GO:0030851; GO:0048839; GO:0055088; GO:0001889; GO:0030324; GO:0030225; GO:0007005; GO:0030099; GO:0008285; GO:0045736; GO:0045892; GO:0000122; GO:0007219; GO:2000144; GO:0045600; GO:0050729; GO:0043032; GO:0045669; GO:0032436; GO:0045944; GO:0045945; GO:0006351; GO:0006360; GO:0006366; GO:0000050; GO:0016032; GO:0050872"]
[299,150,"PN216","C3G (RapGEF1)","Y504","Rap guanine nucleotide exchange factor 1",{"v":178.04794516250408,"d":"178"},{"v":163.55248264428167,"d":"164"},{"v":95.80551105034372,"d":"96"},{"v":53.808827146475736,"d":"54"},{"v":35.42617615098017,"d":"35"},{"v":497.05823221321185,"d":"497"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the Y504 phosphosite.","Y504 phosphorylation increases RapGEF1 activity. Its phosphorylation has apparently not been reported from high throughput mass spectrometry, although there are several literature reports for Y504 phosphorylation.","Abl1; Hck; Src","Q13905","Q13905",933,null,null,"NP_001291204.1","Block1",12,7,"1, 9, 17, 25",{"$nulls":13},"Guanine nucleotide exchange factor for Rap G protein","GO:0005737; GO:0005829; GO:0005769; GO:0005768; GO:0048471; GO:0030670; GO:0032991","GO:0005085; GO:0017034; GO:0017124","GO:0000186; GO:0001568; GO:0098609; GO:0071320; GO:1990090; GO:0019221; GO:0061028; GO:0090090; GO:0070373; GO:2000178; GO:0051898; GO:0046580; GO:0038180; GO:0048008; GO:0070374; GO:1905451; GO:0043547; GO:0010976; GO:0032486; GO:1901888; GO:0046328; GO:0007165; GO:0007169"]
[301,151,"PN691","CAD","S1859","Aspartate carbamoyltransferase",{"v":2214.961392366323,"d":"2215"},{"v":1958.549157131842,"d":"1959"},{"v":1214.4178403795925,"d":"1214"},{"v":54.82794619197341,"d":"55"},{"v":322.0602801680018,"d":"322"},{"v":8952.253730166029,"d":"8952"},"Kinexus","RpAb","HRA(pS)DPG(bA)C","Corresponds to amino acid residues H1856 to G1862.","S1859 phosphorylation stimulates enzyme activity. This is the major in vivo phosphorylation site in CAD (≥162 reports from high throughput mass spectrometry studies). However, This human phosphosite is not highly conserved in nature, but is found in the rhesus monkey.","PKACa (PRKACA); p70 S6Kb (RPS6KB1)","P27708","P27708",4928,null,null,"NP_001293008.1","Block1",12,8,"1, 9, 17, 25",{"$nulls":3},"De novo pyrimidine synthesis",{"$nulls":8},"X","EC 6.3.5.5; EC 2.1.3.2; Ligase; Nucleotide Metabolism - pyrimidine; EC 3.5.2.3; Transferase; Hydrolase; Amino Acid Metabolism - alanine, aspartate and glutamate","GO:0042995; GO:0005829; GO:0070062; GO:0016020; GO:0043025; GO:0016363; GO:0005654; GO:0005634; GO:0032991; GO:0043195","GO:0070335; GO:0004070; GO:0005524; GO:0004087; GO:0004088; GO:0004151; GO:0019899; GO:0042802; GO:0004672; GO:0008270","GO:0006207; GO:0044205; GO:0031100; GO:0006526; GO:0035690; GO:0071364; GO:0019240; GO:0017144; GO:0007565; GO:0006541; GO:0007507; GO:0007595; GO:0001889; GO:0018107; GO:0046777; GO:0046134; GO:0014075; GO:0031000; GO:0051414; GO:0032868; GO:0042594; GO:0033574; GO:0000050; GO:0006228"]
[303,153,"PN015","CALD1","S789","Caldesmon",{"v":138.78273769280167,"d":"139"},{"v":65.89151466646393,"d":"66"},{"v":201.89141526936652,"d":"202"},{"v":145.4730023529707,"d":"145"},{"v":14.040183349809384,"d":"14"},{"v":1241.1268759445434,"d":"1241"},"External","RpAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the S789 phosphosite.","The effect of S789 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in caldesmon (≥18 reports from high throughput mass spectrometry studies).","CDK1 (CDC2); CDK6; ERK1 (MAPK3); ERK2 (MAPK1); p38a MAPK (MAPK14); PKCa (PRKCA)","Q05682","Q05682",1152,null,null,"NP_004333","Block1",12,10,"1, 9, 17, 25",{"$nulls":13},"Cytoskeletal, calcium binding protein","GO:0030478; GO:0015629; GO:0005856; GO:0005829; GO:0043231; GO:0030016; GO:0005886","GO:0003779; GO:0045296; GO:0005516; GO:0017022; GO:0005523","GO:0006936"]
[305,154,"NK211","CaMK1a (CAMK1)","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase 1 alpha",{"v":433.28952131478076,"d":"433"},{"v":344.5081972339629,"d":"345"},{"v":359.02816448477495,"d":"359"},{"v":82.86103097885544,"d":"83"},{"v":74.18520082407,"d":"74"},{"v":3695.279651531983,"d":"3695"},"External","GpAb","Epitope undefined.",{"$nulls":3},"Q14012","Q14012",1430,"Q14012",null,"NP_003647.1","Block1",12,11,"1, 9, 17, 25","CaMK1a","X","PSTK","Protein kinase - Non-receptor- tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"EC 2.7.11.17; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; CAMK1 family","GO:0005737; GO:0098978; GO:0005622; GO:0005634; GO:0014069","GO:0005524; GO:0005516; GO:0004683","GO:0007049; GO:0035556; GO:0032091; GO:0006913; GO:0018107; GO:0060999; GO:0051149; GO:0010976; GO:0033138; GO:1901985; GO:0046827; GO:0071902; GO:0051835; GO:0060143; GO:0045944; GO:0006468; GO:0051147; GO:0043393; GO:0032880; GO:0007165"]
[307,155,"PK553","CaMK1a (CAMK1)","T177","Calcium/calmodulin-dependent protein-serine kinase 1 alpha",{"v":683.7276713611963,"d":"684"},{"v":21.602429498708513,"d":"22"},{"v":1296.2117412784285,"d":"1296"},{"v":189.5801202104152,"d":"190"},{"v":2.6189648524488427,"d":"3"},{"v":5091.804053787729,"d":"5092"},"Kinexus","RpAb","VLS(pT)ACG(bA)C","Corresponds to amino acid residues V174 to G180; In the protein kinase catalytic domain.","T177 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in CaMK1a (≥12 reports from high throughput mass spectrometry studies).","CAMKK1","Q14012","Q14012",1430,"Q14012",null,"NP_003647.1","Block1",12,12,"1, 9, 17, 25","CaMK1a","X","PSTK","Protein kinase - Non-receptor- tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"EC 2.7.11.17; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; CAMK1 family","GO:0005737; GO:0098978; GO:0005622; GO:0005634; GO:0014069","GO:0005524; GO:0005516; GO:0004683","GO:0007049; GO:0035556; GO:0032091; GO:0006913; GO:0018107; GO:0060999; GO:0051149; GO:0010976; GO:0033138; GO:1901985; GO:0046827; GO:0071902; GO:0051835; GO:0060143; GO:0045944; GO:0006468; GO:0051147; GO:0043393; GO:0032880; GO:0007165"]
[309,156,"PK874","CaMK1a (CAMK1)","Y235","Calcium/calmodulin-dependent protein-serine kinase 1 alpha",{"v":6330.602224245435,"d":"6331"},{"v":6161.753194479296,"d":"6162"},{"v":1555.5269789525537,"d":"1556"},{"v":24.571548232726975,"d":"25"},{"v":2642.94648365385,"d":"2643"},{"v":11371.637597407584,"d":"11372"},"Kinexus","RpAb","KAE(pY)EFD(bA)C","Corresponds to amino acid residues K232 to D238. Y235 is located in the Gap/Insert 10 (G/I10) region in the protein-serine/threonine kinase catalytic domain of CaMK1a, and has been observed in only a small number of mass spectrometry studies (~2). The effect of its phosphorylation is unknown. However, it has homology with the Y245 phosphosite in VACAMKL.","The effect of Y235 phosphorylation is unclear. This is one of the minor in vivo phosphorylation sites in CaMK1a (≥2 reports from high throughput mass spectrometry studies).",null,"Q14012","Q14012",1430,"Q14012",null,"NP_003647.1","Block1",12,13,"1, 9, 17, 25","CaMK1a","X","PSTK","Protein kinase - Non-receptor- tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"EC 2.7.11.17; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; CAMK1 family","GO:0005737; GO:0098978; GO:0005622; GO:0005634; GO:0014069","GO:0005524; GO:0005516; GO:0004683","GO:0007049; GO:0035556; GO:0032091; GO:0006913; GO:0018107; GO:0060999; GO:0051149; GO:0010976; GO:0033138; GO:1901985; GO:0046827; GO:0071902; GO:0051835; GO:0060143; GO:0045944; GO:0006468; GO:0051147; GO:0043393; GO:0032880; GO:0007165"]
[311,157,"NK016-3","CaMK1d","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase 1 delta",{"v":121.27290829759494,"d":"121"},{"v":94.51956326708397,"d":"95"},{"v":102.49386323138988,"d":"102"},{"v":84.5150534197443,"d":"85"},{"v":29.70117993676857,"d":"30"},{"v":972.1788760723566,"d":"972"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 319-385 mapping at the C-terminus of human CaMKIδ.",null,null,"Q8IU85","Q8IU85",2086,"Q8IU85",null,"NP_003647","Block1",13,1,"1, 9, 17, 25","CaMK1d","X","PSTK","Protein kinase - Non-receptor- tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"Protein-serine kinase, CAMK group, CAMK1 family","GO:0005737; GO:0005634","GO:0005524; GO:0005516; GO:0004683","GO:0006954; GO:0035556; GO:0043066; GO:0018105; GO:0018107; GO:0043065; GO:0032793; GO:0010976; GO:0090023; GO:0050766; GO:0060267; GO:0050773; GO:0071622"]
[313,158,"NK016-2","CaMK1d","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase 1 delta",{"v":574.9416712690398,"d":"575"},{"v":482.7321138651629,"d":"483"},{"v":361.6279376274971,"d":"362"},{"v":62.898195712496175,"d":"63"},{"v":95.90266213584309,"d":"96"},{"v":2700.3180907280475,"d":"2700"},"External","GpAb","Epitope undefined.",{"$nulls":3},"Q8IU85","Q8IU85",2086,"Q8IU85",null,"NP_003647","Block1",13,2,"1, 9, 17, 25","CaMK1d","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK1",{"$nulls":6},"Protein-serine kinase, CAMK group, CAMK1 family","GO:0005737; GO:0005634","GO:0005524; GO:0005516; GO:0004683","GO:0006954; GO:0035556; GO:0043066; GO:0018105; GO:0018107; GO:0043065; GO:0032793; GO:0010976; GO:0090023; GO:0050766; GO:0060267; GO:0050773; GO:0071622"]
[315,159,"PK554","CaMK1d","T180","Calcium/calmodulin-dependent protein-serine kinase 1 delta",{"v":5247.487321297446,"d":"5247"},{"v":5181.60476687876,"d":"5182"},{"v":1440.8060807240577,"d":"1441"},{"v":27.4570664492395,"d":"27"},{"v":561.3160364533055,"d":"561"},{"v":10708.139617204351,"d":"10708"},"Kinexus","RpAb","VMS(pT)ACG(bA)C","Corresponds to amino acid residues V177 to G183; In the protein kinase catalytic domain.","T180 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation site in CaMK1d (≥19 reports from high throughput mass spectrometry studies).","CaMKK1","Q8IU85","Q8IU85",2086,"Q8IU85",null,"NP_003647","Block1",13,3,"1, 9, 17, 25","CaMK1d","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK1",{"$nulls":6},"Protein-serine kinase, CAMK group, CAMK1 family","GO:0005737; GO:0005634","GO:0005524; GO:0005516; GO:0004683","GO:0006954; GO:0035556; GO:0043066; GO:0018105; GO:0018107; GO:0043065; GO:0032793; GO:0010976; GO:0090023; GO:0050766; GO:0060267; GO:0050773; GO:0071622"]
[317,160,"NK302-2","CaMK2a","Pan-specific","Calcium/calmodulin-dependent protein kinase type II subunit alpha",{"v":4285.989081117336,"d":"4286"},{"v":3951.7564612703404,"d":"3952"},{"v":2463.4789511359722,"d":"2463"},{"v":57.477490131490384,"d":"57"},{"v":14.726705338671916,"d":"15"},{"v":11980.66166177345,"d":"11981"},"External","MmAb","Epitope undefined.",{"$nulls":3},"Q9UQM7","Q9UQM7",580,"Q9UQM7",null,"NP_741960.1","Block1",13,4,"1, 9, 17, 25","CaMK2a","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK2",{"$nulls":6},"EC 2.7.11.17; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; CAMK2 family","GO:0005954; GO:0030054; GO:0005737; GO:0005829; GO:0043197; GO:0030666; GO:0005739; GO:0043005; GO:0005654; GO:0005634; GO:0005886; GO:0014069; GO:0042734; GO:0098685","GO:0005524; GO:0009931; GO:0005516; GO:0004683; GO:0035254; GO:0042802; GO:0016301; GO:0046872; GO:0042803; GO:0004674; GO:0005088","GO:0038166; GO:0006816; GO:0030154; GO:0048813; GO:0060996; GO:0000082; GO:0060333; GO:0035556; GO:0000165; GO:0007399; GO:0018105; GO:1990443; GO:0018107; GO:0051928; GO:0010666; GO:0051092; GO:0046777; GO:0006468; GO:1902108; GO:0048168; GO:2001222; GO:0046928; GO:0099148; GO:0002931; GO:0007223"]
[319,161,"PK875","CaMK2a","Y230","Calcium/calmodulin-dependent protein-serine kinase 2 alpha",{"v":3004.9181871968044,"d":"3005"},{"v":22.272551409081522,"d":"22"},{"v":6128.480859873488,"d":"6128"},{"v":203.94834328553083,"d":"204"},{"v":4.546965594083387,"d":"5"},{"v":21156.662174813064,"d":"21157"},"Kinexus","RpAb","AGA(pY)DFP(bA)C","Corresponds to amino acid residues A227 to P230. Y230 is located in the Gap/Insert 10 (G/I10) region in the protein-serine/threonine kinase catalytic domain of CaMK2a. ","The effect of Y230 phosphorylation is unknown. It appears to be the third most commonly observed phosphosite in CaMK2a by mass spectrometry studies (~28 reports). Phosphorylation of Y230 in rat brain appears to be induced by 15 min ischemia treatment.",null,"Q9UQM7","Q9UQM7",580,"Q9UQM7",null,"NP_741960.1","Block1",13,5,"1, 9, 17, 25","CaMK2a","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK2",{"$nulls":6},"EC 2.7.11.17; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; CAMK2 family","GO:0005954; GO:0030054; GO:0005737; GO:0005829; GO:0043197; GO:0030666; GO:0005739; GO:0043005; GO:0005654; GO:0005634; GO:0005886; GO:0014069; GO:0042734; GO:0098685","GO:0005524; GO:0009931; GO:0005516; GO:0004683; GO:0035254; GO:0042802; GO:0016301; GO:0046872; GO:0042803; GO:0004674; GO:0005088","GO:0038166; GO:0006816; GO:0030154; GO:0048813; GO:0060996; GO:0000082; GO:0060333; GO:0035556; GO:0000165; GO:0007399; GO:0018105; GO:1990443; GO:0018107; GO:0051928; GO:0010666; GO:0051092; GO:0046777; GO:0006468; GO:1902108; GO:0048168; GO:2001222; GO:0046928; GO:0099148; GO:0002931; GO:0007223"]
[321,162,"PK555","CaMK2a","T286","Calcium/calmodulin-dependent protein-serine kinase 2 alpha",{"v":10523.286843100677,"d":"10523"},{"v":10707.694287851858,"d":"10708"},{"v":3154.272950073309,"d":"3154"},{"v":29.9742181041214,"d":"30"},{"v":50.996292992481465,"d":"51"},{"v":20845.245612793995,"d":"20845"},"Kinexus","RpAb","HRQE(pT)VDC","Corresponds to amino acid residues H282 to C289; In the region between the kinase catalytic domain and the CamKII-AD domains. ","T286 phosphorylation stimulates calcium/calmodulin-independent phosphotransferase activity and regulates cell growth, intracellular location, molecular association, including inducing interaction with GIT1 and MAP2, and inhibiting interaction with MBP and neurogranin. This is a major site of in vivo phosphorylation of CaMK2a (≥88 reports from high throughput mass spectrometry studies).","CaMK2a; CaMK2b; CaMK2d; PKCa (PRKCA)","Q9UQM7","Q9UQM7",580,"Q9UQM7",null,"NP_741960.1","Block1",13,6,"1, 9, 17, 25","CaMK2a","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK2",{"$nulls":6},"EC 2.7.11.17; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; CAMK2 family","GO:0005954; GO:0030054; GO:0005737; GO:0005829; GO:0043197; GO:0030666; GO:0005739; GO:0043005; GO:0005654; GO:0005634; GO:0005886; GO:0014069; GO:0042734; GO:0098685","GO:0005524; GO:0009931; GO:0005516; GO:0004683; GO:0035254; GO:0042802; GO:0016301; GO:0046872; GO:0042803; GO:0004674; GO:0005088","GO:0038166; GO:0006816; GO:0030154; GO:0048813; GO:0060996; GO:0000082; GO:0060333; GO:0035556; GO:0000165; GO:0007399; GO:0018105; GO:1990443; GO:0018107; GO:0051928; GO:0010666; GO:0051092; GO:0046777; GO:0006468; GO:1902108; GO:0048168; GO:2001222; GO:0046928; GO:0099148; GO:0002931; GO:0007223"]
[323,163,"PK178","CaMK2a","T286","Calcium/calmodulin-dependent protein-serine kinase 2 alpha",{"v":363.4316790994552,"d":"363"},{"v":99.79932073095429,"d":"100"},{"v":2076.511152233562,"d":"2077"},{"v":571.3621766211834,"d":"571"},{"v":21.16359704354898,"d":"21"},{"v":19075.811098167083,"d":"19076"},"External","MmAb","Not precisely defined.","Antibody raised against a synthetic peptide corresponding to amino acid residues 281-294 of rat CaMKII.","T286 phosphorylation stimulates calcium/calmodulin-independent phosphotransferase activity and regulates cell growth, intracellular location, molecular association, including inducing interaction with GIT1 and MAP2, and inhibiting interaction with MBP and neurogranin. This is a major site of in vivo phosphorylation of CaMK2a (≥88 reports from high throughput mass spectrometry studies).","CaMK2a; CaMK2b; CaMK2d; PKCa (PRKCA)","Q9UQM7","Q9UQM7",580,"Q9UQM7",null,"NP_741960.1","Block1",13,7,"1, 9, 17, 25","CaMK2a","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK2",{"$nulls":6},"EC 2.7.11.17; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; CAMK2 family","GO:0005954; GO:0030054; GO:0005737; GO:0005829; GO:0043197; GO:0030666; GO:0005739; GO:0043005; GO:0005654; GO:0005634; GO:0005886; GO:0014069; GO:0042734; GO:0098685","GO:0005524; GO:0009931; GO:0005516; GO:0004683; GO:0035254; GO:0042802; GO:0016301; GO:0046872; GO:0042803; GO:0004674; GO:0005088","GO:0038166; GO:0006816; GO:0030154; GO:0048813; GO:0060996; GO:0000082; GO:0060333; GO:0035556; GO:0000165; GO:0007399; GO:0018105; GO:1990443; GO:0018107; GO:0051928; GO:0010666; GO:0051092; GO:0046777; GO:0006468; GO:1902108; GO:0048168; GO:2001222; GO:0046928; GO:0099148; GO:0002931; GO:0007223"]
[325,164,"NK018-3","CaMK2b","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase 2 beta",{"v":7566.997554063051,"d":"7567"},{"v":7494.676553317582,"d":"7495"},{"v":1772.8728075697818,"d":"1773"},{"v":23.42901256282089,"d":"23"},{"v":3256.9073861646457,"d":"3257"},{"v":14760.826733368116,"d":"14761"},"Kinexus","RpAb","RISDILNSVRRGSGTPEAEC","Corresponds to amino acid residues R449 to E467; Before CaMAD, repeated 3X.",null,null,"Q13554","Q13554",674,"Q13554","Q13554","NP_001211.3","Block1",13,8,"1, 9, 17, 25","CAMK2b","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK2",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.1.123; EC 2.7.11.17; CAMK domain target; CAMK</A> group; CAMK2 family","GO:0030054; GO:0005737; GO:0005829; GO:0030666; GO:0005815; GO:0043005; GO:0005654; GO:0005886; GO:0033017; GO:0045202","GO:0003779; GO:0005524; GO:0005516; GO:0004683; GO:0042802; GO:0042803; GO:0004674; GO:0005088","GO:0060333; GO:0035556; GO:0000165; GO:0018105; GO:0018107; GO:0061003; GO:0010976; GO:0090129; GO:0046777; GO:0006468; GO:0051924; GO:0060998; GO:0048169; GO:2001222; GO:0014733; GO:0051823; GO:0007165"]
[327,165,"NK019-3","CaMK2d","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase 2 delta",{"v":11525.682041668804,"d":"11526"},{"v":11070.454172297083,"d":"11070"},{"v":2598.0542435245884,"d":"2598"},{"v":22.541436022023177,"d":"23"},{"v":5979.663743798001,"d":"5980"},{"v":24033.77786559765,"d":"24034"},"Kinexus","RpAb","CTRFTDEYQLFEELGKGAFS","Corresponds to amino acid residues C7 to S26; N-terminus and kinase domain I, highly conserved in all CaMK2 isoforms.",null,null,"Q13557","Q13557",2093,"Q13557","Q13557","NP_001212.2","Block1",13,9,"1, 9, 17, 25","CAMK2d","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK2",{"$nulls":6},"EC 2.7.11.17; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; CAMK2 family","GO:0005737; GO:0005829; GO:0030666; GO:0016020; GO:0043005; GO:0005654; GO:0005634; GO:0005886; GO:0042383; GO:0033017","GO:0005524; GO:0005516; GO:0004683; GO:0042802; GO:0044325; GO:0042803; GO:0004674; GO:0005088; GO:0019871; GO:0031432","GO:0086003; GO:0030154; GO:0071277; GO:0032469; GO:0060333; GO:0000165; GO:1902306; GO:2000650; GO:0007399; GO:0018105; GO:0018107; GO:0010666; GO:0010613; GO:0046777; GO:0051259; GO:0006468; GO:1902514; GO:0098901; GO:0098909; GO:0010881; GO:0010649; GO:1901844; GO:0001558; GO:0060341; GO:0008016; GO:0086091; GO:1901725; GO:0003254; GO:1901897; GO:0010880; GO:0060314; GO:0002026; GO:0006357; GO:0055119"]
[329,166,"NK020-1","CaMK2g","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase 2 gamma",{"v":3346.8740933511845,"d":"3347"},{"v":3260.9622182565745,"d":"3261"},{"v":920.6628189849449,"d":"921"},{"v":27.50814023192299,"d":"28"},{"v":1134.6020307547333,"d":"1135"},{"v":7325.099572508232,"d":"7325"},"Kinexus","RpAb","CDGIKGSTESSNTTTEDEDL","Corresponds to amino acid residues D376 to L394; Before CaMAD, highly conserved in all CaMK2 isoforms.",null,null,"Q13555","Q13555",2090,"Q13555",null,"NP_751909.1","Block1",13,10,"1, 9, 17, 25","CaMK2g","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK2",{"$nulls":6},"EC 2.7.11.17; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; CAMK2 family","GO:0005737; GO:0005829; GO:0030666; GO:0016020; GO:0043005; GO:0005654; GO:0005886; GO:0033017","GO:0005524; GO:0004723; GO:0005516; GO:0004683; GO:0042802; GO:0042803; GO:0004674; GO:0005088","GO:0030154; GO:0030073; GO:0060333; GO:0035556; GO:0000165; GO:0007399; GO:0018105; GO:0018107; GO:0051259; GO:0051924; GO:0014733"]
[331,167,"NK021-2 (NK021-3)","CaMK4 (CaMPK4)","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase 4",{"v":2638.9099528110623,"d":"2639"},{"v":2514.8652360161764,"d":"2515"},{"v":823.0500168718742,"d":"823"},{"v":31.18901484285705,"d":"31"},{"v":1171.337721479341,"d":"1171"},{"v":7577.98790616824,"d":"7578"},"Kinexus","RpAb","CPQQDAILPEY","Corresponds to amino acid residues Q466 to Y474; C-terminus.",null,null,"Q16566","Q16566",889,"Q16566","Q16566","NP_001735","Block1",13,11,"1, 9, 17, 25","CAMK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK1",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.17; CAMK domain target; CAMK</A> group; CAMK1 family","GO:0005737; GO:0005829; GO:0070062; GO:0001650; GO:0098978; GO:0005654; GO:0005634; GO:0098794","GO:0005524; GO:0009931; GO:0005516; GO:0004683","GO:0002250; GO:0006954; GO:0035556; GO:0007616; GO:0043011; GO:0018105; GO:0045893; GO:0046777; GO:0006468; GO:0045670; GO:0033081; GO:0007165"]
[333,168,"NK021 SG-KAP-CA003","CaMK4 (CaMPK4)","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase 4",{"v":2937.0371840998164,"d":"2937"},{"v":2850.2077194749236,"d":"2850"},{"v":895.2015914938789,"d":"895"},{"v":30.479750012707196,"d":"30"},{"v":1103.7958227829165,"d":"1104"},{"v":8075.317426434845,"d":"8075"},"Kinexus","RpAb","CSSVTSSTENLVPDYWID","Corresponds to amino acid residues C14 to D31; N-terminus.",null,null,"Q16566","Q16566",889,"Q16566","Q16566","NP_001735","Block1",13,12,"1, 9, 17, 25","CAMK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK1",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.17; CAMK domain target; CAMK</A> group; CAMK1 family","GO:0005737; GO:0005829; GO:0070062; GO:0001650; GO:0098978; GO:0005654; GO:0005634; GO:0098794","GO:0005524; GO:0009931; GO:0005516; GO:0004683","GO:0002250; GO:0006954; GO:0035556; GO:0007616; GO:0043011; GO:0018105; GO:0045893; GO:0046777; GO:0006468; GO:0045670; GO:0033081; GO:0007165"]
[335,169,"PK556","CaMK4 (CaMPK4)","T200","Calcium/calmodulin-dependent protein-serine kinase 4",{"v":12492.907329350426,"d":"12493"},{"v":12063.454830159071,"d":"12063"},{"v":2723.179335489379,"d":"2723"},{"v":21.797803054951277,"d":"22"},{"v":7423.188319020465,"d":"7423"},{"v":22828.525625303,"d":"22829"},"Kinexus","RpAb","LMK(pT)VCG(bA)C","Corresponds to amino acid residues L197 to G203; In the protein kinase catalytic domain.","T200 phosphorylation stimulates phosphotransferase activity and regulates transcription. This is one of the major in vivo phosphorylation sites in CaMK4 (≥13 reports from high throughput mass spectrometry studies).","CaMKK1","Q16566","Q16566",889,"Q16566","Q16566","NP_001735","Block1",13,13,"1, 9, 17, 25","CAMK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMK1",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.17; CAMK domain target; CAMK</A> group; CAMK1 family","GO:0005737; GO:0005829; GO:0070062; GO:0001650; GO:0098978; GO:0005654; GO:0005634; GO:0098794","GO:0005524; GO:0009931; GO:0005516; GO:0004683","GO:0002250; GO:0006954; GO:0035556; GO:0007616; GO:0043011; GO:0018105; GO:0045893; GO:0046777; GO:0006468; GO:0045670; GO:0033081; GO:0007165"]
[337,170,"NK022","CaMKK1 (CaMKK)","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase kinase",{"v":9186.41893252716,"d":"9186"},{"v":8954.964132637131,"d":"8955"},{"v":1930.732606531471,"d":"1931"},{"v":21.017249710822096,"d":"21"},{"v":2664.0285958888553,"d":"2664"},{"v":17734.475611688125,"d":"17734"},"Kinexus","RpAb","CGKSPELPGVQEDEA","Corresponds to amino acid residues G490 to A503; near the very C-terminus of the kinase.",null,null,"Q8N5S9","Q8N5S9",2182,"Q8N5S9",null,"NP_006540","Block2",1,1,"2, 10, 18, 26","CaMKK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","CAMKK","Meta",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.17; Other group; CAMKK family; Meta subfamily","GO:0005737; GO:0005829; GO:0005634","GO:0005524; GO:0005516; GO:0004683","GO:0035556; GO:0018105; GO:0018107; GO:0045860"]
[339,171,"PK557","CaMKK1 (CaMKK)","S74","Calcium/calmodulin-dependent protein-serine kinase kinase",{"v":512.6432187461053,"d":"513"},{"v":440.8539928774391,"d":"441"},{"v":355.52024208564364,"d":"356"},{"v":69.35042327395355,"d":"69"},{"v":25.380486817924524,"d":"25"},{"v":2544.145091957253,"d":"2544"},"Kinexus","RpAb","RKL(pS)LQE(bA)C","Corresponds to amino acid residues R71 to E77; In the N-terminal quarter of the protein located before the kinase catalytic domain.  ","S74 phosphorylation stimulates phosphotransferase activity and inhibits phosphotransferase activity by inducing binding to 14-3-3 eta. This is the major in vivo phosphorylation sites in CaMMK1 (≥75 reports from high throughput mass spectrometry studies).","PKACa (PRKACA)","Q8N5S9","Q8N5S9",2182,"Q8N5S9",null,"NP_006540","Block2",1,2,"2, 10, 18, 26","CaMKK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","CAMKK","Meta",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.17; Other group; CAMKK family; Meta subfamily","GO:0005737; GO:0005829; GO:0005634","GO:0005524; GO:0005516; GO:0004683","GO:0035556; GO:0018105; GO:0018107; GO:0045860"]
[341,172,"NK366-1","CaMKKb (CaMKK2)","Pan-specific","Calcium/calmodulin-dependent protein kinase kinase 2",{"v":195.6623080995715,"d":"196"},{"v":146.609784265384,"d":"147"},{"v":157.39067628886502,"d":"157"},{"v":80.43995689183517,"d":"80"},{"v":19.83261959850212,"d":"20"},{"v":1514.238730739457,"d":"1514"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 1-95 mapping at the N-terminus of human CaMKKβ.",null,null,"Q96RR4","Q96RR4",2180,"Q96RR4","Q96RR4","NP_001257414.1","Block2",1,3,"2, 10, 18, 26",null,"X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","CAMKK","Meta",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.17; Other group; CAMKK family; Meta subfamily","GO:0042995; GO:0005737; GO:0005829; GO:0005622; GO:0005634","GO:0005524; GO:0005509; GO:0005516; GO:0004683; GO:0004713","GO:0019722; GO:0061762; GO:0034614; GO:0000165; GO:0018105; GO:0018107; GO:1903599; GO:0045860; GO:0001934; GO:0045893; GO:0046777; GO:0006468; GO:0045859"]
[343,173,"PN505","Cas-L","Y166","Enhancer of filamentation 1",{"v":4656.926994430007,"d":"4657"},{"v":4649.5156035258915,"d":"4650"},{"v":1539.8954288157565,"d":"1540"},{"v":33.066771943334594,"d":"33"},{"v":283.6923902774374,"d":"284"},{"v":9770.766843901643,"d":"9771"},"Kinexus","RpAb","GYV(pY)EYP(bA)C","Corresponds to amino acid residues G163 to P169; In the region between the SH3_9 and Serine_rich domains. ","The effect of Y166 phosphorylation is unclear. This is the second major in vivo phosphorylation site in Cas-L (≥569 reports from high throughput mass spectrometry studies).",null,"Q14511","Q14511",2591,null,"Q14511","NP_006394.1","Block2",1,4,"2, 10, 18, 26",{"$nulls":11},"X",null,"Adapter/scaffold protein","GO:0005938; GO:0005737; GO:0005829; GO:0005925; GO:0005794; GO:0030027; GO:0005654; GO:0005634; GO:0005886; GO:0005819; GO:0000922","GO:1990782","GO:0051017; GO:0007155; GO:0007049; GO:0051301; GO:0007010; GO:0007229; GO:0030335; GO:0061098; GO:1900026; GO:0040008; GO:0007165"]
[345,174,"NK023-1","CASK (/Lin2)","Pan-specific","Calcium/calmodulin-dependent protein-serine kinase (Lin2 homolog)",{"v":530.5848396005235,"d":"531"},{"v":402.6064620179556,"d":"403"},{"v":564.5676784932064,"d":"565"},{"v":106.40478889639373,"d":"106"},{"v":48.014468506128395,"d":"48"},{"v":6080.940433062027,"d":"6081"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 353-459 of human CASK.",null,null,"O14936","O14936",819,"O14936",null,"NP_001119526.1","Block2",1,5,"2, 10, 18, 26",null,"X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CASK",{"$nulls":6},"EC 2.7.11.1; Adaptor/scaffold; Protein kinase, Ser/Thr (non-receptor); CAMK group; CASK family","GO:0015629; GO:0005604; GO:0005911; GO:0060170; GO:0005737; GO:0005829; GO:0005925; GO:0005652; GO:0016363; GO:0005730; GO:0005886; GO:0042734","GO:0005524; GO:0005516; GO:0004385; GO:0004674","GO:0007155; GO:0001953; GO:0090288; GO:0010839; GO:0061045; GO:0007269"]
[347,181,"NN147-2","Caveolin 1","Pan-specific","Caveolin 1",{"v":240.9349919856877,"d":"241"},{"v":204.06184475408088,"d":"204"},{"v":177.6329275334253,"d":"178"},{"v":73.72649612638136,"d":"74"},{"v":33.53816199081965,"d":"34"},{"v":1759.446473089581,"d":"1759"},"External","MmAb","Not precisely defined.","Antibody raised against purified Glut4 vesicles from rat adipocytes.",null,null,"Q03135","Q03135",935,null,"Q03135","NP_001744.2","Block2",1,12,"2, 10, 18, 26",{"$nulls":13},"Adapter/scaffold protein","GO:0002080; GO:0016324; GO:0016323; GO:0005901; GO:0005938; GO:0005929; GO:0031410; GO:0031901; GO:0030666; GO:0005783; GO:0005789; GO:0005768; GO:0005925; GO:0000139; GO:0005887; GO:0005622; GO:0005811; GO:0016020; GO:0045121; GO:0048471; GO:0005886; GO:0032991","GO:0051117; GO:0015485; GO:0019899; GO:0042802; GO:0070320; GO:0044325; GO:0050998; GO:0005113; GO:0016504; GO:0030674; GO:0032947; GO:0046982; GO:0019901; GO:0048365; GO:0005102; GO:0005198","GO:0001525; GO:0086098; GO:0097190; GO:1904886; GO:0055074; GO:0006816; GO:0070836; GO:0072584; GO:0006874; GO:0071360; GO:0071455; GO:0071375; GO:0009267; GO:0071560; GO:0042632; GO:0030301; GO:0000188; GO:0007595; GO:0050900; GO:0019915; GO:0032507; GO:0030879; GO:0060056; GO:0051899; GO:2000811; GO:0030514; GO:0090090; GO:0001960; GO:0001937; GO:0030857; GO:1903609; GO:0046426; GO:0043409; GO:0060546; GO:0045019; GO:0051001; GO:0033137; GO:1900085; GO:0048550; GO:1901380; GO:0032091; GO:0061099; GO:0031397; GO:0000122; GO:0030512; GO:0042532; GO:0033484; GO:0010524; GO:0090263; GO:0043085; GO:0060355; GO:0030335; GO:0120162; GO:1903071; GO:2001238; GO:1903598; GO:0010628; GO:2001244; GO:0033138; GO:0032092; GO:0031398; GO:0034141; GO:0045907; GO:0010608; GO:0051260; GO:0008104; GO:1903361; GO:0044860; GO:0031623; GO:2000286; GO:0019065; GO:0030193; GO:0098909; GO:1901844; GO:0051480; GO:2000535; GO:0019217; GO:0086091; GO:0098903; GO:0050999; GO:0052547; GO:1900027; GO:0006940; GO:0003057; GO:0098911; GO:0009617; GO:0051592; GO:0043627; GO:0001666; GO:0002931; GO:0032570; GO:0007519; GO:0031295; GO:0006641; GO:0001570; GO:0042310; GO:0016050"]
[349,182,"PN147","Caveolin 1","Y14","Caveolin 1",{"v":653.6981839008904,"d":"654"},{"v":597.3132619762866,"d":"597"},{"v":477.6756998641247,"d":"478"},{"v":73.07282039757767,"d":"73"},{"v":6.542032288358078,"d":"7"},{"v":3519.783379536985,"d":"3520"},"External","RpAb","HL(pY)TV","Corresponds to amino acid residues H12 to V16; Surrounds the Y14 phosphosite.","Y14 phosphorylation induces activation and interaction with CSK, Grb7, MMP9 and TRAF2. This is one of the major in vivo phosphorylation sites in caveolin 1 (≥845 reports from high throughput mass spectrometry studies).","Abl1, Fyn; InsR; Src","Q03135","Q03135",935,null,"Q03135","NP_001744.2","Block2",1,13,"2, 10, 18, 26",{"$nulls":13},"Adapter/scaffold protein","GO:0002080; GO:0016324; GO:0016323; GO:0005901; GO:0005938; GO:0005929; GO:0031410; GO:0031901; GO:0030666; GO:0005783; GO:0005789; GO:0005768; GO:0005925; GO:0000139; GO:0005887; GO:0005622; GO:0005811; GO:0016020; GO:0045121; GO:0048471; GO:0005886; GO:0032991","GO:0051117; GO:0015485; GO:0019899; GO:0042802; GO:0070320; GO:0044325; GO:0050998; GO:0005113; GO:0016504; GO:0030674; GO:0032947; GO:0046982; GO:0019901; GO:0048365; GO:0005102; GO:0005198","GO:0001525; GO:0086098; GO:0097190; GO:1904886; GO:0055074; GO:0006816; GO:0070836; GO:0072584; GO:0006874; GO:0071360; GO:0071455; GO:0071375; GO:0009267; GO:0071560; GO:0042632; GO:0030301; GO:0000188; GO:0007595; GO:0050900; GO:0019915; GO:0032507; GO:0030879; GO:0060056; GO:0051899; GO:2000811; GO:0030514; GO:0090090; GO:0001960; GO:0001937; GO:0030857; GO:1903609; GO:0046426; GO:0043409; GO:0060546; GO:0045019; GO:0051001; GO:0033137; GO:1900085; GO:0048550; GO:1901380; GO:0032091; GO:0061099; GO:0031397; GO:0000122; GO:0030512; GO:0042532; GO:0033484; GO:0010524; GO:0090263; GO:0043085; GO:0060355; GO:0030335; GO:0120162; GO:1903071; GO:2001238; GO:1903598; GO:0010628; GO:2001244; GO:0033138; GO:0032092; GO:0031398; GO:0034141; GO:0045907; GO:0010608; GO:0051260; GO:0008104; GO:1903361; GO:0044860; GO:0031623; GO:2000286; GO:0019065; GO:0030193; GO:0098909; GO:1901844; GO:0051480; GO:2000535; GO:0019217; GO:0086091; GO:0098903; GO:0050999; GO:0052547; GO:1900027; GO:0006940; GO:0003057; GO:0098911; GO:0009617; GO:0051592; GO:0043627; GO:0001666; GO:0002931; GO:0032570; GO:0007519; GO:0031295; GO:0006641; GO:0001570; GO:0042310; GO:0016050"]
[351,183,"PN217","Caveolin 1","Y14","Caveolin 1",{"v":276.5171055997941,"d":"277"},{"v":250.80058186197732,"d":"251"},{"v":139.15533972972207,"d":"139"},{"v":50.3243151731535,"d":"50"},{"v":62.205990897384154,"d":"62"},{"v":1028.0616081418157,"d":"1028"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the Y14 phosphosite.","Y14 phosphorylation induces activation and interaction with CSK, Grb7, MMP9 and TRAF2. This is one of the major in vivo phosphorylation sites in caveolin 1 (≥845 reports from high throughput mass spectrometry studies).","Abl1, Fyn; InsR; Src","Q03135","Q03135",935,null,"Q03135","NP_001744.2","Block2",2,1,"2, 10, 18, 26",{"$nulls":13},"Adapter/scaffold protein","GO:0002080; GO:0016324; GO:0016323; GO:0005901; GO:0005938; GO:0005929; GO:0031410; GO:0031901; GO:0030666; GO:0005783; GO:0005789; GO:0005768; GO:0005925; GO:0000139; GO:0005887; GO:0005622; GO:0005811; GO:0016020; GO:0045121; GO:0048471; GO:0005886; GO:0032991","GO:0051117; GO:0015485; GO:0019899; GO:0042802; GO:0070320; GO:0044325; GO:0050998; GO:0005113; GO:0016504; GO:0030674; GO:0032947; GO:0046982; GO:0019901; GO:0048365; GO:0005102; GO:0005198","GO:0001525; GO:0086098; GO:0097190; GO:1904886; GO:0055074; GO:0006816; GO:0070836; GO:0072584; GO:0006874; GO:0071360; GO:0071455; GO:0071375; GO:0009267; GO:0071560; GO:0042632; GO:0030301; GO:0000188; GO:0007595; GO:0050900; GO:0019915; GO:0032507; GO:0030879; GO:0060056; GO:0051899; GO:2000811; GO:0030514; GO:0090090; GO:0001960; GO:0001937; GO:0030857; GO:1903609; GO:0046426; GO:0043409; GO:0060546; GO:0045019; GO:0051001; GO:0033137; GO:1900085; GO:0048550; GO:1901380; GO:0032091; GO:0061099; GO:0031397; GO:0000122; GO:0030512; GO:0042532; GO:0033484; GO:0010524; GO:0090263; GO:0043085; GO:0060355; GO:0030335; GO:0120162; GO:1903071; GO:2001238; GO:1903598; GO:0010628; GO:2001244; GO:0033138; GO:0032092; GO:0031398; GO:0034141; GO:0045907; GO:0010608; GO:0051260; GO:0008104; GO:1903361; GO:0044860; GO:0031623; GO:2000286; GO:0019065; GO:0030193; GO:0098909; GO:1901844; GO:0051480; GO:2000535; GO:0019217; GO:0086091; GO:0098903; GO:0050999; GO:0052547; GO:1900027; GO:0006940; GO:0003057; GO:0098911; GO:0009617; GO:0051592; GO:0043627; GO:0001666; GO:0002931; GO:0032570; GO:0007519; GO:0031295; GO:0006641; GO:0001570; GO:0042310; GO:0016050"]
[353,184,"NN022-1","Caveolin 2","Pan-specific","Caveolin 2",{"v":779.871430743074,"d":"780"},{"v":667.4174096268807,"d":"667"},{"v":595.6712972422823,"d":"596"},{"v":76.38070504451191,"d":"76"},{"v":26.558428052180407,"d":"27"},{"v":3358.5468857887413,"d":"3359"},"External","MmAb","Epitope undefined.",{"$nulls":3},"P51636","P51636",3909,null,null,"NP_001224","Block2",2,2,"2, 10, 18, 26",{"$nulls":13},"Adapter/scaffold protein","GO:0002080; GO:0005901; GO:0031410; GO:0031234; GO:0005925; GO:0005794; GO:0000139; GO:0005887; GO:0005622; GO:0016020; GO:0045121; GO:0005634; GO:0048471; GO:0005886; GO:0032991; GO:0030133","GO:0031748; GO:0030674; GO:0032947; GO:0046982; GO:0042803; GO:0019901; GO:0097110","GO:0070836; GO:0007029; GO:0008286; GO:0007005; GO:0001937; GO:0030512; GO:0044794; GO:0044791; GO:0060161; GO:0001938; GO:0043547; GO:0043410; GO:0051259; GO:0019065; GO:0007088; GO:0048741; GO:0048278; GO:0006906; GO:0016050"]
[355,185,"PN018","Caveolin 2","S36","Caveolin 2",{"v":157.82780273188993,"d":"158"},{"v":73.18038498240304,"d":"73"},{"v":229.40128909382653,"d":"229"},{"v":145.34909890592732,"d":"145"},{"v":13.474088414914494,"d":"13"},{"v":1675.4531601133683,"d":"1675"},"External","RpAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the S36 phosphosite.","S36 phosphorylation induces activity. This is one of the minor in vivo phosphorylation sites in caveolin 2 (≥9 reports from high throughput mass spectrometry studies).","CK2a1 (CSNK2A1)","P51636","P51636",3909,null,null,"NP_001224","Block2",2,3,"2, 10, 18, 26",{"$nulls":13},"Adapter/scaffold protein","GO:0002080; GO:0005901; GO:0031410; GO:0031234; GO:0005925; GO:0005794; GO:0000139; GO:0005887; GO:0005622; GO:0016020; GO:0045121; GO:0005634; GO:0048471; GO:0005886; GO:0032991; GO:0030133","GO:0031748; GO:0030674; GO:0032947; GO:0046982; GO:0042803; GO:0019901; GO:0097110","GO:0070836; GO:0007029; GO:0008286; GO:0007005; GO:0001937; GO:0030512; GO:0044794; GO:0044791; GO:0060161; GO:0001938; GO:0043547; GO:0043410; GO:0051259; GO:0019065; GO:0007088; GO:0048741; GO:0048278; GO:0006906; GO:0016050"]
[357,186,"NN171-2","Cbl","Pan-specific","E3 ubiquitin-protein ligase CBL",{"v":536.0640774703513,"d":"536"},{"v":501.2911349513285,"d":"501"},{"v":274.2406857944117,"d":"274"},{"v":51.15819121634381,"d":"51"},{"v":40.372486910028414,"d":"40"},{"v":1637.4767741310125,"d":"1637"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues 892-906 at the C-terminus of human Cbl.",null,null,"P22681","P22681",1435,null,"P22681","NP_005179.2","Block2",2,4,"2, 10, 18, 26",{"$nulls":3},"Ubiquitin protein ligase",{"$nulls":9},"Ubiquitin conjugating system; EC 6.3.2.-; Ligase; Adaptor/scaffold","GO:0005829; GO:0016600; GO:0005925; GO:0030426; GO:0042629; GO:0045121; GO:0048471; GO:0005886","GO:0045296; GO:0005509; GO:0003700; GO:0046875; GO:0005154; GO:0036312; GO:0001784; GO:0030971; GO:0017124; GO:0061630; GO:0004842","GO:0007166; GO:0006974; GO:0071364; GO:1990090; GO:0090650; GO:0036120; GO:0019221; GO:0035635; GO:0007173; GO:0008543; GO:0070102; GO:0008584; GO:0043303; GO:0061024; GO:0043066; GO:0007175; GO:0042059; GO:1901215; GO:0070997; GO:0045742; GO:0014068; GO:0048260; GO:0006513; GO:0000209; GO:0016567; GO:0014823; GO:0045471; GO:0010332; GO:0042594; GO:0033574; GO:0007179; GO:0006511"]
[359,187,"PN743","Cbl","Y674","E3 ubiquitin-protein ligase CBL",{"v":5155.659009152404,"d":"5156"},{"v":4721.887801076107,"d":"4722"},{"v":2607.915916871684,"d":"2608"},{"v":50.583560942298014,"d":"51"},{"v":142.43556167370917,"d":"142"},{"v":12845.927562841778,"d":"12846"},"Kinexus","RpAb","NAI(pY)SLAAC","Corresponds to amino acid residues N671 to A678.","The effect of Y674 phosphorylation is unclear. This is the major in vivo phosphorylation site in Cbl (≥732 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in fish.",null,"P22681","P22681",1435,null,"P22681","NP_005179.2","Block2",2,5,"2, 10, 18, 26",{"$nulls":3},"Ubiquitin protein ligase",{"$nulls":9},"Ubiquitin conjugating system; EC 6.3.2.-; Ligase; Adaptor/scaffold","GO:0005829; GO:0016600; GO:0005925; GO:0030426; GO:0042629; GO:0045121; GO:0048471; GO:0005886","GO:0045296; GO:0005509; GO:0003700; GO:0046875; GO:0005154; GO:0036312; GO:0001784; GO:0030971; GO:0017124; GO:0061630; GO:0004842","GO:0007166; GO:0006974; GO:0071364; GO:1990090; GO:0090650; GO:0036120; GO:0019221; GO:0035635; GO:0007173; GO:0008543; GO:0070102; GO:0008584; GO:0043303; GO:0061024; GO:0043066; GO:0007175; GO:0042059; GO:1901215; GO:0070997; GO:0045742; GO:0014068; GO:0048260; GO:0006513; GO:0000209; GO:0016567; GO:0014823; GO:0045471; GO:0010332; GO:0042594; GO:0033574; GO:0007179; GO:0006511"]
[361,188,"PN171","Cbl","Y700","E3 ubiquitin-protein ligase CBL",{"v":919.8013414269374,"d":"920"},{"v":914.3333781055052,"d":"914"},{"v":539.2092534946744,"d":"539"},{"v":58.622359982446866,"d":"59"},{"v":15.016393533381013,"d":"15"},{"v":3112.6699741700786,"d":"3113"},"External","RpAb","TE(pY)MT","Corresponds to amino acid residues T768 to T772.","Y700 phosphorylation induces interaction with CRK, Src, and VAV1. This is one of the major in vivo phosphorylation sites in Cbl (≥505 reports from high throughput mass spectrometry studies).","Abl1; Fyn; InsR; Lck; Src; Syk; Yes","P22681","P22681",1435,null,"P22681","NP_005179.2","Block2",2,6,"2, 10, 18, 26",{"$nulls":3},"Ubiquitin protein ligase",{"$nulls":9},"Ubiquitin conjugating system; EC 6.3.2.-; Ligase; Adaptor/scaffold","GO:0005829; GO:0016600; GO:0005925; GO:0030426; GO:0042629; GO:0045121; GO:0048471; GO:0005886","GO:0045296; GO:0005509; GO:0003700; GO:0046875; GO:0005154; GO:0036312; GO:0001784; GO:0030971; GO:0017124; GO:0061630; GO:0004842","GO:0007166; GO:0006974; GO:0071364; GO:1990090; GO:0090650; GO:0036120; GO:0019221; GO:0035635; GO:0007173; GO:0008543; GO:0070102; GO:0008584; GO:0043303; GO:0061024; GO:0043066; GO:0007175; GO:0042059; GO:1901215; GO:0070997; GO:0045742; GO:0014068; GO:0048260; GO:0006513; GO:0000209; GO:0016567; GO:0014823; GO:0045471; GO:0010332; GO:0042594; GO:0033574; GO:0007179; GO:0006511"]
[363,189,"PN218","Cbl","Y700","E3 ubiquitin-protein ligase CBL",{"v":116.14322702711435,"d":"116"},{"v":103.66981036162464,"d":"104"},{"v":59.04562244783024,"d":"59"},{"v":50.83862740790358,"d":"51"},{"v":-262.89225962230444,"d":"-263"},{"v":347.6561713459727,"d":"348"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues surrounding the phosphorylated Y700 of human Cbl.","Y700 phosphorylation induces interaction with CRK, Src, and VAV1. This is one of the major in vivo phosphorylation sites in Cbl (≥505 reports from high throughput mass spectrometry studies).","Abl1; Fyn; InsR; Lck; Src; Syk; Yes","P22681","P22681",1435,null,"P22681","NP_005179.2","Block2",2,7,"2, 10, 18, 26",{"$nulls":3},"Ubiquitin protein ligase",{"$nulls":9},"Ubiquitin conjugating system; EC 6.3.2.-; Ligase; Adaptor/scaffold","GO:0005829; GO:0016600; GO:0005925; GO:0030426; GO:0042629; GO:0045121; GO:0048471; GO:0005886","GO:0045296; GO:0005509; GO:0003700; GO:0046875; GO:0005154; GO:0036312; GO:0001784; GO:0030971; GO:0017124; GO:0061630; GO:0004842","GO:0007166; GO:0006974; GO:0071364; GO:1990090; GO:0090650; GO:0036120; GO:0019221; GO:0035635; GO:0007173; GO:0008543; GO:0070102; GO:0008584; GO:0043303; GO:0061024; GO:0043066; GO:0007175; GO:0042059; GO:1901215; GO:0070997; GO:0045742; GO:0014068; GO:0048260; GO:0006513; GO:0000209; GO:0016567; GO:0014823; GO:0045471; GO:0010332; GO:0042594; GO:0033574; GO:0007179; GO:0006511"]
[365,190,"PN744","CBS","S227","Cystathionine beta-synthase",{"v":1293.7239437760718,"d":"1294"},{"v":1295.8614249865586,"d":"1296"},{"v":578.4903513368807,"d":"578"},{"v":44.71513062117451,"d":"45"},{"v":64.32478436218597,"d":"64"},{"v":3073.7532967021452,"d":"3074"},"Kinexus","RpAb","RNA(pS)NPLAC","Corresponds to amino acid residues R224 to A 231.","S227 phosphorylation stimulates enzyme activity. This phosphorylation site has not been detected in high throughput mass spectrometry studies.  in CBS. This human phosphosite is highly conserved in vertebrates and also found in sea urchin.","PKG1","P35520","P35520",1171715,null,null,"NP_000062.1","Block2",2,8,"2, 10, 18, 26",{"$nulls":12},"X",null,"GO:0005737; GO:0005829; GO:0005634","GO:0070025; GO:0004122; GO:0019899; GO:0020037; GO:0042802; GO:0046872; GO:0072341; GO:0070026; GO:0050421; GO:0019825; GO:0042803; GO:0030170; GO:1904047; GO:0031625","GO:0019344; GO:0006535; GO:0019343; GO:0042262; GO:0043418; GO:0050667; GO:0070814; GO:0019448; GO:0006565; GO:0006563; GO:0019346"]
[367,191,"NP001","CD45 (PTPRC; Receptor-type tyrosine-protein phosphatase C)","Pan-specific","Receptor protein-tyrosine phosphatase CD45",{"v":293.8150420955441,"d":"294"},{"v":187.68424617721115,"d":"188"},{"v":290.00049290651174,"d":"290"},{"v":98.70171752888271,"d":"99"},{"v":23.036565654410094,"d":"23"},{"v":1290.7113937966367,"d":"1291"},"External","MmAb","Epitope undefined.",{"$nulls":3},"P08575","P08575",3725,null,null,"NP_002829.3","Block2",2,9,"2, 10, 18, 26",null,null,"PYP","Protein phosphatase - Receptor protein-tyrosine phosphatase",{"$nulls":6},"X",null,null,"EC 3.1.3.48; Receptor protein phosphatase, tyrosine","GO:0009986; GO:0009898; GO:0009897; GO:0070062; GO:0005925; GO:0016021; GO:0005887; GO:0016020; GO:0098857; GO:0045121; GO:0005886; GO:0030667","GO:0043395; GO:0008201; GO:0019901; GO:0004725; GO:0005001","GO:0000187; GO:0030183; GO:0042100; GO:0050853; GO:0048539; GO:0044770; GO:0007166; GO:0031668; GO:0051607; GO:0016311; GO:0002244; GO:0034113; GO:0002378; GO:0007159; GO:0006933; GO:0001960; GO:0070373; GO:0045085; GO:1903979; GO:0031953; GO:0006469; GO:0061099; GO:0001915; GO:0045060; GO:0043312; GO:0044855; GO:0046641; GO:0050857; GO:0030890; GO:0070374; GO:2001238; GO:0045588; GO:2000473; GO:0002925; GO:0045086; GO:0048304; GO:0045860; GO:1903615; GO:2000648; GO:0001916; GO:0042102; GO:0045059; GO:0006470; GO:0045577; GO:0050855; GO:0051726; GO:0051209; GO:0010332; GO:0048864; GO:0030217; GO:0042098; GO:0050852"]
[369,192,"PP527","CD45 (PTPRC; Receptor-type tyrosine-protein phosphatase C)","Y1216","Receptor protein-tyrosine phosphatase CD45",{"v":8776.208969656009,"d":"8776"},{"v":8956.953484622707,"d":"8957"},{"v":2120.817220880813,"d":"2121"},{"v":24.16552782885638,"d":"24"},{"v":606.598682140234,"d":"607"},{"v":15009.117346204039,"d":"15009"},"Kinexus","RpAb","FEQ(pY)QFL(bA)C","Corresponds to amino acid residues F1215 to L1221.","Y1216 phosphorylation stimulates phosphatase activity. Phosphorylation at this site has only be reported in a single mass spectrometry study. This human phosphosite is highly conserved in vertebrates and also found in fish.","CSK","P08575","P08575",3725,null,null,"NP_002829.3","Block2",2,10,"2, 10, 18, 26",null,null,"PYP","Protein phosphatase - Receptor protein-tyrosine phosphatase",{"$nulls":6},"X",null,null,"EC 3.1.3.48; Receptor protein phosphatase, tyrosine","GO:0009986; GO:0009898; GO:0009897; GO:0070062; GO:0005925; GO:0016021; GO:0005887; GO:0016020; GO:0098857; GO:0045121; GO:0005886; GO:0030667","GO:0043395; GO:0008201; GO:0019901; GO:0004725; GO:0005001","GO:0000187; GO:0030183; GO:0042100; GO:0050853; GO:0048539; GO:0044770; GO:0007166; GO:0031668; GO:0051607; GO:0016311; GO:0002244; GO:0034113; GO:0002378; GO:0007159; GO:0006933; GO:0001960; GO:0070373; GO:0045085; GO:1903979; GO:0031953; GO:0006469; GO:0061099; GO:0001915; GO:0045060; GO:0043312; GO:0044855; GO:0046641; GO:0050857; GO:0030890; GO:0070374; GO:2001238; GO:0045588; GO:2000473; GO:0002925; GO:0045086; GO:0048304; GO:0045860; GO:1903615; GO:2000648; GO:0001916; GO:0042102; GO:0045059; GO:0006470; GO:0045577; GO:0050855; GO:0051726; GO:0051209; GO:0010332; GO:0048864; GO:0030217; GO:0042098; GO:0050852"]
[371,193,"NK024","CDC2L5 (CHED, CDK13)","Pan-specific","Cholinesterase-related cell division controller",{"v":222.62472835718492,"d":"223"},{"v":201.0849104841363,"d":"201"},{"v":129.88527909310466,"d":"130"},{"v":58.34270076445116,"d":"58"},{"v":36.569247512252474,"d":"37"},{"v":810.4970285632139,"d":"810"},"External","RpAb","Epitope undefined.",{"$nulls":3},"Q14004","Q14004",2132,"Q14004",null,"NP_003709.3","Block2",2,11,"2, 10, 18, 26","CHED","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CRK7","X",{"$nulls":4},"EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC domain target; CMGC</A> group; CDK family; CRK7 subfamily; CDK/CRK7 subfamily","GO:0005694; GO:0008024; GO:0002945; GO:0005829; GO:0005576; GO:0005615; GO:1904813; GO:0005794; GO:0019908; GO:0016607; GO:0005654","GO:0005524; GO:0030332; GO:0004693; GO:0004672; GO:0019901; GO:0003723; GO:0008353; GO:0008134; GO:0044212","GO:0000380; GO:0030097; GO:0007275; GO:2000737; GO:0043312; GO:0070816; GO:0008284; GO:0045944; GO:0007088; GO:0006368; GO:0016032"]
[373,194,"NK024-2","CDC2L5 (CHED, CDK13)","Pan-specific","CDC2-related protein kinase 5",{"v":1523.703299975795,"d":"1524"},{"v":1419.7166235501588,"d":"1420"},{"v":652.238124299103,"d":"652"},{"v":42.806110895045265,"d":"43"},{"v":435.3348880174194,"d":"435"},{"v":5039.619260982834,"d":"5040"},"Kinexus","RpAb","CGPRYGETKEKDIDWGKR ","Corresponds to amino acid residues C683 to R700; Just before kinase catalytic domain.",null,null,"Q14004","Q14004",2132,"Q14004",null,"NP_003709.3","Block2",2,12,"2, 10, 18, 26","CHED","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CRK7",{"$nulls":5},"EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC domain target; CMGC</A> group; CDK family; CRK7 subfamily; CDK/CRK7 subfamily","GO:0005694; GO:0008024; GO:0002945; GO:0005829; GO:0005576; GO:0005615; GO:1904813; GO:0005794; GO:0019908; GO:0016607; GO:0005654","GO:0005524; GO:0030332; GO:0004693; GO:0004672; GO:0019901; GO:0003723; GO:0008353; GO:0008134; GO:0044212","GO:0000380; GO:0030097; GO:0007275; GO:2000737; GO:0043312; GO:0070816; GO:0008284; GO:0045944; GO:0007088; GO:0006368; GO:0016032"]
[375,195,"PN576","CDC5L","T385","Cell division cycle 5-like protein",{"v":18840.569257385967,"d":"18841"},{"v":18504.422044207015,"d":"18504"},{"v":4382.886399564963,"d":"4383"},{"v":23.263025334793234,"d":"23"},{"v":2051.3660806644803,"d":"2051"},{"v":33294.056338350754,"d":"33294"},"Kinexus","RpAb","CGGLN(pT)PLHE","Corresponds to amino acid residues C381 to E389.","The effect of T385 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in CDC5L (≥66 reports from high throughput mass spectrometry studies).","ERK1 (MAPK3)","Q99459","Q99459",3137,null,null,"NP_001244.1","Block2",2,13,"2, 10, 18, 26",{"$nulls":3},"Transcription protein; RNA processing",{"$nulls":4},"X",{"$nulls":4},"Transcription factor; RNA processing","GO:0071013; GO:0005737; GO:0016020; GO:0016607; GO:0005654; GO:0005634; GO:0048471; GO:0032993; GO:0000974; GO:0071007","GO:0003677; GO:0043522; GO:0019901; GO:0008157; GO:0003723; GO:0000977; GO:0000981; GO:0001135; GO:0043565; GO:0001228; GO:0001222; GO:0044212; GO:0071987","GO:0030154; GO:0044344; GO:0071352; GO:1990090; GO:1990646; GO:1904568; GO:0006281; GO:0000278; GO:0000398; GO:0045944; GO:0006357; GO:0072422"]
[377,196,"PK558","CDC7","T376","Cell division cycle 7-related protein kinase",{"v":11341.810400053208,"d":"11342"},{"v":11292.00484965612,"d":"11292"},{"v":2191.8229332653914,"d":"2192"},{"v":19.325159352470827,"d":"19"},{"v":3499.397692775364,"d":"3499"},{"v":20741.71144258976,"d":"20742"},"Kinexus","RpAb","RAG(pT)PGF(bA)C","Corresponds to amino acid residues R373 to F379; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T376 phosphorylation was originally suggested to be stimulatory based on loss of phosphotransferase activity with an alanine substitution. However, it is predicted to be inhibitory for phosphotransferase activity. This phosphosite is located in the kinase activation loop just before the catalytic subdomain VIII. This is one of the major in vivo phosphorylation sites in CDC7 (≥13 reports from high throughput mass spectrometry studies).","CDK1 (CDC2); CDK2","O00311","O00311",806,"O00311",null,"NP_001127891.1","Block2",3,1,"2, 10, 18, 26","CDC7","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","CDC7",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; CDC7 family","GO:0005737; GO:0045171; GO:0072686; GO:0005654; GO:0005634","GO:0005524; GO:0016301; GO:0046872; GO:0004672; GO:0004674","GO:0044770; GO:0051301; GO:0006260; GO:0006270; GO:0000727; GO:0000082; GO:0070317; GO:0018105; GO:0006909; GO:0008284; GO:0010971; GO:0010571; GO:0008360"]
[379,197,"NK025-6","CDK1 (CDC2)","Pan-specific","Cyclin-dependent protein-serine kinase 1; Cell division control protein 2 homologue",{"v":287.1956243039212,"d":"287"},{"v":227.26004546699676,"d":"227"},{"v":299.5136851559448,"d":"300"},{"v":104.28908374975386,"d":"104"},{"v":35.31875501137773,"d":"35"},{"v":3956.6745324109943,"d":"3957"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues at the C-terminus of human Cdc2 p34.",null,null,"P06493","P06493",582,"P06493","P06493","NP_001777","Block2",3,2,"2, 10, 18, 26","CDK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"EC 2.7.11.23; EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; CDK/CDK1 subfamily; CDK1 subfamily","GO:0005813; GO:0097125; GO:0000307; GO:0005829; GO:0005789; GO:0070062; GO:0016020; GO:0030496; GO:0005759; GO:0005739; GO:0072686; GO:0000784; GO:0005654; GO:0005634; GO:0005876","GO:0005524; GO:0003682; GO:0030332; GO:0097472; GO:0004693; GO:0035173; GO:0030544; GO:0004672; GO:0004674; GO:0008353; GO:0001618","GO:0000187; GO:0031145; GO:0031100; GO:0006915; GO:0007569; GO:0051301; GO:0016477; GO:0008283; GO:0070301; GO:0007098; GO:0030261; GO:0097711; GO:0006977; GO:0006281; GO:0006260; GO:0030855; GO:0000086; GO:0090166; GO:0000226; GO:0007095; GO:0007077; GO:0043066; GO:0018105; GO:0018107; GO:0060045; GO:0045740; GO:0010971; GO:0010628; GO:1905448; GO:0033160; GO:1900182; GO:0007344; GO:0065003; GO:0016579; GO:0034501; GO:0006468; GO:0045995; GO:0010389; GO:0010468; GO:0051445; GO:0014038; GO:0014823; GO:0014075; GO:0048678; GO:0046686; GO:0046688; GO:0045471; GO:0014070; GO:0055015"]
[381,198,"NK025-1","CDK1 (CDC2)","Pan-specific","Cyclin-dependent protein-serine kinase 1; Cell division control protein 2 homologue",{"v":584.4825036046662,"d":"584"},{"v":397.35398594078094,"d":"397"},{"v":554.509970982342,"d":"555"},{"v":94.87195383309589,"d":"95"},{"v":66.87015118076262,"d":"67"},{"v":3853.555390488201,"d":"3854"},"External","MmAb","Epitope undefined.",{"$nulls":3},"P06493","P06493",582,"P06493","P06493","NP_001777","Block2",3,3,"2, 10, 18, 26","CDK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"EC 2.7.11.23; EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; CDK/CDK1 subfamily; CDK1 subfamily","GO:0005813; GO:0097125; GO:0000307; GO:0005829; GO:0005789; GO:0070062; GO:0016020; GO:0030496; GO:0005759; GO:0005739; GO:0072686; GO:0000784; GO:0005654; GO:0005634; GO:0005876","GO:0005524; GO:0003682; GO:0030332; GO:0097472; GO:0004693; GO:0035173; GO:0030544; GO:0004672; GO:0004674; GO:0008353; GO:0001618","GO:0000187; GO:0031145; GO:0031100; GO:0006915; GO:0007569; GO:0051301; GO:0016477; GO:0008283; GO:0070301; GO:0007098; GO:0030261; GO:0097711; GO:0006977; GO:0006281; GO:0006260; GO:0030855; GO:0000086; GO:0090166; GO:0000226; GO:0007095; GO:0007077; GO:0043066; GO:0018105; GO:0018107; GO:0060045; GO:0045740; GO:0010971; GO:0010628; GO:1905448; GO:0033160; GO:1900182; GO:0007344; GO:0065003; GO:0016579; GO:0034501; GO:0006468; GO:0045995; GO:0010389; GO:0010468; GO:0051445; GO:0014038; GO:0014823; GO:0014075; GO:0048678; GO:0046686; GO:0046688; GO:0045471; GO:0014070; GO:0055015"]
[383,199,"NK204","CDK1 (CDC2)","Pan-specific","Cyclin-dependent protein-serine kinase 1; Cell division control protein 2 homologue",{"v":18.86729922200384,"d":"19"},{"v":14.326136886684756,"d":"14"},{"v":13.765830600424307,"d":"14"},{"v":72.96132021042003,"d":"73"},{"v":2.137222910292363,"d":"2"},{"v":94.44164276225375,"d":"94"},"Kinexus","RpAb","EGVPSTAIREISLLKEGGC","Corresponds to amino acid residues E42 to E57; Kinase catalytic subdomain 3.",null,null,"P06493","P06493",582,"P06493","P06493","NP_001777","Block2",3,4,"2, 10, 18, 26","CDK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"EC 2.7.11.23; EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; CDK/CDK1 subfamily; CDK1 subfamily","GO:0005813; GO:0097125; GO:0000307; GO:0005829; GO:0005789; GO:0070062; GO:0016020; GO:0030496; GO:0005759; GO:0005739; GO:0072686; GO:0000784; GO:0005654; GO:0005634; GO:0005876","GO:0005524; GO:0003682; GO:0030332; GO:0097472; GO:0004693; GO:0035173; GO:0030544; GO:0004672; GO:0004674; GO:0008353; GO:0001618","GO:0000187; GO:0031145; GO:0031100; GO:0006915; GO:0007569; GO:0051301; GO:0016477; GO:0008283; GO:0070301; GO:0007098; GO:0030261; GO:0097711; GO:0006977; GO:0006281; GO:0006260; GO:0030855; GO:0000086; GO:0090166; GO:0000226; GO:0007095; GO:0007077; GO:0043066; GO:0018105; GO:0018107; GO:0060045; GO:0045740; GO:0010971; GO:0010628; GO:1905448; GO:0033160; GO:1900182; GO:0007344; GO:0065003; GO:0016579; GO:0034501; GO:0006468; GO:0045995; GO:0010389; GO:0010468; GO:0051445; GO:0014038; GO:0014823; GO:0014075; GO:0048678; GO:0046686; GO:0046688; GO:0045471; GO:0014070; GO:0055015"]
[385,200,"PK559","CDK1 (CDC2)","T14","Cyclin-dependent protein-serine kinase 1; Cell division control protein 2 homologue",{"v":13572.09837136763,"d":"13572"},{"v":13484.885722635354,"d":"13485"},{"v":3441.4050545452947,"d":"3441"},{"v":25.356470019444107,"d":"25"},{"v":1195.1926484601486,"d":"1195"},{"v":26907.767625718792,"d":"26908"},"Kinexus","RpAb","GEG(pT)YGV(bA)C","Corresponds to amino acid residues G11 to V17; In the protein kinase catalytic domain in subdomain I.","T14 phosphorylation inhibits phosphotransferase activity. This phosphosite is located in the kinase subdomain I region, which is involved in binding the phosphates in the ATP substrate. Phosphorylation regulates cell cycle progression. This is one of the major in vivo phosphorylation sites in CDK1 (≥1823 reports from high throughput mass spectrometry studies).","MYT1 (PKMYT1)","P06493","P06493",582,"P06493","P06493","NP_001777","Block2",3,5,"2, 10, 18, 26","CDK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"EC 2.7.11.23; EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; CDK/CDK1 subfamily; CDK1 subfamily","GO:0005813; GO:0097125; GO:0000307; GO:0005829; GO:0005789; GO:0070062; GO:0016020; GO:0030496; GO:0005759; GO:0005739; GO:0072686; GO:0000784; GO:0005654; GO:0005634; GO:0005876","GO:0005524; GO:0003682; GO:0030332; GO:0097472; GO:0004693; GO:0035173; GO:0030544; GO:0004672; GO:0004674; GO:0008353; GO:0001618","GO:0000187; GO:0031145; GO:0031100; GO:0006915; GO:0007569; GO:0051301; GO:0016477; GO:0008283; GO:0070301; GO:0007098; GO:0030261; GO:0097711; GO:0006977; GO:0006281; GO:0006260; GO:0030855; GO:0000086; GO:0090166; GO:0000226; GO:0007095; GO:0007077; GO:0043066; GO:0018105; GO:0018107; GO:0060045; GO:0045740; GO:0010971; GO:0010628; GO:1905448; GO:0033160; GO:1900182; GO:0007344; GO:0065003; GO:0016579; GO:0034501; GO:0006468; GO:0045995; GO:0010389; GO:0010468; GO:0051445; GO:0014038; GO:0014823; GO:0014075; GO:0048678; GO:0046686; GO:0046688; GO:0045471; GO:0014070; GO:0055015"]
[387,201,"PK560","CDK1 (CDC2)","T14+Y15","Cyclin-dependent protein-serine kinase 1; Cell division control protein 2 homologue",{"v":14694.220491255783,"d":"14694"},{"v":14615.775535630455,"d":"14616"},{"v":2594.3237702124256,"d":"2594"},{"v":17.65540248804795,"d":"18"},{"v":8510.583215924402,"d":"8511"},{"v":23195.1305980118,"d":"23195"},"Kinexus","RpAb","EG(pT)(pY)GVV(bA)C","Corresponds to amino acid residues E12 to V18; In the protein kinase catalytic domain in subdomain I.","T14 and Y15 phosphorylation inhibits phosphotransferase activity. These phosphosites are located in the kinase subdomain I region, which is involved in binding the phosphates in the ATP substrate. Phosphorylation regulates cell cycle progression. These are two of the major in vivo phosphorylation sites in CDK1 (≥1823 and ≥3976 reports, respectively, by mass spectrometry).","T14: MYT1 (PKMYT1). Y15: CDK1 (CDC2); Chk1 (CHEK1); MYT1 (PKMYT1); Src; Wee1.","P06493","P06493",582,"P06493","P06493","NP_001777","Block2",3,6,"2, 10, 18, 26","CDK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"EC 2.7.11.23; EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; CDK/CDK1 subfamily; CDK1 subfamily","GO:0005813; GO:0097125; GO:0000307; GO:0005829; GO:0005789; GO:0070062; GO:0016020; GO:0030496; GO:0005759; GO:0005739; GO:0072686; GO:0000784; GO:0005654; GO:0005634; GO:0005876","GO:0005524; GO:0003682; GO:0030332; GO:0097472; GO:0004693; GO:0035173; GO:0030544; GO:0004672; GO:0004674; GO:0008353; GO:0001618","GO:0000187; GO:0031145; GO:0031100; GO:0006915; GO:0007569; GO:0051301; GO:0016477; GO:0008283; GO:0070301; GO:0007098; GO:0030261; GO:0097711; GO:0006977; GO:0006281; GO:0006260; GO:0030855; GO:0000086; GO:0090166; GO:0000226; GO:0007095; GO:0007077; GO:0043066; GO:0018105; GO:0018107; GO:0060045; GO:0045740; GO:0010971; GO:0010628; GO:1905448; GO:0033160; GO:1900182; GO:0007344; GO:0065003; GO:0016579; GO:0034501; GO:0006468; GO:0045995; GO:0010389; GO:0010468; GO:0051445; GO:0014038; GO:0014823; GO:0014075; GO:0048678; GO:0046686; GO:0046688; GO:0045471; GO:0014070; GO:0055015"]
[389,202,"PK007-1","CDK1 (CDC2)","Y15","Cyclin-dependent protein-serine kinase 1; Cell division control protein 2 homologue",{"v":404.4451422250924,"d":"404"},{"v":322.5089734773982,"d":"323"},{"v":320.5554170789982,"d":"321"},{"v":79.25807077702378,"d":"79"},{"v":25.229943758314963,"d":"25"},{"v":1823.989418049548,"d":"1824"},"External","RpAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the Y15 phosphosite.","The effect of Y15 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in CDK1 (≥3976 reports from high throughput mass spectrometry studies).","CDK1 (CDC2); Chk1 (CHEK1); MYT1 (PKMYT1); Src; Wee1","P06493","P06493",582,"P06493","P06493","NP_001777","Block2",3,7,"2, 10, 18, 26","CDK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"EC 2.7.11.23; EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; CDK/CDK1 subfamily; CDK1 subfamily","GO:0005813; GO:0097125; GO:0000307; GO:0005829; GO:0005789; GO:0070062; GO:0016020; GO:0030496; GO:0005759; GO:0005739; GO:0072686; GO:0000784; GO:0005654; GO:0005634; GO:0005876","GO:0005524; GO:0003682; GO:0030332; GO:0097472; GO:0004693; GO:0035173; GO:0030544; GO:0004672; GO:0004674; GO:0008353; GO:0001618","GO:0000187; GO:0031145; GO:0031100; GO:0006915; GO:0007569; GO:0051301; GO:0016477; GO:0008283; GO:0070301; GO:0007098; GO:0030261; GO:0097711; GO:0006977; GO:0006281; GO:0006260; GO:0030855; GO:0000086; GO:0090166; GO:0000226; GO:0007095; GO:0007077; GO:0043066; GO:0018105; GO:0018107; GO:0060045; GO:0045740; GO:0010971; GO:0010628; GO:1905448; GO:0033160; GO:1900182; GO:0007344; GO:0065003; GO:0016579; GO:0034501; GO:0006468; GO:0045995; GO:0010389; GO:0010468; GO:0051445; GO:0014038; GO:0014823; GO:0014075; GO:0048678; GO:0046686; GO:0046688; GO:0045471; GO:0014070; GO:0055015"]
[391,203,"PK008-1","CDK1 (CDC2)","T161","Cyclin-dependent protein-serine kinase 1; Cell division control protein 2 homologue",{"v":1257.5441953576515,"d":"1258"},{"v":932.9916717406812,"d":"933"},{"v":2142.4564001073463,"d":"2142"},{"v":170.36827874649939,"d":"170"},{"v":12.012323935191466,"d":"12"},{"v":18680.218351618434,"d":"18680"},"External","RpAb","TY(pT)HE","Corresponds to amino acid residues T159 to E163.","T161 phosphorylation stimulates phosphotransferase activity and protein interaction. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation regulates cell cycle progression, cell growth and molecular association. This is one of the major in vivo phosphorylation sites in CDK1 (≥122 reports from high throughput mass spectrometry studies).","CDK7","P06493","P06493",582,"P06493","P06493","NP_001777","Block2",3,8,"2, 10, 18, 26","CDK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"EC 2.7.11.23; EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; CDK/CDK1 subfamily; CDK1 subfamily","GO:0005813; GO:0097125; GO:0000307; GO:0005829; GO:0005789; GO:0070062; GO:0016020; GO:0030496; GO:0005759; GO:0005739; GO:0072686; GO:0000784; GO:0005654; GO:0005634; GO:0005876","GO:0005524; GO:0003682; GO:0030332; GO:0097472; GO:0004693; GO:0035173; GO:0030544; GO:0004672; GO:0004674; GO:0008353; GO:0001618","GO:0000187; GO:0031145; GO:0031100; GO:0006915; GO:0007569; GO:0051301; GO:0016477; GO:0008283; GO:0070301; GO:0007098; GO:0030261; GO:0097711; GO:0006977; GO:0006281; GO:0006260; GO:0030855; GO:0000086; GO:0090166; GO:0000226; GO:0007095; GO:0007077; GO:0043066; GO:0018105; GO:0018107; GO:0060045; GO:0045740; GO:0010971; GO:0010628; GO:1905448; GO:0033160; GO:1900182; GO:0007344; GO:0065003; GO:0016579; GO:0034501; GO:0006468; GO:0045995; GO:0010389; GO:0010468; GO:0051445; GO:0014038; GO:0014823; GO:0014075; GO:0048678; GO:0046686; GO:0046688; GO:0045471; GO:0014070; GO:0055015"]
[393,204,"PK561","CDK1 (CDC2)","T161","Cyclin-dependent protein-serine kinase 1; Cell division control protein 2 homologue",{"v":16911.87825943698,"d":"16912"},{"v":16551.74657119177,"d":"16552"},{"v":4527.423028794013,"d":"4527"},{"v":26.77066946285325,"d":"27"},{"v":149.02487458525587,"d":"149"},{"v":30363.606646968692,"d":"30364"},"Kinexus","RpAb","RVY(pT)HEV(bA)C","Corresponds to amino acid residues R158 to V164; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T161 phosphorylation stimulates phosphotransferase activity and protein interaction. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation regulates cell cycle progression, cell growth and molecular association. This is one of the major in vivo phosphorylation sites in CDK1 (≥122 reports from high throughput mass spectrometry studies).","CDK7","P06493","P06493",582,"P06493","P06493","NP_001777","Block2",3,9,"2, 10, 18, 26","CDK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"EC 2.7.11.23; EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; CDK/CDK1 subfamily; CDK1 subfamily","GO:0005813; GO:0097125; GO:0000307; GO:0005829; GO:0005789; GO:0070062; GO:0016020; GO:0030496; GO:0005759; GO:0005739; GO:0072686; GO:0000784; GO:0005654; GO:0005634; GO:0005876","GO:0005524; GO:0003682; GO:0030332; GO:0097472; GO:0004693; GO:0035173; GO:0030544; GO:0004672; GO:0004674; GO:0008353; GO:0001618","GO:0000187; GO:0031145; GO:0031100; GO:0006915; GO:0007569; GO:0051301; GO:0016477; GO:0008283; GO:0070301; GO:0007098; GO:0030261; GO:0097711; GO:0006977; GO:0006281; GO:0006260; GO:0030855; GO:0000086; GO:0090166; GO:0000226; GO:0007095; GO:0007077; GO:0043066; GO:0018105; GO:0018107; GO:0060045; GO:0045740; GO:0010971; GO:0010628; GO:1905448; GO:0033160; GO:1900182; GO:0007344; GO:0065003; GO:0016579; GO:0034501; GO:0006468; GO:0045995; GO:0010389; GO:0010468; GO:0051445; GO:0014038; GO:0014823; GO:0014075; GO:0048678; GO:0046686; GO:0046688; GO:0045471; GO:0014070; GO:0055015"]
[395,205,"NK026-6","CDK2","Pan-specific","Cyclin-dependent protein-serine kinase 2",{"v":796.2106580047573,"d":"796"},{"v":461.62852719592814,"d":"462"},{"v":1720.32142979297,"d":"1720"},{"v":216.06360232654552,"d":"216"},{"v":184.44201406431188,"d":"184"},{"v":16490.68452341076,"d":"16491"},"External","RpAb","Epitope undefined.",{"$nulls":3},"P24941","P24941",583,"P24941","P24941","NP_001789.2","Block2",3,10,"2, 10, 18, 26","CDK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; CDK1 subfamily; CDK/CDK1 subfamily","GO:0015030; GO:0005813; GO:0000781; GO:0000793; GO:0097123; GO:0097124; GO:0000307; GO:0097134; GO:0097135; GO:0005737; GO:0005829; GO:0005768; GO:0005654; GO:0005634; GO:0005667; GO:0000805; GO:0000806","GO:0005524; GO:0030332; GO:0097472; GO:0004693; GO:0000287; GO:0019904; GO:0004674","GO:0031145; GO:0051301; GO:0071732; GO:0007099; GO:0051298; GO:0006977; GO:0006281; GO:0006260; GO:0000082; GO:0000086; GO:0016572; GO:0051321; GO:0031571; GO:0007275; GO:0000122; GO:0018105; GO:0008284; GO:0032298; GO:0045893; GO:0006813; GO:0006468; GO:0007265; GO:0010389; GO:0060968; GO:1901796; GO:0010033"]
[397,206,"NK026-3","CDK2","Pan-specific","Cyclin-dependent protein-serine kinase 2",{"v":637.6275760889528,"d":"638"},{"v":279.2311010323101,"d":"279"},{"v":1772.4731699759775,"d":"1772"},{"v":277.97937800116523,"d":"278"},{"v":23.89194899424689,"d":"24"},{"v":16889.05568929489,"d":"16889"},"External","MmAb","Epitope undefined.",{"$nulls":3},"P24941","P24941",583,"P24941","P24941","NP_001789.2","Block2",3,11,"2, 10, 18, 26","CDK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; CDK1 subfamily; CDK/CDK1 subfamily","GO:0015030; GO:0005813; GO:0000781; GO:0000793; GO:0097123; GO:0097124; GO:0000307; GO:0097134; GO:0097135; GO:0005737; GO:0005829; GO:0005768; GO:0005654; GO:0005634; GO:0005667; GO:0000805; GO:0000806","GO:0005524; GO:0030332; GO:0097472; GO:0004693; GO:0000287; GO:0019904; GO:0004674","GO:0031145; GO:0051301; GO:0071732; GO:0007099; GO:0051298; GO:0006977; GO:0006281; GO:0006260; GO:0000082; GO:0000086; GO:0016572; GO:0051321; GO:0031571; GO:0007275; GO:0000122; GO:0018105; GO:0008284; GO:0032298; GO:0045893; GO:0006813; GO:0006468; GO:0007265; GO:0010389; GO:0060968; GO:1901796; GO:0010033"]
[399,207,"PK568","CDK2","T160","Cyclin-dependent protein-serine kinase 2",{"v":8214.12110723945,"d":"8214"},{"v":8040.1672190529725,"d":"8040"},{"v":2112.295594343046,"d":"2112"},{"v":25.715418201971612,"d":"26"},{"v":3443.9204296552034,"d":"3444"},{"v":17052.248468127174,"d":"17052"},"Kinexus","RpAb","RTY(pT)HEV(bA)C","Corresponds to amino acid residues R157 to V163; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T160 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in CDK2 (≥267 reports from high throughput mass spectrometry studies).","CCRK (CDK20); CDK2; CDK7; ERK1 (MAPK3); ERK2 (MAPK1)","P24941","P24941",583,"P24941","P24941","NP_001789.2","Block2",3,12,"2, 10, 18, 26","CDK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDC2",{"$nulls":5},"EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; CDK1 subfamily; CDK/CDK1 subfamily","GO:0015030; GO:0005813; GO:0000781; GO:0000793; GO:0097123; GO:0097124; GO:0000307; GO:0097134; GO:0097135; GO:0005737; GO:0005829; GO:0005768; GO:0005654; GO:0005634; GO:0005667; GO:0000805; GO:0000806","GO:0005524; GO:0030332; GO:0097472; GO:0004693; GO:0000287; GO:0019904; GO:0004674","GO:0031145; GO:0051301; GO:0071732; GO:0007099; GO:0051298; GO:0006977; GO:0006281; GO:0006260; GO:0000082; GO:0000086; GO:0016572; GO:0051321; GO:0031571; GO:0007275; GO:0000122; GO:0018105; GO:0008284; GO:0032298; GO:0045893; GO:0006813; GO:0006468; GO:0007265; GO:0010389; GO:0060968; GO:1901796; GO:0010033"]
[401,208,"NK027-2","CDK4","Pan-specific","Cyclin-dependent protein-serine kinase 4",{"v":466.623715430352,"d":"467"},{"v":280.2574092980102,"d":"280"},{"v":1000.2159991203723,"d":"1000"},{"v":214.35172839380985,"d":"214"},{"v":69.98407298002465,"d":"70"},{"v":9260.219632008715,"d":"9260"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues at the C-terminus of human CDK4.",null,null,"P11802","P11802",584,"P11802","P11802","NP_000066","Block2",3,13,"2, 10, 18, 26","CDK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK4",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.22; CMGC group; CDK family; CDK4 subfamily; CDK/CDK4 subfamily","GO:0005923; GO:0000785; GO:0097129; GO:0000307; GO:0005829; GO:0031965; GO:0005730; GO:0005654; GO:0005634; GO:0048471; GO:0005667","GO:0005524; GO:0030332; GO:0004693; GO:0016538; GO:0044877","GO:0060612; GO:0031100; GO:0051301; GO:0032869; GO:0071353; GO:1904637; GO:0071222; GO:1904628; GO:0007623; GO:0000082; GO:0002088; GO:0007275; GO:0071157; GO:0031658; GO:0043065; GO:0045787; GO:0008284; GO:0045793; GO:0048146; GO:0010971; GO:0045727; GO:0006468; GO:0010468; GO:0046626; GO:0046890; GO:0050994; GO:0040014; GO:0042493; GO:0055093; GO:0010288; GO:0010033; GO:0033574; GO:0009636; GO:0007165; GO:0006367"]
[403,209,"PK569","CDK4","T172","Cyclin-dependent protein-serine kinase 4",{"v":19021.323865468414,"d":"19021"},{"v":17983.734253211118,"d":"17984"},{"v":4936.152695229438,"d":"4936"},{"v":25.950626413499016,"d":"26"},{"v":10198.664983964123,"d":"10199"},{"v":33374.53548568308,"d":"33375"},"Kinexus","RpAb","MAL(pT)PVV(bA)C","Corresponds to amino acid residues M169 to V175; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T172 stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in CDK4 (≥5 reports from high throughput mass spectrometry studies).","CDK7; JNK1; JNK2","P11802","P11802",584,"P11802","P11802","NP_000066","Block2",4,1,"2, 10, 18, 26","CDK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK4",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.22; CMGC group; CDK family; CDK4 subfamily; CDK/CDK4 subfamily","GO:0005923; GO:0000785; GO:0097129; GO:0000307; GO:0005829; GO:0031965; GO:0005730; GO:0005654; GO:0005634; GO:0048471; GO:0005667","GO:0005524; GO:0030332; GO:0004693; GO:0016538; GO:0044877","GO:0060612; GO:0031100; GO:0051301; GO:0032869; GO:0071353; GO:1904637; GO:0071222; GO:1904628; GO:0007623; GO:0000082; GO:0002088; GO:0007275; GO:0071157; GO:0031658; GO:0043065; GO:0045787; GO:0008284; GO:0045793; GO:0048146; GO:0010971; GO:0045727; GO:0006468; GO:0010468; GO:0046626; GO:0046890; GO:0050994; GO:0040014; GO:0042493; GO:0055093; GO:0010288; GO:0010033; GO:0033574; GO:0009636; GO:0007165; GO:0006367"]
[405,210,"NK028-4","CDK5","Pan-specific","Cyclin-dependent protein-serine kinase 5",{"v":506.33596678003585,"d":"506"},{"v":301.7439204857978,"d":"302"},{"v":1064.2712034096642,"d":"1064"},{"v":210.19071787013868,"d":"210"},{"v":80.66875380536443,"d":"81"},{"v":9668.841728528338,"d":"9669"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues 142-171 of human CDK5.",null,null,"Q00535","Q00535",585,"Q00535","Q00535","NP_004926","Block2",4,2,"2, 10, 18, 26","CDK5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK5",{"$nulls":5},"Protein-serine kinase, CMGC group, CDK family, CDK5 subfamily","GO:0030424; GO:0030054; GO:0005737; GO:0005829; GO:0030425; GO:0030175; GO:0098978; GO:0030426; GO:0030027; GO:0016020; GO:0005874; GO:0031594; GO:0043025; GO:0043005; GO:0005654; GO:0005634; GO:0043204; GO:0005886; GO:0014069; GO:0045211; GO:0098793; GO:0016533; GO:0098685","GO:0030549; GO:0005524; GO:0004693; GO:0008092; GO:0046875; GO:0005176; GO:0043125; GO:0051879; GO:0016301; GO:0002039; GO:0004672; GO:0019901; GO:0004674; GO:0050321","GO:0048675; GO:0048148; GO:0070509; GO:0007049; GO:0051301; GO:0007160; GO:0008283; GO:1904646; GO:0021954; GO:0021697; GO:0007268; GO:0022038; GO:0030866; GO:0048813; GO:0060079; GO:0021766; GO:0006886; GO:0021819; GO:0000226; GO:0007005; GO:0008045; GO:0030517; GO:0045786; GO:1901215; GO:0046826; GO:0031397; GO:0045861; GO:0031914; GO:0045892; GO:0051402; GO:0030182; GO:0001764; GO:0031175; GO:0006913; GO:0048709; GO:0018105; GO:0018107; GO:0016310; GO:2000251; GO:0045956; GO:0034352; GO:0043525; GO:0032092; GO:0045860; GO:0090314; GO:0046777; GO:0035418; GO:0006468; GO:0032801; GO:0043113; GO:0042981; GO:0071156; GO:0030334; GO:0061001; GO:0016241; GO:1903076; GO:0048167; GO:0051966; GO:1903421; GO:0009611; GO:0048511; GO:0014044; GO:0019233; GO:0042501; GO:0007519; GO:0007416; GO:0098883; GO:0001963; GO:0035249; GO:0048488; GO:0016079; GO:0008542"]
[407,211,"NK028-5","CDK5","Pan-specific","Cyclin-dependent protein-serine kinase 5",{"v":276.45691491191303,"d":"276"},{"v":227.49334012377727,"d":"227"},{"v":193.9721763006852,"d":"194"},{"v":70.1636189358802,"d":"70"},{"v":64.03081965034119,"d":"64"},{"v":1647.0922898383167,"d":"1647"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 1-291 representing full length human CDK5.",null,null,"Q00535","Q00535",585,"Q00535","Q00535","NP_004926","Block2",4,3,"2, 10, 18, 26","CDK5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK5",{"$nulls":5},"Protein-serine kinase, CMGC group, CDK family, CDK5 subfamily","GO:0030424; GO:0030054; GO:0005737; GO:0005829; GO:0030425; GO:0030175; GO:0098978; GO:0030426; GO:0030027; GO:0016020; GO:0005874; GO:0031594; GO:0043025; GO:0043005; GO:0005654; GO:0005634; GO:0043204; GO:0005886; GO:0014069; GO:0045211; GO:0098793; GO:0016533; GO:0098685","GO:0030549; GO:0005524; GO:0004693; GO:0008092; GO:0046875; GO:0005176; GO:0043125; GO:0051879; GO:0016301; GO:0002039; GO:0004672; GO:0019901; GO:0004674; GO:0050321","GO:0048675; GO:0048148; GO:0070509; GO:0007049; GO:0051301; GO:0007160; GO:0008283; GO:1904646; GO:0021954; GO:0021697; GO:0007268; GO:0022038; GO:0030866; GO:0048813; GO:0060079; GO:0021766; GO:0006886; GO:0021819; GO:0000226; GO:0007005; GO:0008045; GO:0030517; GO:0045786; GO:1901215; GO:0046826; GO:0031397; GO:0045861; GO:0031914; GO:0045892; GO:0051402; GO:0030182; GO:0001764; GO:0031175; GO:0006913; GO:0048709; GO:0018105; GO:0018107; GO:0016310; GO:2000251; GO:0045956; GO:0034352; GO:0043525; GO:0032092; GO:0045860; GO:0090314; GO:0046777; GO:0035418; GO:0006468; GO:0032801; GO:0043113; GO:0042981; GO:0071156; GO:0030334; GO:0061001; GO:0016241; GO:1903076; GO:0048167; GO:0051966; GO:1903421; GO:0009611; GO:0048511; GO:0014044; GO:0019233; GO:0042501; GO:0007519; GO:0007416; GO:0098883; GO:0001963; GO:0035249; GO:0048488; GO:0016079; GO:0008542"]
[409,212,"PK570","CDK5","Y15","Cyclin-dependent protein-serine kinase 5",{"v":6036.846238088372,"d":"6037"},{"v":6100.474365881057,"d":"6100"},{"v":1937.1139711806793,"d":"1937"},{"v":32.08817807812985,"d":"32"},{"v":239.89554331844863,"d":"240"},{"v":11471.19603531629,"d":"11471"},"Kinexus","RpAb","EGT(pY)GTV(bA)C","Corresponds to amino acid residues E12 to V18; In the protein kinase catalytic domain in subdomain I.","Y15 phosphorylation inhibits phosphotransferase activity. This is the major in vivo phosphorylation site in CDK5 (≥915 reports from high throughput mass spectrometry studies).","Abl1; EphA4; Fyn; TrkA (NTRK1)","Q00535","Q00535",585,"Q00535","Q00535","NP_004926","Block2",4,4,"2, 10, 18, 26","CDK5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK5",{"$nulls":5},"Protein-serine kinase, CMGC group, CDK family, CDK5 subfamily","GO:0030424; GO:0030054; GO:0005737; GO:0005829; GO:0030425; GO:0030175; GO:0098978; GO:0030426; GO:0030027; GO:0016020; GO:0005874; GO:0031594; GO:0043025; GO:0043005; GO:0005654; GO:0005634; GO:0043204; GO:0005886; GO:0014069; GO:0045211; GO:0098793; GO:0016533; GO:0098685","GO:0030549; GO:0005524; GO:0004693; GO:0008092; GO:0046875; GO:0005176; GO:0043125; GO:0051879; GO:0016301; GO:0002039; GO:0004672; GO:0019901; GO:0004674; GO:0050321","GO:0048675; GO:0048148; GO:0070509; GO:0007049; GO:0051301; GO:0007160; GO:0008283; GO:1904646; GO:0021954; GO:0021697; GO:0007268; GO:0022038; GO:0030866; GO:0048813; GO:0060079; GO:0021766; GO:0006886; GO:0021819; GO:0000226; GO:0007005; GO:0008045; GO:0030517; GO:0045786; GO:1901215; GO:0046826; GO:0031397; GO:0045861; GO:0031914; GO:0045892; GO:0051402; GO:0030182; GO:0001764; GO:0031175; GO:0006913; GO:0048709; GO:0018105; GO:0018107; GO:0016310; GO:2000251; GO:0045956; GO:0034352; GO:0043525; GO:0032092; GO:0045860; GO:0090314; GO:0046777; GO:0035418; GO:0006468; GO:0032801; GO:0043113; GO:0042981; GO:0071156; GO:0030334; GO:0061001; GO:0016241; GO:1903076; GO:0048167; GO:0051966; GO:1903421; GO:0009611; GO:0048511; GO:0014044; GO:0019233; GO:0042501; GO:0007519; GO:0007416; GO:0098883; GO:0001963; GO:0035249; GO:0048488; GO:0016079; GO:0008542"]
[411,213,"PK179","CDK5","S159","Cyclin-dependent protein-serine kinase 5",{"v":513.4148577756973,"d":"513"},{"v":376.0317672210922,"d":"376"},{"v":850.5928871978616,"d":"851"},{"v":165.6736018281481,"d":"166"},{"v":89.4941272088372,"d":"89"},{"v":8210.890379961535,"d":"8211"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 142-171 of CDK5 with phosphorylated S159.","S159 phosphorylation stimulates phosphotransferase activity. Phosphorylation of this site in CDK5 has apparently not been detected in high throughput mass spectrometry studies).","CDK7; CK1a1 (CSNK1A1)","Q00535","Q00535",585,"Q00535","Q00535","NP_004926","Block2",4,5,"2, 10, 18, 26","CDK5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK5",{"$nulls":5},"Protein-serine kinase, CMGC group, CDK family, CDK5 subfamily","GO:0030424; GO:0030054; GO:0005737; GO:0005829; GO:0030425; GO:0030175; GO:0098978; GO:0030426; GO:0030027; GO:0016020; GO:0005874; GO:0031594; GO:0043025; GO:0043005; GO:0005654; GO:0005634; GO:0043204; GO:0005886; GO:0014069; GO:0045211; GO:0098793; GO:0016533; GO:0098685","GO:0030549; GO:0005524; GO:0004693; GO:0008092; GO:0046875; GO:0005176; GO:0043125; GO:0051879; GO:0016301; GO:0002039; GO:0004672; GO:0019901; GO:0004674; GO:0050321","GO:0048675; GO:0048148; GO:0070509; GO:0007049; GO:0051301; GO:0007160; GO:0008283; GO:1904646; GO:0021954; GO:0021697; GO:0007268; GO:0022038; GO:0030866; GO:0048813; GO:0060079; GO:0021766; GO:0006886; GO:0021819; GO:0000226; GO:0007005; GO:0008045; GO:0030517; GO:0045786; GO:1901215; GO:0046826; GO:0031397; GO:0045861; GO:0031914; GO:0045892; GO:0051402; GO:0030182; GO:0001764; GO:0031175; GO:0006913; GO:0048709; GO:0018105; GO:0018107; GO:0016310; GO:2000251; GO:0045956; GO:0034352; GO:0043525; GO:0032092; GO:0045860; GO:0090314; GO:0046777; GO:0035418; GO:0006468; GO:0032801; GO:0043113; GO:0042981; GO:0071156; GO:0030334; GO:0061001; GO:0016241; GO:1903076; GO:0048167; GO:0051966; GO:1903421; GO:0009611; GO:0048511; GO:0014044; GO:0019233; GO:0042501; GO:0007519; GO:0007416; GO:0098883; GO:0001963; GO:0035249; GO:0048488; GO:0016079; GO:0008542"]
[413,214,"NK029-3","CDK6","Pan-specific","Cyclin-dependent protein-serine kinase 6",{"v":655.5809309127922,"d":"656"},{"v":584.1140639892961,"d":"584"},{"v":312.0290691091911,"d":"312"},{"v":47.59581226298639,"d":"48"},{"v":87.6775396506647,"d":"88"},{"v":1929.94156631819,"d":"1930"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues at the C-terminus of human CDK6.",null,null,"Q00534","Q00534",679,"Q00534","Q00534","NP_001250","Block2",4,6,"2, 10, 18, 26","CDK6","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK4",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.22; CMGC domain target; CMGC</A> group; CDK family; CDK4 subfamily; CDK/CDK4 subfamily","GO:0005813; GO:0000307; GO:0005737; GO:0005829; GO:0005654; GO:0005634; GO:0001726","GO:0005524; GO:0030332; GO:0004693; GO:0098770","GO:0014002; GO:0007050; GO:0043697; GO:0051301; GO:0021542; GO:0000082; GO:0048699; GO:0042063; GO:0021670; GO:0045786; GO:0045596; GO:0008285; GO:2000773; GO:0031658; GO:0050680; GO:0045656; GO:0045638; GO:0045668; GO:0001954; GO:0048146; GO:0006468; GO:2000145; GO:0045646; GO:0010389; GO:0010468; GO:0009615; GO:0007165; GO:0003323"]
[415,215,"NK029-4","CDK6","Pan-specific","Cyclin-dependent protein-serine kinase 6",{"v":424.33320561756216,"d":"424"},{"v":103.26730339045329,"d":"103"},{"v":2122.6931014031775,"d":"2123"},{"v":500.2420440591897,"d":"500"},{"v":28.522208501871773,"d":"29"},{"v":19081.13808803699,"d":"19081"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 1-326 representing full length human CDK6.",null,null,"Q00534","Q00534",679,"Q00534","Q00534","NP_001250","Block2",4,7,"2, 10, 18, 26","CDK6","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK4",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.22; CMGC domain target; CMGC</A> group; CDK family; CDK4 subfamily; CDK/CDK4 subfamily","GO:0005813; GO:0000307; GO:0005737; GO:0005829; GO:0005654; GO:0005634; GO:0001726","GO:0005524; GO:0030332; GO:0004693; GO:0098770","GO:0014002; GO:0007050; GO:0043697; GO:0051301; GO:0021542; GO:0000082; GO:0048699; GO:0042063; GO:0021670; GO:0045786; GO:0045596; GO:0008285; GO:2000773; GO:0031658; GO:0050680; GO:0045656; GO:0045638; GO:0045668; GO:0001954; GO:0048146; GO:0006468; GO:2000145; GO:0045646; GO:0010389; GO:0010468; GO:0009615; GO:0007165; GO:0003323"]
[417,216,"PK571","CDK6","Y13","Cyclin-dependent protein-serine kinase 6",{"v":10938.247493673669,"d":"10938"},{"v":10984.685655580883,"d":"10985"},{"v":2114.873500438805,"d":"2115"},{"v":19.334664914667364,"d":"19"},{"v":121.55206343249957,"d":"122"},{"v":17420.101776311792,"d":"17420"},"Kinexus","RpAb","DQQ(pY)ECV(bA)C","Corresponds to amino acid residues D10 to V16; In the protein kinase catalytic domain in subdomain I.","Y13 phosphorylation inhibits phosphotransferase activity. This is the major in vivo phosphorylation site in CDK6(≥288 reports from high throughput mass spectrometry studies).",null,"Q00534","Q00534",679,"Q00534","Q00534","NP_001250","Block2",4,8,"2, 10, 18, 26","CDK6","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK4",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.22; CMGC domain target; CMGC</A> group; CDK family; CDK4 subfamily; CDK/CDK4 subfamily","GO:0005813; GO:0000307; GO:0005737; GO:0005829; GO:0005654; GO:0005634; GO:0001726","GO:0005524; GO:0030332; GO:0004693; GO:0098770","GO:0014002; GO:0007050; GO:0043697; GO:0051301; GO:0021542; GO:0000082; GO:0048699; GO:0042063; GO:0021670; GO:0045786; GO:0045596; GO:0008285; GO:2000773; GO:0031658; GO:0050680; GO:0045656; GO:0045638; GO:0045668; GO:0001954; GO:0048146; GO:0006468; GO:2000145; GO:0045646; GO:0010389; GO:0010468; GO:0009615; GO:0007165; GO:0003323"]
[419,217,"PK572","CDK6","Y24","Cyclin-dependent protein-serine kinase 6",{"v":5746.505777504981,"d":"5747"},{"v":5666.538349715639,"d":"5667"},{"v":1347.8167253721776,"d":"1348"},{"v":23.45454398824903,"d":"23"},{"v":109.85981214086078,"d":"110"},{"v":9975.813128532402,"d":"9976"},"Kinexus","RpAb","EGA(pY)GKV(bA)C","Corresponds to amino acid residues E21 to V27; In the protein kinase catalytic domain in subdomain I.","Y24 phosphorylation is predicted to be inhibitory for phosphotransferase activity. This phosphosite is located in the kinase subdomain I region, which is involved in binding the phosphates in the ATP substrate. This is one of the major in vivo phosphorylation sites in CDK6 (≥243 reports from high throughput mass spectrometry studies).",null,"Q00534","Q00534",679,"Q00534","Q00534","NP_001250","Block2",4,9,"2, 10, 18, 26","CDK6","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK4",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.22; CMGC domain target; CMGC</A> group; CDK family; CDK4 subfamily; CDK/CDK4 subfamily","GO:0005813; GO:0000307; GO:0005737; GO:0005829; GO:0005654; GO:0005634; GO:0001726","GO:0005524; GO:0030332; GO:0004693; GO:0098770","GO:0014002; GO:0007050; GO:0043697; GO:0051301; GO:0021542; GO:0000082; GO:0048699; GO:0042063; GO:0021670; GO:0045786; GO:0045596; GO:0008285; GO:2000773; GO:0031658; GO:0050680; GO:0045656; GO:0045638; GO:0045668; GO:0001954; GO:0048146; GO:0006468; GO:2000145; GO:0045646; GO:0010389; GO:0010468; GO:0009615; GO:0007165; GO:0003323"]
[421,218,"NK030-2","CDK7","Pan-specific","Cyclin-dependent protein-serine kinase 7",{"v":1509.45671184949,"d":"1509"},{"v":1285.8165369090902,"d":"1286"},{"v":805.3474613240927,"d":"805"},{"v":53.35346519061985,"d":"53"},{"v":140.83801010310532,"d":"141"},{"v":4760.579806026583,"d":"4761"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 1-346 representing full length CDK7.",null,null,"P50613","P50613",578,"P50613","P50613","NP_001790","Block2",4,10,"2, 10, 18, 26","CDK7","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK7",{"$nulls":5},"Protein-serine kinase, CMGC group, CDK family, CDK7 subfamily","GO:0019907; GO:0005737; GO:0005675; GO:0005654; GO:0005634; GO:0048471; GO:0070985","GO:0050681; GO:0005524; GO:0004693; GO:0008094; GO:0016301; GO:0008022; GO:0004672; GO:0004674; GO:0008353; GO:0003713","GO:0006370; GO:0030521; GO:0007050; GO:0051301; GO:0008283; GO:0006294; GO:0045893; GO:0045944; GO:0050821; GO:0000079; GO:0042795; GO:0006363; GO:0006366; GO:0006283; GO:0006368; GO:0006367; GO:0006361"]
[423,219,"NK030-1","CDK7","Pan-specific","Cyclin-dependent protein-serine kinase 7",{"v":770.5091156080614,"d":"771"},{"v":664.6674343598663,"d":"665"},{"v":729.9364715007617,"d":"730"},{"v":94.73430705939397,"d":"95"},{"v":78.19512406593434,"d":"78"},{"v":7129.89125965278,"d":"7130"},"Kinexus","RpAb","VATKRKRAEALEQGC","Corresponds to amino acid residues V325 to Q338; Pre-C-terminus.",null,null,"P50613","P50613",578,"P50613","P50613","NP_001790","Block2",4,11,"2, 10, 18, 26","CDK7","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK7",{"$nulls":5},"Protein-serine kinase, CMGC group, CDK family, CDK7 subfamily","GO:0019907; GO:0005737; GO:0005675; GO:0005654; GO:0005634; GO:0048471; GO:0070985","GO:0050681; GO:0005524; GO:0004693; GO:0008094; GO:0016301; GO:0008022; GO:0004672; GO:0004674; GO:0008353; GO:0003713","GO:0006370; GO:0030521; GO:0007050; GO:0051301; GO:0008283; GO:0006294; GO:0045893; GO:0045944; GO:0050821; GO:0000079; GO:0042795; GO:0006363; GO:0006366; GO:0006283; GO:0006368; GO:0006367; GO:0006361"]
[425,220,"PK573","CDK7","T170","Cyclin-dependent protein-serine kinase 7",{"v":7973.85951682484,"d":"7974"},{"v":7846.4990706681765,"d":"7846"},{"v":1935.1959175459592,"d":"1935"},{"v":24.26925021017359,"d":"24"},{"v":243.4659732610412,"d":"243"},{"v":13815.638304618089,"d":"13816"},"Kinexus","RpAb","RAY(pT)HQV(bA)C","Corresponds to amino acid residues R167 to V173; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T170 phosphorylation stimulates phosphotransferase activity and regulates transcription. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation site in CDK7 (≥152 reports from high throughput mass spectrometry studies).","CDK1 (CDC2); CDK2; PKCi","P50613","P50613",578,"P50613","P50613","NP_001790","Block2",4,12,"2, 10, 18, 26","CDK7","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK7",{"$nulls":5},"Protein-serine kinase, CMGC group, CDK family, CDK7 subfamily","GO:0019907; GO:0005737; GO:0005675; GO:0005654; GO:0005634; GO:0048471; GO:0070985","GO:0050681; GO:0005524; GO:0004693; GO:0008094; GO:0016301; GO:0008022; GO:0004672; GO:0004674; GO:0008353; GO:0003713","GO:0006370; GO:0030521; GO:0007050; GO:0051301; GO:0008283; GO:0006294; GO:0045893; GO:0045944; GO:0050821; GO:0000079; GO:0042795; GO:0006363; GO:0006366; GO:0006283; GO:0006368; GO:0006367; GO:0006361"]
[427,221,"NK031-5","CDK8","Pan-specific","Cyclin-dependent protein-serine kinase 8",{"v":438.45322473328844,"d":"438"},{"v":367.1994694754804,"d":"367"},{"v":316.82573022161637,"d":"317"},{"v":72.2598700042272,"d":"72"},{"v":31.56185022323269,"d":"32"},{"v":3115.3398097658715,"d":"3115"},"External","GpAb","Not precisely defined.","Antibody raised against amino acid residues at the C-terminus of human CDK8.",null,null,"P49336","P49336",680,"P49336",null,"NP_001252","Block2",4,13,"2, 10, 18, 26","CDK8","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK8",{"$nulls":5},"Protein-serine kinase, CMGC group, CDK family, CDK8 subfamily.","GO:0016592; GO:0005730; GO:0005654; GO:0005634; GO:0032991","GO:0005524; GO:0004693; GO:0004672; GO:0004674; GO:0008353","GO:0045944; GO:0007346; GO:0006367"]
[429,222,"NK031-4","CDK8","Pan-specific","Cyclin-dependent protein-serine kinase 8",{"v":7943.17550637137,"d":"7943"},{"v":7886.9960063802055,"d":"7887"},{"v":2110.682782101668,"d":"2111"},{"v":26.572279315856107,"d":"27"},{"v":3994.7428317505987,"d":"3995"},{"v":13589.439076384468,"d":"13589"},"Kinexus","RpAb","MDYDFKVKLSSERERC","Corresponds to amino acid residues M1 to R15; N-terminus.",null,null,"P49336","P49336",680,"P49336",null,"NP_001252","Block2",5,1,"2, 10, 18, 26","CDK8","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK8",{"$nulls":5},"Protein-serine kinase, CMGC group, CDK family, CDK8 subfamily.","GO:0016592; GO:0005730; GO:0005654; GO:0005634; GO:0032991","GO:0005524; GO:0004693; GO:0004672; GO:0004674; GO:0008353","GO:0045944; GO:0007346; GO:0006367"]
[431,223,"NK032","CDK9","Pan-specific","Cyclin-dependent protein-serine kinase 9",{"v":799.0201531745204,"d":"799"},{"v":665.9799125934067,"d":"666"},{"v":618.8481814827738,"d":"619"},{"v":77.45088519032714,"d":"77"},{"v":202.63109314858804,"d":"203"},{"v":5617.53365346481,"d":"5618"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues at the C-terminus of human CDK9.",null,null,"P50750","P50750",681,"P50750","P50750","NP_001252","Block2",5,2,"2, 10, 18, 26","CDK9","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK9",{"$nulls":5},"EC 2.7.11.23; EC 2.7.11.22; Nuclear receptor co-regulator; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; CDK/CDK9 subfamily; CDK9 subfamily","GO:0005694; GO:0008024; GO:0036464; GO:0016020; GO:0005654; GO:0016605; GO:0008023","GO:0097322; GO:0005524; GO:0003682; GO:0030332; GO:0004693; GO:0003677; GO:0016301; GO:0004672; GO:0019901; GO:0004674; GO:0008353; GO:0000978; GO:0001223; GO:0044212","GO:0008283; GO:0071345; GO:0006281; GO:0071157; GO:1900364; GO:0070816; GO:0010613; GO:2001168; GO:0033129; GO:1903839; GO:0045944; GO:0050434; GO:0006468; GO:0006282; GO:0031056; GO:0051147; GO:0031297; GO:0042493; GO:0042795; GO:0006366; GO:0006368; GO:0006367"]
[433,224,"PK575","CDK9","T186","Cyclin-dependent protein-serine kinase 9",{"v":8504.187511433583,"d":"8504"},{"v":8599.465040718802,"d":"8599"},{"v":1698.5388329329849,"d":"1699"},{"v":19.972970147346338,"d":"20"},{"v":886.4653418705274,"d":"886"},{"v":15055.67735974412,"d":"15056"},"Kinexus","RpAb","NRY(pT)NRV(bA)C","Corresponds to amino acid residues N183 to V189; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T186 phosphorylation stimulates phosphotransferase activity by promoting cyclin and substrate binding. Phosphorylation induces binding to EDG-1, RNA and TEAD1. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in CDK9 (≥33 reports from high throughput mass spectrometry studies).","CDK9","P50750","P50750",681,"P50750","P50750","NP_001252","Block2",5,3,"2, 10, 18, 26","CDK9","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK9",{"$nulls":5},"EC 2.7.11.23; EC 2.7.11.22; Nuclear receptor co-regulator; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; CDK/CDK9 subfamily; CDK9 subfamily","GO:0005694; GO:0008024; GO:0036464; GO:0016020; GO:0005654; GO:0016605; GO:0008023","GO:0097322; GO:0005524; GO:0003682; GO:0030332; GO:0004693; GO:0003677; GO:0016301; GO:0004672; GO:0019901; GO:0004674; GO:0008353; GO:0000978; GO:0001223; GO:0044212","GO:0008283; GO:0071345; GO:0006281; GO:0071157; GO:1900364; GO:0070816; GO:0010613; GO:2001168; GO:0033129; GO:1903839; GO:0045944; GO:0050434; GO:0006468; GO:0006282; GO:0031056; GO:0051147; GO:0031297; GO:0042493; GO:0042795; GO:0006366; GO:0006368; GO:0006367"]
[435,225,"PK574","CDK9","S347","Cyclin-dependent protein-serine kinase 9",{"v":9523.95675320835,"d":"9524"},{"v":9577.44955200053,"d":"9577"},{"v":2082.438392087425,"d":"2082"},{"v":21.865265099885203,"d":"22"},{"v":424.2419757128149,"d":"424"},{"v":17021.402263825785,"d":"17021"},"Kinexus","RpAb","RKG(pS)QIT(bA)C","Corresponds to amino acid residues R344 to T350; Near the C-terminus of the kinase after the catalytic domain.","S347 phosphorylation induces interaction with RNA [PubMed: 10958691). This is the major in vivo phosphorylation site in CDK9 (≥93 reports from high throughput mass spectrometry studies).","CDK9","P50750","P50750",681,"P50750","P50750","NP_001252","Block2",5,4,"2, 10, 18, 26","CDK9","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK9",{"$nulls":5},"EC 2.7.11.23; EC 2.7.11.22; Nuclear receptor co-regulator; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; CDK/CDK9 subfamily; CDK9 subfamily","GO:0005694; GO:0008024; GO:0036464; GO:0016020; GO:0005654; GO:0016605; GO:0008023","GO:0097322; GO:0005524; GO:0003682; GO:0030332; GO:0004693; GO:0003677; GO:0016301; GO:0004672; GO:0019901; GO:0004674; GO:0008353; GO:0000978; GO:0001223; GO:0044212","GO:0008283; GO:0071345; GO:0006281; GO:0071157; GO:1900364; GO:0070816; GO:0010613; GO:2001168; GO:0033129; GO:1903839; GO:0045944; GO:0050434; GO:0006468; GO:0006282; GO:0031056; GO:0051147; GO:0031297; GO:0042493; GO:0042795; GO:0006366; GO:0006368; GO:0006367"]
[437,226,"NK033-2","CDK10 (PISSLRE)","Pan-specific","Cyclin-dependent protein-serine kinase 10 [PISSLRE]",{"v":14382.998707711567,"d":"14383"},{"v":12705.109478143055,"d":"12705"},{"v":7608.337247668542,"d":"7608"},{"v":52.89812925860355,"d":"53"},{"v":3221.6200775234593,"d":"3222"},{"v":39124.27722021419,"d":"39124"},"Kinexus","RpAb","CIRKEGFFTVPPEHRLGR","Corresponds to amino acid residues C15 to R32; Post-N-terminus.",null,null,"Q15131","Q15131",677,"Q15131","Q15131","NP_443714.3","Block2",5,5,"2, 10, 18, 26","CDK10","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK10",{"$nulls":5},"Protein-serine kinase, CMGC group, CDK family, CDK10 subfamily","GO:0036064; GO:0005737; GO:0016592","GO:0005524; GO:0004693; GO:0004674","GO:0030030; GO:0008285; GO:1902018; GO:0018107; GO:0043410; GO:0006468; GO:0032956; GO:0007089"]
[439,227,"NK033-3","CDK10 (PISSLRE)","Pan-specific","Cyclin-dependent protein-serine kinase 10 [PISSLRE]",{"v":13615.122039003369,"d":"13615"},{"v":11892.99946084135,"d":"11893"},{"v":7367.4787736021,"d":"7367"},{"v":54.11246959444369,"d":"54"},{"v":110.91393958460436,"d":"111"},{"v":37389.241670838805,"d":"37389"},"Kinexus","RpAb","HRNKRAAPATSEGQSKRC","Corresponds to amino acid residues H341 to C358; C-terminus.",null,null,"Q15131","Q15131",677,"Q15131","Q15131","NP_443714.3","Block2",5,6,"2, 10, 18, 26","CDK10","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK10",{"$nulls":5},"Protein-serine kinase, CMGC group, CDK family, CDK10 subfamily","GO:0036064; GO:0005737; GO:0016592","GO:0005524; GO:0004693; GO:0004674","GO:0030030; GO:0008285; GO:1902018; GO:0018107; GO:0043410; GO:0006468; GO:0032956; GO:0007089"]
[441,228,"PK564","CDK10 (PISSLRE)","T196","Cyclin-dependent protein-serine kinase 10 [PISSLRE]",{"v":1284.7149756180029,"d":"1285"},{"v":21.246055916463163,"d":"21"},{"v":2620.904062980652,"d":"2621"},{"v":204.0066561627714,"d":"204"},{"v":3.5909943034672063,"d":"4"},{"v":9917.899917531913,"d":"9918"},"Kinexus","RpAb","KPM(pT)PKV(bA)C","Corresponds to amino acid residues K193 to V199; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T196 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation site in CDK10 (≥27 reports from high throughput mass spectrometry studies).",null,"Q15131","Q15131",677,"Q15131","Q15131","NP_443714.3","Block2",5,7,"2, 10, 18, 26","CDK10","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK10",{"$nulls":5},"Protein-serine kinase, CMGC group, CDK family, CDK10 subfamily","GO:0036064; GO:0005737; GO:0016592","GO:0005524; GO:0004693; GO:0004674","GO:0030030; GO:0008285; GO:1902018; GO:0018107; GO:0043410; GO:0006468; GO:0032956; GO:0007089"]
[443,229,"PK565","CDK11A (Cdc2L2; PITSLRE)","T583(labeledasT580)","Cell division cycle 2-like 2 protein kinase",{"v":9746.36458335755,"d":"9746"},{"v":9649.333668396144,"d":"9649"},{"v":2172.466639699858,"d":"2172"},{"v":22.290020254418387,"d":"22"},{"v":378.33985219541097,"d":"378"},{"v":16167.505147643653,"d":"16168"},"Kinexus","RpAb","KAY(pT)PVV(bA)C","Corresponds to amino acid residues K580 to V586; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T583 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in CDK11a (≥49 reports from high throughput mass spectrometry studies).",null,"Q9UQ88","Q9UQ88",23582,"Q9UQ88","Q9UQ88","NP_001300825.1","Block2",5,8,"2, 10, 18, 26","CDK11","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CDK8",{"$nulls":5},"EC 2.7.11.22; RNA processing; Protein kinase, Ser/Thr (non-receptor)","GO:0005737; GO:0005634","GO:0005524; GO:0004693; GO:0004672; GO:0004674","GO:0006915; GO:0000278; GO:0006468; GO:0001558; GO:0007346; GO:0050684; GO:0006355"]
[445,230,"PK566","CDK12 (Cdc2L7)","S383+S385","Cell division protein kinase 12; Cell division cycle 2-related protein kinase 7",{"v":14470.241163086432,"d":"14470"},{"v":13259.987488477766,"d":"13260"},{"v":5341.964471320748,"d":"5342"},{"v":36.91690007868074,"d":"37"},{"v":5953.60803935976,"d":"5954"},{"v":55550.72968784267,"d":"55551"},"Kinexus","RpAb","RHS(pS)I(pS)PVR(bA)C","Corresponds to amino acid residues R380 to R388; In the first quarter of the protein. ","The effects of S383 and S385 phosphorylation are unclear. These are the major in vivo phosphorylation sites in CDK12 (≥163 and ≥174 reports, respectively, from high throughput mass spectrometry studies).",null,"Q9NYV4","Q9NYV4",2133,"Q9NYV4",null,"NP_057591.2","Block2",5,9,"2, 10, 18, 26","CRK7","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CRK7",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.22; CMGC domain target; CMGC</A> group; CDK family; CRK7 subfamily; CDK/CRK7 subfamily","GO:0005694; GO:0008024; GO:0002944; GO:0001650; GO:0019908; GO:0016607; GO:0005654; GO:0005634","GO:0005524; GO:0030332; GO:0004693; GO:0004672; GO:0019901; GO:0008353; GO:0008134; GO:0044212","GO:0006397; GO:2000737; GO:0070816; GO:0045944; GO:0046777; GO:0043405; GO:0043484; GO:0008380; GO:0006368"]
[447,231,"PK567","CDK12 (Cdc2L7)","T893","Cell division protein kinase 12; Cell division cycle 2-related protein kinase 7",{"v":7698.129791954961,"d":"7698"},{"v":7886.730045559102,"d":"7887"},{"v":1995.3958580736191,"d":"1995"},{"v":25.920527608652893,"d":"26"},{"v":1069.8325566719768,"d":"1070"},{"v":14805.333249340561,"d":"14805"},"Kinexus","RpAb","RPY(pT)NKV(bA)C","Corresponds to amino acid residues R890 to V896; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T893 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in CDK12 (≥73 reports from high throughput mass spectrometry studies).",null,"Q9NYV4","Q9NYV4",2133,"Q9NYV4",null,"NP_057591.2","Block2",5,10,"2, 10, 18, 26","CRK7","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","CRK7",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.22; CMGC domain target; CMGC</A> group; CDK family; CRK7 subfamily; CDK/CRK7 subfamily","GO:0005694; GO:0008024; GO:0002944; GO:0001650; GO:0019908; GO:0016607; GO:0005654; GO:0005634","GO:0005524; GO:0030332; GO:0004693; GO:0004672; GO:0019901; GO:0008353; GO:0008134; GO:0044212","GO:0006397; GO:2000737; GO:0070816; GO:0045944; GO:0046777; GO:0043405; GO:0043484; GO:0008380; GO:0006368"]
[449,232,"NK199","CDKL1","Pan-specific","Cyclin-dependent kinase-like 1; Serine/threonine protein kinase KKIALRE",{"v":3907.7513730761757,"d":"3908"},{"v":3936.5980332133736,"d":"3937"},{"v":1252.545319696723,"d":"1253"},{"v":32.05284062662158,"d":"32"},{"v":264.1834921983476,"d":"264"},{"v":7570.799370770765,"d":"7571"},"Kinexus","RpAb","CLDNKKYYSDTKKLNYR","Corresponds to amino acid residues L338 to R353; C-terminus.",null,null,"Q00532","Q00532",703,"Q00532","Q00532","NP_004187.2","Block2",5,11,"2, 10, 18, 26","CDKL1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDKL",{"$nulls":7},"GO:0035869; GO:0005737; GO:0070062; GO:0043231; GO:0005654; GO:0005634","GO:0005524; GO:0004693","GO:0007507; GO:0006468; GO:1902017"]
[451,233,"NK261-1","CDKL2","Pan-specific","Cyclin-dependent kinase-like 2; Serine/threonine protein kinase KKIAMRE",{"v":11349.514501375708,"d":"11350"},{"v":10127.995878459256,"d":"10128"},{"v":6315.5255651141,"d":"6316"},{"v":55.64577730922831,"d":"56"},{"v":1056.5616614049125,"d":"1057"},{"v":31048.05267417,"d":"31048"},"Kinexus","RpAb","CLSDDSGADLPQMEHQH","Corresponds to amino acid residues L478 to H493; C-terminus.",null,null,"Q92772","Q92772",704,"Q92772","Q92772","NP_003939.1","Block2",5,12,"2, 10, 18, 26","CDKL2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDKL",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.22; CMGC domain target; CMGC</A> group; CDKL family","GO:0005813; GO:0005737; GO:0005634","GO:0005524; GO:0004693; GO:0004672","GO:0007548; GO:0007165"]
[453,234,"NK262-1","CDKL3","Pan-specific","Cyclin-dependent kinase-like 3; Serine/threonine protein kinase NKIAMRE",{"v":10266.658477056088,"d":"10267"},{"v":9082.757013438992,"d":"9083"},{"v":5987.734498564461,"d":"5988"},{"v":58.3221357946779,"d":"58"},{"v":506.2718102073608,"d":"506"},{"v":33941.200842783845,"d":"33941"},"Kinexus","RpAb","CANENKRKLNFSRSDRKEFH","Corresponds to amino acid residues A505 to H523; Pre-C-terminus.",null,null,"Q8IVW4","Q8IVW4",805,"Q8IVW4",null,"NP_001107047.1","Block2",5,13,"2, 10, 18, 26","CDKL3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDKL",{"$nulls":7},"GO:0005737; GO:0005634","GO:0005524; GO:0004693; GO:0004672","GO:0006464; GO:0097484; GO:0030517; GO:0050775"]
[455,235,"PK576","CDKL5 (STK9)","Y171","Cyclin-dependent kinase-like 5; Serine-threonine-protein kinase 9",{"v":9495.011451827328,"d":"9495"},{"v":9363.384784064523,"d":"9363"},{"v":2234.4522637026575,"d":"2234"},{"v":23.532907517164016,"d":"24"},{"v":2728.885368310124,"d":"2729"},{"v":17402.372614688724,"d":"17402"},"Kinexus","RpAb","YTE(pY)VAT(bA)C","Corresponds to amino acid residues Y168 to T174; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y171 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation site in CDKL5 (≥548 reports from high throughput mass spectrometry studies).","CDKL5 (STK9)","O76039","O76039",772,"O76039",null,"NP_001032420.1","Block2",6,1,"2, 10, 18, 26","CDKL5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDKL",{"$nulls":6},"EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDKL family","GO:0005813; GO:0036064; GO:0097542; GO:0005829; GO:0032839; GO:0044294; GO:0098978; GO:0005654; GO:0005634; GO:0048471; GO:0099092; GO:0032587","GO:0005524; GO:0016301; GO:0004672; GO:0004674; GO:0048365","GO:0001764; GO:0045773; GO:0050775; GO:0060999; GO:0043547; GO:0046777; GO:0006468; GO:0051726; GO:1902017; GO:0050773; GO:0099175"]
[457,255,"PN019","CFL1","S3","Cofilin 1",{"v":161.87436176677042,"d":"162"},{"v":137.03474557817725,"d":"137"},{"v":127.7324149559025,"d":"128"},{"v":78.90836668745614,"d":"79"},{"v":10.118810809628087,"d":"10"},{"v":597.083957107762,"d":"597"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S3 phosphosite.","S3 phosphorylation inhibits activity and induces interaction with 14-3-3 zeta, although one report indicates stimulation of activity. This is one of the major in vivo phosphorylation sites in cofilin 1 (≥67 reports from high throughput mass spectrometry studies).","ILK; LIMK1; LIMK2; PKD1 (PRKCM; PRKD1); TESK1; TESK2","P23528","P23528",948,null,null,"NP_005498","Block2",7,8,"2, 10, 18, 26",{"$nulls":13},"Intracellular, Nuclear matrix, Cortical actin cytoskeleton, Cytoplasm, Nucleus, Cytoskeleton protein","GO:0005911; GO:0030864; GO:0005737; GO:0005829; GO:0070062; GO:0005615; GO:0005925; GO:0030027; GO:0031258; GO:0016020; GO:0016363; GO:0005634; GO:0032587; GO:0031982","GO:0051015; GO:0005102","GO:0030036; GO:0030042; GO:0030043; GO:0007010; GO:0030010; GO:0035722; GO:0000281; GO:0043066; GO:0001755; GO:0001842; GO:0044794; GO:0030836; GO:0006468; GO:0022604; GO:0061001; GO:0043200; GO:0009615; GO:0007266"]
[459,256,"PN220","CFL1","S3","Cofilin 1",{"v":249.54675428037146,"d":"250"},{"v":220.08820066752457,"d":"220"},{"v":157.52195399905415,"d":"158"},{"v":63.12322292201591,"d":"63"},{"v":23.0825897164938,"d":"23"},{"v":1019.947709512751,"d":"1020"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S3 phosphosite.","S3 phosphorylation inhibits activity and induces interaction with 14-3-3 zeta, although one report indicates stimulation of activity. This is one of the major in vivo phosphorylation sites in cofilin 1 (≥67 reports from high throughput mass spectrometry studies).","ILK; LIMK1; LIMK2; PKD1 (PRKCM; PRKD1); TESK1; TESK2","P23528","P23528",948,null,null,"NP_005498","Block2",7,9,"2, 10, 18, 26",{"$nulls":13},"Intracellular, Nuclear matrix, Cortical actin cytoskeleton, Cytoplasm, Nucleus, Cytoskeleton protein","GO:0005911; GO:0030864; GO:0005737; GO:0005829; GO:0070062; GO:0005615; GO:0005925; GO:0030027; GO:0031258; GO:0016020; GO:0016363; GO:0005634; GO:0032587; GO:0031982","GO:0051015; GO:0005102","GO:0030036; GO:0030042; GO:0030043; GO:0007010; GO:0030010; GO:0035722; GO:0000281; GO:0043066; GO:0001755; GO:0001842; GO:0044794; GO:0030836; GO:0006468; GO:0022604; GO:0061001; GO:0043200; GO:0009615; GO:0007266"]
[461,236,"NK034-2","Chk1 (CHEK1)","Pan-specific","Checkpoint protein-serine kinase 1",{"v":731.6489376020173,"d":"732"},{"v":489.7959369952704,"d":"490"},{"v":725.2298902805252,"d":"725"},{"v":99.12266020059694,"d":"99"},{"v":93.53631962714189,"d":"94"},{"v":5007.994060864408,"d":"5008"},"External","RpAb","Epitope undefined.",{"$nulls":3},"O14757","O14757",586,"O14757","O14757","NP_001265","Block2",6,2,"2, 10, 18, 26","CHK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","CHK1",{"$nulls":5},"Protein-serine kinase, CAMK group, CAMKL family, CHK1 subfamily","GO:0005813; GO:0000785; GO:0000794; GO:0005737; GO:0005829; GO:0005615; GO:0043231; GO:0005654; GO:0005634; GO:0032991","GO:0005524; GO:0035402; GO:0016301; GO:0019904; GO:0004672; GO:0004674","GO:0006915; GO:0007049; GO:0006974; GO:0071260; GO:0048096; GO:0000077; GO:0006975; GO:0006281; GO:0006260; GO:0035556; GO:0070317; GO:0045839; GO:0018107; GO:0045787; GO:0010569; GO:2000615; GO:0046602; GO:1901796; GO:0010767; GO:0090399; GO:0072425"]
[463,237,"NK034","Chk1 (CHEK1)","Pan-specific","Checkpoint protein-serine kinase 1",{"v":1549.2319617034289,"d":"1549"},{"v":1423.7810139745288,"d":"1424"},{"v":665.4231141834234,"d":"665"},{"v":42.95180648427689,"d":"43"},{"v":237.33243324536988,"d":"237"},{"v":4161.9825931626465,"d":"4162"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 1-476 representing full length human Chk1.",null,null,"O14757","O14757",586,"O14757","O14757","NP_001265","Block2",6,3,"2, 10, 18, 26","CHK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","CHK1",{"$nulls":5},"Protein-serine kinase, CAMK group, CAMKL family, CHK1 subfamily","GO:0005813; GO:0000785; GO:0000794; GO:0005737; GO:0005829; GO:0005615; GO:0043231; GO:0005654; GO:0005634; GO:0032991","GO:0005524; GO:0035402; GO:0016301; GO:0019904; GO:0004672; GO:0004674","GO:0006915; GO:0007049; GO:0006974; GO:0071260; GO:0048096; GO:0000077; GO:0006975; GO:0006281; GO:0006260; GO:0035556; GO:0070317; GO:0045839; GO:0018107; GO:0045787; GO:0010569; GO:2000615; GO:0046602; GO:1901796; GO:0010767; GO:0090399; GO:0072425"]
[465,238,"PK577","Chk1 (CHEK1)","S280","Checkpoint protein-serine kinase 1",{"v":9759.655267466314,"d":"9760"},{"v":9461.685355814458,"d":"9462"},{"v":2144.7193600158384,"d":"2145"},{"v":21.975359797443183,"d":"22"},{"v":4440.201439074974,"d":"4440"},{"v":16832.88895587086,"d":"16833"},"Kinexus","RpAb","RVT(pS)GGV(bA)C","Corresponds to amino acid residues R277 to V283; After the kinase catalytic domain in the second half of the kinase.","S280 phosphorylation inhibits phosphotransferase activity. Phosphorylation regulates cell cycle progression, intracellular location, protein degradation, and molecular association. This is the major in vivo phosphorylation site in Chk1 (≥168 reports from high throughput mass spectrometry studies).","Akt1 (PKBa); RSK1","O14757","O14757",586,"O14757","O14757","NP_001265","Block2",6,4,"2, 10, 18, 26","CHK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","CHK1",{"$nulls":5},"Protein-serine kinase, CAMK group, CAMKL family, CHK1 subfamily","GO:0005813; GO:0000785; GO:0000794; GO:0005737; GO:0005829; GO:0005615; GO:0043231; GO:0005654; GO:0005634; GO:0032991","GO:0005524; GO:0035402; GO:0016301; GO:0019904; GO:0004672; GO:0004674","GO:0006915; GO:0007049; GO:0006974; GO:0071260; GO:0048096; GO:0000077; GO:0006975; GO:0006281; GO:0006260; GO:0035556; GO:0070317; GO:0045839; GO:0018107; GO:0045787; GO:0010569; GO:2000615; GO:0046602; GO:1901796; GO:0010767; GO:0090399; GO:0072425"]
[467,239,"PK578","Chk1 (CHEK1)","S317","Checkpoint protein-serine kinase 1",{"v":7277.789188266383,"d":"7278"},{"v":7053.970084213799,"d":"7054"},{"v":1817.6721386981972,"d":"1818"},{"v":24.97560854921079,"d":"25"},{"v":2362.568047409837,"d":"2363"},{"v":15057.19710319618,"d":"15057"},"Kinexus","RpAb","YSS(pS)QPE(bA)C","Corresponds to amino acid residues Y314 to E320; In the C-terminal half of the kinase after the catalytic domain.","S317 phosphorylation stimulates phosphotransferase activity. Phosphorylation regulates cell cycle progression and induces interaction with claspin. This is one of the major in vivo phosphorylation sites in Chk1 (≥26 reports from high throughput mass spectrometry studies).","ATM, ATR","O14757","O14757",586,"O14757","O14757","NP_001265","Block2",6,5,"2, 10, 18, 26","CHK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","CHK1",{"$nulls":5},"Protein-serine kinase, CAMK group, CAMKL family, CHK1 subfamily","GO:0005813; GO:0000785; GO:0000794; GO:0005737; GO:0005829; GO:0005615; GO:0043231; GO:0005654; GO:0005634; GO:0032991","GO:0005524; GO:0035402; GO:0016301; GO:0019904; GO:0004672; GO:0004674","GO:0006915; GO:0007049; GO:0006974; GO:0071260; GO:0048096; GO:0000077; GO:0006975; GO:0006281; GO:0006260; GO:0035556; GO:0070317; GO:0045839; GO:0018107; GO:0045787; GO:0010569; GO:2000615; GO:0046602; GO:1901796; GO:0010767; GO:0090399; GO:0072425"]
[469,240,"PK579","Chk1 (CHEK1)","S345","Checkpoint protein-serine kinase 1",{"v":5103.997165476633,"d":"5104"},{"v":4744.704197149895,"d":"4745"},{"v":1502.1180670661795,"d":"1502"},{"v":29.430229256914274,"d":"29"},{"v":2247.5288790322957,"d":"2248"},{"v":12266.137495805513,"d":"12266"},"Kinexus","RpAb","ISF(pS)QPT(bA)C","Corresponds to amino acid residues I342 to T348; In the C-terminal half of the kinase after the catalytic domain.","S345 phosphorylation stimulates phosphotransferase activity. Phosphorylation regulates apoptosis, cell cycle progression, intracellular location, and protein degradation. It induces binding to 14-3-3-sigma, claspin, p21Cip1 and p53. This is one of the major in vivo phosphorylation sites in Chk1 (≥13 reports from high throughput mass spectrometry studies).","ATM, ATR; COT (MAP3K8)","O14757","O14757",586,"O14757","O14757","NP_001265","Block2",6,6,"2, 10, 18, 26","CHK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","CHK1",{"$nulls":5},"Protein-serine kinase, CAMK group, CAMKL family, CHK1 subfamily","GO:0005813; GO:0000785; GO:0000794; GO:0005737; GO:0005829; GO:0005615; GO:0043231; GO:0005654; GO:0005634; GO:0032991","GO:0005524; GO:0035402; GO:0016301; GO:0019904; GO:0004672; GO:0004674","GO:0006915; GO:0007049; GO:0006974; GO:0071260; GO:0048096; GO:0000077; GO:0006975; GO:0006281; GO:0006260; GO:0035556; GO:0070317; GO:0045839; GO:0018107; GO:0045787; GO:0010569; GO:2000615; GO:0046602; GO:1901796; GO:0010767; GO:0090399; GO:0072425"]
[471,241,"NK035","Chk2 (CHEK2)","Pan-specific","Checkpoint protein-serine kinase 2",{"v":877.6825306270874,"d":"878"},{"v":764.9526912449492,"d":"765"},{"v":483.2489511871753,"d":"483"},{"v":55.0596524738738,"d":"55"},{"v":277.94687564278667,"d":"278"},{"v":3022.388122040276,"d":"3022"},"External","RpAb","Epitope undefined.",{"$nulls":3},"O96017","O96017",468,"O96017","O96017","NP_009125","Block2",6,7,"2, 10, 18, 26","CHK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","RAD53",{"$nulls":6},"Protein-serine kinase, CAMK group, RAD53 family","GO:0005794; GO:0005654; GO:0016605","GO:0005524; GO:0042802; GO:0016301; GO:0046872; GO:0042803; GO:0019901; GO:0004674; GO:0031625","GO:0051301; GO:0044257; GO:1903926; GO:0006974; GO:0071480; GO:0000077; GO:0006975; GO:0006977; GO:0006978; GO:0006302; GO:0000086; GO:0008630; GO:0042771; GO:0090307; GO:0071157; GO:2000002; GO:0018105; GO:0018107; GO:2000210; GO:0001934; GO:0045893; GO:0046777; GO:0006468; GO:0050821; GO:0042981; GO:0042176; GO:1901796; GO:0006355; GO:0001302; GO:0090399; GO:1903416; GO:0042770; GO:0072428; GO:0006351"]
[473,242,"NK035-2","Chk2 (CHEK2)","Pan-specific","Checkpoint protein-serine kinase 2",{"v":282.56086674179403,"d":"283"},{"v":244.36254901340504,"d":"244"},{"v":162.48713511256574,"d":"162"},{"v":57.50518002942266,"d":"58"},{"v":65.66618437134579,"d":"66"},{"v":1587.8661141888438,"d":"1588"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 1-300 of human Chk2.",null,null,"O96017","O96017",468,"O96017","O96017","NP_009125","Block2",6,8,"2, 10, 18, 26","CHK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","RAD53",{"$nulls":6},"Protein-serine kinase, CAMK group, RAD53 family","GO:0005794; GO:0005654; GO:0016605","GO:0005524; GO:0042802; GO:0016301; GO:0046872; GO:0042803; GO:0019901; GO:0004674; GO:0031625","GO:0051301; GO:0044257; GO:1903926; GO:0006974; GO:0071480; GO:0000077; GO:0006975; GO:0006977; GO:0006978; GO:0006302; GO:0000086; GO:0008630; GO:0042771; GO:0090307; GO:0071157; GO:2000002; GO:0018105; GO:0018107; GO:2000210; GO:0001934; GO:0045893; GO:0046777; GO:0006468; GO:0050821; GO:0042981; GO:0042176; GO:1901796; GO:0006355; GO:0001302; GO:0090399; GO:1903416; GO:0042770; GO:0072428; GO:0006351"]
[475,243,"PK581","Chk2 (CHEK2)","T68","Checkpoint protein-serine kinase 2",{"v":12558.328645268164,"d":"12558"},{"v":12603.95618802638,"d":"12604"},{"v":1990.0440595118346,"d":"1990"},{"v":15.846408512821174,"d":"16"},{"v":6066.639033635312,"d":"6067"},{"v":21137.337826225554,"d":"21137"},"Kinexus","RpAb","TVS(pT)QEL(bA)C","Corresponds to amino acid residues T65 to L71; In the N-terminal portion of the kinase before the FHA domain.","T68 phosphorylation stimulates phosphotransferase activity, and induces interactions with Chk2, MDC1, NBS1 and Plk1. This is one of the minor in vivo phosphorylation sites in Chk2 (≥3 reports from high throughput mass spectrometry studies).","ATM; ATR; Chk2 (CHEK2); DNAPK (PRKDC); Plk1 (PLK); TTK; ZAK (MLTK)","O96017","O96017",468,"O96017","O96017","NP_009125","Block2",6,9,"2, 10, 18, 26","CHK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","RAD53",{"$nulls":6},"Protein-serine kinase, CAMK group, RAD53 family","GO:0005794; GO:0005654; GO:0016605","GO:0005524; GO:0042802; GO:0016301; GO:0046872; GO:0042803; GO:0019901; GO:0004674; GO:0031625","GO:0051301; GO:0044257; GO:1903926; GO:0006974; GO:0071480; GO:0000077; GO:0006975; GO:0006977; GO:0006978; GO:0006302; GO:0000086; GO:0008630; GO:0042771; GO:0090307; GO:0071157; GO:2000002; GO:0018105; GO:0018107; GO:2000210; GO:0001934; GO:0045893; GO:0046777; GO:0006468; GO:0050821; GO:0042981; GO:0042176; GO:1901796; GO:0006355; GO:0001302; GO:0090399; GO:1903416; GO:0042770; GO:0072428; GO:0006351"]
[477,244,"PK580","Chk2 (CHEK2)","T383","Checkpoint protein-serine kinase 2",{"v":12642.860324893541,"d":"12643"},{"v":12701.030870768605,"d":"12701"},{"v":2267.534950239333,"d":"2268"},{"v":17.93530017708573,"d":"18"},{"v":2848.1118870350683,"d":"2848"},{"v":19792.447685324514,"d":"19792"},"Kinexus","RpAb","LMR(pT)LCG(bA)C","Corresponds to amino acid residues L380 to G386; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T383 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in XXX.","Chk2 (CHEK2); DNAPK (PRKDC)","O96017","O96017",468,"O96017","O96017","NP_009125","Block2",6,10,"2, 10, 18, 26","CHK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","RAD53",{"$nulls":6},"Protein-serine kinase, CAMK group, RAD53 family","GO:0005794; GO:0005654; GO:0016605","GO:0005524; GO:0042802; GO:0016301; GO:0046872; GO:0042803; GO:0019901; GO:0004674; GO:0031625","GO:0051301; GO:0044257; GO:1903926; GO:0006974; GO:0071480; GO:0000077; GO:0006975; GO:0006977; GO:0006978; GO:0006302; GO:0000086; GO:0008630; GO:0042771; GO:0090307; GO:0071157; GO:2000002; GO:0018105; GO:0018107; GO:2000210; GO:0001934; GO:0045893; GO:0046777; GO:0006468; GO:0050821; GO:0042981; GO:0042176; GO:1901796; GO:0006355; GO:0001302; GO:0090399; GO:1903416; GO:0042770; GO:0072428; GO:0006351"]
[479,849,"PN249","Cip (WAF1; p21) p21(WAF1/CIP1)","T145","Cyclin-dependent kinase inhibitor 1",{"v":288.2149182817122,"d":"288"},{"v":224.12594447465256,"d":"224"},{"v":335.17579860739136,"d":"335"},{"v":116.29370214618031,"d":"116"},{"v":33.29492286314314,"d":"33"},{"v":4484.042871034382,"d":"4484"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 140-149 with phospho-T145 of human p21.","T145 phosphorylation -reduces binding to PCNA, CDK2 and CDK4. This is one of the major in vivo phosphorylation sites in Cip.","Akt1 (PKBa); Akt3 (PKBg); DAPK3 (ZIPK); Pim1","P38936","P38936",1020,null,"P38936","NP_000380.1","Block6",1,4,"6, 14, 22, 30",{"$nulls":13},"Inhibitor protein","GO:0000307; GO:0005829; GO:0016604; GO:0005730; GO:0005654; GO:0005634; GO:0070557; GO:0048471; GO:0032991","GO:0030332; GO:0019912; GO:0004693; GO:0004861; GO:0046872; GO:0044877; GO:0019901; GO:0004860; GO:0031625","GO:0031100; GO:0007050; GO:0034198; GO:0006974; GO:0031668; GO:0071480; GO:0034605; GO:0071479; GO:0071493; GO:0090398; GO:0019221; GO:0006977; GO:0006978; GO:0000082; GO:0000086; GO:0060574; GO:0097193; GO:0042771; GO:0071850; GO:0043066; GO:0030308; GO:0008285; GO:1904030; GO:0045736; GO:2000134; GO:0010629; GO:0042326; GO:1904706; GO:0030890; GO:0048146; GO:0043068; GO:0045860; GO:2000379; GO:0050821; GO:0007265; GO:0000079; GO:2000278; GO:0033158; GO:0006357; GO:0090399; GO:0046685; GO:0051412; GO:0042493; GO:0055093; GO:0010243; GO:0009636; GO:0010165; GO:0090400; GO:0006367"]
[481,850,"PN248","Cip (WAF1; p21) p21(WAF1/CIP1)","S146","Cyclin-dependent kinase inhibitor 1",{"v":155.19530108327442,"d":"155"},{"v":118.19829571205678,"d":"118"},{"v":150.3495279100645,"d":"150"},{"v":96.87762893632342,"d":"97"},{"v":15.057625993035721,"d":"15"},{"v":1710.1390815385444,"d":"1710"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S146 phosphosite.","S146 phosphorylation induces its release from CDK2 and PCNA, cytoplasmic relocalization and subsequent degradation. This is one of the major in vivo phosphorylation sites in Cip.","Akt1 (PKBa); Akt3 (PKBg); Pim1; PKCa (PRKCA)","P38936","P38936",1020,null,"P38936","NP_000380.1","Block6",1,5,"6, 14, 22, 30",{"$nulls":13},"Inhibitor protein","GO:0000307; GO:0005829; GO:0016604; GO:0005730; GO:0005654; GO:0005634; GO:0070557; GO:0048471; GO:0032991","GO:0030332; GO:0019912; GO:0004693; GO:0004861; GO:0046872; GO:0044877; GO:0019901; GO:0004860; GO:0031625","GO:0031100; GO:0007050; GO:0034198; GO:0006974; GO:0031668; GO:0071480; GO:0034605; GO:0071479; GO:0071493; GO:0090398; GO:0019221; GO:0006977; GO:0006978; GO:0000082; GO:0000086; GO:0060574; GO:0097193; GO:0042771; GO:0071850; GO:0043066; GO:0030308; GO:0008285; GO:1904030; GO:0045736; GO:2000134; GO:0010629; GO:0042326; GO:1904706; GO:0030890; GO:0048146; GO:0043068; GO:0045860; GO:2000379; GO:0050821; GO:0007265; GO:0000079; GO:2000278; GO:0033158; GO:0006357; GO:0090399; GO:0046685; GO:0051412; GO:0042493; GO:0055093; GO:0010243; GO:0009636; GO:0010165; GO:0090400; GO:0006367"]
[483,245,"NK036","CK1 delta (CSNK1D)","Pan-specific","Casein protein-serine kinase 1 delta",{"v":592.3614561785174,"d":"592"},{"v":506.1158261632145,"d":"506"},{"v":345.7037708245593,"d":"346"},{"v":58.360274325542214,"d":"58"},{"v":141.17061144630856,"d":"141"},2288,"External","GpAb","Epitope undefined.",{"$nulls":3},"P48730","P48730",683,"P48730",null,"NP_001884.2","Block2",6,11,"2, 10, 18, 26","CK1d","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CK1","CK1",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); CK1 group; CK1 family","GO:0005813; GO:0005829; GO:0033116; GO:0005794; GO:0000139; GO:0043005; GO:0005654; GO:0005634; GO:0048471; GO:0005886; GO:0005819; GO:0005876","GO:0005524; GO:0045296; GO:0042277; GO:0004672; GO:0004674; GO:0050321","GO:1990090; GO:0097711; GO:0032922; GO:0048208; GO:0006897; GO:0000086; GO:0007030; GO:0007020; GO:1905515; GO:0018105; GO:0090263; GO:2000052; GO:0032436; GO:0001934; GO:1905426; GO:0071539; GO:0061512; GO:0034067; GO:0006468; GO:0008360; GO:0042752; GO:0010389; GO:0051225; GO:0016055"]
[485,246,"NK037-1","CK1 epsilon (CSNK1E)","Pan-specific","Casein protein-serine kinase 1 epsilon",{"v":5750.896179608117,"d":"5751"},{"v":5535.0257316200405,"d":"5535"},{"v":2408.4840768214895,"d":"2408"},{"v":41.880152268469764,"d":"42"},{"v":1523.6184178350966,"d":"1524"},{"v":13104.86292203511,"d":"13105"},"External","MmAb","Not precisely defined.","Antibody raised against recombinant full length protein (Human) with a His tag.",null,null,"P49674","P49674",684,"P49674",null,"NP_001276841.1","Block2",6,12,"2, 10, 18, 26","CK1e","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CK1","CK1",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); CK1 group; CK1 family","GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0004672; GO:0004674; GO:0003723","GO:0060070; GO:0097711; GO:0032922; GO:0006281; GO:0006897; GO:0000086; GO:0032091; GO:0018105; GO:2000052; GO:0032436; GO:1905426; GO:0006468; GO:0008360; GO:1903827; GO:0042752; GO:0010389; GO:0007165; GO:0016055"]
[487,247,"NK041-3","CK2a1 (CSNK2A1)","Pan-specific","Casein protein-serine kinase 2 alpha/ alpha prime",{"v":342.69449903535394,"d":"343"},{"v":272.63967234366146,"d":"273"},{"v":336.33900919737493,"d":"336"},{"v":98.14543569976495,"d":"98"},{"v":42.344531736403184,"d":"42"},{"v":4401.927678056899,"d":"4402"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 2-27 at the N-terminus of human casein kinase IIα .",null,null,"P68400","P68400",798,"P68400","P68400","NP_001887","Block2",6,13,"2, 10, 18, 26","CK2a1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","CK2",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; CK2 family","GO:0005829; GO:0005654; GO:0005634; GO:0016581; GO:0005886; GO:0005956; GO:0016580","GO:0005524; GO:0051879; GO:0042802; GO:0016301; GO:0047485; GO:0004674","GO:0006915; GO:0007049; GO:0061077; GO:2001234; GO:0043154; GO:2000059; GO:0018105; GO:0018107; GO:0030307; GO:0008284; GO:0045732; GO:0030177; GO:0006468; GO:1905818; GO:1901796; GO:0006355; GO:0048511; GO:0007165; GO:0006351; GO:0016055"]
[489,248,"NK041-2","CK2a1 (CSNK2A1)","Pan-specific","Casein protein-serine kinase 2 alpha/ alpha prime",{"v":4584.7744743347575,"d":"4585"},{"v":4257.219222829827,"d":"4257"},{"v":1558.2428903547795,"d":"1558"},{"v":33.987340033358514,"d":"34"},{"v":620.422508825829,"d":"620"},{"v":10070.92707175137,"d":"10071"},"Kinexus","RpAb","CARVYTDVNTHRPREYWDYE","Corresponds to amino acid residues A9 to E27; Post-N-terminus, conserved in both CK2 isoforms.",null,null,"P68400","P68400",798,"P68400","P68400","NP_001887","Block2",7,1,"2, 10, 18, 26","CK2a1","X","DSK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","CK2",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; CK2 family","GO:0005829; GO:0005654; GO:0005634; GO:0016581; GO:0005886; GO:0005956; GO:0016580","GO:0005524; GO:0051879; GO:0042802; GO:0016301; GO:0047485; GO:0004674","GO:0006915; GO:0007049; GO:0061077; GO:2001234; GO:0043154; GO:2000059; GO:0018105; GO:0018107; GO:0030307; GO:0008284; GO:0045732; GO:0030177; GO:0006468; GO:1905818; GO:1901796; GO:0006355; GO:0048511; GO:0007165; GO:0006351; GO:0016055"]
[491,249,"PK582","CK2a1 (CSNK2A1)","Y255","Casein protein-serine kinase 2 alpha/ alpha prime",{"v":158.80034194720162,"d":"159"},{"v":137.61753248565876,"d":"138"},{"v":101.67376239981145,"d":"102"},{"v":64.02616087162849,"d":"64"},{"v":38.63732077285264,"d":"39"},{"v":884.4537340893396,"d":"884"},"Kinexus","RpAb","EDL(pY)DYI(bA)C","Corresponds to amino acid residues E252 to I258; In the last quarter of the kinase catalytic domain. ","The effect of Y255 phosphorylation is unclear. This is the major in vivo phosphorylation site in CK2a1 (≥16 reports from high throughput mass spectrometry studies).","Fgr; Lyn","P68400","P68400",798,"P68400","P68400","NP_001887","Block2",7,2,"2, 10, 18, 26","CK2a1","X","DSK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","CK2",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; CK2 family","GO:0005829; GO:0005654; GO:0005634; GO:0016581; GO:0005886; GO:0005956; GO:0016580","GO:0005524; GO:0051879; GO:0042802; GO:0016301; GO:0047485; GO:0004674","GO:0006915; GO:0007049; GO:0061077; GO:2001234; GO:0043154; GO:2000059; GO:0018105; GO:0018107; GO:0030307; GO:0008284; GO:0045732; GO:0030177; GO:0006468; GO:1905818; GO:1901796; GO:0006355; GO:0048511; GO:0007165; GO:0006351; GO:0016055"]
[493,250,"PK167","CK2a1 (CSNK2A1)","T360+S362","Casein protein-serine kinase 2 alpha/ alpha prime",{"v":715.4135267933093,"d":"715"},{"v":667.1007315401985,"d":"667"},{"v":470.1978716181727,"d":"470"},{"v":65.723928051198,"d":"66"},{"v":5.2152054890991355,"d":"5"},{"v":2248.477796688939,"d":"2248"},"External","RpAb","VP(pT)P(pS)PL","Corresponds to amino acid residues V358 to L364.","Phosphorylation at T360 and S362 stimulates phosphotransferase activity. The effects of T360 and S362 phosphorylation are unclear. T360 phosphorylation has not been reported following high throughput mass spectrometry, and S362 phosphorylation has been described only once from high throughput mass spectrometry studies.","T360: CDK1 (CDC2); ERK2 (MAPK1). S362: CDK1 (CDC2); ERK2 (MAPK1).","P68400","P68400",798,"P68400","P68400","NP_001887","Block2",7,3,"2, 10, 18, 26","CK2a1","X","DSK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","CK2",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; CK2 family","GO:0005829; GO:0005654; GO:0005634; GO:0016581; GO:0005886; GO:0005956; GO:0016580","GO:0005524; GO:0051879; GO:0042802; GO:0016301; GO:0047485; GO:0004674","GO:0006915; GO:0007049; GO:0061077; GO:2001234; GO:0043154; GO:2000059; GO:0018105; GO:0018107; GO:0030307; GO:0008284; GO:0045732; GO:0030177; GO:0006468; GO:1905818; GO:1901796; GO:0006355; GO:0048511; GO:0007165; GO:0006351; GO:0016055"]
[495,251,"PK583","CLK1","S337","Dual specificity protein kinase CLK1",{"v":2924.402995287481,"d":"2924"},{"v":2698.428927212637,"d":"2698"},{"v":1422.2897765820715,"d":"1422"},{"v":48.635218158168186,"d":"49"},{"v":126.44210063291251,"d":"126"},{"v":12194.591699392437,"d":"12195"},"Kinexus","RpAb","EHH(pS)TLV(bA)C","Corresponds to amino acid residues E334 to V340; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S337 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. The phosphorylation of this site in CLK1has not been reported in high throughput mass spectrometry studies.",null,"P49759","P49759",2136,"P49759",null,"NP_004062.2","Block2",7,4,"2, 10, 18, 26","CLK1","X","DSK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CLK",{"$nulls":6},"Protein kinase, dual-specificity; EC 2.7.12.1; EC 2.7.1.112; CMGC group; CLK family","GO:0005737; GO:0005634","GO:0005524; GO:0004715; GO:0004712; GO:0004674","GO:0008283; GO:0018105; GO:0018107; GO:0046777; GO:0043484"]
[497,252,"PK584","CLK1","S337+T338","Dual specificity protein kinase CLK1",{"v":6501.584364371963,"d":"6502"},{"v":6386.907769983048,"d":"6387"},{"v":1496.1181806494128,"d":"1496"},{"v":23.011593740873256,"d":"23"},{"v":2553.5263719954532,"d":"2554"},{"v":12939.12658887446,"d":"12939"},"Kinexus","RpAb","EHH(pS)(pT)LVS(bA)C","Corresponds to amino acid residues E334 to S341; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S337 and T338 phosphorylation are predicted to be stimulatory for phosphotransferase activity. These phosphosits are located in the kinase activation loop between catalytic subdomains VII and VIII. The phosphorylation of this S337 in CLK1 has not been reported in high throughput mass spectrometry studies, whereas phosphorylation of the T338 has been described at least twice.",null,"P49759","P49759",2136,"P49759",null,"NP_004062.2","Block2",7,5,"2, 10, 18, 26","CLK1","X","DSK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CLK",{"$nulls":6},"Protein kinase, dual-specificity; EC 2.7.12.1; EC 2.7.1.112; CMGC group; CLK family","GO:0005737; GO:0005634","GO:0005524; GO:0004715; GO:0004712; GO:0004674","GO:0008283; GO:0018105; GO:0018107; GO:0046777; GO:0043484"]
[499,253,"NK370-1","CLK1/4","Pan-specific","Dual specificity protein kinase CLK1/4",{"v":318.80300014847603,"d":"319"},{"v":263.97389982488625,"d":"264"},{"v":231.40084562735228,"d":"231"},{"v":72.58427477770975,"d":"73"},{"v":79.12726949985091,"d":"79"},{"v":2663.9361114267385,"d":"2664"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 202-227 within an internal region of human CLK1.",null,null,"P49759/Q9HAZ1","P49759",2136,"P49759",null,"NP_004062.2","Block2",7,6,"2, 10, 18, 26","CLK1","X","DSK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CLK",{"$nulls":6},"Protein kinase, dual-specificity; EC 2.7.12.1; EC 2.7.1.112; CMGC group; CLK family","GO:0005737; GO:0005634","GO:0005524; GO:0004715; GO:0004712; GO:0004674","GO:0008283; GO:0018105; GO:0018107; GO:0046777; GO:0043484"]
[501,254,"NK372-1","CLK3","Pan-specific","Dual specificity protein kinase CLK3",{"v":900.8444625787407,"d":"901"},{"v":781.7970455243527,"d":"782"},{"v":664.1641000232564,"d":"664"},{"v":73.72683383344918,"d":"74"},{"v":101.8560866536826,"d":"102"},{"v":7995.3707985376495,"d":"7995"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 211-241 within an internal region of human CLK3.",null,null,"P49761","P49761",2137,"P49761",null,"NP_001123500.1","Block2",7,7,"2, 10, 18, 26","CLK3","X","DSK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CLK",{"$nulls":6},"Protein-serine kinase, CMGC group, CLK family","GO:0001669; GO:0045111; GO:0016020; GO:0016607; GO:0005654; GO:0005634","GO:0005524; GO:0042802; GO:0004712; GO:0004674; GO:0004713; GO:0003723","GO:0046777; GO:0006468; GO:0043484"]
[503,284,"NN029","CLNB1","Pan-specific","Cyclin B1",{"v":514.1579075880418,"d":"514"},{"v":503.3950086649948,"d":"503"},{"v":243.26953919686548,"d":"243"},{"v":47.31416858646859,"d":"47"},{"v":83.46153348153288,"d":"83"},{"v":1388.1624408548141,"d":"1388"},"External","MmAb","Not precisely defined.","Antibody raised against a recombinant protein corresponding to human cyclin B1.",null,null,"P14635","P14635",1165,null,"P14635","NP_114172","Block2",9,11,"2, 10, 18, 26",{"$nulls":13},"Protein-serine kinase regulatory subunit, activator, cyclin","GO:0005813; GO:0000942; GO:0097125; GO:0005737; GO:0005829; GO:0016020; GO:0005759; GO:0005654; GO:0005634; GO:0000922","GO:0061575; GO:0004693; GO:0035173; GO:0005113; GO:0019901; GO:0044389","GO:0031145; GO:0051301; GO:0071398; GO:0071456; GO:0071283; GO:0071407; GO:0048565; GO:0006977; GO:0000086; GO:2000775; GO:0001701; GO:0007080; GO:0007077; GO:0007052; GO:0010629; GO:0001933; GO:0001556; GO:0051987; GO:0060045; GO:0048146; GO:0010971; GO:0033129; GO:1905448; GO:0045931; GO:0031442; GO:0065003; GO:0051726; GO:0060623; GO:0090266; GO:0046680; GO:0009612; GO:0007283; GO:0042246; GO:0055015"]
[505,285,"PN190","CLNB1","S147","Cyclin B1",{"v":515.6548078612964,"d":"516"},{"v":402.0101651512623,"d":"402"},{"v":431.4501094557343,"d":"431"},{"v":83.67033582896178,"d":"84"},{"v":11.975752901734472,"d":"12"},{"v":2629.8650561899776,"d":"2630"},"External","RpAb","AF(pS)DV","Corresponds to amino acid residues A145 to V149."," S147 phosphorylation induces interaction with DNA. This is one of the minor in vivo phosphorylation sites in cyclin B1 (≥1 reports from high throughput mass spectrometry studies).","Plk1 (PLK)","P14635","P14635",1165,null,"P14635","NP_114172","Block2",9,12,"2, 10, 18, 26",{"$nulls":13},"Protein-serine kinase regulatory subunit, activator, cyclin","GO:0005813; GO:0000942; GO:0097125; GO:0005737; GO:0005829; GO:0016020; GO:0005759; GO:0005654; GO:0005634; GO:0000922","GO:0061575; GO:0004693; GO:0035173; GO:0005113; GO:0019901; GO:0044389","GO:0031145; GO:0051301; GO:0071398; GO:0071456; GO:0071283; GO:0071407; GO:0048565; GO:0006977; GO:0000086; GO:2000775; GO:0001701; GO:0007080; GO:0007077; GO:0007052; GO:0010629; GO:0001933; GO:0001556; GO:0051987; GO:0060045; GO:0048146; GO:0010971; GO:0033129; GO:1905448; GO:0045931; GO:0031442; GO:0065003; GO:0051726; GO:0060623; GO:0090266; GO:0046680; GO:0009612; GO:0007283; GO:0042246; GO:0055015"]
[507,286,"PN191","CLNE","T395","Cyclin E",{"v":513.7389276225975,"d":"514"},{"v":394.52161812570284,"d":"395"},{"v":427.1666955146172,"d":"427"},{"v":83.1485940711937,"d":"83"},{"v":17.871034854502785,"d":"18"},{"v":2739.682616257839,"d":"2740"},"External","RpAb","LL(pT)PP","Corresponds to amino acid residues L393 to P397.","T395 phosphorylation induces interaction with FBXW7 and SKP2. This is one of the major in vivo phosphorylation sites in cyclin E (≥10 reports from high throughput mass spectrometry studies).","CDK2; GSK3a; GSK3b","P24864","P24864",1167,null,"P24864","NP_001229","Block2",9,13,"2, 10, 18, 26",{"$nulls":13},"Protein-serine kinase regulatory subunit, activator, cyclin","GO:0097134; GO:0005829; GO:0005654; GO:0005634","GO:0050681; GO:0004693; GO:0016538; GO:0019901; GO:0003713","GO:0030521; GO:0051301; GO:0006270; GO:0000082; GO:0000122; GO:0045893; GO:0006468; GO:1903827; GO:0000083; GO:0007129; GO:0000723; GO:0016055"]
[509,257,"PN148","Connexin 43","S368","Gap junction alpha-1 protein",{"v":663.9420564796735,"d":"664"},{"v":607.4235541004941,"d":"607"},{"v":467.6159883593883,"d":"468"},{"v":70.43024068075499,"d":"70"},{"v":18.45340107684861,"d":"18"},{"v":2315.3304765242065,"d":"2315"},"External","RpAb","RA(pS)SR","Corresponds to amino acid residues  R365 to R369; Surrounds the S367 phosphosite.","S368 phosphorylation inhibits activity and induces interaction with CLTA and endocytosis. This is one of the minor in vivo phosphorylation sites in connexin 45 (≥5 reports from high throughput mass spectrometry studies).","PKACa (PRKACA); PKCa (PRKCA); PKCb1 (PRKCB1); PKCe (PRKCE); PKCg (PRKCG)","P17302","P17302",949,null,null,"NP_000156.1","Block2",7,10,"2, 10, 18, 26",{"$nulls":13},"Cytoskeletal protein","GO:0016324; GO:0030054; GO:0005922; GO:0043292; GO:0005829; GO:0005769; GO:0005789; GO:0005916; GO:0005925; GO:0005921; GO:0005794; GO:0030660; GO:0000139; GO:0005887; GO:0014704; GO:0005882; GO:0043231; GO:0016328; GO:0005764; GO:0045121; GO:0005741; GO:0005739; GO:0005771; GO:0005654; GO:0005886","GO:0048487; GO:0071253; GO:0097718; GO:0005243; GO:0086075; GO:1903763; GO:0015075; GO:0030165; GO:1990782; GO:0097110; GO:0017124; GO:0005102","GO:0007512; GO:0006915; GO:0015867; GO:0086014; GO:0003294; GO:0048514; GO:0007267; GO:0010643; GO:0010644; GO:0086064; GO:0071260; GO:0071374; GO:0071467; GO:0002544; GO:0046697; GO:0042733; GO:0003158; GO:1905867; GO:0002070; GO:0016264; GO:0007507; GO:0001947; GO:0001701; GO:0034220; GO:0002088; GO:0060156; GO:0006936; GO:0060044; GO:0030308; GO:2000279; GO:0001937; GO:0010629; GO:0061045; GO:0001764; GO:0048812; GO:0001649; GO:2000987; GO:0097755; GO:0010652; GO:0120162; GO:0007204; GO:0010628; GO:0003104; GO:0043123; GO:0032024; GO:0045669; GO:0045732; GO:0045844; GO:0045907; GO:0051259; GO:0060371; GO:2000810; GO:0030500; GO:0046850; GO:0051924; GO:0022898; GO:0060373; GO:0060307; GO:0032355; GO:0034405; GO:0009749; GO:0002931; GO:0032496; GO:0043434; GO:0032526; GO:0007165; GO:0043403; GO:0010232"]
[511,258,"NN398-1","Connexin 43","Pan-specific","Gap junction alpha-1 protein",{"v":381.0269375049693,"d":"381"},{"v":313.2551782147486,"d":"313"},{"v":269.03246664276213,"d":"269"},{"v":70.60720389073633,"d":"71"},{"v":57.951825491079894,"d":"58"},{"v":2631.016413256775,"d":"2631"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 357-381 at the C-terminus of human connexin 43.",null,null,"P17302","P17302",949,null,null,"NP_000156.1","Block2",7,11,"2, 10, 18, 26",{"$nulls":13},"Cytoskeletal protein","GO:0016324; GO:0030054; GO:0005922; GO:0043292; GO:0005829; GO:0005769; GO:0005789; GO:0005916; GO:0005925; GO:0005921; GO:0005794; GO:0030660; GO:0000139; GO:0005887; GO:0014704; GO:0005882; GO:0043231; GO:0016328; GO:0005764; GO:0045121; GO:0005741; GO:0005739; GO:0005771; GO:0005654; GO:0005886","GO:0048487; GO:0071253; GO:0097718; GO:0005243; GO:0086075; GO:1903763; GO:0015075; GO:0030165; GO:1990782; GO:0097110; GO:0017124; GO:0005102","GO:0007512; GO:0006915; GO:0015867; GO:0086014; GO:0003294; GO:0048514; GO:0007267; GO:0010643; GO:0010644; GO:0086064; GO:0071260; GO:0071374; GO:0071467; GO:0002544; GO:0046697; GO:0042733; GO:0003158; GO:1905867; GO:0002070; GO:0016264; GO:0007507; GO:0001947; GO:0001701; GO:0034220; GO:0002088; GO:0060156; GO:0006936; GO:0060044; GO:0030308; GO:2000279; GO:0001937; GO:0010629; GO:0061045; GO:0001764; GO:0048812; GO:0001649; GO:2000987; GO:0097755; GO:0010652; GO:0120162; GO:0007204; GO:0010628; GO:0003104; GO:0043123; GO:0032024; GO:0045669; GO:0045732; GO:0045844; GO:0045907; GO:0051259; GO:0060371; GO:2000810; GO:0030500; GO:0046850; GO:0051924; GO:0022898; GO:0060373; GO:0060307; GO:0032355; GO:0034405; GO:0009749; GO:0002931; GO:0032496; GO:0043434; GO:0032526; GO:0007165; GO:0043403; GO:0010232"]
[513,259,"NK042-1","COT (MAP3K8, TPL2)","Pan-specific","Osaka thyroid oncogene protein-serine kinase (Tpl2); Mitogen-activated protein kinase kinase kinase 8",{"v":6838.41402886236,"d":"6838"},{"v":6682.562088167788,"d":"6683"},{"v":1283.71699840766,"d":"1284"},{"v":18.772145017683574,"d":"19"},{"v":3806.5444209302386,"d":"3807"},{"v":11755.49102052085,"d":"11755"},"Kinexus","RpAb","MEYMSTGSDNKEEIDC","Corresponds to amino acid residues M1 to D15; N-terminus.",null,null,"P41279","P41279",711,"P41279","P41279","NP_005195","Block2",7,12,"2, 10, 18, 26","COT","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE-Unique",{"$nulls":6},"Protein-serine kinase, STE group, STE-Unique family","GO:0005737; GO:0005829","GO:0005524; GO:0000287; GO:0004709; GO:0004674","GO:0032147; GO:0007049; GO:0070498; GO:0006468; GO:0042981; GO:0007346; GO:0023014; GO:0051403; GO:0031098; GO:0031295"]
[515,260,"NK042-2","COT (MAP3K8, TPL2)","Pan-specific","Osaka thyroid oncogene protein-serine kinase (Tpl2); Mitogen-activated protein kinase kinase kinase 8",{"v":5745.792221364756,"d":"5746"},{"v":5485.656374374816,"d":"5486"},{"v":1320.652063946991,"d":"1321"},{"v":22.98468188662252,"d":"23"},{"v":3121.6137674106894,"d":"3122"},{"v":11354.96984278972,"d":"11355"},"Kinexus","RpAb","CAGYFNLVRGPPTLEYG","Corresponds to amino acid residues A452 to G467; C-terminus.",null,null,"P41279","P41279",711,"P41279","P41279","NP_005195","Block2",7,13,"2, 10, 18, 26","COT","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE-Unique",{"$nulls":6},"Protein-serine kinase, STE group, STE-Unique family","GO:0005737; GO:0005829","GO:0005524; GO:0000287; GO:0004709; GO:0004674","GO:0032147; GO:0007049; GO:0070498; GO:0006468; GO:0042981; GO:0007346; GO:0023014; GO:0051403; GO:0031098; GO:0031295"]
[517,261,"PK585","COT (MAP3K8, TPL2)","S334","Osaka thyroid oncogene protein-serine kinase (Tpl2); Mitogen-activated protein kinase kinase kinase 8",{"v":14329.870151285138,"d":"14330"},{"v":14444.818385452538,"d":"14445"},{"v":2723.822200038236,"d":"2724"},{"v":19.008003361383963,"d":"19"},{"v":7543.348664315517,"d":"7543"},{"v":25048.375413938815,"d":"25048"},"Kinexus","RpAb","YPR(pS)AYP(bA)C","Corresponds to amino acid residues Y331 to P337; In the kinase catalytic subdomain X region.","The effect of S334 phosphorylation is unclear. This is one of the minor in vivo phosphorylation sites in COT (≥1 report from high throughput mass spectrometry studies).",null,"P41279","P41279",711,"P41279","P41279","NP_005195","Block2",8,1,"2, 10, 18, 26","COT","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE-Unique",{"$nulls":6},"Protein-serine kinase, STE group, STE-Unique family","GO:0005737; GO:0005829","GO:0005524; GO:0000287; GO:0004709; GO:0004674","GO:0032147; GO:0007049; GO:0070498; GO:0006468; GO:0042981; GO:0007346; GO:0023014; GO:0051403; GO:0031098; GO:0031295"]
[519,262,"PN695","COX2","Y446","Prostaglandin G/H synthase 2",{"v":364.1794287252497,"d":"364"},{"v":337.1001892674456,"d":"337"},{"v":174.57861286937487,"d":"175"},{"v":47.93752724596737,"d":"48"},{"v":75.43476912795039,"d":"75"},{"v":1104.146521058097,"d":"1104"},"Kinexus","RpAb","ac-QMK(pY)QSF(bA)C","Corresponds to amino acid residues Q443 to F449.","Y446 phosphorylation activates COX2 enzymatic activity. However, this phosphosite has been poorly detected in  mass spectrometry studies (≥1 report by mass spectrometry). The phosphosite is commonly conserved in vertebrates and found in fish.","Fyn","P35354","P35354",23002,null,"P35354","NP_000954.1","Block2",8,2,"2, 10, 18, 26",{"$nulls":12},"X","Oxidoreductase; Lipid Metabolism - arachidonic acid; EC 1.14.99.1","GO:0005901; GO:0005737; GO:0005783; GO:0005788; GO:0005789; GO:0043005; GO:0031090; GO:0032991","GO:0050473; GO:0019899; GO:0020037; GO:0046872; GO:0016702; GO:0004601; GO:0004666; GO:0042803","GO:0007568; GO:0001525; GO:0030282; GO:0050873; GO:0071318; GO:0071498; GO:0034605; GO:0071456; GO:0071284; GO:0071260; GO:0071471; GO:0034644; GO:0019371; GO:0019221; GO:0046697; GO:0007566; GO:0042633; GO:0006954; GO:0007612; GO:0019372; GO:0042759; GO:0035633; GO:0007613; GO:0034356; GO:0097756; GO:0051926; GO:0045786; GO:0008285; GO:0043154; GO:1902219; GO:0045986; GO:0032227; GO:0030728; GO:0043065; GO:0090336; GO:0090050; GO:0031622; GO:0090271; GO:0045429; GO:0033138; GO:0090362; GO:0031394; GO:0042307; GO:0048661; GO:0045987; GO:0031915; GO:0051968; GO:0071636; GO:0010575; GO:0045907; GO:0001516; GO:0008217; GO:0050727; GO:1990776; GO:0032355; GO:0070542; GO:0009750; GO:0051384; GO:0032496; GO:0010226; GO:0010042; GO:0006979; GO:0034612; GO:0033280; GO:0019233"]
[521,263,"NN027-2","COX2","Pan-specific","Prostaglandin G/H synthase 2",{"v":384.08243361600586,"d":"384"},{"v":340.2198983557434,"d":"340"},{"v":218.39440278125585,"d":"218"},{"v":56.86133591821595,"d":"57"},{"v":87.40678798116872,"d":"87"},{"v":1900.151884695576,"d":"1900"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 169-192 within an internal region of human COX2.",null,null,"P00403","P00403",7428,null,null,"NP_000954.1","Block2",8,3,"2, 10, 18, 26",{"$nulls":12},"X",null,"GO:0016021; GO:0016020; GO:0005743; GO:0005751; GO:0005739; GO:0045277","GO:0005507; GO:0004129","GO:0042773; GO:0007595; GO:0006123; GO:2001171; GO:0010729; GO:0010940; GO:0009409"]
[523,265,"PN221","CPS2 (CAD)","T456","Carbamoyl phosphate synthetase 2",{"v":607.5589879255301,"d":"608"},{"v":493.057504306865,"d":"493"},{"v":534.2246734917157,"d":"534"},{"v":87.92967993376092,"d":"88"},{"v":131.20030961461183,"d":"131"},{"v":6219.413788471911,"d":"6219"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 447-460 Thr 456 of CPS2","The effect of T456 phosphorylation is unclear. This is one of the minor in vivo phosphorylation sites in CPS2 (≥1 reports from high throughput mass spectrometry studies).","ERK1 (MAPK3); ERK2 (MAPK1)","P27708","P27708",4928,null,null,"NP_001293008.1","Block2",8,5,"2, 10, 18, 26",{"$nulls":12},"X","EC 6.3.5.5; EC 2.1.3.2; Ligase; Nucleotide Metabolism - pyrimidine; EC 3.5.2.3; Transferase; Hydrolase; Amino Acid Metabolism - alanine, aspartate and glutamate","GO:0042995; GO:0005829; GO:0070062; GO:0016020; GO:0043025; GO:0016363; GO:0005654; GO:0005634; GO:0032991; GO:0043195","GO:0070335; GO:0004070; GO:0005524; GO:0004087; GO:0004088; GO:0004151; GO:0019899; GO:0042802; GO:0004672; GO:0008270","GO:0006207; GO:0044205; GO:0031100; GO:0006526; GO:0035690; GO:0071364; GO:0019240; GO:0017144; GO:0007565; GO:0006541; GO:0007507; GO:0007595; GO:0001889; GO:0018107; GO:0046777; GO:0046134; GO:0014075; GO:0031000; GO:0051414; GO:0032868; GO:0042594; GO:0033574; GO:0000050; GO:0006228"]
[525,266,"PN577","CREB1","S129+S133","cAMP-response element-binding protein 1",{"v":14645.846287645027,"d":"14646"},{"v":14148.375864780875,"d":"14148"},{"v":3346.7164594627156,"d":"3347"},{"v":22.85095988127327,"d":"23"},{"v":8771.909923503403,"d":"8772"},{"v":26939.798301683655,"d":"26940"},"Kinexus","RpAb","EIL(pS)RRP(pS)YRK(bA)C","Corresponds to amino acid residues E126 to K136.","S129 and S133 phosphorylation stimulate transcriptional activity and induce interactions with CBP, DNA, MEIS1, Myb, Nur77, RGS13, SOX9 and p300. S129 is a minor in vivo phosphorylation site in CREB1 (≥2 reports from high throughput mass spectrometry studies), but S133 is the major site (≥65 reports).","S129: BARK2 (GRK3, ADRBK2); GSK3a; GSK3b. S133: Akt1 (PKBa); Btk; CaMK1a; CaMK2a; CaMK4; DYRK3; MAPKAPK2; MSK1 (RPS6KA5); MSK2 (RPS6KA4); PKACa (PRKACA); PKCa (PRKCA); PKCe (PRKCE); PKD1 (PRKCM; PRKD1); RSK1 (RPS6KA1); RSK2 (RPS6KA3); RSK3 (RPS6KA2); SGK1; TSSK4; VRK1","P16220","P16220",1489,null,"P16220","NP_004370","Block2",8,6,"2, 10, 18, 26",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:1990589; GO:0030424; GO:0005759; GO:0005719; GO:0005654; GO:0005634","GO:1990763; GO:0035497; GO:0003700; GO:0019899; GO:0035035; GO:0030544; GO:0042802; GO:0001102; GO:0000980; GO:0000978; GO:0001225; GO:0000981; GO:0001077; GO:0001190; GO:0001228; GO:0003712; GO:0003705","GO:0007568; GO:0007409; GO:0071398; GO:0035729; GO:1990314; GO:1990830; GO:1990090; GO:0036120; GO:0071300; GO:0071294; GO:0034670; GO:0007623; GO:0007595; GO:0060430; GO:0007613; GO:1901215; GO:0010944; GO:0021983; GO:0043065; GO:0055025; GO:0045600; GO:0046887; GO:0046889; GO:1900273; GO:0040018; GO:0045672; GO:0045899; GO:0045893; GO:0045944; GO:0032916; GO:0006468; GO:0050821; GO:0008361; GO:0042752; GO:0048145; GO:0060251; GO:0014823; GO:0033762; GO:0001666; GO:1902065; GO:0035094; GO:0010033; GO:0033363; GO:0007165; GO:0007179; GO:0060509; GO:0016032; GO:0008542"]
[527,267,"PN553","CREB1","S133","cAMP-response element-binding protein 1",{"v":13427.992279243568,"d":"13428"},{"v":12577.838697437877,"d":"12578"},{"v":5159.297699944023,"d":"5159"},{"v":38.421959088545584,"d":"38"},{"v":3914.750839080134,"d":"3915"},{"v":28287.77322870541,"d":"28288"},"Kinexus","RpAb","RRP(pS)YRK(bA)C     ","Corresponds to amino acid residues R130 to K136; In the PKID domain.","S133 phosphorylation stimulates transcriptional activity and induces interactions with CBP, DNA, MEIS1, Myb, Nur77, RGS13, SOX9 and p300. This is one of the major in vivo phosphorylation sites in CREB1 (≥65 reports from high throughput mass spectrometry studies).","Akt1 (PKBa); Btk; CaMK1a; CaMK2a; CaMK4; DYRK3; MAPKAPK2; MSK1 (RPS6KA5); MSK2 (RPS6KA4); PKACa (PRKACA); PKCa (PRKCA); PKCe (PRKCE); PKD1 (PRKCM; PRKD1); RSK1 (RPS6KA1); RSK2 (RPS6KA3); RSK3 (RPS6KA2); SGK1; TSSK4; VRK1","P16220","P16220",1489,null,"P16220","NP_004370","Block2",8,7,"2, 10, 18, 26",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:1990589; GO:0030424; GO:0005759; GO:0005719; GO:0005654; GO:0005634","GO:1990763; GO:0035497; GO:0003700; GO:0019899; GO:0035035; GO:0030544; GO:0042802; GO:0001102; GO:0000980; GO:0000978; GO:0001225; GO:0000981; GO:0001077; GO:0001190; GO:0001228; GO:0003712; GO:0003705","GO:0007568; GO:0007409; GO:0071398; GO:0035729; GO:1990314; GO:1990830; GO:1990090; GO:0036120; GO:0071300; GO:0071294; GO:0034670; GO:0007623; GO:0007595; GO:0060430; GO:0007613; GO:1901215; GO:0010944; GO:0021983; GO:0043065; GO:0055025; GO:0045600; GO:0046887; GO:0046889; GO:1900273; GO:0040018; GO:0045672; GO:0045899; GO:0045893; GO:0045944; GO:0032916; GO:0006468; GO:0050821; GO:0008361; GO:0042752; GO:0048145; GO:0060251; GO:0014823; GO:0033762; GO:0001666; GO:1902065; GO:0035094; GO:0010033; GO:0033363; GO:0007165; GO:0007179; GO:0060509; GO:0016032; GO:0008542"]
[529,268,"NN182-2","CrkL","Pan-specific","Crk-like protein",{"v":1249.1697850173114,"d":"1249"},{"v":1101.962126414747,"d":"1102"},{"v":742.6567591507784,"d":"743"},{"v":59.45202710298396,"d":"59"},{"v":74.04868876776962,"d":"74"},{"v":6929.133714147258,"d":"6929"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 181-242 of human Crk-L .",null,null,"P46109","P46109",1084,null,"P46109","NP_005198.1","Block2",8,8,"2, 10, 18, 26",{"$nulls":11},"X",null,"Adapter/scaffold protein","GO:0005829; GO:0005768; GO:0098890; GO:0031594; GO:0005654","GO:0045296; GO:0042802; GO:0001784; GO:0003723; GO:0005070","GO:0000186; GO:0009887; GO:0009952; GO:0001568; GO:0071560; GO:0019221; GO:0007507; GO:0035556; GO:0007254; GO:0010629; GO:0001933; GO:0060017; GO:0008284; GO:0070374; GO:1903977; GO:0001934; GO:1900026; GO:0007265; GO:0007416; GO:0048538"]
[531,269,"PN507","CrkL","Y251","Crk-like protein",{"v":867.1633163647858,"d":"867"},{"v":811.3840934743164,"d":"811"},{"v":495.5399062446858,"d":"496"},{"v":57.1449341655764,"d":"57"},{"v":75.16105681823959,"d":"75"},{"v":4282.5191403618865,"d":"4283"},"Kinexus","RpAb","PCA(pY)DKT(bA)C","Corresponds to amino acid residues P248 to T254; In the SH3_2 domain. ","Y251 phosphorylation induces activity. The second major in vivo phosphoryation site in CrkL (≥697 reports from high throughput mass spectrometry studies).","Abl1","P46109","P46109",1084,null,"P46109","NP_005198.1","Block2",8,9,"2, 10, 18, 26",{"$nulls":11},"X",null,"Adapter/scaffold protein","GO:0005829; GO:0005768; GO:0098890; GO:0031594; GO:0005654","GO:0045296; GO:0042802; GO:0001784; GO:0003723; GO:0005070","GO:0000186; GO:0009887; GO:0009952; GO:0001568; GO:0071560; GO:0019221; GO:0007507; GO:0035556; GO:0007254; GO:0010629; GO:0001933; GO:0060017; GO:0008284; GO:0070374; GO:1903977; GO:0001934; GO:1900026; GO:0007265; GO:0007416; GO:0048538"]
[533,270,"PN025","CRYAB","S19","Crystallin aB",{"v":716.7265627313541,"d":"717"},{"v":535.9290479231458,"d":"536"},{"v":676.8727335812453,"d":"677"},{"v":94.43946531042035,"d":"94"},{"v":51.51964631689914,"d":"52"},{"v":4230.350717819735,"d":"4230"},"External","RpAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the S19 phosphosite.","S19 phosphorylation appears to induce activity, although one report indicates inhibition. Phosphorylation induces interaction with FBXO4 and inhibits interaction with CRYAB. This is one of the major in vivo phosphorylation sites in crystallin aB (≥16 reports from high throughput mass spectrometry studies).",null,"P02511","P02511",1265,null,"P02511","NP_001876","Block2",8,10,"2, 10, 18, 26",{"$nulls":9},"X",{"$nulls":3},"Chaperone protein","GO:0032432; GO:0030424; GO:0097512; GO:0009986; GO:0005737; GO:0005829; GO:0043197; GO:0070062; GO:0005794; GO:0031430; GO:0015630; GO:0005739; GO:0043209; GO:0005654; GO:0005634; GO:0043204; GO:0014069; GO:0097060; GO:0030018","GO:0001540; GO:0042802; GO:0046872; GO:0008017; GO:0044877; GO:0042803; GO:0005212; GO:0051082","GO:0060561; GO:0071480; GO:0002088; GO:0031109; GO:0010259; GO:0006936; GO:0007517; GO:1905907; GO:0043066; GO:0030308; GO:0043154; GO:0010629; GO:0032387; GO:0032463; GO:2000378; GO:0006457; GO:0051260; GO:0050821; GO:0010941; GO:1900034; GO:0032355; GO:0042542; GO:0001666; GO:0051403; GO:0007021"]
[535,271,"PN110","CRYAB","S45","Crystallin aB",{"v":2106.5109660808785,"d":"2107"},{"v":1843.5346401300471,"d":"1844"},{"v":1128.1563522247436,"d":"1128"},{"v":53.55568380086129,"d":"54"},{"v":144.18298969722565,"d":"144"},{"v":7315.802729555056,"d":"7316"},"External","RpAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the S45 phosphosite.","The effect of S45 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in crystallin aB (≥8 reports from high throughput mass spectrometry studies).","ERK1 (MAPK3); ERK2 (MAPK1)","P02511","P02511",1265,null,"P02511","NP_001876","Block2",8,11,"2, 10, 18, 26",{"$nulls":9},"X",{"$nulls":3},"Chaperone protein","GO:0032432; GO:0030424; GO:0097512; GO:0009986; GO:0005737; GO:0005829; GO:0043197; GO:0070062; GO:0005794; GO:0031430; GO:0015630; GO:0005739; GO:0043209; GO:0005654; GO:0005634; GO:0043204; GO:0014069; GO:0097060; GO:0030018","GO:0001540; GO:0042802; GO:0046872; GO:0008017; GO:0044877; GO:0042803; GO:0005212; GO:0051082","GO:0060561; GO:0071480; GO:0002088; GO:0031109; GO:0010259; GO:0006936; GO:0007517; GO:1905907; GO:0043066; GO:0030308; GO:0043154; GO:0010629; GO:0032387; GO:0032463; GO:2000378; GO:0006457; GO:0051260; GO:0050821; GO:0010941; GO:1900034; GO:0032355; GO:0042542; GO:0001666; GO:0051403; GO:0007021"]
[537,272,"NK234-3","CSF1R (Fms)","Pan-specific","Macrophage colony-stimulating factor 1 receptor",{"v":14488.83969138527,"d":"14489"},{"v":14096.187596512407,"d":"14096"},{"v":2273.776305106209,"d":"2274"},{"v":15.693294656701488,"d":"16"},{"v":9535.844858956922,"d":"9536"},{"v":21909.577954727538,"d":"21910"},"Kinexus","RpAb","CLAQEVVVFEDQDALL","Corresponds to amino acid residues L111 to L125.",null,null,"P07333","P07333",876,"P07333","P07333","NP_005202.2","Block2",8,12,"2, 10, 18, 26","Fms","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; PDGFR family","GO:0009986; GO:1990682; GO:0005887; GO:0043231; GO:0005654; GO:0005886","GO:0005524; GO:0019955; GO:0005011; GO:0042803; GO:0019903","GO:0007411; GO:0045217; GO:0008283; GO:0071345; GO:0036006; GO:0019221; GO:0021879; GO:0030097; GO:0006954; GO:0045087; GO:0038145; GO:0030225; GO:0060603; GO:0030224; GO:0007275; GO:0043066; GO:0008285; GO:0021772; GO:0030316; GO:0018108; GO:0048015; GO:0046488; GO:0030335; GO:2000147; GO:0008284; GO:0090197; GO:0070374; GO:0001934; GO:0071902; GO:0061098; GO:0042531; GO:0046777; GO:2000249; GO:0045124; GO:0008360; GO:0031529; GO:0007165; GO:0007169"]
[539,273,"NK234-4","CSF1R (Fms)","Pan-specific","Macrophage colony-stimulating factor 1 receptor",{"v":15536.139095764325,"d":"15536"},{"v":15382.296446095494,"d":"15382"},{"v":2821.808381204262,"d":"2822"},{"v":18.16286764562749,"d":"18"},{"v":7522.7889129349405,"d":"7523"},{"v":25214.792538390957,"d":"25215"},"Kinexus","RpAb","CLSSEQNLIQEVTVGE","Corresponds to amino acid residues L303 to E317.",null,null,"P07333","P07333",876,"P07333","P07333","NP_005202.2","Block2",8,13,"2, 10, 18, 26","Fms","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; PDGFR family","GO:0009986; GO:1990682; GO:0005887; GO:0043231; GO:0005654; GO:0005886","GO:0005524; GO:0019955; GO:0005011; GO:0042803; GO:0019903","GO:0007411; GO:0045217; GO:0008283; GO:0071345; GO:0036006; GO:0019221; GO:0021879; GO:0030097; GO:0006954; GO:0045087; GO:0038145; GO:0030225; GO:0060603; GO:0030224; GO:0007275; GO:0043066; GO:0008285; GO:0021772; GO:0030316; GO:0018108; GO:0048015; GO:0046488; GO:0030335; GO:2000147; GO:0008284; GO:0090197; GO:0070374; GO:0001934; GO:0071902; GO:0061098; GO:0042531; GO:0046777; GO:2000249; GO:0045124; GO:0008360; GO:0031529; GO:0007165; GO:0007169"]
[541,274,"PK587","CSF1R (Fms)","Y699","Macrophage colony-stimulating factor 1 receptor",{"v":1902.8986135030555,"d":"1903"},{"v":1766.6347544313853,"d":"1767"},{"v":958.2490186647328,"d":"958"},{"v":50.35733442995618,"d":"50"},{"v":534.5879407099333,"d":"535"},{"v":8369.91602938576,"d":"8370"},"Kinexus","RpAb","GVD(pY)KNI(bA)C","Corresponds to amino acid residues G696 to I702; In the kinase catallytic domain. ","Y699 phosphorylation induces binding to PIK3CB and Grb2. This is the major in vivo phosphorylation site in CSF1R (≥36 reports from high throughput mass spectrometry studies).","CSF1R","P07333","P07333",876,"P07333","P07333","NP_005202.2","Block2",9,1,"2, 10, 18, 26","Fms","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; PDGFR family","GO:0009986; GO:1990682; GO:0005887; GO:0043231; GO:0005654; GO:0005886","GO:0005524; GO:0019955; GO:0005011; GO:0042803; GO:0019903","GO:0007411; GO:0045217; GO:0008283; GO:0071345; GO:0036006; GO:0019221; GO:0021879; GO:0030097; GO:0006954; GO:0045087; GO:0038145; GO:0030225; GO:0060603; GO:0030224; GO:0007275; GO:0043066; GO:0008285; GO:0021772; GO:0030316; GO:0018108; GO:0048015; GO:0046488; GO:0030335; GO:2000147; GO:0008284; GO:0090197; GO:0070374; GO:0001934; GO:0071902; GO:0061098; GO:0042531; GO:0046777; GO:2000249; GO:0045124; GO:0008360; GO:0031529; GO:0007165; GO:0007169"]
[543,275,"PK586","CSF1R (Fms)","S807+Y809","Macrophage colony-stimulating factor 1 receptor",{"v":9229.402683139448,"d":"9229"},{"v":9207.209879189559,"d":"9207"},{"v":2104.9330551495905,"d":"2105"},{"v":22.80681781275993,"d":"23"},{"v":908.2319522359618,"d":"908"},{"v":15767.250993308515,"d":"15767"},"Kinexus","RpAb","MND(pS)N(pY)IVKG(bA)C","Corresponds to amino acid residues M804 to G813; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y809 phosphorylation induces interaction with and activation of Src family members, including Fyn, Yes1 and Src as well as binding to PLCG2. S807 and Y809 phosphorylation stimulates receptor activation, transcription, cell cycle progression and cell growth. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. Y809 is one of the major in vivo phosphorylation sites in CSF1R (≥13 reports from high throughput mass spectrometry studies), but phosphorylation of S807 has not been observed in high throughput experiments.","Y809: CSF1R","P07333","P07333",876,"P07333","P07333","NP_005202.2","Block2",9,2,"2, 10, 18, 26","Fms","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; PDGFR family","GO:0009986; GO:1990682; GO:0005887; GO:0043231; GO:0005654; GO:0005886","GO:0005524; GO:0019955; GO:0005011; GO:0042803; GO:0019903","GO:0007411; GO:0045217; GO:0008283; GO:0071345; GO:0036006; GO:0019221; GO:0021879; GO:0030097; GO:0006954; GO:0045087; GO:0038145; GO:0030225; GO:0060603; GO:0030224; GO:0007275; GO:0043066; GO:0008285; GO:0021772; GO:0030316; GO:0018108; GO:0048015; GO:0046488; GO:0030335; GO:2000147; GO:0008284; GO:0090197; GO:0070374; GO:0001934; GO:0071902; GO:0061098; GO:0042531; GO:0046777; GO:2000249; GO:0045124; GO:0008360; GO:0031529; GO:0007165; GO:0007169"]
[545,276,"PK588","CSF1R (Fms)","Y809","Macrophage colony-stimulating factor 1 receptor",{"v":3352.9611627123268,"d":"3353"},{"v":3202.901322107952,"d":"3203"},{"v":1014.5115069707435,"d":"1015"},{"v":30.257180376943882,"d":"30"},{"v":778.1838826450264,"d":"778"},{"v":8909.150805055444,"d":"8909"},"Kinexus","RpAb","DSN(pY)IVK(bA)C","Corresponds to amino acid residues D806 to K812; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y809 phosphorylation induces interaction with and activation of Src family members, including Fyn, Yes1 and Src as well as binding to PLCG2. Its phosphorylation stimulates receptor activation, transcription, cell cycle progression and cell growth. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in CSF1R (≥13 reports from high throughput mass spectrometry studies).","CSF1R","P07333","P07333",876,"P07333","P07333","NP_005202.2","Block2",9,3,"2, 10, 18, 26","Fms","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; PDGFR family","GO:0009986; GO:1990682; GO:0005887; GO:0043231; GO:0005654; GO:0005886","GO:0005524; GO:0019955; GO:0005011; GO:0042803; GO:0019903","GO:0007411; GO:0045217; GO:0008283; GO:0071345; GO:0036006; GO:0019221; GO:0021879; GO:0030097; GO:0006954; GO:0045087; GO:0038145; GO:0030225; GO:0060603; GO:0030224; GO:0007275; GO:0043066; GO:0008285; GO:0021772; GO:0030316; GO:0018108; GO:0048015; GO:0046488; GO:0030335; GO:2000147; GO:0008284; GO:0090197; GO:0070374; GO:0001934; GO:0071902; GO:0061098; GO:0042531; GO:0046777; GO:2000249; GO:0045124; GO:0008360; GO:0031529; GO:0007165; GO:0007169"]
[547,277,"NK044-3","Csk","Pan-specific","C-terminus of Src tyrosine kinase",{"v":3860.818121320434,"d":"3861"},{"v":3732.1540279027704,"d":"3732"},{"v":952.6988485516648,"d":"953"},{"v":24.676087259604795,"d":"25"},{"v":669.9919389543924,"d":"670"},{"v":7942.197411710259,"d":"7942"},"External","MmAb","Not precisely defined.","Antibody raised against a peptide mapping at the C-terminus of human Csk.",null,null,"P41240","P41240",1240,"P41240","P41240","NP_004374","Block2",9,4,"2, 10, 18, 26","CSK","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Csk",{"$nulls":6},"Protein-tyrosine kinase, TK group, Csk family","GO:0005911; GO:0005737; GO:0005829; GO:0070062; GO:0031234; GO:0045121; GO:0005886","GO:0005524; GO:0042802; GO:0016301; GO:0046872; GO:0004715; GO:0070064; GO:0008022; GO:0034236; GO:0019903; GO:0004713; GO:0005102","GO:0002250; GO:0034332; GO:0007420; GO:0030154; GO:0071375; GO:0007417; GO:0045087; GO:0045779; GO:0008285; GO:0070373; GO:0042997; GO:0032715; GO:0033673; GO:0010989; GO:0050765; GO:0048709; GO:0038083; GO:0043406; GO:0006468; GO:0042127; GO:0001817; GO:0060368; GO:0031295; GO:0050852; GO:0007169"]
[549,278,"NK044","Csk","Pan-specific","C-terminus of Src tyrosine kinase",{"v":58.039298131108836,"d":"58"},{"v":30.1401530363867,"d":"30"},{"v":100.45298682075634,"d":"100"},{"v":173.07753548955122,"d":"173"},{"v":9.54066442070478,"d":"10"},{"v":686.4883599536249,"d":"686"},"External","MmAb","Epitope undefined.",{"$nulls":3},"P41240","P41240",1240,"P41240","P41240","NP_004374","Block2",9,5,"2, 10, 18, 26","CSK","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Csk",{"$nulls":6},"Protein-tyrosine kinase, TK group, Csk family","GO:0005911; GO:0005737; GO:0005829; GO:0070062; GO:0031234; GO:0045121; GO:0005886","GO:0005524; GO:0042802; GO:0016301; GO:0046872; GO:0004715; GO:0070064; GO:0008022; GO:0034236; GO:0019903; GO:0004713; GO:0005102","GO:0002250; GO:0034332; GO:0007420; GO:0030154; GO:0071375; GO:0007417; GO:0045087; GO:0045779; GO:0008285; GO:0070373; GO:0042997; GO:0032715; GO:0033673; GO:0010989; GO:0050765; GO:0048709; GO:0038083; GO:0043406; GO:0006468; GO:0042127; GO:0001817; GO:0060368; GO:0031295; GO:0050852; GO:0007169"]
[551,279,"PK589","Csk","Y184","C-terminus of Src tyrosine kinase",{"v":3616.2384724992226,"d":"3616"},{"v":3534.608668275334,"d":"3535"},{"v":1243.509335382517,"d":"1244"},{"v":34.38681781744095,"d":"34"},{"v":253.582426105454,"d":"254"},{"v":9348.257210833875,"d":"9348"},"Kinexus","RpAb","DEF(pY)RSG(bA)C","Corresponds to amino acid residues D181 to G187; In the region between the SH2 domain and the protein kinase catalytic domain.","Y184 phosphorylation stimulates phosphotransferase activity. This is the major in vivo phosphorylation site in Csk (≥40 reports from high throughput mass spectrometry studies).",null,"P41240","P41240",1240,"P41240","P41240","NP_004374","Block2",9,6,"2, 10, 18, 26","CSK","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Csk",{"$nulls":6},"Protein-tyrosine kinase, TK group, Csk family","GO:0005911; GO:0005737; GO:0005829; GO:0070062; GO:0031234; GO:0045121; GO:0005886","GO:0005524; GO:0042802; GO:0016301; GO:0046872; GO:0004715; GO:0070064; GO:0008022; GO:0034236; GO:0019903; GO:0004713; GO:0005102","GO:0002250; GO:0034332; GO:0007420; GO:0030154; GO:0071375; GO:0007417; GO:0045087; GO:0045779; GO:0008285; GO:0070373; GO:0042997; GO:0032715; GO:0033673; GO:0010989; GO:0050765; GO:0048709; GO:0038083; GO:0043406; GO:0006468; GO:0042127; GO:0001817; GO:0060368; GO:0031295; GO:0050852; GO:0007169"]
[553,175,"PN162","CTNNA1","S641","Catenin alpha-1",{"v":721.3456034189841,"d":"721"},{"v":690.5415925228567,"d":"691"},{"v":443.4877896145695,"d":"443"},{"v":61.480625585372216,"d":"61"},{"v":16.92242949355449,"d":"17"},{"v":2529.7240640082064,"d":"2530"},"External","RpAb","DD(pS)DF","Corresponds to amino acid residues D639 to F643.","The effect of S641 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in CTNNA1.",null,"P35221","P35221",2880,null,"P35221","NP_001277236.1","Block2",1,6,"2, 10, 18, 26",{"$nulls":13},"Cytoskeletal protein; Plasma membrane, cytoplasm, cell junction and actin associated ","GO:0001669; GO:0015629; GO:0016342; GO:0005911; GO:0030054; GO:0005829; GO:0016600; GO:0005925; GO:0005794; GO:0014704; GO:0043231; GO:0030027; GO:0005886; GO:0005915","GO:0051015; GO:0008013; GO:0045296; GO:0045295; GO:0042802; GO:0046982; GO:0003723; GO:0005198; GO:0017166","GO:0007015; GO:0034332; GO:0007568; GO:0043297; GO:0031103; GO:0007155; GO:0034613; GO:0071681; GO:0090136; GO:0007163; GO:0016264; GO:0008584; GO:2000146; GO:2001240; GO:2001045; GO:0007406; GO:0042475; GO:0001541; GO:2001241; GO:0051149; GO:0045880; GO:0051291; GO:0043627"]
[555,176,"NN021-2","CTNNB1","Pan-specific","Catenin (cadherin-associated protein) beta 1",{"v":168.39482872217948,"d":"168"},{"v":128.74531244398793,"d":"129"},{"v":120.80531580473689,"d":"121"},{"v":71.73932639228694,"d":"72"},{"v":19.650982108786906,"d":"20"},{"v":857.5502657962095,"d":"858"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 680-781 mapping at the C-terminus of human β-catenin ",null,null,"P35222","P35222",454,null,"P35222","NP_001895","Block2",1,7,"2, 10, 18, 26",{"$nulls":3},"Transcription protein; Cytoskeletal protein",{"$nulls":4},"X",{"$nulls":4},"Cytoskeletal protein","GO:0005912; GO:0016323; GO:0030877; GO:0070369; GO:1990907; GO:0016342; GO:0005913; GO:0005911; GO:0005938; GO:0030054; GO:0071944; GO:0042995; GO:0005813; GO:0005737; GO:0005829; GO:0070062; GO:0005925; GO:0005622; GO:0016328; GO:0016020; GO:0005719; GO:0005654; GO:0005634; GO:0048471; GO:0005886; GO:0032991; GO:0032993; GO:0000922; GO:0045202; GO:0005667; GO:1990909","GO:0045294; GO:0050681; GO:0045296; GO:0003682; GO:0019899; GO:0030331; GO:0044325; GO:0070411; GO:0019900; GO:0035257; GO:0008022; GO:0019903; GO:0001102; GO:0001085; GO:0046332; GO:0003713; GO:0008134","GO:0034333; GO:0030521; GO:1904886; GO:1904837; GO:0001569; GO:0060070; GO:1904954; GO:0044336; GO:0061324; GO:0044334; GO:0007155; GO:0098609; GO:0071363; GO:0071681; GO:0036023; GO:0061154; GO:0035635; GO:0001837; GO:0035315; GO:1904948; GO:0016525; GO:0043066; GO:0008285; GO:0045976; GO:0033234; GO:0045892; GO:1990138; GO:0043065; GO:1904798; GO:0051091; GO:2000144; GO:0010718; GO:0010909; GO:0051571; GO:0051149; GO:0002052; GO:0043525; GO:0045893; GO:0045944; GO:0032481; GO:0034394; GO:0045765; GO:0090279; GO:0060828; GO:0030997; GO:0070602; GO:0048145; GO:0072182; GO:0050767; GO:2000008; GO:0048660; GO:0042493; GO:0032355; GO:0019827; GO:0061549; GO:0006351; GO:0016032; GO:0016055; GO:0007223"]
[557,177,"NN021","CTNNB1","Pan-specific","Catenin (cadherin-associated protein) beta 1",{"v":2119.372317139239,"d":"2119"},{"v":1909.098555254287,"d":"1909"},{"v":1566.4735904091685,"d":"1566"},{"v":73.91214737218132,"d":"74"},{"v":226.97787934562695,"d":"227"},{"v":18285.83160166407,"d":"18286"},"External","RpAb","Epitope undefined.",{"$nulls":3},"P35222","P35222",454,null,"P35222","NP_001895","Block2",1,8,"2, 10, 18, 26",{"$nulls":3},"Transcription protein; Cytoskeletal protein",{"$nulls":4},"X",{"$nulls":4},"Cytoskeletal protein","GO:0005912; GO:0016323; GO:0030877; GO:0070369; GO:1990907; GO:0016342; GO:0005913; GO:0005911; GO:0005938; GO:0030054; GO:0071944; GO:0042995; GO:0005813; GO:0005737; GO:0005829; GO:0070062; GO:0005925; GO:0005622; GO:0016328; GO:0016020; GO:0005719; GO:0005654; GO:0005634; GO:0048471; GO:0005886; GO:0032991; GO:0032993; GO:0000922; GO:0045202; GO:0005667; GO:1990909","GO:0045294; GO:0050681; GO:0045296; GO:0003682; GO:0019899; GO:0030331; GO:0044325; GO:0070411; GO:0019900; GO:0035257; GO:0008022; GO:0019903; GO:0001102; GO:0001085; GO:0046332; GO:0003713; GO:0008134","GO:0034333; GO:0030521; GO:1904886; GO:1904837; GO:0001569; GO:0060070; GO:1904954; GO:0044336; GO:0061324; GO:0044334; GO:0007155; GO:0098609; GO:0071363; GO:0071681; GO:0036023; GO:0061154; GO:0035635; GO:0001837; GO:0035315; GO:1904948; GO:0016525; GO:0043066; GO:0008285; GO:0045976; GO:0033234; GO:0045892; GO:1990138; GO:0043065; GO:1904798; GO:0051091; GO:2000144; GO:0010718; GO:0010909; GO:0051571; GO:0051149; GO:0002052; GO:0043525; GO:0045893; GO:0045944; GO:0032481; GO:0034394; GO:0045765; GO:0090279; GO:0060828; GO:0030997; GO:0070602; GO:0048145; GO:0072182; GO:0050767; GO:2000008; GO:0048660; GO:0042493; GO:0032355; GO:0019827; GO:0061549; GO:0006351; GO:0016032; GO:0016055; GO:0007223"]
[559,178,"PN166","CTNNB1","S33","Catenin (cadherin-associated protein) beta 1",{"v":1510.3213837838816,"d":"1510"},{"v":1518.3916866026534,"d":"1518"},{"v":753.9797152786875,"d":"754"},{"v":49.92180627077566,"d":"50"},{"v":20.54999782175299,"d":"21"},{"v":5236.898821476076,"d":"5237"},"External","RpAb","LD(pS)GI","Corresponds to amino acid residues L31 to I35.","S33 phosphorylation inhibits transcriptional activity and induces binding to CBLL1. This is one of the minor in vivo phosphorylation sites in CTNNB1 (≥5 reports from high throughput mass spectrometry studies).","CDK2; GSK3a; GSK3b; IKKa (CHUK, IKBKA)","P35222","P35222",454,null,"P35222","NP_001895","Block2",1,9,"2, 10, 18, 26",{"$nulls":3},"Transcription protein; Cytoskeletal protein",{"$nulls":4},"X",{"$nulls":4},"Cytoskeletal protein","GO:0005912; GO:0016323; GO:0030877; GO:0070369; GO:1990907; GO:0016342; GO:0005913; GO:0005911; GO:0005938; GO:0030054; GO:0071944; GO:0042995; GO:0005813; GO:0005737; GO:0005829; GO:0070062; GO:0005925; GO:0005622; GO:0016328; GO:0016020; GO:0005719; GO:0005654; GO:0005634; GO:0048471; GO:0005886; GO:0032991; GO:0032993; GO:0000922; GO:0045202; GO:0005667; GO:1990909","GO:0045294; GO:0050681; GO:0045296; GO:0003682; GO:0019899; GO:0030331; GO:0044325; GO:0070411; GO:0019900; GO:0035257; GO:0008022; GO:0019903; GO:0001102; GO:0001085; GO:0046332; GO:0003713; GO:0008134","GO:0034333; GO:0030521; GO:1904886; GO:1904837; GO:0001569; GO:0060070; GO:1904954; GO:0044336; GO:0061324; GO:0044334; GO:0007155; GO:0098609; GO:0071363; GO:0071681; GO:0036023; GO:0061154; GO:0035635; GO:0001837; GO:0035315; GO:1904948; GO:0016525; GO:0043066; GO:0008285; GO:0045976; GO:0033234; GO:0045892; GO:1990138; GO:0043065; GO:1904798; GO:0051091; GO:2000144; GO:0010718; GO:0010909; GO:0051571; GO:0051149; GO:0002052; GO:0043525; GO:0045893; GO:0045944; GO:0032481; GO:0034394; GO:0045765; GO:0090279; GO:0060828; GO:0030997; GO:0070602; GO:0048145; GO:0072182; GO:0050767; GO:2000008; GO:0048660; GO:0042493; GO:0032355; GO:0019827; GO:0061549; GO:0006351; GO:0016032; GO:0016055; GO:0007223"]
[561,179,"PN278","CTNNB1","S33+S37","Catenin (cadherin-associated protein) beta 1",{"v":66.95435621617139,"d":"67"},{"v":53.445644356777656,"d":"53"},{"v":52.93716265304766,"d":"53"},{"v":79.06455329378825,"d":"79"},{"v":12.6061294036579,"d":"13"},{"v":467.81858433656686,"d":"468"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 32-45 of human β-catenin.","S33 and S37 phosphorylation inhibits transcriptional activity and induces binding to CBLL1.  These are two of the minor in vivo phosphorylation sites in CTNNB1 (≥5 and ≥15 reports, respectively, by mass spectrometry).","S33: CDK2; GSK3a; GSK3b; IKKa (CHUK, IKBKA). S37: CDK2; GSK3a; GSK3b; IKKa (CHUK, IKBKA); JNK1. ","P35222","P35222",454,null,"P35222","NP_001895","Block2",1,10,"2, 10, 18, 26",{"$nulls":3},"Transcription protein; Cytoskeletal protein",{"$nulls":4},"X",{"$nulls":4},"Cytoskeletal protein","GO:0005912; GO:0016323; GO:0030877; GO:0070369; GO:1990907; GO:0016342; GO:0005913; GO:0005911; GO:0005938; GO:0030054; GO:0071944; GO:0042995; GO:0005813; GO:0005737; GO:0005829; GO:0070062; GO:0005925; GO:0005622; GO:0016328; GO:0016020; GO:0005719; GO:0005654; GO:0005634; GO:0048471; GO:0005886; GO:0032991; GO:0032993; GO:0000922; GO:0045202; GO:0005667; GO:1990909","GO:0045294; GO:0050681; GO:0045296; GO:0003682; GO:0019899; GO:0030331; GO:0044325; GO:0070411; GO:0019900; GO:0035257; GO:0008022; GO:0019903; GO:0001102; GO:0001085; GO:0046332; GO:0003713; GO:0008134","GO:0034333; GO:0030521; GO:1904886; GO:1904837; GO:0001569; GO:0060070; GO:1904954; GO:0044336; GO:0061324; GO:0044334; GO:0007155; GO:0098609; GO:0071363; GO:0071681; GO:0036023; GO:0061154; GO:0035635; GO:0001837; GO:0035315; GO:1904948; GO:0016525; GO:0043066; GO:0008285; GO:0045976; GO:0033234; GO:0045892; GO:1990138; GO:0043065; GO:1904798; GO:0051091; GO:2000144; GO:0010718; GO:0010909; GO:0051571; GO:0051149; GO:0002052; GO:0043525; GO:0045893; GO:0045944; GO:0032481; GO:0034394; GO:0045765; GO:0090279; GO:0060828; GO:0030997; GO:0070602; GO:0048145; GO:0072182; GO:0050767; GO:2000008; GO:0048660; GO:0042493; GO:0032355; GO:0019827; GO:0061549; GO:0006351; GO:0016032; GO:0016055; GO:0007223"]
[563,280,"PN578","CTNNB1","S33+S37+T41+S45","Catenin (cadherin-associated protein) beta 1",{"v":13865.130759510608,"d":"13865"},{"v":13330.964759853818,"d":"13331"},{"v":3445.0162031872574,"d":"3445"},{"v":24.846618924413626,"d":"25"},{"v":2923.925129751691,"d":"2924"},{"v":27094.113972885763,"d":"27094"},"Kinexus","RpAb","LD(pS)GIH(pS)GAT(pT)TAP(pS)LSGC","Corresponds to amino acid residues L31 to G48.","S33+S37+T41+S45 phosphorylation induces binding to CBLL1. S33 phosphorylation also inhibits transcriptional activity. S45 phosphorylation alters cellular adhesion and also induces interaction with CDH1 and axin 1. These are four of the major in vivo phosphorylation sites in CTNNB1 (≥5, ≥15, ≥3 and ≥5 reports, respectively, from high throughput mass spectrometry studies).","S33: CDK2; GSK3a; GSK3b; IKKa (CHUK, IKBKA). S37: CDK2; GSK3a; GSK3b; IKKa (CHUK, IKBKA). T41: CDK2; CK1e1 (CSNK1E); GSK3a; GSK3b; IKKa (CHUK, IKBKA). S45: CDK2; CK1a1 (CSNK1A1); CK1d1 (CSNK1D); CK1e1 (CSNK1E); GSK3b; IKKa (CHUK, IKBKA); PKACa (PRKACA).","P35222","P35222",454,null,"P35222","NP_001091679.1","Block2",9,7,"2, 10, 18, 26",{"$nulls":3},"Transcription protein; Cytoskeletal protein",{"$nulls":4},"X",{"$nulls":4},"Cytoskeletal protein","GO:0005912; GO:0016323; GO:0030877; GO:0070369; GO:1990907; GO:0016342; GO:0005913; GO:0005911; GO:0005938; GO:0030054; GO:0071944; GO:0042995; GO:0005813; GO:0005737; GO:0005829; GO:0070062; GO:0005925; GO:0005622; GO:0016328; GO:0016020; GO:0005719; GO:0005654; GO:0005634; GO:0048471; GO:0005886; GO:0032991; GO:0032993; GO:0000922; GO:0045202; GO:0005667; GO:1990909","GO:0045294; GO:0050681; GO:0045296; GO:0003682; GO:0019899; GO:0030331; GO:0044325; GO:0070411; GO:0019900; GO:0035257; GO:0008022; GO:0019903; GO:0001102; GO:0001085; GO:0046332; GO:0003713; GO:0008134","GO:0034333; GO:0030521; GO:1904886; GO:1904837; GO:0001569; GO:0060070; GO:1904954; GO:0044336; GO:0061324; GO:0044334; GO:0007155; GO:0098609; GO:0071363; GO:0071681; GO:0036023; GO:0061154; GO:0035635; GO:0001837; GO:0035315; GO:1904948; GO:0016525; GO:0043066; GO:0008285; GO:0045976; GO:0033234; GO:0045892; GO:1990138; GO:0043065; GO:1904798; GO:0051091; GO:2000144; GO:0010718; GO:0010909; GO:0051571; GO:0051149; GO:0002052; GO:0043525; GO:0045893; GO:0045944; GO:0032481; GO:0034394; GO:0045765; GO:0090279; GO:0060828; GO:0030997; GO:0070602; GO:0048145; GO:0072182; GO:0050767; GO:2000008; GO:0048660; GO:0042493; GO:0032355; GO:0019827; GO:0061549; GO:0006351; GO:0016032; GO:0016055; GO:0007223"]
[565,180,"PN167","CTNNB1","Y333","Catenin (cadherin-associated protein) beta 1",{"v":817.6885609865985,"d":"818"},{"v":737.4051968762093,"d":"737"},{"v":588.8562308448161,"d":"589"},{"v":72.01473261828681,"d":"72"},{"v":9.579244256256047,"d":"10"},{"v":3118.923730107366,"d":"3119"},"External","RpAb","YT(pY)EK","Corresponds to amino acid residues Y331 to K335.","Y333 phosphorylation induces interaction with PKM and transcription. This is one of the minor in vivo phosphorylation sites in CTNNB1 (≥2 reports from high throughput mass spectrometry studies).","Brk; Src","P35222","P35222",454,null,"P35222","NP_001895","Block2",1,11,"2, 10, 18, 26",{"$nulls":3},"Transcription protein; Cytoskeletal protein",{"$nulls":4},"X",{"$nulls":4},"Cytoskeletal protein","GO:0005912; GO:0016323; GO:0030877; GO:0070369; GO:1990907; GO:0016342; GO:0005913; GO:0005911; GO:0005938; GO:0030054; GO:0071944; GO:0042995; GO:0005813; GO:0005737; GO:0005829; GO:0070062; GO:0005925; GO:0005622; GO:0016328; GO:0016020; GO:0005719; GO:0005654; GO:0005634; GO:0048471; GO:0005886; GO:0032991; GO:0032993; GO:0000922; GO:0045202; GO:0005667; GO:1990909","GO:0045294; GO:0050681; GO:0045296; GO:0003682; GO:0019899; GO:0030331; GO:0044325; GO:0070411; GO:0019900; GO:0035257; GO:0008022; GO:0019903; GO:0001102; GO:0001085; GO:0046332; GO:0003713; GO:0008134","GO:0034333; GO:0030521; GO:1904886; GO:1904837; GO:0001569; GO:0060070; GO:1904954; GO:0044336; GO:0061324; GO:0044334; GO:0007155; GO:0098609; GO:0071363; GO:0071681; GO:0036023; GO:0061154; GO:0035635; GO:0001837; GO:0035315; GO:1904948; GO:0016525; GO:0043066; GO:0008285; GO:0045976; GO:0033234; GO:0045892; GO:1990138; GO:0043065; GO:1904798; GO:0051091; GO:2000144; GO:0010718; GO:0010909; GO:0051571; GO:0051149; GO:0002052; GO:0043525; GO:0045893; GO:0045944; GO:0032481; GO:0034394; GO:0045765; GO:0090279; GO:0060828; GO:0030997; GO:0070602; GO:0048145; GO:0072182; GO:0050767; GO:2000008; GO:0048660; GO:0042493; GO:0032355; GO:0019827; GO:0061549; GO:0006351; GO:0016032; GO:0016055; GO:0007223"]
[567,281,"PN745","CTNNB1","Y489","Catenin (cadherin-associated protein) beta 1",{"v":14093.869227831725,"d":"14094"},{"v":13854.078713127874,"d":"13854"},{"v":2948.3089583270685,"d":"2948"},{"v":20.919088368614386,"d":"21"},{"v":6717.081887660206,"d":"6717"},{"v":24704.358955868796,"d":"24704"},"Kinexus","RpAb","VRLH(pY)GLP(bA)C","Corresponds to amino acid residues V485 to P492.","T489 phosphorylation induces transcription. This is the major in vivo phosphorylation site in CTNNB1 (≥90 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in sea urchin.","Abl1","P35222","P35222",454,null,"P35222","NP_001091679.1","Block2",9,8,"2, 10, 18, 26",{"$nulls":3},"Transcription protein; Cytoskeletal protein",{"$nulls":4},"X",{"$nulls":4},"Cytoskeletal protein","GO:0005912; GO:0016323; GO:0030877; GO:0070369; GO:1990907; GO:0016342; GO:0005913; GO:0005911; GO:0005938; GO:0030054; GO:0071944; GO:0042995; GO:0005813; GO:0005737; GO:0005829; GO:0070062; GO:0005925; GO:0005622; GO:0016328; GO:0016020; GO:0005719; GO:0005654; GO:0005634; GO:0048471; GO:0005886; GO:0032991; GO:0032993; GO:0000922; GO:0045202; GO:0005667; GO:1990909","GO:0045294; GO:0050681; GO:0045296; GO:0003682; GO:0019899; GO:0030331; GO:0044325; GO:0070411; GO:0019900; GO:0035257; GO:0008022; GO:0019903; GO:0001102; GO:0001085; GO:0046332; GO:0003713; GO:0008134","GO:0034333; GO:0030521; GO:1904886; GO:1904837; GO:0001569; GO:0060070; GO:1904954; GO:0044336; GO:0061324; GO:0044334; GO:0007155; GO:0098609; GO:0071363; GO:0071681; GO:0036023; GO:0061154; GO:0035635; GO:0001837; GO:0035315; GO:1904948; GO:0016525; GO:0043066; GO:0008285; GO:0045976; GO:0033234; GO:0045892; GO:1990138; GO:0043065; GO:1904798; GO:0051091; GO:2000144; GO:0010718; GO:0010909; GO:0051571; GO:0051149; GO:0002052; GO:0043525; GO:0045893; GO:0045944; GO:0032481; GO:0034394; GO:0045765; GO:0090279; GO:0060828; GO:0030997; GO:0070602; GO:0048145; GO:0072182; GO:0050767; GO:2000008; GO:0048660; GO:0042493; GO:0032355; GO:0019827; GO:0061549; GO:0006351; GO:0016032; GO:0016055; GO:0007223"]
[569,282,"PN579","CTNNB1","Y654","Catenin (cadherin-associated protein) beta 1",{"v":7583.299740098439,"d":"7583"},{"v":7456.1264115382555,"d":"7456"},{"v":1779.5305477722418,"d":"1780"},{"v":23.4664408471495,"d":"23"},{"v":1855.0070200822083,"d":"1855"},{"v":13613.440064656841,"d":"13613"},"Kinexus","RpAb","GVAT(pY)AAAC","Corresponds to amino acid residues G650 to A657.","Y654 phosphorylation induces activity and binding to Smad2, TBN and TCF4, stabilizes protein, and inhibits binding to CDH1, LEF-1, Met and Axin-1. This is one of the major in vivo phosphorylation sites in CTNNB1 (≥21 reports from high throughput mass spectrometry studies).","Abl1; CSK; EGFR; ErbB2; Met; Src; TrkA (NTRK1).","P35222","P35222",454,null,"P35222","NP_001091679.1","Block2",9,9,"2, 10, 18, 26",{"$nulls":3},"Transcription protein; Cytoskeletal protein",{"$nulls":4},"X",{"$nulls":4},"Cytoskeletal protein","GO:0005912; GO:0016323; GO:0030877; GO:0070369; GO:1990907; GO:0016342; GO:0005913; GO:0005911; GO:0005938; GO:0030054; GO:0071944; GO:0042995; GO:0005813; GO:0005737; GO:0005829; GO:0070062; GO:0005925; GO:0005622; GO:0016328; GO:0016020; GO:0005719; GO:0005654; GO:0005634; GO:0048471; GO:0005886; GO:0032991; GO:0032993; GO:0000922; GO:0045202; GO:0005667; GO:1990909","GO:0045294; GO:0050681; GO:0045296; GO:0003682; GO:0019899; GO:0030331; GO:0044325; GO:0070411; GO:0019900; GO:0035257; GO:0008022; GO:0019903; GO:0001102; GO:0001085; GO:0046332; GO:0003713; GO:0008134","GO:0034333; GO:0030521; GO:1904886; GO:1904837; GO:0001569; GO:0060070; GO:1904954; GO:0044336; GO:0061324; GO:0044334; GO:0007155; GO:0098609; GO:0071363; GO:0071681; GO:0036023; GO:0061154; GO:0035635; GO:0001837; GO:0035315; GO:1904948; GO:0016525; GO:0043066; GO:0008285; GO:0045976; GO:0033234; GO:0045892; GO:1990138; GO:0043065; GO:1904798; GO:0051091; GO:2000144; GO:0010718; GO:0010909; GO:0051571; GO:0051149; GO:0002052; GO:0043525; GO:0045893; GO:0045944; GO:0032481; GO:0034394; GO:0045765; GO:0090279; GO:0060828; GO:0030997; GO:0070602; GO:0048145; GO:0072182; GO:0050767; GO:2000008; GO:0048660; GO:0042493; GO:0032355; GO:0019827; GO:0061549; GO:0006351; GO:0016032; GO:0016055; GO:0007223"]
[571,283,"PN580","CUX1 (CUTL1)","S1270","Homeobox protein cut-like 1",{"v":7154.281215779654,"d":"7154"},{"v":7074.589198439292,"d":"7075"},{"v":1314.3617726993332,"d":"1314"},{"v":18.37168169739184,"d":"18"},{"v":4287.352632027595,"d":"4287"},{"v":11648.122620958326,"d":"11648"},"Kinexus","RpAb","KPYP(pS)PKT(bA)C","Corresponds to amino acid residues K1266 to T1273.","S1270 phosphorylation inhibits transcriptional activity by inhibiting DNA binding. This is one of the major in vivo phosphorylation sites in CUX1 (≥14 reports from high throughput mass spectrometry studies).","CDK1 (CDC2); PKACa (PRKACA)","P39880","P39880",8232,null,"P39880","NP_001189472.1","Block2",9,10,"2, 10, 18, 26",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005829; GO:0005794; GO:0000139; GO:0005654; GO:0005634","GO:0030674; GO:0004713; GO:0000977; GO:0043565","GO:0048193; GO:0007275; GO:0000122; GO:0050775; GO:0006357; GO:0000301; GO:0006351"]
[573,1351,"NK188-1","DAPK3 (ZIPK)","Pan-specific","ZIP kinase (death associated protein-serine kinase 3 (DAPK3))",{"v":689.444136254096,"d":"689"},{"v":562.4262627449386,"d":"562"},{"v":664.015779897389,"d":"664"},{"v":96.31175971778296,"d":"96"},{"v":197.74006123575873,"d":"198"},{"v":9210.319596027222,"d":"9210"},"External","RpAb","Epitope undefined.",{"$nulls":3},"O43293","O43293",2083,"O43293",null,"NP_001339.1","Block8",13,12,"8, 16, 24, 32","DAPK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","DAPK",{"$nulls":6},"Protein-serine kinase, CAMK group, DAPK family","GO:0005884; GO:0005737; GO:0045121; GO:0005634; GO:0016605","GO:0005524; GO:0008140; GO:0042802; GO:0043522; GO:0008022; GO:0042803; GO:0004674; GO:0017048","GO:0006915; GO:0097190; GO:0071346; GO:0006325; GO:0035556; GO:0017148; GO:0030182; GO:0018105; GO:0018107; GO:0043065; GO:0090263; GO:0030335; GO:2001241; GO:0046777; GO:0006468; GO:2000249; GO:0042981; GO:0010506; GO:2000145; GO:0008360; GO:0051893; GO:0007346; GO:0007088; GO:0043519; GO:0006940; GO:0006355; GO:0006351"]
[575,264,"NK043","DCAMLK1 (CaMKinase VI, DCLK1)","Pan-specific","Serine-threonine-protein kinase DCAMKL1",{"v":367.1605125253615,"d":"367"},{"v":252.8674522529728,"d":"253"},{"v":355.75771309885835,"d":"356"},{"v":96.89432849189753,"d":"97"},{"v":8.403881405553955,"d":"8"},{"v":1972.731053686251,"d":"1973"},"External","MmAb","Epitope undefined.",{"$nulls":3},"O15075","O15075",811,"O15075",null,"NP_001182344.1","Block2",8,4,"2, 10, 18, 26","DCAMKL1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","DCAMKL",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; CAMK group; DCAMKL family","GO:0005887; GO:0005622; GO:0014069","GO:0005524; GO:0004672; GO:0004674","GO:0048675; GO:0007417; GO:0021952; GO:0048813; GO:0016197; GO:0030900; GO:0035556; GO:1900181; GO:0007399; GO:0001764; GO:0048812; GO:0018105; GO:0018107; GO:0006468; GO:0009615"]
[577,287,"PN696","DCK","S74","Deoxycytidine kinase",{"v":13137.446602262267,"d":"13137"},{"v":12897.188434457337,"d":"12897"},{"v":2352.622663363922,"d":"2353"},{"v":17.907761946364833,"d":"18"},{"v":7169.031877487932,"d":"7169"},{"v":21476.02514938696,"d":"21476"},"Kinexus","RpAb","LTM(pS)QKNGGC","Corresponds to amino acid residues L71 to G79.","S74 phosphorylation stimulates enzyme activity. This is the major in vivo phosphorylation sites in DCK (≥115 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and found in fish.","ATR; CK1D","P27707","P27707",6911,null,null,"NP_000779.1","Block2",10,1,"2, 10, 18, 26",{"$nulls":3},"Enzyme - Metabolite kinase",{"$nulls":8},"X","Kinase (non-protein); Nucleotide Metabolism - pyrimidine; EC 2.7.1.74; Nucleotide Metabolism - purine","GO:0005829; GO:0005634","GO:0005524; GO:0004137; GO:0008144; GO:0019206; GO:0042803","GO:0043101; GO:0043097; GO:0006220"]
[579,288,"NK263-1","DDR1","Pan-specific","Epithelial discoidin domain-containing receptor 1",{"v":3963.3939740800092,"d":"3963"},{"v":3710.6443725839185,"d":"3711"},{"v":1294.6566098695207,"d":"1295"},{"v":32.6653524311834,"d":"33"},{"v":411.3746677982142,"d":"411"},{"v":12010.893401466808,"d":"12011"},"Kinexus","RpAb","RESEQRPPFSQLHRFLAEDC","Corresponds to amino acid residues R890 to D908; Pre-C-terminus.",null,null,"Q08345","Q08345",1902,"Q08345","Q08345","NP_001284583.1","Block2",10,2,"2, 10, 18, 26","DDR1","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","DDR",{"$nulls":6},"EC 2.7.1.112; EC 2.7.10.1; Receptor tyrosine kinase; TK domain target; TK</A> group; DDR family","GO:0070062; GO:0005615; GO:0005887; GO:0005886; GO:0043235","GO:0005524; GO:0005518; GO:0046872; GO:0038062; GO:0004714","GO:0061564; GO:0060444; GO:0007155; GO:0038063; GO:0043583; GO:0007566; GO:0030198; GO:0007595; GO:0060749; GO:0008285; GO:1990138; GO:0038083; GO:0046777; GO:0001558; GO:0001952; GO:0010715; GO:0061302; GO:0014909; GO:0044319"]
[581,289,"PK591","DDR1","Y796+Y797","Epithelial discoidin domain-containing receptor 1",{"v":2635.5048847941935,"d":"2636"},{"v":2643.104194780414,"d":"2643"},{"v":924.7109141054361,"d":"925"},{"v":35.08667046836632,"d":"35"},{"v":266.43362798492024,"d":"266"},{"v":5274.743840846668,"d":"5275"},"Kinexus","RpAb","AGD(pY)(pY)RV(bA)C","Corresponds to amino acid residues A793 to V799; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y796 phosphorylation stimulates phosphotransferase activity and induces interaction with the protein-tyrosine phosphatase SHP2. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are the two major in vivo phosphorylation sites in DDR1 (≥946 and ≥307 reports, respectively, from high throughput mass spectrometry studies).",null,"Q08345","Q08345",1902,"Q08345","Q08345","NP_001284583.1","Block2",10,3,"2, 10, 18, 26","DDR1","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","DDR",{"$nulls":6},"EC 2.7.1.112; EC 2.7.10.1; Receptor tyrosine kinase; TK domain target; TK</A> group; DDR family","GO:0070062; GO:0005615; GO:0005887; GO:0005886; GO:0043235","GO:0005524; GO:0005518; GO:0046872; GO:0038062; GO:0004714","GO:0061564; GO:0060444; GO:0007155; GO:0038063; GO:0043583; GO:0007566; GO:0030198; GO:0007595; GO:0060749; GO:0008285; GO:1990138; GO:0038083; GO:0046777; GO:0001558; GO:0001952; GO:0010715; GO:0061302; GO:0014909; GO:0044319"]
[583,290,"PK592","DDR1","Y797","Epithelial discoidin domain-containing receptor 1",{"v":8367.831291504139,"d":"8368"},{"v":8089.875344632813,"d":"8090"},{"v":1767.3884280270977,"d":"1767"},{"v":21.121224442246195,"d":"21"},{"v":2378.1457065911964,"d":"2378"},{"v":14356.900408633182,"d":"14357"},"Kinexus","RpAb","GDY(pY)RVQ(bA)C","Corresponds to amino acid residues G794 to Q800; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y797 phosphorylation likely stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in DDR1 (≥307 reports from high throughput mass spectrometry studies).",null,"Q08345","Q08345",1902,"Q08345","Q08345","NP_001284583.1","Block2",10,4,"2, 10, 18, 26","DDR1","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","DDR",{"$nulls":6},"EC 2.7.1.112; EC 2.7.10.1; Receptor tyrosine kinase; TK domain target; TK</A> group; DDR family","GO:0070062; GO:0005615; GO:0005887; GO:0005886; GO:0043235","GO:0005524; GO:0005518; GO:0046872; GO:0038062; GO:0004714","GO:0061564; GO:0060444; GO:0007155; GO:0038063; GO:0043583; GO:0007566; GO:0030198; GO:0007595; GO:0060749; GO:0008285; GO:1990138; GO:0038083; GO:0046777; GO:0001558; GO:0001952; GO:0010715; GO:0061302; GO:0014909; GO:0044319"]
[585,1293,"NK183-1","DDR2 (Tyro10)","Pan-specific","Neurotrophic receptor-tyrosine kinase of discoidin domain receptor family, member 2 precursor",{"v":51.74061729120897,"d":"52"},{"v":46.555021263569316,"d":"47"},{"v":25.690898794462452,"d":"26"},{"v":49.65325142888754,"d":"50"},{"v":17.7101878235884,"d":"18"},{"v":182.81633001869366,"d":"183"},"External","RpAb","Epitope undefined.",{"$nulls":3},"Q16832","Q16832",1905,"Q16832","Q16832","NP_001014796.1","Block8",9,6,"8, 16, 24, 32",null,"X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","DDR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.1.112; EC 2.7.10.1; TK domain target; TK</A> group; DDR family","GO:0015629; GO:0016324; GO:0005925; GO:0005887; GO:0005886","GO:0005524; GO:0005518; GO:0038062; GO:0004714","GO:0031214; GO:0007155; GO:0035988; GO:0038063; GO:0030199; GO:0003416; GO:0030198; GO:0001503; GO:0018108; GO:0051091; GO:0090091; GO:0010763; GO:0048146; GO:0045669; GO:0045860; GO:0046777; GO:0030500; GO:0010715; GO:0007165"]
[587,291,"NK183-3","DDR2 (Tyro10)","Pan-specific","Neurotrophic receptor-tyrosine kinase of discoidin domain receptor family, member 2 precursor",{"v":203.96664254570632,"d":"204"},{"v":165.52865382654215,"d":"166"},{"v":143.52760154330502,"d":"144"},{"v":70.36817381113792,"d":"70"},{"v":20.20363392818534,"d":"20"},{"v":1359.8106161719518,"d":"1360"},"External","MmAb","Not precisely defined.","Antibody raised against a recombinant protein corresponding to amino acids 422-639 of human DDR2.",null,null,"Q16832","Q16832",1905,"Q16832","Q16832","NP_001014796.1","Block2",10,5,"2, 10, 18, 26","DDR2","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","DDR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.1.112; EC 2.7.10.1; TK domain target; TK</A> group; DDR family","GO:0015629; GO:0016324; GO:0005925; GO:0005887; GO:0005886","GO:0005524; GO:0005518; GO:0038062; GO:0004714","GO:0031214; GO:0007155; GO:0035988; GO:0038063; GO:0030199; GO:0003416; GO:0030198; GO:0001503; GO:0018108; GO:0051091; GO:0090091; GO:0010763; GO:0048146; GO:0045669; GO:0045860; GO:0046777; GO:0030500; GO:0010715; GO:0007165"]
[589,292,"PK593","DDR2 (Tyro10)","Y736","Discoidin domain-containing receptor 2",{"v":8569.410243320024,"d":"8569"},{"v":8510.709075123083,"d":"8511"},{"v":1761.614314824199,"d":"1762"},{"v":20.55700759801297,"d":"21"},{"v":3747.424673524027,"d":"3747"},{"v":14321.355131407368,"d":"14321"},"Kinexus","RpAb","RNL(pY)SGD(bA)C","Corresponds to amino acid residues R733 to D739; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y736 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in DDR2 (≥412 reports from high throughput mass spectrometry studies).","DDR2; Src","Q16832","Q16832",1905,"Q16832","Q16832","NP_001014796.1","Block2",10,6,"2, 10, 18, 26","DDR2","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","DDR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.1.112; EC 2.7.10.1; TK domain target; TK</A> group; DDR family","GO:0015629; GO:0016324; GO:0005925; GO:0005887; GO:0005886","GO:0005524; GO:0005518; GO:0038062; GO:0004714","GO:0031214; GO:0007155; GO:0035988; GO:0038063; GO:0030199; GO:0003416; GO:0030198; GO:0001503; GO:0018108; GO:0051091; GO:0090091; GO:0010763; GO:0048146; GO:0045669; GO:0045860; GO:0046777; GO:0030500; GO:0010715; GO:0007165"]
[591,293,"PK594","DDR2 (Tyro10)","Y740","Discoidin domain-containing receptor 2",{"v":9513.985469601981,"d":"9514"},{"v":9454.695193636395,"d":"9455"},{"v":1758.270568458993,"d":"1758"},{"v":18.48090449661524,"d":"18"},{"v":3220.885308017715,"d":"3221"},{"v":15660.381688616515,"d":"15660"},"Kinexus","RpAb","SGD(pY)YRI(bA)C","Corresponds to amino acid residues S737 to I743; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y740 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in DDR2 (≥370 reports from high throughput mass spectrometry studies).","DDR2; Src","Q16832","Q16832",1905,"Q16832","Q16832","NP_001014796.1","Block2",10,7,"2, 10, 18, 26","DDR2","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","DDR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.1.112; EC 2.7.10.1; TK domain target; TK</A> group; DDR family","GO:0015629; GO:0016324; GO:0005925; GO:0005887; GO:0005886","GO:0005524; GO:0005518; GO:0038062; GO:0004714","GO:0031214; GO:0007155; GO:0035988; GO:0038063; GO:0030199; GO:0003416; GO:0030198; GO:0001503; GO:0018108; GO:0051091; GO:0090091; GO:0010763; GO:0048146; GO:0045669; GO:0045860; GO:0046777; GO:0030500; GO:0010715; GO:0007165"]
[593,294,"PK590","DLK (ZPK)","S269","Mitogen-activated protein kinase kinase kinase 12",{"v":5692.590844057458,"d":"5693"},{"v":5318.511704873978,"d":"5319"},{"v":2309.1653773107278,"d":"2309"},{"v":40.56440100066711,"d":"41"},{"v":477.0913982153809,"d":"477"},{"v":12756.108869055082,"d":"12756"},"Kinexus","RpAb","TKM(pS)FAG(bA)C","Corresponds to amino acid residues T266 to G272; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S269 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the minor in vivo phosphorylation sites in DLK (≥2 reports from high throughput mass spectrometry studies).",null,"Q12852","Q12852",708,"Q12852",null,"NP_006292.3","Block2",10,8,"2, 10, 18, 26","DLK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","MLK","LZK",{"$nulls":5},"EC 2.7.11.25; Protein kinase, Ser/Thr (non-receptor); TKL domain target; TKL</A> group; MLK family; LZK subfamily","GO:0005737; GO:0005829; GO:0030426; GO:0016020; GO:0005886","GO:0005524; GO:0004706; GO:0042803; GO:0004672; GO:0019901; GO:0004674","GO:0007256; GO:0007257; GO:0016572; GO:0035556; GO:0007254; GO:0000165; GO:2000672; GO:0018105; GO:0018107; GO:0046777; GO:0006468"]
[595,295,"NK264-1","DMPK1 (DMPK)","Pan-specific","Myotonic dystrophy protein kinase",{"v":5751.459563806336,"d":"5751"},{"v":5467.631918063659,"d":"5468"},{"v":1560.237500171476,"d":"1560"},{"v":27.12767920668307,"d":"27"},{"v":2266.4445700394363,"d":"2266"},{"v":10820.844740793129,"d":"10821"},"Kinexus","RpAb","CMALRDSEVPGPTPMELEA","Corresponds to amino acid residues C407 to A425; Just after kinase catalytic domain.",null,null,"Q09013","Q09013",691,"Q09013",null,"NP_001075032.1","Block2",10,9,"2, 10, 18, 26","DMPK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","DMPK","GEK",{"$nulls":6},"GO:0005829; GO:0005789; GO:0031307; GO:0031965; GO:0005640; GO:0005886; GO:0033017","GO:0005524; GO:0031072; GO:0046872; GO:0017020; GO:0004674","GO:0006874; GO:0010657; GO:0006998; GO:0018105; GO:0006468; GO:1903779; GO:0014853; GO:0008016; GO:0010830; GO:0014722; GO:0002028; GO:0051823"]
[597,296,"NK265-1","DMPK2 (MRCK-g)","Pan-specific","Myotonic dystrophy protein kinase 2; Serine-threonine-protein kinase MRCK gamma",{"v":5941.69632982468,"d":"5942"},{"v":5692.981704736605,"d":"5693"},{"v":1359.7811649717396,"d":"1360"},{"v":22.88540325001534,"d":"23"},{"v":2361.3504921055332,"d":"2361"},{"v":10154.248346456385,"d":"10154"},"Kinexus","RpAb","MERRLRALEQLARGEAGGC","Corresponds to amino acid residues M1 to C19; N-terminus.",null,null,"Q6DT37","Q6DT37",2417,"Q6DT37",null,"NP_059995.2","Block2",10,10,"2, 10, 18, 26","DMPK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","DMPK","GEK",{"$nulls":5},"Protein-serine kinase, AGC family. DMPK subfamily","GO:0031252; GO:0005829; GO:0005815","GO:0005524; GO:0000287; GO:0004674","GO:0031532; GO:0035556; GO:0006468"]
[599,297,"NK048-4","DNAPK (PRKDC)","Pan-specific","DNA-dependent protein kinase catalytic subunit",{"v":8704.292384662049,"d":"8704"},{"v":8562.136891858881,"d":"8562"},{"v":1299.2138337016727,"d":"1299"},{"v":14.926128124912658,"d":"15"},{"v":4524.84923528832,"d":"4525"},{"v":13305.969113993204,"d":"13306"},"Kinexus","RpAb","CGHDEREHPFLVKGGE","Corresponds to amino acid residues G3742 to E3755.",null,null,"P78527","P78527",2072,"P78527","P78527","NP_008835","Block2",10,11,"2, 10, 18, 26","DNAPK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PIKK","DNAPK",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); ATYPICAL group; PIKK family; DNAPK subfamily","GO:0005829; GO:0005958; GO:0016020; GO:0070419; GO:0000784; GO:0005730; GO:0005654; GO:0005634; GO:0032991; GO:0032993; GO:0005667","GO:0005524; GO:0004677; GO:0003690; GO:0019899; GO:0019904; GO:0004672; GO:0004674; GO:0003723; GO:0008134","GO:0002218; GO:0002326; GO:0007420; GO:0008283; GO:0006464; GO:0032869; GO:0006302; GO:0097681; GO:0006303; GO:0035234; GO:0007507; GO:0033152; GO:0045087; GO:0008630; GO:0043066; GO:2000773; GO:0002638; GO:0001933; GO:2001229; GO:0018105; GO:0043065; GO:0048639; GO:0048146; GO:0045944; GO:0032481; GO:0002328; GO:0031648; GO:0006468; GO:0016567; GO:0042752; GO:0048660; GO:0014823; GO:0010332; GO:0048511; GO:0072431; GO:0001756; GO:0048536; GO:0033077; GO:0002360; GO:0033153; GO:0016233; GO:0048538"]
[601,298,"NK048-7","DNAPK (PRKDC)","Pan-specific","DNA-dependent protein kinase catalytic subunit",{"v":10209.993066320585,"d":"10210"},{"v":10191.272737252972,"d":"10191"},{"v":1622.6654713303453,"d":"1623"},{"v":15.89291452785591,"d":"16"},{"v":5945.565803158385,"d":"5946"},{"v":15790.803674651595,"d":"15791"},"Kinexus","RpAb","CLMDQATDPNILGRTW","Corresponds to amino acid residues C4106 to W4121; C-terminus.",null,null,"P78527","P78527",2072,"P78527","P78527","NP_008835","Block2",10,12,"2, 10, 18, 26","DNAPK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PIKK","DNAPK",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); ATYPICAL group; PIKK family; DNAPK subfamily","GO:0005829; GO:0005958; GO:0016020; GO:0070419; GO:0000784; GO:0005730; GO:0005654; GO:0005634; GO:0032991; GO:0032993; GO:0005667","GO:0005524; GO:0004677; GO:0003690; GO:0019899; GO:0019904; GO:0004672; GO:0004674; GO:0003723; GO:0008134","GO:0002218; GO:0002326; GO:0007420; GO:0008283; GO:0006464; GO:0032869; GO:0006302; GO:0097681; GO:0006303; GO:0035234; GO:0007507; GO:0033152; GO:0045087; GO:0008630; GO:0043066; GO:2000773; GO:0002638; GO:0001933; GO:2001229; GO:0018105; GO:0043065; GO:0048639; GO:0048146; GO:0045944; GO:0032481; GO:0002328; GO:0031648; GO:0006468; GO:0016567; GO:0042752; GO:0048660; GO:0014823; GO:0010332; GO:0048511; GO:0072431; GO:0001756; GO:0048536; GO:0033077; GO:0002360; GO:0033153; GO:0016233; GO:0048538"]
[603,299,"PK596","DNAPK (PRKDC)","Y883","DNA-dependent protein kinase catalytic subunit",{"v":8742.303707186573,"d":"8742"},{"v":8668.673558216185,"d":"8669"},{"v":1812.1616979034893,"d":"1812"},{"v":20.728651835943534,"d":"21"},{"v":1745.6202348720535,"d":"1746"},{"v":13546.368988607139,"d":"13546"},"Kinexus","RpAb","MKS(pY)VAW(bA)C","Corresponds to amino acid residues M880 to W886; In the N-terminal quarter of the protein.","Y883 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in DNAPK (≥25 reports from high throughput mass spectrometry studies).",null,"P78527","P78527",2072,"P78527","P78527","NP_008835","Block2",10,13,"2, 10, 18, 26","DNAPK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PIKK","DNAPK",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); ATYPICAL group; PIKK family; DNAPK subfamily","GO:0005829; GO:0005958; GO:0016020; GO:0070419; GO:0000784; GO:0005730; GO:0005654; GO:0005634; GO:0032991; GO:0032993; GO:0005667","GO:0005524; GO:0004677; GO:0003690; GO:0019899; GO:0019904; GO:0004672; GO:0004674; GO:0003723; GO:0008134","GO:0002218; GO:0002326; GO:0007420; GO:0008283; GO:0006464; GO:0032869; GO:0006302; GO:0097681; GO:0006303; GO:0035234; GO:0007507; GO:0033152; GO:0045087; GO:0008630; GO:0043066; GO:2000773; GO:0002638; GO:0001933; GO:2001229; GO:0018105; GO:0043065; GO:0048639; GO:0048146; GO:0045944; GO:0032481; GO:0002328; GO:0031648; GO:0006468; GO:0016567; GO:0042752; GO:0048660; GO:0014823; GO:0010332; GO:0048511; GO:0072431; GO:0001756; GO:0048536; GO:0033077; GO:0002360; GO:0033153; GO:0016233; GO:0048538"]
[605,300,"PK595","DNAPK (PRKDC)","T2609","DNA-dependent protein kinase catalytic subunit",{"v":4166.209461618418,"d":"4166"},{"v":3646.642694225176,"d":"3647"},{"v":1985.0113069439012,"d":"1985"},{"v":47.645499469745765,"d":"48"},{"v":1573.774280851149,"d":"1574"},{"v":12796.01043496804,"d":"12796"},"Kinexus","RpAb","FVT(pT)QAS(bA)C","Corresponds to amino acid residues F2606 to S2612; In the mid-region of the protein kinase between the NUC194 and FAT domains.","T2609 phosphorylation stimulates phosphotransferase activity. This is one of the major in vivo phosphorylation sites in DNAPK (≥17 reports from high throughput mass spectrometry studies).","ATM; ATR; DNAPK (PRKDC)","P78527","P78527",2072,"P78527","P78527","NP_008835","Block2",11,1,"2, 10, 18, 26","DNAPK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PIKK","DNAPK",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); ATYPICAL group; PIKK family; DNAPK subfamily","GO:0005829; GO:0005958; GO:0016020; GO:0070419; GO:0000784; GO:0005730; GO:0005654; GO:0005634; GO:0032991; GO:0032993; GO:0005667","GO:0005524; GO:0004677; GO:0003690; GO:0019899; GO:0019904; GO:0004672; GO:0004674; GO:0003723; GO:0008134","GO:0002218; GO:0002326; GO:0007420; GO:0008283; GO:0006464; GO:0032869; GO:0006302; GO:0097681; GO:0006303; GO:0035234; GO:0007507; GO:0033152; GO:0045087; GO:0008630; GO:0043066; GO:2000773; GO:0002638; GO:0001933; GO:2001229; GO:0018105; GO:0043065; GO:0048639; GO:0048146; GO:0045944; GO:0032481; GO:0002328; GO:0031648; GO:0006468; GO:0016567; GO:0042752; GO:0048660; GO:0014823; GO:0010332; GO:0048511; GO:0072431; GO:0001756; GO:0048536; GO:0033077; GO:0002360; GO:0033153; GO:0016233; GO:0048538"]
[607,301,"PN746","DNMT3A","S105","DNA (cytosine-5)-methyltransferase 3A",{"v":6329.942121157243,"d":"6330"},{"v":6222.178141318016,"d":"6222"},{"v":1245.680149871535,"d":"1246"},{"v":19.67917124720564,"d":"20"},{"v":3397.0480024587405,"d":"3397"},{"v":11383.27431522835,"d":"11383"},"Kinexus","RpAb","EEG(pS)PAG(bA)C","Corresponds to amino acid residues E102-G108.","The effect of S105 phosphorylation is unclear. This is the major in vivo phosphorylation site in DNMT3 (≥47 reports from high throughput mass spectrometry studies). This human phosphosite is not conserved in vertebrates and may be restricted to humans.",null,"Q9Y6K1","Q9Y6K1",20750,null,"Q9Y6K1","NP_001307821.1","Block2",11,2,"2, 10, 18, 26",{"$nulls":3},"Methyltransferase",{"$nulls":8},"X","Methyltransferase; EC 2.1.1.37; Amino Acid Metabolism - cysteine and methionine","GO:0000775; GO:0005737; GO:0000791; GO:0005720; GO:0016363; GO:0005654; GO:0005634; GO:0001741","GO:0003682; GO:0003886; GO:0003677; GO:0009008; GO:0042802; GO:0046872; GO:0000981","GO:0007568; GO:0071230; GO:0071361; GO:0071456; GO:0006306; GO:0043045; GO:0043046; GO:0097284; GO:0006346; GO:0000278; GO:0045814; GO:0000122; GO:0030182; GO:0010942; GO:0006349; GO:0042220; GO:0032355; GO:0010212; GO:0010288; GO:0033189; GO:0007283"]
[609,302,"PN508","Dok3","Y398","Docking protein 3",{"v":13468.375660083264,"d":"13468"},{"v":13369.229127985149,"d":"13369"},{"v":1958.9780099887919,"d":"1959"},{"v":14.545020568402242,"d":"15"},{"v":6440.619885021247,"d":"6441"},{"v":19713.98662915318,"d":"19714"},"Kinexus","RpAb","EHL(pY)ENL(bA)C","Corresponds to amino acid residues E395 to L401; In the last quarter of the protein.","The effect of Y398 phosphorylation is unclear. This is the major in vivo phosphorylation site in Dok3 (≥80 reports from high throughput mass spectrometry studies).",null,"Q7L591","Q7L591",6531,null,null,"NP_079148.2","Block2",11,3,"2, 10, 18, 26",{"$nulls":11},"X",null,"Adapter/scaffold protein","GO:0101003; GO:0005886; GO:0030667",null,"GO:0043312; GO:0007265"]
[611,303,"PN747","DPYD","S766+T768","Dihydropyrimidine dehydrogenase [NADP()]",{"v":18239.489274439253,"d":"18239"},{"v":17131.98752531952,"d":"17132"},{"v":4671.065344514178,"d":"4671"},{"v":25.609627957402243,"d":"26"},{"v":11074.929644698346,"d":"11075"},{"v":40695.90458670329,"d":"40696"},"Kinexus","RpAb","CGGV(pS)G(pT)AIR","Corresponds to amino acid residues G763 to R771.","The effects of S766 and T768 phosphorylation are unclear. These phosphorylation sites have only been detected in a single mass spectrometry study. However, this human phosphosite is highly conserved in vertebrates and also found in sea urchin.",null,"Q12882","Q12882",9253,null,null,"NP_000101.2","Block2",11,4,"2, 10, 18, 26",{"$nulls":12},"X","Other Amino Acids Metabolism - beta-alanine; Nucleotide Metabolism - pyrimidine; EC 1.3.1.2; Oxidoreductase; Cofactor and Vitamin Metabolism - pantothenate and CoA biosynthesis; Xenobiotic Metabolism - drug metabolism - other enzymes","GO:0005737; GO:0005829","GO:0051539; GO:0017113; GO:0050660; GO:0046872; GO:0050661; GO:0042803","GO:0019483; GO:0006145; GO:0006208; GO:0046135; GO:0006214; GO:0006210; GO:0006212"]
[613,304,"PN222","Dynamin I","S795","Dynamin-1",{"v":306.27281995591295,"d":"306"},{"v":264.8150358453214,"d":"265"},{"v":184.2018990513571,"d":"184"},{"v":60.14307736412013,"d":"60"},{"v":69.33354521376873,"d":"69"},{"v":1459.4600285821343,"d":"1459"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 781-804 Ser 795 of human Dynamin I.","The effect of S795 phosphorylation is unclear. This is one of the minor in vivo phosphorylation sites in dynamin-1 (≥2 reports from high throughput mass spectrometry studies).","PKCa (PRKCA); DYRK1A","Q05193","Q05193",959,null,null,"NP_001005336.1","Block2",11,5,"2, 10, 18, 26",{"$nulls":13},"Hydrolase; EC 3.6.5.5; Motor protein; G protein; Vesicle protein","GO:0070062; GO:0098978; GO:0005794; GO:0030117; GO:0005874; GO:0031966; GO:0043209; GO:0005654; GO:0005634; GO:0001917; GO:0098684; GO:0005886; GO:0098835; GO:0008021; GO:0043196","GO:0031749; GO:0003924; GO:0005525; GO:0042802; GO:0008017; GO:0050998; GO:0044877; GO:0008022; GO:0046983; GO:0019901; GO:0003723; GO:0017124","GO:0008344; GO:0072583; GO:0003374; GO:0006897; GO:0007032; GO:0048013; GO:0002031; GO:0061025; GO:0000266; GO:0050804; GO:1900244; GO:0051262; GO:0006898; GO:1904645; GO:0007605; GO:0051932; GO:0016185; GO:1901998"]
[615,305,"PK597","DYRK1A","Y321","Dual specificity tyrosine-phosphorylation-regulated kinase 1A",{"v":2708.374383455617,"d":"2708"},{"v":2549.5816203723903,"d":"2550"},{"v":967.2079473731259,"d":"967"},{"v":35.71175215957642,"d":"36"},{"v":675.766862782845,"d":"676"},{"v":5960.105137769589,"d":"5960"},"Kinexus","RpAb","IYQ(pY)IQS(bA)C","Corresponds to amino acid residues I318 to S324; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y321 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in DYRK1A (≥3759 reports from high throughput mass spectrometry studies).","DYRK1A","Q13627","Q13627",1004,"Q13627","Q13627","NP_001387.2","Block2",11,6,"2, 10, 18, 26","DYRK1A","X","PSTK","Protein Kinase - Dual specificity kinase","Protein-serine/threonine kinase","CMGC","DYRK","Dyrk1",{"$nulls":5},"EC 2.7.12.2; Protein kinase, dual-specificity; EC 2.7.12.1; CMGC domain target; CMGC</A> group; DYRK family; Dyrk1 subfamily","GO:0030424; GO:0005737; GO:0005856; GO:0030425; GO:0016607; GO:0005654; GO:0005634; GO:1990904","GO:0003779; GO:0005524; GO:0008092; GO:0042802; GO:0004715; GO:0004672; GO:0043621; GO:0004712; GO:0004674; GO:0004713; GO:0048156; GO:0015631","GO:0034205; GO:0007623; GO:0043518; GO:0031115; GO:0048025; GO:0007399; GO:0036289; GO:0018105; GO:0018107; GO:0038083; GO:0018108; GO:0090312; GO:0033120; GO:0046777; GO:0006468; GO:0000381; GO:0016032"]
[617,306,"NK266-1","DYRK2","Pan-specific","Dual specificity tyrosine-phosphorylation-regulated kinase 2",{"v":3648.924164320294,"d":"3649"},{"v":3322.7260258268675,"d":"3323"},{"v":1457.834766540997,"d":"1458"},{"v":39.95245450140935,"d":"40"},{"v":652.3996505320019,"d":"652"},{"v":11327.842907912302,"d":"11328"},"Kinexus","RpAb","CGSKHTMNDHLHVGSHAHGQ","Corresponds to amino acid residues G69 to Q87; Post-N-terminus.",null,null,"Q92630","Q92630",693,"Q92630",null,"NP_006473.2","Block2",11,7,"2, 10, 18, 26","DYRK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","DYRK","Dyrk2",{"$nulls":5},"Protein kinase, dual-specificity, CMGC group, DYRK family, Dyrk2 subfamily","GO:0005737; GO:0005829; GO:0005654; GO:0005634; GO:1990904; GO:0000151","GO:0005524; GO:0000287; GO:0030145; GO:0004712; GO:0004674; GO:0004713","GO:0006974; GO:0042771; GO:0070885; GO:0045725; GO:0006468; GO:1901796; GO:0007224"]
[619,307,"PK598","DYRK2","Y382","Dual specificity tyrosine-phosphorylation-regulated kinase 2",{"v":2455.1729186471653,"d":"2455"},{"v":2029.6709938464091,"d":"2030"},{"v":1319.6278725328064,"d":"1320"},{"v":53.74887701433021,"d":"54"},{"v":1014.4826479771809,"d":"1014"},{"v":8543.389574844507,"d":"8543"},"Kinexus","RpAb","VYT(pY)IQS(bA)C","Corresponds to amino acid residues V379 to S385; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y382 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in DYRK2 (≥1659 reports from high throughput mass spectrometry studies).",null,"Q92630","Q92630",693,"Q92630",null,"NP_006473.2","Block2",11,8,"2, 10, 18, 26","DYRK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","DYRK","Dyrk2",{"$nulls":5},"Protein kinase, dual-specificity, CMGC group, DYRK family, Dyrk2 subfamily","GO:0005737; GO:0005829; GO:0005654; GO:0005634; GO:1990904; GO:0000151","GO:0005524; GO:0000287; GO:0030145; GO:0004712; GO:0004674; GO:0004713","GO:0006974; GO:0042771; GO:0070885; GO:0045725; GO:0006468; GO:1901796; GO:0007224"]
[621,308,"NK374-1","DYRK3","Pan-specific","Dual specificity tyrosine-phosphorylation-regulated kinase 3",{"v":275.6123286606239,"d":"276"},{"v":228.43995461943342,"d":"228"},{"v":191.7073423364544,"d":"192"},{"v":69.55688204082982,"d":"70"},{"v":36.2077045021712,"d":"36"},{"v":1344.1480577987527,"d":"1344"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 188-210 of human Dyrk3.",null,null,"O43781","O43781",694,"O43781",null,"NP_001004023.1","Block2",11,9,"2, 10, 18, 26","DYRK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","DYRK","Dyrk2",{"$nulls":5},"Protein kinase, dual-specificity, CMGC group, DYRK family, Dyrk2 subfamily","GO:0005737; GO:0010494; GO:0005829; GO:0043231; GO:0005654; GO:0005634","GO:0005524; GO:0000287; GO:0004672; GO:0004712; GO:0004674; GO:0004713","GO:0030218; GO:0043066; GO:0043518; GO:0006468; GO:0080135; GO:1903432; GO:0035617"]
[623,309,"NK375-2","DYRK4","Pan-specific","Dual specificity tyrosine-phosphorylation-regulated kinase 4",{"v":585.3576828253014,"d":"585"},{"v":469.51988045059005,"d":"470"},{"v":396.6124692981467,"d":"397"},{"v":67.75557593843263,"d":"68"},{"v":99.55531014168287,"d":"100"},{"v":3685.438725995524,"d":"3685"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 119-219 mapping within an internal region of mouse Dyrk4.",null,null,"Q9NR20","Q9NR20",695,"Q9NR20",null,"NP_003836.1","Block2",11,10,"2, 10, 18, 26","DYRK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","DYRK","Dyrk2",{"$nulls":5},"EC 2.7.12.1; Protein kinase, dual-specificity; EC 2.7.1.-; CMGC domain target; CMGC</A> group; DYRK family; Dyrk2 subfamily","GO:0005737; GO:0043231; GO:0005634","GO:0005524; GO:0046872; GO:0004712; GO:0004674; GO:0004713"]
[625,310,"NK375-1","DYRK4","Pan-specific","Dual specificity tyrosine-phosphorylation-regulated kinase 4",{"v":564.5093699754149,"d":"565"},{"v":486.051612390746,"d":"486"},{"v":379.15439713508465,"d":"379"},{"v":67.16529738941222,"d":"67"},{"v":79.07456218089393,"d":"79"},{"v":2161.977315892127,"d":"2162"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 1-104 mapping at the N-terminus of human Dyrk4",null,null,"Q9NR20","Q9NR20",695,"Q9NR20",null,"NP_003836.1","Block2",11,11,"2, 10, 18, 26","DYRK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","DYRK","Dyrk2",{"$nulls":5},"EC 2.7.12.1; Protein kinase, dual-specificity; EC 2.7.1.-; CMGC domain target; CMGC</A> group; DYRK family; Dyrk2 subfamily","GO:0005737; GO:0043231; GO:0005634","GO:0005524; GO:0046872; GO:0004712; GO:0004674; GO:0004713"]
[627,311,"PN509","EEF1A1","Y141","Eukaryotic elongation factor 1-alpha 1",{"v":9064.175599654087,"d":"9064"},{"v":9000.913642820076,"d":"9001"},{"v":2010.062693359201,"d":"2010"},{"v":22.175901947838593,"d":"22"},{"v":3224.5168077781445,"d":"3225"},{"v":14136.408815182776,"d":"14136"},"Kinexus","RpAb","LLA(pY)TLG(bA)C","Corresponds to amino acid residues L138 to G144; In the middle of the GTP_EFTU domain. ","The effect of Y141 phosphorylation is unclear. This is the second major in vivo phosphorylation site in EEF1A1 (≥1187 reports from high throughput mass spectrometry studies).",null,"P68104","P68104",3315,null,null,"NP_001393.1","Block2",11,12,"2, 10, 18, 26","EEF1A1",{"$nulls":12},"Translation protein, initiation complex","GO:0030864; GO:0005737; GO:0098574; GO:0005829; GO:0005853; GO:0070062; GO:0005576; GO:0005615; GO:1904813; GO:0016020; GO:0005730; GO:0005634; GO:0005886; GO:0032587; GO:0034774","GO:0003924; GO:0005525; GO:0019901; GO:0003723; GO:0003746; GO:0000049","GO:0071364; GO:0043312; GO:1904714; GO:0006355; GO:0006351; GO:0006414"]
[629,312,"PN555","EEF2","T57","Eukaryotic elongation factor 2",{"v":12862.662801047083,"d":"12863"},{"v":12447.976365343395,"d":"12448"},{"v":2557.2303145883557,"d":"2557"},{"v":19.88103360977623,"d":"20"},{"v":6776.838213375424,"d":"6777"},{"v":25164.620682402296,"d":"25165"},"Kinexus","RpAb","ETRF(pT)DTR(bA)C","Corresponds to amino acid residues E53 to R60; In the N-terminal portion of the protein. ","T57 phosphorylation is likely to be inhibitory as phosphorylation by EF-2 kinase completely inactivates EF-2 activity to catalyze the GTP-dependent ribosomal translocation step during translation elongation. This is one of the major in vivo phosphorylation sites in EEF2 (≥107 reports from high throughput mass spectrometry studies).","eEF2K","P13639","P13639",960,null,null,"NP_001952.1","Block2",11,13,"2, 10, 18, 26",{"$nulls":13},"Protein synthesis protein","GO:0016235; GO:0005737; GO:0005829; GO:0070062; GO:0005576; GO:1904813; GO:0016020; GO:0045121; GO:0005634; GO:0005886; GO:0042788; GO:1990904; GO:0034774; GO:0045202","GO:0008097; GO:0051015; GO:0045296; GO:0003924; GO:0005525; GO:0002039; GO:0019901; GO:0043022; GO:0003723; GO:0003746","GO:0007568; GO:1990416; GO:0014009; GO:0002244; GO:0043312; GO:2000767; GO:0045727; GO:0034976; GO:0032355; GO:0045471; GO:0051593; GO:0042542; GO:0002931; GO:0035914; GO:0003009; GO:0006414"]
[631,313,"PK180","eEF2K","S366","Eukaryotic elongation factor 2 kinase",{"v":1159.742992780713,"d":"1160"},{"v":987.3356897324426,"d":"987"},{"v":645.3665985989508,"d":"645"},{"v":55.647380722823506,"d":"56"},{"v":367.79737688023323,"d":"368"},{"v":5446.607117111527,"d":"5447"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S366 phosphosite.","S366 phosphorylation inhibits phosphotransferase activity. This is one of the major in vivo phosphorylation sites in eEF2K.","AMPKa1 (PRKAA1); p70S6K (RPS6KB1); p70S6Kb (RPS6KB2); PKACa (PRKACA); RSK1 (RPS6KA1); RSK2 (RPS6KA3)","O00418","O00418",591,"O00418",null,"NP_037434.1","Block2",12,1,"2, 10, 18, 26","eEF2K","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","Alpha","eEF2K",{"$nulls":5},"Protein-serine kinase,  Atypical group, Alpha family, eEF2K subfamily","GO:0005737; GO:0005829; GO:0043197; GO:0014069","GO:0005524; GO:0005509; GO:0005516; GO:0004686; GO:0004672; GO:0008135","GO:0071454; GO:1990416; GO:0071277; GO:0071320; GO:0032869; GO:0043066; GO:0061003; GO:0045807; GO:0051965; GO:0046777; GO:0031952; GO:0002931; GO:1990637; GO:0006414"]
[633,314,"NK052-6","EGFR (ErbB1)","Pan-specific","Epidermal growth factor receptor-tyrosine kinase",{"v":28067.909789186204,"d":"28068"},{"v":26813.96896111187,"d":"26814"},{"v":9261.384941626373,"d":"9261"},{"v":32.99634711379374,"d":"33"},{"v":12395.577698475065,"d":"12396"},{"v":66286.815885124,"d":"66287"},"Kinexus","RpAb","CVIQGDERMHLPSPT","Corresponds to amino acid residues V980 to T993; Just after the catalytic domain of the kinase.",null,null,"P00533","P00533",592,"P00533","P00533","NP_005219","Block2",12,2,"2, 10, 18, 26","EGFR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"Protein-tyrosine kinase (receptor), TK group, EGFR family","GO:0016324; GO:0016323; GO:0009986; GO:0030665; GO:0005737; GO:0031901; GO:0030139; GO:0005789; GO:0005768; GO:0010008; GO:0005615; GO:0005925; GO:0000139; GO:0016021; GO:0016020; GO:0045121; GO:0097489; GO:0031965; GO:0005634; GO:0048471; GO:0005886; GO:0032991; GO:0043235; GO:0070435; GO:0045202","GO:0051015; GO:0005524; GO:0045296; GO:0005516; GO:0003682; GO:0003690; GO:0019899; GO:0005006; GO:0048408; GO:0042802; GO:0005178; GO:0004709; GO:0046934; GO:0046982; GO:0019901; GO:0019903; GO:0004713; GO:0005088; GO:0004714; GO:0004888; GO:0031625; GO:0001618","GO:0043006; GO:0007202; GO:0048143; GO:0098609; GO:0008283; GO:0007166; GO:0071230; GO:0071276; GO:0071549; GO:0071364; GO:0071392; GO:0071260; GO:0034614; GO:0021795; GO:0007623; GO:0048546; GO:0016101; GO:0001892; GO:0007173; GO:0038128; GO:0061029; GO:0001942; GO:0042743; GO:0007611; GO:0097421; GO:0030324; GO:0010960; GO:0000165; GO:0061024; GO:0007494; GO:0060571; GO:0043066; GO:1905208; GO:0042059; GO:1901185; GO:0045930; GO:0045746; GO:0042177; GO:0048812; GO:0001503; GO:0042698; GO:0038083; GO:0018108; GO:0097755; GO:0045780; GO:0090263; GO:0030307; GO:0030335; GO:0008284; GO:0031659; GO:0045739; GO:0045740; GO:0050679; GO:0070374; GO:0048146; GO:0050729; GO:0043406; GO:1901224; GO:0010750; GO:0033138; GO:0042327; GO:1903800; GO:1902722; GO:0051897; GO:1900020; GO:1903078; GO:0001934; GO:0048661; GO:0032930; GO:0051968; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0051205; GO:2000145; GO:0070372; GO:0046328; GO:0050999; GO:0050730; GO:0014066; GO:0006357; GO:0051592; GO:0033590; GO:0033594; GO:0006970; GO:0070141; GO:0007435; GO:0007165; GO:0043586; GO:0006412; GO:0042060"]
[635,315,"NK052-4","EGFR (ErbB1)","Pan-specific","Epidermal growth factor receptor-tyrosine kinase",{"v":12210.162364934307,"d":"12210"},{"v":11866.386983436536,"d":"11866"},{"v":2604.235878453082,"d":"2604"},{"v":21.328429554156,"d":"21"},{"v":6608.380552429124,"d":"6608"},{"v":26255.828203104305,"d":"26256"},"Kinexus","RpAb","CEYLRVAPQSSEFIGA","Corresponds to amino acid residues E1196 to A1210; C-terminus.",null,null,"P00533","P00533",592,"P00533","P00533","NP_005219","Block2",12,3,"2, 10, 18, 26","EGFR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"Protein-tyrosine kinase (receptor), TK group, EGFR family","GO:0016324; GO:0016323; GO:0009986; GO:0030665; GO:0005737; GO:0031901; GO:0030139; GO:0005789; GO:0005768; GO:0010008; GO:0005615; GO:0005925; GO:0000139; GO:0016021; GO:0016020; GO:0045121; GO:0097489; GO:0031965; GO:0005634; GO:0048471; GO:0005886; GO:0032991; GO:0043235; GO:0070435; GO:0045202","GO:0051015; GO:0005524; GO:0045296; GO:0005516; GO:0003682; GO:0003690; GO:0019899; GO:0005006; GO:0048408; GO:0042802; GO:0005178; GO:0004709; GO:0046934; GO:0046982; GO:0019901; GO:0019903; GO:0004713; GO:0005088; GO:0004714; GO:0004888; GO:0031625; GO:0001618","GO:0043006; GO:0007202; GO:0048143; GO:0098609; GO:0008283; GO:0007166; GO:0071230; GO:0071276; GO:0071549; GO:0071364; GO:0071392; GO:0071260; GO:0034614; GO:0021795; GO:0007623; GO:0048546; GO:0016101; GO:0001892; GO:0007173; GO:0038128; GO:0061029; GO:0001942; GO:0042743; GO:0007611; GO:0097421; GO:0030324; GO:0010960; GO:0000165; GO:0061024; GO:0007494; GO:0060571; GO:0043066; GO:1905208; GO:0042059; GO:1901185; GO:0045930; GO:0045746; GO:0042177; GO:0048812; GO:0001503; GO:0042698; GO:0038083; GO:0018108; GO:0097755; GO:0045780; GO:0090263; GO:0030307; GO:0030335; GO:0008284; GO:0031659; GO:0045739; GO:0045740; GO:0050679; GO:0070374; GO:0048146; GO:0050729; GO:0043406; GO:1901224; GO:0010750; GO:0033138; GO:0042327; GO:1903800; GO:1902722; GO:0051897; GO:1900020; GO:1903078; GO:0001934; GO:0048661; GO:0032930; GO:0051968; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0051205; GO:2000145; GO:0070372; GO:0046328; GO:0050999; GO:0050730; GO:0014066; GO:0006357; GO:0051592; GO:0033590; GO:0033594; GO:0006970; GO:0070141; GO:0007435; GO:0007165; GO:0043586; GO:0006412; GO:0042060"]
[637,338,"NK052-5","EGFR (ErbB1)","Pan-specific","Epidermal growth factor receptor-tyrosine kinase",{"v":18162.679072360042,"d":"18163"},{"v":17741.99442156622,"d":"17742"},{"v":4135.740643500101,"d":"4136"},{"v":22.770542974543165,"d":"23"},{"v":4155.530497221887,"d":"4156"},{"v":33446.90360085107,"d":"33447"},"Kinexus","RpAb","SNMSMDFQNHLGSC","Corresponds to amino acid residues S174 to C187; In the extracellular domain of the EGF receptor.",null,null,"P00533","P00533",592,"P00533","P00533","NP_005219","Block2",13,13,"2, 10, 18, 26","EGFR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"Protein-tyrosine kinase (receptor), TK group, EGFR family","GO:0016324; GO:0016323; GO:0009986; GO:0030665; GO:0005737; GO:0031901; GO:0030139; GO:0005789; GO:0005768; GO:0010008; GO:0005615; GO:0005925; GO:0000139; GO:0016021; GO:0016020; GO:0045121; GO:0097489; GO:0031965; GO:0005634; GO:0048471; GO:0005886; GO:0032991; GO:0043235; GO:0070435; GO:0045202","GO:0051015; GO:0005524; GO:0045296; GO:0005516; GO:0003682; GO:0003690; GO:0019899; GO:0005006; GO:0048408; GO:0042802; GO:0005178; GO:0004709; GO:0046934; GO:0046982; GO:0019901; GO:0019903; GO:0004713; GO:0005088; GO:0004714; GO:0004888; GO:0031625; GO:0001618","GO:0043006; GO:0007202; GO:0048143; GO:0098609; GO:0008283; GO:0007166; GO:0071230; GO:0071276; GO:0071549; GO:0071364; GO:0071392; GO:0071260; GO:0034614; GO:0021795; GO:0007623; GO:0048546; GO:0016101; GO:0001892; GO:0007173; GO:0038128; GO:0061029; GO:0001942; GO:0042743; GO:0007611; GO:0097421; GO:0030324; GO:0010960; GO:0000165; GO:0061024; GO:0007494; GO:0060571; GO:0043066; GO:1905208; GO:0042059; GO:1901185; GO:0045930; GO:0045746; GO:0042177; GO:0048812; GO:0001503; GO:0042698; GO:0038083; GO:0018108; GO:0097755; GO:0045780; GO:0090263; GO:0030307; GO:0030335; GO:0008284; GO:0031659; GO:0045739; GO:0045740; GO:0050679; GO:0070374; GO:0048146; GO:0050729; GO:0043406; GO:1901224; GO:0010750; GO:0033138; GO:0042327; GO:1903800; GO:1902722; GO:0051897; GO:1900020; GO:1903078; GO:0001934; GO:0048661; GO:0032930; GO:0051968; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0051205; GO:2000145; GO:0070372; GO:0046328; GO:0050999; GO:0050730; GO:0014066; GO:0006357; GO:0051592; GO:0033590; GO:0033594; GO:0006970; GO:0070141; GO:0007435; GO:0007165; GO:0043586; GO:0006412; GO:0042060"]
[639,316,"PK602","EGFR (ErbB1)","Y869","Epidermal growth factor receptor-tyrosine kinase",{"v":10111.964635659764,"d":"10112"},{"v":9966.346879423636,"d":"9966"},{"v":2119.5724190349915,"d":"2120"},{"v":20.961034728704806,"d":"21"},{"v":4912.758867854693,"d":"4913"},{"v":16982.22009513022,"d":"16982"},"Kinexus","RpAb","EKE(pY)HAEG(bA)C","Corresponds to amino acid residues E866 to G873; In the protein kinase catalytic domain.","Y869 phosphorylation stimulates phosphotransferase activity and induces protein interaction with COX2 and PKCE and PKCZ. This is one of the major in vivo phosphorylation sites in EGFR (≥165 reports from high throughput mass spectrometry studies).","Src","P00533","P00533",592,"P00533","P00533","NP_005219","Block2",12,4,"2, 10, 18, 26","EGFR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"Protein-tyrosine kinase (receptor), TK group, EGFR family","GO:0016324; GO:0016323; GO:0009986; GO:0030665; GO:0005737; GO:0031901; GO:0030139; GO:0005789; GO:0005768; GO:0010008; GO:0005615; GO:0005925; GO:0000139; GO:0016021; GO:0016020; GO:0045121; GO:0097489; GO:0031965; GO:0005634; GO:0048471; GO:0005886; GO:0032991; GO:0043235; GO:0070435; GO:0045202","GO:0051015; GO:0005524; GO:0045296; GO:0005516; GO:0003682; GO:0003690; GO:0019899; GO:0005006; GO:0048408; GO:0042802; GO:0005178; GO:0004709; GO:0046934; GO:0046982; GO:0019901; GO:0019903; GO:0004713; GO:0005088; GO:0004714; GO:0004888; GO:0031625; GO:0001618","GO:0043006; GO:0007202; GO:0048143; GO:0098609; GO:0008283; GO:0007166; GO:0071230; GO:0071276; GO:0071549; GO:0071364; GO:0071392; GO:0071260; GO:0034614; GO:0021795; GO:0007623; GO:0048546; GO:0016101; GO:0001892; GO:0007173; GO:0038128; GO:0061029; GO:0001942; GO:0042743; GO:0007611; GO:0097421; GO:0030324; GO:0010960; GO:0000165; GO:0061024; GO:0007494; GO:0060571; GO:0043066; GO:1905208; GO:0042059; GO:1901185; GO:0045930; GO:0045746; GO:0042177; GO:0048812; GO:0001503; GO:0042698; GO:0038083; GO:0018108; GO:0097755; GO:0045780; GO:0090263; GO:0030307; GO:0030335; GO:0008284; GO:0031659; GO:0045739; GO:0045740; GO:0050679; GO:0070374; GO:0048146; GO:0050729; GO:0043406; GO:1901224; GO:0010750; GO:0033138; GO:0042327; GO:1903800; GO:1902722; GO:0051897; GO:1900020; GO:1903078; GO:0001934; GO:0048661; GO:0032930; GO:0051968; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0051205; GO:2000145; GO:0070372; GO:0046328; GO:0050999; GO:0050730; GO:0014066; GO:0006357; GO:0051592; GO:0033590; GO:0033594; GO:0006970; GO:0070141; GO:0007435; GO:0007165; GO:0043586; GO:0006412; GO:0042060"]
[641,317,"PK603","EGFR (ErbB1)","Y998","Epidermal growth factor receptor-tyrosine kinase",{"v":8954.871678186037,"d":"8955"},{"v":8814.932615824828,"d":"8815"},{"v":1985.8187662952112,"d":"1986"},{"v":22.175848383541247,"d":"22"},{"v":318.7526526035424,"d":"319"},{"v":15174.538646753484,"d":"15175"},"Kinexus","RpAb","SNF(pY)RAL(bA)C","Corresponds to amino acid residues S995 to L1001; In the cytoplasmic region of EGFR after the kinase catalytic domain.","Y998 phosphorylation inhibits phosphotransferase activity. Phosphorylation induces molecular association with CBL, CRK, CSK, SHC1, SHP-2 and STAT5A, as well as receptor internalization. This is one of the major in vivo phosphorylation sites in EGFR (≥147 reports from high throughput mass spectrometry studies).",null,"P00533","P00533",592,"P00533","P00533","NP_005219","Block2",12,5,"2, 10, 18, 26","EGFR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"Protein-tyrosine kinase (receptor), TK group, EGFR family","GO:0016324; GO:0016323; GO:0009986; GO:0030665; GO:0005737; GO:0031901; GO:0030139; GO:0005789; GO:0005768; GO:0010008; GO:0005615; GO:0005925; GO:0000139; GO:0016021; GO:0016020; GO:0045121; GO:0097489; GO:0031965; GO:0005634; GO:0048471; GO:0005886; GO:0032991; GO:0043235; GO:0070435; GO:0045202","GO:0051015; GO:0005524; GO:0045296; GO:0005516; GO:0003682; GO:0003690; GO:0019899; GO:0005006; GO:0048408; GO:0042802; GO:0005178; GO:0004709; GO:0046934; GO:0046982; GO:0019901; GO:0019903; GO:0004713; GO:0005088; GO:0004714; GO:0004888; GO:0031625; GO:0001618","GO:0043006; GO:0007202; GO:0048143; GO:0098609; GO:0008283; GO:0007166; GO:0071230; GO:0071276; GO:0071549; GO:0071364; GO:0071392; GO:0071260; GO:0034614; GO:0021795; GO:0007623; GO:0048546; GO:0016101; GO:0001892; GO:0007173; GO:0038128; GO:0061029; GO:0001942; GO:0042743; GO:0007611; GO:0097421; GO:0030324; GO:0010960; GO:0000165; GO:0061024; GO:0007494; GO:0060571; GO:0043066; GO:1905208; GO:0042059; GO:1901185; GO:0045930; GO:0045746; GO:0042177; GO:0048812; GO:0001503; GO:0042698; GO:0038083; GO:0018108; GO:0097755; GO:0045780; GO:0090263; GO:0030307; GO:0030335; GO:0008284; GO:0031659; GO:0045739; GO:0045740; GO:0050679; GO:0070374; GO:0048146; GO:0050729; GO:0043406; GO:1901224; GO:0010750; GO:0033138; GO:0042327; GO:1903800; GO:1902722; GO:0051897; GO:1900020; GO:1903078; GO:0001934; GO:0048661; GO:0032930; GO:0051968; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0051205; GO:2000145; GO:0070372; GO:0046328; GO:0050999; GO:0050730; GO:0014066; GO:0006357; GO:0051592; GO:0033590; GO:0033594; GO:0006970; GO:0070141; GO:0007435; GO:0007165; GO:0043586; GO:0006412; GO:0042060"]
[643,318,"PK599","EGFR (ErbB1)","Y1069","Epidermal growth factor receptor-tyrosine kinase",{"v":9138.16379049962,"d":"9138"},{"v":9148.652720770755,"d":"9149"},{"v":2400.402835034397,"d":"2400"},{"v":26.26789024650605,"d":"26"},{"v":661.9328716577827,"d":"662"},{"v":15257.785089642126,"d":"15258"},"Kinexus","RpAb","LQR(pY)SSD(bA)C","Corresponds to amino acid residues L1066 to D1072; In the C-terminal region of the kinase after the catalytic domain.","Y1069 phosphorylation stimulates phosphotransferase activity. Phosphorylation induces protein ubquitination and degradation, and induces molecular association with CBL. This is one of the major in vivo phosphorylation sites in EGFR (≥132 reports from high throughput mass spectrometry studies).","EGFR","P00533","P00533",592,"P00533","P00533","NP_005219","Block2",12,6,"2, 10, 18, 26","EGFR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"Protein-tyrosine kinase (receptor), TK group, EGFR family","GO:0016324; GO:0016323; GO:0009986; GO:0030665; GO:0005737; GO:0031901; GO:0030139; GO:0005789; GO:0005768; GO:0010008; GO:0005615; GO:0005925; GO:0000139; GO:0016021; GO:0016020; GO:0045121; GO:0097489; GO:0031965; GO:0005634; GO:0048471; GO:0005886; GO:0032991; GO:0043235; GO:0070435; GO:0045202","GO:0051015; GO:0005524; GO:0045296; GO:0005516; GO:0003682; GO:0003690; GO:0019899; GO:0005006; GO:0048408; GO:0042802; GO:0005178; GO:0004709; GO:0046934; GO:0046982; GO:0019901; GO:0019903; GO:0004713; GO:0005088; GO:0004714; GO:0004888; GO:0031625; GO:0001618","GO:0043006; GO:0007202; GO:0048143; GO:0098609; GO:0008283; GO:0007166; GO:0071230; GO:0071276; GO:0071549; GO:0071364; GO:0071392; GO:0071260; GO:0034614; GO:0021795; GO:0007623; GO:0048546; GO:0016101; GO:0001892; GO:0007173; GO:0038128; GO:0061029; GO:0001942; GO:0042743; GO:0007611; GO:0097421; GO:0030324; GO:0010960; GO:0000165; GO:0061024; GO:0007494; GO:0060571; GO:0043066; GO:1905208; GO:0042059; GO:1901185; GO:0045930; GO:0045746; GO:0042177; GO:0048812; GO:0001503; GO:0042698; GO:0038083; GO:0018108; GO:0097755; GO:0045780; GO:0090263; GO:0030307; GO:0030335; GO:0008284; GO:0031659; GO:0045739; GO:0045740; GO:0050679; GO:0070374; GO:0048146; GO:0050729; GO:0043406; GO:1901224; GO:0010750; GO:0033138; GO:0042327; GO:1903800; GO:1902722; GO:0051897; GO:1900020; GO:1903078; GO:0001934; GO:0048661; GO:0032930; GO:0051968; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0051205; GO:2000145; GO:0070372; GO:0046328; GO:0050999; GO:0050730; GO:0014066; GO:0006357; GO:0051592; GO:0033590; GO:0033594; GO:0006970; GO:0070141; GO:0007435; GO:0007165; GO:0043586; GO:0006412; GO:0042060"]
[645,319,"PK600","EGFR (ErbB1)","Y1110","Epidermal growth factor receptor-tyrosine kinase",{"v":761.5340078121963,"d":"762"},{"v":704.1945521783457,"d":"704"},{"v":407.5440255713888,"d":"408"},{"v":53.51619512596923,"d":"54"},{"v":47.473483850520935,"d":"47"},{"v":2431.2712069071517,"d":"2431"},"Kinexus","RpAb","NPV(pY)HNQ(bA)C","Corresponds to amino acid residues N1107 to Q1113; In the cytoplasmic region of the EGFR after the kinase catalytic domain. ","Y1110 phosphorylation stimulates phosphotransferase activity, induces binding of CBL, DNA, DOK1, DOK2, GRB2, RASA1, SHC1 and STAT3. Phosphorylation regulates transcription, protein conformation, intracellular location, receptor internalization, molecular association, and ubquitination. One of the major in vivo sites of phosphorylation in EGFR (≥459 reports from high throughput mass spectrometry studies).","EGFR, Src","P00533","P00533",592,"P00533","P00533","NP_005219","Block2",12,7,"2, 10, 18, 26","EGFR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"Protein-tyrosine kinase (receptor), TK group, EGFR family","GO:0016324; GO:0016323; GO:0009986; GO:0030665; GO:0005737; GO:0031901; GO:0030139; GO:0005789; GO:0005768; GO:0010008; GO:0005615; GO:0005925; GO:0000139; GO:0016021; GO:0016020; GO:0045121; GO:0097489; GO:0031965; GO:0005634; GO:0048471; GO:0005886; GO:0032991; GO:0043235; GO:0070435; GO:0045202","GO:0051015; GO:0005524; GO:0045296; GO:0005516; GO:0003682; GO:0003690; GO:0019899; GO:0005006; GO:0048408; GO:0042802; GO:0005178; GO:0004709; GO:0046934; GO:0046982; GO:0019901; GO:0019903; GO:0004713; GO:0005088; GO:0004714; GO:0004888; GO:0031625; GO:0001618","GO:0043006; GO:0007202; GO:0048143; GO:0098609; GO:0008283; GO:0007166; GO:0071230; GO:0071276; GO:0071549; GO:0071364; GO:0071392; GO:0071260; GO:0034614; GO:0021795; GO:0007623; GO:0048546; GO:0016101; GO:0001892; GO:0007173; GO:0038128; GO:0061029; GO:0001942; GO:0042743; GO:0007611; GO:0097421; GO:0030324; GO:0010960; GO:0000165; GO:0061024; GO:0007494; GO:0060571; GO:0043066; GO:1905208; GO:0042059; GO:1901185; GO:0045930; GO:0045746; GO:0042177; GO:0048812; GO:0001503; GO:0042698; GO:0038083; GO:0018108; GO:0097755; GO:0045780; GO:0090263; GO:0030307; GO:0030335; GO:0008284; GO:0031659; GO:0045739; GO:0045740; GO:0050679; GO:0070374; GO:0048146; GO:0050729; GO:0043406; GO:1901224; GO:0010750; GO:0033138; GO:0042327; GO:1903800; GO:1902722; GO:0051897; GO:1900020; GO:1903078; GO:0001934; GO:0048661; GO:0032930; GO:0051968; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0051205; GO:2000145; GO:0070372; GO:0046328; GO:0050999; GO:0050730; GO:0014066; GO:0006357; GO:0051592; GO:0033590; GO:0033594; GO:0006970; GO:0070141; GO:0007435; GO:0007165; GO:0043586; GO:0006412; GO:0042060"]
[647,320,"PK601","EGFR (ErbB1)","Y1172","Epidermal growth factor receptor-tyrosine kinase",{"v":7744.3795141884775,"d":"7744"},{"v":7745.618138141579,"d":"7746"},{"v":1829.1501101781062,"d":"1829"},{"v":23.619066018483732,"d":"24"},{"v":680.2874524784487,"d":"680"},{"v":13651.921470091645,"d":"13652"},"Kinexus","RpAb","NPD(pY)QQD(bA)C","Corresponds to amino acid residues N1169 to D1175; In the C-terminal of the kinase after the catalytic domain.","Y1172 phosphorylation stimulates phosphotransferase activity. Phosphorylation regulates cell growth, protein degradation, receptor internalization, and induces molecular association with DOK1, DOK2, EGFR, GRB2, RASA1, SHC1, SHP-1 and VAV2. This is one of the major in vivo phosphorylation sites in EGFR (≥995 reports from high throughput mass spectrometry studies).","EGFR","P00533","P00533",592,"P00533","P00533","NP_005219","Block2",12,8,"2, 10, 18, 26","EGFR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"Protein-tyrosine kinase (receptor), TK group, EGFR family","GO:0016324; GO:0016323; GO:0009986; GO:0030665; GO:0005737; GO:0031901; GO:0030139; GO:0005789; GO:0005768; GO:0010008; GO:0005615; GO:0005925; GO:0000139; GO:0016021; GO:0016020; GO:0045121; GO:0097489; GO:0031965; GO:0005634; GO:0048471; GO:0005886; GO:0032991; GO:0043235; GO:0070435; GO:0045202","GO:0051015; GO:0005524; GO:0045296; GO:0005516; GO:0003682; GO:0003690; GO:0019899; GO:0005006; GO:0048408; GO:0042802; GO:0005178; GO:0004709; GO:0046934; GO:0046982; GO:0019901; GO:0019903; GO:0004713; GO:0005088; GO:0004714; GO:0004888; GO:0031625; GO:0001618","GO:0043006; GO:0007202; GO:0048143; GO:0098609; GO:0008283; GO:0007166; GO:0071230; GO:0071276; GO:0071549; GO:0071364; GO:0071392; GO:0071260; GO:0034614; GO:0021795; GO:0007623; GO:0048546; GO:0016101; GO:0001892; GO:0007173; GO:0038128; GO:0061029; GO:0001942; GO:0042743; GO:0007611; GO:0097421; GO:0030324; GO:0010960; GO:0000165; GO:0061024; GO:0007494; GO:0060571; GO:0043066; GO:1905208; GO:0042059; GO:1901185; GO:0045930; GO:0045746; GO:0042177; GO:0048812; GO:0001503; GO:0042698; GO:0038083; GO:0018108; GO:0097755; GO:0045780; GO:0090263; GO:0030307; GO:0030335; GO:0008284; GO:0031659; GO:0045739; GO:0045740; GO:0050679; GO:0070374; GO:0048146; GO:0050729; GO:0043406; GO:1901224; GO:0010750; GO:0033138; GO:0042327; GO:1903800; GO:1902722; GO:0051897; GO:1900020; GO:1903078; GO:0001934; GO:0048661; GO:0032930; GO:0051968; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0051205; GO:2000145; GO:0070372; GO:0046328; GO:0050999; GO:0050730; GO:0014066; GO:0006357; GO:0051592; GO:0033590; GO:0033594; GO:0006970; GO:0070141; GO:0007435; GO:0007165; GO:0043586; GO:0006412; GO:0042060"]
[649,321,"PK010","EGFR (ErbB1)","Y1172","Epidermal growth factor receptor-tyrosine kinase",{"v":504.43917048173427,"d":"504"},{"v":360.62725919536797,"d":"361"},{"v":959.7780649422863,"d":"960"},{"v":190.2663633408381,"d":"190"},{"v":15.470019341322168,"d":"15"},{"v":8477.892173275442,"d":"8478"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the Y1172 phosphosite.","Y1172 phosphorylation stimulates phosphotransferase activity. Phosphorylation regulates cell growth, protein degradation, receptor internalization, and induces molecular association with DOK1, DOK2, EGFR, GRB2, RASA1, SHC1, SHP-1 and VAV2. This is one of the major in vivo phosphorylation sites in EGFR (≥995 reports from high throughput mass spectrometry studies).","EGFR","P00533","P00533",592,"P00533","P00533","NP_005219","Block2",12,9,"2, 10, 18, 26","EGFR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"Protein-tyrosine kinase (receptor), TK group, EGFR family","GO:0016324; GO:0016323; GO:0009986; GO:0030665; GO:0005737; GO:0031901; GO:0030139; GO:0005789; GO:0005768; GO:0010008; GO:0005615; GO:0005925; GO:0000139; GO:0016021; GO:0016020; GO:0045121; GO:0097489; GO:0031965; GO:0005634; GO:0048471; GO:0005886; GO:0032991; GO:0043235; GO:0070435; GO:0045202","GO:0051015; GO:0005524; GO:0045296; GO:0005516; GO:0003682; GO:0003690; GO:0019899; GO:0005006; GO:0048408; GO:0042802; GO:0005178; GO:0004709; GO:0046934; GO:0046982; GO:0019901; GO:0019903; GO:0004713; GO:0005088; GO:0004714; GO:0004888; GO:0031625; GO:0001618","GO:0043006; GO:0007202; GO:0048143; GO:0098609; GO:0008283; GO:0007166; GO:0071230; GO:0071276; GO:0071549; GO:0071364; GO:0071392; GO:0071260; GO:0034614; GO:0021795; GO:0007623; GO:0048546; GO:0016101; GO:0001892; GO:0007173; GO:0038128; GO:0061029; GO:0001942; GO:0042743; GO:0007611; GO:0097421; GO:0030324; GO:0010960; GO:0000165; GO:0061024; GO:0007494; GO:0060571; GO:0043066; GO:1905208; GO:0042059; GO:1901185; GO:0045930; GO:0045746; GO:0042177; GO:0048812; GO:0001503; GO:0042698; GO:0038083; GO:0018108; GO:0097755; GO:0045780; GO:0090263; GO:0030307; GO:0030335; GO:0008284; GO:0031659; GO:0045739; GO:0045740; GO:0050679; GO:0070374; GO:0048146; GO:0050729; GO:0043406; GO:1901224; GO:0010750; GO:0033138; GO:0042327; GO:1903800; GO:1902722; GO:0051897; GO:1900020; GO:1903078; GO:0001934; GO:0048661; GO:0032930; GO:0051968; GO:0045893; GO:0045944; GO:0045907; GO:0046777; GO:0051205; GO:2000145; GO:0070372; GO:0046328; GO:0050999; GO:0050730; GO:0014066; GO:0006357; GO:0051592; GO:0033590; GO:0033594; GO:0006970; GO:0070141; GO:0007435; GO:0007165; GO:0043586; GO:0006412; GO:0042060"]
[651,322,"NN038-1","eIF2a","Pan-specific","Eukaryotic translation initiation factor 2 alpha",{"v":239.32782814495744,"d":"239"},{"v":170.91251297138513,"d":"171"},{"v":226.48013642429308,"d":"226"},{"v":94.63176020095636,"d":"95"},{"v":15.293254834928552,"d":"15"},{"v":1336.2216249010594,"d":"1336"},"External","RpAb","ELSRR","Corresponds to amino acid residues  E50 to R54; Surrounds the S51 phosphosite.",null,null,"P05198","P05198",961,null,null,"NP_004085","Block2",12,10,"2, 10, 18, 26",{"$nulls":13},"Protein synthesis protein","GO:0010494; GO:0005829; GO:0033290; GO:0005850; GO:0070062; GO:0097451; GO:0016020; GO:0043614; GO:0005634; GO:0005844; GO:0005840; GO:0045202; GO:0044207","GO:0043022; GO:0003723; GO:0003743","GO:0007568; GO:0034198; GO:0034605; GO:0034599; GO:0034644; GO:1905098; GO:0032057; GO:0036499; GO:1901216; GO:2000676; GO:0046777; GO:0034976; GO:1990737; GO:0034063; GO:0006413; GO:0055085"]
[653,323,"PN028-1","eIF2a","S52","Eukaryotic translation initiation factor 2 alpha",{"v":414.77194305968175,"d":"415"},{"v":384.3075126449578,"d":"384"},{"v":307.9104666654349,"d":"308"},{"v":74.23608848613212,"d":"74"},{"v":26.595496029278102,"d":"27"},{"v":1849.5863558986182,"d":"1850"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S52 phosphosite.","S52 phosphorylation inhibits protein synthesis by inducing interaction with eIF2B and PERK. Phosphorylation stabilizes the eIF-2A/GDP/eIF-2B complex and prevents the GDP/GTP exchange reaction, and impairs the recycling of eIF-2 between successive rounds of initiation and causes global inhibition of mRNA translation. Phosphorylation also induces interaction with CELF1. This is one of the minor in vivo phosphorylation sites in eIF2a (≥2 reports from high throughput mass spectrometry studies).","ERK2 (MAPK1); GCN2 (EIF2AK4); HRI (EIF2AK1); p38a MAPK (MAPK14); PEK (EIF2AK3, PERK); PKR (EIF2AK2); RSK2 (RPS6KA3)","P05198","P05198",961,null,null,"NP_004085","Block2",12,11,"2, 10, 18, 26",{"$nulls":13},"Protein synthesis protein","GO:0010494; GO:0005829; GO:0033290; GO:0005850; GO:0070062; GO:0097451; GO:0016020; GO:0043614; GO:0005634; GO:0005844; GO:0005840; GO:0045202; GO:0044207","GO:0043022; GO:0003723; GO:0003743","GO:0007568; GO:0034198; GO:0034605; GO:0034599; GO:0034644; GO:1905098; GO:0032057; GO:0036499; GO:1901216; GO:2000676; GO:0046777; GO:0034976; GO:1990737; GO:0034063; GO:0006413; GO:0055085"]
[655,324,"PK604","EIF2AK3 (PERK)","T982","Eukaryotic translation initiation factor 2-alpha kinase 3",{"v":11345.24098280283,"d":"11345"},{"v":11360.543721591082,"d":"11361"},{"v":2249.030879734077,"d":"2249"},{"v":19.823561995229266,"d":"20"},{"v":2742.6102197423543,"d":"2743"},{"v":17502.346168003707,"d":"17502"},"Kinexus","RpAb","ARH(pT)GQV(bA)C","Corresponds to amino acid residues A889 to V895; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T982 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is phosphorylation site in EIF2AK3 has not been reported from high throughput mass spectrometry studies.",null,"Q9NZJ5","Q9NZJ5",636,"Q9NZJ5",null,"NP_004827.4","Block2",12,12,"2, 10, 18, 26","PERK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","PEK","PEK",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; PEK family; PEK subfamily","GO:0005737; GO:0005783; GO:0005789; GO:0030176; GO:0016020; GO:0048471","GO:0005524; GO:0019899; GO:0004694; GO:0051879; GO:0042802; GO:0042803; GO:0004672; GO:0019903; GO:0004674","GO:0006919; GO:0001525; GO:0030282; GO:0019722; GO:0034198; GO:0070417; GO:0042149; GO:0002063; GO:0036492; GO:0031018; GO:0007029; GO:0030968; GO:0006983; GO:0048009; GO:0031642; GO:0017148; GO:0032057; GO:0001503; GO:0018105; GO:0036499; GO:0010628; GO:1900182; GO:0045943; GO:0010575; GO:0046777; GO:0051260; GO:0006468; GO:0060734; GO:1902235; GO:0010998; GO:0034976; GO:1990737; GO:0001501"]
[657,325,"NN407-1","eIF4B","Pan-specific","Eukaryotic translation initiation factor 4B",{"v":811.343119959345,"d":"811"},{"v":686.8926287554423,"d":"687"},{"v":469.7668004499582,"d":"470"},{"v":57.899893262606014,"d":"58"},{"v":198.93975976479877,"d":"199"},{"v":3609.2849606763216,"d":"3609"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 581-602 at the C-terminus of human eIF4B.",null,null,"P23588","P23588",1088,null,null,"NP_001408.2","Block2",12,13,"2, 10, 18, 26",{"$nulls":13},"Protein synthesis protein","GO:0005829; GO:0016281; GO:0005844","GO:0004386; GO:0043024; GO:0003723; GO:0033592; GO:0034057; GO:0003743","GO:0097010; GO:0001731; GO:0006446; GO:0006413"]
[659,326,"PN172","eIF4B","S422","Eukaryotic translation initiation factor 4B",{"v":388.91119606876964,"d":"389"},{"v":260.6263511120365,"d":"261"},{"v":425.3422501525734,"d":"425"},{"v":109.36744800665544,"d":"109"},{"v":4.671382936747232,"d":"5"},{"v":3439.04513362894,"d":"3439"},"External","RpAb","TG(pS)ES","Corresponds to amino acid residues TS20 to S424.","S422 phosphorylation inhibits activity and induces interaction with eIF3-alpha. This is one of the major in vivo phosphorylation sites in eIF4B (≥522 reports from high throughput mass spectrometry studies).","p70S6K (RPS6KB1); RSK1 (RPS6KA1)","P23588","P23588",1088,null,null,"NP_001408.2","Block2",13,1,"2, 10, 18, 26",{"$nulls":13},"Protein synthesis protein","GO:0005829; GO:0016281; GO:0005844","GO:0004386; GO:0043024; GO:0003723; GO:0033592; GO:0034057; GO:0003743","GO:0097010; GO:0001731; GO:0006446; GO:0006413"]
[661,327,"NN039-3","eIF4E","Pan-specific","Eukaryotic translation initiation factor 4 (mRNA cap binding protein)",{"v":972.132041231067,"d":"972"},{"v":874.0000009169455,"d":"874"},{"v":512.5709880174537,"d":"513"},{"v":52.72647812002529,"d":"53"},{"v":151.5943485832949,"d":"152"},{"v":3955.966777359419,"d":"3956"},"External","MmAb","Not precisely defined.","Antibody raised against full length human eIF4E.",null,null,"P06730","P06730",962,null,"P06730","NP_001959","Block2",13,2,"2, 10, 18, 26",{"$nulls":13},"Protein synthesis protein","GO:0033391; GO:0005737; GO:0036464; GO:0010494; GO:0005829; GO:0016281; GO:0070062; GO:0098978; GO:0005845; GO:0000932; GO:0048471; GO:0099524; GO:0016442","GO:0019899; GO:0031370; GO:0070491; GO:0000340; GO:0003723; GO:0000339; GO:0003743; GO:0045182","GO:0001662; GO:0071549; GO:0000082; GO:0030324; GO:0006406; GO:0045665; GO:0017148; GO:0045931; GO:0006417; GO:0099578; GO:0006405; GO:0019827; GO:0006413; GO:0016032"]
[663,328,"PN030-2","eIF4E","S209","Eukaryotic translation initiation factor 4 (mRNA cap binding protein)",{"v":102.64798015889693,"d":"103"},{"v":65.61733924052805,"d":"66"},{"v":131.09658248736355,"d":"131"},{"v":127.71472198910176,"d":"128"},{"v":11.778398829720786,"d":"12"},{"v":1311.7543050367885,"d":"1312"},"External","RpAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the S209 phosphosite.","S209 phosphorylation increases the affinity of this protein for the 7-methylguanosine-containing mRNA cap and 4E-T, although another report describes inhibition of interaction with RNA. This is one of the major in vivo phosphorylation sites in eIF4E (≥4 reports from high throughput mass spectrometry studies).","MAPKAPK5 (PRAK); MNK1 (MKNK1); MNK2 (MKNK2, GPRK7); PKCa (PRKCA)","P06730","P06730",962,null,"P06730","NP_001959","Block2",13,3,"2, 10, 18, 26",{"$nulls":13},"Protein synthesis protein","GO:0033391; GO:0005737; GO:0036464; GO:0010494; GO:0005829; GO:0016281; GO:0070062; GO:0098978; GO:0005845; GO:0000932; GO:0048471; GO:0099524; GO:0016442","GO:0019899; GO:0031370; GO:0070491; GO:0000340; GO:0003723; GO:0000339; GO:0003743; GO:0045182","GO:0001662; GO:0071549; GO:0000082; GO:0030324; GO:0006406; GO:0045665; GO:0017148; GO:0045931; GO:0006417; GO:0099578; GO:0006405; GO:0019827; GO:0006413; GO:0016032"]
[665,329,"NN408-1 ","eIF4G (eIF4G1)","Pan-specific","Eukaryotic translation initiation factor 4 gamma 1",{"v":552.1614119529107,"d":"552"},{"v":475.6082341237293,"d":"476"},{"v":301.3567117980841,"d":"301"},{"v":54.57764799829662,"d":"55"},{"v":131.59228011475525,"d":"132"},{"v":2034.632823265232,"d":"2035"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 1-300 of human eIF4G.",null,null,"Q04637","Q04637",3566,null,"Q04637","NP_004944","Block2",13,4,"2, 10, 18, 26",{"$nulls":13},"Protein synthesis protein","GO:0005737; GO:0005829; GO:0016281; GO:0016020; GO:0005634; GO:0005844","GO:0005524; GO:0008190; GO:0042802; GO:0003729; GO:0032947; GO:0003723; GO:0008135; GO:0003743; GO:0031369","GO:0001662; GO:0002191; GO:0034645; GO:0031669; GO:0032502; GO:0097009; GO:0007005; GO:0010507; GO:1901215; GO:0010801; GO:0000184; GO:0010942; GO:0030307; GO:0008284; GO:0032270; GO:1905537; GO:1900087; GO:1905618; GO:1905612; GO:0045666; GO:0033138; GO:0080135; GO:0060964; GO:0043488; GO:1905696; GO:1905606; GO:0006446; GO:0006412; GO:0006413; GO:0016032"]
[667,330,"PN031","eIF4G (eIF4G1)","S1106","Eukaryotic translation initiation factor 4 gamma 1",{"v":135.6831194442542,"d":"136"},{"v":110.85056682689799,"d":"111"},{"v":99.36940521332656,"d":"99"},{"v":73.23638019256535,"d":"73"},{"v":15.481996388089541,"d":"15"},{"v":595.8483463589473,"d":"596"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S1106 phosphosite.","The effect of S1106 phosphorylation is unclear. This phosphosite has been poorly detected by mass spectrometry  (≥1 report).",null,"Q04637","Q04637",3566,null,"Q04637","NP_004944","Block2",13,5,"2, 10, 18, 26",{"$nulls":13},"Protein synthesis protein","GO:0005737; GO:0005829; GO:0016281; GO:0016020; GO:0005634; GO:0005844","GO:0005524; GO:0008190; GO:0042802; GO:0003729; GO:0032947; GO:0003723; GO:0008135; GO:0003743; GO:0031369","GO:0001662; GO:0002191; GO:0034645; GO:0031669; GO:0032502; GO:0097009; GO:0007005; GO:0010507; GO:1901215; GO:0010801; GO:0000184; GO:0010942; GO:0030307; GO:0008284; GO:0032270; GO:1905537; GO:1900087; GO:1905618; GO:1905612; GO:0045666; GO:0033138; GO:0080135; GO:0060964; GO:0043488; GO:1905696; GO:1905606; GO:0006446; GO:0006412; GO:0006413; GO:0016032"]
[669,331,"PN193","eIF4G (eIF4G1)","S1231","Eukaryotic translation initiation factor 4 gamma 1",{"v":714.9566700633285,"d":"715"},{"v":536.7891702427864,"d":"537"},{"v":682.905089180152,"d":"683"},{"v":95.51698973864563,"d":"96"},{"v":8.178073067860034,"d":"8"},{"v":3332.5708167085136,"d":"3333"},"External","RpAb","PV(pS)PL","Corresponds to amino acid residues P1229 to L1233.","S1231 phosphorylation induces interaction with EIF4A1 and inhibits binding to RNA. This is one of the major in vivo phosphorylation sites in eIF4G (≥137 reports from high throughput mass spectrometry studies).",null,"Q04637","Q04637",3566,null,"Q04637","NP_004944","Block2",13,6,"2, 10, 18, 26",{"$nulls":13},"Protein synthesis protein","GO:0005737; GO:0005829; GO:0016281; GO:0016020; GO:0005634; GO:0005844","GO:0005524; GO:0008190; GO:0042802; GO:0003729; GO:0032947; GO:0003723; GO:0008135; GO:0003743; GO:0031369","GO:0001662; GO:0002191; GO:0034645; GO:0031669; GO:0032502; GO:0097009; GO:0007005; GO:0010507; GO:1901215; GO:0010801; GO:0000184; GO:0010942; GO:0030307; GO:0008284; GO:0032270; GO:1905537; GO:1900087; GO:1905618; GO:1905612; GO:0045666; GO:0033138; GO:0080135; GO:0060964; GO:0043488; GO:1905696; GO:1905606; GO:0006446; GO:0006412; GO:0006413; GO:0016032"]
[671,332,"PN581","Elk-1","S324","ETS domain-containing protein Elk-1",{"v":13727.8630113812,"d":"13728"},{"v":13511.149075703011,"d":"13511"},{"v":2813.4026381346594,"d":"2813"},{"v":20.494104842116972,"d":"20"},{"v":2736.3181343262772,"d":"2736"},{"v":21361.829565593187,"d":"21362"},"Kinexus","RpAb","ELPL(pS)PSLLGC","Corresponds to amino acid residues E320 to G329.","S324 phosphorylation stimulates transcriptional activity by MAD2L2 and potentiates ternary complex formation. This is the major in vivo phosphorylation site in Elk-1 (≥20 reports from high throughput mass spectrometry studies).","ERK1 (MAPK3); ERK2 (MAPK1); JNK2 (MAPK9)","P19419","P19419",964,null,"P19419","NP_001107595.1","Block2",13,7,"2, 10, 18, 26",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0043679; GO:0030425; GO:0005739; GO:0043025; GO:0005654; GO:0005634","GO:0003682; GO:0003700; GO:0000978; GO:0000981; GO:0001085; GO:0001077","GO:0030154; GO:0071480; GO:0071394; GO:1901216; GO:0045893; GO:0045944; GO:0071774; GO:0009416"]
[673,333,"PN223","Elk-1","S383","ETS domain-containing protein Elk-1",{"v":480.51121261420724,"d":"481"},{"v":389.90360458187945,"d":"390"},{"v":396.6480355486084,"d":"397"},{"v":82.54709258305468,"d":"83"},{"v":91.02844664042067,"d":"91"},{"v":2811.4356825385075,"d":"2811"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S383 phosphosite.","S383 phosphorylation stimulates DNA binding, transcriptional activity and potentiates ternary complex formation and binding to AurKA. This phosphorylation site in Elk-1 was not reported in high throughput mass spectrometry studies.","ERK1 (MAPK3); ERK2 (MAPK1); JNK1 (MAPK8); JNK2 (MAPK9); JNK3 (MAPK10); p38a MAPK (MAPK14)","P19419","P19419",964,null,"P19419","NP_001107595.1","Block2",13,8,"2, 10, 18, 26",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0043679; GO:0030425; GO:0005739; GO:0043025; GO:0005654; GO:0005634","GO:0003682; GO:0003700; GO:0000978; GO:0000981; GO:0001085; GO:0001077","GO:0030154; GO:0071480; GO:0071394; GO:1901216; GO:0045893; GO:0045944; GO:0071774; GO:0009416"]
[675,334,"PN510","EML4","Y226","Echinoderm microtubule-associated protein-like 4",{"v":10795.356899793594,"d":"10795"},{"v":10809.301843406432,"d":"10809"},{"v":2158.894444972169,"d":"2159"},{"v":19.99836100845769,"d":"20"},{"v":2088.4159359031873,"d":"2088"},{"v":19054.51604833456,"d":"19055"},"Kinexus","RpAb","EGE(pY)IKM(bA)C","Corresponds to amino acid residues E223 to M229; In the N-terminal portion of EML4 near the HELP domain. ","The effect of Y226 phosphorylation is unclear. This is the major in vivo phosphorylation site in EML4 (≥386 reports from high throughput mass spectrometry studies).",null,"Q9HC35","Q9HC35",4206,null,"Q9HC35","NP_001138548.1","Block2",13,9,"2, 10, 18, 26","EML4",{"$nulls":12},"Cytoskeletal protein","GO:0005737; GO:0016020; GO:0005874; GO:0015630","GO:0008017","GO:0007017; GO:0000278"]
[677,350,"NN410-1","ENFB2","Pan-specific","Ephrin-B2",{"v":212.72306142386864,"d":"213"},{"v":160.4098762235356,"d":"160"},{"v":205.01918065430672,"d":"205"},{"v":96.37844589204586,"d":"96"},{"v":21.28336013472653,"d":"21"},{"v":2045.2432897085723,"d":"2045"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 168-235 of human ephrin-B2.",null,null,"P52799","P52799",1284,null,null,"NP_004084.1","Block3",1,12,"3, 11, 19, 27",{"$nulls":13},"Ligand, receptor tyrosine kinase","GO:0005925; GO:0005887; GO:0005886","GO:0046875; GO:0004713; GO:0001618","GO:0009653; GO:0007411; GO:0007155; GO:0007267; GO:0002042; GO:0048013; GO:0010977; GO:2000727; GO:0008284; GO:1901216; GO:0050920"]
[679,351,"PN173","ENFB2","Y316","Ephrin-B2",{"v":469.960214932226,"d":"470"},{"v":462.8645990049558,"d":"463"},{"v":284.581957588556,"d":"285"},{"v":60.55447855933852,"d":"61"},{"v":12.45606209155638,"d":"12"},{"v":1783.1887922672909,"d":"1783"},"External","RpAb","PV(pY)IV","Corresponds to amino acid residues P314 to V318","The effect of Y316 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in ephrin-B2 (≥125 reports from high throughput mass spectrometry studies).",null,"P52799","P52799",1284,null,null,"NP_004084.1","Block3",1,13,"3, 11, 19, 27",{"$nulls":13},"Ligand, receptor tyrosine kinase","GO:0005925; GO:0005887; GO:0005886","GO:0046875; GO:0004713; GO:0001618","GO:0009653; GO:0007411; GO:0007155; GO:0007267; GO:0002042; GO:0048013; GO:0010977; GO:2000727; GO:0008284; GO:1901216; GO:0050920"]
[681,335,"PN511","ENO1","Y44","Alpha-enolase",{"v":11140.069071796333,"d":"11140"},{"v":11075.306015367321,"d":"11075"},{"v":1918.1168415502652,"d":"1918"},{"v":17.218177276893396,"d":"17"},{"v":4774.119586007099,"d":"4774"},{"v":20382.70729851173,"d":"20383"},"Kinexus","RpAb","TGI(pY)EAL(bA)C","Corresponds to amino acid residues T41 to L47; In the Enolase_N domain. Also corresponds to the Y44 phosphosite in ENO2.","The effect of Y44 phosphorylation is unclear. This is the major in vivo phosphorylation site in ENO1 (≥1948 reports) and ENO2 (≥1891 reports; Y44) from high throughput mass spectrometry studies.",null,"P06733","P06733",2610,null,"P06733","NP_001419.1","Block2",13,10,"2, 10, 18, 26","ENO1",{"$nulls":11},"X","EC 4.2.1.11; Transcription, coactivator/corepressor; Lyase; Carbohydrate Metabolism - glycolysis and gluconeogenesis","GO:0099738; GO:0009986; GO:0005737; GO:0005829; GO:0070062; GO:0005615; GO:0031430; GO:0016020; GO:0005634; GO:0000015; GO:0005886","GO:0045296; GO:0051020; GO:0000287; GO:0004634; GO:0042803; GO:0003723; GO:0000977; GO:0001078; GO:0001227","GO:0061621; GO:0006094; GO:0030308; GO:1903298; GO:0045892; GO:0000122; GO:2001171; GO:0045933; GO:0010756; GO:0009615; GO:0006351"]
[683,336,"PN512","ENO2","Y25","Gamma-enolase",{"v":8143.040479403465,"d":"8143"},{"v":7930.888010736424,"d":"7931"},{"v":1646.3748137407051,"d":"1646"},{"v":20.21818285080309,"d":"20"},{"v":3968.1133088120223,"d":"3968"},{"v":14923.645346356676,"d":"14924"},"Kinexus","RpAb","VDL(pY)TAK(bA)C","Corresponds to amino acid residues V22 to K28; In the Enolase_N domain. ","The effect of Y25 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in ENO2 (≥100 reports from high throughput mass spectrometry studies).",null,"P09104","P09104",4116,null,null,"NP_001966.1","Block2",13,11,"2, 10, 18, 26","ENO2",{"$nulls":11},"X","Carbohydrate Metabolism - glycolysis and gluconeogenesis; EC 4.2.1.11; Lyase","GO:0005829; GO:0070062; GO:0005615; GO:0016020; GO:0043209; GO:0043204; GO:0000015; GO:0001917; GO:0005886","GO:0000287; GO:0004634","GO:0061621; GO:0006094; GO:0006096"]
[685,337,"PN748","EP300 (p300)","S2279","Histone acetyltransferase p300",{"v":4629.579388576026,"d":"4630"},{"v":4567.857819442002,"d":"4568"},{"v":982.5066841774352,"d":"983"},{"v":21.222374684876854,"d":"21"},{"v":1824.1680176582913,"d":"1824"},{"v":7263.9150962855565,"d":"7264"},"Kinexus","RpAb","NPM(pS)PQQ(bA)C","Corresponds to amino acid residues N2276 to Q2282.","S2279 phosphorylation stimulates enzyme activity. Phosphorylation at this site in EP300 has only been reported in a single mass spectrometry study. However, this human phosphosite is highly conserved in vertebrates and is found in fish.","ERK2 (MAPK1)","Q09472","Q09472",1094,null,"Q09472","NP_001420.2","Block2",13,12,"2, 10, 18, 26",{"$nulls":3},"Histone acetyltransferase and transcriptional co-activator ",{"$nulls":4},"X",{"$nulls":4},"Transcription, coactivator/corepressor; EC 2.3.1.48; Acetyltransferase; Nuclear receptor co-regulator","GO:0005694; GO:0005829; GO:0000123; GO:0005654; GO:0005634; GO:0032993; GO:0005667","GO:0016407; GO:0033613; GO:0050681; GO:0008013; GO:0003682; GO:0031490; GO:0003684; GO:0003677; GO:0004402; GO:0140069; GO:0140068; GO:0004468; GO:0035257; GO:0002039; GO:0140065; GO:0061733; GO:0034212; GO:0097157; GO:0008022; GO:0061920; GO:0001102; GO:0000978; GO:0097677; GO:0001228; GO:0003713; GO:0008134; GO:0016746; GO:0008270","GO:0009887; GO:0006915; GO:0030183; GO:1904837; GO:0034644; GO:0007623; GO:0006977; GO:0045444; GO:0007507; GO:0016573; GO:0043969; GO:0043967; GO:0018393; GO:0006475; GO:0042771; GO:0030324; GO:0010742; GO:0035855; GO:0032460; GO:0000122; GO:0007399; GO:0007219; GO:0018076; GO:0018394; GO:0140067; GO:0140066; GO:0061921; GO:0030220; GO:0043923; GO:0051091; GO:0045815; GO:0010976; GO:0045747; GO:0032092; GO:0045893; GO:0045944; GO:0006990; GO:0007221; GO:0032481; GO:0006473; GO:0031648; GO:0050821; GO:0060765; GO:0010506; GO:0051726; GO:1900034; GO:0045652; GO:1901796; GO:0006355; GO:0061418; GO:0090043; GO:0043627; GO:0001666; GO:0007519; GO:0001756; GO:0002223; GO:0006283; GO:0016032"]
[687,339,"PK605","EphA1","Y781","Ephrin type-A receptor 1 protein-tyrosine kinase",{"v":10998.649678808708,"d":"10999"},{"v":10876.041607801446,"d":"10876"},{"v":2568.416863035421,"d":"2568"},{"v":23.352110832150924,"d":"23"},{"v":439.7605826556495,"d":"440"},{"v":21235.32020466518,"d":"21235"},"Kinexus","RpAb","DGT(pY)ETQ(bA)C","Corresponds to amino acid residues D778 to Q784; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y781 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation site in EphA1 (≥254 reports from high throughput mass spectrometry studies).",null,"P21709","P21709",1907,"P21709","P21709","NP_005223","Block3",1,1,"3, 11, 19, 27","EPHA1","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Eph",{"$nulls":6},"EC 2.7.10.1; Receptor tyrosine kinase; TK group; Eph family","GO:0005887; GO:0005886","GO:0005524; GO:0004672; GO:0019901; GO:0005005","GO:0090630; GO:0001525; GO:0007166; GO:0048013; GO:0030336; GO:0006469; GO:0018108; GO:0045766; GO:0001954; GO:0030335; GO:0008284; GO:0051496; GO:0046777; GO:0043087; GO:0035019; GO:0034446"]
[689,340,"PK606","EphA2","Y588","Ephrin type-A receptor 2 protein-tyrosine kinase",{"v":7373.958372361547,"d":"7374"},{"v":7392.684939313986,"d":"7393"},{"v":1569.532588414974,"d":"1570"},{"v":21.284804024630308,"d":"21"},{"v":2724.3749803125884,"d":"2724"},{"v":12132.284701654871,"d":"12132"},"Kinexus","RpAb","LKT(pY)VDP(bA)C","Corresponds to amino acid residues L585 to P591; In the EphA2-TM domain located prior to the kinase catalytic domain. ","Y588 phosphorylation stimulates phosphotransferase activity and regulates cell adhesion, cell differentiation, cell motility and molecular association, including inducing interaction with Nck1, VAV2 and VAV3. One of the major in vivo sites of phosphorylation in EphA2 (≥655 reports from high throughput mass spectrometry studies).","EphA2","P29317","P29317",1283,"P29317","P29317","NP_004422.2","Block3",1,2,"3, 11, 19, 27","EPHA2","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Eph",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; Eph family","GO:0009986; GO:0005925; GO:0005887; GO:0005622; GO:0030027; GO:0031258; GO:0031256; GO:0005886; GO:0032587","GO:0005524; GO:0045296; GO:0005003; GO:0004714; GO:0001618","GO:0090630; GO:0048320; GO:0002043; GO:0046849; GO:0060444; GO:0046058; GO:0007155; GO:0060326; GO:0016477; GO:0048870; GO:0050830; GO:0048013; GO:0006954; GO:0008630; GO:0030216; GO:0070309; GO:0033598; GO:0007275; GO:0016525; GO:0032682; GO:1901491; GO:0051898; GO:0021915; GO:0030182; GO:0060035; GO:0014028; GO:0001649; GO:0030316; GO:1904238; GO:1903078; GO:0036342; GO:0043491; GO:0045765; GO:0043535; GO:0033628; GO:0070372; GO:0010591; GO:0070848; GO:0001501; GO:0001570"]
[691,341,"PK607","EphA2","Y772","Ephrin type-A receptor 2 protein-tyrosine kinase",{"v":367.10790886490696,"d":"367"},{"v":333.86464165016696,"d":"334"},{"v":204.9698485704963,"d":"205"},{"v":55.83367822400245,"d":"56"},{"v":23.586500183752833,"d":"24"},{"v":1054.3824608718976,"d":"1054"},"Kinexus","RpAb","EAT(pY)TTS(bA)C","Corresponds to amino acid residues E769 to S775; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII. ","Y772 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation site in EphA2 (≥889 reports from high throughput mass spectrometry studies).","EphA2","P29317","P29317",1283,"P29317","P29317","NP_004422.2","Block3",1,3,"3, 11, 19, 27","EPHA2","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Eph",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; Eph family","GO:0009986; GO:0005925; GO:0005887; GO:0005622; GO:0030027; GO:0031258; GO:0031256; GO:0005886; GO:0032587","GO:0005524; GO:0045296; GO:0005003; GO:0004714; GO:0001618","GO:0090630; GO:0048320; GO:0002043; GO:0046849; GO:0060444; GO:0046058; GO:0007155; GO:0060326; GO:0016477; GO:0048870; GO:0050830; GO:0048013; GO:0006954; GO:0008630; GO:0030216; GO:0070309; GO:0033598; GO:0007275; GO:0016525; GO:0032682; GO:1901491; GO:0051898; GO:0021915; GO:0030182; GO:0060035; GO:0014028; GO:0001649; GO:0030316; GO:1904238; GO:1903078; GO:0036342; GO:0043491; GO:0045765; GO:0043535; GO:0033628; GO:0070372; GO:0010591; GO:0070848; GO:0001501; GO:0001570"]
[693,342,"PK608","EphA3","Y779","Ephrin type-A receptor 3 protein-tyrosine kinase",{"v":13860.776263650665,"d":"13861"},{"v":13333.484283710583,"d":"13333"},{"v":3609.779299212868,"d":"3610"},{"v":26.043125078639147,"d":"26"},{"v":612.3056876173273,"d":"612"},{"v":28568.05094751915,"d":"28568"},"Kinexus","RpAb","EAA(pY)TTR(bA)C","Corresponds to amino acid residues E776 to R782; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y779 phosphorylation stimulates phosphotransferase activity. Phosphorylation regulates cell adhesion, cytoskeletal reorganization, and induces molecular association with CRK. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation site in EphA3 (≥718 reports from high throughput mass spectrometry studies).",null,"P29320","P29320",1911,"P29320","P29320","NP_005224.2","Block3",1,4,"3, 11, 19, 27","EPHA3","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Eph",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; Eph family","GO:0005769; GO:0005576; GO:0005887; GO:0005886","GO:0005524; GO:0005004","GO:0007155; GO:0016477; GO:0071300; GO:0048013; GO:0097156; GO:0097155; GO:0045806; GO:0018108; GO:0010976; GO:1903078; GO:0032956; GO:0010717; GO:0051893; GO:0043087; GO:0070507"]
[695,343,"NK376-1","EphA4","Pan-specific","Ephrin type-A receptor 4 protein-tyrosine kinase",{"v":382.4487165862292,"d":"382"},{"v":302.7691202383768,"d":"303"},{"v":355.89142203895364,"d":"356"},{"v":93.05598544444645,"d":"93"},{"v":17.631223094728917,"d":"18"},{"v":3960.271175971932,"d":"3960"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 889-921 near the C-terminus of human EphA4.",null,null,"P54764","P54764",1914,"P54764","P54764","NP_001291465.1","Block3",1,5,"3, 11, 19, 27","EPHA4","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Eph",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.1.112; EC 2.7.10.1; TK group; Eph family","GO:0030424; GO:0044295; GO:0043679; GO:0030054; GO:0009986; GO:0005737; GO:0030425; GO:0043198; GO:0043197; GO:0031901; GO:0005783; GO:0030175; GO:0098978; GO:0005794; GO:0005887; GO:0099055; GO:0099056; GO:0005741; GO:0031594; GO:0043204; GO:0005886; GO:0014069; GO:0098685","GO:0005524; GO:0097161; GO:0046875; GO:0005004; GO:0042802; GO:0016301; GO:0042731; GO:0004672; GO:1990782; GO:0005005","GO:0007628; GO:0007155; GO:1904646; GO:0021957; GO:0048013; GO:0097156; GO:0097155; GO:0008347; GO:0008045; GO:0048681; GO:1900272; GO:0010977; GO:1903051; GO:0072178; GO:0106030; GO:0097485; GO:0018108; GO:1902004; GO:1902961; GO:0050775; GO:0043507; GO:0061098; GO:2001108; GO:0046777; GO:0050821; GO:0048710; GO:0050770; GO:0061001; GO:0043087; GO:1905244; GO:0098883"]
[697,344,"PK609","EphB1","Y594","Ephrin type-B receptor 1 protein-tyrosine kinase",{"v":7226.581925002858,"d":"7227"},{"v":7251.697947630455,"d":"7252"},{"v":1829.511228689339,"d":"1830"},{"v":25.316411654581987,"d":"25"},{"v":1952.3184352121611,"d":"1952"},{"v":11767.152136116147,"d":"11767"},"Kinexus","RpAb","MKI(pY)IDP(bA)C","Corresponds to amino acid residues M591 to P597; In the region between the transmembrane domain and the kinase catalytic domain. ","Y594 phosphorylation induces binding to Nck1. This is one of the two major in vivo phosphorylation sites in EphB1 (≥127 reports from high throughput mass spectrometry studies).",null,"P54762","P54762",1920,"P54762",null,"NP_004432.1","Block3",1,6,"3, 11, 19, 27","EPHB1","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK","Eph",{"$nulls":6},"EC 2.7.10.1; Receptor tyrosine kinase; TK group; Eph family","GO:0030424; GO:0005829; GO:0030425; GO:0031901; GO:0005783; GO:0070062; GO:0005576; GO:0032433; GO:0098978; GO:0005887; GO:0045121; GO:0005886","GO:0005524; GO:0008046; GO:0044877; GO:0004713; GO:0005005","GO:0001525; GO:0007411; GO:0048593; GO:0060326; GO:0031589; GO:0021952; GO:0060996; GO:0060997; GO:0050965; GO:0048013; GO:0030010; GO:0001771; GO:0050804; GO:1902725; GO:1902723; GO:0061351; GO:0022008; GO:0021631; GO:0051965; GO:0046777; GO:0070372; GO:0046328; GO:1901214; GO:0031290; GO:0014719"]
[699,345,"NK267-1","EphB2","Pan-specific","Ephrin type-B receptor 2 protein-tyrosine kinase",{"v":13205.664011419118,"d":"13206"},{"v":11955.271805782202,"d":"11955"},{"v":5328.043166539706,"d":"5328"},{"v":40.34665096683116,"d":"40"},{"v":4412.804534953942,"d":"4413"},{"v":40352.432957710334,"d":"40352"},"Kinexus","RpAb","PNEAVREFAKEIDISC","Corresponds to amino acid residues P605 to C620; Just before catalytic domain; Note the seqence is identical in EPHB1, EPHB2, EPHB3 an EPHB4.",null,null,"P29323","P29323",835,"P29323","P29323","NP_001296122.1","Block3",1,7,"3, 11, 19, 27","EPHB2","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Eph",{"$nulls":6},"EC 2.7.10.1; Receptor tyrosine kinase; TK domain target; TK</A> group; Eph family","GO:0030424; GO:0005829; GO:0030425; GO:0005576; GO:0098978; GO:0005887; GO:0099055; GO:0099056; GO:0043025; GO:0005634; GO:0005886; GO:0098794","GO:0001540; GO:0005524; GO:0008046; GO:0042802; GO:0044877; GO:0004713; GO:0005102; GO:0005005","GO:0001525; GO:0007413; GO:0007411; GO:0048593; GO:0021952; GO:0071679; GO:0022038; GO:0060996; GO:0060997; GO:0048013; GO:0051389; GO:0042472; GO:0007612; GO:0007611; GO:0050771; GO:0070373; GO:1904782; GO:0001933; GO:0046580; GO:0007399; GO:0106028; GO:0021631; GO:0018108; GO:0016310; GO:0010628; GO:0048170; GO:1900273; GO:1904783; GO:1903078; GO:0051965; GO:0031915; GO:0097104; GO:0050878; GO:0048168; GO:0031290; GO:0060021; GO:0099557; GO:0001655"]
[701,346,"NK267-2","EphB2","Pan-specific","Ephrin type-B receptor 2 protein-tyrosine kinase",{"v":10111.626403146143,"d":"10112"},{"v":10204.632951275784,"d":"10205"},{"v":1901.4889641376255,"d":"1901"},{"v":18.80497645310545,"d":"19"},{"v":4701.675167554176,"d":"4702"},{"v":15880.957265005805,"d":"15881"},"Kinexus","RpAb","REIQGIFFKEDSHKESNDC","Corresponds to amino acid residues R1033 to C1051; Near C-terminus.",null,null,"P29323","P29323",835,"P29323","P29323","NP_001296122.1","Block3",1,8,"3, 11, 19, 27","EPHB2","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Eph",{"$nulls":6},"EC 2.7.10.1; Receptor tyrosine kinase; TK domain target; TK</A> group; Eph family","GO:0030424; GO:0005829; GO:0030425; GO:0005576; GO:0098978; GO:0005887; GO:0099055; GO:0099056; GO:0043025; GO:0005634; GO:0005886; GO:0098794","GO:0001540; GO:0005524; GO:0008046; GO:0042802; GO:0044877; GO:0004713; GO:0005102; GO:0005005","GO:0001525; GO:0007413; GO:0007411; GO:0048593; GO:0021952; GO:0071679; GO:0022038; GO:0060996; GO:0060997; GO:0048013; GO:0051389; GO:0042472; GO:0007612; GO:0007611; GO:0050771; GO:0070373; GO:1904782; GO:0001933; GO:0046580; GO:0007399; GO:0106028; GO:0021631; GO:0018108; GO:0016310; GO:0010628; GO:0048170; GO:1900273; GO:1904783; GO:1903078; GO:0051965; GO:0031915; GO:0097104; GO:0050878; GO:0048168; GO:0031290; GO:0060021; GO:0099557; GO:0001655"]
[703,347,"PK610","EphB2","Y780","Ephrin type-B receptor 2 protein-tyrosine kinase",{"v":637.345223611144,"d":"637"},{"v":520.0827266146855,"d":"520"},{"v":445.71750244549895,"d":"446"},{"v":69.93344986883268,"d":"70"},{"v":59.516079906730454,"d":"60"},{"v":2585.7177982916783,"d":"2586"},"Kinexus","RpAb","DPT(pY)TSA(bA)C","Corresponds to amino acid residues D777 to A783; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII. ","Y780 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation site in EphB2 (≥152reports from high throughput mass spectrometry studies).",null,"P29323","P29323",835,"P29323","P29323","NP_001296122.1","Block3",1,9,"3, 11, 19, 27","EPHB2","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Eph",{"$nulls":6},"EC 2.7.10.1; Receptor tyrosine kinase; TK domain target; TK</A> group; Eph family","GO:0030424; GO:0005829; GO:0030425; GO:0005576; GO:0098978; GO:0005887; GO:0099055; GO:0099056; GO:0043025; GO:0005634; GO:0005886; GO:0098794","GO:0001540; GO:0005524; GO:0008046; GO:0042802; GO:0044877; GO:0004713; GO:0005102; GO:0005005","GO:0001525; GO:0007413; GO:0007411; GO:0048593; GO:0021952; GO:0071679; GO:0022038; GO:0060996; GO:0060997; GO:0048013; GO:0051389; GO:0042472; GO:0007612; GO:0007611; GO:0050771; GO:0070373; GO:1904782; GO:0001933; GO:0046580; GO:0007399; GO:0106028; GO:0021631; GO:0018108; GO:0016310; GO:0010628; GO:0048170; GO:1900273; GO:1904783; GO:1903078; GO:0051965; GO:0031915; GO:0097104; GO:0050878; GO:0048168; GO:0031290; GO:0060021; GO:0099557; GO:0001655"]
[705,348,"PK611","EphB3","Y600","Ephrin type-B receptor 3 protein-tyrosine kinase",{"v":903.0217725835897,"d":"903"},{"v":837.7020214840849,"d":"838"},{"v":514.6457469461485,"d":"515"},{"v":56.99151034572751,"d":"57"},{"v":61.09137574399936,"d":"61"},{"v":2808.0721518584282,"d":"2808"},"Kinexus","RpAb","LQQ(pY)IAP(bA)C","Corresponds to amino acid residues L597 to P603; In the EphA2_TM region between the transmembrane and kinase catalytic domains. ","The effect of Y600 phosphorylation is unclear. This is the major in vivo phosphorylation site for EphB3 (≥310 reports from high throughput mass spectrometry studies).",null,"P54753","P54753",1241,"P54753","P54753","NP_004434.2","Block3",1,10,"3, 11, 19, 27","EPHB3","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Eph",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; Eph family","GO:0005829; GO:0030425; GO:0005576; GO:0005887; GO:0005886","GO:0005524; GO:0008046; GO:0005003; GO:0004713","GO:0001525; GO:0007413; GO:0007411; GO:0016477; GO:0021952; GO:0022038; GO:0060996; GO:0060997; GO:0048546; GO:0048013; GO:0051965; GO:0046777; GO:0050770; GO:0022407; GO:0043087; GO:0031290; GO:0060021; GO:0034446; GO:0048538; GO:0001655"]
[707,349,"PK612","EphB4","Y596","Ephrin type-B receptor 4 protein-tyrosine kinase",{"v":5257.973943976574,"d":"5258"},{"v":5271.082917455934,"d":"5271"},{"v":1742.4942789664137,"d":"1742"},{"v":33.14003259682522,"d":"33"},{"v":257.5606249634288,"d":"258"},{"v":10224.384758919557,"d":"10224"},"Kinexus","RpAb","PFT(pY)EDP(bA)C","Corresponds to amino acid residues P593 to P599; In the EphA2_TM region between the transmembrane and kinase catalytic domains. ","The effect of Y596 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites for EphB4 (≥216 reports from high throughput mass spectrometry studies).",null,"P54760","P54760",1922,"P54760",null,"NP_004435.3","Block3",1,11,"3, 11, 19, 27","EPHB4","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Eph",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; EC 2.7.1.112; TK group; Eph family","GO:0005829; GO:0070062; GO:0005576; GO:0005887; GO:0005886","GO:0005524; GO:0005003; GO:0004713; GO:0004714","GO:0001525; GO:0007155; GO:0002042; GO:0048013; GO:0003007; GO:0046777"]
[709,352,"NN411-1","ERa (ESR1)","Pan-specific","Estrogen receptor",{"v":244.1202771089778,"d":"244"},{"v":199.8835616673623,"d":"200"},{"v":171.28584684638892,"d":"171"},{"v":70.16453072840203,"d":"70"},{"v":18.62935518509821,"d":"19"},{"v":1694.5200551189432,"d":"1695"},"External","MmAb","Epitope undefined.",{"$nulls":3},"P03372","P03372",968,null,"P03372","NP_000116.2","Block3",2,1,"3, 11, 19, 27",{"$nulls":3},"Transcription protein (receptor)",{"$nulls":4},"X",{"$nulls":4},"Transcription protein (receptor)","GO:0005737; GO:0005829; GO:0005794; GO:0016021; GO:0016020; GO:0000790; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:0035327; GO:0097550","GO:0051117; GO:0008013; GO:0003682; GO:0003700; GO:0019899; GO:0030284; GO:0030331; GO:0034056; GO:0042802; GO:0030235; GO:0046934; GO:0019901; GO:0000978; GO:0038052; GO:0000981; GO:0005496; GO:0003707; GO:0017025; GO:0001093; GO:0001077; GO:0001223; GO:0008134; GO:0008270","GO:0008209; GO:0001547; GO:0071392; GO:0071391; GO:0006338; GO:0002064; GO:0060750; GO:0030520; GO:0030518; GO:0008584; GO:0060749; GO:0060745; GO:0043433; GO:0010629; GO:0043124; GO:1903799; GO:0000122; GO:0007200; GO:0007204; GO:0051091; GO:0048146; GO:0045429; GO:0051000; GO:0010863; GO:0051897; GO:0045899; GO:0045893; GO:0045944; GO:0060527; GO:0060523; GO:0016579; GO:0071168; GO:0042981; GO:0060687; GO:0050727; GO:0033146; GO:0034121; GO:0006355; GO:0006357; GO:0030111; GO:0032355; GO:0043627; GO:0007165; GO:0048863; GO:0006351; GO:0006366; GO:0006367; GO:0060065; GO:0060068"]
[711,353,"PN198","ERa (ESR1)","S104","Estrogen receptor",{"v":1052.2619854047607,"d":"1052"},{"v":971.6092215999499,"d":"972"},{"v":675.4859007704248,"d":"675"},{"v":64.19369987129146,"d":"64"},{"v":8.7074633844657,"d":"9"},{"v":3447.0257547529964,"d":"3447"},"External","RpAb","SV(pS)PS","Corresponds to amino acid residues S102 to S106.","S104 phosphorylation stimulates transcriptional activity and regulates molecular association, including inducing interactions with CBP, NCoA2, SRC-2, SRC-3 and Src. This is a minor in vivo phosphorylation sites in the estrogen receptor (≥1 report from high throughput mass spectrometry studies).","BARK2 (GRK3, ADRBK2); CDK2; CDK3; ERK1 (MAPK3); ERK2 (MAPK1); GSK3b; mTOR","P03372","P03372",968,null,"P03372","NP_000116.2","Block3",2,2,"3, 11, 19, 27",{"$nulls":3},"Transcription protein (receptor)",{"$nulls":4},"X",{"$nulls":4},"Transcription protein (receptor)","GO:0005737; GO:0005829; GO:0005794; GO:0016021; GO:0016020; GO:0000790; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:0035327; GO:0097550","GO:0051117; GO:0008013; GO:0003682; GO:0003700; GO:0019899; GO:0030284; GO:0030331; GO:0034056; GO:0042802; GO:0030235; GO:0046934; GO:0019901; GO:0000978; GO:0038052; GO:0000981; GO:0005496; GO:0003707; GO:0017025; GO:0001093; GO:0001077; GO:0001223; GO:0008134; GO:0008270","GO:0008209; GO:0001547; GO:0071392; GO:0071391; GO:0006338; GO:0002064; GO:0060750; GO:0030520; GO:0030518; GO:0008584; GO:0060749; GO:0060745; GO:0043433; GO:0010629; GO:0043124; GO:1903799; GO:0000122; GO:0007200; GO:0007204; GO:0051091; GO:0048146; GO:0045429; GO:0051000; GO:0010863; GO:0051897; GO:0045899; GO:0045893; GO:0045944; GO:0060527; GO:0060523; GO:0016579; GO:0071168; GO:0042981; GO:0060687; GO:0050727; GO:0033146; GO:0034121; GO:0006355; GO:0006357; GO:0030111; GO:0032355; GO:0043627; GO:0007165; GO:0048863; GO:0006351; GO:0006366; GO:0006367; GO:0060065; GO:0060068"]
[713,354,"PN583","ERa (ESR1)","S167","Estrogen receptor",{"v":15206.827499323039,"d":"15207"},{"v":14959.15200557459,"d":"14959"},{"v":3626.091072759849,"d":"3626"},{"v":23.845151613124248,"d":"24"},{"v":4276.812770799173,"d":"4277"},{"v":31003.74967277412,"d":"31004"},"Kinexus","RpAb","ERLA(pS)TNDKGC","Corresponds to amino acid residues E163 to G172.","S167 phosphorylation induces transcriptional activity and regulates cell growth, apoptosis, transcription, acetylation, activation and molecular association, including inducing interaction with SRC-3. This is one of the major in vivo phosphorylation sites in the estrogen receptor (≥5 reports from high throughput mass spectrometry studies).","Akt1 (PKBa); Akt2 (PKBb); AurKA; CK2a1 (CSNK2A1); IKKE, p70S6K (RPS6KB1); RSK1 (RPS6KA1); RSK2 (RPS6KA3)","P03372","P03372",968,null,"P03372","NP_000116.2","Block3",2,3,"3, 11, 19, 27",{"$nulls":3},"Transcription protein (receptor)",{"$nulls":4},"X",{"$nulls":4},"Transcription protein (receptor)","GO:0005737; GO:0005829; GO:0005794; GO:0016021; GO:0016020; GO:0000790; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:0035327; GO:0097550","GO:0051117; GO:0008013; GO:0003682; GO:0003700; GO:0019899; GO:0030284; GO:0030331; GO:0034056; GO:0042802; GO:0030235; GO:0046934; GO:0019901; GO:0000978; GO:0038052; GO:0000981; GO:0005496; GO:0003707; GO:0017025; GO:0001093; GO:0001077; GO:0001223; GO:0008134; GO:0008270","GO:0008209; GO:0001547; GO:0071392; GO:0071391; GO:0006338; GO:0002064; GO:0060750; GO:0030520; GO:0030518; GO:0008584; GO:0060749; GO:0060745; GO:0043433; GO:0010629; GO:0043124; GO:1903799; GO:0000122; GO:0007200; GO:0007204; GO:0051091; GO:0048146; GO:0045429; GO:0051000; GO:0010863; GO:0051897; GO:0045899; GO:0045893; GO:0045944; GO:0060527; GO:0060523; GO:0016579; GO:0071168; GO:0042981; GO:0060687; GO:0050727; GO:0033146; GO:0034121; GO:0006355; GO:0006357; GO:0030111; GO:0032355; GO:0043627; GO:0007165; GO:0048863; GO:0006351; GO:0006366; GO:0006367; GO:0060065; GO:0060068"]
[715,355,"NK054-4","ErbB2 (HER2, Neu)","Pan-specific","ErbB2 (Neu) receptor-tyrosine kinase",{"v":11103.780187068687,"d":"11104"},{"v":10883.190911890875,"d":"10883"},{"v":2492.6533291330898,"d":"2493"},{"v":22.44869123072159,"d":"22"},{"v":4643.088235707368,"d":"4643"},{"v":20572.630554124353,"d":"20573"},"Kinexus","RpAb","CGPETHLDMLRHLY","Corresponds to amino acid residues P39 to Y50; In the extracellular domain of the receptor.",null,null,"P04626","P04626",1580,"P04626","P04626","NP_004439","Block3",2,4,"3, 11, 19, 27","ERBB2","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; EGFR family","GO:0016324; GO:0016323; GO:0005829; GO:0010008; GO:0016021; GO:0043209; GO:0005634; GO:0048471; GO:0005886; GO:0043235","GO:0005524; GO:0043125; GO:0042802; GO:0046934; GO:0008022; GO:0046983; GO:0046982; GO:0019903; GO:0004713; GO:0005088; GO:0001042; GO:0004714; GO:0004888","GO:0008283; GO:0007166; GO:0071364; GO:0071363; GO:0007167; GO:0038128; GO:0007507; GO:0000165; GO:0008045; GO:0042552; GO:1901185; GO:0033088; GO:0007528; GO:0048709; GO:0007422; GO:0014065; GO:0045785; GO:0030307; GO:0050679; GO:0043547; GO:0043406; GO:0051897; GO:0001934; GO:0090314; GO:0045943; GO:0045945; GO:0045727; GO:0046777; GO:0006468; GO:0045765; GO:2000145; GO:0070372; GO:0032886; GO:0006357; GO:0007165; GO:0006351; GO:0007169; GO:0042060"]
[717,356,"NK054-6","ErbB2 (HER2, Neu)","Pan-specific","ErbB2 (Neu) receptor-tyrosine kinase",{"v":8966.38813151215,"d":"8966"},{"v":8768.572776423942,"d":"8769"},{"v":2418.3411137401217,"d":"2418"},{"v":26.971184810090044,"d":"27"},{"v":878.3968263399353,"d":"878"},{"v":17289.614874906358,"d":"17290"},"Kinexus","RpAb","CPALVTYNTDTFES","Corresponds to amino acid residues C268 to S281; In the extracellular domain of the receptor.",null,null,"P04626","P04626",1580,"P04626","P04626","NP_004439","Block3",2,5,"3, 11, 19, 27","ERBB2","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; EGFR family","GO:0016324; GO:0016323; GO:0005829; GO:0010008; GO:0016021; GO:0043209; GO:0005634; GO:0048471; GO:0005886; GO:0043235","GO:0005524; GO:0043125; GO:0042802; GO:0046934; GO:0008022; GO:0046983; GO:0046982; GO:0019903; GO:0004713; GO:0005088; GO:0001042; GO:0004714; GO:0004888","GO:0008283; GO:0007166; GO:0071364; GO:0071363; GO:0007167; GO:0038128; GO:0007507; GO:0000165; GO:0008045; GO:0042552; GO:1901185; GO:0033088; GO:0007528; GO:0048709; GO:0007422; GO:0014065; GO:0045785; GO:0030307; GO:0050679; GO:0043547; GO:0043406; GO:0051897; GO:0001934; GO:0090314; GO:0045943; GO:0045945; GO:0045727; GO:0046777; GO:0006468; GO:0045765; GO:2000145; GO:0070372; GO:0032886; GO:0006357; GO:0007165; GO:0006351; GO:0007169; GO:0042060"]
[719,357,"PK614","ErbB2 (HER2, Neu)","Y735","ErbB2 (Neu) receptor-tyrosine kinase",{"v":5959.043311718349,"d":"5959"},{"v":5702.762368145837,"d":"5703"},{"v":1609.3858585574844,"d":"1609"},{"v":27.007453619151526,"d":"27"},{"v":857.8433085274165,"d":"858"},{"v":13329.247906212418,"d":"13329"},"Kinexus","RpAb","GTV(pY)KGIW(bA)C","Corresponds to amino acid residues G732 to W739; In the region between the Transmembrane and kinase catalytic domains. ","Y735 phosphorylation induces interaction with SHC1. This is one of the major in vivo phosphorylation sites in ErbB2 (≥147 reports from high throughput mass spectrometry studies).",null,"P04626","P04626",1580,"P04626","P04626","NP_004439","Block3",2,6,"3, 11, 19, 27","ERBB2","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; EGFR family","GO:0016324; GO:0016323; GO:0005829; GO:0010008; GO:0016021; GO:0043209; GO:0005634; GO:0048471; GO:0005886; GO:0043235","GO:0005524; GO:0043125; GO:0042802; GO:0046934; GO:0008022; GO:0046983; GO:0046982; GO:0019903; GO:0004713; GO:0005088; GO:0001042; GO:0004714; GO:0004888","GO:0008283; GO:0007166; GO:0071364; GO:0071363; GO:0007167; GO:0038128; GO:0007507; GO:0000165; GO:0008045; GO:0042552; GO:1901185; GO:0033088; GO:0007528; GO:0048709; GO:0007422; GO:0014065; GO:0045785; GO:0030307; GO:0050679; GO:0043547; GO:0043406; GO:0051897; GO:0001934; GO:0090314; GO:0045943; GO:0045945; GO:0045727; GO:0046777; GO:0006468; GO:0045765; GO:2000145; GO:0070372; GO:0032886; GO:0006357; GO:0007165; GO:0006351; GO:0007169; GO:0042060"]
[721,358,"PK615","ErbB2 (HER2, Neu)","Y877","ErbB2 (Neu) receptor-tyrosine kinase",{"v":3524.6898526812392,"d":"3525"},{"v":3452.863305716278,"d":"3453"},{"v":1159.9935476073385,"d":"1160"},{"v":32.91051400522315,"d":"33"},{"v":766.2372979743919,"d":"766"},{"v":8474.370241372273,"d":"8474"},"Kinexus","RpAb","ETE(pY)HAD(bA)C","Corresponds to amino acid residues E874 to D880; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y877 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation regulates cell growth. This is one of the major in vivo phosphorylation sites in ErbB2 (≥112 reports from high throughput mass spectrometry studies).",null,"P04626","P04626",1580,"P04626","P04626","NP_004439","Block3",2,7,"3, 11, 19, 27","ERBB2","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; EGFR family","GO:0016324; GO:0016323; GO:0005829; GO:0010008; GO:0016021; GO:0043209; GO:0005634; GO:0048471; GO:0005886; GO:0043235","GO:0005524; GO:0043125; GO:0042802; GO:0046934; GO:0008022; GO:0046983; GO:0046982; GO:0019903; GO:0004713; GO:0005088; GO:0001042; GO:0004714; GO:0004888","GO:0008283; GO:0007166; GO:0071364; GO:0071363; GO:0007167; GO:0038128; GO:0007507; GO:0000165; GO:0008045; GO:0042552; GO:1901185; GO:0033088; GO:0007528; GO:0048709; GO:0007422; GO:0014065; GO:0045785; GO:0030307; GO:0050679; GO:0043547; GO:0043406; GO:0051897; GO:0001934; GO:0090314; GO:0045943; GO:0045945; GO:0045727; GO:0046777; GO:0006468; GO:0045765; GO:2000145; GO:0070372; GO:0032886; GO:0006357; GO:0007165; GO:0006351; GO:0007169; GO:0042060"]
[723,359,"PK613","ErbB2 (HER2, Neu)","Y1248","ErbB2 (Neu) receptor-tyrosine kinase",{"v":13737.879927796697,"d":"13738"},{"v":13935.535078128314,"d":"13936"},{"v":3065.0508358010716,"d":"3065"},{"v":22.310945006873773,"d":"22"},{"v":2299.8325352875763,"d":"2300"},{"v":21919.485347661375,"d":"21919"},"Kinexus","RpAb","NPE(pY)LGL(bA)C","Corresponds to amino acid residues N1245 to L1251; In the C-terminus of the kinase after the catalytic domain.","Y1248 phosphorylation stimulates phosphotransferase activity. Phosphorylation regulates cell motility, cytoskeletal reorganization, transcription, intracellular location and induces molecular association with CPNE3, RACK1 and SHC1. This is the major in vivo phosphorylation site in ErbB2 (≥196 reports from high throughput mass spectrometry studies).","ErbB2","P04626","P04626",1580,"P04626","P04626","NP_004439","Block3",2,8,"3, 11, 19, 27","ERBB2","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; EGFR family","GO:0016324; GO:0016323; GO:0005829; GO:0010008; GO:0016021; GO:0043209; GO:0005634; GO:0048471; GO:0005886; GO:0043235","GO:0005524; GO:0043125; GO:0042802; GO:0046934; GO:0008022; GO:0046983; GO:0046982; GO:0019903; GO:0004713; GO:0005088; GO:0001042; GO:0004714; GO:0004888","GO:0008283; GO:0007166; GO:0071364; GO:0071363; GO:0007167; GO:0038128; GO:0007507; GO:0000165; GO:0008045; GO:0042552; GO:1901185; GO:0033088; GO:0007528; GO:0048709; GO:0007422; GO:0014065; GO:0045785; GO:0030307; GO:0050679; GO:0043547; GO:0043406; GO:0051897; GO:0001934; GO:0090314; GO:0045943; GO:0045945; GO:0045727; GO:0046777; GO:0006468; GO:0045765; GO:2000145; GO:0070372; GO:0032886; GO:0006357; GO:0007165; GO:0006351; GO:0007169; GO:0042060"]
[725,360,"PN513","ERBB2IP (Erbin)","Y1104","Protein LAP2",{"v":16630.887072010046,"d":"16631"},{"v":16693.605649097368,"d":"16694"},{"v":3380.528687107171,"d":"3381"},{"v":20.326809222321256,"d":"20"},{"v":612.7087467899837,"d":"613"},{"v":30262.00089073848,"d":"30262"},"Kinexus","RpAb","EGD(pY)LSY(bA)C","Corresponds to amino acid residues E1101 to Y1107; In the C-terminal quarter of the protein before the PDZ domain. ","The effect of Y1104 phosphorylation is unclear. This is the major in vivo phosphorylation site in ERBB2IP (≥884 reports from high throughput mass spectrometry studies).",null,"Q96RT1","Q96RT1",2653,null,null,"NP_001240626.1","Block3",2,9,"3, 11, 19, 27",{"$nulls":11},"X",null,"Adapter/scaffold protein","GO:0009925; GO:0005604; GO:0016323; GO:0030054; GO:0005737; GO:0098978; GO:0030056; GO:0031594; GO:0031965; GO:0016607; GO:0005634; GO:0005886; GO:0099572","GO:0005176; GO:0005102; GO:0005200","GO:0045175; GO:0007155; GO:0071356; GO:0007173; GO:0038128; GO:0045197; GO:0007229; GO:0045104; GO:0071638; GO:0032088; GO:0070433; GO:0006605; GO:0099072; GO:0032496; GO:0032495; GO:0007165"]
[727,361,"NK231-2","ErbB3 (HER3)","Pan-specific","ErbB3 (HER3) receptor-tyrosine kinase",{"v":21814.117543113603,"d":"21814"},{"v":20017.106789816717,"d":"20017"},{"v":7994.83163553294,"d":"7995"},{"v":36.649805428671996,"d":"37"},{"v":1006.7285832728845,"d":"1007"},{"v":47568.964368884204,"d":"47569"},"Kinexus","RpAb","DRDAEIVVKDNGRSC","Corresponds to amino acid residues D169 to C183; In the extracellular domain of the ErbB3 receptor.",null,null,"P21860","P21860",830,"P21860","P21860","NP_001005915.1","Block3",2,10,"3, 11, 19, 27","ERBB3","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; EGFR family","GO:0016324; GO:0016323; GO:0005615; GO:0005887; GO:0005622; GO:0016328; GO:0005886; GO:0043235","GO:0005524; GO:0019838; GO:0042802; GO:0038132; GO:0046934; GO:0046982; GO:0042803; GO:0030296; GO:0004713; GO:0005088; GO:0004888; GO:0031625","GO:0021545; GO:0003197; GO:0038128; GO:0097192; GO:0007507; GO:0000165; GO:0007162; GO:0043524; GO:0051048; GO:0009968; GO:0051402; GO:0007422; GO:0014065; GO:0070886; GO:0055025; GO:0010628; GO:0014068; GO:0051897; GO:0061098; GO:2000145; GO:0042127; GO:0014037; GO:0007165; GO:0007169; GO:0042060"]
[729,362,"NK231-3","ErbB3 (HER3)","Pan-specific","ErbB3 (HER3) receptor-tyrosine kinase",{"v":10153.182508316206,"d":"10153"},{"v":10167.876630763923,"d":"10168"},{"v":2124.595409833629,"d":"2125"},{"v":20.925413367615807,"d":"21"},{"v":4264.610144471388,"d":"4265"},{"v":17204.724044035756,"d":"17205"},"Kinexus","RpAb","CSEKANKVLARIFKET","Corresponds to amino acid residues S693 to T707.",null,null,"P21860","P21860",830,"P21860","P21860","NP_001005915.1","Block3",2,11,"3, 11, 19, 27","ERBB3","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; EGFR family","GO:0016324; GO:0016323; GO:0005615; GO:0005887; GO:0005622; GO:0016328; GO:0005886; GO:0043235","GO:0005524; GO:0019838; GO:0042802; GO:0038132; GO:0046934; GO:0046982; GO:0042803; GO:0030296; GO:0004713; GO:0005088; GO:0004888; GO:0031625","GO:0021545; GO:0003197; GO:0038128; GO:0097192; GO:0007507; GO:0000165; GO:0007162; GO:0043524; GO:0051048; GO:0009968; GO:0051402; GO:0007422; GO:0014065; GO:0070886; GO:0055025; GO:0010628; GO:0014068; GO:0051897; GO:0061098; GO:2000145; GO:0042127; GO:0014037; GO:0007165; GO:0007169; GO:0042060"]
[731,363,"PK616","ErbB3 (HER3)","Y1289","ErbB3 (HER3) receptor-tyrosine kinase",{"v":10405.510645813232,"d":"10406"},{"v":10131.194579787238,"d":"10131"},{"v":3053.812021585838,"d":"3054"},{"v":29.348026498003456,"d":"29"},{"v":1483.2075534333617,"d":"1483"},{"v":20977.184859286725,"d":"20977"},"Kinexus","RpAb","EQG(pY)EEM(bA)C","Corresponds to amino acid residues E1286 to M1292; In the cytoplasmic region of ErbB3 near the C-terminus after the kinase catalytic domain. ","Y1289 phosphoryation induces interaction with PIK3R2 and regulates carcinogenesis, and cell growth. This is one of the major in vivo phosphorylation sites in ErbB3 (≥127 reports from high throughput mass spectrometry studies).","ROR1","P21860","P21860",830,"P21860","P21860","NP_001005915.1","Block3",2,12,"3, 11, 19, 27","ERBB3","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; EGFR family","GO:0016324; GO:0016323; GO:0005615; GO:0005887; GO:0005622; GO:0016328; GO:0005886; GO:0043235","GO:0005524; GO:0019838; GO:0042802; GO:0038132; GO:0046934; GO:0046982; GO:0042803; GO:0030296; GO:0004713; GO:0005088; GO:0004888; GO:0031625","GO:0021545; GO:0003197; GO:0038128; GO:0097192; GO:0007507; GO:0000165; GO:0007162; GO:0043524; GO:0051048; GO:0009968; GO:0051402; GO:0007422; GO:0014065; GO:0070886; GO:0055025; GO:0010628; GO:0014068; GO:0051897; GO:0061098; GO:2000145; GO:0042127; GO:0014037; GO:0007165; GO:0007169; GO:0042060"]
[733,364,"PK617","ErbB3 (HER3)","Y1307","ErbB3 (HER3) receptor-tyrosine kinase",{"v":6936.886497647984,"d":"6937"},{"v":7030.169897941574,"d":"7030"},{"v":1826.4802940970071,"d":"1826"},{"v":26.32997231129978,"d":"26"},{"v":287.83617743306274,"d":"288"},{"v":12473.876516668053,"d":"12474"},"Kinexus","RpAb","HVH(pY)ARL(bA)C","Corresponds to amino acid residues H1304 to L1310; In the cytoplasmic region of ErbB3 near the C-terminus after the kinase catalytic domain. ","The effect of Y1307 phosphorylation is unclear. This is a major in vivo phosphorylation site in ErbB3 (≥133 reports from high throughput mass spectrometry studies).",null,"P21860","P21860",830,"P21860","P21860","NP_001005915.1","Block3",2,13,"3, 11, 19, 27","ERBB3","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; EGFR family","GO:0016324; GO:0016323; GO:0005615; GO:0005887; GO:0005622; GO:0016328; GO:0005886; GO:0043235","GO:0005524; GO:0019838; GO:0042802; GO:0038132; GO:0046934; GO:0046982; GO:0042803; GO:0030296; GO:0004713; GO:0005088; GO:0004888; GO:0031625","GO:0021545; GO:0003197; GO:0038128; GO:0097192; GO:0007507; GO:0000165; GO:0007162; GO:0043524; GO:0051048; GO:0009968; GO:0051402; GO:0007422; GO:0014065; GO:0070886; GO:0055025; GO:0010628; GO:0014068; GO:0051897; GO:0061098; GO:2000145; GO:0042127; GO:0014037; GO:0007165; GO:0007169; GO:0042060"]
[735,365,"PK618","ErbB3 (HER3)","Y1328","ErbB3 (HER3) receptor-tyrosine kinase",{"v":7810.144511278822,"d":"7810"},{"v":7970.903378760366,"d":"7971"},{"v":2008.160888321778,"d":"2008"},{"v":25.712211668065084,"d":"26"},{"v":231.14674261330845,"d":"231"},{"v":14255.230413460667,"d":"14255"},"Kinexus","RpAb","NPD(pY)WHS(bA)C","Corresponds to amino acid residues N1325 to S1331; In the cytoplasmic region of ErbB3 near the C-terminus after the kinase catalytic domain. ","Y1328 phosphoryation induces interaction with Shc1. This is one of the major in vivo phosphorylation sites in ErbB3 (≥214 reports from high throughput mass spectrometry studies).",null,"P21860","P21860",830,"P21860","P21860","NP_001005915.1","Block3",3,1,"3, 11, 19, 27","ERBB3","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; EGFR family","GO:0016324; GO:0016323; GO:0005615; GO:0005887; GO:0005622; GO:0016328; GO:0005886; GO:0043235","GO:0005524; GO:0019838; GO:0042802; GO:0038132; GO:0046934; GO:0046982; GO:0042803; GO:0030296; GO:0004713; GO:0005088; GO:0004888; GO:0031625","GO:0021545; GO:0003197; GO:0038128; GO:0097192; GO:0007507; GO:0000165; GO:0007162; GO:0043524; GO:0051048; GO:0009968; GO:0051402; GO:0007422; GO:0014065; GO:0070886; GO:0055025; GO:0010628; GO:0014068; GO:0051897; GO:0061098; GO:2000145; GO:0042127; GO:0014037; GO:0007165; GO:0007169; GO:0042060"]
[737,366,"NK235-1","ErbB4 (HER4)","Pan-specific","ErbB4  receptor-tyrosine kinase",{"v":6554.675950152923,"d":"6555"},{"v":6604.007450699522,"d":"6604"},{"v":1719.1769382458422,"d":"1719"},{"v":26.228252186986197,"d":"26"},{"v":323.8903697572033,"d":"324"},{"v":10540.194793621464,"d":"10540"},"Kinexus","RpAb","LEQQYRALRKYYENC","Corresponds to amino acid residues L42 to C56; In the extracellular domain of the ErbB4 receptor.",null,null,"Q15303","Q15303",594,"Q15303","Q15303","NP_001036064.1","Block3",3,2,"3, 11, 19, 27","ERBB4","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK domain target; TK</A> group; EGFR family","GO:0016323; GO:0005829; GO:0005576; GO:0098982; GO:0098978; GO:0099061; GO:0099056; GO:0005759; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0045211; GO:0043235","GO:0005524; GO:0005154; GO:0046934; GO:0042803; GO:0004713; GO:0005088; GO:0044212; GO:0004714","GO:0061026; GO:0045165; GO:0016477; GO:0008283; GO:0071364; GO:0021551; GO:0009880; GO:0038128; GO:0007507; GO:0007595; GO:0060749; GO:0060644; GO:0000165; GO:0043653; GO:0043066; GO:0008285; GO:2001223; GO:0007399; GO:0001755; GO:0021889; GO:0038083; GO:0018108; GO:0043065; GO:0060045; GO:0008284; GO:0070374; GO:0046427; GO:0043552; GO:0014068; GO:0051897; GO:2000010; GO:0001934; GO:0045893; GO:0042531; GO:0046777; GO:0030334; GO:2000145; GO:0007165; GO:0007416; GO:0006351; GO:0007169"]
[739,367,"NK235-3","ErbB4 (HER4)","Pan-specific","ErbB4  receptor-tyrosine kinase",{"v":12603.331278176543,"d":"12603"},{"v":11961.525127397603,"d":"11962"},{"v":3161.9164444404123,"d":"3162"},{"v":25.087942026212296,"d":"25"},{"v":4682.909424876311,"d":"4683"},{"v":23695.534206137054,"d":"23696"},"Kinexus","RpAb","CEYLSEFSLKPGTVL","Corresponds to amino acid residues E1283 to L1296; Pre-C-terminus.",null,null,"Q15303","Q15303",594,"Q15303","Q15303","NP_001036064.1","Block3",3,3,"3, 11, 19, 27","ERBB4","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK domain target; TK</A> group; EGFR family","GO:0016323; GO:0005829; GO:0005576; GO:0098982; GO:0098978; GO:0099061; GO:0099056; GO:0005759; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0045211; GO:0043235","GO:0005524; GO:0005154; GO:0046934; GO:0042803; GO:0004713; GO:0005088; GO:0044212; GO:0004714","GO:0061026; GO:0045165; GO:0016477; GO:0008283; GO:0071364; GO:0021551; GO:0009880; GO:0038128; GO:0007507; GO:0007595; GO:0060749; GO:0060644; GO:0000165; GO:0043653; GO:0043066; GO:0008285; GO:2001223; GO:0007399; GO:0001755; GO:0021889; GO:0038083; GO:0018108; GO:0043065; GO:0060045; GO:0008284; GO:0070374; GO:0046427; GO:0043552; GO:0014068; GO:0051897; GO:2000010; GO:0001934; GO:0045893; GO:0042531; GO:0046777; GO:0030334; GO:2000145; GO:0007165; GO:0007416; GO:0006351; GO:0007169"]
[741,368,"PK619","ErbB4 (HER4)","Y733","ErbB4  receptor-tyrosine kinase",{"v":75.47830012270151,"d":"75"},{"v":22.17956271451105,"d":"22"},{"v":120.91180041478964,"d":"121"},{"v":160.19412230830454,"d":"160"},{"v":2.7445800756969496,"d":"3"},{"v":635.3705993028233,"d":"635"},"Kinexus","RpAb","GTV(pY)KGI(bA)C","Corresponds to amino acid residues G730 to I736; In the region between the transmembrane and kinase catalytic domains. ","Y733 phosphorylation induces interaction with SHC1. This is the major in vivo site of phosphorylation in ErbB4 (≥146 reports from high throughput mass spectrometry studies).",null,"Q15303","Q15303",594,"Q15303","Q15303","NP_001036064.1","Block3",3,4,"3, 11, 19, 27","ERBB4","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK domain target; TK</A> group; EGFR family","GO:0016323; GO:0005829; GO:0005576; GO:0098982; GO:0098978; GO:0099061; GO:0099056; GO:0005759; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0045211; GO:0043235","GO:0005524; GO:0005154; GO:0046934; GO:0042803; GO:0004713; GO:0005088; GO:0044212; GO:0004714","GO:0061026; GO:0045165; GO:0016477; GO:0008283; GO:0071364; GO:0021551; GO:0009880; GO:0038128; GO:0007507; GO:0007595; GO:0060749; GO:0060644; GO:0000165; GO:0043653; GO:0043066; GO:0008285; GO:2001223; GO:0007399; GO:0001755; GO:0021889; GO:0038083; GO:0018108; GO:0043065; GO:0060045; GO:0008284; GO:0070374; GO:0046427; GO:0043552; GO:0014068; GO:0051897; GO:2000010; GO:0001934; GO:0045893; GO:0042531; GO:0046777; GO:0030334; GO:2000145; GO:0007165; GO:0007416; GO:0006351; GO:0007169"]
[743,369,"PK620","ErbB4 (HER4)","Y875","ErbB4  receptor-tyrosine kinase",{"v":73.26858631057729,"d":"73"},{"v":66.48994715034539,"d":"66"},{"v":37.00316050540487,"d":"37"},{"v":50.503445430969066,"d":"51"},{"v":17.687021672956256,"d":"18"},{"v":179.81561480397667,"d":"180"},"Kinexus","RpAb","EKE(pY)NADG(bA)C","Corresponds to amino acid residues E872 to G879; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y875 phosphorylation regulates molecular association, including inducing interaction with PLCG2. Predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is a minor in vivo phosphorylation site in ErbB4 (≥7 reports from high throughput mass spectrometry studies).","ErbB4","Q15303","Q15303",594,"Q15303","Q15303","NP_001036064.1","Block3",3,5,"3, 11, 19, 27","ERBB4","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","EGFR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK domain target; TK</A> group; EGFR family","GO:0016323; GO:0005829; GO:0005576; GO:0098982; GO:0098978; GO:0099061; GO:0099056; GO:0005759; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0045211; GO:0043235","GO:0005524; GO:0005154; GO:0046934; GO:0042803; GO:0004713; GO:0005088; GO:0044212; GO:0004714","GO:0061026; GO:0045165; GO:0016477; GO:0008283; GO:0071364; GO:0021551; GO:0009880; GO:0038128; GO:0007507; GO:0007595; GO:0060749; GO:0060644; GO:0000165; GO:0043653; GO:0043066; GO:0008285; GO:2001223; GO:0007399; GO:0001755; GO:0021889; GO:0038083; GO:0018108; GO:0043065; GO:0060045; GO:0008284; GO:0070374; GO:0046427; GO:0043552; GO:0014068; GO:0051897; GO:2000010; GO:0001934; GO:0045893; GO:0042531; GO:0046777; GO:0030334; GO:2000145; GO:0007165; GO:0007416; GO:0006351; GO:0007169"]
[745,370,"PN584","ERF","T526","ETS domain-containing transcription factor ERF",{"v":9518.49687552037,"d":"9518"},{"v":9819.092216193807,"d":"9819"},{"v":2270.9162905569783,"d":"2271"},{"v":23.857929673720975,"d":"24"},{"v":635.8553020364757,"d":"636"},{"v":16057.152594758,"d":"16057"},"Kinexus","RpAb","CGGPL(pT)PRR","Corresponds to amino acid residues C522 to R529.","T526 phosphorylation inhibits ERF transcriptional repression by inducing its export from the nucleus, and regulates cell cycle progression. Phosphorylation induces transcriptional activity. This is the major in vivo phosphorylation site in ERF (≥150 reports from high throughput mass spectrometry studies).","ERK1; ERK2","P50548","P50548",970,null,null,"NP_001287964.1","Block3",3,6,"3, 11, 19, 27",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005829; GO:0005654; GO:0005634","GO:0000981; GO:0043565; GO:0001227; GO:0003714","GO:0030154; GO:0000278; GO:0000122; GO:0006351"]
[747,371,"NK055-1","ERK1 (MAPK3)","Pan-specific","Extracellular regulated protein-serine kinase 1 (p44 MAP kinase)",{"v":11687.181450282647,"d":"11687"},{"v":11543.299398417537,"d":"11543"},{"v":2260.0439135294796,"d":"2260"},{"v":19.337801189651437,"d":"19"},{"v":531.3348313705586,"d":"531"},{"v":19103.036098720168,"d":"19103"},"Kinexus","RpAb","CGVPGEVEMVKGQPFD","Corresponds to amino acid residues G23 to D37; Post-N-terminus.",null,null,"P27361","P27361",595,"P27361","P27361","NP_002737.2","Block3",3,7,"3, 11, 19, 27","ERK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","ERK",{"$nulls":5},"EC 2.7.1.123; EC 2.7.11.24; Protein kinase, Ser/Thr (non-receptor); CMGC group; MAPK family; MAPK/ERK subfamily; ERK subfamily","GO:0005901; GO:0005737; GO:0005856; GO:0005829; GO:0005769; GO:0005925; GO:0005794; GO:0005770; GO:0005739; GO:0005635; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:0031143","GO:0005524; GO:0042802; GO:0016301; GO:0004707; GO:0004708; GO:0019902; GO:0001784; GO:0004674; GO:0097110","GO:0000187; GO:0006915; GO:0019369; GO:0007411; GO:0060020; GO:0030509; GO:0061308; GO:0051216; GO:0072584; GO:0007049; GO:0034198; GO:0071276; GO:1903351; GO:0071260; GO:0034614; GO:0071356; GO:0006975; GO:0070371; GO:0060324; GO:0038095; GO:0038096; GO:0008543; GO:0070498; GO:0031663; GO:0060425; GO:0000165; GO:2000657; GO:0042473; GO:0018105; GO:0038083; GO:0016310; GO:0030168; GO:0031281; GO:0002741; GO:0070374; GO:0010628; GO:0035066; GO:0033129; GO:0010759; GO:1905050; GO:0001934; GO:0051973; GO:1904355; GO:0032212; GO:0045944; GO:0045727; GO:1904417; GO:0065003; GO:0006468; GO:0030641; GO:1900034; GO:0051493; GO:0051090; GO:2000641; GO:0090170; GO:0030278; GO:0014066; GO:0032872; GO:0070849; GO:0043330; GO:0009636; GO:0019233; GO:0051403; GO:0048538; GO:0030878; GO:0060440; GO:0006361; GO:0016032"]
[749,372,"NK055-3","ERK1 (MAPK3)","Pan-specific","Extracellular regulated protein-serine kinase 1 (p44 MAP kinase)",{"v":13225.757185128145,"d":"13226"},{"v":13277.241888992014,"d":"13277"},{"v":2856.9042793261206,"d":"2857"},{"v":21.60106403993716,"d":"22"},{"v":585.4199010111656,"d":"585"},{"v":23899.89752314226,"d":"23900"},"Kinexus","RpAb","CTDEPVAEEPFTFAME","Corresponds to amino acid residues T337 to E351; Post-kinase last alpha-chain.",null,null,"P27361","P27361",595,"P27361","P27361","NP_002737.2","Block3",3,8,"3, 11, 19, 27","ERK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","ERK",{"$nulls":5},"EC 2.7.1.123; EC 2.7.11.24; Protein kinase, Ser/Thr (non-receptor); CMGC group; MAPK family; MAPK/ERK subfamily; ERK subfamily","GO:0005901; GO:0005737; GO:0005856; GO:0005829; GO:0005769; GO:0005925; GO:0005794; GO:0005770; GO:0005739; GO:0005635; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:0031143","GO:0005524; GO:0042802; GO:0016301; GO:0004707; GO:0004708; GO:0019902; GO:0001784; GO:0004674; GO:0097110","GO:0000187; GO:0006915; GO:0019369; GO:0007411; GO:0060020; GO:0030509; GO:0061308; GO:0051216; GO:0072584; GO:0007049; GO:0034198; GO:0071276; GO:1903351; GO:0071260; GO:0034614; GO:0071356; GO:0006975; GO:0070371; GO:0060324; GO:0038095; GO:0038096; GO:0008543; GO:0070498; GO:0031663; GO:0060425; GO:0000165; GO:2000657; GO:0042473; GO:0018105; GO:0038083; GO:0016310; GO:0030168; GO:0031281; GO:0002741; GO:0070374; GO:0010628; GO:0035066; GO:0033129; GO:0010759; GO:1905050; GO:0001934; GO:0051973; GO:1904355; GO:0032212; GO:0045944; GO:0045727; GO:1904417; GO:0065003; GO:0006468; GO:0030641; GO:1900034; GO:0051493; GO:0051090; GO:2000641; GO:0090170; GO:0030278; GO:0014066; GO:0032872; GO:0070849; GO:0043330; GO:0009636; GO:0019233; GO:0051403; GO:0048538; GO:0030878; GO:0060440; GO:0006361; GO:0016032"]
[751,373,"NK055-4","ERK1 (MAPK3)","Pan-specific","Extracellular regulated protein-serine kinase 1 (p44 MAP kinase)",{"v":523.0451481762024,"d":"523"},{"v":518.1013350137648,"d":"518"},{"v":255.74510457055837,"d":"256"},{"v":48.89541666953834,"d":"49"},{"v":42.386574708546945,"d":"42"},{"v":1352.34082432092,"d":"1352"},"Kinexus","RpAb","CGGGGGEPRRTEGVGPGVPGEVEMVKGGC","Corresponds to amino acid residues G8 to K32; N-terminus.",null,null,"P27361","P27361",595,"P27361","P27361","NP_002737.2","Block3",3,9,"3, 11, 19, 27","ERK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","ERK",{"$nulls":5},"EC 2.7.1.123; EC 2.7.11.24; Protein kinase, Ser/Thr (non-receptor); CMGC group; MAPK family; MAPK/ERK subfamily; ERK subfamily","GO:0005901; GO:0005737; GO:0005856; GO:0005829; GO:0005769; GO:0005925; GO:0005794; GO:0005770; GO:0005739; GO:0005635; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:0031143","GO:0005524; GO:0042802; GO:0016301; GO:0004707; GO:0004708; GO:0019902; GO:0001784; GO:0004674; GO:0097110","GO:0000187; GO:0006915; GO:0019369; GO:0007411; GO:0060020; GO:0030509; GO:0061308; GO:0051216; GO:0072584; GO:0007049; GO:0034198; GO:0071276; GO:1903351; GO:0071260; GO:0034614; GO:0071356; GO:0006975; GO:0070371; GO:0060324; GO:0038095; GO:0038096; GO:0008543; GO:0070498; GO:0031663; GO:0060425; GO:0000165; GO:2000657; GO:0042473; GO:0018105; GO:0038083; GO:0016310; GO:0030168; GO:0031281; GO:0002741; GO:0070374; GO:0010628; GO:0035066; GO:0033129; GO:0010759; GO:1905050; GO:0001934; GO:0051973; GO:1904355; GO:0032212; GO:0045944; GO:0045727; GO:1904417; GO:0065003; GO:0006468; GO:0030641; GO:1900034; GO:0051493; GO:0051090; GO:2000641; GO:0090170; GO:0030278; GO:0014066; GO:0032872; GO:0070849; GO:0043330; GO:0009636; GO:0019233; GO:0051403; GO:0048538; GO:0030878; GO:0060440; GO:0006361; GO:0016032"]
[753,374,"PK621","ERK1 (MAPK3)","T202+Y204","Extracellular regulated protein-serine kinase 1 (p44 MAP kinase)",{"v":7850.15647864808,"d":"7850"},{"v":8079.127970870695,"d":"8079"},{"v":2217.80702312135,"d":"2218"},{"v":28.251755607084295,"d":"28"},{"v":393.7535661210504,"d":"394"},{"v":15217.564791125122,"d":"15218"},"Kinexus","RpAb","L(pT)E(pY)VAT(bA)C","Corresponds to amino acid residues L201 to T207; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T202 and Y204 phosphorylation stimulates phosphotransferase activity and induces molecular association with GSK3B, KSR and TACE and regulates cell growth, cell motility, cytoskeletal reorganization, transcription, protein conformation, intracellular location, and protein degradation. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. These are the two major in vivo phosphorylation sites in ERK1 (≥2092 and ≥3626 reports, respectively, from high throughput mass spectrometry studies).","T202: MEK1; MEK2. Y204:ERK1; JAK2; LCK;  MEK1; MEK2. ","P27361","P27361",595,"P27361","P27361","NP_002737.2","Block3",3,10,"3, 11, 19, 27","ERK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","ERK",{"$nulls":5},"EC 2.7.1.123; EC 2.7.11.24; Protein kinase, Ser/Thr (non-receptor); CMGC group; MAPK family; MAPK/ERK subfamily; ERK subfamily","GO:0005901; GO:0005737; GO:0005856; GO:0005829; GO:0005769; GO:0005925; GO:0005794; GO:0005770; GO:0005739; GO:0005635; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:0031143","GO:0005524; GO:0042802; GO:0016301; GO:0004707; GO:0004708; GO:0019902; GO:0001784; GO:0004674; GO:0097110","GO:0000187; GO:0006915; GO:0019369; GO:0007411; GO:0060020; GO:0030509; GO:0061308; GO:0051216; GO:0072584; GO:0007049; GO:0034198; GO:0071276; GO:1903351; GO:0071260; GO:0034614; GO:0071356; GO:0006975; GO:0070371; GO:0060324; GO:0038095; GO:0038096; GO:0008543; GO:0070498; GO:0031663; GO:0060425; GO:0000165; GO:2000657; GO:0042473; GO:0018105; GO:0038083; GO:0016310; GO:0030168; GO:0031281; GO:0002741; GO:0070374; GO:0010628; GO:0035066; GO:0033129; GO:0010759; GO:1905050; GO:0001934; GO:0051973; GO:1904355; GO:0032212; GO:0045944; GO:0045727; GO:1904417; GO:0065003; GO:0006468; GO:0030641; GO:1900034; GO:0051493; GO:0051090; GO:2000641; GO:0090170; GO:0030278; GO:0014066; GO:0032872; GO:0070849; GO:0043330; GO:0009636; GO:0019233; GO:0051403; GO:0048538; GO:0030878; GO:0060440; GO:0006361; GO:0016032"]
[755,375,"PK182","ERK1 (MAPK3)","T202+Y204","Extracellular regulated protein-serine kinase 1 (p44 MAP kinase)",{"v":825.7371108949156,"d":"826"},{"v":477.67467404747055,"d":"478"},{"v":1864.715883287229,"d":"1865"},{"v":225.8244008515363,"d":"226"},{"v":18.517287888488017,"d":"19"},{"v":17540.163091758244,"d":"17540"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues surrounding the dually phosphorylated Thr-202 and Tyr-204 of rat ERK1.","T202 and Y204 phosphorylation stimulates phosphotransferase activity and induces molecular association with ERK1, GSK3B, KSR and TACE and regulates cell growth, cell motility, cytoskeletal reorganization, transcription, protein conformation, intracellular location, and protein degradation. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. These are the two major in vivo phosphorylation sites in ERK1 (≥2092 and ≥3626 reports, respectively, from high throughput mass spectrometry studies).","T202: MEK1; MEK2. Y204:ERK1; JAK2; LCK;  MEK1; MEK2; RET. ","P27361","P27361",595,"P27361","P27361","NP_002737.2","Block3",3,11,"3, 11, 19, 27","ERK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","ERK",{"$nulls":5},"EC 2.7.1.123; EC 2.7.11.24; Protein kinase, Ser/Thr (non-receptor); CMGC group; MAPK family; MAPK/ERK subfamily; ERK subfamily","GO:0005901; GO:0005737; GO:0005856; GO:0005829; GO:0005769; GO:0005925; GO:0005794; GO:0005770; GO:0005739; GO:0005635; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:0031143","GO:0005524; GO:0042802; GO:0016301; GO:0004707; GO:0004708; GO:0019902; GO:0001784; GO:0004674; GO:0097110","GO:0000187; GO:0006915; GO:0019369; GO:0007411; GO:0060020; GO:0030509; GO:0061308; GO:0051216; GO:0072584; GO:0007049; GO:0034198; GO:0071276; GO:1903351; GO:0071260; GO:0034614; GO:0071356; GO:0006975; GO:0070371; GO:0060324; GO:0038095; GO:0038096; GO:0008543; GO:0070498; GO:0031663; GO:0060425; GO:0000165; GO:2000657; GO:0042473; GO:0018105; GO:0038083; GO:0016310; GO:0030168; GO:0031281; GO:0002741; GO:0070374; GO:0010628; GO:0035066; GO:0033129; GO:0010759; GO:1905050; GO:0001934; GO:0051973; GO:1904355; GO:0032212; GO:0045944; GO:0045727; GO:1904417; GO:0065003; GO:0006468; GO:0030641; GO:1900034; GO:0051493; GO:0051090; GO:2000641; GO:0090170; GO:0030278; GO:0014066; GO:0032872; GO:0070849; GO:0043330; GO:0009636; GO:0019233; GO:0051403; GO:0048538; GO:0030878; GO:0060440; GO:0006361; GO:0016032"]
[757,376,"PK864","ERK1 (MAPK3)","Y204","Extracellular regulated protein-serine kinase 1 (p44 MAP kinase)",{"v":7738.684096366993,"d":"7739"},{"v":8089.9130295782625,"d":"8090"},{"v":2429.9861589318925,"d":"2430"},{"v":31.40050851891829,"d":"31"},{"v":357.6523746493143,"d":"358"},{"v":14994.01795727946,"d":"14994"},"Kinexus","RpAb","C(bA)(pY)VATRW","Corresponds to amino acid residues Y204 to W209; In activation T-loop between kinase catalytic subdomains VII and VIII."," Y204 phosphorylation stimulates phosphotransferase activity and induces molecular association with ERK1, GSK3B, KSR and TACE and regulates cell growth, cell motility, cytoskeletal reorganization, transcription, protein conformation, intracellular location, and protein degradation. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the two major in vivo phosphorylation sitesin ERK1 (≥3626 reports, respectively, from high throughput mass spectrometry studies).","ERK1; JAK2; LCK;  MEK1; MEK2; RET","P27361","P27361",595,"P27361","P27361","NP_002737.2","Block3",3,12,"3, 11, 19, 27","ERK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","ERK",{"$nulls":5},"EC 2.7.1.123; EC 2.7.11.24; Protein kinase, Ser/Thr (non-receptor); CMGC group; MAPK family; MAPK/ERK subfamily; ERK subfamily","GO:0005901; GO:0005737; GO:0005856; GO:0005829; GO:0005769; GO:0005925; GO:0005794; GO:0005770; GO:0005739; GO:0005635; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:0031143","GO:0005524; GO:0042802; GO:0016301; GO:0004707; GO:0004708; GO:0019902; GO:0001784; GO:0004674; GO:0097110","GO:0000187; GO:0006915; GO:0019369; GO:0007411; GO:0060020; GO:0030509; GO:0061308; GO:0051216; GO:0072584; GO:0007049; GO:0034198; GO:0071276; GO:1903351; GO:0071260; GO:0034614; GO:0071356; GO:0006975; GO:0070371; GO:0060324; GO:0038095; GO:0038096; GO:0008543; GO:0070498; GO:0031663; GO:0060425; GO:0000165; GO:2000657; GO:0042473; GO:0018105; GO:0038083; GO:0016310; GO:0030168; GO:0031281; GO:0002741; GO:0070374; GO:0010628; GO:0035066; GO:0033129; GO:0010759; GO:1905050; GO:0001934; GO:0051973; GO:1904355; GO:0032212; GO:0045944; GO:0045727; GO:1904417; GO:0065003; GO:0006468; GO:0030641; GO:1900034; GO:0051493; GO:0051090; GO:2000641; GO:0090170; GO:0030278; GO:0014066; GO:0032872; GO:0070849; GO:0043330; GO:0009636; GO:0019233; GO:0051403; GO:0048538; GO:0030878; GO:0060440; GO:0006361; GO:0016032"]
[759,377,"PK183","ERK1 (MAPK3)","Y204","Extracellular regulated protein-serine kinase 1 (p44 MAP kinase)",{"v":313.920160889381,"d":"314"},{"v":242.3630123880506,"d":"242"},{"v":285.35099055214465,"d":"285"},{"v":90.89922410325741,"d":"91"},{"v":15.999439467451525,"d":"16"},{"v":3203.6154557244254,"d":"3204"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues surrounding the phosphorylated Tyr-204 of human ERK2."," Y204 phosphorylation stimulates phosphotransferase activity and induces molecular association with ERK1, GSK3B, KSR and TACE and regulates cell growth, cell motility, cytoskeletal reorganization, transcription, protein conformation, intracellular location, and protein degradation. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the two major in vivo phosphorylation sitesin ERK1 (≥3626 reports, respectively, from high throughput mass spectrometry studies).","ERK1; JAK2; LCK;  MEK1; MEK2; RET","P27361","P27361",595,"P27361","P27361","NP_002737.2","Block3",3,13,"3, 11, 19, 27","ERK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","ERK",{"$nulls":5},"EC 2.7.1.123; EC 2.7.11.24; Protein kinase, Ser/Thr (non-receptor); CMGC group; MAPK family; MAPK/ERK subfamily; ERK subfamily","GO:0005901; GO:0005737; GO:0005856; GO:0005829; GO:0005769; GO:0005925; GO:0005794; GO:0005770; GO:0005739; GO:0005635; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:0031143","GO:0005524; GO:0042802; GO:0016301; GO:0004707; GO:0004708; GO:0019902; GO:0001784; GO:0004674; GO:0097110","GO:0000187; GO:0006915; GO:0019369; GO:0007411; GO:0060020; GO:0030509; GO:0061308; GO:0051216; GO:0072584; GO:0007049; GO:0034198; GO:0071276; GO:1903351; GO:0071260; GO:0034614; GO:0071356; GO:0006975; GO:0070371; GO:0060324; GO:0038095; GO:0038096; GO:0008543; GO:0070498; GO:0031663; GO:0060425; GO:0000165; GO:2000657; GO:0042473; GO:0018105; GO:0038083; GO:0016310; GO:0030168; GO:0031281; GO:0002741; GO:0070374; GO:0010628; GO:0035066; GO:0033129; GO:0010759; GO:1905050; GO:0001934; GO:0051973; GO:1904355; GO:0032212; GO:0045944; GO:0045727; GO:1904417; GO:0065003; GO:0006468; GO:0030641; GO:1900034; GO:0051493; GO:0051090; GO:2000641; GO:0090170; GO:0030278; GO:0014066; GO:0032872; GO:0070849; GO:0043330; GO:0009636; GO:0019233; GO:0051403; GO:0048538; GO:0030878; GO:0060440; GO:0006361; GO:0016032"]
[761,378,"PK866","ERK1 (MAPK3)","Y204+T207","Extracellular regulated protein-serine kinase 1 (p44 MAP kinase)",{"v":7233.498291020399,"d":"7233"},{"v":7482.921566712044,"d":"7483"},{"v":2315.4918901373344,"d":"2315"},{"v":32.01067860915604,"d":"32"},{"v":161.6923932357916,"d":"162"},{"v":15929.22042764008,"d":"15929"},"Kinexus","RpAb","C(bA)(pY)VA(pT)RW","Corresponds to amino acid residues Y204 to W209; In activation T-loop between kinase catalytic subdomains VII and VIII."," Y204 phosphorylation stimulates phosphotransferase activity and induces molecular association with ERK1, GSK3B, KSR and TACE and regulates cell growth, cell motility, cytoskeletal reorganization, transcription, protein conformation, intracellular location, and protein degradation.  T207 phosphorylation inhibits phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. Y204 is the major in vivo phosphorylation site in ERK1 (≥3626 reports from high throughput mass spectrometry studies), whereas the T207 is a minor phosphosite (43 reports). ","Y204: ERK1; JAK2; LCK;  MEK1; MEK2; RET. T207: ERK1.","P27361","P27361",595,"P27361","P27361","NP_002737.2","Block3",4,1,"3, 11, 19, 27","ERK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","ERK",{"$nulls":5},"EC 2.7.1.123; EC 2.7.11.24; Protein kinase, Ser/Thr (non-receptor); CMGC group; MAPK family; MAPK/ERK subfamily; ERK subfamily","GO:0005901; GO:0005737; GO:0005856; GO:0005829; GO:0005769; GO:0005925; GO:0005794; GO:0005770; GO:0005739; GO:0005635; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:0031143","GO:0005524; GO:0042802; GO:0016301; GO:0004707; GO:0004708; GO:0019902; GO:0001784; GO:0004674; GO:0097110","GO:0000187; GO:0006915; GO:0019369; GO:0007411; GO:0060020; GO:0030509; GO:0061308; GO:0051216; GO:0072584; GO:0007049; GO:0034198; GO:0071276; GO:1903351; GO:0071260; GO:0034614; GO:0071356; GO:0006975; GO:0070371; GO:0060324; GO:0038095; GO:0038096; GO:0008543; GO:0070498; GO:0031663; GO:0060425; GO:0000165; GO:2000657; GO:0042473; GO:0018105; GO:0038083; GO:0016310; GO:0030168; GO:0031281; GO:0002741; GO:0070374; GO:0010628; GO:0035066; GO:0033129; GO:0010759; GO:1905050; GO:0001934; GO:0051973; GO:1904355; GO:0032212; GO:0045944; GO:0045727; GO:1904417; GO:0065003; GO:0006468; GO:0030641; GO:1900034; GO:0051493; GO:0051090; GO:2000641; GO:0090170; GO:0030278; GO:0014066; GO:0032872; GO:0070849; GO:0043330; GO:0009636; GO:0019233; GO:0051403; GO:0048538; GO:0030878; GO:0060440; GO:0006361; GO:0016032"]
[763,379,"PK865","ERK1 (MAPK3)","T207","Extracellular regulated protein-serine kinase 1 (p44 MAP kinase)",{"v":9110.128971819215,"d":"9110"},{"v":9323.112247914316,"d":"9323"},{"v":2758.539186751067,"d":"2759"},{"v":30.27991365747054,"d":"30"},{"v":281.7805772381208,"d":"282"},{"v":27069.874952765407,"d":"27070"},"Kinexus","RpAb","C(bA)YVA(pT)RW","Corresponds to amino acid residues Y204 to W209; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T207 phosphorylation inhibits phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is a minor in vivo phosphorylation sites in ERK1 (≥43 reports from high throughput mass spectrometry studies).","ERK1","P27361","P27361",595,"P27361","P27361","NP_002737.2","Block3",4,2,"3, 11, 19, 27","ERK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","ERK",{"$nulls":5},"EC 2.7.1.123; EC 2.7.11.24; Protein kinase, Ser/Thr (non-receptor); CMGC group; MAPK family; MAPK/ERK subfamily; ERK subfamily","GO:0005901; GO:0005737; GO:0005856; GO:0005829; GO:0005769; GO:0005925; GO:0005794; GO:0005770; GO:0005739; GO:0005635; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:0031143","GO:0005524; GO:0042802; GO:0016301; GO:0004707; GO:0004708; GO:0019902; GO:0001784; GO:0004674; GO:0097110","GO:0000187; GO:0006915; GO:0019369; GO:0007411; GO:0060020; GO:0030509; GO:0061308; GO:0051216; GO:0072584; GO:0007049; GO:0034198; GO:0071276; GO:1903351; GO:0071260; GO:0034614; GO:0071356; GO:0006975; GO:0070371; GO:0060324; GO:0038095; GO:0038096; GO:0008543; GO:0070498; GO:0031663; GO:0060425; GO:0000165; GO:2000657; GO:0042473; GO:0018105; GO:0038083; GO:0016310; GO:0030168; GO:0031281; GO:0002741; GO:0070374; GO:0010628; GO:0035066; GO:0033129; GO:0010759; GO:1905050; GO:0001934; GO:0051973; GO:1904355; GO:0032212; GO:0045944; GO:0045727; GO:1904417; GO:0065003; GO:0006468; GO:0030641; GO:1900034; GO:0051493; GO:0051090; GO:2000641; GO:0090170; GO:0030278; GO:0014066; GO:0032872; GO:0070849; GO:0043330; GO:0009636; GO:0019233; GO:0051403; GO:0048538; GO:0030878; GO:0060440; GO:0006361; GO:0016032"]
[765,380,"PK878","ERK1 (MAPK3)","S265","Extracellular regulated protein-serine kinase 1 (p44 MAP kinase)",{"v":11684.973309890125,"d":"11685"},{"v":11956.462836086124,"d":"11956"},{"v":2656.005388391835,"d":"2656"},{"v":22.730093753349013,"d":"23"},{"v":255.47005137536465,"d":"255"},{"v":19069.9394347568,"d":"19070"},"Kinexus","RpAb","GSP(pS)QED(bA)C","Corresponds to amino acid residues G262 to D268. S265 is located in the Gap/Insert 10 (G/I10) region in the protein-serine/threonine kinase catalytic domain of ERK1.","The effect of S265 phosphorylation is unknown. Its phosphorylation has been observed in only one mass spectrometry study. ",null,"P27361","P27361",595,"P27361","P27361","NP_002737.2","Block3",4,3,"3, 11, 19, 27","ERK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","ERK",{"$nulls":5},"EC 2.7.1.123; EC 2.7.11.24; Protein kinase, Ser/Thr (non-receptor); CMGC group; MAPK family; MAPK/ERK subfamily; ERK subfamily","GO:0005901; GO:0005737; GO:0005856; GO:0005829; GO:0005769; GO:0005925; GO:0005794; GO:0005770; GO:0005739; GO:0005635; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:0031143","GO:0005524; GO:0042802; GO:0016301; GO:0004707; GO:0004708; GO:0019902; GO:0001784; GO:0004674; GO:0097110","GO:0000187; GO:0006915; GO:0019369; GO:0007411; GO:0060020; GO:0030509; GO:0061308; GO:0051216; GO:0072584; GO:0007049; GO:0034198; GO:0071276; GO:1903351; GO:0071260; GO:0034614; GO:0071356; GO:0006975; GO:0070371; GO:0060324; GO:0038095; GO:0038096; GO:0008543; GO:0070498; GO:0031663; GO:0060425; GO:0000165; GO:2000657; GO:0042473; GO:0018105; GO:0038083; GO:0016310; GO:0030168; GO:0031281; GO:0002741; GO:0070374; GO:0010628; GO:0035066; GO:0033129; GO:0010759; GO:1905050; GO:0001934; GO:0051973; GO:1904355; GO:0032212; GO:0045944; GO:0045727; GO:1904417; GO:0065003; GO:0006468; GO:0030641; GO:1900034; GO:0051493; GO:0051090; GO:2000641; GO:0090170; GO:0030278; GO:0014066; GO:0032872; GO:0070849; GO:0043330; GO:0009636; GO:0019233; GO:0051403; GO:0048538; GO:0030878; GO:0060440; GO:0006361; GO:0016032"]
[767,381,"PK879","ERK1 (MAPK3)","S283","Extracellular regulated protein-serine kinase 1 (p44 MAP kinase)",{"v":12689.663704434632,"d":"12690"},{"v":12436.871484789684,"d":"12437"},{"v":3708.614564964768,"d":"3709"},{"v":29.22547556298695,"d":"29"},{"v":1344.1312144206881,"d":"1344"},{"v":28769.370386716815,"d":"28769"},"Kinexus","RpAb","YLQ(pS)LPS(bA)C","Corresponds to amino acid residues Y280 to S286. S283 is located in the Gap/Insert 10 (G/I10) region in the protein-serine/threonine kinase catalytic domain of ERK1.","The effect of S283 phosphorylation is unknown. Phosphorylation of S283 has not been observed in any mass spectrometry studies with human ERK1, although it was reported to be found in hamster ERK1.",null,"P27361","P27361",595,"P27361","P27361","NP_002737.2","Block3",4,4,"3, 11, 19, 27","ERK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","ERK",{"$nulls":5},"EC 2.7.1.123; EC 2.7.11.24; Protein kinase, Ser/Thr (non-receptor); CMGC group; MAPK family; MAPK/ERK subfamily; ERK subfamily","GO:0005901; GO:0005737; GO:0005856; GO:0005829; GO:0005769; GO:0005925; GO:0005794; GO:0005770; GO:0005739; GO:0005635; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:0031143","GO:0005524; GO:0042802; GO:0016301; GO:0004707; GO:0004708; GO:0019902; GO:0001784; GO:0004674; GO:0097110","GO:0000187; GO:0006915; GO:0019369; GO:0007411; GO:0060020; GO:0030509; GO:0061308; GO:0051216; GO:0072584; GO:0007049; GO:0034198; GO:0071276; GO:1903351; GO:0071260; GO:0034614; GO:0071356; GO:0006975; GO:0070371; GO:0060324; GO:0038095; GO:0038096; GO:0008543; GO:0070498; GO:0031663; GO:0060425; GO:0000165; GO:2000657; GO:0042473; GO:0018105; GO:0038083; GO:0016310; GO:0030168; GO:0031281; GO:0002741; GO:0070374; GO:0010628; GO:0035066; GO:0033129; GO:0010759; GO:1905050; GO:0001934; GO:0051973; GO:1904355; GO:0032212; GO:0045944; GO:0045727; GO:1904417; GO:0065003; GO:0006468; GO:0030641; GO:1900034; GO:0051493; GO:0051090; GO:2000641; GO:0090170; GO:0030278; GO:0014066; GO:0032872; GO:0070849; GO:0043330; GO:0009636; GO:0019233; GO:0051403; GO:0048538; GO:0030878; GO:0060440; GO:0006361; GO:0016032"]
[769,382,"NK056-3","ERK2 (MAPK1)","Pan-specific","Extracellular regulated protein-serine kinase 2 (p42 MAP kinase)",{"v":14336.480765416245,"d":"14336"},{"v":14155.52639029118,"d":"14156"},{"v":3941.6508676150343,"d":"3942"},{"v":27.493852446155692,"d":"27"},{"v":824.118300950031,"d":"824"},{"v":28141.168699036163,"d":"28141"},"Kinexus","RpAb","HKNKVPWNRLFPNADC","Corresponds to amino acid residues H269 to D283; Pre-kinase last alpha-chain.",null,null,"P28482","P28482",832,"P28482","P28482","NP_002736","Block3",4,5,"3, 11, 19, 27","ERK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","ERK",{"$nulls":5},"EC 2.7.11.24; Protein kinase, Ser/Thr (non-receptor); CMGC domain target; CMGC</A> group; MAPK family; ERK subfamily; MAPK/ERK subfamily","GO:0030424; GO:0035578; GO:0005901; GO:0005737; GO:0005856; GO:0005829; GO:0032839; GO:0005769; GO:0005576; GO:1904813; GO:0005925; GO:0005794; GO:0005770; GO:0005815; GO:0005739; GO:0072686; GO:0005654; GO:0005634; GO:0043204; GO:0005886; GO:0014069; GO:0032991; GO:0031143","GO:0005524; GO:0003677; GO:0042802; GO:0016301; GO:0004707; GO:0004708; GO:0031435; GO:0019902; GO:0001784; GO:0004674; GO:0008353; GO:0008134","GO:0000187; GO:0006915; GO:0007411; GO:0050853; GO:0060020; GO:0061308; GO:0072584; GO:0007049; GO:0034198; GO:0071276; GO:0006974; GO:1903351; GO:0097011; GO:0034614; GO:0071356; GO:0007268; GO:0006935; GO:0019858; GO:0015966; GO:0038127; GO:0070371; GO:0060324; GO:0038095; GO:0038096; GO:0008543; GO:0060716; GO:0007611; GO:0031663; GO:0060291; GO:0060425; GO:0033598; GO:0000165; GO:0045596; GO:0043312; GO:0042473; GO:0018105; GO:0018107; GO:0030168; GO:0030335; GO:0008284; GO:0010628; GO:0010800; GO:0033160; GO:0051973; GO:1904355; GO:0032212; GO:0045893; GO:0045727; GO:0006468; GO:0030641; GO:1900034; GO:0051493; GO:0051090; GO:2000641; GO:0090170; GO:0030278; GO:0014066; GO:0031647; GO:0032872; GO:0070849; GO:0043627; GO:0043330; GO:0035094; GO:0019233; GO:0007165; GO:0051403; GO:0050852; GO:0048538; GO:0030878; GO:0060440; GO:0006351; GO:0016032"]
[771,383,"NK056-4","ERK2 (MAPK1)","Pan-specific","Extracellular regulated protein-serine kinase 2 (p42 MAP kinase)",{"v":21526.36693847202,"d":"21526"},{"v":20904.724513094825,"d":"20905"},{"v":6143.389213154948,"d":"6143"},{"v":28.538904083138412,"d":"29"},{"v":9316.487344671697,"d":"9316"},{"v":45986.41176548206,"d":"45986"},"Kinexus","RpAb","CSDEPIAEAPFKFDME","Corresponds to amino acid residues S320 to E334; Post-kinase last alpha-chain.",null,null,"P28482","P28482",832,"P28482","P28482","NP_002736","Block3",4,6,"3, 11, 19, 27","ERK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","ERK",{"$nulls":5},"EC 2.7.11.24; Protein kinase, Ser/Thr (non-receptor); CMGC domain target; CMGC</A> group; MAPK family; ERK subfamily; MAPK/ERK subfamily","GO:0030424; GO:0035578; GO:0005901; GO:0005737; GO:0005856; GO:0005829; GO:0032839; GO:0005769; GO:0005576; GO:1904813; GO:0005925; GO:0005794; GO:0005770; GO:0005815; GO:0005739; GO:0072686; GO:0005654; GO:0005634; GO:0043204; GO:0005886; GO:0014069; GO:0032991; GO:0031143","GO:0005524; GO:0003677; GO:0042802; GO:0016301; GO:0004707; GO:0004708; GO:0031435; GO:0019902; GO:0001784; GO:0004674; GO:0008353; GO:0008134","GO:0000187; GO:0006915; GO:0007411; GO:0050853; GO:0060020; GO:0061308; GO:0072584; GO:0007049; GO:0034198; GO:0071276; GO:0006974; GO:1903351; GO:0097011; GO:0034614; GO:0071356; GO:0007268; GO:0006935; GO:0019858; GO:0015966; GO:0038127; GO:0070371; GO:0060324; GO:0038095; GO:0038096; GO:0008543; GO:0060716; GO:0007611; GO:0031663; GO:0060291; GO:0060425; GO:0033598; GO:0000165; GO:0045596; GO:0043312; GO:0042473; GO:0018105; GO:0018107; GO:0030168; GO:0030335; GO:0008284; GO:0010628; GO:0010800; GO:0033160; GO:0051973; GO:1904355; GO:0032212; GO:0045893; GO:0045727; GO:0006468; GO:0030641; GO:1900034; GO:0051493; GO:0051090; GO:2000641; GO:0090170; GO:0030278; GO:0014066; GO:0031647; GO:0032872; GO:0070849; GO:0043627; GO:0043330; GO:0035094; GO:0019233; GO:0007165; GO:0051403; GO:0050852; GO:0048538; GO:0030878; GO:0060440; GO:0006351; GO:0016032"]
[773,384,"PK880","ERK2 (MAPK1)","Y263+S266","Extracellular regulated protein-serine kinase 2 (p42 MAP kinase)",{"v":10805.035738111652,"d":"10805"},{"v":10701.369268692237,"d":"10701"},{"v":2257.6473637222266,"d":"2258"},{"v":20.894399782122196,"d":"21"},{"v":496.5422764404303,"d":"497"},{"v":20043.282221300375,"d":"20043"},"Kinexus","RpAb","ARN(pY)LL(pS)LPH(bA)C","Corresponds to amino acid residues A260 to H269. Y263 and S266 are located in the Gap/Insert 10 (G/I10) region in the protein-serine/threonine kinase catalytic domain of ERK2.","The effects of Y263 and S266 phosphorylation are unknown. Phosphorylation of Y263 has only been observed once in a mass spectrometry studies with human ERK2, and phosphorylation of S266 has not been reported.",null,"P28482","P28482",832,"P28482","P28482","NP_002736","Block3",4,7,"3, 11, 19, 27","ERK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","ERK",{"$nulls":5},"EC 2.7.11.24; Protein kinase, Ser/Thr (non-receptor); CMGC domain target; CMGC</A> group; MAPK family; ERK subfamily; MAPK/ERK subfamily","GO:0030424; GO:0035578; GO:0005901; GO:0005737; GO:0005856; GO:0005829; GO:0032839; GO:0005769; GO:0005576; GO:1904813; GO:0005925; GO:0005794; GO:0005770; GO:0005815; GO:0005739; GO:0072686; GO:0005654; GO:0005634; GO:0043204; GO:0005886; GO:0014069; GO:0032991; GO:0031143","GO:0005524; GO:0003677; GO:0042802; GO:0016301; GO:0004707; GO:0004708; GO:0031435; GO:0019902; GO:0001784; GO:0004674; GO:0008353; GO:0008134","GO:0000187; GO:0006915; GO:0007411; GO:0050853; GO:0060020; GO:0061308; GO:0072584; GO:0007049; GO:0034198; GO:0071276; GO:0006974; GO:1903351; GO:0097011; GO:0034614; GO:0071356; GO:0007268; GO:0006935; GO:0019858; GO:0015966; GO:0038127; GO:0070371; GO:0060324; GO:0038095; GO:0038096; GO:0008543; GO:0060716; GO:0007611; GO:0031663; GO:0060291; GO:0060425; GO:0033598; GO:0000165; GO:0045596; GO:0043312; GO:0042473; GO:0018105; GO:0018107; GO:0030168; GO:0030335; GO:0008284; GO:0010628; GO:0010800; GO:0033160; GO:0051973; GO:1904355; GO:0032212; GO:0045893; GO:0045727; GO:0006468; GO:0030641; GO:1900034; GO:0051493; GO:0051090; GO:2000641; GO:0090170; GO:0030278; GO:0014066; GO:0031647; GO:0032872; GO:0070849; GO:0043627; GO:0043330; GO:0035094; GO:0019233; GO:0007165; GO:0051403; GO:0050852; GO:0048538; GO:0030878; GO:0060440; GO:0006351; GO:0016032"]
[775,385,"NK057-2","ERK3 (MAPK6)","Pan-specific","Extracellular regulated protein-serine kinase 3",{"v":1587.1432273492437,"d":"1587"},{"v":1435.5611645864442,"d":"1436"},{"v":692.7955504385855,"d":"693"},{"v":43.650474544484126,"d":"44"},{"v":402.25389359568965,"d":"402"},{"v":5241.581925531174,"d":"5242"},"External","RpAb","Epitope undefined.",{"$nulls":3},"Q16659","Q16659",596,"Q16659","Q16659","NP_002739","Block3",4,8,"3, 11, 19, 27","ERK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","ERK",{"$nulls":5},"Protein-serine kinase, CMGC group, MAPK family, ERK subfamily","GO:0005737; GO:0005829; GO:0005654; GO:0005634; GO:0032991; GO:0032156","GO:0005524; GO:0004707; GO:0046982; GO:0019901; GO:0004674","GO:0007049; GO:0071310; GO:0060999; GO:0006468; GO:0010468; GO:0007165"]
[777,386,"PK623","ERK3 (MAPK6)","S189","Extracellular regulated protein-serine kinase 3",{"v":6529.595911374316,"d":"6530"},{"v":6435.676111718321,"d":"6436"},{"v":2119.742525764559,"d":"2120"},{"v":32.46360960977762,"d":"32"},{"v":391.99260476019066,"d":"392"},{"v":12756.661891717295,"d":"12757"},"Kinexus","RpAb","GHL(pS)EGL(bA)C","Corresponds to amino acid residues G186 to L192; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S189 phosphorylation stimulates phosphotransferase activity and induces interaction with MAPKAPK5. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in ERK3 (≥S189 reports from high throughput mass spectrometry studies).","ERK3; PAK1; PAK2; PAK3","Q16659","Q16659",596,"Q16659","Q16659","NP_002739","Block3",4,9,"3, 11, 19, 27","ERK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","ERK",{"$nulls":5},"Protein-serine kinase, CMGC group, MAPK family, ERK subfamily","GO:0005737; GO:0005829; GO:0005654; GO:0005634; GO:0032991; GO:0032156","GO:0005524; GO:0004707; GO:0046982; GO:0019901; GO:0004674","GO:0007049; GO:0071310; GO:0060999; GO:0006468; GO:0010468; GO:0007165"]
[779,387,"NK058","ERK4 (MAPK4)","Pan-specific","Extracellular regulated protein-serine kinase 4",{"v":76.82235168979994,"d":"77"},{"v":64.46012921689221,"d":"64"},{"v":47.60484097458241,"d":"48"},{"v":61.9674351636688,"d":"62"},{"v":18.271686528496566,"d":"18"},{"v":353.81730506606607,"d":"354"},"External","RpAb","APVDGGASPQFDLDVFISRALKLCTKPEDLP ","Corresponds to amino acid residues A527 to P557; C-terminus.",null,null,"P31152","P31152",715,"P31152","P31152","NP_002738","Block3",4,10,"3, 11, 19, 27","ERK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","ERK",{"$nulls":5},"Protein-serine kinase, CMGC group, MAPK family, ERK subfamily","GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0004707; GO:0046982; GO:0042803; GO:0019901; GO:0004674","GO:0007049; GO:0071310; GO:0006468; GO:0010468"]
[781,388,"PK624","ERK4 (MAPK4)","S186","Extracellular regulated protein-serine kinase 4",{"v":13426.187321040165,"d":"13426"},{"v":13544.669448316208,"d":"13545"},{"v":3685.2092811500406,"d":"3685"},{"v":27.447920940108983,"d":"27"},{"v":379.47494206624765,"d":"379"},{"v":24463.887344025272,"d":"24464"},"Kinexus","RpAb","GYL(pS)EGLV(bA)C","Corresponds to amino acid residues G183 to V190; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S186 phosphorylation stimulates interaction with MAPKAPK5 and probably phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation site in ERK4 (≥15 reports from high throughput mass spectrometry studies).",null,"P31152","P31152",715,"P31152","P31152","NP_002738","Block3",4,11,"3, 11, 19, 27","ERK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","ERK",{"$nulls":5},"Protein-serine kinase, CMGC group, MAPK family, ERK subfamily","GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0004707; GO:0046982; GO:0042803; GO:0019901; GO:0004674","GO:0007049; GO:0071310; GO:0006468; GO:0010468"]
[783,389,"NK206-3","ERK5 (MAPK7)","Pan-specific","Extracellular regulated protein-serine kinase 5 (Big MAP kinase 1 (BMK1))",{"v":636.0626517940179,"d":"636"},{"v":575.2363850063671,"d":"575"},{"v":373.0093662956345,"d":"373"},{"v":58.643494511674234,"d":"59"},{"v":37.74468444147801,"d":"38"},{"v":2589.6322279302417,"d":"2590"},"External","GpAb","Not precisely defined.","Antibody raised against amino acid residues at the C-terminus of human ERK5.",null,null,"Q13164","Q13164",597,"Q13164","Q13164","NP_620602","Block3",4,12,"3, 11, 19, 27","ERK5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","ERK",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.24; CMGC domain target; CMGC</A> group; MAPK family; MAPK/ERK subfamily; ERK subfamily","GO:0005737; GO:0005829; GO:0005654; GO:0005634; GO:0016605","GO:0005524; GO:0004707; GO:0051019; GO:0004674","GO:0007411; GO:0019933; GO:0007049; GO:0071363; GO:0070301; GO:0071499; GO:0071560; GO:0070885; GO:0051344; GO:2000352; GO:0070377; GO:2001240; GO:0034115; GO:0050728; GO:0043407; GO:1902176; GO:0060761; GO:0018105; GO:0051247; GO:0045944; GO:0036003; GO:0045765; GO:0007165"]
[785,390,"NK206-5","ERK5 (MAPK7)","Pan-specific","Extracellular regulated protein-serine kinase 5 (Big MAP kinase 1 (BMK1))",{"v":4521.531318511386,"d":"4522"},{"v":4467.988118811196,"d":"4468"},{"v":1832.2605137205178,"d":"1832"},{"v":40.52300834938701,"d":"41"},{"v":102.888546478231,"d":"103"},{"v":11784.231460654788,"d":"11784"},"Kinexus","RpAb","CADIESLQREIQMDSP","Corresponds to amino acid residues A790 to D802; Pre-C-terminus.",null,null,"Q13164","Q13164",597,"Q13164","Q13164","NP_620602","Block3",4,13,"3, 11, 19, 27","ERK5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","ERK",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.24; CMGC domain target; CMGC</A> group; MAPK family; MAPK/ERK subfamily; ERK subfamily","GO:0005737; GO:0005829; GO:0005654; GO:0005634; GO:0016605","GO:0005524; GO:0004707; GO:0051019; GO:0004674","GO:0007411; GO:0019933; GO:0007049; GO:0071363; GO:0070301; GO:0071499; GO:0071560; GO:0070885; GO:0051344; GO:2000352; GO:0070377; GO:2001240; GO:0034115; GO:0050728; GO:0043407; GO:1902176; GO:0060761; GO:0018105; GO:0051247; GO:0045944; GO:0036003; GO:0045765; GO:0007165"]
[787,391,"PK184","ERK5 (MAPK7)","T219+Y221","Extracellular regulated protein-serine kinase 5 (Big MAP kinase 1 (BMK1))",{"v":308.5037475691879,"d":"309"},{"v":261.6619240813692,"d":"262"},{"v":188.16408939003455,"d":"188"},{"v":60.99248092532008,"d":"61"},{"v":28.902888946307428,"d":"29"},{"v":1489.002557326863,"d":"1489"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues surrounding the dually phosphorylated Thr-218 and Tyr-220 of human ERK5.","T219 and Y221 phosphorylation stimulate the phosphotransferase activity of ERK5. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. T219 and Y221 are two of the major in vivo phosphorylation sites in ERK5 (≥33 and 964 reports, respectively, by mass spectrometry).","T219: MEK5 (MAP2K5). Y221: MEK5 (MAP2K5).","Q13164","Q13164",7570,"Q13164","Q13164","NP_620602","Block3",5,1,"3, 11, 19, 27","ERK5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","ERK",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.24; CMGC domain target; CMGC</A> group; MAPK family; MAPK/ERK subfamily; ERK subfamily","GO:0005737; GO:0005829; GO:0005654; GO:0005634; GO:0016605","GO:0005524; GO:0004707; GO:0051019; GO:0004674","GO:0007411; GO:0019933; GO:0007049; GO:0071363; GO:0070301; GO:0071499; GO:0071560; GO:0070885; GO:0051344; GO:2000352; GO:0070377; GO:2001240; GO:0034115; GO:0050728; GO:0043407; GO:1902176; GO:0060761; GO:0018105; GO:0051247; GO:0045944; GO:0036003; GO:0045765; GO:0007165"]
[789,392,"PK626","ERK5 (MAPK7)","Y221","Extracellular regulated protein-serine kinase 5 (Big MAP kinase 1 (BMK1))",{"v":17368.357060280487,"d":"17368"},{"v":16282.231514043411,"d":"16282"},{"v":5089.044469824072,"d":"5089"},{"v":29.30066702429877,"d":"29"},{"v":1497.2009857496191,"d":"1497"},{"v":38991.54968359582,"d":"38992"},"Kinexus","RpAb","MTE(pY)VAT(bA)C","Corresponds to amino acid residues M218 to T224; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y221 phosphorylation stimulates phosphotransferase activity, and regulates apoptosis. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Y221 is the major in vivo phosphorylation sites in ERK5 (≥964 reports from high throughput mass spectrometry studies).","MEK5 (MAP2K5)","Q13164","Q13164",7570,"Q13164","Q13164","NP_620602","Block3",5,2,"3, 11, 19, 27","ERK5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","ERK",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.24; CMGC domain target; CMGC</A> group; MAPK family; MAPK/ERK subfamily; ERK subfamily","GO:0005737; GO:0005829; GO:0005654; GO:0005634; GO:0016605","GO:0005524; GO:0004707; GO:0051019; GO:0004674","GO:0007411; GO:0019933; GO:0007049; GO:0071363; GO:0070301; GO:0071499; GO:0071560; GO:0070885; GO:0051344; GO:2000352; GO:0070377; GO:2001240; GO:0034115; GO:0050728; GO:0043407; GO:1902176; GO:0060761; GO:0018105; GO:0051247; GO:0045944; GO:0036003; GO:0045765; GO:0007165"]
[791,393,"PN585","ESRRA (ERR1)","S19+S22","Steroid hormone receptor ERR1",{"v":7149.779386319093,"d":"7150"},{"v":6566.392963770102,"d":"6566"},{"v":2665.396063602965,"d":"2665"},{"v":37.27941688247231,"d":"37"},{"v":359.2380676324242,"d":"359"},{"v":20047.589764204633,"d":"20048"},"Kinexus","RpAb","CAEPA(pS)PD(pS)PKG","Corresponds to amino acid residues C15 to G25.","S19 and S22 phosphorylation represses transactivation activity in response to coactivator. Phosphorylation enhanced the sumoylation at Lys-14, and contributes to regulating GRIP-1-dependent activated transcriptional activation by ERRα1. These are two of the major in vivo phosphorylation sites in ESRRA (≥19 and ≥16 reports, respectively, from high throughput mass spectrometry studies).",null,"P11474","P11474",5795,null,"P11474","NP_001269379.1","Block3",5,3,"3, 11, 19, 27",{"$nulls":3},"Receptor,  nuclear",{"$nulls":4},"X",{"$nulls":4},"Receptor, nuclear","GO:0005737; GO:0001650; GO:0045171; GO:0015630; GO:0005654; GO:0005634","GO:0003677; GO:0003700; GO:0004879; GO:0019904; GO:0000978; GO:0000981; GO:0043565; GO:0005496; GO:0003707; GO:0001077; GO:0001078; GO:0008270","GO:0051216; GO:0007005; GO:1900078; GO:0045944; GO:0042127; GO:0045667; GO:0045670; GO:0006355; GO:0032355; GO:0006367"]
[793,394,"PN514","ESYT1","Y822","Extended synaptotagmin-1",{"v":16691.875764996465,"d":"16692"},{"v":16315.881739798433,"d":"16316"},{"v":3878.96425276171,"d":"3879"},{"v":23.238636012952206,"d":"23"},{"v":5966.5926765686345,"d":"5967"},{"v":32487.365732633945,"d":"32487"},"Kinexus","RpAb","LSP(pY)ATL(bA)C","Corresponds to amino acid residues L819 to L825; In the fourth C2 domain.","The effect of Y822 phosphorylation is unclear. This is the major in vivo phosphorylation site in ESYT1 (≥1233 reports from high throughput mass spectrometry studies).",null,"Q9BSJ8","Q9BSJ8",4201,null,null,"NP_056107.1","Block3",5,4,"3, 11, 19, 27",{"$nulls":13},"Membrane protein, integral","GO:0005783; GO:0005789; GO:0030176; GO:0016020; GO:0044232; GO:0005886","GO:0042802; GO:0008289; GO:0046872","GO:0061817; GO:0006869"]
[795,395,"PN586","Ets-1","S282","Protein C-ets-1",{"v":9997.084702727154,"d":"9997"},{"v":9676.04254171667,"d":"9676"},{"v":2851.379768674528,"d":"2851"},{"v":28.522112730491177,"d":"29"},{"v":3024.06977636376,"d":"3024"},{"v":27719.01801816788,"d":"27719"},"Kinexus","RpAb","RVP(pS)YD(pS)SFDSC","Corresponds to amino acid residues R279 to S289.","S282 phosphorylation inhibits transcriptional activity by inhibiting DNA binding. This is one of the major in vivo phosphorylation sites in Ets-1 (≥95 reports from high throughput mass spectrometry studies).","CaMK2a","P14921","P14921",1294,null,"P14921","NP_001137292.1","Block3",5,5,"3, 11, 19, 27",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005737; GO:0005654; GO:0005634; GO:0005667","GO:0003677; GO:0003700; GO:0035035; GO:0042802; GO:0000978; GO:0000981; GO:0001077; GO:0000982; GO:0008134","GO:0060055; GO:0048870; GO:0070301; GO:0044849; GO:0007565; GO:0021854; GO:0006955; GO:0045786; GO:0008285; GO:0050728; GO:0021983; GO:0030578; GO:0045766; GO:0043536; GO:0008284; GO:0051272; GO:0010595; GO:0045648; GO:0010628; GO:0050729; GO:1904996; GO:0045893; GO:0045944; GO:0061614; GO:0045765; GO:0042981; GO:0010715; GO:0046677; GO:0032355; GO:0001666; GO:0070555; GO:0034616; GO:0009612; GO:0006366"]
[797,396,"PN587","ETV6 (Tel)","S22","Transcription factor ETV6",{"v":11963.820552182098,"d":"11964"},{"v":11599.405779084344,"d":"11599"},{"v":3495.893786049159,"d":"3496"},{"v":29.22054682115353,"d":"29"},{"v":1168.5161255898938,"d":"1169"},{"v":25103.11555217713,"d":"25103"},"Kinexus","RpAb","TPPE(pS)PVP(bA)C","Corresponds to amino acid residues T18 to P25.","S22 phosphorylation inhibits transcriptional repression by ETV6, allowing for increased activation of ETV6-repressed genes. This is one of the major in vivo phosphorylation sites in ETV6 (≥149 reports from high throughput mass spectrometry studies).","p38a MAPK (MAPK14)","P41212","P41212",5036,null,"P41212","NP_001978.1","Block3",5,6,"3, 11, 19, 27",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005829; GO:0005730; GO:0005634","GO:0003700; GO:0019904; GO:0000978; GO:0000977; GO:0000981; GO:0001077; GO:0001227","GO:0030154; GO:0071425; GO:0097152; GO:0000122; GO:0022008; GO:0007296"]
[799,397,"PN697","EZH2","T487","Histone-lysine N-methyltransferase EZH2",{"v":9186.61897864705,"d":"9187"},{"v":9158.143387183318,"d":"9158"},{"v":3004.7380424147323,"d":"3005"},{"v":32.70776821591062,"d":"33"},{"v":235.8824806936632,"d":"236"},{"v":17172.79012914116,"d":"17173"},"Kinexus","RpAb","DVD(pT)PPR(bA)C","Corresponds to amino acid residues D484 to R490. ","The effect of T487 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in EZH2 (≥103 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in the fruit fly.","CDK1 (CDC2); PKCi (PRKCI)","Q15910","Q15910",5913,null,null,"NP_001190176.1","Block3",5,7,"3, 11, 19, 27",{"$nulls":3},"Enzyme - Histone H3 Lys 27 (H3K27) methyltransferase",{"$nulls":8},"X","Methyltransferase; EC 2.1.1.43","GO:0005737; GO:0035098; GO:0000790; GO:0005654; GO:0005634; GO:0045120","GO:0003682; GO:0031490; GO:0003677; GO:0018024; GO:0042054; GO:0046976; GO:0070878; GO:1990841; GO:0016279; GO:0043021; GO:0000979; GO:0000978; GO:0000981","GO:0014898; GO:0070301; GO:0035984; GO:0021695; GO:0006325; GO:0006306; GO:0070314; GO:0036333; GO:0021766; GO:0070734; GO:0098532; GO:0016571; GO:0097421; GO:0043433; GO:0045605; GO:0070317; GO:2000134; GO:0045814; GO:0048387; GO:0051154; GO:0045892; GO:0000122; GO:0034244; GO:1902808; GO:0008284; GO:1900006; GO:0010718; GO:0043547; GO:0043406; GO:0071902; GO:0071168; GO:0042752; GO:0014013; GO:0006355; GO:0032355; GO:1904772; GO:0048511; GO:0014834; GO:0006351"]
[801,398,"PN224","EZR","Y146","Ezrin; Cytovilin",{"v":379.50279723800844,"d":"380"},{"v":331.0250914063706,"d":"331"},{"v":263.36537791113255,"d":"263"},{"v":69.39748002594055,"d":"69"},{"v":12.899260047206923,"d":"13"},{"v":1861.614179198984,"d":"1862"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the Y146 phosphosite.","Y146 phosphorylation induces interaction with EGFR. This is one of the minor in vivo phosphorylation sites in Ezrin (≥1 report from high throughput mass spectrometry studies).","EGFR, Lck, Src","P15311","P15311",971,null,null,"NP_001104547.1","Block3",5,8,"3, 11, 19, 27",{"$nulls":13},"Cytoskeletal protein","GO:0015629; GO:0005884; GO:0045177; GO:0016324; GO:0097449; GO:0016323; GO:0005903; GO:0044297; GO:0071944; GO:0042995; GO:0051286; GO:0036064; GO:0030863; GO:0005737; GO:0098592; GO:0005829; GO:0005768; GO:0070062; GO:0005615; GO:0019898; GO:0001650; GO:0030175; GO:0005925; GO:0001772; GO:0071437; GO:0016020; GO:0044393; GO:0005902; GO:0031528; GO:0043209; GO:0048471; GO:0005886; GO:0044853; GO:0032991; GO:0001726; GO:0032587; GO:0097454; GO:0030315; GO:0001931; GO:0031982","GO:0003779; GO:0051015; GO:0051117; GO:0045296; GO:0050839; GO:0097718; GO:0042802; GO:0008017; GO:0008022; GO:0019904; GO:0051018; GO:0034236; GO:0034237; GO:0003723; GO:0044548","GO:0031532; GO:0051017; GO:0030953; GO:0007411; GO:0034629; GO:0071320; GO:0043622; GO:0007016; GO:0051660; GO:0061028; GO:0035088; GO:0046847; GO:0001951; GO:0007159; GO:0022614; GO:0030033; GO:0070373; GO:1900041; GO:1903753; GO:0050860; GO:0000122; GO:0048015; GO:1903364; GO:2000643; GO:0010628; GO:0040018; GO:1902966; GO:1903078; GO:0050714; GO:0010737; GO:0072697; GO:0072659; GO:0031623; GO:0008360; GO:0032532; GO:1902115; GO:0003376; GO:1902896"]
[803,399,"PN175","EZR","Y354","Ezrin; Cytovilin",{"v":652.8015856827868,"d":"653"},{"v":519.1139527283758,"d":"519"},{"v":493.631939324586,"d":"494"},{"v":75.61745408572806,"d":"76"},{"v":12.14961505760675,"d":"12"},{"v":2549.447789864202,"d":"2549"},"External","RpAb","QD(pY)EE","Corresponds to amino acid residues Q351 to E355.","Y354 phosphorylation induces activity and interaction with PIK3R1. This is the major in vivo phosphorylation site in Ezrin (≥245 reports from high throughput mass spectrometry studies).","EGFR","P15311","P15311",971,null,null,"NP_001104547.1","Block3",5,9,"3, 11, 19, 27",{"$nulls":13},"Cytoskeletal protein","GO:0015629; GO:0005884; GO:0045177; GO:0016324; GO:0097449; GO:0016323; GO:0005903; GO:0044297; GO:0071944; GO:0042995; GO:0051286; GO:0036064; GO:0030863; GO:0005737; GO:0098592; GO:0005829; GO:0005768; GO:0070062; GO:0005615; GO:0019898; GO:0001650; GO:0030175; GO:0005925; GO:0001772; GO:0071437; GO:0016020; GO:0044393; GO:0005902; GO:0031528; GO:0043209; GO:0048471; GO:0005886; GO:0044853; GO:0032991; GO:0001726; GO:0032587; GO:0097454; GO:0030315; GO:0001931; GO:0031982","GO:0003779; GO:0051015; GO:0051117; GO:0045296; GO:0050839; GO:0097718; GO:0042802; GO:0008017; GO:0008022; GO:0019904; GO:0051018; GO:0034236; GO:0034237; GO:0003723; GO:0044548","GO:0031532; GO:0051017; GO:0030953; GO:0007411; GO:0034629; GO:0071320; GO:0043622; GO:0007016; GO:0051660; GO:0061028; GO:0035088; GO:0046847; GO:0001951; GO:0007159; GO:0022614; GO:0030033; GO:0070373; GO:1900041; GO:1903753; GO:0050860; GO:0000122; GO:0048015; GO:1903364; GO:2000643; GO:0010628; GO:0040018; GO:1902966; GO:1903078; GO:0050714; GO:0010737; GO:0072697; GO:0072659; GO:0031623; GO:0008360; GO:0032532; GO:1902115; GO:0003376; GO:1902896"]
[805,400,"PN174","EZR","T567","Ezrin; Cytovilin",{"v":168.3287171211432,"d":"168"},{"v":108.00604823532625,"d":"108"},{"v":160.61296484600194,"d":"161"},{"v":95.41625908692195,"d":"95"},{"v":4.713378994139931,"d":"5"},{"v":751.9063487307777,"d":"752"},"External","RpAb","YK(pT)LR","Corresponds to amino acid residues Y565 to R569.","T567 phosphorylation induces activity and binding of ACTA1, and inhibits interaction with ezrin and moesin. This is one of the less major in vivo phosphorylation sites in Ezrin (≥23 reports from high throughput mass spectrometry studies).","Akt1 (PKBa); Akt2 (PKBb); Akt3 (PKBg); BARK1 (GRK2; ADRBK1); Cot; LOK (STK10); LRRK2; MST4; NIK (MAP3K14); PKCa (PRKCA); PKCi (PRKCI); PKCt (PRKCQ; PKCq); ROCK1; ROCK2","P15311","P15311",971,null,null,"NP_001104547.1","Block3",5,10,"3, 11, 19, 27",{"$nulls":13},"Cytoskeletal protein","GO:0015629; GO:0005884; GO:0045177; GO:0016324; GO:0097449; GO:0016323; GO:0005903; GO:0044297; GO:0071944; GO:0042995; GO:0051286; GO:0036064; GO:0030863; GO:0005737; GO:0098592; GO:0005829; GO:0005768; GO:0070062; GO:0005615; GO:0019898; GO:0001650; GO:0030175; GO:0005925; GO:0001772; GO:0071437; GO:0016020; GO:0044393; GO:0005902; GO:0031528; GO:0043209; GO:0048471; GO:0005886; GO:0044853; GO:0032991; GO:0001726; GO:0032587; GO:0097454; GO:0030315; GO:0001931; GO:0031982","GO:0003779; GO:0051015; GO:0051117; GO:0045296; GO:0050839; GO:0097718; GO:0042802; GO:0008017; GO:0008022; GO:0019904; GO:0051018; GO:0034236; GO:0034237; GO:0003723; GO:0044548","GO:0031532; GO:0051017; GO:0030953; GO:0007411; GO:0034629; GO:0071320; GO:0043622; GO:0007016; GO:0051660; GO:0061028; GO:0035088; GO:0046847; GO:0001951; GO:0007159; GO:0022614; GO:0030033; GO:0070373; GO:1900041; GO:1903753; GO:0050860; GO:0000122; GO:0048015; GO:1903364; GO:2000643; GO:0010628; GO:0040018; GO:1902966; GO:1903078; GO:0050714; GO:0010737; GO:0072697; GO:0072659; GO:0031623; GO:0008360; GO:0032532; GO:1902115; GO:0003376; GO:1902896"]
[807,401,"NK060","FAK (PTK2)","Pan-specific","Focal adhesion protein-tyrosine kinase",{"v":293.3973936244628,"d":"293"},{"v":253.2690653143582,"d":"253"},{"v":162.07246318618397,"d":"162"},{"v":55.239912387780244,"d":"55"},{"v":34.20670941391508,"d":"34"},{"v":1133.8934953854746,"d":"1134"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues at the C-terminus of human FAK.",null,null,"Q05397","Q05397",598,"Q05397","Q05397","NP_005598","Block3",5,11,"3, 11, 19, 27","FAK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Fak",{"$nulls":6},"Protein-tyrosine kinase, TK group, Fak family","GO:0016324; GO:0005938; GO:0005737; GO:0005856; GO:0005829; GO:0031234; GO:0005925; GO:0030027; GO:0005815; GO:0005634; GO:0005886; GO:0001725","GO:0003779; GO:0005524; GO:0008432; GO:0004715; GO:0004672; GO:0019901; GO:0019903; GO:0004713; GO:0005088; GO:0042169; GO:0005102","GO:0001525; GO:0007411; GO:0048870; GO:0021955; GO:0043542; GO:0048013; GO:0007173; GO:0030010; GO:0030198; GO:0038096; GO:0060396; GO:0003007; GO:0045087; GO:0007229; GO:0000165; GO:0000226; GO:2000811; GO:0043066; GO:0010507; GO:0050771; GO:0022408; GO:0046621; GO:0051964; GO:0038007; GO:0001764; GO:0007097; GO:0038083; GO:0018108; GO:0001890; GO:0010613; GO:0030335; GO:0008284; GO:0043552; GO:0014068; GO:0045860; GO:0051897; GO:0001934; GO:2000060; GO:0046777; GO:0033628; GO:0042127; GO:0008360; GO:0051493; GO:0010594; GO:0010632; GO:0051893; GO:0043087; GO:0045667; GO:0001932; GO:1900024; GO:0007172; GO:0007179; GO:0048010; GO:0001570"]
[809,402,"NK060-2","FAK (PTK2)","Pan-specific","Focal adhesion protein-tyrosine kinase",{"v":304.5197337631275,"d":"305"},{"v":230.00559506727691,"d":"230"},{"v":270.80209310910203,"d":"271"},{"v":88.92760077077536,"d":"89"},{"v":15.528128406941367,"d":"16"},{"v":2817.1220744963807,"d":"2817"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 2-31 at the N-terminus of human FAK.",null,null,"Q05397","Q05397",598,"Q05397","Q05397","NP_005598","Block3",5,12,"3, 11, 19, 27","FAK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Fak",{"$nulls":6},"Protein-tyrosine kinase, TK group, Fak family","GO:0016324; GO:0005938; GO:0005737; GO:0005856; GO:0005829; GO:0031234; GO:0005925; GO:0030027; GO:0005815; GO:0005634; GO:0005886; GO:0001725","GO:0003779; GO:0005524; GO:0008432; GO:0004715; GO:0004672; GO:0019901; GO:0019903; GO:0004713; GO:0005088; GO:0042169; GO:0005102","GO:0001525; GO:0007411; GO:0048870; GO:0021955; GO:0043542; GO:0048013; GO:0007173; GO:0030010; GO:0030198; GO:0038096; GO:0060396; GO:0003007; GO:0045087; GO:0007229; GO:0000165; GO:0000226; GO:2000811; GO:0043066; GO:0010507; GO:0050771; GO:0022408; GO:0046621; GO:0051964; GO:0038007; GO:0001764; GO:0007097; GO:0038083; GO:0018108; GO:0001890; GO:0010613; GO:0030335; GO:0008284; GO:0043552; GO:0014068; GO:0045860; GO:0051897; GO:0001934; GO:2000060; GO:0046777; GO:0033628; GO:0042127; GO:0008360; GO:0051493; GO:0010594; GO:0010632; GO:0051893; GO:0043087; GO:0045667; GO:0001932; GO:1900024; GO:0007172; GO:0007179; GO:0048010; GO:0001570"]
[811,403,"PK017-1","FAK (PTK2)","Y397","Focal adhesion protein-tyrosine kinase",{"v":8458.464137493815,"d":"8458"},{"v":7998.7243400823245,"d":"7999"},{"v":3869.1470768568656,"d":"3869"},{"v":45.74290336830899,"d":"46"},{"v":178.80506504595468,"d":"179"},{"v":22723.804531840513,"d":"22724"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the Y397 phosphosite.","Y397 phosphorylation stimulates phosphotransferase activity and induces interaction with Src and other Src family kinases, Bmx, PIK3R1, RASA1 and SHC1, and this leads to phosphorylation at Y576, Y577 and additional tyrosine phosphosites.  Phosphorylation inhibits interaction with PI3KR2. Phosphorylation regulates apoptosis, cell adhesion, cell differentiation, cell growth, cell motility, cytoskeletal reorganization, endocytosis, transcription, alters intracellular location, protein degradation and molecular associations. This is one of the major in vivo phosphorylation sites in FAK (≥485 reports from high throughput mass spectrometry studies).","EphB2; FAK (PTK2); Fgr; Met; Src","Q05397","Q05397",598,"Q05397","Q05397","NP_005598","Block3",5,13,"3, 11, 19, 27","FAK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Fak",{"$nulls":6},"Protein-tyrosine kinase, TK group, Fak family","GO:0016324; GO:0005938; GO:0005737; GO:0005856; GO:0005829; GO:0031234; GO:0005925; GO:0030027; GO:0005815; GO:0005634; GO:0005886; GO:0001725","GO:0003779; GO:0005524; GO:0008432; GO:0004715; GO:0004672; GO:0019901; GO:0019903; GO:0004713; GO:0005088; GO:0042169; GO:0005102","GO:0001525; GO:0007411; GO:0048870; GO:0021955; GO:0043542; GO:0048013; GO:0007173; GO:0030010; GO:0030198; GO:0038096; GO:0060396; GO:0003007; GO:0045087; GO:0007229; GO:0000165; GO:0000226; GO:2000811; GO:0043066; GO:0010507; GO:0050771; GO:0022408; GO:0046621; GO:0051964; GO:0038007; GO:0001764; GO:0007097; GO:0038083; GO:0018108; GO:0001890; GO:0010613; GO:0030335; GO:0008284; GO:0043552; GO:0014068; GO:0045860; GO:0051897; GO:0001934; GO:2000060; GO:0046777; GO:0033628; GO:0042127; GO:0008360; GO:0051493; GO:0010594; GO:0010632; GO:0051893; GO:0043087; GO:0045667; GO:0001932; GO:1900024; GO:0007172; GO:0007179; GO:0048010; GO:0001570"]
[813,404,"PK627","FAK (PTK2)","Y397","Focal adhesion protein-tyrosine kinase",{"v":11635.0925109205,"d":"11635"},{"v":11860.64110623969,"d":"11861"},{"v":2889.7209489034217,"d":"2890"},{"v":24.836252450860865,"d":"25"},{"v":70.32572235369337,"d":"70"},{"v":18462.17013163975,"d":"18462"},"Kinexus","RpAb","TDD(pY)AEI(bA)C","Corresponds to amino acid residues T394 to I400; In the region between the FERM_M and kinase catalytic domains. ","Y397 phosphorylation stimulates phosphotransferase activity and induces interaction with Src and other Src family kinases, Bmx, PIK3R1, RASA1 and SHC1, and this leads to phosphorylation at Y576, Y577 and additional tyrosine phosphosites.  Phosphorylation inhibits interaction with PI3KR2. Phosphorylation regulates apoptosis, cell adhesion, cell differentiation, cell growth, cell motility, cytoskeletal reorganization, endocytosis, transcription, alters intracellular location, protein degradation and molecular associations. This is one of the major in vivo phosphorylation sites in FAK (≥485 reports from high throughput mass spectrometry studies).","EphB2; FAK (PTK2); Fgr; Met; Src","Q05397","Q05397",598,"Q05397","Q05397","NP_005598","Block3",6,1,"3, 11, 19, 27","FAK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Fak",{"$nulls":6},"Protein-tyrosine kinase, TK group, Fak family","GO:0016324; GO:0005938; GO:0005737; GO:0005856; GO:0005829; GO:0031234; GO:0005925; GO:0030027; GO:0005815; GO:0005634; GO:0005886; GO:0001725","GO:0003779; GO:0005524; GO:0008432; GO:0004715; GO:0004672; GO:0019901; GO:0019903; GO:0004713; GO:0005088; GO:0042169; GO:0005102","GO:0001525; GO:0007411; GO:0048870; GO:0021955; GO:0043542; GO:0048013; GO:0007173; GO:0030010; GO:0030198; GO:0038096; GO:0060396; GO:0003007; GO:0045087; GO:0007229; GO:0000165; GO:0000226; GO:2000811; GO:0043066; GO:0010507; GO:0050771; GO:0022408; GO:0046621; GO:0051964; GO:0038007; GO:0001764; GO:0007097; GO:0038083; GO:0018108; GO:0001890; GO:0010613; GO:0030335; GO:0008284; GO:0043552; GO:0014068; GO:0045860; GO:0051897; GO:0001934; GO:2000060; GO:0046777; GO:0033628; GO:0042127; GO:0008360; GO:0051493; GO:0010594; GO:0010632; GO:0051893; GO:0043087; GO:0045667; GO:0001932; GO:1900024; GO:0007172; GO:0007179; GO:0048010; GO:0001570"]
[815,405,"PK151","FAK (PTK2)","Y576+Y577","Focal adhesion protein-tyrosine kinase",{"v":821.7853241163971,"d":"822"},{"v":643.4864902090228,"d":"643"},{"v":1250.8379854079799,"d":"1251"},{"v":152.20982277249965,"d":"152"},{"v":2.008638845801821,"d":"2"},{"v":10859.821468825434,"d":"10860"},"External","RpAb","ST(pY)(pY)KA","Corresponds to amino acid residues S574 to A579.","Y576 and Y577 phosphorylation stimulates phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major in vivo phosphorylation sites in FAK (≥2549 and ≥1764 reports, respectively, by mass spectrometry).","Y576: Bmx (Etk); FAK (PTK2); Fgr, Met; Ret; Src. Y577: Bmx (Etk); FAK (PTK2); Fgr, Met; Ret; Src.","Q05397","Q05397",598,"Q05397","Q05397","NP_005598","Block3",6,2,"3, 11, 19, 27","FAK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Fak",{"$nulls":6},"Protein-tyrosine kinase, TK group, Fak family","GO:0016324; GO:0005938; GO:0005737; GO:0005856; GO:0005829; GO:0031234; GO:0005925; GO:0030027; GO:0005815; GO:0005634; GO:0005886; GO:0001725","GO:0003779; GO:0005524; GO:0008432; GO:0004715; GO:0004672; GO:0019901; GO:0019903; GO:0004713; GO:0005088; GO:0042169; GO:0005102","GO:0001525; GO:0007411; GO:0048870; GO:0021955; GO:0043542; GO:0048013; GO:0007173; GO:0030010; GO:0030198; GO:0038096; GO:0060396; GO:0003007; GO:0045087; GO:0007229; GO:0000165; GO:0000226; GO:2000811; GO:0043066; GO:0010507; GO:0050771; GO:0022408; GO:0046621; GO:0051964; GO:0038007; GO:0001764; GO:0007097; GO:0038083; GO:0018108; GO:0001890; GO:0010613; GO:0030335; GO:0008284; GO:0043552; GO:0014068; GO:0045860; GO:0051897; GO:0001934; GO:2000060; GO:0046777; GO:0033628; GO:0042127; GO:0008360; GO:0051493; GO:0010594; GO:0010632; GO:0051893; GO:0043087; GO:0045667; GO:0001932; GO:1900024; GO:0007172; GO:0007179; GO:0048010; GO:0001570"]
[817,406,"PK628","FAK (PTK2)","Y576+Y577","Focal adhesion protein-tyrosine kinase",{"v":10740.960885310027,"d":"10741"},{"v":10726.9405598954,"d":"10727"},{"v":2422.6004677688456,"d":"2423"},{"v":22.554783446629408,"d":"23"},{"v":911.8466937076641,"d":"912"},{"v":19321.58928363978,"d":"19322"},"Kinexus","RpAb","DST(pY)(pY)KAS(bA)C","Corresponds to amino acid residues D573 to S580; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y576 and Y577 phosphorylation stimulates phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major in vivo phosphorylation sites in FAK (≥2549 and ≥1764 reports, respectively, by mass spectrometry).","Y576: FAK (PTK2); Fgr, Met; Src. Y577: FAK (PTK2); Fgr, Met; Src.","Q05397","Q05397",598,"Q05397","Q05397","NP_005598","Block3",6,3,"3, 11, 19, 27","FAK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Fak",{"$nulls":6},"Protein-tyrosine kinase, TK group, Fak family","GO:0016324; GO:0005938; GO:0005737; GO:0005856; GO:0005829; GO:0031234; GO:0005925; GO:0030027; GO:0005815; GO:0005634; GO:0005886; GO:0001725","GO:0003779; GO:0005524; GO:0008432; GO:0004715; GO:0004672; GO:0019901; GO:0019903; GO:0004713; GO:0005088; GO:0042169; GO:0005102","GO:0001525; GO:0007411; GO:0048870; GO:0021955; GO:0043542; GO:0048013; GO:0007173; GO:0030010; GO:0030198; GO:0038096; GO:0060396; GO:0003007; GO:0045087; GO:0007229; GO:0000165; GO:0000226; GO:2000811; GO:0043066; GO:0010507; GO:0050771; GO:0022408; GO:0046621; GO:0051964; GO:0038007; GO:0001764; GO:0007097; GO:0038083; GO:0018108; GO:0001890; GO:0010613; GO:0030335; GO:0008284; GO:0043552; GO:0014068; GO:0045860; GO:0051897; GO:0001934; GO:2000060; GO:0046777; GO:0033628; GO:0042127; GO:0008360; GO:0051493; GO:0010594; GO:0010632; GO:0051893; GO:0043087; GO:0045667; GO:0001932; GO:1900024; GO:0007172; GO:0007179; GO:0048010; GO:0001570"]
[819,407,"PK629","FAK (PTK2)","Y577","Focal adhesion protein-tyrosine kinase",{"v":9327.654079694672,"d":"9328"},{"v":9459.82404642885,"d":"9460"},{"v":1930.9904799779963,"d":"1931"},{"v":20.70178057076067,"d":"21"},{"v":137.80050801366158,"d":"138"},{"v":13931.863962326026,"d":"13932"},"Kinexus","RpAb","STY(pY)KAS(bA)C","Corresponds to amino acid residues S574 to S580; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y577 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in FAK (≥1764 reports from high throughput mass spectrometry studies).","FAK (PTK2); Fgr, Met; Src","Q05397","Q05397",598,"Q05397","Q05397","NP_005598","Block3",6,4,"3, 11, 19, 27","FAK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Fak",{"$nulls":6},"Protein-tyrosine kinase, TK group, Fak family","GO:0016324; GO:0005938; GO:0005737; GO:0005856; GO:0005829; GO:0031234; GO:0005925; GO:0030027; GO:0005815; GO:0005634; GO:0005886; GO:0001725","GO:0003779; GO:0005524; GO:0008432; GO:0004715; GO:0004672; GO:0019901; GO:0019903; GO:0004713; GO:0005088; GO:0042169; GO:0005102","GO:0001525; GO:0007411; GO:0048870; GO:0021955; GO:0043542; GO:0048013; GO:0007173; GO:0030010; GO:0030198; GO:0038096; GO:0060396; GO:0003007; GO:0045087; GO:0007229; GO:0000165; GO:0000226; GO:2000811; GO:0043066; GO:0010507; GO:0050771; GO:0022408; GO:0046621; GO:0051964; GO:0038007; GO:0001764; GO:0007097; GO:0038083; GO:0018108; GO:0001890; GO:0010613; GO:0030335; GO:0008284; GO:0043552; GO:0014068; GO:0045860; GO:0051897; GO:0001934; GO:2000060; GO:0046777; GO:0033628; GO:0042127; GO:0008360; GO:0051493; GO:0010594; GO:0010632; GO:0051893; GO:0043087; GO:0045667; GO:0001932; GO:1900024; GO:0007172; GO:0007179; GO:0048010; GO:0001570"]
[821,408,"PK020-3","FAK (PTK2)","S722","Focal adhesion protein-tyrosine kinase",{"v":530.2975770947363,"d":"530"},{"v":309.73155838762284,"d":"310"},{"v":1410.8842181576856,"d":"1411"},{"v":266.05518846367175,"d":"266"},{"v":16.55086311259199,"d":"17"},{"v":13050.613070250933,"d":"13051"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S722 phosphosite.","722 phosphorylation inhibits phosphotransferase activity. This is one of the minor in vivo phosphorylation sites in FAK (≥15 reports from high throughput mass spectrometry studies).","CDK1 (CDC2); GSK3b","Q05397","Q05397",598,"Q05397","Q05397","NP_005598","Block3",6,5,"3, 11, 19, 27","FAK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Fak",{"$nulls":6},"Protein-tyrosine kinase, TK group, Fak family","GO:0016324; GO:0005938; GO:0005737; GO:0005856; GO:0005829; GO:0031234; GO:0005925; GO:0030027; GO:0005815; GO:0005634; GO:0005886; GO:0001725","GO:0003779; GO:0005524; GO:0008432; GO:0004715; GO:0004672; GO:0019901; GO:0019903; GO:0004713; GO:0005088; GO:0042169; GO:0005102","GO:0001525; GO:0007411; GO:0048870; GO:0021955; GO:0043542; GO:0048013; GO:0007173; GO:0030010; GO:0030198; GO:0038096; GO:0060396; GO:0003007; GO:0045087; GO:0007229; GO:0000165; GO:0000226; GO:2000811; GO:0043066; GO:0010507; GO:0050771; GO:0022408; GO:0046621; GO:0051964; GO:0038007; GO:0001764; GO:0007097; GO:0038083; GO:0018108; GO:0001890; GO:0010613; GO:0030335; GO:0008284; GO:0043552; GO:0014068; GO:0045860; GO:0051897; GO:0001934; GO:2000060; GO:0046777; GO:0033628; GO:0042127; GO:0008360; GO:0051493; GO:0010594; GO:0010632; GO:0051893; GO:0043087; GO:0045667; GO:0001932; GO:1900024; GO:0007172; GO:0007179; GO:0048010; GO:0001570"]
[823,409,"PK024","FAK (PTK2)","S910","Focal adhesion protein-tyrosine kinase",{"v":280.7093711584908,"d":"281"},{"v":104.72682428711599,"d":"105"},{"v":1173.2306062337123,"d":"1173"},{"v":417.95206244514605,"d":"418"},{"v":6.854289366432409,"d":"7"},{"v":11285.50816882359,"d":"11286"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S910 phosphosite.","S910 phosphorylation regulates cell adhesion, cell growth, and cytoskeletal reorganization. This is one of the minor in vivo phosphorylation sites in FAK (≥46 reports from high throughput mass spectrometry studies).","CDK5; ERK1 (MAPK3); ERK2 (MAPK1)","Q05397","Q05397",598,"Q05397","Q05397","NP_005598","Block3",6,6,"3, 11, 19, 27","FAK","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Fak",{"$nulls":6},"Protein-tyrosine kinase, TK group, Fak family","GO:0016324; GO:0005938; GO:0005737; GO:0005856; GO:0005829; GO:0031234; GO:0005925; GO:0030027; GO:0005815; GO:0005634; GO:0005886; GO:0001725","GO:0003779; GO:0005524; GO:0008432; GO:0004715; GO:0004672; GO:0019901; GO:0019903; GO:0004713; GO:0005088; GO:0042169; GO:0005102","GO:0001525; GO:0007411; GO:0048870; GO:0021955; GO:0043542; GO:0048013; GO:0007173; GO:0030010; GO:0030198; GO:0038096; GO:0060396; GO:0003007; GO:0045087; GO:0007229; GO:0000165; GO:0000226; GO:2000811; GO:0043066; GO:0010507; GO:0050771; GO:0022408; GO:0046621; GO:0051964; GO:0038007; GO:0001764; GO:0007097; GO:0038083; GO:0018108; GO:0001890; GO:0010613; GO:0030335; GO:0008284; GO:0043552; GO:0014068; GO:0045860; GO:0051897; GO:0001934; GO:2000060; GO:0046777; GO:0033628; GO:0042127; GO:0008360; GO:0051493; GO:0010594; GO:0010632; GO:0051893; GO:0043087; GO:0045667; GO:0001932; GO:1900024; GO:0007172; GO:0007179; GO:0048010; GO:0001570"]
[825,410,"PN749","FASN (FAS)","Y45","Fatty acid synthase",{"v":7679.123658529835,"d":"7679"},{"v":7502.840361666302,"d":"7503"},{"v":1702.4021420709437,"d":"1702"},{"v":22.169224221046964,"d":"22"},{"v":809.5365555778315,"d":"810"},{"v":12861.418499377862,"d":"12861"},"Kinexus","RpAb","AGL(pY)GLPRC","Corresponds to amino acid residues A42 to R49.","The effect of Y45 phosphorylation is unclear. This is the major in vivo phosphorylation site in fatty acid synthetase (≥90 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in the bee.",null,"P49327","P49327",5842,null,null,"NP_004095.4","Block3",6,7,"3, 11, 19, 27",{"$nulls":12},"X","Oxidoreductase; Hydrolase; Acetyltransferase; EC 2.3.1.41; EC 2.3.1.85; Lipid Metabolism - fatty acid biosynthesis; EC 1.3.1.10; EC 2.3.1.39; Lyase; EC 4.2.1.61; EC 1.1.1.100; EC 3.1.2.14; EC 2.3.1.38","GO:0005829; GO:0070062; GO:0042587; GO:0005794; GO:0042470; GO:0016020; GO:0005886","GO:0004313; GO:0004314; GO:0047451; GO:0004316; GO:0004315; GO:0102131; GO:0102132; GO:0045296; GO:0008144; GO:0047117; GO:0004312; GO:0016295; GO:0070402; GO:0004320; GO:0016296; GO:0031177; GO:0042803; GO:0003723","GO:0006084; GO:0071353; GO:0090557; GO:0008611; GO:0006633; GO:0006631; GO:0046949; GO:0030879; GO:0030224; GO:0030223; GO:0001649; GO:0031325; GO:0045540"]
[827,411,"PN698","FASN (FAS)","S207","Fatty acid synthase",{"v":9069.301861710848,"d":"9069"},{"v":8934.894132563652,"d":"8935"},{"v":2255.3184197664423,"d":"2255"},{"v":24.86760782864708,"d":"25"},{"v":777.5432740648548,"d":"778"},{"v":16333.421923934806,"d":"16333"},"Kinexus","RpAb","GML(pS)PEGTC","Corresponds to amino acid residues G204 to E212. ","The effect of S207 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in fatty acid synthetase (≥42 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in the nematode worm.",null,"P49327","P49327",5842,null,null,"NP_004095.4","Block3",6,8,"3, 11, 19, 27",{"$nulls":3},"Enzyme - Fatty acid synthesis",{"$nulls":8},"X","Oxidoreductase; Hydrolase; Acetyltransferase; EC 2.3.1.41; EC 2.3.1.85; Lipid Metabolism - fatty acid biosynthesis; EC 1.3.1.10; EC 2.3.1.39; Lyase; EC 4.2.1.61; EC 1.1.1.100; EC 3.1.2.14; EC 2.3.1.38","GO:0005829; GO:0070062; GO:0042587; GO:0005794; GO:0042470; GO:0016020; GO:0005886","GO:0004313; GO:0004314; GO:0047451; GO:0004316; GO:0004315; GO:0102131; GO:0102132; GO:0045296; GO:0008144; GO:0047117; GO:0004312; GO:0016295; GO:0070402; GO:0004320; GO:0016296; GO:0031177; GO:0042803; GO:0003723","GO:0006084; GO:0071353; GO:0090557; GO:0008611; GO:0006633; GO:0006631; GO:0046949; GO:0030879; GO:0030224; GO:0030223; GO:0001649; GO:0031325; GO:0045540"]
[829,412,"PN750","FBPase (FBP1)","S88","Fructose-1,6-bisphosphatase isoform 1",{"v":20963.678256426243,"d":"20964"},{"v":19822.456378663126,"d":"19822"},{"v":5686.598123228436,"d":"5687"},{"v":27.125955920856853,"d":"27"},{"v":9828.554913440692,"d":"9829"},{"v":47823.73928955343,"d":"47824"},"Kinexus","RpAb","MLK(pS)SFATC","Corresponds to amino acid residues M85 to C93.","S88 phosphorylation inhibits enzyme activity. Phosphorylation at this site in fructose-1,6-bisphosphatase isoform 1 has only been reported in a single mass spectrometry study. However, this human phosphosite is highly conserved in vertebrates and found in fish.","ULK1","P09467","P09467",3622,null,null,"NP_000498.2","Block3",6,9,"3, 11, 19, 27",{"$nulls":12},"X","Enzyme","GO:0005737; GO:0005829; GO:0070062; GO:0005634","GO:0016208; GO:0042132; GO:0042802; GO:0046872; GO:0048029; GO:0001191","GO:0035690; GO:0071286; GO:0016311; GO:0030388; GO:0006002; GO:0006000; GO:0006094; GO:0030308; GO:0045820; GO:0046580; GO:0000122; GO:0051289; GO:0006111; GO:0005986"]
[831,413,"PN699","FBPase (FBP1)","Y265","Fructose-1,6-bisphosphatase isoform 1",{"v":10514.004489254123,"d":"10514"},{"v":10495.210609959408,"d":"10495"},{"v":2534.5790201781288,"d":"2535"},{"v":24.106695244125152,"d":"24"},{"v":426.47443756671044,"d":"426"},{"v":20292.79492136318,"d":"20293"},"Kinexus","RpAb","IFL(pY)PAN(bA)C","Corresponds to amino acid residues I262 to N268.","The effect of Y265 phosphorylation is unclear. This is the major in vivo phosphorylation site in fructose-1,6-bisphosphatase isoform 1 (≥142 reports from high throughput mass spectrometry studies). The phosphosite is highly conserved in vertebrates and also found in yeast.",null,"P09467","P09467",3622,null,null,"NP_000498.2","Block3",6,10,"3, 11, 19, 27",{"$nulls":12},"X","Enzyme","GO:0005737; GO:0005829; GO:0070062; GO:0005634","GO:0016208; GO:0042132; GO:0042802; GO:0046872; GO:0048029; GO:0001191","GO:0035690; GO:0071286; GO:0016311; GO:0030388; GO:0006002; GO:0006000; GO:0006094; GO:0030308; GO:0045820; GO:0046580; GO:0000122; GO:0051289; GO:0006111; GO:0005986"]
[833,414,"PN700","FBPase 2 (FBP2)","Y216","Fructose-1,6-bisphosphatase isoform 2",{"v":7457.474581208779,"d":"7457"},{"v":7484.782960519673,"d":"7485"},{"v":1717.1020002302205,"d":"1717"},{"v":23.02524777700142,"d":"23"},{"v":3250.996467755064,"d":"3251"},{"v":15517.975416987447,"d":"15518"},"Kinexus","RpAb","NEG(pY)AKY(bA)C","Corresponds to amino acid residues N213 to Y219.","The effect of Y216 phosphorylation is unclear. This is the major in vivo phosphorylation site in fructose-1,6-bisphosphatase isoform 2 (≥240 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in sea urchin.",null,"O00757","O00757",16938,null,null,"NP_003828.2","Block3",6,11,"3, 11, 19, 27",{"$nulls":12},"X","Carbohydrate Metabolism - fructose and mannose; Carbohydrate Metabolism - glycolysis and gluconeogenesis; Phosphatase (non-protein); Carbohydrate Metabolism - pentose phosphate pathway; EC 3.1.3.11","GO:0030054; GO:0005829; GO:0070062; GO:0005654; GO:0005886; GO:0030018","GO:0042132; GO:0042802; GO:0046872","GO:0030388; GO:0006002; GO:0006000; GO:0006094; GO:0005986"]
[835,415,"PN751","FBPase 2 (FBP2)","Y259","Fructose-1,6-bisphosphatase isoform 2",{"v":6087.681895518269,"d":"6088"},{"v":6108.8272044846,"d":"6109"},{"v":1734.9548350584714,"d":"1735"},{"v":28.4994331969898,"d":"28"},{"v":291.3743935349698,"d":"291"},{"v":11015.918763056023,"d":"11016"},"Kinexus","RpAb","RTLV(pY)GGI(bA)C","Corresponds to amino acid residues T256 to I262.","The effect of Y259 phosphorylation is unclear. Phosphorylation at this site in fructose-1,6-bisphosphatase isoform 2 has only been reported in a single mass spectrometry study. However, this human phosphosite is highly conserved in vertebrates and found in yeast.",null,"O00757","O00757",16938,null,null,"NP_003828.2","Block3",6,12,"3, 11, 19, 27",{"$nulls":12},"X","Carbohydrate Metabolism - fructose and mannose; Carbohydrate Metabolism - glycolysis and gluconeogenesis; Phosphatase (non-protein); Carbohydrate Metabolism - pentose phosphate pathway; EC 3.1.3.11","GO:0030054; GO:0005829; GO:0070062; GO:0005654; GO:0005886; GO:0030018","GO:0042132; GO:0042802; GO:0046872","GO:0030388; GO:0006002; GO:0006000; GO:0006094; GO:0005986"]
[837,416,"PK630","Fer (TYK3)","Y402","Fer (fps/fes related) protein-tyrosine kinase",{"v":3811.3757570887506,"d":"3811"},{"v":3280.3429962330006,"d":"3280"},{"v":1644.9020619315252,"d":"1645"},{"v":43.157698604557254,"d":"43"},{"v":652.5021902218216,"d":"653"},{"v":10782.19707711952,"d":"10782"},"Kinexus","RpAb","VVN(pY)EED(bA)C","Corresponds to amino acid residues V399 to D405; In the region preceding the SH2 domain. ","The effect of Y402 phosphorylation is unclear. One of the two major in vivo phosphorylations sites in Fer (≥627 reports from high throughput mass spectrometry studies).",null,"P16591","P16591",847,"P16591","P16591","NP_005237.2","Block3",6,13,"3, 11, 19, 27","FER","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Fer",{"$nulls":6},"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; Fer family","GO:0005938; GO:0030054; GO:0042995; GO:0005737; GO:0005856; GO:0005829; GO:0031234; GO:0005634","GO:0005524; GO:0005154; GO:0008289; GO:0004715; GO:0008157; GO:0004713","GO:0031532; GO:0007155; GO:0044331; GO:0030154; GO:0008283; GO:0032869; GO:0036006; GO:0034614; GO:0006935; GO:0019221; GO:0050904; GO:0035426; GO:0038095; GO:0045087; GO:0038028; GO:0070102; GO:0035556; GO:0038109; GO:0000226; GO:0000278; GO:0033007; GO:0038083; GO:0018108; GO:0048008; GO:0030838; GO:0030335; GO:0008284; GO:0051092; GO:0046777; GO:0006468; GO:0042058; GO:0010762; GO:0010591; GO:0043304; GO:0001932; GO:0032496; GO:0036119; GO:0034446; GO:0007260"]
[839,417,"NK061","Fes","Pan-specific","Fes/Fps protein-tyrosine kinase",{"v":146.12075706772328,"d":"146"},{"v":127.91310105296418,"d":"128"},{"v":80.23575880076547,"d":"80"},{"v":54.9105824599432,"d":"55"},{"v":25.64503694210791,"d":"26"},{"v":507.56003425162544,"d":"508"},"External","RpAb","Epitope undefined.",{"$nulls":3},"P07332","P07332",826,"P07332","P07332","NP_001996","Block3",7,1,"3, 11, 19, 27","FES","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Fer",{"$nulls":6},"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; Fer family","GO:0005737; GO:0031410; GO:0005829; GO:0031234; GO:0005925; GO:0005794; GO:0015630","GO:0005524; GO:0034987; GO:0008017; GO:0004715; GO:0035091; GO:0004713","GO:0016477; GO:0008283; GO:0007098; GO:0006935; GO:0007173; GO:0045087; GO:0001578; GO:0007275; GO:0038083; GO:0018108; GO:2000251; GO:0031116; GO:0045639; GO:0010976; GO:0046777; GO:0006468; GO:0030155; GO:0045595; GO:2000145; GO:0042127; GO:0008360; GO:0043304; GO:0060627"]
[841,418,"PK632","Fes","Y713","Fes/Fps protein-tyrosine kinase",{"v":3112.183575658653,"d":"3112"},{"v":3040.9201120477073,"d":"3041"},{"v":985.4493637001389,"d":"985"},{"v":31.664242797489266,"d":"32"},{"v":208.52499572018496,"d":"209"},{"v":7604.0512766394095,"d":"7604"},"Kinexus","RpAb","DGV(pY)AAS(bA)C","Corresponds to amino acid residues D710 to S716; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y713 phosphorylation stimulates phosphotransferase activity, and regulates cell differentiation, cell growth and molecular association, including inducing interaction with Fes. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in Fes (≥120 reports from high throughput mass spectrometry studies).","Fes","P07332","P07332",826,"P07332","P07332","NP_001996","Block3",7,2,"3, 11, 19, 27","FES","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Fer",{"$nulls":6},"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; Fer family","GO:0005737; GO:0031410; GO:0005829; GO:0031234; GO:0005925; GO:0005794; GO:0015630","GO:0005524; GO:0034987; GO:0008017; GO:0004715; GO:0035091; GO:0004713","GO:0016477; GO:0008283; GO:0007098; GO:0006935; GO:0007173; GO:0045087; GO:0001578; GO:0007275; GO:0038083; GO:0018108; GO:2000251; GO:0031116; GO:0045639; GO:0010976; GO:0046777; GO:0006468; GO:0030155; GO:0045595; GO:2000145; GO:0042127; GO:0008360; GO:0043304; GO:0060627"]
[843,419,"PK633","Fes","Y713+S716","Fes/Fps protein-tyrosine kinase",{"v":6217.978209390627,"d":"6218"},{"v":6101.9859260365265,"d":"6102"},{"v":1660.934417593236,"d":"1661"},{"v":26.711808270489428,"d":"27"},{"v":2771.9691947986958,"d":"2772"},{"v":13036.976696605534,"d":"13037"},"Kinexus","RpAb","GV(pY)AA(pS)GGSL(bA)C","Corresponds to amino acid residues G711 to L720; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y713 and S716 phosphorylation stimulate phosphotransferase activity, and regulates cell differentiation, cell growth and molecular association, including inducing interaction with Fes. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. Y713 and S716 are major and minor in vivo phosphorylation sites in Fes (≥120 and ≥1 reports from high throughput mass spectrometry studies).","Y713: Fes. ","P07332","P07332",826,"P07332","P07332","NP_001996","Block3",7,3,"3, 11, 19, 27","FES","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Fer",{"$nulls":6},"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; Fer family","GO:0005737; GO:0031410; GO:0005829; GO:0031234; GO:0005925; GO:0005794; GO:0015630","GO:0005524; GO:0034987; GO:0008017; GO:0004715; GO:0035091; GO:0004713","GO:0016477; GO:0008283; GO:0007098; GO:0006935; GO:0007173; GO:0045087; GO:0001578; GO:0007275; GO:0038083; GO:0018108; GO:2000251; GO:0031116; GO:0045639; GO:0010976; GO:0046777; GO:0006468; GO:0030155; GO:0045595; GO:2000145; GO:0042127; GO:0008360; GO:0043304; GO:0060627"]
[845,420,"NK062-3","FGFR1","Pan-specific","Fibroblast growth factor receptor-tyrosine kinase 1; Basic fibroblast growth factor receptor 1",{"v":7434.929526983109,"d":"7435"},{"v":7383.398727248656,"d":"7383"},{"v":1742.2650658259581,"d":"1742"},{"v":23.43351150139175,"d":"23"},{"v":605.874849380501,"d":"606"},{"v":14165.26600183286,"d":"14165"},"Kinexus","RpAb","CRHPAQLANGGLKRR","Corresponds to amino acid residues R809 to R822; C-terminus.",null,null,"P11362","P11362",599,"P11362","P11362","NP_075598.2","Block3",7,4,"3, 11, 19, 27","FGFR1","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","FGFR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; FGFR family","GO:0031410; GO:0005829; GO:0005576; GO:0016021; GO:0005887; GO:0005730; GO:0005886; GO:0043235","GO:0016303; GO:0005524; GO:0005007; GO:0017134; GO:0008201; GO:0042802; GO:0046934; GO:0042803; GO:0004713; GO:0005088; GO:0090722","GO:0001525; GO:0060117; GO:0060445; GO:0048469; GO:0016477; GO:0002062; GO:0043009; GO:0030326; GO:0008543; GO:0035607; GO:0042472; GO:0001701; GO:0060484; GO:0000165; GO:0048762; GO:0030901; GO:0042474; GO:0090272; GO:0000122; GO:0001764; GO:0001759; GO:0042473; GO:0048339; GO:0018108; GO:0048015; GO:0043536; GO:0060045; GO:0008284; GO:2000546; GO:0043410; GO:0043406; GO:0090080; GO:0002053; GO:1903465; GO:0045666; GO:0010976; GO:2000830; GO:0014068; GO:0010518; GO:0010863; GO:0051897; GO:1905564; GO:0046777; GO:0006468; GO:0060665; GO:0045595; GO:2001239; GO:0048378; GO:0010966; GO:0007605; GO:0001501; GO:0048705; GO:0006351; GO:0001657; GO:0021847; GO:0070640"]
[847,421,"PK634","FGFR1","Y653+Y654","Fibroblast growth factor receptor-tyrosine kinase 1; Basic fibroblast growth factor receptor 1",{"v":8866.652099071991,"d":"8867"},{"v":8789.407357885466,"d":"8789"},{"v":1649.01073413173,"d":"1649"},{"v":18.597895978171064,"d":"19"},{"v":3743.3278075290045,"d":"3743"},{"v":13600.8647038637,"d":"13601"},"Kinexus","RpAb","HID(pY)(pY)KKT(bA)C","Corresponds to amino acid residues H650 to T657; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y653 and Y654 phosphorylation stimulate phosphotransferase activity. Phosphorylation regulates cell differentiation, cell growth, and cell motility. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. They correspond to the two major in vivo phosphorylation sites in FGFR1 (≥332 and ≥186 reports, respectively, from high throughput mass spectrometry studies).","Y653: FGFR1. Y654: FGFR1.","P11362","P11362",599,"P11362","P11362","NP_075598.2","Block3",7,5,"3, 11, 19, 27","FGFR1","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","FGFR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; FGFR family","GO:0031410; GO:0005829; GO:0005576; GO:0016021; GO:0005887; GO:0005730; GO:0005886; GO:0043235","GO:0016303; GO:0005524; GO:0005007; GO:0017134; GO:0008201; GO:0042802; GO:0046934; GO:0042803; GO:0004713; GO:0005088; GO:0090722","GO:0001525; GO:0060117; GO:0060445; GO:0048469; GO:0016477; GO:0002062; GO:0043009; GO:0030326; GO:0008543; GO:0035607; GO:0042472; GO:0001701; GO:0060484; GO:0000165; GO:0048762; GO:0030901; GO:0042474; GO:0090272; GO:0000122; GO:0001764; GO:0001759; GO:0042473; GO:0048339; GO:0018108; GO:0048015; GO:0043536; GO:0060045; GO:0008284; GO:2000546; GO:0043410; GO:0043406; GO:0090080; GO:0002053; GO:1903465; GO:0045666; GO:0010976; GO:2000830; GO:0014068; GO:0010518; GO:0010863; GO:0051897; GO:1905564; GO:0046777; GO:0006468; GO:0060665; GO:0045595; GO:2001239; GO:0048378; GO:0010966; GO:0007605; GO:0001501; GO:0048705; GO:0006351; GO:0001657; GO:0021847; GO:0070640"]
[849,422,"NK063-4","FGFR2 (BEK)","Pan-specific","Fibroblast growth factor receptor-tyrosine kinase 2 (BEK)",{"v":8195.234938476658,"d":"8195"},{"v":8128.744966697266,"d":"8129"},{"v":1762.4211438019593,"d":"1762"},{"v":21.505437696818007,"d":"22"},{"v":3313.6882983974697,"d":"3314"},{"v":14007.195348059346,"d":"14007"},"Kinexus","RpAb","CGDVEFVCKVYSDAQ","Corresponds to amino acid residues G272 to Q285.",null,null,"P21802","P21802",1262,"P21802","P21802","NP_000132.3","Block3",7,6,"3, 11, 19, 27","FGFR2","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","FGFR",{"$nulls":6},"EC 2.7.10.1; Receptor tyrosine kinase; TK group; FGFR family","GO:0005938; GO:0009986; GO:0005737; GO:0031410; GO:0060076; GO:0005576; GO:0005794; GO:0016021; GO:0005887; GO:0043231; GO:0016020; GO:0005654; GO:0005634; GO:0005886","GO:0016303; GO:0005524; GO:0005007; GO:0017134; GO:0008201; GO:0042802; GO:0046934; GO:0042803; GO:0004713; GO:0005088","GO:0001525; GO:0009887; GO:0006915; GO:0007409; GO:0060348; GO:0030282; GO:0060349; GO:0060667; GO:0060670; GO:0060442; GO:0060445; GO:0048755; GO:0060449; GO:0007267; GO:0045165; GO:0071300; GO:0071560; GO:0048565; GO:0048701; GO:0048557; GO:0048568; GO:0048562; GO:0009880; GO:0003416; GO:0048730; GO:0030855; GO:0060664; GO:0001837; GO:0008543; GO:0035603; GO:0060595; GO:0035602; GO:0035607; GO:0035604; GO:0022612; GO:0031069; GO:0042472; GO:0001701; GO:0032808; GO:0060601; GO:0060174; GO:0048286; GO:0060484; GO:0030324; GO:0060463; GO:0060615; GO:0000165; GO:0003149; GO:0048762; GO:0060915; GO:0060916; GO:0048333; GO:0030901; GO:0016331; GO:0035264; GO:0050680; GO:0000122; GO:0042476; GO:0021769; GO:0035265; GO:0030916; GO:0003148; GO:0018108; GO:0090263; GO:0060045; GO:0045787; GO:0051781; GO:0008284; GO:0050679; GO:0060501; GO:0070374; GO:0043410; GO:0002053; GO:0010518; GO:0051897; GO:0048661; GO:0045944; GO:0030177; GO:0009791; GO:0060527; GO:0060523; GO:0060512; GO:0046777; GO:0021860; GO:0060687; GO:0010453; GO:0070372; GO:0040036; GO:0060688; GO:0040014; GO:0045667; GO:0033688; GO:0008589; GO:0051150; GO:0048608; GO:0045471; GO:0032496; GO:0048705; GO:0060529; GO:0001657; GO:0055010; GO:0021847; GO:0042060"]
[851,423,"NK063-2","FGFR2 (BEK)","Pan-specific","Fibroblast growth factor receptor-tyrosine kinase 2 (BEK)",{"v":12028.526977370579,"d":"12029"},{"v":11902.996026500074,"d":"11903"},{"v":2081.2630605035,"d":"2081"},{"v":17.302725964858432,"d":"17"},{"v":5863.028428186585,"d":"5863"},{"v":18239.709681894503,"d":"18240"},"Kinexus","RpAb","CLPQYPHINGSVKT","Corresponds to amino acid residues C808 to T821; C-terminus.",null,null,"P21802","P21802",1262,"P21802","P21802","NP_000132.3","Block3",7,7,"3, 11, 19, 27","FGFR2","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","FGFR",{"$nulls":6},"EC 2.7.10.1; Receptor tyrosine kinase; TK group; FGFR family","GO:0005938; GO:0009986; GO:0005737; GO:0031410; GO:0060076; GO:0005576; GO:0005794; GO:0016021; GO:0005887; GO:0043231; GO:0016020; GO:0005654; GO:0005634; GO:0005886","GO:0016303; GO:0005524; GO:0005007; GO:0017134; GO:0008201; GO:0042802; GO:0046934; GO:0042803; GO:0004713; GO:0005088","GO:0001525; GO:0009887; GO:0006915; GO:0007409; GO:0060348; GO:0030282; GO:0060349; GO:0060667; GO:0060670; GO:0060442; GO:0060445; GO:0048755; GO:0060449; GO:0007267; GO:0045165; GO:0071300; GO:0071560; GO:0048565; GO:0048701; GO:0048557; GO:0048568; GO:0048562; GO:0009880; GO:0003416; GO:0048730; GO:0030855; GO:0060664; GO:0001837; GO:0008543; GO:0035603; GO:0060595; GO:0035602; GO:0035607; GO:0035604; GO:0022612; GO:0031069; GO:0042472; GO:0001701; GO:0032808; GO:0060601; GO:0060174; GO:0048286; GO:0060484; GO:0030324; GO:0060463; GO:0060615; GO:0000165; GO:0003149; GO:0048762; GO:0060915; GO:0060916; GO:0048333; GO:0030901; GO:0016331; GO:0035264; GO:0050680; GO:0000122; GO:0042476; GO:0021769; GO:0035265; GO:0030916; GO:0003148; GO:0018108; GO:0090263; GO:0060045; GO:0045787; GO:0051781; GO:0008284; GO:0050679; GO:0060501; GO:0070374; GO:0043410; GO:0002053; GO:0010518; GO:0051897; GO:0048661; GO:0045944; GO:0030177; GO:0009791; GO:0060527; GO:0060523; GO:0060512; GO:0046777; GO:0021860; GO:0060687; GO:0010453; GO:0070372; GO:0040036; GO:0060688; GO:0040014; GO:0045667; GO:0033688; GO:0008589; GO:0051150; GO:0048608; GO:0045471; GO:0032496; GO:0048705; GO:0060529; GO:0001657; GO:0055010; GO:0021847; GO:0042060"]
[853,424,"PK635","FGFR2 (BEK)","Y656+Y657","Fibroblast growth factor receptor-tyrosine kinase 2 (BEK)",{"v":9737.287312839962,"d":"9737"},{"v":9526.670437829927,"d":"9527"},{"v":1984.709111455348,"d":"1985"},{"v":20.38256700958422,"d":"20"},{"v":5010.588788071869,"d":"5011"},{"v":16203.833085016395,"d":"16204"},"Kinexus","RpAb","DID(pY)(pY)KK(bA)C","Corresponds to amino acid residues D653 to K659; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y656 and Y657 phosphorylation is predicted to be stimulatory for phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. They correspond to two of the major in vivo phosphorylation sites in FGFR2 (≥74 and ≥42 reports, respectively, from high throughput mass spectrometry studies).",null,"P21802","P21802",1262,"P21802","P21802","NP_000132.3","Block3",7,8,"3, 11, 19, 27","FGFR2","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","FGFR",{"$nulls":6},"EC 2.7.10.1; Receptor tyrosine kinase; TK group; FGFR family","GO:0005938; GO:0009986; GO:0005737; GO:0031410; GO:0060076; GO:0005576; GO:0005794; GO:0016021; GO:0005887; GO:0043231; GO:0016020; GO:0005654; GO:0005634; GO:0005886","GO:0016303; GO:0005524; GO:0005007; GO:0017134; GO:0008201; GO:0042802; GO:0046934; GO:0042803; GO:0004713; GO:0005088","GO:0001525; GO:0009887; GO:0006915; GO:0007409; GO:0060348; GO:0030282; GO:0060349; GO:0060667; GO:0060670; GO:0060442; GO:0060445; GO:0048755; GO:0060449; GO:0007267; GO:0045165; GO:0071300; GO:0071560; GO:0048565; GO:0048701; GO:0048557; GO:0048568; GO:0048562; GO:0009880; GO:0003416; GO:0048730; GO:0030855; GO:0060664; GO:0001837; GO:0008543; GO:0035603; GO:0060595; GO:0035602; GO:0035607; GO:0035604; GO:0022612; GO:0031069; GO:0042472; GO:0001701; GO:0032808; GO:0060601; GO:0060174; GO:0048286; GO:0060484; GO:0030324; GO:0060463; GO:0060615; GO:0000165; GO:0003149; GO:0048762; GO:0060915; GO:0060916; GO:0048333; GO:0030901; GO:0016331; GO:0035264; GO:0050680; GO:0000122; GO:0042476; GO:0021769; GO:0035265; GO:0030916; GO:0003148; GO:0018108; GO:0090263; GO:0060045; GO:0045787; GO:0051781; GO:0008284; GO:0050679; GO:0060501; GO:0070374; GO:0043410; GO:0002053; GO:0010518; GO:0051897; GO:0048661; GO:0045944; GO:0030177; GO:0009791; GO:0060527; GO:0060523; GO:0060512; GO:0046777; GO:0021860; GO:0060687; GO:0010453; GO:0070372; GO:0040036; GO:0060688; GO:0040014; GO:0045667; GO:0033688; GO:0008589; GO:0051150; GO:0048608; GO:0045471; GO:0032496; GO:0048705; GO:0060529; GO:0001657; GO:0055010; GO:0021847; GO:0042060"]
[855,425,"NK236-2","FGFR3","Pan-specific","Fibroblast growth factor receptor 3",{"v":8463.130808190548,"d":"8463"},{"v":8259.709716262128,"d":"8260"},{"v":1923.881343730525,"d":"1924"},{"v":22.732501568670173,"d":"23"},{"v":4551.848843576697,"d":"4552"},{"v":14328.066372202917,"d":"14328"},"Kinexus","RpAb","CGSPTVHKISRFPLK","Corresponds to amino acid residues G407 to K420.",null,null,"P22607","P22607",1177,"P22607","P22607","NP_000133.1","Block3",7,9,"3, 11, 19, 27","FGFR3","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","FGFR",{"$nulls":6},"EC 2.7.10.1; Receptor tyrosine kinase; TK group; FGFR family","GO:0009986; GO:0005783; GO:0005576; GO:0005794; GO:0005887; GO:0005634; GO:0005886; GO:0030133","GO:0016303; GO:0005524; GO:0005007; GO:0017134; GO:0042802; GO:0046934; GO:0004713; GO:0005088","GO:0070977; GO:0030282; GO:0060349; GO:0007267; GO:0002062; GO:0035988; GO:0003416; GO:0001958; GO:1902178; GO:0008543; GO:0000165; GO:0048640; GO:0018108; GO:0008284; GO:0070374; GO:0043410; GO:0043552; GO:0010518; GO:0051897; GO:0042531; GO:0046777; GO:0001501"]
[857,426,"NK236-3","FGFR3","Pan-specific","Fibroblast growth factor receptor 3",{"v":5519.220228984303,"d":"5519"},{"v":5519.114812041094,"d":"5519"},{"v":1276.4658804275314,"d":"1276"},{"v":23.127648969761047,"d":"23"},{"v":1494.5328271522128,"d":"1495"},{"v":9859.734588904383,"d":"9860"},"Kinexus","RpAb","CADPKWELSRARLTLG","Corresponds to amino acid residues A461 to G475.",null,null,"P22607","P22607",1177,"P22607","P22607","NP_000133.1","Block3",7,10,"3, 11, 19, 27","FGFR3","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","FGFR",{"$nulls":6},"EC 2.7.10.1; Receptor tyrosine kinase; TK group; FGFR family","GO:0009986; GO:0005783; GO:0005576; GO:0005794; GO:0005887; GO:0005634; GO:0005886; GO:0030133","GO:0016303; GO:0005524; GO:0005007; GO:0017134; GO:0042802; GO:0046934; GO:0004713; GO:0005088","GO:0070977; GO:0030282; GO:0060349; GO:0007267; GO:0002062; GO:0035988; GO:0003416; GO:0001958; GO:1902178; GO:0008543; GO:0000165; GO:0048640; GO:0018108; GO:0008284; GO:0070374; GO:0043410; GO:0043552; GO:0010518; GO:0051897; GO:0042531; GO:0046777; GO:0001501"]
[859,427,"PK636","FGFR3","Y647+Y648","Fibroblast growth factor receptor 3",{"v":10396.532521442206,"d":"10397"},{"v":10391.992902368947,"d":"10392"},{"v":2142.8286388039187,"d":"2143"},{"v":20.610993467143654,"d":"21"},{"v":3210.022502279303,"d":"3210"},{"v":17310.765668140073,"d":"17311"},"Kinexus","RpAb","NLD(pY)(pY)KK(bA)C","Corresponds to amino acid residues N644 to K650; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y647 and Y648 phosphorylation is predicted to be stimulatory for phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. They correspond to two of the major in vivo phosphorylation sites in FGFR3 (≥48 and ≥18 reports, respectively, from high throughput mass spectrometry studies).","Y647: FGFR3. Y648: FGFR3.","P22607","P22607",1177,"P22607","P22607","NP_000133.1","Block3",7,11,"3, 11, 19, 27","FGFR3","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","FGFR",{"$nulls":6},"EC 2.7.10.1; Receptor tyrosine kinase; TK group; FGFR family","GO:0009986; GO:0005783; GO:0005576; GO:0005794; GO:0005887; GO:0005634; GO:0005886; GO:0030133","GO:0016303; GO:0005524; GO:0005007; GO:0017134; GO:0042802; GO:0046934; GO:0004713; GO:0005088","GO:0070977; GO:0030282; GO:0060349; GO:0007267; GO:0002062; GO:0035988; GO:0003416; GO:0001958; GO:1902178; GO:0008543; GO:0000165; GO:0048640; GO:0018108; GO:0008284; GO:0070374; GO:0043410; GO:0043552; GO:0010518; GO:0051897; GO:0042531; GO:0046777; GO:0001501"]
[861,428,"PK637","FGFR3","Y647+Y648","Fibroblast growth factor receptor 3",{"v":7021.088972868334,"d":"7021"},{"v":6972.919290536868,"d":"6973"},{"v":1936.4830828227948,"d":"1936"},{"v":27.58095062327178,"d":"28"},{"v":2807.990282440789,"d":"2808"},{"v":13244.054450207437,"d":"13244"},"Kinexus","RpAb","NLD(pY)(pY)KKT(bA)C","Corresponds to amino acid residues N644 to T651; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y647 and Y648 phosphorylation is predicted to be stimulatory for phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. They correspond to two of the major in vivo phosphorylation sites in FGFR3.","Y647: FGFR3. Y648: FGFR3.","P22607","P22607",1177,"P22607","P22607","NP_000133.1","Block3",7,12,"3, 11, 19, 27","FGFR3","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","FGFR",{"$nulls":6},"EC 2.7.10.1; Receptor tyrosine kinase; TK group; FGFR family","GO:0009986; GO:0005783; GO:0005576; GO:0005794; GO:0005887; GO:0005634; GO:0005886; GO:0030133","GO:0016303; GO:0005524; GO:0005007; GO:0017134; GO:0042802; GO:0046934; GO:0004713; GO:0005088","GO:0070977; GO:0030282; GO:0060349; GO:0007267; GO:0002062; GO:0035988; GO:0003416; GO:0001958; GO:1902178; GO:0008543; GO:0000165; GO:0048640; GO:0018108; GO:0008284; GO:0070374; GO:0043410; GO:0043552; GO:0010518; GO:0051897; GO:0042531; GO:0046777; GO:0001501"]
[863,429,"NK239-3","FGFR4","Pan-specific","Fibroblast growth factor receptor 4",{"v":2864.367682601318,"d":"2864"},{"v":2717.5814706452334,"d":"2718"},{"v":1018.2303432624714,"d":"1018"},{"v":35.54817174650394,"d":"36"},{"v":230.29421491860663,"d":"230"},{"v":7446.84758429329,"d":"7447"},"Kinexus","RpAb","CSNDDEDPKSHRDPSN ","Corresponds to amino acid residues S124 to N138.",null,null,"P22455","P22455",1263,"P22455","P22455","NP_002002.3","Block3",7,13,"3, 11, 19, 27","FGFR4","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","FGFR",{"$nulls":6},"Protein-tyrosine kinase (receptor), TK group, FGFR family","GO:0005783; GO:0005768; GO:0005576; GO:0005794; GO:0005887; GO:0005886; GO:0030133","GO:0016303; GO:0005524; GO:0005007; GO:0017134; GO:0008201; GO:0046934; GO:0004713; GO:0005088","GO:0016477; GO:0042632; GO:0008543; GO:0042593; GO:0000165; GO:0018108; GO:0055062; GO:0043085; GO:0008284; GO:2000573; GO:0070374; GO:0010628; GO:0051897; GO:0045862; GO:0046777; GO:0070857; GO:0010715; GO:0019216"]
[865,430,"NK268-1","Fgr","Pan-specific","Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene",{"v":10398.377100137714,"d":"10398"},{"v":9871.32859503668,"d":"9871"},{"v":3190.9433153884024,"d":"3191"},{"v":30.68693590027758,"d":"31"},{"v":3054.2788921116457,"d":"3054"},{"v":21467.18228041455,"d":"21467"},"Kinexus","RpAb","CKKLEPVATAKEDAGLEGDF","Corresponds to amino acid residues C6 to F25; Post-N-terminus.",null,null,"P09769","P09769",1129,"P09769","P09769","NP_001036194.1","Block3",8,1,"3, 11, 19, 27","FGR","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; Src family","GO:0015629; GO:0016235; GO:0005829; GO:0070062; GO:0005576; GO:0031234; GO:0005743; GO:0005758; GO:0005886; GO:0032587; GO:0034774","GO:0005524; GO:0034988; GO:0034987; GO:0004715; GO:0001784; GO:0019901; GO:0004713","GO:0030154; GO:0016477; GO:0050830; GO:0038096; GO:0002768; GO:0045087; GO:0007229; GO:0043312; GO:0038083; GO:0018108; GO:0030335; GO:0050715; GO:0043306; GO:0043552; GO:0014068; GO:0046777; GO:0006468; GO:0042127; GO:0008360; GO:0045088; GO:0050764; GO:0045859; GO:0009615; GO:0007169"]
[867,431,"PK638","Fgr","Y208+Y209","Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene",{"v":7570.528906866809,"d":"7571"},{"v":7582.331173442687,"d":"7582"},{"v":1554.8688440196986,"d":"1555"},{"v":20.538444052559697,"d":"21"},{"v":2438.6199737956176,"d":"2439"},{"v":13452.734430988676,"d":"13453"},"Kinexus","RpAb","MGG(pY)(pY)ITT(bA)C","Corresponds to amino acid residues M205 to T212; In the SH2 domain. ","The effects of Y208 and Y209 phosphorylation are unclear. These are the major in vivo phosphorylation sites in Fgr (≥304 and ≥86 reports, respectively, from high throughput mass spectrometry studies).",null,"P09769","P09769",1129,"P09769","P09769","NP_001036194.1","Block3",8,2,"3, 11, 19, 27","FGR","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; Src family","GO:0015629; GO:0016235; GO:0005829; GO:0070062; GO:0005576; GO:0031234; GO:0005743; GO:0005758; GO:0005886; GO:0032587; GO:0034774","GO:0005524; GO:0034988; GO:0034987; GO:0004715; GO:0001784; GO:0019901; GO:0004713","GO:0030154; GO:0016477; GO:0050830; GO:0038096; GO:0002768; GO:0045087; GO:0007229; GO:0043312; GO:0038083; GO:0018108; GO:0030335; GO:0050715; GO:0043306; GO:0043552; GO:0014068; GO:0046777; GO:0006468; GO:0042127; GO:0008360; GO:0045088; GO:0050764; GO:0045859; GO:0009615; GO:0007169"]
[869,432,"PK639","Fgr","Y412","Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene",{"v":5266.238046164274,"d":"5266"},{"v":5076.835706122113,"d":"5077"},{"v":1486.4364286426555,"d":"1486"},{"v":28.225773609404513,"d":"28"},{"v":1682.2731354743653,"d":"1682"},{"v":12543.948623775505,"d":"12544"},"Kinexus","RpAb","DDE(pY)NPC(bA)C","Corresponds to amino acid residues D409 to C415; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y412 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in Fgr (≥203 reports from high throughput mass spectrometry studies).",null,"P09769","P09769",1129,"P09769","P09769","NP_001036194.1","Block3",8,3,"3, 11, 19, 27","FGR","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; Src family","GO:0015629; GO:0016235; GO:0005829; GO:0070062; GO:0005576; GO:0031234; GO:0005743; GO:0005758; GO:0005886; GO:0032587; GO:0034774","GO:0005524; GO:0034988; GO:0034987; GO:0004715; GO:0001784; GO:0019901; GO:0004713","GO:0030154; GO:0016477; GO:0050830; GO:0038096; GO:0002768; GO:0045087; GO:0007229; GO:0043312; GO:0038083; GO:0018108; GO:0030335; GO:0050715; GO:0043306; GO:0043552; GO:0014068; GO:0046777; GO:0006468; GO:0042127; GO:0008360; GO:0045088; GO:0050764; GO:0045859; GO:0009615; GO:0007169"]
[871,435,"NK240-1","Flt3 (STK1)","Pan-specific","Fetal liver fms-related tyrosine kinase 3; Receptor-type tyrosine-protein kinase FLT3",{"v":8957.516454761459,"d":"8958"},{"v":8482.892174414123,"d":"8483"},{"v":2976.5686692366185,"d":"2977"},{"v":33.22984316321734,"d":"33"},{"v":1901.5422135373715,"d":"1902"},{"v":23431.71309867044,"d":"23432"},"Kinexus","RpAb","CVLINHKNNDSSVGKS","Corresponds to amino acid residues C35 to S50.",null,null,"P36888","P36888",600,"P36888","P36888","NP_004110.2","Block3",8,6,"3, 11, 19, 27","FLT3","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; PDGFR family","GO:0005829; GO:0005783; GO:0005788; GO:0005887; GO:0005634; GO:0005886; GO:0032991","GO:0016303; GO:0005524; GO:0004896; GO:0035259; GO:0044877; GO:0042803; GO:0043621; GO:0005088; GO:0004714; GO:0005021","GO:0031100; GO:0030183; GO:0071345; GO:0071385; GO:0035726; GO:0019221; GO:0097028; GO:0030097; GO:0001776; GO:0046651; GO:0000165; GO:0002318; GO:0018108; GO:0008284; GO:0043410; GO:0043406; GO:0043552; GO:0014068; GO:0042531; GO:0002328; GO:0046777; GO:0042981; GO:0010243; GO:0007169"]
[873,436,"NK240-2","Flt3 (STK1)","Pan-specific","Fetal liver fms-related tyrosine kinase 3; Receptor-type tyrosine-protein kinase FLT3",{"v":3000.8794490298624,"d":"3001"},{"v":2837.5765211626776,"d":"2838"},{"v":1159.593829110679,"d":"1160"},{"v":38.64179980590549,"d":"39"},{"v":540.7532333290974,"d":"541"},{"v":7444.749571438082,"d":"7445"},"Kinexus","RpAb","CKHPSQSALVTIVEKG","Corresponds to amino acid residues K334 to G348.",null,null,"P36888","P36888",600,"P36888","P36888","NP_004110.2","Block3",8,7,"3, 11, 19, 27","FLT3","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; PDGFR family","GO:0005829; GO:0005783; GO:0005788; GO:0005887; GO:0005634; GO:0005886; GO:0032991","GO:0016303; GO:0005524; GO:0004896; GO:0035259; GO:0044877; GO:0042803; GO:0043621; GO:0005088; GO:0004714; GO:0005021","GO:0031100; GO:0030183; GO:0071345; GO:0071385; GO:0035726; GO:0019221; GO:0097028; GO:0030097; GO:0001776; GO:0046651; GO:0000165; GO:0002318; GO:0018108; GO:0008284; GO:0043410; GO:0043406; GO:0043552; GO:0014068; GO:0042531; GO:0002328; GO:0046777; GO:0042981; GO:0010243; GO:0007169"]
[875,437,"PK640","Flt3 (STK1)","Y842","Fetal liver fms-related tyrosine kinase 3; Receptor-type tyrosine-protein kinase FLT3",{"v":82.14636884503878,"d":"82"},{"v":71.23904011411858,"d":"71"},{"v":46.60789952080313,"d":"47"},{"v":56.73762599138673,"d":"57"},{"v":11.566440124791825,"d":"12"},{"v":278.66513768258665,"d":"279"},"Kinexus","RpAb","DSN(pY)VVR(bA)C","Corresponds to amino acid residues D839 to R845; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y842 phosphorylation has been reported to inhibits phosphotransferase activity and regulate cell growth, inhibit apoptosis and alter conformation. However, this phosphosite is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII.This is one of the major in vivo phosphorylation sites in Flt3.","Flt3","P36888","P36888",600,"P36888","P36888","NP_004110.2","Block3",8,8,"3, 11, 19, 27","FLT3","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; PDGFR family","GO:0005829; GO:0005783; GO:0005788; GO:0005887; GO:0005634; GO:0005886; GO:0032991","GO:0016303; GO:0005524; GO:0004896; GO:0035259; GO:0044877; GO:0042803; GO:0043621; GO:0005088; GO:0004714; GO:0005021","GO:0031100; GO:0030183; GO:0071345; GO:0071385; GO:0035726; GO:0019221; GO:0097028; GO:0030097; GO:0001776; GO:0046651; GO:0000165; GO:0002318; GO:0018108; GO:0008284; GO:0043410; GO:0043406; GO:0043552; GO:0014068; GO:0042531; GO:0002328; GO:0046777; GO:0042981; GO:0010243; GO:0007169"]
[877,438,"NN044","Fos","Pan-specific","Fos-c FBJ murine osteosarcoma oncoprotein-related transcription factor",{"v":982.6162448645123,"d":"983"},{"v":921.0885496035645,"d":"921"},{"v":405.1375076034921,"d":"405"},{"v":41.23049152920878,"d":"41"},{"v":239.88224139091568,"d":"240"},{"v":2474.8262474360654,"d":"2475"},"External","RpAb","Epitope undefined.",{"$nulls":3},"P01100","P01100",1285,null,"P01100","NP_005243","Block3",8,9,"3, 11, 19, 27",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005829; GO:0005783; GO:0016020; GO:0043005; GO:0005654; GO:0005634; GO:0032993; GO:0035976","GO:0003682; GO:0003700; GO:0046982; GO:0001102; GO:0000979; GO:0000978; GO:0000981; GO:0070412; GO:0001077; GO:0008134; GO:0044212","GO:0007568; GO:0071276; GO:0071277; GO:0031668; GO:0032870; GO:0034614; GO:0001661; GO:0019221; GO:0006306; GO:0038095; GO:0007565; GO:0006954; GO:0007399; GO:1901216; GO:0045672; GO:1902895; GO:0045893; GO:0045944; GO:0051090; GO:0006357; GO:0051591; GO:0009409; GO:0051412; GO:0009629; GO:0035902; GO:0009416; GO:0032496; GO:0035994; GO:0032570; GO:0009636; GO:0035914; GO:0030431; GO:0060395; GO:0006366; GO:0007179"]
[879,439,"PN033","Fos","T232","Proto-oncogene c-Fos",{"v":829.7947648360831,"d":"830"},{"v":362.15374345895276,"d":"362"},{"v":3601.576090797301,"d":"3602"},{"v":434.03215390359236,"d":"434"},{"v":9.0994455415828,"d":"9"},{"v":31725.037861313012,"d":"31725"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the T232 phosphosite.","T232 phosphorylation stimulates transcriptional activity. This is one of the major in vivo phosphorylation sites in Fos.","ERK1 (MAPK3); ERK2 (MAPK1); ERK5 (MAPK7); Frk","P01100","P01100",1285,null,"P01100","NP_005243","Block3",8,10,"3, 11, 19, 27",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005829; GO:0005783; GO:0016020; GO:0043005; GO:0005654; GO:0005634; GO:0032993; GO:0035976","GO:0003682; GO:0003700; GO:0046982; GO:0001102; GO:0000979; GO:0000978; GO:0000981; GO:0070412; GO:0001077; GO:0008134; GO:0044212","GO:0007568; GO:0071276; GO:0071277; GO:0031668; GO:0032870; GO:0034614; GO:0001661; GO:0019221; GO:0006306; GO:0038095; GO:0007565; GO:0006954; GO:0007399; GO:1901216; GO:0045672; GO:1902895; GO:0045893; GO:0045944; GO:0051090; GO:0006357; GO:0051591; GO:0009409; GO:0051412; GO:0009629; GO:0035902; GO:0009416; GO:0032496; GO:0035994; GO:0032570; GO:0009636; GO:0035914; GO:0030431; GO:0060395; GO:0006366; GO:0007179"]
[881,440,"PN588","Fos","T232","Proto-oncogene c-Fos",{"v":11904.246127040284,"d":"11904"},{"v":11547.258071393891,"d":"11547"},{"v":3627.0421559572455,"d":"3627"},{"v":30.46847416669657,"d":"30"},{"v":557.7506780107667,"d":"558"},{"v":26019.035117372085,"d":"26019"},"Kinexus","RpAb","PEVA(pT)PESE(bA)C","Corresponds to amino acid residues P228 to E236.","T232 phosphorylation stimulates transcriptional activity. This is one of the major in vivo phosphorylation sites in Fos.","ERK1 (MAPK3); ERK2 (MAPK1); ERK5 (MAPK7); Frk","P01100","P01100",1285,null,"P01100","NP_005243","Block3",8,11,"3, 11, 19, 27",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005829; GO:0005783; GO:0016020; GO:0043005; GO:0005654; GO:0005634; GO:0032993; GO:0035976","GO:0003682; GO:0003700; GO:0046982; GO:0001102; GO:0000979; GO:0000978; GO:0000981; GO:0070412; GO:0001077; GO:0008134; GO:0044212","GO:0007568; GO:0071276; GO:0071277; GO:0031668; GO:0032870; GO:0034614; GO:0001661; GO:0019221; GO:0006306; GO:0038095; GO:0007565; GO:0006954; GO:0007399; GO:1901216; GO:0045672; GO:1902895; GO:0045893; GO:0045944; GO:0051090; GO:0006357; GO:0051591; GO:0009409; GO:0051412; GO:0009629; GO:0035902; GO:0009416; GO:0032496; GO:0035994; GO:0032570; GO:0009636; GO:0035914; GO:0030431; GO:0060395; GO:0006366; GO:0007179"]
[883,441,"PN589","Fos","S362+S363","Proto-oncogene c-Fos",{"v":27030.87854717255,"d":"27031"},{"v":25547.574310092947,"d":"25548"},{"v":9447.139802734477,"d":"9447"},{"v":34.94943675710701,"d":"35"},{"v":11191.585234074271,"d":"11192"},{"v":67744.742559089,"d":"67745"},"Kinexus","RpAb","CAHRKG(pS)(pS)SNE","Corresponds to amino acid residues C254 to E366.","S362 and S363 phosphorylation stimulates transcriptional activity. These are two of the major in vivo phosphorylation sites in Fos.","S362: RSK1 (RPS6KA1); RSK2 (RPS6KA3). ","P01100","P01100",1285,null,"P01100","NP_005243","Block3",8,12,"3, 11, 19, 27",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005829; GO:0005783; GO:0016020; GO:0043005; GO:0005654; GO:0005634; GO:0032993; GO:0035976","GO:0003682; GO:0003700; GO:0046982; GO:0001102; GO:0000979; GO:0000978; GO:0000981; GO:0070412; GO:0001077; GO:0008134; GO:0044212","GO:0007568; GO:0071276; GO:0071277; GO:0031668; GO:0032870; GO:0034614; GO:0001661; GO:0019221; GO:0006306; GO:0038095; GO:0007565; GO:0006954; GO:0007399; GO:1901216; GO:0045672; GO:1902895; GO:0045893; GO:0045944; GO:0051090; GO:0006357; GO:0051591; GO:0009409; GO:0051412; GO:0009629; GO:0035902; GO:0009416; GO:0032496; GO:0035994; GO:0032570; GO:0009636; GO:0035914; GO:0030431; GO:0060395; GO:0006366; GO:0007179"]
[885,442,"PN590","FOXK1","S441+S445","Forkhead box protein K1",{"v":11012.020135642506,"d":"11012"},{"v":11049.974169618921,"d":"11050"},{"v":2802.556414174275,"d":"2803"},{"v":25.449975387379343,"d":"25"},{"v":1024.4345481211913,"d":"1024"},{"v":19700.81117304512,"d":"19701"},"Kinexus","RpAb","CL(pS)REG(pS)PIP","Corresponds to amino acid residues C439 to P448.","The effects of S441 and S445 phosphorylation are unclear. These are two of the major in vivo phosphorylation sites in FOXK1.",null,"P85037","P85037",8671,null,null,"NP_001032242.1","Block3",8,13,"3, 11, 19, 27",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005737; GO:0005654; GO:0005634","GO:0000977; GO:0000981","GO:0009653; GO:0030154; GO:0007517; GO:0045892; GO:0045893; GO:0016579; GO:0006351"]
[887,443,"PN591","FOXK2","S424+S428","Forkhead box protein K2",{"v":5863.91020631289,"d":"5864"},{"v":5882.133273092988,"d":"5882"},{"v":1340.1511483122376,"d":"1340"},{"v":22.854223566886745,"d":"23"},{"v":446.36951107053966,"d":"446"},{"v":10576.720819940212,"d":"10577"},"Kinexus","RpAb","FAQ(pS)APG(pS)PLS(bA)C","Corresponds to amino acid residues F421 to S431.","The effects of S424 phosphorylation is unclear. S428 phosphorylation regulates transcription and apoptosis, and stabilizes FOXK2. These are two of the major in vivo phosphorylation sites in FOXK2.","S424: ERK1 (MAPK3). ","Q01167","Q01167",16478,null,null,"NP_004505.2","Block3",9,1,"3, 11, 19, 27",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription factor","GO:0005654; GO:0005634","GO:0003700; GO:0000287; GO:0000978; GO:0000981; GO:0043565; GO:0001077","GO:0009653; GO:0030154; GO:0045944; GO:0016579; GO:0006355; GO:0006357"]
[889,444,"PN592","FOXM1","T611","Forkhead box protein M1",{"v":11316.251748001807,"d":"11316"},{"v":11391.398773266832,"d":"11391"},{"v":2331.625214171119,"d":"2332"},{"v":20.604218305613703,"d":"21"},{"v":3919.3152904548388,"d":"3919"},{"v":18544.16003013554,"d":"18544"},"Kinexus","RpAb","PISS(pT)PSK(bA)C","Corresponds to amino acid residues P607 to K614.","Phosphorylation of T611 facilitates binding histone acetyltransferase CREB binding protein (CBP) to the FoxM1 transcriptional activation domain. This is one of the major in vivo phosphorylation sites in FOXM1.","CDK1 (CDC2); CDK2; CDK4; CDK6","Q08050","Q08050",2992,null,"Q08050","NP_001230017.1","Block3",9,2,"3, 11, 19, 27",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005654; GO:0005634","GO:0003677; GO:0003700; GO:0019901; GO:0000977; GO:0000981; GO:0001227","GO:0009653; GO:0030154; GO:0006978; GO:0006281; GO:0000086; GO:0090344; GO:0032873; GO:0045892; GO:0000122; GO:0008284; GO:2000781; GO:0045893; GO:0045944; GO:0051726; GO:0071156; GO:0001558; GO:0042127; GO:0046578; GO:2000377; GO:0006351; GO:0006366"]
[891,433,"PN194","FOXO1A (FKHR)","S256","Forkhead box protein O1",{"v":404.759701267597,"d":"405"},{"v":362.26381979374344,"d":"362"},{"v":342.7116058786247,"d":"343"},{"v":84.67038709766447,"d":"85"},{"v":8.821236079919316,"d":"9"},{"v":1781.132312102369,"d":"1781"},"External","RpAb","AA(pS)MD","Corresponds to amino acid residues A254 to D258.","S256 phosphorylation Inhibits transcription by preventing nuclear import, regulates protein degradation and molecular association; phosphorylation induces interaction with 14-3-3 beta, SKP2, and inhibits interaction with DNA. This is one of the major in vivo phosphorylation sites in FOXO1A (≥42 reports from high throughput mass spectrometry studies).","Akt1 (PKBa); Akt3 (PKBg)","Q12778","Q12778",973,null,"Q12778","NP_002006.2","Block3",8,4,"3, 11, 19, 27",{"$nulls":3},"Transcription protein; Nuclear receptor co-regulator",{"$nulls":4},"X",{"$nulls":4},"Transcription factor; Nuclear receptor co-regulator","GO:0005737; GO:0005829; GO:0005739; GO:0005654; GO:0005634","GO:0008013; GO:0003682; GO:0051721; GO:0000981; GO:0043565; GO:0001078; GO:0001223; GO:0031625","GO:0009653; GO:0006915; GO:0006914; GO:0001568; GO:0030154; GO:0001678; GO:0070417; GO:0071549; GO:0006974; GO:0070301; GO:0071455; GO:0032869; GO:0071732; GO:0034599; GO:0009267; GO:0019221; GO:0070166; GO:0031018; GO:0097009; GO:0045444; GO:0008286; GO:0043066; GO:0090090; GO:1903243; GO:0045599; GO:0032873; GO:0045892; GO:0097150; GO:0043065; GO:0010508; GO:0045722; GO:0045732; GO:0045893; GO:0045944; GO:0006473; GO:0035947; GO:2000177; GO:2000377; GO:1902617; GO:0001659; GO:0006351"]
[893,434,"PN195","FOXO1A (FKHR)","S319","Forkhead box protein O1",{"v":263.4216597086705,"d":"263"},{"v":129.7055931127789,"d":"130"},{"v":557.880804125891,"d":"558"},{"v":211.78243457385992,"d":"212"},{"v":5.851288867761836,"d":"6"},{"v":4870.842681576762,"d":"4871"},"External","RpAb","TS(pS)NA","Corresponds to amino acid residues T317 to A321.","S319 phosphorylation increases rate of nuclear exclusion. It also creates the pSer–Xaa–Xaa–Ser recognition motif for CK1, allowing it to phosphorylate S322, induces interaction with IQGAP1, and regulates apoptosis and inhibits transcription. This is one of the major in vivo phosphorylation sites in FOXO1A (≥30 reports from high throughput mass spectrometry studies).","Akt1 (PKBa); Akt3 (PKBg); SGK1","Q12778","Q12778",973,null,"Q12778","NP_002006.2","Block3",8,5,"3, 11, 19, 27",{"$nulls":3},"Transcription protein; Nuclear receptor co-regulator",{"$nulls":4},"X",{"$nulls":4},"Transcription factor; Nuclear receptor co-regulator","GO:0005737; GO:0005829; GO:0005739; GO:0005654; GO:0005634","GO:0008013; GO:0003682; GO:0051721; GO:0000981; GO:0043565; GO:0001078; GO:0001223; GO:0031625","GO:0009653; GO:0006915; GO:0006914; GO:0001568; GO:0030154; GO:0001678; GO:0070417; GO:0071549; GO:0006974; GO:0070301; GO:0071455; GO:0032869; GO:0071732; GO:0034599; GO:0009267; GO:0019221; GO:0070166; GO:0031018; GO:0097009; GO:0045444; GO:0008286; GO:0043066; GO:0090090; GO:1903243; GO:0045599; GO:0032873; GO:0045892; GO:0097150; GO:0043065; GO:0010508; GO:0045722; GO:0045732; GO:0045893; GO:0045944; GO:0006473; GO:0035947; GO:2000177; GO:2000377; GO:1902617; GO:0001659; GO:0006351"]
[895,445,"PN593","FOXO1A (FKHR)","S256","Forkhead box protein O1",{"v":4528.0548061157815,"d":"4528"},{"v":4469.946747838669,"d":"4470"},{"v":1347.269104783042,"d":"1347"},{"v":29.7538162074223,"d":"30"},{"v":40.854263640112165,"d":"41"},{"v":11227.474179897305,"d":"11227"},"Kinexus","RpAb","RAA(pS)MDNNSC","Corresponds to amino acid residues R253 to S261.","S256 phosphorylation Inhibits transcription by preventing nuclear import, regulates protein degradation and molecular association; phosphorylation induces interaction with 14-3-3 beta, SKP2, and inhibits interaction with DNA. This is one of the major in vivo phosphorylation sites in FOXO1A (≥42 reports from high throughput mass spectrometry studies).","Akt1 (PKBa); Akt3 (PKBg)","Q12778","Q12778",973,null,"Q12778","NP_002006.2","Block3",9,3,"3, 11, 19, 27",{"$nulls":3},"Transcription protein; Nuclear receptor co-regulator",{"$nulls":4},"X",{"$nulls":4},"Transcription factor; Nuclear receptor co-regulator","GO:0005737; GO:0005829; GO:0005739; GO:0005654; GO:0005634","GO:0008013; GO:0003682; GO:0051721; GO:0000981; GO:0043565; GO:0001078; GO:0001223; GO:0031625","GO:0009653; GO:0006915; GO:0006914; GO:0001568; GO:0030154; GO:0001678; GO:0070417; GO:0071549; GO:0006974; GO:0070301; GO:0071455; GO:0032869; GO:0071732; GO:0034599; GO:0009267; GO:0019221; GO:0070166; GO:0031018; GO:0097009; GO:0045444; GO:0008286; GO:0043066; GO:0090090; GO:1903243; GO:0045599; GO:0032873; GO:0045892; GO:0097150; GO:0043065; GO:0010508; GO:0045722; GO:0045732; GO:0045893; GO:0045944; GO:0006473; GO:0035947; GO:2000177; GO:2000377; GO:1902617; GO:0001659; GO:0006351"]
[897,446,"PN594","FOXO1A (FKHR)","S319","Forkhead box protein O1",{"v":6778.467816302899,"d":"6778"},{"v":6819.988508408837,"d":"6820"},{"v":1481.6170578685721,"d":"1482"},{"v":21.857698495006993,"d":"22"},{"v":779.3299262756037,"d":"779"},{"v":11191.384266359692,"d":"11191"},"Kinexus","RpAb","PRTS(pS)NAS(bA)C","Corresponds to amino acid residues P315 to S322.","S319 phosphorylation increases rate of nuclear exclusion. It also creates the pSer–Xaa–Xaa–Ser recognition motif for CK1, allowing it to phosphorylate S322, induces interaction with IQGAP1, and regulates apoptosis and inhibits transcription. This is one of the major in vivo phosphorylation sites in FOXO1A (≥30 reports from high throughput mass spectrometry studies).","Akt1 (PKBa); Akt3 (PKBg); SGK1","Q12778","Q12778",973,null,"Q12778","NP_002006.2","Block3",9,4,"3, 11, 19, 27",{"$nulls":3},"Transcription protein; Nuclear receptor co-regulator",{"$nulls":4},"X",{"$nulls":4},"Transcription factor; Nuclear receptor co-regulator","GO:0005737; GO:0005829; GO:0005739; GO:0005654; GO:0005634","GO:0008013; GO:0003682; GO:0051721; GO:0000981; GO:0043565; GO:0001078; GO:0001223; GO:0031625","GO:0009653; GO:0006915; GO:0006914; GO:0001568; GO:0030154; GO:0001678; GO:0070417; GO:0071549; GO:0006974; GO:0070301; GO:0071455; GO:0032869; GO:0071732; GO:0034599; GO:0009267; GO:0019221; GO:0070166; GO:0031018; GO:0097009; GO:0045444; GO:0008286; GO:0043066; GO:0090090; GO:1903243; GO:0045599; GO:0032873; GO:0045892; GO:0097150; GO:0043065; GO:0010508; GO:0045722; GO:0045732; GO:0045893; GO:0045944; GO:0006473; GO:0035947; GO:2000177; GO:2000377; GO:1902617; GO:0001659; GO:0006351"]
[899,447,"PN595","FOXO1A (FKHR)","S329","Forkhead box protein O1",{"v":16901.288994779155,"d":"16901"},{"v":16200.788306440314,"d":"16201"},{"v":4371.07845669924,"d":"4371"},{"v":25.86239699261681,"d":"26"},{"v":7345.826113103678,"d":"7346"},{"v":33817.038796328154,"d":"33817"},"Kinexus","RpAb","C(bA)GRL(pS)PIMT","Corresponds to amino acid residues C326 to T333.","S329 phosphorylation inhibits transactivation by preventing nuclear import. This is one of the major in vivo phosphorylation sites in FOXO1A (≥29 reports from high throughput mass spectrometry studies).","DYRK1A; ERK2 (MAPK1); p38a MAPK (MAPK14)","Q12778","Q12778",973,null,"Q12778","NP_002006.2","Block3",9,5,"3, 11, 19, 27",{"$nulls":3},"Transcription protein; Nuclear receptor co-regulator",{"$nulls":4},"X",{"$nulls":4},"Transcription factor; Nuclear receptor co-regulator","GO:0005737; GO:0005829; GO:0005739; GO:0005654; GO:0005634","GO:0008013; GO:0003682; GO:0051721; GO:0000981; GO:0043565; GO:0001078; GO:0001223; GO:0031625","GO:0009653; GO:0006915; GO:0006914; GO:0001568; GO:0030154; GO:0001678; GO:0070417; GO:0071549; GO:0006974; GO:0070301; GO:0071455; GO:0032869; GO:0071732; GO:0034599; GO:0009267; GO:0019221; GO:0070166; GO:0031018; GO:0097009; GO:0045444; GO:0008286; GO:0043066; GO:0090090; GO:1903243; GO:0045599; GO:0032873; GO:0045892; GO:0097150; GO:0043065; GO:0010508; GO:0045722; GO:0045732; GO:0045893; GO:0045944; GO:0006473; GO:0035947; GO:2000177; GO:2000377; GO:1902617; GO:0001659; GO:0006351"]
[901,448,"PN596","FOXO3 (FKHRL1)","T32","Forkhead box protein O3",{"v":9132.543773960919,"d":"9133"},{"v":8875.047208504844,"d":"8875"},{"v":2243.2113296046878,"d":"2243"},{"v":24.562831398636416,"d":"25"},{"v":3946.9964173008484,"d":"3947"},{"v":21171.467662649997,"d":"21171"},"Kinexus","RpAb","PRSA(pT)WPLC","Corresponds to amino acid residues P28 to L35.","T32 phosphorylation inhibits transcriptional activity and induces 14-3-3-beta binding and nuclear exclusion. This is one of the major in vivo phosphorylation sites in FOXO3 (≥97 reports from high throughput mass spectrometry studies).","Akt1 (PKBa); Akt2 (PKBb); Pim1; SGK1","O43524","O43524",974,null,"O43524","NP_001446.1","Block3",9,6,"3, 11, 19, 27",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005737; GO:0005829; GO:0005759; GO:0005741; GO:0005654; GO:0005634; GO:0032991","GO:0008013; GO:0031490; GO:0003677; GO:0003700; GO:0034246; GO:0019901; GO:0000978; GO:0000981; GO:0043565; GO:0001228; GO:0001227; GO:0001221","GO:0007568; GO:0009653; GO:0001547; GO:0048854; GO:1904646; GO:0071386; GO:0071333; GO:0071456; GO:1990090; GO:0034599; GO:0019221; GO:0030330; GO:0097192; GO:0001544; GO:0006390; GO:0090090; GO:0030336; GO:0045665; GO:0000122; GO:0097150; GO:0001556; GO:0001542; GO:0043065; GO:2000353; GO:0045648; GO:1901300; GO:0043525; GO:1903428; GO:0045893; GO:0045944; GO:2000177; GO:0006357; GO:0006417; GO:0071548; GO:0031667; GO:1990785; GO:0033209"]
[903,449,"PN597","FOXO3 (FKHRL1)","S294","Forkhead box protein O3",{"v":18581.061122638068,"d":"18581"},{"v":17433.272942404434,"d":"17433"},{"v":6510.773040183651,"d":"6511"},{"v":35.0398343625882,"d":"35"},{"v":8071.685351597407,"d":"8072"},{"v":47428.49846516791,"d":"47428"},"Kinexus","RpAb","KWPG(pS)PTS(bA)C","Corresponds to amino acid residues K290 to S297.","S294 phosphorylation inhibits FOXO3 dependent transcription, causes degradation of FOXO3, and regulates cell growth, and molecular association, including inducing interaction with MDM2. This is one of the major in vivo phosphorylation sites in FOXO3 (≥77 reports from high throughput mass spectrometry studies).","ERK1 (MAPK3); ERK2 (MAPK1); p38a MAPK (MAPK14)","O43524","O43524",974,null,"O43524","NP_001446.1","Block3",9,7,"3, 11, 19, 27",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005737; GO:0005829; GO:0005759; GO:0005741; GO:0005654; GO:0005634; GO:0032991","GO:0008013; GO:0031490; GO:0003677; GO:0003700; GO:0034246; GO:0019901; GO:0000978; GO:0000981; GO:0043565; GO:0001228; GO:0001227; GO:0001221","GO:0007568; GO:0009653; GO:0001547; GO:0048854; GO:1904646; GO:0071386; GO:0071333; GO:0071456; GO:1990090; GO:0034599; GO:0019221; GO:0030330; GO:0097192; GO:0001544; GO:0006390; GO:0090090; GO:0030336; GO:0045665; GO:0000122; GO:0097150; GO:0001556; GO:0001542; GO:0043065; GO:2000353; GO:0045648; GO:1901300; GO:0043525; GO:1903428; GO:0045893; GO:0045944; GO:2000177; GO:0006357; GO:0006417; GO:0071548; GO:0031667; GO:1990785; GO:0033209"]
[905,450,"PN599","FRA1","S265","Fos-related antigen 1",{"v":8660.567324951293,"d":"8661"},{"v":8620.882636065995,"d":"8621"},{"v":1856.7911162254964,"d":"1857"},{"v":21.439601432068297,"d":"21"},{"v":3521.1757540187928,"d":"3521"},{"v":13860.408513270166,"d":"13860"},"Kinexus","RpAb","DPLG(pS)PTL(bA)C","Corresponds to amino acid residues D261 to L268.","S265 phosphorylation stabilizes protein. This is the major in vivo phosphorylation site in FRA1 (≥13 reports from high throughput mass spectrometry studies).",null,"P15407","P15407",20583,null,"P15407","NP_001287773.1","Block3",9,8,"3, 11, 19, 27",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Nucleus protein","GO:0005829; GO:0043005; GO:0005654; GO:0005634; GO:0042734","GO:0003700; GO:0000978; GO:0000981; GO:0001077","GO:0006968; GO:0031668; GO:0006935; GO:0007565; GO:0001701; GO:0007612; GO:0008285; GO:0060674; GO:0043065; GO:0045787; GO:0008284; GO:0051091; GO:2000144; GO:0061614; GO:0006357; GO:0051591; GO:0051412; GO:0034097; GO:0009629; GO:0042542; GO:0009612; GO:0032570; GO:0009615; GO:0006366; GO:0007296"]
[907,451,"NK269-1","Frk","Pan-specific","Fyn-related kinase; Tyrosine-protein kinase FRK",{"v":2916.6866135051123,"d":"2917"},{"v":2834.189462070839,"d":"2834"},{"v":876.132351010284,"d":"876"},{"v":30.038618031623106,"d":"30"},{"v":559.5887621939222,"d":"560"},{"v":5764.284865055332,"d":"5764"},"Kinexus","RpAb","LSTEADKSTVIENPGALC","Corresponds to amino acid residues L19 to L35; Post-N-terminus.",null,null,"P42685","P42685",1963,"P42685","P42685","NP_002022.1","Block3",9,9,"3, 11, 19, 27","FRK","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"Protein-tyrosine kinase, TK group, Src family","GO:0035578; GO:0005829; GO:0070062; GO:0005576; GO:0031234; GO:0005622; GO:0005634; GO:0035580","GO:0005524; GO:0004715; GO:0004713; GO:0005102","GO:0030154; GO:0016477; GO:0045087; GO:0008285; GO:0000122; GO:0043312; GO:0038083; GO:0006468; GO:0007169"]
[909,452,"NK269-2","Frk","Pan-specific","Fyn-related kinase; Tyrosine-protein kinase FRK",{"v":6882.713803240064,"d":"6883"},{"v":6803.12461569114,"d":"6803"},{"v":1465.1655685971962,"d":"1465"},{"v":21.287614311486607,"d":"21"},{"v":2224.22651898751,"d":"2224"},{"v":11572.769380212554,"d":"11573"},"Kinexus","RpAb","MSNISQRLWEYLEPYLGC","Corresponds to amino acid residues M1 to L16; N-terminus.",null,null,"P42685","P42685",1963,"P42685","P42685","NP_002022.1","Block3",9,10,"3, 11, 19, 27","FRK","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"Protein-tyrosine kinase, TK group, Src family","GO:0035578; GO:0005829; GO:0070062; GO:0005576; GO:0031234; GO:0005622; GO:0005634; GO:0035580","GO:0005524; GO:0004715; GO:0004713; GO:0005102","GO:0030154; GO:0016477; GO:0045087; GO:0008285; GO:0000122; GO:0043312; GO:0038083; GO:0006468; GO:0007169"]
[911,453,"PK641","Frk","Y387","Fyn-related kinase; Tyrosine-protein kinase FRK",{"v":14203.417504997193,"d":"14203"},{"v":14047.534826882827,"d":"14048"},{"v":3220.177863679858,"d":"3220"},{"v":22.671852478791827,"d":"23"},{"v":5560.964922077201,"d":"5561"},{"v":24244.28031233635,"d":"24244"},"Kinexus","RpAb","EDI(pY)ERH(bA)C","Corresponds to amino acid residues E384 to H390; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y387 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the less major in vivo phosphorylation sites in Frk (≥68 reports from high throughput mass spectrometry studies).","Frk","P42685","P42685",1963,"P42685","P42685","NP_002022.1","Block3",9,11,"3, 11, 19, 27","FRK","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"Protein-tyrosine kinase, TK group, Src family","GO:0035578; GO:0005829; GO:0070062; GO:0005576; GO:0031234; GO:0005622; GO:0005634; GO:0035580","GO:0005524; GO:0004715; GO:0004713; GO:0005102","GO:0030154; GO:0016477; GO:0045087; GO:0008285; GO:0000122; GO:0043312; GO:0038083; GO:0006468; GO:0007169"]
[913,454,"PK642","Frk","Y497","Fyn-related kinase; Tyrosine-protein kinase FRK",{"v":4738.748139247328,"d":"4739"},{"v":4604.422452116045,"d":"4604"},{"v":1532.6472951576347,"d":"1533"},{"v":32.342873056787326,"d":"32"},{"v":432.55840617275476,"d":"433"},{"v":11660.400495587877,"d":"11660"},"Kinexus","RpAb","DSS(pY)SDA(bA)C","Corresponds to amino acid residues D494 to A500; In the C-terminus of the kinase. ","By analogy with other Src family kinases, this is likely inhibitory to the phosphotransferase activity of Frk. It is one of the two major in vivo phosphorylation sites in Frk (≥508 reports from high throughput mass spectrometry studies).",null,"P42685","P42685",1963,"P42685","P42685","NP_002022.1","Block3",9,12,"3, 11, 19, 27","FRK","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"Protein-tyrosine kinase, TK group, Src family","GO:0035578; GO:0005829; GO:0070062; GO:0005576; GO:0031234; GO:0005622; GO:0005634; GO:0035580","GO:0005524; GO:0004715; GO:0004713; GO:0005102","GO:0030154; GO:0016477; GO:0045087; GO:0008285; GO:0000122; GO:0043312; GO:0038083; GO:0006468; GO:0007169"]
[915,455,"NN415-1","FRS2","Pan-specific","Fibroblast growth factor receptor substrate 2",{"v":524.2463889430993,"d":"524"},{"v":419.7199955741994,"d":"420"},{"v":314.7249097229158,"d":"315"},{"v":60.03377731555065,"d":"60"},{"v":43.640262129503974,"d":"44"},{"v":1866.9226240857924,"d":"1867"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 258-348 of human FRS2.",null,null,"Q8WU20","Q8WU20",1099,null,null,"NP_001036020.1","Block3",9,13,"3, 11, 19, 27",{"$nulls":11},"X",null,"Adapter/scaffold protein","GO:0005913; GO:0005829; GO:0005768; GO:0005887; GO:0016020; GO:0005886","GO:0016303; GO:0005104; GO:0005168; GO:0019211; GO:0046934; GO:0005088; GO:0005068","GO:0000187; GO:0000186; GO:0008595; GO:0007411; GO:0008543; GO:0030900; GO:0001702; GO:0007186; GO:0070307; GO:0000165; GO:2000726; GO:0007405; GO:0048011; GO:0046619; GO:0001759; GO:0051897; GO:0060527; GO:0042981; GO:0050678; GO:0070372; GO:0007185; GO:0003281"]
[917,456,"PN146","FRS2","Y349","Fibroblast growth factor receptor substrate 2",{"v":105.246875233006,"d":"105"},{"v":74.03211225498157,"d":"74"},{"v":114.46852691278977,"d":"114"},{"v":108.76192443658586,"d":"109"},{"v":5.336288562887242,"d":"5"},{"v":726.0091468629782,"d":"726"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the Y349 phosphosite.","The effect of Y349 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in FRS2 (≥96 reports from high throughput mass spectrometry studies).",null,"Q8WU20","Q8WU20",1099,null,null,"NP_001036020.1","Block3",10,1,"3, 11, 19, 27",{"$nulls":11},"X",null,"Adapter/scaffold protein","GO:0005913; GO:0005829; GO:0005768; GO:0005887; GO:0016020; GO:0005886","GO:0016303; GO:0005104; GO:0005168; GO:0019211; GO:0046934; GO:0005088; GO:0005068","GO:0000187; GO:0000186; GO:0008595; GO:0007411; GO:0008543; GO:0030900; GO:0001702; GO:0007186; GO:0070307; GO:0000165; GO:2000726; GO:0007405; GO:0048011; GO:0046619; GO:0001759; GO:0051897; GO:0060527; GO:0042981; GO:0050678; GO:0070372; GO:0007185; GO:0003281"]
[919,457,"PK643","Fused (STK36)","S159","Serine/threonine-protein kinase 36",{"v":3440.9702604688414,"d":"3441"},{"v":3174.23370030932,"d":"3174"},{"v":1215.557392725836,"d":"1216"},{"v":35.326006931551134,"d":"35"},{"v":684.6673489358596,"d":"685"},{"v":8552.38751508577,"d":"8552"},"Kinexus","RpAb","VLT(pS)IKG(bA)C","Corresponds to amino acid residues V156 to G162; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S159 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the minor in vivo phosphorylation sites in Fused (≥1 reports from high throughput mass spectrometry studies).",null,"Q9NRP7","Q9NRP7",697,"Q9NRP7","Q9NRP7","NP_056505.2","Block3",10,2,"3, 11, 19, 27","Fused","X","PYK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","ULK",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; ULK family","GO:0005737; GO:0005829; GO:0005634","GO:0005524; GO:0046872; GO:0004674; GO:0008134","GO:0007420; GO:0060271; GO:0003351; GO:0007228; GO:0045880; GO:0009791; GO:0006468; GO:0051090"]
[921,458,"NK065","Fyn","Pan-specific","Fyn proto-oncogene-encoded protein-tyrosine kinase",{"v":412.7405288206479,"d":"413"},{"v":341.8908737669543,"d":"342"},{"v":319.84769328712747,"d":"320"},{"v":77.4936481767493,"d":"77"},{"v":47.41654009535203,"d":"47"},{"v":2104.4515172264933,"d":"2104"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 85-206 of human Fyn.",null,null,"P06241","P06241",601,"P06241","P06241","NP_002028","Block3",10,3,"3, 11, 19, 27","FYN","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; Src family","GO:0005884; GO:0044297; GO:0005829; GO:0030425; GO:0005768; GO:0031234; GO:0097386; GO:0098978; GO:0045121; GO:0005739; GO:0005634; GO:0097038; GO:0048471; GO:0005886; GO:0014069; GO:0099092; GO:0098685","GO:0043014; GO:0005524; GO:0042609; GO:0042610; GO:0097718; GO:0019899; GO:0046875; GO:0070851; GO:0042802; GO:0044325; GO:0046872; GO:0004715; GO:0051428; GO:0043548; GO:0046934; GO:0004713; GO:0005088; GO:0048156; GO:0042608; GO:0031802","GO:0050798; GO:0002250; GO:0007411; GO:0007596; GO:0006816; GO:0030154; GO:0016477; GO:1905430; GO:1905232; GO:0071375; GO:0036120; GO:0071560; GO:0007417; GO:0019221; GO:0048813; GO:0097062; GO:0050966; GO:0048013; GO:0038096; GO:0007631; GO:0030900; GO:0003015; GO:0045087; GO:0035556; GO:0007612; GO:0050900; GO:0000165; GO:0050804; GO:1902951; GO:2001240; GO:0010629; GO:0010730; GO:0043524; GO:1903202; GO:0042177; GO:0031397; GO:0001764; GO:0038083; GO:0018108; GO:0030168; GO:2001056; GO:0043123; GO:1901216; GO:0010976; GO:1903997; GO:0014068; GO:0051897; GO:1905477; GO:1900182; GO:0090314; GO:0042531; GO:0006468; GO:0042981; GO:1905664; GO:0042127; GO:0008360; GO:0050690; GO:1900449; GO:0050730; GO:1904645; GO:0045471; GO:0042542; GO:0000304; GO:0002223; GO:0042110; GO:0031295; GO:0050852; GO:0007169; GO:0048010"]
[923,459,"NK065-2","Fyn","Pan-specific","Fyn proto-oncogene-encoded protein-tyrosine kinase",{"v":1167.2890351489882,"d":"1167"},{"v":1163.9067964922701,"d":"1164"},{"v":483.89931467487304,"d":"484"},{"v":41.454969600833266,"d":"41"},{"v":67.77927043228934,"d":"68"},{"v":2742.3033294829,"d":"2742"},"Kinexus","RpAb","CKDKEATKLTEERDGSLNQS","Corresponds to amino acid residues C6 to S25; Near N-terminus.",null,null,"P06241","P06241",601,"P06241","P06241","NP_002028","Block3",10,4,"3, 11, 19, 27","FYN","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; Src family","GO:0005884; GO:0044297; GO:0005829; GO:0030425; GO:0005768; GO:0031234; GO:0097386; GO:0098978; GO:0045121; GO:0005739; GO:0005634; GO:0097038; GO:0048471; GO:0005886; GO:0014069; GO:0099092; GO:0098685","GO:0043014; GO:0005524; GO:0042609; GO:0042610; GO:0097718; GO:0019899; GO:0046875; GO:0070851; GO:0042802; GO:0044325; GO:0046872; GO:0004715; GO:0051428; GO:0043548; GO:0046934; GO:0004713; GO:0005088; GO:0048156; GO:0042608; GO:0031802","GO:0050798; GO:0002250; GO:0007411; GO:0007596; GO:0006816; GO:0030154; GO:0016477; GO:1905430; GO:1905232; GO:0071375; GO:0036120; GO:0071560; GO:0007417; GO:0019221; GO:0048813; GO:0097062; GO:0050966; GO:0048013; GO:0038096; GO:0007631; GO:0030900; GO:0003015; GO:0045087; GO:0035556; GO:0007612; GO:0050900; GO:0000165; GO:0050804; GO:1902951; GO:2001240; GO:0010629; GO:0010730; GO:0043524; GO:1903202; GO:0042177; GO:0031397; GO:0001764; GO:0038083; GO:0018108; GO:0030168; GO:2001056; GO:0043123; GO:1901216; GO:0010976; GO:1903997; GO:0014068; GO:0051897; GO:1905477; GO:1900182; GO:0090314; GO:0042531; GO:0006468; GO:0042981; GO:1905664; GO:0042127; GO:0008360; GO:0050690; GO:1900449; GO:0050730; GO:1904645; GO:0045471; GO:0042542; GO:0000304; GO:0002223; GO:0042110; GO:0031295; GO:0050852; GO:0007169; GO:0048010"]
[925,460,"PK186","Fyn","T12","Fyn proto-oncogene-encoded protein-tyrosine kinase",{"v":520.4056773787413,"d":"520"},{"v":416.6867300220804,"d":"417"},{"v":519.8864904383674,"d":"520"},{"v":99.90023418979804,"d":"100"},{"v":63.61318422821277,"d":"64"},{"v":6316.746466091312,"d":"6317"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the T12 phosphosite.","The effect of T12 phosphorylation is unclear. This is one of the minor in vivo phosphorylation sites in Fyn (≥2 reports from high throughput mass spectrometry studies).",null,"P06241","P06241",601,"P06241","P06241","NP_002028","Block3",10,5,"3, 11, 19, 27","FYN","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; Src family","GO:0005884; GO:0044297; GO:0005829; GO:0030425; GO:0005768; GO:0031234; GO:0097386; GO:0098978; GO:0045121; GO:0005739; GO:0005634; GO:0097038; GO:0048471; GO:0005886; GO:0014069; GO:0099092; GO:0098685","GO:0043014; GO:0005524; GO:0042609; GO:0042610; GO:0097718; GO:0019899; GO:0046875; GO:0070851; GO:0042802; GO:0044325; GO:0046872; GO:0004715; GO:0051428; GO:0043548; GO:0046934; GO:0004713; GO:0005088; GO:0048156; GO:0042608; GO:0031802","GO:0050798; GO:0002250; GO:0007411; GO:0007596; GO:0006816; GO:0030154; GO:0016477; GO:1905430; GO:1905232; GO:0071375; GO:0036120; GO:0071560; GO:0007417; GO:0019221; GO:0048813; GO:0097062; GO:0050966; GO:0048013; GO:0038096; GO:0007631; GO:0030900; GO:0003015; GO:0045087; GO:0035556; GO:0007612; GO:0050900; GO:0000165; GO:0050804; GO:1902951; GO:2001240; GO:0010629; GO:0010730; GO:0043524; GO:1903202; GO:0042177; GO:0031397; GO:0001764; GO:0038083; GO:0018108; GO:0030168; GO:2001056; GO:0043123; GO:1901216; GO:0010976; GO:1903997; GO:0014068; GO:0051897; GO:1905477; GO:1900182; GO:0090314; GO:0042531; GO:0006468; GO:0042981; GO:1905664; GO:0042127; GO:0008360; GO:0050690; GO:1900449; GO:0050730; GO:1904645; GO:0045471; GO:0042542; GO:0000304; GO:0002223; GO:0042110; GO:0031295; GO:0050852; GO:0007169; GO:0048010"]
[927,461,"PK644","Fyn","Y213+Y214","Fyn proto-oncogene-encoded protein-tyrosine kinase",{"v":1414.3847249893097,"d":"1414"},{"v":1328.830216516606,"d":"1329"},{"v":626.0250737007051,"d":"626"},{"v":44.26130052453986,"d":"44"},{"v":125.17502011494614,"d":"125"},{"v":4079.3256655868518,"d":"4079"},"Kinexus","RpAb","NGG(pY)(pY)ITT(bA)C","Corresponds to amino acid residues N210 to T217; In the SH2 domain. ","The effects of Y213 and Y214 phosphorylation are unclear. These are the major in vivo phosphorylation sites in Fyn (≥1800 and ≥671 reports, respectively, by mass spectrometry).",null,"P06241","P06241",601,"P06241","P06241","NP_002028","Block3",10,6,"3, 11, 19, 27","FYN","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; Src family","GO:0005884; GO:0044297; GO:0005829; GO:0030425; GO:0005768; GO:0031234; GO:0097386; GO:0098978; GO:0045121; GO:0005739; GO:0005634; GO:0097038; GO:0048471; GO:0005886; GO:0014069; GO:0099092; GO:0098685","GO:0043014; GO:0005524; GO:0042609; GO:0042610; GO:0097718; GO:0019899; GO:0046875; GO:0070851; GO:0042802; GO:0044325; GO:0046872; GO:0004715; GO:0051428; GO:0043548; GO:0046934; GO:0004713; GO:0005088; GO:0048156; GO:0042608; GO:0031802","GO:0050798; GO:0002250; GO:0007411; GO:0007596; GO:0006816; GO:0030154; GO:0016477; GO:1905430; GO:1905232; GO:0071375; GO:0036120; GO:0071560; GO:0007417; GO:0019221; GO:0048813; GO:0097062; GO:0050966; GO:0048013; GO:0038096; GO:0007631; GO:0030900; GO:0003015; GO:0045087; GO:0035556; GO:0007612; GO:0050900; GO:0000165; GO:0050804; GO:1902951; GO:2001240; GO:0010629; GO:0010730; GO:0043524; GO:1903202; GO:0042177; GO:0031397; GO:0001764; GO:0038083; GO:0018108; GO:0030168; GO:2001056; GO:0043123; GO:1901216; GO:0010976; GO:1903997; GO:0014068; GO:0051897; GO:1905477; GO:1900182; GO:0090314; GO:0042531; GO:0006468; GO:0042981; GO:1905664; GO:0042127; GO:0008360; GO:0050690; GO:1900449; GO:0050730; GO:1904645; GO:0045471; GO:0042542; GO:0000304; GO:0002223; GO:0042110; GO:0031295; GO:0050852; GO:0007169; GO:0048010"]
[929,462,"PK881","Fyn","Y420","Fyn proto-oncogene-encoded protein-tyrosine kinase",{"v":12732.649734851713,"d":"12733"},{"v":12678.710237710178,"d":"12679"},{"v":3004.7612998166896,"d":"3005"},{"v":23.598868753862597,"d":"24"},{"v":4763.787178665937,"d":"4764"},{"v":23203.974314814885,"d":"23204"},"Kinexus","RpAb","DNE(pY)TAR(bA)C","Corresponds to amino acid residues D417 to R423. It is located near the C-terminus of the kinase.","Phosphorylation of Y420 - Expected to be stimulatory to Fyn's phosphotransferase activity. Phosphoryation induces binding of the phosphatase STEP. Y420 is the most commonly reported site for phosphorylation of Fyn by mass spectrometry (≥3090 reports).","Fyn","P06241","P06241",601,"P06241","P06241","NP_002028","Block3",10,7,"3, 11, 19, 27","FYN","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; Src family","GO:0005884; GO:0044297; GO:0005829; GO:0030425; GO:0005768; GO:0031234; GO:0097386; GO:0098978; GO:0045121; GO:0005739; GO:0005634; GO:0097038; GO:0048471; GO:0005886; GO:0014069; GO:0099092; GO:0098685","GO:0043014; GO:0005524; GO:0042609; GO:0042610; GO:0097718; GO:0019899; GO:0046875; GO:0070851; GO:0042802; GO:0044325; GO:0046872; GO:0004715; GO:0051428; GO:0043548; GO:0046934; GO:0004713; GO:0005088; GO:0048156; GO:0042608; GO:0031802","GO:0050798; GO:0002250; GO:0007411; GO:0007596; GO:0006816; GO:0030154; GO:0016477; GO:1905430; GO:1905232; GO:0071375; GO:0036120; GO:0071560; GO:0007417; GO:0019221; GO:0048813; GO:0097062; GO:0050966; GO:0048013; GO:0038096; GO:0007631; GO:0030900; GO:0003015; GO:0045087; GO:0035556; GO:0007612; GO:0050900; GO:0000165; GO:0050804; GO:1902951; GO:2001240; GO:0010629; GO:0010730; GO:0043524; GO:1903202; GO:0042177; GO:0031397; GO:0001764; GO:0038083; GO:0018108; GO:0030168; GO:2001056; GO:0043123; GO:1901216; GO:0010976; GO:1903997; GO:0014068; GO:0051897; GO:1905477; GO:1900182; GO:0090314; GO:0042531; GO:0006468; GO:0042981; GO:1905664; GO:0042127; GO:0008360; GO:0050690; GO:1900449; GO:0050730; GO:1904645; GO:0045471; GO:0042542; GO:0000304; GO:0002223; GO:0042110; GO:0031295; GO:0050852; GO:0007169; GO:0048010"]
[931,463,"PK645","Fyn","Y531","Fyn proto-oncogene-encoded protein-tyrosine kinase",{"v":1794.9453009605943,"d":"1795"},{"v":1767.956602514916,"d":"1768"},{"v":693.401845542527,"d":"693"},{"v":38.63080647479573,"d":"39"},{"v":175.4627210388477,"d":"175"},{"v":3722.9510559545183,"d":"3723"},"Kinexus","RpAb","EPQ(pY)QPG(bA)C","Corresponds to amino acid residues E528 to G534; In the C-terminus of the kinase.","Y531 phosphorylation inhibits phosphotransferase activity of Fyn. This is the major in vivo phosphorylation sites in Fyn (≥1037 reports from high throughput mass spectrometry studies).","CSK","P06241","P06241",601,"P06241","P06241","NP_002028","Block3",10,8,"3, 11, 19, 27","FYN","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; Src family","GO:0005884; GO:0044297; GO:0005829; GO:0030425; GO:0005768; GO:0031234; GO:0097386; GO:0098978; GO:0045121; GO:0005739; GO:0005634; GO:0097038; GO:0048471; GO:0005886; GO:0014069; GO:0099092; GO:0098685","GO:0043014; GO:0005524; GO:0042609; GO:0042610; GO:0097718; GO:0019899; GO:0046875; GO:0070851; GO:0042802; GO:0044325; GO:0046872; GO:0004715; GO:0051428; GO:0043548; GO:0046934; GO:0004713; GO:0005088; GO:0048156; GO:0042608; GO:0031802","GO:0050798; GO:0002250; GO:0007411; GO:0007596; GO:0006816; GO:0030154; GO:0016477; GO:1905430; GO:1905232; GO:0071375; GO:0036120; GO:0071560; GO:0007417; GO:0019221; GO:0048813; GO:0097062; GO:0050966; GO:0048013; GO:0038096; GO:0007631; GO:0030900; GO:0003015; GO:0045087; GO:0035556; GO:0007612; GO:0050900; GO:0000165; GO:0050804; GO:1902951; GO:2001240; GO:0010629; GO:0010730; GO:0043524; GO:1903202; GO:0042177; GO:0031397; GO:0001764; GO:0038083; GO:0018108; GO:0030168; GO:2001056; GO:0043123; GO:1901216; GO:0010976; GO:1903997; GO:0014068; GO:0051897; GO:1905477; GO:1900182; GO:0090314; GO:0042531; GO:0006468; GO:0042981; GO:1905664; GO:0042127; GO:0008360; GO:0050690; GO:1900449; GO:0050730; GO:1904645; GO:0045471; GO:0042542; GO:0000304; GO:0002223; GO:0042110; GO:0031295; GO:0050852; GO:0007169; GO:0048010"]
[933,464,"PN515","G6PD","Y401","Glucose-6-phosphate 1-dehydrogenase",{"v":7395.818530539888,"d":"7396"},{"v":7379.827546008111,"d":"7380"},{"v":1380.1053703165628,"d":"1380"},{"v":18.660617004292778,"d":"19"},{"v":3283.05385677221,"d":"3283"},{"v":12040.291555510721,"d":"12040"},"Kinexus","RpAb","EAV(pY)TKM(bA)C","Corresponds to amino acid residues E398 to M404; In the G6PD_C domain. ","The effect of Y401 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in G6PD (≥571 reports from high throughput mass spectrometry studies).",null,"P11413","P11413",4120,null,null,"NP_001035810.1","Block3",10,9,"3, 11, 19, 27",{"$nulls":3},"Enzyme - Glycolysis",{"$nulls":8},"X","EC 1.1.1.49; Other Amino Acids Metabolism - glutathione; Oxidoreductase; Carbohydrate Metabolism - pentose phosphate pathway; Cell development/differentiation","GO:0005737; GO:0009898; GO:0005829; GO:0070062; GO:0016020; GO:0005634","GO:0004345; GO:0005536; GO:0042802; GO:0050661; GO:0042803","GO:0034599; GO:0006695; GO:0043249; GO:0051156; GO:0006006; GO:0006749; GO:0006629; GO:0006740; GO:0006739; GO:0061052; GO:0010734; GO:2000378; GO:0055114; GO:0019322; GO:0006098; GO:0009051; GO:1904879; GO:0043523; GO:0045471; GO:0032094; GO:0010041; GO:0014070; GO:0046390; GO:0021762"]
[935,465,"PN701","G6PD","Y503+Y507","Glucose-6-phosphate 1-dehydrogenase",{"v":11138.298353313985,"d":"11138"},{"v":11172.962228329568,"d":"11173"},{"v":2043.8876165797824,"d":"2044"},{"v":18.350088601924217,"d":"18"},{"v":5245.8416139272285,"d":"5246"},{"v":17212.95035413626,"d":"17213"},"Kinexus","RpAb","GFQ(pY)EGT(pY)KWV(bA)C","Corresponds to amino acid residues G500 to V510.","The effects of Y503 and Y507 phosphorylation are unclear. These are two of the major in vivo phosphorylation sites in G6PD (≥961 and >771 reports, respectively, by mass spectrometry). These phosphosites are highly conserved in vertebrates and also found in the nematode worm.","Y507: Src","P11413","P11413",4120,null,null,"NP_001035810.1","Block3",10,10,"3, 11, 19, 27",{"$nulls":3},"Enzyme - Glycolysis",{"$nulls":8},"X","EC 1.1.1.49; Other Amino Acids Metabolism - glutathione; Oxidoreductase; Carbohydrate Metabolism - pentose phosphate pathway; Cell development/differentiation","GO:0005737; GO:0009898; GO:0005829; GO:0070062; GO:0016020; GO:0005634","GO:0004345; GO:0005536; GO:0042802; GO:0050661; GO:0042803","GO:0034599; GO:0006695; GO:0043249; GO:0051156; GO:0006006; GO:0006749; GO:0006629; GO:0006740; GO:0006739; GO:0061052; GO:0010734; GO:2000378; GO:0055114; GO:0019322; GO:0006098; GO:0009051; GO:1904879; GO:0043523; GO:0045471; GO:0032094; GO:0010041; GO:0014070; GO:0046390; GO:0021762"]
[937,466,"PN516","Gab1","Y406","GRB2-associated-binding protein 1",{"v":2012.8565552771204,"d":"2013"},{"v":1886.5219416595176,"d":"1887"},{"v":1126.1318535851485,"d":"1126"},{"v":55.9469501506583,"d":"56"},{"v":50.2057932671538,"d":"50"},{"v":6422.010969541452,"d":"6422"},"Kinexus","RpAb","QDC(pY)DIP(bA)C","Corresponds to amino acid residues Q403 to P409; In the mid-region of the protein. ","The effect of Y406 phosphorylation is unclear. This is the second major in vivo phosphorylation site of Gab1 (≥1095 reports from high throughput mass spectrometry studies).","EGFR; Met","Q13480","Q13480",976,null,"Q13480","NP_002030.2","Block3",10,11,"3, 11, 19, 27",{"$nulls":11},"X",null,"Adapter/scaffold protein","GO:0005829","GO:0016303; GO:0046934; GO:0005070","GO:0031532; GO:0001525; GO:0007411; GO:0008283; GO:0090668; GO:0007173; GO:0038128; GO:0008286; GO:0045766; GO:0038089; GO:0051897; GO:0035728; GO:0038084"]
[939,467,"PN192","Gab1","Y627","GRB2-associated-binding protein 1",{"v":167.2706344601251,"d":"167"},{"v":111.54281493208319,"d":"112"},{"v":173.68438492054455,"d":"174"},{"v":103.83435531354333,"d":"104"},{"v":11.130195458192368,"d":"11"},{"v":1335.786109017748,"d":"1336"},"External","RpAb","VE(pY)LD","Corresponds to amino acid residues V625 to D629.","Y627 phosphorylation induces interaction with PIK3R1 and SHP-2. This is one of the major in vivo phosphorylation sites in Gab1.","EGFR; InsR; Met","Q13480","Q13480",976,null,"Q13480","NP_002030.2","Block3",10,12,"3, 11, 19, 27",{"$nulls":11},"X",null,"Adapter/scaffold protein","GO:0005829","GO:0016303; GO:0046934; GO:0005070","GO:0031532; GO:0001525; GO:0007411; GO:0008283; GO:0090668; GO:0007173; GO:0038128; GO:0008286; GO:0045766; GO:0038089; GO:0051897; GO:0035728; GO:0038084"]
[941,468,"PN196","GATA1","S142","Transcription factor GATA-1",{"v":513.3207919722166,"d":"513"},{"v":438.53160817013935,"d":"439"},{"v":363.748463487712,"d":"364"},{"v":70.86182153077482,"d":"71"},{"v":12.501266937766008,"d":"13"},{"v":2328.859742389987,"d":"2329"},"External","RpAb","RL(pS)PD","Corresponds to amino acid residues R140 to D144.","The effect of S142 phosphorylation is unclear. Phosphorylation pf this site in GATA1 has not been reported in high throughput mass spectrometry studies.",null,"P15976","P15976",4966,null,"P15976","NP_002040.1","Block3",10,13,"3, 11, 19, 27",{"$nulls":8},"X",{"$nulls":4},"Transcription protein","GO:0005654; GO:0005634; GO:0032993; GO:0017053; GO:0005667","GO:0070742; GO:0031490; GO:0003677; GO:0008301; GO:0003700; GO:0002039; GO:0000980; GO:0000978; GO:0000977; GO:0000981; GO:0001085; GO:0043565; GO:0001077; GO:0001228; GO:0001078; GO:0000976; GO:0008270","GO:0030221; GO:0007596; GO:0007267; GO:0097067; GO:0097028; GO:0035162; GO:0030222; GO:0035854; GO:0048821; GO:0030218; GO:0048873; GO:0001701; GO:0008584; GO:0030219; GO:0043066; GO:0030502; GO:0008285; GO:2001240; GO:0000122; GO:2000678; GO:0070527; GO:0030220; GO:0045648; GO:0033690; GO:0050731; GO:0045893; GO:0045944; GO:0010724; GO:0010559; GO:1902036; GO:0045652; GO:0010725; GO:0071733; GO:0006366"]
[943,469,"PN702","GATA3","S369","Trans-acting T-cell-specific transcription factor GATA-3",{"v":1522.4715518615026,"d":"1522"},{"v":1430.0656601181886,"d":"1430"},{"v":684.1574738679215,"d":"684"},{"v":44.93729114553324,"d":"45"},{"v":330.89801938979497,"d":"331"},{"v":3949.7754938767057,"d":"3950"},"Kinexus","RpAb","RKM(pS)SKSC","Corresponds to amino acid residues R366 to S372.","The effect of S369 phosphorylation is unclear. This is the major in vivo phosphorylation site in GATA3 (≥28 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in the fruit fly.","Pim","P23771","P23771",7977,null,"P23771","NP_001002295.1","Block3",11,1,"3, 11, 19, 27",{"$nulls":3},"DNA-binding; Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0000790; GO:0005654; GO:0005634; GO:0005667","GO:0003682; GO:0003677; GO:0003700; GO:0070888; GO:0001158; GO:0071837; GO:0005134; GO:0046983; GO:0000987; GO:0000978; GO:0000977; GO:0000981; GO:0001085; GO:0001077; GO:0001228; GO:0001078; GO:0003713; GO:0008134; GO:0044212; GO:0000976; GO:0008270","GO:0048646; GO:0009653; GO:0003180; GO:0007411; GO:0007596; GO:0061290; GO:0003215; GO:0001709; GO:0048469; GO:0071773; GO:0035457; GO:0071353; GO:0071356; GO:0006338; GO:0090102; GO:0019221; GO:0006952; GO:0048589; GO:0043583; GO:0035162; GO:0030218; GO:0006959; GO:0045087; GO:0042472; GO:0072643; GO:0072602; GO:0001701; GO:0001822; GO:0002088; GO:0072676; GO:0008584; GO:0060374; GO:0060231; GO:0001823; GO:0045786; GO:2000146; GO:0008285; GO:2000607; GO:1901536; GO:2000352; GO:0045599; GO:2000703; GO:2000734; GO:0050728; GO:0032689; GO:0032703; GO:0033600; GO:0045892; GO:0072179; GO:0072178; GO:0001764; GO:0042421; GO:0071599; GO:0060017; GO:0035898; GO:0060037; GO:0014065; GO:0010595; GO:0071442; GO:2000617; GO:2000667; GO:0032753; GO:2000664; GO:0051897; GO:0009967; GO:0045582; GO:2000553; GO:2000611; GO:0045893; GO:0045944; GO:2000679; GO:0072107; GO:0009791; GO:0002572; GO:0016579; GO:0043370; GO:2000683; GO:0042035; GO:2000114; GO:1902036; GO:0061085; GO:0051569; GO:0072182; GO:0043523; GO:0010975; GO:0043627; GO:0045471; GO:0010332; GO:0009615; GO:0007165; GO:0048485; GO:0050852; GO:0045064; GO:0045061; GO:0048538; GO:0031929; GO:0006366; GO:0001806; GO:0060676; GO:0035799; GO:0060065; GO:0003281"]
[945,470,"PN225","GATA4","S262","Transcription factor GATA-4",{"v":467.1306615675085,"d":"467"},{"v":396.45209793675525,"d":"396"},{"v":372.7190545120843,"d":"373"},{"v":79.78903659660969,"d":"80"},{"v":68.99725647325582,"d":"69"},{"v":4908.364410819833,"d":"4908"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S262 phosphosite.","S262 phosphorylation induces activity and transcription. This is one of the major in vivo phosphorylation sites in GATA4.","PKACa (PRKACA); PKG1 (PRKG1)","P43694","P43694",3382,null,null,"NP_001295022.1","Block3",11,2,"3, 11, 19, 27",{"$nulls":8},"X",{"$nulls":4},"Transcription protein","GO:0016604; GO:0005654; GO:0005634; GO:0090575","GO:0033613; GO:0003682; GO:0070410; GO:0003677; GO:0001158; GO:0051525; GO:0019901; GO:0000977; GO:0000981; GO:0001085; GO:0043565; GO:0001228; GO:0003713; GO:0008134; GO:0044212; GO:0008270","GO:0003180; GO:0060413; GO:0003289; GO:0003290; GO:0007596; GO:0003215; GO:0003208; GO:0007267; GO:0061049; GO:0071333; GO:0048617; GO:0035054; GO:0003197; GO:0007492; GO:0001947; GO:0060575; GO:0008584; GO:0010507; GO:0045766; GO:0030513; GO:0051891; GO:0045893; GO:0045944; GO:0010575; GO:0086004; GO:0006355; GO:0042493; GO:0009612; GO:0033189; GO:0006366; GO:0060290; GO:0003281"]
[947,471,"PN600","GATAD2B","T120+S122","Transcriptional repressor p66-beta",{"v":16693.648783904966,"d":"16694"},{"v":16320.907173616988,"d":"16321"},{"v":4747.3390142086,"d":"4747"},{"v":28.437995046269965,"d":"28"},{"v":782.8865848690511,"d":"783"},{"v":34571.385146928966,"d":"34571"},"Kinexus","RpAb","CGRL(pT)P(pS)PDI","Corresponds to amino acid residues C117 to I125.","The effect of T120 and S122 phosphorylation are unclear. These are two of the major in vivo phosphorylation sites in GATAD2B (≥90 and ≥86 reports, respectively, from high throughput mass spectrometry studies).","S122: PRP4 (PRPF4B).","Q8WXI9","Q8WXI9",2969,null,null,"NP_065750.1","Block3",11,3,"3, 11, 19, 27",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0000790; GO:0016607; GO:0005654; GO:0032991","GO:0000981; GO:0043565; GO:0008270","GO:0043044; GO:0006351"]
[949,472,"NK066","GCK (MAP4K2)","Pan-specific","Germinal centre protein-serine kinase",{"v":964.2320515805595,"d":"964"},{"v":638.7847915335562,"d":"639"},{"v":2045.111199129118,"d":"2045"},{"v":212.0974091015531,"d":"212"},{"v":141.40651356971057,"d":"141"},{"v":18635.207808497777,"d":"18635"},"External","GpAb","Epitope undefined.",{"$nulls":3},"Q12851","Q12851",2489,"Q12851",null,"NP_004570","Block3",11,4,"3, 11, 19, 27","GCK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","KHS",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; STE domain target; STE</A> group; STE20 family; KHS subfamily","GO:0016323; GO:0005737; GO:0000139","GO:0005524; GO:0008349; GO:0031435; GO:0004674","GO:0007257; GO:0006955; GO:0045087; GO:0035556; GO:0007254; GO:0046330; GO:0006468; GO:0042981; GO:0007346; GO:0006903"]
[951,473,"PK646","GCK (MAP4K2)","S170","Germinal centre protein-serine kinase; Mitogen-activated protein kinase kinase kinase kinase 2",{"v":9322.965991167443,"d":"9323"},{"v":9608.429502212482,"d":"9608"},{"v":3018.626088124642,"d":"3019"},{"v":32.378387854085084,"d":"32"},{"v":172.30363092130054,"d":"172"},{"v":21170.685048629555,"d":"21171"},"Kinexus","RpAb","KRR(pS)FIG(bA)C","Corresponds to amino acid residues K167 to G173; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S170 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the less major in vivo phosphorylation sites in GCK (≥11 reports from high throughput mass spectrometry studies).",null,"Q12851","Q12851",2489,"Q12851",null,"NP_004570","Block3",11,5,"3, 11, 19, 27","GCK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","KHS",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; STE domain target; STE</A> group; STE20 family; KHS subfamily","GO:0016323; GO:0005737; GO:0000139","GO:0005524; GO:0008349; GO:0031435; GO:0004674","GO:0007257; GO:0006955; GO:0045087; GO:0035556; GO:0007254; GO:0046330; GO:0006468; GO:0042981; GO:0007346; GO:0006903"]
[953,474,"PK893","GCK","S411","Glucokinase",{"v":14059.834626524735,"d":"14060"},{"v":13932.344157177718,"d":"13932"},{"v":3504.7976118204065,"d":"3505"},{"v":24.927729983455084,"d":"25"},{"v":833.8394645314972,"d":"834"},{"v":23942.681453204037,"d":"23943"},"Kinexus","RpAb","GVDG(pS)VYK(bA)C","Corresponds to amino acid residues G407 to Y413.","S411 phosphorylation stimulates enzyme activity. This phosphorylation site in glucokinase is poorly detected by mass spectrometry (≥1 report by mass spectrometry). This human phosphosite is highly conserved in vertebrates and also found in yeast.",null,"P35557","P35557",24789,null,null,"NP_000153.1","Block3",11,6,"3, 11, 19, 27",{"$nulls":3},"Metabolite kinase","Protein-serine/threonine kinase",{"$nulls":7},"X",null,"GO:0005829; GO:0005739; GO:0005654","GO:0005524; GO:0004340; GO:0005536","GO:0070509; GO:0061621; GO:0001678; GO:0032869; GO:0044320; GO:0051594; GO:0051156; GO:0042593; GO:0006096; GO:0006739; GO:0045721; GO:0045725; GO:0032024; GO:0006110; GO:0050796; GO:0043266"]
[955,475,"PN752","GCLC","S5+S8","Glutamate--cysteine ligase catalytic subunit",{"v":4795.968955392042,"d":"4796"},{"v":4689.6114226131285,"d":"4690"},{"v":1302.4817978723472,"d":"1302"},{"v":27.157844639673595,"d":"27"},{"v":1590.4903586970363,"d":"1590"},{"v":8516.355309984556,"d":"8516"},"Kinexus","RpAb","GLL(pS)QG(pS)PLS(bA)C","Corresponds to amino acid residues G2 to S11; N-terminus.","The effects of S5 and S8 phosphorylation are unclear. These are two of the major in vivo phosphorylation sites in GCLC (≥12 and >10 reports, respectively, by mass spectrometry). These human phosphosites are highly conserved in vertebrates and also found in yeast.",null,"P48506","P48506",14667,null,null,"NP_001184044.1","Block3",11,7,"3, 11, 19, 27",{"$nulls":13},"Other Amino Acids Metabolism - glutathione; EC 6.3.2.2; Ligase","GO:0005829; GO:0017109","GO:0043531; GO:0005524; GO:0050662; GO:0016595; GO:0004357; GO:0000287; GO:0046982","GO:0007568; GO:0008637; GO:0045454; GO:0044344; GO:0071372; GO:0071333; GO:0035729; GO:0032869; GO:0071260; GO:0097069; GO:0006534; GO:0006536; GO:0006750; GO:0019852; GO:0043066; GO:2001237; GO:2000490; GO:0043524; GO:0031397; GO:0045892; GO:0032436; GO:0050880; GO:0051900; GO:0014823; GO:0046685; GO:0046686; GO:0009408; GO:0009725; GO:0044752; GO:0070555; GO:0051409; GO:0007584; GO:0006979; GO:0009410"]
[957,476,"PK877","GCN2 (EIF2AK4)","T667","Eukaryotic translation initiation factor 2-alpha kinase 4",{"v":13611.62339384078,"d":"13612"},{"v":13719.233429085809,"d":"13719"},{"v":4251.195557894191,"d":"4251"},{"v":31.232098001020542,"d":"31"},{"v":476.9862027858195,"d":"477"},{"v":25322.946739645282,"d":"25323"},"Kinexus","RpAb","CAGPG(pT)PPP","Corresponds to amino acid residues A663-P670. T667 is located in the Gap/Insert 4 (G/I4) region in the protein-serine/threonine kinase catalytic domain of GCN2. ","The effect of T667 phosphorylation is unknown. It appears to be the most commonly observed phosphosite in GCN2 from high throughput mass spectrometry studies (≥22 reports).",null,"Q9P2K8","Q9P2K8",1658,null,null,"NP_001013725.2","Block3",11,8,"3, 11, 19, 27","GCN2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase",{"$nulls":8},"Protein-serine kinase, Other group, PEK family, GCN2 subfamily","GO:0022626; GO:0005844","GO:0005524; GO:0004694; GO:0004674; GO:0000049","GO:0002250; GO:0007050; GO:0034198; GO:0070417; GO:1990253; GO:0034644; GO:0051607; GO:0000077; GO:0036492; GO:0039520; GO:0007612; GO:0007616; GO:0044828; GO:0032792; GO:0045665; GO:0045947; GO:0032057; GO:1990138; GO:0002821; GO:0002230; GO:1900273; GO:0071264; GO:0046777; GO:0006468; GO:0060733; GO:0060259; GO:0006446; GO:0010998; GO:0002286; GO:0019081"]
[959,477,"NN260-2","GFAP","Pan-specific","Glial fibrillary acidic protein",{"v":1887.4147430952164,"d":"1887"},{"v":1905.9848817457864,"d":"1906"},{"v":1081.2258976141693,"d":"1081"},{"v":57.286078831886265,"d":"57"},{"v":4.098336755608759,"d":"4"},{"v":5966.586646997798,"d":"5967"},"External","MmAb","Epitope undefined.",{"$nulls":3},"P14136","P14136",3398,null,null,"NP_002046","Block3",11,9,"3, 11, 19, 27",{"$nulls":13},"Cytoskeletal protein","GO:0097450; GO:0044297; GO:0005737; GO:0098574; GO:0005829; GO:0005882; GO:0043209","GO:0042802; GO:0005178; GO:0019900; GO:0005200","GO:0014002; GO:0060020; GO:0030198; GO:0045109; GO:0060291; GO:0010977; GO:0031102; GO:0010625; GO:1904714; GO:0051580; GO:0043254; GO:0009611"]
[961,478,"PN034","GFAP","S8","Glial fibrillary acidic protein",{"v":1169.2744238429198,"d":"1169"},{"v":981.5543680702636,"d":"982"},{"v":860.8321430966809,"d":"861"},{"v":73.6210529832238,"d":"74"},{"v":37.80470678806517,"d":"38"},{"v":4397.530627354643,"d":"4398"},"External","MmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the S8 phosphosite.","S8 phosphorylation induces interaction with fascin. Phosphorylation of this site in GFAP has not been reported from high throughput mass spectrometry studies.","PKACa (PRKACA); PKCa (PRKCA)","P14136","P14136",3398,null,null,"NP_002046","Block3",11,10,"3, 11, 19, 27",{"$nulls":13},"Cytoskeletal protein","GO:0097450; GO:0044297; GO:0005737; GO:0098574; GO:0005829; GO:0005882; GO:0043209","GO:0042802; GO:0005178; GO:0019900; GO:0005200","GO:0014002; GO:0060020; GO:0030198; GO:0045109; GO:0060291; GO:0010977; GO:0031102; GO:0010625; GO:1904714; GO:0051580; GO:0043254; GO:0009611"]
[963,479,"PN517","GIT1","Y545","ARF GTPase-activating protein GIT1",{"v":11463.424294762899,"d":"11463"},{"v":11320.53722603861,"d":"11321"},{"v":2676.459667023899,"d":"2676"},{"v":23.347819972489788,"d":"23"},{"v":3189.164099286318,"d":"3189"},{"v":21245.61566034179,"d":"21246"},"Kinexus","RpAb","DAI(pY)SVH(bA)C","Corresponds to amino acid residues D542 to H548; In the last third of the protein before the GIT1_C domain. ","Y545 phosphorylation inhibits interaction with His-5 and PXN and induces cell motility. This is the major in vivo phosphorylation site in GIT1 (≥749 reports from high throughput mass spectrometry studies).",null,"Q9Y2X7","Q9Y2X7",2645,null,null,"NP_054749.2","Block3",11,11,"3, 11, 19, 27",{"$nulls":13},"GTPase-activating protein for G protein","GO:0044305; GO:0005829; GO:0005925; GO:0016020","GO:0005096; GO:0046872; GO:0044877","GO:0048013; GO:0099171; GO:0032465; GO:0008277; GO:2000300"]
[965,480,"PN178","GluR1","S849","Glutamate receptor 1",{"v":1013.6544464152902,"d":"1014"},{"v":929.2258322194423,"d":"929"},{"v":698.3471184164422,"d":"698"},{"v":68.89400237784112,"d":"69"},{"v":13.908251407428274,"d":"14"},{"v":4311.965034307133,"d":"4312"},"External","RpAb","QQ(pS)IN","Corresponds to amino acid residues Q847 to N851.","S849 phosphorylation induces activity. This is one of the major in vivo phosphorylation sites in GluR1 (≥6 reports from high throughput mass spectrometry studies).","CaMK2a; PKACa (PRKACA); PKCa (PRKCA)","P42261","P42261",1661,null,null,"NP_000818.2","Block3",11,12,"3, 11, 19, 27",{"$nulls":13},"Channel, calcium; Channel, ligand-gated","GO:0032281; GO:0044308; GO:0030054; GO:0009986; GO:0030425; GO:0043197; GO:0032591; GO:0031901; GO:0030666; GO:0033116; GO:0005789; GO:0012507; GO:0098978; GO:0000139; GO:0099061; GO:0043025; GO:0044309; GO:0005886; GO:0014069; GO:0055037; GO:0055038; GO:0008021","GO:0004971; GO:0001540; GO:0005231; GO:0008066; GO:0099583; GO:0030165; GO:1904315","GO:0007268; GO:0048208; GO:0006888; GO:0007616; GO:0060292; GO:0031623; GO:0007165"]
[967,481,"PN226","GOLGA2 (GM130)","S25","Golgin subfamily A member 2",{"v":1041.2202701738288,"d":"1041"},{"v":950.7996761991446,"d":"951"},{"v":508.6552413461689,"d":"509"},{"v":48.85183816688954,"d":"49"},{"v":52.326933864080594,"d":"52"},{"v":2763.7438279390517,"d":"2764"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues that is supposed to encompass S25 phosphosite of mouse Glur!, except S25 is not known.","The effect of the phosphorylation is unclear as is the exact phosphosite. The S20 phosphorylation site in GOLGA2 has only 1 report from high throughput mass spectrometry studies.",null,"Q08379","Q08379",6685,null,null,"NP_004477.3","Block3",11,13,"3, 11, 19, 27",{"$nulls":13},"Cytoskeletal protein","GO:0005801; GO:0030134; GO:0033116; GO:0005794; GO:0000137; GO:0032580; GO:0000139; GO:0005874; GO:0072686; GO:0000922","GO:0045296; GO:0042802; GO:0061676; GO:0008017; GO:0019901; GO:0019905","GO:0008356; GO:0007098; GO:0048208; GO:0006888; GO:0090166; GO:0090161; GO:0007020; GO:0090307; GO:0010507; GO:0032091; GO:0060050; GO:1904668; GO:0006486; GO:0051289; GO:0051225; GO:0090306"]
[969,483,"PN601","GR","S226","Glucocorticoid receptor",{"v":8601.530306361161,"d":"8602"},{"v":8171.275025924217,"d":"8171"},{"v":2672.5439467389874,"d":"2673"},{"v":31.070563627062253,"d":"31"},{"v":283.62271554237134,"d":"284"},{"v":17627.798961251152,"d":"17628"},"Kinexus","RpAb","LL(pS)PLAGC","Corresponds to amino acid residues L224 to G230.","S226 phosphorylation inhibits transcriptional activity, and regulates intracellular location and molecular association, including inducing interaction with GRIP1. This is one of the major in vivo phosphorylation sites in the glucocorticoid receptor (≥10 reports from high throughput mass spectrometry studies).","CDK5; ERK2 (MAPK1); JAK1; JNK1 (MAPK8); JNK2 (MAPK9); JNK3 (MAPK10)","P04150","P04150",1310,null,"P04150","NP_000167.1","Block3",12,2,"3, 11, 19, 27",{"$nulls":3},"Receptor,  nuclear; Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Receptor, nuclear; Transcription factor","GO:0005737; GO:0005829; GO:0005815; GO:0005759; GO:0016607; GO:0005654; GO:0005634; GO:0032991; GO:0005819","GO:0001047; GO:0003700; GO:0004883; GO:0051879; GO:0004879; GO:0019901; GO:0003723; GO:0000978; GO:0038050; GO:0000981; GO:0005496; GO:1990239; GO:0032183; GO:0001077; GO:0008270","GO:0006915; GO:0007049; GO:0051301; GO:0071549; GO:0071385; GO:0071383; GO:0071560; GO:0006325; GO:0007059; GO:0000122; GO:0045944; GO:0006355; GO:0007165; GO:0006351; GO:0006366; GO:0006367"]
[971,484,"NK382-1","GRK1 (Rhodopsin kinase)","Pan-specific","Rhodopsin kinase",{"v":389.1870503623375,"d":"389"},{"v":312.9686917431608,"d":"313"},{"v":268.20669540421693,"d":"268"},{"v":68.91459907376503,"d":"69"},{"v":47.05455849827841,"d":"47"},{"v":2697.874338045262,"d":"2698"},"External","MmAb","Not precisely defined.","Antibody raised against full length human GRK1.",null,null,"Q15835","Q15835",753,"Q15835","Q15835","NP_002920.1","Block3",12,3,"3, 11, 19, 27","GRK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase",{"$nulls":8},"Protein-serine kinase, AGC group, GRK family, GRK subfamily","GO:0097381","GO:0005524; GO:0004703; GO:0004672; GO:0050254","GO:0046777; GO:0008277; GO:0022400; GO:0016056; GO:0007601"]
[973,485,"NK067-2","GRK2 (BARK1, ADRBK1)","Pan-specific","Beta-adrenergic receptor kinase 1",{"v":559.4045193559114,"d":"559"},{"v":520.8763558012249,"d":"521"},{"v":263.1861009574354,"d":"263"},{"v":47.0475464267724,"d":"47"},{"v":96.9497451138841,"d":"97"},{"v":1488.5611461926228,"d":"1489"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 468-689 of human GRK2.",null,null,"P25098","P25098",602,"P25098",null,"NP_001610","Block3",12,4,"3, 11, 19, 27","GRK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase",{"$nulls":8},"EC 2.7.11.15; Protein kinase, Ser/Thr (non-receptor); AGC group; GRK family; BARK subfamily","GO:0005929; GO:0005737; GO:0005829; GO:0016020; GO:0005886","GO:0031694; GO:0005524; GO:0047696; GO:0031755; GO:0004703; GO:0004672","GO:0060048; GO:0002029; GO:0007213; GO:0007186; GO:0007507; GO:0045988; GO:0003108; GO:0018105; GO:0018107; GO:0033605; GO:0031623; GO:0007217; GO:0046718; GO:0019079"]
[975,486,"NK067","GRK2 (BARK1, ADRBK1)","Pan-specific","G protein-coupled receptor-serine kinase 2",{"v":946.4421033563518,"d":"946"},{"v":861.298637809495,"d":"861"},{"v":443.65331901019493,"d":"444"},{"v":46.87590687659336,"d":"47"},{"v":145.87333779843337,"d":"146"},{"v":2529.849070029374,"d":"2530"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues at the C-terminus of human GRK2.",null,null,"P25098","P25098",602,"P25098",null,"NP_001610","Block3",12,5,"3, 11, 19, 27","BARK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase",{"$nulls":8},"EC 2.7.11.15; Protein kinase, Ser/Thr (non-receptor); AGC group; GRK family; BARK subfamily","GO:0005929; GO:0005737; GO:0005829; GO:0016020; GO:0005886","GO:0031694; GO:0005524; GO:0047696; GO:0031755; GO:0004703; GO:0004672","GO:0060048; GO:0002029; GO:0007213; GO:0007186; GO:0007507; GO:0045988; GO:0003108; GO:0018105; GO:0018107; GO:0033605; GO:0031623; GO:0007217; GO:0046718; GO:0019079"]
[977,117,"PK537","GRK2 (BARK1, ADRBK1)","Y356","Beta-adrenergic receptor kinase 1",{"v":6535.608952559313,"d":"6536"},{"v":6283.821249040315,"d":"6284"},{"v":2315.891502048824,"d":"2316"},{"v":35.43497658534071,"d":"35"},{"v":580.771737572765,"d":"581"},{"v":17871.59379045479,"d":"17872"},"Kinexus","RpAb","THG(pY)MAP(bA)C","Corresponds to amino acid residues T353 to P359; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y356 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in BARK1 (≥71 reports from high throughput mass spectrometry studies).",null,"P25098","P25098",602,"P25098",null,"NP_001610","Block1",9,13,"1, 9, 17, 25","BARK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","GRK","BARK",{"$nulls":5},"EC 2.7.11.15; Protein kinase, Ser/Thr (non-receptor); AGC group; GRK family; BARK subfamily","GO:0005929; GO:0005737; GO:0005829; GO:0016020; GO:0005886","GO:0031694; GO:0005524; GO:0047696; GO:0031755; GO:0004703; GO:0004672","GO:0060048; GO:0002029; GO:0007213; GO:0007186; GO:0007507; GO:0045988; GO:0003108; GO:0018105; GO:0018107; GO:0033605; GO:0031623; GO:0007217; GO:0046718; GO:0019079"]
[979,118,"PK536","GRK2 (BARK1, ADRBK1)","S670","Beta-adrenergic receptor kinase 1",{"v":2989.2245867697966,"d":"2989"},{"v":2832.2715063368832,"d":"2832"},{"v":1403.9636540240256,"d":"1404"},{"v":46.96748649258137,"d":"47"},{"v":302.7416482295747,"d":"303"},{"v":9238.963098404241,"d":"9239"},"Kinexus","RpAb","KPR(pS)PVV(bA)C","Corresponds to amino acid residues K667 to V673; Near the C-terminus of the kinase.","S670 phosphorylation inhibits phosphotransferase activity. Phosphorylation regulates cell cycle progression, cell growth, protein degradation, and induces molecular association with PIN1. This is one of the major in vivo phosphorylation sites in BARK1 (≥54reports from high throughput mass spectrometry studies).","ERK1","P25098","P25098",602,"P25098",null,"NP_001610","Block1",10,1,"1, 9, 17, 25","BARK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","GRK","BARK",{"$nulls":5},"EC 2.7.11.15; Protein kinase, Ser/Thr (non-receptor); AGC group; GRK family; BARK subfamily","GO:0005929; GO:0005737; GO:0005829; GO:0016020; GO:0005886","GO:0031694; GO:0005524; GO:0047696; GO:0031755; GO:0004703; GO:0004672","GO:0060048; GO:0002029; GO:0007213; GO:0007186; GO:0007507; GO:0045988; GO:0003108; GO:0018105; GO:0018107; GO:0033605; GO:0031623; GO:0007217; GO:0046718; GO:0019079"]
[981,487,"PK025","GRK2 (BARK1, ADRBK1)","S670","G protein-coupled receptor-serine kinase 2",{"v":1038.755609257313,"d":"1039"},{"v":839.3022126761375,"d":"839"},{"v":787.9531382233276,"d":"788"},{"v":75.85548816306239,"d":"76"},{"v":197.3540332839704,"d":"197"},{"v":5534.227781041285,"d":"5534"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S670 phosphosite.","S670 phosphorylation may inhibit phosphotransferase activity. Phosphorylation regulates cell cycle progression, cell growth, protein degradation, and molecular association, including inducing binding to PIN1. This is one of the major in vivo phosphorylation sites in GRK2 (≥54 reports from high throughput mass spectrometry studies).","CDK2; ERK1 (MAPK3)","P25098","P25098",602,"P25098",null,"NP_001610","Block3",12,6,"3, 11, 19, 27","BARK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase",{"$nulls":8},"EC 2.7.11.15; Protein kinase, Ser/Thr (non-receptor); AGC group; GRK family; BARK subfamily","GO:0005929; GO:0005737; GO:0005829; GO:0016020; GO:0005886","GO:0031694; GO:0005524; GO:0047696; GO:0031755; GO:0004703; GO:0004672","GO:0060048; GO:0002029; GO:0007213; GO:0007186; GO:0007507; GO:0045988; GO:0003108; GO:0018105; GO:0018107; GO:0033605; GO:0031623; GO:0007217; GO:0046718; GO:0019079"]
[983,488,"NK305","GRK5","Pan-specific","G protein-coupled receptor kinase 5",{"v":87.22828327930387,"d":"87"},{"v":52.980011525479455,"d":"53"},{"v":106.31361380265717,"d":"106"},{"v":121.87975024367074,"d":"122"},{"v":6.04534986947697,"d":"6"},{"v":639.9733991167295,"d":"640"},"External","MmAb","Epitope undefined.",{"$nulls":3},"P34947","P34947",699,"P34947",null,"NP_005299.1","Block3",12,7,"3, 11, 19, 27","GRK5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase",{"$nulls":8},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.16; AGC group; GRK family; GRK subfamily","GO:0005737; GO:0005829; GO:0031965; GO:0016607; GO:0005886","GO:0005524; GO:0047696; GO:0004703; GO:0005543; GO:0005080; GO:0004674","GO:0007188; GO:0006915; GO:0045444; GO:0007186; GO:0043066; GO:0008284; GO:0046777; GO:0051726; GO:0008277; GO:0007217; GO:0016055"]
[985,489,"NK381-1","GRK7","Pan-specific","Rhodopsin kinase",{"v":836.4781106481698,"d":"836"},{"v":766.8802653561627,"d":"767"},{"v":443.9714560427072,"d":"444"},{"v":53.076279031220885,"d":"53"},{"v":218.8888420262395,"d":"219"},{"v":4427.9558249566035,"d":"4428"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 472-501 near the C-terminus of human GRK7.",null,null,"Q8WTQ7","Q8WTQ7",2436,"Q8WTQ7",null,"NP_631948.1","Block3",12,8,"3, 11, 19, 27","GRK7","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase",{"$nulls":8},"Protein-serine kinase, AGC group, GRK family, GRK subfamily","GO:0097381","GO:0005524; GO:0004703; GO:0050254","GO:0046777; GO:0022400; GO:0007165; GO:0007601"]
[987,490,"NK069-NK070-3","GSK3a","Pan-specific","Glycogen synthase-serine kinase 3 alpha/beta",{"v":770.300984568316,"d":"770"},{"v":663.6150287907943,"d":"664"},{"v":500.84844326232127,"d":"501"},{"v":65.01983682949614,"d":"65"},{"v":133.96136196914978,"d":"134"},{"v":3746.9691833153424,"d":"3747"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 1-420 representing full length Xenopus laevis glycogen synthase kinase-3 beta. ",null,null,"P49840","P49840",603,"P49840",null,"NP_002084","Block3",12,9,"3, 11, 19, 27","GSK3a","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","GSK",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.26; CMGC group; GSK family; GSK subfamily","GO:0097440; GO:0030877; GO:0005829; GO:0005739; GO:0043025; GO:0098794; GO:1990635","GO:0005524; GO:0034236; GO:0004674; GO:0005102; GO:0050321","GO:0003214; GO:0032869; GO:0036016; GO:0007212; GO:0060079; GO:0097191; GO:0097192; GO:0005977; GO:0008286; GO:0036498; GO:0090090; GO:0061052; GO:0046325; GO:2000466; GO:0045719; GO:1904227; GO:0046627; GO:0032007; GO:2000077; GO:0010905; GO:0007399; GO:0018107; GO:0071879; GO:0106071; GO:1902004; GO:0010628; GO:2000467; GO:0045823; GO:1901030; GO:0032436; GO:0045732; GO:1903955; GO:0031398; GO:0043161; GO:0006468; GO:1903146; GO:0003073; GO:0016055"]
[989,491,"NK069-3","GSK3a","Pan-specific","Glycogen synthase-serine kinase 3 alpha",{"v":2160.93234245719,"d":"2161"},{"v":1994.5239340880971,"d":"1995"},{"v":795.7634121824168,"d":"796"},{"v":36.825003566634415,"d":"37"},{"v":490.8930209957549,"d":"491"},{"v":4664.403957909274,"d":"4664"},"Kinexus","RpAb","PPGVKLGRDSGKVTTGC","Corresponds to amino acid residues P88 to T102; Before catalytic domain.",null,null,"P49840","P49840",603,"P49840",null,"NP_002084","Block3",12,10,"3, 11, 19, 27","GSK3a","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","GSK",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.26; CMGC group; GSK family; GSK subfamily","GO:0097440; GO:0030877; GO:0005829; GO:0005739; GO:0043025; GO:0098794; GO:1990635","GO:0005524; GO:0034236; GO:0004674; GO:0005102; GO:0050321","GO:0003214; GO:0032869; GO:0036016; GO:0007212; GO:0060079; GO:0097191; GO:0097192; GO:0005977; GO:0008286; GO:0036498; GO:0090090; GO:0061052; GO:0046325; GO:2000466; GO:0045719; GO:1904227; GO:0046627; GO:0032007; GO:2000077; GO:0010905; GO:0007399; GO:0018107; GO:0071879; GO:0106071; GO:1902004; GO:0010628; GO:2000467; GO:0045823; GO:1901030; GO:0032436; GO:0045732; GO:1903955; GO:0031398; GO:0043161; GO:0006468; GO:1903146; GO:0003073; GO:0016055"]
[991,492,"PK648","GSK3a","T19+S21","Glycogen synthase-serine kinase 3 alpha",{"v":12617.853505231584,"d":"12618"},{"v":12369.2928432703,"d":"12369"},{"v":3173.609135391118,"d":"3174"},{"v":25.151735468122876,"d":"25"},{"v":28.897577772853676,"d":"29"},{"v":24935.661209125545,"d":"24936"},"Kinexus","RpAb","RAR(pT)S(pS)FAE(bA)C","Corresponds to amino acid residues R16 to E24; Near the N-terminus of the protein.","T19+S21 phosphorylation inhibits phosphotransferase activity. These are two of the less major in vivo phosphorylation sites in GSK3a (≥78 and ≥296 reports, respectively, from high throughput mass spectrometry studies).","S21: Akt1 (PKBa); PKACa (PRKACA); PKCb1 (PRKCB1); PKCd (PRKCD); PKCg (PRKCG); PKCh (PRKCH); PKCz (PRKCZ); RSK2 (RPS6KA3)","P49840","P49840",603,"P49840",null,"NP_002084","Block3",12,11,"3, 11, 19, 27","GSK3a","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","GSK",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.26; CMGC group; GSK family; GSK subfamily","GO:0097440; GO:0030877; GO:0005829; GO:0005739; GO:0043025; GO:0098794; GO:1990635","GO:0005524; GO:0034236; GO:0004674; GO:0005102; GO:0050321","GO:0003214; GO:0032869; GO:0036016; GO:0007212; GO:0060079; GO:0097191; GO:0097192; GO:0005977; GO:0008286; GO:0036498; GO:0090090; GO:0061052; GO:0046325; GO:2000466; GO:0045719; GO:1904227; GO:0046627; GO:0032007; GO:2000077; GO:0010905; GO:0007399; GO:0018107; GO:0071879; GO:0106071; GO:1902004; GO:0010628; GO:2000467; GO:0045823; GO:1901030; GO:0032436; GO:0045732; GO:1903955; GO:0031398; GO:0043161; GO:0006468; GO:1903146; GO:0003073; GO:0016055"]
[993,493,"PK187","GSK3a","S21","Glycogen synthase-serine kinase 3 alpha",{"v":218.67429929402093,"d":"219"},{"v":60.68157692324954,"d":"61"},{"v":1191.640154659644,"d":"1192"},{"v":544.9383665601283,"d":"545"},{"v":11.463301746815857,"d":"11"},{"v":10978.119958042269,"d":"10978"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S21 phosphosite.","S21 phosphorylation inhibits phosphotransferase activity. This is one of the less major in vivo phosphorylation sites in GSK3a (≥296 reports from high throughput mass spectrometry studies).","Akt1 (PKBa); PKACa (PRKACA); PKCb1 (PRKCB1); PKCd (PRKCD); PKCg (PRKCG); PKCh (PRKCH); PKCz (PRKCZ); RSK2 (RPS6KA3)","P49840","P49840",603,"P49840",null,"NP_002084","Block3",12,12,"3, 11, 19, 27","GSK3a","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","GSK",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.26; CMGC group; GSK family; GSK subfamily","GO:0097440; GO:0030877; GO:0005829; GO:0005739; GO:0043025; GO:0098794; GO:1990635","GO:0005524; GO:0034236; GO:0004674; GO:0005102; GO:0050321","GO:0003214; GO:0032869; GO:0036016; GO:0007212; GO:0060079; GO:0097191; GO:0097192; GO:0005977; GO:0008286; GO:0036498; GO:0090090; GO:0061052; GO:0046325; GO:2000466; GO:0045719; GO:1904227; GO:0046627; GO:0032007; GO:2000077; GO:0010905; GO:0007399; GO:0018107; GO:0071879; GO:0106071; GO:1902004; GO:0010628; GO:2000467; GO:0045823; GO:1901030; GO:0032436; GO:0045732; GO:1903955; GO:0031398; GO:0043161; GO:0006468; GO:1903146; GO:0003073; GO:0016055"]
[995,494,"PK647","GSK3a","S278+Y279","Glycogen synthase-serine kinase 3 alpha",{"v":9825.3205724152,"d":"9825"},{"v":9692.619466805694,"d":"9693"},{"v":2023.3965627654916,"d":"2023"},{"v":20.59369511511127,"d":"21"},{"v":4296.055444675825,"d":"4296"},{"v":15638.330262965204,"d":"15638"},"Kinexus","RpAb","NV(pS)(pY)ICS(bA)C","Corresponds to amino acid residues N276 to S282; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y279 phosphorylation stimulates phosphotransferase activity, promotes nuclear localization, and regulates cell growth, apoptosis, transcription, protein stability, and molecular association. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. The S278 and Y279 phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major in vivo phosphorylation sites in GSK3a (≥1270 and ≥4268 reports,respectively,  from high throughput mass spectrometry studies).","Y279: GSK3a; MEK1 (MAP2K1); MEK2 (MAP2K2).","P49840","P49840",603,"P49840",null,"NP_002084","Block3",12,13,"3, 11, 19, 27","GSK3a","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","GSK",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.26; CMGC group; GSK family; GSK subfamily","GO:0097440; GO:0030877; GO:0005829; GO:0005739; GO:0043025; GO:0098794; GO:1990635","GO:0005524; GO:0034236; GO:0004674; GO:0005102; GO:0050321","GO:0003214; GO:0032869; GO:0036016; GO:0007212; GO:0060079; GO:0097191; GO:0097192; GO:0005977; GO:0008286; GO:0036498; GO:0090090; GO:0061052; GO:0046325; GO:2000466; GO:0045719; GO:1904227; GO:0046627; GO:0032007; GO:2000077; GO:0010905; GO:0007399; GO:0018107; GO:0071879; GO:0106071; GO:1902004; GO:0010628; GO:2000467; GO:0045823; GO:1901030; GO:0032436; GO:0045732; GO:1903955; GO:0031398; GO:0043161; GO:0006468; GO:1903146; GO:0003073; GO:0016055"]
[997,495,"PK649","GSK3a","Y279","Glycogen synthase-serine kinase 3 alpha",{"v":471.9801695457229,"d":"472"},{"v":423.4359592402733,"d":"423"},{"v":232.10846592293112,"d":"232"},{"v":49.17758857248889,"d":"49"},{"v":96.16158140407242,"d":"96"},{"v":1493.5423529279524,"d":"1494"},"Kinexus","RpAb","NVS(pY)ICS(bA)C","Corresponds to amino acid residues N276 to S282; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y279 phosphorylation stimulates phosphotransferase activity, promotes nuclear localization, and regulates cell growth, apoptosis, transcription, protein stability, and molecular association. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in GSK3a.","GSK3a; MEK1 (MAP2K1); MEK2 (MAP2K2)","P49840","P49840",603,"P49840",null,"NP_002084","Block3",13,1,"3, 11, 19, 27","GSK3a","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","GSK",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.26; CMGC group; GSK family; GSK subfamily","GO:0097440; GO:0030877; GO:0005829; GO:0005739; GO:0043025; GO:0098794; GO:1990635","GO:0005524; GO:0034236; GO:0004674; GO:0005102; GO:0050321","GO:0003214; GO:0032869; GO:0036016; GO:0007212; GO:0060079; GO:0097191; GO:0097192; GO:0005977; GO:0008286; GO:0036498; GO:0090090; GO:0061052; GO:0046325; GO:2000466; GO:0045719; GO:1904227; GO:0046627; GO:0032007; GO:2000077; GO:0010905; GO:0007399; GO:0018107; GO:0071879; GO:0106071; GO:1902004; GO:0010628; GO:2000467; GO:0045823; GO:1901030; GO:0032436; GO:0045732; GO:1903955; GO:0031398; GO:0043161; GO:0006468; GO:1903146; GO:0003073; GO:0016055"]
[999,496,"PK650","GSK3a","Y284+Y285","Glycogen synthase-serine kinase 3 alpha",{"v":5177.408409868838,"d":"5177"},{"v":5228.834102918867,"d":"5229"},{"v":1242.970242723226,"d":"1243"},{"v":24.007575688909476,"d":"24"},{"v":1941.2169913391522,"d":"1941"},{"v":8988.995855113415,"d":"8989"},"Kinexus","RpAb","SR(pY)(pY)RAP(bA)C","Corresponds to amino acid residues S282 to P288; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y284 and Y285 phosphorylation is predicted to be inhibitory for phosphotransferase activity. These phosphosites are located in the kinase activation loop just before the catalytic subdomain VIII. These apprear to be minor in vivo phosphorylation sites in GSK3a.",null,"P49840","P49840",603,"P49840",null,"NP_002084","Block3",13,2,"3, 11, 19, 27","GSK3a","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","GSK",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.26; CMGC group; GSK family; GSK subfamily","GO:0097440; GO:0030877; GO:0005829; GO:0005739; GO:0043025; GO:0098794; GO:1990635","GO:0005524; GO:0034236; GO:0004674; GO:0005102; GO:0050321","GO:0003214; GO:0032869; GO:0036016; GO:0007212; GO:0060079; GO:0097191; GO:0097192; GO:0005977; GO:0008286; GO:0036498; GO:0090090; GO:0061052; GO:0046325; GO:2000466; GO:0045719; GO:1904227; GO:0046627; GO:0032007; GO:2000077; GO:0010905; GO:0007399; GO:0018107; GO:0071879; GO:0106071; GO:1902004; GO:0010628; GO:2000467; GO:0045823; GO:1901030; GO:0032436; GO:0045732; GO:1903955; GO:0031398; GO:0043161; GO:0006468; GO:1903146; GO:0003073; GO:0016055"]
[1001,497,"NK270-3","GSK3b","Pan-specific","Glycogen synthase-serine kinase 3 beta",{"v":9811.065770500027,"d":"9811"},{"v":9454.910024076116,"d":"9455"},{"v":2933.9765455828483,"d":"2934"},{"v":29.904768902933533,"d":"30"},{"v":4578.526384232239,"d":"4579"},{"v":19917.171652098667,"d":"19917"},"Kinexus","RpAb","CKPVQQPSAFGSMKVSRDKD","Corresponds to amino acid residues C14 to D33; Near N-terminus.",null,null,"P49841","P49841",604,"P49841","P49841","NP_002084","Block3",13,3,"3, 11, 19, 27","GSK3B","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","GSK",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.26; CMGC group; GSK family; GSK subfamily","GO:0030424; GO:0030877; GO:0005813; GO:0005737; GO:0005829; GO:0030425; GO:0098978; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0098794; GO:1990909","GO:0005524; GO:0008013; GO:0034452; GO:0016301; GO:0051059; GO:0002039; GO:0002020; GO:0034236; GO:0004672; GO:0019901; GO:0004674; GO:0001085; GO:0050321; GO:0031625","GO:1904885; GO:1904886; GO:1904646; GO:0036016; GO:0007623; GO:0007212; GO:0001837; GO:0006983; GO:0030010; GO:0060079; GO:0097191; GO:0097192; GO:0005977; GO:0021766; GO:0035556; GO:0030011; GO:0043066; GO:0070885; GO:0090090; GO:1904339; GO:2000466; GO:0045719; GO:1901215; GO:0032515; GO:1901984; GO:0032091; GO:0031333; GO:1900181; GO:2000077; GO:0031175; GO:0106028; GO:0018105; GO:0018107; GO:0001954; GO:0010628; GO:0043547; GO:1901030; GO:0010822; GO:1901216; GO:0032436; GO:0032092; GO:0045732; GO:0031334; GO:0046827; GO:1904781; GO:0046777; GO:0006468; GO:0030516; GO:0050770; GO:1900034; GO:0048814; GO:0032886; GO:0070507; GO:2000300; GO:0071109; GO:0016055"]
[1003,498,"NK070","GSK3b","Pan-specific","Glycogen synthase-serine kinase 3 beta",{"v":11412.317535465996,"d":"11412"},{"v":10973.867161016336,"d":"10974"},{"v":2406.2887458544274,"d":"2406"},{"v":21.085013962995834,"d":"21"},{"v":6372.232998435034,"d":"6372"},{"v":18433.24490489302,"d":"18433"},"Kinexus","RpAb","CAHSFFDELRDPNVK","Corresponds to amino acid residues C335 to K349; Kinase catalytic subdomain 11.",null,null,"P49841","P49841",604,"P49841","P49841","NP_002084","Block3",13,4,"3, 11, 19, 27","GSK3B","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","GSK",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.26; CMGC group; GSK family; GSK subfamily","GO:0030424; GO:0030877; GO:0005813; GO:0005737; GO:0005829; GO:0030425; GO:0098978; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0098794; GO:1990909","GO:0005524; GO:0008013; GO:0034452; GO:0016301; GO:0051059; GO:0002039; GO:0002020; GO:0034236; GO:0004672; GO:0019901; GO:0004674; GO:0001085; GO:0050321; GO:0031625","GO:1904885; GO:1904886; GO:1904646; GO:0036016; GO:0007623; GO:0007212; GO:0001837; GO:0006983; GO:0030010; GO:0060079; GO:0097191; GO:0097192; GO:0005977; GO:0021766; GO:0035556; GO:0030011; GO:0043066; GO:0070885; GO:0090090; GO:1904339; GO:2000466; GO:0045719; GO:1901215; GO:0032515; GO:1901984; GO:0032091; GO:0031333; GO:1900181; GO:2000077; GO:0031175; GO:0106028; GO:0018105; GO:0018107; GO:0001954; GO:0010628; GO:0043547; GO:1901030; GO:0010822; GO:1901216; GO:0032436; GO:0032092; GO:0045732; GO:0031334; GO:0046827; GO:1904781; GO:0046777; GO:0006468; GO:0030516; GO:0050770; GO:1900034; GO:0048814; GO:0032886; GO:0070507; GO:2000300; GO:0071109; GO:0016055"]
[1005,499,"PK188","GSK3b","S9","Glycogen synthase-serine kinase 3 beta",{"v":1407.949785460197,"d":"1408"},{"v":1291.2430082719613,"d":"1291"},{"v":674.8469894173355,"d":"675"},{"v":47.931183085251696,"d":"48"},{"v":241.15473946767838,"d":"241"},{"v":3988.7895695534985,"d":"3989"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S9 phosphosite.","S9 phosphorylation inhibits phosphotransferase activity. Phosphorylation regulates apoptosis, cell adhesion, cell growth, cell motility, cytoskeletal reorganization, transcription, alters intracellular location, and protein degradation. This is one of the less major in vivo phosphorylation sites in GSK3b (≥262reports from high throughput mass spectrometry studies).","Akt1 (PKBa); Akt3 (PKBg); AurA (STK15); GSK3b; ILK; KHS1 (MAP4K5); p70S6K (RPS6KB1); PKACa (PRKACA); PKCa (PRKCA); PKCb1 (PRKCB1); PKCd (PRKCD); PKCg (PRKCG); PKCh (PRKCH); PKCz (PRKCZ); PKG1 (PRKG1); RSK1 (RPS6KA1); RSK2 (RPS6KA3); SGK3","P49841","P49841",604,"P49841","P49841","NP_002084","Block3",13,5,"3, 11, 19, 27","GSK3B","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","GSK",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.26; CMGC group; GSK family; GSK subfamily","GO:0030424; GO:0030877; GO:0005813; GO:0005737; GO:0005829; GO:0030425; GO:0098978; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0098794; GO:1990909","GO:0005524; GO:0008013; GO:0034452; GO:0016301; GO:0051059; GO:0002039; GO:0002020; GO:0034236; GO:0004672; GO:0019901; GO:0004674; GO:0001085; GO:0050321; GO:0031625","GO:1904885; GO:1904886; GO:1904646; GO:0036016; GO:0007623; GO:0007212; GO:0001837; GO:0006983; GO:0030010; GO:0060079; GO:0097191; GO:0097192; GO:0005977; GO:0021766; GO:0035556; GO:0030011; GO:0043066; GO:0070885; GO:0090090; GO:1904339; GO:2000466; GO:0045719; GO:1901215; GO:0032515; GO:1901984; GO:0032091; GO:0031333; GO:1900181; GO:2000077; GO:0031175; GO:0106028; GO:0018105; GO:0018107; GO:0001954; GO:0010628; GO:0043547; GO:1901030; GO:0010822; GO:1901216; GO:0032436; GO:0032092; GO:0045732; GO:0031334; GO:0046827; GO:1904781; GO:0046777; GO:0006468; GO:0030516; GO:0050770; GO:1900034; GO:0048814; GO:0032886; GO:0070507; GO:2000300; GO:0071109; GO:0016055"]
[1007,500,"PK883","GSK3b","T275+T277","Glycogen synthase-serine kinase 3 beta",{"v":9545.689252795397,"d":"9546"},{"v":9569.485416647678,"d":"9569"},{"v":2429.3768744317936,"d":"2429"},{"v":25.449989100790866,"d":"25"},{"v":409.6122137515984,"d":"410"},{"v":19946.350188037857,"d":"19946"},"Kinexus","RpAb","VLG(pT)P(pT)REQ(bA)C","Corresponds to amino acid residues V272 to Q280. These sites are located in the Gap/Insert 10 (G/I10) region in the protein-serine/threonine kinase catalytic domain of GSK3b, and they are also found in GSK3a at T338 and T340.","The effects of T275 and T277 phosphorylation are unclear. T275 and T277 have not yet been identified as phosphosites in GSK3b by mass spectrometry studies. ",null,"P49841","P49841",604,"P49841","P49841","NP_002084","Block3",13,6,"3, 11, 19, 27","GSK3B","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","GSK",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.26; CMGC group; GSK family; GSK subfamily","GO:0030424; GO:0030877; GO:0005813; GO:0005737; GO:0005829; GO:0030425; GO:0098978; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0098794; GO:1990909","GO:0005524; GO:0008013; GO:0034452; GO:0016301; GO:0051059; GO:0002039; GO:0002020; GO:0034236; GO:0004672; GO:0019901; GO:0004674; GO:0001085; GO:0050321; GO:0031625","GO:1904885; GO:1904886; GO:1904646; GO:0036016; GO:0007623; GO:0007212; GO:0001837; GO:0006983; GO:0030010; GO:0060079; GO:0097191; GO:0097192; GO:0005977; GO:0021766; GO:0035556; GO:0030011; GO:0043066; GO:0070885; GO:0090090; GO:1904339; GO:2000466; GO:0045719; GO:1901215; GO:0032515; GO:1901984; GO:0032091; GO:0031333; GO:1900181; GO:2000077; GO:0031175; GO:0106028; GO:0018105; GO:0018107; GO:0001954; GO:0010628; GO:0043547; GO:1901030; GO:0010822; GO:1901216; GO:0032436; GO:0032092; GO:0045732; GO:0031334; GO:0046827; GO:1904781; GO:0046777; GO:0006468; GO:0030516; GO:0050770; GO:1900034; GO:0048814; GO:0032886; GO:0070507; GO:2000300; GO:0071109; GO:0016055"]
[1009,501,"PK651","GTF2F1","S385+T389","General transcription factor IIF subunit 1",{"v":13280.028078774276,"d":"13280"},{"v":12828.77121986236,"d":"12829"},{"v":3543.911671126277,"d":"3544"},{"v":26.686025436878246,"d":"27"},{"v":4680.33150776165,"d":"4680"},{"v":25013.125070590897,"d":"25013"},"Kinexus","RpAb","RGN(pS)RPG(pT)PSA(bA)C","Corresponds to amino acid residues R382 to A392; in the TFIIF_alpha domain.","S385+T389 phosphorylation inhibits transcriptional activity. These are the two major in vivo phosphorylation sites in GTF2F1 (≥280 and ≥319 reports, respectively, from high throughput mass spectrometry studies).","S385: GTF2F1. T389: GTF2F1","P35269","P35269",8665,"P35269",null,"NP_002087.2","Block3",13,7,"3, 11, 19, 27","GTF2F1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine; Transcription protein ","Protein-serine/threonine kinase","Atypical",null,null,"X",{"$nulls":4},"EC 2.7.11.1; Transcription initiation complex","GO:0030054; GO:0043231; GO:0005654; GO:0005634; GO:0032991; GO:0005669; GO:0005674","GO:0003677; GO:0019211; GO:1990841; GO:0019904; GO:0019903; GO:0003723; GO:0003713; GO:0008134","GO:0006370; GO:0008543; GO:0000398; GO:0032091; GO:0045944; GO:0032968; GO:0009615; GO:0016070; GO:0042795; GO:0006366; GO:0006368; GO:0006367"]
[1011,502,"PN602","GTF2I","S412","General transcription factor II-I",{"v":7844.487083957817,"d":"7844"},{"v":7971.824656557947,"d":"7972"},{"v":1550.074682009521,"d":"1550"},{"v":19.76005142744724,"d":"20"},{"v":719.7600562923715,"d":"720"},{"v":13641.70780354143,"d":"13642"},"Kinexus","RpAb","FRRP(pS)TYGC","Corresponds to amino acid residues F408 to G415.","S412 phosphorylation induces transcription. This is one of the major in vivo phosphorylation sites in GTF2I (≥147 reports from high throughput mass spectrometry studies).","PKG1","P78347","P78347",476,null,null,"NP_001157108.1","Block3",13,8,"3, 11, 19, 27",{"$nulls":3},"Transcription, coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"Transcription, coactivator/corepressor","GO:0042995; GO:0005737; GO:0016020; GO:0043025; GO:0005654; GO:0005634","GO:0003677; GO:0003700; GO:0051019; GO:0000981","GO:0016525; GO:0051481; GO:0007165; GO:0006366; GO:0006367; GO:0014886"]
[1013,503,"PK652","GUK1","Y53","Guanylate kinase",{"v":11236.385818828581,"d":"11236"},{"v":11206.775955048968,"d":"11207"},{"v":2571.5341038519,"d":"2572"},{"v":22.885776132240252,"d":"23"},{"v":3259.6106952432137,"d":"3260"},{"v":17120.233213986103,"d":"17120"},"Kinexus","RpAb","GKD(pY)YFV(bA)C","Corresponds to amino acid residues G50 to V56; In the first third of the Guanylate_kin domain. ","The effect of Y53 phosphorylation is unclear. This Is the major in vivo site of phosphorylation of GUK1 (≥86 reports from high throughput mass spectrometry studies).",null,"Q16774","Q16774",9046,"Q16774",null,"NP_000849.1","Block3",13,9,"3, 11, 19, 27","GUK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical",{"$nulls":7},"Kinase (non-protein), Nucleotide Metabolism group, Purine metabolism family","GO:0005829","GO:0005524; GO:0004385","GO:0046034; GO:0046060; GO:0006185; GO:0046054; GO:0046711; GO:0019673; GO:0034436; GO:0015949; GO:0046939; GO:0006163"]
[1015,504,"PN703","GYS1","S641+S645","Glycogen [starch] synthase, muscle",{"v":7567.317536858549,"d":"7567"},{"v":7660.499343600537,"d":"7660"},{"v":1681.0133319352735,"d":"1681"},{"v":22.21412440732756,"d":"22"},{"v":2527.050961593961,"d":"2527"},{"v":13134.681459479092,"d":"13135"},"Kinexus","RpAb","RPA(pS)VPP(pS)PSL(bA)C","Corresponds to amino acid residues R638 to L648","S641+S645 phosphorylation inhibits enzyme activity. These are two of the major in vivo phosphorylation sites in glycogen synthase isoform 1 (≥26 and >35 reports, respectively, by mass spectrometry). These phosphosites are highly conserved in mammals and found in the platypus.","S641: BARK2 (GRK3, ADRBK2); DYRK1A; DYRK1B; DYRK2; GSK3b; PASK (PASKIN). S645: BARK2 (GRK3, ADRBK2); GSK3b; p38b MAPK (MAPK11).","P13807","P13807",1330,null,null,"NP_001155059.1","Block3",13,10,"3, 11, 19, 27",{"$nulls":3},"Glycogen synthesis",{"$nulls":8},"X","EC 2.4.1.11; Carbohydrate Metabolism - starch and sucrose; Transferase","GO:0005829; GO:0016234; GO:0016020","GO:0005536; GO:0004373; GO:0061547; GO:0019901","GO:0005978; GO:0007507"]
[1017,505,"PN704","GYS2","Y45","Glycogen [starch] synthase, liver",{"v":634.1576072871143,"d":"634"},{"v":586.5129303605383,"d":"587"},{"v":253.960845912376,"d":"254"},{"v":40.04696040765075,"d":"40"},{"v":150.45686030838385,"d":"150"},{"v":1404.4490830290392,"d":"1404"},"Kinexus","RpAb","C(bA)GGI(pY)TVIQ","Corresponds to amino acid residues G42 to Q49.","The effect of Y45 phosphorylation is unclear. This is the major in vivo phosphorylation site in glycogen synthase isoform 2 (≥92 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in yeast.",null,"P54840","P54840",18672,null,null,"NP_068776.2","Block3",13,11,"3, 11, 19, 27",{"$nulls":3},"Glycogen synthesis",{"$nulls":8},"X","Enzyme, glycogen synthesis","GO:0005938; GO:0030864; GO:0005737; GO:0005856; GO:0005829; GO:0043265","GO:0004373; GO:0061547; GO:0042803","GO:0006091; GO:0005978; GO:0009749"]
[1019,520,"PN036","H2AFX","S139","Histone H2A.X",{"v":1518.6050638030513,"d":"1519"},{"v":1365.581830688655,"d":"1366"},{"v":1024.5664241368909,"d":"1025"},{"v":67.46760224617343,"d":"67"},{"v":15.02730602133834,"d":"15"},{"v":5706.726451595028,"d":"5707"},"External","MmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the S139 phosphosite.","S139 phosphorylation regulates DNA damage response mechanism at double strand DNA breaks. This is one of the major in vivo phosphorylation sites in histone H2A.","ATM; JNK2 (MAPK9)","P16104","P16104",2540,null,"P16104","NP_002096","Block4",1,13,"4, 12, 20, 28",{"$nulls":13},"DNA binding protein, helicase","GO:0005813; GO:0000794; GO:0070062; GO:0001673; GO:0000790; GO:0016607; GO:0005654; GO:0000786; GO:0005634; GO:0005657; GO:0090734; GO:0035861; GO:0001741","GO:0003684; GO:0003677; GO:0019899; GO:0042393; GO:0046982","GO:0006974; GO:0071480; GO:0090398; GO:0021987; GO:0006342; GO:0000077; GO:0006302; GO:0000724; GO:0006303; GO:0051321; GO:0006334; GO:0045739; GO:0010212; GO:0007283; GO:0016032"]
[1021,521,"PN037","H2B","S14","Histone H2B",{"v":1014.4369889668766,"d":"1014"},{"v":982.5156925194798,"d":"983"},{"v":471.5401354361039,"d":"472"},{"v":46.48293985379319,"d":"46"},{"v":28.65083248606738,"d":"29"},{"v":2525.1165233763386,"d":"2525"},"External","RpAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the S14 phosphosite.","The effect of S14 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in histone H2B.","MST1 (STK4, KRS2); PKCd (PRKCD)","P33778","P33778",981,null,"P33778","NP_778225","Block4",2,1,"4, 12, 20, 28",{"$nulls":13},"DNA binding protein","GO:0005829; GO:0000784; GO:0005654; GO:0000786; GO:0005634","GO:0003677; GO:0046982","GO:0006334; GO:0016567"]
[1023,522,"PN101-2","H3F3A","T3","Histone H3",{"v":3504.40244911185,"d":"3504"},{"v":3360.865354262948,"d":"3361"},{"v":1542.281980999648,"d":"1542"},{"v":44.00984200289329,"d":"44"},{"v":107.47557184559777,"d":"107"},{"v":7427.766993791838,"d":"7428"},"External","RmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the T3 phosphosite.","T3 phosphorylation recruits and activates AurKB and other components of the chromosomal passenger complex (CPC) at centromeres to ensure proper chromatid cohesion, metaphase alignment and normal progression through the cell cycle (by analogy with histone H3 (H3T3ph) 'S3'). This is one of the major in vivo phosphorylation sites in histone H3.","AurB (STK12); Haspin (GSG2); VRK1","P84243","P84243",982,null,null,"NP_003521","Block4",2,2,"4, 12, 20, 28",{"$nulls":13},"DNA binding protein","GO:0070062; GO:0005576; GO:0000228; GO:0000784; GO:0000788; GO:0005654; GO:0000786; GO:0005634; GO:0032991","GO:0031492; GO:0046982; GO:0000979; GO:0000980","GO:0007596; GO:0044267; GO:0000183; GO:0006336; GO:0045814; GO:0006334; GO:0030307; GO:0060964; GO:0045652; GO:0032200"]
[1025,523,"PN038","H3F3A","S10","Histone H3",{"v":4723.849818783098,"d":"4724"},{"v":4775.073066218912,"d":"4775"},{"v":1394.0744251439187,"d":"1394"},{"v":29.51140443967466,"d":"30"},{"v":140.29849537118483,"d":"140"},{"v":8525.261499398204,"d":"8525"},"External","RpAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the S10 phosphosite.","S10 phosphorylation induces interaction with DNA and inhibits interaction with HP1-alpha. This is one of the major in vivo phosphorylation sites in histone H3.","Akt1 (PKBa); Akt2 (PKBb); AurA (STK15); AurB (STK12); AurC (STK13); DLK (MAP3K12); Fyn; MSK1 (RPS6KA5); MSK2 (RPS6KA4); p38a MAPK (MAPK14); PAK1; PBK (TOPK); Pim1; PKACa (PRKACA); PKCt (PRKCQ; PKCq); ROCK1; RSK1 (RPS6KA1); TLK1; VRK1","P84243","P84243",982,null,null,"NP_003521","Block4",2,3,"4, 12, 20, 28",{"$nulls":13},"DNA binding protein","GO:0070062; GO:0005576; GO:0000228; GO:0000784; GO:0000788; GO:0005654; GO:0000786; GO:0005634; GO:0032991","GO:0031492; GO:0046982; GO:0000979; GO:0000980","GO:0007596; GO:0044267; GO:0000183; GO:0006336; GO:0045814; GO:0006334; GO:0030307; GO:0060964; GO:0045652; GO:0032200"]
[1027,524,"PN039","H3F3A","S28","Histone H3",{"v":1366.3114738058043,"d":"1366"},{"v":1369.2772151664074,"d":"1369"},{"v":627.9178746555143,"d":"628"},{"v":45.9571544771175,"d":"46"},{"v":27.17993278283151,"d":"27"},{"v":4294.424923821516,"d":"4294"},"External","RpAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the S28 phosphosite.","S28 phosphorylation induces transcription. This is one of the major in vivo phosphorylation sites in histone H3.","Akt2 (PKBb); AurB (STK12); AurC (STK13); MSK1 (RPS6KA5); MSK2 (RPS6KA4); ROCK1; TGM2; ZAK (MLTK)","P84243","P84243",982,null,null,"NP_003521","Block4",2,4,"4, 12, 20, 28",{"$nulls":13},"DNA binding protein","GO:0070062; GO:0005576; GO:0000228; GO:0000784; GO:0000788; GO:0005654; GO:0000786; GO:0005634; GO:0032991","GO:0031492; GO:0046982; GO:0000979; GO:0000980","GO:0007596; GO:0044267; GO:0000183; GO:0006336; GO:0045814; GO:0006334; GO:0030307; GO:0060964; GO:0045652; GO:0032200"]
[1029,525,"PN228","H3F3A","S28","Histone H3",{"v":258.8988499749419,"d":"259"},{"v":157.92488946589526,"d":"158"},{"v":503.1248032577179,"d":"503"},{"v":194.33257556239198,"d":"194"},{"v":27.461724459058587,"d":"27"},{"v":4990.5015733732325,"d":"4991"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S28 phosphosite.","S28 phosphorylation induces transcription. This is one of the major in vivo phosphorylation sites in histone H3.","Akt2 (PKBb); AurB (STK12); AurC (STK13); MSK1 (RPS6KA5); MSK2 (RPS6KA4); ROCK1; TGM2; ZAK (MLTK)","P84243","P84243",982,null,null,"NP_003521","Block4",2,5,"4, 12, 20, 28",{"$nulls":13},"DNA binding protein","GO:0070062; GO:0005576; GO:0000228; GO:0000784; GO:0000788; GO:0005654; GO:0000786; GO:0005634; GO:0032991","GO:0031492; GO:0046982; GO:0000979; GO:0000980","GO:0007596; GO:0044267; GO:0000183; GO:0006336; GO:0045814; GO:0006334; GO:0030307; GO:0060964; GO:0045652; GO:0032200"]
[1031,506,"PN518","HCA59","Y147","Uncharacterized protein C9orf78",{"v":17729.818261198172,"d":"17730"},{"v":17438.96270583156,"d":"17439"},{"v":3850.328810863852,"d":"3850"},{"v":21.71668515796534,"d":"22"},{"v":9172.754086196574,"d":"9173"},{"v":29153.94633215322,"d":"29154"},"Kinexus","RpAb","DCL(pY)ELP(bA)C","Corresponds to amino acid residues D144 to P150; In the middle of the Hep_59 domain. ","The effect of Y147 phosphorylation is unclear. This is the major in vivo phosphorylation site in HCA59 (≥518 reports from high throughput mass spectrometry studies).","Syk","Q9NZ63","Q9NZ63",2647,null,null,"NP_057604.1","Block3",13,12,"3, 11, 19, 27",{"$nulls":13},"Uncharacterized protein","GO:0005829; GO:0005654"]
[1033,507,"PN604","HCFC1","S1507","Host cell factor 1",{"v":22510.694635099546,"d":"22511"},{"v":21757.26641602793,"d":"21757"},{"v":7610.259095966332,"d":"7610"},{"v":33.80730456935843,"d":"34"},{"v":8610.370018846354,"d":"8610"},{"v":45150.17095179751,"d":"45150"},"Kinexus","RpAb","ELQV(pS)PGPR(bA)C","Corresponds to amino acid residues E1503 to R1511.","The effect of S1507 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in HCFC1 (≥54 reports from high throughput mass spectrometry studies).","ERK1 (MAPK3)","P51610","P51610",16083,null,null,"NP_005325.2","Block3",13,13,"3, 11, 19, 27",{"$nulls":3},"Transcription,  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"Transcription, coactivator/corepressor","GO:0030424; GO:0005737; GO:0030425; GO:0000123; GO:0016020; GO:0071339; GO:0043025; GO:0005654; GO:0005634; GO:0032991; GO:0048188","GO:0033613; GO:0045296; GO:0003682; GO:0003700; GO:0042802; GO:0030674; GO:0001205; GO:0003713","GO:0007049; GO:0071407; GO:0043984; GO:0043981; GO:0043982; GO:0007005; GO:0000122; GO:0045787; GO:0010628; GO:0045893; GO:0016579; GO:0050821; GO:0043254; GO:0006355; GO:0019046; GO:0006366"]
[1035,508,"NK271-1","Hck","Pan-specific","Tyrosine-protein kinase Hck",{"v":4893.213739235279,"d":"4893"},{"v":4248.962215144353,"d":"4249"},{"v":2680.53303737127,"d":"2681"},{"v":54.78062435486804,"d":"55"},{"v":451.8456238012624,"d":"452"},{"v":18833.842144645692,"d":"18834"},"Kinexus","RpAb","CMKSKFLQVGGNTFSKTETS","Corresponds to amino acid residues C24 to S43; Post-N-terminus.",null,null,"P08631","P08631",1243,"P08631","P08631","NP_002101.2","Block4",1,1,"4, 12, 20, 28","HCK","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; Src family","GO:0005901; GO:0042995; GO:0005856; GO:0005829; GO:0031234; GO:0005925; GO:0005794; GO:0005764; GO:0005654; GO:0005886; GO:0030133","GO:0005524; GO:0004715; GO:0001784; GO:0004713; GO:0005102","GO:0007155; GO:0030154; GO:0019221; GO:0038096; GO:0006954; GO:0002758; GO:0007229; GO:0060333; GO:0043299; GO:0002522; GO:0031663; GO:0007498; GO:0043066; GO:0038083; GO:0018108; GO:2000251; GO:0030838; GO:0008284; GO:0046777; GO:0006468; GO:0008360; GO:0050690; GO:0051090; GO:0050727; GO:0050764; GO:0071801; GO:0045728; GO:0007169"]
[1037,509,"NN169","HDAC4","Pan-specific","Histone deacetylase 4",{"v":377.74676527429233,"d":"378"},{"v":358.22398258438733,"d":"358"},{"v":283.5854731637464,"d":"284"},{"v":75.07290577533529,"d":"75"},{"v":5.56494438853708,"d":"6"},{"v":1343.7920538424269,"d":"1344"},"External","RpAb","AQSSP","Corresponds to amino acid residues  A630 to P634; Surrounds the S632 phosphosite.",null,null,"P56524","P56524",985,null,"P56524","NP_006028.2","Block4",1,2,"4, 12, 20, 28",{"$nulls":13},"Enzyme, hydrolase; Nuclear receptor co-regulator","GO:0031672; GO:0042641; GO:0005737; GO:0005829; GO:0000118; GO:0031594; GO:0005654; GO:0005634; GO:0017053; GO:0030018","GO:0033613; GO:0004407; GO:0042826; GO:0042802; GO:0032041; GO:0030955; GO:1990841; GO:0033558; GO:0019901; GO:0070491; GO:0000978; GO:0001085; GO:0019789; GO:0003714; GO:0008134; GO:0008270","GO:0042113; GO:0030183; GO:0014898; GO:0071260; GO:0071374; GO:0071356; GO:0006338; GO:0016575; GO:0070932; GO:0070933; GO:0006954; GO:0008285; GO:0043433; GO:0045820; GO:0010832; GO:0045668; GO:1902894; GO:0045892; GO:0000122; GO:0007399; GO:0002076; GO:0034983; GO:0008284; GO:0051091; GO:0010592; GO:0043525; GO:0033235; GO:1903428; GO:0014911; GO:0048661; GO:0045893; GO:0045944; GO:0006476; GO:0010882; GO:0040029; GO:0043393; GO:0048742; GO:0014894; GO:0042493; GO:0070555; GO:0001501; GO:0006351"]
[1039,510,"PN179","HDAC4/5/9","S246/259/220","Histone deacetylase 4",{"v":1663.1408710783116,"d":"1663"},{"v":1537.972776398801,"d":"1538"},{"v":926.7724874225091,"d":"927"},{"v":55.724232597424425,"d":"56"},{"v":10.31196554691903,"d":"10"},{"v":5096.303592490387,"d":"5096"},"External","RpAb","TA(pS)EP","Corresponds to amino acid residues T244 to P248.","S246 phosphorylation induces interaction with 14-3-3-beta and 14-3-3-epsilon. This is one of the major in vivo phosphorylation sites in HDAC4 (≥41 reports by mass spectrometry) as well as HDAC5 and HDAC9.","CaMK1a; CaMK4; MARK2; TAK1 (MAP3K7)","P56524","P56524",985,null,"P56524","NP_006028.2","Block4",1,3,"4, 12, 20, 28",{"$nulls":13},"Enzyme, hydrolase; Nuclear receptor co-regulator","GO:0031672; GO:0042641; GO:0005737; GO:0005829; GO:0000118; GO:0031594; GO:0005654; GO:0005634; GO:0017053; GO:0030018","GO:0033613; GO:0004407; GO:0042826; GO:0042802; GO:0032041; GO:0030955; GO:1990841; GO:0033558; GO:0019901; GO:0070491; GO:0000978; GO:0001085; GO:0019789; GO:0003714; GO:0008134; GO:0008270","GO:0042113; GO:0030183; GO:0014898; GO:0071260; GO:0071374; GO:0071356; GO:0006338; GO:0016575; GO:0070932; GO:0070933; GO:0006954; GO:0008285; GO:0043433; GO:0045820; GO:0010832; GO:0045668; GO:1902894; GO:0045892; GO:0000122; GO:0007399; GO:0002076; GO:0034983; GO:0008284; GO:0051091; GO:0010592; GO:0043525; GO:0033235; GO:1903428; GO:0014911; GO:0048661; GO:0045893; GO:0045944; GO:0006476; GO:0010882; GO:0040029; GO:0043393; GO:0048742; GO:0014894; GO:0042493; GO:0070555; GO:0001501; GO:0006351"]
[1041,511,"PN188","HDAC5","S498","Histone deacetylase 5",{"v":1215.1930970696778,"d":"1215"},{"v":1198.4003243934376,"d":"1198"},{"v":635.0977024047188,"d":"635"},{"v":52.26310978363819,"d":"52"},{"v":43.361898547113924,"d":"43"},{"v":3914.868971294859,"d":"3915"},"External","RpAb","TQ(pS)SP","Corresponds to amino acid residues T496 to P500.","S498 phosphorylation inhibits enzyme activity, induces binding of 14-3-3-beta, 14-3-3-epsilon and N-CoR1, and inhibits interactions with GPS2, HDAC3, PRKD1, PRKD2, PRKD3, SMRT, TBL1X and TBL1XR1. This is one of the less major in vivo phosphorylation sites in HDAC5 (≥9 reports from high throughput mass spectrometry studies).","AMPKA1; CaMK1a; CaMK4; PRKD1; PRKD2; PRKD3","Q9UQL6","Q9UQL6",986,null,null,"NP_005465.2","Block4",1,4,"4, 12, 20, 28",{"$nulls":13},"Hydrolase; EC 3.5.1.98","GO:0005737; GO:0005829; GO:0005794; GO:0000118; GO:0016607; GO:0005654; GO:0005634","GO:0003682; GO:0004407; GO:0042826; GO:0046872; GO:0032041; GO:0033558; GO:0005080; GO:0070491; GO:0000978; GO:0001085; GO:0008134","GO:0042113; GO:0030183; GO:0032869; GO:0071222; GO:0006325; GO:0006338; GO:0006342; GO:0016575; GO:0006954; GO:0090051; GO:0010832; GO:0045892; GO:0000122; GO:0030182; GO:0051091; GO:0045944; GO:0006476; GO:0040029; GO:0010830; GO:0043393; GO:0014823; GO:0042220; GO:0006351"]
[1043,512,"PP500","HePTP (PTPN7)","S44","Tyrosine-protein phosphatase non-receptor type 7",{"v":4406.5015131402015,"d":"4407"},{"v":3782.430600067628,"d":"3782"},{"v":2876.696238985203,"d":"2877"},{"v":65.28299673577521,"d":"65"},{"v":229.22050296864631,"d":"229"},{"v":16986.756261334103,"d":"16987"},"Kinexus","RpAb","RRG(pS)NVA(bA)C","Corresponds to amino acid residues R41 to A47.","S44 phosphorylation inhibits interaction with ERK2. This is one of the major in vivo phosphorylation sites in HePTP (≥44 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and found in fish.","PKACa (PRKACA); PKCt (PRKCQ; PKCq)","P35236","P35236",1223,null,"P35236","NP_002823.3","Block4",1,5,"4, 12, 20, 28",null,null,"PYP","Protein phosphatase - Non-receptor protein-tyrosine phosphatase",{"$nulls":6},"X",null,null,"Protein phosphataseProtein-tyrosine phosphatase","GO:0005737; GO:0009898; GO:0005856; GO:0005829; GO:0005654","GO:0004725","GO:0071345; GO:0006470"]
[1045,513,"PP501","HePTP (PTPN7)","T66","Tyrosine-protein phosphatase non-receptor type 7",{"v":11834.473589869742,"d":"11834"},{"v":11906.285688684868,"d":"11906"},{"v":2920.388409994436,"d":"2920"},{"v":24.67696081128844,"d":"25"},{"v":1106.9016712281943,"d":"1107"},{"v":20961.77421001948,"d":"20962"},"Kinexus","RpAb","CSVN(pT)PRE","Corresponds to amino acid residues C62 to E69.","T66 phosphorylation inhibits interaction with ERK2 and p38a MAPK, and promotes dissociation of HePTP from its substrate. This is one of the major in vivo phosphorylation sites in HePTP (≥52 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and found in fish.","ERK1 (MAPK3); ERK2 (MAPK1); p38a MAPK (MAPK14)","P35236","P35236",1223,null,"P35236","NP_002823.3","Block4",1,6,"4, 12, 20, 28",null,null,"PYP","Protein phosphatase - Non-receptor protein-tyrosine phosphatase",{"$nulls":6},"X",null,null,"Protein phosphataseProtein-tyrosine phosphatase","GO:0005737; GO:0009898; GO:0005856; GO:0005829; GO:0005654","GO:0004725","GO:0071345; GO:0006470"]
[1047,514,"PP528","HePTP (PTPN7)","S143","Tyrosine-protein phosphatase non-receptor type 7",{"v":15539.924929640605,"d":"15540"},{"v":15282.91281584882,"d":"15283"},{"v":3621.8826070366254,"d":"3622"},{"v":23.306950473926065,"d":"23"},{"v":2328.5004330934435,"d":"2329"},{"v":28025.227161718532,"d":"28025"},"Kinexus","RpAb","CGRAQ(pS)QED","Corresponds to amino acid residues G139 to D146.","The effect of S143 phosphorylation is unclear. This is the major in vivo phosphorylation site in HePTP (≥99 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in mammals and also found in the chicken.",null,"P35236","P35236",1223,null,"P35236","NP_002823.3","Block4",1,7,"4, 12, 20, 28",null,null,"PYP","Protein phosphatase - Non-receptor protein-tyrosine phosphatase",{"$nulls":6},"X",null,null,"Protein phosphataseProtein-tyrosine phosphatase","GO:0005737; GO:0009898; GO:0005856; GO:0005829; GO:0005654","GO:0004725","GO:0071345; GO:0006470"]
[1049,515,"NK300-1","HGK (ZC1)","Pan-specific","Mitogen-activated protein kinase kinase kinase kinase 4",{"v":8189.792267714311,"d":"8190"},{"v":8196.383546349072,"d":"8196"},{"v":1929.0630894947071,"d":"1929"},{"v":23.55448131571583,"d":"24"},{"v":1132.712726895949,"d":"1133"},{"v":15160.23175972674,"d":"15160"},"Kinexus","RpAb","ANDSPAKSLVDIDLSSLRDC","Corresponds to amino acid residues A2 to D20; N-terminus.",null,null,"O95819","O95819",2496,"O95819",null,"NP_001229488.1","Block4",1,8,"4, 12, 20, 28","ZC1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","MSN",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE group; STE20 family; MSN subfamily","GO:0005737; GO:0005925","GO:0005524; GO:0004111; GO:0008349; GO:0008017; GO:0004674","GO:0035556; GO:0043066; GO:0001953; GO:0061179; GO:0070571; GO:0048812; GO:1903393; GO:0032014; GO:0030335; GO:0051894; GO:0043547; GO:0051549; GO:0006468; GO:0046328; GO:0007346"]
[1051,516,"PK653","HGK (ZC1)","T187","Mitogen-activated protein kinase kinase kinase kinase 4",{"v":7290.3632551834635,"d":"7290"},{"v":7119.1980061900285,"d":"7119"},{"v":2398.9191766248337,"d":"2399"},{"v":32.905344941751665,"d":"33"},{"v":428.04456319659624,"d":"428"},{"v":14883.846663765838,"d":"14884"},"Kinexus","RpAb","RRN(pT)FIG(bA)C","Corresponds to amino acid residues R184 to G190; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T187 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in HGK (≥109 reports from high throughput mass spectrometry studies).",null,"O95819","O95819",2496,"O95819",null,"NP_001229488.1","Block4",1,9,"4, 12, 20, 28","ZC1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","MSN",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE group; STE20 family; MSN subfamily","GO:0005737; GO:0005925","GO:0005524; GO:0004111; GO:0008349; GO:0008017; GO:0004674","GO:0035556; GO:0043066; GO:0001953; GO:0061179; GO:0070571; GO:0048812; GO:1903393; GO:0032014; GO:0030335; GO:0051894; GO:0043547; GO:0051549; GO:0006468; GO:0046328; GO:0007346"]
[1053,517,"PN519","HGS (Hrs)","Y216","Hepatocyte growth factor-regulated tyrosine kinase substrate",{"v":9711.302816828567,"d":"9711"},{"v":9773.525744753822,"d":"9774"},{"v":2513.3927985227624,"d":"2513"},{"v":25.881108291333916,"d":"26"},{"v":3475.0525061377707,"d":"3475"},{"v":17257.669287139644,"d":"17258"},"Kinexus","RpAb","EPC(pY)EQL(bA)C","Corresponds to amino acid residues E213 to L219; In the FYVE domain. ","The effect of Y216 phosphorylation is unclear. This is the major in vivo phosphorylation site in HGS (≥1385 reports from high throughput mass spectrometry studies).",null,"O14964","O14964",3904,null,"O14964","NP_004703.1","Block4",1,10,"4, 12, 20, 28",{"$nulls":11},"X",null,"Adapter/scaffold protein","GO:0005829; GO:0005769; GO:0031901; GO:0005768; GO:0033565; GO:0070062; GO:0043231; GO:0005764; GO:0032585","GO:0046872; GO:0019904; GO:0044389","GO:0016197; GO:0016236; GO:0010324; GO:0061024; GO:0036258; GO:0016525; GO:0008285; GO:0042059; GO:0046426; GO:0010642; GO:0030948; GO:1903543; GO:0010628; GO:0072657; GO:0006622; GO:0043405; GO:0042176; GO:0007165"]
[1055,518,"PK654","HIPK1","Y352","Homeodomain-interacting protein-serine kinase 1",{"v":7777.814955779413,"d":"7778"},{"v":7678.167621333134,"d":"7678"},{"v":1849.9950722560186,"d":"1850"},{"v":23.78553723345339,"d":"24"},{"v":472.92527114798634,"d":"473"},{"v":14173.6198551559,"d":"14174"},"Kinexus","RpAb","CST(pY)LQS(bA)C","Corresponds to amino acid residues C349 to S355; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII. ","Y352 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation site in HIPK1 (≥3356 reports from high throughput mass spectrometry studies).",null,"Q86Z02","Q86Z02",4227,"Q86Z02",null,"NP_938009.1","Block4",1,11,"4, 12, 20, 28","HIPK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","DYRK","HIPK",{"$nulls":5},"EC 2.7.1.; Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; CMGC domain target; CMGC</A> group; DYRK family; HIPK subfamily","GO:0005813; GO:0005737; GO:0005829; GO:0016607; GO:0005654; GO:0005634; GO:0016605","GO:0005524; GO:0004674","GO:0034333; GO:0009952; GO:0060216; GO:0048596; GO:0060059; GO:0072577; GO:0097191; GO:0001654; GO:0042771; GO:0061072; GO:0060235; GO:0030182; GO:0045766; GO:0008284; GO:1901796; GO:0006355; GO:0010803; GO:0010842; GO:0007224; GO:0006351"]
[1057,519,"NK272-1","HIPK2","Pan-specific","Homeodomain-interacting protein-serine kinase 2",{"v":2279.729960427611,"d":"2280"},{"v":2086.2601904029393,"d":"2086"},{"v":1109.2701801575704,"d":"1109"},{"v":48.657963855925445,"d":"49"},{"v":416.78786106276436,"d":"417"},{"v":6557.350143822584,"d":"6557"},"Kinexus","RpAb","HPSQYPAQFAHQTYISASC","Corresponds to amino acid residues H1159 to S1176; Pre-C-terminus.",null,null,"Q9H2X6","Q9H2X6",701,"Q9H2X6","Q9H2X6","NP_073577.3","Block4",1,12,"4, 12, 20, 28","HIPK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","DYRK","HIPK",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; CMGC domain target; CMGC</A> group; DYRK family; HIPK subfamily","GO:0005737; GO:0016604; GO:0005654; GO:0005634; GO:0016605; GO:0090575","GO:0005524; GO:0004672; GO:0004674; GO:0001102; GO:0046332; GO:0003713; GO:0003714; GO:0046790","GO:0007628; GO:0009952; GO:0071456; GO:0006978; GO:0048596; GO:0060059; GO:0030218; GO:0001654; GO:0097193; GO:0042771; GO:0061072; GO:0060235; GO:0019048; GO:0030514; GO:0043524; GO:0000122; GO:2000059; GO:0030182; GO:0018105; GO:0018107; GO:0030578; GO:0045766; GO:0008284; GO:0043388; GO:0051091; GO:0046330; GO:0032092; GO:0045893; GO:0045944; GO:0030511; GO:0006468; GO:0051726; GO:1901796; GO:0010842; GO:0060395; GO:0007224; GO:0006351; GO:0007179; GO:0050882"]
[1059,526,"PN605","HMGA1","S36+T39","High mobility group protein HMG-I/HMG-Y",{"v":15154.865340071512,"d":"15155"},{"v":14709.419658243749,"d":"14709"},{"v":3387.234197453582,"d":"3387"},{"v":22.35080366235441,"d":"22"},{"v":5173.264916094566,"d":"5173"},{"v":26430.58077293061,"d":"26431"},"Kinexus","RpAb","PPV(pS)PG(pT)ALVGC","Corresponds to amino acid residues P33 to G43.","S36 and T39 phosphorylation regulates molecular association, including inducing interaction with DNA. These are two of the minor in vivo phosphorylation sites in HMGA1 (≥64 and ≥27 reports, respectively, from high throughput mass spectrometry studies).","S36: ERK1 (MAPK3); CDK1; CDK2; HIPK2","P17096","P17096",5177,null,"P17096","NP_001306007.1","Block4",2,6,"4, 12, 20, 28",{"$nulls":3},"DNA binding protein",{"$nulls":4},"X",{"$nulls":4},"DNA binding protein","GO:0005829; GO:0005925; GO:0005654; GO:0005634; GO:0090575; GO:0035985; GO:0005667","GO:0051575; GO:0003680; GO:0003682; GO:0003906; GO:0003677; GO:0003700; GO:0001158; GO:0019899; GO:0030374; GO:0042975; GO:0042974; GO:0046965; GO:0000981; GO:0001205; GO:0008134","GO:0006284; GO:0006268; GO:0075713; GO:0008285; GO:0031936; GO:0045892; GO:0051169; GO:0006337; GO:0090402; GO:2000774; GO:0045893; GO:0045944; GO:0065003; GO:0006355; GO:0009615; GO:0035986"]
[1061,527,"PN606","HMGA1","T53","High mobility group protein HMG-I/HMG-Y",{"v":17240.94016367449,"d":"17241"},{"v":15887.63442183446,"d":"15888"},{"v":6445.124250890556,"d":"6445"},{"v":37.382672810790226,"d":"37"},{"v":1825.9276410634384,"d":"1826"},{"v":44937.55478698255,"d":"44938"},"Kinexus","RpAb","SEVP(pT)PKR(bA)C","Corresponds to amino acid residues S49 to R56.","T53 phosphorylation regulates molecular association, including inducing interaction with DNA. This is one of the less major in vivo phosphorylation sites in HMG1 (≥77 reports from high throughput mass spectrometry studies).","CDK1 (CDC2); CDK2; CDK4; CDK6","P17096","P17096",5177,null,"P17096","NP_001306007.1","Block4",2,7,"4, 12, 20, 28",{"$nulls":3},"DNA binding protein",{"$nulls":4},"X",{"$nulls":4},"DNA binding protein","GO:0005829; GO:0005925; GO:0005654; GO:0005634; GO:0090575; GO:0035985; GO:0005667","GO:0051575; GO:0003680; GO:0003682; GO:0003906; GO:0003677; GO:0003700; GO:0001158; GO:0019899; GO:0030374; GO:0042975; GO:0042974; GO:0046965; GO:0000981; GO:0001205; GO:0008134","GO:0006284; GO:0006268; GO:0075713; GO:0008285; GO:0031936; GO:0045892; GO:0051169; GO:0006337; GO:0090402; GO:2000774; GO:0045893; GO:0045944; GO:0065003; GO:0006355; GO:0009615; GO:0035986"]
[1063,528,"PN607","HMGB1","S35+S39","High mobility group protein B1",{"v":13334.866058326781,"d":"13335"},{"v":13210.125452628738,"d":"13210"},{"v":2706.62399463662,"d":"2707"},{"v":20.297346690981605,"d":"20"},{"v":6234.713448514144,"d":"6235"},{"v":21904.36762031891,"d":"21904"},"Kinexus","RpAb","PDA(pS)VNF(pS)EFS(bA)C","Corresponds to amino acid residues P32 to S42.","The effects of S35 and S39 phosphorylation are unknown. S35 and S39 phosphoryation facilitates nucleus to cytoplasmic HMGB1 transport, and regulates cell motility. These are two of the major in vivo phosphorylation sites in HMGB1 (≥22 and 6 reports, respectively, from high throughput mass spectrometry studies).",null,"P09429","P09429",6934,null,"P09429","NP_001300821.1","Block4",2,8,"4, 12, 20, 28",{"$nulls":3},"DNA repair; Nuclear receptor co-regulator",{"$nulls":4},"X",{"$nulls":4},"DNA repair; Nuclear receptor co-regulator","GO:0035868; GO:0009986; GO:0000793; GO:0005793; GO:0005768; GO:0005576; GO:0005615; GO:1904813; GO:0005654; GO:0005634; GO:0034774","GO:0000405; GO:0042056; GO:0019958; GO:0005125; GO:0003684; GO:0008301; GO:0003700; GO:0070182; GO:0003690; GO:0000400; GO:0005178; GO:0001530; GO:0016829; GO:0001786; GO:0050786; GO:0070491; GO:0003723; GO:0003697; GO:0097100; GO:0008134","GO:0002218; GO:0043277; GO:0006309; GO:0006914; GO:0002407; GO:0032392; GO:0051103; GO:0006310; GO:0006265; GO:0006954; GO:0002437; GO:0045087; GO:0001773; GO:2000426; GO:0043537; GO:0043371; GO:0032689; GO:0017055; GO:0000122; GO:0031175; GO:0097350; GO:0043312; GO:0042104; GO:0043065; GO:0043536; GO:0043280; GO:0007204; GO:2001200; GO:0043388; GO:0051106; GO:0070374; GO:0032733; GO:0032735; GO:0050716; GO:2000778; GO:0046330; GO:0043410; GO:0032425; GO:0090026; GO:0034165; GO:0045944; GO:1905564; GO:0010506; GO:0032072; GO:0002840; GO:0002643; GO:0006357; GO:0035711; GO:0045063; GO:0002224; GO:1990774; GO:0033151"]
[1065,529,"PN705","HMGCR","S872","3-hydroxy-3-methylglutaryl-coenzyme A reductase",{"v":9483.581589876854,"d":"9484"},{"v":9399.945561336306,"d":"9400"},{"v":2494.5864469370595,"d":"2495"},{"v":26.304265148094245,"d":"26"},{"v":2202.3491503603077,"d":"2202"},{"v":18291.946742004195,"d":"18292"},"Kinexus","RpAb","HNR(pS)KIN(bA)C","Corresponds to amino acid residues H869 to N875.","The effect of S872 phosphorylation is unclear. This phosphorylation site is not commonly detected by mass spectrometry (≥9 reports), but appears to be the major phosphosite on HMG-CoA reductase.  This phosphosite is not well conserved in vertebrates, but is found in rhesus monkey.","AMPKa1 (PRKAA1); PKACa (PRKACA); PKCa (PRKCA)","P04035","P04035",1659,null,"P04035","NP_000850.1","Block4",2,9,"4, 12, 20, 28",{"$nulls":3},"Cholesterol synthesis",{"$nulls":8},"X","Enzyme, cholesterol synthesis","GO:0005783; GO:0005789; GO:0016021; GO:0005778","GO:0050662; GO:0004420; GO:0042282; GO:0070402; GO:0042803; GO:0051721","GO:0007568; GO:0006695; GO:0015936; GO:0008299; GO:0045445; GO:0097756; GO:0061179; GO:0043407; GO:0010664; GO:0061045; GO:0010666; GO:0070374; GO:0048643; GO:0048661; GO:0032874; GO:0051262; GO:0045540; GO:0019216; GO:0045471; GO:0007584; GO:0006743; GO:0008542"]
[1067,530,"PN754","HMGCS1","S495","HMG-CoA synthase 1",{"v":24124.281580128,"d":"24124"},{"v":22681.28815671213,"d":"22681"},{"v":7590.379086204081,"d":"7590"},{"v":31.46364819608364,"d":"31"},{"v":4430.082209444363,"d":"4430"},{"v":56374.79731947527,"d":"56375"},"Kinexus","RpAb","HIP(pS)PAK(bA)C","Corresponds to amino acid residues H492 to K498.","The effect of S495 phosphorylation is unclear. This is the major in vivo phosphorylation site in HMGCS1 (≥55 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and found in fish.","CDK1 (CDC2)","Q01581","Q01581",9214,null,null,"NP_001091742.1","Block4",2,10,"4, 12, 20, 28",{"$nulls":3},"Ketogenesis",{"$nulls":8},"X","Lipid Metabolism - synthesis and degradation of ketone bodies; EC 2.3.3.10; Transferase; Carbohydrate Metabolism - butanoate; Amino Acid Metabolism - valine, leucine and isoleucine degradation; Secondary Metabolites Metabolism - terpenoid backbone biosynthesis","GO:0005737; GO:0005829","GO:0008144; GO:0004421; GO:0016853; GO:0043177; GO:0042803","GO:0007420; GO:0071397; GO:0071372; GO:0071404; GO:0006695; GO:0008299; GO:0006629; GO:0001889; GO:0008584; GO:0045540; GO:0019216; GO:0042493; GO:0009645; GO:0014074; GO:0046690; GO:0033197"]
[1069,531,"PN608","HNF4A","S167","Hepatocyte nuclear factor 4-alpha",{"v":13211.968132150874,"d":"13212"},{"v":12943.184929116298,"d":"12943"},{"v":3603.5257715062685,"d":"3604"},{"v":27.27470832098975,"d":"27"},{"v":3935.446858598606,"d":"3935"},{"v":28664.40299626457,"d":"28664"},"Kinexus","RpAb","RQIT(pS)PVSGC","Corresponds to amino acid residues R163 to G171.","S167 phosphorylation induces transcription and interaction with PC4. This is one of the major in vivo phosphorylation sites in HNF4A (≥31 reports from high throughput mass spectrometry studies).","p38a MAPK (MAPK14); p38b MAPK (MAPK11)","P41235","P41235",3687,null,null,"NP_000448.3","Block4",2,11,"4, 12, 20, 28",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005737; GO:0005654; GO:0005634","GO:0003677; GO:0003700; GO:0005504; GO:0004879; GO:0042803; GO:0001102; GO:0000978; GO:0000981; GO:0005102; GO:0003707; GO:0001077; GO:0003705; GO:0044212; GO:0008270","GO:0007596; GO:0042632; GO:0042593; GO:0070365; GO:0055088; GO:0006629; GO:0030308; GO:0008285; GO:0006591; GO:0055091; GO:0045893; GO:0045944; GO:0010470; GO:0060398; GO:0050796; GO:0019216; GO:0006357; GO:0009749; GO:0007548; GO:0023019; GO:0060395; GO:0006367; GO:0070328; GO:0003323; GO:0006805"]
[1071,532,"PN229","hnRNP-K","S302","Heterogeneous nuclear ribonucleoprotein K",{"v":201.25032288317465,"d":"201"},{"v":147.26537865145417,"d":"147"},{"v":216.44209884013927,"d":"216"},{"v":107.54869643900318,"d":"108"},{"v":27.03929132760722,"d":"27"},{"v":2236.6249900057965,"d":"2237"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S302 phosphosite.","S302 phosphorylation induces activity and binding to PKCd. This phosphorylation site in hnRNP-K has not apparently been reported from high throughput mass spectrometry studies.","PKCd (PRKCD)","P61978","P61978",988,null,"P61978","NP_001305115.1","Block4",2,12,"4, 12, 20, 28",{"$nulls":13},"RNA binding protein","GO:0071013; GO:0042995; GO:0005737; GO:0010494; GO:0070062; GO:0005925; GO:0016020; GO:0000790; GO:0005654; GO:0005634; GO:0002102","GO:0045296; GO:0042802; GO:0019904; GO:0003723; GO:0000978; GO:0003697; GO:0001077","GO:0000398; GO:0043066; GO:0048025; GO:0045716; GO:0048260; GO:0045944; GO:1902165; GO:0072369; GO:0010988; GO:0016070; GO:0006396; GO:0007165; GO:0016032"]
[1073,533,"NK072","HPK1 (MAP4K1)","Pan-specific","Mitogen-activated protein kinase kinase kinase kinase 1",{"v":811.6296244168202,"d":"812"},{"v":741.9697699860567,"d":"742"},{"v":452.5756390958174,"d":"453"},{"v":55.76135043382705,"d":"56"},{"v":44.97620083866788,"d":"45"},{"v":2699.1516729028817,"d":"2699"},"External","GpAb","Not precisely defined.","Antibody raised against amino acid residues at the N-terminus of human HPK1.",null,null,"Q92918","Q92918",1180,"Q92918",null,"NP_009112.1","Block4",2,13,"4, 12, 20, 28","HPK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","KHS",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE20 family; KHS subfamily","GO:0005737; GO:0005622; GO:0016020","GO:0005524; GO:0008349; GO:0004672; GO:0004674","GO:0007257; GO:0000185; GO:0008283; GO:1904628; GO:0018105; GO:0046777; GO:0006468; GO:0042981; GO:0007346"]
[1075,534,"NN281-3","HRAS","Pan-specific","GTPase HRas",{"v":4648.320487322561,"d":"4648"},{"v":4590.881313166798,"d":"4591"},{"v":1560.569609847202,"d":"1561"},{"v":33.57276276675346,"d":"34"},{"v":99.59278116214591,"d":"100"},{"v":10134.544165572646,"d":"10135"},"Kinexus","RpAb","RQHKLRKLNPPDESGPGC","Corresponds to amino acid residues R164 to C181; C-terminus.",null,null,"P01112","P01112",2698,null,"P01112","NP_001123914.1","Block4",3,1,"4, 12, 20, 28",{"$nulls":3},"GTPase",{"$nulls":9},"G protein; G protein, monomeric (non-Rab)","GO:0005737; GO:0005829; GO:0098978; GO:0005794; GO:0000139; GO:0005634; GO:0048471; GO:0005886","GO:0019003; GO:0003924; GO:0005525; GO:0008022","GO:0009887; GO:0007050; GO:0008283; GO:0007166; GO:0071480; GO:0090398; GO:0006935; GO:0042832; GO:0006897; GO:0048013; GO:0097193; GO:0000165; GO:0007093; GO:0008285; GO:0010629; GO:0034260; GO:0043524; GO:2000251; GO:0030335; GO:0008284; GO:0045740; GO:0050679; GO:0070374; GO:0043547; GO:0032729; GO:0046330; GO:0043410; GO:0043406; GO:2000630; GO:0010863; GO:0001934; GO:0090314; GO:0046579; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0007265; GO:0048169; GO:0098696; GO:0035900; GO:0007165; GO:0002223; GO:0050852; GO:0042088"]
[1077,535,"PN755","HRAS","Y157","GTPase HRas",{"v":7258.806276350844,"d":"7259"},{"v":7350.457043186763,"d":"7350"},{"v":2148.221071927473,"d":"2148"},{"v":29.594688026409617,"d":"30"},{"v":283.3674320111252,"d":"283"},{"v":12969.449190199775,"d":"12969"},"Kinexus","RpAb","DAF(pY)TLV(bA)C","Corresponds to amino acid residues D154 to V160.","The effect of Y157 phosphorylation is unknown. This phosphosite is found in K- and N-Ras. This is the major in vivo phosphorylation site in HRAS (16 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in red bread mould.","Src","P01112","P01112",2698,null,"P01112","NP_001123914.1","Block4",3,2,"4, 12, 20, 28",{"$nulls":3},"GTPase",{"$nulls":9},"G protein; G protein, monomeric (non-Rab)","GO:0005737; GO:0005829; GO:0098978; GO:0005794; GO:0000139; GO:0005634; GO:0048471; GO:0005886","GO:0019003; GO:0003924; GO:0005525; GO:0008022","GO:0009887; GO:0007050; GO:0008283; GO:0007166; GO:0071480; GO:0090398; GO:0006935; GO:0042832; GO:0006897; GO:0048013; GO:0097193; GO:0000165; GO:0007093; GO:0008285; GO:0010629; GO:0034260; GO:0043524; GO:2000251; GO:0030335; GO:0008284; GO:0045740; GO:0050679; GO:0070374; GO:0043547; GO:0032729; GO:0046330; GO:0043410; GO:0043406; GO:2000630; GO:0010863; GO:0001934; GO:0090314; GO:0046579; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0007265; GO:0048169; GO:0098696; GO:0035900; GO:0007165; GO:0002223; GO:0050852; GO:0042088"]
[1079,536,"NK383-1","HRI (HCR; EIF2AK1)","Pan-specific","Eukaryotic translation initiation factor 2-alpha kinase 1",{"v":275.4588179859192,"d":"275"},{"v":225.1372687207437,"d":"225"},{"v":183.66132957904168,"d":"184"},{"v":66.67469602967294,"d":"67"},{"v":38.70585191911246,"d":"39"},{"v":1527.8821220594805,"d":"1528"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 27-165 mapping near the N-terminus of human HRI.",null,null,"Q9BQI3","Q9BQI3",1674,"Q9BQI3",null,"NP_055228.2","Block4",3,3,"4, 12, 20, 28","HRI","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","PEK",{"$nulls":6},"Protein-serine kinase, Other group, PEK family","GO:0005737","GO:0005524; GO:0004694; GO:0020037; GO:0042803","GO:0002526; GO:0055072; GO:0030225; GO:0008285; GO:0046986; GO:0045993; GO:0006909; GO:0046777; GO:0046501; GO:0010999; GO:1990641"]
[1081,537,"PK876","HRI (HCR; EIF2AK1)","S258","Eukaryotic translation initiation factor 2-alpha kinase 1",{"v":526.699037129403,"d":"527"},{"v":20.542114085569004,"d":"21"},{"v":1064.6743576305607,"d":"1065"},{"v":202.1409348749169,"d":"202"},{"v":2.838118260903923,"d":"3"},{"v":4246.421149636561,"d":"4246"},"Kinexus","RpAb","EVL(pS)DQE(bA)C","Corresponds to amino acid residues E255 to E261. S258 is located in the Gap/Insert 4 (G/I4) region in the protein-serine/threonine kinase catalytic domain of HRI. ","The effect of S258 phosphorylation is unknown. S258 appears to be the most commonly observed phosphosite in HRI from high throughput mass spectrometry studies (~12 reports).",null,"Q9BQI3","Q9BQI3",1674,"Q9BQI3",null,"NP_055228.2","Block4",3,4,"4, 12, 20, 28","HRI","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","PEK",{"$nulls":6},"Protein-serine kinase, Other group, PEK family","GO:0005737","GO:0005524; GO:0004694; GO:0020037; GO:0042803","GO:0002526; GO:0055072; GO:0030225; GO:0008285; GO:0046986; GO:0045993; GO:0006909; GO:0046777; GO:0046501; GO:0010999; GO:1990641"]
[1083,538,"NN268-2","HSF1","Pan-specific","Heat shock factor protein 1",{"v":762.7714753715089,"d":"763"},{"v":672.2517199251286,"d":"672"},{"v":582.1249026722919,"d":"582"},{"v":76.3170781116018,"d":"76"},{"v":14.496524449592238,"d":"14"},{"v":3465.123232772378,"d":"3465"},"External","ratmAb","Epitope undefined.",{"$nulls":3},"Q00613","Q00613",1196,null,null,"NP_005517.1","Block4",3,5,"4, 12, 20, 28",{"$nulls":3},"Transcription protein",{"$nulls":4},"X","X",{"$nulls":3},"Transcription protein","GO:0005813; GO:0000777; GO:0005737; GO:0005829; GO:0000791; GO:0000792; GO:0000776; GO:0097431; GO:0097165; GO:0005654; GO:0005634; GO:0048471; GO:0016605; GO:0045120; GO:1990904","GO:0031490; GO:0003677; GO:0003700; GO:0031072; GO:0051879; GO:0042802; GO:1990841; GO:0046982; GO:0019901; GO:0043621; GO:0001162; GO:0000978; GO:0000981; GO:0043565; GO:0098847; GO:0097677; GO:0001078; GO:0061770","GO:0034622; GO:1904385; GO:0071276; GO:0071280; GO:0072738; GO:0071392; GO:0071480; GO:0034605; GO:0070301; GO:1904845; GO:0071222; GO:1904843; GO:0035865; GO:1903936; GO:0034620; GO:0006952; GO:0006281; GO:0001892; GO:0060136; GO:0007143; GO:0000165; GO:0006397; GO:0009299; GO:0051028; GO:0010667; GO:0008285; GO:2001033; GO:0090084; GO:1901215; GO:0000122; GO:0032720; GO:1902512; GO:0008284; GO:0120162; GO:0043280; GO:0090261; GO:1904528; GO:0045931; GO:1900365; GO:0040018; GO:0045944; GO:0061408; GO:0042531; GO:0051260; GO:0070207; GO:1900034; GO:0043497; GO:0014823; GO:1990910; GO:1990911; GO:0033574; GO:0007283"]
[1085,539,"PN609","HSF1","S303+S307","Heat shock factor protein 1",{"v":11430.13433498306,"d":"11430"},{"v":11143.66979967064,"d":"11144"},{"v":2235.566674361747,"d":"2236"},{"v":19.558533686866422,"d":"20"},{"v":5861.314155642679,"d":"5861"},{"v":19947.317381875,"d":"19947"},"Kinexus","RpAb","EPP(pS)PPQ(pS)PRV(bA)C","Corresponds to amino acid residues E300 to V310.","S303 and S307 phosphorylation induces a repression of transcriptional activity, and induce interaction with 14-3-3 epsilon and SUMO1. These are two of the major in vivo phosphorylation sites in HSF1 (≥59 and ≥55 reports, respectively, from high throughput mass spectrometry studies).","S303: BARK2 (GRK3, ADRBK2); ERK1 (MAPK3); ERK2 (MAPK1); GSK3b; p38a MAPK; p38b MAPK; p38d MAPK; p38g MAPK.  S307: ERK1 (MAPK3); ERK2 (MAPK1).","Q00613","Q00613",1196,null,null,"NP_005517.1","Block4",3,6,"4, 12, 20, 28",{"$nulls":3},"Transcription protein",{"$nulls":4},"X","X",{"$nulls":3},"Transcription protein","GO:0005813; GO:0000777; GO:0005737; GO:0005829; GO:0000791; GO:0000792; GO:0000776; GO:0097431; GO:0097165; GO:0005654; GO:0005634; GO:0048471; GO:0016605; GO:0045120; GO:1990904","GO:0031490; GO:0003677; GO:0003700; GO:0031072; GO:0051879; GO:0042802; GO:1990841; GO:0046982; GO:0019901; GO:0043621; GO:0001162; GO:0000978; GO:0000981; GO:0043565; GO:0098847; GO:0097677; GO:0001078; GO:0061770","GO:0034622; GO:1904385; GO:0071276; GO:0071280; GO:0072738; GO:0071392; GO:0071480; GO:0034605; GO:0070301; GO:1904845; GO:0071222; GO:1904843; GO:0035865; GO:1903936; GO:0034620; GO:0006952; GO:0006281; GO:0001892; GO:0060136; GO:0007143; GO:0000165; GO:0006397; GO:0009299; GO:0051028; GO:0010667; GO:0008285; GO:2001033; GO:0090084; GO:1901215; GO:0000122; GO:0032720; GO:1902512; GO:0008284; GO:0120162; GO:0043280; GO:0090261; GO:1904528; GO:0045931; GO:1900365; GO:0040018; GO:0045944; GO:0061408; GO:0042531; GO:0051260; GO:0070207; GO:1900034; GO:0043497; GO:0014823; GO:1990910; GO:1990911; GO:0033574; GO:0007283"]
[1087,540,"NN152-2","HSP27 (HSP28; HSPB1)","Pan-specific","Heat shock 27 kDa protein beta 1",{"v":2271.2268829499053,"d":"2271"},{"v":2293.407407113896,"d":"2293"},{"v":998.2186002285309,"d":"998"},{"v":43.95063336570008,"d":"44"},{"v":32.516227857975814,"d":"33"},{"v":5776.808963272362,"d":"5777"},"External","RpAb","Epitope undefined.",{"$nulls":3},"P04792","P04792",989,null,"P04792","NP_001531","Block4",3,7,"4, 12, 20, 28",{"$nulls":3},"Chaperone protein",{"$nulls":5},"X",{"$nulls":3},"Chaperone protein","GO:1904115; GO:0005737; GO:0005856; GO:0005829; GO:0070062; GO:0005615; GO:0005925; GO:0005634; GO:0005886; GO:0000502; GO:0005819; GO:0030018","GO:0042802; GO:0044183; GO:0042803; GO:0019901; GO:0005080; GO:0008426; GO:0003723; GO:0043130","GO:0099641; GO:0035924; GO:0061077; GO:0035556; GO:0043066; GO:1902176; GO:0006469; GO:0070527; GO:0045766; GO:0043536; GO:2001028; GO:0038033; GO:0032731; GO:0042535; GO:0010506; GO:0043122; GO:0043488; GO:0001932; GO:0006446; GO:0006986; GO:0009615; GO:0001895"]
[1089,541,"PN041","HSP27 (HSP28; HSPB1)","S78","Heat shock 27 kDa protein beta 1",{"v":1247.4418079494076,"d":"1247"},{"v":1152.8190692287858,"d":"1153"},{"v":735.9532771616041,"d":"736"},{"v":58.99700270358841,"d":"59"},{"v":32.87694893836378,"d":"33"},{"v":4691.609496627834,"d":"4692"},"External","RpAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the S78 phosphosite.","S78 phosphorylation inhibits interaction with HSF1, TRAF6, and hnRNP D0, and induces interaction with TPM1. It regulates apoptosis, cell cycle progression, cell growth, cytoskeletal reorganization, transcription, alters conformation, alters intracellular location, induces enzymatic activation, phosphorylation, molecular association, sumoylation, and ubiquitination. This is one of the major in vivo phosphorylation sites in HSP27 (≥51 reports from high throughput mass spectrometry studies).","MAPKAPK2; MAPKAPK5 (PRAK); p70S6K (RPS6KB1); PKACa (PRKACA); PKG1 (PRKG1); RSK2 (RPS6KA3)","P04792","P04792",989,null,"P04792","NP_001531","Block4",3,8,"4, 12, 20, 28",{"$nulls":3},"Chaperone protein",{"$nulls":5},"X",{"$nulls":3},"Chaperone protein","GO:1904115; GO:0005737; GO:0005856; GO:0005829; GO:0070062; GO:0005615; GO:0005925; GO:0005634; GO:0005886; GO:0000502; GO:0005819; GO:0030018","GO:0042802; GO:0044183; GO:0042803; GO:0019901; GO:0005080; GO:0008426; GO:0003723; GO:0043130","GO:0099641; GO:0035924; GO:0061077; GO:0035556; GO:0043066; GO:1902176; GO:0006469; GO:0070527; GO:0045766; GO:0043536; GO:2001028; GO:0038033; GO:0032731; GO:0042535; GO:0010506; GO:0043122; GO:0043488; GO:0001932; GO:0006446; GO:0006986; GO:0009615; GO:0001895"]
[1091,542,"PN230","HSP27 (HSP28; HSPB1)","S82","Heat shock 27 kDa protein beta 1",{"v":241.5189867040054,"d":"242"},{"v":215.90112336759566,"d":"216"},{"v":131.11593140441082,"d":"131"},{"v":54.28804302044398,"d":"54"},{"v":30.712583328087916,"d":"31"},{"v":840.9478942878053,"d":"841"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S82 phosphosite.","S82 phosphorylation induces activation and inhibits interaction with Akt1, HSF1, TRAF6 and hnRNP D0, and induces interaction with TPM1. It regulates cell growth, apoptosis, cytoskeletal reorganization, transcription, protein conformation, intracellular location, molecular association, sumoylation, and ubiquitination. This is one of the major in vivo phosphorylation sites in HSP27 (≥381 reports from high throughput mass spectrometry studies).","Akt1; MAPKAPK2; MAPKAPK5 (PRAK); PKACa (PRKACA); PKCa (PRKCA); PKCd (PRKCD); PKD1 (PRKCM; PRKD1); PKG1 (PRKG1); RSK2 (RPS6KA3)","P04792","P04792",989,null,"P04792","NP_001531","Block4",3,9,"4, 12, 20, 28",{"$nulls":3},"Chaperone protein",{"$nulls":5},"X",{"$nulls":3},"Chaperone protein","GO:1904115; GO:0005737; GO:0005856; GO:0005829; GO:0070062; GO:0005615; GO:0005925; GO:0005634; GO:0005886; GO:0000502; GO:0005819; GO:0030018","GO:0042802; GO:0044183; GO:0042803; GO:0019901; GO:0005080; GO:0008426; GO:0003723; GO:0043130","GO:0099641; GO:0035924; GO:0061077; GO:0035556; GO:0043066; GO:1902176; GO:0006469; GO:0070527; GO:0045766; GO:0043536; GO:2001028; GO:0038033; GO:0032731; GO:0042535; GO:0010506; GO:0043122; GO:0043488; GO:0001932; GO:0006446; GO:0006986; GO:0009615; GO:0001895"]
[1093,543,"NN061","HSP90a (HSP90AA1; HSP90; HSP86; HSPC; HSPCA; LAP2)","Pan-specific","Heat shock 90 kDa protein alpha",{"v":780.776966395749,"d":"781"},{"v":706.9464077827993,"d":"707"},{"v":476.5592313811832,"d":"477"},{"v":61.03653820387316,"d":"61"},{"v":30.567239021696587,"d":"31"},{"v":4932.124425353067,"d":"4932"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 610-723 of human HSP90β.",null,null,"P07900","P07900",1179,null,"P07900","NP_005339","Block4",3,10,"4, 12, 20, 28",{"$nulls":3},"Chaperone protein",{"$nulls":5},"X",{"$nulls":3},"Chaperone protein","GO:0044295; GO:0005737; GO:0005829; GO:0044294; GO:0071682; GO:0070062; GO:0005576; GO:1904813; GO:0043202; GO:0042470; GO:0016020; GO:0043209; GO:0043025; GO:0005654; GO:0005634; GO:0048471; GO:0005886; GO:0032991; GO:0032587; GO:0034774","GO:0016887; GO:0042623; GO:0005524; GO:0097718; GO:0070182; GO:0051020; GO:0042826; GO:0042802; GO:0023026; GO:0030235; GO:0000166; GO:0042803; GO:0004713; GO:1990782; GO:0003723; GO:0097110; GO:0048156; GO:0030911; GO:0031625; GO:0051082","GO:0048675; GO:0021955; GO:0061684; GO:0051131; GO:0097711; GO:0051186; GO:0019221; GO:0038128; GO:0030010; GO:0038096; GO:0000086; GO:0006839; GO:0043312; GO:1903364; GO:0045429; GO:0033138; GO:0051897; GO:0001934; GO:0032273; GO:1902949; GO:0051973; GO:0045040; GO:0042026; GO:0050821; GO:0043335; GO:0006898; GO:1903827; GO:1900034; GO:0010389; GO:0050999; GO:0043254; GO:0031396; GO:0046677; GO:0009409; GO:0009408; GO:0006986; GO:0007165; GO:1905323; GO:0007004; GO:0048010"]
[1095,544,"NN061-18","HSP90AB1 (HSP90; HSP84; HSP90B; HSPC2; HSPCB)","Pan-specific","Heat shock 90 kDa protein beta",{"v":1565.1111473891597,"d":"1565"},{"v":1426.197081163697,"d":"1426"},{"v":779.7733905776795,"d":"780"},{"v":49.822237345792246,"d":"50"},{"v":39.12095577705025,"d":"39"},{"v":4743.845173293736,"d":"4744"},"External","MmAb","Epitope undefined.",{"$nulls":3},"P08238","P08238",2993,null,"P08238","NP_031381","Block4",3,11,"4, 12, 20, 28",{"$nulls":3},"Chaperone protein",{"$nulls":5},"X",{"$nulls":3},"Chaperone protein","GO:0016324; GO:0034751; GO:0044295; GO:0016323; GO:0031526; GO:0009986; GO:0005737; GO:0005829; GO:0044294; GO:0070062; GO:0005576; GO:1904813; GO:0016234; GO:0005765; GO:0042470; GO:0016020; GO:0005739; GO:0043025; GO:0005654; GO:0005634; GO:1990917; GO:0048471; GO:0032991; GO:0034774; GO:1990913","GO:0042623; GO:0005524; GO:0043008; GO:0045296; GO:0002135; GO:0032564; GO:0097718; GO:0070182; GO:0003725; GO:0005525; GO:0031072; GO:0042826; GO:1990226; GO:0042802; GO:0044325; GO:0019900; GO:0023026; GO:0030235; GO:0042277; GO:0046983; GO:0042803; GO:0019901; GO:0019887; GO:0003723; GO:0017098; GO:0048156; GO:0030911; GO:0031625; GO:0051082; GO:0002134","GO:0048675; GO:0035690; GO:0071353; GO:0071407; GO:0021955; GO:0051131; GO:0030010; GO:0038096; GO:0071157; GO:1903660; GO:0043524; GO:1901799; GO:0032435; GO:0051248; GO:1901389; GO:0043312; GO:0001890; GO:0045597; GO:0045793; GO:1904031; GO:0045429; GO:0033138; GO:0032516; GO:0032092; GO:0033160; GO:0051897; GO:2000010; GO:0071902; GO:1902949; GO:0051973; GO:0030511; GO:0006457; GO:0050821; GO:1903827; GO:1900034; GO:0060334; GO:0031396; GO:0060338; GO:0042220; GO:0009651; GO:0006986; GO:0097435; GO:1905323; GO:0007004; GO:0019062; GO:0006805"]
[1097,545,"PN520","HSP90AB1 (HSP90B; HSP90-beta)","Y484","Heat shock 90 kDa protein beta",{"v":12105.093728743412,"d":"12105"},{"v":12222.165040615906,"d":"12222"},{"v":3212.4386573328,"d":"3212"},{"v":26.53790816757494,"d":"27"},{"v":575.4699179768824,"d":"575"},{"v":26542.879529743885,"d":"26543"},"Kinexus","RpAb","KSI(pY)YIT(bA)C","Corresponds to amino acid residues K481 to T487; In the middle of the HSP90 domain. ","The effect of Y484 phosphorylation is unclear. This is the major in vivo phosphorylation site in HSP90AB1 (≥814 reports from high throughput mass spectrometry studies).",null,"P08238","P08238",2993,null,"P08238","NP_031381","Block4",3,12,"4, 12, 20, 28",{"$nulls":3},"Chaperone protein",{"$nulls":5},"X",{"$nulls":3},"Chaperone protein","GO:0016324; GO:0034751; GO:0044295; GO:0016323; GO:0031526; GO:0009986; GO:0005737; GO:0005829; GO:0044294; GO:0070062; GO:0005576; GO:1904813; GO:0016234; GO:0005765; GO:0042470; GO:0016020; GO:0005739; GO:0043025; GO:0005654; GO:0005634; GO:1990917; GO:0048471; GO:0032991; GO:0034774; GO:1990913","GO:0042623; GO:0005524; GO:0043008; GO:0045296; GO:0002135; GO:0032564; GO:0097718; GO:0070182; GO:0003725; GO:0005525; GO:0031072; GO:0042826; GO:1990226; GO:0042802; GO:0044325; GO:0019900; GO:0023026; GO:0030235; GO:0042277; GO:0046983; GO:0042803; GO:0019901; GO:0019887; GO:0003723; GO:0017098; GO:0048156; GO:0030911; GO:0031625; GO:0051082; GO:0002134","GO:0048675; GO:0035690; GO:0071353; GO:0071407; GO:0021955; GO:0051131; GO:0030010; GO:0038096; GO:0071157; GO:1903660; GO:0043524; GO:1901799; GO:0032435; GO:0051248; GO:1901389; GO:0043312; GO:0001890; GO:0045597; GO:0045793; GO:1904031; GO:0045429; GO:0033138; GO:0032516; GO:0032092; GO:0033160; GO:0051897; GO:2000010; GO:0071902; GO:1902949; GO:0051973; GO:0030511; GO:0006457; GO:0050821; GO:1903827; GO:1900034; GO:0060334; GO:0031396; GO:0060338; GO:0042220; GO:0009651; GO:0006986; GO:0097435; GO:1905323; GO:0007004; GO:0019062; GO:0006805"]
[1099,546,"NN422-1","Huntingtin","Pan-specific","Huntington's disease protein",{"v":114.962544192063,"d":"115"},{"v":84.31713441761825,"d":"84"},{"v":132.65769675071573,"d":"133"},{"v":115.39210243041438,"d":"115"},{"v":18.141806187528953,"d":"18"},{"v":1739.0037484144757,"d":"1739"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 997-1276 of mouse Huntingtin.",null,null,"P42858","P42858",1292,null,"P42858","NP_002102","Block4",3,13,"4, 12, 20, 28",{"$nulls":13},"Cytoskeletal protein","GO:0005776; GO:0030424; GO:0005814; GO:0005737; GO:0030659; GO:0005829; GO:0030425; GO:0005783; GO:0005794; GO:0016234; GO:0005770; GO:0005654; GO:0005634; GO:0048471; GO:0099524; GO:0099523; GO:0032991","GO:0048487; GO:0034452; GO:0045505; GO:0031072; GO:0042802; GO:0044325; GO:0019900; GO:0002039; GO:0005522; GO:0008134","GO:0048513; GO:0006915; GO:0000132; GO:0007030; GO:2001237; GO:1905337; GO:0043065; GO:1903599; GO:0045724; GO:0031587; GO:1904504; GO:0031648; GO:1905289; GO:2000479; GO:0043666; GO:0006890; GO:0047496; GO:0042297"]
[1101,547,"PN103","Huntingtin","S419","Huntington's disease protein",{"v":137.95587941915142,"d":"138"},{"v":115.47988027782893,"d":"115"},{"v":79.35421724554423,"d":"79"},{"v":57.52144640710982,"d":"58"},{"v":20.17670883913206,"d":"20"},{"v":530.4188460423467,"d":"530"},"External","RpAb","RSG(pS)IVELI","Corresponds to amino acid residues R416-I424.","S419 phosphorylation induces activity and binding to KIF5B and dynactin 1, and inhibits apoptosis. This is one of the major in vivo phosphorylation sites in the huntingtin protein (≥47 reports from high throughput mass spectrometry studies).","Akt1 (PKBa); Akt3 (PKBg); SGK1","P42858","P42858",1292,null,"P42858","NP_002102","Block4",4,1,"4, 12, 20, 28",{"$nulls":13},"Cytoskeletal protein","GO:0005776; GO:0030424; GO:0005814; GO:0005737; GO:0030659; GO:0005829; GO:0030425; GO:0005783; GO:0005794; GO:0016234; GO:0005770; GO:0005654; GO:0005634; GO:0048471; GO:0099524; GO:0099523; GO:0032991","GO:0048487; GO:0034452; GO:0045505; GO:0031072; GO:0042802; GO:0044325; GO:0019900; GO:0002039; GO:0005522; GO:0008134","GO:0048513; GO:0006915; GO:0000132; GO:0007030; GO:2001237; GO:1905337; GO:0043065; GO:1903599; GO:0045724; GO:0031587; GO:1904504; GO:0031648; GO:1905289; GO:2000479; GO:0043666; GO:0006890; GO:0047496; GO:0042297"]
[1103,548,"NK073-2","ICK","Pan-specific","Intestinal cell (MAK-like) kinase",{"v":478.13295071005,"d":"478"},{"v":443.8512783214011,"d":"444"},{"v":258.36810906379,"d":"258"},{"v":54.036875868960955,"d":"54"},{"v":42.0589200747926,"d":"42"},{"v":1434.5264610074553,"d":"1435"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 579-611 near the C-terminus of mouse ICK.",null,null,"Q9UPZ9","Q9UPZ9",2139,"Q9UPZ9",null,"NP_055735.1","Block4",4,2,"4, 12, 20, 28","ICK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","RCK",{"$nulls":6},"EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC domain target; CMGC</A> group; RCK family","GO:0036064; GO:0097546; GO:0097542; GO:0005929; GO:0005737; GO:0005829; GO:0001650; GO:0005634","GO:0005524; GO:0000287; GO:0004672; GO:0004674","GO:0060271; GO:0035556; GO:0035720; GO:0035721; GO:0042073; GO:0007275; GO:0006468; GO:0010468; GO:0007165"]
[1105,549,"PK655","ICK","Y156+T157","Intestinal cell (MAK-like) kinase",{"v":9977.07348517007,"d":"9977"},{"v":9435.876782860507,"d":"9436"},{"v":2935.001606881979,"d":"2935"},{"v":29.41746005223443,"d":"29"},{"v":1158.9852033791403,"d":"1159"},{"v":18229.649648309736,"d":"18230"},"Kinexus","RpAb","SKPP(pY)(pT)D(bA)C","Corresponds to amino acid residues S152 to D158; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y156 and T157 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major in vivo phosphorylation sites in ICK (≥179 and ≥103 reports, respectively, from high throughput mass spectrometry studies).","T157: CCRK (CDK20).","Q9UPZ9","Q9UPZ9",2139,"Q9UPZ9",null,"NP_055735.1","Block4",4,3,"4, 12, 20, 28","ICK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","RCK",{"$nulls":6},"EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC domain target; CMGC</A> group; RCK family","GO:0036064; GO:0097546; GO:0097542; GO:0005929; GO:0005737; GO:0005829; GO:0001650; GO:0005634","GO:0005524; GO:0000287; GO:0004672; GO:0004674","GO:0060271; GO:0035556; GO:0035720; GO:0035721; GO:0042073; GO:0007275; GO:0006468; GO:0010468; GO:0007165"]
[1107,550,"PK656","ICK","Y159","Intestinal cell (MAK-like) kinase",{"v":5657.389472369385,"d":"5657"},{"v":5467.793119657752,"d":"5468"},{"v":1661.0072128846866,"d":"1661"},{"v":29.359958705283134,"d":"29"},{"v":2260.197418452822,"d":"2260"},{"v":11132.188223480385,"d":"11132"},"Kinexus","RpAb","YTD(pY)VST(bA)C","Corresponds to amino acid residues Y156 to T162; In the protein kinase catalytic domain in subdomain I.","Y159 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in ICK (≥448 reports from high throughput mass spectrometry studies).","ICK","Q9UPZ9","Q9UPZ9",2139,"Q9UPZ9",null,"NP_055735.1","Block4",4,4,"4, 12, 20, 28","ICK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","RCK",{"$nulls":6},"EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC domain target; CMGC</A> group; RCK family","GO:0036064; GO:0097546; GO:0097542; GO:0005929; GO:0005737; GO:0005829; GO:0001650; GO:0005634","GO:0005524; GO:0000287; GO:0004672; GO:0004674","GO:0060271; GO:0035556; GO:0035720; GO:0035721; GO:0042073; GO:0007275; GO:0006468; GO:0010468; GO:0007165"]
[1109,551,"PN706","IDH1","T75+T77","Isocitrate dehydrogenase [NADP] cytoplasmic",{"v":19827.4480918774,"d":"19827"},{"v":19775.863525142868,"d":"19776"},{"v":4953.177280387424,"d":"4953"},{"v":24.981415951438372,"d":"25"},{"v":7980.810585453344,"d":"7981"},{"v":33376.75428669095,"d":"33377"},"Kinexus","RpAb","CA(pT)I(pT)PDEK","Corresponds to amino acid residues C73 to K81.","The effects of T75 and T77 phosphorylation are unknown. These are two of the main in vivo phosphorylation sites in IDH1 (≥14 and >16 reports, respectively, by mass spectrometry). These phosphosites are almost identical in IDH2 to T115 and T117. These phosphosites are highly conserved in vertebrates and also found in yeast.",null,"O75874","O75874",10630,null,"O75874","NP_001269315.1","Block4",4,5,"4, 12, 20, 28",{"$nulls":3},"Carbohydrate Metabolism - citrate (TCA) cycle",{"$nulls":8},"X","Carbohydrate Metabolism - citrate (TCA) cycle; EC 1.1.1.42; Other Amino Acids Metabolism - glutathione; Oxidoreductase","GO:0005737; GO:0005829; GO:0070062; GO:0005576; GO:1904813; GO:0005739; GO:0005782; GO:0005777; GO:0034774; GO:1904724","GO:0051990; GO:0045296; GO:0042802; GO:0004450; GO:0000287; GO:0051287; GO:0050661; GO:0042803; GO:0005102","GO:0006103; GO:0008585; GO:0006749; GO:0006097; GO:0006102; GO:0006740; GO:0043312; GO:0006625; GO:0071071; GO:0060696; GO:0006979; GO:0048545; GO:0006099"]
[1111,552,"PN757","IDH1","Y391","Isocitrate dehydrogenase [NADP] cytoplasmic",{"v":7310.025589506433,"d":"7310"},{"v":7006.363760834953,"d":"7006"},{"v":1941.2738114869046,"d":"1941"},{"v":26.556320326342085,"d":"27"},{"v":1064.1892508572532,"d":"1064"},{"v":12961.573526909433,"d":"12962"},"Kinexus","RpAb","RSD(pY)LNT(bA)C","Corresponds to amino acid residues R388 to T394.","The effect of Y391 phosphorylation is unclear. This is the major in vivo phosphorylation site in IDH1 (≥34 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in sea urchin.",null,"O75874","O75874",10630,null,"O75874","NP_001269315.1","Block4",4,6,"4, 12, 20, 28",{"$nulls":3},"Carbohydrate Metabolism - citrate (TCA) cycle",{"$nulls":8},"X","Carbohydrate Metabolism - citrate (TCA) cycle; EC 1.1.1.42; Other Amino Acids Metabolism - glutathione; Oxidoreductase","GO:0005737; GO:0005829; GO:0070062; GO:0005576; GO:1904813; GO:0005739; GO:0005782; GO:0005777; GO:0034774; GO:1904724","GO:0051990; GO:0045296; GO:0042802; GO:0004450; GO:0000287; GO:0051287; GO:0050661; GO:0042803; GO:0005102","GO:0006103; GO:0008585; GO:0006749; GO:0006097; GO:0006102; GO:0006740; GO:0043312; GO:0006625; GO:0071071; GO:0060696; GO:0006979; GO:0048545; GO:0006099"]
[1113,553,"NK074-4","IGF1R","Pan-specific","Insulin-like growth factor 1 receptor protein-tyrosine kinase",{"v":355.89620493907256,"d":"356"},{"v":279.2216561363948,"d":"279"},{"v":366.3108234254369,"d":"366"},{"v":102.92630782285168,"d":"103"},{"v":21.154062812269174,"d":"21"},{"v":4266.263837419598,"d":"4266"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 741-800 of human IGF-IRβ.",null,null,"P08069","P08069",606,"P08069","P08069","NP_000866","Block4",4,7,"4, 12, 20, 28","IGF1R","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","InsR",{"$nulls":6},"EC 2.7.10.1; Receptor tyrosine kinase; TK domain target; TK</A> group; InsR family","GO:0035867; GO:0005887; GO:0043231; GO:0016020; GO:0005886; GO:0043235","GO:0005524; GO:0042802; GO:0043559; GO:0005010; GO:0005520; GO:0031994; GO:0005158; GO:0043560; GO:0043548; GO:0004713","GO:0097242; GO:1904646; GO:0097062; GO:0006955; GO:0051389; GO:0048009; GO:0008286; GO:0043066; GO:0038083; GO:0014065; GO:0048015; GO:0030335; GO:0008284; GO:0120162; GO:0043243; GO:0046777; GO:0051262; GO:0046328; GO:0007165"]
[1115,554,"NK074-2","IGF1R","Pan-specific","Insulin-like growth factor 1 receptor protein-tyrosine kinase",{"v":821.3947542658225,"d":"821"},{"v":781.8750260420323,"d":"782"},{"v":488.14827343790233,"d":"488"},{"v":59.42919295536749,"d":"59"},{"v":54.770345039941745,"d":"55"},{"v":2716.982871929843,"d":"2717"},"Kinexus","RpAb","VIMLYVFHRKRNNSRLGC","Corresponds to amino acid residues V952 to G968; Just before kinase catalytic domain.",null,null,"P08069","P08069",606,"P08069","P08069","NP_000866","Block4",4,8,"4, 12, 20, 28","IGF1R","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","InsR",{"$nulls":6},"EC 2.7.10.1; Receptor tyrosine kinase; TK domain target; TK</A> group; InsR family","GO:0035867; GO:0005887; GO:0043231; GO:0016020; GO:0005886; GO:0043235","GO:0005524; GO:0042802; GO:0043559; GO:0005010; GO:0005520; GO:0031994; GO:0005158; GO:0043560; GO:0043548; GO:0004713","GO:0097242; GO:1904646; GO:0097062; GO:0006955; GO:0051389; GO:0048009; GO:0008286; GO:0043066; GO:0038083; GO:0014065; GO:0048015; GO:0030335; GO:0008284; GO:0120162; GO:0043243; GO:0046777; GO:0051262; GO:0046328; GO:0007165"]
[1117,555,"PK657","IGF1R","Y1161+T1163","Insulin-like growth factor 1 receptor protein-tyrosine kinase",{"v":2862.373169649136,"d":"2862"},{"v":2837.7074734293597,"d":"2838"},{"v":1195.8588736670374,"d":"1196"},{"v":41.77858031745118,"d":"42"},{"v":79.94278213017007,"d":"80"},{"v":7027.304429009313,"d":"7027"},"Kinexus","RpAb","RDI(pY)E(pT)DY(bA)C","Corresponds to amino acid residues R1158 to Y1165; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y1161 and T1163 phosphorylation stimulate phosphotransferase activity and protein interaction. Y1161 phosphorylation induces binding to Src. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major in vivo phosphorylation sites in IGF1R (≥465 and ≥49 reports, respectively, from high throughput mass spectrometry studies).","Y1161: IGF1R; Src.","P08069","P08069",606,"P08069","P08069","NP_000866","Block4",4,9,"4, 12, 20, 28","IGF1R","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","InsR",{"$nulls":6},"EC 2.7.10.1; Receptor tyrosine kinase; TK domain target; TK</A> group; InsR family","GO:0035867; GO:0005887; GO:0043231; GO:0016020; GO:0005886; GO:0043235","GO:0005524; GO:0042802; GO:0043559; GO:0005010; GO:0005520; GO:0031994; GO:0005158; GO:0043560; GO:0043548; GO:0004713","GO:0097242; GO:1904646; GO:0097062; GO:0006955; GO:0051389; GO:0048009; GO:0008286; GO:0043066; GO:0038083; GO:0014065; GO:0048015; GO:0030335; GO:0008284; GO:0120162; GO:0043243; GO:0046777; GO:0051262; GO:0046328; GO:0007165"]
[1119,556,"PK152","IGF1R","Y1280","Insulin-like growth factor 1 receptor protein-tyrosine kinase",{"v":2001.2555789234357,"d":"2001"},{"v":1843.5109804596427,"d":"1844"},{"v":1026.2400354602155,"d":"1026"},{"v":51.279808849416206,"d":"51"},{"v":75.56795024129994,"d":"76"},{"v":5601.658684470619,"d":"5602"},"External","RpAb","SF(pY)YS","Corresponds to amino acid residues S1278 to S1282.","Y1280 phosphorylation phosphorylation regulates cell differentiation and cell growth. This is one of the major in vivo phosphorylation sites in IGF1R.","IGF1R","P08069","P08069",606,"P08069","P08069","NP_000866","Block4",4,10,"4, 12, 20, 28","IGF1R","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","InsR",{"$nulls":6},"EC 2.7.10.1; Receptor tyrosine kinase; TK domain target; TK</A> group; InsR family","GO:0035867; GO:0005887; GO:0043231; GO:0016020; GO:0005886; GO:0043235","GO:0005524; GO:0042802; GO:0043559; GO:0005010; GO:0005520; GO:0031994; GO:0005158; GO:0043560; GO:0043548; GO:0004713","GO:0097242; GO:1904646; GO:0097062; GO:0006955; GO:0051389; GO:0048009; GO:0008286; GO:0043066; GO:0038083; GO:0014065; GO:0048015; GO:0030335; GO:0008284; GO:0120162; GO:0043243; GO:0046777; GO:0051262; GO:0046328; GO:0007165"]
[1121,557,"PK658","IGF1R","Y1346","Insulin-like growth factor 1 receptor",{"v":4031.7856809804066,"d":"4032"},{"v":3610.987766537563,"d":"3611"},{"v":1435.5093726272028,"d":"1436"},{"v":35.60480358366001,"d":"36"},{"v":1379.3866741990107,"d":"1379"},{"v":8433.262411963846,"d":"8433"},"Kinexus","RpAb","RQP(pY)AHM(bA)C","Corresponds to amino acid residues R1343 to M1349; In the C-terminal of the kinase after the catalytic domain.","Y1346 phosphorylation stimulates phosphotransferase activity and induces binding to Grb10. Phosphorylation regulates cell differentiation, cell growth, molecular association and protein interaction. This is one of the major in vivo phosphorylation sites in IGF1R.","IGF1R; Src","P08069","P08069",606,"P08069","P08069","NP_000866","Block4",4,11,"4, 12, 20, 28","IGF1R","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","InsR",{"$nulls":6},"EC 2.7.10.1; Receptor tyrosine kinase; TK domain target; TK</A> group; InsR family","GO:0035867; GO:0005887; GO:0043231; GO:0016020; GO:0005886; GO:0043235","GO:0005524; GO:0042802; GO:0043559; GO:0005010; GO:0005520; GO:0031994; GO:0005158; GO:0043560; GO:0043548; GO:0004713","GO:0097242; GO:1904646; GO:0097062; GO:0006955; GO:0051389; GO:0048009; GO:0008286; GO:0043066; GO:0038083; GO:0014065; GO:0048015; GO:0030335; GO:0008284; GO:0120162; GO:0043243; GO:0046777; GO:0051262; GO:0046328; GO:0007165"]
[1123,558,"NN064","IkBa","Pan-specific","Inhibitor of NF-kappa-B alpha (MAD3)",{"v":3336.5515651266087,"d":"3337"},{"v":3093.4093747975376,"d":"3093"},{"v":2232.6111591475733,"d":"2233"},{"v":66.91373160488993,"d":"67"},{"v":220.3408380026867,"d":"220"},{"v":23307.98208418543,"d":"23308"},"External","RpAb","Epitope undefined.",{"$nulls":3},"P25963","P25963",990,null,"P25963","NP_065390","Block4",4,12,"4, 12, 20, 28",{"$nulls":13},"Inhibitor protein","GO:0005737; GO:0005829; GO:0033256; GO:0005622; GO:0005654; GO:0005634; GO:0005886","GO:0019899; GO:0031072; GO:0042802; GO:0051059; GO:0008139; GO:0044877; GO:0008134; GO:0031625","GO:0006915; GO:0070417; GO:0071407; GO:0007253; GO:0042994; GO:0007249; GO:0070498; GO:0031663; GO:0097421; GO:0043066; GO:0043392; GO:0010888; GO:0010745; GO:0045638; GO:0032088; GO:0045746; GO:0070427; GO:0070431; GO:0032270; GO:0010875; GO:0050729; GO:0045944; GO:0016579; GO:0000060; GO:0042127; GO:1901222; GO:0043330; GO:0032495; GO:0035994; GO:0034142; GO:0033209; GO:0016032"]
[1125,559,"PN232","IkBa","S32","Inhibitor of NF-kappa-B alpha (MAD3)",{"v":159.70241651067278,"d":"160"},{"v":131.02950515969223,"d":"131"},{"v":100.54203595293117,"d":"101"},{"v":62.955863880877494,"d":"63"},{"v":17.606167899507536,"d":"18"},{"v":578.701680246596,"d":"579"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S32 phosphosite.","S32 phosphorylation induces release of the inhibitory protein and facilitates it degradation. It also induces interaction with AurC. This is one of the major in vivo phosphorylation sites in IkBa (≥19 reports from high throughput mass spectrometry studies).","AUKC, CK2a1 (CSNK2A1); ERK7 (MAPK15); IKKa (CHUK, IKBKA); IKKb (IKBKB); IKKe (IKBKE); NIK (MAP3K14); PKR (EIF2AK2); RSK1 (RPS6KA1); RSK2 (RPS6KA3); SGK1","P25963","P25963",990,null,"P25963","NP_065390","Block4",4,13,"4, 12, 20, 28",{"$nulls":13},"Inhibitor protein","GO:0005737; GO:0005829; GO:0033256; GO:0005622; GO:0005654; GO:0005634; GO:0005886","GO:0019899; GO:0031072; GO:0042802; GO:0051059; GO:0008139; GO:0044877; GO:0008134; GO:0031625","GO:0006915; GO:0070417; GO:0071407; GO:0007253; GO:0042994; GO:0007249; GO:0070498; GO:0031663; GO:0097421; GO:0043066; GO:0043392; GO:0010888; GO:0010745; GO:0045638; GO:0032088; GO:0045746; GO:0070427; GO:0070431; GO:0032270; GO:0010875; GO:0050729; GO:0045944; GO:0016579; GO:0000060; GO:0042127; GO:1901222; GO:0043330; GO:0032495; GO:0035994; GO:0034142; GO:0033209; GO:0016032"]
[1127,560,"PN164","IkBa","Y42","Inhibitor of NF-kappa-B alpha (MAD3)",{"v":155.980293210998,"d":"156"},{"v":124.48349839217488,"d":"124"},{"v":119.16535016095058,"d":"119"},{"v":76.39769595749699,"d":"76"},{"v":15.147268549449079,"d":"15"},{"v":835.6132768907037,"d":"836"},"External","RpAb","EE(pY)EQ","Corresponds to amino acid residues E40 to Q44.","Y42 phosphorylation inhibits inhibitory action (induces transcription) and binding to NFkB-p65 and facilitates degradation of IkBa. This is one of the major in vivo phosphorylation sites in IkBa (≥27 reports from high throughput mass spectrometry studies).","InsR; Lck; Src","P25963","P25963",990,null,"P25963","NP_065390","Block4",5,1,"4, 12, 20, 28",{"$nulls":13},"Inhibitor protein","GO:0005737; GO:0005829; GO:0033256; GO:0005622; GO:0005654; GO:0005634; GO:0005886","GO:0019899; GO:0031072; GO:0042802; GO:0051059; GO:0008139; GO:0044877; GO:0008134; GO:0031625","GO:0006915; GO:0070417; GO:0071407; GO:0007253; GO:0042994; GO:0007249; GO:0070498; GO:0031663; GO:0097421; GO:0043066; GO:0043392; GO:0010888; GO:0010745; GO:0045638; GO:0032088; GO:0045746; GO:0070427; GO:0070431; GO:0032270; GO:0010875; GO:0050729; GO:0045944; GO:0016579; GO:0000060; GO:0042127; GO:1901222; GO:0043330; GO:0032495; GO:0035994; GO:0034142; GO:0033209; GO:0016032"]
[1129,561,"PN168","IkBe","S161","NF-kappa-B inhibitor epsilon",{"v":207.83912006283418,"d":"208"},{"v":149.81157765615444,"d":"150"},{"v":201.13236963459107,"d":"201"},{"v":96.77310487736115,"d":"97"},{"v":7.024494690500388,"d":"7"},{"v":1177.6986497665246,"d":"1178"},"External","RpAb","IE(pS)LR","Corresponds to amino acid residues I20 to R24.","The effect of S161 phosphorylation is unclear. This phosphorylation site in IkBe has apparently not been seen high throughput mass spectrometry studies.",null,"O00221","O00221",6938,null,"O00221","NP_004547.2","Block4",5,2,"4, 12, 20, 28",{"$nulls":13},"Regulatory protein, transcription factor inhibitor","GO:0005737; GO:0005829; GO:0001650; GO:0005794; GO:0005634; GO:0048471",null,"GO:0042994; GO:0042942"]
[1131,562,"PK154","IKKa (IkBKA)","T23","Inhibitor of NF-kappa-B protein-serine kinase alpha (CHUK)",{"v":1597.2576393820373,"d":"1597"},{"v":1379.7216706935822,"d":"1380"},{"v":2142.8598588910795,"d":"2143"},{"v":134.1586858661155,"d":"134"},{"v":36.16527308054535,"d":"36"},{"v":19749.81940731846,"d":"19750"},"External","RpAb","LG(pT)GG","Corresponds to amino acid residues L21 to G25.","T23 phosphorylation stimulates phosphotransferase activity, and regulates transcription and apoptosis. This is one of the major in vivo phosphorylation sites in IKKa (≥3 reports from high throughput mass spectrometry studies).","Akt1 (PKBa); Akt2 (PKBb); Akt3 (PKBg)","O15111","O15111",461,"O15111",null,"NP_001269","Block4",5,3,"4, 12, 20, 28","IKKa","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","IKK",{"$nulls":6},"Protein-serine kinase, Other group, IKK family","GO:0035631; GO:0005737; GO:0009898; GO:0005829; GO:0008385; GO:0043231; GO:0005654","GO:0005524; GO:0008384; GO:0046982; GO:0042803; GO:0004672; GO:0097110","GO:0009653; GO:0002479; GO:0071276; GO:0034614; GO:0071356; GO:0098586; GO:0038095; GO:0007249; GO:0007252; GO:0006955; GO:0006954; GO:0045087; GO:0070498; GO:0002756; GO:0032088; GO:0038061; GO:0018105; GO:0043123; GO:1902741; GO:0051092; GO:0045893; GO:0045944; GO:0006468; GO:0010803; GO:0010034; GO:0043200; GO:0042493; GO:0033194; GO:0032496; GO:0009636; GO:0009615; GO:0007266; GO:0003009; GO:0002223; GO:0051403; GO:0051146; GO:0050852; GO:0035666; GO:0033209"]
[1133,563,"PK659","IKKa (IkBKA)","T179+S180","Inhibitor of NF-kappa-B protein-serine kinase alpha (CHUK)",{"v":18171.46129356483,"d":"18171"},{"v":17755.39297999058,"d":"17755"},{"v":5211.536883417355,"d":"5212"},{"v":28.67978969453023,"d":"29"},{"v":1075.2740335857147,"d":"1075"},{"v":41107.79094068639,"d":"41108"},"Kinexus","RpAb","CC(pT)(pS)FVGT","Corresponds to amino acid residues C177 to T184; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T179 and S180 phosphorylation stimulate phosphotransferase activity and regulates chromatin organization, transcription, molecular association and ubiquitination. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. However, these two phosphorylation sites in IKKa have apparently not been reported in high throughput mass spectrometry studies.","S180: NIK (MAP3K14)","O15111","O15111",461,"O15111",null,"NP_001269","Block4",5,4,"4, 12, 20, 28","IKKa","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","IKK",{"$nulls":6},"Protein-serine kinase, Other group, IKK family","GO:0035631; GO:0005737; GO:0009898; GO:0005829; GO:0008385; GO:0043231; GO:0005654","GO:0005524; GO:0008384; GO:0046982; GO:0042803; GO:0004672; GO:0097110","GO:0009653; GO:0002479; GO:0071276; GO:0034614; GO:0071356; GO:0098586; GO:0038095; GO:0007249; GO:0007252; GO:0006955; GO:0006954; GO:0045087; GO:0070498; GO:0002756; GO:0032088; GO:0038061; GO:0018105; GO:0043123; GO:1902741; GO:0051092; GO:0045893; GO:0045944; GO:0006468; GO:0010803; GO:0010034; GO:0043200; GO:0042493; GO:0033194; GO:0032496; GO:0009636; GO:0009615; GO:0007266; GO:0003009; GO:0002223; GO:0051403; GO:0051146; GO:0050852; GO:0035666; GO:0033209"]
[1135,564,"NK076-7","IKKb (IkBKB)","Pan-specific","Inhibitor of nuclear factor kappa B kinase beta subunit",{"v":750.8984234020136,"d":"751"},{"v":683.1652485477355,"d":"683"},{"v":403.6025419467743,"d":"404"},{"v":53.749286104266446,"d":"54"},{"v":96.5557957452211,"d":"97"},{"v":3701.3967855046567,"d":"3701"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 470-755 mapping at the C-terminus of human IKKβ.",null,null,"O14920","O14920",459,"O14920",null,"NP_001547.1","Block4",5,5,"4, 12, 20, 28","IKKb","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","IKK",{"$nulls":6},"Protein-serine kinase, Other group, IKK family","GO:0035631; GO:0009898; GO:0005829; GO:0008385; GO:0045121; GO:0005634","GO:0005524; GO:0042802; GO:0008384; GO:0046982; GO:0042803; GO:0004672; GO:0019901; GO:0004674; GO:0097110","GO:0009653; GO:0002479; GO:0071356; GO:0030866; GO:0038095; GO:0007249; GO:0006954; GO:0045087; GO:0070498; GO:0002756; GO:0043066; GO:1903347; GO:0035509; GO:0018105; GO:0043123; GO:0051092; GO:0045893; GO:0045944; GO:0072659; GO:0006468; GO:1903140; GO:0042325; GO:0010803; GO:0009615; GO:0002223; GO:0051403; GO:0050852; GO:0035666; GO:0033209; GO:0016032"]
[1137,580,"NK076-5","IKKb (IkBKB)","Pan-specific","Inhibitor of nuclear factor kappa B kinase beta subunit",{"v":9247.948780807099,"d":"9248"},{"v":9197.608701117579,"d":"9198"},{"v":1840.7048170681617,"d":"1841"},{"v":19.903925299503197,"d":"20"},{"v":3545.274443723146,"d":"3545"},{"v":14286.232444763602,"d":"14286"},"Kinexus","RpAb","CTLLENAIQDTVREQDQSFT","Corresponds to amino acid residues C716 to T735; Pre-C-terminus.",null,null,"O14920","O14920",459,"O14920",null,"NP_001547.1","Block4",6,8,"4, 12, 20, 28","IKKb","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","IKK",{"$nulls":6},"Protein-serine kinase, Other group, IKK family","GO:0035631; GO:0009898; GO:0005829; GO:0008385; GO:0045121; GO:0005634","GO:0005524; GO:0042802; GO:0008384; GO:0046982; GO:0042803; GO:0004672; GO:0019901; GO:0004674; GO:0097110","GO:0009653; GO:0002479; GO:0071356; GO:0030866; GO:0038095; GO:0007249; GO:0006954; GO:0045087; GO:0070498; GO:0002756; GO:0043066; GO:1903347; GO:0035509; GO:0018105; GO:0043123; GO:0051092; GO:0045893; GO:0045944; GO:0072659; GO:0006468; GO:1903140; GO:0042325; GO:0010803; GO:0009615; GO:0002223; GO:0051403; GO:0050852; GO:0035666; GO:0033209; GO:0016032"]
[1139,565,"PK660","IKKe (IkBKE)","S172","Inhibitor of nuclear factor kappa-B kinase subunit epsilon",{"v":9138.923684694779,"d":"9139"},{"v":9114.733788144265,"d":"9115"},{"v":2449.435734828331,"d":"2449"},{"v":26.802234260151142,"d":"27"},{"v":484.7408659918003,"d":"485"},{"v":17136.619528578285,"d":"17137"},"Kinexus","RpAb","KFV(pS)VYG(bA)C","Corresponds to amino acid residues K169 to G175; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S172 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the less major in vivo phosphorylation sites in IKKe (≥4 reports from high throughput mass spectrometry studies).","IKKe (IKBKE)","Q14164","Q14164",1136,"Q14164","Q14164","NP_054721.1","Block4",5,6,"4, 12, 20, 28","IKKe","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","IKK",{"$nulls":6},"Protein-serine kinase, Other group, IKK family","GO:0005737; GO:0005829; GO:0010008; GO:0031966; GO:0005654; GO:0005634; GO:0016605","GO:0005524; GO:0008384; GO:0036435; GO:0004704; GO:0004672; GO:0031625","GO:0098586; GO:0006955; GO:0045087; GO:0008630; GO:0032480; GO:0018105; GO:0043123; GO:0010884; GO:0051260; GO:0006468; GO:0035456; GO:0034340; GO:0035666"]
[1141,566,"NN077-2","IKKg (NEMO)","Pan-specific","I-kappa-B kinase gamma/NF-kappa-B essential modulator",{"v":357.051948315661,"d":"357"},{"v":312.3812735098845,"d":"312"},{"v":215.44351780615492,"d":"215"},{"v":60.33954409784834,"d":"60"},{"v":38.36845850300183,"d":"38"},{"v":2214.64818529808,"d":"2215"},"External","MmAb","Not precisely defined.","Antibody raised against full length human IKKg.",null,null,"Q9Y6K9","Q9Y6K9",2445,null,"Q9Y6K9","NP_001093327.1","Block4",5,7,"4, 12, 20, 28",{"$nulls":3},"Regulatory subunit IKK",{"$nulls":7},"X",null,"Adaptor/scaffold, Protein kinase, regulatory subunit","GO:0005737; GO:0005829; GO:0008385; GO:0005622; GO:0072686; GO:0005654; GO:0005634; GO:0000922; GO:0000151","GO:0042802; GO:0070530; GO:1990450; GO:0046872; GO:0042975; GO:0019904; GO:0046982; GO:0042803; GO:0031625","GO:0000187; GO:0043276; GO:0002479; GO:0006915; GO:0006974; GO:0051650; GO:0038095; GO:0007249; GO:0006955; GO:0006954; GO:0045087; GO:0070498; GO:0007254; GO:0002756; GO:1901215; GO:0070423; GO:0043123; GO:0016239; GO:0051092; GO:0045944; GO:0016579; GO:0010803; GO:0009615; GO:0002223; GO:0051403; GO:0050852; GO:0006351; GO:0035666; GO:0016032"]
[1143,567,"PK189","IKKg (NEMO)","S376","I-kappa-B kinase gamma/NF-kappa-B essential modulator",{"v":386.71625909877974,"d":"387"},{"v":350.3177266071792,"d":"350"},{"v":212.5456197300157,"d":"213"},{"v":54.96164558101104,"d":"55"},{"v":51.460520241349045,"d":"51"},{"v":1422.2855291940946,"d":"1422"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S376 phosphosite.","The effect of S376 phosphorylation is unclear. This is one of the minor in vivo phosphorylation sites in IKKg (≥8 reports from high throughput mass spectrometry studies). This human phosphosite is not conserved in vertebrates, but is found in the chimpanzee.","IKKb (IKBKB)","Q9Y6K9","Q9Y6K9",2445,null,"Q9Y6K9","NP_001093327.1","Block4",5,8,"4, 12, 20, 28",{"$nulls":3},"Regulatory subunit IKK",{"$nulls":7},"X",null,"Adaptor/scaffold, Protein kinase, regulatory subunit","GO:0005737; GO:0005829; GO:0008385; GO:0005622; GO:0072686; GO:0005654; GO:0005634; GO:0000922; GO:0000151","GO:0042802; GO:0070530; GO:1990450; GO:0046872; GO:0042975; GO:0019904; GO:0046982; GO:0042803; GO:0031625","GO:0000187; GO:0043276; GO:0002479; GO:0006915; GO:0006974; GO:0051650; GO:0038095; GO:0007249; GO:0006955; GO:0006954; GO:0045087; GO:0070498; GO:0007254; GO:0002756; GO:1901215; GO:0070423; GO:0043123; GO:0016239; GO:0051092; GO:0045944; GO:0016579; GO:0010803; GO:0009615; GO:0002223; GO:0051403; GO:0050852; GO:0006351; GO:0035666; GO:0016032"]
[1145,568,"PN758","IKKg (NEMO)","S377","I-kappa-B kinase gamma/NF-kappa-B essential modulator",{"v":14564.78173422495,"d":"14565"},{"v":14399.849907584503,"d":"14400"},{"v":3360.134517528329,"d":"3360"},{"v":23.070270319482653,"d":"23"},{"v":956.9570854963133,"d":"957"},{"v":25587.560893183152,"d":"25588"},"Kinexus","RpAb","AYLS(pS)PLAC","Corresponds to amino acid residues A373 to A380.","S377 phosphorylation inhibits enzymatic activity. This is the major in vivo phosphorylation sites in IKKg (≥56 reports from high throughput mass spectrometry studies). This human phosphosite is not conserved in vertebrates, but is found in the chimpanzee.","ERK1 (MAPK3)","Q9Y6K9","Q9Y6K9",2445,null,"Q9Y6K9","NP_001093327.1","Block4",5,9,"4, 12, 20, 28",{"$nulls":3},"Regulatory subunit IKK",{"$nulls":7},"X",null,"Adaptor/scaffold, Protein kinase, regulatory subunit","GO:0005737; GO:0005829; GO:0008385; GO:0005622; GO:0072686; GO:0005654; GO:0005634; GO:0000922; GO:0000151","GO:0042802; GO:0070530; GO:1990450; GO:0046872; GO:0042975; GO:0019904; GO:0046982; GO:0042803; GO:0031625","GO:0000187; GO:0043276; GO:0002479; GO:0006915; GO:0006974; GO:0051650; GO:0038095; GO:0007249; GO:0006955; GO:0006954; GO:0045087; GO:0070498; GO:0007254; GO:0002756; GO:1901215; GO:0070423; GO:0043123; GO:0016239; GO:0051092; GO:0045944; GO:0016579; GO:0010803; GO:0009615; GO:0002223; GO:0051403; GO:0050852; GO:0006351; GO:0035666; GO:0016032"]
[1147,569,"PN707","IKZF1","Y413","DNA-binding protein IKZF1 (Ikaros)",{"v":950.3216309918794,"d":"950"},{"v":881.0962960026998,"d":"881"},{"v":441.7535197844295,"d":"442"},{"v":46.48463271570048,"d":"46"},{"v":69.82554409922028,"d":"70"},{"v":2524.5828778207524,"d":"2525"},"Kinexus","RpAb","GLI(pY)LTN(bA)C","Corresponds to amino acid residues G410 to N416.","Y413 phosphorylation induces transcription. This is the major in vivo phosphorylation site in IKZF1 (≥92 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in the chicken.",null,"Q13422","Q13422",4546,null,"Q13422","NP_006051.1","Block4",5,10,"4, 12, 20, 28",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription factor","GO:0005737; GO:0031618; GO:0005654; GO:0005634; GO:0032991","GO:0003677; GO:0003700; GO:0046872; GO:0019904; GO:0000981; GO:0044212","GO:0007049; GO:0006325; GO:0030218; GO:0030098; GO:0007498; GO:0045892; GO:0045944; GO:0051291; GO:0006351"]
[1149,482,"PN227","IL6ST (GP130)","S782","Interleukin-6 receptor subunit beta",{"v":308.6897285424336,"d":"309"},{"v":261.1667625464567,"d":"261"},{"v":181.57768763734109,"d":"182"},{"v":58.822069815769964,"d":"59"},{"v":47.780154624476026,"d":"48"},{"v":1020.3105245959008,"d":"1020"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 768-789 Ser 782 of human gp130.","S782 phosphorylation phosphorylation induces receptor internalization and protein degradation. This is one of the minor  in vivo phosphorylation sites in IL6ST (≥3 reports from high throughput mass spectrometry studies).","CaMK2a; CaMK4","P40189","P40189",1105,null,"P40189","NP_001177910.1","Block3",12,1,"3, 11, 19, 27",{"$nulls":13},"Receptor, cytokine","GO:0070110; GO:0030425; GO:0009897; GO:0070062; GO:0005576; GO:0005615; GO:0005896; GO:0016020; GO:0043025; GO:0005900; GO:0005886","GO:0004897; GO:0005127; GO:0019838; GO:0019970; GO:0004921; GO:0045509; GO:0042803","GO:0070120; GO:0019221; GO:0005977; GO:0070106; GO:0070757; GO:0070102; GO:0048861; GO:0043066; GO:0070104; GO:0038165; GO:0002675; GO:0002821; GO:0048711; GO:0010613; GO:0008284; GO:0045669; GO:0042102; GO:0042531; GO:0010575; GO:0008593; GO:0034097; GO:0016032"]
[1151,570,"NK078-4","ILK1 (ILK)","Pan-specific","Integrin-linked protein-serine kinase-1",{"v":482.0588739059784,"d":"482"},{"v":402.20477311926726,"d":"402"},{"v":370.3164272390141,"d":"370"},{"v":76.81975113090466,"d":"77"},{"v":63.82124322089568,"d":"64"},{"v":4230.35534265468,"d":"4230"},"External","MmAb","Not precisely defined.","Antibody raised against full length recombinant  mouse ILK-1.",null,null,"Q13418","Q13418",607,"Q13418","Q13418","NP_034692","Block4",5,11,"4, 12, 20, 28","ILK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","MLK","ILK",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); TKL domain target; TKL</A> group; MLK family; ILK subfamily","GO:0005911; GO:0030054; GO:0043034; GO:0005737; GO:0005829; GO:0043198; GO:0005925; GO:0030027; GO:0016020; GO:0043025; GO:0005654; GO:0005886; GO:0032991; GO:0030017; GO:0001725; GO:0043195","GO:0005524; GO:0005178; GO:0019901; GO:0004674; GO:0017124","GO:0001658; GO:0007569; GO:0007050; GO:0034329; GO:0007160; GO:0008283; GO:0045197; GO:0010761; GO:0007229; GO:0000165; GO:0007275; GO:0032288; GO:0022011; GO:0010667; GO:2000178; GO:0043524; GO:0006469; GO:0014912; GO:0048662; GO:0021675; GO:0048812; GO:0003151; GO:0018105; GO:0070527; GO:0045773; GO:0030513; GO:0090263; GO:0001954; GO:0030335; GO:0008284; GO:0050775; GO:0043406; GO:0045663; GO:1901224; GO:0045669; GO:0042327; GO:0051897; GO:0001934; GO:0009967; GO:0045893; GO:0051291; GO:0043491; GO:0006468; GO:0032956; GO:0034446; GO:0097435; GO:0033209"]
[1153,571,"PK661","ILK1 (ILK)","S343","Integrin-linked protein-serine kinase-1",{"v":1646.0493578727244,"d":"1646"},{"v":1625.624225762924,"d":"1626"},{"v":701.3386193888532,"d":"701"},{"v":42.60738695559104,"d":"43"},{"v":191.9581946026637,"d":"192"},{"v":3924.8062780613163,"d":"3925"},"Kinexus","RpAb","DVKF(pS)FQC","Corresponds to amino acid residues D339 to C346; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S343 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation regulates molecular association, including inducing interaction with Akt1. This is one of the minor in vivo phosphorylation sites in ILK1 (≥1 reports from high throughput mass spectrometry studies).",null,"Q13418","Q13418",607,"Q13418","Q13418","NP_034692","Block4",5,12,"4, 12, 20, 28","ILK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","MLK","ILK",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); TKL domain target; TKL</A> group; MLK family; ILK subfamily","GO:0005911; GO:0030054; GO:0043034; GO:0005737; GO:0005829; GO:0043198; GO:0005925; GO:0030027; GO:0016020; GO:0043025; GO:0005654; GO:0005886; GO:0032991; GO:0030017; GO:0001725; GO:0043195","GO:0005524; GO:0005178; GO:0019901; GO:0004674; GO:0017124","GO:0001658; GO:0007569; GO:0007050; GO:0034329; GO:0007160; GO:0008283; GO:0045197; GO:0010761; GO:0007229; GO:0000165; GO:0007275; GO:0032288; GO:0022011; GO:0010667; GO:2000178; GO:0043524; GO:0006469; GO:0014912; GO:0048662; GO:0021675; GO:0048812; GO:0003151; GO:0018105; GO:0070527; GO:0045773; GO:0030513; GO:0090263; GO:0001954; GO:0030335; GO:0008284; GO:0050775; GO:0043406; GO:0045663; GO:1901224; GO:0045669; GO:0042327; GO:0051897; GO:0001934; GO:0009967; GO:0045893; GO:0051291; GO:0043491; GO:0006468; GO:0032956; GO:0034446; GO:0097435; GO:0033209"]
[1155,572,"PK662","ILK1 (ILK)","Y351","Integrin-linked protein-serine kinase-1",{"v":100.8383785383295,"d":"101"},{"v":84.71497722739481,"d":"85"},{"v":61.67011504291809,"d":"62"},{"v":61.1573846553639,"d":"61"},{"v":19.98633037672589,"d":"20"},{"v":364.2752199778928,"d":"364"},"Kinexus","RpAb","GRM(pY)APA(bA)C","Corresponds to amino acid residues G348 to A354; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y351 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation of this site in ILK1 has apparently not been reported from high throughput mass spectrometry studies.",null,"Q13418","Q13418",607,"Q13418","Q13418","NP_034692","Block4",5,13,"4, 12, 20, 28","ILK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","MLK","ILK",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); TKL domain target; TKL</A> group; MLK family; ILK subfamily","GO:0005911; GO:0030054; GO:0043034; GO:0005737; GO:0005829; GO:0043198; GO:0005925; GO:0030027; GO:0016020; GO:0043025; GO:0005654; GO:0005886; GO:0032991; GO:0030017; GO:0001725; GO:0043195","GO:0005524; GO:0005178; GO:0019901; GO:0004674; GO:0017124","GO:0001658; GO:0007569; GO:0007050; GO:0034329; GO:0007160; GO:0008283; GO:0045197; GO:0010761; GO:0007229; GO:0000165; GO:0007275; GO:0032288; GO:0022011; GO:0010667; GO:2000178; GO:0043524; GO:0006469; GO:0014912; GO:0048662; GO:0021675; GO:0048812; GO:0003151; GO:0018105; GO:0070527; GO:0045773; GO:0030513; GO:0090263; GO:0001954; GO:0030335; GO:0008284; GO:0050775; GO:0043406; GO:0045663; GO:1901224; GO:0045669; GO:0042327; GO:0051897; GO:0001934; GO:0009967; GO:0045893; GO:0051291; GO:0043491; GO:0006468; GO:0032956; GO:0034446; GO:0097435; GO:0033209"]
[1157,573,"NK079-2","InsR (IR)","Pan-specific","Insulin receptor",{"v":1107.0754086277882,"d":"1107"},{"v":989.4999807048982,"d":"989"},{"v":525.816555852614,"d":"526"},{"v":47.49600178585484,"d":"47"},{"v":177.54147947892397,"d":"178"},{"v":3366.864508648509,"d":"3367"},"Kinexus","RpAb","SLGFKRSYEEHIPYTHMNGC","Corresponds to amino acid residues S1348 to G1366; Pre-C-terminus.",null,null,"P06213","P06213",608,"P06213",null,"NP_000199.2","Block4",6,1,"4, 12, 20, 28","INSR","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK","InsR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; InsR family","GO:0005901; GO:0032590; GO:0010008; GO:0009897; GO:0070062; GO:0005899; GO:0005887; GO:0005622; GO:0016020; GO:0032809; GO:0005886; GO:0043235","GO:0001540; GO:0005524; GO:0005525; GO:0042802; GO:0005009; GO:0043559; GO:0031994; GO:0031995; GO:0005159; GO:0043560; GO:0043548; GO:0044877; GO:0019904; GO:0004713; GO:0051425","GO:0000187; GO:0032147; GO:0032148; GO:0030325; GO:0097242; GO:0005975; GO:0071363; GO:0032869; GO:0097062; GO:0008544; GO:0031017; GO:0042593; GO:0007186; GO:0003007; GO:0008286; GO:0007612; GO:0008584; GO:0030238; GO:0007613; GO:1990535; GO:0038083; GO:0018108; GO:0030335; GO:0008284; GO:0048639; GO:0046326; GO:0045725; GO:0045821; GO:0043410; GO:0051446; GO:0045840; GO:0045429; GO:0043243; GO:0051897; GO:0001934; GO:0060267; GO:0045893; GO:0046777; GO:0051290; GO:0006468; GO:0045995; GO:2000194; GO:0006355; GO:0019087"]
[1159,574,"NK079-3","InsR (IR)","Pan-specific","Insulin receptor",{"v":323.5626541590414,"d":"324"},{"v":273.038248424146,"d":"273"},{"v":243.6565007120946,"d":"244"},{"v":75.3042718559014,"d":"75"},{"v":44.79985065123565,"d":"45"},{"v":3004.4525937180365,"d":"3004"},"External","MmAb","Not precisely defined.","Antibody raised against the C-terminus of human insulin receptor.",null,null,"P06213","P06213",608,"P06213",null,"NP_000199.2","Block4",6,2,"4, 12, 20, 28","INSR","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK","InsR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; InsR family","GO:0005901; GO:0032590; GO:0010008; GO:0009897; GO:0070062; GO:0005899; GO:0005887; GO:0005622; GO:0016020; GO:0032809; GO:0005886; GO:0043235","GO:0001540; GO:0005524; GO:0005525; GO:0042802; GO:0005009; GO:0043559; GO:0031994; GO:0031995; GO:0005159; GO:0043560; GO:0043548; GO:0044877; GO:0019904; GO:0004713; GO:0051425","GO:0000187; GO:0032147; GO:0032148; GO:0030325; GO:0097242; GO:0005975; GO:0071363; GO:0032869; GO:0097062; GO:0008544; GO:0031017; GO:0042593; GO:0007186; GO:0003007; GO:0008286; GO:0007612; GO:0008584; GO:0030238; GO:0007613; GO:1990535; GO:0038083; GO:0018108; GO:0030335; GO:0008284; GO:0048639; GO:0046326; GO:0045725; GO:0045821; GO:0043410; GO:0051446; GO:0045840; GO:0045429; GO:0043243; GO:0051897; GO:0001934; GO:0060267; GO:0045893; GO:0046777; GO:0051290; GO:0006468; GO:0045995; GO:2000194; GO:0006355; GO:0019087"]
[1161,575,"PK663","InsR (IR)","Y1189","Insulin receptor",{"v":7219.742002209469,"d":"7220"},{"v":7121.333978685066,"d":"7121"},{"v":1969.0630868045218,"d":"1969"},{"v":27.273316500810225,"d":"27"},{"v":1626.1835650337646,"d":"1626"},{"v":12020.518626555682,"d":"12021"},"Kinexus","RpAb","ETD(pY)YRK(bA)C","Corresponds to amino acid residues E1186 to K1192; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y1189 phosphorylation stimulates phosphotransferase activity, receptor internalization and induces interaction with APS, GRB7, SOCS1, IRS2 and PTP1B. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation site in the insulin receptor (≥719 reports from high throughput mass spectrometry studies).","InsR","P06213","P06213",608,"P06213",null,"NP_000199.2","Block4",6,3,"4, 12, 20, 28","INSR","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK","InsR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; InsR family","GO:0005901; GO:0032590; GO:0010008; GO:0009897; GO:0070062; GO:0005899; GO:0005887; GO:0005622; GO:0016020; GO:0032809; GO:0005886; GO:0043235","GO:0001540; GO:0005524; GO:0005525; GO:0042802; GO:0005009; GO:0043559; GO:0031994; GO:0031995; GO:0005159; GO:0043560; GO:0043548; GO:0044877; GO:0019904; GO:0004713; GO:0051425","GO:0000187; GO:0032147; GO:0032148; GO:0030325; GO:0097242; GO:0005975; GO:0071363; GO:0032869; GO:0097062; GO:0008544; GO:0031017; GO:0042593; GO:0007186; GO:0003007; GO:0008286; GO:0007612; GO:0008584; GO:0030238; GO:0007613; GO:1990535; GO:0038083; GO:0018108; GO:0030335; GO:0008284; GO:0048639; GO:0046326; GO:0045725; GO:0045821; GO:0043410; GO:0051446; GO:0045840; GO:0045429; GO:0043243; GO:0051897; GO:0001934; GO:0060267; GO:0045893; GO:0046777; GO:0051290; GO:0006468; GO:0045995; GO:2000194; GO:0006355; GO:0019087"]
[1163,578,"NK080-2","IRAK1","Pan-specific","Interleukin 1 receptor-associated kinase 1 (Pelle-like protein kinase)",{"v":614.2203407419876,"d":"614"},{"v":480.80285986479134,"d":"481"},{"v":503.147060881413,"d":"503"},{"v":81.91637878250721,"d":"82"},{"v":120.71979663498888,"d":"121"},{"v":6339.700328528061,"d":"6340"},"External","RpAb","Not precisely defined.","Corresponds to amino acid residues 440-712;  In the C-terminus of human IRAK1.",null,null,"P51617","P51617",789,"P51617",null,"NP_001560","Block4",6,6,"4, 12, 20, 28","IRAK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","IRAK",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); TKL group; IRAK family","GO:0005737; GO:0005829; GO:0010008; GO:0045323; GO:0005811; GO:0005634; GO:0005886","GO:0005524; GO:0031072; GO:0016301; GO:0004704; GO:0046982; GO:0042803; GO:0004672; GO:0004674","GO:0000187; GO:0007250; GO:0007568; GO:0034605; GO:0071456; GO:0070498; GO:0007254; GO:0031663; GO:0002755; GO:0043066; GO:0032088; GO:0070423; GO:0043123; GO:0043406; GO:0051092; GO:0048661; GO:0045893; GO:0032481; GO:0046777; GO:0051259; GO:0006468; GO:0001959; GO:0070555; GO:0032496; GO:0007165; GO:0034134; GO:0034142; GO:0034162; GO:0002224; GO:0007178; GO:0060337; GO:0016032"]
[1165,579,"PK664","IRAK1","T387","Interleukin 1 receptor-associated kinase 1 (Pelle-like protein kinase)",{"v":11444.444707925652,"d":"11444"},{"v":11347.33007652091,"d":"11347"},{"v":2503.059269111252,"d":"2503"},{"v":21.87139116830895,"d":"22"},{"v":2800.1591536275337,"d":"2800"},{"v":18263.46701597714,"d":"18263"},"Kinexus","RpAb","VRG(pT)LAY(bA)C","Corresponds to amino acid residues V384 to Y390; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T387 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the minor in vivo phosphorylation sites in IRAK1 (≥1 reports from high throughput mass spectrometry studies).","IRAK1; IRAK4","P51617","P51617",789,"P51617",null,"NP_001560","Block4",6,7,"4, 12, 20, 28","IRAK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","IRAK",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); TKL group; IRAK family","GO:0005737; GO:0005829; GO:0010008; GO:0045323; GO:0005811; GO:0005634; GO:0005886","GO:0005524; GO:0031072; GO:0016301; GO:0004704; GO:0046982; GO:0042803; GO:0004672; GO:0004674","GO:0000187; GO:0007250; GO:0007568; GO:0034605; GO:0071456; GO:0070498; GO:0007254; GO:0031663; GO:0002755; GO:0043066; GO:0032088; GO:0070423; GO:0043123; GO:0043406; GO:0051092; GO:0048661; GO:0045893; GO:0032481; GO:0046777; GO:0051259; GO:0006468; GO:0001959; GO:0070555; GO:0032496; GO:0007165; GO:0034134; GO:0034142; GO:0034162; GO:0002224; GO:0007178; GO:0060337; GO:0016032"]
[1167,581,"PK665","IRAK4","T345+S346","Interleukin 1 receptor-associated kinase 4",{"v":20933.206619729826,"d":"20933"},{"v":20127.863217684506,"d":"20128"},{"v":7583.156668741725,"d":"7583"},{"v":36.22548999059943,"d":"36"},{"v":8036.116117890317,"d":"8036"},{"v":40192.036457449685,"d":"40192"},"Kinexus","RpAb","TVM(pT)(pS)RIV(bA)C","Corresponds to amino acid residues T342 to V349; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T345 and S346 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation regulates molecular association, including inducing interaction with Akt1. These are minor in vivo phosphorylation sites in IRAK4 (≥2 and ≥3 reports from high throughput mass spectrometry studies).","T345: IRAK4. S346: IRAK4.","Q9NWZ3","Q9NWZ3",1998,"Q9NWZ3",null,"NP_001107654.1","Block4",6,9,"4, 12, 20, 28","IRAK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","IRAK",{"$nulls":6},"Cytoplasm, Nucleus protein; Protein-serine kinase, TKL group, IRAK family","GO:0005737; GO:0005829; GO:0010008; GO:0005615; GO:0005634; GO:0005886","GO:0005524; GO:0005149; GO:0000287; GO:0004672; GO:0004674","GO:0001816; GO:0045087; GO:0070498; GO:0007254; GO:0002755; GO:0002446; GO:1990266; GO:0043123; GO:0051092; GO:0048661; GO:0034162; GO:0002224"]
[1169,582,"PN610","IRF3","T135","Interferon regulatory factor 3",{"v":17361.480092274356,"d":"17361"},{"v":16749.175031065086,"d":"16749"},{"v":3868.1341723756054,"d":"3868"},{"v":22.279979309464963,"d":"22"},{"v":7866.359304645974,"d":"7866"},{"v":28949.50440863076,"d":"28950"},"Kinexus","RpAb","CSTSD(pT)QEDI","Corresponds to amino acid residues C131 to I139.","T135 phosphoryation causes nuclear retention and delayed proteolysis. This is the major in vivo phosphorylation site in IRF3 (≥30 reports from high throughput mass spectrometry studies).","DNAPK (PRKDC)","Q14653","Q14653",2057,null,null,"NP_001562.1","Block4",6,10,"4, 12, 20, 28",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0003677; GO:0042802; GO:0019904; GO:0042803; GO:0000978; GO:0000981; GO:0043565; GO:0001077; GO:0001228; GO:0001078; GO:0003712","GO:0006915; GO:0006974; GO:0071359; GO:0051607; GO:0060333; GO:0031663; GO:0071888; GO:0039530; GO:0050689; GO:0045358; GO:0032480; GO:0050715; GO:0043123; GO:0032727; GO:0032728; GO:0045944; GO:0060340; GO:0032481; GO:0097300; GO:0032479; GO:0043330; GO:0006366; GO:0035666; GO:0045351; GO:0060337; GO:0016032"]
[1171,583,"NK273-1","IRR (INSRR)","Pan-specific","Insulin receptor-related protein",{"v":2177.2275586481733,"d":"2177"},{"v":2128.6658770815807,"d":"2129"},{"v":805.6732076740666,"d":"806"},{"v":37.004547571237985,"d":"37"},{"v":198.75361104841167,"d":"199"},{"v":5399.737636661339,"d":"5400"},"Kinexus","RpAb","RGSLPTTDAEPDSSPTPRDC","Corresponds to amino acid residues R1269 to C1288; Pre-C-terminus.",null,null,"P14616","P14616",1937,"P14616",null,"NP_055030.1","Block4",6,11,"4, 12, 20, 28","IRR","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK","InsR",{"$nulls":6},"Membrane, Integral plasma membrane protein","GO:0005887; GO:0043235","GO:0005524; GO:0043560; GO:0043548; GO:0004714","GO:0031532; GO:0071469; GO:0030238; GO:0046777; GO:0007169"]
[1173,584,"NN383-2","IRS1","Pan-specific","Insulin receptor substrate 1",{"v":276.7550214385973,"d":"277"},{"v":209.25635443012175,"d":"209"},{"v":296.91011677288856,"d":"297"},{"v":107.28264846994402,"d":"107"},{"v":45.36908772057653,"d":"45"},{"v":3809.766900509534,"d":"3810"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 2-25 at the N-terminus of  human IRS1.",null,null,"P35568","P35568",855,null,null,"NP_005535","Block4",6,12,"4, 12, 20, 28",{"$nulls":11},"X",null,"Adapter/scaffold protein","GO:0005901; GO:0005737; GO:0005829; GO:0005899; GO:0043231; GO:0005634; GO:0005886","GO:0016303; GO:0005159; GO:0005158; GO:0043548; GO:0046934; GO:0001784; GO:0005080; GO:0005088; GO:0042169; GO:0005068","GO:0032869; GO:0042593; GO:0048009; GO:0008286; GO:0038111; GO:0000165; GO:0046627; GO:0046676; GO:0014065; GO:0048015; GO:0008284; GO:0032000; GO:0046326; GO:2001275; GO:0010907; GO:0045725; GO:0046628; GO:0043552; GO:0051897; GO:0032868; GO:0043434; GO:0007165"]
[1175,585,"PN117","IRS1","S312","Insulin receptor substrate 1",{"v":353.93536031021745,"d":"354"},{"v":310.67457368092425,"d":"311"},{"v":303.16032387372235,"d":"303"},{"v":85.65414984476493,"d":"86"},{"v":11.355251683450568,"d":"11"},{"v":1944.0450099498828,"d":"1944"},"External","RpAb","AT(pS)PA","Corresponds to amino acid residues  A310 to A314; Surrounds the S312 phosphosite.","S312 phosphorylation regulates apoptosis, alters intracellular location, protein degradation, regulates molecular association, and inhibits interaction with IKK-alpha and IKK-beta. It may also faciliate degradation by the Cul7-RING(FBXW8) complex. This is one of the major in vivo phosphorylation sites in IRS1 (≥13 reports from high throughput mass spectrometry studies).","CK2a1 (CSNK2A1); ERK1 (MAPK3); ERK2 (MAPK1); IKKa (CHUK, IKBKA); IKKb (IKBKB); JNK1 (MAPK8); p70S6K (RPS6KB1); PKCa (PRKCA); PKCz (PRKCZ)","P35568","P35568",855,null,null,"NP_005535","Block4",6,13,"4, 12, 20, 28",{"$nulls":11},"X",null,"Adapter/scaffold protein","GO:0005901; GO:0005737; GO:0005829; GO:0005899; GO:0043231; GO:0005634; GO:0005886","GO:0016303; GO:0005159; GO:0005158; GO:0043548; GO:0046934; GO:0001784; GO:0005080; GO:0005088; GO:0042169; GO:0005068","GO:0032869; GO:0042593; GO:0048009; GO:0008286; GO:0038111; GO:0000165; GO:0046627; GO:0046676; GO:0014065; GO:0048015; GO:0008284; GO:0032000; GO:0046326; GO:2001275; GO:0010907; GO:0045725; GO:0046628; GO:0043552; GO:0051897; GO:0032868; GO:0043434; GO:0007165"]
[1177,586,"PN118","IRS1","S639","Insulin receptor substrate 1",{"v":308.9286915914985,"d":"309"},{"v":259.436671469339,"d":"259"},{"v":247.72868151016385,"d":"248"},{"v":80.18959981798635,"d":"80"},{"v":13.161295004020673,"d":"13"},1144,"External","RpAb","PK(pS)VS","Corresponds to amino acid residues  P637 to S341; Surrounds the S639 phosphosite.","S639 phosphorylation regulates intracellular location and Inhibition of tyrosine phosphorylation. It may also facilitate degradation by the Cul7-RING(FBXW8) complex. This is one of the minor in vivo phosphorylation sites in IRS1 (≥4 reports from high throughput mass spectrometry studies).","BARK1 (GRK2; ADRBK1); ERK2 (MAPK1); FRAP1 (mTOR); p70S6K (RPS6KB1); ROCK1; ROCK2","P35568","P35568",855,null,null,"NP_005535","Block4",7,1,"4, 12, 20, 28",{"$nulls":11},"X",null,"Adapter/scaffold protein","GO:0005901; GO:0005737; GO:0005829; GO:0005899; GO:0043231; GO:0005634; GO:0005886","GO:0016303; GO:0005159; GO:0005158; GO:0043548; GO:0046934; GO:0001784; GO:0005080; GO:0005088; GO:0042169; GO:0005068","GO:0032869; GO:0042593; GO:0048009; GO:0008286; GO:0038111; GO:0000165; GO:0046627; GO:0046676; GO:0014065; GO:0048015; GO:0008284; GO:0032000; GO:0046326; GO:2001275; GO:0010907; GO:0045725; GO:0046628; GO:0043552; GO:0051897; GO:0032868; GO:0043434; GO:0007165"]
[1179,576,"NN424-1","ITGA4 (CD49D; Integrin a4 )","Pan-specific","Integrin alpha 4 (VLA4)",{"v":532.4117712851322,"d":"532"},{"v":437.1897036038997,"d":"437"},{"v":557.8455885061919,"d":"558"},{"v":104.7770952095345,"d":"105"},{"v":35.437596147793755,"d":"35"},{"v":7470.222778147752,"d":"7470"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 796-1005 mapping near the C-terminus of human Integrin α4.",null,null,"P13612","P13612",7867,null,null,"NP_000876.3","Block4",6,4,"4, 12, 20, 28",{"$nulls":13},"Receptor, misc.; Adhesion","GO:0009986; GO:0070062; GO:0005925; GO:0030426; GO:0034669; GO:0016020; GO:0043025; GO:0005886","GO:0050839; GO:0015026; GO:0001968; GO:0046872; GO:1990405","GO:0060385; GO:0030183; GO:0007160; GO:0003366; GO:0071345; GO:1990771; GO:0050904; GO:0035987; GO:0030198; GO:0034113; GO:0007229; GO:0007159; GO:0050900; GO:0050901; GO:0090074; GO:1990138; GO:2000353; GO:1903238; GO:2000406; GO:1905564; GO:0043113; GO:0050776; GO:0034446"]
[1181,577,"PN231","ITGB3","Y785","Integrin beta-3",{"v":28.535758110606768,"d":"29"},{"v":24.373622810196856,"d":"24"},{"v":16.05200818165518,"d":"16"},{"v":56.252257674165776,"d":"56"},{"v":6.013803484774263,"d":"6"},{"v":106.07226099836807,"d":"106"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the Y759 phosphosite.","Y785 phosphorylation induces binding of Grb2 and Shc, and inhibits interaction with kindlin-2. This is one of the minor in vivo phosphorylation sites in ITGB3 (≥7 reports from high throughput mass spectrometry studies).","Src; Syk","P05106","P05106",992,null,null,"NP_000203.2","Block4",6,5,"4, 12, 20, 28",{"$nulls":13},"Adhesion protein","GO:0035868; GO:0035867; GO:0035866; GO:0071062; GO:0009986; GO:0070062; GO:0031527; GO:0005925; GO:0098978; GO:0005887; GO:0034683; GO:0008305; GO:0031258; GO:0042470; GO:0031528; GO:0005634; GO:0005886; GO:0031092; GO:0043235; GO:0032587","GO:0050839; GO:0015026; GO:0019899; GO:0050840; GO:0001968; GO:0042802; GO:0005178; GO:0005161; GO:0002020; GO:0003756; GO:0043184; GO:0001618","GO:0032147; GO:0060055; GO:0038027; GO:0043277; GO:0007596; GO:0007155; GO:0033627; GO:0007160; GO:0031589; GO:0030198; GO:0034113; GO:0007229; GO:0050900; GO:0048333; GO:0050919; GO:0010888; GO:0032369; GO:0050748; GO:0045715; GO:0010745; GO:0030168; GO:0070527; GO:0002576; GO:0010595; GO:0001938; GO:0050731; GO:0001934; GO:0030949; GO:0045124; GO:0099149; GO:0014909; GO:0034446; GO:0035295; GO:0048010; GO:0046718; GO:0042060"]
[1183,587,"NK274-1","ITK","Pan-specific","Tyrosine-protein kinase ITK/TSK",{"v":3718.3376446643556,"d":"3718"},{"v":3546.2546341228226,"d":"3546"},{"v":1316.103457402524,"d":"1316"},{"v":35.394942126653625,"d":"35"},{"v":470.8718705630739,"d":"471"},{"v":8198.042870331508,"d":"8198"},"Kinexus","RpAb","CWKERPEDRPAFSRLLRQLA","Corresponds to amino acid residues C594 to A613; Pre-C-terminus.",null,null,"Q08881","Q08881",1222,"Q08881","Q08881","NP_005537.3","Block4",7,2,"4, 12, 20, 28","ITK","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"Protein-tyrosine kinase, TK group, Tec family","GO:0005911; GO:0005829; GO:0031234; GO:0005634","GO:0005524; GO:0046872; GO:0004715","GO:0007202; GO:0002250; GO:0006968; GO:0001816; GO:0038095; GO:0045087; GO:0032609; GO:0032633; GO:0035556; GO:0001865; GO:0038083; GO:0042127; GO:0007165; GO:0042110; GO:0050852; GO:0007169"]
[1185,588,"PK666","ITK","Y512","Tyrosine-protein kinase ITK/TSK",{"v":13964.219952780006,"d":"13964"},{"v":13603.81298946137,"d":"13604"},{"v":2741.2253117936516,"d":"2741"},{"v":19.63035043176849,"d":"20"},{"v":5680.700505102032,"d":"5681"},{"v":22726.433258952835,"d":"22726"},"Kinexus","RpAb","DDQ(pY)TSS(bA)C","Corresponds to amino acid residues D509 to S515; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y512 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation site in ITK (≥256 reports from high throughput mass spectrometry studies).",null,"Q08881","Q08881",1222,"Q08881","Q08881","NP_005537.3","Block4",7,3,"4, 12, 20, 28","ITK","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"Protein-tyrosine kinase, TK group, Tec family","GO:0005911; GO:0005829; GO:0031234; GO:0005634","GO:0005524; GO:0046872; GO:0004715","GO:0007202; GO:0002250; GO:0006968; GO:0001816; GO:0038095; GO:0045087; GO:0032609; GO:0032633; GO:0035556; GO:0001865; GO:0038083; GO:0042127; GO:0007165; GO:0042110; GO:0050852; GO:0007169"]
[1187,589,"PN521","ITSN2","Y968","Intersectin-2",{"v":9198.714356196086,"d":"9199"},{"v":9031.15007019944,"d":"9031"},{"v":1932.4697581849998,"d":"1932"},{"v":21.008041812748797,"d":"21"},{"v":4200.86818107824,"d":"4201"},{"v":15219.699744783615,"d":"15220"},"Kinexus","RpAb","EAL(pY)AAV(bA)C","Corresponds to amino acid residues E965 to V971; In the insert region that separates the SH3_2 and SH3_1 domains. ","The effect of Y968 phosphorylation is unclear. This is the second major in vivo phosphorylation site in ITSN2 (≥765 reports from high throughput mass spectrometry studies).",null,"Q9NZM3","Q9NZM3",2656,null,null,"NP_006268.2","Block4",7,4,"4, 12, 20, 28",{"$nulls":11},"X",null,"Adapter/scaffold protein","GO:0005813; GO:0005737; GO:0070062","GO:0005509; GO:0005089; GO:0005070","GO:0006897; GO:1903861; GO:0035023; GO:0016032"]
[1189,590,"PN611","IWS1","S720+T721+T725","Protein IWS1 homologue",{"v":19108.416909894884,"d":"19108"},{"v":19016.90901544579,"d":"19017"},{"v":4814.368046257773,"d":"4814"},{"v":25.195012590314352,"d":"25"},{"v":8308.862551116807,"d":"8309"},{"v":33749.0448781797,"d":"33749"},"Kinexus","RpAb","RMN(pS)(pT)GGQ(pT)PRRC","Corresponds to amino acid residues R717 to R728.","The effects of S720, T721 and T725 phosphorylation are unclear. These are three of the major in vivo phosphorylation sites in ITSN2 (≥790, ≥81 and ≥239 reports, respectively, from high throughput mass spectrometry studies).",null,"Q96ST2","Q96ST2",6251,null,null,"NP_060439.2","Block4",7,5,"4, 12, 20, 28",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005654; GO:0005634",null,"GO:0006397; GO:0051028; GO:0032784; GO:2001253; GO:0090239; GO:0010793; GO:0050684; GO:0008380; GO:0006366; GO:0006368"]
[1191,591,"NK084-2","JAK1","Pan-specific","Janus protein-tyrosine kinase 1",{"v":149.44446666837894,"d":"149"},{"v":129.81911547352124,"d":"130"},{"v":85.2118430110288,"d":"85"},{"v":57.0190686284264,"d":"57"},{"v":35.13007928463903,"d":"35"},{"v":500.1762512789645,"d":"500"},"External",null,"Not precisely defined.","Antibody raised against amino acid residues within an internal region of mouse JAK1.",null,null,"P23458","P23458",887,"P23458","P23458","NP_002218","Block4",7,6,"4, 12, 20, 28","JAK1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","JakA",{"$nulls":6},"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; JakA family","GO:0005737; GO:0005856; GO:0005829; GO:0005768; GO:0031234; GO:0005925; GO:0005634","GO:0005524; GO:0031730; GO:0005131; GO:0046872; GO:0004715; GO:0019903; GO:0004713; GO:0005088; GO:0005102; GO:0031625","GO:0030154; GO:0016477; GO:0019221; GO:0045087; GO:0060333; GO:0035722; GO:0035723; GO:0038114; GO:0070106; GO:0038110; GO:0070757; GO:0070102; GO:0038111; GO:0038113; GO:0035556; GO:0000165; GO:0038083; GO:1903672; GO:0006468; GO:0042127; GO:0060334; GO:0046677; GO:0007169; GO:0060337"]
[1193,592,"NK084-5","JAK1","Pan-specific","Janus protein-tyrosine kinase 1",{"v":16657.265820047985,"d":"16657"},{"v":16549.342903210054,"d":"16549"},{"v":3514.4379283974345,"d":"3514"},{"v":21.098528212040684,"d":"21"},{"v":8091.886627032792,"d":"8092"},{"v":29217.775291079357,"d":"29218"},"Kinexus","RpAb","CFQNLIEGFEALLK","Corresponds to amino acid residues F1142 to K1154; Kinase last alpha-chain+C-terminus.",null,null,"P23458","P23458",887,"P23458","P23458","NP_002218","Block4",7,7,"4, 12, 20, 28","JAK1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","JakA",{"$nulls":6},"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; JakA family","GO:0005737; GO:0005856; GO:0005829; GO:0005768; GO:0031234; GO:0005925; GO:0005634","GO:0005524; GO:0031730; GO:0005131; GO:0046872; GO:0004715; GO:0019903; GO:0004713; GO:0005088; GO:0005102; GO:0031625","GO:0030154; GO:0016477; GO:0019221; GO:0045087; GO:0060333; GO:0035722; GO:0035723; GO:0038114; GO:0070106; GO:0038110; GO:0070757; GO:0070102; GO:0038111; GO:0038113; GO:0035556; GO:0000165; GO:0038083; GO:1903672; GO:0006468; GO:0042127; GO:0060334; GO:0046677; GO:0007169; GO:0060337"]
[1195,593,"PK126","JAK1","Y1022","Janus protein-tyrosine kinase 1",{"v":786.2742803767421,"d":"786"},{"v":570.1222214429608,"d":"570"},{"v":1547.5514570280977,"d":"1548"},{"v":196.82081630427882,"d":"197"},{"v":10.08122484047093,"d":"10"},{"v":14076.376511490527,"d":"14076"},"External","RpAb","KE(pY)YT","Corresponds to amino acid residues K1020 to T1024; Surrounds the Y1022 phosphosite.","The effect of Y1022 phosphorylation is unclear. Phosphorylation of this site in JAK1 from high throughput mass spectrometry studies has not been reported.","JAK1; JAK3","P23458","P23458",887,"P23458","P23458","NP_002218","Block4",7,8,"4, 12, 20, 28","JAK1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","JakA",{"$nulls":6},"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; JakA family","GO:0005737; GO:0005856; GO:0005829; GO:0005768; GO:0031234; GO:0005925; GO:0005634","GO:0005524; GO:0031730; GO:0005131; GO:0046872; GO:0004715; GO:0019903; GO:0004713; GO:0005088; GO:0005102; GO:0031625","GO:0030154; GO:0016477; GO:0019221; GO:0045087; GO:0060333; GO:0035722; GO:0035723; GO:0038114; GO:0070106; GO:0038110; GO:0070757; GO:0070102; GO:0038111; GO:0038113; GO:0035556; GO:0000165; GO:0038083; GO:1903672; GO:0006468; GO:0042127; GO:0060334; GO:0046677; GO:0007169; GO:0060337"]
[1197,594,"PK884","JAK1","Y1034+Y1035","Janus protein-tyrosine kinase 1",{"v":14078.508134285745,"d":"14079"},{"v":13855.022301509234,"d":"13855"},{"v":3691.3184156006973,"d":"3691"},{"v":26.219528236881413,"d":"26"},{"v":588.79636252123,"d":"589"},{"v":26525.584664389524,"d":"26526"},"Kinexus","RpAb","DKE(pY)(pY)TVK(bA)C","Corresponds to amino acid residues D1031 to K1038. Y1034+Y1035 are located in the Gap/Insert 8 (G/I8) region in the second protein-tyrosine kinase catalytic domain of JAK1 within the T-activation loop (between subdomains VII and VIII). ","Y1034+Y1035 phosphorylation appears to stimulate the phosphotransferase activity of JAK1. Phosphorylation of Y1034 and Y1035 have been observed to be the most frequent in JAK1 by mass spectrometry studies (≥175 and >52, respectively). ","Y1034: JAK3. Y1035: JAK3","P23458","P23458",887,"P23458","P23458","NP_002218","Block4",7,9,"4, 12, 20, 28","JAK1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","JakA",{"$nulls":6},"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; JakA family","GO:0005737; GO:0005856; GO:0005829; GO:0005768; GO:0031234; GO:0005925; GO:0005634","GO:0005524; GO:0031730; GO:0005131; GO:0046872; GO:0004715; GO:0019903; GO:0004713; GO:0005088; GO:0005102; GO:0031625","GO:0030154; GO:0016477; GO:0019221; GO:0045087; GO:0060333; GO:0035722; GO:0035723; GO:0038114; GO:0070106; GO:0038110; GO:0070757; GO:0070102; GO:0038111; GO:0038113; GO:0035556; GO:0000165; GO:0038083; GO:1903672; GO:0006468; GO:0042127; GO:0060334; GO:0046677; GO:0007169; GO:0060337"]
[1199,595,"PK895","JAK1","T1107","Janus protein-tyrosine kinase 1",{"v":10008.497161845433,"d":"10008"},{"v":9948.106278601552,"d":"9948"},{"v":3663.800581161688,"d":"3664"},{"v":36.60690033593547,"d":"37"},{"v":2084.763112170398,"d":"2085"},{"v":24614.438945006157,"d":"24614"},"Kinexus","RpAb","LVN(pT)LKE(bA)C","Corresponds to amino acid residues L1104 to E1110. T1107 is located in the Gap/Insert 10 (G/I10) region in the second protein-tyrosine kinase catalytic domain of JAK1.","The effect of T1107 phosphorylation is unknown. Its phosphorylation has been observed in only one mass spectrometry study. ",null,"P23458","P23458",887,"P23458","P23458","NP_002218","Block4",7,10,"4, 12, 20, 28","JAK1","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","JakA",{"$nulls":6},"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; JakA family","GO:0005737; GO:0005856; GO:0005829; GO:0005768; GO:0031234; GO:0005925; GO:0005634","GO:0005524; GO:0031730; GO:0005131; GO:0046872; GO:0004715; GO:0019903; GO:0004713; GO:0005088; GO:0005102; GO:0031625","GO:0030154; GO:0016477; GO:0019221; GO:0045087; GO:0060333; GO:0035722; GO:0035723; GO:0038114; GO:0070106; GO:0038110; GO:0070757; GO:0070102; GO:0038111; GO:0038113; GO:0035556; GO:0000165; GO:0038083; GO:1903672; GO:0006468; GO:0042127; GO:0060334; GO:0046677; GO:0007169; GO:0060337"]
[1201,596,"NK085-3","JAK2","Pan-specific","Janus protein-tyrosine kinase 2",{"v":12468.743360753035,"d":"12469"},{"v":11748.542741760168,"d":"11749"},{"v":3706.423422392726,"d":"3706"},{"v":29.72571746130543,"d":"30"},{"v":5283.395685495522,"d":"5283"},{"v":27866.977778371707,"d":"27867"},"Kinexus","RpAb","CDLALRVDQIRDNMAG","Corresponds to amino acid residues D1118 to G1132; Kinase last alpha-chain+C-terminus.",null,null,"O60674","O60674",611,"O60674","O60674","NP_004963","Block4",7,11,"4, 12, 20, 28","JAK2","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","JakA",{"$nulls":6},"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; JakA family","GO:0005901; GO:0005737; GO:0005856; GO:0005829; GO:0031904; GO:0031234; GO:0005925; GO:0098978; GO:0045121; GO:0016363; GO:0005654; GO:0005634; GO:0005886; GO:0098794","GO:0033130; GO:0005524; GO:0005131; GO:0020037; GO:0042393; GO:0035401; GO:0042802; GO:0043560; GO:0005143; GO:0046872; GO:0004715; GO:0051428; GO:0043548; GO:0008022; GO:0004672; GO:0019901; GO:0004713; GO:0005088; GO:0042169; GO:0005102; GO:0031702","GO:0030041; GO:0006919; GO:0097296; GO:0042976; GO:0000186; GO:0002250; GO:0006915; GO:0031103; GO:0007596; GO:0030154; GO:0016477; GO:0019221; GO:0007167; GO:0030218; GO:0097191; GO:0007186; GO:0060396; GO:0035409; GO:0045087; GO:0060333; GO:0035722; GO:0038155; GO:0070106; GO:0070757; GO:0070102; GO:0035556; GO:0008631; GO:0007259; GO:0060397; GO:0061180; GO:0000165; GO:0007498; GO:0031959; GO:0050804; GO:0010667; GO:0022408; GO:0008285; GO:0043392; GO:0045822; GO:0043524; GO:0038083; GO:0018108; GO:0048008; GO:0050867; GO:0045597; GO:0030335; GO:0010811; GO:0120162; GO:0007204; GO:0043388; GO:0051091; GO:1904037; GO:1902728; GO:0060399; GO:0050729; GO:0032024; GO:0032731; GO:0045429; GO:0051770; GO:0050731; GO:0014068; GO:0032516; GO:0033160; GO:0032760; GO:0042531; GO:1904707; GO:0099527; GO:0046777; GO:0006468; GO:0042981; GO:0042127; GO:0050727; GO:0060334; GO:0046425; GO:0046677; GO:0033194; GO:0070671; GO:0032496; GO:0034612; GO:0007165; GO:0033209; GO:0007260"]
[1203,597,"NK085-4","JAK2","Pan-specific","Janus protein-tyrosine kinase 2",{"v":9677.802763223573,"d":"9678"},{"v":9522.467738855437,"d":"9522"},{"v":2060.710303375991,"d":"2061"},{"v":21.293162857243335,"d":"21"},{"v":2520.903295469316,"d":"2521"},{"v":16344.429572842055,"d":"16344"},"Kinexus","RpAb","ELLTENDMLPNMRIGC","Corresponds to amino acid residues E814 to G828; Post-kinase last alpha-chain.",null,null,"O60674","O60674",611,"O60674","O60674","NP_004963","Block4",7,12,"4, 12, 20, 28","JAK2","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","JakA",{"$nulls":6},"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; JakA family","GO:0005901; GO:0005737; GO:0005856; GO:0005829; GO:0031904; GO:0031234; GO:0005925; GO:0098978; GO:0045121; GO:0016363; GO:0005654; GO:0005634; GO:0005886; GO:0098794","GO:0033130; GO:0005524; GO:0005131; GO:0020037; GO:0042393; GO:0035401; GO:0042802; GO:0043560; GO:0005143; GO:0046872; GO:0004715; GO:0051428; GO:0043548; GO:0008022; GO:0004672; GO:0019901; GO:0004713; GO:0005088; GO:0042169; GO:0005102; GO:0031702","GO:0030041; GO:0006919; GO:0097296; GO:0042976; GO:0000186; GO:0002250; GO:0006915; GO:0031103; GO:0007596; GO:0030154; GO:0016477; GO:0019221; GO:0007167; GO:0030218; GO:0097191; GO:0007186; GO:0060396; GO:0035409; GO:0045087; GO:0060333; GO:0035722; GO:0038155; GO:0070106; GO:0070757; GO:0070102; GO:0035556; GO:0008631; GO:0007259; GO:0060397; GO:0061180; GO:0000165; GO:0007498; GO:0031959; GO:0050804; GO:0010667; GO:0022408; GO:0008285; GO:0043392; GO:0045822; GO:0043524; GO:0038083; GO:0018108; GO:0048008; GO:0050867; GO:0045597; GO:0030335; GO:0010811; GO:0120162; GO:0007204; GO:0043388; GO:0051091; GO:1904037; GO:1902728; GO:0060399; GO:0050729; GO:0032024; GO:0032731; GO:0045429; GO:0051770; GO:0050731; GO:0014068; GO:0032516; GO:0033160; GO:0032760; GO:0042531; GO:1904707; GO:0099527; GO:0046777; GO:0006468; GO:0042981; GO:0042127; GO:0050727; GO:0060334; GO:0046425; GO:0046677; GO:0033194; GO:0070671; GO:0032496; GO:0034612; GO:0007165; GO:0033209; GO:0007260"]
[1205,598,"PK668","JAK2","Y570","Janus protein-tyrosine kinase 2",{"v":8353.888864598039,"d":"8354"},{"v":8246.684030319131,"d":"8247"},{"v":2619.747482068297,"d":"2620"},{"v":31.359616156377374,"d":"31"},{"v":247.67334238213562,"d":"248"},{"v":16511.635383051078,"d":"16512"},"Kinexus","RpAb","VGD(pY)GQL(bA)C","Corresponds to amino acid residues V567 to L573; In the protein kinase catalytic domain.","Y570 phosphorylation stimulates phosphotransferase activity. This is the major in vivo phosphorylation site in JAK2 (≥847 reports from high throughput mass spectrometry studies).","JAK2","O60674","O60674",611,"O60674","O60674","NP_004963","Block4",7,13,"4, 12, 20, 28","JAK2","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","JakA",{"$nulls":6},"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; JakA family","GO:0005901; GO:0005737; GO:0005856; GO:0005829; GO:0031904; GO:0031234; GO:0005925; GO:0098978; GO:0045121; GO:0016363; GO:0005654; GO:0005634; GO:0005886; GO:0098794","GO:0033130; GO:0005524; GO:0005131; GO:0020037; GO:0042393; GO:0035401; GO:0042802; GO:0043560; GO:0005143; GO:0046872; GO:0004715; GO:0051428; GO:0043548; GO:0008022; GO:0004672; GO:0019901; GO:0004713; GO:0005088; GO:0042169; GO:0005102; GO:0031702","GO:0030041; GO:0006919; GO:0097296; GO:0042976; GO:0000186; GO:0002250; GO:0006915; GO:0031103; GO:0007596; GO:0030154; GO:0016477; GO:0019221; GO:0007167; GO:0030218; GO:0097191; GO:0007186; GO:0060396; GO:0035409; GO:0045087; GO:0060333; GO:0035722; GO:0038155; GO:0070106; GO:0070757; GO:0070102; GO:0035556; GO:0008631; GO:0007259; GO:0060397; GO:0061180; GO:0000165; GO:0007498; GO:0031959; GO:0050804; GO:0010667; GO:0022408; GO:0008285; GO:0043392; GO:0045822; GO:0043524; GO:0038083; GO:0018108; GO:0048008; GO:0050867; GO:0045597; GO:0030335; GO:0010811; GO:0120162; GO:0007204; GO:0043388; GO:0051091; GO:1904037; GO:1902728; GO:0060399; GO:0050729; GO:0032024; GO:0032731; GO:0045429; GO:0051770; GO:0050731; GO:0014068; GO:0032516; GO:0033160; GO:0032760; GO:0042531; GO:1904707; GO:0099527; GO:0046777; GO:0006468; GO:0042981; GO:0042127; GO:0050727; GO:0060334; GO:0046425; GO:0046677; GO:0033194; GO:0070671; GO:0032496; GO:0034612; GO:0007165; GO:0033209; GO:0007260"]
[1207,599,"PK034-1","JAK2","Y1007+Y1008","Janus protein-tyrosine kinase 2",{"v":626.0198728797288,"d":"626"},{"v":423.63025517360563,"d":"424"},{"v":621.6675960847792,"d":"622"},{"v":99.30477018645928,"d":"99"},{"v":31.487998919624598,"d":"31"},{"v":3487.671378063092,"d":"3488"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the Y1007+Y1008 phosphosite.","T1007 and Y1008 phosphorylation stimulate phosphotransferase activity and induce interactions with SOCS1. These are two of the major in vivo phosphorylation sites in JAK2 (≥19 and ≥18 reports, respectively, from high throughput mass spectrometry studies).","Y1007: JAK2; PYK2 (PTK2B; FAK2). Y1008 JAK2; PYK2 (PTK2B; FAK2). ","O60674","O60674",611,"O60674","O60674","NP_004963","Block4",8,1,"4, 12, 20, 28","JAK2","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","JakA",{"$nulls":6},"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; JakA family","GO:0005901; GO:0005737; GO:0005856; GO:0005829; GO:0031904; GO:0031234; GO:0005925; GO:0098978; GO:0045121; GO:0016363; GO:0005654; GO:0005634; GO:0005886; GO:0098794","GO:0033130; GO:0005524; GO:0005131; GO:0020037; GO:0042393; GO:0035401; GO:0042802; GO:0043560; GO:0005143; GO:0046872; GO:0004715; GO:0051428; GO:0043548; GO:0008022; GO:0004672; GO:0019901; GO:0004713; GO:0005088; GO:0042169; GO:0005102; GO:0031702","GO:0030041; GO:0006919; GO:0097296; GO:0042976; GO:0000186; GO:0002250; GO:0006915; GO:0031103; GO:0007596; GO:0030154; GO:0016477; GO:0019221; GO:0007167; GO:0030218; GO:0097191; GO:0007186; GO:0060396; GO:0035409; GO:0045087; GO:0060333; GO:0035722; GO:0038155; GO:0070106; GO:0070757; GO:0070102; GO:0035556; GO:0008631; GO:0007259; GO:0060397; GO:0061180; GO:0000165; GO:0007498; GO:0031959; GO:0050804; GO:0010667; GO:0022408; GO:0008285; GO:0043392; GO:0045822; GO:0043524; GO:0038083; GO:0018108; GO:0048008; GO:0050867; GO:0045597; GO:0030335; GO:0010811; GO:0120162; GO:0007204; GO:0043388; GO:0051091; GO:1904037; GO:1902728; GO:0060399; GO:0050729; GO:0032024; GO:0032731; GO:0045429; GO:0051770; GO:0050731; GO:0014068; GO:0032516; GO:0033160; GO:0032760; GO:0042531; GO:1904707; GO:0099527; GO:0046777; GO:0006468; GO:0042981; GO:0042127; GO:0050727; GO:0060334; GO:0046425; GO:0046677; GO:0033194; GO:0070671; GO:0032496; GO:0034612; GO:0007165; GO:0033209; GO:0007260"]
[1209,600,"PK667","JAK2","Y1007+Y1008","Janus protein-tyrosine kinase 2",{"v":3918.6270952767186,"d":"3919"},{"v":3864.1206972476393,"d":"3864"},{"v":1071.7103549895392,"d":"1072"},{"v":27.34912837920494,"d":"27"},{"v":1581.1891964618894,"d":"1581"},{"v":8018.467477465019,"d":"8018"},"Kinexus","RpAb","KE(pY)(pY)KVKE(bA)C","Corresponds to amino acid residues K1005 to E1012; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T1007 and Y1008 phosphorylation stimulate phosphotransferase activity and induce interactions with SOCS1. These are two of the major in vivo phosphorylation sites in JAK2 (≥19 and ≥18 reports, respectively, from high throughput mass spectrometry studies).","Y1007: JAK2; PYK2 (PTK2B; FAK2). Y1008 JAK2; PYK2 (PTK2B; FAK2). ","O60674","O60674",611,"O60674","O60674","NP_004963","Block4",8,2,"4, 12, 20, 28","JAK2","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","JakA",{"$nulls":6},"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; JakA family","GO:0005901; GO:0005737; GO:0005856; GO:0005829; GO:0031904; GO:0031234; GO:0005925; GO:0098978; GO:0045121; GO:0016363; GO:0005654; GO:0005634; GO:0005886; GO:0098794","GO:0033130; GO:0005524; GO:0005131; GO:0020037; GO:0042393; GO:0035401; GO:0042802; GO:0043560; GO:0005143; GO:0046872; GO:0004715; GO:0051428; GO:0043548; GO:0008022; GO:0004672; GO:0019901; GO:0004713; GO:0005088; GO:0042169; GO:0005102; GO:0031702","GO:0030041; GO:0006919; GO:0097296; GO:0042976; GO:0000186; GO:0002250; GO:0006915; GO:0031103; GO:0007596; GO:0030154; GO:0016477; GO:0019221; GO:0007167; GO:0030218; GO:0097191; GO:0007186; GO:0060396; GO:0035409; GO:0045087; GO:0060333; GO:0035722; GO:0038155; GO:0070106; GO:0070757; GO:0070102; GO:0035556; GO:0008631; GO:0007259; GO:0060397; GO:0061180; GO:0000165; GO:0007498; GO:0031959; GO:0050804; GO:0010667; GO:0022408; GO:0008285; GO:0043392; GO:0045822; GO:0043524; GO:0038083; GO:0018108; GO:0048008; GO:0050867; GO:0045597; GO:0030335; GO:0010811; GO:0120162; GO:0007204; GO:0043388; GO:0051091; GO:1904037; GO:1902728; GO:0060399; GO:0050729; GO:0032024; GO:0032731; GO:0045429; GO:0051770; GO:0050731; GO:0014068; GO:0032516; GO:0033160; GO:0032760; GO:0042531; GO:1904707; GO:0099527; GO:0046777; GO:0006468; GO:0042981; GO:0042127; GO:0050727; GO:0060334; GO:0046425; GO:0046677; GO:0033194; GO:0070671; GO:0032496; GO:0034612; GO:0007165; GO:0033209; GO:0007260"]
[1211,601,"NK086","JAK3","Pan-specific","Janus protein-tyrosine kinase 3",{"v":220.0022158848646,"d":"220"},{"v":192.79103194413716,"d":"193"},{"v":137.25110644610183,"d":"137"},{"v":62.38623819949636,"d":"62"},{"v":29.51253375131527,"d":"30"},{"v":734.9213204095505,"d":"735"},"External","MmAb","Epitope undefined.",{"$nulls":3},"P52333","P52333",612,"P52333","P52333","NP_000206","Block4",8,3,"4, 12, 20, 28","JAK3","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","JakA",{"$nulls":6},"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; JakA family","GO:0005856; GO:0005829; GO:0005768; GO:0031234; GO:0005886","GO:0005524; GO:0004715; GO:0019903; GO:0004713; GO:0005088; GO:0005102","GO:0002250; GO:0030183; GO:0016477; GO:0019221; GO:0007167; GO:0030218; GO:0006954; GO:0045087; GO:0035723; GO:0038114; GO:0038110; GO:0035771; GO:0038111; GO:0038113; GO:0035556; GO:0060397; GO:0000165; GO:0002731; GO:0045221; GO:0032693; GO:0032695; GO:0050868; GO:0045626; GO:0070244; GO:0038083; GO:0018108; GO:0042102; GO:0006468; GO:0042981; GO:0046425; GO:0070232; GO:0070672; GO:0070669; GO:0070670; GO:0071104; GO:0043029; GO:0007260"]
[1213,602,"NK086-4","JAK3","Pan-specific","Janus protein-tyrosine kinase 3",{"v":7755.0058899011665,"d":"7755"},{"v":7620.834531043296,"d":"7621"},{"v":1901.1581421476951,"d":"1901"},{"v":24.515237888129114,"d":"25"},{"v":3484.868328786347,"d":"3485"},{"v":15963.818809913177,"d":"15964"},"Kinexus","RpAb","CFTAHPEGKHHSLSFS","Corresponds to amino acid residues F1110 to S1124; C-terminus.",null,null,"P52333","P52333",612,"P52333","P52333","NP_000206","Block4",8,4,"4, 12, 20, 28","JAK3","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","JakA",{"$nulls":6},"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; JakA family","GO:0005856; GO:0005829; GO:0005768; GO:0031234; GO:0005886","GO:0005524; GO:0004715; GO:0019903; GO:0004713; GO:0005088; GO:0005102","GO:0002250; GO:0030183; GO:0016477; GO:0019221; GO:0007167; GO:0030218; GO:0006954; GO:0045087; GO:0035723; GO:0038114; GO:0038110; GO:0035771; GO:0038111; GO:0038113; GO:0035556; GO:0060397; GO:0000165; GO:0002731; GO:0045221; GO:0032693; GO:0032695; GO:0050868; GO:0045626; GO:0070244; GO:0038083; GO:0018108; GO:0042102; GO:0006468; GO:0042981; GO:0046425; GO:0070232; GO:0070672; GO:0070669; GO:0070670; GO:0071104; GO:0043029; GO:0007260"]
[1215,603,"PK669","JAK3","Y980+Y981","Janus protein-tyrosine kinase 3",{"v":8392.147308695798,"d":"8392"},{"v":8339.244353404054,"d":"8339"},{"v":1943.0986829715794,"d":"1943"},{"v":23.15377234808753,"d":"23"},{"v":3900.321103690015,"d":"3900"},{"v":13569.628000779729,"d":"13570"},"Kinexus","RpAb","DKD(pY)(pY)VVRE(bA)C","Corresponds to amino acid residues D977 to E985; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y980 phosphorylation stimulates phosphotransferase activity, whereas Y981 phosphorylation inhibits phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major in vivo phosphorylation sites in JAK3 (≥9 and ≥6 reports, respectively, from high throughput mass spectrometry studies).","Y980: JAK3. Y981: JAK3.","P52333","P52333",612,"P52333","P52333","NP_000206","Block4",8,5,"4, 12, 20, 28","JAK3","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","JakA",{"$nulls":6},"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; JakA family","GO:0005856; GO:0005829; GO:0005768; GO:0031234; GO:0005886","GO:0005524; GO:0004715; GO:0019903; GO:0004713; GO:0005088; GO:0005102","GO:0002250; GO:0030183; GO:0016477; GO:0019221; GO:0007167; GO:0030218; GO:0006954; GO:0045087; GO:0035723; GO:0038114; GO:0038110; GO:0035771; GO:0038111; GO:0038113; GO:0035556; GO:0060397; GO:0000165; GO:0002731; GO:0045221; GO:0032693; GO:0032695; GO:0050868; GO:0045626; GO:0070244; GO:0038083; GO:0018108; GO:0042102; GO:0006468; GO:0042981; GO:0046425; GO:0070232; GO:0070672; GO:0070669; GO:0070670; GO:0071104; GO:0043029; GO:0007260"]
[1217,604,"NK189-5","JNK1 (MAPK8)","Pan-specific","Jun N-terminus protein-serine kinase 2 (Stress-activated protein kinase-alpha)",{"v":1023.0597914784923,"d":"1023"},{"v":886.4933792612557,"d":"886"},{"v":688.1264026256908,"d":"688"},{"v":67.26160175166626,"d":"67"},{"v":282.54232387274885,"d":"283"},{"v":7350.109360017731,"d":"7350"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 1-424 representing full length human JNK2 p54.",null,null,"P45983","P45983",613,"P45983","P45983","NP_002741","Block4",8,6,"4, 12, 20, 28","JNK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","JNK",{"$nulls":5},"EC 2.7.11.24; Protein kinase, Ser/Thr (non-receptor); CMGC group; MAPK family; MAPK/JNK subfamily; JNK subfamily","GO:0030424; GO:0097441; GO:0005737; GO:0005829; GO:0005739; GO:0043005; GO:0005654; GO:0005634","GO:0005524; GO:0019899; GO:0042826; GO:0035033; GO:0004705; GO:0016301; GO:0004674","GO:0034198; GO:0071276; GO:0071345; GO:0071222; GO:0071260; GO:0034614; GO:0038095; GO:0007254; GO:0007258; GO:0043066; GO:0032091; GO:0048666; GO:0018105; GO:0018107; GO:0043065; GO:0031281; GO:0090045; GO:0010628; GO:1900740; GO:0051247; GO:0006468; GO:0042752; GO:1902595; GO:0016241; GO:0032880; GO:0009411; GO:0048511; GO:0051403"]
[1219,605,"NK217-2","JNK1 (MAPK8)","Pan-specific","Jun N-terminus protein-serine kinase (stress-activated protein kinase (SAPK)) 1",{"v":9532.143681702553,"d":"9532"},{"v":9301.210823895726,"d":"9301"},{"v":1937.687076026207,"d":"1938"},{"v":20.327925603405436,"d":"20"},{"v":4434.513170995275,"d":"4435"},{"v":16421.113021793808,"d":"16421"},"Kinexus","RpAb","VMDLEERTKNGVIRGC","Corresponds to amino acid residues V360 to G374.",null,null,"P45983","P45983",613,"P45983","P45983","NP_002741","Block4",8,7,"4, 12, 20, 28","JNK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","JNK",{"$nulls":5},"EC 2.7.11.24; Protein kinase, Ser/Thr (non-receptor); CMGC group; MAPK family; MAPK/JNK subfamily; JNK subfamily","GO:0030424; GO:0097441; GO:0005737; GO:0005829; GO:0005739; GO:0043005; GO:0005654; GO:0005634","GO:0005524; GO:0019899; GO:0042826; GO:0035033; GO:0004705; GO:0016301; GO:0004674","GO:0034198; GO:0071276; GO:0071345; GO:0071222; GO:0071260; GO:0034614; GO:0038095; GO:0007254; GO:0007258; GO:0043066; GO:0032091; GO:0048666; GO:0018105; GO:0018107; GO:0043065; GO:0031281; GO:0090045; GO:0010628; GO:1900740; GO:0051247; GO:0006468; GO:0042752; GO:1902595; GO:0016241; GO:0032880; GO:0009411; GO:0048511; GO:0051403"]
[1221,606,"PK035-2","JNK1 (MAPK8)","T183+Y185","Jun N-terminus protein-serine kinase (stress-activated protein kinase (SAPK)) 1",{"v":519.9131193053571,"d":"520"},{"v":457.3547037003646,"d":"457"},{"v":372.91889969711616,"d":"373"},{"v":71.72715706719688,"d":"72"},{"v":22.26329546340433,"d":"22"},{"v":1733.72668467321,"d":"1734"},"External","RpAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the T183 and Y185 phosphosites.","T183 and Y185 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation regulates apoptosis, cell adhesion and transcription.These are the two  major in vivo phosphorylation sites in JNK1 (≥417 and ≥1286 reports, respectively, from high throughput mass spectrometry studies).","MKK4 (MAP2K4, MEK4); MKK7 (MAP2K7, MEK7)","P45983","P45983",613,"P45983","P45983","NP_002741","Block4",8,8,"4, 12, 20, 28","JNK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","JNK",{"$nulls":5},"EC 2.7.11.24; Protein kinase, Ser/Thr (non-receptor); CMGC group; MAPK family; MAPK/JNK subfamily; JNK subfamily","GO:0030424; GO:0097441; GO:0005737; GO:0005829; GO:0005739; GO:0043005; GO:0005654; GO:0005634","GO:0005524; GO:0019899; GO:0042826; GO:0035033; GO:0004705; GO:0016301; GO:0004674","GO:0034198; GO:0071276; GO:0071345; GO:0071222; GO:0071260; GO:0034614; GO:0038095; GO:0007254; GO:0007258; GO:0043066; GO:0032091; GO:0048666; GO:0018105; GO:0018107; GO:0043065; GO:0031281; GO:0090045; GO:0010628; GO:1900740; GO:0051247; GO:0006468; GO:0042752; GO:1902595; GO:0016241; GO:0032880; GO:0009411; GO:0048511; GO:0051403"]
[1223,607,"PK190","JNK1 (MAPK8)","T183+Y185","Jun N-terminus protein-serine kinase (stress-activated protein kinase (SAPK)) 1",{"v":153.87844877373718,"d":"154"},{"v":138.60888744544172,"d":"139"},{"v":84.17996353289658,"d":"84"},{"v":54.70549268187306,"d":"55"},{"v":27.901064677909595,"d":"28"},{"v":492.80661393381564,"d":"493"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the Thr-183  and Tyr-185 phosphosites.","T183 and Y185 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation regulates apoptosis, cell adhesion and transcription.These are the two  major in vivo phosphorylation sites in JNK1 (≥417 and ≥1286 reports, respectively, from high throughput mass spectrometry studies).","MKK4 (MAP2K4, MEK4); MKK7 (MAP2K7, MEK7)","P45983","P45983",613,"P45983","P45983","NP_002741","Block4",8,9,"4, 12, 20, 28","JNK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","JNK",{"$nulls":5},"EC 2.7.11.24; Protein kinase, Ser/Thr (non-receptor); CMGC group; MAPK family; MAPK/JNK subfamily; JNK subfamily","GO:0030424; GO:0097441; GO:0005737; GO:0005829; GO:0005739; GO:0043005; GO:0005654; GO:0005634","GO:0005524; GO:0019899; GO:0042826; GO:0035033; GO:0004705; GO:0016301; GO:0004674","GO:0034198; GO:0071276; GO:0071345; GO:0071222; GO:0071260; GO:0034614; GO:0038095; GO:0007254; GO:0007258; GO:0043066; GO:0032091; GO:0048666; GO:0018105; GO:0018107; GO:0043065; GO:0031281; GO:0090045; GO:0010628; GO:1900740; GO:0051247; GO:0006468; GO:0042752; GO:1902595; GO:0016241; GO:0032880; GO:0009411; GO:0048511; GO:0051403"]
[1225,608,"PK670","JNK1 (MAPK8)","Y185","Jun N-terminus protein-serine kinase (stress-activated protein kinase (SAPK)) 1",{"v":6710.769708839497,"d":"6711"},{"v":6243.455288395809,"d":"6243"},{"v":2455.3379223777674,"d":"2455"},{"v":36.58802237161514,"d":"37"},{"v":1947.3953433759357,"d":"1947"},{"v":15674.500715993465,"d":"15675"},"Kinexus","RpAb","MTP(pY)VVT(bA)C","Corresponds to amino acid residues M182 to T188; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y185 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in JNK1 (≥1286 reports from high throughput mass spectrometry studies).","MKK4 (MAP2K4, MEK4); MKK7 (MAP2K7, MEK7)","P45983","P45983",613,"P45983","P45983","NP_002741","Block4",8,10,"4, 12, 20, 28","JNK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","JNK",{"$nulls":5},"EC 2.7.11.24; Protein kinase, Ser/Thr (non-receptor); CMGC group; MAPK family; MAPK/JNK subfamily; JNK subfamily","GO:0030424; GO:0097441; GO:0005737; GO:0005829; GO:0005739; GO:0043005; GO:0005654; GO:0005634","GO:0005524; GO:0019899; GO:0042826; GO:0035033; GO:0004705; GO:0016301; GO:0004674","GO:0034198; GO:0071276; GO:0071345; GO:0071222; GO:0071260; GO:0034614; GO:0038095; GO:0007254; GO:0007258; GO:0043066; GO:0032091; GO:0048666; GO:0018105; GO:0018107; GO:0043065; GO:0031281; GO:0090045; GO:0010628; GO:1900740; GO:0051247; GO:0006468; GO:0042752; GO:1902595; GO:0016241; GO:0032880; GO:0009411; GO:0048511; GO:0051403"]
[1227,609,"NK189-2","JNK2 (MAPK9)","Pan-specific","Jun N-terminus protein-serine kinase (stress-activated protein kinase (SAPK)) 2",{"v":23389.89863460459,"d":"23390"},{"v":22263.966169328887,"d":"22264"},{"v":7569.051950234614,"d":"7569"},{"v":32.36034524337976,"d":"32"},{"v":10531.90464873402,"d":"10532"},{"v":49247.16355265441,"d":"49247"},"Kinexus","RpAb","CLFPDWIFPSESERDK","Corresponds to amino acid residues L274 to K288; Pre-kinase last alpha-chain.",null,null,"P45984","P45984",1234,"P45984","P45984","NP_002744","Block4",8,11,"4, 12, 20, 28","JNK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","JNK",{"$nulls":5},"EC 2.7.11.24; Protein kinase, Ser/Thr (non-receptor); CMGC group; MAPK family; JNK subfamily; MAPK/JNK subfamily","GO:0005737; GO:0005829; GO:0005739; GO:0043005; GO:0005654; GO:0005634","GO:0005524; GO:0004705; GO:0004712; GO:0008134","GO:0071276; GO:0071310; GO:0034614; GO:0038095; GO:0007254; GO:0048666; GO:0018105; GO:0043065; GO:2001235; GO:0010628; GO:0010744; GO:0071803; GO:0031398; GO:1901485; GO:0061833; GO:0006468; GO:0042752; GO:0009612; GO:0048511"]
[1229,610,"NK189-3","JNK2 (MAPK9)","Pan-specific","Jun N-terminus protein-serine kinase (stress-activated protein kinase (SAPK)) 2",{"v":5432.896390565103,"d":"5433"},{"v":4971.942957471156,"d":"4972"},{"v":2042.8982282675468,"d":"2043"},{"v":37.602377836899166,"d":"38"},{"v":798.4221623921321,"d":"798"},{"v":17419.63375896893,"d":"17420"},"Kinexus","RpAb","CVKDQPSDAAVSSNAT","Corresponds to amino acid residues V372 to T386.",null,null,"P45984","P45984",1234,"P45984","P45984","NP_002744","Block4",8,12,"4, 12, 20, 28","JNK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","JNK",{"$nulls":5},"EC 2.7.11.24; Protein kinase, Ser/Thr (non-receptor); CMGC group; MAPK family; JNK subfamily; MAPK/JNK subfamily","GO:0005737; GO:0005829; GO:0005739; GO:0043005; GO:0005654; GO:0005634","GO:0005524; GO:0004705; GO:0004712; GO:0008134","GO:0071276; GO:0071310; GO:0034614; GO:0038095; GO:0007254; GO:0048666; GO:0018105; GO:0043065; GO:2001235; GO:0010628; GO:0010744; GO:0071803; GO:0031398; GO:1901485; GO:0061833; GO:0006468; GO:0042752; GO:0009612; GO:0048511"]
[1231,611,"NK197-2","JNK3 (MAPK10)","Pan-specific","Jun N-terminus protein-serine kinase (stress-activated protein kinase (SAPKb)) 3",{"v":16009.872231810343,"d":"16010"},{"v":16276.66972406665,"d":"16277"},{"v":3890.319486486402,"d":"3890"},{"v":24.299503644736443,"d":"24"},{"v":5819.151380697465,"d":"5819"},{"v":27077.999698716383,"d":"27078"},"Kinexus","RpAb","CAGLTFPKLFPDSLFP","Corresponds to amino acid residues A305 to P319; Pre-kinase last alpha-chain.",null,null,"P53779","P53779",713,"P53779",null,"NP_620448.1","Block4",8,13,"4, 12, 20, 28","JNK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","JNK",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.24; CMGC group; MAPK family; MAPK/JNK subfamily; JNK subfamily","GO:0005737; GO:0005829; GO:0005739; GO:0043005; GO:0005654; GO:0005634; GO:0005886","GO:0005524; GO:0004705; GO:0004708","GO:0038095; GO:0007254; GO:0048666; GO:0006468; GO:0042752; GO:0010468; GO:0009416; GO:0048511; GO:0007165"]
[1233,612,"NN162","Jun (c-Jun)","Pan-specific","Jun proto-oncogene-encoded AP1 transcription factor",{"v":171.15221849181916,"d":"171"},{"v":77.37278765293411,"d":"77"},{"v":251.5722469143329,"d":"252"},{"v":146.98742974597067,"d":"147"},{"v":11.697031478339827,"d":"12"},{"v":1873.8659682343691,"d":"1874"},"External","MmAb","Epitope undefined.",{"$nulls":3},"P05412","P05412",943,null,"P05412","NP_002219","Block4",9,1,"4, 12, 20, 28",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005829; GO:0000228; GO:0005719; GO:0005654; GO:0005634; GO:0017053; GO:0035976","GO:0035497; GO:0003682; GO:0003677; GO:0003700; GO:0019899; GO:0005096; GO:0071837; GO:0042802; GO:0046982; GO:0042803; GO:0003723; GO:0001102; GO:0000980; GO:0000978; GO:0000981; GO:0070412; GO:0001077; GO:0001190; GO:0003713; GO:0003705; GO:0000982; GO:0008134; GO:0044212; GO:0031625","GO:0007568; GO:0001525; GO:0031103; GO:0071276; GO:0071277; GO:0032870; GO:0051365; GO:0034614; GO:0007623; GO:0061029; GO:0038095; GO:0035026; GO:0007612; GO:0001889; GO:0051899; GO:0001774; GO:0030224; GO:0043922; GO:0008285; GO:0043392; GO:0043524; GO:0031953; GO:0045892; GO:1990441; GO:0003151; GO:0043923; GO:0043065; GO:0045597; GO:0045740; GO:2000144; GO:0001938; GO:0010634; GO:0070374; GO:0048146; GO:0045657; GO:0043525; GO:1902895; GO:0045893; GO:0045944; GO:1904707; GO:0007265; GO:0051726; GO:0042127; GO:0051090; GO:0001836; GO:0051591; GO:0034097; GO:0042493; GO:0042542; GO:0032496; GO:0009612; GO:0035994; GO:0009314; GO:0060395; GO:0007179"]
[1235,613,"PN213","Jun (c-Jun)","S63","Transcription factor AP-1",{"v":377.34799752296954,"d":"377"},{"v":243.09500675210703,"d":"243"},{"v":958.2171500841698,"d":"958"},{"v":253.93460582120676,"d":"254"},{"v":36.99954567055364,"d":"37"},{"v":8995.047061295387,"d":"8995"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S63 phosphosite.","S63 phosphorylation stimulates transcriptional activity and binding to PIN1, although it has been reported to decrease binding to DNA and JNK1. This is one of the major in vivo sites of phosphorylation of c-Jun (≥44 reports from high throughput mass spectrometry studies).","CDK1 (CDC2); CDK3; CK2a1 (CSNK2A1); ERK1 (MAPK3); ERK2 (MAPK1); ERK7 (MAPK15); JNK1 (MAPK8); JNK2 (MAPK9); JNK3 (MAPK10); PBK (TOPK); PKD1 (PRKCM; PRKD1); Plk3 (CNK); VRK1","P05412","P05412",943,null,"P05412","NP_002219","Block4",9,2,"4, 12, 20, 28",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005829; GO:0000228; GO:0005719; GO:0005654; GO:0005634; GO:0017053; GO:0035976","GO:0035497; GO:0003682; GO:0003677; GO:0003700; GO:0019899; GO:0005096; GO:0071837; GO:0042802; GO:0046982; GO:0042803; GO:0003723; GO:0001102; GO:0000980; GO:0000978; GO:0000981; GO:0070412; GO:0001077; GO:0001190; GO:0003713; GO:0003705; GO:0000982; GO:0008134; GO:0044212; GO:0031625","GO:0007568; GO:0001525; GO:0031103; GO:0071276; GO:0071277; GO:0032870; GO:0051365; GO:0034614; GO:0007623; GO:0061029; GO:0038095; GO:0035026; GO:0007612; GO:0001889; GO:0051899; GO:0001774; GO:0030224; GO:0043922; GO:0008285; GO:0043392; GO:0043524; GO:0031953; GO:0045892; GO:1990441; GO:0003151; GO:0043923; GO:0043065; GO:0045597; GO:0045740; GO:2000144; GO:0001938; GO:0010634; GO:0070374; GO:0048146; GO:0045657; GO:0043525; GO:1902895; GO:0045893; GO:0045944; GO:1904707; GO:0007265; GO:0051726; GO:0042127; GO:0051090; GO:0001836; GO:0051591; GO:0034097; GO:0042493; GO:0042542; GO:0032496; GO:0009612; GO:0035994; GO:0009314; GO:0060395; GO:0007179"]
[1237,614,"PN557","Jun (c-Jun)","S63","Jun proto-oncogene-encoded AP1 transcription factor",{"v":20620.6885672329,"d":"20621"},{"v":20236.309849379588,"d":"20236"},{"v":5876.345411645874,"d":"5876"},{"v":28.497328750620003,"d":"28"},{"v":91.11443478647423,"d":"91"},{"v":39574.09182662981,"d":"39574"},"Kinexus","RpAb","DLLT(pS)PDVGC","Corresponds to amino acid residues D59 to G67; In the N-terminus of the transcription factor. ","S63 phosphorylation stimulates transcriptional activity and binding to PIN1, although it has been reported to decrease binding to DNA and JNK1. This is one of the major in vivo sites of phosphorylation of c-Jun (≥44 reports from high throughput mass spectrometry studies).","CDK1 (CDC2); CDK3; CK2a1 (CSNK2A1); ERK1 (MAPK3); ERK2 (MAPK1); JNK1 (MAPK8); JNK2 (MAPK9); JNK3 (MAPK10); PKD1 (PRKCM; PRKD1); Plk3 (CNK); VRK1","P05412","P05412",943,null,"P05412","NP_002219","Block4",9,3,"4, 12, 20, 28",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005829; GO:0000228; GO:0005719; GO:0005654; GO:0005634; GO:0017053; GO:0035976","GO:0035497; GO:0003682; GO:0003677; GO:0003700; GO:0019899; GO:0005096; GO:0071837; GO:0042802; GO:0046982; GO:0042803; GO:0003723; GO:0001102; GO:0000980; GO:0000978; GO:0000981; GO:0070412; GO:0001077; GO:0001190; GO:0003713; GO:0003705; GO:0000982; GO:0008134; GO:0044212; GO:0031625","GO:0007568; GO:0001525; GO:0031103; GO:0071276; GO:0071277; GO:0032870; GO:0051365; GO:0034614; GO:0007623; GO:0061029; GO:0038095; GO:0035026; GO:0007612; GO:0001889; GO:0051899; GO:0001774; GO:0030224; GO:0043922; GO:0008285; GO:0043392; GO:0043524; GO:0031953; GO:0045892; GO:1990441; GO:0003151; GO:0043923; GO:0043065; GO:0045597; GO:0045740; GO:2000144; GO:0001938; GO:0010634; GO:0070374; GO:0048146; GO:0045657; GO:0043525; GO:1902895; GO:0045893; GO:0045944; GO:1904707; GO:0007265; GO:0051726; GO:0042127; GO:0051090; GO:0001836; GO:0051591; GO:0034097; GO:0042493; GO:0042542; GO:0032496; GO:0009612; GO:0035994; GO:0009314; GO:0060395; GO:0007179"]
[1239,615,"PN612","Jun (c-Jun)","S73","Jun proto-oncogene-encoded AP1 transcription factor",{"v":12703.62892434519,"d":"12704"},{"v":12572.889390187367,"d":"12573"},{"v":2364.0019551384185,"d":"2364"},{"v":18.608871285653294,"d":"19"},{"v":6994.845237081078,"d":"6995"},{"v":22652.671600332855,"d":"22653"},"Kinexus","RpAb","CLKLA(pS)PELE","Corresponds to amino acid residues C69 to E77.","S73 phosphorylation stimulates transcriptional activity and binding to PIN1, although it has been reported to decrease binding to DNA and JNK1. This is the major in vivo phosphorylation site in c-Jun (≥78 reports from high throughput mass spectrometry studies).","CDK1 (CDC2); CDK3; CK2a1 (CSNK2A1); ERK1 (MAPK3); ERK2 (MAPK1); ERK7 (MAPK15); JNK1 (MAPK8); JNK2 (MAPK9); JNK3 (MAPK10); Plk3 (CNK); PBK (TOPK); VRK1","P05412","P05412",943,null,"P05412","NP_002219","Block4",9,4,"4, 12, 20, 28",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005829; GO:0000228; GO:0005719; GO:0005654; GO:0005634; GO:0017053; GO:0035976","GO:0035497; GO:0003682; GO:0003677; GO:0003700; GO:0019899; GO:0005096; GO:0071837; GO:0042802; GO:0046982; GO:0042803; GO:0003723; GO:0001102; GO:0000980; GO:0000978; GO:0000981; GO:0070412; GO:0001077; GO:0001190; GO:0003713; GO:0003705; GO:0000982; GO:0008134; GO:0044212; GO:0031625","GO:0007568; GO:0001525; GO:0031103; GO:0071276; GO:0071277; GO:0032870; GO:0051365; GO:0034614; GO:0007623; GO:0061029; GO:0038095; GO:0035026; GO:0007612; GO:0001889; GO:0051899; GO:0001774; GO:0030224; GO:0043922; GO:0008285; GO:0043392; GO:0043524; GO:0031953; GO:0045892; GO:1990441; GO:0003151; GO:0043923; GO:0043065; GO:0045597; GO:0045740; GO:2000144; GO:0001938; GO:0010634; GO:0070374; GO:0048146; GO:0045657; GO:0043525; GO:1902895; GO:0045893; GO:0045944; GO:1904707; GO:0007265; GO:0051726; GO:0042127; GO:0051090; GO:0001836; GO:0051591; GO:0034097; GO:0042493; GO:0042542; GO:0032496; GO:0009612; GO:0035994; GO:0009314; GO:0060395; GO:0007179"]
[1241,616,"PN163","Jun (c-Jun)","T91","Jun proto-oncogene-encoded AP1 transcription factor",{"v":1245.4728259143385,"d":"1245"},{"v":934.9013697237913,"d":"935"},{"v":1603.586623822698,"d":"1604"},{"v":128.75324057315,"d":"129"},{"v":12.377988293337161,"d":"12"},{"v":14745.092270986164,"d":"14745"},"External","RpAb","TT(pT)PT","Corresponds to amino acid residues T89 to T93.","T91 phosphorylation contributes to binding with FBXW7, but reduces interaction with DNA. This is one of the minor in vivo phosphorylation sites in c-Jun (≥2 reports from high throughput mass spectrometry studies).","JNK1 (MAPK8)","P05412","P05412",943,null,"P05412","NP_002219","Block4",9,5,"4, 12, 20, 28",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005829; GO:0000228; GO:0005719; GO:0005654; GO:0005634; GO:0017053; GO:0035976","GO:0035497; GO:0003682; GO:0003677; GO:0003700; GO:0019899; GO:0005096; GO:0071837; GO:0042802; GO:0046982; GO:0042803; GO:0003723; GO:0001102; GO:0000980; GO:0000978; GO:0000981; GO:0070412; GO:0001077; GO:0001190; GO:0003713; GO:0003705; GO:0000982; GO:0008134; GO:0044212; GO:0031625","GO:0007568; GO:0001525; GO:0031103; GO:0071276; GO:0071277; GO:0032870; GO:0051365; GO:0034614; GO:0007623; GO:0061029; GO:0038095; GO:0035026; GO:0007612; GO:0001889; GO:0051899; GO:0001774; GO:0030224; GO:0043922; GO:0008285; GO:0043392; GO:0043524; GO:0031953; GO:0045892; GO:1990441; GO:0003151; GO:0043923; GO:0043065; GO:0045597; GO:0045740; GO:2000144; GO:0001938; GO:0010634; GO:0070374; GO:0048146; GO:0045657; GO:0043525; GO:1902895; GO:0045893; GO:0045944; GO:1904707; GO:0007265; GO:0051726; GO:0042127; GO:0051090; GO:0001836; GO:0051591; GO:0034097; GO:0042493; GO:0042542; GO:0032496; GO:0009612; GO:0035994; GO:0009314; GO:0060395; GO:0007179"]
[1243,617,"PN214","Jun (c-Jun)","T91+T93","Jun proto-oncogene-encoded AP1 transcription factor",{"v":411.1241760817225,"d":"411"},{"v":316.2904391189239,"d":"316"},{"v":635.401414881525,"d":"635"},{"v":154.55218930137087,"d":"155"},{"v":77.43056236373698,"d":"77"},{"v":7072.454173233093,"d":"7072"},"External","MmAb","Not precisely defined.","Antibody raised against c-Jun phosphorylated at Thr 91 and Thr-93.","T91 phosphorylation contributes to binding with FBXW7, but reduces binding to DNA. T93 phosphorylation also inhibits DNA binding. These are two of the minor in vivo phosphorylation sites in c-Jun (≥2 and ≥3 reports, respectively, from high throughput mass spectrometry studies).","T91: JNK1 (MAPK8). T93: JNK1 (MAPK8); PAK2","P05412","P05412",943,null,"P05412","NP_002219","Block4",9,6,"4, 12, 20, 28",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005829; GO:0000228; GO:0005719; GO:0005654; GO:0005634; GO:0017053; GO:0035976","GO:0035497; GO:0003682; GO:0003677; GO:0003700; GO:0019899; GO:0005096; GO:0071837; GO:0042802; GO:0046982; GO:0042803; GO:0003723; GO:0001102; GO:0000980; GO:0000978; GO:0000981; GO:0070412; GO:0001077; GO:0001190; GO:0003713; GO:0003705; GO:0000982; GO:0008134; GO:0044212; GO:0031625","GO:0007568; GO:0001525; GO:0031103; GO:0071276; GO:0071277; GO:0032870; GO:0051365; GO:0034614; GO:0007623; GO:0061029; GO:0038095; GO:0035026; GO:0007612; GO:0001889; GO:0051899; GO:0001774; GO:0030224; GO:0043922; GO:0008285; GO:0043392; GO:0043524; GO:0031953; GO:0045892; GO:1990441; GO:0003151; GO:0043923; GO:0043065; GO:0045597; GO:0045740; GO:2000144; GO:0001938; GO:0010634; GO:0070374; GO:0048146; GO:0045657; GO:0043525; GO:1902895; GO:0045893; GO:0045944; GO:1904707; GO:0007265; GO:0051726; GO:0042127; GO:0051090; GO:0001836; GO:0051591; GO:0034097; GO:0042493; GO:0042542; GO:0032496; GO:0009612; GO:0035994; GO:0009314; GO:0060395; GO:0007179"]
[1245,618,"PN155","Jun (c-Jun)","Y170","Jun proto-oncogene-encoded AP1 transcription factor",{"v":819.4656496155691,"d":"819"},{"v":715.4040051182736,"d":"715"},{"v":585.5842387104867,"d":"586"},{"v":71.45927824859996,"d":"71"},{"v":5.231211504947632,"d":"5"},{"v":2696.902433641212,"d":"2697"},"External","RpAb","PV(pY)AN","Corresponds to amino acid residues P168 to N172.","Y170 phosphorylation induces interaction with Abl1. This is one of the minor in vivo phosphorylation sites in c-Jun (≥1 reports from high throughput mass spectrometry studies).","Abl1","P05412","P05412",943,null,"P05412","NP_002219","Block4",9,7,"4, 12, 20, 28",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005829; GO:0000228; GO:0005719; GO:0005654; GO:0005634; GO:0017053; GO:0035976","GO:0035497; GO:0003682; GO:0003677; GO:0003700; GO:0019899; GO:0005096; GO:0071837; GO:0042802; GO:0046982; GO:0042803; GO:0003723; GO:0001102; GO:0000980; GO:0000978; GO:0000981; GO:0070412; GO:0001077; GO:0001190; GO:0003713; GO:0003705; GO:0000982; GO:0008134; GO:0044212; GO:0031625","GO:0007568; GO:0001525; GO:0031103; GO:0071276; GO:0071277; GO:0032870; GO:0051365; GO:0034614; GO:0007623; GO:0061029; GO:0038095; GO:0035026; GO:0007612; GO:0001889; GO:0051899; GO:0001774; GO:0030224; GO:0043922; GO:0008285; GO:0043392; GO:0043524; GO:0031953; GO:0045892; GO:1990441; GO:0003151; GO:0043923; GO:0043065; GO:0045597; GO:0045740; GO:2000144; GO:0001938; GO:0010634; GO:0070374; GO:0048146; GO:0045657; GO:0043525; GO:1902895; GO:0045893; GO:0045944; GO:1904707; GO:0007265; GO:0051726; GO:0042127; GO:0051090; GO:0001836; GO:0051591; GO:0034097; GO:0042493; GO:0042542; GO:0032496; GO:0009612; GO:0035994; GO:0009314; GO:0060395; GO:0007179"]
[1247,619,"PN613","Jun (c-Jun)","T239","Jun proto-oncogene-encoded AP1 transcription factor",{"v":5992.251763099404,"d":"5992"},{"v":5892.409867499817,"d":"5892"},{"v":1511.4105670358322,"d":"1511"},{"v":25.222748088509505,"d":"25"},{"v":74.01980788233317,"d":"74"},{"v":10004.044809696292,"d":"10004"},"Kinexus","RpAb","MPGE(pT)PPL(bA)C","Corresponds to amino acid residues M235 to L242.","T239 phosphorylation inhibits transcriptional activity by reducing binding of DNA. Its phosphorylation has been separately reported to both induce and inhibit FBXW7 interaction. This is one of the major in vivo phosphorylation sites in c-Jun (≥24 reports from high throughput mass spectrometry studies).","GSK3b","P05412","P05412",943,null,"P05412","NP_002219","Block4",9,8,"4, 12, 20, 28",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005829; GO:0000228; GO:0005719; GO:0005654; GO:0005634; GO:0017053; GO:0035976","GO:0035497; GO:0003682; GO:0003677; GO:0003700; GO:0019899; GO:0005096; GO:0071837; GO:0042802; GO:0046982; GO:0042803; GO:0003723; GO:0001102; GO:0000980; GO:0000978; GO:0000981; GO:0070412; GO:0001077; GO:0001190; GO:0003713; GO:0003705; GO:0000982; GO:0008134; GO:0044212; GO:0031625","GO:0007568; GO:0001525; GO:0031103; GO:0071276; GO:0071277; GO:0032870; GO:0051365; GO:0034614; GO:0007623; GO:0061029; GO:0038095; GO:0035026; GO:0007612; GO:0001889; GO:0051899; GO:0001774; GO:0030224; GO:0043922; GO:0008285; GO:0043392; GO:0043524; GO:0031953; GO:0045892; GO:1990441; GO:0003151; GO:0043923; GO:0043065; GO:0045597; GO:0045740; GO:2000144; GO:0001938; GO:0010634; GO:0070374; GO:0048146; GO:0045657; GO:0043525; GO:1902895; GO:0045893; GO:0045944; GO:1904707; GO:0007265; GO:0051726; GO:0042127; GO:0051090; GO:0001836; GO:0051591; GO:0034097; GO:0042493; GO:0042542; GO:0032496; GO:0009612; GO:0035994; GO:0009314; GO:0060395; GO:0007179"]
[1249,620,"PN614","Jun (c-Jun)","S243","Jun proto-oncogene-encoded AP1 transcription factor",{"v":8400.761488061344,"d":"8401"},{"v":8212.926226031152,"d":"8213"},{"v":2213.8361704213644,"d":"2214"},{"v":26.352803535340634,"d":"26"},{"v":532.0365783908547,"d":"532"},{"v":16601.686143284463,"d":"16602"},"Kinexus","RpAb","PPL(pS)PIDM(bA)C","Corresponds to amino acid residues P240 to M247.","S243 phosphorylation inhibits transcriptional activity by reducing binding of DNA and SP1. Its phosphorylation has been separately reported to both induce and inhibit FBXW7 interaction. This is one of the major in vivo phosphorylation sites in c-Jun (≥34 reports from high throughput mass spectrometry studies). ","CDK1 (CDC2); CK2a1 (CSNK2A1); DYRK2; ERK1 (MAPK3); ERK2 (MAPK1); GSK3b","P05412","P05412",943,null,"P05412","NP_002219","Block4",9,9,"4, 12, 20, 28",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005829; GO:0000228; GO:0005719; GO:0005654; GO:0005634; GO:0017053; GO:0035976","GO:0035497; GO:0003682; GO:0003677; GO:0003700; GO:0019899; GO:0005096; GO:0071837; GO:0042802; GO:0046982; GO:0042803; GO:0003723; GO:0001102; GO:0000980; GO:0000978; GO:0000981; GO:0070412; GO:0001077; GO:0001190; GO:0003713; GO:0003705; GO:0000982; GO:0008134; GO:0044212; GO:0031625","GO:0007568; GO:0001525; GO:0031103; GO:0071276; GO:0071277; GO:0032870; GO:0051365; GO:0034614; GO:0007623; GO:0061029; GO:0038095; GO:0035026; GO:0007612; GO:0001889; GO:0051899; GO:0001774; GO:0030224; GO:0043922; GO:0008285; GO:0043392; GO:0043524; GO:0031953; GO:0045892; GO:1990441; GO:0003151; GO:0043923; GO:0043065; GO:0045597; GO:0045740; GO:2000144; GO:0001938; GO:0010634; GO:0070374; GO:0048146; GO:0045657; GO:0043525; GO:1902895; GO:0045893; GO:0045944; GO:1904707; GO:0007265; GO:0051726; GO:0042127; GO:0051090; GO:0001836; GO:0051591; GO:0034097; GO:0042493; GO:0042542; GO:0032496; GO:0009612; GO:0035994; GO:0009314; GO:0060395; GO:0007179"]
[1251,635,"PN233","KCND2 (KV4.2)","T602","Potassium voltage-gated channel subfamily D member 2",{"v":215.1861203990892,"d":"215"},{"v":195.94311351884465,"d":"196"},{"v":113.61899250899138,"d":"114"},{"v":52.80033503009904,"d":"53"},{"v":37.230620056865234,"d":"37"},{"v":711.4559467001561,"d":"711"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 601-614 Thr 602 of human KV4.2.","The effect of T602 phosphorylation is unclear. This phosphorylation site in Kv4.2 has not apparently been detected in high throughput mass spectrometry studies.","ERK1 (MAPK3); ERK2 (MAPK1)","Q9NZV8","Q9NZV8",4051,null,null,"NP_036413.1","Block4",10,11,"4, 12, 20, 28",{"$nulls":13},"Channel protein, potassium","GO:0030054; GO:0043197; GO:0098982; GO:0098978; GO:0005887; GO:0099060; GO:0031226; GO:0032809; GO:0043204; GO:0005886; GO:0044853; GO:0045211; GO:0008076","GO:0005250; GO:0046872; GO:1905030; GO:0005249","GO:0001508; GO:0071456; GO:0007268; GO:0045475; GO:0019228; GO:0071805; GO:0051260; GO:0034765; GO:0019233"]
[1253,636,"PN234","KCND2 (KV4.2)","T607","Potassium voltage-gated channel subfamily D member 2",{"v":554.8465218533419,"d":"555"},{"v":508.5619505810943,"d":"509"},{"v":249.4927328094226,"d":"249"},{"v":44.96608034525429,"d":"45"},{"v":86.47633113662492,"d":"86"},{"v":1824.611422312809,"d":"1825"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues surrounding the phosphorylated Thr-607 of human KV4.2.","T607 phosphorylation increases activity of the potassium channel. This phosphorylation site in Kv4.2 has not apparently been detected in high throughput mass spectrometry studies.","ERK1 (MAPK3); ERK2 (MAPK1)","Q9NZV8","Q9NZV8",4051,null,null,"NP_036413.1","Block4",10,12,"4, 12, 20, 28",{"$nulls":13},"Channel protein, potassium","GO:0030054; GO:0043197; GO:0098982; GO:0098978; GO:0005887; GO:0099060; GO:0031226; GO:0032809; GO:0043204; GO:0005886; GO:0044853; GO:0045211; GO:0008076","GO:0005250; GO:0046872; GO:1905030; GO:0005249","GO:0001508; GO:0071456; GO:0007268; GO:0045475; GO:0019228; GO:0071805; GO:0051260; GO:0034765; GO:0019233"]
[1255,621,"NK089","KHS1 (MAP4K5; KHS)","Pan-specific","Kinase homologous to SPS1/STE20 (MAP kinase kinase kinase protein-serine kinase 5 (MEKKK5)",{"v":232.70654308255035,"d":"233"},{"v":159.39975172624804,"d":"159"},{"v":389.14264482661446,"d":"389"},{"v":167.22462534651203,"d":"167"},{"v":27.424238208815876,"d":"27"},{"v":5363.754479180609,"d":"5364"},"External","GpAb","Epitope undefined.",{"$nulls":3},"Q9Y4K4","Q9Y4K4",712,"Q9Y4K4","Q9Y4K4","NP_006566.2","Block4",9,10,"4, 12, 20, 28","KHS1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","KHS",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE20 family; KHS subfamily","GO:0005737","GO:0005524; GO:0008349; GO:0004672; GO:0004674","GO:0007257; GO:0035556; GO:0006468; GO:0042981; GO:0007346"]
[1257,622,"PK672","KHS1 (MAP4K5; KHS)","Y31","Kinase homologous to SPS1/STE20 (MAP kinase kinase kinase protein-serine kinase 5 (MEKKK5)",{"v":7275.799148623148,"d":"7276"},{"v":6955.709767944351,"d":"6956"},{"v":1668.5887018496337,"d":"1669"},{"v":22.93340797024878,"d":"23"},{"v":3448.2512026803756,"d":"3448"},{"v":11964.969657042937,"d":"11965"},"Kinexus","RpAb","SGT(pY)GDV(bA)C","Corresponds to amino acid residues S28 to V34; In the protein kinase catalytic domain in subdomain I.","Y31 phosphorylation is predicted to be inhibitory for phosphotransferase activity. This phosphosite is located in the kinase subdomain I region, which is involved in binding the phosphates in the ATP substrate. This is one of the major in vivo phosphorylation sites in KHS1 (≥161 reports from high throughput mass spectrometry studies).",null,"Q9Y4K4","Q9Y4K4",712,"Q9Y4K4","Q9Y4K4","NP_006566.2","Block4",9,11,"4, 12, 20, 28","KHS1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","KHS",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE20 family; KHS subfamily","GO:0005737","GO:0005524; GO:0008349; GO:0004672; GO:0004674","GO:0007257; GO:0035556; GO:0006468; GO:0042981; GO:0007346"]
[1259,623,"PK671","KHS1 (MAP4K5; KHS)","S174","Kinase homologous to SPS1/STE20 (MAP kinase kinase kinase protein-serine kinase 5 (MEKKK5)",{"v":14136.133838663618,"d":"14136"},{"v":14477.132312661974,"d":"14477"},{"v":4038.8972599067133,"d":"4039"},{"v":28.571441852509633,"d":"29"},{"v":4308.813943690622,"d":"4309"},{"v":23679.870188685734,"d":"23680"},"Kinexus","RpAb","KRK(pS)FIG(bA)C","Corresponds to amino acid residues K171 to G177; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S174 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the minor in vivo phosphorylation sites in KHS1 (≥6 reports from high throughput mass spectrometry studies).",null,"Q9Y4K4","Q9Y4K4",712,"Q9Y4K4","Q9Y4K4","NP_006566.2","Block4",9,12,"4, 12, 20, 28","KHS1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","KHS",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE20 family; KHS subfamily","GO:0005737","GO:0005524; GO:0008349; GO:0004672; GO:0004674","GO:0007257; GO:0035556; GO:0006468; GO:0042981; GO:0007346"]
[1261,624,"NK241-4","Kit","Pan-specific","Mast/stem cell growth factor receptor Kit",{"v":191.495221810488,"d":"191"},{"v":158.3856529974368,"d":"158"},{"v":141.82842951558243,"d":"142"},{"v":74.06369108047093,"d":"74"},{"v":22.26217129031526,"d":"22"},{"v":1697.5458240580488,"d":"1698"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 951-981 within the C-terminus of human c-Kit .",null,null,"P10721","P10721",588,"P10721","P10721","NP_006566","Block4",9,13,"4, 12, 20, 28","KIT","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"EC 2.7.10.1; Receptor tyrosine kinase; TK group; PDGFR family","GO:0001669; GO:0005911; GO:0009898; GO:0009897; GO:0005615; GO:0016021; GO:0042629; GO:0005886","GO:0005524; GO:0019955; GO:0046872; GO:0046934; GO:0002020; GO:0042803; GO:0004713; GO:0005088; GO:0005020; GO:0004714","GO:0031532; GO:0000187; GO:0060326; GO:0097067; GO:0019221; GO:0002371; GO:0050910; GO:0048565; GO:0035234; GO:0035162; GO:0050673; GO:0030218; GO:0038162; GO:0038093; GO:0008354; GO:0006687; GO:0035701; GO:0030097; GO:0002327; GO:0006954; GO:0038109; GO:0030032; GO:0002320; GO:0008584; GO:0000165; GO:0002551; GO:0032762; GO:0043303; GO:0060374; GO:0070662; GO:0035855; GO:0097326; GO:0030318; GO:0097324; GO:0002318; GO:0043069; GO:0001541; GO:0018108; GO:0043473; GO:0030335; GO:0008284; GO:1904343; GO:0051091; GO:0010628; GO:0046427; GO:0048170; GO:0043410; GO:0045747; GO:0043552; GO:0014068; GO:0010863; GO:0051897; GO:0031274; GO:0120072; GO:1904349; GO:0042531; GO:1905065; GO:0046777; GO:1904251; GO:0042127; GO:0008360; GO:0048070; GO:0006357; GO:0046686; GO:0007165; GO:0048103; GO:0035019; GO:0007286; GO:0007283; GO:0048863; GO:0019827; GO:0030217; GO:0043586; GO:0008542"]
[1263,625,"NK241-2","Kit","Pan-specific","Mast/stem cell growth factor receptor protein-tyrosine Kit",{"v":9937.716288008503,"d":"9938"},{"v":9831.952619310876,"d":"9832"},{"v":1949.9964798637818,"d":"1950"},{"v":19.62217901326862,"d":"20"},{"v":1799.0122312281558,"d":"1799"},{"v":16114.446230361831,"d":"16114"},"Kinexus","RpAb","CLVDRSLYGKEDNDTL","Corresponds to amino acid residues L119 to L133; In the extracellular domain of the receptor.",null,null,"P10721","P10721",588,"P10721","P10721","NP_006566","Block4",10,1,"4, 12, 20, 28","KIT","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"EC 2.7.10.1; Receptor tyrosine kinase; TK group; PDGFR family","GO:0001669; GO:0005911; GO:0009898; GO:0009897; GO:0005615; GO:0016021; GO:0042629; GO:0005886","GO:0005524; GO:0019955; GO:0046872; GO:0046934; GO:0002020; GO:0042803; GO:0004713; GO:0005088; GO:0005020; GO:0004714","GO:0031532; GO:0000187; GO:0060326; GO:0097067; GO:0019221; GO:0002371; GO:0050910; GO:0048565; GO:0035234; GO:0035162; GO:0050673; GO:0030218; GO:0038162; GO:0038093; GO:0008354; GO:0006687; GO:0035701; GO:0030097; GO:0002327; GO:0006954; GO:0038109; GO:0030032; GO:0002320; GO:0008584; GO:0000165; GO:0002551; GO:0032762; GO:0043303; GO:0060374; GO:0070662; GO:0035855; GO:0097326; GO:0030318; GO:0097324; GO:0002318; GO:0043069; GO:0001541; GO:0018108; GO:0043473; GO:0030335; GO:0008284; GO:1904343; GO:0051091; GO:0010628; GO:0046427; GO:0048170; GO:0043410; GO:0045747; GO:0043552; GO:0014068; GO:0010863; GO:0051897; GO:0031274; GO:0120072; GO:1904349; GO:0042531; GO:1905065; GO:0046777; GO:1904251; GO:0042127; GO:0008360; GO:0048070; GO:0006357; GO:0046686; GO:0007165; GO:0048103; GO:0035019; GO:0007286; GO:0007283; GO:0048863; GO:0019827; GO:0030217; GO:0043586; GO:0008542"]
[1265,626,"PK036","Kit","Y703","Mast/stem cell growth factor receptor protein-tyrosine Kit",{"v":5497.301926148288,"d":"5497"},{"v":5181.283001108637,"d":"5181"},{"v":1826.7636548908365,"d":"1827"},{"v":33.230185997274624,"d":"33"},{"v":1638.8080352582656,"d":"1639"},{"v":11958.43049325423,"d":"11958"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the Y703 phosphosite.","Y703 phosphorylation induces interaction with Grb2. This is one of the major in vivo phosphorylation sites in Kit (≥26 reports from high throughput mass spectrometry studies).","Kit","P10721","P10721",588,"P10721","P10721","NP_006566","Block4",10,2,"4, 12, 20, 28","KIT","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"EC 2.7.10.1; Receptor tyrosine kinase; TK group; PDGFR family","GO:0001669; GO:0005911; GO:0009898; GO:0009897; GO:0005615; GO:0016021; GO:0042629; GO:0005886","GO:0005524; GO:0019955; GO:0046872; GO:0046934; GO:0002020; GO:0042803; GO:0004713; GO:0005088; GO:0005020; GO:0004714","GO:0031532; GO:0000187; GO:0060326; GO:0097067; GO:0019221; GO:0002371; GO:0050910; GO:0048565; GO:0035234; GO:0035162; GO:0050673; GO:0030218; GO:0038162; GO:0038093; GO:0008354; GO:0006687; GO:0035701; GO:0030097; GO:0002327; GO:0006954; GO:0038109; GO:0030032; GO:0002320; GO:0008584; GO:0000165; GO:0002551; GO:0032762; GO:0043303; GO:0060374; GO:0070662; GO:0035855; GO:0097326; GO:0030318; GO:0097324; GO:0002318; GO:0043069; GO:0001541; GO:0018108; GO:0043473; GO:0030335; GO:0008284; GO:1904343; GO:0051091; GO:0010628; GO:0046427; GO:0048170; GO:0043410; GO:0045747; GO:0043552; GO:0014068; GO:0010863; GO:0051897; GO:0031274; GO:0120072; GO:1904349; GO:0042531; GO:1905065; GO:0046777; GO:1904251; GO:0042127; GO:0008360; GO:0048070; GO:0006357; GO:0046686; GO:0007165; GO:0048103; GO:0035019; GO:0007286; GO:0007283; GO:0048863; GO:0019827; GO:0030217; GO:0043586; GO:0008542"]
[1267,627,"PK885","Kit","Y721","Mast/stem cell growth factor receptor protein-tyrosine Kit",{"v":12658.906971823957,"d":"12659"},{"v":12583.41781793936,"d":"12583"},{"v":2700.076075392194,"d":"2700"},{"v":21.329456653737886,"d":"21"},{"v":4212.287401689894,"d":"4212"},{"v":22735.48760749614,"d":"22735"},"Kinexus","RpAb","TNE(pY)MDM(bA)C","Corresponds to amino acid residues T718 to M724; The phosphosite located in the Gap/Insert 5(G/5) region in the protein-tyrosine kinase catalytic domain of Kit. ","Y721 phosphorylation stimulates phosphotransferase activity and induces interaction with PIK3R1. Phosphorylation regulates cell adhesion. Y721 is the second most observed phosphosite in Kit by mass spectrometry (≥53 reports).","Kit","P10721","P10721",588,"P10721","P10721","NP_006566","Block4",10,3,"4, 12, 20, 28","KIT","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"EC 2.7.10.1; Receptor tyrosine kinase; TK group; PDGFR family","GO:0001669; GO:0005911; GO:0009898; GO:0009897; GO:0005615; GO:0016021; GO:0042629; GO:0005886","GO:0005524; GO:0019955; GO:0046872; GO:0046934; GO:0002020; GO:0042803; GO:0004713; GO:0005088; GO:0005020; GO:0004714","GO:0031532; GO:0000187; GO:0060326; GO:0097067; GO:0019221; GO:0002371; GO:0050910; GO:0048565; GO:0035234; GO:0035162; GO:0050673; GO:0030218; GO:0038162; GO:0038093; GO:0008354; GO:0006687; GO:0035701; GO:0030097; GO:0002327; GO:0006954; GO:0038109; GO:0030032; GO:0002320; GO:0008584; GO:0000165; GO:0002551; GO:0032762; GO:0043303; GO:0060374; GO:0070662; GO:0035855; GO:0097326; GO:0030318; GO:0097324; GO:0002318; GO:0043069; GO:0001541; GO:0018108; GO:0043473; GO:0030335; GO:0008284; GO:1904343; GO:0051091; GO:0010628; GO:0046427; GO:0048170; GO:0043410; GO:0045747; GO:0043552; GO:0014068; GO:0010863; GO:0051897; GO:0031274; GO:0120072; GO:1904349; GO:0042531; GO:1905065; GO:0046777; GO:1904251; GO:0042127; GO:0008360; GO:0048070; GO:0006357; GO:0046686; GO:0007165; GO:0048103; GO:0035019; GO:0007286; GO:0007283; GO:0048863; GO:0019827; GO:0030217; GO:0043586; GO:0008542"]
[1269,628,"PK037","Kit","Y730","Mast/stem cell growth factor receptor protein-tyrosine Kit",{"v":1727.7766887303176,"d":"1728"},{"v":1380.4106187739176,"d":"1380"},{"v":1861.926533594284,"d":"1862"},{"v":107.76430459670966,"d":"108"},{"v":230.95650287468146,"d":"231"},{"v":16780.876935829074,"d":"16781"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the Y730 phosphosite.","The effect of Y730 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in Kit (≥29 reports from high throughput mass spectrometry studies).","Kit","P10721","P10721",588,"P10721","P10721","NP_006566","Block4",10,4,"4, 12, 20, 28","KIT","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"EC 2.7.10.1; Receptor tyrosine kinase; TK group; PDGFR family","GO:0001669; GO:0005911; GO:0009898; GO:0009897; GO:0005615; GO:0016021; GO:0042629; GO:0005886","GO:0005524; GO:0019955; GO:0046872; GO:0046934; GO:0002020; GO:0042803; GO:0004713; GO:0005088; GO:0005020; GO:0004714","GO:0031532; GO:0000187; GO:0060326; GO:0097067; GO:0019221; GO:0002371; GO:0050910; GO:0048565; GO:0035234; GO:0035162; GO:0050673; GO:0030218; GO:0038162; GO:0038093; GO:0008354; GO:0006687; GO:0035701; GO:0030097; GO:0002327; GO:0006954; GO:0038109; GO:0030032; GO:0002320; GO:0008584; GO:0000165; GO:0002551; GO:0032762; GO:0043303; GO:0060374; GO:0070662; GO:0035855; GO:0097326; GO:0030318; GO:0097324; GO:0002318; GO:0043069; GO:0001541; GO:0018108; GO:0043473; GO:0030335; GO:0008284; GO:1904343; GO:0051091; GO:0010628; GO:0046427; GO:0048170; GO:0043410; GO:0045747; GO:0043552; GO:0014068; GO:0010863; GO:0051897; GO:0031274; GO:0120072; GO:1904349; GO:0042531; GO:1905065; GO:0046777; GO:1904251; GO:0042127; GO:0008360; GO:0048070; GO:0006357; GO:0046686; GO:0007165; GO:0048103; GO:0035019; GO:0007286; GO:0007283; GO:0048863; GO:0019827; GO:0030217; GO:0043586; GO:0008542"]
[1271,629,"PK674","Kit","S821+Y823","Mast/stem cell growth factor receptor protein-tyrosine Kit",{"v":8582.249259010974,"d":"8582"},{"v":8491.316113174224,"d":"8491"},{"v":1909.455384096418,"d":"1909"},{"v":22.24889217813822,"d":"22"},{"v":560.691929556684,"d":"561"},{"v":13721.329869107436,"d":"13721"},"Kinexus","RpAb","KND(pS)N(pY)VVKG(bA)C","Corresponds to amino acid residues K818 to G827; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","S821 and Y823 phosphorylation stimulate phosphotransferase activity. Y823 phosphorylation also induces interaction with Grb2 and Grb7. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. S821 phosphorylation is not frequently observed (≥1 reports) in high throughput mass spectrometry studies, where as Y283 appears to be more commonly observed (13 reports). ","Y823: Kit.","P10721","P10721",588,"P10721","P10721","NP_006566","Block4",10,5,"4, 12, 20, 28","KIT","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"EC 2.7.10.1; Receptor tyrosine kinase; TK group; PDGFR family","GO:0001669; GO:0005911; GO:0009898; GO:0009897; GO:0005615; GO:0016021; GO:0042629; GO:0005886","GO:0005524; GO:0019955; GO:0046872; GO:0046934; GO:0002020; GO:0042803; GO:0004713; GO:0005088; GO:0005020; GO:0004714","GO:0031532; GO:0000187; GO:0060326; GO:0097067; GO:0019221; GO:0002371; GO:0050910; GO:0048565; GO:0035234; GO:0035162; GO:0050673; GO:0030218; GO:0038162; GO:0038093; GO:0008354; GO:0006687; GO:0035701; GO:0030097; GO:0002327; GO:0006954; GO:0038109; GO:0030032; GO:0002320; GO:0008584; GO:0000165; GO:0002551; GO:0032762; GO:0043303; GO:0060374; GO:0070662; GO:0035855; GO:0097326; GO:0030318; GO:0097324; GO:0002318; GO:0043069; GO:0001541; GO:0018108; GO:0043473; GO:0030335; GO:0008284; GO:1904343; GO:0051091; GO:0010628; GO:0046427; GO:0048170; GO:0043410; GO:0045747; GO:0043552; GO:0014068; GO:0010863; GO:0051897; GO:0031274; GO:0120072; GO:1904349; GO:0042531; GO:1905065; GO:0046777; GO:1904251; GO:0042127; GO:0008360; GO:0048070; GO:0006357; GO:0046686; GO:0007165; GO:0048103; GO:0035019; GO:0007286; GO:0007283; GO:0048863; GO:0019827; GO:0030217; GO:0043586; GO:0008542"]
[1273,630,"PK673","Kit","Y936","Mast/stem cell growth factor receptor protein-tyrosine Kit",{"v":15702.429396946864,"d":"15702"},{"v":15450.282513019643,"d":"15450"},{"v":3296.7718434866665,"d":"3297"},{"v":20.995297989543463,"d":"21"},{"v":6651.3802153230945,"d":"6651"},{"v":28253.47433243159,"d":"28253"},"Kinexus","RpAb","NHI(pY)SNL(bA)C","Corresponds to amino acid residues N933 to L939; In the C-terminal of the kinase after the catalytic domain.","Y936 phosphorylation stimulates phosphotransferase activity and induces interaction with APS, Cbl, Grb2 and Grb7. Phosphorylation also induces receptor internalization and protein degradation. This is the major in vivo phosphorylation sites in Kit (≥107 reports from high throughput mass spectrometry studies).","Kit","P10721","P10721",588,"P10721","P10721","NP_006566","Block4",10,6,"4, 12, 20, 28","KIT","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"EC 2.7.10.1; Receptor tyrosine kinase; TK group; PDGFR family","GO:0001669; GO:0005911; GO:0009898; GO:0009897; GO:0005615; GO:0016021; GO:0042629; GO:0005886","GO:0005524; GO:0019955; GO:0046872; GO:0046934; GO:0002020; GO:0042803; GO:0004713; GO:0005088; GO:0005020; GO:0004714","GO:0031532; GO:0000187; GO:0060326; GO:0097067; GO:0019221; GO:0002371; GO:0050910; GO:0048565; GO:0035234; GO:0035162; GO:0050673; GO:0030218; GO:0038162; GO:0038093; GO:0008354; GO:0006687; GO:0035701; GO:0030097; GO:0002327; GO:0006954; GO:0038109; GO:0030032; GO:0002320; GO:0008584; GO:0000165; GO:0002551; GO:0032762; GO:0043303; GO:0060374; GO:0070662; GO:0035855; GO:0097326; GO:0030318; GO:0097324; GO:0002318; GO:0043069; GO:0001541; GO:0018108; GO:0043473; GO:0030335; GO:0008284; GO:1904343; GO:0051091; GO:0010628; GO:0046427; GO:0048170; GO:0043410; GO:0045747; GO:0043552; GO:0014068; GO:0010863; GO:0051897; GO:0031274; GO:0120072; GO:1904349; GO:0042531; GO:1905065; GO:0046777; GO:1904251; GO:0042127; GO:0008360; GO:0048070; GO:0006357; GO:0046686; GO:0007165; GO:0048103; GO:0035019; GO:0007286; GO:0007283; GO:0048863; GO:0019827; GO:0030217; GO:0043586; GO:0008542"]
[1275,631,"NK090-2","Ksr1","Pan-specific","Mammalian STE20-like protein-serine kinase 2",{"v":167.80473080177535,"d":"168"},{"v":124.18879337414546,"d":"124"},{"v":228.60415498258618,"d":"229"},{"v":136.23224678488478,"d":"136"},{"v":25.813886558566807,"d":"26"},{"v":3011.5775222329034,"d":"3012"},"External","GpAb","Epitope undefined.",{"$nulls":3},"Q8IVT5","Q8IVT5",2001,"Q8IVT5","Q8IVT5","XP_011523731.1","Block4",10,7,"4, 12, 20, 28","KSR1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RAF",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); TKL domain target; TKL</A> group; RAF family","GO:0005829; GO:0005783; GO:0005789; GO:0016020; GO:0032991; GO:0032587","GO:0071889; GO:0005524; GO:0051087; GO:0051879; GO:0005078; GO:0046872; GO:0031434; GO:0008022; GO:0004672","GO:0019933; GO:0000165; GO:0043410; GO:0006468; GO:0007265; GO:0042127; GO:0043405"]
[1277,632,"NK090-1","Ksr1","Pan-specific","Protein-serine kinase suppressor of Ras 1",{"v":461.02099462181025,"d":"461"},{"v":426.2499469279985,"d":"426"},{"v":249.74427404280672,"d":"250"},{"v":54.17199584320008,"d":"54"},{"v":54.99338767591199,"d":"55"},{"v":1327.4464815166252,"d":"1327"},"Kinexus","RpAb","EKLPKLNRRLSHPGHFWKSC","Corresponds to amino acid residues E829 to S847; C-terminus.",null,null,"Q8IVT5","Q8IVT5",2001,"Q8IVT5","Q8IVT5","XP_011523731.1","Block4",10,8,"4, 12, 20, 28","KSR1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RAF",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); TKL domain target; TKL</A> group; RAF family","GO:0005829; GO:0005783; GO:0005789; GO:0016020; GO:0032991; GO:0032587","GO:0071889; GO:0005524; GO:0051087; GO:0051879; GO:0005078; GO:0046872; GO:0031434; GO:0008022; GO:0004672","GO:0019933; GO:0000165; GO:0043410; GO:0006468; GO:0007265; GO:0042127; GO:0043405"]
[1279,633,"PK675","Ksr1","S406","Protein-serine kinase suppressor of Ras 1",{"v":11144.04659180315,"d":"11144"},{"v":11046.78403676596,"d":"11047"},{"v":2033.310527544553,"d":"2033"},{"v":18.24571093448341,"d":"18"},{"v":6342.4027725874375,"d":"6342"},{"v":16616.89602845652,"d":"16617"},"Kinexus","RpAb","RTE(pS)VPS(bA)C","Corresponds to amino acid residues R401 to S407; In the region between the KSR1-SAM and kinase catalytic domains. ","The effect of S406 phosphorylation is unclear. This is the major in vivo phosphorylation site in Krs1.","MARK3; NM23 (NME1); TAK1 (MAP3K7)","Q8IVT5","Q8IVT5",2001,"Q8IVT5","Q8IVT5","XP_011523731.1","Block4",10,9,"4, 12, 20, 28","KSR1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RAF",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); TKL domain target; TKL</A> group; RAF family","GO:0005829; GO:0005783; GO:0005789; GO:0016020; GO:0032991; GO:0032587","GO:0071889; GO:0005524; GO:0051087; GO:0051879; GO:0005078; GO:0046872; GO:0031434; GO:0008022; GO:0004672","GO:0019933; GO:0000165; GO:0043410; GO:0006468; GO:0007265; GO:0042127; GO:0043405"]
[1281,634,"PK676","Ksr2","S490","Kinase suppressor of Ras 2",{"v":10918.515869528614,"d":"10919"},{"v":10935.43091764148,"d":"10935"},{"v":2811.4726529115705,"d":"2811"},{"v":25.749586175515176,"d":"26"},{"v":886.8170967072937,"d":"887"},{"v":17729.033786344182,"d":"17729"},"Kinexus","RpAb","PRY(pS)DLH(bA)C","Corresponds to amino acid residues P487 to H493; In the region between the KSR1-SAM and kinase catalytic domains. ","The effect of S490 phosphorylation is unclear. This is the major in vivo phosphorylation site in Krs2 (≥48 reports from high throughput mass spectrometry studies).",null,"Q6VAB6","Q6VAB6",3796,"Q6VAB6",null,"NP_006273","Block4",10,10,"4, 12, 20, 28","KSR2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RAF",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); TKL domain target; TKL</A> group; RAF family","GO:0005829; GO:0005886","GO:0005524; GO:0046872; GO:0004672; GO:0004674","GO:0019722; GO:0120162; GO:0043410; GO:0006468"]
[1283,637,"NK091-3","LATS1","Pan-specific","Large tumour suppressor 1 protein-serine kinase (WARTS)",{"v":187.2635575499009,"d":"187"},{"v":151.58563430261,"d":"152"},{"v":145.90723550217183,"d":"146"},{"v":77.91544570186397,"d":"78"},{"v":28.113620286744734,"d":"28"},{"v":1522.5342513764099,"d":"1523"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 3-28 at the N-terminus of human LATS1.",null,null,"O95835","O95835",2448,"O95835","O95835","NP_004681.1","Block4",10,13,"4, 12, 20, 28","LATS1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","NDR",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); AGC group; NDR family","GO:0005829; GO:0005815; GO:0000922","GO:0005524; GO:0030331; GO:0000287; GO:0019901; GO:0004674","GO:0051301; GO:0034613; GO:0051220; GO:0000082; GO:0000086; GO:0035329; GO:0009755; GO:0001827; GO:0001828; GO:0030216; GO:0060644; GO:0090090; GO:0045736; GO:0043065; GO:0033138; GO:0006468; GO:0030833; GO:0033146; GO:0046620; GO:0043254; GO:2000058; GO:0000819"]
[1285,638,"NK091-2","LATS1","Pan-specific","Large tumour suppressor 1 protein-serine kinase (WARTS)",{"v":1552.7047810001175,"d":"1553"},{"v":1475.0642703635424,"d":"1475"},{"v":561.4274559268973,"d":"561"},{"v":36.15802970383556,"d":"36"},{"v":553.5426532716348,"d":"554"},{"v":3406.9863115986554,"d":"3407"},"Kinexus","RpAb","CGSEQQSDEDDQNTGSEIKN","Corresponds to amino acid residues G1106 to N1124; C-terminus.",null,null,"O95835","O95835",2448,"O95835","O95835","NP_004681.1","Block4",11,1,"4, 12, 20, 28","LATS1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","NDR",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); AGC group; NDR family","GO:0005829; GO:0005815; GO:0000922","GO:0005524; GO:0030331; GO:0000287; GO:0019901; GO:0004674","GO:0051301; GO:0034613; GO:0051220; GO:0000082; GO:0000086; GO:0035329; GO:0009755; GO:0001827; GO:0001828; GO:0030216; GO:0060644; GO:0090090; GO:0045736; GO:0043065; GO:0033138; GO:0006468; GO:0030833; GO:0033146; GO:0046620; GO:0043254; GO:2000058; GO:0000819"]
[1287,639,"PK677","LATS1","S464","Large tumour suppressor 1 protein-serine kinase (WARTS)",{"v":3475.6194252530304,"d":"3476"},{"v":3337.5143694868993,"d":"3338"},{"v":1167.396016834954,"d":"1167"},{"v":33.58814283154623,"d":"34"},{"v":1194.4323767866115,"d":"1194"},{"v":7436.099245719488,"d":"7436"},"Kinexus","RpAb","RSN(pS)FNN(bA)C","Corresponds to amino acid residues R461 to N467; In the N-terminal half of the protein. One of the two major in vivo phosphorylation sites in LATS1.","S464 phosphorylation induces protein degradation. This is the major in vivo phosphorylation site in LATS1 (≥56 reports from high throughput mass spectrometry studies).","NuaK1; NuaK2","O95835","O95835",2448,"O95835","O95835","NP_004681.1","Block4",11,2,"4, 12, 20, 28","LATS1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","NDR",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); AGC group; NDR family","GO:0005829; GO:0005815; GO:0000922","GO:0005524; GO:0030331; GO:0000287; GO:0019901; GO:0004674","GO:0051301; GO:0034613; GO:0051220; GO:0000082; GO:0000086; GO:0035329; GO:0009755; GO:0001827; GO:0001828; GO:0030216; GO:0060644; GO:0090090; GO:0045736; GO:0043065; GO:0033138; GO:0006468; GO:0030833; GO:0033146; GO:0046620; GO:0043254; GO:2000058; GO:0000819"]
[1289,640,"PK678","LATS1","S909","Large tumour suppressor 1 protein-serine kinase (WARTS)",{"v":12986.424909163608,"d":"12986"},{"v":12608.222332685484,"d":"12608"},{"v":2458.513883559892,"d":"2459"},{"v":18.931414155600987,"d":"19"},{"v":6347.385886873391,"d":"6347"},{"v":21590.76732802031,"d":"21591"},"Kinexus","RpAb","LAH(pS)LVG(bA)C","Corresponds to amino acid residues L906 to G912; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","S909 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in LATS1 (≥13 reports from high throughput mass spectrometry studies).","LATS1; MST2 (CLIK1; STK3)","O95835","O95835",2448,"O95835","O95835","NP_004681.1","Block4",11,3,"4, 12, 20, 28","LATS1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","NDR",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); AGC group; NDR family","GO:0005829; GO:0005815; GO:0000922","GO:0005524; GO:0030331; GO:0000287; GO:0019901; GO:0004674","GO:0051301; GO:0034613; GO:0051220; GO:0000082; GO:0000086; GO:0035329; GO:0009755; GO:0001827; GO:0001828; GO:0030216; GO:0060644; GO:0090090; GO:0045736; GO:0043065; GO:0033138; GO:0006468; GO:0030833; GO:0033146; GO:0046620; GO:0043254; GO:2000058; GO:0000819"]
[1291,641,"NK092-1","LATS2 (KPM)","Pan-specific","Large tumour suppressor 2 protein-serine kinase",{"v":6143.38346712658,"d":"6143"},{"v":6245.906149748251,"d":"6246"},{"v":1887.6844335007238,"d":"1888"},{"v":30.72711387139964,"d":"31"},{"v":1747.8254184095772,"d":"1748"},{"v":18723.149619120268,"d":"18723"},"Kinexus","RpAb","CSDTSLDAKVLGSKDATRQQ","Corresponds to amino acid residues S43 to Q61; Post-N-terminus.",null,null,"Q9NRM7","Q9NRM7",705,"Q9NRM7","Q9NRM7","NP_055387.2","Block4",11,4,"4, 12, 20, 28","LATS2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","NDR",{"$nulls":6},"Protein-serine kinase, AGC group, NDR family","GO:0005829; GO:0005815; GO:0005634; GO:0000922","GO:0005524; GO:0046872; GO:0004674","GO:0051301; GO:0034613; GO:0000082; GO:0035329; GO:0009755; GO:0001827; GO:0001828; GO:0035556; GO:0030216; GO:0090090; GO:0045736; GO:0018105; GO:0043065; GO:0006468; GO:0046620"]
[1293,642,"NK092-2","LATS2 (KPM)","Pan-specific","Large tumour suppressor 2 protein-serine kinase",{"v":6725.932375606878,"d":"6726"},{"v":6490.017203976357,"d":"6490"},{"v":1800.4947389684446,"d":"1800"},{"v":26.769444567988042,"d":"27"},{"v":1207.3244358193558,"d":"1207"},{"v":12551.784337047076,"d":"12552"},"Kinexus","RpAb","SQAESSDLESSDLVDQTEGC","Corresponds to amino acid residues S1064 to C1083; C-terminus.",null,null,"Q9NRM7","Q9NRM7",705,"Q9NRM7","Q9NRM7","NP_055387.2","Block4",11,5,"4, 12, 20, 28","LATS2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","NDR",{"$nulls":6},"Protein-serine kinase, AGC group, NDR family","GO:0005829; GO:0005815; GO:0005634; GO:0000922","GO:0005524; GO:0046872; GO:0004674","GO:0051301; GO:0034613; GO:0000082; GO:0035329; GO:0009755; GO:0001827; GO:0001828; GO:0035556; GO:0030216; GO:0090090; GO:0045736; GO:0018105; GO:0043065; GO:0006468; GO:0046620"]
[1295,643,"NK353-4","Lck","Pan-specific","Lymphocyte-specific protein-tyrosine kinase",{"v":272.0772009793568,"d":"272"},{"v":191.81630455897897,"d":"192"},{"v":342.62893287154685,"d":"343"},{"v":125.93077686709331,"d":"126"},{"v":38.94495421984673,"d":"39"},{"v":4206.152769110623,"d":"4206"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 1-225 of mouse Lck.",null,null,"P06239","P06239",615,"P06239","P06239","NP_005347","Block4",11,6,"4, 12, 20, 28","LCK","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"Protein-tyrosine kinase, TK group, Src family","GO:0005829; GO:0070062; GO:0031234; GO:0001772; GO:0045121; GO:0000242; GO:0005886","GO:0051117; GO:0005524; GO:0042609; GO:0042610; GO:0042802; GO:0016301; GO:0004715; GO:0043548; GO:0046934; GO:0001784; GO:0008022; GO:0019901; GO:0019903; GO:0004722; GO:0004713; GO:0042169; GO:0042608","GO:0006919; GO:0050853; GO:0016477; GO:0006882; GO:0030097; GO:0045087; GO:0050900; GO:0038083; GO:0018108; GO:0030168; GO:0034116; GO:2001244; GO:1903039; GO:0051897; GO:0050870; GO:0050862; GO:0006468; GO:0042127; GO:0050690; GO:0051249; GO:0051209; GO:0042493; GO:0031295; GO:0030217; GO:0050852; GO:0007169"]
[1297,644,"PK679","Lck","Y192","Lymphocyte-specific protein-tyrosine kinase; Proto-oncogene tyrosine-protein kinase LCK",{"v":9387.012938820322,"d":"9387"},{"v":9322.601329715962,"d":"9323"},{"v":1776.9681291674767,"d":"1777"},{"v":18.930070095235116,"d":"19"},{"v":5295.995218126236,"d":"5296"},{"v":15057.434175361199,"d":"15057"},"Kinexus","RpAb","GGF(pY)ISP(bA)C","Corresponds to amino acid residues G189 to P195; In the SH2 domain.","Y192 phosphorylation inhibits phosphotransferase activity. Phosphorylation regulates molecular association. This is one of the major in vivo phosphorylation sites in Lck (≥1068 reports from high throughput mass spectrometry studies).",null,"P06239","P06239",615,"P06239","P06239","NP_005347","Block4",11,7,"4, 12, 20, 28","LCK","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"Protein-tyrosine kinase, TK group, Src family","GO:0005829; GO:0070062; GO:0031234; GO:0001772; GO:0045121; GO:0000242; GO:0005886","GO:0051117; GO:0005524; GO:0042609; GO:0042610; GO:0042802; GO:0016301; GO:0004715; GO:0043548; GO:0046934; GO:0001784; GO:0008022; GO:0019901; GO:0019903; GO:0004722; GO:0004713; GO:0042169; GO:0042608","GO:0006919; GO:0050853; GO:0016477; GO:0006882; GO:0030097; GO:0045087; GO:0050900; GO:0038083; GO:0018108; GO:0030168; GO:0034116; GO:2001244; GO:1903039; GO:0051897; GO:0050870; GO:0050862; GO:0006468; GO:0042127; GO:0050690; GO:0051249; GO:0051209; GO:0042493; GO:0031295; GO:0030217; GO:0050852; GO:0007169"]
[1299,645,"PK680","Lck","Y263+Y264","Lymphocyte-specific protein-tyrosine kinase; Proto-oncogene tyrosine-protein kinase LCK",{"v":8639.160663599603,"d":"8639"},{"v":8478.61009197433,"d":"8479"},{"v":1809.1699541585072,"d":"1809"},{"v":20.941501432903046,"d":"21"},{"v":3182.828556710446,"d":"3183"},{"v":19899.711393647893,"d":"19900"},"Kinexus","RpAb","GEVWMG(pY)(pY)NGHT(bA)C","Corresponds to amino acid residues G257 to T268; In the kinase catalytic domain between subdomains I and II.","The effects of Y263 and Y264 phosphorylation are unclear. These are two of the major in vivo phosphorylation sites in Lck (≥67 and ≥19 reports from high throughput mass spectrometry studies).",null,"P06239","P06239",615,"P06239","P06239","NP_005347","Block4",11,8,"4, 12, 20, 28","LCK","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"Protein-tyrosine kinase, TK group, Src family","GO:0005829; GO:0070062; GO:0031234; GO:0001772; GO:0045121; GO:0000242; GO:0005886","GO:0051117; GO:0005524; GO:0042609; GO:0042610; GO:0042802; GO:0016301; GO:0004715; GO:0043548; GO:0046934; GO:0001784; GO:0008022; GO:0019901; GO:0019903; GO:0004722; GO:0004713; GO:0042169; GO:0042608","GO:0006919; GO:0050853; GO:0016477; GO:0006882; GO:0030097; GO:0045087; GO:0050900; GO:0038083; GO:0018108; GO:0030168; GO:0034116; GO:2001244; GO:1903039; GO:0051897; GO:0050870; GO:0050862; GO:0006468; GO:0042127; GO:0050690; GO:0051249; GO:0051209; GO:0042493; GO:0031295; GO:0030217; GO:0050852; GO:0007169"]
[1301,646,"PK149","Lck","Y394","Lymphocyte-specific protein-tyrosine kinase; Proto-oncogene tyrosine-protein kinase LCK",{"v":298.2487258894218,"d":"298"},{"v":273.4637149799313,"d":"273"},{"v":178.02104251979952,"d":"178"},{"v":59.68878558958281,"d":"60"},{"v":20.57534148843434,"d":"21"},{"v":963.4795973281907,"d":"963"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the Y394 phosphosite.","Y394 phosphorylation stimulates phosphotransferase activity and induces interaction with Lck. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation regulates cell growth and molecular association.This is the major in vivo phosphorylation sites in Lck (≥2998 reports from high throughput mass spectrometry studies).","Lck","P06239","P06239",615,"P06239","P06239","NP_005347","Block4",11,9,"4, 12, 20, 28","LCK","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"Protein-tyrosine kinase, TK group, Src family","GO:0005829; GO:0070062; GO:0031234; GO:0001772; GO:0045121; GO:0000242; GO:0005886","GO:0051117; GO:0005524; GO:0042609; GO:0042610; GO:0042802; GO:0016301; GO:0004715; GO:0043548; GO:0046934; GO:0001784; GO:0008022; GO:0019901; GO:0019903; GO:0004722; GO:0004713; GO:0042169; GO:0042608","GO:0006919; GO:0050853; GO:0016477; GO:0006882; GO:0030097; GO:0045087; GO:0050900; GO:0038083; GO:0018108; GO:0030168; GO:0034116; GO:2001244; GO:1903039; GO:0051897; GO:0050870; GO:0050862; GO:0006468; GO:0042127; GO:0050690; GO:0051249; GO:0051209; GO:0042493; GO:0031295; GO:0030217; GO:0050852; GO:0007169"]
[1303,647,"PK041","Lck","Y505","Lymphocyte-specific protein-tyrosine kinase; Proto-oncogene tyrosine-protein kinase LCK",{"v":84.79482860072498,"d":"85"},{"v":61.587227102450356,"d":"62"},{"v":78.67347384525729,"d":"79"},{"v":92.78098103801656,"d":"93"},{"v":15.14033557793409,"d":"15"},{"v":612.3918085626075,"d":"612"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the Y505 phosphosite.","Y505 phosphorylation inhibits phosphotransferase activity, and regulates cell growth and molecular association, including inducing interaction with Lck. This is one of the major in vivo phosphorylation sites in Lck (≥814 reports from high throughput mass spectrometry studies).","CSK; Lck","P06239","P06239",615,"P06239","P06239","NP_005347","Block4",11,10,"4, 12, 20, 28","LCK","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"Protein-tyrosine kinase, TK group, Src family","GO:0005829; GO:0070062; GO:0031234; GO:0001772; GO:0045121; GO:0000242; GO:0005886","GO:0051117; GO:0005524; GO:0042609; GO:0042610; GO:0042802; GO:0016301; GO:0004715; GO:0043548; GO:0046934; GO:0001784; GO:0008022; GO:0019901; GO:0019903; GO:0004722; GO:0004713; GO:0042169; GO:0042608","GO:0006919; GO:0050853; GO:0016477; GO:0006882; GO:0030097; GO:0045087; GO:0050900; GO:0038083; GO:0018108; GO:0030168; GO:0034116; GO:2001244; GO:1903039; GO:0051897; GO:0050870; GO:0050862; GO:0006468; GO:0042127; GO:0050690; GO:0051249; GO:0051209; GO:0042493; GO:0031295; GO:0030217; GO:0050852; GO:0007169"]
[1305,648,"PN615","LEDGF","S273+S275","PC4 and SFRS1-interacting protein",{"v":2200.7492999589062,"d":"2201"},{"v":2149.761651818044,"d":"2150"},{"v":755.9383929841263,"d":"756"},{"v":34.34913704156315,"d":"34"},{"v":192.37733669941542,"d":"192"},{"v":4899.254908450075,"d":"4899"},"Kinexus","RpAb","TST(pS)D(pS)EEEGC","Corresponds to amino acid residues T270 to G279.","The effect of S273 and S275 phosphorylation are unclear. This are two of the major in vivo phosphorylation sites in LEDGF (≥135 and ≥154 reports, respectively, from high throughput mass spectrometry studies).","S275: CK2a1 (CSNK2A1).","O75475","O75475",6419,null,"O75475","NP_001121689.1","Block4",11,11,"4, 12, 20, 28",{"$nulls":3},"Nucleus protein; Transcription protein,  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"Nucleus protein; Transcription protein, coactivator/corepressor","GO:0005829; GO:0005720; GO:0034399; GO:0005654; GO:0005634; GO:0035327","GO:0033613; GO:0003682; GO:0003723; GO:0097100; GO:0003713","GO:0075713; GO:0000395; GO:0051169; GO:0045944; GO:0006355; GO:0009408; GO:0006979; GO:0006351"]
[1307,649,"PN616","LEF1","T155","Lymphoid enhancer-binding factor 1",{"v":12745.720814733715,"d":"12746"},{"v":12576.856462525255,"d":"12577"},{"v":2939.958071746944,"d":"2940"},{"v":23.06623622532537,"d":"23"},{"v":3010.7884679797526,"d":"3011"},{"v":23003.827981595052,"d":"23004"},"Kinexus","RpAb","VHPL(pT)PLIT(bA)C","Corresponds to amino acid residues V151 to T159.","T155 phosphorylation regulates transcription, although one report indicates inhibition, wheras another describes induction. This is one of the major in vivo phosphorylation sites in LEF1 (≥11 reports from high throughput mass spectrometry studies).","NLK","Q9UJU2","Q9UJU2",16463,null,"Q9UJU2","NP_057353.1","Block4",11,12,"4, 12, 20, 28",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:1990907; GO:0005737; GO:0005654; GO:0005634; GO:0032993; GO:0005667","GO:0070016; GO:0008013; GO:0070742; GO:0003682; GO:0043027; GO:0003677; GO:0008301; GO:0003700; GO:0035326; GO:0030284; GO:0030331; GO:0045295; GO:0042393; GO:0042826; GO:0000978; GO:0000977; GO:0000981; GO:0043565; GO:0001077; GO:0001228; GO:0003705; GO:0044212","GO:0046632; GO:0060033; GO:1902262; GO:0060561; GO:0042100; GO:1904837; GO:0030509; GO:0001569; GO:0060070; GO:0060326; GO:0071345; GO:0071353; GO:0060710; GO:0021542; GO:0030326; GO:0001837; GO:0048069; GO:0060325; GO:0021873; GO:0021879; GO:0021861; GO:0021943; GO:0043966; GO:0043967; GO:0021854; GO:0030879; GO:0048747; GO:0043066; GO:0071866; GO:0022408; GO:0043154; GO:0043392; GO:0071899; GO:0032696; GO:0032713; GO:0032714; GO:0045843; GO:0045892; GO:0000122; GO:0001755; GO:0030223; GO:0071895; GO:0042475; GO:0001649; GO:0048341; GO:0043923; GO:0022409; GO:0090068; GO:0030307; GO:0030335; GO:0008284; GO:0071864; GO:0010718; GO:0010628; GO:0030854; GO:0045893; GO:0045944; GO:0022407; GO:0016202; GO:0030111; GO:0062009; GO:0050909; GO:0001756; GO:0002040; GO:0033153; GO:0045063; GO:0043586; GO:0061153; GO:0006366; GO:0007223"]
[1309,650,"NK093","LIMK1","Pan-specific","LIM domain kinase 1",{"v":357.1584978118735,"d":"357"},{"v":264.80880937353066,"d":"265"},{"v":311.14567200955145,"d":"311"},{"v":87.11697297300248,"d":"87"},{"v":4.679115934229434,"d":"5"},{"v":1568.7425393383314,"d":"1569"},"External","MmAb","Epitope undefined.",{"$nulls":3},"P53667","P53667",616,"P53667","P53667","NP_002305","Block4",11,13,"4, 12, 20, 28","LIMK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","LISK","LIMK",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); TKL group; LISK family; LIMK subfamily","GO:0005737; GO:0005829; GO:0005925; GO:0005794; GO:0030027; GO:0016020; GO:0043005; GO:0016607; GO:0005634","GO:0005524; GO:0031072; GO:0046872; GO:0046982; GO:0004672; GO:0004674","GO:0030036; GO:0038096; GO:0051444; GO:0007399; GO:0032233; GO:0045773; GO:0051496; GO:0006468; GO:0007266; GO:0007165"]
[1311,651,"PK681","LIMK1","T508","LIM domain kinase 1",{"v":17093.19612449931,"d":"17093"},{"v":16348.188828507622,"d":"16348"},{"v":3672.1189411373657,"d":"3672"},{"v":21.482927560131344,"d":"21"},{"v":7441.578635859605,"d":"7442"},{"v":32224.236571854657,"d":"32224"},"Kinexus","RpAb","KRY(pT)VVG(bA)C","Corresponds to amino acid residues K505 to G511; In the protein kinase catalytic domain.","T508 phosphorylation stimulates phosphotransferase activity and induced interaction with NISCH. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the minor in vivo phosphorylation sites in LIMK1 (≥2 reports from high throughput mass spectrometry studies).","MRCKa (CDC42BPA, PK428); PAK1; PAK4; ROCK1","P53667","P53667",616,"P53667","P53667","NP_002305","Block4",12,1,"4, 12, 20, 28","LIMK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","LISK","LIMK",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); TKL group; LISK family; LIMK subfamily","GO:0005737; GO:0005829; GO:0005925; GO:0005794; GO:0030027; GO:0016020; GO:0043005; GO:0016607; GO:0005634","GO:0005524; GO:0031072; GO:0046872; GO:0046982; GO:0004672; GO:0004674","GO:0030036; GO:0038096; GO:0051444; GO:0007399; GO:0032233; GO:0045773; GO:0051496; GO:0006468; GO:0007266; GO:0007165"]
[1313,652,"NK227-3","LKB1 (STK11)","Pan-specific","Serine/threonine-protein kinase 11",{"v":10537.829160120262,"d":"10538"},{"v":10387.408934945419,"d":"10387"},{"v":1933.588980157687,"d":"1934"},{"v":18.349025693785496,"d":"18"},{"v":4959.097024129062,"d":"4959"},{"v":17228.868862416413,"d":"17229"},"Kinexus","RpAb","CLRRIPNGEANVKKEI","Corresponds to amino acid residues L85 to I99.",null,null,"Q15831","Q15831",617,"Q15831","Q15831","NP_000446.1","Block4",12,2,"4, 12, 20, 28","LKB1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","LKB",{"$nulls":5},"Protein-serine kinase, CAMK group, CAMKL family, LKB subfamily","GO:0005737; GO:0005829; GO:0070062; GO:0016020; GO:0005739; GO:0005654; GO:0005634; GO:0036398","GO:0005524; GO:0030275; GO:0000287; GO:0002039; GO:0030295; GO:0004674","GO:0032147; GO:0043276; GO:0006914; GO:0007409; GO:0060070; GO:0007050; GO:0030154; GO:0006974; GO:0071493; GO:0097484; GO:0030010; GO:0042593; GO:0051645; GO:0072332; GO:0090090; GO:0030308; GO:0008285; GO:0120163; GO:0060770; GO:0051055; GO:1904262; GO:0007399; GO:0018105; GO:0018107; GO:0010508; GO:0050772; GO:0050731; GO:1900182; GO:0071902; GO:0030511; GO:0045059; GO:0046777; GO:0006470; GO:0006468; GO:0001558; GO:0048814; GO:0051896; GO:1901796; GO:0010212; GO:0007283; GO:0050852; GO:0036399; GO:0001894; GO:0001944"]
[1315,653,"NK227-4","LKB1 (STK11)","Pan-specific","Serine/threonine-protein kinase 11",{"v":12354.330705729451,"d":"12354"},{"v":12257.752778645598,"d":"12258"},{"v":2040.4792692767955,"d":"2040"},{"v":16.51630766473251,"d":"17"},{"v":7475.699535618554,"d":"7476"},{"v":19442.531639729314,"d":"19443"},"Kinexus","RpAb","CAKRFSIRQIRQHSWF","Corresponds to amino acid residues A295 to F309; Kinase last alpha-chain.",null,null,"Q15831","Q15831",617,"Q15831","Q15831","NP_000446.1","Block4",12,3,"4, 12, 20, 28","LKB1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","LKB",{"$nulls":5},"Protein-serine kinase, CAMK group, CAMKL family, LKB subfamily","GO:0005737; GO:0005829; GO:0070062; GO:0016020; GO:0005739; GO:0005654; GO:0005634; GO:0036398","GO:0005524; GO:0030275; GO:0000287; GO:0002039; GO:0030295; GO:0004674","GO:0032147; GO:0043276; GO:0006914; GO:0007409; GO:0060070; GO:0007050; GO:0030154; GO:0006974; GO:0071493; GO:0097484; GO:0030010; GO:0042593; GO:0051645; GO:0072332; GO:0090090; GO:0030308; GO:0008285; GO:0120163; GO:0060770; GO:0051055; GO:1904262; GO:0007399; GO:0018105; GO:0018107; GO:0010508; GO:0050772; GO:0050731; GO:1900182; GO:0071902; GO:0030511; GO:0045059; GO:0046777; GO:0006470; GO:0006468; GO:0001558; GO:0048814; GO:0051896; GO:1901796; GO:0010212; GO:0007283; GO:0050852; GO:0036399; GO:0001894; GO:0001944"]
[1317,654,"PK682","LKB1 (STK11)","S31","Serine/threonine-protein kinase 11",{"v":6135.43909980916,"d":"6135"},{"v":6013.36464094613,"d":"6013"},{"v":1368.5495730900568,"d":"1369"},{"v":22.30565002483074,"d":"22"},{"v":3377.577929946524,"d":"3378"},{"v":11381.771228715395,"d":"11382"},"Kinexus","RpAb","RID(pS)TEV(bA)C","Corresponds to amino acid residues R28 to V34; In the post-Nterminal region.","The effect of S31 phosphorylation is unclear. This is a major site of phosphorylation for LKB1. This is one of the major in vivo phosphorylation sites in LKB1 (≥309 reports from high throughput mass spectrometry studies).",null,"Q15831","Q15831",617,"Q15831","Q15831","NP_000446.1","Block4",12,4,"4, 12, 20, 28","LKB1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","LKB",{"$nulls":5},"Protein-serine kinase, CAMK group, CAMKL family, LKB subfamily","GO:0005737; GO:0005829; GO:0070062; GO:0016020; GO:0005739; GO:0005654; GO:0005634; GO:0036398","GO:0005524; GO:0030275; GO:0000287; GO:0002039; GO:0030295; GO:0004674","GO:0032147; GO:0043276; GO:0006914; GO:0007409; GO:0060070; GO:0007050; GO:0030154; GO:0006974; GO:0071493; GO:0097484; GO:0030010; GO:0042593; GO:0051645; GO:0072332; GO:0090090; GO:0030308; GO:0008285; GO:0120163; GO:0060770; GO:0051055; GO:1904262; GO:0007399; GO:0018105; GO:0018107; GO:0010508; GO:0050772; GO:0050731; GO:1900182; GO:0071902; GO:0030511; GO:0045059; GO:0046777; GO:0006470; GO:0006468; GO:0001558; GO:0048814; GO:0051896; GO:1901796; GO:0010212; GO:0007283; GO:0050852; GO:0036399; GO:0001894; GO:0001944"]
[1319,655,"PK683","LKB1 (STK11)","S428","Serine/threonine-protein kinase 11",{"v":13613.50667048186,"d":"13614"},{"v":13363.189142819116,"d":"13363"},{"v":3890.073624870467,"d":"3890"},{"v":28.57510352791986,"d":"29"},{"v":6864.8004540408265,"d":"6865"},{"v":30401.8534067565,"d":"30402"},"Kinexus","RpAb","RRL(pS)ACK(bA)C","Corresponds to amino acid residues R425 to K431; In the C-terminus of the kinase.","S428 phosphorylation stimulates phosphotransferase activity. Phosphorylation regulates cell growth, intracellular location and molecular association, including inducing interaction with STRAD and exportin 1. This is one of the minor in vivo phosphorylation sites in LKB1 (≥5 reports from high throughput mass spectrometry studies).","DNAPK (PRKDC); LKB1 (STK11); MSK1 (RPS6KA5); p70S6K (RPS6KB1); PKACa (PRKACA); PKCz (PRKCZ); RSK1 (RPS6KA1)","Q15831","Q15831",617,"Q15831","Q15831","NP_000446.1","Block4",12,5,"4, 12, 20, 28","LKB1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","LKB",{"$nulls":5},"Protein-serine kinase, CAMK group, CAMKL family, LKB subfamily","GO:0005737; GO:0005829; GO:0070062; GO:0016020; GO:0005739; GO:0005654; GO:0005634; GO:0036398","GO:0005524; GO:0030275; GO:0000287; GO:0002039; GO:0030295; GO:0004674","GO:0032147; GO:0043276; GO:0006914; GO:0007409; GO:0060070; GO:0007050; GO:0030154; GO:0006974; GO:0071493; GO:0097484; GO:0030010; GO:0042593; GO:0051645; GO:0072332; GO:0090090; GO:0030308; GO:0008285; GO:0120163; GO:0060770; GO:0051055; GO:1904262; GO:0007399; GO:0018105; GO:0018107; GO:0010508; GO:0050772; GO:0050731; GO:1900182; GO:0071902; GO:0030511; GO:0045059; GO:0046777; GO:0006470; GO:0006468; GO:0001558; GO:0048814; GO:0051896; GO:1901796; GO:0010212; GO:0007283; GO:0050852; GO:0036399; GO:0001894; GO:0001944"]
[1321,656,"PK191","LKB1 (STK11)","S428","Serine/threonine-protein kinase 11",{"v":1279.2544410397877,"d":"1279"},{"v":1147.9111621168238,"d":"1148"},{"v":604.0277841495304,"d":"604"},{"v":47.21717312613525,"d":"47"},{"v":182.87572210048273,"d":"183"},{"v":4074.3222822086864,"d":"4074"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues surrounding the phosphorylated Ser-431 of mouse LKB1.","S428 phosphorylation stimulates phosphotransferase activity. Phosphorylation regulates cell growth, intracellular location and molecular association, including inducing interaction with STRAD and exportin 1. This is one of the major in vivo phosphorylation sites in LKB1 (≥5 reports from high throughput mass spectrometry studies).","DNAPK (PRKDC); LKB1 (STK11); MSK1 (RPS6KA5); p70S6K (RPS6KB1); PKACa (PRKACA); PKCz (PRKCZ); RSK1 (RPS6KA1)","Q15831","Q15831",617,"Q15831","Q15831","NP_000446.1","Block4",12,6,"4, 12, 20, 28","LKB1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","LKB",{"$nulls":5},"Protein-serine kinase, CAMK group, CAMKL family, LKB subfamily","GO:0005737; GO:0005829; GO:0070062; GO:0016020; GO:0005739; GO:0005654; GO:0005634; GO:0036398","GO:0005524; GO:0030275; GO:0000287; GO:0002039; GO:0030295; GO:0004674","GO:0032147; GO:0043276; GO:0006914; GO:0007409; GO:0060070; GO:0007050; GO:0030154; GO:0006974; GO:0071493; GO:0097484; GO:0030010; GO:0042593; GO:0051645; GO:0072332; GO:0090090; GO:0030308; GO:0008285; GO:0120163; GO:0060770; GO:0051055; GO:1904262; GO:0007399; GO:0018105; GO:0018107; GO:0010508; GO:0050772; GO:0050731; GO:1900182; GO:0071902; GO:0030511; GO:0045059; GO:0046777; GO:0006470; GO:0006468; GO:0001558; GO:0048814; GO:0051896; GO:1901796; GO:0010212; GO:0007283; GO:0050852; GO:0036399; GO:0001894; GO:0001944"]
[1323,657,"NK384-1","LMR2 (LMTK2, KPI-2)","Pan-specific","Protein-serine/threonine kinase LMTK2",{"v":489.4574397971083,"d":"489"},{"v":450.61019451606523,"d":"451"},{"v":251.85184459116314,"d":"252"},{"v":51.455310332101945,"d":"51"},{"v":65.76747494967807,"d":"66"},{"v":1455.5877364730104,"d":"1456"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 15-148 mapping near the N-terminus of human KPI-2.",null,null,"Q8IWU2","Q8IWU2",827,"Q8IWU2",null,"NP_055731.2","Block4",12,7,"4, 12, 20, 28","LMR2","X","PSTK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Lmr",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.11.1; TK domain target; TK</A> group; Lmr family","GO:0005829; GO:0005769; GO:0005794; GO:0030426; GO:0016021; GO:0043025; GO:0048471; GO:0055037","GO:0005524; GO:0070853; GO:0004864; GO:0004674","GO:0045022; GO:0032456; GO:0018105; GO:0018107; GO:0046777; GO:0006468; GO:0001881; GO:0033572"]
[1325,658,"PK684","LMR2 (LMTK2, KPI-2)","S1450","Serine/threonine-protein kinase LMTK2",{"v":9075.48452178027,"d":"9075"},{"v":8895.694487768136,"d":"8896"},{"v":2664.2099533961627,"d":"2664"},{"v":29.356118089368348,"d":"29"},{"v":4376.996497328841,"d":"4377"},{"v":16334.747116559787,"d":"16335"},"Kinexus","RpAb","KYF(pS)PPP(bA)C","Corresponds to amino acid residues K1447 to P1453; Near the C-terminus of the protein kinase.","S1450 phosphorylation stimulates phosphotransferase activity. This is one of the major in vivo phosphorylation sites in LMR2 (≥19 reports from high throughput mass spectrometry studies).","CDK5","Q8IWU2","Q8IWU2",827,"Q8IWU2",null,"NP_055731.2","Block4",12,8,"4, 12, 20, 28","LMR2","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Lmr",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.11.1; TK domain target; TK</A> group; Lmr family","GO:0005829; GO:0005769; GO:0005794; GO:0030426; GO:0016021; GO:0043025; GO:0048471; GO:0055037","GO:0005524; GO:0070853; GO:0004864; GO:0004674","GO:0045022; GO:0032456; GO:0018105; GO:0018107; GO:0046777; GO:0006468; GO:0001881; GO:0033572"]
[1327,659,"PK685","LOK","S191","Lymphocyte-oriented protein-serine kinase; Serine-threonine-protein kinase 10",{"v":15457.259861141018,"d":"15457"},{"v":15304.360698798195,"d":"15304"},{"v":3269.169345166717,"d":"3269"},{"v":21.149734005477182,"d":"21"},{"v":8587.206790786227,"d":"8587"},{"v":27699.028056674917,"d":"27699"},"Kinexus","RpAb","KRD(pS)FIG(bA)C","Corresponds to amino acid residues K188 to G194; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S191 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in LOK (≥81 reports from high throughput mass spectrometry studies).",null,"O94804","O94804",761,"O94804",null,"NP_005981.3","Block4",12,9,"4, 12, 20, 28","LOK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","SLK",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; STE group; STE20 family; SLK subfamily","GO:0005737; GO:0070062; GO:0005886; GO:0035579","GO:0005524; GO:0042802; GO:0042803; GO:0004674","GO:0032147; GO:0007049; GO:0071593; GO:0043312; GO:0046777; GO:0006468; GO:0042981; GO:2000401; GO:0007346; GO:0023014; GO:0031098"]
[1329,660,"PK686","LOK","T952","Lymphocyte-oriented protein-serine kinase; Serine-threonine-protein kinase 10",{"v":2894.2152080541973,"d":"2894"},{"v":2829.733173263923,"d":"2830"},{"v":890.8858260038287,"d":"891"},{"v":30.781602678495286,"d":"31"},{"v":437.0458462076755,"d":"437"},{"v":5658.158407046665,"d":"5658"},"Kinexus","RpAb","NPS(pT)PSK(bA)C","Corresponds to amino acid residues N949 to K955; In the C-terminus of the kinase. This is the major in vivo site of phosphorylation in LOK.","The effect of T952 phosphorylation is unclear. This is the major in vivo phosphorylation site in LOK (≥109 reports from high throughput mass spectrometry studies).","ERK1 (MAPK3)","O94804","O94804",761,"O94804",null,"NP_005981.3","Block4",12,10,"4, 12, 20, 28","LOK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","SLK",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; STE group; STE20 family; SLK subfamily","GO:0005737; GO:0070062; GO:0005886; GO:0035579","GO:0005524; GO:0042802; GO:0042803; GO:0004674","GO:0032147; GO:0007049; GO:0071593; GO:0043312; GO:0046777; GO:0006468; GO:0042981; GO:2000401; GO:0007346; GO:0023014; GO:0031098"]
[1331,661,"NK303-1","LRRK2 (PARK8)","Pan-specific","Leucine-rich repeat protein-serine/threonine kinase 2",{"v":1290.6821919887464,"d":"1291"},{"v":1167.3402657980948,"d":"1167"},{"v":1061.7802520878402,"d":"1062"},{"v":82.26504236893493,"d":"82"},{"v":16.77685144279362,"d":"17"},{"v":8073.192151896912,"d":"8073"},"External","MmAb","Epitope undefined.",{"$nulls":3},"Q5S007","Q5S007",7124,"Q5S007",null,"NP_940980.3","Block4",12,11,"4, 12, 20, 28","LRRK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TLK","LRRK",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; TKL domain target; TKL</A> group; LRRK family","GO:0044753; GO:0044754; GO:0030424; GO:0099400; GO:0030054; GO:0005737; GO:0032473; GO:0031410; GO:0005829; GO:0030425; GO:0032839; GO:0005783; GO:0005768; GO:0070062; GO:0005615; GO:0098978; GO:0005794; GO:0005798; GO:0030426; GO:0016234; GO:0005622; GO:0043231; GO:0005764; GO:0005902; GO:0005743; GO:0005759; GO:0031966; GO:0005741; GO:0005739; GO:0097487; GO:0043025; GO:0043005; GO:0005634; GO:0043204; GO:0005886; GO:0098794; GO:0099523; GO:1990904; GO:0030672; GO:0043195; GO:0005802; GO:1990909","GO:0003779; GO:0005524; GO:1904713; GO:0030276; GO:0039706; GO:0005096; GO:0003924; GO:0005525; GO:0034211; GO:0042802; GO:0044325; GO:0016301; GO:0004708; GO:0008017; GO:0036479; GO:0042803; GO:0051018; GO:0004672; GO:0004674; GO:0030159; GO:0017048; GO:0000149; GO:0017075; GO:0015631","GO:0000187; GO:0000186; GO:0006914; GO:0019722; GO:0060070; GO:0034613; GO:1903351; GO:0071287; GO:0034599; GO:0009267; GO:0008340; GO:0006897; GO:0060079; GO:0035640; GO:0007030; GO:0046039; GO:0048312; GO:0035556; GO:0035641; GO:0007040; GO:0000165; GO:0051646; GO:0007005; GO:1902902; GO:1902236; GO:0090394; GO:0034260; GO:1903206; GO:1902823; GO:0016242; GO:1901215; GO:0010977; GO:0032091; GO:0001933; GO:0010955; GO:1903217; GO:1903215; GO:1903125; GO:0007528; GO:0070997; GO:0140058; GO:0048812; GO:0021772; GO:0018105; GO:0018107; GO:0016310; GO:0010508; GO:0090263; GO:0060161; GO:1901727; GO:0043406; GO:1903980; GO:0051770; GO:0043068; GO:0032436; GO:1902499; GO:0032092; GO:0033160; GO:0001934; GO:0031398; GO:1900244; GO:1904469; GO:0046777; GO:0070585; GO:0006468; GO:0072593; GO:0010506; GO:2000172; GO:1905289; GO:0060828; GO:0061001; GO:0060159; GO:0035564; GO:0040012; GO:0035751; GO:0042391; GO:0051900; GO:0090140; GO:1902692; GO:1901214; GO:0014041; GO:0010738; GO:1905279; GO:0051966; GO:2000300; GO:1902803; GO:0006979; GO:0007283; GO:0021756; GO:0022028; GO:1904887"]
[1333,662,"PK687","LTK","Y672","Leukocyte tyrosine kinase receptor",{"v":8874.764980087559,"d":"8875"},{"v":8305.83297195578,"d":"8306"},{"v":2391.6889218013566,"d":"2392"},{"v":26.949321217718154,"d":"27"},{"v":3002.246922405533,"d":"3002"},{"v":16237.22938990167,"d":"16237"},"Kinexus","RpAb","RDI(pY)RAS(bA)C","Corresponds to amino acid residues R669 to S675; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII. ","Y672 is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation site in LTK (≥24reports from high throughput mass spectrometry studies).",null,"P29376","P29376",1887,"P29376","P29376","NP_002335.2","Block4",12,12,"4, 12, 20, 28","LTK","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Alk",{"$nulls":6},"Receptor tyrosine kinase, TK group, Alk family","GO:0005887; GO:0005622; GO:0016020; GO:0005886","GO:0005524; GO:0004672; GO:0004713; GO:0004714","GO:0008283; GO:0071300; GO:0043066; GO:0014065; GO:0010666; GO:0010976; GO:0006468; GO:0007165; GO:0007169"]
[1335,663,"NK095","Lyn","Pan-specific","Yes-related protein-tyrosine kinase",{"v":529.1803116797187,"d":"529"},{"v":413.48094219194104,"d":"413"},{"v":637.6456723722627,"d":"638"},{"v":120.49686246796567,"d":"120"},{"v":75.45731318195098,"d":"75"},{"v":7855.841942335055,"d":"7856"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 44-63 near the N-terminus of human Lyn.",null,null,"P07948","P07948",618,"P07948","P07948","NP_002341","Block4",12,13,"4, 12, 20, 28","LYN","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; Src family","GO:0005913; GO:0005737; GO:0005829; GO:0070062; GO:0031234; GO:0098978; GO:0005794; GO:0034666; GO:0043231; GO:0042629; GO:0045121; GO:0030061; GO:0005758; GO:0005634; GO:0048471; GO:0005886; GO:0014069; GO:0099091","GO:0005524; GO:0019899; GO:0046875; GO:0043015; GO:0043208; GO:0005178; GO:0044325; GO:0016301; GO:0004715; GO:0051219; GO:0140031; GO:0005161; GO:0004713; GO:0017124; GO:0005102; GO:0031625","GO:0002250; GO:0001782; GO:0050853; GO:0007596; GO:0006974; GO:0031668; GO:0034605; GO:0071300; GO:0007417; GO:0050663; GO:0097028; GO:0048013; GO:0030218; GO:0038095; GO:0038096; GO:0002774; GO:0002431; GO:0002553; GO:0002768; GO:0006954; GO:0045087; GO:0060397; GO:0050900; GO:0031663; GO:0030889; GO:0008285; GO:0070373; GO:0050777; GO:1902532; GO:0043407; GO:0070667; GO:0002762; GO:0001933; GO:0034136; GO:0034144; GO:0031175; GO:0014003; GO:0038083; GO:0018108; GO:0030168; GO:0002576; GO:1902961; GO:0050861; GO:0030335; GO:0008284; GO:0051272; GO:2000670; GO:0060369; GO:0060252; GO:0070668; GO:0010976; GO:0070447; GO:0043552; GO:0001934; GO:0070304; GO:0042531; GO:0046777; GO:0006468; GO:0002902; GO:0050855; GO:0033628; GO:0001817; GO:0050707; GO:0070372; GO:0045646; GO:0050727; GO:0033003; GO:0043304; GO:0090025; GO:0090330; GO:0001932; GO:0051279; GO:0043200; GO:0048678; GO:0009743; GO:0042493; GO:0009725; GO:0032868; GO:0014070; GO:0006991; GO:0009636; GO:0007165; GO:0002223; GO:0031295; GO:0002513; GO:0007169; GO:0016032"]
[1337,664,"NK095-2","Lyn","Pan-specific","Yes-related protein-tyrosine kinase; Tyrosine-protein kinase Lyn",{"v":1823.7395818797486,"d":"1824"},{"v":1796.2898999994056,"d":"1796"},{"v":584.4629592850624,"d":"584"},{"v":32.047500920205394,"d":"32"},{"v":467.46425468337424,"d":"467"},{"v":4135.938088953792,"d":"4136"},"Kinexus","RpAb","CGVDLKTQPVRNTERTIYVR","Corresponds to amino acid residues G16 to R34; Post-N-terminus.",null,null,"P07948","P07948",618,"P07948","P07948","NP_002341","Block4",13,1,"4, 12, 20, 28","LYN","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; Src family","GO:0005913; GO:0005737; GO:0005829; GO:0070062; GO:0031234; GO:0098978; GO:0005794; GO:0034666; GO:0043231; GO:0042629; GO:0045121; GO:0030061; GO:0005758; GO:0005634; GO:0048471; GO:0005886; GO:0014069; GO:0099091","GO:0005524; GO:0019899; GO:0046875; GO:0043015; GO:0043208; GO:0005178; GO:0044325; GO:0016301; GO:0004715; GO:0051219; GO:0140031; GO:0005161; GO:0004713; GO:0017124; GO:0005102; GO:0031625","GO:0002250; GO:0001782; GO:0050853; GO:0007596; GO:0006974; GO:0031668; GO:0034605; GO:0071300; GO:0007417; GO:0050663; GO:0097028; GO:0048013; GO:0030218; GO:0038095; GO:0038096; GO:0002774; GO:0002431; GO:0002553; GO:0002768; GO:0006954; GO:0045087; GO:0060397; GO:0050900; GO:0031663; GO:0030889; GO:0008285; GO:0070373; GO:0050777; GO:1902532; GO:0043407; GO:0070667; GO:0002762; GO:0001933; GO:0034136; GO:0034144; GO:0031175; GO:0014003; GO:0038083; GO:0018108; GO:0030168; GO:0002576; GO:1902961; GO:0050861; GO:0030335; GO:0008284; GO:0051272; GO:2000670; GO:0060369; GO:0060252; GO:0070668; GO:0010976; GO:0070447; GO:0043552; GO:0001934; GO:0070304; GO:0042531; GO:0046777; GO:0006468; GO:0002902; GO:0050855; GO:0033628; GO:0001817; GO:0050707; GO:0070372; GO:0045646; GO:0050727; GO:0033003; GO:0043304; GO:0090025; GO:0090330; GO:0001932; GO:0051279; GO:0043200; GO:0048678; GO:0009743; GO:0042493; GO:0009725; GO:0032868; GO:0014070; GO:0006991; GO:0009636; GO:0007165; GO:0002223; GO:0031295; GO:0002513; GO:0007169; GO:0016032"]
[1339,665,"PK688","Lyn","Y508","Yes-related protein-tyrosine kinase; Tyrosine-protein kinase Lyn",{"v":16012.727185117343,"d":"16013"},{"v":15712.509056505623,"d":"15713"},{"v":3784.9317679158817,"d":"3785"},{"v":23.637021502706286,"d":"24"},{"v":6478.124113535401,"d":"6478"},{"v":28054.193908611705,"d":"28054"},"Kinexus","RpAb","EGQ(pY)QQQ(bA)C","Corresponds to amino acid residues E505 to Q511; Near the C-terminus of the kinase.","Y508 phosphorylation inhibits phosphotransferase activity. This is one of the major in vivo phosphorylation sites in Lyn (≥1583 reports from high throughput mass spectrometry studies).","CSK; CTK (MATK)","P07948","P07948",618,"P07948","P07948","NP_002341","Block4",13,2,"4, 12, 20, 28","LYN","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; Src family","GO:0005913; GO:0005737; GO:0005829; GO:0070062; GO:0031234; GO:0098978; GO:0005794; GO:0034666; GO:0043231; GO:0042629; GO:0045121; GO:0030061; GO:0005758; GO:0005634; GO:0048471; GO:0005886; GO:0014069; GO:0099091","GO:0005524; GO:0019899; GO:0046875; GO:0043015; GO:0043208; GO:0005178; GO:0044325; GO:0016301; GO:0004715; GO:0051219; GO:0140031; GO:0005161; GO:0004713; GO:0017124; GO:0005102; GO:0031625","GO:0002250; GO:0001782; GO:0050853; GO:0007596; GO:0006974; GO:0031668; GO:0034605; GO:0071300; GO:0007417; GO:0050663; GO:0097028; GO:0048013; GO:0030218; GO:0038095; GO:0038096; GO:0002774; GO:0002431; GO:0002553; GO:0002768; GO:0006954; GO:0045087; GO:0060397; GO:0050900; GO:0031663; GO:0030889; GO:0008285; GO:0070373; GO:0050777; GO:1902532; GO:0043407; GO:0070667; GO:0002762; GO:0001933; GO:0034136; GO:0034144; GO:0031175; GO:0014003; GO:0038083; GO:0018108; GO:0030168; GO:0002576; GO:1902961; GO:0050861; GO:0030335; GO:0008284; GO:0051272; GO:2000670; GO:0060369; GO:0060252; GO:0070668; GO:0010976; GO:0070447; GO:0043552; GO:0001934; GO:0070304; GO:0042531; GO:0046777; GO:0006468; GO:0002902; GO:0050855; GO:0033628; GO:0001817; GO:0050707; GO:0070372; GO:0045646; GO:0050727; GO:0033003; GO:0043304; GO:0090025; GO:0090330; GO:0001932; GO:0051279; GO:0043200; GO:0048678; GO:0009743; GO:0042493; GO:0009725; GO:0032868; GO:0014070; GO:0006991; GO:0009636; GO:0007165; GO:0002223; GO:0031295; GO:0002513; GO:0007169; GO:0016032"]
[1341,666,"PN617","MAFG","S124","Transcription factor MafG",{"v":18315.27848421625,"d":"18315"},{"v":18134.229964455968,"d":"18134"},{"v":7566.863308036057,"d":"7567"},{"v":41.31448677975075,"d":"41"},{"v":5627.424466110489,"d":"5627"},{"v":52574.77112826647,"d":"52575"},"Kinexus","RpAb","TVAR(pS)PVAC","Corresponds to amino acid residues T120 to A127.","S124 phosphorylation stabilizes protein. This is the major in vivo phosphorylation site in MAFG (≥10 reports from high throughput mass spectrometry studies).",null,"O15525","O15525",12291,null,"O15525","NP_002350.1","Block4",13,3,"4, 12, 20, 28",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":5},"GO:0005654","GO:0003700; GO:0046982; GO:0000978; GO:0000981; GO:0001077","GO:0030534; GO:0007596; GO:0001701; GO:0042127; GO:0030641; GO:0045604"]
[1343,667,"PK689","MAK","T157","Male germ cell-associated protein-serine kinase",{"v":12718.649503871242,"d":"12719"},{"v":12570.443504443156,"d":"12570"},{"v":2963.6137853824075,"d":"2964"},{"v":23.301324440777748,"d":"23"},{"v":4247.269828329932,"d":"4247"},{"v":21479.554116206502,"d":"21480"},"Kinexus","RpAb","PPY(pT)DYV(bA)C","Corresponds to amino acid residues P154 to V160; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T157 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in MAK (≥616 reports from high throughput mass spectrometry studies).",null,"P20794","P20794",812,"P20794",null,"NP_005897.1","Block4",13,4,"4, 12, 20, 28","MAK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","RCK",{"$nulls":6},"Protein-serine kinase, CMGC group, RCK family","GO:0005930; GO:0005813; GO:0097542; GO:0005929; GO:0005737; GO:0030496; GO:0072686; GO:0031514; GO:0005634; GO:0032391; GO:0001917; GO:0001750","GO:0005524; GO:0046872; GO:0004672; GO:0004674; GO:0003713","GO:0030154; GO:0060271; GO:0035556; GO:0042073; GO:0007275; GO:1902856; GO:0045494; GO:0046777; GO:0006468; GO:0010468; GO:0006355; GO:0007283; GO:0006351"]
[1345,668,"NK097-2","MAPKAPK2 (RPS6KC1)","Pan-specific","Mitogen-activated protein kinase-activated protein kinase 2",{"v":932.9285408357534,"d":"933"},{"v":842.4417008367204,"d":"842"},{"v":511.9522117242611,"d":"512"},{"v":54.87582267186665,"d":"55"},{"v":84.35786314982482,"d":"84"},{"v":3374.751563570898,"d":"3375"},"Kinexus","RpAb","SRVLKEDKERWEDVKGC","Corresponds to amino acid residues S339 to K353.",null,null,"P49137","P49137",716,"P49137","P49137","NP_116584","Block4",13,5,"4, 12, 20, 28","MAPKAPK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","MAPKAPK","MAPKAPK",{"$nulls":5},"Protein-serine kinase, CAMK group, MAPKAPK family, MAPKAPK subfamily","GO:0005813; GO:0005737; GO:0005829; GO:0070062; GO:0005654; GO:0005634","GO:0005524; GO:0009931; GO:0005516; GO:0004683; GO:0051019; GO:0004672; GO:0004674","GO:0070935; GO:0000187; GO:0006974; GO:0035924; GO:0006954; GO:0048839; GO:0006691; GO:0044351; GO:0000165; GO:0038066; GO:0018105; GO:0042535; GO:0046777; GO:0006468; GO:1900034; GO:0032675; GO:0043488; GO:0032680; GO:0034097; GO:0032496; GO:0002224; GO:0048010"]
[1347,669,"NK097","MAPKAPK2 (RPS6KC1)","Pan-specific","Mitogen-activated protein kinase-activated protein kinase 2",{"v":928.3969604276236,"d":"928"},{"v":876.8180541295794,"d":"877"},{"v":498.69033814489114,"d":"499"},{"v":53.7152058226464,"d":"54"},{"v":201.21820127350787,"d":"201"},{"v":4726.5957605431795,"d":"4727"},"External","GpAb","Not precisely defined.","Antibody raised against amino acid residues at the C-terminus of human MAPKAPK2.",null,null,"P49137","P49137",716,"P49137","P49137","NP_116584","Block4",13,6,"4, 12, 20, 28","MAPKAPK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","MAPKAPK","MAPKAPK",{"$nulls":5},"Protein-serine kinase, CAMK group, MAPKAPK family, MAPKAPK subfamily","GO:0005813; GO:0005737; GO:0005829; GO:0070062; GO:0005654; GO:0005634","GO:0005524; GO:0009931; GO:0005516; GO:0004683; GO:0051019; GO:0004672; GO:0004674","GO:0070935; GO:0000187; GO:0006974; GO:0035924; GO:0006954; GO:0048839; GO:0006691; GO:0044351; GO:0000165; GO:0038066; GO:0018105; GO:0042535; GO:0046777; GO:0006468; GO:1900034; GO:0032675; GO:0043488; GO:0032680; GO:0034097; GO:0032496; GO:0002224; GO:0048010"]
[1349,670,"PK690","MAPKAPK2 (RPS6KC1)","T222","Mitogen-activated protein kinase-activated protein kinase 2",{"v":20807.660119776476,"d":"20808"},{"v":20399.270299466472,"d":"20399"},{"v":4908.300955283638,"d":"4908"},{"v":23.588913539675623,"d":"24"},{"v":7557.254267912258,"d":"7557"},{"v":40129.631118973295,"d":"40130"},"Kinexus","RpAb","SLT(pT)PCYT(bA)C","Corresponds to amino acid residues S219 to T226; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T222 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation sites in MAPKAPK2 (≥44 reports from high throughput mass spectrometry studies).","ERK1 (MAPK3); ERK2 (MAPK1); p38a MAPK (MAPK14)","P49137","P49137",716,"P49137","P49137","NP_116584","Block4",13,7,"4, 12, 20, 28","MAPKAPK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","MAPKAPK","MAPKAPK",{"$nulls":5},"Protein-serine kinase, CAMK group, MAPKAPK family, MAPKAPK subfamily","GO:0005813; GO:0005737; GO:0005829; GO:0070062; GO:0005654; GO:0005634","GO:0005524; GO:0009931; GO:0005516; GO:0004683; GO:0051019; GO:0004672; GO:0004674","GO:0070935; GO:0000187; GO:0006974; GO:0035924; GO:0006954; GO:0048839; GO:0006691; GO:0044351; GO:0000165; GO:0038066; GO:0018105; GO:0042535; GO:0046777; GO:0006468; GO:1900034; GO:0032675; GO:0043488; GO:0032680; GO:0034097; GO:0032496; GO:0002224; GO:0048010"]
[1351,671,"PK691","MAPKAPK2 (RPS6KC1)","Y225+T226","Mitogen-activated protein kinase-activated protein kinase 2",{"v":24369.75417249646,"d":"24370"},{"v":23592.309149428696,"d":"23592"},{"v":8932.39882867699,"d":"8932"},{"v":36.653627137355514,"d":"37"},{"v":231.0738518759913,"d":"231"},{"v":61403.7124778742,"d":"61404"},"Kinexus","RpAb","PC(pY)(pT)PYYV(bA)C","Corresponds to amino acid residues P223 to V230; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y225 phosphorylation has been reported to stimulate phosphotransferase activity. However, T226 phosphorylation is predicted to be inhibitory. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the minor in vivo phosphorylation sites in MAPKAPK2 (≥3 and ≥4 reports, respectively, from high throughput mass spectrometry studies).",null,"P49137","P49137",716,"P49137","P49137","NP_116584","Block4",13,8,"4, 12, 20, 28","MAPKAPK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","MAPKAPK","MAPKAPK",{"$nulls":5},"Protein-serine kinase, CAMK group, MAPKAPK family, MAPKAPK subfamily","GO:0005813; GO:0005737; GO:0005829; GO:0070062; GO:0005654; GO:0005634","GO:0005524; GO:0009931; GO:0005516; GO:0004683; GO:0051019; GO:0004672; GO:0004674","GO:0070935; GO:0000187; GO:0006974; GO:0035924; GO:0006954; GO:0048839; GO:0006691; GO:0044351; GO:0000165; GO:0038066; GO:0018105; GO:0042535; GO:0046777; GO:0006468; GO:1900034; GO:0032675; GO:0043488; GO:0032680; GO:0034097; GO:0032496; GO:0002224; GO:0048010"]
[1353,672,"PK192","MAPKAPK2 (RPS6KC1)","T334","Mitogen-activated protein kinase-activated protein kinase 2",{"v":959.4096809627872,"d":"959"},{"v":614.3365697552226,"d":"614"},{"v":2555.349905247341,"d":"2555"},{"v":266.3460621622033,"d":"266"},{"v":203.80315418565286,"d":"204"},{"v":26580.72474101985,"d":"26581"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the Thr-334 phosphosite.","T334 phosphorylation stimulates phosphotransferase activity. This is one of the major in vivo phosphorylation sites in MAPKAPK2 (≥36 reports from high throughput mass spectrometry studies).","ERK1 (MAPK3); ERK2 (MAPK1); p38a MAPK (MAPK14)","P49137","P49137",716,"P49137","P49137","NP_116584","Block4",13,9,"4, 12, 20, 28","MAPKAPK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","MAPKAPK","MAPKAPK",{"$nulls":5},"Protein-serine kinase, CAMK group, MAPKAPK family, MAPKAPK subfamily","GO:0005813; GO:0005737; GO:0005829; GO:0070062; GO:0005654; GO:0005634","GO:0005524; GO:0009931; GO:0005516; GO:0004683; GO:0051019; GO:0004672; GO:0004674","GO:0070935; GO:0000187; GO:0006974; GO:0035924; GO:0006954; GO:0048839; GO:0006691; GO:0044351; GO:0000165; GO:0038066; GO:0018105; GO:0042535; GO:0046777; GO:0006468; GO:1900034; GO:0032675; GO:0043488; GO:0032680; GO:0034097; GO:0032496; GO:0002224; GO:0048010"]
[1355,673,"PK692","MAPKAPK3","Y76","MAP kinase-activated protein kinase 3",{"v":11056.780480160822,"d":"11057"},{"v":11215.997826727898,"d":"11216"},{"v":2562.5594991828043,"d":"2563"},{"v":23.176362267305606,"d":"23"},{"v":2786.8412197027556,"d":"2787"},{"v":17864.81496153917,"d":"17865"},"Kinexus","RpAb","KLL(pY)DSP(bA)C","Corresponds to amino acid residues K73 to P79; In the protein kinase catalytic domain in subdomain II. ","The effect of Y76 phosphorylation is unclear. This is the major in vivo site of phosphorylation of MAPKAPK3 (≥93 reports from high throughput mass spectrometry studies).",null,"Q16644","Q16644",717,"Q16644","Q16644","NP_001230854.1","Block4",13,10,"4, 12, 20, 28","MAPKAPK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","MAPKAPK","MAPKAPK",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; MAPKAPK family; MAPKAPK subfamily","GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0009931; GO:0005516; GO:0004683; GO:0004708; GO:0051019; GO:0004674","GO:0000187; GO:0007166; GO:0044351; GO:0018105; GO:0046777; GO:0034097; GO:0032496; GO:0007165; GO:0002224; GO:0048010"]
[1357,674,"PK693","MAPKAPK5 (PRAK)","T186","MAP kinase-activated protein kinase 5",{"v":11708.357604890092,"d":"11708"},{"v":11613.386298846366,"d":"11613"},{"v":2127.024043566897,"d":"2127"},{"v":18.166715737128904,"d":"18"},{"v":2850.581375845879,"d":"2851"},{"v":20409.264876363235,"d":"20409"},"Kinexus","RpAb","PQF(pT)PYYV(bA)C","Corresponds to amino acid residues P183 to V190; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T186 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the less major in vivo phosphorylation sites in MAPKAPK5 (≥11 reports from high throughput mass spectrometry studies).",null,"Q8IW41","Q8IW41",649,"Q8IW41",null,"NP_620777.1","Block4",13,11,"4, 12, 20, 28","MAPKAPK5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","MAPKAPK","MAPKAPK",{"$nulls":5},"Protein-serine kinase, CAMK group, MAPKAPK family, MAPKAPK subfamily","GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0009931; GO:0005516; GO:0004683; GO:0004708; GO:0051019; GO:0002039; GO:0004674","GO:0007166; GO:0032007; GO:0018105; GO:0051973; GO:1904355; GO:0032212; GO:0046777; GO:0007265; GO:1901796; GO:0006417; GO:0007165; GO:0090400"]
[1359,675,"NK098-2","MARK1","Pan-specific","MAP/microtubule affinity-regulating protein-serine kinase 1",{"v":1760.8225678243336,"d":"1761"},{"v":1661.1206992925063,"d":"1661"},{"v":711.3855598518832,"d":"711"},{"v":40.40075206049118,"d":"40"},{"v":493.9763917333404,"d":"494"},{"v":4411.910916136107,"d":"4412"},"Kinexus","RpAb","YTEPHIQPTKSSSRQNIPRC","Corresponds to amino acid residues Y24 to C43; Post-N-terminus.",null,null,"Q9P0L2","Q9P0L2",2100,"Q9P0L2",null,"NP_061120.3","Block4",13,12,"4, 12, 20, 28","MARK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","MARK",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; CAMK domain target; CAMK</A> group; CAMKL family; MARK subfamily","GO:0005737; GO:0005856; GO:0030425; GO:0015630; GO:0005886","GO:0005524; GO:0000287; GO:0070300; GO:0005546; GO:0001786; GO:0004674; GO:0050321","GO:0007010; GO:0030010; GO:0051654; GO:0035556; GO:0000226; GO:0001764; GO:0018105; GO:0006468; GO:0050773; GO:0010975; GO:0016055"]
[1361,676,"PK695","MARK1","T215","MAP/microtubule affinity-regulating protein-serine kinase 1",{"v":16799.901741910653,"d":"16800"},{"v":16666.60050459207,"d":"16667"},{"v":3485.7928523850096,"d":"3486"},{"v":20.74888833241813,"d":"21"},{"v":4563.164868299056,"d":"4563"},{"v":27226.59134735769,"d":"27227"},"Kinexus","RpAb","KLD(pT)FCG(bA)C","Corresponds to amino acid residues N211 to F216; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII. ","T215 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation site in MARK1 (≥75 reports from high throughput mass spectrometry studies).","LKB1 (STK11); TAO1 (TAOK1/MAP3K16)","Q9P0L2","Q9P0L2",2099,"Q9P0L2",null,"NP_061120.3","Block4",13,13,"4, 12, 20, 28","MARK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","MARK",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; CAMK domain target; CAMK</A> group; CAMKL family; MARK subfamily","GO:0005737; GO:0005856; GO:0030425; GO:0015630; GO:0005886","GO:0005524; GO:0000287; GO:0070300; GO:0005546; GO:0001786; GO:0004674; GO:0050321","GO:0007010; GO:0030010; GO:0051654; GO:0035556; GO:0000226; GO:0001764; GO:0018105; GO:0006468; GO:0050773; GO:0010975; GO:0016055"]
[1363,677,"NK275-1","MARK2","Pan-specific","MAP/microtubule affinity-regulating protein-serine kinase 2",{"v":632.2418384440759,"d":"632"},{"v":608.6721888906311,"d":"609"},{"v":309.62429877716403,"d":"310"},{"v":48.97244692618541,"d":"49"},{"v":39.84338113692336,"d":"40"},{"v":1815.3533626753092,"d":"1815"},"Kinexus","RpAb","PTLGHLDSKPSSKSNMIRGC","Corresponds to amino acid residues P19 to G37; Post-N-terminus.",null,null,"Q7KZI7","Q7KZI7",2099,"Q7KZI7",null,"NP_001034558.2","Block5",1,1,"5, 13, 21, 29","MARK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","MARK",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; CAMKL family; MARK subfamily","GO:0005884; GO:0005737; GO:0030425; GO:0016328; GO:0016020; GO:0097427; GO:0005739; GO:0005654; GO:0005886","GO:0005524; GO:0045296; GO:0008289; GO:0000287; GO:0030295; GO:0004674; GO:0003723; GO:0048156; GO:0050321","GO:0032147; GO:0000422; GO:0061564; GO:0030010; GO:0071963; GO:0045197; GO:0035556; GO:0000226; GO:0051646; GO:0001764; GO:0018105; GO:0018107; GO:0010976; GO:0046777; GO:0006468; GO:0050770; GO:0051493; GO:1904526; GO:0070507; GO:0016055"]
[1365,678,"NK275-2","MARK2","Pan-specific","MAP/microtubule affinity-regulating protein-serine kinase 2",{"v":5185.980396848023,"d":"5186"},{"v":5211.135027255641,"d":"5211"},{"v":1856.7491919912322,"d":"1857"},{"v":35.80324355101192,"d":"36"},{"v":139.5749686090799,"d":"140"},{"v":10776.499969814387,"d":"10776"},"Kinexus","RpAb","CGGNDKEKEEFREAKP","Corresponds to amino acid residues G676 to P690; Pre-C-terminus.",null,null,"Q7KZI7","Q7KZI7",2099,"Q7KZI7",null,"NP_001034558.2","Block5",1,2,"5, 13, 21, 29","MARK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","MARK",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; CAMKL family; MARK subfamily","GO:0005884; GO:0005737; GO:0030425; GO:0016328; GO:0016020; GO:0097427; GO:0005739; GO:0005654; GO:0005886","GO:0005524; GO:0045296; GO:0008289; GO:0000287; GO:0030295; GO:0004674; GO:0003723; GO:0048156; GO:0050321","GO:0032147; GO:0000422; GO:0061564; GO:0030010; GO:0071963; GO:0045197; GO:0035556; GO:0000226; GO:0051646; GO:0001764; GO:0018105; GO:0018107; GO:0010976; GO:0046777; GO:0006468; GO:0050770; GO:0051493; GO:1904526; GO:0070507; GO:0016055"]
[1367,679,"NK276-1","MARK3","Pan-specific","MAP/microtubule affinity-regulating protein-serine kinase 3",{"v":294.6857791380474,"d":"295"},{"v":253.56619208959322,"d":"254"},{"v":181.8979137449034,"d":"182"},{"v":61.72605759156507,"d":"62"},{"v":45.43121197871184,"d":"45"},{"v":999.5917667497222,"d":"1000"},"Kinexus","RpAb","HGDGRQEVTSRTSRSGARC","Corresponds to amino acid residues H21 to C39; Post-N-terminus.",null,null,"P27448","P27448",721,"P27448",null,"NP_001122390.2","Block5",1,3,"5, 13, 21, 29","MARK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","MARK",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; CAMKL family; MARK subfamily","GO:0005737; GO:0005829; GO:0030425; GO:0070062; GO:0005886","GO:0005524; GO:0004674; GO:0050321","GO:0030010; GO:0000165; GO:0000226; GO:0035331; GO:0036289; GO:0018105; GO:0032092; GO:0006468"]
[1369,680,"NK276-2","MARK3","Pan-specific","MAP/microtubule affinity-regulating protein-serine kinase 3",{"v":909.9124549787695,"d":"910"},{"v":839.3387281235196,"d":"839"},{"v":470.18699754805226,"d":"470"},{"v":51.67387202750433,"d":"52"},{"v":92.92729480641665,"d":"93"},{"v":2569.874905392192,"d":"2570"},"Kinexus","RpAb","RFIKRLPTEYERNGRYEGC","Corresponds to amino acid residues R620 to G637; Pre-C-terminus.",null,null,"P27448","P27448",721,"P27448",null,"NP_001122390.2","Block5",1,4,"5, 13, 21, 29","MARK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","MARK",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; CAMKL family; MARK subfamily","GO:0005737; GO:0005829; GO:0030425; GO:0070062; GO:0005886","GO:0005524; GO:0004674; GO:0050321","GO:0030010; GO:0000165; GO:0000226; GO:0035331; GO:0036289; GO:0018105; GO:0032092; GO:0006468"]
[1371,681,"PK697","MARK3","T507","MAP/microtubule affinity-regulating protein-serine kinase 3",{"v":11354.4260490972,"d":"11354"},{"v":11094.599916082394,"d":"11095"},{"v":2260.3720925549887,"d":"2260"},{"v":19.90740952278,"d":"20"},{"v":5843.828441424813,"d":"5844"},{"v":20274.06571239856,"d":"20274"},"Kinexus","RpAb","RRN(pT)YVC(bA)C","Corresponds to amino acid residues R504 to C510; In the C-terminal quarter of the protein kinase. This is the major in vivo phosphorylation site in MARK3.","The effect of T507 phosphorylation is unclear. This is the major in vivo phosphorylation site in MARK3 (≥317 reports from high throughput mass spectrometry studies).","PKACa (PRKACA)","P27448","P27448",721,"P27448",null,"NP_001122390.2","Block5",1,5,"5, 13, 21, 29","MARK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","MARK",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; CAMKL family; MARK subfamily","GO:0005737; GO:0005829; GO:0030425; GO:0070062; GO:0005886","GO:0005524; GO:0004674; GO:0050321","GO:0030010; GO:0000165; GO:0000226; GO:0035331; GO:0036289; GO:0018105; GO:0032092; GO:0006468"]
[1373,682,"NK277-1","MARK4","Pan-specific","MAP/microtubule affinity-regulating protein-serine kinase 4",{"v":1477.0184615268759,"d":"1477"},{"v":1341.0550652532438,"d":"1341"},{"v":648.1227882059194,"d":"648"},{"v":43.880479837463845,"d":"44"},{"v":207.0450353234312,"d":"207"},{"v":3682.831070075002,"d":"3683"},"Kinexus","RpAb","CGSGRSSDKGPSWSSRSLGA","Corresponds to amino acid residues G22 to C40; Post-N-terminus.",null,null,"Q96L34","Q96L34",823,"Q96L34","Q96L34","NP_001186796.1","Block5",1,6,"5, 13, 21, 29","MARK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","MARK",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; CAMKL family; MARK subfamily","GO:0005813; GO:0036064; GO:0005737; GO:0005829; GO:0030425; GO:0000930; GO:0015630; GO:0005815; GO:0030496; GO:0043005","GO:0005524; GO:0043015; GO:0008017; GO:0004674; GO:0050321; GO:0043130","GO:0007049; GO:0051301; GO:0097711; GO:0044782; GO:0030010; GO:0001578; GO:0000226; GO:0007399; GO:0045724; GO:0043068; GO:1904781; GO:0006468; GO:0046605"]
[1375,683,"NK277-2","MARK4","Pan-specific","MAP/microtubule affinity-regulating protein-serine kinase 4",{"v":1155.3139367358297,"d":"1155"},{"v":1115.7253036453603,"d":"1116"},{"v":559.2910739373834,"d":"559"},{"v":48.41031135810397,"d":"48"},{"v":114.52198629481198,"d":"115"},{"v":3439.2133823099266,"d":"3439"},"Kinexus","RpAb","CSSRTVLAPGNDRNSDTHGT","Corresponds to amino acid residues S2 to T20; N-terminus.",null,null,"Q96L34","Q96L34",823,"Q96L34","Q96L34","NP_001186796.1","Block5",1,7,"5, 13, 21, 29","MARK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","MARK",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; CAMKL family; MARK subfamily","GO:0005813; GO:0036064; GO:0005737; GO:0005829; GO:0030425; GO:0000930; GO:0015630; GO:0005815; GO:0030496; GO:0043005","GO:0005524; GO:0043015; GO:0008017; GO:0004674; GO:0050321; GO:0043130","GO:0007049; GO:0051301; GO:0097711; GO:0044782; GO:0030010; GO:0001578; GO:0000226; GO:0007399; GO:0045724; GO:0043068; GO:1904781; GO:0006468; GO:0046605"]
[1377,684,"PN759","MAT1A","T341","S-adenosylmethionine synthase isoform type-1",{"v":14881.59028831366,"d":"14882"},{"v":14733.438099332487,"d":"14733"},{"v":2855.1971831655937,"d":"2855"},{"v":19.18610261302347,"d":"19"},{"v":6495.605456454078,"d":"6496"},{"v":22968.523405223557,"d":"22969"},"Kinexus","RpAb","SQK(pT)ERE(bA)C","Corresponds to amino acid residues S338 to E344.","The effect of T341 phosphorylation is unclear. Phosphorylation at this site in MAT1A has only been reported in one mass spectrometry study. This human phosphosite is highly conserved in vertebrates and also found in yeast.",null,"Q00266","Q00266",5383,null,null,"NP_000420.1","Block5",1,8,"5, 13, 21, 29",{"$nulls":12},"X","Enzyme, transferase","GO:0005829","GO:0005524; GO:0042802; GO:0046872; GO:0004478; GO:0098601","GO:0009087; GO:0032259; GO:0006730; GO:0051289; GO:0006556; GO:0001887; GO:0000096"]
[1379,685,"PN235","MBP","T232","Myelin basic protein",{"v":74.13952415274916,"d":"74"},{"v":63.01641809918751,"d":"63"},{"v":43.886710549651205,"d":"44"},{"v":59.194756172472474,"d":"59"},{"v":20.6237283482539,"d":"21"},324,"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the Thr-125 phosphosite.","The effect of T232 phosphorylation is unclear. This is the main phosphosite targeted by the ERK1 and ERK2 MAP kinases. This is one of the less major in vivo phosphorylation sites in myelin basic protein (≥19 reports from high throughput mass spectrometry studies).","CDK9; ERK1 (MAPK3); ERK2 (MAPK1)","P02686","P02686",4588,null,null,"NP_001020272.1","Block5",1,9,"5, 13, 21, 29",{"$nulls":13},"Cytoskeletal protein","GO:0071944; GO:0043218; GO:0033269; GO:0005622; GO:0043209; GO:0043025; GO:0005634; GO:0005886; GO:0032991","GO:0005516; GO:0002020; GO:0019911","GO:0008366; GO:0007417; GO:0007268; GO:0006955; GO:0035633; GO:0000165; GO:0061024; GO:0042552; GO:0034115; GO:1904209; GO:2000778; GO:1904685; GO:0009636; GO:0007605; GO:0021762"]
[1381,686,"PN558","MBP","T232","Myelin basic protein",{"v":5140.8925757059715,"d":"5141"},{"v":4907.07444686521,"d":"4907"},{"v":1357.0023225818272,"d":"1357"},{"v":26.396239614002777,"d":"26"},{"v":2594.166985664274,"d":"2594"},{"v":10601.14685198215,"d":"10601"},"Kinexus","RpAb","VTPR(pT)PPP(bA)C     ","Corresponds to amino acid residues V228 to P235; In the middle of the Myelin_MBP domain in the C-terminal half of the protein.","The effect of T232 phosphorylation is unclear. This is the main phosphosite targeted by the ERK1 and ERK2 MAP kinases. This is one of the less major in vivo phosphorylation sites in myelin basic protein (≥19 reports from high throughput mass spectrometry studies).","CDK9; ERK1 (MAPK3); ERK2 (MAPK1)","P02686","P02686",4588,null,null,"NP_001020272.1","Block5",1,10,"5, 13, 21, 29",{"$nulls":13},"Cytoskeletal protein","GO:0071944; GO:0043218; GO:0033269; GO:0005622; GO:0043209; GO:0043025; GO:0005634; GO:0005886; GO:0032991","GO:0005516; GO:0002020; GO:0019911","GO:0008366; GO:0007417; GO:0007268; GO:0006955; GO:0035633; GO:0000165; GO:0061024; GO:0042552; GO:0034115; GO:1904209; GO:2000778; GO:1904685; GO:0009636; GO:0007605; GO:0021762"]
[1383,687,"PN618","MCM2","S40+S41","DNA replication licensing factor MCM2",{"v":983.2245594378998,"d":"983"},{"v":933.3391486270461,"d":"933"},{"v":452.2346836808547,"d":"452"},{"v":45.995055690979996,"d":"46"},{"v":90.54317196418809,"d":"91"},{"v":2671.5099394341496,"d":"2672"},"Kinexus","RpAb","DALT(pS)(pS)PGR(bA)C","Corresponds to amino acid residues D36 to R44.","S40 phosphorylation induces binding to DNA. S41 phosphorylation stimulates transcriptional activity and induces binding to DNA. These are two of the major in vivo phosphorylation sites in MCM2 (≥404 and ≥80 reports, respectively, from high throughput mass spectrometry studies).","S40: CDC7 (CDC7L1); CDK2; CDK7; CK2a1 (CSNK2A1). S41: CDC7 (CDC7L1); CDK1; CDK2; CDK7; CK2a1 (CSNK2A1).","P49736","P49736",2996,null,"P49736","NP_004517.2","Block5",1,11,"5, 13, 21, 29",{"$nulls":3},"DNA binding protein",{"$nulls":4},"X",{"$nulls":4},"DNA binding protein","GO:0000785; GO:0005737; GO:0042555; GO:0015630; GO:0000784; GO:0005664; GO:0005654; GO:0005634","GO:0005524; GO:0003677; GO:0003688; GO:0019899; GO:0004386; GO:0042393; GO:0046872","GO:0006915; GO:0071353; GO:0090102; GO:0006260; GO:0006270; GO:0006268; GO:0000082; GO:1905775; GO:0006334"]
[1385,688,"PN620","MCM2","Y137+S139","DNA replication licensing factor MCM2",{"v":17306.662251810387,"d":"17307"},{"v":17190.025645583424,"d":"17190"},{"v":4470.419165739294,"d":"4470"},{"v":25.830625805802963,"d":"26"},{"v":1926.1916752809122,"d":"1926"},{"v":34789.58102204998,"d":"34790"},"Kinexus","RpAb","CGLL(pY)D(pS)DEE","Corresponds to amino acid residues C134 to E142.","Y137 and S139 phosphorylation stimulates transcriptional activty and induces interaction with DNA. These are two of the major in vivo phosphorylation sites in MCM2.","S139: CDC7 (CDC7L1); CDK2; CDK7; CK2a1 (CSNK2A1); CK2a1 (CSNK2A1)","P49736","P49736",2996,null,"P49736","NP_004517.2","Block5",1,12,"5, 13, 21, 29",{"$nulls":3},"DNA binding protein",{"$nulls":4},"X",{"$nulls":4},"DNA binding protein","GO:0000785; GO:0005737; GO:0042555; GO:0015630; GO:0000784; GO:0005664; GO:0005654; GO:0005634","GO:0005524; GO:0003677; GO:0003688; GO:0019899; GO:0004386; GO:0042393; GO:0046872","GO:0006915; GO:0071353; GO:0090102; GO:0006260; GO:0006270; GO:0006268; GO:0000082; GO:1905775; GO:0006334"]
[1387,689,"NN428-1","MDM2","Pan-specific","E3 ubiquitin-protein ligase double minute 2 protein",{"v":228.63779711288228,"d":"229"},{"v":188.20258010534135,"d":"188"},{"v":187.59876078595843,"d":"188"},{"v":82.05063342756831,"d":"82"},{"v":22.41436023439691,"d":"22"},{"v":1978.3483925759342,"d":"1978"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 154-167 of human MDM2.",null,null,"Q00987","Q00987",997,null,"Q00987","XP_005268929.1","Block5",1,13,"5, 13, 21, 29",{"$nulls":3},"DNA binding protein",{"$nulls":9},"Ligase; Ubiquitin ligase; Inhibitor protein; Ubiquitin conjugating system; EC 6.3.2.-","GO:0005737; GO:0005829; GO:0030666; GO:0005730; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:0045202","GO:0008097; GO:0097718; GO:0019899; GO:0042802; GO:0016874; GO:0061663; GO:0002039; GO:0042975; GO:0019904; GO:0047485; GO:0033612; GO:0043021; GO:0097110; GO:0019789; GO:0043130; GO:0061630; GO:0031625; GO:0004842; GO:0008270","GO:1990000; GO:0003283; GO:0003181; GO:0001568; GO:0001974; GO:0060411; GO:0072717; GO:0071312; GO:0071391; GO:0071480; GO:0071363; GO:0070301; GO:0071456; GO:0071375; GO:0071494; GO:0071301; GO:0006977; GO:0003203; GO:0045184; GO:0071157; GO:0043154; GO:0043518; GO:1902254; GO:0010977; GO:0010955; GO:1901797; GO:0045892; GO:0000122; GO:0018205; GO:0008284; GO:0010628; GO:0045931; GO:0032436; GO:0046827; GO:1904754; GO:1904707; GO:0051865; GO:0065003; GO:0031648; GO:0016579; GO:0034504; GO:0016567; GO:0051603; GO:0002027; GO:0042176; GO:1901796; GO:0046677; GO:0042220; GO:0045472; GO:1904404; GO:0010039; GO:0032026; GO:0043278; GO:0048545; GO:1990785; GO:0036369; GO:0007089; GO:0006511; GO:0003281; GO:0016032"]
[1389,690,"PN169","MDM2","S166","E3 ubiquitin-protein ligase double minute 2 protein",{"v":3001.754889161604,"d":"3002"},{"v":2933.855429947883,"d":"2934"},{"v":1461.5681148800686,"d":"1462"},{"v":48.69045504539138,"d":"49"},{"v":38.51296671932422,"d":"39"},{"v":8776.680929714039,"d":"8777"},"External","RpAb","AI(pS)ET","Corresponds to amino acid residues A164 to T168.","S166 phosphorylation induces transcriptional activity and binding to ARF1 and p300. This is the major in vivo phosphorylation site in MDM2 (≥24 reports from high throughput mass spectrometry studies).","AKT1; CK1D; DAPK3; MAPKAPK2; PIM1; PKM","Q00987","Q00987",997,null,"Q00987","XP_005268929.1","Block5",2,1,"5, 13, 21, 29",{"$nulls":3},"DNA binding protein",{"$nulls":9},"Ligase; Ubiquitin ligase; Inhibitor protein; Ubiquitin conjugating system; EC 6.3.2.-","GO:0005737; GO:0005829; GO:0030666; GO:0005730; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:0045202","GO:0008097; GO:0097718; GO:0019899; GO:0042802; GO:0016874; GO:0061663; GO:0002039; GO:0042975; GO:0019904; GO:0047485; GO:0033612; GO:0043021; GO:0097110; GO:0019789; GO:0043130; GO:0061630; GO:0031625; GO:0004842; GO:0008270","GO:1990000; GO:0003283; GO:0003181; GO:0001568; GO:0001974; GO:0060411; GO:0072717; GO:0071312; GO:0071391; GO:0071480; GO:0071363; GO:0070301; GO:0071456; GO:0071375; GO:0071494; GO:0071301; GO:0006977; GO:0003203; GO:0045184; GO:0071157; GO:0043154; GO:0043518; GO:1902254; GO:0010977; GO:0010955; GO:1901797; GO:0045892; GO:0000122; GO:0018205; GO:0008284; GO:0010628; GO:0045931; GO:0032436; GO:0046827; GO:1904754; GO:1904707; GO:0051865; GO:0065003; GO:0031648; GO:0016579; GO:0034504; GO:0016567; GO:0051603; GO:0002027; GO:0042176; GO:1901796; GO:0046677; GO:0042220; GO:0045472; GO:1904404; GO:0010039; GO:0032026; GO:0043278; GO:0048545; GO:1990785; GO:0036369; GO:0007089; GO:0006511; GO:0003281; GO:0016032"]
[1391,691,"NN429-1","MEF2A","Pan-specific","Myocyte-specific enhancer factor 2A",{"v":186.83588891753624,"d":"187"},{"v":154.18741525839107,"d":"154"},{"v":142.69779701468107,"d":"143"},{"v":76.37600989907438,"d":"76"},{"v":30.65073439602375,"d":"31"},{"v":1647.1895603790413,"d":"1647"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 1-300 mapping at the N-terminus of human MEF-2A.",null,null,"Q02078","Q02078",998,null,null,"XP_011519883.1","Block5",2,2,"5, 13, 21, 29",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005829; GO:0000790; GO:0005654; GO:0005634; GO:0005667","GO:0033613; GO:0003682; GO:0003700; GO:0035035; GO:0042826; GO:0046982; GO:0019901; GO:0000978; GO:0000977; GO:0000981; GO:0001085; GO:0043565; GO:0046332; GO:0001077; GO:0003713; GO:0003705","GO:0006915; GO:0061337; GO:0071277; GO:0048813; GO:0070375; GO:0007507; GO:0000165; GO:0000002; GO:0048311; GO:0007517; GO:0000122; GO:0010613; GO:0046326; GO:0051149; GO:0045944; GO:0006351; GO:0055005"]
[1393,692,"PN622","MEF2A","T108","Myocyte-specific enhancer factor 2A",{"v":11048.124356313323,"d":"11048"},{"v":11974.880548560766,"d":"11975"},{"v":5669.508330253739,"d":"5670"},{"v":51.31647823111227,"d":"51"},{"v":8.02898221785889,"d":"8"},{"v":26300.431901495205,"d":"26300"},"Kinexus","RpAb","SYVL(pT)PHTE(bA)C","Corresponds to amino acid residues S104 to E112.","The effect of T108 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in MEF2A (≥26 reports from high throughput mass spectrometry studies).","p38a MAPK (MAPK14)","Q02078","Q02078",998,null,null,"XP_011519883.1","Block5",2,3,"5, 13, 21, 29",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005829; GO:0000790; GO:0005654; GO:0005634; GO:0005667","GO:0033613; GO:0003682; GO:0003700; GO:0035035; GO:0042826; GO:0046982; GO:0019901; GO:0000978; GO:0000977; GO:0000981; GO:0001085; GO:0043565; GO:0046332; GO:0001077; GO:0003713; GO:0003705","GO:0006915; GO:0061337; GO:0071277; GO:0048813; GO:0070375; GO:0007507; GO:0000165; GO:0000002; GO:0048311; GO:0007517; GO:0000122; GO:0010613; GO:0046326; GO:0051149; GO:0045944; GO:0006351; GO:0055005"]
[1395,693,"PN236","MEF2A","S387","Myocyte-specific enhancer factor 2A",{"v":630.8541723775711,"d":"631"},{"v":301.38079018843297,"d":"301"},{"v":2109.6727181999936,"d":"2110"},{"v":334.41527544298117,"d":"334"},{"v":57.589662558308355,"d":"58"},{"v":19775.507953228687,"d":"19776"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the Ser-387 phosphosite.","The effect of S387 phosphorylation is unclear. This phosphorylation site in MEF2C has apparently not been described from high throughput mass spectrometry studies.","ERK5 (MAPK7); p38a MAPK (MAPK14)","Q02078","Q02078",998,null,null,"XP_011519883.1","Block5",2,4,"5, 13, 21, 29",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005829; GO:0000790; GO:0005654; GO:0005634; GO:0005667","GO:0033613; GO:0003682; GO:0003700; GO:0035035; GO:0042826; GO:0046982; GO:0019901; GO:0000978; GO:0000977; GO:0000981; GO:0001085; GO:0043565; GO:0046332; GO:0001077; GO:0003713; GO:0003705","GO:0006915; GO:0061337; GO:0071277; GO:0048813; GO:0070375; GO:0007507; GO:0000165; GO:0000002; GO:0048311; GO:0007517; GO:0000122; GO:0010613; GO:0046326; GO:0051149; GO:0045944; GO:0006351; GO:0055005"]
[1397,694,"PN623","MEF2C","S396","Myocyte-specific enhancer factor 2C",{"v":8338.759464847019,"d":"8339"},{"v":7936.0136548066685,"d":"7936"},{"v":2645.061246594103,"d":"2645"},{"v":31.72008087947203,"d":"32"},{"v":488.58586231192663,"d":"489"},{"v":18562.575012895206,"d":"18563"},"Kinexus","RpAb","SEPV(pS)PPRD(bA)C","Corresponds to amino acid residues S392 to D400.","S396 phosphorylation induces MEF2C transcriptional activity and facilitates its sumoylation at K391, which in turn recruits co-repressors to inhibit transcription. This is one of the less major in vivo phosphorylation sites in MEF2C (≥8 reports from high throughput mass spectrometry studies).","CDK1 (CDC2)","Q06413","Q06413",999,null,"Q06413","NP_001180279.1","Block5",2,5,"5, 13, 21, 29",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005737; GO:0005829; GO:0043231; GO:0016607; GO:0005654; GO:0005634; GO:0098794; GO:0032991; GO:0016528","GO:0033613; GO:0003680; GO:0003682; GO:0003677; GO:0003700; GO:0042826; GO:0071837; GO:0046982; GO:0000980; GO:0000978; GO:0000977; GO:0000981; GO:0001205; GO:0001077; GO:0000983; GO:0044212","GO:0006915; GO:0001782; GO:0042100; GO:0050853; GO:0001568; GO:0001974; GO:0014898; GO:0003211; GO:0060536; GO:0048667; GO:0071277; GO:0035690; GO:0071498; GO:0071222; GO:0071374; GO:0071560; GO:0035984; GO:0002062; GO:0048703; GO:0001958; GO:2001013; GO:0060079; GO:0002467; GO:0072102; GO:0007507; GO:0001947; GO:0006959; GO:0007611; GO:0000165; GO:0030318; GO:0030224; GO:0007521; GO:0007517; GO:0014902; GO:0043537; GO:0010629; GO:0043524; GO:0030279; GO:0000122; GO:1904753; GO:1905563; GO:1904706; GO:0072160; GO:0007399; GO:0014033; GO:0048666; GO:0030182; GO:0001764; GO:0001649; GO:0003151; GO:0030220; GO:0010694; GO:0030890; GO:2000987; GO:0030501; GO:2000727; GO:0060045; GO:0071864; GO:0010628; GO:2000111; GO:0043406; GO:0051149; GO:0045663; GO:0045666; GO:0045669; GO:0090073; GO:2001016; GO:0048643; GO:0045893; GO:0045944; GO:0003138; GO:2000311; GO:0060998; GO:0002634; GO:0045652; GO:0043523; GO:0046928; GO:2000310; GO:0060297; GO:0051963; GO:0060025; GO:0048167; GO:0051966; GO:0006355; GO:0061333; GO:0002931; GO:0060021; GO:0003139; GO:0003185; GO:0035914; GO:0007519; GO:0051145; GO:0055012"]
[1399,695,"PN624","MEF2D","S121","Myocyte-specific enhancer factor 2D",{"v":8194.386570603385,"d":"8194"},{"v":8164.229805677662,"d":"8164"},{"v":1662.065397668874,"d":"1662"},{"v":20.282975221493484,"d":"20"},{"v":3874.5185386621542,"d":"3875"},{"v":15635.957150307655,"d":"15636"},"Kinexus","RpAb","YRRA(pS)EELD(bA)C","Corresponds to amino acid residues Y117 to D125.","S121 phosphorylation inhibits MEF2D transcriptional activity from the myogenin promoter. This is one of the major in vivo phosphorylation sites in MEF2D (≥37 reports from high throughput mass spectrometry studies).",null,"Q14814","Q14814",3154,null,"Q14814","NP_005911.1","Block5",2,6,"5, 13, 21, 29",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005737; GO:0043231; GO:0005654; GO:0005634","GO:0033613; GO:0003700; GO:0042826; GO:0046982; GO:0042803; GO:0000978; GO:0000977; GO:0000981; GO:0001077","GO:0007512; GO:0006915; GO:0002062; GO:0001958; GO:0007517; GO:0007399; GO:0001649; GO:0045944; GO:1904707; GO:0035914"]
[1401,696,"PN625","MEF2D","S180","Myocyte-specific enhancer factor 2D",{"v":8603.15160002509,"d":"8603"},{"v":8643.876028798455,"d":"8644"},{"v":1899.718412166371,"d":"1900"},{"v":22.08165682167952,"d":"22"},{"v":974.6113227922881,"d":"975"},{"v":14841.033786106098,"d":"14841"},"Kinexus","RpAb","PRLL(pS)PQQ(bA)C","Corresponds to amino acid residues P176 to Q183.","S180 phosphorylation stimulates transcriptional activity. This is the major in vivo phosphorylation site in MEF2D (≥51 reports from high throughput mass spectrometry studies).","ERK5 (MAPK7)","Q14814","Q14814",3154,null,"Q14814","NP_005911.1","Block5",2,7,"5, 13, 21, 29",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005737; GO:0043231; GO:0005654; GO:0005634","GO:0033613; GO:0003700; GO:0042826; GO:0046982; GO:0042803; GO:0000978; GO:0000977; GO:0000981; GO:0001077","GO:0007512; GO:0006915; GO:0002062; GO:0001958; GO:0007517; GO:0007399; GO:0001649; GO:0045944; GO:1904707; GO:0035914"]
[1403,697,"NK099-10","MEK1 (MKK1, MAP2K1)","Pan-specific","MAPK/ERK dual-specificity kinase 1",{"v":103.29967990086817,"d":"103"},{"v":88.52660300049806,"d":"89"},{"v":65.4585529259787,"d":"65"},{"v":63.36762416766071,"d":"63"},{"v":21.649600559058413,"d":"22"},{"v":552.0840001547655,"d":"552"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 1-393 representing full length human MEK1.",null,null,"Q02750","Q02750",619,"Q02750",null,"NP_002746","Block5",2,8,"5, 13, 21, 29","MEK1","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"Protein kinase, dual-specificity; EC 2.7.12.2; STE domain target; STE</A> group; STE7 family","GO:0005829; GO:0005769; GO:0005783; GO:0005925; GO:0005794; GO:0005770; GO:0005815; GO:0005739; GO:0005634; GO:0005886","GO:0005524; GO:0004708; GO:0008022; GO:0004672; GO:0047485; GO:0004712; GO:0043539; GO:0004674; GO:0004713; GO:0097110","GO:0000187; GO:0060020; GO:0007050; GO:0048870; GO:0090398; GO:0021697; GO:0006935; GO:0060502; GO:0070371; GO:0060324; GO:0007507; GO:0030216; GO:0060711; GO:0000165; GO:0008285; GO:0010629; GO:0030182; GO:0018107; GO:0060674; GO:0050772; GO:0070374; GO:0010628; GO:1903800; GO:0071902; GO:0045893; GO:0006468; GO:0042981; GO:0048679; GO:2000641; GO:0090170; GO:0007346; GO:0032872; GO:0007165; GO:0048538; GO:0030878; GO:0060440"]
[1405,698,"NK099-7","MEK1 (MKK1, MAP2K1)","Pan-specific","MAPK/ERK protein-serine kinase 1 (MKK1); Dual specificity mitogen-activated protein kinase kinase 1",{"v":11656.814030915044,"d":"11657"},{"v":11801.114600385554,"d":"11801"},{"v":2344.4760302606296,"d":"2344"},{"v":20.112494066070223,"d":"20"},{"v":865.0536825209872,"d":"865"},{"v":17742.02905321416,"d":"17742"},"Kinexus","RpAb","CIGLNQPSTPTHAAGV","Corresponds to amino acid residues I379 to V393; C-terminus.",null,null,"Q02750","Q02750",619,"Q02750",null,"NP_002746","Block5",2,9,"5, 13, 21, 29","MEK1","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"Protein kinase, dual-specificity; EC 2.7.12.2; STE domain target; STE</A> group; STE7 family","GO:0005829; GO:0005769; GO:0005783; GO:0005925; GO:0005794; GO:0005770; GO:0005815; GO:0005739; GO:0005634; GO:0005886","GO:0005524; GO:0004708; GO:0008022; GO:0004672; GO:0047485; GO:0004712; GO:0043539; GO:0004674; GO:0004713; GO:0097110","GO:0000187; GO:0060020; GO:0007050; GO:0048870; GO:0090398; GO:0021697; GO:0006935; GO:0060502; GO:0070371; GO:0060324; GO:0007507; GO:0030216; GO:0060711; GO:0000165; GO:0008285; GO:0010629; GO:0030182; GO:0018107; GO:0060674; GO:0050772; GO:0070374; GO:0010628; GO:1903800; GO:0071902; GO:0045893; GO:0006468; GO:0042981; GO:0048679; GO:2000641; GO:0090170; GO:0007346; GO:0032872; GO:0007165; GO:0048538; GO:0030878; GO:0060440"]
[1407,699,"NK099-3","MEK1 (MKK1, MAP2K1)","Pan-specific","MAPK/ERK protein-serine kinase 1 (MKK1); Dual specificity mitogen-activated protein kinase kinase 1",{"v":2354.3953678369576,"d":"2354"},{"v":2276.3907933366468,"d":"2276"},{"v":912.7680426937922,"d":"913"},{"v":38.7686815546352,"d":"39"},{"v":225.11846164079464,"d":"225"},{"v":5646.150904532449,"d":"5646"},"Kinexus","RpAb","EFQDFVNKCLIKNPAERADLKC","Corresponds to amino acid residues E333 to K353; Kinase catalytic subdomain 11.",null,null,"Q02750","Q02750",619,"Q02750",null,"NP_002746","Block5",2,10,"5, 13, 21, 29","MEK1","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"Protein kinase, dual-specificity; EC 2.7.12.2; STE domain target; STE</A> group; STE7 family","GO:0005829; GO:0005769; GO:0005783; GO:0005925; GO:0005794; GO:0005770; GO:0005815; GO:0005739; GO:0005634; GO:0005886","GO:0005524; GO:0004708; GO:0008022; GO:0004672; GO:0047485; GO:0004712; GO:0043539; GO:0004674; GO:0004713; GO:0097110","GO:0000187; GO:0060020; GO:0007050; GO:0048870; GO:0090398; GO:0021697; GO:0006935; GO:0060502; GO:0070371; GO:0060324; GO:0007507; GO:0030216; GO:0060711; GO:0000165; GO:0008285; GO:0010629; GO:0030182; GO:0018107; GO:0060674; GO:0050772; GO:0070374; GO:0010628; GO:1903800; GO:0071902; GO:0045893; GO:0006468; GO:0042981; GO:0048679; GO:2000641; GO:0090170; GO:0007346; GO:0032872; GO:0007165; GO:0048538; GO:0030878; GO:0060440"]
[1409,700,"PK045-PN007","MEK1 (MKK1, MAP2K1)","S218+S222","MAPK/ERK protein-serine kinase 1 (MKK1); Dual specificity mitogen-activated protein kinase kinase 1",{"v":103.31197042481176,"d":"103"},{"v":59.55300552290295,"d":"60"},{"v":117.13163923759541,"d":"117"},{"v":113.376638501771,"d":"113"},{"v":7.306123872297887,"d":"7"},{"v":730.7343077020569,"d":"731"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S217 and S221 phosphosites.","S218 and S222 phosphorylation stimulates phosphotransferase activity and regulates cell cycle progression and cell growth. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major in vivo phosphorylation sites in MEK1 (≥84 and ≥213 reports, respectively, from high throughput mass spectrometry studies).","S218: A-Raf (RafA); B-Raf (RafB); COT (MAP3K8); MEKK1 (MAP3K1); Mos; Plk1; Raf1. S222: A-Raf (RafA); B-Raf (RafB); COT (MAP3K8); MEKK1 (MAP3K1); Mos; PDPK1 (PDK1); Plk1; Raf1.","Q02750","Q02750",619,"Q02750",null,"NP_002746","Block5",2,11,"5, 13, 21, 29","MEK1","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"Protein kinase, dual-specificity; EC 2.7.12.2; STE domain target; STE</A> group; STE7 family","GO:0005829; GO:0005769; GO:0005783; GO:0005925; GO:0005794; GO:0005770; GO:0005815; GO:0005739; GO:0005634; GO:0005886","GO:0005524; GO:0004708; GO:0008022; GO:0004672; GO:0047485; GO:0004712; GO:0043539; GO:0004674; GO:0004713; GO:0097110","GO:0000187; GO:0060020; GO:0007050; GO:0048870; GO:0090398; GO:0021697; GO:0006935; GO:0060502; GO:0070371; GO:0060324; GO:0007507; GO:0030216; GO:0060711; GO:0000165; GO:0008285; GO:0010629; GO:0030182; GO:0018107; GO:0060674; GO:0050772; GO:0070374; GO:0010628; GO:1903800; GO:0071902; GO:0045893; GO:0006468; GO:0042981; GO:0048679; GO:2000641; GO:0090170; GO:0007346; GO:0032872; GO:0007165; GO:0048538; GO:0030878; GO:0060440"]
[1411,701,"PK698","MEK1 (MKK1, MAP2K1)","S222","MAPK/ERK protein-serine kinase 1 (MKK1); Dual specificity mitogen-activated protein kinase kinase 1",{"v":1559.8396719184004,"d":"1560"},{"v":1373.6631582802293,"d":"1374"},{"v":991.8908947570487,"d":"992"},{"v":63.58928501524465,"d":"64"},{"v":69.39149939820615,"d":"69"},{"v":5105.9284638371455,"d":"5106"},"Kinexus","RpAb","MAN(pS)YIC(bA)C","Corresponds to amino acid residues M219 to S222; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S222 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation sites in MEK1 (≥213 reports from high throughput mass spectrometry studies).","A-Raf (RafA); B-Raf (RafB); COT (MAP3K8); MEKK1 (MAP3K1); Mos; PDPK1 (PDK1); Plk1; Raf1.","Q02750","Q02750",619,"Q02750",null,"NP_002746","Block5",2,12,"5, 13, 21, 29","MEK1","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"Protein kinase, dual-specificity; EC 2.7.12.2; STE domain target; STE</A> group; STE7 family","GO:0005829; GO:0005769; GO:0005783; GO:0005925; GO:0005794; GO:0005770; GO:0005815; GO:0005739; GO:0005634; GO:0005886","GO:0005524; GO:0004708; GO:0008022; GO:0004672; GO:0047485; GO:0004712; GO:0043539; GO:0004674; GO:0004713; GO:0097110","GO:0000187; GO:0060020; GO:0007050; GO:0048870; GO:0090398; GO:0021697; GO:0006935; GO:0060502; GO:0070371; GO:0060324; GO:0007507; GO:0030216; GO:0060711; GO:0000165; GO:0008285; GO:0010629; GO:0030182; GO:0018107; GO:0060674; GO:0050772; GO:0070374; GO:0010628; GO:1903800; GO:0071902; GO:0045893; GO:0006468; GO:0042981; GO:0048679; GO:2000641; GO:0090170; GO:0007346; GO:0032872; GO:0007165; GO:0048538; GO:0030878; GO:0060440"]
[1413,702,"PK193","MEK1 (MKK1, MAP2K1)","S222","MAPK/ERK protein-serine kinase 1 (MKK1); Dual specificity mitogen-activated protein kinase kinase 1",{"v":27.664020986112583,"d":"28"},{"v":24.76148326062104,"d":"25"},{"v":15.582688947561016,"d":"16"},{"v":56.32835861201656,"d":"56"},{"v":4.3868402384915886,"d":"4"},{"v":93.50696258646238,"d":"94"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues surrounding the phosphorylated Ser-222 of human MEK1.","S222 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in MEK1 (≥213 reports from high throughput mass spectrometry studies).","A-Raf (RafA); B-Raf (RafB); COT (MAP3K8); MEKK1 (MAP3K1); Mos; PDPK1 (PDK1); Plk1; Raf1.","Q02750","Q02750",619,"Q02750",null,"NP_002746","Block5",2,13,"5, 13, 21, 29","MEK1","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"Protein kinase, dual-specificity; EC 2.7.12.2; STE domain target; STE</A> group; STE7 family","GO:0005829; GO:0005769; GO:0005783; GO:0005925; GO:0005794; GO:0005770; GO:0005815; GO:0005739; GO:0005634; GO:0005886","GO:0005524; GO:0004708; GO:0008022; GO:0004672; GO:0047485; GO:0004712; GO:0043539; GO:0004674; GO:0004713; GO:0097110","GO:0000187; GO:0060020; GO:0007050; GO:0048870; GO:0090398; GO:0021697; GO:0006935; GO:0060502; GO:0070371; GO:0060324; GO:0007507; GO:0030216; GO:0060711; GO:0000165; GO:0008285; GO:0010629; GO:0030182; GO:0018107; GO:0060674; GO:0050772; GO:0070374; GO:0010628; GO:1903800; GO:0071902; GO:0045893; GO:0006468; GO:0042981; GO:0048679; GO:2000641; GO:0090170; GO:0007346; GO:0032872; GO:0007165; GO:0048538; GO:0030878; GO:0060440"]
[1415,703,"PK886","MEK1 (MKK1, MAP2K1)","T286","MAPK/ERK protein-serine kinase 1 (MKK1); Dual specificity mitogen-activated protein kinase kinase 1",{"v":1500.5766280708326,"d":"1501"},{"v":1367.5552310594721,"d":"1368"},{"v":956.6109288466889,"d":"957"},{"v":63.749555401014376,"d":"64"},{"v":62.87128168996044,"d":"63"},{"v":7396.906741075256,"d":"7397"},"Kinexus","RpAb","AAE(pT)PPR(bA)C","Corresponds to amino acid residues A283 to R289.","T286 phosphorylation inhibits phosphotransferase activity. This site has been reported to be phosphorylated by CDK1. It is likely phosphorylated by ERK1 and ERK2. T286 is one of the more common observed (≥21 reports) phosphosites by mass spectrometry.","CDK1 (CDC2); CDK5","Q02750","Q02750",619,"Q02750",null,"NP_002746","Block5",3,1,"5, 13, 21, 29","MEK1","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"Protein kinase, dual-specificity; EC 2.7.12.2; STE domain target; STE</A> group; STE7 family","GO:0005829; GO:0005769; GO:0005783; GO:0005925; GO:0005794; GO:0005770; GO:0005815; GO:0005739; GO:0005634; GO:0005886","GO:0005524; GO:0004708; GO:0008022; GO:0004672; GO:0047485; GO:0004712; GO:0043539; GO:0004674; GO:0004713; GO:0097110","GO:0000187; GO:0060020; GO:0007050; GO:0048870; GO:0090398; GO:0021697; GO:0006935; GO:0060502; GO:0070371; GO:0060324; GO:0007507; GO:0030216; GO:0060711; GO:0000165; GO:0008285; GO:0010629; GO:0030182; GO:0018107; GO:0060674; GO:0050772; GO:0070374; GO:0010628; GO:1903800; GO:0071902; GO:0045893; GO:0006468; GO:0042981; GO:0048679; GO:2000641; GO:0090170; GO:0007346; GO:0032872; GO:0007165; GO:0048538; GO:0030878; GO:0060440"]
[1417,704,"PK046-1","MEK1 (MKK1, MAP2K1)","T292","MAPK/ERK protein-serine kinase 1 (MKK1); Dual specificity mitogen-activated protein kinase kinase 1",{"v":2874.728726165975,"d":"2875"},{"v":2667.270067962524,"d":"2667"},{"v":1357.816350025657,"d":"1358"},{"v":47.23285149192412,"d":"47"},{"v":157.6817715544968,"d":"158"},{"v":8300.343377234105,"d":"8300"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the T292 phosphosite.","T292 phosphorylation increases molecular association with ERK2 and Raf1, but reduces interaction with ERK1 and phosphorylation of S298 by PAK isoforms. It promotes dephosphorylation of the activating residues S218 and S222. This is one of the minor in vivo phosphorylation sites in MEK1 (≥5 reports from high throughput mass spectrometry studies).","CDK1 (CDC2); CDK5; ERK1 (MAPK3); ERK2 (MAPK1); MEKK1 (MAP3K1)","Q02750","Q02750",619,"Q02750",null,"NP_002746","Block5",3,2,"5, 13, 21, 29","MEK1","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"Protein kinase, dual-specificity; EC 2.7.12.2; STE domain target; STE</A> group; STE7 family","GO:0005829; GO:0005769; GO:0005783; GO:0005925; GO:0005794; GO:0005770; GO:0005815; GO:0005739; GO:0005634; GO:0005886","GO:0005524; GO:0004708; GO:0008022; GO:0004672; GO:0047485; GO:0004712; GO:0043539; GO:0004674; GO:0004713; GO:0097110","GO:0000187; GO:0060020; GO:0007050; GO:0048870; GO:0090398; GO:0021697; GO:0006935; GO:0060502; GO:0070371; GO:0060324; GO:0007507; GO:0030216; GO:0060711; GO:0000165; GO:0008285; GO:0010629; GO:0030182; GO:0018107; GO:0060674; GO:0050772; GO:0070374; GO:0010628; GO:1903800; GO:0071902; GO:0045893; GO:0006468; GO:0042981; GO:0048679; GO:2000641; GO:0090170; GO:0007346; GO:0032872; GO:0007165; GO:0048538; GO:0030878; GO:0060440"]
[1419,705,"PK194","MEK1 (MKK1, MAP2K1)","S298","MAPK/ERK protein-serine kinase 1 (MKK1); Dual specificity mitogen-activated protein kinase kinase 1",{"v":1124.30278725105,"d":"1124"},{"v":1079.152151043026,"d":"1079"},{"v":611.9029222939655,"d":"612"},{"v":54.4251005363141,"d":"54"},{"v":70.60912810734483,"d":"71"},{"v":3507.098789487615,"d":"3507"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues surrounding the phosphorylated Ser-298 of human MEK1.","S298 phosphorylation stimulates phosphotransferase activity. Phosphorylation induces interaction with ERK1 and Raf1 and regulates cell growth. MAPK1/ERK2 phosphorylation of Thr-292 in response to cellular adhesion leads to inhibition of S298 phosphorylation by PAK. This is one of the minor in vivo phosphorylation sites in MEK1 (≥3 reports from high throughput mass spectrometry studies).","MEK1 (MAP2K1); PAK1; PAK2; PAK3 (STK4)","Q02750","Q02750",619,"Q02750",null,"NP_002746","Block5",3,3,"5, 13, 21, 29","MEK1","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"Protein kinase, dual-specificity; EC 2.7.12.2; STE domain target; STE</A> group; STE7 family","GO:0005829; GO:0005769; GO:0005783; GO:0005925; GO:0005794; GO:0005770; GO:0005815; GO:0005739; GO:0005634; GO:0005886","GO:0005524; GO:0004708; GO:0008022; GO:0004672; GO:0047485; GO:0004712; GO:0043539; GO:0004674; GO:0004713; GO:0097110","GO:0000187; GO:0060020; GO:0007050; GO:0048870; GO:0090398; GO:0021697; GO:0006935; GO:0060502; GO:0070371; GO:0060324; GO:0007507; GO:0030216; GO:0060711; GO:0000165; GO:0008285; GO:0010629; GO:0030182; GO:0018107; GO:0060674; GO:0050772; GO:0070374; GO:0010628; GO:1903800; GO:0071902; GO:0045893; GO:0006468; GO:0042981; GO:0048679; GO:2000641; GO:0090170; GO:0007346; GO:0032872; GO:0007165; GO:0048538; GO:0030878; GO:0060440"]
[1421,706,"PK048-1","MEK1 (MKK1, MAP2K1)","T386","MAPK/ERK protein-serine kinase 1 (MKK1); Dual specificity mitogen-activated protein kinase kinase 1",{"v":292.8831224663187,"d":"293"},{"v":224.15540091190297,"d":"224"},{"v":248.43981038699974,"d":"248"},{"v":84.8255810355102,"d":"85"},{"v":20.60547198793713,"d":"21"},{"v":1194.418096559768,"d":"1194"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the T386 phosphosite.","T386 phosphorylation may inhibit phosphotransferase activity and induces interaction with ERK2. This is one of the major in vivo phosphorylation sites in MEK1 (≥54 reports from high throughput mass spectrometry studies).","CDK1 (CDC2); CDK5; ERK1; ERK2","Q02750","Q02750",619,"Q02750",null,"NP_002746","Block5",3,4,"5, 13, 21, 29","MEK1","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"Protein kinase, dual-specificity; EC 2.7.12.2; STE domain target; STE</A> group; STE7 family","GO:0005829; GO:0005769; GO:0005783; GO:0005925; GO:0005794; GO:0005770; GO:0005815; GO:0005739; GO:0005634; GO:0005886","GO:0005524; GO:0004708; GO:0008022; GO:0004672; GO:0047485; GO:0004712; GO:0043539; GO:0004674; GO:0004713; GO:0097110","GO:0000187; GO:0060020; GO:0007050; GO:0048870; GO:0090398; GO:0021697; GO:0006935; GO:0060502; GO:0070371; GO:0060324; GO:0007507; GO:0030216; GO:0060711; GO:0000165; GO:0008285; GO:0010629; GO:0030182; GO:0018107; GO:0060674; GO:0050772; GO:0070374; GO:0010628; GO:1903800; GO:0071902; GO:0045893; GO:0006468; GO:0042981; GO:0048679; GO:2000641; GO:0090170; GO:0007346; GO:0032872; GO:0007165; GO:0048538; GO:0030878; GO:0060440"]
[1423,707,"NK100-5","MEK2 (MKK2, MAP2K2)","Pan-specific","MAPK/ERK protein-serine kinase 2 (MKK2); Dual specificity mitogen-activated protein kinase kinase 2",{"v":9691.360859752844,"d":"9691"},{"v":9638.389260194133,"d":"9638"},{"v":2329.7909108796034,"d":"2330"},{"v":24.03987370396008,"d":"24"},{"v":4201.781826799841,"d":"4202"},{"v":17917.057433720496,"d":"17917"},"Kinexus","RpAb","PNGVFTPDFQEFVNKC","Corresponds to amino acid residues P334 to C349.",null,null,"P36507","P36507",719,"P36507",null,"NP_109587.1","Block5",3,5,"5, 13, 21, 29","MEK2","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"Protein kinase, dual-specificity, STE group, STE7 family, N/A subfamily","GO:0005911; GO:0009898; GO:0005829; GO:0005769; GO:0005783; GO:0005576; GO:0005925; GO:0005794; GO:0005770; GO:0005874; GO:0005739; GO:0005634; GO:0048471; GO:0005778","GO:0005524; GO:0004708; GO:0046872; GO:0030165; GO:0004712; GO:0043539; GO:0004674; GO:0004713; GO:0097110","GO:0000187; GO:0070371; GO:0000165; GO:0010629; GO:0036289; GO:1903800; GO:0071902; GO:0045893; GO:0042981; GO:2000641; GO:0090170; GO:0007346; GO:0032872"]
[1425,708,"NK100-4","MEK2 (MKK2, MAP2K2)","Pan-specific","MAPK/ERK protein-serine kinase 2 (MKK2); Dual specificity mitogen-activated protein kinase kinase 2",{"v":7960.22044965094,"d":"7960"},{"v":7538.854931023281,"d":"7539"},{"v":2129.4399073140767,"d":"2129"},{"v":26.751016768730995,"d":"27"},{"v":3686.9633576681754,"d":"3687"},{"v":15540.279984635801,"d":"15540"},"Kinexus","RpAb","CLKMLTNHTFIKRSEV","Corresponds to amino acid residues L360 to V374; Kinase last alpha-chain.",null,null,"P36507","P36507",719,"P36507",null,"NP_109587.1","Block5",3,6,"5, 13, 21, 29","MEK2","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"Protein kinase, dual-specificity, STE group, STE7 family, N/A subfamily","GO:0005911; GO:0009898; GO:0005829; GO:0005769; GO:0005783; GO:0005576; GO:0005925; GO:0005794; GO:0005770; GO:0005874; GO:0005739; GO:0005634; GO:0048471; GO:0005778","GO:0005524; GO:0004708; GO:0046872; GO:0030165; GO:0004712; GO:0043539; GO:0004674; GO:0004713; GO:0097110","GO:0000187; GO:0070371; GO:0000165; GO:0010629; GO:0036289; GO:1903800; GO:0071902; GO:0045893; GO:0042981; GO:2000641; GO:0090170; GO:0007346; GO:0032872"]
[1427,709,"PK049-3","MEK2 (MKK2, MAP2K2)","T394","MAPK/ERK protein-serine kinase 2 (MKK2); Dual specificity mitogen-activated protein kinase kinase 2",{"v":210.332156287613,"d":"210"},{"v":142.0426908851471,"d":"142"},{"v":206.39979575044447,"d":"206"},{"v":98.13040449611931,"d":"98"},{"v":19.357758995639887,"d":"19"},{"v":1184.0693374694772,"d":"1184"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the T394 phosphosite.","The effect of T394 phosphorylation is unclear. However, based on similarity with the T386 phosphosite in MEK1, phosphorylation likely promotes binding to ERK2. This is one of the major in vivo phosphorylation sites in MEK2 (≥111 reports from high throughput mass spectrometry studies).","ERK2 (MAPK1)","P36507","P36507",719,"P36507",null,"NP_109587.1","Block5",3,7,"5, 13, 21, 29","MEK2","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"Protein kinase, dual-specificity, STE group, STE7 family, N/A subfamily","GO:0005911; GO:0009898; GO:0005829; GO:0005769; GO:0005783; GO:0005576; GO:0005925; GO:0005794; GO:0005770; GO:0005874; GO:0005739; GO:0005634; GO:0048471; GO:0005778","GO:0005524; GO:0004708; GO:0046872; GO:0030165; GO:0004712; GO:0043539; GO:0004674; GO:0004713; GO:0097110","GO:0000187; GO:0070371; GO:0000165; GO:0010629; GO:0036289; GO:1903800; GO:0071902; GO:0045893; GO:0042981; GO:2000641; GO:0090170; GO:0007346; GO:0032872"]
[1429,710,"PK049-2","MEK2 (MKK2, MAP2K2)","T394","MAPK/ERK protein-serine kinase 2 (MKK2); Dual specificity mitogen-activated protein kinase kinase 2",{"v":185.53531647764032,"d":"186"},{"v":111.59324363663498,"d":"112"},{"v":195.60458823203066,"d":"196"},{"v":105.4271455944636,"d":"105"},{"v":20.735613615520382,"d":"21"},{"v":1191.9960335509693,"d":"1192"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the T394 phosphosite.","The effect of T394 phosphorylation is unclear. However, based on similarity with the T386 phosphosite in MEK1, phosphorylation likely promotes binding to ERK2. This is one of the major in vivo phosphorylation sites in MEK2 (≥111 reports from high throughput mass spectrometry studies).","ERK2 (MAPK1)","P36507","P36507",719,"P36507",null,"NP_109587.1","Block5",3,8,"5, 13, 21, 29","MEK2","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"Protein kinase, dual-specificity, STE group, STE7 family, N/A subfamily","GO:0005911; GO:0009898; GO:0005829; GO:0005769; GO:0005783; GO:0005576; GO:0005925; GO:0005794; GO:0005770; GO:0005874; GO:0005739; GO:0005634; GO:0048471; GO:0005778","GO:0005524; GO:0004708; GO:0046872; GO:0030165; GO:0004712; GO:0043539; GO:0004674; GO:0004713; GO:0097110","GO:0000187; GO:0070371; GO:0000165; GO:0010629; GO:0036289; GO:1903800; GO:0071902; GO:0045893; GO:0042981; GO:2000641; GO:0090170; GO:0007346; GO:0032872"]
[1431,711,"NK104","MEK5 (MAP2K5, MKK5)","Pan-specific","MAPK/ERK protein-serine kinase 5 (MKK5); Dual specificity mitogen-activated protein kinase kinase 5",{"v":207.77933259380816,"d":"208"},{"v":134.19698502487773,"d":"134"},{"v":284.4466961106139,"d":"284"},{"v":136.89845499055687,"d":"137"},{"v":38.90673637630498,"d":"39"},{"v":3726.097889366628,"d":"3726"},"External","GpAb","Epitope undefined.",{"$nulls":3},"Q13163","Q13163",720,"Q13163","Q13163","NP_660143","Block5",3,9,"5, 13, 21, 29","MEK5","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"Protein kinase, dual-specificity; EC 2.7.12.2; STE domain target; STE</A> group; STE7 family","GO:0005737; GO:0005829; GO:0005634; GO:0005819","GO:0005524; GO:0046872; GO:0004672; GO:0004674; GO:0004713","GO:0000187; GO:0032147; GO:0071363; GO:0071499; GO:0070375; GO:0007507; GO:0090051; GO:2000342; GO:0043154; GO:2001240; GO:0034115; GO:0045415; GO:0032088; GO:0060761; GO:0000122; GO:0030307; GO:0050679; GO:0051247; GO:0045944; GO:0042981; GO:0007346; GO:0007165; GO:0023014; GO:0031098"]
[1433,712,"NK104-2","MEK5 (MAP2K5, MKK5)","Pan-specific","MAPK/ERK protein-serine kinase 5 (MKK5); Dual specificity mitogen-activated protein kinase kinase 5",{"v":85.45382775967104,"d":"85"},{"v":72.1037316235493,"d":"72"},{"v":46.47310226041448,"d":"46"},{"v":54.38387428485319,"d":"54"},{"v":22.12393476653362,"d":"22"},{"v":292.5461028055875,"d":"293"},"Kinexus","RpAb","AFEYEDEDGDRITVRSC","Corresponds to amino acid residues A59 to S74; Post-N-terminus.",null,null,"Q13163","Q13163",720,"Q13163","Q13163","NP_660143","Block5",3,10,"5, 13, 21, 29","MEK5","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"Protein kinase, dual-specificity; EC 2.7.12.2; STE domain target; STE</A> group; STE7 family","GO:0005737; GO:0005829; GO:0005634; GO:0005819","GO:0005524; GO:0046872; GO:0004672; GO:0004674; GO:0004713","GO:0000187; GO:0032147; GO:0071363; GO:0071499; GO:0070375; GO:0007507; GO:0090051; GO:2000342; GO:0043154; GO:2001240; GO:0034115; GO:0045415; GO:0032088; GO:0060761; GO:0000122; GO:0030307; GO:0050679; GO:0051247; GO:0045944; GO:0042981; GO:0007346; GO:0007165; GO:0023014; GO:0031098"]
[1435,713,"PK699","MEK5 (MAP2K5, MKK5)","S311","MAPK/ERK protein-serine kinase 5 (MKK5); Dual specificity mitogen-activated protein kinase kinase 5",{"v":8455.151619785202,"d":"8455"},{"v":8312.999838761563,"d":"8313"},{"v":2065.652037776851,"d":"2066"},{"v":24.430691851145394,"d":"24"},{"v":873.4475193388512,"d":"873"},{"v":14791.904633282666,"d":"14792"},"Kinexus","RpAb","LVN(pS)IAK(bA)C","Corresponds to amino acid residues L308 to K314; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S311 phosphorylation stimulates phosphotransferase activity and inhibits interaction with ERK5. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the main in vivo phosphorylation sites in MEK5 (≥5 reports from high throughput mass spectrometry studies).","MEKK2 (MAP3K2)","Q13163","Q13163",720,"Q13163","Q13163","NP_660143","Block5",3,11,"5, 13, 21, 29","MEK5","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"Protein kinase, dual-specificity; EC 2.7.12.2; STE domain target; STE</A> group; STE7 family","GO:0005737; GO:0005829; GO:0005634; GO:0005819","GO:0005524; GO:0046872; GO:0004672; GO:0004674; GO:0004713","GO:0000187; GO:0032147; GO:0071363; GO:0071499; GO:0070375; GO:0007507; GO:0090051; GO:2000342; GO:0043154; GO:2001240; GO:0034115; GO:0045415; GO:0032088; GO:0060761; GO:0000122; GO:0030307; GO:0050679; GO:0051247; GO:0045944; GO:0042981; GO:0007346; GO:0007165; GO:0023014; GO:0031098"]
[1437,714,"NK107-4","MEKK1 (MAP3K1)","Pan-specific","MAPK/ERK kinase kinase 1; Mitogen-activated protein kinase kinase kinase 1 [Fragment]",{"v":693.3170693877316,"d":"693"},{"v":551.9567716001792,"d":"552"},{"v":443.55589510836046,"d":"444"},{"v":63.975908670482426,"d":"64"},{"v":134.3594190446052,"d":"134"},{"v":2675.4649389895094,"d":"2675"},"External","RpAb","Epitope undefined.",{"$nulls":3},"Q13233","Q13233",1736,"Q13233","Q13233","XP_042066","Block5",3,12,"5, 13, 21, 29","MEKK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"EC 2.7.11.25; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE11 family","GO:0005737; GO:0005829","GO:0005524; GO:0004709; GO:0004672; GO:0019901; GO:0004674; GO:0008270","GO:0032147; GO:0071260; GO:0038095; GO:0002755; GO:0006468; GO:0042981; GO:0007346; GO:0023014; GO:0031098"]
[1439,715,"NK107-3","MEKK1 (MAP3K1)","Pan-specific","MAPK/ERK kinase kinase 1; Mitogen-activated protein kinase kinase kinase 1 [Fragment]",{"v":4665.150977691324,"d":"4665"},{"v":4589.646923665353,"d":"4590"},{"v":1184.2274724347474,"d":"1184"},{"v":25.3845476405309,"d":"25"},{"v":686.7490413325654,"d":"687"},{"v":8076.469208728853,"d":"8076"},"Kinexus","RpAb","CGSTHFTRMRRRLMAIAD","Corresponds to amino acid residues G35 to D51; N-terminus.",null,null,"Q13233","Q13233",1736,"Q13233","Q13233","XP_042066","Block5",3,13,"5, 13, 21, 29","MEKK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"EC 2.7.11.25; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE11 family","GO:0005737; GO:0005829","GO:0005524; GO:0004709; GO:0004672; GO:0019901; GO:0004674; GO:0008270","GO:0032147; GO:0071260; GO:0038095; GO:0002755; GO:0006468; GO:0042981; GO:0007346; GO:0023014; GO:0031098"]
[1441,716,"NK108-3","MEKK2 (MAP3K2)","Pan-specific","MAPK/ERK kinase kinase 2; Mitogen-activated protein kinase kinase kinase 2",{"v":7220.417851380194,"d":"7220"},{"v":6580.976523377006,"d":"6581"},{"v":2753.747162302941,"d":"2754"},{"v":38.13833519034577,"d":"38"},{"v":344.8018160055892,"d":"345"},{"v":15961.523378462856,"d":"15962"},"Kinexus","RpAb","CSSSPKKQNDVRVKFE","Corresponds to amino acid residues S39 to E45.",null,null,"Q9Y2U5","Q9Y2U5",841,"Q9Y2U5","Q9Y2U5","NP_006600","Block5",4,1,"5, 13, 21, 29","MEKK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.25; STE domain target; STE</A> group; STE11 family","GO:0005737; GO:0005829; GO:0005654","GO:0005524; GO:0004709; GO:0046872; GO:0004672; GO:0019901; GO:0004674","GO:0007257; GO:0000187; GO:0071260; GO:0045893; GO:0006468; GO:0042981; GO:0007346"]
[1443,717,"NK108-4","MEKK2 (MAP3K2)","Pan-specific","MAPK/ERK kinase kinase 2; Mitogen-activated protein kinase kinase kinase 2",{"v":4265.623134421063,"d":"4266"},{"v":4047.051404914583,"d":"4047"},{"v":1366.3489261895836,"d":"1366"},{"v":32.03163718716625,"d":"32"},{"v":482.68212323957346,"d":"483"},{"v":9269.56833982054,"d":"9270"},"Kinexus","RpAb","CLVINGSTQATNLEP","Corresponds to amino acid residues L119 to P132.",null,null,"Q9Y2U5","Q9Y2U5",841,"Q9Y2U5","Q9Y2U5","NP_006600","Block5",4,2,"5, 13, 21, 29","MEKK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.25; STE domain target; STE</A> group; STE11 family","GO:0005737; GO:0005829; GO:0005654","GO:0005524; GO:0004709; GO:0046872; GO:0004672; GO:0019901; GO:0004674","GO:0007257; GO:0000187; GO:0071260; GO:0045893; GO:0006468; GO:0042981; GO:0007346"]
[1445,718,"PK700","MEKK2 (MAP3K2)","S239","MAPK/ERK kinase kinase 2; Mitogen-activated protein kinase kinase kinase 2",{"v":10417.63576799312,"d":"10418"},{"v":10216.517902126805,"d":"10217"},{"v":2370.072582490926,"d":"2370"},{"v":22.750580220635825,"d":"23"},{"v":4274.355504563537,"d":"4274"},{"v":20690.142459371145,"d":"20690"},"Kinexus","RpAb","RAQ(pS)YPD(bA)C","Corresponds to amino acid residues R236 to D242; In the region between the PB1 domain and the protein kinase catalytic domain.","The effect of S239 phosphorylation is unclear. This is a major site of phosphorylation for MEKK2 (≥281 reports from high throughput mass spectrometry studies).",null,"Q9Y2U5","Q9Y2U5",841,"Q9Y2U5","Q9Y2U5","NP_006600","Block5",4,3,"5, 13, 21, 29","MEKK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.25; STE domain target; STE</A> group; STE11 family","GO:0005737; GO:0005829; GO:0005654","GO:0005524; GO:0004709; GO:0046872; GO:0004672; GO:0019901; GO:0004674","GO:0007257; GO:0000187; GO:0071260; GO:0045893; GO:0006468; GO:0042981; GO:0007346"]
[1447,719,"NK225-2","MEKK6 (MAP3K6)","Pan-specific","Mitogen-activated protein kinase kinase kinase 6",{"v":5723.0887912298995,"d":"5723"},{"v":5434.044476605461,"d":"5434"},{"v":1566.4754937767207,"d":"1566"},{"v":27.371154824248027,"d":"27"},{"v":2638.425200776543,"d":"2638"},{"v":11355.927360819358,"d":"11356"},"Kinexus","RpAb","CGKRSRSPSSPRHAPR","Corresponds to amino acid residues G909 to R923; Post-kinase last alpha-chain.",null,null,"O95382","O95382",710,"O95382","O95382","NP_004663.3","Block5",4,4,"5, 13, 21, 29","ASK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.25; STE group; STE11 family","GO:0005622","GO:0005524; GO:0000287; GO:0004709","GO:0007257; GO:0006468; GO:0007165"]
[1449,720,"NK229-2","MELK","Pan-specific","Maternal embryonic leucine zipper kinase",{"v":7582.646462106411,"d":"7583"},{"v":7447.465040411471,"d":"7447"},{"v":1839.807092766559,"d":"1840"},{"v":24.263390123235055,"d":"24"},{"v":3301.2616928441566,"d":"3301"},{"v":15336.629008391217,"d":"15337"},"Kinexus","RpAb","MKDYDELLKYYELHEC","Corresponds to amino acid residues M1 to E15; N-terminus.",null,null,"Q14680","Q14680",2101,"Q14680",null,"NP_001243614.1","Block5",4,5,"5, 13, 21, 29","MELK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","MELK",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; CAMK domain target; CAMK</A> group; CAMKL family; MELK subfamily","GO:0005938; GO:0016020; GO:0005634; GO:0005886","GO:0005524; GO:0005509; GO:0008289; GO:0004715; GO:0004674","GO:0006915; GO:0008283; GO:0000086; GO:0030097; GO:0035556; GO:0008631; GO:0061351; GO:0043065; GO:0046777"]
[1451,721,"NK229-3","MELK","Pan-specific","Maternal embryonic leucine zipper kinase",{"v":13084.558268452387,"d":"13085"},{"v":12924.965276596342,"d":"12925"},{"v":2590.7512324981026,"d":"2591"},{"v":19.800066455010185,"d":"20"},{"v":6763.9770734525155,"d":"6764"},{"v":21215.24500422268,"d":"21215"},"Kinexus","RpAb","CKKRISMKNLLNHPWI","Corresponds to amino acid residues K249 to I263; Kinase last alpha-chain.",null,null,"Q14680","Q14680",2101,"Q14680",null,"NP_001243614.1","Block5",4,6,"5, 13, 21, 29","MELK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","MELK",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; CAMK domain target; CAMK</A> group; CAMKL family; MELK subfamily","GO:0005938; GO:0016020; GO:0005634; GO:0005886","GO:0005524; GO:0005509; GO:0008289; GO:0004715; GO:0004674","GO:0006915; GO:0008283; GO:0000086; GO:0030097; GO:0035556; GO:0008631; GO:0061351; GO:0043065; GO:0046777"]
[1453,722,"PK701","MELK","Y438","Maternal embryonic leucine zipper kinase",{"v":1863.652925170936,"d":"1864"},{"v":1828.894102409322,"d":"1829"},{"v":777.4199909234019,"d":"777"},{"v":41.71484831877138,"d":"42"},{"v":84.50020689518323,"d":"85"},{"v":4584.450749294187,"d":"4584"},"Kinexus","RpAb","NEE(pY)FMF(bA)C","Corresponds to amino acid residues N435 to F441; In the C-terminal third of the protein kinase. ","The effect of Y438 phosphorylation is unclear. This is the major in vivo phosphorylation site in MELK (≥210 reports from high throughput mass spectrometry studies).",null,"Q14680","Q14680",2101,"Q14680",null,"NP_001243614.1","Block5",4,7,"5, 13, 21, 29","MELK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","MELK",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; CAMK domain target; CAMK</A> group; CAMKL family; MELK subfamily","GO:0005938; GO:0016020; GO:0005634; GO:0005886","GO:0005524; GO:0005509; GO:0008289; GO:0004715; GO:0004674","GO:0006915; GO:0008283; GO:0000086; GO:0030097; GO:0035556; GO:0008631; GO:0061351; GO:0043065; GO:0046777"]
[1455,723,"PK702","MERTK (MER)","Y749","Tyrosine-protein kinase Mer; Proto-oncogene tyrosine-protein kinase MER",{"v":4586.146999583925,"d":"4586"},{"v":4307.368869845428,"d":"4307"},{"v":1397.8876163188563,"d":"1398"},{"v":30.480654380369376,"d":"30"},{"v":1833.371731742405,"d":"1833"},{"v":10907.089953562161,"d":"10907"},"Kinexus","RpAb","KKI(pY)SGD(bA)C","Corresponds to amino acid residues K746 to D752; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y749 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in MERTK (≥445 reports from high throughput mass spectrometry studies).","MER (MERTK)","Q12866","Q12866",1891,"Q12866","Q12866","NP_006334.2","Block5",4,8,"5, 13, 21, 29","MERTK","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Axl",{"$nulls":6},"EC 2.7.10.1; Receptor tyrosine kinase; TK domain target; TK</A> group; Axl family","GO:0005737; GO:0005615; GO:0005887; GO:0001750; GO:0005886; GO:0016028","GO:0005524; GO:0004714","GO:0043277; GO:0007267; GO:0007166; GO:0050900; GO:0001779; GO:0001818; GO:2000107; GO:0051250; GO:0097350; GO:0006909; GO:0030168; GO:0050766; GO:0043491; GO:0006468; GO:0060041; GO:0032940; GO:0007283; GO:0034446; GO:0060068"]
[1457,724,"PK703","MERTK (MER)","Y749+Y753","Tyrosine-protein kinase Mer; Proto-oncogene tyrosine-protein kinase MER",{"v":11465.006558976787,"d":"11465"},{"v":11359.200111064263,"d":"11359"},{"v":1840.7221234100882,"d":"1841"},{"v":16.055133627192326,"d":"16"},{"v":4879.482707327175,"d":"4879"},{"v":17200.25955808372,"d":"17200"},"Kinexus","RpAb","KI(pY)SGD(pY)Y(bA)C","Corresponds to amino acid residues K747 to Y754; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y749 and Y753 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in MERTK (≥449 and ≥403 reports, respectively, from high throughput mass spectrometry studies).","Y749: MER (MERTK). Y753: MER (MERTK). ","Q12866","Q12866",1891,"Q12866","Q12866","NP_006334.2","Block5",4,9,"5, 13, 21, 29","MERTK","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Axl",{"$nulls":6},"EC 2.7.10.1; Receptor tyrosine kinase; TK domain target; TK</A> group; Axl family","GO:0005737; GO:0005615; GO:0005887; GO:0001750; GO:0005886; GO:0016028","GO:0005524; GO:0004714","GO:0043277; GO:0007267; GO:0007166; GO:0050900; GO:0001779; GO:0001818; GO:2000107; GO:0051250; GO:0097350; GO:0006909; GO:0030168; GO:0050766; GO:0043491; GO:0006468; GO:0060041; GO:0032940; GO:0007283; GO:0034446; GO:0060068"]
[1459,725,"PK704","MERTK (MER)","Y753","Tyrosine-protein kinase Mer; Proto-oncogene tyrosine-protein kinase MER",{"v":5662.275302251515,"d":"5662"},{"v":5651.745297648538,"d":"5652"},{"v":1406.0290322272995,"d":"1406"},{"v":24.831520142939958,"d":"25"},{"v":805.7652429865574,"d":"806"},{"v":9880.261002108331,"d":"9880"},"Kinexus","RpAb","SGD(pY)YRQG(bA)C","Corresponds to amino acid residues S750 to G757; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y753 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in MERTK (≥403 reports from high throughput mass spectrometry studies).","MER (MERTK)","Q12866","Q12866",1891,"Q12866","Q12866","NP_006334.2","Block5",4,10,"5, 13, 21, 29","MERTK","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Axl",{"$nulls":6},"EC 2.7.10.1; Receptor tyrosine kinase; TK domain target; TK</A> group; Axl family","GO:0005737; GO:0005615; GO:0005887; GO:0001750; GO:0005886; GO:0016028","GO:0005524; GO:0004714","GO:0043277; GO:0007267; GO:0007166; GO:0050900; GO:0001779; GO:0001818; GO:2000107; GO:0051250; GO:0097350; GO:0006909; GO:0030168; GO:0050766; GO:0043491; GO:0006468; GO:0060041; GO:0032940; GO:0007283; GO:0034446; GO:0060068"]
[1461,726,"NK110-2","Met","Pan-specific","Hepatocyte growth factor (HGF) receptor-tyrosine kinase",{"v":15633.086360504412,"d":"15633"},{"v":15180.611290761773,"d":"15181"},{"v":3365.281219936631,"d":"3365"},{"v":21.526659178693667,"d":"22"},{"v":9287.42956173704,"d":"9287"},{"v":28499.51219627132,"d":"28500"},"Kinexus","RpAb","CNVNMKYQLPNFTAET","Corresponds to amino acid residues N36 to T50; Post-N-terminus in the extracellular domain of the receptor.",null,null,"P08581","P08581",620,"P08581","P08581","NP_000236.2","Block5",4,11,"5, 13, 21, 29","MET","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Met",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; Met family","GO:0009925; GO:0009986; GO:0005576; GO:0016021; GO:0005887; GO:0005622; GO:0005886","GO:0005524; GO:0005008; GO:0042802; GO:0046934; GO:0019903; GO:0004713; GO:0005088","GO:0048754; GO:0008283; GO:0007166; GO:0001886; GO:0035635; GO:0061436; GO:0000165; GO:0010507; GO:1905098; GO:1901299; GO:0035024; GO:0051497; GO:0070495; GO:0050918; GO:2001028; GO:0031116; GO:0051897; GO:0045944; GO:0071526; GO:0007165"]
[1463,727,"NK110-3","Met","Pan-specific","Hepatocyte growth factor (HGF) receptor-tyrosine kinase",{"v":8967.709312682067,"d":"8968"},{"v":9072.382263175696,"d":"9072"},{"v":1649.4130817072926,"d":"1649"},{"v":18.392802712446365,"d":"18"},{"v":1777.5860348693332,"d":"1778"},{"v":12991.919869867888,"d":"12992"},"Kinexus","RpAb","CEMRPSFSELVSRISA","Corresponds to amino acid residues E1325 to A1349; In the C-terminal part of the cytoplasmic portion immediately after the kinase catalytic domain.",null,null,"P08581","P08581",620,"P08581","P08581","NP_000236.2","Block5",4,12,"5, 13, 21, 29","MET","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Met",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; Met family","GO:0009925; GO:0009986; GO:0005576; GO:0016021; GO:0005887; GO:0005622; GO:0005886","GO:0005524; GO:0005008; GO:0042802; GO:0046934; GO:0019903; GO:0004713; GO:0005088","GO:0048754; GO:0008283; GO:0007166; GO:0001886; GO:0035635; GO:0061436; GO:0000165; GO:0010507; GO:1905098; GO:1901299; GO:0035024; GO:0051497; GO:0070495; GO:0050918; GO:2001028; GO:0031116; GO:0051897; GO:0045944; GO:0071526; GO:0007165"]
[1465,728,"PK708","Met","Y1003","Hepatocyte growth factor (HGF) receptor-tyrosine kinase",{"v":7021.866322920836,"d":"7022"},{"v":6985.576719186709,"d":"6986"},{"v":1436.216861239281,"d":"1436"},{"v":20.45349192352423,"d":"20"},{"v":2015.10241701726,"d":"2015"},{"v":12245.33613512602,"d":"12245"},"Kinexus","RpAb","SVD(pY)RAT(bA)C","Corresponds to amino acid residues S1000 to T1006; In the region between the Transmembrane domain and the protein kinase catalytic domain.","Y1003 phosphorylation stimulates phosphotransferase activity and induces interaction with CBL, PTP1B and PTPN2. Phosphorylation regulates cell growth, receptor desensitization, protein stabililzation, and ubquitination. This is one of the major in vivo phosphorylation sites in Met (≥370 reports from high throughput mass spectrometry studies).","Met","P08581","P08581",620,"P08581","P08581","NP_000236.2","Block5",4,13,"5, 13, 21, 29","MET","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Met",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; Met family","GO:0009925; GO:0009986; GO:0005576; GO:0016021; GO:0005887; GO:0005622; GO:0005886","GO:0005524; GO:0005008; GO:0042802; GO:0046934; GO:0019903; GO:0004713; GO:0005088","GO:0048754; GO:0008283; GO:0007166; GO:0001886; GO:0035635; GO:0061436; GO:0000165; GO:0010507; GO:1905098; GO:1901299; GO:0035024; GO:0051497; GO:0070495; GO:0050918; GO:2001028; GO:0031116; GO:0051897; GO:0045944; GO:0071526; GO:0007165"]
[1467,729,"PK055-1","Met","Y1230+Y1234+Y1235","Hepatocyte growth factor (HGF) receptor-tyrosine kinase",{"v":382.8763744859523,"d":"383"},{"v":266.53258349497867,"d":"267"},{"v":601.7029845509674,"d":"602"},{"v":157.15333320286751,"d":"157"},{"v":11.39968670206057,"d":"11"},{"v":5177.770047538779,"d":"5178"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the Y1230 phosphosite.","Y1230, Y1234 and Y1235 phosphorylation stimulates phosphotransferase activity. Phosphorylation at Y1234 induces binding to Grb2, PTP1B and PTPN2. Phosphorylation at Y1235 induces binding to PTP1B and PTPN2. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are three of the major in vivo phosphorylation sites in Met (≥114, ≥746 and ≥446 reports, respectively, from high throughput mass spectrometry studies).","Y1230: Met. Y1234: Met; Ron (MST1R). Y1235: Met; Ron (MST1R). ","P08581","P08581",620,"P08581","P08581","NP_000236.2","Block5",5,1,"5, 13, 21, 29","MET","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Met",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; Met family","GO:0009925; GO:0009986; GO:0005576; GO:0016021; GO:0005887; GO:0005622; GO:0005886","GO:0005524; GO:0005008; GO:0042802; GO:0046934; GO:0019903; GO:0004713; GO:0005088","GO:0048754; GO:0008283; GO:0007166; GO:0001886; GO:0035635; GO:0061436; GO:0000165; GO:0010507; GO:1905098; GO:1901299; GO:0035024; GO:0051497; GO:0070495; GO:0050918; GO:2001028; GO:0031116; GO:0051897; GO:0045944; GO:0071526; GO:0007165"]
[1469,730,"PK709","Met","Y1230","Hepatocyte growth factor (HGF) receptor-tyrosine kinase",{"v":7918.61496164117,"d":"7919"},{"v":7745.287052336082,"d":"7745"},{"v":1838.4609804031509,"d":"1838"},{"v":23.216951314199537,"d":"23"},{"v":1072.2682854746465,"d":"1072"},{"v":13099.387931611702,"d":"13099"},"Kinexus","RpAb","M(pY)DKEYY(bA)C","Corresponds to amino acid residues M1229 to Y1235; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y1230 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major in vivo phosphorylation sites in MEK1 (≥114 reports from high throughput mass spectrometry studies).","Met","P08581","P08581",620,"P08581","P08581","NP_000236.2","Block5",5,2,"5, 13, 21, 29","MET","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Met",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; Met family","GO:0009925; GO:0009986; GO:0005576; GO:0016021; GO:0005887; GO:0005622; GO:0005886","GO:0005524; GO:0005008; GO:0042802; GO:0046934; GO:0019903; GO:0004713; GO:0005088","GO:0048754; GO:0008283; GO:0007166; GO:0001886; GO:0035635; GO:0061436; GO:0000165; GO:0010507; GO:1905098; GO:1901299; GO:0035024; GO:0051497; GO:0070495; GO:0050918; GO:2001028; GO:0031116; GO:0051897; GO:0045944; GO:0071526; GO:0007165"]
[1471,731,"PK710","Met","Y1234","Hepatocyte growth factor (HGF) receptor-tyrosine kinase",{"v":8143.587399653826,"d":"8144"},{"v":8146.311070611628,"d":"8146"},{"v":1717.0402367832303,"d":"1717"},{"v":21.084568170241774,"d":"21"},{"v":3371.478963849164,"d":"3371"},{"v":16420.93940862922,"d":"16421"},"Kinexus","RpAb","DKE(pY)YSV(bA)C","Corresponds to amino acid residues D1231 to V1237; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y1234 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation induces binding to Grb2, PTPN1 and PTPN2. This is one of the major in vivo phosphorylation sites in Met (≥746 reports from high throughput mass spectrometry studies).","Met; Ron (MST1R)","P08581","P08581",620,"P08581","P08581","NP_000236.2","Block5",5,3,"5, 13, 21, 29","MET","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Met",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; Met family","GO:0009925; GO:0009986; GO:0005576; GO:0016021; GO:0005887; GO:0005622; GO:0005886","GO:0005524; GO:0005008; GO:0042802; GO:0046934; GO:0019903; GO:0004713; GO:0005088","GO:0048754; GO:0008283; GO:0007166; GO:0001886; GO:0035635; GO:0061436; GO:0000165; GO:0010507; GO:1905098; GO:1901299; GO:0035024; GO:0051497; GO:0070495; GO:0050918; GO:2001028; GO:0031116; GO:0051897; GO:0045944; GO:0071526; GO:0007165"]
[1473,732,"PK711","Met","Y1234+Y1235","Hepatocyte growth factor (HGF) receptor-tyrosine kinase",{"v":9613.952464538255,"d":"9614"},{"v":9399.35494434575,"d":"9399"},{"v":1909.181454427554,"d":"1909"},{"v":19.85844491607073,"d":"20"},{"v":5574.65558151482,"d":"5575"},{"v":15485.875836307112,"d":"15486"},"Kinexus","RpAb","KE(pY)(pY)SVH(bA)C","Corresponds to amino acid residues K1232 to H1238; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y1234 and Y1235 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. Y1234 and Y1235 phosphorylation induces binding to PTPN1 and PTPN2, and Y1234 phosphorylation also induces interaction with Grb2. These are two of the major in vivo phosphorylation sites in Met (≥746 and ≥446 reports, respectively, from high throughput mass spectrometry studies).","Y1234: Met; Ron (MST1R). Y1235: Met; Ron (MST1R). ","P08581","P08581",620,"P08581","P08581","NP_000236.2","Block5",5,4,"5, 13, 21, 29","MET","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Met",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; Met family","GO:0009925; GO:0009986; GO:0005576; GO:0016021; GO:0005887; GO:0005622; GO:0005886","GO:0005524; GO:0005008; GO:0042802; GO:0046934; GO:0019903; GO:0004713; GO:0005088","GO:0048754; GO:0008283; GO:0007166; GO:0001886; GO:0035635; GO:0061436; GO:0000165; GO:0010507; GO:1905098; GO:1901299; GO:0035024; GO:0051497; GO:0070495; GO:0050918; GO:2001028; GO:0031116; GO:0051897; GO:0045944; GO:0071526; GO:0007165"]
[1475,733,"PK705","Met","S1236","Hepatocyte growth factor (HGF) receptor-tyrosine kinase",{"v":12887.577651042979,"d":"12888"},{"v":12628.600340706631,"d":"12629"},{"v":2648.5132914322226,"d":"2649"},{"v":20.550900744469082,"d":"21"},{"v":129.80207399499778,"d":"130"},{"v":25012.97892659632,"d":"25013"},"Kinexus","RpAb","EYY(pS)VHN(bA)C","Corresponds to amino acid residues E1233 to N1239; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Phosphorylation of S1236 is likely to stimulate phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in Met (≥178 reports from high throughput mass spectrometry studies).",null,"P08581","P08581",620,"P08581","P08581","NP_000236.2","Block5",5,5,"5, 13, 21, 29","MET","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Met",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; Met family","GO:0009925; GO:0009986; GO:0005576; GO:0016021; GO:0005887; GO:0005622; GO:0005886","GO:0005524; GO:0005008; GO:0042802; GO:0046934; GO:0019903; GO:0004713; GO:0005088","GO:0048754; GO:0008283; GO:0007166; GO:0001886; GO:0035635; GO:0061436; GO:0000165; GO:0010507; GO:1905098; GO:1901299; GO:0035024; GO:0051497; GO:0070495; GO:0050918; GO:2001028; GO:0031116; GO:0051897; GO:0045944; GO:0071526; GO:0007165"]
[1477,734,"PK706","Met","T1241","Hepatocyte growth factor (HGF) receptor-tyrosine kinase",{"v":5440.974686707502,"d":"5441"},{"v":5333.4923583796035,"d":"5333"},{"v":1629.6765115310952,"d":"1630"},{"v":29.95192231848558,"d":"30"},{"v":2052.1944829720746,"d":"2052"},{"v":11399.589105441708,"d":"11400"},"Kinexus","RpAb","VHNK(pT)GAK(bA)C","Corresponds to amino acid residues V1237 to K1244; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T1241 phosphorylation is likely to stimulate phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is a minor in vivo phosphorylation sites in Met (≥5 reports from high throughput mass spectrometry studies).",null,"P08581","P08581",620,"P08581","P08581","NP_000236.2","Block5",5,6,"5, 13, 21, 29","MET","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Met",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; Met family","GO:0009925; GO:0009986; GO:0005576; GO:0016021; GO:0005887; GO:0005622; GO:0005886","GO:0005524; GO:0005008; GO:0042802; GO:0046934; GO:0019903; GO:0004713; GO:0005088","GO:0048754; GO:0008283; GO:0007166; GO:0001886; GO:0035635; GO:0061436; GO:0000165; GO:0010507; GO:1905098; GO:1901299; GO:0035024; GO:0051497; GO:0070495; GO:0050918; GO:2001028; GO:0031116; GO:0051897; GO:0045944; GO:0071526; GO:0007165"]
[1479,735,"PK707","Met","T1355+Y1356","Hepatocyte growth factor (HGF) receptor-tyrosine kinase",{"v":1325.7111043592834,"d":"1326"},{"v":1174.7553379119759,"d":"1175"},{"v":933.8206496716607,"d":"934"},{"v":70.43922666114926,"d":"70"},{"v":283.1877463780917,"d":"283"},{"v":8349.284359026846,"d":"8349"},"Kinexus","RpAb","NA(pT)(pY)VNV(bA)C","Corresponds to amino acid residues N1353 to V1359; In the C-terminus of the kinase. ","Y1356 phosphorylation stimulates phosphotransferase activity, and induces binding to FAK, GAB1, Grb2, INPPL1 (SHIP2), Met, PI3R1; PLCG1;  Ron; Shc1 and Src.  Y1356 is one of the major in vivo phosphorylation sites in Met (≥119 reports from high throughput mass spectrometry studies), whereas T1355 is less frequently observed (≥40 reports). The effect of T1355 phosphorylation is unknown.","Abl1; Met; Ron (MST1R)","P08581","P08581",620,"P08581","P08581","NP_000236.2","Block5",5,7,"5, 13, 21, 29","MET","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Met",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; Met family","GO:0009925; GO:0009986; GO:0005576; GO:0016021; GO:0005887; GO:0005622; GO:0005886","GO:0005524; GO:0005008; GO:0042802; GO:0046934; GO:0019903; GO:0004713; GO:0005088","GO:0048754; GO:0008283; GO:0007166; GO:0001886; GO:0035635; GO:0061436; GO:0000165; GO:0010507; GO:1905098; GO:1901299; GO:0035024; GO:0051497; GO:0070495; GO:0050918; GO:2001028; GO:0031116; GO:0051897; GO:0045944; GO:0071526; GO:0007165"]
[1481,736,"PN626","MITF","S414","Microphthalmia-associated transcription factor",{"v":13518.200514671642,"d":"13518"},{"v":13214.071190708091,"d":"13214"},{"v":3114.4424098750146,"d":"3114"},{"v":23.03888307097407,"d":"23"},{"v":6250.020420411297,"d":"6250"},{"v":23684.604402345914,"d":"23685"},"Kinexus","RpAb","TGLA(pS)PDL(bA)C","Corresponds to amino acid residues T410 to D417.","The effect of S414 phosphorylation is unclear. This is the major in vivo phosphorylation sites in MITF (≥24 reports from high throughput mass spectrometry studies).","p38a MAPK (MAPK14)","O75030","O75030",1001,null,"O75030","NP_937802.1","Block5",5,8,"5, 13, 21, 29",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005654; GO:0005634; GO:0032991","GO:0003682; GO:0070888; GO:0046983; GO:0000978; GO:0000981; GO:0001077; GO:0001227; GO:0003705","GO:0046849; GO:0043010; GO:0044336; GO:0045165; GO:0030318; GO:0030336; GO:0000122; GO:0030316; GO:2000144; GO:0010628; GO:0045893; GO:0045944; GO:0065003; GO:0042127; GO:0045670; GO:2001141; GO:0006355"]
[1483,737,"NK101-3","MKK3 (MAP2K3, MEK3)","Pan-specific","MAPK/ERK protein-serine kinase 3 beta isoform (MKK3 beta); Dual specificity mitogen-activated protein kinase kinase 3",{"v":1170.9213328027386,"d":"1171"},{"v":1033.1901601737882,"d":"1033"},{"v":583.690115528869,"d":"584"},{"v":49.848789938068485,"d":"50"},{"v":137.20203866900684,"d":"137"},{"v":3794.406685577923,"d":"3794"},"External","RpAb","Epitope undefined.",{"$nulls":3},"P46734","P46734",621,"P46734",null,"NP_002747","Block5",5,9,"5, 13, 21, 29","MKK3","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"Protein kinase, dual-specificity, STE group, STE7 family, N/A subfamily","GO:0005737; GO:0005829; GO:0016020; GO:0005654","GO:0005524; GO:0004708; GO:0019901; GO:0004674; GO:0004713","GO:0000187; GO:0032147; GO:0060048; GO:0035924; GO:0006954; GO:0038066; GO:0043536; GO:0045860; GO:0045893; GO:0042981; GO:0042035; GO:0007346; GO:0007165; GO:0023014; GO:0031098"]
[1485,738,"NK101-4","MKK3 (MAP2K3, MEK3)","Pan-specific","MAPK/ERK protein-serine kinase 3 beta isoform (MKK3 beta); Dual specificity mitogen-activated protein kinase kinase 3",{"v":6862.351446720336,"d":"6862"},{"v":6739.447884886188,"d":"6739"},{"v":1715.8348742968917,"d":"1716"},{"v":25.003599533173514,"d":"25"},{"v":3203.2403793528238,"d":"3203"},{"v":12835.012022999093,"d":"12835"},"Kinexus","RpAb","SRTFITIGDRNFEVEA","Corresponds to amino acid residues S46 to A61.",null,null,"P46734","P46734",621,"P46734",null,"NP_002747","Block5",5,10,"5, 13, 21, 29","MKK3","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"Protein kinase, dual-specificity, STE group, STE7 family, N/A subfamily","GO:0005737; GO:0005829; GO:0016020; GO:0005654","GO:0005524; GO:0004708; GO:0019901; GO:0004674; GO:0004713","GO:0000187; GO:0032147; GO:0060048; GO:0035924; GO:0006954; GO:0038066; GO:0043536; GO:0045860; GO:0045893; GO:0042981; GO:0042035; GO:0007346; GO:0007165; GO:0023014; GO:0031098"]
[1487,739,"NK101-5","MKK3 (MAP2K3, MEK3)","Pan-specific","MAPK/ERK protein-serine kinase 3 beta isoform (MKK3 beta); Dual specificity mitogen-activated protein kinase kinase 3",{"v":12795.621888110902,"d":"12796"},{"v":12504.616443912942,"d":"12505"},{"v":2583.587958747207,"d":"2584"},{"v":20.191187121180544,"d":"20"},{"v":7785.149524129086,"d":"7785"},{"v":23350.57931486738,"d":"23351"},"Kinexus","RpAb","CAERMSYLELMEHPFF","Corresponds to amino acid residues A311 to F325; Kinase last alpha-chain.",null,null,"P46734","P46734",621,"P46734",null,"NP_002747","Block5",5,11,"5, 13, 21, 29","MKK3","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"Protein kinase, dual-specificity, STE group, STE7 family, N/A subfamily","GO:0005737; GO:0005829; GO:0016020; GO:0005654","GO:0005524; GO:0004708; GO:0019901; GO:0004674; GO:0004713","GO:0000187; GO:0032147; GO:0060048; GO:0035924; GO:0006954; GO:0038066; GO:0043536; GO:0045860; GO:0045893; GO:0042981; GO:0042035; GO:0007346; GO:0007165; GO:0023014; GO:0031098"]
[1489,740,"PK051-4","MKK3 (MAP2K3, MEK3)","S218","MAPK/ERK protein-serine kinase 3 beta isoform (MKK3 beta); Dual specificity mitogen-activated protein kinase kinase 3",{"v":327.12859239276685,"d":"327"},{"v":270.61696458804624,"d":"271"},{"v":269.60490709211257,"d":"270"},{"v":82.4155739857834,"d":"82"},{"v":9.300884196939645,"d":"9"},{"v":1538.690317007618,"d":"1539"},"External","RpAb","VD(pS)VA","Corresponds to amino acid residues V187 to A199.","S218 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in MKK3 (≥74 reports from high throughput mass spectrometry studies).","ASK1 (MAP3K5); COT (MAP3K8); MEKK3 (MAP3K3); MKK3 (MAP2K3, MEK3); MLK3 (MAP3K11)","P46734","P46734",621,"P46734",null,"NP_002747","Block5",5,12,"5, 13, 21, 29","MKK3","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"Protein kinase, dual-specificity, STE group, STE7 family, N/A subfamily","GO:0005737; GO:0005829; GO:0016020; GO:0005654","GO:0005524; GO:0004708; GO:0019901; GO:0004674; GO:0004713","GO:0000187; GO:0032147; GO:0060048; GO:0035924; GO:0006954; GO:0038066; GO:0043536; GO:0045860; GO:0045893; GO:0042981; GO:0042035; GO:0007346; GO:0007165; GO:0023014; GO:0031098"]
[1491,741,"PK713","MKK3 (MAP2K3, MEK3)","S218","MAPK/ERK protein-serine kinase 3 beta isoform (MKK3 beta); Dual specificity mitogen-activated protein kinase kinase 3",{"v":30476.105379812594,"d":"30476"},{"v":29462.391531355566,"d":"29462"},{"v":10519.531190232014,"d":"10520"},{"v":34.51730809803592,"d":"35"},{"v":9843.451261891914,"d":"9843"},{"v":69431.73333873221,"d":"69432"},"Kinexus","RpAb","YLVD(pS)VAK(bA)C","Corresponds to amino acid residues Y214 to K221; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S218 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in MKK3 (≥74 reports from high throughput mass spectrometry studies).","ASK1 (MAP3K5); COT (MAP3K8); MEKK3 (MAP3K3); MKK3 (MAP2K3, MEK3); MLK3 (MAP3K11)","P46734","P46734",621,"P46734",null,"NP_002747","Block5",5,13,"5, 13, 21, 29","MKK3","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"Protein kinase, dual-specificity, STE group, STE7 family, N/A subfamily","GO:0005737; GO:0005829; GO:0016020; GO:0005654","GO:0005524; GO:0004708; GO:0019901; GO:0004674; GO:0004713","GO:0000187; GO:0032147; GO:0060048; GO:0035924; GO:0006954; GO:0038066; GO:0043536; GO:0045860; GO:0045893; GO:0042981; GO:0042035; GO:0007346; GO:0007165; GO:0023014; GO:0031098"]
[1493,742,"PK714","MKK3 (MAP2K3, MEK3)","Y230","MAPK/ERK protein-serine kinase 3 beta isoform (MKK3 beta); Dual specificity mitogen-activated protein kinase kinase 3",{"v":9078.716589879255,"d":"9079"},{"v":8817.534248596536,"d":"8818"},{"v":2089.0729091782573,"d":"2089"},{"v":23.01066332995908,"d":"23"},{"v":4313.563805004667,"d":"4314"},{"v":19760.65670177148,"d":"19761"},"Kinexus","RpAb","KP(pY)MAP(bA)C","Corresponds to amino acid residues K228 to P233; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y230 phosphorylation is predicted to be inhibitory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the minor in vivo phosphorylation sites in MKK3 (≥3 reports from high throughput mass spectrometry studies).",null,"P46734","P46734",621,"P46734",null,"NP_002747","Block5",6,1,"5, 13, 21, 29","MKK3","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"Protein kinase, dual-specificity, STE group, STE7 family, N/A subfamily","GO:0005737; GO:0005829; GO:0016020; GO:0005654","GO:0005524; GO:0004708; GO:0019901; GO:0004674; GO:0004713","GO:0000187; GO:0032147; GO:0060048; GO:0035924; GO:0006954; GO:0038066; GO:0043536; GO:0045860; GO:0045893; GO:0042981; GO:0042035; GO:0007346; GO:0007165; GO:0023014; GO:0031098"]
[1495,743,"NK103-5","MKK4 (MAP2K4, MEK4)","Pan-specific","MAPK/ERK protein-serine kinase 4 (MKK4); Dual specificity mitogen-activated protein kinase kinase 4",{"v":13539.815993692371,"d":"13540"},{"v":13167.84543868876,"d":"13168"},{"v":2773.6267824388633,"d":"2774"},{"v":20.484966588401047,"d":"20"},{"v":7451.713101078109,"d":"7452"},{"v":27985.51465944055,"d":"27986"},"Kinexus","RpAb","CGDPPQLSNSEEREFS","Corresponds to amino acid residues G323 to S337.",null,null,"P45985","P45985",659,"P45985","P45985","NP_003001","Block5",6,2,"5, 13, 21, 29","MKK4","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"Protein kinase, dual-specificity; EC 2.7.12.2; STE group; STE7 family","GO:0030424; GO:0005737; GO:0005829; GO:0032839; GO:0005634; GO:0043204","GO:0005524; GO:0008545; GO:0031435; GO:0004672; GO:0004674; GO:0004713","GO:0032147; GO:0006915; GO:0061049; GO:0071260; GO:0072709; GO:0007254; GO:2000672; GO:0045740; GO:0043525; GO:0051770; GO:0034393; GO:0042981; GO:0007346; GO:0009611; GO:0007165; GO:0023014; GO:0031098"]
[1497,744,"NK103-6","MKK4 (MAP2K4, MEK4)","Pan-specific","MAPK/ERK protein-serine kinase 4 (MKK4); Dual specificity mitogen-activated protein kinase kinase 4",{"v":14471.22806917622,"d":"14471"},{"v":13731.764505438192,"d":"13732"},{"v":3479.504461267396,"d":"3480"},{"v":24.04429288678516,"d":"24"},{"v":7215.237941239835,"d":"7215"},{"v":28618.624394508028,"d":"28619"},"Kinexus","RpAb","CLDQMPATPSSPMYVD","Corresponds to amino acid residues L385 to D399; C-terminus.",null,null,"P45985","P45985",659,"P45985","P45985","NP_003001","Block5",6,3,"5, 13, 21, 29","MKK4","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"Protein kinase, dual-specificity; EC 2.7.12.2; STE group; STE7 family","GO:0030424; GO:0005737; GO:0005829; GO:0032839; GO:0005634; GO:0043204","GO:0005524; GO:0008545; GO:0031435; GO:0004672; GO:0004674; GO:0004713","GO:0032147; GO:0006915; GO:0061049; GO:0071260; GO:0072709; GO:0007254; GO:2000672; GO:0045740; GO:0043525; GO:0051770; GO:0034393; GO:0042981; GO:0007346; GO:0009611; GO:0007165; GO:0023014; GO:0031098"]
[1499,745,"PK716","MKK4 (MAP2K4, MEK4)","S80","MAPK/ERK protein-serine kinase 4 (MKK4); Dual specificity mitogen-activated protein kinase kinase 4",{"v":13020.653417469082,"d":"13021"},{"v":12755.996753103196,"d":"12756"},{"v":3028.132309874479,"d":"3028"},{"v":23.256377485724357,"d":"23"},{"v":4741.103092176995,"d":"4741"},{"v":22263.288766352838,"d":"22263"},"Kinexus","RpAb","RTH(pS)IES(bA)C","Corresponds to amino acid residues R77 to S83; In the N-terminal portion of the kinase before the kinase catalytic domain.","S80 phosphorylation inhibits phosphotransferase activity. Phosphorylation regulates apoptosis. This is the major in vivo phosphorylation sites in MKK4 (≥100 reports from high throughput mass spectrometry studies).","Akt1 (PKBa); Akt3 (PKBg); SGK1","P45985","P45985",659,"P45985","P45985","NP_003001","Block5",6,4,"5, 13, 21, 29","MKK4","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"Protein kinase, dual-specificity; EC 2.7.12.2; STE group; STE7 family","GO:0030424; GO:0005737; GO:0005829; GO:0032839; GO:0005634; GO:0043204","GO:0005524; GO:0008545; GO:0031435; GO:0004672; GO:0004674; GO:0004713","GO:0032147; GO:0006915; GO:0061049; GO:0071260; GO:0072709; GO:0007254; GO:2000672; GO:0045740; GO:0043525; GO:0051770; GO:0034393; GO:0042981; GO:0007346; GO:0009611; GO:0007165; GO:0023014; GO:0031098"]
[1501,746,"PK715","MKK4 (MAP2K4, MEK4)","S257","MAPK/ERK protein-serine kinase 4 (MKK4); Dual specificity mitogen-activated protein kinase kinase 4",{"v":12059.869456584775,"d":"12060"},{"v":11835.56022347768,"d":"11836"},{"v":2196.8107697457576,"d":"2197"},{"v":18.21587520208424,"d":"18"},{"v":6723.554293635644,"d":"6724"},{"v":19331.14406558419,"d":"19331"},"Kinexus","RpAb","LVD(pS)IAK(bA)C","Corresponds to amino acid residues L254 to K260; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S257 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in MKK3 (≥50 reports from high throughput mass spectrometry studies).","ASK1 (MAP3K5); MEKK1 (MAP3K1); MEKK4 (MAP3K4); MLK2 (MAP3K10); MLK3 (MAP3K11)","P45985","P45985",659,"P45985","P45985","NP_003001","Block5",6,5,"5, 13, 21, 29","MKK4","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"Protein kinase, dual-specificity; EC 2.7.12.2; STE group; STE7 family","GO:0030424; GO:0005737; GO:0005829; GO:0032839; GO:0005634; GO:0043204","GO:0005524; GO:0008545; GO:0031435; GO:0004672; GO:0004674; GO:0004713","GO:0032147; GO:0006915; GO:0061049; GO:0071260; GO:0072709; GO:0007254; GO:2000672; GO:0045740; GO:0043525; GO:0051770; GO:0034393; GO:0042981; GO:0007346; GO:0009611; GO:0007165; GO:0023014; GO:0031098"]
[1503,747,"NK105-4","MKK6 (MAP2K6, MEK6)","Pan-specific","MAPK/ERK protein-serine kinase 6 (MKK6); Dual specificity mitogen-activated protein kinase kinase 6",{"v":4641.87814526941,"d":"4642"},{"v":4311.177837343865,"d":"4311"},{"v":1481.2868344791445,"d":"1481"},{"v":31.91136837550853,"d":"32"},{"v":2033.3664213617299,"d":"2033"},{"v":11334.518650166792,"d":"11335"},"Kinexus","RpAb","CSKERPTYPELMQHPF","Corresponds to amino acid residues S299 to F313; Kinase last alpha-chain.",null,null,"P52564","P52564",894,"P52564",null,"NP_002749.2","Block5",6,6,"5, 13, 21, 29","MKK6","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"Protein kinase, dual-specificity, STE group, STE7 family, N/A subfamily","GO:0005737; GO:0005856; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0042802; GO:0004708; GO:0019901; GO:0004674; GO:0004713","GO:0000187; GO:0032147; GO:0006915; GO:0060048; GO:0007050; GO:0072709; GO:0006975; GO:0120163; GO:0070423; GO:0022602; GO:0043065; GO:0051770; GO:0032308; GO:0042981; GO:0007346; GO:0006355; GO:0042493; GO:0002931; GO:0007165; GO:0023014; GO:0031098; GO:0006351"]
[1505,748,"NK105-5","MKK6 (MAP2K6, MEK6)","Pan-specific","MAPK/ERK protein-serine kinase 6 (MKK6); Dual specificity mitogen-activated protein kinase kinase 6",{"v":4223.550001068413,"d":"4224"},{"v":3884.8722463594686,"d":"3885"},{"v":1397.1564824978384,"d":"1397"},{"v":33.08014542610851,"d":"33"},{"v":1721.7011223601105,"d":"1722"},{"v":9204.895672126153,"d":"9205"},"Kinexus","RpAb","HESKGTDVASFVKLC","Corresponds to amino acid residues H317 to L330; C-terminus.",null,null,"P52564","P52564",894,"P52564",null,"NP_002749.2","Block5",6,7,"5, 13, 21, 29","MKK6","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"Protein kinase, dual-specificity, STE group, STE7 family, N/A subfamily","GO:0005737; GO:0005856; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0042802; GO:0004708; GO:0019901; GO:0004674; GO:0004713","GO:0000187; GO:0032147; GO:0006915; GO:0060048; GO:0007050; GO:0072709; GO:0006975; GO:0120163; GO:0070423; GO:0022602; GO:0043065; GO:0051770; GO:0032308; GO:0042981; GO:0007346; GO:0006355; GO:0042493; GO:0002931; GO:0007165; GO:0023014; GO:0031098; GO:0006351"]
[1507,749,"NK106-4","MKK7 (MEK7, MAP2K7)","Pan-specific","MAPK/ERK protein-serine kinase 7 (MKK7); Dual specificity mitogen-activated protein kinase kinase 7",{"v":6683.088622049155,"d":"6683"},{"v":6553.3436097145,"d":"6553"},{"v":1365.2685173150087,"d":"1365"},{"v":20.42870586528887,"d":"20"},{"v":3419.130049263443,"d":"3419"},{"v":11501.025174699156,"d":"11501"},"Kinexus","RpAb","CKYNKLLEHSFIKRYE","Corresponds to amino acid residues K370 to E384; Kinase last alpha-chain.",null,null,"O14733","O14733",1002,"O14733","O14733","NP_005034","Block5",6,8,"5, 13, 21, 29","MKK7","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"Protein kinase, dual-specificity, STE group, STE7 family, N/A subfamily","GO:0005737; GO:0005829; GO:0005634","GO:0005524; GO:0019899; GO:0000287; GO:0004708; GO:0019901; GO:0019903; GO:0004674; GO:0004713","GO:0007257; GO:0006915; GO:0051973; GO:1904355; GO:0032212; GO:0042981; GO:0007346; GO:0009408; GO:0006970; GO:0034612; GO:0009411; GO:0007165; GO:0051403"]
[1509,750,"NK106-5","MKK7 (MEK7, MAP2K7)","Pan-specific","MAPK/ERK protein-serine kinase 7 (MKK7); Dual specificity mitogen-activated protein kinase kinase 7",{"v":11419.080089744746,"d":"11419"},{"v":11066.328818027203,"d":"11066"},{"v":2593.4538893766507,"d":"2593"},{"v":22.711583323649524,"d":"23"},{"v":4876.253139901675,"d":"4876"},{"v":21542.504107211702,"d":"21543"},"Kinexus","RpAb","EVDVASWFKDVMAKTE","Corresponds to amino acid residues E387 to E402.",null,null,"O14733","O14733",1002,"O14733","O14733","NP_005034","Block5",6,9,"5, 13, 21, 29","MKK7","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"Protein kinase, dual-specificity, STE group, STE7 family, N/A subfamily","GO:0005737; GO:0005829; GO:0005634","GO:0005524; GO:0019899; GO:0000287; GO:0004708; GO:0019901; GO:0019903; GO:0004674; GO:0004713","GO:0007257; GO:0006915; GO:0051973; GO:1904355; GO:0032212; GO:0042981; GO:0007346; GO:0009408; GO:0006970; GO:0034612; GO:0009411; GO:0007165; GO:0051403"]
[1511,751,"PK717","MKK7 (MEK7, MAP2K7)","T275","MAPK/ERK protein-serine kinase 7 (MKK7); Dual specificity mitogen-activated protein kinase kinase 7",{"v":8768.283856656177,"d":"8768"},{"v":8628.72699590273,"d":"8629"},{"v":1754.6987615102653,"d":"1755"},{"v":20.01188362735587,"d":"20"},{"v":3287.310270840041,"d":"3287"},{"v":13374.993081583445,"d":"13375"},"Kinexus","RpAb","KAK(pT)RSA(bA)C","Corresponds to amino acid residues K272 to A278; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T275 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is a minor in vivo phosphorylation sites in MKK7 (≥1 report) in high throughput mass spectrometry studies.","ASK1 (MAP3K5); DLK (MAP3K12); MEKK1 (MAP3K1); MEKK2 (MAP3K2); MEKK3 (MAP3K3); MLK3 (MAP3K11)","O14733","O14733",1002,"O14733","O14733","NP_005034","Block5",6,10,"5, 13, 21, 29","MKK7","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","STE","STE7",{"$nulls":6},"Protein kinase, dual-specificity, STE group, STE7 family, N/A subfamily","GO:0005737; GO:0005829; GO:0005634","GO:0005524; GO:0019899; GO:0000287; GO:0004708; GO:0019901; GO:0019903; GO:0004674; GO:0004713","GO:0007257; GO:0006915; GO:0051973; GO:1904355; GO:0032212; GO:0042981; GO:0007346; GO:0009408; GO:0006970; GO:0034612; GO:0009411; GO:0007165; GO:0051403"]
[1513,753,"NK278-1","MLK1 (MAP3K9)","Pan-specific","Mixed-lineage protein-serine kinase 1; Mitogen-activated protein kinase kinase kinase 9",{"v":1361.7967116126824,"d":"1362"},{"v":1064.0915229794875,"d":"1064"},{"v":899.4052507414076,"d":"899"},{"v":66.04548557591269,"d":"66"},{"v":236.85909460259217,"d":"237"},{"v":5999.896751114466,"d":"6000"},"Kinexus","RpAb","CAELNTHRPAPYEIQQEFWS","Corresponds to amino acid residues A1086 to S1104; C-terminus.",null,null,"P80192","P80192",804,"P80192",null,"NP_001271159.1","Block5",6,12,"5, 13, 21, 29","MLK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","MLK","MLK",{"$nulls":5},"Protein-serine kinase, TKL group, MLK family, MLK subfamily","GO:0005737","GO:0005524; GO:0004706; GO:0004708; GO:0042803; GO:0004674","GO:0007257; GO:0006915; GO:0043065; GO:0046777; GO:0006468; GO:0006355; GO:0006351"]
[1515,754,"NK279-1","MLK2 (MAP3K10)","Pan-specific","Mixed-lineage protein-serine kinase 2; Mitogen-activated protein kinase kinase kinase 10",{"v":1522.0829954373378,"d":"1522"},{"v":1488.7108058784402,"d":"1489"},{"v":549.1034451324671,"d":"549"},{"v":36.07578869079304,"d":"36"},{"v":283.45436096790166,"d":"283"},{"v":3851.8305137810203,"d":"3852"},"Kinexus","RpAb","CGSVQPTLLDMDMEGQNQDT","Corresponds to amino acid residues S926 to S943; Pre-C-terminus.",null,null,"Q02779","Q02779",724,"Q02779","Q02779","NP_002437.2.","Block5",6,13,"5, 13, 21, 29","MLK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","MLK","MLK",{"$nulls":5},"EC 2.7.11.25; Protein kinase, Ser/Thr (non-receptor); TKL domain target; TKL</A> group; MLK family; MLK subfamily","GO:0005737","GO:0005524; GO:0043425; GO:0004706; GO:0042803; GO:0004672; GO:0004674; GO:0003714","GO:0007257; GO:0006915; GO:0007254; GO:0043433; GO:0045892; GO:0018105; GO:0018107; GO:0043065; GO:0046330; GO:0043507; GO:0046777; GO:0007165; GO:0007224"]
[1517,755,"NK208","MLK3 (MAP3K11)","Pan-specific","Mixed-lineage protein-serine kinase 3",{"v":433.27407295909387,"d":"433"},{"v":343.86572343098294,"d":"344"},{"v":352.026752031996,"d":"352"},{"v":81.24805383063654,"d":"81"},{"v":111.78152141907279,"d":"112"},{"v":4007.1312368713934,"d":"4007"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues at the C-terminus of human MLK3",null,null,"Q16584","Q16584",623,"Q16584","Q16584","NP_002410.1","Block5",7,1,"5, 13, 21, 29","MLK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","MLK","MLK",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.25; TKL domain target; TKL</A> group; MLK family; MLK subfamily","GO:0005813; GO:0005737; GO:0016020; GO:0005874","GO:0005524; GO:0042802; GO:0004706; GO:0031434; GO:0031435; GO:0042803; GO:0004672; GO:0004674; GO:0048365","GO:0007257; GO:0000187; GO:0008219; GO:0008283; GO:0007254; GO:0007017; GO:0043065; GO:0046330; GO:0043507; GO:0043525; GO:0046777; GO:0006468"]
[1519,756,"PK870","MLK3 (MAP3K11)","T277+S281","Mixed-lineage protein-serine kinase 3; Mitogen-activated protein kinase kinase kinase 11",{"v":6486.651679957797,"d":"6487"},{"v":6354.029655751425,"d":"6354"},{"v":2075.3812349202035,"d":"2075"},{"v":31.994645886916288,"d":"32"},{"v":313.06940747803395,"d":"313"},{"v":14598.285111013609,"d":"14598"},"Kinexus","RpAb","WHK(pT)TQM(pS)AAGC","Corresponds to amino acid residues W274 to G280; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T277 and S281 phosphorylation stimulates phosphotransferase activity and induces binding with GEFT. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These two phosphorylation sites in MLK3 have apparently not been reported in high throughput mass spectrometry studies, although they have been detected by Western blotting.","T277: MLK3 (MAP3K11). S281: HPK1 (MAP4K1); MLK3 (MAP3K11).","Q16584","Q16584",623,"Q16584","Q16584","NP_002410.1","Block5",7,2,"5, 13, 21, 29","MLK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","MLK","MLK",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.25; TKL domain target; TKL</A> group; MLK family; MLK subfamily","GO:0005813; GO:0005737; GO:0016020; GO:0005874","GO:0005524; GO:0042802; GO:0004706; GO:0031434; GO:0031435; GO:0042803; GO:0004672; GO:0004674; GO:0048365","GO:0007257; GO:0000187; GO:0008219; GO:0008283; GO:0007254; GO:0007017; GO:0043065; GO:0046330; GO:0043507; GO:0043525; GO:0046777; GO:0006468"]
[1521,757,"PK718","MLK3 (MAP3K11)","S281","Mixed-lineage protein-serine kinase 3; Mitogen-activated protein kinase kinase kinase 11",{"v":665.7091885919833,"d":"666"},{"v":520.9691890924012,"d":"521"},{"v":1110.6965414404835,"d":"1111"},{"v":166.84410557554062,"d":"167"},{"v":71.0106077871927,"d":"71"},{"v":10418.867859102844,"d":"10419"},"Kinexus","RpAb","TQM(pS)AAG(bA)C","Corresponds to amino acid residues T278 to G284; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S281 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in MLK3.","HPK1 (MAP4K1); MLK3 (MAP3K11)","Q16584","Q16584",623,"Q16584","Q16584","NP_002410.1","Block5",7,3,"5, 13, 21, 29","MLK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","MLK","MLK",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.25; TKL domain target; TKL</A> group; MLK family; MLK subfamily","GO:0005813; GO:0005737; GO:0016020; GO:0005874","GO:0005524; GO:0042802; GO:0004706; GO:0031434; GO:0031435; GO:0042803; GO:0004672; GO:0004674; GO:0048365","GO:0007257; GO:0000187; GO:0008219; GO:0008283; GO:0007254; GO:0007017; GO:0043065; GO:0046330; GO:0043507; GO:0043525; GO:0046777; GO:0006468"]
[1523,758,"NK280-1","MLK4","Pan-specific","Mixed-lineage protein-serine kinase 4",{"v":3828.0934519249636,"d":"3828"},{"v":3608.462227441765,"d":"3608"},{"v":1288.3296327474939,"d":"1288"},{"v":33.65460245229006,"d":"34"},{"v":577.8857858940161,"d":"578"},{"v":8956.653640474127,"d":"8957"},"Kinexus","RpAb","CMRSKTSRPSIYELEKEFLS","Corresponds to amino acid residues M1018 to S1036; C-terminus.",null,null,"Q5TCX8","Q5TCX8",2000,"Q5TCX8",null,"NP_115811.2","Block5",7,4,"5, 13, 21, 29","MLK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","MLK","MLK",{"$nulls":5},"EC 2.7.11.25; Protein kinase, Ser/Thr (non-receptor); TKL domain target; TKL</A> group; MLK family; MLK subfamily","GO:0005737","GO:0005524; GO:0004706; GO:0042803","GO:0007257; GO:0046777; GO:0006468"]
[1525,759,"PK719","MLTK (ZAK)","T161+T162","Mitogen-activated protein kinase kinase kinase MLT",{"v":14266.514974666834,"d":"14267"},{"v":13568.98577667136,"d":"13569"},{"v":5358.101762984586,"d":"5358"},{"v":37.55718738948517,"d":"38"},{"v":5039.8641268231,"d":"5040"},{"v":42314.28370134006,"d":"42314"},"Kinexus","RpAb","HNH(pT)(pT)HMS(bA)C","Corresponds to amino acid residues H158 to S165; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T161 and T162 phosphorylation stimulates phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These phosphorylation sites in MLTK have apparently not been reported in high throughput mass spectrometry studies.","T161: ZAK (MLTK). T162: ZAK (MLTK).","Q9NYL2","Q9NYL2",799,"Q9NYL2","Q9NYL2","NP_057737.2","Block5",7,5,"5, 13, 21, 29","ZAK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","MLK","MLK",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.25; TKL domain target; TKL</A> group; MLK family; MLK subfamily","GO:0005737; GO:0005829; GO:0005634","GO:0005524; GO:0000287; GO:0004709; GO:0004674; GO:0003723","GO:0007257; GO:0000186; GO:0007050; GO:0008219; GO:0030154; GO:0008283; GO:0071480; GO:0007010; GO:0000077; GO:0042733; GO:0060173; GO:0007093; GO:0043065; GO:0006468; GO:0051403"]
[1527,760,"NK387-1","Mnk1","Pan-specific","MAP kinase-interacting protein-serine/threonine kinase 1",{"v":491.3131512837286,"d":"491"},{"v":370.07085483169305,"d":"370"},{"v":349.4415884779997,"d":"349"},{"v":71.12400463227179,"d":"71"},{"v":74.18996840398346,"d":"74"},{"v":2126.8104921434324,"d":"2127"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 411-465 mapping at the C-terminus of human Mnk1.",null,null,"Q9BUB5","Q9BUB5",624,"Q9BUB5",null,"NP_001129025.1","Block5",7,6,"5, 13, 21, 29","MNK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","MAPKAPK","MNK",{"$nulls":5},"Protein-serine kinase, CAMK group, MAPKAPK family, MNK subfamily","GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0009931; GO:0005516; GO:0004683; GO:0046872; GO:0004674","GO:0035556; GO:0018105; GO:0046777; GO:0006468; GO:0006417"]
[1529,761,"NK111","Mnk2","Pan-specific","MAP kinase-interacting serine-threonine kinase 2",{"v":292.99616706348297,"d":"293"},{"v":195.06076025674133,"d":"195"},{"v":402.2891774357054,"d":"402"},{"v":137.30185669921823,"d":"137"},{"v":46.65445790570912,"d":"47"},{"v":5327.228188471483,"d":"5327"},"External","GpAb","Epitope undefined.",{"$nulls":3},"Q9HBH9","Q9HBH9",725,"Q9HBH9",null,"NP_951009.1","Block5",7,7,"5, 13, 21, 29","MNK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","MAPKAPK","MNK",{"$nulls":5},"Protein-serine kinase, CAMK group, MAPKAPK family, MNK subfamily","GO:0005737; GO:0016604; GO:0005654; GO:0005634; GO:0016605","GO:0005524; GO:0009931; GO:0005516; GO:0004683; GO:0046872; GO:0004674","GO:0007166; GO:0071243; GO:0097192; GO:0030097; GO:0035556; GO:0018105; GO:0046777; GO:0006468; GO:0006417"]
[1531,762,"NK281-2","MOK (RAGE)","Pan-specific","MAPK-MAK-MRK overlapping kinase; MOK protein kinase",{"v":707.0388332070537,"d":"707"},{"v":617.3233646141396,"d":"617"},{"v":414.44272032705356,"d":"414"},{"v":58.616684241682314,"d":"59"},{"v":75.68122157568004,"d":"76"},{"v":2644.9120359458107,"d":"2645"},"Kinexus","RpAb","CIPASKKTDPQKDLKPAPQQ","Corresponds to amino acid residues C388 to Q407; C-terminus.",null,null,"Q9UQ07","Q9UQ07",726,"Q9UQ07",null,"NP_055041.1","Block5",7,8,"5, 13, 21, 29","MOK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","RCK",{"$nulls":6},"Protein-serine kinase, CMGC group, RCK family","GO:0097546; GO:0005929; GO:0005737; GO:0005634","GO:0005524; GO:0004693; GO:0046872; GO:0004672; GO:0004674","GO:0035556; GO:0006468; GO:0010468; GO:0007165"]
[1533,763,"NK281-1","MOK (RAGE)","Pan-specific","MAPK-MAK-MRK overlapping kinase; MOK protein kinase",{"v":147.44126277653308,"d":"147"},{"v":131.66461048611424,"d":"132"},{"v":81.5627026704469,"d":"82"},{"v":55.31877653141514,"d":"55"},{"v":35.94547706885523,"d":"36"},{"v":454.1655733704432,"d":"454"},"Kinexus","RpAb","EQRKTEKRALGSHRKAGC","Corresponds to amino acid residues E287 to G303; Right after kinase catalytic domain.",null,null,"Q9UQ07","Q9UQ07",726,"Q9UQ07",null,"NP_055041.1","Block5",7,9,"5, 13, 21, 29","MOK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","RCK",{"$nulls":6},"Protein-serine kinase, CMGC group, RCK family","GO:0097546; GO:0005929; GO:0005737; GO:0005634","GO:0005524; GO:0004693; GO:0046872; GO:0004672; GO:0004674","GO:0035556; GO:0006468; GO:0010468; GO:0007165"]
[1535,764,"PK720","MOK (RAGE)","T159+Y161","MAPK-MAK-MRK overlapping kinase; MOK protein kinase",{"v":8000.723929844134,"d":"8001"},{"v":7841.483921150692,"d":"7841"},{"v":2059.870769692356,"d":"2060"},{"v":25.746054828972024,"d":"26"},{"v":3708.873494248371,"d":"3709"},{"v":18723.710871480693,"d":"18724"},"Kinexus","RpAb","QPY(pT)E(pY)IS(bA)C","Corresponds to amino acid residues Q156 to S163; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T159 and Y161 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major in vivo phosphorylation sites in MOK.",null,"Q9UQ07","Q9UQ07",726,"Q9UQ07",null,"NP_055041.1","Block5",7,10,"5, 13, 21, 29","MOK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","RCK",{"$nulls":6},"Protein-serine kinase, CMGC group, RCK family","GO:0097546; GO:0005929; GO:0005737; GO:0005634","GO:0005524; GO:0004693; GO:0046872; GO:0004672; GO:0004674","GO:0035556; GO:0006468; GO:0010468; GO:0007165"]
[1537,765,"PK721","MOK (RAGE)","Y167","MAPK-MAK-MRK overlapping kinase; MOK protein kinase",{"v":6311.5141119539785,"d":"6312"},{"v":6228.321268317013,"d":"6228"},{"v":1389.0237259233297,"d":"1389"},{"v":22.007773432567078,"d":"22"},{"v":2321.39363104934,"d":"2321"},{"v":11095.22716619452,"d":"11095"},"Kinexus","RpAb","STRW(pY)RAP(bA)C","Corresponds to amino acid residues S163 to P170; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y167 phosphorylation is predicted to be inhibitory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This phosphorylation site in MOK have not been reported in high throughput mass spectrometry studies.",null,"Q9UQ07","Q9UQ07",726,"Q9UQ07",null,"NP_055041.1","Block5",7,11,"5, 13, 21, 29","MOK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","RCK",{"$nulls":6},"Protein-serine kinase, CMGC group, RCK family","GO:0097546; GO:0005929; GO:0005737; GO:0005634","GO:0005524; GO:0004693; GO:0046872; GO:0004672; GO:0004674","GO:0035556; GO:0006468; GO:0010468; GO:0007165"]
[1539,766,"NK112","Mos","Pan-specific","Moloney sarcoma oncogene-encoded protein-serine kinase",{"v":245.67305767677672,"d":"246"},{"v":220.11730323747466,"d":"220"},{"v":116.54371942993622,"d":"117"},{"v":47.43854313209576,"d":"47"},{"v":44.861319527142214,"d":"45"},{"v":676.1273289627702,"d":"676"},"Kinexus","RpAb","ASQRSFWAELNIARLRHDNIVRVVAASTRC","Corresponds to amino acid residues A148 to R177; Kinase Catalytic Subdomain III.",null,null,"P00540","P00540",814,"P00540","P00540","NP_005363","Block5",7,12,"5, 13, 21, 29","MOS","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","MOS",{"$nulls":6},"Protein-serine kinase, Other group, MOS family","GO:0005737; GO:0005829","GO:0005524; GO:0004709; GO:0004674","GO:0000187; GO:0000186; GO:0006325; GO:0051296; GO:0035556; GO:0000212; GO:1902103; GO:0043410; GO:0046777"]
[1541,767,"PK722","Mos","Y263","Moloney sarcoma oncogene-encoded protein-serine kinase",{"v":145.38533940631433,"d":"145"},{"v":131.88031894730003,"d":"132"},{"v":76.43804891395237,"d":"76"},{"v":52.57617392928997,"d":"53"},{"v":28.746266073654095,"d":"29"},{"v":519.9470613125235,"d":"520"},"Kinexus","RpAb","ADI(pY)SFA(bA)C","Corresponds to amino acid residues A260 to A266; In the protein kinase catalytic domain near subdomain IX.","The effect of Y263 phosphorylation is unclear. This is a minor in vivo phosphorylation sites in Mos (≥1 report from high throughput mass spectrometry studies).",null,"P00540","P00540",814,"P00540","P00540","NP_005363","Block5",7,13,"5, 13, 21, 29","MOS","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","MOS",{"$nulls":6},"Protein-serine kinase, Other group, MOS family","GO:0005737; GO:0005829","GO:0005524; GO:0004709; GO:0004674","GO:0000187; GO:0000186; GO:0006325; GO:0051296; GO:0035556; GO:0000212; GO:1902103; GO:0043410; GO:0046777"]
[1543,768,"PN760","MPL","Y591","Thrombopoietin receptor",{"v":5195.653806314975,"d":"5196"},{"v":4959.572034489927,"d":"4960"},{"v":2372.380260816808,"d":"2372"},{"v":45.6608609667822,"d":"46"},{"v":247.58565707129162,"d":"248"},{"v":14380.534575307147,"d":"14381"},"Kinexus","RpAb","CAQMD(pY)RRL","Corresponds to amino acid residues A587 to L594.","The effect of Y591 phosphorylation is unclear. This is the major in vivo phosphorylation site in MPL (≥17 reports from high throughput mass spectrometry studies). This human phosphosite is conserved in mammals, and found in the mouse.",null,"P40238","P40238",3972,null,"P40238","NP_005364.1","Block5",8,1,"5, 13, 21, 29",{"$nulls":3},"Thrombopoietin receptor",{"$nulls":9},"Receptor, cytokine","GO:0009986; GO:0005794; GO:0005887; GO:0043025; GO:0043005; GO:0005886","GO:0038164; GO:0004888","GO:1990960; GO:0008283; GO:0007166; GO:0071456; GO:1990959; GO:0035702; GO:0001780; GO:0070527; GO:0050671; GO:1905221"]
[1545,769,"NK282-1","MRCKa (PK428)","Pan-specific","Myotonic dystrophy kinase-related CDC42-binding kinasealpha",{"v":983.2451690575464,"d":"983"},{"v":846.4665696118614,"d":"846"},{"v":609.9728830380078,"d":"610"},{"v":62.03670277095539,"d":"62"},{"v":103.0263881696403,"d":"103"},{"v":4186.812221190994,"d":"4187"},"Kinexus","RpAb","CVLSDRSSLRVTAGPTSLDL","Corresponds to amino acid residues C408 to L427; Right after kinase catalytic domain.",null,null,"Q5VT25","Q5VT25",2419,"Q5VT25",null,"XP_005273381.1","Block5",8,2,"5, 13, 21, 29","MRCKa","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","DMPK","GEK",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); AGC domain target; AGC</A> group; DMPK family; GEK subfamily","GO:0042641; GO:0005911; GO:0031252; GO:0005737; GO:0070062; GO:0030027","GO:0005524; GO:0042802; GO:0000287; GO:0004674","GO:0031532; GO:0031032; GO:0016477; GO:0035556; GO:0006468"]
[1547,770,"NK283-1","MRCKb (CDC42BPB)","Pan-specific","Myotonic dystrophy kinase-related CDC42-binding kinase beta",{"v":174.3647903907981,"d":"174"},{"v":156.31509038625293,"d":"156"},{"v":93.02804612900836,"d":"93"},{"v":53.35254091179053,"d":"53"},{"v":39.771367896901495,"d":"40"},{"v":628.5041311456145,"d":"629"},"Kinexus","RpAb","CFSDRGSLKSIMQSNTLTKD","Corresponds to amino acid residues C408 to D427; Right after kinase catalytic domain.",null,null,"Q9Y5S2","Q9Y5S2",675,"Q9Y5S2",null,"NP_006026.3","Block5",8,3,"5, 13, 21, 29","MRCKb","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","DMPK","GEK",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); AGC domain target; AGC</A> group; DMPK family; GEK subfamily","GO:0042641; GO:0005911; GO:0031252; GO:0005737; GO:0005856; GO:0070062; GO:0030027; GO:0005886","GO:0005524; GO:0000287; GO:0044877; GO:0004672; GO:0004674; GO:0017048","GO:0031532; GO:0031032; GO:0016477; GO:0007010; GO:0007163; GO:0035556; GO:0006468; GO:0007165"]
[1549,752,"PN051-1","MRLC2 (MLC)","S20","Myosin regulatory light chain 12A",{"v":756.0438156570124,"d":"756"},{"v":628.1771412367182,"d":"628"},{"v":491.35717109269,"d":"491"},{"v":64.99056812807787,"d":"65"},{"v":130.88066853787367,"d":"131"},{"v":3029.830722839568,"d":"3030"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S19 phosphosite.","S20 phosphorylation induces activation of contractile response. This is one of the major in vivo phosphorylation sites in myosin regulatory light chain (≥353 reports from high throughput mass spectrometry studies).","AurB (STK12); CaMK1a; CRIK; DAPK1; DAPK2; DAPK3 (ZIPK); DLK (MAP3K12); ILK; MRCKa (CDC42BPA, PK428); MYLK1 (smMLCK); MYLK2 (skMLCK); PAK1; PAK3 (STK4); PKACa (PRKACA); PKCa (PRKCA); ROCK1; ROCK2","P19105","P19105",1771,null,null,"NP_291024","Block5",6,11,"5, 13, 21, 29",{"$nulls":13},"Contractile protein","GO:0005829; GO:0070062; GO:0016459","GO:0005509","GO:0006936; GO:0070527"]
[1551,771,"PN708","MSH6","S14","DNA mismatch repair protein Msh6",{"v":7376.832208400335,"d":"7377"},{"v":7158.324203728088,"d":"7158"},{"v":2148.7917804327126,"d":"2149"},{"v":29.1289230895856,"d":"29"},{"v":1495.215438651765,"d":"1495"},{"v":16480.090457162038,"d":"16480"},"Kinexus","RpAb","FPK(pS)PAL(bA)C","Corresponds to amino acid residues F11-L17; Near N-terminus.","The effect of S14 phosphorylation is unclear. This is the major in vivo phosphorylation site in MSH6 (≥123 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in fish.",null,"P52701","P52701",5852,null,"P52701","NP_000170.1","Block5",8,4,"5, 13, 21, 29",{"$nulls":3},"DNA-binding",{"$nulls":9},"DNA binding protein","GO:0005829; GO:0005794; GO:0043231; GO:0032301; GO:0000790; GO:0005654","GO:0005524; GO:0003682; GO:0003684; GO:0008094; GO:0032137; GO:0035064; GO:0030983","GO:0008340; GO:0006281; GO:0097193; GO:0008630; GO:0045190; GO:0000710; GO:0006298; GO:0045910; GO:0051096; GO:0045830; GO:0009411; GO:0016446; GO:0016447; GO:0016032"]
[1553,772,"PK723","MSK1 (RPS6KA5)","S212","Mitogen & stress-activated protein-serine kinase 1; Ribosomal protein S6 kinase alpha 5",{"v":7935.273756666839,"d":"7935"},{"v":7819.969777289365,"d":"7820"},{"v":1879.591613101665,"d":"1880"},{"v":23.68653773945129,"d":"24"},{"v":1359.7264112122841,"d":"1360"},{"v":14272.539306461527,"d":"14273"},"Kinexus","RpAb","RAY(pS)FCG(bA)C","Corresponds to amino acid residues R209 to G215; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S212 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in MSK1 (≥13 reports from high throughput mass spectrometry studies).","MSK1 (RPS6KA5)","O75582","O75582",625,"O75582",null,"NP_004746","Block5",8,5,"5, 13, 21, 29","MSK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","MSK",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); AGC group; RSK family; MSK subfamily","GO:0005737; GO:0005654; GO:0005634","GO:0005524; GO:0000287; GO:0004672; GO:0004674","GO:0007411; GO:0007173; GO:0043990; GO:0043987; GO:0043988; GO:0016572; GO:0006954; GO:0070498; GO:0035556; GO:0001818; GO:0045892; GO:0032793; GO:0035066; GO:0033129; GO:0051092; GO:0045944; GO:0006468; GO:0006355; GO:0002223"]
[1555,773,"PK868","MSK2 (RPS6KA4)","T194+S196","Ribosomal protein S6 kinase alpha-4",{"v":12184.877262437149,"d":"12185"},{"v":12277.249294092744,"d":"12277"},{"v":2460.9774170303444,"d":"2461"},{"v":20.19698158648595,"d":"20"},{"v":5180.652886966554,"d":"5181"},{"v":20531.684514265515,"d":"20532"},"Kinexus","RpAb","KER(pT)F(pS)FCGC","Corresponds to amino acid residues K191 to G199; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T194 and S196 phosphorylation stimulates phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the minor in vivo phosphorylation sites in MSK2 (≥1 and ≥2 reports, respectively, from high throughput mass spectrometry studies).","S196: MSK2 (RPS6KA4); p38a MAPK (MAPK14).","O75676","O75676",1779,"O75676",null,"NP_003933.1","Block5",8,6,"5, 13, 21, 29","MSK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","MSK",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); AGC group; RSK family; MSK subfamily","GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0000287; GO:0004674; GO:0004711","GO:0043987; GO:0043988; GO:0016572; GO:0006954; GO:0070498; GO:0035556; GO:0001818; GO:0032793; GO:0035066; GO:0033129; GO:0051092; GO:0045944; GO:0006468; GO:0006355"]
[1557,774,"PK725","MSK2 (RPS6KA4)","T687","Ribosomal protein S6 kinase alpha-4",{"v":7983.897718280958,"d":"7984"},{"v":7734.150279182575,"d":"7734"},{"v":2070.863671357266,"d":"2071"},{"v":25.938003521958336,"d":"26"},{"v":3206.312874617105,"d":"3206"},{"v":14569.823885468264,"d":"14570"},"Kinexus","RpAb","PLR(pT)PDC(bA)C","Corresponds to amino acid residues P684 to C690; In the C-terminal part of the kinase after the second catalytic domain.","T687 phosphorylation stimulates phosphotransferase activity. This is one of the major in vivo phosphorylation sites in MSK2 (≥27 reports from high throughput mass spectrometry studies).","ERK1 (MAPK3); ERK2 (MAPK1); p38a MAPK (MAPK14)","O75676","O75676",1779,"O75676",null,"NP_003933.1","Block5",8,7,"5, 13, 21, 29","MSK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","MSK",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); AGC group; RSK family; MSK subfamily","GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0000287; GO:0004674; GO:0004711","GO:0043987; GO:0043988; GO:0016572; GO:0006954; GO:0070498; GO:0035556; GO:0001818; GO:0032793; GO:0035066; GO:0033129; GO:0051092; GO:0045944; GO:0006468; GO:0006355"]
[1559,775,"NK113-3","MST1 (STK4, Krs2)","Pan-specific","Mammalian STE20-like protein-serine kinase 1",{"v":199.84874913501557,"d":"200"},{"v":167.51414036948427,"d":"168"},{"v":120.26656162918128,"d":"120"},{"v":60.178791285769094,"d":"60"},{"v":46.63607777708553,"d":"47"},{"v":746.597641378702,"d":"747"},"External","GpAb","Epitope undefined.",{"$nulls":3},"Q13043","Q13043",771,"Q13043","Q13043","NP_006273","Block5",8,8,"5, 13, 21, 29","MST1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","MST",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE20 family; MST subfamily","GO:0005737; GO:0005829; GO:0016604; GO:0005654; GO:0005634; GO:0032991","GO:0005524; GO:0042802; GO:0000287; GO:0046983; GO:0042803; GO:0004672; GO:0043539; GO:0004674; GO:0008134","GO:0006915; GO:0001569; GO:0060706; GO:0000902; GO:0007417; GO:0003157; GO:0097284; GO:0035329; GO:0035556; GO:0030216; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0018105; GO:0043065; GO:1902043; GO:0045600; GO:0033138; GO:0032092; GO:0001934; GO:1905461; GO:0060215; GO:0046777; GO:0006468; GO:0050821; GO:0060800; GO:0007346; GO:0007165; GO:0023014; GO:0031098"]
[1561,776,"NK113-2","MST1 (STK4, Krs2)","Pan-specific","Mammalian STE20-like protein-serine kinase 1",{"v":130.32948602602096,"d":"130"},{"v":63.499186293481145,"d":"63"},{"v":181.32758235829863,"d":"181"},{"v":139.13012924956647,"d":"139"},{"v":8.227007266580369,"d":"8"},{"v":1054.6481650427456,"d":"1055"},"External","MmAb","Epitope undefined.",{"$nulls":3},"Q13043","Q13043",771,"Q13043","Q13043","NP_006273","Block5",8,9,"5, 13, 21, 29","MST1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","MST",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE20 family; MST subfamily","GO:0005737; GO:0005829; GO:0016604; GO:0005654; GO:0005634; GO:0032991","GO:0005524; GO:0042802; GO:0000287; GO:0046983; GO:0042803; GO:0004672; GO:0043539; GO:0004674; GO:0008134","GO:0006915; GO:0001569; GO:0060706; GO:0000902; GO:0007417; GO:0003157; GO:0097284; GO:0035329; GO:0035556; GO:0030216; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0018105; GO:0043065; GO:1902043; GO:0045600; GO:0033138; GO:0032092; GO:0001934; GO:1905461; GO:0060215; GO:0046777; GO:0006468; GO:0050821; GO:0060800; GO:0007346; GO:0007165; GO:0023014; GO:0031098"]
[1563,777,"PK871","MST1 (STK4, Krs2)","T183","Mammalian STE20-like protein-serine kinase 1 (KRS2); Serine-threonine-protein kinase 4",{"v":4173.335885356525,"d":"4173"},{"v":3999.0843074438335,"d":"3999"},{"v":1496.7008724846937,"d":"1497"},{"v":35.8634175057978,"d":"36"},{"v":434.765491865242,"d":"435"},{"v":10537.7240551654,"d":"10538"},"Kinexus","RpAb","AKRN(pT)VIGT(bA)C","Corresponds to amino acid residues A179 to T187; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T183 stimulates phosphotransferase activity. Phosphorylation induces protein ubquitination and degradation, and regulates molecular association. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the minor in vivo phosphorylation sites in MST1 (≥6 reports from high throughput mass spectrometry studies).","MST1 (STK4, KRS2)","Q13043","Q13043",771,"Q13043","Q13043","NP_006273","Block5",8,10,"5, 13, 21, 29","MST1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","MST",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE20 family; MST subfamily","GO:0005737; GO:0005829; GO:0016604; GO:0005654; GO:0005634; GO:0032991","GO:0005524; GO:0042802; GO:0000287; GO:0046983; GO:0042803; GO:0004672; GO:0043539; GO:0004674; GO:0008134","GO:0006915; GO:0001569; GO:0060706; GO:0000902; GO:0007417; GO:0003157; GO:0097284; GO:0035329; GO:0035556; GO:0030216; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0018105; GO:0043065; GO:1902043; GO:0045600; GO:0033138; GO:0032092; GO:0001934; GO:1905461; GO:0060215; GO:0046777; GO:0006468; GO:0050821; GO:0060800; GO:0007346; GO:0007165; GO:0023014; GO:0031098"]
[1565,778,"PK726","MST1 (STK4, Krs2)","T187","Mammalian STE20-like protein-serine kinase 1 (KRS2); Serine-threonine-protein kinase 4",{"v":2138.2462398832754,"d":"2138"},{"v":2032.8977778277767,"d":"2033"},{"v":888.1399517257216,"d":"888"},{"v":41.53590616271605,"d":"42"},{"v":196.44562152606733,"d":"196"},{"v":6160.121277970689,"d":"6160"},"Kinexus","RpAb","VIG(pT)PFW(bA)C","Corresponds to amino acid residues V184 to W190; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T187 phosphorylation is predicted to be inhibitory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This phosphorylation site in MST1 has not apparently been reported in high throughput mass spectrometry studies.","MST1 (STK4, KRS2)","Q13043","Q13043",771,"Q13043","Q13043","NP_006273","Block5",8,11,"5, 13, 21, 29","MST1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","MST",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE20 family; MST subfamily","GO:0005737; GO:0005829; GO:0016604; GO:0005654; GO:0005634; GO:0032991","GO:0005524; GO:0042802; GO:0000287; GO:0046983; GO:0042803; GO:0004672; GO:0043539; GO:0004674; GO:0008134","GO:0006915; GO:0001569; GO:0060706; GO:0000902; GO:0007417; GO:0003157; GO:0097284; GO:0035329; GO:0035556; GO:0030216; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0018105; GO:0043065; GO:1902043; GO:0045600; GO:0033138; GO:0032092; GO:0001934; GO:1905461; GO:0060215; GO:0046777; GO:0006468; GO:0050821; GO:0060800; GO:0007346; GO:0007165; GO:0023014; GO:0031098"]
[1567,780,"NK115","MST3 (STK24)","Pan-specific","Mammalian STE20-like protein-serine kinase 3",{"v":70.79044111261891,"d":"71"},{"v":37.320478294094286,"d":"37"},{"v":132.18762763067744,"d":"132"},{"v":186.73089975577795,"d":"187"},{"v":8.464470881155313,"d":"8"},{"v":1463.8981737853974,"d":"1464"},"External","MmAb","Epitope undefined.",{"$nulls":3},"Q9Y6E0","Q9Y6E0",768,"Q9Y6E0",null,"NP_003567","Block5",8,13,"5, 13, 21, 29","MST3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","YSK",{"$nulls":5},"Protein-serine kinase, STE group, STE20 family, YSK subfamily","GO:0005737; GO:0005829; GO:0070062; GO:0005794; GO:0016020; GO:0005730; GO:0005654; GO:0005634","GO:0005524; GO:0045296; GO:0008349; GO:0046872; GO:0004672; GO:0004674","GO:0009267; GO:0097194; GO:0008631; GO:0030336; GO:0048812; GO:0046777; GO:0006468; GO:0042981; GO:0048679; GO:0007346; GO:0042542; GO:0007165; GO:0031098"]
[1569,781,"PK727","MST3 (STK24)","T184","Mammalian STE20-like protein-serine kinase 3; Serine-threonine-protein kinase 24",{"v":7176.484662361145,"d":"7176"},{"v":7170.280989738235,"d":"7170"},{"v":2343.731998760552,"d":"2344"},{"v":32.658496590299094,"d":"33"},{"v":285.4759028996083,"d":"285"},{"v":15460.397568922179,"d":"15460"},"Kinexus","RpAb","LTD(pT)QIK(bA)C","Corresponds to amino acid residues L181 to K187; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T184 phosphorylation is predicted to stimulate phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in MST3 (≥51 reports from high throughput mass spectrometry studies).",null,"Q9Y6E0","Q9Y6E0",768,"Q9Y6E0",null,"NP_003567","Block5",9,1,"5, 13, 21, 29","MST3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","YSK",{"$nulls":5},"Protein-serine kinase, STE group, STE20 family, YSK subfamily","GO:0005737; GO:0005829; GO:0070062; GO:0005794; GO:0016020; GO:0005730; GO:0005654; GO:0005634","GO:0005524; GO:0045296; GO:0008349; GO:0046872; GO:0004672; GO:0004674","GO:0009267; GO:0097194; GO:0008631; GO:0030336; GO:0048812; GO:0046777; GO:0006468; GO:0042981; GO:0048679; GO:0007346; GO:0042542; GO:0007165; GO:0031098"]
[1571,782,"PK728","MST3 (STK24)","T190","Mammalian STE20-like protein-serine kinase 3; Serine-threonine-protein kinase 24",{"v":10675.281116137794,"d":"10675"},{"v":10470.892281851204,"d":"10471"},{"v":2256.7805628717947,"d":"2257"},{"v":21.14024481716201,"d":"21"},{"v":2469.792101686724,"d":"2470"},{"v":20611.429203938053,"d":"20611"},"Kinexus","RpAb","KRN(pT)FVG(bA)C","Corresponds to amino acid residues K187 to G193; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T190 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation regulates cell motility. This is the major in vivo phosphorylation site in MST3 (≥160 reports from high throughput mass spectrometry studies).","MST3 (STK24)","Q9Y6E0","Q9Y6E0",768,"Q9Y6E0",null,"NP_003567","Block5",9,2,"5, 13, 21, 29","MST3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","YSK",{"$nulls":5},"Protein-serine kinase, STE group, STE20 family, YSK subfamily","GO:0005737; GO:0005829; GO:0070062; GO:0005794; GO:0016020; GO:0005730; GO:0005654; GO:0005634","GO:0005524; GO:0045296; GO:0008349; GO:0046872; GO:0004672; GO:0004674","GO:0009267; GO:0097194; GO:0008631; GO:0030336; GO:0048812; GO:0046777; GO:0006468; GO:0042981; GO:0048679; GO:0007346; GO:0042542; GO:0007165; GO:0031098"]
[1573,779,"NK116-4","mTOR (FRAP)","Pan-specific","Mammalian target of rapamycin (FRAP); FKBP12-rapamycin complex-associated protein",{"v":17543.476845167646,"d":"17543"},{"v":16862.36623330773,"d":"16862"},{"v":4860.7273900528835,"d":"4861"},{"v":27.70675067976489,"d":"28"},{"v":4462.1662779007065,"d":"4462"},{"v":33713.08043953055,"d":"33713"},"Kinexus","RpAb","FNQAYGRDLMEAQEWC","Corresponds to amino acid residues F2070 to C2085.",null,null,"P42345","P42345",564,"P42345","P42345","NP_004949","Block5",8,12,"5, 13, 21, 29","FRAP1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PIKK","FRAP",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); Autophagy; EC 2.7.11.1; ATYPICAL group; PIKK family; FRAP subfamily","GO:0005737; GO:0005829; GO:0030425; GO:0012505; GO:0005789; GO:0098978; GO:0000139; GO:0005765; GO:0005764; GO:0016020; GO:0005741; GO:0043025; GO:0005654; GO:0005634; GO:0016605; GO:0099524; GO:0031931; GO:0031932","GO:0005524; GO:0042802; GO:0016301; GO:0051219; GO:0019904; GO:0004672; GO:0019901; GO:0004674; GO:0043022; GO:0001030; GO:0001031; GO:0001032; GO:0001156; GO:0045182","GO:0006207; GO:0032148; GO:0043276; GO:0007420; GO:0055013; GO:0060048; GO:0007569; GO:0007050; GO:0034198; GO:0071230; GO:0071456; GO:0071233; GO:1990253; GO:0031669; GO:0009267; GO:0006281; GO:0006112; GO:0007281; GO:0003007; GO:0003179; GO:0007616; GO:0060135; GO:0048255; GO:0035264; GO:0010507; GO:0070885; GO:0045792; GO:1904193; GO:1904213; GO:0016242; GO:0014736; GO:0001933; GO:0031397; GO:0018105; GO:0018107; GO:0016310; GO:0030838; GO:0061051; GO:1904056; GO:1904690; GO:0060999; GO:1904000; GO:0001938; GO:0010718; GO:0010628; GO:0060252; GO:1904197; GO:0051549; GO:0010592; GO:0046889; GO:0010831; GO:1901216; GO:0014042; GO:0045429; GO:0048714; GO:0050731; GO:0032516; GO:0051897; GO:0001934; GO:1904058; GO:1904206; GO:0048661; GO:0051496; GO:0045945; GO:1901838; GO:0045727; GO:1903691; GO:0009791; GO:0046777; GO:0030163; GO:0006468; GO:0032956; GO:0090335; GO:0043610; GO:0001558; GO:0008361; GO:1900034; GO:0031998; GO:0005979; GO:0043087; GO:0016241; GO:0090559; GO:0031641; GO:0045670; GO:0032095; GO:0099547; GO:0014823; GO:0043200; GO:0042220; GO:0032868; GO:0043278; GO:0007584; GO:0031529; GO:0035176; GO:0021510; GO:0002296; GO:0038202; GO:0031929; GO:0008542; GO:0050882; GO:0042060"]
[1575,783,"NK116-6","mTOR (FRAP)","Pan-specific","Mammalian target of rapamycin (FRAP); FKBP12-rapamycin complex-associated protein",{"v":237.0910685278633,"d":"237"},{"v":187.28392379702038,"d":"187"},{"v":180.71910153959016,"d":"181"},{"v":76.22349617035522,"d":"76"},{"v":44.03994241187199,"d":"44"},{"v":1954.9186602902691,"d":"1955"},"External","MmAb","Epitope undefined.",{"$nulls":3},"P42345","P42345",564,"P42345","P42345","NP_004949","Block5",9,3,"5, 13, 21, 29","FRAP1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PIKK","FRAP",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); Autophagy; EC 2.7.11.1; ATYPICAL group; PIKK family; FRAP subfamily","GO:0005737; GO:0005829; GO:0030425; GO:0012505; GO:0005789; GO:0098978; GO:0000139; GO:0005765; GO:0005764; GO:0016020; GO:0005741; GO:0043025; GO:0005654; GO:0005634; GO:0016605; GO:0099524; GO:0031931; GO:0031932","GO:0005524; GO:0042802; GO:0016301; GO:0051219; GO:0019904; GO:0004672; GO:0019901; GO:0004674; GO:0043022; GO:0001030; GO:0001031; GO:0001032; GO:0001156; GO:0045182","GO:0006207; GO:0032148; GO:0043276; GO:0007420; GO:0055013; GO:0060048; GO:0007569; GO:0007050; GO:0034198; GO:0071230; GO:0071456; GO:0071233; GO:1990253; GO:0031669; GO:0009267; GO:0006281; GO:0006112; GO:0007281; GO:0003007; GO:0003179; GO:0007616; GO:0060135; GO:0048255; GO:0035264; GO:0010507; GO:0070885; GO:0045792; GO:1904193; GO:1904213; GO:0016242; GO:0014736; GO:0001933; GO:0031397; GO:0018105; GO:0018107; GO:0016310; GO:0030838; GO:0061051; GO:1904056; GO:1904690; GO:0060999; GO:1904000; GO:0001938; GO:0010718; GO:0010628; GO:0060252; GO:1904197; GO:0051549; GO:0010592; GO:0046889; GO:0010831; GO:1901216; GO:0014042; GO:0045429; GO:0048714; GO:0050731; GO:0032516; GO:0051897; GO:0001934; GO:1904058; GO:1904206; GO:0048661; GO:0051496; GO:0045945; GO:1901838; GO:0045727; GO:1903691; GO:0009791; GO:0046777; GO:0030163; GO:0006468; GO:0032956; GO:0090335; GO:0043610; GO:0001558; GO:0008361; GO:1900034; GO:0031998; GO:0005979; GO:0043087; GO:0016241; GO:0090559; GO:0031641; GO:0045670; GO:0032095; GO:0099547; GO:0014823; GO:0043200; GO:0042220; GO:0032868; GO:0043278; GO:0007584; GO:0031529; GO:0035176; GO:0021510; GO:0002296; GO:0038202; GO:0031929; GO:0008542; GO:0050882; GO:0042060"]
[1577,784,"NK116-5","mTOR (FRAP)","Pan-specific","Mammalian target of rapamycin (FRAP); FKBP12-rapamycin complex-associated protein",{"v":2658.9223139331543,"d":"2659"},{"v":2311.5981091627928,"d":"2312"},{"v":1225.1286449147024,"d":"1225"},{"v":46.0761353761576,"d":"46"},{"v":637.3373813891488,"d":"637"},{"v":8079.517778184627,"d":"8080"},"Kinexus","RpAb","CRKLTLMGSNGHEFVF","Corresponds to amino acid residues R2170 to F2184.",null,null,"P42345","P42345",564,"P42345","P42345","NP_004949","Block5",9,4,"5, 13, 21, 29","FRAP1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PIKK","FRAP",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); Autophagy; EC 2.7.11.1; ATYPICAL group; PIKK family; FRAP subfamily","GO:0005737; GO:0005829; GO:0030425; GO:0012505; GO:0005789; GO:0098978; GO:0000139; GO:0005765; GO:0005764; GO:0016020; GO:0005741; GO:0043025; GO:0005654; GO:0005634; GO:0016605; GO:0099524; GO:0031931; GO:0031932","GO:0005524; GO:0042802; GO:0016301; GO:0051219; GO:0019904; GO:0004672; GO:0019901; GO:0004674; GO:0043022; GO:0001030; GO:0001031; GO:0001032; GO:0001156; GO:0045182","GO:0006207; GO:0032148; GO:0043276; GO:0007420; GO:0055013; GO:0060048; GO:0007569; GO:0007050; GO:0034198; GO:0071230; GO:0071456; GO:0071233; GO:1990253; GO:0031669; GO:0009267; GO:0006281; GO:0006112; GO:0007281; GO:0003007; GO:0003179; GO:0007616; GO:0060135; GO:0048255; GO:0035264; GO:0010507; GO:0070885; GO:0045792; GO:1904193; GO:1904213; GO:0016242; GO:0014736; GO:0001933; GO:0031397; GO:0018105; GO:0018107; GO:0016310; GO:0030838; GO:0061051; GO:1904056; GO:1904690; GO:0060999; GO:1904000; GO:0001938; GO:0010718; GO:0010628; GO:0060252; GO:1904197; GO:0051549; GO:0010592; GO:0046889; GO:0010831; GO:1901216; GO:0014042; GO:0045429; GO:0048714; GO:0050731; GO:0032516; GO:0051897; GO:0001934; GO:1904058; GO:1904206; GO:0048661; GO:0051496; GO:0045945; GO:1901838; GO:0045727; GO:1903691; GO:0009791; GO:0046777; GO:0030163; GO:0006468; GO:0032956; GO:0090335; GO:0043610; GO:0001558; GO:0008361; GO:1900034; GO:0031998; GO:0005979; GO:0043087; GO:0016241; GO:0090559; GO:0031641; GO:0045670; GO:0032095; GO:0099547; GO:0014823; GO:0043200; GO:0042220; GO:0032868; GO:0043278; GO:0007584; GO:0031529; GO:0035176; GO:0021510; GO:0002296; GO:0038202; GO:0031929; GO:0008542; GO:0050882; GO:0042060"]
[1579,785,"NK116-3","mTOR (FRAP)","Pan-specific","Mammalian target of rapamycin (FRAP); FKBP12-rapamycin complex-associated protein",{"v":5793.369484133997,"d":"5793"},{"v":5538.258288237404,"d":"5538"},{"v":1809.1990036834793,"d":"1809"},{"v":31.228786781824287,"d":"31"},{"v":2425.949578221918,"d":"2426"},{"v":11419.844456714112,"d":"11420"},"Kinexus","RpAb","CALNKKAIQIINRVRD","Corresponds to amino acid residues A2492 to D2505.",null,null,"P42345","P42345",564,"P42345","P42345","NP_004949","Block5",9,5,"5, 13, 21, 29","FRAP1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PIKK","FRAP",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); Autophagy; EC 2.7.11.1; ATYPICAL group; PIKK family; FRAP subfamily","GO:0005737; GO:0005829; GO:0030425; GO:0012505; GO:0005789; GO:0098978; GO:0000139; GO:0005765; GO:0005764; GO:0016020; GO:0005741; GO:0043025; GO:0005654; GO:0005634; GO:0016605; GO:0099524; GO:0031931; GO:0031932","GO:0005524; GO:0042802; GO:0016301; GO:0051219; GO:0019904; GO:0004672; GO:0019901; GO:0004674; GO:0043022; GO:0001030; GO:0001031; GO:0001032; GO:0001156; GO:0045182","GO:0006207; GO:0032148; GO:0043276; GO:0007420; GO:0055013; GO:0060048; GO:0007569; GO:0007050; GO:0034198; GO:0071230; GO:0071456; GO:0071233; GO:1990253; GO:0031669; GO:0009267; GO:0006281; GO:0006112; GO:0007281; GO:0003007; GO:0003179; GO:0007616; GO:0060135; GO:0048255; GO:0035264; GO:0010507; GO:0070885; GO:0045792; GO:1904193; GO:1904213; GO:0016242; GO:0014736; GO:0001933; GO:0031397; GO:0018105; GO:0018107; GO:0016310; GO:0030838; GO:0061051; GO:1904056; GO:1904690; GO:0060999; GO:1904000; GO:0001938; GO:0010718; GO:0010628; GO:0060252; GO:1904197; GO:0051549; GO:0010592; GO:0046889; GO:0010831; GO:1901216; GO:0014042; GO:0045429; GO:0048714; GO:0050731; GO:0032516; GO:0051897; GO:0001934; GO:1904058; GO:1904206; GO:0048661; GO:0051496; GO:0045945; GO:1901838; GO:0045727; GO:1903691; GO:0009791; GO:0046777; GO:0030163; GO:0006468; GO:0032956; GO:0090335; GO:0043610; GO:0001558; GO:0008361; GO:1900034; GO:0031998; GO:0005979; GO:0043087; GO:0016241; GO:0090559; GO:0031641; GO:0045670; GO:0032095; GO:0099547; GO:0014823; GO:0043200; GO:0042220; GO:0032868; GO:0043278; GO:0007584; GO:0031529; GO:0035176; GO:0021510; GO:0002296; GO:0038202; GO:0031929; GO:0008542; GO:0050882; GO:0042060"]
[1581,786,"PK729","mTOR (FRAP)","S2448","Mammalian target of rapamycin (FRAP); FKBP12-rapamycin complex-associated protein",{"v":9645.82213389973,"d":"9646"},{"v":9693.825796231642,"d":"9694"},{"v":2716.0802557692773,"d":"2716"},{"v":28.15810013978754,"d":"28"},{"v":2101.647561292857,"d":"2102"},{"v":24881.7343869889,"d":"24882"},"Kinexus","RpAb","RTD(pS)YSA(bA)C","Corresponds to amino acid residues R2445 to A2451; In the C-terminal fifth of the kinase in the PI3_PI4-kinase domain.","S2448 phosphorylation stimulates phosphotransferase activity. This is the major in vivo phosphorylation site in mTOR (≥114 reports from high throughput mass spectrometry studies).","Akt1 (PKBa); p70S6K (RPS6KB1)","P42345","P42345",564,"P42345","P42345","NP_004949","Block5",9,6,"5, 13, 21, 29","FRAP1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PIKK","FRAP",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); Autophagy; EC 2.7.11.1; ATYPICAL group; PIKK family; FRAP subfamily","GO:0005737; GO:0005829; GO:0030425; GO:0012505; GO:0005789; GO:0098978; GO:0000139; GO:0005765; GO:0005764; GO:0016020; GO:0005741; GO:0043025; GO:0005654; GO:0005634; GO:0016605; GO:0099524; GO:0031931; GO:0031932","GO:0005524; GO:0042802; GO:0016301; GO:0051219; GO:0019904; GO:0004672; GO:0019901; GO:0004674; GO:0043022; GO:0001030; GO:0001031; GO:0001032; GO:0001156; GO:0045182","GO:0006207; GO:0032148; GO:0043276; GO:0007420; GO:0055013; GO:0060048; GO:0007569; GO:0007050; GO:0034198; GO:0071230; GO:0071456; GO:0071233; GO:1990253; GO:0031669; GO:0009267; GO:0006281; GO:0006112; GO:0007281; GO:0003007; GO:0003179; GO:0007616; GO:0060135; GO:0048255; GO:0035264; GO:0010507; GO:0070885; GO:0045792; GO:1904193; GO:1904213; GO:0016242; GO:0014736; GO:0001933; GO:0031397; GO:0018105; GO:0018107; GO:0016310; GO:0030838; GO:0061051; GO:1904056; GO:1904690; GO:0060999; GO:1904000; GO:0001938; GO:0010718; GO:0010628; GO:0060252; GO:1904197; GO:0051549; GO:0010592; GO:0046889; GO:0010831; GO:1901216; GO:0014042; GO:0045429; GO:0048714; GO:0050731; GO:0032516; GO:0051897; GO:0001934; GO:1904058; GO:1904206; GO:0048661; GO:0051496; GO:0045945; GO:1901838; GO:0045727; GO:1903691; GO:0009791; GO:0046777; GO:0030163; GO:0006468; GO:0032956; GO:0090335; GO:0043610; GO:0001558; GO:0008361; GO:1900034; GO:0031998; GO:0005979; GO:0043087; GO:0016241; GO:0090559; GO:0031641; GO:0045670; GO:0032095; GO:0099547; GO:0014823; GO:0043200; GO:0042220; GO:0032868; GO:0043278; GO:0007584; GO:0031529; GO:0035176; GO:0021510; GO:0002296; GO:0038202; GO:0031929; GO:0008542; GO:0050882; GO:0042060"]
[1583,787,"PK196","mTOR (FRAP)","S2448","Mammalian target of rapamycin (FRAP); FKBP12-rapamycin complex-associated protein",{"v":488.4986043153339,"d":"488"},{"v":432.0124115804944,"d":"432"},{"v":287.0124741223758,"d":"287"},{"v":58.75400084809751,"d":"59"},{"v":73.71472598354083,"d":"74"},{"v":1987.0335170344867,"d":"1987"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues surrounding the phosphorylated Ser-2448 of human mTOR. ","S2448 phosphorylation stimulates phosphotransferase activity. This is the major in vivo phosphorylation site in mTOR (≥114 reports from high throughput mass spectrometry studies).","Akt1 (PKBa); p70S6K (RPS6KB1)","P42345","P42345",564,"P42345","P42345","NP_004949","Block5",9,7,"5, 13, 21, 29","FRAP1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PIKK","FRAP",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); Autophagy; EC 2.7.11.1; ATYPICAL group; PIKK family; FRAP subfamily","GO:0005737; GO:0005829; GO:0030425; GO:0012505; GO:0005789; GO:0098978; GO:0000139; GO:0005765; GO:0005764; GO:0016020; GO:0005741; GO:0043025; GO:0005654; GO:0005634; GO:0016605; GO:0099524; GO:0031931; GO:0031932","GO:0005524; GO:0042802; GO:0016301; GO:0051219; GO:0019904; GO:0004672; GO:0019901; GO:0004674; GO:0043022; GO:0001030; GO:0001031; GO:0001032; GO:0001156; GO:0045182","GO:0006207; GO:0032148; GO:0043276; GO:0007420; GO:0055013; GO:0060048; GO:0007569; GO:0007050; GO:0034198; GO:0071230; GO:0071456; GO:0071233; GO:1990253; GO:0031669; GO:0009267; GO:0006281; GO:0006112; GO:0007281; GO:0003007; GO:0003179; GO:0007616; GO:0060135; GO:0048255; GO:0035264; GO:0010507; GO:0070885; GO:0045792; GO:1904193; GO:1904213; GO:0016242; GO:0014736; GO:0001933; GO:0031397; GO:0018105; GO:0018107; GO:0016310; GO:0030838; GO:0061051; GO:1904056; GO:1904690; GO:0060999; GO:1904000; GO:0001938; GO:0010718; GO:0010628; GO:0060252; GO:1904197; GO:0051549; GO:0010592; GO:0046889; GO:0010831; GO:1901216; GO:0014042; GO:0045429; GO:0048714; GO:0050731; GO:0032516; GO:0051897; GO:0001934; GO:1904058; GO:1904206; GO:0048661; GO:0051496; GO:0045945; GO:1901838; GO:0045727; GO:1903691; GO:0009791; GO:0046777; GO:0030163; GO:0006468; GO:0032956; GO:0090335; GO:0043610; GO:0001558; GO:0008361; GO:1900034; GO:0031998; GO:0005979; GO:0043087; GO:0016241; GO:0090559; GO:0031641; GO:0045670; GO:0032095; GO:0099547; GO:0014823; GO:0043200; GO:0042220; GO:0032868; GO:0043278; GO:0007584; GO:0031529; GO:0035176; GO:0021510; GO:0002296; GO:0038202; GO:0031929; GO:0008542; GO:0050882; GO:0042060"]
[1585,788,"PK730","mTOR (FRAP)","S2478+S2481","Mammalian target of rapamycin (FRAP); FKBP12-rapamycin complex-associated protein",{"v":2058.2074245016065,"d":"2058"},{"v":1959.4961109013675,"d":"1959"},{"v":928.7985029860316,"d":"929"},{"v":45.126574315557114,"d":"45"},{"v":172.79724647954185,"d":"173"},{"v":5208.243660141552,"d":"5208"},"Kinexus","RpAb","VPE(pS)IH(pS)FIG(bA)C","Corresponds to amino acid residues V2475 to G2484; In the C-terminal fifth of the kinase at the end of the PI3_PI4-kinase domain.","S2478 and S2481 phosphorylation stimulate phosphotransferase activity. These are two of the major in vivo phosphorylation sites in mTOR (≥23 and ≥26 reports, respectively, from high throughput mass spectrometry studies).","S2481: mTOR (FRAP1)","P42345","P42345",564,"P42345","P42345","NP_004949","Block5",9,8,"5, 13, 21, 29","FRAP1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PIKK","FRAP",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); Autophagy; EC 2.7.11.1; ATYPICAL group; PIKK family; FRAP subfamily","GO:0005737; GO:0005829; GO:0030425; GO:0012505; GO:0005789; GO:0098978; GO:0000139; GO:0005765; GO:0005764; GO:0016020; GO:0005741; GO:0043025; GO:0005654; GO:0005634; GO:0016605; GO:0099524; GO:0031931; GO:0031932","GO:0005524; GO:0042802; GO:0016301; GO:0051219; GO:0019904; GO:0004672; GO:0019901; GO:0004674; GO:0043022; GO:0001030; GO:0001031; GO:0001032; GO:0001156; GO:0045182","GO:0006207; GO:0032148; GO:0043276; GO:0007420; GO:0055013; GO:0060048; GO:0007569; GO:0007050; GO:0034198; GO:0071230; GO:0071456; GO:0071233; GO:1990253; GO:0031669; GO:0009267; GO:0006281; GO:0006112; GO:0007281; GO:0003007; GO:0003179; GO:0007616; GO:0060135; GO:0048255; GO:0035264; GO:0010507; GO:0070885; GO:0045792; GO:1904193; GO:1904213; GO:0016242; GO:0014736; GO:0001933; GO:0031397; GO:0018105; GO:0018107; GO:0016310; GO:0030838; GO:0061051; GO:1904056; GO:1904690; GO:0060999; GO:1904000; GO:0001938; GO:0010718; GO:0010628; GO:0060252; GO:1904197; GO:0051549; GO:0010592; GO:0046889; GO:0010831; GO:1901216; GO:0014042; GO:0045429; GO:0048714; GO:0050731; GO:0032516; GO:0051897; GO:0001934; GO:1904058; GO:1904206; GO:0048661; GO:0051496; GO:0045945; GO:1901838; GO:0045727; GO:1903691; GO:0009791; GO:0046777; GO:0030163; GO:0006468; GO:0032956; GO:0090335; GO:0043610; GO:0001558; GO:0008361; GO:1900034; GO:0031998; GO:0005979; GO:0043087; GO:0016241; GO:0090559; GO:0031641; GO:0045670; GO:0032095; GO:0099547; GO:0014823; GO:0043200; GO:0042220; GO:0032868; GO:0043278; GO:0007584; GO:0031529; GO:0035176; GO:0021510; GO:0002296; GO:0038202; GO:0031929; GO:0008542; GO:0050882; GO:0042060"]
[1587,789,"PK872","MUSK","Y756","Muscle, skeletal receptor tyrosine protein kinase",{"v":2887.828892068903,"d":"2888"},{"v":2870.159003640387,"d":"2870"},{"v":923.6108150987898,"d":"924"},{"v":31.98287882067331,"d":"32"},{"v":276.43799027956493,"d":"276"},{"v":5468.441232678428,"d":"5468"},"Kinexus","RpAb","SADY(pY)KAN(bA)C","Corresponds to amino acid residues S752 to N759; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y756 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This phosphorylation site in MUSK has ony been reported in one high throughput mass spectrometry study.","MUSK","O15146","O15146",1947,"O15146",null,"NP_005583","Block5",9,9,"5, 13, 21, 29","MUSK","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK",{"$nulls":7},"Receptor tyrosine kinase, TK group, Musk family","GO:0030054; GO:0005887; GO:0031594; GO:0045211; GO:0043235","GO:0005524; GO:0046872; GO:0004713; GO:0004714","GO:0030154; GO:0007613; GO:0007275; GO:0007528; GO:0010628; GO:2000541; GO:0001934; GO:0046777; GO:0008582; GO:0071340; GO:0007169"]
[1589,790,"PN627","Myb","S532","Transcriptional activator Myb",{"v":9912.30794579726,"d":"9912"},{"v":9842.9312908603,"d":"9843"},{"v":2146.446468864455,"d":"2146"},{"v":21.65435618628587,"d":"22"},{"v":1319.1709765485443,"d":"1319"},{"v":16729.653631292196,"d":"16730"},"Kinexus","RpAb","QEVE(pS)PTD(bA)C","Corresponds to amino acid residues Q528 to D535.","S532 phosphorylation inhibits transcriptional activity by promoting interaction with a putative inhibitory factor resulting in decreased Myb activity. This is one of the major in vivo phosphorylation sites in Myb (≥11 reports from high throughput mass spectrometry studies).","ERK1 (MAPK3)","P10242","P10242",1256,null,"P10242","NP_005366.2","Block5",9,10,"5, 13, 21, 29",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0016363; GO:0005654; GO:0005634","GO:0000978; GO:0000981; GO:0001135; GO:0001077","GO:0070301; GO:0071300; GO:0006338; GO:0000278; GO:0045892; GO:0000122; GO:0032967; GO:0060252; GO:2000491; GO:1904899; GO:0051571; GO:0051574; GO:0043525; GO:0048661; GO:2000845; GO:0045624; GO:0045893; GO:0045944; GO:0071636; GO:1902036; GO:0006355; GO:0001666"]
[1591,791,"NN430-1","Myc","Pan-specific","Myc proto-oncogene protein",{"v":779.0721476142226,"d":"779"},{"v":707.117587472448,"d":"707"},{"v":408.9404396893982,"d":"409"},{"v":52.4907020411023,"d":"52"},{"v":166.04023173095004,"d":"166"},{"v":2829.9765236984626,"d":"2830"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 408-439 within the C-terminal domain of human c-Myc.",null,null,"P01106","P01106",947,null,"MYC","NP_002458.2","Block5",9,11,"5, 13, 21, 29",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0000790; GO:0005730; GO:0005654; GO:0005634; GO:0032991","GO:0033613; GO:0003677; GO:0003700; GO:0070888; GO:0044877; GO:0046983; GO:0070491; GO:0000978; GO:0000981; GO:0001077; GO:0008134","GO:1904837; GO:0001658; GO:0007050; GO:0006879; GO:0006974; GO:0035690; GO:0071456; GO:0034644; GO:0006338; GO:0051276; GO:0019221; GO:0006112; GO:0070371; GO:0044346; GO:0000082; GO:0000165; GO:0043066; GO:0051782; GO:0048147; GO:0045656; GO:0032873; GO:0000122; GO:0007219; GO:0015671; GO:0008284; GO:0043280; GO:2000573; GO:0050679; GO:0048146; GO:0010628; GO:0002053; GO:0090096; GO:2001022; GO:0051973; GO:0045893; GO:0045944; GO:0016579; GO:0032986; GO:0010468; GO:0032204; GO:0006357; GO:0042493; GO:0010332; GO:0070848"]
[1593,792,"PN199","Myc","T58","Myc proto-oncogene protein",{"v":771.4957344474172,"d":"771"},{"v":692.4135161097518,"d":"692"},{"v":546.4933356114761,"d":"546"},{"v":70.83556152165912,"d":"71"},{"v":18.19180690385631,"d":"18"},{"v":3184.3603112615847,"d":"3184"},"External","RpAb","LP(pT)PP","Corresponds to amino acid residues L56 to P60.","T58 phosphorylation induces transcriptional activation and binding to AurA, CDC73, CIP2A, DNA, FWXW7, PIN1, and SH2BP1, and inhibits interaction with DNA, FBXW7 and TUBA4A. This is one of the major in vivo phosphorylation sites in c-Myc (≥57 reports from high throughput mass spectrometry studies).","ERK2 (MAPK1); GSK3a; GSK3b; JNK3 (MAPK10)","P01106","P01106",947,null,"MYC","NP_002458.2","Block5",9,12,"5, 13, 21, 29",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0000790; GO:0005730; GO:0005654; GO:0005634; GO:0032991","GO:0033613; GO:0003677; GO:0003700; GO:0070888; GO:0044877; GO:0046983; GO:0070491; GO:0000978; GO:0000981; GO:0001077; GO:0008134","GO:1904837; GO:0001658; GO:0007050; GO:0006879; GO:0006974; GO:0035690; GO:0071456; GO:0034644; GO:0006338; GO:0051276; GO:0019221; GO:0006112; GO:0070371; GO:0044346; GO:0000082; GO:0000165; GO:0043066; GO:0051782; GO:0048147; GO:0045656; GO:0032873; GO:0000122; GO:0007219; GO:0015671; GO:0008284; GO:0043280; GO:2000573; GO:0050679; GO:0048146; GO:0010628; GO:0002053; GO:0090096; GO:2001022; GO:0051973; GO:0045893; GO:0045944; GO:0016579; GO:0032986; GO:0010468; GO:0032204; GO:0006357; GO:0042493; GO:0010332; GO:0070848"]
[1595,793,"PN628","Myc","T58+S62","Myc proto-oncogene protein",{"v":22366.91923819565,"d":"22367"},{"v":22608.591039903815,"d":"22609"},{"v":6979.163796313187,"d":"6979"},{"v":31.203062531718608,"d":"31"},{"v":489.3302781926021,"d":"489"},{"v":40867.010333363374,"d":"40867"},"Kinexus","RpAb","ELLP(pT)PPL(pS)PSR(bA)C","Corresponds to amino acid residues E54 to R65.","T58 phosphorylation induces transcriptional activation and binding to AurA, CDC73, CIP2A, DNA, FWXW7, PIN1, and SH2BP1, and inhibits interaction with DNA, FBXW7 and TUBA4A. S62 phosphorylation induces transcriptional activation and binding to AurA, CDC73, CIP2A, DNA, FWXW7, PIN1, RNF4, SH2BP1 and Axin 1. These are two of the major in vivo phosphorylation sites in mTOR (≥57 and ≥59 reports, respectively, from high throughput mass spectrometry studies).","T58: ERK2 (MAPK1); GSK3a; GSK3b; JNK3 (MAPK10). S62: CDK5; ERK1 (MAPK3); ERK2 (MAPK1); JNK1 (MAPK8); JNK2 (MAPK9); JNK3 (MAPK10); Plk1.","P01106","P01106",947,null,"MYC","NP_002458.2","Block5",9,13,"5, 13, 21, 29",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0000790; GO:0005730; GO:0005654; GO:0005634; GO:0032991","GO:0033613; GO:0003677; GO:0003700; GO:0070888; GO:0044877; GO:0046983; GO:0070491; GO:0000978; GO:0000981; GO:0001077; GO:0008134","GO:1904837; GO:0001658; GO:0007050; GO:0006879; GO:0006974; GO:0035690; GO:0071456; GO:0034644; GO:0006338; GO:0051276; GO:0019221; GO:0006112; GO:0070371; GO:0044346; GO:0000082; GO:0000165; GO:0043066; GO:0051782; GO:0048147; GO:0045656; GO:0032873; GO:0000122; GO:0007219; GO:0015671; GO:0008284; GO:0043280; GO:2000573; GO:0050679; GO:0048146; GO:0010628; GO:0002053; GO:0090096; GO:2001022; GO:0051973; GO:0045893; GO:0045944; GO:0016579; GO:0032986; GO:0010468; GO:0032204; GO:0006357; GO:0042493; GO:0010332; GO:0070848"]
[1597,794,"PN215","Myc","T58+S62","Myc proto-oncogene protein",{"v":660.6724045396468,"d":"661"},{"v":275.0132493298504,"d":"275"},{"v":2817.6739860412845,"d":"2818"},{"v":426.4857994189459,"d":"426"},{"v":33.51873878563238,"d":"34"},{"v":27433.83792363265,"d":"27434"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues surrounding the Thr-58 and Ser-62 dually phosphorylated human c-Myc.","T58 phosphorylation induces transcriptional activation and binding to AurA, CDC73, CIP2A, DNA, FWXW7, PIN1, and SH2BP1, and inhibits interaction with DNA, FBXW7 and TUBA4A. S62 phosphorylation induces transcriptional activation and binding to AurA, CDC73, CIP2A, DNA, FWXW7, PIN1, RNF4, SH2BP1 and Axin 1. These are two of the major in vivo phosphorylation sites in mTOR (≥57 and ≥59 reports, respectively, from high throughput mass spectrometry studies).","T58: ERK2 (MAPK1); GSK3a; GSK3b; JNK3 (MAPK10). S62: CDK5; ERK1 (MAPK3); ERK2 (MAPK1); JNK1 (MAPK8); JNK2 (MAPK9); JNK3 (MAPK10); Plk1.","P01106","P01106",947,null,"MYC","NP_002458.2","Block5",10,1,"5, 13, 21, 29",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0000790; GO:0005730; GO:0005654; GO:0005634; GO:0032991","GO:0033613; GO:0003677; GO:0003700; GO:0070888; GO:0044877; GO:0046983; GO:0070491; GO:0000978; GO:0000981; GO:0001077; GO:0008134","GO:1904837; GO:0001658; GO:0007050; GO:0006879; GO:0006974; GO:0035690; GO:0071456; GO:0034644; GO:0006338; GO:0051276; GO:0019221; GO:0006112; GO:0070371; GO:0044346; GO:0000082; GO:0000165; GO:0043066; GO:0051782; GO:0048147; GO:0045656; GO:0032873; GO:0000122; GO:0007219; GO:0015671; GO:0008284; GO:0043280; GO:2000573; GO:0050679; GO:0048146; GO:0010628; GO:0002053; GO:0090096; GO:2001022; GO:0051973; GO:0045893; GO:0045944; GO:0016579; GO:0032986; GO:0010468; GO:0032204; GO:0006357; GO:0042493; GO:0010332; GO:0070848"]
[1599,795,"PN186","Myc","S373","Myc proto-oncogene protein",{"v":665.1483077991774,"d":"665"},{"v":597.0495770298621,"d":"597"},{"v":453.20720447182225,"d":"453"},{"v":68.13626362087285,"d":"68"},{"v":17.036665733423646,"d":"17"},{"v":2569.8356960884375,"d":"2570"},"External","RpAb","Not precisely defined.","Corresponds to amino acid residues surrounding S373 phosphosite.","S373 phosphorylation inhibits binding to MAX and DNA. This phosphorylation site has not been detected in high throughput mass spectrometry studies.","PAK2","P01106","P01106",947,null,"MYC","NP_002458.2","Block5",10,2,"5, 13, 21, 29",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0000790; GO:0005730; GO:0005654; GO:0005634; GO:0032991","GO:0033613; GO:0003677; GO:0003700; GO:0070888; GO:0044877; GO:0046983; GO:0070491; GO:0000978; GO:0000981; GO:0001077; GO:0008134","GO:1904837; GO:0001658; GO:0007050; GO:0006879; GO:0006974; GO:0035690; GO:0071456; GO:0034644; GO:0006338; GO:0051276; GO:0019221; GO:0006112; GO:0070371; GO:0044346; GO:0000082; GO:0000165; GO:0043066; GO:0051782; GO:0048147; GO:0045656; GO:0032873; GO:0000122; GO:0007219; GO:0015671; GO:0008284; GO:0043280; GO:2000573; GO:0050679; GO:0048146; GO:0010628; GO:0002053; GO:0090096; GO:2001022; GO:0051973; GO:0045893; GO:0045944; GO:0016579; GO:0032986; GO:0010468; GO:0032204; GO:0006357; GO:0042493; GO:0010332; GO:0070848"]
[1601,796,"NN431-1","MyoD","Pan-specific","Myoblast determination protein 1",{"v":394.87393989059564,"d":"395"},{"v":354.44950536360085,"d":"354"},{"v":225.7664702428117,"d":"226"},{"v":57.17431499920276,"d":"57"},{"v":93.2035546250778,"d":"93"},{"v":1800.739488259225,"d":"1801"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 1-318 of mouse MyoD.",null,null,"P15172","P15172",3637,null,"P15172","NP_002469.2","Block5",10,3,"5, 13, 21, 29",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005829; GO:0030016; GO:0016604; GO:0000790; GO:0005654; GO:0005634; GO:0005667","GO:0003682; GO:0031490; GO:0070888; GO:0035257; GO:1990841; GO:0046982; GO:0000978; GO:0000977; GO:0000981; GO:0001228; GO:0003713; GO:0003705; GO:0031625","GO:0071392; GO:0071385; GO:0071453; GO:0009267; GO:0071356; GO:0043966; GO:0043967; GO:0042693; GO:0007517; GO:0007518; GO:0007520; GO:0014904; GO:0014908; GO:2000818; GO:0051149; GO:0045663; GO:1901741; GO:0048743; GO:0043415; GO:1905382; GO:0045944; GO:0006468; GO:0000381; GO:0043484; GO:0006357; GO:0035914; GO:0043503; GO:0048741; GO:0007519"]
[1603,797,"PN182","MyoD","S200","Myoblast determination protein 1",{"v":317.971985586186,"d":"318"},{"v":222.06267879023616,"d":"222"},{"v":329.22426926167844,"d":"329"},{"v":103.53876573583949,"d":"104"},{"v":12.652159309659487,"d":"13"},{"v":2020.240217319001,"d":"2020"},"External","RpAb","AS(pS)PR","Corresponds to amino acid residues A198 to R202.","The effect of S200 phosphorylation is unclear. Phosphorylation of this site in MyoD has not been reported in high throughput mass spectrometry studies.","CDK1 (CDC2); CDK2; CDK9","P15172","P15172",3637,null,"P15172","NP_002469.2","Block5",10,4,"5, 13, 21, 29",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005829; GO:0030016; GO:0016604; GO:0000790; GO:0005654; GO:0005634; GO:0005667","GO:0003682; GO:0031490; GO:0070888; GO:0035257; GO:1990841; GO:0046982; GO:0000978; GO:0000977; GO:0000981; GO:0001228; GO:0003713; GO:0003705; GO:0031625","GO:0071392; GO:0071385; GO:0071453; GO:0009267; GO:0071356; GO:0043966; GO:0043967; GO:0042693; GO:0007517; GO:0007518; GO:0007520; GO:0014904; GO:0014908; GO:2000818; GO:0051149; GO:0045663; GO:1901741; GO:0048743; GO:0043415; GO:1905382; GO:0045944; GO:0006468; GO:0000381; GO:0043484; GO:0006357; GO:0035914; GO:0043503; GO:0048741; GO:0007519"]
[1605,798,"NP049-2","MYPT1 (MBS)","Pan-specific","Protein phosphatase 1 regulatory subunit 12A",{"v":484.107037024023,"d":"484"},{"v":398.233861075022,"d":"398"},{"v":302.85260731705733,"d":"303"},{"v":62.55901776987158,"d":"63"},{"v":96.39669780841672,"d":"96"},{"v":1630.8012993700358,"d":"1631"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 711-840 of human MYPT1.",null,null,"O14974","O14974",1748,null,null,"NP_446342","Block5",10,5,"5, 13, 21, 29",{"$nulls":13},"Protein phosphatase, regulatory subunit","GO:0031672; GO:0015629; GO:0005813; GO:0043292; GO:0005829; GO:0005925; GO:0000776; GO:0005654; GO:0072357; GO:0030018","GO:0071889; GO:0004857; GO:0019208; GO:0019901","GO:0035690; GO:0007098; GO:0000278; GO:0043086; GO:0035508; GO:0045944; GO:0006470; GO:0030155; GO:0035507; GO:0046822; GO:0007165"]
[1607,799,"PK197","MYPT1 (MBS)","S695","Protein phosphatase 1 regulatory subunit 12A",{"v":254.22296752640125,"d":"254"},{"v":213.56678784392673,"d":"214"},{"v":185.09031351396698,"d":"185"},{"v":72.80629099522457,"d":"73"},{"v":36.5761434669031,"d":"37"},{"v":1765.6524599538448,"d":"1766"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the Ser-695 phosphosite.","The effect of S695 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in MYPT1 (≥66 reports from high throughput mass spectrometry studies).","PKACa (PRKACA); PKG1 (PRKG1)","O14974","O14974",1748,null,null,"NP_446342","Block5",10,6,"5, 13, 21, 29",{"$nulls":13},"Protein phosphatase, regulatory subunit","GO:0031672; GO:0015629; GO:0005813; GO:0043292; GO:0005829; GO:0005925; GO:0000776; GO:0005654; GO:0072357; GO:0030018","GO:0071889; GO:0004857; GO:0019208; GO:0019901","GO:0035690; GO:0007098; GO:0000278; GO:0043086; GO:0035508; GO:0045944; GO:0006470; GO:0030155; GO:0035507; GO:0046822; GO:0007165"]
[1609,800,"PN052","MYPT1 (MBS)","T696","Protein phosphatase 1 regulatory subunit 12A",{"v":971.3172933948283,"d":"971"},{"v":872.0138322697776,"d":"872"},{"v":677.2430780705748,"d":"677"},{"v":69.72418618261787,"d":"70"},{"v":22.029089235177366,"d":"22"},{"v":3176.938031281011,"d":"3177"},"External","RpAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the T696 phosphosite.","T696 phosphorylation affects the intracellular localization of the protein. This is one of the major in vivo phosphorylation sites in MYPT1 (≥260 reports from high throughput mass spectrometry studies).","DAPK3 (ZIPK); ILK; PAK1; PKG1 (PRKG1); Raf1; ROCK1; ROCK2","O14974","O14974",1748,null,null,"NP_446342","Block5",10,7,"5, 13, 21, 29",{"$nulls":13},"Protein phosphatase, regulatory subunit","GO:0031672; GO:0015629; GO:0005813; GO:0043292; GO:0005829; GO:0005925; GO:0000776; GO:0005654; GO:0072357; GO:0030018","GO:0071889; GO:0004857; GO:0019208; GO:0019901","GO:0035690; GO:0007098; GO:0000278; GO:0043086; GO:0035508; GO:0045944; GO:0006470; GO:0030155; GO:0035507; GO:0046822; GO:0007165"]
[1611,801,"PK198","MYPT1 (MBS)","S903","Protein phosphatase 1 regulatory subunit 12A",{"v":296.06805238353235,"d":"296"},{"v":223.6913038860614,"d":"224"},{"v":276.677433441708,"d":"277"},{"v":93.45062096848417,"d":"93"},{"v":37.330194209500696,"d":"37"},{"v":2897.253070835245,"d":"2897"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the Ser-903 phosphosite.","The effect of S903 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in MYPT1 (≥43 reports from high throughput mass spectrometry studies).",null,"O14974","O14974",1748,null,null,"NP_446342","Block5",10,8,"5, 13, 21, 29",{"$nulls":13},"Protein phosphatase, regulatory subunit","GO:0031672; GO:0015629; GO:0005813; GO:0043292; GO:0005829; GO:0005925; GO:0000776; GO:0005654; GO:0072357; GO:0030018","GO:0071889; GO:0004857; GO:0019208; GO:0019901","GO:0035690; GO:0007098; GO:0000278; GO:0043086; GO:0035508; GO:0045944; GO:0006470; GO:0030155; GO:0035507; GO:0046822; GO:0007165"]
[1613,803,"PK887","MYT1","S143","Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase",{"v":10980.393990663864,"d":"10980"},{"v":10747.271725212278,"d":"10747"},{"v":2499.77049498399,"d":"2500"},{"v":22.76576320585065,"d":"23"},{"v":1553.7682574651794,"d":"1554"},{"v":20936.56129372306,"d":"20937"},"Kinexus","RpAb","RSM(pS)PFR(bA)C","Corresponds to amino acid residues R140 to R146.Located in the Gap/Insert 2 (G/I2) region in the protein-serine/threonine/tyrosine kinase catalytic domain of MYT1.","The effect of S143 phosphorylation is unknown. S143 is the most common phosphosite in MYT1 by mass spectrometry (≥23 reports).",null,"Q99640","Q99640",1820,"Q99640",null,"NP_004194.3","Block5",10,10,"5, 13, 21, 29","MYT1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/tyrosine kinase, dual-specificity","Other ","WEE",{"$nulls":6},"Protein-serine/tyrosine kinase, dual-specificity, Other group, WEE family","GO:0005829; GO:0005783; GO:0005789; GO:0005794; GO:0000139; GO:0016020; GO:0005730; GO:0005654; GO:0005634","GO:0005524; GO:0016301; GO:0046872; GO:0004672; GO:0004674","GO:0000086; GO:0000278; GO:0010923; GO:0000079; GO:0007088"]
[1615,889,"PN187","NBN (p95NBS1)","S343","Nibrin",{"v":451.5891088562552,"d":"452"},{"v":388.16036673815654,"d":"388"},{"v":328.19271086644505,"d":"328"},{"v":72.67507219066076,"d":"73"},{"v":13.237345843917335,"d":"13"},{"v":2300.7777980268947,"d":"2301"},"External","RpAb","SL(pS)QG","Corresponds to amino acid residues S341 to G345.","S343 phosphorylation induces activity. This is one of the major in vivo phosphorylation sites in nibrin (≥73 reports from high throughput mass spectrometry studies).","ATM; ATR","O60934","O60934",1802,null,"O60934","NP_001019859.1","Block6",4,5,"6, 14, 22, 30",{"$nulls":8},"X",{"$nulls":4},"DNA binding protein","GO:0005829; GO:0030870; GO:0000784; GO:0042405; GO:0005730; GO:0005654; GO:0005634; GO:0016605; GO:0005657; GO:0035861","GO:0003684; GO:0047485; GO:0008134","GO:0001832; GO:0007050; GO:0008283; GO:0000077; GO:0030330; GO:0000729; GO:0032508; GO:0006260; GO:0006302; GO:0000724; GO:0006303; GO:0097193; GO:0045190; GO:0051321; GO:0007093; GO:0007095; GO:1904354; GO:0050885; GO:0033674; GO:0031954; GO:0032206; GO:0030174; GO:0090656; GO:0000723; GO:0090737; GO:0031860"]
[1617,804,"PN629","NCOA3 (SRC-3)","S867","Nuclear receptor coactivator 3",{"v":15720.764397613008,"d":"15721"},{"v":14967.650124942307,"d":"14968"},{"v":5749.848766201576,"d":"5750"},{"v":36.57486761314618,"d":"37"},{"v":5757.24434315152,"d":"5757"},{"v":31368.0309875892,"d":"31368"},"Kinexus","RpAb","CSVGS(pS)PPVK","Corresponds to amino acid residues C863 to K871.","S867 phosphorylation inhibits binding to ER-alpha. This is one of the less major in vivo phosphorylation sites in NCOA3 (≥12 reports from high throughput mass spectrometry studies).","CDK1 (CDC2); JNK1 (MAPK8); p38a MAPK (MAPK14)","Q9Y6Q9","Q9Y6Q9",6027,null,"Q9Y6Q9","NP_858045.1","Block5",10,11,"5, 13, 21, 29",{"$nulls":3},"Acetyltransferase; Transcription,  coactivator/corepressor; Nuclear receptor co-regulator",{"$nulls":4},"X",{"$nulls":4},"EC 2.3.1.48; Acetyltransferase; Transcription, coactivator/corepressor; Nuclear receptor co-regulator","GO:0005737; GO:0005829; GO:0070062; GO:0000790; GO:0005654; GO:0005634; GO:0032991","GO:0050681; GO:0097718; GO:0004402; GO:0035257; GO:0016922; GO:0030374; GO:0046982; GO:0047485; GO:0000993; GO:0000981; GO:0046966; GO:0003713","GO:0030521; GO:0043697; GO:0071392; GO:0032870; GO:0030522; GO:0010628; GO:0045618; GO:1902459; GO:0045893; GO:0045944; GO:0035624; GO:2001141; GO:2000035; GO:0006351"]
[1619,805,"PK731","NDR1 (NDR, STK38)","S281+T282","Serine/threonine-protein kinase 38",{"v":10033.301539767239,"d":"10033"},{"v":9854.135299172114,"d":"9854"},{"v":2026.0955444107776,"d":"2026"},{"v":20.19370728947294,"d":"20"},{"v":5363.1862200560645,"d":"5363"},{"v":17180.50566778393,"d":"17181"},"Kinexus","RpAb","LAF(pS)(pT)VGT(bA)C","Corresponds to amino acid residues L278 to T285; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S281 phosphorylation stimulates phosphotransferase activity. T282 phosphorylation is predicted to be stimulatory for phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major in vivo phosphorylation sites in NDR1 (≥15 and ≥12 reports, respectively, from high throughput mass spectrometry studies).","S281: NDR1 (NDR; STK38).","Q15208","Q15208",728,"Q15208","Q15208","NP_001292031.1","Block5",10,12,"5, 13, 21, 29","NDR1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","NDR",{"$nulls":6},"Protein-serine kinase, AGC group, NDR family","GO:0005737; GO:0005829; GO:0005634","GO:0005524; GO:0045296; GO:0000287; GO:0031435; GO:0004674","GO:0006464; GO:0035556; GO:0043407; GO:0018105; GO:0006468"]
[1621,806,"NK117-4","Nek2","Pan-specific","NIMA (never-in-mitosis)-related protein-serine kinase 2",{"v":421.58485106616484,"d":"422"},{"v":338.64237858594805,"d":"339"},{"v":409.38088915746255,"d":"409"},{"v":97.10521811259603,"d":"97"},{"v":81.09316969357833,"d":"81"},{"v":5933.685549588039,"d":"5934"},"External","GpAb","Epitope undefined.",{"$nulls":3},"P51955","P51955",729,"P51955",null,"NP_002488","Block5",10,13,"5, 13, 21, 29","NEK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","NEK",{"$nulls":6},"Protein kinase, tyrosine (non-receptor); Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; Other group; NEK family","GO:0005813; GO:0000777; GO:0000794; GO:0005829; GO:0000776; GO:0005874; GO:0030496; GO:0005730; GO:0005654; GO:0032991; GO:0000922","GO:0005524; GO:0046872; GO:0004672; GO:0019903; GO:0004674","GO:0001824; GO:0051301; GO:0051299; GO:0007059; GO:0097711; GO:0000086; GO:0051321; GO:0000278; GO:0000070; GO:0090307; GO:1903126; GO:0043392; GO:0051973; GO:1904355; GO:0032212; GO:0046777; GO:0006468; GO:0051988; GO:0010389; GO:0046602; GO:0007088; GO:0051225"]
[1623,807,"NK117-3","Nek2","Pan-specific","NIMA (never-in-mitosis)-related protein-serine kinase 2",{"v":198.853519171649,"d":"199"},{"v":146.60761645020938,"d":"147"},{"v":266.93894953824895,"d":"267"},{"v":134.23898689357821,"d":"134"},{"v":40.95820187598168,"d":"41"},{"v":3754.9220059296176,"d":"3755"},"External","GpAb","Epitope undefined.",{"$nulls":3},"P51955","P51955",729,"P51955",null,"NP_002488","Block5",11,1,"5, 13, 21, 29","NEK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","NEK",{"$nulls":6},"Protein kinase, tyrosine (non-receptor); Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; Other group; NEK family","GO:0005813; GO:0000777; GO:0000794; GO:0005829; GO:0000776; GO:0005874; GO:0030496; GO:0005730; GO:0005654; GO:0032991; GO:0000922","GO:0005524; GO:0046872; GO:0004672; GO:0019903; GO:0004674","GO:0001824; GO:0051301; GO:0051299; GO:0007059; GO:0097711; GO:0000086; GO:0051321; GO:0000278; GO:0000070; GO:0090307; GO:1903126; GO:0043392; GO:0051973; GO:1904355; GO:0032212; GO:0046777; GO:0006468; GO:0051988; GO:0010389; GO:0046602; GO:0007088; GO:0051225"]
[1625,808,"PK733","Nek2","T170+S171","NIMA (never-in-mitosis)-related protein-serine kinase 2",{"v":807.4602105010027,"d":"807"},{"v":519.2297433305617,"d":"519"},{"v":1849.9281787284801,"d":"1850"},{"v":229.10456201682808,"d":"229"},{"v":88.44597216697494,"d":"88"},{"v":17175.083153596606,"d":"17175"},"Kinexus","RpAb","HD(pT)(pS)FAK(bA)C","Corresponds to amino acid residues H168 to K174; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T170 and S171 stimulates phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These two in vivo phosphorylation sites in Nek2  have been reported ≥1 and ≥5 times from high throughput mass spectrometry studies.",null,"P51955","P51955",729,"P51955",null,"NP_002488","Block5",11,2,"5, 13, 21, 29","NEK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","NEK",{"$nulls":6},"Protein kinase, tyrosine (non-receptor); Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; Other group; NEK family","GO:0005813; GO:0000777; GO:0000794; GO:0005829; GO:0000776; GO:0005874; GO:0030496; GO:0005730; GO:0005654; GO:0032991; GO:0000922","GO:0005524; GO:0046872; GO:0004672; GO:0019903; GO:0004674","GO:0001824; GO:0051301; GO:0051299; GO:0007059; GO:0097711; GO:0000086; GO:0051321; GO:0000278; GO:0000070; GO:0090307; GO:1903126; GO:0043392; GO:0051973; GO:1904355; GO:0032212; GO:0046777; GO:0006468; GO:0051988; GO:0010389; GO:0046602; GO:0007088; GO:0051225"]
[1627,809,"PK732","Nek2","S171","NIMA (never-in-mitosis)-related protein-serine kinase 2",{"v":15348.393530601032,"d":"15348"},{"v":14996.151060455,"d":"14996"},{"v":4462.7951763315705,"d":"4463"},{"v":29.076627253750186,"d":"29"},{"v":149.3420534522395,"d":"149"},{"v":35573.49632357237,"d":"35573"},"Kinexus","RpAb","HDT(pS)FAK(bA)C","Corresponds to amino acid residues H168 to K174; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S171 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in Nek2 (≥5 reports from high throughput mass spectrometry studies).",null,"P51955","P51955",729,"P51955",null,"NP_002488","Block5",11,3,"5, 13, 21, 29","NEK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","NEK",{"$nulls":6},"Protein kinase, tyrosine (non-receptor); Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; Other group; NEK family","GO:0005813; GO:0000777; GO:0000794; GO:0005829; GO:0000776; GO:0005874; GO:0030496; GO:0005730; GO:0005654; GO:0032991; GO:0000922","GO:0005524; GO:0046872; GO:0004672; GO:0019903; GO:0004674","GO:0001824; GO:0051301; GO:0051299; GO:0007059; GO:0097711; GO:0000086; GO:0051321; GO:0000278; GO:0000070; GO:0090307; GO:1903126; GO:0043392; GO:0051973; GO:1904355; GO:0032212; GO:0046777; GO:0006468; GO:0051988; GO:0010389; GO:0046602; GO:0007088; GO:0051225"]
[1629,810,"NK393-1","Nek3","Pan-specific","NIMA (never-in-mitosis)-related protein-serine kinase 3",{"v":467.4156620947647,"d":"467"},{"v":413.11986579613404,"d":"413"},{"v":289.4280417672736,"d":"289"},{"v":61.920912206958626,"d":"62"},{"v":79.35902146841137,"d":"79"},{"v":2029.9182082092445,"d":"2030"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 78-126 mapping near the N-terminus of human Nek3.",null,null,"P51956","P51956",730,"P51956",null,"NP_002489.1","Block5",11,4,"5, 13, 21, 29","NEK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","NEK",{"$nulls":6},"Protein kinase, tyrosine (non-receptor); EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; NEK family","GO:0030424; GO:0005737; GO:0005634","GO:0005524; GO:0046872; GO:0004674","GO:0051301; GO:0030010; GO:0000278; GO:0048812; GO:0006468; GO:0090043"]
[1631,811,"PK734","Nek6","S206","NIMA (never-in-mitosis)-related protein-serine kinase 6",{"v":6077.065146908305,"d":"6077"},{"v":5759.548687413155,"d":"5760"},{"v":2132.452854728862,"d":"2132"},{"v":35.09017598427002,"d":"35"},{"v":1812.8157518085684,"d":"1813"},{"v":14795.51924741158,"d":"14796"},"Kinexus","RpAb","AAH(pS)LVG(bA)C","Corresponds to amino acid residues A203 to G209; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S206 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation site in Nek6 (≥60 reports from high throughput mass spectrometry studies).","NEK9","Q9HC98","Q9HC98",731,"Q9HC98",null,"NP_001159640.1","Block5",11,5,"5, 13, 21, 29","NEK6","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","NEK",{"$nulls":6},"EC 2.7.11.1; Protein kinase, tyrosine (non-receptor); Protein kinase, Ser/Thr (non-receptor); Other group; NEK family","GO:0005737; GO:0005829; GO:0043231; GO:0005874; GO:0005815; GO:0016607; GO:0005654; GO:0005634; GO:0032991; GO:0000922","GO:0033613; GO:0005524; GO:0019894; GO:0000287; GO:0019901; GO:0004674; GO:0001222; GO:0031625","GO:0006915; GO:0051301; GO:0007059; GO:0007077; GO:0018105; GO:0043123; GO:0046777; GO:0006468; GO:2000772; GO:0007346; GO:0030071; GO:0051225"]
[1633,812,"NK119-2","Nek7","Pan-specific","NIMA (never-in-mitosis)-related protein-serine kinase 7",{"v":330.18897130582155,"d":"330"},{"v":256.2778253308171,"d":"256"},{"v":278.2824662886738,"d":"278"},{"v":84.27975809977255,"d":"84"},{"v":41.141570573780676,"d":"41"},{"v":2860.974256300681,"d":"2861"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 1-26 at the N-terminus of human Nek7.",null,null,"Q8TDX7","Q8TDX7",1752,"Q8TDX7",null,"NP_598001","Block5",11,6,"5, 13, 21, 29","NEK7","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","NEK",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Protein kinase, tyrosine (non-receptor); Other group; NEK family","GO:0005737; GO:0005874; GO:0005815; GO:0005654; GO:0000922","GO:0005524; GO:0046872; GO:0004674","GO:0051973; GO:1904355; GO:0032212; GO:0006468; GO:0007346; GO:0051225"]
[1635,813,"NK119","Nek7","Pan-specific","NIMA (never-in-mitosis)-related protein-serine kinase 7",{"v":102.84054731002755,"d":"103"},{"v":83.46174955080859,"d":"83"},{"v":62.4048583745048,"d":"62"},{"v":60.6811807276525,"d":"61"},{"v":21.256104368583415,"d":"21"},{"v":418.3040553573521,"d":"418"},"External","RpAb","MDEQSQGMQG PPVPQFQPQK ALRPDMGYNT","Corresponds to amino acid residues M1 to T30; N-terminus.",null,null,"Q8TDX7","Q8TDX7",1752,"Q8TDX7",null,"NP_598001","Block5",11,7,"5, 13, 21, 29","NEK7","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","NEK",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Protein kinase, tyrosine (non-receptor); Other group; NEK family","GO:0005737; GO:0005874; GO:0005815; GO:0005654; GO:0000922","GO:0005524; GO:0046872; GO:0004674","GO:0051973; GO:1904355; GO:0032212; GO:0006468; GO:0007346; GO:0051225"]
[1637,814,"PK735","Nek7","T191+S195","NIMA (never-in-mitosis)-related protein-serine kinase 7",{"v":5340.137761908064,"d":"5340"},{"v":5307.921055119787,"d":"5308"},{"v":1466.9076034705233,"d":"1467"},{"v":27.46947117982942,"d":"27"},{"v":762.825934589694,"d":"763"},{"v":10643.420592544971,"d":"10643"},"Kinexus","RpAb","(pT)AAH(pS)LVG(bA)C","Corresponds to amino acid residues T191 to G198; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T191 and S195 phosphorylation is predicted to be stimulatory for phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. T191 is a minor phosphosite (≥1 report) and S195 is a major phosphosite (≥80 reports) from high throughput mass spectrometry studies.","NEK9","Q8TDX7","Q8TDX7",1752,"Q8TDX7",null,"NP_598001","Block5",11,8,"5, 13, 21, 29","NEK7","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","NEK",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Protein kinase, tyrosine (non-receptor); Other group; NEK family","GO:0005737; GO:0005874; GO:0005815; GO:0005654; GO:0000922","GO:0005524; GO:0046872; GO:0004674","GO:0051973; GO:1904355; GO:0032212; GO:0006468; GO:0007346; GO:0051225"]
[1639,815,"PN237","NES","T315","Nestin",{"v":249.61784660310886,"d":"250"},{"v":229.18402899968368,"d":"229"},{"v":157.6751310208546,"d":"158"},{"v":63.166609746280386,"d":"63"},{"v":46.20136928560827,"d":"46"},{"v":1145.1996371187051,"d":"1145"},"External","MmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the T316 phosphosite.","The effect of T315 phosphorylation is unclear. This is the minor in vivo phosphorylation site in NES (≥7 reports from high throughput mass spectrometry studies). ","CDK5","P48681","P48681",3572,null,null,"NP_006608.1","Block5",11,9,"5, 13, 21, 29",{"$nulls":13},"Cytoskeletal protein","GO:0005737; GO:0005882; GO:0045111","GO:0019215; GO:0005198","GO:0007420; GO:0007417; GO:0031076; GO:0000086; GO:0043086; GO:0032091; GO:0030844; GO:2000179; GO:0072089"]
[1641,816,"PN761","NF1","Y2577","Neurofibromin",{"v":6260.436267622896,"d":"6260"},{"v":6147.10874198915,"d":"6147"},{"v":1961.4743669743623,"d":"1961"},{"v":31.33127282388483,"d":"31"},{"v":1120.3377893790928,"d":"1120"},{"v":11739.509814171035,"d":"11740"},"Kinexus","RpAb","CAETD(pY)EME","Corresponds to amino acid residues A2573 to E2576.","The effect of Y2577 phosphorylation is unclear. This is the major in vivo phosphorylation site in NF1 (≥103 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in fish.",null,"P21359","P21359",5810,null,"P21359","NP_001035957.1","Block5",11,10,"5, 13, 21, 29",{"$nulls":3},"GTPase activating protein",{"$nulls":9},"Tumor suppressor; GTPase activating protein, Ras","GO:0030424; GO:0005737; GO:0005829; GO:0030425; GO:0031235; GO:0016020; GO:0005730; GO:0005634; GO:0098793","GO:0005096; GO:0031210; GO:0008429","GO:0030036; GO:0030325; GO:0021764; GO:0048844; GO:0007420; GO:0048593; GO:0007154; GO:0034605; GO:0021987; GO:0050890; GO:0030199; GO:0030198; GO:0008625; GO:0021897; GO:0048853; GO:0061534; GO:0061535; GO:0048820; GO:0007507; GO:0001889; GO:0000165; GO:0001656; GO:0022011; GO:0016525; GO:0048712; GO:0001953; GO:0030336; GO:0001937; GO:0048147; GO:0043409; GO:0043407; GO:0007406; GO:0046929; GO:0048715; GO:0045671; GO:0042308; GO:0006469; GO:0035021; GO:0046580; GO:0021915; GO:0098597; GO:0001649; GO:0007422; GO:0014065; GO:0043473; GO:0045762; GO:0043065; GO:0001938; GO:2001241; GO:1902043; GO:0043547; GO:0043525; GO:0007265; GO:0045765; GO:0043535; GO:0045124; GO:0001952; GO:0010468; GO:0045685; GO:0043087; GO:0048169; GO:1900271; GO:0032228; GO:0001666; GO:0014044; GO:0007519; GO:0048745; GO:0021510; GO:0048485; GO:0008542; GO:0042060"]
[1643,817,"PN709","NF2","S518","Merlin",{"v":23574.713531001595,"d":"23575"},{"v":23115.84047094152,"d":"23116"},{"v":7071.0701345586085,"d":"7071"},{"v":29.99429929555622,"d":"30"},{"v":4020.873653994164,"d":"4021"},{"v":47121.38361713254,"d":"47121"},"Kinexus","RpAb","MKRL(pS)MEI(bA)C","Corresponds to amino acid residues M514 to I521.","S518 phosphorylation inhibits activity. Phosphorylation induces binding of Ezrin, Merlin and SPTAN1, and inhibits interaction with CD44, DDB1, Hrs, LIN28B, LRP6, Merlin, PIK3R2, SRc, TUBA4A and VPRBP. This is the major in vivo phosphorylation site in NF2 (≥37 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in fish.","PAK1; PAK2; PKACa (PRKACA)","P35240","P35240",1093,null,null,"NP_000259.1","Block5",11,11,"5, 13, 21, 29",{"$nulls":3},"Cytoskeletal protein",{"$nulls":9},"Cytoskeletal protein","GO:0005912; GO:0045177; GO:0044297; GO:0032154; GO:0030864; GO:0005737; GO:0005856; GO:0005829; GO:0005769; GO:0031527; GO:0030027; GO:0016020; GO:0043005; GO:0005730; GO:0005634; GO:0048471; GO:0005886; GO:0032587","GO:0003779","GO:0030036; GO:0045216; GO:0007398; GO:0021766; GO:0070306; GO:0001707; GO:0022408; GO:0001953; GO:0030336; GO:0008285; GO:0046426; GO:0043409; GO:0006469; GO:0042532; GO:0042475; GO:0045597; GO:0051496; GO:0042981; GO:0051726; GO:0014013; GO:0035330; GO:2000177; GO:1900180; GO:0031647; GO:0072091; GO:0014010"]
[1645,818,"PN630","NFAT1","S217+S221","Nuclear factor of activated T-cells, cytoplasmic 2",{"v":6282.663950548646,"d":"6283"},{"v":6188.103007080375,"d":"6188"},{"v":1600.8277972265666,"d":"1601"},{"v":25.48007994422129,"d":"25"},{"v":2380.2289631634694,"d":"2380"},{"v":11960.165104854008,"d":"11960"},"Kinexus","RpAb","C(bA)PRT(pS)PIM(pS)PRT","Corresponds to amino acid residues C214 to T224.","The effects of S217 and S221 phosphorylation are unclear. These are two of the major in vivo phosphorylation sites in NFAT1 (≥13 and ≥14 reports, respectively, from high throughput mass spectrometry studies).","S217: JNK1 (MAPK8). S221: JNK1 (MAPK8).","Q13469","Q13469",1010,null,null,"NP_775114.1","Block5",11,12,"5, 13, 21, 29",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005737; GO:0005829; GO:0000790; GO:0044798; GO:0005654; GO:0005634; GO:1990904","GO:0003682; GO:0003677; GO:0003700; GO:0019902; GO:0000978; GO:0000981; GO:0001077; GO:0001078; GO:0008134","GO:0050853; GO:0033173; GO:0016477; GO:0006974; GO:0001816; GO:0038095; GO:0014904; GO:1905064; GO:0030890; GO:1901741; GO:0045893; GO:0045589; GO:0006355; GO:0042493"]
[1647,819,"PN631","NFAT3 (NFATc4)","S213+S217","Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4",{"v":13534.194254036463,"d":"13534"},{"v":12868.162443624096,"d":"12868"},{"v":5261.643873101806,"d":"5262"},{"v":38.87666878678473,"d":"39"},{"v":38.8098866078021,"d":"39"},{"v":27774.741157115037,"d":"27775"},"Kinexus","RpAb","CGLG(pS)PLPS(pS)PRA","Corresponds to amino acid residues C210 to A220.","S213 and S217 phosphorylation stimulates transcriptional activity. These are two of the major in vivo phosphorylation sites in NFAT3 (≥12 and ≥16 reports, respectively, from high throughput mass spectrometry studies).","S213: JNK1 (MAPK8); JNK2 (MAPK9). S217: JNK1 (MAPK8); JNK2 (MAPK9).","Q14934","Q14934",2576,null,null,"NP_004545.2","Block5",11,13,"5, 13, 21, 29",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005829; GO:0016607; GO:0005634; GO:0005667","GO:0042975; GO:0000978; GO:0000981; GO:0001078; GO:0001227; GO:0003713; GO:0008134","GO:0001569; GO:0033173; GO:0045333; GO:1904637; GO:0071285; GO:0034644; GO:0007507; GO:0006954; GO:0008630; GO:0055001; GO:0035562; GO:0050774; GO:1902894; GO:0032091; GO:2000297; GO:0030178; GO:2001235; GO:0045944; GO:0032760; GO:0048167; GO:0051145; GO:0006366"]
[1649,823,"PN240","NFAT3 (NFATc4)","S168+S170","Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4",{"v":458.7809856871966,"d":"459"},{"v":218.0337541212313,"d":"218"},{"v":1581.0901552226662,"d":"1581"},{"v":344.62852745616533,"d":"345"},{"v":48.987047364443136,"d":"49"},{"v":14466.701299527283,"d":"14467"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues surrounding the dually phosphorylated Ser-168 and Ser-170 of human NFATc4.","S168 and S170 phosphorylation inhibits nuclear translocation and transcriptional activity. These are two of the minor in vivo phosphorylation sites in NFAT3 (≥1 and ≥1 reports, respectively, from high throughput mass spectrometry studies).","S168: ERK5 (MAPK7); FRAP1 (mTOR); p38a MAPK (MAPK14). S170: ERK5 (MAPK7); FRAP1 (mTOR); p38a MAPK (MAPK14).","Q14934","Q14934",2576,null,null,"NP_004545.2","Block5",12,4,"5, 13, 21, 29",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005829; GO:0016607; GO:0005634; GO:0005667","GO:0042975; GO:0000978; GO:0000981; GO:0001078; GO:0001227; GO:0003713; GO:0008134","GO:0001569; GO:0033173; GO:0045333; GO:1904637; GO:0071285; GO:0034644; GO:0007507; GO:0006954; GO:0008630; GO:0055001; GO:0035562; GO:0050774; GO:1902894; GO:0032091; GO:2000297; GO:0030178; GO:2001235; GO:0045944; GO:0032760; GO:0048167; GO:0051145; GO:0006366"]
[1651,821,"PN238","NFAT4 (NFATc3)","S169","Nuclear factor of activated T-cells, cytoplasmic 3",{"v":474.0205567982971,"d":"474"},{"v":383.7114490791327,"d":"384"},{"v":314.391141175428,"d":"314"},{"v":66.32436856724891,"d":"66"},{"v":88.91962070100566,"d":"89"},{"v":1841.6016315910874,"d":"1842"},"External","MmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the S169 phosphosite.","The effect of S169 phosphorylation is unclear. This phosphorylation site in NFAT4 has not been reported in high throughput mass spectrometry studies.",null,"Q12968","Q12968",2574,null,"Q12968","NP_775188.1","Block5",12,2,"5, 13, 21, 29",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0000978; GO:0000981; GO:0001077; GO:0001227","GO:0038095; GO:0006954; GO:1902894; GO:1905064; GO:0045944; GO:0006357; GO:0006366"]
[1653,822,"PN239","NFAT4 (NFATc3)","S240","Nuclear factor of activated T-cells, cytoplasmic 3",{"v":454.5534240564417,"d":"455"},{"v":373.8860174831375,"d":"374"},{"v":319.53791878169386,"d":"320"},{"v":70.29710961808023,"d":"70"},{"v":101.54151892782994,"d":"102"},{"v":3118.484248003141,"d":"3118"},"External","MmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the S240 phosphosite.","The effect of S240 phosphorylation is unclear. This phosphorylation site in NFAT4 has only been reported once in high throughput mass spectrometry studies.",null,"Q12968","Q12968",2574,null,"Q12968","NP_775188.1","Block5",12,3,"5, 13, 21, 29",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0000978; GO:0000981; GO:0001077; GO:0001227","GO:0038095; GO:0006954; GO:1902894; GO:1905064; GO:0045944; GO:0006357; GO:0006366"]
[1655,820,"PN632","NFAT5","T135","Nuclear factor of activated T-cells 5",{"v":11201.352618393026,"d":"11201"},{"v":11234.09750018533,"d":"11234"},{"v":3068.289294891518,"d":"3068"},{"v":27.392131998891596,"d":"27"},{"v":2839.8085033908333,"d":"2840"},{"v":20666.628401576683,"d":"20667"},"Kinexus","RpAb","QHPS(pT)PKRH(bA)C","Corresponds to amino acid residues Q131 to H139.","T135 phosphorylation increases nuclear localization and induces transcriptional activity. This is one of the major in vivo phosphorylation sites in NFAT5 (≥14 reports from high throughput mass spectrometry studies).","CDK5","O94916","O94916",5526,null,"O94916","NP_006590.1","Block5",12,1,"5, 13, 21, 29",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription factor","GO:0005829; GO:0005654; GO:0005634","GO:0003700; GO:0000978; GO:0000981; GO:0001077","GO:0001816; GO:0007588; GO:0045944; GO:0070884; GO:0007165; GO:0006366"]
[1657,824,"PN242","NFkB p50","S337","Nuclear factor NF-kappa-B p105 subunit",{"v":903.0188323945787,"d":"903"},{"v":813.1215607432736,"d":"813"},{"v":458.141362982494,"d":"458"},{"v":50.73441954334644,"d":"51"},{"v":192.2752981143301,"d":"192"},{"v":3783.0865835791965,"d":"3783"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues surrounding the phosphorylated Ser-337 of human NFκB p50.","The effect of S337 phosphorylation is unclear. This phosphorylation site in NFkB p50 has not been reported in high throughput mass spectrometry studies.","PKACa (PRKACA); PKCa (PRKCA)","P19838","P19838",1011,null,"P19838","NP_001158884.1","Block5",12,5,"5, 13, 21, 29",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005737; GO:0005829; GO:0005576; GO:0033256; GO:0005739; GO:0005654; GO:0005634; GO:0034774; GO:0035580","GO:0042805; GO:0003682; GO:0003700; GO:0042802; GO:0046982; GO:0042803; GO:0000980; GO:0000977; GO:0000981; GO:0001205; GO:0001227; GO:0008134; GO:0044212; GO:0000976","GO:0006915; GO:1904385; GO:0071359; GO:0071347; GO:0071354; GO:0071222; GO:0071260; GO:0071316; GO:0071356; GO:0038095; GO:0007249; GO:0006954; GO:0045087; GO:0070498; GO:0031293; GO:0043066; GO:0010956; GO:0032269; GO:0032375; GO:0010629; GO:0050728; GO:0045083; GO:0000122; GO:0010957; GO:0043312; GO:0038061; GO:0090263; GO:1900127; GO:0010884; GO:0010744; GO:2000630; GO:0051092; GO:0045893; GO:0045944; GO:0032481; GO:0035994; GO:0002223; GO:0051403; GO:0050852; GO:0006366"]
[1659,825,"NN071","NFKB p65 (Rel A)","Pan-specific","NF-kappa-B p65 nuclear transcription factor",{"v":1976.5948843831002,"d":"1977"},{"v":1827.2426977414789,"d":"1827"},{"v":1006.4592509699252,"d":"1006"},{"v":50.91884325522999,"d":"51"},{"v":423.6508541551894,"d":"424"},{"v":11947.790504346647,"d":"11948"},"External","RpAb","Epitope undefined.",{"$nulls":3},"Q04206","Q04206",1012,null,"Q04206","NP_003989","Block5",12,6,"5, 13, 21, 29",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Nuclear receptor co-regulator; Transcription factor","GO:0005737; GO:0005829; GO:0098978; GO:0033256; GO:0035525; GO:0000790; GO:0005654; GO:0005634; GO:0005667","GO:0042805; GO:0033613; GO:0071532; GO:0003682; GO:0031490; GO:0003677; GO:0003700; GO:0042826; GO:0042802; GO:0051059; GO:0042301; GO:0044877; GO:0046982; GO:0042803; GO:0019901; GO:0047485; GO:0070491; GO:0000980; GO:0000978; GO:0000977; GO:0000981; GO:0001205; GO:0001077; GO:0001078; GO:0000983; GO:0003705; GO:0008134; GO:0044212; GO:0031625","GO:0006117; GO:0007568; GO:0009887; GO:0006968; GO:1904385; GO:0035729; GO:0070301; GO:0071347; GO:0071354; GO:0071222; GO:0071223; GO:0071316; GO:0071224; GO:0071356; GO:0035924; GO:0019221; GO:0051607; GO:0038095; GO:0001942; GO:0006954; GO:0070498; GO:0001889; GO:0031293; GO:0043066; GO:2001237; GO:0046627; GO:1901223; GO:1902894; GO:0042177; GO:0033234; GO:0045892; GO:0000122; GO:0070431; GO:0008284; GO:0032332; GO:0043123; GO:0045084; GO:2000630; GO:0051092; GO:1901224; GO:1902895; GO:0014040; GO:0050862; GO:0045893; GO:0045944; GO:1901522; GO:0032481; GO:0099527; GO:0061614; GO:0043620; GO:0050727; GO:1901222; GO:0006355; GO:0043200; GO:0051591; GO:0033590; GO:0032868; GO:0070555; GO:0043278; GO:0032495; GO:0035994; GO:0010033; GO:0032570; GO:0010224; GO:0002223; GO:0050852; GO:0033209; GO:0016032"]
[1661,826,"PN053-1","NFKB p65 (Rel A)","S276","NF-kappa-B p65 nuclear transcription factor",{"v":8668.48165437977,"d":"8668"},{"v":8720.08462502878,"d":"8720"},{"v":2195.013009595456,"d":"2195"},{"v":25.321770260497935,"d":"25"},{"v":1024.491788384924,"d":"1024"},{"v":14744.871871706768,"d":"14745"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S276 phosphosite.","S276 phosphorylation induces transcriptional activity and binding to CBP, DNA, DNMT1, PKACA, eEF1B and p300, and inhibits interaction with HDAC1. This phosphorylation site in NFKB p65 has not been detected in high throughput mass spectrometry studies, although it is commonly reported by Western blotting.","MSK1; MSK2; Pim1; PKACa (PRKACA); PKCa (PRKCA)","Q04206","Q04206",1012,null,"Q04206","NP_003989","Block5",12,7,"5, 13, 21, 29",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Nuclear receptor co-regulator; Transcription factor","GO:0005737; GO:0005829; GO:0098978; GO:0033256; GO:0035525; GO:0000790; GO:0005654; GO:0005634; GO:0005667","GO:0042805; GO:0033613; GO:0071532; GO:0003682; GO:0031490; GO:0003677; GO:0003700; GO:0042826; GO:0042802; GO:0051059; GO:0042301; GO:0044877; GO:0046982; GO:0042803; GO:0019901; GO:0047485; GO:0070491; GO:0000980; GO:0000978; GO:0000977; GO:0000981; GO:0001205; GO:0001077; GO:0001078; GO:0000983; GO:0003705; GO:0008134; GO:0044212; GO:0031625","GO:0006117; GO:0007568; GO:0009887; GO:0006968; GO:1904385; GO:0035729; GO:0070301; GO:0071347; GO:0071354; GO:0071222; GO:0071223; GO:0071316; GO:0071224; GO:0071356; GO:0035924; GO:0019221; GO:0051607; GO:0038095; GO:0001942; GO:0006954; GO:0070498; GO:0001889; GO:0031293; GO:0043066; GO:2001237; GO:0046627; GO:1901223; GO:1902894; GO:0042177; GO:0033234; GO:0045892; GO:0000122; GO:0070431; GO:0008284; GO:0032332; GO:0043123; GO:0045084; GO:2000630; GO:0051092; GO:1901224; GO:1902895; GO:0014040; GO:0050862; GO:0045893; GO:0045944; GO:1901522; GO:0032481; GO:0099527; GO:0061614; GO:0043620; GO:0050727; GO:1901222; GO:0006355; GO:0043200; GO:0051591; GO:0033590; GO:0032868; GO:0070555; GO:0043278; GO:0032495; GO:0035994; GO:0010033; GO:0032570; GO:0010224; GO:0002223; GO:0050852; GO:0033209; GO:0016032"]
[1663,827,"PN243","NFKB p65 (Rel A)","S311","NF-kappa-B p65 nuclear transcription factor",{"v":235.37183197236317,"d":"235"},{"v":212.8408330354427,"d":"213"},{"v":138.54525148185544,"d":"139"},{"v":58.862290496223494,"d":"59"},{"v":27.684123397409174,"d":"28"},{"v":938.0304076056354,"d":"938"},"External","MmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the S311 phosphosite.","The effect of S311 phosphorylation induces transcriptional activity. This is one of the minor in vivo phosphorylation sites in NFKB p65 (≥2 reports from high throughput mass spectrometry studies).","IKKb; PKCz (PRKCZ)","Q04206","Q04206",1012,null,"Q04206","NP_003989","Block5",12,8,"5, 13, 21, 29",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Nuclear receptor co-regulator; Transcription factor","GO:0005737; GO:0005829; GO:0098978; GO:0033256; GO:0035525; GO:0000790; GO:0005654; GO:0005634; GO:0005667","GO:0042805; GO:0033613; GO:0071532; GO:0003682; GO:0031490; GO:0003677; GO:0003700; GO:0042826; GO:0042802; GO:0051059; GO:0042301; GO:0044877; GO:0046982; GO:0042803; GO:0019901; GO:0047485; GO:0070491; GO:0000980; GO:0000978; GO:0000977; GO:0000981; GO:0001205; GO:0001077; GO:0001078; GO:0000983; GO:0003705; GO:0008134; GO:0044212; GO:0031625","GO:0006117; GO:0007568; GO:0009887; GO:0006968; GO:1904385; GO:0035729; GO:0070301; GO:0071347; GO:0071354; GO:0071222; GO:0071223; GO:0071316; GO:0071224; GO:0071356; GO:0035924; GO:0019221; GO:0051607; GO:0038095; GO:0001942; GO:0006954; GO:0070498; GO:0001889; GO:0031293; GO:0043066; GO:2001237; GO:0046627; GO:1901223; GO:1902894; GO:0042177; GO:0033234; GO:0045892; GO:0000122; GO:0070431; GO:0008284; GO:0032332; GO:0043123; GO:0045084; GO:2000630; GO:0051092; GO:1901224; GO:1902895; GO:0014040; GO:0050862; GO:0045893; GO:0045944; GO:1901522; GO:0032481; GO:0099527; GO:0061614; GO:0043620; GO:0050727; GO:1901222; GO:0006355; GO:0043200; GO:0051591; GO:0033590; GO:0032868; GO:0070555; GO:0043278; GO:0032495; GO:0035994; GO:0010033; GO:0032570; GO:0010224; GO:0002223; GO:0050852; GO:0033209; GO:0016032"]
[1665,828,"PN156","NFKB p65 (Rel A)","S529","NF-kappa-B p65 nuclear transcription factor",{"v":725.1449623293413,"d":"725"},{"v":646.4193351973511,"d":"646"},{"v":454.7053074914747,"d":"455"},{"v":62.70543561812125,"d":"63"},{"v":20.881366596199932,"d":"21"},{"v":2507.7334139752475,"d":"2508"},"External","RpAb","LL(pS)GD","Corresponds to amino acid residues L527 to D531.","S529 phosphorylation induces transcriptional activity. This is one of the minor in vivo phosphorylation sites in NFKB p65 (≥3 reports from high throughput mass spectrometry studies).","CK2a1 (CSNK2A1)","Q04206","Q04206",1012,null,"Q04206","NP_003989","Block5",12,9,"5, 13, 21, 29",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Nuclear receptor co-regulator; Transcription factor","GO:0005737; GO:0005829; GO:0098978; GO:0033256; GO:0035525; GO:0000790; GO:0005654; GO:0005634; GO:0005667","GO:0042805; GO:0033613; GO:0071532; GO:0003682; GO:0031490; GO:0003677; GO:0003700; GO:0042826; GO:0042802; GO:0051059; GO:0042301; GO:0044877; GO:0046982; GO:0042803; GO:0019901; GO:0047485; GO:0070491; GO:0000980; GO:0000978; GO:0000977; GO:0000981; GO:0001205; GO:0001077; GO:0001078; GO:0000983; GO:0003705; GO:0008134; GO:0044212; GO:0031625","GO:0006117; GO:0007568; GO:0009887; GO:0006968; GO:1904385; GO:0035729; GO:0070301; GO:0071347; GO:0071354; GO:0071222; GO:0071223; GO:0071316; GO:0071224; GO:0071356; GO:0035924; GO:0019221; GO:0051607; GO:0038095; GO:0001942; GO:0006954; GO:0070498; GO:0001889; GO:0031293; GO:0043066; GO:2001237; GO:0046627; GO:1901223; GO:1902894; GO:0042177; GO:0033234; GO:0045892; GO:0000122; GO:0070431; GO:0008284; GO:0032332; GO:0043123; GO:0045084; GO:2000630; GO:0051092; GO:1901224; GO:1902895; GO:0014040; GO:0050862; GO:0045893; GO:0045944; GO:1901522; GO:0032481; GO:0099527; GO:0061614; GO:0043620; GO:0050727; GO:1901222; GO:0006355; GO:0043200; GO:0051591; GO:0033590; GO:0032868; GO:0070555; GO:0043278; GO:0032495; GO:0035994; GO:0010033; GO:0032570; GO:0010224; GO:0002223; GO:0050852; GO:0033209; GO:0016032"]
[1667,829,"PN245","NFKB p65 (Rel A)","S536","NF-kappa-B p65 nuclear transcription factor",{"v":730.7428573880215,"d":"731"},{"v":640.6276341004703,"d":"641"},{"v":404.79868049110684,"d":"405"},{"v":55.395502863760505,"d":"55"},{"v":129.66247194883434,"d":"130"},{"v":3022.2577590676265,"d":"3022"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues surrounding the phosphorylated Ser-536 of human NFκB p65. ","The effect of S536 phosphorylation is unclear. This is one of the minor in vivo phosphorylation sites in NFKB p65 (≥4 reports from high throughput mass spectrometry studies).","CaMK4; IKKa (CHUK, IKBKA); IKKb; IKKe (IKBKE); TBK1","Q04206","Q04206",1012,null,"Q04206","NP_003989","Block5",12,10,"5, 13, 21, 29",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Nuclear receptor co-regulator; Transcription factor","GO:0005737; GO:0005829; GO:0098978; GO:0033256; GO:0035525; GO:0000790; GO:0005654; GO:0005634; GO:0005667","GO:0042805; GO:0033613; GO:0071532; GO:0003682; GO:0031490; GO:0003677; GO:0003700; GO:0042826; GO:0042802; GO:0051059; GO:0042301; GO:0044877; GO:0046982; GO:0042803; GO:0019901; GO:0047485; GO:0070491; GO:0000980; GO:0000978; GO:0000977; GO:0000981; GO:0001205; GO:0001077; GO:0001078; GO:0000983; GO:0003705; GO:0008134; GO:0044212; GO:0031625","GO:0006117; GO:0007568; GO:0009887; GO:0006968; GO:1904385; GO:0035729; GO:0070301; GO:0071347; GO:0071354; GO:0071222; GO:0071223; GO:0071316; GO:0071224; GO:0071356; GO:0035924; GO:0019221; GO:0051607; GO:0038095; GO:0001942; GO:0006954; GO:0070498; GO:0001889; GO:0031293; GO:0043066; GO:2001237; GO:0046627; GO:1901223; GO:1902894; GO:0042177; GO:0033234; GO:0045892; GO:0000122; GO:0070431; GO:0008284; GO:0032332; GO:0043123; GO:0045084; GO:2000630; GO:0051092; GO:1901224; GO:1902895; GO:0014040; GO:0050862; GO:0045893; GO:0045944; GO:1901522; GO:0032481; GO:0099527; GO:0061614; GO:0043620; GO:0050727; GO:1901222; GO:0006355; GO:0043200; GO:0051591; GO:0033590; GO:0032868; GO:0070555; GO:0043278; GO:0032495; GO:0035994; GO:0010033; GO:0032570; GO:0010224; GO:0002223; GO:0050852; GO:0033209; GO:0016032"]
[1669,830,"PN633","NFkB-p100","S866","Nuclear factor NF-kappa-B p100 subunit",{"v":4693.937935251934,"d":"4694"},{"v":4703.648321015438,"d":"4704"},{"v":1106.9657528075377,"d":"1107"},{"v":23.582880048202522,"d":"24"},{"v":440.5379519191331,"d":"441"},{"v":10044.865967128671,"d":"10045"},"Kinexus","RpAb","KED(pS)AYG(pS)QSV(bA)C","Corresponds to amino acid residues K863 to V873.","S866 phosphorylation induces interaction with IKKa. This is a minor in vivo phosphorylation site in NFKB p100 (≥1 report from high throughput mass spectrometry studies).","NIK (MAP3K14)","Q00653","Q00653",3881,null,"Q00653","NP_001070962.1","Block5",12,11,"5, 13, 21, 29",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0033257; GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0003682; GO:0003700; GO:0000978; GO:0000981; GO:0001077; GO:0003713","GO:0007568; GO:0030198; GO:0002268; GO:0002467; GO:0007249; GO:0006954; GO:0045087; GO:0000122; GO:0038061; GO:0051092; GO:0045944; GO:0032481; GO:0006355; GO:0034097; GO:0032496; GO:0048511; GO:0048536"]
[1671,831,"PN634","NFKB1 (NFkB-p105)","S903","Nuclear factor NF-kappa-B p105 subunit",{"v":18946.176339141915,"d":"18946"},{"v":18374.410679451932,"d":"18374"},{"v":4570.269466869303,"d":"4570"},{"v":24.122384300980773,"d":"24"},{"v":6781.533070447014,"d":"6782"},{"v":34881.82682206541,"d":"34882"},"Kinexus","RpAb","CSQAH(pS)LPL(pS)PAS","Corresponds to amino acid residues C899 to S910.","S903 phosphorylation promotes protein proteolysis. This is one of the major in vivo phosphorylation sites in NFKB1 (≥30 reports from high throughput mass spectrometry studies).","GSK3b","P19838","P19838",1011,null,"P19838","NP_001158884.1","Block5",12,12,"5, 13, 21, 29",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005737; GO:0005829; GO:0005576; GO:0033256; GO:0005739; GO:0005654; GO:0005634; GO:0034774; GO:0035580","GO:0042805; GO:0003682; GO:0003700; GO:0042802; GO:0046982; GO:0042803; GO:0000980; GO:0000977; GO:0000981; GO:0001205; GO:0001227; GO:0008134; GO:0044212; GO:0000976","GO:0006915; GO:1904385; GO:0071359; GO:0071347; GO:0071354; GO:0071222; GO:0071260; GO:0071316; GO:0071356; GO:0038095; GO:0007249; GO:0006954; GO:0045087; GO:0070498; GO:0031293; GO:0043066; GO:0010956; GO:0032269; GO:0032375; GO:0010629; GO:0050728; GO:0045083; GO:0000122; GO:0010957; GO:0043312; GO:0038061; GO:0090263; GO:1900127; GO:0010884; GO:0010744; GO:2000630; GO:0051092; GO:0045893; GO:0045944; GO:0032481; GO:0035994; GO:0002223; GO:0051403; GO:0050852; GO:0006366"]
[1673,832,"PN241","NFKB1 (NFkB-p105)","S932","Nuclear factor NF-kappa-B p105 subunit",{"v":665.5124190055741,"d":"666"},{"v":585.029173880683,"d":"585"},{"v":333.68022923400366,"d":"334"},{"v":50.13884334909893,"d":"50"},{"v":186.48471809149837,"d":"186"},{"v":2447.299212563331,"d":"2447"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues surrounding the phosphorylated Ser-932 of human NFκB p105.","S932 phosphorylation facilitates protein degradation. This phosphorylation site in NFKB1 has not been reported high throughput mass spectrometry studies.","IKKa (CHUK, IKBKA); IKKb (IKBKB)","P19838","P19838",1011,null,"P19838","NP_001158884.1","Block5",12,13,"5, 13, 21, 29",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005737; GO:0005829; GO:0005576; GO:0033256; GO:0005739; GO:0005654; GO:0005634; GO:0034774; GO:0035580","GO:0042805; GO:0003682; GO:0003700; GO:0042802; GO:0046982; GO:0042803; GO:0000980; GO:0000977; GO:0000981; GO:0001205; GO:0001227; GO:0008134; GO:0044212; GO:0000976","GO:0006915; GO:1904385; GO:0071359; GO:0071347; GO:0071354; GO:0071222; GO:0071260; GO:0071316; GO:0071356; GO:0038095; GO:0007249; GO:0006954; GO:0045087; GO:0070498; GO:0031293; GO:0043066; GO:0010956; GO:0032269; GO:0032375; GO:0010629; GO:0050728; GO:0045083; GO:0000122; GO:0010957; GO:0043312; GO:0038061; GO:0090263; GO:1900127; GO:0010884; GO:0010744; GO:2000630; GO:0051092; GO:0045893; GO:0045944; GO:0032481; GO:0035994; GO:0002223; GO:0051403; GO:0050852; GO:0006366"]
[1675,833,"NK207-2","NIK (MAP3K14; NLK; LAK1)","Pan-specific","NF-kappa beta-inducing kinase (nemo-like kinase)",{"v":502.74261592566444,"d":"503"},{"v":430.45125899049515,"d":"430"},{"v":291.02041163305324,"d":"291"},{"v":57.88656111780338,"d":"58"},{"v":77.93055660171953,"d":"78"},{"v":2102.533725955669,"d":"2103"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 700-9473 mapping at the C-terminus of human NIK.",null,null,"Q99558","Q99558",464,"Q99558","Q99558","NP_003945.2","Block5",13,1,"5, 13, 21, 29","NIK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE-Unique",{"$nulls":6},"Protein-serine kinase, STE group, STE-Unique family","GO:0005737; GO:0005829; GO:0001650; GO:0043231; GO:0005634","GO:0005524; GO:0016301; GO:0004709; GO:0004704; GO:0004672; GO:0004674","GO:0032147; GO:0071260; GO:0051607; GO:0007249; GO:0006955; GO:0038061; GO:0043123; GO:0042981; GO:0007346; GO:0023014; GO:0031098; GO:0033209"]
[1677,834,"NK207","NIK (MAP3K14; NLK; LAK1)","Pan-specific","Serine/threonine protein kinase NLK",{"v":396.2047390542182,"d":"396"},{"v":334.4842040054099,"d":"334"},{"v":325.027032786386,"d":"325"},{"v":82.03511991357277,"d":"82"},{"v":97.5680758051709,"d":"98"},{"v":3944.9038000238133,"d":"3945"},"External","GpAb","Epitope undefined.",{"$nulls":3},"Q99558","Q99558",464,"Q99558","Q99558","NP_003945.2","Block5",13,2,"5, 13, 21, 29","NIK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE-Unique",{"$nulls":6},"Protein-serine kinase, STE group, STE-Unique family","GO:0005737; GO:0005829; GO:0001650; GO:0043231; GO:0005634","GO:0005524; GO:0016301; GO:0004709; GO:0004704; GO:0004672; GO:0004674","GO:0032147; GO:0071260; GO:0051607; GO:0007249; GO:0006955; GO:0038061; GO:0043123; GO:0042981; GO:0007346; GO:0023014; GO:0031098; GO:0033209"]
[1679,835,"PK736","NLK","T298","Serine/threonine protein kinase NLK",{"v":369.5933128829445,"d":"370"},{"v":312.9825698102434,"d":"313"},{"v":284.3133150092619,"d":"284"},{"v":76.92599002712693,"d":"77"},{"v":71.22599673215095,"d":"71"},{"v":2989.1559577969374,"d":"2989"},"Kinexus","RpAb","RHM(pT)QEV(bA)C","Corresponds to amino acid residues R295 to V301; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T298 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation site in NLK (≥56 reports from high throughput mass spectrometry studies).",null,"Q9UBE8","Q9UBE8",809,"Q9UBE8",null,"NP_057315.3","Block5",13,3,"5, 13, 21, 29","NLK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","nmo",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.24; CMGC domain target; CMGC</A> group; MAPK family; nmo subfamily","GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0000287; GO:0004707; GO:0004672; GO:0004674; GO:0042169; GO:0008134; GO:0031625","GO:0035556; GO:0030178; GO:0018107; GO:0046777; GO:0006468; GO:0050821; GO:0010468; GO:0006355; GO:0042501; GO:0006351; GO:0007179; GO:0007223"]
[1681,836,"PN055-1","NMDAR1","S896","Glutamate [NMDA] receptor subunit zeta-1",{"v":850.9096598114504,"d":"851"},{"v":644.1461918980075,"d":"644"},{"v":706.6616759199914,"d":"707"},{"v":83.0477910048145,"d":"83"},{"v":9.622439648690396,"d":"10"},{"v":3820.559127010963,"d":"3821"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S896 phosphosite.","The effect of S896 phosphorylation is unclear. This phosphorylation site in NMDAR1 has not been reported from high throughput mass spectrometry studies.","PKCa (PRKCA)","Q05586","Q05586",1016,null,null,"NP_000823","Block5",13,4,"5, 13, 21, 29",{"$nulls":3},"Channel, ligand-gated - Glutamate receptor",{"$nulls":9},"Channel protein","GO:0030054; GO:0009986; GO:0030425; GO:0043197; GO:0005783; GO:0060076; GO:0098978; GO:0005887; GO:0099061; GO:0005622; GO:0043005; GO:0017146; GO:0005886; GO:0014069; GO:0045211; GO:0045202; GO:0043083; GO:0097060; GO:0008021; GO:0043195","GO:0005509; GO:0005516; GO:0016595; GO:0022849; GO:0016594; GO:0042165; GO:0004972; GO:0044877; GO:0005088; GO:0005102; GO:1904315","GO:0008344; GO:0007420; GO:0055074; GO:0097553; GO:0006812; GO:0021987; GO:0001661; GO:0048013; GO:0098976; GO:0060079; GO:0035235; GO:0007616; GO:0060179; GO:0000165; GO:0043524; GO:0008355; GO:0021586; GO:0043065; GO:0010524; GO:2001056; GO:2000463; GO:1903428; GO:0045944; GO:0060134; GO:0018964; GO:0051290; GO:1903539; GO:0050770; GO:0048814; GO:0048169; GO:0042391; GO:0043576; GO:0051963; GO:0048167; GO:0007585; GO:0001975; GO:0045471; GO:1905429; GO:0043278; GO:0019233; GO:0035176; GO:0001967; GO:0035249; GO:0008542"]
[1683,837,"NN297-1","NMDAR2A (GRIN2A)","Pan-specific","Glutamate [NMDA] receptor subunit epsilon-1",{"v":1567.871069766928,"d":"1568"},{"v":1566.9962092028,"d":"1567"},{"v":958.2268097058544,"d":"958"},{"v":61.11642903445497,"d":"61"},{"v":16.401167975024357,"d":"16"},{"v":4591.005642225311,"d":"4591"},"External","MmAb","Epitope undefined.",{"$nulls":3},"Q12879","Q12879",1100,null,null,"NP_000824.1","Block5",13,5,"5, 13, 21, 29",{"$nulls":3},"Channel, ligand-gated - Glutamate receptor",{"$nulls":9},"Channel, ligand-gated","GO:0030054; GO:0009986; GO:0005783; GO:0098978; GO:0005887; GO:0099061; GO:0043005; GO:0017146; GO:0005886; GO:0014069; GO:0042734; GO:0097060; GO:0008021","GO:0022849; GO:0004972; GO:0005088; GO:0008270","GO:0097202; GO:0007420; GO:0097553; GO:0007268; GO:0033058; GO:0042417; GO:0098976; GO:0060079; GO:0007215; GO:0007611; GO:0060291; GO:0000165; GO:0007613; GO:0042177; GO:0022008; GO:0043065; GO:1900273; GO:1903539; GO:0051930; GO:0048167; GO:0001975; GO:0045471; GO:0009611; GO:0019233; GO:0042428; GO:0030431; GO:0001964; GO:0008542"]
[1685,838,"PN710","NMDAR2A (GRIN2A)","Y943","Glutamate [NMDA] receptor subunit epsilon-1",{"v":4675.522760030491,"d":"4676"},{"v":4395.084814236804,"d":"4395"},{"v":1599.0194325855969,"d":"1599"},{"v":34.19979999359835,"d":"34"},{"v":1498.055532319338,"d":"1498"},{"v":11355.562545342522,"d":"11356"},"Kinexus","RpAb","NLM(pY)SDN(bA)C","Corresponds to amino acid residues N940 to N946.","The effect of Y943 phosphorylation is unclear. This is the major in vivo phosphorylation site in NMDAR2A (≥134 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in fish.","Fyn","Q12879","Q12879",1100,null,null,"NP_000824.1","Block5",13,6,"5, 13, 21, 29",{"$nulls":3},"Channel, ligand-gated - Glutamate receptor",{"$nulls":9},"Channel, ligand-gated","GO:0030054; GO:0009986; GO:0005783; GO:0098978; GO:0005887; GO:0099061; GO:0043005; GO:0017146; GO:0005886; GO:0014069; GO:0042734; GO:0097060; GO:0008021","GO:0022849; GO:0004972; GO:0005088; GO:0008270","GO:0097202; GO:0007420; GO:0097553; GO:0007268; GO:0033058; GO:0042417; GO:0098976; GO:0060079; GO:0007215; GO:0007611; GO:0060291; GO:0000165; GO:0007613; GO:0042177; GO:0022008; GO:0043065; GO:1900273; GO:1903539; GO:0051930; GO:0048167; GO:0001975; GO:0045471; GO:0009611; GO:0019233; GO:0042428; GO:0030431; GO:0001964; GO:0008542"]
[1687,839,"PN054","NMDAR2B (GRIN2B)","Y1474","Glutamate [NMDA] receptor subunit epsilon-2",{"v":69.50743300650468,"d":"70"},{"v":44.93633347936871,"d":"45"},{"v":80.5356286465214,"d":"81"},{"v":115.86621050871591,"d":"116"},{"v":8.267592706756984,"d":"8"},{"v":586.8269135887044,"d":"587"},"External","RpAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the Y1474 phosphosite.","The effect of Y1474 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in NMDAR2B (≥105 reports from high throughput mass spectrometry studies).","Fyn","Q13224","Q13224",1236,null,"Q13224","NP_000825.2","Block5",13,7,"5, 13, 21, 29",{"$nulls":3},"Channel, ligand-gated - Glutamate receptor",{"$nulls":9},"Channel, ligand-gated; Channel, calcium","GO:0030054; GO:0009986; GO:0005887; GO:0005622; GO:0043005; GO:0017146; GO:0005886; GO:0014069; GO:0045211; GO:0097060","GO:0016595; GO:0022849; GO:0016594; GO:0004972; GO:0005088; GO:0008270","GO:0007420; GO:0097553; GO:0007268; GO:0048013; GO:0098976; GO:0007215; GO:0007611; GO:0000165; GO:0007275; GO:1902951; GO:2001056; GO:1901216; GO:0051290; GO:0048167; GO:0045471"]
[1689,840,"PN635","NOLC1","T607+T610","Nucleolar and coiled-body phosphoprotein 1",{"v":6650.002849851517,"d":"6650"},{"v":6529.691158062894,"d":"6530"},{"v":1808.4736421012396,"d":"1808"},{"v":27.19508070799729,"d":"27"},{"v":1986.8596480780552,"d":"1987"},{"v":15869.333505489722,"d":"15869"},"Kinexus","RpAb","KLQ(pT)PN(pT)FPK","Corresponds to amino acid residues K604 to K613.","The effects of T607 and T610 phosphorylation are unclear. These are two of the major in vivo phosphorylation sites in NOLC1 (≥102 and ≥101 reports, respectively, from high throughput mass spectrometry studies).","T607: CDK1 (CDC2). T610: CDK1 (CDC2).","Q14978","Q14978",5435,null,null,"NP_004732.2","Block5",13,8,"5, 13, 21, 29",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription, coactivator/corepressor","GO:0031428; GO:0031429; GO:0015030; GO:0005737; GO:0001650; GO:0005730","GO:0005524; GO:0034512; GO:0034513; GO:0003677; GO:0003700; GO:0005525; GO:0008139; GO:0019904; GO:0046982; GO:0003723; GO:0001042; GO:0008134","GO:0033979; GO:0000278; GO:0014032; GO:0014029; GO:0007000; GO:0008284; GO:0045893; GO:0042306; GO:0006417; GO:0006970; GO:0006364"]
[1691,841,"PN762","NOS1","S746","Nitric oxide synthase, brain",{"v":7060.177056348293,"d":"7060"},{"v":6584.396726267528,"d":"6584"},{"v":2485.1440007800566,"d":"2485"},{"v":35.19945719414348,"d":"35"},{"v":2554.5149999501796,"d":"2555"},{"v":19577.919011530103,"d":"19578"},"Kinexus","RpAb","CAVKF(pS)AKL","Corresponds to amino acid residues A742 to L749.","S746 phosphorylation inhibits the enzymatic activity of NOS1. Phosphorylation of this site in NOS1 has not been reported by mass spectrometry. This human phosphosite is highly conserved in vertebrates and also found in the fruit fly. ","CaMK1a","P29475","P29475",1018,null,null,"NP_000611.1","Block5",13,9,"5, 13, 21, 29",{"$nulls":12},"X","Oxidoreductase; Amino Acid Metabolism - arginine and proline; EC 1.14.13.39","GO:0044305; GO:0005901; GO:0005737; GO:0005856; GO:0005829; GO:0043197; GO:0045121; GO:0005739; GO:0005654; GO:0048471; GO:0001917; GO:0005886; GO:0032991; GO:0042383; GO:0016529; GO:0033017; GO:0045202; GO:0030315; GO:0030018","GO:0034618; GO:0046870; GO:0005516; GO:0050660; GO:0010181; GO:0020037; GO:0044325; GO:0050661; GO:0003958; GO:0004517; GO:0097110; GO:0017080; GO:0034617","GO:0006527; GO:0045454; GO:0071363; GO:0042738; GO:0033555; GO:0007520; GO:0045776; GO:0051926; GO:0010523; GO:0051346; GO:0043267; GO:0051612; GO:0042136; GO:0006809; GO:0007263; GO:0018119; GO:0140196; GO:0031284; GO:0035066; GO:1902307; GO:0098735; GO:0045893; GO:0045944; GO:1902514; GO:1903779; GO:0055117; GO:0050767; GO:0060314; GO:0002028; GO:0009408; GO:0001666; GO:0098924; GO:0006941; GO:0042311"]
[1693,842,"PN711","NOS2","S745","Nitric oxide synthase, inducible",{"v":7018.547085353557,"d":"7019"},{"v":6904.928915232116,"d":"6905"},{"v":1498.7776940359383,"d":"1499"},{"v":21.354529303701863,"d":"21"},{"v":3616.6103180430237,"d":"3617"},{"v":12132.314438129235,"d":"12132"},"Kinexus","RpAb","NLQ(pS)PTS(bA)C","Corresponds to amino acid residues N742 to S748.","S745 phosphorylation stimulates enzyme activity. This phosphorylation site appears to be poorly detected by mass spectrometry (≥1 report ). This human phosphosite is highly conserved in vertebrates and found in the frog.","ERK1 (MAPK3); ERK2 (MAPK1)","P35228","P35228",7500,null,null,"NP_000616.3","Block5",13,10,"5, 13, 21, 29",{"$nulls":12},"X","Oxidoreductase, Amino Acid Metabolism group, Arginine and proline metabolism family","GO:0030863; GO:0005737; GO:0005829; GO:0005622; GO:0005634; GO:0048471; GO:0005782; GO:0005777","GO:0034618; GO:0005516; GO:0050660; GO:0010181; GO:0020037; GO:0046872; GO:0050661; GO:0003958; GO:0004517; GO:0042803; GO:0005102; GO:0034617","GO:0006527; GO:0045454; GO:0035690; GO:0071346; GO:0071222; GO:0007623; GO:0019221; GO:0042742; GO:0050829; GO:0002227; GO:0072604; GO:0072606; GO:0045776; GO:0010629; GO:0042177; GO:0006809; GO:0007263; GO:0018119; GO:0097755; GO:0031284; GO:0051712; GO:0001912; GO:0032310; GO:0006625; GO:0042127; GO:0043457; GO:1900015; GO:0050796; GO:0009617; GO:0001666; GO:0006801"]
[1695,843,"PN247","NOS3","T495","Nitric oxide synthase, endothelial",{"v":765.8634996131797,"d":"766"},{"v":406.7700070908131,"d":"407"},{"v":2287.356708647338,"d":"2287"},{"v":298.6637579415431,"d":"299"},{"v":111.75709487792886,"d":"112"},{"v":22103.581940198485,"d":"22104"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues surrounding the phosphorylated Thr-495 of human NOS3.","T495 phosphorylation induces enzymatic inhibition. This is one of the minor in vivo phosphorylation sites in NOS3 (≥2 reports from high throughput mass spectrometry studies).","AMPKa1 (PRKAA1); PKACa (PRKACA); PKCa (PRKCA); PKG2 (PRKG2)","P29474","P29474",966,null,null,"NP_000594.2","Block5",13,11,"5, 13, 21, 29",{"$nulls":12},"X","Amino Acid Metabolism - arginine and proline; Oxidoreductase; EC 1.14.13.39","GO:0005901; GO:0005623; GO:0005737; GO:0005856; GO:0005829; GO:0030666; GO:0000139; GO:0005634; GO:0005886","GO:0003785; GO:0034618; GO:0046870; GO:0005516; GO:0050660; GO:0010181; GO:0020037; GO:0050661; GO:0003958; GO:0004517; GO:0097110; GO:0034617","GO:0001525; GO:0003180; GO:0006527; GO:0001974; GO:0045454; GO:0051186; GO:0003203; GO:0043542; GO:0048873; GO:0001701; GO:0031663; GO:0030324; GO:0007005; GO:0070168; GO:0045776; GO:0051926; GO:0008285; GO:1902042; GO:0051346; GO:0014740; GO:0010544; GO:0043267; GO:0006809; GO:0007263; GO:0001542; GO:0045766; GO:0097755; GO:0043536; GO:0010628; GO:0031284; GO:0003184; GO:0008217; GO:0050880; GO:0050999; GO:0002028; GO:0003100; GO:0003057; GO:0019430; GO:0034405; GO:0009408; GO:0014806; GO:0042311; GO:0060412"]
[1697,844,"PN712","NOS3","T1175+S1177","Nitric oxide synthase, endothelial",{"v":18794.360728708732,"d":"18794"},{"v":18468.221471852652,"d":"18468"},{"v":5452.147765306183,"d":"5452"},{"v":29.009487707543713,"d":"29"},{"v":245.3985557119351,"d":"245"},{"v":33896.98968711617,"d":"33897"},"Kinexus","RpAb","RIR(pT)Q(pS)FSL(bA)C","Corresponds to amino acid residues R1172 to L1180.","T1175+S1177 phosphorylation stimulates enzyme activity. These are two of the major in vivo phosphorylation sites in NOS3 (≥17 and >22 reports, respectively, by mass spectrometry). These phosphosites are not highly conserved in vertebrates, but are found in the rat.","S1177: Akt1 (PKBa); AMPKa1 (PRKAA1); PKACa (PRKACA); PKCd (PRKCD); PKG2 (PRKG2).","P29474","P29474",966,null,null,"NP_000594.2","Block5",13,12,"5, 13, 21, 29",{"$nulls":12},"X","Amino Acid Metabolism - arginine and proline; Oxidoreductase; EC 1.14.13.39","GO:0005901; GO:0005623; GO:0005737; GO:0005856; GO:0005829; GO:0030666; GO:0000139; GO:0005634; GO:0005886","GO:0003785; GO:0034618; GO:0046870; GO:0005516; GO:0050660; GO:0010181; GO:0020037; GO:0050661; GO:0003958; GO:0004517; GO:0097110; GO:0034617","GO:0001525; GO:0003180; GO:0006527; GO:0001974; GO:0045454; GO:0051186; GO:0003203; GO:0043542; GO:0048873; GO:0001701; GO:0031663; GO:0030324; GO:0007005; GO:0070168; GO:0045776; GO:0051926; GO:0008285; GO:1902042; GO:0051346; GO:0014740; GO:0010544; GO:0043267; GO:0006809; GO:0007263; GO:0001542; GO:0045766; GO:0097755; GO:0043536; GO:0010628; GO:0031284; GO:0003184; GO:0008217; GO:0050880; GO:0050999; GO:0002028; GO:0003100; GO:0003057; GO:0019430; GO:0034405; GO:0009408; GO:0014806; GO:0042311; GO:0060412"]
[1699,845,"NK361-1","NuaK1 (ARK5)/Nuak2","Pan-specific","NUAK family SNF1-like kinase 1/2",{"v":812.575261012734,"d":"813"},{"v":666.7885384145325,"d":"667"},{"v":722.9941624432607,"d":"723"},{"v":88.97565519557831,"d":"89"},{"v":198.90497997505236,"d":"199"},{"v":10222.194811624193,"d":"10222"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 526-661 mapping at the C-terminus of human ARK5.",null,null,"O60285","O60285",802,"O60285","O60285","NP_055655.1","Block5",13,13,"5, 13, 21, 29","NUAK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","NuaK",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); CAMK group; CAMKL family; NuaK subfamily","GO:0005737; GO:0001650; GO:0015630; GO:0005654; GO:0005634","GO:0005524; GO:0046872; GO:0002039; GO:0004674","GO:0007155; GO:0006974; GO:0035556; GO:0006468; GO:0030155; GO:0042127; GO:2000772; GO:0035507; GO:1901796"]
[1701,846,"PK737","NuaK1 (ARK5)/Nuak2","T211","NUAK family SNF1-like kinase 1; AMPK-related protein kinase 5",{"v":7642.489363299902,"d":"7642"},{"v":7479.586714211802,"d":"7480"},{"v":2639.6557832337758,"d":"2640"},{"v":34.5392143548109,"d":"35"},{"v":602.8249002521982,"d":"603"},{"v":21334.815412193282,"d":"21335"},"Kinexus","RpAb","FLQ(pT)FCG(bA)C","Corresponds to amino acid residues F208 to G214; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T211 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is a minor in vivo phosphorylation sites in Nuak1 (≥1 report from high throughput mass spectrometry studies).","LKB1 (STK11); NDR2 (STK38L)","O60285","O60285",802,"O60285","O60285","NP_055655.1","Block6",1,1,"6, 14, 22, 30","NUAK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","NuaK",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); CAMK group; CAMKL family; NuaK subfamily","GO:0005737; GO:0001650; GO:0015630; GO:0005654; GO:0005634","GO:0005524; GO:0046872; GO:0002039; GO:0004674","GO:0007155; GO:0006974; GO:0035556; GO:0006468; GO:0030155; GO:0042127; GO:2000772; GO:0035507; GO:1901796"]
[1703,847,"PN636","Nur77","S351","Nuclear receptor subfamily 4 group A member 1",{"v":9941.897635050875,"d":"9942"},{"v":9631.222603135167,"d":"9631"},{"v":2813.9710838081646,"d":"2814"},{"v":28.304164728947796,"d":"28"},{"v":1227.6245208873247,"d":"1228"},{"v":21329.050672997946,"d":"21329"},"Kinexus","RpAb","CGRLP(pS)KPKQ","Corresponds to amino acid residues C347 to Q355.","S351 phosphorylation inhibits transcriptional activity and regulates apoptosis and cytoskeletal reorganization. This is the major in vivo phosphorylation site in Nur77 (≥4 reports from high throughput mass spectrometry studies).","Akt1 (PKBa); MSK1 (RPS6KA5); PKACa (PRKACA); RSK1 (RPS6KA1); RSK2 (RPS6KA3)","P22736","P22736",1767,null,null,"NP_002126.2","Block6",1,2,"6, 14, 22, 30",{"$nulls":3},"Receptor,  nuclear",{"$nulls":4},"X",{"$nulls":4},"Receptor, nuclear","GO:0005829; GO:0031965; GO:0005654; GO:0005634","GO:0003677; GO:0004879; GO:0046982; GO:0000981; GO:0043565; GO:0003707; GO:0001077; GO:0008270","GO:0002042; GO:0071376; GO:0044344; GO:0035924; GO:0035767; GO:0045444; GO:0045786; GO:0001938; GO:0045944; GO:0061469; GO:0007165; GO:0006367"]
[1705,848,"PK738","OSR1 (OXSR1)","T185","Serine/threonine-protein kinase OSR1",{"v":6945.387774027888,"d":"6945"},{"v":6957.745535303362,"d":"6958"},{"v":1646.923975607413,"d":"1647"},{"v":23.71248415770313,"d":"24"},{"v":2641.9875642677544,"d":"2642"},{"v":13782.276134567772,"d":"13782"},"Kinexus","RpAb","VRK(pT)FVG(bA)C","Corresponds to amino acid residues V182 to G188; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T185 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in OSR1 (≥50 reports from high throughput mass spectrometry studies).","Wnk1 (PRKWNK1)","O95747","O95747",824,"O95747",null,"NP_005100.1","Block6",1,3,"6, 14, 22, 30","OSR1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","FRAY",{"$nulls":5},"Protein-serine kinase, STE group, STE20 family, FRAY subfamily","GO:0005737; GO:0005829; GO:0070062","GO:0005524; GO:0042802; GO:0000287; GO:0004674","GO:0032147; GO:0071476; GO:1990869; GO:0038116; GO:0038146; GO:0035556; GO:1901017; GO:0018107; GO:0010820; GO:0006468; GO:0042981; GO:0007346; GO:0006979; GO:0023014; GO:0031098"]
[1707,851,"NK120-7","p38a MAPK (MAPK14)","Pan-specific","Mitogen-activated protein-serine kinase p38 alpha; Mitogen-activated protein kinase 14",{"v":1048.6119743916338,"d":"1049"},{"v":1014.0706880154402,"d":"1014"},{"v":525.8199097513419,"d":"526"},{"v":50.14437395266283,"d":"50"},{"v":70.41647365241367,"d":"70"},{"v":3010.4198840090858,"d":"3010"},"External","RpAb","Epitope undefined.",{"$nulls":3},"Q16539","Q16539",626,"Q16539","Q16539","NP_001306","Block6",1,6,"6, 14, 22, 30","p38a","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","p38",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.24; EC 2.7.1.37; CMGC domain target; CMGC</A> group; MAPK family; MAPK/p38 subfamily; p38 subfamily","GO:0005737; GO:0005829; GO:0005576; GO:1904813; GO:0098978; GO:0005739; GO:0016607; GO:0005654; GO:0005634; GO:0034774; GO:0000922","GO:0005524; GO:0019899; GO:0004707; GO:0004708; GO:0048273; GO:0051525; GO:0019903; GO:0004674","GO:0070935; GO:0000187; GO:0001525; GO:0006915; GO:0001502; GO:0000902; GO:0007166; GO:0071479; GO:0071222; GO:0071223; GO:0071356; GO:0035924; GO:0098586; GO:0006935; GO:0002062; GO:0000077; GO:0019395; GO:0006006; GO:0035556; GO:0031663; GO:0014835; GO:0090090; GO:0043312; GO:0030316; GO:0038066; GO:0018105; GO:0001890; GO:0090336; GO:0060045; GO:0031281; GO:0002741; GO:0045648; GO:0010628; GO:0046326; GO:2001184; GO:0010759; GO:1905050; GO:0051149; GO:0045663; GO:1901741; GO:0010831; GO:0042307; GO:2000379; GO:0045944; GO:1900015; GO:0030278; GO:1901796; GO:0099179; GO:0006357; GO:0032495; GO:0035994; GO:0007165; GO:0042770; GO:0007519; GO:0090400; GO:0051146; GO:0006351; GO:0007178; GO:0048010"]
[1709,852,"NK120-10","p38a MAPK (MAPK14)","Pan-specific","Mitogen-activated protein-serine kinase p38 alpha; Mitogen-activated protein kinase 14",{"v":1132.0495059786115,"d":"1132"},{"v":1057.83959373294,"d":"1058"},{"v":529.2326308862746,"d":"529"},{"v":46.74995466993947,"d":"47"},{"v":66.85986519608986,"d":"67"},{"v":3544.999239625249,"d":"3545"},"Kinexus","RpAb","MSQERPTFYRQELC","Corresponds to amino acid residues M1 to L13; N-terminus.",null,null,"Q16539","Q16539",626,"Q16539","Q16539","NP_001306","Block6",1,7,"6, 14, 22, 30","p38a","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","p38",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.24; EC 2.7.1.37; CMGC domain target; CMGC</A> group; MAPK family; MAPK/p38 subfamily; p38 subfamily","GO:0005737; GO:0005829; GO:0005576; GO:1904813; GO:0098978; GO:0005739; GO:0016607; GO:0005654; GO:0005634; GO:0034774; GO:0000922","GO:0005524; GO:0019899; GO:0004707; GO:0004708; GO:0048273; GO:0051525; GO:0019903; GO:0004674","GO:0070935; GO:0000187; GO:0001525; GO:0006915; GO:0001502; GO:0000902; GO:0007166; GO:0071479; GO:0071222; GO:0071223; GO:0071356; GO:0035924; GO:0098586; GO:0006935; GO:0002062; GO:0000077; GO:0019395; GO:0006006; GO:0035556; GO:0031663; GO:0014835; GO:0090090; GO:0043312; GO:0030316; GO:0038066; GO:0018105; GO:0001890; GO:0090336; GO:0060045; GO:0031281; GO:0002741; GO:0045648; GO:0010628; GO:0046326; GO:2001184; GO:0010759; GO:1905050; GO:0051149; GO:0045663; GO:1901741; GO:0010831; GO:0042307; GO:2000379; GO:0045944; GO:1900015; GO:0030278; GO:1901796; GO:0099179; GO:0006357; GO:0032495; GO:0035994; GO:0007165; GO:0042770; GO:0007519; GO:0090400; GO:0051146; GO:0006351; GO:0007178; GO:0048010"]
[1711,853,"PK739","p38a MAPK (MAPK14)","T180+Y182","Mitogen-activated protein-serine kinase p38 alpha; Mitogen-activated protein kinase 14",{"v":10391.965996705254,"d":"10392"},{"v":9711.733041091426,"d":"9712"},{"v":3236.8159950857175,"d":"3237"},{"v":31.147292014927125,"d":"31"},{"v":1155.6049736441291,"d":"1156"},{"v":25919.035233652547,"d":"25919"},"Kinexus","RpAb","DEM(pT)G(pY)(bA)C","Corresponds to amino acid residues D177 to Y182; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T180 and Y182 phosphorylation is stimulatory for phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major in vivo phosphorylation sites in p38a (≥1578 and ≥3744 reports, respectively, by mass spectrometry).","T180: MKK3 (MAP2K3, MEK3); MKK4 (MAP2K4, MEK4); MKK6 (MAP2K6, MEK6); p38a MAPK (MAPK14); PBK (TOPK).","Q16539","Q16539",626,"Q16539","Q16539","NP_001306","Block6",1,8,"6, 14, 22, 30","p38a","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","p38",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.24; EC 2.7.1.37; CMGC domain target; CMGC</A> group; MAPK family; MAPK/p38 subfamily; p38 subfamily","GO:0005737; GO:0005829; GO:0005576; GO:1904813; GO:0098978; GO:0005739; GO:0016607; GO:0005654; GO:0005634; GO:0034774; GO:0000922","GO:0005524; GO:0019899; GO:0004707; GO:0004708; GO:0048273; GO:0051525; GO:0019903; GO:0004674","GO:0070935; GO:0000187; GO:0001525; GO:0006915; GO:0001502; GO:0000902; GO:0007166; GO:0071479; GO:0071222; GO:0071223; GO:0071356; GO:0035924; GO:0098586; GO:0006935; GO:0002062; GO:0000077; GO:0019395; GO:0006006; GO:0035556; GO:0031663; GO:0014835; GO:0090090; GO:0043312; GO:0030316; GO:0038066; GO:0018105; GO:0001890; GO:0090336; GO:0060045; GO:0031281; GO:0002741; GO:0045648; GO:0010628; GO:0046326; GO:2001184; GO:0010759; GO:1905050; GO:0051149; GO:0045663; GO:1901741; GO:0010831; GO:0042307; GO:2000379; GO:0045944; GO:1900015; GO:0030278; GO:1901796; GO:0099179; GO:0006357; GO:0032495; GO:0035994; GO:0007165; GO:0042770; GO:0007519; GO:0090400; GO:0051146; GO:0006351; GO:0007178; GO:0048010"]
[1713,854,"PN250","p38a MAPK (MAPK14)","Y182","Mitogen-activated protein-serine kinase p38 alpha; Mitogen-activated protein kinase 14",{"v":914.2822254662127,"d":"914"},{"v":883.0247832601465,"d":"883"},{"v":450.8850564530601,"d":"451"},{"v":49.315741233309424,"d":"49"},{"v":86.62732490559759,"d":"87"},{"v":2837.5697580968053,"d":"2838"},"External","MmAb","Not precisely defined.","Antibody raised against phosphorylated Tyr-182 of human p38α.","Y182 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in p38a (≥3744 reports from high throughput mass spectrometry studies).","Y182: MKK3 (MAP2K3, MEK3); MKK4 (MAP2K4, MEK4); MKK6 (MAP2K6, MEK6); p38a MAPK (MAPK14); PBK (TOPK).","Q16539","Q16539",626,"Q16539","Q16539","NP_001306","Block6",1,9,"6, 14, 22, 30","p38a","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","p38",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.24; EC 2.7.1.37; CMGC domain target; CMGC</A> group; MAPK family; MAPK/p38 subfamily; p38 subfamily","GO:0005737; GO:0005829; GO:0005576; GO:1904813; GO:0098978; GO:0005739; GO:0016607; GO:0005654; GO:0005634; GO:0034774; GO:0000922","GO:0005524; GO:0019899; GO:0004707; GO:0004708; GO:0048273; GO:0051525; GO:0019903; GO:0004674","GO:0070935; GO:0000187; GO:0001525; GO:0006915; GO:0001502; GO:0000902; GO:0007166; GO:0071479; GO:0071222; GO:0071223; GO:0071356; GO:0035924; GO:0098586; GO:0006935; GO:0002062; GO:0000077; GO:0019395; GO:0006006; GO:0035556; GO:0031663; GO:0014835; GO:0090090; GO:0043312; GO:0030316; GO:0038066; GO:0018105; GO:0001890; GO:0090336; GO:0060045; GO:0031281; GO:0002741; GO:0045648; GO:0010628; GO:0046326; GO:2001184; GO:0010759; GO:1905050; GO:0051149; GO:0045663; GO:1901741; GO:0010831; GO:0042307; GO:2000379; GO:0045944; GO:1900015; GO:0030278; GO:1901796; GO:0099179; GO:0006357; GO:0032495; GO:0035994; GO:0007165; GO:0042770; GO:0007519; GO:0090400; GO:0051146; GO:0006351; GO:0007178; GO:0048010"]
[1715,855,"NK248-1","p38b MAPK (MAPK11)","Pan-specific","Mitogen-activated protein-serine kinase p38 beta; Mitogen-activated protein kinase 11",{"v":1894.1359876387467,"d":"1894"},{"v":1577.593212730286,"d":"1578"},{"v":1097.3443995029345,"d":"1097"},{"v":57.933770683006635,"d":"58"},{"v":506.875108802833,"d":"507"},{"v":7172.761578236748,"d":"7173"},"Kinexus","RpAb","MSGPRAGFYRQELNKC","Corresponds to amino acid residues M1 to K15; N-terminus.",null,null,"Q15759","Q15759",627,"Q15759",null,"NP_002742.3","Block6",1,10,"6, 14, 22, 30","p38b","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","p38",{"$nulls":5},"Protein-serine kinase, CMGC group, MAPK family, p38 subfamily","GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0004707; GO:0004674","GO:0000187; GO:0071347; GO:0098586; GO:0060044; GO:0010628; GO:2001184; GO:0051149; GO:1901796; GO:0006355; GO:0051403; GO:0006351"]
[1717,856,"NK248-2","p38b MAPK (MAPK11)","Pan-specific","Mitogen-activated protein-serine kinase p38 beta; Mitogen-activated protein kinase 11",{"v":4127.819797835256,"d":"4128"},{"v":3897.125705450705,"d":"3897"},{"v":1227.4689302026663,"d":"1227"},{"v":29.73649505839342,"d":"30"},{"v":1557.155635873882,"d":"1557"},{"v":9077.169921734567,"d":"9077"},"Kinexus","RpAb","CAEPYDESVEAKERTL","Corresponds to amino acid residues A320 to L334; Post-kinase last alpha-chain.",null,null,"Q15759","Q15759",627,"Q15759",null,"NP_002742.3","Block6",1,11,"6, 14, 22, 30","p38b","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","p38",{"$nulls":5},"Protein-serine kinase, CMGC group, MAPK family, p38 subfamily","GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0004707; GO:0004674","GO:0000187; GO:0071347; GO:0098586; GO:0060044; GO:0010628; GO:2001184; GO:0051149; GO:1901796; GO:0006355; GO:0051403; GO:0006351"]
[1719,857,"PK741","p38b MAPK (MAPK11)","T180+Y182","Mitogen-activated protein-serine kinase p38 beta; Mitogen-activated protein kinase 11",{"v":9361.675973907953,"d":"9362"},{"v":9339.861463178324,"d":"9340"},{"v":3329.888012931056,"d":"3330"},{"v":35.569357689924644,"d":"36"},{"v":596.8173875001306,"d":"597"},{"v":21003.2319150022,"d":"21003"},"Kinexus","RpAb","EEM(pT)G(pY)(bA)C","Corresponds to amino acid residues E177 to Y182; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T180 and Y182 phosphorylation is stimulatory for phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major in vivo phosphorylation sites in p38a (≥59 and ≥663 reports, respectively, by mass spectrometry).","T180: MKK3 (MAP2K3, MEK3);; MKK6 (MAP2K6, MEK6). Y182: MKK3 (MAP2K3, MEK3); MKK6 (MAP2K6, MEK6).","Q15759","Q15759",627,"Q15759",null,"NP_002742.3","Block6",1,12,"6, 14, 22, 30","p38b","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","p38",{"$nulls":5},"Protein-serine kinase, CMGC group, MAPK family, p38 subfamily","GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0004707; GO:0004674","GO:0000187; GO:0071347; GO:0098586; GO:0060044; GO:0010628; GO:2001184; GO:0051149; GO:1901796; GO:0006355; GO:0051403; GO:0006351"]
[1721,858,"NK121-2","p38d MAPK (MAPK13)","Pan-specific","Mitogen-activated protein-serine kinase p38 delta; Mitogen-activated protein kinase 13",{"v":4010.015614146056,"d":"4010"},{"v":3867.8471142688686,"d":"3868"},{"v":1227.415342137469,"d":"1227"},{"v":30.60874221555495,"d":"31"},{"v":520.232052354339,"d":"520"},{"v":8941.954888342296,"d":"8942"},"Kinexus","RpAb","MSLIRKKGFYKQDVNC","Corresponds to amino acid residues M1 to N15; N-terminus.",null,null,"O15264","O15264",714,"O15264","O15264","NP_002745","Block6",1,13,"6, 14, 22, 30","p38d","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","p38",{"$nulls":5},"EC 2.7.11.24; EC 2.7.1.37; Protein kinase, Ser/Thr (non-receptor); CMGC group; MAPK family; MAPK/p38 subfamily; p38 subfamily","GO:0005737; GO:0005829; GO:0005634","GO:0005524; GO:0004707; GO:0004674","GO:0007049; GO:0072740; GO:0070301; GO:0071347; GO:1903936; GO:0072709; GO:0034644; GO:0018105; GO:0050729; GO:0032755; GO:0010468; GO:0006355; GO:0006970; GO:0051403; GO:0006351"]
[1723,859,"NK121-3","p38d MAPK (MAPK13)","Pan-specific","Mitogen-activated protein-serine kinase p38 delta; Mitogen-activated protein kinase 13",{"v":12341.073976639098,"d":"12341"},{"v":12162.849465623076,"d":"12163"},{"v":2272.531530908462,"d":"2273"},{"v":18.414374107231072,"d":"18"},{"v":4461.723493035703,"d":"4462"},{"v":21339.339659269404,"d":"21339"},"Kinexus","RpAb","CFDDSLEHEKLTVDEW","Corresponds to amino acid residues F324 to W338; Post-kinase last alpha-chain.",null,null,"O15264","O15264",714,"O15264","O15264","NP_002745","Block6",2,1,"6, 14, 22, 30","p38d","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","p38",{"$nulls":5},"EC 2.7.11.24; EC 2.7.1.37; Protein kinase, Ser/Thr (non-receptor); CMGC group; MAPK family; MAPK/p38 subfamily; p38 subfamily","GO:0005737; GO:0005829; GO:0005634","GO:0005524; GO:0004707; GO:0004674","GO:0007049; GO:0072740; GO:0070301; GO:0071347; GO:1903936; GO:0072709; GO:0034644; GO:0018105; GO:0050729; GO:0032755; GO:0010468; GO:0006355; GO:0006970; GO:0051403; GO:0006351"]
[1725,860,"PK742","p38d MAPK (MAPK13)","T180+Y182","Mitogen-activated protein-serine kinase p38 delta; Mitogen-activated protein kinase 13",{"v":879.2459487194789,"d":"879"},{"v":456.77091293539837,"d":"457"},{"v":2538.782882984273,"d":"2539"},{"v":288.74547408284565,"d":"289"},{"v":32.826588547571774,"d":"33"},{"v":24217.35035900923,"d":"24217"},"Kinexus","RpAb","AEM(pT)G(pY)(bA)C","Corresponds to amino acid residues A177 to Y182; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T180 and Y182 phosphorylation is stimulatory for phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major in vivo phosphorylation sites in p38a (≥382 and >986 reports, respectively, from high throughput mass spectrometry studies).","T180: MKK3 (MAP2K3, MEK3); MKK6 (MAP2K6, MEK6). Y182: MKK3 (MAP2K3, MEK3); MKK6 (MAP2K6, MEK6).","O15264","O15264",714,"O15264","O15264","NP_002745","Block6",2,2,"6, 14, 22, 30","p38d","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","p38",{"$nulls":5},"EC 2.7.11.24; EC 2.7.1.37; Protein kinase, Ser/Thr (non-receptor); CMGC group; MAPK family; MAPK/p38 subfamily; p38 subfamily","GO:0005737; GO:0005829; GO:0005634","GO:0005524; GO:0004707; GO:0004674","GO:0007049; GO:0072740; GO:0070301; GO:0071347; GO:1903936; GO:0072709; GO:0034644; GO:0018105; GO:0050729; GO:0032755; GO:0010468; GO:0006355; GO:0006970; GO:0051403; GO:0006351"]
[1727,861,"PK743","p38d MAPK (MAPK13)","Y182","Mitogen-activated protein-serine kinase p38 delta; Mitogen-activated protein kinase 13",{"v":8373.569372380955,"d":"8374"},{"v":8405.204588087603,"d":"8405"},{"v":2693.213212733436,"d":"2693"},{"v":32.16326387187551,"d":"32"},{"v":515.2969457441928,"d":"515"},{"v":15242.169072316421,"d":"15242"},"Kinexus","RpAb","MTG(pY)VVT(bA)C","Corresponds to amino acid residues M179 to T185; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y182 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in p38d (≥986 reports from high throughput mass spectrometry studies).","MKK3 (MAP2K3, MEK3); MKK6 (MAP2K6, MEK6)","O15264","O15264",714,"O15264","O15264","NP_002745","Block6",2,3,"6, 14, 22, 30","p38d","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","p38",{"$nulls":5},"EC 2.7.11.24; EC 2.7.1.37; Protein kinase, Ser/Thr (non-receptor); CMGC group; MAPK family; MAPK/p38 subfamily; p38 subfamily","GO:0005737; GO:0005829; GO:0005634","GO:0005524; GO:0004707; GO:0004674","GO:0007049; GO:0072740; GO:0070301; GO:0071347; GO:1903936; GO:0072709; GO:0034644; GO:0018105; GO:0050729; GO:0032755; GO:0010468; GO:0006355; GO:0006970; GO:0051403; GO:0006351"]
[1729,862,"PK888","p38d MAPK (MAPK13)","S261+T265","Mitogen-activated protein-serine kinase p38 delta; Mitogen-activated protein kinase 13",{"v":20096.91785958851,"d":"20097"},{"v":19125.919740004356,"d":"19126"},{"v":7233.494338565065,"d":"7233"},{"v":35.99305320897188,"d":"36"},{"v":506.3037019456795,"d":"506"},{"v":44883.98730024113,"d":"44884"},"Kinexus","RpAb","YIQ(pS)LPQ(pT)PRK(bA)C","Corresponds to amino acid residues Y258 to K268. S261 and T265 are located in the Gap/Insert 10 (G/I10) region in the protein-serine/threonine kinase catalytic domain of p38d. ","The effects of S261 and T265 phosphorylation are unclear. The S261 site has been reported to be phosphorylated by mass spectrometry studies only once and the T265 site only 7-times.",null,"O15264","O15264",714,"O15264","O15264","NP_002745.1","Block6",2,4,"6, 14, 22, 30","p38d","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","p38",{"$nulls":5},"EC 2.7.11.24; EC 2.7.1.37; Protein kinase, Ser/Thr (non-receptor); CMGC group; MAPK family; MAPK/p38 subfamily; p38 subfamily","GO:0005737; GO:0005829; GO:0005634","GO:0005524; GO:0004707; GO:0004674","GO:0007049; GO:0072740; GO:0070301; GO:0071347; GO:1903936; GO:0072709; GO:0034644; GO:0018105; GO:0050729; GO:0032755; GO:0010468; GO:0006355; GO:0006970; GO:0051403; GO:0006351"]
[1731,863,"NK059-3","p38g MAPK (MAPK12, ERK6)","Pan-specific","Mitogen-activated protein-serine kinase p38 gamma; Mitogen-activated protein kinase 12",{"v":3598.132504890742,"d":"3598"},{"v":3339.913408342158,"d":"3340"},{"v":1345.475939831901,"d":"1345"},{"v":37.39372960843077,"d":"37"},{"v":290.9360471049382,"d":"291"},{"v":8715.582533765119,"d":"8716"},"Kinexus","RpAb","MSSPPPARSGFYRQEC","Corresponds to amino acid residues M1 to E15; N-terminus.",null,null,"P53778","P53778",658,"P53778","P53778","NP_002960.2","Block6",2,5,"6, 14, 22, 30","p38g","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","p38",{"$nulls":5},"Protein-serine kinase, CMGC group, MAPK family, p38 subfamily","GO:0005737; GO:0005829; GO:0005739; GO:0005654; GO:0005634","GO:0005524; GO:0000287; GO:0004707; GO:0004674","GO:0007050; GO:0006975; GO:0007517; GO:0045445; GO:0018105; GO:0051149; GO:0010952; GO:0010468; GO:0006355; GO:0007165; GO:0006351"]
[1733,864,"NK059-4","p38g MAPK (MAPK12, ERK6)","Pan-specific","Mitogen-activated protein-serine kinase p38 gamma; Mitogen-activated protein kinase 12",{"v":8467.313395845533,"d":"8467"},{"v":8350.595700357793,"d":"8351"},{"v":1546.017378463962,"d":"1546"},{"v":18.258653083781116,"d":"18"},{"v":3981.206385350077,"d":"3981"},{"v":12526.902071080587,"d":"12527"},"Kinexus","RpAb","CVQKYDDSFDDVDRTL","Corresponds to amino acid residues V323 to L337; Post-kinase last alpha-chain.",null,null,"P53778","P53778",658,"P53778","P53778","NP_002960.2","Block6",2,6,"6, 14, 22, 30","p38g","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","MAPK","p38",{"$nulls":5},"Protein-serine kinase, CMGC group, MAPK family, p38 subfamily","GO:0005737; GO:0005829; GO:0005739; GO:0005654; GO:0005634","GO:0005524; GO:0000287; GO:0004707; GO:0004674","GO:0007050; GO:0006975; GO:0007517; GO:0045445; GO:0018105; GO:0051149; GO:0010952; GO:0010468; GO:0006355; GO:0007165; GO:0006351"]
[1735,865,"PN251","p40-phox","T154","Neutrophil cytosol factor 4",{"v":188.38319600130106,"d":"188"},{"v":161.02505229270042,"d":"161"},{"v":129.16299010989763,"d":"129"},{"v":68.56396581625337,"d":"69"},{"v":25.700596077902773,"d":"26"},{"v":826.7965083764466,"d":"827"},"External","MmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the T154 phosphosite.","The effect of T154 phosphorylation is unclear. This phosphorylation site in p40-phox has not been reported by mass spectrometry.","PKCa (PRKCA)","Q15080","Q15080",1800,null,null,"NP_000622.2","Block6",2,7,"6, 14, 22, 30",{"$nulls":13},"Oxidoreductase","GO:0005829; GO:0010008; GO:0016020; GO:0043020; GO:0032010; GO:0005802","GO:0005086; GO:0032266; GO:0046983; GO:0016176","GO:0006955; GO:0055114; GO:0006909; GO:0045730; GO:0048010; GO:0016192"]
[1737,866,"NN082-2","p53 (TP53)","Pan-specific","Cellular tumor antigen p53",{"v":5132.203155369395,"d":"5132"},{"v":4512.627104657855,"d":"4513"},{"v":2604.8211553795986,"d":"2605"},{"v":50.75444358928761,"d":"51"},{"v":9.793703092254884,"d":"10"},{"v":14875.527036204658,"d":"14876"},"External","MmAb","Epitope undefined.",{"$nulls":3},"P04637","P04637",465,null,"P04637","NP_000537.3","Block6",2,8,"6, 14, 22, 30",{"$nulls":3},"Tumour suppressor; Nuclear receptor co-regulator; Activator protein; Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Tumor suppressor; Nuclear receptor co-regulator; Activator protein; Transcription factor","GO:0005737; GO:0005829; GO:0005783; GO:0005622; GO:0005759; GO:0005739; GO:0000790; GO:0016363; GO:0005730; GO:0005654; GO:0005634; GO:0016605; GO:0032991; GO:0005657","GO:0005524; GO:0051087; GO:0003682; GO:0005507; GO:0001046; GO:0003684; GO:0097718; GO:0003677; GO:0003700; GO:0019899; GO:0035035; GO:0042826; GO:0042802; GO:0003730; GO:0002039; GO:1990841; GO:0002020; GO:0046982; GO:0019901; GO:0047485; GO:0051721; GO:0019903; GO:0043621; GO:0030971; GO:0000980; GO:0000978; GO:0000981; GO:0001085; GO:0001094; GO:0001228; GO:0001074; GO:0008134; GO:0044212; GO:0031625; GO:0008270","GO:0006914; GO:0006284; GO:0007569; GO:0007050; GO:0030154; GO:0008283; GO:0034613; GO:0072717; GO:0006974; GO:0035690; GO:0071480; GO:0042149; GO:0071456; GO:0071479; GO:0034644; GO:0031497; GO:0048512; GO:0019221; GO:0008340; GO:0030330; GO:0006977; GO:0006978; GO:0000733; GO:0043153; GO:0006983; GO:0097193; GO:0072332; GO:0042771; GO:0031571; GO:0009299; GO:0007275; GO:0043066; GO:0030308; GO:0008285; GO:0048147; GO:0051097; GO:0051974; GO:0045892; GO:0000122; GO:0006289; GO:0097252; GO:0090403; GO:0043065; GO:0071158; GO:1900119; GO:0010628; GO:0031065; GO:2001244; GO:0043525; GO:0050731; GO:1902895; GO:1903800; GO:0046827; GO:1900740; GO:0032461; GO:2000379; GO:0090200; GO:0045899; GO:0070245; GO:0045893; GO:0045944; GO:1990440; GO:0065003; GO:0016579; GO:0051289; GO:0008104; GO:0051262; GO:0007265; GO:0042981; GO:1902749; GO:0046902; GO:1901796; GO:0006355; GO:0090399; GO:0046677; GO:0010332; GO:0010165; GO:0072331; GO:0016032"]
[1739,867,"PN160","p53 (TP53)","S6","Cellular tumor antigen p53",{"v":973.7393449612505,"d":"974"},{"v":949.6589343287988,"d":"950"},{"v":614.7071141155487,"d":"615"},{"v":63.12850736662086,"d":"63"},{"v":7.1516922336689905,"d":"7"},{"v":3527.9964240568297,"d":"3528"},"External","RpAb","PQ(pS)DP","Corresponds to amino acid residues P4 to P8; At N-terminus.","S6 phosphorylation stimulates transcriptional activity.  This is one of the minor in vivo phosphorylation sites in p53 (≥3 reports from high throughput mass spectrometry studies).","ATM; CK1d1 (CSNK1D); CK1e1 (CSNK1E)","P04637","P04637",465,null,"P04637","NP_000537.3","Block6",2,9,"6, 14, 22, 30",{"$nulls":3},"Tumour suppressor; Nuclear receptor co-regulator; Activator protein; Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Tumor suppressor; Nuclear receptor co-regulator; Activator protein; Transcription factor","GO:0005737; GO:0005829; GO:0005783; GO:0005622; GO:0005759; GO:0005739; GO:0000790; GO:0016363; GO:0005730; GO:0005654; GO:0005634; GO:0016605; GO:0032991; GO:0005657","GO:0005524; GO:0051087; GO:0003682; GO:0005507; GO:0001046; GO:0003684; GO:0097718; GO:0003677; GO:0003700; GO:0019899; GO:0035035; GO:0042826; GO:0042802; GO:0003730; GO:0002039; GO:1990841; GO:0002020; GO:0046982; GO:0019901; GO:0047485; GO:0051721; GO:0019903; GO:0043621; GO:0030971; GO:0000980; GO:0000978; GO:0000981; GO:0001085; GO:0001094; GO:0001228; GO:0001074; GO:0008134; GO:0044212; GO:0031625; GO:0008270","GO:0006914; GO:0006284; GO:0007569; GO:0007050; GO:0030154; GO:0008283; GO:0034613; GO:0072717; GO:0006974; GO:0035690; GO:0071480; GO:0042149; GO:0071456; GO:0071479; GO:0034644; GO:0031497; GO:0048512; GO:0019221; GO:0008340; GO:0030330; GO:0006977; GO:0006978; GO:0000733; GO:0043153; GO:0006983; GO:0097193; GO:0072332; GO:0042771; GO:0031571; GO:0009299; GO:0007275; GO:0043066; GO:0030308; GO:0008285; GO:0048147; GO:0051097; GO:0051974; GO:0045892; GO:0000122; GO:0006289; GO:0097252; GO:0090403; GO:0043065; GO:0071158; GO:1900119; GO:0010628; GO:0031065; GO:2001244; GO:0043525; GO:0050731; GO:1902895; GO:1903800; GO:0046827; GO:1900740; GO:0032461; GO:2000379; GO:0090200; GO:0045899; GO:0070245; GO:0045893; GO:0045944; GO:1990440; GO:0065003; GO:0016579; GO:0051289; GO:0008104; GO:0051262; GO:0007265; GO:0042981; GO:1902749; GO:0046902; GO:1901796; GO:0006355; GO:0090399; GO:0046677; GO:0010332; GO:0010165; GO:0072331; GO:0016032"]
[1741,868,"PN637","p53 (TP53)","S6+S9","Cellular tumor antigen p53",{"v":20105.00323470584,"d":"20105"},{"v":18868.049727490252,"d":"18868"},{"v":8432.651552100022,"d":"8433"},{"v":41.94304996451497,"d":"42"},{"v":11.167284322289651,"d":"11"},{"v":47366.6390331778,"d":"47367"},"Kinexus","RpAb","EPQ(pS)DP(pS)VEP(bA)C","Corresponds to amino acid residues E3 to P12.","S6 and S9 phosphorylation stimulates transcriptional activity. This are two of the minor in vivo phosphorylation sites in p53 (≥3 and ≥3 reports, repectively, by mass spectrometry).","S6: ATM; CK1d1 (CSNK1D); CK1e1 (CSNK1E). S9: ATM; CK1d1 (CSNK1D); CK1e1 (CSNK1E); DNAPK (PRKDC); HIPK4","P04637","P04637",465,null,"P04637","NP_000537.3","Block6",2,10,"6, 14, 22, 30",{"$nulls":3},"Tumour suppressor; Nuclear receptor co-regulator; Activator protein; Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Tumor suppressor; Nuclear receptor co-regulator; Activator protein; Transcription factor","GO:0005737; GO:0005829; GO:0005783; GO:0005622; GO:0005759; GO:0005739; GO:0000790; GO:0016363; GO:0005730; GO:0005654; GO:0005634; GO:0016605; GO:0032991; GO:0005657","GO:0005524; GO:0051087; GO:0003682; GO:0005507; GO:0001046; GO:0003684; GO:0097718; GO:0003677; GO:0003700; GO:0019899; GO:0035035; GO:0042826; GO:0042802; GO:0003730; GO:0002039; GO:1990841; GO:0002020; GO:0046982; GO:0019901; GO:0047485; GO:0051721; GO:0019903; GO:0043621; GO:0030971; GO:0000980; GO:0000978; GO:0000981; GO:0001085; GO:0001094; GO:0001228; GO:0001074; GO:0008134; GO:0044212; GO:0031625; GO:0008270","GO:0006914; GO:0006284; GO:0007569; GO:0007050; GO:0030154; GO:0008283; GO:0034613; GO:0072717; GO:0006974; GO:0035690; GO:0071480; GO:0042149; GO:0071456; GO:0071479; GO:0034644; GO:0031497; GO:0048512; GO:0019221; GO:0008340; GO:0030330; GO:0006977; GO:0006978; GO:0000733; GO:0043153; GO:0006983; GO:0097193; GO:0072332; GO:0042771; GO:0031571; GO:0009299; GO:0007275; GO:0043066; GO:0030308; GO:0008285; GO:0048147; GO:0051097; GO:0051974; GO:0045892; GO:0000122; GO:0006289; GO:0097252; GO:0090403; GO:0043065; GO:0071158; GO:1900119; GO:0010628; GO:0031065; GO:2001244; GO:0043525; GO:0050731; GO:1902895; GO:1903800; GO:0046827; GO:1900740; GO:0032461; GO:2000379; GO:0090200; GO:0045899; GO:0070245; GO:0045893; GO:0045944; GO:1990440; GO:0065003; GO:0016579; GO:0051289; GO:0008104; GO:0051262; GO:0007265; GO:0042981; GO:1902749; GO:0046902; GO:1901796; GO:0006355; GO:0090399; GO:0046677; GO:0010332; GO:0010165; GO:0072331; GO:0016032"]
[1743,869,"PN638","p53 (TP53)","T18+S20","Cellular tumor antigen p53",{"v":23630.853740428436,"d":"23631"},{"v":22529.591041101776,"d":"22530"},{"v":7821.897121412273,"d":"7822"},{"v":33.100357724402976,"d":"33"},{"v":1208.3163986072454,"d":"1208"},{"v":48345.642413467176,"d":"48346"},"Kinexus","RpAb","LSQE(pT)F(pS)DLW(bA)C","Corresponds to amino acid residues L14 to W23.","T18 and S20 phosphorylation stimulates binding of CBP/p300, and inhibits binding to its negative regulatory partner MDM2. T18 phosphorylation has not been reported by mass spectrometry studies, and phosphorylation of the S20 site has only been reported once by mass spectrometry, although ≥117 reports for S20 phosphorylation has been made based on Western blotting data..","T18: AMPKA1; Chk1 (CHEK1); Chk2 (CHEK2);  CK1a1 (CSNK1A1); CK1d1 (CSNK1D); DAPK1; DNAPK (PRKDC); VRK1; VRK2. S20: ATM; Chk1 (CHEK1); Chk2 (CHEK2); CK1a1 (CSNK1A1); CK1d1 (CSNK1D); DAPK1; DAPK3 (ZIPK); DNAPK (PRKDC); DRAK1 (STK17A); JNK1 (MAPK8); JNK2 (MAPK9); MAPKAPK2; Plk3 (CNK).","P04637","P04637",465,null,"P04637","NP_000537.3","Block6",2,11,"6, 14, 22, 30",{"$nulls":3},"Tumour suppressor; Nuclear receptor co-regulator; Activator protein; Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Tumor suppressor; Nuclear receptor co-regulator; Activator protein; Transcription factor","GO:0005737; GO:0005829; GO:0005783; GO:0005622; GO:0005759; GO:0005739; GO:0000790; GO:0016363; GO:0005730; GO:0005654; GO:0005634; GO:0016605; GO:0032991; GO:0005657","GO:0005524; GO:0051087; GO:0003682; GO:0005507; GO:0001046; GO:0003684; GO:0097718; GO:0003677; GO:0003700; GO:0019899; GO:0035035; GO:0042826; GO:0042802; GO:0003730; GO:0002039; GO:1990841; GO:0002020; GO:0046982; GO:0019901; GO:0047485; GO:0051721; GO:0019903; GO:0043621; GO:0030971; GO:0000980; GO:0000978; GO:0000981; GO:0001085; GO:0001094; GO:0001228; GO:0001074; GO:0008134; GO:0044212; GO:0031625; GO:0008270","GO:0006914; GO:0006284; GO:0007569; GO:0007050; GO:0030154; GO:0008283; GO:0034613; GO:0072717; GO:0006974; GO:0035690; GO:0071480; GO:0042149; GO:0071456; GO:0071479; GO:0034644; GO:0031497; GO:0048512; GO:0019221; GO:0008340; GO:0030330; GO:0006977; GO:0006978; GO:0000733; GO:0043153; GO:0006983; GO:0097193; GO:0072332; GO:0042771; GO:0031571; GO:0009299; GO:0007275; GO:0043066; GO:0030308; GO:0008285; GO:0048147; GO:0051097; GO:0051974; GO:0045892; GO:0000122; GO:0006289; GO:0097252; GO:0090403; GO:0043065; GO:0071158; GO:1900119; GO:0010628; GO:0031065; GO:2001244; GO:0043525; GO:0050731; GO:1902895; GO:1903800; GO:0046827; GO:1900740; GO:0032461; GO:2000379; GO:0090200; GO:0045899; GO:0070245; GO:0045893; GO:0045944; GO:1990440; GO:0065003; GO:0016579; GO:0051289; GO:0008104; GO:0051262; GO:0007265; GO:0042981; GO:1902749; GO:0046902; GO:1901796; GO:0006355; GO:0090399; GO:0046677; GO:0010332; GO:0010165; GO:0072331; GO:0016032"]
[1745,870,"PN158","p53 (TP53)","S33","Cellular tumor antigen p53",{"v":420.3016576165215,"d":"420"},{"v":180.0018110166327,"d":"180"},{"v":1490.3408042404562,"d":"1490"},{"v":354.5883717642214,"d":"355"},{"v":2.736521833488421,"d":"3"},{"v":17914.920288139052,"d":"17915"},"External","RpAb","VL(pS)PL","Corresponds to amino acid residues V31 to L35.","S33 phosphorylation induces activation, binding to CBP and Pin1, and inhibits binding to MDM2. This is one of the minor vivo phosphorylation sites in p53 (≥3 reports from high throughput mass spectrometry studies).","BARK2 (GRK3, ADRBK2); CDK5; CDK7; CDK9; GSK3b; p38a MAPK (MAPK14)","P04637","P04637",465,null,"P04637","NP_000537.3","Block6",2,12,"6, 14, 22, 30",{"$nulls":3},"Tumour suppressor; Nuclear receptor co-regulator; Activator protein; Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Tumor suppressor; Nuclear receptor co-regulator; Activator protein; Transcription factor","GO:0005737; GO:0005829; GO:0005783; GO:0005622; GO:0005759; GO:0005739; GO:0000790; GO:0016363; GO:0005730; GO:0005654; GO:0005634; GO:0016605; GO:0032991; GO:0005657","GO:0005524; GO:0051087; GO:0003682; GO:0005507; GO:0001046; GO:0003684; GO:0097718; GO:0003677; GO:0003700; GO:0019899; GO:0035035; GO:0042826; GO:0042802; GO:0003730; GO:0002039; GO:1990841; GO:0002020; GO:0046982; GO:0019901; GO:0047485; GO:0051721; GO:0019903; GO:0043621; GO:0030971; GO:0000980; GO:0000978; GO:0000981; GO:0001085; GO:0001094; GO:0001228; GO:0001074; GO:0008134; GO:0044212; GO:0031625; GO:0008270","GO:0006914; GO:0006284; GO:0007569; GO:0007050; GO:0030154; GO:0008283; GO:0034613; GO:0072717; GO:0006974; GO:0035690; GO:0071480; GO:0042149; GO:0071456; GO:0071479; GO:0034644; GO:0031497; GO:0048512; GO:0019221; GO:0008340; GO:0030330; GO:0006977; GO:0006978; GO:0000733; GO:0043153; GO:0006983; GO:0097193; GO:0072332; GO:0042771; GO:0031571; GO:0009299; GO:0007275; GO:0043066; GO:0030308; GO:0008285; GO:0048147; GO:0051097; GO:0051974; GO:0045892; GO:0000122; GO:0006289; GO:0097252; GO:0090403; GO:0043065; GO:0071158; GO:1900119; GO:0010628; GO:0031065; GO:2001244; GO:0043525; GO:0050731; GO:1902895; GO:1903800; GO:0046827; GO:1900740; GO:0032461; GO:2000379; GO:0090200; GO:0045899; GO:0070245; GO:0045893; GO:0045944; GO:1990440; GO:0065003; GO:0016579; GO:0051289; GO:0008104; GO:0051262; GO:0007265; GO:0042981; GO:1902749; GO:0046902; GO:1901796; GO:0006355; GO:0090399; GO:0046677; GO:0010332; GO:0010165; GO:0072331; GO:0016032"]
[1747,871,"PN159","p53 (TP53)","S37","Cellular tumor antigen p53",{"v":2415.103959707456,"d":"2415"},{"v":2396.6688866109234,"d":"2397"},{"v":1017.425761932996,"d":"1017"},{"v":42.127617647409174,"d":"42"},{"v":38.724536863503864,"d":"39"},{"v":5212.472837934543,"d":"5212"},"External","RpAb","LP(pS)QA","Corresponds to amino acid residues L35 to A39.","S37 phosphorylation induces activation, binding to CBP and PPP2CA, and Inhibits binding to MDM2. This is one of the minor vivo phosphorylation sites in p53 (≥3 reports from high throughput mass spectrometry studies).","ATM; ATR; Chk1 (CHEK1); Chk2 (CHEK2); DNAPK (PRKDC); JNK1 (MAPK8); JNK3 (MAPK10); MAPKAPK5 (PRAK)","P04637","P04637",465,null,"P04637","NP_000537.3","Block6",2,13,"6, 14, 22, 30",{"$nulls":3},"Tumour suppressor; Nuclear receptor co-regulator; Activator protein; Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Tumor suppressor; Nuclear receptor co-regulator; Activator protein; Transcription factor","GO:0005737; GO:0005829; GO:0005783; GO:0005622; GO:0005759; GO:0005739; GO:0000790; GO:0016363; GO:0005730; GO:0005654; GO:0005634; GO:0016605; GO:0032991; GO:0005657","GO:0005524; GO:0051087; GO:0003682; GO:0005507; GO:0001046; GO:0003684; GO:0097718; GO:0003677; GO:0003700; GO:0019899; GO:0035035; GO:0042826; GO:0042802; GO:0003730; GO:0002039; GO:1990841; GO:0002020; GO:0046982; GO:0019901; GO:0047485; GO:0051721; GO:0019903; GO:0043621; GO:0030971; GO:0000980; GO:0000978; GO:0000981; GO:0001085; GO:0001094; GO:0001228; GO:0001074; GO:0008134; GO:0044212; GO:0031625; GO:0008270","GO:0006914; GO:0006284; GO:0007569; GO:0007050; GO:0030154; GO:0008283; GO:0034613; GO:0072717; GO:0006974; GO:0035690; GO:0071480; GO:0042149; GO:0071456; GO:0071479; GO:0034644; GO:0031497; GO:0048512; GO:0019221; GO:0008340; GO:0030330; GO:0006977; GO:0006978; GO:0000733; GO:0043153; GO:0006983; GO:0097193; GO:0072332; GO:0042771; GO:0031571; GO:0009299; GO:0007275; GO:0043066; GO:0030308; GO:0008285; GO:0048147; GO:0051097; GO:0051974; GO:0045892; GO:0000122; GO:0006289; GO:0097252; GO:0090403; GO:0043065; GO:0071158; GO:1900119; GO:0010628; GO:0031065; GO:2001244; GO:0043525; GO:0050731; GO:1902895; GO:1903800; GO:0046827; GO:1900740; GO:0032461; GO:2000379; GO:0090200; GO:0045899; GO:0070245; GO:0045893; GO:0045944; GO:1990440; GO:0065003; GO:0016579; GO:0051289; GO:0008104; GO:0051262; GO:0007265; GO:0042981; GO:1902749; GO:0046902; GO:1901796; GO:0006355; GO:0090399; GO:0046677; GO:0010332; GO:0010165; GO:0072331; GO:0016032"]
[1749,872,"PN254","p53 (TP53)","S46","Cellular tumor antigen p53",{"v":206.53773685019715,"d":"207"},{"v":175.47852649969636,"d":"175"},{"v":121.80873802386495,"d":"122"},{"v":58.9765046724674,"d":"59"},{"v":37.952331730649455,"d":"38"},{"v":881.7958512685542,"d":"882"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 42-51 Ser-46 of human p53.","S46 phosphorylation induces activation, and binding to CBP, GTF2H1, Pin1, and TFB1M. This is one of the minor in vivo phosphorylation sites in p53 (≥3 reports from high throughput mass spectrometry studies).","ATM; CDK5; DNAPK (PRKDC); DYRK2; HIPK2; p38a MAPK (MAPK14); PKCd (PRKCD)","P04637","P04637",465,null,"P04637","NP_000537.3","Block6",3,1,"6, 14, 22, 30",{"$nulls":3},"Tumour suppressor; Nuclear receptor co-regulator; Activator protein; Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Tumor suppressor; Nuclear receptor co-regulator; Activator protein; Transcription factor","GO:0005737; GO:0005829; GO:0005783; GO:0005622; GO:0005759; GO:0005739; GO:0000790; GO:0016363; GO:0005730; GO:0005654; GO:0005634; GO:0016605; GO:0032991; GO:0005657","GO:0005524; GO:0051087; GO:0003682; GO:0005507; GO:0001046; GO:0003684; GO:0097718; GO:0003677; GO:0003700; GO:0019899; GO:0035035; GO:0042826; GO:0042802; GO:0003730; GO:0002039; GO:1990841; GO:0002020; GO:0046982; GO:0019901; GO:0047485; GO:0051721; GO:0019903; GO:0043621; GO:0030971; GO:0000980; GO:0000978; GO:0000981; GO:0001085; GO:0001094; GO:0001228; GO:0001074; GO:0008134; GO:0044212; GO:0031625; GO:0008270","GO:0006914; GO:0006284; GO:0007569; GO:0007050; GO:0030154; GO:0008283; GO:0034613; GO:0072717; GO:0006974; GO:0035690; GO:0071480; GO:0042149; GO:0071456; GO:0071479; GO:0034644; GO:0031497; GO:0048512; GO:0019221; GO:0008340; GO:0030330; GO:0006977; GO:0006978; GO:0000733; GO:0043153; GO:0006983; GO:0097193; GO:0072332; GO:0042771; GO:0031571; GO:0009299; GO:0007275; GO:0043066; GO:0030308; GO:0008285; GO:0048147; GO:0051097; GO:0051974; GO:0045892; GO:0000122; GO:0006289; GO:0097252; GO:0090403; GO:0043065; GO:0071158; GO:1900119; GO:0010628; GO:0031065; GO:2001244; GO:0043525; GO:0050731; GO:1902895; GO:1903800; GO:0046827; GO:1900740; GO:0032461; GO:2000379; GO:0090200; GO:0045899; GO:0070245; GO:0045893; GO:0045944; GO:1990440; GO:0065003; GO:0016579; GO:0051289; GO:0008104; GO:0051262; GO:0007265; GO:0042981; GO:1902749; GO:0046902; GO:1901796; GO:0006355; GO:0090399; GO:0046677; GO:0010332; GO:0010165; GO:0072331; GO:0016032"]
[1751,873,"PN256","p53 (TP53)","T55","Cellular tumor antigen p53",{"v":193.8170787754272,"d":"194"},{"v":150.3021234982563,"d":"150"},{"v":181.86535396312686,"d":"182"},{"v":93.83350276053402,"d":"94"},{"v":31.31934576222654,"d":"31"},{"v":2042.5621984294594,"d":"2043"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues surrounding the Thr-55 phosphorylated human p53.","T55 phosphorylation produces activation and induces binding to CBP, GTF2H1, MDM2, TFB1M, and Exportin 1. Phosphorylation of p53 inhibits p53-mediated apoptosis.This phosphorylation site in p53 has not been reported by mass spectrometry, although there are ≥ 19 reports by Western blotting.","ERK2 (MAPK1); GRK5 (GPRK5); TAF1","P04637","P04637",465,null,"P04637","NP_000537.3","Block6",3,2,"6, 14, 22, 30",{"$nulls":3},"Tumour suppressor; Nuclear receptor co-regulator; Activator protein; Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Tumor suppressor; Nuclear receptor co-regulator; Activator protein; Transcription factor","GO:0005737; GO:0005829; GO:0005783; GO:0005622; GO:0005759; GO:0005739; GO:0000790; GO:0016363; GO:0005730; GO:0005654; GO:0005634; GO:0016605; GO:0032991; GO:0005657","GO:0005524; GO:0051087; GO:0003682; GO:0005507; GO:0001046; GO:0003684; GO:0097718; GO:0003677; GO:0003700; GO:0019899; GO:0035035; GO:0042826; GO:0042802; GO:0003730; GO:0002039; GO:1990841; GO:0002020; GO:0046982; GO:0019901; GO:0047485; GO:0051721; GO:0019903; GO:0043621; GO:0030971; GO:0000980; GO:0000978; GO:0000981; GO:0001085; GO:0001094; GO:0001228; GO:0001074; GO:0008134; GO:0044212; GO:0031625; GO:0008270","GO:0006914; GO:0006284; GO:0007569; GO:0007050; GO:0030154; GO:0008283; GO:0034613; GO:0072717; GO:0006974; GO:0035690; GO:0071480; GO:0042149; GO:0071456; GO:0071479; GO:0034644; GO:0031497; GO:0048512; GO:0019221; GO:0008340; GO:0030330; GO:0006977; GO:0006978; GO:0000733; GO:0043153; GO:0006983; GO:0097193; GO:0072332; GO:0042771; GO:0031571; GO:0009299; GO:0007275; GO:0043066; GO:0030308; GO:0008285; GO:0048147; GO:0051097; GO:0051974; GO:0045892; GO:0000122; GO:0006289; GO:0097252; GO:0090403; GO:0043065; GO:0071158; GO:1900119; GO:0010628; GO:0031065; GO:2001244; GO:0043525; GO:0050731; GO:1902895; GO:1903800; GO:0046827; GO:1900740; GO:0032461; GO:2000379; GO:0090200; GO:0045899; GO:0070245; GO:0045893; GO:0045944; GO:1990440; GO:0065003; GO:0016579; GO:0051289; GO:0008104; GO:0051262; GO:0007265; GO:0042981; GO:1902749; GO:0046902; GO:1901796; GO:0006355; GO:0090399; GO:0046677; GO:0010332; GO:0010165; GO:0072331; GO:0016032"]
[1753,874,"PN255","p53 (TP53)","T155","Cellular tumor antigen p53",{"v":413.2591699069671,"d":"413"},{"v":71.88728108987345,"d":"72"},{"v":2765.3218434692644,"d":"2765"},{"v":669.1495421848217,"d":"669"},{"v":16.819480119807352,"d":"17"},{"v":24849.091956792134,"d":"24849"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 150-163 Thr-155 of human p53.","T155 phosphorylation induces binding to MDM2 and degradation. This is one of the minor in vivo phosphorylation sites in p53 (≥1 reports from high throughput mass spectrometry studies).","CK2a1 (CSNK2A1)","P04637","P04637",465,null,"P04637","NP_000537.3","Block6",3,3,"6, 14, 22, 30",{"$nulls":3},"Tumour suppressor; Nuclear receptor co-regulator; Activator protein; Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Tumor suppressor; Nuclear receptor co-regulator; Activator protein; Transcription factor","GO:0005737; GO:0005829; GO:0005783; GO:0005622; GO:0005759; GO:0005739; GO:0000790; GO:0016363; GO:0005730; GO:0005654; GO:0005634; GO:0016605; GO:0032991; GO:0005657","GO:0005524; GO:0051087; GO:0003682; GO:0005507; GO:0001046; GO:0003684; GO:0097718; GO:0003677; GO:0003700; GO:0019899; GO:0035035; GO:0042826; GO:0042802; GO:0003730; GO:0002039; GO:1990841; GO:0002020; GO:0046982; GO:0019901; GO:0047485; GO:0051721; GO:0019903; GO:0043621; GO:0030971; GO:0000980; GO:0000978; GO:0000981; GO:0001085; GO:0001094; GO:0001228; GO:0001074; GO:0008134; GO:0044212; GO:0031625; GO:0008270","GO:0006914; GO:0006284; GO:0007569; GO:0007050; GO:0030154; GO:0008283; GO:0034613; GO:0072717; GO:0006974; GO:0035690; GO:0071480; GO:0042149; GO:0071456; GO:0071479; GO:0034644; GO:0031497; GO:0048512; GO:0019221; GO:0008340; GO:0030330; GO:0006977; GO:0006978; GO:0000733; GO:0043153; GO:0006983; GO:0097193; GO:0072332; GO:0042771; GO:0031571; GO:0009299; GO:0007275; GO:0043066; GO:0030308; GO:0008285; GO:0048147; GO:0051097; GO:0051974; GO:0045892; GO:0000122; GO:0006289; GO:0097252; GO:0090403; GO:0043065; GO:0071158; GO:1900119; GO:0010628; GO:0031065; GO:2001244; GO:0043525; GO:0050731; GO:1902895; GO:1903800; GO:0046827; GO:1900740; GO:0032461; GO:2000379; GO:0090200; GO:0045899; GO:0070245; GO:0045893; GO:0045944; GO:1990440; GO:0065003; GO:0016579; GO:0051289; GO:0008104; GO:0051262; GO:0007265; GO:0042981; GO:1902749; GO:0046902; GO:1901796; GO:0006355; GO:0090399; GO:0046677; GO:0010332; GO:0010165; GO:0072331; GO:0016032"]
[1755,875,"PN253","p53 (TP53)","S315","Cellular tumor antigen p53",{"v":20.87476519989349,"d":"21"},{"v":16.25396023713513,"d":"16"},{"v":16.623982168842073,"d":"17"},{"v":79.63673847180276,"d":"80"},{"v":-1.1007187637449383,"d":"-1"},{"v":152.29041131943893,"d":"152"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues surrounding the phosphorylated human Ser-315 of human p53.","S315 phosphorylation induces activation and binding to DNA and Pin1. This is one of the major in vivo phosphorylation sites in p53 (≥31 reports from high throughput mass spectrometry studies).","AurA (STK15); CDK1 (CDC2); CDK2; CDK5; CDK9","P04637","P04637",465,null,"P04637","NP_000537.3","Block6",3,4,"6, 14, 22, 30",{"$nulls":3},"Tumour suppressor; Nuclear receptor co-regulator; Activator protein; Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Tumor suppressor; Nuclear receptor co-regulator; Activator protein; Transcription factor","GO:0005737; GO:0005829; GO:0005783; GO:0005622; GO:0005759; GO:0005739; GO:0000790; GO:0016363; GO:0005730; GO:0005654; GO:0005634; GO:0016605; GO:0032991; GO:0005657","GO:0005524; GO:0051087; GO:0003682; GO:0005507; GO:0001046; GO:0003684; GO:0097718; GO:0003677; GO:0003700; GO:0019899; GO:0035035; GO:0042826; GO:0042802; GO:0003730; GO:0002039; GO:1990841; GO:0002020; GO:0046982; GO:0019901; GO:0047485; GO:0051721; GO:0019903; GO:0043621; GO:0030971; GO:0000980; GO:0000978; GO:0000981; GO:0001085; GO:0001094; GO:0001228; GO:0001074; GO:0008134; GO:0044212; GO:0031625; GO:0008270","GO:0006914; GO:0006284; GO:0007569; GO:0007050; GO:0030154; GO:0008283; GO:0034613; GO:0072717; GO:0006974; GO:0035690; GO:0071480; GO:0042149; GO:0071456; GO:0071479; GO:0034644; GO:0031497; GO:0048512; GO:0019221; GO:0008340; GO:0030330; GO:0006977; GO:0006978; GO:0000733; GO:0043153; GO:0006983; GO:0097193; GO:0072332; GO:0042771; GO:0031571; GO:0009299; GO:0007275; GO:0043066; GO:0030308; GO:0008285; GO:0048147; GO:0051097; GO:0051974; GO:0045892; GO:0000122; GO:0006289; GO:0097252; GO:0090403; GO:0043065; GO:0071158; GO:1900119; GO:0010628; GO:0031065; GO:2001244; GO:0043525; GO:0050731; GO:1902895; GO:1903800; GO:0046827; GO:1900740; GO:0032461; GO:2000379; GO:0090200; GO:0045899; GO:0070245; GO:0045893; GO:0045944; GO:1990440; GO:0065003; GO:0016579; GO:0051289; GO:0008104; GO:0051262; GO:0007265; GO:0042981; GO:1902749; GO:0046902; GO:1901796; GO:0006355; GO:0090399; GO:0046677; GO:0010332; GO:0010165; GO:0072331; GO:0016032"]
[1757,876,"PN640","p53 (TP53)","S392","Cellular tumor antigen p53",{"v":11349.258336209774,"d":"11349"},{"v":9541.492963703135,"d":"9541"},{"v":6538.1141265825745,"d":"6538"},{"v":57.60829415366061,"d":"58"},{"v":206.06313429532196,"d":"206"},{"v":35134.17498295922,"d":"35134"},"Kinexus","RpAb","CEGPD(pS)D(-cooh)","Corresponds to amino acid residues C388 to D393.","S392 phosphorylation induces activity, stimulates binding to DNA, NFkB-p65, UBE4B and p21Cip1, and inhibits binding of CDK1 and MDM2. This is one of the minor in vivo phosphorylation sites in p53 (≥13 reports by mass spectrometry), althoug there are ≥94 reports with Western blotting.","ATM; CDK7; CDK9; CK2a1 (CSNK2A1); ERK1 (MAPK3); LKB1 (STK11); NuaK1; PKR (EIF2AK2)","P04637","P04637",465,null,"P04637","NP_000537.3","Block6",3,5,"6, 14, 22, 30",{"$nulls":3},"Tumour suppressor; Nuclear receptor co-regulator; Activator protein; Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Tumor suppressor; Nuclear receptor co-regulator; Activator protein; Transcription factor","GO:0005737; GO:0005829; GO:0005783; GO:0005622; GO:0005759; GO:0005739; GO:0000790; GO:0016363; GO:0005730; GO:0005654; GO:0005634; GO:0016605; GO:0032991; GO:0005657","GO:0005524; GO:0051087; GO:0003682; GO:0005507; GO:0001046; GO:0003684; GO:0097718; GO:0003677; GO:0003700; GO:0019899; GO:0035035; GO:0042826; GO:0042802; GO:0003730; GO:0002039; GO:1990841; GO:0002020; GO:0046982; GO:0019901; GO:0047485; GO:0051721; GO:0019903; GO:0043621; GO:0030971; GO:0000980; GO:0000978; GO:0000981; GO:0001085; GO:0001094; GO:0001228; GO:0001074; GO:0008134; GO:0044212; GO:0031625; GO:0008270","GO:0006914; GO:0006284; GO:0007569; GO:0007050; GO:0030154; GO:0008283; GO:0034613; GO:0072717; GO:0006974; GO:0035690; GO:0071480; GO:0042149; GO:0071456; GO:0071479; GO:0034644; GO:0031497; GO:0048512; GO:0019221; GO:0008340; GO:0030330; GO:0006977; GO:0006978; GO:0000733; GO:0043153; GO:0006983; GO:0097193; GO:0072332; GO:0042771; GO:0031571; GO:0009299; GO:0007275; GO:0043066; GO:0030308; GO:0008285; GO:0048147; GO:0051097; GO:0051974; GO:0045892; GO:0000122; GO:0006289; GO:0097252; GO:0090403; GO:0043065; GO:0071158; GO:1900119; GO:0010628; GO:0031065; GO:2001244; GO:0043525; GO:0050731; GO:1902895; GO:1903800; GO:0046827; GO:1900740; GO:0032461; GO:2000379; GO:0090200; GO:0045899; GO:0070245; GO:0045893; GO:0045944; GO:1990440; GO:0065003; GO:0016579; GO:0051289; GO:0008104; GO:0051262; GO:0007265; GO:0042981; GO:1902749; GO:0046902; GO:1901796; GO:0006355; GO:0090399; GO:0046677; GO:0010332; GO:0010165; GO:0072331; GO:0016032"]
[1759,877,"PN252","p53 (TP53)","S392","Cellular tumor antigen p53",{"v":203.26443501497758,"d":"203"},{"v":159.65490809958771,"d":"160"},{"v":177.18204767523878,"d":"177"},{"v":87.16824842584148,"d":"87"},{"v":35.613834769015966,"d":"36"},{"v":1860.8312003623569,"d":"1861"},"External","MmAb","Not precisely defined.","Antibody raised against amino acid residues 78-393; At the C-terminus of human p53.","S392 phosphorylation induces activity, stimulates binding to DNA, NFkB-p65, UBE4B and p21Cip1, and inhibits binding of CDK1 and MDM2. This is one of the minor in vivo phosphorylation sites in p53 (≥13 reports by mass spectrometry), althoug there are ≥94 reports with Western blotting.","ATM; CDK7; CDK9; CK2a1 (CSNK2A1); ERK1 (MAPK3); LKB1 (STK11); NuaK1; PKR (EIF2AK2)","P04637","P04637",465,null,"P04637","NP_000537.3","Block6",3,6,"6, 14, 22, 30",{"$nulls":3},"Tumour suppressor; Nuclear receptor co-regulator; Activator protein; Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Tumor suppressor; Nuclear receptor co-regulator; Activator protein; Transcription factor","GO:0005737; GO:0005829; GO:0005783; GO:0005622; GO:0005759; GO:0005739; GO:0000790; GO:0016363; GO:0005730; GO:0005654; GO:0005634; GO:0016605; GO:0032991; GO:0005657","GO:0005524; GO:0051087; GO:0003682; GO:0005507; GO:0001046; GO:0003684; GO:0097718; GO:0003677; GO:0003700; GO:0019899; GO:0035035; GO:0042826; GO:0042802; GO:0003730; GO:0002039; GO:1990841; GO:0002020; GO:0046982; GO:0019901; GO:0047485; GO:0051721; GO:0019903; GO:0043621; GO:0030971; GO:0000980; GO:0000978; GO:0000981; GO:0001085; GO:0001094; GO:0001228; GO:0001074; GO:0008134; GO:0044212; GO:0031625; GO:0008270","GO:0006914; GO:0006284; GO:0007569; GO:0007050; GO:0030154; GO:0008283; GO:0034613; GO:0072717; GO:0006974; GO:0035690; GO:0071480; GO:0042149; GO:0071456; GO:0071479; GO:0034644; GO:0031497; GO:0048512; GO:0019221; GO:0008340; GO:0030330; GO:0006977; GO:0006978; GO:0000733; GO:0043153; GO:0006983; GO:0097193; GO:0072332; GO:0042771; GO:0031571; GO:0009299; GO:0007275; GO:0043066; GO:0030308; GO:0008285; GO:0048147; GO:0051097; GO:0051974; GO:0045892; GO:0000122; GO:0006289; GO:0097252; GO:0090403; GO:0043065; GO:0071158; GO:1900119; GO:0010628; GO:0031065; GO:2001244; GO:0043525; GO:0050731; GO:1902895; GO:1903800; GO:0046827; GO:1900740; GO:0032461; GO:2000379; GO:0090200; GO:0045899; GO:0070245; GO:0045893; GO:0045944; GO:1990440; GO:0065003; GO:0016579; GO:0051289; GO:0008104; GO:0051262; GO:0007265; GO:0042981; GO:1902749; GO:0046902; GO:1901796; GO:0006355; GO:0090399; GO:0046677; GO:0010332; GO:0010165; GO:0072331; GO:0016032"]
[1761,878,"NK223-4","p70S6K (S6Ka, RPS6KB1)","Pan-specific","Ribosomal protein S6 kinase beta-1; Ribosomal protein S6 kinase 1",{"v":2510.5924152984217,"d":"2511"},{"v":2229.8877467986886,"d":"2230"},{"v":1131.1879654643387,"d":"1131"},{"v":45.056615266237074,"d":"45"},{"v":218.46098265367172,"d":"218"},{"v":6836.591748434295,"d":"6837"},"Kinexus","RpAb","AMIVRNAKDTAHTKAERNILEEVKHP-GGC","Corresponds to amino acid residues A128 to P153; Kinase subdomain III region.",null,null,"P23443","P23443",628,"P23443","P23443","NP_003152","Block6",3,7,"6, 14, 22, 30","p70S6K","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","p70",{"$nulls":5},"Protein-serine kinase, AGC group, RSK family, p70 subfamily","GO:0030054; GO:0009986; GO:0005737; GO:0005829; GO:0005741; GO:0005739; GO:0043005; GO:0005654; GO:0005634; GO:0048471; GO:0045202","GO:0005524; GO:0042802; GO:0016301; GO:0030165; GO:0042277; GO:0004672; GO:0051721; GO:0004712; GO:0004674; GO:0004711","GO:0007568; GO:0006915; GO:0001662; GO:0016477; GO:0071549; GO:0071363; GO:0032869; GO:0071346; GO:0000082; GO:0007281; GO:0044539; GO:0007616; GO:0043066; GO:2001237; GO:0046627; GO:0018105; GO:0048015; GO:0045931; GO:0048633; GO:0014911; GO:0048661; GO:0045727; GO:0045948; GO:0043491; GO:0046324; GO:0014878; GO:0045471; GO:0033762; GO:0009749; GO:0009408; GO:0043201; GO:0032496; GO:0009612; GO:0007584; GO:0033574; GO:0034612; GO:0009611; GO:0007165; GO:0014732; GO:0003009; GO:0031929"]
[1763,879,"NK223-2","p70S6K (S6Ka, RPS6KB1)","Pan-specific","Ribosomal protein S6 kinase beta-1; Ribosomal protein S6 kinase 1",{"v":5431.7948061347115,"d":"5432"},{"v":5308.517008854469,"d":"5309"},{"v":1804.8385305748764,"d":"1805"},{"v":33.22729585691414,"d":"33"},{"v":496.8170097414508,"d":"497"},{"v":13032.438794276339,"d":"13032"},"Kinexus","RpAb","MAGVFDIDLDQPEDAC","Corresponds to amino acid residues M24 to A38; Post-N-terminus.",null,null,"P23443","P23443",628,"P23443","P23443","NP_003152","Block6",3,8,"6, 14, 22, 30","p70S6K","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","p70",{"$nulls":5},"Protein-serine kinase, AGC group, RSK family, p70 subfamily","GO:0030054; GO:0009986; GO:0005737; GO:0005829; GO:0005741; GO:0005739; GO:0043005; GO:0005654; GO:0005634; GO:0048471; GO:0045202","GO:0005524; GO:0042802; GO:0016301; GO:0030165; GO:0042277; GO:0004672; GO:0051721; GO:0004712; GO:0004674; GO:0004711","GO:0007568; GO:0006915; GO:0001662; GO:0016477; GO:0071549; GO:0071363; GO:0032869; GO:0071346; GO:0000082; GO:0007281; GO:0044539; GO:0007616; GO:0043066; GO:2001237; GO:0046627; GO:0018105; GO:0048015; GO:0045931; GO:0048633; GO:0014911; GO:0048661; GO:0045727; GO:0045948; GO:0043491; GO:0046324; GO:0014878; GO:0045471; GO:0033762; GO:0009749; GO:0009408; GO:0043201; GO:0032496; GO:0009612; GO:0007584; GO:0033574; GO:0034612; GO:0009611; GO:0007165; GO:0014732; GO:0003009; GO:0031929"]
[1765,880,"PK145","p70S6K (S6Ka, RPS6KB1)","T252","Ribosomal protein S6 kinase beta-1; Ribosomal protein S6 kinase 1",{"v":602.1727062887863,"d":"602"},{"v":521.0193167891935,"d":"521"},{"v":452.5112031438619,"d":"453"},{"v":75.14641537520123,"d":"75"},{"v":17.026519113649407,"d":"17"},{"v":2258.5283085882165,"d":"2259"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the T229 phosphosite.","T252 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation regulates protein translation and protein conformation. This is one of the minor in vivo phosphorylation sites in p70 S6K (≥18 reports from high throughput mass spectrometry studies).","PDPK1 (PDK1); PIK3CD","P23443","P23443",628,"P23443","P23443","NP_003152","Block6",3,9,"6, 14, 22, 30","p70S6K","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","p70",{"$nulls":5},"Protein-serine kinase, AGC group, RSK family, p70 subfamily","GO:0030054; GO:0009986; GO:0005737; GO:0005829; GO:0005741; GO:0005739; GO:0043005; GO:0005654; GO:0005634; GO:0048471; GO:0045202","GO:0005524; GO:0042802; GO:0016301; GO:0030165; GO:0042277; GO:0004672; GO:0051721; GO:0004712; GO:0004674; GO:0004711","GO:0007568; GO:0006915; GO:0001662; GO:0016477; GO:0071549; GO:0071363; GO:0032869; GO:0071346; GO:0000082; GO:0007281; GO:0044539; GO:0007616; GO:0043066; GO:2001237; GO:0046627; GO:0018105; GO:0048015; GO:0045931; GO:0048633; GO:0014911; GO:0048661; GO:0045727; GO:0045948; GO:0043491; GO:0046324; GO:0014878; GO:0045471; GO:0033762; GO:0009749; GO:0009408; GO:0043201; GO:0032496; GO:0009612; GO:0007584; GO:0033574; GO:0034612; GO:0009611; GO:0007165; GO:0014732; GO:0003009; GO:0031929"]
[1767,881,"PK744","p70S6K (S6Ka, RPS6KB1)","T252","Ribosomal protein S6 kinase beta-1; Ribosomal protein S6 kinase 1",{"v":14956.74500350215,"d":"14957"},{"v":13989.650357442526,"d":"13990"},{"v":5444.852063699297,"d":"5445"},{"v":36.4039907240805,"d":"36"},{"v":543.0295934195293,"d":"543"},{"v":30784.482755488338,"d":"30784"},"Kinexus","RpAb","VTH(pT)FCG(bA)C","Corresponds to amino acid residues V249 to G255; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T252 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation regulates protein translation and protein conformation. This is one of the minor in vivo phosphorylation sites in p70 S6K (≥18 reports from high throughput mass spectrometry studies).","PDPK1 (PDK1); PIK3CD","P23443","P23443",628,"P23443","P23443","NP_003152","Block6",3,10,"6, 14, 22, 30","p70S6K","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","p70",{"$nulls":5},"Protein-serine kinase, AGC group, RSK family, p70 subfamily","GO:0030054; GO:0009986; GO:0005737; GO:0005829; GO:0005741; GO:0005739; GO:0043005; GO:0005654; GO:0005634; GO:0048471; GO:0045202","GO:0005524; GO:0042802; GO:0016301; GO:0030165; GO:0042277; GO:0004672; GO:0051721; GO:0004712; GO:0004674; GO:0004711","GO:0007568; GO:0006915; GO:0001662; GO:0016477; GO:0071549; GO:0071363; GO:0032869; GO:0071346; GO:0000082; GO:0007281; GO:0044539; GO:0007616; GO:0043066; GO:2001237; GO:0046627; GO:0018105; GO:0048015; GO:0045931; GO:0048633; GO:0014911; GO:0048661; GO:0045727; GO:0045948; GO:0043491; GO:0046324; GO:0014878; GO:0045471; GO:0033762; GO:0009749; GO:0009408; GO:0043201; GO:0032496; GO:0009612; GO:0007584; GO:0033574; GO:0034612; GO:0009611; GO:0007165; GO:0014732; GO:0003009; GO:0031929"]
[1769,882,"PK199","p70S6K (S6Ka, RPS6KB1)","S434","Ribosomal protein S6 kinase beta-1; Ribosomal protein S6 kinase 1",{"v":254.35543429243225,"d":"254"},{"v":208.0136776931186,"d":"208"},{"v":162.08432098593852,"d":"162"},{"v":63.72355339559614,"d":"64"},{"v":40.3670476792319,"d":"40"},{"v":1472.9291747293519,"d":"1473"},"External","MmAb","Not precisely defined.","Antibody raised against a sequence containing phosphorylated Ser-411 of human p70 S6 kinase α.","S434 phosphorylation stimulates phosphotransferase activity. This is one of the minor in vivo phosphorylation sites in p70 S6K (≥1 reports from high throughput mass spectrometry studies).","CDK5; ERK1 (MAPK3); ERK2 (MAPK1); JNK1 (MAPK8); JNK2 (MAPK9); mTOR (FRAP)","P23443","P23443",628,"P23443","P23443","NP_003152","Block6",3,11,"6, 14, 22, 30","p70S6K","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","p70",{"$nulls":5},"Protein-serine kinase, AGC group, RSK family, p70 subfamily","GO:0030054; GO:0009986; GO:0005737; GO:0005829; GO:0005741; GO:0005739; GO:0043005; GO:0005654; GO:0005634; GO:0048471; GO:0045202","GO:0005524; GO:0042802; GO:0016301; GO:0030165; GO:0042277; GO:0004672; GO:0051721; GO:0004712; GO:0004674; GO:0004711","GO:0007568; GO:0006915; GO:0001662; GO:0016477; GO:0071549; GO:0071363; GO:0032869; GO:0071346; GO:0000082; GO:0007281; GO:0044539; GO:0007616; GO:0043066; GO:2001237; GO:0046627; GO:0018105; GO:0048015; GO:0045931; GO:0048633; GO:0014911; GO:0048661; GO:0045727; GO:0045948; GO:0043491; GO:0046324; GO:0014878; GO:0045471; GO:0033762; GO:0009749; GO:0009408; GO:0043201; GO:0032496; GO:0009612; GO:0007584; GO:0033574; GO:0034612; GO:0009611; GO:0007165; GO:0014732; GO:0003009; GO:0031929"]
[1771,883,"PK166","p70S6K (S6Ka, RPS6KB1)","S434","Ribosomal protein S6 kinase beta-1; Ribosomal protein S6 kinase 1",{"v":1021.1316650448092,"d":"1021"},{"v":927.066208156339,"d":"927"},{"v":563.7123308803144,"d":"564"},{"v":55.204666565263906,"d":"55"},{"v":52.814099631770375,"d":"53"},{"v":2950.1517546680097,"d":"2950"},"External","RpAb","IR(pS)PR","Corresponds to amino acid residues I409 to R413.","S434 phosphorylation stimulates phosphotransferase activity. This is one of the minor in vivo phosphorylation sites in p70 S6K (≥1 reports from high throughput mass spectrometry studies).","CDK5; ERK1 (MAPK3); ERK2 (MAPK1); JNK1 (MAPK8); JNK2 (MAPK9); mTOR (FRAP)","P23443","P23443",628,"P23443","P23443","NP_003152","Block6",3,12,"6, 14, 22, 30","p70S6K","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","p70",{"$nulls":5},"Protein-serine kinase, AGC group, RSK family, p70 subfamily","GO:0030054; GO:0009986; GO:0005737; GO:0005829; GO:0005741; GO:0005739; GO:0043005; GO:0005654; GO:0005634; GO:0048471; GO:0045202","GO:0005524; GO:0042802; GO:0016301; GO:0030165; GO:0042277; GO:0004672; GO:0051721; GO:0004712; GO:0004674; GO:0004711","GO:0007568; GO:0006915; GO:0001662; GO:0016477; GO:0071549; GO:0071363; GO:0032869; GO:0071346; GO:0000082; GO:0007281; GO:0044539; GO:0007616; GO:0043066; GO:2001237; GO:0046627; GO:0018105; GO:0048015; GO:0045931; GO:0048633; GO:0014911; GO:0048661; GO:0045727; GO:0045948; GO:0043491; GO:0046324; GO:0014878; GO:0045471; GO:0033762; GO:0009749; GO:0009408; GO:0043201; GO:0032496; GO:0009612; GO:0007584; GO:0033574; GO:0034612; GO:0009611; GO:0007165; GO:0014732; GO:0003009; GO:0031929"]
[1773,884,"PK745","p70S6K (S6Ka, RPS6KB1)","T412","Ribosomal protein S6 kinase beta-1; Ribosomal protein S6 kinase 1",{"v":11831.08996561801,"d":"11831"},{"v":11229.080673872033,"d":"11229"},{"v":3639.8431694007872,"d":"3640"},{"v":30.765070504733128,"d":"31"},{"v":613.0164263179308,"d":"613"},{"v":27102.199105676398,"d":"27102"},"Kinexus","RpAb","LGF(pT)YVA(bA)C","Corresponds to amino acid residues L409 to A415; In the C-terminal third of the kinase.","T412 phosphorylation stimulates phosphotransferase activity. This is one of the minor in vivo phosphorylation sites in p70 S6K (≥ 9 reports from high throughput mass spectrometry studies).","FRAP1 (mTOR); NEK6; p70S6K (RPS6KB1); PDPK1 (PDK1); PIK3CD","P23443","P23443",628,"P23443","P23443","NP_003152","Block6",3,13,"6, 14, 22, 30","p70S6K","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","p70",{"$nulls":5},"Protein-serine kinase, AGC group, RSK family, p70 subfamily","GO:0030054; GO:0009986; GO:0005737; GO:0005829; GO:0005741; GO:0005739; GO:0043005; GO:0005654; GO:0005634; GO:0048471; GO:0045202","GO:0005524; GO:0042802; GO:0016301; GO:0030165; GO:0042277; GO:0004672; GO:0051721; GO:0004712; GO:0004674; GO:0004711","GO:0007568; GO:0006915; GO:0001662; GO:0016477; GO:0071549; GO:0071363; GO:0032869; GO:0071346; GO:0000082; GO:0007281; GO:0044539; GO:0007616; GO:0043066; GO:2001237; GO:0046627; GO:0018105; GO:0048015; GO:0045931; GO:0048633; GO:0014911; GO:0048661; GO:0045727; GO:0045948; GO:0043491; GO:0046324; GO:0014878; GO:0045471; GO:0033762; GO:0009749; GO:0009408; GO:0043201; GO:0032496; GO:0009612; GO:0007584; GO:0033574; GO:0034612; GO:0009611; GO:0007165; GO:0014732; GO:0003009; GO:0031929"]
[1775,885,"PK200","p70S6K (S6Ka, RPS6KB1)","T421+S424","Ribosomal protein S6 kinase beta-1; Ribosomal protein S6 kinase 1",{"v":810.0900650784301,"d":"810"},{"v":474.6748894992661,"d":"475"},{"v":1793.9162076950931,"d":"1794"},{"v":221.44651379244013,"d":"221"},{"v":87.40448400396812,"d":"87"},{"v":16077.70290944408,"d":"16078"},"External","MmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the T421 and S424 phosphosites.","T444 and S447 phosphorylation stimulate phosphotransferase activity. Their phosphorylation regulates cell adhesion, cell cycle progression, and molecular association. These are two of the major in vivo phosphorylation sites in p70 S6K.","T444: CDK1 (CDC2); ERK1 (MAPK3); ERK2 (MAPK1). S447: CDK1 (CDC2); CDK5; ERK1 (MAPK3); ERK2 (MAPK1); TBK1","P23443","P23443",628,"P23443","P23443","NP_003152","Block6",4,1,"6, 14, 22, 30","p70S6K","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","p70",{"$nulls":5},"Protein-serine kinase, AGC group, RSK family, p70 subfamily","GO:0030054; GO:0009986; GO:0005737; GO:0005829; GO:0005741; GO:0005739; GO:0043005; GO:0005654; GO:0005634; GO:0048471; GO:0045202","GO:0005524; GO:0042802; GO:0016301; GO:0030165; GO:0042277; GO:0004672; GO:0051721; GO:0004712; GO:0004674; GO:0004711","GO:0007568; GO:0006915; GO:0001662; GO:0016477; GO:0071549; GO:0071363; GO:0032869; GO:0071346; GO:0000082; GO:0007281; GO:0044539; GO:0007616; GO:0043066; GO:2001237; GO:0046627; GO:0018105; GO:0048015; GO:0045931; GO:0048633; GO:0014911; GO:0048661; GO:0045727; GO:0045948; GO:0043491; GO:0046324; GO:0014878; GO:0045471; GO:0033762; GO:0009749; GO:0009408; GO:0043201; GO:0032496; GO:0009612; GO:0007584; GO:0033574; GO:0034612; GO:0009611; GO:0007165; GO:0014732; GO:0003009; GO:0031929"]
[1777,886,"PK156","p70S6K (S6Ka, RPS6KB1)","S447","Ribosomal protein S6 kinase beta-1; Ribosomal protein S6 kinase 1",{"v":439.84493812518383,"d":"440"},{"v":369.88478010791994,"d":"370"},{"v":322.1120210762937,"d":"322"},{"v":73.23308583458513,"d":"73"},{"v":11.526129563604805,"d":"12"},{"v":2213.155862642667,"d":"2213"},"External","RpAb","PV(pS)PV","Corresponds to amino acid residues P422 to V426.","S447 phosphorylation stimulates phosphotransferase activity. This is one of the major in vivo phosphorylation sites in p70 S6K (≥280 reports from high throughput mass spectrometry studies).","S447: CDK1 (CDC2); CDK5; ERK1 (MAPK3); ERK2 (MAPK1); TBK","P23443","P23443",628,"P23443","P23443","NP_003152","Block6",4,2,"6, 14, 22, 30","p70S6K","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","p70",{"$nulls":5},"Protein-serine kinase, AGC group, RSK family, p70 subfamily","GO:0030054; GO:0009986; GO:0005737; GO:0005829; GO:0005741; GO:0005739; GO:0043005; GO:0005654; GO:0005634; GO:0048471; GO:0045202","GO:0005524; GO:0042802; GO:0016301; GO:0030165; GO:0042277; GO:0004672; GO:0051721; GO:0004712; GO:0004674; GO:0004711","GO:0007568; GO:0006915; GO:0001662; GO:0016477; GO:0071549; GO:0071363; GO:0032869; GO:0071346; GO:0000082; GO:0007281; GO:0044539; GO:0007616; GO:0043066; GO:2001237; GO:0046627; GO:0018105; GO:0048015; GO:0045931; GO:0048633; GO:0014911; GO:0048661; GO:0045727; GO:0045948; GO:0043491; GO:0046324; GO:0014878; GO:0045471; GO:0033762; GO:0009749; GO:0009408; GO:0043201; GO:0032496; GO:0009612; GO:0007584; GO:0033574; GO:0034612; GO:0009611; GO:0007165; GO:0014732; GO:0003009; GO:0031929"]
[1779,887,"PK746","p70S6K (S6Ka, RPS6KB1)","T444+S447","Ribosomal protein S6 kinase beta-1; Ribosomal protein S6 kinase 1",{"v":9627.789626901515,"d":"9628"},{"v":9548.382681812773,"d":"9548"},{"v":2150.219868765263,"d":"2150"},{"v":22.333473747257838,"d":"22"},{"v":3138.522250255502,"d":"3139"},{"v":16740.05701300415,"d":"16740"},"Kinexus","RpAb","PR(pT)PV(pS)VK(bA)C","Corresponds to amino acid residues P442 to K449; In the C-terminal third of the kinase.","T444 and S447 phosphorylation stimulate phosphotransferase activity. Their phosphorylation regulates cell adhesion, cell cycle progression, and molecular association. These are two of the major in vivo phosphorylation sites in p70 S6K.","T444: CDK1 (CDC2); ERK1 (MAPK3); ERK2 (MAPK1). S447: CDK1 (CDC2); CDK5; ERK1 (MAPK3); ERK2 (MAPK1); TBK1","P23443","P23443",628,"P23443","P23443","NP_003152","Block6",4,3,"6, 14, 22, 30","p70S6K","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","p70",{"$nulls":5},"Protein-serine kinase, AGC group, RSK family, p70 subfamily","GO:0030054; GO:0009986; GO:0005737; GO:0005829; GO:0005741; GO:0005739; GO:0043005; GO:0005654; GO:0005634; GO:0048471; GO:0045202","GO:0005524; GO:0042802; GO:0016301; GO:0030165; GO:0042277; GO:0004672; GO:0051721; GO:0004712; GO:0004674; GO:0004711","GO:0007568; GO:0006915; GO:0001662; GO:0016477; GO:0071549; GO:0071363; GO:0032869; GO:0071346; GO:0000082; GO:0007281; GO:0044539; GO:0007616; GO:0043066; GO:2001237; GO:0046627; GO:0018105; GO:0048015; GO:0045931; GO:0048633; GO:0014911; GO:0048661; GO:0045727; GO:0045948; GO:0043491; GO:0046324; GO:0014878; GO:0045471; GO:0033762; GO:0009749; GO:0009408; GO:0043201; GO:0032496; GO:0009612; GO:0007584; GO:0033574; GO:0034612; GO:0009611; GO:0007165; GO:0014732; GO:0003009; GO:0031929"]
[1781,888,"PK747","p70S6KB (RPS6KB2)","S423","Ribosomal protein S6 kinase beta-2; Ribosomal protein S6 kinase 2",{"v":7724.277010601309,"d":"7724"},{"v":7713.34803882539,"d":"7713"},{"v":1752.184826701872,"d":"1752"},{"v":22.68412725614394,"d":"23"},{"v":1172.4156627579719,"d":"1172"},{"v":12155.087444508095,"d":"12155"},"Kinexus","RpAb","APV(pS)PLK(bA)C","Corresponds to amino acid residues A420 to K426; In the C-terminal fifth of the kinase.","S423 phosphorylation stimulates phosphotransferase activity. This is one of the major in vivo phosphorylation sites in p70 S6KB (≥61 reports from high throughput mass spectrometry studies).",null,"Q9UBS0","Q9UBS0",791,"Q9UBS0","Q9UBS0","NP_003943.2","Block6",4,4,"6, 14, 22, 30","p70S6Kb","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","p70",{"$nulls":5},"Protein-serine kinase, AGC group, RSK family, p70 subfamily","GO:0005737; GO:0005654; GO:0005634","GO:0005524; GO:0042277; GO:0004672; GO:0004674; GO:0004711","GO:0035556; GO:0045948; GO:0043491; GO:0007165; GO:0006412"]
[1783,890,"PN713","PAH","S16","Phenylalanine-4-hydroxylase",{"v":8526.839864554388,"d":"8527"},{"v":8452.708058549588,"d":"8453"},{"v":2513.2487830690575,"d":"2513"},{"v":29.474562944667188,"d":"29"},{"v":337.42531231236126,"d":"337"},{"v":20605.198333726876,"d":"20605"},"Kinexus","RpAb","RKL(pS)DFG(bA)C","Corresponds to amino acid residues R13 to G19; Near N-terminus.","S16 phosphorylation stimulates enzyme activity and inhibits interaction with PAH. This is the major in vivo phosphorylation sites in phenylalanine-4-hydroxylase (≥41 reports from high throughput mass spectrometry studies). This human phosphosite is not highly conserved in vertebrates, but is found in the rat.","PKACa (PRKACA)","P00439","P00439",2793,null,null,"NP_000268.1","Block6",4,6,"6, 14, 22, 30",{"$nulls":12},"X","Enzyme","GO:0005829","GO:0005506; GO:0004505","GO:0042423; GO:0008652; GO:0006559; GO:0042136"]
[1785,891,"NK122","PAK1 (PAKa)","Pan-specific","p21-activated kinase 1 (alpha) (Protein-serine/threonine kinase PAK 1)",{"v":283.41888677795845,"d":"283"},{"v":244.75326894064648,"d":"245"},{"v":159.36395829325556,"d":"159"},{"v":56.22912435546598,"d":"56"},{"v":65.05115996533944,"d":"65"},{"v":1145.2201266508873,"d":"1145"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues at the C-terminus of rat αPAK.",null,null,"Q13153","Q13153",630,"Q13153","Q13153","NP_002567","Block6",4,7,"6, 14, 22, 30","PAK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","PAKA",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE20 family; PAKA subfamily","GO:0030424; GO:0005911; GO:0005737; GO:0005829; GO:0030425; GO:0005925; GO:0014704; GO:0071437; GO:0030027; GO:0031965; GO:0005886; GO:0032991; GO:0001726; GO:0032587; GO:0030018","GO:0005524; GO:0005518; GO:0042802; GO:0004672; GO:0019901; GO:0004674; GO:0048365","GO:0031532; GO:0032147; GO:0006915; GO:0048754; GO:0032869; GO:0021549; GO:0048013; GO:0030010; GO:0006887; GO:0038095; GO:0038096; GO:0048012; GO:0061052; GO:0060244; GO:0048812; GO:0045773; GO:0030335; GO:0008284; GO:0010763; GO:2001275; GO:0033148; GO:0043507; GO:0031116; GO:0033138; GO:0001934; GO:0090314; GO:0051496; GO:1904754; GO:1904707; GO:0046777; GO:0006468; GO:0042981; GO:0050770; GO:0007346; GO:0001666; GO:0007266; GO:0002223; GO:0031295; GO:0050852; GO:0042060"]
[1787,892,"NK122-2","PAK1 (PAKa)","Pan-specific","p21-activated kinase 1 (alpha) (Protein-serine/threonine kinase PAK 1)",{"v":4924.31372926997,"d":"4924"},{"v":4765.249591377477,"d":"4765"},{"v":1638.6250779410345,"d":"1639"},{"v":33.27621203744792,"d":"33"},{"v":1144.946052690815,"d":"1145"},{"v":10205.977005590212,"d":"10206"},"Kinexus","RpAb","MSNNGLDVQDKPC","Corresponds to amino acid residues M1 to P12; N-terminus.",null,null,"Q13153","Q13153",630,"Q13153","Q13153","NP_002567","Block6",4,8,"6, 14, 22, 30","PAK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","PAKA",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE20 family; PAKA subfamily","GO:0030424; GO:0005911; GO:0005737; GO:0005829; GO:0030425; GO:0005925; GO:0014704; GO:0071437; GO:0030027; GO:0031965; GO:0005886; GO:0032991; GO:0001726; GO:0032587; GO:0030018","GO:0005524; GO:0005518; GO:0042802; GO:0004672; GO:0019901; GO:0004674; GO:0048365","GO:0031532; GO:0032147; GO:0006915; GO:0048754; GO:0032869; GO:0021549; GO:0048013; GO:0030010; GO:0006887; GO:0038095; GO:0038096; GO:0048012; GO:0061052; GO:0060244; GO:0048812; GO:0045773; GO:0030335; GO:0008284; GO:0010763; GO:2001275; GO:0033148; GO:0043507; GO:0031116; GO:0033138; GO:0001934; GO:0090314; GO:0051496; GO:1904754; GO:1904707; GO:0046777; GO:0006468; GO:0042981; GO:0050770; GO:0007346; GO:0001666; GO:0007266; GO:0002223; GO:0031295; GO:0050852; GO:0042060"]
[1789,893,"PK061","PAK1 (PAKa)","S141","p21-activated kinase 1 (alpha) (Protein-serine/threonine kinase PAK 1)",{"v":211.41573654643582,"d":"211"},{"v":163.50583786318896,"d":"164"},{"v":200.76251605296503,"d":"201"},{"v":94.96100873686339,"d":"95"},{"v":7.090613065897278,"d":"7"},{"v":1025.695790503077,"d":"1026"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S141 phosphosite.","S141 phosphorylation stimulates phosphotransferase activity. This is one of the major in vivo phosphorylation sites in PAK2 (≥154 reports from high throughput mass spectrometry studies).","PAK2","Q13153","Q13153",630,"Q13153","Q13153","NP_002567","Block6",4,9,"6, 14, 22, 30","PAK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","PAKA",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE20 family; PAKA subfamily","GO:0030424; GO:0005911; GO:0005737; GO:0005829; GO:0030425; GO:0005925; GO:0014704; GO:0071437; GO:0030027; GO:0031965; GO:0005886; GO:0032991; GO:0001726; GO:0032587; GO:0030018","GO:0005524; GO:0005518; GO:0042802; GO:0004672; GO:0019901; GO:0004674; GO:0048365","GO:0031532; GO:0032147; GO:0006915; GO:0048754; GO:0032869; GO:0021549; GO:0048013; GO:0030010; GO:0006887; GO:0038095; GO:0038096; GO:0048012; GO:0061052; GO:0060244; GO:0048812; GO:0045773; GO:0030335; GO:0008284; GO:0010763; GO:2001275; GO:0033148; GO:0043507; GO:0031116; GO:0033138; GO:0001934; GO:0090314; GO:0051496; GO:1904754; GO:1904707; GO:0046777; GO:0006468; GO:0042981; GO:0050770; GO:0007346; GO:0001666; GO:0007266; GO:0002223; GO:0031295; GO:0050852; GO:0042060"]
[1791,894,"PK748","PAK1 (PAKa)","S144","p21-activated kinase 1 (alpha) (Protein-serine/threonine kinase PAK 1)",{"v":14824.739434219999,"d":"14825"},{"v":14064.583244998608,"d":"14065"},{"v":5070.742948647489,"d":"5071"},{"v":34.20460083731843,"d":"34"},{"v":603.8358068246469,"d":"604"},{"v":32097.675562089884,"d":"32098"},"Kinexus","RpAb","KYM(pS)FTD(bA)C","Corresponds to amino acid residues K141 to D147; Just after the PBD. The major site of phosphorylation of PAK1.","S144 phosphorylation stimulates phosphotransferase activity and regulates cytoskeletal reorganization, and intracellular location. This is one of the major in vivo phosphorylation sites in PAK1 (≥163 reports from high throughput mass spectrometry studies).","PAK1","Q13153","Q13153",630,"Q13153","Q13153","NP_002567","Block6",4,10,"6, 14, 22, 30","PAK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","PAKA",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE20 family; PAKA subfamily","GO:0030424; GO:0005911; GO:0005737; GO:0005829; GO:0030425; GO:0005925; GO:0014704; GO:0071437; GO:0030027; GO:0031965; GO:0005886; GO:0032991; GO:0001726; GO:0032587; GO:0030018","GO:0005524; GO:0005518; GO:0042802; GO:0004672; GO:0019901; GO:0004674; GO:0048365","GO:0031532; GO:0032147; GO:0006915; GO:0048754; GO:0032869; GO:0021549; GO:0048013; GO:0030010; GO:0006887; GO:0038095; GO:0038096; GO:0048012; GO:0061052; GO:0060244; GO:0048812; GO:0045773; GO:0030335; GO:0008284; GO:0010763; GO:2001275; GO:0033148; GO:0043507; GO:0031116; GO:0033138; GO:0001934; GO:0090314; GO:0051496; GO:1904754; GO:1904707; GO:0046777; GO:0006468; GO:0042981; GO:0050770; GO:0007346; GO:0001666; GO:0007266; GO:0002223; GO:0031295; GO:0050852; GO:0042060"]
[1793,895,"PK130","PAK1 (PAKa)","T212","p21-activated kinase 1 (alpha) (Protein-serine/threonine kinase PAK 1)",{"v":1579.0827077658967,"d":"1579"},{"v":1509.476319906367,"d":"1509"},{"v":831.9359302974407,"d":"832"},{"v":52.684759715624566,"d":"53"},{"v":26.575457398353144,"d":"27"},{"v":4260.8523366143945,"d":"4261"},"External","RpAb","PV(pT)PT","Corresponds to amino acid residues P210 to T214; Surrounds the T212 phosphosite.","T212 phosphorylation inhibits phosphotransferase activity. This is one of the major in vivo phosphorylation sites in PAK1 (≥38 reports from high throughput mass spectrometry studies).","CDK1 (CDC2); CDK5","Q13153","Q13153",630,"Q13153","Q13153","NP_002567","Block6",4,11,"6, 14, 22, 30","PAK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","PAKA",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE20 family; PAKA subfamily","GO:0030424; GO:0005911; GO:0005737; GO:0005829; GO:0030425; GO:0005925; GO:0014704; GO:0071437; GO:0030027; GO:0031965; GO:0005886; GO:0032991; GO:0001726; GO:0032587; GO:0030018","GO:0005524; GO:0005518; GO:0042802; GO:0004672; GO:0019901; GO:0004674; GO:0048365","GO:0031532; GO:0032147; GO:0006915; GO:0048754; GO:0032869; GO:0021549; GO:0048013; GO:0030010; GO:0006887; GO:0038095; GO:0038096; GO:0048012; GO:0061052; GO:0060244; GO:0048812; GO:0045773; GO:0030335; GO:0008284; GO:0010763; GO:2001275; GO:0033148; GO:0043507; GO:0031116; GO:0033138; GO:0001934; GO:0090314; GO:0051496; GO:1904754; GO:1904707; GO:0046777; GO:0006468; GO:0042981; GO:0050770; GO:0007346; GO:0001666; GO:0007266; GO:0002223; GO:0031295; GO:0050852; GO:0042060"]
[1795,896,"PK749","PAK1 (PAKa)","T423","p21-activated kinase 1 (alpha) (Protein-serine/threonine kinase PAK 1)",{"v":7568.312378437009,"d":"7568"},{"v":7282.500519269335,"d":"7283"},{"v":2059.78438910361,"d":"2060"},{"v":27.215900799393168,"d":"27"},{"v":569.0901194748329,"d":"569"},{"v":16575.89591834067,"d":"16576"},"Kinexus","RpAb","KRS(pT)MVG(bA)C","Corresponds to amino acid residues K420 to G426; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T423 phosphorylation stimulates phosphotransferase activty and interaction with CDC42 and PAK1, and induces cell motility. This is one of the minor in vivo phosphorylation sites in PAK1 (≥12 reports from high throughput mass spectrometry studies).","PAK1; PDPK1 (PDK1); PKACa (PRKACA)","Q13153","Q13153",630,"Q13153","Q13153","NP_002567","Block6",4,12,"6, 14, 22, 30","PAK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","PAKA",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE20 family; PAKA subfamily","GO:0030424; GO:0005911; GO:0005737; GO:0005829; GO:0030425; GO:0005925; GO:0014704; GO:0071437; GO:0030027; GO:0031965; GO:0005886; GO:0032991; GO:0001726; GO:0032587; GO:0030018","GO:0005524; GO:0005518; GO:0042802; GO:0004672; GO:0019901; GO:0004674; GO:0048365","GO:0031532; GO:0032147; GO:0006915; GO:0048754; GO:0032869; GO:0021549; GO:0048013; GO:0030010; GO:0006887; GO:0038095; GO:0038096; GO:0048012; GO:0061052; GO:0060244; GO:0048812; GO:0045773; GO:0030335; GO:0008284; GO:0010763; GO:2001275; GO:0033148; GO:0043507; GO:0031116; GO:0033138; GO:0001934; GO:0090314; GO:0051496; GO:1904754; GO:1904707; GO:0046777; GO:0006468; GO:0042981; GO:0050770; GO:0007346; GO:0001666; GO:0007266; GO:0002223; GO:0031295; GO:0050852; GO:0042060"]
[1797,897,"NK200-2","PAK2 (PAKg)","Pan-specific","p21-activated kinase 2 (gamma) (Protein-serine/threonine kinase PAK2)",{"v":115.67322104864546,"d":"116"},{"v":92.63072848254832,"d":"93"},{"v":76.4641429922354,"d":"76"},{"v":66.10358240139178,"d":"66"},{"v":26.549318736227484,"d":"27"},{"v":443.07216026844026,"d":"443"},"External","GpAb","Epitope undefined.",{"$nulls":3},"Q13177","Q13177",631,"Q13177",null,"NP_002568.2","Block6",4,13,"6, 14, 22, 30","PAK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","PAKA",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE20 family; PAKA subfamily","GO:0005737; GO:0005829; GO:0098978; GO:0005634; GO:0048471; GO:0005886; GO:0014069","GO:0005524; GO:0045296; GO:0042802; GO:0004672; GO:0019901; GO:0004674; GO:0030296; GO:0048365; GO:0031267","GO:0030036; GO:0006915; GO:0016477; GO:0071407; GO:0060996; GO:0038095; GO:0035722; GO:0043066; GO:2001271; GO:0006469; GO:0018105; GO:0016310; GO:2001238; GO:0050731; GO:0046777; GO:0006468; GO:0050690; GO:0040008; GO:0043408; GO:0007346; GO:0007266; GO:0007165; GO:0023014; GO:0002223; GO:0031098; GO:0031295; GO:0050852; GO:0048010"]
[1799,898,"PK751","PAK2 (PAKg)","Y130","p21-activated kinase 2 gamma; Protein-serine/threonine kinase PAK 2",{"v":6933.116277512041,"d":"6933"},{"v":6646.977417831438,"d":"6647"},{"v":1857.6698373109266,"d":"1858"},{"v":26.794153782425155,"d":"27"},{"v":2827.115818315789,"d":"2827"},{"v":15766.111292611635,"d":"15766"},"Kinexus","RpAb","LKF(pY)DSN(bA)C","Corresponds to amino acid residues L127 to N133; At the end of the PBD (p21-binding domain) in the N-terminal third of the protein.","Y130 phosphorylation stimulates phosphotransferase activity. This is one of the major in vivo phosphorylation sites in PAK2 (≥126 reports from high throughput mass spectrometry studies).","Src","Q13177","Q13177",631,"Q13177",null,"NP_002568.2","Block6",5,1,"6, 14, 22, 30","PAK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","PAKA",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE20 family; PAKA subfamily","GO:0005737; GO:0005829; GO:0098978; GO:0005634; GO:0048471; GO:0005886; GO:0014069","GO:0005524; GO:0045296; GO:0042802; GO:0004672; GO:0019901; GO:0004674; GO:0030296; GO:0048365; GO:0031267","GO:0030036; GO:0006915; GO:0016477; GO:0071407; GO:0060996; GO:0038095; GO:0035722; GO:0043066; GO:2001271; GO:0006469; GO:0018105; GO:0016310; GO:2001238; GO:0050731; GO:0046777; GO:0006468; GO:0050690; GO:0040008; GO:0043408; GO:0007346; GO:0007266; GO:0007165; GO:0023014; GO:0002223; GO:0031098; GO:0031295; GO:0050852; GO:0048010"]
[1801,899,"PK750","PAK2 (PAKg)","S141","p21-activated kinase 2 gamma; Protein-serine/threonine kinase PAK 2",{"v":19093.365751756166,"d":"19093"},{"v":17896.52540657283,"d":"17897"},{"v":6078.705759121987,"d":"6079"},{"v":31.83674286741656,"d":"32"},{"v":690.9681876313339,"d":"691"},{"v":42851.11311206767,"d":"42851"},"Kinexus","RpAb","KYL(pS)FTP(bA)C","Corresponds to amino acid residues K138 to P144; In the region between the PBD (p21-binding domain) and the kinase catalytic domain in the N-terminal third of the protein.","S141 phosphorylation stimulates phosphotransferase activity. This is one of the major in vivo phosphorylation sites in PAK2 (≥154 reports from high throughput mass spectrometry studies).","PAK2","Q13177","Q13177",631,"Q13177",null,"NP_002568.2","Block6",5,2,"6, 14, 22, 30","PAK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","PAKA",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE20 family; PAKA subfamily","GO:0005737; GO:0005829; GO:0098978; GO:0005634; GO:0048471; GO:0005886; GO:0014069","GO:0005524; GO:0045296; GO:0042802; GO:0004672; GO:0019901; GO:0004674; GO:0030296; GO:0048365; GO:0031267","GO:0030036; GO:0006915; GO:0016477; GO:0071407; GO:0060996; GO:0038095; GO:0035722; GO:0043066; GO:2001271; GO:0006469; GO:0018105; GO:0016310; GO:2001238; GO:0050731; GO:0046777; GO:0006468; GO:0050690; GO:0040008; GO:0043408; GO:0007346; GO:0007266; GO:0007165; GO:0023014; GO:0002223; GO:0031098; GO:0031295; GO:0050852; GO:0048010"]
[1803,900,"NK123","PAK3","Pan-specific","p21-activated kinase 3 (beta) (Protein-serine/threonine kinase PAK3)",{"v":556.1229678781758,"d":"556"},{"v":458.7975280594992,"d":"459"},{"v":372.1172325878046,"d":"372"},{"v":66.91276104052594,"d":"67"},{"v":129.95387708063345,"d":"130"},{"v":3099.212711778253,"d":"3099"},"External","GpAb","Epitope undefined.",{"$nulls":3},"O75914","O75914",632,"O75914",null,"NP_002569","Block6",5,3,"6, 14, 22, 30","PAK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","PAKA",{"$nulls":5},"Protein-serine kinase, STE group, STE20 family, PAKA subfamily","GO:0005737; GO:0005829; GO:0005768; GO:0098978; GO:0005886; GO:0014069","GO:0005524; GO:0004708; GO:0046872; GO:0004674; GO:0048365; GO:0017124","GO:0007409; GO:0016477; GO:0071407; GO:0016358; GO:0060997; GO:0048013; GO:0061003; GO:2000573; GO:0010763; GO:0043525; GO:0030833; GO:0042981; GO:0050770; GO:0007346; GO:0007266; GO:0002223; GO:0031098; GO:0050808; GO:0031295; GO:0050852"]
[1805,901,"PK752","PAK4","S474","p21-activated kinase 4",{"v":8174.459421636034,"d":"8174"},{"v":7633.416036350071,"d":"7633"},{"v":3206.310456559071,"d":"3206"},{"v":39.22351670218899,"d":"39"},{"v":984.5738824086945,"d":"985"},{"v":22424.344985757743,"d":"22424"},"Kinexus","RpAb","RRK(pS)LVG(bA)C","Corresponds to amino acid residues R471 to G477; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S474 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation site in PAK4 (≥184 reports from high throughput mass spectrometry studies).","PAK4","O96013","O96013",633,"O96013",null,"NP_001014831.1","Block6",5,4,"6, 14, 22, 30","PAK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","PAKB",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; STE group; STE20 family; PAKB subfamily","GO:0005913; GO:0005925; GO:0005794","GO:0005524; GO:0098641; GO:0004672; GO:0004674; GO:0048365","GO:0030036; GO:0032147; GO:0006915; GO:0007049; GO:0016477; GO:0008283; GO:0071407; GO:0007010; GO:0060996; GO:2000352; GO:0045766; GO:0042981; GO:0001558; GO:0043408; GO:0007346; GO:0007266; GO:0007165; GO:0023014; GO:0031098"]
[1807,902,"NK190-2","PAK5 (PAK7)","Pan-specific","p21-activated kinase 5;  Protein-serine/threonine kinase PAK 7",{"v":671.9818144034884,"d":"672"},{"v":606.6100188739999,"d":"607"},{"v":339.34871138139505,"d":"339"},{"v":50.49968676349248,"d":"50"},{"v":104.14122222526825,"d":"104"},{"v":1987.1595694464777,"d":"1987"},"Kinexus","RpAb","CGLPQQWHSLLADTANRP","Corresponds to amino acid residues G34 to R49; Post-N-terminus.",null,null,"Q9P286","Q9P286",732,"Q9P286","Q9P286","NP_065074.1","Block6",5,5,"6, 14, 22, 30","PAK5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","PAKB",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE20 family; PAKB subfamily","GO:0005737; GO:0005739; GO:0005654; GO:0045202","GO:0005524; GO:0004674; GO:0048365","GO:0030036; GO:0032147; GO:0006915; GO:0016477; GO:0008283; GO:0007010; GO:0007612; GO:0007626; GO:0007613; GO:2001237; GO:0042981; GO:0001558; GO:0043408; GO:0007346; GO:0007266; GO:0007165; GO:0023014; GO:0031098"]
[1809,903,"NK190-3","PAK5 (PAK7)","Pan-specific","p21-activated kinase 5;  Protein-serine/threonine kinase PAK 7",{"v":10222.54585575065,"d":"10223"},{"v":9973.311630068569,"d":"9973"},{"v":2594.06195058047,"d":"2594"},{"v":25.375889599176425,"d":"25"},{"v":698.585292546099,"d":"699"},{"v":22242.377986440453,"d":"22242"},"Kinexus","RpAb","CKETSINGLLEDFDNISV","Corresponds to amino acid residues C77 to V94; Post-PBD.",null,null,"Q9P286","Q9P286",732,"Q9P286","Q9P286","NP_065074.1","Block6",5,6,"6, 14, 22, 30","PAK5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","PAKB",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE20 family; PAKB subfamily","GO:0005737; GO:0005739; GO:0005654; GO:0045202","GO:0005524; GO:0004674; GO:0048365","GO:0030036; GO:0032147; GO:0006915; GO:0016477; GO:0008283; GO:0007010; GO:0007612; GO:0007626; GO:0007613; GO:2001237; GO:0042981; GO:0001558; GO:0043408; GO:0007346; GO:0007266; GO:0007165; GO:0023014; GO:0031098"]
[1811,904,"PK753","PAK5 (PAK7)","S602","p21-activated kinase 5;  Protein-serine/threonine kinase PAK 7",{"v":4634.474546647474,"d":"4634"},{"v":4349.765907056273,"d":"4350"},{"v":1488.7633334731513,"d":"1489"},{"v":32.12367051514191,"d":"32"},{"v":1588.5056904350852,"d":"1589"},{"v":10511.5747313049,"d":"10512"},"Kinexus","RpAb","KRK(pS)LVG(bA)C","Corresponds to amino acid residues K599 to G605; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S602 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major in vivo phosphorylation site in PAK5 (≥42 reports from high throughput mass spectrometry studies).",null,"Q9P286","Q9P286",732,"Q9P286","Q9P286","NP_065074.1","Block6",5,7,"6, 14, 22, 30","PAK5","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","PAKB",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE20 family; PAKB subfamily","GO:0005737; GO:0005739; GO:0005654; GO:0045202","GO:0005524; GO:0004674; GO:0048365","GO:0030036; GO:0032147; GO:0006915; GO:0016477; GO:0008283; GO:0007010; GO:0007612; GO:0007626; GO:0007613; GO:2001237; GO:0042981; GO:0001558; GO:0043408; GO:0007346; GO:0007266; GO:0007165; GO:0023014; GO:0031098"]
[1813,905,"NK124-2","PAK6","Pan-specific","Protein-serine/threonine kinase PAK 6",{"v":10194.951417827946,"d":"10195"},{"v":9968.33736414679,"d":"9968"},{"v":2563.183662618067,"d":"2563"},{"v":25.141695703775685,"d":"25"},{"v":2302.4693283468137,"d":"2302"},{"v":18265.883300457826,"d":"18266"},"Kinexus","RpAb","CGSAMPVDGYISGLLNDIQK","Corresponds to amino acid residues G73 to K91; Post-PBD.",null,null,"Q9NQU5","Q9NQU5",733,"Q9NQU5",null,"NP_001122100.1","Block6",5,8,"6, 14, 22, 30","PAK6","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","PAKB",{"$nulls":5},"Protein-serine kinase, STE group, STE20 family, PAKB subfamily","GO:0030054; GO:0005737; GO:0001650; GO:0005634","GO:0005524; GO:0045296; GO:0004674; GO:0048365","GO:0030036; GO:0032147; GO:0006915; GO:0016477; GO:0007010; GO:0042981; GO:0043408; GO:0007346; GO:0006355; GO:0007266; GO:0023014; GO:0031098"]
[1815,909,"NK284-1","PBK","Pan-specific","Lymphokine-activated killer T-cell-originated protein kinase",{"v":547.2148756018538,"d":"547"},{"v":510.1834554242022,"d":"510"},{"v":277.01703936403925,"d":"277"},{"v":50.6230827623906,"d":"51"},{"v":73.4472460225025,"d":"73"},{"v":1746.839358539435,"d":"1747"},"Kinexus","RpAb","GISNFKTPSKLSEKKKSVLC","Corresponds to amino acid residues G3-C22; N-terminus.",null,null,"Q96KB5","Q96KB5",2235,"Q96KB5","Q96KB5","NP_060962.2","Block6",5,12,"6, 14, 22, 30","PBK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","TOPK",{"$nulls":6},"Protein-serine kinase, Other group, TOPK family","GO:0005634","GO:0005524; GO:0004674","GO:0034644; GO:0000278; GO:0050728; GO:0032435; GO:0032873"]
[1817,910,"PK754","PBK","Y74","Lymphokine-activated killer T-cell-originated protein kinase",{"v":8993.141643534806,"d":"8993"},{"v":9028.343389639114,"d":"9028"},{"v":2507.883645076859,"d":"2508"},{"v":27.88662454660417,"d":"28"},{"v":976.4544346638273,"d":"976"},{"v":19821.025994048923,"d":"19821"},"Kinexus","RpAb","NDH(pY)RSV(bA)C","Corresponds to amino acid residues N71 to V77; In the protein kinase catalytic domain between subdomains II and III. ","Y74 phosphorylation stimulates phosphotransferase activity. This is the major in vivo phosphorylation site in PBK (≥166 reports from high throughput mass spectrometry studies).","Src","Q96KB5","Q96KB5",2235,"Q96KB5","Q96KB5","NP_060962.2","Block6",5,13,"6, 14, 22, 30","PBK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","TOPK",{"$nulls":6},"Protein-serine kinase, Other group, TOPK family","GO:0005634","GO:0005524; GO:0004674","GO:0034644; GO:0000278; GO:0050728; GO:0032435; GO:0032873"]
[1819,911,"PK889","PBK","Y272","Lymphokine-activated killer T-cell-originated protein kinase",{"v":8793.353808713695,"d":"8793"},{"v":8700.543813858454,"d":"8701"},{"v":1775.2561902190125,"d":"1775"},{"v":20.188613228093228,"d":"20"},{"v":587.1686018365957,"d":"587"},{"v":14875.183036978506,"d":"14875"},"Kinexus","RpAb","EAY(pY)AAL(bA)C","Corresponds to amino acid residues  E269 to L275. Y272 is located in the Gap/Insert 10 (G/I10) region in the protein-serine/threonine kinase catalytic domain of PBK.","Phosphorylation of Y272 by Src stimulates phosphotransferase activity of PBK and stabilizes the protein. PBK can phosphorylate p38 MAPK, and it is primarly activated during mitosis. Phosphorylation of Y272 has not been observed in reported mass spectrometry studies.","Src","Q96KB5","Q96KB5",2235,"Q96KB5","Q96KB5","NP_060962.2","Block6",6,1,"6, 14, 22, 30","PBK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","TOPK",{"$nulls":6},"Protein-serine kinase, Other group, TOPK family","GO:0005634","GO:0005524; GO:0004674","GO:0034644; GO:0000278; GO:0050728; GO:0032435; GO:0032873"]
[1821,912,"PN714","PBRM1","S948","Protein polybromo-1",{"v":260.3036955199797,"d":"260"},{"v":213.90035755391182,"d":"214"},{"v":197.25992901751158,"d":"197"},{"v":75.78068710222011,"d":"76"},{"v":5.19403675003947,"d":"5"},{"v":1135.4989205524073,"d":"1135"},"Kinexus","RpAb","HRTY(pS)QDC","Corresponds to amino acid residues H944 to C951.","S948 phosphorylation inhibits this protein. It is possibly targeted by ATM. This is one of the major in vivo phosphorylation sites in PBRM1 (≥47 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in fish.",null,"Q86U86","Q86U86",6221,null,"Q86U86","XP_016862237.1","Block6",6,2,"6, 14, 22, 30",{"$nulls":3},"DNA-binding",{"$nulls":4},"X",{"$nulls":4},"DNA binding protein","GO:0000228; GO:0005654; GO:0016586","GO:0003682; GO:0003677","GO:0006338; GO:0000278; GO:0008285; GO:0006355; GO:0006351"]
[1823,913,"PK755","PCTK1 (PCTAIRE1, CDK16)","Y176","Cell division protein kinase 16; Protein-serine kinase PCTAIRE-1",{"v":9299.38085347596,"d":"9299"},{"v":9064.556249532843,"d":"9065"},{"v":1805.774629256909,"d":"1806"},{"v":19.418224263628687,"d":"19"},{"v":5027.139246412389,"d":"5027"},{"v":14957.689918033313,"d":"14958"},"Kinexus","RpAb","EGT(pY)ATV(bA)C","Corresponds to amino acid residues E173 to V179; In the protein kinase catalytic domain in subdomain I. ","Y176 phosphorylation is predicted to be inhibitory for phosphotransferase activity. These phosphosites are located in the kinase subdomain I region, which is involved in binding the phosphates in the ATP substrate. This is the major in vivo phosphorylation site in PCTK1 (≥336 reports from high throughput mass spectrometry studies).",null,"Q00536","Q00536",734,"Q00536","Q00536","NP_148978","Block6",6,3,"6, 14, 22, 30","PCTAIRE1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","TAIRE",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.22; CMGC domain target; CMGC</A> group; CDK family; TAIRE subfamily; CDK/TAIRE subfamily","GO:0030054; GO:0005737; GO:0005829; GO:0031234; GO:0015630; GO:0043005; GO:0005886; GO:0008021","GO:0005524; GO:0004674","GO:0006887; GO:0030252; GO:0031175; GO:0006468; GO:0051726; GO:0061178; GO:0007283"]
[1825,914,"NK285-1","PCTK2 (PCTAIRE2, CDK17)","Pan-specific","Cell division protein kinase 17; Protein-serine kinase PCTAIRE-2",{"v":2235.408738535675,"d":"2235"},{"v":1968.1225991834172,"d":"1968"},{"v":1135.376497167264,"d":"1135"},{"v":50.79055465762394,"d":"51"},{"v":533.47479979223,"d":"533"},{"v":6195.586405237405,"d":"6196"},"Kinexus","RpAb","CGSQTIDESLSELAEQMTIE","Corresponds to amino acid residues G14 to E32; Post-N-terminus.",null,null,"Q00537","Q00537",735,"Q00537",null,"NP_002586.2","Block6",6,4,"6, 14, 22, 30","PCTAIRE2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","TAIRE",{"$nulls":5},"EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC domain target; CMGC</A> group; CDK family; TAIRE subfamily; CDK/TAIRE subfamily","GO:0005737; GO:0005634","GO:0005524; GO:0004672; GO:0004674","GO:0006468; GO:0051726"]
[1827,915,"PK756","PCTK2 (PCTAIRE2, CDK17))","S180","Cell division protein kinase 17; Protein-serine kinase PCTAIRE-2",{"v":9717.05640179371,"d":"9717"},{"v":9587.367570389117,"d":"9587"},{"v":1929.2143254019675,"d":"1929"},{"v":19.853896546755106,"d":"20"},{"v":3938.7611728866805,"d":"3939"},{"v":18936.13832742472,"d":"18936"},"Kinexus","RpAb","RRA(pS)LSE(bA)C","Corresponds to amino acid residues R177 to E183; Just before kinase catalytic domain. ","The effect of S180 phosphorylation is unclear. One of two major sites of phosphorylation of PCTK2 (≥339 reports from high throughput mass spectrometry studies).",null,"Q00537","Q00537",735,"Q00537",null,"NP_002586.2","Block6",6,5,"6, 14, 22, 30","PCTAIRE2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","TAIRE",{"$nulls":5},"EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC domain target; CMGC</A> group; CDK family; TAIRE subfamily; CDK/TAIRE subfamily","GO:0005737; GO:0005634","GO:0005524; GO:0004672; GO:0004674","GO:0006468; GO:0051726"]
[1829,916,"NK286-1","PCTK3 (PCTAIRE3, CDK18)","Pan-specific","Cell division protein kinase 18; Protein-serine kinase PCTAIRE-3",{"v":12690.397972752802,"d":"12690"},{"v":12798.391584512552,"d":"12798"},{"v":3131.296985666393,"d":"3131"},{"v":24.67453733436503,"d":"25"},{"v":4735.242930354823,"d":"4735"},{"v":24017.557124923645,"d":"24018"},"Kinexus","RpAb","CIEESLAEFTEQFNQLHNRR","Corresponds to amino acid residues I21 to R39; Post-N-terminus.",null,null,"Q07002","Q07002",2135,"Q07002","Q07002","NP_002587.2","Block6",6,6,"6, 14, 22, 30","PCTAIRE3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","TAIRE",{"$nulls":5},"EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC domain target; CMGC</A> group; CDK family; CDK/TAIRE subfamily; TAIRE subfamily","GO:0005737; GO:0005634","GO:0005524; GO:0004674","GO:0006468; GO:0051726"]
[1831,917,"NN-456-2","PCYT1A (CTPCT; CCTA)","Pan-specific","CTP: phosphocholine cytidylyltransferase isoform A",{"v":5659.61269169789,"d":"5660"},{"v":5723.121743873299,"d":"5723"},{"v":1554.4417055834192,"d":"1554"},{"v":27.465513812696695,"d":"27"},{"v":1201.6959911324716,"d":"1202"},{"v":10686.439650501768,"d":"10686"},"External","RpAb","Epitope undefined.",{"$nulls":3},"P49585","P49585",5400,null,null,"NP_001299602.1","Block6",6,7,"6, 14, 22, 30",{"$nulls":3},"Metabolic enzyme",{"$nulls":8},"X","EC 2.7.7.15; Lipid Metabolism - glycerophospholipid; Transferase","GO:0005829; GO:0005789; GO:0042587; GO:0005635; GO:0005886","GO:0005516; GO:0004105; GO:0031210; GO:0042803","GO:0006657; GO:0006656"]
[1833,918,"NN-456-1","PCYT1A (CTPCT; CCTA)","Pan-specific","CTP: phosphocholine cytidylyltransferase isoform A",{"v":333.36689532908923,"d":"333"},{"v":259.53747055291205,"d":"260"},{"v":272.8936046310515,"d":"273"},{"v":81.85983925058294,"d":"82"},{"v":65.14493562402299,"d":"65"},{"v":3269.1709998737697,"d":"3269"},"External","MmAb","Epitope undefined.",{"$nulls":3},"P49585","P49585",5400,null,null,"NP_001299602.1","Block6",6,8,"6, 14, 22, 30",{"$nulls":3},"Metabolic enzyme",{"$nulls":8},"X","EC 2.7.7.15; Lipid Metabolism - glycerophospholipid; Transferase","GO:0005829; GO:0005789; GO:0042587; GO:0005635; GO:0005886","GO:0005516; GO:0004105; GO:0031210; GO:0042803","GO:0006657; GO:0006656"]
[1835,919,"PN561","PCYT1A (CTPCT; CCTA)","S329+S331","CTP: phosphocholine cytidylyltransferase isoform A",{"v":5887.9983894692605,"d":"5888"},{"v":5506.465334319875,"d":"5506"},{"v":1980.1542639918084,"d":"1980"},{"v":33.63034656282061,"d":"34"},{"v":2015.0209573562925,"d":"2015"},{"v":19920.623563934067,"d":"19921"},"Kinexus","RpAb","TRER(pS)P(pS)PSF(bA)C","Corresponds to amino acid residues T325 to F334; Near the C-terminus of the protein. ","The effects of S329 and S331 phosphorylation are unclear. These are among the main in vivo phosphorylation sites in PCYT1A (≥20 and ≥43 reports, respectively, from high throughput mass spectrometry studies).",null,"P49585","P49585",5400,null,null,"NP_001299602.1","Block6",6,9,"6, 14, 22, 30",{"$nulls":3},"Metabolic enzyme",{"$nulls":8},"X","EC 2.7.7.15; Lipid Metabolism - glycerophospholipid; Transferase","GO:0005829; GO:0005789; GO:0042587; GO:0005635; GO:0005886","GO:0005516; GO:0004105; GO:0031210; GO:0042803","GO:0006657; GO:0006656"]
[1837,920,"PN547","PCYT1A (CTPCT; CCTA)","T342+S343","CTP: phosphocholine cytidylyltransferase isoform A",{"v":1352.1426732719115,"d":"1352"},{"v":1283.8368271187242,"d":"1284"},{"v":591.088192737875,"d":"591"},{"v":43.71492775296865,"d":"44"},{"v":43.82398789819605,"d":"44"},{"v":3823.3563217794813,"d":"3823"},"Kinexus","RpAb","FSGK(pT)(pS)PP(bA)C                                                                                                                                          ","Corresponds to amino acid residues F338 to C346; Near the C-terminus of the protein. ","The effects of T342 and S343 phosphorylation are unclear. These are among the main in vivo phosphorylation sites in PCYT1A (≥33 and ≥50 reports, respectively, from high throughput mass spectrometry studies).",null,"P49585","P49585",5400,null,null,"NP_001299602.1","Block6",6,10,"6, 14, 22, 30",{"$nulls":3},"Metabolic enzyme",{"$nulls":8},"X","EC 2.7.7.15; Lipid Metabolism - glycerophospholipid; Transferase","GO:0005829; GO:0005789; GO:0042587; GO:0005635; GO:0005886","GO:0005516; GO:0004105; GO:0031210; GO:0042803","GO:0006657; GO:0006656"]
[1839,921,"PN548","PCYT1A (CTPCT; CCTA)","Y359+S362","CTP: phosphocholine cytidylyltransferase isoform A",{"v":902.2835594630222,"d":"902"},{"v":835.2618040258117,"d":"835"},{"v":425.0680757314609,"d":"425"},{"v":47.1102538967276,"d":"47"},{"v":37.89860025580663,"d":"38"},{"v":2459.652664842005,"d":"2460"},"Kinexus","RpAb","KAAA(pY)DI(pS)EDE(bA)C     ","Corresponds to amino acid residues K355 to E365; in the C-terminus of the protein. ","The effects of Y359 and S362 phosphorylation are unclear. These are among the main in vivo phosphorylation sites in PCYT1A (≥32 and ≥98 reports, respectively, from high throughput mass spectrometry studies).",null,"P49585","P49585",5400,null,null,"NP_001299602.1","Block6",6,11,"6, 14, 22, 30",{"$nulls":3},"Metabolic enzyme",{"$nulls":8},"X","EC 2.7.7.15; Lipid Metabolism - glycerophospholipid; Transferase","GO:0005829; GO:0005789; GO:0042587; GO:0005635; GO:0005886","GO:0005516; GO:0004105; GO:0031210; GO:0042803","GO:0006657; GO:0006656"]
[1841,922,"PN546","PCYT1B (CCTB)","S315+S319","CTP: phosphocholine cytidylyltransferase isoform B",{"v":1580.223125427411,"d":"1580"},{"v":1469.3796729241558,"d":"1469"},{"v":645.0941671449017,"d":"645"},{"v":40.822979790934255,"d":"41"},{"v":204.41118423415796,"d":"204"},{"v":4202.6416680118,"d":"4203"},"Kinexus","RpAb","LQAL(pS)PKQ(pS)PV(bA)C","Corresponds to amino acid residues L311 to V321; Near the C-terminus of the protein. ","S315 phosphorylation inhibits cytidyltransferase activity. S315 and S319 are the main in vivo phosphorylation sites in PCYT1B (≥36 and ≥9 reports, respectively, from high throughput mass spectrometry studies).","S315: ERK1 (MAPK3); ERK2 (MAPK1).","Q9Y5K3","Q9Y5K3",6022,null,null,"NP_004836.2","Block6",6,12,"6, 14, 22, 30",{"$nulls":3},"Metabolic enzyme",{"$nulls":8},"X",null,"GO:0005737; GO:0005789","GO:0004105","GO:0001541; GO:0006656; GO:0007283"]
[1843,923,"NK242-1","PDGFRa","Pan-specific","Platelet-derived growth factor receptor kinase alpha",{"v":14080.941630278105,"d":"14081"},{"v":13571.819261485096,"d":"13572"},{"v":3728.5158337893063,"d":"3729"},{"v":26.47916546839394,"d":"26"},{"v":4850.889601758698,"d":"4851"},{"v":28391.0637718235,"d":"28391"},"Kinexus","RpAb","CPSILPNENEKVVQLN","Corresponds to amino acid residues P28 to N42.",null,null,"P16234","P16234",1027,"P16234","P16234","NP_006197","Block6",6,13,"6, 14, 22, 30","PDGFRA","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; PDGFR family","GO:0030054; GO:0005737; GO:0005887; GO:0031226; GO:0016020; GO:0005634; GO:0005886; GO:0032991","GO:0005524; GO:0046934; GO:0005018; GO:0048407; GO:0005161; GO:0042803; GO:0004672; GO:0005088; GO:0004714; GO:0005021; GO:0038085","GO:0055003; GO:0001775; GO:0060326; GO:0034614; GO:0048701; GO:0048557; GO:0048704; GO:0001553; GO:0000165; GO:0072277; GO:0010544; GO:0018108; GO:0048015; GO:0070527; GO:0035790; GO:0048008; GO:0030335; GO:0008284; GO:0038091; GO:0007204; GO:0070374; GO:0048146; GO:0043552; GO:0014068; GO:0010863; GO:0051897; GO:0046777; GO:2000249; GO:0050920; GO:2000739; GO:0061298; GO:0016032; GO:0042060"]
[1845,924,"NK242-2","PDGFRa","Pan-specific","Platelet-derived growth factor receptor kinase alpha",{"v":7979.271871770387,"d":"7979"},{"v":8007.195438978055,"d":"8007"},{"v":1538.80355270154,"d":"1539"},{"v":19.28501218445287,"d":"19"},{"v":3554.8456151386467,"d":"3555"},{"v":12074.013007185471,"d":"12074"},"Kinexus","RpAb","CSQLEAVNLHEVKHFV","Corresponds to amino acid residues S322 to V336.",null,null,"P16234","P16234",1027,"P16234","P16234","NP_006197","Block6",7,1,"6, 14, 22, 30","PDGFRA","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; PDGFR family","GO:0030054; GO:0005737; GO:0005887; GO:0031226; GO:0016020; GO:0005634; GO:0005886; GO:0032991","GO:0005524; GO:0046934; GO:0005018; GO:0048407; GO:0005161; GO:0042803; GO:0004672; GO:0005088; GO:0004714; GO:0005021; GO:0038085","GO:0055003; GO:0001775; GO:0060326; GO:0034614; GO:0048701; GO:0048557; GO:0048704; GO:0001553; GO:0000165; GO:0072277; GO:0010544; GO:0018108; GO:0048015; GO:0070527; GO:0035790; GO:0048008; GO:0030335; GO:0008284; GO:0038091; GO:0007204; GO:0070374; GO:0048146; GO:0043552; GO:0014068; GO:0010863; GO:0051897; GO:0046777; GO:2000249; GO:0050920; GO:2000739; GO:0061298; GO:0016032; GO:0042060"]
[1847,925,"PK063","PDGFRa","Y754","Platelet-derived growth factor receptor kinase alpha",{"v":1526.2338318166317,"d":"1526"},{"v":1214.665819841367,"d":"1215"},{"v":1033.6674885112004,"d":"1034"},{"v":67.72667902931074,"d":"68"},{"v":217.47621504750418,"d":"217"},{"v":7422.391158302386,"d":"7422"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the Y754 phosphosite.","Y574 phosphorylation induces interaction with Src and promotes internalization of the activated receptor. This is one of the minor in vivo phosphorylation sites in PDGFRa (≥16 reports from high throughput mass spectrometry studies).","PDGFRA","P16234","P16234",1027,"P16234","P16234","NP_006197","Block6",7,2,"6, 14, 22, 30","PDGFRA","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; PDGFR family","GO:0030054; GO:0005737; GO:0005887; GO:0031226; GO:0016020; GO:0005634; GO:0005886; GO:0032991","GO:0005524; GO:0046934; GO:0005018; GO:0048407; GO:0005161; GO:0042803; GO:0004672; GO:0005088; GO:0004714; GO:0005021; GO:0038085","GO:0055003; GO:0001775; GO:0060326; GO:0034614; GO:0048701; GO:0048557; GO:0048704; GO:0001553; GO:0000165; GO:0072277; GO:0010544; GO:0018108; GO:0048015; GO:0070527; GO:0035790; GO:0048008; GO:0030335; GO:0008284; GO:0038091; GO:0007204; GO:0070374; GO:0048146; GO:0043552; GO:0014068; GO:0010863; GO:0051897; GO:0046777; GO:2000249; GO:0050920; GO:2000739; GO:0061298; GO:0016032; GO:0042060"]
[1849,926,"PK758","PDGFRa","Y762","Platelet-derived growth factor receptor kinase alpha",{"v":5703.468739800442,"d":"5703"},{"v":5565.645909867664,"d":"5566"},{"v":1606.3300940209588,"d":"1606"},{"v":28.164090438710154,"d":"28"},{"v":663.0190706790929,"d":"663"},{"v":10916.993416138026,"d":"10917"},"Kinexus","RpAb","RSL(pY)DRP(bA)C","Corresponds to amino acid residues R759 to P765; In the protein kinase catalytic domain near subdomain VI. ","Phosphorylation of Y762 induces interaction with CDK6, CRK and CRKL. This is the major in vivo phosphorylation sites in PDGFRa (≥328 reports from high throughput mass spectrometry studies).","PDGFRA","P16234","P16234",1027,"P16234","P16234","NP_006197","Block6",7,3,"6, 14, 22, 30","PDGFRA","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; PDGFR family","GO:0030054; GO:0005737; GO:0005887; GO:0031226; GO:0016020; GO:0005634; GO:0005886; GO:0032991","GO:0005524; GO:0046934; GO:0005018; GO:0048407; GO:0005161; GO:0042803; GO:0004672; GO:0005088; GO:0004714; GO:0005021; GO:0038085","GO:0055003; GO:0001775; GO:0060326; GO:0034614; GO:0048701; GO:0048557; GO:0048704; GO:0001553; GO:0000165; GO:0072277; GO:0010544; GO:0018108; GO:0048015; GO:0070527; GO:0035790; GO:0048008; GO:0030335; GO:0008284; GO:0038091; GO:0007204; GO:0070374; GO:0048146; GO:0043552; GO:0014068; GO:0010863; GO:0051897; GO:0046777; GO:2000249; GO:0050920; GO:2000739; GO:0061298; GO:0016032; GO:0042060"]
[1851,927,"PK759","PDGFRa","Y768","Platelet-derived growth factor receptor kinase alpha",{"v":4951.7235142169575,"d":"4952"},{"v":3886.744633967335,"d":"3887"},{"v":3066.997723637433,"d":"3067"},{"v":61.93798411465698,"d":"62"},{"v":1786.4925600240485,"d":"1786"},{"v":20457.389464342425,"d":"20457"},"Kinexus","RpAb","PAS(pY)KKK(bA)C","Corresponds to amino acid residues P765 to K771; In the protein kinase catalytic domain near subdomain VI. ","The effect of Y768 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in PDGFRa (≥268 reports from high throughput mass spectrometry studies).",null,"P16234","P16234",1027,"P16234","P16234","NP_006197","Block6",7,4,"6, 14, 22, 30","PDGFRA","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; PDGFR family","GO:0030054; GO:0005737; GO:0005887; GO:0031226; GO:0016020; GO:0005634; GO:0005886; GO:0032991","GO:0005524; GO:0046934; GO:0005018; GO:0048407; GO:0005161; GO:0042803; GO:0004672; GO:0005088; GO:0004714; GO:0005021; GO:0038085","GO:0055003; GO:0001775; GO:0060326; GO:0034614; GO:0048701; GO:0048557; GO:0048704; GO:0001553; GO:0000165; GO:0072277; GO:0010544; GO:0018108; GO:0048015; GO:0070527; GO:0035790; GO:0048008; GO:0030335; GO:0008284; GO:0038091; GO:0007204; GO:0070374; GO:0048146; GO:0043552; GO:0014068; GO:0010863; GO:0051897; GO:0046777; GO:2000249; GO:0050920; GO:2000739; GO:0061298; GO:0016032; GO:0042060"]
[1853,928,"PK757","PDGFRa","S847+Y849","Platelet-derived growth factor receptor kinase alpha",{"v":8206.836203429879,"d":"8207"},{"v":8026.305140187443,"d":"8026"},{"v":1585.3782103846768,"d":"1585"},{"v":19.31777570657619,"d":"19"},{"v":2485.9241763096716,"d":"2486"},{"v":12860.264513263744,"d":"12860"},"Kinexus","RpAb","D(pS)N(pY)VSKG(bA)C","Corresponds to amino acid residues D846 to G853; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S847 and Y849 phosphorylation is predicted to be stimulatory for phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the less major in vivo phosphorylation sites in PDGFRa (≥16 and ≥67 reports, respectively, from high throughput mass spectrometry studies).",null,"P16234","P16234",1027,"P16234","P16234","NP_006197","Block6",7,5,"6, 14, 22, 30","PDGFRA","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; PDGFR family","GO:0030054; GO:0005737; GO:0005887; GO:0031226; GO:0016020; GO:0005634; GO:0005886; GO:0032991","GO:0005524; GO:0046934; GO:0005018; GO:0048407; GO:0005161; GO:0042803; GO:0004672; GO:0005088; GO:0004714; GO:0005021; GO:0038085","GO:0055003; GO:0001775; GO:0060326; GO:0034614; GO:0048701; GO:0048557; GO:0048704; GO:0001553; GO:0000165; GO:0072277; GO:0010544; GO:0018108; GO:0048015; GO:0070527; GO:0035790; GO:0048008; GO:0030335; GO:0008284; GO:0038091; GO:0007204; GO:0070374; GO:0048146; GO:0043552; GO:0014068; GO:0010863; GO:0051897; GO:0046777; GO:2000249; GO:0050920; GO:2000739; GO:0061298; GO:0016032; GO:0042060"]
[1855,929,"NK243-1","PDGFRb","Pan-specific","Platelet-derived growth factor receptor kinase beta",{"v":7653.989740644565,"d":"7654"},{"v":7702.101235161568,"d":"7702"},{"v":1687.0642216947278,"d":"1687"},{"v":22.04163160470418,"d":"22"},{"v":3699.021193244256,"d":"3699"},{"v":12697.458943181638,"d":"12697"},"Kinexus","RpAb","CKGDVALPVPYDHQRG","Corresponds to amino acid residues K164 to G178.",null,null,"P09619","P09619",634,"P09619","P09619","NP_032835","Block6",7,6,"6, 14, 22, 30","PDGFRB","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; PDGFR family","GO:0016324; GO:0009986; GO:0005737; GO:0031410; GO:0005925; GO:0005794; GO:0016021; GO:0043231; GO:0031226; GO:0043202; GO:0016020; GO:0005634; GO:0005886","GO:0005524; GO:0019899; GO:0043548; GO:0046934; GO:0004992; GO:0005017; GO:0005019; GO:0048407; GO:0005161; GO:0019901; GO:0004713; GO:0005088; GO:0005102; GO:0038085","GO:0007568; GO:0035909; GO:0055003; GO:0060326; GO:0016477; GO:0060981; GO:0035441; GO:0006024; GO:0048839; GO:0060437; GO:0008584; GO:0000165; GO:0072278; GO:0072277; GO:0072262; GO:0035789; GO:0072075; GO:0072284; GO:0043066; GO:0018108; GO:0048015; GO:0046488; GO:0035791; GO:0048008; GO:0043065; GO:0090280; GO:0030335; GO:0008284; GO:0038091; GO:0050921; GO:0032967; GO:2000573; GO:0070374; GO:0048146; GO:2000491; GO:0043406; GO:0035793; GO:0045840; GO:0043552; GO:0014068; GO:0010863; GO:0032516; GO:0051897; GO:2000379; GO:0035025; GO:0014911; GO:0048661; GO:0046777; GO:0032956; GO:0032355; GO:0043627; GO:0034405; GO:0042542; GO:0055093; GO:0032526; GO:0061298; GO:0007165; GO:0071670; GO:0042060"]
[1857,930,"NK243-3","PDGFRb","Pan-specific","Platelet-derived growth factor receptor kinase beta",{"v":4444.3458884077445,"d":"4444"},{"v":4173.686738878477,"d":"4174"},{"v":1430.6994911132092,"d":"1431"},{"v":32.19145239898912,"d":"32"},{"v":817.495490321025,"d":"817"},{"v":10129.96950303864,"d":"10130"},"Kinexus","RpAb","CSQEPPQEMAKAQDGT","Corresponds to amino acid residues S66 to T80; N-terminus.",null,null,"P09619","P09619",634,"P09619","P09619","NP_032835","Block6",7,7,"6, 14, 22, 30","PDGFRB","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; PDGFR family","GO:0016324; GO:0009986; GO:0005737; GO:0031410; GO:0005925; GO:0005794; GO:0016021; GO:0043231; GO:0031226; GO:0043202; GO:0016020; GO:0005634; GO:0005886","GO:0005524; GO:0019899; GO:0043548; GO:0046934; GO:0004992; GO:0005017; GO:0005019; GO:0048407; GO:0005161; GO:0019901; GO:0004713; GO:0005088; GO:0005102; GO:0038085","GO:0007568; GO:0035909; GO:0055003; GO:0060326; GO:0016477; GO:0060981; GO:0035441; GO:0006024; GO:0048839; GO:0060437; GO:0008584; GO:0000165; GO:0072278; GO:0072277; GO:0072262; GO:0035789; GO:0072075; GO:0072284; GO:0043066; GO:0018108; GO:0048015; GO:0046488; GO:0035791; GO:0048008; GO:0043065; GO:0090280; GO:0030335; GO:0008284; GO:0038091; GO:0050921; GO:0032967; GO:2000573; GO:0070374; GO:0048146; GO:2000491; GO:0043406; GO:0035793; GO:0045840; GO:0043552; GO:0014068; GO:0010863; GO:0032516; GO:0051897; GO:2000379; GO:0035025; GO:0014911; GO:0048661; GO:0046777; GO:0032956; GO:0032355; GO:0043627; GO:0034405; GO:0042542; GO:0055093; GO:0032526; GO:0061298; GO:0007165; GO:0071670; GO:0042060"]
[1859,931,"PK203","PDGFRb","Y716","Platelet-derived growth factor receptor kinase beta",{"v":175.13101198132017,"d":"175"},{"v":153.7144633906769,"d":"154"},{"v":91.47150818272635,"d":"91"},{"v":52.230331537445174,"d":"52"},{"v":44.2454089029578,"d":"44"},{"v":674.6717164892789,"d":"675"},"External","MmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the Y716 phosphosite.","Y716 phosphorylation stimulates phosphotransferase activity and interaction with Grb2 and Grb7. This is a minor in vivo phosphorylation sites in PDGFRb (≥1 report from high throughput mass spectrometry studies).","PDGFRB","P09619","P09619",634,"P09619","P09619","NP_032835","Block6",7,8,"6, 14, 22, 30","PDGFRB","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; PDGFR family","GO:0016324; GO:0009986; GO:0005737; GO:0031410; GO:0005925; GO:0005794; GO:0016021; GO:0043231; GO:0031226; GO:0043202; GO:0016020; GO:0005634; GO:0005886","GO:0005524; GO:0019899; GO:0043548; GO:0046934; GO:0004992; GO:0005017; GO:0005019; GO:0048407; GO:0005161; GO:0019901; GO:0004713; GO:0005088; GO:0005102; GO:0038085","GO:0007568; GO:0035909; GO:0055003; GO:0060326; GO:0016477; GO:0060981; GO:0035441; GO:0006024; GO:0048839; GO:0060437; GO:0008584; GO:0000165; GO:0072278; GO:0072277; GO:0072262; GO:0035789; GO:0072075; GO:0072284; GO:0043066; GO:0018108; GO:0048015; GO:0046488; GO:0035791; GO:0048008; GO:0043065; GO:0090280; GO:0030335; GO:0008284; GO:0038091; GO:0050921; GO:0032967; GO:2000573; GO:0070374; GO:0048146; GO:2000491; GO:0043406; GO:0035793; GO:0045840; GO:0043552; GO:0014068; GO:0010863; GO:0032516; GO:0051897; GO:2000379; GO:0035025; GO:0014911; GO:0048661; GO:0046777; GO:0032956; GO:0032355; GO:0043627; GO:0034405; GO:0042542; GO:0055093; GO:0032526; GO:0061298; GO:0007165; GO:0071670; GO:0042060"]
[1861,932,"PK202","PDGFRb","Y1009","Platelet-derived growth factor receptor kinase beta",{"v":399.6103401802636,"d":"400"},{"v":352.03590032326923,"d":"352"},{"v":228.65458346977968,"d":"229"},{"v":57.21938610663426,"d":"57"},{"v":64.01347378579737,"d":"64"},{"v":1633.6349528953133,"d":"1634"},"External","MmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the Y1009 phosphosite.","Y1009 phosphorylation induces molecular association with PLCG1 and upregulates cell growth. This is a minor in vivo phosphorylation sites in PDGFRb (≥0 reports from high throughput mass spectrometry studies, but ≥16 reports from low throughput Western studies).","PDGFRB","P09619","P09619",634,"P09619","P09619","NP_032835","Block6",7,9,"6, 14, 22, 30","PDGFRB","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","PDGFR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK group; PDGFR family","GO:0016324; GO:0009986; GO:0005737; GO:0031410; GO:0005925; GO:0005794; GO:0016021; GO:0043231; GO:0031226; GO:0043202; GO:0016020; GO:0005634; GO:0005886","GO:0005524; GO:0019899; GO:0043548; GO:0046934; GO:0004992; GO:0005017; GO:0005019; GO:0048407; GO:0005161; GO:0019901; GO:0004713; GO:0005088; GO:0005102; GO:0038085","GO:0007568; GO:0035909; GO:0055003; GO:0060326; GO:0016477; GO:0060981; GO:0035441; GO:0006024; GO:0048839; GO:0060437; GO:0008584; GO:0000165; GO:0072278; GO:0072277; GO:0072262; GO:0035789; GO:0072075; GO:0072284; GO:0043066; GO:0018108; GO:0048015; GO:0046488; GO:0035791; GO:0048008; GO:0043065; GO:0090280; GO:0030335; GO:0008284; GO:0038091; GO:0050921; GO:0032967; GO:2000573; GO:0070374; GO:0048146; GO:2000491; GO:0043406; GO:0035793; GO:0045840; GO:0043552; GO:0014068; GO:0010863; GO:0032516; GO:0051897; GO:2000379; GO:0035025; GO:0014911; GO:0048661; GO:0046777; GO:0032956; GO:0032355; GO:0043627; GO:0034405; GO:0042542; GO:0055093; GO:0032526; GO:0061298; GO:0007165; GO:0071670; GO:0042060"]
[1863,933,"NK126-4","PDK1 (PDPK1)","Pan-specific","3-phosphoinositide-dependent protein-serine kinase 1",{"v":3760.8052216098554,"d":"3761"},{"v":3377.887909804029,"d":"3378"},{"v":1599.3661360232531,"d":"1599"},{"v":42.52722600025072,"d":"43"},{"v":428.05396166054356,"d":"428"},{"v":13134.867449716501,"d":"13135"},"Kinexus","RpAb","ARTTSQLYDAVPIQSSVVLC","Corresponds to amino acid residues A2 to C21; N-terminus.",null,null,"O15530","O15530",635,"O15530",null,"NP_002604.1","Block6",7,10,"6, 14, 22, 30","PDK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKB",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); AGC group; PKB family","GO:0042995; GO:0005737; GO:0031410; GO:0005829; GO:0005925; GO:0005654; GO:0043204; GO:0005886; GO:0014069","GO:0004676; GO:0005524; GO:0005158; GO:0016301; GO:0016004; GO:0043274; GO:0019901; GO:0004674","GO:0030036; GO:0032148; GO:0019722; GO:0016477; GO:1990416; GO:0071364; GO:0032869; GO:0007173; GO:0097191; GO:0038095; GO:0048041; GO:0006972; GO:0035556; GO:0010667; GO:2000352; GO:0043524; GO:0006469; GO:0034122; GO:0030512; GO:0018105; GO:0018107; GO:0030168; GO:0045766; GO:0043536; GO:0010518; GO:1903078; GO:0051281; GO:1903672; GO:1905564; GO:0046777; GO:0006468; GO:0043122; GO:0043304; GO:0006355; GO:0002223; GO:0031295; GO:0050852; GO:0006351; GO:0003323"]
[1865,934,"PK760","PDK1 (PDPK1)","S241","3-phosphoinositide-dependent protein-serine kinase 1",{"v":18176.311442034377,"d":"18176"},{"v":17954.75515513207,"d":"17955"},{"v":5042.347404052255,"d":"5042"},{"v":27.741312752769886,"d":"28"},{"v":1735.1416894409076,"d":"1735"},{"v":37793.72869455789,"d":"37794"},"Kinexus","RpAb","RAN(pS)FVG(bA)C","Corresponds to amino acid residues R238 to G244; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S241 phosphorylation is stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation induces interaction with 14-3-3 eta and 14-3-3 theta. This is the major in vivo phosphorylation site in PDK1 (≥334 reports from high throughput mass spectrometry studies).","PDPK1 (PDK1)","O15530","O15530",635,"O15530",null,"NP_002604.1","Block6",7,11,"6, 14, 22, 30","PDK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKB",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); AGC group; PKB family","GO:0042995; GO:0005737; GO:0031410; GO:0005829; GO:0005925; GO:0005654; GO:0043204; GO:0005886; GO:0014069","GO:0004676; GO:0005524; GO:0005158; GO:0016301; GO:0016004; GO:0043274; GO:0019901; GO:0004674","GO:0030036; GO:0032148; GO:0019722; GO:0016477; GO:1990416; GO:0071364; GO:0032869; GO:0007173; GO:0097191; GO:0038095; GO:0048041; GO:0006972; GO:0035556; GO:0010667; GO:2000352; GO:0043524; GO:0006469; GO:0034122; GO:0030512; GO:0018105; GO:0018107; GO:0030168; GO:0045766; GO:0043536; GO:0010518; GO:1903078; GO:0051281; GO:1903672; GO:1905564; GO:0046777; GO:0006468; GO:0043122; GO:0043304; GO:0006355; GO:0002223; GO:0031295; GO:0050852; GO:0006351; GO:0003323"]
[1867,935,"NN179-1","PDK1 (PDHK1)","Pan-specific","Pyruvate dehydrogenase kinase isoform 1; [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 1, mitochondrial",{"v":13542.576081707344,"d":"13543"},{"v":12786.089020204678,"d":"12786"},{"v":3546.9500050615493,"d":"3547"},{"v":26.191102665117,"d":"26"},{"v":1003.8763385457776,"d":"1004"},{"v":24097.513172063038,"d":"24098"},"Kinexus","RpAb","CNVLEVIKDGYENARR","Corresponds to amino acid residues C223 to R238.",null,null,"Q15118","Q15118",2352,"Q15118",null,"NP_002601.1","Block6",7,12,"6, 14, 22, 30","PDHK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PDHK",{"$nulls":6},"Protein kinase, atypical; EC 2.7.11.2; ATYPICAL domain target; ATYPICAL</A> group; PDHK family","GO:0005759; GO:0005967; GO:0005739; GO:0005730; GO:0005634","GO:0005524; GO:0004672; GO:0004740","GO:0008283; GO:0006006; GO:0097411; GO:0008631; GO:0010510; GO:0010906"]
[1869,936,"NN180-2","PDK2 (PDHK2)","Pan-specific","Pyruvate dehydrogenase kinase isoform 2; [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 2, mitochondrial",{"v":9527.647607537856,"d":"9528"},{"v":9783.344163336795,"d":"9783"},{"v":2381.150513883081,"d":"2381"},{"v":24.992008646491286,"d":"25"},{"v":6.694959975368215,"d":"7"},{"v":15508.736196932354,"d":"15509"},"Kinexus","RpAb","CDKYYMASPDLEIQEI","Corresponds to amino acid residues C212 to I227.",null,null,"Q15119","Q15119",2341,"Q15119",null,"NP_002602","Block6",7,13,"6, 14, 22, 30","PDHK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PDHK",{"$nulls":6},"Nucleolus, Nucleus, Mitochondrion, Mitochondrial matrix protein","GO:0005829; GO:0005759; GO:0005967; GO:0005739; GO:0005654","GO:0005524; GO:0042803; GO:0004672; GO:0004740","GO:0031670; GO:0034614; GO:0042593; GO:0006006; GO:0008286; GO:0072332; GO:0010510; GO:0050848; GO:0010565; GO:0006111; GO:0010906; GO:0006885"]
[1871,937,"NN181-2","PDK3 (PDHK3)","Pan-specific","Pyruvate dehydrogenase kinase isoform 3; [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 3, mitochondrial",{"v":15186.241032013697,"d":"15186"},{"v":14510.22345148922,"d":"14510"},{"v":3544.624895238977,"d":"3545"},{"v":23.341028815272,"d":"23"},7584,{"v":30691.4835848757,"d":"30691"},"Kinexus","RpAb","LEYENKSPEDPQVLDC","Corresponds to amino acid residues L92 to D106.",null,null,"Q15120","Q15120",2347,"Q15120",null,"NP_005382.1","Block6",8,1,"6, 14, 22, 30","PDHK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PDHK",{"$nulls":6},"Protein kinase, atypical, ATYPICAL group, PDHK family","GO:0005759; GO:0005739; GO:0005730","GO:0005524; GO:0004672; GO:0004674; GO:0004740","GO:0071398; GO:0071333; GO:0006006; GO:0097411; GO:0018105; GO:0035357; GO:0010510; GO:0010906; GO:2000377"]
[1873,938,"NN178-2","PDK4 (PDHK4)","Pan-specific","Pyruvate dehydrogenase kinase isoform 4; [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 4, mitochondrial",{"v":10356.782926053973,"d":"10357"},{"v":10237.470176597302,"d":"10237"},{"v":1921.9929492136873,"d":"1922"},{"v":18.557818223443096,"d":"19"},{"v":5216.625334056193,"d":"5217"},{"v":19584.473216901773,"d":"19584"},"Kinexus","RpAb","CREVEHFSRYSPSPLS","Corresponds to amino acid residues R22 to S36.",null,null,"Q16654","Q16654",2344,"Q16654","Q16654","NP_002603.1","Block6",8,2,"6, 14, 22, 30","PDHK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PDHK",{"$nulls":7},"GO:0005759; GO:0005739","GO:0005524; GO:0004672; GO:0004740","GO:0071398; GO:0009267; GO:0042593; GO:0006006; GO:0008286; GO:2000811; GO:0072593; GO:0010510; GO:0045124; GO:0010565; GO:0042304; GO:0046320; GO:0010906; GO:0006885; GO:0042594"]
[1875,939,"PN522","PDLIM5 (LIM)","Y251","PDZ and LIM domain protein 5",{"v":10300.84162319929,"d":"10301"},{"v":9813.93764991053,"d":"9814"},{"v":2203.823626241281,"d":"2204"},{"v":21.394597712073217,"d":"21"},{"v":4623.785570622261,"d":"4624"},{"v":18326.46024198072,"d":"18326"},"Kinexus","RpAb","TEF(pY)HVP(bA)C","Corresponds to amino acid residues T248 to P254; In the middle of the protein between the PDZ and first LIM domains. ","The effect of Y251 phosphorylation is unclear. This is the major in vivo phosphorylation site of PDLIM5 (≥970 reports from high throughput mass spectrometry studies).",null,"Q96HC4","Q96HC4",3269,null,"Q96HC4","NP_001011515.1","Block6",8,3,"6, 14, 22, 30",{"$nulls":11},"X",null,"Adapter/scaffold protein","GO:0015629; GO:0005913; GO:0005829; GO:0016020; GO:0043005; GO:0014069; GO:0045211","GO:0003779; GO:0042805; GO:0098641; GO:0046872; GO:0005080; GO:0047485","GO:0061049; GO:0061001; GO:0051963"]
[1877,1136,"PN267","PEBP1","S153","Phosphatidylethanolamine-binding protein 1",{"v":216.00478813844353,"d":"216"},{"v":163.57165661027574,"d":"164"},{"v":241.60114090202808,"d":"242"},{"v":111.8499006360818,"d":"112"},{"v":28.328581704758278,"d":"28"},{"v":2949.638708200957,"d":"2950"},"External","MmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the S153 phosphosite.","S153 phosphorylation induces interaction with GRK2 and inhibits binding to Raf1. This is one of the less major in vivo phosphorylation sites in PEBP1 (≥15 reports from high throughput mass spectrometry studies).","PKCa (PRKCA); PKCb1 (PRKCB1); PKCd (PRKCD); PKCg (PRKCG)","P30086","P30086",2295,null,"P30086","NP_002558.1","Block7",10,5,"7, 15, 23, 31",{"$nulls":13},"Lipid binding protein","GO:0005829; GO:0070062; GO:0005634","GO:0005524; GO:0019899; GO:0008429; GO:0019901; GO:0003723; GO:0004867","GO:0000165"]
[1879,940,"PN523","PECAM-1","Y713","Platelet endothelial cell adhesion molecule",{"v":14730.313533600045,"d":"14730"},{"v":14282.870124368343,"d":"14283"},{"v":3336.907352385232,"d":"3337"},{"v":22.65333555035133,"d":"23"},{"v":4589.196153276567,"d":"4589"},{"v":25549.63321017957,"d":"25550"},"Kinexus","RpAb","ETV(pY)SEV(bA)C","Corresponds to amino acid residues E710 to V716; In the C-terminal region of the protein after the transmembrane domain. ","Y713 phosphorylation induces activity and interaction with SHP-2 and STAT5A. This is the major in vivo phosphorylation site in PECAM-1 (≥791 reports from high throughput mass spectrometry studies).","CSK; Fer; Fes; Fyn; Lck","P16284","P16284",2301,null,null,"NP_000433.4","Block6",8,4,"6, 14, 22, 30",{"$nulls":13},"Cell surface protein","GO:0030054; GO:0009897; GO:0070062; GO:0005615; GO:0016021; GO:0045121; GO:0005886; GO:0031092; GO:0030667; GO:0030485","GO:0042803","GO:0001525; GO:0098742; GO:0008037; GO:0050904; GO:0090673; GO:0043542; GO:0001886; GO:0030198; GO:0072011; GO:0007156; GO:0007159; GO:0050900; GO:0043312; GO:0072672; GO:0006909; GO:0002576; GO:0042531; GO:0030334; GO:0007266; GO:0007165; GO:0042060"]
[1881,941,"PN061","PED15 (PEA15)","S116","Astrocytic phosphoprotein PEA-15",{"v":969.3965780261713,"d":"969"},{"v":915.2557257538527,"d":"915"},{"v":624.1604580772197,"d":"624"},{"v":64.38649281680969,"d":"64"},{"v":11.8154798217215,"d":"12"},{"v":2874.563432641815,"d":"2875"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S116 phosphosite.","S116 phosphorylation stabilizes the protein and inhibits apoptosis. This is the major in vivo phosphorylation site in PED15 (≥1154 reports from high throughput mass spectrometry studies).","Akt1;  CaMK2a; CK2a1 (CSNK2A1); PKCa (PRKCA)","Q15121","Q15121",3980,null,"Q15121","NP_003759","Block6",8,5,"6, 14, 22, 30",{"$nulls":13},"Inhibitor protein","GO:0005829; GO:0005875; GO:0005634",null,"GO:0000187; GO:0006915; GO:0008643; GO:0000077; GO:0000165; GO:1902042; GO:0046325; GO:1902043; GO:0043278"]
[1883,942,"PN258","PFKFB2 (PFK2)","S483","6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2",{"v":412.1900146370195,"d":"412"},{"v":388.0922218514903,"d":"388"},{"v":200.2602619455573,"d":"200"},{"v":48.584452518072126,"d":"49"},{"v":89.19049997488015,"d":"89"},{"v":1473.1675430844593,"d":"1473"},"External","MmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the S483 phosphosite.","S483 phosphorylation induces interaction with 14-3-3 beta. This is one of the major in vivo phosphorylation sites in PFKFB2 (≥134 reports from high throughput mass spectrometry studies).","Akt1 (PKBa); Akt3 (PKBg); p70S6K (RPS6KB1); PKACa (PRKACA); RSK2 (RPS6KA3)","O60825","O60825",1185,null,null,"NP_006203.2","Block6",8,6,"6, 14, 22, 30",{"$nulls":3},"Gluconeogenesis",{"$nulls":8},"X","Phosphatase (non-protein); EC 2.7.1.105; Carbohydrate Metabolism - fructose and mannose; Kinase (non-protein); EC 3.1.3.46","GO:0005829; GO:0005654; GO:0005634","GO:0003873; GO:0005524; GO:0004331; GO:0019901","GO:0006003; GO:0006000; GO:0006007; GO:0006096; GO:0006089; GO:0033133; GO:0045821; GO:0032024; GO:0009749"]
[1885,943,"PN715","PFKFB3","S461","6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3",{"v":3001.507383385848,"d":"3002"},{"v":2875.346293750371,"d":"2875"},{"v":1001.6043934914027,"d":"1002"},{"v":33.37004596542234,"d":"33"},{"v":93.91515532042061,"d":"94"},{"v":6973.165474259982,"d":"6973"},"Kinexus","RpAb","RRN(pS)VTP(bA)C","Corresponds to amino acid residues R458 to P464.","S461 phosphorylation stimulates enzyme activity. This is the major in vivo phosphorylation site in PFKFB3 (≥125 reports from high throughput mass spectrometry studies). This human phosphosite is conserved in many vertebrates and  found in fish.","Akt1; AMPKa1 (PRKAA1); PKACa (PRKACA); PKCa (PRKCA)","Q16875","Q16875",2454,null,null,"NP_004557.1","Block6",8,7,"6, 14, 22, 30",{"$nulls":3},"Gluconeogenesis",{"$nulls":8},"X","EC 3.1.3.46; EC 2.7.1.105; Carbohydrate Metabolism - fructose and mannose; Phosphatase (non-protein); Kinase (non-protein)","GO:0005829; GO:0005654","GO:0003873; GO:0005524; GO:0004331","GO:0007420; GO:0006003; GO:0006000; GO:0045821"]
[1887,944,"PN716","PFKP","S386","6-phosphofructokinase type C",{"v":8505.933666020246,"d":"8506"},{"v":8302.241305294949,"d":"8302"},{"v":1895.3871120158435,"d":"1895"},{"v":22.283116544719736,"d":"22"},{"v":3770.445492349718,"d":"3770"},{"v":15151.747210586327,"d":"15152"},"Kinexus","RpAb","RGR(pS)FAG(bA)C","Corresponds to amino acid residues R383 to G389.","The effect of S386 phosphorylation is unclear. This is the major in vivo phosphorylation site in PFKP (≥231 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in the fruit fly.",null,"Q01813","Q01813",2998,null,null,"NP_002618.1","Block6",8,8,"6, 14, 22, 30",{"$nulls":3},"Glycolysis",{"$nulls":8},"X","Carbohydrate Metabolism - glycolysis and gluconeogenesis; Carbohydrate Metabolism - galactose; EC 2.7.1.11; Carbohydrate Metabolism - pentose phosphate pathway; Carbohydrate Metabolism - fructose and mannose; Kinase (non-protein)","GO:0005737; GO:0005829; GO:0070062; GO:0016020; GO:0005634","GO:0003872; GO:0005524; GO:0045296; GO:0042802; GO:0046872; GO:0044877","GO:0061621; GO:1990830; GO:0006002"]
[1889,945,"PN524","PFN1","Y129","Profilin 1",{"v":2038.650830488036,"d":"2039"},{"v":1801.6437477220138,"d":"1802"},{"v":1080.5491622972959,"d":"1081"},{"v":53.003150227477725,"d":"53"},{"v":131.76666569579447,"d":"132"},{"v":8928.212141373002,"d":"8928"},"Kinexus","RpAb","KKC(pY)EMA(bA)C","Corresponds to amino acid residues K126 to A132; In the end of the Profilin domain.","Y129 phosphorylation induces interaction with VHL. This is the major in vivo phosphorylation site in Profilin 1 (≥666 reports from high throughput mass spectrometry studies).","KDR (VEGFR2); Src","P07737","P07737",4113,null,"P07737","NP_005013.1","Block6",8,9,"6, 14, 22, 30",{"$nulls":13},"Cytoskeletal protein; Actin binding protein","GO:0072562; GO:0005938; GO:0005737; GO:0005856; GO:0005829; GO:0070062; GO:0005925; GO:0098978; GO:0016020; GO:0043005; GO:0005634; GO:0098688; GO:0098794; GO:0098793; GO:0098685","GO:0003779; GO:0003785; GO:0000774; GO:0045296; GO:0005546; GO:0070064; GO:0017048; GO:0003723; GO:0005102","GO:0030036; GO:0071363; GO:0098885; GO:0032232; GO:0030837; GO:0051497; GO:0001843; GO:0032233; GO:0030838; GO:0032781; GO:0051054; GO:0010634; GO:1900029; GO:0051496; GO:0045944; GO:0050434; GO:0050821; GO:0060074; GO:0060071"]
[1891,946,"NK287-1","PFTAIRE1 (CDK14)","Pan-specific","Serine/threonine protein kinase PFTAIRE-1",{"v":5547.77344036765,"d":"5548"},{"v":5429.350799960595,"d":"5429"},{"v":1838.3441486152246,"d":"1838"},{"v":33.136611802471116,"d":"33"},{"v":1431.8308861960177,"d":"1432"},{"v":12139.295992458221,"d":"12139"},"Kinexus","RpAb","CAEKIGKMKKLRRTLSESFS","Corresponds to amino acid residues A10 to S28; Post-N-terminus.",null,null,"O94921","O94921",736,"O94921",null,"NP_001274064.1","Block6",8,10,"6, 14, 22, 30","PFTAIRE1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","TAIRE",{"$nulls":5},"EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC group; CDK family; TAIRE subfamily; CDK/TAIRE subfamily","GO:0005737; GO:0000308; GO:0005829; GO:0005634; GO:0005886","GO:0005524; GO:0030332; GO:0004693","GO:0051301; GO:0000086; GO:0060828; GO:0016055"]
[1893,947,"NK004-2","PFTAIRE2 (ALS2CR7)","Pan-specific","Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 7 protein",{"v":4747.44084391652,"d":"4747"},{"v":4584.877492215001,"d":"4585"},{"v":1392.124518104033,"d":"1392"},{"v":29.323683303772675,"d":"29"},{"v":1642.4130978138828,"d":"1642"},{"v":9711.032920888865,"d":"9711"},"Kinexus","RpAb","PETTEAAFKLTDLKEASC","Corresponds to amino acid residues P33 to C50; Post-N-terminus.",null,null,"Q96Q40","Q96Q40",3760,"Q96Q40",null,"XP_005246838.1","Block6",8,11,"6, 14, 22, 30","PFTAIRE2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","TAIRE",{"$nulls":5},"EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC domain target; CMGC</A> group; CDK family; CDK/TAIRE subfamily; TAIRE subfamily","GO:0005829; GO:0005634","GO:0005524; GO:0030332; GO:0004693; GO:0046872; GO:0004674"]
[1895,948,"NK004-3","PFTAIRE2 (ALS2CR7)","Pan-specific","Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 7 protein",{"v":2211.0882623533303,"d":"2211"},{"v":2005.6719532671525,"d":"2006"},{"v":995.8630029824535,"d":"996"},{"v":45.03949570617888,"d":"45"},{"v":262.30335380560626,"d":"262"},{"v":6808.494443092959,"d":"6808"},"Kinexus","RpAb","CDLLASYQKGHHPAQFSK","Corresponds to amino acid residues C416 to K433; C-terminus.",null,null,"Q96Q40","Q96Q40",3760,"Q96Q40",null,"XP_005246838.1","Block6",8,12,"6, 14, 22, 30","PFTAIRE2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","TAIRE",{"$nulls":5},"EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); CMGC domain target; CMGC</A> group; CDK family; CDK/TAIRE subfamily; TAIRE subfamily","GO:0005829; GO:0005634","GO:0005524; GO:0030332; GO:0004693; GO:0046872; GO:0004674"]
[1897,949,"PN525","PGK1","Y196","Phosphoglycerate kinase 1",{"v":11708.240344359563,"d":"11708"},{"v":11271.990347092458,"d":"11272"},{"v":3360.269795659518,"d":"3360"},{"v":28.70004114049748,"d":"29"},{"v":2028.6971836391804,"d":"2029"},{"v":28558.884531256517,"d":"28559"},"Kinexus","RpAb","ELN(pY)FAK(bA)C","Corresponds to amino acid residues E193 to K199; In the middle of the PGK domain. ","The effect of Y196 phosphorylation is unclear. This is the major in vivo phosphorylation site in PGK1 (≥523 reports from high throughput mass spectrometry studies).",null,"P00558","P00558",4113,null,null,"NP_000282.1","Block6",8,13,"6, 14, 22, 30",{"$nulls":12},"X","Enzyme, glycolytic enzyme and a polymerase alpha cofactor protein (primer recognition protein","GO:0005829; GO:0070062; GO:0005615; GO:0016020; GO:0045121","GO:0005524; GO:0004618; GO:0047134","GO:0061621; GO:0071456; GO:0030855; GO:0006094; GO:0006096; GO:0016525; GO:0016310; GO:0031639"]
[1899,951,"PK894","PIK3CA","Y317","Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",{"v":3631.05136628253,"d":"3631"},{"v":3404.4868310228294,"d":"3404"},{"v":1150.6114402608682,"d":"1151"},{"v":31.688106947351287,"d":"32"},{"v":508.2544720994953,"d":"508"},{"v":8406.316041700062,"d":"8406"},"Kinexus","RpAb","ATP(pY)MNGC","Corresponds to amino acid residues A314 to G320.","The effect of Y317 phosphorylation is unclear. This is the major in vivo phosphorylation site in PIK3CA (≥23 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in fish.",null,"P42336","P42336",7359,null,"P42336","NP_006209.2","Block6",9,2,"6, 14, 22, 30",{"$nulls":3},"Lipid kinase ",{"$nulls":8},"X","Phosphoinositide 3-kinase complex, Cytoplasm, Lamellipodium, Mitochondrion protein","GO:0005737; GO:0005829; GO:0030027; GO:0005942; GO:0005943; GO:0005886","GO:0016303; GO:0035005; GO:0005524; GO:0043560; GO:0016301; GO:0035004; GO:0046934; GO:0030295; GO:0004674","GO:0002250; GO:0060612; GO:0001525; GO:0043276; GO:0007411; GO:0060048; GO:0060326; GO:0071333; GO:0019221; GO:0043542; GO:0097009; GO:0007173; GO:0038128; GO:0038095; GO:0038096; GO:0006006; GO:0007186; GO:0044029; GO:0006954; GO:0045087; GO:0038028; GO:0050900; GO:0001889; GO:2000811; GO:2000270; GO:0016242; GO:0043524; GO:0014065; GO:0048015; GO:0046854; GO:0016310; GO:0030168; GO:0033138; GO:0051897; GO:0032008; GO:0043491; GO:0006468; GO:0043457; GO:0010468; GO:2000653; GO:0040014; GO:0031295; GO:0050852; GO:0048010; GO:0001944"]
[1901,950,"NN089","PIK3R1","Pan-specific","Phosphatidylinositol 3-kinase regulatory subunit alpha",{"v":706.5099194115347,"d":"707"},{"v":634.3540150954642,"d":"634"},{"v":386.1773078403079,"d":"386"},{"v":54.65985646202422,"d":"55"},{"v":126.54987235814477,"d":"127"},{"v":2084.0154025045986,"d":"2084"},"External","MmAb","Epitope undefined.",{"$nulls":3},"P27986","P27986",872,null,"P27986","NP_852664.1","Block6",9,1,"6, 14, 22, 30",{"$nulls":13},"Regulator, inositol phosphate metabolism","GO:0005911; GO:0005801; GO:0005737; GO:0005829; GO:0016020; GO:0005634; GO:1990578; GO:0005942; GO:0005943; GO:0005886","GO:0016303; GO:0046935; GO:0043125; GO:0043559; GO:0005159; GO:0005158; GO:0043560; GO:0005168; GO:0043548; GO:0035014; GO:0036312; GO:0046934; GO:0001784; GO:0046982; GO:0019903; GO:0008134; GO:0005068","GO:0007411; GO:0030183; GO:0001678; GO:0032869; GO:0034644; GO:0019221; GO:0007173; GO:0038128; GO:0008625; GO:0038095; GO:0038096; GO:0007186; GO:0060396; GO:0048009; GO:0008286; GO:0008630; GO:0050900; GO:0043066; GO:0001953; GO:0045671; GO:0014065; GO:0048015; GO:0046854; GO:0030168; GO:0030335; GO:1900103; GO:0046326; GO:2001275; GO:0042307; GO:0051897; GO:1903078; GO:0033120; GO:0045944; GO:0032760; GO:0006606; GO:0006468; GO:0050821; GO:0046626; GO:0043551; GO:0051492; GO:0034976; GO:0031295; GO:0050852; GO:0048010; GO:0016032"]
[1903,952,"PN526","PIK3R1","Y467","Phosphatidylinositol 3-kinase regulatory subunit alpha",{"v":9854.931946769646,"d":"9855"},{"v":9772.273713029907,"d":"9772"},{"v":1860.7069618511503,"d":"1861"},{"v":18.88097220662262,"d":"19"},{"v":1566.6783034234336,"d":"1567"},{"v":14639.422079961038,"d":"14639"},"Kinexus","RpAb","DRL(pY)EEY(bA)C","Corresponds to amino acid residues D464 to Y470; In the region between the two SH2 domains in the C-terminus half of the protein. ","The effect of Y467 phosphorylation is unclear. This is the major in vivo phosphorylation site in PI3KR1 (≥2220 reports from high throughput mass spectrometry studies).",null,"P27986","P27986",872,null,"P27986","NP_852664","Block6",9,3,"6, 14, 22, 30",{"$nulls":13},"Regulator, inositol phosphate metabolism","GO:0005911; GO:0005801; GO:0005737; GO:0005829; GO:0016020; GO:0005634; GO:1990578; GO:0005942; GO:0005943; GO:0005886","GO:0016303; GO:0046935; GO:0043125; GO:0043559; GO:0005159; GO:0005158; GO:0043560; GO:0005168; GO:0043548; GO:0035014; GO:0036312; GO:0046934; GO:0001784; GO:0046982; GO:0019903; GO:0008134; GO:0005068","GO:0007411; GO:0030183; GO:0001678; GO:0032869; GO:0034644; GO:0019221; GO:0007173; GO:0038128; GO:0008625; GO:0038095; GO:0038096; GO:0007186; GO:0060396; GO:0048009; GO:0008286; GO:0008630; GO:0050900; GO:0043066; GO:0001953; GO:0045671; GO:0014065; GO:0048015; GO:0046854; GO:0030168; GO:0030335; GO:1900103; GO:0046326; GO:2001275; GO:0042307; GO:0051897; GO:1903078; GO:0033120; GO:0045944; GO:0032760; GO:0006606; GO:0006468; GO:0050821; GO:0046626; GO:0043551; GO:0051492; GO:0034976; GO:0031295; GO:0050852; GO:0048010; GO:0016032"]
[1905,953,"PN527","PIK3R1","Y580","Phosphatidylinositol 3-kinase regulatory subunit alpha",{"v":8663.374055285121,"d":"8663"},{"v":8451.599779673685,"d":"8452"},{"v":1696.595202691508,"d":"1697"},{"v":19.583538605914104,"d":"20"},{"v":4454.65158299725,"d":"4455"},{"v":14062.680079670918,"d":"14063"},"Kinexus","RpAb","RDQ(pY)LMW(bA)C","Corresponds to amino acid residues R577 to W583; In the region between the two SH2 domains in the C-terminus half of the protein. ","The effect of Y580 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in PIK3R1 (≥924 reports from high throughput mass spectrometry studies).","InsR","P27986","P27986",872,null,"P27986","NP_852664","Block6",9,4,"6, 14, 22, 30",{"$nulls":13},"Regulator, inositol phosphate metabolism","GO:0005911; GO:0005801; GO:0005737; GO:0005829; GO:0016020; GO:0005634; GO:1990578; GO:0005942; GO:0005943; GO:0005886","GO:0016303; GO:0046935; GO:0043125; GO:0043559; GO:0005159; GO:0005158; GO:0043560; GO:0005168; GO:0043548; GO:0035014; GO:0036312; GO:0046934; GO:0001784; GO:0046982; GO:0019903; GO:0008134; GO:0005068","GO:0007411; GO:0030183; GO:0001678; GO:0032869; GO:0034644; GO:0019221; GO:0007173; GO:0038128; GO:0008625; GO:0038095; GO:0038096; GO:0007186; GO:0060396; GO:0048009; GO:0008286; GO:0008630; GO:0050900; GO:0043066; GO:0001953; GO:0045671; GO:0014065; GO:0048015; GO:0046854; GO:0030168; GO:0030335; GO:1900103; GO:0046326; GO:2001275; GO:0042307; GO:0051897; GO:1903078; GO:0033120; GO:0045944; GO:0032760; GO:0006606; GO:0006468; GO:0050821; GO:0046626; GO:0043551; GO:0051492; GO:0034976; GO:0031295; GO:0050852; GO:0048010; GO:0016032"]
[1907,954,"PN528","PIK3R2","Y464","Phosphatidylinositol 3-kinase regulatory subunit beta",{"v":4239.7096834290505,"d":"4240"},{"v":4229.087242962311,"d":"4229"},{"v":1538.1355522368913,"d":"1538"},{"v":36.27926596598607,"d":"36"},{"v":238.91835984864497,"d":"239"},{"v":9383.0535061087,"d":"9383"},"Kinexus","RpAb","DQL(pY)EEY(bA)C","Corresponds to amino acid residues D461 to Y467; In the region between the two SH2 domains in the protein. ","The effect of Y464 phosphorylation is unclear. This is the major in vivo phosphorylation site in PIK3R2 (≥1687 reports from high throughput mass spectrometry studies).",null,"O00459","O00459",3317,null,"O00459","NP_005018.1","Block6",9,5,"6, 14, 22, 30",{"$nulls":13},"Regulator, inositol phosphate metabolism","GO:0005829; GO:0005634; GO:0005942","GO:0016303; GO:0046935; GO:0005096; GO:0046934; GO:0001784; GO:0046982; GO:0019903; GO:0030971","GO:0001678; GO:0032869; GO:0038095; GO:0038096; GO:0008286; GO:0050900; GO:0043409; GO:0014065; GO:0048015; GO:0046854; GO:2001275; GO:0042307; GO:0051897; GO:0045944; GO:0015031; GO:0010506; GO:0043551; GO:0051056; GO:0034976; GO:0050852; GO:0048010"]
[1909,955,"NK258-1","Pim1","Pan-specific","Proto-oncogene serine/threonine-protein kinase Pim-1",{"v":363.541355911003,"d":"364"},{"v":332.08365142041566,"d":"332"},{"v":175.27683753174173,"d":"175"},{"v":48.213727181743394,"d":"48"},{"v":47.258404227420655,"d":"47"},{"v":983.1761738531216,"d":"983"},"Kinexus","RpAb","VEKDRISDWGELPNGTRVPMEVGGC","Corresponds to amino acid residues V160 to V181; Kinase catalytic subdomain 3.",null,null,"P11309","P11309",2119,"P11309","P11309","NP_001230115.1","Block6",9,6,"6, 14, 22, 30","PIM1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","PIM",{"$nulls":6},"Protein-serine kinase, CAMK group, PIM family","GO:0005737; GO:0005829; GO:0005730; GO:0005654; GO:0005634; GO:0005886","GO:0005524; GO:0030145; GO:0004674; GO:0043024; GO:0008134","GO:0006915; GO:0007049; GO:0008283; GO:0019221; GO:0030212; GO:0007275; GO:0043066; GO:0043433; GO:0060045; GO:1905062; GO:0031659; GO:0046777; GO:0006468; GO:0007346; GO:0070561"]
[1911,956,"NK288-1","Pim2","Pan-specific","Serine/threonine-protein kinase Pim-2",{"v":600.9914227748322,"d":"601"},{"v":569.3829512447182,"d":"569"},{"v":318.68837665650693,"d":"319"},{"v":53.0271089702235,"d":"53"},{"v":124.38847749963779,"d":"124"},{"v":1517.884186723607,"d":"1518"},"Kinexus","RpAb","PGGKDREAFEAEYRLGC","Corresponds to amino acid residues P20 to G35; Just before kinase catalytic domain.",null,null,"Q9P1W9","Q9P1W9",737,"Q9P1W9","Q9P1W9","NP_006866.2","Block6",9,7,"6, 14, 22, 30","PIM2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","PIM",{"$nulls":6},"Protein-serine kinase, CAMK group, PIM family","GO:0005737","GO:0005524; GO:0004674","GO:0008637; GO:0008283; GO:0000082; GO:0007140; GO:0043066; GO:0008285; GO:0032091; GO:0010508; GO:0043123; GO:0016239; GO:0045893; GO:0046777; GO:0006468; GO:0050821; GO:0007346; GO:0009615"]
[1913,957,"NK288-2","Pim2","Pan-specific","Serine/threonine-protein kinase Pim-2",{"v":7286.437141983194,"d":"7286"},{"v":7231.036501333048,"d":"7231"},{"v":1701.1389739011727,"d":"1701"},{"v":23.34664995735026,"d":"23"},{"v":770.3799474002044,"d":"770"},{"v":14959.971756173043,"d":"14960"},"Kinexus","RpAb","LDPWMQTPAEDVPLNPSKGC","Corresponds to amino acid residues L282 to G300; C-terminus.",null,null,"Q9P1W9","Q9P1W9",737,"Q9P1W9","Q9P1W9","NP_006866.2","Block6",9,8,"6, 14, 22, 30","PIM2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","PIM",{"$nulls":6},"Protein-serine kinase, CAMK group, PIM family","GO:0005737","GO:0005524; GO:0004674","GO:0008637; GO:0008283; GO:0000082; GO:0007140; GO:0043066; GO:0008285; GO:0032091; GO:0010508; GO:0043123; GO:0016239; GO:0045893; GO:0046777; GO:0006468; GO:0050821; GO:0007346; GO:0009615"]
[1915,958,"PK761","Pim2","T195","Serine/threonine-protein kinase Pim-2",{"v":9059.669434530915,"d":"9060"},{"v":9267.6280013215,"d":"9268"},{"v":2783.1472272300907,"d":"2783"},{"v":30.720185182719025,"d":"31"},{"v":722.9670655506399,"d":"723"},{"v":20479.423958526997,"d":"20479"},"Kinexus","RpAb","EPY(pT)DFD(bA)C","Corresponds to amino acid residues E192 to D198; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T195 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the few in vivo phosphorylation sites in Pim2 (≥1 report from high throughput mass spectrometry studies).",null,"Q9P1W9","Q9P1W9",737,"Q9P1W9","Q9P1W9","NP_006866.2","Block6",9,9,"6, 14, 22, 30","PIM2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","PIM",{"$nulls":6},"Protein-serine kinase, CAMK group, PIM family","GO:0005737","GO:0005524; GO:0004674","GO:0008637; GO:0008283; GO:0000082; GO:0007140; GO:0043066; GO:0008285; GO:0032091; GO:0010508; GO:0043123; GO:0016239; GO:0045893; GO:0046777; GO:0006468; GO:0050821; GO:0007346; GO:0009615"]
[1917,959,"NK289-1","Pim3","Pan-specific","Serine/threonine-protein kinase Pim-3",{"v":1054.9975318800575,"d":"1055"},{"v":1033.0081515915776,"d":"1033"},{"v":456.5768626419842,"d":"457"},{"v":43.277528984199776,"d":"43"},{"v":192.64801069628322,"d":"193"},{"v":2248.2818310337643,"d":"2248"},"Kinexus","RpAb","CVKILQPAKADKESFEKAYQ","Corresponds to amino acid residues V23 to Q41; Post-N-terminus.",null,null,"Q86V86","Q86V86",6656,"Q86V86","Q86V86","NP_001001852.2","Block6",9,10,"6, 14, 22, 30","PIM3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","PIM",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; CAMK domain target; CAMK</A> group; PIM family","GO:0005737; GO:0005829","GO:0005524; GO:0004674","GO:0006915; GO:0007049; GO:0043066; GO:0061179; GO:0046777; GO:0006468; GO:0007346"]
[1919,960,"PK762","PIP5K","S307","1-phosphatidylinositol-3-phosphate 5-kinase",{"v":7625.618722605784,"d":"7626"},{"v":6984.276051069502,"d":"6984"},{"v":2868.241039649864,"d":"2868"},{"v":37.61322384434328,"d":"38"},{"v":688.7101492885763,"d":"689"},{"v":18297.9711369468,"d":"18298"},"Kinexus","RpAb","RSA(pS)ITN(bA)C","Corresponds to amino acid residues R304 to N310; In the region between the FYVE and DEP domains in the N-terminal part of the kinase.","S307 phosphorylation stimulates phosphotransferase activity. This is one of the major in vivo phosphorylation sites in PIP5K (≥196 reports from high throughput mass spectrometry studies).","Akt1 (PKBa)","Q9Y2I7","Q9Y2I7",2667,"Q9Y2I7",null,"NP_055855.2","Block6",9,11,"6, 14, 22, 30","PIP5K","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical",{"$nulls":7},"Carbohydrate Metabolism - inositol phosphate; EC 2.7.1.68; Kinase, lipid","GO:0005911; GO:0005829; GO:0031901; GO:0010008; GO:0000139; GO:0031902; GO:0045121; GO:0048471; GO:0012506","GO:0000285; GO:0016308; GO:0005524; GO:0043813; GO:0008270","GO:0035556; GO:0032288; GO:1904562; GO:0006661; GO:0006457; GO:0034504; GO:2000785; GO:0042147"]
[1921,961,"NK213","PITSLRE (CDK11B;  p58/GTA; CLK-1)","Pan-specific","Cell division protein kinase 11B",{"v":471.8153251713001,"d":"472"},{"v":371.8827158888074,"d":"372"},{"v":472.62333426194,"d":"473"},{"v":100.17125537207731,"d":"100"},{"v":122.94339630295931,"d":"123"},{"v":6471.895541369771,"d":"6472"},"External","RpAb","Epitope undefined.",{"$nulls":3},"P21127","P21127",2134,"P21127","P21127","NP_001778.2","Block6",9,12,"6, 14, 22, 30","PITSLRE","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","CDK","PITSLRE",{"$nulls":5},"EC 2.7.11.22; Protein kinase, Ser/Thr (non-receptor); Apoptosis; CMGC group; CDK family; CDK/PITSLRE subfamily; PITSLRE subfamily","GO:0005737; GO:0005634","GO:0005524; GO:0004693; GO:0004672; GO:0004674; GO:0003723","GO:0006915; GO:0008283; GO:0000278; GO:0006468; GO:0001558; GO:0007346; GO:0050684; GO:0006355"]
[1923,963,"NK201","PKCa (PRKCA)","Pan-specific","Protein-serine kinase C alpha",{"v":2569.91226692978,"d":"2570"},{"v":2514.0922367999146,"d":"2514"},{"v":887.5057300154613,"d":"888"},{"v":34.53447580433342,"d":"35"},{"v":219.45460993738084,"d":"219"},{"v":5018.680956895863,"d":"5019"},"Kinexus","RpAb","KKDVVIQDDDVESTMVEKC","Corresponds to amino acid residues K371 to K388; Kinase catalytic subdomain 3.",null,null,"P17252","P17252",1773,"P17252",null,"NP_002728","Block6",10,1,"6, 14, 22, 30","PKCa","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Alpha",{"$nulls":5},"EC 2.7.11.13; Protein kinase, Ser/Thr (non-receptor); AGC group; PKC family; Alpha subfamily","GO:0035866; GO:0005737; GO:0005829; GO:0005783; GO:0070062; GO:0031966; GO:0005739; GO:0005654; GO:0048471; GO:0005886","GO:0005524; GO:0004698; GO:0019899; GO:0035403; GO:0005178; GO:0004672; GO:0004697; GO:0004674; GO:0008270","GO:0001525; GO:0097190; GO:0007411; GO:0007155; GO:0002159; GO:0038128; GO:0035408; GO:0035556; GO:0007077; GO:0034351; GO:0018105; GO:0018107; GO:0030168; GO:0106071; GO:0045766; GO:0043536; GO:0045780; GO:0010613; GO:0045785; GO:0030335; GO:2000707; GO:0010595; GO:0001938; GO:0070374; GO:0031666; GO:0045651; GO:0045931; GO:0006468; GO:0050796; GO:0043488; GO:0090330; GO:0070555"]
[1925,964,"NK132","PKCa (PRKCA)","Pan-specific","Protein-serine kinase C alpha",{"v":912.2800564647301,"d":"912"},{"v":762.946586527471,"d":"763"},{"v":704.4379297370085,"d":"704"},{"v":77.21728922441295,"d":"77"},{"v":18.260722169530275,"d":"18"},{"v":3153.160867036944,"d":"3153"},"External","MmAb","Epitope undefined.",{"$nulls":3},"P17252","P17252",1773,"P17252",null,"NP_002728","Block6",10,2,"6, 14, 22, 30","PKCa","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Alpha",{"$nulls":5},"EC 2.7.11.13; Protein kinase, Ser/Thr (non-receptor); AGC group; PKC family; Alpha subfamily","GO:0035866; GO:0005737; GO:0005829; GO:0005783; GO:0070062; GO:0031966; GO:0005739; GO:0005654; GO:0048471; GO:0005886","GO:0005524; GO:0004698; GO:0019899; GO:0035403; GO:0005178; GO:0004672; GO:0004697; GO:0004674; GO:0008270","GO:0001525; GO:0097190; GO:0007411; GO:0007155; GO:0002159; GO:0038128; GO:0035408; GO:0035556; GO:0007077; GO:0034351; GO:0018105; GO:0018107; GO:0030168; GO:0106071; GO:0045766; GO:0043536; GO:0045780; GO:0010613; GO:0045785; GO:0030335; GO:2000707; GO:0010595; GO:0001938; GO:0070374; GO:0031666; GO:0045651; GO:0045931; GO:0006468; GO:0050796; GO:0043488; GO:0090330; GO:0070555"]
[1927,965,"PK764","PKCa (PRKCA)","Y195","Protein-serine kinase C alpha",{"v":1948.9140232681914,"d":"1949"},{"v":1884.9965113814355,"d":"1885"},{"v":874.7286734190855,"d":"875"},{"v":44.88287646225805,"d":"45"},{"v":50.4419145496708,"d":"50"},{"v":5770.369758877325,"d":"5770"},"Kinexus","RpAb","SDP(pY)VKL(bA)C","Corresponds to amino acid residues S192 to L198; In the C2 domain.","The effect of Y195 phosphorylation is unclear. This is the major in vivo site of phosphorylation of PKCa (≥124 reports from high throughput mass spectrometry studies).",null,"P17252","P17252",1773,"P17252",null,"NP_002728","Block6",10,3,"6, 14, 22, 30","PKCa","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Alpha",{"$nulls":5},"EC 2.7.11.13; Protein kinase, Ser/Thr (non-receptor); AGC group; PKC family; Alpha subfamily","GO:0035866; GO:0005737; GO:0005829; GO:0005783; GO:0070062; GO:0031966; GO:0005739; GO:0005654; GO:0048471; GO:0005886","GO:0005524; GO:0004698; GO:0019899; GO:0035403; GO:0005178; GO:0004672; GO:0004697; GO:0004674; GO:0008270","GO:0001525; GO:0097190; GO:0007411; GO:0007155; GO:0002159; GO:0038128; GO:0035408; GO:0035556; GO:0007077; GO:0034351; GO:0018105; GO:0018107; GO:0030168; GO:0106071; GO:0045766; GO:0043536; GO:0045780; GO:0010613; GO:0045785; GO:0030335; GO:2000707; GO:0010595; GO:0001938; GO:0070374; GO:0031666; GO:0045651; GO:0045931; GO:0006468; GO:0050796; GO:0043488; GO:0090330; GO:0070555"]
[1929,966,"PK763","PKCa (PRKCA)","T497","Protein-serine kinase C alpha",{"v":9604.72898923288,"d":"9605"},{"v":9628.319484741956,"d":"9628"},{"v":2229.954615159855,"d":"2230"},{"v":23.217257016410198,"d":"23"},{"v":856.6673659920889,"d":"857"},{"v":15843.722447089356,"d":"15844"},"Kinexus","RpAb","TTR(pT)FCG(bA)C","Corresponds to amino acid residues T494 to G500; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T497 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in PKCa (≥92 reports from high throughput mass spectrometry studies).","PDPK1 (PDK1); PKCa (PRKCA); PKCb1 (PRKCB1)","P17252","P17252",1773,"P17252",null,"NP_002728","Block6",10,4,"6, 14, 22, 30","PKCa","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Alpha",{"$nulls":5},"EC 2.7.11.13; Protein kinase, Ser/Thr (non-receptor); AGC group; PKC family; Alpha subfamily","GO:0035866; GO:0005737; GO:0005829; GO:0005783; GO:0070062; GO:0031966; GO:0005739; GO:0005654; GO:0048471; GO:0005886","GO:0005524; GO:0004698; GO:0019899; GO:0035403; GO:0005178; GO:0004672; GO:0004697; GO:0004674; GO:0008270","GO:0001525; GO:0097190; GO:0007411; GO:0007155; GO:0002159; GO:0038128; GO:0035408; GO:0035556; GO:0007077; GO:0034351; GO:0018105; GO:0018107; GO:0030168; GO:0106071; GO:0045766; GO:0043536; GO:0045780; GO:0010613; GO:0045785; GO:0030335; GO:2000707; GO:0010595; GO:0001938; GO:0070374; GO:0031666; GO:0045651; GO:0045931; GO:0006468; GO:0050796; GO:0043488; GO:0090330; GO:0070555"]
[1931,967,"PK210","PKCa (PRKCA)","S657","Protein-serine kinase C alpha",{"v":288.07869851863427,"d":"288"},{"v":224.89215311586136,"d":"225"},{"v":321.05245826483133,"d":"321"},{"v":111.44609438870543,"d":"111"},{"v":46.928852445937466,"d":"47"},{"v":3128.147149045567,"d":"3128"},"External","MmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the S657 phosphosite.","S657 phosphorylation regulates intracellular localization. This is one of the minor in vivo phosphorylation sites in PKCa (≥6 reports from high throughput mass spectrometry studies).","PKCa (PRKCA)","P17252","P17252",1773,"P17252",null,"NP_002728","Block6",10,5,"6, 14, 22, 30","PKCa","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Alpha",{"$nulls":5},"EC 2.7.11.13; Protein kinase, Ser/Thr (non-receptor); AGC group; PKC family; Alpha subfamily","GO:0035866; GO:0005737; GO:0005829; GO:0005783; GO:0070062; GO:0031966; GO:0005739; GO:0005654; GO:0048471; GO:0005886","GO:0005524; GO:0004698; GO:0019899; GO:0035403; GO:0005178; GO:0004672; GO:0004697; GO:0004674; GO:0008270","GO:0001525; GO:0097190; GO:0007411; GO:0007155; GO:0002159; GO:0038128; GO:0035408; GO:0035556; GO:0007077; GO:0034351; GO:0018105; GO:0018107; GO:0030168; GO:0106071; GO:0045766; GO:0043536; GO:0045780; GO:0010613; GO:0045785; GO:0030335; GO:2000707; GO:0010595; GO:0001938; GO:0070374; GO:0031666; GO:0045651; GO:0045931; GO:0006468; GO:0050796; GO:0043488; GO:0090330; GO:0070555"]
[1933,968,"NK133-3","PKCb (PRKCB1)","Pan-specific","Protein-serine kinase C beta 1",{"v":255.43287113294573,"d":"255"},{"v":211.8108805849336,"d":"212"},{"v":181.42910835770584,"d":"181"},{"v":71.02809734432223,"d":"71"},{"v":44.51794805996511,"d":"45"},{"v":1628.7009339354863,"d":"1629"},"External","MmAb","Epitope undefined.",{"$nulls":3},"P05771","P05771",639,"P05771",null,"NP_002729","Block6",10,6,"6, 14, 22, 30","PKCb","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Alpha",{"$nulls":5},"EC 2.7.11.13; Protein kinase, Ser/Thr (non-receptor); AGC group; PKC family; Alpha subfamily","GO:0005737; GO:0005829; GO:0070062; GO:0005654; GO:0005634; GO:0005886","GO:0050681; GO:0005524; GO:0004698; GO:0003682; GO:0042393; GO:0035403; GO:0030374; GO:0004697; GO:0005080; GO:0004674; GO:0008270","GO:0002250; GO:0006915; GO:0042113; GO:0050853; GO:0035408; GO:0035556; GO:0042953; GO:0007077; GO:0010829; GO:0046627; GO:0018105; GO:0030168; GO:0045766; GO:0050861; GO:0043123; GO:0051092; GO:0030949; GO:0006468; GO:0045637; GO:0006357; GO:0007165; GO:0006351"]
[1935,969,"PK766","PKCb (PRKCB1)","T500","Protein-serine kinase C beta 1",{"v":3194.251194365934,"d":"3194"},{"v":2889.922817830858,"d":"2890"},{"v":1395.2497664762518,"d":"1395"},{"v":43.680026446799594,"d":"44"},{"v":220.29179200721035,"d":"220"},{"v":8515.38721802722,"d":"8515"},"Kinexus","RpAb","TTK(pT)FCG(bA)C","Corresponds to amino acid residues T497 to G503; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T500 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in PKCb (≥82 reports from high throughput mass spectrometry studies).","BLVRA; PKCa (PRKCA); PKCb1 (PRKCB1)","P05771","P05771",639,"P05771",null,"NP_002729","Block6",10,7,"6, 14, 22, 30","PKCb","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Alpha",{"$nulls":5},"EC 2.7.11.13; Protein kinase, Ser/Thr (non-receptor); AGC group; PKC family; Alpha subfamily","GO:0005737; GO:0005829; GO:0070062; GO:0005654; GO:0005634; GO:0005886","GO:0050681; GO:0005524; GO:0004698; GO:0003682; GO:0042393; GO:0035403; GO:0030374; GO:0004697; GO:0005080; GO:0004674; GO:0008270","GO:0002250; GO:0006915; GO:0042113; GO:0050853; GO:0035408; GO:0035556; GO:0042953; GO:0007077; GO:0010829; GO:0046627; GO:0018105; GO:0030168; GO:0045766; GO:0050861; GO:0043123; GO:0051092; GO:0030949; GO:0006468; GO:0045637; GO:0006357; GO:0007165; GO:0006351"]
[1937,970,"PK765","PKCb (PRKCB1)","S661","Protein-serine kinase C beta 1",{"v":9372.049623799647,"d":"9372"},{"v":9417.614020965813,"d":"9418"},{"v":2293.260550790742,"d":"2293"},{"v":24.469146481759672,"d":"24"},{"v":626.8435695706063,"d":"627"},{"v":16750.045201472763,"d":"16750"},"Kinexus","RpAb","AGF(pS)YTN(bA)C","Corresponds to amino acid residues A658 to N664; In Pkinase_C domain near C-terminus of the kinase.","S661 phosphorylation inhibits phosphotransferase activity. Phosphorylation inhibits membrane binding and causes release into cytoplasm. This is one of the major in vivo phosphorylation sites in PKCb (≥171 reports from high throughput mass spectrometry studies).","PKCb1 (PRKCB1)","P05771","P05771",639,"P05771",null,"NP_002729","Block6",10,8,"6, 14, 22, 30","PKCb","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Alpha",{"$nulls":5},"EC 2.7.11.13; Protein kinase, Ser/Thr (non-receptor); AGC group; PKC family; Alpha subfamily","GO:0005737; GO:0005829; GO:0070062; GO:0005654; GO:0005634; GO:0005886","GO:0050681; GO:0005524; GO:0004698; GO:0003682; GO:0042393; GO:0035403; GO:0030374; GO:0004697; GO:0005080; GO:0004674; GO:0008270","GO:0002250; GO:0006915; GO:0042113; GO:0050853; GO:0035408; GO:0035556; GO:0042953; GO:0007077; GO:0010829; GO:0046627; GO:0018105; GO:0030168; GO:0045766; GO:0050861; GO:0043123; GO:0051092; GO:0030949; GO:0006468; GO:0045637; GO:0006357; GO:0007165; GO:0006351"]
[1939,971,"NK134-3","PKCb2 (PRKCB2)","Pan-specific","Protein-serine kinase C beta 2",{"v":324.4480636321471,"d":"324"},{"v":275.6711621770014,"d":"276"},{"v":323.429816595563,"d":"323"},{"v":99.68616023619158,"d":"100"},{"v":67.48909271652187,"d":"67"},{"v":4363.892890120342,"d":"4364"},"External","MmAb","Epitope undefined.",{"$nulls":3},"P05771-2","P05771-2",639,"P05771-2",null,"NP_002729","Block6",10,9,"6, 14, 22, 30","PKCb","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Alpha",{"$nulls":5},"EC 2.7.11.13; Protein kinase, Ser/Thr (non-receptor); AGC group; PKC family; Alpha subfamily"]
[1941,972,"PK076-2","PKCb2 (PRKCB2)","T641","Protein-serine kinase C beta 2",{"v":260.56226876441264,"d":"261"},{"v":222.97358455911825,"d":"223"},{"v":212.58717171454154,"d":"213"},{"v":81.58785718386272,"d":"82"},{"v":17.14706664653825,"d":"17"},{"v":1263.372028881484,"d":"1263"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the T641 phosphosite.","T641 phosphorylation regulates intracellular localization. This is one of the major in vivo phosphorylation sites in PKCb2 (≥86 reports from high throughput mass spectrometry studies).",null,"P05771","P05771",639,"P05771",null,"NP_002729","Block6",10,10,"6, 14, 22, 30","PKCb","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Alpha",{"$nulls":5},"EC 2.7.11.13; Protein kinase, Ser/Thr (non-receptor); AGC group; PKC family; Alpha subfamily","GO:0005737; GO:0005829; GO:0070062; GO:0005654; GO:0005634; GO:0005886","GO:0050681; GO:0005524; GO:0004698; GO:0003682; GO:0042393; GO:0035403; GO:0030374; GO:0004697; GO:0005080; GO:0004674; GO:0008270","GO:0002250; GO:0006915; GO:0042113; GO:0050853; GO:0035408; GO:0035556; GO:0042953; GO:0007077; GO:0010829; GO:0046627; GO:0018105; GO:0030168; GO:0045766; GO:0050861; GO:0043123; GO:0051092; GO:0030949; GO:0006468; GO:0045637; GO:0006357; GO:0007165; GO:0006351"]
[1943,973,"PK204","PKCb2/d (PRKCB2/D)","S660","Protein-serine kinase C beta 2 and delta",{"v":241.28296671133862,"d":"241"},{"v":196.84795385124642,"d":"197"},{"v":226.73845649271996,"d":"227"},{"v":93.97201119629007,"d":"94"},{"v":47.38048440078793,"d":"47"},{"v":3004.996444973942,"d":"3005"},"External","MmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the S660 phosphosite.","S660 phosphorylation regulates intracellular localization. This is one of the major in vivo phosphorylation sites in PKCb2 (≥171 reports from high throughput mass spectrometry studies).","PKCb (PRKCB1); PKCb2 (PRKCB2)","P05771","P05771",639,"P05771",null,"NP_002729","Block6",10,11,"6, 14, 22, 30","PKCb","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Alpha",{"$nulls":5},"EC 2.7.11.13; Protein kinase, Ser/Thr (non-receptor); AGC group; PKC family; Alpha subfamily","GO:0005737; GO:0005829; GO:0070062; GO:0005654; GO:0005634; GO:0005886","GO:0050681; GO:0005524; GO:0004698; GO:0003682; GO:0042393; GO:0035403; GO:0030374; GO:0004697; GO:0005080; GO:0004674; GO:0008270","GO:0002250; GO:0006915; GO:0042113; GO:0050853; GO:0035408; GO:0035556; GO:0042953; GO:0007077; GO:0010829; GO:0046627; GO:0018105; GO:0030168; GO:0045766; GO:0050861; GO:0043123; GO:0051092; GO:0030949; GO:0006468; GO:0045637; GO:0006357; GO:0007165; GO:0006351"]
[1945,974,"NK135","PKCd (PRKCD)","Pan-specific","Protein-serine kinase C delta",{"v":491.24767023989466,"d":"491"},{"v":414.7388331562937,"d":"415"},{"v":322.09697701421044,"d":"322"},{"v":65.56712561240614,"d":"66"},{"v":101.39544280366673,"d":"101"},{"v":2333.6795294975554,"d":"2334"},"External","RpAb","Epitope undefined.",{"$nulls":3},"Q05655","Q05655",882,"Q05655","Q05655","NP_006245","Block6",10,12,"6, 14, 22, 30","PKCd","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Alpha",{"$nulls":5},"EC 2.7.11.13; Protein kinase, Ser/Thr (non-receptor); AGC domain target; AGC</A> group; PKC family; Delta subfamily","GO:0035578; GO:0005911; GO:0005737; GO:0005829; GO:0005783; GO:0070062; GO:0005576; GO:0016363; GO:0005654; GO:0005634; GO:0048471; GO:0005886","GO:0005524; GO:0004699; GO:0008047; GO:0019899; GO:0043560; GO:0019900; GO:0046872; GO:0004715; GO:0004672; GO:0019901; GO:0004697; GO:0004674","GO:0032147; GO:0006915; GO:0042100; GO:0060326; GO:0007049; GO:1904385; GO:0070301; GO:0071447; GO:0090398; GO:0042742; GO:0038096; GO:0016572; GO:0016064; GO:0060333; GO:0032613; GO:0032615; GO:0008631; GO:0030837; GO:0051490; GO:0034351; GO:0050728; GO:0046627; GO:0043407; GO:0050732; GO:0090331; GO:0032091; GO:0042119; GO:0043312; GO:0018105; GO:0018107; GO:0030168; GO:2001235; GO:2000304; GO:0032079; GO:2000753; GO:1900163; GO:0035307; GO:0042307; GO:2001022; GO:2000755; GO:0032930; GO:0006468; GO:0050821; GO:0032956; GO:0043488; GO:0010469; GO:0007165; GO:0002223; GO:0023021"]
[1947,976,"PK207","PKCd (PRKCD)","Y313","Protein-serine kinase C delta",{"v":241.30781803125404,"d":"241"},{"v":201.9178056000006,"d":"202"},{"v":161.43502560395436,"d":"161"},{"v":66.9000395101353,"d":"67"},{"v":54.66214602758575,"d":"55"},{"v":1275.9205850520866,"d":"1276"},"External","MmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the Y313 phosphosite between amino acids 309-318","Y313 phosphorylation stimulates phosphotransferase activity. This is the major in vivo phosphorylation site in PKCd (≥1737 reports from high throughput mass spectrometry studies).","EGFR; Fyn; Lck; Lyn; PDGFRA; PKCd (PRKCD); Src; Yes","Q05655","Q05655",882,"Q05655","Q05655","NP_006245","Block6",11,1,"6, 14, 22, 30","PKCd","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Delta",{"$nulls":5},"EC 2.7.11.13; Protein kinase, Ser/Thr (non-receptor); AGC domain target; AGC</A> group; PKC family; Delta subfamily","GO:0035578; GO:0005911; GO:0005737; GO:0005829; GO:0005783; GO:0070062; GO:0005576; GO:0016363; GO:0005654; GO:0005634; GO:0048471; GO:0005886","GO:0005524; GO:0004699; GO:0008047; GO:0019899; GO:0043560; GO:0019900; GO:0046872; GO:0004715; GO:0004672; GO:0019901; GO:0004697; GO:0004674","GO:0032147; GO:0006915; GO:0042100; GO:0060326; GO:0007049; GO:1904385; GO:0070301; GO:0071447; GO:0090398; GO:0042742; GO:0038096; GO:0016572; GO:0016064; GO:0060333; GO:0032613; GO:0032615; GO:0008631; GO:0030837; GO:0051490; GO:0034351; GO:0050728; GO:0046627; GO:0043407; GO:0050732; GO:0090331; GO:0032091; GO:0042119; GO:0043312; GO:0018105; GO:0018107; GO:0030168; GO:2001235; GO:2000304; GO:0032079; GO:2000753; GO:1900163; GO:0035307; GO:0042307; GO:2001022; GO:2000755; GO:0032930; GO:0006468; GO:0050821; GO:0032956; GO:0043488; GO:0010469; GO:0007165; GO:0002223; GO:0023021"]
[1949,977,"PK768","PKCd (PRKCD)","Y313","Protein-serine kinase C delta",{"v":8510.572796257457,"d":"8511"},{"v":8807.766695818838,"d":"8808"},{"v":2338.163507383473,"d":"2338"},{"v":27.473632660914266,"d":"27"},{"v":118.74484150727795,"d":"119"},{"v":13459.5265337339,"d":"13460"},"Kinexus","RpAb","VGI(pY)QGF(bA)C","Corresponds to amino acid residues V310 to F316; In the region between the C1_1 domain and the protein kinase catalytic domain.","Y313 phosphorylation stimulates phosphotransferase activity. This is the major in vivo phosphorylation site in PKCd (≥1737 reports from high throughput mass spectrometry studies).","EGFR; Fyn; Lck; Lyn; PDGFRA; PKCd (PRKCD); Src; Yes","Q05655","Q05655",882,"Q05655","Q05655","NP_006245","Block6",11,2,"6, 14, 22, 30","PKCd","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Delta",{"$nulls":5},"EC 2.7.11.13; Protein kinase, Ser/Thr (non-receptor); AGC domain target; AGC</A> group; PKC family; Delta subfamily","GO:0035578; GO:0005911; GO:0005737; GO:0005829; GO:0005783; GO:0070062; GO:0005576; GO:0016363; GO:0005654; GO:0005634; GO:0048471; GO:0005886","GO:0005524; GO:0004699; GO:0008047; GO:0019899; GO:0043560; GO:0019900; GO:0046872; GO:0004715; GO:0004672; GO:0019901; GO:0004697; GO:0004674","GO:0032147; GO:0006915; GO:0042100; GO:0060326; GO:0007049; GO:1904385; GO:0070301; GO:0071447; GO:0090398; GO:0042742; GO:0038096; GO:0016572; GO:0016064; GO:0060333; GO:0032613; GO:0032615; GO:0008631; GO:0030837; GO:0051490; GO:0034351; GO:0050728; GO:0046627; GO:0043407; GO:0050732; GO:0090331; GO:0032091; GO:0042119; GO:0043312; GO:0018105; GO:0018107; GO:0030168; GO:2001235; GO:2000304; GO:0032079; GO:2000753; GO:1900163; GO:0035307; GO:0042307; GO:2001022; GO:2000755; GO:0032930; GO:0006468; GO:0050821; GO:0032956; GO:0043488; GO:0010469; GO:0007165; GO:0002223; GO:0023021"]
[1951,978,"PK769","PKCd (PRKCD)","Y334","Protein-serine kinase C delta",{"v":201.272928970877,"d":"201"},{"v":169.7490521970689,"d":"170"},{"v":126.210225496615,"d":"126"},{"v":62.706011256425285,"d":"63"},{"v":29.649876814464918,"d":"30"},{"v":870.4564798919735,"d":"870"},"Kinexus","RpAb","SGT(pY)GKI(bA)C","Corresponds to amino acid residues S331 to I337; In the region between the C1_1 and kinase catalytic domain. ","Y334 phosphorylation stimulates phosphotransferase activity and regulates apoptosis and molecular association, including inducing interaction with Src. This is one of the major in vivo phosphorylation sites in PKCd (≥545 reports from high throughput mass spectrometry studies).","EGFR; Fyn; Lck; Lyn; PDGFRA; PKCd (PRKCD); Src; Yes","Q05655","Q05655",882,"Q05655","Q05655","NP_006245","Block6",11,3,"6, 14, 22, 30","PKCd","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Delta",{"$nulls":5},"EC 2.7.11.13; Protein kinase, Ser/Thr (non-receptor); AGC domain target; AGC</A> group; PKC family; Delta subfamily","GO:0035578; GO:0005911; GO:0005737; GO:0005829; GO:0005783; GO:0070062; GO:0005576; GO:0016363; GO:0005654; GO:0005634; GO:0048471; GO:0005886","GO:0005524; GO:0004699; GO:0008047; GO:0019899; GO:0043560; GO:0019900; GO:0046872; GO:0004715; GO:0004672; GO:0019901; GO:0004697; GO:0004674","GO:0032147; GO:0006915; GO:0042100; GO:0060326; GO:0007049; GO:1904385; GO:0070301; GO:0071447; GO:0090398; GO:0042742; GO:0038096; GO:0016572; GO:0016064; GO:0060333; GO:0032613; GO:0032615; GO:0008631; GO:0030837; GO:0051490; GO:0034351; GO:0050728; GO:0046627; GO:0043407; GO:0050732; GO:0090331; GO:0032091; GO:0042119; GO:0043312; GO:0018105; GO:0018107; GO:0030168; GO:2001235; GO:2000304; GO:0032079; GO:2000753; GO:1900163; GO:0035307; GO:0042307; GO:2001022; GO:2000755; GO:0032930; GO:0006468; GO:0050821; GO:0032956; GO:0043488; GO:0010469; GO:0007165; GO:0002223; GO:0023021"]
[1953,979,"PK206","PKCd (PRKCD)","T507","Protein-serine kinase C delta",{"v":320.821685372044,"d":"321"},{"v":286.42464304712905,"d":"286"},{"v":170.64816265059642,"d":"171"},{"v":53.19096882515988,"d":"53"},{"v":63.04161841028573,"d":"63"},{"v":1072.3947686760048,"d":"1072"},"External","MmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the T507 phosphosite.","T507 phosphorylation stimulates phosphotransferase activity and degradation. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in PKCd (≥126 reports from high throughput mass spectrometry studies).","PDPK1 (PDK1); PKCe (PRKCE); Src","Q05655","Q05655",882,"Q05655","Q05655","NP_006245","Block6",11,4,"6, 14, 22, 30","PKCd","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Delta",{"$nulls":5},"EC 2.7.11.13; Protein kinase, Ser/Thr (non-receptor); AGC domain target; AGC</A> group; PKC family; Delta subfamily","GO:0035578; GO:0005911; GO:0005737; GO:0005829; GO:0005783; GO:0070062; GO:0005576; GO:0016363; GO:0005654; GO:0005634; GO:0048471; GO:0005886","GO:0005524; GO:0004699; GO:0008047; GO:0019899; GO:0043560; GO:0019900; GO:0046872; GO:0004715; GO:0004672; GO:0019901; GO:0004697; GO:0004674","GO:0032147; GO:0006915; GO:0042100; GO:0060326; GO:0007049; GO:1904385; GO:0070301; GO:0071447; GO:0090398; GO:0042742; GO:0038096; GO:0016572; GO:0016064; GO:0060333; GO:0032613; GO:0032615; GO:0008631; GO:0030837; GO:0051490; GO:0034351; GO:0050728; GO:0046627; GO:0043407; GO:0050732; GO:0090331; GO:0032091; GO:0042119; GO:0043312; GO:0018105; GO:0018107; GO:0030168; GO:2001235; GO:2000304; GO:0032079; GO:2000753; GO:1900163; GO:0035307; GO:0042307; GO:2001022; GO:2000755; GO:0032930; GO:0006468; GO:0050821; GO:0032956; GO:0043488; GO:0010469; GO:0007165; GO:0002223; GO:0023021"]
[1955,980,"PK767","PKCd (PRKCD)","T507","Protein-serine kinase C delta",{"v":9299.701566262991,"d":"9300"},{"v":9210.79174242365,"d":"9211"},{"v":2798.711447253319,"d":"2799"},{"v":30.094637202190977,"d":"30"},{"v":487.1070517288337,"d":"487"},{"v":19500.96907005916,"d":"19501"},"Kinexus","RpAb","RAS(pT)FCG(bA)C","Corresponds to amino acid residues R504 to G510; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T507 phosphorylation stimulates phosphotransferase activity and degradation. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in PKCd (≥126 reports from high throughput mass spectrometry studies).","PDPK1 (PDK1); PKCe (PRKCE); Src","Q05655","Q05655",882,"Q05655","Q05655","NP_006245","Block6",11,5,"6, 14, 22, 30","PKCd","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Delta",{"$nulls":5},"EC 2.7.11.13; Protein kinase, Ser/Thr (non-receptor); AGC domain target; AGC</A> group; PKC family; Delta subfamily","GO:0035578; GO:0005911; GO:0005737; GO:0005829; GO:0005783; GO:0070062; GO:0005576; GO:0016363; GO:0005654; GO:0005634; GO:0048471; GO:0005886","GO:0005524; GO:0004699; GO:0008047; GO:0019899; GO:0043560; GO:0019900; GO:0046872; GO:0004715; GO:0004672; GO:0019901; GO:0004697; GO:0004674","GO:0032147; GO:0006915; GO:0042100; GO:0060326; GO:0007049; GO:1904385; GO:0070301; GO:0071447; GO:0090398; GO:0042742; GO:0038096; GO:0016572; GO:0016064; GO:0060333; GO:0032613; GO:0032615; GO:0008631; GO:0030837; GO:0051490; GO:0034351; GO:0050728; GO:0046627; GO:0043407; GO:0050732; GO:0090331; GO:0032091; GO:0042119; GO:0043312; GO:0018105; GO:0018107; GO:0030168; GO:2001235; GO:2000304; GO:0032079; GO:2000753; GO:1900163; GO:0035307; GO:0042307; GO:2001022; GO:2000755; GO:0032930; GO:0006468; GO:0050821; GO:0032956; GO:0043488; GO:0010469; GO:0007165; GO:0002223; GO:0023021"]
[1957,981,"PK205","PKCd (PRKCD)","S645","Protein-serine kinase C delta",{"v":247.28164170439643,"d":"247"},{"v":217.52912910365188,"d":"218"},{"v":143.2912531948654,"d":"143"},{"v":57.94657953870978,"d":"58"},{"v":43.36938304794815,"d":"43"},{"v":885.1367322688943,"d":"885"},"External","MmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the S645 phosphosite.","S645 phosphorylation stimulates phosphotransferase activity. This is one of the major in vivo phosphorylation sites in PKCd (≥127 reports from high throughput mass spectrometry studies).","PKCd (PRKCD)","Q05655","Q05655",882,"Q05655","Q05655","NP_006245","Block6",11,6,"6, 14, 22, 30","PKCd","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Delta",{"$nulls":5},"EC 2.7.11.13; Protein kinase, Ser/Thr (non-receptor); AGC domain target; AGC</A> group; PKC family; Delta subfamily","GO:0035578; GO:0005911; GO:0005737; GO:0005829; GO:0005783; GO:0070062; GO:0005576; GO:0016363; GO:0005654; GO:0005634; GO:0048471; GO:0005886","GO:0005524; GO:0004699; GO:0008047; GO:0019899; GO:0043560; GO:0019900; GO:0046872; GO:0004715; GO:0004672; GO:0019901; GO:0004697; GO:0004674","GO:0032147; GO:0006915; GO:0042100; GO:0060326; GO:0007049; GO:1904385; GO:0070301; GO:0071447; GO:0090398; GO:0042742; GO:0038096; GO:0016572; GO:0016064; GO:0060333; GO:0032613; GO:0032615; GO:0008631; GO:0030837; GO:0051490; GO:0034351; GO:0050728; GO:0046627; GO:0043407; GO:0050732; GO:0090331; GO:0032091; GO:0042119; GO:0043312; GO:0018105; GO:0018107; GO:0030168; GO:2001235; GO:2000304; GO:0032079; GO:2000753; GO:1900163; GO:0035307; GO:0042307; GO:2001022; GO:2000755; GO:0032930; GO:0006468; GO:0050821; GO:0032956; GO:0043488; GO:0010469; GO:0007165; GO:0002223; GO:0023021"]
[1959,982,"PK079-1","PKCd (PRKCD)","S645","Protein-serine kinase C delta",{"v":439.3402342699221,"d":"439"},{"v":232.28774593168694,"d":"232"},{"v":1104.0985652562904,"d":"1104"},{"v":251.30832078037125,"d":"251"},{"v":11.70805926605296,"d":"12"},{"v":9920.884879465677,"d":"9921"},"External","RpAb","RL(pS)YS","Corresponds to amino acid residues R643 to S647.","S645 phosphorylation stimulates phosphotransferase activity. This is one of the major in vivo phosphorylation sites in PKCd (≥127 reports from high throughput mass spectrometry studies).","PKCd (PRKCD)","Q05655","Q05655",882,"Q05655","Q05655","NP_006245","Block6",11,7,"6, 14, 22, 30","PKCd","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Delta",{"$nulls":5},"EC 2.7.11.13; Protein kinase, Ser/Thr (non-receptor); AGC domain target; AGC</A> group; PKC family; Delta subfamily","GO:0035578; GO:0005911; GO:0005737; GO:0005829; GO:0005783; GO:0070062; GO:0005576; GO:0016363; GO:0005654; GO:0005634; GO:0048471; GO:0005886","GO:0005524; GO:0004699; GO:0008047; GO:0019899; GO:0043560; GO:0019900; GO:0046872; GO:0004715; GO:0004672; GO:0019901; GO:0004697; GO:0004674","GO:0032147; GO:0006915; GO:0042100; GO:0060326; GO:0007049; GO:1904385; GO:0070301; GO:0071447; GO:0090398; GO:0042742; GO:0038096; GO:0016572; GO:0016064; GO:0060333; GO:0032613; GO:0032615; GO:0008631; GO:0030837; GO:0051490; GO:0034351; GO:0050728; GO:0046627; GO:0043407; GO:0050732; GO:0090331; GO:0032091; GO:0042119; GO:0043312; GO:0018105; GO:0018107; GO:0030168; GO:2001235; GO:2000304; GO:0032079; GO:2000753; GO:1900163; GO:0035307; GO:0042307; GO:2001022; GO:2000755; GO:0032930; GO:0006468; GO:0050821; GO:0032956; GO:0043488; GO:0010469; GO:0007165; GO:0002223; GO:0023021"]
[1961,983,"PK080","PKCd (PRKCD)","S664","Protein-serine kinase C delta",{"v":96.57080848895262,"d":"97"},{"v":54.81795330067868,"d":"55"},{"v":150.452810373409,"d":"150"},{"v":155.79533062583843,"d":"156"},{"v":9.916384713133741,"d":"10"},{"v":873.8601588145522,"d":"874"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S664 phosphosite.","The effect of S664 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in PKCd (≥128 reports from high throughput mass spectrometry studies).",null,"Q05655","Q05655",882,"Q05655","Q05655","NP_006245","Block6",11,8,"6, 14, 22, 30","PKCd","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Delta",{"$nulls":5},"EC 2.7.11.13; Protein kinase, Ser/Thr (non-receptor); AGC domain target; AGC</A> group; PKC family; Delta subfamily","GO:0035578; GO:0005911; GO:0005737; GO:0005829; GO:0005783; GO:0070062; GO:0005576; GO:0016363; GO:0005654; GO:0005634; GO:0048471; GO:0005886","GO:0005524; GO:0004699; GO:0008047; GO:0019899; GO:0043560; GO:0019900; GO:0046872; GO:0004715; GO:0004672; GO:0019901; GO:0004697; GO:0004674","GO:0032147; GO:0006915; GO:0042100; GO:0060326; GO:0007049; GO:1904385; GO:0070301; GO:0071447; GO:0090398; GO:0042742; GO:0038096; GO:0016572; GO:0016064; GO:0060333; GO:0032613; GO:0032615; GO:0008631; GO:0030837; GO:0051490; GO:0034351; GO:0050728; GO:0046627; GO:0043407; GO:0050732; GO:0090331; GO:0032091; GO:0042119; GO:0043312; GO:0018105; GO:0018107; GO:0030168; GO:2001235; GO:2000304; GO:0032079; GO:2000753; GO:1900163; GO:0035307; GO:0042307; GO:2001022; GO:2000755; GO:0032930; GO:0006468; GO:0050821; GO:0032956; GO:0043488; GO:0010469; GO:0007165; GO:0002223; GO:0023021"]
[1963,984,"PK081-1","PKCe (PRKCE)","S729","Protein-serine kinase C epsilon",{"v":310.314089815551,"d":"310"},{"v":205.42154810613178,"d":"205"},{"v":359.44875037053873,"d":"359"},{"v":115.83384775863486,"d":"116"},{"v":9.455710381747,"d":"9"},{"v":1927.5409157753793,"d":"1928"},"External","RpAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the S729 phosphosite.","S729 phosphorylation stimulates phosphotransferase activity. This is one of the major in vivo phosphorylation sites in PKCe (≥23 reports from high throughput mass spectrometry studies).","PKCe (PRKCE)","Q02156","Q02156",1756,"Q02156",null,"NP_005391","Block6",11,9,"6, 14, 22, 30","PKCe","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Eta",{"$nulls":5},"Protein-serine kinase, AGC group, PKC family, Eta subfamily","GO:0071944; GO:0005737; GO:0005856; GO:0005829; GO:0005783; GO:0005794; GO:0005739; GO:0005634; GO:0048471; GO:0005886","GO:0071889; GO:0003785; GO:0005524; GO:0004699; GO:0008047; GO:0019899; GO:0035276; GO:0046872; GO:0004697; GO:0004674; GO:0030546","GO:0006915; GO:0007155; GO:0007049; GO:0051301; GO:0071361; GO:0071456; GO:0071380; GO:0038096; GO:0035556; GO:0031663; GO:0035641; GO:0002281; GO:0031397; GO:2000650; GO:0018105; GO:0030168; GO:0030838; GO:0010811; GO:2001031; GO:0032467; GO:0010634; GO:0010763; GO:0043123; GO:0032024; GO:0050996; GO:0043410; GO:0070257; GO:1903078; GO:0032230; GO:0090303; GO:0006468; GO:0061178; GO:0050730; GO:0051279; GO:0051209; GO:0043278; GO:0007165; GO:0035669"]
[1965,985,"NK137","PKCg (PRKCG)","Pan-specific","Protein-serine kinase C gamma",{"v":781.4367372728119,"d":"781"},{"v":657.2512725800135,"d":"657"},{"v":499.01046444559404,"d":"499"},{"v":63.85807585488288,"d":"64"},{"v":165.35768908475885,"d":"165"},{"v":4177.653740120293,"d":"4178"},"External","RpAb","Epitope undefined.",{"$nulls":3},"P05129","P05129",643,"P05129",null,"NP_002730","Block6",11,10,"6, 14, 22, 30","PKCg","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Alpha",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.13; AGC group; PKC family; Alpha subfamily","GO:0044305; GO:0005911; GO:0005829; GO:0030425; GO:0005622; GO:0005634; GO:0048471; GO:0005886; GO:0099524; GO:0014069; GO:0099523; GO:0097060","GO:0005524; GO:0004698; GO:0004672; GO:0004697; GO:0004712; GO:0008270","GO:0007268; GO:0007635; GO:0060384; GO:0035556; GO:0007611; GO:0043524; GO:1901799; GO:0042177; GO:0031397; GO:0018105; GO:0016310; GO:0030168; GO:0032425; GO:0099171; GO:0046777; GO:0006468; GO:0042752; GO:0050764; GO:0032095; GO:2000300; GO:0043278; GO:0048265; GO:1990911; GO:0048511"]
[1967,986,"NK137-2","PKCg (PRKCG)","Pan-specific","Protein-serine kinase C gamma",{"v":1181.9966531480925,"d":"1182"},{"v":1080.007307388445,"d":"1080"},{"v":726.6218549655749,"d":"727"},{"v":61.47410426504282,"d":"61"},{"v":146.75287812690934,"d":"147"},{"v":9720.883815633759,"d":"9721"},"External","MmAb","Epitope undefined.",{"$nulls":3},"P05129","P05129",643,"P05129",null,"NP_002730","Block6",11,11,"6, 14, 22, 30","PKCg","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Alpha",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.13; AGC group; PKC family; Alpha subfamily","GO:0044305; GO:0005911; GO:0005829; GO:0030425; GO:0005622; GO:0005634; GO:0048471; GO:0005886; GO:0099524; GO:0014069; GO:0099523; GO:0097060","GO:0005524; GO:0004698; GO:0004672; GO:0004697; GO:0004712; GO:0008270","GO:0007268; GO:0007635; GO:0060384; GO:0035556; GO:0007611; GO:0043524; GO:1901799; GO:0042177; GO:0031397; GO:0018105; GO:0016310; GO:0030168; GO:0032425; GO:0099171; GO:0046777; GO:0006468; GO:0042752; GO:0050764; GO:0032095; GO:2000300; GO:0043278; GO:0048265; GO:1990911; GO:0048511"]
[1969,987,"PK082-2","PKCg (PRKCG)","T514","Protein-serine kinase C gamma",{"v":6485.578387446448,"d":"6486"},{"v":6301.135148003238,"d":"6301"},{"v":1850.6561933499897,"d":"1851"},{"v":28.5349444998173,"d":"29"},{"v":727.6523551028887,"d":"728"},{"v":10909.961040936454,"d":"10910"},"External","RpAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the T514 phosphosite.","T514 phosphorylation stimulates phosphotransferase activity. Phosphorylation induces preactivation of PKC. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in PKCg (≥72 reports from high throughput mass spectrometry studies).","PDPK1 (PDK1)","P05129","P05129",643,"P05129",null,"NP_002730","Block6",11,12,"6, 14, 22, 30","PKCg","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Alpha",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.13; AGC group; PKC family; Alpha subfamily","GO:0044305; GO:0005911; GO:0005829; GO:0030425; GO:0005622; GO:0005634; GO:0048471; GO:0005886; GO:0099524; GO:0014069; GO:0099523; GO:0097060","GO:0005524; GO:0004698; GO:0004672; GO:0004697; GO:0004712; GO:0008270","GO:0007268; GO:0007635; GO:0060384; GO:0035556; GO:0007611; GO:0043524; GO:1901799; GO:0042177; GO:0031397; GO:0018105; GO:0016310; GO:0030168; GO:0032425; GO:0099171; GO:0046777; GO:0006468; GO:0042752; GO:0050764; GO:0032095; GO:2000300; GO:0043278; GO:0048265; GO:1990911; GO:0048511"]
[1971,988,"PK083","PKCg (PRKCG)","T655","Protein-serine kinase C gamma",{"v":265.9497240159227,"d":"266"},{"v":259.5286006076328,"d":"260"},{"v":134.54259653465888,"d":"135"},{"v":50.58948529933562,"d":"51"},{"v":31.528292684444914,"d":"32"},{"v":857.9294541657566,"d":"858"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the T655 phosphosite.","T655 phosphorylation stimulates phosphotransferase activity.This is one of the major in vivo phosphorylation sites in PKCg (≥14 reports from high throughput mass spectrometry studies).","PKCg (PRKCG)","P05129","P05129",643,"P05129",null,"NP_002730","Block6",11,13,"6, 14, 22, 30","PKCg","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Alpha",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.13; AGC group; PKC family; Alpha subfamily","GO:0044305; GO:0005911; GO:0005829; GO:0030425; GO:0005622; GO:0005634; GO:0048471; GO:0005886; GO:0099524; GO:0014069; GO:0099523; GO:0097060","GO:0005524; GO:0004698; GO:0004672; GO:0004697; GO:0004712; GO:0008270","GO:0007268; GO:0007635; GO:0060384; GO:0035556; GO:0007611; GO:0043524; GO:1901799; GO:0042177; GO:0031397; GO:0018105; GO:0016310; GO:0030168; GO:0032425; GO:0099171; GO:0046777; GO:0006468; GO:0042752; GO:0050764; GO:0032095; GO:2000300; GO:0043278; GO:0048265; GO:1990911; GO:0048511"]
[1973,989,"PK085","PKCh (PRKCeta)","T656","Protein-serine kinase C eta",{"v":8789.767903090762,"d":"8790"},{"v":8622.69416627004,"d":"8623"},{"v":2139.053689918445,"d":"2139"},{"v":24.335724372952846,"d":"24"},{"v":384.2608412688685,"d":"384"},{"v":14432.313753157303,"d":"14432"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the T655 phosphosite.","The effect of T656 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in PKCh (≥14 reports from high throughput mass spectrometry studies).","PKCg (PRKCG)","P24723","P24723",642,"P24723",null,"NP_006246","Block6",12,1,"6, 14, 22, 30","PKCh","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Eta",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.13; AGC group; PKC family; Eta subfamily","GO:0005911; GO:0005737; GO:0005829; GO:0070062; GO:0005886","GO:0005524; GO:0004699; GO:0019899; GO:0046872; GO:0004697; GO:0017160","GO:0035556; GO:0034351; GO:0018105; GO:0030168; GO:0050861; GO:0060252; GO:0045618; GO:0010744; GO:0051092; GO:1903078; GO:0070528; GO:0006468; GO:2000810; GO:0007165"]
[1975,990,"NK138-1","PKCi (PRKCiota)","Pan-specific","Protein-serine kinase C lambda/iota",{"v":118.9071354370427,"d":"119"},{"v":108.82695384700153,"d":"109"},{"v":67.72116858049165,"d":"68"},{"v":56.95298968525545,"d":"57"},{"v":22.10613582883013,"d":"22"},{"v":645.0744014163012,"d":"645"},"External","GpAb","Epitope undefined.",{"$nulls":3},"P41743","P41743",644,"P41743","P41743","NP_002731","Block6",12,2,"6, 14, 22, 30","PKCi","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Iota",{"$nulls":5},"Adhesion; Motility/polarity/chemotaxis; EC 2.7.11.13; Hydrolase; Protein kinase, Ser/Thr (non-receptor); EC 3.-.-.-; Cell development/differentiation; AGC group; PKC family; Iota subfamily","GO:0016324; GO:0005923; GO:0031252; GO:0005829; GO:0005768; GO:0070062; GO:0098978; GO:0000139; GO:0045171; GO:0015630; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:0098685; GO:0043220","GO:0005524; GO:0046872; GO:0005543; GO:0019904; GO:0004672; GO:0004697; GO:0004674","GO:0007015; GO:0070830; GO:0045216; GO:0016477; GO:0032869; GO:0007010; GO:0035089; GO:0045197; GO:0042462; GO:0048194; GO:0035556; GO:0061024; GO:0043066; GO:0034351; GO:0043524; GO:0018105; GO:2000353; GO:0060252; GO:0046326; GO:0010976; GO:0051092; GO:0045747; GO:1903078; GO:0006468; GO:0006612; GO:0099072; GO:0070555; GO:0046903; GO:0016192"]
[1977,991,"PK087","PKCi (PRKCiota)","T564","Protein-serine kinase C lambda/iota",{"v":219.22402088532283,"d":"219"},{"v":162.20272822657745,"d":"162"},{"v":223.1631703078431,"d":"223"},{"v":101.79686031056828,"d":"102"},{"v":14.04016366866793,"d":"14"},{"v":1589.6542439304994,"d":"1590"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the T555 phosphosite.","The effect of T564 phosphorylation is unclear. This is the major in vivo phosphorylation sites in PKCi (≥27 reports from high throughput mass spectrometry studies).",null,"P41743","P41743",644,"P41743","P41743","NP_002731","Block6",12,3,"6, 14, 22, 30","PKCi","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Iota",{"$nulls":5},"Adhesion; Motility/polarity/chemotaxis; EC 2.7.11.13; Hydrolase; Protein kinase, Ser/Thr (non-receptor); EC 3.-.-.-; Cell development/differentiation; AGC group; PKC family; Iota subfamily","GO:0016324; GO:0005923; GO:0031252; GO:0005829; GO:0005768; GO:0070062; GO:0098978; GO:0000139; GO:0045171; GO:0015630; GO:0005654; GO:0005634; GO:0005886; GO:0032991; GO:0098685; GO:0043220","GO:0005524; GO:0046872; GO:0005543; GO:0019904; GO:0004672; GO:0004697; GO:0004674","GO:0007015; GO:0070830; GO:0045216; GO:0016477; GO:0032869; GO:0007010; GO:0035089; GO:0045197; GO:0042462; GO:0048194; GO:0035556; GO:0061024; GO:0043066; GO:0034351; GO:0043524; GO:0018105; GO:2000353; GO:0060252; GO:0046326; GO:0010976; GO:0051092; GO:0045747; GO:1903078; GO:0006468; GO:0006612; GO:0099072; GO:0070555; GO:0046903; GO:0016192"]
[1979,992,"NK140","PKCt (PRKCQ)","Pan-specific","Protein-serine kinase C theta",{"v":106.45398764008884,"d":"106"},{"v":56.951253859872104,"d":"57"},{"v":173.54306135900617,"d":"174"},{"v":163.02166335538254,"d":"163"},{"v":12.179509722936265,"d":"12"},{"v":1081.645901229785,"d":"1082"},"External","MmAb","Epitope undefined.",{"$nulls":3},"Q04759","Q04759",1760,"Q04759",null,"NP_006248","Block6",12,4,"6, 14, 22, 30","PKCt","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Delta",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.13; AGC domain target; AGC</A> group; PKC family; Delta subfamily","GO:0016235; GO:0005829; GO:0001772; GO:0005622; GO:0005815; GO:0005886","GO:0005524; GO:0046872; GO:0004672; GO:0004697; GO:0004674","GO:0007411; GO:0060326; GO:0038095; GO:0006954; GO:0035556; GO:0006509; GO:0046627; GO:0070233; GO:0018105; GO:0030168; GO:0032740; GO:0045086; GO:0032753; GO:0051092; GO:0050870; GO:0042102; GO:0051973; GO:1904355; GO:0032212; GO:2000318; GO:2000570; GO:0001558; GO:0045652; GO:0090330; GO:0006355; GO:0050852"]
[1981,993,"PK209","PKCt (PRKCQ)","T538","Protein-serine kinase C theta",{"v":304.80451015142074,"d":"305"},{"v":249.84672515756824,"d":"250"},{"v":214.09511352087202,"d":"214"},{"v":70.24013962736768,"d":"70"},{"v":65.48279262872076,"d":"65"},{"v":1384.7385009804918,"d":"1385"},"External","MmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the T538 phosphosite.","T538 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. Phosphorylation regulates transcription. This is one of the major in vivo phosphorylation sites in PKCt (≥19 reports from high throughput mass spectrometry studies).","KHS2","Q04759","Q04759",1760,"Q04759",null,"NP_006248","Block6",12,5,"6, 14, 22, 30","PKCt","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Delta",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.13; AGC domain target; AGC</A> group; PKC family; Delta subfamily","GO:0016235; GO:0005829; GO:0001772; GO:0005622; GO:0005815; GO:0005886","GO:0005524; GO:0046872; GO:0004672; GO:0004697; GO:0004674","GO:0007411; GO:0060326; GO:0038095; GO:0006954; GO:0035556; GO:0006509; GO:0046627; GO:0070233; GO:0018105; GO:0030168; GO:0032740; GO:0045086; GO:0032753; GO:0051092; GO:0050870; GO:0042102; GO:0051973; GO:1904355; GO:0032212; GO:2000318; GO:2000570; GO:0001558; GO:0045652; GO:0090330; GO:0006355; GO:0050852"]
[1983,994,"PK773","PKCt (PRKCQ)","Y545","Protein-serine kinase C theta",{"v":6592.882282144036,"d":"6593"},{"v":6497.4228979085165,"d":"6497"},{"v":1690.8218422953871,"d":"1691"},{"v":25.646170672192316,"d":"26"},{"v":969.2843977984176,"d":"969"},{"v":11561.646325629517,"d":"11562"},"Kinexus","RpAb","TPD(pY)IAP(bA)C","Corresponds to amino acid residues T542 to P548; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y545 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in PKCt.",null,"Q04759","Q04759",1760,"Q04759",null,"NP_006248","Block6",12,6,"6, 14, 22, 30","PKCt","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Delta",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.13; AGC domain target; AGC</A> group; PKC family; Delta subfamily","GO:0016235; GO:0005829; GO:0001772; GO:0005622; GO:0005815; GO:0005886","GO:0005524; GO:0046872; GO:0004672; GO:0004697; GO:0004674","GO:0007411; GO:0060326; GO:0038095; GO:0006954; GO:0035556; GO:0006509; GO:0046627; GO:0070233; GO:0018105; GO:0030168; GO:0032740; GO:0045086; GO:0032753; GO:0051092; GO:0050870; GO:0042102; GO:0051973; GO:1904355; GO:0032212; GO:2000318; GO:2000570; GO:0001558; GO:0045652; GO:0090330; GO:0006355; GO:0050852"]
[1985,995,"PK089-1","PKCt (PRKCQ)","S676","Protein-serine kinase C theta",{"v":451.14707953130426,"d":"451"},{"v":379.7455515419035,"d":"380"},{"v":398.4000145790851,"d":"398"},{"v":88.30823309174073,"d":"88"},{"v":10.825394991541248,"d":"11"},{"v":2369.2895049725357,"d":"2369"},"External","RpAb","RL(pS)FA","Corresponds to amino acid residues R674 to A678.","S676 phosphorylation stimulates phosphotransferase activity. This is one of the major in vivo phosphorylation sites in PKCt (≥25 reports from high throughput mass spectrometry studies).","PKCt (PRKCQ; PKCq)","Q04759","Q04759",1760,"Q04759",null,"NP_006248","Block6",12,7,"6, 14, 22, 30","PKCt","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Delta",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.13; AGC domain target; AGC</A> group; PKC family; Delta subfamily","GO:0016235; GO:0005829; GO:0001772; GO:0005622; GO:0005815; GO:0005886","GO:0005524; GO:0046872; GO:0004672; GO:0004697; GO:0004674","GO:0007411; GO:0060326; GO:0038095; GO:0006954; GO:0035556; GO:0006509; GO:0046627; GO:0070233; GO:0018105; GO:0030168; GO:0032740; GO:0045086; GO:0032753; GO:0051092; GO:0050870; GO:0042102; GO:0051973; GO:1904355; GO:0032212; GO:2000318; GO:2000570; GO:0001558; GO:0045652; GO:0090330; GO:0006355; GO:0050852"]
[1987,996,"PK772","PKCt (PRKCQ)","S695","Protein-serine kinase C theta",{"v":9431.131724217284,"d":"9431"},{"v":7150.631575407984,"d":"7151"},{"v":6076.07604890938,"d":"6076"},{"v":64.42573623807222,"d":"64"},{"v":1767.9806891382068,"d":"1768"},{"v":32821.129621029206,"d":"32821"},"Kinexus","RpAb","RNF(pS)FMN(bA)C","Corresponds to amino acid residues R692 to N698; In Pkinase_C domain near C-terminus of the kinase.","S695 phosphorylation stimulates phosphotransferase activity. This is one of the major in vivo phosphorylation sites in PKCt (≥75 reports from high throughput mass spectrometry studies).","PDK1; PKCt (PRKCQ; PKCq)","Q04759","Q04759",1760,"Q04759",null,"NP_006248","Block6",12,8,"6, 14, 22, 30","PKCt","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Delta",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.13; AGC domain target; AGC</A> group; PKC family; Delta subfamily","GO:0016235; GO:0005829; GO:0001772; GO:0005622; GO:0005815; GO:0005886","GO:0005524; GO:0046872; GO:0004672; GO:0004697; GO:0004674","GO:0007411; GO:0060326; GO:0038095; GO:0006954; GO:0035556; GO:0006509; GO:0046627; GO:0070233; GO:0018105; GO:0030168; GO:0032740; GO:0045086; GO:0032753; GO:0051092; GO:0050870; GO:0042102; GO:0051973; GO:1904355; GO:0032212; GO:2000318; GO:2000570; GO:0001558; GO:0045652; GO:0090330; GO:0006355; GO:0050852"]
[1989,997,"PK774","PKCz (PRKCZ)","S262+Y263","Protein-serine kinase C zeta",{"v":8857.889259714544,"d":"8858"},{"v":8975.05066418713,"d":"8975"},{"v":1748.5891129960573,"d":"1749"},{"v":19.740471592353227,"d":"20"},{"v":1020.4207342306788,"d":"1020"},{"v":13460.40695682143,"d":"13460"},"Kinexus","RpAb","IGRG(pS)(pY)AKVL(bA)C","Corresponds to amino acid residues I258 to L267; In the kinase catalytic subdomain I region.","S262 and Y263 phosphorylation is predicted to be inhibitory for phosphotransferase activity. These phosphosites are located in the kinase subdomain I region, which is involved in binding the phosphates in the ATP substrate. Phosphorylation of S262 induces interaction with 14-3-3 proteins. These are minor in vivo phosphorylation sites in PKCz (≥1 and ≥0 reports, respectively, from high throughput mass spectrometry studies).",null,"Q05513","Q05513",457,"Q05513",null,"NP_002735","Block6",12,9,"6, 14, 22, 30","PKCz","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Iota",{"$nulls":5},"EC 2.7.11.13; Protein kinase, Ser/Thr (non-receptor); AGC domain target; AGC</A> group; PKC family; Iota subfamily","GO:0045179; GO:0016324; GO:0043203; GO:0005923; GO:0005911; GO:0030054; GO:0031252; GO:0005737; GO:0005829; GO:0005768; GO:0070062; GO:0098978; GO:0016020; GO:0045121; GO:0005815; GO:0035748; GO:0005635; GO:0016363; GO:0048471; GO:0005886; GO:0014069; GO:0032991; GO:0098685; GO:0001725; GO:0031982","GO:0071889; GO:0005524; GO:0043560; GO:0046872; GO:0043274; GO:0015459; GO:0019904; GO:0004672; GO:0019901; GO:0004697; GO:0004674","GO:0031584; GO:0032148; GO:0016477; GO:0032869; GO:0030010; GO:0006954; GO:0007616; GO:0060291; GO:0051899; GO:0060081; GO:0000226; GO:0043066; GO:0051346; GO:0046627; GO:0050732; GO:0031333; GO:1990138; GO:0018105; GO:0001954; GO:0008284; GO:0070374; GO:2000463; GO:0046628; GO:2001181; GO:2000667; GO:0032753; GO:2000664; GO:0051092; GO:2000553; GO:0045630; GO:0051291; GO:0070528; GO:0072659; GO:0006468; GO:0098696; GO:0007165; GO:0007179; GO:0047496"]
[1991,998,"PK208","PKCz (PRKCZ)","T410","Protein-serine kinase C zeta",{"v":506.30196888318545,"d":"506"},{"v":438.3080686627918,"d":"438"},{"v":320.7899477419687,"d":"321"},{"v":63.359411469320534,"d":"63"},{"v":104.14880099933927,"d":"104"},{"v":1984.0642261971375,"d":"1984"},"External","MmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the T410 phosphosite.","T410 phosphorylation stimulates phosphotransferase activity, and induces interaction with MYO1C, TNNI1, TPM1 and desmin. In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in PKCz (≥11 reports from high throughput mass spectrometry studies).","PDPK1 (PDK1)","Q05513","Q05513",457,"Q05513",null,"NP_002735","Block6",12,10,"6, 14, 22, 30","PKCz","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Iota",{"$nulls":5},"EC 2.7.11.13; Protein kinase, Ser/Thr (non-receptor); AGC domain target; AGC</A> group; PKC family; Iota subfamily","GO:0045179; GO:0016324; GO:0043203; GO:0005923; GO:0005911; GO:0030054; GO:0031252; GO:0005737; GO:0005829; GO:0005768; GO:0070062; GO:0098978; GO:0016020; GO:0045121; GO:0005815; GO:0035748; GO:0005635; GO:0016363; GO:0048471; GO:0005886; GO:0014069; GO:0032991; GO:0098685; GO:0001725; GO:0031982","GO:0071889; GO:0005524; GO:0043560; GO:0046872; GO:0043274; GO:0015459; GO:0019904; GO:0004672; GO:0019901; GO:0004697; GO:0004674","GO:0031584; GO:0032148; GO:0016477; GO:0032869; GO:0030010; GO:0006954; GO:0007616; GO:0060291; GO:0051899; GO:0060081; GO:0000226; GO:0043066; GO:0051346; GO:0046627; GO:0050732; GO:0031333; GO:1990138; GO:0018105; GO:0001954; GO:0008284; GO:0070374; GO:2000463; GO:0046628; GO:2001181; GO:2000667; GO:0032753; GO:2000664; GO:0051092; GO:2000553; GO:0045630; GO:0051291; GO:0070528; GO:0072659; GO:0006468; GO:0098696; GO:0007165; GO:0007179; GO:0047496"]
[1993,999,"PK775","PKCz (PRKCZ)","T410","Protein-serine kinase C zeta",{"v":9762.20135939053,"d":"9762"},{"v":10014.376693028678,"d":"10014"},{"v":2341.458869811128,"d":"2341"},{"v":23.984947488906425,"d":"24"},{"v":896.1041061767464,"d":"896"},{"v":15291.806459347848,"d":"15292"},"Kinexus","RpAb","TTS(pT)FCG(bA)C","Corresponds to amino acid residues T407 to G413; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T410 phosphorylation stimulates phosphotransferase activity, and induces interaction with MYO1C, TNNI1, TPM1 and desmin. In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII. This is one of the major in vivo phosphorylation sites in PKCz (≥11 reports from high throughput mass spectrometry studies).","PDPK1 (PDK1)","Q05513","Q05513",457,"Q05513",null,"NP_002735","Block6",12,11,"6, 14, 22, 30","PKCz","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKC","Iota",{"$nulls":5},"EC 2.7.11.13; Protein kinase, Ser/Thr (non-receptor); AGC domain target; AGC</A> group; PKC family; Iota subfamily","GO:0045179; GO:0016324; GO:0043203; GO:0005923; GO:0005911; GO:0030054; GO:0031252; GO:0005737; GO:0005829; GO:0005768; GO:0070062; GO:0098978; GO:0016020; GO:0045121; GO:0005815; GO:0035748; GO:0005635; GO:0016363; GO:0048471; GO:0005886; GO:0014069; GO:0032991; GO:0098685; GO:0001725; GO:0031982","GO:0071889; GO:0005524; GO:0043560; GO:0046872; GO:0043274; GO:0015459; GO:0019904; GO:0004672; GO:0019901; GO:0004697; GO:0004674","GO:0031584; GO:0032148; GO:0016477; GO:0032869; GO:0030010; GO:0006954; GO:0007616; GO:0060291; GO:0051899; GO:0060081; GO:0000226; GO:0043066; GO:0051346; GO:0046627; GO:0050732; GO:0031333; GO:1990138; GO:0018105; GO:0001954; GO:0008284; GO:0070374; GO:2000463; GO:0046628; GO:2001181; GO:2000667; GO:0032753; GO:2000664; GO:0051092; GO:2000553; GO:0045630; GO:0051291; GO:0070528; GO:0072659; GO:0006468; GO:0098696; GO:0007165; GO:0007179; GO:0047496"]
[1995,1000,"NK142","PKD1 (PRKCM, PKCm, PRKD1)","Pan-specific","Protein-serine kinase C mu (Protein kinase D)",{"v":705.2619543298716,"d":"705"},{"v":622.1043292403665,"d":"622"},{"v":460.16376661886034,"d":"460"},{"v":65.24721258445034,"d":"65"},{"v":154.25831104608847,"d":"154"},{"v":3821.0279573842936,"d":"3821"},"External","RpAb","Epitope undefined.",{"$nulls":3},"Q15139","Q15139",1763,"Q15139","Q15139","NP_002733","Block6",12,12,"6, 14, 22, 30","PKD1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","PKD",{"$nulls":6},"EC 2.7.11.13; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; PKD family","GO:0000421; GO:0005829; GO:0005794; GO:0005886; GO:0005802","GO:0005524; GO:0042802; GO:0016301; GO:0046872; GO:0004697; GO:0004674","GO:0001525; GO:0006915; GO:0008283; GO:0034198; GO:0071447; GO:0034599; GO:0035924; GO:0007030; GO:0048193; GO:0006954; GO:0045087; GO:0007229; GO:0035556; GO:0060548; GO:0045806; GO:0018105; GO:0018107; GO:0045766; GO:0010508; GO:0043536; GO:0032793; GO:2001028; GO:0038033; GO:0010595; GO:0001938; GO:1901727; GO:0043123; GO:0010976; GO:0051092; GO:0045669; GO:0033138; GO:0043552; GO:0045944; GO:0046777; GO:0089700; GO:0006468; GO:0007265; GO:2001044; GO:0010837; GO:0031647; GO:0007165; GO:0030148; GO:0048010"]
[1997,1001,"PK770","PKD1 (PRKCM, PKCm, PRKD1)","S205","Protein-serine kinase C mu (Protein kinase D)",{"v":6999.245959034409,"d":"6999"},{"v":6814.421903425471,"d":"6814"},{"v":1717.4635450349795,"d":"1717"},{"v":24.537836719655935,"d":"25"},{"v":700.3908595981263,"d":"700"},{"v":12584.138137804184,"d":"12584"},"Kinexus","RpAb","RRL(pS)NVS(bA)C","Corresponds to amino acid residues R202 to S208; In the region between the two C1_1 domains in the N-terminal quarter of the protein kinase.","S205 phosphorylation inhibits phosphotransferase activity and induces binding to 14-3-3-beta. This is one of the major in vivo phosphorylation sites in PKD1 (≥112 reports from high throughput mass spectrometry studies).","p38d MAPK (MAPK13); PKD1 (PRKCM; PRKD1)","Q15139","Q15139",1763,"Q15139","Q15139","NP_002733","Block6",12,13,"6, 14, 22, 30","PKD1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","PKD",{"$nulls":6},"EC 2.7.11.13; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; PKD family","GO:0000421; GO:0005829; GO:0005794; GO:0005886; GO:0005802","GO:0005524; GO:0042802; GO:0016301; GO:0046872; GO:0004697; GO:0004674","GO:0001525; GO:0006915; GO:0008283; GO:0034198; GO:0071447; GO:0034599; GO:0035924; GO:0007030; GO:0048193; GO:0006954; GO:0045087; GO:0007229; GO:0035556; GO:0060548; GO:0045806; GO:0018105; GO:0018107; GO:0045766; GO:0010508; GO:0043536; GO:0032793; GO:2001028; GO:0038033; GO:0010595; GO:0001938; GO:1901727; GO:0043123; GO:0010976; GO:0051092; GO:0045669; GO:0033138; GO:0043552; GO:0045944; GO:0046777; GO:0089700; GO:0006468; GO:0007265; GO:2001044; GO:0010837; GO:0031647; GO:0007165; GO:0030148; GO:0048010"]
[1999,1002,"PK771","PKD1 (PRKCM, PKCm, PRKD1)","S738+S742","Protein-serine kinase C mu (Protein kinase D)",{"v":347.80586926488,"d":"348"},{"v":310.32676663401605,"d":"310"},{"v":225.19154305635504,"d":"225"},{"v":64.74633206515988,"d":"65"},{"v":58.42427798014286,"d":"58"},{"v":1965.734608260825,"d":"1966"},"Kinexus","RpAb","GEK(pS)FRR(pS)VVG(bA)C","Corresponds to amino acid residues G735 to G745; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S738 and S742 phosphorylation stimulate phosphotransferase activity and induces interaction with ASK1, IKKB, JNK1 and PKCD. These are two of the major in vivo phosphorylation sites in PKD1 (≥32 and ≥79 reports, respectively, from high throughput mass spectrometry studies).","S378: PKCa (PRKCA); PKCd (PRKCD); PKCe (PRKCE); PKCh (PRKCH); PKCz (PRKCZ); PKD1 (PRKCM; PRKD1); PKD3 (PRKCN). S742: p38d MAPK (MAPK13); PKCa (PRKCA); PKCd (PRKCD); PKCe (PRKCE); PKCh (PRKCH); PKCz (PRKCZ); PKD1 (PRKCM; PRKD1); PKD3 (PRKCN).","Q15139","Q15139",1763,"Q15139","Q15139","NP_002733","Block6",13,1,"6, 14, 22, 30","PKD1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","PKD",{"$nulls":6},"EC 2.7.11.13; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; PKD family","GO:0000421; GO:0005829; GO:0005794; GO:0005886; GO:0005802","GO:0005524; GO:0042802; GO:0016301; GO:0046872; GO:0004697; GO:0004674","GO:0001525; GO:0006915; GO:0008283; GO:0034198; GO:0071447; GO:0034599; GO:0035924; GO:0007030; GO:0048193; GO:0006954; GO:0045087; GO:0007229; GO:0035556; GO:0060548; GO:0045806; GO:0018105; GO:0018107; GO:0045766; GO:0010508; GO:0043536; GO:0032793; GO:2001028; GO:0038033; GO:0010595; GO:0001938; GO:1901727; GO:0043123; GO:0010976; GO:0051092; GO:0045669; GO:0033138; GO:0043552; GO:0045944; GO:0046777; GO:0089700; GO:0006468; GO:0007265; GO:2001044; GO:0010837; GO:0031647; GO:0007165; GO:0030148; GO:0048010"]
[2001,1003,"PK092","PKD1 (PRKCM, PKCm, PRKD1)","S738+S742","Protein-serine kinase C mu (Protein kinase D)",{"v":61.59741799150599,"d":"62"},{"v":54.67314398020687,"d":"55"},{"v":37.6165466241335,"d":"38"},{"v":61.068382167123715,"d":"61"},{"v":8.23292036927621,"d":"8"},{"v":261.149089296435,"d":"261"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S738 phosphosite.","S738 and S742 phosphorylation stimulate phosphotransferase activity and induces interaction with ASK1, IKKB, JNK1 and PKCD. These are two of the major in vivo phosphorylation sites in PKD1.","S378: PKCa (PRKCA); PKCd (PRKCD); PKCe (PRKCE); PKCh (PRKCH); PKCz (PRKCZ); PKD1 (PRKCM; PRKD1); PKD3 (PRKCN). S742: p38d MAPK (MAPK13); PKCa (PRKCA); PKCd (PRKCD); PKCe (PRKCE); PKCh (PRKCH); PKCz (PRKCZ); PKD1 (PRKCM; PRKD1); PKD3 (PRKCN).","Q15139","Q15139",1763,"Q15139","Q15139","NP_002733","Block6",13,2,"6, 14, 22, 30","PKD1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","PKD",{"$nulls":6},"EC 2.7.11.13; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; PKD family","GO:0000421; GO:0005829; GO:0005794; GO:0005886; GO:0005802","GO:0005524; GO:0042802; GO:0016301; GO:0046872; GO:0004697; GO:0004674","GO:0001525; GO:0006915; GO:0008283; GO:0034198; GO:0071447; GO:0034599; GO:0035924; GO:0007030; GO:0048193; GO:0006954; GO:0045087; GO:0007229; GO:0035556; GO:0060548; GO:0045806; GO:0018105; GO:0018107; GO:0045766; GO:0010508; GO:0043536; GO:0032793; GO:2001028; GO:0038033; GO:0010595; GO:0001938; GO:1901727; GO:0043123; GO:0010976; GO:0051092; GO:0045669; GO:0033138; GO:0043552; GO:0045944; GO:0046777; GO:0089700; GO:0006468; GO:0007265; GO:2001044; GO:0010837; GO:0031647; GO:0007165; GO:0030148; GO:0048010"]
[2003,1004,"PK093-1","PKD1 (PRKCM, PKCm, PRKD1)","S910","Protein-serine kinase C mu (Protein kinase D)",{"v":784.4603533292628,"d":"784"},{"v":732.3825526207813,"d":"732"},{"v":509.128577395958,"d":"509"},{"v":64.90176020180087,"d":"65"},{"v":23.41992883839297,"d":"23"},{"v":2589.8216387497114,"d":"2590"},"External","RpAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the mouse PKD1 S916 phosphosite.","S910 phosphorylation stimulates phosphotransferase activity. This is one of the minor in vivo phosphorylation sites in PKD1 (≥11 reports from high throughput mass spectrometry studies).","PKD1 (PRKCM, PKCm, PRKD1)","Q15139","Q15139",1763,"Q15139","Q15139","NP_002733","Block6",13,3,"6, 14, 22, 30","PKD1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","PKD",{"$nulls":6},"EC 2.7.11.13; Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; PKD family","GO:0000421; GO:0005829; GO:0005794; GO:0005886; GO:0005802","GO:0005524; GO:0042802; GO:0016301; GO:0046872; GO:0004697; GO:0004674","GO:0001525; GO:0006915; GO:0008283; GO:0034198; GO:0071447; GO:0034599; GO:0035924; GO:0007030; GO:0048193; GO:0006954; GO:0045087; GO:0007229; GO:0035556; GO:0060548; GO:0045806; GO:0018105; GO:0018107; GO:0045766; GO:0010508; GO:0043536; GO:0032793; GO:2001028; GO:0038033; GO:0010595; GO:0001938; GO:1901727; GO:0043123; GO:0010976; GO:0051092; GO:0045669; GO:0033138; GO:0043552; GO:0045944; GO:0046777; GO:0089700; GO:0006468; GO:0007265; GO:2001044; GO:0010837; GO:0031647; GO:0007165; GO:0030148; GO:0048010"]
[2005,1005,"PK784","PKD2 (PRKD2)","S197+S198","Serine/threonine-protein kinase D2",{"v":6651.327032655521,"d":"6651"},{"v":6554.60039747262,"d":"6555"},{"v":1642.941026855619,"d":"1643"},{"v":24.700950934894568,"d":"25"},{"v":1432.618514655465,"d":"1433"},{"v":12064.324409666253,"d":"12064"},"Kinexus","RpAb","RRL(pS)(pS)TSL(bA)C","Corresponds to amino acid residues R194 to L201; In the C1_1 domain.","The effects of S197 and S198 phosphorylation are unclear. These are the major in vivo sites of phosphorylation of PRKD2 (≥353 and ≥190 reports, respectively, by mass spectrometry).",null,"Q9BZL6","Q9BZL6",2122,"Q9BZL6",null,"NP_001073349.1","Block6",13,4,"6, 14, 22, 30","PKD2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","PKD",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.13; CAMK domain target; CAMK</A> group; PKD family","GO:0005737; GO:0005829; GO:0005794; GO:0005654; GO:0005634; GO:0005886","GO:0005524; GO:0046872; GO:0004672; GO:0004697; GO:0005080; GO:0004674","GO:0002250; GO:0001525; GO:0007155; GO:0008219; GO:0035924; GO:0061154; GO:0035556; GO:0018105; GO:0018107; GO:0045766; GO:0043536; GO:0045785; GO:0032793; GO:0051091; GO:2000573; GO:2001028; GO:0038033; GO:0010595; GO:0001938; GO:0070374; GO:0045743; GO:1901727; GO:0032743; GO:0032757; GO:1902533; GO:0051092; GO:0033138; GO:0050862; GO:0045944; GO:0030949; GO:0046777; GO:0089700; GO:0006468; GO:0030148; GO:0050852; GO:0048010"]
[2007,1006,"NK139-2","PKD3 (PRKCN)","Pan-specific","Protein-serine kinase C nu; Serine/threonine-protein kinase D3",{"v":2598.808757250648,"d":"2599"},{"v":2550.8373624831693,"d":"2551"},{"v":1032.39299676077,"d":"1032"},{"v":39.72562405295907,"d":"40"},{"v":361.06597063557535,"d":"361"},{"v":6182.285910877525,"d":"6182"},"Kinexus","RpAb","TDTMVYFVGENNGDSSHNGC","Corresponds to amino acid residues T490 to N507; Just before kinase catalytic domain.",null,null,"O94806","O94806",739,"O94806",null,"NP_005804.1","Block6",13,5,"6, 14, 22, 30","PKD3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","PKD",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.13; CAMK group; PKD family","GO:0005829; GO:0016020; GO:0005654","GO:0005524; GO:0016301; GO:0046872; GO:0004697; GO:0004674","GO:0007205; GO:0089700; GO:0006468; GO:0030148"]
[2009,1007,"NK202","PKG1a (PRKG1A)","Pan-specific","cGMP-dependent protein kinase 1, alpha isozyme",{"v":189.53139998382952,"d":"190"},{"v":143.8146407691517,"d":"144"},{"v":135.42987066114708,"d":"135"},{"v":71.45511016786756,"d":"71"},{"v":26.25195299502385,"d":"26"},{"v":648.094587804701,"d":"648"},"Kinexus","RpAb","ELEEDFAKILMLKEEC","Corresponds to amino acid residues E3 to E17; N-terminus.",null,null,"Q13976","Q13976",745,"Q13976",null,"NP_006249.1","Block6",13,6,"6, 14, 22, 30","PKG1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKG",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.12","GO:0005737; GO:0005829; GO:0005794; GO:0005886","GO:0005524; GO:0005246; GO:0030553; GO:0004692; GO:0042802; GO:0004672; GO:0004674","GO:0030036; GO:0019934; GO:0016358; GO:0030900; GO:0090331; GO:1904753; GO:1904706; GO:0001764; GO:0006468; GO:0043087; GO:0060087; GO:0007165"]
[2011,1008,"PK776","PKG1a (PRKG1A)","T515+T517","cGMP-dependent protein kinase 1, alpha isozyme",{"v":5980.998686759105,"d":"5981"},{"v":5649.436614350148,"d":"5649"},{"v":1837.66317149995,"d":"1838"},{"v":30.725022153377463,"d":"31"},{"v":1386.8738983197593,"d":"1387"},{"v":14375.957733935586,"d":"14376"},"Kinexus","RpAb","FGKK(pT)W(pT)FCG(bA)C","Corresponds to amino acid residues F511 to G521; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T515 and T517 phosphorylation stimulates phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major in vivo phosphorylation sites in PKG1a (≥4 and ≥13 reports, respectively, from high throughput mass spectrometry studies).","T517: PKG1 (PRKG1).","Q13976","Q13976",745,"Q13976",null,"NP_006249.1","Block6",13,7,"6, 14, 22, 30","PKG1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKG",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.12","GO:0005737; GO:0005829; GO:0005794; GO:0005886","GO:0005524; GO:0005246; GO:0030553; GO:0004692; GO:0042802; GO:0004672; GO:0004674","GO:0030036; GO:0019934; GO:0016358; GO:0030900; GO:0090331; GO:1904753; GO:1904706; GO:0001764; GO:0006468; GO:0043087; GO:0060087; GO:0007165"]
[2013,975,"PK776","PKG1a (PRKG1A)","T515+T517","cGMP-dependent protein kinase 1, alpha isozyme",{"v":5081.968612103744,"d":"5082"},{"v":4955.113600989431,"d":"4955"},{"v":1871.566546341121,"d":"1872"},{"v":36.82758964476097,"d":"37"},{"v":218.1816152839516,"d":"218"},{"v":14967.858087149838,"d":"14968"},"Kinexus","RpAb","FGKK(pT)W(pT)FCG(bA)C","Corresponds to amino acid residues F511 to G521; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T515 and T517 phosphorylation stimulates phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major in vivo phosphorylation sites in PKG1a (≥4 and ≥13 reports, respectively, from high throughput mass spectrometry studies).","T517: PKG1 (PRKG1).","Q13976","Q13976",745,"Q13976",null,"NP_001091982.1","Block6",10,13,"6, 14, 22, 30","PKG1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKG",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.12","GO:0005737; GO:0005829; GO:0005794; GO:0005886","GO:0005524; GO:0005246; GO:0030553; GO:0004692; GO:0042802; GO:0004672; GO:0004674","GO:0030036; GO:0019934; GO:0016358; GO:0030900; GO:0090331; GO:1904753; GO:1904706; GO:0001764; GO:0006468; GO:0043087; GO:0060087; GO:0007165"]
[2015,1009,"NK290-1","PKG2 (PRKG2)","Pan-specific","cGMP-dependent protein kinase 2",{"v":7455.76013326522,"d":"7456"},{"v":6227.407718134988,"d":"6227"},{"v":4259.851848874946,"d":"4260"},{"v":57.135044217273666,"d":"57"},{"v":2028.7269876115452,"d":"2029"},{"v":27476.70497058516,"d":"27477"},"Kinexus","RpAb","LQKYLEGYVANLNRDDEKRC","Corresponds to amino acid residues L397 to R415; Post-cNMP2.",null,null,"Q13237","Q13237",747,"Q13237","Q13237","NP_006250.1","Block6",13,8,"6, 14, 22, 30","PKG2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKG",{"$nulls":6},"EC 2.7.11.12; Protein kinase, Ser/Thr (non-receptor); AGC domain target; AGC</A> group; PKG family","GO:0016324; GO:0005829; GO:0031965","GO:0005524; GO:0030553; GO:0004692; GO:0042803; GO:0004672","GO:0051186; GO:2001226; GO:0036289; GO:0072659; GO:0006468; GO:0007165"]
[2017,1010,"NK290-2","PKG2 (PRKG2)","Pan-specific","cGMP-dependent protein kinase 2",{"v":242.60349242331336,"d":"243"},{"v":216.94242884660844,"d":"217"},{"v":135.2991461518048,"d":"135"},{"v":55.7696613516694,"d":"56"},{"v":36.68413473720686,"d":"37"},{"v":814.6527278666451,"d":"815"},"Kinexus","RpAb","CSNWKLSKALSLEMIQLKEK","Corresponds to amino acid residues S422 to K440; Just before kinase catalytic domain.",null,null,"Q13237","Q13237",747,"Q13237","Q13237","NP_006250.1","Block6",13,9,"6, 14, 22, 30","PKG2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKG",{"$nulls":6},"EC 2.7.11.12; Protein kinase, Ser/Thr (non-receptor); AGC domain target; AGC</A> group; PKG family","GO:0016324; GO:0005829; GO:0031965","GO:0005524; GO:0030553; GO:0004692; GO:0042803; GO:0004672","GO:0051186; GO:2001226; GO:0036289; GO:0072659; GO:0006468; GO:0007165"]
[2019,1011,"NN115-2","PKM2","Pan-specific","Pyruvate kinase isozymes M1/M2",{"v":425.8037633356426,"d":"426"},{"v":361.1445552551908,"d":"361"},{"v":277.79267415704857,"d":"278"},{"v":65.23960051007738,"d":"65"},{"v":51.956629957664795,"d":"52"},{"v":2613.002533061169,"d":"2613"},"External","MmAb","Epitope undefined.",{"$nulls":3},"P14618","P14618",4126,"P14618","P14618","NP_002645.3","Block6",13,10,"6, 14, 22, 30",{"$nulls":12},"X","Nucleotide Metabolism - purine; Mitochondrial; Carbohydrate Metabolism - glycolysis and gluconeogenesis; Kinase (non-protein); Carbohydrate Metabolism - pyruvate; EC 2.7.1.40","GO:0005929; GO:0005737; GO:0005829; GO:0070062; GO:0031012; GO:0005576; GO:1903561; GO:1904813; GO:0005739; GO:0043209; GO:0005634; GO:0001917; GO:1902912; GO:0034774; GO:0031982","GO:0043531; GO:0005524; GO:0045296; GO:0042802; GO:0016301; GO:0000287; GO:0023026; GO:0030955; GO:0004743; GO:0003723; GO:0070324","GO:0031100; GO:0061621; GO:0032869; GO:0001889; GO:0043312; GO:0012501; GO:0051289; GO:0009629; GO:0001666; GO:0014870; GO:0007584; GO:0043403"]
[2021,1012,"PN717","PKM2","Y148","Pyruvate kinase isozymes M1/M2",{"v":1264.3656195192343,"d":"1264"},{"v":1144.0269076173054,"d":"1144"},{"v":832.352960889526,"d":"832"},{"v":65.83166672991489,"d":"66"},{"v":185.96061664572892,"d":"186"},{"v":7668.084509148965,"d":"7668"},"Kinexus","RpAb","DNA(pY)MEK(bA)C","Corresponds to amino acid residues D145 to C152.","Y148 phosphorylation inhibits enzyme activity. This is one of the major in vivo phosphorylation sites in PKM2 (≥336 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in fish.","EGFR","P14618","P14618",4126,"P14618","P14618","NP_002645.3","Block6",13,11,"6, 14, 22, 30",{"$nulls":12},"X","Nucleotide Metabolism - purine; Mitochondrial; Carbohydrate Metabolism - glycolysis and gluconeogenesis; Kinase (non-protein); Carbohydrate Metabolism - pyruvate; EC 2.7.1.40","GO:0005929; GO:0005737; GO:0005829; GO:0070062; GO:0031012; GO:0005576; GO:1903561; GO:1904813; GO:0005739; GO:0043209; GO:0005634; GO:0001917; GO:1902912; GO:0034774; GO:0031982","GO:0043531; GO:0005524; GO:0045296; GO:0042802; GO:0016301; GO:0000287; GO:0023026; GO:0030955; GO:0004743; GO:0003723; GO:0070324","GO:0031100; GO:0061621; GO:0032869; GO:0001889; GO:0043312; GO:0012501; GO:0051289; GO:0009629; GO:0001666; GO:0014870; GO:0007584; GO:0043403"]
[2023,1013,"PN718","PKM2","S37","Pyruvate kinase isozymes M1/M2",{"v":5530.414168810114,"d":"5530"},{"v":5351.926381636199,"d":"5352"},{"v":1659.0299591856667,"d":"1659"},{"v":29.998295038047978,"d":"30"},{"v":969.6160342586145,"d":"970"},{"v":11602.054454537683,"d":"11602"},"Kinexus","RpAb","DID(pS)API(bA)C","Corresponds to amino acid residues D34 to I40.","S37 phosphorylation stimulates enzyme activity, induces interaction with ERK1 and ERK2, and inhibit interaction with CTNNB1. This is one of the major in vivo phosphorylation sites in PKM2 (≥62 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in the fruit fly.","Akt1","P14618","P14618",4126,"P14618","P14618","NP_002645.3","Block6",13,12,"6, 14, 22, 30",{"$nulls":12},"X","Nucleotide Metabolism - purine; Mitochondrial; Carbohydrate Metabolism - glycolysis and gluconeogenesis; Kinase (non-protein); Carbohydrate Metabolism - pyruvate; EC 2.7.1.40","GO:0005929; GO:0005737; GO:0005829; GO:0070062; GO:0031012; GO:0005576; GO:1903561; GO:1904813; GO:0005739; GO:0043209; GO:0005634; GO:0001917; GO:1902912; GO:0034774; GO:0031982","GO:0043531; GO:0005524; GO:0045296; GO:0042802; GO:0016301; GO:0000287; GO:0023026; GO:0030955; GO:0004743; GO:0003723; GO:0070324","GO:0031100; GO:0061621; GO:0032869; GO:0001889; GO:0043312; GO:0012501; GO:0051289; GO:0009629; GO:0001666; GO:0014870; GO:0007584; GO:0043403"]
[2025,1014,"PN529","PKM2","Y390","Pyruvate kinase isozymes M1/M2",{"v":9742.355973896614,"d":"9742"},{"v":9678.538731470657,"d":"9679"},{"v":2313.7652233194676,"d":"2314"},{"v":23.74954507430136,"d":"24"},{"v":2315.11469574051,"d":"2315"},{"v":15028.06621342638,"d":"15028"},"Kinexus","RpAb","AAI(pY)HLQ(bA)C","Corresponds to amino acid residues A387 to Q393; At the end of the PK domain. A major phosphorylation site in PKM2.","The effect of Y390 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in PKM2 (≥127 reports from high throughput mass spectrometry studies).",null,"P14618","P14618",4126,"P14618","P14618","NP_002645.3","Block6",13,13,"6, 14, 22, 30",{"$nulls":12},"X","Nucleotide Metabolism - purine; Mitochondrial; Carbohydrate Metabolism - glycolysis and gluconeogenesis; Kinase (non-protein); Carbohydrate Metabolism - pyruvate; EC 2.7.1.40","GO:0005929; GO:0005737; GO:0005829; GO:0070062; GO:0031012; GO:0005576; GO:1903561; GO:1904813; GO:0005739; GO:0043209; GO:0005634; GO:0001917; GO:1902912; GO:0034774; GO:0031982","GO:0043531; GO:0005524; GO:0045296; GO:0042802; GO:0016301; GO:0000287; GO:0023026; GO:0030955; GO:0004743; GO:0003723; GO:0070324","GO:0031100; GO:0061621; GO:0032869; GO:0001889; GO:0043312; GO:0012501; GO:0051289; GO:0009629; GO:0001666; GO:0014870; GO:0007584; GO:0043403"]
[2027,1016,"NK149-3","PKN2 (PRK2)","Pan-specific","Serine/threonine-protein kinase N2",{"v":283.0815880309564,"d":"283"},{"v":267.0523258676386,"d":"267"},{"v":145.2459572262572,"d":"145"},{"v":51.30886760829313,"d":"51"},{"v":28.668499206241542,"d":"29"},{"v":738.4344606966145,"d":"738"},"Kinexus","RpAb","CGIQELEDRRSQQRFQFNLQ","Corresponds to amino acid residues G637 to Q655; Just before kinase catalytic domain.",null,null,"Q16513","Q16513",651,"Q16513",null,"NP_006247.1","Block7",1,2,"7, 15, 23, 31","PKN2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKN",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.13; AGC domain target; AGC</A> group; PKN family","GO:0043296; GO:0005813; GO:0032154; GO:0005737; GO:0005829; GO:0045111; GO:0030027; GO:0030496; GO:0016604; GO:0005654; GO:0005634; GO:0048471; GO:0005886; GO:0032991","GO:0005524; GO:0045296; GO:0017049; GO:0042826; GO:0016301; GO:0004672; GO:0004697; GO:0004674; GO:0003723; GO:0070063","GO:0043297; GO:0006915; GO:0007155; GO:0007049; GO:0051301; GO:0030030; GO:0010631; GO:0035556; GO:0018105; GO:0032467; GO:0045931; GO:0045070; GO:0006468; GO:2000145; GO:0006355; GO:0007165; GO:0006351"]
[2029,1017,"NK144-1","PKR1 (PRKR; EIF2AK2)","Pan-specific","Double stranded RNA dependent protein-serine kinase",{"v":216.1644961881407,"d":"216"},{"v":145.81196500597866,"d":"146"},{"v":405.06605459099904,"d":"405"},{"v":187.38787438916248,"d":"187"},{"v":19.967705776666335,"d":"20"},{"v":5291.950012541536,"d":"5292"},"External","MmAb","Epitope undefined.",{"$nulls":3},"P19525","P19525",646,"P19525","P19525","NP_002750","Block7",1,3,"7, 15, 23, 31","PKR","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","PEK",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; PEK family","GO:0005737; GO:0005829; GO:0016020; GO:0005634; GO:0048471; GO:0005840","GO:0005524; GO:0003725; GO:0004694; GO:0042802; GO:0004715; GO:0004672; GO:0019888; GO:0004674; GO:0003723","GO:0000186; GO:0034198; GO:0051607; GO:0030968; GO:0030683; GO:0045087; GO:0043066; GO:0008285; GO:0033689; GO:0017148; GO:0045071; GO:0032722; GO:0001819; GO:0051092; GO:1901224; GO:0032874; GO:0046777; GO:0006468; GO:1901532; GO:1902036; GO:1902033; GO:1900225; GO:0035455; GO:0009636; GO:0009615; GO:0006351; GO:0006412"]
[2031,1018,"PK132","PKR1 (PRKR; EIF2AK2)","T446","Double-stranded RNA-dependent protein-serine kinase; Interferon-induced, double-stranded RNA-activated protein kinase",{"v":745.2091376771367,"d":"745"},{"v":693.5074221481304,"d":"694"},{"v":467.36389594351306,"d":"467"},{"v":62.71580316370186,"d":"63"},{"v":9.004862963776842,"d":"9"},{"v":2634.6842651456427,"d":"2635"},"External","RpAb","KR(pT)RS","Corresponds to amino acid residues K444 to S448; Surrounds the T446 phosphosite.","T446 phosphorylation stimulates phosphotransferase activity. Phosphorylation regulates cell cycle progression and cell growth. This is a minor in vivo phosphorylation sites in PKR1 (≥1 report from high throughput mass spectrometry studies).","PKR (EIF2AK2)","P19525","P19525",646,"P19525","P19525","NP_002750","Block7",1,4,"7, 15, 23, 31","PKR","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","PEK",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; PEK family","GO:0005737; GO:0005829; GO:0016020; GO:0005634; GO:0048471; GO:0005840","GO:0005524; GO:0003725; GO:0004694; GO:0042802; GO:0004715; GO:0004672; GO:0019888; GO:0004674; GO:0003723","GO:0000186; GO:0034198; GO:0051607; GO:0030968; GO:0030683; GO:0045087; GO:0043066; GO:0008285; GO:0033689; GO:0017148; GO:0045071; GO:0032722; GO:0001819; GO:0051092; GO:1901224; GO:0032874; GO:0046777; GO:0006468; GO:1901532; GO:1902036; GO:1902033; GO:1900225; GO:0035455; GO:0009636; GO:0009615; GO:0006351; GO:0006412"]
[2033,1019,"PK777","PKR1 (PRKR; EIF2AK2)","T446","Double-stranded RNA-dependent protein-serine kinase; Interferon-induced, double-stranded RNA-activated protein kinase",{"v":5024.412915341269,"d":"5024"},{"v":4939.987488889237,"d":"4940"},{"v":1659.3381756309846,"d":"1659"},{"v":33.02551369861445,"d":"33"},{"v":807.2964147505269,"d":"807"},{"v":9948.609433376354,"d":"9949"},"Kinexus","RpAb","GKR(pT)RSK(bA)C","Corresponds to amino acid residues G443 to K449; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T446 phosphorylation stimulates phosphotransferase activity. Phosphorylation regulates cell cycle progression and cell growth. This is a minor in vivo phosphorylation sites in PKR1 (≥1 report from high throughput mass spectrometry studies).","PKR (EIF2AK2)","P19525","P19525",646,"P19525","P19525","NP_002750","Block7",1,5,"7, 15, 23, 31","PKR","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","PEK",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; PEK family","GO:0005737; GO:0005829; GO:0016020; GO:0005634; GO:0048471; GO:0005840","GO:0005524; GO:0003725; GO:0004694; GO:0042802; GO:0004715; GO:0004672; GO:0019888; GO:0004674; GO:0003723","GO:0000186; GO:0034198; GO:0051607; GO:0030968; GO:0030683; GO:0045087; GO:0043066; GO:0008285; GO:0033689; GO:0017148; GO:0045071; GO:0032722; GO:0001819; GO:0051092; GO:1901224; GO:0032874; GO:0046777; GO:0006468; GO:1901532; GO:1902036; GO:1902033; GO:1900225; GO:0035455; GO:0009636; GO:0009615; GO:0006351; GO:0006412"]
[2035,1020,"PN719","PLCB3","S1105","1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta-3",{"v":1846.561023596925,"d":"1847"},{"v":1707.6570029679297,"d":"1708"},{"v":762.6253274973894,"d":"763"},{"v":41.29976305965064,"d":"41"},{"v":382.0214143189561,"d":"382"},{"v":5297.773278689316,"d":"5298"},"Kinexus","RpAb","RHN(pS)ISEAC","Corresponds to amino acid residues R1102 to A1109.","S1105 phosphorylation inhibits enzyme activity. This is the major in vivo phosphorylation site in PLCB3 (≥232 reports from high throughput mass spectrometry studies). This human phosphosite is conserved in mammals and also found in the rat.","PKACa (PRKACA); PKCa (PRKCA); PKCb1 (PRKCB1); PKCd (PRKCD); PKCe (PRKCE); PKG1 (PRKG1); PKG2 (PRKG2)","Q01970","Q01970",1028,null,"Q01970","NP_000923.1","Block7",1,6,"7, 15, 23, 31",{"$nulls":3},"Phospholipase",{"$nulls":8},"X","Carbohydrate Metabolism - inositol phosphate; EC 3.1.4.11; Phospholipase","GO:0005829; GO:0016020; GO:0005654; GO:0099524; GO:0032991","GO:0045296; GO:0005509; GO:0005516; GO:0004435; GO:0004629","GO:0007186; GO:0043647; GO:0035556; GO:0016042; GO:0003073; GO:0007223"]
[2037,1021,"PN720","PLCD1","S460","1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase delta-1",{"v":1283.2429598885967,"d":"1283"},{"v":1217.4654082059599,"d":"1217"},{"v":515.9538620900231,"d":"516"},{"v":40.20702845974039,"d":"40"},{"v":149.18866057420507,"d":"149"},{"v":3460.2082217138714,"d":"3460"},"Kinexus","RpAb","CATVV(pS)DED","Corresponds to amino acid residues A456 to D463.","The effect of S460 phosphorylation is unclear. This is the major in vivo phosphorylation site in PLCD1 (≥21 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in the sea urchin.",null,"P51178","P51178",3754487,null,"P51178","NP_006216.2","Block7",1,7,"7, 15, 23, 31",{"$nulls":3},"Phospholipase",{"$nulls":8},"X","EC 3.1.4.11; Carbohydrate Metabolism - inositol phosphate; Phospholipase","GO:0005737; GO:0005829; GO:0070062; GO:0005886","GO:0005509; GO:0032794; GO:0070300; GO:0005546; GO:0004435; GO:0001786","GO:0001525; GO:0043647; GO:0035556; GO:0060716; GO:0016042; GO:0006644; GO:0042127"]
[2039,1022,"PN721","PLCE1","S1096+T1100","1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase epsilon-1",{"v":1220.4086198064686,"d":"1220"},{"v":1202.500837798458,"d":"1203"},{"v":604.730089083613,"d":"605"},{"v":49.551443612346056,"d":"50"},{"v":55.720138565503845,"d":"56"},{"v":2995.8547969534184,"d":"2996"},"Kinexus","RpAb","RGE(pS)GEV(pT)DDE(pA)C","Corresponds to amino acid residues R1093 to 1153E.","The effect of S1096 and T1100 phosphorylation is unclear. These are two of the major in vivo phosphorylation sites in PLCE1 (≥19 and >5 reports, respectively, by mass spectrometry). These human phosphosites are conserved in mammals and found in the rat.",null,"Q9P212","Q9P212",15990,null,"Q9P212","NP_057425.3","Block7",1,8,"7, 15, 23, 31",{"$nulls":3},"Phospholipase",{"$nulls":8},"X","Phospholipase; EC 3.1.4.11; Carbohydrate Metabolism - inositol phosphate","GO:0005829; GO:0000139; GO:0005886","GO:0019899; GO:0005085; GO:0046872; GO:0004435; GO:0004629; GO:0017016","GO:0000187; GO:0019722; GO:0008283; GO:0007010; GO:0006651; GO:0007173; GO:0032835; GO:0007507; GO:0048016; GO:0043647; GO:0016042; GO:0007200; GO:0007204; GO:0007265; GO:0001558; GO:0008277; GO:0045859; GO:0046578; GO:0006940"]
[2041,1023,"NN144-2","PLCG1","Pan-specific","1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1",{"v":871.1103838261636,"d":"871"},{"v":773.688005582299,"d":"774"},{"v":738.8566072078489,"d":"739"},{"v":84.81779358002615,"d":"85"},{"v":134.58207396928486,"d":"135"},{"v":9354.268436340313,"d":"9354"},"External","MmAb","Epitope undefined.",{"$nulls":3},"P19174","P19174",1029,null,null,"NP_877963.1","Block7",1,9,"7, 15, 23, 31",{"$nulls":3},"Phospholipase",{"$nulls":8},"X","EC 3.1.4.11; Phospholipase; Carbohydrate Metabolism - inositol phosphate","GO:0005911; GO:0042995; GO:0008180; GO:0005737; GO:0005829; GO:0098978; GO:0030027; GO:0005886; GO:0001726; GO:0098685","GO:0005509; GO:0035254; GO:0005168; GO:0004435; GO:0004629; GO:0019901; GO:0030971","GO:0007202; GO:0007411; GO:0019722; GO:0016477; GO:0071364; GO:0007173; GO:0038095; GO:0038096; GO:0043647; GO:0001701; GO:0050900; GO:0050804; GO:0009395; GO:0045766; GO:0043536; GO:2000353; GO:0010634; GO:0010863; GO:0051281; GO:1905564; GO:0007165; GO:0050852; GO:0016032"]
[2043,1024,"PN165","PLCG1","Y771","1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2",{"v":1037.4262042209539,"d":"1037"},{"v":967.6245478910816,"d":"968"},{"v":580.9702752310983,"d":"581"},{"v":56.00111823542888,"d":"56"},{"v":11.285905233445977,"d":"11"},{"v":3651.5174716743886,"d":"3652"},"External","RpAb","PD(pY)GA","Corresponds to amino acid residues P769 to A773.","The effect of Y771 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in PLCG1 (≥569 reports from high throughput mass spectrometry studies). This human phosphosite is conserved in many mammals and found in the rat.","EGFR; Syk","P19174","P19174",1029,null,null,"NP_877963.1","Block7",1,10,"7, 15, 23, 31",{"$nulls":3},"Phospholipase",{"$nulls":8},"X","EC 3.1.4.11; Phospholipase; Carbohydrate Metabolism - inositol phosphate","GO:0005911; GO:0042995; GO:0008180; GO:0005737; GO:0005829; GO:0098978; GO:0030027; GO:0005886; GO:0001726; GO:0098685","GO:0005509; GO:0035254; GO:0005168; GO:0004435; GO:0004629; GO:0019901; GO:0030971","GO:0007202; GO:0007411; GO:0019722; GO:0016477; GO:0071364; GO:0007173; GO:0038095; GO:0038096; GO:0043647; GO:0001701; GO:0050900; GO:0050804; GO:0009395; GO:0045766; GO:0043536; GO:2000353; GO:0010634; GO:0010863; GO:0051281; GO:1905564; GO:0007165; GO:0050852; GO:0016032"]
[2045,1025,"PN144","PLCG1","Y783","1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2",{"v":263.9090271620467,"d":"264"},{"v":196.84121605333877,"d":"197"},{"v":242.4234625031162,"d":"242"},{"v":91.85872310243568,"d":"92"},{"v":17.4879625896729,"d":"17"},{"v":1424.641564676112,"d":"1425"},"External","RpAb","GF(pY)VE","Corresponds to amino acid residues G347 to E351; Surrounds the Y349 phosphosite.","Y783 phosphorylation stimulates phospholipase activity, induces interaction with Grb2 and VEGFR-2 and regulates cell motility. This is one of the major sites of in vivo phosphorylation of PLCG1 (≥566 reports from high throughput mass spectrometry studies). ","EGFR; ITK; Ret; Src; Syk; TrkB (NTRK2); ZAP70","P19174","P19174",1029,null,null,"NP_877963.1","Block7",1,11,"7, 15, 23, 31",{"$nulls":3},"Phospholipase",{"$nulls":8},"X","EC 3.1.4.11; Phospholipase; Carbohydrate Metabolism - inositol phosphate","GO:0005911; GO:0042995; GO:0008180; GO:0005737; GO:0005829; GO:0098978; GO:0030027; GO:0005886; GO:0001726; GO:0098685","GO:0005509; GO:0035254; GO:0005168; GO:0004435; GO:0004629; GO:0019901; GO:0030971","GO:0007202; GO:0007411; GO:0019722; GO:0016477; GO:0071364; GO:0007173; GO:0038095; GO:0038096; GO:0043647; GO:0001701; GO:0050900; GO:0050804; GO:0009395; GO:0045766; GO:0043536; GO:2000353; GO:0010634; GO:0010863; GO:0051281; GO:1905564; GO:0007165; GO:0050852; GO:0016032"]
[2047,1026,"PN530","PLCG1","Y783","1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2",{"v":11245.212164588245,"d":"11245"},{"v":11368.874973854985,"d":"11369"},{"v":2041.605213509609,"d":"2042"},{"v":18.155328540076187,"d":"18"},{"v":2206.492446528592,"d":"2206"},{"v":17504.786936125536,"d":"17505"},"Kinexus","RpAb","PGF(pY)VEA(bA)C","Corresponds to amino acid residues P780 to A786; In the intervening region between the second SH2 domain and the SH3 domain in PLCG1. ","Y783 phosphorylation stimulates phospholipase activity, induces interaction with Grb2 and VEGFR-2 and regulates cell motility. This is one of the major sites of in vivo phosphorylation of PLCG1 (≥566 reports from high throughput mass spectrometry studies). ","EGFR; ITK; Ret; Src; Syk; TrkB (NTRK2); ZAP70","P19174","P19174",1029,null,null,"NP_877963.1","Block7",1,12,"7, 15, 23, 31",{"$nulls":3},"Phospholipase",{"$nulls":8},"X","EC 3.1.4.11; Phospholipase; Carbohydrate Metabolism - inositol phosphate","GO:0005911; GO:0042995; GO:0008180; GO:0005737; GO:0005829; GO:0098978; GO:0030027; GO:0005886; GO:0001726; GO:0098685","GO:0005509; GO:0035254; GO:0005168; GO:0004435; GO:0004629; GO:0019901; GO:0030971","GO:0007202; GO:0007411; GO:0019722; GO:0016477; GO:0071364; GO:0007173; GO:0038095; GO:0038096; GO:0043647; GO:0001701; GO:0050900; GO:0050804; GO:0009395; GO:0045766; GO:0043536; GO:2000353; GO:0010634; GO:0010863; GO:0051281; GO:1905564; GO:0007165; GO:0050852; GO:0016032"]
[2049,1027,"PN722","PLCG1","Y977","1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2",{"v":7867.1377222493,"d":"7867"},{"v":7719.645710521934,"d":"7720"},{"v":2832.9843610002226,"d":"2833"},{"v":36.010356765309574,"d":"36"},{"v":421.1907473349395,"d":"421"},{"v":19931.61679822414,"d":"19932"},"Kinexus","RpAb","RAS(pY)RDM(bA)C","Corresponds to amino acid residues R974 to M980 (C976S change).","The effect of Y977 phosphorylation is unclear. This is the major site of in vivo phosphorylation of PLCG1 (≥665 reports from high throughput mass spectrometry studies). This human phosphosite is conserved in mammals and found in the rat.",null,"P19174","P19174",1029,null,null,"NP_877963.1","Block7",1,13,"7, 15, 23, 31",{"$nulls":3},"Phospholipase",{"$nulls":8},"X","EC 3.1.4.11; Phospholipase; Carbohydrate Metabolism - inositol phosphate","GO:0005911; GO:0042995; GO:0008180; GO:0005737; GO:0005829; GO:0098978; GO:0030027; GO:0005886; GO:0001726; GO:0098685","GO:0005509; GO:0035254; GO:0005168; GO:0004435; GO:0004629; GO:0019901; GO:0030971","GO:0007202; GO:0007411; GO:0019722; GO:0016477; GO:0071364; GO:0007173; GO:0038095; GO:0038096; GO:0043647; GO:0001701; GO:0050900; GO:0050804; GO:0009395; GO:0045766; GO:0043536; GO:2000353; GO:0010634; GO:0010863; GO:0051281; GO:1905564; GO:0007165; GO:0050852; GO:0016032"]
[2051,1028,"PN143","PLCG2","Y753","1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2",{"v":651.9753840875602,"d":"652"},{"v":633.6758776685153,"d":"634"},{"v":419.56782556966516,"d":"420"},{"v":64.35332311768956,"d":"64"},{"v":5.184148656121069,"d":"5"},{"v":2729.3272935944397,"d":"2729"},"External","RpAb","SL(pY)DV","Corresponds to amino acid residues S751 to V755; Surrounds the Y753 phosphosite.","Y753 phosphorylation stimulates phospholipase activity, and induces interaction with Lyn. This is one of the major sites of in vivo phosphorylation of PLCG2 (≥276 reports from high throughput mass spectrometry studies). This human phosphosite is conserved in mammals and found in the rat.","Btk; Fyn; Lck; Src","P16885","P16885",1202,null,"P16885","NP_002652.2","Block7",2,1,"7, 15, 23, 31",{"$nulls":3},"Phospholipase",{"$nulls":8},"X","Phospholipase; EC 3.1.4.11; Carbohydrate Metabolism - inositol phosphate","GO:0005829; GO:0070062; GO:0005886","GO:0004435; GO:0004629; GO:0001784","GO:0032237; GO:0030183; GO:0050853; GO:0019722; GO:0038095; GO:0038096; GO:0002316; GO:0043647; GO:0032959; GO:0043069; GO:0006661; GO:0009395; GO:0030168; GO:0002092; GO:0032481; GO:0010468; GO:0051209; GO:0032496; GO:0002223; GO:0050852; GO:0016055"]
[2053,1029,"PN723","PLCG2","Y753","1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2",{"v":7853.291227734733,"d":"7853"},{"v":7641.8530071791665,"d":"7642"},{"v":2276.619580094067,"d":"2277"},{"v":28.989369094755364,"d":"29"},{"v":675.8959330024664,"d":"676"},{"v":16051.843202330305,"d":"16052"},"Kinexus","RpAb","NSL(pY)DVS(bA)C","Corresponds to amino acid residues N750 to S756.","Y753 phosphorylation stimulates phospholipase activity, and regulates molecular association, including inducing interaction with Lyn. This is one of the major sites of in vivo phosphorylation of PLCG2 (≥276 reports from high throughput mass spectrometry studies). This human phosphosite is conserved in mammals and found in the rat.","Btk; Fyn; Lck; Src","P16885","P16885",1202,null,"P16885","NP_002652.2","Block7",2,2,"7, 15, 23, 31",{"$nulls":3},"Phospholipase",{"$nulls":8},"X","Phospholipase; EC 3.1.4.11; Carbohydrate Metabolism - inositol phosphate","GO:0005829; GO:0070062; GO:0005886","GO:0004435; GO:0004629; GO:0001784","GO:0032237; GO:0030183; GO:0050853; GO:0019722; GO:0038095; GO:0038096; GO:0002316; GO:0043647; GO:0032959; GO:0043069; GO:0006661; GO:0009395; GO:0030168; GO:0002092; GO:0032481; GO:0010468; GO:0051209; GO:0032496; GO:0002223; GO:0050852; GO:0016055"]
[2055,1030,"PN531","PLCG2","Y759","1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2",{"v":8029.580621304962,"d":"8030"},{"v":7964.097263108132,"d":"7964"},{"v":1795.494045894677,"d":"1795"},{"v":22.360994061516433,"d":"22"},{"v":3749.7368346967623,"d":"3750"},{"v":14365.625472133934,"d":"14366"},"Kinexus","RpAb","SRM(pY)VDP(bA)C","Corresponds to amino acid residues S756 to P762; Near the end of the second SH2 domain in the protein. ","Y759 phosphorylation stimulates phospholipase activity, and induces interaction with Lyn. This is one of the major in vivo phosphorylation sites in PLCG2 (≥229 reports from high throughput mass spectrometry studies). This human phosphosite is conserved in many mammals and found in the rat.","Btk; Fyn; Lck; Src; Syk","P16885","P16885",1202,null,"P16885","NP_002652.2","Block7",2,3,"7, 15, 23, 31",{"$nulls":3},"Phospholipase",{"$nulls":8},"X","Phospholipase; EC 3.1.4.11; Carbohydrate Metabolism - inositol phosphate","GO:0005829; GO:0070062; GO:0005886","GO:0004435; GO:0004629; GO:0001784","GO:0032237; GO:0030183; GO:0050853; GO:0019722; GO:0038095; GO:0038096; GO:0002316; GO:0043647; GO:0032959; GO:0043069; GO:0006661; GO:0009395; GO:0030168; GO:0002092; GO:0032481; GO:0010468; GO:0051209; GO:0032496; GO:0002223; GO:0050852; GO:0016055"]
[2057,1031,"NK145-2","Plk1 (PLK)","Pan-specific","Polo-like protein-serine kinase 1",{"v":13419.706507422643,"d":"13420"},{"v":11416.666285049301,"d":"11417"},{"v":9138.550947615655,"d":"9139"},{"v":68.0979941145582,"d":"68"},{"v":755.7386442825821,"d":"756"},{"v":82126.9409991312,"d":"82127"},"Kinexus","RpAb","CAKEIPEVLVDPRSRRRYVR","Corresponds to amino acid residues A37 to R55; Just before kinase catalytic domain.",null,null,"P53350","P53350",648,"P53350","P53350","NP_002652.2","Block7",2,4,"7, 15, 23, 31","PLK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","PLK",{"$nulls":6},"EC 2.7.11.21; Protein kinase, Ser/Thr (non-receptor); Other group; PLK family","GO:0034451; GO:0005814; GO:0005813; GO:0000785; GO:0000942; GO:0005829; GO:0000776; GO:0015630; GO:0030496; GO:0005654; GO:0005634; GO:0005819; GO:0051233; GO:0000922; GO:0000795","GO:0010997; GO:0005524; GO:0042802; GO:0016301; GO:0000287; GO:0008017; GO:0004672; GO:0019901; GO:0004674","GO:0031145; GO:0008283; GO:0007098; GO:0097711; GO:0045184; GO:0016321; GO:0000086; GO:0045143; GO:0001578; GO:0000278; GO:0000281; GO:0007077; GO:0000070; GO:0007094; GO:0043066; GO:0045736; GO:0000122; GO:0051081; GO:0018105; GO:0010800; GO:0032436; GO:1900182; GO:0045862; GO:1904668; GO:0051443; GO:0031648; GO:0071168; GO:0090435; GO:0006468; GO:0016567; GO:0051726; GO:1902749; GO:0032465; GO:0010389; GO:0007346; GO:0030071; GO:1901673; GO:0043393; GO:0072425; GO:0007062; GO:0070194"]
[2059,1032,"PK778","Plk1 (PLK)","T210","Polo-like protein-serine kinase 1",{"v":2589.6422343161034,"d":"2590"},{"v":2521.592373002324,"d":"2522"},{"v":914.5835307604946,"d":"915"},{"v":35.316983892256694,"d":"35"},{"v":431.8929214010441,"d":"432"},{"v":5623.831297371937,"d":"5624"},"Kinexus","RpAb","RKK(pT)LCG(bA)C","Corresponds to amino acid residues R207 to G213; In the protein kinase catalytic domain.","T210 phosphorylation stimulates phosphotransferase activity, and inhibits interaction with Plk1. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of Plk1 (≥71 reports from high throughput mass spectrometry studies).","AurA (STK15); AurB (STK12); COT (MAP3K8); LOK (STK10)","P53350","P53350",648,"P53350","P53350","NP_002652.2","Block7",2,5,"7, 15, 23, 31","PLK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","PLK",{"$nulls":6},"EC 2.7.11.21; Protein kinase, Ser/Thr (non-receptor); Other group; PLK family","GO:0034451; GO:0005814; GO:0005813; GO:0000785; GO:0000942; GO:0005829; GO:0000776; GO:0015630; GO:0030496; GO:0005654; GO:0005634; GO:0005819; GO:0051233; GO:0000922; GO:0000795","GO:0010997; GO:0005524; GO:0042802; GO:0016301; GO:0000287; GO:0008017; GO:0004672; GO:0019901; GO:0004674","GO:0031145; GO:0008283; GO:0007098; GO:0097711; GO:0045184; GO:0016321; GO:0000086; GO:0045143; GO:0001578; GO:0000278; GO:0000281; GO:0007077; GO:0000070; GO:0007094; GO:0043066; GO:0045736; GO:0000122; GO:0051081; GO:0018105; GO:0010800; GO:0032436; GO:1900182; GO:0045862; GO:1904668; GO:0051443; GO:0031648; GO:0071168; GO:0090435; GO:0006468; GO:0016567; GO:0051726; GO:1902749; GO:0032465; GO:0010389; GO:0007346; GO:0030071; GO:1901673; GO:0043393; GO:0072425; GO:0007062; GO:0070194"]
[2061,1033,"PK779","Plk1 (PLK)","Y217","Polo-like protein-serine kinase 1",{"v":6129.8394152265455,"d":"6130"},{"v":5911.074376827777,"d":"5911"},{"v":1460.7081771561627,"d":"1461"},{"v":23.82946890138358,"d":"24"},{"v":2842.235432442531,"d":"2842"},{"v":13178.408386178628,"d":"13178"},"Kinexus","RpAb","TPN(pY)IAP(bA)C","Corresponds to amino acid residues T214 to P220; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y217 phosphorylation is predicted to be inhibitory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is the major site of in vivo phosphorylation of Plk1 (≥149 reports from high throughput mass spectrometry studies).","Abl1","P53350","P53350",648,"P53350","P53350","NP_002652.2","Block7",2,6,"7, 15, 23, 31","PLK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","PLK",{"$nulls":6},"EC 2.7.11.21; Protein kinase, Ser/Thr (non-receptor); Other group; PLK family","GO:0034451; GO:0005814; GO:0005813; GO:0000785; GO:0000942; GO:0005829; GO:0000776; GO:0015630; GO:0030496; GO:0005654; GO:0005634; GO:0005819; GO:0051233; GO:0000922; GO:0000795","GO:0010997; GO:0005524; GO:0042802; GO:0016301; GO:0000287; GO:0008017; GO:0004672; GO:0019901; GO:0004674","GO:0031145; GO:0008283; GO:0007098; GO:0097711; GO:0045184; GO:0016321; GO:0000086; GO:0045143; GO:0001578; GO:0000278; GO:0000281; GO:0007077; GO:0000070; GO:0007094; GO:0043066; GO:0045736; GO:0000122; GO:0051081; GO:0018105; GO:0010800; GO:0032436; GO:1900182; GO:0045862; GO:1904668; GO:0051443; GO:0031648; GO:0071168; GO:0090435; GO:0006468; GO:0016567; GO:0051726; GO:1902749; GO:0032465; GO:0010389; GO:0007346; GO:0030071; GO:1901673; GO:0043393; GO:0072425; GO:0007062; GO:0070194"]
[2063,1034,"NK147-2","Plk3 (CNK)","Pan-specific","Polo-like protein-serine kinase 3 (cytokine- inducible kinase (CNK))",{"v":3436.779946038067,"d":"3437"},{"v":3283.811506067894,"d":"3284"},{"v":1207.3175216862305,"d":"1207"},{"v":35.12932281503885,"d":"35"},{"v":211.82447821679602,"d":"212"},{"v":7845.543090077497,"d":"7846"},"Kinexus","RpAb","KSKNHAQERDEVSGLVSGC","Corresponds to amino acid residues K357 to G374; After catalytic domain.",null,null,"Q9H4B4","Q9H4B4",696,"Q9H4B4","Q9H4B4","NP_004064.2","Block7",2,7,"7, 15, 23, 31","PLK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","PLK",{"$nulls":6},"Membrane, Dendrite protein","GO:0005813; GO:0005737; GO:0030425; GO:0005795; GO:0043025; GO:0005730; GO:0005654; GO:0005634","GO:0005524; GO:0002039; GO:0004674","GO:0006915; GO:0006974; GO:0031122; GO:0006977; GO:0007113; GO:0000082; GO:0000086; GO:0090166; GO:0007093; GO:0044819; GO:0043066; GO:0000122; GO:1904716; GO:0090316; GO:2000777; GO:0043491; GO:0006468; GO:0051302; GO:0032465; GO:1901796; GO:0006970; GO:0009314; GO:0000302"]
[2065,1035,"NK291-1","Plk4 (SAK; STK18)","Pan-specific","Polo-like kinase-serine 4 (SAK)",{"v":1305.0302483986607,"d":"1305"},{"v":1187.1463584400353,"d":"1187"},{"v":631.0772014474411,"d":"631"},{"v":48.35728537494095,"d":"48"},{"v":224.95318473635922,"d":"225"},{"v":4850.142902353404,"d":"4850"},"Kinexus","RpAb","EKYWRKYQYASRFVQLVRSC","Corresponds to amino acid residues E680 to S698; Middle sequence.",null,null,"O00444","O00444",765,"O00444",null,"NP_001177728.1","Block7",2,8,"7, 15, 23, 31","PLK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","PLK",{"$nulls":6},"EC 2.7.11.21; Protein kinase, Ser/Thr (non-receptor); Other group; PLK family","GO:0005814; GO:0005813; GO:0032154; GO:0005829; GO:0098536; GO:0005730; GO:0001741","GO:0005524; GO:0042802; GO:0004674","GO:0007099; GO:0097711; GO:0098535; GO:0000086; GO:0046601; GO:0006468; GO:0010389; GO:0060707"]
[2067,1036,"PK780","Plk4 (SAK; STK18)","T170","Polo-like kinase-serine 4 (SAK)",{"v":11958.646116128817,"d":"11959"},{"v":11926.222063238252,"d":"11926"},{"v":2201.633694865567,"d":"2202"},{"v":18.410392560209544,"d":"18"},{"v":2902.2388000809324,"d":"2902"},{"v":20830.47321259939,"d":"20830"},"Kinexus","RpAb","KHY(pT)LCG(bA)C","Corresponds to amino acid residues K167 to G173; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T170 stimulates phosphotransferase activity and interaction with STIL. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of Plk4.",null,"O00444","O00444",765,"O00444",null,"NP_001177728.1","Block7",2,9,"7, 15, 23, 31","PLK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","PLK",{"$nulls":6},"EC 2.7.11.21; Protein kinase, Ser/Thr (non-receptor); Other group; PLK family","GO:0005814; GO:0005813; GO:0032154; GO:0005829; GO:0098536; GO:0005730; GO:0001741","GO:0005524; GO:0042802; GO:0004674","GO:0007099; GO:0097711; GO:0098535; GO:0000086; GO:0046601; GO:0006468; GO:0010389; GO:0060707"]
[2069,802,"NN432-1","PLPB1 (MYT1)","Pan-specific","Myelin transcription factor 1",{"v":583.3997401162816,"d":"583"},{"v":498.5290280775379,"d":"499"},{"v":368.28217050462587,"d":"368"},{"v":63.12689999334263,"d":"63"},{"v":58.727346016855236,"d":"59"},{"v":2643.896145919879,"d":"2644"},"External","MmAb","Epitope undefined.",{"$nulls":3},"Q01538","Q01538",16500,null,null,"NP_004526.1","Block5",10,9,"5, 13, 21, 29",{"$nulls":8},"X",{"$nulls":4},"Transcription factor","GO:0005829; GO:0005654; GO:0005634","GO:0003677; GO:0003700; GO:0000981; GO:0008270","GO:0030154; GO:0007399; GO:0006355; GO:0006351"]
[2071,1037,"PN641","PML","S518","Probable transcription factor PML",{"v":10541.271282840706,"d":"10541"},{"v":10490.059309844622,"d":"10490"},{"v":3108.63316584859,"d":"3109"},{"v":29.490116347815526,"d":"29"},{"v":4611.102894924836,"d":"4611"},{"v":20292.765301798718,"d":"20293"},"Kinexus","RpAb","SKAV(pS)PPH(bA)C","Corresponds to amino acid residues S14 to H21.","S518 prevents ubiquitination by the BCR(KLHL20) E3 ubiquitin ligase complex. This is one of the major sites of in vivo phosphorylation of PML.",null,"P29590","P29590",5135,null,"P29590","NP_150241.2","Block7",2,10,"7, 15, 23, 31",{"$nulls":3},"Transcription protein; Tumour suppressor",{"$nulls":4},"X",{"$nulls":4},"Transcription factor; Tumor suppressor","GO:0005737; GO:0005829; GO:0031901; GO:0042406; GO:0000792; GO:0000784; GO:0016363; GO:0031965; GO:0005730; GO:0005654; GO:0005634; GO:0016605","GO:0050897; GO:0003677; GO:0046982; GO:0042803; GO:0046332; GO:0032183; GO:0019789; GO:0003713; GO:0031625; GO:0008270","GO:0006919; GO:0006915; GO:0060444; GO:0007050; GO:0045165; GO:0071353; GO:1990830; GO:0090398; GO:0032922; GO:0007182; GO:0051607; GO:0006977; GO:0032469; GO:0043153; GO:0097191; GO:0010761; GO:0045087; GO:0060333; GO:0008630; GO:0042771; GO:0070059; GO:0008631; GO:0051457; GO:0030099; GO:0016525; GO:0030308; GO:0008285; GO:0050713; GO:0045930; GO:0051974; GO:0032211; GO:0045892; GO:0032938; GO:2000059; GO:1902187; GO:0030578; GO:0060058; GO:0002230; GO:2001238; GO:0048146; GO:0031065; GO:0045345; GO:1904816; GO:0032206; GO:0045944; GO:0043161; GO:0065003; GO:0006606; GO:0050821; GO:0006605; GO:0010522; GO:0030155; GO:0042752; GO:2000779; GO:0001932; GO:1901796; GO:0006355; GO:0034097; GO:0010332; GO:0001666; GO:0009411; GO:0048384; GO:0006351; GO:0007179; GO:0016032"]
[2073,1038,"PN643","POU2F1","S385","POU domain, class 2, transcription factor 1",{"v":23931.178764963584,"d":"23931"},{"v":23471.110989298795,"d":"23471"},{"v":7020.679233100806,"d":"7021"},{"v":29.336955367110555,"d":"29"},{"v":5956.277541733568,"d":"5956"},{"v":51637.9980981961,"d":"51638"},"Kinexus","RpAb","KKRT(pS)IET(bA)C","Corresponds to amino acid residues K381 to T388.","S385 phosphorylation inhibits transcriptional activity by inhibiting DNA binding. This is one of the major sites of in vivo phosphorylation of POU2F1.","PKACa (PRKACA)","P14859","P14859",5799,null,null,"XP_011507956.1","Block7",2,11,"7, 15, 23, 31",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription factor","GO:0005783; GO:0043231; GO:0005654; GO:0005634; GO:0090575","GO:0003677; GO:0000979; GO:0000978; GO:0000981; GO:0043565; GO:0000983","GO:0019221; GO:0045892; GO:0045944; GO:0042795"]
[2075,1039,"NP009","PP1/Ca pan","Pan-specific","Protein-serine phosphatase 1 - catalytic subunit†- alpha isoform",{"v":408.0902439326145,"d":"408"},{"v":356.64611764880544,"d":"357"},{"v":242.07442650169946,"d":"242"},{"v":59.31884677489907,"d":"59"},{"v":83.956146905402,"d":"84"},{"v":1472.0042417350328,"d":"1472"},"External","RpAb","Epitope undefined.",{"$nulls":3},"P62136","P62136",1688,null,"P62136","NP_002699.1","Block7",2,12,"7, 15, 23, 31",null,null,"PSTP","Protein phosphatase - Serine/threonine phosphatase",{"$nulls":6},"X",null,null,"Protein phosphatase, Ser/Thr (non-receptor); EC 3.1.3.16","GO:0005913; GO:0005737; GO:0005829; GO:0043197; GO:0070062; GO:0098978; GO:0042587; GO:0005730; GO:0005654; GO:0005634; GO:0043204; GO:0005886; GO:0098793; GO:0000164; GO:0072357","GO:0098641; GO:0046872; GO:0016791; GO:0004721; GO:0008157; GO:0004722; GO:0043021","GO:1904886; GO:0048754; GO:0007049; GO:0051301; GO:0032922; GO:0016311; GO:0043153; GO:0005977; GO:0030324; GO:0032091; GO:0070262; GO:0035970; GO:2001241; GO:0006470; GO:0060828; GO:0042752; GO:0005979; GO:0005981; GO:0036496; GO:0010288"]
[2077,1040,"NP010-3","PP1/Cb (PPP1CB)","Pan-specific","Protein-serine phosphatase 1 - catalytic subunit†- beta isoform",{"v":420.743784134785,"d":"421"},{"v":314.59121373943844,"d":"315"},{"v":546.4690795708078,"d":"546"},{"v":129.88167625448432,"d":"130"},{"v":33.441861112599625,"d":"33"},{"v":7240.161770337102,"d":"7240"},"External","MmAb","Epitope undefined.",{"$nulls":3},"P62140","P62140",1689,null,null,"NP_996759.1","Block7",2,13,"7, 15, 23, 31",null,null,"PSTP","Protein phosphatase - Serine/threonine phosphatase",{"$nulls":6},"X",null,null,"EC 3.1.3.16; Protein phosphatase, Ser/Thr (non-receptor)","GO:0005829; GO:0070062; GO:0005925; GO:0005730; GO:0005654; GO:0005634; GO:0005886; GO:0000164; GO:0072357","GO:0046872; GO:0050115; GO:0017018; GO:0016791; GO:0019901","GO:0007049; GO:0051301; GO:0032922; GO:0043153; GO:0005977; GO:0006470; GO:0030155; GO:0042752"]
[2079,1041,"PP502","PP1/Cb (PPP1CB)","T316","Serine/threonine-protein phosphatase PP1-beta catalytic subunit",{"v":8536.574136677962,"d":"8537"},{"v":8514.949278325827,"d":"8515"},{"v":1673.210482230304,"d":"1673"},{"v":19.6004914318174,"d":"20"},{"v":1325.7032681879218,"d":"1326"},{"v":14279.63944070525,"d":"14280"},"Kinexus","RpAb","CGRPV(pT)PPR","Corresponds to amino acid residues G312 to R319; Near C-terminus.","T316 phosphorylation inhibits phosphatase activity. This is one of the major sites of in vivo phosphorylation of PP1/Cb.",null,"P62140","P62140",1689,null,null,"NP_996759.1","Block7",3,1,"7, 15, 23, 31",null,null,"PSTP","Protein phosphatase - Serine/threonine phosphatase",{"$nulls":6},"X",null,null,"EC 3.1.3.16; Protein phosphatase, Ser/Thr (non-receptor)","GO:0005829; GO:0070062; GO:0005925; GO:0005730; GO:0005654; GO:0005634; GO:0005886; GO:0000164; GO:0072357","GO:0046872; GO:0050115; GO:0017018; GO:0016791; GO:0019901","GO:0007049; GO:0051301; GO:0032922; GO:0043153; GO:0005977; GO:0006470; GO:0030155; GO:0042752"]
[2081,1042,"NP013-NP014-2","PP2A/Ca (PPP2CA)","Pan-specific","Protein-serine phosphatase 2A - catalytic subunit - alpha and beta isoform",{"v":304.5679730512736,"d":"305"},{"v":267.55821141839374,"d":"268"},{"v":193.74291511583843,"d":"194"},{"v":63.612373019674685,"d":"64"},{"v":53.37163632049529,"d":"53"},{"v":1781.803411066722,"d":"1782"},"External","MmAb","Epitope undefined.",{"$nulls":3},"P67775","P67775",1685,null,"P67775","NP_002706.1","Block7",3,2,"7, 15, 23, 31",null,null,"PSTP","Protein phosphatase - Serine/threonine phosphatase",{"$nulls":6},"X",null,null,"Protein phosphatase, Ser/Thr (non-receptor); EC 3.1.3.16","GO:0000775; GO:0005829; GO:0070062; GO:0016020; GO:0015630; GO:0005739; GO:0005634; GO:0005886; GO:0000159; GO:0000922; GO:0045202","GO:0050811; GO:0046872; GO:0004721; GO:0008022; GO:0046982; GO:0004722","GO:0006915; GO:0006672; GO:0000188; GO:0051321; GO:0007498; GO:0030308; GO:0010719; GO:0042532; GO:0000184; GO:0070262; GO:0035970; GO:1904528; GO:0071902; GO:0006470; GO:0030155; GO:0045595; GO:0006275; GO:0040008; GO:1904526; GO:0001932; GO:0006355; GO:0030111; GO:0010288; GO:0010033; GO:0008380; GO:0019932"]
[2083,1043,"PP504","PP2A/Ca (PPP2CA)","Y307","Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform",{"v":7706.093419976487,"d":"7706"},{"v":7537.721012413427,"d":"7538"},{"v":1901.943341840589,"d":"1902"},{"v":24.681031466737554,"d":"25"},{"v":3532.897137397317,"d":"3533"},{"v":15406.701155492077,"d":"15407"},"Kinexus","RpAb","C(bA)TPD(pY)Fl-cooh","Corresponds to amino acid residues T304 to L309; At the C-terminus.","The effect of Y307 phosphorylation is unclear. It has been separately report to both stimulate and inhibits phosphatase activity. It regulates cell growth, apoptosis, cytoskeletal reorganization, intracellular location, methylation and molecular association, including inducing interaction with LCMT1. This phosphorylation site has not been reported by mass spectrometry, although other phosphosites in this protein have been reported. This particular human phosphosite is highly conserved in vertebrates and also found in yeast and mould.","EGFR; InsR; Lck; Src","P67775","P67775",1685,null,"P67775","NP_002706.1","Block7",3,3,"7, 15, 23, 31",null,null,"PSTP","Protein phosphatase - Serine/threonine phosphatase",{"$nulls":6},"X",null,null,"Protein phosphatase, Ser/Thr (non-receptor); EC 3.1.3.16","GO:0000775; GO:0005829; GO:0070062; GO:0016020; GO:0015630; GO:0005739; GO:0005634; GO:0005886; GO:0000159; GO:0000922; GO:0045202","GO:0050811; GO:0046872; GO:0004721; GO:0008022; GO:0046982; GO:0004722","GO:0006915; GO:0006672; GO:0000188; GO:0051321; GO:0007498; GO:0030308; GO:0010719; GO:0042532; GO:0000184; GO:0070262; GO:0035970; GO:1904528; GO:0071902; GO:0006470; GO:0030155; GO:0045595; GO:0006275; GO:0040008; GO:1904526; GO:0001932; GO:0006355; GO:0030111; GO:0010288; GO:0010033; GO:0008380; GO:0019932"]
[2085,1044,"PP007","PP2A/Ca (PPP2CA)","Y307","Protein-serine phosphatase 2A - catalytic subunit - alpha and beta isoform",{"v":18.915650461064224,"d":"19"},{"v":14.561854942514984,"d":"15"},{"v":14.87298977959754,"d":"15"},{"v":78.62795842105427,"d":"79"},{"v":2.726124509361644,"d":"3"},{"v":132.75039183189364,"d":"133"},"External","MmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the Y307 phosphosite.","The effect of Y307 phosphorylation is unclear. It has been separately report to both stimulate and inhibits phosphatase activity. It regulates cell growth, apoptosis, cytoskeletal reorganization, intracellular location, methylation and molecular association, including inducing interaction with LCMT1. This phosphorylation site has not been reported by mass spectrometry, although other phosphosites in this protein have been reported. This particular human phosphosite is highly conserved in vertebrates and also found in yeast and mould.","EGFR; InsR; Lck; Src","P67775","P67775",1685,null,"P67775","NP_002706.1","Block7",3,4,"7, 15, 23, 31",null,null,"PSTP","Protein phosphatase - Serine/threonine phosphatase",{"$nulls":6},"X",null,null,"Protein phosphatase, Ser/Thr (non-receptor); EC 3.1.3.16","GO:0000775; GO:0005829; GO:0070062; GO:0016020; GO:0015630; GO:0005739; GO:0005634; GO:0005886; GO:0000159; GO:0000922; GO:0045202","GO:0050811; GO:0046872; GO:0004721; GO:0008022; GO:0046982; GO:0004722","GO:0006915; GO:0006672; GO:0000188; GO:0051321; GO:0007498; GO:0030308; GO:0010719; GO:0042532; GO:0000184; GO:0070262; GO:0035970; GO:1904528; GO:0071902; GO:0006470; GO:0030155; GO:0045595; GO:0006275; GO:0040008; GO:1904526; GO:0001932; GO:0006355; GO:0030111; GO:0010288; GO:0010033; GO:0008380; GO:0019932"]
[2087,1045,"PP508","PP2Ca (PPM1A; PPPM1A)/'PP2Cb (PPM1B; PPPM1B)","Y362","Protein phosphatase 1A",{"v":7243.021133770064,"d":"7243"},{"v":6929.708762798069,"d":"6930"},{"v":2001.413010597815,"d":"2001"},{"v":27.63229560751067,"d":"28"},{"v":3775.1091473441365,"d":"3775"},{"v":18125.227214673247,"d":"18125"},"Kinexus","RpAb","EAV(pY)NRL(bA)C","Corresponds to amino acid residues E359 to L365.","The effect of Y362 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of PP2Ca.",null,"P35813","P35813",5702,null,null,"NP_066283.1","Block7",3,5,"7, 15, 23, 31",null,null,"PSTP","Protein phosphatase - Serine/threonine phosphatase",{"$nulls":6},"X",null,null,"Protein-serine phosphatase","GO:0005829; GO:0016020; GO:0005654; GO:0005634; GO:0005886","GO:0033192; GO:0000287; GO:0030145; GO:0004722; GO:0070412","GO:0007050; GO:0071560; GO:0016311; GO:0030514; GO:0043124; GO:1901223; GO:0010991; GO:0000122; GO:0030512; GO:0006499; GO:0035970; GO:0090263; GO:0043123; GO:0046827; GO:0045893; GO:0006470"]
[2089,1046,"PN644","PPARg-1","S112","Peroxisome proliferator-activated receptor gamma",{"v":8667.753389466809,"d":"8668"},{"v":8521.863256738547,"d":"8522"},{"v":1565.469227383711,"d":"1565"},{"v":18.060841801130316,"d":"18"},{"v":3767.0288553646074,"d":"3767"},{"v":14263.286945420345,"d":"14263"},"Kinexus","RpAb","C(bA)EPA(pS)PPYY","Corresponds to amino acid residues C108 to Y116.","S112 phosphorylation inhibits transcriptional activity by inhibiting both ligand-independent and ligand-dependent transactivation functions of peroxisome proliferator-activated receptor gamma and targets PPARG to the ubiquitin-proteasome system to regulate cell growth and differentiation. This is one of the major sites of in vivo phosphorylation of PPARg-1.","CDK9; ERK1 (MAPK3); ERK2 (MAPK1); JNK1 (MAPK8)","P37231","P37231",1032,null,"P37231","NP_056953.2","Block7",3,6,"7, 15, 23, 31",{"$nulls":3},"Transcription protein (receptor)",{"$nulls":4},"X",{"$nulls":4},"Transcription protein (receptor)","GO:0005829; GO:0043231; GO:0005654; GO:0005634; GO:0048471; GO:0032991; GO:0090575","GO:0033613; GO:0051393; GO:0050544; GO:0003682; GO:0050692; GO:0003677; GO:0003700; GO:0003690; GO:0008144; GO:0070888; GO:0019899; GO:0030331; GO:0042802; GO:0050693; GO:0004879; GO:0030374; GO:0042277; GO:0004955; GO:0008022; GO:0046982; GO:0019903; GO:0043621; GO:0046965; GO:0000981; GO:0003707; GO:0008134; GO:0044212; GO:0008270","GO:0006919; GO:0031100; GO:0045165; GO:0048469; GO:0071455; GO:0032869; GO:0071404; GO:0071380; GO:0071300; GO:0071306; GO:0030855; GO:0019395; GO:0042593; GO:0007507; GO:0045087; GO:0055088; GO:0006629; GO:0042953; GO:0015909; GO:0045713; GO:0010742; GO:0030224; GO:0002674; GO:0016525; GO:0043537; GO:0030308; GO:0010887; GO:0032966; GO:0060965; GO:0060336; GO:0010745; GO:2000230; GO:0010871; GO:0010891; GO:0048662; GO:0051974; GO:0045892; GO:0000122; GO:1905563; GO:1904706; GO:0035357; GO:0001890; GO:0043388; GO:0051091; GO:0045600; GO:0046321; GO:0048714; GO:0060100; GO:0045893; GO:0045944; GO:1905461; GO:0061614; GO:0008217; GO:0060694; GO:0042752; GO:0006357; GO:0060850; GO:0031000; GO:0009409; GO:0043627; GO:0035902; GO:0033993; GO:0009612; GO:1901558; GO:0007584; GO:0032526; GO:0042594; GO:0033189; GO:0048511; GO:0007165; GO:0006367; GO:0050872"]
[2091,1047,"PN532","PPP1R11 (HCG V)","Y64","Protein phosphatase 1 regulatory subunit 11",{"v":4816.340364596736,"d":"4816"},{"v":4408.244149372727,"d":"4408"},{"v":1604.9921455463582,"d":"1605"},{"v":33.32389374605051,"d":"33"},{"v":1998.800110240819,"d":"1999"},{"v":12639.839903337366,"d":"12640"},"Kinexus","RpAb","CCI(pY)EKP(bA)C","Corresponds to amino acid residues C61 to P67; In the PPI_Ypi1 domain. ","The effect of Y64 phosphorylation is unclear. This is the major in vivo phosphorylation site in PPP1R11.",null,"O60927","O60927",6488,null,null,"NP_068778.1","Block7",3,7,"7, 15, 23, 31",{"$nulls":3},"Protein-serine/threonine phosphatase regulatory subunit",{"$nulls":6},"X",null,null,"Protein phosphatase, regulatory subunit","GO:0005737; GO:0005634; GO:0000164","GO:0008157; GO:0004865; GO:0061630","GO:0050830; GO:0050710; GO:0032515; GO:0006511"]
[2093,1048,"PP503","PPP1R12B","T646","Protein phosphatase 1 regulatory subunit 12B",{"v":5269.37682068922,"d":"5269"},{"v":5061.124768874171,"d":"5061"},{"v":1342.305903425232,"d":"1342"},{"v":25.473712530007713,"d":"25"},{"v":2820.799648112734,"d":"2821"},{"v":11301.859015407445,"d":"11302"},"Kinexus","RpAb","RRS(pT)QGV(bA)C","Corresponds to amino acid residues R643 to V649.","T646 phosphorylation inhibits. This is the minor site of in vivo phosphorylation of PPPP1R12B (≥9 reports from high throughput mass spectrometry studies).  This human phosphosite is conserved in mammals and found in the rat.","ROCK1","O60237","O60237",18156,null,null,"NP_002472.2","Block7",3,8,"7, 15, 23, 31",{"$nulls":3},"Protein-serine/threonine phosphatase regulatory subunit",{"$nulls":6},"X",null,null,"Regulatory protein - Protein phosphatase targeting protein","GO:0031672; GO:0005829; GO:0005654; GO:0030018","GO:0008047; GO:0019208; GO:0019901","GO:0006937; GO:0007165"]
[2095,1049,"PP505","PPP2CB","T304","Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform",{"v":20834.10563655612,"d":"20834"},{"v":20536.718075255867,"d":"20537"},{"v":5984.191298413038,"d":"5984"},{"v":28.723053452858583,"d":"29"},{"v":7959.356840838847,"d":"7959"},{"v":44031.94964463363,"d":"44032"},"Kinexus","RpAb","TRR(pT)PDY(bA)C","Corresponds to amino acid residues T301 to Y307; In C-terminus.","T304 phosphorylation inhibits phosphatase activity. This is one of the major sites of in vivo phosphorylation of PPP2CB.  This particular human phosphosite is highly conserved in vertebrates and also found in yeast and mould.",null,"P62714","P62714",1372,null,null,"NP_001009552.1","Block7",3,9,"7, 15, 23, 31",null,null,"PSTP","Protein phosphatase - Serine/threonine phosphatase",{"$nulls":6},"X",null,null,"EC 3.1.3.16; Protein phosphatase, Ser/Thr (non-receptor)","GO:0000775; GO:0005829; GO:0005634; GO:0000159; GO:0000922","GO:0046872; GO:0008022; GO:0004722","GO:0008637; GO:0046580; GO:0070262; GO:0035970; GO:1904528; GO:0043161; GO:0006470; GO:0010468; GO:0034976; GO:0042542; GO:0010288"]
[2097,152,"NP049-3","PPP3CC (Calcinerin)","Pan-specific","Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform",{"v":473.6600504756796,"d":"474"},{"v":372.4427887152548,"d":"372"},{"v":393.92523179463166,"d":"394"},{"v":83.16623523538176,"d":"83"},{"v":22.4093108241936,"d":"22"},{"v":2244.1742106136826,"d":"2244"},"External","RpAb","Epitope undefined.",{"$nulls":3},"P48454","P48454",1369,null,null,"NP_001230903.1","Block1",12,9,"1, 9, 17, 25",null,null,"PSTP","Protein phosphatase - Serine/threonine phosphatase",{"$nulls":6},"X",null,null,"Cytosol protein","GO:0005737; GO:0005829; GO:0098978; GO:0099523","GO:0005516; GO:0033192; GO:0046872","GO:0007420; GO:0033173; GO:1900244; GO:0006470"]
[2099,1050,"PP506","PPP3CC (Calcinerin)","S463","Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform",{"v":14274.845024160348,"d":"14275"},{"v":13939.548818075158,"d":"13940"},{"v":4179.135497354897,"d":"4179"},{"v":29.27622324642866,"d":"29"},{"v":5151.874819070577,"d":"5152"},{"v":29082.77839655867,"d":"29083"},"Kinexus","RpAb","KIR(pS)FEE(bA)C","Corresponds to amino acid residues K460 to E466.","The effect of S463 phosphorylation is unclear. This is one of the minor sites of in vivo phosphorylation of PPP3CC (≥7 reports from high throughput mass spectrometry studies).  This particular human phosphosite is highly conserved in vertebrates and also found in the fruit fly.",null,"P48454","P48454",1369,null,null,"NP_005596.2","Block7",3,10,"7, 15, 23, 31",null,null,"PSTP","Protein phosphatase - Serine/threonine phosphatase",{"$nulls":6},"X",null,null,"Cytosol protein","GO:0005737; GO:0005829; GO:0098978; GO:0099523","GO:0005516; GO:0033192; GO:0046872","GO:0007420; GO:0033173; GO:1900244; GO:0006470"]
[2101,1051,"PP507","PPP5C","Y119","Serine/threonine-protein phosphatase 5",{"v":14350.063410238503,"d":"14350"},{"v":14049.259286978664,"d":"14049"},{"v":2583.206721936404,"d":"2583"},{"v":18.001361025996125,"d":"18"},{"v":8725.162479857712,"d":"8725"},{"v":22774.38518035385,"d":"22774"},"Kinexus","RpAb","LRD(pY)ETV(bA)C","Corresponds to amino acid residues L116 to V122.","The effect of Y119 phosphorylation is unclear. This is one of the minor sites of in vivo phosphorylation of PPP5C (≥12 reports from high throughput mass spectrometry studies).  This particular human phosphosite is highly conserved in vertebrates and also found in the sea urchin.",null,"P53041","P53041",1377,null,null,"NP_006238.1","Block7",3,11,"7, 15, 23, 31",null,null,"PSTP","Protein phosphatase - Serine/threonine phosphatase",{"$nulls":6},"X",null,null,"Protein phosphatase, Ser/Thr (non-receptor); EC 3.1.3.16","GO:0101031; GO:0005829; GO:0043231; GO:0005654; GO:0005634; GO:0043204; GO:0005886; GO:0032991; GO:1990635","GO:0043531; GO:0005524; GO:0001965; GO:0051879; GO:0042802; GO:0008289; GO:0046872; GO:0008017; GO:0016791; GO:0004721; GO:0004722; GO:0003723","GO:0071276; GO:0070301; GO:0006281; GO:0016576; GO:0000165; GO:0000278; GO:1901215; GO:0001933; GO:0070262; GO:0035970; GO:2000324; GO:0043123; GO:0006470; GO:0051291; GO:1904550; GO:0010288; GO:0043278; GO:0006351"]
[2103,1053,"PN260","PRC1","T481","Protein regulator of cytokinesis 1",{"v":311.385682854134,"d":"311"},{"v":260.3793171522899,"d":"260"},{"v":298.43277357586635,"d":"298"},{"v":95.84023608293663,"d":"96"},{"v":39.75223119667441,"d":"40"},{"v":3916.5006911216437,"d":"3917"},"External","MmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the T481 phosphosite.","The effect of T481 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of PRC1.","CDK1 (CDC2)","O43663","O43663",13469,null,null,"NP_001254509.1","Block7",3,13,"7, 15, 23, 31",{"$nulls":13},"Cytoskeletal protein; Cell cycle regulation; Microtubule binding protein","GO:0070938; GO:0005829; GO:0030496; GO:0005634; GO:0005819; GO:0005876; GO:0000922","GO:0042802; GO:0019894; GO:0008017; GO:0019901","GO:0000910; GO:0001578; GO:0000022; GO:0008284; GO:0032465"]
[2105,1015,"NK148","PRK1 (PKN1)","Pan-specific","Protein kinase C-related protein-serine kinase 1; Protein kinase N1",{"v":317.95394195741073,"d":"318"},{"v":226.45005108413085,"d":"226"},{"v":477.2833302094711,"d":"477"},{"v":150.11083909549458,"d":"150"},{"v":61.80836092181619,"d":"62"},{"v":6904.414720441344,"d":"6904"},"External","GpAb","Epitope undefined.",{"$nulls":3},"Q16512","Q16512",650,"Q16512",null,"NP_002732","Block7",1,1,"7, 15, 23, 31","PKN1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKN",{"$nulls":6},"Protein-serine kinase, AGC group, PKN family","GO:0032154; GO:0005737; GO:0005829; GO:0005768; GO:0030496; GO:0005654; GO:0005634; GO:0032991","GO:0050681; GO:0005524; GO:0003682; GO:0017049; GO:0042393; GO:0042826; GO:0035402; GO:0030374; GO:0004672; GO:0004697; GO:0005080; GO:0004674; GO:0048365","GO:0007257; GO:0001783; GO:0001782; GO:0010631; GO:0035407; GO:0006972; GO:0030889; GO:0006469; GO:0018105; GO:0006468; GO:2000145; GO:0002634; GO:0002637; GO:0006357; GO:0003014; GO:0007165; GO:0048536; GO:0006351"]
[2107,1054,"PK781","PRK1 (PKN1)","T774","Protein kinase C-related protein-serine kinase 1; Protein kinase N1",{"v":9690.882494159709,"d":"9691"},{"v":9599.032606086643,"d":"9599"},{"v":1940.9581378327625,"d":"1941"},{"v":20.028703670718297,"d":"20"},{"v":4674.107451695349,"d":"4674"},{"v":18233.511808161704,"d":"18234"},"Kinexus","RpAb","RTS(pT)FCG(bA)C","Corresponds to amino acid residues R771 to G777; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T774 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of PPRK1.","PDPK1 (PDK1); PKN1 (PRKCL1)","Q16512","Q16512",650,"Q16512",null,"NP_002732","Block7",4,1,"7, 15, 23, 31","PKN1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKN",{"$nulls":6},"Protein-serine kinase, AGC group, PKN family","GO:0032154; GO:0005737; GO:0005829; GO:0005768; GO:0030496; GO:0005654; GO:0005634; GO:0032991","GO:0050681; GO:0005524; GO:0003682; GO:0017049; GO:0042393; GO:0042826; GO:0035402; GO:0030374; GO:0004672; GO:0004697; GO:0005080; GO:0004674; GO:0048365","GO:0007257; GO:0001783; GO:0001782; GO:0010631; GO:0035407; GO:0006972; GO:0030889; GO:0006469; GO:0018105; GO:0006468; GO:2000145; GO:0002634; GO:0002637; GO:0006357; GO:0003014; GO:0007165; GO:0048536; GO:0006351"]
[2109,1055,"NK127-1","PRKACA (PKA)","Pan-specific","cAMP-dependent protein kinase catalytic subunit alpha",{"v":560.9814820659254,"d":"561"},{"v":481.86441778756216,"d":"482"},{"v":424.78638676227376,"d":"425"},{"v":75.72199802352009,"d":"76"},{"v":19.28453839278909,"d":"19"},{"v":2349.086340068953,"d":"2349"},"External","MmAb","Epitope undefined.",{"$nulls":3},"P17612","P17612",637,"P17612",null,"NP_002721","Block7",4,2,"7, 15, 23, 31","PKACa","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKA",{"$nulls":6},"EC 2.7.11.11; Protein kinase, Ser/Thr (non-receptor); AGC group; PKA family","GO:0001669; GO:0034704; GO:0005952; GO:0005813; GO:0097546; GO:0005737; GO:0005829; GO:0070062; GO:0045171; GO:0016020; GO:0005739; GO:0031514; GO:0016607; GO:0005654; GO:0031588; GO:0005634; GO:0048471; GO:0044853; GO:0097225","GO:0005524; GO:0004691; GO:0004672; GO:0034237; GO:0019901; GO:0004712; GO:0004674; GO:0031625","GO:0034199; GO:0007596; GO:0035584; GO:0086064; GO:0071872; GO:0071377; GO:0071333; GO:0034605; GO:0097711; GO:0019221; GO:0000086; GO:0034380; GO:0006397; GO:0018105; GO:0071158; GO:0010737; GO:0006468; GO:2000810; GO:1903779; GO:0055117; GO:0010881; GO:0051480; GO:0010389; GO:0002027; GO:0016241; GO:0045667; GO:0061136; GO:0043393; GO:0060314; GO:0003091; GO:0048240; GO:0002223"]
[2111,1056,"NK127-3","PRKACA (PKA)","Pan-specific","cAMP-dependent protein kinase catalytic subunit alpha",{"v":799.3804817886261,"d":"799"},{"v":679.3403077059158,"d":"679"},{"v":461.74634685737425,"d":"462"},{"v":57.763024914520024,"d":"58"},{"v":211.67172350955076,"d":"212"},{"v":3025.7931582419633,"d":"3026"},"External","MmAb","Epitope undefined.",{"$nulls":3},"P17612","P17612",637,"P17612",null,"NP_002721","Block7",4,3,"7, 15, 23, 31","PKACa","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKA",{"$nulls":6},"EC 2.7.11.11; Protein kinase, Ser/Thr (non-receptor); AGC group; PKA family","GO:0001669; GO:0034704; GO:0005952; GO:0005813; GO:0097546; GO:0005737; GO:0005829; GO:0070062; GO:0045171; GO:0016020; GO:0005739; GO:0031514; GO:0016607; GO:0005654; GO:0031588; GO:0005634; GO:0048471; GO:0044853; GO:0097225","GO:0005524; GO:0004691; GO:0004672; GO:0034237; GO:0019901; GO:0004712; GO:0004674; GO:0031625","GO:0034199; GO:0007596; GO:0035584; GO:0086064; GO:0071872; GO:0071377; GO:0071333; GO:0034605; GO:0097711; GO:0019221; GO:0000086; GO:0034380; GO:0006397; GO:0018105; GO:0071158; GO:0010737; GO:0006468; GO:2000810; GO:1903779; GO:0055117; GO:0010881; GO:0051480; GO:0010389; GO:0002027; GO:0016241; GO:0045667; GO:0061136; GO:0043393; GO:0060314; GO:0003091; GO:0048240; GO:0002223"]
[2113,1057,"PK782","PRKACA/B (PKA, PKACA/B)","T196+T198","cAMP-dependent protein kinase catalytic subunit alpha/beta",{"v":10144.022689561943,"d":"10144"},{"v":10152.939045383533,"d":"10153"},{"v":2075.0104060628796,"d":"2075"},{"v":20.4554984700304,"d":"20"},{"v":1830.4888577313702,"d":"1830"},{"v":16231.624817073822,"d":"16232"},"Kinexus","RpAb","KGR(pT)W(pT)LCG(bA)C","Corresponds to amino acid residues K193 to G201; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T196 and T198 phosphorylation stimulate phosphotransferase activity and regulates stability. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major sites of in vivo phosphorylation of PRKACA.","T198: PDPK1 (PDK1); PKACa (PRKACA)","P17612","P17612",637,"P17612",null,"NP_002721","Block7",4,4,"7, 15, 23, 31","PKACa","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKA",{"$nulls":6},"EC 2.7.11.11; Protein kinase, Ser/Thr (non-receptor); AGC group; PKA family","GO:0001669; GO:0034704; GO:0005952; GO:0005813; GO:0097546; GO:0005737; GO:0005829; GO:0070062; GO:0045171; GO:0016020; GO:0005739; GO:0031514; GO:0016607; GO:0005654; GO:0031588; GO:0005634; GO:0048471; GO:0044853; GO:0097225","GO:0005524; GO:0004691; GO:0004672; GO:0034237; GO:0019901; GO:0004712; GO:0004674; GO:0031625","GO:0034199; GO:0007596; GO:0035584; GO:0086064; GO:0071872; GO:0071377; GO:0071333; GO:0034605; GO:0097711; GO:0019221; GO:0000086; GO:0034380; GO:0006397; GO:0018105; GO:0071158; GO:0010737; GO:0006468; GO:2000810; GO:1903779; GO:0055117; GO:0010881; GO:0051480; GO:0010389; GO:0002027; GO:0016241; GO:0045667; GO:0061136; GO:0043393; GO:0060314; GO:0003091; GO:0048240; GO:0002223"]
[2115,1059,"PK783","PRKACB (PKA)","Y69","cAMP-dependent protein-serine kinase catalytic subunit beta",{"v":2203.5833200534444,"d":"2204"},{"v":1743.6146449713433,"d":"1744"},{"v":1576.4123423763099,"d":"1576"},{"v":71.53858572218982,"d":"72"},{"v":408.40614019673626,"d":"408"},{"v":10149.708433221436,"d":"10150"},"Kinexus","RpAb","TEQ(pY)YAM(bA)C","Corresponds to amino acid residues T66 to M72; In the protein kinase catalytic domain in subdomain II. ","The effect of Y69 phosphorylation is unclear. This is the second major in vivo phosphorylation site in PRKACB  (≥169 reports from high throughput mass spectrometry studies).",null,"P22694","P22694",743,"P22694","P22694","NP_002722","Block7",4,6,"7, 15, 23, 31","PKACb","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKA",{"$nulls":6},"Protein-serine kinase, AGC group, PKA family","GO:0005952; GO:0005813; GO:0097546; GO:0005829; GO:0070062; GO:0045171; GO:0005654; GO:0048471; GO:0005886","GO:0005524; GO:0004691; GO:0016301; GO:0000287; GO:0034237; GO:0004674; GO:0031625","GO:0034199; GO:0007188; GO:0007596; GO:0071377; GO:0034380; GO:0051447; GO:1901621; GO:0001843; GO:0006468; GO:0070613; GO:0003091; GO:0097338; GO:0007165; GO:0002223"]
[2117,1058,"PK068","PRKACB (PKA)","S339","cAMP-dependent protein-serine kinase catalytic subunit beta",{"v":525.897082206285,"d":"526"},{"v":466.0664105269534,"d":"466"},{"v":370.93722191428816,"d":"371"},{"v":70.53418519800549,"d":"71"},{"v":19.70668361192974,"d":"20"},{"v":1975.0316120018474,"d":"1975"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S339 phosphosite.","The effect of S339 phosphorylation is unclear. This is one of the minor sites of in vivo phosphorylation of PRKACB (≥13 reports from high throughput mass spectrometry studies).",null,"P22694","P22694",743,"P22694","P22694","NP_002722","Block7",4,5,"7, 15, 23, 31","PKACb","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKA",{"$nulls":6},"Protein-serine kinase, AGC group, PKA family","GO:0005952; GO:0005813; GO:0097546; GO:0005829; GO:0070062; GO:0045171; GO:0005654; GO:0048471; GO:0005886","GO:0005524; GO:0004691; GO:0016301; GO:0000287; GO:0034237; GO:0004674; GO:0031625","GO:0034199; GO:0007188; GO:0007596; GO:0071377; GO:0034380; GO:0051447; GO:1901621; GO:0001843; GO:0006468; GO:0070613; GO:0003091; GO:0097338; GO:0007165; GO:0002223"]
[2119,962,"PN259","PRKAR2A (PKA2RA)","S99","cAMP-dependent protein kinase type II-alpha regulatory subunit",{"v":294.26513877935105,"d":"294"},{"v":254.8451506934096,"d":"255"},{"v":194.33484416802534,"d":"194"},{"v":66.04072945036943,"d":"66"},{"v":43.901244697572494,"d":"44"},{"v":1314.2365056360159,"d":"1314"},"External","MmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the S96 phosphosite of mouse PRKAR2A.","The effect of S99 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of PRKAR2A (≥251 reports from high throughput mass spectrometry studies).","PKACa (PRKACA)","P13861","P13861",8869,null,null,"NP_004148.1","Block6",9,13,"6, 14, 22, 30",{"$nulls":13},"Protein-serine kinase regulatory subunit","GO:0005952; GO:0005813; GO:0097546; GO:0005737; GO:0005829; GO:0070062; GO:0005925; GO:0016020; GO:0031588; GO:0005886; GO:0044853; GO:0032991","GO:0030552; GO:0004862; GO:0008603; GO:0019904; GO:0034236; GO:0031625","GO:0034199; GO:0007596; GO:0071377; GO:0035556; GO:2000480; GO:0003091"]
[2121,1060,"NK292-1","PRKX","Pan-specific","Serine/threonine-protein kinase PRKX",{"v":7471.222821574906,"d":"7471"},{"v":7089.252594329759,"d":"7089"},{"v":2311.7925061262563,"d":"2312"},{"v":30.942625609430547,"d":"31"},{"v":2435.7901315270237,"d":"2436"},{"v":20639.472623729856,"d":"20639"},"Kinexus","RpAb","CDWDTAAPVPQKDLEIFKNF","Corresponds to amino acid residues D340 to F358; C-terminus.",null,null,"P51817","P51817",749,"P51817",null,"NP_005035.1","Block7",4,7,"7, 15, 23, 31","PRKX","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKA",{"$nulls":6},"Protein kinase, Ser/Thr, AGC group, PKA family","GO:0005737; GO:0005634","GO:0005524; GO:0004691","GO:0001525; GO:0007155; GO:0031589; GO:0043542; GO:0001935; GO:0060562; GO:0060993; GO:0030099; GO:0018105; GO:0046777; GO:0030155; GO:0030334; GO:2000696"]
[2123,1061,"PK785","PRKX","T201+T203","Serine/threonine-protein kinase PRKX",{"v":14768.94199110363,"d":"14769"},{"v":14537.32628905398,"d":"14537"},{"v":2482.3588814657137,"d":"2482"},{"v":16.807966900818034,"d":"17"},{"v":6983.033882661517,"d":"6983"},{"v":21585.50009169703,"d":"21586"},"Kinexus","RpAb","VDR(pT)W(pT)LCG(bA)C","Corresponds to amino acid residues V198 to G206; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T201 and T203 phosphorylation are predicted to stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major sites of in vivo phosphorylation of PRKX.",null,"P51817","P51817",749,"P51817",null,"NP_005035.1","Block7",4,8,"7, 15, 23, 31","PRKX","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKA",{"$nulls":6},"Protein kinase, Ser/Thr, AGC group, PKA family","GO:0005737; GO:0005634","GO:0005524; GO:0004691","GO:0001525; GO:0007155; GO:0031589; GO:0043542; GO:0001935; GO:0060562; GO:0060993; GO:0030099; GO:0018105; GO:0046777; GO:0030155; GO:0030334; GO:2000696"]
[2125,1062,"NK293-1","PRKY","Pan-specific","Serine/threonine-protein kinase PRKY",{"v":22168.670392375865,"d":"22169"},{"v":22305.199177968567,"d":"22305"},{"v":7753.8224057359685,"d":"7754"},{"v":34.97648829856131,"d":"35"},{"v":4521.337570448319,"d":"4521"},{"v":47073.402768366635,"d":"47073"},"Kinexus","RpAb","CAESNSREVTEDAADWAPAL","Corresponds to amino acid residues A12 to L30; Post-N-terminus.",null,null,"O43930","O43930",2471,"O43930",null,"AAH74852.1","Block7",4,9,"7, 15, 23, 31","PRKY","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","PKA",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); AGC group; PKA family",null,"GO:0005524; GO:0004674","GO:0006468"]
[2127,1063,"PN549","PRMT5","T634","Protein arginine N-methyltransferase 5",{"v":13678.406527838746,"d":"13678"},{"v":13199.213026081055,"d":"13199"},{"v":3094.2175166501224,"d":"3094"},{"v":22.62118405643719,"d":"23"},{"v":1411.96069426858,"d":"1412"},{"v":24339.907080501285,"d":"24340"},"Kinexus","RpAb","GRSY(pT)IGL(bA)C     ","Corresponds to amino acid residues G630 to L637; At the C-terminus of the protein.","The effect of T634 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of PRMT5.",null,"O14744","O14744",8220,null,"O14744","NP_006100.2","Block7",4,10,"7, 15, 23, 31",{"$nulls":13},"EC 2.1.1.-; EC 2.1.1.125; Cell cycle regulation; Methyltransferase; RNA processing","GO:0005737; GO:0005829; GO:0005794; GO:0035097; GO:0034709; GO:0005654; GO:0005634","GO:0070888; GO:0008469; GO:0044020; GO:0042802; GO:0008327; GO:0008168; GO:0016274; GO:0035243; GO:0046982; GO:0043021; GO:0003714","GO:0008283; GO:0032922; GO:0006353; GO:0042118; GO:0090161; GO:0043985; GO:0097421; GO:0045596; GO:0018216; GO:0035246; GO:1904992; GO:0048714; GO:0044030; GO:0070372; GO:0007088; GO:1901796; GO:0006355; GO:0000387"]
[2129,1064,"PK786","PRP4K (PRP4, PRPF4B)","Y849","Protein-serine kinase PRP4 homologue",{"v":3863.7449260843246,"d":"3864"},{"v":3520.352116190149,"d":"3520"},{"v":1492.5102085045476,"d":"1493"},{"v":38.62859057875536,"d":"39"},{"v":795.3006361737403,"d":"795"},{"v":10192.54212018746,"d":"10193"},"Kinexus","RpAb","ITP(pY)LVS(bA)C","Corresponds to amino acid residues I846 to S852; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y849 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of PRP4K.",null,"Q13523","Q13523",817,"Q13523","Q13523","NP_003904.3","Block7",4,11,"7, 15, 23, 31","PRPF4B","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","DYRK","PRP4",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; CMGC domain target; CMGC</A> group; DYRK family; PRP4 subfamily","GO:0071013; GO:0005694; GO:0016607","GO:0005524; GO:0004672; GO:0004674; GO:0003723","GO:0000398; GO:0006468; GO:0051726; GO:0008380"]
[2131,1065,"NP023","PTEN","Pan-specific","Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and protein phosphatase and tensin homolog deleted on chromosome 10",{"v":3704.1795165506164,"d":"3704"},{"v":3539.0464227357434,"d":"3539"},{"v":1076.1613818505775,"d":"1076"},{"v":29.052624934676867,"d":"29"},{"v":1899.8151435579753,"d":"1900"},{"v":7214.268682979135,"d":"7214"},"External","MmAb","Epitope undefined.",{"$nulls":3},"P60484","P60484",1035,null,"P60484","NP_000305","Block7",4,12,"7, 15, 23, 31",null,null,"PIPP","Lipid phosphatase",{"$nulls":8},"X","Nuclear receptor co-regulator; Phosphatase, lipid; Tumor suppressor; EC 3.1.3.16; Carbohydrate Metabolism - inositol phosphate; EC 3.1.3.48; EC 3.1.3.67","GO:0016324; GO:0042995; GO:0005737; GO:0009898; GO:0005829; GO:0043197; GO:0005576; GO:0005739; GO:0035749; GO:0043005; GO:0005654; GO:0005634; GO:0005886; GO:0016605; GO:0099524; GO:0045211; GO:0043220","GO:0010997; GO:0019899; GO:0042802; GO:0051717; GO:0035255; GO:0008289; GO:0030165; GO:0016314; GO:0051800; GO:0004438; GO:0004721; GO:0005161; GO:0004722; GO:0008138; GO:1990782; GO:0004725; GO:1990381","GO:0030534; GO:0007568; GO:0001525; GO:0006915; GO:0048854; GO:0060070; GO:0048738; GO:0016477; GO:0008283; GO:0071257; GO:0071361; GO:0071456; GO:1990314; GO:0032869; GO:0044320; GO:1990090; GO:0007417; GO:0032286; GO:0021955; GO:0060997; GO:0021542; GO:0043542; GO:0048853; GO:0007507; GO:0046855; GO:0043647; GO:0007611; GO:0045475; GO:0007626; GO:0060292; GO:0060291; GO:0060179; GO:0042711; GO:0007613; GO:0033555; GO:0043066; GO:0050771; GO:0048681; GO:0060044; GO:0090344; GO:0030336; GO:0008285; GO:0045792; GO:0031658; GO:0061002; GO:0050680; GO:0010719; GO:0070373; GO:0090394; GO:0051895; GO:2000134; GO:0051548; GO:0031642; GO:0046621; GO:0050765; GO:0014067; GO:1901017; GO:0051898; GO:0001933; GO:0090071; GO:2000272; GO:2000808; GO:1904706; GO:1903690; GO:0007270; GO:0006661; GO:0046856; GO:0048008; GO:0010666; GO:0008284; GO:0051091; GO:0070374; GO:2000463; GO:0010628; GO:0045666; GO:1903984; GO:2000060; GO:1904668; GO:0097107; GO:0060134; GO:0097105; GO:0060736; GO:0006470; GO:0016579; GO:0043491; GO:0050821; GO:0002902; GO:0032535; GO:0000079; GO:0033032; GO:0010975; GO:0031647; GO:0032228; GO:0014823; GO:0046685; GO:0033198; GO:0032355; GO:0009749; GO:0010043; GO:0060024; GO:0035176; GO:0007416; GO:0060074"]
[2133,1066,"NP023-5","PTEN","Pan-specific","Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and protein phosphatase and tensin homolog deleted on chromosome 10",{"v":7010.873091223921,"d":"7011"},{"v":6901.916598101754,"d":"6902"},{"v":1832.5741092647045,"d":"1833"},{"v":26.139028412291275,"d":"26"},{"v":2069.0495835972174,"d":"2069"},{"v":14152.160924606706,"d":"14152"},"Kinexus","RpAb","CNEPFDEDQHTQITKV","Corresponds to amino acid residues N389 to V403; C-terminus.",null,null,"P60484","P60484",1035,null,"P60484","NP_000305","Block7",4,13,"7, 15, 23, 31",null,null,"PIPP","Lipid phosphatase",{"$nulls":8},"X","Nuclear receptor co-regulator; Phosphatase, lipid; Tumor suppressor; EC 3.1.3.16; Carbohydrate Metabolism - inositol phosphate; EC 3.1.3.48; EC 3.1.3.67","GO:0016324; GO:0042995; GO:0005737; GO:0009898; GO:0005829; GO:0043197; GO:0005576; GO:0005739; GO:0035749; GO:0043005; GO:0005654; GO:0005634; GO:0005886; GO:0016605; GO:0099524; GO:0045211; GO:0043220","GO:0010997; GO:0019899; GO:0042802; GO:0051717; GO:0035255; GO:0008289; GO:0030165; GO:0016314; GO:0051800; GO:0004438; GO:0004721; GO:0005161; GO:0004722; GO:0008138; GO:1990782; GO:0004725; GO:1990381","GO:0030534; GO:0007568; GO:0001525; GO:0006915; GO:0048854; GO:0060070; GO:0048738; GO:0016477; GO:0008283; GO:0071257; GO:0071361; GO:0071456; GO:1990314; GO:0032869; GO:0044320; GO:1990090; GO:0007417; GO:0032286; GO:0021955; GO:0060997; GO:0021542; GO:0043542; GO:0048853; GO:0007507; GO:0046855; GO:0043647; GO:0007611; GO:0045475; GO:0007626; GO:0060292; GO:0060291; GO:0060179; GO:0042711; GO:0007613; GO:0033555; GO:0043066; GO:0050771; GO:0048681; GO:0060044; GO:0090344; GO:0030336; GO:0008285; GO:0045792; GO:0031658; GO:0061002; GO:0050680; GO:0010719; GO:0070373; GO:0090394; GO:0051895; GO:2000134; GO:0051548; GO:0031642; GO:0046621; GO:0050765; GO:0014067; GO:1901017; GO:0051898; GO:0001933; GO:0090071; GO:2000272; GO:2000808; GO:1904706; GO:1903690; GO:0007270; GO:0006661; GO:0046856; GO:0048008; GO:0010666; GO:0008284; GO:0051091; GO:0070374; GO:2000463; GO:0010628; GO:0045666; GO:1903984; GO:2000060; GO:1904668; GO:0097107; GO:0060134; GO:0097105; GO:0060736; GO:0006470; GO:0016579; GO:0043491; GO:0050821; GO:0002902; GO:0032535; GO:0000079; GO:0033032; GO:0010975; GO:0031647; GO:0032228; GO:0014823; GO:0046685; GO:0033198; GO:0032355; GO:0009749; GO:0010043; GO:0060024; GO:0035176; GO:0007416; GO:0060074"]
[2135,1067,"PP006-2","PTEN","S380","Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and protein phosphatase and tensin homolog deleted on chromosome 10",{"v":580.4070434358126,"d":"580"},{"v":512.4207219025458,"d":"512"},{"v":293.26869605150677,"d":"293"},{"v":50.52810770790369,"d":"51"},{"v":150.8912315406085,"d":"151"},{"v":1747.7650690527594,"d":"1748"},"External","MmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the S380 phosphosite.","S380 phosphorylation inhibits phosphatase activity, regulates cell differentiation, cell motility, transcription, and induces/inhibits interaction with PTEN.  This is one of the major sites of in vivo phosphorylation of PTEN.","CK2a1 (CSNK2A1); LKB1 (STK11); PKCz (PRKCZ)","P60484","P60484",1035,null,"P60484","NP_000305","Block7",5,1,"7, 15, 23, 31",null,null,"PIPP","Lipid phosphatase",{"$nulls":8},"X","Nuclear receptor co-regulator; Phosphatase, lipid; Tumor suppressor; EC 3.1.3.16; Carbohydrate Metabolism - inositol phosphate; EC 3.1.3.48; EC 3.1.3.67","GO:0016324; GO:0042995; GO:0005737; GO:0009898; GO:0005829; GO:0043197; GO:0005576; GO:0005739; GO:0035749; GO:0043005; GO:0005654; GO:0005634; GO:0005886; GO:0016605; GO:0099524; GO:0045211; GO:0043220","GO:0010997; GO:0019899; GO:0042802; GO:0051717; GO:0035255; GO:0008289; GO:0030165; GO:0016314; GO:0051800; GO:0004438; GO:0004721; GO:0005161; GO:0004722; GO:0008138; GO:1990782; GO:0004725; GO:1990381","GO:0030534; GO:0007568; GO:0001525; GO:0006915; GO:0048854; GO:0060070; GO:0048738; GO:0016477; GO:0008283; GO:0071257; GO:0071361; GO:0071456; GO:1990314; GO:0032869; GO:0044320; GO:1990090; GO:0007417; GO:0032286; GO:0021955; GO:0060997; GO:0021542; GO:0043542; GO:0048853; GO:0007507; GO:0046855; GO:0043647; GO:0007611; GO:0045475; GO:0007626; GO:0060292; GO:0060291; GO:0060179; GO:0042711; GO:0007613; GO:0033555; GO:0043066; GO:0050771; GO:0048681; GO:0060044; GO:0090344; GO:0030336; GO:0008285; GO:0045792; GO:0031658; GO:0061002; GO:0050680; GO:0010719; GO:0070373; GO:0090394; GO:0051895; GO:2000134; GO:0051548; GO:0031642; GO:0046621; GO:0050765; GO:0014067; GO:1901017; GO:0051898; GO:0001933; GO:0090071; GO:2000272; GO:2000808; GO:1904706; GO:1903690; GO:0007270; GO:0006661; GO:0046856; GO:0048008; GO:0010666; GO:0008284; GO:0051091; GO:0070374; GO:2000463; GO:0010628; GO:0045666; GO:1903984; GO:2000060; GO:1904668; GO:0097107; GO:0060134; GO:0097105; GO:0060736; GO:0006470; GO:0016579; GO:0043491; GO:0050821; GO:0002902; GO:0032535; GO:0000079; GO:0033032; GO:0010975; GO:0031647; GO:0032228; GO:0014823; GO:0046685; GO:0033198; GO:0032355; GO:0009749; GO:0010043; GO:0060024; GO:0035176; GO:0007416; GO:0060074"]
[2137,1068,"PP003","PTEN","S380+T382+S385","Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and protein phosphatase and tensin homolog deleted on chromosome 10",{"v":892.59056152131,"d":"893"},{"v":884.8127178263885,"d":"885"},{"v":517.005918971228,"d":"517"},{"v":57.92195674689361,"d":"58"},{"v":24.768887276235397,"d":"25"},2834,"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S380 phosphosite.","S380, T382 and S385 phosphorylation inhibits phosphatase activity, regulates cell differentiation, cell motility, transcription, and induces/inhibits interaction with PTEN. T382 phosphorylation also inhibit interactions with MAGI2 (AIP1). These are major sites of in vivo phosphorylation of PTEN.","S380: CK2a1 (CSNK2A1); LKB1 (STK11); PKCz (PRKCZ). T382: CK2a1 (CSNK2A1); LKB1 (STK11); MAGI2 (AIP1); PKCz (PRKCZ). S385: CK2a1 (CSNK2A1).","P60484","P60484",1035,null,"P60484","NP_000305","Block7",5,2,"7, 15, 23, 31",null,null,"PIPP","Lipid phosphatase",{"$nulls":8},"X","Nuclear receptor co-regulator; Phosphatase, lipid; Tumor suppressor; EC 3.1.3.16; Carbohydrate Metabolism - inositol phosphate; EC 3.1.3.48; EC 3.1.3.67","GO:0016324; GO:0042995; GO:0005737; GO:0009898; GO:0005829; GO:0043197; GO:0005576; GO:0005739; GO:0035749; GO:0043005; GO:0005654; GO:0005634; GO:0005886; GO:0016605; GO:0099524; GO:0045211; GO:0043220","GO:0010997; GO:0019899; GO:0042802; GO:0051717; GO:0035255; GO:0008289; GO:0030165; GO:0016314; GO:0051800; GO:0004438; GO:0004721; GO:0005161; GO:0004722; GO:0008138; GO:1990782; GO:0004725; GO:1990381","GO:0030534; GO:0007568; GO:0001525; GO:0006915; GO:0048854; GO:0060070; GO:0048738; GO:0016477; GO:0008283; GO:0071257; GO:0071361; GO:0071456; GO:1990314; GO:0032869; GO:0044320; GO:1990090; GO:0007417; GO:0032286; GO:0021955; GO:0060997; GO:0021542; GO:0043542; GO:0048853; GO:0007507; GO:0046855; GO:0043647; GO:0007611; GO:0045475; GO:0007626; GO:0060292; GO:0060291; GO:0060179; GO:0042711; GO:0007613; GO:0033555; GO:0043066; GO:0050771; GO:0048681; GO:0060044; GO:0090344; GO:0030336; GO:0008285; GO:0045792; GO:0031658; GO:0061002; GO:0050680; GO:0010719; GO:0070373; GO:0090394; GO:0051895; GO:2000134; GO:0051548; GO:0031642; GO:0046621; GO:0050765; GO:0014067; GO:1901017; GO:0051898; GO:0001933; GO:0090071; GO:2000272; GO:2000808; GO:1904706; GO:1903690; GO:0007270; GO:0006661; GO:0046856; GO:0048008; GO:0010666; GO:0008284; GO:0051091; GO:0070374; GO:2000463; GO:0010628; GO:0045666; GO:1903984; GO:2000060; GO:1904668; GO:0097107; GO:0060134; GO:0097105; GO:0060736; GO:0006470; GO:0016579; GO:0043491; GO:0050821; GO:0002902; GO:0032535; GO:0000079; GO:0033032; GO:0010975; GO:0031647; GO:0032228; GO:0014823; GO:0046685; GO:0033198; GO:0032355; GO:0009749; GO:0010043; GO:0060024; GO:0035176; GO:0007416; GO:0060074"]
[2139,1069,"PP006-1","PTEN","S380+T382+T383","Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and protein phosphatase and tensin homolog deleted on chromosome 10",{"v":1081.6160267090022,"d":"1082"},{"v":1071.5340208383268,"d":"1072"},{"v":608.7450497300317,"d":"609"},{"v":56.28106783719177,"d":"56"},{"v":10.099955697094122,"d":"10"},{"v":2853.9465613465163,"d":"2854"},"External","RpAb","RY(pS)D(pT)(pT)DS","Corresponds to amino acid residues R378 to S385.","S380, T382 and T383 phosphorylation inhibits phosphatase activity, regulates cell differentiation, cell motility, transcription, and induces/inhibits (depending on different studies) interaction with PTEN. T382 phosphorylation also inhibits interactions with MAGI2 (AIP1) and PTEN. T383 phosphorylation also inhibits interaction with MAGI1 (AIP1), PTEN, and induces interaction with PTEN in different studies. These are major sites of in vivo phosphorylation of PTEN.","S380: CK2a1 (CSNK2A1); LKB1 (STK11); PKCz (PRKCZ). T382: CK2a1 (CSNK2A1); LKB1 (STK11); MAGI2 (AIP1); PKCz (PRKCZ). T383: CK2a1 (CSNK2A1); LKB1 (STK11); MAGI2 (AIP1); PKCz (PRKCZ).","P60484","P60484",1035,null,"P60484","NP_000305","Block7",5,3,"7, 15, 23, 31",null,null,"PIPP","Lipid phosphatase",{"$nulls":8},"X","Nuclear receptor co-regulator; Phosphatase, lipid; Tumor suppressor; EC 3.1.3.16; Carbohydrate Metabolism - inositol phosphate; EC 3.1.3.48; EC 3.1.3.67","GO:0016324; GO:0042995; GO:0005737; GO:0009898; GO:0005829; GO:0043197; GO:0005576; GO:0005739; GO:0035749; GO:0043005; GO:0005654; GO:0005634; GO:0005886; GO:0016605; GO:0099524; GO:0045211; GO:0043220","GO:0010997; GO:0019899; GO:0042802; GO:0051717; GO:0035255; GO:0008289; GO:0030165; GO:0016314; GO:0051800; GO:0004438; GO:0004721; GO:0005161; GO:0004722; GO:0008138; GO:1990782; GO:0004725; GO:1990381","GO:0030534; GO:0007568; GO:0001525; GO:0006915; GO:0048854; GO:0060070; GO:0048738; GO:0016477; GO:0008283; GO:0071257; GO:0071361; GO:0071456; GO:1990314; GO:0032869; GO:0044320; GO:1990090; GO:0007417; GO:0032286; GO:0021955; GO:0060997; GO:0021542; GO:0043542; GO:0048853; GO:0007507; GO:0046855; GO:0043647; GO:0007611; GO:0045475; GO:0007626; GO:0060292; GO:0060291; GO:0060179; GO:0042711; GO:0007613; GO:0033555; GO:0043066; GO:0050771; GO:0048681; GO:0060044; GO:0090344; GO:0030336; GO:0008285; GO:0045792; GO:0031658; GO:0061002; GO:0050680; GO:0010719; GO:0070373; GO:0090394; GO:0051895; GO:2000134; GO:0051548; GO:0031642; GO:0046621; GO:0050765; GO:0014067; GO:1901017; GO:0051898; GO:0001933; GO:0090071; GO:2000272; GO:2000808; GO:1904706; GO:1903690; GO:0007270; GO:0006661; GO:0046856; GO:0048008; GO:0010666; GO:0008284; GO:0051091; GO:0070374; GO:2000463; GO:0010628; GO:0045666; GO:1903984; GO:2000060; GO:1904668; GO:0097107; GO:0060134; GO:0097105; GO:0060736; GO:0006470; GO:0016579; GO:0043491; GO:0050821; GO:0002902; GO:0032535; GO:0000079; GO:0033032; GO:0010975; GO:0031647; GO:0032228; GO:0014823; GO:0046685; GO:0033198; GO:0032355; GO:0009749; GO:0010043; GO:0060024; GO:0035176; GO:0007416; GO:0060074"]
[2141,1070,"NP024-2","PTPN1 (PTP1B)","Pan-specific","Protein-tyrosine phosphatase, non-receptor type 1",{"v":287.8307566145904,"d":"288"},{"v":232.8180326822818,"d":"233"},{"v":295.1973991565822,"d":"295"},{"v":102.55936600682874,"d":"103"},{"v":59.63848249903933,"d":"60"},{"v":3840.0138559942247,"d":"3840"},"External","MmAb","Epitope undefined.",{"$nulls":3},"P18031","P18031",1134,null,null,"NP_002818.1","Block7",5,4,"7, 15, 23, 31",null,null,"PYP","Protein phosphatase, tyrosine (non-receptor)",{"$nulls":6},"X",null,null,"Phosphatase; EC 3.1.3.48; Protein phosphatase, tyrosine (non-receptor)","GO:0098554; GO:0005829; GO:0005769; GO:0005783; GO:0097443","GO:0045296; GO:0019899; GO:0046875; GO:0005158; GO:0019901; GO:0051721; GO:0004725; GO:0030971; GO:0003723; GO:0008270","GO:0031532; GO:0007257; GO:0034620; GO:0030968; GO:0008286; GO:0036498; GO:0060397; GO:1902236; GO:0070373; GO:0046627; GO:0043407; GO:1903898; GO:0009968; GO:0030948; GO:0035335; GO:1990264; GO:0035791; GO:1903896; GO:0061098; GO:2000646; GO:0006470; GO:0030100; GO:1902202; GO:0033157; GO:0009966; GO:0060338"]
[2143,1071,"PP509","PTPN1 (PTP1B)","S50","Tyrosine-protein phosphatase non-receptor type 1",{"v":954.0330587119712,"d":"954"},{"v":893.2123421191873,"d":"893"},{"v":368.9387844260967,"d":"369"},{"v":38.671488483239415,"d":"39"},{"v":113.82225753653975,"d":"114"},{"v":2112.7352731394867,"d":"2113"},"Kinexus","RpAb","RDV(pS)PFD(bA)C","Corresponds to amino acid residues R47 to D53.","S50 phosphorylation stimulates phosphatase activity and protein interaction inhibition. This is one of the major sites of in vivo phosphorylation of PTPN1 (≥30 reports from high throughput mass spectrometry studies).  This particular human phosphosite is highly conserved in vertebrates and also found in the frog.","Akt3 (PKBg); CLK1; CLK2","P18031","P18031",1134,null,null,"NP_002818.1","Block7",5,5,"7, 15, 23, 31",null,null,"PYP","Protein phosphatase, tyrosine (non-receptor)",{"$nulls":6},"X",null,null,"Phosphatase; EC 3.1.3.48; Protein phosphatase, tyrosine (non-receptor)","GO:0098554; GO:0005829; GO:0005769; GO:0005783; GO:0097443","GO:0045296; GO:0019899; GO:0046875; GO:0005158; GO:0019901; GO:0051721; GO:0004725; GO:0030971; GO:0003723; GO:0008270","GO:0031532; GO:0007257; GO:0034620; GO:0030968; GO:0008286; GO:0036498; GO:0060397; GO:1902236; GO:0070373; GO:0046627; GO:0043407; GO:1903898; GO:0009968; GO:0030948; GO:0035335; GO:1990264; GO:0035791; GO:1903896; GO:0061098; GO:2000646; GO:0006470; GO:0030100; GO:1902202; GO:0033157; GO:0009966; GO:0060338"]
[2145,1072,"PP510","PTPN1 (PTP1B)","Y66","Tyrosine-protein phosphatase non-receptor type 1",{"v":2733.3967512563036,"d":"2733"},{"v":2622.511913098373,"d":"2623"},{"v":1055.6435888003116,"d":"1056"},{"v":38.620210853588105,"d":"39"},{"v":459.58141374907353,"d":"460"},{"v":5861.17978515389,"d":"5861"},"Kinexus","RpAb","DND(pY)INA(bA)C","Corresponds to amino acid residues D63 to A69.","Y66 phosphorylation stimulates phosphatase activity and protein interaction. This is one of the major sites of in vivo phosphorylation of PTPN1 (≥46 reports from high throughput mass spectrometry studies).  This particular human phosphosite is highly conserved in vertebrates and also found in the bee.","EGFR","P18031","P18031",1134,null,null,"NP_002818.1","Block7",5,6,"7, 15, 23, 31",null,null,"PYP","Protein phosphatase, tyrosine (non-receptor)",{"$nulls":6},"X",null,null,"Phosphatase; EC 3.1.3.48; Protein phosphatase, tyrosine (non-receptor)","GO:0098554; GO:0005829; GO:0005769; GO:0005783; GO:0097443","GO:0045296; GO:0019899; GO:0046875; GO:0005158; GO:0019901; GO:0051721; GO:0004725; GO:0030971; GO:0003723; GO:0008270","GO:0031532; GO:0007257; GO:0034620; GO:0030968; GO:0008286; GO:0036498; GO:0060397; GO:1902236; GO:0070373; GO:0046627; GO:0043407; GO:1903898; GO:0009968; GO:0030948; GO:0035335; GO:1990264; GO:0035791; GO:1903896; GO:0061098; GO:2000646; GO:0006470; GO:0030100; GO:1902202; GO:0033157; GO:0009966; GO:0060338"]
[2147,1073,"PP515","PTPN2","S304","Tyrosine-protein phosphatase non-receptor type 2",{"v":15369.802851007416,"d":"15370"},{"v":14797.095825394988,"d":"14797"},{"v":5020.6017860588545,"d":"5021"},{"v":32.66536229987998,"d":"33"},{"v":322.2671876156585,"d":"322"},{"v":35141.385048222095,"d":"35141"},"Kinexus","RpAb","FDH(pS)PNK(bA)C","Corresponds to amino acid residues F301 to K307.","The effect of S304 phosphorylation is unclear. This is the major site of in vivo phosphorylation of PTPN2 (≥40 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in fish.","CDK1 (CDC2); CDK2","P17706","P17706",4823,null,null,"NP_002819.2","Block7",5,7,"7, 15, 23, 31",null,null,"PYP","Protein phosphatase, tyrosine (non-receptor)",{"$nulls":6},"X",null,null,"Protein phosphatase, tyrosine (non-receptor); EC 3.1.3.48","GO:0005829; GO:0005783; GO:0005793; GO:0005654; GO:0005634; GO:0005886","GO:0005178; GO:0004726; GO:0019901; GO:0004725; GO:0030971; GO:0097677; GO:0019905","GO:0030183; GO:0071345; GO:0030218; GO:0042593; GO:0008286; GO:0008285; GO:0050922; GO:0042059; GO:0070373; GO:0050728; GO:0046627; GO:0060336; GO:1902206; GO:1902215; GO:0070104; GO:0010888; GO:1902227; GO:0045650; GO:2000587; GO:1902233; GO:0061099; GO:0050860; GO:0000122; GO:0010804; GO:0060339; GO:0042532; GO:0035335; GO:1902237; GO:0045722; GO:1903899; GO:1902202; GO:0060334; GO:0030217"]
[2149,1074,"NP026-3","PTPN11 (PTP1D; PTP2C; SHP2; SHPTP2; Syp)","Pan-specific","Tyrosine-protein phosphatase non-receptor type 11",{"v":751.9333467446712,"d":"752"},{"v":683.4015605970504,"d":"683"},{"v":458.06600533974324,"d":"458"},{"v":60.918432108755184,"d":"61"},{"v":141.43641864755884,"d":"141"},{"v":5346.793714465189,"d":"5347"},"External","MmAb","Epitope undefined.",{"$nulls":3},"Q06124","Q06124",1103,null,"Q06124","NP_002825","Block7",5,8,"7, 15, 23, 31",null,null,"PYP","Protein phosphatase, tyrosine (non-receptor)",{"$nulls":6},"X",null,null,"EC 3.1.3.48; Protein phosphatase, tyrosine (non-receptor)","GO:0005737; GO:0005829; GO:0005739; GO:0005654; GO:0005634; GO:0032991","GO:0016303; GO:0050839; GO:0031748; GO:0005158; GO:0043560; GO:0004726; GO:0051428; GO:0046934; GO:0043274; GO:0004721; GO:0001784; GO:0019904; GO:0004725; GO:0030971; GO:0005070","GO:0033277; GO:0000187; GO:0036302; GO:0007411; GO:0060020; GO:0007420; GO:0071345; GO:0071364; GO:0071260; GO:0021697; GO:0019221; GO:0000077; GO:0048013; GO:0007173; GO:0038127; GO:0060325; GO:0008543; GO:0048806; GO:0042593; GO:0007507; GO:0048873; GO:0009755; GO:0042445; GO:0048839; GO:0007229; GO:0070102; GO:0061582; GO:0050900; GO:0035855; GO:0032528; GO:0048609; GO:0035264; GO:0033629; GO:0051463; GO:0060125; GO:0046676; GO:0048011; GO:0035265; GO:0035335; GO:0030168; GO:0048008; GO:0030220; GO:0070374; GO:2001275; GO:0046887; GO:0045931; GO:0051897; GO:0033628; GO:0040014; GO:0043254; GO:0046825; GO:0060338; GO:0031295; GO:0006641"]
[2151,1075,"PP512","PTPN11 (PTP1D; PTP2C; SHP2; SHPTP2; Syp)","Y62","Tyrosine-protein phosphatase non-receptor type 11",{"v":13155.877606021393,"d":"13156"},{"v":12660.64976250085,"d":"12661"},{"v":4398.084181455206,"d":"4398"},{"v":33.43056474957034,"d":"33"},{"v":200.44171451516328,"d":"200"},{"v":27736.042207916402,"d":"27736"},"Kinexus","RpAb","TGD(pY)YDL(bA)C","Corresponds to amino acid residues T59 to L65.","The effect of Y62 phosphorylation is unclear. This is the major site of in vivo phosphorylation of PTPN11 (≥2090 reports from high throughput mass spectrometry studies).  This particular human phosphosite is highly conserved in vertebrates and also found in the frog.",null,"Q06124","Q06124",1103,null,"Q06124","NP_002825","Block7",5,9,"7, 15, 23, 31",null,null,"PYP","Protein phosphatase, tyrosine (non-receptor)",{"$nulls":6},"X",null,null,"EC 3.1.3.48; Protein phosphatase, tyrosine (non-receptor)","GO:0005737; GO:0005829; GO:0005739; GO:0005654; GO:0005634; GO:0032991","GO:0016303; GO:0050839; GO:0031748; GO:0005158; GO:0043560; GO:0004726; GO:0051428; GO:0046934; GO:0043274; GO:0004721; GO:0001784; GO:0019904; GO:0004725; GO:0030971; GO:0005070","GO:0033277; GO:0000187; GO:0036302; GO:0007411; GO:0060020; GO:0007420; GO:0071345; GO:0071364; GO:0071260; GO:0021697; GO:0019221; GO:0000077; GO:0048013; GO:0007173; GO:0038127; GO:0060325; GO:0008543; GO:0048806; GO:0042593; GO:0007507; GO:0048873; GO:0009755; GO:0042445; GO:0048839; GO:0007229; GO:0070102; GO:0061582; GO:0050900; GO:0035855; GO:0032528; GO:0048609; GO:0035264; GO:0033629; GO:0051463; GO:0060125; GO:0046676; GO:0048011; GO:0035265; GO:0035335; GO:0030168; GO:0048008; GO:0030220; GO:0070374; GO:2001275; GO:0046887; GO:0045931; GO:0051897; GO:0033628; GO:0040014; GO:0043254; GO:0046825; GO:0060338; GO:0031295; GO:0006641"]
[2153,1076,"PP008","PTPN11 (PTP1D; PTP2C; SHP2; SHPTP2; Syp)","T542","Tyrosine-protein phosphatase non-receptor type 11",{"v":584.1050054091659,"d":"584"},{"v":347.7928848265142,"d":"348"},{"v":1668.8252514572994,"d":"1669"},{"v":285.706377449768,"d":"286"},{"v":95.76213165379393,"d":"96"},{"v":17720.8931816231,"d":"17721"},"External","MmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the T542 phosphosite.","The effect of T542 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of PTPN11.",null,"Q06124","Q06124",1103,null,"Q06124","NP_002825","Block7",5,10,"7, 15, 23, 31",null,null,"PYP","Protein phosphatase, tyrosine (non-receptor)",{"$nulls":6},"X",null,null,"EC 3.1.3.48; Protein phosphatase, tyrosine (non-receptor)","GO:0005737; GO:0005829; GO:0005739; GO:0005654; GO:0005634; GO:0032991","GO:0016303; GO:0050839; GO:0031748; GO:0005158; GO:0043560; GO:0004726; GO:0051428; GO:0046934; GO:0043274; GO:0004721; GO:0001784; GO:0019904; GO:0004725; GO:0030971; GO:0005070","GO:0033277; GO:0000187; GO:0036302; GO:0007411; GO:0060020; GO:0007420; GO:0071345; GO:0071364; GO:0071260; GO:0021697; GO:0019221; GO:0000077; GO:0048013; GO:0007173; GO:0038127; GO:0060325; GO:0008543; GO:0048806; GO:0042593; GO:0007507; GO:0048873; GO:0009755; GO:0042445; GO:0048839; GO:0007229; GO:0070102; GO:0061582; GO:0050900; GO:0035855; GO:0032528; GO:0048609; GO:0035264; GO:0033629; GO:0051463; GO:0060125; GO:0046676; GO:0048011; GO:0035265; GO:0035335; GO:0030168; GO:0048008; GO:0030220; GO:0070374; GO:2001275; GO:0046887; GO:0045931; GO:0051897; GO:0033628; GO:0040014; GO:0043254; GO:0046825; GO:0060338; GO:0031295; GO:0006641"]
[2155,1077,"PP004","PTPN11 (PTP1D; PTP2C; SHP2; SHPTP2; Syp)","S580","Tyrosine-protein phosphatase non-receptor type 11",{"v":374.4453788654072,"d":"374"},{"v":288.3618410854031,"d":"288"},{"v":586.6954801748592,"d":"587"},{"v":156.68386186326643,"d":"157"},{"v":7.691277583676175,"d":"8"},{"v":5188.460800454957,"d":"5188"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S580 phosphosite.","The effect of S580 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of PTPN11.","PKCa (PRKCA); PKCb1 (PRKCB1); PKCh (PRKCH)","Q06124","Q06124",1103,null,"Q06124","NP_002825","Block7",5,11,"7, 15, 23, 31",null,null,"PYP","Protein phosphatase, tyrosine (non-receptor)",{"$nulls":6},"X",null,null,"EC 3.1.3.48; Protein phosphatase, tyrosine (non-receptor)","GO:0005737; GO:0005829; GO:0005739; GO:0005654; GO:0005634; GO:0032991","GO:0016303; GO:0050839; GO:0031748; GO:0005158; GO:0043560; GO:0004726; GO:0051428; GO:0046934; GO:0043274; GO:0004721; GO:0001784; GO:0019904; GO:0004725; GO:0030971; GO:0005070","GO:0033277; GO:0000187; GO:0036302; GO:0007411; GO:0060020; GO:0007420; GO:0071345; GO:0071364; GO:0071260; GO:0021697; GO:0019221; GO:0000077; GO:0048013; GO:0007173; GO:0038127; GO:0060325; GO:0008543; GO:0048806; GO:0042593; GO:0007507; GO:0048873; GO:0009755; GO:0042445; GO:0048839; GO:0007229; GO:0070102; GO:0061582; GO:0050900; GO:0035855; GO:0032528; GO:0048609; GO:0035264; GO:0033629; GO:0051463; GO:0060125; GO:0046676; GO:0048011; GO:0035265; GO:0035335; GO:0030168; GO:0048008; GO:0030220; GO:0070374; GO:2001275; GO:0046887; GO:0045931; GO:0051897; GO:0033628; GO:0040014; GO:0043254; GO:0046825; GO:0060338; GO:0031295; GO:0006641"]
[2157,1078,"PP513","PTPN12 (PTP-PEST, PTPG1)","S39","Protein-tyrosine phosphatase, non-receptor type 12",{"v":6404.879218341435,"d":"6405"},{"v":6272.847019361019,"d":"6273"},{"v":1574.5285628967372,"d":"1575"},{"v":24.583267056587317,"d":"25"},{"v":2562.9897345693307,"d":"2563"},{"v":12528.944413892801,"d":"12529"},"Kinexus","RpAb","RRL(pS)TKY(bA)C","Corresponds to amino acid residues R36 to Y42.","S39 phosphorylation inhibits phosphatase activity. This is one of the minor sites of in vivo phosphorylation of PTPN11 (≥15 reports from high throughput mass spectrometry studies).  This particular human phosphosite is highly conserved in vertebrates and also found in the sea urchin.","PKACa (PRKACA); PKCa (PRKCA)","Q05209","Q05209",4997,null,null,"NP_002826.3","Block7",5,12,"7, 15, 23, 31",null,null,"PYP","Protein phosphatase, tyrosine (non-receptor)",{"$nulls":6},"X",null,null,"EC 3.1.3.48; Protein phosphatase, tyrosine (non-receptor)","GO:0042995; GO:0005737; GO:0005829; GO:0005925; GO:0005654; GO:0002102","GO:0004726; GO:0004721; GO:0004725; GO:0017124","GO:0071345; GO:0071364; GO:0038128; GO:1901185; GO:2000587; GO:0035335; GO:0006470; GO:0042058; GO:0042246"]
[2159,1079,"PP514","PTPN14","S486","Tyrosine-protein phosphatase non-receptor type 14",{"v":11255.496629177349,"d":"11255"},{"v":11119.942702244734,"d":"11120"},{"v":2873.6191676922576,"d":"2874"},{"v":25.53080741229174,"d":"26"},{"v":4111.233234508423,"d":"4111"},{"v":28656.167077770664,"d":"28656"},"Kinexus","RpAb","LVY(pS)QPE(bA)C","Corresponds to amino acid residues L483 to E489.","The effect of S486 phosphorylation is unclear. This is the major site of in vivo phosphorylation of PTPN14 (≥55 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in the frog. Note that the PTPN14 S486 site has the same sequence as S492 in PTPN21 (PTPD1; Tyrosine-protein phosphatase non-receptor type 21).",null,"Q15678","Q15678",10132,null,"Q15678","NP_005392.2","Block7",5,13,"7, 15, 23, 31",null,null,"PYP","Protein phosphatase, tyrosine (non-receptor)",{"$nulls":6},"X",null,null,"EC 3.1.3.48; Protein phosphatase, tyrosine (non-receptor)","GO:0005737; GO:0005856; GO:0005654; GO:0005634","GO:0004725; GO:0030971; GO:0003712","GO:0071345; GO:0001946; GO:0008285; GO:0006470; GO:0046825; GO:0006355; GO:0006351"]
[2161,1080,"PP516","PTPN21","S637","Tyrosine-protein phosphatase non-receptor type 21",{"v":1246.8002164992645,"d":"1247"},{"v":1151.7592353018022,"d":"1152"},{"v":476.49627695550953,"d":"476"},{"v":38.2175324201823,"d":"38"},{"v":189.21361995236282,"d":"189"},{"v":3085.444210355406,"d":"3085"},"Kinexus","RpAb","KRN(pS)IEVA(bA)C","Corresponds to amino acid residues K634 to A641.","The effect of S637 phosphorylation is unclear. This is the major site of in vivo phosphorylation of PTPN21 (≥27 reports from high throughput mass spectrometry studies). This human phosphosite is conserved in mammals and also found in chicken.",null,"Q16825","Q16825",12102,null,"Q16825","NP_008970.2","Block7",6,1,"7, 15, 23, 31",null,null,"PYP","Protein phosphatase, tyrosine (non-receptor)",{"$nulls":6},"X",null,null,"EC 3.1.3.48; Protein phosphatase, tyrosine (non-receptor)","GO:0005737; GO:0005856","GO:0004725","GO:0006470"]
[2163,1081,"PP517","PTPN22","Y499","Protein-tyrosine phosphatase, non-receptor type 22",{"v":10866.263439009123,"d":"10866"},{"v":10829.307932945452,"d":"10829"},{"v":2194.34369086307,"d":"2194"},{"v":20.194096187522295,"d":"20"},{"v":1247.4219344556896,"d":"1247"},{"v":17320.540493552442,"d":"17321"},"Kinexus","RpAb","CAELN(pY)SLP","Corresponds to amino acid residues A495 to P502.","The effect of Y499 phosphorylation is unclear. This is the major site of in vivo phosphorylation of PTPN22 (≥59 reports from high throughput mass spectrometry studies). This human phosphosite is conserved in mammals and found in rat. ",null,"Q9Y2R2","Q9Y2R2",13003,null,null,"NP_057051.3","Block7",6,2,"7, 15, 23, 31",null,null,"PYP","Protein phosphatase, tyrosine (non-receptor)",{"$nulls":6},"X",null,null,"Protein-tyrosine phosphatase","GO:0005737; GO:0009898; GO:0005829; GO:0005634; GO:0048471","GO:0019900; GO:0016791; GO:0004725; GO:0017124; GO:0031625","GO:0006914; GO:0071225; GO:0031663; GO:0010507; GO:0010629; GO:1900165; GO:2000483; GO:0043508; GO:0070433; GO:1903753; GO:0050868; GO:0050860; GO:0032720; GO:0035644; GO:0070374; GO:0010628; GO:1902715; GO:1902523; GO:0034141; GO:0034145; GO:0032481; GO:0006470; GO:0050855; GO:0045088; GO:0032817; GO:1901222; GO:0032496; GO:0030217; GO:0050852"]
[2165,1082,"PP521","PTPRA","Y798","Receptor-type tyrosine-protein phosphatase alpha",{"v":10167.217050967503,"d":"10167"},{"v":10113.699863394484,"d":"10114"},{"v":2742.7315421602607,"d":"2743"},{"v":26.976226910580852,"d":"27"},{"v":3508.230018716156,"d":"3508"},{"v":21215.029538766645,"d":"21215"},"Kinexus","RpAb","CAFSD(pY)ANF","Corresponds to amino acid residues A794 to F801; At the C-terminus.","Y798 phosphorylation stimulates phosphatase activity and regulates cytoskeletal reorganization. This is the major site of in vivo phosphorylation of PTPRA (≥2372 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in the frog.","Src","P18433","P18433",1307,null,null,"NP_002827.1","Block7",6,3,"7, 15, 23, 31",null,null,"PYP","Protein phosphatase, tyrosine (receptor)",{"$nulls":6},"X",null,null,"EC 3.1.3.48; Receptor protein phosphatase, tyrosine","GO:0070062; GO:0005887; GO:0099699; GO:0005622; GO:0005886; GO:0043235; GO:0098685","GO:0004725; GO:0005088; GO:0005001","GO:0007411; GO:0008286; GO:0000165; GO:0050804"]
[2167,1083,"PP522","PTPRB","Y1981","Receptor-type tyrosine-protein phosphatase beta",{"v":10461.877030319918,"d":"10462"},{"v":10052.567425996309,"d":"10053"},{"v":2707.242197083053,"d":"2707"},{"v":25.877212944074024,"d":"26"},{"v":1086.6271460971798,"d":"1087"},{"v":21780.732700109933,"d":"21781"},"Kinexus","RpAb","FPI(pY)ENV(bA)C","Corresponds to amino acid residues F1978 to V1984.","The effect of Y1981 phosphorylation is unclear. This is the major site of in vivo phosphorylation of PTPRB (≥39 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved inmammals and also found in the chicken. ",null,"P23467","P23467",5428,null,null,"NP_002828.3","Block7",6,4,"7, 15, 23, 31",null,null,"PYP","Protein phosphatase, tyrosine (receptor)",{"$nulls":6},"X",null,null,"Protein-tyrosine phosphatase, receptor class 3 subfamily","GO:0005887; GO:0005886; GO:0043235; GO:0035579; GO:0070821","GO:0005001","GO:0001525; GO:0016311; GO:0043312; GO:0006796; GO:0006470"]
[2169,1084,"PP523","PTPRF","Y1621","Receptor-type tyrosine-protein phosphatase F",{"v":7335.31801242071,"d":"7335"},{"v":7252.575426300383,"d":"7253"},{"v":1661.315508575391,"d":"1661"},{"v":22.648172932139097,"d":"23"},{"v":2919.427683873758,"d":"2919"},{"v":15199.832347884167,"d":"15200"},"Kinexus","RpAb","CARNL(pY)AHI","Corresponds to amino acid residues A1617 to I1624.","The effect of Y1621 phosphorylation is unclear. This is the major site of in vivo phosphorylation of PTPRF (≥143 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in fish.",null,"P10586","P10586",9981,null,null,"NP_002831.2","Block7",6,5,"7, 15, 23, 31",null,null,"PYP","Protein phosphatase, tyrosine (receptor)",{"$nulls":6},"X",null,null,"EC 3.1.3.48; Receptor protein phosphatase, tyrosine","GO:0070062; GO:0005887; GO:0043025; GO:0043005; GO:0005886","GO:0050839; GO:0035373; GO:0008201; GO:0044877; GO:0004725; GO:0005001","GO:0007155; GO:0016477; GO:1900121; GO:0031102; GO:0035335; GO:0048679; GO:0099560; GO:0007185"]
[2171,1085,"PP524","PTPRK","Y916","Receptor-type tyrosine-protein phosphatase kappa",{"v":5596.820171283573,"d":"5597"},{"v":5292.4700274776205,"d":"5292"},{"v":1839.372596995776,"d":"1839"},{"v":32.86460062507127,"d":"33"},{"v":2504.5365188954647,"d":"2505"},{"v":12852.55982715818,"d":"12853"},"Kinexus","RpAb","CAKNR(pY)GNI","Corresponds to amino acid residues A912 to I919.","The effect of Y916 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of PTPRK (≥75 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in the nematode worm.",null,"Q15262","Q15262",6856,null,null,"NP_001278913.1","Block7",6,6,"7, 15, 23, 31",null,null,"PYP","Protein phosphatase, tyrosine (receptor)",{"$nulls":6},"X",null,null,"Receptor protein phosphatase, tyrosine; EC 3.1.3.48","GO:0005912; GO:0030424; GO:0005911; GO:0030054; GO:0009986; GO:0030425; GO:0016021; GO:0005887; GO:0043231; GO:0031256; GO:0043025; GO:0001750; GO:0005886","GO:0008013; GO:0045295; GO:0019901; GO:0004725; GO:0005001","GO:0007155; GO:0016477; GO:0034614; GO:0034644; GO:0048041; GO:0045786; GO:0030336; GO:0008285; GO:0010839; GO:0045892; GO:0031175; GO:0006470; GO:0034394; GO:0007165; GO:0007179"]
[2173,1086,"PP526","PTPRM","Y929","Receptor-type tyrosine-protein phosphatase mu",{"v":12012.628771689164,"d":"12013"},{"v":11486.767035216024,"d":"11487"},{"v":2859.9279585671206,"d":"2860"},{"v":23.807677844064184,"d":"24"},{"v":6364.7338658068775,"d":"6365"},{"v":22747.194805914318,"d":"22747"},"Kinexus","RpAb","KNR(pY)GNI(bA)C","Corresponds to amino acid residues K926 to I932.","The effect of Y929 phosphorylation is unclear. This is the major site of in vivo phosphorylation of PTPRM (≥75 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in the nematode worm.",null,"P28827","P28827",17785,null,null,"NP_002836.3","Block7",6,7,"7, 15, 23, 31",null,null,"PYP","Protein phosphatase, tyrosine (receptor)",{"$nulls":6},"X",null,null,"Protein-tyrosine phosphatase (receptor)","GO:0005913; GO:0005911; GO:0005737; GO:0005887; GO:0030027; GO:0048471; GO:0005886","GO:0045296; GO:0042802; GO:0004725; GO:0005001","GO:0007156; GO:0016525; GO:0010596; GO:0001937; GO:0031175; GO:0097755; GO:0006470; GO:0042493; GO:0010842; GO:0031290; GO:0007165"]
[2175,1087,"PN646","PTRF","Y308","Polymerase I and transcript release factor",{"v":21349.930449227246,"d":"21350"},{"v":19609.21537071022,"d":"19609"},{"v":7407.733053808376,"d":"7408"},{"v":34.69675496800739,"d":"35"},{"v":1204.5157982371989,"d":"1205"},{"v":55918.562442712646,"d":"55919"},"Kinexus","RpAb","DHVV(pY)ARSK(bA)C","Corresponds to amino acid residues D304 to K312.","The effect of Y308 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of PTPRF.",null,"Q6NZI2","Q6NZI2",5074,null,null,"NP_036364.2","Block7",6,8,"7, 15, 23, 31",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein, initiation complex","GO:0005901; GO:0005737; GO:0005829; GO:0005783; GO:0043231; GO:0045121; GO:0005739; GO:0005654; GO:0005634; GO:0005886; GO:0032991","GO:0042802; GO:0003723; GO:0042134","GO:2000147; GO:0006355; GO:0009303; GO:0006363; GO:0006361"]
[2177,1088,"PN647","PU.1","S146","Transcription factor PU.1",{"v":1505.4645145437803,"d":"1505"},{"v":1452.0497962209383,"d":"1452"},{"v":501.0764587615563,"d":"501"},{"v":33.28384388478288,"d":"33"},{"v":340.02335842306655,"d":"340"},{"v":3411.0132088215287,"d":"3411"},"Kinexus","RpAb","PLEV(pS)DGEAC","Corresponds to amino acid residues P142 to A150.","S146 phosphorylation induces transcriptional activation and interaction with DNA, IRF2, IRF4 , IRF8, PIP and PU1. This is one of the major sites of in vivo phosphorylation of PU.1.","CK2a1 (CSNK2A1)","P17947","P17947",4728,null,"P17947","NP_003111.2","Block7",6,9,"7, 15, 23, 31",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0000790; GO:0005654; GO:0005634","GO:0003700; GO:0051525; GO:0003723; GO:0000980; GO:0000978; GO:0000981; GO:0001085; GO:0001205; GO:0001077; GO:0001078; GO:0003705","GO:0060033; GO:1902262; GO:0071361; GO:0030218; GO:0030851; GO:0043966; GO:0044027; GO:0030098; GO:0002320; GO:0030225; GO:0043011; GO:0045814; GO:0090241; GO:0045347; GO:0045892; GO:0000122; GO:1902895; GO:0045893; GO:0045944; GO:0061614; GO:0045646; GO:0006357; GO:0035019"]
[2179,906,"NN086","PXN","Pan-specific","Paxillin 1",{"v":26.953556409120583,"d":"27"},{"v":22.82751219932157,"d":"23"},{"v":16.301513433745026,"d":"16"},{"v":60.48000934017337,"d":"60"},{"v":7.12924408296721,"d":"7"},{"v":99.19337985896057,"d":"99"},"External","MmAb","Epitope undefined.",{"$nulls":3},"P49023","P49023",1792,null,"P49023","NP_002850","Block6",5,9,"6, 14, 22, 30",{"$nulls":13},"Focal adhesion, Cytoplasm, Lamellipodium, Cell junction, Microtubule associated complex, Cytoskeleton protein","GO:0005938; GO:0005829; GO:0005925; GO:0030027; GO:0005875; GO:0005886; GO:0001725","GO:0008013; GO:0005178; GO:0046872; GO:0038191; GO:0019901; GO:0019903; GO:0031625; GO:0017166","GO:0007155; GO:0007160; GO:0034614; GO:0043542; GO:0060396; GO:0006936; GO:0051496; GO:0007172; GO:0007165; GO:0007179; GO:0048010"]
[2181,907,"PN059","PXN","Y31","Paxillin 1",{"v":560.9231674419494,"d":"561"},{"v":531.1830407381424,"d":"531"},{"v":360.38714556813636,"d":"360"},{"v":64.24893220432605,"d":"64"},{"v":11.96420839833593,"d":"12"},{"v":1674.1614375582499,"d":"1674"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the Y31 phosphosite.","The effect of Y31 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of PXN.","Abl1; Brk (PTK6); FAK (PTK2); PYK2 (PTK2B; FAK2); Src","P49023","P49023",1792,null,"P49023","NP_002850","Block6",5,10,"6, 14, 22, 30",{"$nulls":13},"Focal adhesion, Cytoplasm, Lamellipodium, Cell junction, Microtubule associated complex, Cytoskeleton protein","GO:0005938; GO:0005829; GO:0005925; GO:0030027; GO:0005875; GO:0005886; GO:0001725","GO:0008013; GO:0005178; GO:0046872; GO:0038191; GO:0019901; GO:0019903; GO:0031625; GO:0017166","GO:0007155; GO:0007160; GO:0034614; GO:0043542; GO:0060396; GO:0006936; GO:0051496; GO:0007172; GO:0007165; GO:0007179; GO:0048010"]
[2183,908,"PN257","PXN","Y118","Paxillin 1",{"v":295.2945177179757,"d":"295"},{"v":249.3060541760677,"d":"249"},{"v":166.8420852332974,"d":"167"},{"v":56.500231200581176,"d":"57"},{"v":38.0230401335974,"d":"38"},{"v":925.4124284103746,"d":"925"},"External","MmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the Y118 phosphosite.","Y118 phosphorylation induces activation, and binding to CrkL and Src. This is one of the major sites of in vivo phosphorylation of PXN.","Abl1; Brk (PTK6); FAK (PTK2); Fyn; PYK2 (PTK2B; FAK2); Src","P49023","P49023",1792,null,"P49023","NP_002850","Block6",5,11,"6, 14, 22, 30",{"$nulls":13},"Focal adhesion, Cytoplasm, Lamellipodium, Cell junction, Microtubule associated complex, Cytoskeleton protein","GO:0005938; GO:0005829; GO:0005925; GO:0030027; GO:0005875; GO:0005886; GO:0001725","GO:0008013; GO:0005178; GO:0046872; GO:0038191; GO:0019901; GO:0019903; GO:0031625; GO:0017166","GO:0007155; GO:0007160; GO:0034614; GO:0043542; GO:0060396; GO:0006936; GO:0051496; GO:0007172; GO:0007165; GO:0007179; GO:0048010"]
[2185,1089,"NK154","PYK2 (PTK2B)","Pan-specific","Protein-tyrosine kinase 2",{"v":636.492528080495,"d":"636"},{"v":551.6007189383507,"d":"552"},{"v":381.5039787719674,"d":"382"},{"v":59.93848504749767,"d":"60"},{"v":193.0508133903335,"d":"193"},{"v":3860.182269728852,"d":"3860"},"External","GpAb","Epitope undefined.",{"$nulls":3},"Q14289","Q14289",652,"Q14289",null,"NP_004094","Block7",6,10,"7, 15, 23, 31","PYK2","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Fak",{"$nulls":6},"Protein kinase, tyrosine (non-receptor); Nuclear receptor co-regulator; EC 2.7.10.2; TK domain target; TK</A> group; Fak family","GO:0097440; GO:0044297; GO:0005938; GO:0005737; GO:0005856; GO:0005829; GO:0030425; GO:0043197; GO:0031234; GO:0005925; GO:0098978; GO:0030426; GO:0030027; GO:0045121; GO:0043025; GO:0017146; GO:0005634; GO:0048471; GO:0014069","GO:0043423; GO:0005524; GO:0004683; GO:0004972; GO:0004715; GO:0044877; GO:0008022; GO:0004713; GO:0005102; GO:0031625","GO:0090630; GO:0042976; GO:0002250; GO:0001525; GO:0006915; GO:0043534; GO:0045453; GO:0007166; GO:0006968; GO:0071498; GO:0071300; GO:0070098; GO:0007173; GO:0048041; GO:0014009; GO:0045087; GO:0007229; GO:0038110; GO:0035235; GO:0060292; GO:0060291; GO:0000165; GO:0002315; GO:0043066; GO:0030502; GO:0008285; GO:0010656; GO:0045638; GO:0043524; GO:0043267; GO:0031175; GO:0001556; GO:0038083; GO:0018108; GO:0030838; GO:0045766; GO:2000538; GO:0030307; GO:0001954; GO:0030335; GO:0008284; GO:0007204; GO:2000573; GO:0010595; GO:0070374; GO:2000463; GO:0046330; GO:0043507; GO:0010976; GO:0045429; GO:0051000; GO:0050731; GO:0043552; GO:0045860; GO:0051968; GO:0045727; GO:2000060; GO:0046777; GO:0065003; GO:0006468; GO:2000249; GO:0050848; GO:0030155; GO:0008360; GO:0010752; GO:2000114; GO:0032960; GO:0010758; GO:2000310; GO:0051279; GO:0048167; GO:2000058; GO:0051592; GO:0051591; GO:0042220; GO:0045471; GO:0009749; GO:0009725; GO:0042542; GO:0001666; GO:0035902; GO:0010226; GO:0009612; GO:0006970; GO:0007172; GO:0007165; GO:0002040; GO:0043149; GO:0033209; GO:0048010"]
[2187,1090,"NK154-3","PYK2 (PTK2B)","Pan-specific","Protein-tyrosine kinase 2",{"v":328.0183631546983,"d":"328"},{"v":278.48642654047273,"d":"278"},{"v":214.63512040623343,"d":"215"},{"v":65.43387337891457,"d":"65"},{"v":61.721224111206354,"d":"62"},{"v":1547.1942085973087,"d":"1547"},"External","MmAb","Epitope undefined.",{"$nulls":3},"Q14289","Q14289",652,"Q14289",null,"NP_004094","Block7",6,11,"7, 15, 23, 31","PYK2","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Fak",{"$nulls":6},"Protein kinase, tyrosine (non-receptor); Nuclear receptor co-regulator; EC 2.7.10.2; TK domain target; TK</A> group; Fak family","GO:0097440; GO:0044297; GO:0005938; GO:0005737; GO:0005856; GO:0005829; GO:0030425; GO:0043197; GO:0031234; GO:0005925; GO:0098978; GO:0030426; GO:0030027; GO:0045121; GO:0043025; GO:0017146; GO:0005634; GO:0048471; GO:0014069","GO:0043423; GO:0005524; GO:0004683; GO:0004972; GO:0004715; GO:0044877; GO:0008022; GO:0004713; GO:0005102; GO:0031625","GO:0090630; GO:0042976; GO:0002250; GO:0001525; GO:0006915; GO:0043534; GO:0045453; GO:0007166; GO:0006968; GO:0071498; GO:0071300; GO:0070098; GO:0007173; GO:0048041; GO:0014009; GO:0045087; GO:0007229; GO:0038110; GO:0035235; GO:0060292; GO:0060291; GO:0000165; GO:0002315; GO:0043066; GO:0030502; GO:0008285; GO:0010656; GO:0045638; GO:0043524; GO:0043267; GO:0031175; GO:0001556; GO:0038083; GO:0018108; GO:0030838; GO:0045766; GO:2000538; GO:0030307; GO:0001954; GO:0030335; GO:0008284; GO:0007204; GO:2000573; GO:0010595; GO:0070374; GO:2000463; GO:0046330; GO:0043507; GO:0010976; GO:0045429; GO:0051000; GO:0050731; GO:0043552; GO:0045860; GO:0051968; GO:0045727; GO:2000060; GO:0046777; GO:0065003; GO:0006468; GO:2000249; GO:0050848; GO:0030155; GO:0008360; GO:0010752; GO:2000114; GO:0032960; GO:0010758; GO:2000310; GO:0051279; GO:0048167; GO:2000058; GO:0051592; GO:0051591; GO:0042220; GO:0045471; GO:0009749; GO:0009725; GO:0042542; GO:0001666; GO:0035902; GO:0010226; GO:0009612; GO:0006970; GO:0007172; GO:0007165; GO:0002040; GO:0043149; GO:0033209; GO:0048010"]
[2189,1091,"PK788","PYK2 (PTK2B)","Y402","Protein tyrosine kinase 2 beta",{"v":6754.159888361664,"d":"6754"},{"v":6578.52132913924,"d":"6579"},{"v":1898.7102460732392,"d":"1899"},{"v":28.11171600105255,"d":"28"},{"v":1400.9010740288838,"d":"1401"},{"v":14503.494436678235,"d":"14503"},"Kinexus","RpAb","SDI(pY)AEI(bA)C","Corresponds to amino acid residues S399 to I405; In the region between the FERM_M domain and the protein kinase catalytic domain.","Y402 phosphorylation stimulates phosphotransferase activity. Its phosphorylation regulates cell cycle progression, cell motility, alters intracellular location, and induces binding to ErbB2, RASA1 and Src. This is one of the major sites of in vivo phosphorylation of PYK2.","PYK2 (PTK2B; FAK2); Src","Q14289","Q14289",652,"Q14289",null,"NP_004094","Block7",6,12,"7, 15, 23, 31","PYK2","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Fak",{"$nulls":6},"Protein kinase, tyrosine (non-receptor); Nuclear receptor co-regulator; EC 2.7.10.2; TK domain target; TK</A> group; Fak family","GO:0097440; GO:0044297; GO:0005938; GO:0005737; GO:0005856; GO:0005829; GO:0030425; GO:0043197; GO:0031234; GO:0005925; GO:0098978; GO:0030426; GO:0030027; GO:0045121; GO:0043025; GO:0017146; GO:0005634; GO:0048471; GO:0014069","GO:0043423; GO:0005524; GO:0004683; GO:0004972; GO:0004715; GO:0044877; GO:0008022; GO:0004713; GO:0005102; GO:0031625","GO:0090630; GO:0042976; GO:0002250; GO:0001525; GO:0006915; GO:0043534; GO:0045453; GO:0007166; GO:0006968; GO:0071498; GO:0071300; GO:0070098; GO:0007173; GO:0048041; GO:0014009; GO:0045087; GO:0007229; GO:0038110; GO:0035235; GO:0060292; GO:0060291; GO:0000165; GO:0002315; GO:0043066; GO:0030502; GO:0008285; GO:0010656; GO:0045638; GO:0043524; GO:0043267; GO:0031175; GO:0001556; GO:0038083; GO:0018108; GO:0030838; GO:0045766; GO:2000538; GO:0030307; GO:0001954; GO:0030335; GO:0008284; GO:0007204; GO:2000573; GO:0010595; GO:0070374; GO:2000463; GO:0046330; GO:0043507; GO:0010976; GO:0045429; GO:0051000; GO:0050731; GO:0043552; GO:0045860; GO:0051968; GO:0045727; GO:2000060; GO:0046777; GO:0065003; GO:0006468; GO:2000249; GO:0050848; GO:0030155; GO:0008360; GO:0010752; GO:2000114; GO:0032960; GO:0010758; GO:2000310; GO:0051279; GO:0048167; GO:2000058; GO:0051592; GO:0051591; GO:0042220; GO:0045471; GO:0009749; GO:0009725; GO:0042542; GO:0001666; GO:0035902; GO:0010226; GO:0009612; GO:0006970; GO:0007172; GO:0007165; GO:0002040; GO:0043149; GO:0033209; GO:0048010"]
[2191,1092,"PK787","PYK2 (PTK2B)","Y402","Protein tyrosine kinase 2 beta",{"v":7549.566032757483,"d":"7550"},{"v":7447.336789135478,"d":"7447"},{"v":1783.4780774791445,"d":"1783"},{"v":23.623584054244347,"d":"24"},{"v":2615.6022399363974,"d":"2616"},{"v":14612.246962237401,"d":"14612"},"Kinexus","RpAb","SDI(pY)AEI(bA)C","Corresponds to amino acid residues S399 to I405; In the region between the FERM_M domain and the protein kinase catalytic domain.","Y402 phosphorylation stimulates phosphotransferase activity. Its phosphorylation regulates cell cycle progression, cell motility, alters intracellular location, and induces binding to ErbB2, RASA1 and Src. This is one of the major sites of in vivo phosphorylation of PYK2.","PYK2 (PTK2B; FAK2); Src","Q14289","Q14289",652,"Q14289",null,"NP_004094","Block7",6,13,"7, 15, 23, 31","PYK2","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Fak",{"$nulls":6},"Protein kinase, tyrosine (non-receptor); Nuclear receptor co-regulator; EC 2.7.10.2; TK domain target; TK</A> group; Fak family","GO:0097440; GO:0044297; GO:0005938; GO:0005737; GO:0005856; GO:0005829; GO:0030425; GO:0043197; GO:0031234; GO:0005925; GO:0098978; GO:0030426; GO:0030027; GO:0045121; GO:0043025; GO:0017146; GO:0005634; GO:0048471; GO:0014069","GO:0043423; GO:0005524; GO:0004683; GO:0004972; GO:0004715; GO:0044877; GO:0008022; GO:0004713; GO:0005102; GO:0031625","GO:0090630; GO:0042976; GO:0002250; GO:0001525; GO:0006915; GO:0043534; GO:0045453; GO:0007166; GO:0006968; GO:0071498; GO:0071300; GO:0070098; GO:0007173; GO:0048041; GO:0014009; GO:0045087; GO:0007229; GO:0038110; GO:0035235; GO:0060292; GO:0060291; GO:0000165; GO:0002315; GO:0043066; GO:0030502; GO:0008285; GO:0010656; GO:0045638; GO:0043524; GO:0043267; GO:0031175; GO:0001556; GO:0038083; GO:0018108; GO:0030838; GO:0045766; GO:2000538; GO:0030307; GO:0001954; GO:0030335; GO:0008284; GO:0007204; GO:2000573; GO:0010595; GO:0070374; GO:2000463; GO:0046330; GO:0043507; GO:0010976; GO:0045429; GO:0051000; GO:0050731; GO:0043552; GO:0045860; GO:0051968; GO:0045727; GO:2000060; GO:0046777; GO:0065003; GO:0006468; GO:2000249; GO:0050848; GO:0030155; GO:0008360; GO:0010752; GO:2000114; GO:0032960; GO:0010758; GO:2000310; GO:0051279; GO:0048167; GO:2000058; GO:0051592; GO:0051591; GO:0042220; GO:0045471; GO:0009749; GO:0009725; GO:0042542; GO:0001666; GO:0035902; GO:0010226; GO:0009612; GO:0006970; GO:0007172; GO:0007165; GO:0002040; GO:0043149; GO:0033209; GO:0048010"]
[2193,1093,"PK097-3","PYK2 (PTK2B)","Y579","Protein tyrosine kinase 2 beta",{"v":71.12986218206979,"d":"71"},{"v":59.806014128113695,"d":"60"},{"v":48.5616216305844,"d":"49"},{"v":68.27177804208605,"d":"68"},{"v":10.507743987314242,"d":"11"},{"v":424.5110327851056,"d":"425"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the Y579 phosphosite.","Y579 phosphorylation stimulates phosphotransferase activity. This is one of the major sites of in vivo phosphorylation of PYK2.","Src","Q14289","Q14289",652,"Q14289",null,"NP_004094","Block7",7,1,"7, 15, 23, 31","PYK2","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Fak",{"$nulls":6},"Protein kinase, tyrosine (non-receptor); Nuclear receptor co-regulator; EC 2.7.10.2; TK domain target; TK</A> group; Fak family","GO:0097440; GO:0044297; GO:0005938; GO:0005737; GO:0005856; GO:0005829; GO:0030425; GO:0043197; GO:0031234; GO:0005925; GO:0098978; GO:0030426; GO:0030027; GO:0045121; GO:0043025; GO:0017146; GO:0005634; GO:0048471; GO:0014069","GO:0043423; GO:0005524; GO:0004683; GO:0004972; GO:0004715; GO:0044877; GO:0008022; GO:0004713; GO:0005102; GO:0031625","GO:0090630; GO:0042976; GO:0002250; GO:0001525; GO:0006915; GO:0043534; GO:0045453; GO:0007166; GO:0006968; GO:0071498; GO:0071300; GO:0070098; GO:0007173; GO:0048041; GO:0014009; GO:0045087; GO:0007229; GO:0038110; GO:0035235; GO:0060292; GO:0060291; GO:0000165; GO:0002315; GO:0043066; GO:0030502; GO:0008285; GO:0010656; GO:0045638; GO:0043524; GO:0043267; GO:0031175; GO:0001556; GO:0038083; GO:0018108; GO:0030838; GO:0045766; GO:2000538; GO:0030307; GO:0001954; GO:0030335; GO:0008284; GO:0007204; GO:2000573; GO:0010595; GO:0070374; GO:2000463; GO:0046330; GO:0043507; GO:0010976; GO:0045429; GO:0051000; GO:0050731; GO:0043552; GO:0045860; GO:0051968; GO:0045727; GO:2000060; GO:0046777; GO:0065003; GO:0006468; GO:2000249; GO:0050848; GO:0030155; GO:0008360; GO:0010752; GO:2000114; GO:0032960; GO:0010758; GO:2000310; GO:0051279; GO:0048167; GO:2000058; GO:0051592; GO:0051591; GO:0042220; GO:0045471; GO:0009749; GO:0009725; GO:0042542; GO:0001666; GO:0035902; GO:0010226; GO:0009612; GO:0006970; GO:0007172; GO:0007165; GO:0002040; GO:0043149; GO:0033209; GO:0048010"]
[2195,1094,"PK789","PYK2 (PTK2B)","Y579+Y580","Protein tyrosine kinase 2 beta",{"v":11760.349257390164,"d":"11760"},{"v":11676.65027219759,"d":"11677"},{"v":2372.7780959763436,"d":"2373"},{"v":20.17608528492721,"d":"20"},{"v":6523.684115067648,"d":"6524"},{"v":20519.70622343344,"d":"20520"},"Kinexus","RpAb","ED(pY)(pY)KAS(bA)C","Corresponds to amino acid residues E577 to S583; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y579 and Y580 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major sites of in vivo phosphorylation of PYK2.","Y579: Src. Y580: Src.","Q14289","Q14289",652,"Q14289",null,"NP_004094","Block7",7,2,"7, 15, 23, 31","PYK2","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Fak",{"$nulls":6},"Protein kinase, tyrosine (non-receptor); Nuclear receptor co-regulator; EC 2.7.10.2; TK domain target; TK</A> group; Fak family","GO:0097440; GO:0044297; GO:0005938; GO:0005737; GO:0005856; GO:0005829; GO:0030425; GO:0043197; GO:0031234; GO:0005925; GO:0098978; GO:0030426; GO:0030027; GO:0045121; GO:0043025; GO:0017146; GO:0005634; GO:0048471; GO:0014069","GO:0043423; GO:0005524; GO:0004683; GO:0004972; GO:0004715; GO:0044877; GO:0008022; GO:0004713; GO:0005102; GO:0031625","GO:0090630; GO:0042976; GO:0002250; GO:0001525; GO:0006915; GO:0043534; GO:0045453; GO:0007166; GO:0006968; GO:0071498; GO:0071300; GO:0070098; GO:0007173; GO:0048041; GO:0014009; GO:0045087; GO:0007229; GO:0038110; GO:0035235; GO:0060292; GO:0060291; GO:0000165; GO:0002315; GO:0043066; GO:0030502; GO:0008285; GO:0010656; GO:0045638; GO:0043524; GO:0043267; GO:0031175; GO:0001556; GO:0038083; GO:0018108; GO:0030838; GO:0045766; GO:2000538; GO:0030307; GO:0001954; GO:0030335; GO:0008284; GO:0007204; GO:2000573; GO:0010595; GO:0070374; GO:2000463; GO:0046330; GO:0043507; GO:0010976; GO:0045429; GO:0051000; GO:0050731; GO:0043552; GO:0045860; GO:0051968; GO:0045727; GO:2000060; GO:0046777; GO:0065003; GO:0006468; GO:2000249; GO:0050848; GO:0030155; GO:0008360; GO:0010752; GO:2000114; GO:0032960; GO:0010758; GO:2000310; GO:0051279; GO:0048167; GO:2000058; GO:0051592; GO:0051591; GO:0042220; GO:0045471; GO:0009749; GO:0009725; GO:0042542; GO:0001666; GO:0035902; GO:0010226; GO:0009612; GO:0006970; GO:0007172; GO:0007165; GO:0002040; GO:0043149; GO:0033209; GO:0048010"]
[2197,1095,"NN092-3","Rac1","Pan-specific","Ras-related C3 botulinum toxin substrate 1",{"v":678.606846556689,"d":"679"},{"v":557.9048894170754,"d":"558"},{"v":489.154140668255,"d":"489"},{"v":72.08211104121132,"d":"72"},{"v":134.41008590386076,"d":"134"},{"v":5434.464683698427,"d":"5434"},"External","MmAb","Epitope undefined.",{"$nulls":3},"P63000","P63000",1036,null,"P63000","NP_008839","Block7",7,3,"7, 15, 23, 31",{"$nulls":3},"Small G protein",{"$nulls":9},"G protein; G protein, monomeric (non-Rab)","GO:0005737; GO:0036464; GO:0005829; GO:0043197; GO:0005789; GO:0070062; GO:0101003; GO:0005925; GO:0098978; GO:0000139; GO:0030027; GO:0042470; GO:0016020; GO:0005886; GO:0098794; GO:0055038; GO:0032587; GO:0030667; GO:0005802","GO:0051117; GO:0019899; GO:0003924; GO:0005525; GO:0042826; GO:0019901; GO:0004674; GO:0017137; GO:0051022; GO:0031996","GO:0030036; GO:0030041; GO:0009653; GO:0007596; GO:0045453; GO:0007155; GO:0007160; GO:0048870; GO:0008283; GO:0071260; GO:0048013; GO:0038095; GO:0038096; GO:0007186; GO:0048012; GO:0006954; GO:0035556; GO:0030032; GO:0051668; GO:0002551; GO:0032707; GO:0048261; GO:0001764; GO:0043312; GO:0010811; GO:0045740; GO:0051894; GO:0010592; GO:0031116; GO:0090023; GO:0001934; GO:0035025; GO:0051496; GO:1900026; GO:0016601; GO:0030334; GO:0008361; GO:0050690; GO:0010310; GO:0010591; GO:0060263; GO:0051056; GO:0051492; GO:0009611; GO:0097178; GO:0031529; GO:0071526; GO:0034446; GO:0031295; GO:0048010; GO:0060071"]
[2199,1096,"PN063","Rac1/cdc42","S71","Ras-related C3 botulinum toxin substrate 1",{"v":160.14619481337482,"d":"160"},{"v":123.39887194364903,"d":"123"},{"v":146.528139649708,"d":"147"},{"v":91.49648533358129,"d":"91"},{"v":6.2304474261734475,"d":"6"},{"v":770.4661782953068,"d":"770"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S71 phosphosite.","S71 phosphorylation induces inhibition of Rac1 function. This is one of the major sites of in vivo phosphorylation of Rac1.","Akt1 (PKBa)","P63000","P63000",1036,null,"P63000","NP_008839","Block7",7,4,"7, 15, 23, 31",{"$nulls":3},"Small G protein",{"$nulls":9},"G protein; G protein, monomeric (non-Rab)","GO:0005737; GO:0036464; GO:0005829; GO:0043197; GO:0005789; GO:0070062; GO:0101003; GO:0005925; GO:0098978; GO:0000139; GO:0030027; GO:0042470; GO:0016020; GO:0005886; GO:0098794; GO:0055038; GO:0032587; GO:0030667; GO:0005802","GO:0051117; GO:0019899; GO:0003924; GO:0005525; GO:0042826; GO:0019901; GO:0004674; GO:0017137; GO:0051022; GO:0031996","GO:0030036; GO:0030041; GO:0009653; GO:0007596; GO:0045453; GO:0007155; GO:0007160; GO:0048870; GO:0008283; GO:0071260; GO:0048013; GO:0038095; GO:0038096; GO:0007186; GO:0048012; GO:0006954; GO:0035556; GO:0030032; GO:0051668; GO:0002551; GO:0032707; GO:0048261; GO:0001764; GO:0043312; GO:0010811; GO:0045740; GO:0051894; GO:0010592; GO:0031116; GO:0090023; GO:0001934; GO:0035025; GO:0051496; GO:1900026; GO:0016601; GO:0030334; GO:0008361; GO:0050690; GO:0010310; GO:0010591; GO:0060263; GO:0051056; GO:0051492; GO:0009611; GO:0097178; GO:0031529; GO:0071526; GO:0034446; GO:0031295; GO:0048010; GO:0060071"]
[2201,1097,"NK205-3","Raf-A (ARaf)","Pan-specific","A-Raf proto-oncogene serine/threonine-protein kinase",{"v":8462.574488143828,"d":"8463"},{"v":8428.505758559277,"d":"8429"},{"v":1751.489127036492,"d":"1751"},{"v":20.696882839735707,"d":"21"},{"v":2268.352849174546,"d":"2268"},{"v":15373.957791739249,"d":"15374"},"Kinexus","RpAb","CGRKTVTAWDTAIAPL","Corresponds to amino acid residues G67 to L81.",null,null,"P10398","P10398",671,"P10398",null,"NP_001645.1","Block7",7,5,"7, 15, 23, 31","A-RAF","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RAF",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); TKL group; RAF family","GO:0005829; GO:0005739","GO:0005524; GO:0004709; GO:0046872; GO:0031434; GO:0004672; GO:0004674","GO:0030154; GO:0006464; GO:0000165; GO:0007275; GO:0043066; GO:0009968; GO:0070374; GO:0033138; GO:0032434; GO:0032006"]
[2203,1098,"NK205-4","Raf-A (ARaf)","Pan-specific","A-Raf proto-oncogene serine/threonine-protein kinase",{"v":13660.019937862155,"d":"13660"},{"v":13305.717873872225,"d":"13306"},{"v":2376.1513238438247,"d":"2376"},{"v":17.394933057584552,"d":"17"},{"v":6364.821492073358,"d":"6365"},{"v":21325.93259605323,"d":"21326"},"Kinexus","RpAb","CGYYWEVPPSEVQLLK","Corresponds to amino acid residues G300 to K314.",null,null,"P10398","P10398",671,"P10398",null,"NP_001645.1","Block7",7,6,"7, 15, 23, 31","A-RAF","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RAF",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); TKL group; RAF family","GO:0005829; GO:0005739","GO:0005524; GO:0004709; GO:0046872; GO:0031434; GO:0004672; GO:0004674","GO:0030154; GO:0006464; GO:0000165; GO:0007275; GO:0043066; GO:0009968; GO:0070374; GO:0033138; GO:0032434; GO:0032006"]
[2205,1099,"PK500","Raf-A (ARaf)","Y302","A-Raf proto-oncogene serine/threonine-protein kinase",{"v":9275.50571386388,"d":"9276"},{"v":9239.542623540685,"d":"9240"},{"v":1863.497296009179,"d":"1863"},{"v":20.090519627666804,"d":"20"},{"v":4050.3675584763796,"d":"4050"},{"v":15461.358948384037,"d":"15461"},"Kinexus","RpAb","SGY(pY)WEV(bA)C","Corresponds to amino acid residues S299 to V305; Just before kinase catalytic domain.","Y302 phosphorylation stimulates phosphotransferase activity. This is one of the major sites of in vivo phosphorylation of Raf-A.","Src","P10398","P10398",671,"P10398",null,"NP_001645.1","Block7",7,7,"7, 15, 23, 31","A-RAF","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RAF",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); TKL group; RAF family","GO:0005829; GO:0005739","GO:0005524; GO:0004709; GO:0046872; GO:0031434; GO:0004672; GO:0004674","GO:0030154; GO:0006464; GO:0000165; GO:0007275; GO:0043066; GO:0009968; GO:0070374; GO:0033138; GO:0032434; GO:0032006"]
[2207,1100,"NK156-6","Raf-B (BRaf)","Pan-specific","B-Raf proto-oncogene serine-threonine-protein kinase; RafB proto-oncogene-encoded protein-serine kinase",{"v":13863.073295238393,"d":"13863"},{"v":13210.32269444799,"d":"13210"},{"v":4063.5573603206803,"d":"4064"},{"v":29.31209605388444,"d":"29"},{"v":6352.861950144097,"d":"6353"},{"v":35857.742681490454,"d":"35858"},"Kinexus","RpAb","CGEKKPIGWDTDISWL","Corresponds to amino acid residues G203 to L217.",null,null,"P15056","P15056",577,"P15056","P15056","NP_004324","Block7",7,8,"7, 15, 23, 31","B-RAF","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RAF",{"$nulls":6},"EC 2.7.1.37; Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; TKL domain target; TKL</A> group; RAF family","GO:0005829; GO:0005622; GO:0043231; GO:0005634; GO:0005886","GO:0005524; GO:0005509; GO:0042802; GO:0004709; GO:0031434; GO:0004672; GO:0004674","GO:0009887; GO:0030154; GO:0071277; GO:0090150; GO:0000165; GO:0043066; GO:0009968; GO:0070374; GO:0010628; GO:0010828; GO:0033138; GO:0006468; GO:0070413"]
[2209,1101,"NK156-4","Raf-B (BRaf)","Pan-specific","B-Raf proto-oncogene serine-threonine-protein kinase; RafB proto-oncogene-encoded protein-serine kinase",{"v":10128.185579032684,"d":"10128"},{"v":9702.756545974216,"d":"9703"},{"v":2678.406369979454,"d":"2678"},{"v":26.445075962315272,"d":"26"},{"v":1572.8379339388557,"d":"1573"},{"v":18932.678664695235,"d":"18933"},"Kinexus","RpAb","CSDDWEIPDGQITVGQ","Corresponds to amino acid residues S447 to Q461.",null,null,"P15056","P15056",577,"P15056","P15056","NP_004324","Block7",7,9,"7, 15, 23, 31","B-RAF","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RAF",{"$nulls":6},"EC 2.7.1.37; Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; TKL domain target; TKL</A> group; RAF family","GO:0005829; GO:0005622; GO:0043231; GO:0005634; GO:0005886","GO:0005524; GO:0005509; GO:0042802; GO:0004709; GO:0031434; GO:0004672; GO:0004674","GO:0009887; GO:0030154; GO:0071277; GO:0090150; GO:0000165; GO:0043066; GO:0009968; GO:0070374; GO:0010628; GO:0010828; GO:0033138; GO:0006468; GO:0070413"]
[2211,1102,"PK534","Raf-B (BRaf)","S446+S447","B-Raf proto-oncogene serine-threonine-protein kinase; RafB proto-oncogene-encoded protein-serine kinase",{"v":4894.791784138033,"d":"4895"},{"v":4889.814892580191,"d":"4890"},{"v":1280.5081171587044,"d":"1281"},{"v":26.16062487700282,"d":"26"},{"v":573.5642054756903,"d":"574"},{"v":8993.970831839673,"d":"8994"},"Kinexus","RpAb","RRD(pS)(pS)DDW(bA)C","Corresponds to amino acid residues R443 to W450; Just before the kinase catalytic domain. ","S446 and S447 phosphorylation stimulate phosphotransferase activity and induces interaction with H-Ras-1. This is the major in vivo phosphorylation sites in B-Raf.","PAK1; PKACa (PRKACA)","P15056","P15056",577,"P15056","P15056","NP_004324","Block7",7,10,"7, 15, 23, 31","B-RAF","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RAF",{"$nulls":6},"EC 2.7.1.37; Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; TKL domain target; TKL</A> group; RAF family","GO:0005829; GO:0005622; GO:0043231; GO:0005634; GO:0005886","GO:0005524; GO:0005509; GO:0042802; GO:0004709; GO:0031434; GO:0004672; GO:0004674","GO:0009887; GO:0030154; GO:0071277; GO:0090150; GO:0000165; GO:0043066; GO:0009968; GO:0070374; GO:0010628; GO:0010828; GO:0033138; GO:0006468; GO:0070413"]
[2213,1103,"PK535","Raf-B (BRaf)","S729","B-Raf proto-oncogene serine-threonine-protein kinase; RafB proto-oncogene-encoded protein-serine kinase",{"v":3625.081163663804,"d":"3625"},{"v":3374.8521768803157,"d":"3375"},{"v":1379.6393287684853,"d":"1380"},{"v":38.05816384464365,"d":"38"},{"v":686.5760041898142,"d":"687"},{"v":9176.369465876927,"d":"9176"},"Kinexus","RpAb","RSA(pS)EPS(bA)C","Corresponds to amino acid residues R726 to S732; In the C-terminal region after the kinase catalytic domain.","S729 phosphorylation stimulates phosphotransferase activity and regulates cell differentiation, cell growth, and molecular association with 14-3-3 beta. This is one of the major sites of in vivo phosphorylation of Raf-B.",null,"P15056","P15056",577,"P15056","P15056","NP_004324","Block7",7,11,"7, 15, 23, 31","B-RAF","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RAF",{"$nulls":6},"EC 2.7.1.37; Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; TKL domain target; TKL</A> group; RAF family","GO:0005829; GO:0005622; GO:0043231; GO:0005634; GO:0005886","GO:0005524; GO:0005509; GO:0042802; GO:0004709; GO:0031434; GO:0004672; GO:0004674","GO:0009887; GO:0030154; GO:0071277; GO:0090150; GO:0000165; GO:0043066; GO:0009968; GO:0070374; GO:0010628; GO:0010828; GO:0033138; GO:0006468; GO:0070413"]
[2215,1104,"NK155-7","Raf1 (RafC)","Pan-specific","Raf1 proto-oncogene-encoded protein-serine kinase",{"v":9036.280306025397,"d":"9036"},{"v":8879.088785483727,"d":"8879"},{"v":1897.1390205072819,"d":"1897"},{"v":20.994689808839468,"d":"21"},{"v":1175.5181349387667,"d":"1176"},{"v":15748.808881539913,"d":"15749"},"Kinexus","RpAb","CLIGEELQVDFLDHVP","Corresponds to amino acid residues L121 to P135.",null,null,"P04049","P04049",653,"P04049","P04049","NP_002871","Block7",7,12,"7, 15, 23, 31","RAF1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RAF",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; TKL group; RAF family","GO:0005737; GO:0005829; GO:0005794; GO:0005741; GO:0016607; GO:0005886; GO:0031143","GO:0010856; GO:0008179; GO:0005524; GO:0019899; GO:0042802; GO:0016301; GO:0004709; GO:0046872; GO:0031434; GO:0046982; GO:0004672; GO:0004674","GO:0007190; GO:0000186; GO:0006915; GO:0030154; GO:0008283; GO:0071550; GO:0060324; GO:0007507; GO:0035773; GO:0045104; GO:0034220; GO:0000165; GO:0007275; GO:0043066; GO:0008285; GO:0043154; GO:1902042; GO:0031333; GO:0009968; GO:0048011; GO:0030168; GO:0070374; GO:0033138; GO:0045944; GO:0006468; GO:0042981; GO:0045595; GO:2000145; GO:0035023; GO:0001666; GO:0035994; GO:0007165; GO:0035019; GO:0002223; GO:0048538; GO:0030878; GO:0042060"]
[2217,1105,"NK155-8","Raf1 (RafC)","Pan-specific","Raf1 proto-oncogene-encoded protein-serine kinase",{"v":2630.584175116281,"d":"2631"},{"v":2215.3276548640415,"d":"2215"},{"v":1628.8446940184574,"d":"1629"},{"v":61.91950477868501,"d":"62"},{"v":699.7054740981575,"d":"700"},{"v":10284.109830308207,"d":"10284"},"Kinexus","RpAb","CLTDPSKTSNTIRVFL","Corresponds to amino acid residues L48 to L62.",null,null,"P04049","P04049",653,"P04049","P04049","NP_002871","Block7",7,13,"7, 15, 23, 31","RAF1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RAF",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; TKL group; RAF family","GO:0005737; GO:0005829; GO:0005794; GO:0005741; GO:0016607; GO:0005886; GO:0031143","GO:0010856; GO:0008179; GO:0005524; GO:0019899; GO:0042802; GO:0016301; GO:0004709; GO:0046872; GO:0031434; GO:0046982; GO:0004672; GO:0004674","GO:0007190; GO:0000186; GO:0006915; GO:0030154; GO:0008283; GO:0071550; GO:0060324; GO:0007507; GO:0035773; GO:0045104; GO:0034220; GO:0000165; GO:0007275; GO:0043066; GO:0008285; GO:0043154; GO:1902042; GO:0031333; GO:0009968; GO:0048011; GO:0030168; GO:0070374; GO:0033138; GO:0045944; GO:0006468; GO:0042981; GO:0045595; GO:2000145; GO:0035023; GO:0001666; GO:0035994; GO:0007165; GO:0035019; GO:0002223; GO:0048538; GO:0030878; GO:0042060"]
[2219,1106,"PK790","Raf1 (RafC)","S259","Raf1 proto-oncogene-encoded protein-serine kinase",{"v":6058.287605609947,"d":"6058"},{"v":5916.842322710851,"d":"5917"},{"v":1496.2955100238178,"d":"1496"},{"v":24.698324137636764,"d":"25"},{"v":2012.5432268369877,"d":"2013"},{"v":10922.884276919158,"d":"10923"},"Kinexus","RpAb","RST(pS)TPN(bA)C","Corresponds to amino acid residues R256 to N262; In the region between the C1_1 and kinase catalytic domains. ","S259 phosphorylation inhibits phosphotransferase activity, reduces H-Ras-1 and PPP2CB binding, and induces binding of 14-3-3-beta, theta and zeta. It appears to necessary for PKC-alpha activation of Raf1. This is a major in vivo phosphorylation site in Raf1.","Akt1 (PKBa); Akt3 (PKBg); AMPKa1 (PRKAA1); LATS1; PKACa (PRKACA); Raf1","P04049","P04049",653,"P04049","P04049","NP_002871","Block7",8,1,"7, 15, 23, 31","RAF1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RAF",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; TKL group; RAF family","GO:0005737; GO:0005829; GO:0005794; GO:0005741; GO:0016607; GO:0005886; GO:0031143","GO:0010856; GO:0008179; GO:0005524; GO:0019899; GO:0042802; GO:0016301; GO:0004709; GO:0046872; GO:0031434; GO:0046982; GO:0004672; GO:0004674","GO:0007190; GO:0000186; GO:0006915; GO:0030154; GO:0008283; GO:0071550; GO:0060324; GO:0007507; GO:0035773; GO:0045104; GO:0034220; GO:0000165; GO:0007275; GO:0043066; GO:0008285; GO:0043154; GO:1902042; GO:0031333; GO:0009968; GO:0048011; GO:0030168; GO:0070374; GO:0033138; GO:0045944; GO:0006468; GO:0042981; GO:0045595; GO:2000145; GO:0035023; GO:0001666; GO:0035994; GO:0007165; GO:0035019; GO:0002223; GO:0048538; GO:0030878; GO:0042060"]
[2221,1107,"PK791","Raf1 (RafC)","S296","Raf1 proto-oncogene-encoded protein-serine kinase",{"v":7774.811593451591,"d":"7775"},{"v":7025.958075887636,"d":"7026"},{"v":2843.589621733255,"d":"2844"},{"v":36.57438624144019,"d":"37"},{"v":2978.611284669765,"d":"2979"},{"v":20985.478670229804,"d":"20985"},"Kinexus","RpAb","LSS(pS)PNN(bA)C","Corresponds to amino acid residues L293 to N299; In the region between the C1_1 and kinase catalytic domains. ","S296 phosphorylation inhibits phosphotransferase activity and inhibits interaction with H-Ras-1. This is a major in vivo phosphorylation site in Raf1.","ERK1 (MAPK3)","P04049","P04049",653,"P04049","P04049","NP_002871","Block7",8,2,"7, 15, 23, 31","RAF1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RAF",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; TKL group; RAF family","GO:0005737; GO:0005829; GO:0005794; GO:0005741; GO:0016607; GO:0005886; GO:0031143","GO:0010856; GO:0008179; GO:0005524; GO:0019899; GO:0042802; GO:0016301; GO:0004709; GO:0046872; GO:0031434; GO:0046982; GO:0004672; GO:0004674","GO:0007190; GO:0000186; GO:0006915; GO:0030154; GO:0008283; GO:0071550; GO:0060324; GO:0007507; GO:0035773; GO:0045104; GO:0034220; GO:0000165; GO:0007275; GO:0043066; GO:0008285; GO:0043154; GO:1902042; GO:0031333; GO:0009968; GO:0048011; GO:0030168; GO:0070374; GO:0033138; GO:0045944; GO:0006468; GO:0042981; GO:0045595; GO:2000145; GO:0035023; GO:0001666; GO:0035994; GO:0007165; GO:0035019; GO:0002223; GO:0048538; GO:0030878; GO:0042060"]
[2223,1108,"PK792","Raf1 (RafC)","S301+T303","Raf1 proto-oncogene-encoded protein-serine kinase",{"v":1313.5869124660003,"d":"1314"},{"v":1262.0610820399827,"d":"1262"},{"v":510.34953563265555,"d":"510"},{"v":38.85160020927545,"d":"39"},{"v":192.45410908743432,"d":"192"},{"v":3298.2547989304226,"d":"3298"},"Kinexus","RpAb","NNL(pS)P(pT)GW(bA)C","Corresponds to amino acid residues N298 to W305; In the region between the C1_1 and kinase catalytic domains. This is the major in vivo phosphorylation sites in Raf1.","S301+T303 phosphorylation inhibits phosphotransferase activity, inhibits interaction with H-Ras-1, and regulates intracellular location. These two are major in vivo phosphorylation sites in Raf1.","S301: ERK1 (MAPK3).","P04049","P04049",653,"P04049","P04049","NP_002871","Block7",8,3,"7, 15, 23, 31","RAF1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RAF",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; TKL group; RAF family","GO:0005737; GO:0005829; GO:0005794; GO:0005741; GO:0016607; GO:0005886; GO:0031143","GO:0010856; GO:0008179; GO:0005524; GO:0019899; GO:0042802; GO:0016301; GO:0004709; GO:0046872; GO:0031434; GO:0046982; GO:0004672; GO:0004674","GO:0007190; GO:0000186; GO:0006915; GO:0030154; GO:0008283; GO:0071550; GO:0060324; GO:0007507; GO:0035773; GO:0045104; GO:0034220; GO:0000165; GO:0007275; GO:0043066; GO:0008285; GO:0043154; GO:1902042; GO:0031333; GO:0009968; GO:0048011; GO:0030168; GO:0070374; GO:0033138; GO:0045944; GO:0006468; GO:0042981; GO:0045595; GO:2000145; GO:0035023; GO:0001666; GO:0035994; GO:0007165; GO:0035019; GO:0002223; GO:0048538; GO:0030878; GO:0042060"]
[2225,1109,"PK212","Raf1 (RafC)","S621","Raf1 proto-oncogene-encoded protein-serine kinase",{"v":837.6494069035332,"d":"838"},{"v":753.2832336211377,"d":"753"},{"v":571.2834805782194,"d":"571"},{"v":68.2007861367722,"d":"68"},{"v":141.8791919663872,"d":"142"},{"v":6822.2019425954995,"d":"6822"},"External","MmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the S621 phosphosite.","Phosphorylation of S621 stimulates phosphotransferase activity, but has also been reported to be inhibitory; Phosphorylation regulates protein interactions and cell growth. This is one of the major sites of in vivo phosphorylation of Raf-1.","PKACa (PRKACA); Raf1","P04049","P04049",653,"P04049","P04049","NP_002871","Block7",8,4,"7, 15, 23, 31","RAF1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RAF",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; TKL group; RAF family","GO:0005737; GO:0005829; GO:0005794; GO:0005741; GO:0016607; GO:0005886; GO:0031143","GO:0010856; GO:0008179; GO:0005524; GO:0019899; GO:0042802; GO:0016301; GO:0004709; GO:0046872; GO:0031434; GO:0046982; GO:0004672; GO:0004674","GO:0007190; GO:0000186; GO:0006915; GO:0030154; GO:0008283; GO:0071550; GO:0060324; GO:0007507; GO:0035773; GO:0045104; GO:0034220; GO:0000165; GO:0007275; GO:0043066; GO:0008285; GO:0043154; GO:1902042; GO:0031333; GO:0009968; GO:0048011; GO:0030168; GO:0070374; GO:0033138; GO:0045944; GO:0006468; GO:0042981; GO:0045595; GO:2000145; GO:0035023; GO:0001666; GO:0035994; GO:0007165; GO:0035019; GO:0002223; GO:0048538; GO:0030878; GO:0042060"]
[2227,1110,"PN648","RARA","S77","Retinoic acid receptor alpha",{"v":14694.671548130054,"d":"14695"},{"v":13520.63251812899,"d":"13521"},{"v":4365.463185104786,"d":"4365"},{"v":29.707796943990257,"d":"30"},{"v":6426.979762457484,"d":"6427"},{"v":34316.46645123485,"d":"34316"},"Kinexus","RpAb","PSPP(pS)PPP(bA)C","Corresponds to amino acid residues P73 to P80.","S77 phosphoryation stimulates transcriptional activity, and regulates protein degradation and molecular association, including inducing interaction with DNA, N-CoR1, Pin1, and inhibiting interaction with SRC-3. This is one of the major sites of in vivo phosphorylation of RARA.","CDK7","P10276","P10276",5166,null,"P10276","NP_000955.1","Block7",8,5,"7, 15, 23, 31",{"$nulls":3},"Transcription protein (receptor)",{"$nulls":4},"X",{"$nulls":4},"Transcription protein (receptor)","GO:0015629; GO:0009986; GO:0005737; GO:0005829; GO:0030425; GO:0043025; GO:0000790; GO:0005654; GO:0005634; GO:0048471","GO:0051393; GO:0031490; GO:0003700; GO:0008144; GO:0019899; GO:0042826; GO:0048027; GO:0019904; GO:0046982; GO:0051018; GO:0043422; GO:0001972; GO:0003708; GO:0044323; GO:0000981; GO:0005102; GO:0003707; GO:0003713; GO:0003714; GO:0008134; GO:0000900; GO:0008270","GO:0043277; GO:0071391; GO:0071222; GO:0071300; GO:0060591; GO:0031076; GO:0060324; GO:0007565; GO:0007281; GO:0002068; GO:0003417; GO:0021766; GO:0060173; GO:0001889; GO:0035264; GO:0043066; GO:0061037; GO:0008285; GO:0030853; GO:0032689; GO:0045892; GO:0000122; GO:0045947; GO:0032720; GO:0001843; GO:0003148; GO:0051099; GO:0045787; GO:0008284; GO:0032736; GO:0032753; GO:0032754; GO:0045666; GO:0045630; GO:0045893; GO:0045944; GO:0030850; GO:0006468; GO:0031641; GO:0048167; GO:0034097; GO:0032355; GO:0045471; GO:0032526; GO:0033189; GO:0048384; GO:0060010; GO:0007165; GO:0007283; GO:0060534; GO:0006367; GO:0001657; GO:0055012"]
[2229,1111,"NN093","Rb","Pan-specific","Retinoblastoma-associated protein 1",{"v":294.2511459675922,"d":"294"},{"v":178.24860805212955,"d":"178"},{"v":365.56982449224745,"d":"366"},{"v":124.23734945539007,"d":"124"},{"v":22.875893738439153,"d":"23"},{"v":3714.024682481343,"d":"3714"},"External","MmAb","Epitope undefined.",{"$nulls":3},"P06400","P06400",452,null,"P06400","NP_000312","Block7",8,6,"7, 15, 23, 31",{"$nulls":13},"Nuclear receptor co-regulator; Transcription, coactivator/corepressor; Tumor suppressor","GO:0000785; GO:0005654; GO:0005634; GO:0016605; GO:0035189; GO:0005819; GO:0016514","GO:0050681; GO:0097718; GO:0003677; GO:0003700; GO:0042802; GO:0061676; GO:0019900; GO:0051219; GO:0000987; GO:0001102; GO:0003713; GO:0008134; GO:0031625","GO:0030521; GO:0003180; GO:0007050; GO:0051301; GO:0048667; GO:0071466; GO:0006338; GO:0048565; GO:0043353; GO:0000082; GO:0034349; GO:0097284; GO:0034088; GO:0007093; GO:0045445; GO:0120163; GO:0043433; GO:0050680; GO:2000134; GO:0010629; GO:0050728; GO:1904761; GO:0006469; GO:0045879; GO:0045892; GO:0000122; GO:0071930; GO:0051402; GO:0042551; GO:0031175; GO:1904028; GO:1903055; GO:0045651; GO:0045842; GO:0045893; GO:0045944; GO:2000679; GO:0071459; GO:0007265; GO:0001558; GO:0090230; GO:0071922; GO:0043550; GO:0007346; GO:0006355; GO:0031134; GO:0035914; GO:0051146; GO:0001894; GO:0006351; GO:0016032"]
[2231,1112,"PN261","Rb","S249+T252","Retinoblastoma-associated protein 1",{"v":1784.498380044712,"d":"1784"},{"v":1663.660917153516,"d":"1664"},{"v":850.4250495318631,"d":"850"},{"v":47.65625225787849,"d":"48"},{"v":139.7939239137948,"d":"140"},{"v":5668.6880618667765,"d":"5669"},"External","MmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the S249 and T252 phosphosites.","The effects of S249 and T252 phosphorylation are unclear. These are two of the major sites of in vivo phosphorylation of Rb (≥114 and >76 reports, respectively, by mass spectrometry). These human phosphosites are highly conserved in mammals and also found in the chicken.","S249: CDK1 (CDC2); CDK2; CDK4; CDK6. T252: CDK1 (CDC2); CDK2; CDK4; CDK6. ","P06400","P06400",452,null,"P06400","NP_000312","Block7",8,7,"7, 15, 23, 31",{"$nulls":13},"Nuclear receptor co-regulator; Transcription, coactivator/corepressor; Tumor suppressor","GO:0000785; GO:0005654; GO:0005634; GO:0016605; GO:0035189; GO:0005819; GO:0016514","GO:0050681; GO:0097718; GO:0003677; GO:0003700; GO:0042802; GO:0061676; GO:0019900; GO:0051219; GO:0000987; GO:0001102; GO:0003713; GO:0008134; GO:0031625","GO:0030521; GO:0003180; GO:0007050; GO:0051301; GO:0048667; GO:0071466; GO:0006338; GO:0048565; GO:0043353; GO:0000082; GO:0034349; GO:0097284; GO:0034088; GO:0007093; GO:0045445; GO:0120163; GO:0043433; GO:0050680; GO:2000134; GO:0010629; GO:0050728; GO:1904761; GO:0006469; GO:0045879; GO:0045892; GO:0000122; GO:0071930; GO:0051402; GO:0042551; GO:0031175; GO:1904028; GO:1903055; GO:0045651; GO:0045842; GO:0045893; GO:0045944; GO:2000679; GO:0071459; GO:0007265; GO:0001558; GO:0090230; GO:0071922; GO:0043550; GO:0007346; GO:0006355; GO:0031134; GO:0035914; GO:0051146; GO:0001894; GO:0006351; GO:0016032"]
[2233,1113,"PN264","Rb","T356","Retinoblastoma-associated protein 1",{"v":865.4140386875074,"d":"865"},{"v":771.0899524608825,"d":"771"},{"v":461.604961653928,"d":"462"},{"v":53.33920424424835,"d":"53"},{"v":183.790807689783,"d":"184"},{"v":4881.1043794084335,"d":"4881"},"External","MmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the T356 phosphosite.","T356 phosphorylation inhibits interaction with EF21. This is one of the major sites of in vivo phosphorylation of Rb.","CDK2; CDK4","P06400","P06400",452,null,"P06400","NP_000312","Block7",8,8,"7, 15, 23, 31",{"$nulls":13},"Nuclear receptor co-regulator; Transcription, coactivator/corepressor; Tumor suppressor","GO:0000785; GO:0005654; GO:0005634; GO:0016605; GO:0035189; GO:0005819; GO:0016514","GO:0050681; GO:0097718; GO:0003677; GO:0003700; GO:0042802; GO:0061676; GO:0019900; GO:0051219; GO:0000987; GO:0001102; GO:0003713; GO:0008134; GO:0031625","GO:0030521; GO:0003180; GO:0007050; GO:0051301; GO:0048667; GO:0071466; GO:0006338; GO:0048565; GO:0043353; GO:0000082; GO:0034349; GO:0097284; GO:0034088; GO:0007093; GO:0045445; GO:0120163; GO:0043433; GO:0050680; GO:2000134; GO:0010629; GO:0050728; GO:1904761; GO:0006469; GO:0045879; GO:0045892; GO:0000122; GO:0071930; GO:0051402; GO:0042551; GO:0031175; GO:1904028; GO:1903055; GO:0045651; GO:0045842; GO:0045893; GO:0045944; GO:2000679; GO:0071459; GO:0007265; GO:0001558; GO:0090230; GO:0071922; GO:0043550; GO:0007346; GO:0006355; GO:0031134; GO:0035914; GO:0051146; GO:0001894; GO:0006351; GO:0016032"]
[2235,1114,"PN262","Rb","S608","Retinoblastoma-associated protein 1",{"v":1093.7989616384389,"d":"1094"},{"v":1012.4194601501804,"d":"1012"},{"v":606.7633236359562,"d":"607"},{"v":55.47302062959217,"d":"55"},{"v":142.4560608457862,"d":"142"},{"v":5549.9865619840875,"d":"5550"},"External","MmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the S608 phosphosite.","S608 phosphorylation inhibits binding to E2F1. This is one of the major sites of in vivo phosphorylation of Rb.","CDK2; CDK4","P06400","P06400",452,null,"P06400","NP_000312","Block7",8,9,"7, 15, 23, 31",{"$nulls":13},"Nuclear receptor co-regulator; Transcription, coactivator/corepressor; Tumor suppressor","GO:0000785; GO:0005654; GO:0005634; GO:0016605; GO:0035189; GO:0005819; GO:0016514","GO:0050681; GO:0097718; GO:0003677; GO:0003700; GO:0042802; GO:0061676; GO:0019900; GO:0051219; GO:0000987; GO:0001102; GO:0003713; GO:0008134; GO:0031625","GO:0030521; GO:0003180; GO:0007050; GO:0051301; GO:0048667; GO:0071466; GO:0006338; GO:0048565; GO:0043353; GO:0000082; GO:0034349; GO:0097284; GO:0034088; GO:0007093; GO:0045445; GO:0120163; GO:0043433; GO:0050680; GO:2000134; GO:0010629; GO:0050728; GO:1904761; GO:0006469; GO:0045879; GO:0045892; GO:0000122; GO:0071930; GO:0051402; GO:0042551; GO:0031175; GO:1904028; GO:1903055; GO:0045651; GO:0045842; GO:0045893; GO:0045944; GO:2000679; GO:0071459; GO:0007265; GO:0001558; GO:0090230; GO:0071922; GO:0043550; GO:0007346; GO:0006355; GO:0031134; GO:0035914; GO:0051146; GO:0001894; GO:0006351; GO:0016032"]
[2237,1115,"PN066","Rb","S612","Retinoblastoma-associated protein 1",{"v":974.3532720485852,"d":"974"},{"v":807.6131159944721,"d":"808"},{"v":743.4474567870635,"d":"743"},{"v":76.30163289993983,"d":"76"},{"v":48.088737226127876,"d":"48"},{"v":4544.15418799136,"d":"4544"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S612 phosphosite.","S612 phosphorylation is reported to either induce and inhibit binding to E2F1. This is one of the major sites of in vivo phosphorylation of Rb.","CDK2; CDK6; Chk1 (CHEK1); Chk2 (CHEK2)","P06400","P06400",452,null,"P06400","NP_000312","Block7",8,10,"7, 15, 23, 31",{"$nulls":13},"Nuclear receptor co-regulator; Transcription, coactivator/corepressor; Tumor suppressor","GO:0000785; GO:0005654; GO:0005634; GO:0016605; GO:0035189; GO:0005819; GO:0016514","GO:0050681; GO:0097718; GO:0003677; GO:0003700; GO:0042802; GO:0061676; GO:0019900; GO:0051219; GO:0000987; GO:0001102; GO:0003713; GO:0008134; GO:0031625","GO:0030521; GO:0003180; GO:0007050; GO:0051301; GO:0048667; GO:0071466; GO:0006338; GO:0048565; GO:0043353; GO:0000082; GO:0034349; GO:0097284; GO:0034088; GO:0007093; GO:0045445; GO:0120163; GO:0043433; GO:0050680; GO:2000134; GO:0010629; GO:0050728; GO:1904761; GO:0006469; GO:0045879; GO:0045892; GO:0000122; GO:0071930; GO:0051402; GO:0042551; GO:0031175; GO:1904028; GO:1903055; GO:0045651; GO:0045842; GO:0045893; GO:0045944; GO:2000679; GO:0071459; GO:0007265; GO:0001558; GO:0090230; GO:0071922; GO:0043550; GO:0007346; GO:0006355; GO:0031134; GO:0035914; GO:0051146; GO:0001894; GO:0006351; GO:0016032"]
[2239,1116,"PN067","Rb","S780","Retinoblastoma-associated protein 1",{"v":154.58709004692813,"d":"155"},{"v":87.1497054963227,"d":"87"},{"v":179.5935489704639,"d":"180"},{"v":116.17629189859551,"d":"116"},{"v":9.859544205647488,"d":"10"},{"v":928.6414717724226,"d":"929"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S780 phosphosites.","S780 phosphorylation reported to both inhibit and induce interaction with E2F1. This is one of the major sites of in vivo phosphorylation of Rb.","CDK4, CDK6;  PKACa (PRKACA)","P06400","P06400",452,null,"P06400","NP_000312","Block7",8,11,"7, 15, 23, 31",{"$nulls":13},"Nuclear receptor co-regulator; Transcription, coactivator/corepressor; Tumor suppressor","GO:0000785; GO:0005654; GO:0005634; GO:0016605; GO:0035189; GO:0005819; GO:0016514","GO:0050681; GO:0097718; GO:0003677; GO:0003700; GO:0042802; GO:0061676; GO:0019900; GO:0051219; GO:0000987; GO:0001102; GO:0003713; GO:0008134; GO:0031625","GO:0030521; GO:0003180; GO:0007050; GO:0051301; GO:0048667; GO:0071466; GO:0006338; GO:0048565; GO:0043353; GO:0000082; GO:0034349; GO:0097284; GO:0034088; GO:0007093; GO:0045445; GO:0120163; GO:0043433; GO:0050680; GO:2000134; GO:0010629; GO:0050728; GO:1904761; GO:0006469; GO:0045879; GO:0045892; GO:0000122; GO:0071930; GO:0051402; GO:0042551; GO:0031175; GO:1904028; GO:1903055; GO:0045651; GO:0045842; GO:0045893; GO:0045944; GO:2000679; GO:0071459; GO:0007265; GO:0001558; GO:0090230; GO:0071922; GO:0043550; GO:0007346; GO:0006355; GO:0031134; GO:0035914; GO:0051146; GO:0001894; GO:0006351; GO:0016032"]
[2241,1117,"PN263","Rb","S795","Retinoblastoma-associated protein 1",{"v":391.01830206164243,"d":"391"},{"v":331.8324080471739,"d":"332"},{"v":240.87761182648637,"d":"241"},{"v":61.60264380374528,"d":"62"},{"v":58.349450035097924,"d":"58"},{"v":1534.3069613479956,"d":"1534"},"External","MmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the S795 phosphosite.","S795 phosphorylation inhibits interaction with ARF1, E2F1 and TFDP1. This is one of the major sites of in vivo phosphorylation of Rb.","CDK4; CDK5; CDK6; CDK9","P06400","P06400",452,null,"P06400","NP_000312","Block7",8,12,"7, 15, 23, 31",{"$nulls":13},"Nuclear receptor co-regulator; Transcription, coactivator/corepressor; Tumor suppressor","GO:0000785; GO:0005654; GO:0005634; GO:0016605; GO:0035189; GO:0005819; GO:0016514","GO:0050681; GO:0097718; GO:0003677; GO:0003700; GO:0042802; GO:0061676; GO:0019900; GO:0051219; GO:0000987; GO:0001102; GO:0003713; GO:0008134; GO:0031625","GO:0030521; GO:0003180; GO:0007050; GO:0051301; GO:0048667; GO:0071466; GO:0006338; GO:0048565; GO:0043353; GO:0000082; GO:0034349; GO:0097284; GO:0034088; GO:0007093; GO:0045445; GO:0120163; GO:0043433; GO:0050680; GO:2000134; GO:0010629; GO:0050728; GO:1904761; GO:0006469; GO:0045879; GO:0045892; GO:0000122; GO:0071930; GO:0051402; GO:0042551; GO:0031175; GO:1904028; GO:1903055; GO:0045651; GO:0045842; GO:0045893; GO:0045944; GO:2000679; GO:0071459; GO:0007265; GO:0001558; GO:0090230; GO:0071922; GO:0043550; GO:0007346; GO:0006355; GO:0031134; GO:0035914; GO:0051146; GO:0001894; GO:0006351; GO:0016032"]
[2243,1119,"PN070","Rb","T821","Retinoblastoma-associated protein 1",{"v":1110.6638029217604,"d":"1111"},{"v":1079.6514054976155,"d":"1080"},{"v":631.0337770218525,"d":"631"},{"v":56.81591273271243,"d":"57"},{"v":13.910567535432383,"d":"14"},{"v":3694.365362142529,"d":"3694"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the T821 phosphosite.","T821 phosphorylation inhibits interaction with E2F1, Elf-1 and TFDP1, and induces binding with Rb. This is one of the major sites of in vivo phosphorylation of Rb.","CDK2; CDK6","P06400","P06400",452,null,"P06400","NP_000312","Block7",9,1,"7, 15, 23, 31",{"$nulls":13},"Nuclear receptor co-regulator; Transcription, coactivator/corepressor; Tumor suppressor","GO:0000785; GO:0005654; GO:0005634; GO:0016605; GO:0035189; GO:0005819; GO:0016514","GO:0050681; GO:0097718; GO:0003677; GO:0003700; GO:0042802; GO:0061676; GO:0019900; GO:0051219; GO:0000987; GO:0001102; GO:0003713; GO:0008134; GO:0031625","GO:0030521; GO:0003180; GO:0007050; GO:0051301; GO:0048667; GO:0071466; GO:0006338; GO:0048565; GO:0043353; GO:0000082; GO:0034349; GO:0097284; GO:0034088; GO:0007093; GO:0045445; GO:0120163; GO:0043433; GO:0050680; GO:2000134; GO:0010629; GO:0050728; GO:1904761; GO:0006469; GO:0045879; GO:0045892; GO:0000122; GO:0071930; GO:0051402; GO:0042551; GO:0031175; GO:1904028; GO:1903055; GO:0045651; GO:0045842; GO:0045893; GO:0045944; GO:2000679; GO:0071459; GO:0007265; GO:0001558; GO:0090230; GO:0071922; GO:0043550; GO:0007346; GO:0006355; GO:0031134; GO:0035914; GO:0051146; GO:0001894; GO:0006351; GO:0016032"]
[2245,1118,"PN265","Rb","T821+T826","Retinoblastoma-associated protein 1",{"v":392.683233450527,"d":"393"},{"v":292.199897023768,"d":"292"},{"v":449.5707122250644,"d":"450"},{"v":114.48686216487125,"d":"114"},{"v":50.862959879815115,"d":"51"},{"v":6130.179246877945,"d":"6130"},"External","MmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the T821 and T826 phosphosites.","T821 and T826 phosphorylation inhibits interaction with E2F1, Elf-1 and TFDP1, and induces binding with Rb. These are two of the major sites of in vivo phosphorylation of Rb.","T821: CDK2; CDK6. T826: CDK2; CDK4; CDK6.","P06400","P06400",452,null,"P06400","NP_000312","Block7",8,13,"7, 15, 23, 31",{"$nulls":13},"Nuclear receptor co-regulator; Transcription, coactivator/corepressor; Tumor suppressor","GO:0000785; GO:0005654; GO:0005634; GO:0016605; GO:0035189; GO:0005819; GO:0016514","GO:0050681; GO:0097718; GO:0003677; GO:0003700; GO:0042802; GO:0061676; GO:0019900; GO:0051219; GO:0000987; GO:0001102; GO:0003713; GO:0008134; GO:0031625","GO:0030521; GO:0003180; GO:0007050; GO:0051301; GO:0048667; GO:0071466; GO:0006338; GO:0048565; GO:0043353; GO:0000082; GO:0034349; GO:0097284; GO:0034088; GO:0007093; GO:0045445; GO:0120163; GO:0043433; GO:0050680; GO:2000134; GO:0010629; GO:0050728; GO:1904761; GO:0006469; GO:0045879; GO:0045892; GO:0000122; GO:0071930; GO:0051402; GO:0042551; GO:0031175; GO:1904028; GO:1903055; GO:0045651; GO:0045842; GO:0045893; GO:0045944; GO:2000679; GO:0071459; GO:0007265; GO:0001558; GO:0090230; GO:0071922; GO:0043550; GO:0007346; GO:0006355; GO:0031134; GO:0035914; GO:0051146; GO:0001894; GO:0006351; GO:0016032"]
[2247,1120,"PN071","Rb","T826","Retinoblastoma-associated protein 1",{"v":2004.9756749626677,"d":"2005"},{"v":1870.1158358042726,"d":"1870"},{"v":968.8271360891356,"d":"969"},{"v":48.3211416571014,"d":"48"},{"v":254.40746029893992,"d":"254"},{"v":6496.030697724236,"d":"6496"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the T826 phosphosite.","T826 phosphorylation inhibits interaction with E2F1, Elf-1 and TFDP1, and induces binding with Rb. This is one of the major sites of in vivo phosphorylation of Rb.","CDK2; CDK4; CDK6","P06400","P06400",452,null,"P06400","NP_000312","Block7",9,2,"7, 15, 23, 31",{"$nulls":13},"Nuclear receptor co-regulator; Transcription, coactivator/corepressor; Tumor suppressor","GO:0000785; GO:0005654; GO:0005634; GO:0016605; GO:0035189; GO:0005819; GO:0016514","GO:0050681; GO:0097718; GO:0003677; GO:0003700; GO:0042802; GO:0061676; GO:0019900; GO:0051219; GO:0000987; GO:0001102; GO:0003713; GO:0008134; GO:0031625","GO:0030521; GO:0003180; GO:0007050; GO:0051301; GO:0048667; GO:0071466; GO:0006338; GO:0048565; GO:0043353; GO:0000082; GO:0034349; GO:0097284; GO:0034088; GO:0007093; GO:0045445; GO:0120163; GO:0043433; GO:0050680; GO:2000134; GO:0010629; GO:0050728; GO:1904761; GO:0006469; GO:0045879; GO:0045892; GO:0000122; GO:0071930; GO:0051402; GO:0042551; GO:0031175; GO:1904028; GO:1903055; GO:0045651; GO:0045842; GO:0045893; GO:0045944; GO:2000679; GO:0071459; GO:0007265; GO:0001558; GO:0090230; GO:0071922; GO:0043550; GO:0007346; GO:0006355; GO:0031134; GO:0035914; GO:0051146; GO:0001894; GO:0006351; GO:0016032"]
[2249,1121,"PN649","RBM9 iso6","T7","RNA-binding protein 9",{"v":17071.31730625882,"d":"17071"},{"v":16740.954476511124,"d":"16741"},{"v":3480.729815465453,"d":"3481"},{"v":20.38934519827196,"d":"20"},{"v":2938.1668624680974,"d":"2938"},{"v":30681.01950670123,"d":"30681"},"Kinexus","RpAb","NEPL(pT)PGYHGC","Corresponds to amino acid residues N3 to G12.","The effect of T7 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of RBM9 isoform 6.","ERK1 (MAPK3)","O43251","O43251",4903212,null,null,"NP_001076047.1","Block7",9,3,"7, 15, 23, 31",{"$nulls":8},"X",{"$nulls":5},"GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0003729; GO:0003723; GO:0003714; GO:0008134","GO:0048813; GO:0008543; GO:0030520; GO:0006397; GO:0045892; GO:0007399; GO:0050885; GO:0021942; GO:0000381; GO:0042127; GO:0010724; GO:0016070; GO:0008380"]
[2251,1122,"PN650","RDBP","S89+T91","Negative elongation factor E",{"v":15164.640307910286,"d":"15165"},{"v":14699.818710265501,"d":"14700"},{"v":3389.610514713555,"d":"3390"},{"v":22.35206668862065,"d":"22"},{"v":7147.003060131409,"d":"7147"},{"v":23741.1321369692,"d":"23741"},"Kinexus","RpAb","CGFKR(pS)R(pT)LEGK","Corresponds to amino acid residues C85 to K95.","The effects of S89 and T91 phosphorylation are unclear. These are two of the major sites of in vivo phosphorylation of RDBP.",null,"P18615","P18615",5808,null,null,"NP_002895.3","Block7",9,4,"7, 15, 23, 31",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription, coactivator/corepressor","GO:0032021; GO:0016604; GO:0005654; GO:0005634; GO:0005886","GO:0003682; GO:0003723","GO:1900364; GO:0034244; GO:0070374; GO:0051571; GO:0045944; GO:0006366; GO:0006368"]
[2253,1123,"NN170","RelB","Pan-specific","Transcription factor RelB",{"v":471.0177328609999,"d":"471"},{"v":425.89863796482325,"d":"426"},{"v":381.9369620014404,"d":"382"},{"v":81.08759720818244,"d":"81"},{"v":8.856637909926675,"d":"9"},{"v":2300.607124408016,"d":"2301"},"External","RpAb","LLSPG","Corresponds to amino acid residues  L550 to G554; Surrounds the S552 phosphosite.",null,null,"Q01201","Q01201",3937,null,"Q01201","NP_006500.2","Block7",9,5,"7, 15, 23, 31",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005829; GO:0033256; GO:0005815; GO:0005654; GO:0005634; GO:0032991","GO:0003682; GO:0003700; GO:0042802; GO:0019901; GO:0000980; GO:0000977; GO:0000981; GO:0003714","GO:0019882; GO:0071470; GO:0032922; GO:0007249; GO:0006954; GO:0045087; GO:0030098; GO:0043011; GO:0032688; GO:0000122; GO:0038061; GO:0045944; GO:0034097; GO:0002223; GO:0045063; GO:0006351"]
[2255,1124,"PN151","RelB","S552","Transcription factor RelB",{"v":501.4673670241813,"d":"501"},{"v":436.15518239051346,"d":"436"},{"v":362.950624411556,"d":"363"},{"v":72.37771553618447,"d":"72"},{"v":28.528212471013862,"d":"29"},{"v":2113.65581959449,"d":"2114"},"External","RpAb","LL(pS)PG","Corresponds to amino acid residues  L550 to G554; Surrounds the S552 phosphosite.","The effect of S552 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of RelB.",null,"Q01201","Q01201",3937,null,"Q01201","NP_006500.2","Block7",9,6,"7, 15, 23, 31",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005829; GO:0033256; GO:0005815; GO:0005654; GO:0005634; GO:0032991","GO:0003682; GO:0003700; GO:0042802; GO:0019901; GO:0000980; GO:0000977; GO:0000981; GO:0003714","GO:0019882; GO:0071470; GO:0032922; GO:0007249; GO:0006954; GO:0045087; GO:0030098; GO:0043011; GO:0032688; GO:0000122; GO:0038061; GO:0045944; GO:0034097; GO:0002223; GO:0045063; GO:0006351"]
[2257,1125,"NK244-2","Ret (GDNF receptor)","Pan-specific","Proto-oncogene tyrosine-protein kinase receptor Ret",{"v":7087.925385022795,"d":"7088"},{"v":7025.602592172527,"d":"7026"},{"v":1694.9003677064059,"d":"1695"},{"v":23.91250296296615,"d":"24"},{"v":756.5489352098336,"d":"757"},{"v":13602.923265710075,"d":"13603"},"Kinexus","RpAb","CKRPVFADISKDLEKM","Corresponds to amino acid residues K994 to M1008; Kinase last alpha-chain.",null,null,"P07949","P07949",654,"P07949","P07949","NP_065681","Block7",9,7,"7, 15, 23, 31","RET","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Ret",{"$nulls":6},"Protein-tyrosine kinase (receptor), TK group, Ret family","GO:0030424; GO:0005829; GO:0030425; GO:0005769; GO:0010008; GO:0005887; GO:0043231; GO:0045121; GO:0043025; GO:0005886; GO:0098797; GO:0043235","GO:0005524; GO:0005509; GO:0004713; GO:0005088; GO:0038023; GO:0004714","GO:0006919; GO:0000187; GO:0007411; GO:0071300; GO:0001838; GO:0048484; GO:0035860; GO:0007156; GO:0060384; GO:0097021; GO:0000165; GO:0033619; GO:0001755; GO:0007158; GO:0042551; GO:0061146; GO:0033630; GO:0030335; GO:0045793; GO:2001241; GO:0043410; GO:0072300; GO:0014042; GO:0010976; GO:0033141; GO:0051897; GO:0045893; GO:0007497; GO:0006468; GO:0050770; GO:0030155; GO:0042493; GO:0048265; GO:0060041; GO:0007165; GO:0001657; GO:0035799"]
[2259,1127,"NK244-4","Ret (GDNF receptor)","Pan-specific","Proto-oncogene tyrosine-protein kinase receptor Ret",{"v":683.3499995410093,"d":"683"},{"v":562.3617914526667,"d":"562"},{"v":526.386503737106,"d":"526"},{"v":77.03029254271864,"d":"77"},{"v":102.71336380612124,"d":"103"},{"v":5375.982783844644,"d":"5376"},"External","MmAb","Epitope undefined.",{"$nulls":3},"P07949","P07949",654,"P07949","P07949","NP_065681","Block7",9,9,"7, 15, 23, 31","RET","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Ret",{"$nulls":6},"Protein-tyrosine kinase (receptor), TK group, Ret family","GO:0030424; GO:0005829; GO:0030425; GO:0005769; GO:0010008; GO:0005887; GO:0043231; GO:0045121; GO:0043025; GO:0005886; GO:0098797; GO:0043235","GO:0005524; GO:0005509; GO:0004713; GO:0005088; GO:0038023; GO:0004714","GO:0006919; GO:0000187; GO:0007411; GO:0071300; GO:0001838; GO:0048484; GO:0035860; GO:0007156; GO:0060384; GO:0097021; GO:0000165; GO:0033619; GO:0001755; GO:0007158; GO:0042551; GO:0061146; GO:0033630; GO:0030335; GO:0045793; GO:2001241; GO:0043410; GO:0072300; GO:0014042; GO:0010976; GO:0033141; GO:0051897; GO:0045893; GO:0007497; GO:0006468; GO:0050770; GO:0030155; GO:0042493; GO:0048265; GO:0060041; GO:0007165; GO:0001657; GO:0035799"]
[2261,1126,"PK793","Ret (GDNF receptor)","Y905","Proto-oncogene tyrosine-protein kinase receptor Ret",{"v":15344.16642688093,"d":"15344"},{"v":14748.01815734287,"d":"14748"},{"v":3778.8596530584223,"d":"3779"},{"v":24.627337503576374,"d":"25"},{"v":6548.188273335869,"d":"6548"},{"v":25329.8790298098,"d":"25330"},"Kinexus","RpAb","EDS(pY)VKR(bA)C","Corresponds to amino acid residues E902 to R908; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y905 phosphorylation stimulates phosphotransferase activity, and regulates cell growth. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of Ret.","FAK (PTK2); Ret; Src","P07949","P07949",654,"P07949","P07949","NP_065681","Block7",9,8,"7, 15, 23, 31","RET","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Ret",{"$nulls":6},"Protein-tyrosine kinase (receptor), TK group, Ret family","GO:0030424; GO:0005829; GO:0030425; GO:0005769; GO:0010008; GO:0005887; GO:0043231; GO:0045121; GO:0043025; GO:0005886; GO:0098797; GO:0043235","GO:0005524; GO:0005509; GO:0004713; GO:0005088; GO:0038023; GO:0004714","GO:0006919; GO:0000187; GO:0007411; GO:0071300; GO:0001838; GO:0048484; GO:0035860; GO:0007156; GO:0060384; GO:0097021; GO:0000165; GO:0033619; GO:0001755; GO:0007158; GO:0042551; GO:0061146; GO:0033630; GO:0030335; GO:0045793; GO:2001241; GO:0043410; GO:0072300; GO:0014042; GO:0010976; GO:0033141; GO:0051897; GO:0045893; GO:0007497; GO:0006468; GO:0050770; GO:0030155; GO:0042493; GO:0048265; GO:0060041; GO:0007165; GO:0001657; GO:0035799"]
[2263,1129,"PK794","RIOK1","Y466","Serine/threonine-protein kinase RIO1",{"v":5401.603662072163,"d":"5402"},{"v":4189.77243359692,"d":"4190"},{"v":3890.5794693884304,"d":"3891"},{"v":72.02637795709592,"d":"72"},{"v":1060.1439863316414,"d":"1060"},{"v":29870.47106624008,"d":"29870"},"Kinexus","RpAb","NIL(pY)QTV(bA)C","Corresponds to amino acid residues N463 to V469; In the C-terminal third of the kinase after the catalytic domain. ","The effect of Y466 phosphorylation is unclear. This is a major in vivo phosphorylation site in RIOK1.",null,"Q9BRS2","Q9BRS2",2358,"Q9BRS2",null,"NP_113668.2","Block7",9,11,"7, 15, 23, 31","RIOK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","RIO","RIO1",{"$nulls":5},"EC 2.7.11.1; Protein kinase, atypical; ATYPICAL domain target; ATYPICAL</A> group; RIO family; RIO1 subfamily","GO:0005829; GO:0034708; GO:0005654; GO:0030688","GO:0005524; GO:0016787; GO:0046872; GO:0004674","GO:0030490; GO:2000234; GO:0042274"]
[2265,1130,"PK890","RIOK2","S332+S335+S337","Serine/threonine-protein kinase RIO2",{"v":8729.320927362607,"d":"8729"},{"v":7675.7248576765505,"d":"7676"},{"v":3997.76433823078,"d":"3998"},{"v":45.79696830368025,"d":"46"},{"v":708.497296877143,"d":"708"},{"v":31188.191944435122,"d":"31188"},"Kinexus","RpAb","KEG(pS)EF(pS)F(pS)DGC","Corresponds to amino acid residues K329 to G339. S332, S335 and S337 are located in RIOK2 after the RIO domain.","The effect of their phosphoryation on RIOK2 is unknown. S332+S335+S337 are major sites of phosphorylation of RIOK2 from mass spectrometry studies (≥40-, >37-, and >50-times, respectively). ",null,"Q9BVS4","Q9BVS4",2360,"Q9BVS4",null,"NP_060813.2","Block7",9,12,"7, 15, 23, 31","RIOK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","RIO","RIO2",{"$nulls":5},"EC 2.7.11.1; Protein kinase, atypical; ATYPICAL domain target; ATYPICAL</A> group; RIO family; RIO2 subfamily","GO:0005737; GO:0005829; GO:0005654; GO:0030688","GO:0005524; GO:0046872; GO:0004674","GO:0007049; GO:0030490; GO:2000208; GO:2000234; GO:0046777; GO:0030071; GO:0042274"]
[2267,1132,"NK158-2","RIPK1 (RIP; RIPK)","Pan-specific","Receptor-interacting protein-serine/threonine kinase 1",{"v":689.9560895480153,"d":"690"},{"v":569.3526977796125,"d":"569"},{"v":439.53487018251553,"d":"440"},{"v":63.70475988848092,"d":"64"},{"v":147.41603405895083,"d":"147"},{"v":2879.608686136926,"d":"2880"},"External","MmAb","Epitope undefined.",{"$nulls":3},"Q13546","Q13546",750,"Q13546",null,"NP_003795","Block7",10,1,"7, 15, 23, 31","RIPK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RIPK",{"$nulls":6},"Protein-serine kinase, TKL group, RIPK family","GO:0005829; GO:0031264; GO:0010008; GO:0045121; GO:0005739; GO:0043235; GO:0097342","GO:0005524; GO:0070513; GO:0005123; GO:0042802; GO:0044877; GO:0004672; GO:0004674; GO:0031625","GO:0006919; GO:0007257; GO:1990000; GO:0006915; GO:0097190; GO:0044257; GO:0071363; GO:0071356; GO:0071550; GO:0097191; GO:0007249; GO:0002756; GO:0070266; GO:0097527; GO:2001237; GO:2001240; GO:1902042; GO:0043124; GO:0036289; GO:0043065; GO:2001238; GO:1905206; GO:0043123; GO:0032757; GO:0046330; GO:0045651; GO:0060545; GO:0010940; GO:0051092; GO:0043068; GO:0001934; GO:2000379; GO:0045944; GO:0032760; GO:0046777; GO:0016579; GO:0051291; GO:0051260; GO:0070926; GO:1902041; GO:0010803; GO:0034612; GO:0097343; GO:1901026; GO:0070231; GO:0034138; GO:0035666; GO:0033209; GO:0016032"]
[2269,1133,"PK795","RIPK1 (RIP; RIPK)","Y384","Receptor-interacting protein-serine kinase 1",{"v":4694.571448493492,"d":"4695"},{"v":4395.344050180545,"d":"4395"},{"v":1882.749972351747,"d":"1883"},{"v":40.10483157000261,"d":"40"},{"v":1237.9005668540567,"d":"1238"},{"v":13020.052936433112,"d":"13020"},"Kinexus","RpAb","EAN(pY)HLY(bA)C","Corresponds to amino acid residues E381 to Y387; In the region between the kinase catalytic and RHIM domains. ","The effect of Y384 phosphorylation is unclear. This is the major site of in vivo phosphorylation of RIPK1.",null,"Q13546","Q13546",750,"Q13546",null,"NP_003795","Block7",10,2,"7, 15, 23, 31","RIPK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RIPK",{"$nulls":6},"Protein-serine kinase, TKL group, RIPK family","GO:0005829; GO:0031264; GO:0010008; GO:0045121; GO:0005739; GO:0043235; GO:0097342","GO:0005524; GO:0070513; GO:0005123; GO:0042802; GO:0044877; GO:0004672; GO:0004674; GO:0031625","GO:0006919; GO:0007257; GO:1990000; GO:0006915; GO:0097190; GO:0044257; GO:0071363; GO:0071356; GO:0071550; GO:0097191; GO:0007249; GO:0002756; GO:0070266; GO:0097527; GO:2001237; GO:2001240; GO:1902042; GO:0043124; GO:0036289; GO:0043065; GO:2001238; GO:1905206; GO:0043123; GO:0032757; GO:0046330; GO:0045651; GO:0060545; GO:0010940; GO:0051092; GO:0043068; GO:0001934; GO:2000379; GO:0045944; GO:0032760; GO:0046777; GO:0016579; GO:0051291; GO:0051260; GO:0070926; GO:1902041; GO:0010803; GO:0034612; GO:0097343; GO:1901026; GO:0070231; GO:0034138; GO:0035666; GO:0033209; GO:0016032"]
[2271,1128,"NK157-3","RIPK2 (RICK; RIP2; CARD3)","Pan-specific","Receptor-interacting serine-threonine-protein kinase 2",{"v":461.47060465795147,"d":"461"},{"v":431.1565483077086,"d":"431"},{"v":229.38442679551497,"d":"229"},{"v":49.70726726256767,"d":"50"},{"v":85.97123972434565,"d":"86"},{"v":1705.1667531172138,"d":"1705"},"External","MmAb","Epitope undefined.",{"$nulls":3},"O43353","O43353",751,"O43353",null,"NP_003812.1","Block7",9,10,"7, 15, 23, 31","RIPK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RIPK",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; TKL group; RIPK family","GO:0005737; GO:0005856; GO:0005829; GO:0032991; GO:0031982","GO:0005524; GO:0050700; GO:0089720; GO:0042802; GO:0030274; GO:0004715; GO:0042803; GO:0004674; GO:0005102","GO:0097202; GO:0000187; GO:0002250; GO:0006915; GO:0071223; GO:0071225; GO:0071224; GO:0050830; GO:0007249; GO:0006954; GO:0045087; GO:0070498; GO:0007254; GO:0031663; GO:0000165; GO:0043066; GO:0070427; GO:0070431; GO:0070423; GO:0046641; GO:0043065; GO:0010942; GO:0032722; GO:0001961; GO:0070374; GO:0043123; GO:0033091; GO:0032727; GO:0032728; GO:0032729; GO:0032735; GO:0050718; GO:0032743; GO:0032755; GO:0046330; GO:0051092; GO:0033138; GO:0010800; GO:0050731; GO:0032092; GO:0031398; GO:0045627; GO:0045944; GO:0032760; GO:1904417; GO:0043330; GO:0070671; GO:0070673; GO:0007165; GO:0042098; GO:0050852; GO:0034134; GO:0034142"]
[2273,1131,"NK157","RIPK2 (RICK; RIP2; CARD3)","Pan-specific","Receptor-interacting serine-threonine-protein kinase 2",{"v":60.698916808233406,"d":"61"},{"v":36.54920088734917,"d":"37"},{"v":83.12569142455489,"d":"83"},{"v":136.94756973534567,"d":"137"},{"v":6.782977338870666,"d":"7"},{"v":492.24213594599235,"d":"492"},"External","MmAb","Epitope undefined.",{"$nulls":3},"O43353","O43353",751,"O43353",null,"NP_003812.1","Block7",9,13,"7, 15, 23, 31","RIPK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RIPK",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; TKL group; RIPK family","GO:0005737; GO:0005856; GO:0005829; GO:0032991; GO:0031982","GO:0005524; GO:0050700; GO:0089720; GO:0042802; GO:0030274; GO:0004715; GO:0042803; GO:0004674; GO:0005102","GO:0097202; GO:0000187; GO:0002250; GO:0006915; GO:0071223; GO:0071225; GO:0071224; GO:0050830; GO:0007249; GO:0006954; GO:0045087; GO:0070498; GO:0007254; GO:0031663; GO:0000165; GO:0043066; GO:0070427; GO:0070431; GO:0070423; GO:0046641; GO:0043065; GO:0010942; GO:0032722; GO:0001961; GO:0070374; GO:0043123; GO:0033091; GO:0032727; GO:0032728; GO:0032729; GO:0032735; GO:0050718; GO:0032743; GO:0032755; GO:0046330; GO:0051092; GO:0033138; GO:0010800; GO:0050731; GO:0032092; GO:0031398; GO:0045627; GO:0045944; GO:0032760; GO:1904417; GO:0043330; GO:0070671; GO:0070673; GO:0007165; GO:0042098; GO:0050852; GO:0034134; GO:0034142"]
[2275,1134,"PK796","RIPK2 (RICK; RIP2; CARD3)","S176","Receptor-interacting serine/threonine-protein kinase 2 (RIPK2)",{"v":11848.939761712245,"d":"11849"},{"v":11606.366387071448,"d":"11606"},{"v":2787.5238219312173,"d":"2788"},{"v":23.52551264492548,"d":"24"},{"v":1507.0038808214344,"d":"1507"},{"v":22124.34335461737,"d":"22124"},"Kinexus","RpAb","MSL(pS)QSR(bA)C","Corresponds to amino acid residues M173 to R179; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S176 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of RIPK2.","RIPK2","O43353","O43353",751,"O43353",null,"NP_003812.1","Block7",10,3,"7, 15, 23, 31","RIPK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RIPK",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; TKL group; RIPK family","GO:0005737; GO:0005856; GO:0005829; GO:0032991; GO:0031982","GO:0005524; GO:0050700; GO:0089720; GO:0042802; GO:0030274; GO:0004715; GO:0042803; GO:0004674; GO:0005102","GO:0097202; GO:0000187; GO:0002250; GO:0006915; GO:0071223; GO:0071225; GO:0071224; GO:0050830; GO:0007249; GO:0006954; GO:0045087; GO:0070498; GO:0007254; GO:0031663; GO:0000165; GO:0043066; GO:0070427; GO:0070431; GO:0070423; GO:0046641; GO:0043065; GO:0010942; GO:0032722; GO:0001961; GO:0070374; GO:0043123; GO:0033091; GO:0032727; GO:0032728; GO:0032729; GO:0032735; GO:0050718; GO:0032743; GO:0032755; GO:0046330; GO:0051092; GO:0033138; GO:0010800; GO:0050731; GO:0032092; GO:0031398; GO:0045627; GO:0045944; GO:0032760; GO:1904417; GO:0043330; GO:0070671; GO:0070673; GO:0007165; GO:0042098; GO:0050852; GO:0034134; GO:0034142"]
[2277,1135,"PK797","RIPK2 (RICK; RIP2; CARD3)","Y381","Receptor-interacting serine/threonine-protein kinase 2 (RIPK2)",{"v":10353.880119515386,"d":"10354"},{"v":10369.665405822458,"d":"10370"},{"v":2151.689174514688,"d":"2152"},{"v":20.781476602757863,"d":"21"},{"v":2107.7975796421647,"d":"2108"},{"v":16497.124020980158,"d":"16497"},"Kinexus","RpAb","QDA(pY)FMK(bA)C","Corresponds to amino acid residues Q378 to K384; In the region between the kinase catalytic and RHIM domains. ","Y381 phosphorylation stimulates phosphotransferase activity towards ARHGEF2. This is a major in vivo phosphorylation site in RIPK2.",null,"O43353","O43353",751,"O43353",null,"NP_003812.1","Block7",10,4,"7, 15, 23, 31","RIPK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RIPK",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; TKL group; RIPK family","GO:0005737; GO:0005856; GO:0005829; GO:0032991; GO:0031982","GO:0005524; GO:0050700; GO:0089720; GO:0042802; GO:0030274; GO:0004715; GO:0042803; GO:0004674; GO:0005102","GO:0097202; GO:0000187; GO:0002250; GO:0006915; GO:0071223; GO:0071225; GO:0071224; GO:0050830; GO:0007249; GO:0006954; GO:0045087; GO:0070498; GO:0007254; GO:0031663; GO:0000165; GO:0043066; GO:0070427; GO:0070431; GO:0070423; GO:0046641; GO:0043065; GO:0010942; GO:0032722; GO:0001961; GO:0070374; GO:0043123; GO:0033091; GO:0032727; GO:0032728; GO:0032729; GO:0032735; GO:0050718; GO:0032743; GO:0032755; GO:0046330; GO:0051092; GO:0033138; GO:0010800; GO:0050731; GO:0032092; GO:0031398; GO:0045627; GO:0045944; GO:0032760; GO:1904417; GO:0043330; GO:0070671; GO:0070673; GO:0007165; GO:0042098; GO:0050852; GO:0034134; GO:0034142"]
[2279,1137,"NK160","ROCK1 (ROKb)","Pan-specific","Rho-associated protein kinase 1",{"v":57.093239228641124,"d":"57"},{"v":33.85344957401689,"d":"34"},{"v":83.9957294646486,"d":"84"},{"v":147.12027308219658,"d":"147"},{"v":9.470638701660214,"d":"9"},{"v":562.3693329688326,"d":"562"},"External","MmAb","Epitope undefined.",{"$nulls":3},"Q13464","Q13464",754,"Q13464",null,"NP_005397","Block7",10,6,"7, 15, 23, 31","ROCK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","DMPK","ROCK",{"$nulls":6},"GO:0032059; GO:0005814; GO:0010494; GO:0005856; GO:0005829; GO:0005576; GO:0000139; GO:0030027; GO:0005886; GO:0001726; GO:0034774","GO:0005524; GO:0017049; GO:0046872; GO:0004672; GO:0004674","GO:0030036; GO:0003383; GO:0006915; GO:0032060; GO:0030866; GO:0048013; GO:0007186; GO:0007249; GO:0007159; GO:0050900; GO:0050901; GO:0022614; GO:0051451; GO:1902430; GO:1902992; GO:0016525; GO:1903347; GO:0070168; GO:0051045; GO:0035509; GO:0043524; GO:0032091; GO:0140058; GO:0031175; GO:0043312; GO:1900223; GO:0010508; GO:0010613; GO:1905205; GO:0051894; GO:0010628; GO:0043410; GO:0072659; GO:0006468; GO:0032956; GO:1902003; GO:0110061; GO:0010506; GO:0030155; GO:2000145; GO:2000114; GO:1903140; GO:0051893; GO:0045616; GO:0045664; GO:0051492; GO:1900242; GO:1990776; GO:0071559; GO:0007266; GO:0007165; GO:0006939; GO:0048010"]
[2281,1138,"PK798","ROCK1 (ROKb)","Y913","Rho-associated protein kinase 1",{"v":12120.040000683875,"d":"12120"},{"v":11862.476850695311,"d":"11862"},{"v":2630.778767807562,"d":"2631"},{"v":21.706023805689746,"d":"22"},{"v":2096.4856140749944,"d":"2096"},{"v":22342.79904693315,"d":"22343"},"Kinexus","RpAb","EEQ(pY)FEL(bA)C","Corresponds to amino acid residues E910 to L916; Just before Rho-Binding domain.","The effect of Y913 phosphorylation is unclear. This is the major in vivo phosphorylation site in ROCK1.",null,"Q13464","Q13464",754,"Q13464",null,"NP_005397","Block7",10,7,"7, 15, 23, 31","ROCK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","DMPK","ROCK",{"$nulls":6},"GO:0032059; GO:0005814; GO:0010494; GO:0005856; GO:0005829; GO:0005576; GO:0000139; GO:0030027; GO:0005886; GO:0001726; GO:0034774","GO:0005524; GO:0017049; GO:0046872; GO:0004672; GO:0004674","GO:0030036; GO:0003383; GO:0006915; GO:0032060; GO:0030866; GO:0048013; GO:0007186; GO:0007249; GO:0007159; GO:0050900; GO:0050901; GO:0022614; GO:0051451; GO:1902430; GO:1902992; GO:0016525; GO:1903347; GO:0070168; GO:0051045; GO:0035509; GO:0043524; GO:0032091; GO:0140058; GO:0031175; GO:0043312; GO:1900223; GO:0010508; GO:0010613; GO:1905205; GO:0051894; GO:0010628; GO:0043410; GO:0072659; GO:0006468; GO:0032956; GO:1902003; GO:0110061; GO:0010506; GO:0030155; GO:2000145; GO:2000114; GO:1903140; GO:0051893; GO:0045616; GO:0045664; GO:0051492; GO:1900242; GO:1990776; GO:0071559; GO:0007266; GO:0007165; GO:0006939; GO:0048010"]
[2283,1139,"NK159-1","ROCK2 (ROKa)","Pan-specific","Rho-associated protein kinase 2",{"v":281.4213598374308,"d":"281"},{"v":201.91712786340793,"d":"202"},{"v":254.55069491778335,"d":"255"},{"v":90.45180332609796,"d":"90"},{"v":10.58027501232661,"d":"11"},{"v":1101.27216127366,"d":"1101"},"External","MmAb","Epitope undefined.",{"$nulls":3},"O75116","O75116",755,"O75116",null,"NP_004841","Block7",10,8,"7, 15, 23, 31","ROCK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","DMPK","ROCK",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; AGC domain target; AGC</A> group; DMPK family; ROCK subfamily","GO:0005813; GO:0036464; GO:0005829; GO:0005634; GO:0005886","GO:0005524; GO:0046872; GO:0004674; GO:0072518; GO:0017048; GO:0003723; GO:0005198","GO:0071394; GO:0051298; GO:0030866; GO:0048013; GO:0007186; GO:0007249; GO:0016525; GO:1903347; GO:0070168; GO:0035509; GO:0150033; GO:0018105; GO:0018107; GO:1902004; GO:1902993; GO:1902961; GO:0010613; GO:0030335; GO:0010825; GO:0032723; GO:1905205; GO:0010595; GO:0090271; GO:0010628; GO:0043410; GO:1902966; GO:0001934; GO:0051496; GO:0072659; GO:0006468; GO:0032956; GO:0110061; GO:0030155; GO:2000145; GO:0042752; GO:2000114; GO:1903140; GO:0051893; GO:0045616; GO:0051246; GO:0051492; GO:1990776; GO:0071559; GO:0007266; GO:0048511; GO:0006939; GO:0048010; GO:0039694"]
[2285,1140,"NK159-2","ROCK2 (ROKa)","Pan-specific","Rho-associated protein kinase 2",{"v":905.4869490808063,"d":"905"},{"v":931.5292290178279,"d":"932"},{"v":553.76869625829,"d":"554"},{"v":61.157004727725926,"d":"61"},{"v":11.403464593493478,"d":"11"},{"v":2607.290166535599,"d":"2607"},"External","RpAb","Epitope undefined.",{"$nulls":3},"O75116","O75116",755,"O75116",null,"NP_004841","Block7",10,9,"7, 15, 23, 31","ROCK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","DMPK","ROCK",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; AGC domain target; AGC</A> group; DMPK family; ROCK subfamily","GO:0005813; GO:0036464; GO:0005829; GO:0005634; GO:0005886","GO:0005524; GO:0046872; GO:0004674; GO:0072518; GO:0017048; GO:0003723; GO:0005198","GO:0071394; GO:0051298; GO:0030866; GO:0048013; GO:0007186; GO:0007249; GO:0016525; GO:1903347; GO:0070168; GO:0035509; GO:0150033; GO:0018105; GO:0018107; GO:1902004; GO:1902993; GO:1902961; GO:0010613; GO:0030335; GO:0010825; GO:0032723; GO:1905205; GO:0010595; GO:0090271; GO:0010628; GO:0043410; GO:1902966; GO:0001934; GO:0051496; GO:0072659; GO:0006468; GO:0032956; GO:0110061; GO:0030155; GO:2000145; GO:0042752; GO:2000114; GO:1903140; GO:0051893; GO:0045616; GO:0051246; GO:0051492; GO:1990776; GO:0071559; GO:0007266; GO:0048511; GO:0006939; GO:0048010; GO:0039694"]
[2287,1141,"PK799","ROCK2 (ROKa)","Y722","Rho-associated protein kinase 2",{"v":3301.759248764739,"d":"3302"},{"v":3068.7846341002355,"d":"3069"},{"v":1431.6022060136108,"d":"1432"},{"v":43.35877022375889,"d":"43"},{"v":214.31036921688292,"d":"214"},{"v":8124.200202880465,"d":"8124"},"Kinexus","RpAb","NKI(pY)ESI(bA)C","Corresponds to amino acid residues N719 to I725; In the region between the kinase catalytic and Rho_Binding domains. ","Y722 phosphorylation inhibits phosphotransferase activity and inhibits interaction with RhoA. This is the major site of in vivo phosphorylation of ROCK2.",null,"O75116","O75116",755,"O75116",null,"NP_004841","Block7",10,10,"7, 15, 23, 31","ROCK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","DMPK","ROCK",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; AGC domain target; AGC</A> group; DMPK family; ROCK subfamily","GO:0005813; GO:0036464; GO:0005829; GO:0005634; GO:0005886","GO:0005524; GO:0046872; GO:0004674; GO:0072518; GO:0017048; GO:0003723; GO:0005198","GO:0071394; GO:0051298; GO:0030866; GO:0048013; GO:0007186; GO:0007249; GO:0016525; GO:1903347; GO:0070168; GO:0035509; GO:0150033; GO:0018105; GO:0018107; GO:1902004; GO:1902993; GO:1902961; GO:0010613; GO:0030335; GO:0010825; GO:0032723; GO:1905205; GO:0010595; GO:0090271; GO:0010628; GO:0043410; GO:1902966; GO:0001934; GO:0051496; GO:0072659; GO:0006468; GO:0032956; GO:0110061; GO:0030155; GO:2000145; GO:0042752; GO:2000114; GO:1903140; GO:0051893; GO:0045616; GO:0051246; GO:0051492; GO:1990776; GO:0071559; GO:0007266; GO:0048511; GO:0006939; GO:0048010; GO:0039694"]
[2289,1142,"NK161-2","Ron (RONa)","Pan-specific","Macrophage-stimulating protein receptor alpha chain",{"v":8118.567164733429,"d":"8119"},{"v":8003.125255353588,"d":"8003"},{"v":1788.7188042133298,"d":"1789"},{"v":22.0324444932034,"d":"22"},{"v":1862.4329997187601,"d":"1862"},{"v":13425.788769979315,"d":"13426"},"Kinexus","RpAb","CLRDLDSALLAEVKDV","Corresponds to amino acid residues R1060 to V1073.",null,null,"Q04912","Q04912",1945,"Q04912","Q04912","NP_002438","Block7",10,11,"7, 15, 23, 31","RON","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK","Met",{"$nulls":6},"EC 2.7.10.1; Receptor tyrosine kinase; TK domain target; TK</A> group; Met family","GO:0009986; GO:0005887; GO:0005886; GO:0001725; GO:0005773","GO:0005524; GO:0019899; GO:0005011","GO:0006952; GO:0048012; GO:0045087; GO:0008284; GO:0043406; GO:0051897; GO:0009615; GO:0007165; GO:0007338"]
[2291,1143,"PK800","Ron (RONa)","Y1238","Macrophage-stimulating protein receptor alpha chain",{"v":9285.943973490626,"d":"9286"},{"v":9136.875125935296,"d":"9137"},{"v":2382.4480713570106,"d":"2382"},{"v":25.656498447097974,"d":"26"},{"v":2943.727378328766,"d":"2944"},{"v":16800.72697586937,"d":"16801"},"Kinexus","RpAb","DRE(pY)YSV(bA)C","Corresponds to amino acid residues D1235 to V1241; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y1238 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of Ron.",null,"Q04912","Q04912",1945,"Q04912","Q04912","NP_002438","Block7",10,12,"7, 15, 23, 31","RON","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK","Met",{"$nulls":6},"EC 2.7.10.1; Receptor tyrosine kinase; TK domain target; TK</A> group; Met family","GO:0009986; GO:0005887; GO:0005886; GO:0001725; GO:0005773","GO:0005524; GO:0019899; GO:0005011","GO:0006952; GO:0048012; GO:0045087; GO:0008284; GO:0043406; GO:0051897; GO:0009615; GO:0007165; GO:0007338"]
[2293,1144,"PK801","Ron (RONa)","Y1238+Y1239","Macrophage-stimulating protein receptor alpha chain",{"v":8262.997460928142,"d":"8263"},{"v":8005.5129342057235,"d":"8006"},{"v":2294.3831671938174,"d":"2294"},{"v":27.766959605674383,"d":"28"},{"v":2637.5291919361493,"d":"2638"},{"v":18092.825993177732,"d":"18093"},"Kinexus","RpAb","DRE(pY)(pY)SV(bA)C","Corresponds to amino acid residues D1235 to V1241; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y1238 and Y1239 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major sites of in vivo phosphorylation of Ron.",null,"Q04912","Q04912",1945,"Q04912","Q04912","NP_002438","Block7",10,13,"7, 15, 23, 31","RON","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK","Met",{"$nulls":6},"EC 2.7.10.1; Receptor tyrosine kinase; TK domain target; TK</A> group; Met family","GO:0009986; GO:0005887; GO:0005886; GO:0001725; GO:0005773","GO:0005524; GO:0019899; GO:0005011","GO:0006952; GO:0048012; GO:0045087; GO:0008284; GO:0043406; GO:0051897; GO:0009615; GO:0007165; GO:0007338"]
[2295,1145,"PK802","ROR2 (RON2)","Y645+Y646","Neurotrophic tyrosine kinase, receptor-related 2",{"v":5435.381880202445,"d":"5435"},{"v":5284.664272929935,"d":"5285"},{"v":1381.201752117132,"d":"1381"},{"v":25.411310236507024,"d":"25"},{"v":2725.1997259576547,"d":"2725"},{"v":10990.906700771686,"d":"10991"},"Kinexus","RpAb","AAD(pY)(pY)KLL(bA)C","Corresponds to amino acid residues A642 to L649; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y645 and Y646 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major sites of in vivo phosphorylation of ROR2.",null,"Q01974","Q01974",1127,"Q01974","Q01974","NP_004551.2","Block7",11,1,"7, 15, 23, 31","ROR2","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Ror",{"$nulls":6},"Protein-tyrosine kinase, TK group, Ror family","GO:0009986; GO:0030669; GO:0030425; GO:0005887; GO:0005874; GO:0043025; GO:0005886","GO:0005524; GO:1904929; GO:0005109; GO:0046872; GO:0031435; GO:0004714; GO:0017147","GO:0014002; GO:0030509; GO:0030282; GO:0001502; GO:0045165; GO:0042733; GO:0030538; GO:0042472; GO:0007254; GO:1905517; GO:0030539; GO:0007275; GO:0090090; GO:0008285; GO:0090263; GO:0030335; GO:0043507; GO:0045651; GO:1900020; GO:0051968; GO:0045893; GO:0007165; GO:0060395; GO:0007224; GO:0001756; GO:0007169; GO:0007223; GO:0060071"]
[2297,1146,"PN651","RORA","S35","Nuclear receptor ROR-alpha",{"v":7248.824550637544,"d":"7249"},{"v":7221.098885993024,"d":"7221"},{"v":1667.9677544597405,"d":"1668"},{"v":23.010182448312126,"d":"23"},{"v":810.5137561885915,"d":"811"},{"v":11975.462928456222,"d":"11975"},"Kinexus","RpAb","LNQE(pS)ARK(bA)C","Corresponds to amino acid residues L31 to K38.","S35 phosphorylation induces interaction with CTNNB1. This is one of the major sites of in vivo phosphorylation of RORA.","PKCa (PRKCA)","P35398","P35398",12615200,null,null,"NP_599022.1","Block7",11,2,"7, 15, 23, 31",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":5},"GO:0005654; GO:0005634","GO:0008013; GO:0003677; GO:0003700; GO:0004879; GO:0008142; GO:0000978; GO:0000977; GO:0000981; GO:0043565; GO:0003707; GO:0001228; GO:0001223; GO:0001222; GO:0098531; GO:0008134; GO:0008270","GO:0001525; GO:0071456; GO:0071347; GO:0036315; GO:0071356; GO:0021930; GO:0021702; GO:0046068; GO:0042632; GO:0032922; GO:0019221; GO:0030522; GO:0042692; GO:0045599; GO:0043124; GO:0050728; GO:0006809; GO:0042753; GO:0045893; GO:0045944; GO:0010575; GO:0010906; GO:0043030; GO:0008589; GO:0019218; GO:0006355; GO:0060850; GO:0072539; GO:0006367; GO:0070328; GO:0006805"]
[2299,1147,"NK163-3","Ros","Pan-specific","Orosomucoid 1 receptor-tyrosine kinase; Proto-oncogene tyrosine-protein kinase ROS1",{"v":8840.507696053219,"d":"8841"},{"v":8640.899088720415,"d":"8641"},{"v":1901.54757959524,"d":"1902"},{"v":21.509483900389252,"d":"22"},{"v":1771.7085402804282,"d":"1772"},{"v":14189.396997905273,"d":"14189"},"Kinexus","RpAb","CAIHTLPTQEEIENLP","Corresponds to amino acid residues A1924 to P1938.",null,null,"P08922","P08922",1958,"P08922","P08922","NP_002935","Block7",11,3,"7, 15, 23, 31","ROS1","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Sev",{"$nulls":6},"EC 2.7.10.1; Receptor tyrosine kinase; TK group; Sev family","GO:0009986; GO:0016021; GO:0016020; GO:0048471; GO:0005886","GO:0005524; GO:0019903; GO:0004713; GO:0004714","GO:0030154; GO:0008283; GO:0002066; GO:0010629; GO:0038083; GO:0006468; GO:0001558; GO:0070372; GO:0010966; GO:0032006; GO:0023014; GO:0007283; GO:0007169"]
[2301,1148,"NK163-4","Ros","Pan-specific","Orosomucoid 1 receptor-tyrosine kinase; Proto-oncogene tyrosine-protein kinase ROS1",{"v":5088.592387489974,"d":"5089"},{"v":4857.592173479083,"d":"4858"},{"v":1449.2558191764801,"d":"1449"},{"v":28.480485541333522,"d":"28"},{"v":2588.061292417763,"d":"2588"},{"v":11563.070843786874,"d":"11563"},"Kinexus","RpAb","CRPTFHRIQDQLQLFR","Corresponds to amino acid residues R2205 to R2219; Kinase last alpha-chain.",null,null,"P08922","P08922",1958,"P08922","P08922","NP_002935","Block7",11,4,"7, 15, 23, 31","ROS1","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Sev",{"$nulls":6},"EC 2.7.10.1; Receptor tyrosine kinase; TK group; Sev family","GO:0009986; GO:0016021; GO:0016020; GO:0048471; GO:0005886","GO:0005524; GO:0019903; GO:0004713; GO:0004714","GO:0030154; GO:0008283; GO:0002066; GO:0010629; GO:0038083; GO:0006468; GO:0001558; GO:0070372; GO:0010966; GO:0032006; GO:0023014; GO:0007283; GO:0007169"]
[2303,1149,"PK803","Ros","Y2114+Y2115","Orosomucoid 1 receptor-tyrosine kinase; Proto-oncogene tyrosine-protein kinase ROS1",{"v":12036.042201817541,"d":"12036"},{"v":11765.685021606747,"d":"11766"},{"v":2538.680063617123,"d":"2539"},{"v":21.092316070757555,"d":"21"},{"v":5299.688418791877,"d":"5300"},{"v":23142.035558247015,"d":"23142"},"Kinexus","RpAb","ND(pY)(pY)RKR(bA)C","Corresponds to amino acid residues N2112 to R2118; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y2114 and Y2115 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of Ros.",null,"P08922","P08922",1958,"P08922","P08922","NP_002935","Block7",11,5,"7, 15, 23, 31","ROS1","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Sev",{"$nulls":6},"EC 2.7.10.1; Receptor tyrosine kinase; TK group; Sev family","GO:0009986; GO:0016021; GO:0016020; GO:0048471; GO:0005886","GO:0005524; GO:0019903; GO:0004713; GO:0004714","GO:0030154; GO:0008283; GO:0002066; GO:0010629; GO:0038083; GO:0006468; GO:0001558; GO:0070372; GO:0010966; GO:0032006; GO:0023014; GO:0007283; GO:0007169"]
[2305,1150,"PN685","RPS6","S235+S236","40S Ribosomal S6",{"v":14044.820215369558,"d":"14045"},{"v":12410.784457027756,"d":"12411"},{"v":7548.774480505666,"d":"7549"},{"v":53.747747317155934,"d":"54"},{"v":1488.6858685020293,"d":"1489"},{"v":52256.19279770971,"d":"52256"},"Kinexus","RpAb","RRL(pS)(pS)LRA(bA)C     ","Corresponds to amino acid residues R232 to A239. S235 and S236 are located near the C-terminus of the protein. Phosphorylation appears to induce interaction with mRNA for proteins involved in protein synthesis, which often have a 7-methylGuanylate cap.","S235+S236 phosphorylation is believed to increase the translation of mRNA important for protein synthesis by facilitating the assembly of the preinitiation complex. S235 and S236 are the major sites of phosphorylation of the 40S ribosomal protein S6.","S235: Akt1 (PKBa); Akt2 (PKBb); AurB (STK12); DAPK1; p70S6K (RPS6KB1); PASK; PKACa (PRKACA); PKCd (PRKCD); RSK1 (RPS6KA1); RSK2 (RPS6KA3). S236: Akt1 (PKBa); Akt2 (PKBb); AurB (STK12); DAPK1; p70S6K (RPS6KB1); PASK; PKACa (PRKACA); PKCd (PRKCD); RSK1 (RPS6KA1); RSK2 (RPS6KA3).","P62753","P62753",1040,null,null,"NP_001001","Block7",11,6,"7, 15, 23, 31",{"$nulls":3},"Translation protein - 40S ribosomal protein subunit",{"$nulls":9},"Protein synthesis, 40S ribosome","GO:0044297; GO:0036464; GO:0005829; GO:0022627; GO:0030425; GO:0005783; GO:0016020; GO:0005730; GO:0005654; GO:0005634; GO:1990904; GO:0015935","GO:0019901; GO:0003723; GO:0003735","GO:0042593; GO:0000184; GO:0043065; GO:0042274; GO:0006364; GO:0006614; GO:0031929; GO:0006412; GO:0006413"]
[2307,1151,"PN559","RPS6","S235+S236+S240","40S Ribosomal S6",{"v":5875.207450280321,"d":"5875"},{"v":5691.78801950654,"d":"5692"},{"v":1736.6434965708045,"d":"1737"},{"v":29.558845560218387,"d":"30"},{"v":1942.0028047541375,"d":"1942"},{"v":10939.025290377303,"d":"10939"},"Kinexus","RpAb","RRL(pS)(pS)LRA(pS)TS(bA)C     ","Corresponds to amino acid residues R232 to A239. S235 and S236 are located near the C-terminus of the protein. Phosphorylation appears to induce interaction with mRNA for proteins involved in protein synthesis, which often have a 7-methylGuanylate cap.","S235+S236+S240 phosphorylation is believed to increase the translation of mRNA important for protein synthesis by facilitating the assembly of the preinitiation complex. S235 and S236 are the major sites of phosphorylation of the 40S ribosomal protein S6.","S235: Akt1 (PKBa); Akt2 (PKBb); AurB (STK12); DAPK1; p70S6K (RPS6KB1); PASK; PKACa (PRKACA); PKCd (PRKCD); RSK1 (RPS6KA1); RSK2 (RPS6KA3). S236: Akt1 (PKBa); Akt2 (PKBb); AurB (STK12); DAPK1; p70S6K (RPS6KB1); PASK; PKACa (PRKACA); PKCd (PRKCD); RSK1 (RPS6KA1); RSK2 (RPS6KA3).","P62753","P62753",1040,null,null,"NP_001001","Block7",11,7,"7, 15, 23, 31",{"$nulls":3},"Translation protein - 40S ribosomal protein subunit",{"$nulls":9},"Protein synthesis, 40S ribosome","GO:0044297; GO:0036464; GO:0005829; GO:0022627; GO:0030425; GO:0005783; GO:0016020; GO:0005730; GO:0005654; GO:0005634; GO:1990904; GO:0015935","GO:0019901; GO:0003723; GO:0003735","GO:0042593; GO:0000184; GO:0043065; GO:0042274; GO:0006364; GO:0006614; GO:0031929; GO:0006412; GO:0006413"]
[2309,1152,"PN268","RPS6","S236","40S Ribosomal S6",{"v":647.7128881165617,"d":"648"},{"v":594.8477034837175,"d":"595"},{"v":359.0814297171609,"d":"359"},{"v":55.43836417418038,"d":"55"},{"v":156.87748625811378,"d":"157"},{"v":2273.298586760834,"d":"2273"},"External","MmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the S236 phosphosite.","S236 phosphorylation is believed to increase the translation of mRNA important for protein synthesis by facilitating the assembly of the preinitiation complex. S236 is a the major site of phosphorylation of the 40S ribosomal protein S6.","S236: Akt1 (PKBa); Akt2 (PKBb); AurB (STK12); DAPK1; p70S6K (RPS6KB1); PASK; PKACa (PRKACA); PKCd (PRKCD); RSK1 (RPS6KA1); RSK2 (RPS6KA3).","P62753","P62753",1040,null,null,"NP_001001","Block7",11,8,"7, 15, 23, 31",{"$nulls":13},"Protein synthesis, 40S ribosome","GO:0044297; GO:0036464; GO:0005829; GO:0022627; GO:0030425; GO:0005783; GO:0016020; GO:0005730; GO:0005654; GO:0005634; GO:1990904; GO:0015935","GO:0019901; GO:0003723; GO:0003735","GO:0042593; GO:0000184; GO:0043065; GO:0042274; GO:0006364; GO:0006614; GO:0031929; GO:0006412; GO:0006413"]
[2311,1153,"NK164-3","RSK1 (RPS6KA1, p90RSK)","Pan-specific","Ribosomal S6 protein-serine kinase 1; Ribosomal protein S6 kinase alpha 2",{"v":1906.3777719251054,"d":"1906"},{"v":1832.4625980190826,"d":"1832"},{"v":718.8821995465142,"d":"719"},{"v":37.70932551424841,"d":"38"},{"v":238.2554860831376,"d":"238"},{"v":4862.911309850508,"d":"4863"},"Kinexus","RpAb","CSALNSSKPTPQLKPIESSILAQRRVKKLPSTTL","Corresponds to amino acid residues S703 to L734; C-terminus.",null,null,"Q15418","Q15418",890,"Q15418","Q15418","NP_002944","Block7",11,9,"7, 15, 23, 31","RSK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","RSK",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); AGC domain target; AGC</A> group; RSK family; RSK subfamily","GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0043027; GO:0016301; GO:0000287; GO:0004712; GO:0004674","GO:0007049; GO:0072574; GO:0035556; GO:0043066; GO:0043154; GO:0045597; GO:0030307; GO:2000491; GO:0045944; GO:0043620; GO:0043555; GO:0007165"]
[2313,1154,"PK807","RSK1 (RPS6KA1, p90RSK)","Y220+S221","Ribosomal S6 protein-serine kinase 1; Ribosomal protein S6 kinase alpha 2",{"v":10457.754762392575,"d":"10458"},{"v":10094.734776301599,"d":"10095"},{"v":2673.516127277954,"d":"2674"},{"v":25.56491510866425,"d":"26"},{"v":4710.134371559055,"d":"4710"},{"v":18808.917224443085,"d":"18809"},"Kinexus","RpAb","KKA(pY)(pS)FCG(bA)C","Corresponds to amino acid residues K217 to G224; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII. ","Y220 and S221 phosphorylation is predicted to stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major in vivo phosphorylation sites in RSK1.","S221: PDPK1 (PDK1); RSK1 (RPS6KA1).","Q15418","Q15418",890,"Q15418","Q15418","NP_002944","Block7",11,10,"7, 15, 23, 31","RSK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","RSK",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); AGC domain target; AGC</A> group; RSK family; RSK subfamily","GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0043027; GO:0016301; GO:0000287; GO:0004712; GO:0004674","GO:0007049; GO:0072574; GO:0035556; GO:0043066; GO:0043154; GO:0045597; GO:0030307; GO:2000491; GO:0045944; GO:0043620; GO:0043555; GO:0007165"]
[2315,1155,"PK804","RSK1 (RPS6KA1, p90RSK)","S221","Ribosomal S6 protein-serine kinase 1; Ribosomal protein S6 kinase alpha 2",{"v":10444.144269881202,"d":"10444"},{"v":10448.67822146885,"d":"10449"},{"v":2508.2685188301393,"d":"2508"},{"v":24.016027105863312,"d":"24"},{"v":462.0446178308836,"d":"462"},{"v":18144.233335326084,"d":"18144"},"Kinexus","RpAb","KAY(pS)FCG(bA)C","Corresponds to amino acid residues K218 to G224; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S221 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of RSK1.","S221: PDPK1 (PDK1); RSK1 (RPS6KA1).","Q15418","Q15418",890,"Q15418","Q15418","NP_002944","Block7",11,11,"7, 15, 23, 31","RSK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","RSK",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); AGC domain target; AGC</A> group; RSK family; RSK subfamily","GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0043027; GO:0016301; GO:0000287; GO:0004712; GO:0004674","GO:0007049; GO:0072574; GO:0035556; GO:0043066; GO:0043154; GO:0045597; GO:0030307; GO:2000491; GO:0045944; GO:0043620; GO:0043555; GO:0007165"]
[2317,1156,"PK099","RSK1 (RPS6KA1, p90RSK)","S221/S227","Ribosomal S6 protein-serine kinase 1; Ribosomal protein S6 kinase alpha 2",{"v":1085.6896730126894,"d":"1086"},{"v":1132.2645319399371,"d":"1132"},{"v":699.6077527704562,"d":"700"},{"v":64.43901698255164,"d":"64"},{"v":4.105049088243163,"d":"4"},{"v":2837.4033029828097,"d":"2837"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S221 phosphosite.","S221 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII.  This is one of the major sites of in vivo phosphorylation of RSK1.","S221: PDPK1 (PDK1); RSK1 (RPS6KA1).","Q15418","Q15418",890,"Q15418","Q15418","NP_002944","Block7",11,12,"7, 15, 23, 31","RSK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","RSK",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); AGC domain target; AGC</A> group; RSK family; RSK subfamily","GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0043027; GO:0016301; GO:0000287; GO:0004712; GO:0004674","GO:0007049; GO:0072574; GO:0035556; GO:0043066; GO:0043154; GO:0045597; GO:0030307; GO:2000491; GO:0045944; GO:0043620; GO:0043555; GO:0007165"]
[2319,1157,"PK158","RSK1 (RPS6KA1, p90RSK)","T348","Ribosomal S6 protein-serine kinase 1; Ribosomal protein S6 kinase alpha 2",{"v":340.7015404900288,"d":"341"},{"v":272.9626786283094,"d":"273"},{"v":351.54380776637163,"d":"352"},{"v":103.18233585347119,"d":"103"},{"v":5.745847214920638,"d":"6"},{"v":2115.4287293881157,"d":"2115"},"External","RpAb","SR(pT)PR","Corresponds to amino acid residues S346 to R350.","The effect of T348 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of RSK1.",null,"Q15418","Q15418",890,"Q15418","Q15418","NP_002944","Block7",11,13,"7, 15, 23, 31","RSK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","RSK",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); AGC domain target; AGC</A> group; RSK family; RSK subfamily","GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0043027; GO:0016301; GO:0000287; GO:0004712; GO:0004674","GO:0007049; GO:0072574; GO:0035556; GO:0043066; GO:0043154; GO:0045597; GO:0030307; GO:2000491; GO:0045944; GO:0043620; GO:0043555; GO:0007165"]
[2321,1158,"PK157","RSK1 (RPS6KA1, p90RSK)","S352","Ribosomal S6 protein-serine kinase 1; Ribosomal protein S6 kinase alpha 2",{"v":861.985381130074,"d":"862"},{"v":866.3205672501025,"d":"866"},{"v":429.3839117359458,"d":"429"},{"v":49.81336355995016,"d":"50"},{"v":21.537467321574766,"d":"22"},{"v":2558.59461805738,"d":"2559"},"External","RpAb","RD(pS)PG","Corresponds to amino acid residues D350 to G354.","The effect of S352 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of RSK1.",null,"Q15418","Q15418",890,"Q15418","Q15418","NP_002944","Block7",12,1,"7, 15, 23, 31","RSK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","RSK",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); AGC domain target; AGC</A> group; RSK family; RSK subfamily","GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0043027; GO:0016301; GO:0000287; GO:0004712; GO:0004674","GO:0007049; GO:0072574; GO:0035556; GO:0043066; GO:0043154; GO:0045597; GO:0030307; GO:2000491; GO:0045944; GO:0043620; GO:0043555; GO:0007165"]
[2323,1159,"PK100","RSK1 (RPS6KA1, p90RSK)","S363/S369","Ribosomal S6 protein-serine kinase 1; Ribosomal protein S6 kinase alpha 2",{"v":352.9821434292212,"d":"353"},{"v":201.55807168508534,"d":"202"},{"v":978.7175837058257,"d":"979"},{"v":277.27113167753623,"d":"277"},{"v":13.086342429055442,"d":"13"},{"v":9123.355817300326,"d":"9123"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S363 phosphosite.","S363 phosphorylation stimulates phosphotransferase activity. This is one of the major sites of in vivo phosphorylation of RSK1.","ERK1 (MAPK3); ERK2 (MAPK1); PDPK1 (PDK1); PKCa (PRKCA)","Q15418","Q15418",890,"Q15418","Q15418","NP_002944","Block7",12,2,"7, 15, 23, 31","RSK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","RSK",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); AGC domain target; AGC</A> group; RSK family; RSK subfamily","GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0043027; GO:0016301; GO:0000287; GO:0004712; GO:0004674","GO:0007049; GO:0072574; GO:0035556; GO:0043066; GO:0043154; GO:0045597; GO:0030307; GO:2000491; GO:0045944; GO:0043620; GO:0043555; GO:0007165"]
[2325,1160,"PK213","RSK1 (RPS6KA1, p90RSK)","S380","Ribosomal S6 protein-serine kinase 1; Ribosomal protein S6 kinase alpha 2",{"v":565.4252479516998,"d":"565"},{"v":472.9471201097212,"d":"473"},{"v":421.2898250512361,"d":"421"},{"v":74.508491896567,"d":"75"},{"v":71.04839386039802,"d":"71"},{"v":4791.957498049795,"d":"4792"},"External","MmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the S380 phosphosite.","S380 phosphorylation stimulates phosphotransferase activity. This is one of the major sites of in vivo phosphorylation of RSK1.","JNK1 (MAPK8); JNK2 (MAPK9); p70S6K (RPS6KB1); RSK1 (RPS6KA1)","Q15418","Q15418",890,"Q15418","Q15418","NP_002944","Block7",12,3,"7, 15, 23, 31","RSK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","RSK",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); AGC domain target; AGC</A> group; RSK family; RSK subfamily","GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0043027; GO:0016301; GO:0000287; GO:0004712; GO:0004674","GO:0007049; GO:0072574; GO:0035556; GO:0043066; GO:0043154; GO:0045597; GO:0030307; GO:2000491; GO:0045944; GO:0043620; GO:0043555; GO:0007165"]
[2327,1161,"PK805","RSK1 (RPS6KA1, p90RSK)","S380","Ribosomal S6 protein-serine kinase 1; Ribosomal protein S6 kinase alpha 2",{"v":8775.27844897893,"d":"8775"},{"v":8616.580291921175,"d":"8617"},{"v":2035.3568128304814,"d":"2035"},{"v":23.194213433390374,"d":"23"},{"v":3487.7810406447825,"d":"3488"},{"v":14830.723846062781,"d":"14831"},"Kinexus","RpAb","RGF(pS)FVA(bA)C","Corresponds to amino acid residues R377 to A383; In Pkinase_C domain that follows the first kinase catalytic domain .","S380 phosphorylation stimulates phosphotransferase activity. This is one of the major sites of in vivo phosphorylation of RSK1.","JNK1 (MAPK8); JNK2 (MAPK9); p70S6K (RPS6KB1); RSK1 (RPS6KA1)","Q15418","Q15418",890,"Q15418","Q15418","NP_002944","Block7",12,4,"7, 15, 23, 31","RSK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","RSK",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); AGC domain target; AGC</A> group; RSK family; RSK subfamily","GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0043027; GO:0016301; GO:0000287; GO:0004712; GO:0004674","GO:0007049; GO:0072574; GO:0035556; GO:0043066; GO:0043154; GO:0045597; GO:0030307; GO:2000491; GO:0045944; GO:0043620; GO:0043555; GO:0007165"]
[2329,1162,"PK806","RSK1 (RPS6KA1, p90RSK)","T573","Ribosomal S6 protein-serine kinase 1; Ribosomal protein S6 kinase alpha 2",{"v":14323.709998404336,"d":"14324"},{"v":13611.401779706655,"d":"13611"},{"v":4993.107429156737,"d":"4993"},{"v":34.85903742614846,"d":"35"},{"v":3730.16479129503,"d":"3730"},{"v":56379.515158864015,"d":"56380"},"Kinexus","RpAb","LLM(pT)PCY(bA)C","Corresponds to amino acid residues L570 to Y576; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T573 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of RSK1.","ERK1 (MAPK3); ERK2 (MAPK1)","Q15418","Q15418",890,"Q15418","Q15418","NP_002944","Block7",12,5,"7, 15, 23, 31","RSK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","RSK",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); AGC domain target; AGC</A> group; RSK family; RSK subfamily","GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0043027; GO:0016301; GO:0000287; GO:0004712; GO:0004674","GO:0007049; GO:0072574; GO:0035556; GO:0043066; GO:0043154; GO:0045597; GO:0030307; GO:2000491; GO:0045944; GO:0043620; GO:0043555; GO:0007165"]
[2331,1163,"NK165-2","RSK2 (RPS6KA3)","Pan-specific","Ribosomal S6 protein-serine kinase 2; Ribosomal protein S6 kinase alpha-3",{"v":395.863397621698,"d":"396"},{"v":361.9773691565703,"d":"362"},{"v":194.33625073894626,"d":"194"},{"v":49.09174526023275,"d":"49"},{"v":68.01187832509397,"d":"68"},{"v":977.804696622248,"d":"978"},"Kinexus","RpAb","CTSDDESQAMQTVGVHSIVQ","Corresponds to amino acid residues T391 to Q409; Just before kinase catalytic domain 2.",null,null,"P51812","P51812",655,"P51812",null,"NP_004577.1","Block7",12,6,"7, 15, 23, 31","RSK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","RSK",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; AGC group; RSK family; RSK subfamily","GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0043027; GO:0016301; GO:0000287; GO:0004672; GO:0004674","GO:0007049; GO:0007417; GO:0035556; GO:0043066; GO:0043154; GO:0018105; GO:0045597; GO:0030307; GO:0045944; GO:0043620; GO:0043555; GO:0032496; GO:0007165; GO:0001501; GO:0002224"]
[2333,1164,"NK165-3","RSK2 (RPS6KA3)","Pan-specific","Ribosomal S6 protein-serine kinase 2; Ribosomal protein S6 kinase alpha-3",{"v":9850.966663843208,"d":"9851"},{"v":9357.730901196206,"d":"9358"},{"v":4248.095125179268,"d":"4248"},{"v":43.12363720376185,"d":"43"},{"v":467.96887560369635,"d":"468"},{"v":23610.67269094874,"d":"23611"},"Kinexus","RpAb","CNRNQSPVLEPVGRS","Corresponds to amino acid residues N711 to S724; Pre-C-terminus.",null,null,"P51812","P51812",655,"P51812",null,"NP_004577.1","Block7",12,7,"7, 15, 23, 31","RSK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","RSK",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; AGC group; RSK family; RSK subfamily","GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0043027; GO:0016301; GO:0000287; GO:0004672; GO:0004674","GO:0007049; GO:0007417; GO:0035556; GO:0043066; GO:0043154; GO:0018105; GO:0045597; GO:0030307; GO:0045944; GO:0043620; GO:0043555; GO:0032496; GO:0007165; GO:0001501; GO:0002224"]
[2335,1165,"PK214","RSK2 (RPS6KA3)","T577","Ribosomal S6 protein-serine kinase 2; Ribosomal protein S6 kinase alpha-3",{"v":1642.9449235884542,"d":"1643"},{"v":1502.436686022282,"d":"1502"},{"v":734.7563365485784,"d":"735"},{"v":44.7219091765872,"d":"45"},{"v":420.29498327166243,"d":"420"},{"v":5612.8359690727975,"d":"5613"},"External","MmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the T577 phosphosite.","T577 phosphorylation is predicted to be inhibitory for phosphotransferase activity. This phosphosite is located in the kinase activation loop just before catalytic subdomain VIII. This is one of the minor sites of in vivo phosphorylation of RSK2.",null,"P51812","P51812",655,"P51812",null,"NP_004577.1","Block7",12,8,"7, 15, 23, 31","RSK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","RSK",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; AGC group; RSK family; RSK subfamily","GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0043027; GO:0016301; GO:0000287; GO:0004672; GO:0004674","GO:0007049; GO:0007417; GO:0035556; GO:0043066; GO:0043154; GO:0018105; GO:0045597; GO:0030307; GO:0045944; GO:0043620; GO:0043555; GO:0032496; GO:0007165; GO:0001501; GO:0002224"]
[2337,1166,"PK808","RSK3 (RPS6KA2)","Y217+S218","Ribosomal S6 protein-serine kinase 3; Ribosomal protein S6 kinase alpha-3",{"v":11093.944427391654,"d":"11094"},{"v":11052.566897627788,"d":"11053"},{"v":2377.05785364627,"d":"2377"},{"v":21.42662485109591,"d":"21"},{"v":4299.918949743921,"d":"4300"},{"v":17150.921805745944,"d":"17151"},"Kinexus","RpAb","KRA(pY)(pS)FCG(bA)C","Corresponds to amino acid residues K214 to G221; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y217 and S218 phosphorylation are predicted to be stimulatory for phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major sites of in vivo phosphorylation of RSK2.",null,"Q15349","Q15349",656,"Q15349",null,"NP_002944","Block7",12,9,"7, 15, 23, 31","RSK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","RSK","RSK",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); AGC domain target; AGC</A> group; RSK family; RSK subfamily","GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0016301; GO:0000287; GO:0004712; GO:0004674","GO:0035556; GO:0045786; GO:0008285; GO:0043065; GO:0007165"]
[2339,1167,"PN652","RXRa","S260","Retinoic acid receptor RXR-alpha",{"v":14080.97432380644,"d":"14081"},{"v":13613.606994692418,"d":"13614"},{"v":3819.401082263353,"d":"3819"},{"v":27.124551145626075,"d":"27"},{"v":6191.703908755273,"d":"6192"},{"v":27361.216022018118,"d":"27361"},"Kinexus","RpAb","C(bA)NPS(pS)PNDP","Corresponds to amino acid residues C257 to P264.","S260 phosphorylation inhibits transcriptional activity and regulates transcription, intracellular location, and protein stability. This is one of the major sites of in vivo phosphorylation of RXR1.","ERK1 (MAPK3); ERK2 (MAPK1); JNK1 (MAPK8); JNK2 (MAPK9)","P19793","P19793",4524,null,"P19793","NP_002948.1","Block7",12,10,"7, 15, 23, 31",{"$nulls":3},"Transcription protein (receptor)",{"$nulls":4},"X",{"$nulls":4},"Transcription protein (receptor)","GO:0000790; GO:0005654; GO:0005634; GO:0032991; GO:0043235; GO:0090575","GO:0004886; GO:0031490; GO:0050692; GO:0003677; GO:0003700; GO:0003690; GO:0019899; GO:0050693; GO:0004879; GO:0016922; GO:0042277; GO:0046982; GO:0001972; GO:0003708; GO:0044323; GO:0000977; GO:0000981; GO:0043565; GO:0003707; GO:0003713; GO:0042809; GO:0008270","GO:0015721; GO:0043010; GO:0060038; GO:0008203; GO:0007566; GO:0001701; GO:0001893; GO:0019048; GO:0000122; GO:0035357; GO:0045944; GO:1901522; GO:0045994; GO:0051289; GO:0060687; GO:0019216; GO:0032526; GO:0048384; GO:0060528; GO:0006367; GO:0055012; GO:0055010; GO:0006766"]
[2341,1168,"PN653","SATB1","S38","DNA-binding protein SATB1",{"v":1104.9584163167035,"d":"1105"},{"v":1048.6244478397173,"d":"1049"},{"v":431.1753647775286,"d":"431"},{"v":39.021863484674796,"d":"39"},{"v":180.23745641487096,"d":"180"},{"v":2914.6593327714527,"d":"2915"},"Kinexus","RpAb","EQNG(pS)PLGC","Corresponds to amino acid residues E34 to G41.","The effect of S38 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of SATB1.",null,"Q01826","Q01826",14602,null,"Q01826","NP_001124482.1","Block7",12,11,"7, 15, 23, 31",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0016604; GO:0005720; GO:0016363; GO:0005654; GO:0005634; GO:0016605","GO:0003682; GO:0003690; GO:0000977; GO:0000981; GO:0001227","GO:0050798; GO:0043367; GO:0043374; GO:0006325; GO:0006338; GO:0008544; GO:0016571; GO:0000122; GO:0060004; GO:0006351; GO:0016032"]
[2343,1169,"PK809","SCYL1","S754","N-terminal kinase-like protein",{"v":6052.594148378243,"d":"6053"},{"v":6021.176807219388,"d":"6021"},{"v":1736.5362651498667,"d":"1737"},{"v":28.690776592300697,"d":"29"},{"v":562.8846245141447,"d":"563"},{"v":11877.754074014107,"d":"11878"},"Kinexus","RpAb","RPD(pS)WGE(bA)C","Corresponds to amino acid residues R751 to E757; In the C-terminus. ","The effect of S754 phosphorylation is unclear. This is the major in vivo phosphorylation site of SCYL1.",null,"Q96KG9","Q96KG9",2224,"Q96KG9","Q96KG9","NP_065731.3","Block7",12,12,"7, 15, 23, 31","SCYL1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","SCY1",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor), Other group, SCY1 family","GO:0005801; GO:0030126; GO:0005737; GO:0005829; GO:0005793; GO:0005794; GO:0016020; GO:0005815; GO:0005634","GO:0005524; GO:0045296; GO:0003677; GO:0004713","GO:0006355; GO:0006890; GO:0006351"]
[2345,1170,"NK294-1","SGK1","Pan-specific","Serine-threonine-protein kinase Sgk1",{"v":4777.136056732155,"d":"4777"},{"v":4717.316461735212,"d":"4717"},{"v":1041.116160756,"d":"1041"},{"v":21.793730561406395,"d":"22"},{"v":1877.3247389148605,"d":"1877"},{"v":8347.776717750214,"d":"8348"},"Kinexus","RpAb","MTVKTEAAKGTLTYSRMRGC","Corresponds to amino acid residues M1 to G19; N-terminus.",null,null,"O00141","O00141",660,"O00141","O00141","NP_005618.2","Block7",12,13,"7, 15, 23, 31","SGK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","AGC","SGK",{"$nulls":6},"Protein-serine kinase, AGC group, SGK family","GO:0005737; GO:0005829; GO:0005789; GO:0005739; GO:0016607; GO:0005634; GO:0005886","GO:0005524; GO:0005246; GO:0017081; GO:0015459; GO:0004712; GO:0004674; GO:0017080","GO:0006915; GO:0006974; GO:0035556; GO:0034220; GO:0007616; GO:0048812; GO:0018105; GO:0032411; GO:0006468; GO:0042981; GO:0008217; GO:0050790; GO:0001558; GO:0030334; GO:0042127; GO:0051090; GO:0060453; GO:0070294; GO:0006814"]
[2347,1171,"PK810","Sgk223","Y413","Tyrosine-protein kinase SgK223; Homologue of rat pragma of Rnd2",{"v":17149.659383263628,"d":"17150"},{"v":16399.795765197126,"d":"16400"},{"v":3915.812319371397,"d":"3916"},{"v":22.833178384830443,"d":"23"},{"v":8528.958537181146,"d":"8529"},{"v":30804.695180794377,"d":"30805"},"Kinexus","RpAb","EPI(pY)AES(bA)C","Corresponds to amino acid residues E410 to S416; In the first third of the protein. ","The effect of Y413 phosphorylation is unclear. This is the major in vivo site for phosphorylation of Sgk223.",null,"Q86YV5","Q86YV5",3935,"Q86YV5",null,"NP_001074295.2","Block7",13,1,"7, 15, 23, 31","SgK223","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","NKF3",{"$nulls":6},"EC 2.7.10.2; Protein kinase, Ser/Thr (non-receptor); Other group; NKF3 family","GO:0005737; GO:0005925; GO:0005634","GO:0042802; GO:0004672","GO:0016477; GO:0010977; GO:0035025; GO:2000145; GO:0008360; GO:0008593"]
[2349,1172,"PK811","SgK269 (PEAK1)","Y635","Tyrosine-protein kinase SgK269; Pseudopodium-enriched atypical kinase 1",{"v":9714.048917899701,"d":"9714"},{"v":9371.928891300999,"d":"9372"},{"v":2010.5274704069302,"d":"2011"},{"v":20.697110827825966,"d":"21"},{"v":4843.470827183421,"d":"4843"},{"v":15669.272241032764,"d":"15669"},"Kinexus","RpAb","PNA(pY)DNL(bA)C","Corresponds to amino acid residues P632 to L638; In the N-terminal half of the protein. ","Y635 phosphorylation induces interaction with Grb2 and stimulates cells growth and motility. This is the major in vivo phosphorylation site in SgK269.",null,"Q9H792","Q9H792",2204,"Q9H792",null,"NP_079052.2","Block7",13,2,"7, 15, 23, 31","SgK269","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","NKF3",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.10.2; Other group; NKF3 family","GO:0015629; GO:0005737; GO:0005925","GO:0042802; GO:0004715","GO:0016477; GO:0048041; GO:0046777; GO:0051893; GO:0034446"]
[2351,1173,"NK295-1","SgK288 (ANKK1)","Pan-specific","Protein kinase Sgk288; Protein kinase PKK2",{"v":14314.327861551357,"d":"14314"},{"v":13813.9095546877,"d":"13814"},{"v":3662.880173959185,"d":"3663"},{"v":25.58890790672591,"d":"26"},{"v":3013.9400232628677,"d":"3014"},{"v":26574.20730994403,"d":"26574"},"Kinexus","RpAb","CGSLPVFTRDDFEGDWRLVA","Corresponds to amino acid residues G11 to A29; Post-N-terminus.",null,null,"Q8NFD2","Q8NFD2",2002,"Q8NFD2",null,"NP_848605.1","Block7",13,3,"7, 15, 23, 31","SgK288","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","RIPK",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); TKL domain target; TKL</A> group; RIPK family",null,"GO:0005524; GO:0004674"]
[2353,1174,"PN654","SH2BP1","T925","RNA polymerase-associated protein CTR9 homolog",{"v":5200.054679188992,"d":"5200"},{"v":5044.400569078182,"d":"5044"},{"v":1344.1535072928987,"d":"1344"},{"v":25.848834103077834,"d":"26"},{"v":2361.0147238378363,"d":"2361"},{"v":11214.778493615242,"d":"11215"},"Kinexus","RpAb","VNDD(pT)DDDLC","Corresponds to amino acid residues V921 to L929.","The effect of T925 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of SH2BP1.","CK2a1 (CSNK2A1)","Q6PD62","Q6PD62",2917,null,null,"NP_055448.1","Block7",13,4,"7, 15, 23, 31",{"$nulls":3},"Transcription regulation",{"$nulls":4},"X",{"$nulls":4},"Transcription regulation","GO:0016593; GO:0016607; GO:0005654; GO:0035327","GO:0000993; GO:0042169","GO:0001832; GO:0071222; GO:0001711; GO:0033523; GO:0080182; GO:0010390; GO:0001826; GO:0070102; GO:0007259; GO:1900364; GO:0045638; GO:0000122; GO:2001168; GO:0051571; GO:2001162; GO:0045944; GO:0032968; GO:0016567; GO:2000653; GO:0019827; GO:0006366; GO:0006368; GO:0001829; GO:0016055"]
[2355,1175,"PN161","Shc1 (Shc)","Y349","SH2 domain-containing transforming protein 1",{"v":260.38471311759673,"d":"260"},{"v":207.70745606268252,"d":"208"},{"v":221.42803650670322,"d":"221"},{"v":85.03880041786492,"d":"85"},{"v":12.48429261995129,"d":"12"},{"v":1397.9212813578906,"d":"1398"},"External","RpAb","HQ(pY)YN","Corresponds to amino acid residues H347 to N351.","Y349 phosphorylation regulates apoptosis and molecular association, including inducing interaction with Grb2. This is one of the major sites of in vivo phosphorylation of Shc1.","EGFR; Lck; Src; ZAP70","P29353","P29353",1043,null,"P29353","NP_003020","Block7",13,5,"7, 15, 23, 31",{"$nulls":11},"X",null,"Adapter/scaffold protein","GO:0005829; GO:0005759; GO:0005886; GO:0070435","GO:0046875; GO:0048408; GO:0005154; GO:0005159; GO:0005158; GO:0005168; GO:0005543; GO:0001784; GO:0005088; GO:0005068","GO:0031532; GO:0000187; GO:0001525; GO:0007411; GO:0098609; GO:0071363; GO:0019221; GO:0042742; GO:0007173; GO:0038128; GO:0038095; GO:0007507; GO:0008286; GO:0035723; GO:0038110; GO:0036498; GO:0050900; GO:0000165; GO:0016525; GO:0043066; GO:0045892; GO:0008284; GO:0071864; GO:0070374; GO:0043410; GO:0045893; GO:0007265; GO:0007176; GO:0040008; GO:0090322; GO:0016032"]
[2357,1176,"PN074","Shc1 (Shc)","Y349+Y350","SH2 domain-containing transforming protein 1",{"v":1445.6239741363681,"d":"1446"},{"v":1353.7317864654115,"d":"1354"},{"v":682.8600835633068,"d":"683"},{"v":47.23635577303254,"d":"47"},{"v":306.7260020952916,"d":"307"},{"v":4234.476235765093,"d":"4234"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the Y349 and Y350 phosphosites.","Y349 and Y350 phosphorylation regulates apoptosis and molecular association, including inducing interaction with Grb2.  These are two of the major sites of in vivo phosphorylation of Shc1.","Y349: EGFR; Lck; Src; ZAP70. Y350: EGFR; Lck; Src; ZAP70.","P29353","P29353",1043,null,"P29353","NP_003020","Block7",13,6,"7, 15, 23, 31",{"$nulls":11},"X",null,"Adapter/scaffold protein","GO:0005829; GO:0005759; GO:0005886; GO:0070435","GO:0046875; GO:0048408; GO:0005154; GO:0005159; GO:0005158; GO:0005168; GO:0005543; GO:0001784; GO:0005088; GO:0005068","GO:0031532; GO:0000187; GO:0001525; GO:0007411; GO:0098609; GO:0071363; GO:0019221; GO:0042742; GO:0007173; GO:0038128; GO:0038095; GO:0007507; GO:0008286; GO:0035723; GO:0038110; GO:0036498; GO:0050900; GO:0000165; GO:0016525; GO:0043066; GO:0045892; GO:0008284; GO:0071864; GO:0070374; GO:0043410; GO:0045893; GO:0007265; GO:0007176; GO:0040008; GO:0090322; GO:0016032"]
[2359,1177,"NP044-3","SHIP1 (INPP5D)","Pan-specific","Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 1",{"v":3663.655474088064,"d":"3664"},{"v":3432.9485668145244,"d":"3433"},{"v":1452.0412356054833,"d":"1452"},{"v":39.633673140810735,"d":"40"},{"v":1710.9781545546728,"d":"1711"},{"v":10859.823258984497,"d":"10860"},"Kinexus","RpAb","CGRDYRDNTELPHHGK","Corresponds to amino acid residues R1159 to K1172.",null,null,"Q92835","Q92835",2582,null,null,"NP_001017915.1","Block7",13,7,"7, 15, 23, 31",{"$nulls":3},"Lipid phosphatase",{"$nulls":8},"X","Phosphatase, lipid; EC 3.1.3.n1","GO:0005856; GO:0005829; GO:0045121; GO:0005886","GO:0052659; GO:0004445; GO:0016314; GO:0034485; GO:0051425; GO:0017124","GO:0006915; GO:0019221; GO:0008340; GO:0016064; GO:0043647; GO:0035556; GO:0050900; GO:0030889; GO:0045779; GO:0050777; GO:0045409; GO:0045656; GO:0045659; GO:0045671; GO:0009968; GO:0006796; GO:0006661; GO:0046856; GO:0043065; GO:0045579; GO:0045648; GO:0007165; GO:0050852"]
[2361,1178,"PN560","SHIP1 (INPP5D)","Y187","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",{"v":5328.470191490238,"d":"5328"},{"v":5223.585266350179,"d":"5224"},{"v":1558.7497894180035,"d":"1559"},{"v":29.253232792920265,"d":"29"},{"v":763.8023459060196,"d":"764"},{"v":9924.84970529205,"d":"9925"},"Kinexus","RpAb","CAIQD(pY)LSTQ(bA)C     ","Corresponds to amino acid residues A183 to Q191; In the region between the SH2 and Exo-endo_phos domains.","The effect of Y187 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of SHIP1.",null,"Q92835","Q92835",2582,null,null,"NP_001017915.1","Block7",13,8,"7, 15, 23, 31",{"$nulls":3},"Lipid phosphatase",{"$nulls":8},"X","Phosphatase, lipid; EC 3.1.3.n1","GO:0005856; GO:0005829; GO:0045121; GO:0005886","GO:0052659; GO:0004445; GO:0016314; GO:0034485; GO:0051425; GO:0017124","GO:0006915; GO:0019221; GO:0008340; GO:0016064; GO:0043647; GO:0035556; GO:0050900; GO:0030889; GO:0045779; GO:0050777; GO:0045409; GO:0045656; GO:0045659; GO:0045671; GO:0009968; GO:0006796; GO:0006661; GO:0046856; GO:0043065; GO:0045579; GO:0045648; GO:0007165; GO:0050852"]
[2363,1179,"NP045-2","SHIP2 (INPPL1)","Pan-specific","Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 2",{"v":6732.520825046137,"d":"6733"},{"v":6572.529081687675,"d":"6573"},{"v":1675.9227236876134,"d":"1676"},{"v":24.892945261348352,"d":"25"},{"v":3050.0524606454296,"d":"3050"},{"v":13233.551075601463,"d":"13234"},"Kinexus","RpAb","CRRLHSEVDKVLSGLE","Corresponds to amino acid residues C215 to E230.",null,null,"O15357","O15357",2588,null,"O15357","NP_001558.3","Block7",13,9,"7, 15, 23, 31",{"$nulls":3},"Lipid phosphatase",{"$nulls":8},"X","EC 3.1.3.n1; Carbohydrate Metabolism - inositol phosphate; Phosphatase, lipid","GO:0005856; GO:0005829; GO:0030175; GO:0005794; GO:0030027; GO:0005886","GO:0003779; GO:0052659; GO:0034485; GO:0042169; GO:0017124","GO:0007015; GO:0007155; GO:0019221; GO:0001958; GO:0006897; GO:0006006; GO:0002376; GO:0043647; GO:0008285; GO:0010629; GO:0006661; GO:0046856; GO:0009791; GO:0032868; GO:0097178"]
[2365,1180,"PN534","SHIP2 (INPPL1)","Y886","Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 2",{"v":16026.41849213251,"d":"16026"},{"v":15568.12669617678,"d":"15568"},{"v":3759.0848612885598,"d":"3759"},{"v":23.45555161394246,"d":"23"},{"v":4346.956066865254,"d":"4347"},{"v":28266.798348844717,"d":"28267"},"Kinexus","RpAb","ERL(pY)EWI(bA)C","Corresponds to amino acid residues E883 to I889; In the region between the Exo-endo_phos and SHAM_1 domains. ","The effect of Y886 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of SHIP2.",null,"O15357","O15357",2588,null,"O15357","NP_001558.3","Block7",13,10,"7, 15, 23, 31",{"$nulls":3},"Lipid phosphatase",{"$nulls":8},"X","EC 3.1.3.n1; Carbohydrate Metabolism - inositol phosphate; Phosphatase, lipid","GO:0005856; GO:0005829; GO:0030175; GO:0005794; GO:0030027; GO:0005886","GO:0003779; GO:0052659; GO:0034485; GO:0042169; GO:0017124","GO:0007015; GO:0007155; GO:0019221; GO:0001958; GO:0006897; GO:0006006; GO:0002376; GO:0043647; GO:0008285; GO:0010629; GO:0006661; GO:0046856; GO:0009791; GO:0032868; GO:0097178"]
[2367,1181,"NK251-2","SIK (SNF1LK)","Pan-specific","Salt-inducible serine/threonine-protein kinase SIK1; Serine-threonine-protein kinase SNF1-like kinase 1",{"v":6175.034016074928,"d":"6175"},{"v":5969.960239194848,"d":"5970"},{"v":1756.0112741412838,"d":"1756"},{"v":28.437272889023973,"d":"28"},{"v":2956.122153893868,"d":"2956"},{"v":13056.932475293244,"d":"13057"},"Kinexus","RpAb","CARRITIAQIRQHRWM","Corresponds to amino acid residues A264 to M278; Kinase last alpha-chain.",null,null,"P57059","P57059",3764,"P57059",null,"NP_775490.2","Block7",13,11,"7, 15, 23, 31","SIK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","QIK",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; CAMK group; CAMKL family; QIK subfamily","GO:0005737; GO:0005634","GO:0071889; GO:0005524; GO:0008140; GO:0000287; GO:0019901; GO:0004674","GO:0055007; GO:0007049; GO:0032870; GO:0043153; GO:0035556; GO:0032792; GO:0045721; GO:0010868; GO:2000210; GO:0046777; GO:0006468; GO:0045595; GO:0007346; GO:0010830; GO:0002028; GO:0048511"]
[2369,1182,"NK251-3","SIK (SNF1LK)","Pan-specific","Salt-inducible serine/threonine-protein kinase SIK1; Serine-threonine-protein kinase SNF1-like kinase 1",{"v":5760.383055830841,"d":"5760"},{"v":5622.726070408152,"d":"5623"},{"v":1510.9183337784148,"d":"1511"},{"v":26.229476740249343,"d":"26"},{"v":1908.166142171876,"d":"1908"},{"v":10469.198121707872,"d":"10469"},"Kinexus","RpAb","CEDLMPASLGTFVLVQ","Corresponds to amino acid residues E769 to Q783; C-terminus.",null,null,"P57059","P57059",3764,"P57059",null,"NP_775490.2","Block7",13,12,"7, 15, 23, 31","SIK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","QIK",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; CAMK group; CAMKL family; QIK subfamily","GO:0005737; GO:0005634","GO:0071889; GO:0005524; GO:0008140; GO:0000287; GO:0019901; GO:0004674","GO:0055007; GO:0007049; GO:0032870; GO:0043153; GO:0035556; GO:0032792; GO:0045721; GO:0010868; GO:2000210; GO:0046777; GO:0006468; GO:0045595; GO:0007346; GO:0010830; GO:0002028; GO:0048511"]
[2371,1183,"PK812","SIK (SNF1LK)","T182","Salt-inducible serine/threonine-protein kinase SIK1; Serine-threonine-protein kinase SNF1-like kinase 1",{"v":4754.976919923037,"d":"4755"},{"v":4677.672997956678,"d":"4678"},{"v":1765.0209528395162,"d":"1765"},{"v":37.119443113260886,"d":"37"},{"v":625.5679785691151,"d":"626"},{"v":10093.442965353275,"d":"10093"},"Kinexus","RpAb","PLS(pT)WCG(bA)C","Corresponds to amino acid residues P179 to G185; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T182 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of SIK.","GSK3b; LKB1 (STK11)","P57059","P57059",3764,"P57059",null,"NP_775490.2","Block7",13,13,"7, 15, 23, 31","SIK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","QIK",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; CAMK group; CAMKL family; QIK subfamily","GO:0005737; GO:0005634","GO:0071889; GO:0005524; GO:0008140; GO:0000287; GO:0019901; GO:0004674","GO:0055007; GO:0007049; GO:0032870; GO:0043153; GO:0035556; GO:0032792; GO:0045721; GO:0010868; GO:2000210; GO:0046777; GO:0006468; GO:0045595; GO:0007346; GO:0010830; GO:0002028; GO:0048511"]
[2373,1184,"NK249-2","SIK2 (QIK)","Pan-specific","Salt-inducible serine/threonine-protein kinase SIK2; Serine-threonine-protein kinase SNF1-like kinase 2",{"v":2385.246575082388,"d":"2385"},{"v":2236.6364408194995,"d":"2237"},{"v":894.4457406223303,"d":"894"},{"v":37.49908919128981,"d":"37"},{"v":269.85705241808773,"d":"270"},{"v":6197.953212595703,"d":"6198"},"Kinexus","RpAb","CAQIKEHKWMLIEVPV","Corresponds to amino acid residues A263 to V277; Kinase last alpha-chain.",null,null,"Q9H0K1","Q9H0K1",2105,"Q9H0K1",null,"NP_056006.1","Block8",1,1,"8, 16, 24, 32","SIK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","QIK",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; CAMK domain target; CAMK</A> group; CAMKL family; QIK subfamily","GO:0005737; GO:0005634","GO:0005524; GO:0000287; GO:0004674","GO:0032870; GO:0035556; GO:0046777; GO:0006468; GO:0046626"]
[2375,1185,"NK249-3","SIK2 (QIK)","Pan-specific","Salt-inducible serine/threonine-protein kinase SIK2; Serine-threonine-protein kinase SNF1-like kinase 2",{"v":3627.164386846693,"d":"3627"},{"v":3516.6486476674727,"d":"3517"},{"v":1057.908306300314,"d":"1058"},{"v":29.166263049357294,"d":"29"},{"v":789.0214267111562,"d":"789"},{"v":9588.31248839114,"d":"9588"},"Kinexus","RpAb","CLDAVDPQHNGYVLVN","Corresponds to amino acid residues L912 to N926; C-terminus.",null,null,"Q9H0K1","Q9H0K1",2105,"Q9H0K1",null,"NP_056006.1","Block8",1,2,"8, 16, 24, 32","SIK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","QIK",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; CAMK domain target; CAMK</A> group; CAMKL family; QIK subfamily","GO:0005737; GO:0005634","GO:0005524; GO:0000287; GO:0004674","GO:0032870; GO:0035556; GO:0046777; GO:0006468; GO:0046626"]
[2377,1186,"PK813","SIK2 (QIK)","S358","Salt-inducible serine/threonine-protein kinase SIK2; Serine-threonine-protein kinase SNF1-like kinase 2",{"v":7556.658418966067,"d":"7557"},{"v":7489.747448208907,"d":"7490"},{"v":1544.4394439321513,"d":"1544"},{"v":20.438126990838203,"d":"20"},{"v":3188.6419472086213,"d":"3189"},{"v":13816.327796395053,"d":"13816"},"Kinexus","RpAb","RRP(pS)TIA(bA)C","Corresponds to amino acid residues R355 to A361; After the kinase catalytic domain.","S358 phosphorylation stimulates phosphotransferase activity. This is one of the major sites of in vivo phosphorylation of SIK2.","Akt1 (PKBa); Akt2 (PKBb)","Q9H0K1","Q9H0K1",2105,"Q9H0K1",null,"NP_056006.1","Block8",1,3,"8, 16, 24, 32","SIK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","QIK",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; CAMK domain target; CAMK</A> group; CAMKL family; QIK subfamily","GO:0005737; GO:0005634","GO:0005524; GO:0000287; GO:0004674","GO:0032870; GO:0035556; GO:0046777; GO:0006468; GO:0046626"]
[2379,1187,"NK250-2","SIK3 (QSK)","Pan-specific","Salt-inducible serine/threonine-protein kinase SIK3",{"v":16001.900631392264,"d":"16002"},{"v":15595.261230001674,"d":"15595"},{"v":4476.614900729784,"d":"4477"},{"v":27.975519932598726,"d":"28"},{"v":7729.054137059401,"d":"7729"},{"v":41855.30578941523,"d":"41855"},"Kinexus","RpAb","CKHKWMKLGDADPNFD","Corresponds to amino acid residues C254 to D269; Kinase last alpha-chain.",null,null,"Q9Y2K2","Q9Y2K2",2104,"Q9Y2K2","Q9Y2K2","NP_001268678.1","Block8",1,4,"8, 16, 24, 32","SIK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","QIK",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; CAMK domain target; CAMK</A> group; CAMKL family; QIK subfamily","GO:0005737","GO:0005524; GO:0000287; GO:0004674","GO:0006468"]
[2381,1188,"NK250-3","SIK3 (QSK)","Pan-specific","Salt-inducible serine/threonine-protein kinase SIK3",{"v":6240.107121418487,"d":"6240"},{"v":6093.488809750854,"d":"6093"},{"v":1469.2038518136414,"d":"1469"},{"v":23.54452933621539,"d":"24"},{"v":2755.7662126764008,"d":"2756"},{"v":9747.838081571377,"d":"9748"},"Kinexus","RpAb","CYKHPEVSFSMEQAGV","Corresponds to amino acid residues Y1249 to V1263; C-terminus.",null,null,"Q9Y2K2","Q9Y2K2",2104,"Q9Y2K2","Q9Y2K2","NP_001268678.1","Block8",1,5,"8, 16, 24, 32","SIK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","QIK",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; CAMK domain target; CAMK</A> group; CAMKL family; QIK subfamily","GO:0005737","GO:0005524; GO:0000287; GO:0004674","GO:0006468"]
[2383,1189,"PK814","SIK3 (QSK)","T163","Salt-inducible serine/threonine-protein kinase SIK3",{"v":10931.83576443987,"d":"10932"},{"v":11033.349005216816,"d":"11033"},{"v":2624.3663185625555,"d":"2624"},{"v":24.006638730334274,"d":"24"},{"v":3099.7762288169934,"d":"3100"},{"v":21592.783781127615,"d":"21593"},"Kinexus","RpAb","LLK(pT)WCG(bA)C","Corresponds to amino acid residues L160 to G166; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T163 phosphorylation is predicted to stimulate phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII.",null,"Q9Y2K2","Q9Y2K2",2104,"Q9Y2K2","Q9Y2K2","NP_001268678.1","Block8",1,6,"8, 16, 24, 32","SIK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","QIK",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; CAMK domain target; CAMK</A> group; CAMKL family; QIK subfamily","GO:0005737","GO:0005524; GO:0000287; GO:0004674","GO:0006468"]
[2385,1190,"PK815","SIK3 (QSK)","T411","Salt-inducible serine/threonine-protein kinase SIK3",{"v":4794.589300022218,"d":"4795"},{"v":4654.2478673567475,"d":"4654"},{"v":1506.776266215652,"d":"1507"},{"v":31.426597189641868,"d":"31"},{"v":918.3344307661348,"d":"918"},{"v":8660.898676986035,"d":"8661"},"Kinexus","RpAb","RRH(pT)VGV(bA)C","Corresponds to amino acid residues R408 to V414; In the first third of the protein. ","The effect of T411 phosphorylation is unclear. This is one of the two major in vivo sites for phosphorylation of SIK3 by ERK1. This is one of the major sites of in vivo phosphorylation of SIK3.",null,"Q9Y2K2","Q9Y2K2",2104,"Q9Y2K2","Q9Y2K2","NP_001268678.1","Block8",1,7,"8, 16, 24, 32","SIK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","CAMKL","QIK",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; CAMK domain target; CAMK</A> group; CAMKL family; QIK subfamily","GO:0005737","GO:0005524; GO:0000287; GO:0004674","GO:0006468"]
[2387,1191,"PN655","SIN3A","S832","Paired amphipathic helix protein Sin3a",{"v":14149.368865404667,"d":"14149"},{"v":13889.443477405111,"d":"13889"},{"v":3685.341881358348,"d":"3685"},{"v":26.045980682354262,"d":"26"},{"v":3437.923323985254,"d":"3438"},{"v":25593.90998403976,"d":"25594"},"Kinexus","RpAb","CGDL(pS)DVEE","Corresponds to amino acid residues C829 to E836.","The effect of S832 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of SIN3A.","CK2a1 (CSNK2A1)","Q96ST3","Q96ST3",5956,null,null,"NP_001138829.1","Block8",1,8,"8, 16, 24, 32",{"$nulls":3},"Nuclear receptor co-regulator; Transcription,  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"Nuclear receptor co-regulator; Transcription, coactivator/corepressor","GO:0000776; GO:0005730; GO:0005654; GO:0005634; GO:0016580; GO:0017053; GO:0005667","GO:0003682; GO:0003700; GO:0044877; GO:0033558; GO:0003723; GO:0001102; GO:0001103; GO:0003714; GO:0000976","GO:0002218; GO:0007568; GO:0034613; GO:1903351; GO:0071333; GO:0006260; GO:0002244; GO:0016575; GO:0001701; GO:0043066; GO:0042754; GO:1901675; GO:1900181; GO:0045892; GO:0000122; GO:2000678; GO:0031937; GO:0002230; GO:0010971; GO:0045944; GO:0006476; GO:0010817; GO:0019216; GO:0045652; GO:0043619; GO:0051595; GO:0048511; GO:0006351"]
[2389,1192,"PN535","SIT","Y90","Signaling threshold-regulating transmembrane adapter 1",{"v":7951.193854954499,"d":"7951"},{"v":7295.323233481435,"d":"7295"},{"v":2811.4507489812586,"d":"2811"},{"v":35.358850510598536,"d":"35"},{"v":2086.278754222255,"d":"2086"},{"v":22421.5081974363,"d":"22422"},"Kinexus","RpAb","VPL(pY)GNL(bA)C","Corresponds to amino acid residues V87 to L93; In the Sit domain. ","Y90 phosphorylation induces interaction with Grb2. This is the major in vivo phosphorylation site of SIT.",null,"Q9Y3P8","Q9Y3P8",2644,null,null,"NP_055265.1","Block8",1,9,"8, 16, 24, 32",{"$nulls":11},"X",null,"Adapter/scaffold protein","GO:0070062; GO:0005887; GO:0005886","GO:0019900; GO:0042169","GO:0002250; GO:0050863; GO:0007165; GO:0043029"]
[2391,1193,"PN536","SIT","Y95","Signaling threshold-regulating transmembrane adapter 1",{"v":14070.989741034104,"d":"14071"},{"v":13747.445741113432,"d":"13747"},{"v":3381.5694076662417,"d":"3382"},{"v":24.032207185858724,"d":"24"},{"v":6025.275946663208,"d":"6025"},{"v":28072.59997795713,"d":"28073"},"Kinexus","RpAb","NLH(pY)LQT(bA)C","Corresponds to amino acid residues N92 to T98; In the middle of the SIT domain I the protein. ","The effect of phosphorylation is unclear.This is one of the major in vivo phosphorylation sites in SIT.",null,"Q9Y3P8","Q9Y3P8",2644,null,null,"NP_055265.1","Block8",1,10,"8, 16, 24, 32",{"$nulls":11},"X",null,"Adapter/scaffold protein","GO:0070062; GO:0005887; GO:0005886","GO:0019900; GO:0042169","GO:0002250; GO:0050863; GO:0007165; GO:0043029"]
[2393,1194,"PK816","SLK","S189","STE20-like serine/threonine-protein kinase; CTCL tumour antigen se20-9",{"v":2999.4387823635043,"d":"2999"},{"v":2046.7821747541425,"d":"2047"},{"v":2674.378274412246,"d":"2674"},{"v":89.16262235913625,"d":"89"},{"v":98.33980378905329,"d":"98"},{"v":11218.904126379199,"d":"11219"},"Kinexus","RpAb","RRD(pS)FIG(bA)C","Corresponds to amino acid residues R186 to G192; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S189 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. It is one of the major in vivo phosphorylation sites in SIT.",null,"Q9H2G2","Q9H2G2",2519,"Q9H2G2",null,"NP_055535.2","Block8",1,11,"8, 16, 24, 32","SLK","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","SLK",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; STE domain target; STE</A> group; STE20 family; SLK subfamily","GO:0031252; GO:0005737; GO:0070062; GO:0048471","GO:0005524; GO:0045296; GO:0042802; GO:0042803; GO:0004674","GO:0032147; GO:0006915; GO:0031122; GO:0046777; GO:0042981; GO:0030334; GO:0051893; GO:0007346; GO:0023014; GO:0031098"]
[2395,1195,"NN445-1","Smad1","Pan-specific","SMA- and mothers against decapentaplegic homologue 1",{"v":223.6229799900512,"d":"224"},{"v":160.2914559840232,"d":"160"},{"v":272.726408092979,"d":"273"},{"v":121.95813154136144,"d":"122"},{"v":18.144205309850996,"d":"18"},{"v":3541.548644550172,"d":"3542"},"External","MmAb","Epitope undefined.",{"$nulls":3},"Q15797","Q15797",1044,null,null,"NP_005891.1","Block8",1,12,"8, 16, 24, 32",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005737; GO:0005829; GO:0016021; GO:0005622; GO:0005637; GO:0005654; GO:0005634; GO:0032991; GO:0071141; GO:0005667","GO:0070410; GO:0017151; GO:0003700; GO:0042802; GO:0070411; GO:0046872; GO:0070878; GO:0019901; GO:0000978; GO:0000981; GO:0001077; GO:0030618","GO:0030509; GO:0009880; GO:0010628; GO:1903672; GO:0045944; GO:1901522; GO:0031053; GO:0016579; GO:0007165; GO:0007183; GO:0060395; GO:0007179"]
[2397,1196,"PN185","Smad2","T220","Mothers against decapentaplegic homologue 2",{"v":630.0888450944313,"d":"630"},{"v":581.3954542472809,"d":"581"},{"v":448.98580722549747,"d":"449"},{"v":71.25753942814335,"d":"71"},{"v":10.94591692601345,"d":"11"},{"v":2205.0341197999824,"d":"2205"},"External","RpAb","PE(pT)PP","Corresponds to amino acid residues P218 to P222.","The effect of T220 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of Smad2.","ERK1 (MAPK3); ERK2 (MAPK1)","Q15796","Q15796",540,null,"Q15796","NP_001003652","Block8",1,13,"8, 16, 24, 32",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0032444; GO:0005737; GO:0005829; GO:0071144; GO:0000790; GO:0005654; GO:0005634; GO:0032991; GO:0071141; GO:0005667","GO:0033613; GO:0003682; GO:0070410; GO:0097718; GO:0003700; GO:0003690; GO:0035326; GO:0070411; GO:0046872; GO:0019902; GO:0070878; GO:0046982; GO:0042803; GO:0000978; GO:0000981; GO:0070412; GO:0046332; GO:0048156; GO:0001077; GO:0001228; GO:0008134; GO:0030618; GO:0005160; GO:0034713; GO:0031625","GO:0032924; GO:0030325; GO:0009952; GO:0045165; GO:0007182; GO:0048701; GO:0048617; GO:0001706; GO:0007369; GO:0030073; GO:0035556; GO:0001701; GO:0030324; GO:0001707; GO:0008285; GO:0045892; GO:0000122; GO:0030512; GO:0038092; GO:0035265; GO:0031016; GO:0048340; GO:0060039; GO:0030513; GO:0010718; GO:1900224; GO:0045893; GO:0045944; GO:0009791; GO:0031053; GO:0016579; GO:0051098; GO:0017015; GO:0070723; GO:0009749; GO:0062009; GO:0023019; GO:0007183; GO:0060395; GO:0035019; GO:0007179; GO:0001657; GO:0042060; GO:0007352"]
[2399,1197,"NN096-2","Smad2/3","Pan-specific","Mothers against decapentaplegic homologue 2/3",{"v":545.932787635549,"d":"546"},{"v":426.0179936130814,"d":"426"},{"v":536.7686890251135,"d":"537"},{"v":98.3213870245593,"d":"98"},{"v":57.000707332111226,"d":"57"},{"v":6716.831358091942,"d":"6717"},"External","MmAb","Epitope undefined.",{"$nulls":3},"Q15796","Q15796",540,null,"Q15796","NP_001003652","Block8",2,1,"8, 16, 24, 32",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0032444; GO:0005737; GO:0005829; GO:0071144; GO:0000790; GO:0005654; GO:0005634; GO:0032991; GO:0071141; GO:0005667","GO:0033613; GO:0003682; GO:0070410; GO:0097718; GO:0003700; GO:0003690; GO:0035326; GO:0070411; GO:0046872; GO:0019902; GO:0070878; GO:0046982; GO:0042803; GO:0000978; GO:0000981; GO:0070412; GO:0046332; GO:0048156; GO:0001077; GO:0001228; GO:0008134; GO:0030618; GO:0005160; GO:0034713; GO:0031625","GO:0032924; GO:0030325; GO:0009952; GO:0045165; GO:0007182; GO:0048701; GO:0048617; GO:0001706; GO:0007369; GO:0030073; GO:0035556; GO:0001701; GO:0030324; GO:0001707; GO:0008285; GO:0045892; GO:0000122; GO:0030512; GO:0038092; GO:0035265; GO:0031016; GO:0048340; GO:0060039; GO:0030513; GO:0010718; GO:1900224; GO:0045893; GO:0045944; GO:0009791; GO:0031053; GO:0016579; GO:0051098; GO:0017015; GO:0070723; GO:0009749; GO:0062009; GO:0023019; GO:0007183; GO:0060395; GO:0035019; GO:0007179; GO:0001657; GO:0042060; GO:0007352"]
[2401,1198,"PN658","Smad3","T8","Mothers against decapentaplegic homologue 3",{"v":6262.882388646329,"d":"6263"},{"v":5919.859699363871,"d":"5920"},{"v":1904.5007652530862,"d":"1905"},{"v":30.40933306851909,"d":"30"},{"v":374.1299122354284,"d":"374"},{"v":12116.29547197549,"d":"12116"},"Kinexus","RpAb","ILPF(pT)PPIV(bA)C","Corresponds to amino acid residues I4 to V12.","T8 phosphorylation inhibits transcriptional and antiproliferative activities. This is one of the major sites of in vivo phosphorylation of Smad3.","CDK2; CDK4","P84022","P84022",1045,null,"P84022","NP_005893.1","Block8",2,2,"8, 16, 24, 32",{"$nulls":3},"Nuclear receptor co-regulator; Transcription,  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"Nuclear receptor co-regulator; Transcription, coactivator/corepressor","GO:0005737; GO:0005829; GO:0071144; GO:0000790; GO:0005637; GO:0005654; GO:0005634; GO:0005886; GO:0043235; GO:0071141; GO:0005667","GO:0008013; GO:0043425; GO:0031490; GO:0005518; GO:0070410; GO:0017151; GO:0003700; GO:0035326; GO:0035259; GO:0042802; GO:0031962; GO:0019902; GO:0070878; GO:0046982; GO:0042803; GO:0019901; GO:0000987; GO:0001102; GO:0000978; GO:0000981; GO:0070412; GO:0043565; GO:0001228; GO:0003712; GO:0000983; GO:0008134; GO:0044212; GO:0030618; GO:0005160; GO:0043130; GO:0031625; GO:0008270","GO:0006919; GO:0097296; GO:0032924; GO:0030325; GO:0045216; GO:0007050; GO:0071345; GO:0071560; GO:0048589; GO:0048701; GO:0048617; GO:0009880; GO:0007492; GO:0019049; GO:0097191; GO:0001947; GO:0006955; GO:0002520; GO:0001701; GO:0070306; GO:0001889; GO:0001707; GO:0043066; GO:1903243; GO:0030308; GO:0051481; GO:0045599; GO:0050728; GO:0061767; GO:0045930; GO:0045668; GO:0033689; GO:0042177; GO:0000122; GO:0030512; GO:0061045; GO:0038092; GO:0002076; GO:0048340; GO:0060039; GO:0010694; GO:0030501; GO:0090263; GO:0030335; GO:0032332; GO:0051091; GO:0010718; GO:1901203; GO:0051894; GO:0010628; GO:0032731; GO:0045429; GO:0050927; GO:1902895; GO:0042307; GO:0051496; GO:0045893; GO:0045944; GO:0032916; GO:0031053; GO:0016579; GO:0050821; GO:0051098; GO:0050678; GO:0050776; GO:0016202; GO:0006357; GO:0032909; GO:0017015; GO:0001666; GO:0023019; GO:0007183; GO:0060395; GO:0001756; GO:0042110; GO:0030878; GO:0060290; GO:0007179; GO:0001657; GO:0042060"]
[2403,1199,"PN727","SMARCB1","T134","SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1",{"v":10232.23538853894,"d":"10232"},{"v":10126.109413431615,"d":"10126"},{"v":2948.956756501566,"d":"2949"},{"v":28.8202591567105,"d":"29"},{"v":1167.5389075386754,"d":"1168"},{"v":18945.75646417532,"d":"18946"},"Kinexus","RpAb","WVP(pT)LPNSC","Corresponds to amino acid residues W131 to S138.","The effect of T134 phosphorylation is unclear. In vivo phosphorylation of SMARCB1 is not commonly detected (≥7 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and found in the frog.",null,"Q12824","Q12824",18296,null,"Q12824","NP_003064.2","Block8",2,3,"8, 16, 24, 32",{"$nulls":3},"Transcription protein, coactivator/corepressor",{"$nulls":4},"X",{"$nulls":5},"GO:0001650; GO:0043231; GO:0071565; GO:0071564; GO:0000790; GO:0005730; GO:0005654; GO:0005634; GO:0032991; GO:0016514","GO:0003677; GO:0002039; GO:0001164; GO:0030957; GO:0003713","GO:0043044; GO:0007049; GO:0030154; GO:0006338; GO:0015074; GO:0006281; GO:0008285; GO:1900110; GO:1900113; GO:0007399; GO:0006337; GO:0043923; GO:0051091; GO:1902661; GO:2000617; GO:0090240; GO:0045944; GO:1901838; GO:0006357; GO:0039692"]
[2405,1200,"PN270","SMC1A","S957","Structural maintenance of chromosomes protein 1A",{"v":611.4110887789656,"d":"611"},{"v":527.4611379473291,"d":"527"},{"v":449.64475337287513,"d":"450"},{"v":73.5421325561579,"d":"74"},{"v":19.933005011772124,"d":"20"},{"v":3784.8886871925156,"d":"3785"},"External","MmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the S957 phosphosite.","The effect of S957 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of SMC1A.","ATM; ATR","Q14683","Q14683",2062,null,null,"NP_006297.2","Block8",2,4,"8, 16, 24, 32",{"$nulls":13},"DNA replication protein","GO:0005694; GO:0000775; GO:0008278; GO:0000777; GO:0000794; GO:0005829; GO:0000776; GO:0030893; GO:0097431; GO:0016363; GO:0005654; GO:0005634","GO:0005524; GO:0003682; GO:0036033; GO:0046982; GO:0003723","GO:0051301; GO:0006281; GO:0051321; GO:0007064; GO:0000070; GO:0032876; GO:1901673; GO:0072423; GO:0009314; GO:0007062; GO:0019827"]
[2407,1201,"NK233-2","SMG1","Pan-specific","Serine/threonine-protein kinase SMG1; Lambda/iota protein kinase C-interacting protein",{"v":8072.228770606024,"d":"8072"},{"v":8064.755675880739,"d":"8065"},{"v":1622.8043778957385,"d":"1623"},{"v":20.103547904947522,"d":"20"},{"v":1334.3236013116516,"d":"1334"},{"v":12509.56256325947,"d":"12510"},"Kinexus","RpAb","CGTKYPRSWNDWQPRT","Corresponds to amino acid residues G18 to T32.",null,null,"Q96Q15","Q96Q15",2356,"Q96Q15",null,"NP_055907.3","Block8",2,5,"8, 16, 24, 32","SMG1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PIKK","SMG1",{"$nulls":5},"Protein-serine kinase, Atypical group, PIKK family, SMG1 subfamily","GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0046872; GO:0004672; GO:0004674; GO:0003723; GO:0042162","GO:0006281; GO:0006406; GO:0000184; GO:0018105; GO:0046854; GO:0046777; GO:2001020; GO:0032204"]
[2409,1202,"NK233-1","SMG1","Pan-specific","Serine/threonine-protein kinase SMG1; Lambda/iota protein kinase C-interacting protein",{"v":11018.689039642639,"d":"11019"},{"v":10427.429738177794,"d":"10427"},{"v":3449.9725124322717,"d":"3450"},{"v":31.310190350413613,"d":"31"},{"v":865.3233894871307,"d":"865"},{"v":28070.681357277062,"d":"28071"},"Kinexus","RpAb","CSRQRHDDTRVHADIQ","Corresponds to amino acid residues S67 to Q81.",null,null,"Q96Q15","Q96Q15",2356,"Q96Q15",null,"NP_055907.3","Block8",2,6,"8, 16, 24, 32","SMG1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PIKK","SMG1",{"$nulls":5},"Protein-serine kinase, Atypical group, PIKK family, SMG1 subfamily","GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0046872; GO:0004672; GO:0004674; GO:0003723; GO:0042162","GO:0006281; GO:0006406; GO:0000184; GO:0018105; GO:0046854; GO:0046777; GO:2001020; GO:0032204"]
[2411,1203,"PK817","SMG1","T3550","Serine/threonine-protein kinase SMG1; Lambda/iota protein kinase C-interacting protein",{"v":1662.6078046619116,"d":"1663"},{"v":1586.1787164838254,"d":"1586"},{"v":1248.9275691269233,"d":"1249"},{"v":75.11859174634938,"d":"75"},{"v":-2.6902637255167074,"d":"-3"},{"v":4518.953688389223,"d":"4519"},"Kinexus","RpAb","GQK(pT)QPD(bA)C","Corresponds to amino acid residues G3547 to D3553; In the C-terminus of SMG1. ","The effect of T3550 phosphorylation is unclear. This is one of the two major in vivo sites for phosphorylation of SMG1.",null,"Q96Q15","Q96Q15",2356,"Q96Q15",null,"NP_055907.3","Block8",2,7,"8, 16, 24, 32","SMG1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PIKK","SMG1",{"$nulls":5},"Protein-serine kinase, Atypical group, PIKK family, SMG1 subfamily","GO:0005737; GO:0005829; GO:0005654; GO:0005634","GO:0005524; GO:0046872; GO:0004672; GO:0004674; GO:0003723; GO:0042162","GO:0006281; GO:0006406; GO:0000184; GO:0018105; GO:0046854; GO:0046777; GO:2001020; GO:0032204"]
[2413,1204,"PN197","SNCA (a-Synuclein)","S129","Alpha-synuclein",{"v":122.44137214724593,"d":"122"},{"v":103.60803080755164,"d":"104"},{"v":104.16920535821423,"d":"104"},{"v":85.07680331525695,"d":"85"},{"v":7.930811178439365,"d":"8"},{"v":622.1675735628235,"d":"622"},"External","RpAb","MP(pS)EE","Corresponds to amino acid residues M127 to E129","The effect of S129 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of SNCA.","BARK1 (GRK2; ADRBK1); CaMK2a; CK1a1 (CSNK1A1); CK2a1 (CSNK2A1); GRK5 (GPRK5); Plk2 (SNK); Plk3 (CNK);","P37840","P37840",1058,null,null,"NP_000336.1","Block8",2,8,"8, 16, 24, 32",{"$nulls":13},"Cytoskeletal protein","GO:0015629; GO:0030424; GO:0005938; GO:0030054; GO:0005737; GO:0005829; GO:0005576; GO:0005615; GO:0005794; GO:0030426; GO:0016234; GO:0005764; GO:0016020; GO:0005743; GO:0005758; GO:0005759; GO:0005741; GO:0005739; GO:0043025; GO:0005640; GO:0005634; GO:0048471; GO:0005886; GO:0098794; GO:0005840; GO:0005791; GO:0099512; GO:0030672; GO:0043195","GO:0003779; GO:0043014; GO:0048487; GO:0005509; GO:0005507; GO:1903136; GO:0043027; GO:0070840; GO:0008198; GO:0042393; GO:0030544; GO:0042802; GO:0019894; GO:0000287; GO:0008017; GO:0016491; GO:0043274; GO:0005543; GO:0051219; GO:0019904; GO:0047485; GO:0048156; GO:0044212; GO:0008270","GO:0006919; GO:0008344; GO:0007568; GO:0048148; GO:0044267; GO:0071280; GO:0071872; GO:0044344; GO:0034599; GO:0042416; GO:0051583; GO:0060079; GO:0006631; GO:0060291; GO:0001774; GO:0042775; GO:0007006; GO:0043066; GO:1904715; GO:0043154; GO:0045963; GO:0051585; GO:0045920; GO:0035067; GO:0031115; GO:1902957; GO:0032769; GO:0043524; GO:1901215; GO:0051622; GO:0010642; GO:0001933; GO:0051612; GO:0070495; GO:0000122; GO:0032410; GO:0006638; GO:0055114; GO:0006644; GO:0043065; GO:0045807; GO:1903284; GO:1903285; GO:0050729; GO:0060732; GO:1901216; GO:0001956; GO:0033138; GO:0071902; GO:0001921; GO:0051281; GO:0031648; GO:0031623; GO:0050812; GO:0014059; GO:0014048; GO:0040012; GO:0048169; GO:0043030; GO:0051621; GO:0010517; GO:1905606; GO:1903426; GO:1903421; GO:0022898; GO:1904307; GO:0034341; GO:0070555; GO:0010040; GO:0032496; GO:0032026; GO:0097435; GO:0050808; GO:0048488; GO:0048489"]
[2415,1205,"PN661","SND1","Y908","Staphylococcal nuclease domain-containing protein 1",{"v":1389.2109707413233,"d":"1389"},{"v":1355.0297783204496,"d":"1355"},{"v":661.9401296718914,"d":"662"},{"v":47.64863966764249,"d":"48"},{"v":97.89167746307281,"d":"98"},{"v":3381.8439000364397,"d":"3382"},"Kinexus","RpAb","CADEFG(pY)SR(-cooh)","Corresponds to amino acid residues C903 to R910.","The effect of Y908 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of SND1.",null,"Q7KZF4","Q7KZF4",2643,null,null,"NP_055205.2","Block8",2,9,"8, 16, 24, 32",{"$nulls":3},"Transcription protein, coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"Transcription protein, coactivator/corepressor","GO:0005737; GO:0005829; GO:0097433; GO:0070062; GO:0042470; GO:0016020; GO:0005634; GO:0016442","GO:0045296; GO:0004519; GO:0004521; GO:0004518; GO:1905172; GO:0003723; GO:0003712","GO:0031047; GO:0010587; GO:0001649; GO:0010564; GO:0006355; GO:0006401; GO:0006351; GO:0016032"]
[2417,1206,"PN537","snRNP 70","Y126","U1 small nuclear ribonucleoprotein 70 kDa",{"v":6492.637589719529,"d":"6493"},{"v":6332.100518419642,"d":"6332"},{"v":1842.3459374968108,"d":"1842"},{"v":28.375924453476188,"d":"28"},{"v":2520.994854907325,"d":"2521"},{"v":16848.465344323908,"d":"16848"},"Kinexus","RpAb","FEV(pY)GPI(bA)C","Corresponds to amino acid residues F123 to I129; In the RRM_1 domain. This is the major in vivo phosphorylation site in snRNP70.","The effect of Y126 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of snRNP 70.",null,"P08621","P08621",5427,null,null,"NP_003080.2","Block8",2,10,"8, 16, 24, 32",{"$nulls":13},"RNA binding protein","GO:0000243; GO:0005737; GO:0016607; GO:0005654; GO:0005634; GO:0071011; GO:0005681; GO:0005685; GO:0071004","GO:0003729; GO:0003723; GO:0030619; GO:1990446","GO:0071300; GO:0071560; GO:0071356; GO:0006397; GO:0000398; GO:1904715; GO:0061084; GO:0048026; GO:0043462; GO:0043484; GO:0008380"]
[2419,1207,"PN728","SOCS7","Y561","Suppressor of cytokine signaling 7",{"v":11056.323708436606,"d":"11056"},{"v":10263.172526371525,"d":"10263"},{"v":4334.383503050145,"d":"4334"},{"v":39.202755068963505,"d":"39"},{"v":200.3101919435715,"d":"200"},{"v":29956.927290871376,"d":"29957"},"Kinexus","RpAb","EEV(pY)LSL(bA)C","Corresponds to amino acid residues E558 to L564.","The effect of Y561 phosphorylation is unclear. This is the major site of in vivo phosphorylation of SOCS7 (≥36 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in fish.",null,"O14512","O14512",10059,null,"O14512","NP_055413.1","Block8",2,11,"8, 16, 24, 32",{"$nulls":3},"Transcription protein",{"$nulls":9},"Inhibitor protein","GO:0005737; GO:0005829; GO:0005634; GO:0005886","GO:0004860; GO:0017124","GO:0019221; GO:0045444; GO:0008286; GO:0035556; GO:0021819; GO:0046426; GO:0006469; GO:0016567; GO:0021942; GO:0040008"]
[2421,1208,"PN663","SPT5","T791","Transcription elongation factor SPT5",{"v":7915.824381901624,"d":"7916"},{"v":7370.328965665418,"d":"7370"},{"v":2490.5266702099902,"d":"2491"},{"v":31.462631686274083,"d":"31"},{"v":2635.4639919725623,"d":"2635"},{"v":17444.66967978262,"d":"17445"},"Kinexus","RpAb","CGSQ(pT)PLQD","Corresponds to amino acid residues C785 to D795.","The effect of T791 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of SPT5.","CDK9","O00267","O00267",6160,null,"O00267","NP_003160.2","Block8",2,12,"8, 16, 24, 32",{"$nulls":3},"Transcription elongation factor",{"$nulls":4},"X",{"$nulls":4},"Transcription, coactivator/corepressor","GO:0032044; GO:0005654; GO:0005634","GO:0003682; GO:0003677; GO:0019899; GO:0003729; GO:0046982; GO:0003723","GO:0006370; GO:0032785; GO:1900364; GO:0000122; GO:0032786; GO:0016239; GO:0045944; GO:0006366; GO:0006368"]
[2423,1209,"NK172-3","Src","Pan-specific","Src proto-oncogene-encoded protein-tyrosine kinase",{"v":356.7996807980935,"d":"357"},{"v":262.3974243982259,"d":"262"},{"v":431.7443508833162,"d":"432"},{"v":121.00469090039138,"d":"121"},{"v":20.48734658606539,"d":"20"},{"v":5390.746675723709,"d":"5391"},"External","RpAb","Epitope undefined.",{"$nulls":3},"P12931","P12931",661,"P12931","P12931","NP_005408","Block8",2,13,"8, 16, 24, 32","SRC","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"Protein-tyrosine kinase, TK group, Src family","GO:0005884; GO:0005901; GO:0005737; GO:0005829; GO:0070062; GO:0031234; GO:0098978; GO:0005770; GO:0005764; GO:0005743; GO:0005739; GO:0043005; GO:0005634; GO:0048471; GO:0005886; GO:0002102; GO:0014069; GO:0099091; GO:0032587","GO:0005524; GO:0045296; GO:0071253; GO:0019899; GO:0046875; GO:0030331; GO:0070851; GO:0020037; GO:0051427; GO:0005158; GO:0005178; GO:0044325; GO:0016301; GO:0019900; GO:0004715; GO:0046934; GO:0051219; GO:0008022; GO:0004672; GO:0005080; GO:0004713; GO:0097110; GO:0042169; GO:0005070; GO:0005102; GO:0031625","GO:0032148; GO:0034332; GO:0086098; GO:0007411; GO:0045453; GO:0060444; GO:0098609; GO:0007049; GO:0008283; GO:0071398; GO:0071498; GO:0071456; GO:0032869; GO:0071222; GO:0071375; GO:0036120; GO:0071393; GO:0034614; GO:0007417; GO:0035635; GO:0048013; GO:0007173; GO:0038096; GO:0030900; GO:0045087; GO:0007229; GO:0030520; GO:0035556; GO:0050900; GO:0016236; GO:2000811; GO:0043066; GO:0043154; GO:2001237; GO:0051895; GO:2001243; GO:0051902; GO:0032463; GO:0051974; GO:0032211; GO:0045892; GO:0048011; GO:0048477; GO:0036035; GO:0018105; GO:0038083; GO:0018108; GO:0030168; GO:0048008; GO:0043065; GO:0090263; GO:0045737; GO:0050715; GO:2000573; GO:0010634; GO:0070374; GO:0010907; GO:0046628; GO:0033625; GO:2000394; GO:0043406; GO:1903997; GO:2000386; GO:0050731; GO:0043552; GO:0014068; GO:0010641; GO:0071803; GO:0031954; GO:0051897; GO:1900182; GO:0010954; GO:0071902; GO:0051057; GO:0014911; GO:0045893; GO:0001545; GO:0050847; GO:0046777; GO:0031648; GO:0045124; GO:2001286; GO:0022407; GO:0051726; GO:0060491; GO:0042127; GO:2000641; GO:0010632; GO:0033146; GO:0071801; GO:0098962; GO:0043393; GO:0043114; GO:0010447; GO:0051602; GO:0042542; GO:0070555; GO:0009612; GO:0051385; GO:0031667; GO:0009615; GO:0007172; GO:0007165; GO:0002223; GO:0043149; GO:0034446; GO:0031295; GO:0045056; GO:0007179; GO:0060065; GO:0048010; GO:0016032"]
[2425,1210,"NK172-4","Src","Pan-specific","Src proto-oncogene-encoded protein-tyrosine kinase",{"v":153.7316182301284,"d":"154"},{"v":91.75093914232193,"d":"92"},{"v":372.03348082872003,"d":"372"},{"v":242.00192849840744,"d":"242"},{"v":18.893956061047657,"d":"19"},{"v":5175.766806358069,"d":"5176"},"External","MmAb","Epitope undefined.",{"$nulls":3},"P12931","P12931",661,"P12931","P12931","NP_005408","Block8",3,1,"8, 16, 24, 32","SRC","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"Protein-tyrosine kinase, TK group, Src family","GO:0005884; GO:0005901; GO:0005737; GO:0005829; GO:0070062; GO:0031234; GO:0098978; GO:0005770; GO:0005764; GO:0005743; GO:0005739; GO:0043005; GO:0005634; GO:0048471; GO:0005886; GO:0002102; GO:0014069; GO:0099091; GO:0032587","GO:0005524; GO:0045296; GO:0071253; GO:0019899; GO:0046875; GO:0030331; GO:0070851; GO:0020037; GO:0051427; GO:0005158; GO:0005178; GO:0044325; GO:0016301; GO:0019900; GO:0004715; GO:0046934; GO:0051219; GO:0008022; GO:0004672; GO:0005080; GO:0004713; GO:0097110; GO:0042169; GO:0005070; GO:0005102; GO:0031625","GO:0032148; GO:0034332; GO:0086098; GO:0007411; GO:0045453; GO:0060444; GO:0098609; GO:0007049; GO:0008283; GO:0071398; GO:0071498; GO:0071456; GO:0032869; GO:0071222; GO:0071375; GO:0036120; GO:0071393; GO:0034614; GO:0007417; GO:0035635; GO:0048013; GO:0007173; GO:0038096; GO:0030900; GO:0045087; GO:0007229; GO:0030520; GO:0035556; GO:0050900; GO:0016236; GO:2000811; GO:0043066; GO:0043154; GO:2001237; GO:0051895; GO:2001243; GO:0051902; GO:0032463; GO:0051974; GO:0032211; GO:0045892; GO:0048011; GO:0048477; GO:0036035; GO:0018105; GO:0038083; GO:0018108; GO:0030168; GO:0048008; GO:0043065; GO:0090263; GO:0045737; GO:0050715; GO:2000573; GO:0010634; GO:0070374; GO:0010907; GO:0046628; GO:0033625; GO:2000394; GO:0043406; GO:1903997; GO:2000386; GO:0050731; GO:0043552; GO:0014068; GO:0010641; GO:0071803; GO:0031954; GO:0051897; GO:1900182; GO:0010954; GO:0071902; GO:0051057; GO:0014911; GO:0045893; GO:0001545; GO:0050847; GO:0046777; GO:0031648; GO:0045124; GO:2001286; GO:0022407; GO:0051726; GO:0060491; GO:0042127; GO:2000641; GO:0010632; GO:0033146; GO:0071801; GO:0098962; GO:0043393; GO:0043114; GO:0010447; GO:0051602; GO:0042542; GO:0070555; GO:0009612; GO:0051385; GO:0031667; GO:0009615; GO:0007172; GO:0007165; GO:0002223; GO:0043149; GO:0034446; GO:0031295; GO:0045056; GO:0007179; GO:0060065; GO:0048010; GO:0016032"]
[2427,1211,"PK107","Src","Y419","Src oncogene-encoded protein-tyrosine kinase",{"v":622.908369691862,"d":"623"},{"v":550.917175564156,"d":"551"},{"v":511.5377651489723,"d":"512"},{"v":82.12086882088579,"d":"82"},{"v":20.049734372151796,"d":"20"},{"v":2401.531851274356,"d":"2402"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the Y418 phosphosite.","Y419 phosphorylation stimulates phosphotransferase activity and induces interaction with Cbl-c and SHPS1. This is one of the major sites of in vivo phosphorylation of Src.","EphB2; FAK (PTK2); Met; PDGFRA; PDGFRB; PKACa (PRKACA); PYK2 (PTK2B; FAK2); Src","P12931","P12931",661,"P12931","P12931","NP_005408","Block8",3,2,"8, 16, 24, 32","SRC","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"Protein-tyrosine kinase, TK group, Src family","GO:0005884; GO:0005901; GO:0005737; GO:0005829; GO:0070062; GO:0031234; GO:0098978; GO:0005770; GO:0005764; GO:0005743; GO:0005739; GO:0043005; GO:0005634; GO:0048471; GO:0005886; GO:0002102; GO:0014069; GO:0099091; GO:0032587","GO:0005524; GO:0045296; GO:0071253; GO:0019899; GO:0046875; GO:0030331; GO:0070851; GO:0020037; GO:0051427; GO:0005158; GO:0005178; GO:0044325; GO:0016301; GO:0019900; GO:0004715; GO:0046934; GO:0051219; GO:0008022; GO:0004672; GO:0005080; GO:0004713; GO:0097110; GO:0042169; GO:0005070; GO:0005102; GO:0031625","GO:0032148; GO:0034332; GO:0086098; GO:0007411; GO:0045453; GO:0060444; GO:0098609; GO:0007049; GO:0008283; GO:0071398; GO:0071498; GO:0071456; GO:0032869; GO:0071222; GO:0071375; GO:0036120; GO:0071393; GO:0034614; GO:0007417; GO:0035635; GO:0048013; GO:0007173; GO:0038096; GO:0030900; GO:0045087; GO:0007229; GO:0030520; GO:0035556; GO:0050900; GO:0016236; GO:2000811; GO:0043066; GO:0043154; GO:2001237; GO:0051895; GO:2001243; GO:0051902; GO:0032463; GO:0051974; GO:0032211; GO:0045892; GO:0048011; GO:0048477; GO:0036035; GO:0018105; GO:0038083; GO:0018108; GO:0030168; GO:0048008; GO:0043065; GO:0090263; GO:0045737; GO:0050715; GO:2000573; GO:0010634; GO:0070374; GO:0010907; GO:0046628; GO:0033625; GO:2000394; GO:0043406; GO:1903997; GO:2000386; GO:0050731; GO:0043552; GO:0014068; GO:0010641; GO:0071803; GO:0031954; GO:0051897; GO:1900182; GO:0010954; GO:0071902; GO:0051057; GO:0014911; GO:0045893; GO:0001545; GO:0050847; GO:0046777; GO:0031648; GO:0045124; GO:2001286; GO:0022407; GO:0051726; GO:0060491; GO:0042127; GO:2000641; GO:0010632; GO:0033146; GO:0071801; GO:0098962; GO:0043393; GO:0043114; GO:0010447; GO:0051602; GO:0042542; GO:0070555; GO:0009612; GO:0051385; GO:0031667; GO:0009615; GO:0007172; GO:0007165; GO:0002223; GO:0043149; GO:0034446; GO:0031295; GO:0045056; GO:0007179; GO:0060065; GO:0048010; GO:0016032"]
[2429,1212,"PK818","Src","Y419","Src oncogene-encoded protein-tyrosine kinase",{"v":77.8481909741262,"d":"78"},{"v":61.45548658275223,"d":"61"},{"v":78.70620947031149,"d":"79"},{"v":101.10216883070599,"d":"101"},{"v":15.092889154141016,"d":"15"},{"v":1181.713535811918,"d":"1182"},"Kinexus","RpAb","DNE(pY)TAR(bA)C","Corresponds to amino acid residues D416 to R422; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y419 phosphorylation stimulates phosphotransferase activity and induces interaction with Cbl-c and SHPS1. This is one of the major sites of in vivo phosphorylation of Src.","EphB2; FAK (PTK2); Met; PDGFRA; PDGFRB; PKACa (PRKACA); PYK2 (PTK2B; FAK2); Src","P12931","P12931",661,"P12931","P12931","NP_005408","Block8",3,3,"8, 16, 24, 32","SRC","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"Protein-tyrosine kinase, TK group, Src family","GO:0005884; GO:0005901; GO:0005737; GO:0005829; GO:0070062; GO:0031234; GO:0098978; GO:0005770; GO:0005764; GO:0005743; GO:0005739; GO:0043005; GO:0005634; GO:0048471; GO:0005886; GO:0002102; GO:0014069; GO:0099091; GO:0032587","GO:0005524; GO:0045296; GO:0071253; GO:0019899; GO:0046875; GO:0030331; GO:0070851; GO:0020037; GO:0051427; GO:0005158; GO:0005178; GO:0044325; GO:0016301; GO:0019900; GO:0004715; GO:0046934; GO:0051219; GO:0008022; GO:0004672; GO:0005080; GO:0004713; GO:0097110; GO:0042169; GO:0005070; GO:0005102; GO:0031625","GO:0032148; GO:0034332; GO:0086098; GO:0007411; GO:0045453; GO:0060444; GO:0098609; GO:0007049; GO:0008283; GO:0071398; GO:0071498; GO:0071456; GO:0032869; GO:0071222; GO:0071375; GO:0036120; GO:0071393; GO:0034614; GO:0007417; GO:0035635; GO:0048013; GO:0007173; GO:0038096; GO:0030900; GO:0045087; GO:0007229; GO:0030520; GO:0035556; GO:0050900; GO:0016236; GO:2000811; GO:0043066; GO:0043154; GO:2001237; GO:0051895; GO:2001243; GO:0051902; GO:0032463; GO:0051974; GO:0032211; GO:0045892; GO:0048011; GO:0048477; GO:0036035; GO:0018105; GO:0038083; GO:0018108; GO:0030168; GO:0048008; GO:0043065; GO:0090263; GO:0045737; GO:0050715; GO:2000573; GO:0010634; GO:0070374; GO:0010907; GO:0046628; GO:0033625; GO:2000394; GO:0043406; GO:1903997; GO:2000386; GO:0050731; GO:0043552; GO:0014068; GO:0010641; GO:0071803; GO:0031954; GO:0051897; GO:1900182; GO:0010954; GO:0071902; GO:0051057; GO:0014911; GO:0045893; GO:0001545; GO:0050847; GO:0046777; GO:0031648; GO:0045124; GO:2001286; GO:0022407; GO:0051726; GO:0060491; GO:0042127; GO:2000641; GO:0010632; GO:0033146; GO:0071801; GO:0098962; GO:0043393; GO:0043114; GO:0010447; GO:0051602; GO:0042542; GO:0070555; GO:0009612; GO:0051385; GO:0031667; GO:0009615; GO:0007172; GO:0007165; GO:0002223; GO:0043149; GO:0034446; GO:0031295; GO:0045056; GO:0007179; GO:0060065; GO:0048010; GO:0016032"]
[2431,1213,"PK108","Src","Y530","Src oncogene-encoded protein-tyrosine kinase",{"v":16.72065288912618,"d":"17"},{"v":12.424761552110994,"d":"12"},{"v":12.336833941662814,"d":"12"},{"v":73.7820109266531,"d":"74"},{"v":-2.0945353688084944,"d":"-2"},{"v":72.86059607582284,"d":"73"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the Y529 phosphosite.","Y530 phosphorylation phosphorylation inhibits phosphotransferase activity and induces interaction with Src and AFAP. This is one of the major sites of in vivo phosphorylation of Src.","Akt1 (PKBa); CTK (MATK); Src","P12931","P12931",661,"P12931","P12931","NP_005408","Block8",3,4,"8, 16, 24, 32","SRC","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"Protein-tyrosine kinase, TK group, Src family","GO:0005884; GO:0005901; GO:0005737; GO:0005829; GO:0070062; GO:0031234; GO:0098978; GO:0005770; GO:0005764; GO:0005743; GO:0005739; GO:0043005; GO:0005634; GO:0048471; GO:0005886; GO:0002102; GO:0014069; GO:0099091; GO:0032587","GO:0005524; GO:0045296; GO:0071253; GO:0019899; GO:0046875; GO:0030331; GO:0070851; GO:0020037; GO:0051427; GO:0005158; GO:0005178; GO:0044325; GO:0016301; GO:0019900; GO:0004715; GO:0046934; GO:0051219; GO:0008022; GO:0004672; GO:0005080; GO:0004713; GO:0097110; GO:0042169; GO:0005070; GO:0005102; GO:0031625","GO:0032148; GO:0034332; GO:0086098; GO:0007411; GO:0045453; GO:0060444; GO:0098609; GO:0007049; GO:0008283; GO:0071398; GO:0071498; GO:0071456; GO:0032869; GO:0071222; GO:0071375; GO:0036120; GO:0071393; GO:0034614; GO:0007417; GO:0035635; GO:0048013; GO:0007173; GO:0038096; GO:0030900; GO:0045087; GO:0007229; GO:0030520; GO:0035556; GO:0050900; GO:0016236; GO:2000811; GO:0043066; GO:0043154; GO:2001237; GO:0051895; GO:2001243; GO:0051902; GO:0032463; GO:0051974; GO:0032211; GO:0045892; GO:0048011; GO:0048477; GO:0036035; GO:0018105; GO:0038083; GO:0018108; GO:0030168; GO:0048008; GO:0043065; GO:0090263; GO:0045737; GO:0050715; GO:2000573; GO:0010634; GO:0070374; GO:0010907; GO:0046628; GO:0033625; GO:2000394; GO:0043406; GO:1903997; GO:2000386; GO:0050731; GO:0043552; GO:0014068; GO:0010641; GO:0071803; GO:0031954; GO:0051897; GO:1900182; GO:0010954; GO:0071902; GO:0051057; GO:0014911; GO:0045893; GO:0001545; GO:0050847; GO:0046777; GO:0031648; GO:0045124; GO:2001286; GO:0022407; GO:0051726; GO:0060491; GO:0042127; GO:2000641; GO:0010632; GO:0033146; GO:0071801; GO:0098962; GO:0043393; GO:0043114; GO:0010447; GO:0051602; GO:0042542; GO:0070555; GO:0009612; GO:0051385; GO:0031667; GO:0009615; GO:0007172; GO:0007165; GO:0002223; GO:0043149; GO:0034446; GO:0031295; GO:0045056; GO:0007179; GO:0060065; GO:0048010; GO:0016032"]
[2433,1214,"PK215","Src","Y530","Src oncogene-encoded protein-tyrosine kinase",{"v":296.06923577290775,"d":"296"},{"v":247.71460780192248,"d":"248"},{"v":287.23180859165603,"d":"287"},{"v":97.01508089545979,"d":"97"},{"v":18.469728903860442,"d":"18"},{"v":3669.8009357865685,"d":"3670"},"External","MmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the Y530 phosphosite.","Y530 phosphorylation phosphorylation inhibits phosphotransferase activity and induces interaction with Src and AFAP. This is one of the major sites of in vivo phosphorylation of Src.","Akt1 (PKBa); CTK (MATK); Src","P12931","P12931",661,"P12931","P12931","NP_005408","Block8",3,5,"8, 16, 24, 32","SRC","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"Protein-tyrosine kinase, TK group, Src family","GO:0005884; GO:0005901; GO:0005737; GO:0005829; GO:0070062; GO:0031234; GO:0098978; GO:0005770; GO:0005764; GO:0005743; GO:0005739; GO:0043005; GO:0005634; GO:0048471; GO:0005886; GO:0002102; GO:0014069; GO:0099091; GO:0032587","GO:0005524; GO:0045296; GO:0071253; GO:0019899; GO:0046875; GO:0030331; GO:0070851; GO:0020037; GO:0051427; GO:0005158; GO:0005178; GO:0044325; GO:0016301; GO:0019900; GO:0004715; GO:0046934; GO:0051219; GO:0008022; GO:0004672; GO:0005080; GO:0004713; GO:0097110; GO:0042169; GO:0005070; GO:0005102; GO:0031625","GO:0032148; GO:0034332; GO:0086098; GO:0007411; GO:0045453; GO:0060444; GO:0098609; GO:0007049; GO:0008283; GO:0071398; GO:0071498; GO:0071456; GO:0032869; GO:0071222; GO:0071375; GO:0036120; GO:0071393; GO:0034614; GO:0007417; GO:0035635; GO:0048013; GO:0007173; GO:0038096; GO:0030900; GO:0045087; GO:0007229; GO:0030520; GO:0035556; GO:0050900; GO:0016236; GO:2000811; GO:0043066; GO:0043154; GO:2001237; GO:0051895; GO:2001243; GO:0051902; GO:0032463; GO:0051974; GO:0032211; GO:0045892; GO:0048011; GO:0048477; GO:0036035; GO:0018105; GO:0038083; GO:0018108; GO:0030168; GO:0048008; GO:0043065; GO:0090263; GO:0045737; GO:0050715; GO:2000573; GO:0010634; GO:0070374; GO:0010907; GO:0046628; GO:0033625; GO:2000394; GO:0043406; GO:1903997; GO:2000386; GO:0050731; GO:0043552; GO:0014068; GO:0010641; GO:0071803; GO:0031954; GO:0051897; GO:1900182; GO:0010954; GO:0071902; GO:0051057; GO:0014911; GO:0045893; GO:0001545; GO:0050847; GO:0046777; GO:0031648; GO:0045124; GO:2001286; GO:0022407; GO:0051726; GO:0060491; GO:0042127; GO:2000641; GO:0010632; GO:0033146; GO:0071801; GO:0098962; GO:0043393; GO:0043114; GO:0010447; GO:0051602; GO:0042542; GO:0070555; GO:0009612; GO:0051385; GO:0031667; GO:0009615; GO:0007172; GO:0007165; GO:0002223; GO:0043149; GO:0034446; GO:0031295; GO:0045056; GO:0007179; GO:0060065; GO:0048010; GO:0016032"]
[2435,1215,"PN664","SRF","S224","Serum response factor",{"v":11014.772408911605,"d":"11015"},{"v":11111.70918157584,"d":"11112"},{"v":3077.248174260661,"d":"3077"},{"v":27.937464888253018,"d":"28"},{"v":1214.2844260130162,"d":"1214"},{"v":26377.242499483575,"d":"26377"},"Kinexus","RpAb","NSPD(pS)PPR(bA)C","Corresponds to amino acid residues N220 to R227.","The effect of S224 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of SRF.",null,"P11831","P11831",1235,null,"P11831","NP_003122.1","Block8",3,6,"8, 16, 24, 32",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005737; GO:0000790; GO:0005654; GO:0005634","GO:0031490; GO:0003700; GO:0042826; GO:0070878; GO:0042803; GO:0000978; GO:0000981; GO:0001085; GO:0010736; GO:0001077; GO:0001228; GO:0003705; GO:0001076; GO:0008134","GO:0060055; GO:0008306; GO:0070830; GO:0001569; GO:0060532; GO:0055003; GO:0060947; GO:0007160; GO:0002042; GO:0071333; GO:0090398; GO:0048589; GO:0035912; GO:0090136; GO:0010669; GO:0048821; GO:0061029; GO:0060324; GO:0007507; GO:0001947; GO:0060347; GO:0060218; GO:0021766; GO:0007616; GO:0060292; GO:0060425; GO:0061145; GO:0035855; GO:0001707; GO:0002011; GO:0042789; GO:0046716; GO:1900222; GO:0030336; GO:0008285; GO:1902894; GO:0048666; GO:0001764; GO:0031175; GO:0030168; GO:0030220; GO:0045773; GO:0045597; GO:0051091; GO:0051491; GO:1902895; GO:0045987; GO:0046016; GO:0045944; GO:0003257; GO:0060261; GO:0010735; GO:0045059; GO:0090009; GO:0030155; GO:0051150; GO:0033561; GO:0034097; GO:0009725; GO:0001666; GO:0009636; GO:0045214; GO:0043589; GO:0043149; GO:0022028; GO:0048538; GO:0030878; GO:0060534; GO:0006366; GO:0001829"]
[2437,1216,"PK819","SRPK1","S222","Serine/arginine-rich protein-specific kinase 1; SRPK1a protein kinase",{"v":945.7547950272301,"d":"946"},{"v":859.2060555289984,"d":"859"},{"v":654.1429340395662,"d":"654"},{"v":69.16622971187073,"d":"69"},{"v":28.12584739654759,"d":"28"},{"v":3418.4370452159583,"d":"3418"},"Kinexus","RpAb","ILG(pS)DDD(bA)C","Corresponds to amino acid residues I219 to D225; Near the N-terminus of the kinase.","S222 phosphorylation stimulates phosphotransferase activity. This is one of the major sites of in vivo phosphorylation of SRPK1.","CK2a1 (CSNK2A1); CK2a2 (CSNK2A2)","Q96SB4","Q96SB4",6658,"Q96SB4",null,"NP_003128.3","Block8",3,7,"8, 16, 24, 32","SRPK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","SRPK",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; CMGC domain target; CMGC</A> group; SRPK family","GO:0005737; GO:0005829; GO:0005783; GO:0016363; GO:0005634; GO:0005886","GO:0005524; GO:0000287; GO:0004672; GO:0004674; GO:0003723","GO:0007059; GO:0045087; GO:0035556; GO:0045071; GO:0045070; GO:0006468; GO:0050684; GO:0048024; GO:0008380; GO:0035092; GO:0000245; GO:0016032"]
[2439,1217,"PK891","SRPK1","S587","Serine/arginine-rich protein-specific kinase 1; SRPK1a protein kinase",{"v":6622.166329888744,"d":"6622"},{"v":6616.280630166548,"d":"6616"},{"v":1578.4610702780633,"d":"1578"},{"v":23.836022709876303,"d":"24"},{"v":575.17880657824,"d":"575"},{"v":10428.802423326371,"d":"10429"},"Kinexus","RpAb","GKY(pS)KEF(bA)C","Corresponds to amino acid residues G584 to F590. S587 is located in the Gap/Insert 10 (G/I10) region in the protein-serine/threonine kinase catalytic domain of SRPK1. ","S587 phosphorylation appears to induce RNA splicing. It has been observed in only one mass spectrometry study. ",null,"Q96SB4","Q96SB4",6658,"Q96SB4",null,"NP_003128.3","Block8",3,8,"8, 16, 24, 32","SRPK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","SRPK",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; CMGC domain target; CMGC</A> group; SRPK family","GO:0005737; GO:0005829; GO:0005783; GO:0016363; GO:0005634; GO:0005886","GO:0005524; GO:0000287; GO:0004672; GO:0004674; GO:0003723","GO:0007059; GO:0045087; GO:0035556; GO:0045071; GO:0045070; GO:0006468; GO:0050684; GO:0048024; GO:0008380; GO:0035092; GO:0000245; GO:0016032"]
[2441,1218,"NK296-1","SRPK2","Pan-specific","Serine/arginine-rich protein-specific kinase 2; Serine kinase SRPK2",{"v":5642.66081358423,"d":"5643"},{"v":5112.401068681464,"d":"5112"},{"v":2320.0486608558217,"d":"2320"},{"v":41.11621693209877,"d":"41"},{"v":255.99391037235358,"d":"256"},{"v":12689.6487197847,"d":"12690"},"Kinexus","RpAb","CGEAEDQEEKEDAEKENIEK","Corresponds to amino acid residues G343 to K361; Insert into kinase domain.",null,null,"P78362","P78362",760,"P78362","P78362","NP_001265202.1","Block8",3,9,"8, 16, 24, 32","SRPK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","SRPK",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; CMGC group; SRPK family","GO:0005737; GO:0005829; GO:0005730; GO:0005654; GO:0005634","GO:0071889; GO:0005524; GO:0000287; GO:0004674; GO:0003723","GO:0001525; GO:0030154; GO:0045087; GO:0035556; GO:0045071; GO:0035063; GO:0045787; GO:0008284; GO:0010628; GO:0043525; GO:0045070; GO:0006468; GO:0048024; GO:0008380; GO:0000245"]
[2443,1219,"PK820","SRPK2","Y319","Serine/arginine-rich protein-specific kinase 2; Serine kinase SRPK2",{"v":624.6383584179728,"d":"625"},{"v":578.0225086476853,"d":"578"},{"v":389.67944951192703,"d":"390"},{"v":62.384809427789826,"d":"62"},{"v":29.21681688593646,"d":"29"},{"v":2096.682561667556,"d":"2097"},"Kinexus","RpAb","DGE(pY)CPE(bA)C","Corresponds to amino acid residues D316 to E322; In the insert region between the kinase catalytic domain. ","The effect of Y319 phosphorylation is unclear. This is the major in vivo phosphorylation site in SRPK2.",null,"P78362","P78362",760,"P78362","P78362","NP_001265202.1","Block8",3,10,"8, 16, 24, 32","SRPK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CMGC","SRPK",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; CMGC group; SRPK family","GO:0005737; GO:0005829; GO:0005730; GO:0005654; GO:0005634","GO:0071889; GO:0005524; GO:0000287; GO:0004674; GO:0003723","GO:0001525; GO:0030154; GO:0045087; GO:0035556; GO:0045071; GO:0035063; GO:0045787; GO:0008284; GO:0010628; GO:0043525; GO:0045070; GO:0006468; GO:0048024; GO:0008380; GO:0000245"]
[2445,1220,"PN665","SSRP1","Y441+S444","FACT complex subunit SSRP1",{"v":1207.9615433590109,"d":"1208"},{"v":1154.2044136606355,"d":"1154"},{"v":556.4053358915249,"d":"556"},{"v":46.06151072858775,"d":"46"},{"v":128.7169142355194,"d":"129"},{"v":2920.5481750983477,"d":"2921"},"Kinexus","RpAb","YDE(pY)AD(pS)DED(bA)C","Corresponds to amino acid residues Y438 to D447.","The effects of Y441 and S444 phosphorylation are unclear. This is one of the major sites of in vivo phosphorylation of SSRP1.",null,"Q08945","Q08945",2869,null,null,"NP_003137.1","Block8",3,11,"8, 16, 24, 32",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription initiation complex; Transcription, coactivator/corepressor","GO:0005694; GO:0005730; GO:0005654","GO:0003682; GO:0003677; GO:0003723; GO:0000981","GO:0006281; GO:0006260; GO:1901796; GO:0006366; GO:0006368"]
[2447,1221,"PN729","STAG2","Y433","Putative uncharacterized protein DKFZp781H1753",{"v":5578.115194890537,"d":"5578"},{"v":5521.754226229323,"d":"5522"},{"v":1673.6497132793938,"d":"1674"},{"v":30.003857123862016,"d":"30"},{"v":554.3166397270977,"d":"554"},{"v":11407.665474034464,"d":"11408"},"Kinexus","RpAb","CGEFL(pY)KKL","Corresponds to amino acid residues G428 to L436.","The effect of Y433 phosphorylation is unclear. This is the major site of in vivo phosphorylation of STAG2 (≥42 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in the frog.",null,"Q8N3U4","Q8N3U4",5921,null,null,"NP_006594.3","Block8",3,12,"8, 16, 24, 32",{"$nulls":3},"Transcription, coactivator/corepressor",{"$nulls":4},"X",{"$nulls":5},"GO:0000785; GO:0005694; GO:0000775; GO:0008278; GO:0005829; GO:0016020; GO:0097431; GO:0016363; GO:0005654; GO:0005634",null,"GO:0051301; GO:0051321; GO:0032876; GO:1901673; GO:0007062"]
[2449,1222,"PN538","STAM2","Y374","Signal transducing adapter molecule 2",{"v":628.5826981073352,"d":"629"},{"v":556.3795482089774,"d":"556"},{"v":422.3570586674715,"d":"422"},{"v":67.19196375261205,"d":"67"},{"v":26.043572743530028,"d":"26"},{"v":2271.5554218342368,"d":"2272"},"Kinexus","RpAb","YSV(pY)SKL(bA)C","Corresponds to amino acid residues Y371 to L377; In the C-terminal half of the protein. ","The effect of Y374 phosphorylation is unclear. This is the second major in vivo phosphorylation site in STAM2.",null,"O75886","O75886",3469,null,"O75886","NP_005834.4","Block8",3,13,"8, 16, 24, 32",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",null,null,"X",null,"Transcription protein","GO:0005737; GO:0005829; GO:0031901; GO:0033565; GO:0043231; GO:0005654",null,"GO:0016197; GO:0006886; GO:0016236; GO:0061024; GO:0036258; GO:0042059"]
[2451,1223,"NN139-2","STAT1","Pan-specific","Signal transducer and activator of transcription 1 alpha",{"v":255.8932124000824,"d":"256"},{"v":216.0248601158737,"d":"216"},{"v":170.32461084031917,"d":"170"},{"v":66.56081622595798,"d":"67"},{"v":40.49511868011707,"d":"40"},{"v":1593.1909014102157,"d":"1593"},"External","MmAb","Epitope undefined.",{"$nulls":3},"P42224","P42224",1048,null,null,"NP_009330.1","Block8",4,1,"8, 16, 24, 32",{"$nulls":3},"Transcription protein, SH2 protein;  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"Transcription factor; Transcription, coactivator/corepressor","GO:0030424; GO:0005737; GO:0005829; GO:0030425; GO:0000790; GO:0005730; GO:0005654; GO:0005634; GO:0048471; GO:0032991","GO:0045296; GO:0031730; GO:0003700; GO:0003690; GO:0019899; GO:0035035; GO:0042393; GO:0042802; GO:0035257; GO:1990841; GO:0042803; GO:0051721; GO:0070491; GO:0000979; GO:0000978; GO:0000981; GO:0000983; GO:0000982; GO:0005164; GO:0044389","GO:0008015; GO:0032869; GO:0035458; GO:0071346; GO:0071407; GO:0019221; GO:0051607; GO:0060333; GO:0038114; GO:0070106; GO:0070757; GO:0070102; GO:0038113; GO:0007259; GO:0010742; GO:0072162; GO:0072136; GO:0046725; GO:0016525; GO:0001937; GO:0043124; GO:0003340; GO:0072308; GO:0000122; GO:0002230; GO:0045648; GO:0032727; GO:0002053; GO:0051770; GO:0048661; GO:0045893; GO:0045944; GO:0007221; GO:0042981; GO:0060334; GO:0006355; GO:0061326; GO:0051591; GO:0034097; GO:0042542; GO:0035456; GO:0009612; GO:0007584; GO:0043434; GO:0006351; GO:0033209; GO:0060337; GO:0016032"]
[2453,1224,"PN666","STAT1","Y701","Signal transducer and activator of transcription 1-alpha/beta",{"v":14046.095664221068,"d":"14046"},{"v":14138.576527688643,"d":"14139"},{"v":3123.569323999249,"d":"3124"},{"v":22.237989820585973,"d":"22"},{"v":2298.4702059349793,"d":"2298"},{"v":23494.597658745613,"d":"23495"},"Kinexus","RpAb","CGTG(pY)IKTE","Corresponds to amino acid residues C698 to E705.","Y701 phosphorylation regulates transcription and molecular association, and stimulates transcriptional activity. This is one of the major sites of in vivo phosphorylation of STAT1.","FGFR3; JAK1; JAK2; JAK3; Src; Tyk2","P42224","P42224",1048,null,null,"NP_009330.1","Block8",4,2,"8, 16, 24, 32",{"$nulls":3},"Transcription protein, SH2 protein;  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"Transcription factor; Transcription, coactivator/corepressor","GO:0030424; GO:0005737; GO:0005829; GO:0030425; GO:0000790; GO:0005730; GO:0005654; GO:0005634; GO:0048471; GO:0032991","GO:0045296; GO:0031730; GO:0003700; GO:0003690; GO:0019899; GO:0035035; GO:0042393; GO:0042802; GO:0035257; GO:1990841; GO:0042803; GO:0051721; GO:0070491; GO:0000979; GO:0000978; GO:0000981; GO:0000983; GO:0000982; GO:0005164; GO:0044389","GO:0008015; GO:0032869; GO:0035458; GO:0071346; GO:0071407; GO:0019221; GO:0051607; GO:0060333; GO:0038114; GO:0070106; GO:0070757; GO:0070102; GO:0038113; GO:0007259; GO:0010742; GO:0072162; GO:0072136; GO:0046725; GO:0016525; GO:0001937; GO:0043124; GO:0003340; GO:0072308; GO:0000122; GO:0002230; GO:0045648; GO:0032727; GO:0002053; GO:0051770; GO:0048661; GO:0045893; GO:0045944; GO:0007221; GO:0042981; GO:0060334; GO:0006355; GO:0061326; GO:0051591; GO:0034097; GO:0042542; GO:0035456; GO:0009612; GO:0007584; GO:0043434; GO:0006351; GO:0033209; GO:0060337; GO:0016032"]
[2455,1225,"PN667","STAT1","S727","Signal transducer and activator of transcription 1-alpha/beta",{"v":9561.174156702824,"d":"9561"},{"v":8666.136265550038,"d":"8666"},{"v":4187.45148846428,"d":"4187"},{"v":43.7964147481686,"d":"44"},{"v":899.3876938947719,"d":"899"},{"v":23076.961216453037,"d":"23077"},"Kinexus","RpAb","LLPM(pS)PEE(bA)C","Corresponds to amino acid residues L723 to E730.","S727 phosphorylation regulates cell cycle, cell differentiation, cell growth, transcription, alters intracellular location, molecular association, induces interaction with DNA, PIAS1, STAT2, and inhibits interaction with DNA. This is one of the major sites of in vivo phosphorylation of STAT1.","CaMK2a; CaMK2g; CK2a1 (CSNK2A1); ERK1 (MAPK3); ERK2 (MAPK1); JNK1 (MAPK8); p38a MAPK (MAPK14); PKCd (PRKCD)","P42224","P42224",1048,null,null,"NP_009330.1","Block8",4,3,"8, 16, 24, 32",{"$nulls":3},"Transcription protein, SH2 protein;  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"Transcription factor; Transcription, coactivator/corepressor","GO:0030424; GO:0005737; GO:0005829; GO:0030425; GO:0000790; GO:0005730; GO:0005654; GO:0005634; GO:0048471; GO:0032991","GO:0045296; GO:0031730; GO:0003700; GO:0003690; GO:0019899; GO:0035035; GO:0042393; GO:0042802; GO:0035257; GO:1990841; GO:0042803; GO:0051721; GO:0070491; GO:0000979; GO:0000978; GO:0000981; GO:0000983; GO:0000982; GO:0005164; GO:0044389","GO:0008015; GO:0032869; GO:0035458; GO:0071346; GO:0071407; GO:0019221; GO:0051607; GO:0060333; GO:0038114; GO:0070106; GO:0070757; GO:0070102; GO:0038113; GO:0007259; GO:0010742; GO:0072162; GO:0072136; GO:0046725; GO:0016525; GO:0001937; GO:0043124; GO:0003340; GO:0072308; GO:0000122; GO:0002230; GO:0045648; GO:0032727; GO:0002053; GO:0051770; GO:0048661; GO:0045893; GO:0045944; GO:0007221; GO:0042981; GO:0060334; GO:0006355; GO:0061326; GO:0051591; GO:0034097; GO:0042542; GO:0035456; GO:0009612; GO:0007584; GO:0043434; GO:0006351; GO:0033209; GO:0060337; GO:0016032"]
[2457,1226,"PN668","STAT2","Y690","Signal transducer and activator of transcription 2",{"v":416.9837137797729,"d":"417"},{"v":401.78334315624716,"d":"402"},{"v":223.622235646628,"d":"224"},{"v":53.62852990578249,"d":"54"},{"v":40.89963646012519,"d":"41"},{"v":1500.3433965370023,"d":"1500"},"Kinexus","RpAb","ERRK(pY)LKHR(bA)C","Corresponds to amino acid residues E686 to R694.","Y690 phosphorylation stimulates transcriptional activity. This is one of the major sites of in vivo phosphorylation of STAT2.","JAK1; Lck; Tyk2","P52630","P52630",1049,null,null,"NP_005410.1","Block8",4,4,"8, 16, 24, 32",{"$nulls":3},"Transcription protein, SH2 protein;  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005829; GO:0005654; GO:0005886","GO:0003677; GO:0042802; GO:0000981; GO:0044389","GO:0019221; GO:0051607; GO:0007259; GO:0090140; GO:0001932; GO:0006357; GO:0006351; GO:0060337; GO:0016032"]
[2459,1227,"PN273","STAT3","Y705","Signal transducer and activator of transcription 3",{"v":2610.398330469588,"d":"2610"},{"v":2391.244236726484,"d":"2391"},{"v":1395.9321295697398,"d":"1396"},{"v":53.47582831615678,"d":"53"},{"v":83.89076948910467,"d":"84"},{"v":10864.74851086708,"d":"10865"},"External","MmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the Y705 phosphosite.","Y705 phosphorylation stimulates transcriptional activity and induces molecular association DNA, PKCD, and STAT1. It regulates apoptosis, cell adhesion, cell differentiation, cell growth, cell motility, transcription, activation, alters intracellular location, and protein degradation. This is one of the major sites of in vivo phosphorylation of STAT3(≥XXX reports from high throughput mass spectrometry studies).","EphB1; Fer; JAK1; JAK2; MAPKAPK2; MEKK1 (MAP3K1); PKM2","P40763","P40763",1050,null,"P40763","NP_003141","Block8",4,5,"8, 16, 24, 32",{"$nulls":3},"Transcription protein, SH2 protein;  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"Nuclear receptor co-regulator; Transcription factor","GO:0005737; GO:0005829; GO:0098978; GO:0005743; GO:0000790; GO:0005654; GO:0005634; GO:0005886; GO:0014069; GO:0090575; GO:0098685","GO:0031730; GO:0031490; GO:0003677; GO:0003700; GO:0035259; GO:0042802; GO:0004879; GO:0046983; GO:0042803; GO:0019901; GO:0019903; GO:0000978; GO:0001103; GO:0000981; GO:0001077; GO:0001228; GO:0008134; GO:0044212","GO:0006953; GO:0007568; GO:0048708; GO:0008283; GO:0071345; GO:0032870; GO:0044320; GO:0071407; GO:0019221; GO:0042755; GO:0097009; GO:0001754; GO:0042593; GO:0060396; GO:0006954; GO:0035723; GO:0038114; GO:0038155; GO:0070106; GO:0070757; GO:0070102; GO:0038111; GO:0038113; GO:0030522; GO:0007259; GO:0060397; GO:0033210; GO:0035278; GO:0050804; GO:0042789; GO:0043066; GO:0008285; GO:0045820; GO:0010730; GO:1901215; GO:2001223; GO:2000737; GO:0000122; GO:0007399; GO:0016310; GO:0045766; GO:2001171; GO:0045648; GO:0010628; GO:2000637; GO:1902728; GO:1904685; GO:0045747; GO:1902895; GO:0045893; GO:0045944; GO:0042531; GO:1905564; GO:0099527; GO:0006606; GO:0060019; GO:0051726; GO:0060259; GO:0046902; GO:0040014; GO:0006355; GO:0006357; GO:0032355; GO:0045471; GO:0044321; GO:0019953; GO:0007165; GO:0035019; GO:0001659; GO:0072540; GO:0016032"]
[2461,1228,"PN539","STAT3","Y705+T708","Signal transducer and activator of transcription 3",{"v":4958.596651993197,"d":"4959"},{"v":4403.515922057099,"d":"4404"},{"v":2451.3758043717116,"d":"2451"},{"v":49.43688661158469,"d":"49"},{"v":357.54024412280546,"d":"358"},{"v":19178.652913728965,"d":"19179"},"Kinexus","RpAb","AAP(pY)LK(pT)(bA)C","Corresponds to amino acid residues A702 to T708; In the C-terminus of the transcription factor. ","Phosphorylation of Y705 and T708 induces transcriptional activity and interaction with DNA, PKCD and STAT1. Y705 is the major in vivo phosphorylation site in STAT3.","Y705: EphB1; Fer; JAK1; JAK2; MAPKAPK2; MEKK1 (MAP3K1); PKM2","P40763","P40763",1050,null,"P40763","NP_003141","Block8",4,6,"8, 16, 24, 32",{"$nulls":3},"Transcription protein, SH2 protein;  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"Nuclear receptor co-regulator; Transcription factor","GO:0005737; GO:0005829; GO:0098978; GO:0005743; GO:0000790; GO:0005654; GO:0005634; GO:0005886; GO:0014069; GO:0090575; GO:0098685","GO:0031730; GO:0031490; GO:0003677; GO:0003700; GO:0035259; GO:0042802; GO:0004879; GO:0046983; GO:0042803; GO:0019901; GO:0019903; GO:0000978; GO:0001103; GO:0000981; GO:0001077; GO:0001228; GO:0008134; GO:0044212","GO:0006953; GO:0007568; GO:0048708; GO:0008283; GO:0071345; GO:0032870; GO:0044320; GO:0071407; GO:0019221; GO:0042755; GO:0097009; GO:0001754; GO:0042593; GO:0060396; GO:0006954; GO:0035723; GO:0038114; GO:0038155; GO:0070106; GO:0070757; GO:0070102; GO:0038111; GO:0038113; GO:0030522; GO:0007259; GO:0060397; GO:0033210; GO:0035278; GO:0050804; GO:0042789; GO:0043066; GO:0008285; GO:0045820; GO:0010730; GO:1901215; GO:2001223; GO:2000737; GO:0000122; GO:0007399; GO:0016310; GO:0045766; GO:2001171; GO:0045648; GO:0010628; GO:2000637; GO:1902728; GO:1904685; GO:0045747; GO:1902895; GO:0045893; GO:0045944; GO:0042531; GO:1905564; GO:0099527; GO:0006606; GO:0060019; GO:0051726; GO:0060259; GO:0046902; GO:0040014; GO:0006355; GO:0006357; GO:0032355; GO:0045471; GO:0044321; GO:0019953; GO:0007165; GO:0035019; GO:0001659; GO:0072540; GO:0016032"]
[2463,1229,"PN272","STAT3","S727","Signal transducer and activator of transcription 3",{"v":222.620992123284,"d":"223"},{"v":111.69875076371568,"d":"112"},{"v":596.1153708617785,"d":"596"},{"v":267.77141058272673,"d":"268"},{"v":17.06114299032844,"d":"17"},{"v":6038.941042762222,"d":"6039"},"External","MmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the S727 phosphosite.","S727 phosphorylation regulates carcinogenesis, cell differentiation, cell growth, cell motility, transcription, activation/inhibition, alters intracellular location, molecular association, induces interaction with DNA, p300, and inhibits interaction with gp130. This is one of the major sites of in vivo phosphorylation of STAT3.","CDK1 (CDC2); CDK5; DYRK1A; DYRK2; ERK1 (MAPK3); ERK2 (MAPK1); FRAP1 (mTOR); HIPK2; IRAK1; JNK1 (MAPK8); MAPKAPK2; MEKK1 (MAP3K1); MSK1 (RPS6KA5); NLK; p38a MAPK (MAPK14); PKCd (PRKCD); PKCe (PRKCE); RSK2 (RPS6KA3)","P40763","P40763",1050,null,"P40763","NP_003141","Block8",4,7,"8, 16, 24, 32",{"$nulls":3},"Transcription protein, SH2 protein;  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"Nuclear receptor co-regulator; Transcription factor","GO:0005737; GO:0005829; GO:0098978; GO:0005743; GO:0000790; GO:0005654; GO:0005634; GO:0005886; GO:0014069; GO:0090575; GO:0098685","GO:0031730; GO:0031490; GO:0003677; GO:0003700; GO:0035259; GO:0042802; GO:0004879; GO:0046983; GO:0042803; GO:0019901; GO:0019903; GO:0000978; GO:0001103; GO:0000981; GO:0001077; GO:0001228; GO:0008134; GO:0044212","GO:0006953; GO:0007568; GO:0048708; GO:0008283; GO:0071345; GO:0032870; GO:0044320; GO:0071407; GO:0019221; GO:0042755; GO:0097009; GO:0001754; GO:0042593; GO:0060396; GO:0006954; GO:0035723; GO:0038114; GO:0038155; GO:0070106; GO:0070757; GO:0070102; GO:0038111; GO:0038113; GO:0030522; GO:0007259; GO:0060397; GO:0033210; GO:0035278; GO:0050804; GO:0042789; GO:0043066; GO:0008285; GO:0045820; GO:0010730; GO:1901215; GO:2001223; GO:2000737; GO:0000122; GO:0007399; GO:0016310; GO:0045766; GO:2001171; GO:0045648; GO:0010628; GO:2000637; GO:1902728; GO:1904685; GO:0045747; GO:1902895; GO:0045893; GO:0045944; GO:0042531; GO:1905564; GO:0099527; GO:0006606; GO:0060019; GO:0051726; GO:0060259; GO:0046902; GO:0040014; GO:0006355; GO:0006357; GO:0032355; GO:0045471; GO:0044321; GO:0019953; GO:0007165; GO:0035019; GO:0001659; GO:0072540; GO:0016032"]
[2465,1230,"PN669","STAT3","S727","Signal transducer and activator of transcription 3",{"v":14436.897375036824,"d":"14437"},{"v":14339.021666591118,"d":"14339"},{"v":4099.40768946319,"d":"4099"},{"v":28.39535104371921,"d":"28"},{"v":4883.514697092911,"d":"4884"},{"v":25228.27507888195,"d":"25228"},"Kinexus","RpAb","DLPM(pS)PRT(bA)C","Corresponds to amino acid residues D723 to T730.","S727 phosphorylation regulates carcinogenesis, cell differentiation, cell growth, cell motility, transcription, activation/inhibition, alters intracellular location, molecular association, induces interaction with DNA, p300, and inhibits interaction with gp130. This is one of the major sites of in vivo phosphorylation of STAT3.","CDK1 (CDC2); CDK5; DYRK1A; DYRK2; ERK1 (MAPK3); ERK2 (MAPK1); FRAP1 (mTOR); HIPK2; IRAK1; JNK1 (MAPK8); MAPKAPK2; MEKK1 (MAP3K1); MSK1 (RPS6KA5); NLK; p38a MAPK (MAPK14); PKCd (PRKCD); PKCe (PRKCE); RSK2 (RPS6KA3)","P40763","P40763",1050,null,"P40763","NP_003141","Block8",4,8,"8, 16, 24, 32",{"$nulls":3},"Transcription protein, SH2 protein;  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"Nuclear receptor co-regulator; Transcription factor","GO:0005737; GO:0005829; GO:0098978; GO:0005743; GO:0000790; GO:0005654; GO:0005634; GO:0005886; GO:0014069; GO:0090575; GO:0098685","GO:0031730; GO:0031490; GO:0003677; GO:0003700; GO:0035259; GO:0042802; GO:0004879; GO:0046983; GO:0042803; GO:0019901; GO:0019903; GO:0000978; GO:0001103; GO:0000981; GO:0001077; GO:0001228; GO:0008134; GO:0044212","GO:0006953; GO:0007568; GO:0048708; GO:0008283; GO:0071345; GO:0032870; GO:0044320; GO:0071407; GO:0019221; GO:0042755; GO:0097009; GO:0001754; GO:0042593; GO:0060396; GO:0006954; GO:0035723; GO:0038114; GO:0038155; GO:0070106; GO:0070757; GO:0070102; GO:0038111; GO:0038113; GO:0030522; GO:0007259; GO:0060397; GO:0033210; GO:0035278; GO:0050804; GO:0042789; GO:0043066; GO:0008285; GO:0045820; GO:0010730; GO:1901215; GO:2001223; GO:2000737; GO:0000122; GO:0007399; GO:0016310; GO:0045766; GO:2001171; GO:0045648; GO:0010628; GO:2000637; GO:1902728; GO:1904685; GO:0045747; GO:1902895; GO:0045893; GO:0045944; GO:0042531; GO:1905564; GO:0099527; GO:0006606; GO:0060019; GO:0051726; GO:0060259; GO:0046902; GO:0040014; GO:0006355; GO:0006357; GO:0032355; GO:0045471; GO:0044321; GO:0019953; GO:0007165; GO:0035019; GO:0001659; GO:0072540; GO:0016032"]
[2467,1231,"NN117","STAT4","Pan-specific","Signal transducer and activator of transcription 4",{"v":1036.2291632991519,"d":"1036"},{"v":880.9348707016147,"d":"881"},{"v":657.7576596916447,"d":"658"},{"v":63.476080676736835,"d":"63"},{"v":139.99087140215457,"d":"140"},{"v":4008.283967436102,"d":"4008"},"External","RpAb",null,"Likely to correspond to the C-terminal 20 amino acids.",null,null,"Q14765","Q14765",1051,null,null,"NP_003142.1","Block8",4,9,"8, 16, 24, 32",{"$nulls":3},"Transcription protein, SH2 protein;  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005829; GO:0005654","GO:0003677; GO:0003700; GO:0042802; GO:0000981","GO:0019221; GO:0035722; GO:0038114; GO:0038155; GO:0070757; GO:0007259; GO:0045944; GO:0006351"]
[2469,1232,"PN670","STAT4","Y693","Signal transducer and activator of transcription 4",{"v":9866.210223006377,"d":"9866"},{"v":10173.752461344875,"d":"10174"},{"v":2319.3970876347753,"d":"2319"},{"v":23.508490445767343,"d":"24"},{"v":613.626362154102,"d":"614"},{"v":17611.461779063873,"d":"17611"},"Kinexus","RpAb","CGDKG(pY)VPSV","Corresponds to amino acid residues C689 to V697.","The effect of Y693 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of STAT4.",null,"Q14765","Q14765",1051,null,null,"NP_003142.1","Block8",4,10,"8, 16, 24, 32",{"$nulls":3},"Transcription protein, SH2 protein;  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005829; GO:0005654","GO:0003677; GO:0003700; GO:0042802; GO:0000981","GO:0019221; GO:0035722; GO:0038114; GO:0038155; GO:0070757; GO:0007259; GO:0045944; GO:0006351"]
[2471,1233,"PN274","STAT4","S721","Signal transducer and activator of transcription 4",{"v":1604.715001126406,"d":"1605"},{"v":1332.0000465356973,"d":"1332"},{"v":1341.4494702182958,"d":"1341"},{"v":83.5942500242526,"d":"84"},{"v":34.47321873457647,"d":"34"},{"v":11246.892838244112,"d":"11247"},"External","MmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the S721 phosphosite.","The effect of S721 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of STAT4.","p38a MAPK (MAPK14)","Q14765","Q14765",1051,null,null,"NP_003142.1","Block8",4,11,"8, 16, 24, 32",{"$nulls":3},"Transcription protein, SH2 protein;  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005829; GO:0005654","GO:0003677; GO:0003700; GO:0042802; GO:0000981","GO:0019221; GO:0035722; GO:0038114; GO:0038155; GO:0070757; GO:0007259; GO:0045944; GO:0006351"]
[2473,1234,"PN083-1","STAT5","Y694","Signal transducer and activator of transcription 5",{"v":2423.287632012836,"d":"2423"},{"v":2499.3001193848654,"d":"2499"},{"v":953.8568232692061,"d":"954"},{"v":39.36209679231976,"d":"39"},{"v":40.77033173983586,"d":"41"},{"v":6360.8506594137625,"d":"6361"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the Y694 phosphosite.","Y694 phosphorylation stimulates transcriptional activity. This is one of the major sites of in vivo phosphorylation of STAT5A.","Btk; JAK1; JAK2; JAK3; Lck; Lyn; Src; Syk","P42229","P42229",1052,null,"P42229","NP_003143","Block8",4,12,"8, 16, 24, 32",{"$nulls":3},"Transcription protein, SH2 protein;  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005829; GO:0005654","GO:0003677; GO:0003700; GO:0004713; GO:0000981","GO:0006103; GO:0000255; GO:0006101; GO:0006600; GO:0046449; GO:0019221; GO:0006631; GO:0035723; GO:0038110; GO:0038111; GO:0038113; GO:0006549; GO:0007259; GO:0060397; GO:0007595; GO:0006107; GO:0043536; GO:0001938; GO:0040014; GO:0006357; GO:0006105; GO:0019530; GO:0006351; GO:0006573"]
[2475,1235,"PN671","STAT5A","Y694","Signal transducer and activator of transcription 5A",{"v":3940.238586345572,"d":"3940"},{"v":3350.69146348313,"d":"3351"},{"v":2982.981062450498,"d":"2983"},{"v":75.7055949045234,"d":"76"},{"v":44.937423460216834,"d":"45"},{"v":26831.036240273585,"d":"26831"},"Kinexus","RpAb","CAVDG(pY)VKPQ","Corresponds to amino acid residues C690 to Q698.","Y694 phosphorylation stimulates transcriptional activity. This is one of the major sites of in vivo phosphorylation of STAT5A.","Btk; JAK1; JAK2; JAK3; Lck; Lyn; Src; Syk","P42229","P42229",1052,null,"P42229","NP_003143","Block8",4,13,"8, 16, 24, 32",{"$nulls":3},"Transcription protein, SH2 protein;  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005829; GO:0005654","GO:0003677; GO:0003700; GO:0004713; GO:0000981","GO:0006103; GO:0000255; GO:0006101; GO:0006600; GO:0046449; GO:0019221; GO:0006631; GO:0035723; GO:0038110; GO:0038111; GO:0038113; GO:0006549; GO:0007259; GO:0060397; GO:0007595; GO:0006107; GO:0043536; GO:0001938; GO:0040014; GO:0006357; GO:0006105; GO:0019530; GO:0006351; GO:0006573"]
[2477,1236,"PN672","STAT5A","S780","Signal transducer and activator of transcription 5A",{"v":16932.234247521257,"d":"16932"},{"v":16334.266542400817,"d":"16334"},{"v":5254.87584816911,"d":"5255"},{"v":31.034745747971105,"d":"31"},{"v":4802.256588597345,"d":"4802"},{"v":43292.43335919957,"d":"43292"},"Kinexus","RpAb","DSRL(pS)PPAGC","Corresponds to amino acid residues D776 to G784.","S780 phosphorylation regulates molecular association, including inhibiting interaction with ERK1. This is one of the major sites of in vivo phosphorylation of STAT5A.","ERK1 (MAPK3); ERK2 (MAPK1); PAK1","P42229","P42229",1052,null,"P42229","NP_003143","Block8",5,1,"8, 16, 24, 32",{"$nulls":3},"Transcription protein, SH2 protein;  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005829; GO:0005654","GO:0003677; GO:0003700; GO:0004713; GO:0000981","GO:0006103; GO:0000255; GO:0006101; GO:0006600; GO:0046449; GO:0019221; GO:0006631; GO:0035723; GO:0038110; GO:0038111; GO:0038113; GO:0006549; GO:0007259; GO:0060397; GO:0007595; GO:0006107; GO:0043536; GO:0001938; GO:0040014; GO:0006357; GO:0006105; GO:0019530; GO:0006351; GO:0006573"]
[2479,1237,"NN107-2","STAT6","Pan-specific","Signal transducer and activator of transcription 6",{"v":957.7314137987214,"d":"958"},{"v":848.735440795349,"d":"849"},{"v":712.4067430354237,"d":"712"},{"v":74.3848152802832,"d":"74"},{"v":30.10902894456471,"d":"30"},{"v":7354.290626107637,"d":"7354"},"External","MmAb","Epitope undefined.",{"$nulls":3},"P42226","P42226",1053,null,null,"NP_003144.3","Block8",5,2,"8, 16, 24, 32",{"$nulls":3},"Transcription protein, SH2 protein;  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005829; GO:0045121; GO:0000790; GO:0031965; GO:0005654","GO:0003700; GO:0042802; GO:0019903; GO:0000978; GO:0000977; GO:0000981; GO:0001228","GO:0070301; GO:1902170; GO:0019221; GO:0035771; GO:0033598; GO:0060443; GO:0000122; GO:0002829; GO:0120162; GO:0048295; GO:0045944; GO:0032481; GO:0042127; GO:0006357; GO:0007165; GO:0002296"]
[2481,1238,"PN673","STAT6","Y641","Signal transducer and activator of transcription 6",{"v":8254.00292761967,"d":"8254"},{"v":8129.022789741566,"d":"8129"},{"v":1688.5467375906148,"d":"1689"},{"v":20.457307228961284,"d":"20"},{"v":4052.871106567863,"d":"4053"},{"v":12780.703594706774,"d":"12781"},"Kinexus","RpAb","CGRG(pY)VPAT","Corresponds to amino acid residues C638 to T645.","The effect of Y641 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of STAT6.",null,"P42226","P42226",1053,null,null,"NP_003144.3","Block8",5,3,"8, 16, 24, 32",{"$nulls":3},"Transcription protein, SH2 protein;  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005829; GO:0045121; GO:0000790; GO:0031965; GO:0005654","GO:0003700; GO:0042802; GO:0019903; GO:0000978; GO:0000977; GO:0000981; GO:0001228","GO:0070301; GO:1902170; GO:0019221; GO:0035771; GO:0033598; GO:0060443; GO:0000122; GO:0002829; GO:0120162; GO:0048295; GO:0045944; GO:0032481; GO:0042127; GO:0006357; GO:0007165; GO:0002296"]
[2483,1239,"NK174","Syk","Pan-specific","Spleen protein-tyrosine kinase",{"v":568.9793820522657,"d":"569"},{"v":475.6874127112133,"d":"476"},{"v":340.8002970278258,"d":"341"},{"v":59.89677443119026,"d":"60"},{"v":86.43901761242853,"d":"86"},{"v":2317.906810467443,"d":"2318"},"External","MmAb","Epitope undefined.",{"$nulls":3},"P43405","P43405",662,"P43405","P43405","NP_003168","Block8",5,4,"8, 16, 24, 32","SYK","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Syk",{"$nulls":6},"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; Syk family","GO:0019815; GO:0005737; GO:0005829; GO:0032009; GO:0031234; GO:0005634; GO:0005886; GO:0032991; GO:0042101","GO:0005524; GO:0005178; GO:0004715; GO:0019902; GO:0001784; GO:0004672; GO:0019901; GO:0004674; GO:0004713; GO:0042169; GO:0035325","GO:0007257; GO:0002250; GO:0001525; GO:0009887; GO:0050853; GO:0043366; GO:0048514; GO:0008283; GO:0071404; GO:0071226; GO:0038063; GO:0042742; GO:0038095; GO:0038096; GO:0006954; GO:0045087; GO:0007229; GO:0038110; GO:0038156; GO:0002366; GO:0007159; GO:0019370; GO:0001945; GO:0002281; GO:0002283; GO:0030593; GO:0018105; GO:0038083; GO:0030168; GO:0046638; GO:0046641; GO:0045579; GO:0045780; GO:0050850; GO:0033630; GO:0120162; GO:0050715; GO:0045588; GO:0045425; GO:0045401; GO:0032753; GO:0043306; GO:1900086; GO:0002092; GO:0032481; GO:0006606; GO:0006468; GO:0031623; GO:0090237; GO:0051090; GO:0070372; GO:0043313; GO:0050764; GO:0010543; GO:0090330; GO:0032928; GO:0010803; GO:0002554; GO:0002223; GO:0007169; GO:0016032"]
[2485,1240,"PK821","Syk","Y323","Spleen protein-tyrosine kinase",{"v":2896.1306957147217,"d":"2896"},{"v":2884.2852093836286,"d":"2884"},{"v":1164.4649573092709,"d":"1164"},{"v":40.20761076260401,"d":"40"},{"v":195.64190255676726,"d":"196"},{"v":6460.120682200117,"d":"6460"},"Kinexus","RpAb","FNP(pY)EPE(bA)C","Corresponds to amino acid residues F320 to E326; In the region between the SH2 and kinase catalytic domains. ","Y323 phosphorylation stimulates phosphotransferase activity and regulates molecular association, including inducing interaction with Cbl, and Fyn. This is the major site of phosphorylation in Syk.","Lck; Lyn; Syk","P43405","P43405",662,"P43405","P43405","NP_003168","Block8",5,5,"8, 16, 24, 32","SYK","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Syk",{"$nulls":6},"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; Syk family","GO:0019815; GO:0005737; GO:0005829; GO:0032009; GO:0031234; GO:0005634; GO:0005886; GO:0032991; GO:0042101","GO:0005524; GO:0005178; GO:0004715; GO:0019902; GO:0001784; GO:0004672; GO:0019901; GO:0004674; GO:0004713; GO:0042169; GO:0035325","GO:0007257; GO:0002250; GO:0001525; GO:0009887; GO:0050853; GO:0043366; GO:0048514; GO:0008283; GO:0071404; GO:0071226; GO:0038063; GO:0042742; GO:0038095; GO:0038096; GO:0006954; GO:0045087; GO:0007229; GO:0038110; GO:0038156; GO:0002366; GO:0007159; GO:0019370; GO:0001945; GO:0002281; GO:0002283; GO:0030593; GO:0018105; GO:0038083; GO:0030168; GO:0046638; GO:0046641; GO:0045579; GO:0045780; GO:0050850; GO:0033630; GO:0120162; GO:0050715; GO:0045588; GO:0045425; GO:0045401; GO:0032753; GO:0043306; GO:1900086; GO:0002092; GO:0032481; GO:0006606; GO:0006468; GO:0031623; GO:0090237; GO:0051090; GO:0070372; GO:0043313; GO:0050764; GO:0010543; GO:0090330; GO:0032928; GO:0010803; GO:0002554; GO:0002223; GO:0007169; GO:0016032"]
[2487,1241,"PK822","Syk","Y352","Spleen protein-tyrosine kinase",{"v":619.5224785611729,"d":"620"},{"v":439.8269054153342,"d":"440"},{"v":560.8371776861147,"d":"561"},{"v":90.52733308219042,"d":"91"},{"v":26.582154637520325,"d":"27"},{"v":3124.368297364499,"d":"3124"},"Kinexus","RpAb","ESP(pY)ADP(bA)C","Corresponds to amino acid residues E349 to P355; In the region between the SH2 and kinase catalytic domains. ","Y352 phosphorylation stimulates phosphotransferase activity and regulates molecular association, including inducing interaction with ITGAM, PLCG1, and CLTC. This is one of the major sites of in vivo phosphorylation of Syk.","Lck; Lyn; Syk","P43405","P43405",662,"P43405","P43405","NP_003168","Block8",5,6,"8, 16, 24, 32","SYK","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Syk",{"$nulls":6},"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; Syk family","GO:0019815; GO:0005737; GO:0005829; GO:0032009; GO:0031234; GO:0005634; GO:0005886; GO:0032991; GO:0042101","GO:0005524; GO:0005178; GO:0004715; GO:0019902; GO:0001784; GO:0004672; GO:0019901; GO:0004674; GO:0004713; GO:0042169; GO:0035325","GO:0007257; GO:0002250; GO:0001525; GO:0009887; GO:0050853; GO:0043366; GO:0048514; GO:0008283; GO:0071404; GO:0071226; GO:0038063; GO:0042742; GO:0038095; GO:0038096; GO:0006954; GO:0045087; GO:0007229; GO:0038110; GO:0038156; GO:0002366; GO:0007159; GO:0019370; GO:0001945; GO:0002281; GO:0002283; GO:0030593; GO:0018105; GO:0038083; GO:0030168; GO:0046638; GO:0046641; GO:0045579; GO:0045780; GO:0050850; GO:0033630; GO:0120162; GO:0050715; GO:0045588; GO:0045425; GO:0045401; GO:0032753; GO:0043306; GO:1900086; GO:0002092; GO:0032481; GO:0006606; GO:0006468; GO:0031623; GO:0090237; GO:0051090; GO:0070372; GO:0043313; GO:0050764; GO:0010543; GO:0090330; GO:0032928; GO:0010803; GO:0002554; GO:0002223; GO:0007169; GO:0016032"]
[2489,1242,"PK823","Syk","Y525+Y526","Spleen protein-tyrosine kinase",{"v":239.19647965653172,"d":"239"},{"v":217.29463301158552,"d":"217"},{"v":147.29056115964346,"d":"147"},{"v":61.57722779663886,"d":"62"},{"v":33.743276358238454,"d":"34"},{"v":868.2380558808871,"d":"868"},"Kinexus","RpAb","DEN(pY)(pY)KAQ(bA)C","Corresponds to amino acid residues D522 to Q529; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y525 and Y526 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of Syk(≥XXX reports from high throughput mass spectrometry studies).","Y525: Syk. Y526: Syk.","P43405","P43405",662,"P43405","P43405","NP_003168","Block8",5,7,"8, 16, 24, 32","SYK","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Syk",{"$nulls":6},"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; Syk family","GO:0019815; GO:0005737; GO:0005829; GO:0032009; GO:0031234; GO:0005634; GO:0005886; GO:0032991; GO:0042101","GO:0005524; GO:0005178; GO:0004715; GO:0019902; GO:0001784; GO:0004672; GO:0019901; GO:0004674; GO:0004713; GO:0042169; GO:0035325","GO:0007257; GO:0002250; GO:0001525; GO:0009887; GO:0050853; GO:0043366; GO:0048514; GO:0008283; GO:0071404; GO:0071226; GO:0038063; GO:0042742; GO:0038095; GO:0038096; GO:0006954; GO:0045087; GO:0007229; GO:0038110; GO:0038156; GO:0002366; GO:0007159; GO:0019370; GO:0001945; GO:0002281; GO:0002283; GO:0030593; GO:0018105; GO:0038083; GO:0030168; GO:0046638; GO:0046641; GO:0045579; GO:0045780; GO:0050850; GO:0033630; GO:0120162; GO:0050715; GO:0045588; GO:0045425; GO:0045401; GO:0032753; GO:0043306; GO:1900086; GO:0002092; GO:0032481; GO:0006606; GO:0006468; GO:0031623; GO:0090237; GO:0051090; GO:0070372; GO:0043313; GO:0050764; GO:0010543; GO:0090330; GO:0032928; GO:0010803; GO:0002554; GO:0002223; GO:0007169; GO:0016032"]
[2491,1243,"NK175-5","TAK1 (MAP3K7)","Pan-specific","TGF-beta-activated protein-serine kinase 1; Mitogen-activated protein kinase kinase kinase 7",{"v":357.69910116103546,"d":"358"},{"v":259.9235242539851,"d":"260"},{"v":526.7506633859025,"d":"527"},{"v":147.26082947263552,"d":"147"},{"v":58.765451502207156,"d":"59"},{"v":7531.11503630896,"d":"7531"},"External","MmAb","Epitope undefined.",{"$nulls":3},"O43318","O43318",664,"O43318","O43318","NP_663306","Block8",5,8,"8, 16, 24, 32","TAK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","MLK","TAK1",{"$nulls":5},"EC 2.7.11.25; Protein kinase, Ser/Thr (non-receptor); TKL group; MLK family; TAK1 subfamily","GO:0005671; GO:0005829; GO:0010008; GO:0005634; GO:0005886","GO:0005524; GO:0042802; GO:0000287; GO:0004709; GO:0004672; GO:0004674; GO:0030971; GO:0097110","GO:0000187; GO:0000186; GO:0007250; GO:0043276; GO:0038095; GO:0043966; GO:0007249; GO:0007252; GO:0070498; GO:0007254; GO:0002755; GO:0070423; GO:0043123; GO:0032743; GO:0043507; GO:0016239; GO:0051092; GO:0002726; GO:0016579; GO:0002223; GO:0051403; GO:0050852; GO:0006351; GO:0007179; GO:0016032; GO:0007223"]
[2493,1244,"NK175-3","TAK1 (MAP3K7)","Pan-specific","TGF-beta-activated protein-serine kinase 1; Mitogen-activated protein kinase kinase kinase 7",{"v":2423.627714292396,"d":"2424"},{"v":2245.190075012447,"d":"2245"},{"v":1033.843321354402,"d":"1034"},{"v":42.656853412663814,"d":"43"},{"v":266.8260264465705,"d":"267"},{"v":6934.17753257709,"d":"6934"},"Kinexus","RpAb",null,"Corresponds to C-terminal amino acids.",null,null,"O43318","O43318",664,"O43318","O43318","NP_663306","Block8",5,9,"8, 16, 24, 32","TAK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","MLK","TAK1",{"$nulls":5},"EC 2.7.11.25; Protein kinase, Ser/Thr (non-receptor); TKL group; MLK family; TAK1 subfamily","GO:0005671; GO:0005829; GO:0010008; GO:0005634; GO:0005886","GO:0005524; GO:0042802; GO:0000287; GO:0004709; GO:0004672; GO:0004674; GO:0030971; GO:0097110","GO:0000187; GO:0000186; GO:0007250; GO:0043276; GO:0038095; GO:0043966; GO:0007249; GO:0007252; GO:0070498; GO:0007254; GO:0002755; GO:0070423; GO:0043123; GO:0032743; GO:0043507; GO:0016239; GO:0051092; GO:0002726; GO:0016579; GO:0002223; GO:0051403; GO:0050852; GO:0006351; GO:0007179; GO:0016032; GO:0007223"]
[2495,1245,"PK825","TAK1 (MAP3K7)","T184+T187","TGF-beta-activated protein-serine kinase 1; Mitogen-activated protein kinase kinase kinase 7",{"v":3872.8432761441186,"d":"3873"},{"v":3642.425890045814,"d":"3642"},{"v":1594.9731611188533,"d":"1595"},{"v":41.183519378218705,"d":"41"},{"v":523.5973738487646,"d":"524"},{"v":12887.27459666244,"d":"12887"},"Kinexus","RpAb","DIQ(pT)HM(pT)NNK(bA)C","Corresponds to amino acid residues D181 to K190; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T184 and T187 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major sites of in vivo phosphorylation of TAK1.","T184: TAK1 (MAP3K7). T187: TAK1 (MAP3K7). ","O43318","O43318",664,"O43318","O43318","NP_663306","Block8",5,10,"8, 16, 24, 32","TAK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","MLK","TAK1",{"$nulls":5},"EC 2.7.11.25; Protein kinase, Ser/Thr (non-receptor); TKL group; MLK family; TAK1 subfamily","GO:0005671; GO:0005829; GO:0010008; GO:0005634; GO:0005886","GO:0005524; GO:0042802; GO:0000287; GO:0004709; GO:0004672; GO:0004674; GO:0030971; GO:0097110","GO:0000187; GO:0000186; GO:0007250; GO:0043276; GO:0038095; GO:0043966; GO:0007249; GO:0007252; GO:0070498; GO:0007254; GO:0002755; GO:0070423; GO:0043123; GO:0032743; GO:0043507; GO:0016239; GO:0051092; GO:0002726; GO:0016579; GO:0002223; GO:0051403; GO:0050852; GO:0006351; GO:0007179; GO:0016032; GO:0007223"]
[2497,1246,"PK824","TAK1 (MAP3K7)","S439","TGF-beta-activated protein-serine kinase 1; Mitogen-activated protein kinase kinase kinase 7",{"v":11006.286533166764,"d":"11006"},{"v":11117.958967801955,"d":"11118"},{"v":2735.786735796629,"d":"2736"},{"v":24.856582895170906,"d":"25"},{"v":1223.4632527906783,"d":"1223"},{"v":17284.064702479398,"d":"17284"},"Kinexus","RpAb","RRR(pS)IQD(bA)C","Corresponds to amino acid residues R436 to D442; In the C-terminal half of the protein. ","The effect of S439 phosphorylation is unclear. This is the major in vivo phosphorylation site in TAK1.",null,"O43318","O43318",664,"O43318","O43318","NP_663306","Block8",5,11,"8, 16, 24, 32","TAK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","TKL","MLK","TAK1",{"$nulls":5},"EC 2.7.11.25; Protein kinase, Ser/Thr (non-receptor); TKL group; MLK family; TAK1 subfamily","GO:0005671; GO:0005829; GO:0010008; GO:0005634; GO:0005886","GO:0005524; GO:0042802; GO:0000287; GO:0004709; GO:0004672; GO:0004674; GO:0030971; GO:0097110","GO:0000187; GO:0000186; GO:0007250; GO:0043276; GO:0038095; GO:0043966; GO:0007249; GO:0007252; GO:0070498; GO:0007254; GO:0002755; GO:0070423; GO:0043123; GO:0032743; GO:0043507; GO:0016239; GO:0051092; GO:0002726; GO:0016579; GO:0002223; GO:0051403; GO:0050852; GO:0006351; GO:0007179; GO:0016032; GO:0007223"]
[2499,1247,"PK826","TAO1 (TAOK1)","S181","Serine/threonine-protein kinase TAO1",{"v":2496.582193266354,"d":"2497"},{"v":2496.330550802498,"d":"2496"},{"v":1164.0454555102222,"d":"1164"},{"v":46.625561083060774,"d":"47"},{"v":179.7500993805738,"d":"180"},{"v":5342.859732712541,"d":"5343"},"Kinexus","RpAb","PAN(pS)FVG(bA)C","Corresponds to amino acid residues P178 to G184; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S181 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of TAO1.",null,"Q7L7X3","Q7L7X3",2525,"Q7L7X3","Q7L7X3","NP_065842.1","Block8",5,12,"8, 16, 24, 32","TAO1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","TAO",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; STE domain target; STE</A> group; STE20 family; TAO subfamily","GO:0005737; GO:0005829; GO:0070062; GO:0015630; GO:0048471","GO:0043014; GO:0005524; GO:0048487; GO:0016301; GO:0004709; GO:0004672; GO:0043539; GO:0004674; GO:0016740","GO:0007257; GO:0000187; GO:0006974; GO:0006281; GO:0097194; GO:0000226; GO:0007095; GO:0007026; GO:0007399; GO:0070050; GO:0046330; GO:1901985; GO:0032874; GO:0046777; GO:0006468; GO:0032956; GO:0042981; GO:0051493; GO:0070507; GO:0007346"]
[2501,1248,"PK827","TAO1 (TAOK1)","Y309","Serine/threonine-protein kinase TAO1",{"v":4080.7050313797918,"d":"4081"},{"v":4015.29385463215,"d":"4015"},{"v":1404.6830652042993,"d":"1405"},{"v":34.42255821978242,"d":"34"},{"v":227.32219837983445,"d":"227"},{"v":10727.05161306158,"d":"10727"},"Kinexus","RpAb","NLQ(pY)RKM(bA)C","Corresponds to amino acid residues N306 to M312; Just after the kinase catalytic domain.","The effect of Y309 phosphorylation is unclear. This is the major in vivo site of phosphorylation on TAO1.",null,"Q7L7X3","Q7L7X3",2525,"Q7L7X3","Q7L7X3","NP_065842.1","Block8",5,13,"8, 16, 24, 32","TAO1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","TAO",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; STE domain target; STE</A> group; STE20 family; TAO subfamily","GO:0005737; GO:0005829; GO:0070062; GO:0015630; GO:0048471","GO:0043014; GO:0005524; GO:0048487; GO:0016301; GO:0004709; GO:0004672; GO:0043539; GO:0004674; GO:0016740","GO:0007257; GO:0000187; GO:0006974; GO:0006281; GO:0097194; GO:0000226; GO:0007095; GO:0007026; GO:0007399; GO:0070050; GO:0046330; GO:1901985; GO:0032874; GO:0046777; GO:0006468; GO:0032956; GO:0042981; GO:0051493; GO:0070507; GO:0007346"]
[2503,1249,"NK087-2","TAO3 (JIK, TAOK3)","Pan-specific","Serine/threonine-protein kinase TAO3",{"v":480.4818556953746,"d":"480"},{"v":457.86482598994854,"d":"458"},{"v":241.64317164932822,"d":"242"},{"v":50.29184115591868,"d":"50"},{"v":53.82278375159861,"d":"54"},{"v":1696.407953279145,"d":"1696"},"Kinexus","RpAb","CSEHGTSLNREMDSLGSNHS","Corresponds to amino acid residues S331 to S349; After catalytic domain.",null,null,"Q9H2K8","Q9H2K8",2524,"Q9H2K8","Q9H2K8","NP_057365.3","Block8",6,1,"8, 16, 24, 32","TAO3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","TAO",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; STE domain target; STE</A> group; STE20 family; TAO subfamily","GO:0005737; GO:0005886","GO:0005524; GO:0004709; GO:0004860; GO:0004674; GO:0016740","GO:0006974; GO:0006281; GO:0000165; GO:0007095; GO:0046329; GO:0007399; GO:0046330; GO:0043507; GO:0032874; GO:0046777; GO:0006468; GO:0042981"]
[2505,1250,"NK087-3","TAO3 (JIK, TAOK3)","Pan-specific","Protein-serine/threonine kinase TAO3",{"v":292.82507345543456,"d":"293"},{"v":214.50807515989945,"d":"215"},{"v":450.21889863729666,"d":"450"},{"v":153.7501189104341,"d":"154"},{"v":27.062233668916647,"d":"27"},{"v":6359.35649639775,"d":"6359"},"External","MmAb","Epitope undefined.",{"$nulls":3},"Q9H2K8","Q9H2K8",2524,"Q9H2K8","Q9H2K8","NP_057365.3","Block8",6,2,"8, 16, 24, 32","TAO3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","TAO",{"$nulls":5},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.11.1; STE domain target; STE</A> group; STE20 family; TAO subfamily","GO:0005737; GO:0005886","GO:0005524; GO:0004709; GO:0004860; GO:0004674; GO:0016740","GO:0006974; GO:0006281; GO:0000165; GO:0007095; GO:0046329; GO:0007399; GO:0046330; GO:0043507; GO:0032874; GO:0046777; GO:0006468; GO:0042981"]
[2507,1251,"PN674","TARDBP","S409+S410","TAR DNA-binding protein 43",{"v":5366.890098491593,"d":"5367"},{"v":5216.12606726667,"d":"5216"},{"v":1600.9294230706157,"d":"1601"},{"v":29.829741129235526,"d":"30"},{"v":1096.4569140534081,"d":"1096"},{"v":10594.911704086067,"d":"10595"},"Kinexus","RpAb","MDSK(pS)(pS)GWGC","Corresponds to amino acid residues M405 to G413.","S409+S410 phosphorylation inhibits interaction with TDP43. These are two of the major sites of in vivo phosphorylation of TARDBP.","S409: CK1a1 (CSNK1A1); CK2a1 (CSNK2A1). S410: CK1a1 (CSNK1A1); CK2a1 (CSNK2A1). ","Q13148","Q13148",10272,null,null,"NP_031401.1","Block8",6,3,"8, 16, 24, 32",{"$nulls":3},"RNA binding protein",{"$nulls":4},"X",{"$nulls":4},"RNA binding protein","GO:0005737; GO:0035061; GO:0016607; GO:0005654; GO:0005634; GO:0005726","GO:0003700; GO:0003690; GO:0042802; GO:0003730; GO:0003723; GO:0001205","GO:0070935; GO:0006397; GO:0043922; GO:0010629; GO:0001933; GO:0071765; GO:0032024; GO:0042981; GO:0051726; GO:0034976; GO:0008380; GO:0006366"]
[2509,1252,"PN275","Tau","S396","Microtubule-associated protein tau",{"v":171.74855335169877,"d":"172"},{"v":137.93095609532728,"d":"138"},{"v":132.87548632822524,"d":"133"},{"v":77.3662914389322,"d":"77"},{"v":39.22579202149607,"d":"39"},{"v":1489.715332660666,"d":"1490"},"External","MmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the S396 phosphosite.","The effect of S396 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of Tau.",null,"P10636","P10636",1060,null,null,"NP_005901","Block8",6,4,"8, 16, 24, 32",{"$nulls":13},"Cytoskeletal protein","GO:0030673; GO:0030424; GO:1904115; GO:0044297; GO:0005737; GO:0036464; GO:0005829; GO:0030425; GO:0043197; GO:0005576; GO:0097386; GO:0030426; GO:0005622; GO:0044304; GO:0045121; GO:0005874; GO:0005875; GO:0015630; GO:0005739; GO:0097418; GO:0043025; GO:0034399; GO:0016607; GO:0005634; GO:0005886; GO:0036477; GO:0045298","GO:0003779; GO:0034185; GO:0003680; GO:0051087; GO:0003677; GO:0003690; GO:0034452; GO:0019899; GO:0099077; GO:0051879; GO:0042802; GO:0071813; GO:0008017; GO:0099609; GO:0035091; GO:1902936; GO:0030674; GO:0042803; GO:0019901; GO:0051721; GO:0048018; GO:0003723; GO:0043565; GO:0017124; GO:0003697","GO:0006919; GO:1990000; GO:0048143; GO:0098930; GO:0019896; GO:0061564; GO:0007267; GO:1990416; GO:0034605; GO:1990090; GO:0034614; GO:0021954; GO:0031122; GO:0048699; GO:0006475; GO:0048312; GO:0007611; GO:0007613; GO:0001774; GO:0000226; GO:0046785; GO:1903748; GO:0010629; GO:0033673; GO:0090258; GO:0010917; GO:1904428; GO:1902988; GO:0031175; GO:0072386; GO:0045773; GO:1903829; GO:1905689; GO:0031116; GO:1901216; GO:1902474; GO:0032930; GO:0051259; GO:0051260; GO:0010506; GO:0050848; GO:1900034; GO:0033044; GO:1900452; GO:0070507; GO:0031113; GO:0031110; GO:0090140; GO:2001020; GO:0048167; GO:0010288; GO:0016072; GO:0034063; GO:0097435; GO:0007416; GO:0050808"]
[2511,1253,"PN085","Tau","S516","Microtubule-associated protein tau",{"v":356.9211089956726,"d":"357"},{"v":316.1828827901634,"d":"316"},{"v":286.86130487364284,"d":"287"},{"v":80.37106734337777,"d":"80"},{"v":12.646064195400347,"d":"13"},{"v":1688.6758925736158,"d":"1689"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S516 phosphosite.","The effect of S516 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of Tau.",null,"P10636","P10636",1060,null,null,"NP_005901","Block8",6,5,"8, 16, 24, 32",{"$nulls":13},"Cytoskeletal protein","GO:0030673; GO:0030424; GO:1904115; GO:0044297; GO:0005737; GO:0036464; GO:0005829; GO:0030425; GO:0043197; GO:0005576; GO:0097386; GO:0030426; GO:0005622; GO:0044304; GO:0045121; GO:0005874; GO:0005875; GO:0015630; GO:0005739; GO:0097418; GO:0043025; GO:0034399; GO:0016607; GO:0005634; GO:0005886; GO:0036477; GO:0045298","GO:0003779; GO:0034185; GO:0003680; GO:0051087; GO:0003677; GO:0003690; GO:0034452; GO:0019899; GO:0099077; GO:0051879; GO:0042802; GO:0071813; GO:0008017; GO:0099609; GO:0035091; GO:1902936; GO:0030674; GO:0042803; GO:0019901; GO:0051721; GO:0048018; GO:0003723; GO:0043565; GO:0017124; GO:0003697","GO:0006919; GO:1990000; GO:0048143; GO:0098930; GO:0019896; GO:0061564; GO:0007267; GO:1990416; GO:0034605; GO:1990090; GO:0034614; GO:0021954; GO:0031122; GO:0048699; GO:0006475; GO:0048312; GO:0007611; GO:0007613; GO:0001774; GO:0000226; GO:0046785; GO:1903748; GO:0010629; GO:0033673; GO:0090258; GO:0010917; GO:1904428; GO:1902988; GO:0031175; GO:0072386; GO:0045773; GO:1903829; GO:1905689; GO:0031116; GO:1901216; GO:1902474; GO:0032930; GO:0051259; GO:0051260; GO:0010506; GO:0050848; GO:1900034; GO:0033044; GO:1900452; GO:0070507; GO:0031113; GO:0031110; GO:0090140; GO:2001020; GO:0048167; GO:0010288; GO:0016072; GO:0034063; GO:0097435; GO:0007416; GO:0050808"]
[2513,1254,"PN121","Tau","T522","Microtubule-associated protein tau",{"v":730.4113135282932,"d":"730"},{"v":619.4982872863122,"d":"619"},{"v":611.5875957600138,"d":"612"},{"v":83.73194451297657,"d":"84"},{"v":7.304868007475694,"d":"7"},{"v":2825.1979328127836,"d":"2825"},"External","RpAb","PG(pT)PG","Corresponds to amino acid residues P203 to G207; Surrounds the T305 phosphosite.","The effect of T522 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of Tau.",null,"P10636","P10636",1060,null,null,"NP_005901","Block8",6,6,"8, 16, 24, 32",{"$nulls":13},"Cytoskeletal protein","GO:0030673; GO:0030424; GO:1904115; GO:0044297; GO:0005737; GO:0036464; GO:0005829; GO:0030425; GO:0043197; GO:0005576; GO:0097386; GO:0030426; GO:0005622; GO:0044304; GO:0045121; GO:0005874; GO:0005875; GO:0015630; GO:0005739; GO:0097418; GO:0043025; GO:0034399; GO:0016607; GO:0005634; GO:0005886; GO:0036477; GO:0045298","GO:0003779; GO:0034185; GO:0003680; GO:0051087; GO:0003677; GO:0003690; GO:0034452; GO:0019899; GO:0099077; GO:0051879; GO:0042802; GO:0071813; GO:0008017; GO:0099609; GO:0035091; GO:1902936; GO:0030674; GO:0042803; GO:0019901; GO:0051721; GO:0048018; GO:0003723; GO:0043565; GO:0017124; GO:0003697","GO:0006919; GO:1990000; GO:0048143; GO:0098930; GO:0019896; GO:0061564; GO:0007267; GO:1990416; GO:0034605; GO:1990090; GO:0034614; GO:0021954; GO:0031122; GO:0048699; GO:0006475; GO:0048312; GO:0007611; GO:0007613; GO:0001774; GO:0000226; GO:0046785; GO:1903748; GO:0010629; GO:0033673; GO:0090258; GO:0010917; GO:1904428; GO:1902988; GO:0031175; GO:0072386; GO:0045773; GO:1903829; GO:1905689; GO:0031116; GO:1901216; GO:1902474; GO:0032930; GO:0051259; GO:0051260; GO:0010506; GO:0050848; GO:1900034; GO:0033044; GO:1900452; GO:0070507; GO:0031113; GO:0031110; GO:0090140; GO:2001020; GO:0048167; GO:0010288; GO:0016072; GO:0034063; GO:0097435; GO:0007416; GO:0050808"]
[2515,1255,"PN090","Tau","S713","Microtubule-associated protein tau",{"v":386.8605102564902,"d":"387"},{"v":345.97417234270415,"d":"346"},{"v":301.6249408819846,"d":"302"},{"v":77.96736365828757,"d":"78"},{"v":22.78268747546491,"d":"23"},{"v":1690.6302583360753,"d":"1691"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S713 phosphosite.","The effect of S713 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of Tau.",null,"P10636","P10636",1060,null,null,"NP_005901","Block8",6,7,"8, 16, 24, 32",{"$nulls":13},"Cytoskeletal protein","GO:0030673; GO:0030424; GO:1904115; GO:0044297; GO:0005737; GO:0036464; GO:0005829; GO:0030425; GO:0043197; GO:0005576; GO:0097386; GO:0030426; GO:0005622; GO:0044304; GO:0045121; GO:0005874; GO:0005875; GO:0015630; GO:0005739; GO:0097418; GO:0043025; GO:0034399; GO:0016607; GO:0005634; GO:0005886; GO:0036477; GO:0045298","GO:0003779; GO:0034185; GO:0003680; GO:0051087; GO:0003677; GO:0003690; GO:0034452; GO:0019899; GO:0099077; GO:0051879; GO:0042802; GO:0071813; GO:0008017; GO:0099609; GO:0035091; GO:1902936; GO:0030674; GO:0042803; GO:0019901; GO:0051721; GO:0048018; GO:0003723; GO:0043565; GO:0017124; GO:0003697","GO:0006919; GO:1990000; GO:0048143; GO:0098930; GO:0019896; GO:0061564; GO:0007267; GO:1990416; GO:0034605; GO:1990090; GO:0034614; GO:0021954; GO:0031122; GO:0048699; GO:0006475; GO:0048312; GO:0007611; GO:0007613; GO:0001774; GO:0000226; GO:0046785; GO:1903748; GO:0010629; GO:0033673; GO:0090258; GO:0010917; GO:1904428; GO:1902988; GO:0031175; GO:0072386; GO:0045773; GO:1903829; GO:1905689; GO:0031116; GO:1901216; GO:1902474; GO:0032930; GO:0051259; GO:0051260; GO:0010506; GO:0050848; GO:1900034; GO:0033044; GO:1900452; GO:0070507; GO:0031113; GO:0031110; GO:0090140; GO:2001020; GO:0048167; GO:0010288; GO:0016072; GO:0034063; GO:0097435; GO:0007416; GO:0050808"]
[2517,1256,"PN092","Tau","S721","Microtubule-associated protein tau",{"v":191.33730586998965,"d":"191"},{"v":145.580089235583,"d":"146"},{"v":170.08689961920928,"d":"170"},{"v":88.89374648913493,"d":"89"},{"v":11.80122108632917,"d":"12"},{"v":955.482964560326,"d":"955"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S721 phosphosite.","The effect of S721 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of Tau.",null,"P10636","P10636",1060,null,null,"NP_005901","Block8",6,8,"8, 16, 24, 32",{"$nulls":13},"Cytoskeletal protein","GO:0030673; GO:0030424; GO:1904115; GO:0044297; GO:0005737; GO:0036464; GO:0005829; GO:0030425; GO:0043197; GO:0005576; GO:0097386; GO:0030426; GO:0005622; GO:0044304; GO:0045121; GO:0005874; GO:0005875; GO:0015630; GO:0005739; GO:0097418; GO:0043025; GO:0034399; GO:0016607; GO:0005634; GO:0005886; GO:0036477; GO:0045298","GO:0003779; GO:0034185; GO:0003680; GO:0051087; GO:0003677; GO:0003690; GO:0034452; GO:0019899; GO:0099077; GO:0051879; GO:0042802; GO:0071813; GO:0008017; GO:0099609; GO:0035091; GO:1902936; GO:0030674; GO:0042803; GO:0019901; GO:0051721; GO:0048018; GO:0003723; GO:0043565; GO:0017124; GO:0003697","GO:0006919; GO:1990000; GO:0048143; GO:0098930; GO:0019896; GO:0061564; GO:0007267; GO:1990416; GO:0034605; GO:1990090; GO:0034614; GO:0021954; GO:0031122; GO:0048699; GO:0006475; GO:0048312; GO:0007611; GO:0007613; GO:0001774; GO:0000226; GO:0046785; GO:1903748; GO:0010629; GO:0033673; GO:0090258; GO:0010917; GO:1904428; GO:1902988; GO:0031175; GO:0072386; GO:0045773; GO:1903829; GO:1905689; GO:0031116; GO:1901216; GO:1902474; GO:0032930; GO:0051259; GO:0051260; GO:0010506; GO:0050848; GO:1900034; GO:0033044; GO:1900452; GO:0070507; GO:0031113; GO:0031110; GO:0090140; GO:2001020; GO:0048167; GO:0010288; GO:0016072; GO:0034063; GO:0097435; GO:0007416; GO:0050808"]
[2519,1257,"PN107","Tau","S739","Microtubule-associated protein tau",{"v":312.993846535979,"d":"313"},{"v":260.6101113997815,"d":"261"},{"v":255.2810449585954,"d":"255"},{"v":81.56104274377502,"d":"82"},{"v":6.820080804655942,"d":"7"},{"v":1255.911593078773,"d":"1256"},"External","RpAb","Not precisely defined.","Antibody raised against amino acid residues that encompass the S739 phosphosite.","The effect of S739 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of Tau.",null,"P10636","P10636",1060,null,null,"NP_005901","Block8",6,9,"8, 16, 24, 32",{"$nulls":13},"Cytoskeletal protein","GO:0030673; GO:0030424; GO:1904115; GO:0044297; GO:0005737; GO:0036464; GO:0005829; GO:0030425; GO:0043197; GO:0005576; GO:0097386; GO:0030426; GO:0005622; GO:0044304; GO:0045121; GO:0005874; GO:0005875; GO:0015630; GO:0005739; GO:0097418; GO:0043025; GO:0034399; GO:0016607; GO:0005634; GO:0005886; GO:0036477; GO:0045298","GO:0003779; GO:0034185; GO:0003680; GO:0051087; GO:0003677; GO:0003690; GO:0034452; GO:0019899; GO:0099077; GO:0051879; GO:0042802; GO:0071813; GO:0008017; GO:0099609; GO:0035091; GO:1902936; GO:0030674; GO:0042803; GO:0019901; GO:0051721; GO:0048018; GO:0003723; GO:0043565; GO:0017124; GO:0003697","GO:0006919; GO:1990000; GO:0048143; GO:0098930; GO:0019896; GO:0061564; GO:0007267; GO:1990416; GO:0034605; GO:1990090; GO:0034614; GO:0021954; GO:0031122; GO:0048699; GO:0006475; GO:0048312; GO:0007611; GO:0007613; GO:0001774; GO:0000226; GO:0046785; GO:1903748; GO:0010629; GO:0033673; GO:0090258; GO:0010917; GO:1904428; GO:1902988; GO:0031175; GO:0072386; GO:0045773; GO:1903829; GO:1905689; GO:0031116; GO:1901216; GO:1902474; GO:0032930; GO:0051259; GO:0051260; GO:0010506; GO:0050848; GO:1900034; GO:0033044; GO:1900452; GO:0070507; GO:0031113; GO:0031110; GO:0090140; GO:2001020; GO:0048167; GO:0010288; GO:0016072; GO:0034063; GO:0097435; GO:0007416; GO:0050808"]
[2521,1258,"PN540","TBC1D7","Y14","TBC1 domain family member 7",{"v":2337.4717208899883,"d":"2337"},{"v":2033.3276566942757,"d":"2033"},{"v":1390.5139026753286,"d":"1391"},{"v":59.48794546895707,"d":"59"},{"v":59.059846098072946,"d":"59"},{"v":6722.982436694845,"d":"6723"},"Kinexus","RpAb","SVY(pY)EKV(bA)C","Corresponds to amino acid residues S11 to V17; In the N-terminus of protein. ","The effect of Y14 phosphorylation is unclear. This is the main phosphosite targeted by the ERK1 and ERK2 MAP kinases. This is one of the major sites of in vivo phosphorylation of TBC1D7.",null,"Q9P0N9","Q9P0N9",14236,null,null,"NP_001137436.1","Block8",6,10,"8, 16, 24, 32",{"$nulls":13},"GTPase activating protein, Rab","GO:0036064; GO:0031410; GO:0005829","GO:0005096; GO:0017137","GO:0090630; GO:1902018; GO:0032007; GO:0043547; GO:0031398; GO:0070848"]
[2523,1259,"PK828","TBK1","S172","TANK binding kinase TBK1; Serine/threonine-protein kinase TBK1",{"v":6866.688191981044,"d":"6867"},{"v":7279.684625455307,"d":"7280"},{"v":4441.7602450091445,"d":"4442"},{"v":64.68562603725412,"d":"65"},{"v":4.312085240109749,"d":"4"},{"v":18059.323433370722,"d":"18059"},"Kinexus","RpAb","QFV(pS)LYG(bA)C","Corresponds to amino acid residues Q169 to G175; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","S172 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of TBK1.",null,"Q9UHD2","Q9UHD2",825,"Q9UHD2","Q9UHD2","NP_037386","Block8",6,11,"8, 16, 24, 32","TBK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","IKK",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; IKK family","GO:0016235; GO:0005737; GO:0005829; GO:0010008; GO:0005654","GO:0005524; GO:0042802; GO:0003676; GO:0051219; GO:0004672; GO:0004674","GO:0071345; GO:0050830; GO:0051607; GO:0044565; GO:0007249; GO:0006954; GO:0045087; GO:0010629; GO:0032480; GO:0018105; GO:0018107; GO:0043123; GO:0032727; GO:0045359; GO:0032728; GO:0016239; GO:0033138; GO:0045944; GO:0032481; GO:1904417; GO:0006468; GO:1901214; GO:0032479; GO:0009615; GO:0035666; GO:0032606; GO:0016032"]
[2525,1260,"PK829","TEC","Y519","Tyrosine-protein kinase Tec",{"v":3666.9756037261436,"d":"3667"},{"v":3092.7540042268947,"d":"3093"},{"v":2265.3521761961047,"d":"2265"},{"v":61.77712701154052,"d":"62"},{"v":84.24050476677623,"d":"84"},{"v":13817.149672077307,"d":"13817"},"Kinexus","RpAb","DDQ(pY)TSS(bA)C","Corresponds to amino acid residues D516 to S522; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y519 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of TEC.",null,"P42680","P42680",844,"P42680",null,"NP_003206.2","Block8",6,12,"8, 16, 24, 32","Tec","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; Tec family","GO:0005856; GO:0005829; GO:0031234; GO:0005886","GO:0005524; GO:0046872; GO:0004715; GO:0005543","GO:0002250; GO:0050853; GO:0030154; GO:0019221; GO:0038095; GO:0045087; GO:0007229; GO:0035556; GO:0038083; GO:0018108; GO:0050731; GO:0006468; GO:0042127; GO:0010543; GO:0042246; GO:0007169"]
[2527,1261,"PN675","TERF1","T371","Telomeric repeat-binding factor 1",{"v":9124.554706309716,"d":"9125"},{"v":9283.275641482145,"d":"9283"},{"v":3240.9878023270876,"d":"3241"},{"v":35.51940786859345,"d":"36"},{"v":52.44289866863949,"d":"52"},{"v":19037.051768669713,"d":"19037"},"Kinexus","RpAb","SQPV(pT)PEKH(bA)C","Corresponds to amino acid residues S367 to H375.","T371 phosphoryation generates a docking site for Plk1 at S435. This is one of the major sites of in vivo phosphorylation of TERF1.","CDK1 (CDC2)","P54274","P54274",1061,null,null,"NP_059523.2","Block8",6,13,"8, 16, 24, 32",{"$nulls":3},"DNA binding protein",{"$nulls":4},"X",{"$nulls":4},"DNA binding protein","GO:0000781; GO:0005737; GO:0001650; GO:0016604; GO:0000784; GO:0000783; GO:0005730; GO:0005654; GO:0005634; GO:0070187; GO:0005819","GO:0071532; GO:0003677; GO:0008301; GO:0003691; GO:0098505; GO:0008017; GO:0008022; GO:0046982; GO:0042803; GO:0000981; GO:0042162","GO:0051301; GO:0000086; GO:0045141; GO:0007094; GO:0008156; GO:1904914; GO:1904850; GO:1904911; GO:1905778; GO:0051974; GO:0032214; GO:0032211; GO:1904357; GO:1905839; GO:0043065; GO:0031116; GO:0045931; GO:0045840; GO:1904792; GO:0051260; GO:0042493; GO:0090656; GO:0016233; GO:0000723; GO:0007004; GO:0061820; GO:0031627"]
[2529,1262,"PN541","TGM2","Y369","Protein-glutamine gamma-glutamyltransferase 2",{"v":10546.772674990578,"d":"10547"},{"v":10365.25521333835,"d":"10365"},{"v":2119.3318935272378,"d":"2119"},{"v":20.094601057940515,"d":"20"},{"v":5921.907952756892,"d":"5922"},{"v":17688.723133473228,"d":"17689"},"Kinexus","RpAb","EGT(pY)CCG(bA)C","Corresponds to amino acid residues E366 to G372; In the region between the Transglut_core and Transglut_C domains. ","The effect of Y369 phosphorylation is unclear. This is the major in vivo phosphorylation site in TGM2.",null,"P21980","P21980",4135,null,null,"NP_004604.2","Block8",7,1,"8, 16, 24, 32",{"$nulls":12},"X","Transferase; EC 2.3.2.13","GO:0062023; GO:0005829; GO:0005783; GO:0070062; GO:0005925; GO:0031226; GO:0005739","GO:0005525; GO:0046872; GO:0019904; GO:0003810","GO:0043277; GO:0001974; GO:0060445; GO:0018153; GO:0032471; GO:0043065; GO:0045785; GO:0051482; GO:0043123; GO:0050729; GO:0051561; GO:0048661; GO:0051260; GO:0060662"]
[2531,1263,"NN449-1","TH (TY3H)","Pan-specific","Tyrosine 3-monooxygenase",{"v":214.02066539300606,"d":"214"},{"v":142.138797865882,"d":"142"},{"v":295.3305917906754,"d":"295"},{"v":137.99162396227482,"d":"138"},{"v":22.2494842277502,"d":"22"},{"v":3676.8620571913675,"d":"3677"},"External","MmAb","Epitope undefined.",{"$nulls":3},"P07101","P07101",1063,null,null,"NP_954986","Block8",7,2,"8, 16, 24, 32",{"$nulls":3},"Metabolic enzyme",{"$nulls":8},"X","Endoplasmic reticulum; Vesicle protein; EC 1.14.16.2; Amino Acid Metabolism - tyrosine; Mitochondrial; Oxidoreductase","GO:0005737; GO:0009898; GO:0031410; GO:0005829; GO:0030425; GO:0033162; GO:0005739; GO:0043005; GO:0005634; GO:0043204; GO:0005790; GO:0008021; GO:0043195","GO:0016597; GO:0035240; GO:0019899; GO:0008199; GO:0008198; GO:0019825; GO:0019904; GO:0034617; GO:0004511","GO:0015842; GO:0009653; GO:0009887; GO:0042423; GO:0071312; GO:0071333; GO:0071363; GO:0071287; GO:0071316; GO:0021987; GO:0042745; GO:0042416; GO:0006585; GO:0042755; GO:0048596; GO:0042418; GO:0042462; GO:0006631; GO:0016137; GO:0007507; GO:0003007; GO:0033076; GO:0007612; GO:0007626; GO:0007617; GO:0007613; GO:0010259; GO:0042136; GO:0042421; GO:0018963; GO:0052314; GO:0043473; GO:0008016; GO:0014823; GO:0001975; GO:0051412; GO:0051602; GO:0032355; GO:0045471; GO:0045472; GO:0009635; GO:0001666; GO:0035902; GO:0035900; GO:0009416; GO:0032496; GO:0031667; GO:0043434; GO:0046684; GO:0009651; GO:0009414; GO:0010043; GO:0007605; GO:0035176; GO:0006665; GO:0001963; GO:0042214; GO:0007601"]
[2533,1264,"PN731","TH (TY3H)","S19","Tyrosine 3-monooxygenase",{"v":3429.27321653226,"d":"3429"},{"v":3323.2113811054405,"d":"3323"},{"v":1415.4720939926117,"d":"1415"},{"v":41.276154001633074,"d":"41"},{"v":199.19116439656136,"d":"199"},{"v":11371.431492383887,"d":"11371"},"Kinexus","RpAb","RAV(pS)ELDAC","Corresponds to amino acid residues R16 to A23.","S19 phosphorylation stimulates enzyme activity. This is one of the major sites of in vivo phosphorylation of tyrosine hydroxylase (≥11 reports from high throughput mass spectrometry studies). This human phosphosite is conserved in mammals and found in the rat.","CaMK1a; CaMK2a; MAPKAPK2; MAPKAPK5 (PRAK)","P07101","P07101",1063,null,null,"NP_954986","Block8",7,3,"8, 16, 24, 32",{"$nulls":3},"Metabolic enzyme",{"$nulls":8},"X","Endoplasmic reticulum; Vesicle protein; EC 1.14.16.2; Amino Acid Metabolism - tyrosine; Mitochondrial; Oxidoreductase","GO:0005737; GO:0009898; GO:0031410; GO:0005829; GO:0030425; GO:0033162; GO:0005739; GO:0043005; GO:0005634; GO:0043204; GO:0005790; GO:0008021; GO:0043195","GO:0016597; GO:0035240; GO:0019899; GO:0008199; GO:0008198; GO:0019825; GO:0019904; GO:0034617; GO:0004511","GO:0015842; GO:0009653; GO:0009887; GO:0042423; GO:0071312; GO:0071333; GO:0071363; GO:0071287; GO:0071316; GO:0021987; GO:0042745; GO:0042416; GO:0006585; GO:0042755; GO:0048596; GO:0042418; GO:0042462; GO:0006631; GO:0016137; GO:0007507; GO:0003007; GO:0033076; GO:0007612; GO:0007626; GO:0007617; GO:0007613; GO:0010259; GO:0042136; GO:0042421; GO:0018963; GO:0052314; GO:0043473; GO:0008016; GO:0014823; GO:0001975; GO:0051412; GO:0051602; GO:0032355; GO:0045471; GO:0045472; GO:0009635; GO:0001666; GO:0035902; GO:0035900; GO:0009416; GO:0032496; GO:0031667; GO:0043434; GO:0046684; GO:0009651; GO:0009414; GO:0010043; GO:0007605; GO:0035176; GO:0006665; GO:0001963; GO:0042214; GO:0007601"]
[2535,1265,"PN730","TH (TY3H)","S71","Tyrosine 3-monooxygenase",{"v":14458.094139687646,"d":"14458"},{"v":14092.82179077274,"d":"14093"},{"v":3600.0147926318355,"d":"3600"},{"v":24.899649689994412,"d":"25"},{"v":4775.863326625052,"d":"4776"},{"v":25673.992720299884,"d":"25674"},"Kinexus","RpAb","CGRRQ(pS)LIE","Corresponds to amino acid residues G67 to E74.","S71 phosphorylation stimulates enzyme activity. This is one of the major sites of in vivo phosphorylation of tyrosine hydroxylase.","CaMK1a; CaMK2a; MAPKAPK2; MSK1 (RPS6KA5); PKACa (PRKACA); PKACa (PRKACA); RSK2 (RPS6KA3)","P07101","P07101",1063,null,null,"NP_954986","Block8",7,4,"8, 16, 24, 32",{"$nulls":3},"Metabolic enzyme",{"$nulls":8},"X","Endoplasmic reticulum; Vesicle protein; EC 1.14.16.2; Amino Acid Metabolism - tyrosine; Mitochondrial; Oxidoreductase","GO:0005737; GO:0009898; GO:0031410; GO:0005829; GO:0030425; GO:0033162; GO:0005739; GO:0043005; GO:0005634; GO:0043204; GO:0005790; GO:0008021; GO:0043195","GO:0016597; GO:0035240; GO:0019899; GO:0008199; GO:0008198; GO:0019825; GO:0019904; GO:0034617; GO:0004511","GO:0015842; GO:0009653; GO:0009887; GO:0042423; GO:0071312; GO:0071333; GO:0071363; GO:0071287; GO:0071316; GO:0021987; GO:0042745; GO:0042416; GO:0006585; GO:0042755; GO:0048596; GO:0042418; GO:0042462; GO:0006631; GO:0016137; GO:0007507; GO:0003007; GO:0033076; GO:0007612; GO:0007626; GO:0007617; GO:0007613; GO:0010259; GO:0042136; GO:0042421; GO:0018963; GO:0052314; GO:0043473; GO:0008016; GO:0014823; GO:0001975; GO:0051412; GO:0051602; GO:0032355; GO:0045471; GO:0045472; GO:0009635; GO:0001666; GO:0035902; GO:0035900; GO:0009416; GO:0032496; GO:0031667; GO:0043434; GO:0046684; GO:0009651; GO:0009414; GO:0010043; GO:0007605; GO:0035176; GO:0006665; GO:0001963; GO:0042214; GO:0007601"]
[2537,1266,"PN676","THRAP3","S253","Thyroid hormone receptor-associated protein 3",{"v":5104.649887919306,"d":"5105"},{"v":5216.957873678808,"d":"5217"},{"v":1712.6615842394385,"d":"1713"},{"v":33.551009801722806,"d":"34"},{"v":248.62299680259534,"d":"249"},{"v":10389.509380617626,"d":"10390"},"Kinexus","RpAb","PALK(pS)PLQ(bA)C","Corresponds to amino acid residues P249 to Q256.","The effect of S253 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of THRAP3.","ERK1 (MAPK3)","Q9Y2W1","Q9Y2W1",5473,null,"Q9Y2W1","NP_005110.2","Block8",7,5,"8, 16, 24, 32",{"$nulls":3},"Transcription,  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"Transcription, coactivator/corepressor","GO:0070062; GO:0016592; GO:0016607; GO:0005654; GO:0005634","GO:0005524; GO:0030374; GO:0051219; GO:0003723; GO:0000980; GO:0038023; GO:0046966; GO:0003713; GO:0003712; GO:0042809","GO:0030521; GO:0007623; GO:0030518; GO:0006397; GO:0048255; GO:0000956; GO:0042753; GO:0048026; GO:0045893; GO:0045944; GO:0000381; GO:0008380; GO:0006367"]
[2539,1267,"PK830","TIE2 (TEK)","Y897","Angiopoietin-1 receptor",{"v":5479.428214395893,"d":"5479"},{"v":5276.366083516578,"d":"5276"},{"v":2119.408981546219,"d":"2119"},{"v":38.679382202288494,"d":"39"},{"v":691.6625790670541,"d":"692"},{"v":11815.462897331588,"d":"11815"},"Kinexus","RpAb","HRG(pY)LYL(bA)C","Corresponds to amino acid residues H894 to L900; In the protein kinase catalytic domain.","Y897 phosphorylation inhibits phosphotransferase activity. This is one of the major sites of in vivo phosphorylation of TIE2.",null,"Q02763","Q02763",1246,"Q02763","Q02763","NP_000450.2","Block8",7,6,"8, 16, 24, 32","TIE2","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK","Tie",{"$nulls":6},"Protein-tyrosine kinase (receptor), TK group, Tie","GO:0016324; GO:0009925; GO:0016323; GO:0005911; GO:0009986; GO:0005737; GO:0005576; GO:0005925; GO:0005887; GO:0045121; GO:0005815; GO:0005902; GO:0005886","GO:0005524; GO:0019838; GO:0004672; GO:0004713; GO:0005088; GO:0038023; GO:0004714","GO:0001525; GO:0007267; GO:0060216; GO:0001958; GO:0001935; GO:0072012; GO:0007507; GO:0060347; GO:0050900; GO:0000165; GO:0016525; GO:0043066; GO:2000352; GO:0050728; GO:0018108; GO:2000251; GO:0045766; GO:0010595; GO:0001938; GO:0070374; GO:0051894; GO:1902533; GO:0043552; GO:0014068; GO:0051897; GO:0001934; GO:0046777; GO:0051259; GO:2000351; GO:0032878; GO:0043114; GO:0051591; GO:0043627; GO:0001666; GO:0043434; GO:0007165; GO:0002040; GO:0034446; GO:0048014; GO:0007169"]
[2541,1268,"PK831","TIE2 (TEK)","Y992","Angiopoietin-1 receptor",{"v":316.590549334798,"d":"317"},{"v":240.5114714600959,"d":"241"},{"v":253.54719759047398,"d":"254"},{"v":80.08678658387399,"d":"80"},{"v":13.046642979519763,"d":"13"},{"v":1289.3142836824575,"d":"1289"},"Kinexus","RpAb","QEV(pY)VKK(bA)C","Corresponds to amino acid residues Q989 to K995; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y992 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of TIE2.","Tie2","Q02763","Q02763",1246,"Q02763","Q02763","NP_000450.2","Block8",7,7,"8, 16, 24, 32","TIE2","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK","Tie",{"$nulls":6},"Protein-tyrosine kinase (receptor), TK group, Tie","GO:0016324; GO:0009925; GO:0016323; GO:0005911; GO:0009986; GO:0005737; GO:0005576; GO:0005925; GO:0005887; GO:0045121; GO:0005815; GO:0005902; GO:0005886","GO:0005524; GO:0019838; GO:0004672; GO:0004713; GO:0005088; GO:0038023; GO:0004714","GO:0001525; GO:0007267; GO:0060216; GO:0001958; GO:0001935; GO:0072012; GO:0007507; GO:0060347; GO:0050900; GO:0000165; GO:0016525; GO:0043066; GO:2000352; GO:0050728; GO:0018108; GO:2000251; GO:0045766; GO:0010595; GO:0001938; GO:0070374; GO:0051894; GO:1902533; GO:0043552; GO:0014068; GO:0051897; GO:0001934; GO:0046777; GO:0051259; GO:2000351; GO:0032878; GO:0043114; GO:0051591; GO:0043627; GO:0001666; GO:0043434; GO:0007165; GO:0002040; GO:0034446; GO:0048014; GO:0007169"]
[2543,1269,"PN542","TLN1","Y70","Talin 1",{"v":7240.239425347598,"d":"7240"},{"v":7077.946158055189,"d":"7078"},{"v":2065.4451464318695,"d":"2065"},{"v":28.527304486656657,"d":"29"},{"v":802.3839859095727,"d":"802"},{"v":12448.435527889325,"d":"12448"},"Kinexus","RpAb","ALD(pY)YML(bA)C","Corresponds to amino acid residues A67 to L73; In the N-terminus of the protein. ","The effect of Y70 phosphorylation is unclear. This is the major in vivo phosphorylation site in TLN1.",null,"Q9Y490","Q9Y490",3465,null,null,"NP_006280.3","Block8",7,8,"8, 16, 24, 32",{"$nulls":13},"Cytoskeletal protein","GO:0009986; GO:0005856; GO:0005829; GO:0070062; GO:0005576; GO:0005925; GO:0001726; GO:0032587","GO:0051015; GO:0045296; GO:0005178; GO:0030274; GO:0035091; GO:0001786; GO:0005200; GO:0017166","GO:0007043; GO:0007044; GO:0030866; GO:0007016; GO:0033622; GO:0007229; GO:0036498; GO:0006936; GO:0070527; GO:0002576; GO:0016032"]
[2545,1270,"PK832","TNK1","Y277","Non-receptor tyrosine-protein kinase TNK1",{"v":5362.21218125741,"d":"5362"},{"v":5213.098822118324,"d":"5213"},{"v":2769.528179546472,"d":"2770"},{"v":51.64898526818521,"d":"52"},{"v":14.070332893870976,"d":"14"},{"v":11986.807470718497,"d":"11987"},"Kinexus","RpAb","RGR(pY)VMG(bA)C","Corresponds to amino acid residues R274 to G280; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y277 phosphorylation is predicted to stimulate phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of TNK1.",null,"Q13470","Q13470",1885,"Q13470","Q13470","NP_001238831.1","Block8",7,9,"8, 16, 24, 32","TNK1","X","PSTK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Ack",{"$nulls":6},"Protein-serine kinase, TK group, Ack family","GO:0005737; GO:0005829; GO:0031234; GO:0016020","GO:0005524; GO:0004715; GO:0004713; GO:0005102","GO:0030154; GO:0016477; GO:0045087; GO:0030308; GO:0046580; GO:0038083; GO:0046777; GO:0006468; GO:0042127; GO:0007169"]
[2547,1271,"PN677","TORC2","S433","CREB-regulated transcription coactivator 2",{"v":9162.08931939161,"d":"9162"},{"v":7436.673005173841,"d":"7437"},{"v":7927.7723491224015,"d":"7928"},{"v":86.52799675662656,"d":"87"},{"v":4.201651270649222,"d":"4"},{"v":42851.80733991598,"d":"42852"},"Kinexus","RpAb","RVPL(pS)PLS(bA)C","Corresponds to amino acid residues R429 to S436.","The effect of S433 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of TORC2.",null,"Q53ET0","Q53ET0",6850,null,"Q53ET0","NP_859066.1","Block8",7,10,"8, 16, 24, 32",{"$nulls":8},"X",{"$nulls":4},"Transcription protein, coactivator/corepressor","GO:0005737; GO:0070062; GO:0005654; GO:0005634","GO:0008140; GO:0003682","GO:0006094; GO:0042593; GO:0043970; GO:0032793; GO:0045944; GO:0051289; GO:1901998; GO:0006351; GO:0016032"]
[2549,1272,"PN678","TP53BP1","T1056","Tumor suppressor p53-binding protein 1",{"v":6724.599633484277,"d":"6725"},{"v":7391.810672297617,"d":"7392"},{"v":3505.82893715245,"d":"3506"},{"v":52.13438908237193,"d":"52"},{"v":6.620638492924803,"d":"7"},{"v":16694.795155058495,"d":"16695"},"Kinexus","RpAb","DPPT(pT)PIRGC","Corresponds to amino acid residues D1052 to G1060.","The effect of T1056 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of TP53P1.","ERK1 (MAPK3)","Q12888","Q12888",3129,null,"Q12888","NP_005648.1","Block8",7,11,"8, 16, 24, 32",{"$nulls":3},"Transcription,  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"Transcription, coactivator/corepressor","GO:0000777; GO:0005737; GO:1990391; GO:0016604; GO:0000784; GO:0005654; GO:0005634; GO:0005657; GO:0035861","GO:0003684; GO:0035064; GO:0002039; GO:0001102; GO:0042162; GO:0003712; GO:0061649","GO:0006974; GO:0071481; GO:0000077; GO:0006303; GO:2000042; GO:0051091; GO:0045830; GO:0045893; GO:0045944; GO:0051260; GO:0006351"]
[2551,1273,"PK834","TRIM28 (TIF1B)","Y458","Transcription intermediary factor 1-beta",{"v":41.94242728659897,"d":"42"},{"v":22.900733549741464,"d":"23"},{"v":129.5930124664883,"d":"130"},{"v":308.9783325627761,"d":"309"},{"v":-6.303526959117955,"d":"-6"},{"v":1772.4339783796113,"d":"1772"},"Kinexus","RpAb","DDP(pY)SSA(bA)C","Corresponds to amino acid residues D455 to A461; In the region between the zf-B_box and PHD domains. ","Y458 phosphorylation stimulates interaction with HP1 alpha and induces DNA repair. This is one of the major in vivo sites of phosphorylation in TRIM28.",null,"Q13263","Q13263",2366,"Q13263",null,"NP_005753.1","Block8",7,12,"8, 16, 24, 32","TIF1b","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","TIF1",null,"X",{"$nulls":4},"Protein kinase, atypical; Nuclear receptor co-regulator; Transcription, coactivator/corepressor; ATYPICAL domain target; ATYPICAL</A> group; TIF1 family","GO:0005719; GO:0005720; GO:0005654; GO:0005634; GO:0090575","GO:0003682; GO:0070087; GO:0003677; GO:0003700; GO:0035851; GO:1990841; GO:0004672; GO:0003723; GO:0043565; GO:0019789; GO:0003713; GO:0003714; GO:0031625; GO:0004842; GO:0008270","GO:0006325; GO:0060028; GO:0043045; GO:0006281; GO:0007566; GO:0060669; GO:0001837; GO:0045087; GO:1901536; GO:0045869; GO:0045892; GO:0000122; GO:1902187; GO:0043388; GO:0045739; GO:0090309; GO:0042307; GO:0045893; GO:0046777; GO:0051259; GO:0016925; GO:0007265; GO:2000653; GO:0006367; GO:0016032"]
[2553,1274,"PK833","TRIM28 (TIF1B)","S473","Transcription intermediary factor 1-beta",{"v":670.5059701454006,"d":"671"},{"v":519.5709967148639,"d":"520"},{"v":642.0116306211492,"d":"642"},{"v":95.75032277220852,"d":"96"},{"v":9.722111585334565,"d":"10"},{"v":4122.53911762952,"d":"4123"},"Kinexus","RpAb","RSR(pS)GEG(bA)C","Corresponds to amino acid residues R470 to G476; In the mid-region of the protein kinase between the zf-B_box and PHD domains.","S473 phosphorylation stimulates transcription and induces DNA repair and inhibits interaction with HP1-alpha. This is one of the major sites of in vivo phosphorylation of TRIM28.","Chk1 (CHEK1)","Q13263","Q13263",2366,"Q13263",null,"NP_005753.1","Block8",7,13,"8, 16, 24, 32","TIF1b","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","TIF1",null,"X",{"$nulls":4},"Protein kinase, atypical; Nuclear receptor co-regulator; Transcription, coactivator/corepressor; ATYPICAL domain target; ATYPICAL</A> group; TIF1 family","GO:0005719; GO:0005720; GO:0005654; GO:0005634; GO:0090575","GO:0003682; GO:0070087; GO:0003677; GO:0003700; GO:0035851; GO:1990841; GO:0004672; GO:0003723; GO:0043565; GO:0019789; GO:0003713; GO:0003714; GO:0031625; GO:0004842; GO:0008270","GO:0006325; GO:0060028; GO:0043045; GO:0006281; GO:0007566; GO:0060669; GO:0001837; GO:0045087; GO:1901536; GO:0045869; GO:0045892; GO:0000122; GO:1902187; GO:0043388; GO:0045739; GO:0090309; GO:0042307; GO:0045893; GO:0046777; GO:0051259; GO:0016925; GO:0007265; GO:2000653; GO:0006367; GO:0016032"]
[2555,1275,"PK835","TRIM28 (TIF1B)","Y517","Transcription intermediary factor 1-beta",{"v":1967.55802222131,"d":"1968"},{"v":1708.1348540917909,"d":"1708"},{"v":1121.5050496906135,"d":"1122"},{"v":56.999846359014626,"d":"57"},{"v":196.19780475968037,"d":"196"},{"v":6496.258584081965,"d":"6496"},"Kinexus","RpAb","TED(pY)NLI(bA)C","Corresponds to amino acid residues T514 to I520; In the region between the zf-B_box and PHD domains. ","Y517 phosphorylation stimulates interaction with HP1 alpha and induces DNA repair. This is the major site of phosphorylation in TRIM28.",null,"Q13263","Q13263",2366,"Q13263",null,"NP_005753.1","Block8",8,1,"8, 16, 24, 32","TIF1b","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","TIF1",null,"X",{"$nulls":4},"Protein kinase, atypical; Nuclear receptor co-regulator; Transcription, coactivator/corepressor; ATYPICAL domain target; ATYPICAL</A> group; TIF1 family","GO:0005719; GO:0005720; GO:0005654; GO:0005634; GO:0090575","GO:0003682; GO:0070087; GO:0003677; GO:0003700; GO:0035851; GO:1990841; GO:0004672; GO:0003723; GO:0043565; GO:0019789; GO:0003713; GO:0003714; GO:0031625; GO:0004842; GO:0008270","GO:0006325; GO:0060028; GO:0043045; GO:0006281; GO:0007566; GO:0060669; GO:0001837; GO:0045087; GO:1901536; GO:0045869; GO:0045892; GO:0000122; GO:1902187; GO:0043388; GO:0045739; GO:0090309; GO:0042307; GO:0045893; GO:0046777; GO:0051259; GO:0016925; GO:0007265; GO:2000653; GO:0006367; GO:0016032"]
[2557,1276,"PK836","TRIM33 (TIF1G)","S1119","Transcription intermediary factor 1-gamma",{"v":4132.136668799037,"d":"4132"},{"v":3931.459499483117,"d":"3931"},{"v":1437.8345122883522,"d":"1438"},{"v":34.79639294472426,"d":"35"},{"v":575.8839923130699,"d":"576"},{"v":9271.439543103996,"d":"9271"},"Kinexus","RpAb","RLK(pS)DER(bA)C","Corresponds to amino acid residues R1116 to R1122; In C-terminus of kinase.","The effect of S1119 phosphorylation is unclear. This is a major site of phosphorylation for TRIM33.",null,"Q9UPN9","Q9UPN9",2368,"Q9UPN9",null,"NP_056990.3","Block8",8,2,"8, 16, 24, 32","TIF1g","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine; Ligase","Protein-serine/threonine kinase","Atypical","TIF1",null,"X",{"$nulls":4},"Ligase; Protein kinase, atypical; EC 6.3.2.-; Transcription, coactivator/corepressor; ATYPICAL domain target; ATYPICAL</A> group; TIF1 family","GO:0005654; GO:0005634","GO:0070410; GO:0003677; GO:0070412; GO:0004842; GO:0008270","GO:0030514; GO:0045892; GO:0000122; GO:0016567; GO:0017015; GO:0006351"]
[2559,1277,"PK837","TrkA (NGFR; NTRK1)","Y680+Y681","Nerve growth factor (NGF) receptor-tyrosine kinase; High affinity nerve growth factor receptor",{"v":11847.68992943056,"d":"11848"},{"v":12402.111001297266,"d":"12402"},{"v":4972.243198314865,"d":"4972"},{"v":41.96803957506886,"d":"42"},{"v":19.47188818374699,"d":"19"},{"v":23776.42833564582,"d":"23776"},"Kinexus","RpAb","STD(pY)(pY)RVG(bA)C","Corresponds to amino acid residues S677 to G684; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y680 and Y681 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major sites of in vivo phosphorylation of TrkA.","Y680: TrkA (NTRK1). Y681: TrkA (NTRK1)","P04629","P04629",667,"P04629","P04629","NP_002520","Block8",8,3,"8, 16, 24, 32","TRKA","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK","Trk",{"$nulls":6},"Protein-tyrosine kinase (receptor), TK group, Trk family","GO:0030424; GO:0009986; GO:0030425; GO:0005769; GO:0031901; GO:0005768; GO:0005887; GO:0005770; GO:0031902; GO:0043025; GO:0005886; GO:0032991; GO:0043235","GO:0005524; GO:0005004; GO:0019900; GO:0048406; GO:0010465; GO:0043121; GO:0005166; GO:0042803; GO:0004713; GO:0004714","GO:0000186; GO:0007568; GO:0007411; GO:0060385; GO:0030183; GO:0061368; GO:1990090; GO:0071316; GO:0007623; GO:0050966; GO:0050965; GO:0007611; GO:0042490; GO:0043066; GO:0008285; GO:0043524; GO:0038180; GO:0048666; GO:0031175; GO:0048011; GO:0021553; GO:0038083; GO:0018108; GO:0048015; GO:0045766; GO:0070374; GO:0043547; GO:0010976; GO:0051092; GO:0043068; GO:0001934; GO:0046579; GO:0051965; GO:0051968; GO:0010623; GO:0046777; GO:0006468; GO:0048678; GO:0051602; GO:0051599; GO:0031667; GO:0009314; GO:0060009; GO:0048485"]
[2561,1278,"NK179-2","TrkB (NTRK2)","Pan-specific","BNDF/NT3/4/5 receptor- tyrosine kinase",{"v":324.6364166059738,"d":"325"},{"v":284.0132929459987,"d":"284"},{"v":298.9572199499365,"d":"299"},{"v":92.08985950359188,"d":"92"},{"v":9.115155910266472,"d":"9"},{"v":3504.5095116479774,"d":"3505"},"External","MmAb","Epitope undefined.",{"$nulls":3},"Q16620","Q16620",1975,"Q16620","Q16620","NP_006171","Block8",8,4,"8, 16, 24, 32","TRKB","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK","Trk",{"$nulls":6},"Protein-tyrosine kinase (receptor), TK group, Trk family","GO:0030424; GO:0005829; GO:0030425; GO:0005769; GO:0031901; GO:0005887; GO:0048471; GO:0005886; GO:0014069; GO:0045211; GO:0043235; GO:0043195","GO:0005524; GO:0060175; GO:0048403; GO:0043121; GO:0042803","GO:0007202; GO:0031547; GO:0071230; GO:0021954; GO:0021987; GO:0007623; GO:0007631; GO:0014047; GO:0007612; GO:0060291; GO:0042490; GO:2000811; GO:0043524; GO:0007528; GO:0030182; GO:0001764; GO:0048011; GO:0048709; GO:0048935; GO:0050772; GO:0008284; GO:0010628; GO:0043410; GO:0010976; GO:1903997; GO:0033138; GO:0014068; GO:0001934; GO:0051965; GO:0046777; GO:0043087; GO:0051896; GO:0060041; GO:0046548; GO:0099183; GO:0099551; GO:0001570"]
[2563,1279,"PK838","TrkB (NTRK2)","Y516","BNDF/NT3/4/5 receptor- tyrosine kinase",{"v":5963.8529951042765,"d":"5964"},{"v":5859.7391538507745,"d":"5860"},{"v":1446.2746562481238,"d":"1446"},{"v":24.250675820402847,"d":"24"},{"v":176.32580486060505,"d":"176"},{"v":10634.872305100896,"d":"10635"},"Kinexus","RpAb","NPQ(pY)FGI(bA)C","Corresponds to amino acid residues N513 to I519; In the region between the transmembrane domain and the protein kinase catalytic domain.","Y516 phosphorylation stimulates phosphotransferase activity. This is one of the major sites of in vivo phosphorylation of TrkB.","TrkB (NTRK2)","Q16620","Q16620",1975,"Q16620","Q16620","NP_006171","Block8",8,5,"8, 16, 24, 32","TRKB","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK","Trk",{"$nulls":6},"Protein-tyrosine kinase (receptor), TK group, Trk family","GO:0030424; GO:0005829; GO:0030425; GO:0005769; GO:0031901; GO:0005887; GO:0048471; GO:0005886; GO:0014069; GO:0045211; GO:0043235; GO:0043195","GO:0005524; GO:0060175; GO:0048403; GO:0043121; GO:0042803","GO:0007202; GO:0031547; GO:0071230; GO:0021954; GO:0021987; GO:0007623; GO:0007631; GO:0014047; GO:0007612; GO:0060291; GO:0042490; GO:2000811; GO:0043524; GO:0007528; GO:0030182; GO:0001764; GO:0048011; GO:0048709; GO:0048935; GO:0050772; GO:0008284; GO:0010628; GO:0043410; GO:0010976; GO:1903997; GO:0033138; GO:0014068; GO:0001934; GO:0051965; GO:0046777; GO:0043087; GO:0051896; GO:0060041; GO:0046548; GO:0099183; GO:0099551; GO:0001570"]
[2565,1280,"PK839","TrkB (NTRK2)","Y702","BNDF/NT3/4/5 receptor- tyrosine kinase",{"v":119.11709869513301,"d":"119"},{"v":111.31380218757509,"d":"111"},{"v":59.37351780908067,"d":"59"},{"v":49.844664166175335,"d":"50"},{"v":20.040170994802793,"d":"20"},{"v":325.4437144457961,"d":"325"},"Kinexus","RpAb","RDV(pY)STD(bA)C","Corresponds to amino acid residues R699 to D705; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y702 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of TrkB.","TrkB (NTRK2)","Q16620","Q16620",1975,"Q16620","Q16620","NP_006171","Block8",8,6,"8, 16, 24, 32","TRKB","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK","Trk",{"$nulls":6},"Protein-tyrosine kinase (receptor), TK group, Trk family","GO:0030424; GO:0005829; GO:0030425; GO:0005769; GO:0031901; GO:0005887; GO:0048471; GO:0005886; GO:0014069; GO:0045211; GO:0043235; GO:0043195","GO:0005524; GO:0060175; GO:0048403; GO:0043121; GO:0042803","GO:0007202; GO:0031547; GO:0071230; GO:0021954; GO:0021987; GO:0007623; GO:0007631; GO:0014047; GO:0007612; GO:0060291; GO:0042490; GO:2000811; GO:0043524; GO:0007528; GO:0030182; GO:0001764; GO:0048011; GO:0048709; GO:0048935; GO:0050772; GO:0008284; GO:0010628; GO:0043410; GO:0010976; GO:1903997; GO:0033138; GO:0014068; GO:0001934; GO:0051965; GO:0046777; GO:0043087; GO:0051896; GO:0060041; GO:0046548; GO:0099183; GO:0099551; GO:0001570"]
[2567,1281,"PK840","TrkC (NTRK3)","Y709+Y710","NT-3 growth factor receptor",{"v":332.1435688003825,"d":"332"},{"v":299.7472449983652,"d":"300"},{"v":190.09939509088144,"d":"190"},{"v":57.23410384776432,"d":"57"},{"v":30.518846418087065,"d":"31"},{"v":1173.468168127263,"d":"1173"},"Kinexus","RpAb","STD(pY)(pY)RLF(bA)C","Corresponds to amino acid residues S706 to F713; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y709 and Y710 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. These are two of the major sites of in vivo phosphorylation of TrkC.","Y709: TrkC (NTRK3). Y710: TrkC (NTRK3).","Q16288","Q16288",1978,"Q16288","Q16288","NP_001012338.1","Block8",8,7,"8, 16, 24, 32","TRKC","X","PYK","Protein kinase - Receptor protein-tyrosine","Protein-tyrosine kinase","TK","Trk",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; TK domain target; TK</A> group; Trk family","GO:0005737; GO:0098978; GO:0005887; GO:0099055; GO:0005886; GO:0043235","GO:0005524; GO:0005004; GO:0043121; GO:0005030; GO:0002039","GO:0090630; GO:0000187; GO:0032148; GO:0071300; GO:0007623; GO:0090102; GO:0007507; GO:0070306; GO:0042490; GO:0019056; GO:0048712; GO:0060548; GO:0001933; GO:0048665; GO:0001764; GO:2000251; GO:0043065; GO:0048691; GO:0030335; GO:0008284; GO:0010628; GO:0033138; GO:0014068; GO:0010863; GO:0050927; GO:0001934; GO:0051965; GO:0046777; GO:0099151; GO:1905606; GO:0048678; GO:0051412; GO:0045471; GO:0007169"]
[2569,1282,"NK232-3","TRRAP","Pan-specific","Transformation/transcription domain-associated protein",{"v":10831.091573880305,"d":"10831"},{"v":10678.769215463242,"d":"10679"},{"v":2422.065745092821,"d":"2422"},{"v":22.362157392646818,"d":"22"},{"v":1931.1423062439621,"d":"1931"},{"v":18501.529935256207,"d":"18502"},"Kinexus","RpAb","CETKLKMMQEVSENFE","Corresponds to amino acid residues E36 to E50.",null,null,"Q9Y4A5","Q9Y4A5",2357,"Q9Y4A5","Q9Y4A5","NP_001231509.1","Block8",8,8,"8, 16, 24, 32","TRRAP","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PIKK","TRRAP",{"$nulls":5},"Transcription, coactivator/corepressor; Protein kinase, Ser/Thr (non-receptor); Nuclear receptor co-regulator; ATYPICAL domain target; ATYPICAL</A> group; PIKK family; TRRAP subfamily","GO:0005794; GO:0035267; GO:0005654; GO:0005634; GO:0000125; GO:0030914; GO:0000812; GO:0033276","GO:0016301; GO:0036459; GO:0003712","GO:1904837; GO:0006281; GO:0016573; GO:0016578; GO:0043968; GO:0043967; GO:0016579; GO:0006355; GO:0006351"]
[2571,1283,"NK232-1","TRRAP","Pan-specific","Transformation/transcription domain-associated protein",{"v":4264.767173409838,"d":"4265"},{"v":4725.79810329854,"d":"4726"},{"v":2361.963152002162,"d":"2362"},{"v":55.383167614134635,"d":"55"},{"v":5.374441138746221,"d":"5"},{"v":15270.474279602147,"d":"15270"},"Kinexus","RpAb","CARRLYIRGHNGKIYP","Corresponds to amino acid residues A3513 to P3527.",null,null,"Q9Y4A5","Q9Y4A5",2357,"Q9Y4A5","Q9Y4A5","NP_001231509.1","Block8",8,9,"8, 16, 24, 32","TRRAP","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Atypical","PIKK","TRRAP",{"$nulls":5},"Transcription, coactivator/corepressor; Protein kinase, Ser/Thr (non-receptor); Nuclear receptor co-regulator; ATYPICAL domain target; ATYPICAL</A> group; PIKK family; TRRAP subfamily","GO:0005794; GO:0035267; GO:0005654; GO:0005634; GO:0000125; GO:0030914; GO:0000812; GO:0033276","GO:0016301; GO:0036459; GO:0003712","GO:1904837; GO:0006281; GO:0016573; GO:0016578; GO:0043968; GO:0043967; GO:0016579; GO:0006355; GO:0006351"]
[2573,1284,"PK841","TSSK3","T168","Testis-specific serine/threonine-protein kinase 3",{"v":552.9005489930178,"d":"553"},{"v":567.7157098153046,"d":"568"},{"v":441.73508497205853,"d":"442"},{"v":79.89413028736871,"d":"80"},{"v":3.526981379358192,"d":"4"},{"v":2648.607884272299,"d":"2649"},"Kinexus","RpAb","LSQ(pT)FCG(bA)C","Corresponds to amino acid residues L165 to G171; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T168 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of TSSK3.","PDPK1 (PDK1); TSSK3 (STK22C)","Q96PN8","Q96PN8",2027,"Q96PN8",null,"NP_443073.1","Block8",8,10,"8, 16, 24, 32","TSSK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","CAMK","TSSK",{"$nulls":6},"Protein-serine kinase, CAMK group, TSSK family","GO:0005737; GO:0005634","GO:0005524; GO:0000287; GO:0004674","GO:0030154; GO:0035556; GO:0007275; GO:0006468; GO:0007283"]
[2575,1285,"NK180","TTK","Pan-specific","Dual specificity protein kinase",{"v":96.86429863091098,"d":"97"},{"v":75.67293610906718,"d":"76"},{"v":77.14229524832216,"d":"77"},{"v":79.63955382804454,"d":"80"},{"v":3.930331214828403,"d":"4"},{"v":716.6771633057454,"d":"717"},"External","RpAb","SEDLSGRELTIDSIMNKVRDIKNKFKNEDL","Corresponds to amino acid residues S2 to L32; N-terminus.",null,null,"P33981","P33981",779,"P33981","P33981","NP_003309.2","Block8",8,11,"8, 16, 24, 32","TTK","X","DSK","Protein Kinase - Dual specificity kinase","Protein-serine/threonine kinase","Other","TTK",{"$nulls":6},"Protein kinase, dual-specificity; EC 2.7.12.1; Other group; TTK family","GO:0005737; GO:0000776; GO:0016020; GO:0005819","GO:0005524; GO:0043515; GO:0042803; GO:0004712; GO:0004674; GO:0004713","GO:0051304; GO:0016321; GO:0033316; GO:0007094; GO:0007052; GO:0018105; GO:0018107; GO:0008284; GO:0010862; GO:0046777; GO:0034501; GO:1903096; GO:0007051"]
[2577,1286,"PK842","TTK","S677","Dual specificity protein kinase TTK",{"v":4222.946672270764,"d":"4223"},{"v":4090.749686953671,"d":"4091"},{"v":2134.855032331227,"d":"2135"},{"v":50.55368201425268,"d":"51"},{"v":59.89268395813675,"d":"60"},{"v":11990.161386729098,"d":"11990"},"Kinexus","RpAb","DTT(pS)VVK(bA)C","Corresponds to amino acid residues D674 to K680; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","T676 and likely S677 phosphorylation stimulates phosphotransferase activity. Phosphorylation regulates cell cycle progression and molecular association. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the less major sites of in vivo phosphorylation of TTK.","TTK","P33981","P33981",779,"P33981","P33981","NP_003309.2","Block8",8,12,"8, 16, 24, 32","TTK","X","DSK","Protein Kinase - Dual specificity kinase","Protein-serine/threonine kinase","Other","TTK",{"$nulls":6},"Protein kinase, dual-specificity; EC 2.7.12.1; Other group; TTK family","GO:0005737; GO:0000776; GO:0016020; GO:0005819","GO:0005524; GO:0043515; GO:0042803; GO:0004712; GO:0004674; GO:0004713","GO:0051304; GO:0016321; GO:0033316; GO:0007094; GO:0007052; GO:0018105; GO:0018107; GO:0008284; GO:0010862; GO:0046777; GO:0034501; GO:1903096; GO:0007051"]
[2579,1287,"PK843","TTK","Y833+Y836","Dual specificity protein kinase TTK",{"v":8446.24472310251,"d":"8446"},{"v":8232.602261232376,"d":"8233"},{"v":3006.489663077846,"d":"3006"},{"v":35.59557840959041,"d":"36"},{"v":1586.4814061077818,"d":"1586"},{"v":19876.74831176088,"d":"19877"},"Kinexus","RpAb","KTL(pY)EH(pY)SGG(bA)C","Corresponds to amino acid residues K830 to G839; In the C-terminal region after the kinase catalytic domain. ","The effect of Y833 and Y836 phosphorylation is unclear. These are two of the major sites of in vivo phosphorylation of TTK.",null,"P33981","P33981",779,"P33981","P33981","NP_003309.2","Block8",8,13,"8, 16, 24, 32","TTK","X","DSK","Protein Kinase - Dual specificity kinase","Protein-serine/threonine kinase","Other","TTK",{"$nulls":6},"Protein kinase, dual-specificity; EC 2.7.12.1; Other group; TTK family","GO:0005737; GO:0000776; GO:0016020; GO:0005819","GO:0005524; GO:0043515; GO:0042803; GO:0004712; GO:0004674; GO:0004713","GO:0051304; GO:0016321; GO:0033316; GO:0007094; GO:0007052; GO:0018105; GO:0018107; GO:0008284; GO:0010862; GO:0046777; GO:0034501; GO:1903096; GO:0007051"]
[2581,1288,"PK844","TXK","Y420","Tyrosine-protein kinase TXK",{"v":452.4991016888105,"d":"452"},{"v":391.07832818505426,"d":"391"},{"v":227.9430590207283,"d":"228"},{"v":50.37425669354979,"d":"50"},{"v":78.22789336857264,"d":"78"},{"v":1293.9083306494895,"d":"1294"},"Kinexus","RpAb","DDE(pY)VSS(bA)C","Corresponds to amino acid residues D417 to S423.","Y420 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of TXK.","Fyn; TXK","P42681","P42681",1968,"P42681","P42681","NP_003319.2","Block8",9,1,"8, 16, 24, 32","TXK","X","DSK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Tec",{"$nulls":6},"Protein-serine kinase, TK group, Tec family","GO:0005737; GO:0031234; GO:0005634","GO:0005524; GO:0004715; GO:0000978; GO:0001012; GO:0001077","GO:0007202; GO:0002250; GO:0030154; GO:0001816; GO:0007229; GO:0038083; GO:0060335; GO:0032729; GO:0045944; GO:0046777; GO:0006468; GO:0042127; GO:0010543; GO:0006357; GO:0050852; GO:0042246; GO:0007169"]
[2583,1289,"NK181-3","TYK2","Pan-specific","Protein-tyrosine kinase 2 (Jak-related)",{"v":6178.9066567312875,"d":"6179"},{"v":6014.084572008984,"d":"6014"},{"v":1616.9100338569112,"d":"1617"},{"v":26.168222368199284,"d":"26"},{"v":2732.0155950439835,"d":"2732"},{"v":14006.832542857499,"d":"14007"},"Kinexus","RpAb","CSFRTILRDLTRLQPH","Corresponds to amino acid residues S858 to H872; Kinase last alpha-chain.",null,null,"P29597","P29597",568,"P29597","P29597","NP_003322","Block8",9,2,"8, 16, 24, 32","TYK2","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","JakA",{"$nulls":6},"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; JakA family","GO:0005737; GO:0005856; GO:0005829; GO:0070062; GO:0031234; GO:0005634","GO:0005524; GO:0005131; GO:0004715; GO:0004713; GO:0031702","GO:0030154; GO:0016477; GO:0019221; GO:0045087; GO:0035722; GO:0038155; GO:0070106; GO:0035556; GO:0038083; GO:0006468; GO:0042127; GO:0007169; GO:0060337"]
[2585,1290,"NK181-5","TYK2","Pan-specific","Protein-tyrosine kinase 2 (Jak-related)",{"v":11278.026176152413,"d":"11278"},{"v":11108.089001058843,"d":"11108"},{"v":2317.761084754902,"d":"2318"},{"v":20.551123472792156,"d":"21"},{"v":3855.9585974521638,"d":"3856"},{"v":18140.309425619555,"d":"18140"},"Kinexus","RpAb","CWETEASFRPTFENLI","Corresponds to amino acid residues C1151 t oI 1166: Near C-terminus.",null,null,"P29597","P29597",568,"P29597","P29597","NP_003322","Block8",9,3,"8, 16, 24, 32","TYK2","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","JakA",{"$nulls":6},"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; JakA family","GO:0005737; GO:0005856; GO:0005829; GO:0070062; GO:0031234; GO:0005634","GO:0005524; GO:0005131; GO:0004715; GO:0004713; GO:0031702","GO:0030154; GO:0016477; GO:0019221; GO:0045087; GO:0035722; GO:0038155; GO:0070106; GO:0035556; GO:0038083; GO:0006468; GO:0042127; GO:0007169; GO:0060337"]
[2587,1291,"PK846","TYK2","Y292","Protein-tyrosine kinase 2 (Jak-related)",{"v":1650.0409207096193,"d":"1650"},{"v":1362.7551560355519,"d":"1363"},{"v":1512.2133208432454,"d":"1512"},{"v":91.64701928682474,"d":"92"},{"v":24.661191558318922,"d":"25"},{"v":11696.44631532412,"d":"11696"},"Kinexus","RpAb","EPA(pY)IRD(bA)C","Corresponds to amino acid residues E289 to D295; In the N-terminal half of the kinase. ","The effect of Y292 phosphorylation is unclear. This is the major in vivo site of phosphorylation of Tyk2 by mass spectrometry studies (≥1467 reports).",null,"P29597","P29597",568,"P29597","P29597","NP_003322","Block8",9,4,"8, 16, 24, 32","TYK2","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","JakA",{"$nulls":6},"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; JakA family","GO:0005737; GO:0005856; GO:0005829; GO:0070062; GO:0031234; GO:0005634","GO:0005524; GO:0005131; GO:0004715; GO:0004713; GO:0031702","GO:0030154; GO:0016477; GO:0019221; GO:0045087; GO:0035722; GO:0038155; GO:0070106; GO:0035556; GO:0038083; GO:0006468; GO:0042127; GO:0007169; GO:0060337"]
[2589,1292,"PK845","TYK2","Y1054+Y1055","Protein-tyrosine kinase 2 (Jak-related)",{"v":8018.684028995771,"d":"8019"},{"v":7916.067187422515,"d":"7916"},{"v":2208.5873006468846,"d":"2209"},{"v":27.543014448013853,"d":"28"},{"v":923.1857500840754,"d":"923"},{"v":15206.613182635785,"d":"15207"},"Kinexus","RpAb","GHE(pY)(pY)RVR(bA)C","Corresponds to amino acid residues G1051 to R1058; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y1054 and Y1055 phosphorylation stimulate phosphotransferase activity. These phosphosites are located in the kinase activation loop between catalytic subdomains VII and VIII. The Y1054 site is one of the major in vivo phosphorylation sites in TYK2 (<60).","Y1054: Tyk2. Y1055: Tyk2.","P29597","P29597",568,"P29597","P29597","NP_003322","Block8",9,5,"8, 16, 24, 32","TYK2","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","JakA",{"$nulls":6},"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; JakA family","GO:0005737; GO:0005856; GO:0005829; GO:0070062; GO:0031234; GO:0005634","GO:0005524; GO:0005131; GO:0004715; GO:0004713; GO:0031702","GO:0030154; GO:0016477; GO:0019221; GO:0045087; GO:0035722; GO:0038155; GO:0070106; GO:0035556; GO:0038083; GO:0006468; GO:0042127; GO:0007169; GO:0060337"]
[2591,1294,"PK847","Tyro3","Y681","Tyrosine-protein kinase receptor TYRO3",{"v":3310.767254586351,"d":"3311"},{"v":3266.314363929262,"d":"3266"},{"v":1138.0173363884094,"d":"1138"},{"v":34.37322073340954,"d":"34"},{"v":308.05669658325394,"d":"308"},{"v":6214.749018342388,"d":"6215"},"Kinexus","RpAb","RKI(pY)SGD(bA)C","Corresponds to amino acid residues R678 to D684; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y681 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of Tyro3.",null,"Q06418","Q06418",780,"Q06418","Q06418","NP_006284.2","Block8",9,7,"8, 16, 24, 32","TYRO3","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Axl",{"$nulls":6},"Protein-tyrosine kinase (receptor) TK group, Axl family","GO:0009986; GO:0005789; GO:0005887; GO:0005635; GO:0005634","GO:0005524; GO:0043548; GO:0046982; GO:0004713; GO:0004714; GO:0001618","GO:0043277; GO:0007155; GO:0021885; GO:0001779; GO:0050728; GO:0045824; GO:0051250; GO:0043524; GO:0034122; GO:0070050; GO:0007218; GO:0042698; GO:0014065; GO:0030168; GO:0070527; GO:0046777; GO:0043491; GO:0032940; GO:0007165; GO:0007283; GO:0034446; GO:0060068"]
[2593,1295,"PK848","Tyro3","Y685+Y686","Tyrosine-protein kinase receptor TYRO3",{"v":3812.6328613572628,"d":"3813"},{"v":3649.7589930795475,"d":"3650"},{"v":1511.97310468615,"d":"1512"},{"v":39.6569289430061,"d":"40"},{"v":81.38975151817074,"d":"81"},{"v":10878.276812318842,"d":"10878"},"Kinexus","RpAb","SGD(pY)(pY)RQG(bA)C","Corresponds to amino acid residues S682 to G689; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y685 and Y686 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII.",null,"Q06418","Q06418",780,"Q06418","Q06418","NP_006284.2","Block8",9,8,"8, 16, 24, 32","TYRO3","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Axl",{"$nulls":6},"Protein-tyrosine kinase (receptor) TK group, Axl family","GO:0009986; GO:0005789; GO:0005887; GO:0005635; GO:0005634","GO:0005524; GO:0043548; GO:0046982; GO:0004713; GO:0004714; GO:0001618","GO:0043277; GO:0007155; GO:0021885; GO:0001779; GO:0050728; GO:0045824; GO:0051250; GO:0043524; GO:0034122; GO:0070050; GO:0007218; GO:0042698; GO:0014065; GO:0030168; GO:0070527; GO:0046777; GO:0043491; GO:0032940; GO:0007165; GO:0007283; GO:0034446; GO:0060068"]
[2595,1296,"PN680","UBF","T201","Nucleolar transcription factor 1",{"v":10030.485370161758,"d":"10030"},{"v":9835.90971403,"d":"9836"},{"v":2502.3223138621465,"d":"2502"},{"v":24.947170765095215,"d":"25"},{"v":193.78756726055664,"d":"194"},{"v":17409.40257638647,"d":"17409"},"Kinexus","RpAb","EKPK(pT)PQQ(bA)C","Corresponds to amino acid residues E197 to Q204.","T201 phosphorylation inhibits transcriptional activity by inhibiting DNA binding. This is one of the major sites of in vivo phosphorylation of UBF.","ERK1 (MAPK3); ERK2 (MAPK1)","P17480","P17480",1131,null,null,"NP_055048.1","Block8",9,9,"8, 16, 24, 32",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0001650; GO:0005730; GO:0005654; GO:0005634","GO:0003682; GO:0003723; GO:0001164; GO:0000981; GO:0001165; GO:0097110","GO:0045943; GO:0006356; GO:0006363; GO:0006360; GO:0006361"]
[2597,1297,"PN679","UBF","S484","Nucleolar transcription factor 1",{"v":460.05640729705624,"d":"460"},{"v":249.4840541786708,"d":"249"},{"v":1672.5257715742305,"d":"1673"},{"v":363.5479791273266,"d":"364"},{"v":25.50204158376875,"d":"26"},{"v":15310.766956399671,"d":"15311"},"Kinexus","RpAb","KLPE(pS)PKRAC","Corresponds to amino acid residues K480 to A488.","S484 phosphorylation stimulates of DNA transcription. This is one of the major sites of in vivo phosphorylation of UBF.","CDK2; CDK4","P17480","P17480",1131,null,null,"NP_055048.1","Block8",9,10,"8, 16, 24, 32",{"$nulls":3},"Transcription protein",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0001650; GO:0005730; GO:0005654; GO:0005634","GO:0003682; GO:0003723; GO:0001164; GO:0000981; GO:0001165; GO:0097110","GO:0045943; GO:0006356; GO:0006363; GO:0006360; GO:0006361"]
[2599,1298,"NK298-2","ULK1","Pan-specific","Unc-51-like protein-serine/threonine kinase 1",{"v":284.1383734190551,"d":"284"},{"v":226.52759079241196,"d":"227"},{"v":256.61496276850824,"d":"257"},{"v":90.313377837933,"d":"90"},{"v":6.847748858916808,"d":"7"},{"v":1373.8046833612784,"d":"1374"},"External","RpAb","Epitope undefined.",{"$nulls":3},"O75385","O75385",796,"O75385",null,"NP_003556.1","Block8",9,11,"8, 16, 24, 32","ULK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","ULK",{"$nulls":6},"Protein-serine kinase, Other group, ULK family","GO:1990316; GO:0005776; GO:0030424; GO:0005737; GO:0005829; GO:0005789; GO:0097635; GO:0097629; GO:0097632; GO:0005741; GO:0034045; GO:0055037","GO:0005524; GO:0051020; GO:0042802; GO:0016301; GO:0044877; GO:0004674; GO:0017137","GO:0006914; GO:0075044; GO:0048675; GO:0031669; GO:0016236; GO:0031333; GO:0031175; GO:0031102; GO:0018105; GO:0018107; GO:2000786; GO:0046777; GO:0008104; GO:0006468; GO:0016241; GO:0042594; GO:0007165"]
[2601,1299,"NK298-1","ULK1","Pan-specific","Unc-51-like kinase 1; Serine-threonine-protein kinase ULK1",{"v":1442.5008173705592,"d":"1443"},{"v":1348.8712863000765,"d":"1349"},{"v":623.5752562691357,"d":"624"},{"v":43.228762768107856,"d":"43"},{"v":80.77333209844608,"d":"81"},{"v":4418.343451876532,"d":"4418"},"Kinexus","RpAb","RGGTETVGKFEFSRKDLIGC","Corresponds to amino acid residues R5 to G23; N-terminus.",null,null,"O75385","O75385",796,"O75385",null,"NP_003556.1","Block8",9,12,"8, 16, 24, 32","ULK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","ULK",{"$nulls":6},"Protein-serine kinase, Other group, ULK family","GO:1990316; GO:0005776; GO:0030424; GO:0005737; GO:0005829; GO:0005789; GO:0097635; GO:0097629; GO:0097632; GO:0005741; GO:0034045; GO:0055037","GO:0005524; GO:0051020; GO:0042802; GO:0016301; GO:0044877; GO:0004674; GO:0017137","GO:0006914; GO:0075044; GO:0048675; GO:0031669; GO:0016236; GO:0031333; GO:0031175; GO:0031102; GO:0018105; GO:0018107; GO:2000786; GO:0046777; GO:0008104; GO:0006468; GO:0016241; GO:0042594; GO:0007165"]
[2603,1300,"NK354-1","ULK2","Pan-specific","Unc-51-like protein-serine/threonine kinase 2",{"v":638.8667175820632,"d":"639"},{"v":596.2179153633093,"d":"596"},{"v":461.56271253892186,"d":"462"},{"v":72.2471056695223,"d":"72"},{"v":5.916467702191303,"d":"6"},{"v":2236.192526329117,"d":"2236"},"External","RpAb","Epitope undefined.",{"$nulls":3},"Q8IYT8","Q8IYT8",807,"Q8IYT8",null,"NP_001136082.1","Block8",9,13,"8, 16, 24, 32","ULK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","ULK",{"$nulls":6},"Protein-serine kinase, Other group, ULK family","GO:0030659; GO:0034045","GO:0005524; GO:0004674","GO:0006914; GO:0075044; GO:0048675; GO:0048671; GO:0046777; GO:0042594; GO:0007165"]
[2605,1301,"NK355-1","ULK3","Pan-specific","Unc-51-like protein-serine/threonine kinase 3",{"v":356.5346258966103,"d":"357"},{"v":291.0313783436254,"d":"291"},{"v":284.0504150072399,"d":"284"},{"v":79.66979765090481,"d":"80"},{"v":11.352460943901278,"d":"11"},{"v":1742.5474969600791,"d":"1743"},"External","RpAb","Epitope undefined.",{"$nulls":3},"Q6PHR2","Q6PHR2",2812801,"Q6PHR2",null,"NP_001092906.3","Block8",10,1,"8, 16, 24, 32","ULK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","ULK",{"$nulls":6},"Protein-serine kinase, Other group, ULK family","GO:0097542; GO:0005737; GO:0000407","GO:0005524; GO:0004674","GO:0006914; GO:0090398; GO:0045879; GO:0045880; GO:0046777"]
[2607,1302,"PK892","VACAMKL","Y245","CaM kinase-like vesicle-associated protein",{"v":6930.96770959267,"d":"6931"},{"v":6668.950807870209,"d":"6669"},{"v":1932.9924825090297,"d":"1933"},{"v":27.88921494806143,"d":"28"},{"v":374.7953024406468,"d":"375"},{"v":16993.234166523296,"d":"16993"},"Kinexus","RpAb","CAGD(pY)EFD","Corresponds to amino acid residues A242 to D248. Y245 is located in the Gap/Insert 10 (G/I10) region in the protein-serine/threonine kinase catalytic domain of VACAMKL.","The effect of Y245 phosphorylation is unknown. Y245 phosphorylation has been observed in only a small number of mass spectrometry studies (~6 reports). The effect of its phosphorylation is unknown. However, it has homology with the Y25 phosphosite in CaMK1a. VACAMKL has been suggested to not have detectable phosphotransferase activity. This is one of the major sites of in vivo phosphorylation of VACAMKL.",null,"Q8NCB2","Q8NCB2",2107,"Q8NCB2",null,"NP_076951.2","Block8",10,2,"8, 16, 24, 32","VACAMKL","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine",null,"CAMK","CAMK-Unique",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); CAMK domain target; CAMK</A> group; CAMK-Unique family","GO:0030659; GO:0098978; GO:0005622; GO:0005886","GO:0005524; GO:0005516; GO:0004683","GO:0035556; GO:0018105; GO:0018107; GO:0099159"]
[2609,1303,"PN276","VASP","S157","Vasodilator-stimulated phosphoprotein",{"v":348.47314191579073,"d":"348"},{"v":304.54712524904966,"d":"305"},{"v":226.5374465846073,"d":"227"},{"v":65.0085815334803,"d":"65"},{"v":66.8458416764197,"d":"67"},{"v":2260.090774229025,"d":"2260"},"External","MmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the S157 phosphosite.","S157 phosphorylation induces activity and association with VASP and vinculin, and inhibits interactions with CRKL and SPTAN1. This is one of the major sites of in vivo phosphorylation of VASP (≥3 reports from high throughput mass spectrometry studies).","PKACa (PRKACA); PKG1","P50552","P50552",1064,null,null,"NP_003361.1","Block8",10,3,"8, 16, 24, 32",{"$nulls":13},"Cytoskeletal protein","GO:0015629; GO:0005923; GO:0005829; GO:0070062; GO:0031527; GO:0005925; GO:0031258; GO:0005886","GO:0003779; GO:0045296; GO:0005522; GO:0017124","GO:0008154; GO:0007411; GO:0034329; GO:0001843; GO:0030838; GO:0051289"]
[2611,1304,"PN277","Vav","Y174","Vav 1 guanine nucleotide exchange factor",{"v":1764.3612539937474,"d":"1764"},{"v":1384.1776830145764,"d":"1384"},{"v":1248.3284086364336,"d":"1248"},{"v":70.75242702200359,"d":"71"},{"v":126.24449743909945,"d":"126"},{"v":10518.201362182173,"d":"10518"},"External","MmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the Y174 phosphosite.","The effect of Y174 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of Vav.",null,"P15498","P15498",1065,null,"P15498","NP_005419.2","Block8",10,4,"8, 16, 24, 32",{"$nulls":13},"Guanine nucleotide exchange factor for G protein","GO:0005911; GO:0005829; GO:0005886","GO:0003700; GO:0005085; GO:0046872; GO:0046934; GO:0001784; GO:0030676; GO:0005089","GO:0019221; GO:0038095; GO:0038096; GO:0007186; GO:0006955; GO:0007229; GO:0030593; GO:0030168; GO:0043065; GO:0043547; GO:0045954; GO:0051897; GO:0072593; GO:0008361; GO:0043087; GO:0035023; GO:0051056; GO:0007264; GO:0031295; GO:0030217; GO:0048010"]
[2613,1305,"PN543","Vav","Y826","Vav 1 guanine nucleotide exchange factor",{"v":1707.7957948284911,"d":"1708"},{"v":1699.518833328163,"d":"1700"},{"v":663.195374703661,"d":"663"},{"v":38.833411858252276,"d":"39"},{"v":131.39544421112026,"d":"131"},{"v":3847.8189219000233,"d":"3848"},"Kinexus","RpAb","GEI(pY)GRV(bA)C","Corresponds to amino acid residues G823 to V829; In the SH3_1 domain.","Y826 phosphorylation regulates carcinogenesis, cell growth, activation and molecular associations, including inducing interaction with Abl, CSK, SH2D1A, and Shc1. This is one of the major sites of in vivo phosphorylation of Vav.",null,"P15498","P15498",1065,null,"P15498","NP_005419.2","Block8",10,5,"8, 16, 24, 32",{"$nulls":13},"Guanine nucleotide exchange factor for G protein","GO:0005911; GO:0005829; GO:0005886","GO:0003700; GO:0005085; GO:0046872; GO:0046934; GO:0001784; GO:0030676; GO:0005089","GO:0019221; GO:0038095; GO:0038096; GO:0007186; GO:0006955; GO:0007229; GO:0030593; GO:0030168; GO:0043065; GO:0043547; GO:0045954; GO:0051897; GO:0072593; GO:0008361; GO:0043087; GO:0035023; GO:0051056; GO:0007264; GO:0031295; GO:0030217; GO:0048010"]
[2615,1306,"NK226-2","VEGFR1 (Flt1)","Pan-specific","Vascular endothelial growth factor receptor 1",{"v":13587.359209717813,"d":"13587"},{"v":13620.79478649938,"d":"13621"},{"v":2996.780017610168,"d":"2997"},{"v":22.055647247971788,"d":"22"},{"v":5292.164134484781,"d":"5292"},{"v":21800.113359319814,"d":"21800"},"Kinexus","RpAb","PEIIHMTEGRELVIPC","Corresponds to amino acid residues P143 to C158; Just before and part of the second Ig-like C2-type domain.",null,null,"P17948","P17948",1140,"P17948","P17948","NP_001153392.1","Block8",10,6,"8, 16, 24, 32","FLT1","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; EC 2.7.1.112; TK group; VEGFR family","GO:0015629; GO:0005768; GO:0005615; GO:0005925; GO:0005887; GO:0005886; GO:0043235","GO:0005524; GO:0019838; GO:0036332; GO:0004714; GO:0005021; GO:0036326; GO:0036327","GO:0001525; GO:0048514; GO:0030154; GO:0016477; GO:0035924; GO:0048598; GO:0002548; GO:1905563; GO:0018108; GO:0045766; GO:0030335; GO:0008284; GO:0043410; GO:0043406; GO:0043552; GO:0014068; GO:0010863; GO:0030949; GO:0046777; GO:0007169; GO:0036323; GO:0048010"]
[2617,1307,"PK850","VEGFR1 (Flt1)","Y1048","Vascular endothelial growth factor receptor 1",{"v":8893.872831200952,"d":"8894"},{"v":8937.993535741842,"d":"8938"},{"v":1676.0504214427926,"d":"1676"},{"v":18.845000971488744,"d":"19"},{"v":4016.8495448453755,"d":"4017"},{"v":12973.48447034221,"d":"12973"},"Kinexus","RpAb","RDI(pY)KNP(bA)C","Corresponds to amino acid residues R1045 to P1051; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y1048 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of VEGFR1.",null,"P17948","P17948",1140,"P17948","P17948","NP_001153392.1","Block8",10,7,"8, 16, 24, 32","FLT1","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; EC 2.7.1.112; TK group; VEGFR family","GO:0015629; GO:0005768; GO:0005615; GO:0005925; GO:0005887; GO:0005886; GO:0043235","GO:0005524; GO:0019838; GO:0036332; GO:0004714; GO:0005021; GO:0036326; GO:0036327","GO:0001525; GO:0048514; GO:0030154; GO:0016477; GO:0035924; GO:0048598; GO:0002548; GO:1905563; GO:0018108; GO:0045766; GO:0030335; GO:0008284; GO:0043410; GO:0043406; GO:0043552; GO:0014068; GO:0010863; GO:0030949; GO:0046777; GO:0007169; GO:0036323; GO:0048010"]
[2619,1308,"PK851","VEGFR1 (Flt1)","Y1053","Vascular endothelial growth factor receptor 1",{"v":3759.481689137612,"d":"3759"},{"v":3661.8483630784285,"d":"3662"},{"v":1209.7504811447754,"d":"1210"},{"v":32.17865070709468,"d":"32"},{"v":186.9054596625229,"d":"187"},{"v":8031.58750051421,"d":"8032"},"Kinexus","RpAb","NPD(pY)VRK(bA)C","Corresponds to amino acid residues N1050 to K1056; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y1053 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of VEGFR1.","Flt1 (VEGFR1)","P17948","P17948",1140,"P17948","P17948","NP_001153392.1","Block8",10,8,"8, 16, 24, 32","FLT1","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"Receptor tyrosine kinase; EC 2.7.10.1; EC 2.7.1.112; TK group; VEGFR family","GO:0015629; GO:0005768; GO:0005615; GO:0005925; GO:0005887; GO:0005886; GO:0043235","GO:0005524; GO:0019838; GO:0036332; GO:0004714; GO:0005021; GO:0036326; GO:0036327","GO:0001525; GO:0048514; GO:0030154; GO:0016477; GO:0035924; GO:0048598; GO:0002548; GO:1905563; GO:0018108; GO:0045766; GO:0030335; GO:0008284; GO:0043410; GO:0043406; GO:0043552; GO:0014068; GO:0010863; GO:0030949; GO:0046777; GO:0007169; GO:0036323; GO:0048010"]
[2621,1309,"NK245-2","VEGFR2 (KDR)","Pan-specific","Vascular endothelial growth factor receptor 2 ; Vascular endothelial growth factor receptor-tyrosine kinase 2 (Flk1)",{"v":6160.753091140183,"d":"6161"},{"v":6092.259002243589,"d":"6092"},{"v":1352.109282469136,"d":"1352"},{"v":21.947142864946375,"d":"22"},{"v":2406.5146191371846,"d":"2407"},{"v":9802.987741784194,"d":"9803"},"Kinexus","RpAb","CLMTKKNSTFVRVHEK","Corresponds to amino acid residues L313 to K327; In the extracellular domain of the receptor.",null,null,"P35968","P35968",614,"P35968","P35968","NP_002244","Block8",10,9,"8, 16, 24, 32","KDR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"EC 2.7.10.1; Receptor tyrosine kinase; TK group; VEGFR family","GO:0030054; GO:0005769; GO:0005783; GO:0005768; GO:0005576; GO:0005794; GO:0005887; GO:0045121; GO:0005634; GO:0005886; GO:0097443","GO:0005524; GO:0019838; GO:0051879; GO:0042802; GO:0005178; GO:0004713; GO:0004714; GO:0005021; GO:0038085","GO:0001525; GO:0035584; GO:0002042; GO:1904881; GO:0035924; GO:0035162; GO:0003158; GO:0070371; GO:0030198; GO:0043066; GO:2000352; GO:0010629; GO:0038083; GO:0018108; GO:0045766; GO:0043536; GO:0030335; GO:0090050; GO:0008284; GO:0038033; GO:0010595; GO:0001938; GO:0070374; GO:0051894; GO:0016239; GO:0043410; GO:0051901; GO:0090141; GO:0051770; GO:0014068; GO:0050927; GO:0001934; GO:2001214; GO:0046777; GO:0043491; GO:0008360; GO:0007169; GO:0048010; GO:0001570; GO:0016032"]
[2623,1310,"NK245-3","VEGFR2 (KDR)","Pan-specific","Vascular endothelial growth factor receptor 2 ; Vascular endothelial growth factor receptor-tyrosine kinase 2 (Flk1)",{"v":9078.557395262605,"d":"9079"},{"v":9023.420398199993,"d":"9023"},{"v":1832.4074101805365,"d":"1832"},{"v":20.18390511180474,"d":"20"},{"v":3259.8173865953604,"d":"3260"},{"v":14108.702666738722,"d":"14109"},"Kinexus","RpAb","CILQPDSGTTLSSPPV","Corresponds to amino acid residues I1342 to V1356; C-terminus.",null,null,"P35968","P35968",614,"P35968","P35968","NP_002244","Block8",10,10,"8, 16, 24, 32","KDR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"EC 2.7.10.1; Receptor tyrosine kinase; TK group; VEGFR family","GO:0030054; GO:0005769; GO:0005783; GO:0005768; GO:0005576; GO:0005794; GO:0005887; GO:0045121; GO:0005634; GO:0005886; GO:0097443","GO:0005524; GO:0019838; GO:0051879; GO:0042802; GO:0005178; GO:0004713; GO:0004714; GO:0005021; GO:0038085","GO:0001525; GO:0035584; GO:0002042; GO:1904881; GO:0035924; GO:0035162; GO:0003158; GO:0070371; GO:0030198; GO:0043066; GO:2000352; GO:0010629; GO:0038083; GO:0018108; GO:0045766; GO:0043536; GO:0030335; GO:0090050; GO:0008284; GO:0038033; GO:0010595; GO:0001938; GO:0070374; GO:0051894; GO:0016239; GO:0043410; GO:0051901; GO:0090141; GO:0051770; GO:0014068; GO:0050927; GO:0001934; GO:2001214; GO:0046777; GO:0043491; GO:0008360; GO:0007169; GO:0048010; GO:0001570; GO:0016032"]
[2625,1311,"PK852","VEGFR2 (KDR)","Y1054","Vascular endothelial growth factor receptor 2 ; Vascular endothelial growth factor receptor-tyrosine kinase 2 (Flk1)",{"v":8593.530616023208,"d":"8594"},{"v":8611.189338872917,"d":"8611"},{"v":1917.091431139248,"d":"1917"},{"v":22.308542516444916,"d":"22"},{"v":657.5735569634667,"d":"658"},{"v":13615.769137626503,"d":"13616"},"Kinexus","RpAb","RDI(pY)KDP(bA)C","Corresponds to amino acid residues R1051 to P1057; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","Y1054 phosphorylation stimulates phosphotransferase activity and induces interaction with Cbl and PLCG1. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of VEGFR2.","KDR (VEGFR2)","P35968","P35968",614,"P35968","P35968","NP_002244","Block8",10,11,"8, 16, 24, 32","KDR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"EC 2.7.10.1; Receptor tyrosine kinase; TK group; VEGFR family","GO:0030054; GO:0005769; GO:0005783; GO:0005768; GO:0005576; GO:0005794; GO:0005887; GO:0045121; GO:0005634; GO:0005886; GO:0097443","GO:0005524; GO:0019838; GO:0051879; GO:0042802; GO:0005178; GO:0004713; GO:0004714; GO:0005021; GO:0038085","GO:0001525; GO:0035584; GO:0002042; GO:1904881; GO:0035924; GO:0035162; GO:0003158; GO:0070371; GO:0030198; GO:0043066; GO:2000352; GO:0010629; GO:0038083; GO:0018108; GO:0045766; GO:0043536; GO:0030335; GO:0090050; GO:0008284; GO:0038033; GO:0010595; GO:0001938; GO:0070374; GO:0051894; GO:0016239; GO:0043410; GO:0051901; GO:0090141; GO:0051770; GO:0014068; GO:0050927; GO:0001934; GO:2001214; GO:0046777; GO:0043491; GO:0008360; GO:0007169; GO:0048010; GO:0001570; GO:0016032"]
[2627,1312,"PK161","VEGFR2 (KDR)","Y1059","Vascular endothelial growth factor receptor 3 ; Vascular endothelial growth factor receptor-protein-tyrosine kinase 3",{"v":805.3869645290418,"d":"805"},{"v":805.4523963172891,"d":"805"},{"v":529.3215598774003,"d":"529"},{"v":65.72263808452952,"d":"66"},{"v":11.886596268007404,"d":"12"},{"v":3332.058087178789,"d":"3332"},"External","RpAb","PD(pY)VR","Corresponds to amino acid residues P1057 to R1061.","Y1059 phosphorylation stimulates phosphotransferase activity and induces interaction with Cbl, PLCG1 and Src. This is one of the major sites of in vivo phosphorylation of VEGFR2.","KDR (VEGFR2)","P35968","P35968",614,"P35968","P35968","NP_002244","Block8",10,12,"8, 16, 24, 32","KDR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"EC 2.7.10.1; Receptor tyrosine kinase; TK group; VEGFR family","GO:0030054; GO:0005769; GO:0005783; GO:0005768; GO:0005576; GO:0005794; GO:0005887; GO:0045121; GO:0005634; GO:0005886; GO:0097443","GO:0005524; GO:0019838; GO:0051879; GO:0042802; GO:0005178; GO:0004713; GO:0004714; GO:0005021; GO:0038085","GO:0001525; GO:0035584; GO:0002042; GO:1904881; GO:0035924; GO:0035162; GO:0003158; GO:0070371; GO:0030198; GO:0043066; GO:2000352; GO:0010629; GO:0038083; GO:0018108; GO:0045766; GO:0043536; GO:0030335; GO:0090050; GO:0008284; GO:0038033; GO:0010595; GO:0001938; GO:0070374; GO:0051894; GO:0016239; GO:0043410; GO:0051901; GO:0090141; GO:0051770; GO:0014068; GO:0050927; GO:0001934; GO:2001214; GO:0046777; GO:0043491; GO:0008360; GO:0007169; GO:0048010; GO:0001570; GO:0016032"]
[2629,1313,"PK133","VEGFR2 (KDR)","Y1214","Vascular endothelial growth factor receptor 3 ; Vascular endothelial growth factor receptor-protein-tyrosine kinase 3",{"v":299.8495387080779,"d":"300"},{"v":242.51229805787796,"d":"243"},{"v":257.16229784980567,"d":"257"},{"v":85.76377971358798,"d":"86"},{"v":10.994202032197855,"d":"11"},{"v":1320.6069033930773,"d":"1321"},"External","RpAb","FH(pY)DN","Corresponds to amino acid residues F1212 to N1216; Surrounds the Y1214 phosphosite.","Y1214 phosphorylation stimulates phosphotransferase activity and induces interaction with NCK1 and Fyn. This is one of the major sites of in vivo phosphorylation of VEGFR2.","KDR (VEGFR2)","P35968","P35968",614,"P35968","P35968","NP_002244","Block8",10,13,"8, 16, 24, 32","KDR","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"EC 2.7.10.1; Receptor tyrosine kinase; TK group; VEGFR family","GO:0030054; GO:0005769; GO:0005783; GO:0005768; GO:0005576; GO:0005794; GO:0005887; GO:0045121; GO:0005634; GO:0005886; GO:0097443","GO:0005524; GO:0019838; GO:0051879; GO:0042802; GO:0005178; GO:0004713; GO:0004714; GO:0005021; GO:0038085","GO:0001525; GO:0035584; GO:0002042; GO:1904881; GO:0035924; GO:0035162; GO:0003158; GO:0070371; GO:0030198; GO:0043066; GO:2000352; GO:0010629; GO:0038083; GO:0018108; GO:0045766; GO:0043536; GO:0030335; GO:0090050; GO:0008284; GO:0038033; GO:0010595; GO:0001938; GO:0070374; GO:0051894; GO:0016239; GO:0043410; GO:0051901; GO:0090141; GO:0051770; GO:0014068; GO:0050927; GO:0001934; GO:2001214; GO:0046777; GO:0043491; GO:0008360; GO:0007169; GO:0048010; GO:0001570; GO:0016032"]
[2631,1314,"NK064-2","VEGFR3 (Flt4)","Pan-specific","Vascular endothelial growth factor receptor 3 ; Vascular endothelial growth factor receptor-protein-tyrosine kinase 3",{"v":4025.7948978407503,"d":"4026"},{"v":3855.965021189766,"d":"3856"},{"v":1376.7451074571688,"d":"1377"},{"v":34.19809360371516,"d":"34"},{"v":357.73077670621547,"d":"358"},{"v":10550.335107264742,"d":"10550"},"Kinexus","RpAb","CNELYDIQLLPRKSLE","Corresponds to amino acid residues N227 to E241.",null,null,"P35916","P35916",1984,"P35916","P35916","NP_002011","Block8",11,1,"8, 16, 24, 32","FLT4","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"EC 2.7.10.1; EC 2.7.1.112; Receptor tyrosine kinase; TK group; VEGFR family","GO:0005737; GO:0005576; GO:0005887; GO:0005654; GO:0005886; GO:0043235","GO:0005524; GO:0019838; GO:0042803; GO:0019903; GO:0004714; GO:0005021; GO:0036328","GO:0048514; GO:0035924; GO:0048286; GO:0001946; GO:0001945; GO:0043066; GO:0018108; GO:0008284; GO:0010595; GO:0001938; GO:0070374; GO:0046330; GO:0043410; GO:0090037; GO:0001934; GO:0010575; GO:0046777; GO:0060312; GO:0003016; GO:0002040; GO:0007169; GO:0048010; GO:0038084; GO:0001944"]
[2633,1315,"NK064-3","VEGFR3 (Flt4)","Pan-specific","Vascular endothelial growth factor receptor 3 ; Vascular endothelial growth factor receptor-protein-tyrosine kinase 3",{"v":9197.305234761847,"d":"9197"},{"v":8305.516290739746,"d":"8306"},{"v":2889.811987265371,"d":"2890"},{"v":31.42020313018566,"d":"31"},{"v":428.55701945299296,"d":"429"},{"v":19728.747070415033,"d":"19729"},"Kinexus","RpAb","CIQRFRESTEVIVHEN","Corresponds to amino acid residues I316 to N330.",null,null,"P35916","P35916",1984,"P35916","P35916","NP_002011","Block8",11,2,"8, 16, 24, 32","FLT4","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"EC 2.7.10.1; EC 2.7.1.112; Receptor tyrosine kinase; TK group; VEGFR family","GO:0005737; GO:0005576; GO:0005887; GO:0005654; GO:0005886; GO:0043235","GO:0005524; GO:0019838; GO:0042803; GO:0019903; GO:0004714; GO:0005021; GO:0036328","GO:0048514; GO:0035924; GO:0048286; GO:0001946; GO:0001945; GO:0043066; GO:0018108; GO:0008284; GO:0010595; GO:0001938; GO:0070374; GO:0046330; GO:0043410; GO:0090037; GO:0001934; GO:0010575; GO:0046777; GO:0060312; GO:0003016; GO:0002040; GO:0007169; GO:0048010; GO:0038084; GO:0001944"]
[2635,1316,"PK853","VEGFR3 (Flt4)","Y1068","Vascular endothelial growth factor receptor 3 ; Vascular endothelial growth factor receptor-protein-tyrosine kinase 3",{"v":8664.385974339852,"d":"8664"},{"v":8564.885530976011,"d":"8565"},{"v":2135.761739154983,"d":"2136"},{"v":24.649891469287976,"d":"25"},{"v":3717.94080823955,"d":"3718"},{"v":15414.95508030704,"d":"15415"},"Kinexus","RpAb","DPD(pY)VRK(bA)C","Corresponds to amino acid residues D1065 to K1071; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","Y1068 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of VEGFR3.","VEGFR3 (FLT4)","P35916","P35916",1984,"P35916","P35916","NP_002011","Block8",11,3,"8, 16, 24, 32","FLT4","X","PYK","Protein kinase - Receptor-tyrosine kinase","Protein-tyrosine kinase","TK","VEGFR",{"$nulls":6},"EC 2.7.10.1; EC 2.7.1.112; Receptor tyrosine kinase; TK group; VEGFR family","GO:0005737; GO:0005576; GO:0005887; GO:0005654; GO:0005886; GO:0043235","GO:0005524; GO:0019838; GO:0042803; GO:0019903; GO:0004714; GO:0005021; GO:0036328","GO:0048514; GO:0035924; GO:0048286; GO:0001946; GO:0001945; GO:0043066; GO:0018108; GO:0008284; GO:0010595; GO:0001938; GO:0070374; GO:0046330; GO:0043410; GO:0090037; GO:0001934; GO:0010575; GO:0046777; GO:0060312; GO:0003016; GO:0002040; GO:0007169; GO:0048010; GO:0038084; GO:0001944"]
[2637,1317,"NN185-2","VIM","Pan-specific","Vimentin",{"v":303.31428037162146,"d":"303"},{"v":215.04424085959627,"d":"215"},{"v":364.85795955488885,"d":"365"},{"v":120.29039948526786,"d":"120"},{"v":28.377397354630247,"d":"28"},{"v":4240.248426355856,"d":"4240"},"External","MmAb","Epitope undefined.",{"$nulls":3},"P08670","P08670",2622,null,"P08670","NP_003371","Block8",11,4,"8, 16, 24, 32",{"$nulls":13},"Cytoskeletal protein - Microtubule dynamics","GO:0031252; GO:0005737; GO:0005856; GO:0005829; GO:0070062; GO:0005925; GO:0005882; GO:0043005; GO:0016363; GO:0005777; GO:0045335; GO:0005886; GO:0005844; GO:1990904","GO:0003725; GO:0042802; GO:1990254; GO:0008022; GO:0019904; GO:0097110; GO:0005200; GO:0005212","GO:0014002; GO:0060020; GO:0071346; GO:0071222; GO:0071225; GO:0019221; GO:0045109; GO:0070307; GO:0030049; GO:0010977; GO:0032967; GO:0045727; GO:0043488; GO:0060395; GO:0016032"]
[2639,1318,"PN094","VIM","S34","Vimentin",{"v":686.2320214702914,"d":"686"},{"v":645.8887440945618,"d":"646"},{"v":567.7866664052932,"d":"568"},{"v":82.73975108138757,"d":"83"},{"v":11.348399671389478,"d":"11"},{"v":3852.910806869272,"d":"3853"},"External","MmAb","Epitope undefined.","Antibody raised against amino acid residues that encompass the S34 phosphosite.","The effect of S34 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of vimentin.","PKCa (PRKCA)","P08670","P08670",2622,null,"P08670","NP_003371","Block8",11,5,"8, 16, 24, 32",{"$nulls":13},"Cytoskeletal protein - Microtubule dynamics","GO:0031252; GO:0005737; GO:0005856; GO:0005829; GO:0070062; GO:0005925; GO:0005882; GO:0043005; GO:0016363; GO:0005777; GO:0045335; GO:0005886; GO:0005844; GO:1990904","GO:0003725; GO:0042802; GO:1990254; GO:0008022; GO:0019904; GO:0097110; GO:0005200; GO:0005212","GO:0014002; GO:0060020; GO:0071346; GO:0071222; GO:0071225; GO:0019221; GO:0045109; GO:0070307; GO:0030049; GO:0010977; GO:0032967; GO:0045727; GO:0043488; GO:0060395; GO:0016032"]
[2641,1319,"PN544","VIM","Y117","Vimentin",{"v":5303.5392713713445,"d":"5304"},{"v":5208.930478903101,"d":"5209"},{"v":1258.1376342856674,"d":"1258"},{"v":23.72260428195809,"d":"24"},{"v":2167.0129761421117,"d":"2167"},{"v":9203.195145442016,"d":"9203"},"Kinexus","RpAb","FAN(pY)IDK(bA)C","Corresponds to amino acid residues F114 to K120; In the N-terminal part of the Filament domain. ","The effect of Y117 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in vimentin.",null,"P08670","P08670",2622,null,"P08670","NP_003371","Block8",11,6,"8, 16, 24, 32",{"$nulls":13},"Cytoskeletal protein - Microtubule dynamics","GO:0031252; GO:0005737; GO:0005856; GO:0005829; GO:0070062; GO:0005925; GO:0005882; GO:0043005; GO:0016363; GO:0005777; GO:0045335; GO:0005886; GO:0005844; GO:1990904","GO:0003725; GO:0042802; GO:1990254; GO:0008022; GO:0019904; GO:0097110; GO:0005200; GO:0005212","GO:0014002; GO:0060020; GO:0071346; GO:0071222; GO:0071225; GO:0019221; GO:0045109; GO:0070307; GO:0030049; GO:0010977; GO:0032967; GO:0045727; GO:0043488; GO:0060395; GO:0016032"]
[2643,1320,"PN545","WASP","Y291","Wiskott-Aldrich syndrome protein",{"v":1205.7300404161458,"d":"1206"},{"v":1001.130419912228,"d":"1001"},{"v":762.8631742526148,"d":"763"},{"v":63.26981568687798,"d":"63"},{"v":52.467156102618134,"d":"52"},{"v":5162.424500760034,"d":"5162"},"Kinexus","RpAb","KLI(pY)DFI(bA)C","Corresponds to amino acid residues K288 to I294; In the PBD domain.","Y291 phosphorylation induces activation of WASP to regulate cell cytoskeleton and cell motility. This is one of the major sites of in vivo phosphorylation of WASP(≥XXX reports from high throughput mass spectrometry studies).","Abl1; Btk; Fyn; Hck; Lck; Lyn","P42768","P42768",1066,null,"P42768","NP_000368.1","Block8",11,7,"8, 16, 24, 32",{"$nulls":3},"Adapter/scaffold protein",{"$nulls":7},"X",null,"Adapter/scaffold protein","GO:0015629; GO:0005884; GO:0005911; GO:0005829; GO:0070062; GO:0045335; GO:0012506","GO:0003779; GO:0030695; GO:0042802; GO:0043274; GO:0019901; GO:0048365; GO:0017124; GO:0031267","GO:0030048; GO:0030041; GO:0008154; GO:0007596; GO:0032488; GO:0071346; GO:0006952; GO:0016197; GO:0008544; GO:0038096; GO:0006955; GO:2000146; GO:0051497; GO:2000601; GO:0065003; GO:0008064; GO:0010591; GO:0051492; GO:0002625; GO:0042110; GO:0050852"]
[2645,1321,"NK185","Wee1","Pan-specific","Wee1 protein-tyrosine kinase",{"v":3458.0143732362617,"d":"3458"},{"v":3200.4045767495936,"d":"3200"},{"v":1259.7777563982436,"d":"1260"},{"v":36.43066859838561,"d":"36"},{"v":306.1430402106562,"d":"306"},{"v":7182.091582353887,"d":"7182"},"Kinexus","RpAb","LTVVCAAGAEPLPRNGDQWHEIRQGRLPGGC","Corresponds to amino acid residues L361 to P388; Kinase subdomain X.",null,null,"P30291","P30291",821,"P30291",null,"NP_003381","Block8",11,8,"8, 16, 24, 32","WEE1","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","Other","WEE",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.10.2; Other group; WEE family","GO:0005737; GO:0005730; GO:0005654; GO:0005634","GO:0005524; GO:0016301; GO:0000287; GO:0004715; GO:0004713","GO:0051301; GO:0030010; GO:0000086; GO:0000226; GO:2000134; GO:0048812"]
[2647,1322,"PK854","Wee1","S642","Wee1 protein-tyrosine kinase",{"v":6892.937778576053,"d":"6893"},{"v":6260.48787580538,"d":"6260"},{"v":2443.17423434102,"d":"2443"},{"v":35.44460015197951,"d":"35"},{"v":248.74096752165175,"d":"249"},{"v":13718.819631986185,"d":"13719"},"Kinexus","RpAb","RSV(pS)LTI(bA)C","Corresponds to amino acid residues R639 to I645; In the C-terminus of the kinase.","S642 phosphorylation inhibits phosphotransferase activity and induces interaction with 14-3-3. This is one of the major sites of in vivo phosphorylation of Wee1.","Akt1 (PKBa); BRSK1; BRSK2","P30291","P30291",821,"P30291",null,"NP_003381","Block8",11,9,"8, 16, 24, 32","WEE1","X","DSK","Protein kinase - Non-receptor protein-tyrosine/threonine/serine","Dual specificity protein kinase","Other","WEE",{"$nulls":6},"Protein kinase, Ser/Thr (non-receptor); EC 2.7.10.2; Other group; WEE family","GO:0005737; GO:0005730; GO:0005654; GO:0005634","GO:0005524; GO:0016301; GO:0000287; GO:0004715; GO:0004713","GO:0051301; GO:0030010; GO:0000086; GO:0000226; GO:2000134; GO:0048812"]
[2649,1323,"NK252-1","WNK1","Pan-specific","Serine/threonine-protein kinase WNK1",{"v":10012.568860207457,"d":"10013"},{"v":9916.961241916433,"d":"9917"},{"v":2349.1947410831604,"d":"2349"},{"v":23.462457775641063,"d":"23"},{"v":3332.607034910071,"d":"3333"},{"v":17646.303130890177,"d":"17646"},"Kinexus","RpAb","MSGGAAEKQSSTPGSC","Corresponds to amino acid residues M1 to S15; N-terminus.",null,null,"Q9H4A3","Q9H4A3",748,"Q9H4A3","Q9H4A3","NP_061852.3","Block8",11,10,"8, 16, 24, 32","WNK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; Wnk family","GO:0005737; GO:0005829; GO:0016020","GO:0005524; GO:0019869; GO:0000287; GO:0019902; GO:0019870; GO:0030295; GO:0004672; GO:0019901; GO:0004674; GO:0030291","GO:0071277; GO:1990869; GO:0038116; GO:0035556; GO:0006811; GO:0097022; GO:0033633; GO:0034260; GO:0034115; GO:1903038; GO:0090188; GO:0010923; GO:0010766; GO:0048666; GO:0018105; GO:0018107; GO:0090263; GO:0003084; GO:0010820; GO:0046777; GO:0006468; GO:0050794; GO:0002028; GO:0023016; GO:0050852"]
[2651,1324,"NK252-3","WNK1","Pan-specific","Serine/threonine-protein kinase WNK1",{"v":7310.964728834499,"d":"7311"},{"v":7100.770804219059,"d":"7101"},{"v":2111.0036591326825,"d":"2111"},{"v":28.874488353183658,"d":"29"},{"v":473.39668147981524,"d":"473"},{"v":14609.705533182652,"d":"14610"},"Kinexus","RpAb","CQKSISNPPGSNLRTT","Corresponds to amino acid residues Q2368 to T2382; C-terminus.",null,null,"Q9H4A3","Q9H4A3",748,"Q9H4A3","Q9H4A3","NP_061852.3","Block8",11,11,"8, 16, 24, 32","WNK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; Wnk family","GO:0005737; GO:0005829; GO:0016020","GO:0005524; GO:0019869; GO:0000287; GO:0019902; GO:0019870; GO:0030295; GO:0004672; GO:0019901; GO:0004674; GO:0030291","GO:0071277; GO:1990869; GO:0038116; GO:0035556; GO:0006811; GO:0097022; GO:0033633; GO:0034260; GO:0034115; GO:1903038; GO:0090188; GO:0010923; GO:0010766; GO:0048666; GO:0018105; GO:0018107; GO:0090263; GO:0003084; GO:0010820; GO:0046777; GO:0006468; GO:0050794; GO:0002028; GO:0023016; GO:0050852"]
[2653,1325,"PK856","WNK1","T60","Serine/threonine-protein kinase WNK1",{"v":7342.508861197621,"d":"7343"},{"v":7234.714163069453,"d":"7235"},{"v":2203.181590431509,"d":"2203"},{"v":30.0058417644477,"d":"30"},{"v":941.002827182494,"d":"941"},{"v":14945.676189956015,"d":"14946"},"Kinexus","RpAb","RRH(pT)MDK(bA)C","Corresponds to amino acid residues R57 to K63; In the N-terminal portion of the protein kinase.","T60 phosphorylation stimulates phosphotransferase activity. This is one of the major sites of in vivo phosphorylation of WNK1.","Akt1 (PKBa); Akt3 (PKBg); MSK1 (RPS6KA5); SGK1","Q9H4A3","Q9H4A3",748,"Q9H4A3","Q9H4A3","NP_061852.3","Block8",11,12,"8, 16, 24, 32","WNK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; Wnk family","GO:0005737; GO:0005829; GO:0016020","GO:0005524; GO:0019869; GO:0000287; GO:0019902; GO:0019870; GO:0030295; GO:0004672; GO:0019901; GO:0004674; GO:0030291","GO:0071277; GO:1990869; GO:0038116; GO:0035556; GO:0006811; GO:0097022; GO:0033633; GO:0034260; GO:0034115; GO:1903038; GO:0090188; GO:0010923; GO:0010766; GO:0048666; GO:0018105; GO:0018107; GO:0090263; GO:0003084; GO:0010820; GO:0046777; GO:0006468; GO:0050794; GO:0002028; GO:0023016; GO:0050852"]
[2655,1326,"PK855","WNK1","S382","Serine/threonine-protein kinase WNK1",{"v":9847.156292204272,"d":"9847"},{"v":9842.415902370492,"d":"9842"},{"v":2760.5276213509405,"d":"2761"},{"v":28.033754511811456,"d":"28"},{"v":306.3771665521439,"d":"306"},{"v":17246.31410862601,"d":"17246"},"Kinexus","RpAb","FAK(pS)VIG(bA)C","Corresponds to amino acid residues F379 to G385; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.","S382 phosphorylation stimulates phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of WNK1.","Wnk1 (PRKWNK1)","Q9H4A3","Q9H4A3",748,"Q9H4A3","Q9H4A3","NP_061852.3","Block8",11,13,"8, 16, 24, 32","WNK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; Wnk family","GO:0005737; GO:0005829; GO:0016020","GO:0005524; GO:0019869; GO:0000287; GO:0019902; GO:0019870; GO:0030295; GO:0004672; GO:0019901; GO:0004674; GO:0030291","GO:0071277; GO:1990869; GO:0038116; GO:0035556; GO:0006811; GO:0097022; GO:0033633; GO:0034260; GO:0034115; GO:1903038; GO:0090188; GO:0010923; GO:0010766; GO:0048666; GO:0018105; GO:0018107; GO:0090263; GO:0003084; GO:0010820; GO:0046777; GO:0006468; GO:0050794; GO:0002028; GO:0023016; GO:0050852"]
[2657,1327,"PK857","WNK1","T2245","Serine/threonine-protein kinase WNK2",{"v":8624.49339599012,"d":"8624"},{"v":8479.188187599186,"d":"8479"},{"v":3387.514421296879,"d":"3388"},{"v":39.2778365726603,"d":"39"},{"v":76.39362809022194,"d":"76"},{"v":16176.986677797791,"d":"16177"},"Kinexus","RpAb","RKG(pT)FTD(bA)C","Corresponds to amino acid residues R2242 to D2248; In the C-terminal region of WNK1. ","The effect of T2245 phosphorylation is unclear. This is the major in vivo phosphorylation sites in WNK1.",null,"Q9H4A3","Q9H4A3",748,"Q9H4A3","Q9H4A3","NP_061852.3","Block8",12,1,"8, 16, 24, 32","WNK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; Wnk family","GO:0005737; GO:0005829; GO:0016020","GO:0005524; GO:0019869; GO:0000287; GO:0019902; GO:0019870; GO:0030295; GO:0004672; GO:0019901; GO:0004674; GO:0030291","GO:0071277; GO:1990869; GO:0038116; GO:0035556; GO:0006811; GO:0097022; GO:0033633; GO:0034260; GO:0034115; GO:1903038; GO:0090188; GO:0010923; GO:0010766; GO:0048666; GO:0018105; GO:0018107; GO:0090263; GO:0003084; GO:0010820; GO:0046777; GO:0006468; GO:0050794; GO:0002028; GO:0023016; GO:0050852"]
[2659,1328,"NK253-1","WNK2","Pan-specific","Serine/threonine-protein kinase WNK2",{"v":8138.608802200406,"d":"8139"},{"v":8149.1295727775505,"d":"8149"},{"v":1808.0370295498724,"d":"1808"},{"v":22.215553953902294,"d":"22"},{"v":3221.5740799537643,"d":"3222"},{"v":14586.686749004224,"d":"14587"},"Kinexus","RpAb","MDGDGGRRDVPGTLMC","Corresponds to amino acid residues M1 to M15; N-terminus.",null,null,"Q9Y3S1","Q9Y3S1",2242,"Q9Y3S1","Q9Y3S1","NP_001269323.1","Block8",12,2,"8, 16, 24, 32","WNK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; Wnk family","GO:0005737; GO:0005829; GO:0005886","GO:0005524; GO:0004674","GO:0035556; GO:0050801; GO:0008285; GO:0070373; GO:0090263; GO:2000651; GO:0046777; GO:0006468"]
[2661,1329,"NK253-2","WNK2","Pan-specific","Serine/threonine-protein kinase WNK2",{"v":1825.1061603659227,"d":"1825"},{"v":1550.522400484068,"d":"1551"},{"v":1182.726006797075,"d":"1183"},{"v":64.80313487955931,"d":"65"},{"v":94.66074157033756,"d":"95"},{"v":8760.416146600903,"d":"8760"},"Kinexus","RpAb","CDEDDLKAVATSLDGR","Corresponds to amino acid residues D179 to R193.",null,null,"Q9Y3S1","Q9Y3S1",2242,"Q9Y3S1","Q9Y3S1","NP_001269323.1","Block8",12,3,"8, 16, 24, 32","WNK2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; Wnk family","GO:0005737; GO:0005829; GO:0005886","GO:0005524; GO:0004674","GO:0035556; GO:0050801; GO:0008285; GO:0070373; GO:0090263; GO:2000651; GO:0046777; GO:0006468"]
[2663,1330,"NK254-1","WNK3 (PRKWNK3)","Pan-specific","Serine/threonine-protein kinase WNK3",{"v":6644.664122275916,"d":"6645"},{"v":6838.207266719846,"d":"6838"},{"v":2810.662048447062,"d":"2811"},{"v":42.29953533730099,"d":"42"},{"v":124.87712295256091,"d":"125"},{"v":13633.934544010659,"d":"13634"},"Kinexus","RpAb","MATDSGDPASTEDSEC","Corresponds to amino acid residues M1 to E15; N-terminus.",null,null,"Q9BYP7","Q9BYP7",803,"Q9BYP7","Q9BYP7","NP_065973.2","Block8",12,4,"8, 16, 24, 32","WNK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"Protein-serine kinase, Other group, Wnk family","GO:0005912; GO:0005923; GO:0005737; GO:0005829","GO:0005524; GO:0019869; GO:0004672; GO:0004674","GO:0035556; GO:0050801; GO:0043066; GO:0090188; GO:0051928; GO:0032414; GO:0010800; GO:1903078; GO:2000651; GO:0010765; GO:0046777; GO:0072659; GO:0006468; GO:0090279"]
[2665,1331,"NK254-3","WNK3 (PRKWNK3)","Pan-specific","Serine/threonine-protein kinase WNK3",{"v":2879.0315418951614,"d":"2879"},{"v":2731.612805374722,"d":"2732"},{"v":1179.8802674011947,"d":"1180"},{"v":40.98184581279449,"d":"41"},{"v":139.16562327032318,"d":"139"},{"v":6965.5689419257305,"d":"6966"},"Kinexus","RpAb","CGPFQPGMNMQAFPTS","Corresponds to amino acid residues G1773 to S1787.",null,null,"Q9BYP7","Q9BYP7",803,"Q9BYP7","Q9BYP7","NP_065973.2","Block8",12,5,"8, 16, 24, 32","WNK3","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"Protein-serine kinase, Other group, Wnk family","GO:0005912; GO:0005923; GO:0005737; GO:0005829","GO:0005524; GO:0019869; GO:0004672; GO:0004674","GO:0035556; GO:0050801; GO:0043066; GO:0090188; GO:0051928; GO:0032414; GO:0010800; GO:1903078; GO:2000651; GO:0010765; GO:0046777; GO:0072659; GO:0006468; GO:0090279"]
[2667,1332,"NK255-1","WNK4 (PRKWNK4)","Pan-specific","Serine/threonine-protein kinase WNK4",{"v":7962.779726064917,"d":"7963"},{"v":7901.566315755739,"d":"7902"},{"v":3424.580647407569,"d":"3425"},{"v":43.0073512670172,"d":"43"},{"v":105.8369429012872,"d":"106"},{"v":18080.85063723239,"d":"18081"},"Kinexus","RpAb","MLASPATETTVLMSQC","Corresponds to amino acid residues M1 to Q15; N-terminus.",null,null,"Q96J92","Q96J92",6663,"Q96J92","Q96J92","NP_115763.2","Block8",12,6,"8, 16, 24, 32","WNK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; Wnk family","GO:0005923; GO:0005829; GO:0016020","GO:0005524; GO:0019869; GO:0004674","GO:0006821; GO:0072156; GO:0035556; GO:0050801; GO:0006811; GO:0090188; GO:0010766; GO:0008104; GO:0006468; GO:0050794; GO:0070294"]
[2669,1333,"NK255-3","WNK4 (PRKWNK4)","Pan-specific","Serine/threonine-protein kinase WNK4",{"v":8567.54047261086,"d":"8568"},{"v":8602.240703954023,"d":"8602"},{"v":3449.5484374506445,"d":"3450"},{"v":40.26299552921089,"d":"40"},{"v":169.6233587595795,"d":"170"},{"v":18019.70009952334,"d":"18020"},"Kinexus","RpAb","CRASKGVTFAGDVGRM","Corresponds to amino acid residues R1229 to M1243; C-terminus.",null,null,"Q96J92","Q96J92",6663,"Q96J92","Q96J92","NP_115763.2","Block8",12,7,"8, 16, 24, 32","WNK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","Other","Wnk",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); Other group; Wnk family","GO:0005923; GO:0005829; GO:0016020","GO:0005524; GO:0019869; GO:0004674","GO:0006821; GO:0072156; GO:0035556; GO:0050801; GO:0006811; GO:0090188; GO:0010766; GO:0008104; GO:0006468; GO:0050794; GO:0070294"]
[2671,1334,"PN732","WT1","S365","Wilms tumour protein",{"v":7817.9439303260515,"d":"7818"},{"v":7961.323263809949,"d":"7961"},{"v":3089.330942742191,"d":"3089"},{"v":39.51590047555315,"d":"40"},{"v":66.21233948261045,"d":"66"},{"v":14925.967030063106,"d":"14926"},"Kinexus","RpAb","CERRF(pS)RSD","Corresponds to amino acid residues S360 to D368. Sequence is almost identical to S393.","The effect of S365 phosphorylation is unclear. In vivo phosphorylation of WT1 has not been reported for this phosphosite (0 reports from high throughput mass spectrometry studies). This human phosphosite is highly conserved in vertebrates and also found in fish. A nearly identical amino acid sequence surrounds S393.","PKACa (PRKACA)","P19544","P19544",4793,null,"P19544","NP_077742.2","Block8",12,8,"8, 16, 24, 32",{"$nulls":3},"Transcription protein, coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"Transcription protein","GO:0005737; GO:0005829; GO:0016607; GO:0005730; GO:0005654; GO:0005634","GO:0070742; GO:0003700; GO:0010385; GO:0044729; GO:0003723; GO:0000981; GO:0043565; GO:0001077; GO:0044212; GO:0008270","GO:0035802; GO:0030325; GO:0001658; GO:0043010; GO:0060923; GO:0071320; GO:0071371; GO:0060539; GO:0030855; GO:0007281; GO:0032836; GO:0072112; GO:0032835; GO:0008406; GO:0007507; GO:0001822; GO:0030539; GO:0008584; GO:0060231; GO:0072207; GO:0072075; GO:0072284; GO:0043066; GO:0030308; GO:0008285; GO:2000195; GO:0072302; GO:0045892; GO:0000122; GO:0017148; GO:0043065; GO:0060421; GO:2000020; GO:2001076; GO:0045893; GO:0072166; GO:0003156; GO:0006355; GO:0006357; GO:0008380; GO:0007530; GO:0007356; GO:0009888; GO:0001657; GO:0001570; GO:0061032"]
[2673,1335,"PN681","YAP1","S109","Yorkie homologue",{"v":5843.91653730924,"d":"5844"},{"v":6018.84344427259,"d":"6019"},{"v":2764.324466819355,"d":"2764"},{"v":47.30260004863373,"d":"47"},{"v":29.55022363683608,"d":"30"},{"v":14876.65700463989,"d":"14877"},"Kinexus","RpAb","SRQA(pS)TDAGC","Corresponds to amino acid residues S105 to G113.","S109 phosphorylation promotes nuclear export. This is one of the major sites of in vivo phosphorylation of YAP1.","LATS1; LATS2 (KPM)","P46937","P46937",2550,null,"P46937","NP_001123617.1","Block8",12,9,"8, 16, 24, 32",{"$nulls":3},"Transcription,  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"Transcription, coactivator/corepressor","GO:0005737; GO:0005829; GO:0016020; GO:0005654; GO:0005634; GO:0071148; GO:0071149","GO:0033613; GO:0003682; GO:0070064; GO:0008022; GO:0046982; GO:0000978; GO:0003713; GO:0003714; GO:0001076; GO:0044212","GO:0060449; GO:0061026; GO:0000902; GO:0008283; GO:0006974; GO:0071480; GO:0071300; GO:0060242; GO:0003143; GO:0003015; GO:0035329; GO:0030216; GO:0048368; GO:0060487; GO:0030857; GO:2001237; GO:2000737; GO:0030903; GO:0048339; GO:0090263; GO:0060045; GO:0033148; GO:1902459; GO:0045893; GO:0045944; GO:0050847; GO:0065003; GO:1902036; GO:0010837; GO:0072307; GO:0050767; GO:0072091; GO:0032570; GO:0035019; GO:0001894; GO:0006367; GO:0001570"]
[2675,1336,"PN682","YAP1","T119","Yorkie homologue",{"v":9810.85844239687,"d":"9811"},{"v":10304.742512763085,"d":"10305"},{"v":4660.417471762499,"d":"4660"},{"v":47.502647185519095,"d":"48"},{"v":13.156264736890385,"d":"13"},{"v":23209.846072692322,"d":"23210"},"Kinexus","RpAb","CAGAL(pT)PQHV","Corresponds to amino acid residues C115 to V123.","The effect of T119 phosphorylation is unclear. This is one of the major sites of in vivo phosphorylation of YAP1.","ERK1 (MAPK3); JNK1 (MAPK8); JNK2 (MAPK9)","P46937","P46937",2550,null,"P46937","NP_001123617.1","Block8",12,10,"8, 16, 24, 32",{"$nulls":3},"Transcription,  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"Transcription, coactivator/corepressor","GO:0005737; GO:0005829; GO:0016020; GO:0005654; GO:0005634; GO:0071148; GO:0071149","GO:0033613; GO:0003682; GO:0070064; GO:0008022; GO:0046982; GO:0000978; GO:0003713; GO:0003714; GO:0001076; GO:0044212","GO:0060449; GO:0061026; GO:0000902; GO:0008283; GO:0006974; GO:0071480; GO:0071300; GO:0060242; GO:0003143; GO:0003015; GO:0035329; GO:0030216; GO:0048368; GO:0060487; GO:0030857; GO:2001237; GO:2000737; GO:0030903; GO:0048339; GO:0090263; GO:0060045; GO:0033148; GO:1902459; GO:0045893; GO:0045944; GO:0050847; GO:0065003; GO:1902036; GO:0010837; GO:0072307; GO:0050767; GO:0072091; GO:0032570; GO:0035019; GO:0001894; GO:0006367; GO:0001570"]
[2677,1337,"PN683","YAP1","S127","Yorkie homologue",{"v":8180.819101613815,"d":"8181"},{"v":7978.656047910774,"d":"7979"},{"v":3072.8310583714283,"d":"3073"},{"v":37.56141066320922,"d":"38"},{"v":59.36824497125465,"d":"59"},{"v":18237.76223551525,"d":"18238"},"Kinexus","RpAb","VRAH(pS)SPA(bA)C","Corresponds to amino acid residues V123 to A130.","S127 phosphorylation facilitates cytoplasmic retention with binding to the 14-3-3 protein YWHAB, and increased interaction with and transcriptional coactivity towards ERBB4. This is one of the major sites of in vivo phosphorylation of YAP1.","Akt1 (PKBa); LATS1; LATS2 (KPM); MST2 (CLIK1; STK3)","P46937","P46937",2550,null,"P46937","NP_001123617.1","Block8",12,11,"8, 16, 24, 32",{"$nulls":3},"Transcription,  coactivator/corepressor",{"$nulls":4},"X",{"$nulls":4},"Transcription, coactivator/corepressor","GO:0005737; GO:0005829; GO:0016020; GO:0005654; GO:0005634; GO:0071148; GO:0071149","GO:0033613; GO:0003682; GO:0070064; GO:0008022; GO:0046982; GO:0000978; GO:0003713; GO:0003714; GO:0001076; GO:0044212","GO:0060449; GO:0061026; GO:0000902; GO:0008283; GO:0006974; GO:0071480; GO:0071300; GO:0060242; GO:0003143; GO:0003015; GO:0035329; GO:0030216; GO:0048368; GO:0060487; GO:0030857; GO:2001237; GO:2000737; GO:0030903; GO:0048339; GO:0090263; GO:0060045; GO:0033148; GO:1902459; GO:0045893; GO:0045944; GO:0050847; GO:0065003; GO:1902036; GO:0010837; GO:0072307; GO:0050767; GO:0072091; GO:0032570; GO:0035019; GO:0001894; GO:0006367; GO:0001570"]
[2679,1338,"NK186","Yes","Pan-specific","Yamaguchi sarcoma proto-oncogene-encoded tyrosine kinase",{"v":424.6586231827725,"d":"425"},{"v":322.84702435209095,"d":"323"},{"v":485.5490064595083,"d":"486"},{"v":114.33866639051591,"d":"114"},{"v":36.42233768071823,"d":"36"},{"v":6667.183463177833,"d":"6667"},"External","MmAb","Epitope undefined.",{"$nulls":3},"P07947","P07947",833,"P07947","P07947","NP_005424","Block8",12,12,"8, 16, 24, 32","Yes","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; Src family","GO:0005884; GO:0005829; GO:0070062; GO:0031234; GO:0005925; GO:0098978; GO:0005794; GO:0005815; GO:0005886; GO:0099091","GO:0005524; GO:0019899; GO:0005154; GO:0044325; GO:0004715; GO:0001784; GO:0004713; GO:0005102","GO:0030154; GO:0016477; GO:0006464; GO:0036120; GO:0071300; GO:0071560; GO:0048013; GO:0038096; GO:0045087; GO:0050900; GO:0038083; GO:0050731; GO:0045944; GO:0042127; GO:0010827; GO:0043114; GO:0031295; GO:0007169"]
[2681,1339,"PK858","Yes","Y222+Y223","Yamaguchi sarcoma proto-oncogene-encoded tyrosine kinase",{"v":11909.084489916164,"d":"11909"},{"v":11820.488645046555,"d":"11820"},{"v":2790.5886278469657,"d":"2791"},{"v":23.432436223035065,"d":"23"},{"v":3569.636524471016,"d":"3570"},{"v":19877.36198052126,"d":"19877"},"Kinexus","RpAb","NGG(pY)(pY)ITT(bA)C","Corresponds to amino acid residues N219 to T226; In the SH2 domain. ","The effects of Y222 and Y223 phosphorylation are unclear. These are two of the major in vivo phosphorylation sites in Yes (Y222 has >1799 reports; Y223 has > 670 reports).",null,"P07947","P07947",833,"P07947","P07947","NP_005424","Block8",12,13,"8, 16, 24, 32","Yes","X","PYK","Protein kinase - Non-receptor-tyrosine kinase","Protein-tyrosine kinase","TK","Src",{"$nulls":6},"EC 2.7.10.2; Protein kinase, tyrosine (non-receptor); TK group; Src family","GO:0005884; GO:0005829; GO:0070062; GO:0031234; GO:0005925; GO:0098978; GO:0005794; GO:0005815; GO:0005886; GO:0099091","GO:0005524; GO:0019899; GO:0005154; GO:0044325; GO:0004715; GO:0001784; GO:0004713; GO:0005102","GO:0030154; GO:0016477; GO:0006464; GO:0036120; GO:0071300; GO:0071560; GO:0048013; GO:0038096; GO:0045087; GO:0050900; GO:0038083; GO:0050731; GO:0045944; GO:0042127; GO:0010827; GO:0043114; GO:0031295; GO:0007169"]
[2683,1340,"NK214","YSK1 (STK25, SOK1)","Pan-specific","Protein-serine/threonine kinase 25",{"v":789.1666135919356,"d":"789"},{"v":666.3354348865074,"d":"666"},{"v":689.4235239390229,"d":"689"},{"v":87.36095927843088,"d":"87"},{"v":48.24968430129332,"d":"48"},{"v":7805.616801789678,"d":"7806"},"External","GpAb","Epitope undefined.",{"$nulls":3},"O00506","O00506",769,"O00506","O00506","NP_006365.2","Block8",13,1,"8, 16, 24, 32","YSK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","YSK",{"$nulls":5},"Protein-serine kinase, STE group, STE20 family, YSK subfamily","GO:0005737; GO:0070062; GO:0000139","GO:0005524; GO:0008349; GO:0046872; GO:0042803; GO:0004672","GO:0051683; GO:0007163; GO:0051645; GO:0090168; GO:0036481; GO:0048812; GO:0050772; GO:0032874; GO:0046777; GO:0006468; GO:0042981; GO:0007346; GO:0042542; GO:0006979; GO:0007165"]
[2685,1341,"PK859","YSK1 (STK25, SOK1)","T174","Serine/threonine-protein kinase 25",{"v":9693.325513495161,"d":"9693"},{"v":9339.176983969612,"d":"9339"},{"v":3970.3492167071013,"d":"3970"},{"v":40.95961918517577,"d":"41"},{"v":162.40483549663713,"d":"162"},{"v":22277.720837949248,"d":"22278"},"Kinexus","RpAb","KRN(pT)FVG(bA)C","Corresponds to amino acid residues K171 to G177; In the protein kinase catalytic domain activation T loop region between subdomains VII and VIII.","T174 phosphorylation is predicted to be stimulatory for phosphotransferase activity. This phosphosite is located in the kinase activation loop between catalytic subdomains VII and VIII. This is one of the major sites of in vivo phosphorylation of YSK1.",null,"O00506","O00506",769,"O00506","O00506","NP_006365.2","Block8",13,2,"8, 16, 24, 32","YSK1","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","YSK",{"$nulls":5},"Protein-serine kinase, STE group, STE20 family, YSK subfamily","GO:0005737; GO:0070062; GO:0000139","GO:0005524; GO:0008349; GO:0046872; GO:0042803; GO:0004672","GO:0051683; GO:0007163; GO:0051645; GO:0090168; GO:0036481; GO:0048812; GO:0050772; GO:0032874; GO:0046777; GO:0006468; GO:0042981; GO:0007346; GO:0042542; GO:0006979; GO:0007165"]
[2687,1342,"NK256-2","YSK4 (MAP3K19)","Pan-specific","SPS1/STE20-related protein kinase YSK4; Mitogen-activated protein kinase kinase kinase 8",{"v":3282.415509155015,"d":"3282"},{"v":3075.695844680048,"d":"3076"},{"v":1550.5813046546211,"d":"1551"},{"v":47.23903175359367,"d":"47"},{"v":60.56851810502364,"d":"61"},{"v":7407.222922868506,"d":"7407"},"Kinexus","RpAb","CSALQLLKHSFLERSH","Corresponds to amino acid residues S1314 to H1328; Kinase last alpha-chain + C-terminus.",null,null,"Q56UN5","Q56UN5",1911504,"Q56UN5",null,"NP_079328.3","Block8",13,3,"8, 16, 24, 32","YSK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE11 family","GO:0005737","GO:0005524; GO:0004674","GO:0032147; GO:0042981; GO:0007346; GO:0023014; GO:0031098"]
[2689,1343,"NK256-3","YSK4 (MAP3K19)","Pan-specific","SPS1/STE20-related protein kinase YSK4; Mitogen-activated protein kinase kinase kinase 8",{"v":3509.441654410338,"d":"3509"},{"v":3244.250552923972,"d":"3244"},{"v":2038.592331327369,"d":"2039"},{"v":58.08879394719263,"d":"58"},{"v":49.11482632960933,"d":"49"},{"v":10724.706565139479,"d":"10725"},"Kinexus","RpAb","CHGSKTRKPEEENSQY","Corresponds to amino acid residues C350 to Y366.",null,null,"Q56UN5","Q56UN5",1911504,"Q56UN5",null,"NP_079328.3","Block8",13,4,"8, 16, 24, 32","YSK4","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE11",{"$nulls":6},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE11 family","GO:0005737","GO:0005524; GO:0004674","GO:0032147; GO:0042981; GO:0007346; GO:0023014; GO:0031098"]
[2691,1344,"NK187-2","ZAP70","Pan-specific","Zeta-chain (TCR) associated protein-tyrosine kinase, 70 kDa",{"v":393.65063867299705,"d":"394"},{"v":339.7017574659666,"d":"340"},{"v":376.03200282219376,"d":"376"},{"v":95.52429638874816,"d":"96"},{"v":19.96113437094249,"d":"20"},{"v":5084.92694943417,"d":"5085"},"External","RpAb","Epitope undefined.",{"$nulls":3},"P43403","P43403",851,"P43403",null,"NP_003168","Block8",13,5,"8, 16, 24, 32","ZAP70","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Syk",{"$nulls":6},"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; Syk family","GO:0005911; GO:0005737; GO:0005829; GO:0031234; GO:0001772; GO:0005886; GO:0042101","GO:0005524; GO:0004715; GO:0001784; GO:0004713; GO:0005102","GO:0002250; GO:0042113; GO:0043366; GO:0006955; GO:0045087; GO:0035556; GO:0045060; GO:0038083; GO:0018108; GO:0046638; GO:0046641; GO:0050850; GO:0045582; GO:0045059; GO:0006468; GO:0042127; GO:0042110; GO:0070489; GO:0030217; GO:0072678; GO:0050852; GO:0007169"]
[2693,1345,"NK187","ZAP70","Pan-specific","Zeta-chain (TCR) associated protein-tyrosine kinase, 70 kDa",{"v":165.42048493570593,"d":"165"},{"v":91.88791000431883,"d":"92"},{"v":183.40274551263784,"d":"183"},{"v":110.8706370821734,"d":"111"},{"v":6.978706106430229,"d":"7"},{"v":1009.5506352276295,"d":"1010"},"External","MmAb","Epitope undefined.",{"$nulls":3},"P43403","P43403",851,"P43403",null,"NP_003168","Block8",13,6,"8, 16, 24, 32","ZAP70","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Syk",{"$nulls":6},"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; Syk family","GO:0005911; GO:0005737; GO:0005829; GO:0031234; GO:0001772; GO:0005886; GO:0042101","GO:0005524; GO:0004715; GO:0001784; GO:0004713; GO:0005102","GO:0002250; GO:0042113; GO:0043366; GO:0006955; GO:0045087; GO:0035556; GO:0045060; GO:0038083; GO:0018108; GO:0046638; GO:0046641; GO:0050850; GO:0045582; GO:0045059; GO:0006468; GO:0042127; GO:0042110; GO:0070489; GO:0030217; GO:0072678; GO:0050852; GO:0007169"]
[2695,1346,"PK860","ZAP70","Y248","Zeta-chain (TCR) associated protein-tyrosine kinase, 70 kDa",{"v":178.0150308276605,"d":"178"},{"v":157.4210127244494,"d":"157"},{"v":95.06420005149336,"d":"95"},{"v":53.402344515237424,"d":"53"},{"v":23.022745232031934,"d":"23"},{"v":723.2793418327726,"d":"723"},"Kinexus","RpAb","GLI(pY)CLK(bA)C","Corresponds to amino acid residues G245 to K251; In the intervening region between the SH2 and kinase catalytic domains. ","The effect of Y248 phosphorylation is unclear. This is one of the major in vivo phosphorylation sites in ZAP70 (≥344 reports).",null,"P43403","P43403",851,"P43403",null,"NP_003168","Block8",13,7,"8, 16, 24, 32","ZAP70","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Syk",{"$nulls":6},"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; Syk family","GO:0005911; GO:0005737; GO:0005829; GO:0031234; GO:0001772; GO:0005886; GO:0042101","GO:0005524; GO:0004715; GO:0001784; GO:0004713; GO:0005102","GO:0002250; GO:0042113; GO:0043366; GO:0006955; GO:0045087; GO:0035556; GO:0045060; GO:0038083; GO:0018108; GO:0046638; GO:0046641; GO:0050850; GO:0045582; GO:0045059; GO:0006468; GO:0042127; GO:0042110; GO:0070489; GO:0030217; GO:0072678; GO:0050852; GO:0007169"]
[2697,1347,"PK861","ZAP70","Y292","Zeta-chain (TCR) associated protein-tyrosine kinase, 70 kDa",{"v":2130.2909521383963,"d":"2130"},{"v":2024.384591878449,"d":"2024"},{"v":1061.280837108492,"d":"1061"},{"v":49.818586331748406,"d":"50"},{"v":29.34797628676075,"d":"29"},{"v":5319.059339050517,"d":"5319"},"Kinexus","RpAb","SDG(pY)TPE(bA)C","Corresponds to amino acid residues S289 to E295; In the region between the SH2 domain and the protein kinase catalytic domain.","Phosphorylation of Y292 Inhibits phosphotransferase activity, and regulates cell adhesion, cell growth, intracellular location, protein degradation and molecular association, including inducing interaction with Cbl. This is one of the major in vivo phosphorylation sites of ZAP70 by mass spectrometry studies (≥448 reports).","Lck; ZAP70","P43403","P43403",851,"P43403",null,"NP_003168","Block8",13,8,"8, 16, 24, 32","ZAP70","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Syk",{"$nulls":6},"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; Syk family","GO:0005911; GO:0005737; GO:0005829; GO:0031234; GO:0001772; GO:0005886; GO:0042101","GO:0005524; GO:0004715; GO:0001784; GO:0004713; GO:0005102","GO:0002250; GO:0042113; GO:0043366; GO:0006955; GO:0045087; GO:0035556; GO:0045060; GO:0038083; GO:0018108; GO:0046638; GO:0046641; GO:0050850; GO:0045582; GO:0045059; GO:0006468; GO:0042127; GO:0042110; GO:0070489; GO:0030217; GO:0072678; GO:0050852; GO:0007169"]
[2699,1348,"PK862","ZAP70","Y319","Zeta-chain (TCR) associated protein-tyrosine kinase, 70 kDa",{"v":6219.499334108876,"d":"6219"},{"v":6348.07535601209,"d":"6348"},{"v":2692.293955632037,"d":"2692"},{"v":43.28795311331577,"d":"43"},{"v":47.76689365139009,"d":"48"},{"v":13307.65892408576,"d":"13308"},"Kinexus","RpAb","ESP(pY)SDP(bA)C","Corresponds to amino acid residues E316 to P322; In the region between the SH2 and kinase catalytic domains.","Y319 phosphorylation stimulates phosphotransferase activity and regulates intracellular location, transcription and molecular association, including inducing interaction with Lck and PLCG1. This is one of the major in vivo phosphorylation sites of ZAP70 by mass spectrometry studies (≥259 reports).","Abl1; ZAP70","P43403","P43403",851,"P43403",null,"NP_003168","Block8",13,9,"8, 16, 24, 32","ZAP70","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Syk",{"$nulls":6},"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; Syk family","GO:0005911; GO:0005737; GO:0005829; GO:0031234; GO:0001772; GO:0005886; GO:0042101","GO:0005524; GO:0004715; GO:0001784; GO:0004713; GO:0005102","GO:0002250; GO:0042113; GO:0043366; GO:0006955; GO:0045087; GO:0035556; GO:0045060; GO:0038083; GO:0018108; GO:0046638; GO:0046641; GO:0050850; GO:0045582; GO:0045059; GO:0006468; GO:0042127; GO:0042110; GO:0070489; GO:0030217; GO:0072678; GO:0050852; GO:0007169"]
[2701,1349,"PK863","ZAP70","Y492+Y493","Zeta-chain (TCR) associated protein-tyrosine kinase, 70 kDa",{"v":7356.838872951236,"d":"7357"},{"v":7378.298284403298,"d":"7378"},{"v":3443.855691369565,"d":"3444"},{"v":46.811623182771214,"d":"47"},{"v":38.5207766544514,"d":"39"},{"v":17115.241538193775,"d":"17115"},"Kinexus","RpAb","DDS(pY)(pY)TAR(bA)C","Corresponds to amino acid residues D489 to R496; In the protein kinase catalytic domain.","Y492+Y493 phosphorylation inhibits phosphotransferase activity and regulates transcription. This is one of the major sites of in vivo phosphorylation of ZAP70.","Y492: Lck; ZAP70. Y493: Lck; ZAP70.","P43403","P43403",851,"P43403",null,"NP_003168","Block8",13,10,"8, 16, 24, 32","ZAP70","X","PYK","Protein kinase - Non-receptor protein-tyrosine","Protein-tyrosine kinase","TK","Syk",{"$nulls":6},"Protein kinase, tyrosine (non-receptor); EC 2.7.10.2; TK group; Syk family","GO:0005911; GO:0005737; GO:0005829; GO:0031234; GO:0001772; GO:0005886; GO:0042101","GO:0005524; GO:0004715; GO:0001784; GO:0004713; GO:0005102","GO:0002250; GO:0042113; GO:0043366; GO:0006955; GO:0045087; GO:0035556; GO:0045060; GO:0038083; GO:0018108; GO:0046638; GO:0046641; GO:0050850; GO:0045582; GO:0045059; GO:0006468; GO:0042127; GO:0042110; GO:0070489; GO:0030217; GO:0072678; GO:0050852; GO:0007169"]
[2703,1350,"NK301-1","ZC2 (TNIK)","Pan-specific","TRAF2 and NCK-interacting kinase",{"v":1267.8343623534097,"d":"1268"},{"v":1245.8153894599645,"d":"1246"},{"v":591.8465730144187,"d":"592"},{"v":46.68169522679659,"d":"47"},{"v":78.25665236045408,"d":"78"},{"v":3225.8443336625583,"d":"3226"},"Kinexus","RpAb","CGSSQVFFMTLNRNSMMNW","Corresponds to amino acid residues G1343 to W1360; C-terminus.",null,null,"Q9UKE5","Q9UKE5",2498,"Q9UKE5",null,"NP_055843.1","Block8",13,11,"8, 16, 24, 32","ZC2","X","PSTK","Protein kinase - Non-receptor protein-serine/threonine","Protein-serine/threonine kinase","STE","STE20","MSN",{"$nulls":5},"EC 2.7.11.1; Protein kinase, Ser/Thr (non-receptor); STE domain target; STE</A> group; STE20 family; MSN subfamily","GO:0016324; GO:0005737; GO:0005856; GO:0005829; GO:0070062; GO:0098978; GO:0005654; GO:0005634; GO:0099092; GO:0098793; GO:0055037","GO:0005524; GO:0008349; GO:0004672; GO:0004674","GO:0031532; GO:0007256; GO:0007010; GO:0035556; GO:0030033; GO:0001934; GO:0046777; GO:0072659; GO:0006468; GO:0042981; GO:0048814; GO:0007346; GO:0016055"]

{"sheet":"Gene Ontology Terms","index":4,"n_rows":11649,"n_cols":4,"rows_kept":11649}
["Gene Ontology Terms"]
["GO_ID","Class","Description","Uniprot_ID_list"]
["GO:0031145","biological_process","anaphase-promoting complex-dependent catabolic process ","P24941; O60566; P06493; O14965; Q96GD4; P53350; P14635; Q13042; Q9UKT4; P62979; Q9UJX5; P0CG47; Q13257; Q9H1A4; Q9UJX3; Q8NHZ8; Q5XUX0; Q16763; Q9UJX2; Q12834; O43684; P30260; P62987; O95997; Q9UM11"]
["GO:0051301","biological_process","cell division ","P24941; P54274; P62140; P62136; P51956; P11802; Q14683; P50613; O95835; Q00534; P06400; O96017; O60566; P06493; O00311; O94921; O14965; P24864; P30291; P14635; Q16513; Q96L34; Q00535; Q14511; Q02156; P51955; Q8N3U4; Q9HC98; P04150; Q9NRM7; P30279; Q9ULW0; Q13042; Q8IX90; Q9NTI5; Q29RF7; Q02224; Q2NKX8; O95271; Q03188; Q99661; O00401; Q9UKT4; Q6P1K2; Q9NWV8; Q9HC77; P81274; O75410; O43566; Q99741; O43683; Q86T82; P04899; Q8IWQ3; Q15019; O75400; P56945; Q9UH03; P07437; Q99986; Q8ND76; Q96GX5; P23396; Q9UJX5; Q15003; Q96Q89; Q7Z5K2; P18754; Q12798; Q96PY6; Q13257; Q9NXR1; O43236; Q8IVT2; Q9Y5T5; Q9H1A4; Q9Y6A5; Q9UPY8; Q15555; Q8WYJ6; Q9BSJ6; P30304; P12270; Q9UJX3; P62826; Q6PGQ7; Q8NHZ8; P30307; Q86WB0; P11171; Q9NTJ3; Q9BQE3; Q96BD8; P27816; Q8TAP9; Q15058; O15392; Q16181; P63279; Q00526; Q71U36; Q8IWB6; Q15691; Q14203; Q8N2Z9; P18858; P41208; Q8IYM1; Q562F6; P56211; Q9BW19; P30305; Q16763; O75122; P49916; Q53HL2; P20248; Q8TDN4; P41002; Q9H2D6; Q9Y5B0; O43768; Q9UJX2; Q8NHV4; Q9NQR1; Q7Z3K3; O00139; Q96FF9; Q9UQE7; Q96R06; Q9Y6D9; Q99708; P30281; Q12834; Q86XL3; O43264; O43684; Q13352; P49917; Q14204; P11234; P24385; Q8N4N8; Q9H410; P36873; Q6P0N0; Q96EP1; Q99719; Q8WVI7; P22674; Q8NEB9; Q9Y6G9; Q7Z4H7; P09496; Q9BVW5; Q8NG31; O75449; P52926; Q8TD19; P48729; O60563; P68363; P11233; Q9H211; Q14980; P52732; Q9UHD8; Q69YH5; Q00839; O94762; Q9Y266; Q99618; Q8IXJ6; O95997; Q6P1M3; Q08J23; Q00610; Q9Y265; Q5FBB7; O14777; Q9UM11; Q9NPB6; Q99828; Q14457; Q9BPX3"]
["GO:0071732","biological_process","cellular response to nitric oxide ","P24941; Q12778; P29972; P46108; Q12933; P50570; Q02153; P20248; Q14103; O15519"]
["GO:0007099","biological_process","centriole replication ","P24941; O00444; Q9HC77; P41208; Q96SN8; O43379; O43303; Q8N137"]
["GO:0051298","biological_process","centrosome duplication ","P24941; O75116; Q8TDC3; Q8TEP8; Q13563; Q15468; Q9NXR1; O43303; P51587"]
["GO:0006977","biological_process","DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest ","P24941; Q9H4B4; Q09472; O96017; P06493; O14965; P29590; Q00987; P14635; P04637; Q13315; P38936; Q16254; Q96PM9; O75175; P15941; P78543; Q9NYY3; Q9H0Z9; Q14186; P46527; Q86X55; Q13362; Q08999; Q07812; P12004; Q01094; Q9NYZ3; P31947; P30307; Q9ULM6; O15151; Q9H4X1; P24522; Q9C0C2; Q9NZN8; Q99856; P42575; A0AVK6; Q96AV8; Q99873"]
["GO:0006281","biological_process","DNA repair ","P24941; P50750; Q14683; P49674; P06748; P52701; Q9H2K8; P06493; Q99459; Q9Y4A5; Q12824; Q96Q15; Q08050; P42345; Q13535; Q00613; Q08945; Q13263; Q7L7X3; P53041; Q13315; O14757; Q9NTI5; Q29RF7; Q9NSU2; O00167; O95071; Q99638; P19447; Q96RU2; P54132; Q8NBZ0; P43681; P78543; Q14807; O15360; Q7Z2Z1; O15287; O43542; Q9Y294; Q6P4R8; Q14669; P23396; Q9BXW9; Q9Y5B9; Q7LG56; Q96T60; Q9BTK6; Q9UBT6; P55072; Q13112; Q9P2Y5; Q9NZM5; Q99497; P27694; Q96PK6; P49959; P39748; Q03468; Q8IY92; P06746; Q9BQ15; Q96I25; Q96T88; Q9Y253; P23025; Q06609; O94782; Q9HAW4; P13051; P63146; Q8N2Z9; P18858; Q92900; P40937; P63165; Q14686; Q92878; O75943; O00255; Q9UQE7; Q99708; P0C1Z6; Q9UNE7; Q9NS91; P24522; P43246; P49459; Q96FW1; Q9Y230; Q16531; O60671; Q8N0Z6; Q96AH0; Q7Z589; P09874; O95243; P27695; Q96EZ8; O94762; Q92547; O95997; Q9NZC9; Q9Y265; Q13111; Q92698; Q9UM11; Q9NUW8"]
["GO:0006260","biological_process","DNA replication ","P24941; O60934; P06493; Q96ST3; O00311; P38398; Q13535; Q08945; Q13315; P49736; O14757; P25205; Q7Z6E9; Q9NSU2; P49005; P55209; O95251; P54132; Q8WXE1; Q01105; Q99741; Q7Z2Z1; P33992; P33316; Q9UBU7; Q9Y5B9; Q9UBT6; Q13112; Q13829; P27694; Q96PK6; Q8WYH8; Q04837; P49959; P39748; Q8IY92; Q9H9A7; P11387; Q9NZJ0; Q9Y253; P15927; Q9HAW4; P49321; Q13416; Q92900; P40937; P49916; Q14686; Q92878; Q99543; O75943; Q8WVB6; Q99708; Q9UGP5; Q13415; P49917; P31350; Q92993; Q3V6T2; P52948; O43929; Q99728; P33993; P33991; O94762; Q14191; Q96E14; Q9Y5N6; Q13111"]
["GO:0000082","biological_process","1/S transition of mitotic cell cycle ","P24941; Q9P1W9; Q9H4B4; P11802; O95835; Q00534; P06400; P01106; O00311; Q06203; Q04771; P24864; P06730; P23443; Q9UQM7; Q13541; P49736; P38936; Q9NRM7; P25205; Q12962; P49792; Q9UPP1; P08476; Q99741; Q9NYY3; Q86T82; P33992; P05556; Q13156; P46527; Q9UBU7; P42771; P18754; P27694; P49643; O75925; Q08209; P30304; P15927; O75496; P49321; Q13416; P49427; Q00526; P47928; Q9H6Z4; Q7L0Q8; Q99708; P61244; Q13415; Q93034; P24385; Q7Z3J3; O43929; Q13309; Q9H211; P33993; P33991; P36896; Q9Y5N6; P55273"]
["GO:0000086","biological_process","2/M transition of mitotic cell cycle ","P24941; P54274; Q9H4B4; O95835; P49674; Q99640; O96017; P06493; O94921; O14965; P48730; O00444; P53350; P30291; P14635; Q14680; P48681; Q08050; P17612; P51955; P38936; P07900; P08183; Q96CV9; Q8WV24; Q99996; Q9HC77; Q8TAP6; Q8TEP8; P31323; Q9NQ66; Q15154; Q8IWQ3; P50570; P07437; Q8ND76; Q96GX5; Q9Y570; O15297; Q9NXR1; P30304; O14578; Q6PGQ7; P30307; O15392; O95684; O95613; P61981; Q71U36; Q15691; Q14203; P62258; P41208; P56211; Q96SN8; P30305; P20248; O43303; O43768; Q8NHV4; P23258; Q5BJF6; Q9UPN4; Q14204; Q9BV73; P63167; Q9Y2I6; P30153; Q7Z4H7; Q13409; Q13309; Q07666; Q96IF1"]
["GO:0016572","biological_process","histone phosphorylation ","P24941; O75676; Q12852; O75582; Q13315; Q05655; Q8NG66; Q8NE63; Q9UIG0; P20248"]
["GO:0051321","biological_process","meiotic cell cycle ","P24941; Q9UQB9; Q14683; O60934; P16104; P67775; P51955; Q8N3U4; Q5VUA4; Q9Y580; Q06609; Q9UQE7; Q99708; O43264; O43684; Q4G163; Q14980; Q9UH99; Q8IXJ6; Q9BXT4; Q92698"]
["GO:0031571","biological_process","mitotic  DNA damage checkpoint ","P24941; P04637; Q13574; O15350; P15927; Q5XUX0; P24385; Q6Y7W6; Q71UM5; Q6PCD5; Q9H3D4"]
["GO:0007275","biological_process","multicellular organism development ","P24941; P39880; Q96PN8; Q01974; P11802; P11309; O15146; Q14004; P29317; Q13224; Q13418; P20794; Q9UPZ9; P04637; P07332; P07333; Q13535; P04049; P10398; O95376; P78545; Q13045; Q02224; Q16760; Q15717; Q86UP8; Q8N4C8; Q9Y295; Q92904; P09629; Q14202; P19622; Q99504; O60869; Q02535; Q9UEE9; Q99801; Q9Y4C8; Q9UBW7; Q9UGP4; O95238; P60174; P25445; Q6SA08; Q9NVP2; P15822; Q9NQI0; Q9UHL0; Q8N3F0; Q14990; Q96PF2; P31314; Q02363; Q5XXA6; Q07820; Q00526; Q9H3P2; Q16621; P11308; P35368; P31270; Q93009; P98082; P31269; Q99598; Q5BJF6; P57682; Q9UPN4; P52566; Q9UGM3; P48357; Q99523; Q9Y283; Q9UMX1; Q15583; P52926; Q9UL17; P50221; Q05952; P25942; P20333; Q9BQW3; Q8N9N5; P36955; Q9Y266; Q03060; Q9H0D2; Q86YF9; Q04724; Q9BXT4; Q9NUK0; Q05195; O43255; P31260; Q9BXA7"]
["GO:0000122","biological_process","negative regulation of transcription by RNA polymerase II ","P24941; P41212; Q01826; P09467; Q13761; P39880; Q06413; Q04206; Q9H4B4; Q13163; P37840; Q09472; P06400; P15976; Q9Y6K1; P01106; Q9H2X6; Q6PD62; P19544; O00267; Q15796; P10276; Q96ST3; P11362; P09429; P03372; P42224; Q9UJU2; O14497; P49715; P10242; P21802; P15336; Q96GD4; P24864; P37231; O75030; Q00987; P19793; Q01196; P19838; P42226; Q00653; P40763; P50548; Q9UQL6; Q01201; P53350; P51610; Q02078; P84022; Q03135; P17947; P04637; P17706; Q08050; Q9UPN9; Q00613; P10275; P06733; Q13263; P35813; O43524; P04150; P42685; Q15910; P56524; P15311; Q9H7L9; Q92769; Q13887; Q9Y618; Q96IZ0; Q14469; P16403; Q49AN0; Q86UE4; Q96EB6; Q9NP66; Q96T58; Q9Y2X9; P61925; Q04864; Q96PU5; Q14863; Q16649; Q8N680; P16671; Q13705; Q9H3M7; P35251; O43623; Q14134; O15055; P14317; P62979; P17844; Q9UFW8; Q8WUI4; Q02535; P28324; P17535; P16989; Q8IZQ8; Q32MZ4; O75626; O60315; P48552; O75461; Q9UHI6; P51532; P10588; Q06546; Q15545; P52945; O95238; Q5VWG9; Q8WUF5; Q9GZV1; Q9P1Z0; Q9HBA0; P15923; Q6KC79; P58012; Q92908; P17676; O60504; P35462; P40305; O15350; O94992; Q96RI1; Q15022; P17542; P37275; P0CG47; Q12948; P48023; P62633; Q9HC52; Q5VWQ8; P28069; Q99576; P26358; Q15906; Q99697; P10828; Q13547; Q01094; Q9Y3T9; Q9NZM5; P36956; Q13573; Q13485; O94763; P54259; P45973; Q9Y3F4; P55055; Q13118; O00257; Q16526; Q13516; P10070; Q9BZS1; Q5UIP0; P11473; O75925; Q92793; P12270; P35226; P28749; Q96T88; P52952; P35548; O60341; P55317; Q99592; Q92985; P50553; Q12946; Q13501; O15105; Q9NX63; Q9ULV5; Q99626; Q02363; P63279; Q13416; Q9Y4K3; Q9BU19; Q14494; P17813; Q12959; Q8IUX7; Q12772; P28698; P49768; O15151; Q9NQB0; Q9BZI1; O15379; P63165; P05067; Q53H80; P35232; P43354; Q07869; O95600; Q13133; Q99958; P17275; Q9UKY1; Q14192; Q6P1N0; O43474; P16401; Q15327; O96004; P33076; P47928; Q9NYF0; Q9Y483; P01375; Q6NUN9; P17861; Q99967; Q9NQR1; P41182; P17544; O00255; P53539; Q9Y5B6; P15036; P98175; Q96KQ7; Q7RTU3; P61244; Q9NRG4; P22626; P30281; Q13569; P57682; O15119; Q9BZK7; Q96LA8; Q9BY41; P35638; Q6GQQ9; Q9NRY4; Q99750; Q8N2W9; Q9UH92; P46531; O95863; P43356; Q8NER1; P22004; P24385; O15534; Q6P1J9; Q9H165; P29375; P23246; Q15466; Q9UMX1; Q7L2J0; O96028; P67809; O00213; Q15583; O95983; Q92993; Q15596; P51858; Q9GZV5; P51608; Q05516; P48431; P52926; Q9UL17; Q8NE35; Q02556; Q9NZN8; P62987; Q16666; P43699; P09874; P14316; O75376; Q96IT1; Q9NZC7; P40337; P51449; Q03014; P13631; O94880; O14980; P10071; P12755; Q15648; P49711; P20393; Q96RK0; Q07021; P23769; Q00839; Q13363; O95931; Q8IXJ6; Q96IF1; A0AVK6; Q8IX03; P26651; P41134; Q03060; P05549; Q92731; Q06330; P23497; P18146; Q01860; O75444; P25490; Q96AV8; Q15672; Q9H3D4; Q14585; O94776; Q05195; Q9UQR1; P10412; Q9UKV0; P56645; O60260; Q71DI3; P10599; Q9UMR3; Q01851; Q9HCU9"]
["GO:0018105","biological_process","peptidyl-serine phosphorylation ","P24941; O75116; Q8IWU2; Q13164; Q13554; O00141; Q16566; Q9H4A3; Q14164; Q8N5S9; P31749; P24723; Q92918; Q15120; O15530; Q05513; Q13557; P49674; Q9UHD2; P27361; P17252; O15264; Q9H2X6; Q96RR4; Q9Y243; Q8IW41; O96017; Q12852; P49137; P06493; O00311; P45984; Q15831; Q9NZJ5; Q13177; P48730; P49759; Q04759; Q13627; P45983; P25098; Q13418; P23443; Q16512; Q9UQM7; P53778; Q7KZI7; Q15139; P78527; P53350; Q9BUB5; Q9BZL6; Q9HBH9; Q09013; P05129; Q16513; P51812; P31751; P28482; Q5S007; O75385; Q8IU85; P05771; P43405; Q96Q15; Q00535; P42345; Q13043; Q02779; Q16539; Q13535; P17612; O14920; P49841; Q9P0L2; Q16644; O43293; Q8NCB2; O15111; P12931; Q02156; O15075; P68400; P51817; Q15208; Q9HC98; Q13315; P33981; P41743; Q13555; Q05655; Q9NRM7; P27448; Q96BR1; O95271; Q15078; Q9UEW8; Q6P2M8; Q9Y2H1; Q9NYY3; Q8IWQ3; O15021; Q96GX5; Q8NE63; Q52WX2; Q9UIK4; Q6R327; P10415; P11387; Q9H422; Q9HBY8; Q96PF2; Q9HAW4; P78368; P37173; P36897; Q6P5Z2; Q6P0Q8; Q9BXM7; P19784; Q9H1R3; Q86UE8; P98161; Q96NX5; Q9Y2H9; P48729; Q16816; Q8TAS1; Q9BXA7"]
["GO:0008284","biological_process","positive regulation of cell proliferation ","P24941; P36888; P00533; P15407; Q16620; P07948; Q13131; Q04206; P14921; P22455; P31749; Q15303; P11802; Q05513; Q16288; P17948; P08631; P06748; Q86Z02; P01106; Q9H2X6; P29353; P09619; P10276; P11362; O00311; Q9UJU2; P21802; P78362; Q14004; P22607; Q05397; P01112; Q00987; O43663; P35916; Q13418; Q14289; P34947; P35968; Q14978; P49407; P16234; P16591; P10721; P31751; P28482; P08069; Q08050; P07333; P35568; Q00613; P10275; Q04912; P06213; P52799; P68400; P60484; P46109; Q04637; P33981; P40189; Q13153; Q15910; P56524; P21709; P30279; Q92769; Q13887; P08151; P36544; P16871; Q14469; P41180; P28223; Q96EB6; P55209; P14317; Q03431; Q9Y3Y2; Q99801; Q8IZQ8; O00560; P01116; P52945; P12272; P04899; P05556; P32241; O95471; Q99650; P35462; P46527; Q86X55; P42702; Q15022; P48023; P62633; Q9Y4H2; Q9HC52; P28069; Q96Q89; P43307; Q13547; P82970; O00716; P78536; P52952; Q92819; Q9BQA1; P50052; Q15058; O15392; Q9ULV5; Q99626; P49006; O95684; Q9ULM6; Q12959; Q00526; P37173; P09038; Q53H80; Q8TD43; P30305; Q96BF6; P36897; P47928; P17861; Q02297; Q07817; Q9NP71; Q9BUL8; Q13009; Q13291; Q9BWW4; O15119; Q12834; O76071; Q9UPN4; Q01954; Q8TD08; P08913; P46531; P49459; P22004; P16473; O14713; O94874; P46087; P20265; P29350; Q9BVW5; Q13950; Q9GZV5; P51608; Q9NRA0; Q9ULC4; P30048; Q16595; Q9UQC2; P11926; P13631; Q969Z0; Q9H3R0; Q9NQG5; O14686; Q99538; P48436; P52943; Q9UM11; Q68CZ2; Q99828; Q99873"]
["GO:0032298","biological_process","positive regulation of DNA-dependent DNA replication initiation ","P24941"]
["GO:0045893","biological_process","positive regulation of transcription, DNA-templated ","P24941; P46937; P00533; P46734; Q13761; P51617; Q06413; Q16566; Q9P1W9; Q04206; P14921; P31749; Q15303; Q01974; P50613; Q09472; P06748; P06400; P15976; P01106; Q9H2X6; Q96RR4; P29353; O96017; P19544; Q15796; P10276; P03372; P07949; P42224; Q9UJU2; P36507; O14497; P10242; Q04771; P24864; P37231; P38398; O75030; Q9Y2W1; Q9Y6Q9; P85037; Q01196; P19838; P29475; Q13418; P40763; P17096; Q14978; P41235; Q12888; P16220; P05412; P28482; P51610; Q13469; P84022; P17947; P04637; Q08050; P35398; Q9Y2U5; Q99683; O14920; P10275; P19419; Q12778; Q02750; Q13263; O15111; P06213; P12931; P35222; P23771; P01100; P35813; O43524; P43694; P56524; Q15650; O75469; Q92769; P08151; O15164; P78545; Q14469; Q96TA1; P12980; Q9Y2X9; P14598; Q9HC44; Q9Y2G1; Q9Y4C1; Q14207; Q86WV1; Q5VUA4; Q04917; Q7Z5J4; O14640; P32314; P35251; P20749; P61457; Q9UBK2; O15516; Q9UPP1; Q9GZV9; P62508; P08476; P54132; O60869; P49918; P27540; Q13772; Q99801; Q9Y261; Q9H4L7; Q8IZQ8; Q9NQ66; O60244; P48552; Q00059; P51532; Q15046; Q12906; P20823; Q92997; Q9NS56; Q99966; Q9Y463; P12830; P50570; P15923; Q9P0U4; P58012; Q92908; P17676; P78317; O00327; P23760; O15350; P12956; Q8IZD2; Q02962; P17542; Q8TAQ2; Q12948; P62633; P28069; O43918; P62195; P26367; Q13547; Q01094; Q16665; Q13485; Q8WYH8; Q9Y5T5; P55055; P56178; P10070; Q9UPY8; Q9BZS1; Q9Y5V3; O75925; P82970; Q92793; P62826; P04198; P52952; O00482; Q9BTA9; Q02447; Q13351; P15884; P18848; Q6N069; P50052; Q92985; Q12946; O76054; P23511; O95999; Q96T23; Q99626; Q02363; O14641; Q14494; P08047; P56693; P09038; P49768; O75581; P61296; Q16621; P35232; Q96SN8; Q07869; Q9UK80; Q13133; Q99958; Q03112; P31270; O43294; Q14192; P36897; Q14686; O75928; O43474; P20248; P98082; Q99543; P33076; P01375; Q99967; Q6STE5; Q8N4X5; Q9NP71; O00409; P15036; Q86V15; Q13404; Q15788; O95361; P10914; O15119; Q9BZK7; P51587; P35638; Q14103; P46531; O95863; Q99607; P37023; P37198; P29375; Q92794; Q9UBR4; P28347; Q15306; Q86WP2; Q9NYV6; O00213; O95644; Q92993; Q13950; P01730; P51608; Q05516; P48431; P52926; Q9UL17; P35869; P43699; Q8N726; Q96IT1; P40337; P51449; O15169; Q03164; Q8N9N5; P10071; Q15648; P49711; P20393; P10243; O60885; P05549; Q92731; P23497; P18146; Q9UBS8; Q9H3D4; P48436; O95409; Q13562; Q01543; Q5VTR2"]
["GO:0006813","biological_process","potassium ion transport ","P24941; P29972; Q12791; O75351; O15554; P48544; Q9NS61; O00168; P46527; P48048; P48549; O60706; P22459; Q14500; P22001; Q92952; O60928; P16389; P46459; P22460; Q7Z418; Q9NPC2; Q09470; Q9UK17; Q03721; Q92574; P48050; Q9H2S1; O14649; Q15842; P63252; P78508; Q9NPI9"]
["GO:0006468","biological_process","protein phosphorylation ","P24941; P15056; P49840; Q9BYP7; O75116; Q8IWU2; P08922; Q13554; Q8TDC3; Q13761; P42336; P50750; P04629; Q00537; P51617; P51956; Q96PN8; Q96J92; Q6VAB6; O00141; Q5VT25; Q16659; P07948; P41279; P31152; P06239; Q13131; Q9UQB9; P42681; Q16566; Q9P1W9; Q9H4A3; Q14164; Q2M2I8; Q16584; P31749; O75676; Q9H4B4; P11802; Q9Y2K2; P24723; Q92918; O15530; Q05513; Q13557; P54646; P53779; Q9H0K1; Q9Y3S1; P51813; Q13237; O95835; P08631; Q00534; P49674; Q9UHD2; P27361; P17252; Q13882; Q9H2X6; Q96RR4; Q9H2K8; Q9Y243; P00519; Q12851; O96017; Q12852; O60285; Q00532; P49137; P10276; P06493; P11362; P45984; P11309; P07949; O60674; Q15831; Q9NZJ5; Q13177; O14965; P09769; O76039; P78362; P04626; Q96GD4; Q04771; P24864; P48730; O95382; Q13627; O00444; Q06187; P45983; P80192; P42680; Q8IVT5; P29597; Q13418; P21127; Q14289; Q13523; Q16512; Q9UQM7; Q7KZI7; P20794; P15172; Q15139; Q13233; Q9UPZ9; Q9NYL2; P43403; P78527; P53350; Q9BUB5; P11274; Q9BZL6; Q9HBH9; P53667; Q09013; Q9UBE8; O75582; P16220; O95747; P05129; Q16513; Q00536; P16591; Q96L34; P41240; Q5TCX8; O95819; P28482; Q9P2K8; Q86V86; Q5S007; Q9Y4K4; O75385; P05771; P07332; P43405; O94804; Q00535; Q6DT37; P06241; Q8TDX7; Q12866; Q9Y2U5; P42345; Q13043; Q99683; P17612; P57059; O14920; P49841; Q9P0L2; Q02750; O94806; O43781; O43293; P49761; O15111; Q7L7X3; Q9Y6E0; P06213; Q13976; Q9UQ07; O00506; O43930; Q02156; P23528; P04049; O15075; P51955; Q9UKE5; P68400; Q15208; P27986; Q9NRP7; Q13464; Q9UQ88; Q96SB4; Q9HC98; Q13315; Q9Y5S2; P23458; P41743; P52333; Q15131; Q07002; Q92630; P29376; P42685; P22694; Q13153; Q14012; Q05655; P19525; Q9NRM7; Q13470; P27448; Q96BR1; Q9UJY1; Q8N4C8; Q9P289; P60983; P19447; Q9UEW8; Q9Y2H1; Q13188; Q8NG66; Q12906; Q9NYY3; Q8IWQ3; O43741; Q9Y463; Q15300; Q99986; O15198; Q6SA08; Q15746; Q9UIK4; Q96PY6; Q9NRH2; O60229; Q8TF76; Q7RTN6; Q9H422; O75460; Q9HBY8; Q96PF2; P17936; P51946; O15392; Q96S44; P53355; P78368; Q00526; P37173; Q92519; P05067; P11308; P30305; Q5MAI5; P36897; Q05469; Q9UHY1; Q6P5Z2; Q9Y478; Q6P0Q8; Q9BXM7; P54619; P37023; Q86UE8; Q96RG2; Q8NEB9; P49760; Q7Z7A4; Q9Y2H9; Q9BY44; Q8IVH8; P48729; O60563; O00329; P36894; O94768; Q13363; Q9H093; P36896; Q8NB16; P08100; Q9UKI8; Q9NRD5; Q9BXA7; O15117"]
["GO:0007265","biological_process","Ras protein signal transduction ","P24941; P06400; P21359; P29353; Q8IW41; Q9P212; P01112; Q8IVT5; Q15139; Q7L591; P05412; P04637; Q13263; P46109; P38936; P62070; Q12967; Q13393; P62993; Q96RU2; A0MZ66; P01116; Q9NYY3; Q92529; P26358; P42771; Q99497; Q96PV0; P09038; O60496; P20248; Q7LDG7; P10301; Q15047; Q13283; P08913; P11234; Q07889; O43561; Q8IV61; Q9NS23; Q99704; O95267; P11233; P01111; Q969H4"]
["GO:0010389","biological_process","regulation of 2/M transition of mitotic cell cycle ","P24941; Q00534; P49674; P06493; O14965; P48730; O00444; P53350; P17612; P51955; P07900; Q9ULW0; Q99996; P61925; Q9HC77; Q8TAP6; Q8TEP8; P31323; Q15154; P07437; Q9NXR1; Q15058; O95684; O95613; Q00526; P61981; Q71U36; Q15691; Q14203; P62258; P41208; Q96SN8; O43303; Q8NHV4; P23258; Q5BJF6; Q9UPN4; Q14204; Q9BV73; P63167; Q9Y2I6; P30153; Q7Z4H7; Q13409; Q8N726"]
["GO:0060968","biological_process","regulation of gene silencing ","P24941; P68431"]
["GO:1901796","biological_process","regulation of signal transduction by p53 class mediator ","P24941; P31749; Q9H4B4; Q09472; Q86Z02; Q9H2X6; Q8IW41; O96017; O60285; Q15831; O14965; Q96GD4; P29590; Q00987; O14744; P04637; Q15759; Q16539; Q08945; P68400; Q13315; Q92630; O14757; Q9ULW0; O15164; Q12962; Q96PM9; Q15545; Q5VWG9; Q8WUF5; O15350; Q8NE63; Q9Y5B9; Q9Y3T9; Q9NZM5; Q8WYH8; P62913; P67870; Q96S44; O15151; Q9BVI0; Q9NQR1; Q13625; Q9NRG4; Q96LA8; P19784; Q92794; P46087; Q8N0Z6; Q8N9N5; Q13526; Q9H3D4; Q01851"]
["GO:0010033","biological_process","response to organic substance ","P24941; Q04206; P11802; P16220; P67775; Q16760; O43542; O43315; Q9UBN7; Q00526; P00441; P22460; P31415; P08758; P30153; P18887; O75762"]
["GO:0007568","biological_process","aging ","P05198; P04629; P51617; Q04206; P31749; P13639; P37840; P04035; Q9Y6K1; P00966; P09619; Q96ST3; Q96GD4; Q00653; P35221; P23443; P40763; P16220; P05412; P60484; P01100; O43524; P48506; P35354; Q08499; P28223; Q9UKT5; Q9ULJ8; Q9UBK2; P55211; Q03431; P62993; P09622; O43464; Q9Y210; P04818; P21554; P17535; P04040; Q9UKV5; P04844; Q13144; O14727; Q86X55; P55316; Q02962; P05107; P36956; Q01959; Q9NTG7; P06746; P55011; Q16236; P37173; P06396; P27824; P98177; Q16611; Q14118; P08833; O95983; Q07954; P20333; P27695; P42575; P36955; Q14191; Q14457"]
["GO:0034198","biological_process","cellular response to amino acid starvation ","P05198; P27361; Q9NZJ5; P45983; Q15139; P28482; Q9P2K8; P42345; Q99683; P38936; P19525; P25445; P18848; P51397; Q9Y371; Q9H492; Q9HB90; Q5T011; Q14457"]
["GO:0034605","biological_process","cellular response to heat ","P05198; P51617; P10636; P07948; P21359; P17612; Q00613; P38936; P35354; Q92769; O95817; O43464; Q9HBA0; Q12798; P55072; P0DMV8; Q9UER7; P12270; P54252; Q5XXA6; P62258; P63165; Q9UNE7; P09601; Q8NER1; Q9UBL0"]
["GO:0034599","biological_process","cellular response to oxidative stress ","P05198; Q13131; P54646; P37840; P11413; P00519; Q15139; Q5S007; Q12778; O43524; Q9BYN0; Q96PH1; Q9UBK2; O43464; P04040; P13498; P43351; Q9BXW9; Q5D1E8; Q99497; P30044; P0DMV8; P41161; Q16236; Q14494; Q06830; P00441; P43354; P17861; Q96HE7; P32322; P22392; Q9BXM7; P99999; P07203; Q9NPH5; P04179; Q96C36; P09874; P30048; P32119; Q8IXJ6; P16615; Q8TCS8"]
["GO:0034644","biological_process","cellular response to UV ","P05198; Q15262; Q09472; P06748; P01106; O15264; Q96GD4; Q14934; Q9P2K8; P04637; Q13535; P27986; Q96KB5; P35354; P29972; P55211; Q96RU2; O15350; Q9UBT6; Q07812; Q96LC9; P12004; Q9Y3T9; Q06787; P30304; Q92793; O60341; P18848; Q16611; Q86U44; Q9Y230; P09874; P46934; P25490; Q969H0; Q9H3D4"]
["GO:1905098","biological_process","negative regulation of guanyl-nucleotide exchange factor activity ","P05198; P08581; P16949"]
["GO:0032057","biological_process","negative regulation of translational initiation in response to stress ","P05198; Q9NZJ5; Q9P2K8; P18848"]
["GO:0036499","biological_process","PERK-mediated unfolded protein response ","P05198; Q9NZJ5; P18848; Q16236; P35638; P08833; P11021"]
["GO:1901216","biological_process","positive regulation of neuron death ","P05198; P10636; P37840; P00519; Q13224; P06241; P42345; Q99683; P49841; P19419; Q92934; P52799; P01100; Q8WYL5; P05107; P04156; Q14790; P02649; Q9UER7; P05067; Q6NUN9; Q13625; P31994; Q13155; P09874; P18146"]
["GO:2000676","biological_process","positive regulation of type B pancreatic cell apoptotic process ","P05198"]
["GO:0046777","biological_process","protein autophosphorylation ","P05198; Q9BYP7; P36888; Q8IWU2; P00533; Q13554; P04629; P51617; Q16620; P07948; P42681; Q16566; Q9P1W9; Q9H4A3; Q2M2I8; P22455; Q16584; P31749; Q15303; Q92918; O15530; Q13557; Q16288; P54760; P17948; Q9H0K1; Q9Y3S1; P51813; P08631; Q6PHR2; Q13882; Q96RR4; Q9H2K8; O00418; P00519; Q8IW41; O96017; P09619; Q12852; P49137; P11362; P11309; Q15835; O15146; O60674; Q15831; Q9NYV4; Q9NZJ5; Q13177; O14965; P09769; O76039; P21802; P04626; Q96GD4; Q9H792; Q8IYT8; P49759; Q13627; Q06418; P22607; Q05397; P27708; P35916; P80192; Q14289; Q9UM73; P34947; Q9UQM7; Q7KZI7; P20794; Q15139; Q13546; P14616; Q9BUB5; P11274; P35968; Q9BZL6; Q9HBH9; Q9UBE8; P05129; Q14680; P16234; P16591; P10721; Q9BVS4; Q5TCX8; P54762; Q9P2K8; Q86V86; Q5S007; O75385; P07332; P08069; O94804; Q96Q15; Q08345; Q00535; Q16832; P42345; P07333; Q13043; Q02779; Q13535; P57059; P49841; P54753; Q16644; Q13263; O43293; P49761; Q7L7X3; Q9Y6E0; P06213; P12931; O00506; P51955; Q9UKE5; P51817; P54764; Q9HC98; Q13315; Q9H2G2; P33981; Q02763; Q8WTQ7; Q13153; Q9BQI3; P21709; P00540; P19525; Q13470; O15164; Q8N4C8; Q9P289; Q9UEW8; Q9HAZ1; P29322; Q99986; Q9UL54; Q8NE63; Q99759; Q9UIK4; O75460; Q96PF2; P53355; P78368; Q8NEV4; P22392; O75716; Q8TD08; Q9H1R3; Q96RG2; Q9Y572; P49760; Q96QT4; Q8TAS1; O94768; P36896"]
["GO:0034976","biological_process","response to endoplasmic reticulum stress ","P05198; P13639; Q9NZJ5; Q13148; P62714; Q99683; O00459; P27986; Q9BXH1; O43521; Q12933; Q13144; P17676; P14625; O75460; P18848; O75955; Q9BZQ8; P17861; Q96HE7; Q9UMX0; P35638; Q13972; O94874; P30101; O14827; Q9H3N1; Q15084; O60260; P16615"]
["GO:1990737","biological_process","response to manganese-induced endoplasmic reticulum stress ","P05198; Q9NZJ5; P18848"]
["GO:0034063","biological_process","stress granule assembly ","P05198; P10636; O00571; Q8WWM7; Q13283; Q14204; Q14451"]
["GO:0006413","biological_process","translational initiation ","P05198; P62753; P06730; P23588; Q04637; P62917; Q6PKG0; P60866; P62280; P55010; P05388; P62979; Q13144; P26373; P05387; P23396; P42677; Q14240; P84098; P41091; O00303; Q15056; P62913; P46782; O75822; P46778; O00571; P40429; P46783; P11940; P62841; Q8NE71; P20042; Q14232; P30050; Q99613; P62987; Q07020; O15523; P39019"]
["GO:0055085","biological_process","transmembrane transport ","P05198; Q9UEY8; P08183; P62979; Q08495; P35611; P0CG47; Q15311; O60706; P55072; P41091; P33527; P13569; Q8NE71; P40855; P20042; P62987; P35612"]
["GO:0033277","biological_process","abortive mitotic cell cycle ","Q06124; P29350"]
["GO:0000187","biological_process","activation of MAPK activity ","Q06124; P46734; P51617; Q13131; P08575; Q16584; Q13163; Q16288; P27361; P29353; P49137; P06493; P07949; P36507; Q9P212; Q8WU20; Q9UM73; P49407; P10721; P28482; Q5S007; Q15759; Q9Y2U5; Q16539; O43353; P52564; Q9Y6K9; O43318; Q02750; Q16644; Q7L7X3; P06213; Q15121; P00540; P36544; P62979; Q15750; Q9UEW8; P61073; Q15046; Q9NYJ8; O15350; Q9UL54; P0CG47; Q6UVK1; P21462; P10912; P42338; Q13255; Q9Y4K3; P00441; P09038; P05067; Q16828; P01375; Q02297; O00206; P21730; Q13404; Q8N5C8; P30040; Q9UBU3; P61088; P62987; P18545; Q16690"]
["GO:0036302","biological_process","atrioventricular canal development ","Q06124; Q9P2D1; Q13485; Q92819; Q06330"]
["GO:0007411","biological_process","axon guidance ","Q06124; Q13164; P42336; P04629; Q13480; P27361; P17252; P29353; P07949; Q8WU20; Q04759; Q05397; P29323; P18433; P19174; O75582; P54762; P28482; P06241; P07333; P54753; P52799; P12931; P23771; P27986; P50552; P15311; Q96TA1; P08138; Q15078; P23560; O14640; P62993; P47736; P61073; Q92858; Q8N8S7; Q92529; P29322; Q01082; Q15768; Q9Y4H2; P26367; P98172; Q13485; Q9ULB1; P10070; P32004; Q13813; Q9BYB0; P42338; Q96MS0; P13591; O60496; Q14194; O95185; Q13322; O75553; P50549; Q13509; Q96B97; Q9Y6N7; Q96S59; Q9NRY4; Q07889; Q99704; P43699; Q9UQC2; P10071; O00329; P43146; Q8IUQ4; Q14451; P33176; Q99689; O60282; Q16555"]
["GO:0060020","biological_process","Bergmann glial cell differentiation ","Q06124; P27361; P08670; P00519; P28482; P14136; Q02750"]
["GO:0007420","biological_process","brain development ","Q06124; P48454; Q16875; Q12879; Q13873; Q01581; P21359; Q05586; Q13224; P78527; P11274; P48681; P41240; P42345; Q9NRP7; Q9NQZ2; O43521; P13010; Q14863; P41220; Q15078; Q9UPP1; O95817; P49675; Q9NUY8; Q08828; Q99966; Q9H2B2; Q6KC79; Q99624; O43181; P12956; P55316; Q9Y4H2; O75386; P21579; O43236; P46379; Q08209; Q9NYA1; P50052; O60716; O00562; P37173; Q9UQB8; Q96SN8; P19235; P21453; Q9BRQ0; Q14686; P54253; P49798; P84074; O95185; O00255; Q05086; P51587; Q16611; O00186; O43175; O95983; Q9NRA0; P43699; P32121; Q15648; P42575; Q96RK0; P24752; Q14191; O14649; P41134; Q14957; P16949; Q66K74; O95409; Q16555"]
["GO:0071345","biological_process","cellular response to cytokine stimulus ","Q06124; P36888; P13612; P50750; Q9UHD2; Q9UJU2; P45983; P40763; Q15678; P84022; P17706; P07333; P35236; Q05209; P54829; P14317; Q14195; P61073; P08473; P32248; Q12923; Q99952; Q12946; P29350; Q92945; Q01851"]
["GO:0071364","biological_process","cellular response to epidermal growth factor stimulus ","Q06124; P00533; P31749; Q15303; O15530; P22681; P04626; P27708; P68104; P19174; Q05209; P51452; P09327; O43623; Q02962; Q12948; Q5VWQ8; P56192; P09211; P19338; Q96A49; Q9UQB8; P46940; P51692; O15519; Q07352; P33993; Q15648; P26651; P41134; P48436; Q9UJM3; Q14457"]
["GO:0071260","biological_process","cellular response to mechanical stimulus ","Q06124; P00533; P45985; P31749; P27361; P45983; P19838; Q13233; P63000; P17302; Q9Y2U5; Q99558; Q92934; P48506; O14757; P56524; P35354; P11166; Q13158; P29972; O95817; P19438; P13498; O15455; P25445; Q99439; P17301; Q14790; P19634; O95999; P17813; Q15327; O00206; P24522; P10914; P05023; O60602; P22004; Q16611; Q14118; P25942; Q5JVS0; P42575; P63252; P48436"]
["GO:0021697","biological_process","cerebellar cortex formation ","Q06124; Q00535; Q02750"]
["GO:0019221","biological_process","cytokine-mediated signaling pathway ","Q06124; P36888; P42336; P42229; Q04206; P31749; P08631; P08670; P01106; P35228; P29353; P11309; O60674; P42224; P22681; P49715; Q14765; P42680; P09917; P29597; P42226; P40763; O15357; P16591; P10721; Q92835; P04637; Q13905; P06241; P52630; P35398; P07333; P17612; Q12778; Q92934; P14859; P23771; P27986; P01100; P46109; P04083; O43524; P23458; P15498; P52333; P38936; P40189; P07900; O14512; P35354; P46108; P16671; Q14005; P15941; P49716; P62979; P62993; Q99062; P41143; P01116; Q16658; P51681; Q16623; P05556; P19438; Q99650; P14625; Q9HCJ2; P42702; P37275; P0CG47; P48023; P05107; Q16665; P41597; P10415; O14543; Q9H9S0; P21462; O14492; O15392; P42338; Q07820; P09038; P01589; P14784; P17275; P21453; P01375; P78552; P18827; Q07817; Q7L0Q8; P41182; P21397; P11142; Q9NRD9; P09601; Q13651; P24385; Q07889; P32927; Q15306; P29350; P51692; P13726; P14778; P01730; P24394; P48431; Q9Y6R0; P62987; P20333; P51449; P08253; Q9UQC2; P63104; P42574; O00329; Q15672; P35372"]
["GO:0000077","biological_process","DNA damage checkpoint ","Q06124; O60934; O96017; Q9NYL2; P16104; Q12888; Q9P2K8; Q16539; Q13535; Q15121; O14757; Q99638; O15516; Q96RU2; Q8WXE1; Q13156; Q01094; Q9HAW4; O75943; O60671"]
["GO:0048013","biological_process","ephrin receptor signaling pathway ","Q06124; O75116; Q05193; P07948; P54760; Q05586; Q05397; P01112; P29317; Q13224; P29323; P60709; Q9Y2X7; P54762; P63000; O75914; P06241; P07947; P54753; P29320; P52799; P12931; Q13464; P54764; Q13153; P21709; P46108; Q15078; O00401; Q8N5V2; O00560; P52735; P16333; P29322; O15511; Q15768; P98172; Q14155; P61160; O60229; Q9UKW4; O15143; P61158; Q92625; Q13009; O15197; P34741; Q96CW1; P61586; P60953; P20936; P63010; P08253; O43166; P63261"]
["GO:0007173","biological_process","epidermal growth factor receptor signaling pathway ","Q06124; P00533; P42336; Q13480; P31749; O15530; P29353; P00519; P22681; Q9P212; Q05397; Q14289; P19174; O75582; P07332; P12931; Q96RT1; P27986; Q16760; P09327; P62993; P42566; P56945; Q92529; O00443; Q13191; P78536; Q8NFH8; P46940; Q07889; Q14451; P48436; Q12929"]
["GO:0038127","biological_process","ERBB signaling pathway ","Q06124; P28482; Q02297"]
["GO:0060325","biological_process","face morphogenesis ","Q06124; Q9UJU2; O00501; Q6KC79; P56178; O75581; P10301; P08253; P12755"]
["GO:0008543","biological_process","fibroblast growth factor receptor signaling pathway ","Q06124; P22455; P35269; P27361; P11362; P22681; P21802; Q8WU20; P22607; O43251; P28482; P62993; Q9GZV9; P61106; P24928; P61218; P09651; Q14512; P09038; P46940; P26599; Q8NEM2; P52272; P31943; P52298; Q09161; P31483"]
["GO:0048806","biological_process","genitalia development ","Q06124; Q9P2D1; Q92886; P98161"]
["GO:0042593","biological_process","glucose homeostasis ","Q06124; P35557; Q13131; P22455; P31749; P54646; P62753; Q15831; P49715; Q15119; P37231; Q53ET0; P40763; Q16654; P41235; P17706; P35568; P06213; Q92934; Q49AN0; P08138; P14672; Q8NE86; P21554; P52945; O15240; P20823; Q9HBA0; Q96RI1; P26367; Q14721; Q16665; Q99497; Q9NRY6; Q16526; Q96A54; Q9H9A7; P08237; P55317; P00973; Q9NQB0; P35368; Q9NP71; Q8N6T7; P08913; P22415; P48357; P06737; Q6J4K2; Q13562"]
["GO:0007507","biological_process","heart development ","Q06124; Q06413; Q15303; Q13163; Q16288; Q09472; P21359; P29353; P19544; Q00532; Q9P212; P04626; P37231; P27708; P25098; P07101; P78527; Q14934; P21860; Q02078; P17302; P11831; Q02750; P04049; P60484; P46109; P13807; Q02763; Q14863; Q13705; P19429; Q13563; Q02535; Q99801; P30626; P42892; Q9NYJ8; O94992; Q12948; P12004; Q12802; P10070; P50553; Q12946; Q13936; A1X283; O14641; P37173; P61296; Q07869; P19235; Q99958; Q16635; P36897; Q14686; O96004; Q99967; P49815; P10916; Q9HC62; Q9NRG4; P46531; O95983; P98161; Q07352; P42574; P10071; P19021; P41134; Q15842; Q9UKV0; Q01851"]
["GO:0048873","biological_process","homeostasis of number of cells within a tissue ","Q06124; P15976; Q9Y243; P29474; P01116; P35611; Q07812; P41597; P10415; P07954; P46531; Q6Y7W6; Q03164; P23769; O75995"]
["GO:0009755","biological_process","hormone-mediated signaling pathway ","Q06124; O95835; Q9NRM7; Q9Y4C1; P10827; Q96A54; O00482; Q13285; Q9UBU3; P16473; P37198; P23945"]
["GO:0042445","biological_process","hormone metabolic process ","Q06124; Q15424; P55317; P10912; Q13285"]
["GO:0048839","biological_process","inner ear development ","Q06124; P09619; P49137; P49715; Q9BSQ5; P46527; Q92886; P84074; P51787; Q9UBR4; P48431; Q92688; O75444; Q13562"]
["GO:0007229","biological_process","integrin-mediated signaling pathway ","Q06124; P13612; P42681; P08631; P00519; Q9Y490; P09769; Q05397; P42680; Q13418; Q14289; Q15139; P05106; P43405; Q14511; P12931; Q96RT1; P15498; Q96AC1; Q9BSQ5; P05556; P56945; P26010; P05107; P17301; Q9UKW4; P18084; Q15942; O43914; P30273; P13688; P22392; P16144; O43561; O14713; Q14185; P60953; P08567; P35579; Q13444"]
["GO:0070102","biological_process","interleukin-6-mediated signaling pathway ","Q06124; Q6PD62; O60674; P42224; P22681; P40763; P16591; P23458; P40189; Q13485; O14543"]
["GO:0061582","biological_process","intestinal epithelial cell migration ","Q06124"]
["GO:0050900","biological_process","leukocyte migration ","Q06124; P13612; P42336; P07948; P06239; P29353; P16284; P19174; P05106; Q03135; Q92835; P06241; Q12866; P07947; P12931; O00459; P27986; Q13464; Q02763; Q12904; P62993; P26038; P05556; P28906; Q14449; P16150; P16070; P05107; P32004; P21462; P42338; P30273; P13688; O60496; P18827; P21730; Q07343; Q07889; P34741; P31431; P29350; O75056; P35612; P08195; Q14451; P35579; Q9Y624; P78324"]
["GO:0035855","biological_process","megakaryocyte development ","Q06124; Q09472; P10721; P11831; Q96PM9; P48426; P17542; Q9Y6W5; P29350; Q15648; Q8IZP0; Q01543"]
["GO:0032528","biological_process","microvillus organization ","Q06124"]
["GO:0048609","biological_process","multicellular organismal reproductive process ","Q06124"]
["GO:0035264","biological_process","multicellular organism growth ","Q06124; P10276; P21802; P42345; P10275; Q7Z6E9; Q08499; Q504Y2; Q12962; Q99767; Q16559; Q9BSQ5; Q8WUF5; Q9H2X9; Q15468; P35611; Q03468; Q9H9A7; P23025; Q15633; Q02410; Q9BZK7; Q07889; Q9GZV5; Q07352; Q6Y7W6; Q96PX8; Q03014; P13631"]
["GO:0033629","biological_process","negative regulation of cell adhesion mediated by integrin ","Q06124; O43623; P15941; Q13370"]
["GO:0051463","biological_process","negative regulation of cortisol secretion ","Q06124"]
["GO:0060125","biological_process","negative regulation of growth hormone secretion ","Q06124; O60229"]
["GO:0046676","biological_process","negative regulation of insulin secretion ","Q06124; P35568; Q16836; P17858; Q14721; P36956; Q08209; P14416; P08913; Q9UBU3; Q14654; O60260"]
["GO:0048011","biological_process","neurotrophin TRK receptor signaling pathway ","Q06124; P04629; Q16620; Q96B36; Q8WU20; P12931; P04049; P08138; P23560; P62993; P56945; Q07889; Q99523; P42574"]
["GO:0035265","biological_process","organ growth ","Q06124; Q15796; P21802; Q13705; P10415; Q8N0W4"]
["GO:0035335","biological_process","peptidyl-tyrosine dephosphorylation ","Q06124; P18031; P10586; P17706; Q05209; P51452; Q12923; Q12913; P28562; O95278; Q16828; P29350; Q16690"]
["GO:0030168","biological_process","platelet activation ","Q06124; P42336; P07948; P06239; P24723; O15530; P27361; P17252; Q04759; Q06418; P16885; P05106; P30530; P49407; P05129; P28482; P05771; P43405; P06241; Q12866; P11831; P12931; Q02156; P04049; P27986; P15498; Q05655; O15162; Q14344; Q16760; Q13094; Q9Y210; P52735; Q13574; P49619; P48736; Q9UKW4; Q9HCX4; Q13507; P23743; Q14573; P30679; P42338; P30273; Q14643; Q14571; P21333; P08913; P29350; P25942; P32121; P63104; O00329; Q03113; P13224"]
["GO:0048008","biological_process","platelet-derived growth factor receptor signaling pathway ","Q06124; P09619; O60674; P11274; P16234; P16591; Q13905; P12931; P60484; Q9H3M7; O43566; P56945; O00443; Q12913; P46940"]
["GO:0030220","biological_process","platelet formation ","Q06124; Q06413; Q09472; P15976; P12814; P11831; Q96PM9; P55211; P17542; P29350; P42574; P35579; Q99828"]
["GO:0070374","biological_process","positive regulation of ERK1 and ERK2 cascade ","Q06124; P15056; P00533; P04629; P08575; P22455; Q15303; Q05513; P04035; P27361; P17252; P29353; P00519; P09619; P09429; P21802; P22607; P01112; P35916; Q14289; P35968; Q9BZL6; Q9Y2R2; P49407; P16234; P05412; P18615; Q13905; P07333; O43353; Q02750; P12931; P04049; P60484; P46109; P10398; Q02763; P02671; P36544; P28223; P16671; Q9GZV9; P78524; Q15046; P04899; Q9HBA0; P32248; P16070; P62834; Q8TDQ0; Q9Y4G8; P85298; P58400; P09038; P14416; P61296; P05067; P35232; P01375; Q13291; P21730; Q9NPH5; P46531; Q9ULZ3; O15519; P01730; O95267; P58753; P32121; O43597; O43613; P23945; Q969H0; Q5NUL3; Q99623; Q15109; Q99828; P35372"]
["GO:2001275","biological_process","positive regulation of glucose import in response to insulin stimulus ","Q06124; P31751; P35568; O00459; P27986; Q13153; Q86YS7; Q9BX66; Q96RI1; Q92569"]
["GO:0046887","biological_process","positive regulation of hormone secretion ","Q06124; P16220"]
["GO:0045931","biological_process","positive regulation of mitotic cell cycle ","Q06124; P54274; P17252; P00519; P06730; Q00987; P23443; P14635; Q16513; Q13541; Q00613; P51452; Q99801; P17542; Q9NYA1; P55317; O15392; P05067; P30305; P51587; P51692; Q99538"]
["GO:0051897","biological_process","positive regulation of protein kinase B signaling ","Q06124; P00533; P42336; Q13480; P06239; P22455; Q15303; P09619; P11362; P03372; P07949; P21802; Q8WU20; P04626; P22607; Q05397; Q13418; P30530; P21860; P16234; P10721; P06241; P42345; P35568; Q04912; P08238; P06213; P12931; O00459; P23771; P08581; P27986; P15498; Q02763; P07900; Q86UE4; P14317; P62993; Q9GZV9; Q13188; P05556; P15391; P32248; Q9Y6D6; Q9NQC3; Q9Y4H2; P48736; Q12913; Q99497; Q6R327; P58400; P42338; P17813; P09038; Q6PIZ9; Q9NQB0; P05067; P36897; P10747; P01375; P17861; Q02297; Q9BXM7; P07203; Q9NPH5; O14713; Q9H244; P13726; P32121; Q6ZUJ8; O00329; Q07021; O43597; P10599"]
["GO:0033628","biological_process","regulation of cell adhesion mediated by integrin ","Q06124; P07948; Q05397; P29317; P29322; P48736; O60711; P00749; O14713"]
["GO:0040014","biological_process","regulation of multicellular organism growth ","Q06124; P42336; P42229; P11802; P21802; P40763; O43464; P01236; P35462; P10912; P00441; P05067; P51692"]
["GO:0043254","biological_process","regulation of protein complex assembly ","Q06124; O95835; P51610; P14136; P07900; Q8NCD3; Q5VWQ8; P11142; Q9BXM7"]
["GO:0046825","biological_process","regulation of protein export from nucleus ","Q06124; Q15678; P40305; Q8N726; O14980; Q8TAS1"]
["GO:0060338","biological_process","regulation of type I interferon-mediated signaling pathway ","Q06124; P18031; P08238; Q16543; P48551; P29350"]
["GO:0031295","biological_process","T cell costimulation ","Q06124; P42336; P07948; P41279; P06239; P31749; O15530; Q13177; P41240; Q03135; P63000; O75914; P06241; P07947; P12931; P27986; P15498; Q13153; P07766; P62993; P09382; Q96BF3; Q15768; P98172; Q9BXL7; P10747; P06127; P29350; P60953; P16410"]
["GO:0006641","biological_process","triglyceride metabolic process ","Q06124; Q03135; P04040; P50416; P02649; P07203"]
["GO:0009887","biological_process","animal organ morphogenesis ","P15056; Q04206; Q09472; P21802; P01112; P07101; P43405; P46109; Q13642; Q16254; P52945; P23760; P26367; P17301; O75496; Q99626; P09038; O15119; Q9UBR4; Q04724; Q15329; Q01543; Q53GA4"]
["GO:0030154","biological_process","cell differentiation ","P15056; P41212; Q01538; P08922; Q96PN8; P42681; P31749; Q13557; P17948; P08631; O15146; O60674; Q15831; P09769; P78362; Q07912; Q01167; P42680; P85037; P29597; Q99459; Q9UQM7; P20794; P50548; Q9NYL2; P10244; P51451; P16591; P41240; Q12824; P04637; P06241; Q08050; P07947; P19419; Q12778; P04049; P10398; P23458; Q13555; P42685; Q13470; Q9C0C7; Q96TA1; Q13642; Q99502; Q504Y2; Q14344; P51114; Q15464; P32314; Q9UGV2; P62993; Q9GZV9; P08476; Q9UBC0; Q99504; Q6T4R5; P27540; P28324; Q99581; Q06546; O95238; Q9H0Z9; Q96EP5; O14727; Q7Z5H3; P58012; Q6SA08; Q5D1E8; Q9NVP2; P55316; Q01534; P46379; Q9NQI0; Q9H9S0; P49116; P52952; Q14990; Q9UHJ3; P41161; Q96A49; Q12946; Q13501; Q8N264; Q16181; Q99626; Q9BWF3; Q13285; Q99426; Q8IYM1; P11308; Q99958; Q03112; Q9UKY1; A8MYZ6; Q96SB3; Q16828; Q96HZ4; O60861; Q99967; O00409; Q99598; O00139; Q01892; P15036; Q9P0K7; Q13404; P62745; P15531; Q9UPN4; Q01954; Q9HBH7; P41162; Q9NP31; P41970; P48634; Q99607; O14713; P29350; P13693; Q7Z6Z7; O95267; Q03014; P20393; Q9UJV9; Q5JSZ5; P10243; Q03113; Q03060; Q9H0D2; Q9UN36; P25490; Q9UQQ2; Q6PUV4; Q96TC7; O95409; Q01543"]
["GO:0071277","biological_process","cellular response to calcium ion ","P15056; Q06413; Q13131; Q9H4A3; Q13557; P54646; O00418; O14497; P05412; Q02078; P01100; P30405; Q13563; P17535; Q08828; Q08495; P35611; Q9NQC3; P21579; Q14524; P58400; Q9H8V3; P80108; P17275; Q7LDG7; P23258; P84074; P53539; P46940; Q9H8S9; P35637; P61586; O94759; Q9GZU1; Q969Z0; Q8N2Q7; P21817; Q99623; Q99538; P11021"]
["GO:0090150","biological_process","establishment of protein localization to membrane ","P15056; P62491; P55957"]
["GO:0000165","biological_process","MAPK cascade ","P15056; P36888; P00533; Q13554; Q06413; P02686; Q12879; P22455; Q15303; Q13557; P27361; P21359; P01106; Q96RR4; Q9H2K8; P29353; P09619; Q12852; P49137; P11362; P07949; O60674; P36507; Q05586; P30086; P21802; Q8WU20; P04626; P22607; Q05397; P01112; Q13224; Q8IVT5; P18433; Q13418; Q14289; Q9UQM7; P21860; P16234; P10721; P28482; Q5S007; Q02078; P06241; Q99683; O43353; P35568; Q00613; Q02750; P53041; Q15121; P04049; P08581; P10398; P23458; P52333; Q13555; Q02763; P27448; P78352; Q99996; P62993; Q9GZV9; Q92913; P01116; P51681; Q92529; Q01082; P0DP23; Q99759; Q9Y4H2; Q5VWQ8; Q9Y4G8; P07196; Q9UJF2; Q6TCH7; Q96PV0; Q13813; Q9BYB0; P09038; P62258; P01589; P13591; P14784; Q16828; P01375; Q02297; O00255; Q96S59; Q07889; O43561; P32927; Q13972; Q8IV61; P20936; Q07352; O14827; O95267; P26651; P31946; P01111; Q16690; Q14957"]
["GO:0043066","biological_process","negative regulation of apoptotic process ","P15056; Q9BYP7; P00533; P04629; P51617; Q13131; Q9P1W9; Q04206; P31749; Q15303; Q9H4B4; Q05513; P54646; P37840; P04792; P08631; P06748; P15976; P01106; O00418; P29353; P19544; P09619; P02511; P10276; P06493; Q96ST3; P11309; Q9UJU2; Q13177; P22681; O14965; Q05397; P45983; P35916; P19838; Q14289; P23443; P40763; P34947; P25963; P78527; P53350; P35968; P51812; P31751; O95819; Q86V86; P84022; P04637; Q8IU85; P08069; P07333; P61978; O14920; O43353; P49841; Q12778; O43781; P12931; P23528; P04049; P35222; P60484; P27986; P04083; P10398; P41743; P48506; Q02763; P38936; P40189; P29376; Q15418; P19525; P30279; Q92769; O15033; P30405; Q96TA1; Q86UE4; P08138; Q96EB6; P29972; P52565; P20749; P62979; O95817; Q9C0K0; P38646; P04040; O60936; Q13423; Q9NYY3; Q9NS56; P10809; Q92858; Q15468; O95471; Q92908; Q9H1Y0; P14625; P46695; Q04760; P25445; P35462; P46527; P82094; Q86VP1; P16070; Q96RI1; Q02962; P0CG47; Q13547; P25189; P09211; Q99497; P04156; Q13257; P10415; O14543; P46379; Q9NZS9; P49959; P19634; O00257; P30044; P0DMV8; P10070; Q53EL6; O75925; P82970; Q8IYB8; P23759; Q9NYA1; P52952; P35548; Q9H422; Q9NQS1; Q6N069; P50553; O43541; Q13501; P28562; Q15058; O15392; Q07820; Q9Y4K3; P13051; P63146; P49768; O15151; P18583; O15379; P14784; O00571; Q92614; Q14432; Q14192; P49810; P98082; P10747; P17861; Q99967; P28715; Q07817; P21333; Q9BUL8; Q9NY61; P22392; Q9H4A6; O15119; Q86XL3; Q9UBU3; P08758; Q6P1J9; P98170; P37198; P16471; Q9UBR4; O94874; Q16531; P55957; P13693; P51692; P20936; O15519; Q9UQ80; Q9NRA0; P52926; Q99728; P62987; Q7Z6J0; P30048; Q16595; P05783; P40337; P63104; P42574; P13631; P10071; Q15648; P32119; P42575; Q9H093; P41134; Q96J02; P05549; O43597; Q15672; Q9H3D4; Q5NUL3; O43255; Q99623; O43504; P48436; P11021; Q99828; Q14457"]
["GO:0009968","biological_process","negative regulation of signal transduction ","P15056; P18031; Q13882; Q04771; P21860; Q92835; P04049; P10398; O15492; Q9NS28; O75916; P49795; P17936; O15539; P49802; O43665"]
["GO:0010628","biological_process","positive regulation of gene expression ","P15056; P49840; O75116; Q16620; Q06413; Q13131; P14921; P22455; P31749; Q16288; P27361; P01106; P06493; P45984; O15146; Q9UJU2; Q9NZJ5; Q15797; P78362; P15336; P38398; O75030; Q00987; Q9Y6Q9; P45983; P29323; P40763; Q9Y2R2; P21860; P10721; P28482; P51610; P84022; Q03135; P04637; O14964; Q15759; P17302; P42345; Q16539; P49841; P10275; Q02750; P29474; P60484; Q13464; Q13315; P15311; Q96IZ0; P16871; P41180; O15162; P01130; O95071; Q16649; Q15554; P16671; P07766; P26038; P08476; Q99801; Q8WZ42; O75626; P49675; Q99581; P01116; Q06546; O95786; Q99966; P28906; Q9HBA0; O15455; P35241; P23396; Q5D1E8; P26358; P26367; Q01094; Q16665; Q99497; Q14157; P02545; P52179; P0DMV8; P11473; P82970; P04198; P62913; P58400; P18848; A1X283; P42338; Q02363; Q16236; P48678; Q13285; P08047; P63267; P68133; P61296; P05067; Q92569; P35232; O00571; Q86UR5; P36897; O43474; Q9H4X1; P10747; P01375; P06396; Q99967; O14737; Q12955; Q9BUL8; Q9Y478; P15529; O00206; Q96AE4; Q96PU8; Q9Y6N7; P30040; Q14103; P46531; P54619; Q9H1R3; Q9UPQ9; P21728; Q15466; P52926; Q96H20; P43699; P32121; Q8N726; P30518; O00329; Q15648; P49711; Q9NRR4; P23769; Q9H3R0; P41134; P05549; Q06330; O43597; P18146; P31645; Q04724; Q9UKV8; Q15672; O60260; Q01851"]
["GO:0010828","biological_process","positive regulation of glucose transmembrane transport ","P15056; Q86YS7"]
["GO:0033138","biological_process","positive regulation of peptidyl-serine phosphorylation ","P15056; P00533; P42336; Q16620; P31749; Q16288; P37840; O95835; Q9UHD2; Q15139; Q9BZL6; P49407; Q03135; Q13043; O43353; P08238; P04049; Q04637; P10398; Q13153; P07900; Q14012; P35354; Q99996; P14317; P41143; P16070; Q99497; P10415; Q96N67; P58400; Q9UBN7; P05067; Q9NYB0; P01375; Q9BUL8; Q9BXM7; Q9C0C2; P23634; Q8N122; P32121; O15169; O43597; O95398; P10599"]
["GO:0070413","biological_process","trehalose metabolism in response to stress ","P15056"]
["GO:0060449","biological_process","bud elongation involved in lung branching ","P46937; P21802; O43597"]
["GO:0061026","biological_process","cardiac muscle tissue regeneration ","P46937; Q15303"]
["GO:0000902","biological_process","cell morphogenesis ","P46937; Q13043; Q16539; P16871; O75631; Q8WYL5; P35611; Q92974; P11473; Q9H8V3; Q01518; Q02297; Q15020; P41182; Q9NPH5; P48729; P40337; Q15648"]
["GO:0008283","biological_process","cell proliferation ","P46937; Q15118; O96013; P00533; P08922; P50750; P40238; Q13480; Q9P1W9; Q16584; P31749; Q15303; P50613; Q92918; O60934; O60566; P06493; P11309; Q9P212; P04626; Q96GD4; P49759; P01112; Q13418; P21127; Q9UM73; P40763; Q15139; Q9NYL2; P78527; P53350; Q14680; P16591; O14744; P04637; P63000; P07332; P43405; Q9P286; Q00535; P07333; P10275; P12931; P04049; P08581; P60484; P29376; Q9ULW0; Q13042; P46013; Q9NTI5; P09958; P56277; P04004; Q6PKG0; Q99661; Q5T2W1; P13010; O95071; Q15078; Q96PH1; Q8N3Y1; Q15819; Q9UKG1; O60832; P11488; Q96RU2; O75410; Q15398; P42566; Q9UBU8; Q8N3C0; Q16658; O43683; Q14160; P04899; Q99966; P14679; P01236; Q96EP5; Q01113; P28906; P56945; Q15468; Q14186; O75081; Q01534; P37275; Q12948; P42677; Q9Y4H2; P12004; Q13485; P17301; Q13118; P49959; Q6UVK1; Q13895; P56178; P10070; Q9Y6A5; Q53H47; Q15555; P30304; Q9H9S0; Q96T88; P08173; P30307; Q92888; P49321; P68036; Q00526; Q06830; P50747; Q15691; O15151; P01589; Q9NQB0; P11308; P35368; Q9BXP5; Q9UKY7; P98082; Q5ZPR3; Q99967; Q02297; Q07817; O43598; Q9H4A6; Q93034; Q9Y2T1; P49917; Q9NP31; P06127; Q16611; Q13972; Q12972; P30260; Q9NYV6; P20309; P29350; P51858; Q07352; Q9UQ80; Q9NRA0; Q07954; Q13261; Q16666; Q13309; P33993; P40818; P14316; Q03014; P12755; Q9UJV9; P36955; Q07666; Q9Y266; O95905; A0AVK6; Q05195; Q01955; O95398; P09758; P10599; Q9UMR3; Q12929"]
["GO:0006974","biological_process","cellular response to DNA damage stimulus ","P46937; Q8TDC3; O00141; P07948; P31749; Q9H4B4; P01106; Q9H2K8; P25054; P00519; O96017; O60285; P49137; Q15831; Q14653; P22681; P15336; P38398; P16104; Q12888; P28482; Q13469; P04637; Q13535; Q9Y6K9; Q12778; Q7L7X3; Q13315; Q92630; P38936; O14757; Q7Z6E9; Q15291; Q96EB6; Q9BXH1; P49005; P22314; P13010; O95071; Q96PM9; Q99638; P20749; P55211; Q96RU2; P54132; Q9Y3Z3; P78543; Q9NS56; O43542; Q9P1Z0; Q6KC79; Q14669; P43351; Q96GX5; P23396; O15350; Q9UL54; Q5D1E8; Q8IW19; Q9UBT6; P55072; Q9NZM5; P27694; P10415; P45973; Q9Y5T5; Q9UKW4; Q06787; P49959; P83916; Q5UIP0; P06746; Q9BQ15; Q9NZJ0; Q9UIG0; Q9BTA9; Q92985; Q06609; Q9Y4K3; Q5XUX0; Q00526; P63146; Q8N2Z9; P49768; Q8N163; Q14686; Q92878; Q14694; O75943; P41182; O00255; Q9NY61; Q9NS91; Q8N884; Q93034; P35638; Q8TD08; Q96FW1; P24385; P98170; Q86U44; Q86UE8; Q16531; Q9NS23; O60671; O00213; Q96AH0; P11388; Q99728; Q9ULC4; P09874; P33993; P42574; O00148; P16410; Q7Z2E3; Q14191; Q92547; O60885; Q9NZC9; Q13185; Q6PCD5; P25490; Q13794; Q969H0; Q9H3D4; Q9UKI8; Q6ZWJ1; Q99828"]
["GO:0071480","biological_process","cellular response to gamma radiation ","P46937; O96017; P02511; P01112; Q00987; Q9NYL2; P16104; P04637; Q13535; Q00613; P19419; Q13315; P38936; P13010; P13498; P12956; O60341; Q07817; Q9NPH5; Q86UE8; Q14191; P18146; P11021"]
["GO:0071300","biological_process","cellular response to retinoic acid ","P46937; P07948; Q16288; Q13882; P10276; P07949; P10242; P21802; P37231; Q14289; P16220; P08621; Q6IBS0; P07947; P42684; P29320; Q13315; P29376; Q92769; P29972; O43464; P15173; Q02962; Q13573; O43474; O95477; Q9P0J0; P13631; P36955; P31645; Q99623; P48436"]
["GO:0060242","biological_process","contact inhibition ","P46937; Q12913"]
["GO:0003143","biological_process","embryonic heart tube morphogenesis ","P46937; Q04771; Q14469; Q92736; Q9UMR3"]
["GO:0003015","biological_process","heart process ","P46937; P06241; Q9NPH5; Q9GZV5"]
["GO:0035329","biological_process","hippo signaling ","P46937; O95835; Q13043; Q9NRM7; Q13188; Q9H4B6; O14641; P62258; Q9Y2J4; O43164; Q15561; Q07157; Q9H8S9; Q7L9L4; P28347; Q9GZV5; Q4VCS5; P42574; Q9UDY2; Q8IX03; P31946"]
["GO:0030216","biological_process","keratinocyte differentiation ","P46937; O95835; P29317; Q13043; Q02750; P04083; Q9NRM7; Q9H3M7; P26367; Q9H4B6; P46531; P42574; Q15648; Q06330; Q9H3D4; P15924"]
["GO:0048368","biological_process","lateral mesoderm development ","P46937; P36894"]
["GO:0060487","biological_process","lung epithelial cell differentiation ","P46937; Q9H4B6; P55317; P50553; P48436"]
["GO:0030857","biological_process","negative regulation of epithelial cell differentiation ","P46937; Q03135; O15119; P24385; P48436"]
["GO:2001237","biological_process","negative regulation of extrinsic apoptotic signaling pathway ","P46937; Q04206; Q04771; P23443; Q13546; Q9P286; P42858; P10275; P12931; P48506; O60936; P61289; P09211; Q99497; Q8N2H9; P02545; P48678; P17931; Q9NQB0; P36897; O15519; Q14247; Q7Z6J0; O43255"]
["GO:2000737","biological_process","negative regulation of stem cell differentiation ","P46937; Q9NYV4; Q14004; P40763; Q14469; P46531; Q00839"]
["GO:0030903","biological_process","notochord development ","P46937; Q02535; Q15468; P48436"]
["GO:0048339","biological_process","paraxial mesoderm development ","P46937; P11362; Q8WUM0"]
["GO:0090263","biological_process","positive regulation of canonical Wnt signaling pathway ","P46937; P00533; Q9H4A3; Q01974; Q9Y3S1; P21802; P48730; P19838; Q13418; Q5S007; P84022; Q03135; O43293; P12931; P35813; O95271; O95071; Q38SD2; Q70CQ2; O00327; P55072; P56178; P14923; P63146; Q8TD43; O00571; Q8N163; Q9NYF0; Q9BZK7; Q9Y2T1; P98170; Q92837; P40818; O15169; Q13526; Q01860; Q9Y265"]
["GO:0060045","biological_process","positive regulation of cardiac muscle cell proliferation ","P46937; Q06413; Q15303; P06493; P11362; P11309; P21802; P14635; Q16539; P08151; Q03167; Q92908; P09038; Q02297; P46531; P36894; Q06330; Q9UMR3"]
["GO:0033148","biological_process","positive regulation of intracellular estrogen receptor signaling pathway ","P46937; P10275; Q13153; Q9BTK6; P55317; Q969T9; P09874; Q13309; Q15648; O14686"]
["GO:1902459","biological_process","positive regulation of stem cell population maintenance ","P46937; Q9Y6Q9; Q6U7Q0"]
["GO:0045944","biological_process","positive regulation of transcription by RNA polymerase II ","P46937; Q13164; P00533; O94916; P50750; Q13422; P11474; Q06413; P42681; Q13873; Q04206; P14921; P31749; O75676; P50613; Q13163; P35269; Q09472; Q9UHD2; P06748; P27361; P06400; P15976; Q12968; P01106; Q9H2X6; Q6PD62; O75475; O00267; Q15796; P10276; Q96ST3; P09429; P03372; P42224; Q9UJU2; Q9NYV4; Q14653; Q05586; Q15797; P49715; P10242; P21802; P15336; Q04771; P37231; P29590; P38398; Q14004; O75030; Q9Y2W1; P01112; Q9Y6Q9; Q01167; P19793; Q14765; Q01196; P19838; P42226; Q99459; Q00653; P29475; Q53ET0; P40763; P15172; P25963; P17096; Q15139; Q9UQL6; Q01201; P78527; Q13546; Q14934; Q9BZL6; P10244; P49336; O75582; P41235; Q12888; P49407; P16220; P05412; P18615; P51812; Q02078; Q12824; P84022; P17947; P07737; P04637; O14974; Q08050; P35398; P11831; P61978; Q16539; O14920; O43353; P07947; Q00613; P10275; Q9Y6K9; P19419; Q12778; Q14814; O15111; O00459; P14859; P04049; P35222; P23771; P08581; P22736; P27986; P01100; Q13315; O43524; P04150; P43694; Q14012; Q15418; P56524; O75469; P06401; Q92769; Q13887; P08151; Q14469; Q7Z434; O15162; Q13158; Q99502; Q96EB6; O95271; Q14693; Q16254; Q9Y6H1; Q04864; O96006; Q9Y4C1; Q86WV1; Q14684; Q7Z5J4; Q8N1B3; P20749; Q9UBK2; O15516; P09629; P14317; P62979; O95251; P19622; P19447; Q9C0K0; P08476; Q9UBC0; Q13563; Q8TDD2; P27540; Q99801; P28324; Q9Y261; Q92598; P17535; Q8IZQ8; P15173; O60315; O60244; P48552; P17980; P51532; Q06546; Q15545; P52945; O95238; P20823; O95786; P16333; P19438; Q9Y613; P15923; Q15651; Q6KC79; Q92974; Q92908; P19532; Q14186; O15455; P17676; P78317; O00327; P19484; P35462; P23760; O15014; Q86X55; O15350; P12956; Q5D1E8; Q96RI1; Q02962; P17542; P37275; P0CG47; Q12948; P62633; Q13568; Q96P20; Q5VWQ8; Q9BTK6; P28069; O43918; P26367; Q9P2D1; Q15424; Q99697; P10828; Q13547; Q01094; Q16665; P36956; P56545; Q99497; Q13573; Q13485; Q96PK6; Q9Y5T5; P55055; P10827; Q13118; P19634; P19338; P10070; Q9BZS1; P11473; Q08209; Q6UUV7; Q92886; Q9H9S0; P23759; Q92793; P50461; P28749; P04198; Q9HB09; Q96T88; O00716; P49116; P52952; P08237; O00482; Q99814; O60341; Q02447; P15884; P18848; P55317; Q99592; Q92985; P41161; Q969V6; P50553; Q12946; P18850; P51946; Q13501; O15105; Q9ULV5; Q16236; Q9Y4K3; Q15853; Q13285; P17813; P08047; Q12772; P28698; Q9NP62; P09038; P14416; O75581; P61296; Q9NQB0; O15379; P05067; Q53H80; P11308; P43354; Q07869; Q13133; Q99958; O00571; Q9HB65; P17275; P21453; Q9NZI5; Q14686; O75928; O43474; Q86WV6; O96004; P33076; P47928; Q9H4X1; Q9Y483; P10747; P01375; Q6NUN9; P17861; Q15561; Q99967; Q02297; Q6UUV9; Q8IZL8; P31269; Q9NP71; Q06265; P18846; O00255; Q9Y5B6; Q9NY61; P40425; P22392; Q01892; P50549; P15036; Q9HC62; O00206; Q05086; P98177; Q15788; Q9BWW4; P10914; Q9BZK7; P54845; P35638; Q9HBH7; Q9UH92; P46531; P41970; Q92841; P22004; Q9H0E9; O15534; Q6P1J9; Q99607; P37023; P22415; Q9H165; Q969T9; O14713; Q16633; P23246; Q9UBR4; Q9Y230; P28347; Q15306; P67809; Q9BWG4; P29374; O00213; O15266; Q8N0Z6; O95644; Q92993; Q15596; Q15365; P51692; Q13950; P98161; Q9GZV5; P48431; P52926; P50221; P11388; Q02556; Q8WVC0; P35869; P62987; P25942; Q16666; O60563; P43699; P09874; P07550; P14316; Q8N726; O14813; Q9NZC7; Q8WWK9; Q03164; Q03014; P13631; P10071; P12755; Q8WWI1; Q15648; P36894; Q9UJV9; Q9UM54; P38159; P23769; Q00839; Q13526; P10243; Q8IXJ6; O95905; A0AVK6; Q9NQG5; O14686; O60885; Q03060; P05549; Q92731; Q06330; P18146; P36896; Q14994; Q01860; P15408; P17081; P25490; P49640; Q96AV8; Q9Y2N7; Q9UKV8; Q15672; Q9H3D4; O94776; Q9UQR1; P48436; O15294; O60260; P31260; P23409; Q15329; Q13562; Q01851; Q96S94"]
["GO:0050847","biological_process","progesterone receptor signaling pathway ","P46937; P12931; P06401; O95071; P35232; Q05086; Q969T9; P46934"]
["GO:0065003","biological_process","protein-containing complex assembly ","P46937; P27361; P25054; P06493; P29590; O75030; Q00987; Q14289; P17096; P14635; P42768; P04637; P78352; P02671; Q14469; P11166; P09327; O00401; O14745; Q9UBK2; P09693; Q92558; P07766; Q15836; Q8TEW0; Q16625; Q12933; Q08495; O00505; O15360; Q15599; P25445; P11047; O75563; Q8TDM6; Q92793; P63027; P11171; O43516; Q8NFH8; O15151; P14784; Q86UR5; O60711; O15273; P61244; Q9BWW4; Q02410; Q96S59; O43264; Q13077; P28347; P30153; P52907; Q13155; Q9BYG3; P25942; P35612; Q7L5Y6; Q03164; Q9Y566; Q15334; Q9UQR1; P07814; P48436"]
["GO:1902036","biological_process","regulation of hematopoietic stem cell differentiation ","P46937; P15976; P00519; P10242; Q01196; P23771; P19525; P15923; O15350; P17542; Q86U44; Q03164; P23769; Q96J02"]
["GO:0010837","biological_process","regulation of keratinocyte proliferation ","P46937; Q15139; Q9C0K0; Q13247; Q07352; P26651"]
["GO:0072307","biological_process","regulation of metanephric nephron tubule epithelial cell differentiation ","P46937; Q02962; Q9GZV5"]
["GO:0050767","biological_process","regulation of neurogenesis ","P46937; P29475; P35222; O15055; O00327; Q9P2D1; Q96N67; Q01851"]
["GO:0072091","biological_process","regulation of stem cell proliferation ","P46937; P35240; Q07352"]
["GO:0032570","biological_process","response to progesterone ","P46937; P15407; Q04206; Q03135; Q92934; P01100; Q9H3M7; P04818; P36956; P18505; Q13133; O14493; P53539; Q05086; Q969T9; Q15596"]
["GO:0035019","biological_process","somatic stem cell population maintenance ","P46937; Q15796; P40763; P10721; P17947; P04049; P21709; Q14469; Q15906; Q13485; Q13118; Q9H9S0; Q9ULK5; Q99626; P09038; O43474; P49917; P48431; P12755; P23769; Q06330; Q01860; P48436"]
["GO:0001894","biological_process","tissue homeostasis ","P46937; P06400; Q15831; Q13085; P28906; Q8WY41; Q13049; Q9GZV5; Q99728; P48436"]
["GO:0006367","biological_process","transcription initiation from RNA polymerase II promoter ","P46937; P50750; P11474; P11802; P50613; P78347; P35269; P10276; P03372; P37231; Q9Y2W1; P19793; P49336; P41235; P35398; P10275; Q13263; P22736; P04150; P38936; O75469; P06401; Q12962; P52655; Q9UBK2; P19447; P62508; O60244; P10588; Q15545; Q5VWG9; P29083; P13056; Q96RI1; P24928; P56270; Q07812; O15297; P10828; Q13573; P61218; P55055; P10827; P11473; Q92793; O00716; P49116; O00482; P15884; P51946; P48443; Q13285; P43354; Q07869; Q13133; P08235; Q15561; Q9UHY1; P46531; P24385; Q15466; P28347; Q13950; Q9GZV5; P51449; P13631; Q15648; P20393; Q00403; Q92731; Q06330; Q14994; P48436"]
["GO:0001570","biological_process","vasculogenesis ","P46937; Q16620; P19544; Q05397; P29317; P35968; Q03135; P19429; Q9BSQ5; Q8WUI4; Q8IZQ8; Q99966; Q99697; P52952; Q92819; Q12946; P17813; P37173; P17275; Q8N302; Q96PU8; P35590; P20936; Q07352; Q4VCS5; Q03014; P36383"]
["GO:0045141","biological_process","meiotic telomere clustering ","P54274; P40692; P63146"]
["GO:0007094","biological_process","mitotic spindle assembly checkpoint ","P54274; P25054; O60566; P53350; Q13315; P33981; O43683; Q13257; P12270; O15392; Q8IWB6; Q9Y6D9; Q12834; O43264; O43684"]
["GO:0008156","biological_process","negative regulation of DNA replication ","P54274; Q13535; Q29RF7; Q99741; Q7Z5K2; O75496; O75943; Q9H2G4; P31949"]
["GO:1904914","biological_process","negative regulation of establishment of protein-containing complex localization to telomere ","P54274"]
["GO:1904850","biological_process","negative regulation of establishment of protein localization to telomere ","P54274"]
["GO:1904911","biological_process","negative regulation of establishment of RNA localization to telomere ","P54274"]
["GO:1905778","biological_process","negative regulation of exonuclease activity ","P54274; Q15554"]
["GO:0051974","biological_process","negative regulation of telomerase activity ","P54274; P37231; P29590; P04637; P12931; Q96BK5; O00255; Q96EZ8"]
["GO:0032214","biological_process","negative regulation of telomere maintenance via semi-conservative replication ","P54274; Q15554"]
["GO:0032211","biological_process","negative regulation of telomere maintenance via telomerase ","P54274; P29590; P12931; P07910; Q15554; P09651; Q96BK5; Q9BSI4; Q96AP0; Q00839"]
["GO:1904357","biological_process","negative regulation of telomere maintenance via telomere lengthening ","P54274; O95271; Q15554; Q8IY92; Q96BK5; P09874; Q96EZ8"]
["GO:1905839","biological_process","negative regulation of telomeric D-loop disassembly ","P54274; Q15554"]
["GO:0043065","biological_process","positive regulation of apoptotic process ","P54274; P15407; Q15349; Q12879; Q16584; P31749; Q15303; P11802; Q16288; P37840; O95835; P62753; P21359; P25054; P00519; Q9NYF8; P19544; P09619; P09429; P45984; P21980; Q05586; P45983; P80192; Q9NYL2; P78527; Q13546; P16220; Q14680; P05412; Q92835; P04637; Q8IU85; Q13043; Q02779; Q99683; P42858; O43353; P52564; Q12778; O43293; Q92934; P12931; P35222; Q13315; O43524; P15498; P35354; Q9NRM7; Q9H7L9; Q96IZ0; Q13158; P08138; Q96EB6; O43521; Q14344; Q8ND90; Q9UKV3; Q12791; Q8N5V2; Q9H3M7; Q14684; P55211; P62979; P19447; O43464; Q02535; P21554; Q13188; Q8TCU6; Q9UHI6; P00338; P52735; O75962; Q13144; O95238; Q14160; P10809; P05556; O14727; P50570; P58012; Q92974; O15455; P25445; Q9NPP4; P0CG47; P48023; Q13568; Q5VWQ8; Q07812; Q96LC9; Q96DR7; Q14155; Q01094; Q12802; Q8IVF5; O43236; Q969S3; Q8WYH8; O60229; Q9UKW4; P19634; P50749; Q9NR28; Q96PE2; Q9H4B6; Q9UL40; Q15052; Q9H7P9; P18848; P55317; P17936; Q92888; P18850; Q13501; O95999; P28562; P11717; Q9Y4K3; Q9UHH9; P00441; Q9H8V3; P49768; Q16342; P05067; P80108; P63244; O00571; Q8N163; Q15327; Q16828; P01375; O14737; O00429; P41182; O95185; O94827; Q13009; P17405; P24522; Q15788; P62745; Q9NPH5; Q13352; P09601; Q15287; Q8NER1; Q16611; Q07889; Q9UNN5; Q9ULZ3; O00213; Q05639; P55957; Q05516; P52926; O14827; P11388; Q99728; P62987; Q8N726; P13631; Q9NR80; P42575; P16410; Q07021; Q8IUQ4; Q13794; Q7Z628; Q13562; Q01851"]
["GO:0031116","biological_process","positive regulation of microtubule polymerization ","P54274; P10636; P63000; P07332; P08581; Q13153; Q99996; Q15078; P46527; P23396; P30622; Q15691; Q14203; Q96SN8; Q14980; Q9P270"]
["GO:0045840","biological_process","positive regulation of mitotic nuclear division ","P54274; P09619; O14965; P06213; P35462; Q9NRF2; Q9BXS6; Q9H4X1; P10747; P37198"]
["GO:1904792","biological_process","positive regulation of shelterin complex assembly ","P54274"]
["GO:0051260","biological_process","protein homooligomerization ","P54274; P10636; Q14164; P25054; P02511; P21980; Q9NZJ5; Q13546; Q12888; Q03135; Q00613; Q9NZV8; Q96CX2; Q12962; Q16760; Q15717; Q9GZY8; P09693; P07766; O15245; P54132; Q14195; Q9H4L7; P48165; O14727; P43351; Q9UII2; Q9NPP4; Q07812; Q14721; P22459; P55072; P50416; P21579; P26678; Q13829; P40259; P04156; O15551; O43236; O95202; P08133; P22001; Q14573; Q9UBL9; O95999; O60271; Q06609; P30273; O75955; Q9H8V3; P43005; P05067; P16389; P29966; Q9P219; Q96BF6; P22460; P09601; Q09470; Q9Y572; Q9UK17; P55957; Q03721; P38159; P24752; Q8N2Q7; P19021; Q9NR22; P31645; Q676U5; Q8TCS8; Q7LC44; Q99873"]
["GO:0042493","biological_process","response to drug ","P54274; P50750; P07948; P06239; O00763; P11802; Q01581; P01106; P07949; P49407; P05412; Q13469; Q13535; P52564; O15111; P33121; P35222; P38936; P43694; P28827; P56524; Q16836; P28223; P08183; P29972; P13010; Q16790; P08476; P17535; P09382; P04844; Q92997; Q9H2X9; Q92908; Q9H1Y0; P35462; P46527; O15350; O60706; P50416; P10415; P17301; Q9UKW4; P11387; P78536; Q9UNQ0; P33527; P17813; P37173; P00441; P63146; P14416; P17275; Q14432; Q16828; P17812; O75553; O95477; P05023; P24385; Q9Y5P2; P21728; P22674; Q99259; Q15583; P18887; P33993; O14980; Q9UM54; Q03113; P19021; O14649; Q14654; Q92698; Q13562"]
["GO:0090656","biological_process","t-circle formation ","P54274; O60934; P54132; O43542; Q8IY92; Q14191; Q9NZC9"]
["GO:0016233","biological_process","telomere capping ","P54274; P78527; Q15554; Q9NYB0; Q9BSI4; P62805; Q9H816; Q96AP0"]
["GO:0000723","biological_process","telomere maintenance ","P54274; O60934; P24864; Q13315; O14746; P49005; Q9UKT5; P13010; Q15554; Q15054; P12956; P12004; P27694; Q15185; Q5UIP0; P15927; Q9NYB0; Q92878; Q9H816; Q9HCU8; P09874; P27695; Q96AP0; Q14191; P23497"]
["GO:0007004","biological_process","telomere maintenance via telomerase ","P54274; P08238; P07900; O14746; P35251; O60832; Q15185; P49959; Q96BK5; Q9NYB0; Q92878; Q9C0C2; Q9BUR4"]
["GO:0061820","biological_process","telomeric D-loop disassembly ","P54274; Q15554; P54132; Q8IY92; Q14191"]
["GO:0031627","biological_process","telomeric loop formation ","P54274; Q15554; Q9H816"]
["GO:0070509","biological_process","calcium ion import ","P35557; Q00535; P41180; Q96D31; Q9HBA0; P32418; Q01668; O43497; O95180; Q08289"]
["GO:0061621","biological_process","canonical glycolysis ","P35557; P14618; Q01813; P09104; P06733; P00558; P04075; P52789; P17858; P60174; P05062; P18669; P08237; P19367; P04406; P30613; P06744"]
["GO:0001678","biological_process","cellular glucose homeostasis ","P35557; Q12778; O00459; P27986; Q96EB6; P52789; Q9UBK2; Q9H1E3; P19367"]
["GO:0032869","biological_process","cellular response to insulin stimulus ","P35557; P49840; P31749; P11802; O15530; Q05513; P14618; O00418; P42224; Q06203; P37231; P23443; Q9UQL6; P78527; P16591; P31751; P35568; Q12778; P06213; P12931; O00459; P60484; P27986; P41743; P48506; Q13153; Q14693; P14672; Q86YS7; Q9BX66; P49675; Q13370; Q13243; Q9Y4H2; Q9BZB8; P56192; P09211; P19634; Q9Y4I1; P63027; Q96A49; P07741; P08047; P61981; P13688; P80108; P17861; P22415; O60343; O15519; Q07352; P09874; Q5VZ89; P30613; P17081; Q9UKV0; P07814; Q9UJM3; P22413"]
["GO:0044320","biological_process","cellular response to leptin stimulus ","P35557; P40763; P60484; Q9GZV9; P20248"]
["GO:0051594","biological_process","detection of glucose ","P35557; P52945"]
["GO:0051156","biological_process","glucose -phosphate metabolic process ","P35557; P11413"]
["GO:0006096","biological_process","glycolytic process ","P35557; O60825; P09104; P00558; P04075; P52789; P00338; P17858; P60174; P36871; P05062; P18669; P08237; P19367; Q9UGI9; P30613; P16118"]
["GO:0006739","biological_process","NADP metabolic process ","P35557; P11413; Q8NCW5"]
["GO:0045721","biological_process","negative regulation of gluconeogenesis ","P35557; P57059; P48357; P49760"]
["GO:0045725","biological_process","positive regulation of glycogen biosynthetic process ","P35557; P31749; P31751; P35568; P06213; Q92630; Q9BX66; Q9Y4H2"]
["GO:0032024","biological_process","positive regulation of insulin secretion ","P35557; O60825; O60674; Q13148; P51451; P17302; Q92934; Q02156; P41180; Q8NE86; Q9Y4H2; Q9NTG7; P08237; Q9NQB0; Q9UBU3; Q15466; P00367"]
["GO:0006110","biological_process","regulation of glycolytic process ","P35557; P18669; P56537; P54619; O95905; O15294"]
["GO:0050796","biological_process","regulation of insulin secretion ","P35557; P17252; P35228; P41235; P11166; O15516; O15055; P21554; P11168; Q16623; O00327; P62834; P43220; Q14721; P50416; O43581; Q14573; Q13936; Q14643; Q01668; Q14571; P12235; P01375; O43768; P22460; P08913; P60880; Q6J4K2; Q14654; O95398; Q13562"]
["GO:0043266","biological_process","regulation of potassium ion transport ","P35557; P14416; P22460; Q12955"]
["GO:0007155","biological_process","cell adhesion ","O14936; Q15262; P54760; P51813; P08631; P17252; P25054; O60285; Q06418; P29317; P35221; P10586; Q9BZL6; P05106; O15357; Q16513; P16591; P63000; Q08345; Q16832; Q14511; P42684; P29320; P52799; Q02156; Q96RT1; P35222; P51817; P54764; P49023; Q14469; P04004; Q12904; P35580; P16671; Q99062; Q96LC7; Q9UEE9; P32942; Q14254; O14522; P56945; P29322; P26010; O60504; P55196; P19022; Q15762; P18206; P11047; O00592; P05107; P98172; Q93052; P17301; P20138; O43312; Q13895; Q15124; Q9UQB3; P32004; P78536; Q92797; P21815; O60716; P17813; P13688; P13591; O60500; P05067; P21453; O43294; P61587; Q8N302; O60711; Q9NY61; P22392; Q13291; O43184; P16144; Q02410; P62745; Q9Y6N7; Q13352; Q13017; P21854; Q9Y5H0; P01730; P50895; P43121; P13224; Q9Y624; Q14896; P78324; Q01955; Q00872; Q99689; P16615; Q99828"]
["GO:0001953","biological_process","negative regulation of cell-matrix adhesion ","O14936; P35240; P21359; O95819; P27986; P42771; P41182; P20936; Q13444"]
["GO:0090288","biological_process","negative regulation of cellular response to growth factor stimulus ","O14936"]
["GO:0010839","biological_process","negative regulation of keratinocyte proliferation ","O14936; Q15262; O43623; P11473; P31947; Q15648"]
["GO:0061045","biological_process","negative regulation of wound healing ","O14936; P04035; P84022; P17302; P46108; P09038"]
["GO:0007269","biological_process","neurotransmitter secretion ","O14936; Q8TDC3; O14994; Q00975; O14640; Q9P2S2; P21579; Q9ULB1; Q92777; P28329; O95295; Q02410; P17600; Q05940; Q16572"]
["GO:0003214","biological_process","cardiac left ventricle morphogenesis ","P49840; Q12946; P37173; P46531; Q06330"]
["GO:0036016","biological_process","cellular response to interleukin- ","P49840; P49841; P32927"]
["GO:0007212","biological_process","dopamine receptor signaling pathway ","P49840; P49841; O75916; O43306; P32121"]
["GO:0060079","biological_process","excitatory postsynaptic potential ","P49840; Q06413; Q12879; P31749; P37840; Q05586; Q5S007; Q00535; P49841; Q99808; Q9ULJ8; O43424; Q08209; P14416; Q9UBU3; Q16478; P51608; P32121; Q14957; P35372"]
["GO:0097191","biological_process","extrinsic apoptotic signaling pathway ","P49840; O15530; Q86Z02; O60674; P29590; Q13546; P84022; P49841; Q92934; Q13158; P08476; O15304; O15455; P25445; P48023; P05787; Q07812; Q9H4P4; Q14790; P01375; Q9P0J0; P20333; P05783; Q9NZC7; P36896; Q99828"]
["GO:0097192","biological_process","extrinsic apoptotic signaling pathway in absence of ligand ","P49840; Q9HBH9; P21860; P49841; Q92934; O43524; O00167; Q13158; O43521; P55211; Q9UKG1; O95817; Q07812; P10415; Q07820; Q07817; Q16611; P42574; P42575; P43146"]
["GO:0005977","biological_process","glycogen metabolic process ","P49840; P62140; P62136; P49841; P40189; Q9UQK1; P46020; Q16821; P41236; O95278; Q93100; P36873; P06737; Q14749; Q13522; P11217; Q16816"]
["GO:0008286","biological_process","insulin receptor signaling pathway ","P49840; Q13480; P51636; P31749; P18031; P29353; P25054; Q15119; P18433; Q16654; P31751; P17706; P08069; Q13541; P35568; Q12778; P06213; O00459; P27986; O14512; P38606; Q9UKG1; P62993; Q9BX66; P56945; Q13542; O00443; Q9Y4H2; Q9GZM8; P36956; O14654; O14492; Q9UQB8; Q92569; P80108; Q99958; Q13322; P98177; Q07889; P08833; Q9UHR4; P17081; Q6ZWJ1"]
["GO:0036498","biological_process","IRE1-mediated unfolded protein response ","P49840; P18031; P29353; Q9Y490; P35611; Q9P0U4; P43307; P02545; O75460; Q14203; O14773; P17861; Q9H2G4; Q06210; P51858; Q15084; P11021"]
["GO:0090090","biological_process","negative regulation of canonical Wnt signaling pathway ","P49840; Q01974; O95835; P25054; Q15831; Q03135; Q13905; Q13043; Q16539; P49841; Q12778; O43524; Q9NRM7; P08151; O14745; O14640; O43623; Q13188; Q9UGP4; Q92997; P19022; Q5VWQ8; Q13547; Q9NQC7; P02649; P52952; O60716; O14641; O75581; Q9NQB0; P05067; Q6IE81; P98082; Q9NYF0; Q13283; P35638; Q9Y2T1; P46531; O75096; P08833; Q9Y283; Q9Y230; P50402; Q9GZV5; P48431; Q99471; P48729; O15169; P10071; P18146; O43255; P48436; O60260"]
["GO:0061052","biological_process","negative regulation of cell growth involved in cardiac muscle cell development ","P49840; P11413; Q13153; P41220; P49798; Q9Y5B0"]
["GO:0046325","biological_process","negative regulation of glucose import ","P49840; Q15121; P01375; Q13322; Q8N6T7; P22413"]
["GO:2000466","biological_process","negative regulation of glycogen (starch) synthase activity ","P49840; P49841"]
["GO:0045719","biological_process","negative regulation of glycogen biosynthetic process ","P49840; P49841; Q13322; Q96RG2; P22413"]
["GO:1904227","biological_process","negative regulation of glycogen synthase activity, transferring glucose--phosphate ","P49840"]
["GO:0046627","biological_process","negative regulation of insulin receptor signaling pathway ","P49840; Q04206; P18031; Q05513; Q04759; P23443; P17706; P05771; P35568; Q05655; P02765; P16333; Q14449; O14543; P49815; Q13322; P23469; Q92574; P22413"]
["GO:0032007","biological_process","negative regulation of TR signaling ","P49840; Q13131; P54646; Q96B36; Q8IW41; Q9P0N9; Q9P0V3; Q96EB6; Q8TCU6; O00327; Q8TB45; Q16665; P49815; Q70Z35; Q92574; P05813"]
["GO:2000077","biological_process","negative regulation of type B pancreatic cell development ","P49840; P49841"]
["GO:0010905","biological_process","negative regulation of UDP-glucose catabolic process ","P49840"]
["GO:0007399","biological_process","nervous system development ","P49840; Q01538; Q06413; Q15303; Q13557; Q09472; Q9H2K8; Q15831; Q13627; O43251; P29323; P40763; Q9UQM7; P53667; Q96L34; Q12824; Q14814; Q7L7X3; O15075; P01100; Q13555; P56524; P78352; Q9UBB4; Q14469; P48167; P60891; Q14738; Q99767; P23560; Q9NR56; P60983; Q15700; P08476; Q92913; O60315; P51532; O14727; O75916; P23760; Q9UL54; Q15768; Q5D1E8; Q8TAQ2; Q9NZ72; O95861; Q14155; O60229; P56178; P39086; Q9Y5Q3; P08172; Q92886; P32004; O43526; P49116; P54252; O14492; O95278; Q92784; Q12959; Q14203; P09038; Q9UNA1; O14773; Q99426; Q14194; O43602; Q96SB3; Q8TDN4; Q96HZ4; O60861; Q02297; Q9UQD0; O00139; P17405; Q92915; Q02410; Q9Y6N7; P15531; Q9HBH7; Q92686; P19404; P16473; Q9Y5H0; P20265; P20309; P08034; Q9Y6R0; P31040; Q8IUQ4; Q8N2Q7; Q6PUV4; Q99689; Q66K74; Q16555; O95390"]
["GO:0018107","biological_process","peptidyl-threonine phosphorylation ","P49840; O75116; Q8IWU2; Q13554; Q9H4A3; Q8N5S9; P31749; O15530; Q13557; Q9UHD2; P17252; Q9H2X6; Q96RR4; O96017; Q12852; P06493; Q15831; Q04771; P49759; Q13627; P27708; P45983; P25098; Q9UQM7; Q7KZI7; Q15139; Q9BZL6; Q9UBE8; O95747; P28482; Q5S007; O75385; Q8IU85; Q00535; P42345; Q02779; P49841; Q02750; O43293; Q8NCB2; O15075; P68400; P33981; Q13555; Q15131; O14757; Q14012; Q05655; O95271; Q15078; Q9UEW8; Q6P2M8; Q52WX2; Q9UIK4; P10415; P67870; Q9H422; P37173; P36897; Q9H1R3; Q96NX5; Q16816; P36896"]
["GO:0071879","biological_process","positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway ","P49840"]
["GO:0106071","biological_process","positive regulation of adenylate cyclase-activating -protein coupled receptor signaling pathway ","P49840; P17252"]
["GO:1902004","biological_process","positive regulation of amyloid-beta formation ","P49840; O75116; P54764; P36544; P02649; P05067"]
["GO:2000467","biological_process","positive regulation of glycogen (starch) synthase activity ","P49840"]
["GO:0045823","biological_process","positive regulation of heart contraction ","P49840; P23327; P52952; P05023"]
["GO:1901030","biological_process","positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway ","P49840; P49841; O15304; Q9UII2; Q07812; Q16611; P55957"]
["GO:0032436","biological_process","positive regulation of proteasomal ubiquitin-dependent protein catabolic process ","P49840; P31749; P49674; O14965; P49715; P48730; Q00987; P53350; Q5S007; P49841; P48506; O95376; Q14145; O14640; Q15819; P25686; Q9NYY3; O75081; P55072; Q9NZM5; P0DMV8; O75925; O15105; Q8NHY2; P49768; Q96E09; Q92519; P63165; P63244; P98082; Q9UNE7; Q96EP1; P48729; Q7L5Y6; Q96PM5; Q8IXJ6; Q8WVD3; Q9UBS8; O60260"]
["GO:0045732","biological_process","positive regulation of protein catabolic process ","P49840; P25054; P17302; P49841; Q12778; P68400; Q96PU5; Q9Y4P1; Q9NYY3; Q8NF37; P46527; Q5VWQ8; P55072; Q9H4P4; Q92673; O95190; Q9NZJ0; Q96KS0; P46459; Q9NYF0; P01375; Q9UJY5; Q13049; Q9P0J0; Q16531; Q07954; Q99728; Q96H20; O15169; P46934; Q96J02; P48436; Q9UM11; O60260"]
["GO:1903955","biological_process","positive regulation of protein targeting to mitochondrion ","P49840; Q13131; O95376; O43464; Q8N7F7; P34931; P68036; Q12772; Q7L0Q8; Q9BXM7; P19784; Q7Z6Z7; O75143; Q9Y371; Q969H0"]
["GO:0031398","biological_process","positive regulation of protein ubiquitination ","P49840; P45984; P38398; P49407; Q5S007; Q03135; O43353; Q9P0N9; Q9BUL5; Q9UKT5; Q9NVI1; P25686; P0CG47; Q96FA3; O43236; Q9NYA1; O95999; O15105; Q9Y4K3; P68036; P53801; Q8N2Z9; Q9HC62; Q9UNE7; Q9BXM7; Q05086; Q9UMX0; Q96EP1; P98170; Q9NV92; Q9NS23; Q13155; Q96PM5; P07550; P32121; O15169; P30518; Q969H0; P11021"]
["GO:0043161","biological_process","proteasome-mediated ubiquitin-dependent protein catabolic process ","P49840; P62714; P29590; P49407; Q96EB6; Q96PU5; Q15366; Q8WW12; P25686; O15516; Q8NHG8; Q5T447; Q9NS56; Q9BYM8; Q13330; P78317; O00327; Q13362; Q96FA3; P54727; P62195; P55072; Q13829; Q9NZS9; Q969U6; Q99460; Q13200; P54252; Q15058; Q8NHY2; Q14CS0; Q16236; P49427; P63146; Q9UNZ2; Q712K3; Q9UNE7; Q9BZK7; P35638; P49459; Q9UNN5; Q16531; Q92993; Q9Y3C5; P61086; Q9UL17; Q9H0M0; P32121; Q8IUQ4; Q8IXJ6; Q96J02; Q969H0; Q04323; Q8ND25; O60260"]
["GO:1903146","biological_process","regulation of autophagy of mitochondrion ","P49840; O43464; P36956; Q9UBN7; Q12772; O00429; Q9BXM7; P19784; Q14247; P21796; Q969H0"]
["GO:0003073","biological_process","regulation of systemic arterial blood pressure ","P49840; P10275; Q01970; P61601"]
["GO:0016055","biological_process","Wnt signaling pathway ","P49840; Q13131; P54646; P49674; Q6PD62; P25054; O94921; P24864; P48730; P34947; Q7KZI7; P16885; P49841; Q9P0L2; P35222; Q9UKE5; P68400; O95271; Q96AC1; O14745; P62979; Q70CQ2; Q8ND76; P0CG47; Q99697; Q9NQC7; Q9UQB3; Q9UIW0; P67870; O60716; O60381; P78368; P14416; O75581; Q9Y2J4; Q9P219; O00571; O43294; Q8N163; P98082; Q9NYF0; Q9HC62; P35638; Q9Y2T1; Q8N2W9; O43815; P19784; P24385; Q9UPN3; Q6P1J9; P98170; Q9Y283; Q16531; Q8WVC0; P48729; P62987; Q9NZC7; O15169; Q03014; P43250; Q8WVD3; Q04724; Q9UN36"]
["GO:0071425","biological_process","hematopoietic stem cell proliferation ","P41212; Q01196; O95376; P28906; Q03112; Q15020"]
["GO:0097152","biological_process","mesenchymal cell apoptotic process ","P41212"]
["GO:0022008","biological_process","neurogenesis ","P41212; Q12879; P54762; Q9C0K0; Q969G3; P50553; Q9P2E2; Q96SN8; Q8WUM0; O43379; Q9H165; Q9Y496; Q13562"]
["GO:0007296","biological_process","vitellogenesis ","P41212; P15407; Q07889"]
["GO:0006355","biological_process","regulation of transcription, DNA-templated ","Q01538; Q13761; P11474; Q06413; Q04206; O75676; Q9NQU5; O15530; P54646; Q96KG9; Q09472; Q86Z02; P06400; O15264; P00519; O96017; O75475; P19544; P03372; P42224; P10242; P15336; P29590; Q04759; O75030; Q01167; P80192; Q00653; P21127; P40763; P68104; Q86U86; P53778; P20794; P17096; Q9UBE8; O75582; Q6NZI2; Q15678; Q9Y4A5; Q16513; O14744; P51610; Q13469; P04637; Q15759; P35398; P67775; P52564; Q7KZF4; O43293; P06213; P68400; Q9UQ88; P04150; P43694; Q15910; Q71F23; Q15650; Q13045; Q15291; Q9BX82; O00167; P12980; Q9NP66; Q12962; P49773; P52655; Q9HC44; O00401; Q86UP8; Q13705; O75175; Q6P1K2; Q14005; Q9UBK2; O15516; P09629; P14317; O95251; Q8N9K5; P62508; Q9UBC0; Q9Y3Y2; Q99504; O60869; Q8NBZ0; Q99801; Q14498; Q9UGP4; Q8N3C0; Q9H8M2; Q9BYM8; P29083; P39687; Q8TAQ5; Q9BQG0; Q7Z5H3; P50570; P15923; Q9P0U4; Q6P4R8; P17676; Q01844; O00327; P19484; P49789; P51508; Q86X55; P82094; Q9NVP2; Q96RI1; Q15022; Q12948; Q93062; P62633; P24928; O60828; P28069; O43918; Q99576; O75386; Q9P2D1; Q9BUJ2; Q13112; Q99697; Q01094; Q16665; Q14135; O94953; Q9UKM9; Q8WXF1; Q9BZS1; Q9Y5Q3; Q9UIF9; Q9Y5V3; Q9UER7; P82970; Q9UQB3; Q9H9S0; Q92793; P49116; Q8IYU2; Q9NZH5; O00482; Q9NZV7; P54252; Q9NUQ3; P42166; Q9H422; Q02447; Q5VVH5; Q13351; Q9H0D6; O75460; P18848; P57740; Q9UPS6; O60716; P23511; Q9ULV5; Q92784; Q9Y534; P68036; P17813; Q9ULM6; P08047; Q7KZ85; P28698; Q9NP62; Q8N9N2; Q9UQF2; P35232; Q9BXP5; Q6U7Q0; Q8WUM0; Q6IE81; Q9NYB0; P36897; Q7L2R6; Q9H204; Q9UHX1; Q96HZ4; Q9UK13; O60711; Q9UK11; Q9NP71; P17544; Q9H2G4; Q8NHW3; P22392; P0C1Z6; Q15669; O75525; Q13404; Q8WXB4; P29692; P98177; Q15637; Q9HCS4; P35638; Q14103; P35637; Q13352; Q9UH92; P46531; Q8TEV9; P19784; P49750; Q7LBC6; Q9H0E9; P63167; Q12972; P37023; Q9BQI9; Q9H8N7; O60678; Q9UMX1; P30153; O00625; P67809; Q86WP2; Q9UNP9; E9PAV3; O00213; O43823; Q9UNY4; Q92681; Q15596; Q8N720; Q9GZV5; Q14527; P48431; P52926; Q16385; Q9UL17; O00151; Q99471; P35869; Q7Z589; Q96RS0; Q9ULC4; P14316; Q92945; P40337; Q5JVS0; P27695; Q96EZ8; Q9BWT1; Q8TAD8; Q5VWX1; Q96IF1; O14686; Q14966; O75494; Q9NR22; Q03060; Q92731; Q15654; P62324; P36896; Q01860; Q9UBS8; Q8NFH5; O75534; Q5VTR2; Q99873"]
["GO:0006351","biological_process","transcription, DNA-templated ","Q01538; Q01826; P39880; Q13422; P42229; Q13131; Q15303; O15530; P54646; Q96KG9; Q86Z02; P06400; O15264; Q9H2X6; Q9NYF8; O96017; O75475; Q96ST3; P11362; P03372; P42224; O14497; P49715; P04626; P29590; P38398; Q9Y6Q9; Q06187; Q14765; P80192; P85037; Q53ET0; Q16512; P68104; Q86U86; P53778; P20794; Q8WXI9; P50548; Q9UQL6; Q01201; Q9UBE8; Q12888; Q15678; Q9Y4A5; Q16513; P28482; Q02078; P25440; P05771; P52630; Q15759; Q08050; Q16539; P52564; Q7KZF4; Q9UPN9; P10275; Q9Y6K9; O43318; Q12778; P06733; O43293; P53041; P35222; P68400; P04150; Q15910; P56524; P19525; Q71F23; Q9H7L9; Q15650; Q92769; Q9Y618; Q96IZ0; P08151; Q13045; Q15291; Q14469; Q9BX82; Q49AN0; O00167; Q99502; P12980; Q14693; Q9NQV6; Q9NP66; P22670; Q96T58; Q9Y2X9; Q9Y6H1; Q92610; Q9UQR0; P49773; P13010; Q9HC44; Q14863; Q9Y2G1; Q96PM9; Q9Y4C1; O00401; Q86UP8; Q14207; Q8N680; O75175; P06454; Q9NWH9; Q5VUA4; Q14005; Q9H3M7; Q14684; Q16559; Q14145; Q9Y295; P32314; P35251; P20749; P61457; O43623; O15055; Q9UPP1; O95251; Q96LX8; Q9UFW8; Q8N9K5; Q8WUI4; Q9Y3Y2; Q99504; O60869; Q02535; P27540; Q13772; Q6N043; Q8NBZ0; Q99801; Q9Y261; P16989; Q9Y5Q9; Q9UBW7; Q32MZ4; Q14498; O75626; P48552; O75461; P78543; Q9UGP4; Q8NCP5; Q9UBU8; Q8N3C0; Q96N95; Q12906; O95238; Q8WUF5; Q9NS56; Q9H8M2; Q9H063; Q99966; P39687; Q8TAQ5; Q9BQG0; Q9P1Z0; Q7Z5H3; Q9Y294; P15923; Q14839; Q13330; Q9P0U4; Q6KC79; P78317; Q01844; Q9H2A3; P19484; P49789; O15198; P51508; O15014; Q86X55; P23396; P12956; Q8IZD2; O75081; Q5D1E8; Q9NVP2; Q14151; O94992; P55316; Q02962; Q15022; Q8TAQ2; P37275; P48023; Q93062; P62633; Q9HC52; Q96P20; O60828; Q9BTK6; Q96FV9; Q08999; P26358; Q9P2D1; Q9BUJ2; Q15906; Q8WYK2; Q15424; Q9UD71; Q13112; P10828; Q13547; Q01094; Q9Y3T9; P56545; Q8NCA9; Q14135; O14771; O94763; P54259; Q96PK6; Q8WYH8; Q9Y5T5; Q06455; O94953; O00257; Q16526; Q9UKM9; Q13516; Q8WXF1; Q9BZS1; Q9UIF9; Q8NF99; Q9Y250; Q96LI6; O75925; Q9UER7; Q12789; Q6UUV7; P82970; Q52LA3; A8MT65; Q9UQB3; Q92886; P23759; P35226; Q9BY66; Q15653; P50461; P28749; P17509; Q96T88; P54198; Q8IYU2; Q9UIW0; P35548; Q9NZV7; Q9P2F9; Q9UIG0; P54252; Q9NUQ3; O60341; Q9BTA9; Q02447; Q5VVH5; Q13351; O75460; Q99592; Q9UHJ3; Q9P2K5; Q9UPS6; O60716; Q969V6; P50553; O76054; O43541; O15105; Q9NX63; O15392; Q9ULV5; Q02363; Q9P0W2; Q92784; P50219; P68036; Q9BU19; O95625; O60381; Q9ULM6; Q9UBN7; Q8IUX7; Q12772; Q8NCK3; Q9NQB0; Q8N9N2; O15379; Q16621; Q53H80; P43354; O95600; Q9UK80; O00571; Q8TBZ5; Q6U7Q0; Q03112; P31270; Q8N163; Q9UKY1; Q96BF6; Q6IE81; Q8NEY8; Q9NYB0; Q14192; Q7L2R6; Q6P1N0; O75928; A8MYZ6; P54253; Q9H204; Q8TBC5; Q9UHX1; Q99543; P33076; P47928; P17041; Q9BVI0; Q8TB69; Q6NUN9; Q9ULU4; Q96HZ4; Q9UK13; Q99967; O60711; Q6UUV9; Q9UK11; Q8IZL8; Q9NQR1; Q9BUG6; Q6STE5; P31269; Q9NP71; Q15047; P41182; O00409; P17544; Q9H2G4; O00255; Q9Y5B6; Q9Y2W7; P22392; P0C1Z6; P15036; Q7RTU3; Q86V15; O75525; P11142; Q9NRG4; O94805; Q8WXB4; P29692; Q86Y01; Q13569; Q15788; Q13765; P57682; O15119; Q9BZK7; Q96LA8; Q9BY41; Q15637; Q9HCS4; Q01954; P41162; Q9NRY4; Q14103; Q13352; Q8N2W9; Q9Y3Q8; Q9UH92; Q8TEV9; P43356; Q15287; Q86YP4; Q92841; P19784; P49750; Q7LBC6; Q9H0E9; O15534; P63167; Q12972; Q5TB30; Q9BQI9; Q9H8N7; Q9UBD0; Q9H165; O14713; P37198; Q68DY1; Q92794; P23246; Q9Y230; Q9H2P0; Q5TKA1; O96028; Q86WP2; E9PAV3; O00213; O43823; Q15583; O95983; O75151; Q92681; Q92993; Q15596; P51858; Q8N720; Q8NFD5; Q9NRL2; Q9UQ80; P51608; Q05516; Q16385; Q9HD90; Q9UL17; Q8NDW4; Q02556; Q9NZN8; Q7Z589; Q96RS0; Q16666; Q96H20; Q9HCG1; P43699; Q9ULC4; Q9BQW3; Q92945; Q8N726; Q96IT1; O14813; Q92785; Q03014; Q5JVS0; Q6IPX3; Q8N9N5; P12755; P49711; P27695; Q96EZ8; Q8TAW3; Q9BWT1; Q96RK0; Q07021; P59923; P23769; Q00839; Q13363; Q07666; Q5VWX1; Q9H3R0; Q96IQ9; O95931; Q8IXJ6; Q96IF1; A0AVK6; O14686; Q8IX03; O60885; Q14966; P41134; Q03060; Q15654; P23497; Q9H0D2; Q9BYE7; Q04724; Q13185; Q96RL1; P25490; Q96AV8; Q9UKV8; Q9UBS8; Q15672; Q9HB90; Q9Y265; Q05195; Q9UKV0; Q99623; P56645; Q99676; Q9NRM2; O60260; Q8ND82; Q15329; P10599; O95409; Q96S94; Q86VK4; Q9HCU9; Q9Y2K7"]
["GO:0030183","biological_process","B cell differentiation ","Q8WV28; P36888; P13612; P04629; P08575; Q09472; P16885; Q9UQL6; P17706; P27986; P52333; P56524; P12980; Q9GZX7; Q9UBC0; P05556; P15923; P28069; P40259; Q9NP87; P78536; Q02447; P11912; Q9BXL7; Q9H9Q4; P41182; P43246; P55895; Q03014; Q06330; Q96SD1; Q9UKV0; P55327"]
["GO:0006959","biological_process","humoral immune response ","Q8WV28; Q06413; P23771; O43734; P19532; P19484; O43918; P41597; P10415; P50219; P10747; P01375; P46531; Q16633; Q06330; P06744"]
["GO:0006954","biological_process","inflammatory response ","Q8WV28; P46734; P42336; P07948; Q16566; Q04206; P31749; O75676; Q05513; P08631; Q9UHD2; Q12968; P49137; P09429; Q04759; P29317; P19838; Q00653; P40763; Q15139; Q9UQL6; Q01201; Q14934; O75582; P30530; P10721; P63000; Q8IU85; P43405; P07333; O14920; O43353; Q9Y6K9; O15111; P01100; P04083; P52333; P56524; P35354; P78545; P08138; Q13287; Q04864; Q12904; P30411; P61073; P51681; P19438; P13498; Q6P4R8; O15455; P17676; P25445; P32248; Q8TDQ0; Q5D1E8; Q96RI1; Q9NPP4; Q96P20; P48736; Q5VWQ8; P05107; Q01362; P41597; Q99497; P30044; O15553; P06746; Q9NYA1; P21462; P50052; P42338; Q16236; Q14494; P01589; O43164; P01375; P18827; Q8N4X5; P41182; P35367; O00206; P21730; Q9NPH5; P31994; Q8NE71; O60602; P22004; O43561; P06702; Q86XR7; Q9ULZ3; Q15722; P14778; Q7Z7A4; P21731; Q9Y6Y9; P25942; Q16666; P20333; P58753; O00329; Q13151; P34972; Q96J02; Q9Y624; Q9UKV0; Q15109"]
["GO:0035556","biological_process","intracellular signal transduction ","Q8WV28; Q9BYP7; Q13554; Q15349; Q8TDC3; Q96PN8; Q96J92; O00141; Q5VT25; Q16566; Q9H4A3; Q8N5S9; P31749; O75676; P24723; O15530; P54646; Q9H0K1; Q9Y3S1; P51813; P04792; P17252; Q9Y243; Q12851; Q15796; Q12852; O60285; O60674; P78362; Q04759; Q06187; P42680; P29597; Q9UQM7; Q7KZI7; P20794; Q15139; Q9UPZ9; P43403; Q9BUB5; P11274; Q9BZL6; Q9HBH9; Q9UBE8; O75582; P13861; P51451; O95747; P05129; Q16513; Q14680; Q08881; P16591; P51812; P31751; Q9UBS0; O95819; Q5S007; P51178; Q92835; Q9Y4K4; P63000; Q8IU85; P05771; Q6DT37; P06241; Q13043; Q16539; P57059; P49841; Q9Y2I7; Q9P0L2; O43293; Q8NCB2; P12931; Q9UQ07; Q02156; O15075; Q9UKE5; Q15208; P46109; Q96SB4; Q9Y5S2; P23458; P41743; Q01970; P52333; Q13555; O14757; Q14012; Q15418; P00540; O14512; Q9NRM7; Q9NWQ8; Q96BR1; Q13094; O43734; O14640; P14317; Q9UEW8; Q6P2M8; Q38SD2; P31323; P25092; O96001; O43566; Q9Y2H1; Q03167; Q13188; Q8TCU6; Q9NQ66; O00560; Q8NG66; Q15111; Q92997; O15021; Q9Y6R4; P39687; O75916; Q92974; Q13574; Q96GX5; Q6SA08; Q99759; P52757; P49619; Q9UIK4; Q8TB45; Q9Y4G8; Q9UD71; Q14155; Q9NZJ9; Q8IVF5; Q13485; Q9NRH2; O60229; Q6UVK1; O43157; Q8TDM6; Q8TF76; P14314; Q02846; O14578; Q9NYA1; P53671; Q9H0H5; P23743; O43914; O14492; Q9HBY8; Q96PF2; P50052; Q13501; P28562; P53355; Q15569; Q9H8V3; P14416; P49768; P62258; Q9GZY6; P35368; O00571; P36897; P49810; O43602; Q9UHY1; Q6P5Z2; Q9NP71; Q6P0Q8; Q9BXM7; Q9UKA4; P10644; P09601; O43561; Q5TB30; Q9H1R3; O60239; O14713; Q86UE8; P49802; Q96Q27; Q8WVI7; Q13522; O95644; P29350; P20936; Q96NX5; Q9UGI9; Q9Y2H9; Q8IVH8; Q9Y2V2; Q16816; Q9NR80; O94768; Q9H093; Q8NB16; Q9UQQ2; Q9UKI8; P16949; Q7Z628; Q9BRC7; Q9BXA7; O15117"]
["GO:0050801","biological_process","ion homeostasis ","Q9BYP7; Q96J92; Q9Y3S1; Q9UEW8; Q9UH77"]
["GO:0090188","biological_process","negative regulation of pancreatic juice secretion ","Q9BYP7; Q96J92; Q9H4A3; Q9UEW8; Q13133"]
["GO:0051928","biological_process","positive regulation of calcium ion transport ","Q9BYP7; Q9UQM7; Q9Y210; Q96D31; Q15746; Q01668; Q86YM7; P32121; Q08289"]
["GO:0032414","biological_process","positive regulation of ion transmembrane transporter activity ","Q9BYP7; Q5T2W1; Q9UEW8; Q9Y210"]
["GO:0010800","biological_process","positive regulation of peptidyl-threonine phosphorylation ","Q9BYP7; P53350; P28482; O43353; Q9Y210; P0DP23; Q9NYA1; P05067; Q9C0C2; Q8N122; P61086; O15169"]
["GO:1903078","biological_process","positive regulation of protein localization to plasma membrane ","Q9BYP7; P00533; P31749; P24723; O15530; P29317; P29323; P29320; Q02156; P27986; P41743; P15311; P09327; Q9BX66; Q7L804; P05556; Q01082; P04156; P58400; Q13501; Q12959; P62491; Q07954; Q14654; P33176; Q99828"]
["GO:2000651","biological_process","positive regulation of sodium ion transmembrane transporter activity ","Q9BYP7; Q9Y3S1; Q12955"]
["GO:0010765","biological_process","positive regulation of sodium ion transport ","Q9BYP7; P31749; O43865; Q14524; P52952; Q12955; Q8N335"]
["GO:0072659","biological_process","protein localization to plasma membrane ","Q9BYP7; O75116; Q05513; Q13237; P07355; P31751; O14920; Q9UKE5; Q13464; P15311; Q9BY11; Q86WV1; Q86VP3; O14745; Q6PIL6; Q86YS7; Q92913; Q14254; P19438; P12830; P35241; Q01082; P19022; Q9Y4G8; Q14721; Q9Y4I1; Q6VY07; P14923; P30273; P61764; Q12959; O75955; O75581; P62491; O75122; P01375; Q12955; P21333; Q9Y2W7; P22307; Q14244; Q96AX2; Q5VZ89; Q9Y624; Q08289; O15117"]
["GO:0090279","biological_process","regulation of calcium ion import ","Q9BYP7; P35222; Q13563; Q96P31; Q86YM7"]
["GO:0006006","biological_process","glucose metabolic process ","Q15118; P42336; Q13131; P31749; Q15120; P11413; Q15119; Q16654; O15357; P31751; Q16539; P10515; Q9UBC0; P51649; P52945; P36871; Q9Y4H2; P50416; P00973; P01375; Q9UBU3; P08559; P22415; P29803; Q03060; Q14654"]
["GO:0097411","biological_process","hypoxia-inducible factor-alpha signaling pathway ","Q15118; Q15120; Q16665"]
["GO:0008631","biological_process","intrinsic apoptotic signaling pathway in response to oxidative stress ","Q15118; O60674; P29590; Q14680; Q99683; Q9Y6E0; Q05655; P10415; Q969S3; P07203"]
["GO:0010510","biological_process","regulation of acetyl-CoA biosynthetic process from pyruvate ","Q15118; Q15120; Q15119; Q16654; Q9P0J1"]
["GO:0010906","biological_process","regulation of glucose metabolic process ","Q15118; O00763; Q15120; Q15119; Q16654; P35398; Q96EB6; Q96A54; P17936; Q15596; P51449; O60260"]
["GO:0031100","biological_process","animal organ regeneration ","P36888; P11802; P14618; P06493; Q06203; P37231; P27708; P30530; P38936; Q14693; Q03167; P09211; P31939; P11717; P37173; P20248; P21730; P46531; Q16611; P13796; Q15466; Q15648; P16118"]
["GO:0071385","biological_process","cellular response to glucocorticoid stimulus ","P36888; P15172; P04083; P04150; O43521; P09211; P68036; Q07352; Q00839; P30874; P26651"]
["GO:0035726","biological_process","common myeloid progenitor cell proliferation ","P36888; Q9UKT5; P09211; P13688"]
["GO:0097028","biological_process","dendritic cell differentiation ","P36888; P07948; P15976; P30530; O94759"]
["GO:0030097","biological_process","hemopoiesis ","P36888; Q13761; P06239; Q14004; Q01196; Q9HBH9; Q14680; P10721; P07333; P28906; P17542; P41597; P35226; P52952; Q16635; P51587; Q13950; Q05516; Q16666; P35612; Q9HCG1; P52943"]
["GO:0001776","biological_process","leukocyte homeostasis ","P36888"]
["GO:0046651","biological_process","lymphocyte proliferation ","P36888; P12268"]
["GO:0002318","biological_process","myeloid progenitor cell differentiation ","P36888; P10721"]
["GO:0018108","biological_process","peptidyl-tyrosine phosphorylation ","P36888; P00533; P04629; P07948; P06239; P22455; Q15303; P17948; P08631; P00519; P09619; P11362; Q12792; O60674; P09769; P21802; Q13627; P22607; Q05397; Q06187; P35916; P42680; P29323; Q14289; P43403; P35968; P16234; P16591; P10721; P07332; P06241; Q16832; P07333; P42684; P29320; P06213; P12931; P54764; P52333; Q02763; P21709; Q504Y2; Q9NYB9; P29350; Q8IZP0"]
["GO:0043410","biological_process","positive regulation of MAPK cascade ","P36888; O75116; Q16620; Q6VAB6; P51636; P17948; P29353; P11362; P09429; P07949; P21802; P22607; P01112; P35916; Q8IVT5; P35968; P10721; P10275; P06213; Q02156; Q13464; Q15131; P00540; P29322; O60504; P19022; Q5VWQ8; Q969S3; Q9HAT8; P17936; P05067; P35368; Q96P31; P08913; P01730; P48431; P07550; Q8IX03"]
["GO:0043406","biological_process","positive regulation of MAP kinase activity ","P36888; P00533; P51617; Q06413; P17948; P09619; P11362; P04626; P01112; Q13418; P41240; Q5S007; Q04912; P12931; Q15910; P28223; P01116; O76074; P48736; Q12802; Q9Y5V3; P09038; P01375; Q9BUL8; Q9Y6N7; Q9NPH5; P46940; P08913; O95267; P25942; Q96IF1"]
["GO:0043552","biological_process","positive regulation of phosphatidylinositol -kinase activity ","P36888; P07948; Q15303; P17948; P09619; P09769; P22607; Q05397; Q14289; Q15139; P16234; P10721; P35568; P12931; Q02763; Q9C0C7; P52735; P29322; P32248; Q9UKW4; P09038; Q9H244; P60953"]
["GO:0014068","biological_process","positive regulation of phosphatidylinositol 3-kinase signaling ","P36888; Q16620; Q15303; Q16288; P17948; P09619; P11362; O60674; P22681; P09769; Q05397; P35968; P21860; P16234; P10721; P06241; P12931; Q02763; Q96EB6; P14598; P14317; Q99801; P85299; P04040; O43157; P10747; P01375; Q02297; Q05086; P29350; Q6ZUJ8; P46934; P23945; P48436; Q14457"]
["GO:0042531","biological_process","positive regulation of tyrosine phosphorylation of STAT protein ","P36888; P07948; Q15303; Q13882; O60674; P16284; P22607; P40763; P10721; P06241; P07333; Q00613; P40189; Q92769; Q14469; P14317; P19438; O14543; Q9UGK3; P10912; P25942"]
["GO:0002328","biological_process","pro-B cell differentiation ","P36888; P78527; P49917"]
["GO:0042981","biological_process","regulation of apoptotic process ","P36888; O96013; P46734; O00141; P41279; P45985; P14921; P31749; Q9NQU5; Q92918; Q13163; Q96B36; P35240; Q9H2K8; Q12851; O96017; P03372; O60674; P42224; Q13148; P36507; Q8WU20; P38398; P12814; Q9UM73; Q13233; O95747; Q56UN5; Q9Y4K4; P04637; O94804; Q9P286; O75914; Q00535; P06241; Q9Y2U5; O14733; P52564; Q02750; O43293; Q99558; Q7L7X3; Q9Y6E0; O00506; P04049; Q9UKE5; Q13315; Q9H2G2; P52333; Q13153; O15164; Q96BR1; Q96EB6; Q9BXH1; O43521; Q8N4C8; Q9P289; P20749; P07766; O60346; Q9UEW8; O43707; Q12933; Q13188; Q92597; P09382; Q99966; Q9Y6R4; P39687; Q8TAQ5; P19438; O14727; P56945; Q9BST9; P25445; Q8NC51; P23396; O15350; Q9UL54; Q9NPP4; Q99759; Q9NQC3; Q9UIK4; Q07812; P55072; Q96PY6; Q9NZM5; O43236; Q8TDM6; Q7RTN6; Q9Y5V3; Q9BZR8; P55212; Q92793; Q9BUZ4; Q9HBY8; Q9BXL7; P17936; P28562; O15392; P53355; P35232; Q13114; P41182; Q13625; P15531; P22004; P55957; P13693; Q8IVH8; Q13309; P32119; P27695; P42575; Q14191; P18146; O60361; Q9H257; Q13794; Q9H3D4; O76021; P48436; Q9HCU9; O95390"]
["GO:0010243","biological_process","response to organonitrogen compound ","P36888; P38936; O15350; P24385"]
["GO:0007169","biological_process","transmembrane receptor protein tyrosine kinase signaling pathway ","P36888; P08922; P07948; P06239; P42681; Q15303; Q01974; Q16288; P17948; P51813; P08631; Q13882; O15146; P09769; P04626; Q07912; Q06187; P35916; P42680; P29597; Q9UM73; P43403; P14616; P35968; P51451; Q08881; P21860; P41240; P43405; Q13905; P06241; P07333; P07947; P42684; P23458; Q02763; P29376; P42685; Q13470; Q9NWQ8; Q13094; P07766; P30411; O14522; Q92529; Q6UVK1; O43312; O95297; P42338; Q02297; O15446; Q99704; P01730; Q8IZP0; Q969H4"]
["GO:0033173","biological_process","calcineurin-NFAT signaling cascade ","P48454; Q14934; Q13469; Q08209; P53805; O95644"]
["GO:1900244","biological_process","positive regulation of synaptic vesicle endocytosis ","P48454; Q05193; Q5S007; O00429; Q8N2Q7; Q99961"]
["GO:0006470","biological_process","protein dephosphorylation ","P48454; P62140; P62136; Q16825; P08575; P18031; Q15262; P23467; Q15831; P62714; Q15678; Q9Y2R2; O14974; P67775; P53041; P60484; P35236; P35813; Q05209; P28827; P54829; Q14738; Q6ZVD8; O14522; Q8WYL5; Q12923; O15297; Q15256; Q99952; P10415; O15355; Q08209; Q9UN19; O95278; P26045; Q9Y5B0; O75688; P23469; P99999; Q9P2B4; P36873; Q13614; P30153; P29350; Q9Y6W6; Q16690; Q15172"]
["GO:0071394","biological_process","cellular response to testosterone stimulus ","O75116; P10275; P19419; P26038"]
["GO:0030866","biological_process","cortical actin cytoskeleton organization ","O75116; Q9Y490; Q00535; O14920; Q13464; P11171; Q12959; P01375; Q96PY5; P08567; P17081; Q15334"]
["GO:0007186","biological_process","-protein coupled receptor signaling pathway ","O75116; P42336; P31749; O60674; Q8WU20; P25098; P34947; P49407; P63000; P06213; P27986; Q13464; P04083; P15498; Q01970; Q08499; O15492; P41180; Q9NYQ6; P28223; O95069; Q08493; P43119; Q14344; Q8N5V2; Q9NS28; P81274; P07766; P34998; Q03431; P41143; P41146; P30411; O60266; P21554; Q8TCU6; Q9NQ66; P61073; Q08828; Q06481; P20941; P52735; O75962; Q13370; P51681; Q9NPQ8; P12272; P19086; P04899; Q96P88; P32241; P56945; P28222; Q9UBH6; Q92974; P32248; Q9NPC1; P35462; P0DP23; P48736; P43220; O75386; Q9Y4G8; Q96DR7; Q14155; Q12802; P41597; Q8IVF5; Q02952; O60229; Q9UKW4; O43157; P08588; P35626; Q9UBS5; P02649; Q96PE2; P32245; P41594; P08172; O14921; O43306; P21462; Q15052; Q14573; P08173; Q9H7P9; P50052; P30679; Q08462; P49795; Q9Y272; Q92888; P42338; P11717; Q13255; Q9UBI6; Q9H8V3; P14416; Q9HCR9; P05067; P54750; P35368; Q9UHM6; P21453; P41145; Q14432; O75899; P49798; P35367; O94827; O95477; P34981; Q13009; P21730; P62745; Q14416; Q07343; Q70Z35; P08913; Q9UBU3; Q07889; P16473; Q99523; Q14831; P21728; P40145; P49802; P49685; P20309; Q9H244; P61586; Q15722; P29350; Q14832; O14827; P21731; P07550; P32121; P43250; P30518; Q9NR80; P30556; Q9Y233; P30874; Q03113; P34972; P27815; O43613; P23945; Q5NUL3; P08100; Q7Z628; P35372"]
["GO:0007249","biological_process","I-kappaB kinase/NF-kappaB signaling ","O75116; P31749; Q9UHD2; Q06187; P19838; Q00653; P25963; Q01201; Q13546; O14920; O43353; Q9Y6K9; O43318; Q99558; O15111; Q13464; Q04864; P20749; P62979; Q15750; Q12933; Q9BYM8; P19438; O15455; Q9NYJ8; P0CG47; Q5VVH5; Q9BXL7; O95999; Q9Y4K3; Q96CG3; P01375; O00206; Q8N5C8; Q86XR7; Q9Y572; Q9Y6Y9; P62987; Q8TAD8; Q9H257"]
["GO:0016525","biological_process","negative regulation of angiogenesis ","O75116; P78347; P21359; P29353; P42224; P15336; P37231; P29590; P29317; O14964; P35222; Q13464; P00558; Q02763; P28827; Q96TA1; Q13370; Q9NYY3; P01236; P16066; Q12948; P48023; Q5VWQ8; P41597; P57105; O43474; Q9H4X1; P98177; Q9UBU3; P35590; P51608; Q4VCS5; Q03014; P36955; O43597; Q01955"]
["GO:1903347","biological_process","negative regulation of bicellular tight junction assembly ","O75116; O14920; Q13464; P01375"]
["GO:0070168","biological_process","negative regulation of biomineral tissue development ","O75116; P29474; Q13464; P02765; P46531; P48436"]
["GO:0035509","biological_process","negative regulation of myosin-light-chain-phosphatase activity ","O75116; O14920; Q13464; P01375"]
["GO:0150033","biological_process","negative regulation of protein localization to lysosome ","O75116"]
["GO:1902993","biological_process","positive regulation of amyloid precursor protein catabolic process ","O75116"]
["GO:1902961","biological_process","positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process ","O75116; P07948; P54764"]
["GO:0010613","biological_process","positive regulation of cardiac muscle hypertrophy ","O75116; P50750; Q13557; P17252; Q12792; Q05397; Q02078; Q13464; P40189; O76074; P19634; P61296; P09874; Q14457"]
["GO:0030335","biological_process","positive regulation of cell migration ","O75116; P00533; P07948; Q01974; Q16288; P17948; P17252; P25054; P09619; P07949; O60674; Q9UJU2; P09769; Q04771; Q05397; P01112; Q13418; Q14289; P35968; P16234; P16591; P10721; P31751; O95819; P28482; P84022; Q03135; P08069; Q14511; P07333; O43293; P06213; P27986; Q13315; Q13153; P21709; P08151; P62070; P49757; P09327; O43623; Q9UBC0; O43707; Q8TCU6; O00560; P04899; P56945; P35241; Q15746; Q9Y4H2; O00592; Q08209; Q9NYZ3; Q9NYA1; P78536; Q92819; Q12946; Q6ZS17; O95297; O60271; O95684; Q15691; Q92569; P63244; P21453; P36897; P98082; P17861; Q13049; P00749; Q9BUL8; Q13009; Q5VZK9; P08913; P46531; O95863; O60610; P21728; P04179; P13726; O00329; P43121; Q9UH99; Q14451; Q15654; O43597; P50281; P11021; Q99828"]
["GO:0010825","biological_process","positive regulation of centrosome duplication ","O75116"]
["GO:0032723","biological_process","positive regulation of connective tissue growth factor production ","O75116"]
["GO:1905205","biological_process","positive regulation of connective tissue replacement ","O75116; Q13464; Q08209"]
["GO:0010595","biological_process","positive regulation of endothelial cell migration ","O75116; Q13873; P14921; P17252; P00519; P35916; Q14289; Q15139; P35968; Q9BZL6; P05106; P23771; Q02763; P56945; Q5D1E8; Q8WTV0; P80108; Q99958; P62745; O14713; P06744"]
["GO:0090271","biological_process","positive regulation of fibroblast growth factor production ","O75116; P35354"]
["GO:1902966","biological_process","positive regulation of protein localization to early endosome ","O75116; P15311; P26038; P35241; Q92673"]
["GO:0001934","biological_process","positive regulation of protein phosphorylation ","O75116; P00533; P04629; Q16620; P07948; P31749; Q15303; Q16288; P27361; Q96RR4; P00519; O96017; O15146; P04626; P48730; Q05397; P01112; P35916; Q13418; P07355; Q13546; P35968; P05106; P49407; P31751; Q5S007; P63000; P42345; P07333; Q13043; P06213; Q9UKE5; P46109; Q02763; Q13153; P07900; P30279; P36544; Q7Z434; Q96EB6; O14640; Q99801; P01116; Q92997; P25445; Q9UER7; P78536; Q9HAT8; Q13501; O14641; P17813; O75955; O15379; P05067; Q92569; Q9BZQ8; P63244; P98082; P01375; P17861; Q9HC62; Q9BXM7; P30281; P30040; Q9Y2T1; P11234; P24385; O14519; P54652; P01730; O95267; P25942; O15169; Q13526; Q15109; P48436; Q99828"]
["GO:0051496","biological_process","positive regulation of stress fiber assembly ","O75116; P35240; P00519; P53667; P84022; P07737; P63000; P42345; P49023; Q13153; P21709; Q9Y613; O60504; A1X283; Q15569; P36897; Q9H4X1; Q5VZK9; Q9NPH5; P31431; O14713; P61586; P60953; Q4VCS5; Q92574; P09493; O95398"]
["GO:0032956","biological_process","regulation of actin cytoskeleton organization ","O75116; P00519; P09619; Q13418; P42345; Q6IBS0; P29320; Q7L7X3; Q13464; Q15131; Q05655; Q9NYQ6; P46108; Q155Q3; Q15078; Q08495; Q16658; Q9UL54; Q96QB1; Q6R327; Q9ULK5; Q9UQB8; O75122; Q9NRY4; P61586; Q3V6T2; Q07954; P19021; P17081"]
["GO:0110061","biological_process","regulation of angiotensin-activated signaling pathway ","O75116; Q13464"]
["GO:0030155","biological_process","regulation of cell adhesion ","O75116; P62140; P00519; O60285; P07949; P29590; Q14289; P07332; O14974; P11831; P67775; P42684; P51817; Q13464; P29322; Q12913; Q15058; P17813; P21453; Q15438; P06396; Q9UNN5; P30153; P98161; Q8WWI1; P48436"]
["GO:2000145","biological_process","regulation of cell motility ","O75116; P00533; Q15303; Q00534; P00519; P04626; Q86YV5; Q16512; Q16513; P21860; P07332; P42684; O43293; P04049; Q13464; Q02297; O60610; P61586"]
["GO:0042752","biological_process","regulation of circadian rhythm ","O75116; P62140; P62136; Q13131; P54646; P53779; P49674; P45984; P37231; P29590; P48730; P45983; P78527; P16220; P05129; Q15910; Q49AN0; Q9UBK2; O15055; Q08828; Q13118; Q16526; Q8WXF1; Q9Y5V3; Q02363; Q07869; Q13133; Q9UHM6; Q8N163; Q05086; Q14103; O15534; P36873; P23246; P11388; P20393; Q03060"]
["GO:2000114","biological_process","regulation of establishment of cell polarity ","O75116; Q14289; P23771; Q13464; P61224; A0MZ66; Q9Y6D6; Q96Q89; Q9H4P4; Q6R327; P63244; P33151"]
["GO:1903140","biological_process","regulation of establishment of endothelial barrier ","O75116; O14920; Q13464; P19438; P01375"]
["GO:0051893","biological_process","regulation of focal adhesion assembly ","O75116; Q9H792; Q05397; O43293; P29320; Q13464; Q9H2G2; P51452; P19634; Q9ULV4; Q9UPN3; P61586"]
["GO:0045616","biological_process","regulation of keratinocyte differentiation ","O75116; Q01196; Q13464; Q9NZI5; Q07352; P26651; Q9UJM3"]
["GO:0051246","biological_process","regulation of protein metabolic process ","O75116; P01130; P02649; Q07954"]
["GO:0051492","biological_process","regulation of stress fiber assembly ","O75116; P42768; P63000; P27986; Q13464; Q9Y613; P19634; Q8TDY4; P60953; Q92574"]
["GO:1990776","biological_process","response to angiotensin ","O75116; Q13464; P35354; P46940"]
["GO:0071559","biological_process","response to transforming growth factor beta ","O75116; Q13761; Q13464; Q99966; Q13485; P17813; O00255"]
["GO:0007266","biological_process","Rho protein signal transduction ","O75116; O96013; Q9NQU5; P16284; Q13177; P53667; Q9P286; O75914; O15111; P23528; Q13464; Q13153; Q13459; Q9NYQ6; P08138; Q14344; Q9H3Q1; Q9BST9; O60229; Q8IZ21; Q9ULK5; Q6ZS17; Q92888; P57105; P41182; P62745; P08913; Q13017; P61586; Q00587; P30556; Q03113; Q969H4; O14613"]
["GO:0048511","biological_process","rhythmic process ","O75116; Q13131; P54646; P53779; Q96ST3; P45984; P37231; P45983; Q00653; P78527; P05129; Q00535; P57059; P68400; Q15910; Q15078; P17844; Q8WXF1; Q92793; P23511; P08047; P63244; Q9UHM6; Q8N163; Q6UUV9; Q05086; P23246; P11388; P43699; Q8N2Q7; Q03060; Q13185; Q15672"]
["GO:0006939","biological_process","smooth muscle contraction ","O75116; Q13464; Q08499; P35749; P30411; Q15746; P20309"]
["GO:0048010","biological_process","vascular endothelial growth factor receptor signaling pathway ","O75116; P42336; P17948; P49137; Q13177; Q15080; Q05397; P35916; Q14289; Q15139; P35968; Q9BZL6; P05106; P30530; P63000; P06241; Q16539; Q16644; P12931; O00459; P27986; Q13464; P15498; P49023; P07900; P46108; P14598; Q15464; P52735; P16333; P13498; P56945; Q12948; Q9UKW4; Q9Y6W5; P42338; Q9UQB8; Q99958; P17861; Q92556; Q96JJ3; Q9NP31; Q14185; P61586; P60953; Q8IZP0; P19878"]
["GO:0039694","biological_process","viral RNA genome replication ","O75116; Q15366; Q15075; P20339; P60953; Q15365"]
["GO:0050798","biological_process","activated T cell proliferation ","Q01826; P00519; P06241"]
["GO:0043367","biological_process","CD-positive, alpha-beta T cell differentiation ","Q01826"]
["GO:0043374","biological_process","CD8-positive, alpha-beta T cell differentiation ","Q01826; P10914"]
["GO:0006325","biological_process","chromatin organization ","Q01826; Q13422; Q9UQL6; Q13263; O43293; P04150; Q15910; P00540; Q9NQZ2; Q96EB6; Q9NP66; Q9NWV8; Q9Y261; Q9H4L7; P51532; P05114; Q9H8M2; Q9Y4W2; Q15651; Q08999; P26358; Q15424; Q13547; P46379; O00257; P82970; P28749; Q9UHJ3; Q92784; O15379; Q8WUM0; P16401; P68431; Q9H1E3; Q99543; Q9Y483; O94805; Q13569; Q9BY41; Q9HCS4; P55895; Q86UE8; Q8IXM2; Q14527; P48431; P52926; Q7Z589; O75376; Q8N9N5; Q00839; O95931; O60885; Q5VWQ0; Q9UKI8; Q6UWZ7; Q71DI3"]
["GO:0006338","biological_process","chromatin remodeling ","Q01826; P06400; P01106; P03372; O14497; P10242; Q86U86; Q9UQL6; Q12824; P23771; P56524; Q92769; Q8NBZ0; Q9H4L7; P51532; Q9UBU8; P35659; Q8TAQ2; Q9P2D1; Q13547; Q969G3; Q9BZS1; Q9UIF9; Q9UER7; P11387; P23759; Q9UIG0; P55317; Q96T23; Q7KZ85; Q6STE5; O94805; Q9Y230; Q9NRL2; O60885; Q13185; Q9H3D4; Q9Y265; P48436"]
["GO:0008544","biological_process","epidermis development ","Q01826; P42768; P06213; P78545; P12272; Q14254; Q9UMD9; Q07869; Q04695; Q9NZI5; Q01954; P20265; P16615; P15924"]
["GO:0016571","biological_process","histone methylation ","Q01826; Q15910; Q86X55; Q96KQ7; Q96LA8; P51608; Q9NR22; Q99873"]
["GO:0060004","biological_process","reflex ","Q01826"]
["GO:0016032","biological_process","viral process ","Q01826; P51617; P07948; Q04206; Q9NZM3; Q09472; Q9UHD2; P06748; P27361; P06400; P08670; P52701; P29353; P42224; Q14653; Q9Y490; P49715; P06730; P29590; Q14004; Q13627; Q00987; Q53ET0; P40763; P25963; P19174; Q13546; P35968; P16104; P16220; P16234; P28482; P25440; P04637; P43405; P52630; P61978; Q99683; O14920; Q7KZF4; Q9Y6K9; O43318; Q13263; P12931; P35222; P27986; Q96SB4; Q04637; P40189; Q71F23; Q9HC16; Q7Z434; O14818; Q13158; Q96EB6; Q96T58; Q8TEM1; P01889; Q86VP3; P49450; Q14005; Q5T4S7; P49792; P62993; P19447; P35658; Q01105; P17980; Q15046; O43683; O95786; Q9BYM8; P10809; P29083; P19438; O60506; A8CG34; Q86X55; O15350; P05787; Q07812; Q7Z5K2; P18754; P12004; Q14240; Q7L5N1; P41597; Q13573; P45973; Q06787; P49959; Q9Y6W5; Q9UER7; Q6UUV7; Q9BTX1; Q15056; P11387; Q92793; P12270; P62826; P28749; Q15942; P09651; O43765; P30307; P57740; Q8TAE8; P63279; Q16236; P13051; Q12959; P08047; Q9H6F5; Q7KZ85; P62258; P63165; P63244; P14784; O00571; Q93009; P49790; Q8WUM0; Q07866; Q86WV6; P20248; Q92878; P25788; P12235; Q9NYB9; O95295; Q6UUV9; P49815; Q92538; O75179; P17544; Q9BYX4; P11142; Q05086; P08727; P31994; Q96LA8; Q93034; Q13435; Q9UGM3; P63167; P37198; Q16531; Q9Y6G9; Q13409; P61586; Q92993; P52948; O15519; Q96HA1; P08729; O60563; P21796; P05783; O14980; Q9NPY3; Q07021; Q8IZP0; Q00403; O60885; P31946; P23497; Q9UKX7; Q969H0; Q8NFH5; Q04323; Q86V81; Q9NPB6; Q14457"]
["GO:0030036","biological_process","actin cytoskeleton organization ","O96013; Q9NQU5; O15530; P35240; P21359; P00519; Q13177; P11274; P53667; P07737; P63000; Q9P286; Q13976; P23528; Q13464; Q13045; O14745; P23677; P53365; Q15642; O00560; P01116; Q08495; Q16658; Q8WYL5; P35611; O15511; Q9UL54; Q96QB1; O60331; O43312; Q9Y6W5; Q96PE2; O75369; Q99418; Q8IZ21; O15259; P54252; O14492; P11171; Q9BR76; Q9UNA1; Q9ULV4; P61587; Q7L0Q8; P41182; Q92556; Q8WX93; P08913; Q27J81; P47756; P61586; P60953; Q9NSV4; Q4VCS5; P35612; Q9H093; O14613"]
["GO:0032147","biological_process","activation of protein kinase activity ","O96013; P46734; P41279; P45985; Q9NQU5; Q13163; Q15831; Q7KZI7; Q13233; P05106; O95747; Q56UN5; O94804; Q9P286; P52564; Q99558; P06213; Q9H2G2; Q13153; Q05655; Q9ULW0; Q13705; Q9UEW8; Q9UL54; Q99759; Q96PY6; P04156; Q7RTN6; Q15058; Q9HAW4; Q9Y4K3; Q12959; P37173; Q9H8V3; P14416; O75674; P08913; Q9H2P0; Q9Y572; O15169"]
["GO:0006915","biological_process","apoptotic process ","O96013; O00141; Q06413; P45985; Q9H4B4; Q9NQU5; P51813; Q09472; P27361; Q9NYF8; O60566; P06493; P11309; O60674; Q14653; Q13177; P21802; P29590; P38398; P80192; P19838; P21127; Q14289; P23443; P34947; P25963; Q15139; Q13546; Q16513; Q14680; P28482; Q86V86; Q02078; Q92835; P05771; Q9P286; P17302; O14733; Q13043; Q02779; Q16539; P42858; P67775; O43353; P52564; Q9Y6K9; Q12778; O43293; Q14814; Q92934; Q02156; Q15121; P04049; P68400; P60484; Q13464; Q9UQ88; Q9HC98; Q13315; P49736; Q9H2G2; P04150; O14757; Q13153; Q05655; Q9ULW0; Q9H7L9; Q96IZ0; O15033; P41180; O15162; P0DN86; Q13158; Q8WV24; Q12962; O43521; P14598; Q12904; Q96PM9; Q86VP3; Q96PH1; P51114; Q9NWH9; Q9P289; Q14684; Q15464; P55211; Q9H8G2; P19447; O60346; Q13188; P61073; P09382; O43683; Q8WUF5; Q99966; Q14674; O75940; O14727; Q9H1Y0; Q9BST9; P46695; P25445; Q13323; P23760; O95140; Q86VP1; P23396; Q9UL54; Q5D1E8; Q9NQC3; P48023; Q96P20; Q96FV9; Q9UIK4; Q96QB1; Q07812; P05107; Q13829; Q9Y3T9; P61289; P10415; O43236; P46379; Q9NZS9; Q14790; Q9NRY6; Q15276; Q53EL6; Q9NR28; Q9UER7; Q9H4B6; Q9BZR8; P55212; Q9HB09; Q9Y3E5; Q9BUZ4; Q15052; Q9H422; Q9NQS1; P17936; Q13501; O15392; P53355; P37173; P01589; Q16342; P0DN87; Q13114; Q03112; Q6IE81; P36897; Q86WV6; P98082; P55210; Q9UHX1; O14737; O95185; Q92556; Q9Y2W7; Q13009; P21730; P35900; Q96JJ3; P24522; Q96B97; P10914; P62745; Q13352; Q9Y3E7; Q13077; P11234; P19784; Q16611; P63167; P06702; Q9UNN5; P30153; Q9ULZ3; Q14185; O00213; P29350; Q13155; O15519; Q07352; Q05516; P35869; Q7Z6J0; P21796; P09874; Q8WWK9; Q92785; O15169; Q03164; P42574; P42575; Q9BWT1; Q9UJV9; P43146; Q07021; O94768; Q8IUQ4; Q9UPG8; Q9H093; Q96J02; P51397; Q9Y371; Q9Y2N7; Q13794; Q9HB90; Q9H3D4; O43255; O15294; P31483; Q96TC7; Q66K74; Q9HCU9; Q99828; Q14457; Q53GA4"]
["GO:0007049","biological_process","cell cycle ","O96013; Q13164; P62140; P62136; Q13422; Q16659; P41279; P31152; P27361; O15264; P11309; Q16513; Q96L34; Q9BVS4; P51812; P28482; P51610; Q86V86; Q12824; O94804; Q00535; Q14511; P57059; P12931; Q02156; P68400; P04150; O14757; Q14012; Q15418; Q05655; P30279; P46013; Q2NKX8; Q8NCD3; P41220; Q15554; Q6P1K2; Q9H3M7; P19474; Q8WW12; Q9NWV8; Q9UKG1; Q8TEW0; O75410; P15173; P85299; Q9H0Z9; P04899; Q15019; O75400; Q9UH03; Q9UJX5; Q5VWQ8; Q12798; Q13112; Q96PY6; P61289; Q9NQC7; O43236; Q8IVT2; Q9H1A4; Q9UPY8; Q5UIP0; P50749; Q15555; Q8WYJ6; Q9BSJ6; Q52LA3; Q9UJX3; P28749; Q96T88; O00716; Q8IYU2; Q9NUQ3; Q8NHZ8; Q86WB0; P11171; P51946; Q8TAP9; Q16181; P63279; Q9P0W2; Q8IYM1; P63244; Q8N163; P49916; Q8TDN4; Q9H2D6; Q9NQR1; Q9H2G4; Q8WVB6; Q13625; P30281; Q13352; Q9Y3E7; P49917; P11234; P19784; Q9UK53; Q6P1J9; O14519; P36873; Q6P0N0; Q86UE8; Q5TKA1; Q99719; Q8WVI7; Q8NEB9; Q9Y6G9; P09496; O75449; P35869; P48729; O60563; Q9ULC4; P11233; P05783; Q8N9N5; Q8IUQ4; Q9UHD8; Q69YH5; Q00839; Q13526; Q9Y266; Q99618; Q6P1M3; Q9Y265; Q9UKI8; O43255; Q13111; Q9UM11"]
["GO:0016477","biological_process","cell migration ","O96013; Q5VT25; P06239; P22455; Q15303; Q15262; Q9NQU5; O15530; Q05513; P17948; Q13882; P25054; P09619; P06493; P11362; O60674; Q13177; P09769; Q9H792; Q07912; P29317; Q86YV5; P29597; P10586; P23443; P19174; P51451; Q13469; P07332; Q9P286; O75914; P06241; P07947; P54753; P29320; P60484; Q9Y5S2; P23458; P41743; P52333; P42685; Q13470; Q14469; P04004; P62993; Q03167; Q9UGP4; P52735; Q16658; Q14160; O75400; P05556; P56945; Q13574; O15511; P19022; Q9UL54; P11047; O00443; Q12948; O00592; Q9GZM8; Q13829; Q9NXR1; P19634; O43157; P32004; Q8WY41; P14923; P42338; Q9BR76; P17813; P13688; P11308; P21453; Q92614; P62820; Q96SB3; Q9NYB9; P18827; Q92556; Q13009; Q9H4A6; Q96B97; Q5VZK9; Q8WX93; Q9NRY4; O95863; P34741; P31431; P13796; O14713; Q8TDY4; Q14185; P61586; Q3V6T2; O75056; Q8IX03; P62324; Q68CZ2; Q7LC44"]
["GO:0071407","biological_process","cellular response to organic cyclic compound ","O96013; P31749; P42224; Q13177; P49715; P40763; P25963; P14635; P51610; O75914; P08238; Q13887; P09382; P13498; P17676; O15198; P46527; P82094; Q14790; P10070; Q12946; Q86WV6; Q15327; P01375"]
["GO:0007010","biological_process","cytoskeleton organization ","O96013; Q9NQU5; Q9P212; Q9NYL2; Q9P286; Q14511; Q9P0L2; P23528; Q9UKE5; Q9Y5S2; P41743; O14939; Q14202; Q9UBW7; Q9UGP4; Q08495; O75400; Q92692; Q99439; P02649; O95425; Q8WWN8; Q9NYB9; Q7L0Q8; Q6P0Q8; Q96JJ3; Q96B97; Q8WX93; O60610; P17661; P47756; Q14185; Q9NZQ3; Q9Y2H9; Q96PY5; Q96IF1; P09493; P48436; Q16555; Q7LC44"]
["GO:0060996","biological_process","dendritic spine development ","O96013; Q13177; P29323; Q9UQM7; P54762; P54753; Q9H2X9; Q8NFD5"]
["GO:2000352","biological_process","negative regulation of endothelial cell apoptotic process ","O96013; Q13164; O15530; P00519; P35968; P23771; Q02763; P02671; O14746; Q16236; P23769"]
["GO:0045766","biological_process","positive regulation of angiogenesis ","O96013; P04629; Q13480; P14921; O15530; P17948; P04792; Q86Z02; P17252; Q9H2X6; P38398; Q01196; Q14289; P40763; Q15139; P19174; P35968; Q9BZL6; P05771; P29474; Q02763; P43694; P21709; P36544; O14746; Q86UE4; Q96EB6; P29972; P52789; O14558; P05556; Q96BF3; P28906; Q92908; O15455; Q5D1E8; P05107; Q16665; Q13586; Q9NYA1; P14923; Q16236; P17813; P08047; P37173; P09038; Q8N302; P17861; P10301; P21730; O43184; P62745; P09601; P37023; P13726; P52926; P21731; P25942; P33151; P23769; P62324; Q9UKV8; Q15672; O95398"]
["GO:0001558","biological_process","regulation of cell growth ","O96013; P08922; O00141; Q13557; P06400; Q15831; Q9P212; Q04759; P21127; Q9P286; Q08345; Q08050; P42345; Q9UQ88; Q96BR1; P56945; Q9UL54; O94763; Q9HBY8; Q8WY41; P17936; Q15058; Q96KS0; P13688; P17861; Q7LDG7; Q8N122; Q6P1J9; P30556; Q9NZT2; Q96J02; Q7Z628"]
["GO:0043408","biological_process","regulation of MAPK cascade ","O96013; Q9NQU5; Q13177; Q9P286; P62993; O60346; P08476; Q9H4P4; Q96PV0; P22004; P41134; O95390"]
["GO:0007346","biological_process","regulation of mitotic cell cycle ","O96013; P46734; P41279; P45985; Q9P1W9; Q9NQU5; Q92918; Q13163; P06400; Q12851; P11309; Q13177; P36507; P21127; Q13233; P53350; P49336; O95747; O95819; Q56UN5; Q86V86; Q9Y4K4; O94804; Q9P286; O75914; Q8TDX7; Q9Y2U5; O14733; Q13043; P57059; P52564; Q02750; O43293; Q99558; Q7L7X3; Q9Y6E0; O00506; Q9UKE5; Q9UQ88; Q9HC98; Q9H2G2; Q13153; Q96EB6; Q9UKT4; Q8N4C8; Q9P289; Q9UEW8; P49918; Q13188; O00560; Q9Y6R4; O15350; Q9UL54; Q99759; Q96PY6; Q9NQC7; Q7RTN6; P50553; O15392; Q8N4X5; Q92538; Q9NY61; P46940; Q8IVH8; Q00839"]
["GO:0007165","biological_process","signal transduction ","O96013; Q13164; P00533; O94916; Q13554; Q15349; P46734; P51617; Q16659; P07948; Q13131; P45985; Q16566; P31749; Q15303; Q01974; P11802; Q15262; P24723; Q05513; Q13163; P78347; P54646; P53779; P51813; Q13237; Q00534; P49674; P06748; Q9Y243; Q8IW41; P09619; P10276; P03372; P07949; O60674; P16284; Q13177; Q15797; P04626; Q8IYT8; P37231; O95382; Q06418; P01112; P42226; Q14289; P23443; Q9UM73; P40763; Q16512; P53778; Q15139; P19174; Q9UPZ9; P11274; P53667; P30530; P16220; Q16513; O60237; Q08881; P21860; P10721; P51812; P31751; Q9UBS0; P28482; Q92772; Q92835; O75385; P05771; P08069; Q9P286; O14974; Q13905; O14964; Q16832; P17302; O14733; Q14511; P07333; Q13043; Q02779; P61978; Q16539; O43353; P52564; P35568; P42684; P10275; Q02750; Q16644; Q04912; Q9Y6E0; Q13976; P12931; Q9UQ07; O00506; Q02156; P04049; Q96RT1; P68400; P42261; P23771; P08581; P22736; Q13464; Q13315; P04083; Q9Y5S2; P49023; P04150; Q02763; Q8WTQ7; P29376; P28827; P22694; P07900; Q14012; Q15418; Q05655; Q9Y3P8; P78352; O75469; P06401; P36544; P16871; Q9NWQ8; Q7Z434; P0DN86; Q96CV9; Q99996; Q14344; Q16760; P49773; Q14738; Q9NQT8; Q12904; Q92882; P28472; Q70E73; Q13705; Q15464; Q9UL63; O15516; Q9UKG1; Q6ZVD8; Q13671; P11488; Q9UGV2; P60983; Q99062; Q9P2F6; Q96II8; P47736; Q9C0K0; Q9UIQ6; Q92913; P23677; O60266; Q15642; O75628; P32298; Q9P2S2; Q12933; Q13188; Q9NQ66; P43681; Q9UKV5; Q08828; Q9UGP4; Q9NS61; Q13371; P30626; Q07001; P52735; P10588; Q9UHC3; O00299; Q96P48; P04899; O14522; O43741; Q01113; Q7Z5H3; P28906; P50570; O43572; Q13330; Q9UK32; O15455; Q15300; Q9BST9; Q14449; Q13576; P25445; P55196; P16150; O76074; Q15762; Q13362; P62834; Q96RI1; P35659; P48023; P49619; Q9Y4H2; Q96P20; Q15311; Q96FV9; Q9NRF2; Q96QB1; Q9UD71; Q14155; P40259; Q13191; Q9UJF2; Q16665; P78314; O75563; Q15036; P15822; Q13136; Q15185; P20138; O60229; O43157; Q8TDM6; P35626; P85298; P11473; Q15555; O75369; Q9Y450; Q9UQB3; Q9P227; Q92793; Q15653; Q9NYA1; O15259; P57789; P58400; Q9BUZ4; O14654; Q99814; P21462; P67870; O43914; P08173; P31947; O14492; Q08462; Q9Y272; Q9UN19; Q14512; O43295; P18850; P18505; P42338; P53805; Q8N264; P11717; O95613; Q9UBI6; P78368; Q00526; P09038; Q9HCR9; Q9UNA1; P0DN87; Q6PIZ9; Q9ULV4; P11308; P35232; Q13114; P43354; P19235; P14784; O60496; Q9BZL4; P28799; Q68EM7; Q14643; Q14571; Q01518; P55040; O75674; Q04695; Q8WWN8; P36897; Q99962; Q7Z3T8; P08235; Q7LDG7; O60711; Q12955; Q6P5Z2; Q15382; P00749; Q96NW7; Q9Y478; Q5JQC9; Q9Y2W7; Q5VSY0; P21730; P17405; Q13625; Q92915; P30281; Q14C86; P46940; P31994; P31150; Q8WXD9; Q9NRY4; Q13352; Q92686; Q9NP31; Q13077; P41970; P35590; P11234; P31949; P54619; P08758; Q07889; Q9UNS2; Q9H0E9; P32927; Q13972; P08833; Q5TB30; P37023; P57796; O60239; Q9H165; P40145; Q9UMX1; Q96Q27; Q9UBF8; Q9ULZ3; P07510; Q14185; O00213; O43823; Q9Y572; P20309; Q99704; P51858; Q9NZQ3; P20936; P01730; P24394; Q13261; O95267; P55039; P48729; Q5T5U3; P11233; P42262; Q9H0M0; P63104; P50895; O00329; P15260; P46060; Q07666; Q03060; Q92731; Q99961; P50395; P36896; Q14994; P27815; Q04724; Q9UN36; Q8NFJ5; Q9UBS8; Q15172; P16949; Q7Z628; O95398; P48436; P33241; P78348; O15294; P10599; O15117; Q12929; Q16555"]
["GO:0023014","biological_process","signal transduction by protein phosphorylation ","O96013; P08922; P46734; P41279; P45985; Q9NQU5; Q13163; Q13177; Q13233; O95747; Q56UN5; O94804; Q9P286; Q13043; P52564; Q99558; Q9H2G2; Q9UEW8; Q13188; Q96PY6"]
["GO:0031098","biological_process","stress-activated protein kinase signaling cascade ","O96013; P46734; P41279; P45985; Q9NQU5; Q13163; Q13177; Q13233; O95747; Q56UN5; O94804; Q9P286; O75914; Q13043; P52564; Q99558; Q9Y6E0; Q9H2G2; Q9P289; O95251; Q9UEW8; Q13188; Q99759; Q96PY6; Q7RTN6; Q9P219; P61586; Q9BPZ7"]
["GO:0045022","biological_process","early endosome to late endosome transport ","Q8IWU2; Q15075; P20339; Q8NEB9; Q96H20; Q14457"]
["GO:0032456","biological_process","endocytic recycling ","Q8IWU2; P61106; P42566; Q8TEH3; Q96JG6; Q96H20; O75154"]
["GO:0001881","biological_process","receptor recycling ","Q8IWU2"]
["GO:0033572","biological_process","transferrin transport ","Q8IWU2; P38606; P02786; P50570; Q9GZU1; Q00610"]
["GO:0019933","biological_process","cAMP-mediated signaling ","Q13164; Q8IVT5; Q08499; Q08828; Q13542; O43181; P43220; Q9Y4G8; Q08462; Q14432; P35869; O95398; P48436"]
["GO:0071363","biological_process","cellular response to growth factor stimulus ","Q13164; Q13163; P29353; P04626; Q00987; P07101; P29475; P23443; Q13546; P07737; Q6IBS0; P06213; P35222; P41143; O43464; P15173; P04040; O94763; P21815; P63244; O43474; Q15583; P51692; P50402; P20333; Q15672; Q99689; Q99828"]
["GO:0070301","biological_process","cellular response to hydrogen peroxide ","Q13164; Q13131; Q04206; P14921; O15264; P00519; P06493; P10242; Q00987; P42226; P30530; Q99683; Q00613; Q12778; P53041; P04083; Q15910; Q05655; Q92769; P30405; Q96EB6; P29972; Q9Y210; P23396; Q02962; Q9HC52; P12004; Q99497; Q16236; Q9UBN7; Q9H8V3; O43474; P62745; O94759; Q16595; P27695; Q9H492; Q7Z628; Q9NRM2; Q14457"]
["GO:0071499","biological_process","cellular response to laminar fluid shear stress ","Q13164; Q13163; P00966; Q16236; Q12772; O43474; P17861"]
["GO:0071560","biological_process","cellular response to transforming growth factor beta stimulus ","Q13164; Q06413; P21802; P84022; Q03135; P06241; P08621; P07947; P35813; P46109; P04150; Q92769; P46108; Q9UBK2; P49675; O14727; O15105; Q14432; P36897; Q15327; O14737; O75716; Q9NPH5; P37023; Q07352; Q9NZC7; P48436"]
["GO:0070885","biological_process","negative regulation of calcineurin-NFAT signaling cascade ","Q13164; P42345; P49841; Q92630; P04156; Q9NSB8; P53805; Q14192; P23634"]
["GO:0051344","biological_process","negative regulation of cyclic-nucleotide phosphodiesterase activity ","Q13164; P11488; O00170"]
["GO:0070377","biological_process","negative regulation of ERK5 cascade ","Q13164"]
["GO:2001240","biological_process","negative regulation of extrinsic apoptotic signaling pathway in absence of ligand ","Q13164; P31749; Q13163; P15976; P35221; Q13546; P06241; O00167; O14746; Q96BR1; Q99502; O43623; Q99504; P10415; P0DMV8; Q86WB0; Q07820; P01375; Q02297; Q07817"]
["GO:0034115","biological_process","negative regulation of heterotypic cell-cell adhesion ","Q13164; Q9H4A3; P02686; Q13163; O43474"]
["GO:0050728","biological_process","negative regulation of inflammatory response ","Q13164; P14921; P06400; Q06418; P19838; P11274; P84022; P17706; P35398; P23771; Q96KB5; Q02763; Q05655; P19438; Q96RI1; Q96P20; O14543; O15553; P02649; Q12946; O14638; P01589; Q07869; Q13133; O43474; Q9UBU3; P20333; P33151; P36955; P34972; P78324; Q5NUL3"]
["GO:0043407","biological_process","negative regulation of MAP kinase activity ","Q13164; P07948; P18031; P04035; P21359; Q15208; Q05655; P41220; O43566; Q5VWQ8; Q12913; P09211; Q92673; P02649; Q6TCH7; P28562; P17405; P37198; P29350; O43597; Q9ULV8"]
["GO:1902176","biological_process","negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway ","Q13164; P31749; P04792; Q96EB6; O43464; O60936; Q16236; P07203; P04179"]
["GO:0060761","biological_process","negative regulation of response to cytokine stimulus ","Q13164; Q13163; O43474"]
["GO:0051247","biological_process","positive regulation of protein metabolic process ","Q13164; Q13163; P45983; P36544; P05067; O43474"]
["GO:0036003","biological_process","positive regulation of transcription from RNA polymerase II promoter in response to stress ","Q13164; P15941; P18848; Q16236; Q14494"]
["GO:0045765","biological_process","regulation of angiogenesis ","Q13164; P14921; P21359; P04626; P29317; P35222; P09038; P09601; P13489; P41134; P23497"]
["GO:0043006","biological_process","activation of phospholipase A2 activity by calcium-mediated signaling ","P00533"]
["GO:0007202","biological_process","activation of phospholipase C activity ","P00533; Q16620; P42681; P19174; Q08881; P28223; P23560; P30679; P21730; Q9H244"]
["GO:0048143","biological_process","astrocyte activation ","P00533; P10636; P49768; P05067"]
["GO:0098609","biological_process","cell-cell adhesion ","P00533; P29353; Q13905; P12931; P35222; P32942; Q14160; P28906; P12830; P16070; Q96J84; O60331; P05107; P10415; Q8TDM6; Q9UQB3; O15259; O60716; Q12946; P14923; Q12959; P49768; O75581; Q96JJ3; Q9NPY3; P48436; P09758"]
["GO:0007166","biological_process","cell surface receptor signaling pathway ","P00533; P40238; P08575; Q8IW41; P22681; P04626; P01112; Q07912; Q14289; Q9HBH9; Q12866; Q16539; Q16644; P08581; P04083; P21709; P16871; Q13158; P09693; P07766; P34998; Q03431; P08476; P30411; P51681; P32241; P01236; P16066; P15391; P42702; P43220; P38484; Q96F46; P48551; Q14790; P08173; P50052; P01589; O60496; P55040; O95551; P10747; P78552; O75022; Q86Y01; Q8NER1; Q9H0E9; P16473; P48357; P37198; P16471; Q99704; P14778; P01730; P48729; Q9Y6Y9; P07550; P58753; O75689; O75762; P78356; Q07666; P13224; Q8NB16; Q01955; Q15109; Q9ULV8; P09758; Q99873"]
["GO:0071230","biological_process","cellular response to amino acid stimulus ","P00533; Q16620; Q9Y6K1; P00966; P42345; Q9P0V3; P17676; P37275; Q9BZB8; P26358; P01375; P17861; Q07817; Q14103; P17655; Q8N122; Q6X4W1; Q8NE35; P08253; Q9HB90; Q04656; O43504"]
["GO:0071276","biological_process","cellular response to cadmium ion ","P00533; P31749; P27361; P45984; P45983; P05412; P28482; Q00613; O15111; P53041; P01100; P04731; P14598; P49675; Q9UER7; P00441; P63165; P06396; P09601; Q04656"]
["GO:0071549","biological_process","cellular response to dexamethasone stimulus ","P00533; P00966; P06730; P23443; Q13541; Q12778; P04150; P29972; P55211; P49675; P50052; O15519; P40818; P36955; Q9UJM3"]
["GO:0071392","biological_process","cellular response to estradiol stimulus ","P00533; P03372; Q9Y6Q9; P15172; Q00613; Q9UBK2; P15173; P48552; P17301; P35548; P20248; Q14103; Q9Y230; Q92993; O15519; P30874; Q92731; Q01851"]
["GO:0034614","biological_process","cellular response to reactive oxygen species ","P00533; P10636; P31749; Q15262; P27361; Q96RR4; P45984; Q15119; Q06187; P45983; P16234; P05412; P16591; P28482; O15111; P12931; P01100; P49023; P14598; Q13563; P32418; P30044; P30048; P09493"]
["GO:0021795","biological_process","cerebral cortex cell migration ","P00533; Q92913; P49768; P61586; P43699"]
["GO:0007623","biological_process","circadian rhythm ","P00533; P04629; Q16620; P11802; Q16288; Q09472; P00966; P35228; Q13627; Q9Y2W1; P16220; P05412; P49841; Q49AN0; Q16613; Q16649; Q9UBK2; O15516; O15055; Q02535; P04818; P17535; P48552; Q08828; P01236; P17752; O00327; P50416; P36956; Q13118; P11387; O15379; O14493; P47928; P12268; O15534; Q86U44; Q8IWU9; O75376; P20393; P41134; P31645"]
["GO:0048546","biological_process","digestive tract morphogenesis ","P00533; P54753; P08151; Q16665; P10415; Q9ULK5"]
["GO:0016101","biological_process","diterpenoid metabolic process ","P00533; P49675"]
["GO:0001892","biological_process","embryonic placenta development ","P00533; P49715; Q00613; Q13563; P27540; P17676; P19484; Q16665; Q99814; Q02447; P98161; Q15648; P23769"]
["GO:0038128","biological_process","ERBB signaling pathway ","P00533; P42336; Q13480; Q15303; P17252; Q13882; P29353; P04626; P21860; Q96RT1; P27986; Q05209; P07900; Q16543; P62993; Q15256; Q99952; Q02297; Q9UNE7; Q93034; Q07889; Q14451"]
["GO:0061029","biological_process","eyelid development in camera-type eye ","P00533; P05412; P11831; Q92769; P08476; Q13547; Q07889; P05549; Q15672"]
["GO:0001942","biological_process","hair follicle development ","P00533; Q04206; Q9NYQ6; P08476; Q9H4B6; Q9ULK5; O75096; Q07889; P36896; P48436"]
["GO:0042743","biological_process","hydrogen peroxide metabolic process ","P00533; Q99497"]
["GO:0007611","biological_process","learning or memory ","P00533; P04629; P10636; Q06413; Q12879; Q13224; P29323; P05129; P28482; P60484; P36544; Q96PM9; Q9UKV5; Q92529; P35462; P43220; P04156; P10827; P41594; P49768; P05067; P40145; P42574; Q15109"]
["GO:0097421","biological_process","liver regeneration ","P00533; O14965; P25963; O14744; Q15910; P08151; P04004; P04818; P17676; P62834; Q13243; P12004; P84098; P67870; Q07955; P26045; P09601; P19784; P24385; P10071; Q8TCS8"]
["GO:0030324","biological_process","lung development ","P00533; P62136; Q09472; Q15796; P49715; P21802; P06730; P29474; P08151; Q14469; Q13705; Q15750; P36956; P46379; P10070; P04198; Q99814; Q02447; Q12946; P46531; Q4G0X9; Q9UBR4; P43699; P10071; P36894; P50281"]
["GO:0010960","biological_process","magnesium ion homeostasis ","P00533; Q12955; Q09470"]
["GO:0061024","biological_process","membrane organization ","P00533; P02686; Q2M2I8; P22681; O75886; P60709; P49407; O14964; P41743; P16871; P01130; O00401; Q04917; P09693; P53675; P62979; P02786; P62993; Q15836; P09497; Q7L5N7; Q15642; P42566; P50570; O43426; O15511; O00443; P0CG47; O60331; Q9Y6I3; P21579; P61160; P08172; P27348; P31947; P63027; O14641; P11717; P51809; Q86TI0; Q8NFH8; P61981; P62258; P20645; Q96D71; P98082; Q99962; P61158; P13569; P11142; Q8N9I0; Q96B97; Q14C86; O75379; P20339; Q96CW1; P09496; Q3V6T2; P01730; Q14247; P62987; P11233; P63010; P07550; P32121; P63104; P30518; P31946; P63261; Q00610; O15056; Q16572; O95208; P49418"]
["GO:0007494","biological_process","midgut development ","P00533; P00966; Q12946; O75553"]
["GO:0060571","biological_process","morphogenesis of an epithelial fold ","P00533; P10275"]
["GO:1905208","biological_process","negative regulation of cardiocyte differentiation ","P00533"]
["GO:0042059","biological_process","negative regulation of epidermal growth factor receptor signaling pathway ","P00533; P22681; O75886; P17706; O14964; P51452; P62993; P42566; Q5VWQ8; Q9Y6I3; Q12913; Q14155; P26045; Q99962; Q96B97; P37198; P60953; O43597; Q9ULV8"]
["GO:1901185","biological_process","negative regulation of ERBB signaling pathway ","P00533; P04626; Q05209; Q99952; Q99538"]
["GO:0045930","biological_process","negative regulation of mitotic cell cycle ","P00533; P00519; P29590; P84022; O14745; Q99801; Q14160; Q13574; P46527; Q12948; Q13257; Q12959; P26045; P01375"]
["GO:0045746","biological_process","negative regulation of Notch signaling pathway ","P00533; P31749; P25963; P49407; Q96TA1; P41182; Q86U44; P23769; Q969H0; P50281"]
["GO:0042177","biological_process","negative regulation of protein catabolic process ","P00533; Q12879; Q04206; P35228; P05129; P84022; P06241; Q13257; O15151; P35232; Q02297; P21333; Q99490; Q8N9N5; Q13526; Q8IXJ6; Q14957"]
["GO:0048812","biological_process","neuron projection morphogenesis ","P00533; P51956; O00141; Q13418; P30291; O95819; Q5S007; P17302; Q9Y6E0; O00506; O15075; Q13153; Q9P242; Q9BY11; Q8N4C8; Q9P289; A0MZ66; P51674; P50570; P0CG47; Q5VWQ8; Q96Q89; P07196; O43157; P50219; P61586; Q14247; Q9UJU6; Q04656; Q66K74"]
["GO:0001503","biological_process","ossification ","P00533; Q13761; Q9NZJ5; Q01196; Q16832; P41180; Q92882; P02765; P15173; P10415; P10827; P50749; Q02447; Q9Y4K3; O94901; P80108; Q99958; P13349; Q99523; Q13950; Q15672; P48436"]
["GO:0042698","biological_process","ovulation cycle ","P00533; Q06418; P30530; P01236; P18505; P36955"]
["GO:0038083","biological_process","peptidyl-tyrosine autophosphorylation ","P00533; P08922; P04629; P07948; P06239; P42681; Q15303; P51813; P08631; P27361; Q13882; P00519; O60674; P09769; Q13627; Q05397; Q07912; Q06187; P42680; P29597; Q14289; P43403; P35968; P51451; Q08881; P16591; P41240; P07332; P08069; P43405; Q08345; P06241; P07947; P42684; P06213; P12931; P23458; P52333; P42685; Q13470; P62993"]
["GO:0097755","biological_process","positive regulation of blood vessel diameter ","P00533; P35228; P17302; P29474; P28827; P09601"]
["GO:0045780","biological_process","positive regulation of bone resorption ","P00533; P17252; P43405; P02786; P32245; P00918"]
["GO:0030307","biological_process","positive regulation of cell growth ","P00533; P31749; Q13163; Q9UJU2; P04626; Q14289; P51812; P84243; P68400; Q04637; Q15418; P46108; O00560; P13498; P10415; P19634; Q8IYB8; Q9NYA1; P78536; P31947; O95684; Q96E09; O00571; Q04695; P36897; P16401; Q02297; Q13049; Q06265; O43598; Q8N122; P08833; P06702; P61586; P60953; Q16595; P50281; Q09161; Q99828"]
["GO:0031659","biological_process","positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in /S transition of mitotic cell cycle ","P00533; P31749; P11309; Q13563; P78536; Q9H4X1; P98161"]
["GO:0045739","biological_process","positive regulation of DNA repair ","P00533; P38398; P16104; Q13263; O00167; Q99502; Q96EB6; Q15819; Q9NWV8; Q99504; P23396; Q9HC52; P12004; O00213; P61088; Q9BUR4; Q96RL1; Q6UWZ7"]
["GO:0045740","biological_process","positive regulation of DNA replication ","P00533; P45985; P06493; P01112; P05412; P63000; P08151; P12004; Q13829; P10070; P18846; Q9UNN5; P60953; Q9H211"]
["GO:0050679","biological_process","positive regulation of epithelial cell proliferation ","P00533; Q13163; P01106; P21802; P04626; P01112; Q92934; Q99502; P01236; P11047; Q02962; Q14524; P56178; P22392; P21730; P15531; P46531; P22004; P36894; P41134; Q15672; Q04656; P48436"]
["GO:0048146","biological_process","positive regulation of fibroblast proliferation ","P00533; P11802; Q00534; P01106; P09619; P03372; P29590; P07355; P78527; P14635; P16234; P05412; Q16832; P38936; P29972; Q99741; O43181; Q7Z5K2; Q01094; P35226; Q9NYA1; P20248; Q8N6T7; P49917; P15408"]
["GO:0050729","biological_process","positive regulation of inflammatory response ","P00533; P14921; P37840; O15264; P21980; O60674; P49715; P25963; P01130; O15516; P19438; Q9HBA0; O15455; P41597; P17301; Q53EL6; P15090; O00206; P06702; P51692; P30556"]
["GO:1901224","biological_process","positive regulation of NIK/NF-kappaB signaling ","P00533; Q04206; Q13418; P19525; O43707; Q9BYM8; O15455; P23396; Q8TDQ0; Q53EL6; Q9NYA1; P05067; Q9NYB0; P01375; O00206; Q5TC82; P61586; Q15654; Q15109"]
["GO:0010750","biological_process","positive regulation of nitric oxide mediated signal transduction ","P00533; Q02108"]
["GO:0042327","biological_process","positive regulation of phosphorylation ","P00533; Q13418; P10275; O00560; Q15185; O95999; P49768; P05067; Q13322"]
["GO:1903800","biological_process","positive regulation of production of miRNAs involved in gene silencing by miRNA ","P00533; P36507; P04637; Q02750; P17844; P04198"]
["GO:1902722","biological_process","positive regulation of prolactin secretion ","P00533"]
["GO:1900020","biological_process","positive regulation of protein kinase C activity ","P00533; Q01974; P58400"]
["GO:0048661","biological_process","positive regulation of smooth muscle cell proliferation ","P00533; P51617; P31749; P04035; P09619; P21980; P42224; P10242; P21802; P23443; Q9NWZ3; P42345; P56524; P35354; Q9UBK2; P13498; P17301; Q02363; Q9Y4K3; P37173; P21453; P01375; P09601; Q13309"]
["GO:0032930","biological_process","positive regulation of superoxide anion generation ","P00533; P10636; Q05655; P04899; P13498; P05107; P09211; P00441; P05067"]
["GO:0051968","biological_process","positive regulation of synaptic transmission, glutamatergic ","P00533; P04629; Q01974; Q14289; P35354; Q9ULB1; P58400; Q9BYB0; P21728; Q8N2Q7"]
["GO:0045907","biological_process","positive regulation of vasoconstriction ","P00533; P31749; Q03135; P17302; P35354; P02671; P41180; P28223; A8MU46; P35368; Q8TD43; P35367; P21731; P30518"]
["GO:0051205","biological_process","protein insertion into membrane ","P00533"]
["GO:0070372","biological_process","regulation of ERK1 and ERK cascade ","P00533; P08922; P07948; P21802; Q8WU20; P04626; P29317; P54762; O14744; P43405; P09211; P13688; P10301; Q13009; P29350; O95267"]
["GO:0046328","biological_process","regulation of JNK cascade ","P00533; P54762; O95819; P08069; Q13905; Q13002; O60346; Q9UQF2; Q9UPT6"]
["GO:0050999","biological_process","regulation of nitric-oxide synthase activity ","P00533; P31749; Q03135; P29474; P07900; O00401; P50570; P0DP23; P35270"]
["GO:0050730","biological_process","regulation of peptidyl-tyrosine phosphorylation ","P00533; P06241; Q02156; P05107; P04156; P05067"]
["GO:0014066","biological_process","regulation of phosphatidylinositol 3-kinase signaling ","P00533; P27361; P28482; Q53EZ4; P48426; P46695; Q13362; O60331; Q12923; Q96T49; P13688; O14986; O95267; P78356"]
["GO:0006357","biological_process","regulation of transcription by RNA polymerase II ","P00533; P15407; Q13761; P39880; P42229; P42681; Q13557; P06748; Q12968; P01106; P19544; P09429; P03372; O14497; P04626; P15336; P37231; P38398; Q01167; P42226; Q99459; P40763; Q16512; P15172; P10244; P41235; P10721; Q12824; P84022; P17947; P25440; P05771; P52630; Q16539; P01100; O43524; P38936; P78545; P0DN86; P46108; O96006; Q9NWH9; Q9Y692; O15516; P17844; P08476; Q8TDD2; Q9Y261; P17535; Q32MZ4; O60244; Q99581; P51532; P53999; P20823; P05114; P10809; Q99966; Q14839; Q14186; Q04760; O15014; Q9HBU1; Q14151; P35659; P17542; Q8TAQ2; P37275; Q08999; P62195; Q15424; Q99697; P36956; Q13573; O94763; Q969G3; Q9Y5T5; P10827; Q9Y5V3; P02649; P82970; Q92886; P04198; P54198; Q9UIG0; Q9BQA1; O60341; P18850; P50219; Q14494; P56693; Q9NQB0; Q16621; P17275; A8MYZ6; Q9H1E3; P47928; P01375; Q15561; Q6STE5; Q9NP71; Q9Y2W7; Q01892; Q99708; Q12800; O94805; P13349; O15119; P10644; Q9HCS4; P23634; O76071; P41162; Q92841; Q9H0E9; P22415; Q9H8N7; P04179; P29374; P46087; P20265; P61586; P51692; Q13950; Q9NRL2; P35869; Q9NZN8; Q96H20; Q6IPX3; Q9H3R0; P19021; P05549; Q9NZC9; Q9H0D2; P15408; P25490; Q9Y2N7; Q9UBS8; Q9Y265; O15294; P23409; Q01543"]
["GO:0051592","biological_process","response to calcium ion ","P00533; Q14289; Q03135; Q92934; P02671; Q16613; P50995; P45379; Q12791; Q9H3M7; O43865; Q8WZ42; P0DP23; Q08209; Q9Y698; Q13507; Q14573; P28562; P18827; P31150; Q14103; P24385; Q86YM7; Q8IWU9; Q9H1D0; P46934"]
["GO:0033590","biological_process","response to cobalamin ","P00533; Q04206; P25942"]
["GO:0033594","biological_process","response to hydroxyisoflavone ","P00533"]
["GO:0006970","biological_process","response to osmotic stress ","P00533; Q9H4B4; O15264; P15336; Q14289; Q14978; O14733; Q12791; Q99576; O43315; Q14244"]
["GO:0070141","biological_process","response to UV-A ","P00533; P31749; P24385"]
["GO:0007435","biological_process","salivary gland morphogenesis ","P00533; P26367; P06746"]
["GO:0043586","biological_process","tongue development ","P00533; Q9UJU2; P10721; P61296; P10071"]
["GO:0006412","biological_process","translation ","P00533; P31749; P62753; Q9UBS0; Q04637; P19525; P62917; P60866; P62280; P05388; P62979; P26373; P05387; Q13542; P23396; Q9H0U6; P42677; P84098; Q9Y450; P62913; P46782; P46778; P40429; P46783; P62841; Q13765; Q9P2E9; Q8NE71; P30050; P62987; Q71UM5; Q07020; Q9Y676; Q9UKV8; P39019"]
["GO:0042060","biological_process","wound healing ","P00533; P21359; P09619; Q15796; P16284; P21802; P04626; P05106; P21860; P16234; P84022; P42345; Q99683; P04049; Q13153; Q9NYQ6; Q14160; Q8WTV0; Q9ULK5; Q9BR76; P17813; P37173; P09038; Q07869; P36897; Q02297; P18827; P41970; Q9UPN3; P31431; P42574; P10071; P09493; P15924; P35372"]
["GO:0006968","biological_process","cellular defense response ","P15407; Q04206; Q14289; Q08881; P14598; P51681; P05556; P15391; P16150; P41597; O43914; O95999; Q6PIZ9; P21730; Q9Y6Y9; Q9UQR1; P19878; P33241; Q14457"]
["GO:0031668","biological_process","cellular response to extracellular stimulus ","P15407; P07948; P08575; P30530; P01100; P38936; P43354; Q9NRY4; Q9H2P0"]
["GO:0006935","biological_process","chemotaxis ","P15407; P01112; P16591; P28482; P07332; Q16539; Q02750; Q12904; Q13393; P51681; Q9NPC1; P16150; Q15311; P41597; P32004; P21462; P42338; P09038; P21453; P00749; P21730; Q4VCS5; P11233"]
["GO:0007565","biological_process","female pregnancy ","P15407; P14921; P10276; P27708; P01100; Q9NZA1; P11166; P34998; Q9UIQ6; P01116; P12272; P01236; Q99624; Q9Y6I3; P10415; P17301; Q13895; O14493; P30427; P53539; P51692; Q9NRA0; Q9UNF1"]
["GO:0001701","biological_process","in utero embryonic development ","P15407; P15976; Q15796; Q96ST3; P11362; P21802; Q04771; P19793; P19174; P14635; O15525; P84022; P17302; P10275; P29474; P23771; Q7Z6E9; P51452; O43521; Q14344; Q99767; Q14145; Q9NR56; Q9BSQ5; Q15750; P16989; Q06546; Q9NPQ8; P05556; P53992; Q15468; P35611; Q92908; Q12948; Q9Y6I3; Q9P2D1; Q99697; Q15256; Q13485; P10070; Q07955; Q12946; P37173; P63146; P61296; Q9BRQ0; P36897; Q07817; Q02410; O15119; P43246; P49917; P46531; P35590; P49459; P20042; Q9UNS2; P37023; P67809; Q9NYV6; O95983; P98161; Q4VCS5; Q03014; P10071; P36894; Q15293; P35579; Q03113; P36896; P09493; P55199; Q15672; Q04656; P30419; Q9ULH0; O96018; Q99873"]
["GO:0007612","biological_process","learning ","P15407; Q16620; P29323; P07101; P05412; Q9P2K8; Q9P286; P06241; P06213; P35354; P78352; O00501; P60983; P31323; Q92913; O43566; Q9H2X9; O43426; P35462; Q9ULB1; Q9UI40; P41594; P58400; Q9BYB0; P05067; P54253; Q9UPX8; P21728; Q8N0W4; P21796; Q96RK0; O60260; Q7LC44"]
["GO:0008285","biological_process","negative regulation of cell proliferation ","P15407; Q15349; P04629; P07948; Q9P1W9; P14921; Q15303; Q01974; Q15262; Q9Y3S1; Q00534; P06748; P15976; P35240; P25054; P19544; Q15796; P10276; O60674; Q15831; P49715; P29590; P01112; Q14289; P40763; Q86U86; P17096; P41235; O15357; Q15678; P05412; P41240; Q12824; P04637; P17706; Q08345; O14964; P11831; P07333; Q13043; Q00613; P10275; Q02750; P29474; P04049; P35222; P23771; P60484; Q15131; P38936; P42685; P56524; Q9BQI3; P35354; P19525; Q9NTI5; O15164; Q9C0C7; Q9P0V3; Q96TA1; O14745; P25686; Q03431; Q9C0K0; P08476; Q13563; Q99801; Q8IZQ8; Q13188; P15173; Q92597; Q9UHI6; P78543; P52945; Q99741; Q15046; O00204; P12272; Q9H0Z9; P46527; Q13362; O15350; O75081; P00747; P37275; Q5VWQ8; P28069; Q96QB1; P42771; Q12913; Q9Y4G8; Q14106; P50616; O15297; Q9H4P4; O75563; P56545; Q13485; Q8WYH8; P20138; P02545; Q13118; Q8TDM6; P0DMV8; Q9BZS1; P11473; P35548; P67870; Q14512; O43541; P17936; P28562; P48678; O95751; P14416; O15151; Q96BK5; P05067; P35232; P80108; O43294; Q96BF6; O43474; Q9H4X1; O14737; P49815; P41182; O00255; P98175; Q9NRG4; P98177; Q8N6T7; P10914; Q9NPH5; P15531; Q93034; Q9Y2T1; P41162; Q15772; O43815; P46531; P31949; Q16611; Q9UK53; Q6P1J9; P37023; O14713; P37198; P04179; P29350; Q13155; Q05516; Q92574; Q8N726; P40337; Q86UL8; P33151; Q03164; P13631; P10071; P12755; P49711; Q8IZP0; Q13363; P30874; Q8IXJ6; P05549; Q06330; O43597; P62324; Q0VD86; Q96AV8; Q01955; P55273; Q99828; Q14457; P35372; O95390"]
["GO:0060674","biological_process","placenta blood vessel development ","P15407; O14497; Q02750; Q13563; O14543; P98161"]
["GO:0045787","biological_process","positive regulation of cell cycle ","P15407; P11802; Q13882; P10276; P21802; P78362; P51610; O14757; O43521; P19474; P15923; P46527; P50553; O75581; Q99967; Q13049; O75179; O15119; P24385; P31645"]
["GO:0051091","biological_process","positive regulation of DNA-binding transcription factor activity ","P15407; P31749; Q09472; Q9H2X6; P03372; O60674; P15336; P37231; Q9UQL6; Q9BZL6; Q12888; P10721; Q12824; P84022; Q16832; P11831; P35222; P60484; P56524; Q7Z434; P19474; Q9UBK2; P14317; Q8IZQ8; Q12933; Q13188; P51532; O95786; P15923; Q12899; Q9H2A3; Q9H4P4; Q99497; Q08209; Q9H4B6; Q92886; O60341; P55317; P14923; O14641; Q9Y4K3; O75581; P05067; Q86WV6; Q9H4X1; P01375; Q13049; Q9BXM7; P35638; Q9HBH7; Q9ULZ3; Q92731; P23497; Q14142; Q99623; O95409; Q13562"]
["GO:2000144","biological_process","positive regulation of DNA-templated transcription, initiation ","P15407; Q9NYF8; P49715; O75030; P05412; P35222; Q15672"]
["GO:0061614","biological_process","pri-miRNA transcription by RNA polymerase II ","P15407; Q04206; P14921; P37231; P17947; P17844; Q13485; O43474; P23769"]
["GO:0051591","biological_process","response to cAMP ","P15407; Q04206; P42224; Q14289; P05412; P01100; Q02763; P17535; P00338; O15240; Q99966; P14679; Q86X55; O43181; P36956; Q01959; P28562; P17275; P18827; P53539; Q9NRD9; O15534; P30613; P16118; Q8TCS8"]
["GO:0051412","biological_process","response to corticosterone ","P15407; Q16288; P07101; P01100; P38936; Q16613; P49675; P0DP23; P07196; P53539; P24385"]
["GO:0034097","biological_process","response to cytokine ","P15407; P49137; P10276; P42224; P29590; Q00653; Q01201; P05412; P11831; Q16644; P40189; Q16613; Q04864; P04818; P17535; Q99966; Q99650; P42702; P10415; Q14624; Q07820; P17275; Q07817; P23497"]
["GO:0009629","biological_process","response to gravity ","P15407; P14618; P01100; P15173; Q16623"]
["GO:0042542","biological_process","response to hydrogen peroxide ","P15407; P13639; P09619; P02511; P42224; P62714; Q14289; P05412; P06241; Q9Y6E0; Q92934; P12931; O00506; Q96EB6; P46108; Q9P289; Q9H3M7; P04040; P49675; P00338; P10415; P32418; P28562; P00441; P18827; P22460; Q9BUL8; P07203; P09601; Q16611; P30048; O75762; P42574; Q7Z2E3"]
["GO:0009612","biological_process","response to mechanical stimulus ","P15407; P14921; P45984; P42224; P37231; Q14289; P23443; P14635; P05412; P12931; P43694; O95069; Q9H3M7; P17535; P78543; Q9HBA0; O60229; P10070; O94901; P37173; P68133; P17275; P22460; P53539; P61586; P50281"]
["GO:0009615","biological_process","response to virus ","P15407; Q9P1W9; P04792; Q00534; P35269; Q9UHD2; P09769; P17096; O14920; Q9Y6K9; P06733; O15111; Q04912; P12931; P23528; O15075; P23771; P19525; P20749; P61073; O95786; Q9UBH6; P38484; Q9BUJ2; P48551; O94763; P26641; Q9BZS1; P08172; Q7Z2W4; Q92985; Q01628; P00973; P17181; O00571; P01375; Q9BYX4; O75531; P13693; P52926; Q9UL17; P11926; P15260; O43504; P16949"]
["GO:0006366","biological_process","transcription by RNA polymerase II ","P15407; O94916; Q13761; P50750; Q13873; P14921; P50613; P78347; P35269; P15976; Q12968; Q6PD62; O00267; P03372; Q9UJU2; Q13148; Q14653; P49715; Q96ST2; P19838; Q14934; P49407; P18615; P51610; Q08050; P11831; Q08945; P23771; P01100; P04150; P43694; Q13887; O15164; P78545; Q12962; Q13287; P52655; Q16649; Q6P1K2; O14640; Q14134; P49716; O75529; P19447; Q99581; Q06546; Q15545; P52945; Q5VWG9; P29083; Q92858; P55347; Q6P4R8; Q92908; Q14186; P17676; P23760; P82094; Q02962; P35659; P17542; Q9Y5B9; P24928; P28069; P26367; Q16665; P15822; P61218; Q8IXH7; P10827; Q03468; Q03111; Q99814; P18848; Q92985; P23511; P51946; Q99626; O14641; Q16236; Q15853; Q14494; Q7KZ85; Q9NP62; Q9H3P2; Q9HB65; O43294; O43474; O96004; Q9Y5B0; P17861; P50549; Q96AE4; P61244; Q86Y01; P98177; P10914; P54845; Q9BYV9; Q6P1J9; P22415; Q16633; P29375; O00625; P67809; P29374; O15266; O43148; Q8WX92; O95644; Q9UIS9; Q8WVC0; P35869; O60563; P09874; O75376; P32121; Q03164; P38159; Q00403; O95905; P52298; O95997; P18146; Q01860; Q9Y2T7; O75444; Q9Y2N7; P55199; Q14585; Q9UQR1; Q9H5H4; Q09161"]
["GO:0006657","biological_process","CDP-choline pathway ","P49585"]
["GO:0006656","biological_process","phosphatidylcholine biosynthetic process ","P49585; Q9Y5K3; Q14693; Q9Y259; Q8NF37; Q9Y365; P28329; P35790"]
["GO:0007017","biological_process","microtubule-based process ","Q9HC35; Q16584; P07437; P0DPH7; Q9NYZ3; Q9BQE3; Q71U36; Q13509; P68363"]
["GO:0000278","biological_process","mitotic cell cycle ","Q9HC35; P51956; Q9Y6K1; Q99640; P00519; O60566; O14965; P10242; Q99459; P21127; Q86U86; P50548; P53350; Q14978; P16591; O14974; P53041; P51955; Q9UQ88; Q96KB5; Q9ULW0; Q13042; Q8IX90; Q02224; Q03188; Q99661; P53675; O43566; Q14807; Q99741; Q96GX5; Q01130; Q9Y5T5; O14578; P62826; Q96JH7; P30622; Q96BD8; O15392; Q14203; P41208; P56211; P30305; P55040; O43768; Q9UJX2; Q96FF9; O00255; Q9UQE7; Q9Y2Z0; Q9BV73; O43823; P22674; Q9H211; P52732; O94762; P10243; Q00610; O14777"]
["GO:0002066","biological_process","columnar/cuboidal epithelial cell development ","P08922"]
["GO:0010629","biological_process","negative regulation of gene expression ","P08922; P10636; Q06413; Q13131; O00763; P31749; P54646; Q9UHD2; P06400; P35228; P02511; P03372; Q13148; P36507; P01112; Q01196; P19838; P35968; P14635; O15357; Q9Y2R2; P06241; P17302; Q02750; P46109; P38936; P06401; O14746; Q96EB6; Q9Y2X9; P01130; Q04864; Q15554; P07766; P41143; Q99801; Q14254; P28906; P82094; Q8TDQ0; Q5D1E8; Q08999; P26358; Q13547; Q16665; O76061; Q99497; P47989; P02649; P28749; P04198; Q9Y3E5; P58400; Q02363; P17813; P61296; P05067; P63244; O43474; P10747; P01375; Q99967; Q9BUL8; P15529; Q9BXM7; Q9Y6N7; P30040; P46531; Q8TEV9; Q16611; P37023; Q9UPQ9; Q15466; Q9H2P0; Q9NV92; P20265; P51608; P40337; Q53GL7; O00329; P36955; P23769; P36896; P25490; Q9UKV8; Q969H0; Q9UQR1; Q99538; O60260; Q01851"]
["GO:0010966","biological_process","regulation of phosphate transport ","P08922; P11362; Q9GZV9"]
["GO:0032006","biological_process","regulation of TR signaling ","P08922; P10398; O43156; Q9Y4R8; Q03113; Q9HB90"]
["GO:0007283","biological_process","spermatogenesis ","P08922; Q9Y5K3; Q96PN8; Q9UQB9; Q9Y6K1; P10276; Q15831; Q06418; P20794; P16104; P14635; P30530; Q00536; P10721; Q5S007; P25440; Q12866; Q00613; P10275; Q92934; P08151; Q96EB6; O43521; Q8NF91; P41220; Q92904; O15516; Q9UGV2; P21554; P16989; Q15019; Q96EP5; Q14671; P50570; O00327; Q6SA08; Q9NVP2; Q01534; P54727; Q01094; Q13485; P46379; Q9NQI0; P40692; O75925; Q9BTX1; Q8TCG1; P49116; P53671; Q9H0H5; Q14990; Q9H0D6; P30307; Q9UHJ3; Q16181; P11717; O94901; Q15569; P00441; P63146; P41208; Q8IYM1; Q9HB65; Q9BW19; P31270; Q07817; P31269; P41182; Q99598; Q9P0K7; P51587; P23634; Q9UPN4; Q01954; P46531; P19784; P54619; Q08378; P22612; Q86U44; P37198; P29375; P29374; P54652; Q9NSV4; Q05952; Q8IUQ4; Q07666; P30874; Q96KC9; P10243; Q03060; O95997; Q9H0D2; Q86YF9; Q9Y2T7; P25490; Q9BXT4; P23945; Q02539; Q9H3D4; P12821; Q9Y265; P48436; P31260"]
["GO:0006003","biological_process","fructose 2,-bisphosphate metabolic process ","Q16875; O60825; P16118"]
["GO:0006000","biological_process","fructose metabolic process ","Q16875; P09467; O60825; O00757; P04075; P05062; P16118"]
["GO:0045821","biological_process","positive regulation of glycolytic process ","Q16875; Q13131; O60825; P54646; P06213; P28223; P27540; Q16665; Q9NP71; P16118"]
["GO:0001816","biological_process","cytokine production ","O94916; P42681; Q08881; Q13469; Q9NWZ3; Q15762; P48736; Q9BZS1; P15090; P06702; P01730; O95267; O00329; O75444"]
["GO:0007588","biological_process","excretion ","O94916; Q96PU5; Q9HAW7; Q96J84; P48048; O43315; O15259; P41181; O60500; P55064; P09601; P30518; P51170; P51168; Q9Y5I7"]
["GO:0070884","biological_process","regulation of calcineurin-NFAT signaling cascade ","O94916; P53805"]
["GO:0060333","biological_process","interferon-gamma-mediated signaling pathway ","Q13554; Q13557; P08631; O60674; P42224; Q14653; P29590; Q9UQM7; P23458; Q13555; Q05655; Q13287; P01889; P19474; Q12899; P16070; Q13568; P38484; Q92985; P00973; P13591; P33076; P10914; Q15306; Q02556; P14316; P15260; P23497; P01892"]
["GO:0061003","biological_process","positive regulation of dendritic spine morphogenesis ","Q13554; O00418; O75914; P23677; P61160; O60229; Q9UQB8; O00429; Q13009"]
["GO:0010976","biological_process","positive regulation of neuron projection development ","Q13554; P04629; Q16620; P07948; Q09472; Q13882; P11362; P07949; Q14289; Q7KZI7; Q15139; Q8IU85; P07332; Q13905; P06241; Q6IBS0; P42684; P29320; P41743; P29376; Q14012; P41220; Q15819; Q14195; P21554; P16333; P62834; Q5VWQ8; Q9Y4G8; P02649; O60341; Q16236; Q15327; Q96NW7; P18846; P22392; Q9NRY4; Q9H165; P06702; Q9NYV6; O00213; Q9NZQ3; O15519; Q93045; Q86UL8; P36955; Q99689; Q9ULH0; P11021"]
["GO:0090129","biological_process","positive regulation of synapse maturation ","Q13554; Q5VWQ8; Q9ULB1; Q12834"]
["GO:0051924","biological_process","regulation of calcium ion transport ","Q13554; P17302; Q13555; O00631; Q00975; Q14005; P41143; P30626; Q96D31; P04899; P26678; P10415; Q13586; P49798; Q9H244; P61586; P01730; O76090"]
["GO:0060998","biological_process","regulation of dendritic spine development ","Q13554; Q06413; Q06787; Q8NE35"]
["GO:0048169","biological_process","regulation of long-term neuronal synaptic plasticity ","Q13554; P37840; P21359; Q05586; P01112; P78352; Q13002; P01116; P41594; Q96PV0; P14416; P05067; P62491; P78508"]
["GO:2001222","biological_process","regulation of neuron migration ","Q13554; Q9UQM7"]
["GO:0014733","biological_process","regulation of skeletal muscle adaptation ","Q13554; Q13555"]
["GO:0051823","biological_process","regulation of synapse structural plasticity ","Q13554; Q09013; Q9ULJ8; P14416"]
["GO:0060385","biological_process","axonogenesis involved in innervation ","P13612; P04629"]
["GO:0007160","biological_process","cell-matrix adhesion ","P13612; Q13418; P05106; P63000; Q00535; P11831; P49023; P02671; P04004; O43521; Q96AC1; Q9UL63; Q9BX66; P05556; Q9UMD9; P28906; P26010; P16070; P18206; P14543; P05107; Q13136; P17301; P18084; P32004; Q15942; Q8TER0; Q13009; P16144; O14713; P61586; P98161; Q92574; P50895; Q13444"]
["GO:0003366","biological_process","cell-matrix adhesion involved in ameboidal cell migration ","P13612; P26010"]
["GO:1990771","biological_process","clathrin-dependent extracellular exosome endocytosis ","P13612"]
["GO:0050904","biological_process","diapedesis ","P13612; P16284; P16591; Q8TCZ2"]
["GO:0035987","biological_process","endodermal cell differentiation ","P13612; P04004; P08476; P05107; P18084; P52926; P08253; P50281"]
["GO:0030198","biological_process","extracellular matrix organization ","P13612; P21359; P16284; Q05397; Q00653; P35968; P05106; P14136; Q08345; Q16832; P02671; P78545; P09958; P04004; P20749; P32942; Q76M96; P05556; P12830; P26010; P16070; P11047; P14543; P05107; Q5TCZ1; P17301; P18084; P21815; Q12946; P09038; P05067; P01375; Q96HE7; O43184; P16144; P13349; Q14118; Q9Y624; Q13444; Q01955; Q04656; P48436"]
["GO:0034113","biological_process","heterotypic cell-cell adhesion ","P13612; P08575; P05106; P05556; P26010; P05107"]
["GO:0007159","biological_process","leukocyte cell-cell adhesion ","P13612; P08575; P16284; P43405; Q13464; P15311; P26038; P05556; P05107"]
["GO:0050901","biological_process","leukocyte tethering or rolling ","P13612; Q13464; P05556; P26010; P16150; P01375; Q9H4A6; P35612"]
["GO:0090074","biological_process","negative regulation of protein homodimerization activity ","P13612; O60271; P41134; P11021"]
["GO:1990138","biological_process","neuron projection extension ","P13612; Q05513; O14965; Q9P2K8; Q08345; P35222; Q9GZM8; Q13009; P46940"]
["GO:2000353","biological_process","positive regulation of endothelial cell apoptotic process ","P13612; P19174; O43524; P41743; P48023; Q53EL6; Q9H4X1; P17861; P25942"]
["GO:1903238","biological_process","positive regulation of leukocyte tethering or rolling ","P13612; P41597"]
["GO:2000406","biological_process","positive regulation of T cell migration ","P13612; P16150; Q8NF50; P05067; Q9ULZ3; P61586"]
["GO:1905564","biological_process","positive regulation of vascular endothelial cell proliferation ","P13612; O15530; Q9Y243; P11362; P09429; P40763; P19174; P78536; P08047; P09038; Q8N6T7; Q9UBU3"]
["GO:0043113","biological_process","receptor clustering ","P13612; Q00535; Q13002; O14640; Q15700; Q14160; P26010; P05107; Q96PV0; Q12959; P21333; O14713; Q16478; Q86UL8; Q9NRD5"]
["GO:0050776","biological_process","regulation of immune response ","P13612; P84022; P01889; P09693; P07766; P32942; P05556; Q9UMD9; Q92692; P28906; P26010; P15391; Q15762; P05107; P20963; P20138; O43914; Q92985; Q8TDQ1; Q5ZPR3; P41182; A8K4G0; P31994; P25942; P01892; P43629"]
["GO:0034446","biological_process","substrate adhesion-dependent cell spreading ","P13612; P00519; Q9H792; Q06418; Q13418; P05106; P30530; P16591; P63000; Q12866; P54753; P12931; Q02763; P21709; Q96AC1; Q15836; Q9C0H9; P26010; P11047; Q15058; P62820"]
["GO:0035690","biological_process","cellular response to drug ","P09467; Q06413; P54646; P01106; P35228; Q06203; P27708; P04637; O14974; P08238; P02786; Q99801; P28222; O15455; P62834; P04156; Q08209; P80108; Q15327; P09417; P51787; Q07343; Q12809; Q15029; Q96A00; P27815; P11021"]
["GO:0071286","biological_process","cellular response to magnesium ion ","P09467; Q12955; Q09470"]
["GO:0016311","biological_process","dephosphorylation ","P09467; P62136; P08575; P23467; P35813; P51452; Q13202; Q96T60; Q08209; O95278; Q9Y6W6; Q9BY84; Q16690"]
["GO:0030388","biological_process","fructose 1,6-bisphosphate metabolic process ","P09467; O00757; P04075; P17858; P05062"]
["GO:0006002","biological_process","fructose -phosphate metabolic process ","P09467; Q01813; O00757; P17858; P08237; O94808; Q06210"]
["GO:0006094","biological_process","gluconeogenesis ","P09467; Q53ET0; P09104; P06733; P00558; O00757; P40926; P04075; Q9UBK2; O15055; P60174; P36871; P40925; Q16526; P05062; P18669; P18848; P04406; P16118; P06744"]
["GO:0030308","biological_process","negative regulation of cell growth ","P09467; Q13873; P19544; P02511; Q15831; P37231; P29590; P41235; P84022; P04637; P17302; P67775; P06733; P38936; Q13470; Q9P0V3; Q13642; Q96EB6; P25686; Q9UGV2; P08476; O75489; P51532; P16066; P46527; Q9NQC3; P42771; Q12913; Q13485; P10415; P0DMV8; Q96A54; P50052; Q9UHH9; P35232; P63244; O00571; Q8N163; Q6IE81; Q96SB3; P41182; Q9H2G4; P10916; Q9UK53; P37023; Q9P0J0; P30153; O00213; Q92731; P62324; P36896; Q13444; P55273; P22413"]
["GO:0045820","biological_process","negative regulation of glycolytic process ","P09467; P40763; P56524; Q9UBK2; P15173; O75081; Q07869; Q8N6T7; P16118"]
["GO:0046580","biological_process","negative regulation of Ras protein signal transduction ","P09467; P21359; P62714; P29323; Q13905; Q13470; O95140; Q5VWQ8; Q9UJF2; Q96PV0; P37198; P20936; Q9BPZ7; O43597"]
["GO:0051289","biological_process","protein homotetramerization ","P09467; O00763; P14618; Q00266; Q06203; P19793; Q53ET0; Q13085; P04637; Q08379; P50552; Q8NCW5; P04075; Q7Z2W7; P61457; Q13563; Q9Y3Z3; P04040; P51649; P17858; Q9NQA5; P32929; Q9UII2; P20963; Q9Y5T5; Q6UUV7; Q14500; P11912; Q9Y3M2; P48443; Q8TD43; P30301; Q6UUV9; O00429; P04183; Q99714; Q8NER1; Q9H773; P12268; P04179; Q14749; Q9GZU1; O75762; P21817; P63252; Q9H3D4"]
["GO:0006111","biological_process","regulation of gluconeogenesis ","P09467; Q15119; P49792; Q14749; O15294"]
["GO:0005986","biological_process","sucrose biosynthetic process ","P09467; O00757"]
["GO:0045786","biological_process","negative regulation of cell cycle ","Q15349; Q13761; P14921; Q15262; Q00534; Q00535; P23771; P22736; P35354; P08476; O43464; P46527; Q53EL6; O75496; Q9H2G4; O00255; Q13625; P62745"]
["GO:0008344","biological_process","adult locomotory behavior ","Q05193; P37840; Q05586; P30279; P41143; Q9Y261; Q14671; Q99497; O60229; Q02363; P05067; P43354; Q70Z35; P28289; P51608; Q6Y7W6; Q92574; O60260"]
["GO:0072583","biological_process","clathrin-dependent endocytosis ","Q05193; P09497; O60331; P27824; Q96CW1; P09496; P63010; Q00610"]
["GO:0003374","biological_process","dynamin family protein polymerization involved in mitochondrial fission ","Q05193; P50570; O00429"]
["GO:0006897","biological_process","endocytosis ","Q05193; Q2M2I8; Q9NZM3; P49674; P48730; P01112; Q07912; O15357; Q5S007; Q9P0V3; Q16760; P01130; Q96T51; Q13671; Q9H1K0; Q15642; Q9Y2K6; P50570; O60784; Q14677; O00443; Q15075; P48736; Q15311; Q8TEH3; Q9Y6I3; Q15276; Q99418; Q9Y6Q2; P10912; P51809; P78368; P05067; P62820; Q8N3F8; Q07817; P49815; Q96B97; O60749; Q14C86; P15531; Q5T1M5; Q9Y5X2; P20339; O75096; Q99523; Q8NEB9; Q9UM54; O95208; Q16555; P49418; Q7LC44"]
["GO:0007032","biological_process","endosome organization ","Q05193; P61020; Q9BTU6; Q13501; Q8NEB9; P40818; Q8IYI6"]
["GO:0002031","biological_process","-protein coupled receptor internalization ","Q05193; P49407; P32298; P50570; P28222; P35462; P14416; P32121"]
["GO:0061025","biological_process","membrane fusion ","Q05193; Q15836; P50570; Q15276; Q8IYU2; P63027; Q14CS0; O00161; Q86UR5; Q9UNZ2; O00429; O60763"]
["GO:0000266","biological_process","mitochondrial fission ","Q05193; Q9GZY8; P50570; Q9NQG6; O00429; O60260"]
["GO:0050804","biological_process","modulation of chemical synaptic transmission ","Q05193; O60674; P18433; P40763; P19174; P11274; P54762; P06241; Q13002; P31323; P05556; Q13542; Q9HCJ2; P62195; Q96SB3; P35367; P40145; Q7Z7A4; Q8N2Q7"]
["GO:0051262","biological_process","protein tetramerization ","Q05193; P04035; P04637; P08069; Q8N684; P04040; Q9NQA5; O15350; Q9BX84; P50542; P05067; Q86YM7; Q13614; Q96QT4; P39019"]
["GO:0006898","biological_process","receptor-mediated endocytosis ","Q05193; P07900; P01130; P16671; Q92558; P53675; Q92598; P50570; P14625; Q15036; Q8WTV0; Q92673; P02649; P11717; P37173; Q01518; P20645; Q96D71; Q8N3F8; P31994; Q9UGM3; Q9UBF8; Q07954; Q14247; P07550; Q9UJU6; Q00610"]
["GO:1904645","biological_process","response to amyloid-beta ","Q05193; P06241; P36544; P04156; Q15109"]
["GO:0007605","biological_process","sensory perception of sound ","Q05193; P02686; P11362; P07101; Q9NZA1; Q99502; P28472; Q01814; O14745; O43623; Q6KC79; P43003; P23760; P46527; Q9P2D1; P10828; Q9NSB8; Q9UBL9; O15392; P00441; Q01668; Q8NEV4; Q9H2D6; P51787; P07203; O60610; Q14831; P47870; P42574; Q9UM54; P05549; O43597; P15382; Q01955; P55273; Q8IVM0"]
["GO:0051932","biological_process","synaptic transmission, ABAergic ","Q05193; P18507; P47870; P14867"]
["GO:0016185","biological_process","synaptic vesicle budding from presynaptic endocytic zone membrane ","Q05193"]
["GO:1901998","biological_process","toxin transport ","Q05193; O14497; Q53ET0; Q15650; Q9UJY5; P78371; P11021"]
["GO:0008306","biological_process","associative learning ","Q8TDC3; P11831; Q13671; P78543; P38919; P61160; P78559; P14416; P05067; Q92686; P60880; Q9Y566; Q99538; P78348"]
["GO:0007409","biological_process","axonogenesis ","Q8TDC3; Q15831; P21802; P16220; O75914; P11137; P49757; Q8TEW0; A0MZ66; Q08828; Q8IWQ3; Q9UL54; Q02962; P12036; P10415; Q96N67; Q9UIW0; O75955; Q9UQB8; P14416; P05067; Q02880; Q12955; Q00169; P46531; O00213; Q9Y6R0; Q96PX8; P43146; Q15334; P16949; Q01851"]
["GO:0030010","biological_process","establishment of cell polarity ","Q8TDC3; P51956; Q05513; Q15831; Q05397; Q7KZI7; P30291; Q96L34; P54762; P49841; Q9P0L2; P08238; P23528; Q13153; P07900; P27448; P11137; Q7L804; Q8IWQ3; Q6R327; P48678; P98161; Q8IX03; Q99689"]
["GO:0090176","biological_process","microtubule cytoskeleton organization involved in establishment of planar polarity ","Q8TDC3; Q8IWQ3"]
["GO:0007095","biological_process","mitotic 2 DNA damage checkpoint ","Q8TDC3; O60934; Q9H2K8; P06493; Q7L7X3; Q9NVI1; P54132; Q9UL54; Q9NZM5; P49959; Q9HAW4; O00409; P98177; P52926; Q92547"]
["GO:0030182","biological_process","neuron differentiation ","Q8TDC3; Q16620; Q06413; Q86Z02; Q9Y6K1; Q9H2X6; P29317; Q9UQL6; Q00535; Q02750; O43293; Q15078; Q01814; Q9Y210; Q02535; Q8IWQ3; P17676; Q9H2A3; Q13547; Q92886; Q9H0D6; P18848; Q9P2K5; P50553; P21453; P36873; P20265; Q13950; Q8N0W4; P42574; Q13526; P41134; Q9UKV0; P11021"]
["GO:0050770","biological_process","regulation of axonogenesis ","Q8TDC3; P07949; Q05586; Q7KZI7; O75914; P49841; P54753; P54764; Q13153; Q9NQT8; Q8TE77; Q8IWQ3; Q8WYL5; Q9HCJ2; Q9NRY4; P20265; O43166"]
["GO:0010975","biological_process","regulation of neuron projection development ","Q8TDC3; P31749; Q9P0L2; P23771; P60484; O43424; Q8IWQ3; Q9GZM8; P60880; Q3V6T2"]
["GO:0048167","biological_process","regulation of synaptic plasticity ","Q8TDC3; P10636; Q06413; Q12879; P10276; Q05586; Q13224; Q14289; Q14934; Q00535; Q04917; P23677; O15240; Q9NYY3; Q13542; Q9Y4G8; P78559; Q96PV0; P61981; Q9UQB8; P49768; P35367; Q92915; Q13972; Q8NE35; O43166; Q14957; Q15109"]
["GO:2000807","biological_process","regulation of synaptic vesicle clustering ","Q8TDC3; Q8IWQ3"]
["GO:0009411","biological_process","response to UV ","Q8TDC3; Q13131; P52701; P29590; P45983; O14733; P19447; P14679; Q03468; Q9NZJ0; O94782; P63146; Q8N163; Q13049; P28715; O00255; Q9NS91; P49459; P22415; Q9BVW5; Q8IVH8; P42574; P55273"]
["GO:0099504","biological_process","synaptic vesicle cycle ","Q8TDC3; Q5T5C0"]
["GO:0060048","biological_process","cardiac muscle contraction ","P46734; P42336; P25098; P42345; P52564; P45379; P19429; Q8WZ42; Q8WUF5; Q92736; P32418; Q14524; P50461; P52952; Q07955; Q16635; O15273; P10916; P51787; O14958; Q12809; Q9H1R3; Q14896; P09493"]
["GO:0035924","biological_process","cellular response to vascular endothelial growth factor stimulus ","P46734; Q04206; P31749; P17948; P04792; P49137; P35916; Q15139; P35968; Q9BZL6; Q16539; P22736; P04083; Q5VWQ8; O75460; P17861; P46531; O14713; O43597"]
["GO:0038066","biological_process","pMAPK cascade ","P46734; P49137; Q16539; Q99683; Q07352; P26651"]
["GO:0043536","biological_process","positive regulation of blood vessel endothelial cell migration ","P46734; P42229; P14921; P31749; O15530; P04792; P17252; Q9Y243; P11362; P09429; Q15139; P19174; P35968; Q9BZL6; P29474; Q96EB6; P00747; Q16665; P78536; Q16236; P08047; P09038; Q4VCS5; P25942"]
["GO:0045860","biological_process","positive regulation of protein kinase activity ","P46734; P08575; Q8N5S9; Q96RR4; Q05397; Q14289; Q00535; Q16832; P38936; Q02224; P13010; Q9ULJ8; Q13094; Q9NYJ8; P32248; P62834; P12956; Q9Y4G8; Q9UPY8; P50749; Q9UER7; Q9BUZ4; P30305; P01375; O75553; P46940; P54619; O43561; Q14118; P31431; P01730"]
["GO:0042035","biological_process","regulation of cytokine biosynthetic process ","P46734; P23771; Q9NZI8; Q9Y6M1"]
["GO:0001541","biological_process","ovarian follicle development ","Q9Y5K3; P35221; P10721; P08476; Q13144; O15240; O15287; P58012; P17676; Q12948; Q07812; Q13485; P10415; P00441; Q07817; Q05086; P50281"]
["GO:0030490","biological_process","maturation of SSU-rRNA ","Q9BRS2; Q9BVS4; O00566; Q9ULX3; Q9BVJ6; P39019"]
["GO:2000234","biological_process","positive regulation of rRNA processing ","Q9BRS2; Q9BVS4"]
["GO:0042274","biological_process","ribosomal small subunit biogenesis ","Q9BRS2; P62753; Q9BVS4; P62841; P39019"]
["GO:0002062","biological_process","chondrocyte differentiation ","Q13761; Q06413; P11362; P22607; Q01196; Q16539; Q14814; Q03431; P10070; P80108; Q13950; P52926; P36894; P48436"]
["GO:0043371","biological_process","negative regulation of CD-positive, alpha-beta T cell differentiation ","Q13761; P09429; Q01196"]
["GO:0050680","biological_process","negative regulation of epithelial cell proliferation ","Q13761; Q00534; P06400; P21802; P15336; P10275; P60484; P49918; Q99801; Q03167; Q5VWQ8; P26367; Q9Y3F4; O43312; Q9Y5V3; Q9H4B6; Q12959; Q9BSI4; O00255; Q6P1J9; P48431; Q9Y6W6; P48436"]
["GO:0048935","biological_process","peripheral nervous system neuron development ","Q13761; Q16620; Q01196; P61296; P50549; Q01851"]
["GO:0043378","biological_process","positive regulation of CD-positive, alpha-beta T cell differentiation ","Q13761; Q01196"]
["GO:0045595","biological_process","regulation of cell differentiation ","Q13761; P11362; P07332; P57059; P67775; P04049; Q9H9S0; O43474; P30153; Q13950; P05549; O43597"]
["GO:0048193","biological_process","olgi vesicle transport ","P39880; Q15139; O43739"]
["GO:0050775","biological_process","positive regulation of dendrite morphogenesis ","P39880; O76039; Q13418; Q8IVW4; P54764; Q8N3Y1; P51809; Q5XUX0"]
["GO:0000301","biological_process","retrograde transport, vesicle recycling within olgi ","P39880"]
["GO:0002250","biological_process","adaptive immune response ","P42336; P07948; P42681; Q16566; O60674; Q06187; P42680; Q14289; P43403; Q9BZL6; Q08881; P41240; Q9P2K8; P05771; P43405; P06241; O43353; P04083; P52333; Q9Y3P8; P02671; Q9NWQ8; Q86WV1; P09693; P07766; Q96LC7; O75626; Q8N1K5; Q96D31; P19532; P19484; Q8TDQ0; P48736; P20963; Q9H400; P40259; P11912; O95999; P42338; Q6PIZ9; Q9GZY6; Q8TD43; P15529; Q13291; O75022; Q6GQQ9; Q96FW1; O43561; P01730; Q9GZU1; Q92574; O00329; P16410; Q96SD1; Q9UJU6; P30203"]
["GO:0060612","biological_process","adipose tissue development ","P42336; P11802; P15336; Q9UBK2; Q9Y463; A1X283; Q02363; P17861; P51449; P24752"]
["GO:0001525","biological_process","angiogenesis ","P42336; Q13480; P54760; P17948; P23467; P17252; P29353; P11362; Q9NZJ5; P16284; P21802; P78362; Q05397; P29323; Q14289; Q15139; P07355; P35968; Q9BZL6; P05412; P54762; P51178; Q03135; P43405; P35398; Q16539; P54753; P29474; P51817; P60484; Q02763; P21709; P35354; Q13887; Q96EB6; Q12904; Q96PH1; Q15464; P52735; Q13370; Q7Z5H3; P55347; Q9UII2; Q5D1E8; P17542; Q12948; Q9NQC3; P48736; Q5VWQ8; Q16665; Q9UKW4; Q6UVK1; P19338; Q9Y6W5; P58400; P21673; Q99814; Q9Y2U8; Q8N264; P13688; P61296; P21453; Q8N302; O96004; P17861; Q9BUL8; P62745; P09601; Q9NP31; P41970; P35590; P37023; P48357; P08253; Q15648; P43121; P35579; P41134; Q06330; Q9UHW9; Q9Y2N7; Q13444; P50281; O95398; Q99828"]
["GO:0043276","biological_process","anoikis ","P42336; P31749; Q15831; P42345; Q9Y6K9; O43318; Q9UIK4; Q96LC9; Q01094; P49815"]
["GO:0060326","biological_process","cell chemotaxis ","P42336; P09619; Q9UJU2; Q04759; P29317; P16234; P10721; P54762; Q05655; P56945; P21462; P42338; P33527; P17813; P21730; Q96JJ3; P32121; P30556"]
["GO:0071333","biological_process","cellular response to glucose stimulus ","P42336; Q13131; Q15120; P54646; Q96ST3; P07101; P11831; P17612; O43524; P48506; P43694; P41180; Q99808; Q9UBK2; P09382; P49675; P13498; P62834; Q02962; Q9Y4H2; Q14721; Q08209; O75460; P63244; P41145; P17861; O00255; P22392; Q9NPH5; Q16478; P36955; Q14654; Q13562"]
["GO:0043542","biological_process","endothelial cell migration ","P42336; P00519; P16284; Q05397; P29474; P51817; P60484; P49023; P05107; P36897; P61586"]
["GO:0097009","biological_process","energy homeostasis ","P42336; Q13131; O00763; P54646; P40763; Q12778; Q04637; P16671; Q9UBK2; Q01433; Q9HBA0; Q6UUV7; Q6UUV9; Q9NP71; Q9UBU3; P48357; Q96RG2"]
["GO:0038095","biological_process","Fc-epsilon receptor signaling pathway ","P42336; P07948; Q04206; O15530; P53779; P27361; Q12968; P29353; P45984; Q13177; Q04759; Q06187; P45983; P42680; P19838; P19174; Q13233; P16885; Q08881; P05412; P16591; P28482; Q13469; P63000; P43405; O14920; Q9Y6K9; O43318; O15111; O00459; P27986; P01100; P15498; Q13153; Q13094; P62993; Q15750; P52735; Q9NYJ8; P0DP23; Q01362; Q9UKW4; Q08209; Q9BXL7; O95999; P42338; P30273; Q9Y4K3; Q9GZY6; Q8N5C8; Q07889; O43561; O95644; Q9UQC2"]
["GO:0038096","biological_process","Fc-gamma receptor signaling pathway involved in phagocytosis ","P42336; P07948; P08631; P27361; P00519; P09769; Q05397; P60709; P19174; P16885; P53667; P42768; P28482; P63000; P43405; P06241; P07947; P08238; P12931; O00459; Q02156; P27986; P15498; Q13153; P07900; Q05655; P46108; O00401; O14939; P09693; P62993; P52735; P16333; O15511; Q9UKX2; P20963; P61160; Q9UKW4; Q9Y6W5; O43516; P42338; O15143; Q9UQB8; P61158; Q92556; Q96JJ3; P12318; P31994; Q14185; P60953; Q9NZQ3; Q8IZP0; P63261"]
["GO:0044029","biological_process","hypomethylation of Cp island ","P42336; Q96TA1"]
["GO:0045087","biological_process","innate immune response ","P42336; P07948; P06239; Q14164; P51813; Q9UHD2; Q13882; P00519; Q12851; P09429; O60674; P09769; P78362; P37231; P29590; Q05397; Q07912; Q06187; P42680; P29597; P19838; Q00653; Q14289; Q15139; P43403; Q01201; P78527; P30530; P51451; Q08881; P16591; P41240; Q9NWZ3; P07332; P43405; P06241; P07333; Q99683; O14920; O43353; P07947; P42684; Q9Y6K9; Q13263; O15111; Q04912; P12931; P23771; Q96SB4; P04083; P23458; P52333; P42685; P19525; Q13470; P02671; Q9HC16; P00736; Q7Z434; Q13158; Q96CV9; P14598; Q04864; P13010; Q15366; P19474; Q14134; P62993; Q96LC7; O75626; Q8IWZ3; O95786; P13498; Q12899; Q92974; O15455; P12956; Q8TDQ0; O94992; Q96RI1; Q9NPP4; Q96P20; P48736; Q5VWQ8; O60828; Q9NQC7; Q96PK6; Q8WXF1; O43914; Q7Z2W4; P54578; Q92985; O95999; P42338; P30273; P43243; P17931; P05067; Q53H80; Q13114; O43164; O00571; Q86WV6; Q13049; O75179; Q9BYX4; A8K4G0; P15529; O00206; Q13291; Q8N884; O60602; Q9UGM3; Q99607; P23246; P06702; Q86XR7; Q9ULZ3; Q96C90; O43823; P52907; Q9BQ95; Q9Y6Y9; Q16666; Q9Y2Y1; P58753; O00329; Q07021; Q8IXJ6; Q96J02; Q14142; Q9H257; Q13444; P05423; Q15109; P19878; P30203"]
["GO:0038028","biological_process","insulin receptor signaling pathway via phosphatidylinositol -kinase ","P42336; P16591; Q86YS7"]
["GO:0001889","biological_process","liver development ","P42336; Q04206; P14618; Q01581; P00966; P21359; P10276; P49715; P27708; P05412; P84022; Q14469; Q9UBC0; Q13563; Q03167; P01116; P52945; P20823; Q92908; Q02447; P11717; Q99798; Q86X29; P17861; Q99967; P09417; Q14103; P46531; O75151; P98161; Q15648; P24752; Q04656"]
["GO:2000811","biological_process","negative regulation of anoikis ","P42336; Q16620; Q05397; Q16654; Q03135; P12931; O43623; P05556; P10415; Q9Y3E5; Q07820; Q07817; P46531; Q04724"]
["GO:2000270","biological_process","negative regulation of fibroblast apoptotic process ","P42336; Q9UEE9; P48736"]
["GO:0016242","biological_process","negative regulation of macroautophagy ","P42336; P31749; Q5S007; P42345; Q9Y250; Q9BXM7; P09601; Q8TEV9; Q92574"]
["GO:0043524","biological_process","negative regulation of neuron apoptotic process ","P42336; P04629; Q16620; Q06413; O15530; P37840; Q9H2X6; O60674; Q05586; Q06418; P01112; Q13418; Q14289; P30530; P49407; P05129; P21860; P05412; P06241; P08238; Q13464; P41743; P48506; Q9C0C7; O14746; Q13002; P28472; P23560; Q15819; Q9UBK2; P19622; Q01105; P78543; P49675; P01116; Q99966; P17676; O15350; Q07812; P07196; Q99497; P10415; P02649; Q96PV0; Q15058; P61764; P00441; P49768; P43354; Q07817; P21730; Q9BXM7; P43246; P09601; P49917; P47870; Q9H2P0; P04179; P61586; P20936; Q99490; P51608; Q16143; Q07954; P32121; Q13526; Q99538; O60260; Q01851; Q9H3Z4"]
["GO:0014065","biological_process","phosphatidylinositol 3-kinase signaling ","P42336; P31749; P21359; P04626; Q06418; P21860; P08069; P35568; O00459; P23771; P27986; P29376; P28223; Q9P242; O00443; P48736; P42338; P17861; Q70Z35; Q07352; O00329; Q07021; Q8IXJ6"]
["GO:0048015","biological_process","phosphatidylinositol-mediated signaling ","P42336; P04629; P09619; P11362; P23443; P16234; P08069; P07333; P35568; O00459; P27986; P15311; P17342; Q9Y4H2; P42338; P06396; Q9UBF8; Q8NEB9; P61586; Q9UQC2; O15294"]
["GO:0046854","biological_process","phosphatidylinositol phosphorylation ","P42336; Q96Q15; O00459; P27986; Q9BTU6; O95861; Q9UHH9"]
["GO:0016310","biological_process","phosphorylation ","P42336; P31749; O14874; P27361; Q13177; Q07912; P29323; Q9UM73; P40763; P05129; Q5S007; Q00535; P42345; P00558; Q9UGP4; P48736; P11387; P53671; P42338; O00329"]
["GO:0032008","biological_process","positive regulation of TR signaling ","P42336; Q9Y243; Q6R327; O15379; P17861; Q15382; Q9H4A6; Q8TEV9; Q8N122; Q9HB90; O43504"]
["GO:0043491","biological_process","protein kinase B signaling ","P42336; P31749; Q9H4B4; Q06418; P29317; Q13418; P23443; P35968; P30530; P31751; Q9UBS0; Q12866; P60484; Q99801; Q02962; Q92569; P01375; P49815; Q9H244; Q07352; P25942; Q8IXJ6; P48436"]
["GO:0043457","biological_process","regulation of cellular respiration ","P42336; P35228; Q8TCS8"]
["GO:0010468","biological_process","regulation of gene expression ","P42336; Q16659; P31152; P11802; P53779; Q00534; P21359; P01106; O15264; P06493; P62714; P53778; P20794; P16885; Q9UPZ9; Q9UBE8; Q9UQ07; Q9NUU7; Q14207; Q99767; P12272; Q9Y6R4; O15350; Q5D1E8; Q9UMR2; Q14106; Q16665; Q6R327; P10415; Q9UHL0; Q9H9S0; P35226; P50553; Q00526; P37173; P05067; P36897; Q15020; Q02410; Q8TD08; O43175; Q99523; Q07352; P48431; P35869; O00148; Q13526; Q01860; P61266; Q04656; O15523; O96018; Q53GA4"]
["GO:2000653","biological_process","regulation of genetic imprinting ","P42336; Q6PD62; Q13263"]
["GO:0050852","biological_process","T cell receptor signaling pathway ","P42336; P06239; P42681; Q9H4A3; Q04206; P08575; O15530; Q15831; Q13177; Q04759; P01112; P19838; P19174; P16885; P43403; Q9BZL6; Q9Y2R2; P42768; Q08881; P41240; P28482; Q92835; O75914; P06241; O14920; O43353; Q9Y6K9; O43318; O15111; O00459; P23771; P27986; Q13153; Q08499; Q9NWQ8; Q13094; Q86WV1; P09693; P07766; Q8N1K5; Q13144; Q9BYM8; P16333; P56945; Q9NYJ8; Q5D1E8; P20963; Q9H400; Q12913; Q9BZS1; Q9UJZ1; Q9BXL7; O95999; P42338; Q9Y4K3; P49768; Q6PIZ9; P10747; Q5TC82; Q07343; O43561; Q14232; P01730; P61088; O00329; O15117"]
["GO:0001944","biological_process","vasculature development ","P42336; Q15831; P35916; Q9NPQ8; Q92688; Q969H0"]
["GO:0032922","biological_process","circadian regulation of gene expression ","P62140; P62136; P49674; P29590; P48730; Q01201; O14744; P35398; Q92769; Q49AN0; P08138; Q96EB6; Q7Z5J4; Q9UBK2; O15516; O15055; P48552; Q9BQG0; Q13330; O00327; P35462; Q13547; Q16526; Q9Y5V3; P11387; P18848; Q02363; P14416; Q07869; O15534; P36873; P29375; Q06210; Q15596; P35869; P51449; Q03164; P20393; Q00839; P56645; O15294"]
["GO:0043153","biological_process","entrainment of circadian clock by photoperiod ","P62140; P62136; P29590; P04637; P57059; Q49AN0; Q13330; Q16526; Q02363; Q9BWF3; Q9UHM6; Q6UUV9; O15534; P36873"]
["GO:0071157","biological_process","negative regulation of cell cycle arrest ","P50750; P11802; O96017; Q00987; P08238; Q53H47; P82970; O15151; Q9NP71; P24385; Q9NS23"]
["GO:1900364","biological_process","negative regulation of mRNA polyadenylation ","P50750; Q6PD62; O00267; P18615; O75150; Q6PJT7; O60563; Q5VTR2"]
["GO:0070816","biological_process","phosphorylation of RNA polymerase II C-terminal domain ","P50750; Q9NYV4; Q14004"]
["GO:2001168","biological_process","positive regulation of histone HB ubiquitination ","P50750; Q6PD62; O75150; Q5VTR2"]
["GO:0033129","biological_process","positive regulation of histone phosphorylation ","P50750; O75676; P27361; P14635; O75582; Q13315; Q06787"]
["GO:1903839","biological_process","positive regulation of mRNA '-UTR binding ","P50750"]
["GO:0050434","biological_process","positive regulation of viral transcription ","P50750; P07737; Q96T23; O60563; Q00403"]
["GO:0006282","biological_process","regulation of DNA repair ","P50750; Q15819; Q9Y253; O94782; Q13404; P61088"]
["GO:0031056","biological_process","regulation of histone modification ","P50750"]
["GO:0051147","biological_process","regulation of muscle cell differentiation ","P50750; Q14012; Q7KZ85; Q96KG7"]
["GO:0031297","biological_process","replication fork processing ","P50750; P54132; Q96FV9; P12004; Q53H47; Q06609; Q8N2Z9; Q9H1E3; Q14191; Q9NZC9; Q6PCD5; Q86V81"]
["GO:0042795","biological_process","snRNA transcription by RNA polymerase II ","P50750; P50613; P35269; P14859; Q9H814; P52655; P29083; Q5VT52; P24928; P61218; Q9BQ15; P08047; Q9BXP5; Q9HB65; Q96AH0; O60563; Q00403; Q9NQG5; P52298; P55199; Q09161; Q96SY0"]
["GO:0006368","biological_process","transcription elongation from RNA polymerase II promoter ","P50750; P50613; P35269; Q6PD62; O00267; Q9NYV4; Q96ST2; Q14004; P18615; Q08945; P19447; Q9Y5B9; P24928; P61218; Q8IXH7; Q03111; P51946; Q7KZ85; P56693; Q9H3P2; Q9HB65; Q9Y5B0; Q6P1J9; Q8WX92; Q8WVC0; O60563; P52298; P55199; Q09161"]
["GO:0000186","biological_process","activation of MAPKK activity ","P04629; O60674; Q8WU20; Q9NYL2; Q5S007; Q13905; Q99683; O43318; P04049; P46109; P00540; P19525; P46108; Q9Y6R4; Q9UL54; Q13255; P49768; P36897; P57077; Q6ZN16; Q9ULH0"]
["GO:0061368","biological_process","behavioral response to formalin induced pain ","P04629; O60229"]
["GO:1990090","biological_process","cellular response to nerve growth factor stimulus ","P04629; P10636; P31749; P22681; P48730; Q99459; P16220; Q13905; P60484; O43524; P46108; P62834; Q9Y4G8; Q01094; P05067; Q8N3F8; Q15057; Q8NER1; Q93045; P40818; Q86UL8; P41134; Q9ULH0; P11021; Q99828"]
["GO:0071316","biological_process","cellular response to nicotine ","P04629; Q04206; P07101; P19838; Q92934; P01375; Q14654"]
["GO:0050966","biological_process","detection of mechanical stimulus involved in sensory perception of pain ","P04629; P06241; P28223; Q9UHC3; P17301; Q09470; O75762"]
["GO:0050965","biological_process","detection of temperature stimulus involved in sensory perception of pain ","P04629; P54762; P28223; Q9UHC3; Q5XXA6; Q8NER1; P32121"]
["GO:0042490","biological_process","mechanoreceptor differentiation ","P04629; Q16620; Q16288"]
["GO:0038180","biological_process","nerve growth factor signaling pathway ","P04629; Q13905; P62834; Q9Y4G8; Q86UL8; Q9ULH0"]
["GO:0048666","biological_process","neuron development ","P04629; Q06413; Q9H4A3; P53779; P45984; P45983; Q9UM73; P11831; P19622; O43464; Q14195; P49619; Q8NI27; P10070; P50553; P49768; O95551; P17861; Q13614; P17600; P20265; Q9HD90; P12755; Q13562; Q14457"]
["GO:0031175","biological_process","neuron projection development ","P04629; P10636; P07948; Q15262; P06400; P09429; Q14289; Q00536; O75385; Q00535; P11831; P49841; Q13464; P28827; Q9UBB4; P11137; Q9ULJ8; Q15078; P78543; Q9NUY8; Q15019; P12830; P29322; Q9Y6D6; O60828; Q9NZ72; Q9Y4G8; Q96N67; P32004; P58400; P27816; P05067; P62491; Q9UK80; Q99962; O95295; Q8N3F8; Q13972; O43175; Q8TAS1; P46934; Q8N2Q7; Q15109; P16949; Q01851; Q99873"]
["GO:0021553","biological_process","olfactory nerve development ","P04629; Q9P2D1"]
["GO:0043547","biological_process","positive regulation of TPase activity ","P04629; P51636; P21359; O76039; P04626; P01112; P11274; O95819; Q13905; P49841; Q9P0N9; P15498; Q15910; O15492; P49792; P47736; Q96P48; Q92997; P05556; P55196; P62834; Q9Y6D6; Q8NF50; Q15311; Q8TEH3; Q9Y4G8; Q14155; Q9GZM8; O43157; P08588; Q15555; Q9P227; O14641; Q9H8V3; P63244; P21453; Q9H6Z4; Q7LDG7; Q13972; Q8TDY4; Q7Z3J3; P49802; O95267; Q5T5U3; P25942; O43665; Q13526; Q9Y624; Q7Z628; O95398"]
["GO:0051092","biological_process","positive regulation of NF-kappaB transcription factor activity ","P04629; P51617; Q04206; O75676; P24723; Q05513; P06748; Q04759; Q06187; P19838; Q00653; Q9UM73; Q9UQM7; Q15139; Q13546; Q9BZL6; O75582; P16591; Q9NWZ3; P05771; O14920; O43353; P10275; Q9Y6K9; O43318; O15111; P57078; P41743; P19525; Q86UE4; P16671; O15516; P62979; Q15750; Q12933; P04040; P01116; Q9BYM8; P32929; Q92974; O15455; Q9NYJ8; Q86X55; P23396; Q9NPP4; P0CG47; Q96P20; P05107; P0DMV8; Q9NYA1; Q9BXL7; O95999; Q9Y4K3; P05067; Q9NYB0; P01375; Q13049; O00206; Q13404; Q8N5C8; Q13077; P06702; Q9ULZ3; Q9Y572; O15519; P61088; P62987; P25942; P30048; P60900; P58753; Q14142; Q15109; Q99828"]
["GO:0043068","biological_process","positive regulation of programmed cell death ","P04629; Q13546; Q96L34; Q5S007; P38936; P01375; P13631"]
["GO:0046579","biological_process","positive regulation of Ras protein signal transduction ","P04629; P01112; Q02297; P46531; Q13972; O95267"]
["GO:0051965","biological_process","positive regulation of synapse assembly ","P04629; Q16620; Q16288; O00418; P29323; P54762; P54753; O43424; P23560; Q15819; Q9ULB1; Q8TDM6; P58400; Q9UBU3; Q9H2P0; P51608; Q96PX8; Q8N2Q7"]
["GO:0010623","biological_process","programmed cell death involved in cell development ","P04629"]
["GO:0048678","biological_process","response to axon injury ","P04629; P07948; Q16288; P06493; O95069; Q14195; P09382; Q07812; P00441; P14416; P61244; Q9H244; P46060"]
["GO:0051602","biological_process","response to electrical stimulus ","P04629; P07101; P12931; Q99996; P78543; P48549; Q14103; Q9UBU3; Q05639"]
["GO:0051599","biological_process","response to hydrostatic pressure ","P04629; P05787; P23634"]
["GO:0031667","biological_process","response to nutrient levels ","P04629; O00763; P07101; P12931; O43524; Q02962; P98177; Q8N6T7; Q8IWU9; O95983"]
["GO:0009314","biological_process","response to radiation ","P04629; Q9H4B4; Q14683; P05412; P17535; O15287; Q96T60; O15297; P10415; P30304; P17275; P41145; P51608; O95243; Q9Y624; P10599; P35372"]
["GO:0060009","biological_process","Sertoli cell development ","P04629; P18827; P48436"]
["GO:0048485","biological_process","sympathetic nervous system development ","P04629; P21359; P23771; P50553; P61296; O14813; Q9H3D4"]
["GO:0051726","biological_process","regulation of cell cycle ","Q00537; P08575; Q09472; P35240; Q9H2X6; Q13148; O76039; Q13523; P40763; P34947; P53350; P11274; P10244; P14635; Q00536; P05412; Q08050; P12931; Q07002; O15055; Q02535; P17535; P35658; O00299; P05556; Q14671; O00327; Q96GX5; Q13243; Q9NZM5; Q9Y5T5; Q52LA3; P30304; Q9NZJ0; Q8IZ21; P28749; Q9NUQ3; Q9NQ86; P18583; P63244; P17275; Q03112; P20248; Q8TDN4; P49815; P10914; Q16611; Q5TKA1; Q13309; Q92574; Q15648; Q13363; Q8IXJ6; Q15329"]
["GO:0007250","biological_process","activation of NF-kappaB-inducing kinase activity ","P51617; O43318; Q12933; O15455; Q9BUZ4; Q9Y4K3; Q96JP5; P58753"]
["GO:0071456","biological_process","cellular response to hypoxia ","P51617; P40238; Q13131; P31749; Q9Y6K1; P01106; Q9H2X6; Q00987; P14635; P04637; P35398; P42345; Q92934; P12931; Q02156; P60484; O43524; Q9NZV8; P00558; P35354; P41180; O14746; O95069; Q96EB6; Q99808; P29972; Q9BXH1; P14672; Q9UBK2; P41143; Q9Y210; Q99801; Q92597; Q92908; Q9BZB8; Q01094; Q9NZM5; Q16665; O76061; P10415; P32418; P02545; P19634; Q99814; P48678; O15151; P20248; Q15327; Q9H4X1; Q96HE7; Q9UNE7; Q9BXM7; Q9UMX0; P09601; O15519; Q07352; Q8IXJ6; O14649; Q15672; Q13794; Q04656; Q99623"]
["GO:0070498","biological_process","interleukin-1-mediated signaling pathway ","P51617; P41279; Q04206; O75676; P27361; P19838; P25963; O75582; Q9NWZ3; O14920; O43353; Q9Y6K9; O43318; O15111; P62979; Q15750; Q9NQ66; Q9NYJ8; P0CG47; Q99759; Q96FA3; Q8N2H9; Q9HAT8; Q13501; Q9Y4K3; Q13404; Q8N5C8; P14778; P61088; P62987; P18146"]
["GO:0007254","biological_process","JNK cascade ","P51617; P45985; Q16584; Q01974; P53779; Q12851; Q12852; P45984; P45983; Q9NWZ3; Q02779; Q99683; O43353; Q9Y6K9; O43318; P46109; P41180; Q8N4C8; P62979; Q15750; Q13098; Q9NYJ8; P0CG47; Q15052; Q9Y4K3; O60500; P01375; Q92915; Q13404; Q8N5C8; Q8IVH8; P61088; P62987"]
["GO:0031663","biological_process","lipopolysaccharide-mediated signaling pathway ","P51617; P07948; P31749; P08631; P27361; Q14653; P25963; Q9Y2R2; P28482; Q16539; O43353; P29474; Q02156; Q86UE4; P01375; O00206; P30203"]
["GO:0002755","biological_process","MyD88-dependent toll-like receptor signaling pathway ","P51617; Q06187; Q13233; Q9NWZ3; O43318; P16671; P62979; Q15750; P10809; Q9NYJ8; P0CG47; Q9Y4K3; O00206; Q8N5C8; O60602; Q9Y6Y9; P62987; P58753"]
["GO:0032088","biological_process","negative regulation of NF-kappaB transcription factor activity ","P51617; Q13163; P25963; P49407; O15111; Q96RT1; Q96EB6; P19474; P04040; O15304; Q9BYM8; Q86VP1; Q8TDQ0; Q5D1E8; Q96RI1; Q96P20; Q5VWQ8; Q96FA3; P42771; Q9NQC7; Q9BZS1; Q13114; Q93009; O43474; Q8N2W9; O94874; Q9ULZ3; P32121; Q53GL7; Q96J02; P51397; Q9HCU9"]
["GO:0070423","biological_process","nucleotide-binding oligomerization domain containing signaling pathway ","P51617; O43353; P52564; Q9Y6K9; O43318; P62979; Q15750; Q9NYJ8; P0CG47; Q9NQC7; Q14790; Q9Y4K3; Q13404; Q8N5C8; P61088; P62987; Q96J02"]
["GO:0043123","biological_process","positive regulation of I-kappaB kinase/NF-kappaB signaling ","P51617; Q9P1W9; Q04206; Q14164; Q9UHD2; P00519; P21980; Q14653; Q15139; Q13546; Q9NWZ3; P05771; P06241; P17302; O14920; O43353; Q9Y6K9; O43318; Q99558; O15111; P53041; Q02156; P35813; Q9HC98; Q7Z434; Q13158; Q86UE4; Q04864; O43734; P16671; P09382; Q9NYY3; Q9BYM8; P19438; P32929; O15455; Q9NYJ8; P32248; Q99759; P48023; Q96FA3; Q12802; Q14790; Q9HAT8; Q7Z2W4; Q9BXL7; O95999; P63279; Q9Y4K3; Q9H8V3; Q9NYB0; Q6P1N0; P01375; Q13049; P21333; O75179; O94827; Q9BXM7; Q13404; P29692; P09601; P37198; Q86XR7; Q9NV92; P61586; O15519; P01730; Q92734; P61088; P25942; P58753; Q96IF1; O60885; Q9H257; O60260"]
["GO:0032481","biological_process","positive regulation of type I interferon production ","P51617; Q04206; Q09472; Q9UHD2; Q14653; P19838; P42226; Q00653; P16885; P78527; Q9Y2R2; P43405; P35222; P13010; Q32MZ4; P12956; O60828; P49959; Q92793; Q92985; Q86WV6; P10914; Q8N884; Q16666; Q9UJV9"]
["GO:0051259","biological_process","protein complex oligomerization ","P51617; P10636; P51636; Q13557; P06748; P17302; P10275; Q13263; Q13555; Q02763; Q8NE86; P54132; Q9UKV5; O60936; P17858; Q5D1E8; Q96P20; Q07812; P19634; P08237; Q9UJZ1; O95999; O14641; P00973; O00429; P22392; O75525; O60749; P35638; P08034; O95267; P38159; Q07666; P31645; Q9Y371; Q09666"]
["GO:0001959","biological_process","regulation of cytokine-mediated signaling pathway ","P51617; Q01196; P42702"]
["GO:0070555","biological_process","response to interleukin-1 ","P51617; Q04206; P14921; P37840; P17252; P12931; P04083; P41743; P48506; P56524; Q99966; P13498; Q9Y4K3; P14778; P42898"]
["GO:0032496","biological_process","response to lipopolysaccharide ","P51617; P37840; P49137; O60674; P21802; P07101; Q00653; P23443; P16885; Q9Y2R2; P05412; P16591; P51812; P17302; Q16644; O15111; Q96RT1; P01100; P35354; Q92769; P08138; P43119; P55211; P21554; P17535; Q99966; P01236; P19438; P25445; P32248; P48023; Q96FA3; Q14790; P78536; Q9UBI6; Q53H80; P17181; P17275; O00206; P21730; Q13651; P46531; P32927; Q9Y6Y9; P25942; P30048; P58753; Q9Y6W6; P42574; Q13151; P34972; Q15842; P16615; P30203; P35372"]
["GO:0034134","biological_process","toll-like receptor 2 signaling pathway ","P51617; O43353; Q6ZUJ8"]
["GO:0034142","biological_process","toll-like receptor  signaling pathway ","P51617; P25963; O43353; Q96RI1; P05107; O00206; Q86XR7; Q9Y6Y9; Q6ZUJ8"]
["GO:0034162","biological_process","toll-like receptor 9 signaling pathway ","P51617; Q9NWZ3; Q8TDQ0; Q96RI1; Q9Y4K3; Q8NEB9; Q6ZUJ8"]
["GO:0002224","biological_process","toll-like receptor signaling pathway ","P51617; P49137; P09429; P51812; Q9NWZ3; Q16644; P02671; P16671; O15455; P14625; O95999; Q9Y4K3; Q13114; O00206; P06702; Q9Y6Y9"]
["GO:0007178","biological_process","transmembrane receptor protein serine/threonine kinase signaling pathway ","P51617; Q13873; Q16539; Q13705; Q5JQC9; P36896"]
["GO:0060337","biological_process","type I interferon signaling pathway ","P51617; P42224; Q14653; P29597; P52630; P23458; P01889; Q9Y3Z3; P40305; Q13568; P48551; Q92985; Q01628; Q9UHH9; P00973; P17181; P10914; Q15306; Q02556; P14316; P23497; P18146; P01892"]
["GO:1904886","biological_process","beta-catenin destruction complex disassembly ","P62136; P25054; Q03135; P49841; P35222; O14640; Q92997; O14641; O75581; Q92837; P48729; O15169"]
["GO:0048754","biological_process","branching morphogenesis of an epithelial tube ","P62136; P08581; Q13153; P41180; Q99801; P10070; P04198; P46531; P98161; P50281"]
["GO:0032091","biological_process","negative regulation of protein binding ","P62136; Q9P1W9; P31749; P49674; P35269; O14965; Q96GD4; P45983; P60709; Q14934; P48681; Q5S007; Q03135; P49841; Q08379; Q13464; Q14012; Q05655; Q9UBB9; O95816; O14640; P25686; Q86X55; Q07812; Q99497; Q92673; Q92797; O60341; Q8IWB6; Q07869; P98082; Q9NYF0; Q9HC62; Q9UNE7; Q13569; P30533; P11234; O14713; Q9H2P0; Q13526"]
["GO:0070262","biological_process","peptidyl-serine dephosphorylation ","P62136; P62714; P67775; P53041; P16333; P28562; P30153"]
["GO:0035970","biological_process","peptidyl-threonine dephosphorylation ","P62136; P62714; P67775; P53041; P35813; O15297; O15355; Q9P0J1; P28562; O75688; Q9Y6W6; Q16690"]
["GO:2001241","biological_process","positive regulation of extrinsic apoptotic signaling pathway in absence of ligand ","P62136; P21359; P07949; P35221; O43293; P08476; O43464; Q07812; P30154; P30153; Q9NZC7"]
["GO:0060828","biological_process","regulation of canonical Wnt signaling pathway ","P62136; O94921; Q5S007; P35222; Q8ND76; Q9UQB3; P49768; Q9NYF0; P50402; O60260"]
["GO:0005979","biological_process","regulation of glycogen biosynthetic process ","P62136; P31749; P42345"]
["GO:0005981","biological_process","regulation of glycogen catabolic process ","P62136"]
["GO:0036496","biological_process","regulation of translational initiation by eIF2 alpha dephosphorylation ","P62136"]
["GO:0010288","biological_process","response to lead ion ","P62136; P10636; P11802; Q9Y6K1; P62714; P67775; P53041; P04040; P49675; P05067; P09417; Q9H492; Q14457"]
["GO:0031547","biological_process","brain-derived neurotrophic factor receptor signaling pathway ","Q16620; P23560; Q9Y4G8"]
["GO:0021954","biological_process","central nervous system neuron development ","Q16620; P10636; Q00535; P11137; P78543; P50553; P18505; P23769; Q04656"]
["GO:0021987","biological_process","cerebral cortex development ","Q16620; P21359; Q05586; P07101; P16104; Q92934; P11166; O75410; Q9NQ66; Q92858; P19022; Q07812; P07196; Q16665; Q9NXR1; Q9Y6A5; P31939; O60341; P50553; Q15058; Q9UBI6; P62258; O75581; O43379; P21333; P19784; Q07954; Q92574"]
["GO:0007631","biological_process","feeding behavior ","Q16620; P06241; P32245; Q6Y7W6; O43613"]
["GO:0014047","biological_process","glutamate secretion ","Q16620; P43003; P21579; P63027; P43005; Q02410; Q14416; Q8NER1; P48664"]
["GO:0060291","biological_process","long-term synaptic potentiation ","Q16620; Q12879; Q05513; P37840; Q14289; P28482; P14136; P60484; O43566; Q9NYY3; Q9UI40; Q14573; P63027; Q9UPX8; Q8IV01; P21728; P60880; P51608; Q8N2Q7; Q7LC44"]
["GO:0007528","biological_process","neuromuscular junction development ","Q16620; O15146; P04626; Q5S007; O14640; O60229; Q9Y698; Q9UBL9; Q14203; P46939; Q12955; Q02641; Q08289"]
["GO:0001764","biological_process","neuron migration ","Q16620; Q06413; Q16288; P11362; O76039; Q05397; Q7KZI7; P30530; P63000; Q00535; P06241; P17302; P11831; Q9P0L2; Q13976; O15075; P23771; Q9NYQ6; Q15078; Q92913; P51674; Q15154; Q92858; Q07812; P26367; Q9Y4G8; Q99697; Q9GZM8; Q9NXR1; P50553; P49768; P62258; P43354; Q02880; O43602; Q13319; P46821; Q9HD90; P43699; Q7Z6J0; P43146; P23769; Q15672; Q9UMR3"]
["GO:0048709","biological_process","oligodendrocyte differentiation ","Q16620; P04626; P41240; Q00535; P04004; Q9Y2G1; Q07955; P56693; Q02297; P46531; P43699; Q9Y6W6; P10071; P48436"]
["GO:0050772","biological_process","positive regulation of axonogenesis ","Q16620; Q15831; Q02750; O00506; P08138; P52565; O60315; P07196; O43157; Q13009; Q9Y6N7; P61586; Q96PX8"]
["GO:1903997","biological_process","positive regulation of non-membrane spanning protein tyrosine kinase activity ","Q16620; P06241; P12931; P23560"]
["GO:0043087","biological_process","regulation of TPase activity ","Q16620; P21359; Q05397; P42345; P54753; P29320; Q13976; P54764; P15498; P21709; P46108; Q8N5V2; P47736; P52735; P35241; P52757; Q5VWQ8; Q15311; Q9NZ72; Q6R327; Q9UKW4; O43157; P00441; P41182; Q4KMP7; O14713; O75689; O43166; Q96IF1"]
["GO:0051896","biological_process","regulation of protein kinase B signaling ","Q16620; Q15831; Q9H4P4; Q6R327; P10301"]
["GO:0060041","biological_process","retina development in camera-type eye ","Q16620; P07949; Q12866; P11488; Q8NF37; Q07812; P26367; Q9P2D1; O15259; Q9UIW0; Q9H0D6; P84074; P61244; P12268; Q99471; P12755; P36955; P08100; P48436"]
["GO:0046548","biological_process","retinal rod cell development ","Q16620; Q9NS56; P54845"]
["GO:0099183","biological_process","trans-synaptic signaling by BDNF, modulating synaptic transmission ","Q16620; Q9H2B2"]
["GO:0099551","biological_process","trans-synaptic signaling by neuropeptide, modulating synaptic transmission ","Q16620"]
["GO:0030218","biological_process","erythrocyte differentiation ","Q13422; P07948; P15976; Q9H2X6; O60674; P10721; P17947; P17706; O43781; P23771; P52333; Q9UKV3; P14317; P08476; P38646; P55347; P35611; Q9UII2; Q8IZD2; P17542; P10827; Q99814; Q13351; Q14494; P42574; P39019"]
["GO:0030098","biological_process","lymphocyte differentiation ","Q13422; Q01201; P17947; O94900"]
["GO:0007498","biological_process","mesoderm development ","Q13422; P51813; P08631; O60674; Q06187; P67775; Q13705; Q13485; Q99958; P15036; P35590; Q01851; O95390"]
["GO:0045892","biological_process","negative regulation of transcription, DNA-templated ","Q13422; Q04206; Q15262; P06400; P29353; Q9NYF8; P19544; Q15796; P10276; Q96ST3; Q9UJU2; P49715; P10242; P37231; P29590; P38398; Q00987; O43251; P85037; P17096; Q9UQL6; O75582; P05412; P17947; P04637; Q00535; Q08050; Q02779; Q9UPN9; Q12778; P06733; Q13263; P12931; P14859; P35222; P23771; P48506; Q15910; P56524; Q9H7L9; O75469; Q92769; O15164; P78545; Q14469; Q49AN0; Q96TA1; Q96EB6; Q96T58; Q9Y2X9; P13010; Q15078; Q5VUA4; P20749; O15516; O15055; Q02535; P49918; Q99801; Q32MZ4; Q9NQ66; Q01105; Q9UGP4; P51532; Q15545; Q96N95; Q12906; Q99966; Q9BQG0; Q9P1Z0; Q6KC79; P58012; Q92908; O00327; P46527; P12956; O75081; O94992; P55316; Q02962; Q8TAQ2; P37275; Q5VWQ8; P62195; P42771; Q13547; Q01094; P56545; Q13573; Q13485; Q8IXH7; P45973; Q969G3; Q06455; P55055; P10827; Q13118; O00257; Q16526; Q8WXF1; P83916; Q9BZS1; Q9Y5V3; Q53EL6; Q8NF99; P11473; Q9UER7; P15090; P52952; P35548; P27348; O60341; Q02447; Q99592; Q9UHJ3; Q9Y272; P50553; Q9Y3M2; O75496; Q96T23; O15392; Q02363; P63279; Q9Y4K3; Q9UBN7; P56693; P78337; Q9NQB0; O15379; P63165; P35232; Q03112; Q8N163; Q9UKY1; Q96BF6; Q8NEY8; O43474; P98082; P54253; O96004; P33076; P47928; P01375; Q6NUN9; Q99967; Q02297; Q9NQR1; Q9NP71; P41182; O00409; O00255; P11142; Q8N6T7; P10914; O15119; Q96LA8; P35638; Q9NRY4; Q99750; Q8N2W9; Q9Y3Q8; Q9UH92; P46531; P41970; Q86YP4; O15534; Q5TB30; Q92794; Q9P0J0; P23246; P29374; Q92993; Q9UIS9; Q13950; Q9UQ80; P51608; Q05516; P52926; Q9UL17; Q99471; P35869; Q16666; P43699; Q9H0M0; Q03014; P10071; P49711; P20393; Q96RK0; Q13363; Q07666; Q8IXJ6; P41134; P05549; P31946; Q06330; P23497; P51397; Q14994; Q9BYE7; Q04724; Q13185; Q96RL1; Q15672; Q9H3D4; Q9UQR1; Q9UKV0; Q99623; P48436; P23409; O95409; Q9UMR3; Q9HCU9"]
["GO:0051291","biological_process","protein heterooligomerization ","Q13422; Q13131; Q05513; P01112; P35221; Q13418; Q13546; P53041; P48167; P45379; P61457; P62993; Q12933; P21579; O15551; Q14573; Q13501; P14923; O95999; Q16181; Q9Y478; Q9Y3E7; O00186; Q9Y572; Q92574; Q86UL8; Q9UHD8; P31946"]
["GO:1990960","biological_process","basophil homeostasis ","P40238"]
["GO:1990959","biological_process","eosinophil homeostasis ","P40238"]
["GO:0035702","biological_process","monocyte homeostasis ","P40238"]
["GO:0001780","biological_process","neutrophil homeostasis ","P40238; P04083; Q07343"]
["GO:0070527","biological_process","platelet aggregation ","P40238; P04792; P15976; Q9Y490; Q06418; Q13418; P60709; P19105; P05106; P16234; P02671; O00299; P18206; P48736; P42338; P61764; P21291; P21333; O00186; Q9H244; P24844; P29350; P08567; P35579; P63261"]
["GO:0050671","biological_process","positive regulation of lymphocyte proliferation ","P40238"]
["GO:1905221","biological_process","positive regulation of platelet formation ","P40238"]
["GO:0090043","biological_process","regulation of tubulin deacetylation ","P51956; Q09472"]
["GO:0006103","biological_process","2-oxoglutarate metabolic process ","P42229; O75874; P09622; P10912; P51692"]
["GO:0000255","biological_process","allantoin metabolic process ","P42229; P10912; P51692"]
["GO:0006101","biological_process","citrate metabolic process ","P42229; P21399; P53396; P10912; Q99798; P51692"]
["GO:0006600","biological_process","creatine metabolic process ","P42229; P12277; P10912; P06732; P51692"]
["GO:0046449","biological_process","creatinine metabolic process ","P42229; P08473; P10912; P51692"]
["GO:0006631","biological_process","fatty acid metabolic process ","P42229; P37840; P07101; P49327; Q9Y6X9; O15055; P31323; Q9HAW7; P10912; Q07869; P51692; Q03060; Q9NP80"]
["GO:0035723","biological_process","interleukin-1-mediated signaling pathway ","P42229; P29353; P40763; P23458; P52333; P62993; Q9NQ66; P14784; P51692; P01730; Q13261"]
["GO:0038110","biological_process","interleukin-2-mediated signaling pathway ","P42229; P29353; Q14289; P43405; P23458; P52333; P01589; P14784; P51692"]
["GO:0038111","biological_process","interleukin-7-mediated signaling pathway ","P42229; P40763; P35568; P23458; P52333; P16871; P51532; Q9Y4H2; P68431; P51692; Q71DI3"]
["GO:0038113","biological_process","interleukin-9-mediated signaling pathway ","P42229; P42224; P40763; P23458; P52333; Q01113; P51692"]
["GO:0006549","biological_process","isoleucine metabolic process ","P42229; P10912; P51692"]
["GO:0007259","biological_process","JAK-STAT cascade ","P42229; Q6PD62; O60674; P42224; Q14765; P40763; P52630; Q13287; Q13563; P48551; P41597; O14543; O75925; P10912; P17181; P51692; P98161"]
["GO:0060397","biological_process","JAK-STAT cascade involved in growth hormone signaling pathway ","P42229; P07948; P18031; O60674; P40763; P52333; P01236; P10912; P16471; P51692"]
["GO:0007595","biological_process","lactation ","P42229; Q15303; Q06203; P27708; P16220; Q03135; Q08345; P00403; Q99808; P52789; P05388; P01236; Q16665; Q01959; O60229; P47989; P11473; P07741; Q15853; P24385; P16471; P51692; Q15648; P19021; Q04656"]
["GO:0006107","biological_process","oxaloacetate metabolic process ","P42229; P53396; P40926; P40925; P10912; P51692"]
["GO:0001938","biological_process","positive regulation of endothelial cell proliferation ","P42229; Q13873; P51636; P31749; P21359; P17252; Q9Y243; P35916; Q15139; P35968; Q9BZL6; P05106; P05412; P42345; P22736; Q02763; Q96EB6; P27540; P13498; Q16665; Q6R327; Q96T49; P09038; P36897; Q8N302; P22004; Q8N122; P37023; P13726; P01111"]
["GO:0006105","biological_process","succinate metabolic process ","P42229; P51649; P10912; P51692; P31040"]
["GO:0019530","biological_process","taurine metabolic process ","P42229; P10912; O43175; P51692"]
["GO:0006573","biological_process","valine metabolic process ","P42229; P10912; P51692"]
["GO:0031532","biological_process","actin cytoskeleton reorganization ","Q13480; Q5VT25; P18031; P29353; P14616; P16591; P10721; Q6DT37; Q9UKE5; P04083; Q9Y5S2; Q13153; P15311; Q8N4C8; Q9UL63; Q8IWQ3; Q9HBA0; Q6R327; P21453; P21333; P06702; P61586; Q14247; P11233; O43166; P08567; P35579; P50479"]
["GO:0090668","biological_process","endothelial cell chemotaxis to vascular endothelial growth factor ","Q13480"]
["GO:0038089","biological_process","positive regulation of cell migration by vascular endothelial growth factor signaling pathway ","Q13480"]
["GO:0035728","biological_process","response to hepatocyte growth factor ","Q13480; P46108"]
["GO:0038084","biological_process","vascular endothelial growth factor signaling pathway ","Q13480; P35916; Q12948"]
["GO:0006919","biological_process","activation of cysteine-type endopeptidase activity involved in apoptotic process ","P10636; P06239; P37840; P07949; O60674; Q9NZJ5; P37231; P29590; Q13546; P84022; Q92934; Q13158; P08138; Q9BXH1; O43521; Q99801; Q12933; P10809; O14727; P25445; P40305; Q9NPP4; P48023; Q96P20; Q96QB1; Q07812; P55072; Q14790; P47989; Q9NR28; Q16342; P63244; P01375; Q9Y6N7; P06702; Q9ULZ3; P55957; P13726; Q92688; Q8N726; Q71UM5; P51397; Q13794; Q01955"]
["GO:1990000","biological_process","amyloid fibril formation ","P10636; Q00987; Q13546; P16671; P05067; P06396; Q9Y572; Q8N726"]
["GO:0098930","biological_process","axonal transport ","P10636"]
["GO:0019896","biological_process","axonal transport of mitochondrion ","P10636; P07196; Q16665"]
["GO:0061564","biological_process","axon development ","P10636; Q7KZI7; Q08345; Q08AD1; P12036; P32004; P07197; P17677; Q13049; Q9UPT6"]
["GO:0007267","biological_process","cell-cell signaling ","P10636; P15976; P21802; P22607; Q12866; P17302; P10275; P52799; Q02763; P43694; P06401; P0DN86; P43119; Q12904; P23560; P62993; P08476; Q9UIQ6; Q92913; P48165; P51681; P12272; P55196; Q9HBU1; Q15768; P48023; Q96RD7; P05107; P98172; P20138; Q13118; P08588; Q15942; Q96RD6; Q14512; O95297; P0DN87; P35368; Q92915; Q96B97; P16473; O95989; P06702; Q9Y5H0; P08034; Q9UMX6; P07550; Q92731; Q9UL51; P10599"]
["GO:1990416","biological_process","cellular response to brain-derived neurotrophic factor stimulus ","P10636; P13639; O15530; O00418; Q92558; P38919; Q99962"]
["GO:0031122","biological_process","cytoplasmic microtubule organization ","P10636; Q9H4B4; Q9H2G2; O14640; Q15154; Q9NZ72; Q9P219; P23258; Q14204; Q9NRH3; Q3V6T2; O15169; Q9P270; Q99828"]
["GO:0048699","biological_process","generation of neurons ","P10636; Q00534; Q8NI27; O14578"]
["GO:0006475","biological_process","internal protein amino acid acetylation ","P10636; Q09472; P40926"]
["GO:0048312","biological_process","intracellular distribution of mitochondria ","P10636; Q5S007; P57105; O00429"]
["GO:0007613","biological_process","memory ","P10636; Q12879; O15146; P07101; P16220; Q9P286; P06213; P60484; P35354; P36544; P28223; O95069; Q13671; Q92913; P21554; Q9NQ66; Q9NYY3; Q9H2B2; P17676; Q13542; Q9UD71; Q9UI40; O60229; P39748; P78559; P57789; Q14573; Q9BYB0; P49768; P05067; A8MYZ6; P54253; Q6UUV9; P35367; P21728; Q96RK0; P31645; Q99538; P78348"]
["GO:0001774","biological_process","microglial cell activation ","P10636; P37840; P05412; O15455; P05107; P05067; Q8NER1"]
["GO:0000226","biological_process","microtubule cytoskeleton organization ","P10636; Q05513; P06493; Q05397; Q7KZI7; P30291; P16591; Q96L34; Q00535; Q9P0L2; Q7L7X3; P27448; P11137; Q08AD1; Q15078; O75410; P12036; P07196; Q96N67; Q86SQ0; P78559; P54252; P27816; O95613; Q96T17; P18583; Q96SN8; O75122; Q14194; P23258; O00139; P04406; O75379; Q14244; Q15813; Q9Y6G9; P68363; Q3KQU3"]
["GO:0046785","biological_process","microtubule polymerization ","P10636; Q9UKT4; Q9HC77; Q92913; Q9HBA0; O94811"]
["GO:1903748","biological_process","negative regulation of establishment of protein localization to mitochondrion ","P10636; Q92598"]
["GO:0033673","biological_process","negative regulation of kinase activity ","P10636; P41240; P49918; P46527; Q9Y4H2; P30048; Q00839; Q96IF1"]
["GO:0090258","biological_process","negative regulation of mitochondrial fission ","P10636; Q9UBK2; Q9BXM7"]
["GO:0010917","biological_process","negative regulation of mitochondrial membrane potential ","P10636; Q13794"]
["GO:1904428","biological_process","negative regulation of tubulin deacetylation ","P10636; Q13131; P54646"]
["GO:1902988","biological_process","neurofibrillary tangle assembly ","P10636"]
["GO:0072386","biological_process","plus-end-directed organelle transport along microtubule ","P10636"]
["GO:0045773","biological_process","positive regulation of axon extension ","P10636; O76039; Q13418; P53667; P11831; Q6IBS0; Q13153; A0MZ66; Q9GZM8; P32004; P62491; Q02297; Q13439; P46821; P31150; Q9UPN3; Q9H2P0; Q9Y5S1"]
["GO:1903829","biological_process","positive regulation of cellular protein localization ","P10636; Q13131; P54646; Q9NQC7; P78559; P46940"]
["GO:1905689","biological_process","positive regulation of diacylglycerol kinase activity ","P10636"]
["GO:1902474","biological_process","positive regulation of protein localization to synapse ","P10636; Q8N2Q7"]
["GO:0010506","biological_process","regulation of autophagy ","P10636; P04792; Q09472; P00519; P09429; Q5S007; P42684; O43293; O00459; Q13464; Q13315; P48426; Q9UIK4; P53355; Q9UBN7; Q14643; Q14694; P17861; Q8TD08; Q8TEV9; Q8N122; Q16666; P78356; Q9HB90; O60260"]
["GO:0050848","biological_process","regulation of calcium-mediated signaling ","P10636; Q15119; Q14289"]
["GO:1900034","biological_process","regulation of cellular response to heat ","P10636; Q96B36; Q09472; P27361; P02511; P49137; P28482; P42345; Q13535; P49841; Q00613; P08238; Q13315; P07900; Q96EB6; Q9UJY1; O95816; O95817; Q92598; Q02790; P25685; P27694; Q15185; P34931; P0DMV8; Q92793; P15927; P62258; Q8N163; Q99543; P11142; Q8N122"]
["GO:0033044","biological_process","regulation of chromosome organization ","P10636; Q9H211"]
["GO:1900452","biological_process","regulation of long term synaptic depression ","P10636; Q9BYB0; Q7LC44"]
["GO:0070507","biological_process","regulation of microtubule cytoskeleton organization ","P10636; Q13131; P54646; Q7KZI7; P49841; P29320; Q7L7X3; Q155Q3; Q9NQC7; Q86SQ0; Q9NQ86; Q9NS23; P61586; Q86UU1"]
["GO:0031113","biological_process","regulation of microtubule polymerization ","P10636; P00519; P11137; Q08AD1; O75122"]
["GO:0031110","biological_process","regulation of microtubule polymerization or depolymerization ","P10636; Q8IX90; Q9NZ72; Q96BD8; O75122; P16949"]
["GO:0090140","biological_process","regulation of mitochondrial fission ","P10636; Q5S007; P52630; Q27J81"]
["GO:2001020","biological_process","regulation of response to DNA damage stimulus ","P10636; P00519; Q96Q15; P55211; P46695; Q07820"]
["GO:0016072","biological_process","rRNA metabolic process ","P10636; Q9BYG3"]
["GO:0097435","biological_process","supramolecular fiber organization ","P10636; P37840; Q13418; P08238"]
["GO:0007416","biological_process","synapse assembly ","P10636; Q15303; Q00535; P60484; P46109; P23560; Q9P2S2; P51674; P12830; Q9ULB1; P58400; Q9BYB0; P14416; Q9UPX8; Q02297; P21728; P51608; P35612; Q96PX8; Q8N2Q7; Q9UJU6; Q01851"]
["GO:0050808","biological_process","synapse organization ","P10636; P37840; O75914; P36544; O14640; P41594; Q9Y4I1; Q9UQB3; P32004; P49768; P05067; O75096; P17600; Q8N0W4; Q16143; Q92574; Q13526"]
["GO:0006821","biological_process","chloride transport ","Q96J92; Q9NZA1; O00299; O00168; Q5XXA6; P54105; P02730; O76090"]
["GO:0072156","biological_process","distal tubule morphogenesis ","Q96J92; Q9UH77"]
["GO:0006811","biological_process","ion transport ","Q96J92; Q9H4A3; P36544; P48167; P55017; Q9UP95; P43681; Q9H2X9; P43003; Q13621; Q9UI40; P32418; P19634; P55011; P18505; P43005; Q9Y666; P48764; P48664; Q14847; Q6J4K2; Q16595; O75762; Q14940; Q9UHW9"]
["GO:0010766","biological_process","negative regulation of sodium ion transport ","Q96J92; Q9H4A3; P46934"]
["GO:0008104","biological_process","protein localization ","Q96J92; P06748; Q03135; P04637; O75385; P19447; O43572; Q5TZA2; Q9UPY8; Q13501; Q9Y3M2; Q15691; P14416; Q8N1F8; P49815; Q5BJF6; Q9BV73; P51608; O60282"]
["GO:0050794","biological_process","regulation of cellular process ","Q96J92; Q9H4A3"]
["GO:0070294","biological_process","renal sodium ion absorption ","Q96J92; O00141; Q9UH77; Q9UNF1"]
["GO:0019722","biological_process","calcium-mediated signaling ","Q6VAB6; O15530; Q96RR4; Q9NZJ5; Q9P212; Q06187; P19174; P16885; Q5S007; Q9ULJ8; Q8NE86; P61073; P51681; Q92736; Q9NZJ9; Q9NYA1; P05067; Q9GZY6; Q8TD43; P84074; O43561; Q9H244; P30556; P61601"]
["GO:0120162","biological_process","positive regulation of cold-induced thermogenesis ","Q6VAB6; P25054; O60674; P42226; Q03135; P08069; P43405; P17302; Q00613; P33121; Q16836; Q14693; O00631; Q9Y4C1; P16671; O75175; Q7Z2W7; Q9UBK2; O15055; P62508; P61073; O43741; P17676; O95140; P41597; P10827; P08588; Q96A54; P15090; Q99814; O60341; O15379; Q13322; Q9Y478; P07954; Q8N6T7; O00767; Q9UBU3; Q14204; P16473; P48357; P16471; Q15306; P24394; P07550; Q9Y5S1; Q9Y2T7; Q5NUL3; O15294"]
["GO:0034220","biological_process","ion transmembrane transport ","O00141; P17302; P04049; P38606; P36544; Q96BR1; Q96PU5; Q01814; Q9UHC3; Q13621; Q99576; Q92736; Q9UI40; P08133; Q9HBY8; P41181; Q5XXA6; P30301; P55064; P31415; O14958; P23634; O76090; Q9H0M0; O14649; P21817; P78348; P16615; P55087"]
["GO:0007616","biological_process","long-term memory ","O00141; Q16566; Q05513; Q05586; P23443; Q9P2K8; P11831; P42345; P42261; P30279; P01130; O43566; Q08828; P04156; P02649; P14416; O43164; Q13972; P40145; P51608; Q8NE35; Q9Y566; Q7LC44"]
["GO:0032411","biological_process","positive regulation of transporter activity ","O00141; Q96BR1; Q9HBY8; Q03164"]
["GO:0008217","biological_process","regulation of blood pressure ","O00141; P37231; P29474; P35354; Q00975; Q9UEW8; Q9UIQ6; P17342; P28906; P16066; Q02108; P50052; P00441; P05023; P09601; P37023; P04179; P12821"]
["GO:0050790","biological_process","regulation of catalytic activity ","O00141; P10275; Q9P0V3; Q8WZ42; O43741; Q9Y478; Q86XL3; P09874; Q14457"]
["GO:0030334","biological_process","regulation of cell migration ","O00141; P31749; Q15303; P16284; P31751; P63000; Q00535; P51817; Q9H2G2; Q96BR1; Q14344; Q8N4C8; Q9C0H9; O95786; P16333; Q9NQC3; P26367; Q99697; P02545; Q8IYU2; Q15058; P48678; P13688; P21333; O95185; O00139; P62745; Q9UPN3; P61586; Q4VCS5; Q96IF1; Q53GA4"]
["GO:0042127","biological_process","regulation of cell proliferation ","O00141; P11474; P06239; P42681; Q13873; P51813; P35228; Q13882; P00519; O60285; O60674; P09769; P38398; O75030; Q05397; Q07912; Q06187; O43251; P42680; Q8IVT5; P29597; P42226; Q9UM73; P25963; P43403; P51451; Q08881; P21860; P05412; P10721; P41240; O15525; P51178; P07332; P06241; Q08050; P07947; P42684; P12931; P23458; Q13470; Q9NTI5; Q96BR1; Q96EB6; Q16254; P47712; Q9H3M7; P62993; Q13563; P25092; Q9UEE9; P17535; P42566; O15360; Q9NS56; P19438; Q92974; P25445; P17542; P46379; O75925; O00482; P21673; Q9HBY8; O75884; P14923; P17813; P37173; P31950; P17275; Q96SB3; P00749; P41182; P30281; Q9UBU3; P98170; P55957; Q3V6T2; P24394; P25942; P20333; Q03014; P30556; Q9BWT1; P48436; Q99828"]
["GO:0051090","biological_process","regulation of DNA-binding transcription factor activity ","O00141; P08631; P27361; P15336; P05412; P28482; P43405; Q9NRP7; P01100; Q96BR1; O15360; Q9BXW9; Q93009; P09601; P29375; Q01851"]
["GO:0060453","biological_process","regulation of gastric acid secretion ","O00141; P51787"]
["GO:0006814","biological_process","sodium ion transport ","O00141; Q96PU5; P55017; Q92913; O00168; Q99624; Q99250; Q14524; Q9UQD0; Q9Y6R1; P51170; P51168; P78348"]
["GO:0031032","biological_process","actomyosin structure organization ","Q5VT25; Q9Y5S2; P35580; Q99439; P11171; Q92614; P51911; Q96QT4; P35579; Q9Y624; Q15417"]
["GO:0071310","biological_process","cellular response to organic substance ","Q16659; P31152; P45984; P11137; P20265; Q9UL17"]
["GO:0060999","biological_process","positive regulation of dendritic spine development ","Q16659; O76039; P42345; Q14012; Q9ULJ8; Q06787; Q8TDM6; P02649; Q9BYB0; P49768; A8MYZ6; Q9ULU4; Q02297; Q8NE35; Q8N2Q7; Q9Y566"]
["GO:0051216","biological_process","cartilage development ","P11474; P27361; P04818; O15198; P16070; P37275; Q16665; P23759; P78337; Q9UBU3; P22004; P98161; Q05516; Q04656; P48436"]
["GO:0007005","biological_process","mitochondrion organization ","P11474; P51636; P49715; P51610; Q5S007; Q00535; P29474; Q04637; O14746; Q9Y6H1; Q9UBK2; O43464; Q00059; Q06546; O15287; Q99497; Q04837; Q9NTG7; Q99814; Q9UJZ1; P35232; P49916; O00429; Q9BXM7; P99999; Q99714; P09874; P30048; Q04656; Q99623; O60260"]
["GO:1900078","biological_process","positive regulation of cellular response to insulin stimulus ","P11474"]
["GO:0045667","biological_process","regulation of osteoblast differentiation ","P11474; P21802; Q05397; P17612; P08151; O43623; P17844; P50749; O75928"]
["GO:0045670","biological_process","regulation of osteoclast differentiation ","P11474; Q16566; O75030; P42345; P19532; P17676; P50749; P23945"]
["GO:0032355","biological_process","response to estradiol ","P11474; P14921; P13639; Q9Y6K1; P00966; P09619; P02511; P10276; P03372; P07101; P40763; P17302; Q92934; P35222; P60484; P04083; Q15910; P35354; Q9H3M7; P55211; P41146; P04040; P01236; O75916; P46527; P12004; P09211; Q14790; P55317; P28562; P10912; P10646; P61764; O15143; Q99708; P24385; O95983; P51692; P01730; O95243; P42574; P19021; P31645; Q14654"]
["GO:0001782","biological_process","B cell homeostasis ","P07948; Q06413; Q16512; O43521; Q07812; P10415; Q9BZS1; Q5TC82; Q16611; Q07889; P42574"]
["GO:0050853","biological_process","B cell receptor signaling pathway ","P07948; Q06413; P06239; P08575; P00519; Q06187; P42680; P16885; P51451; P28482; Q13469; P05771; P43405; P56945; P15391; Q9H400; P40259; P10415; Q9UKW4; P11912; Q9GZY6; P29350; O00329; P16410"]
["GO:0007596","biological_process","blood coagulation ","P07948; P15976; O60674; P05106; P41235; P13861; P42768; O15525; P63000; P84243; P06241; P17612; P23771; P43694; P22694; P02671; Q92769; P16671; P01009; Q9H1K0; P31323; O43572; Q92908; O95140; P00747; Q8NF50; Q9NRF2; Q13547; P45973; P17301; O60341; O14492; Q9UBL9; P10646; Q9P0W2; P30273; Q16621; P68431; P00749; Q5VZK9; P10914; P10644; P20339; Q96HP0; P08758; P22612; P47756; Q14185; P52907; P60953; P13726; P14316; P12259; P23769; Q03113; P13224; Q9UQQ2; Q71DI3; Q92667"]
["GO:0007417","biological_process","central nervous system development ","P07948; P02686; P48681; P51812; P41240; P06241; Q13043; P12931; O15075; P60484; Q9NYQ6; Q02535; O96001; Q13188; P51649; Q92858; Q92529; Q9UK32; P37275; P26367; Q9P2D1; P09211; P54259; P39086; P53805; Q9H9Q4; O14773; O43602; Q99962; Q86XL3; P49917; Q05516; Q03393; Q9H0M0; P19021; Q99961; P36896; O60260; Q5T011"]
["GO:0050663","biological_process","cytokine secretion ","P07948; Q13094; Q96PH1"]
["GO:0002774","biological_process","Fc receptor mediated inhibitory signaling pathway ","P07948"]
["GO:0002431","biological_process","Fc receptor mediated stimulatory signaling pathway ","P07948; P30273"]
["GO:0002553","biological_process","histamine secretion by mast cell ","P07948; Q06187; O00161"]
["GO:0002768","biological_process","immune response-regulating cell surface receptor signaling pathway ","P07948; P09769; P25942"]
["GO:0030889","biological_process","negative regulation of B cell proliferation ","P07948; Q06187; Q16512; Q92835; Q13315; Q96IZ0; O75626; Q5TC82; P31994; Q8N726; P42574; P16410"]
["GO:0070373","biological_process","negative regulation of ERK1 and ERK2 cascade ","P07948; P08575; P18031; Q9Y3S1; P00519; P29323; P49407; P41240; P17706; Q13905; P60484; P15311; P51452; O14745; O43566; Q9UK32; Q5VWQ8; Q15256; P09211; Q13485; Q9NTG7; P28562; Q12959; P57105; P35232; O43474; Q16828; P17861; O00206; Q96S59; O14713; Q9Y6W6; P05813; Q13526; O43597; Q9UN36; Q9UJM3"]
["GO:0050777","biological_process","negative regulation of immune response ","P07948; Q92835; Q9BZS1; P01589; P31994; P16410"]
["GO:1902532","biological_process","negative regulation of intracellular signal transduction ","P07948"]
["GO:0070667","biological_process","negative regulation of mast cell proliferation ","P07948; O14638"]
["GO:0002762","biological_process","negative regulation of myeloid leukocyte differentiation ","P07948; P22392"]
["GO:0001933","biological_process","negative regulation of protein phosphorylation ","P07948; Q16288; P37840; Q13148; P29323; P78527; P14635; Q5S007; P42345; P53041; P60484; P46109; Q9UBK2; Q9UEW8; Q13423; Q5D1E8; Q96J84; Q5VWQ8; P26367; Q99497; P04156; P47989; Q6TCH7; P17936; P14416; O75581; Q9ULV4; Q9BZQ8; Q9NYB0; O00255; Q9GZV5; P32121; Q9P2D0; O60260; Q9NPB6; Q99828"]
["GO:0034136","biological_process","negative regulation of toll-like receptor 2 signaling pathway ","P07948"]
["GO:0034144","biological_process","negative regulation of toll-like receptor  signaling pathway ","P07948; Q5VWQ8; Q86XR7; P20393"]
["GO:0014003","biological_process","oligodendrocyte development ","P07948; Q9Y2G1; Q13144; P09211; P50553; Q02363; P56693; P06396; Q14232"]
["GO:0002576","biological_process","platelet degranulation ","P07948; P16284; Q9Y490; P12814; P05106; P02671; P16671; P04075; P01009; P02765; O43707; Q8WZ42; P13473; Q06481; P18206; P0DP23; P00747; Q14624; P61764; P00441; P05067; P21333; P08758; P37802; Q5JVS0; P08567; P12259; Q9UNF1; Q9Y6I9"]
["GO:0050861","biological_process","positive regulation of B cell receptor signaling pathway ","P07948; P24723; P05771"]
["GO:0051272","biological_process","positive regulation of cellular component movement ","P07948; P14921; O43707; P78536; P36897; P41182; P16949; P39019"]
["GO:2000670","biological_process","positive regulation of dendritic cell apoptotic process ","P07948; Q9Y4G8"]
["GO:0060369","biological_process","positive regulation of Fc receptor mediated stimulatory signaling pathway ","P07948; Q15762"]
["GO:0060252","biological_process","positive regulation of glial cell proliferation ","P07948; P24723; P10242; P42345; P41743; P41161; P36873; O94874"]
["GO:0070668","biological_process","positive regulation of mast cell proliferation ","P07948"]
["GO:0070447","biological_process","positive regulation of oligodendrocyte progenitor proliferation ","P07948"]
["GO:0070304","biological_process","positive regulation of stress-activated protein kinase signaling cascade ","P07948"]
["GO:0002902","biological_process","regulation of B cell apoptotic process ","P07948; Q06187; P60484"]
["GO:0050855","biological_process","regulation of B cell receptor signaling pathway ","P07948; P08575; Q01196; Q9Y2R2; P51451; Q8N6F7"]
["GO:0001817","biological_process","regulation of cytokine production ","P07948; P41240; Q9GZV1; Q13114; P46940; Q9Y624"]
["GO:0050707","biological_process","regulation of cytokine secretion ","P07948; O60602"]
["GO:0045646","biological_process","regulation of erythrocyte differentiation ","P07948; Q00534; P17947; P38646"]
["GO:0050727","biological_process","regulation of inflammatory response ","P07948; Q04206; P08631; P03372; O60674; P04083; P35354; Q9UEW8; P02765; Q9NUY8; O15360; Q9BXW9; Q99497; Q6R327; Q15942; P41182; P98170; P14778; P60900; Q6ZUJ8; P30556; Q9NRR4; O60885"]
["GO:0033003","biological_process","regulation of mast cell activation ","P07948; O15162"]
["GO:0043304","biological_process","regulation of mast cell degranulation ","P07948; O15530; P16591; P07332"]
["GO:0090025","biological_process","regulation of monocyte chemotaxis ","P07948"]
["GO:0090330","biological_process","regulation of platelet aggregation ","P07948; P17252; Q04759; P43405"]
["GO:0001932","biological_process","regulation of protein phosphorylation ","P07948; P04792; P29590; Q05397; P16591; P52630; P67775; O43181; Q9NZM5; P41594; Q9ULV4; Q9P219; P21728; Q3V6T2; Q13526"]
["GO:0051279","biological_process","regulation of release of sequestered calcium ion into cytosol ","P07948; Q14289; Q02156; P13498; Q9H1Y0; O60610; P29350"]
["GO:0043200","biological_process","response to amino acid ","P07948; Q04206; P42345; O15111; Q92934; P23528; P48167; P46527; P09211; P61586; P42574; P42898; Q9HB90"]
["GO:0009743","biological_process","response to carbohydrate ","P07948; Q9UBL9; Q9H2P0"]
["GO:0009725","biological_process","response to hormone ","P07948; Q14289; P11831; P48506; P14317; Q99697; Q96PK6; Q99958; Q14192; Q14686; Q9UBU3; P43699; P24752; P50281"]
["GO:0032868","biological_process","response to insulin ","P07948; Q04206; P27708; O15357; P42345; P35568; Q16836; P11166; Q96EB6; Q16613; Q08170; P04040; O15240; Q99966; Q9HBA0; P26678; Q16526; P32245; P56537; Q07869; P41145; Q13247; Q13322; P61244; O00186; Q99523; Q92574; P16118; P18146; O15294"]
["GO:0014070","biological_process","response to organic cyclic compound ","P07948; O00763; P11413; P06493; P33121; P78543; P38919; P50416; Q16828; P18846; Q16611; O75762; P24752; P50281"]
["GO:0006991","biological_process","response to sterol depletion ","P07948"]
["GO:0009636","biological_process","response to toxic substance ","P07948; P02686; P11802; P27361; P11831; O15111; P01100; P38936; P19525; Q13242; P25092; O14559; P12830; Q07812; Q7Z5K2; P10415; Q03468; Q9BX84; P18848; P23025; P18505; Q9UBN7; P14416; P35790; P35869; P31645"]
["GO:0002223","biological_process","stimulatory C-type lectin receptor signaling pathway ","P07948; Q04206; O15530; Q09472; Q13177; P01112; P19838; P16885; Q01201; O75582; P43405; O75914; P06241; P17612; O14920; Q9Y6K9; O43318; O15111; P12931; P04049; P22694; Q13153; Q05655; P15941; Q15750; P32942; P01116; Q9NYJ8; Q92793; Q9BXL7; O95999; P30273; Q9Y4K3; Q7Z5P9; Q8N5C8; P22612; P01111; Q9H257"]
["GO:0002513","biological_process","tolerance induction to self antigen ","P07948; Q9BZS1"]
["GO:0042100","biological_process","B cell proliferation ","Q06413; P08575; Q9UJU2; Q05655; P16871; P10809; P10415; P11912; Q9BXL7; P17812; P25942"]
["GO:0001568","biological_process","blood vessel development ","Q06413; Q00987; Q13905; Q12778; P46109; Q99759; P26367; Q9Y4G8; Q9NYA1; Q12946; Q99626; P37173; P49768; P13688; Q9NQB0; O60479; O15119; Q9NRA0; P35869; Q04656"]
["GO:0001974","biological_process","blood vessel remodeling ","Q06413; Q13873; P21980; Q00987; P30530; P29474; Q13705; O60936; Q9H1Y0; Q12948; Q07812; Q9P2D1; P41597; Q99814; P50052; Q99958; Q16611; P37023; Q06330; P12821; Q04656"]
["GO:0014898","biological_process","cardiac muscle hypertrophy in response to stress ","Q06413; Q15910; P56524; Q92908; Q08209; O15273; P16615"]
["GO:0003211","biological_process","cardiac ventricle formation ","Q06413; P52952"]
["GO:0060536","biological_process","cartilage morphogenesis ","Q06413; P61296; O96004; O95863"]
["GO:0048667","biological_process","cell morphogenesis involved in neuron differentiation ","Q06413; P06400; Q14469; P43003; Q02363"]
["GO:0071498","biological_process","cellular response to fluid shear stress ","Q06413; Q14289; P12931; P35354; Q13563; O43312; Q92819; P00918; Q16236; O15379; P17861"]
["GO:0071222","biological_process","cellular response to lipopolysaccharide ","Q06413; Q04206; P11802; P00966; P08670; P35228; Q6PD62; P00519; P10276; P45983; P19838; Q9UQL6; P11274; P30530; Q16539; Q00613; P12931; Q08499; P16671; Q9GZX7; Q9UBK2; P49675; P51681; P17676; Q8TDQ0; Q5D1E8; Q96RI1; Q96P20; Q5VWQ8; P09211; Q9NRY6; Q53EL6; Q15653; P10646; Q9Y4K3; O95751; Q92900; Q13133; P41145; Q15327; P17861; O95477; O00206; Q07343; Q6P1J9; Q86XR7; Q9ULZ3; O43823; P61586; Q6P2Q9; Q02556; P21731; P25942; P20333; P20393; P26651"]
["GO:0071374","biological_process","cellular response to parathyroid hormone stimulus ","Q06413; P17302; P56524; Q9GZV9"]
["GO:0035984","biological_process","cellular response to trichostatin A ","Q06413; Q15910; P61160; Q9BY41"]
["GO:0048703","biological_process","embryonic viscerocranium morphogenesis ","Q06413; Q6UB35; Q6KC79; Q99958"]
["GO:0001958","biological_process","endochondral ossification ","Q06413; P22607; O15357; Q14814; Q02763; Q12948; P56178; P22004; Q13950; P50281"]
["GO:2001013","biological_process","epithelial cell proliferation involved in renal tubule morphogenesis ","Q06413; O43312"]
["GO:0002467","biological_process","germinal center formation ","Q06413; Q00653; P20749; P78536; P41182"]
["GO:0072102","biological_process","glomerulus morphogenesis ","Q06413; O43312"]
["GO:0001947","biological_process","heart looping ","Q06413; P84022; P17302; P11831; P43694; Q13563; Q15468; Q16665; Q9ULK5; P52952; P17813; P37173; P49768; P61296; O96004; O15119; P46531; Q4G0X9; Q9UMX1; Q9UMR3"]
["GO:0030318","biological_process","melanocyte differentiation ","Q06413; O75030; P10721; Q99966; P10415; Q9Y4I1; P10071"]
["GO:0030224","biological_process","monocyte differentiation ","Q06413; P37231; P49327; P05412; P07333; Q02447; O00625; Q13769; Q16666; Q15648; P35579"]
["GO:0007521","biological_process","muscle cell fate determination ","Q06413"]
["GO:0007517","biological_process","muscle organ development ","Q06413; P02511; P85037; P53778; P15172; Q02078; Q14814; Q13642; Q96EB6; Q14863; P51114; Q02535; P30626; Q9GZV1; P23760; O15014; P02545; P48678; Q8IUX7; P17861; Q15561; P46939; Q9Y5B6; P50549; P13349; P98177; O95180; Q15772; Q01995; P50402; Q15672"]
["GO:0014902","biological_process","myotube differentiation ","Q06413; Q9P2K5; Q99523; P12755"]
["GO:0043537","biological_process","negative regulation of blood vessel endothelial cell migration ","Q06413; P09429; P37231; P02649; P67870; P50052; P14923; P09038; Q9H4X1; P37023; P51608"]
["GO:0030279","biological_process","negative regulation of ossification ","Q06413; P17752; P10415; O43541; P46531; O75096; Q06330; P48436"]
["GO:1904753","biological_process","negative regulation of vascular associated smooth muscle cell migration ","Q06413; Q13976; Q8IZQ8; Q16236; P09493"]
["GO:1905563","biological_process","negative regulation of vascular endothelial cell proliferation ","Q06413; P17948; P37231"]
["GO:1904706","biological_process","negative regulation of vascular smooth muscle cell proliferation ","Q06413; P37231; Q13976; P60484; P38936; Q8IZQ8; P46527; P09211; Q53EL6; P09601; P04179; P51911; P09493"]
["GO:0072160","biological_process","nephron tubule epithelial cell differentiation ","Q06413; O43312"]
["GO:0014033","biological_process","neural crest cell differentiation ","Q06413; Q13485; O75581"]
["GO:0001649","biological_process","osteoblast differentiation ","Q06413; P31749; P21359; Q9UJU2; P29317; P49327; P17302; Q7KZF4; Q14814; P08151; P62070; P07910; O43623; Q8TDD2; P04040; Q9BQG0; Q9Y294; O60506; P56178; P10070; P22087; P54198; P35548; P21815; P17936; P35232; P17275; Q14192; P62841; Q9P2E9; O95863; P22004; O94874; Q13950; Q9GZV5; P48431; Q9NZC7; P35998; P38159; Q00839; Q00610; Q15672; O76021; Q86V81"]
["GO:0003151","biological_process","outflow tract morphogenesis ","Q06413; Q13873; P15336; Q13418; P05412; O00501; Q14469; Q99502; Q03167; Q6KC79; Q16665; O14641; P37173; Q99967; O15119; P46531; P36894; Q06330; P21817"]
["GO:0010694","biological_process","positive regulation of alkaline phosphatase activity ","Q06413; P84022; P17301; P80108"]
["GO:0030890","biological_process","positive regulation of B cell proliferation ","Q06413; P08575; Q13469; P38936; P02786; P15923; Q9Y4H2; Q96FA3; P10415; Q9UKW4; Q9BXL7; Q96P31; P41182; P25942; P58753; O75995"]
["GO:2000987","biological_process","positive regulation of behavioral fear response ","Q06413; P17302"]
["GO:0030501","biological_process","positive regulation of bone mineralization ","Q06413; Q13873; Q04771; P84022; Q504Y2; Q13705; P32418; P22004; P07550; P36894; P05549"]
["GO:2000727","biological_process","positive regulation of cardiac muscle cell differentiation ","Q06413; P52799; Q8IZQ8; Q02297; P32121"]
["GO:0071864","biological_process","positive regulation of cell proliferation in bone marrow ","Q06413; P29353; Q9UJU2; Q99759; P52926"]
["GO:2000111","biological_process","positive regulation of macrophage apoptotic process ","Q06413; Q96EB6; P42771"]
["GO:0051149","biological_process","positive regulation of muscle cell differentiation ","Q06413; P00519; P35221; P53778; P15172; Q02078; Q15759; Q16539; P35222; Q14012; P15173; P15923; P19022; O60271; Q9BWF3; Q15633; P13349; P60953; P23409"]
["GO:0045663","biological_process","positive regulation of myoblast differentiation ","Q06413; Q13418; P15172; Q16539; Q99683; P15173; Q9NQ66; P50461; P17936; P13349; P62324; P23409"]
["GO:0045666","biological_process","positive regulation of neuron differentiation ","Q06413; P10276; P11362; P60484; Q04637; Q9Y210; Q92858; P15923; Q92974; P37275; Q9UMS4; P10070; Q92886; P52952; P15884; P55317; P41161; P50553; O60271; Q9P0W2; Q9H8V3; P05067; Q13049; P41182; O75553; Q15788; P22004; P61586; P23769; Q9H3R0; Q13562"]
["GO:0045669","biological_process","positive regulation of osteoblast differentiation ","Q06413; Q13873; P49715; Q04771; Q13418; Q15139; Q16832; P17302; P40189; Q9UKT4; Q13705; P17535; O00299; P17676; P35548; P48678; P47928; P22004; Q13950; P10071; P36894; Q9H3D4"]
["GO:0090073","biological_process","positive regulation of protein homodimerization activity ","Q06413; Q12933; Q99497; Q9BUZ4; Q96A49; P58753"]
["GO:2001016","biological_process","positive regulation of skeletal muscle cell differentiation ","Q06413; O00327"]
["GO:0048643","biological_process","positive regulation of skeletal muscle tissue development ","Q06413; Q13131; P04035; O75955"]
["GO:0003138","biological_process","primary heart field specification ","Q06413"]
["GO:2000311","biological_process","regulation of AMPA receptor activity ","Q06413; Q8N4C8; Q9Y698; P58400; Q8N2Q7; Q9Y566"]
["GO:0002634","biological_process","regulation of germinal center formation ","Q06413; Q16512; P41182; Q5TC82"]
["GO:0045652","biological_process","regulation of megakaryocyte differentiation ","Q06413; Q09472; P15976; Q96ST3; Q04759; Q01196; P84243; Q15291; Q8IZD2; Q13547; P56537; Q16621; P68431; P62805; Q96LA8; Q9UPQ9; P24844; Q03164; O14686; Q71DI3; Q99873"]
["GO:0043523","biological_process","regulation of neuron apoptotic process ","Q06413; Q96B36; P11413; P23771; O43424; Q99497; Q15058; Q96KS0; P07203; Q6X4W1; Q9H3D4"]
["GO:0046928","biological_process","regulation of neurotransmitter secretion ","Q06413; Q9UQM7; Q9Y6H5; Q06787; Q8IXI2; Q86UR5; Q8IV01; P17600; Q03721"]
["GO:2000310","biological_process","regulation of NMDA receptor activity ","Q06413; Q14289; P78352; Q9UBK2; P58400; P53355; P05067; Q13972; Q8N2Q7; P35372"]
["GO:0060297","biological_process","regulation of sarcomere organization ","Q06413; Q12802"]
["GO:0051963","biological_process","regulation of synapse assembly ","Q06413; Q05586; Q96HC4; Q9ULJ8"]
["GO:0060025","biological_process","regulation of synaptic activity ","Q06413; P61266"]
["GO:0051966","biological_process","regulation of synaptic transmission, glutamatergic ","Q06413; Q5S007; Q00535; P21554; P21579; O60229; P39086; P41594; Q13255; P49768; Q14416; Q86YM7; Q14831; Q14832"]
["GO:0061333","biological_process","renal tubule morphogenesis ","Q06413; Q13563; O43312"]
["GO:0002931","biological_process","response to ischemia ","Q06413; P13639; O00418; Q9UQM7; Q03135; P17302; Q99683; P52564; P41180; P30405; P52789; Q9UBK2; O15055; O60936; Q96RD7; P10415; Q96RD6; Q9UBL9; Q13501; Q9UNE7; Q9BXM7; Q8NFD5; P18146; Q14654; Q99828"]
["GO:0060021","biological_process","roof of mouth development ","Q06413; P29323; P54753; O00501; Q504Y2; P28472; Q13705; P08476; P56178; O75581; P63165; Q9BRQ0; P36897; O15119; O95863; Q07889; Q92688; P10071; P12755; P36894; P05549; Q15672; O95390"]
["GO:0003139","biological_process","secondary heart field specification ","Q06413; Q6STE5; Q9Y2T1; Q06330"]
["GO:0003185","biological_process","sinoatrial valve morphogenesis ","Q06413"]
["GO:0035914","biological_process","skeletal muscle cell differentiation ","Q06413; P13639; P06400; P15172; Q14814; P01100; Q13887; P32314; P15173; P78543; Q9GZV1; Q9P0W2; Q15327; P13349; P46531; Q9H1R3; Q96Q27; P50402; P18146; P23409"]
["GO:0007519","biological_process","skeletal muscle tissue development ","Q06413; Q09472; P21359; P15172; Q03135; Q00535; Q16539; P15173; O75369; O95425; P50461; Q99592; O60500; Q16635; P31415; P13349; Q9Y281; P61586; O15519; P23409"]
["GO:0051145","biological_process","smooth muscle cell differentiation ","Q06413; Q04771; Q14934; Q8IZQ8; Q92908; Q969V6; Q12946"]
["GO:0055012","biological_process","ventricular cardiac muscle cell differentiation ","Q06413; P10276; P19793; Q8IZQ8; Q02297"]
["GO:0051403","biological_process","stress-activated MAPK cascade ","P41279; P27361; O15264; P02511; P45983; P19838; Q9NYL2; P28482; Q15759; O14733; Q99683; O14920; Q9Y6K9; O43318; O15111; P62979; Q9BSQ5; Q9UL54; P0CG47; P62987"]
["GO:0006882","biological_process","cellular zinc ion homeostasis ","P06239"]
["GO:0034116","biological_process","positive regulation of heterotypic cell-cell adhesion ","P06239; P02671; Q86WV1; P16070; O75955; P01375"]
["GO:2001244","biological_process","positive regulation of intrinsic apoptotic signaling pathway ","P06239; Q9NYF8; Q03135; P04637; Q92934; Q9BXH1; O43521; O14745; Q99801; Q07812; Q96LC9; P10415; O43236; P63244; O00429; Q07817; P06702; Q9Y572; P55957; Q8IUQ4; Q9UPG8; Q13794"]
["GO:1903039","biological_process","positive regulation of leukocyte cell-cell adhesion ","P06239; Q86WV1"]
["GO:0050870","biological_process","positive regulation of T cell activation ","P06239; Q04759; P10809; P41597; O95999; Q9ULZ3"]
["GO:0050862","biological_process","positive regulation of T cell receptor signaling pathway ","P06239; Q04206; Q9BZL6; O15554; Q92692; P32248; P23396; Q15762; Q9NQC7; Q6PIZ9"]
["GO:0050690","biological_process","regulation of defense response to virus by virus ","P06239; P08631; Q13177; P63000; P06241; P20963; Q6VY07; P10747; Q92556; Q96CW1; P01730; P63010; P01892"]
["GO:0051249","biological_process","regulation of lymphocyte activation ","P06239"]
["GO:0051209","biological_process","release of sequestered calcium ion into cytosol ","P06239; P08575; P16885; Q02156; P28223; Q9BXH1; Q13563; P32248; Q92736; P09038; P14416; Q14643; Q14571; Q96HE7; P35638; O94759; Q9P2D0; P21817"]
["GO:0030217","biological_process","T cell differentiation ","P06239; P08575; P43403; Q9Y2R2; P10721; P17706; P15498; P16871; Q8TCU6; P55347; Q9P2D1; Q02447; P24390; Q9H9Q4; Q15669; P48357; Q13950; P01730; Q9UL17; O00329; P18146"]
["GO:0061762","biological_process","CAMKK-AMPK signaling cascade ","Q13131; Q96RR4"]
["GO:0007050","biological_process","cell cycle arrest ","Q13131; P50613; P54646; Q00534; P06400; O60934; P01106; P25054; P00519; Q15831; P29590; P01112; Q13418; P53778; Q9NYL2; Q9P2K8; P84022; P04637; P42345; P52564; Q02750; P35813; Q13315; P38936; P08476; Q13563; P49918; Q9H0Z9; O43741; P46527; O15350; Q8IZD2; Q96Q89; P42771; P04156; O15355; Q7RTN6; O75460; O60381; Q9NQB0; P36897; Q96SB3; O60861; Q15382; Q9Y478; P24522; P98177; P10914; P43246; Q93034; P35638; P46531; Q8N122; P54619; Q9NS23; O00213; P98161; Q9UQ80; Q9UGI9; P48431; Q99728; Q8N726; Q8TAS1; Q969Z0; Q07666; Q9HB90; O43504; P55273"]
["GO:0071361","biological_process","cellular response to ethanol ","Q13131; Q9Y6K1; P17947; Q02156; P60484; Q14571"]
["GO:0042149","biological_process","cellular response to glucose starvation ","Q13131; P54646; Q9NZJ5; P04637; P11166; Q9BQG0; Q5D1E8; P10415; P09651; P18848; Q16236; P17861; Q8NEB9; Q16666; Q9H093; Q9Y371; Q13794; Q9NRD5; P11021; Q5T011; Q14457"]
["GO:0031669","biological_process","cellular response to nutrient levels ","Q13131; P54646; O75385; P42345; Q04637; Q14721; Q8N122"]
["GO:0071417","biological_process","cellular response to organonitrogen compound ","Q13131; Q96RI1; P68133"]
["GO:0071380","biological_process","cellular response to prostaglandin E stimulus ","Q13131; P31749; P54646; P37231; Q13085; Q02156; O43306; O43823"]
["GO:0006695","biological_process","cholesterol biosynthetic process ","Q13131; P54646; P04035; P11413; Q01581; P53396; P62633; P13569; Q14739; Q13907"]
["GO:0009631","biological_process","cold acclimation ","Q13131"]
["GO:0006633","biological_process","fatty acid biosynthetic process ","Q13131; O00763; P54646; P38398; Q13085; P49327; P53396; O43741; P17861; Q9Y478; P54619; Q9UGI9"]
["GO:0055089","biological_process","fatty acid homeostasis ","Q13131; P54646; Q96EB6; Q96RI1; P02649; P17861; Q9NP71"]
["GO:0019395","biological_process","fatty acid oxidation ","Q13131; P37231; Q16539; Q9UBK2; Q96A54"]
["GO:0008610","biological_process","lipid biosynthetic process ","Q13131; P54646; P33121; P53396; P36956; Q9UMS4; Q9NR19"]
["GO:0016236","biological_process","macroautophagy ","Q13131; P54646; O75886; O75385; O14964; P12931; Q9C0C7; Q9Y4P1; O75351; O43741; Q9H1Y0; O95140; Q8IWA4; P55072; Q13501; Q9Y4P8; Q9Y478; Q9BXM7; Q9UMX0; Q9GZQ8; Q9Y3E7; P54619; Q9H6K1; P63167; Q8NEB9; Q9NT62; Q9UGI9; Q96H20; P21796; O75143; Q96CF2; Q9H492; Q676U5; O60260; Q14457"]
["GO:0061744","biological_process","motor behavior ","Q13131; Q14203"]
["GO:2001274","biological_process","negative regulation of glucose import in response to insulin stimulus ","Q13131; O00186"]
["GO:0046318","biological_process","negative regulation of glucosylceramide biosynthetic process ","Q13131"]
["GO:0050995","biological_process","negative regulation of lipid catabolic process ","Q13131; Q13370; Q6UUV7; P01375; P08913"]
["GO:0070050","biological_process","neuron cellular homeostasis ","Q13131; Q06418; Q7L7X3; P25686; P78559; Q14203; P23975; O60260"]
["GO:0010508","biological_process","positive regulation of autophagy ","Q13131; Q9P1W9; P54646; Q15831; Q15139; Q5S007; Q12778; Q92934; Q13464; Q9C0C7; Q9P0V3; Q96CV9; Q86UE4; P19474; Q9NYY3; P19484; Q5D1E8; O15553; P42338; P53355; P17861; Q9Y371"]
["GO:0045542","biological_process","positive regulation of cholesterol biosynthetic process ","Q13131; P36956"]
["GO:1903109","biological_process","positive regulation of mitochondrial transcription ","Q13131"]
["GO:2000758","biological_process","positive regulation of peptidyl-lysine acetylation ","Q13131; P54646"]
["GO:0033135","biological_process","regulation of peptidyl-serine phosphorylation ","Q13131; P23327; Q15111; Q6R327"]
["GO:0062028","biological_process","regulation of stress granule assembly ","Q13131; P54646"]
["GO:0060627","biological_process","regulation of vesicle-mediated transport ","Q13131; P07332; Q9P2Y5; P63027; P62491"]
["GO:0014823","biological_process","response to activity ","Q13131; P06493; P22681; P07101; Q9UQL6; P78527; P16220; P42345; Q00613; P60484; P48506; Q16836; P04040; P49675; P13498; Q9UKX2; P22004; Q8IWU9"]
["GO:0031000","biological_process","response to caffeine ","Q13131; P37231; P27708; Q92769; Q92736; P21817"]
["GO:1901563","biological_process","response to camptothecin ","Q13131"]
["GO:0010332","biological_process","response to gamma radiation ","Q13131; P08575; P01106; P22681; P29590; P78527; P04637; P23771; O15350; Q9BXW9; Q07812; P10415; Q03468; P06746; O00255; P07203; P51587; P49917; Q16611; P09874; Q9H3D4"]
["GO:0001666","biological_process","response to hypoxia ","Q13131; P14921; P14618; Q09472; P21359; P35228; P02511; P10242; P29590; P07101; P29475; Q14289; P16220; P84022; Q03135; P11831; P04049; Q13315; Q02763; Q13153; P36544; Q12791; P19447; P27540; O43707; Q8IZQ8; Q03167; P61073; P04040; P43681; Q9UGP4; O60936; P00338; O14727; P13498; P14625; P46527; O75081; Q92736; Q16665; Q13485; O15551; P17301; Q92793; P78536; Q99814; Q9UBL9; P17813; Q96KS0; P37173; P14416; P43354; Q07869; Q14643; Q14571; P49810; Q99967; P22460; P00749; Q9NPH5; P17655; P37023; P22415; P61586; P51608; O00151; P18887; P08253; P42574; P30613; Q96IF1; P19021; P18146; P31645; P21817; P42898; P50281; Q15109; Q14457"]
["GO:0006084","biological_process","acetyl-CoA metabolic process ","O00763; Q13085; P49327"]
["GO:0006853","biological_process","carnitine shuttle ","O00763; Q13085; P50416"]
["GO:2001295","biological_process","malonyl-CoA biosynthetic process ","O00763; Q13085"]
["GO:0043086","biological_process","negative regulation of catalytic activity ","O00763; P48681; O14974; O00631; P26678; P04156; Q8N163; P46531; Q04656; O96018"]
["GO:0031999","biological_process","negative regulation of fatty acid beta-oxidation ","O00763; P31749; P21554"]
["GO:0031325","biological_process","positive regulation of cellular metabolic process ","O00763; Q13085; P49327; P53396"]
["GO:0060421","biological_process","positive regulation of heart growth ","O00763; P19544"]
["GO:0010884","biological_process","positive regulation of lipid storage ","O00763; Q14164; P19838; Q5D1E8; P55055"]
["GO:0045540","biological_process","regulation of cholesterol biosynthetic process ","O00763; P04035; Q01581; Q13085; P49327; P36956; P62826; O76054; P23511; P08047; Q12772; O00767; Q13907"]
["GO:0008608","biological_process","attachment of spindle microtubules to kinetochore ","Q9UQB9; Q96GD4; Q8IWB6; O43684; Q8NG31; Q5FBB7; O14777"]
["GO:0000910","biological_process","cytokinesis ","Q9UQB9; O43663; Q49MG5; O75154"]
["GO:0016570","biological_process","histone modification ","Q9UQB9; Q96GD4; P50747"]
["GO:0051256","biological_process","mitotic spindle midzone assembly ","Q9UQB9; Q96GD4; Q9H0H5; O95239; Q02241"]
["GO:0048599","biological_process","oocyte development ","Q9UQB9; P10415; Q9Y2T7"]
["GO:0032467","biological_process","positive regulation of cytokinesis ","Q9UQB9; Q96GD4; Q16513; Q02156; Q99741; P35462; Q96Q89; O95425; O14578; Q9H0H5; Q15058; Q9H8V3; P14416; P30305; P61586; P60953; Q02241"]
["GO:0060335","biological_process","positive regulation of interferon-gamma-mediated signaling pathway ","P42681; Q15648"]
["GO:0032729","biological_process","positive regulation of interferon-gamma production ","P42681; P01112; O43353; Q08499; Q13158; P20749; P07766; P10809; Q15762; Q8TDQ0; P41597; P01375; O00206; Q07343; Q86XR7; Q9ULZ3; P14778; Q02556; O75995; P01892"]
["GO:0010543","biological_process","regulation of platelet activation ","P42681; P42680; P43405; P30273"]
["GO:0042246","biological_process","tissue regeneration ","P42681; P42680; P14635; Q05209; P17677; P06396; P46531; P08833; P48431; Q13444"]
["GO:0061049","biological_process","cell growth involved in cardiac muscle cell development ","P45985; Q96HC4; P43694; P50052; O94875"]
["GO:0072709","biological_process","cellular response to sorbitol ","P45985; O15264; P52564"]
["GO:2000672","biological_process","negative regulation of motor neuron apoptotic process ","P45985; Q12852"]
["GO:0043525","biological_process","positive regulation of neuron apoptotic process ","P45985; Q16584; P21359; P10242; P78362; P15336; P10244; P05412; P04637; O75914; Q00535; P35222; Q13315; O43524; P56524; Q9BXH1; O43521; Q13002; Q15078; P55211; P48023; P56817; Q07812; P04156; P18848; P50553; P49427; P05067; P35638; Q16478; P61586; P60953; P42574; P42575; Q13526; P05549"]
["GO:0051770","biological_process","positive regulation of nitric-oxide synthase biosynthetic process ","P45985; O60674; P42224; P35968; Q5S007; P52564; O00206"]
["GO:0034393","biological_process","positive regulation of smooth muscle cell apoptotic process ","P45985; P49407; P42771; P98175"]
["GO:0009611","biological_process","response to wounding ","P45985; Q12879; O14965; P23443; P63000; P14136; Q00535; Q9HAN9; P08151; Q12904; Q02535; P43003; P26367; P41597; Q6ZS17; P17677; P16144; Q07352; P48431; Q03014; P26651; Q01860; Q14957; Q99623; Q15109"]
["GO:0043011","biological_process","myeloid dendritic cell differentiation ","Q16566; Q01201; P17947; Q9Y4K3; P37173; P49768; Q15306; Q06330"]
["GO:0033081","biological_process","regulation of T cell differentiation in thymus ","Q16566; P37275; P00441; Q07889"]
["GO:0008637","biological_process","apoptotic mitochondrial changes ","Q9P1W9; P31749; P62714; P48506; P30405; P52789; P10809; Q07812; Q07820; P12235; Q07817; P55957; Q8N726"]
["GO:0007140","biological_process","male meiotic nuclear division ","Q9P1W9; O15360; Q9NQI0; Q8IWB6; P54652"]
["GO:0016239","biological_process","positive regulation of macroautophagy ","Q9P1W9; P54646; Q9UHD2; O00267; P35968; Q9Y6K9; O43318; Q6PKG0; Q96EB6; Q16665; Q9BTA9; O95278; P49815; Q9BXM7; P09601; Q92574"]
["GO:0050821","biological_process","protein stabilization ","Q9P1W9; Q2M2I8; P50613; Q09472; O96017; P02511; P29590; Q9UBE8; P16220; P51610; P84022; P07737; Q13043; P08238; P60484; P27986; P54764; P38936; P07900; Q05655; Q16543; O95816; O95785; O14640; Q9UBK2; O95817; Q13188; P13473; Q92997; P10809; Q14254; Q9Y4R8; Q9NQC3; Q9NZM5; Q99497; Q15185; P46379; P0DMV8; P50749; Q9H4B6; Q9NYZ3; P62913; Q6N069; P51946; O15105; P61764; O75955; P63146; O15151; P63165; P35232; Q93009; P16401; P21333; Q9BUL8; Q9BXM7; P78371; P04406; P40855; Q9NS23; Q92574; Q8N726; P40337; Q13526; Q969H0; Q6ZWJ1; Q99623; P56645; O60260"]
["GO:1990869","biological_process","cellular response to chemokine ","Q9H4A3; O95747; Q9UEW8; Q5D1E8; Q12948; Q8NF50; P55011; Q6ZS17; P61586"]
["GO:0038116","biological_process","chemokine (C-C motif) ligand 2 signaling pathway ","Q9H4A3; O95747"]
["GO:0097022","biological_process","lymphocyte migration into lymph node ","Q9H4A3; P32248"]
["GO:0033633","biological_process","negative regulation of cell-cell adhesion mediated by integrin ","Q9H4A3; Q9UH65"]
["GO:0034260","biological_process","negative regulation of TPase activity ","Q9H4A3; P01112; P49407; Q5S007; Q9P0V3; Q14684; P35241; Q9Y6D6; Q5VWQ8; Q4VCS5; Q92574; P32121; Q9Y624; O43597"]
["GO:1903038","biological_process","negative regulation of leukocyte cell-cell adhesion ","Q9H4A3; P31749; P00966; Q07869"]
["GO:0010923","biological_process","negative regulation of phosphatase activity ","Q9H4A3; Q99640; Q14684; Q15700; Q8TEP8; Q5T8P6; O94763; Q9H4Z3; O95278; Q9UJT2; Q9H788; Q5T1M5; O00566; Q8NG31; P55199"]
["GO:0003084","biological_process","positive regulation of systemic arterial blood pressure ","Q9H4A3; P17813"]
["GO:0010820","biological_process","positive regulation of T cell chemotaxis ","Q9H4A3; O95747; Q9UEW8; P41597; P78536"]
["GO:0002028","biological_process","regulation of sodium ion transport ","Q9H4A3; P29475; Q09013; P57059; P29474; Q04917; P32418; P14416; P05023; O15534; P07550"]
["GO:0023016","biological_process","signal transduction by trans-phosphorylation ","Q9H4A3; Q9UEW8"]
["GO:0008366","biological_process","axon ensheathment ","P02686; Q02297"]
["GO:0007268","biological_process","chemical synaptic transmission ","P02686; Q12879; Q13224; P05129; P28482; Q00535; P42261; Q9NZV8; P78352; P48167; P28223; Q99996; Q13002; Q00975; O43525; Q99767; Q8N4C8; Q9UP95; Q15700; P41143; P41146; Q9P2S2; O00560; P43681; Q9NS61; Q14160; Q9H2X9; O14810; P28222; P43003; P21579; P25189; Q9ULB1; P39086; Q9UKL4; P41594; Q9Y4I1; O43526; P54252; Q92952; P54578; Q92777; Q13255; Q12959; O75581; P43005; P41145; O75899; Q9Y666; O43497; P23975; Q02410; Q14416; Q86YM7; P48664; Q14831; Q09470; P47870; P17600; Q05940; P60880; Q99259; Q14832; O14490; Q16143; Q03721; P42262; Q02641; P36383; O14649; O43613; Q9UHW9; Q08289; O96018; P49418; P35372"]
["GO:0006955","biological_process","immune response ","P02686; P14921; Q14164; Q12851; Q15080; P43403; P42768; P84022; P08069; Q9Y6K9; Q99558; O15111; P15498; P16871; P00736; P04004; P08138; P22670; P01889; Q13094; Q16649; Q14005; P34998; P41143; P31995; Q9Y3Z3; Q03167; P51681; Q96BF3; P19438; P17676; P25445; P32248; P16150; P37275; P48023; Q96FA3; O43918; Q01362; Q13829; P40259; P41597; Q8N2H9; O43315; Q9HAT8; Q5VVH5; O43541; Q01628; P01589; P41145; P55040; P33076; Q5ZPR3; P17861; Q06265; O00206; P21730; P31994; Q6GQQ9; P46531; P22004; O43561; Q15722; P14778; P01730; P24394; Q02556; P25942; P20333; P16410; Q9Y5P4; P36894; Q07021; P34972; O15117; P22413; P43629"]
["GO:0035633","biological_process","maintenance of permeability of blood-brain barrier ","P02686; P35354"]
["GO:0042552","biological_process","myelination ","P02686; P04626; Q13144; Q99250; P25189; Q13516; Q9Y4I1; Q9UQD0; Q96PU8; Q92574"]
["GO:1904209","biological_process","positive regulation of chemokine (C-C motif) ligand  secretion ","P02686"]
["GO:2000778","biological_process","positive regulation of interleukin-6 secretion ","P02686; P09429; Q7Z434; O95786; Q9HBA0; P17861; Q9BYX4; Q9ULZ3; Q15672"]
["GO:1904685","biological_process","positive regulation of metalloendopeptidase activity ","P02686; P40763"]
["GO:0021762","biological_process","substantia nigra development ","P02686; P11413; P60709; Q9H7L9; Q04917; O75489; P00338; P0DP23; P12277; P27348; P62258; P63167; O60671; O15027; P61586; P60953; P00367; P18859; Q9BPZ7; Q8IXJ6; Q9UN36; Q9UQR1; P11021"]
["GO:0006007","biological_process","glucose catabolic process ","O60825; Q92934"]
["GO:0006089","biological_process","lactate metabolic process ","O60825; P00338; Q16665; P07195"]
["GO:0033133","biological_process","positive regulation of glucokinase activity ","O60825; Q92934; P49792; P16118"]
["GO:0009749","biological_process","response to glucose ","O60825; Q15796; Q14289; P23443; P41235; P17302; P54840; Q92934; P60484; Q13705; Q9H3M7; P00338; P17858; Q13144; P46527; Q9Y4H2; P36956; P32418; Q9H9A7; P63027; P37173; Q9NQB0; P80108; O43768; Q8NHW3; Q14232; Q15466; P61586; P42574; P30613; P18146; Q13562"]
["GO:0097202","biological_process","activation of cysteine-type endopeptidase activity ","Q12879; O43353; Q92934; Q13158; Q14790; Q16611; Q16666; Q99538"]
["GO:0097553","biological_process","calcium ion transmembrane import into cytosol ","Q12879; Q05586; Q13224; P23634; O94759; Q14957"]
["GO:0033058","biological_process","directional locomotion ","Q12879; Q14957"]
["GO:0042417","biological_process","dopamine metabolic process ","Q12879; P16066; P35462; Q9Y6H5; P14416; P21728; Q16143; Q04656; O60260"]
["GO:0098976","biological_process","excitatory chemical synaptic transmission ","Q12879; Q05586; Q13224; Q8WYL5; P50479; Q14957"]
["GO:0007215","biological_process","glutamate receptor signaling pathway ","Q12879; Q13224; Q13002; O43424; Q9NQ66; Q14721; Q06787; P39086; P48058; Q14957"]
["GO:1900273","biological_process","positive regulation of long-term synaptic potentiation ","Q12879; P29323; P16220; Q9P2K8; P36544; O60229; Q9BYB0; Q13501; P14416; P05067; Q6UUV9; Q92686; Q99538"]
["GO:1903539","biological_process","protein localization to postsynaptic membrane ","Q12879; Q05586; Q14957"]
["GO:0051930","biological_process","regulation of sensory perception of pain ","Q12879; P41143; P19634; Q13255; P41145; P35372"]
["GO:0001975","biological_process","response to amphetamine ","Q12879; Q05586; P07101; Q92769; P41220; P49792; O75916; P35462; P0DP23; Q9UD71; Q08209; P00441; P14416; P43354; P49798; P21728; Q05940; O43665; P34972; Q9UKV0; P78348"]
["GO:0045471","biological_process","response to ethanol ","Q12879; P13639; Q16288; P04035; P11413; P10276; P06493; P22681; Q05586; P21802; Q13224; P07101; Q14289; P23443; P40763; P06241; Q92934; P23771; P14672; P41220; P49411; P04818; P21554; P04040; P49675; P01236; P24534; P28222; O95471; P09211; Q01959; O15551; P61160; Q14790; P06746; P49795; P00441; P41145; P49798; P06396; Q15047; P24385; Q16611; P61586; P21731"]
["GO:0019233","biological_process","sensory perception of pain ","Q12879; P27361; Q05586; P28482; Q00535; Q9NZV8; P35354; Q15700; P41143; P41146; P21554; P43681; P08473; P41597; Q9Y5Y9; Q13255; P16389; P41145; P51608; O75762; P34972; P35372"]
["GO:0042428","biological_process","serotonin metabolic process ","Q12879; Q04656"]
["GO:0030431","biological_process","sleep ","Q12879; P01100; P28223; Q99808; P10515"]
["GO:0001964","biological_process","startle response ","Q12879; P48167; Q02297; Q09470; P51608; O60260"]
["GO:0008542","biological_process","visual learning ","Q12879; P04035; P21359; Q05586; P16220; P10721; Q00535; P42345; O43566; P01116; Q9NPQ8; P05556; P35462; Q9UD71; Q16665; Q9C0D5; O75925; Q96PV0; P14416; P05067; P35367; P21728; P51608; Q03164"]
["GO:0009952","biological_process","anterior/posterior pattern specification ","Q13873; Q86Z02; Q9H2X6; Q15796; P46109; Q9NYQ6; Q13705; P09629; P78543; Q9HBU1; O75386; P10070; Q9ULK5; P17509; P35548; P31270; P36897; P31269; Q05516; Q03164; Q03014; P13631; P10071; P25490; P31260; Q13562; Q7LC44"]
["GO:0060840","biological_process","artery development ","Q13873; Q13705; Q86V48; P37023; P10071"]
["GO:0060413","biological_process","atrial septum morphogenesis ","Q13873; P43694; P52952; Q9UMR3"]
["GO:0030509","biological_process","BMP signaling pathway ","Q13873; Q01974; P27361; Q9UJU2; Q15797; Q04771; Q13705; P17844; Q03167; O15198; P50616; Q92736; Q13485; P56178; Q53EL6; P52952; O43541; O15105; P17813; Q7Z3T8; O75096; P22004; P37023; Q13950; Q9Y4E8; P12755; P36894; P41134; P18146"]
["GO:0071773","biological_process","cellular response to BMP stimulus ","Q13873; Q04771; P23771; Q92908; O15198; Q13485; P56178; P22004; P37023; Q13950; P36894; P48436"]
["GO:0009267","biological_process","cellular response to starvation ","Q13873; P15172; Q16654; Q5S007; Q03135; P42345; Q12778; Q9Y6E0; Q9C0C7; Q96EB6; Q9P289; P13473; O15297; P56192; P36956; Q13118; Q6ZS17; Q12772; Q96KQ7; P35900; P11142; P61244; Q9GZQ8; P11234; Q8N122; Q14191; Q9H492"]
["GO:0002063","biological_process","chondrocyte development ","Q13873; Q9NZJ5; P35548; Q13950"]
["GO:0003197","biological_process","endocardial cushion development ","Q13873; P21860; P43694; Q12946; P11308"]
["GO:0060350","biological_process","endochondral bone morphogenesis ","Q13873; Q86X55"]
["GO:0072577","biological_process","endothelial cell apoptotic process ","Q13873; Q86Z02; Q99683; Q5VWQ8; P01375; Q01955"]
["GO:0001935","biological_process","endothelial cell proliferation ","Q13873; P51817; Q02763; Q96PH1; P28906; Q8WTV0; O75460; P42338; Q12959; P17861; P09601; P50281"]
["GO:0060173","biological_process","limb development ","Q13873; P10276; Q9NYL2; Q9P2D1; O75096; P19021"]
["GO:0048286","biological_process","lung alveolus development ","Q13873; P21802; P35916; P06401; Q504Y2; Q8IZQ8; Q12946; O94880; Q96RK0; Q04656; Q68CZ2; Q9UJM3"]
["GO:0001946","biological_process","lymphangiogenesis ","Q13873; P35916; Q15678; Q13705; Q99958; P37023"]
["GO:0060836","biological_process","lymphatic endothelial cell differentiation ","Q13873; Q13705; P37023"]
["GO:0001893","biological_process","maternal placenta development ","Q13873; P31749; P19793; O75626; Q96EP5; O95751; P30048"]
["GO:0001707","biological_process","mesoderm formation ","Q13873; P35240; Q15796; Q04771; P84022; P11831; O96004; P10644; O95863; P36894"]
["GO:0003183","biological_process","mitral valve morphogenesis ","Q13873; Q04771; O43541; P36894; Q15672"]
["GO:0003252","biological_process","negative regulation of cell proliferation involved in heart valve morphogenesis ","Q13873; P46531"]
["GO:1902731","biological_process","negative regulation of chondrocyte proliferation ","Q13873"]
["GO:2000279","biological_process","negative regulation of DNA biosynthetic process ","Q13873; P17302; Q96TA1; O95069; P28562; Q15327; Q99543; P37023"]
["GO:0003085","biological_process","negative regulation of systemic arterial blood pressure ","Q13873"]
["GO:0045906","biological_process","negative regulation of vasoconstriction ","Q13873"]
["GO:0003148","biological_process","outflow tract septum morphogenesis ","Q13873; P10276; P21802; Q92908; Q13485; P52952; P35548; O43541; P17813; P37173; Q9Y6N7; P36894; Q9UMR3"]
["GO:0061626","biological_process","pharyngeal arch artery morphogenesis ","Q13873; Q14469; P36894"]
["GO:0048842","biological_process","positive regulation of axon extension involved in axon guidance ","Q13873"]
["GO:0030513","biological_process","positive regulation of BMP signaling pathway ","Q13873; Q15796; Q13418; P43694; Q14469; Q92908; Q13485; P35548; P17813; P46531; P37023; Q14980; Q06330; Q9C0C9"]
["GO:0061036","biological_process","positive regulation of cartilage development ","Q13873; Q05516; P48436"]
["GO:0010634","biological_process","positive regulation of epithelial cell migration ","Q13873; P19174; P05412; P07737; P12931; Q02156; P09327; Q9NQC3; Q16665; P17301; Q9UBN7; P37173; P62491; O75122; Q14185; P48436"]
["GO:0045778","biological_process","positive regulation of ossification ","Q13873; Q6KC79; Q14106; Q05516"]
["GO:0010862","biological_process","positive regulation of pathway-restricted SMAD protein phosphorylation ","Q13873; Q04771; P33981; P08476; O00560; Q93062; Q13485; P67870; P17813; P36897; P98082; P22004; P37023; P36894; P36896; O95390"]
["GO:0030166","biological_process","proteoglycan biosynthetic process ","Q13873"]
["GO:0014916","biological_process","regulation of lung blood pressure ","Q13873"]
["GO:0061298","biological_process","retina vasculature development in camera-type eye ","Q13873; P09619; P16234; Q13705; Q16665; P37023"]
["GO:1905314","biological_process","semi-lunar valve development ","Q13873"]
["GO:0003186","biological_process","tricuspid valve morphogenesis ","Q13873; P37173; P36894"]
["GO:0060841","biological_process","venous blood vessel development ","Q13873; Q13705; Q12946; P37023"]
["GO:0060412","biological_process","ventricular septum morphogenesis ","Q13873; Q04771; P29474; Q14469; Q03167; Q99697; Q13485; Q9H4B6; P52952; O15105; P37173; P36897; Q99967; Q9Y6N7; O15119; P46531; Q06330"]
["GO:0006117","biological_process","acetaldehyde metabolic process ","Q04206"]
["GO:1904385","biological_process","cellular response to angiotensin ","Q04206; P19838; Q00613; Q05655; Q99741; P13498; Q16236; Q8NFD5"]
["GO:0035729","biological_process","cellular response to hepatocyte growth factor stimulus ","Q04206; P16220; P48506; P41180; P09327; P56945; Q15648; Q8IXJ6; Q99538"]
["GO:0071347","biological_process","cellular response to interleukin- ","Q04206; O15264; P19838; Q15759; P35398; Q99801; P17676; Q5D1E8; Q5VWQ8; Q16665; Q92819; P10646; Q92900; Q15327; Q14694; Q5TC82; Q96FW1; Q9ULZ3; P25942; P38159; P25490; P48436"]
["GO:0071354","biological_process","cellular response to interleukin-6 ","Q04206; P19838; Q9UBK2; Q9GZV9; P35232"]
["GO:0071223","biological_process","cellular response to lipoteichoic acid ","Q04206; Q16539; O43353; P16671; P58753"]
["GO:0071224","biological_process","cellular response to peptidoglycan ","Q04206; O43353; Q96P20"]
["GO:0071356","biological_process","cellular response to tumor necrosis factor ","Q04206; P31749; P27361; P00966; P49715; P38398; P19838; P15172; Q13546; P28482; P08621; P35398; Q16539; Q99683; O14920; O15111; Q96RT1; P23771; P56524; Q96EB6; P14672; Q9UBK2; Q99801; Q16625; P16989; P15173; P13498; Q92974; P23396; Q5D1E8; Q5VWQ8; P15090; Q92819; Q16236; Q15327; Q8NER1; Q9ULZ3; Q6P2Q9; Q07352; P26651; Q14654; Q99828"]
["GO:0051607","biological_process","defense response to virus ","Q04206; P08575; Q9UHD2; P42224; Q14653; P29590; Q9P2K8; P52630; Q99558; P19525; Q9HC16; Q7Z434; O15162; Q13158; Q12904; Q15366; Q9Y3Z3; Q12906; O95786; O15455; Q5D1E8; Q13568; Q96P20; O60828; O60706; P48551; P10415; Q7Z2W4; Q92985; Q53F19; Q01628; P00973; P41145; Q86WV6; Q9BYX4; P10914; Q8N884; Q92841; Q9UGM3; Q86XR7; Q9ULZ3; P25942; Q16666; Q9Y2Y1; P14316; Q9UJV9; Q96J02; Q9NQT4; Q15842; Q9H257; Q13794; P05423; Q14457"]
["GO:0031293","biological_process","membrane protein intracellular domain proteolysis ","Q04206; P19838; P08138; P78536; Q9Y4K3"]
["GO:1901223","biological_process","negative regulation of NIK/NF-kappaB signaling ","Q04206; P35813; Q8WUI4; Q5D1E8; Q96P20; Q9NQC7; Q96A54; P50749; O75688"]
["GO:1902894","biological_process","negative regulation of pri-miRNA transcription by RNA polymerase II ","Q04206; Q12968; Q14934; P11831; P56524; P05067; Q07869; P25490; P48436"]
["GO:0033234","biological_process","negative regulation of protein sumoylation ","Q04206; P35222; Q9NP66; Q99497; Q9P0W2; P43356"]
["GO:0070431","biological_process","nucleotide-binding oligomerization domain containing 2 signaling pathway ","Q04206; P25963; O43353"]
["GO:0032332","biological_process","positive regulation of chondrocyte differentiation ","Q04206; P84022; Q504Y2; P31270; P22004; P37023; Q13950; Q05516; P10071; P48436"]
["GO:0045084","biological_process","positive regulation of interleukin-12 biosynthetic process ","Q04206; Q9Y4K3; O00206; P10914"]
["GO:2000630","biological_process","positive regulation of miRNA metabolic process ","Q04206; P01112; P19838"]
["GO:1902895","biological_process","positive regulation of pri-miRNA transcription by RNA polymerase II ","Q04206; P40763; P05412; P84022; P17947; P04637; P11831; P01100; Q13887; O14746; P08138; P51532; P01236; Q16665; P36956; O43541; P28347; P36894"]
["GO:0014040","biological_process","positive regulation of Schwann cell differentiation ","Q04206"]
["GO:1901522","biological_process","positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus ","Q04206; Q15797; P19793; O15198; Q13485; P56178; P48443; Q13950"]
["GO:0099527","biological_process","postsynapse to nucleus signaling pathway ","Q04206; O60674; P40763; P52294; P52292; Q6UUV9"]
["GO:0043620","biological_process","regulation of DNA-templated transcription in response to stress ","Q04206; Q9NYF8; P51812; Q15418; O43566; P35638"]
["GO:1901222","biological_process","regulation of NIK/NF-kappaB signaling ","Q04206; P25963; Q9Y2R2; P20749; O60936; Q06830; Q15109"]
["GO:0043278","biological_process","response to morphine ","Q04206; Q05586; Q00987; P05129; P42345; P53041; Q02156; Q15121; Q13158; P21554; P35462; Q9UD71; P14416; P41145; P49798; P53539; Q9H492"]
["GO:0032495","biological_process","response to muramyl dipeptide ","Q04206; P25963; Q16539; Q96RT1; Q13568; P46531; Q9H257"]
["GO:0035994","biological_process","response to muscle stretch ","Q04206; P19838; P25963; P05412; Q16539; P04049; P01100; Q92736; P32418; P19634; Q15327; O15273"]
["GO:0010224","biological_process","response to UV-B ","Q04206; P05114; P10415; Q03468; P43246"]
["GO:0033209","biological_process","tumor necrosis factor-mediated signaling pathway ","Q04206; O60674; P42224; Q13418; Q14289; P25963; Q13546; O14920; Q99558; O15111; O43524; Q12933; Q15046; P19438; P05787; P78536; Q13114; P01375; Q9ULZ3; P25942; P20333; P05783"]
["GO:0060055","biological_process","angiogenesis involved in wound healing ","P14921; P05106; P11831; P42338; P07203; Q14118"]
["GO:0048870","biological_process","cell motility ","P14921; Q05397; P29317; P60709; P63000; Q02750; O14939; Q13393; Q16658; P28906; P78536; P17813; P36897; Q92556; P16144; Q14247; P12755; P50281"]
["GO:0044849","biological_process","estrous cycle ","P14921; P04083; P41146; P12004; Q92819; P41145; Q9H2P0; P18146; P35372"]
["GO:0021854","biological_process","hypothalamus development ","P14921; Q9UJU2; Q07812"]
["GO:0021983","biological_process","pituitary gland development ","P14921; P16220; P08151; P12830; P26367; P10070; P78337; Q9UBR4; P48431; P43699; P36894; P23769; Q06330"]
["GO:0030578","biological_process","PML body organization ","P14921; Q9H2X6; P29590; P63165"]
["GO:0045648","biological_process","positive regulation of erythrocyte differentiation ","P14921; P15976; P42224; P40763; Q92835; Q16539; O43524; P08476; P27540; P17542; Q16665; P0DMV8; Q02363; Q6NXT1; P51692; Q15648; P23769; P36896; Q99873"]
["GO:1904996","biological_process","positive regulation of leukocyte adhesion to vascular endothelial cell ","P14921; P01375"]
["GO:0010715","biological_process","regulation of extracellular matrix disassembly ","P14921; P22455; Q08345; Q16832; Q07954"]
["GO:0046677","biological_process","response to antibiotic ","P14921; O60674; Q00987; P04637; P23458; P07900; P55211; P43003; P33076; P41134"]
["GO:0034616","biological_process","response to laminar fluid shear stress ","P14921; O43541; O15105; O95477"]
["GO:0098586","biological_process","cellular response to virus ","Q14164; Q15759; Q16539; O15111; Q14684; Q5D1E8; Q06787; P10070; Q92538"]
["GO:0008630","biological_process","intrinsic apoptotic signaling pathway in response to DNA damage ","Q14164; P52701; P00519; O96017; P29590; P38398; P29317; P78527; Q14934; Q92934; P27986; O43521; P55211; O43464; Q9NS56; P19438; O15350; Q07812; Q01094; P10415; Q03468; P40692; P06746; P31947; P23025; Q07820; P01375; Q07817; P09601; Q16611; P20333; P42575"]
["GO:0032480","biological_process","negative regulation of type I interferon production ","Q14164; Q9UHD2; Q14653; Q7Z434; Q15366; O95786; Q86VP1; Q9NQC7; Q9BYX4; Q13526; Q96J02"]
["GO:0035456","biological_process","response to interferon-beta ","Q14164; P42224; O15162; P48551; Q01628"]
["GO:0034340","biological_process","response to type I interferon ","Q14164; P23497"]
["GO:0035666","biological_process","TRIF-dependent toll-like receptor signaling pathway ","Q14164; Q9UHD2; Q14653; Q13546; O14920; Q9Y6K9; O15111; Q13158; P62979; O15455; P0CG47; Q14790; Q92985; Q8TDQ1; Q13114; O00206; Q86XR7; Q9Y6Y9; P62987"]
["GO:0045747","biological_process","positive regulation of Notch signaling pathway ","Q2M2I8; Q09472; P40763; P10721; P41743; P78545; Q14469; Q13573; Q92793; P50553; Q9BUL8; P46531; O14713; Q06330; Q9H3D4; O95208"]
["GO:2000369","biological_process","regulation of clathrin-dependent endocytosis ","Q2M2I8; Q07912; P42338; Q99962"]
["GO:0032880","biological_process","regulation of protein localization ","Q2M2I8; P45983; Q14012; O00401; P25686; P61106; P55196; Q9UH65; Q6PGQ7; Q86TI0; Q15569; P63165; P63244; O94874; Q969H0; O76021"]
["GO:0048539","biological_process","bone marrow development ","P08575"]
["GO:0044770","biological_process","cell cycle phase transition ","P08575; O00311; Q14493; P68036; Q92900; Q9BVW5"]
["GO:0002244","biological_process","hematopoietic progenitor cell differentiation ","P08575; P13639; Q96ST3; P08476; Q14155; Q9NQW6; Q8NCA9; P49768; Q9BWW4; Q9Y520; Q13303; P29350; P11388; P08567"]
["GO:0002378","biological_process","immunoglobulin biosynthetic process ","P08575"]
["GO:0006933","biological_process","negative regulation of cell adhesion involved in substrate-bound cell migration ","P08575; O14713"]
["GO:0001960","biological_process","negative regulation of cytokine-mediated signaling pathway ","P08575; Q03135"]
["GO:0045085","biological_process","negative regulation of interleukin-2 biosynthetic process ","P08575; Q9BZS1; P26651"]
["GO:1903979","biological_process","negative regulation of microglial cell activation ","P08575; P01130"]
["GO:0031953","biological_process","negative regulation of protein autophosphorylation ","P08575; P05412; P17813; Q15569; Q9UJM3; P22413"]
["GO:0006469","biological_process","negative regulation of protein kinase activity ","P08575; P31749; O15530; Q96B36; P04792; P06400; P35240; P21359; Q13177; Q13418; Q16512; P21709; O14512; O14640; Q8TCU6; Q15545; Q9HCJ2; Q8TB45; P09211; Q99497; P15090; Q03111; P31947; O95684; Q15633; P61981; O75581; Q92519; P13688; P49815; P24522; Q70Z35; Q8TEV9; O14713; Q8WVI7; Q13522; Q9GZV5; Q8N726"]
["GO:0061099","biological_process","negative regulation of protein tyrosine kinase activity ","P08575; Q13882; Q03135; P17706; Q9C0H9; O60239"]
["GO:0001915","biological_process","negative regulation of T cell mediated cytotoxicity ","P08575; P16871; P13688"]
["GO:0045060","biological_process","negative thymic T cell selection ","P08575; P43403; P07766; Q9H1Y0; P32248; O43918; P10747; P10071"]
["GO:0043312","biological_process","neutrophil degranulation ","P08575; P13639; P14618; P23467; P09429; P16284; P09769; Q14004; P09917; P19838; P68104; P07355; Q7L591; P28482; P63000; O94804; Q16539; P08238; O75874; Q13464; P42685; P07900; P53396; Q05655; P61224; P13010; Q92542; P01889; Q92882; P16671; P04075; P01009; Q13393; Q5T4S7; P61106; P02765; P13473; P04040; O00560; P30041; P17980; P17858; P36871; P08473; O14727; P13498; Q8NF37; P07437; Q13576; O15511; O60784; P16070; P18206; P62834; P12956; P61020; P11216; P05107; Q12913; P55072; Q99439; P09211; P61160; P20138; P0DMV8; P51148; Q99460; Q13200; P18669; Q13813; P21462; P67870; O43914; P14923; P11717; P51809; P30273; P07741; P49768; P13688; P17931; Q8N1F8; O00571; P28799; Q01518; O00161; Q96D96; Q86WV6; P06396; P00749; Q96NW7; P22392; P21730; P11142; O75022; P12318; P78371; P46940; Q14204; P31949; P12268; Q13303; O00186; P63167; O60610; Q9H410; P06737; P06702; Q86XR7; Q9ULZ3; Q9UNP9; P60880; Q9Y6G9; P61586; P29350; O94759; Q7Z6Z7; Q9UQ80; P20333; Q96AX2; Q9NPY3; P35998; P01111; P50395; Q9UJU6; P06744; P78324; O00264; O00231; P15924; Q9H3Z4"]
["GO:0044855","biological_process","plasma membrane raft distribution ","P08575"]
["GO:0046641","biological_process","positive regulation of alpha-beta T cell proliferation ","P08575; P43403; P43405; O43353; P07766; P41597; P10747"]
["GO:0050857","biological_process","positive regulation of antigen receptor-mediated signaling pathway ","P08575"]
["GO:2001238","biological_process","positive regulation of extrinsic apoptotic signaling pathway ","P08575; Q13177; P29590; Q13546; Q03135; Q13158; Q12933; Q9BYM8; Q9NQC7; Q9BZR8; P50052; O95999; Q9ULZ3; P55957; P30101; Q9NZC7"]
["GO:0045588","biological_process","positive regulation of gamma-delta T cell differentiation ","P08575; P43405; P51692"]
["GO:2000473","biological_process","positive regulation of hematopoietic stem cell migration ","P08575; P41597"]
["GO:0002925","biological_process","positive regulation of humoral immune response mediated by circulating immunoglobulin ","P08575; P01375"]
["GO:0045086","biological_process","positive regulation of interleukin-2 biosynthetic process ","P08575; Q04759; P07766; Q9BXL7; P10747; Q15306; P51692; P01730"]
["GO:0048304","biological_process","positive regulation of isotype switching to Ig isotypes ","P08575; P40692; P10747; P43246; Q9UL17; P25942"]
["GO:1903615","biological_process","positive regulation of protein tyrosine phosphatase activity ","P08575"]
["GO:2000648","biological_process","positive regulation of stem cell proliferation ","P08575; O14746; Q8N6T7; O15119; P52926; Q00839"]
["GO:0001916","biological_process","positive regulation of T cell mediated cytotoxicity ","P08575; Q13158; P01892"]
["GO:0042102","biological_process","positive regulation of T cell proliferation ","P08575; Q04759; P04083; P52333; P40189; Q14469; P07766; P02786; P16333; Q8TDQ0; P98172; Q9BXL7; Q9Y4K3; P10747; Q5ZPR3; P15529; P01730; O75995; P30203"]
["GO:0045059","biological_process","positive thymic T cell selection ","P08575; Q15831; P43403; P11831"]
["GO:0045577","biological_process","regulation of B cell differentiation ","P08575; Q9NQC7; Q9BXL7; Q96P31; P29350; Q07352"]
["GO:0048864","biological_process","stem cell development ","P08575"]
["GO:0042098","biological_process","T cell proliferation ","P08575; O43353; Q92542; P26038; P48736; P17812; Q5TC82; P30281"]
["GO:0070836","biological_process","caveola assembly ","P51636; Q03135"]
["GO:0007029","biological_process","endoplasmic reticulum organization ","P51636; Q9NZJ5; P31415; Q8TD08; O15027"]
["GO:0001937","biological_process","negative regulation of endothelial cell proliferation ","P51636; P21359; P42224; Q03135; P17302; P28827; Q12904; P01236; Q9UII2; P47989; P02649; P17813; P57105; P36897; Q9H4X1; P01375; Q9UBU3; P37023"]
["GO:0030512","biological_process","negative regulation of transforming growth factor beta receptor signaling pathway ","P51636; O15530; Q15796; P84022; Q03135; P35813; Q96EB6; P62979; Q9UBC0; Q03167; P50570; P0CG47; Q9Y3F4; P0DMV8; P78536; Q9Y2U8; O43541; O15105; P17813; P37173; O43294; P36897; P17861; Q9UNE7; P62987; P43699; P12755; Q13526; P11021"]
["GO:0044794","biological_process","positive regulation by host of viral process ","P51636; P23528; P02649; Q8TBZ5"]
["GO:0044791","biological_process","positive regulation by host of viral release from host cell ","P51636; Q8TBZ5; Q9UQE7"]
["GO:0060161","biological_process","positive regulation of dopamine receptor signaling pathway ","P51636; Q5S007; P35462"]
["GO:0019065","biological_process","receptor-mediated endocytosis of virus by host cell ","P51636; Q03135; P42566"]
["GO:0007088","biological_process","regulation of mitotic nuclear division ","P51636; Q99640; Q14004; O14744; O43293; P51955; Q13042; P46013; Q9UKT4; Q96Q89; P18754; Q969U6; Q6PGQ7; P30307; Q4G163; P60953; Q13526"]
["GO:0048741","biological_process","skeletal muscle fiber development ","P51636; P15172; P15173; Q08209; Q9UBL9; P68133; P07203; Q86YM7; P12755; P21817"]
["GO:0048278","biological_process","vesicle docking ","P51636; Q16623; P56962; P21579; P61266"]
["GO:0006906","biological_process","vesicle fusion ","P51636; Q8IYJ3; Q86YS7; Q15836; Q9H2B2; P56962; Q5T7P8; Q15075; P21579; O43581; Q9UKW4; P63027; Q9Y2J0; P51809; Q8N9I0; Q8IV01; P23763"]
["GO:0016050","biological_process","vesicle organization ","P51636; Q03135; O00401; Q9UKT4; P42566; Q7Z3T8; Q9ULU8; O60749; Q9Y5X2; Q99523"]
["GO:0042632","biological_process","cholesterol homeostasis ","P22455; P41235; Q03135; P35398; Q96EB6; P01130; Q96RI1; P55055; Q8WTV0; Q9NRY6; Q9UKM9; P02649; P15090; O00482; Q14494; Q12772; Q13133; P17861; O95477; P20393"]
["GO:0055062","biological_process","phosphate ion homeostasis ","P22455; Q9GZV9"]
["GO:0043085","biological_process","positive regulation of catalytic activity ","P22455; Q03135; P13010; Q92542; P10415; Q8IZ21; P00441; P49768; P43354; P49810; Q16595; P31946; Q04656; Q99828"]
["GO:2000573","biological_process","positive regulation of DNA biosynthetic process ","P22455; P01106; P09619; Q14289; Q9BZL6; O75914; P12931; P09038; Q9H4X1; Q9NPH5; P32121"]
["GO:0045862","biological_process","positive regulation of proteolysis ","P22455; P53350; Q92934; Q92769; Q13158; Q14790; Q13049; Q16611; O15294"]
["GO:0070857","biological_process","regulation of bile acid biosynthetic process ","P22455; Q96EB6; Q96RI1"]
["GO:0019216","biological_process","regulation of lipid metabolic process ","P22455; P04035; Q01581; Q96ST3; P19793; P41235; P33121; Q9Y618; P16671; Q9C0K0; O60869; P35462; Q86X55; Q9Y4H2; P50416; Q8IVF5; Q96A54; Q92793; O14654; Q02363; Q86X29; O15379; Q07869; Q14192; Q9NZI5; Q14686; Q15327; Q6STE5; O95477; Q15788; Q9BZK7; Q15596; Q96RS0; O75376; Q15648; P20393"]
["GO:0007257","biological_process","activation of JUN kinase activity ","Q16584; P18031; Q92918; Q12851; Q12852; O95382; P80192; Q16512; Q9NYL2; Q13546; Q5TCX8; Q9Y4K4; P43405; Q9Y2U5; O14733; Q02779; Q99683; Q7L7X3; Q9UL54; Q5VWQ8; Q03468; Q9UER7; O75460; O60271; Q9UPT6; O15169; Q9UJU6"]
["GO:0008219","biological_process","cell death ","Q16584; Q9NYL2; Q9BZL6; P28223; Q96CV9; Q9Y6H5; O95999; P09601; P37198; Q9UNN5; P15408; Q9NP80"]
["GO:0046330","biological_process","positive regulation of JNK cascade ","Q16584; Q9H2X6; Q9H2K8; Q12851; P09429; P01112; P35916; Q14289; Q13546; Q02779; Q99683; O43353; Q7L7X3; P14598; Q8N4C8; Q13188; Q9NQ66; O00560; Q9HBA0; O15455; P32248; Q9UL54; Q5VWQ8; Q969S3; P50749; Q9BUZ4; P05067; Q9UQF2; O43164; Q13291; P24522; P31994; Q9ULZ3; P60953; O95267; Q7Z6J0; P58753; O15169; Q9H257; Q15109"]
["GO:0043507","biological_process","positive regulation of JUN kinase activity ","Q16584; Q01974; Q9H2K8; Q14289; Q02779; Q99683; O43318; P54764; Q13153; Q12933; O60315; Q92997; Q9Y6R4; P23396; Q5VWQ8; Q9ULK5; O14641; Q9Y4K3; P01375; Q13009; Q15109"]
["GO:0006924","biological_process","activation-induced cell death of T cells ","P31749; O15304; P01589"]
["GO:0032148","biological_process","activation of protein kinase B activity ","P31749; O15530; Q05513; Q16288; P42345; P06213; P12931; P85299; Q99497; Q6R327; Q02297; Q9BXM7; P08913; O14713; Q3V6T2; Q9BPZ7; P10599"]
["GO:0008643","biological_process","carbohydrate transport ","P31749; P31751; Q15121"]
["GO:0002042","biological_process","cell migration involved in sprouting angiogenesis ","P31749; P54760; P35968; P11831; P52799; P22736; P05556; P09038; Q92569; P80108; Q9Y6N7"]
["GO:0030030","biological_process","cell projection organization ","P31749; Q16513; Q6IBS0; Q15131; Q13371; P05556; O15259; Q9P2E2; Q9Y3M2; Q9H244; Q92574; P08567; Q15329"]
["GO:0006464","biological_process","cellular protein modification process ","P31749; P00519; P78527; P31751; Q8IVW4; P07947; P42684; Q15208; P10398; P04844; P63279; P68036; P49427; Q16763; Q96HE7; Q9UHP3; Q14749; Q9Y572; P20309; Q9NT62; P61088; P62987; Q96EZ8; P04843"]
["GO:0097011","biological_process","cellular response to granulocyte macrophage colony-stimulating factor stimulus ","P31749; P28482; P41162; P01730; P26651"]
["GO:0140052","biological_process","cellular response to oxidised low-density lipoprotein particle stimulus ","P31749; P16671; O00206"]
["GO:0051186","biological_process","cofactor metabolic process ","P31749; Q13237; P29474; P07900; P0DP23; P35270; Q03393"]
["GO:0031018","biological_process","endocrine pancreas development ","P31749; Q9NZJ5; Q12778; P04083; Q9UBC0; Q9Y261; P50219; Q16611; P48436; Q13562"]
["GO:0072655","biological_process","establishment of protein localization to mitochondrion ","P31749; P52789; P19367; Q9BXM7; P35638"]
["GO:0097194","biological_process","execution phase of apoptosis ","P31749; Q7L7X3; Q9Y6E0; Q9BXH1; P55211; O43464; Q14790; P55212; P55210; O00429; O15519; P42574; P42575"]
["GO:0007281","biological_process","germ cell development ","P31749; P19544; P10276; Q04771; P23443; P42345; Q92904; O75626; Q07812; Q92879; Q07817; P43246; Q86YF9; Q9BXT4"]
["GO:0005978","biological_process","glycogen biosynthetic process ","P31749; P31751; P54840; P13807; Q9UQK1; O15055; P36871; O95278; Q9UGI9; Q16816; P20393"]
["GO:0060709","biological_process","glycogen cell differentiation involved in embryonic placenta development ","P31749"]
["GO:0030212","biological_process","hyaluronan metabolic process ","P31749; P11309; Q14624"]
["GO:0048009","biological_process","insulin-like growth factor receptor signaling pathway ","P31749; Q9NZJ5; P08069; P35568; P27986; Q9NQ66; P10912; P49815; Q13322; Q6Y7W6"]
["GO:0035655","biological_process","interleukin-18-mediated signaling pathway ","P31749; P09917"]
["GO:0060716","biological_process","labyrinthine layer blood vessel development ","P31749; P28482; P51178; Q14469; Q8N3Y1; P17275; Q06330"]
["GO:0072656","biological_process","maintenance of protein location in mitochondrion ","P31749; P52789; P19367; Q9BXM7"]
["GO:0060644","biological_process","mammary gland epithelial cell differentiation ","P31749; Q15303; O95835; P31751; P17676"]
["GO:0010507","biological_process","negative regulation of autophagy ","P31749; Q05397; Q9Y2R2; P42345; Q08379; P08581; Q04637; P43694; Q9NYJ8; Q96LC9; P10415; Q07820; Q07817; Q8N5C8; P48357; Q86UE8; Q8IXJ6; P51397"]
["GO:0045792","biological_process","negative regulation of cell size ","P31749; Q96B36; P42345; P60484; P35241; Q8TB45; P61586; Q92574"]
["GO:0043154","biological_process","negative regulation of cysteine-type endopeptidase activity involved in apoptotic process ","P31749; Q13163; P37840; P02511; Q9UJU2; Q00987; P51812; P12931; P04049; P68400; Q15418; P35354; P08138; P29972; P16070; Q02962; P31947; O15392; P62258; O00571; O43474; P07203; P98170; O15519; P20333; Q7Z6J0; P32121; O43255; O43504; P55273"]
["GO:0010951","biological_process","negative regulation of endopeptidase activity ","P31749; P04004; P04406; Q9UGM5"]
["GO:0046329","biological_process","negative regulation of JNK cascade ","P31749; Q9H2K8; P51452; Q9NQC7; O15379; Q03112; Q9NYF0; O00255; Q9BXM7; O15534; O75376; Q9Y6W6; Q96J02; O60260"]
["GO:2000402","biological_process","negative regulation of lymphocyte migration ","P31749; O00401; Q8N6F7"]
["GO:1901215","biological_process","negative regulation of neuron death ","P31749; P37840; P22681; P40763; P16220; Q5S007; Q00535; P49841; Q00613; Q9Y6K9; P53041; Q04637; Q96EB6; Q04864; Q9UBK2; O43464; Q12933; P28906; Q99497; Q92673; P02649; P05067; Q07869; P63010; P36955; O60260"]
["GO:0010748","biological_process","negative regulation of plasma membrane long-chain fatty acid transport ","P31749; P31751; Q9Y4H2"]
["GO:0100002","biological_process","negative regulation of protein kinase activity by protein phosphorylation ","P31749"]
["GO:0051898","biological_process","negative regulation of protein kinase B signaling ","P31749; P29317; Q13905; P60484; Q96EB6; O14745; O60346; P35462; Q12913; Q9NZM5; P47989; Q12959; P14416; P63244; O43474; P49815; P35638; Q14118; P32121; Q86UL8; P05813; Q99828"]
["GO:0071901","biological_process","negative regulation of protein serine/threonine kinase activity ","P31749; P00519; Q5VWQ8; Q15569; O75581; Q9ULZ3"]
["GO:0031397","biological_process","negative regulation of protein ubiquitination ","P31749; P49407; P05129; Q03135; Q00535; P06241; P42345; Q02156; P48506; O95816; O15055; Q9H1Y0; P23396; Q99497; P26368; Q13107; Q16526; P0DMV8; O15105; Q96BK5; Q9HC62; Q9BY41; O60678; O94874; P32121; Q04323; O15294"]
["GO:0045861","biological_process","negative regulation of proteolysis ","P31749; Q00535; Q96KC8; P46379; P55055; Q9UBN7"]
["GO:0090201","biological_process","negative regulation of release of cytochrome c from mitochondria ","P31749; P30405; O60936; P02545; P48678; Q07817; P07203; Q16595; P32121; O60260"]
["GO:0038061","biological_process","NIK/NF-kappaB signaling ","P31749; P19838; Q00653; Q01201; Q99558; O15111; Q04864"]
["GO:0006809","biological_process","nitric oxide biosynthetic process ","P31749; P35228; P29475; P35398; P29474; P35270"]
["GO:0032287","biological_process","peripheral nervous system myelin maintenance ","P31749; P31751; Q92597; P00441"]
["GO:0032270","biological_process","positive regulation of cellular protein metabolic process ","P31749; P25963; Q04637; P08476; P55055; Q96T88; Q13133; O43474; P30556"]
["GO:0032079","biological_process","positive regulation of endodeoxyribonuclease activity ","P31749; Q05655; P23396"]
["GO:0045742","biological_process","positive regulation of epidermal growth factor receptor signaling pathway ","P31749; Q13882; P22681; Q96P48; P48023; Q8N4X5; Q07889; P37198; Q99704; P18545"]
["GO:0045600","biological_process","positive regulation of fat cell differentiation ","P31749; P49715; P37231; P16220; Q13043; Q13887; P28223; Q96PM9; Q13188; P17752; P17676; Q86X55; Q5D1E8; Q9H4B6; Q96A49; A1X283; Q02363; Q8TD43; P17861; Q07352; Q05516; P26651"]
["GO:0010763","biological_process","positive regulation of fibroblast migration ","P31749; O75914; Q16832; Q02156; Q13153; Q08495; Q14155; P32418"]
["GO:0046326","biological_process","positive regulation of glucose import ","P31749; P31751; Q02078; Q16539; P35568; P06213; P27986; P41743; O14746; P53675; Q9BX66; P62834; Q9Y4H2; Q16236; P56211; P17081"]
["GO:0010907","biological_process","positive regulation of glucose metabolic process ","P31749; P31751; P35568; P12931; Q9Y4H2; P80108; Q13794"]
["GO:1903721","biological_process","positive regulation of I-kappaB phosphorylation ","P31749; Q12933"]
["GO:0046889","biological_process","positive regulation of lipid biosynthetic process ","P31749; P16220; P42345; Q9BX66; P02649; Q9NP71"]
["GO:0010918","biological_process","positive regulation of mitochondrial membrane potential ","P31749; P31751; Q92934; Q13423; P55072; Q9UJZ1; P55957"]
["GO:0045429","biological_process","positive regulation of nitric oxide biosynthetic process ","P31749; P00966; P03372; O60674; Q14289; P84022; P42345; P08238; P06213; P07900; P35354; P16671; Q13563; P50570; P05107; P50052; P05067; O43474; P01375; O00206; Q8NER1; P35372"]
["GO:0051000","biological_process","positive regulation of nitric-oxide synthase activity ","P31749; P03372; Q14289; O14746; Q15554; P01116; P17342; P0DP23; Q16665; Q8WTV0; P02649; P50052"]
["GO:0046622","biological_process","positive regulation of organ growth ","P31749; P16989; P55895; O75995"]
["GO:2000010","biological_process","positive regulation of protein localization to cell surface ","P31749; Q15303; P08238; P20963; P78559; P30273; P01375; Q02297; Q8N335"]
["GO:1900182","biological_process","positive regulation of protein localization to nucleus ","P31749; P06493; Q15831; Q9NZJ5; P53350; P06241; P12931; P08138; O95251; Q99497; Q9NYZ3; P09874; Q8N726"]
["GO:0030163","biological_process","protein catabolic process ","P31749; P42345; O15164; Q9UIQ6; Q12933; P56817; P15374; O14773; Q8IUQ4"]
["GO:0000060","biological_process","protein import into nucleus, translocation ","P31749; P25963; P20749; P41143; O00327; P62826; P01375; P41182; Q99623"]
["GO:0016567","biological_process","protein ubiquitination ","P31749; P33778; Q6PD62; P22681; P38398; Q00987; P78527; P53350; P49407; Q9UPN9; O14512; O95376; O15164; O75592; Q96EB6; O75150; P22314; Q9UKT5; Q96PU5; Q8N3Y1; Q14145; Q15819; P19474; Q8WW12; P62979; Q9NRJ4; Q9UH77; Q9H0H3; P78317; P0CG47; P12004; P55072; Q13829; O14543; Q969U6; P58876; Q8IYU2; Q9BTA9; Q96JH7; Q86WB0; P50542; O95999; P63279; P62807; Q16236; P68036; P49427; P63146; P63244; O43164; P06899; Q16763; P41002; Q13049; Q712K3; Q9UNE7; Q9NS91; Q9BXM7; P23527; Q86Y01; Q12834; Q9BYV9; P49459; Q6P1J9; Q99879; Q4G163; Q96Q27; Q16531; Q93079; Q9NT62; Q9GZV5; P61086; Q14527; Q05516; Q99877; Q99728; Q8WVC0; P61088; P62987; Q7L5Y6; Q96PM5; Q9H0M0; P32121; P40337; Q8WWI1; P46934; Q99618; Q96J02; Q8WVD3; Q6PCD5; Q9UBS8; Q969H0; O60814; Q9ULV8; P01892; Q8NCT1; O60260; Q5VTR2"]
["GO:0043488","biological_process","regulation of mRNA stability ","P31749; P04792; P17252; P08670; P49137; Q04637; Q05655; Q15717; Q9NZI8; P62979; P35658; Q01105; P39687; Q14671; Q8NC51; P0CG47; Q6PJT7; Q06787; P0DMV8; Q9Y534; Q9Y6M1; P11940; O95453; Q06265; Q5TC82; P11142; Q9NQT5; Q15024; Q14103; Q9NPI6; Q07352; P62987; Q9Y2V2; Q92945; P63104; O14980; P27695; P26651; P31946; Q9NQT4"]
["GO:0031641","biological_process","regulation of myelination ","P31749; P10276; P42345; Q15058; Q12959; P13631; Q8IXJ6"]
["GO:0006417","biological_process","regulation of translation ","P31749; Q8IW41; P06730; P21399; Q9BUB5; Q9HBH9; Q14978; P31751; O43524; Q9Y5S9; Q96KC8; Q13428; P98179; Q9UHL0; P41594; Q9ULM6; P05067; P06702; Q9UQ80; Q9BY44; Q92574; P26196"]
["GO:0034405","biological_process","response to fluid shear stress ","P31749; P09619; P17302; P29474; Q99967; P98161"]
["GO:0032094","biological_process","response to food ","P31749; P11413; P36956; O95999; P35372"]
["GO:0060416","biological_process","response to growth hormone ","P31749; P00966; P22392; O95361; Q8TCS8"]
["GO:0009408","biological_process","response to heat ","P31749; O75475; P29475; P23443; O14733; P29474; P48506; P07900; Q9UDY4; Q9UHC3; Q13144; P00441; O43294; P31415; Q8NET8; Q14232; P54652; P30613; Q9Y5S1"]
["GO:1990418","biological_process","response to insulin-like growth factor stimulus ","P31749; P17861"]
["GO:0006979","biological_process","response to oxidative stress ","P31749; P00519; O75475; O95747; Q5S007; O00506; O75874; P48506; P35354; Q96EB6; Q9BYN0; P19447; O43566; P30041; P43681; Q9UGH3; P23396; Q7LG56; Q93062; Q96T60; Q96FI4; O76061; P04156; Q03468; P30044; Q9HBY8; P23025; P49768; P05067; Q9BXM7; Q9NRD9; P09601; O95168; O00151; P30048; P32119; Q14191; P50281; O60260"]
["GO:0021510","biological_process","spinal cord development ","P31749; P21359; P42345; O95817; Q13563; P07196; O94805; O43175; P98161"]
["GO:0051146","biological_process","striated muscle cell differentiation ","P31749; P06400; Q16539; O15111; P01116; P19022; O60271"]
["GO:0031929","biological_process","TR signaling ","P31749; P62753; P23443; P42345; Q13541; P23771; Q6PKG0; Q13542; Q6R327; Q8N122; Q3V6T2"]
["GO:0045165","biological_process","cell fate commitment ","Q15303; Q01974; Q15796; P21802; P37231; P29590; O75030; Q9UBC0; O75626; P17542; Q92886; P17677; O43294; Q9HD90; P42574; O43597"]
["GO:0021551","biological_process","central nervous system morphogenesis ","Q15303"]
["GO:0009880","biological_process","embryonic pattern specification ","Q15303; Q15797; P21802; P84022; P98172; O75581; Q05516"]
["GO:0060749","biological_process","mammary gland alveolus development ","Q15303; P03372; Q08345; P10275; P17752; Q02363; P24385; Q99623"]
["GO:0043653","biological_process","mitochondrial fragmentation involved in apoptotic process ","Q15303; Q9GZY8; Q07812; Q8N163; O00429; Q9NT62"]
["GO:2001223","biological_process","negative regulation of neuron migration ","Q15303; P40763; Q02297"]
["GO:0001755","biological_process","neural crest cell migration ","Q15303; P07949; Q9UJU2; Q04771; P23528; O60315; P98172; Q16665; Q8IZ21; Q9ULV4"]
["GO:0021889","biological_process","olfactory bulb interneuron differentiation ","Q15303; P56178"]
["GO:0046427","biological_process","positive regulation of JAK-STAT cascade ","Q15303; P10721; Q14469; P01236; Q96A54; P46531"]
["GO:0043987","biological_process","histone H-S1 phosphorylation ","O75676; O75582; Q99986; Q9UD71; P21728"]
["GO:0043988","biological_process","histone H-S2 phosphorylation ","O75676; Q96GD4; O75582"]
["GO:0001818","biological_process","negative regulation of cytokine production ","O75676; Q06187; O75582; Q12866; P05813; Q9UN36"]
["GO:0032793","biological_process","positive regulation of CREB transcription factor activity ","O75676; Q53ET0; Q15139; Q9BZL6; O75582; Q8IU85; P41143; Q6SA08; Q6UUV7; Q6UUV9"]
["GO:0035066","biological_process","positive regulation of histone acetylation ","O75676; P27361; P38398; P29475; O75582; P49407; Q9UBK2; Q9BZS1; Q9Y230"]
["GO:0014002","biological_process","astrocyte development ","Q01974; Q00534; P08670; P14136; Q13144; P21728; P06702; P20265; Q15109"]
["GO:0030282","biological_process","bone mineralization ","Q01974; Q9NZJ5; P21802; P22607; P35354; Q504Y2; Q03431; P12272; Q13118; P21815; Q9Y2T1"]
["GO:0001502","biological_process","cartilage condensation ","Q01974; Q16539; P10827; P04198; P13349; P98161; P48436"]
["GO:0042733","biological_process","embryonic digit morphogenesis ","Q01974; Q9NYL2; P17302; Q92769; P42892; O75386; Q13547; Q13485; P10070; Q92793; P04198; P61296; P31270; O15119; O75096; Q05516; P10071; P36894; Q03113; Q15672"]
["GO:0030538","biological_process","embryonic genitalia morphogenesis ","Q01974"]
["GO:0042472","biological_process","inner ear morphogenesis ","Q01974; P11362; P21802; P29323; P11274; P23771; Q9NYQ6; Q92858; Q02962; Q9P2D1; P56178; Q9Y5Q3; Q92886; P23769; P05549; O43597"]
["GO:1905517","biological_process","macrophage migration ","Q01974"]
["GO:0030539","biological_process","male genitalia development ","Q01974; P19544; O15119; P22004"]
["GO:0045651","biological_process","positive regulation of macrophage differentiation ","Q01974; P06400; P17252; Q13546; Q13158; P14317; Q14790; Q02363"]
["GO:0060395","biological_process","SMAD protein signal transduction ","Q01974; P08670; Q9H2X6; Q15796; Q15797; P41235; P05412; P84022; P01100; P08476; Q9UIQ6; P53999; Q99966; O15198; Q13485; Q96PK6; P22004; Q86UL8; P12755; O95390"]
["GO:0007224","biological_process","smoothened signaling pathway ","Q01974; Q86Z02; Q9H2X6; Q02779; Q92630; P08151; Q14469; Q9HC77; Q15019; Q15468; P26367; P10070; Q12946; P37173; P10071; Q86YF9"]
["GO:0001756","biological_process","somitogenesis ","Q01974; Q09472; Q9UJU2; P78527; P84022; Q99801; O60315; Q12948; Q12946; P49768; Q99958; O15273; P13349; Q9Y2T1; P36894; Q8IZP0; Q06330; P23409"]
["GO:0007223","biological_process","Wnt signaling pathway, calcium modulating pathway ","Q01974; Q9UJU2; Q9UQM7; Q9UBE8; O43318; P35222; Q01970; Q9NQ66; P0DP23; Q08209; Q9NQB0; Q9UPQ9; O95644; Q9UKV8"]
["GO:0060071","biological_process","Wnt signaling pathway, planar cell polarity pathway ","Q01974; P07737; P63000; Q9NYQ6; O14640; Q92997; O14641; Q13009; Q96CW1; P61586; P60953; P63010; P32121; Q00610; Q9NPB6"]
["GO:0007113","biological_process","endomitotic cell cycle ","Q9H4B4; Q99828"]
["GO:0090166","biological_process","olgi disassembly ","Q9H4B4; P06493; Q08379; Q99986; Q92538"]
["GO:0007093","biological_process","mitotic cell cycle checkpoint ","Q9H4B4; P06400; O60934; O60566; P01112; Q9NYL2; O43683; Q9NYY3; Q92733; Q7Z2Z1; Q13257; Q9BQ15; Q12959; O75943; Q07817; Q9Y6D9; O43264; Q9H816; Q96EP1; Q96AH0"]
["GO:0044819","biological_process","mitotic /S transition checkpoint ","Q9H4B4"]
["GO:1904716","biological_process","positive regulation of chaperone-mediated autophagy ","Q9H4B4"]
["GO:0090316","biological_process","positive regulation of intracellular protein transport ","Q9H4B4; Q15154; Q96Q89; O95190; P12270; P63027; Q6ZS17; O95613; Q9BUL8; Q9UPN4; P60953; P33176"]
["GO:2000777","biological_process","positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia ","Q9H4B4; Q8IXJ6"]
["GO:0051302","biological_process","regulation of cell division ","Q9H4B4; P63244; Q99828"]
["GO:0032465","biological_process","regulation of cytokinesis ","Q9H4B4; O14965; O43663; P53350; Q9Y2X7; O75400; P0DP23; Q9P2Y5; O95235; P41208; P62491; O43303; Q07817; P51587; Q8NEB9; O75154; Q13526; Q9Y371; Q14457"]
["GO:0000302","biological_process","response to reactive oxygen species ","Q9H4B4; Q9UBK2; P04040; P09211; P02649"]
["GO:1903861","biological_process","positive regulation of dendrite extension ","Q9NZM3; Q96PU5; Q9H2B2; P21579; Q86UR5; Q8N9I0; O60260"]
["GO:0035023","biological_process","regulation of Rho protein signal transduction ","Q9NZM3; P11274; P04049; P15498; Q13459; Q8N5V2; P52565; Q8TCU6; P52735; O75962; Q92974; Q96DR7; Q14155; Q8IVF5; O60229; Q9UKW4; Q96PE2; Q15052; Q9H7P9; Q92888; O75955; Q9H8V3; O94827; Q13009; P52566; Q70Z35; Q3KR16; Q07889; Q13972; O14827; Q9NR80; Q7Z628"]
["GO:0034620","biological_process","cellular response to unfolded protein ","P18031; Q00613; Q96CV9; Q5VWQ8; Q07812; P0DMV8; Q9UER7; O75460; Q16611; O60260"]
["GO:0030968","biological_process","endoplasmic reticulum unfolded protein response ","P18031; Q9NZJ5; P19525; Q9UKV5; P32929; P55072; O76061; P18850; Q16236; P17861; Q96HE7; Q9UNE7; P24385; P11021"]
["GO:1902236","biological_process","negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway ","P18031; Q5S007; P52945; Q99497; P0DMV8; P17861; O60260"]
["GO:1903898","biological_process","negative regulation of PERK-mediated unfolded protein response ","P18031; P16333"]
["GO:0030948","biological_process","negative regulation of vascular endothelial growth factor receptor signaling pathway ","P18031; O14964; Q96TA1; Q5VWQ8; Q03014; P46934; O95208"]
["GO:1990264","biological_process","peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity ","P18031; P51452; Q9Y6W6"]
["GO:0035791","biological_process","platelet-derived growth factor receptor-beta signaling pathway ","P18031; P00519; P09619; O75122"]
["GO:1903896","biological_process","positive regulation of IRE-mediated unfolded protein response ","P18031; Q9BXH1; O43521; Q5VWQ8; Q07812; Q16611"]
["GO:0061098","biological_process","positive regulation of protein tyrosine kinase activity ","P18031; P21860; Q14511; P07333; P54764; P78352; Q92598; Q9C0H9; Q18PE1; P17542; P04156; P41594; O14641; P05067; Q9NPH5; P12821"]
["GO:2000646","biological_process","positive regulation of receptor catabolic process ","P18031; Q96J02"]
["GO:0030100","biological_process","regulation of endocytosis ","P18031; P00519; P42684; Q9BY11; Q96T51; P61106; Q9H2B2; P61020; Q15036; P51148; Q9Y6Q2; P57105; Q7Z3T8; P20338; P49815; P20339"]
["GO:1902202","biological_process","regulation of hepatocyte growth factor receptor signaling pathway ","P18031; P17706"]
["GO:0033157","biological_process","regulation of intracellular protein transport ","P18031; Q9GZM8; P13796"]
["GO:0009966","biological_process","regulation of signal transduction ","P18031; P09958; P46108; P41236; Q9NPP4; O15392; P61981; Q8N556; Q9H2G4; P37198"]
["GO:0014009","biological_process","glial cell proliferation ","P13639; Q14289"]
["GO:2000767","biological_process","positive regulation of cytoplasmic translation ","P13639; P16989"]
["GO:0045727","biological_process","positive regulation of translation ","P13639; P11802; P06748; P27361; P08670; P04626; Q14289; P23443; P28482; P42345; Q15717; Q9BRP8; Q9BRS8; P20749; Q9BY77; P38919; P98179; P17301; Q06787; P56537; Q15633; Q9BZQ8; O00571; Q04695; P10747; Q9BXM7; Q14103; Q8NE71; Q96RG2; P61586; Q8NE35; Q99613; Q71UM5"]
["GO:0051593","biological_process","response to folic acid ","P13639; P04818; P50553; P06396; P42898"]
["GO:0003009","biological_process","skeletal muscle contraction ","P13639; P23443; O15111; P19429; Q07001; P45378; O15273; Q86YM7; Q6JBY9"]
["GO:0006414","biological_process","translational elongation ","P13639; O00418; P68104; P49411; P24534; P05387; P26641; P29692"]
["GO:0071353","biological_process","cellular response to interleukin-4 ","P11802; Q9UJU2; P29590; P49327; P08238; P23771; P49736; Q16649; Q14145; P05388; P17861; P12268; P68363; P11021"]
["GO:1904637","biological_process","cellular response to ionomycin ","P11802; Q14934; Q9UBK2; Q5D1E8"]
["GO:1904628","biological_process","cellular response to phorbol 3-acetate -myristate ","P11802; Q92918; P05388; Q13444"]
["GO:0002088","biological_process","lens development in camera-type eye ","P11802; P02511; P17302; P23771; Q9NTI5; Q6T4R5; P48165; P26367; Q12959; P37173; Q9BRQ0; P30301; P36897; Q15648; P05813"]
["GO:0031658","biological_process","negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in /S transition of mitotic cell cycle ","P11802; Q00534; P60484; P42771; P55273"]
["GO:0045793","biological_process","positive regulation of cell size ","P11802; Q9Y243; P07949; P08238; O60341; Q4VCS5; Q04656"]
["GO:0010971","biological_process","positive regulation of 2/M transition of mitotic cell cycle ","P11802; P06493; Q96ST3; O00311; P14635; O75351; Q9NZJ0; P05067; P62491; Q6STE5; P24385; P54652; P51608; O60885"]
["GO:0046626","biological_process","regulation of insulin receptor signaling pathway ","P11802; Q9H0K1; P27986; Q9H1E3; P49815; P30281; Q9UHR4; O15294"]
["GO:0046890","biological_process","regulation of lipid biosynthetic process ","P11802"]
["GO:0050994","biological_process","regulation of lipid catabolic process ","P11802; P10827"]
["GO:0055093","biological_process","response to hyperoxia ","P11802; P09619; P38936; Q92769; P04040; P06746; P22460"]
["GO:0033574","biological_process","response to testosterone ","P11802; P22681; P27708; P23443; Q00613; Q92934; Q16790; Q99801; P26678; P67870; P28562; P49321; O15519; P21731; Q14654"]
["GO:0050830","biological_process","defense response to ram-positive bacterium ","O60927; Q9UHD2; P09769; P29317; O43353; P16671; Q8TDQ0; Q96P20; P78536; P62807; P05067; P06899; P01375; P21730; Q16778; Q9UGM3; P58753; Q9NRR4; Q9H257; O60814; P01892"]
["GO:0050710","biological_process","negative regulation of cytokine secretion ","O60927; Q9BZS1; Q9H4X1; P31994; Q5NUL3"]
["GO:0032515","biological_process","negative regulation of phosphoprotein phosphatase activity ","O60927; P49841; Q49AN0; Q96GX5; Q9UD71"]
["GO:0006511","biological_process","ubiquitin-dependent protein catabolic process ","O60927; P22681; Q00987; P49407; O95376; Q7Z6E9; O15033; O14818; O75150; P22314; Q9UKT5; Q96PU5; O95071; Q8N1E6; Q9UPU5; Q5T4S7; P49792; Q96RU2; Q9UH77; Q9Y2K6; Q9UKV5; P53804; Q86T82; Q9NS56; Q9H0H3; Q70CQ2; Q14669; Q9NQC7; Q13107; P46379; Q9Y5T5; Q9NZS9; Q8TAA3; Q9NZJ0; Q96T88; Q8IYU2; P54252; P54578; Q13501; P63279; O94782; P15374; P68036; P63146; Q9UK80; Q93009; P25788; Q14694; P17861; Q9H6Z4; Q13049; Q9UJX2; Q9UNE7; Q9BXM7; Q05086; Q9UHP3; Q93034; P49459; Q9UNS2; Q96EP1; Q7Z3J3; Q96Q27; Q16531; Q9Y3C5; P61086; P61088; Q96PM5; Q13309; P60900; P40818; Q9Y4E8; P35998; P46934; Q8IUQ4; Q96J02; O43255; Q9ULV8; O60260; O00231; Q5VTR2"]
["GO:0007064","biological_process","mitotic sister chromatid cohesion ","Q14683; Q9NTI5; Q29RF7; Q6KC79; Q7Z5K2; Q8TF76; Q7Z3K3; Q96FF9; Q12834"]
["GO:0000070","biological_process","mitotic sister chromatid segregation ","Q14683; P53350; P51955; Q14674; Q9BXS6; Q13257; P62826; Q9NTJ3; Q9NQS7; Q9BW19; Q96R06; O43264; O43684; Q9H410; O14777"]
["GO:0032876","biological_process","negative regulation of DNA endoreduplication ","Q14683; Q8N3U4; P49959; Q9UQE7; Q969H0"]
["GO:1901673","biological_process","regulation of mitotic spindle assembly ","Q14683; P53350; Q8N3U4; O75351; P0DMV8; P12270; Q8IW35; Q9UQE7; Q00839; Q96CF2"]
["GO:0072423","biological_process","response to DNA damage checkpoint signaling ","Q14683"]
["GO:0007062","biological_process","sister chromatid cohesion ","Q14683; P53350; Q8N3U4; Q14807; P49959; Q9UQE7; Q9BY41; Q969H0; Q99623"]
["GO:0019827","biological_process","stem cell population maintenance ","Q14683; Q6PD62; O14497; P06730; P10721; P35222; Q9NRA8; O60244; Q6KC79; Q5TAX3; Q5UIP0; Q9H9S0; O43474; Q9H204; Q9Y483; Q9UQE7; O15119; Q6P1J9; Q86U44; Q8WVC0; P36894; P26196"]
["GO:0006370","biological_process","-methylguanosine mRNA capping ","P50613; P35269; O00267; Q9BTL3; P19447; P24928; P61218; Q8N1G2; P51946; Q53F19; O43148; P52298; Q09161"]
["GO:0030521","biological_process","androgen receptor signaling pathway ","P50613; P06400; O14497; P24864; P38398; Q9Y2W1; Q9Y6Q9; P10275; P35222; Q9Y4C1; Q9UBK2; P17844; Q13772; Q99801; O60244; P48552; Q02790; P78317; O75925; Q9UER7; P62826; O43294; Q14192; O75928; Q05086; Q15788; Q92841; P61586; Q92993; Q15648; Q9UBS8"]
["GO:0006294","biological_process","nucleotide-excision repair, preincision complex assembly ","P50613; P62979; P19447; P0CG47; P54727; P27694; P15927; P23025; P51946; P41208; P28715; Q16531; P62987; P09874"]
["GO:0000079","biological_process","regulation of cyclin-dependent protein serine/threonine kinase activity ","P50613; Q99640; P60709; P60484; P38936; Q16543; Q15078; P54132; Q99741; P46527; P30304; P31947; P30307; Q13319; P24522; O60563; P55273"]
["GO:0006363","biological_process","termination of RNA polymerase I transcription ","P50613; P17480; Q6NZI2; P19447; O15160; P61218; P51946; O15446"]
["GO:0006283","biological_process","transcription-coupled nucleotide-excision repair ","P50613; Q09472; P49005; Q15054; P35251; P62979; P19447; P05114; Q13098; P0CG47; P24928; Q9UBT6; P12004; Q7L5N1; P61218; P27694; Q9UMS4; Q03468; P15927; P23025; P51946; P18858; P40937; Q93009; P49916; P28715; Q9UNS2; Q16531; Q9HCU8; Q9UNP9; P18887; P62987"]
["GO:0006361","biological_process","transcription initiation from RNA polymerase I promoter ","P50613; P27361; P17480; Q6NZI2; P19447; O15160; P61218; P51946; O15446; Q9NYV6"]
["GO:0048041","biological_process","focal adhesion assembly ","Q15262; O15530; Q9H792; P12814; Q14289; Q96AC1; Q9BX66; Q9UL54; Q96QB1; Q14155; P10415; P17301; Q14247; Q96IF1; Q15654"]
["GO:0030336","biological_process","negative regulation of cell migration ","Q15262; P35240; P21359; O75030; P11831; Q9Y6E0; P60484; O43524; P21709; P51452; Q9P289; O14745; Q14195; P12830; P55196; P18206; Q96QB1; Q12913; Q9H4P4; P10415; Q8TDM6; O43295; O15105; P17813; P14416; Q8WWN8; Q9ULU4; Q99967; P10301; P62745; Q9Y6N7; Q8TD08; P35590; Q14118; P37023; P43699; Q86UL8; Q9Y6W6; P09493; Q13444; Q5JXC2; Q5VTR2"]
["GO:0034394","biological_process","protein localization to cell surface ","Q15262; P35222; P18206; Q13107; P21333"]
["GO:0007179","biological_process","transforming growth factor beta receptor signaling pathway ","Q15262; Q05513; Q9H2X6; Q15796; P22681; Q15797; Q04771; P29590; Q05397; Q9UBE8; P16220; P05412; P84022; O43318; P12931; P01100; P49023; O00501; P09958; Q96EB6; Q96AC1; P62979; Q15750; Q8TEW0; Q03167; Q99966; O15198; P0CG47; Q13485; Q13118; P18084; Q15942; O43541; O15105; P17813; P37173; P36897; P37023; P61586; Q9P2M7; P62987; P09874; P32121; P33151; Q9Y4E8; P12755; P36894; P41134; Q9Y624; Q9NPB6"]
["GO:0034351","biological_process","negative regulation of glial cell apoptotic process ","P24723; P17252; P41743; Q05655; Q12933"]
["GO:0045618","biological_process","positive regulation of keratinocyte differentiation ","P24723; Q9Y6Q9; Q12948; P11473; P22392; O95361; P46531; Q14980; Q15648"]
["GO:0010744","biological_process","positive regulation of macrophage derived foam cell differentiation ","P24723; P45984; P19838; P16671; P30556"]
["GO:0070528","biological_process","protein kinase C signaling ","P24723; Q05513; O75955; P08567"]
["GO:2000810","biological_process","regulation of bicellular tight junction assembly ","P24723; Q01196; P17302; P17612; O00501; O43623; Q16625; Q07157; O95863"]
["GO:0000185","biological_process","activation of MAPKKK activity ","Q92918; Q15750; Q5VWQ8; P05067; P01375; P24522"]
["GO:0071398","biological_process","cellular response to fatty acid ","Q15120; Q16654; P14635; P16220; P12931; P01130; P13010; Q96RI1; P50416; Q01094; P36956; P22392"]
["GO:0035357","biological_process","peroxisome proliferator activated receptor signaling pathway ","Q15120; P37231; P19793; O43707; Q15648"]
["GO:2000377","biological_process","regulation of reactive oxygen species metabolic process ","Q15120; Q08050; Q12778; Q9H4P4; P56537; Q9BXM7; O60260"]
["GO:0006972","biological_process","hyperosmotic response ","O15530; Q16512; O15455; P55011"]
["GO:0010667","biological_process","negative regulation of cardiac muscle cell apoptotic process ","O15530; O60674; Q13418; Q00613; Q9C0C7; Q8IZQ8; O60936; O14558; P52952; Q16236; P61296; Q02297; O15519; Q96QC0"]
["GO:0034122","biological_process","negative regulation of toll-like receptor signaling pathway ","O15530; Q06418; Q15306; P32121"]
["GO:0010518","biological_process","positive regulation of phospholipase activity ","O15530; P11362; P21802; P22607"]
["GO:0051281","biological_process","positive regulation of release of sequestered calcium ion into cytosol ","O15530; P37840; P00519; P19174; P30626; P15391; Q07812; P31415; P21728"]
["GO:1903672","biological_process","positive regulation of sprouting angiogenesis ","O15530; Q15797; P23458; P09038; O43474; Q9UBU3"]
["GO:0043122","biological_process","regulation of I-kappaB kinase/NF-kappaB signaling ","O15530; P04792; Q96CV9; Q5VWQ8; Q13501; P01375"]
["GO:0003323","biological_process","type B pancreatic cell development ","O15530; Q00534; P41235; P22004"]
["GO:0031584","biological_process","activation of phospholipase D activity ","Q05513; Q14344; P84074"]
["GO:0051899","biological_process","membrane depolarization ","Q05513; P05412; Q03135; Q00975; P43681; Q99497; Q14524; Q9Y698; Q03164"]
["GO:0060081","biological_process","membrane hyperpolarization ","Q05513; O43525; Q99497; Q9Y698; P22460; P13569; P05023"]
["GO:0051346","biological_process","negative regulation of hydrolase activity ","Q05513; P29475; P29474; Q9UII2; P48357"]
["GO:0050732","biological_process","negative regulation of peptidyl-tyrosine phosphorylation ","Q05513; Q05655; Q38SD2; Q08495; P29350"]
["GO:0031333","biological_process","negative regulation of protein complex assembly ","Q05513; O75385; P49841; P04049; Q9UBB9; Q9NZM5; P61764; O00571; P60953"]
["GO:0001954","biological_process","positive regulation of cell-matrix adhesion ","Q05513; Q00534; Q13418; Q14289; P49841; P21709; Q86WV1; P16671; P07766; P32248; P14923; P46939; Q14118; Q99828"]
["GO:2000463","biological_process","positive regulation of excitatory postsynaptic potential ","Q05513; Q05586; Q14289; P60484; P78352; P36544; O14640; Q16623; Q8WYL5; Q9ULB1; P58400; Q9BYB0; Q9UQB8; P05067; Q86UR5; P49798; Q8N2Q7; Q9Y566; P61266"]
["GO:0046628","biological_process","positive regulation of insulin receptor signaling pathway ","Q05513; P35568; P12931; Q96EB6; P04899; Q96RI1; Q96A54; Q9H1E3"]
["GO:2001181","biological_process","positive regulation of interleukin- secretion ","Q05513; Q9ULZ3"]
["GO:2000667","biological_process","positive regulation of interleukin-13 secretion ","Q05513; P23771; Q96F46"]
["GO:0032753","biological_process","positive regulation of interleukin-4 production ","Q05513; P10276; Q04759; P43405; P23771; P07766; P17676; Q8TDQ0; Q96P20; Q9BZS1; P30273; P10747; O75995"]
["GO:2000664","biological_process","positive regulation of interleukin-5 secretion ","Q05513; P23771; Q96F46"]
["GO:2000553","biological_process","positive regulation of T-helper  cell cytokine production ","Q05513; P23771; Q96P20"]
["GO:0045630","biological_process","positive regulation of T-helper 2 cell differentiation ","Q05513; P10276; Q96P20; P24394"]
["GO:0098696","biological_process","regulation of neurotransmitter receptor localization to postsynaptic specialization membrane ","Q05513; P01112; P62834; Q14118"]
["GO:0047496","biological_process","vesicle transport along microtubule ","Q05513; P42858; Q9GZM8; Q9NXR1; P51809; P62820; O95267; P33176"]
["GO:0086003","biological_process","cardiac muscle cell contraction ","Q13557; P19634"]
["GO:0032469","biological_process","endoplasmic reticulum calcium ion homeostasis ","Q13557; P29590; Q07812; P10415; P49768; Q14643; Q16611; P16615"]
["GO:1902306","biological_process","negative regulation of sodium ion transmembrane transport ","Q13557; Q96PU5"]
["GO:2000650","biological_process","negative regulation of sodium ion transmembrane transporter activity ","Q13557; Q02156; Q96PU5; Q9UEW8; P46934"]
["GO:0010666","biological_process","positive regulation of cardiac muscle cell apoptotic process ","Q13557; P04035; Q9UQM7; Q99683; P60484; P29376"]
["GO:1902514","biological_process","regulation of calcium ion transmembrane transport via high voltage-gated calcium channel ","Q13557; P29475; Q02641"]
["GO:0098901","biological_process","regulation of cardiac muscle cell action potential ","Q13557"]
["GO:0098909","biological_process","regulation of cardiac muscle cell action potential involved in regulation of contraction ","Q13557; Q03135; Q99996; Q92913; Q9Y3Q4; P16615"]
["GO:0010881","biological_process","regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion ","Q13557; P17612; P23327; P0DP23; P26678; Q92736; P32418; Q13936; O14958"]
["GO:0010649","biological_process","regulation of cell communication by electrical coupling ","Q13557; P30626; P32418; O14958"]
["GO:1901844","biological_process","regulation of cell communication by electrical coupling involved in cardiac conduction ","Q13557; Q03135; Q08499; P23327; P30626; P0DP23"]
["GO:0060341","biological_process","regulation of cellular localization ","Q13557; Q8TEW0"]
["GO:0008016","biological_process","regulation of heart contraction ","Q13557; P07101; Q09013; Q00975; P45379; Q9NS61; P30626; O00168; P43220; P10828; P26678; P10827; Q14500; P08172; P51787; O95180; P17661; O95319; P09493"]
["GO:0086091","biological_process","regulation of heart rate by cardiac conduction ","Q13557; Q03135; Q99996; P48544; P48549; Q9Y6H6; Q14524; Q9Y3Q4; P14923; Q13936; P62258; Q8TD43; Q01668; O43497; P22460; P51787; Q12809; Q9UK17; P15382; P63252; Q08289; P15924"]
["GO:1901725","biological_process","regulation of histone deacetylase activity ","Q13557"]
["GO:0003254","biological_process","regulation of membrane depolarization ","Q13557; Q13642; Q96PU5; Q9Y3Q4"]
["GO:1901897","biological_process","regulation of relaxation of cardiac muscle ","Q13557; P26678"]
["GO:0010880","biological_process","regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum ","Q13557; Q08499; P23327; P30626; P0DP23; Q9P2D1; O14958"]
["GO:0060314","biological_process","regulation of ryanodine-sensitive calcium-release channel activity ","Q13557; P29475; P17612; Q08499; P23327; Q9BR39; P0DP23; P26678"]
["GO:0002026","biological_process","regulation of the force of heart contraction ","Q13557; P26678; P32418; P50461; P10916; P05023; P16615"]
["GO:0055119","biological_process","relaxation of cardiac muscle ","Q13557; P41220; O76074; P26678; P32418; P05023; P63252; P16615"]
["GO:0070375","biological_process","ERK cascade ","Q13163; Q02078"]
["GO:0090051","biological_process","negative regulation of cell migration involved in sprouting angiogenesis ","Q13163; Q9UQL6; O43474; Q9BUL8; P46531; O14713; P61586; P21731"]
["GO:2000342","biological_process","negative regulation of chemokine (C-X-C motif) ligand  production ","Q13163; O43474"]
["GO:0045415","biological_process","negative regulation of interleukin-8 biosynthetic process ","Q13163; P20749; O43474"]
["GO:0051481","biological_process","negative regulation of cytosolic calcium ion concentration ","P78347; P84022; P23327; P32418; P14416; P22460; O14649; P35372"]
["GO:0014886","biological_process","transition between slow and fast fiber ","P78347"]
["GO:0012501","biological_process","programmed cell death ","P14618; P11387"]
["GO:0014870","biological_process","response to muscle inactivity ","P14618"]
["GO:0007584","biological_process","response to nutrient ","P14618; P04035; P00966; P42224; P37231; P23443; P42345; P33121; P48506; P07766; P21554; P49675; P00338; P04899; P01236; O14727; P37173; P30427; O43768; O95477; P21731; P31645; O15294"]
["GO:0043403","biological_process","skeletal muscle tissue regeneration ","P14618; P17302; P15173; P23759; Q15633; P07203; Q13765; Q14118; O15519; P23409"]
["GO:0090630","biological_process","activation of TPase activity ","Q16288; P29317; Q14289; P31751; Q9P0N9; P21709; P55010; Q14160; P32248; Q9GZM8; Q96N67; Q8WUA7; Q86TI0; Q9H8V3; Q9ULV4; Q13009; Q4KMP7; Q13972; O60343; O95267; Q92574; O43166; P46060"]
["GO:0090102","biological_process","cochlea development ","Q16288; P23771; P49736; Q14469; O95069; P28472; Q02962; Q92886; P20248; P47870; P23769; O14649"]
["GO:0070306","biological_process","lens fiber cell differentiation ","Q16288; P35240; P84022; O75444; Q9UM11"]
["GO:0019056","biological_process","modulation by virus of host transcription ","Q16288"]
["GO:0048712","biological_process","negative regulation of astrocyte differentiation ","Q16288; P21359; P04198; P47928; O75553"]
["GO:0060548","biological_process","negative regulation of cell death ","Q16288; Q15139; O75351; P16333; Q9H1Y0; Q99497; Q13485; P0DMV8; P09038; P14416; Q13247; Q9NS91; P30533; O60260; Q14457"]
["GO:0048665","biological_process","neuron fate specification ","Q16288; Q99502; Q99581; P55317; P50553; P20265; Q01851"]
["GO:2000251","biological_process","positive regulation of actin cytoskeleton reorganization ","Q16288; P08631; P00519; P01112; P07332; Q00535; Q02763; P14317; Q9UQB8; P60953; Q9UHR4"]
["GO:0048691","biological_process","positive regulation of axon extension involved in regeneration ","Q16288"]
["GO:0010863","biological_process","positive regulation of phospholipase C activity ","Q16288; P17948; P09619; P11362; P03372; P01112; P19174; P16234; P10721; P42684; P09038"]
["GO:0050927","biological_process","positive regulation of positive chemotaxis ","Q16288; P35968; P84022; P41180; P17301; P21453; P13726"]
["GO:0099151","biological_process","regulation of postsynaptic density assembly ","Q16288; O43424"]
["GO:1905606","biological_process","regulation of presynapse assembly ","Q16288; P37840; Q04637; Q9ULB1; P05067; Q96PX8"]
["GO:0003007","biological_process","heart morphogenesis ","P54760; Q05397; P07101; P42345; P06213; Q15750; Q03167; Q6KC79; Q96QB1; Q9P2D1; P52952; Q14896"]
["GO:0035404","biological_process","histone-serine phosphorylation ","P54646"]
["GO:0042304","biological_process","regulation of fatty acid biosynthetic process ","P54646; Q16654; O43741; Q96A54; P56537"]
["GO:0016241","biological_process","regulation of macroautophagy ","P54646; P45983; O75385; Q00535; P42345; P17612; P38606; Q15078; Q9UPT5; O75460; Q9UBN7; Q15382; P04406; Q8N122; P42574; O75143; P46934; Q9Y371; Q9HB90; Q8IYI6; O43504"]
["GO:0014850","biological_process","response to muscle activity ","P54646; Q9UBK2; Q92736; Q16665; P17301"]
["GO:0038202","biological_process","TRC1 signaling ","Q96B36; P42345; Q6PKG0; Q9BXL7; Q8N122"]
["GO:0048514","biological_process","blood vessel morphogenesis ","P17948; P35916; P43405; P17302; P19022; Q07889; P20936; P41134"]
["GO:0048598","biological_process","embryonic morphogenesis ","P17948; Q9BVC5; P09038"]
["GO:0002548","biological_process","monocyte chemotaxis ","P17948; P04083; P41597; P17931; P39019"]
["GO:0030949","biological_process","positive regulation of vascular endothelial growth factor receptor signaling pathway ","P17948; Q9BZL6; P05106; P05771; P04004; P27540; Q16665; Q13322"]
["GO:0036323","biological_process","vascular endothelial growth factor receptor-1 signaling pathway ","P17948"]
["GO:0009416","biological_process","response to light stimulus ","P53779; P07101; P19419; P01100; Q49AN0; Q16613; P11488; P17535; P50570; P43003; P28562; P14416; Q9UNS2"]
["GO:0032870","biological_process","cellular response to hormone stimulus ","Q9H0K1; Q9Y6Q9; P40763; P05412; P57059; P01100; P17535; P28562; P10912; P17275; P53539; Q15788; O95180; P08913; Q15596; P51692; P30518; O43613"]
["GO:0048148","biological_process","behavioral response to cocaine ","P37840; Q00535; P28223; Q13158; P35462; Q9UD71; O60229; Q9NSB8; P14416; P41145; Q86YM7; P21728"]
["GO:0044267","biological_process","cellular protein metabolic process ","P37840; P84243; P02671; P09958; P23327; P01009; P62979; Q9GZV9; P02765; P09382; Q06481; O15240; P01236; Q92908; P14625; P19022; P11047; P00747; P0CG47; P56817; O76061; Q9Y6H5; Q92673; P14314; P02649; P17936; P05067; P68431; P06396; Q9UJY5; O00255; P62805; Q9UGM3; P32927; P34741; P08833; Q6Y7W6; Q96AD5; P62987; P08253; P00450; Q15084; Q8IUQ4; P12259; Q15293; O43852; O43255; O60260; P05060; Q71DI3"]
["GO:0071280","biological_process","cellular response to copper ion ","P37840; Q00613; P29972; P04156; Q9UER7; P41181; Q9H492; Q04656; Q14457"]
["GO:0071872","biological_process","cellular response to epinephrine stimulus ","P37840; P17612; Q08499; P49675; Q92736; P19634; P51787; Q07343; P23634; P30613; Q8IXJ6"]
["GO:0044344","biological_process","cellular response to fibroblast growth factor stimulus ","P37840; Q99459; P22736; P48506; P49675; P16070; O14713; Q07352; P26651"]
["GO:0042416","biological_process","dopamine biosynthetic process ","P37840; P07101; Q01959; P50052; P43354"]
["GO:0051583","biological_process","dopamine uptake involved in synaptic transmission ","P37840; Q99497; Q01959; P31645; O60260"]
["GO:0042775","biological_process","mitochondrial ATP synthesis coupled electron transport ","P37840; Q16635; P55957"]
["GO:0007006","biological_process","mitochondrial membrane organization ","P37840; O95140"]
["GO:1904715","biological_process","negative regulation of chaperone-mediated autophagy ","P37840; P08621"]
["GO:0045963","biological_process","negative regulation of dopamine metabolic process ","P37840; P05107"]
["GO:0051585","biological_process","negative regulation of dopamine uptake involved in synaptic transmission ","P37840"]
["GO:0045920","biological_process","negative regulation of exocytosis ","P37840; P04083; Q92681"]
["GO:0035067","biological_process","negative regulation of histone acetylation ","P37840; P38398; Q01105; Q15545; Q9Y3T9; Q9BZS1; P51608; Q13363; Q15672"]
["GO:0031115","biological_process","negative regulation of microtubule polymerization ","P37840; Q13627; P11137; Q02790; Q15691; Q93045; P16949"]
["GO:1902957","biological_process","negative regulation of mitochondrial electron transport, NADH to ubiquinone ","P37840"]
["GO:0032769","biological_process","negative regulation of monooxygenase activity ","P37840"]
["GO:0051622","biological_process","negative regulation of norepinephrine uptake ","P37840"]
["GO:0010642","biological_process","negative regulation of platelet-derived growth factor receptor signaling pathway ","P37840; O14964; P43119; O14745; Q12913"]
["GO:0051612","biological_process","negative regulation of serotonin uptake ","P37840; P29475"]
["GO:0070495","biological_process","negative regulation of thrombin-activated receptor signaling pathway ","P37840; P08581; P16949"]
["GO:0032410","biological_process","negative regulation of transporter activity ","P37840; Q9P2B4; Q9NV92"]
["GO:0006638","biological_process","neutral lipid metabolic process ","P37840"]
["GO:0055114","biological_process","oxidation-reduction process ","P37840; P11413; Q15080; Q96PH1; Q13423; P13498; P53004; Q8NFA2; Q5TCZ1; P08684; A1X283; Q9NPH5; Q9NRD9; Q13303; P20813; Q16206; P35270; P31040; Q9NZC7; P16152; P10599"]
["GO:0006644","biological_process","phospholipid metabolic process ","P37840; P51178; P47712; P48426; Q92908; P43699; P78356"]
["GO:0045807","biological_process","positive regulation of endocytosis ","P37840; O00418; P01130; Q96PU5; P02649; Q08209; O75955; P98082; Q07954; P63010"]
["GO:1903284","biological_process","positive regulation of glutathione peroxidase activity ","P37840"]
["GO:1903285","biological_process","positive regulation of hydrogen peroxide catabolic process ","P37840; Q13423"]
["GO:0060732","biological_process","positive regulation of inositol phosphate biosynthetic process ","P37840; Q03431"]
["GO:0001956","biological_process","positive regulation of neurotransmitter secretion ","P37840; Q16623; P61266"]
["GO:0071902","biological_process","positive regulation of protein serine/threonine kinase activity ","P37840; Q15831; P36507; P07333; P67775; Q02750; P33121; P08238; P12931; Q15910; Q14012; Q9Y4R8; P0DP23; Q5VWQ8; Q96A49; O00571; Q9BUL8; P11234; Q8N122; P61586; P07550; Q99828"]
["GO:0001921","biological_process","positive regulation of receptor recycling ","P37840; P07355; Q15836; P42566; Q96P48; Q14160; P42892; P49768; P46459"]
["GO:0031648","biological_process","protein destabilization ","P37840; Q09472; Q00987; P78527; P53350; P42858; P12931; Q96EB6; Q9UKT5; P19474; P04156; Q92793; Q9P219; P06396; P17861; Q9HC62; Q8N6T7; Q6P1J9; Q96EP1; Q8N726; Q8IUQ4; P41134; O60260"]
["GO:0031623","biological_process","receptor internalization ","P37840; P25098; Q03135; P43405; P42261; P15311; P16671; P02786; P62993; P32298; P05556; P50570; P05107; P35626; P10912; P30273; Q96CW1; Q07954; P32121; P46934; Q00610"]
["GO:0050812","biological_process","regulation of acyl-CoA biosynthetic process ","P37840"]
["GO:0014059","biological_process","regulation of dopamine secretion ","P37840; P28223; P43681; Q9H2B2; P28222; P35462; P21579; O43581; P14416; P16389; O60260"]
["GO:0014048","biological_process","regulation of glutamate secretion ","P37840"]
["GO:0040012","biological_process","regulation of locomotion ","P37840; Q5S007; P08173"]
["GO:0043030","biological_process","regulation of macrophage activation ","P37840; P35398; O43164; Q92614"]
["GO:0051621","biological_process","regulation of norepinephrine uptake ","P37840; P60709"]
["GO:0010517","biological_process","regulation of phospholipase activity ","P37840"]
["GO:1903426","biological_process","regulation of reactive oxygen species biosynthetic process ","P37840"]
["GO:1903421","biological_process","regulation of synaptic vesicle recycling ","P37840; Q00535; Q92915"]
["GO:0022898","biological_process","regulation of transmembrane transporter activity ","P37840; P60709; P17302; P10415"]
["GO:1904307","biological_process","response to desipramine ","P37840"]
["GO:0034341","biological_process","response to interferon-gamma ","P37840; P19474; Q99966; O15553; Q01628; P33076; P25942; P23497"]
["GO:0010040","biological_process","response to iron(II) ion ","P37840; P21399; Q9H492; Q14457"]
["GO:0032026","biological_process","response to magnesium ion ","P37840; Q00987; Q9GZV9; P22004; P24385"]
["GO:0048488","biological_process","synaptic vesicle endocytosis ","P37840; P60709; Q00535; Q9BY11; Q14160; P50570; O43426; O60331; Q8TEH3; P21579; O00429; P27824; Q8N9I0; Q8N0W4; Q16143; P63010; Q8N2Q7; P63261"]
["GO:0048489","biological_process","synaptic vesicle transport ","P37840; P50570; O43426; O95295"]
["GO:0001865","biological_process","NK T cell differentiation ","P51813; Q08881"]
["GO:0006661","biological_process","phosphatidylinositol biosynthetic process ","P51813; P16885; O15357; Q92835; Q9Y2I7; P60484; Q96T51; P61106; P48426; O43426; O00443; O60331; Q12923; Q9BTU6; O00562; P09038; P20338; Q9H4M7; P20339; Q13614; Q9UBF8; O14986; P78356; O15056"]
["GO:0099641","biological_process","anterograde axonal protein transport ","P04792; Q15700; P78559; Q9UPT6; P33176; O60282"]
["GO:0061077","biological_process","chaperone-mediated protein folding ","P04792; P68400; P25686; Q02790; O14558; P10809; O43765; P27824; Q12931; P40855; Q9Y680; O95302; Q9H3Z4"]
["GO:2001028","biological_process","positive regulation of endothelial cell chemotaxis ","P04792; Q15139; Q9BZL6; P08581; P09038; Q99538"]
["GO:0038033","biological_process","positive regulation of endothelial cell chemotaxis by VEF-activated vascular endothelial growth factor receptor signaling pathway ","P04792; Q15139; P35968; Q9BZL6"]
["GO:0032731","biological_process","positive regulation of interleukin- beta production ","P04792; O60674; P84022; Q16666"]
["GO:0042535","biological_process","positive regulation of tumor necrosis factor biosynthetic process ","P04792; P49137; P16150; P41597; O00206"]
["GO:0006446","biological_process","regulation of translational initiation ","P04792; P23588; Q9P2K8; Q04637; P55010; Q9H0H3; O60841; Q14240; Q15056; O43432; P52298; Q09161"]
["GO:0006986","biological_process","response to unfolded protein ","P04792; P08238; P07900; P25686; Q9UDY4; Q92598; P10809; P25685; O95140; P34931; P0DMV8; P11142; P35638; P54652; Q8TCJ2"]
["GO:0001895","biological_process","retina homeostasis ","P04792; P60709; Q06830; P00441; Q8NI36; P63261"]
["GO:0015936","biological_process","coenzyme A metabolic process ","P04035; P53396; P24752"]
["GO:0008299","biological_process","isoprenoid biosynthetic process ","P04035; Q01581; Q13907"]
["GO:0045445","biological_process","myoblast differentiation ","P04035; P06400; P53778; Q9NR56; P17844; P15173; P09382; Q15327; Q92841; Q96Q27"]
["GO:0097756","biological_process","negative regulation of blood vessel diameter ","P04035; P35354; A8MU46"]
["GO:0061179","biological_process","negative regulation of insulin secretion involved in cellular response to glucose stimulus ","P04035; O95819; Q86V86; P08913"]
["GO:0010664","biological_process","negative regulation of striated muscle cell apoptotic process ","P04035; O95817; Q13765"]
["GO:0032874","biological_process","positive regulation of stress-activated MAPK cascade ","P04035; Q9H2K8; Q7L7X3; O00506; P19525; Q9UL54; Q9BUL8; Q9H257"]
["GO:0006743","biological_process","ubiquinone metabolic process ","P04035"]
["GO:0006334","biological_process","nucleosome assembly ","P33778; P06748; P16104; P25440; P84243; P49736; P16403; Q99733; P49450; P55209; Q5QNW6; Q01105; Q9Y294; Q01534; Q6DRA6; P58876; Q9UER7; Q6DN03; Q96T23; P62807; P49321; P06899; P16401; P68431; Q15020; Q9H2G4; P62805; P23527; Q16778; Q92794; Q99879; Q93079; Q99877; Q92688; Q02539; O60814; P10412; P48436; Q71DI3"]
["GO:2001226","biological_process","negative regulation of chloride transport ","Q13237"]
["GO:0036289","biological_process","peptidyl-serine autophosphorylation ","Q13237; P36507; Q13627; Q13546; Q13315; P27448; O75460; Q9BXM7"]
["GO:0006890","biological_process","retrograde vesicle-mediated transport, olgi to ER ","Q96KG9; P42858; Q02224; Q99661; Q14807; Q9BVK6; P48739; Q9P2Y5; Q9H0H5; P24390; Q8N6H7; P62820; Q07866; P46459; Q92538; O00139; Q9H4A6; O43264; Q9H0B6; Q8N4N8; O95239; Q9Y496; P52732; Q9NRD5; Q02241"]
["GO:0034613","biological_process","cellular protein localization ","O95835; Q96ST3; P35221; Q5S007; P04637; Q9NRM7; O43424; Q6KC79; P02545; Q9UMS4; O14641; P48678; P47928; Q9Y2T1; Q09470; P60953; Q4VCS5; Q96IF1; Q9HB90"]
["GO:0051220","biological_process","cytoplasmic sequestering of protein ","O95835; P21333; P31946; Q86YF9"]
["GO:0001827","biological_process","inner cell mass cell fate commitment ","O95835; Q9NRM7"]
["GO:0001828","biological_process","inner cell mass cellular morphogenesis ","O95835; Q9NRM7"]
["GO:0045736","biological_process","negative regulation of cyclin-dependent protein serine/threonine kinase activity ","O95835; P25054; P49715; P53350; P38936; Q9NRM7; Q8IZQ8; P46527; O94992; P42771; O00255; Q03014; P42574; Q0VD86"]
["GO:0030833","biological_process","regulation of actin filament polymerization ","O95835; O75914; Q9ULJ8; P14317; Q8TCU6; Q9H7P9; P20936"]
["GO:0033146","biological_process","regulation of intracellular estrogen receptor signaling pathway ","O95835; P03372; Q01196; P12931; Q86X55; O94874; O15169"]
["GO:0046620","biological_process","regulation of organ growth ","O95835; Q9NRM7; O43521; Q12948; P00441; Q99958"]
["GO:2000058","biological_process","regulation of ubiquitin-dependent protein catabolic process ","O95835; Q14289; Q05086"]
["GO:0000819","biological_process","sister chromatid segregation ","O95835; Q02880; P11388"]
["GO:0002758","biological_process","innate immune response-activating signal transduction ","P08631"]
["GO:0043299","biological_process","leukocyte degranulation ","P08631"]
["GO:0002522","biological_process","leukocyte migration involved in immune response ","P08631"]
["GO:0030838","biological_process","positive regulation of actin filament polymerization ","P08631; Q14289; P16591; P07737; P42345; Q02156; P50552; P62993; P16333; Q9H3Q1; P32248; Q96J84; Q6R327; Q12959; Q9UQB8; O60500; Q5VZK9; Q9ULZ3; P61586; Q9UHR4; Q14247; Q00587; O14613"]
["GO:0008360","biological_process","regulation of cell shape ","P08631; P49674; O00311; P09769; P48730; Q05397; Q86YV5; Q14289; P35968; P10721; P07332; P06241; P07333; O43293; P04083; P15311; Q14344; P46108; P09327; P35580; Q96AC1; P04075; O14745; Q9UL63; P26038; Q9UEE9; Q9UGP4; Q08495; Q96P48; O75400; Q9H3Q1; Q99986; P35241; Q9UL54; Q96QB1; P05107; O43157; P11171; Q12959; P78368; Q9UQB8; Q8WWN8; Q7L0Q8; Q96B97; Q9NRY4; O60610; P20936; P48729; Q00587; P35579; Q03113; P17081; O14950; P09493; Q12929; O14613"]
["GO:0050764","biological_process","regulation of phagocytosis ","P08631; P09769; P05129; P43405; O43581; Q8WTV0"]
["GO:0071801","biological_process","regulation of podosome assembly ","P08631; P12931; P06396"]
["GO:0045728","biological_process","respiratory burst after phagocytosis ","P08631"]
["GO:0009083","biological_process","branched-chain amino acid catabolic process ","O14874; P12694; P31937; Q99714; P21953; P24752"]
["GO:0009063","biological_process","cellular amino acid catabolic process ","O14874"]
["GO:0043697","biological_process","cell dedifferentiation ","Q00534; Q9Y6Q9"]
["GO:0021542","biological_process","dentate gyrus development ","Q00534; Q9UJU2; P60484; P78543; P21728; Q13562"]
["GO:0042063","biological_process","gliogenesis ","Q00534; P04083; Q9NP62; Q86U44"]
["GO:0021670","biological_process","lateral ventricle development ","Q00534; P29972; P49757; Q9Y6R0"]
["GO:0045596","biological_process","negative regulation of cell differentiation ","Q00534; P28482; O14744; P01116; P05556; Q15022; Q9H244; Q92688; Q06330"]
["GO:2000773","biological_process","negative regulation of cellular senescence ","Q00534; Q9Y243; P00519; P78527; O14746; Q96EB6; Q15554; Q9NYY3; Q99759; P28749; Q9HB09; P41182; P52926; Q15672; Q9H3D4"]
["GO:0045656","biological_process","negative regulation of monocyte differentiation ","Q00534; P01106; Q92835"]
["GO:0045638","biological_process","negative regulation of myeloid cell differentiation ","Q00534; Q6PD62; Q14289; P25963; P31269; Q6P1J9; Q05516; Q8WVC0"]
["GO:0045668","biological_process","negative regulation of osteoblast differentiation ","Q00534; P84022; P56524; Q9GZV9; Q8WUI4; Q02535; Q9UGP4; Q99966; P50616; O43541; Q02363; P61296; Q8TD43; P01375; O00255; Q9BY41; Q9Y2T1; P46531; Q9UMX1; P12755; P41134; Q15672"]
["GO:0043249","biological_process","erythrocyte maturation ","P11413; P17542"]
["GO:0006749","biological_process","glutathione metabolic process ","P11413; O75874; P51649; Q04760; P09211; P26641; O15217; P00441; P07203"]
["GO:0006629","biological_process","lipid metabolic process ","P11413; Q01581; P37231; P41235; P01130; P16671; Q15111; Q14849; P48739; P36956; P08684; O00562; Q12772; O60240; O14773; Q07869; Q14432; Q99714; Q00169; Q8NER1; P35790; Q07954; P16662; Q9UPG8"]
["GO:0006740","biological_process","NADPH regeneration ","P11413; O75874; Q13423"]
["GO:0010734","biological_process","negative regulation of protein glutathionylation ","P11413; O00168"]
["GO:2000378","biological_process","negative regulation of reactive oxygen species metabolic process ","P11413; P02511; P38398; P11274; P52789; Q9H1Y0; Q02962; Q16665; P10415; Q9NTG7; P04198; Q9NY61; Q9BXM7; P21796; Q8IXJ6; P05549; O60260; Q14457"]
["GO:0019322","biological_process","pentose biosynthetic process ","P11413"]
["GO:0006098","biological_process","pentose-phosphate shunt ","P11413; P29401"]
["GO:0009051","biological_process","pentose-phosphate shunt, oxidative branch ","P11413"]
["GO:1904879","biological_process","positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel ","P11413; Q08289"]
["GO:0010041","biological_process","response to iron(III) ion ","P11413; Q04656"]
["GO:0046390","biological_process","ribose phosphate biosynthetic process ","P11413"]
["GO:0071397","biological_process","cellular response to cholesterol ","Q01581; P08476; Q14494; O75581; P80108; O95477; Q14118"]
["GO:0071372","biological_process","cellular response to follicle-stimulating hormone stimulus ","Q01581; P48506; Q9UBK2; P08476; P49675; P29322; P46531; P23945"]
["GO:0071404","biological_process","cellular response to low-density lipoprotein particle stimulus ","Q01581; P37231; P43405; P41180; P01130; P16671; P05556; P05107; P30273; Q12772; O95477"]
["GO:0008584","biological_process","male gonad development ","Q01581; P15976; P19544; P09619; P03372; P22681; P35221; P10721; P06213; P23771; P43694; O43521; P08476; Q13772; Q99801; P16989; P49675; O15360; Q92908; O15455; Q13323; Q99697; P10415; P49321; Q13285; P31270; P36897; Q07817; P31269; P43246; P20042; P22612; P29375; P23945; Q13444; P50281; P48436; P31260; O75534"]
["GO:0009645","biological_process","response to low light intensity stimulus ","Q01581"]
["GO:0014074","biological_process","response to purine-containing compound ","Q01581; O94759"]
["GO:0046690","biological_process","response to tellurium ion ","Q01581"]
["GO:0033197","biological_process","response to vitamin E ","Q01581; P04040; Q01130; P24385; Q14457"]
["GO:0060070","biological_process","canonical Wnt signaling pathway ","P49674; Q15831; Q9UJU2; Q5S007; P35222; P60484; P08151; Q155Q3; O14640; Q92997; Q92736; P52952; O14641; P49768; O75581; Q9NQB0; P43354; Q9BRQ0; O43474; P18827; Q9HCS4; Q92837; P13631"]
["GO:0097711","biological_process","ciliary basal body-plasma membrane docking ","P49674; P06493; P48730; O00444; P53350; Q96L34; P17612; P51955; P07900; Q96QF0; Q99996; Q9HC77; Q8TAP6; Q8TEP8; P31323; Q15154; P07437; Q9NXR1; O15259; O95684; O95613; P61981; Q71U36; Q15691; Q14203; P62258; P41208; P62491; Q96SN8; O43303; Q8NHV4; P23258; Q8IW35; Q5BJF6; Q9UPN4; Q14204; Q9BV73; P63167; Q9Y2I6; P30153; Q7Z4H7; Q13409"]
["GO:2000052","biological_process","positive regulation of non-canonical Wnt signaling pathway ","P49674; P48730"]
["GO:1905426","biological_process","positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation ","P49674; P48730"]
["GO:1903827","biological_process","regulation of cellular protein localization ","P49674; P24864; P08238; P07900; P11137; O14640; Q92997; O60341; P09874"]
["GO:0000398","biological_process","mRNA splicing, via spliceosome ","P35269; Q99459; Q13523; P08621; P61978; O43660; Q15427; Q13242; Q9BRD0; Q6NZY4; Q9UBB9; Q9Y5S9; Q96T58; Q15717; Q6UN15; P07910; P31942; Q15366; P62316; Q8N684; Q9NXE8; P51003; P17844; Q8IYB3; Q08170; Q92733; O75400; Q12996; O75940; P14678; P38919; O60506; Q13243; Q01130; Q01081; Q15459; Q8TBF4; Q93062; P24928; O60828; Q9BUJ2; Q7L7V1; Q13573; P61218; P26368; Q9UMS4; Q9UKM9; Q8WXF1; Q9H0L4; Q96I25; Q05519; O75533; Q92620; O43395; P09651; Q92797; Q07955; Q14562; P55081; Q9BXP5; Q8NAV1; Q9UHX1; Q13247; Q9UQ35; P11940; Q15020; P14866; P11142; P22626; Q9P2I0; Q15637; P26599; Q14103; P35637; Q9UKF6; Q15287; Q8IY67; Q13435; P52272; Q86U44; P31943; Q9H840; P67809; Q9UNP9; Q6P2Q9; Q15365; Q15029; Q96NC0; O00148; Q9UJV9; P38159; Q00839; Q13151; P52298; O75494; P62304; P33240; Q9P013; Q09161; Q86V81; P55795; Q9BWJ5; Q92917"]
["GO:0032968","biological_process","positive regulation of transcription elongation from RNA polymerase II promoter ","P35269; Q6PD62; Q9Y5B9; Q7KZ85; Q6P1J9; Q8WVC0; O60885; P55199"]
["GO:0016070","biological_process","RNA metabolic process ","P35269; O43251; P61978; P07910; Q15366; P24928; P61218; P09651; Q9H0D6; Q9GZR7; P14866; Q15631; P22626; P26599; Q14103; P52272; P31943; Q15365; P38159; Q00839; Q13151; P52298; Q09161; P55795"]
["GO:1904837","biological_process","beta-catenin-TCF complex assembly ","Q09472; P01106; Q9UJU2; Q9Y4A5; P35222; Q15291; O14746; P51532; Q13547; Q92793; Q9NQB0; Q9BRQ0; O00255; Q9HCS4; Q9Y2T1; Q6P1J9; Q92993; Q8WVC0; O14686; Q04724; Q9Y265"]
["GO:0045444","biological_process","fat cell differentiation ","Q09472; P49715; P15336; P34947; P31751; Q12778; P22736; O14512; Q9NQ66; Q6KC79; P36956; O75925; O43541; Q9Y3M2; Q9NQB0; P43354; O43474; P47928; Q13049; Q9HC62; P07203; P24385; Q9BXB4; P52926; Q15648; Q5NUL3"]
["GO:0016573","biological_process","histone acetylation ","Q09472; P49407; Q9Y4A5; O60869; Q92793; Q92794; O95983; Q92993; Q9NRL2; P51608"]
["GO:0043969","biological_process","histone H2B acetylation ","Q09472"]
["GO:0043967","biological_process","histone H acetylation ","Q09472; Q9UJU2; P15172; Q9Y4A5; Q9UBU8; Q96L91; Q15788; O95361; P51587; Q9H0E9; O15534; Q9Y230; Q15306; O00213; Q9Y265"]
["GO:0018393","biological_process","internal peptidyl-lysine acetylation ","Q09472; P46379"]
["GO:0042771","biological_process","intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator ","Q09472; Q86Z02; Q9H2X6; O96017; P29590; P04637; Q92630; P38936; Q96EB6; P20749; Q96RU2; Q9NS56; Q13362; O15350; Q13573; P46379; P51587; P43246; Q9ULZ3; Q16666; Q71UM5; Q9H3D4"]
["GO:0010742","biological_process","macrophage derived foam cell differentiation ","Q09472; P42224; P37231"]
["GO:0032460","biological_process","negative regulation of protein oligomerization ","Q09472; P41143; Q92673"]
["GO:0007219","biological_process","Notch signaling pathway ","Q09472; P01106; P49715; Q14469; Q96T58; O43623; Q9UBC0; Q92858; P46527; Q96RI1; Q12948; Q9Y6I3; P26678; Q13573; Q92793; P78536; P55317; P50553; P37173; P01589; P05067; Q99958; P22460; Q86Y01; P08727; P46531; O14713; Q15466; P67809; Q9HD90; Q03014; Q96J02; Q06330; Q9H3D4; P48436"]
["GO:0018076","biological_process","N-terminal peptidyl-lysine acetylation ","Q09472; Q92793"]
["GO:0018394","biological_process","peptidyl-lysine acetylation ","Q09472; Q96EB6"]
["GO:0140067","biological_process","peptidyl-lysine butyrylation ","Q09472"]
["GO:0140066","biological_process","peptidyl-lysine crotonylation ","Q09472"]
["GO:0061921","biological_process","peptidyl-lysine propionylation ","Q09472"]
["GO:0043923","biological_process","positive regulation by host of viral transcription ","Q09472; Q9UJU2; P05412; Q12824; Q14684; P51532; Q13573; P08047; Q9H1E3; Q9Y5B0; O60563; Q00403"]
["GO:0045815","biological_process","positive regulation of gene expression, epigenetic ","Q09472; P60709; Q9BQG0; O15160; P35659; P61218; Q03468; O75533; Q9UIG0; O15446; Q969T9"]
["GO:0032092","biological_process","positive regulation of protein binding ","Q09472; Q9H2X6; P49407; Q5S007; Q03135; Q00535; Q13043; O43353; P49841; P08238; P27448; O14746; P04004; Q13188; Q9UKV5; Q9NYY3; P35611; Q96D46; Q9Y4G8; Q14155; P62826; P62913; P11171; O75955; P49768; Q9NQB0; P05067; Q86WV6; Q9NYF0; O00255; Q13009; P11234; P98161; Q07954; P35612; Q13526; O60260"]
["GO:0006990","biological_process","positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response ","Q09472; P17861"]
["GO:0007221","biological_process","positive regulation of transcription of Notch receptor target ","Q09472; P42224; Q15398; Q13573; Q92793; P46531; Q8IX03; Q06330"]
["GO:0006473","biological_process","protein acetylation ","Q09472; Q12778; O15516; Q8WYH8; Q92793; Q92794; Q00403"]
["GO:0060765","biological_process","regulation of androgen receptor signaling pathway ","Q09472; P17844; Q14151; Q99497; Q9BY66; Q9UBN7; P32121; Q9UBS8"]
["GO:0061418","biological_process","regulation of transcription from RNA polymerase II promoter in response to hypoxia ","Q09472; Q16790; P62979; P27540; Q9UGP4; P0CG47; Q16665; Q92793; Q99814; Q96KS0; P62987; P40337; P18146; Q9Y2N7"]
["GO:0043627","biological_process","response to estrogen ","Q09472; P09619; P03372; P37231; P38398; P35221; P28482; Q03135; P23771; Q02763; Q15291; P49675; P00338; Q99966; Q92908; O43541; P00918; O15143; P37173; P41145; Q99967; P08727; Q9UBU3; P09601; P24385; Q969T9; Q8IWU9; P24394; P10071; O14686; P50281"]
["GO:0044565","biological_process","dendritic cell proliferation ","Q9UHD2"]
["GO:0032727","biological_process","positive regulation of interferon-alpha production ","Q9UHD2; P42224; Q14653; O43353; Q7Z434; O95786; P10809; Q13568; Q7Z2W4; Q92985; Q9BYX4; O00206"]
["GO:0045359","biological_process","positive regulation of interferon-beta biosynthetic process ","Q9UHD2; O15455"]
["GO:0032728","biological_process","positive regulation of interferon-beta production ","Q9UHD2; Q14653; O43353; Q7Z434; O95786; O15455; Q13568; Q7Z2W4; Q92985; O75955; O00571; Q9BYX4; O00206; P10914; P05423"]
["GO:1904417","biological_process","positive regulation of xenophagy ","Q9UHD2; P27361; O43353; Q96CV9"]
["GO:1901214","biological_process","regulation of neuron death ","Q9UHD2; P54762; Q5S007; P36544; P62070; P0CG47; P02649; Q92574; P43146"]
["GO:0032479","biological_process","regulation of type I interferon production ","Q9UHD2; Q14653; Q9NSU2; P19474; Q92985; Q86WV6; Q13049"]
["GO:0032606","biological_process","type I interferon production ","Q9UHD2"]
["GO:0007569","biological_process","cell aging ","P06748; P06493; Q13418; P04637; P42345; Q96EB6; P10415; Q53EL6; P00441; Q9NPH5; O15119; P51587; P37198; Q14191"]
["GO:0034080","biological_process","CENP-A containing nucleosome assembly ","P06748; Q71F23; Q03188; Q8NCD3; P49450; Q7L2Z9; Q96T23; Q8N2Z9; P62805; Q13352; Q6P0N0; Q8NG31; Q9Y265"]
["GO:0007098","biological_process","centrosome cycle ","P06748; P06493; P38398; P53350; P07332; O14974; Q08379; Q15154; Q5TZA2; Q9P2Y5; Q96SN8; P24522; P37198; Q7Z4H7; Q9NPB6"]
["GO:0006886","biological_process","intracellular protein transport ","P06748; O75886; Q00535; Q8IYJ3; P08138; Q13002; Q04917; P53675; P09497; Q16623; P53992; P56962; Q92974; O60784; Q15036; Q96JC1; Q8WUA7; P05408; Q15436; P53367; Q9Y2J0; P24390; Q86TI0; Q9UBN7; Q9BV36; O75674; Q86UR5; Q07866; P46459; Q9UJY5; O95295; Q9Y2W7; O60763; O60749; Q02410; P62745; P30040; Q9Y5X2; Q4KMP7; O60343; Q96CW1; P09496; Q14247; P63010; Q9UM54; Q96AP0; Q00610; P61266; Q9UKI8"]
["GO:0010826","biological_process","negative regulation of centrosome duplication ","P06748; P41002"]
["GO:0044387","biological_process","negative regulation of protein kinase activity by regulation of protein phosphorylation ","P06748; Q9ULV4; Q9Y6W6"]
["GO:0006913","biological_process","nucleocytoplasmic transport ","P06748; Q00535; Q14012; O43566; Q99966; P39687; Q6NXT1; P52948; O14980; Q13562"]
["GO:1902751","biological_process","positive regulation of cell cycle /M phase transition ","P06748; P30304; P30307; P30305"]
["GO:0046599","biological_process","regulation of centriole replication ","P06748; Q9HC77; Q8TAP6; Q9NYY3; Q15468"]
["GO:0060735","biological_process","regulation of eIF2 alpha phosphorylation by dsRNA ","P06748"]
["GO:0032071","biological_process","regulation of endodeoxyribonuclease activity ","P06748; Q96EB6"]
["GO:0060699","biological_process","regulation of endoribonuclease activity ","P06748"]
["GO:1902629","biological_process","regulation of mRNA stability involved in cellular response to UV ","P06748"]
["GO:0042255","biological_process","ribosome assembly ","P06748; Q9BY44"]
["GO:0019369","biological_process","arachidonic acid metabolic process ","P27361; P47712; Q9Y4D2; Q9NP80"]
["GO:0061308","biological_process","cardiac neural crest cell development involved in heart development ","P27361; P28482"]
["GO:0072584","biological_process","caveolin-mediated endocytosis ","P27361; P28482; Q03135"]
["GO:1903351","biological_process","cellular response to dopamine ","P27361; P00519; Q96ST3; P28482; Q5S007; Q92769; Q06546; P50570; P18848; P21728; P41134; O60260"]
["GO:0006975","biological_process","DNA damage induced protein phosphorylation ","P27361; P00519; O96017; P53778; P52564; Q13315; O14757; Q16526"]
["GO:0070371","biological_process","ERK and ERK2 cascade ","P27361; P01106; P36507; P35968; P28482; Q02750; Q15046; Q07352; Q15648; P48436"]
["GO:0060324","biological_process","face development ","P27361; P10276; P28482; P11831; Q02750; P04049; Q9P2D1; P13631"]
["GO:0060425","biological_process","lung morphogenesis ","P27361; P28482; P11831; P41134"]
["GO:2000657","biological_process","negative regulation of apolipoprotein binding ","P27361"]
["GO:0042473","biological_process","outer ear morphogenesis ","P27361; P11362; P28482; Q99502; Q15672"]
["GO:0031281","biological_process","positive regulation of cyclase activity ","P27361; P45983; Q16539"]
["GO:0002741","biological_process","positive regulation of cytokine secretion involved in immune response ","P27361; Q16539; Q15046"]
["GO:0010759","biological_process","positive regulation of macrophage chemotaxis ","P27361; Q16539; Q15046; Q9HBA0; P21730"]
["GO:1905050","biological_process","positive regulation of metallopeptidase activity ","P27361; Q16539; Q15046"]
["GO:0051973","biological_process","positive regulation of telomerase activity ","P27361; P01106; Q8IW41; Q96GD4; Q04759; P28482; Q8TDX7; O14733; P08238; P51955; P07900; O95271; P13010; O60832; Q9Y6R4; Q96T60; Q15185; O43474; O95453; P78371; Q8TD08; Q9BUR4; Q96AP0"]
["GO:1904355","biological_process","positive regulation of telomere capping ","P27361; Q8IW41; Q96GD4; Q04759; P28482; Q8TDX7; O14733; P51955; O95271; Q9Y6R4; Q96T60; Q9BQ15; Q8TD08; Q14103"]
["GO:0032212","biological_process","positive regulation of telomere maintenance via telomerase ","P27361; Q8IW41; Q96GD4; Q04759; P28482; Q8TDX7; O14733; Q13535; P51955; Q13315; O95271; Q9UKT5; P13010; O60832; Q9Y6R4; Q96T60; P09651; O95453; P78371; Q8TD08; Q96AP0"]
["GO:0030641","biological_process","regulation of cellular pH ","P27361; O15525; P28482"]
["GO:0051493","biological_process","regulation of cytoskeleton organization ","P27361; Q05397; Q7KZI7; P28482; Q7L7X3; Q9NZ72; O43157; Q8N556; P17655; O60610; P06702"]
["GO:2000641","biological_process","regulation of early endosome to late endosome transport ","P27361; P36507; P28482; Q02750; P12931; Q9Y3E7"]
["GO:0090170","biological_process","regulation of olgi inheritance ","P27361; P36507; P28482; Q02750"]
["GO:0030278","biological_process","regulation of ossification ","P27361; Q04771; P28482; Q16539; P01236"]
["GO:0032872","biological_process","regulation of stress-activated MAPK cascade ","P27361; P36507; P28482; Q02750; P25445; P09211; Q06830"]
["GO:0070849","biological_process","response to epidermal growth factor ","P27361; P28482; P12270; P50553"]
["GO:0043330","biological_process","response to exogenous dsRNA ","P27361; Q14653; P25963; P28482; O43353; O15455; P08195; Q15842; Q9H257"]
["GO:0048538","biological_process","thymus development ","P27361; P00519; P78527; P28482; P11831; P54753; Q02750; P04049; P23771; P46109; Q14469; Q13158; O43521; Q9C0K0; P14679; P10415; Q9Y5Q3; P00441; P49768; P61296; P36897; Q9Y6D9; Q9Y572"]
["GO:0030878","biological_process","thyroid gland development ","P27361; P28482; P84022; P11831; Q02750; P04049; P10827; P52952; P43699; Q03014"]
["GO:0060440","biological_process","trachea formation ","P27361; P28482; Q02750; P37173"]
["GO:0006796","biological_process","phosphate-containing compound metabolic process ","P23467; Q92835; O14638; P22413"]
["GO:0034333","biological_process","adherens junction assembly ","Q86Z02; P35222; P18206; O60331; O15105"]
["GO:0060216","biological_process","definitive hemopoiesis ","Q86Z02; P11274; Q02763; P12980; Q03167; P17542; Q02447; P31269; Q03164; P23769"]
["GO:0048596","biological_process","embryonic camera-type eye morphogenesis ","Q86Z02; Q9H2X6; P07101; P37275; P26367; Q02447"]
["GO:0060059","biological_process","embryonic retina morphogenesis in camera-type eye ","Q86Z02; Q9H2X6; O75581"]
["GO:0001654","biological_process","eye development ","Q86Z02; Q9H2X6; Q12948; P26367; P18850; A1X283; P22004; P48431"]
["GO:0061072","biological_process","iris morphogenesis ","Q86Z02; Q9H2X6; P26367; Q99697; Q16665"]
["GO:0060235","biological_process","lens induction in camera-type eye ","Q86Z02; Q9H2X6"]
["GO:0010803","biological_process","regulation of tumor necrosis factor-mediated signaling pathway ","Q86Z02; Q13546; P43405; O14920; Q9Y6K9; O15111; Q12933; Q9BYM8; P19438; Q86VP1; Q9NQC7; Q14790; Q9NYA1; P63244; P01375; Q13077; Q9ULZ3"]
["GO:0010842","biological_process","retina layer formation ","Q86Z02; Q9H2X6; P28827; Q9NS56; O43490; P05549"]
["GO:0003180","biological_process","aortic valve morphogenesis ","P06400; P29474; P23771; P43694; O43541; Q9Y6N7; P46531; Q15672; Q9UMR3"]
["GO:0071466","biological_process","cellular response to xenobiotic stimulus ","P06400; Q01094; P33993"]
["GO:0048565","biological_process","digestive tract development ","P06400; P21802; P14635; P10721; Q8IZQ8; P52945; Q12946; P37173; P16144; P98161"]
["GO:0043353","biological_process","enucleate erythrocyte differentiation ","P06400; Q02447; Q02363"]
["GO:0034349","biological_process","glial cell apoptotic process ","P06400; P55211; O14727; P42574"]
["GO:0097284","biological_process","hepatocyte apoptotic process ","P06400; Q9Y6K1; Q13043; Q13188; P48736; P05787; P06396; Q07817; P55957; P05783"]
["GO:0034088","biological_process","maintenance of mitotic sister chromatid cohesion ","P06400; Q6KC79"]
["GO:0120163","biological_process","negative regulation of cold-induced thermogenesis ","P06400; Q15831; P52564; Q13705; Q9UIQ6; P17342; Q15111; P19532; O00327; Q96N67; P55055; P78536; P18848; Q13133; Q99958; Q15382; O00206; P35638; P46531; P20393; P41134; Q06330"]
["GO:0043433","biological_process","negative regulation of DNA-binding transcription factor activity ","P06400; P03372; P11309; Q02779; Q15910; P56524; Q92769; Q96EB6; Q14145; Q02535; Q9Y261; Q5VWG9; P04156; Q9BZS1; O60341; O15105; Q02363; P61296; Q9NQB0; P63165; O75928; O96004; P21333; O00255; P35638; P09601; Q15466; Q9UMX1; P41134; P23497; Q15672; Q99623"]
["GO:2000134","biological_process","negative regulation of /S transition of mitotic cell cycle ","P06400; P30291; P60484; P38936; Q15910; Q13642; Q13563; P10415; Q6IE81; O43474; Q9NYF0; Q6P1J9; Q8N720; Q96AV8"]
["GO:1904761","biological_process","negative regulation of myofibroblast differentiation ","P06400; Q53EL6"]
["GO:0045879","biological_process","negative regulation of smoothened signaling pathway ","P06400; Q6PHR2; P07766; O75386; Q9UMX1; Q13950; P10071"]
["GO:0071930","biological_process","negative regulation of transcription involved in /S transition of mitotic cell cycle ","P06400; Q01094; Q96AV8"]
["GO:0051402","biological_process","neuron apoptotic process ","P06400; P21860; Q00535; P08138; Q13002; O14727; Q99250; Q07812; P54259; P10415; P06746; O14578; P49768; P05067; Q07817; P61244; P04406; P49917; P55957; P42574; Q8IUQ4; Q9H3D4; P11021"]
["GO:0042551","biological_process","neuron maturation ","P06400; P07949; Q99581; O60341; P43354; P51608"]
["GO:1904028","biological_process","positive regulation of collagen fibril organization ","P06400"]
["GO:1903055","biological_process","positive regulation of extracellular matrix organization ","P06400; O15519"]
["GO:0045842","biological_process","positive regulation of mitotic metaphase/anaphase transition ","P06400; Q15398; Q14674"]
["GO:2000679","biological_process","positive regulation of transcription regulatory region DNA binding ","P06400; P23771; Q96TA1; Q99497; Q9Y4K3; P61296; P52926; P09874; Q15672; Q13562; Q01851"]
["GO:0071459","biological_process","protein localization to chromosome, centromeric region ","P06400; P49450; Q8TF76; P49711"]
["GO:0090230","biological_process","regulation of centromere complex assembly ","P06400"]
["GO:0071922","biological_process","regulation of cohesin loading ","P06400; Q7Z5K2; Q96FF9; Q9BY41"]
["GO:0043550","biological_process","regulation of lipid kinase activity ","P06400; Q08999; P28749"]
["GO:0031134","biological_process","sister chromatid biorientation ","P06400; Q96JM3"]
["GO:0030221","biological_process","basophil differentiation ","P15976; P17542"]
["GO:0097067","biological_process","cellular response to thyroid hormone stimulus ","P15976; P10721; Q9UBK2; P35241; Q15648"]
["GO:0035162","biological_process","embryonic hemopoiesis ","P15976; P35968; P10721; P23771; P17542; Q16665; P37173; Q03164; Q15648; Q9UQQ2"]
["GO:0030222","biological_process","eosinophil differentiation ","P15976"]
["GO:0035854","biological_process","eosinophil fate commitment ","P15976; P23769"]
["GO:0048821","biological_process","erythrocyte development ","P15976; P11831; Q9NYL9; Q08495; P41182; P29374; Q15648"]
["GO:0030219","biological_process","megakaryocyte differentiation ","P15976; P17542; Q02447"]
["GO:0030502","biological_process","negative regulation of bone mineralization ","P15976; Q14289; Q9GZV9; P02765; Q16665; Q8TD43; P48436"]
["GO:2000678","biological_process","negative regulation of transcription regulatory region DNA binding ","P15976; Q96ST3; O15055; P30626; P35548; Q07869"]
["GO:0033690","biological_process","positive regulation of osteoblast proliferation ","P15976; P00519"]
["GO:0050731","biological_process","positive regulation of peptidyl-tyrosine phosphorylation ","P15976; P00519; O60674; Q15831; Q13177; Q07912; P42680; Q14289; P05106; P04637; P42345; O43353; P07947; P12931; P28223; P04004; P16671; P07766; P14317; Q38SD2; Q92974; P16070; Q6R327; P04156; Q6UVK1; P10912; O75096; Q9H2P0; P01730; P32121"]
["GO:0010724","biological_process","regulation of definitive erythrocyte differentiation ","P15976; O43251"]
["GO:0010559","biological_process","regulation of glycoprotein biosynthetic process ","P15976; P10415"]
["GO:0010725","biological_process","regulation of primitive erythrocyte differentiation ","P15976; P23769"]
["GO:0071733","biological_process","transcriptional activation by promoter-enhancer looping ","P15976; Q9Y230"]
["GO:0045216","biological_process","cell-cell junction organization ","P35240; P84022; P41743; Q9BSQ5; Q16625; Q8N0W4"]
["GO:0007398","biological_process","ectoderm development ","P35240; Q9UIW0; P36894"]
["GO:0021766","biological_process","hippocampus development ","P35240; P10276; Q9UM73; Q00535; P11831; P49841; Q15910; Q15078; Q6ZVD8; Q92913; O60315; Q13144; Q13547; P07196; Q9H0D6; Q15058; P62258; P47928; Q13319; P23634; Q09470; P18887; P43699; Q92574; P42574; P10071; P33176; Q99689"]
["GO:0022408","biological_process","negative regulation of cell-cell adhesion ","P35240; P00519; O60674; Q9UJU2; Q05397; P12830; O00592"]
["GO:0046426","biological_process","negative regulation of JAK-STAT cascade ","P35240; Q03135; O14964; O14512; P20749; Q9HCJ2; O14543; Q96A54; O75553; P40337; Q13562"]
["GO:0043409","biological_process","negative regulation of MAPK cascade ","P35240; P21359; Q03135; O00459; P51452; P09211; P28562; Q14118"]
["GO:0042532","biological_process","negative regulation of tyrosine phosphorylation of STAT protein ","P35240; Q03135; P17706; P67775; O14543; P30153"]
["GO:0042475","biological_process","odontogenesis of dentin-containing tooth ","P35240; Q9UJU2; P35221; Q92769; O43521; Q13705; Q9C0K0; Q12948; Q07812; Q99697; Q13547; Q14524; P10070; Q9Y5Y9; P00918; Q9Y4K3; O75581; P61296; O96004; O60479; O75096; Q13950; P10071; P36894; Q9H3D4"]
["GO:0045597","biological_process","positive regulation of cell differentiation ","P35240; O60674; P05412; P51812; P11831; P10275; P08238; Q15418; P17535; Q8WUF5; O14543; Q9ULV5; Q99626; P17275; Q9UQ80; P48431; Q9HD90; P40337; Q13562"]
["GO:0014013","biological_process","regulation of gliogenesis ","P35240; Q15910"]
["GO:0035330","biological_process","regulation of hippo signaling ","P35240; Q8IX03"]
["GO:2000177","biological_process","regulation of neural precursor cell proliferation ","P35240; Q12778; O43524; Q8NEM2; P61586"]
["GO:1900180","biological_process","regulation of protein localization to nucleus ","P35240; P02545; P48678; Q13526"]
["GO:0031647","biological_process","regulation of protein stability ","P35240; O14965; Q15139; P28482; P60484; O15164; O14746; Q9UKT5; Q96PU5; Q96RU2; P13473; P01116; P36956; Q13107; P10415; Q9UBN7; Q96BK5; O15379; Q8N163; Q9NYF0; P17861; Q9UNE7; P11142; Q9Y2Z0; Q9BY41; Q9ULZ3; Q8N726; Q7Z2E3; Q9Y371; O60260"]
["GO:0014010","biological_process","Schwann cell proliferation ","P35240"]
["GO:1905064","biological_process","negative regulation of vascular smooth muscle cell differentiation ","Q12968; Q13469; Q53EL6; O95644"]
["GO:0006306","biological_process","DNA methylation ","Q9Y6K1; P01100; Q15910; Q8IZD2; P26358; O15297; Q9UIF9; Q96KQ7; Q86YP4; Q03164; O94776"]
["GO:0043045","biological_process","DNA methylation involved in embryo development ","Q9Y6K1; Q13263; P26358; Q9NRD5"]
["GO:0043046","biological_process","DNA methylation involved in gamete generation ","Q9Y6K1; Q9NQI0; Q9BXT4; Q9NRD5"]
["GO:0006346","biological_process","methylation-dependent chromatin silencing ","Q9Y6K1; Q96EB6; Q13547; O95983"]
["GO:0045814","biological_process","negative regulation of gene expression, epigenetic ","Q9Y6K1; P17947; P84243; Q15910; Q15022; P26358; O15297; P35226; P68431; Q9Y483; P62805; Q71DI3"]
["GO:0010942","biological_process","positive regulation of cell death ","Q9Y6K1; P25054; O43353; Q04637; O95069; P16671; O43464; Q99801; P46527; Q5D1E8; P04198; P35232; Q9Y2T1; Q9UNN5; Q07954"]
["GO:0006349","biological_process","regulation of gene expression by genetic imprinting ","Q9Y6K1; P38398; P51787; P29374; P51608"]
["GO:0042220","biological_process","response to cocaine ","Q9Y6K1; Q00987; Q14289; Q9UQL6; P42345; P08238; Q92769; P21554; P50570; P28222; P35462; Q01959; P14416; P49798; Q13009; P17405; Q15029; P11021; P35372"]
["GO:0010212","biological_process","response to ionizing radiation ","Q9Y6K1; Q15831; P38398; P16104; Q13315; Q99502; Q9NWV8; Q96RU2; Q99504; P49675; Q7Z2Z1; O43542; Q13330; Q9BQ15; Q8NHY2; Q9H9Q4; Q92993; P49760; Q96AH0; Q92547; Q96SD1; Q6PCD5; Q96RL1; Q92698; Q6UWZ7"]
["GO:0033189","biological_process","response to vitamin A ","Q9Y6K1; P10276; P37231; P43694; P04818; P04040; Q99697"]
["GO:0000184","biological_process","nuclear-transcribed mRNA catabolic process, nonsense-mediated decay ","P62753; Q96Q15; P67775; Q04637; P62917; Q9Y5S9; P60866; P62280; Q9BRP8; P05388; P62979; P38919; P26373; P05387; P23396; P42677; P84098; P62495; P62913; P46782; Q92900; P46778; P40429; P46783; P11940; O95453; P62841; Q15287; Q9NPI6; P30050; P30153; P62987; P52298; Q07020; Q09161; P39019"]
["GO:0006364","biological_process","rRNA processing ","P62753; Q14978; Q9NQZ2; Q96EB6; Q14684; O60832; Q9Y5J1; Q9Y4W2; P38919; Q99547; Q9Y2R4; P42677; O43818; Q9Y237; Q9P2D1; P22087; P62913; Q9H0D6; Q9BVI4; Q9UKD2; Q8IZL8; Q06265; P62841; Q9NQT5; Q15024; Q8NI36; Q92841; O00566; Q9ULX3; O95707; Q99848; Q9UQ80; Q8N726; Q9BVJ6; Q9NQT4; Q9H0S4; P39019"]
["GO:0006614","biological_process","SRP-dependent cotranslational protein targeting to membrane ","P62753; P62917; P60866; P62280; P05388; P62979; P26373; P05387; P23396; P42677; P84098; P62913; P46782; P46778; P40429; P46783; P62841; P30050; P62987; Q07020; P39019"]
["GO:0006953","biological_process","acute-phase response ","P00966; P40763; O15162; P01009; P02765; P17676; Q14624"]
["GO:0006526","biological_process","arginine biosynthetic process ","P00966; P27708"]
["GO:0000053","biological_process","argininosuccinate metabolic process ","P00966"]
["GO:0006531","biological_process","aspartate metabolic process ","P00966"]
["GO:0071418","biological_process","cellular response to amine stimulus ","P00966"]
["GO:0071242","biological_process","cellular response to ammonium ion ","P00966"]
["GO:0071320","biological_process","cellular response to cAMP ","P00966; O00418; P19544; Q13905; P15311; Q08499; P29972; Q99996; Q16613; P61224; P05388; Q13563; P49675; Q08495; P62834; P10109; P48736; Q9Y4G8; P32418; O43315; Q9Y3Q4; O60341; P05067; Q14571; P13569; P51787; Q9NPH5; Q07352; P35869; P27695; P15382; O95398; Q9UL51; P11021"]
["GO:0071377","biological_process","cellular response to glucagon stimulus ","P00966; P13861; P17612; P22694; P31323; O60266; Q08828; O43306; Q08462; P10644; P22612; P40145"]
["GO:0071346","biological_process","cellular response to interferon-gamma ","P00966; P08670; P35228; P42224; P23443; P42768; O43293; Q15836; P49675; O15455; Q9H3Q1; O60506; P61160; O75369; Q15942; P61764; P53355; P40429; P06396; P61158; O00206; P04406; O00186; P60953; Q02556; P63261; Q6ZWJ1; P07814; P33176; O14613; P55087"]
["GO:0071400","biological_process","cellular response to oleic acid ","P00966"]
["GO:0000052","biological_process","citrulline metabolic process ","P00966"]
["GO:0060539","biological_process","diaphragm development ","P00966; P19544"]
["GO:0001822","biological_process","kidney development ","P00966; P19544; Q06203; P23771; O43521; Q13705; O75631; P08473; O15350; Q12948; Q7LG56; Q07812; P46379; P10070; Q92819; P00918; Q9BRQ0; P36897; O75096; P22004; P98161; Q92574; P11926; P30556; P36955; P05549; Q15842; P12821"]
["GO:0010046","biological_process","response to mycotoxin ","P00966; Q16611"]
["GO:0010043","biological_process","response to zinc ion ","P00966; P07101; P60484; Q16613; P26678; P00918; Q96D96; Q04656"]
["GO:0000050","biological_process","urea cycle ","P00966; P49715; P27708"]
["GO:0030325","biological_process","adrenal gland development ","P21359; P19544; Q15796; P84022; P06213; Q13285"]
["GO:0021764","biological_process","amygdala development ","P21359"]
["GO:0048844","biological_process","artery morphogenesis ","P21359; Q14469; O75626; Q12948; P02649; O15105; P17813; Q99958; P36897"]
["GO:0048593","biological_process","camera-type eye morphogenesis ","P21359; P29323; P54762; O95140; P55064; P10071; P12755; P25490; O95390"]
["GO:0007154","biological_process","cell communication ","P21359; Q15642; Q02297"]
["GO:0050890","biological_process","cognition ","P21359; P36544; P43681; Q6KC79; Q9P2D1; P41594"]
["GO:0030199","biological_process","collagen fibril organization ","P21359; P07355; Q16832; Q12948; Q99958; P36897; Q04656"]
["GO:0008625","biological_process","extrinsic apoptotic signaling pathway via death domain receptors ","P21359; Q92934; P27986; Q13158; O95817; P19438; P48023; Q5VWQ8; Q07812; P10415; Q9NR28; Q9UER7; P53355; O00571; P01375; Q99523; P55957; Q9H0S4"]
["GO:0021897","biological_process","forebrain astrocyte development ","P21359; P01116"]
["GO:0048853","biological_process","forebrain morphogenesis ","P21359; P60484; Q03014"]
["GO:0061534","biological_process","gamma-aminobutyric acid secretion, neurotransmission ","P21359"]
["GO:0061535","biological_process","glutamate secretion, neurotransmission ","P21359"]
["GO:0048820","biological_process","hair follicle maturation ","P21359; Q9Y4I1; Q06330; Q08J23"]
["GO:0001656","biological_process","metanephros development ","P21359; Q99502; Q02535; Q99801; Q99966; Q6KC79; P10415; Q02363; Q99958; P31270; P10071; O95390"]
["GO:0022011","biological_process","myelination in peripheral nervous system ","P21359; Q13418; Q8TEW0; Q14118; P20265; P12755; Q8IXJ6"]
["GO:0048147","biological_process","negative regulation of fibroblast proliferation ","P21359; P01106; P04637; Q96IZ0; Q9UKT5; Q5VWQ8; Q07812; P09211; P50052; Q13049; Q6P1J9; P50402; Q53GL7; P12755"]
["GO:0007406","biological_process","negative regulation of neuroblast proliferation ","P21359; P35221"]
["GO:0046929","biological_process","negative regulation of neurotransmitter secretion ","P21359; Q9H2B2; P78348"]
["GO:0048715","biological_process","negative regulation of oligodendrocyte differentiation ","P21359; Q14469; P35462; Q02363; P47928; P46531; Q9Y6W6"]
["GO:0045671","biological_process","negative regulation of osteoclast differentiation ","P21359; Q92835; P27986; O15455; Q14106; Q9Y5Q3; O00206; O75022"]
["GO:0042308","biological_process","negative regulation of protein import into nucleus ","P21359; P61925; P16671; Q9UMX1"]
["GO:0035021","biological_process","negative regulation of Rac protein signal transduction ","P21359; Q9NZ72; Q8WWN8"]
["GO:0021915","biological_process","neural tube development ","P21359; P29317; Q9C0C7; O14640; Q13563; Q15468; Q8WUM0; Q9NYF0; P46531; O43175; P98161; Q07352"]
["GO:0098597","biological_process","observational learning ","P21359"]
["GO:0007422","biological_process","peripheral nervous system development ","P21359; P04626; P21860; Q02297; Q9UQD0"]
["GO:0043473","biological_process","pigmentation ","P21359; P07101; P10721; O43623; Q99966; P14416; P63244; Q04656; Q5T011"]
["GO:0045762","biological_process","positive regulation of adenylate cyclase activity ","P21359; P84074; P16473; P23945"]
["GO:1902043","biological_process","positive regulation of extrinsic apoptotic signaling pathway via death domain receptors ","P21359; Q13043; Q15121; Q13158; Q13188; Q9UNN5; Q13794"]
["GO:0043535","biological_process","regulation of blood vessel endothelial cell migration ","P21359; P29317; P37023"]
["GO:0045124","biological_process","regulation of bone resorption ","P21359; Q16654; P05106; P07333; P12931; P21453"]
["GO:0001952","biological_process","regulation of cell-matrix adhesion ","P21359; Q08345; Q8N4C8; Q9UBC0; P10415; P42338; P13349; Q92574"]
["GO:0045685","biological_process","regulation of glial cell differentiation ","P21359"]
["GO:1900271","biological_process","regulation of long-term synaptic potentiation ","P21359; Q9BYB0; Q15109; Q7LC44"]
["GO:0032228","biological_process","regulation of synaptic transmission, ABAergic ","P21359; P60484; O14994; P21554; P01116; Q15111; P14416"]
["GO:0014044","biological_process","Schwann cell development ","P21359; Q00535"]
["GO:0048745","biological_process","smooth muscle tissue development ","P21359; P17813; Q12959; Q9H3D4"]
["GO:0097190","biological_process","apoptotic signaling pathway ","P17252; Q06187; Q13546; Q03135; Q99683; O43293; Q96IZ0; Q13158; P08138; Q9BXH1; P07766; O15455; P25445; P40305; P48023; Q07812; Q14790; P08133; P53355; P51398; P10747; P0C1Z6; O00206; P06127; Q16611; Q9P0J0; Q86XR7; Q9Y572; Q9Y6Y9; P25942; P20333; Q92785; P42574; P42575; P51397"]
["GO:0002159","biological_process","desmosome assembly ","P17252; P14923"]
["GO:0035408","biological_process","histone H-T6 phosphorylation ","P17252; P05771"]
["GO:0007077","biological_process","mitotic nuclear envelope disassembly ","P17252; P06493; P53350; P14635; P05771; Q9HC98; Q14693; Q99986; Q8TD19"]
["GO:0045785","biological_process","positive regulation of cell adhesion ","P17252; P21980; P04626; Q9BZL6; Q13315; O43739; P19532; P32248; Q12913; P17301; Q9UKW4; Q08209; P21815; P30301; P01375; Q02297; Q07021; P09493"]
["GO:2000707","biological_process","positive regulation of dense core granule biogenesis ","P17252"]
["GO:0031666","biological_process","positive regulation of lipopolysaccharide-mediated signaling pathway ","P17252; Q9Y4K3; P22004; Q9Y6Y9"]
["GO:0006914","biological_process","autophagy ","Q6PHR2; P00519; P09429; Q15831; Q8IYT8; Q9Y2R2; Q5S007; P04637; O75385; Q12778; Q96CV9; Q9BUL5; Q9Y4P1; Q9H1Y0; P19484; P35462; P55072; Q9H4P4; Q9P2Y5; Q99497; Q96JC1; P49795; Q13501; P42338; O95278; Q9UBN7; P14416; P62820; Q14694; P17861; P16144; Q9GZQ8; Q8TEV9; P06702; Q8NEB9; Q16666; Q8IXJ6; P51397; Q9Y371; Q00610; Q66K74; Q14457"]
["GO:0090398","biological_process","cellular senescence ","Q6PHR2; P29590; P01112; P16104; P11831; Q02750; P38936; Q05655; Q15554; P42771; Q02363; O15119; Q96LA8; P43356; Q92794; Q8N726"]
["GO:0045880","biological_process","positive regulation of smoothened signaling pathway ","Q6PHR2; P35221; Q9NRP7; P08151; Q13371; Q8TDM6; P55317"]
["GO:0001832","biological_process","blastocyst growth ","O60934; Q6PD62"]
["GO:0030330","biological_process","DNA damage response, signal transduction by p5 class mediator ","O60934; P04637; O43524; P20749; Q92597; O15151; Q14694; Q9UM54; Q96AV8"]
["GO:0000729","biological_process","DNA double-strand break processing ","O60934; P38398; Q13315; Q15819; P54132; Q9H4L7; P49959; Q53H47; Q92878; Q99708; Q92993; Q99728; P61088"]
["GO:0032508","biological_process","DNA duplex unwinding ","O60934; P04083; P54132; Q8N3C0; P49959; Q03468; Q8IYB8; Q92878; Q9Y248; Q14191"]
["GO:0006302","biological_process","double-strand break repair ","O60934; O96017; P38398; P78527; P16104; Q99502; P13010; Q9NWV8; Q99504; Q13330; P43351; Q8IW19; P55072; P49959; P39748; Q13426; P49916; Q92878; O95551; Q96FF9; P51587; P43246; Q9C0C2; P49917; O00213; Q92993; P09874; Q7Z2E3; Q14191; Q96RL1; Q6UWZ7; Q9NUW8; Q99828"]
["GO:0000724","biological_process","double-strand break repair via homologous recombination ","O60934; P38398; P16104; P54132; Q9Y3Z3; Q9UBU8; O43542; P27694; P49959; P39748; Q8IY92; Q9BQ15; P15927; Q06609; P49916; Q92878; Q9H1E3; Q99708; Q9UGP5; P51587; P23246; Q96AH0; P18887; P61088; P09874; O94762; Q14191; Q8WVD3; Q6PCD5; P25490; Q92698"]
["GO:0006303","biological_process","double-strand break repair via nonhomologous end joining ","O60934; P38398; P78527; P16104; Q12888; Q13315; P13010; Q15819; Q9NWV8; P12956; Q9NP87; Q9UMS4; P49959; P40692; Q5UIP0; Q53H47; Q13426; Q9H9Q4; P63165; Q92878; P62805; Q9UGP5; Q8N2W9; Q9H816; P49917; O96028; Q14676; Q92993; P18887; Q99728; P61088; Q96SD1; Q96RL1; Q6UWZ7; Q9Y2K7"]
["GO:0097193","biological_process","intrinsic apoptotic signaling pathway ","O60934; Q9H2X6; P52701; P01112; P04637; Q92934; P38936; O60936; O15304; O14727; Q07812; Q9NR28; O00571; P99999; Q93034; Q13794"]
["GO:0045190","biological_process","isotype switching ","O60934; P52701; Q9GZX7; Q9UH65; P40692; Q9NQT5; P43246; P49917"]
["GO:1904354","biological_process","negative regulation of telomere capping ","O60934; Q13315; Q15554; Q92878"]
["GO:0050885","biological_process","neuromuscular process controlling balance ","O60934; P00519; O43251; P11274; P78352; P43003; P07196; Q9ULB1; Q92886; O14773; P05067; Q6Y7W6; Q9Y566; Q14957"]
["GO:0033674","biological_process","positive regulation of kinase activity ","O60934; Q969S3; P49959; Q92878; P01730"]
["GO:0031954","biological_process","positive regulation of protein autophosphorylation ","O60934; P12931; Q9UL54; P0DP23; P49959; P50749; O75674; Q92878; Q9C0C2"]
["GO:0032206","biological_process","positive regulation of telomere maintenance ","O60934; P29590; P49959; Q92878; Q8N6T7; Q96QC0"]
["GO:0030174","biological_process","regulation of DNA-dependent DNA replication initiation ","O60934; Q7Z2Z1; Q9H211"]
["GO:0090737","biological_process","telomere maintenance via telomere trimming ","O60934; O43542"]
["GO:0031860","biological_process","telomeric ' overhang formation ","O60934; P49959; Q92878; Q9H816"]
["GO:0071225","biological_process","cellular response to muramyl dipeptide ","P08670; Q9Y2R2; O43353; Q92974; O95751"]
["GO:0045109","biological_process","intermediate filament organization ","P08670; P14136; P07196; Q04695; P35900; P17661; P15924"]
["GO:0070307","biological_process","lens fiber cell development ","P08670; Q8WU20; P28289"]
["GO:0030049","biological_process","muscle filament sliding ","P08670; P45379; P19429; Q8WZ42; Q9UKX2; P68133; P45378; O15273; P10916; P17661; P28289; Q14896; P09493; Q00872"]
["GO:0010977","biological_process","negative regulation of neuron projection development ","P08670; Q00987; Q86YV5; Q5S007; P14136; P52799; P54764; Q92769; P08138; Q14195; P09382; Q02790; Q9HBA0; P02649; Q6TCH7; O43306; Q14194; O95295; Q9H165; Q07954; Q93045; Q92574; P43146; P61266; Q684P5; Q99828"]
["GO:0032967","biological_process","positive regulation of collagen biosynthetic process ","P08670; P09619; P10242; Q92769; Q9BRS8; Q9HC52; P17301; P30044; P17813; Q9H4X1; P32121"]
["GO:0001658","biological_process","branching involved in ureteric bud morphogenesis ","P01106; P19544; Q13418; Q99502; Q13563; Q99966; Q02962; Q13485; P10415; Q12959; P09038; P31270; P10071; P48436"]
["GO:0006879","biological_process","cellular iron ion homeostasis ","P01106; P21399; P38606; Q9H1K1; P02786; Q13772; Q16665; Q13485; Q9UNQ0; P00441; P48200; P09601; P22004; Q16595; P00450"]
["GO:0051276","biological_process","chromosome organization ","P01106; Q9NZH5; P55040; Q53HL2; P49917; O95997; P25490"]
["GO:0006112","biological_process","energy reserve metabolic process ","P01106; P42345; P32245; O94808; P48357; Q06210"]
["GO:0044346","biological_process","fibroblast apoptotic process ","P01106; Q16611"]
["GO:0051782","biological_process","negative regulation of cell division ","P01106; Q9H3M7; P54132; Q9Y5N6"]
["GO:0032873","biological_process","negative regulation of stress-activated MAPK cascade ","P01106; Q08050; Q12778; Q96KB5; P09211"]
["GO:0015671","biological_process","oxygen transport ","P01106"]
["GO:0043280","biological_process","positive regulation of cysteine-type endopeptidase activity involved in apoptotic process ","P01106; P09429; P49407; Q99683; Q00613; Q92934; Q96EB6; O43521; O43464; Q99801; P58012; Q96P20; O95999; P53355; P05067; O00571; P01375; O14737; Q9P0J0; Q9ULZ3; P61586; Q13794"]
["GO:0002053","biological_process","positive regulation of mesenchymal cell proliferation ","P01106; P11362; P42224; P21802; Q9Y4H2; P04198; Q12946; P37173; P36894; Q9H3D4; P48436"]
["GO:0090096","biological_process","positive regulation of metanephric cap mesenchymal cell proliferation ","P01106"]
["GO:2001022","biological_process","positive regulation of response to DNA damage stimulus ","P01106; Q9NYF8; Q05655; Q99801; Q06787; P52926"]
["GO:0016579","biological_process","protein deubiquitination ","P01106; P25054; Q15796; P06493; P03372; Q15797; P38398; Q00987; Q01167; P85037; P25963; P60709; Q13546; Q9Y4A5; P51610; P84022; P04637; P10275; Q9Y6K9; O43318; P23771; P60484; O14818; Q12962; Q9UPU5; Q14145; Q9NWV8; P62979; Q15750; Q96RU2; Q9Y2K6; Q8NBZ0; Q12933; P17980; Q86T82; O95786; Q70CQ2; Q6P4R8; Q5D1E8; P0CG47; Q96P20; P54727; P62195; P55072; P61289; Q16665; Q9NQC7; Q13107; Q13485; Q9Y5T5; O00303; P06746; Q8TAA3; Q99460; Q13200; P30304; Q8IXI2; P54252; P54578; O15105; O94782; P15374; Q9HAW4; Q9Y4K3; O15151; Q13114; Q9UK80; Q93009; P36897; P20248; P25788; Q14694; O43303; P13569; Q9BYX4; P0C1Z6; P98177; Q12834; Q9UHP3; Q6GQQ9; Q96FW1; P43686; P61586; Q99728; P62987; Q13309; P07550; P60900; P40818; P32121; Q9Y4E8; Q96EZ8; P35998; Q96RL1; P25490; Q9Y265; O43255; O15294; O60260; Q6UWZ7; O00231; Q14457"]
["GO:0032986","biological_process","protein-DNA complex disassembly ","P01106"]
["GO:0032204","biological_process","regulation of telomere maintenance ","P01106; Q96Q15; P13010; Q15554; P02545; P48678; Q92900; Q9NYB0; Q9BY41; Q14103"]
["GO:0070848","biological_process","response to growth factor ","P01106; P29317; Q9P0N9; Q92908; P48023; P49427; Q9UBN7; Q16828; P48431; P35372"]
["GO:0006169","biological_process","adenosine salvage ","P55263"]
["GO:0044209","biological_process","AMP salvage ","P55263; P07741"]
["GO:0046835","biological_process","carbohydrate phosphorylation ","P55263; P19367"]
["GO:0006175","biological_process","dATP biosynthetic process ","P55263"]
["GO:0043101","biological_process","purine-containing compound salvage ","P55263; P27707; Q01433; P07741"]
["GO:0009156","biological_process","ribonucleoside monophosphate biosynthetic process ","P55263; P60891; P11908"]
["GO:0006527","biological_process","arginine catabolic process ","P35228; P29475; P29474"]
["GO:0045454","biological_process","cell redox homeostasis ","P35228; P29475; P29474; P48506; P09622; P30041; Q13423; P30044; Q16236; Q14494; Q96KS0; Q06830; Q96HE7; P07203; P35638; P30101; P30048; Q9H3N1; P32119; P27695; Q15084; P10599"]
["GO:0042742","biological_process","defense response to bacterium ","P35228; P29353; P43405; Q05655; Q7Z434; Q9GZX7; P20749; P61106; O15240; P19438; O15455; P17676; P16150; P82094; Q96RI1; Q9NPP4; P30273; P62820; O75179; O00206; O60602; P55895; P06702; Q02556; Q06330"]
["GO:0050829","biological_process","defense response to ram-negative bacterium ","P35228; Q96CV9; P05067; P06899; O00206; Q9UGM3; Q9ULZ3; P01730; Q9NRR4; O60814; P39019"]
["GO:0002227","biological_process","innate immune response in mucosa ","P35228; P62807; P06899; Q16778; O60814"]
["GO:0072604","biological_process","interleukin- secretion ","P35228"]
["GO:0072606","biological_process","interleukin-8 secretion ","P35228; P62820"]
["GO:0045776","biological_process","negative regulation of blood pressure ","P35228; P29475; P29474; P41146; P21554; P35462; P14416; Q07869"]
["GO:0007263","biological_process","nitric oxide mediated signal transduction ","P35228; P29475; P29474; P16671; P52945; Q02153; Q02108; P02649; P21462; P50052; Q9Y272; Q8NHW3; Q13562"]
["GO:0018119","biological_process","peptidyl-cysteine S-nitrosylation ","P35228; P29475"]
["GO:0031284","biological_process","positive regulation of guanylate cyclase activity ","P35228; P29475; P29474"]
["GO:0051712","biological_process","positive regulation of killing of cells of other organism ","P35228"]
["GO:0001912","biological_process","positive regulation of leukocyte mediated cytotoxicity ","P35228"]
["GO:0032310","biological_process","prostaglandin secretion ","P35228"]
["GO:0006625","biological_process","protein targeting to peroxisome ","P35228; O75874; P62979; P04040; P0CG47; P50542; P40855; P22307; P62987"]
["GO:1900015","biological_process","regulation of cytokine production involved in inflammatory response ","P35228; Q16539; O15534"]
["GO:0009617","biological_process","response to bacterium ","P35228; Q03135; P09327; O00401; Q8TEP8; Q76M96; P51674; Q9P2D1; O15297; P40259; P40692; P15090; Q9UQB8; P31994; P06737; Q6UY09; Q9UHR4; Q9Y2D0"]
["GO:0006801","biological_process","superoxide metabolic process ","P35228; P14598; Q86UR1; Q8TCU6; P13498; Q8NFA2; Q5TCZ1; A1X283; P00441; Q9NPH5; P04179; P19878"]
["GO:0072740","biological_process","cellular response to anisomycin ","O15264"]
["GO:1903936","biological_process","cellular response to sodium arsenite ","O15264; Q00613; Q5D1E8; Q9UER7; P09651"]
["GO:0032755","biological_process","positive regulation of interleukin-6 production ","O15264; O43353; P16671; Q9NUY8; O95786; P10809; P13498; Q92974; O15455; P30273; Q53H80; P01375; O00206; Q86XR7; Q9ULZ3; Q9H257"]
["GO:0060575","biological_process","intestinal epithelial cell differentiation ","Q13882; P43694; Q92908; Q9H4B6; Q99626"]
["GO:0045926","biological_process","negative regulation of growth ","Q13882; P04731; Q9BXH1; Q16665; Q8WYH8; Q8TCS8"]
["GO:0007260","biological_process","tyrosine phosphorylation of STAT protein ","Q13882; O60674; P16591; P52333"]
["GO:0007628","biological_process","adult walking behavior ","Q9H2X6; P54764; P48167; O43464; Q15768; Q9P2D1; P14416; O75553; P21728; P32121; P78508"]
["GO:0006978","biological_process","DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator ","Q9H2X6; O96017; P38398; P04637; Q08050; P38936; P15941; Q9H0Z9; Q9UK32; O15350; P51587; Q92993; Q71UM5; P23497; Q9H3D4"]
["GO:0019048","biological_process","modulation by virus of host morphology or physiology ","Q9H2X6; P19793; Q14118"]
["GO:0030514","biological_process","negative regulation of BMP signaling pathway ","Q9H2X6; P00519; Q03135; Q9UPN9; P35813; P50616; Q9Y2U8; O43541; O15105; P46531; P12755"]
["GO:2000059","biological_process","negative regulation of ubiquitin-dependent protein catabolic process ","Q9H2X6; P29590; P68400; P62913; O43765; P49768; P19784; Q9UMX1; Q8N726"]
["GO:0043388","biological_process","positive regulation of DNA binding ","Q9H2X6; P09429; O60674; P37231; Q13263; Q14469; O60869; Q8IZQ8; Q12948; Q99697; P17301; P15531; Q15306; P12755; Q8IXJ6; O60260; P10599"]
["GO:0030511","biological_process","positive regulation of transforming growth factor beta receptor signaling pathway ","Q9H2X6; Q15831; P08238; P49918; Q8IZQ8; Q03167; O00560; Q99966; Q13573; Q13485; P78536; O43294; P98082; Q99967; O00255"]
["GO:0050882","biological_process","voluntary musculoskeletal movement ","Q9H2X6; P42345; P78559; Q14643; P18887"]
["GO:0008340","biological_process","determination of adult lifespan ","P52701; Q5S007; Q92835; P04637; Q9BXH1; P28069; P43246; Q92698"]
["GO:0000710","biological_process","meiotic mismatch repair ","P52701"]
["GO:0006298","biological_process","mismatch repair ","P52701; P00519; Q9NSU2; Q15054; O15350; P12004; P27694; P40692; P15927; P18858; Q13569; P43246"]
["GO:0045910","biological_process","negative regulation of DNA recombination ","P52701; P54132; P43246"]
["GO:0051096","biological_process","positive regulation of helicase activity ","P52701; Q9Y3Y2; Q04837; P43246"]
["GO:0045830","biological_process","positive regulation of isotype switching ","P52701; Q12888; P02786; Q5UIP0; P13051; Q9NQT5"]
["GO:0016446","biological_process","somatic hypermutation of immunoglobulin genes ","P52701; Q9GZX7; Q9Y3Z3; Q9NP87; P40692; P06746; P13051; Q9UGP5; P43246"]
["GO:0016447","biological_process","somatic recombination of immunoglobulin gene segments ","P52701; P13051; P43246"]
["GO:1903599","biological_process","positive regulation of autophagy of mitochondrion ","Q96RR4; P42858; Q16665; Q99497; O60260"]
["GO:0045859","biological_process","regulation of protein kinase activity ","Q96RR4; P09769; Q9P212; O14745; Q8WZ42; P00441; Q9H8V3; Q9H2G4; Q92574; Q9ULH0"]
["GO:0071454","biological_process","cellular response to anoxia ","O00418"]
["GO:0031952","biological_process","regulation of protein autophosphorylation ","O00418; Q7L9L4"]
["GO:1990637","biological_process","response to prolactin ","O00418"]
["GO:0001711","biological_process","endodermal cell fate commitment ","Q6PD62; Q6P1J9; Q8WVC0"]
["GO:0033523","biological_process","histone HB ubiquitination ","Q6PD62; O75150; Q6P1J9; Q8WVC0; Q5VTR2"]
["GO:0080182","biological_process","histone H3-K4 trimethylation ","Q6PD62; P16403; P29374; Q03164; P10412; O15294"]
["GO:0010390","biological_process","histone monoubiquitination ","Q6PD62; O75150; Q96T88; Q9BTA9; Q6P1J9; Q8WVC0; Q5VTR2"]
["GO:0001826","biological_process","inner cell mass cell differentiation ","Q6PD62"]
["GO:0051571","biological_process","positive regulation of histone H3-K4 methylation ","Q6PD62; P10242; P38398; P18615; P35222; P26358; Q13573; Q13485; Q03164"]
["GO:2001162","biological_process","positive regulation of histone H3-K79 methylation ","Q6PD62"]
["GO:0001829","biological_process","trophectodermal cell differentiation ","Q6PD62; P11831; O75175; Q8TBY0; Q13895; Q02447; Q99626; P17275; O96004; Q9NZN8"]
["GO:0048854","biological_process","brain morphogenesis ","Q9Y243; P60484; O43524; P19022; Q9BXW9; Q02962; Q9BYB0; P49768; P31645"]
["GO:0000002","biological_process","mitochondrial genome maintenance ","Q9Y243; Q02078; P12235"]
["GO:1905653","biological_process","positive regulation of artery morphogenesis ","Q9Y243"]
["GO:0090050","biological_process","positive regulation of cell migration involved in sprouting angiogenesis ","Q9Y243; P00519; P35968; P04083; P35354; Q8WUI4; Q9NYY3; O00443; Q99759; Q14512; P09038; Q99958; P09601; P23769; Q9UKV0; Q99828"]
["GO:0007176","biological_process","regulation of epidermal growth factor-activated receptor activity ","P29353; P05067"]
["GO:0040008","biological_process","regulation of growth ","P29353; Q13177; Q14511; P67775; O14512; Q9UBU8; Q5VWQ8; Q15424; O14543; P17677; Q07817; Q9H0E9; Q9Y230; P30153; Q16206; Q92993; P52926; P29401; Q9ULC4; Q9Y265"]
["GO:0090322","biological_process","regulation of superoxide metabolic process ","P29353"]
["GO:1904885","biological_process","beta-catenin destruction complex assembly ","P25054; P49841; P48729; O15169"]
["GO:0070830","biological_process","bicellular tight junction assembly ","P25054; P11831; P41743; Q86UE4; Q8TEW0; Q16625; O43707; O15551; Q12959; Q9H8V3; O43815; Q9Y624; Q9NPB6"]
["GO:0000281","biological_process","mitotic cytokinesis ","P25054; P53350; P23528; Q53EZ4; P35580; P49450; Q14674; Q01082; Q9BXS6; Q9NQW6; O14578; Q9H0H5; O15392; Q9NQ86; Q9NQS7; O95235; Q9H8V3; P18583; Q12955; P62745; P51587; O95239; P20936; P40818; Q8WWK9; P16949; Q02241"]
["GO:0007026","biological_process","negative regulation of microtubule depolymerization ","P25054; Q7L7X3; Q92913; Q92974; Q9UBN7; O75122; Q93045; Q8WWK9; Q99828"]
["GO:1904781","biological_process","positive regulation of protein localization to centrosome ","P25054; Q96L34; P49841; Q9BV73; P37198; Q9NPB6"]
["GO:0031274","biological_process","positive regulation of pseudopodium assembly ","P25054; P10721; Q9H3Q1; P32248; P60953; Q00587; O14613"]
["GO:0051988","biological_process","regulation of attachment of spindle microtubules to kinetochore ","P25054; P51955; Q9H0H5; Q9H8V3; Q96R06; P60953"]
["GO:0032886","biological_process","regulation of microtubule-based process ","P25054; P04626; P49841; O75122; Q9UPN3; O60610"]
["GO:0009087","biological_process","methionine catabolic process ","Q00266"]
["GO:0032259","biological_process","methylation ","Q00266; Q9BTL3; O60869"]
["GO:0006730","biological_process","one-carbon metabolic process ","Q00266; O43865; Q14749"]
["GO:0006556","biological_process","S-adenosylmethionine biosynthetic process ","Q00266"]
["GO:0001887","biological_process","selenium compound metabolic process ","Q00266"]
["GO:0000096","biological_process","sulfur amino acid metabolic process ","Q00266"]
["GO:0090135","biological_process","actin filament branching ","P00519; Q9BR76; P60953"]
["GO:1990051","biological_process","activation of protein kinase C activity ","P00519"]
["GO:0046632","biological_process","alpha-beta T cell differentiation ","P00519; Q9UJU2; P04083; Q9C0K0"]
["GO:0001922","biological_process","B- B cell homeostasis ","P00519; Q16665; O14492"]
["GO:0002322","biological_process","B cell proliferation involved in immune response ","P00519"]
["GO:0072358","biological_process","cardiovascular system development ","P00519; P51787"]
["GO:0021587","biological_process","cerebellum morphogenesis ","P00519; O75581; P18887"]
["GO:0048668","biological_process","collateral sprouting ","P00519; P23560; O14640; O60315; Q9UBN7"]
["GO:0045184","biological_process","establishment of protein localization ","P00519; Q00987; P53350; P78352; Q53EZ4; P35241; P55072; P17301; Q86SQ0; P58400; Q15058; Q9ULV4; Q12955; P21333; Q5JQC9; Q969T9; Q8N2Q7; Q86YF9"]
["GO:0030035","biological_process","microspike assembly ","P00519; Q16658; O43312"]
["GO:0051882","biological_process","mitochondrial depolarization ","P00519; Q9UII2; Q8N726"]
["GO:0043124","biological_process","negative regulation of I-kappaB kinase/NF-kappaB signaling ","P00519; P03372; P42224; Q13546; P35398; P35813; Q96CV9; Q96EB6; Q5D1E8; Q96RI1; Q5VWQ8; Q13547; P09211; Q14790; Q14694; O75688; Q15669; Q6GQQ9; O15534; Q9ULZ3; P61586; Q04724"]
["GO:1900272","biological_process","negative regulation of long-term synaptic potentiation ","P00519; P54764; Q9ULJ8; P04156; P02649; P05067; Q15109"]
["GO:1900275","biological_process","negative regulation of phospholipase C activity ","P00519"]
["GO:0051444","biological_process","negative regulation of ubiquitin-protein transferase activity ","P00519; P53667; Q99497; O15105; P49768; Q8N726"]
["GO:0001843","biological_process","neural tube closure ","P00519; P10276; O14497; P07737; P50552; P22694; Q9NYQ6; O60315; Q6UB35; Q14160; O14727; Q15468; Q02962; Q96Q89; Q96QB1; O75386; Q8IZ21; Q9ULK5; O95999; O14641; Q9Y4K3; O75581; P49815; Q9NRY4; P31431; Q9UMX1; P11233; Q92574; P13631; P12755; Q15672; P42898"]
["GO:0060563","biological_process","neuroepithelial cell differentiation ","P00519; P19022"]
["GO:0038189","biological_process","neuropilin signaling pathway ","P00519; P60953"]
["GO:1905555","biological_process","positive regulation blood vessel branching ","P00519; Q8N6T7"]
["GO:1904531","biological_process","positive regulation of actin filament binding ","P00519"]
["GO:0007204","biological_process","positive regulation of cytosolic calcium ion concentration ","P00519; P09429; P03372; O60674; Q9P212; Q14289; P16234; P17302; P42684; P78352; Q14344; P16671; Q03431; Q9Y210; P30411; P61073; P51681; Q9HBA0; P32248; P48736; P43220; P41597; Q9UH65; P21462; Q14573; Q13936; O75581; P05067; P35368; Q8TD43; P21730; Q9UBU3; P98161; P21731; P30556; P23769; P35372"]
["GO:0051894","biological_process","positive regulation of focal adhesion assembly ","P00519; P35968; O95819; P84022; P63000; Q13464; Q02763; Q12913; P46940; P31431; O14713; Q92574"]
["GO:1902715","biological_process","positive regulation of interferon-gamma secretion ","P00519; Q9Y2R2; O95267"]
["GO:1900042","biological_process","positive regulation of interleukin- secretion ","P00519; Q01082"]
["GO:1904528","biological_process","positive regulation of microtubule binding ","P00519; P62714; P67775; Q00613"]
["GO:0051353","biological_process","positive regulation of oxidoreductase activity ","P00519; P42684; Q9Y572; Q04656"]
["GO:1900026","biological_process","positive regulation of substrate adhesion-dependent cell spreading ","P00519; P63000; Q14511; P46109; P02671; P46108; Q8TCU6; Q08495; P50570; Q14155; Q92819; Q9H2D6; P21333; Q5VZK9; Q14185; P60953; Q07021; Q7Z628; Q99828"]
["GO:2000096","biological_process","positive regulation of Wnt signaling pathway, planar cell polarity pathway ","P00519; P98082"]
["GO:0009791","biological_process","post-embryonic development ","P00519; Q15796; P21802; P21399; O15357; P42345; P23771; Q9NRP7; P18507; Q13705; Q16559; O75626; P51649; Q8WUF5; P10415; P11717; P49768; P43354; Q14643; Q9BRQ0; P36897; P10916; P48200; Q05940; P51608; Q6Y7W6; Q03164; Q9UPG8; Q9UKV8; Q5T011"]
["GO:2000249","biological_process","regulation of actin cytoskeleton reorganization ","P00519; Q14289; P16234; P07333; P42684; O43293; P52565; P52566; O94759; Q9Y624; O95398"]
["GO:0030516","biological_process","regulation of axon extension ","P00519; P49841; P50570; P02649; O75122; Q8NI36; Q14247; Q16555"]
["GO:0032489","biological_process","regulation of Cdc protein signal transduction ","P00519; P02649; O95477"]
["GO:1903053","biological_process","regulation of extracellular matrix organization ","P00519"]
["GO:1905244","biological_process","regulation of modification of synaptic structure ","P00519; P54764; Q4V328"]
["GO:0045580","biological_process","regulation of T cell differentiation ","P00519; Q9BXL7; Q86U44; Q9UL17"]
["GO:0042770","biological_process","signal transduction in response to DNA damage ","P00519; O96017; Q16539; P55211; P62993; P24522; P55957"]
["GO:0048536","biological_process","spleen development ","P00519; Q00653; Q16512; P78527; Q13158; O43521; P20749; Q9UBC0; Q9HBU1; Q99697; P10415; P06746; P78536; P52952; Q99967; Q5TC82; Q9Y572; Q03164"]
["GO:0002333","biological_process","transitional one stage B cell differentiation ","P00519"]
["GO:0006903","biological_process","vesicle targeting ","Q12851; O00161; O75122"]
["GO:1990830","biological_process","cellular response to leukemia inhibitory factor ","Q01813; Q9NYF8; P29590; P10244; P16220; Q13887; Q96EB6; P13010; Q9Y4C1; P52789; P02786; P32929; P12036; P26367; Q14240; P56545; O14543; P19338; Q5UIP0; O00482; O94808; O15105; Q8IWB6; O43474; Q9Y483; P17861; Q9BUL8; Q86Y01; O43148; P13631; Q00839; O43597; Q8WVD3"]
["GO:0090400","biological_process","stress-induced premature senescence ","Q8IW41; Q16539; P38936; Q96EB6"]
["GO:0044257","biological_process","cellular protein catabolic process ","O96017; Q13546; O43464; A2RUS2; Q5VWQ8; P43356; O43255; O60260"]
["GO:1903926","biological_process","cellular response to bisphenol A ","O96017"]
["GO:0090307","biological_process","mitotic spindle assembly ","O96017; P10244; Q08379; P51955; Q9ULW0; Q8TEP8; O15392; P62491; Q9BW19; Q49MG5; P21333; O00139; Q12834; P61586; P52732"]
["GO:2000002","biological_process","negative regulation of DNA damage checkpoint ","O96017; Q96FV9; Q13769; O60885"]
["GO:2000210","biological_process","positive regulation of anoikis ","O96017; P57059; Q9BQG0; Q9Y3E5; P05813; Q9HCU9"]
["GO:0042176","biological_process","regulation of protein catabolic process ","O96017; Q00987; O14964; P09958; Q96PU5; O00327; Q99460; Q13200; Q9UNN5; Q96H20; P11926; O14980"]
["GO:0001302","biological_process","replicative cell aging ","O96017; Q14191; Q9H3D4"]
["GO:0090399","biological_process","replicative senescence ","O96017; P04637; Q13535; Q13315; P38936; O14757; O14746; P08473; P42771"]
["GO:1903416","biological_process","response to glycoside ","O96017; P05023"]
["GO:0072428","biological_process","signal transduction involved in intra-S DNA damage checkpoint ","O96017"]
["GO:0075713","biological_process","establishment of integrated proviral latency ","O75475; P17096; P13010; P12956; Q13426; P49917; O75531"]
["GO:0000395","biological_process","mRNA '-splice site recognition ","O75475; Q07955"]
["GO:0051169","biological_process","nuclear transport ","O75475; P17096; P28069; O75531"]
["GO:0035802","biological_process","adrenal cortex formation ","P19544; Q99967"]
["GO:0043010","biological_process","camera-type eye development ","P19544; O75030; P19793; P55347; Q02962; Q12948; Q99697; Q13936; Q9ULV5; Q99958; P43320; P13349; Q9NRY4; P12755; Q15293"]
["GO:0060923","biological_process","cardiac muscle cell fate commitment ","P19544; Q04771; O15119"]
["GO:0071371","biological_process","cellular response to gonadotropin stimulus ","P19544; Q92908; Q6X4W1"]
["GO:0030855","biological_process","epithelial cell differentiation ","P19544; P06493; P21802; P37231; P00558; P78545; P31942; P09327; O75631; Q02535; Q9HBU1; P12004; P50416; P56178; P55212; O00482; O14773; P17931; O43294; P30427; O43598; Q9UGM3; Q01995; P37802; P21796; P16152; Q15417"]
["GO:0032836","biological_process","glomerular basement membrane development ","P19544; P14543; O60500; Q01955"]
["GO:0072112","biological_process","glomerular visceral epithelial cell differentiation ","P19544; O43490; Q99958"]
["GO:0032835","biological_process","glomerulus development ","P19544; Q9P212; P10415; Q9ULK5; Q9GZV5"]
["GO:0008406","biological_process","gonad development ","P19544; P23945"]
["GO:0060231","biological_process","mesenchymal to epithelial transition ","P19544; P23771; Q99966; Q02962"]
["GO:0072207","biological_process","metanephric epithelium development ","P19544; Q02962"]
["GO:0072075","biological_process","metanephric mesenchyme development ","P19544; P09619; Q13563; Q02962"]
["GO:0072284","biological_process","metanephric S-shaped body morphogenesis ","P19544; P09619; Q13563"]
["GO:2000195","biological_process","negative regulation of female gonad development ","P19544; Q13285"]
["GO:0072302","biological_process","negative regulation of metanephric glomerular mesangial cell proliferation ","P19544"]
["GO:0017148","biological_process","negative regulation of translation ","P19544; Q9NZJ5; P06730; O43293; P19525; Q6PKG0; P41220; P51114; O75175; Q9NRA8; Q9NZI8; P04818; P78543; Q12906; P38919; O60506; P23396; P50616; P19338; Q8WY41; Q9BWF3; P53355; P63244; O00571; Q9Y6M1; P40429; P04406; Q8NE35; Q6Y7W6; Q9NZN8; Q92574; Q14451; P07814; P31483"]
["GO:2000020","biological_process","positive regulation of male gonad development ","P19544; Q13285; Q99967; P48436"]
["GO:2001076","biological_process","positive regulation of metanephric ureteric bud development ","P19544"]
["GO:0072166","biological_process","posterior mesonephric tubule development ","P19544"]
["GO:0003156","biological_process","regulation of animal organ formation ","P19544; Q99967"]
["GO:0008380","biological_process","RNA splicing ","P19544; Q9NYV4; Q13148; P78362; Q96ST2; Q9Y2W1; O43251; Q13523; P08621; P67775; Q96SB4; Q15427; Q9NUU7; P07910; P31942; Q9UKV3; P62316; Q14684; Q9UBK2; Q9NR56; Q8IYB3; Q08170; Q14498; O60936; Q96J01; Q9H0Z9; Q99590; O95218; P14678; P38919; O60506; Q8N2M8; Q01130; Q01081; Q8TBF4; Q96FV9; Q9UMR2; Q8IX01; Q8NI27; Q9UHL0; Q06787; Q05519; O43395; Q14562; Q9BWF3; Q7KZ85; P18583; P17931; Q96E39; Q8N163; O43379; Q96SB3; P98175; Q96PU8; P26599; Q15287; Q13435; Q12972; O00566; P23246; P30153; Q9UNY4; Q6P2Q9; Q13769; Q92945; Q15029; Q5JVS0; Q07021; O95905; P52298; Q14966; Q9H0S4; Q9HB90; Q9NUK0; Q09161; Q8WXA9"]
["GO:0007530","biological_process","sex determination ","P19544; Q13285; Q99967"]
["GO:0007356","biological_process","thorax and anterior abdomen determination ","P19544; Q92886"]
["GO:0009888","biological_process","tissue development ","P19544; Q9HBU1; O00482; Q13285; O95983"]
["GO:0001657","biological_process","ureteric bud development ","P19544; Q15796; P10276; P11362; P07949; P21802; P84022; P04040; O15198; Q12948; O43541; O15105; Q99958; P18827; P31431; O95390"]
["GO:0061032","biological_process","visceral serous pericardium development ","P19544; P61296"]
["GO:0035909","biological_process","aorta morphogenesis ","P09619; Q99502; Q9P2D1; Q07954"]
["GO:0055003","biological_process","cardiac myofibril assembly ","P09619; P16234; P11831; Q8WZ42; P50461; O15273; P10916"]
["GO:0060981","biological_process","cell migration involved in coronary angiogenesis ","P09619"]
["GO:0035441","biological_process","cell migration involved in vasculogenesis ","P09619"]
["GO:0006024","biological_process","glycosaminoglycan biosynthetic process ","P09619; P18827; O60701; P34741; P31431; O75056"]
["GO:0060437","biological_process","lung growth ","P09619; O43597"]
["GO:0072278","biological_process","metanephric comma-shaped body morphogenesis ","P09619"]
["GO:0072277","biological_process","metanephric glomerular capillary formation ","P09619; P16234"]
["GO:0072262","biological_process","metanephric glomerular mesangial cell proliferation involved in metanephros development ","P09619"]
["GO:0035789","biological_process","metanephric mesenchymal cell migration ","P09619"]
["GO:0046488","biological_process","phosphatidylinositol metabolic process ","P09619; P07333; Q9NQ66; O43426; P08567; Q9BRC7"]
["GO:0090280","biological_process","positive regulation of calcium ion import ","P09619; P41180; P17931; Q8NET8; Q9Y5S1"]
["GO:0038091","biological_process","positive regulation of cell proliferation by VEF-activated platelet derived growth factor receptor signaling pathway ","P09619; P16234"]
["GO:0050921","biological_process","positive regulation of chemotaxis ","P09619; Q9H244"]
["GO:2000491","biological_process","positive regulation of hepatic stellate cell activation ","P09619; P10242; Q15418"]
["GO:0035793","biological_process","positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway ","P09619"]
["GO:0032516","biological_process","positive regulation of phosphoprotein phosphatase activity ","P09619; O60674; P42345; P08238; P0DP23; P50052; Q86UL8"]
["GO:2000379","biological_process","positive regulation of reactive oxygen species metabolic process ","P09619; Q13546; P04637; Q16539; P38936; Q96PH1; P62993; Q5D1E8; Q9H4P4; P47989; Q16236; P37173; P24522; Q9NPH5; Q9Y572; P30556"]
["GO:0035025","biological_process","positive regulation of Rho protein signal transduction ","P09619; Q86YV5; P49407; P63000; Q12802; Q9Y6N7"]
["GO:0014911","biological_process","positive regulation of smooth muscle cell migration ","P09619; P23443; P12931; P56524; P04004; P46108; P10415; P17301; Q92819; P98177; Q9NPH5"]
["GO:0032526","biological_process","response to retinoic acid ","P09619; P10276; P37231; P19793; P17302; P36956; P50553; P28562; P11717; O95361; P35590; P22004; P49760; P13631; P23497; P55273"]
["GO:0071670","biological_process","smooth muscle cell chemotaxis ","P09619"]
["GO:0032785","biological_process","negative regulation of DNA-templated transcription, elongation ","O00267"]
["GO:0032786","biological_process","positive regulation of DNA-templated transcription, elongation ","O00267; P05114; Q9Y5B9; Q96FV9; Q03468; Q9HB65; Q13769; P55199; Q86V81"]
["GO:0060561","biological_process","apoptotic process involved in morphogenesis ","P02511; Q9UJU2; Q14160; P30154"]
["GO:0031109","biological_process","microtubule polymerization or depolymerization ","P02511"]
["GO:0010259","biological_process","multicellular organism aging ","P02511; P07101; Q13285; Q14191; Q9H3D4"]
["GO:0006936","biological_process","muscle contraction ","P02511; Q9Y490; P19105; Q05682; P17302; P49023; Q9NYL9; P35749; P23327; Q9BX66; Q8WZ42; Q9NS61; Q07001; Q9GZV1; O00168; O60504; P18206; P0DP23; Q9UKX2; Q15746; P32418; P18084; P54296; Q14500; Q9Y3Q4; P63267; P68133; Q16635; P46939; O95180; Q13424; Q01449; P17661; P07510; P28289; P24844; Q15722; P50402; P36383; O14950; P21817; P09493; Q9UKX3; Q13698; Q9UMR3"]
["GO:1905907","biological_process","negative regulation of amyloid fibril formation ","P02511; P01130"]
["GO:0032387","biological_process","negative regulation of intracellular transport ","P02511; P46821"]
["GO:0032463","biological_process","negative regulation of protein homooligomerization ","P02511; P12931; P13473; O95471; Q9H165"]
["GO:0006457","biological_process","protein folding ","P02511; Q9Y2I7; P08238; Q16543; P30405; O95816; P49792; P11488; Q9UDY4; O95817; Q96KC8; Q13724; P38646; Q9UKV5; P50502; Q13371; Q02790; P19086; P04899; O75916; P54727; P55072; Q9NYA1; P18850; P27824; Q96HE7; P11142; P78371; P30040; Q9Y230; P49802; Q9UNP9; Q15813; P30101; O95302; Q99471; Q9H3N1; Q15084; Q9Y266; Q04323"]
["GO:0010941","biological_process","regulation of cell death ","P02511; P17535; P46695; P17275; P29692; Q9UK53"]
["GO:0007021","biological_process","tubulin complex assembly ","P02511"]
["GO:0032924","biological_process","activin receptor signaling pathway ","Q15796; Q04771; P84022; Q13705; P08476; P36897; P36896"]
["GO:0007182","biological_process","common-partner SMAD protein phosphorylation ","Q15796; P29590; Q01082; P37173"]
["GO:0048701","biological_process","embryonic cranial skeleton morphogenesis ","Q15796; P21802; P16234; P84022; P38919; P37173; P36897; Q13950; P05549; Q15672; P50281"]
["GO:0048617","biological_process","embryonic foregut morphogenesis ","Q15796; P84022; P43694; Q13705; Q12946"]
["GO:0001706","biological_process","endoderm formation ","Q15796; P28562; Q16690; Q9UMR3"]
["GO:0007369","biological_process","gastrulation ","Q15796; P09622; P54198; P37173; P63244"]
["GO:0030073","biological_process","insulin secretion ","Q15796; P04083; Q13555; Q13705; P52945; O15240; P20823; O14810; Q99497; P32245; Q9Y4I1; Q8NHW3; O00186; Q13562"]
["GO:0038092","biological_process","nodal signaling pathway ","Q15796; P84022; P36896"]
["GO:0031016","biological_process","pancreas development ","Q15796; Q14469; Q13705; P20823; Q12946; Q9NQB0; Q03014; O95390"]
["GO:0048340","biological_process","paraxial mesoderm morphogenesis ","Q15796; P84022"]
["GO:0060039","biological_process","pericardium development ","Q15796; P84022; Q9BSQ5"]
["GO:0010718","biological_process","positive regulation of epithelial to mesenchymal transition ","Q15796; Q9UJU2; P84022; P42345; P35222; Q15910; Q92769; O00560; Q12948; Q13485; P37173; O43294; P36897; P98082; Q9H4X1; Q13009; Q9Y2T1; P46531; O95863; Q9GZV5; Q15672"]
["GO:1900224","biological_process","positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry ","Q15796"]
["GO:0031053","biological_process","primary miRNA processing ","Q15796; Q15797; P84022; Q9BXP5; P22626; Q86U44; Q8WYQ5; Q9NRR4; Q09161"]
["GO:0051098","biological_process","regulation of binding ","Q15796; P84022; Q13485"]
["GO:0017015","biological_process","regulation of transforming growth factor beta receptor signaling pathway ","Q15796; P84022; Q9UPN9; P37275; Q13485; O15105; P17813"]
["GO:0070723","biological_process","response to cholesterol ","Q15796; P51681; P37173; P36897"]
["GO:0062009","biological_process","secondary palate development ","Q15796; Q9UJU2; Q03167; Q9P2D1; Q13485; P37173"]
["GO:0023019","biological_process","signal transduction involved in regulation of gene expression ","Q15796; P41235; P84022; P26367; P35548; P09874; Q13562"]
["GO:0007183","biological_process","SMAD protein complex assembly ","Q15796; Q15797; P84022; Q13485"]
["GO:0007352","biological_process","zygotic specification of dorsal/ventral axis ","Q15796; O43541"]
["GO:0007256","biological_process","activation of JNKK activity ","Q12852; Q9UKE5; Q03468"]
["GO:2000772","biological_process","regulation of cellular senescence ","O60285; Q9HC98; O00327; P36894; O76021; Q9NRM2; Q8TCS8"]
["GO:0035507","biological_process","regulation of myosin-light-chain-phosphatase activity ","O60285; O14974"]
["GO:1902017","biological_process","regulation of cilium assembly ","Q00532; O76039; Q9H1Y0; Q9NQC7; Q5BJF6; Q8N137; Q8TD08; Q9NT62"]
["GO:0070935","biological_process","'-UTR-mediated mRNA stabilization ","P49137; Q13148; Q16539; Q15717; P07910; Q92904; P16989; Q9H0Z9; P98175; P58753; Q13151; P26651"]
["GO:0006691","biological_process","leukotriene metabolic process ","P49137; P09917; Q16873; P33527"]
["GO:0044351","biological_process","macropinocytosis ","P49137; Q16644; P50570; Q5VZK9; Q9ULZ3"]
["GO:0032675","biological_process","regulation of interleukin- production ","P49137; P01889; Q8N4X5"]
["GO:0032680","biological_process","regulation of tumor necrosis factor production ","P49137; Q9NUY8; P26651"]
["GO:0051754","biological_process","meiotic sister chromatid cohesion, centromeric ","O60566; O43683; Q562F6; P30153"]
["GO:0007091","biological_process","metaphase/anaphase transition of mitotic cell cycle ","O60566; Q9Y6A5; Q9UJX2; P30260"]
["GO:0034501","biological_process","protein localization to kinetochore ","O60566; P06493; Q96GD4; P33981; Q96JM3; O43264; Q8NG31"]
["GO:0043277","biological_process","apoptotic cell clearance ","P10276; P09429; P21980; Q06418; P05106; P30530; Q12866; P16671; Q13133; Q07954; Q15084"]
["GO:0071391","biological_process","cellular response to estrogen stimulus ","P10276; P03372; Q00987; O15164; Q8IZL8; Q969T9"]
["GO:0060591","biological_process","chondroblast differentiation ","P10276; P09038"]
["GO:0031076","biological_process","embryonic camera-type eye development ","P10276; P48681; Q8WUF5; O75386; Q99697; P13631"]
["GO:0002068","biological_process","glandular epithelial cell development ","P10276; P13631"]
["GO:0003417","biological_process","growth plate cartilage development ","P10276"]
["GO:0061037","biological_process","negative regulation of cartilage development ","P10276"]
["GO:0030853","biological_process","negative regulation of granulocyte differentiation ","P10276; Q01196; P13688"]
["GO:0032689","biological_process","negative regulation of interferon-gamma production ","P10276; P09429; P30530; P23771; Q8TDQ0; P04156; Q9BZS1; O00206; Q07021"]
["GO:0045947","biological_process","negative regulation of translational initiation ","P10276; Q9P2K8; Q13541; Q13542; Q06787; P12270; Q9BWF3; Q9UKV8"]
["GO:0032720","biological_process","negative regulation of tumor necrosis factor production ","P10276; P30530; Q9Y2R2; Q00613; P36544; P28906; Q8TDQ0; Q5D1E8; P09211; Q9BZS1; O00206; Q13291; O43823; P32121; Q15672"]
["GO:0051099","biological_process","positive regulation of binding ","P10276"]
["GO:0032736","biological_process","positive regulation of interleukin-1 production ","P10276; Q96P20"]
["GO:0032754","biological_process","positive regulation of interleukin- production ","P10276; Q08499; Q96P20"]
["GO:0030850","biological_process","prostate gland development ","P10276; P10275; P04083; P08151; Q02790; P10071; P48436"]
["GO:0048384","biological_process","retinoic acid receptor signaling pathway ","P10276; P29590; P19793; O43707; Q13573; P55055; P13631; Q03060; P23497"]
["GO:0060010","biological_process","Sertoli cell fate commitment ","P10276"]
["GO:0060534","biological_process","trachea cartilage development ","P10276; P11831; P13631; P48436"]
["GO:0030261","biological_process","chromosome condensation ","P06493; P52926"]
["GO:1905448","biological_process","positive regulation of mitochondrial ATP synthesis coupled electron transport ","P06493; P14635"]
["GO:0033160","biological_process","positive regulation of protein import into nucleus, translocation ","P06493; O60674; P28482; Q5S007; P08238; Q7Z434; O95071; P49768; Q86WV6; Q15648"]
["GO:0007344","biological_process","pronuclear fusion ","P06493"]
["GO:0045995","biological_process","regulation of embryonic development ","P06493; P06213; P61106; Q6KC79; Q14669; P46379; Q9H0H5; Q16236; Q13569"]
["GO:0051445","biological_process","regulation of meiotic cell cycle ","P06493; Q86U44"]
["GO:0014038","biological_process","regulation of Schwann cell differentiation ","P06493"]
["GO:0014075","biological_process","response to amine ","P06493; P27708; Q7LG56; P17301"]
["GO:0046686","biological_process","response to cadmium ion ","P06493; P10721; P48506; O14746; P04040; P46527; P12004; P04156"]
["GO:0046688","biological_process","response to copper ion ","P06493; Q16613; P00441; P19021"]
["GO:0055015","biological_process","ventricular cardiac muscle cell development ","P06493; P14635; Q9H1Y0; Q99697; P02545; P52952; P48678; Q14192"]
["GO:0002218","biological_process","activation of innate immune response ","Q96ST3; P09429; P78527; Q7Z434; P13010; P12956; O94992; Q9NPP4; O60828; Q96PK6; Q8WXF1; P43243; Q86WV6; Q8N884; P23246; Q9ULZ3; Q16666"]
["GO:0016575","biological_process","histone deacetylation ","Q96ST3; Q9UQL6; P56524; Q9H7L9; Q92769; Q96EB6; Q9UBU8; Q13547; Q96PK6; Q9UIF9; Q9UBN7; P35232; Q9BZK7; Q8IXJ6; Q9UKV0; Q9HCU9"]
["GO:0042754","biological_process","negative regulation of circadian rhythm ","Q96ST3; Q49AN0; O15055; Q16526; P23246"]
["GO:1901675","biological_process","negative regulation of histone H3-K2 acetylation ","Q96ST3"]
["GO:1900181","biological_process","negative regulation of protein localization to nucleus ","Q96ST3; P49841; O15075; Q9UKT5; Q14134; P05067; Q6GQQ9"]
["GO:0031937","biological_process","positive regulation of chromatin silencing ","Q96ST3; Q96EB6"]
["GO:0002230","biological_process","positive regulation of defense response to virus by host ","Q96ST3; P42224; P29590; Q9P2K8; Q9HC16; Q7Z434; O43734; O95786; Q5D1E8; O60828; Q86WV6; Q8N884"]
["GO:0006476","biological_process","protein deacetylation ","Q96ST3; Q9UQL6; P56524; Q96EB6; Q13547; Q9NTG7; Q9UBN7; O15379; Q8IXJ6"]
["GO:0010817","biological_process","regulation of hormone levels ","Q96ST3"]
["GO:0043619","biological_process","regulation of transcription from RNA polymerase II promoter in response to oxidative stress ","Q96ST3; P27540; Q9GZV1; Q16665; Q99814; P09601"]
["GO:0051595","biological_process","response to methylglyoxal ","Q96ST3"]
["GO:0060117","biological_process","auditory receptor cell development ","P11362"]
["GO:0060445","biological_process","branching involved in salivary gland morphogenesis ","P11362; P21980; P21802; Q14118"]
["GO:0048469","biological_process","cell maturation ","P11362; P49715; P37231; Q06187; P30530; P23771; Q14469; Q03431; Q99814; P50553; Q02363; Q13950; P23769; O95390"]
["GO:0043009","biological_process","chordate embryonic development ","P11362; P38398; Q71F23"]
["GO:0030326","biological_process","embryonic limb morphogenesis ","P11362; Q9UJU2; Q9NR56; P56178; P49768; P31270; P40425; P12755; P31260"]
["GO:0035607","biological_process","fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development ","P11362; P21802"]
["GO:0060484","biological_process","lung-associated mesenchyme development ","P11362; P21802"]
["GO:0048762","biological_process","mesenchymal cell differentiation ","P11362; P21802; P36897; Q9GZV5; P52926"]
["GO:0030901","biological_process","midbrain development ","P11362; P21802; Q14469; Q16559; P19622; O15198; Q8TDM6; O14813"]
["GO:0042474","biological_process","middle ear morphogenesis ","P11362; Q99502"]
["GO:0090272","biological_process","negative regulation of fibroblast growth factor production ","P11362; Q9H4X1"]
["GO:0001759","biological_process","organ induction ","P11362; Q8WU20; P31270"]
["GO:2000546","biological_process","positive regulation of endothelial cell chemotaxis to fibroblast growth factor ","P11362; P09038"]
["GO:0090080","biological_process","positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway ","P11362; Q9GZV9"]
["GO:1903465","biological_process","positive regulation of mitotic cell cycle DNA replication ","P11362"]
["GO:2000830","biological_process","positive regulation of parathyroid hormone secretion ","P11362"]
["GO:0060665","biological_process","regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling ","P11362"]
["GO:2001239","biological_process","regulation of extrinsic apoptotic signaling pathway in absence of ligand ","P11362"]
["GO:0048378","biological_process","regulation of lateral mesodermal cell fate specification ","P11362; P36894"]
["GO:0001501","biological_process","skeletal system development ","P11362; Q9NZJ5; P22607; P29317; P51812; P56524; Q504Y2; Q7Z5J4; Q03431; P02765; P17342; P12272; Q13428; Q9P2D1; Q13118; P56178; P10070; P50749; P11473; A1X283; O94782; Q06830; Q8IUX7; P78337; P31270; P36897; Q15561; P15036; O15119; P22004; Q9UMX1; O15266; Q9H3D4; P48436; P31260; O95390"]
["GO:0048705","biological_process","skeletal system morphogenesis ","P11362; P21802; Q13705; A1X283; P49768; P36897; Q9NZC7"]
["GO:0021847","biological_process","ventricular zone neuroblast division ","P11362; P21802"]
["GO:0070640","biological_process","vitamin D3 metabolic process ","P11362"]
["GO:0006309","biological_process","apoptotic DNA fragmentation ","P09429; P52294; P58012; P42574"]
["GO:0002407","biological_process","dendritic cell chemotaxis ","P09429; P61073; P51681; P32248; P48736; P41597; Q8TD43; O94759"]
["GO:0032392","biological_process","DNA geometric change ","P09429"]
["GO:0051103","biological_process","DNA ligation involved in DNA repair ","P09429; Q13426; P49917; P09874"]
["GO:0006310","biological_process","DNA recombination ","P09429; Q9NSU2; P13010; P54132; Q8NBZ0; O43542; Q13156; Q6P4R8; P43351; P12956; Q9BTK6; Q9NP87; P27694; Q96PK6; P49959; Q8IYB8; Q06609; Q13426; P18858; Q14686; Q92878; P0C1Z6; Q15631; Q9Y230; P27695; Q96EZ8; Q06330; Q9Y265; Q92698"]
["GO:0006265","biological_process","DNA topological change ","P09429; P19447; P11387; Q02880; P11388"]
["GO:0002437","biological_process","inflammatory response to antigenic stimulus ","P09429; Q8ND90; P01589; P46531; O95267; Q06330"]
["GO:0001773","biological_process","myeloid dendritic cell activation ","P09429; Q9ULZ3"]
["GO:2000426","biological_process","negative regulation of apoptotic cell clearance ","P09429; Q8TDQ1"]
["GO:0017055","biological_process","negative regulation of RNA polymerase II transcriptional preinitiation complex assembly ","P09429; P10827"]
["GO:0097350","biological_process","neutrophil clearance ","P09429; P30530; Q12866; P04083; P41597"]
["GO:0042104","biological_process","positive regulation of activated T cell proliferation ","P09429; Q13158; Q96BF3; P23396; P01589; Q9ULZ3; P51692; Q15109"]
["GO:2001200","biological_process","positive regulation of dendritic cell differentiation ","P09429; Q15109"]
["GO:0051106","biological_process","positive regulation of DNA ligation ","P09429; Q8IW19; Q06609"]
["GO:0032733","biological_process","positive regulation of interleukin-1 production ","P09429; P10809; P28906; P30273; P10747; P15529; O00206; O75995"]
["GO:0032735","biological_process","positive regulation of interleukin-1 production ","P09429; O43353; P16671; Q9NQ66; P10809; O15455; P32248; Q13568; O00206; Q02556; P25942; P58753; Q15109"]
["GO:0050716","biological_process","positive regulation of interleukin- secretion ","P09429; Q96RD6"]
["GO:0032425","biological_process","positive regulation of mismatch repair ","P09429; P05129"]
["GO:0090026","biological_process","positive regulation of monocyte chemotaxis ","P09429; P41597; P05067; Q99538"]
["GO:0034165","biological_process","positive regulation of toll-like receptor 9 signaling pathway ","P09429"]
["GO:0032072","biological_process","regulation of restriction endodeoxyribonuclease activity ","P09429"]
["GO:0002840","biological_process","regulation of T cell mediated immune response to tumor cell ","P09429"]
["GO:0002643","biological_process","regulation of tolerance induction ","P09429"]
["GO:0035711","biological_process","T-helper  cell activation ","P09429; P17676"]
["GO:0045063","biological_process","T-helper 1 cell differentiation ","P09429; Q9UJU2; Q01201"]
["GO:1990774","biological_process","tumor necrosis factor secretion ","P09429"]
["GO:0033151","biological_process","V(D)J recombination ","P09429; P49917; P55895; Q96SD1"]
["GO:0006270","biological_process","DNA replication initiation ","O00311; P24864; P49736; P25205; Q99741; P33992; Q13156; Q13416; P49427; Q13415; O43929; P33993; P33991; Q92547; Q9Y5N6"]
["GO:0000727","biological_process","double-strand break repair via break-induced replication ","O00311; Q9Y248"]
["GO:0070317","biological_process","negative regulation of  to  transition ","O00311; P38398; O14757; Q15910; O75461; O14727; Q14186; Q15022; Q5VWQ8; Q01094; P45973; P35226; Q06609; Q99708; Q96KQ7; P61244; P98177; P31350; Q9BYE7; Q13185"]
["GO:0006909","biological_process","phagocytosis ","O00311; P16284; Q15080; P30530; Q12866; P04083; Q9BQI3; P50995; P32942; P05556; P50570; O60331; O43581; Q9ULV4; Q13291; P20339; P48357; Q07954; Q02556; P48729; Q9NPY3; P23769; P19878"]
["GO:0010571","biological_process","positive regulation of nuclear cell cycle DNA replication ","O00311; O95785"]
["GO:0008209","biological_process","androgen metabolic process ","P03372; Q9UBK2; P08684; P16662"]
["GO:0001547","biological_process","antral ovarian follicle growth ","P03372; O43524"]
["GO:0002064","biological_process","epithelial cell development ","P03372; Q16254; Q9UBC0; Q9H3D4"]
["GO:0060750","biological_process","epithelial cell proliferation involved in mammary gland duct elongation ","P03372; Q15648"]
["GO:0030520","biological_process","intracellular estrogen receptor signaling pathway ","P03372; O14497; O43251; P12931; Q15650; P17844; Q15545; Q86X55; Q15424; Q96PK6; Q96KS0; Q14686; Q92841; Q92731"]
["GO:0030518","biological_process","intracellular steroid hormone receptor signaling pathway ","P03372; Q9Y2W1; O60244; Q15648"]
["GO:0060745","biological_process","mammary gland branching involved in pregnancy ","P03372; P11473; Q15648"]
["GO:1903799","biological_process","negative regulation of production of miRNAs involved in gene silencing by miRNA ","P03372; Q9Y618; Q5D1E8; Q08209; O75376"]
["GO:0007200","biological_process","phospholipase C-activating -protein coupled receptor signaling pathway ","P03372; Q9P212; P41180; P28223; Q03431; P41143; P17342; Q9NPC1; P21462; Q5XXA6; P35368; P41145; P35367; P21730; Q9H244; Q15722; P30556; P35372"]
["GO:0045899","biological_process","positive regulation of RNA polymerase II transcriptional preinitiation complex assembly ","P03372; P16220; P04637; P17980; P62195; P43686; P35998"]
["GO:0060527","biological_process","prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis ","P03372; P21802; Q8WU20"]
["GO:0060523","biological_process","prostate epithelial cord elongation ","P03372; P21802"]
["GO:0071168","biological_process","protein localization to chromatin ","P03372; P53350; Q15910; Q86X55; Q7Z5K2; Q8WUX9"]
["GO:0060687","biological_process","regulation of branching involved in prostate gland morphogenesis ","P03372; P21802; P19793"]
["GO:0034121","biological_process","regulation of toll-like receptor signaling pathway ","P03372; P16671; P05067"]
["GO:0030111","biological_process","regulation of Wnt signaling pathway ","P03372; Q9UJU2; Q01196; P67775; Q9BZS1; Q9ULK5; P05067; Q9HC62; Q9HCS4; P30153; O15169"]
["GO:0048863","biological_process","stem cell differentiation ","P03372; P10721; Q9Y2X9; P51674; Q14671; Q02962; P35548; P56693; Q9HB65; Q9Y483; P98177; Q13950; P52926; O00231"]
["GO:0060065","biological_process","uterus development ","P03372; P12931; P23771; Q8IZQ8; P58012; P11511; Q13485; P31270; P31269; P31260"]
["GO:0060068","biological_process","vagina development ","P03372; Q06418; P30530; Q12866; Q07812; Q16611"]
["GO:2001235","biological_process","positive regulation of apoptotic signaling pathway ","P45984; Q14934; Q05655; Q99801; O14727; P25445; P23396; Q5VWQ8; Q9Y5V3; P36897; P42575; Q0VD86"]
["GO:0071803","biological_process","positive regulation of podosome assembly ","P45984; P12931; P26038; Q16658; Q9ULH1; P01375; P13796; P61586"]
["GO:1901485","biological_process","positive regulation of transcription factor catabolic process ","P45984; Q8N3Y1"]
["GO:0061833","biological_process","protein localization to tricellular tight junction ","P45984; Q86X29"]
["GO:1905062","biological_process","positive regulation of cardioblast proliferation ","P11309"]
["GO:0070561","biological_process","vitamin D receptor signaling pathway ","P11309; P11473"]
["GO:0001838","biological_process","embryonic epithelial tube formation ","P07949"]
["GO:0048484","biological_process","enteric nervous system development ","P07949; Q9NTI5; Q8IZ21"]
["GO:0035860","biological_process","glial cell-derived neurotrophic factor receptor signaling pathway ","P07949"]
["GO:0007156","biological_process","homophilic cell adhesion via plasma membrane adhesion molecules ","P07949; P16284; P28827; Q9NYQ6; P05556; O14522; Q92692; P12830; P19022; Q15762; P42338; P13688; Q9Y6N7; Q9Y5H0; P98161; P33151"]
["GO:0060384","biological_process","innervation ","P07949; P05129; P28472; Q9P2D1; P47870; Q01851"]
["GO:0097021","biological_process","lymphocyte migration into lymphoid organs ","P07949"]
["GO:0033619","biological_process","membrane protein proteolysis ","P07949"]
["GO:0007158","biological_process","neuron cell-cell adhesion ","P07949; Q15078; Q9P2S2; Q9ULB1; P58400; Q8N0W4; Q8N2Q7"]
["GO:0061146","biological_process","Peyer's patch morphogenesis ","P07949"]
["GO:0033630","biological_process","positive regulation of cell adhesion mediated by integrin ","P07949; P43405; Q99958; Q9H244; P29350; Q99828"]
["GO:0072300","biological_process","positive regulation of metanephric glomerulus development ","P07949; Q02962; P50052"]
["GO:0014042","biological_process","positive regulation of neuron maturation ","P07949; P42345; P10415"]
["GO:0033141","biological_process","positive regulation of peptidyl-serine phosphorylation of STAT protein ","P07949"]
["GO:0007497","biological_process","posterior midgut development ","P07949"]
["GO:0048265","biological_process","response to pain ","P07949; P05129; Q00975; P23975; O75762"]
["GO:0035799","biological_process","ureter maturation ","P07949; P23771; Q02962"]
["GO:0018153","biological_process","isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine ","P21980"]
["GO:0032471","biological_process","negative regulation of endoplasmic reticulum calcium ion concentration ","P21980; Q9BXH1; Q07812; Q16611"]
["GO:0051482","biological_process","positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating -protein coupled signaling pathway ","P21980; P41146; P30679; Q13255; P14416; P21453; P21728; P30556"]
["GO:0051561","biological_process","positive regulation of mitochondrial calcium ion concentration ","P21980; Q8NE86"]
["GO:0060662","biological_process","salivary gland cavitation ","P21980"]
["GO:0008277","biological_process","regulation of -protein coupled receptor protein signaling pathway ","Q15835; Q9P212; P34947; Q9Y2X7; O15492; P41220; Q9NS28; Q9Y2K6; O43566; P32298; Q9NQ66; Q13371; O75916; O75386; Q9NSB8; Q14161; P49798; O15539; O43665; P43250"]
["GO:0022400","biological_process","regulation of rhodopsin mediated signaling pathway ","Q15835; Q8WTQ7; P11488; P32298; P29973; P0DP23; Q02846; Q9UMX6; P18545; P08100; P30419"]
["GO:0016056","biological_process","rhodopsin mediated signaling pathway ","Q15835; P11488; P29973; Q9UHM6; P08100"]
["GO:0007601","biological_process","visual perception ","Q15835; P07101; Q8WTQ7; O15492; P48167; P11488; Q99504; Q13371; P20941; P48165; P29973; P14679; O75916; Q02962; P26367; Q9UI40; Q9UKL4; Q02846; Q9Y4I1; Q9UIW0; Q99814; P18850; Q9ULV5; Q9UHM6; P30301; Q86UR5; Q8NEV4; P43320; Q8NI36; P54845; Q00169; P57796; Q9ULX3; O76090; Q9UMX6; P05813; P36383; P18545; P78508; P08100; Q08289; P09758; O95409"]
["GO:0051016","biological_process","barbed-end actin filament capping ","Q12792; Q6IBS0; P09327; P35611; P35241; Q9H2D6; P06396; P47756; P52907; P35612; Q12929"]
["GO:0030837","biological_process","negative regulation of actin filament polymerization ","Q12792; P07737; Q6IBS0; Q05655; Q9Y6D6"]
["GO:0043538","biological_process","regulation of actin phosphorylation ","Q12792"]
["GO:0042989","biological_process","sequestering of actin monomers ","Q12792; Q6IBS0; P06396"]
["GO:2000541","biological_process","positive regulation of protein geranylgeranylation ","O15146"]
["GO:0008582","biological_process","regulation of synaptic growth at neuromuscular junction ","O15146"]
["GO:0071340","biological_process","skeletal muscle acetylcholine-gated channel clustering ","O15146; O14640; P41161; O75096"]
["GO:0030041","biological_process","actin filament polymerization ","O60674; P42768; P63000; P09327; Q92558; P14317; Q8TCU6; Q53SF7; P57737; P06396; O60610; Q14247"]
["GO:0097296","biological_process","activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway ","O60674; P84022; Q07812; Q14790"]
["GO:0042976","biological_process","activation of Janus kinase activity ","O60674; Q14289; P10912; P16471"]
["GO:0031103","biological_process","axon regeneration ","O60674; P35221; P05412; P10415; Q9UPT6; Q14118"]
["GO:0007167","biological_process","enzyme linked receptor protein signaling pathway ","O60674; P04626; P52333; P01730"]
["GO:0060396","biological_process","growth hormone receptor signaling pathway ","O60674; Q05397; P40763; P27986; P49023; P10912"]
["GO:0035409","biological_process","histone H-Y1 phosphorylation ","O60674"]
["GO:0035722","biological_process","interleukin-1-mediated signaling pathway ","O60674; Q13177; Q14765; P29597; P07355; P23528; P23458; P61224; P05388; P26038; P38646; Q9NQ66; P20700; Q99439; Q53EL6; P00441; P22626; Q00169; P13796; P04179; P52907; P60953; P11233; O00170"]
["GO:0038155","biological_process","interleukin-2-mediated signaling pathway ","O60674; Q14765; P29597; P40763"]
["GO:0070106","biological_process","interleukin-2-mediated signaling pathway ","O60674; P42224; P29597; P40763; P23458; P40189; P27824"]
["GO:0070757","biological_process","interleukin-3-mediated signaling pathway ","O60674; P42224; Q14765; P40763; P23458; P40189; P27824"]
["GO:0061180","biological_process","mammary gland epithelium development ","O60674; Q96D31"]
["GO:0031959","biological_process","mineralocorticoid receptor signaling pathway ","O60674"]
["GO:0043392","biological_process","negative regulation of DNA binding ","O60674; Q9UJU2; P25963; P05412; P51955; Q92769; Q01094; O60341; Q96T23; Q02363; P61296; P63165; Q99750; P09601; P52926; Q16666; Q5JVS0; P23497; P55854"]
["GO:0045822","biological_process","negative regulation of heart contraction ","O60674; Q08499; P05023; P16615"]
["GO:0050867","biological_process","positive regulation of cell activation ","O60674; P05067"]
["GO:0010811","biological_process","positive regulation of cell-substrate adhesion ","O60674; P63000; Q02156; P04004; Q8NC24; Q76M96; P14543; Q12946"]
["GO:1904037","biological_process","positive regulation of epithelial cell apoptotic process ","O60674; Q99523; P32121; P31483"]
["GO:1902728","biological_process","positive regulation of growth factor dependent skeletal muscle satellite cell proliferation ","O60674; P40763"]
["GO:0060399","biological_process","positive regulation of growth hormone receptor signaling pathway ","O60674; Q9UBU3"]
["GO:0032760","biological_process","positive regulation of tumor necrosis factor production ","O60674; Q13546; Q14934; O43353; P27986; Q92769; Q7Z434; Q13158; P16671; P13498; Q92974; O15455; P30273; O00206; Q9ULZ3; O95267; Q9Y6Y9; P58753; O75995; Q15672; Q9H257"]
["GO:1904707","biological_process","positive regulation of vascular smooth muscle cell proliferation ","O60674; Q00987; P05412; Q99683; Q14814; Q13153; O14746; P04899; P28222; O95140; P26358; O75460; P09038; P01375; P17861; P08253; P36894"]
["GO:0060334","biological_process","regulation of interferon-gamma-mediated signaling pathway ","O60674; P42224; P17706; P08238; P23458; Q16543; P38484; O14543; O75925; P63165; P15260"]
["GO:0046425","biological_process","regulation of JAK-STAT cascade ","O60674; P52333; Q14469"]
["GO:0033194","biological_process","response to hydroperoxide ","O60674; O15111; P08047; P07203; P18887"]
["GO:0070671","biological_process","response to interleukin-2 ","O60674; O43353; Q86XR7"]
["GO:0034612","biological_process","response to tumor necrosis factor ","O60674; P23443; Q13546; O14733; P35354; Q14790; Q13049; Q8IVH8; P42574"]
["GO:0008015","biological_process","blood circulation ","P42224; Q16254; P30411; Q9P2D1; P26678; Q02153; Q02108; Q9Y3Q4; P53805; Q16621; P37023; P12259; P42898; Q01955; Q9UMR3; Q01543"]
["GO:0035458","biological_process","cellular response to interferon-beta ","P42224; Q9NSU2; O43464; O15455; P49427; Q86WV6; P10914; Q9P0J0; P61086; Q9UJV9; Q8TCS8"]
["GO:0038114","biological_process","interleukin-2-mediated signaling pathway ","P42224; Q14765; P40763; P23458; P52333"]
["GO:0072162","biological_process","metanephric mesenchymal cell differentiation ","P42224; Q02962"]
["GO:0072136","biological_process","metanephric mesenchymal cell proliferation involved in metanephros development ","P42224"]
["GO:0046725","biological_process","negative regulation by virus of viral protein levels in host cell ","P42224"]
["GO:0003340","biological_process","negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis ","P42224; Q99966"]
["GO:0072308","biological_process","negative regulation of metanephric nephron tubule epithelial cell differentiation ","P42224"]
["GO:0061326","biological_process","renal tubule development ","P42224"]
["GO:0043434","biological_process","response to peptide hormone ","P42224; P07101; P17302; P35568; P04083; Q02763; O75150; P17535; P78543; Q13144; P46527; P07196; O76061; O75581; Q8NER1; Q14118; Q14232; Q03014"]
["GO:0071493","biological_process","cellular response to UV-B ","Q15831; P38936; P08473"]
["GO:0097484","biological_process","dendrite extension ","Q15831; Q8IVW4; Q92558; Q99962"]
["GO:0051645","biological_process","olgi localization ","Q15831; O00506; O75553"]
["GO:0072332","biological_process","intrinsic apoptotic signaling pathway by p5 class mediator ","Q15831; Q15119; P04637; P49773; P17844; Q9BQG0; P49789; Q07812; Q01094; Q9UL40; Q13625; Q9ULZ3; Q16666; Q9NZC7; Q13794; Q01851"]
["GO:0060770","biological_process","negative regulation of epithelial cell proliferation involved in prostate gland development ","Q15831; Q99801; P46527; Q9BQA1; P36955"]
["GO:0051055","biological_process","negative regulation of lipid biosynthetic process ","Q15831; P02649; P13688"]
["GO:1904262","biological_process","negative regulation of TRC signaling ","Q15831; Q13315; Q5T011"]
["GO:0048814","biological_process","regulation of dendrite morphogenesis ","Q15831; Q05586; P49841; Q9UKE5; O60828; P34741; Q6X4W1; P46934"]
["GO:0036399","biological_process","TCR signalosome assembly ","Q15831"]
["GO:0060033","biological_process","anatomical structure regression ","Q9UJU2; P17947"]
["GO:1902262","biological_process","apoptotic process involved in blood vessel morphogenesis ","Q9UJU2; P17947; Q07812; Q16611"]
["GO:0001569","biological_process","branching involved in blood vessel morphogenesis ","Q9UJU2; Q04771; Q14934; P11831; Q13043; P35222; Q14344; Q99697; P17813; P37173; Q99958; Q9UMR3"]
["GO:0060710","biological_process","chorio-allantoic fusion ","Q9UJU2; Q07352"]
["GO:0001837","biological_process","epithelial to mesenchymal transition ","Q9UJU2; P21802; P49841; Q13263; P35222; O43623; P17844; Q03167; Q16665; Q8TDM6; P36897; P46531; O95863; Q92841; P52926; Q06330; P48436"]
["GO:0048069","biological_process","eye pigmentation ","Q9UJU2"]
["GO:0021873","biological_process","forebrain neuroblast division ","Q9UJU2"]
["GO:0021879","biological_process","forebrain neuron differentiation ","Q9UJU2; P07333"]
["GO:0021861","biological_process","forebrain radial glial cell differentiation ","Q9UJU2; Q14469; Q86U44; P61586; P10071"]
["GO:0021943","biological_process","formation of radial glial scaffolds ","Q9UJU2; P05556; P21333"]
["GO:0043966","biological_process","histone H acetylation ","Q9UJU2; P15172; P17947; O43318; Q12962; O95251; O75529; Q8WYH8; Q6IE81; O95361; P51587; O15534; Q92794; Q15306"]
["GO:0030879","biological_process","mammary gland development ","Q9UJU2; P49327; Q03135; O43521; Q9Y4H2; P11511; P17301; P10070; Q9BRQ0; Q02297; P31269; O15119; Q9NRY4; Q13017; P48436"]
["GO:0048747","biological_process","muscle fiber development ","Q9UJU2; P10916; Q14315"]
["GO:0071866","biological_process","negative regulation of apoptotic process in bone marrow ","Q9UJU2; Q9NYY3"]
["GO:0071899","biological_process","negative regulation of estrogen receptor binding ","Q9UJU2; Q99801; Q9Y230"]
["GO:0032696","biological_process","negative regulation of interleukin-1 production ","Q9UJU2"]
["GO:0032713","biological_process","negative regulation of interleukin-4 production ","Q9UJU2; Q9BZS1"]
["GO:0032714","biological_process","negative regulation of interleukin-5 production ","Q9UJU2; Q9BZS1"]
["GO:0045843","biological_process","negative regulation of striated muscle tissue development ","Q9UJU2; Q8IXJ6"]
["GO:0030223","biological_process","neutrophil differentiation ","Q9UJU2; P49327"]
["GO:0071895","biological_process","odontoblast differentiation ","Q9UJU2; O60479"]
["GO:0048341","biological_process","paraxial mesoderm formation ","Q9UJU2; Q12948"]
["GO:0022409","biological_process","positive regulation of cell-cell adhesion ","Q9UJU2; O15105; Q99967; P48431"]
["GO:0090068","biological_process","positive regulation of cell cycle process ","Q9UJU2"]
["GO:0030854","biological_process","positive regulation of granulocyte differentiation ","Q9UJU2; Q01196; P14317"]
["GO:0022407","biological_process","regulation of cell-cell adhesion ","Q9UJU2; P54753; P12931; Q8N4C8"]
["GO:0016202","biological_process","regulation of striated muscle tissue development ","Q9UJU2; P84022"]
["GO:0050909","biological_process","sensory perception of taste ","Q9UJU2; P16671; Q9UBL9; P37088; P51170; P51168"]
["GO:0002040","biological_process","sprouting angiogenesis ","Q9UJU2; P35916; Q14289; Q02763; P46531; P60953; A0AVK6; Q96AV8"]
["GO:0033153","biological_process","T cell receptor V(D)J recombination ","Q9UJU2; P78527; Q9C0K0; P49917"]
["GO:0061153","biological_process","trachea gland development ","Q9UJU2"]
["GO:0006397","biological_process","mRNA processing ","Q9NYV4; Q13148; Q96ST2; Q9Y2W1; O43251; P08621; P17612; Q00613; Q15427; Q13242; Q7Z6E9; Q9UKV3; Q9GZX7; Q14684; Q9UBK2; Q9NR56; Q08170; Q14498; Q5T8P6; Q9H0Z9; Q99590; O95218; Q8N2M8; Q13243; Q01130; Q01081; Q15459; Q9BZB8; Q8IX01; P26368; Q06787; Q05519; O43395; Q92879; Q9H0D6; Q07955; Q9BWF3; Q9Y534; Q7KZ85; P18583; P17931; Q96E39; Q8N163; Q9P2N5; P98175; O75525; P22626; Q96PU8; P26599; Q13435; Q12972; Q86U44; P23246; Q9UNY4; Q6P2Q9; Q07352; Q92945; Q15029; Q5JVS0; Q07021; Q13151; Q07666; Q5VWX1; O95905; Q9H0S4; Q9NUK0; Q8WXA9"]
["GO:0043405","biological_process","regulation of MAP kinase activity ","Q9NYV4; Q8IVT5; O14964; Q92519"]
["GO:0043484","biological_process","regulation of RNA splicing ","Q9NYV4; P49759; P15172; P08621; P49761; Q14684; Q9NR56; Q9H0Z9; Q9HAZ1; O60828; Q96I25; Q92879; P18583; P31943; P49760; Q9NUK0; Q09666"]
["GO:0006189","biological_process","'de novo' IMP biosynthetic process ","Q06203; P31939; P22234"]
["GO:0006543","biological_process","glutamine catabolic process ","Q06203"]
["GO:0060135","biological_process","maternal process involved in female pregnancy ","Q06203; P42345; P41220; P21554; Q8TDQ0; Q13351; P49459; P19021"]
["GO:0009116","biological_process","nucleoside metabolic process ","Q06203; P60891; P11908; P31939; O43598"]
["GO:0009113","biological_process","purine nucleobase biosynthetic process ","Q06203; Q6UB35; P49915; P22234"]
["GO:0006164","biological_process","purine nucleotide biosynthetic process ","Q06203; P60891; P00973"]
["GO:0009168","biological_process","purine ribonucleoside monophosphate biosynthetic process ","Q06203; P49915; P31939; P22234; P12268"]
["GO:0070417","biological_process","cellular response to cold ","Q9NZJ5; P25963; Q9P2K8; Q12778; P19634"]
["GO:0036492","biological_process","eiFalpha phosphorylation in response to endoplasmic reticulum stress ","Q9NZJ5; Q9P2K8"]
["GO:0006983","biological_process","ER overload response ","Q9NZJ5; P04637; P49841; P35638; P11021"]
["GO:0031642","biological_process","negative regulation of myelination ","Q9NZJ5; P60484; Q13614"]
["GO:0045943","biological_process","positive regulation of transcription by RNA polymerase I ","Q9NZJ5; P17480; P04626; Q9UPP1; P18848"]
["GO:0010575","biological_process","positive regulation of vascular endothelial growth factor production ","Q9NZJ5; P38398; P35916; P35398; P43694; P40189; P35354; P27540; Q16665; P18848; P21730"]
["GO:0060734","biological_process","regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation ","Q9NZJ5"]
["GO:1902235","biological_process","regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway ","Q9NZJ5; P30040"]
["GO:0010998","biological_process","regulation of translational initiation by eIF2 alpha phosphorylation ","Q9NZJ5; Q9P2K8"]
["GO:0098742","biological_process","cell-cell adhesion via plasma-membrane adhesion molecules ","P16284; P05107; P25189; P13688"]
["GO:0008037","biological_process","cell recognition ","P16284; Q92692; Q15762; P06127"]
["GO:0090673","biological_process","endothelial cell-matrix adhesion ","P16284"]
["GO:0001886","biological_process","endothelial cell morphogenesis ","P16284; P08581; Q96DR7; P41134"]
["GO:0072011","biological_process","glomerular endothelium development ","P16284; P28906; Q99958"]
["GO:0072672","biological_process","neutrophil extravasation ","P16284; P48736; O00329"]
["GO:0043922","biological_process","negative regulation by host of viral transcription ","Q13148; P05412; Q13547; P52926"]
["GO:0071765","biological_process","nuclear inner membrane organization ","Q13148"]
["GO:0071359","biological_process","cellular response to dsRNA ","Q14653; P19838"]
["GO:0071888","biological_process","macrophage apoptotic process ","Q14653"]
["GO:0039530","biological_process","MDA- signaling pathway ","Q14653; Q92985; Q9BYX4"]
["GO:0050689","biological_process","negative regulation of defense response to virus by host ","Q14653; Q15633"]
["GO:0045358","biological_process","negative regulation of interferon-beta biosynthetic process ","Q14653; Q13287"]
["GO:0050715","biological_process","positive regulation of cytokine secretion ","Q14653; P09769; P43405; P12931; P50052; Q9H4X1; P01375; P04406"]
["GO:0060340","biological_process","positive regulation of type I interferon-mediated signaling pathway ","Q14653; Q7Z434; Q13158; Q92985; P61086"]
["GO:0097300","biological_process","programmed necrotic cell death ","Q14653; Q99683; Q12933"]
["GO:0045351","biological_process","type I interferon biosynthetic process ","Q14653; Q92985"]
["GO:0006356","biological_process","regulation of transcription by RNA polymerase I ","P17480; Q15648"]
["GO:0006360","biological_process","transcription by RNA polymerase I ","P17480; P49715; O15160"]
["GO:2001271","biological_process","negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis ","Q13177"]
["GO:0090650","biological_process","cellular response to oxygen-glucose deprivation ","P22681; P18848; O00429; Q92574"]
["GO:0036120","biological_process","cellular response to platelet-derived growth factor stimulus ","P22681; P16220; P06241; P07947; P12931; P35241; P56192; Q92819; Q96A49; Q9BR76; P20248; P46940; Q04656; Q9UJM3"]
["GO:0035635","biological_process","entry of bacterium into host cell ","P22681; P12931; P35222; P08581; P62993; P12830; O60716"]
["GO:0043303","biological_process","mast cell degranulation ","P22681; P10721; P48736; Q9GZY6; O43561; O95267; O00329; Q6PUV4"]
["GO:0007175","biological_process","negative regulation of epidermal growth factor-activated receptor activity ","P22681; Q13191; P49768; Q8NFJ5; Q9ULV8; Q9UJM3"]
["GO:0070997","biological_process","neuron death ","P22681; Q5S007; P19634"]
["GO:0048260","biological_process","positive regulation of receptor-mediated endocytosis ","P22681; P61978; P04004; Q02539"]
["GO:0006513","biological_process","protein monoubiquitination ","P22681; Q96PU5; P19474; Q9NS56; Q9NZJ0; P63146; Q712K3; Q9NS91; Q7Z6Z7; O60260; Q9C0C9"]
["GO:0000209","biological_process","protein polyubiquitination ","P22681; O95376; Q7Z6E9; O95271; Q9UKT5; Q96PU5; O95071; Q8N1E6; Q8N3Y1; Q15819; P19474; P62979; Q9UIQ6; Q9UKV5; Q8NHG8; Q9NS56; Q9BYM8; Q14669; P0CG47; Q9H4P4; P10415; Q9NZS9; Q9UMS4; Q969U6; Q9NZJ0; Q9HAT8; Q9NQ86; Q9Y4K3; P68036; P49427; Q9UBN7; Q5XUX0; P63146; P41002; Q13049; Q9UNE7; Q5TC82; Q13404; P49459; Q96EP1; Q96Q27; Q7Z6Z7; P62987; Q13309; Q8N726; Q8WWI1; Q8IUQ4; Q8WVD3; Q9UBS8; Q969H0; O43255; Q8ND25; O60260; Q5VTR2"]
["GO:0042594","biological_process","response to starvation ","P22681; Q8IYT8; P37231; P27708; Q16654; O75385; Q9UBK2; P35638; P24752; P30874; P26651; P16118"]
["GO:0009948","biological_process","anterior/posterior axis specification ","O14965; Q99626; P12755"]
["GO:0051642","biological_process","centrosome localization ","O14965; P49792; Q9GZM8; Q9NXR1; O94901; Q9UH99; P33176"]
["GO:0007100","biological_process","mitotic centrosome separation ","O14965; Q9GZM8; Q9NXR1; P37198; P52732"]
["GO:0007052","biological_process","mitotic spindle organization ","O14965; P14635; P33981; Q02224; O95271; P81274; Q9NYY3; Q15468; P18754; P62826; P27816; O95613; O75122; O43379; O00139; Q14204; Q15813; P51608; P52732; Q9UH99; P16949; O14777"]
["GO:0010972","biological_process","negative regulation of /M transition of mitotic cell cycle ","O14965; Q13642; Q96BK5; Q5JXC2"]
["GO:1900195","biological_process","positive regulation of oocyte maturation ","O14965; Q8IXJ6"]
["GO:0071539","biological_process","protein localization to centrosome ","O14965; P48730; Q8TEP8; Q15154; Q15468; Q8NHV4; Q96R06; Q9UPN4"]
["GO:0046605","biological_process","regulation of centrosome cycle ","O14965; Q96L34"]
["GO:0007057","biological_process","spindle assembly involved in female meiosis I ","O14965; Q9UKT4"]
["GO:0007051","biological_process","spindle organization ","O14965; Q96GD4; P33981; P49792; O43566; Q9P2Y5; Q9NQ86; Q9H6Z4; Q96R06; Q7Z3J3; Q2M2Z5; P52732"]
["GO:0055074","biological_process","calcium ion homeostasis ","Q05586; Q03135; O15164; Q9BR39; Q9NQA5; P32418; Q9H1D0"]
["GO:0006812","biological_process","cation transport ","Q05586; Q9Y210; Q96RD7; Q9Y3Q4; Q96RD6; Q5XXA6; Q9GZU1"]
["GO:0001661","biological_process","conditioned taste aversion ","Q05586; P01100; P21728"]
["GO:0035235","biological_process","ionotropic glutamate receptor signaling pathway ","Q05586; Q14289; Q15078; P05067; P42262"]
["GO:0060179","biological_process","male mating behavior ","Q05586; P60484"]
["GO:0008355","biological_process","olfactory learning ","Q05586; O60266"]
["GO:0021586","biological_process","pons maturation ","Q05586"]
["GO:0010524","biological_process","positive regulation of calcium ion transport into cytosol ","Q05586; Q03135; Q13507; Q9UBL9; Q16611; P01730"]
["GO:2001056","biological_process","positive regulation of cysteine-type endopeptidase activity ","Q05586; Q13224; P06241; Q9BXH1; O15553; Q9ULZ3"]
["GO:1903428","biological_process","positive regulation of reactive oxygen species biosynthetic process ","Q05586; O43524; P56524; P16671; P13498; Q99497; O00206"]
["GO:0060134","biological_process","prepulse inhibition ","Q05586; P60484; O43424; O14640; P35462; Q01959; Q9ULB1; P14416; P21728"]
["GO:0018964","biological_process","propylene metabolic process ","Q05586"]
["GO:0051290","biological_process","protein heterotetramerization ","Q05586; Q13224; P07355; P06213; Q8N684; P12956; P18754; P68431; Q9Y285; P62805; O75096; Q8N2Q7; P01892"]
["GO:0042391","biological_process","regulation of membrane potential ","Q05586; Q5S007; Q96PU5; Q12791; P09622; P43681; P29973; Q9Y3Q4; Q12959; Q86UR5; O43497; P22460; O95180; Q12809; P48664; Q09470; P46934; Q14654; P33176; P78348; Q9UL51"]
["GO:0043576","biological_process","regulation of respiratory gaseous exchange ","Q05586; P43354; Q96RG2; O14813"]
["GO:0007585","biological_process","respiratory gaseous exchange ","Q05586; P43681; Q9Y5Q3; Q9BUZ4; P32927; P51608"]
["GO:1905429","biological_process","response to glycine ","Q05586"]
["GO:0035176","biological_process","social behavior ","Q05586; P07101; P42345; P60484; P78352; O14640; Q9P2S2; Q15154; P35462; Q13542; Q9ULB1; O60229; P58400; Q9BYB0; P54253; Q9UPX8; Q99259; Q8N0W4; P51608; Q96RK0; P31645; Q9Y566"]
["GO:0001967","biological_process","suckling behavior ","Q05586; P61296; P05067; Q01851"]
["GO:0035249","biological_process","synaptic transmission, glutamatergic ","Q05586; Q00535; Q13002; O43424; Q92529; Q16478; P42262; O60260"]
["GO:0061817","biological_process","endoplasmic reticulum-plasma membrane tethering ","Q9BSJ8"]
["GO:0006869","biological_process","lipid transport ","Q9BSJ8; Q9Y365; Q92673; Q00341; P35790; Q9BXB4"]
["GO:0007043","biological_process","cell-cell junction assembly ","Q9Y490; O00501; Q8WUI4; Q16658; Q9HBA0; Q96RI1; Q07157; Q4VCS5; P33151; P36383"]
["GO:0007044","biological_process","cell-substrate junction assembly ","Q9Y490"]
["GO:0007016","biological_process","cytoskeletal anchoring at plasma membrane ","Q9Y490; P15311; O75369; P14923; Q12955; Q14118; Q9Y566"]
["GO:0033622","biological_process","integrin activation ","Q9Y490; Q96AC1; O14713"]
["GO:0043306","biological_process","positive regulation of mast cell degranulation ","P09769; P43405; P30273; P61764; P24394; Q9UQC2; P23769"]
["GO:0045088","biological_process","regulation of innate immune response ","P09769; Q9Y2R2; Q9Y3Z3; P10914; P31994; P98170; P58753"]
["GO:0016197","biological_process","endosomal transport ","O75886; P42768; O14964; O15075; O75351; P62979; Q9H1K0; O60784; P0CG47; Q15036; Q13501; Q7Z3T8; O95477; Q9Y3E7; Q8WUX9; P62987; Q96H20; Q96CF2"]
["GO:0036258","biological_process","multivesicular body assembly ","O75886; O14964; O75351; P62491; Q9Y3E7; Q8WUX9; Q96H20; Q96CF2"]
["GO:0043044","biological_process","ATP-dependent chromatin remodeling ","O14497; P60709; Q8WXI9; Q12824; Q92769; P07910; Q9H4L7; P51532; Q14839; Q8TAQ2; Q13547; Q969G3; O95983; O94776"]
["GO:0003205","biological_process","cardiac chamber development ","O14497"]
["GO:0055007","biological_process","cardiac muscle cell differentiation ","O14497; P57059; Q8IZQ8; P05556; Q92908; Q12802; P19634; P52952; Q9Y3M2; Q02297; Q9NPH5; Q92574"]
["GO:0048096","biological_process","chromatin-mediated maintenance of transcription ","O14497; O14757; Q8NFD5"]
["GO:0007566","biological_process","embryo implantation ","O14497; P19793; Q08345; Q13263; P35354; Q02790; O76061; P37173; P00441; P16471; P08253"]
["GO:0030900","biological_process","forebrain development ","O14497; Q8WU20; P06241; Q13976; P12931; O15075; Q9UBK2; O43464; O14727; P25685; Q15468; Q96QB1; Q01094; Q9UIW0; P05067; Q02880; Q9NRY4; P46531; P48431; P43699; P30874"]
["GO:0001704","biological_process","formation of primary germ layer ","O14497"]
["GO:0042921","biological_process","glucocorticoid receptor signaling pathway ","O14497; Q04917; Q96PK6; Q14686; P46934"]
["GO:0006344","biological_process","maintenance of chromatin silencing ","O14497; Q92769; Q96EB6; P63146"]
["GO:0006337","biological_process","nucleosome disassembly ","O14497; P17096; Q12824; Q01105; P51532; Q8TAQ2; Q9Y5B9; Q969G3; Q16621; Q6STE5"]
["GO:0042766","biological_process","nucleosome mobilization ","O14497"]
["GO:0003408","biological_process","optic cup formation involved in camera-type eye development ","O14497"]
["GO:0050873","biological_process","brown fat cell differentiation ","P49715; P35354; P14672; P41220; Q9UBK2; P17676; P08588; P15090; O14492; Q96HE7; P07550"]
["GO:0071285","biological_process","cellular response to lithium ion ","P49715; Q14934; P15173; P12830; P46527; P15090; Q02363; Q13426; P49917; Q8IWU9"]
["GO:0008203","biological_process","cholesterol metabolic process ","P49715; P19793; P01130; P04040; P49675; O00204; Q14849; P10109; P36956; Q92673; P02649; Q14494; Q12772; P05067; Q05469; Q00341; O95477; P48357; Q15466"]
["GO:0006091","biological_process","generation of precursor metabolites and energy ","P49715; P54840; P46020; P52945; O15240; P41236; Q9UII2; Q06455; Q99798; Q93100; P12235; P22413"]
["GO:0030851","biological_process","granulocyte differentiation ","P49715; P17947; O75081; Q02447"]
["GO:0055088","biological_process","lipid homeostasis ","P49715; P37231; Q13085; P41235; Q9Y4H2; Q15853; Q14494; Q13133; P22415; Q96AD5; Q969H0"]
["GO:0030225","biological_process","macrophage differentiation ","P49715; P17947; P07333; Q9BQI3; Q96EB6; Q14790; P60953; P09874"]
["GO:0030099","biological_process","myeloid cell differentiation ","P49715; P29590; Q01196; P51817; P09629; Q9NRH2; Q14686; Q92794; Q05516; Q02556; Q16666; P30048; P58753"]
["GO:0043032","biological_process","positive regulation of macrophage activation ","P49715; Q15046; P10809; Q8TDQ0; O00206; P24394"]
["GO:0045945","biological_process","positive regulation of transcription by RNA polymerase III ","P49715; P04626; P42345; P10275; Q92994; Q8N122; P55199"]
["GO:0050872","biological_process","white fat cell differentiation ","P49715; P37231; Q96EB6; O15055; P56545; P15090; Q9BZK7; Q13363"]
["GO:0050773","biological_process","regulation of dendrite development ","O76039; Q8IU85; Q9P0L2; Q08AD1; Q8TCU6; Q12834; Q9H165; P61586; Q16643"]
["GO:0099175","biological_process","regulation of postsynapse organization ","O76039; Q7Z5H3; Q9UBU3"]
["GO:1904899","biological_process","positive regulation of hepatic stellate cell proliferation ","P10242"]
["GO:0051574","biological_process","positive regulation of histone H3-K9 methylation ","P10242; P38398; Q96EB6; Q5UIP0; P16401"]
["GO:2000845","biological_process","positive regulation of testosterone secretion ","P10242; P82094"]
["GO:0045624","biological_process","positive regulation of T-helper cell differentiation ","P10242"]
["GO:0071636","biological_process","positive regulation of transforming growth factor beta production ","P10242; P35354; P28906; P15529"]
["GO:0006651","biological_process","diacylglycerol biosynthetic process ","Q9P212"]
["GO:0048016","biological_process","inositol phosphate-mediated signaling ","Q9P212; P35367"]
["GO:0043647","biological_process","inositol phosphate metabolic process ","Q9P212; P19174; P16885; O15357; P51178; Q92835; P60484; Q01970; P23677; Q9NQ66; O43426; P0DP23; Q9NZJ9; Q9UHH9; O95989; Q9BRC7"]
["GO:0016042","biological_process","lipid catabolic process ","Q9P212; P51178; Q01970; O14939; Q13393; Q9NQ66; O60240; Q8NEL9; Q05469; Q9BZK7; Q9BRC7"]
["GO:0046578","biological_process","regulation of Ras protein signal transduction ","Q9P212; Q08050; O14492; Q13501; Q13972; P37198"]
["GO:0006940","biological_process","regulation of smooth muscle contraction ","Q9P212; Q03135; O43293; P19429; P08172; P08913; P51911"]
["GO:0060348","biological_process","bone development ","P21802; O15198; O75386; Q12802; A1X283; P17813; O96028"]
["GO:0060349","biological_process","bone morphogenesis ","P21802; P22607; Q92819; P12755; P05549"]
["GO:0060667","biological_process","branch elongation involved in salivary gland morphogenesis ","P21802"]
["GO:0060670","biological_process","branching involved in labyrinthine layer morphogenesis ","P21802; P62993; O14543; Q9NP62"]
["GO:0060442","biological_process","branching involved in prostate gland morphogenesis ","P21802; Q99801"]
["GO:0048755","biological_process","branching morphogenesis of a nerve ","P21802; P14416"]
["GO:0048557","biological_process","embryonic digestive tract morphogenesis ","P21802; P16234; Q6KC79; Q99697; Q12946; Q02363; P10071"]
["GO:0048568","biological_process","embryonic organ development ","P21802; Q7Z6E9; P19447; P54727; Q9Y6I3; Q15561; P28347; O95983; P36894"]
["GO:0048562","biological_process","embryonic organ morphogenesis ","P21802; Q13562"]
["GO:0003416","biological_process","endochondral bone growth ","P21802; P22607; Q16832; P35548"]
["GO:0048730","biological_process","epidermis morphogenesis ","P21802; O43474"]
["GO:0060664","biological_process","epithelial cell proliferation involved in salivary gland morphogenesis ","P21802; Q99801; P01375"]
["GO:0035603","biological_process","fibroblast growth factor receptor signaling pathway involved in hemopoiesis ","P21802"]
["GO:0060595","biological_process","fibroblast growth factor receptor signaling pathway involved in mammary gland specification ","P21802"]
["GO:0035602","biological_process","fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow ","P21802"]
["GO:0035604","biological_process","fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow ","P21802"]
["GO:0022612","biological_process","gland morphogenesis ","P21802; O14745; P26038; P10415"]
["GO:0031069","biological_process","hair follicle morphogenesis ","P21802; P10415; Q04695; P46531; O95863; Q9H3D4; Q04656"]
["GO:0032808","biological_process","lacrimal gland development ","P21802; Q12948; P26367; P48436"]
["GO:0060601","biological_process","lateral sprouting from an epithelium ","P21802"]
["GO:0060174","biological_process","limb bud formation ","P21802; P48436"]
["GO:0060463","biological_process","lung lobe morphogenesis ","P21802; Q12946; P37173"]
["GO:0060615","biological_process","mammary gland bud formation ","P21802"]
["GO:0003149","biological_process","membranous septum morphogenesis ","P21802; Q9ULK5; Q02363; P37173; O96028"]
["GO:0060915","biological_process","mesenchymal cell differentiation involved in lung development ","P21802"]
["GO:0060916","biological_process","mesenchymal cell proliferation involved in lung development ","P21802"]
["GO:0048333","biological_process","mesodermal cell differentiation ","P21802; P05106; P08476; P05556; P17301; P16144; P52926"]
["GO:0016331","biological_process","morphogenesis of embryonic epithelium ","P21802; P52945; O43294"]
["GO:0042476","biological_process","odontogenesis ","P21802; P29972; P08476; Q02535; Q99697; Q9Y4I1; P55064; P18827; Q9Y2T1; P61586; P19021; Q15672"]
["GO:0021769","biological_process","orbitofrontal cortex development ","P21802; O15511; P14416"]
["GO:0030916","biological_process","otic vesicle formation ","P21802; O15273; P48436"]
["GO:0051781","biological_process","positive regulation of cell division ","P21802; Q99801; P04040; P17542; P09038; O14713; P67809; Q8IXJ6"]
["GO:0060501","biological_process","positive regulation of epithelial cell proliferation involved in lung morphogenesis ","P21802; Q13247; P60953"]
["GO:0030177","biological_process","positive regulation of Wnt signaling pathway ","P21802; P68400; O14746; Q155Q3; O60315; P51532; Q9NYF0; Q9UPN3; Q6P1J9; Q03014; P12755"]
["GO:0060512","biological_process","prostate gland morphogenesis ","P21802"]
["GO:0021860","biological_process","pyramidal neuron development ","P21802; Q04656"]
["GO:0010453","biological_process","regulation of cell fate commitment ","P21802; P23759"]
["GO:0040036","biological_process","regulation of fibroblast growth factor receptor signaling pathway ","P21802; Q16828; Q13950"]
["GO:0060688","biological_process","regulation of morphogenesis of a branching structure ","P21802"]
["GO:0033688","biological_process","regulation of osteoblast proliferation ","P21802; P17342; P61586"]
["GO:0008589","biological_process","regulation of smoothened signaling pathway ","P21802; P35398; P08151; P10070; Q92793"]
["GO:0051150","biological_process","regulation of smooth muscle cell differentiation ","P21802; P11831; Q8IZQ8; P37275; Q12946"]
["GO:0048608","biological_process","reproductive structure development ","P21802; Q12959"]
["GO:0060529","biological_process","squamous basal epithelial stem cell differentiation involved in prostate gland acinus development ","P21802; Q9H3D4"]
["GO:0055010","biological_process","ventricular cardiac muscle tissue morphogenesis ","P21802; P19793; P45379; P19429; Q03167; Q12948; O15105; Q99958; O96004; P10916; Q14896; P09493"]
["GO:0045071","biological_process","negative regulation of viral genome replication ","P78362; Q96SB4; P19525; Q9HC16; Q7Z434; O15162; Q12906; Q7Z2W4; Q01628; P00973; P01375; O75531; Q16666; Q53GL7"]
["GO:0035063","biological_process","nuclear speck organization ","P78362"]
["GO:0045070","biological_process","positive regulation of viral genome replication ","P78362; Q16513; Q96SB4; Q6PKG0; O00482; Q15633; O00571; P10747; P11940; P46531; Q16531; Q9UNP9; P11388"]
["GO:0048024","biological_process","regulation of mRNA splicing, via spliceosome ","P78362; Q96SB4; P18583; O75525; Q07666; Q5VWX1; O75494; P31483"]
["GO:0000245","biological_process","spliceosomal complex assembly ","P78362; Q96SB4; P62316; Q99590; Q9UMS4; O75533; Q15637; P62304; Q09161"]
["GO:0031670","biological_process","cellular response to nutrient ","Q15119; O95271; P17861; P09601"]
["GO:0010565","biological_process","regulation of cellular ketone metabolic process ","Q15119; Q16654"]
["GO:0006885","biological_process","regulation of pH ","Q15119; Q16654; P19634; P51790"]
["GO:0008595","biological_process","anterior/posterior axis specification, embryo ","Q8WU20; O15119"]
["GO:0001702","biological_process","gastrulation with mouth forming second ","Q8WU20; Q04771; Q13705; Q13485; O60701; Q4VCS5"]
["GO:2000726","biological_process","negative regulation of cardiac muscle cell differentiation ","Q8WU20"]
["GO:0007405","biological_process","neuroblast proliferation ","Q8WU20; Q9Y4D2; Q9NXR1; Q9H0H5; P50553; P47928; Q09470; Q9HD90"]
["GO:0046619","biological_process","optic placode formation involved in camera-type eye formation ","Q8WU20"]
["GO:0050678","biological_process","regulation of epithelial cell proliferation ","Q8WU20; P84022; P06401; Q14469; P05114; P09758"]
["GO:0007185","biological_process","transmembrane receptor protein tyrosine phosphatase signaling pathway ","Q8WU20; P10586; O75962"]
["GO:0003281","biological_process","ventricular septum development ","Q8WU20; Q00987; P23771; P43694; Q14469; O75626; P50570; O43541; Q86V48; Q9UMX1; P63010"]
["GO:0008045","biological_process","motor neuron axon guidance ","P04626; Q00535; P54764; Q9UBR4; O60282"]
["GO:0033088","biological_process","negative regulation of immature T cell proliferation in thymus ","P04626; Q8N726"]
["GO:0090314","biological_process","positive regulation of protein targeting to membrane ","P04626; P01112; P31751; Q00535; P06241; Q13153; Q5T2W1; Q15078; Q9GZY8; Q86YS7; P05107; Q14721; P04156; Q9NQG6; Q12955; P84074; O14713; Q99828"]
["GO:0097186","biological_process","amelogenesis ","P15336; Q99062; P16144"]
["GO:0031573","biological_process","intra-S DNA damage checkpoint ","P15336; Q99638; Q8NG66; P49959; P43246; Q14676; Q9BVW5"]
["GO:0110024","biological_process","positive regulation of cardiac muscle myoblast proliferation ","P15336; Q92908"]
["GO:1902110","biological_process","positive regulation of mitochondrial membrane permeability involved in apoptotic process ","P15336"]
["GO:0032915","biological_process","positive regulation of transforming growth factor beta production ","P15336"]
["GO:0009414","biological_process","response to water deprivation ","P15336; P07101"]
["GO:0009838","biological_process","abscission ","Q96GD4; Q96CF2"]
["GO:0036089","biological_process","cleavage furrow formation ","Q96GD4; P61586"]
["GO:0044878","biological_process","mitotic cytokinesis checkpoint ","Q96GD4; Q96CF2"]
["GO:0002903","biological_process","negative regulation of B cell apoptotic process ","Q96GD4; Q9Y4H2; Q9Y3T9; P41182"]
["GO:0032466","biological_process","negative regulation of cytokinesis ","Q96GD4; Q8IWB6; A0AVK6; Q96CF2; Q96AV8"]
["GO:0051983","biological_process","regulation of chromosome segregation ","Q96GD4; P46013; Q99661; O43683; Q14671; Q8N4N8"]
["GO:0031577","biological_process","spindle checkpoint ","Q96GD4"]
["GO:0002526","biological_process","acute inflammatory response ","Q04771; Q9BQI3"]
["GO:0003289","biological_process","atrial septum primum morphogenesis ","Q04771; P43694; O96028"]
["GO:0003181","biological_process","atrioventricular valve morphogenesis ","Q04771; Q00987; P37173; P46531"]
["GO:0061312","biological_process","BMP signaling pathway involved in heart development ","Q04771; P35548; P36894"]
["GO:0007368","biological_process","determination of left/right symmetry ","Q04771; Q13705; Q13563; Q15468; Q99697; Q12946; Q99967; P46531; O15169"]
["GO:0061445","biological_process","endocardial cushion cell fate commitment ","Q04771"]
["GO:0003274","biological_process","endocardial cushion fusion ","Q04771; P37173"]
["GO:0003203","biological_process","endocardial cushion morphogenesis ","Q04771; Q00987; P29474; P17813; P46531; P37023; P36894; Q15672; P48436; Q9UMR3"]
["GO:0032926","biological_process","negative regulation of activin receptor signaling pathway ","Q04771; Q9Y2U8; Q86UL8; P12755"]
["GO:0060389","biological_process","pathway-restricted SMAD protein phosphorylation ","Q04771; Q03167; O15105; P37173; P36897; Q9Y4E8"]
["GO:0060037","biological_process","pharyngeal system development ","Q04771; P23771; Q99502; Q99801; P42892; P52952; P36897"]
["GO:2000017","biological_process","positive regulation of determination of dorsal identity ","Q04771"]
["GO:1905007","biological_process","positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation ","Q04771; P17813; P37173; P36897"]
["GO:0051028","biological_process","mRNA transport ","Q96ST2; Q00613; Q9NUU7; O95271; Q14493; Q9NZI8; Q06787; P09651; Q53F19; Q7KZ85; Q9Y6M1; Q9HC62; Q96PU8; O60318; Q07352; Q92945; O14980; P26651; O60282; Q7LC44"]
["GO:0032784","biological_process","regulation of DNA-templated transcription, elongation ","Q96ST2; Q96FV9; Q03468; Q8N163"]
["GO:2001253","biological_process","regulation of histone H-K6 trimethylation ","Q96ST2"]
["GO:0090239","biological_process","regulation of histone H4 acetylation ","Q96ST2"]
["GO:0010793","biological_process","regulation of mRNA export from nucleus ","Q96ST2; Q7KZ85"]
["GO:0050684","biological_process","regulation of mRNA processing ","Q96ST2; P21127; Q9UQ88; Q96SB4; Q9NWH9; Q14151; Q15424; Q7KZ85"]
["GO:0000083","biological_process","regulation of transcription involved in 1/S transition of mitotic cell cycle ","P24864; Q16254; Q9UKT4; Q14207; P04818; O75461; Q99741; Q14186; P12004; Q01094; Q13415; P31350; Q9H211; O60885"]
["GO:0007129","biological_process","synapsis ","P24864; Q9BXW9; P49959; P40692; Q9BTX1; O94901"]
["GO:0075044","biological_process","autophagy of host cells involved in interaction with symbiont ","Q8IYT8; O75385; Q9H1Y0"]
["GO:0048675","biological_process","axon extension ","Q8IYT8; O75385; Q00535; P08238; O15075; P07900; Q70E73; O14640; P05556; P18206; O43157; P46821"]
["GO:0048671","biological_process","negative regulation of collateral sprouting ","Q8IYT8; Q92913; Q9H165; P43146"]
["GO:0001662","biological_process","behavioral fear response ","P06730; P23443; Q04637; Q13002; P10415; O60229; P21728; P51608; P21796; P78348"]
["GO:0006406","biological_process","mRNA export from nucleus ","P06730; Q96Q15; Q13242; Q9Y5S9; Q6UN15; Q8TEM1; P49792; Q14493; Q9Y3Y2; Q8IYB3; Q9BY77; Q08170; P35658; Q96J01; P38919; A8CG34; Q13243; Q01130; Q01081; Q96FV9; Q9UMR2; P26368; Q8NI27; Q9UHL0; Q9BTX1; Q05519; P12270; Q92620; Q92797; Q07955; P57740; Q92900; P49790; Q8WUM0; Q13247; P22626; Q9P2I0; Q9UKF6; Q15287; O75152; P37198; P52948; Q96HA1; Q13769; Q03014; O00148; Q9H4D5; P52298; Q96QD9; Q9UKX7; Q8NFH5; Q09161; Q86V81"]
["GO:0045665","biological_process","negative regulation of neuron differentiation ","P06730; Q9P2K8; O43524; Q9NP66; Q155Q3; Q9NRA8; O15350; P26367; Q9UMS4; Q13516; P50553; Q02363; P05067; Q96SN8; P47928; Q86Y01; P48431; P10071; Q15648; P26196; P31645; O95390"]
["GO:0099578","biological_process","regulation of translation at postsynapse, modulating synaptic transmission ","P06730; P38919"]
["GO:0006405","biological_process","RNA export from nucleus ","P06730; Q13242; Q9Y5S9; P49792; Q9Y3Y2; Q8IYB3; Q9BY77; Q08170; P35658; Q96J01; P38919; A8CG34; Q13243; Q01130; Q01081; Q96FV9; P26368; Q8NI27; Q05519; P12270; Q92620; P09651; Q07955; Q13247; Q9H6Z4; Q15287; O75152; Q7Z3J3; P52948; Q96HA1; Q13769; O00148; P52298; Q09161; Q86V81"]
["GO:0045730","biological_process","respiratory burst ","Q15080; P14598; P13498; P18669; P19878"]
["GO:0016192","biological_process","vesicle-mediated transport ","Q15080; P41743; Q15836; P61106; Q9NUY8; O60229; Q15276; Q9Y4I1; P63027; Q9P2E2; P51809; O95235; Q9UQF2; P62491; P62820; Q8WWN8; P46459; Q15438; Q9UJY5; P49815; Q9UPT6; Q13439; O60343; O75154; P61601"]
["GO:0071455","biological_process","cellular response to hyperoxia ","P37231; Q03135; Q12778; P25445"]
["GO:0071306","biological_process","cellular response to vitamin E ","P37231"]
["GO:0042953","biological_process","lipoprotein transport ","P37231; P05771; P16671; Q07954"]
["GO:0015909","biological_process","long-chain fatty acid transport ","P37231; P02649; P15090"]
["GO:0045713","biological_process","low-density lipoprotein particle receptor biosynthetic process ","P37231"]
["GO:0002674","biological_process","negative regulation of acute inflammatory response ","P37231; Q96P20; P09211"]
["GO:0010887","biological_process","negative regulation of cholesterol storage ","P37231; P55055; Q07869; Q13133; O95477"]
["GO:0032966","biological_process","negative regulation of collagen biosynthetic process ","P37231; P62834; P33076; Q9UJM3"]
["GO:0060965","biological_process","negative regulation of gene silencing by miRNA ","P37231; Q15717; Q01860"]
["GO:0060336","biological_process","negative regulation of interferon-gamma-mediated signaling pathway ","P37231; P17706; P55055; Q13133"]
["GO:0010745","biological_process","negative regulation of macrophage derived foam cell differentiation ","P37231; P25963; P05106; P55055; Q07869; Q13133; O95477"]
["GO:2000230","biological_process","negative regulation of pancreatic stellate cell proliferation ","P37231"]
["GO:0010871","biological_process","negative regulation of receptor biosynthetic process ","P37231; Q07869; P20393"]
["GO:0010891","biological_process","negative regulation of sequestering of triglyceride ","P37231; Q07869; Q96AD5"]
["GO:0048662","biological_process","negative regulation of smooth muscle cell proliferation ","P37231; Q13418; P43119; Q9UBK2; P17342; P16066; O95140; P17936; O43474; Q15637; P09601; Q9UN36"]
["GO:0001890","biological_process","placenta development ","P37231; Q05397; Q16539; P08238; Q99966; Q9Y6R4; P46527; P00441; P41002; O60479; Q9UBR4; A0AVK6; Q96AV8; Q53GA4"]
["GO:0046321","biological_process","positive regulation of fatty acid oxidation ","P37231; Q9UBK2; Q07869"]
["GO:0048714","biological_process","positive regulation of oligodendrocyte differentiation ","P37231; O14744; P42345; Q92769; P61073; O15350; Q13547; Q13516; Q15382; Q14118"]
["GO:0060100","biological_process","positive regulation of phagocytosis, engulfment ","P37231; P16671; P17301; P23769"]
["GO:1905461","biological_process","positive regulation of vascular associated smooth muscle cell apoptotic process ","P37231; Q13043; O95140; Q53EL6; O00716; P18848; P04179"]
["GO:0060694","biological_process","regulation of cholesterol transporter activity ","P37231"]
["GO:0060850","biological_process","regulation of transcription involved in cell fate commitment ","P37231; P35398; P17676; P51449"]
["GO:0009409","biological_process","response to cold ","P37231; P00403; P01100; P07900; Q7Z2W7; Q9UBK2; P16989; O15240; P10809; P10827; Q14790; P08588; P54652; P07550; O75762"]
["GO:0035902","biological_process","response to immobilization stress ","P37231; P07101; Q14289; P01100; P17752; P32418; P61160"]
["GO:0033993","biological_process","response to lipid ","P37231; P16671; O75351; P23769"]
["GO:1901558","biological_process","response to metformin ","P37231; Q9UBK2"]
["GO:0060444","biological_process","branching involved in mammary gland duct morphogenesis ","P29590; P29317; Q08345; P12931; P35548; O15119"]
["GO:0010761","biological_process","fibroblast migration ","P29590; Q13418"]
["GO:0070059","biological_process","intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress ","P29590; Q99683; Q9BXH1; Q12933; Q8IWQ3; O14727; P17676; Q5VWQ8; Q07812; P10415; P46379; O75460; P18848; Q14643; P17861; Q96HE7; P35638; Q16611; P61086"]
["GO:0051457","biological_process","maintenance of protein location in nucleus ","P29590; P20749; Q5VWG9; Q9NS56; Q13285; Q00839"]
["GO:0050713","biological_process","negative regulation of interleukin- beta secretion ","P29590; Q5D1E8; Q96P20"]
["GO:0032938","biological_process","negative regulation of translation in response to oxidative stress ","P29590"]
["GO:1902187","biological_process","negative regulation of viral release from host cell ","P29590; Q13263; P19474; Q12899; Q13049; Q9Y3E7"]
["GO:0060058","biological_process","positive regulation of apoptotic process involved in mammary gland involution ","P29590; Q07812; P11473"]
["GO:0031065","biological_process","positive regulation of histone deacetylation ","P29590; P04637; Q6KC79; Q8WYK2; P36956; P41182; O43823; Q13363"]
["GO:0045345","biological_process","positive regulation of MHC class I biosynthetic process ","P29590; Q92598; P33076"]
["GO:1904816","biological_process","positive regulation of protein localization to chromosome, telomeric region ","P29590"]
["GO:0006606","biological_process","protein import into nucleus ","P29590; P40763; P43405; P27986; O95149; Q9H3M7; P35658; A8CG34; P02545; Q08209; P12270; P62826; P57740; P48678; P53801; P49790; Q8WUM0; Q9H6Z4; P49815; P37198; P21728; Q7Z3J3; P52948; Q96HA1; Q96QC0; Q9UKX7"]
["GO:0006605","biological_process","protein targeting ","P29590; Q96RT1; Q16543; Q9NQT8; P13473; Q9NYG2; Q02952; Q92673; P62913; P61981; P62258; P57105; P63104; Q8N2Q7; P31946; Q6ZWJ1"]
["GO:0010522","biological_process","regulation of calcium ion transport into cytosol ","P29590"]
["GO:2000779","biological_process","regulation of double-strand break repair ","P29590; P35659"]
["GO:0071681","biological_process","cellular response to indole-3-methanol ","P38398; P35221; P35222; P12830; P14923"]
["GO:0007059","biological_process","chromosome segregation ","P38398; P51955; Q96SB4; Q9HC98; P04150; Q8IX90; Q02224; Q03188; Q8NCD3; Q6P1K2; O43566; P23396; P18754; Q9GZM8; Q9P2Y5; Q9NXR1; P11387; Q96BD8; O15392; P63279; Q9NQS7; Q96SN8; O00571; Q96R06; Q15435; O76071; Q86UE8; P30153; P11388; Q9H211; Q14980; P49711; P52732; Q69YH5; Q5FBB7; O14777; O15523"]
["GO:0009048","biological_process","dosage compensation by inactivation of X chromosome ","P38398; Q92900; Q86U44; Q00839"]
["GO:0044818","biological_process","mitotic 2/M transition checkpoint ","P38398"]
["GO:0046600","biological_process","negative regulation of centriole replication ","P38398; Q96PK6; Q96SN8"]
["GO:1902042","biological_process","negative regulation of extrinsic apoptotic signaling pathway via death domain receptors ","P38398; Q13546; P29474; Q15121; P04049; P02671; Q13158; Q12933; Q92974; P25445; P48023; Q14790; P53355; Q07817; P07203; P09601; O15519"]
["GO:0045717","biological_process","negative regulation of fatty acid biosynthetic process ","P38398; P13688"]
["GO:0051572","biological_process","negative regulation of histone H3-K4 methylation ","P38398; Q96LA8"]
["GO:0051573","biological_process","negative regulation of histone H-K9 methylation ","P38398; Q9Y4C1; P26358"]
["GO:0033147","biological_process","negative regulation of intracellular estrogen receptor signaling pathway ","P38398; Q9NZN8; Q9H3D4; Q99623"]
["GO:0071158","biological_process","positive regulation of cell cycle arrest ","P38398; P04637; P17612; Q15078; Q13563; P15173; Q9BQG0; Q92908; O15350; Q5VWQ8; Q02363; Q9H4X1; P98177; P52926; Q8N726; Q01851"]
["GO:2000617","biological_process","positive regulation of histone H3-K9 acetylation ","P38398; Q12824; P23771; Q13485"]
["GO:2000620","biological_process","positive regulation of histone H4-K1 acetylation ","P38398"]
["GO:0070512","biological_process","positive regulation of histone H4-K methylation ","P38398"]
["GO:0006301","biological_process","postreplication repair ","P38398; Q15819; P63146; Q9NS91; Q13404; P43246; P49459; P61088"]
["GO:0051865","biological_process","protein autoubiquitination ","P38398; Q00987; P19474; Q12933; Q9UKV5; P78317; Q9H4P4; Q9NZS9; Q96T88; Q9Y4K3; P63146; Q9UNE7; Q9NS91; Q05086; P49459; Q9Y3C5; Q7Z6J0; Q96PM5; Q96J02; O60260"]
["GO:0085020","biological_process","protein K6-linked ubiquitination ","P38398; P78317; Q16763; Q99728; O60260"]
["GO:0044030","biological_process","regulation of DNA methylation ","P38398; O14744; O95983; P09874"]
["GO:0006359","biological_process","regulation of transcription by RNA polymerase III ","P38398; Q9Y5Q9; Q12789; Q14585"]
["GO:0072425","biological_process","signal transduction involved in  DNA damage checkpoint ","P38398; P53350; O14757; Q9NWV8; Q9NZJ0; Q96RL1; Q9UM11; Q6UWZ7"]
["GO:0048208","biological_process","CPII vesicle coating ","P48730; Q08379; P42261; P01009; Q9BQQ3; P53992; Q15436; O15084; P62820; P46459; O60763; J3KNL6; O15027; Q92734; Q5H9R7; P12259"]
["GO:0007030","biological_process","olgi organization ","P48730; Q15139; Q5S007; P42858; Q96CV9; Q8NF91; Q8N3Y1; Q9BQQ3; P56962; Q9BVK6; Q9Y6D6; Q9BTU6; Q14155; O14578; Q8IYU2; Q14CS0; Q92614; P62820; O75122; Q9UNZ2; Q92538; O60763; Q9H4A6; O43264; Q9H8Y8; P60953; P48729; Q5T5U3"]
["GO:0007020","biological_process","microtubule nucleation ","P48730; Q08379; Q99996; Q9HC77; Q9GZM8; Q9NXR1; O75122; P23258; Q96S59; Q9NRH3; Q9P270"]
["GO:1905515","biological_process","non-motile cilium assembly ","P48730; Q9HC77; Q15154; Q9ULK5; Q14203; Q9BV73"]
["GO:0061512","biological_process","protein localization to cilium ","P48730; Q9NRJ4; Q4G0X9; Q86YF9"]
["GO:0034067","biological_process","protein localization to olgi apparatus ","P48730; Q96CV9; Q92673; Q6TCH7; Q6VY07; Q6ZS17; Q92538"]
["GO:0051225","biological_process","spindle assembly ","P48730; Q8TDX7; Q08379; P51955; Q9HC98; O95271; P07437; P23396; P18754; O15379; Q7Z4H7; O75376"]
["GO:0046034","biological_process","ATP metabolic process ","Q16774; Q92934; P38606; P55072; P0DMV8; O14638; P11142; P54819; P22413"]
["GO:0046060","biological_process","dATP metabolic process ","Q16774"]
["GO:0006185","biological_process","dDP biosynthetic process ","Q16774"]
["GO:0046054","biological_process","dMP metabolic process ","Q16774"]
["GO:0046711","biological_process","DP biosynthetic process ","Q16774"]
["GO:0019673","biological_process","DP-mannose metabolic process ","Q16774"]
["GO:0034436","biological_process","glycoprotein transport ","Q16774"]
["GO:0015949","biological_process","nucleobase-containing small molecule interconversion ","Q16774; P04818; P33316; P17812; P22392; P15531; Q9NRF8; P54819"]
["GO:0046939","biological_process","nucleotide phosphorylation ","Q16774; Q96T60"]
["GO:0006163","biological_process","purine nucleotide metabolic process ","Q16774; P49789"]
["GO:0000380","biological_process","alternative mRNA splicing, via spliceosome ","Q14004; P17844; O60828; Q96I25; O60341; Q07955; Q13247; Q92841; P52272; P23246"]
["GO:0006509","biological_process","membrane protein ectodomain proteolysis ","Q04759; Q92542; P56817; P78536; P49768; P49810; Q14118; P38159; P35579"]
["GO:0070233","biological_process","negative regulation of T cell apoptotic process ","Q04759; P16871; Q8NF50"]
["GO:0032740","biological_process","positive regulation of interleukin-1 production ","Q04759"]
["GO:2000318","biological_process","positive regulation of T-helper 7 type immune response ","Q04759"]
["GO:2000570","biological_process","positive regulation of T-helper  cell activation ","Q04759"]
["GO:0034205","biological_process","amyloid-beta formation ","Q13627; Q92542; P49768"]
["GO:0043518","biological_process","negative regulation of DNA damage response, signal transduction by p class mediator ","Q13627; Q00987; O43781; Q96EB6; O43623; P16070; O60341; P53801; Q9HC62; O95863; Q15672"]
["GO:0048025","biological_process","negative regulation of mRNA splicing, via spliceosome ","Q13627; P61978; Q13242; Q9UKV3; Q08170; P26368; Q9BTD8; Q13247; P98175; P22626; P26599; Q15287; Q07021; P38159; O75494"]
["GO:0090312","biological_process","positive regulation of protein deacetylation ","Q13627; Q9HCU9"]
["GO:0033120","biological_process","positive regulation of RNA splicing ","Q13627; P27986; Q13243; P24928; P26368; P0DMV8; O75460; Q07955; Q5JVS0"]
["GO:0000381","biological_process","regulation of alternative mRNA splicing, via spliceosome ","Q13627; Q9Y2W1; O43251; P15172; Q9Y5S9; P17844; Q9Y580; Q01130; Q15459; Q06787; P09651; Q9BWF3; Q13247; P98175; P14866; P26599; Q15287; Q92841; P38159; Q00839; Q8WXA9"]
["GO:0021885","biological_process","forebrain cell migration ","Q06418; P30530"]
["GO:0001779","biological_process","natural killer cell differentiation ","Q06418; P30530; Q12866; P20823; Q02447; Q02363; P51692; O00329"]
["GO:0045824","biological_process","negative regulation of innate immune response ","Q06418; Q13287; P14416; Q16666"]
["GO:0051250","biological_process","negative regulation of lymphocyte activation ","Q06418; P30530; Q12866"]
["GO:0007218","biological_process","neuropeptide signaling pathway ","Q06418; P48167; P41143; P41146; Q9NPC1; Q9Y4G8; P05408; P41145; Q99523; Q15722; O43613"]
["GO:0032940","biological_process","secretion by cell ","Q06418; P30530; Q12866; P09958; Q16623"]
["GO:0046849","biological_process","bone remodeling ","O75030; P29317; P17752; P28222; P50749"]
["GO:0044336","biological_process","canonical Wnt signaling pathway involved in negative regulation of apoptotic process ","O75030; P35222"]
["GO:0030316","biological_process","osteoclast differentiation ","O75030; P29317; P07333; Q16539; P02786; Q04760; O43914; P30273; Q9Y4K3; P17275; P01375; P48200; Q9UQC2"]
["GO:2001141","biological_process","regulation of RNA biosynthetic process ","O75030; Q9Y6Q9; Q15648"]
["GO:0048255","biological_process","mRNA stabilization ","Q9Y2W1; P42345; Q6PKG0; Q15717; Q8TBY0; Q01094; P11940; Q9Y2T1; Q14103; Q00839"]
["GO:0000956","biological_process","nuclear-transcribed mRNA catabolic process ","Q9Y2W1; P17844; Q9UKD2; Q92900; Q06265; Q5TC82"]
["GO:0042753","biological_process","positive regulation of circadian rhythm ","Q9Y2W1; P35398; O00327; P43699; P51449"]
["GO:0048026","biological_process","positive regulation of mRNA splicing, via spliceosome ","Q9Y2W1; P08621; Q15427; P30041; Q96EP5; Q13573; Q9UMS4; P52948; P38159; Q09161"]
["GO:0070977","biological_process","bone maturation ","P22607"]
["GO:0035988","biological_process","chondrocyte proliferation ","P22607; Q16832; P52926; P50281"]
["GO:1902178","biological_process","fibroblast growth factor receptor apoptotic signaling pathway ","P22607"]
["GO:0048640","biological_process","negative regulation of developmental growth ","P22607"]
["GO:0021955","biological_process","central nervous system neuron axonogenesis ","Q05397; P08238; P60484; P07900; Q9GZM8; Q9NRY4"]
["GO:0050771","biological_process","negative regulation of axonogenesis ","Q05397; P29323; P60484; P08138; P52565; Q15768; Q9NQC3; Q96PV0; P49768; O75553; P31150; O75096; P61586"]
["GO:0046621","biological_process","negative regulation of organ growth ","Q05397; Q13043; P60484; Q13188; Q8IX03; P31645"]
["GO:0051964","biological_process","negative regulation of synapse assembly ","Q05397"]
["GO:0038007","biological_process","netrin-activated signaling pathway ","Q05397; A0MZ66"]
["GO:0007097","biological_process","nuclear migration ","Q05397; O14745; Q9Y613; P60953; Q9UH99"]
["GO:2000060","biological_process","positive regulation of ubiquitin-dependent protein catabolic process ","Q05397; Q14289; P60484; O15169; Q969H0"]
["GO:0010594","biological_process","regulation of endothelial cell migration ","Q05397; P13688"]
["GO:0010632","biological_process","regulation of epithelial cell migration ","Q05397; P12931; Q9ULV4; Q9UPN3"]
["GO:1900024","biological_process","regulation of substrate adhesion-dependent cell spreading ","Q05397; Q9ULV4"]
["GO:0007172","biological_process","signal complex assembly ","Q05397; Q14289; P12931; P49023; P07766; P16333"]
["GO:0042832","biological_process","defense response to protozoan ","P01112; P20749; Q15306; P24394; Q02556; P25942"]
["GO:1900029","biological_process","positive regulation of ruffle assembly ","P01112; P07737; Q9GZM8; Q9H244; Q8N2Q7"]
["GO:0090303","biological_process","positive regulation of wound healing ","P01112; Q02156; P04083; P04004; Q08495; Q9Y6D6; Q15746; P08913"]
["GO:0035900","biological_process","response to isolation stress ","P01112; P07101; P09382; P01116; Q99798"]
["GO:0042088","biological_process","T-helper 1 type immune response ","P01112; P20749; Q9Y4K3; O00206"]
["GO:0007264","biological_process","small TPase mediated signal transduction ","Q07912; P15498; O14939; Q13393; P55042; P53365; P52735; O14559; Q2M1Z3; Q8NF50; Q15311; Q9Y4G8; Q96N67; Q9UKW4; P49795; P61587; O75553; Q15669; P09601; Q96HP0; Q13972; Q8IV61; Q14185; O14827; P50395; P17081; Q9HB90; O43255"]
["GO:0003283","biological_process","atrial septum development ","Q00987"]
["GO:0060411","biological_process","cardiac septum morphogenesis ","Q00987; Q9P2D1; O96004; P46531"]
["GO:0072717","biological_process","cellular response to actinomycin D ","Q00987; P04637"]
["GO:0071312","biological_process","cellular response to alkaloid ","Q00987; P07101; P49675; P28222; Q07817; Q8NER1"]
["GO:0071375","biological_process","cellular response to peptide hormone stimulus ","Q00987; P41240; Q03135; P06241; P12931; P17861; O00255; P61244; Q07352; P27695"]
["GO:0071494","biological_process","cellular response to UV-C ","Q00987; Q9Y253"]
["GO:0071301","biological_process","cellular response to vitamin B ","Q00987"]
["GO:1902254","biological_process","negative regulation of intrinsic apoptotic signaling pathway by p3 class mediator ","Q00987; Q7LG56; P53801; Q9NYV6; O60260"]
["GO:0010955","biological_process","negative regulation of protein processing ","Q00987; Q5S007; P04156"]
["GO:1901797","biological_process","negative regulation of signal transduction by p53 class mediator ","Q00987; Q9NZM5"]
["GO:0018205","biological_process","peptidyl-lysine modification ","Q00987; Q04656"]
["GO:0046827","biological_process","positive regulation of protein export from nucleus ","Q00987; P04637; P49841; P35813; Q14012; O95817; Q9NYZ3; P12270; P31947; P62258; Q9NQB0; P50402; Q92688; O95398"]
["GO:1904754","biological_process","positive regulation of vascular associated smooth muscle cell migration ","Q00987; Q13153; O14746; Q8WYL5; Q96N67; P17861; P46940; Q04656"]
["GO:0034504","biological_process","protein localization to nucleus ","Q00987; Q9Y2I7; O43660; O14640; Q9NS56; Q5JTV8; P02545; P62913; P23025; P48678; P62258; Q05516; Q03014; Q8N9N5; O14980; P48436"]
["GO:0051603","biological_process","proteolysis involved in cellular protein catabolic process ","Q00987; Q14790; P17655; P60900; Q99538"]
["GO:0002027","biological_process","regulation of heart rate ","Q00987; P17612; Q08499; P23327; P0DP23; Q92736; P32418; Q14524; Q9Y3Q4; Q99814; Q9Y5Y9; P14416; O14958; Q8N335; Q13424"]
["GO:0045472","biological_process","response to ether ","Q00987; P07101"]
["GO:1904404","biological_process","response to formaldehyde ","Q00987"]
["GO:0010039","biological_process","response to iron ion ","Q00987; Q16665; Q01959; P10415; P14416; P24385; O00213; Q16595"]
["GO:0048545","biological_process","response to steroid hormone ","Q00987; O75874; P00918; P37173; P68133"]
["GO:1990785","biological_process","response to water-immersion restraint stress ","Q00987; O43524; P98177"]
["GO:0036369","biological_process","transcription factor catabolic process ","Q00987"]
["GO:0007089","biological_process","traversing start control point of mitotic cell cycle ","Q00987; Q15131; Q99741"]
["GO:0048320","biological_process","axial mesoderm formation ","P29317; O15169"]
["GO:0002043","biological_process","blood vessel endothelial cell proliferation involved in sprouting angiogenesis ","P29317; P37023; O14713"]
["GO:0046058","biological_process","cAMP metabolic process ","P29317; P12272"]
["GO:0070309","biological_process","lens fiber cell morphogenesis ","P29317"]
["GO:0033598","biological_process","mammary gland epithelial cell proliferation ","P29317; P42226; P28482; P17676; Q02363; P24385"]
["GO:0032682","biological_process","negative regulation of chemokine production ","P29317"]
["GO:1901491","biological_process","negative regulation of lymphangiogenesis ","P29317; Q12948"]
["GO:0060035","biological_process","notochord cell development ","P29317"]
["GO:0014028","biological_process","notochord formation ","P29317"]
["GO:1904238","biological_process","pericyte cell differentiation ","P29317"]
["GO:0036342","biological_process","post-anal tail morphogenesis ","P29317; Q9ULK5; Q9H3D4"]
["GO:0010591","biological_process","regulation of lamellipodium assembly ","P29317; P42768; P16591; P63000; Q08495; Q8TE77; Q8WYL5; P47756; P60953"]
["GO:1902951","biological_process","negative regulation of dendritic spine maintenance ","Q13224; P06241; P04156; P02649"]
["GO:0030522","biological_process","intracellular receptor signaling pathway ","Q9Y6Q9; P40763; P35398; P10275; Q96RI1; Q15788; Q15596"]
["GO:0035624","biological_process","receptor transactivation ","Q9Y6Q9; P78536; P08913"]
["GO:2000035","biological_process","regulation of stem cell division ","Q9Y6Q9"]
["GO:0009653","biological_process","anatomical structure morphogenesis ","Q01167; P85037; P07101; P63000; Q08050; O14920; Q12778; O15111; P52799; P23771; O43524; P41180; Q99502; Q9UQR0; P53675; Q9UBC0; Q99504; Q9Y261; Q16658; P58012; P46695; P55316; Q9BZS1; P23759; P54198; P55317; P50219; Q14494; Q9NP62; P56693; P18858; P78337; Q9Y6M1; P31270; A8MYZ6; Q9NP71; O96028; P98161; Q9NQ50; P05783; P43121; Q8IUQ4; Q01860; P55327"]
["GO:0015721","biological_process","bile acid and bile salt transport ","P19793; Q96RI1; P13688; Q15788; Q15596"]
["GO:0060038","biological_process","cardiac muscle cell proliferation ","P19793; Q03167; Q12948; P52952; Q99958; P10644; P46531"]
["GO:0045994","biological_process","positive regulation of translational initiation by iron ","P19793; P01375"]
["GO:0060528","biological_process","secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development ","P19793; Q9BQA1; P55317; P46531"]
["GO:0006766","biological_process","vitamin metabolic process ","P19793"]
["GO:0001578","biological_process","microtubule bundle formation ","O43663; P53350; Q96L34; P07332; P11137; Q9HCH0; P30622; O95235; Q96SN8; P46821; Q14980; O94811; Q66K74"]
["GO:0000022","biological_process","mitotic spindle elongation ","O43663; Q02241"]
["GO:0098535","biological_process","de novo centriole assembly involved in multi-ciliated epithelial cell differentiation ","O00444"]
["GO:0046601","biological_process","positive regulation of centriole replication ","O00444; P37198"]
["GO:0060707","biological_process","trophoblast giant cell differentiation ","O00444; O75626; O14543; O96004; Q9HC62; Q99750; O95863; A0AVK6; Q96AV8"]
["GO:0006207","biological_process","'de novo' pyrimidine nucleobase biosynthetic process ","P27708; P42345"]
["GO:0044205","biological_process","'de novo' UMP biosynthetic process ","P27708"]
["GO:0019240","biological_process","citrulline biosynthetic process ","P27708"]
["GO:0017144","biological_process","drug metabolic process ","P27708; Q9HAW7; P08684; P20813; P16152"]
["GO:0006541","biological_process","glutamine metabolic process ","P27708; P51649; P49915; O94808; P17812; Q9NRF8; O43175; Q06210; P00367; P51608"]
["GO:0046134","biological_process","pyrimidine nucleoside biosynthetic process ","P27708"]
["GO:0051414","biological_process","response to cortisol ","P27708"]
["GO:0006228","biological_process","UTP biosynthetic process ","P27708; P22392; P15531; O60361"]
["GO:0042113","biological_process","B cell activation ","Q06187; Q9UQL6; P43403; P05771; P56524; P43681; P10809; O75563; Q14790; P11912; Q9GZY6; O00329; Q9UKV0"]
["GO:0002344","biological_process","B cell affinity maturation ","Q06187"]
["GO:0098761","biological_process","cellular response to interleukin- ","Q06187"]
["GO:0071226","biological_process","cellular response to molecule of fungal origin ","Q06187; P43405"]
["GO:0045579","biological_process","positive regulation of B cell differentiation ","Q06187; Q92835; P43405; Q92934; O75626; P17861; P51692; P50281"]
["GO:0001812","biological_process","positive regulation of type I hypersensitivity ","Q06187; P30273"]
["GO:0001805","biological_process","positive regulation of type III hypersensitivity ","Q06187; P30273"]
["GO:0002721","biological_process","regulation of B cell cytokine production ","Q06187"]
["GO:0007258","biological_process","JUN phosphorylation ","P45983; Q9UQF2"]
["GO:0090045","biological_process","positive regulation of deacetylase activity ","P45983"]
["GO:1900740","biological_process","positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway ","P45983; P04637; Q92934; Q9BXH1; Q04917; Q14186; O15350; Q01094; P10415; Q14790; P27348; P31947; P61981; P62258; Q13625; P55957; P63104; P31946; Q13794; Q9H3D4; P30419"]
["GO:1902595","biological_process","regulation of DNA replication origin binding ","P45983; Q9H211"]
["GO:0008593","biological_process","regulation of Notch signaling pathway ","Q86YV5; P40189; P57105; P15529; Q86Y01"]
["GO:0001945","biological_process","lymph vessel development ","P35916; P43405; Q12948"]
["GO:0090037","biological_process","positive regulation of protein kinase C signaling ","P35916; P25942"]
["GO:0060312","biological_process","regulation of blood vessel remodeling ","P35916; P13688"]
["GO:0003016","biological_process","respiratory system process ","P35916"]
["GO:0048813","biological_process","dendrite morphogenesis ","O43251; Q9UQM7; Q02078; Q00535; P06241; O15075; P11137; Q8N4C8; O14640; P05556; Q70Z35; O75096; P34741; Q8IZP0; Q9ULH0"]
["GO:0021942","biological_process","radial glia guided migration of Purkinje cell ","O43251; O14512; O75553"]
["GO:0019370","biological_process","leukotriene biosynthetic process ","P09917; P43405; Q16873"]
["GO:0002540","biological_process","leukotriene production involved in inflammatory response ","P09917"]
["GO:0019372","biological_process","lipoxygenase pathway ","P09917; P35354; P07203"]
["GO:0042759","biological_process","long-chain fatty acid biosynthetic process ","P09917; P35354; Q16873; P08684; Q9Y4I1; Q96PU8"]
["GO:0002029","biological_process","desensitization of -protein coupled receptor protein signaling pathway ","P25098"]
["GO:0007213","biological_process","-protein coupled acetylcholine receptor signaling pathway ","P25098; Q15078; Q9NQ66; P04899; P08172; P08173; P20309; O43665"]
["GO:0045988","biological_process","negative regulation of striated muscle contraction ","P25098"]
["GO:0003108","biological_process","negative regulation of the force of heart contraction by chemical signal ","P25098"]
["GO:0033605","biological_process","positive regulation of catecholamine secretion ","P25098; Q16623; Q14721"]
["GO:0007217","biological_process","tachykinin receptor signaling pathway ","P25098; P34947"]
["GO:0046718","biological_process","viral entry into host cell ","P25098; P05106; P30530; P0C6L3; P42566; O00505; Q9P2Y5; P49790; P49685; Q9H0M0; Q96J02"]
["GO:0019079","biological_process","viral genome replication ","P25098; P35659; P55072; P56545; Q13363; O43504"]
["GO:0007413","biological_process","axonal fasciculation ","P29323; P54753; Q15078; P21554; Q9NQC3; Q9NRY4"]
["GO:0021952","biological_process","central nervous system projection neuron axonogenesis ","P29323; P54762; P54753; O15075; O75592; P43354"]
["GO:0071679","biological_process","commissural neuron axon guidance ","P29323; P13591; Q14118"]
["GO:0022038","biological_process","corpus callosum development ","P29323; Q00535; P54753"]
["GO:0060997","biological_process","dendritic spine morphogenesis ","P29323; P54762; O75914; P54753; P60484; P78352; O00401; O14640; Q9UQB3; Q9BYB0; Q9UBN7; P60953; Q9Y566; Q7LC44"]
["GO:0051389","biological_process","inactivation of MAPKK activity ","P29323; P08069"]
["GO:1904782","biological_process","negative regulation of NMDA glutamate receptor activity ","P29323"]
["GO:0106028","biological_process","neuron projection retraction ","P29323; P49841"]
["GO:0021631","biological_process","optic nerve morphogenesis ","P29323; P54762; Q02962; P10071"]
["GO:0048170","biological_process","positive regulation of long-term neuronal synaptic plasticity ","P29323; P10721; Q9BYB0"]
["GO:1904783","biological_process","positive regulation of NMDA glutamate receptor activity ","P29323; O75916; Q9BXM7"]
["GO:0031915","biological_process","positive regulation of synaptic plasticity ","P29323; P35354; Q8WYL5; Q12834; P60880; Q6PUV4"]
["GO:0097104","biological_process","postsynaptic membrane assembly ","P29323; Q9P2S2; Q9ULB1; P58400; O75096; Q8N0W4; Q8N2Q7"]
["GO:0050878","biological_process","regulation of body fluid levels ","P29323"]
["GO:0048168","biological_process","regulation of neuronal synaptic plasticity ","P29323; Q9UQM7; P49675; O60229; P02649; Q13972; Q6X4W1; Q16643; Q7LC44"]
["GO:0031290","biological_process","retinal ganglion cell axon guidance ","P29323; P54762; P54753; P28827"]
["GO:0099557","biological_process","trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission ","P29323; Q15768"]
["GO:0001655","biological_process","urogenital system development ","P29323; P54753; Q02962; P23769"]
["GO:0015842","biological_process","aminergic neurotransmitter loading into synaptic vesicle ","P07101; Q05940"]
["GO:0042423","biological_process","catecholamine biosynthetic process ","P07101; P00439"]
["GO:0071287","biological_process","cellular response to manganese ion ","P07101; Q5S007; O60260; P11021"]
["GO:0042745","biological_process","circadian sleep/wake cycle ","P07101"]
["GO:0006585","biological_process","dopamine biosynthetic process from tyrosine ","P07101"]
["GO:0042755","biological_process","eating behavior ","P07101; P40763; P41143; P41146; P50416; P41145; P35372"]
["GO:0042418","biological_process","epinephrine biosynthetic process ","P07101"]
["GO:0042462","biological_process","eye photoreceptor cell development ","P07101; P41743; P11488; O75626; P26367"]
["GO:0016137","biological_process","glycoside metabolic process ","P07101"]
["GO:0033076","biological_process","isoquinoline alkaloid metabolic process ","P07101"]
["GO:0007626","biological_process","locomotory behavior ","P07101; Q9P286; P60484; Q9NYQ6; Q00975; Q96PM9; Q99767; P60983; P43681; P35462; P17542; Q9UD71; Q01959; P41594; P41161; Q13255; P00441; P14416; P05067; P41145; Q02297; Q02410; O43815; Q05940; P60880; P51608; P43699; Q04656; P35372"]
["GO:0007617","biological_process","mating behavior ","P07101; P05067; P21728"]
["GO:0042136","biological_process","neurotransmitter biosynthetic process ","P07101; P29475; P00439; Q9Y4D2; Q01959; P28329; P31645"]
["GO:0042421","biological_process","norepinephrine biosynthetic process ","P07101; P23771"]
["GO:0018963","biological_process","phthalate metabolic process ","P07101; P49675"]
["GO:0052314","biological_process","phytoalexin metabolic process ","P07101"]
["GO:0009635","biological_process","response to herbicide ","P07101; O43464; P49675"]
["GO:0046684","biological_process","response to pyrethroid ","P07101"]
["GO:0009651","biological_process","response to salt stress ","P07101; P08238; P30411; Q07812; P01375"]
["GO:0006665","biological_process","sphingolipid metabolic process ","P07101; O15269"]
["GO:0001963","biological_process","synaptic transmission, dopaminergic ","P07101; Q00535; P35462; P14416; P21728"]
["GO:0042214","biological_process","terpene metabolic process ","P07101"]
["GO:0032743","biological_process","positive regulation of interleukin- production ","Q01196; Q9BZL6; O43353; O43318; P04083; Q08499; Q12933; P23396; P41597; Q9Y4K3; Q07343; O75995"]
["GO:0045637","biological_process","regulation of myeloid cell differentiation ","Q01196; P05771; Q99062; Q9H4P4; Q92793; P17931; P13631"]
["GO:0045589","biological_process","regulation of regulatory T cell differentiation ","Q01196; Q13469; O15360; Q9BXW9; Q9BZS1; P01589; P10747; P16410; Q9NRR4"]
["GO:0010956","biological_process","negative regulation of calcidiol -monooxygenase activity ","P19838"]
["GO:0032269","biological_process","negative regulation of cellular protein metabolic process ","P19838; P02649"]
["GO:0032375","biological_process","negative regulation of cholesterol transport ","P19838"]
["GO:0045083","biological_process","negative regulation of interleukin-12 biosynthetic process ","P19838"]
["GO:0010957","biological_process","negative regulation of vitamin D biosynthetic process ","P19838; O43623; O95863"]
["GO:1900127","biological_process","positive regulation of hyaluronan biosynthetic process ","P19838; Q92819"]
["GO:1902170","biological_process","cellular response to reactive nitrogen species ","P42226; Q99683"]
["GO:0035771","biological_process","interleukin-4-mediated signaling pathway ","P42226; P52333"]
["GO:0060443","biological_process","mammary gland morphogenesis ","P42226; P37173"]
["GO:0002829","biological_process","negative regulation of type  immune response ","P42226; P41597"]
["GO:0048295","biological_process","positive regulation of isotype switching to IgE isotypes ","P42226"]
["GO:0002296","biological_process","T-helper 1 cell lineage commitment ","P42226; P42345; P16150"]
["GO:0071352","biological_process","cellular response to interleukin- ","Q99459"]
["GO:1990646","biological_process","cellular response to prolactin ","Q99459"]
["GO:1904568","biological_process","cellular response to wortmannin ","Q99459"]
["GO:0072422","biological_process","signal transduction involved in DNA damage checkpoint ","Q99459; Q9UMS4"]
["GO:0002268","biological_process","follicular dendritic cell differentiation ","Q00653; P20749"]
["GO:0007015","biological_process","actin filament organization ","P35221; P12814; O15357; P41743; Q9NYL9; Q9ULJ8; Q9BY11; P04075; P16333; P56945; Q9HBA0; Q92974; O60504; P10415; P52179; P54296; Q17R91; Q12959; Q5VZK9; O94875; P28289; P60953; Q14896; P09493; Q00872; Q16643; O14613"]
["GO:0034332","biological_process","adherens junction organization ","P35221; P41240; P12931; P49757; Q92692; P12830; P55196; P19022; O60716; P14923; P60953; Q9Y6R0; P33151; P15924"]
["GO:0043297","biological_process","apical junction assembly ","P35221; Q16513; P18206; P61586"]
["GO:0090136","biological_process","epithelial cell-cell adhesion ","P35221; P11831; P18206; P18084"]
["GO:0007163","biological_process","establishment or maintenance of cell polarity ","P35221; O00506; Q9Y5S2; P09693; Q8TEW0; P16150; P61160; Q12959; Q01518; O75122; P61158; Q14244; P60953; Q9NPB6"]
["GO:0016264","biological_process","gap junction assembly ","P35221; P17302; P08034; P36383"]
["GO:2000146","biological_process","negative regulation of cell motility ","P35221; P42768; P23771; P46108; Q13526; P09758"]
["GO:2001045","biological_process","negative regulation of integrin-mediated signaling pathway ","P35221; Q8IZ21"]
["GO:0051764","biological_process","actin crosslink formation ","P12814; P45379; Q14195; Q9UQB8; P29966; P21333; P13796; Q9UHR4; Q12929"]
["GO:0051017","biological_process","actin filament bundle assembly ","P12814; Q14511; P15311; Q96IZ0; Q14195; O43707; Q08495; Q16658; P35611; Q9UH65; Q9BR76; Q9UHB6; Q9UQB8; P29966; Q9H2D6; P13796; Q9UHR4; P35612; Q12929"]
["GO:0051639","biological_process","actin filament network formation ","P12814; O15511; Q53SF7; Q5VZK9; P13796"]
["GO:0051271","biological_process","negative regulation of cellular component movement ","P12814; O43707; Q03167; P46527; P23497"]
["GO:0036344","biological_process","platelet morphogenesis ","P12814"]
["GO:0042738","biological_process","exogenous drug catabolic process ","P29475; O75469; P08684; P20813"]
["GO:0033555","biological_process","multicellular organismal response to stress ","P29475; P60484; P01236; Q08209"]
["GO:0007520","biological_process","myoblast fusion ","P29475; P15172; Q9Y463; Q99697; Q9C0D5; O60500; O43184; O95180; P17655; P35579"]
["GO:0051926","biological_process","negative regulation of calcium ion transport ","P29475; P29474; P35354; P26678; P08913"]
["GO:0010523","biological_process","negative regulation of calcium ion transport into cytosol ","P29475; P10415"]
["GO:0043267","biological_process","negative regulation of potassium ion transport ","P29475; Q14289; P29474; P28223; P18848; P22460; O14958"]
["GO:0140196","biological_process","positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process ","P29475"]
["GO:1902307","biological_process","positive regulation of sodium ion transmembrane transport ","P29475"]
["GO:0098735","biological_process","positive regulation of the force of heart contraction ","P29475; Q92736; P32418; P19634; P10916"]
["GO:1903779","biological_process","regulation of cardiac conduction ","P29475; Q09013; P17612; Q01814; O43865; P16066; Q92736; P32418; Q13586; P52952; Q14573; Q14643; Q14571; P31415; O14958; P23634; P21817; P16615"]
["GO:0055117","biological_process","regulation of cardiac muscle contraction ","P29475; P17612; P0DP23; Q92736; P52952; Q9Y3Q4; O15105; Q9Y5Y9; P35368"]
["GO:0098924","biological_process","retrograde trans-synaptic signaling by nitric oxide ","P29475"]
["GO:0006941","biological_process","striated muscle contraction ","P29475; P04075; Q8WZ42; P52179; P54296; O14958; Q9H1R3; Q9UHP9; Q14896; Q00872"]
["GO:0042311","biological_process","vasodilation ","P29475; P29474; P41180; P30411; Q9H1Y0; P02649; P50052; P07203; P21728"]
["GO:0034329","biological_process","cell junction assembly ","Q13418; P60709; P50552; Q96AC1; P21333; Q14315; P61586; P52907; P60953; P63261"]
["GO:0045197","biological_process","establishment or maintenance of epithelial cell apical/basal polarity ","Q13418; Q7KZI7; Q96RT1; P41743; P78352; Q14160; Q8TDM6; Q9ULK5; Q99626; Q12959"]
["GO:0032288","biological_process","myelin assembly ","Q13418; Q9Y2I7; Q13614"]
["GO:2000178","biological_process","negative regulation of neural precursor cell proliferation ","Q13418; Q13905; P78543; P26367; Q02363; P23769"]
["GO:0014912","biological_process","negative regulation of smooth muscle cell migration ","Q13418; Q9UBK2; P17936; Q07954; P27695; P36894"]
["GO:0021675","biological_process","nerve development ","Q13418"]
["GO:0009967","biological_process","positive regulation of signal transduction ","Q13418; P23771; Q9UBN7; Q86YM7; Q9BY44"]
["GO:0043970","biological_process","histone H-K acetylation ","Q53ET0"]
["GO:1900121","biological_process","negative regulation of receptor binding ","P10586; Q13444"]
["GO:0031102","biological_process","neuron projection regeneration ","P10586; O75385; P14136; P02649"]
["GO:0048679","biological_process","regulation of axon regeneration ","P10586; Q02750; Q9Y6E0; O43474"]
["GO:0099560","biological_process","synaptic membrane adhesion ","P10586; Q9HCJ2; Q9ULB1; Q02297; Q96PX8; Q8N2Q7"]
["GO:0043534","biological_process","blood vessel endothelial cell migration ","Q14289; Q8WTV0; P07203; Q4VCS5; P35579; P41134"]
["GO:0045453","biological_process","bone resorption ","Q14289; P63000; P12931; Q03431; Q38SD2; Q9Y4K3; O14773; Q9NPH5; P07550"]
["GO:0070098","biological_process","chemokine-mediated signaling pathway ","Q14289; Q12948; P41597"]
["GO:0060292","biological_process","long term synaptic depression ","Q14289; P11831; P42261; P60484; Q9NYY3; Q9UI40; P61764; Q9UPX8; P21728; Q9NRD5"]
["GO:0002315","biological_process","marginal zone B cell differentiation ","Q14289; P20749"]
["GO:0010656","biological_process","negative regulation of muscle cell apoptotic process ","Q14289; Q5D1E8; P09601"]
["GO:0001556","biological_process","oocyte maturation ","Q14289; P14635; O43524; Q9UKT4; Q92904; Q5TAX3; P30305; Q14432; P51587"]
["GO:2000538","biological_process","positive regulation of B cell chemotaxis ","Q14289"]
["GO:0010752","biological_process","regulation of cMP-mediated signaling ","Q14289"]
["GO:0032960","biological_process","regulation of inositol trisphosphate biosynthetic process ","Q14289"]
["GO:0010758","biological_process","regulation of macrophage chemotaxis ","Q14289"]
["GO:0010226","biological_process","response to lithium ion ","Q14289; P35354; Q08828; Q13144; P50553; P68133; P30613"]
["GO:0043149","biological_process","stress fiber assembly ","Q14289; P49407; P11831; P12931; Q9BX66; Q13829; P18084; Q15942; P61586"]
["GO:0044539","biological_process","long-chain fatty acid import ","P23443; P33121; P16671; P07814"]
["GO:0048633","biological_process","positive regulation of skeletal muscle tissue growth ","P23443; Q13765"]
["GO:0045948","biological_process","positive regulation of translational initiation ","P23443; Q9UBS0; Q92904; Q13144; O00571; Q5JVS0; Q8TAS1; Q07666"]
["GO:0046324","biological_process","regulation of glucose import ","P23443; P52789; O75298; Q9UKG1"]
["GO:0014878","biological_process","response to electrical stimulus involved in regulation of muscle adaptation ","P23443; Q9UBK2; P15173"]
["GO:0033762","biological_process","response to glucagon ","P23443; P16220; P36956; Q16526; P20248; P09417; P16118"]
["GO:0043201","biological_process","response to leucine ","P23443; Q9UBK2; Q8NEB9"]
["GO:0014732","biological_process","skeletal muscle atrophy ","P23443; Q9UBK2; P15173; O15519"]
["GO:0030534","biological_process","adult behavior ","Q9UM73; O15525; P60484; P18507; Q9P2S2; Q9ULB1; P58400; Q9BYB0; Q9UPX8; Q8N0W4; Q96PX8; Q9Y566"]
["GO:0060159","biological_process","regulation of dopamine receptor signaling pathway ","Q9UM73; Q5S007"]
["GO:0090648","biological_process","response to environmental enrichment ","Q9UM73"]
["GO:0036269","biological_process","swimming behavior ","Q9UM73"]
["GO:0048708","biological_process","astrocyte differentiation ","P40763; Q13144; P26367; P46531"]
["GO:0001754","biological_process","eye photoreceptor cell differentiation ","P40763"]
["GO:0033210","biological_process","leptin-mediated signaling pathway ","P40763; Q96EB6; Q96A54; P48357"]
["GO:0035278","biological_process","miRNA mediated inhibition of translation ","P40763; P56537; Q9BWF3; Q9UPQ9; P26651; Q9UKV8"]
["GO:0042789","biological_process","mRNA transcription by RNA polymerase II ","P40763; P11831; P27540; P15173; Q16665; P36956; P18848; Q7KZ85; P21333; P21730; Q12800; P35638; Q14103; Q15648; Q01860"]
["GO:0010730","biological_process","negative regulation of hydrogen peroxide biosynthetic process ","P40763; P06241"]
["GO:2001171","biological_process","positive regulation of ATP biosynthetic process ","P40763; P06733; P00403; Q9UBK2; P55072; Q16635; Q9BXM7"]
["GO:2000637","biological_process","positive regulation of gene silencing by miRNA ","P40763; P51114; Q9UGP4; Q14671; Q06787; Q96IF1; P26651"]
["GO:0060019","biological_process","radial glial cell differentiation ","P40763; P19022"]
["GO:0060259","biological_process","regulation of feeding behavior ","P40763; Q9P2K8; P21554; P48357"]
["GO:0046902","biological_process","regulation of mitochondrial membrane permeability ","P40763; P04637; Q92934; P30405; P10415; P12235; Q07817; Q16611; Q13794"]
["GO:0044321","biological_process","response to leptin ","P40763; Q96EB6; P49675; P24385; P48357; P20393"]
["GO:0019953","biological_process","sexual reproduction ","P40763; O15240; Q15056; P48357"]
["GO:0001659","biological_process","temperature homeostasis ","P40763; Q12778; P28223; Q9UBK2; P08588; P14416; P07203; P21728; O94759"]
["GO:0072540","biological_process","T-helper 1 cell lineage commitment ","P40763; Q15306"]
["GO:0001783","biological_process","B cell apoptotic process ","Q16512; O43521; O43734; Q07812; O95999; Q16611"]
["GO:0010631","biological_process","epithelial cell migration ","Q16512; Q16513; Q8WY41; Q6P5Z2"]
["GO:0035407","biological_process","histone H-T11 phosphorylation ","Q16512"]
["GO:0002637","biological_process","regulation of immunoglobulin production ","Q16512"]
["GO:0003014","biological_process","renal system process ","Q16512; P11274; Q7LG56; P10415; Q99538"]
["GO:0007188","biological_process","adenylate cyclase-modulating -protein coupled receptor signaling pathway ","P34947; P22694; Q14344; P11488; Q03431; P21554; P19086; Q9Y6W5; P32245; P08172; P21462; P30679; Q08462; P35368; Q01668; P07550; P30518; Q03113"]
["GO:0046949","biological_process","fatty-acyl-CoA biosynthetic process ","Q13085; P49327; P53396; O00767"]
["GO:0019538","biological_process","protein metabolic process ","Q13085; O95816; Q9Y6R0"]
["GO:1904714","biological_process","regulation of chaperone-mediated autophagy ","P68104; P14136; Q05639"]
["GO:0038166","biological_process","angiotensin-activated signaling pathway ","Q9UQM7; O43865; P00918; P30556"]
["GO:0006816","biological_process","calcium ion transport ","Q9UQM7; Q03135; P06241; P36544; O00631; Q01814; O15554; Q13563; P43681; P30626; P51681; Q9NQA5; Q9HBA0; Q96RD7; P26678; Q92736; P11473; Q08209; P08133; Q13507; Q14643; Q01668; P49810; P13693; O94759; Q9H1D0; P08195; P21817; Q13698"]
["GO:1990443","biological_process","peptidyl-threonine autophosphorylation ","Q9UQM7"]
["GO:1902108","biological_process","regulation of mitochondrial membrane permeability involved in apoptotic process ","Q9UQM7"]
["GO:0099148","biological_process","regulation of synaptic vesicle docking ","Q9UQM7"]
["GO:0010952","biological_process","positive regulation of peptidase activity ","P53778; Q9BXM7; Q9P0J0"]
["GO:0000422","biological_process","autophagy of mitochondrion ","Q7KZI7; Q9C0C7; Q9Y4P1; Q9UBK2; Q5MNZ6; Q9H1Y0; Q96BY7; Q13501; Q9Y4P8; Q9BXM7; Q9GZQ8; Q9NT62; Q8N726; Q7Z3C6; Q9H492; O60260; Q14457"]
["GO:0071963","biological_process","establishment or maintenance of cell polarity regulating cell shape ","Q7KZI7"]
["GO:0051646","biological_process","mitochondrion localization ","Q7KZI7; Q5S007; O95140; Q8IWA4; Q9UBN7"]
["GO:1904526","biological_process","regulation of microtubule binding ","Q7KZI7; P67775"]
["GO:0060271","biological_process","cilium assembly ","P20794; Q9UPZ9; Q9NRP7; Q9UBB4; Q96QF0; Q9UBC0; Q15154; Q15019; Q96PY6; P61160; Q9ULH1; Q16181; O95613; Q9UBN7; P06396; P61158; P21333; P46531; P63167; P22674; Q9Y496; Q9GZV5; Q86YF9"]
["GO:0042073","biological_process","intraciliary transport ","P20794; Q9UPZ9"]
["GO:1902856","biological_process","negative regulation of non-motile cilium assembly ","P20794; P50570; P27816"]
["GO:0045494","biological_process","photoreceptor cell maintenance ","P20794; Q5TZA2; Q03468; O43490; P08100"]
["GO:0071453","biological_process","cellular response to oxygen levels ","P15172"]
["GO:0042693","biological_process","muscle cell fate commitment ","P15172; P15173; P13349; P23409"]
["GO:0007518","biological_process","myoblast fate determination ","P15172"]
["GO:0014904","biological_process","myotube cell development ","P15172; Q13469"]
["GO:0014908","biological_process","myotube differentiation involved in skeletal muscle regeneration ","P15172"]
["GO:2000818","biological_process","negative regulation of myoblast proliferation ","P15172"]
["GO:1901741","biological_process","positive regulation of myoblast fusion ","P15172; Q13469; Q16539; P15173; O75955; P13349; P24394; P23409"]
["GO:0048743","biological_process","positive regulation of skeletal muscle fiber development ","P15172; Q96TA1; P15173; P10415; P13349; P23409"]
["GO:0043415","biological_process","positive regulation of skeletal muscle tissue regeneration ","P15172; P37173"]
["GO:1905382","biological_process","positive regulation of snRNA transcription by RNA polymerase II ","P15172"]
["GO:0043503","biological_process","skeletal muscle fiber adaptation ","P15172; P68133"]
["GO:0007253","biological_process","cytoplasmic sequestering of NF-kappaB ","P25963; Q9UNN5"]
["GO:0042994","biological_process","cytoplasmic sequestering of transcription factor ","P25963; O00221; Q14145; Q13563; P30626; P10827; Q99750; Q9UMX1; P98161"]
["GO:0010888","biological_process","negative regulation of lipid storage ","P25963; P05106; P17706; P01375"]
["GO:0070427","biological_process","nucleotide-binding oligomerization domain containing 1 signaling pathway ","P25963; O43353"]
["GO:0010875","biological_process","positive regulation of cholesterol efflux ","P25963; Q96EB6; P55055; P02649; Q13133; O95477; Q07954"]
["GO:0072749","biological_process","cellular response to cytochalasin B ","P60709"]
["GO:0051623","biological_process","positive regulation of norepinephrine uptake ","P60709"]
["GO:0098974","biological_process","postsynaptic actin cytoskeleton organization ","P60709; Q9ULJ8; Q9Y6W5"]
["GO:1903076","biological_process","regulation of protein localization to plasma membrane ","P60709; Q00535; P10275; Q9UKG1; Q01082; O60229; P50281"]
["GO:0006284","biological_process","base-excision repair ","P17096; P04637; Q53HV7; Q96FI4; P27694; P39748; Q03468; P06746; P15927; P23025; P13051; P18858; Q13569; Q8N6T7; Q96LA8; Q7Z6Z7; P52926; P18887; P27695; Q14191"]
["GO:0006268","biological_process","DNA unwinding involved in DNA replication ","P17096; P49736; Q06609; P33993; P33991"]
["GO:0031936","biological_process","negative regulation of chromatin silencing ","P17096; Q9Y294"]
["GO:0090402","biological_process","oncogene-induced cell senescence ","P17096; P52926"]
["GO:2000774","biological_process","positive regulation of cellular senescence ","P17096; Q96IZ0; Q96EB6; P01116; P42771; Q8N884; P52926"]
["GO:0035986","biological_process","senescence-associated heterochromatin focus assembly ","P17096; P42771; P52926"]
["GO:0071447","biological_process","cellular response to hydroperoxide ","Q15139; Q05655; P16671; P53355"]
["GO:0045806","biological_process","negative regulation of endocytosis ","Q15139; P29320; P17931; Q13614"]
["GO:1901727","biological_process","positive regulation of histone deacetylase activity ","Q15139; Q9BZL6; Q5S007; Q9BXM7"]
["GO:0089700","biological_process","protein kinase D signaling ","Q15139; Q9BZL6; O94806"]
["GO:2001044","biological_process","regulation of integrin-mediated signaling pathway ","Q15139; O14713"]
["GO:0030148","biological_process","sphingolipid biosynthetic process ","Q15139; Q9BZL6; O94806; Q6ZMG9; Q8N5B7; Q9NYA1; P78368; O15269; Q9NRA0; Q9HA82; Q9Y5P4"]
["GO:0009395","biological_process","phospholipid catabolic process ","P19174; P16885; P47712"]
["GO:0032237","biological_process","activation of store-operated calcium channel activity ","P16885; Q13586"]
["GO:0002316","biological_process","follicular B cell differentiation ","P16885; P31994"]
["GO:0032959","biological_process","inositol trisphosphate biosynthetic process ","P16885; P22307"]
["GO:0043069","biological_process","negative regulation of programmed cell death ","P16885; P10721; Q02962; P62195; Q03112; P37198; Q01851"]
["GO:0002092","biological_process","positive regulation of receptor internalization ","P16885; P49407; P43405; Q06787; P14416; P32121; Q86UL8; Q9NRD5"]
["GO:0007589","biological_process","body fluid secretion ","P07355; P16066; Q9UMX6"]
["GO:0052362","biological_process","catabolism by host of symbiont protein ","P07355"]
["GO:0042730","biological_process","fibrinolysis ","P07355; P02671; P00747; P00749"]
["GO:0001765","biological_process","membrane raft assembly ","P07355; Q14254; O75955"]
["GO:0052405","biological_process","negative regulation by host of symbiont molecular function ","P07355"]
["GO:0044147","biological_process","negative regulation of development of symbiont involved in interaction with host ","P07355"]
["GO:0032804","biological_process","negative regulation of low-density lipoprotein particle receptor catabolic process ","P07355; P09958"]
["GO:0036035","biological_process","osteoclast development ","P07355; P12931; Q38SD2"]
["GO:1905581","biological_process","positive regulation of low-density lipoprotein particle clearance ","P07355"]
["GO:1905597","biological_process","positive regulation of low-density lipoprotein particle receptor binding ","P07355"]
["GO:1905599","biological_process","positive regulation of low-density lipoprotein receptor activity ","P07355"]
["GO:1905602","biological_process","positive regulation of receptor-mediated endocytosis involved in cholesterol transport ","P07355"]
["GO:0044090","biological_process","positive regulation of vacuole organization ","P07355"]
["GO:0031340","biological_process","positive regulation of vesicle fusion ","P07355; P31751; P04083; Q86YS7; P33176"]
["GO:0097066","biological_process","response to thyroid hormone ","P07355"]
["GO:0006900","biological_process","vesicle budding from membrane ","P07355; O00401; Q96CW1"]
["GO:0035720","biological_process","intraciliary anterograde transport ","Q9UPZ9"]
["GO:0035721","biological_process","intraciliary retrograde transport ","Q9UPZ9"]
["GO:0050892","biological_process","intestinal absorption ","P21399; P16671; Q8WTV0; P11473; P51787; P48200; P08913; Q9UDY2; Q9Y624"]
["GO:0006099","biological_process","tricarboxylic acid cycle ","P21399; O75874; P40926; P10515; Q13423; P40925; Q99798; P07954; P08559; P29803; P31040"]
["GO:0006342","biological_process","chromatin silencing ","Q9UQL6; P16104; Q96EB6; Q9UBU8; O15297; Q7KZ85; P0C0S8; P51608; Q8IXJ6; O14686"]
["GO:0010832","biological_process","negative regulation of myotube differentiation ","Q9UQL6; P56524; P23560; Q8IZQ8; Q9GZV1; P52952; P17861; P46531"]
["GO:0040029","biological_process","regulation of gene expression, epigenetic ","Q9UQL6; P56524; Q13330; Q9UBN7; Q13569; P07203; Q16666; P49711"]
["GO:0010830","biological_process","regulation of myotube differentiation ","Q9UQL6; Q09013; P57059; Q9H0Z9"]
["GO:0043393","biological_process","regulation of protein binding ","Q9UQL6; P53350; P17612; P12931; Q14012; P56524; P46108; Q03167; Q9NQC7; P23759; P36897; O95295; Q6STE5; Q9NR22; Q86YF9"]
["GO:0043366","biological_process","beta selection ","P43403; P43405; P61586"]
["GO:0046638","biological_process","positive regulation of alpha-beta T cell differentiation ","P43403; P43405; P61586; P10071"]
["GO:0050850","biological_process","positive regulation of calcium-mediated signaling ","P43403; P43405; P49773; P07766; Q9UBL9; Q6PIZ9; P01730"]
["GO:0045582","biological_process","positive regulation of T cell differentiation ","P43403; Q92934; P23771; Q9NQC7; P01589; P17861"]
["GO:0042110","biological_process","T cell activation ","P43403; P42768; Q08881; P84022; P06241; Q9NQT8; P09693; P07766; P10809; P16333; P48736; Q14790; Q9BZS1; Q08209; Q12959; P10747; Q5ZPR3; O43561; P16471; Q15306; O00329"]
["GO:0070489","biological_process","T cell aggregation ","P43403; P26038"]
["GO:0072678","biological_process","T cell migration ","P43403; P26038; P26010; P21453; P49685"]
["GO:0097010","biological_process","eukaryotic translation initiation factor 4F complex assembly ","P23588; Q15056"]
["GO:0001731","biological_process","formation of translation preinitiation complex ","P23588; P55010; Q7Z2Z1; Q15056; Q9ULC4"]
["GO:0019882","biological_process","antigen processing and presentation ","Q01201; P61020; P20338"]
["GO:0071470","biological_process","cellular response to osmotic stress ","Q01201; P14672; Q13563; Q9HBA0; O00571"]
["GO:0032688","biological_process","negative regulation of interferon-beta production ","Q01201; Q04864; O75688; Q9ULZ3; P25490"]
["GO:0072593","biological_process","reactive oxygen species metabolic process ","Q16654; Q5S007; P15498; O75489; Q13423; Q9UII2; O43181; Q02962; P10415; P00441; Q9NPH5; Q9P0J0; Q13794"]
["GO:0046320","biological_process","regulation of fatty acid oxidation ","Q16654"]
["GO:0002326","biological_process","B cell lineage commitment ","P78527; P15923; P10415; P55895"]
["GO:0097681","biological_process","double-strand break repair via alternative nonhomologous end joining ","P78527; P49916"]
["GO:0035234","biological_process","ectopic germ cell programmed cell death ","P78527; P10721; Q07812; P42575"]
["GO:0033152","biological_process","immunoglobulin V(D)J recombination ","P78527; P15923; P49917"]
["GO:0002638","biological_process","negative regulation of immunoglobulin production ","P78527; Q96P31; P31994"]
["GO:2001229","biological_process","negative regulation of response to gamma radiation ","P78527"]
["GO:0048639","biological_process","positive regulation of developmental growth ","P78527; P06213; Q9NQ66"]
["GO:0048660","biological_process","regulation of smooth muscle cell proliferation ","P78527; P35222; P13010; P12956; Q9NQB0; P54750"]
["GO:0072431","biological_process","signal transduction involved in mitotic  DNA damage checkpoint ","P78527"]
["GO:0033077","biological_process","T cell differentiation in thymus ","P78527; Q13158; Q9C0K0; P10415; Q9Y5Q3; P78536; P49917; P55895; Q9Y572; P51692; Q07352; P10071; Q6IBW4"]
["GO:0002360","biological_process","T cell lineage commitment ","P78527; P55895"]
["GO:0071550","biological_process","death-inducing signaling complex assembly ","Q13546; P04049; Q13158; Q12933; P19438; Q14790; P01375"]
["GO:0002756","biological_process","MyD88-independent toll-like receptor signaling pathway ","Q13546; O14920; Q9Y6K9; O15111; O15455; O00206; Q86XR7; Q9Y6Y9"]
["GO:0070266","biological_process","necroptotic process ","Q13546; P30405; O15455; P48023; Q9NQC7; O00429; O00206; P06737; Q86XR7; Q9Y572; Q96QT4; Q9Y6Y9; Q8NB16"]
["GO:0097527","biological_process","necroptotic signaling pathway ","Q13546; Q13158; O15455; P25445; P48023; P01375"]
["GO:1905206","biological_process","positive regulation of hydrogen peroxide-induced cell death ","Q13546"]
["GO:0032757","biological_process","positive regulation of interleukin-8 production ","Q13546; Q9BZL6; Q7Z434; Q13158; O95786; O15455; Q99497; P0DMV8; P01375; Q8N4X5; O00206; P35638; O60602; P58753"]
["GO:0060545","biological_process","positive regulation of necroptotic process ","Q13546; Q9Y572"]
["GO:0010940","biological_process","positive regulation of necrotic cell death ","Q13546; P00403"]
["GO:0070926","biological_process","regulation of ATPADP antiporter activity ","Q13546"]
["GO:1902041","biological_process","regulation of extrinsic apoptotic signaling pathway via death domain receptors ","Q13546; Q13158; Q12933; P25445; P48023; Q14790; P17931; O15519; P23497"]
["GO:0097343","biological_process","ripoptosome assembly ","Q13546"]
["GO:1901026","biological_process","ripoptosome assembly involved in necroptotic process ","Q13546; Q9NQC7"]
["GO:0070231","biological_process","T cell apoptotic process ","Q13546; P48023; O95999; P24390"]
["GO:0034138","biological_process","toll-like receptor  signaling pathway ","Q13546; Q13158; O15455; Q8TDQ0; Q14790"]
["GO:0071469","biological_process","cellular response to alkaline pH ","P14616"]
["GO:0030238","biological_process","male sex determination ","P14616; P06213; Q13285; Q15637"]
["GO:0016321","biological_process","female meiosis chromosome segregation ","P53350; P33981; P40692"]
["GO:0045143","biological_process","homologous chromosome segregation ","P53350; Q14674; Q9NZH5; O95997"]
["GO:0051081","biological_process","nuclear envelope disassembly ","P53350; Q9GZM8; Q14203"]
["GO:1904668","biological_process","positive regulation of ubiquitin protein ligase activity ","P53350; Q08379; P60484; Q9BQQ3; Q96GX5; Q16763; P62820; Q12834; Q9UM11"]
["GO:0051443","biological_process","positive regulation of ubiquitin-protein transferase activity ","P53350; Q9NS56; P35226; P68036; Q9UNE7; Q9BXM7; P43356; P61088; O15169; Q13526; Q969H0; Q8NCT1"]
["GO:0090435","biological_process","protein localization to nuclear envelope ","P53350"]
["GO:1902749","biological_process","regulation of cell cycle /M phase transition ","P53350; P04637; Q9NYZ3"]
["GO:0030071","biological_process","regulation of mitotic metaphase/anaphase transition ","P53350; Q9BVS4; Q9HC98; Q02224; Q99741; Q9UJX5; Q8NHZ8; Q9UJX2"]
["GO:0070194","biological_process","synaptonemal complex disassembly ","P53350; P54652"]
["GO:0090557","biological_process","establishment of endothelial intestinal barrier ","P49327; P55196; Q9Y4G8; Q07157; Q9UDY2; Q9Y624"]
["GO:0008611","biological_process","ether lipid biosynthetic process ","P49327"]
["GO:0045333","biological_process","cellular respiration ","Q14934; Q9UBK2; O75489; O43181; P99999; Q969Z0"]
["GO:0055001","biological_process","muscle cell development ","Q14934; O60341; Q96KG7; O15169"]
["GO:0035562","biological_process","negative regulation of chromatin binding ","Q14934; Q7Z5K2; Q08209; Q9HC62; Q13569; Q7L2J0"]
["GO:0050774","biological_process","negative regulation of dendrite morphogenesis ","Q14934; Q04917; Q9Y210; Q9BQQ3; Q9Y4G8; Q08209; P41134"]
["GO:2000297","biological_process","negative regulation of synapse maturation ","Q14934"]
["GO:0030178","biological_process","negative regulation of Wnt signaling pathway ","Q14934; Q9UBE8; Q99966; Q9HBU1; Q9Y3M2; P63244; Q9NYF0; P49815; Q13322; Q99750; O95644; Q07954; Q9NZC7; Q04724"]
["GO:0048872","biological_process","homeostasis of number of cells ","P11274; P16871; P32248; P19022; Q9NQC7; P50749; P06746; Q9BXL7; Q15020; Q9NYV6"]
["GO:0065002","biological_process","intracellular protein transmembrane transport ","P11274; P31751; O75298; Q86YS7"]
["GO:0060313","biological_process","negative regulation of blood vessel remodeling ","P11274"]
["GO:0002692","biological_process","negative regulation of cellular extravasation ","P11274"]
["GO:0043314","biological_process","negative regulation of neutrophil degranulation ","P11274"]
["GO:0060268","biological_process","negative regulation of respiratory burst ","P11274"]
["GO:0050766","biological_process","positive regulation of phagocytosis ","P11274; Q8IU85; Q12866; P02765; P13498; P50570; P30273; P01375; P31994; Q9ULZ3; P23769"]
["GO:0051171","biological_process","regulation of nitrogen compound metabolic process ","P11274"]
["GO:0051056","biological_process","regulation of small TPase mediated signal transduction ","P11274; P63000; O00459; P15498; Q13459; Q14344; Q8N5V2; P52565; Q9P2F6; P47736; Q15642; Q8TCU6; P52735; O75962; Q96P48; O14559; Q7Z5H3; Q92974; Q2M1Z3; P52757; Q15311; Q96QB1; Q96DR7; Q14155; Q12802; Q8IVF5; O60229; Q9UKW4; P85298; Q96PE2; Q9P227; Q8IXI2; Q9H0H5; Q15052; Q9H7P9; Q92888; O43295; Q8N264; Q9H8V3; Q9UNA1; Q68EM7; Q8WWN8; P49815; Q7L0Q8; O94827; Q15669; Q13009; P62745; P31150; P52566; Q9NRY4; Q07889; Q13017; P61586; P60953; O14827; Q5T5U3; Q4VCS5; O43166; Q9NR80; P50395; P17081; Q684P5; Q7Z628"]
["GO:0043114","biological_process","regulation of vascular permeability ","P11274; P07947; P12931; Q02763; P30411; P16066; P35367"]
["GO:0035584","biological_process","calcium-mediated signaling using intracellular calcium source ","P35968; P17612; Q08495; Q92736; P04156; P41594; Q9NSB8; O94759"]
["GO:1904881","biological_process","cellular response to hydrogen sulfide ","P35968; Q9BXM7"]
["GO:0003158","biological_process","endothelium development ","P35968; P17302; P28906"]
["GO:0051901","biological_process","positive regulation of mitochondrial depolarization ","P35968; P63244; P09874"]
["GO:0090141","biological_process","positive regulation of mitochondrial fission ","P35968; Q9GZY8; Q9NQG6; Q8NEL9; O00429; Q9BXM7; O60260"]
["GO:2001214","biological_process","positive regulation of vasculogenesis ","P35968; P28906; P62834; Q9Y4G8; P13688"]
["GO:0061154","biological_process","endothelial tube morphogenesis ","Q9BZL6; P35222; Q9BSQ5; P67870; P62745; P37023"]
["GO:0045743","biological_process","positive regulation of fibroblast growth factor receptor signaling pathway ","Q9BZL6; P58400; Q14512"]
["GO:1902533","biological_process","positive regulation of intracellular signal transduction ","Q9BZL6; Q02763; Q38SD2; Q8N2Q7"]
["GO:0071243","biological_process","cellular response to arsenic-containing substance ","Q9HBH9; P30405; O00571; P09601"]
["GO:0032233","biological_process","positive regulation of actin filament bundle assembly ","P53667; P07737; P09327; Q9UH65; P21333; P08567; P41134"]
["GO:0006874","biological_process","cellular calcium ion homeostasis ","Q09013; Q03135; P36544; P41180; P28223; Q13002; Q7Z2W7; P19429; Q7L0J3; Q9HBA0; P35462; Q92736; P41597; O76061; Q9UI40; P11473; P02649; Q13586; P50461; Q9UJZ1; P18848; P42338; P14416; P23634; P13693; P25942; P16615; Q96TC7"]
["GO:0010657","biological_process","muscle cell apoptotic process ","Q09013"]
["GO:0006998","biological_process","nuclear envelope organization ","Q09013; P02545; Q9Y2U8; P48678; O94901; Q9UH99"]
["GO:0014853","biological_process","regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction ","Q09013"]
["GO:0014722","biological_process","regulation of skeletal muscle contraction by calcium ion signaling ","Q09013"]
["GO:0042501","biological_process","serine phosphorylation of STAT protein ","Q9UBE8; Q00535; Q15078"]
["GO:0033979","biological_process","box H/ACA snoRNA metabolic process ","Q14978"]
["GO:0014032","biological_process","neural crest cell development ","Q14978; O43623; Q12948; Q13428; Q99958; Q02297; P36894; P48436"]
["GO:0014029","biological_process","neural crest formation ","Q14978; Q13428; O75581"]
["GO:0007000","biological_process","nucleolus organization ","Q14978; Q9NYV6; P39019"]
["GO:0042306","biological_process","regulation of protein import into nucleus ","Q14978; P50052; P37198"]
["GO:0071283","biological_process","cellular response to iron(III) ion ","P14635"]
["GO:2000775","biological_process","histone H3-S1 phosphorylation involved in chromosome condensation ","P14635"]
["GO:0007080","biological_process","mitotic metaphase plate congression ","P14635; Q02224; Q99661; O75351; Q14807; Q15058; Q96BK5; P62491; Q9BW19; Q53HL2; Q9UJX2; Q96FF9; O43264; P37198; Q8WUX9; Q96CF2; Q14457"]
["GO:0051987","biological_process","positive regulation of attachment of spindle microtubules to kinetochore ","P14635; Q8IXJ6"]
["GO:0031442","biological_process","positive regulation of mRNA '-end processing ","P14635; Q6P1J9; Q8WVC0; P52298; Q09161"]
["GO:0060623","biological_process","regulation of chromosome condensation ","P14635; Q7Z5K2"]
["GO:0090266","biological_process","regulation of mitotic cell cycle spindle assembly checkpoint ","P14635; P28562; Q96SN8"]
["GO:0046680","biological_process","response to DDT ","P14635"]
["GO:0043990","biological_process","histone H2A-S1 phosphorylation ","O75582"]
["GO:0038027","biological_process","apolipoprotein A-I-mediated signaling pathway ","P05106; P61586"]
["GO:0033627","biological_process","cell adhesion mediated by integrin ","P05106; P04004; P05556; P17301; P78536"]
["GO:0031589","biological_process","cell-substrate adhesion ","P05106; P54762; P51817; P05556; O60504; P17301; O43541"]
["GO:0050919","biological_process","negative chemotaxis ","P05106; P61586"]
["GO:0032369","biological_process","negative regulation of lipid transport ","P05106; P55055; Q13133"]
["GO:0050748","biological_process","negative regulation of lipoprotein metabolic process ","P05106"]
["GO:0045715","biological_process","negative regulation of low-density lipoprotein particle receptor biosynthetic process ","P05106"]
["GO:0099149","biological_process","regulation of postsynaptic neurotransmitter receptor internalization ","P05106; P49757; Q14160; P35462; Q02297; P84074; Q7LC44"]
["GO:0014909","biological_process","smooth muscle cell migration ","P05106; Q08345; O15511; O60229; P00749"]
["GO:0035295","biological_process","tube development ","P05106; P10070"]
["GO:0070365","biological_process","hepatocyte differentiation ","P41235; P04083; Q12962; P17301; Q03014; A0AVK6; Q96AV8"]
["GO:0006591","biological_process","ornithine metabolic process ","P41235"]
["GO:0055091","biological_process","phospholipid homeostasis ","P41235; O95477"]
["GO:0010470","biological_process","regulation of gastrulation ","P41235; Q86SQ0; O75122; Q14118; Q86UU1"]
["GO:0060398","biological_process","regulation of growth hormone receptor signaling pathway ","P41235"]
["GO:0007548","biological_process","sex differentiation ","P41235; Q92772; P10275; P05093; Q01534"]
["GO:0070328","biological_process","triglyceride homeostasis ","P41235; P35398; Q8WTV0; P02649; Q13133; Q9NP71"]
["GO:0006805","biological_process","xenobiotic metabolic process ","P41235; P35398; P08238; O75469; P27540; P09211; Q15185; P08684; O15217; P20813; P20815; P35869; P51449; Q6UWW8; O00170"]
["GO:0035457","biological_process","cellular response to interferon-alpha ","P30530; P23771; P49675; P12270; P00973; P17181"]
["GO:0034101","biological_process","erythrocyte homeostasis ","P30530; P17509; Q06830; P48200; P09601"]
["GO:2000669","biological_process","negative regulation of dendritic cell apoptotic process ","P30530; P32248"]
["GO:0001961","biological_process","positive regulation of cytokine-mediated signaling pathway ","P30530; O43353"]
["GO:0032825","biological_process","positive regulation of natural killer cell differentiation ","P30530; O94900; P51692; O95267"]
["GO:0048549","biological_process","positive regulation of pinocytosis ","P30530; O43707"]
["GO:0071481","biological_process","cellular response to X-ray ","Q12888; Q13315; P30279; P13010; P50570; Q6KC79; P12956; Q9H1E3"]
["GO:2000042","biological_process","negative regulation of double-strand break repair via homologous recombination ","Q12888; Q5UIP0; O94762"]
["GO:0002376","biological_process","immune system process ","O15357; O15554; Q13501; Q6UY09; O60318"]
["GO:0046856","biological_process","phosphatidylinositol dephosphorylation ","O15357; Q92835; P60484; O43426; Q13614; O15056"]
["GO:0097178","biological_process","ruffle assembly ","O15357; P63000; Q96DR7; Q9UJU6"]
["GO:0043097","biological_process","pyrimidine nucleoside salvage ","P27707; P04183"]
["GO:0006220","biological_process","pyrimidine nucleotide metabolic process ","P27707; O14638; Q9NRF8"]
["GO:0019344","biological_process","cysteine biosynthetic process ","P35520; P32929"]
["GO:0006535","biological_process","cysteine biosynthetic process from serine ","P35520"]
["GO:0019343","biological_process","cysteine biosynthetic process via cystathionine ","P35520; P32929"]
["GO:0042262","biological_process","DNA protection ","P35520; Q9H773"]
["GO:0043418","biological_process","homocysteine catabolic process ","P35520"]
["GO:0050667","biological_process","homocysteine metabolic process ","P35520; Q9NPH5; P42898"]
["GO:0070814","biological_process","hydrogen sulfide biosynthetic process ","P35520; P32929"]
["GO:0019448","biological_process","L-cysteine catabolic process ","P35520"]
["GO:0006565","biological_process","L-serine catabolic process ","P35520"]
["GO:0006563","biological_process","L-serine metabolic process ","P35520"]
["GO:0019346","biological_process","transsulfuration ","P35520; P32929"]
["GO:2000147","biological_process","positive regulation of cell motility ","Q6NZI2; P31751; P07333; O95471; P32248; Q13049; Q15672"]
["GO:0009303","biological_process","rRNA transcription ","Q6NZI2; P56192; Q12789; Q92994; O15446; Q9BYG3"]
["GO:0034199","biological_process","activation of protein kinase A activity ","P13861; P17612; P22694; P31323; P10644; P22612"]
["GO:2000480","biological_process","negative regulation of cAMP-dependent protein kinase activity ","P13861; Q96EB6; P61925; P31323; P10644"]
["GO:0003091","biological_process","renal water homeostasis ","P13861; P17612; P22694; P29972; P31323; O60266; Q7L804; Q08828; O43306; Q08462; P41181; P62491; P10644; P22612; P40145; P30518; P55087"]
["GO:1900165","biological_process","negative regulation of interleukin- secretion ","Q9Y2R2; Q5D1E8"]
["GO:2000483","biological_process","negative regulation of interleukin- secretion ","Q9Y2R2; P04083"]
["GO:0043508","biological_process","negative regulation of JUN kinase activity ","Q9Y2R2; O15350; P09211; Q53EL6; Q9H422; Q9UQF2; Q9Y6W6"]
["GO:0070433","biological_process","negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway ","Q9Y2R2; Q96RT1"]
["GO:1903753","biological_process","negative regulation of p8MAPK cascade ","Q9Y2R2; P15311; Q92598; Q9NQC7; Q12959; Q9Y6W6"]
["GO:0050868","biological_process","negative regulation of T cell activation ","Q9Y2R2; P52333; P51452; Q9NWQ8"]
["GO:0050860","biological_process","negative regulation of T cell receptor signaling pathway ","Q9Y2R2; P17706; P15311; Q96IZ0; P51452; Q12913; P04156; P13688; P17931; P29350"]
["GO:0035644","biological_process","phosphoanandamide dephosphorylation ","Q9Y2R2"]
["GO:1902523","biological_process","positive regulation of protein K6-linked ubiquitination ","Q9Y2R2"]
["GO:0034141","biological_process","positive regulation of toll-like receptor  signaling pathway ","Q9Y2R2; Q03135; Q96FA3; O75955; P58753"]
["GO:0034145","biological_process","positive regulation of toll-like receptor  signaling pathway ","Q9Y2R2; Q96FA3; Q13133; Q86XR7; P58753"]
["GO:0032817","biological_process","regulation of natural killer cell proliferation ","Q9Y2R2"]
["GO:0042699","biological_process","follicle-stimulating hormone signaling pathway ","P49407; P32121; P23945"]
["GO:0032715","biological_process","negative regulation of interleukin-6 production ","P49407; P41240; Q8TDQ0; Q5D1E8; Q96RI1; Q9BZS1; P01375; O00206; Q13291; P32121"]
["GO:0032717","biological_process","negative regulation of interleukin-8 production ","P49407; Q6GQQ9"]
["GO:0007602","biological_process","phototransduction ","P49407; P20941; Q13507; O00562; Q9UHM6; P57796; Q9UMX6"]
["GO:0090240","biological_process","positive regulation of histone H acetylation ","P49407; Q12824; P15941; O95251"]
["GO:0035774","biological_process","positive regulation of insulin secretion involved in cellular response to glucose stimulus ","P49407; Q92934; P30626; P52945; Q96RI1; Q16665; Q5XXA6; P80108; Q8TD43; P13569; Q9UBU3; P33176"]
["GO:0015031","biological_process","protein transport ","P49407; O00459; Q9NUU7; Q9H814; Q504Y2; O95271; Q16760; Q99767; O75351; P09693; P61106; Q9H1K0; O43707; Q9BQQ3; P42566; Q15027; O14559; Q9BVK6; P14625; O60784; P62834; Q9Y6D6; P61020; Q8TEH3; Q9UPT5; Q15276; P51148; Q9BTX1; Q5T5C0; P63027; O00562; Q9P2E2; P49321; P61764; O95235; Q8TBN0; Q9H8V3; P49768; Q8N6H7; P57737; O00161; P98082; P17861; Q9ULU8; Q92538; Q641Q2; Q9HC62; Q13765; J3KNL6; P31150; Q96JG6; Q9P2E9; O43264; Q6WKZ4; P20339; Q9Y3E7; Q9UGM3; O14713; O60318; O43823; O15027; Q99490; P32121; Q5VZ89; P35579; Q7Z3C6; P50395; Q96CF2; Q676U5; Q8IYI6; Q8NCT1; O96018"]
["GO:1990314","biological_process","cellular response to insulin-like growth factor stimulus ","P16220; P60484; P46108; Q96A49; P20248"]
["GO:0071294","biological_process","cellular response to zinc ion ","P16220; P04731; Q96D96; P09874; O14649"]
["GO:0034670","biological_process","chemotaxis to arachidonic acid ","P16220"]
["GO:0060430","biological_process","lung saccule development ","P16220; Q92908; P43699"]
["GO:0010944","biological_process","negative regulation of transcription by competitive promoter binding ","P16220; P15941; O15105; P35232; Q03014; P05549"]
["GO:0055025","biological_process","positive regulation of cardiac muscle tissue development ","P16220; P21860"]
["GO:0040018","biological_process","positive regulation of multicellular organism growth ","P16220; Q00613; P15311; P09327; Q6KC79; P28069; Q9P2D1; Q01959; P10415; P10912; A1X283; P14416; Q9UBU3; P20265; P51692"]
["GO:0045672","biological_process","positive regulation of osteoclast differentiation ","P16220; P01100; Q13118; P00918; Q9Y4K3; P01375; Q01851"]
["GO:0032916","biological_process","positive regulation of transforming growth factor beta production ","P16220; P84022"]
["GO:0008361","biological_process","regulation of cell size ","P16220; P63000; P42345; P15498; P16871; O14745; P26038; P52735; P35241; Q9UKW4; Q8N122; P13631; Q684P5; O43504"]
["GO:0048145","biological_process","regulation of fibroblast proliferation ","P16220; P35222"]
["GO:0060251","biological_process","regulation of glial cell proliferation ","P16220"]
["GO:1902065","biological_process","response to L-glutamate ","P16220; P12004; P84074; O94874"]
["GO:0035094","biological_process","response to nicotine ","P16220; P28482; Q92769; P36544; P21554; P43681; P49675; Q07001; Q9UD71; Q01959; P10415; P14416; P09601; P07510; P42574"]
["GO:0033363","biological_process","secretory granule organization ","P16220"]
["GO:0060509","biological_process","type I pneumocyte differentiation ","P16220; P10828; P10827"]
["GO:0030048","biological_process","actin filament-based movement ","P42768; Q13459; P35580; Q9Y6W5; Q9Y4I1; O43516; Q9UM54; P35579"]
["GO:0008154","biological_process","actin polymerization or depolymerization ","P42768; P50552; O00401; P60981; O43516; Q01518; Q9NYB9; Q9UBU3; Q8IZP0"]
["GO:0032488","biological_process","Cdc protein signal transduction ","P42768; A0MZ66; P60953"]
["GO:0006952","biological_process","defense response ","P42768; Q00613; Q04912; P23771; O15554; Q99062; P08476; Q96P20; O75022; P31994; Q15773"]
["GO:0051497","biological_process","negative regulation of stress fiber assembly ","P42768; P07737; P08581; Q9ULJ8; Q96P48; Q96QB1; Q13136; Q86SQ0; Q9Y6W5; P21453; O75122; P16949; P09758"]
["GO:2000601","biological_process","positive regulation of Arp/3 complex-mediated actin nucleation ","P42768; O00401; Q92558; Q9NYB9"]
["GO:0008064","biological_process","regulation of actin polymerization or depolymerization ","P42768; Q8TE77; Q8WYL5; O14578; Q9NRY4"]
["GO:0002625","biological_process","regulation of T cell antigen processing and presentation ","P42768"]
["GO:0016578","biological_process","histone deubiquitination ","Q9Y4A5; Q12962; Q9Y5T5; Q9UK80"]
["GO:0043968","biological_process","histone H2A acetylation ","Q9Y4A5; Q9UBU8; Q96L91; Q9H0E9; Q9Y230; Q9Y265"]
["GO:0071476","biological_process","cellular hypotonic response ","O95747; Q9UEW8; Q9HBA0; Q15746; Q9UHW9"]
["GO:0038146","biological_process","chemokine (C-X-C motif) ligand 2 signaling pathway ","O95747; Q9UEW8"]
["GO:1901017","biological_process","negative regulation of potassium ion transmembrane transporter activity ","O95747; P60484; Q96PU5; Q9UEW8; O14958"]
["GO:0007635","biological_process","chemosensory behavior ","P05129; P41180; Q8NER1"]
["GO:1901799","biological_process","negative regulation of proteasomal protein catabolic process ","P05129; P08238"]
["GO:0099171","biological_process","presynaptic modulation of chemical synaptic transmission ","P05129; Q9Y2X7; P28222"]
["GO:0032095","biological_process","regulation of response to food ","P05129; P42345; Q9UBU3"]
["GO:2000300","biological_process","regulation of synaptic vesicle exocytosis ","P05129; Q9Y2X7; Q5S007; P49841; P28223; Q99767; O14640; P43681; Q08828; P28222; P0DP23; P56817; P08172; P14416; Q86UR5; O95295; Q02410; P20339; P21728; P17600; Q99719"]
["GO:1990911","biological_process","response to psychosocial stress ","P05129; Q00613; P43220; P07550"]
["GO:0006937","biological_process","regulation of muscle contraction ","O60237; O14558; P08133; Q09470; P24844; P30874; P09493"]
["GO:0006887","biological_process","exocytosis ","Q00536; Q13153; Q8IYJ3; Q15836; Q9C0H9; Q8IWQ3; P56962; O14810; O00443; Q9Y6D6; Q9UPT5; Q5T5C0; Q9Y4I1; P63027; P46459; Q9ULU8; O75379; P11233; P23763; Q6P1M3; Q15334; Q9H3Z4"]
["GO:0030252","biological_process","growth hormone secretion ","Q00536; P62820; Q9UBU3"]
["GO:0061178","biological_process","regulation of insulin secretion involved in cellular response to glucose stimulus ","Q00536; Q02156; Q9Y261; Q8IWQ3; Q15651; Q96RI1; Q9ULB1; Q13009; P20393; Q6ZWJ1"]
["GO:0061351","biological_process","neural precursor cell proliferation ","Q14680; P54762; Q15633; Q16643"]
["GO:0032609","biological_process","interferon-gamma production ","Q08881; P16150"]
["GO:0032633","biological_process","interleukin-4 production ","Q08881"]
["GO:0021545","biological_process","cranial nerve development ","P21860; P43003; Q9P2D1"]
["GO:0007162","biological_process","negative regulation of cell adhesion ","P21860; P52565; Q13370; O95471; P16150; O00592; O43157; O60711; O75553; P52566; P37023; P20936"]
["GO:0051048","biological_process","negative regulation of secretion ","P21860; Q02297"]
["GO:0070886","biological_process","positive regulation of calcineurin-NFAT signaling cascade ","P21860; P19634; Q08209; P01375; Q02297; P26599; Q99828"]
["GO:0014037","biological_process","Schwann cell differentiation ","P21860"]
["GO:0001775","biological_process","cell activation ","P16234"]
["GO:0048704","biological_process","embryonic skeletal system morphogenesis ","P16234; Q99502; P09629; P37275; P17509; P04198; Q12959; P13349; Q99750; P10071"]
["GO:0001553","biological_process","luteinization ","P16234; Q13285; P51692"]
["GO:0010544","biological_process","negative regulation of platelet activation ","P16234; P29474; P02649"]
["GO:0035790","biological_process","platelet-derived growth factor receptor-alpha signaling pathway ","P16234"]
["GO:0050920","biological_process","regulation of chemotaxis ","P16234; P52799; P61073; P54578; Q9H244"]
["GO:2000739","biological_process","regulation of mesenchymal stem cell differentiation ","P16234"]
["GO:0051365","biological_process","cellular response to potassium ion starvation ","P05412; Q99624"]
["GO:0035026","biological_process","leading edge cell differentiation ","P05412; P98082"]
["GO:1990441","biological_process","negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress ","P05412; P16333"]
["GO:0045657","biological_process","positive regulation of monocyte differentiation ","P05412; Q9UKV3; P01730; Q07352"]
["GO:0001836","biological_process","release of cytochrome c from mitochondria ","P05412; Q92934; Q9BXH1; Q9GZY8; Q07812; P10415; P31947; O00429; Q07817; Q16611; P04179; P55957; Q13794"]
["GO:0030844","biological_process","positive regulation of intermediate filament depolymerization ","P48681"]
["GO:2000179","biological_process","positive regulation of neural precursor cell proliferation ","P48681; P55209; P04899; Q8TCG1; P50553; Q9HB65; P21333"]
["GO:0072089","biological_process","stem cell proliferation ","P48681; P08183; P28906; P09038"]
["GO:0044331","biological_process","cell-cell adhesion mediated by cadherin ","P16591; P55196; P19022"]
["GO:0036006","biological_process","cellular response to macrophage colony-stimulating factor stimulus ","P16591; P07333"]
["GO:0035426","biological_process","extracellular matrix-cell signaling ","P16591"]
["GO:0038109","biological_process","Kit signaling pathway ","P16591; P10721"]
["GO:0033007","biological_process","negative regulation of mast cell activation involved in immune response ","P16591; O14638"]
["GO:0042058","biological_process","regulation of epidermal growth factor receptor signaling pathway ","P16591; Q05209; P13688"]
["GO:0010762","biological_process","regulation of fibroblast migration ","P16591; Q9ULV4; P31431; Q03113; O94776"]
["GO:0036119","biological_process","response to platelet-derived growth factor ","P16591"]
["GO:0034244","biological_process","negative regulation of transcription elongation from RNA polymerase II promoter ","P18615; Q15910; Q9H3P2; Q8WX92; O15169; Q00839; O94762"]
["GO:0044782","biological_process","cilium organization ","Q96L34; Q92692; Q5BJF6"]
["GO:0045724","biological_process","positive regulation of cilium assembly ","Q96L34; P42858; Q5TZA2; O43303; Q9NRY4; Q3V6T2; Q86YF9"]
["GO:0002371","biological_process","dendritic cell cytokine production ","P10721"]
["GO:0050910","biological_process","detection of mechanical stimulus involved in sensory perception of sound ","P10721"]
["GO:0050673","biological_process","epithelial cell proliferation ","P10721; Q92542; P49768"]
["GO:0038162","biological_process","erythropoietin-mediated signaling pathway ","P10721"]
["GO:0038093","biological_process","Fc receptor signaling pathway ","P10721"]
["GO:0008354","biological_process","germ cell migration ","P10721; P05556; Q12948; P36897"]
["GO:0006687","biological_process","glycosphingolipid metabolic process ","P10721; Q07812; P17405; Q03060; Q8TCT0"]
["GO:0035701","biological_process","hematopoietic stem cell migration ","P10721; Q9C0K0; P80108"]
["GO:0002327","biological_process","immature B cell differentiation ","P10721"]
["GO:0030032","biological_process","lamellipodium assembly ","P10721; P63000; P53365; P52735; P05556; P16333; P18206; Q9NRF2; Q14155; Q9UKW4; Q9Y6W5; Q15052; P21453; Q9H4A6; Q5VZK9; Q9H244; Q3V6T2; Q9NR80; Q96IF1"]
["GO:0002320","biological_process","lymphoid progenitor cell differentiation ","P10721; P17947; P10415"]
["GO:0002551","biological_process","mast cell chemotaxis ","P10721; P63000; O00329"]
["GO:0032762","biological_process","mast cell cytokine production ","P10721"]
["GO:0060374","biological_process","mast cell differentiation ","P10721; P23771; O00329"]
["GO:0070662","biological_process","mast cell proliferation ","P10721"]
["GO:0097326","biological_process","melanocyte adhesion ","P10721"]
["GO:0097324","biological_process","melanocyte migration ","P10721; O60315"]
["GO:1904343","biological_process","positive regulation of colon smooth muscle contraction ","P10721"]
["GO:0120072","biological_process","positive regulation of pyloric antrum smooth muscle contraction ","P10721"]
["GO:1904349","biological_process","positive regulation of small intestine smooth muscle contraction ","P10721; Q9UBU3"]
["GO:1905065","biological_process","positive regulation of vascular smooth muscle cell differentiation ","P10721; P17813"]
["GO:1904251","biological_process","regulation of bile acid metabolic process ","P10721"]
["GO:0048070","biological_process","regulation of developmental pigmentation ","P10721; O43521"]
["GO:0048103","biological_process","somatic stem cell division ","P10721; Q9ULK5; P46531; Q8N726"]
["GO:0007286","biological_process","spermatid development ","P10721; O15287; Q92692; Q9UHL0; Q96PF2; Q15633; Q9Y385; Q5BJF6; Q96PU8; P54652; Q08J23; Q9BXA7; Q99828"]
["GO:2000208","biological_process","positive regulation of ribosomal small subunit export from nucleus ","Q9BVS4"]
["GO:0043555","biological_process","regulation of translation in response to stress ","P51812; Q15418"]
["GO:0045779","biological_process","negative regulation of bone resorption ","P41240; Q92835"]
["GO:0042997","biological_process","negative regulation of olgi to plasma membrane protein transport ","P41240; Q504Y2"]
["GO:0010989","biological_process","negative regulation of low-density lipoprotein particle clearance ","P41240; Q92945"]
["GO:0050765","biological_process","negative regulation of phagocytosis ","P41240; P60484; Q9H1Y0; P63244; P31994; Q9NT62"]
["GO:0060368","biological_process","regulation of Fc receptor mediated stimulatory signaling pathway ","P41240; O15162"]
["GO:0071486","biological_process","cellular response to high light intensity ","P31751"]
["GO:0032000","biological_process","positive regulation of fatty acid beta-oxidation ","P31751; P35568; Q9Y4H2; P50416; Q07869; Q15672"]
["GO:0071156","biological_process","regulation of cell cycle arrest ","P31751; Q00535; Q08050; Q13562"]
["GO:0097473","biological_process","retinal rod cell apoptotic process ","P31751"]
["GO:0001771","biological_process","immunological synapse formation ","P54762; P26038; Q8NF50; Q12959; P30203"]
["GO:1902725","biological_process","negative regulation of satellite cell differentiation ","P54762"]
["GO:1902723","biological_process","negative regulation of skeletal muscle satellite cell proliferation ","P54762"]
["GO:0014719","biological_process","skeletal muscle satellite cell activation ","P54762; Q96KG7"]
["GO:0070571","biological_process","negative regulation of neuron projection regeneration ","O95819"]
["GO:1903393","biological_process","positive regulation of adherens junction organization ","O95819; P35611; Q15555"]
["GO:0032014","biological_process","positive regulation of ARF protein signal transduction ","O95819; Q15555"]
["GO:0051549","biological_process","positive regulation of keratinocyte migration ","O95819; P42345; Q15555; Q92819"]
["GO:0045604","biological_process","regulation of epidermal cell differentiation ","O15525; Q14145"]
["GO:0019858","biological_process","cytosine metabolic process ","P28482"]
["GO:0015966","biological_process","diadenosine tetraphosphate biosynthetic process ","P28482; Q15046"]
["GO:0006353","biological_process","DNA-templated transcription, termination ","O14744; P24928; Q9H0D6; Q9UNY4"]
["GO:0042118","biological_process","endothelial cell activation ","O14744; Q13485; P36897; P31269"]
["GO:0090161","biological_process","olgi ribbon formation ","O14744; Q08379; Q96CV9; Q92614; Q9H4A6; O75379"]
["GO:0043985","biological_process","histone H-R methylation ","O14744; Q99873"]
["GO:0018216","biological_process","peptidyl-arginine methylation ","O14744; Q9NR22; Q99873"]
["GO:0035246","biological_process","peptidyl-arginine N-methylation ","O14744"]
["GO:1904992","biological_process","positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway ","O14744"]
["GO:0000387","biological_process","spliceosomal snRNP assembly ","O14744; O95149; P62316; Q9UHI6; P14678; Q9Y3F4; P54105; Q15020; Q9H840; Q96RS0; P62304"]
["GO:1990253","biological_process","cellular response to leucine starvation ","Q9P2K8; P42345"]
["GO:0039520","biological_process","induction by virus of host autophagy ","Q9P2K8"]
["GO:0044828","biological_process","negative regulation by host of viral genome replication ","Q9P2K8; Q5D1E8; O60260"]
["GO:0032792","biological_process","negative regulation of CREB transcription factor activity ","Q9P2K8; P57059; Q9BZS1; P35548; P35638"]
["GO:0002821","biological_process","positive regulation of adaptive immune response ","Q9P2K8; P40189; Q13158; Q96EB6; Q86WV1; Q9ULZ3"]
["GO:0071264","biological_process","positive regulation of translational initiation in response to starvation ","Q9P2K8"]
["GO:0060733","biological_process","regulation of eIF2 alpha phosphorylation by amino acid starvation ","Q9P2K8"]
["GO:0002286","biological_process","T cell activation involved in immune response ","Q9P2K8; P49768; P13796"]
["GO:0019081","biological_process","viral translation ","Q9P2K8"]
["GO:0043984","biological_process","histone H-K16 acetylation ","P51610; Q9H9L4; Q9BVI0; Q03164; Q96EZ8; O15294"]
["GO:0043981","biological_process","histone H-K5 acetylation ","P51610; O95251; Q9H9L4; Q6IE81; Q9BVI0; Q96EZ8; O15294"]
["GO:0043982","biological_process","histone H-K acetylation ","P51610; O95251; Q9H9L4; Q6IE81; Q9BVI0; Q96EZ8; O15294"]
["GO:0019046","biological_process","release from viral latency ","P51610; Q9H1E3"]
["GO:0035640","biological_process","exploration behavior ","Q5S007; P43681; P38919; P50052; Q03164"]
["GO:0046039","biological_process","TP metabolic process ","Q5S007; Q8IWA4; P62826; P61586; P17081"]
["GO:0035641","biological_process","locomotory exploration behavior ","Q5S007; Q02156; P78352; P02649; Q99259"]
["GO:0007040","biological_process","lysosome organization ","Q5S007; P19484; O14773; O95477; Q14457"]
["GO:1902902","biological_process","negative regulation of autophagosome assembly ","Q5S007; Q9BUL5; Q9BXM7; Q8TEV9; Q99689; Q14457"]
["GO:0090394","biological_process","negative regulation of excitatory postsynaptic potential ","Q5S007; P60484; P38919; Q13614; Q8N0W4"]
["GO:1903206","biological_process","negative regulation of hydrogen peroxide-induced cell death ","Q5S007; Q99497; Q16236; P32322; P10599"]
["GO:1902823","biological_process","negative regulation of late endosome to lysosome transport ","Q5S007"]
["GO:1903217","biological_process","negative regulation of protein processing involved in protein targeting to mitochondrion ","Q5S007"]
["GO:1903215","biological_process","negative regulation of protein targeting to mitochondrion ","Q5S007; O95817"]
["GO:1903125","biological_process","negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation ","Q5S007"]
["GO:0140058","biological_process","neuron projection arborization ","Q5S007; Q13464; Q8N2Q7"]
["GO:0021772","biological_process","olfactory bulb development ","Q5S007; P07333; Q9P2D1; Q15058; Q02363; P12755"]
["GO:1903980","biological_process","positive regulation of microglial cell activation ","Q5S007; P05107; P05067; Q15109"]
["GO:1902499","biological_process","positive regulation of protein autoubiquitination ","Q5S007; Q13330"]
["GO:1904469","biological_process","positive regulation of tumor necrosis factor secretion ","Q5S007; Q7Z434; O95786; Q8TDQ0; Q9BYX4"]
["GO:0070585","biological_process","protein localization to mitochondrion ","Q5S007; O60260"]
["GO:2000172","biological_process","regulation of branching morphogenesis of a nerve ","Q5S007; Q9NQC3"]
["GO:1905289","biological_process","regulation of CAMKK-AMPK signaling cascade ","Q5S007; P42858"]
["GO:0061001","biological_process","regulation of dendritic spine morphogenesis ","Q5S007; Q00535; Q96HC4; P23528; P54764; Q9ULJ8; Q15078; Q9C0H9; O14559; Q9BYB0; O43166; Q7LC44"]
["GO:0035564","biological_process","regulation of kidney size ","Q5S007"]
["GO:0035751","biological_process","regulation of lysosomal lumen pH ","Q5S007"]
["GO:0051900","biological_process","regulation of mitochondrial depolarization ","Q5S007; P48506"]
["GO:1902692","biological_process","regulation of neuroblast proliferation ","Q5S007"]
["GO:0014041","biological_process","regulation of neuron maturation ","Q5S007"]
["GO:0010738","biological_process","regulation of protein kinase A signaling ","Q5S007; Q02952; O43164; Q5JQC9; Q9UKA4; Q9Y233; P27815; P23945; O00170; Q92667"]
["GO:1905279","biological_process","regulation of retrograde transport, endosome to olgi ","Q5S007"]
["GO:1902803","biological_process","regulation of synaptic vesicle transport ","Q5S007; Q9BXM7; O60260"]
["GO:0021756","biological_process","striatum development ","Q5S007; P14416; P21728"]
["GO:0022028","biological_process","tangential migration from the subventricular zone to the olfactory bulb ","Q5S007; P11831"]
["GO:1904887","biological_process","Wnt signalosome assembly ","Q5S007"]
["GO:0061337","biological_process","cardiac conduction ","Q02078; Q13936; O14649"]
["GO:0048311","biological_process","mitochondrion distribution ","Q02078"]
["GO:0055005","biological_process","ventricular cardiac myofibril assembly ","Q02078; P52952"]
["GO:0030517","biological_process","negative regulation of axon extension ","Q8IVW4; Q00535; P11137; Q15078; Q9NQC3; Q9H165"]
["GO:0002446","biological_process","neutrophil mediated immunity ","Q9NWZ3; Q8IZD2; P78536; P12821"]
["GO:1990266","biological_process","neutrophil migration ","Q9NWZ3; Q9UIK4; P05107"]
["GO:0015074","biological_process","DNA integration ","Q12824; Q53H47"]
["GO:1900110","biological_process","negative regulation of histone H3-K dimethylation ","Q12824"]
["GO:1900113","biological_process","negative regulation of histone H-K trimethylation ","Q12824; Q96EB6; Q9H3R0"]
["GO:1902661","biological_process","positive regulation of glucose mediated signaling pathway ","Q12824; P51532"]
["GO:1901838","biological_process","positive regulation of transcription of nucleolar large rRNA by RNA polymerase I ","Q12824; P42345; P51532; P56192; P19338"]
["GO:0039692","biological_process","single stranded viral RNA replication via double stranded DNA intermediate ","Q12824"]
["GO:0048589","biological_process","developmental growth ","P84022; P11831; P23771; P04818; Q6KC79; Q13485; P10070; Q15056; P31270; Q9BRQ0; P10071; P36894"]
["GO:0007492","biological_process","endoderm development ","P84022; P43694; Q9UBC0; P11047; Q13547; Q13485; P46531; P43699; Q03014; Q7LC44"]
["GO:0019049","biological_process","evasion or tolerance of host defenses by virus ","P84022"]
["GO:0002520","biological_process","immune system development ","P84022; Q13936"]
["GO:1903243","biological_process","negative regulation of cardiac muscle hypertrophy in response to stress ","P84022; Q12778; P02545; P48678; P23634; Q9UJM3"]
["GO:0045599","biological_process","negative regulation of fat cell differentiation ","P84022; P35398; Q12778; P23771; Q96EB6; O75962; O00327; Q8WYK2; Q01094; Q06455; P35548; Q92519; O43294; P47928; P01375; P35638; Q99523; Q9GZV5; O15169; P23769; Q8IXJ6; P22413"]
["GO:0061767","biological_process","negative regulation of lung blood pressure ","P84022"]
["GO:0033689","biological_process","negative regulation of osteoblast proliferation ","P84022; P19525; P10415; O43157"]
["GO:0002076","biological_process","osteoblast development ","P84022; P56524; Q03431; P17535; Q9UGP4; P12272; P10070; P35548; O00255; Q13950"]
["GO:1901203","biological_process","positive regulation of extracellular matrix assembly ","P84022; Q9H4X1; P48436"]
["GO:0042307","biological_process","positive regulation of protein import into nucleus ","P84022; Q16539; Q13263; O00459; P27986; Q05655; P35354; P14317; O95817; P12830; Q5D1E8; P12270; P14923; Q9H8V3; O15379; P17861; P21333; P10071"]
["GO:0032909","biological_process","regulation of transforming growth factor beta production ","P84022; Q16665; Q13485"]
["GO:0060290","biological_process","transdifferentiation ","P84022; P43694; P28906"]
["GO:0086098","biological_process","angiotensin-activated signaling pathway involved in heart process ","Q03135; P12931"]
["GO:0071360","biological_process","cellular response to exogenous dsRNA ","Q03135; Q7Z434; O95786; O15455; O60828; O75955; Q86WV6; Q9BYX4; Q8N884; P11234"]
["GO:0030301","biological_process","cholesterol transport ","Q03135; P01130; P16671; O75351; Q14849; P13569"]
["GO:0000188","biological_process","inactivation of MAPK activity ","Q03135; P67775; P51452; Q13202; Q13098; P28562; P49798; Q16828; P30153; Q9Y6W6; Q9BY84"]
["GO:0019915","biological_process","lipid storage ","Q03135; P16671; P48552; Q16526; P51692; Q96AD5"]
["GO:0032507","biological_process","maintenance of protein location in cell ","Q03135; P01730; Q16643"]
["GO:0060056","biological_process","mammary gland involution ","Q03135; P78545"]
["GO:1903609","biological_process","negative regulation of inward rectifier potassium channel activity ","Q03135"]
["GO:0060546","biological_process","negative regulation of necroptotic process ","Q03135; Q13158; P16989; Q9BYM8; Q92974; Q96FA3; P12235; O15519"]
["GO:0045019","biological_process","negative regulation of nitric oxide biosynthetic process ","Q03135; P28906; Q5D1E8; P23634; Q92945; P35372"]
["GO:0051001","biological_process","negative regulation of nitric-oxide synthase activity ","Q03135; P21554; P17813; P23634; P34972"]
["GO:0033137","biological_process","negative regulation of peptidyl-serine phosphorylation ","Q03135; Q08499; P30411; Q08495; P16333; Q07812; P50749; Q6TCH7; O15105; P63244; Q9NP71; Q8N335; Q16611"]
["GO:1900085","biological_process","negative regulation of peptidyl-tyrosine autophosphorylation ","Q03135"]
["GO:0048550","biological_process","negative regulation of pinocytosis ","Q03135; P55055; Q13133"]
["GO:1901380","biological_process","negative regulation of potassium ion transmembrane transport ","Q03135; Q96PU5; Q9UEW8; P49798; Q12809"]
["GO:0033484","biological_process","nitric oxide homeostasis ","Q03135; Q9H2P0"]
["GO:0060355","biological_process","positive regulation of cell adhesion molecule production ","Q03135; O75955"]
["GO:1903071","biological_process","positive regulation of ER-associated ubiquitin-dependent protein catabolic process ","Q03135; O43765; Q16236; P17861; Q9UMX0"]
["GO:1903598","biological_process","positive regulation of gap junction assembly ","Q03135"]
["GO:0010608","biological_process","posttranscriptional regulation of gene expression ","Q03135; Q16543; Q9UKT5; Q14671; Q8WY41; P43243; Q96BF6; Q5TC82; O15534; Q8IWR0"]
["GO:1903361","biological_process","protein localization to basolateral plasma membrane ","Q03135"]
["GO:0044860","biological_process","protein localization to plasma membrane raft ","Q03135; Q14254"]
["GO:2000286","biological_process","receptor internalization involved in canonical Wnt signaling pathway ","Q03135; P20339"]
["GO:0030193","biological_process","regulation of blood coagulation ","Q03135; Q9Y261"]
["GO:0051480","biological_process","regulation of cytosolic calcium ion concentration ","Q03135; P17612; P23327; Q01814; Q9Y210; P26678; Q92736; Q9HCX4; P62258; Q6J4K2; O43613; P21817"]
["GO:2000535","biological_process","regulation of entry of bacterium into host cell ","Q03135; Q9UPT5"]
["GO:0019217","biological_process","regulation of fatty acid metabolic process ","Q03135; P36956"]
["GO:0098903","biological_process","regulation of membrane repolarization during action potential ","Q03135"]
["GO:0052547","biological_process","regulation of peptidase activity ","Q03135"]
["GO:1900027","biological_process","regulation of ruffle assembly ","Q03135; P35241; Q9ULV4"]
["GO:0003057","biological_process","regulation of the force of heart contraction by chemical signal ","Q03135; P29474"]
["GO:0098911","biological_process","regulation of ventricular cardiac muscle cell action potential ","Q03135; Q92736; P14923; Q13936; Q12959; Q8TD43; P15924"]
["GO:0042310","biological_process","vasoconstriction ","Q03135; P30411; P28222; Q8TD43; P31645"]
["GO:0016064","biological_process","immunoglobulin mediated immune response ","Q92835; Q05655; Q92985; O95999; P30273; P31994; P24394"]
["GO:0045409","biological_process","negative regulation of interleukin-6 biosynthetic process ","Q92835; Q9UBU3"]
["GO:0045659","biological_process","negative regulation of neutrophil differentiation ","Q92835"]
["GO:0044027","biological_process","hypermethylation of Cp island ","P17947"]
["GO:0090241","biological_process","negative regulation of histone H acetylation ","P17947; Q13363"]
["GO:0045347","biological_process","negative regulation of MHC class II biosynthetic process ","P17947; Q92769"]
["GO:0098885","biological_process","modification of postsynaptic actin cytoskeleton ","P07737; Q92558"]
["GO:0032232","biological_process","negative regulation of actin filament bundle assembly ","P07737; Q9BYB0; Q9Y566; O60260"]
["GO:0032781","biological_process","positive regulation of ATPase activity ","P07737; P41180; P45379; P25686; Q9Y3Y2; P25685; Q5JTV8; P05062; Q14896; P09493; O95433"]
["GO:0051054","biological_process","positive regulation of DNA metabolic process ","P07737"]
["GO:0060074","biological_process","synapse maturation ","P07737; P60484; P07196; Q9Y566"]
["GO:0071479","biological_process","cellular response to ionizing radiation ","P04637; Q16539; P38936; Q96EB6; Q9UKT5; Q99638; O15516; P62993; P54132; Q06609; Q9H8V3; P24522; P29692; P62745; Q9C0C2; O60671; Q16666; Q7Z628"]
["GO:0031497","biological_process","chromatin assembly ","P04637; Q13112; Q9Y3T9; Q13111"]
["GO:0048512","biological_process","circadian behavior ","P04637"]
["GO:0000733","biological_process","DNA strand renaturation ","P04637"]
["GO:0009299","biological_process","mRNA transcription ","P04637; Q00613; P17844; Q9H422; P29692"]
["GO:0051097","biological_process","negative regulation of helicase activity ","P04637; Q96EB6"]
["GO:0006289","biological_process","nucleotide-excision repair ","P04637; P19447; Q13156; P54727; Q96FI4; P27694; Q8IY92; P54252; P15927; P41208; Q99708; Q9UGP5; P51587; Q16531; Q969S2"]
["GO:0097252","biological_process","oligodendrocyte apoptotic process ","P04637"]
["GO:0090403","biological_process","oxidative stress-induced premature senescence ","P04637; O00327"]
["GO:1900119","biological_process","positive regulation of execution phase of apoptosis ","P04637; Q5D1E8; Q96QB1; Q13625; Q8IXJ6"]
["GO:0032461","biological_process","positive regulation of protein oligomerization ","P04637; Q07812; Q9UBN7; P55957; Q9Y371; Q13794"]
["GO:0090200","biological_process","positive regulation of release of cytochrome c from mitochondria ","P04637; Q92934; P30405; Q9BXH1; O43521; Q9GZY8; Q13323; Q07812; Q96LC9; O14737; O00429; Q9BXM7; Q16611; Q9ULZ3; P55957; Q13794"]
["GO:0070245","biological_process","positive regulation of thymocyte apoptotic process ","P04637; Q9BXH1"]
["GO:1990440","biological_process","positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress ","P04637; P17676; P18848; P18850; P17861; P35638; P11021"]
["GO:0010165","biological_process","response to X-ray ","P04637; P04083; P38936; P54132; Q15046; O15350; Q03468; Q13426; P51587; P43246; P49917; P24385; P42574; Q9H3D4"]
["GO:0072331","biological_process","signal transduction by p5 class mediator ","P04637; P43356"]
["GO:0048012","biological_process","hepatocyte growth factor receptor signaling pathway ","P63000; Q04912; Q13153; P56945; Q8IXJ6; P16949"]
["GO:0051668","biological_process","localization within membrane ","P63000; Q9NYG2"]
["GO:0032707","biological_process","negative regulation of interleukin- production ","P63000; O00206"]
["GO:0048261","biological_process","negative regulation of receptor-mediated endocytosis ","P63000"]
["GO:0010592","biological_process","positive regulation of lamellipodium assembly ","P63000; P42345; Q6IBS0; P56524; Q16658; P50570; Q9Y6W5; P60953; Q04656"]
["GO:0090023","biological_process","positive regulation of neutrophil chemotaxis ","P63000; Q8IU85; P32248; Q9UIK4; P21730; P58753; Q07021"]
["GO:0016601","biological_process","Rac protein signal transduction ","P63000; Q92558; Q9Y6W5; Q8IYU2; Q9NYB9; Q7L0Q8; Q92556; Q13009; Q9UJU6; Q12929"]
["GO:0010310","biological_process","regulation of hydrogen peroxide metabolic process ","P63000; Q86UR1; Q8NFA2; Q9BXM7"]
["GO:0060263","biological_process","regulation of respiratory burst ","P63000; Q86UR1; Q8NFA2"]
["GO:0031529","biological_process","ruffle organization ","P63000; P42345; P07333; P53365; P32248; Q9BR76; Q9UHB6; Q5VZK9; P08567; P09493"]
["GO:0071526","biological_process","semaphorin-plexin signaling pathway ","P63000; P08581; P52565; O43157; P21333"]
["GO:0050922","biological_process","negative regulation of chemotaxis ","P17706; P51452"]
["GO:1902206","biological_process","negative regulation of interleukin--mediated signaling pathway ","P17706"]
["GO:1902215","biological_process","negative regulation of interleukin-4-mediated signaling pathway ","P17706"]
["GO:0070104","biological_process","negative regulation of interleukin-6-mediated signaling pathway ","P17706; P40189"]
["GO:1902227","biological_process","negative regulation of macrophage colony-stimulating factor signaling pathway ","P17706"]
["GO:0045650","biological_process","negative regulation of macrophage differentiation ","P17706; P08476; P23769"]
["GO:2000587","biological_process","negative regulation of platelet-derived growth factor receptor-beta signaling pathway ","P17706; Q05209; Q8IZQ8; Q07954"]
["GO:1902233","biological_process","negative regulation of positive thymic T cell selection ","P17706"]
["GO:0010804","biological_process","negative regulation of tumor necrosis factor-mediated signaling pathway ","P17706; O60936; Q96RI1; P09211; Q8N2H9; P06899; Q8N2W9"]
["GO:0060339","biological_process","negative regulation of type I interferon-mediated signaling pathway ","P17706; Q9Y3Z3"]
["GO:1902237","biological_process","positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway ","P17706; Q96EB6; Q9BXH1; O43521; P16333; P35638; Q13794"]
["GO:0045722","biological_process","positive regulation of gluconeogenesis ","P17706; Q12778; Q9UBK2; P56211; Q07869"]
["GO:1903899","biological_process","positive regulation of PERK-mediated unfolded protein response ","P17706"]
["GO:2000786","biological_process","positive regulation of autophagosome assembly ","O75385; P48426; P11234; P78356; Q9Y371; Q14457"]
["GO:0060267","biological_process","positive regulation of respiratory burst ","Q8IU85; P06213"]
["GO:0071622","biological_process","regulation of granulocyte chemotaxis ","Q8IU85"]
["GO:0010829","biological_process","negative regulation of glucose transmembrane transport ","P05771; Q92681"]
["GO:0045639","biological_process","positive regulation of myeloid cell differentiation ","P07332"]
["GO:0010625","biological_process","positive regulation of Schwann cell proliferation ","P14136"]
["GO:0051580","biological_process","regulation of neurotransmitter uptake ","P14136; O75955"]
["GO:0097242","biological_process","amyloid-beta clearance ","P08069; P06213; P01130; P08473; P05107; Q07954"]
["GO:1904646","biological_process","cellular response to amyloid-beta ","P08069; Q00535; P49841; P54764; O43524; P08138; P16671; P04156; P41594; P49768; P05067; O00206; P31994; Q07954; P09874; P07550; Q02641; Q15109; Q99538"]
["GO:0097062","biological_process","dendritic spine maintenance ","P08069; P06241; P06213; P23677; P04156; Q9C0D5; Q13614; Q14247; Q9NRD5"]
["GO:0043243","biological_process","positive regulation of protein complex disassembly ","P08069; P06213; P01375"]
["GO:0038063","biological_process","collagen-activated tyrosine kinase receptor signaling pathway ","P43405; Q08345; Q16832; Q01955"]
["GO:0038156","biological_process","interleukin--mediated signaling pathway ","P43405; P30273; P32927"]
["GO:0002366","biological_process","leukocyte activation involved in immune response ","P43405"]
["GO:0002281","biological_process","macrophage activation involved in immune response ","P43405; Q02156; Q8TDQ0; O43914"]
["GO:0002283","biological_process","neutrophil activation involved in immune response ","P43405; P30273"]
["GO:0030593","biological_process","neutrophil chemotaxis ","P43405; P15498; Q08499; Q99062; Q8TCU6; P48736; O60331; P05107; Q9UKW4; P30273; P17931; Q92538; P21730; Q07343; P06702; O00329"]
["GO:0045425","biological_process","positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process ","P43405"]
["GO:0045401","biological_process","positive regulation of interleukin-3 biosynthetic process ","P43405"]
["GO:1900086","biological_process","positive regulation of peptidyl-tyrosine autophosphorylation ","P43405; Q02297; P46940; P12821"]
["GO:0090237","biological_process","regulation of arachidonic acid secretion ","P43405"]
["GO:0043313","biological_process","regulation of neutrophil degranulation ","P43405"]
["GO:0032928","biological_process","regulation of superoxide anion generation ","P43405"]
["GO:0002554","biological_process","serotonin secretion by platelet ","P43405; P30273"]
["GO:0071593","biological_process","lymphocyte aggregation ","O94804"]
["GO:2000401","biological_process","regulation of lymphocyte migration ","O94804; P26038"]
["GO:0000183","biological_process","chromatin silencing at rDNA ","P84243; Q96EB6; Q9UIF9; P68431; P62805; Q8IXJ6; Q71DI3"]
["GO:0006336","biological_process","DNA replication-independent nucleosome assembly ","P84243; Q9Y294; Q9NVP2; P54198; P49321; P62805"]
["GO:0060964","biological_process","regulation of gene silencing by miRNA ","P84243; Q04637; Q14671; P24928; P61218; Q06787; P68431; P62805; Q9UKV8; Q71DI3"]
["GO:0032200","biological_process","telomere organization ","P84243; P68431; P62805"]
["GO:0016358","biological_process","dendrite development ","O75914; Q13976; Q92769; P11137; P07766; Q96PV0; Q9UQB8; P05067; O75553; P46821; O43815; Q9UBU3; P51608"]
["GO:0043583","biological_process","ear development ","Q08345; P23771; O43521; P42892; P10415"]
["GO:0061302","biological_process","smooth muscle cell-matrix adhesion ","Q08345; P04004"]
["GO:0044319","biological_process","wound healing, spreading of cells ","Q08345; P16070; P13688; P21333; Q9BUL8; Q9NRY4; P61586"]
["GO:0035508","biological_process","positive regulation of myosin-light-chain-phosphatase activity ","O14974"]
["GO:0046822","biological_process","regulation of nucleocytoplasmic transport ","O14974; P35658; Q9BWF3; P36873"]
["GO:0021819","biological_process","layer formation in cerebral cortex ","Q00535; O14512; Q15078; Q5VWQ8; Q13319; P10071"]
["GO:0046826","biological_process","negative regulation of protein export from nucleus ","Q00535; Q99497; Q99728; P46060; P23497; P10599"]
["GO:0031914","biological_process","negative regulation of synaptic plasticity ","Q00535; Q13671; O43566"]
["GO:0045956","biological_process","positive regulation of calcium ion-dependent exocytosis ","Q00535; Q16623; Q9H2B2; Q14721; P61764; O43497; Q13319; O95180"]
["GO:0034352","biological_process","positive regulation of glial cell apoptotic process ","Q00535"]
["GO:0035418","biological_process","protein localization to synapse ","Q00535; P78352; P58400; Q9UQB8; O60500; Q07866; Q8N2Q7; Q9Y566"]
["GO:0032801","biological_process","receptor catabolic process ","Q00535; Q9P2Y5; P46934; Q9Y371; Q99538; Q14457"]
["GO:0098883","biological_process","synapse pruning ","Q00535; P54764"]
["GO:0016079","biological_process","synaptic vesicle exocytosis ","Q00535; O14810; O60331; P63027; Q86UR5; O95295; P60880; Q6PUV4; Q9H3Z4"]
["GO:0061028","biological_process","establishment of endothelial barrier ","Q13905; P15311; Q08499; P61224; P26038; P35241; P62834; Q9Y4G8; Q96T49; O95398"]
["GO:1905451","biological_process","positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis ","Q13905; P62834"]
["GO:0032486","biological_process","Rap protein signal transduction ","Q13905; P61224; Q9NYY3; P62834; Q9Y4G8; O95398"]
["GO:1901888","biological_process","regulation of cell junction assembly ","Q13905; P61224; P62834; Q9Y4G8"]
["GO:0010324","biological_process","membrane invagination ","O14964"]
["GO:1903543","biological_process","positive regulation of exosomal secretion ","O14964; O75351; O00560; P18827; P31431; Q96H20"]
["GO:0072657","biological_process","protein localization to membrane ","O14964; Q9BY11; Q96AC1; Q16623; A1X283; Q13009; Q15109"]
["GO:0006622","biological_process","protein targeting to lysosome ","O14964; Q13772; Q92673; Q7Z3T8; P46934"]
["GO:1905430","biological_process","cellular response to glycine ","P06241"]
["GO:1905232","biological_process","cellular response to L-glutamate ","P06241; Q9UQB8"]
["GO:1903202","biological_process","negative regulation of oxidative stress-induced cell death ","P06241; Q99497; Q9BXM7; O60260"]
["GO:1905477","biological_process","positive regulation of protein localization to membrane ","P06241; P63010; O60260"]
["GO:1905664","biological_process","regulation of calcium ion import across plasma membrane ","P06241; P04156"]
["GO:1900449","biological_process","regulation of glutamate receptor signaling pathway ","P06241; P04156"]
["GO:0000304","biological_process","response to singlet oxygen ","P06241"]
["GO:0060044","biological_process","negative regulation of cardiac muscle cell proliferation ","Q15759; P17302; P60484; O95069; O15350; Q9H4B6; P37173"]
["GO:2001184","biological_process","positive regulation of interleukin- secretion ","Q15759; Q16539"]
["GO:0090344","biological_process","negative regulation of cell aging ","Q08050; P60484; Q9UM11"]
["GO:2000781","biological_process","positive regulation of double-strand break repair ","Q08050; Q9BUR4"]
["GO:0061084","biological_process","negative regulation of protein refolding ","P08621; Q13371"]
["GO:0043462","biological_process","regulation of ATPase activity ","P08621; Q8IWQ3; P45378"]
["GO:0036315","biological_process","cellular response to sterol ","P35398; P51449"]
["GO:0021930","biological_process","cerebellar granule cell precursor proliferation ","P35398"]
["GO:0021702","biological_process","cerebellar Purkinje cell differentiation ","P35398; Q04656"]
["GO:0046068","biological_process","cMP metabolic process ","P35398"]
["GO:0042692","biological_process","muscle cell differentiation ","P35398; Q8NF91; Q9Y294; P54198; Q6STE5; Q96PU8; Q15772"]
["GO:0019218","biological_process","regulation of steroid metabolic process ","P35398; P51692; P51449"]
["GO:0072539","biological_process","T-helper 1 cell differentiation ","P35398; P51449"]
["GO:0031214","biological_process","biomineral tissue development ","Q16832; Q9UBB9; O14713; P22413"]
["GO:0090091","biological_process","positive regulation of extracellular matrix disassembly ","Q16832; Q16658; O75122"]
["GO:0030500","biological_process","regulation of bone mineralization ","Q16832; P17302; P02765; Q9NUQ3; P21453; Q15672; P22413"]
["GO:2000107","biological_process","negative regulation of leukocyte apoptotic process ","Q12866; P14317"]
["GO:0007512","biological_process","adult heart development ","P17302; Q14814; Q9P2D1; P52952; P61296; O15273"]
["GO:0015867","biological_process","ATP transport ","P17302"]
["GO:0086014","biological_process","atrial cardiac muscle cell action potential ","P17302; Q14524; P22460; P51787; P36383"]
["GO:0003294","biological_process","atrial ventricular junction remodeling ","P17302"]
["GO:0010643","biological_process","cell communication by chemical coupling ","P17302; Q16643"]
["GO:0010644","biological_process","cell communication by electrical coupling ","P17302; Q09470; Q16643"]
["GO:0086064","biological_process","cell communication by electrical coupling involved in cardiac conduction ","P17302; P17612; Q92736; P32418; Q13936; P05023"]
["GO:0071467","biological_process","cellular response to pH ","P17302; P80108; Q96D96; Q7Z418; Q9GZU1; P78348"]
["GO:0002544","biological_process","chronic inflammatory response ","P17302"]
["GO:0046697","biological_process","decidualization ","P17302; P35354; O76061; P11473; P19235; P17275; O00255; Q9UBU3"]
["GO:1905867","biological_process","epididymis development ","P17302; P08034"]
["GO:0002070","biological_process","epithelial cell maturation ","P17302; P06401"]
["GO:0060156","biological_process","milk ejection reflex ","P17302"]
["GO:0010652","biological_process","positive regulation of cell communication by chemical coupling ","P17302"]
["GO:0003104","biological_process","positive regulation of glomerular filtration ","P17302"]
["GO:0045844","biological_process","positive regulation of striated muscle tissue development ","P17302"]
["GO:0060371","biological_process","regulation of atrial cardiac muscle cell membrane depolarization ","P17302; Q14524; Q9Y5Y9; O43497"]
["GO:0046850","biological_process","regulation of bone remodeling ","P17302; O43581; P48357"]
["GO:0060373","biological_process","regulation of ventricular cardiac muscle cell membrane depolarization ","P17302; Q14524; O15105; Q8N335"]
["GO:0060307","biological_process","regulation of ventricular cardiac muscle cell membrane repolarization ","P17302; Q99996; Q14524; P51787; Q12809; Q13424; P15382"]
["GO:0010232","biological_process","vascular transport ","P17302"]
["GO:0060532","biological_process","bronchus cartilage development ","P11831; P48436"]
["GO:0060947","biological_process","cardiac vascular smooth muscle cell differentiation ","P11831; Q92908"]
["GO:0035912","biological_process","dorsal aorta morphogenesis ","P11831; P17813; P37023; P36894; Q06330"]
["GO:0010669","biological_process","epithelial structure maintenance ","P11831; Q5TZA2"]
["GO:0060347","biological_process","heart trabecula formation ","P11831; Q02763; Q03167; P52952; Q14192"]
["GO:0060218","biological_process","hematopoietic stem cell differentiation ","P11831; P13010; Q8TDD2; P17542; P50221; P12821"]
["GO:0061145","biological_process","lung smooth muscle development ","P11831; P48436"]
["GO:0002011","biological_process","morphogenesis of an epithelial sheet ","P11831; Q14118"]
["GO:0046716","biological_process","muscle cell cellular homeostasis ","P11831; P04075; P13473; Q16665; P08237; P00441; Q13049; Q9Y281"]
["GO:1900222","biological_process","negative regulation of amyloid-beta clearance ","P11831; Q8IZQ8; P30533"]
["GO:0051491","biological_process","positive regulation of filopodium assembly ","P11831; O00401; Q14195; P51674; Q16658; Q96P48; P32248; Q06787; P36897; Q9ULU4; P60953; P11233; Q8N2Q7; P17081"]
["GO:0045987","biological_process","positive regulation of smooth muscle contraction ","P11831; P35354; Q8IZQ8; P17301; Q9NYA1; P35368; P20309; Q14247; P21731"]
["GO:0046016","biological_process","positive regulation of transcription by glucose ","P11831"]
["GO:0003257","biological_process","positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation ","P11831; Q8IZQ8"]
["GO:0060261","biological_process","positive regulation of transcription initiation from RNA polymerase II promoter ","P11831; P53999; P20823; P52952; Q02556; Q00403"]
["GO:0010735","biological_process","positive regulation of transcription via serum response element binding ","P11831; P52952; Q969V6"]
["GO:0090009","biological_process","primitive streak formation ","P11831; Q9Y261; O75581; P15036; Q03014"]
["GO:0033561","biological_process","regulation of water loss via skin ","P11831"]
["GO:0045214","biological_process","sarcomere organization ","P11831; Q8WZ42; P05556; P05787; P52179; P54296; P52952; Q15327; O15273; P31415; O14958; P08727; P10644; Q9Y281; Q14896; P63261; P09493; Q00872"]
["GO:0043589","biological_process","skin morphogenesis ","P11831; P17301; P49768; Q9H3D4; Q9UJM3"]
["GO:0055013","biological_process","cardiac muscle cell development ","P42345; P32418; Q00839"]
["GO:0071233","biological_process","cellular response to leucine ","P42345; Q8N122"]
["GO:0003179","biological_process","heart valve morphogenesis ","P42345; P48436"]
["GO:1904193","biological_process","negative regulation of cholangiocyte apoptotic process ","P42345"]
["GO:1904213","biological_process","negative regulation of iodide transmembrane transport ","P42345"]
["GO:0014736","biological_process","negative regulation of muscle atrophy ","P42345; O60936"]
["GO:0061051","biological_process","positive regulation of cell growth involved in cardiac muscle cell development ","P42345; Q13526"]
["GO:1904056","biological_process","positive regulation of cholangiocyte proliferation ","P42345"]
["GO:1904690","biological_process","positive regulation of cytoplasmic translational initiation ","P42345"]
["GO:1904000","biological_process","positive regulation of eating behavior ","P42345; P41145; Q9UBU3"]
["GO:1904197","biological_process","positive regulation of granulosa cell proliferation ","P42345"]
["GO:0010831","biological_process","positive regulation of myotube differentiation ","P42345; Q16539; P15173; P10827; P50281"]
["GO:1904058","biological_process","positive regulation of sensory perception of pain ","P42345; P41146"]
["GO:1904206","biological_process","positive regulation of skeletal muscle hypertrophy ","P42345"]
["GO:1903691","biological_process","positive regulation of wound healing, spreading of epidermal cells ","P42345"]
["GO:0090335","biological_process","regulation of brown fat cell differentiation ","P42345; Q96EB6; Q9Y6W6"]
["GO:0043610","biological_process","regulation of carbohydrate utilization ","P42345"]
["GO:0031998","biological_process","regulation of fatty acid beta-oxidation ","P42345"]
["GO:0090559","biological_process","regulation of membrane permeability ","P42345; Q9UDY2; Q9Y624"]
["GO:0099547","biological_process","regulation of translation at synapse, modulating synaptic transmission ","P42345"]
["GO:0045217","biological_process","cell-cell junction maintenance ","P07333; Q9NPB6"]
["GO:0038145","biological_process","macrophage colony-stimulating factor signaling pathway ","P07333; Q99704"]
["GO:0060603","biological_process","mammary gland duct morphogenesis ","P07333; Q14160; P10070"]
["GO:0090197","biological_process","positive regulation of chemokine secretion ","P07333; P01375; Q9ULZ3; P24394"]
["GO:0060706","biological_process","cell differentiation involved in embryonic placenta development ","Q13043; Q13188; P05787; Q9NP62; P08727"]
["GO:0003157","biological_process","endocardium development ","Q13043; Q13188; P46531"]
["GO:0001841","biological_process","neural tube formation ","Q13043; Q13188"]
["GO:0060215","biological_process","primitive hemopoiesis ","Q13043; Q13188; Q13769"]
["GO:0060800","biological_process","regulation of cell differentiation involved in embryonic placenta development ","Q13043; Q13188; Q9NP62"]
["GO:0045716","biological_process","positive regulation of low-density lipoprotein particle receptor biosynthetic process ","P61978"]
["GO:1902165","biological_process","regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p3 class mediator ","P61978"]
["GO:0072369","biological_process","regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter ","P61978; Q07869"]
["GO:0010988","biological_process","regulation of low-density lipoprotein particle clearance ","P61978; Q96RI1"]
["GO:0006396","biological_process","RNA processing ","P61978; Q9UBB9; P31942; Q9BRS8; O60832; Q14498; Q9UHI6; O60506; Q93062; Q96FV9; Q9BUJ2; P98179; Q9H0D6; Q14562; Q9BWF3; P54253; P14866; Q14103; Q92841; O00566; P31943; O95319; Q00839"]
["GO:0014835","biological_process","myoblast differentiation involved in skeletal muscle regeneration ","Q16539"]
["GO:0090336","biological_process","positive regulation of brown fat cell differentiation ","Q16539; P35354; Q00839"]
["GO:0099179","biological_process","regulation of synaptic membrane adhesion ","Q16539"]
["GO:0097695","biological_process","establishment of protein-containing complex localization to telomere ","Q13535; Q13315"]
["GO:0097694","biological_process","establishment of RNA localization to telomere ","Q13535; Q13315"]
["GO:0036297","biological_process","interstrand cross-link repair ","Q13535; Q9NVI1; P62979; Q8WXE1; O15360; O15287; O43542; Q9BXW9; P0CG47; P27694; Q8IY92; P15927; Q9BTP7; Q06609; Q8N2Z9; Q9HB96; Q9H1E3; Q9H816; P62987; Q96SD1; Q6PCD5"]
["GO:0043517","biological_process","positive regulation of DNA damage response, signal transduction by p class mediator ","Q13535; Q13315; P17844; Q15327; Q8N726; Q13794"]
["GO:1904884","biological_process","positive regulation of telomerase catalytic core complex assembly ","Q13535; Q13315"]
["GO:0070198","biological_process","protein localization to chromosome, telomeric region ","Q13535; O95271; P13010; Q15554; Q96BK5; Q9NYB0; Q9BSI4; Q96AP0"]
["GO:0008652","biological_process","cellular amino acid biosynthetic process ","P00439; P32322; Q96C36; P00367"]
["GO:0006559","biological_process","L-phenylalanine catabolic process ","P00439; P61457; P09417"]
["GO:1900745","biological_process","positive regulation of p38MAPK cascade ","Q99683; P14598; Q8N4C8; Q15046; Q9Y6R4; Q5D1E8; Q99759; P47989; P61296; O43164; P41145; P24522; Q15109; Q99873"]
["GO:0048513","biological_process","animal organ development ","P42858; Q9HBU1"]
["GO:0000132","biological_process","establishment of mitotic spindle orientation ","P42858; P49450; P81274; Q92974; P26367; Q9GZM8; Q9NXR1; Q14CS0; Q14203; Q96SN8; Q9UNZ2; O43264; Q14980; O43597; O14777"]
["GO:1905337","biological_process","positive regulation of aggrephagy ","P42858"]
["GO:0031587","biological_process","positive regulation of inositol ,4,-trisphosphate-sensitive calcium-release channel activity ","P42858; Q13563"]
["GO:1904504","biological_process","positive regulation of lipophagy ","P42858; O15269; P07550"]
["GO:2000479","biological_process","regulation of cAMP-dependent protein kinase activity ","P42858"]
["GO:0043666","biological_process","regulation of phosphoprotein phosphatase activity ","P42858; P41236; P14625; P14416; Q5H9R7; Q92574"]
["GO:0042297","biological_process","vocal learning ","P42858; Q9P2S2; Q9ULB1; Q9BYB0"]
["GO:0034380","biological_process","high-density lipoprotein particle assembly ","P17612; P22694; P02649; O95477; P22612"]
["GO:0010737","biological_process","protein kinase A signaling ","P17612; P15311; Q8WZ42; P35241; P52179; P13796"]
["GO:0061136","biological_process","regulation of proteasomal protein catabolic process ","P17612; P82094; P0CG47; P61289; P54578; Q9BXM7; P07203; P98161"]
["GO:0048240","biological_process","sperm capacitation ","P17612; P09622; O75952; O43236; P13569"]
["GO:0010868","biological_process","negative regulation of triglyceride biosynthetic process ","P57059; Q969H0"]
["GO:0002479","biological_process","antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent ","O14920; Q9Y6K9; O15111; P01889; P16671; Q15836; P18084; O00161; P30101; P01892"]
["GO:0042325","biological_process","regulation of phosphorylation ","O14920; Q6R327; Q8TAE6; P17813; P49768; O75943; Q96C90; Q9NXH3; Q99728; P33993; Q96A00; Q8IXJ6"]
["GO:0006672","biological_process","ceramide metabolic process ","P67775; O43464; P30153; Q8TCT0"]
["GO:0010719","biological_process","negative regulation of epithelial to mesenchymal transition ","P67775; P60484; Q9Y261; Q5VWQ8; Q9Y3F4; Q96A54; P55317; O15105; P43699"]
["GO:0006275","biological_process","regulation of DNA replication ","P67775; Q7Z6E9; Q02535; Q86T82; Q9H1E3; O75179; Q9UQE7; Q96KQ7; P37023; P30153; Q3V6T2"]
["GO:0019932","biological_process","second-messenger-mediated signaling ","P67775; Q16760; P30153; P21731"]
["GO:0032532","biological_process","regulation of microvillus length ","Q6IBS0; P15311; P09327"]
["GO:0032722","biological_process","positive regulation of chemokine production ","O43353; P19525; O15455; Q8TDQ0; Q16665; P78536; P01375; O00206"]
["GO:0033091","biological_process","positive regulation of immature T cell proliferation ","O43353"]
["GO:0050718","biological_process","positive regulation of interleukin- beta secretion ","O43353; Q96P20; Q96RD7; O00206; O95361; Q9ULZ3"]
["GO:0045627","biological_process","positive regulation of T-helper 1 cell differentiation ","O43353; P04083"]
["GO:0070673","biological_process","response to interleukin-18 ","O43353; Q16625"]
["GO:0030011","biological_process","maintenance of cell polarity ","P49841; O15511; P19634; Q8TDM6"]
["GO:1904339","biological_process","negative regulation of dopaminergic neuron differentiation ","P49841"]
["GO:1901984","biological_process","negative regulation of protein acetylation ","P49841; Q96EB6; Q99497; P43356"]
["GO:0010822","biological_process","positive regulation of mitochondrion organization ","P49841; Q9UBK2; O43464"]
["GO:0031334","biological_process","positive regulation of protein complex assembly ","P49841; P23396; P17542; P55072; P63165; P01375; Q9UNN5; Q9H211; O94811; Q96IF1; O14613"]
["GO:0071109","biological_process","superior temporal gyrus development ","P49841"]
["GO:0010827","biological_process","regulation of glucose transmembrane transport ","P07947; P11166; Q5NUL3; Q6ZWJ1"]
["GO:0002192","biological_process","IRES-dependent translational initiation of linear mRNA ","Q13541; Q9BWF3"]
["GO:0022602","biological_process","ovulation cycle process ","P52564; P19021"]
["GO:0032308","biological_process","positive regulation of prostaglandin secretion ","P52564"]
["GO:0031047","biological_process","gene silencing by RNA ","Q7KZF4; O75175; Q9NQI0; Q06787; P11940; Q92841; Q9UPQ9; Q9NZN8; P52298; Q9BXT4; Q9UKV8"]
["GO:0010587","biological_process","miRNA catabolic process ","Q7KZF4; Q5TAX3; O95453"]
["GO:0010564","biological_process","regulation of cell cycle process ","Q7KZF4; Q9NUQ3; P52926; Q9NQG5; P48436"]
["GO:0006401","biological_process","RNA catabolic process ","Q7KZF4; Q8IYB8; Q9H0D6; Q15024; Q14103; Q12972; Q8TDP1; Q8TCS8"]
["GO:1904562","biological_process","phosphatidylinositol -phosphate metabolic process ","Q9Y2I7"]
["GO:2000785","biological_process","regulation of autophagosome assembly ","Q9Y2I7; P20339"]
["GO:0042147","biological_process","retrograde transport, endosome to olgi ","Q9Y2I7; P53675; Q15836; Q9NUY8; O60271; Q14203; Q8NBN3; Q92538; Q641Q2; Q5SRD0; O60749; Q4KMP7; Q00610; Q9C0C9"]
["GO:0051654","biological_process","establishment of mitochondrion localization ","Q9P0L2; Q92692; Q99689"]
["GO:0034622","biological_process","cellular protein-containing complex assembly ","Q00613; P02671; Q12962; Q12933; P67870; P18846; O15169"]
["GO:0072738","biological_process","cellular response to diamide ","Q00613; Q9UER7"]
["GO:1904845","biological_process","cellular response to L-glutamine ","Q00613; P13498"]
["GO:1904843","biological_process","cellular response to nitroglycerin ","Q00613"]
["GO:0035865","biological_process","cellular response to potassium ion ","Q00613; P78352; Q9UBK2; Q15700; P00441; O95180"]
["GO:0060136","biological_process","embryonic process involved in female pregnancy ","Q00613; Q02447; P17275"]
["GO:0007143","biological_process","female meiotic nuclear division ","Q00613; P10644; P30153; P11388"]
["GO:2001033","biological_process","negative regulation of double-strand break repair via nonhomologous end joining ","Q00613; Q9UBB9; P52926"]
["GO:0090084","biological_process","negative regulation of inclusion body assembly ","Q00613; P25686; P25685; P0DMV8; P54652"]
["GO:1902512","biological_process","positive regulation of apoptotic DNA fragmentation ","Q00613; Q07812"]
["GO:0090261","biological_process","positive regulation of inclusion body assembly ","Q00613; P62195; P49427"]
["GO:1900365","biological_process","positive regulation of mRNA polyadenylation ","Q00613; Q9BZB8; Q8NE35"]
["GO:0061408","biological_process","positive regulation of transcription from RNA polymerase II promoter in response to heat stress ","Q00613"]
["GO:0070207","biological_process","protein homotrimerization ","Q00613; Q9UBB4; Q7Z2W7; O43464; Q12933; P20963; Q13485; Q9ULV5; P12755; Q8NB16; P78348; Q8TCS8"]
["GO:0043497","biological_process","regulation of protein heterodimerization activity ","Q00613; P16671; Q5VWQ8; Q07812; P10415; Q02297; Q16611; P60953"]
["GO:1990910","biological_process","response to hypobaric hypoxia ","Q00613; O00429"]
["GO:0060520","biological_process","activation of prostate induction by androgen receptor signaling pathway ","P10275"]
["GO:0048645","biological_process","animal organ formation ","P10275; Q92908"]
["GO:0071383","biological_process","cellular response to steroid hormone stimulus ","P10275; P04150; Q99801; O94763; P10646; P68036; P05023; Q15648"]
["GO:0060742","biological_process","epithelial cell differentiation involved in prostate gland development ","P10275"]
["GO:0003382","biological_process","epithelial cell morphogenesis ","P10275; Q9C0K0; O15551; O75369; Q8WX93"]
["GO:0060599","biological_process","lateral sprouting involved in mammary gland duct morphogenesis ","P10275"]
["GO:0033327","biological_process","Leydig cell differentiation ","P10275; P82094; Q15637; P24385; P43699"]
["GO:0048808","biological_process","male genitalia morphogenesis ","P10275"]
["GO:0019102","biological_process","male somatic sex determination ","P10275"]
["GO:0045720","biological_process","negative regulation of integrin biosynthetic process ","P10275"]
["GO:0060769","biological_process","positive regulation of epithelial cell proliferation involved in prostate gland development ","P10275"]
["GO:0043568","biological_process","positive regulation of insulin-like growth factor receptor signaling pathway ","P10275; P17936"]
["GO:0045726","biological_process","positive regulation of integrin biosynthetic process ","P10275"]
["GO:0060740","biological_process","prostate gland epithelium morphogenesis ","P10275; P55317; P47928; P46531; P13631"]
["GO:0060736","biological_process","prostate gland growth ","P10275; P60484; P11511; Q05086"]
["GO:0048638","biological_process","regulation of developmental growth ","P10275; Q6KC79"]
["GO:0072520","biological_process","seminiferous tubule development ","P10275; Q13485"]
["GO:0007338","biological_process","single fertilization ","P10275; Q04912; Q9Y210; O60266; P58012; Q99497; Q13485; Q9HCX4; Q13507; Q15633; P31270; P31269; Q5JQC9; P15529; Q9UGM5; P31260"]
["GO:0060748","biological_process","tertiary branching involved in mammary gland duct morphogenesis ","P10275; P06401"]
["GO:0051650","biological_process","establishment of vesicle localization ","Q9Y6K9; P62491"]
["GO:0071774","biological_process","response to fibroblast growth factor ","P19419; P41180"]
["GO:0007252","biological_process","I-kappaB phosphorylation ","O43318; O15111; O15455; Q5VWQ8; O00206"]
["GO:0002726","biological_process","positive regulation of T cell cytokine production ","O43318; Q12933; Q9Y4K3; O75995; P01892"]
["GO:0070166","biological_process","enamel mineralization ","Q12778; Q13586; P35548; Q07869"]
["GO:0097150","biological_process","neuronal stem cell population maintenance ","Q12778; O43524; Q14469; Q9NZI8; Q15154; P19022; Q9BXW9; Q9BXP5; P46531; P48431"]
["GO:0035947","biological_process","regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter ","Q12778; P20393"]
["GO:1902617","biological_process","response to fluoride ","Q12778"]
["GO:0060502","biological_process","epithelial cell proliferation involved in lung morphogenesis ","Q02750"]
["GO:0060711","biological_process","labyrinthine layer development ","Q02750; Q99966; Q99626; Q9HC62"]
["GO:1903298","biological_process","negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway ","P06733; O60936; Q9BXM7"]
["GO:0045933","biological_process","positive regulation of muscle contraction ","P06733"]
["GO:0010756","biological_process","positive regulation of plasminogen activation ","P06733"]
["GO:0007205","biological_process","protein kinase C-activating -protein coupled receptor signaling pathway ","O94806; Q16760; Q8TEW0; P28222; Q13574; P49619; P23743; P17677; Q07954; Q9NRD5"]
["GO:0060028","biological_process","convergent extension involved in axis elongation ","Q13263; Q9ULK5"]
["GO:0060669","biological_process","embryonic placenta morphogenesis ","Q13263"]
["GO:1901536","biological_process","negative regulation of DNA demethylation ","Q13263; P23771"]
["GO:0045869","biological_process","negative regulation of single stranded viral RNA replication via double stranded DNA intermediate ","Q13263; Q9HC16; P52926"]
["GO:0090309","biological_process","positive regulation of methylation-dependent chromatin silencing ","Q13263; P26358; Q15047"]
["GO:0016925","biological_process","protein sumoylation ","Q13263; Q99502; P49792; Q9NS56; O75925; P63279; P63165; Q8TD43; O75928; Q9BYX4; Q9HC62; Q8N2W9; Q6EEV6; Q9H165; P55854"]
["GO:0080135","biological_process","regulation of cellular response to stress ","O43781; Q04637; P35372"]
["GO:1903432","biological_process","regulation of TRC signaling ","O43781; Q8TEV9; Q9HB90"]
["GO:0035617","biological_process","stress granule disassembly ","O43781; P55072; Q07866; P33176"]
["GO:0043519","biological_process","regulation of myosin II filament organization ","O43293"]
["GO:0099159","biological_process","regulation of modification of postsynaptic structure ","Q8NCB2; P60953"]
["GO:0097156","biological_process","fasciculation of motor neuron axon ","P29320; P54764"]
["GO:0097155","biological_process","fasciculation of sensory neuron axon ","P29320; P54764"]
["GO:0010717","biological_process","regulation of epithelial to mesenchymal transition ","P29320; Q86SQ0; C9JLW8; O15105; Q9HB65; O75122; P36897; Q13009; Q14118; Q86UU1"]
["GO:0008356","biological_process","asymmetric cell division ","Q08379; Q8TEW0; P61160; P61158"]
["GO:0006888","biological_process","ER to olgi vesicle-mediated transport ","Q08379; P42261; P01009; Q9BQQ3; P53992; P56962; Q9BVK6; Q01082; P55072; Q13813; Q15436; P24390; P51809; Q14203; Q8N6H7; P62820; P46459; Q9UHY1; Q12955; Q92538; O60763; O43264; Q14204; P63167; P47756; Q9Y6G9; Q13409; P52907; Q92734; P12259; O00399"]
["GO:0060050","biological_process","positive regulation of protein glycosylation ","Q08379"]
["GO:0006486","biological_process","protein glycosylation ","Q08379; P49768"]
["GO:0090306","biological_process","spindle assembly involved in meiosis ","Q08379"]
["GO:1902741","biological_process","positive regulation of interferon-alpha secretion ","O15111; Q7Z434; O95786; Q9BYX4"]
["GO:0010034","biological_process","response to acetate ","O15111"]
["GO:1901985","biological_process","positive regulation of protein acetylation ","Q7L7X3; Q14012; O00327; Q9NYB0; P17861; Q92993; O95398"]
["GO:0042773","biological_process","ATP synthesis coupled electron transport ","P00403"]
["GO:0006123","biological_process","mitochondrial electron transport, cytochrome c to oxygen ","P00403; P99999"]
["GO:0010729","biological_process","positive regulation of hydrogen peroxide biosynthetic process ","P00403"]
["GO:0016576","biological_process","histone dephosphorylation ","P53041; O00167; Q99502; Q99504"]
["GO:2000324","biological_process","positive regulation of glucocorticoid receptor signaling pathway ","P53041"]
["GO:1904550","biological_process","response to arachidonic acid ","P53041"]
["GO:0014740","biological_process","negative regulation of muscle hyperplasia ","P29474; O43474"]
["GO:0001542","biological_process","ovulation from ovarian follicle ","P29474; O43524; P06401; Q96EB6"]
["GO:0003184","biological_process","pulmonary valve morphogenesis ","P29474; O43541; Q9Y6N7; P46531"]
["GO:0050880","biological_process","regulation of blood vessel size ","P29474; P48506; Q12948; Q99958; O14713"]
["GO:0003100","biological_process","regulation of systemic arterial blood pressure by endothelin ","P29474; P42892; P61586"]
["GO:0019430","biological_process","removal of superoxide radicals ","P29474; Q06830; P00441; P04179; P32119; Q04656"]
["GO:0014806","biological_process","smooth muscle hyperplasia ","P29474; P09601"]
["GO:0033211","biological_process","adiponectin-activated signaling pathway ","P33121; Q96A54; P67870"]
["GO:0036109","biological_process","alpha-linolenic acid metabolic process ","P33121; P22307"]
["GO:0043651","biological_process","linoleic acid metabolic process ","P33121; P09211; Q9NP80"]
["GO:0001676","biological_process","long-chain fatty acid metabolic process ","P33121; P50416; P19021"]
["GO:0035338","biological_process","long-chain fatty-acyl-CoA biosynthetic process ","P33121"]
["GO:0034201","biological_process","response to oleic acid ","P33121; Q92934"]
["GO:0019432","biological_process","triglyceride biosynthetic process ","P33121; Q14693"]
["GO:0042178","biological_process","xenobiotic catabolic process ","P33121"]
["GO:0051131","biological_process","chaperone-mediated protein complex assembly ","P08238; P07900; P10809; Q15185; P0DMV8; P78371"]
["GO:1903660","biological_process","negative regulation of complement-dependent cytotoxicity ","P08238"]
["GO:0032435","biological_process","negative regulation of proteasomal ubiquitin-dependent protein catabolic process ","P08238; Q96KB5; O00560; P49789; Q9NZM5; Q99497; P46379; P78559; P62913; Q9BTA9; Q93009; Q8N163; Q86UE8; Q04323; O15294"]
["GO:0051248","biological_process","negative regulation of protein metabolic process ","P08238; P01130"]
["GO:1901389","biological_process","negative regulation of transforming growth factor beta activation ","P08238"]
["GO:1904031","biological_process","positive regulation of cyclin-dependent protein kinase activity ","P08238"]
["GO:1902949","biological_process","positive regulation of tau-protein kinase activity ","P08238; P07900; P05067; P18146"]
["GO:0031396","biological_process","regulation of protein ubiquitination ","P08238; P07900; P25686; P0DMV8; Q9UER7; P36897; Q9BXM7; Q9UMX0; O43255; O60260"]
["GO:1905323","biological_process","telomerase holoenzyme complex assembly ","P08238; P07900; Q15185"]
["GO:0019062","biological_process","virion attachment to host cell ","P08238"]
["GO:0005975","biological_process","carbohydrate metabolic process ","P06213; P14672; P11168; Q04760; Q15124; P07195; Q14697; Q8N335; P05091; Q9UQ10; Q16816; P09848; P08195; P06744"]
["GO:0031017","biological_process","exocrine pancreas development ","P06213; P52945; P17861"]
["GO:1990535","biological_process","neuron projection maintenance ","P06213; P04156; P78559; Q14203; P49768; P05067"]
["GO:0051446","biological_process","positive regulation of meiotic cell cycle ","P06213"]
["GO:2000194","biological_process","regulation of female gonad development ","P06213"]
["GO:0019087","biological_process","transformation of host cell by virus ","P06213"]
["GO:0046031","biological_process","ADP metabolic process ","Q92934"]
["GO:0060154","biological_process","cellular process regulating host cell cycle in response to virus ","Q92934; O43521; Q07817"]
["GO:0071247","biological_process","cellular response to chromate ","Q92934"]
["GO:0071396","biological_process","cellular response to lipid ","Q92934"]
["GO:0046931","biological_process","pore complex assembly ","Q92934"]
["GO:0060139","biological_process","positive regulation of apoptotic process by virus ","Q92934; O43521"]
["GO:1902220","biological_process","positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress ","Q92934"]
["GO:2000078","biological_process","positive regulation of type B pancreatic cell development ","Q92934"]
["GO:0001844","biological_process","protein insertion into mitochondrial membrane involved in apoptotic signaling pathway ","Q92934; Q9BXH1; O43521; Q07812; Q96LC9; Q13794"]
["GO:0051384","biological_process","response to glucocorticoid ","Q92934; P35354; P04818; P01116; P10415; P28562; P01375; P18827; P22004; Q8IWU9; P61586; P42574; P19021; P16118"]
["GO:0019050","biological_process","suppression by virus of host apoptotic process ","Q92934; Q07817"]
["GO:0044342","biological_process","type B pancreatic cell proliferation ","Q92934; P17936"]
["GO:0019934","biological_process","cMP-mediated signaling ","Q13976; P29972; P16671; P16066; P02649; Q14432; Q9H2P0"]
["GO:0090331","biological_process","negative regulation of platelet aggregation ","Q13976; Q05655; P13688"]
["GO:0060087","biological_process","relaxation of vascular smooth muscle ","Q13976; P41220; Q02108; P00441"]
["GO:0071393","biological_process","cellular response to progesterone stimulus ","P12931; P56693"]
["GO:0051895","biological_process","negative regulation of focal adhesion assembly ","P12931; P60484; Q08495; Q96QB1; Q86SQ0; Q9ULV4; O75122; P37023; O14713; P50281"]
["GO:2001243","biological_process","negative regulation of intrinsic apoptotic signaling pathway ","P12931; P30405; O75489; Q13547; Q9Y3T9; O94763; P10415; Q07820; Q9UQF2; O00571; Q07817; Q9BXM7; Q9P0J0"]
["GO:0051902","biological_process","negative regulation of mitochondrial depolarization ","P12931; P10415"]
["GO:0048477","biological_process","oogenesis ","P12931; Q9UHI6; P40692; O14686"]
["GO:0045737","biological_process","positive regulation of cyclin-dependent protein serine/threonine kinase activity ","P12931; P30279; Q8N1B3; Q99741; Q8ND76; P46527; Q9UPY8; P51946; P30281; P24385; O60563; Q96S94"]
["GO:0033625","biological_process","positive regulation of integrin activation ","P12931; Q86WV1; P08567"]
["GO:2000394","biological_process","positive regulation of lamellipodium morphogenesis ","P12931; P09327; Q14155; Q9BR76; Q9ULV4"]
["GO:2000386","biological_process","positive regulation of ovarian follicle development ","P12931"]
["GO:0010641","biological_process","positive regulation of platelet-derived growth factor receptor signaling pathway ","P12931; P13726"]
["GO:0010954","biological_process","positive regulation of protein processing ","P12931; O95816; Q05952; P50281"]
["GO:0051057","biological_process","positive regulation of small TPase mediated signal transduction ","P12931; Q07889"]
["GO:0001545","biological_process","primary ovarian follicle growth ","P12931; P23945"]
["GO:2001286","biological_process","regulation of caveolin-mediated endocytosis ","P12931"]
["GO:0060491","biological_process","regulation of cell projection assembly ","P12931"]
["GO:0098962","biological_process","regulation of postsynaptic neurotransmitter receptor activity ","P12931; Q99996"]
["GO:0010447","biological_process","response to acidic pH ","P12931; Q9UHC3; P19634; P36955; Q99538; P78348"]
["GO:0051385","biological_process","response to mineralocorticoid ","P12931; P01116; P28222"]
["GO:0045056","biological_process","transcytosis ","P12931; O60763; P30533; P20339; Q07954; Q00610"]
["GO:0042942","biological_process","D-serine transport ","O00221"]
["GO:0051683","biological_process","establishment of olgi localization ","O00506; O14745; Q6ZS17; Q9BUL8; P60953; Q5T5U3; P63104"]
["GO:0090168","biological_process","olgi reassembly ","O00506; Q96JH7; Q9BUL8; P63104"]
["GO:0036481","biological_process","intrinsic apoptotic signaling pathway in response to hydrogen peroxide ","O00506; Q9BUL8"]
["GO:0043551","biological_process","regulation of phosphatidylinositol -kinase activity ","O00459; P27986; Q92569"]
["GO:2001031","biological_process","positive regulation of cellular glucuronidation ","Q02156"]
["GO:0050996","biological_process","positive regulation of lipid catabolic process ","Q02156"]
["GO:0070257","biological_process","positive regulation of mucus secretion ","Q02156; P13498; Q9H1Y0; Q9GZQ8"]
["GO:0032230","biological_process","positive regulation of synaptic transmission, ABAergic ","Q02156; P00918; Q8N2Q7; P33176"]
["GO:0035669","biological_process","TRAM-dependent toll-like receptor 4 signaling pathway ","Q02156; Q86XR7"]
["GO:0030042","biological_process","actin filament depolymerization ","P23528; P09327; P60981; Q9Y281"]
["GO:0030043","biological_process","actin filament fragmentation ","P23528; P60981; Q9Y281"]
["GO:0001842","biological_process","neural fold formation ","P23528"]
["GO:0030836","biological_process","positive regulation of actin filament depolymerization ","P23528; P09327; P60981; Q9Y281; P08567"]
["GO:0022604","biological_process","regulation of cell morphogenesis ","P23528; Q14202; Q9UBW7; P47756; Q96PY5; Q7LC44"]
["GO:0007190","biological_process","activation of adenylate cyclase activity ","P04049; P34998; P0DP23; P43220; P08588; Q01518; P16473; P21728; P07550; P30518; P23945"]
["GO:0035773","biological_process","insulin secretion involved in cellular response to glucose stimulus ","P04049; Q9BXF6; Q7L804"]
["GO:0045104","biological_process","intermediate filament cytoskeleton organization ","P04049; Q96RT1; P54252; P48729; P05783"]
["GO:0045175","biological_process","basal protein localization ","Q96RT1"]
["GO:0071638","biological_process","negative regulation of monocyte chemotactic protein- production ","Q96RT1; Q96RI1; P09211"]
["GO:0099072","biological_process","regulation of postsynaptic membrane neurotransmitter receptor levels ","Q96RT1; P41743; Q14254; O60716; P62258"]
["GO:0001824","biological_process","blastocyst development ","P51955; P78545; P17980; P49321; P36897; O96004; P17655; P43686; Q01860"]
["GO:0051299","biological_process","centrosome separation ","P51955; Q8N137"]
["GO:1903126","biological_process","negative regulation of centriole-centriole cohesion ","P51955"]
["GO:0046602","biological_process","regulation of mitotic centrosome separation ","P51955; O14757; Q49MG5; P52732"]
["GO:1904954","biological_process","canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation ","P35222"]
["GO:0061324","biological_process","canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation ","P35222"]
["GO:0044334","biological_process","canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition ","P35222; Q9NQB0"]
["GO:0036023","biological_process","embryonic skeletal limb joint morphogenesis ","P35222"]
["GO:0035315","biological_process","hair cell differentiation ","P35222; P19447; Q99697"]
["GO:1904948","biological_process","midbrain dopaminergic neuron differentiation ","P35222; O75581; P43354"]
["GO:0045976","biological_process","negative regulation of mitotic cell cycle, embryonic ","P35222"]
["GO:1904798","biological_process","positive regulation of core promoter binding ","P35222; Q12948; O43474; Q00403"]
["GO:0010909","biological_process","positive regulation of heparan sulfate proteoglycan biosynthetic process ","P35222; Q9NQB0"]
["GO:0002052","biological_process","positive regulation of neuroblast proliferation ","P35222; P26367; Q16665; O60341; P14416; Q6STE5; P46531; P10071"]
["GO:0030997","biological_process","regulation of centriole-centriole cohesion ","P35222; Q9BV73"]
["GO:0070602","biological_process","regulation of centromeric sister chromatid cohesion ","P35222; Q9Y2T1; P49711"]
["GO:0072182","biological_process","regulation of nephron tubule epithelial cell differentiation ","P35222; P23771"]
["GO:2000008","biological_process","regulation of protein localization to cell surface ","P35222; P23560; Q9BXF6; Q92538; Q13303"]
["GO:0061549","biological_process","sympathetic ganglion development ","P35222; P50553"]
["GO:0030033","biological_process","microvillus assembly ","Q9UKE5; P15311; Q13887; Q9P289; O14745; P35241; Q9Y4G8"]
["GO:2001234","biological_process","negative regulation of apoptotic signaling pathway ","P68400; P04899; P32929; Q07812; P10415; P49768; P43354; P19784"]
["GO:1905818","biological_process","regulation of chromosome separation ","P68400; P19784"]
["GO:0048646","biological_process","anatomical structure formation involved in morphogenesis ","P23771; P62993; P56178; P55317; P43699"]
["GO:0061290","biological_process","canonical Wnt signaling pathway involved in metanephric kidney development ","P23771"]
["GO:0003215","biological_process","cardiac right ventricle morphogenesis ","P23771; P43694; Q8WUF5; P36894; Q9UMR3"]
["GO:0001709","biological_process","cell fate determination ","P23771; Q02962; P26367; Q07820; P23769"]
["GO:0072643","biological_process","interferon-gamma secretion ","P23771"]
["GO:0072602","biological_process","interleukin-4 secretion ","P23771; P46531; Q06330"]
["GO:0072676","biological_process","lymphocyte migration ","P23771; Q9UL17"]
["GO:0001823","biological_process","mesonephros development ","P23771; Q02962; Q05516"]
["GO:2000607","biological_process","negative regulation of cell proliferation involved in mesonephros development ","P23771"]
["GO:2000703","biological_process","negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation ","P23771"]
["GO:2000734","biological_process","negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation ","P23771"]
["GO:0032703","biological_process","negative regulation of interleukin- production ","P23771; Q8WUI4; Q8TDQ0; Q96RI1; P04156; Q9BZS1; Q9NSB8; Q92993; Q9UL17"]
["GO:0033600","biological_process","negative regulation of mammary gland epithelial cell proliferation ","P23771; Q9Y6N7; P51587; Q99623"]
["GO:0072179","biological_process","nephric duct formation ","P23771; Q02962"]
["GO:0072178","biological_process","nephric duct morphogenesis ","P23771; P54764"]
["GO:0071599","biological_process","otic vesicle development ","P23771"]
["GO:0060017","biological_process","parathyroid gland development ","P23771; P46109; P36897"]
["GO:0035898","biological_process","parathyroid hormone secretion ","P23771"]
["GO:0071442","biological_process","positive regulation of histone H3-K acetylation ","P23771; Q969T9"]
["GO:2000611","biological_process","positive regulation of thyroid hormone generation ","P23771"]
["GO:0072107","biological_process","positive regulation of ureteric bud formation ","P23771"]
["GO:0002572","biological_process","pro-T cell differentiation ","P23771"]
["GO:0043370","biological_process","regulation of CD-positive, alpha-beta T cell differentiation ","P23771; Q7Z6J0"]
["GO:2000683","biological_process","regulation of cellular response to X-ray ","P23771"]
["GO:0061085","biological_process","regulation of histone H3-K27 methylation ","P23771"]
["GO:0051569","biological_process","regulation of histone H3-K4 methylation ","P23771; Q9BRQ0"]
["GO:0045064","biological_process","T-helper 2 cell differentiation ","P23771; P20749"]
["GO:0045061","biological_process","thymic T cell selection ","P23771; Q9BXL7"]
["GO:0001806","biological_process","type IV hypersensitivity ","P23771"]
["GO:0060676","biological_process","ureteric bud formation ","P23771"]
["GO:0060562","biological_process","epithelial tube morphogenesis ","P51817"]
["GO:0060993","biological_process","kidney morphogenesis ","P51817; Q9ULK5; Q9GZV5"]
["GO:2000696","biological_process","regulation of epithelial cell differentiation involved in kidney development ","P51817"]
["GO:0061436","biological_process","establishment of skin barrier ","P08581; P31947; Q9NZI5; O14493; Q9H3D4; P16949"]
["GO:1901299","biological_process","negative regulation of hydrogen peroxide-mediated programmed cell death ","P08581"]
["GO:0035024","biological_process","negative regulation of Rho protein signal transduction ","P08581; P05556; Q96QB1; Q13829; Q6ZS17; Q8WWN8; P41182; Q9NRY4; P16949"]
["GO:0050918","biological_process","positive chemotaxis ","P08581; Q14160; Q12913; P17931; P49815"]
["GO:0048738","biological_process","cardiac muscle tissue development ","P60484; P26678; P50461; Q16635; P19404; P36383"]
["GO:0071257","biological_process","cellular response to electrical stimulus ","P60484; P11488; P19634; Q13255; P84074; Q6X4W1"]
["GO:0032286","biological_process","central nervous system myelin maintenance ","P60484; Q9Y2G1"]
["GO:0046855","biological_process","inositol phosphate dephosphorylation ","P60484; O43426; Q13614"]
["GO:0045475","biological_process","locomotor rhythm ","P60484; Q9NZV8; Q13330; Q02363; Q15596"]
["GO:0042711","biological_process","maternal behavior ","P60484; O60229; P41145; P21728"]
["GO:0048681","biological_process","negative regulation of axon regeneration ","P60484; P54764"]
["GO:0061002","biological_process","negative regulation of dendritic spine morphogenesis ","P60484; Q8N5V2; Q8N2Q7"]
["GO:0051548","biological_process","negative regulation of keratinocyte migration ","P60484"]
["GO:0014067","biological_process","negative regulation of phosphatidylinositol 3-kinase signaling ","P60484; O14745; Q5VWQ8; Q9NZM5; O43474; P49815; P05813; Q15672"]
["GO:0090071","biological_process","negative regulation of ribosome biogenesis ","P60484"]
["GO:2000272","biological_process","negative regulation of signaling receptor activity ","P60484; Q9UBK2"]
["GO:2000808","biological_process","negative regulation of synaptic vesicle clustering ","P60484"]
["GO:1903690","biological_process","negative regulation of wound healing, spreading of epidermal cells ","P60484; Q86SQ0; O75122"]
["GO:0007270","biological_process","neuron-neuron synaptic transmission ","P60484; Q9P1A6; P14416; Q8NFD5; P21796"]
["GO:1903984","biological_process","positive regulation of TRAIL-activated apoptotic signaling pathway ","P60484"]
["GO:0097107","biological_process","postsynaptic density assembly ","P60484; Q9BYB0"]
["GO:0097105","biological_process","presynaptic membrane assembly ","P60484; P58400; O75096; Q8N0W4; Q8N2Q7"]
["GO:0032535","biological_process","regulation of cellular component size ","P60484"]
["GO:0033032","biological_process","regulation of myeloid cell apoptotic process ","P60484; P10827"]
["GO:0046685","biological_process","response to arsenic-containing substance ","P60484; P48506; P38936; P78317; Q9BWF3; Q9BXP5; P36955"]
["GO:0033198","biological_process","response to ATP ","P60484; Q96RD7; P32418; Q13507; Q9UBL9; P30613; Q14654"]
["GO:0060024","biological_process","rhythmic synaptic transmission ","P60484"]
["GO:1902018","biological_process","negative regulation of cilium assembly ","Q9P0N9; Q15131; O43303; Q8IW35"]
["GO:0008585","biological_process","female gonad development ","O75874; O15360; Q99697; P11511; P57740; Q13285; P51587; P23945"]
["GO:0006097","biological_process","glyoxylate cycle ","O75874"]
["GO:0006102","biological_process","isocitrate metabolic process ","O75874; Q99798"]
["GO:0071071","biological_process","regulation of phospholipid biosynthetic process ","O75874"]
["GO:0060696","biological_process","regulation of phospholipid catabolic process ","O75874"]
["GO:0071376","biological_process","cellular response to corticotropin-releasing hormone stimulus ","P22736; P34998; P43354"]
["GO:0035767","biological_process","endothelial cell chemotaxis ","P22736; Q9BR76; O94827"]
["GO:0061469","biological_process","regulation of type B pancreatic cell proliferation ","P22736; O00255; P20393; Q9UJM3"]
["GO:1900103","biological_process","positive regulation of endoplasmic reticulum unfolded protein response ","P27986; Q07812; O75460; P17861; Q16611"]
["GO:0003351","biological_process","epithelial cilium movement ","Q9NRP7; O75952; Q4G0X9"]
["GO:0007228","biological_process","positive regulation of hh target transcription factor activity ","Q9NRP7"]
["GO:0003383","biological_process","apical constriction ","Q13464"]
["GO:0032060","biological_process","bleb assembly ","Q13464; Q15746"]
["GO:0022614","biological_process","membrane to membrane docking ","Q13464; P15311; P26038"]
["GO:0051451","biological_process","myoblast migration ","Q13464; O14713; Q96KG7; Q7Z628"]
["GO:1902430","biological_process","negative regulation of amyloid-beta formation ","Q13464; P36544; P04156; Q92673; P02649"]
["GO:1902992","biological_process","negative regulation of amyloid precursor protein catabolic process ","Q13464; Q14254; P04156"]
["GO:0051045","biological_process","negative regulation of membrane protein ectodomain proteolysis ","Q13464; P26045"]
["GO:1900223","biological_process","positive regulation of amyloid-beta clearance ","Q13464; P01130; P30533; Q07954"]
["GO:1902003","biological_process","regulation of amyloid-beta formation ","Q13464"]
["GO:0045664","biological_process","regulation of neuron differentiation ","Q13464; Q99502; Q15078; Q04917; Q9C0K0; P61981; Q96SN8; Q86V15; Q8N2Q7"]
["GO:1900242","biological_process","regulation of synaptic vesicle endocytosis ","Q13464; P0DP23; O43581; O75379"]
["GO:0002009","biological_process","morphogenesis of an epithelium ","P57078; Q16790; P18206; P00918"]
["GO:0010991","biological_process","negative regulation of SMAD protein complex assembly ","P35813; O43541; Q9UMR3"]
["GO:0006499","biological_process","N-terminal protein myristoylation ","P35813; O75688; P30419"]
["GO:1903977","biological_process","positive regulation of glial cell migration ","P46109"]
["GO:0035092","biological_process","sperm chromatin condensation ","Q96SB4"]
["GO:0021957","biological_process","corticospinal tract morphogenesis ","P54764; O60315"]
["GO:0008347","biological_process","glial cell migration ","P54764; Q6UVK1"]
["GO:1903051","biological_process","negative regulation of proteolysis involved in cellular protein catabolic process ","P54764; Q8N726"]
["GO:0106030","biological_process","neuron projection fasciculation ","P54764"]
["GO:0097485","biological_process","neuron projection guidance ","P54764; Q9NRY4"]
["GO:2001108","biological_process","positive regulation of Rho guanyl-nucleotide exchange factor activity ","P54764"]
["GO:0048710","biological_process","regulation of astrocyte differentiation ","P54764"]
["GO:0002191","biological_process","cap-dependent translational initiation ","Q04637"]
["GO:0034645","biological_process","cellular macromolecule biosynthetic process ","Q04637"]
["GO:0032502","biological_process","developmental process ","Q04637"]
["GO:0010801","biological_process","negative regulation of peptidyl-threonine phosphorylation ","Q04637; Q14738; Q8TEW0; Q08495; P0DP23; O15105; Q8IXJ6; O43597"]
["GO:1905537","biological_process","positive regulation of eukaryotic translation initiation factor 4F complex assembly ","Q04637"]
["GO:1900087","biological_process","positive regulation of /S transition of mitotic cell cycle ","Q04637; P04083; O43660; P30279; O14746; Q9NQ66; P35241; Q8IZD2; O00571; P22460; O75179; Q8N122; Q7L2J0; P27695"]
["GO:1905618","biological_process","positive regulation of miRNA mediated inhibition of translation ","Q04637; Q9UKV8"]
["GO:1905612","biological_process","positive regulation of mRNA cap binding ","Q04637"]
["GO:1905696","biological_process","regulation of polysome binding ","Q04637"]
["GO:0071500","biological_process","cellular response to nitrosative stress ","Q13315; Q9H1Y0"]
["GO:0071044","biological_process","histone mRNA catabolic process ","Q13315; Q92900"]
["GO:1903626","biological_process","positive regulation of DNA catabolic process ","Q13315"]
["GO:1904358","biological_process","positive regulation of telomere maintenance via telomere lengthening ","Q13315; P22626"]
["GO:0002331","biological_process","pre-B cell allelic exclusion ","Q13315; P55895"]
["GO:0007131","biological_process","reciprocal meiotic recombination ","Q13315; O43542; P49959; Q06609; Q92878"]
["GO:1905843","biological_process","regulation of cellular response to gamma radiation ","Q13315"]
["GO:1903978","biological_process","regulation of microglial cell activation ","Q13315"]
["GO:0032210","biological_process","regulation of telomere maintenance via telomerase ","Q13315; O95271; Q15554"]
["GO:0072434","biological_process","signal transduction involved in mitotic  DNA damage checkpoint ","Q13315"]
["GO:0050482","biological_process","arachidonic acid secretion ","P04083; P47712; P30411; P35462; P14416; P12821; Q9NP80"]
["GO:0007187","biological_process","-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger ","P04083; P43119; Q03431; P41143; P21554; P32241; P28222; P08172; P16473; P21728; P30874; P34972; P35372"]
["GO:0071621","biological_process","granulocyte chemotaxis ","P04083; Q96F46"]
["GO:0014839","biological_process","myoblast migration involved in skeletal muscle regeneration ","P04083"]
["GO:1900138","biological_process","negative regulation of phospholipase A2 activity ","P04083"]
["GO:0045629","biological_process","negative regulation of T-helper  cell differentiation ","P04083; P41182"]
["GO:0018149","biological_process","peptide cross-linking ","P04083; P15924"]
["GO:0033031","biological_process","positive regulation of neutrophil apoptotic process ","P04083; P42338; O00329"]
["GO:0031394","biological_process","positive regulation of prostaglandin biosynthetic process ","P04083; P35354"]
["GO:0070459","biological_process","prolactin secretion ","P04083"]
["GO:0046883","biological_process","regulation of hormone secretion ","P04083; P05408"]
["GO:0032652","biological_process","regulation of interleukin-1 production ","P04083"]
["GO:0002685","biological_process","regulation of leukocyte migration ","P04083"]
["GO:0071386","biological_process","cellular response to corticosterone stimulus ","O43524"]
["GO:0001544","biological_process","initiation of primordial ovarian follicle growth ","O43524"]
["GO:0006390","biological_process","mitochondrial transcription ","O43524; Q00059"]
["GO:1901300","biological_process","positive regulation of hydrogen peroxide-mediated programmed cell death ","O43524; Q96IZ0; Q9UBN7"]
["GO:0071548","biological_process","response to dexamethasone ","O43524; P12004"]
["GO:0032434","biological_process","regulation of proteasomal ubiquitin-dependent protein catabolic process ","P10398; Q9BW61; P54727; O94874; P61086; Q03113"]
["GO:1905775","biological_process","negative regulation of DNA helicase activity ","P49736"]
["GO:0051304","biological_process","chromosome separation ","P33981; Q9H4L7; O94762"]
["GO:0033316","biological_process","meiotic spindle assembly checkpoint ","P33981"]
["GO:1903096","biological_process","protein localization to meiotic spindle midzone ","P33981"]
["GO:0045954","biological_process","positive regulation of natural killer cell mediated cytotoxicity ","P15498; Q92692; Q15762; P51692; O95267"]
["GO:0035089","biological_process","establishment of apical/basal cell polarity ","P41743; Q16658; Q14160"]
["GO:0048194","biological_process","olgi vesicle budding ","P41743; Q92614; Q9H4A6"]
["GO:0006612","biological_process","protein targeting to membrane ","P41743; Q96QF0; P14598; Q9Y4P1; Q8TEW0; O00560; Q9UL54; Q9Y698; Q8N3F8; Q9NT62"]
["GO:0046903","biological_process","secretion ","P41743; Q16790; P00918; Q86UR5; P55327"]
["GO:0001508","biological_process","action potential ","Q9NZV8; P43681; P30626; Q14721; Q9UKL4"]
["GO:0019228","biological_process","neuronal action potential ","Q9NZV8; Q13002; Q99250; Q14524; Q9Y5Y9; P16389; O43497; Q9UQD0; Q12955; O95180; P21728; Q09470"]
["GO:0071805","biological_process","potassium ion transmembrane transport ","Q9NZV8; O95069; O43525; Q13563; Q9NS61; P43003; Q14721; P22459; P19634; O43526; P57789; P22001; Q9Y3Q4; P16389; P22460; P51787; Q9NPC2; Q12809; P48764; Q09470; Q9H244; Q9H2S1; Q14940; P15382; P63252; Q14654; Q9UL51"]
["GO:0034765","biological_process","regulation of ion transmembrane transport ","Q9NZV8; Q9NZA1; Q00975; Q96PU5; O43525; Q12791; P48544; O00299; Q99250; P48048; P48549; Q14721; P22459; Q14500; O43526; P57789; P22001; Q9Y3Q4; Q9Y5Y9; O60928; P16389; Q96D96; O43497; Q9UQD0; O95180; Q9UK17; Q03721; P48050; P46934; Q15842; P78508; Q9UL51; Q13698; Q9NPI9"]
["GO:0002731","biological_process","negative regulation of dendritic cell cytokine production ","P52333"]
["GO:0045221","biological_process","negative regulation of FasL biosynthetic process ","P52333"]
["GO:0032693","biological_process","negative regulation of interleukin-1 production ","P52333; Q9BZS1; P31994; Q15109"]
["GO:0032695","biological_process","negative regulation of interleukin-1 production ","P52333; O15553; Q13291; P32121; Q07021"]
["GO:0045626","biological_process","negative regulation of T-helper 1 cell differentiation ","P52333; P24394"]
["GO:0070244","biological_process","negative regulation of thymocyte apoptotic process ","P52333; Q16665; P51449"]
["GO:0070232","biological_process","regulation of T cell apoptotic process ","P52333; P17931"]
["GO:0070672","biological_process","response to interleukin-15 ","P52333"]
["GO:0070669","biological_process","response to interleukin-2 ","P52333; Q99966"]
["GO:0070670","biological_process","response to interleukin-4 ","P52333; Q99966; P51692"]
["GO:0071104","biological_process","response to interleukin-9 ","P52333; Q99966"]
["GO:0043029","biological_process","T cell homeostasis ","P52333; Q9Y3P8; Q13158; O43521; P10415; Q9BZS1; Q5TC82; Q9Y572; P51692; P42574; Q13794"]
["GO:0097069","biological_process","cellular response to thyroxine stimulus ","P48506"]
["GO:0006534","biological_process","cysteine metabolic process ","P48506; P32929"]
["GO:0006536","biological_process","glutamate metabolic process ","P48506; P51649"]
["GO:0006750","biological_process","glutathione biosynthetic process ","P48506"]
["GO:0019852","biological_process","L-ascorbic acid metabolic process ","P48506; P11166; Q9UGH3"]
["GO:2000490","biological_process","negative regulation of hepatic stellate cell activation ","P48506"]
["GO:0044752","biological_process","response to human chorionic gonadotropin ","P48506"]
["GO:0051409","biological_process","response to nitrosative stress ","P48506; Q16828"]
["GO:0009410","biological_process","response to xenobiotic stimulus ","P48506; P07203; P35869"]
["GO:0031639","biological_process","plasminogen activation ","P00558; P02671; P00749"]
["GO:0072012","biological_process","glomerulus vasculature development ","Q02763; Q14469"]
["GO:2000351","biological_process","regulation of endothelial cell apoptotic process ","Q02763"]
["GO:0032878","biological_process","regulation of establishment or maintenance of cell polarity ","Q02763; Q6P1M3"]
["GO:0048014","biological_process","Tie signaling pathway ","Q02763"]
["GO:0060574","biological_process","intestinal epithelial cell maturation ","P38936; P04818; Q16665"]
["GO:0071850","biological_process","mitotic cell cycle arrest ","P38936; Q99801; P46527; Q8TAE8; P28562; Q9H4X1; P24522; Q86UL8; Q8TCS8"]
["GO:1904030","biological_process","negative regulation of cyclin-dependent protein kinase activity ","P38936; P49918; P46527"]
["GO:0042326","biological_process","negative regulation of phosphorylation ","P38936; Q96EB6; P08476; P49918; P46527; P42771; Q13322; Q86XL3; P63167; P55273"]
["GO:2000278","biological_process","regulation of DNA biosynthetic process ","P38936; Q9NRF2"]
["GO:0033158","biological_process","regulation of protein import into nucleus, translocation ","P38936; Q96EB6; P10599"]
["GO:0003290","biological_process","atrial septum secundum morphogenesis ","P43694; O96028"]
["GO:0003208","biological_process","cardiac ventricle morphogenesis ","P43694; Q16665; P17813; P46531"]
["GO:0035054","biological_process","embryonic heart tube anterior/posterior pattern specification ","P43694"]
["GO:0051891","biological_process","positive regulation of cardioblast differentiation ","P43694; Q92908; P52952"]
["GO:0086004","biological_process","regulation of cardiac muscle cell contraction ","P43694; Q08499; P30626; P26678; Q14524; P63165; P05023; Q07343; P63252"]
["GO:0070120","biological_process","ciliary neurotrophic factor-mediated signaling pathway ","P40189; P42702"]
["GO:0048861","biological_process","leukemia inhibitory factor signaling pathway ","P40189; P42702"]
["GO:0038165","biological_process","oncostatin-M-mediated signaling pathway ","P40189; Q99650; P42702"]
["GO:0002675","biological_process","positive regulation of acute inflammatory response ","P40189; Q99650; P48736"]
["GO:0048711","biological_process","positive regulation of astrocyte differentiation ","P40189; Q14469; Q9UMS4; Q02363; P46531"]
["GO:0010596","biological_process","negative regulation of endothelial cell migration ","P28827; Q5VWQ8; P57105; P37023; P36955; P23497"]
["GO:0045839","biological_process","negative regulation of mitotic nuclear division ","O14757; O75674"]
["GO:0010569","biological_process","regulation of double-strand break repair via homologous recombination ","O14757; P15927; O60341; Q06609; Q9NYB0; Q8N6T7"]
["GO:2000615","biological_process","regulation of histone H3-K9 acetylation ","O14757; Q03164"]
["GO:0010767","biological_process","regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage ","O14757"]
["GO:0051447","biological_process","negative regulation of meiotic cell cycle ","P22694; P28562"]
["GO:1901621","biological_process","negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning ","P22694; O75386; Q9UMX1"]
["GO:0070613","biological_process","regulation of protein processing ","P22694"]
["GO:0097338","biological_process","response to clozapine ","P22694; P31323"]
["GO:0021549","biological_process","cerebellum development ","Q13153; Q15078; Q9UBK2; P07766; Q12948; Q14524; P12277; P31939; Q13319; P31994; Q14103; Q8N0W4; P51608; P30874; Q13562"]
["GO:0060244","biological_process","negative regulation of cell proliferation involved in contact inhibition ","Q13153"]
["GO:0061684","biological_process","chaperone-mediated autophagy ","P07900; P13473; P11142"]
["GO:0006839","biological_process","mitochondrial transport ","P07900; Q14849; P49768"]
["GO:1903364","biological_process","positive regulation of cellular protein catabolic process ","P07900; P15311; P26038; P35241; P53801; Q9NYF0; Q9UNN5"]
["GO:0032273","biological_process","positive regulation of protein polymerization ","P07900; O94811"]
["GO:0045040","biological_process","protein import into mitochondrial outer membrane ","P07900"]
["GO:0042026","biological_process","protein refolding ","P07900; P25686; P10809; P34931; P0DMV8; P11142; P54652"]
["GO:0043335","biological_process","protein unfolding ","P07900; P30040"]
["GO:0021695","biological_process","cerebellar cortex development ","Q15910; P50052; Q15058"]
["GO:0070314","biological_process"," to  transition ","Q15910; O43175"]
["GO:0036333","biological_process","hepatocyte homeostasis ","Q15910"]
["GO:0070734","biological_process","histone H-K2 methylation ","Q15910; Q15022"]
["GO:0098532","biological_process","histone H-K7 trimethylation ","Q15910; P16403; P10412"]
["GO:0045605","biological_process","negative regulation of epidermal cell differentiation ","Q15910"]
["GO:0048387","biological_process","negative regulation of retinoic acid receptor signaling pathway ","Q15910"]
["GO:0051154","biological_process","negative regulation of striated muscle cell differentiation ","Q15910; P67809"]
["GO:1902808","biological_process","positive regulation of cell cycle /S phase transition ","Q15910; P08151; Q9BTK6; Q6P1J9; Q9H3D4; Q6ZWJ1; Q99623"]
["GO:1900006","biological_process","positive regulation of dendrite development ","Q15910; Q9BY11; Q5VWQ8; Q6UUV9; P46940"]
["GO:1904772","biological_process","response to tetrachloromethane ","Q15910"]
["GO:0014834","biological_process","skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration ","Q15910"]
["GO:0051835","biological_process","positive regulation of synapse structural plasticity ","Q14012; Q9BYB0; P60953"]
["GO:0060143","biological_process","positive regulation of syncytium formation by plasma membrane fusion ","Q14012; Q9NP62; O95398"]
["GO:0072574","biological_process","hepatocyte proliferation ","Q15418; P17676"]
["GO:0006085","biological_process","acetyl-CoA biosynthetic process ","P53396; P24752"]
["GO:0019483","biological_process","beta-alanine biosynthetic process ","Q12882"]
["GO:0006145","biological_process","purine nucleobase catabolic process ","Q12882"]
["GO:0006208","biological_process","pyrimidine nucleobase catabolic process ","Q12882"]
["GO:0046135","biological_process","pyrimidine nucleoside catabolic process ","Q12882"]
["GO:0006214","biological_process","thymidine catabolic process ","Q12882"]
["GO:0006210","biological_process","thymine catabolic process ","Q12882"]
["GO:0006212","biological_process","uracil catabolic process ","Q12882"]
["GO:0070932","biological_process","histone H deacetylation ","P56524; Q92769; Q96EB6; O15055; P28324; Q9H4L7; Q13547; O15534; P23246; Q8IXJ6; Q9UKV0"]
["GO:0070933","biological_process","histone H4 deacetylation ","P56524; Q92769; Q9H4L7; Q13547; Q8IXJ6; Q9UKV0"]
["GO:0034983","biological_process","peptidyl-lysine deacetylation ","P56524; Q96EB6; Q9NTG7; Q9UBN7; Q8IXJ6; Q9UKV0"]
["GO:0033235","biological_process","positive regulation of protein sumoylation ","P56524; P27540; O75925; Q8N2W9; Q8N726"]
["GO:0010882","biological_process","regulation of cardiac muscle contraction by calcium ion signaling ","P56524; P19429; Q92736; P32418; P19634; P16615"]
["GO:0048742","biological_process","regulation of skeletal muscle fiber development ","P56524; Q13765; Q9UKV0"]
["GO:0014894","biological_process","response to denervation involved in regulation of muscle adaptation ","P56524; P15173; Q14524; P46939; P31415; Q14118"]
["GO:0032613","biological_process","interleukin- production ","Q05655; P15529"]
["GO:0032615","biological_process","interleukin- production ","Q05655"]
["GO:0051490","biological_process","negative regulation of filopodium assembly ","Q05655; P58400; P47756"]
["GO:0042119","biological_process","neutrophil activation ","Q05655; Q8TCU6; Q8IZD2"]
["GO:2000304","biological_process","positive regulation of ceramide biosynthetic process ","Q05655; P19438; P63244; P01375"]
["GO:2000753","biological_process","positive regulation of glucosylceramide catabolic process ","Q05655"]
["GO:1900163","biological_process","positive regulation of phospholipid scramblase activity ","Q05655"]
["GO:0035307","biological_process","positive regulation of protein dephosphorylation ","Q05655; Q14738; P0DP23; Q96QB1; Q92797; Q96T49; Q15435; Q9BXM7; P17405; Q86XL3; P26599; Q6X4W1; Q69YH5; Q13526; Q15172"]
["GO:2000755","biological_process","positive regulation of sphingomyelin catabolic process ","Q05655"]
["GO:0010469","biological_process","regulation of signaling receptor activity ","Q05655; Q08499; Q9UBN7; P00749; P31994"]
["GO:0023021","biological_process","termination of signal transduction ","Q05655; P17405"]
["GO:0055072","biological_process","iron ion homeostasis ","Q9BQI3; Q99814; P09601"]
["GO:0046986","biological_process","negative regulation of hemoglobin biosynthetic process ","Q9BQI3"]
["GO:0045993","biological_process","negative regulation of translational initiation by iron ","Q9BQI3"]
["GO:0046501","biological_process","protoporphyrinogen IX metabolic process ","Q9BQI3"]
["GO:0010999","biological_process","regulation of eIF2 alpha phosphorylation by heme ","Q9BQI3"]
["GO:1990641","biological_process","response to iron ion starvation ","Q9BQI3"]
["GO:0051296","biological_process","establishment of meiotic spindle orientation ","P00540"]
["GO:0000212","biological_process","meiotic spindle organization ","P00540; Q14674; P23258; P35579"]
["GO:1902103","biological_process","negative regulation of metaphase/anaphase transition of meiotic cell cycle ","P00540"]
["GO:0071318","biological_process","cellular response to ATP ","P35354; Q8WYL5; P14625; P00441; Q8TD43; Q8NER1; Q9H244"]
["GO:0071284","biological_process","cellular response to lead ion ","P35354; Q04656"]
["GO:0071471","biological_process","cellular response to non-ionic osmotic stress ","P35354"]
["GO:0019371","biological_process","cyclooxygenase pathway ","P35354; Q15185; P16152"]
["GO:0042633","biological_process","hair cycle ","P35354; Q8WUF5; P62304"]
["GO:0034356","biological_process","NAD biosynthesis via nicotinamide riboside salvage pathway ","P35354; Q8NCW5; Q53GL7"]
["GO:1902219","biological_process","negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress ","P35354; P16989; Q92974"]
["GO:0045986","biological_process","negative regulation of smooth muscle contraction ","P35354; P07550"]
["GO:0032227","biological_process","negative regulation of synaptic transmission, dopaminergic ","P35354; P31645"]
["GO:0030728","biological_process","ovulation ","P35354; P41220; P24394"]
["GO:0031622","biological_process","positive regulation of fever generation ","P35354; P21554; P01375"]
["GO:0090362","biological_process","positive regulation of platelet-derived growth factor production ","P35354"]
["GO:0001516","biological_process","prostaglandin biosynthetic process ","P35354; Q15185; Q9NP80"]
["GO:0070542","biological_process","response to fatty acid ","P35354; P16671; P04040"]
["GO:0009750","biological_process","response to fructose ","P35354"]
["GO:0010042","biological_process","response to manganese ion ","P35354; Q04656"]
["GO:0033280","biological_process","response to vitamin D ","P35354; P14679; O76061; P01730; P55273"]
["GO:0030683","biological_process","evasion or tolerance by virus of host immune response ","P19525"]
["GO:0001819","biological_process","positive regulation of cytokine production ","P19525; Q96BF3; P82094; Q96FA3; Q9BXL7; O75955; P00441; P01375; P08913; Q6UY09; Q16666"]
["GO:1901532","biological_process","regulation of hematopoietic progenitor cell differentiation ","P19525; Q16342"]
["GO:1902033","biological_process","regulation of hematopoietic stem cell proliferation ","P19525; P12821"]
["GO:1900225","biological_process","regulation of NLRP3 inflammasome complex assembly ","P19525"]
["GO:0035455","biological_process","response to interferon-alpha ","P19525; P48551; Q01628"]
["GO:0030953","biological_process","astral microtubule organization ","P15311; Q12959; P62491; Q14980"]
["GO:0034629","biological_process","cellular protein-containing complex localization ","P15311; O00401; O15105; Q12959; Q96BF6; O95295"]
["GO:0043622","biological_process","cortical microtubule organization ","P15311; Q9HBA0; Q12959"]
["GO:0051660","biological_process","establishment of centrosome localization ","P15311; Q9Y613; Q12959"]
["GO:0035088","biological_process","establishment or maintenance of apical/basal cell polarity ","P15311"]
["GO:0046847","biological_process","filopodium assembly ","P15311; Q96SB3; P60953; Q9NR80"]
["GO:0001951","biological_process","intestinal D-glucose absorption ","P15311; P09327"]
["GO:1900041","biological_process","negative regulation of interleukin-2 secretion ","P15311; P28906"]
["GO:2000643","biological_process","positive regulation of early endosome to late endosome transport ","P15311; P26038; P35241; P98082; Q13614"]
["GO:0050714","biological_process","positive regulation of protein secretion ","P15311; P02671; P35580; O15554; Q8WZ42; P52179; Q92614; Q15327; O00429; Q9H4A6; P22004; O00213"]
["GO:0072697","biological_process","protein localization to cell cortex ","P15311"]
["GO:1902115","biological_process","regulation of organelle assembly ","P15311; P26038; P35241"]
["GO:0003376","biological_process","sphingosine-1-phosphate receptor signaling pathway ","P15311; P21453"]
["GO:1902896","biological_process","terminal web assembly ","P15311; P09327"]
["GO:0050863","biological_process","regulation of T cell activation ","Q9Y3P8; Q9NWQ8; O43561; P01730"]
["GO:0035331","biological_process","negative regulation of hippo signaling ","P27448; Q9UGP4; Q8TDM6; Q96IF1; Q8IX03"]
["GO:0015030","cellular_component","Cajal body ","P24941; Q14978; Q9H814; Q14207; O75940; Q01081; Q06787; P22087; O43395; Q9UQ35; Q15020; P22626; P38432; Q96RS0; Q9BUR4; Q15029; Q5JVS0; O14980; P55199"]
["GO:0005813","cellular_component","centrosome ","P24941; O75116; Q8TDC3; Q16584; Q9H4B4; Q9NZM3; Q00534; P06748; Q86Z02; P25054; P49137; P06493; O14965; O76039; P48730; O00444; P20794; P53350; P16104; P14635; P13861; Q16513; Q96L34; Q92772; O14974; P17612; P49841; Q00613; P51955; P35222; O14757; P22694; P25205; Q96QF0; Q13042; Q08499; Q5SW79; Q9H814; Q9NP97; Q53EZ4; Q99996; Q5T4S7; O75351; P49792; Q9HC77; P81274; Q8TAP6; Q8TEP8; Q99504; P31323; Q9BX66; Q9Y2K6; O43566; Q92597; Q15154; Q9NYY3; P04899; Q8IWQ3; Q14674; Q9HCH0; P50570; Q14839; Q15468; Q96GX5; P0DP23; Q96Q89; P12004; Q5TZA2; Q12798; Q96PY6; Q9GZM8; Q01094; Q9P2Y5; Q9NQC7; Q9NXR1; Q13485; P0DMV8; Q8TF76; Q9NZJ0; P30622; O15105; Q8TAP9; O95684; Q13416; O95613; Q16236; Q5XUX0; Q15691; Q14203; P49768; P41208; P29966; Q96SN8; Q9P219; Q6U7Q0; P30305; O43379; P49810; Q14194; P41002; Q9H4X1; Q9Y5B0; O43303; Q9H6Z4; Q8NHV4; P23258; Q07817; O00139; Q8IW35; Q5BJF6; Q9Y6D9; Q9NS91; Q8N137; P51587; Q12834; Q07343; Q9UPN4; Q9Y2T1; Q9H816; Q14204; Q9BV73; Q3KR16; P63167; P37198; Q7Z3J3; Q9Y230; P30260; Q9Y6G9; Q7Z4H7; Q13409; Q3V6T2; Q9Y496; O75449; Q8WVC0; Q2M2Z5; P48729; Q8WWK9; Q92785; O75154; Q14980; P12755; Q9P270; P27695; Q00839; Q8IXJ6; Q14191; Q9NQG5; O00399; P41134; P05549; P61266; Q684P5; Q15172; Q5FBB7; O14777; Q99689; Q9NPB6; Q02241; Q99828"]
["GO:0000781","cellular_component","chromosome, telomeric region ","P24941; P54274; O14746; O95271; Q15554; Q9Y4R8; Q15185; Q8IY92; Q5UIP0; Q96BK5; Q9NYB0; Q9BSI4; P22626; Q9H816; Q8IXJ6; Q14191"]
["GO:0000793","cellular_component","condensed chromosome ","P24941; Q9UQB9; P09429; Q9BXW9; Q96JM3; Q5UIP0; Q9UIG0; Q06609; P49917; O43823; P11388; P49711"]
["GO:0097123","cellular_component","cyclin A-CDK complex ","P24941"]
["GO:0097124","cellular_component","cyclin A-CDK complex ","P24941; P20248"]
["GO:0000307","cellular_component","cyclin-dependent protein kinase holoenzyme complex ","P24941; P11802; Q00534; P06493; P38936; P30279; Q8N1B3; Q00526; P20248; P30281; P24385; Q96S94"]
["GO:0097134","cellular_component","cyclin E-CDK2 complex ","P24941; P24864"]
["GO:0097135","cellular_component","cyclin E2-CDK2 complex ","P24941"]
["GO:0005737","cellular_component","cytoplasm ","P24941; Q06124; P46937; P54274; O14936; Q8WV28; Q9BYP7; P48454; Q13164; P00533; Q9HC35; Q13554; P09467; Q15349; Q8TDC3; P46734; Q9Y5K3; Q13761; P42336; Q00537; P51617; P62136; Q16825; Q13422; P51956; P10636; Q96PN8; O00141; Q5VT25; Q16659; P11474; P07948; Q06413; P41279; P31152; Q13131; Q9UQB9; P42681; P45985; Q16566; Q9P1W9; Q9H4A3; Q13873; Q04206; P14921; Q14164; Q2M2I8; Q8N5S9; Q16584; P31749; O75676; Q9H4B4; Q9NZM3; P13639; O60927; P50613; Q9Y2K2; P24723; Q9NQU5; Q92918; O15530; Q05513; Q13557; Q13163; P78347; P14618; Q16288; P54646; Q96B36; P53779; Q9H0K1; Q9Y3S1; P37840; P04792; Q96KG9; Q00534; P11413; Q01581; P49674; Q9UHD2; P06748; P27361; Q86Z02; P35240; Q12968; Q9Y6K1; P00966; P21359; P17252; Q6PHR2; P08670; P35228; O15264; Q13882; Q9H2X6; Q96RR4; Q9H2K8; O00418; Q9Y243; P25054; P00519; Q12851; Q01813; Q9NYF8; Q8IW41; P19544; P09619; P02511; Q15796; Q12852; O60285; Q00532; P49137; O60566; P10276; P24666; O00311; P03372; P45984; P11309; O60674; P42224; O94921; Q15831; Q9UJU2; Q9NZJ5; Q13148; Q14653; Q13177; Q15797; O75886; P21802; P78362; P15336; Q9H792; P06730; P29590; P38398; P49759; Q13627; Q05397; P01112; Q07912; Q00987; Q9Y6Q9; Q06187; P45983; Q86YV5; P35916; O43251; P80192; P85037; P25098; P07101; P29597; P19838; Q99459; Q00653; P12814; P29475; Q13418; Q53ET0; P21127; Q14289; P23443; P40763; Q16512; P34947; P68104; Q9UQM7; P53778; Q7KZI7; P20794; P25963; P60709; P19174; Q13233; P07355; Q9UPZ9; P21399; Q9NYL2; Q9UQL6; P43403; Q9BUB5; Q9BZL6; P30291; Q9HBH9; P53667; Q9UBE8; Q14978; P14635; O75582; P41235; Q12888; P35520; Q6NZI2; Q15678; P13861; Q9Y2R2; P49407; O95747; Q16513; Q00536; P16234; P48681; P16591; Q96L34; Q9BVS4; P51812; P41240; Q5TCX8; Q9UBS0; O95819; P28482; O14744; P51610; Q56UN5; Q86V86; Q13469; Q5S007; P51178; Q8IVW4; Q9NWZ3; Q92772; P84022; P07737; P25440; Q9Y4K4; P04637; P63000; O75385; Q8IU85; P05771; P07332; P14136; P43405; O94804; Q9P286; Q96Q15; O75914; Q9NR20; Q00535; Q13905; Q15759; P08621; Q8TDX7; Q12866; P11831; Q9Y2U5; P42345; O14733; Q14511; Q13043; Q02779; P61978; Q16539; P42858; P17612; P57059; Q6IBS0; O43353; P49841; P52564; Q7KZF4; P35568; Q9P0L2; Q00613; P10275; Q9Y6K9; Q12778; Q16644; P06733; P54840; O43781; O43293; Q14814; Q99558; O15111; Q7L7X3; P29474; Q9Y6E0; P08238; Q13976; P12931; O00221; Q9UQ07; O00506; Q02156; P23528; P04049; Q96RT1; P35222; Q9UKE5; P51817; P60484; Q15208; O75874; P27986; Q9NRP7; P35236; P57078; Q9UQ88; Q96SB4; P54764; Q04637; Q9HC98; P04083; Q9Y5S2; O43524; P49736; Q9H2G2; P33981; P23458; Q13555; Q15131; Q07002; Q92630; P04150; Q02763; Q05209; P28827; O14757; Q13153; P07900; Q15910; Q14012; Q15418; Q12882; P56524; Q05655; Q9BQI3; P00540; O14512; P35354; P19525; P15311; Q13470; P27448; P78352; Q13459; Q9UBB4; O95376; Q15650; P04731; Q13042; Q92769; O60941; Q8IX90; Q96IZ0; Q9HC16; P11137; P08151; Q9NZA1; Q9C0C7; Q16543; O15492; Q14469; Q16836; P41180; P48167; Q9P0V3; Q99733; Q9NUU7; Q96TA1; Q13158; Q13642; Q99502; Q9UBB9; O75592; Q9Y5S9; Q96CV9; Q6PKG0; Q9H1K1; Q86UE4; Q9BUL5; Q9NP97; Q96EB6; P29972; Q14693; Q9UJY1; Q32P44; Q12962; Q8ND90; Q16760; Q15717; Q13287; P50995; P62280; P22314; P46108; P61925; Q8NF91; Q9UKT5; Q9NQT8; Q96PU5; Q96PM9; Q15366; Q9Y4C1; Q9BY11; P41220; Q8N684; P09327; Q15078; Q9UKT4; Q86UP8; P35580; Q14207; Q8N1E6; Q9BRS8; Q86WV1; Q9Y4P1; Q96AC1; Q15054; P55010; P51114; Q8N6F7; Q13705; Q9NS28; Q8N4C8; P23560; Q9P289; Q99638; Q9GZX7; Q04917; Q9H3M7; Q01814; Q14145; O14745; Q9UL63; Q92904; P55209; Q6PIL6; P35251; Q15819; P19474; Q9Y692; O75351; P20749; P25686; O43623; P49792; Q9NWV8; Q9NR56; O60832; Q6ZVD8; P51003; Q9NRA8; Q14493; Q14202; Q9NZI8; P81274; Q13671; P05388; P14317; Q9UGV2; P62979; Q03431; P62993; Q9BSQ5; P17844; O43865; O95817; Q13425; P26038; P31995; O60346; Q8WUI4; Q9NRJ4; Q9UEW8; P54132; Q6P2M8; Q38SD2; Q9Y210; Q99504; P31323; Q92913; O60869; Q13563; O75410; Q8TDD2; O60266; P53365; Q15642; Q02535; P49918; P27540; O43566; P04818; Q9Y261; Q9BY77; Q9Y4C8; O43707; Q92598; P16989; Q9Y2H1; Q03167; A8MU46; Q9UBW7; Q13188; Q32MZ4; P38646; Q9NQ66; O75626; P61073; O00560; Q92597; P30041; Q01105; A0MZ66; P09382; Q9UHI6; P50502; Q8N1K5; Q08828; Q9UGP4; O60936; Q9NS61; Q13371; Q8NHG8; P01116; P20941; P30626; Q5VWZ2; Q9C0H9; P11168; Q02790; Q15154; O15304; Q99741; Q16658; O00299; Q96N95; Q8TE77; O15360; Q8IWZ3; Q13144; P51681; Q5T447; Q12906; P20823; O00204; Q9NYY3; Q9NPQ8; O14558; Q15111; P12272; Q13202; P36871; P05114; O95786; P04899; Q8IWQ3; P52294; Q15019; P08473; P10809; P05556; O15021; Q9H063; Q9H0H3; O43156; O43542; Q9Y4W2; Q99966; Q14674; Q9HCH0; P14679; Q9Y6R4; P16333; P39687; Q9BQG0; O75940; P24534; Q9Y613; Q9Y4R8; O75916; P28906; P56945; P55347; P15923; Q14839; P32929; P25685; Q15468; Q8WYL5; P28222; P35611; O60841; P38919; Q13330; Q9UH03; P07437; Q9UK32; Q9UBH6; Q92974; Q9H1Y0; O15455; Q14669; Q9H3Q1; P17676; P78317; Q01844; P19484; Q14449; Q13576; Q13574; O15511; Q04760; P49789; O15198; Q96GX5; Q8NC51; Q99547; O60784; Q01082; Q9UGH3; Q9Y2R4; P46527; Q13542; Q86X55; Q9HCJ2; P19022; P23396; Q86UC2; P62834; Q14849; Q8IZD2; P0DP23; Q6SA08; Q5D1E8; Q8NE63; Q14151; O00443; Q9Y4F5; O94992; Q01534; Q99759; Q15746; P52757; Q52WX2; P49619; Q13568; P0DPH7; Q15075; Q9NX07; Q96P20; P48736; P24928; Q5VWQ8; P12036; P05787; Q8NF50; Q96FV9; O43918; Q5TAX3; O00592; Q9BZB8; Q9UIK4; Q9UMR2; P62195; P11216; Q99576; Q9NZ72; Q96Q89; Q96FI4; Q96QB1; Q96D46; Q07812; P42771; Q9BXS6; P20963; Q12923; Q7Z5K2; Q9Y237; Q8TB45; P18754; P26367; Q9Y4G8; Q14106; P50616; Q9UD71; P56192; Q9Y6H6; P55072; P98172; Q13112; Q96PY6; Q99697; Q13547; P21579; Q13829; P07196; Q9P2Y5; P40259; Q9UJF2; P61289; Q16665; P36956; Q7L7V1; Q9NZJ9; O75563; P09211; P41597; Q13136; Q99497; Q8N7F7; O75952; Q01959; P04156; Q13107; Q13485; O94763; P54259; Q14157; O15551; P10415; Q96PK6; Q9Y6H5; P98179; Q96JM3; P61160; Q9NRH2; Q6PJT7; O14543; Q02952; Q9Y3F4; P46379; Q9NQI0; Q9UH65; Q9Y5T5; Q9UHL0; P55055; Q9UMS4; Q06787; Q9BTD8; P49959; Q9UBF6; P19634; P41091; Q8TDM6; O43312; Q9BWU0; Q969U6; Q13895; P26641; P56178; Q13516; P30044; P0DMV8; Q8WXF1; O15553; Q9Y6A5; Q9UPY8; Q8TF76; Q9BZS1; Q5UIP0; O15355; Q9UBS5; P50749; Q7RTN6; Q9Y5V3; Q53EL6; P06746; P85298; Q8NF99; P11473; Q9Y250; P02649; Q96LI6; Q15555; Q08209; Q92599; Q9UER7; Q8WYJ6; O75369; O95425; Q6UUV7; Q9BTX1; P78559; Q99418; P08684; P41594; O95190; Q5T5C0; Q9H4B6; Q9Y4I1; Q9BV57; O14921; Q8TCG1; Q9UQB3; C9JLW8; Q92793; P12270; Q8TAE6; Q8IZ21; Q92620; Q9UL40; Q9NYA1; P62826; P62495; Q96PV0; P15090; P78536; P18669; P62913; P53671; Q9NZH5; Q9NSB8; P52952; Q9H0H5; P09651; Q92819; Q92797; Q9NP81; Q9UIW0; Q9BUZ4; O00482; Q92879; P27348; P54252; Q9BQA1; O43765; P67870; Q96JH7; Q14573; Q9Y6Q2; Q5VVH5; O75460; Q07955; P11912; P56537; P18848; Q7Z2W4; O14492; Q6N069; Q96RD6; Q96PF2; Q92985; O75884; Q8WY41; Q14562; Q9NZI2; Q9BXL7; O60716; Q08462; Q969V6; Q99666; P23025; Q9UN19; Q6ZS17; O76054; O95810; O43541; P50542; Q92888; O43295; Q9BQE3; Q13501; Q96JY6; Q53F19; P14923; O95999; P18505; Q13936; P28562; O75496; O15105; A1X283; Q9NX63; Q8TAP9; O15392; P28329; P42338; P53805; Q9NQ86; Q02363; Q5XXA6; O14641; P49006; O60271; P63279; P00918; Q07820; Q06609; O95278; P15374; Q9BWF3; Q96S44; P51809; P49321; Q9Y534; Q9BR76; Q16236; P61764; Q9Y4K3; P07741; P68036; P53355; Q9C0B9; Q9GZR7; Q14494; Q8TED9; Q15633; P49427; Q12959; P08047; Q9UBN7; P78368; Q00526; P37088; Q15569; Q06830; Q8IUX7; P00441; Q12772; P63267; P53801; P63146; Q8IWB6; Q9H8V3; Q9UKD2; Q14203; Q9UQB8; P62258; P31950; P17677; P00973; Q16342; Q92519; Q92900; P78337; Q8NEL9; P17931; Q8N1F8; Q99426; Q9ULV4; P07195; O15379; Q16621; P05067; Q9UQF2; P56211; P11308; P35232; P80108; Q9BZQ8; P43354; Q96SN8; P63244; Q9P219; O43164; P35368; P52292; O00571; Q9BXP5; Q9Y6M1; Q9BZL4; Q9Y385; P26045; Q5MAI5; Q16763; O43294; Q8N163; O75674; O00161; O75122; P40429; Q6IE81; Q9NYB0; O75899; Q8WWN8; Q16612; Q8N302; O43474; Q8NEV4; A8MYZ6; P20248; P54253; Q15327; P55210; O96004; O43497; P49798; Q9H1E3; Q96SB3; Q9P2N5; Q16828; Q99543; Q6NXT1; P25788; P47928; O95551; Q15438; Q9H4X1; Q9NYF0; Q14694; Q9Y5B0; Q9Y483; Q49MG5; Q9NYB9; P06396; Q6NUN9; Q9ULU4; O60861; Q9Y285; P17861; Q9H6Z4; Q99967; O14737; Q02297; Q13049; P46939; O60711; Q6UUV9; O43768; P11940; Q15020; P09417; Q8IZL8; O00429; O95453; Q7Z3K3; P23258; Q07817; P84074; Q6STE5; P21333; P13569; Q8N4X5; P31269; P49815; Q9NP71; Q96NW7; Q13319; Q13322; O75179; P17544; Q712K3; O00139; Q9H2G4; Q92556; Q96FF9; P22234; Q9BUL8; Q9UPT6; Q06265; O00255; Q96R06; Q5JQC9; Q9NY61; O94827; P22392; Q01892; P0C1Z6; P14866; O00206; Q6P0Q8; P51787; Q9UNE7; Q15669; Q15435; P23469; P07954; P35900; Q9NS91; Q9BXM7; P48200; Q13509; Q13439; Q13625; P61244; Q9NRG4; Q13404; P24522; P29692; Q96B97; Q05086; Q86Y01; Q9NQT5; P22626; O75716; P30281; O14958; O60749; P98177; Q96PU8; Q9P2B4; Q8N6T7; O95361; P10914; P07203; Q13765; Q9Y6N7; P46940; P31150; Q9H4M7; Q9UMX0; P54845; Q9BY41; Q9C0C2; Q96S59; P10644; Q8WXD9; Q14315; P04406; Q07157; P15531; Q99714; Q9Y2T1; Q01954; P05204; Q8TD08; Q6WKZ4; Q9HBH7; P52566; Q6GQQ9; Q70Z35; Q9NRY4; O75817; P08913; Q99750; P17655; Q13352; Q8N2W9; O43815; Q8NE71; P20339; Q9Y3Q8; Q9UH92; Q9H816; P49917; Q7L9L4; Q9NP31; O95863; Q8TEV9; Q15287; Q13077; Q13424; P40855; Q9NPI6; Q92841; P49459; O15539; Q8IY67; Q9BQ89; P22004; Q8N122; Q8NEM2; P31949; P20042; P08758; P12268; Q3KR16; Q07889; Q9UPN3; Q9UNS2; O75531; Q14118; Q9UGM3; O15534; P63167; Q12972; Q14232; P36873; P13796; Q9H1R3; O95989; Q13017; Q9BQI9; P06737; Q9H8N7; Q9UBD0; O60239; O60678; Q9H165; Q13614; P98170; Q969T9; O14713; Q86U44; P37198; Q4G0X9; Q9P0J0; Q15466; P06702; Q9Y283; Q9NQX3; Q7Z3J3; Q9UMX1; Q14847; P30260; O94874; O00625; Q9H840; Q9H2P0; Q16531; Q96RG2; Q9UBF8; O96028; P67809; Q8IVF2; Q9ULZ3; Q9Y680; O95239; Q9NV92; Q8WVI7; Q13522; Q14185; Q9NS23; Q96C90; Q15813; P60880; O00213; P22674; Q9NXH3; Q05639; Q8N0Z6; Q8WX92; Q13409; O95983; O95644; Q9UBL0; P29350; Q15596; P60953; P00367; Q15365; Q01995; P51858; P13693; P51692; P50402; Q9BVW5; Q8N720; P20936; P98161; Q7Z6Z7; Q99490; Q9GZV5; O95302; P61086; O15519; P11217; Q7Z7A4; Q07352; Q9UQ80; Q14527; Q92837; Q9BQ95; Q9Y2H9; Q9BY44; O75449; P48431; Q6X4W1; Q9BYG3; P08729; P50221; Q9Y6R0; Q8NE35; Q03393; Q8IVH8; Q99471; P11388; Q92688; Q92734; Q02556; Q99728; Q14247; Q2M2Z5; Q13769; Q93045; P35869; Q9NZN8; P61088; O95319; Q96AD5; Q4VCS5; Q96RS0; P25942; Q96H20; Q969S2; P30048; Q96PM5; Q9Y2V2; Q9H211; Q92574; P40818; Q7Z417; Q8WYQ5; P05783; P58753; Q9H0M0; P32121; Q9NZC7; Q86UL8; O75689; Q00587; O15169; Q9UQC2; P63104; Q03014; P11926; Q9Y6W6; Q5JVS0; P42167; Q53GL7; P30613; O43166; Q9Y4E8; O14980; P10071; P12755; Q8WWI1; O00329; P32119; P27695; Q96EZ8; P42575; O00148; P20393; O94811; P35998; P46934; Q9UJV9; Q9NZT2; Q7Z2E3; Q07021; Q9UM54; P08567; P46060; Q8IUQ4; Q9H4D5; P05813; Q9UHD8; P23769; O94762; Q13526; Q07666; P05455; Q9H093; Q9P2D0; Q9Y266; Q8IXJ6; O95905; Q14191; Q92547; Q9NR19; P35579; Q03113; Q8IX03; P52298; Q14966; O75494; Q9BY84; P26651; Q03060; Q96J02; P26196; O95997; P31946; Q06330; P23497; Q99961; P18146; P62324; Q14142; P50395; Q6P1M3; Q14994; Q08J23; Q01860; Q9NQT4; P50479; Q9UJU6; Q86YF9; Q8NB16; P21817; Q6PCD5; Q9Y2T7; Q9UN36; O75444; Q9Y371; P25490; Q0VD86; P22059; O75995; Q9BXT4; Q15334; P61266; Q9UKV8; Q9UBS8; Q9H0S4; Q9H257; Q969H0; A0A024R539; Q9HB90; Q9H3D4; Q8TCT0; Q9NUK0; O00170; Q04323; Q15172; O43255; Q9UKV0; Q99623; P56645; Q09666; P55273; P07814; Q99538; P16949; P30419; Q8WU79; O60260; Q13698; Q9NRD5; P31260; Q15773; P31483; Q16643; Q9BXA7; Q15329; Q8WUN7; P55327; P10599; O95409; Q13562; Q9UMR3; Q9NUW8; P55854; Q01851; Q9C0C9; O14613; Q8TCS8; Q9HCU9; Q9UJM3; Q99828; P55087; P39019; Q7LC44; Q53GA4; Q99873; Q9BPX3"]
["GO:0005829","cellular_component","cytosol ","P24941; P05198; Q06124; P15056; P46937; P35557; O14936; P49840; P41212; Q01538; Q8WV28; Q9BYP7; P36888; P48454; O75116; Q8IWU2; Q13164; P15407; P49585; Q16875; O94916; Q13554; P09467; Q15349; P46734; Q9BRS2; Q13761; P39880; P42336; P62140; P51617; P62136; Q16620; P42229; Q13480; P10636; Q96J92; Q6VAB6; O00141; Q16659; P07948; Q06413; P41279; P31152; P06239; Q13131; O00763; P45985; Q16566; Q9H4A3; O60825; Q04206; Q14164; Q2M2I8; Q8N5S9; P31749; Q15303; O75676; P18031; P13639; P11802; Q14683; P24723; O15530; Q05513; Q13557; Q13163; P14618; P54760; P54646; Q96B36; P53779; Q9Y3S1; P37840; P51813; P04792; P33778; Q13237; Q96KG9; O95835; P08631; Q00534; P11413; Q01581; P49674; Q09472; Q9UHD2; P06748; P27361; Q86Z02; P35240; Q12968; P62753; P00966; P21359; P17252; O60934; Q9UEY8; Q99640; P08670; P55263; P35228; O15264; Q13882; P52701; Q96RR4; O00418; P29353; P25054; Q00266; P00519; Q01813; Q8IW41; O75475; P19544; P02511; Q15796; Q12852; Q9NZ63; P49137; O60566; P10276; P06493; P11362; P24666; P03372; P45984; P11309; P07949; P21980; Q12792; O60674; P42224; O94921; Q15831; Q06203; Q14653; Q13177; P22681; P36507; O14965; Q9Y490; P30086; P09769; Q15797; O75886; O76039; Q9P212; P78362; Q15119; Q8WU20; P04626; Q96GD4; P62714; P24864; P06730; Q15080; P37231; P29590; P48730; Q16774; Q14004; Q04759; Q05397; P01112; Q00987; Q9Y6Q9; O43663; O00444; P27708; Q06187; P45983; Q14765; O43251; P42680; P09917; Q8IVT5; P25098; P29323; P07101; P29597; Q01196; P19838; P42226; Q00653; P35221; P12814; P29475; Q13418; Q14289; P23443; P40763; Q16512; P34947; Q13085; P68104; Q9UQM7; P53778; P15172; P25963; P60709; P17096; Q15139; P19174; Q13233; P16885; P07355; Q9UPZ9; P21399; P50548; Q9NYL2; Q9UQL6; P43403; P23588; Q01201; P78527; Q13546; P53350; Q9BUB5; P49327; Q14934; P11274; Q9BZL6; P53667; P19105; Q09013; Q9UBE8; P14635; O15357; P27707; P35520; Q6NZI2; P13861; Q9Y2R2; P49407; P42768; P51451; O95747; P05129; Q16513; O60237; Q00536; Q08881; P05412; P16591; Q96L34; Q9BVS4; Q9Y2X7; P51812; P41240; P31751; P54762; P28482; O14744; Q86V86; Q13469; Q5S007; Q02078; P51178; Q9NWZ3; P84022; Q92835; P09104; P07737; P04637; P63000; P17706; O75385; P05771; Q05682; P07332; P14136; P43405; Q96Q15; O75914; O14974; Q00535; Q6DT37; Q13905; O14964; P06241; P52630; Q15759; P17302; Q9Y2U5; P42345; O14733; Q14511; Q13043; Q16539; P00439; Q99683; P42858; P17612; O14920; P67775; O43353; P49841; P07947; Q13541; P52564; Q7KZF4; P35568; Q9Y2I7; P42684; Q00613; P10275; Q9Y6K9; Q96HC4; O43318; Q12778; P54753; Q02750; Q16644; P06733; O94806; P54840; O43781; Q99558; O15111; Q7L7X3; P53041; P29474; Q9Y6E0; P08238; Q92934; Q13976; P12931; O00221; O00459; Q02156; Q15121; P23528; P04049; P51955; P35222; Q9UKE5; P68400; P60484; Q15208; Q96Q40; Q9P0N9; O75874; P22736; P27986; Q9NRP7; Q13464; P01100; Q8N3U4; P35236; P35813; P46109; Q96SB4; Q04637; Q9HC98; P04083; P13807; O43524; P10398; P23458; P15498; P41743; Q01970; P52333; Q13555; P48506; Q92630; P49023; P04150; P00558; P50552; P38936; Q05209; P42685; O14757; P22694; Q13153; P07900; Q15418; P53396; Q12882; P56524; Q05655; P00540; O14512; P19525; Q9NRM7; P15311; O00757; Q13470; P27448; P30279; P78352; Q13459; Q9UBB4; Q71F23; Q7Z6E9; Q9ULW0; Q9H7L9; Q96QF0; Q15650; P04731; Q13042; P06401; Q08499; P38606; P62917; Q9NTI5; Q9HC16; P11137; P08151; O15164; P78545; Q9C0C7; Q16543; O15033; Q13045; P51452; Q29RF7; P11166; P35749; Q02224; Q9NSU2; O15162; Q49AN0; O00167; O14818; O14746; Q5SW79; Q96TA1; Q9H814; P28223; Q13158; Q13642; Q96BR1; Q9Y5S9; Q96CV9; Q2NKX8; Q8WV24; Q9H1K1; P08138; Q96EB6; O95271; Q08493; P60891; Q03188; Q14693; Q9UJY1; Q99661; Q9BXH1; P43119; O95149; O43521; Q99996; O75150; P60866; Q14344; Q16760; O95816; Q16613; Q15717; Q13287; P50995; P62280; Q9BRP8; Q08AD1; P22314; P46108; P49773; Q14738; Q9UKT5; P47712; P14598; Q04864; Q8NCW5; Q8NCD3; P07910; P61224; P13010; P14672; Q9NQT8; P52655; Q9BYN0; Q155Q3; Q9UQK1; Q96PU5; Q12904; Q9ULJ8; Q9UKV3; O95071; Q9Y2G1; Q13094; Q15366; Q9BY11; P62316; P41220; P45379; Q15078; O00401; Q9UKT4; Q96T51; P35580; Q8N1E6; Q12967; Q70E73; Q86WV1; Q9Y4P1; P55017; Q96AC1; P55010; P46020; P51114; Q8N5V2; Q8NHS2; O75175; P04075; P06454; Q9NVI1; P49450; Q6P1K2; Q8N4C8; Q8N3Y1; Q9P289; Q5VUA4; P52789; Q04917; Q14005; Q9H3M7; Q14684; Q15464; Q14145; O14640; Q9Y295; Q9UL63; Q5T4S7; Q6PIL6; Q5QNW6; P52565; P19474; Q9Y6X9; O75351; P19429; P20749; P61457; P25686; O15516; P49792; Q9NWV8; P55211; Q9NR56; Q9UKG1; Q9Y259; P09629; Q6ZVD8; Q9NRA8; Q14493; Q9HC77; Q9NZI8; P81274; Q13671; P53675; P11488; P05388; P14317; Q86YS7; P62979; O95251; Q9UDY4; P62993; Q15836; P26640; Q15700; Q8TAP6; O43865; Q9P2F6; P09497; O95817; Q96II8; Q15750; P47736; P26038; Q7L2Z9; O60346; Q86UR1; P61106; Q8WUI4; Q9NRJ4; Q8TEP8; Q9UEW8; Q9UH77; Q9H1K0; Q9UIQ6; P54132; O43464; Q8TEW0; Q38SD2; P31323; Q92913; O60869; Q14195; P23677; Q15398; Q8IYB3; P53365; Q15642; Q9BX66; Q9Y2K6; P04818; P32298; P28324; Q9BY77; O43707; Q92598; Q86TB9; Q8WZ42; P16989; Q9Y2H1; Q12933; Q9UBW7; Q13188; Q32MZ4; Q8TCU6; P85299; Q9NQ66; A2RUS2; O43739; O60315; P04040; O00560; Q92597; P30041; P35658; Q01105; P42566; P09382; Q9UHI6; P50502; P78543; P49675; Q9NUY8; Q9H9L4; Q9UGP4; Q00059; P17980; O60936; Q13371; P00338; Q8NHG8; P01116; Q14807; P20941; P30626; Q07001; Q5VWZ2; P52735; Q2NL82; P17858; Q4V328; Q02790; O75962; Q15154; Q8N3C0; P52945; Q08495; Q99741; Q16658; O00505; Q15046; P53804; Q13370; Q13144; Q16623; P60174; O00204; O43683; Q96P48; Q9NYY3; P12272; Q9H0Z9; Q01433; P36871; Q8WUF5; P19086; Q92997; O95786; P04899; P52294; Q9BYM8; O15287; O75400; P33992; P10809; P29083; Q5MNZ6; P53992; Q9H063; Q9H0H3; O43542; P48426; Q9GZV1; Q99966; Q14674; P14679; O14559; P56962; Q96EP5; P17752; O43741; P16333; O14810; Q9BVK6; Q9NQ48; P24534; O14727; Q9Y613; P14678; Q9Y4R8; Q9P1Z0; Q7Z5H3; Q70CQ2; Q14671; Q8N8S7; P56945; Q92529; P50570; Q15651; P32929; P25685; Q15468; Q8WYL5; O43572; Q12899; P35611; O43426; O60841; P38919; Q13330; Q9P0U4; Q5T7P8; Q9UK32; Q15149; Q92974; Q9H1Y0; Q13098; P19532; Q14186; Q14669; Q9BST9; Q99986; P14625; P26373; Q2M1Z3; Q14449; Q13576; P46695; O15160; O60504; O15511; Q04760; Q9NYJ8; P49789; P25445; O15198; P55196; P05387; Q8NC51; O60784; Q01082; Q14677; P46527; Q86X55; O95140; P82094; Q86VP1; O76074; P23396; P16070; Q13362; Q9UJX5; O15350; P18206; Q9BXW9; P62834; P12956; Q14849; Q16204; Q9UL54; P0DP23; Q13243; O00443; Q01130; Q8IW19; Q9Y6D6; Q9NPP4; P37275; P0CG47; Q12948; Q15003; P42677; P43364; Q99759; Q13428; Q9UKX2; Q15746; Q7LG56; P52757; Q93062; P62633; Q9Y4H2; Q13568; Q15075; Q96P20; P48736; Q5VWQ8; O60828; P05787; Q8NF50; Q15311; Q96FV9; Q08999; Q96FA3; Q9Y365; Q5TAX3; P54727; Q9BZB8; P62195; Q9NRF2; Q99576; Q96QB1; O60331; Q07812; P42771; Q96LC9; Q8TEH3; Q9Y6I3; Q7Z5K2; P53004; P26367; Q9Y4G8; Q14106; O15297; Q5TCZ1; Q5TZA2; Q14240; Q9UD71; Q9BTU6; P56192; O95861; Q96DR7; P55072; Q7L5N1; Q14155; P49915; Q9H4P4; Q9GZM8; Q13547; Q93052; P40925; P07196; Q15256; O43581; P40259; Q9Y3T9; Q9HBL8; Q13191; P84098; Q9UJF2; Q9NZM5; P61289; Q16665; Q9NQC7; P36956; Q9UPT5; Q12802; Q9NZJ9; O75563; P09211; Q15036; P56545; P41597; Q13136; Q99952; Q99497; Q6R327; O75952; Q9NP77; P61218; P04156; Q8IVF5; Q13257; Q13107; Q8N2H9; Q9NXR1; Q13485; O94763; P10415; Q15185; Q969S3; Q9Y6H5; P61160; O14543; Q02952; O60229; Q9Y3F4; P46379; Q9UKW4; Q86SQ0; P02545; P10827; Q9UK99; Q14790; Q06787; P47989; P49959; Q9UBF6; P41091; O00303; Q9H1A4; Q969U6; P34931; Q13895; P26641; P35626; Q8IY92; P30044; P0DMV8; O15553; P10070; Q9Y6A5; Q9H4E7; P58876; P50749; Q7RTN6; Q9UIF9; Q53EL6; P85298; Q8NF99; Q8TAA3; Q9NR28; Q9Y6W5; Q99460; Q13200; Q96PE2; Q08209; Q9UER7; O75369; Q9Y450; O95425; Q6UUV7; O95848; Q15056; Q99418; O95190; Q9BQ15; Q5T5C0; Q9H4B6; Q9Y4I1; Q9BV57; Q9BZR8; O14921; Q8TCG1; Q9NYZ3; P30304; Q9NZJ0; P55212; Q9P227; O14578; Q9UJX3; P35226; Q96F86; P05062; Q15653; Q9NYA1; Q6VY07; P62826; Q8IXI2; O43395; P62495; P12277; Q96PV0; P31939; Q9H6E5; P15090; P78536; O15259; P18669; P62913; Q9Y698; Q9NSB8; Q9H0H5; Q9Y3E5; Q15942; P08237; Q13813; Q92797; Q03111; Q9HAT8; P35548; P23743; Q9Y253; P27348; O14654; P54252; Q9BQA1; P21673; Q9NUQ3; O43765; O94808; Q99814; Q15052; P67870; Q9H422; Q6PGQ7; Q9H7P9; P31947; Q8NHZ8; P56537; P63027; P30307; Q9ULH1; P57740; Q7Z2W4; O14492; Q6N069; P54578; P30622; Q8N1G2; Q9HBY8; Q92985; Q96A49; Q9BYB0; P11171; Q9UPS6; O43516; Q9BXL7; O60716; Q969V6; Q9NTJ3; O00562; Q9UN19; Q9P2E2; O76054; O95810; O43541; P50542; Q92888; O43295; Q9UGK3; P46782; Q15436; P53367; P18850; Q13501; Q96BD8; P14923; Q9Y3M2; O95999; Q96LL9; P10912; O75496; O15105; P27816; Q15058; O15392; P28329; Q8NHY2; P42338; Q8N264; Q9NQ86; Q16181; Q02363; O14641; Q9Y2J0; O60271; P63279; P00918; Q07820; Q06609; O95278; P15374; Q14CS0; Q9BWF3; Q96S44; O95684; P62807; P50219; O95613; Q9BR76; Q16236; P61764; Q9Y4K3; O75822; P07741; Q9NQS7; P68036; Q9H425; Q8TBN0; Q14494; O15143; Q13426; O15217; Q15633; P49427; Q9ULM6; Q86TI0; Q12959; Q9UBN7; Q8NFH8; P78368; Q5XUX0; Q9UHB6; Q15569; Q06830; P37173; P61981; P00441; Q12772; O60240; P63267; P50747; Q71U36; Q15691; Q9H8V3; Q14203; Q8N2Z9; Q9UQB8; P68133; Q9H3P2; P62258; O15084; Q9HCR9; Q9UNA1; P41208; P00973; Q92900; Q8NEL9; P13591; Q99426; P07195; O15379; P63165; Q562F6; P05067; Q9UQF2; Q92569; Q9Y2J4; Q93100; P46778; Q13114; Q9BZQ8; P62491; Q96SN8; P63244; O95600; P54750; Q9UK80; P14784; Q8TD43; P52292; O00571; Q16635; Q9Y6M1; O60496; Q9Y4P8; Q02880; Q8N6H7; Q6U7Q0; Q68EM7; P06899; Q03112; P30305; P57737; Q16763; Q93009; P49790; P41145; P54105; Q9UKY7; O75674; Q04695; P62820; O75122; P40429; Q8WUM0; Q14432; Q6IE81; Q8NEY8; Q9NYB0; Q8NBN3; Q9UPT8; Q8WWN8; Q9NZI5; Q86UR5; O43379; P46783; Q14686; Q07866; Q6P1N0; P31948; Q96D71; Q8N556; Q53HL2; Q14194; O43602; P20248; P98082; P54253; Q15327; P55210; Q99962; Q9UNZ2; P49798; P46459; Q8TDN4; P06732; P41002; Q16828; Q99543; Q05469; P25788; Q15438; Q9H4X1; Q9NYF0; Q14694; Q9BVI0; Q7Z3T8; P10747; Q9NYB9; O43303; P06396; O60502; Q9UPX8; P08235; P17812; Q9Y285; P17861; P61158; Q8WWM7; Q9ULU8; O14737; P45378; P19367; Q13049; Q7LDG7; O60711; Q9UHY1; Q6UUV9; P11940; P09417; Q9UJX2; Q8NHV4; O00429; Q9NQR1; O95453; Q7Z3K3; Q12955; P23258; Q07817; Q15382; P20338; P84074; P21333; P13569; Q8N4X5; P49815; Q9NP71; Q15047; O15273; Q7L0Q8; Q92538; Q13322; Q99598; Q00341; Q712K3; O00139; Q92556; Q96FF9; P22234; Q9BUL8; Q8IW35; Q06265; O43598; Q5BJF6; O60701; O00255; Q9UQE7; Q641Q2; Q9Y5B6; Q8WVB6; P35367; Q9Y478; Q9Y2W7; O94827; O75553; Q9Y6D9; Q92625; P22392; Q9BYX4; P10916; O75688; P15036; Q9HC62; Q9P0K7; Q15631; Q9UNE7; Q15669; Q13009; Q86V15; P35900; Q9H788; P11142; Q96JJ3; O60763; Q9BXM7; P23527; Q12800; P48200; P62841; P99999; Q5SRD0; Q13439; Q13625; Q9H4A6; Q9NRG4; Q13404; Q9UKA4; P29692; Q96B97; Q05086; Q5VZK9; Q86Y01; Q9NQT5; O75716; Q8N5C8; O60749; P98177; Q15024; Q14C86; P78371; Q15788; Q02410; O95361; Q8N137; P10914; P07203; P08727; P62745; Q9Y2Z0; Q16778; Q13283; P46821; Q9Y520; P46940; Q13415; Q8N884; Q96LA8; P31150; P51587; Q9UMX0; P54845; Q9C0C2; Q96S59; P10644; P04183; Q12834; Q14315; Q9UHP3; P04406; Q9HCS4; Q07157; P15531; Q96JG6; Q07343; Q9H8S9; Q93034; P35638; Q9UPN4; Q9Y2T1; Q8N335; Q9GZQ8; Q00169; O43264; Q6WKZ4; P52566; Q6GQQ9; Q8WX93; Q70Z35; Q9NRY4; Q9H0B6; O43684; Q14103; P17655; Q13352; Q9Y5X2; Q8NE71; P20339; P09601; Q9UH92; Q9BYV9; Q9NRF8; Q9Y3E7; Q7L9L4; Q9NP31; O15446; P46531; O15197; O95863; Q15287; Q13077; O43432; P40855; Q8NER1; Q14204; Q9NPI6; P35790; Q92841; Q96HP0; Q9UJ70; P49459; Q9BV73; O15539; Q96FW1; P19784; P49750; Q4KMP7; P24385; Q9H773; Q8N122; P20042; P54619; P08758; Q08378; P43686; P12268; Q16611; Q07889; Q9UBP6; Q9UNS2; O75531; Q13303; Q14118; Q86YM7; O15534; O00186; P63167; Q8N4N8; Q9Y2I6; O60610; Q01449; P22307; Q6P1J9; P48634; Q13972; Q14232; O14519; Q9H410; P36873; P13796; O95989; P57796; Q13017; P06737; Q9UPQ9; Q9H8N7; O43175; O60678; Q13614; Q99523; P98170; P22612; O14713; P57077; Q8TDY4; Q92794; Q09470; P47870; P31943; P06702; P30050; Q99879; Q9UNN5; Q14244; Q9ULX3; P17600; O60318; Q9Y230; P49802; Q9UMX1; P30260; O94874; P30153; O00625; Q9H840; Q96Q27; Q96RG2; O60343; P17661; P47756; Q9UBF8; Q15306; Q16206; P67809; Q14749; Q8IVF2; Q9ULZ3; Q86WP2; O95239; Q9HCU8; Q9UNP9; Q14185; Q8IWU9; P60880; P29374; Q96CW1; Q9Y572; Q8NEB9; P54652; P31350; Q9Y6G9; Q7Z4H7; Q13409; O15027; P61586; P52907; P28289; P24844; Q93079; P09496; O95644; Q9UNY4; Q06210; P55957; O14986; Q9NRH3; P29350; P60953; Q9H910; Q99704; Q15365; Q96SU4; P13693; P51692; Q8IXM2; Q13155; P35270; Q9UHR4; Q9NZQ3; Q9NT62; Q13950; Q8NG31; Q9H0C8; Q3V6T2; Q8NFD5; P20936; Q9Y496; Q7Z6Z7; P52948; Q9GZV5; P13489; P61086; O15519; P11217; O43929; Q7Z7A4; Q07352; Q9NSV4; P51608; Q9NRA0; Q05516; O76090; Q92837; Q9UGI9; Q9BQ95; Q99877; Q16143; P48431; Q8WUX9; P08729; Q96AH0; Q03393; O14827; Q6Y7W6; Q9H467; Q92734; Q02556; O95267; P37802; Q8TD19; P55039; Q14247; Q5H9R7; P35869; Q9NZN8; Q9GZU1; P48729; P61088; Q5T5U3; Q99613; Q96AD5; Q99856; P62987; Q4VCS5; Q96RS0; P29401; Q16666; Q96H20; P35612; O43665; Q5JSH3; Q7Z6J0; Q9Y2Y1; Q9ULC4; P30048; Q16595; Q96PM5; Q9Y2V2; Q13309; P63010; Q9H211; P33993; P60900; Q92574; P40818; Q16816; Q7Z417; P14316; P05783; O75376; P58753; Q9H0M0; P32121; Q92945; Q9NZC7; P40337; O75689; Q8WWK9; Q5VZ89; Q9BPZ7; Q9BUR4; Q92785; Q15029; O15169; P78356; Q9UQC2; Q03164; P63104; O75154; P11926; Q9Y6W6; P42574; Q5JVS0; Q9BVJ6; Q53GL7; O75143; Q6ZUJ8; P30613; P23763; Q14980; Q9Y4E8; O14980; P10071; Q8WWI1; P16152; Q96PY5; O00329; Q9P270; P32119; Q9NR80; P52732; P42575; Q15084; Q9Y5P4; O94811; P08195; Q9BWT1; P35998; P46934; Q9UJV9; Q6UWW8; P61601; P43146; Q8TAD8; Q6UB98; Q07021; Q9UM54; Q9UDY2; P08567; P46060; Q8IUQ4; Q8IZP0; Q69YH5; O94762; Q9Y233; Q13526; Q13363; Q07666; P30874; Q96A00; Q14451; Q13907; Q9Y266; Q99618; O95931; Q9UNF1; Q8IXJ6; Q96IF1; O95905; Q96E14; A0AVK6; Q9NQG5; Q9NR19; P35579; Q8IX03; O60885; P52298; O75494; O00399; Q9BY84; Q9NR22; P26651; Q96J02; P05549; P16118; P26196; O95997; P31946; Q15654; O43597; P62304; Q99961; Q14896; P50395; Q6P1M3; P36896; P31645; Q14994; Q96CF2; Q01860; P27815; Q07020; Q9NQT4; Q9UJU6; Q86YF9; Q04724; P17081; O14950; Q8NB16; P63261; P06744; Q9UN36; Q9Y371; O75616; P22059; P09493; Q00610; Q9UQQ2; Q9Y566; Q9H492; Q9Y2N7; O95433; P61266; Q9UKV8; Q9UBS8; P42898; Q9H257; Q13794; Q9BRV8; O15056; Q969H0; Q684P5; P04843; Q9HB90; Q9H3D4; O60814; Q9Y265; O00170; Q3KQU3; Q14654; P05423; Q676U5; Q05195; Q04323; P50281; Q15172; O43255; Q04656; Q8IYI6; Q5FBB7; Q09666; O43504; Q00872; Q8ND25; P55273; P07814; P19878; P33176; Q6PUV4; P16949; O14777; Q09161; Q7Z628; Q8IVM0; Q9UM11; P30419; Q86V81; O15294; O15523; O60260; P55795; Q15417; Q9NRD5; P09758; P31483; Q9BRC7; Q9ULH0; Q68CZ2; Q66K74; P10599; Q9NPB6; O75534; O15117; Q9BR01; O00231; Q92667; Q02241; P57721; Q9C0C9; O14613; Q8TCS8; O95208; Q9UJM3; Q16555; P39019; P49418; Q01543; Q14457; Q99873; Q9BPX3"]
["GO:0005768","cellular_component","endosome ","P24941; P00533; P04629; P22455; Q05513; P17948; P09429; Q8WU20; Q07912; Q16512; P07355; P35968; P49407; Q5S007; Q03135; O75914; Q13905; O14964; P06241; P46109; P04083; P23458; P41743; P52333; P15311; P08138; Q9BY11; Q96T51; Q13393; O75351; P34998; P02786; P62993; Q9H1K0; P30411; Q7L804; P51681; Q14254; P13498; P12830; P50570; P42892; O15511; O60784; P46527; P61020; P56817; Q9BTU6; Q13829; Q15036; Q15276; Q92673; P51148; P30622; P11717; O75955; P05067; Q13114; P14784; P21453; P28799; O75674; P20645; P36897; P20338; P17405; Q9H4A6; O60749; Q14C86; P05023; O75379; P30533; P20339; Q9UBF8; P49685; P61586; Q13261; Q6Y7W6; Q93045; Q96AX2; P07550; P32121; O75154; P30518; Q7Z3C6; Q00610; P12821; Q14654; Q8ND25; Q8NCT1; Q14457; P35372"]
["GO:0005654","cellular_component","nucleoplasm ","P24941; Q06124; P46937; P54274; P35557; Q01538; Q01826; Q13164; P15407; Q16875; O94916; Q13554; Q15349; Q05193; Q8TDC3; P46734; Q9BRS2; Q13761; P39880; P62140; P50750; P62136; Q13422; P42229; Q16659; P11474; Q06413; P31152; Q13131; Q16566; O60825; Q13873; Q04206; P14921; Q14164; P31749; Q15303; O75676; Q9H4B4; P11802; Q14683; P50613; O15530; Q13557; P78347; P54646; Q96B36; P53779; P51813; P33778; P08631; Q00534; P49674; P35269; Q09472; Q9UHD2; P06748; P27361; Q86Z02; P06400; P15976; Q12968; Q9Y6K1; P62753; P17252; O60934; Q9UEY8; Q99640; P01106; P55263; Q13882; Q9H2X6; P52701; Q6PD62; P25054; P00519; Q9NYF8; Q8IW41; O96017; O75475; P19544; O00267; P02511; Q15796; Q9NZ63; O60285; Q00532; P49137; P10276; P06493; Q96ST3; P09429; O00311; P03372; P45984; P11309; O60674; P42224; Q15831; Q9UJU2; Q9NYV4; Q13148; Q14653; P17480; O14965; Q15797; O75886; O14497; P49715; O76039; P10242; P21802; P78362; Q15119; P15336; Q96GD4; Q96ST2; P24864; P37231; P29590; P38398; P48730; Q14004; Q13627; O75030; Q9Y2W1; Q00987; Q9Y6Q9; Q01167; P19793; P27708; P45983; P35916; Q14765; O43251; P09917; P85037; Q01196; P19838; P42226; Q99459; Q00653; P29475; Q13418; Q53ET0; P23443; P40763; Q16512; Q86U86; Q9UQM7; P53778; Q7KZI7; P15172; P25963; P60709; P17096; Q8WXI9; P50548; Q9UQL6; Q01201; P78527; P53350; Q9BUB5; Q9BZL6; P30291; P10244; Q9HBH9; P16104; Q9UBE8; P14635; P49336; O75582; P41235; Q12888; Q6NZI2; Q15678; P49407; P16220; Q9Y4A5; Q16513; O60237; P05412; P18615; Q9BVS4; P51812; P31751; Q9UBS0; O15525; P28482; O14744; P51610; Q13469; Q02078; Q12824; P84022; P17947; P25440; P04637; P17706; P05771; Q9P286; Q96Q15; P84243; O14974; Q00535; P52630; Q15759; Q08050; P08621; P35398; Q8TDX7; P17302; P11831; Q9Y2U5; P42345; Q14511; P07333; Q13043; P61978; Q16539; Q13535; P42858; P17612; P49841; P52564; Q9UPN9; Q00613; P10275; Q9Y6K9; Q08945; P19419; Q12778; Q16644; O94806; Q13263; O43781; Q14814; P49761; O15111; P53041; Q9Y6E0; P08238; P14859; P51955; P35222; Q9UKE5; P68400; P23771; P60484; P22736; P01100; Q8N3U4; P35236; P35813; P46109; Q9HC98; Q13315; P04083; O43524; P49736; P41743; Q01970; Q13555; Q92630; P04150; P38936; P43694; Q05209; O14757; P22694; P07900; Q15910; Q15418; P53396; P56524; Q05655; O00757; O43660; Q15427; P30279; Q13242; P25205; O95376; Q71F23; Q9HAN9; Q9ULW0; Q9H7L9; Q15650; O75469; Q13042; P06401; Q92769; Q13887; Q9Y618; Q9NTI5; P08151; O15164; Q9BTL3; P78545; Q13045; Q15291; Q14469; Q16836; P51452; Q29RF7; Q02224; P54829; Q9NYQ6; O00167; O14818; O14746; Q96TA1; Q9H814; Q6NZY4; Q9NQZ2; Q99502; Q9UBB9; Q9Y5S9; Q96CV9; Q9BUL5; P08138; Q96EB6; O95271; Q03188; Q14693; Q9UJY1; Q12962; P22670; Q96T58; O75150; P60866; Q16254; Q9Y2X9; P49005; Q9BVC5; Q15717; Q13287; P50995; P62280; Q9BRP8; P22314; Q6UN15; Q8NF91; Q14738; Q04864; Q8NCW5; Q8NCD3; P07910; P13010; P31942; P52655; Q96PU5; Q9UKV3; O96006; O95071; Q9Y2G1; Q96PM9; Q15366; Q9Y4C1; P62316; Q8N684; Q15078; Q9UKT4; Q86UP8; Q14207; Q15554; Q96AC1; Q15054; Q9NXE8; Q53HV7; O95785; P06454; Q9NVI1; P49450; Q6P1K2; Q9NWH9; Q5VUA4; Q99638; Q9UPU5; Q14684; Q15464; Q14145; Q7Z5J4; Q9UL63; Q5T4S7; Q5QNW6; P35251; Q15819; P19474; Q9Y692; P20749; P61457; Q9UBK2; O43623; O15516; Q9NWV8; Q9NR56; O60832; P09629; P51003; Q14493; Q14202; Q9HC77; Q9NZI8; P49716; Q9UPP1; P62979; O95251; Q9UDY4; P62993; P17844; Q9NX46; P09622; P19447; Q9UFW8; Q7L2Z9; P62508; Q8WUI4; Q96RU2; Q9UEW8; P54132; Q9Y3Y2; Q99504; Q8WXE1; Q9Y5J1; Q8IYB3; Q15642; O96001; P27540; Q8NBZ0; P28324; Q9Y261; Q9BY77; Q9Y4C8; Q92598; P17535; Q9H4L7; Q9Y3Z3; Q08170; Q12933; Q9Y5Q9; P15173; Q14498; O75626; O43739; Q7L804; O60244; O00560; P35658; Q01105; P48552; O75461; Q9UHI6; Q9H9L4; P17980; P30626; Q07001; O60673; Q2NL82; P51532; P10588; Q06546; Q4V328; Q15545; Q02790; Q9UBU8; Q8N3C0; Q8NG66; P52945; O15304; Q99741; O00505; Q9BW61; O15360; Q96J01; Q12906; Q18PE1; O43683; Q96P48; Q92733; P12272; Q5VWG9; Q7Z2Z1; P05114; Q8WUF5; Q86T82; Q8N1G1; Q9NS56; Q14160; P20700; P04899; P52294; O15287; Q99590; O75400; P33992; P29083; Q9H063; O43542; Q9Y4W2; P48426; Q99966; Q13156; Q12996; Q96EP5; O43741; P39687; Q8TAQ5; Q9BQG0; O75940; Q5VT52; O95218; P33316; P14678; Q9P1Z0; Q9Y294; Q14671; P15923; Q15651; Q14839; P25685; P35611; P38919; Q13330; Q9P0U4; Q6KC79; Q6P4R8; P58012; Q9UK32; Q92908; Q13098; P19532; Q14186; Q14669; P43351; P17676; P78317; Q99986; O60506; O00327; O15160; Q9NYJ8; Q9NPC1; O15198; Q8N2M8; Q96GX5; P55196; P23760; P13056; Q99547; O15014; Q14677; Q9Y2R4; P46527; Q86X55; P23396; Q13362; Q9UJX5; O15350; Q9Y570; Q9UBU7; Q9Y580; Q9BXW9; P12956; Q8IZD2; O75081; P0DP23; Q13243; Q5D1E8; Q9NVP2; Q14151; Q01130; Q01081; O94992; Q8IW19; Q96RI1; Q9Y6D6; P35659; Q15022; P17542; Q15459; Q8TAQ2; P37275; P0CG47; Q12948; Q8TBF4; Q9Y5B9; P42677; P43364; Q7LG56; Q93062; Q96T60; Q9HC52; P24928; O60828; P05787; Q96FV9; Q08999; P54727; Q9BZB8; P62195; Q96L91; Q9UBT6; Q96Q89; P26358; Q96FI4; O60331; Q96D46; O43818; Q12923; Q96KR7; Q8TEH3; Q7Z5K2; Q8IX01; P18754; P26367; Q9P2D1; Q9BUJ2; O15297; P12004; Q15906; Q15424; P55072; Q13112; Q7L5N1; Q99697; P10828; Q13547; Q01094; P40259; Q9Y3T9; Q9NP87; Q13191; Q9NZM5; P61289; Q9NQW6; Q16665; P36956; O75563; P15822; Q99952; Q99497; Q13573; Q9NP77; P61218; P26368; Q13257; P27694; Q13485; O94763; P54259; P10415; Q15185; O43236; Q96PK6; Q8IXH7; Q9Y6H5; P98179; P32418; P45973; Q96JM3; Q8WYH8; Q8NI27; O60229; Q9Y3F4; P46379; Q969G3; Q9Y5T5; Q06455; P55055; P02545; P10827; Q9UMS4; Q9UK99; Q14790; Q06787; P49959; Q9UBF6; P19634; P39748; O94953; Q03468; P40692; Q9H1A4; Q9BWU0; P34931; O00257; Q13895; Q8IY92; P19338; P0DMV8; Q8WXF1; P83916; P10070; Q9BZS1; Q5UIP0; Q9H4Z3; O15355; Q9H4E7; P58876; P50749; Q7RTN6; P06746; P11473; P49643; O75925; Q99460; Q13200; Q08209; Q9UER7; Q9H9A7; Q12789; Q6UUV7; Q52LA3; Q9H0L4; Q9BQ15; P11387; Q9NYZ3; Q96I25; P30304; Q9H9S0; Q9NZJ0; P55212; Q05519; Q92793; O75533; P12270; Q92620; Q9UJX3; P35226; P22087; Q9BY66; P62826; P28749; O43395; O00716; P49116; P54198; Q92994; P62913; Q9H0H5; P09651; Q92797; Q03111; O00482; Q92879; Q9Y253; Q9UIG0; P54252; Q9BQA1; Q96BY7; P15927; Q99814; O60341; P67870; Q9BTA9; Q14573; Q02447; Q13351; Q9H0D6; Q07955; Q8NHZ8; P56537; P18848; P55317; P30307; Q8N1G2; Q9HBY8; Q9UHJ3; Q92985; P41161; O75884; Q9NTZ6; Q96A49; Q14562; Q9UPS6; Q9BTP7; Q969V6; Q9NTJ3; P23025; O95810; P46782; P23511; P18850; P51946; Q13501; Q9Y3M2; O75496; O15105; Q96T23; Q8TAP9; O15392; Q8NHY2; P48443; Q99626; O14641; P63279; Q07820; Q06609; O94782; O95278; Q9P0W2; Q9HAW4; Q9BWF3; Q96S44; Q92784; P62807; P49321; Q9BVI4; Q13416; Q16236; P61764; P48678; P07741; Q9NQS7; P68036; O95235; Q15853; Q13285; O95625; Q9UHH9; Q13426; P13051; O60381; Q15633; P49427; Q96KS0; P08047; Q9UBN7; Q7KZ85; P00441; Q12772; P53801; P63146; P56693; Q8N2Z9; P18858; Q9H3P2; O15084; P41208; O15151; Q9H9Q4; Q92900; P40937; Q9NQB0; Q8N9N2; O15379; Q16621; P63165; Q562F6; P56211; Q53H80; P35232; P43354; Q07869; P63244; O95600; Q9UK80; Q13133; Q8TD43; P52292; Q99958; Q9BXP5; Q9HB65; Q9Y4P8; P17275; Q02880; P21453; P06899; O43257; Q03112; P30305; P31270; Q8NAV1; Q9BRQ0; Q16763; Q93009; Q8N163; P49790; P54105; Q9UKY1; O00161; Q6IE81; Q8NEY8; Q9NYB0; Q9UPT8; Q14192; Q9HB96; Q9NZI5; P49916; P46783; Q14686; O75928; O43474; Q14161; Q53HL2; P20248; Q92878; P68431; P54253; Q9H204; Q15327; P55210; O96004; Q9UNZ2; Q96SB3; Q9UHX1; Q16828; Q99543; P33076; P25788; O95551; Q9NYF0; Q14694; Q9BVI0; Q9Y5B0; Q9Y483; Q9BSI4; P51398; Q13247; Q9UJY5; P08235; P17861; Q9UQ35; Q9H6Z4; Q15561; Q99967; Q02297; P46939; O75943; Q9UHY1; Q6UUV9; O43768; Q15020; Q9UJX2; P28715; Q8IZL8; Q9NQR1; Q7Z3K3; Q6STE5; Q9NP71; Q15047; P41182; P17544; Q9H2G4; Q96FF9; Q06265; P18846; O60701; O00255; Q9UQE7; Q12931; P53539; P62805; Q8WVB6; Q9Y478; Q92625; Q99708; P0C1Z6; P15036; Q96KQ7; P14866; Q9HC62; Q9UNE7; Q86V15; O75525; Q9NS91; P11142; P23527; Q12800; P62841; O43184; Q13625; Q96AE4; P61244; Q9NRG4; Q13404; P24522; P13349; Q86Y01; Q9NQT5; P22626; P30281; P98177; Q15024; Q9P2I0; Q13569; Q15788; Q8N6T7; P10914; Q8NI36; Q16778; Q9UGP5; P57682; Q9BZK7; Q13415; Q96LA8; P51587; P43246; Q9UMX0; P54845; Q9BY41; Q12834; Q15637; Q9HCS4; P35638; Q01954; P26599; O75817; Q9H0B6; O43684; Q14103; P35637; Q13352; Q8N2W9; Q9UKF6; Q8NE71; Q9UH92; Q9H816; P49917; O15446; P46531; O95863; Q8TEV9; Q15287; P41970; Q86YP4; P40855; Q92841; P49459; Q96FW1; P19784; P55895; P49750; Q13435; P24385; Q7LBC6; Q8N122; P54619; O75152; Q08378; P43686; Q9UBP6; Q9UNS2; O75531; Q14118; Q9H0E9; O15534; O94875; P22307; Q6P1J9; P48634; Q12972; P52272; O14519; Q99607; P22415; O00566; Q6P0N0; O60239; Q9H165; P98170; P22612; O14713; Q8TDY4; Q86U44; P29375; Q92794; Q9P0J0; P23246; P31943; Q15466; P06702; Q99879; Q9ULX3; O60318; Q9Y230; P30260; P28347; P38432; O00625; Q9H840; O95707; Q5TKA1; Q16531; Q15306; O96028; P67809; Q9NYV6; O95239; Q9HCU8; Q9UNP9; O60671; P29374; P46087; O00213; O43823; Q14676; O15266; Q8N0Z6; O43148; Q8WX92; Q15583; O95983; Q93079; O95644; Q6P2Q9; O75151; Q92681; Q92993; Q9UIS9; P29350; Q15596; Q15365; P51858; P51692; Q8IXM2; P50402; Q9BVW5; P35270; Q9UHR4; P49760; Q13950; Q8NG31; Q9H0C8; Q8NFD5; Q7Z6Z7; P52948; Q9GZV5; P13489; O43929; Q96HA1; Q14527; Q9UGI9; Q9BQ95; Q99877; P48431; Q6X4W1; Q9BYG3; Q9BXB4; P52926; Q96AH0; P11388; P18887; Q9H467; Q02556; Q99728; Q8WVC0; P55039; Q13769; Q5H9R7; P35869; P61088; Q7Z589; Q96AD5; Q99856; P62987; Q96RS0; P29401; Q16666; Q96H20; O60563; Q969S2; P43699; Q9Y2Y1; P09874; Q96PM5; Q13309; Q9H211; P33993; P60900; Q7Z417; P14316; Q8WYQ5; O75376; Q92945; Q8N726; P40337; P51449; O95243; Q9BPZ7; Q9BUR4; Q92785; Q15029; Q9Y248; P78356; Q03164; P63104; O75154; Q9Y6W6; P42574; P13631; Q9BVJ6; Q8N9N5; Q14980; O14980; P10071; Q8TAS1; P12755; Q15648; P49711; P27695; Q96EZ8; P33991; O00148; P20393; Q9Y5P4; Q9BWT1; P35998; P51170; Q96RK0; Q7Z2E3; Q8TAD8; Q6UB98; Q9UM54; Q96AP0; Q9NRR4; Q9UDY2; P46060; Q9H4D5; P38159; Q69YH5; P23769; Q00839; Q13151; O94762; Q13526; Q13363; Q07666; Q5VWX1; Q9H3R0; Q9P2D0; Q9Y266; O95931; Q00403; O95905; Q14191; Q96E14; A0AVK6; Q92547; Q9NQG5; Q9NR19; O14686; O60885; P52298; Q14966; O75494; Q9BY84; P41134; Q96J02; P05549; Q92731; Q06330; P62304; P23497; P18146; Q9NZC9; Q96SD1; Q14994; Q08J23; Q01860; P27815; Q9NQT4; P15408; Q86YF9; Q9BYE7; Q04724; Q13185; Q96QD9; P06744; Q6PCD5; Q96RL1; P25490; P49640; Q0VD86; P22059; Q96AV8; Q9Y676; Q9Y2N7; P61266; Q96QC0; Q9UKV8; P55199; Q15672; Q9H0S4; Q9UKX7; Q16690; Q969H0; Q9H3D4; O94776; O60814; Q9Y265; O00170; Q8NFH5; P33240; P05423; Q05195; Q9Y5N6; O43255; Q9UKV0; Q5FBB7; P55273; Q9P013; O14777; Q09161; Q8WXA9; Q96SY0; P48436; Q92698; Q9UM11; Q86V81; O15294; Q6UWZ7; P55795; P16615; P31483; Q71DI3; P23409; Q15329; Q13562; O00231; P55854; Q02241; Q01851; Q96S94; Q9BWJ5; Q6IBW4; Q9HCU9; Q92917; Q9Y2K7; Q99828; P39019; Q5VTR2; Q99873; O95390"]
["GO:0005634","cellular_component","nucleus ","P24941; P05198; Q06124; P15056; P46937; P54274; P41212; Q01538; Q15118; P36888; O75116; Q01826; Q13164; P00533; P15407; O94916; P09467; Q15349; Q05193; Q8TDC3; Q13761; P39880; P62140; Q00537; P51617; P62136; Q13422; P51956; P10636; Q96PN8; O00141; Q16659; P11474; P07948; Q06413; P31152; Q13131; O00763; P42681; P45985; Q16566; P02686; O60825; Q04206; P14921; Q14164; P51636; Q8N5S9; P31749; Q15303; O75676; Q9H4B4; P13639; P11802; O60927; Q14683; P50613; Q9NQU5; Q13557; Q13163; P78347; P14618; P54646; P53779; Q9H0K1; P37840; P04792; P33778; Q96KG9; Q00534; P11413; P49674; P35269; Q09472; P06748; P27361; Q86Z02; P06400; P15976; P35240; Q12968; Q9Y6K1; P62753; P00966; P21359; O60934; Q99640; P01106; P55263; P35228; O15264; Q13882; Q9H2X6; Q96RR4; Q9Y243; P25054; P00519; Q01813; Q9NYF8; Q8IW41; O75475; P19544; P09619; O00267; P02511; Q15796; O60285; Q00532; P49137; P10276; P06493; Q96ST3; P09429; O00311; P03372; P45984; P11309; O60674; P42224; O94921; Q15831; Q9UJU2; Q9NYV4; Q13148; Q14653; P17480; Q13177; P36507; O14965; P30086; Q15797; O14497; P49715; O76039; P10242; P21802; P78362; P04626; P15336; Q96GD4; P62714; Q96ST2; P24864; P37231; P29590; P38398; P48730; P49759; Q13627; Q06418; O75030; Q9Y2W1; P22607; Q05397; P01112; Q07912; Q00987; Q9Y6Q9; Q01167; P19793; O43663; P27708; Q06187; P45983; Q86YV5; O43251; P85037; P29323; P07101; P29597; Q01196; P19838; Q99459; Q00653; Q53ET0; P21127; Q14289; P23443; P40763; Q16512; P68104; Q9UQM7; P53778; P20794; P15172; P25963; P60709; P17096; P07355; Q9UPZ9; P50548; Q9NYL2; Q9UQL6; Q01201; P78527; P53350; Q9BUB5; Q14934; P35968; Q9BZL6; P30291; P10244; Q9HBH9; P53667; P16104; Q9UBE8; P14635; P49336; O75582; P05106; P41235; Q12888; P27707; P35520; Q6NZI2; Q15678; Q9Y2R2; P49407; P16220; Q9Y4A5; P05129; Q16513; Q14680; Q08881; P16234; P05412; P16591; P18615; P51812; P31751; Q9UBS0; P28482; O14744; P51610; Q13469; Q5S007; Q02078; Q8IVW4; Q9NWZ3; Q12824; Q92772; P84022; P17947; P07737; P04637; P17706; Q8IU85; P05771; P43405; Q96Q15; P84243; Q9NR20; Q00535; P06241; Q15759; Q08050; P08621; P35398; P11831; P42345; O14733; Q14511; Q13043; P61978; Q16539; P42858; P17612; P57059; O14920; P67775; P49841; P52564; Q7KZF4; P35568; Q9UPN9; Q00613; P10275; Q9Y6K9; P19419; O43318; Q12778; Q02750; Q16644; P06733; Q13263; O43781; O43293; Q14814; Q99558; P49761; P53041; P29474; Q9Y6E0; P08238; P12931; O00221; Q9UQ07; O00459; Q02156; Q15121; P14859; P23528; Q96RT1; P35222; Q9UKE5; P68400; P23771; P51817; P60484; Q15208; Q96Q40; P22736; P27986; Q9NRP7; P01100; Q8N3U4; P35813; Q9UQ88; Q96KB5; Q96SB4; Q04637; Q9HC98; Q13315; P04083; O43524; P49736; P23458; P41743; Q07002; Q92630; P04150; P38936; P43694; P42685; O14757; P07900; Q15910; Q14012; Q15418; P56524; Q05655; O14512; P19525; Q9NRM7; O43660; P30279; P25205; O95376; Q71F23; Q9HAN9; Q9ULW0; Q9H7L9; Q96QF0; Q15650; P04731; Q92769; P46013; Q9Y618; Q9NTI5; Q96IZ0; P08151; O15164; Q9BTL3; P78545; Q15291; Q14469; P51452; P41180; Q9BX82; Q29RF7; Q02224; O15162; P16403; Q49AN0; Q9BRD0; P40926; Q9P0V3; O00167; Q99733; O14818; O14746; Q96TA1; Q9H814; Q6NZY4; Q13158; Q9NQZ2; Q13642; Q99502; O75592; Q9Y5S9; Q96CV9; Q8WV24; Q9H1K1; Q86UE4; Q9BUL5; P08138; O95069; Q96EB6; P12524; P12980; P29972; Q14693; Q9NQV6; Q9UJY1; Q99661; Q9NP66; Q12962; P22670; Q96T58; O75150; Q14344; Q9Y2X9; Q16760; P49005; Q15717; Q9Y6H1; Q9BRP8; Q92610; P22314; P49757; Q9UQR0; P46108; P49773; P61925; Q8NF91; Q14738; Q04864; Q8NCD3; P07910; P13010; P31942; Q9HC44; Q12904; Q9UKV3; O95071; Q9Y2G1; Q15366; Q9Y4C1; P41220; Q8N684; Q15078; O00401; Q9UKT4; Q96T51; Q16649; Q86UP8; P35580; Q14207; Q8N680; Q12967; Q9BRS8; Q86WV1; Q15554; Q96AC1; Q15054; O75175; P04075; O95785; P06454; P49450; Q9NWH9; Q99638; Q9GZX7; Q9H3M7; Q14684; Q16559; Q7Z5J4; Q8N1B3; P32314; Q92904; P55209; Q8TBY0; Q5QNW6; P35251; Q15819; P19474; Q9Y692; Q8WW12; Q9Y6X9; O75351; P20749; P61457; Q9UBK2; P25686; O43623; O15516; Q9NWV8; P55211; Q9NR56; Q9UKG1; O60832; P09629; Q6ZVD8; P51003; Q9NRA8; Q14493; O15055; P05388; Q9UPP1; P14317; P62979; O95251; Q03431; P62993; P17844; O95817; P19622; Q96LX8; O75529; P09622; P19447; Q9UFW8; P26038; Q8N9K5; Q8WUI4; Q9C0K0; Q9UBC0; P54132; Q6P2M8; O43464; Q99504; Q92913; O60869; O75410; Q15398; Q8TDD2; Q8WXE1; Q9Y5J1; O75391; Q8IYB3; Q02535; P49918; P27540; Q13772; Q6N043; Q9BX66; O43566; Q8NBZ0; Q99801; P04818; P28324; Q9Y261; O43707; P17535; Q9Y3Z3; Q08170; P16989; Q8IZQ8; Q9Y5Q9; A8MU46; Q13188; P15173; Q32MZ4; Q9NQ66; O60315; O60244; O00560; Q92597; P30041; P35658; Q01105; Q9UKV5; P48552; O75461; P09382; Q9UHI6; Q8N1K5; Q99581; Q08828; Q9UGP4; Q00059; P17980; Q06481; P00338; Q14807; P20941; O60673; P51532; P10588; Q06546; Q8NCP5; P53999; Q8N3C0; Q99741; O00299; Q96N95; Q15046; Q8TE77; P53804; O15360; Q13144; Q12906; O95238; Q18PE1; P60174; P20823; O00204; O14558; Q92733; Q5VWG9; Q13202; Q9H0Z9; Q7Z2Z1; P05114; Q8WUF5; Q86T82; Q9NS56; P20700; Q8IWQ3; P52294; Q99590; Q15019; P33992; P29083; Q9H063; O43542; Q15599; Q9GZV1; Q99966; Q14674; P14679; Q13156; Q12996; Q92858; P16333; P39687; Q9BQG0; O75940; O95218; O14727; P33316; Q9Y613; P14678; Q9Y4R8; Q9P1Z0; O75916; Q7Z5H3; Q9Y463; Q9Y294; Q14671; P13498; Q9HAZ1; P55347; P50570; P15923; Q14839; P25685; Q12899; P35611; Q9Y2K5; Q13330; Q9P0U4; Q6KC79; Q6P4R8; P58012; P07437; Q9UK32; Q92908; P19532; Q14186; Q14669; P43351; P17676; P78317; Q99986; Q01844; P14625; O60506; Q9H2A3; P26373; O00327; P19484; P46695; O15160; O60504; Q13574; Q04760; O15198; Q8N2M8; Q8ND76; Q96GX5; P51508; Q8NC51; Q99547; O15014; P46527; Q9HBU1; Q86X55; P82094; P23396; Q5JTV8; Q13362; Q9UJX5; O15350; Q9UBU7; Q9Y580; Q9BXW9; P12956; Q8IZD2; Q9UL54; O75081; P0DP23; Q6SA08; Q13243; Q5D1E8; Q8NE63; Q14151; O00443; Q01130; O94992; Q8IW19; P55316; Q02962; P35659; Q15022; Q9NPP4; P17542; Q01534; P37275; P0CG47; Q12948; Q15003; Q9Y5B9; P42677; Q13428; P48023; Q96T60; P62633; Q13568; Q9HC52; Q9NX07; Q96P20; P24928; O60828; Q9BTK6; P05787; Q96FV9; Q08999; Q96FA3; P28069; O43918; P54727; Q9BZB8; P56270; P62195; Q9NRF2; Q99576; Q96Q89; P26358; Q96FI4; Q96QB1; Q96D46; Q07812; P42771; O75386; Q12923; Q9Y6I3; Q7Z5K2; Q9Y237; P18754; P26367; Q9P2D1; Q9BUJ2; Q14106; P50616; O15297; P12004; Q15906; Q8WYK2; Q15424; Q9UD71; P55072; P98172; Q13112; Q96PY6; Q99697; P10828; Q13547; Q01094; Q93052; Q9Y3T9; Q9HBL8; P61289; Q16665; P36956; Q12802; Q9NZJ9; P09211; P56545; P15822; Q96QF7; Q99497; Q13573; O75952; Q8NCA9; P61218; P26368; Q13257; Q14135; P27694; Q13107; Q13485; O14771; O94763; Q6DRA6; P54259; P10415; Q15185; O43236; Q96PK6; Q969S3; P98179; P45973; Q96JM3; Q8WYH8; Q9NRH2; P17301; Q6PJT7; P20138; Q04837; P46379; Q9UH65; Q969G3; Q9Y5T5; Q9UHL0; P55055; P02545; P10827; Q9UMS4; Q06787; Q9BTD8; Q13118; P49959; Q9UBF6; P39748; Q03468; O94900; P40692; O00257; Q13895; Q16526; P26641; Q9UKM9; Q13516; P19338; P30044; P0DMV8; Q8WXF1; P83916; O15553; P10070; Q8TF76; Q9BZS1; Q5UIP0; O15355; P58876; P50749; Q9Y5Q3; Q7RTN6; Q9Y5V3; Q53EL6; P06746; Q8NF99; P11473; P02649; Q8TAA3; Q96LI6; Q53H47; O75925; Q99460; Q13200; Q9UER7; Q9BSJ6; Q12789; O95425; Q6UUV7; P32245; P82970; O95190; Q9BQ15; Q9H4B6; Q8IYB8; P11387; Q9BV57; A8MT65; O14921; Q9UQB3; Q92886; Q9H9S0; C9JLW8; Q9NZJ0; P23759; Q05519; Q92793; O75533; P12270; Q92620; Q9UJX3; P35226; P22087; Q9UL40; Q15653; Q9NYA1; P50461; P62826; O43395; P12277; P17509; P04198; Q9HB09; Q96T88; Q9H6E5; P15090; P54198; P18669; P53671; Q8IYU2; Q9NZH5; P52952; Q9H0H5; Q15942; P09651; P08237; Q03111; Q9UNQ0; Q14990; Q9UIW0; Q9BUZ4; O00482; Q92879; Q9NZV7; Q9P2F9; P54252; Q9BQA1; P15927; O43765; Q99814; O60341; P42166; P67870; Q9BTA9; Q02447; Q5VVH5; P31947; Q13351; Q9H0D6; P15884; Q07955; P56537; P18848; P55317; P30307; Q7Z2W4; Q99592; Q86WB0; Q6N069; P54578; Q8N1G2; Q9UHJ3; Q96PF2; Q92985; P41161; Q14562; P11171; Q9P2K5; O60716; Q969V6; Q9NTJ3; Q9Y272; P50553; Q12946; P23025; O76054; O43541; P17936; P31314; Q6DN03; P23511; Q9BQE3; P18850; P51946; Q96JY6; Q53F19; P14923; Q8TAE8; Q9Y3M2; O95999; P28562; O75496; O15105; Q96T23; Q9NX63; Q8TAP9; Q15058; O15392; P28329; P42338; P53805; Q16181; Q99626; Q02363; O14641; P63279; Q07820; Q06609; O94782; Q13255; O95278; P15374; Q14CS0; Q9BWF3; Q96S44; O95684; P62807; Q9ULL5; P49321; Q9BVI4; Q9Y534; Q13416; P50219; Q16236; Q9Y4K3; Q96T49; P48678; Q9NQS7; P68036; Q9BU19; Q15853; Q13285; Q14494; Q9UHH9; Q13426; P13051; P49427; Q9ULM6; Q86TI0; Q12959; Q96KS0; P08047; Q9UBN7; P78368; Q9H6F5; Q00526; Q06830; Q7KZ85; Q8IUX7; P00441; Q12772; P28698; Q9NP62; O95751; Q71U36; P53801; P63146; Q9H8V3; P56693; P09038; P18858; P49768; P62258; P31950; O15151; P00973; Q9H9Q4; Q16342; Q92519; Q92900; P55081; P78337; Q8NCK3; P17931; P40937; Q8IYM1; Q9NQB0; Q9BZI1; Q8N9N2; O15379; Q16621; P63165; Q96E39; Q9UQF2; Q53H80; P11308; P35232; P43354; Q07869; P63244; P54750; P35368; P21291; Q13133; Q99958; O00571; Q8TBZ5; Q16635; Q9HB65; Q9Y6M1; Q9BW19; Q02880; Q6U7Q0; Q68EM7; P06899; O43257; Q03112; Q96JP5; Q5MAI5; Q8NAV1; Q14571; Q93009; Q8N163; P41145; P54105; P55040; Q9UKY1; Q96BF6; Q86V48; P40429; Q6IE81; Q9NYB0; Q14192; Q9HB96; Q9NZI5; P49916; O43379; Q14686; Q7L2R6; Q6P1N0; O75928; P31948; P16401; A8MYZ6; Q53HL2; P20248; P68431; P54253; Q8TBC5; Q15327; P55210; O96004; Q9UNZ2; P49798; Q9H1E3; Q8TDN4; P41002; Q99543; Q6NXT1; P25788; P47928; P17041; O95551; Q9H4X1; Q9H2D6; Q9NYF0; Q14694; Q9Y5B0; Q9Y483; Q8TB69; O60502; Q6NUN9; Q9ULU4; Q96HZ4; P17861; Q9UK13; Q9UQ35; Q9H6Z4; Q15561; Q99967; O14737; Q9BXV9; O60479; Q13049; O60711; O75943; Q6UUV9; P11940; Q15020; Q9UK11; P28715; Q8IZL8; Q9NQR1; O95453; Q7Z3K3; Q9BUG6; Q6P5Z2; Q9BXR0; Q6STE5; P21333; P13569; P31269; P49815; Q9NP71; Q15047; P41182; O00409; O75179; Q99598; P17544; Q00341; O00139; Q9H2G4; Q96FF9; Q06265; O43598; P18846; Q5BJF6; O60701; O00255; Q9UQE7; Q8NHW3; P53539; Q9Y5B6; P62805; Q5JQC9; Q9Y2W7; Q9NY61; P40425; P22392; Q01892; Q9BYX4; Q99708; P50549; P0C1Z6; P15036; P98175; Q96KQ7; P14866; Q7RTU3; Q9P0K7; Q15631; Q9UNE7; Q13009; Q15435; O75525; P23469; Q9NS91; P11142; Q9BXM7; P23527; Q12800; P62841; P99999; Q13509; Q13625; Q96AE4; P61244; Q92915; Q9NRG4; O94805; Q13404; Q8WXB4; P24522; P29692; Q05086; P13349; Q5VZK9; Q9NQT5; P22626; P98177; Q96PU8; Q13569; Q9BWW4; Q02410; Q8N6T7; P10914; Q13765; P62745; Q9Y2Z0; Q16778; Q13283; Q9UGP5; Q9NPH5; O15119; P46940; Q9BZK7; Q13415; Q96LA8; P51587; P54845; Q9BY41; Q9C0C2; Q96S59; Q12834; Q15637; Q9UHP3; P04406; Q9HCS4; P15531; Q9H8S9; P35638; Q9Y2T1; Q01954; P05204; Q8TD08; O43264; Q9HBH7; Q6GQQ9; Q8WX93; P41162; Q9NRY4; O75817; Q14103; Q99750; P17655; P35637; Q13352; Q8N2W9; Q15772; Q92686; Q9Y3Q8; Q6EEV6; P09601; Q9UH92; Q9BYV9; P49917; Q7L9L4; O15446; P46531; O95863; P43356; Q15287; P41970; Q86YP4; P40855; P08559; Q9NPI6; Q92841; Q96FW1; P19784; Q8IY67; P49750; P24385; Q9H773; Q7LBC6; P31949; Q08378; P43686; P12268; Q9UBP6; Q9UNS2; O75531; Q9UK53; Q9H0E9; P63167; O94875; Q6P1J9; Q12972; Q5TB30; O14519; Q9H410; P36873; Q9H1R3; O95989; P22415; Q9BQI9; Q9H8N7; Q9UBD0; Q96EP1; Q9H165; Q13614; P98170; Q969T9; O14713; P57077; P0C0S8; Q86U44; P37198; Q68DY1; P29375; P21728; Q92794; P23246; Q9UBR4; P31943; Q15466; Q86UE8; P06702; Q99879; Q9Y283; Q7Z3J3; Q8N9L1; Q9UNN5; O60318; Q9Y230; Q9UMX1; P30260; P30153; P38432; O00625; Q9H840; Q4G163; Q9H2P0; Q16531; Q96RG2; P17661; Q15306; O96028; P67809; Q99848; Q8IVF2; Q9ULZ3; Q86WP2; Q9NYV6; Q9HCU8; Q8IWR0; Q9UNP9; Q9BWG4; Q14185; Q9NS23; O60671; Q16478; E9PAV3; P29374; O00213; O43823; Q14676; P22674; P20265; P54652; O43148; P61586; Q93079; O95644; Q6P2Q9; O75151; Q92993; Q9UIS9; P29350; Q15596; Q9H910; Q9Y3C5; Q99704; P29803; P30101; P13693; P51692; Q13155; Q9BVW5; Q8N720; Q9NZQ3; P49760; Q13950; Q8NG31; Q9H0C8; Q8TDP1; P98161; Q7Z6Z7; Q99490; Q9GZV5; P61086; O43929; Q7Z7A4; Q07352; Q9UQ80; Q9NSV4; P51608; Q14527; Q05516; Q9BQ95; O75449; Q99877; P48431; Q6X4W1; P52926; Q07954; Q16385; Q8WUX9; P08729; Q9HD90; Q9UL17; P50221; Q96AH0; Q8NE35; Q99471; P11388; Q92688; P18887; Q8NDW4; Q02556; Q99728; Q8TD19; Q13769; P35869; Q9NZN8; P61088; O95319; Q99856; P62987; Q4VCS5; Q96RS0; Q16666; Q96H20; P20333; O60563; O43665; Q969S2; Q9HCG1; P43699; Q7L5Y6; P21796; P09874; Q96PM5; Q13309; Q9H211; Q96S66; P07550; P33993; P60900; Q92574; P40818; Q9NQ50; Q9BQW3; Q7Z417; Q8WYQ5; O75376; Q9H0M0; P32121; Q8N726; Q96IT1; Q9NZC7; P40337; P51449; Q86UL8; O95243; O75689; P08253; O15169; Q03164; P63104; Q03014; Q9Y6W6; Q96NC0; P42574; Q5JVS0; P42167; P13631; Q53GL7; Q6IPX3; Q14980; Q9Y4E8; O94880; O14980; P10071; Q8TAS1; P12755; Q8WWI1; Q9UHP9; Q15648; P49711; P27695; Q96EZ8; P33991; P42575; O00148; P20393; O94811; P08195; Q8TAW3; Q9BWT1; P35998; Q9UJV9; P43121; Q96RK0; Q9NZT2; Q7Z2E3; Q8TAD8; Q07021; Q9UM54; O94768; P59923; Q8IUQ4; Q9H4D5; P38159; P05813; Q8IZP0; Q9UPG8; P23769; Q00839; Q13151; O94762; Q13526; Q13363; Q07666; P05455; Q9H093; Q96IQ9; P10243; O95931; Q71UM5; Q9UNF1; Q00403; Q8IXJ6; Q96IF1; O95905; A0AVK6; Q92547; Q9NQG5; P35579; O14686; Q8IX03; O60885; P52298; O75494; Q9BY84; P26651; P41134; Q03060; P05549; Q92731; P26196; O95997; P31946; Q15654; Q06330; O43597; P62304; P23497; P18146; P62324; Q9NZC9; Q9H0D2; Q14994; Q8WVD3; Q01860; Q07020; Q9NQT4; P50479; P15408; Q86YF9; Q9BYE7; Q04724; Q13185; O60361; P56134; P63261; Q6PCD5; Q9Y2T7; Q9UN36; O75444; Q96RL1; P25490; Q0VD86; P22059; O75995; Q9Y2N7; P61266; Q96QC0; Q9UKV8; Q9UBS8; Q15672; Q13794; Q969H0; A0A024R539; Q9HB90; Q9H3D4; Q14585; O60814; Q9Y265; Q9NUK0; Q5VWQ0; Q05195; Q9UQR1; Q9Y5N6; P10412; Q04323; Q9UKI8; P50281; Q15172; Q9BW71; Q04656; Q9UKV0; Q99623; P56645; Q09666; P55273; Q9P013; O14777; Q9UMY1; Q09161; Q7Z628; Q99676; P48436; Q92698; Q9NRM2; O15294; O15523; O60260; Q6UWZ7; P55795; Q8ND82; P31260; Q15773; P09758; Q71DI3; P23409; Q9BXA7; Q15329; Q96TC7; Q66K74; P10599; O95409; Q9NPB6; Q13562; O15117; Q9UMR3; Q9NUW8; O00231; P55854; Q02241; P57721; Q01851; Q9C0C9; P11021; Q8TCS8; Q96S94; P15924; Q9BWJ5; Q86VK4; Q6IBW4; Q9HCU9; Q92917; Q9UJM3; Q99828; Q01543; Q14457; Q5VTR2; Q99873; Q9BPX3"]
["GO:0005667","cellular_component","transcription factor complex ","P24941; Q04206; P14921; P11802; Q09472; P15976; Q15796; Q96ST3; Q9UJU2; Q15797; P15172; P17096; P78527; Q14934; Q02078; P84022; P35222; P23771; Q16254; Q04864; Q6P1K2; O15516; P14317; Q99504; P15173; Q9UGP4; Q15545; P53999; P55347; P15923; Q92908; O00327; O15198; O15350; P12956; P17542; P37275; Q08999; P28069; Q99697; Q13547; Q16665; Q13485; Q96PK6; Q9Y5Q3; P28749; P52952; Q99814; O60341; P15884; Q6N069; Q12946; O43541; O15105; Q9NP62; P78337; P61296; Q8N9N2; P31270; Q14686; Q15327; Q96HZ4; Q15561; P31269; Q9NP71; P40425; Q9HCS4; Q9HBH7; P22415; Q9UBR4; P20265; Q92993; Q13950; Q9GZV5; P48431; O00151; P35869; Q96H20; P43699; P09874; P13631; P12755; P27695; P23769; Q13363; Q96IF1; A0AVK6; Q03060; Q06330; Q9H0D2; Q01860; P25490; Q96AV8; Q9H3D4; O94776; Q9UKV0; P31260; Q15329"]
["GO:0000805","cellular_component","X chromosome ","P24941"]
["GO:0000806","cellular_component","Y chromosome ","P24941"]
["GO:0010494","cellular_component","cytoplasmic stress granule ","P05198; P54646; P06730; P61978; O43781; Q13464; Q6PKG0; Q15717; Q9NR56; Q9NZI8; Q14671; Q93062; O60828; P55072; Q06787; C9JLW8; Q9BWF3; O00571; Q8WWM7; P11940; Q5TC82; Q13283; Q8N122; P67809; Q6Y7W6; Q7Z417; Q92945; Q5JVS0; Q14451; P26651; P26196; P31483"]
["GO:0033290","cellular_component","eukaryotic 48S preinitiation complex ","P05198; O00303; O75822; Q99613"]
["GO:0005850","cellular_component","eukaryotic translation initiation factor 2 complex ","P05198; P41091; P20042; Q9BY44"]
["GO:0070062","cellular_component","extracellular exosome ","P05198; P13612; P09467; Q05193; P62140; P62136; Q5VT25; P07948; P06239; Q16566; P08575; Q9NZM3; P13639; P24723; Q05513; P14618; P54760; P04792; P11413; P00966; P17252; P08670; Q01813; P02511; Q00532; P49137; P06493; P24666; P21980; Q15831; P16284; Q9Y490; P30086; P09769; P06730; Q9Y2W1; Q9Y6Q9; P27708; P29597; P12814; P18433; Q53ET0; P10586; Q9UM73; P68104; P60709; P16885; P07355; P21399; P49327; P11274; P19105; P16104; P05106; P30530; P13861; P42768; O95747; P41240; P54762; Q5S007; P51178; P09104; P07737; P63000; P05771; O94804; P84243; Q08345; O14964; P61978; P17612; P67775; Q6IBS0; P07947; Q7KZF4; P06733; Q7L7X3; Q9Y6E0; P08238; P06213; P12931; O00506; P23528; P35222; Q9UKE5; O75874; P04083; Q9Y5S2; Q9H2G2; P41743; P00558; P50552; P40189; P42685; P22694; P07900; P53396; Q05655; P15311; O00757; Q9Y3P8; P27448; P02671; P38606; Q8IYJ3; Q9NZA1; Q16543; P11166; P00736; P35749; O15162; P09958; P40926; Q9P0V3; O14818; Q96TA1; P04004; P08183; P29972; Q5T2W1; Q96T58; P62070; P60866; Q14344; P50995; P62280; P22314; P46108; P49773; Q8NCW5; P07910; P61224; P14672; Q92542; P01889; Q96PU5; Q15366; P62316; P09327; O00401; P35580; P55017; P04075; O95785; Q8N4C8; Q9P289; Q04917; P01009; Q01814; O14745; Q5QNW6; P52565; P35251; Q15819; P49411; O75351; P61457; Q9UKG1; P15941; P53675; P05388; Q9UGV2; P62979; P02786; P62993; P17844; O43865; O75631; P26038; P61106; Q9H1K0; P31323; Q13724; P02765; Q13563; Q15642; P32942; O43707; Q92598; Q8WZ42; Q03167; P13473; P38646; Q9NQ66; P61073; P04040; O00560; Q92597; P30041; P09382; P50502; P78543; Q08828; Q06481; P00338; P30626; P51674; P17858; Q02790; P53999; Q16658; P17342; O00299; P60174; O00204; P36871; Q14160; P04899; Q15019; P08473; P10809; P05556; Q15599; Q14254; A1KXE4; Q9BVK6; O14727; P33316; Q92692; P12830; P50570; P32929; P25685; Q6KC79; P07437; Q15149; P14625; P35241; P26010; Q13576; P42892; O15511; Q04760; P15391; P25445; Q13621; P05387; Q53SF7; Q8NC51; P60981; O60784; Q01082; P16150; Q86VP1; P23396; P16070; P18206; P62834; P11047; P00747; Q14151; O00443; P42702; P61020; P0CG47; P48023; Q15075; P05787; Q08999; Q5TAX3; O00592; P14543; Q9UMR2; P62195; P11216; Q07812; P05107; Q12923; Q12913; P53004; P12004; Q5TZA2; P56192; P55072; P98172; P40925; O43581; P40259; P09211; Q99497; P04156; Q8IVF5; P61160; Q04837; O60229; P46379; Q8WTV0; P19634; P41091; Q6UVK1; P26641; P18084; Q92673; P19338; P30044; P0DMV8; P58876; P51148; P02649; Q8TAA3; Q9Y6W5; Q13200; O75369; Q9Y450; Q9Y4I1; Q14624; Q9P227; P22087; P08133; P05062; P62826; P12277; P31939; P15090; P54198; P18669; P62913; Q9BW91; Q9H0H5; P55011; P09651; Q13813; P27348; P67870; P31947; P56537; Q6N069; P54578; Q96A49; Q9BXL7; O60716; Q6ZS17; O76054; P46782; O43490; Q13501; P14923; P41181; Q9NX63; Q9Y5Y9; Q16181; Q5XXA6; P11717; P49006; O60271; P00918; P51809; P33527; P62807; O14638; Q9BR76; P61764; P07741; Q9UBI6; O15143; Q86X29; Q12959; P37088; O75955; Q06830; P61981; Q8IUX7; P00441; P63267; Q71U36; P53801; Q8IWB6; Q9BV36; Q9UQB8; P68133; P62258; P43005; Q16342; P13688; O14773; P17931; O60500; P07195; P05067; P29966; P35232; P80108; Q9BZQ8; P62491; Q96SN8; P63244; Q9GZY6; P21291; O00571; P28799; Q01518; O75674; O00161; Q04695; P62820; Q86V48; P55064; Q6P1N0; P68431; P25788; P06396; P61158; O14737; P18827; P46939; P11940; P09417; P10301; P27824; Q15382; P20338; P00749; P21333; P22234; Q9BUL8; Q06265; O43598; O60701; P62805; P22392; P14866; P15529; Q15435; Q13291; P07954; P11142; Q13509; Q13439; P17405; Q13404; P16144; Q5VZK9; P22626; P30154; Q8N5C8; P78371; Q13765; P08727; P62745; Q16778; P46940; Q14697; P04406; P05023; P15531; Q96JG6; Q9H8S9; Q8N335; Q00169; P26599; P02730; P52566; P17655; P20339; Q9Y3E7; Q7L9L4; Q14204; P11234; Q9UJ70; Q9BV73; Q96FW1; P05091; P31949; P08758; P12268; P54819; Q14118; Q9UGM3; O00186; P48634; P52272; P48764; P31431; P13796; P06737; O43175; Q13614; P0C0S8; Q9Y6R1; Q9Y281; P47870; P06702; P30050; Q99879; Q9Y230; P30153; Q16531; P04179; P17661; P47756; P67809; Q96CW1; P54652; P61586; P52907; Q93079; Q06210; P29350; P60953; Q9Y3C5; Q15365; P30101; P13693; P35270; Q9UHR4; P98161; Q9Y496; Q7Z6Z7; Q99490; P13489; P11217; Q9UQ80; Q99877; P08729; Q92688; P07108; P37802; P61088; P62987; P25942; P29401; Q96H20; P21796; P11233; P60900; Q9UGM5; P05783; Q9H0M0; P63104; P30613; Q14980; P50895; P00450; P16152; P32119; Q15084; P08195; P46934; P51170; Q6UWW8; P41219; Q9UM54; P36955; P38159; Q8IZP0; P24752; P35579; P19021; Q96J02; Q9Y624; P31946; P01111; P50395; Q9UJU6; P17081; O60361; O14950; P21817; P63261; P06744; Q9UN36; Q8NFJ5; Q00610; Q9UKX3; O95433; Q9UKV8; Q13444; P12821; Q9Y265; P78324; Q6ZWJ1; Q09666; P51168; Q99538; P16949; O95398; P33241; Q86V81; P09758; Q71DI3; P10599; Q12929; P57721; P11021; P15924; Q99828; Q16555; P39019"]
["GO:0097451","cellular_component","glial limiting end-foot ","P05198"]
["GO:0016020","cellular_component","membrane ","P05198; P46937; P00533; Q9HC35; P08922; P13612; P46734; P50750; Q96J92; Q9H4A3; P08575; P51636; Q16584; P13639; Q92918; Q05513; Q13557; P78347; P37840; Q96KG9; P11413; P06748; P35240; P62753; P21359; Q9UEY8; Q99640; Q9Y243; Q01813; P09619; Q12852; P06493; P03372; Q15831; Q9NZJ5; Q9BSJ8; P21802; Q8WU20; Q15080; Q07912; P27708; Q8IVT5; P25098; Q99459; Q13418; P68104; Q7KZI7; P60709; P07355; P78527; P49327; P11274; P53667; P14635; P13861; Q14680; P16234; Q9Y2X7; P51610; Q03135; P09104; P07737; P63000; P08069; Q00535; P42345; P61978; P17612; P67775; Q7KZF4; Q96HC4; P06733; O94806; P49761; P00403; P33121; Q9Y6E0; P08238; P06213; P23528; P35222; P27986; P01100; Q8N3U4; P57078; P35813; Q04637; P13807; P33981; Q01970; Q13555; P00558; P40189; P29376; P07900; P53396; P19525; P15311; Q13470; P25205; Q13459; Q9UBB4; Q16891; Q08499; P46013; Q9Y618; P62917; P11166; P30405; Q02224; O15162; P09958; P40926; Q9NUU7; P08183; O75592; Q2NKX8; Q6PKG0; Q9NP97; Q53EZ4; Q99808; Q99661; O75150; P62070; P60866; Q14344; Q15717; P50995; P62280; P01130; P07910; P61224; P13010; Q8TEM1; P14672; Q92542; P01889; Q12904; O95071; Q15366; Q9Y4C1; Q8N684; Q15078; P55017; Q6ZMG9; P51114; Q8N5V2; P16671; P04075; Q9NVI1; Q9P289; P52789; O14745; Q9Y295; Q13393; Q9UP95; Q5T4S7; P55209; P49411; P49792; Q9NRA8; P53675; P11488; P05388; O15245; P62979; P02786; Q15700; P17844; P19622; Q96KC8; P47736; Q13425; Q9UIQ6; O43464; Q9Y210; Q13724; O75410; O60266; O75628; Q9Y4C8; Q9Y2H1; P13473; O60244; P04040; O00560; P30041; P43681; Q9UKV5; P42566; Q9UHI6; P04844; P17980; O60936; Q06481; P00338; P01116; P30626; Q15027; P51532; P17858; P11168; Q15154; Q8N3C0; O00299; Q13423; Q96D31; Q13370; Q12906; O43683; Q6UB35; P20700; P04899; O75400; P33992; P10809; P05556; Q9Y4W2; Q14254; Q9BQG0; Q9Y613; Q9Y4R8; P13498; Q8NF37; Q14839; P38919; P43003; Q9H1Y0; O15455; P14625; O60506; P26373; P26010; Q93070; P42892; Q9NPC1; Q13621; P05387; Q8NC51; O60784; Q14677; Q9UGH3; Q9Y2R4; P16150; Q9HCJ2; P23396; P12956; O00443; P61020; Q15003; P52757; Q96T60; Q15075; P48736; Q96RD7; Q8NF50; Q15311; Q9Y365; Q9UMR2; P62195; Q9NRF2; P11216; Q96D46; Q07812; P05107; Q9Y4G8; Q9BTU6; P56192; P50416; P26678; Q99439; Q92736; P84098; P61289; Q9UPT5; Q12802; Q15036; P11511; Q8IVF5; Q9NYG2; Q9NXR1; P10415; Q8IXH7; P61160; P46379; Q9NZS9; Q9UMS4; Q06787; P39748; O00303; P40692; Q13895; P26641; Q92673; P19338; P10070; O15355; Q9H4E7; Q96A54; P02649; Q99460; Q13200; Q9Y450; Q12789; Q9BTX1; Q15056; Q99418; Q9Y4I1; Q9BZR8; Q9NYZ3; O14578; Q8TAE6; Q92620; Q96F86; P22087; P08133; P62826; Q8IXI2; Q9HB09; P31939; P78536; O15259; P18669; P62913; Q9Y3E5; P55011; P09651; Q13813; P23743; Q92879; P27348; O43306; O43765; P21815; Q14573; Q9NQS1; Q9Y6Q2; Q9H0D6; P63027; P57740; Q9Y2U8; P51790; Q08462; P49795; O00562; Q6ZS17; P50542; P46782; P18850; P41181; Q15058; P11717; Q07820; P24390; P51809; P33527; Q13416; O95613; P43243; Q9GZR7; Q9ULM6; P78368; O75955; P36542; P61981; P53801; Q14203; P49768; P62258; P43005; P13688; P13591; P17931; P07195; P05067; P35232; P46778; Q9BZQ8; P14784; P52292; Q9BW19; Q92614; Q14643; P57737; Q14571; P20645; O75122; Q86V48; P40429; Q8WUM0; P46783; P36897; Q07866; Q6P1N0; P49810; Q92878; P68431; Q9H204; O60502; Q9UJY5; P17812; Q9Y285; P61158; Q8WWM7; Q02297; P46939; O60711; Q9UHY1; P11940; Q8IZL8; O00429; P27824; Q15382; Q96HE7; P21333; P49815; Q13319; O43868; Q92538; O75179; O00139; Q92556; P22234; Q12931; P62805; Q8WVB6; O75553; O75688; P14866; P11142; Q96JJ3; O60763; Q9BXM7; P62841; P22626; P23975; O75716; P30281; O60749; Q14C86; Q9P2I0; Q9Y520; Q14697; P43246; P30040; P10644; Q8WXD9; O00767; P04406; P05023; Q86XL3; P15531; Q96JG6; P23634; Q9P2E9; P26599; O43264; Q5T1M5; P52566; Q14739; Q9H0B6; Q15057; Q13352; O43815; Q8NE71; P09601; Q9H8Y8; Q14204; Q9NPI6; Q92841; P24385; P54619; P08758; Q08378; P43686; P12268; Q13303; P63167; P22307; P48634; Q14232; P52272; P48664; O14713; P40145; P31943; P30050; Q9Y283; Q9Y230; O94874; P30153; P38432; Q9UBF8; Q05940; Q15306; O95239; Q14185; P60880; O43823; Q8NEB9; P54652; Q9Y6G9; P28289; P09496; Q6P2Q9; P55957; O14986; P29350; P60953; Q15365; Q13155; P50402; Q3V6T2; O75056; Q7Z6Z7; Q99490; P14778; Q9UQ80; Q14527; Q9NRA0; O76090; Q6X4W1; Q07954; Q6Y7W6; O95267; P55039; Q93045; Q9NZN8; P48729; Q96AD5; Q16666; Q96H20; P21796; P09874; P63010; Q96S66; P07550; P33993; Q92574; Q7Z417; O75376; Q92945; P40337; P16662; Q15029; P33151; P42167; P43250; Q6ZUJ8; O14980; P09848; Q15648; P52732; P33991; P42575; O00148; P08195; P35998; Q9UJV9; Q9NZT2; P41219; Q07021; Q9UM54; P08567; P38159; P12259; Q00839; Q9Y233; Q07666; Q9P2D0; Q9UNF1; P35579; Q7Z3C6; P19021; Q96J02; P26196; P31946; O43597; P01111; P50395; O43852; P27815; Q07020; P63261; P06744; P22059; Q00610; Q9Y566; P61266; Q9UKV8; Q9H0S4; Q8TCJ2; P04843; O94776; O76021; Q9Y265; O00170; Q9NP80; P78324; Q9Y5N6; Q15172; Q04656; Q8IYI6; Q09666; Q8ND25; P07814; P33176; P16949; O14777; O95398; P33241; Q86V81; O00264; O15523; P55795; P16615; Q15773; P09758; Q9ULH0; O00231; Q92667; O14613; P11021; Q6IBW4; Q99828; Q9H3Z4; P39019; Q53GA4; Q9BPX3"]
["GO:0043614","cellular_component","multi-eIF complex ","P05198"]
["GO:0005844","cellular_component","polysome ","P05198; P08670; P23588; Q9P2K8; Q04637; P35580; Q9BRS8; P51114; Q9Y295; Q92904; P23396; Q06787; Q15056; P35637; P60900; Q96EZ8; Q9UKV8"]
["GO:0005840","cellular_component","ribosome ","P05198; P37840; P19525; P62280; P16333; P23396; P42677; Q8TAE8; P46783; P27824; Q15637; Q9P2E9; Q8NE71; O60678; P62987; P27695; P39019"]
["GO:0045202","cellular_component","synapse ","P05198; P00533; Q13554; P13639; Q05586; Q00987; P29475; P23443; Q9P286; P67775; P35222; P78352; P02671; O60941; P60866; Q9BY11; O43424; O14640; P49411; Q13425; Q14195; Q9C0H9; Q18PE1; P08473; Q8N8S7; Q9UH03; Q9BZB8; Q9Y4G8; P98172; P84098; Q9NXR1; Q06787; Q9P1A6; Q9Y6W5; P08172; P27348; P08173; P63027; P54578; Q92777; Q9Y2J0; O75581; P63165; P05067; Q9UQF2; P25788; Q9NYF0; O95295; Q7LDG7; O95185; Q96B97; Q96PU8; Q14103; P43686; P57796; Q09470; O00213; Q05639; P20309; Q8N0W4; O14490; Q6X4W1; Q8NE35; Q96PX8; Q86UL8; Q8N2Q7; P50395; Q9H492; P42898; O95886; P78348; O00264; Q9NRD5; Q66K74; Q12929"]
["GO:0044207","cellular_component","translation initiation ternary complex ","P05198"]
["GO:0005739","cellular_component","mitochondrion ","Q06124; P35557; P49840; Q15118; P10636; O00141; O00763; P31749; Q15303; Q15120; P14618; P53779; P37840; O14874; P27361; P17252; P00519; P02511; P06493; P45984; P21980; Q15831; P36507; Q15119; P45983; P07101; P19838; P29475; P23443; Q9UQM7; P53778; Q7KZI7; P21399; Q16654; Q13546; Q6NZI2; P28482; Q5S007; P04637; Q9P286; P06241; P17302; Q16539; P17612; P67775; P49841; P19419; Q12778; Q02750; P00403; P33121; P08238; Q92934; P12931; Q02156; P60484; O75874; P10398; Q16891; Q9C0C7; Q16836; P30405; Q7Z434; P56277; P40926; O00167; Q9H1K1; Q96EB6; Q9BXH1; O43521; Q9Y6H1; P22314; Q8NCW5; Q8NCD3; P41220; P12694; Q86VP3; P55084; P23560; Q04917; Q9GZY8; Q7Z5J4; P10515; P49411; P49792; P55211; Q8NE86; P14317; Q9BSQ5; P09622; Q5JTZ9; O43464; Q38SD2; Q15398; P04818; O75489; P38646; P04040; Q00059; O60936; P51649; P01116; P30626; Q02790; O15304; O00299; Q13423; Q15046; Q12906; Q18PE1; Q6UB35; O15287; P10809; O43542; P56962; P19438; P33316; O43572; Q9UK32; Q14186; P49789; P25445; P32248; P40305; Q9UII2; O95140; O43181; O15350; Q14849; P10109; Q9H0U6; P0CG47; Q7LG56; Q96T60; Q07812; Q8IWA4; Q9BTU6; P50416; P26678; Q01094; P40925; Q7L7V1; P09211; P15822; Q99497; O94763; P10415; O43236; P32418; Q04837; Q9NTG7; Q14790; Q9NRY6; P19634; P39748; O14925; Q16526; Q92665; P30044; P0DMV8; P54296; Q9NR28; Q08209; Q8IYB8; O95202; O95363; P08133; Q8IXI2; Q9BW91; Q9Y3E5; Q9NP81; P27348; P31947; O75460; Q8TAE8; Q9NX63; Q99798; Q07820; Q06609; P61764; Q9NQG6; P36542; P61981; P00441; Q12772; P50747; P18858; P49768; P62258; P00973; P57105; P35232; Q13114; P63244; Q16635; Q96BF6; P49916; P12235; P51398; P19367; O00429; Q07817; P32322; Q92538; P31415; Q12931; P21397; P07954; Q9BXM7; P99999; Q13625; Q9H4A6; P07203; Q9NPH5; Q99714; Q9GZQ8; Q9H0B6; O15446; P41970; P08559; P19404; P21953; Q9H773; O95168; Q16611; Q9H0E9; P63167; P22307; P36873; O60239; Q9P0J0; P30153; P04179; Q9ULZ3; Q9NV92; Q9HCU8; Q96C36; O43823; Q9Y572; Q9H244; P55957; P00367; P29803; Q99490; P18859; P51608; Q9BQ95; P31040; Q03393; P21796; P09874; P30048; Q16595; Q9Y2D0; Q9NQ50; Q8N726; Q9NZC7; P40337; P08253; P63104; O75143; Q9Y4E8; P27695; P42575; O94811; Q969Z0; Q07021; Q13526; P24752; Q8IXJ6; Q92731; P26196; P31946; Q01860; P56134; Q15842; O75616; Q9Y676; Q9Y2N7; Q13794; Q9H3D4; Q14654; Q05195; Q99623; Q9P013; Q9UMY1; Q09161; Q99689; P30419; O15294; O60260; Q9NRD5; Q96TC7; Q92667; P11021; Q8TCS8; Q9H3Z4"]
["GO:0032991","cellular_component","protein-containing complex ","Q06124; P36888; P00533; P04629; Q13422; Q16659; Q06413; P02686; P51636; P31749; Q05513; Q96B36; P35269; P06748; P27361; P01106; P00519; Q15796; P03372; P42224; Q15797; P37231; P38398; O75030; Q00987; Q9Y6Q9; P19793; P27708; Q8IVT5; P29475; Q13418; Q9UM73; Q16512; P60709; Q8WXI9; Q01201; P78527; P11274; P49336; Q6NZI2; P13861; Q16513; P16234; P31751; P28482; P51610; Q12824; Q03135; P04637; P43405; P84243; Q13905; Q13043; Q99683; P42858; O43353; P10275; P53041; P08238; P51955; P35222; Q9HC98; P04083; O43524; P41743; Q01970; P04150; P38936; O14757; Q13153; P07900; P35354; P15311; Q7Z6E9; Q15650; Q92769; O75150; P46108; P07910; P13010; O95071; Q13705; Q92904; P20749; P55211; Q92558; P81274; Q9BSQ5; Q8TAP6; Q15750; Q13425; Q96RU2; Q8TEW0; O43707; Q92598; Q13188; Q14498; P61073; Q01105; Q9UKV5; Q00059; Q8NHG8; P51532; Q02790; Q15154; P17342; Q96D31; P20823; P10809; O14559; Q96EP5; O14727; Q9Y294; P50570; P15923; Q14839; O43572; Q92974; P43351; P14625; P15391; Q01082; P18206; P12956; Q8IZD2; P0DP23; Q5D1E8; Q9NVP2; Q02962; Q8TAQ2; Q9UKX2; Q9Y4H2; Q96RD7; P18754; Q9Y4G8; Q15906; Q9BTU6; P55072; Q13112; Q14155; Q13547; Q01094; Q9P2Y5; Q92736; Q16665; P36956; Q15036; Q13136; P10415; Q15185; Q9ULB1; P45973; Q969G3; Q9NTG7; P39748; Q15276; P0DMV8; Q9BZS1; P50749; Q9Y5V3; P06746; Q9Y6W5; P62826; P54198; P62913; P52952; P27348; O60341; P18848; P11171; O43541; P50542; O95999; O15105; Q02363; Q9Y2J0; Q06609; P49321; P61764; Q9Y4K3; Q9NQS7; Q14494; P00441; P49768; P61296; P05067; P62491; Q9BXP5; Q9Y4P8; P31270; Q93009; P49810; P31948; Q53HL2; P68431; P49798; Q14694; Q9Y5B0; O43303; Q9UJY5; Q99967; P18827; P46939; O00429; Q9BXR0; P13569; Q13322; Q8IW35; O00255; P62805; Q12800; Q13404; O60749; Q15788; Q9BWW4; Q9Y2Z0; P31150; P51587; Q9UMX0; P10644; Q12834; P05023; P23634; Q9H0B6; Q13424; P40855; Q9BV73; P22307; P36873; Q15466; O94874; Q16531; O00213; O95983; Q93079; P29350; Q15596; P60953; Q7Z7A4; Q05516; P11388; Q6Y7W6; P35869; P61088; P09874; P30048; Q92574; Q8N726; Q86UL8; Q14980; O14980; P12755; Q96RK0; Q00839; P35579; Q8IX03; Q96J02; Q00610; Q969H0; O94776; Q99623; Q13111; P48436; Q92698; O15294; P16615; Q9ULH0; P11021; O95390"]
["GO:0005622","cellular_component","intracellular ","P15056; Q8WV28; P10636; Q13131; P02686; P51636; Q92918; P35228; Q96RR4; Q9Y243; Q05586; Q15797; O95382; Q04759; P29317; Q13224; P12814; P18433; Q9UM73; P25963; P30530; P05129; P21860; Q5S007; Q03135; P04637; Q9Y6K9; Q8NCB2; P06213; O15075; P35222; P08581; P29376; P42685; Q14012; Q9NWQ8; Q9UJY1; P01130; Q9P242; P61224; Q96PU5; Q92882; O43734; P16671; Q92904; P60983; Q15836; P61106; Q9UIQ6; Q6P2M8; P55042; O60869; Q99801; O43707; Q9Y3Z3; P09382; Q8N3C0; O15304; P17342; Q9NYY3; O15021; Q9H063; Q9Y4R8; O15455; P32248; O15198; Q99250; Q9UL54; P61020; Q9NPP4; Q9NQC3; P43220; Q8TB45; Q8NFA2; P48551; Q9NZM5; Q9NZJ9; P09211; Q14524; Q96N67; O43157; P14314; Q9Y6W5; Q9Y450; Q8WUA7; Q9H0L4; Q9BW91; P21673; P21462; Q9NQS1; Q9HBY8; Q08462; P50542; Q86TI0; P14416; P41208; P01589; O60500; P05067; P80108; Q96CG3; O43294; P36897; Q9UJX2; P10301; Q9UQE7; O00206; P11142; Q92915; O14958; Q14416; Q9GZQ8; Q8TD08; Q9Y3E7; Q13424; P11234; Q4KMP7; P24385; P08758; P16473; P32927; Q9Y5H0; Q9Y230; O60343; Q99259; P0DJD0; Q96NX5; Q9Y2H9; Q6ZN16; Q9Y5P4; P30556; P61601; Q8IZP0; Q9Y566; P23945; Q14957; Q9NP80; P16949; O95398; A6NKT7"]
["GO:0043231","cellular_component","intracellular membrane-bounded organelle ","P15056; Q13761; P07948; Q06413; Q15262; P35269; P52701; P09619; Q00532; P07949; O75886; P49715; P21802; P37231; Q01196; P35221; Q6NZI2; P31751; Q5S007; Q12824; Q05682; P08069; Q9NR20; O14964; P17302; P07333; P35568; O43781; Q14814; Q99558; O15111; P53041; P14859; Q9HC98; O14757; Q13887; P04004; O75592; P22670; Q99996; Q6P996; Q8NCW5; P14672; Q15078; Q96T51; Q6P1K2; P01009; Q01814; P32314; P20749; Q9UBK2; O15516; Q9NRA8; Q9BXF6; Q15836; P09497; P61106; Q9UEW8; Q9H1K0; Q15642; Q7L804; P04040; O00560; P35658; P42566; Q4V328; O15240; O00204; Q96P48; Q16873; Q9H063; Q9GZV1; Q9H2B2; P14679; Q9BQG0; Q13330; O00327; Q14449; Q14677; P46527; O15350; Q14151; P61020; O00592; Q9UIK4; Q8TEH3; P55072; Q9NZM5; Q15036; P04156; Q8IVT2; P46379; O43315; Q8WTV0; Q9BWU0; Q15276; Q13895; P30044; P14314; P08684; Q13813; P63027; Q9BTP7; Q13501; Q8TAP9; P51809; Q15853; O94901; Q12772; P18858; P80108; P62491; P21453; Q9NZI5; P36897; Q14686; P98082; Q9Y5B0; Q7Z3T8; Q9UJY5; O00429; Q96HE7; P20338; Q15047; Q641Q2; P53539; O75553; Q99708; O95477; Q86V15; Q13439; Q9H4A6; Q14697; P04406; P23634; Q9UPN4; Q01954; Q6WKZ4; Q9Y5X2; P22307; Q13614; Q8TDY4; P67809; Q86WP2; Q9NV92; O60671; O15266; P20815; Q96SU4; Q9BVW5; P52948; Q9NRA0; Q92837; P55039; Q14247; Q99856; P25942; Q969S2; Q96S66; P32121; P16662; Q92785; O75154; Q53GL7; O14980; Q96RK0; P46060; Q9NR19; Q7Z3C6; Q14966; Q96J02; P05549; Q6P1M3; Q8NFJ5; Q00610; Q9UKX7; Q9HB90; Q01955; O43255; Q9NUW8; Q96S94; O95208; O95390"]
["GO:0005886","cellular_component","plasma membrane ","P15056; O14936; Q8WV28; P36888; O75116; P00533; P49585; P08922; Q13554; P13612; Q05193; P42336; P62140; P04629; P51617; P62136; Q16620; P40238; P10636; Q6VAB6; O00141; P07948; P06239; P02686; Q12879; Q13873; P08575; P51636; P22455; P31749; Q15303; Q01974; P13639; Q15262; P24723; O15530; Q05513; Q13557; Q16288; P54760; P17948; P53779; Q9Y3S1; P37840; P51813; P04792; P08631; P27361; P23467; P35240; P17252; Q9UEY8; P08670; Q13882; Q9H2K8; P29353; P25054; P09619; Q12852; P11362; P03372; P11309; P07949; O60674; O94921; P16284; Q13177; P22681; Q05586; Q9BSJ8; P09769; Q9P212; P21802; Q8WU20; P04626; P38398; P48730; Q04759; P22607; Q05397; P01112; Q07912; Q00987; P29317; Q13224; Q06187; P35916; P42680; P25098; P29323; P35221; P12814; P18433; P29475; Q13418; P10586; Q9UM73; P40763; P34947; P68104; Q9UQM7; Q7KZI7; P25963; P60709; Q15139; P19174; P16885; P07355; P43403; P49327; P35968; Q9BZL6; Q09013; P05106; P30530; O15357; Q6NZI2; P13861; P49407; Q7L591; P05129; Q16513; Q00536; Q14680; P21860; P16234; P18615; P10721; P41240; P31751; P54762; P28482; Q5S007; P51178; Q9NWZ3; P84022; Q03135; Q92835; P09104; P63000; P17706; P05771; Q05682; P08069; P43405; O94804; O75914; Q08345; Q00535; P06241; P52630; Q16832; Q12866; P17302; Q14511; P07333; P67775; P49841; P07947; P35568; Q9P0L2; P10275; O43318; P54753; Q02750; P06733; Q8NCB2; P29320; P53041; P29474; P33121; Q04912; P06213; P52799; Q13976; P12931; Q02156; P04049; Q96RT1; P35222; P68400; P42261; P08581; P60484; P27986; Q13464; P35813; Q96SB4; P54764; P04083; Q9Y5S2; P15498; P41743; Q9NZV8; P52333; Q13555; P49023; P50552; Q02763; P40189; P29376; P28827; P22694; Q13153; P07900; P53396; Q05655; P21709; O14512; P15311; O00757; Q9Y3P8; P27448; P78352; Q9UBB4; O00501; P02671; Q08499; P38606; Q8IUW5; Q8IYJ3; O15492; P36544; P16871; P41180; P48167; Q29RF7; P11166; Q9NWQ8; O15162; P09958; Q9NYQ6; O14746; Q5SW79; Q96TA1; P28223; Q13158; Q13642; P08183; P08138; O95069; Q53EZ4; Q99808; P29972; P43119; Q5T2W1; P62070; Q14344; Q16760; P01130; Q13002; P49757; Q00975; P46108; P49773; P14598; P61224; P13010; P14672; Q92542; P01889; Q9H5V8; Q9UKV3; Q16790; Q9BY11; P28472; P41220; P09327; Q15078; O00401; O43424; O14939; Q70E73; Q86WV1; P55017; O43525; P55010; Q12791; P46020; Q99767; P16671; P18507; Q8N6F7; Q13705; Q9NS28; Q04917; Q14005; Q01814; Q15464; Q13393; Q9UP95; Q5T4S7; Q6PIL6; Q7Z2W7; Q8TCZ2; P20749; P09693; P15941; O15554; Q9HC77; Q13671; P07766; P11488; O15245; P14317; Q86YS7; P34998; P62979; Q03431; P02786; Q9UDY4; P62993; Q15836; Q15700; Q99062; P09497; O95817; P41143; Q96II8; P48544; Q96KC8; P41146; P26038; P31995; O60346; P61106; Q9H1K0; Q9UIQ6; Q8TEW0; Q9Y210; P31323; P30411; P55042; Q92913; Q96LC7; Q13563; O60266; P25092; P53365; Q9BX66; O43566; Q9P2S2; P21554; Q16625; P32942; Q9Y3Z3; Q32MZ4; Q8TCU6; P13473; Q8NC24; O43739; P61073; Q7L804; P04040; O00560; Q92597; P43681; P42566; Q9H9L4; Q08828; Q9UGP4; Q06481; Q9NS61; Q8NHG8; P01116; Q07001; P52735; P51674; P11168; P29973; Q08495; Q9UHC3; O00299; P48065; Q15046; Q96D31; P51681; Q16623; Q18PE1; Q96P48; Q9NPQ8; Q15111; P19086; Q14160; P04899; O15287; Q96P88; P08473; P10809; P05556; Q9BSF0; Q9H063; P32241; Q9BR39; Q7L0J3; P48426; Q15599; Q14254; Q9H2B2; O14559; Q96BF3; Q9H2X9; O14522; P56962; P16333; A1KXE4; P19438; Q9NQA5; Q9UMD9; Q01113; O75916; Q92692; P13498; P28906; Q8N8S7; Q92529; P12830; Q8NF37; P50570; Q9HBA0; Q8WYL5; P28222; O43572; P35611; P29322; Q5T7P8; O95471; P43003; Q99650; Q15149; O00168; Q9H3Q1; Q99624; P16066; Q01844; P14625; P35241; P26010; Q14449; Q13576; Q93070; Q13574; P42892; Q04760; Q9NYJ8; P15391; P49789; P25445; P32248; Q9NPC1; Q8ND76; P55196; P35462; Q13621; P31641; Q8NC51; O60784; Q9UGH3; P16150; P19022; P23396; Q15762; P16070; P18206; P62834; Q8IZD2; P0DP23; Q15768; P00747; O00443; Q96J84; P42702; P61020; P0CG47; Q9NQC3; P48023; Q15746; P49619; Q9Y4H2; Q9Y4D2; P48736; Q96RD7; Q5VWQ8; P48048; P43220; O00592; P56817; P48549; P05107; P38484; Q01362; P20963; O75386; Q96LC9; Q12923; Q9Y6I3; Q9H400; Q12913; Q96F46; Q9Y4G8; O60706; Q14721; Q8NFA2; P22459; Q5TZA2; P98172; P48551; Q14155; P21579; Q93052; Q15256; Q9H310; O43581; P40259; Q92736; P25189; Q13191; Q9UPT5; O75563; P09211; P41597; Q99497; Q01959; P04156; Q13107; Q8IVT2; Q9ULB1; Q9UI40; P32418; P17301; Q14524; P20138; Q02952; Q9UH65; Q9UKW4; O43315; Q86SQ0; Q8WTV0; Q9NRY6; P19634; O43157; Q8TDM6; Q02153; Q9BX84; Q9BWU0; P08588; P18084; P35626; Q02108; Q5UIP0; Q9H4E7; P39086; Q96A54; Q9UBS5; P50749; Q9Y5V3; Q9P1A6; Q8NF99; P51148; P02649; Q13586; Q9UKL4; O75369; O95425; P32245; Q9BTX1; Q99418; Q14500; P41594; P08172; Q5T5C0; Q9BV57; O14921; Q8TCG1; Q9HCX4; Q14624; Q9ULK5; P32004; Q9NYA1; Q8IXI2; O43526; P31939; P20648; P78536; Q9Y698; P57789; P55011; P58400; Q92797; Q9UNQ0; P22001; Q13507; Q9BUZ4; P23743; Q9Y3Q4; O43306; O14654; P54252; P21462; P67870; O43914; Q14573; P08173; Q92952; P11912; P63027; O14492; P54578; Q92777; Q96RD6; P50052; P30679; P41161; Q9NZI2; P11171; P51790; Q9BXL7; O60716; Q08462; Q9Y272; Q9UN19; Q14512; O95810; Q92888; Q9UBL9; Q9UGK3; O43490; P14923; P41181; P18505; Q13936; P10912; Q01628; O15105; P27816; P42338; P10646; Q5XXA6; P11717; Q9Y2J0; P49006; P00918; Q13255; O95278; P51809; P33527; P30273; Q9BR76; Q16236; P61764; Q9Y4K3; Q96T49; Q9UBI6; Q96MS0; P53355; Q86X29; Q8TDQ1; Q12959; Q9UHB6; P37088; O75955; P37173; P63146; Q9UQB8; P14416; P49768; P17677; O75581; P43005; P01589; P13688; P13591; P17931; Q6PIZ9; O60500; O15379; P63165; P05067; Q9UQF2; P16389; P29966; Q93100; P35232; Q9BZQ8; P17181; Q9GZY6; O43164; P35368; Q9UK80; P14784; Q8TD43; Q7Z5P9; P21453; Q8N6H7; Q68EM7; Q14643; P26045; Q01668; Q14571; Q01518; P41145; P54105; Q9UKY7; O00161; P20645; O75122; Q6IE81; O75899; Q8WWN8; Q9Y666; Q96D96; P30301; Q86UR5; P36897; P55064; Q6P1N0; P49810; Q96D71; Q86WV6; P98082; O14493; O43497; Q99962; Q9UNZ2; P49798; P46459; Q96SB3; Q15438; P10747; P01375; P06396; Q96P31; Q9UPX8; P78552; P18827; Q7LDG7; P46939; O60711; Q6UUV9; P10301; P22460; Q9UQD0; Q12955; P20338; P00749; P21333; P13569; Q8N4X5; Q96NW7; Q15047; Q13319; Q7L0Q8; O95185; O43868; Q13322; Q00341; Q92556; Q9BUL8; Q641Q2; P35367; Q9Y2W7; O94827; Q8NET8; P15036; A8K4G0; O95477; P15529; O00206; Q6P0Q8; P34981; P51787; Q15669; Q13009; P23469; Q13291; P21730; P11142; O43184; P17405; Q8N9I0; Q9H4A6; O75022; Q9UKA4; P16144; Q96B97; Q8IV01; Q5VZK9; P23975; Q8N5C8; P12318; Q13569; Q15788; O95361; Q7Z418; P08727; P62745; Q9Y6N7; O95180; P46821; P46940; Q13415; P31994; Q9NPC2; Q9H4M7; Q9UMX0; Q9BY41; Q96S59; Q9NRD9; Q14416; Q14315; P04406; Q07157; P05023; Q12809; P23634; Q99714; Q9Y2T1; Q8N335; O75379; P02730; P30533; Q8WX93; Q70Z35; Q9NRY4; Q9H0B6; P08913; P17655; P20339; Q13651; O60602; Q9Y3E7; P46531; O15197; Q8NER1; P11234; O15539; O75096; P19784; Q4KMP7; P06127; Q07889; Q9UPN3; Q13303; O43561; Q14118; O00186; P63167; O60610; P16473; P32927; P48634; Q13972; P34741; Q14232; P48764; P31431; P13796; P48664; P37023; Q13017; Q99523; P21854; O14713; Q14831; Q9Y6R1; P16471; Q8IV61; P21728; Q09470; Q96KG7; P47870; P40145; P06702; Q9NQX3; P49802; Q05940; Q86XR7; Q99719; Q8IVF2; P48058; Q86WP2; P07510; P49685; Q16478; P60880; P29374; O00213; Q96CW1; Q9Y572; P20309; Q99259; Q9UK17; Q9Y6G9; Q9H244; P61586; Q15722; P09496; Q92681; P60953; Q9H910; Q9UHR4; P13726; O94759; Q6J4K2; Q3V6T2; Q8NFD5; Q8N0W4; Q14832; P98161; Q96NX5; O75056; P14778; Q9P2M7; Q7Z7A4; P01730; O14490; Q05516; O76090; P24394; Q9Y2H9; Q07954; Q96QT4; Q9H1D0; Q03721; Q13261; O14827; O95267; Q14247; Q5H9R7; P21731; Q9NZN8; Q9GZU1; Q9Y6Y9; Q5T5U3; Q96AD5; P62987; P25942; Q96H20; P20333; O43665; Q96PX8; P21796; Q9ULC4; P11233; Q96AX2; P63010; P07550; P42262; Q92574; P58753; Q9H0M0; P32121; P48050; Q86UL8; O75689; Q5VZ89; Q9BPZ7; P08253; O75762; Q00587; P33151; P78356; Q9UQC2; P43250; Q6ZUJ8; P14867; P50895; P30518; P09848; Q9NPY3; Q9H2S1; O00329; Q15084; P16410; P36894; Q02641; P08195; P30556; P46934; Q9Y5S1; P51170; P43121; P43146; O43150; Q07021; Q9UM54; P15260; Q9UDY2; O94768; Q8IUQ4; P12259; P30874; Q8N2Q7; Q14451; Q14940; P36383; Q8IXJ6; Q96IF1; P35579; Q03113; P34972; P19021; Q9NR22; O14649; Q96J02; P13224; Q9Y624; Q15654; O43597; P01111; P15382; Q6P1M3; P36896; P31645; P27815; Q9UJU6; O43613; P17081; Q8NB16; P21817; P63261; P06744; Q15842; P18545; P63252; Q9UHW9; Q8NFJ5; Q00610; Q9Y566; Q15334; P23945; Q9Y2N7; P61266; P78508; Q9H257; O95886; O15056; Q13444; Q684P5; P12821; Q8TCT0; Q8NFH5; Q14957; Q14654; P78324; Q5NUL3; P08100; P50281; Q04656; Q8IYI6; Q09666; Q15109; P51168; P07814; Q9ULV8; Q7Z628; O95398; Q99689; P33241; P30419; P01892; Q8NCT1; P78348; O00264; O15294; Q9UL51; Q08289; Q13698; Q16572; Q9NRD5; Q9BRC7; Q969H4; Q9NPI9; Q9NPB6; O75534; O15117; Q9NUW8; O14613; P11021; P15924; Q99828; Q16555; Q9H3Z4; P22413; P55087; Q7LC44; Q9Y5I7; P35372; P43629"]
["GO:0071148","cellular_component","TEAD--YAP complex ","P46937; P28347"]
["GO:0071149","cellular_component","TEAD-2-YAP complex ","P46937"]
["GO:0001650","cellular_component","fibrillar center ","P54274; P11474; Q16566; Q9NQU5; O60285; Q9NYV4; P17480; Q13085; Q9UPZ9; Q14978; Q12824; Q99558; O00221; P15311; O43660; Q86UE4; O60832; P19622; Q9UK32; P49789; Q13428; Q9NZM5; P61218; Q8WXF1; P11387; P22087; Q9BY66; Q03111; P55317; O15105; Q9UHH9; Q9H9Q4; P63165; Q6P1N0; P98082; Q15327; Q9P0K7; O60763; P29692; O15446; Q9H410; P38432; O43148; Q8WVC0; P61088; Q9Y2T7; Q9Y5N6; Q15109; Q15329"]
["GO:0016604","cellular_component","nuclear body ","P54274; Q01826; Q13882; Q9H2X6; P00519; P15172; Q9HBH9; Q12888; P49407; Q16513; P18615; Q13043; P38936; P43694; Q9HAN9; Q9H7L9; Q15650; O75469; P46013; Q9Y618; Q6NZY4; Q99502; Q86UE4; O95271; Q03188; Q14863; Q70E73; Q15554; Q9NWH9; Q9Y295; Q8WW12; Q9NWV8; P09629; Q9NX46; Q96RU2; Q6T4R5; P27540; O43566; O43707; O75489; Q8N1G1; Q99590; Q9Y4R8; Q9P1Z0; P35611; P25445; Q9UBU7; Q9BXW9; Q14151; Q15022; P43364; O43918; Q9UBT6; Q8IX01; P12004; P10828; Q16665; P15822; Q13573; O00257; Q5UIP0; Q9UER7; Q9H9A7; Q92793; P35226; Q8IYU2; Q9UIG0; P15927; Q9H422; Q14562; O43541; O14641; Q9P0W2; Q9NQS7; Q15633; Q9H3P2; P63165; Q562F6; Q99958; Q93009; Q96BF6; Q9NYB0; O95551; Q9BSI4; Q6UUV9; O00139; Q9NS91; Q86Y01; Q15637; Q9H816; Q9H410; Q99607; O60239; O14713; P38432; Q9H840; Q14676; O95644; Q15596; P49760; Q8NG31; P52948; Q9GZV5; Q05516; P29401; Q9H211; Q7Z417; Q96IT1; P51449; Q9BUR4; Q8N9N5; P12755; P20393; Q96AP0; Q00403; Q92547; P23497; Q96RL1; Q0VD86; Q96QC0; P33240; Q6UWZ7; O95409; Q9C0C9; Q01543"]
["GO:0000784","cellular_component","nuclear chromosome, telomeric region ","P54274; P33778; O60934; P06493; P29590; P78527; Q12888; P84243; P49736; P25205; O14746; Q9UBB9; O95271; P13010; Q15554; P33992; O43542; P12956; P12004; P27694; P45973; P49959; P39748; P83916; Q9BQ15; P15927; O60341; Q06609; Q13416; Q92900; Q96BK5; Q9NYB0; Q92878; Q9BSI4; O00255; P62805; Q13415; P51587; P43246; Q9H816; P49917; Q6P1J9; Q16531; O43929; Q96AH0; P18887; P09874; P33993; P27695; P33991; Q96AP0; Q9UH99; P05455; P23497; Q96SD1; Q13185"]
["GO:0000783","cellular_component","nuclear telomere cap complex ","P54274; O14746; P13010; Q15554; P12956; Q9NYB0; Q9BSI4; Q96AP0"]
["GO:0005730","cellular_component","nucleolus ","P54274; O14936; P41212; Q15118; Q13761; P62140; P62136; Q9H4B4; P11802; Q15120; P06748; P35240; P62753; P21359; O60934; Q99640; P01106; P00519; P19544; Q96ST3; P11362; P11309; P42224; P17480; P49715; P78362; P29590; Q00987; O00444; P68104; P78527; P30291; Q14978; P49336; Q12824; P04637; Q08945; Q9Y6E0; P51955; Q13315; P38936; P30279; Q13242; Q7Z6E9; P46013; P11137; Q15291; O15162; Q9NUU7; O14746; Q9NQZ2; Q9UBB9; Q8WV24; Q96EB6; Q8ND90; P62280; Q9BRP8; Q8NF91; Q8NCD3; P13010; Q9UKV3; Q96PM9; Q16790; P41220; P51114; Q53HV7; Q14684; P35251; O60832; Q14493; O15055; Q9UPP1; P62979; P62993; P17844; P19622; P54132; Q9Y3Y2; Q92913; O60869; Q9Y5J1; Q8NBZ0; P04818; Q9Y4C8; Q9Y5Q9; P38646; O60315; P48552; Q9UHI6; O60936; O60673; Q2NL82; P51532; P53999; Q8NG66; P53804; Q12906; O15287; Q99590; Q9H063; Q9Y4W2; Q9BQG0; P25685; P38919; Q9UK32; Q99986; Q01844; P26373; Q99547; Q01082; Q9Y2R4; P23396; Q9BXW9; P12956; Q9UL54; O75081; Q13243; Q9Y6D6; Q02962; Q15022; Q13428; Q96T60; Q08999; Q5TAX3; O00592; Q9UMR2; Q96Q89; Q96D46; Q9BXS6; O43818; O75386; Q9Y237; Q9P2D1; Q14240; P56192; Q13829; Q9Y3T9; Q9NZM5; Q9ULB1; Q96PK6; Q969S3; Q8N9T8; P98179; P45973; Q6PJT7; Q9NQI0; Q9UHL0; Q06787; P39748; Q03468; Q13895; Q92665; P19338; P10070; Q9UIF9; Q8NF99; Q53H47; Q9UER7; Q9BSJ6; Q12789; P11387; Q9H9S0; Q9NZJ0; P22087; Q9UL40; P62826; P04198; Q9H6E5; P62913; P54252; Q14573; Q9H0D6; P56537; P42338; Q06609; Q9BWF3; Q9BVI4; P50219; Q9BU19; Q9GZR7; Q9H6F5; O95751; Q9UKD2; P78337; Q96BK5; P63165; O00571; Q9HB65; Q14643; Q96JP5; P49790; Q96BF6; P40429; P46783; Q53HL2; P54253; O96004; Q9H1E3; O95551; Q9H4X1; Q5JTH9; O75943; Q8IZL8; O95453; P21333; O00139; Q9H2G4; Q06265; Q641Q2; Q9NY61; O75688; P11142; O94805; Q9UKA4; Q9NQT5; Q15024; Q8NI36; Q9NPH5; Q13415; Q96LA8; O00767; Q9H8S9; P26599; P09601; Q7L9L4; O15446; P08559; Q92841; Q08378; Q9UBP6; Q8N4N8; P52272; Q9H410; P36873; O00566; P29375; Q92794; P38432; O95707; Q99848; Q9ULZ3; Q9NYV6; Q9HCU8; P46087; O43823; O75151; Q92993; P29350; P29803; Q8N720; Q99490; O43929; Q9UQ80; Q14527; Q9BYG3; P31040; P11388; P18887; Q96RS0; Q16666; Q9Y2Y1; P09874; Q13309; Q8WYQ5; P05783; Q8N726; Q5JVS0; Q9BVJ6; Q53GL7; O14980; Q15648; P49711; P27695; Q96EZ8; O00148; Q9UJV9; Q7Z2E3; Q07021; Q9NRR4; Q9UNF1; Q8IXJ6; Q14191; A0AVK6; P26196; Q06330; P23497; Q08J23; Q07020; Q9NQT4; Q8NFJ5; P22059; Q9H0S4; Q969H0; O76021; Q9BW71; P19878; Q9UMY1; O15523; Q15329; Q66K74; P39019; Q5VTR2"]
["GO:0070187","cellular_component","shelterin complex ","P54274; Q15554; Q9NYB0; Q9BSI4; Q96AP0"]
["GO:0005819","cellular_component","spindle ","P54274; Q9UQB9; P31749; Q13163; P04792; P06400; O14965; Q96GD4; P48730; O43663; P53350; Q14511; P33981; P04150; Q9ULW0; Q13042; Q5SW79; P50995; Q9UKT4; P53675; O43566; Q15019; Q92974; Q99986; Q9Y237; Q9GZM8; Q9NQC7; Q96JM3; Q9UMS4; P83916; Q8TF76; O15392; Q16181; Q9NQS7; O95235; Q14203; Q96BK5; Q8IYM1; Q9BW19; Q14194; Q9Y5B0; Q9Y6D9; Q12834; Q8NEM2; Q9Y283; P30260; Q7Z4H7; P09496; O75449; Q14980; P52732; Q8IXJ6; P35579; Q08J23; Q13185; Q00610; P61266; Q3KQU3; Q66K74; Q02241"]
["GO:0015629","cellular_component","actin cytoskeleton ","O14936; P17948; P37840; P00519; P10276; Q12792; P09769; Q9H792; P35221; Q13085; P60709; P42768; Q05682; O14974; Q16832; P42684; Q96HC4; P50552; P15311; Q13459; Q9NZA1; P46108; P07910; Q14863; O00401; P04075; O14745; Q92558; Q7L2Z9; Q9Y2H1; Q9H9L4; Q9C0H9; Q08495; Q16658; P36871; O95786; O14559; P56945; P12830; Q9H3Q1; Q13576; O15511; P60981; Q9UL54; Q15746; Q5TZA2; Q9NQW6; P61160; O60229; O43312; Q9Y6W5; O75369; O95425; Q9BTX1; P78536; O43516; O95810; P14923; P53355; O15143; Q9UHB6; P68133; Q9ULV4; P29966; Q8N556; Q9H2D6; P06396; P61158; P21333; Q9P2B4; Q8WX93; Q9NRY4; P20339; O94875; P13796; Q9Y281; P47756; P52907; Q5T5U3; O94768; Q9UHD8; Q92547; P35579; P09493; Q09666; P33241; Q15417; Q16643; O15117; P49418; Q7LC44"]
["GO:0005604","cellular_component","basement membrane ","O14936; P07355; Q96RT1; P04004; Q8NC24; Q76M96; Q9UMD9; P11047; P14543; Q9UQE7; Q14118; P36955; Q01955"]
["GO:0005911","cellular_component","cell-cell junction ","O14936; Q5VT25; P31749; Q15262; P24723; Q05513; Q9UEY8; Q12792; P36507; P35221; P12814; Q13418; P19174; P43403; P42768; P05129; Q08881; P10721; P41240; Q9Y2I7; P23528; P35222; P27986; Q9Y5S2; P15498; Q02763; P28827; Q13153; Q05655; O00501; P61224; Q13094; Q86WV1; P07766; P62993; Q8TEW0; Q13563; Q16625; O43707; Q8N1K5; Q9UGP4; P11168; Q16658; Q14160; Q7L0J3; P16333; Q9UMD9; Q92692; P55196; P19022; P18206; Q96J84; Q9UKX2; P05787; Q12913; Q9Y4G8; Q99439; Q9Y6W5; Q9ULK5; O15259; O60716; P14923; Q12959; O75955; Q9H8V3; P13688; P05067; P61158; P21333; O94827; Q13009; Q96B97; Q8TD08; O43561; P29350; P60953; P33151; Q96IF1; Q9Y624; P08100; Q969H4"]
["GO:0060170","cellular_component","ciliary membrane ","O14936; P09497; Q13563; P42566; Q15019; Q9BYB0; P37088; P14416; Q9UPX8; P21728; P98161; P08100"]
["GO:0005925","cellular_component","focal adhesion ","O14936; O96013; P00533; P13612; P62140; P08575; P51636; O15530; P17948; P04792; P08631; P06748; P27361; P08670; P09619; P21980; Q12792; O60674; P22681; P36507; Q9Y490; Q9H792; Q05397; P29317; Q86YV5; P35221; P12814; Q13418; Q14289; P60709; P17096; P53667; P05106; P13861; Q9Y2X7; O95819; P28482; Q03135; P07737; P63000; P07332; O14974; Q16832; P17302; Q14511; P61978; P07947; Q02750; P52799; P23528; P35222; P04083; P23458; P49023; P50552; Q02763; Q05209; Q13153; P15311; P62917; Q13045; Q13642; P62070; Q14344; P62280; P49757; Q155Q3; Q92542; Q15366; Q96AC1; Q8TCZ2; Q92558; P05388; Q13425; P26038; Q6T4R5; Q9BX66; O43707; P38646; P04040; O00560; P35658; Q9UGP4; P01116; P08473; P05556; Q15599; Q14254; Q7Z5H3; Q92692; P13498; Q8N8S7; P56945; P50570; Q9HBA0; P35611; Q15149; Q92974; P14625; P35241; Q2M1Z3; O60504; O15511; P05387; P19022; P23396; P16070; P18206; Q96QB1; O60331; Q14155; Q99439; Q93052; P84098; Q13136; Q8IVT2; P61160; P17301; Q96N67; Q02952; P19634; Q6UVK1; P18084; P0DMV8; Q15124; Q15555; O75369; O95425; P08133; P32004; Q15942; P27348; P46782; P14923; O95297; Q8N264; P11717; Q9BR76; O15143; P17813; Q9UHB6; O75955; P61981; Q15691; P62258; Q9UNA1; Q9ULV4; P29966; P21291; O43294; P61587; Q01518; O00161; P40429; Q14192; P46783; Q8N556; Q14161; P98082; Q9H2D6; Q9Y483; P06396; P61158; O60711; P11940; P10301; P00749; P21333; Q7L0Q8; P15529; P11142; P62841; Q96B97; P62745; Q13283; Q9NPH5; P46940; Q14315; Q8WX93; P17655; P08758; Q14118; O94875; P36873; P31431; P13796; Q8TDY4; P30050; Q14847; Q14676; P61586; P60953; P30101; P51911; Q07954; O00151; Q14247; P11233; P14316; Q00587; P63104; Q8WWI1; P43121; Q14451; Q96IF1; P35579; Q03113; P31946; Q15654; P50395; Q07020; P63261; Q00610; P50281; Q09666; Q15417; Q68CZ2; Q02241; P11021; P39019; P35372"]
["GO:0005652","cellular_component","nuclear lamina ","O14936; P02545; P50747; P61266; Q8NFH5"]
["GO:0016363","cellular_component","nuclear matrix ","O14936; Q01826; Q14683; Q05513; Q9Y6K1; P08670; O60674; P10242; P29590; P27708; P09917; P04637; P23528; Q8N3U4; Q96SB4; Q05655; Q9Y618; P54132; Q8IYB3; Q9BX66; Q9H4L7; P20700; O75400; Q9P0U4; P17676; Q9Y6D6; P05787; Q96FV9; Q96KR7; Q13573; P54259; Q06455; Q8WXF1; Q96T88; P54252; P67870; P43243; P48678; P50747; O43294; P54253; Q9BSI4; O00255; Q9UQE7; P22626; Q8N2W9; P52272; Q9Y281; P23246; Q9Y230; O95239; O43823; Q9UIS9; Q6X4W1; P60900; Q14980; Q00839; P25490; Q9Y265; Q99623"]
["GO:0042734","cellular_component","presynaptic membrane ","O14936; P15407; Q12879; Q9UQM7; Q96CX2; Q13002; Q8NHG8; Q8TEH3; Q9BTU6; P21579; Q9ULB1; Q9Y6H5; Q06787; Q9UBS5; P41594; P58400; Q96A49; Q13255; O15083; Q86UR5; Q14416; Q14831; Q09470; P60880; O00213; Q9NRD5"]
["GO:0097440","cellular_component","apical dendrite ","P49840; Q14289; Q9UBK2; P21333; P46821; Q6X4W1; Q8NE35"]
["GO:0030877","cellular_component","beta-catenin destruction complex ","P49840; P25054; P49841; P35222; Q9Y2T1; P48729; O15169; Q8IUQ4"]
["GO:0043025","cellular_component","neuronal cell body ","P49840; Q8IWU2; P13612; P04629; P40238; P10636; Q13131; P02686; Q13873; Q01974; Q9H4B4; Q15262; P78347; P54646; P37840; P00519; P10276; P07949; P27708; P29323; Q13418; P10586; Q14289; P51610; Q5S007; Q00535; P42345; P19419; P08238; P42261; P40189; P07900; Q9UBB4; P11137; P41180; Q9H814; P28223; Q9Y5S9; O95069; Q99996; Q00975; P14598; Q9ULJ8; Q96PM9; Q15078; O14640; Q9UBK2; O15554; Q13671; P11488; Q8TEW0; P31323; P32298; P43681; Q9UKV5; P49675; Q9C0H9; P51674; Q02790; Q7L0J3; Q9H2B2; Q9H2X9; O14810; P05093; P13498; P25685; P38919; P43003; Q92974; P0CG47; Q9NQC3; Q5VWQ8; Q8TEH3; Q9Y4G8; Q9UD71; Q9BTU6; Q14155; Q13547; O43581; P41597; Q01959; Q9ULB1; Q9Y6H5; Q9C0D5; P02649; P78559; P08172; Q9Y4I1; O14578; P32004; P12277; Q9NSB8; P58400; Q14573; Q92952; P50553; Q9UBL9; Q5XUX0; P00441; Q14203; Q9UQB8; P49768; O75581; P63244; P54750; Q8TD43; Q07866; P49810; Q99962; Q9UPX8; Q6UUV9; P27824; P21333; O75553; Q13009; P46821; P31150; Q92686; O43815; P20339; Q8NER1; O75096; Q8N122; Q07889; P37023; Q99523; Q09470; Q9H2P0; P48058; O00213; Q05639; P60953; Q07954; Q9UL17; Q93045; P25942; P20333; O43665; Q14980; Q9H2S1; P36894; P63252; A0A024R539; Q14654; Q04323; O43255; Q04656; Q6PUV4; Q99689; O60282; O00264; Q15417; Q66K74; Q99828; Q7LC44"]
["GO:0098794","cellular_component","postsynapse ","P49840; Q06413; Q16566; P31749; P37840; P00519; O60674; P29323; Q5S007; P07737; P63000; P49841; P62917; P36544; O14818; Q99808; Q15717; Q01814; Q92558; P05388; Q9NQ66; P42566; O14810; P12830; Q13542; P62195; P04156; Q06787; Q9Y4I1; Q9UBL9; P61764; O00429; P21333; Q9UBU3; P60880; P61586; P51608; P63010; P42262; Q8N2Q7; Q15109; Q6PUV4"]
["GO:1990635","cellular_component","proximal dendrite ","P49840; P53041; P11137; Q6Y7W6"]
["GO:0036464","cellular_component","cytoplasmic ribonucleoprotein granule ","Q8WV28; O75116; P50750; P10636; P62753; P06730; P60709; P63000; Q15464; P05388; O75529; Q9Y3Y2; Q9BY77; Q86TB9; P07437; Q5D1E8; Q9Y6H5; Q06787; P19338; Q96F86; O00562; P10912; Q71U36; P11940; P46940; P49917; Q9NPI6; P60953; Q15365; Q99728; P35998; Q00839; P26196; O15523"]
["GO:0005912","cellular_component","adherens junction ","Q9BYP7; Q15262; P35240; P25054; Q07912; P35222; Q96TA1; Q8TEW0; O43739; O00560; Q9UGP4; Q9HBA0; P18206; Q99418; Q9UQB3; O15259; P13688; Q96SB3; Q15438; P46531; Q9UDY2; Q96IF1; Q13444"]
["GO:0005923","cellular_component","bicellular tight junction ","Q9BYP7; Q96J92; P11802; Q05513; P25054; P41743; P50552; O00501; Q86UE4; Q8TEW0; Q6T4R5; Q16625; P16989; O43739; O95786; O95471; Q92974; Q9Y4G8; O15551; Q99418; O15259; Q92797; Q9BUZ4; Q12959; Q9H8V3; Q9Y2J4; Q68EM7; P36897; O14493; Q15438; Q07157; Q8TD08; O43815; P24385; Q9P2M7; Q4VCS5; Q86UL8; P33151; Q9UDY2; Q9Y624; Q9NPB6; Q9Y5I7"]
["GO:0005759","cellular_component","mitochondrial matrix ","Q15118; Q15303; Q15120; P37840; O14874; P29353; P06493; Q15119; Q16654; P14635; P16220; Q5S007; P04637; O43524; P04150; Q16836; P30405; P40926; Q9H1K1; Q8NCW5; P12694; P10515; Q9NX46; P09622; P04818; O75489; P38646; Q00059; P51649; Q9H2U2; Q15046; Q6UB35; P10809; P23396; P10109; Q9Y237; Q99497; Q04837; Q9NTG7; P30044; Q9P0J1; Q8IYB8; O95363; Q9BW91; Q9NP81; P54252; Q8TAE8; Q99798; Q07820; Q06609; P36542; P00441; Q8N163; Q07817; P32322; P31415; Q12931; P07954; P07203; P31937; Q99714; P08559; P21953; P05091; P04179; Q96C36; P00367; P29803; P30048; Q16595; Q9Y2D0; Q969Z0; Q07021; P24752; Q9NR19; O75616"]
["GO:0005967","cellular_component","mitochondrial pyruvate dehydrogenase complex ","Q15118; Q15119; P10515"]
["GO:0005783","cellular_component","endoplasmic reticulum ","P36888; Q12879; P22455; P18031; P04035; P62753; P00966; P17252; Q99640; P21980; Q9NZJ5; P36507; Q05586; Q9BSJ8; P22607; Q8IVT5; P21399; P35968; Q6NZI2; P54762; Q5S007; Q03135; P04637; P17706; P42858; Q02750; Q02156; P14859; P01100; Q96SB4; P54764; Q05655; P35354; P78352; P09958; P04004; Q86UE4; O95069; Q9BXH1; P62070; Q92542; P01889; Q12904; Q86VP3; Q6ZMG9; Q96PH1; P55084; P01009; Q14145; Q6PIL6; O75298; P05388; Q96KC8; Q7L5N7; O43464; Q13724; Q13563; P04040; Q01105; Q9UKV5; Q13370; O00204; P19086; Q8IWQ3; Q16873; Q7L0J3; P16333; P39687; Q9BVK6; P05093; Q8NF37; Q9HBA0; P14625; O60506; P26373; P82094; P23396; Q9HAW7; Q9NQC3; P62633; Q96P20; Q96RD7; Q07812; P38484; P43307; P55072; P26678; Q9P2Y5; P36956; O76061; P11511; Q99497; P04156; P10415; Q9ULB1; Q14524; Q9NZS9; P19634; Q92673; P0DMV8; P14314; P02649; Q13586; Q8N5B7; Q8IYU2; P58400; Q14573; O75460; O43490; P18850; Q13501; P10646; Q14CS0; Q12959; Q12772; O60240; P49768; O75581; P00973; P46778; Q8TD43; P28799; Q14643; Q14571; P30301; P55064; P49810; P17861; O00429; P22460; O15269; P27824; Q12955; Q07817; Q96HE7; P31415; Q9Y2W7; P51787; Q9UNE7; O60763; J3KNL6; P30040; Q9UMX0; O00767; Q9UHP3; P05023; Q9P2E9; O43264; P30533; P17655; P09601; Q16611; Q13017; Q09470; O94874; Q86XR7; Q9ULZ3; Q9NV92; Q16478; O15027; P30101; P50402; Q3V6T2; O95302; O14827; Q6Y7W6; P62987; Q96S66; P40337; Q9HA82; P30518; P27695; Q96EZ8; Q15084; Q9UJV9; Q8IZP0; Q15293; O43852; Q07020; O95433; Q8TCJ2; P04843; Q9H8X9; Q14654; Q01955; Q04323; Q04656; P01892; O00264; O60260; P16615; P55327; P11021; Q99828; Q14457; P35372"]
["GO:0005788","cellular_component","endoplasmic reticulum lumen ","P36888; P35354; P02671; P23327; P01009; Q9GZV9; P02765; P09382; Q06481; O15240; Q9UMD9; P14625; P19022; P11047; P56817; O76061; Q96D15; P14314; P02649; Q96JH7; P17936; P05067; P27824; Q96HE7; Q92538; O00255; Q14697; P30040; Q9UBU3; Q14118; P34741; P08833; Q9Y680; P30101; P01730; P07108; Q96AD5; P00450; Q15084; Q6UWW8; P12259; Q15293; O43852; Q01955; P05060; P11021"]
["GO:0005887","cellular_component","integral component of plasma membrane ","P36888; P04629; Q16620; P40238; Q12879; Q13873; P08575; P51636; P22455; Q01974; Q15262; Q16288; P54760; P17948; P23467; P11362; P07949; O15146; Q05586; P21802; Q8WU20; Q04771; Q06418; P22607; P29317; Q13224; P35916; P29323; P18433; P10586; Q9UM73; P14616; P35968; P05106; P30530; P21860; P16234; P54762; Q03135; P08069; Q08345; Q16832; Q12866; P17302; P07333; P54753; P29320; Q04912; P06213; P52799; O15075; P08581; P54764; Q9NZV8; Q02763; P29376; P28827; P21709; Q9Y3P8; P41180; P48167; P11166; Q9NWQ8; O15162; Q9NYQ6; P28223; P08138; O95069; Q99808; P29972; P43119; P01130; Q13002; P14672; Q92542; P01889; P28472; O43424; P55017; O43525; P16671; P18507; Q13705; Q01814; Q9UP95; P09693; P15941; P07766; O15245; P34998; Q03431; P02786; Q99062; P41143; P41146; Q9UIQ6; Q9Y210; P30411; Q13563; O60266; P21554; P32942; Q03167; Q08828; P48165; P11168; P29973; P17342; Q9UHC3; P48065; Q96D31; P51681; Q96P88; P08473; P32241; Q9H2X9; P19438; Q9NQA5; Q9UMD9; Q01113; Q92692; P28906; Q9HBA0; P28222; P29322; P43003; O00168; O15455; Q99624; P15391; P25445; Q9NPC1; P35462; P31641; Q9UGH3; P16150; Q99250; Q15762; P16070; Q15768; P42702; P48023; P43220; O00592; P56817; P38484; Q01362; Q12913; Q96F46; Q9Y4G8; P22459; Q9BTU6; P98172; P48551; Q9H310; P40259; P25189; P41597; Q01959; O15551; Q9ULB1; Q9UI40; P32418; P20138; Q9NZS9; O43315; Q8WTV0; P19634; Q6UVK1; O43157; P08588; Q92673; P39086; Q9UBS5; Q13586; Q02846; Q14500; P41594; P08172; Q9HCX4; O43526; P20648; P78536; P57789; P55011; Q92819; Q13507; P21462; O43914; Q14573; P08173; P11912; P63027; P50052; P51790; Q08462; Q9UBL9; O43490; O95297; P41181; P18505; Q13936; P10912; P11717; Q13255; P33527; P30273; P37088; P14416; P49768; P43005; P13688; O60928; Q6PIZ9; O60500; P05067; P16389; P35232; P17181; P35368; P19235; P14784; P41145; P20645; O75899; Q9Y666; Q96D96; P30301; P55064; P49810; O14493; P12235; P10747; P01375; Q02297; P18827; P22460; P13569; O43868; P35367; Q8NET8; O95477; P15529; O00206; P34981; P21730; O75022; P23975; Q7Z418; Q9Y6N7; O95180; P31994; Q9NPC2; Q14416; P23634; P02730; P08913; O15197; P35590; Q8NER1; P06127; P16473; P32927; P31431; P48664; P37023; P21854; Q14831; Q9Y6R1; Q8IV61; P21728; Q09470; P47870; Q9Y5H0; Q05940; P07510; P49685; P20309; Q9H244; Q15722; O94759; Q8N0W4; Q14832; P98161; P14778; P01730; P24394; Q07954; Q9H1D0; P21731; Q9GZU1; P25942; P20333; P07550; P42262; O75762; P23763; P14867; P50895; P30518; P09848; P16410; P30556; Q9Y5S1; P51170; P15260; P30874; Q8N2Q7; P34972; O14649; P13224; P36896; P31645; O43613; P21817; P63252; Q9UHW9; Q8NFJ5; P23945; P78508; Q14957; Q14654; P78324; Q5NUL3; P08100; P50281; Q15109; P51168; P78348; O00264; Q9UL51; Q08289; P16615; P30203; P09758; Q9NPI9; P22413; P55087; P35372; P43629"]
["GO:0098978","cellular_component","glutamatergic synapse ","P48454; Q05193; P62136; P07948; Q16566; Q12879; Q04206; Q15303; Q05513; Q16288; O60674; Q13177; Q05586; O76039; P06730; P01112; P29323; P12814; Q14289; P40763; P60709; P19174; P11274; P05106; P54762; Q5S007; P07737; P63000; O75914; Q00535; P06241; P42345; Q16539; P49841; P07947; Q8NCB2; P12931; Q96RT1; Q9UKE5; P42261; P54764; P41743; Q9NZV8; Q14012; P78352; O14994; P28223; Q99996; Q15717; P49757; Q9ULJ8; O43424; P51114; Q04917; Q01814; O14640; Q15700; P31323; O43566; P21554; Q9NQ66; Q92597; P42566; Q08828; P51674; Q4V328; Q16623; Q14160; P52294; P05556; Q7L0J3; Q14254; Q9H2B2; O14810; Q7Z5H3; P12830; P50570; P38919; Q5T7P8; Q92974; Q13574; P35462; Q01082; Q9HCJ2; P62834; Q15768; Q9UD71; P55072; P21579; O43581; P56545; Q9ULB1; Q02108; P02649; Q08209; P08172; Q9Y4I1; Q9Y698; Q9NSB8; P22001; Q92777; P51790; O60716; Q9Y5Y9; Q13255; P61764; Q12959; O75955; Q9UQB8; P14416; P62258; O15083; P62491; P52292; Q99962; Q9ULU8; Q02297; Q6UUV9; P27824; P84074; P21333; Q13009; Q02410; P10644; P23634; Q92686; Q9UBU3; Q14118; P36873; P48664; P21728; Q09470; P40145; P30153; Q16478; P60880; P20309; P61586; Q14832; Q96PX8; P63010; P40818; P63104; P23763; Q07021; Q13526; Q13363; Q99961; Q9Y566; O95886; Q99623; Q6PUV4; Q16643; Q7LC44"]
["GO:0099523","cellular_component","presynaptic cytosol ","P48454; P05129; Q5S007; P42858; P56545; Q5T5C0; Q9UQB8; Q99962"]
["GO:0005720","cellular_component","nuclear heterochromatin ","Q01826; Q9Y6K1; O75475; Q13263; Q96EB6; Q12948; P45973; P83916; Q96T88; P16401; Q9C0C2; Q8IXJ6; Q13185; P10412"]
["GO:0016605","cellular_component","PML body ","Q01826; Q13164; P50750; Q14164; Q86Z02; P06400; O60934; Q9H2X6; O96017; P29590; Q9HBH9; P04637; P42345; Q13535; Q00613; O43293; P60484; O14746; Q96EB6; Q9UBK2; Q9NRA8; P54132; O43566; Q86TB9; Q9UBW7; Q9NS56; Q9GZV1; P78317; O00327; P13056; P16150; Q99497; P27694; P49959; O75925; Q9UER7; P54198; P15927; Q9H422; Q02447; Q13501; P63279; Q06609; Q9NQB0; Q16621; P63165; Q93009; O75928; P33076; O95551; Q9HC62; P61244; Q13569; O95361; Q8N2W9; P43356; Q99607; Q96EP1; Q92794; Q05516; P12755; Q92547; P23497; Q6PCD5; P55854"]
["GO:0005913","cellular_component","cell-cell adherens junction ","O96013; P62136; P07948; Q13873; Q8WU20; P07355; Q96HC4; P35222; P04083; P28827; Q9NYL9; Q8TCZ2; Q14134; Q9BX66; Q92597; Q14160; Q14254; Q92692; P12830; P35611; Q9H3Q1; P35241; P55196; P19022; Q15762; P18206; Q99497; Q8TDM6; Q15124; Q15942; P14923; O75955; Q9UQB8; O00161; Q9C0C2; Q07157; P31949; Q14118; Q9UHR4; O00151; P05783; Q00587; P33151; Q99618; P35579; P26196; Q15417"]
["GO:0005794","cellular_component","olgi apparatus ","O96013; Q8IWU2; Q05193; P39880; P40238; P07948; P51636; P22455; P54646; P37840; Q96KG9; P08631; P27361; Q99640; P52701; O96017; P09619; P02511; P03372; P36507; P21802; P48730; Q14004; P22607; P01112; P35221; Q15139; P21399; Q9UQL6; P49327; P35968; Q9BZL6; P53667; O15357; Q9Y4A5; P28482; O14744; Q5S007; P07332; P17302; Q14511; Q13535; P42858; P07947; Q02750; Q08379; Q9Y6E0; Q13976; O00221; Q02156; P04049; P54764; Q13887; Q9NZA1; P78545; O15162; Q504Y2; Q96CV9; O95271; Q99996; P01130; Q08AD1; Q8NF91; Q6P996; P47712; P14598; Q92542; P01889; Q96PU5; Q12904; Q9Y2G1; O14939; P16671; Q6P1K2; Q8N4C8; Q8N3Y1; Q9P289; P01009; Q13393; Q9BXF6; P62993; P02765; Q6T4R5; O60266; Q15642; Q9BQQ3; P04040; Q9UKV5; Q9NUY8; Q15545; Q13370; O15240; Q96P48; P12272; Q9BVK6; P13498; Q8NF37; P50570; Q92974; Q14677; P82094; P16070; Q13362; O15350; O00443; Q9Y6D6; Q02962; Q9UKX2; P56817; Q9UIK4; Q9NZ72; P21579; P40259; Q15036; O76061; P04156; Q9NYG2; Q969S3; Q92673; P50749; P02649; Q9Y4I1; Q6TCH7; Q6VY07; Q9BQA1; Q96A49; P51790; P49795; Q6ZS17; O43541; P50542; P18850; P41181; Q8TAP9; P11717; Q14CS0; Q9HAW4; Q16236; O95235; Q12959; Q15691; Q9UQB8; P49768; O15379; P05067; P62491; Q96SN8; Q8TD43; Q8N6H7; P57737; P62820; O75122; Q8NEY8; Q9NZI5; P49810; P31948; Q86WV6; Q9UJY5; O00429; P22460; Q12955; Q6P5Z2; P49815; P41182; Q92538; Q99598; P31415; Q9BUL8; Q9Y2W7; Q9NY61; Q5VSY0; O95477; O60763; Q13439; Q9H4A6; Q02410; P31150; Q14697; P05023; Q8TD08; O75379; P30533; P17655; Q9H8Y8; Q08378; Q9UPN3; O43561; P08833; P48664; Q99523; P17600; Q86XR7; Q9NV92; O43823; O15027; Q92681; Q96SU4; Q3V6T2; Q9BXB4; Q6Y7W6; O95267; P07108; Q14247; Q93045; Q5T5U3; Q5JSH3; Q7Z6J0; Q96S66; Q9NZC7; Q9BPZ7; Q9Y6W6; P30518; Q8TAS1; P16410; Q9Y5P4; P46934; Q9UM54; Q8N2Q7; Q96IF1; P41134; P05549; P01111; P50395; Q96SD1; O43852; P63252; Q9UN36; P22059; Q9H3D4; Q9UQR1; P08100; Q04656; Q99689; P01892; P78348; O60260; Q9NRD5; O75534; Q99828; P35372"]
["GO:0005769","cellular_component","early endosome ","Q8IWU2; P04629; Q16620; P18031; P27361; P35240; P07949; P36507; P07355; P35968; P31751; P28482; Q13905; O14964; P17302; Q02750; P29320; Q96BR1; P01130; P49757; Q9UKG1; Q9BXF6; P02786; P61106; P61073; P10809; O15455; P42892; O60784; P62834; Q8TDQ0; P61020; Q15075; P56817; Q9P2Y5; Q15036; Q15276; P08588; Q92673; P51148; P02649; Q9Y6W5; P51790; P11717; O75955; P05067; P35232; Q9BW19; P62820; Q99962; Q14694; Q7Z3T8; P13569; Q641Q2; O00206; P51787; Q5SRD0; P62745; Q5T1M5; P20339; Q99523; Q86XR7; Q9Y3C5; P01730; Q07954; P30048; P07550; P40818; Q8IUQ4; Q9UJU6; O43255; Q8NCT1"]
["GO:0030426","cellular_component","growth cone ","Q8IWU2; P13612; P10636; P37840; Q12852; P22681; Q14289; Q5S007; Q00535; Q6IBS0; Q15078; Q8N5V2; O14640; Q9NZI8; Q92913; Q14195; P21554; Q8TCU6; Q9UKV5; A0MZ66; Q16658; P50570; Q9HBA0; Q8WYL5; O15511; P0DP23; Q9NZ72; Q96Q89; P07196; Q8IVF5; Q96N67; Q06787; Q99418; Q9Y4I1; Q96A49; O60716; P49768; O15083; Q07866; P49810; Q9UPX8; P46939; Q13319; Q9UPT6; Q9BXM7; P46940; Q5T1M5; Q8WX93; Q13972; P60880; O00213; Q93045; Q92574; Q8IZP0; Q8IXJ6; Q9UN36; Q8IYI6; Q99689; Q16643; Q12929; Q99828"]
["GO:0016021","cellular_component","integral component of membrane ","Q8IWU2; P00533; P08922; P08575; Q15262; P04035; P09619; P11362; P03372; P16284; Q15797; P21802; P04626; P10721; P00403; P33121; P08581; O00501; Q8IUW5; P36544; P16871; P54829; Q7Z434; P09958; Q9NYQ6; P08183; Q86UE4; P08138; O00631; Q8NF91; Q8TEM1; Q92542; Q9H5V8; Q9Y2G1; Q16790; O43525; Q6ZMG9; Q12791; Q96PH1; Q5T4S7; Q7Z2W7; Q8TCZ2; P34998; Q15836; Q96KC8; Q7L5N7; P31995; Q13724; Q96LC7; O60266; P25092; Q9P2S2; Q16625; Q8NC24; P61073; P43681; Q9UKV5; P04844; Q06481; Q13423; P48065; Q13370; Q16623; P08473; Q16873; Q9BR39; Q16821; P14679; Q96BF3; Q9H2X9; O14522; P56962; A1KXE4; Q9BVK6; Q92692; P12830; Q8NF37; Q9HBA0; Q5T7P8; O95471; Q9UBH6; P16066; P46695; P42892; A8CG34; P32248; Q13323; Q13621; P31641; P40305; Q9UGH3; Q9HCJ2; O95140; P19022; Q5JTV8; Q14849; Q9UL54; Q8NC67; Q8TDQ0; Q9HAW7; Q96J84; Q96RD7; P43220; P56817; P20963; Q9H400; P43307; Q8IWA4; P22459; Q15256; P36956; P41597; Q01959; Q9NYG2; O15551; Q14524; O43315; Q9NRY6; P19634; Q9BX84; Q96A54; Q9UKL4; O75369; P32245; Q9BTX1; P08684; P08172; Q8TCG1; O95202; Q6TCH7; Q8N5B7; Q9ULK5; P32004; O43526; Q9UNQ0; P22001; Q6ZMQ8; O43306; P21462; Q9Y2U8; Q96RD6; P51790; Q9Y6F6; Q13936; P10912; Q01628; Q07820; P24390; O14638; Q9BVI4; Q96MS0; Q9NQG6; Q14494; Q86X29; Q8TDQ1; P37173; P53801; P49768; O75581; P01589; P13688; P13591; P05067; Q9GZY6; Q9UHM6; Q16635; P21453; Q14643; Q9Y385; P57737; Q14571; P41145; Q14432; Q8NBN3; Q96D96; Q86WV6; Q5ZPR3; Q96P31; P17861; Q5JTH9; O15269; Q9UQD0; Q07817; P13569; O95185; A8K4G0; P21397; P23469; Q13291; O43184; Q8N9I0; Q8IV01; Q5FWE3; P12318; O95180; Q9NPH5; Q9NRD9; O00767; P05023; P02730; Q14739; Q13651; O60602; P46531; P40855; Q8NER1; O75096; O95168; O43561; Q14118; P34741; P48764; P48357; Q99523; Q14831; P16471; Q9P0J0; Q96KG7; Q6UY09; A4D1S0; Q9NV92; P08034; P50402; P13726; Q8N0W4; P98161; O75056; Q96HA1; O76090; Q96QT4; Q03721; Q13261; Q6Y7W6; Q9GZU1; Q96AD5; Q4VCS5; Q9HA82; P16662; P33151; P42167; P13631; Q9H3N1; P30518; Q9NPY3; Q9H2S1; P36894; P08195; P30556; P43121; Q14940; P36383; Q7Z3C6; P19021; Q9Y624; P56134; Q9UHW9; P23945; P61266; Q13444; Q8TCJ2; P04843; P12821; Q9H8X9; Q8TCT0; Q9NP80; P08100; Q04656; Q16572; Q9ULH0; Q96TC7; Q92667; P22413; Q9Y5I7"]
["GO:0048471","cellular_component","perinuclear region of cytoplasm ","Q8IWU2; P00533; P08922; Q16620; P07948; P51636; P11802; P50613; Q05513; P37840; P35240; P17252; P35228; P25054; P00519; O60566; P10276; Q12792; P42224; Q9NZJ5; Q13177; P22681; P36507; O14965; O76039; P04626; P06730; P37231; P48730; P01112; Q07912; Q06187; Q99459; P29475; Q14289; P23443; P07355; Q9Y2R2; P05129; Q16513; Q03135; Q13905; P06241; P42858; P17612; Q6IBS0; Q9Y2I7; Q00613; Q7L7X3; P08238; P12931; O00221; Q02156; P35222; Q9H2G2; P38936; P28827; P22694; P07900; Q05655; P19525; P15311; P25205; Q13459; Q9UBB4; P04731; Q9C0C7; Q96CV9; Q86UE4; Q12962; Q16613; P14672; O95071; Q9BY11; Q15078; P51114; P23560; Q8N3Y1; Q9P289; O14745; Q13393; P20749; P25686; Q9NZI8; O15055; P02786; Q15836; P26038; P61106; P08476; Q9UIQ6; P31323; Q15642; Q9Y2K6; O43707; P16989; Q8TCU6; P13473; Q92597; P30041; Q01105; Q9UKV5; A0MZ66; Q02790; Q08495; Q9UHC3; O00299; Q5T447; Q8IWQ3; Q15019; P05556; Q9H063; O43542; Q14254; Q9H2B2; P14679; Q9Y6R4; A1KXE4; P39687; P28906; P12830; P50570; O43426; P14625; P42892; Q8NC51; Q14677; P62834; Q96J84; Q9Y6D6; P48023; Q96Q89; Q9Y4G8; Q14240; P55072; Q9H4P4; P26678; Q15256; Q9HBL8; Q9NQC7; Q12802; P41597; O76061; Q99497; Q13257; P54259; P17301; Q14524; Q9NQI0; P02545; Q06787; P19634; P30044; P0DMV8; Q9UPY8; Q9H4E7; Q15056; Q9HCX4; P08133; Q9BUZ4; Q9Y3Q4; Q6ZMQ8; P63027; P30307; P50052; Q8WY41; Q96A49; Q9Y272; Q9Y6F6; Q15436; O95999; P11717; O60271; Q06609; P51809; O95684; O14638; Q9BR76; P61764; Q9Y4K3; Q96T49; P48678; Q15633; Q12959; Q9UBN7; Q9BV36; P49768; Q8IYM1; P05067; Q9UQF2; P62491; Q96SN8; P63244; Q14643; P20645; Q8N302; P49810; Q86WV6; Q99962; P30427; P06396; O95295; O60711; O00429; P22460; Q6P5Z2; P20338; P21333; P49815; Q99598; Q9UPT6; Q5JQC9; O94827; O75553; P22392; O95477; O00206; O60763; Q9BXM7; Q13625; O75716; Q02410; Q9NPH5; Q9UMX0; Q12834; P04406; Q12809; P35637; P09601; Q96HP0; Q9BV73; O94875; O14519; Q99523; O14713; Q8IV61; Q27J81; Q86UE8; Q9UNN5; Q14244; Q9UBF8; Q9NV92; P60880; O00213; Q92993; Q99704; Q93045; Q96H20; P20333; Q5JSH3; Q7Z6J0; Q92574; P05783; Q86UL8; O15169; P11926; P27695; P16410; O94811; P46934; Q9UM54; P36955; P46060; Q9UHD8; Q8IXJ6; Q8IX03; P19021; P26196; P31946; P27815; P50479; Q9UN36; P22059; Q684P5; Q9NP80; Q04656; Q8IYI6; P33176; Q99538; O60260; P16615; Q9NRD5; P55327; Q66K74; O96018; Q99828"]
["GO:0055037","cellular_component","recycling endosome ","Q8IWU2; O75385; Q9UKE5; P42261; Q96BR1; Q9BXF6; P02786; Q15836; P61106; P05556; Q15075; Q15276; Q92673; P62826; P41181; Q71U36; Q9Y2J4; P62491; P01375; P23258; P13569; Q96JG6; Q6WKZ4; Q9Y3C5; Q96H20; O75154; Q7Z3C6"]
["GO:0016324","cellular_component","apical plasma membrane ","P00533; Q13131; Q13873; Q05513; Q13237; P09619; P04626; Q05397; P21860; Q03135; Q16832; P17302; P08238; Q9UKE5; P60484; P04083; P41743; Q02763; P15311; Q08499; P38606; P41180; P11166; P08183; Q86UE4; O95069; Q99808; P29972; Q5T2W1; P55017; Q12791; P16671; Q9P289; O14745; Q13393; P15941; P11488; Q03431; Q15836; O43865; P26038; Q9UEW8; Q6T4R5; Q16625; P42566; P11168; Q15599; Q9NQA5; P13498; P28906; Q9HBA0; Q99650; O00168; P35241; Q13621; Q9UGH3; P19022; P16070; O00592; Q9Y4G8; P19634; Q6UVK1; Q9BX84; Q9ULK5; P78536; P55011; P08237; Q9UNQ0; Q9UBL9; O43490; P41181; Q5XXA6; O14638; Q12959; P37088; P43005; P13688; Q9Y2J4; P30301; P55064; O14493; P30427; Q9UPX8; Q02297; P13569; Q9NPH5; Q9NRD9; P05023; P46531; O00186; O94875; P48764; Q09470; Q6UY09; P07550; P09848; Q8WWI1; P08195; P51170; P15382; Q04656; Q15109; P51168; Q99828"]
["GO:0016323","cellular_component","basolateral plasma membrane ","P00533; Q15303; Q12851; P04626; P07355; P49407; P21860; Q03135; P08238; Q96RT1; P35222; P04083; Q02763; P15311; P78352; P41180; P11166; Q99808; P29972; P01130; P49757; Q16790; O15245; Q03431; P02786; P26038; Q9UEW8; Q96D31; Q14160; Q14254; O95471; Q99624; Q9UGH3; P19022; Q9H310; P25189; O43315; P19634; Q9ULK5; P41181; P00918; P33527; Q12959; O75955; Q12955; P51787; P21730; Q07157; P05023; P23634; P02730; P08913; Q14118; O00186; P16473; P48357; Q9Y6R1; Q14244; P20309; P98161; O76090; Q07954; P32121; P48050; Q9UHW9; P78508; Q04656; Q9NPI9; P15924; P22413; P55087"]
["GO:0009986","cellular_component","cell surface ","P00533; P08922; P13612; P04629; P40238; Q12879; Q13873; P08575; Q01974; Q15262; P09619; P02511; P10276; P09429; Q05586; Q9Y490; P21802; Q06418; P22607; P29317; Q13224; P23443; P07355; P05106; P30530; P07333; P06733; Q04912; P08238; P42261; P08581; P54764; P04083; Q02763; P02671; P41180; P09958; P08183; P08138; O95069; P01130; P01889; Q12904; Q96AC1; O43525; P16671; Q8TCZ2; P02786; Q15836; P26038; Q03167; P61073; P09382; P51681; P10809; P05556; O14522; P19438; Q92692; Q9HBA0; P43003; P26010; Q13576; P25445; P32248; Q9UII2; P16150; P19022; Q15762; P16070; Q8TDQ0; P00747; P56817; P05107; Q12913; Q01959; P04156; Q9ULB1; P17301; Q14524; Q8WTV0; P19634; Q6UVK1; P18084; P32004; P78536; Q9Y698; P58400; O43914; P54578; P51790; Q14512; O43490; O95297; P10912; P10646; P11717; P51809; P30273; P17813; P49768; O75581; P13688; P13591; P05067; P35232; Q92614; P36897; P49810; P10747; P01375; Q96P31; P18827; P22460; Q12955; P00749; P13569; P15529; O00206; Q13291; P21730; P16144; P23975; Q9Y6N7; P30040; Q12809; O75379; P30533; P46531; O75096; P16473; P34741; P48764; P31431; P37023; Q99523; P16471; Q09470; P54652; Q9H244; P30101; P13726; Q8N0W4; P98161; O75056; Q4VCS5; P25942; P11233; P33151; P23763; Q9NPY3; Q8WWI1; Q9H2S1; P08195; Q9Y5S1; Q07021; Q00839; Q8N2Q7; P19021; P15382; P36896; Q13444; Q02539; Q99623; Q15109; P01892; P78348; P11021; P22413"]
["GO:0030665","cellular_component","clathrin-coated vesicle membrane ","P00533; P16871; P09693; P02786; Q15836; Q8TEH3; P21579; P08172; P63027; P11717; P51809; P20645; P98082; P13569; Q8N9I0; O75379; P20339; P01730; P07550; P30518; Q9UM54; Q9UJU6; Q16572"]
["GO:0031901","cellular_component","early endosome membrane ","P00533; P04629; Q16620; O75886; P29590; P54762; Q03135; O14964; Q9Y2I7; P42261; P54764; P04083; P01889; Q96T51; Q9UKG1; Q9BXF6; P61106; Q9H1K0; P42566; P29322; P61020; Q15075; Q9BTU6; Q15276; P51148; P51790; O75581; Q7Z3T8; Q9UJY5; P20338; P13569; Q641Q2; O60749; Q9Y5X2; P20339; Q13614; Q86XR7; Q96J02; Q99961; P50479; Q15334; P01892; Q7LC44"]
["GO:0030139","cellular_component","endocytic vesicle ","P00533; Q13393; Q16625; Q14254; P35462; P61020; Q5VWQ8; Q9Y4G8; O43312; Q15276; P51148; P58400; P11717; P14416; O94827; O95477; Q96B97; P20339; Q4VCS5; P58753; P32121; Q9UM54; Q5NUL3"]
["GO:0005789","cellular_component","endoplasmic reticulum membrane ","P00533; P49585; Q9Y5K3; O00141; P04035; Q99640; P06493; Q9NZJ5; Q9BSJ8; Q06418; Q8IVT5; Q09013; Q03135; P63000; O75385; P17302; P42345; P33121; P42261; P35354; Q9NSU2; P54829; Q86UE4; O95069; Q14693; P47712; Q8TEM1; Q9Y2G1; O14939; Q6ZMG9; Q96PH1; Q13393; Q7Z2W7; P25686; P62979; O43865; O75631; Q96KC8; Q7L5N7; O43464; Q13724; Q13563; P25092; O00560; Q9UKV5; P04844; P30626; Q16873; P53992; P56962; Q9BVK6; P05093; P13498; Q8NF37; O15455; P14625; A8CG34; P48739; Q9HAW7; P0CG47; Q9NQC3; Q96RD7; Q07812; P38484; P43307; P55072; P36956; P11511; P10415; P19634; Q13586; P08684; Q8N5B7; Q14573; O75460; O00562; Q9Y6F6; Q15436; P18850; P24390; P51809; Q14494; Q12959; Q12772; P49768; Q9UQF2; P16389; O43164; Q14643; Q9Y385; Q14571; P62820; P49810; Q86WV6; P08235; P17861; O00429; O15269; P27824; Q15382; Q96HE7; P13569; O95477; Q9NPH5; O00767; Q86XL3; O43264; P09601; P46531; Q99523; P20813; P21728; O94874; O15027; P61586; P20815; P60953; P08034; Q96HA1; P01730; Q13261; O14827; O95267; Q96AD5; P62987; P42262; Q9HA82; P16662; P78356; O75143; Q9H3N1; Q15084; Q9Y5P4; P36383; Q7Z3C6; O43852; P22059; P04843; Q9NP80; P01892; P16615; Q9BRC7; P11021; Q8TCS8; Q14457"]
["GO:0010008","cellular_component","endosome membrane ","P00533; P51617; Q14164; Q9UHD2; P07949; P04626; Q15080; Q13546; Q9NWZ3; Q9Y2I7; O43318; P06213; P09958; P01130; O75351; Q9UKG1; P62979; P02786; Q15750; Q9H1K0; Q8NHG8; O15455; Q14449; Q9NYJ8; P0CG47; P56817; O60331; Q15036; Q92673; Q92985; Q9Y4K3; O75674; Q9UJY5; P13569; O00206; Q8N5C8; O60749; P62745; Q15057; P20339; Q99523; Q86XR7; Q9GZU1; Q9Y6Y9; P62987; Q96H20; Q5JSH3; P07550; Q9UH99; P31645; Q14457"]
["GO:0005615","cellular_component","extracellular space ","P00533; Q13873; P17948; P37840; P04792; P09429; P16284; Q14004; P09917; P12814; P68104; P60709; P07355; P30530; P21860; P10721; Q5S007; Q9NWZ3; P09104; Q08345; Q12866; P06733; P23528; P04083; P00558; P40189; O14757; P15311; Q9UBB4; P02671; P00736; P04004; Q08493; Q8NCW5; Q12904; P16671; P04075; Q14005; P01009; P15941; P62979; P02786; Q9GZV9; P26038; P02765; Q14195; O43707; Q03167; P13473; O00560; P30041; P09382; P51532; O00299; Q15046; O15240; P60174; P12272; P10809; Q96BF3; P19438; Q01113; P35241; P16150; Q9HCJ2; P11047; P00747; Q9H0U6; P0CG47; P48023; Q5TAX3; O00592; Q9H400; P48551; P02810; P40925; Q15256; P09211; O76061; P47989; Q92673; P30044; P02649; P12277; P20648; P21815; P31947; Q14512; P17936; O43490; P10912; P10646; P62807; P17813; Q06830; Q8IUX7; P00441; P63267; P68133; P09038; P17931; P05067; P80108; P06899; P01375; P06396; Q02297; P00749; P11142; P17405; Q16778; P05204; Q9UBU3; P09601; P22004; P31949; Q14118; Q9UGM3; P08833; P13796; Q9Y281; P06702; Q9H2P0; Q16531; Q16206; Q13522; P30101; P51858; P13693; P13726; P51608; P24394; Q9UGI9; Q9BY44; Q13261; Q9Y6Y9; P62987; Q96RS0; P08253; P63104; P00450; Q15084; P43121; Q07021; P36955; P38159; P12259; O14649; P63261; O60814; P12821; P50281; P09758; P22413; O95390"]
["GO:0000139","cellular_component","olgi membrane ","P00533; P39880; P51636; Q99640; Q12851; Q9P212; P48730; P01112; P49407; Q03135; P63000; P17302; P42345; Q9Y2I7; Q08379; P29474; O00506; P42261; Q13464; P41743; P11166; P09958; Q96CV9; O95271; P01889; Q9P289; P01009; Q13393; Q9BXF6; P47736; Q7L5N7; P61106; Q9BQQ3; O43739; P53992; Q9BVK6; P19438; Q8NF37; P50570; O15455; P82094; O75081; P48739; Q9Y6D6; P38484; P36956; Q9NYG2; Q92673; Q99418; Q6TCH7; Q8IYU2; P51790; Q15436; P53367; P18850; Q8NHY2; P24390; Q12772; P49768; O15084; P13591; O43164; Q8N6H7; Q92614; P57737; P61587; P62820; P49810; Q99962; P46459; Q15438; O95295; O00429; Q15382; Q7L0Q8; Q92538; Q9BUL8; Q9UPT6; O60763; Q13439; J3KNL6; O75379; P46531; Q9H8Y8; Q08378; Q9UBF8; Q9NV92; O15027; P60953; P98161; Q96NX5; Q13261; Q92734; O95267; Q5H9R7; Q5T5U3; Q14980; P12259; P01111; Q9UJU6; Q9Y371; P22059; Q9NP80; P08100; P01892"]
["GO:0045121","cellular_component","membrane raft ","P00533; P10636; P07948; P06239; P08575; P51636; P13639; Q05513; P07949; O60674; P16284; P22681; Q06187; P42226; P29475; Q14289; P07355; Q13546; P35968; Q6NZI2; P41240; P54762; Q03135; Q92835; P06241; P17302; O14920; Q9Y2I7; O43293; P00558; Q02763; Q9NWQ8; O15162; P09958; Q13158; Q5T2W1; P46108; P14672; P16671; O14745; Q7Z2W7; Q96C19; P41143; P31323; Q9BX66; P21554; Q12933; P13473; O00560; Q08828; P01116; P04899; P05556; P19438; P07437; P25445; Q15762; P18206; Q96J84; O00592; P56817; Q9BTU6; Q9Y6H6; P98172; Q13191; Q99497; Q01959; P04156; Q14790; P19634; P78536; P22001; Q9UJZ1; P11912; Q9BXL7; Q08462; P49795; O95810; O95999; Q12959; O75955; P37173; Q71U36; P49768; O75581; P07195; P05067; Q9GZY6; P21453; P36897; P49810; P01375; P22460; O95477; P51787; P23975; P30154; P46940; P17655; P20339; O43561; P31431; Q15722; O15519; P01730; Q99856; P20333; P68363; P21796; P42574; P15382; P31645; P17081; O15056; Q04656; Q9ULV8; Q7LC44; P35372"]
["GO:0097489","cellular_component","multivesicular body, internal vesicle lumen ","P00533"]
["GO:0031965","cellular_component","nuclear membrane ","P00533; P11802; Q13237; P00519; P29590; P09917; P42226; P34947; Q09013; Q96RT1; P22736; Q13153; O43660; P30279; Q08499; Q9NUU7; Q86UE4; O95271; P29972; Q14693; Q8NF91; Q8TEM1; Q6ZMG9; P25686; P49792; Q9UPP1; Q96KC8; O60346; Q9Y5J1; Q9Y5Q9; Q9NQ66; O00560; Q15154; O00299; Q16623; Q5VWG9; P20700; Q92908; A8CG34; Q5JTV8; Q03252; Q9UMR2; P18754; P04156; P10415; Q9ULB1; P02545; Q5UIP0; Q9BTX1; Q8N5B7; Q9NZJ0; P12270; P58400; Q9NUQ3; P57740; Q9Y2U8; Q86WB0; Q9BVI4; P48678; O94901; P49768; P63165; P35368; Q8NAV1; P49790; Q8WUM0; Q99543; Q9BVI0; Q5JTH9; Q07817; O75179; P0C1Z6; Q9HC62; P04406; Q14739; Q9UH92; O95168; Q99523; P37198; O60318; P67809; P50402; P52948; Q96HA1; Q6X4W1; Q13261; Q9H467; Q9HA82; P42167; O14980; Q9UM54; P46060; Q9UH99; Q9UKX7; Q684P5; Q8NFH5; Q9UM11; Q9BRC7"]
["GO:0043235","cellular_component","receptor complex ","P00533; P04629; Q16620; Q15303; Q16288; P17948; P23467; P11362; P07949; O15146; P04626; P19793; P35916; P18433; Q13546; P14616; P05106; P21860; P84022; P08069; Q08345; P06213; P01130; P16671; Q13705; Q03431; Q03167; P05556; P32241; P19438; P16066; P26010; Q9UL54; P42702; P05107; P18084; P11473; Q9UNQ0; Q14573; Q9UBL9; P10912; P17813; P37173; O75581; P05067; Q13133; Q14571; P36897; P08235; Q8NET8; O00206; P16144; P08913; P46531; O75096; P16473; P48357; Q14831; O43148; P24394; Q07954; Q9GZU1; P07550; P36896; P23945"]
["GO:0070435","cellular_component","Shc-EFR complex ","P00533; P29353"]
["GO:0043005","cellular_component","neuron projection ","P15407; Q13554; P40238; Q12879; Q13557; P53779; P35240; P08670; P45984; Q05586; P48730; Q13224; P45983; P07101; P10586; P23443; Q9UQM7; P53667; Q00536; Q96L34; Q5S007; P07737; Q00535; Q96HC4; P12931; P60484; P01100; Q13555; P35354; P11137; Q13158; P08138; O75150; P41220; Q15078; O14640; Q15836; O95817; P41143; P41146; Q9C0K0; Q92913; O43707; P49675; P51674; Q16623; P17752; P29322; P43003; P62834; Q9UL54; P0CG47; Q9BZB8; Q9NZ72; Q12923; Q9Y4G8; Q9BTU6; Q14155; P21579; Q01959; Q96N67; Q14790; Q06787; P78559; P41594; Q9Y4I1; P63027; P18848; Q9BYB0; P27816; Q9Y2J0; P51809; Q9ULL5; Q14203; P41145; O00161; O75899; O43602; Q9UPX8; Q7LDG7; P09417; Q12955; Q96NW7; Q13319; O95185; O75553; Q92625; Q96B97; P23975; Q02410; P46940; P23634; Q13972; O94874; Q8IWU9; P60880; P60953; Q96NX5; Q6X4W1; Q8NE35; Q93045; P23763; Q13526; P30874; Q14191; P19021; P31645; Q9Y566; Q684P5; O43255; Q04656; P16949; O00264; O60260; Q9NRD5; Q01851; Q99828; P35372"]
["GO:0042587","cellular_component","glycogen granule ","P49585; P62136; P49327"]
["GO:0005635","cellular_component","nuclear envelope ","P49585; Q05513; P27361; Q06418; P09917; Q9NSU2; Q96EB6; Q14693; P50995; Q8NF91; Q8TEM1; P49792; O00299; P19086; P20700; Q16873; Q13330; A8CG34; Q9NQC3; Q9UMR2; Q07812; Q9GZM8; P36956; P45973; P02545; Q9BTX1; Q9HCX4; P12270; P62826; P42166; P57740; P30622; P18850; P18505; P63279; P48678; O94901; Q14203; P63165; Q8WUM0; Q9NYB0; Q9Y6D9; Q14739; Q8NE71; O75531; P37198; Q9UNN5; P50402; P52948; Q96HA1; Q6X4W1; Q8WUX9; P09874; P42167; O14980; Q8WWI1; P46060; Q9UH99; Q13185; Q8NFH5; Q14654"]
["GO:0005874","cellular_component","microtubule ","Q9HC35; Q05193; P10636; Q16584; Q01974; P25054; P36507; O14965; Q00535; Q8TDX7; Q08379; P51955; Q9HC98; Q9ULW0; P11137; Q02224; Q5SW79; Q9NP97; Q32P44; Q9NQT8; O14640; Q9HC77; Q13425; Q92913; O43566; Q92598; Q92597; A0MZ66; Q14807; Q02790; P50570; Q13330; P07437; Q92974; Q13576; Q9Y4F5; P0DPH7; Q96Q89; Q9GZM8; Q9NQC7; Q9NXR1; P32418; O15553; P06746; Q13586; Q9H0H5; P30622; Q9P2E2; Q9BQE3; P27816; Q15058; O15392; O95613; Q9NQS7; O95235; Q12959; Q9UBN7; Q71U36; Q15691; Q14203; Q9UQB8; Q99426; Q96SN8; Q9BW19; O75122; Q07866; O43602; O00429; O00139; Q5BJF6; Q13009; Q13509; P78371; P46821; P46940; Q9GZQ8; Q9H0B6; Q14204; Q9UPN3; P63167; Q8N4N8; Q9Y2I6; Q9Y283; Q14244; Q9NS23; Q15813; Q9Y6G9; Q7Z4H7; Q13409; Q9NRH3; P50402; Q9Y496; O75449; P68363; P52732; O94811; Q9UHD8; Q9Y266; Q8IXJ6; O43597; Q9H492; P33176; P16949; Q99689; O60282; Q96TC7; Q66K74; Q02241"]
["GO:0015630","cellular_component","microtubule cytoskeleton ","Q9HC35; P10636; P11474; P31749; P02511; O60285; O14965; P53350; Q00536; Q96L34; P07332; P67775; Q9P0L2; Q7L7X3; P49736; P41743; Q9ULW0; Q8IUW5; Q02224; Q99661; Q32P44; O75410; Q14498; Q92597; A0MZ66; Q9H3Q1; O95140; Q9Y6A5; Q9UPY8; Q9H4Z3; Q8NF99; Q15555; Q13813; P30622; Q9BQE3; Q96BD8; P27816; Q96T17; Q71U36; Q99426; Q8IYM1; Q6P0Q8; P04406; Q9UPN4; Q8N4N8; Q14244; P30153; Q9NS23; Q9NRH3; Q9Y496; P68363; Q8WWK9; Q9P270; O43597; Q3KQU3; O14613"]
["GO:0030054","cellular_component","cell junction ","Q13554; Q8TDC3; Q12879; Q15262; Q9NQU5; Q05513; P37840; P35269; O15146; P16284; Q05586; Q13224; P35221; Q13418; P23443; Q9UQM7; P11274; P35968; Q00536; P16234; P16591; Q5S007; Q00535; P17302; Q96RT1; P35222; P42261; P54764; Q9NZV8; O00757; P78352; O00501; P36544; O14994; P48167; Q96CX2; Q9BRP8; Q13002; Q9ULJ8; Q9BY11; P28472; O43424; P18507; Q8N4C8; Q9GZY8; Q01814; Q15836; Q15700; Q8TEW0; Q6T4R5; O43566; Q9Y261; Q16625; P61073; P43681; Q8NHG8; Q07001; Q9C0H9; Q4V328; Q16623; Q18PE1; Q8WUF5; Q14160; Q9H2B2; Q8N8S7; P12830; Q5T7P8; Q9UH03; P55196; Q9HCJ2; P19022; O15350; P62834; Q8TDQ0; Q9BZB8; Q8TEH3; Q14721; Q5TCZ1; Q9BTU6; P21579; Q15256; O43581; P56545; P54259; Q9ULB1; Q06787; Q8TDM6; Q9C0D5; Q8IY92; P39086; Q9UBS5; Q9P1A6; Q9Y250; P08172; Q5T5C0; Q9Y698; Q9NSB8; P58400; P08173; P63027; Q92777; Q96A49; Q9BYB0; P11171; P18505; Q13936; A1X283; Q9Y2J0; P51809; Q9ULL5; Q9UHH9; Q8TED9; Q12959; P49768; P17677; P13688; O15083; Q96SN8; O43164; O75899; Q86UR5; P41002; Q9UHX1; Q9NYF0; Q9UPX8; O95295; Q9ULU8; Q7LDG7; P46939; O00429; Q07817; Q96NW7; O95185; Q9P0K7; Q13625; Q8N9I0; P16144; Q8IV01; P46821; Q14416; Q07157; Q13424; Q8NER1; Q3KR16; Q13303; Q86YM7; P13796; Q09470; P47870; P06702; Q9NQX3; P17600; P48058; P07510; Q16478; P60880; P20309; P61586; Q92681; Q8N0W4; Q9P2M7; O14490; Q6X4W1; Q8NE35; Q5T5U3; Q4VCS5; Q96PX8; P42262; P48050; P33151; P23763; P14867; O43166; Q9UDY2; Q8IZP0; Q8N2Q7; Q9Y624; Q99961; P50479; Q9UJU6; P22059; Q9Y676; Q9Y566; Q9UKV8; O95886; Q14957; Q15109; Q8ND25; Q9NRD5; Q66K74; O15117; Q12929; Q6IBW4; P49418; Q7LC44"]
["GO:0030666","cellular_component","endocytic vesicle membrane ","Q13554; Q13557; Q00987; Q9UQM7; Q03135; P29474; P42261; Q13555; P78352; O00401; P16671; P62979; P50570; P0CG47; Q8WTV0; Q9Y698; P48058; Q96CW1; Q07954; P62987; P63010; P42262; Q9NRD5"]
["GO:0005815","cellular_component","microtubule organizing center ","Q13554; Q05513; Q96KG9; O95835; O60566; Q04759; Q05397; Q01201; Q96L34; P28482; Q6DT37; Q8TDX7; P07947; Q02750; Q9HC98; P04150; Q02763; Q9NRM7; Q71F23; Q7Z6E9; Q9ULW0; Q15650; Q9NZA1; Q13045; Q53EZ4; Q14145; Q86YS7; Q9BXF6; O75410; Q15398; Q14498; Q8IZD2; Q02962; O00592; Q96FI4; Q9UPT5; Q9Y6A5; Q8WYJ6; P05062; P18848; O00562; O60271; Q06609; O95613; O75955; P62491; Q9BW19; O75122; O43379; Q6P1N0; Q9H2D6; Q8IW35; Q9UKA4; Q9UPN4; Q9BV73; Q9BQ89; Q8N4N8; Q9Y2I6; O60610; O14713; Q9NS23; Q7Z4H7; P60953; Q7Z7A4; P05783; O75154; Q96IF1; Q92547; Q86YF9; P61266; Q9Y265; P33176"]
["GO:0033017","cellular_component","sarcoplasmic reticulum membrane ","Q13554; Q13557; P29475; Q09013; Q13555; O00631; P23327; P30626; P26678; Q92736; Q13586; Q14571; P31415; O14958; P21817; P16615"]
["GO:0034669","cellular_component","integrin alpha-beta7 complex ","P13612; P26010"]
["GO:0030117","cellular_component","membrane coat ","Q05193; O43426"]
["GO:0031966","cellular_component","mitochondrial membrane ","Q05193; Q14164; P17252; Q5S007; P04083; Q7Z434; O43464; O75489; P50570; Q13323; P0DP23; P26678; Q9NRY6; Q9UNQ0; P54252; Q9UQF2; Q16635; P22392; Q92686; Q9P0J0; Q14457"]
["GO:0043209","cellular_component","myelin sheath ","Q05193; P02686; P14618; P00966; P02511; P04626; P60709; P09104; P14136; P07900; P15311; Q16891; P38606; P40926; P10515; P49411; P09622; P26038; O75489; P38646; Q9NQ66; Q92597; Q16658; P35241; P62834; P0DP23; P12036; P55072; P40925; P07196; P25189; P10415; O43236; P12277; P18669; Q14573; Q92777; Q99798; P00918; P61764; P36542; Q06830; P61981; P00441; Q71U36; P07195; P35232; P31948; P46459; P12235; P06396; P27824; P78371; P31150; P05023; Q00169; P08559; P19404; O43175; P17600; P60880; Q05639; P54652; P60953; P30101; P31040; P29401; P68363; P21796; P30048; P11233; O94811; Q8IXJ6; P50395; P63261; Q14654; P11021"]
["GO:0001917","cellular_component","photoreceptor inner segment ","Q05193; P14618; P29475; P20794; P09104; Q6ZVD8; P11488; P20941; O75916; P50570; Q5TZA2; Q9UPX8; Q9UMX6; P08100"]
["GO:0098684","cellular_component","photoreceptor ribbon synapse ","Q05193; Q99962"]
["GO:0098835","cellular_component","presynaptic endocytic zone membrane ","Q05193; P09497; O00429; P09496"]
["GO:0008021","cellular_component","synaptic vesicle ","Q05193; Q8TDC3; Q12879; Q05586; P07101; Q00536; P42261; P78352; O14994; Q99767; Q9GZY8; Q16623; P08473; Q7L0J3; Q9GZM8; P21579; O43581; Q9Y6H5; Q5T5C0; P63027; P51790; Q9Y2J0; O95295; Q02410; Q9NPC2; Q07343; O75379; P20339; Q13614; P17600; Q05940; Q99719; P60880; P21796; Q96AX2; P61266; P49418"]
["GO:0043196","cellular_component","varicosity ","Q05193; Q9Y4D2; P25942; P20333"]
["GO:0150034","cellular_component","distal axon ","Q8TDC3; Q8IWQ3; O60282"]
["GO:0048786","cellular_component","presynaptic active zone ","Q8TDC3; Q7L0J3; Q13136; O75955; P05067; O15083; Q86UR5; Q14831; P17600; Q99259; Q07021; Q99623"]
["GO:0034708","cellular_component","methyltransferase complex ","Q9BRS2"]
["GO:0030688","cellular_component","preribosome, small subunit precursor ","Q9BRS2; Q9BVS4; Q14684; Q2NL82; Q9ULX3"]
["GO:0016513","cellular_component","core-binding factor complex ","Q13761; Q01196"]
["GO:0000790","cellular_component","nuclear chromatin ","Q13761; Q04206; P01106; P52701; Q15796; P10276; P03372; P42224; O14497; Q9Y6Q9; P19793; P42226; P40763; P15172; P60709; Q8WXI9; P16104; Q13469; Q02078; Q12824; P84022; P17947; P04637; P11831; P61978; P10275; P23771; Q15910; Q92769; Q9Y618; Q96IZ0; Q96EB6; Q16254; P07910; O43623; P15941; P17535; Q8IZQ8; Q9NQ66; O60315; P48552; P51532; Q06546; Q92997; Q9Y294; P15923; Q14839; P17676; Q9NVP2; P17542; Q8TAQ2; Q9HC52; P18754; P26367; Q13112; P10828; Q13547; Q01094; Q13485; Q969G3; P56178; Q5UIP0; Q92793; Q96T88; P54198; O60341; Q13351; P15884; Q06609; P49321; P08047; P63146; P61296; Q9NQB0; Q13133; P17275; Q8N163; Q96BF6; O43474; P16401; Q92878; Q9H1E3; Q99967; O75943; Q7Z3K3; Q6STE5; Q96FF9; O00255; Q96KQ7; P61244; Q15788; P10914; P41162; P49459; P22415; Q969T9; P0C0S8; O95983; O95644; Q9BVW5; Q13950; P18887; O75376; O14813; Q92785; P13631; P20393; Q9H3R0; O95931; Q02539; Q9H3D4; O94776; P05423; Q05195; Q13111; Q01851"]
["GO:0030027","cellular_component","lamellipodium ","P42336; Q5VT25; P35240; P25054; Q05397; P29317; P35221; Q13418; Q14289; P19174; P53667; O15357; Q16513; P63000; Q00535; Q14511; Q6IBS0; P23528; Q13464; Q9Y5S2; P49023; P28827; Q13153; Q96QF0; P09327; O00401; P35580; Q70E73; Q92558; Q9NZI8; Q6T4R5; Q14195; Q13563; A0MZ66; Q9C0H9; Q16658; Q14160; P05556; Q14254; Q8N8S7; P56945; P12830; P50570; Q9HBA0; Q8WYL5; P35241; Q2M1Z3; Q13576; Q13574; O15511; P19022; Q15746; O00592; Q12923; Q14155; Q8IVF5; P61160; Q9UH65; P19634; O15553; Q9Y6W5; Q8IZ21; Q15052; O60716; P51809; Q9BR76; O75955; P63267; P68133; Q9ULV4; P16389; Q8WWN8; Q96SB3; Q9NYB9; P06396; P61158; Q9UHY1; O94827; P22392; Q5VZK9; O60749; Q8WX93; Q14118; O94875; O14713; O00213; P61586; Q3V6T2; Q14247; Q93045; Q4VCS5; Q7Z6J0; Q92574; Q8IZP0; Q96IF1; P50479; Q9UJU6; O95398; Q99828"]
["GO:0005942","cellular_component","phosphatidylinositol 3-kinase complex ","P42336; O00459; P27986; O00443; P42338; Q92569; O00329"]
["GO:0005943","cellular_component","phosphatidylinositol -kinase complex, class IA ","P42336; P27986"]
["GO:0000164","cellular_component","protein phosphatase type  complex ","P62140; P62136; O60927; P16333; P41236; Q96SB3; P36873"]
["GO:0072357","cellular_component","PTW/PP1 phosphatase complex ","P62140; P62136; O14974; P36873; Q96QC0"]
["GO:0005694","cellular_component","chromosome ","P50750; Q14683; Q09472; Q9NYV4; P38398; Q14004; Q13523; Q13535; Q08945; Q8N3U4; Q7Z6E9; P46013; Q9NTI5; Q29RF7; Q02224; O15516; Q9Y4C8; Q9P1Z0; Q9Y5B9; Q96FI4; Q9BXS6; Q7Z5K2; Q8NDD1; Q06787; Q8TF76; Q9NZJ0; P22087; Q9UPS6; Q9P0W2; Q93009; Q8NEY8; Q9UNZ2; Q9NQR1; Q15047; Q96FF9; Q9UQE7; Q99708; Q15435; O15446; O75531; O00566; O96028; O95239; O60671; Q14676; Q9UIS9; Q14980; Q69YH5; O94762; Q00403; Q8IXJ6; Q92547; O60885"]
["GO:0008024","cellular_component","cyclin/CDK positive transcription elongation factor complex ","P50750; Q9NYV4; Q14004; O60563"]
["GO:0008023","cellular_component","transcription elongation factor complex ","P50750; Q03468; Q03111; Q7KZ85; Q9HB65; Q9UNY4; P55199"]
["GO:0030424","cellular_component","axon ","P04629; Q16620; P51956; P10636; Q13131; P45985; Q15262; P54646; P37840; P21359; P02511; P07949; P42224; Q13627; P45983; P29323; P16220; P54762; P28482; P51610; Q5S007; O75385; Q00535; P42858; P49841; P54764; Q13153; P28223; O75592; O95816; Q9NQT8; Q15078; P51114; P18507; Q8N4C8; Q92913; A0MZ66; Q9C0H9; Q4V328; Q16623; P08473; Q9H063; Q9H2B2; A1KXE4; P05093; Q99250; Q9UL54; Q5VWQ8; P12036; P56817; Q14721; P22459; P21579; P07196; Q13136; Q99497; Q01959; Q96N67; Q06787; P78559; P32004; Q96A49; P27816; P00918; P07197; P61764; Q96MS0; Q9UBN7; Q14203; P14416; P49768; P05067; P16389; P62491; P49810; Q49MG5; P27824; P84074; Q9UPT6; Q9BXM7; Q13509; Q9Y6N7; P46821; P46940; P31150; Q14416; Q92686; P20339; Q9UBU3; Q86YM7; Q13614; Q14831; Q14244; P17600; Q9H2P0; P61586; Q14832; Q8TAS1; P43146; Q15334; P61266; O15056; Q99623; Q99689; P35372"]
["GO:0030425","cellular_component","dendrite ","P04629; Q16620; P10636; Q13131; Q13873; Q01974; Q9H4B4; Q15262; P54646; P62753; P21359; P00519; P10276; P07949; P42224; Q05586; Q13627; P29323; P07101; Q14289; Q7KZI7; P05129; Q96L34; P54762; P51610; Q5S007; Q00535; P06241; P42345; P42858; P49841; Q9P0L2; P19419; P54753; P42261; P54764; P40189; Q13153; P27448; Q9UBB4; P11137; P48167; Q9Y5S9; O95816; Q00975; P14598; Q96PM9; Q15078; Q8N4C8; Q13671; P05388; Q92913; O43566; P32298; P43681; Q9UKV5; Q9C0H9; Q4V328; Q9NYY3; P19086; P04899; P52294; P08473; Q9H063; Q7L0J3; Q9H2B2; O14810; P13498; P38919; Q5VWQ8; Q9BZB8; Q8TEH3; Q14721; Q9BTU6; Q9Y6H6; O43581; P41597; Q13136; P04156; O94763; P98179; Q06787; Q9C0D5; Q9UBS5; P02649; P78559; P08172; Q9UQB3; P32004; P12277; Q9NSB8; Q96A49; Q9NZI2; Q08462; P18505; Q13936; Q13255; Q9UBN7; Q9BV36; P14416; P63165; P16389; P63244; P41145; Q02297; Q6UUV9; Q12955; Q96HE7; Q9UPT6; Q9Y2W7; Q13509; P61244; P46821; Q14416; P17655; P20339; O75096; Q8N122; P37023; Q13614; Q99523; Q14831; Q09470; Q9NQX3; P17600; P30153; Q9H2P0; Q16478; P20309; Q9UK17; Q8N0W4; Q6X4W1; Q07954; Q8NE35; P42262; Q86UL8; Q14980; Q96EZ8; P20393; P36894; P46060; Q8N2Q7; P34972; Q9UJU6; Q9Y566; Q9UKV8; A0A024R539; Q9H3D4; Q04323; Q6PUV4; Q99689; O60282; Q16643; Q66K74; Q99828; Q14457; P35372"]
["GO:0005770","cellular_component","late endosome ","P04629; P27361; P36507; P28482; P42858; Q02750; P12931; P01130; P53675; P61106; P13473; P61073; P62834; P56817; Q9Y4G8; Q9P2Y5; P51790; Q13501; P11717; P17181; P20645; Q8N3F8; P51787; P35638; Q9Y3E7; Q86XR7; Q8NEB9; Q9GZU1; Q86UL8; Q7Z3C6; Q9H492; Q04656; Q8IYI6; Q99538; Q9ULH0"]
["GO:0031902","cellular_component","late endosome membrane ","P04629; P07355; Q9Y2I7; Q13393; O75351; P13473; Q14849; Q96JC1; P08133; P51790; Q01628; P51809; Q8N3F8; P62745; Q9Y3E7; Q86XR7; Q96SU4; Q9BXB4; Q9GZU1; Q96H20; Q7Z3C6; Q96CF2"]
["GO:0045323","cellular_component","interleukin-1 receptor complex ","P51617"]
["GO:0005811","cellular_component","lipid droplet ","P51617; P07355; Q03135; P47712; P61224; Q7L5N7; Q01105; Q8NF37; P55072; Q9UMS4; P51148; P15090; Q96BY7; O00562; Q9Y4K3; O60240; Q05469; Q92538; P04406; Q96AD5; Q92574"]
["GO:0043197","cellular_component","dendritic spine ","P62136; P10636; O00418; P02511; Q05586; P29475; Q14289; Q9UQM7; P49407; P63000; P42261; P60484; P54764; Q9NZV8; P78352; Q15078; O43424; P51114; O14640; Q9NZI8; P07766; P31323; P23677; O43566; P51674; P05556; O14559; P25685; P32418; Q06787; Q9Y250; Q08209; Q9ULH1; Q9BYB0; O60716; P14416; P05067; Q96SB3; Q9ULU4; Q9UPX8; P27824; Q13009; P46821; P31994; Q07343; O43815; Q86YM7; Q01449; P36873; Q13614; P48058; O00213; P61586; P60953; Q14832; Q14247; O43665; P42262; P40818; P32121; O43166; Q9H2S1; P20393; Q8N2Q7; P50479; P63252; Q9Y566; Q15417; Q7LC44"]
["GO:0043204","cellular_component","perikaryon ","P62136; P45985; O15530; P00966; P02511; P07101; P28482; Q5S007; P09104; Q00535; P53041; P54764; Q9NZV8; Q13002; A0MZ66; Q14721; Q9BTU6; Q9Y6H6; P41597; Q06787; P11387; Q9UQB3; Q92886; Q96A49; Q13936; Q9UBN7; P14416; P16389; P63244; P41145; P84074; Q13283; P35637; Q09470; Q16478; O94759; Q6X4W1; Q6Y7W6; Q96EZ8; Q9Y233; Q8IXJ6; P34972; P19021; Q04656; P35372"]
["GO:0098793","cellular_component","presynapse ","P62136; P21359; P60709; P07737; Q00535; Q9UKE5; Q8IYJ3; Q99808; Q00975; P14672; Q15078; O14939; Q04917; Q01814; O14640; Q9P2S2; Q14160; P50570; O43426; Q15075; P56817; O60331; Q99497; Q06787; P58400; P28329; P61981; O00161; Q9ULU8; O94827; P23975; O00186; P36873; Q8N0W4; Q16143; P63010; Q8N2Q7; Q99961; P78508; O60260; Q16572"]
["GO:0014069","cellular_component","postsynaptic density ","Q16620; P07948; Q12879; Q13873; O15530; Q05513; Q9UEY8; O00418; P02511; Q13177; Q05586; Q13224; Q14289; P40763; Q9UQM7; P11274; P49407; P05129; P28482; O75914; Q00535; P06241; Q96HC4; P12931; O15075; P42261; P54764; Q14012; P78352; P62917; P11137; O14994; Q13002; Q9ULJ8; Q15078; Q8N4C8; O14640; P05388; Q15700; O43566; Q9C0H9; Q08495; Q16623; Q14160; P52294; Q13574; Q01082; P19022; P23396; Q8NC67; P42677; Q9NQC3; P12036; Q9BZB8; P04156; P61160; O60229; Q06787; Q8TDM6; Q9C0D5; Q9P1A6; Q9Y250; P41594; Q96PV0; Q9NSB8; Q92777; Q9BYB0; P11171; Q13936; P27816; Q13255; Q9ULL5; Q12959; P14416; P17677; O43164; Q14643; P46459; Q9UPX8; Q6UUV9; Q15382; P49815; Q96NW7; O75553; P46821; P05023; Q07343; Q92686; O43815; O75096; Q07889; Q13303; Q86YM7; Q13614; P30050; Q9NQX3; P17600; Q8N0W4; Q14832; O14490; Q6X4W1; Q8NE35; P35612; Q92574; P40818; P32121; Q86UL8; O43166; Q9NRR4; Q8IZP0; Q8N2Q7; Q9UJU6; Q9Y566; O95886; Q99623; P55795; Q15417; Q9NRD5; Q16643; P39019"]
["GO:0045211","cellular_component","postsynaptic membrane ","Q16620; Q15303; O15146; Q05586; Q13224; P11274; P49407; Q00535; Q96HC4; P60484; Q9NZV8; P78352; P36544; P48167; Q96CX2; Q13002; Q8NF91; P28472; P18507; Q8N4C8; Q15700; O43566; P43681; Q07001; Q9C0H9; P50570; Q9BZB8; Q14721; Q06787; Q8TDM6; Q9C0D5; P39086; Q9UBS5; Q9P1A6; Q9Y250; Q9NSB8; P08173; Q96A49; Q9BYB0; P18505; Q13936; Q9ULL5; Q12959; O43164; O75899; Q9UPX8; P46939; Q12955; Q96NW7; Q92686; O43815; Q8NER1; Q14118; Q86YM7; Q14831; Q9NQX3; P48058; P07510; O00213; Q8N0W4; O14490; Q6X4W1; Q8NE35; P42262; P32121; P48050; O43166; Q8IZP0; P50479; Q9Y566; O95886; Q14957; Q9NRD5; Q16643"]
["GO:0043195","cellular_component","terminal bouton ","Q16620; Q2M2I8; P37840; Q05586; P27708; P07101; Q13418; Q5S007; Q13002; O43426; P20339; P57796; Q16478"]
["GO:0005856","cellular_component","cytoskeleton ","Q16825; P04792; P08631; P27361; P35240; Q9UEY8; P08670; O60674; Q9Y490; Q13627; Q05397; P42680; P29597; P29475; Q14289; P60709; O15357; Q15678; P16591; P28482; Q92835; P07737; Q05682; Q6IBS0; O43353; P52564; Q9P0L2; P54840; P29474; Q02156; Q9UKE5; Q13464; P35236; Q9Y5S2; P23458; P52333; Q96QF0; O75592; Q99996; P49773; Q8NF91; Q70E73; P52565; Q92558; Q13671; P26038; Q9UEW8; Q9UH77; O43464; Q8TEW0; Q15642; Q32MZ4; O00560; Q9UHI6; Q16658; Q8TE77; Q9Y613; Q8N8S7; Q8WYL5; Q9UH03; P07437; Q92974; O60504; Q86UC2; P18206; Q16204; Q5D1E8; P12036; Q12923; Q99439; O75952; Q8IVT2; Q02952; Q9UH65; Q14790; Q9H4E7; Q92599; P50461; O15259; Q92797; Q9BUZ4; Q9UJZ1; Q96JY6; P14923; Q8N264; Q9NQ86; P61764; Q9UNA1; Q92519; O15083; Q96SN8; Q9Y6M1; P26045; O43294; P54105; Q8WWN8; O43602; Q96SB3; Q9NYB9; P30427; P46939; Q5JQC9; P10916; Q9P0K7; Q9BXM7; Q96B97; Q9C0C2; Q14315; P52566; Q13424; Q9UPN3; Q13303; Q14118; O14713; P06702; Q9NQX3; P17600; P47756; Q99719; P60880; P61586; P52907; P51911; Q9UHR4; Q9Y2H9; O00151; Q14247; Q92574; Q00587; O43166; Q8IZP0; Q15654; O43597; Q14994; P50479; P63261; P09493; Q15334; O15056; Q9NRD5; Q16643; Q16555"]
["GO:0031618","cellular_component","nuclear pericentric heterochromatin ","Q13422; Q03188; P49450; P45973; Q13185"]
["GO:0030673","cellular_component","axolemma ","P10636; Q01082; Q02297; Q14654"]
["GO:1904115","cellular_component","axon cytoplasm ","P10636; P04792; Q15554; Q15700; Q9GZM8; P07196; Q16665; Q6PJT7; P78559; P00441; O95295; Q9UPT6; O95239; P46060; P33176; O60282"]
["GO:0044297","cellular_component","cell body ","P10636; P35240; P62753; Q14289; P14136; P06241; P15311; Q13158; Q8NCW5; P07766; Q14195; P19086; P04899; P07437; Q12923; Q99497; Q14790; P34931; O00562; P63267; P68133; Q9UQF2; Q02297; Q9UPT6; Q9BXM7; P78371; P31994; Q9Y5S1; O00264"]
["GO:0005576","cellular_component","extracellular region ","P10636; P22455; Q15303; P13639; P14618; P54760; P37840; P11362; P09429; P36507; Q9Y490; P09769; P21802; Q14004; P22607; P35916; P09917; P29323; P19838; P12814; P68104; P07355; P35968; P54762; P28482; P84243; Q16539; P54753; P29320; P08238; P08581; P60484; O75874; Q13464; P04083; Q02763; P40189; P42685; P07900; P53396; Q05655; P02671; P16871; P00736; P09958; Q49AN0; P0DN86; P04004; Q504Y2; P08138; Q8NCW5; P07910; P13010; Q9H5V8; Q92882; P04075; P23560; Q14005; P01009; P02786; Q99062; Q96II8; Q9GZV9; P08476; Q9UIQ6; P02765; Q92913; Q96LC7; O43707; Q92598; Q8WZ42; P04040; O00560; P30041; P09382; P17980; P17858; Q16623; Q12906; O14558; P12272; P36871; P01236; P31951; P19438; O14727; Q9UMD9; P12830; P07437; P14625; Q93070; O15511; P18206; P12956; P0DP23; P11047; P00747; P48023; Q96P20; P14543; P11216; O75386; Q96F46; P55072; P48551; Q99439; P09211; P61160; Q6UVK1; O43157; P0DMV8; Q9UBS5; P02649; Q99460; Q13200; Q14624; P18669; Q13813; P05408; P21815; P67870; P50052; Q14512; P17936; P14923; P10912; P10646; P07741; Q8IUX7; P00441; P09038; O75581; P00973; P55081; P17931; P0DN87; Q8N1F8; P05067; P80108; P19235; O00571; Q7Z5P9; P28799; Q01518; Q8TER0; Q8N302; P68431; P01375; P06396; Q02297; P00749; P21333; Q96NW7; P62805; P22392; P11142; O43184; Q92915; P78371; Q8TD08; P30533; Q9UBU3; P46531; O15197; Q14204; P31949; P08758; P12268; Q14118; Q9UGM3; P08833; Q9H410; P57796; P48357; P06737; P16471; P06702; P67809; Q9ULZ3; Q9UNP9; P52907; P29350; P51858; Q7Z6Z7; P14778; Q9UQ80; P37802; P20333; Q96PX8; Q9UGM5; P08253; Q5JVS0; P50895; P00450; P35998; P43121; P36955; P08567; P12259; Q9UNF1; Q92731; P50395; O43852; Q9UJU6; P06744; P12821; Q01955; Q15109; Q99538; Q9Y6I9; P30203; P05060; Q71DI3; O00231"]
["GO:0097386","cellular_component","glial cell projection ","P10636; P06241; P05556; Q06787; Q8IXJ6"]
["GO:0044304","cellular_component","main axon ","P10636; P05067; Q13009; O00213"]
["GO:0005875","cellular_component","microtubule associated complex ","P10636; Q15121; P49023; P11137; A0MZ66; O15553; P78559; P27816; Q9UBN7; Q14203; O43602; P46821; Q96S59; Q14244"]
["GO:0097418","cellular_component","neurofibrillary tangle ","P10636; P12036; P07197"]
["GO:0034399","cellular_component","nuclear periphery ","P10636; O75475; P11137; Q9Y4R8; P12270; P18848; P57740; P49790; P17544; Q14118; Q99848; P52948; P23497"]
["GO:0016607","cellular_component","nuclear speck ","P10636; O00141; Q06413; Q13131; P54646; Q86Z02; Q6PD62; Q9NYF8; P19544; Q9NYV4; Q13148; Q14004; Q13627; Q9Y2W1; Q99459; Q13523; P34947; Q8WXI9; Q9UQL6; Q14934; P53667; P16104; P25440; P08621; Q16539; P17612; P10275; P49761; P04049; Q96RT1; Q9HC98; P04150; O43660; Q7Z6E9; Q49AN0; O14746; Q9UBB9; Q9Y5S9; Q9UKV3; Q96T51; Q9NXE8; P23560; Q14005; Q9NRA8; O75529; Q15750; Q9Y3Y2; Q8IYB3; Q9BY77; Q86TB9; Q08170; Q14498; Q9NQ66; P48552; Q99581; Q14807; Q9UBU8; P52945; Q96J01; Q92733; Q9NS56; O75400; O75940; Q14671; P15923; P38919; Q9P0U4; Q14669; Q13574; P55196; Q8IZD2; Q13243; Q01130; Q01081; Q15459; O60828; Q96FV9; Q96L91; Q15906; Q16665; Q13573; P26368; Q96PK6; Q8NI27; Q6PJT7; P02545; Q9UMS4; O00257; P0DMV8; Q8WXF1; P10070; Q9UIF9; O75925; Q05519; O75533; O43395; Q9H6E5; P35548; Q99814; Q9BTA9; Q07955; P30307; Q9UPS6; Q9NTJ3; Q53F19; Q9Y3M2; Q8NHY2; Q9ULV5; Q9BWF3; Q96T49; O60381; P49427; P18583; P63165; P43354; O00571; Q03112; Q6IE81; O75928; Q9P2N5; Q13247; Q8WWM7; Q9UQ35; O60711; Q15020; P98175; Q96KQ7; P24522; Q5VZK9; P98177; Q15287; Q86YP4; Q92841; P49750; Q13435; Q12972; P36873; Q86U44; Q92794; P23246; Q9UNP9; Q14185; O00213; Q7Z4H7; Q6P2Q9; Q9UIS9; Q15365; P49760; Q05516; Q99728; P21731; P48729; P29401; Q16666; Q96PM5; O95243; Q15029; Q9Y6W6; Q5JVS0; P10071; Q8TAS1; P27695; O00148; Q00839; Q13526; Q14191; Q96E14; Q14966; O75494; Q9Y383; Q96QD9; Q96AV8; Q9Y2N7; P55199; P05423; Q9P013; Q8WXA9; Q86V81; O60260; Q96S94"]
["GO:0036477","cellular_component","somatodendritic compartment ","P10636; P01130; Q9Y698; P46821; P20339; P60880"]
["GO:0045298","cellular_component","tubulin complex ","P10636"]
["GO:0042641","cellular_component","actomyosin ","Q5VT25; Q9Y5S2; P56524; P35580; Q16623; Q9Y4I1; Q92614; P35579; Q16643"]
["GO:0031252","cellular_component","cell leading edge ","Q5VT25; Q2M2I8; Q05513; P08670; P00519; Q6DT37; Q9Y5S2; Q9H2G2; P41743; P61073; A0MZ66; Q9GZM8; Q86SQ0; Q6ZS17; Q9BR76; Q9UBN7; Q14203; O75122; P23258; Q92538; P16144; Q5VZK9; P35579; Q04656; Q8IYI6"]
["GO:0032156","cellular_component","septin cytoskeleton ","Q16659"]
["GO:0045171","cellular_component","intercellular bridge ","P11474; O00311; P17612; P41743; P22694; Q9ULW0; Q53EZ4; Q03188; Q8WUF5; P28906; P58012; Q96FV9; Q9H4Z3; P23025; O95235; Q8IWB6; Q53HL2; Q9UPN4; Q8N4N8; Q9Y2I6; P22612; O95239; O75154; Q02241; Q6IBW4"]
["GO:0031234","cellular_component","extrinsic component of cytoplasmic side of plasma membrane ","P07948; P06239; P42681; P51636; P51813; P08631; Q13882; P00519; O60674; P09769; Q05397; Q07912; Q06187; P42680; P29597; Q14289; P43403; P51451; Q00536; Q08881; P16591; P41240; P07332; P43405; P06241; P07947; P42684; P12931; P23458; P52333; P42685; Q13470; P78352; Q96AC1; P62993; O43739; P01116; Q9NQC7; Q9H0H5; Q96A49; Q9NZI2; Q9BYB0; Q15438; Q13009; P46940; Q13303; P60880; P61586; P34972; P16615; Q9UJM3"]
["GO:0034666","cellular_component","integrin alpha2-beta1 complex ","P07948; P05556; P17301"]
["GO:0042629","cellular_component","mast cell granule ","P07948; P22681; Q06187; P10721; P04083; P48736; Q9GZY6; O00161; O43561; O95267; O00329; Q6PUV4"]
["GO:0030061","cellular_component","mitochondrial crista ","P07948; P49675; Q6J4K2"]
["GO:0005758","cellular_component","mitochondrial intermembrane space ","P07948; P37840; P09769; P56277; Q9Y6H1; Q9H3M7; O43464; P04040; P49675; Q99497; O14925; Q9NR28; Q9UJZ1; P00441; Q12931; Q9BXM7; P99999; Q9H4A6; P54819; Q8TCS8"]
["GO:0099091","cellular_component","postsynaptic specialization, intracellular component ","P07948; P07947; P12931"]
["GO:0016528","cellular_component","sarcoplasm ","Q06413; Q15149; P30427; P06396; Q14315; Q5JVS0"]
["GO:0001772","cellular_component","immunological synapse ","P06239; Q04759; P43403; P15311; P51452; Q86WV1; P07766; Q8TDQ0; Q12913; Q9BXL7; O95999; Q12959; P17931; P10747; Q15669; O43561; P35579; P30203"]
["GO:0000242","cellular_component","pericentriolar material ","P06239; O95271; Q8TEP8; Q15154; Q96PY6; Q96SN8; Q8NHV4; P23258; Q9NRH3"]
["GO:0031588","cellular_component","nucleotide-activated protein kinase complex ","Q13131; P54646; P13861; P17612; O43741; Q9Y478; P10644; P54619; Q9UGI9"]
["GO:0012505","cellular_component","endomembrane system ","O00763; P42345; O43521; P14672; O14745; Q8TEW0; Q08495; Q15599; Q9H3Q1; Q13323; Q8WUA7; Q9BZR8; Q9NQS1; Q96RD6; Q86TI0; Q9UHY1; Q9GZQ8; Q4KMP7; O60343; O14986; Q00587; P31645; O95398; O14613"]
["GO:0005741","cellular_component","mitochondrial outer membrane ","O00763; P37840; P00966; P15336; P23443; Q5S007; O75385; P17302; P42345; P33121; Q92934; P04049; P54764; O43524; P06401; Q9C0C7; Q7Z434; Q14693; Q9BXH1; O43521; P55084; P52789; Q9GZY8; Q92558; P62979; Q9BXF6; P21554; P40305; O95140; P0CG47; Q07812; Q96LC9; Q8IWA4; P50416; P10415; Q14790; Q8IXI2; Q07820; Q9NQG6; P56693; O00571; Q86WV6; P19367; O00429; Q07817; Q9BXR0; P21397; Q9BXM7; Q16611; P36873; Q9UBF8; P55957; P62987; P21796; P23763; Q14142; Q9Y371; Q13794; Q99623; Q96TC7; Q92667"]
["GO:0032133","cellular_component","chromosome passenger complex ","Q9UQB9; O14965; Q96GD4; O15392; Q53HL2"]
["GO:0000780","cellular_component","condensed nuclear chromosome, centromeric region ","Q9UQB9; O14965; Q96GD4; Q03188; P49450"]
["GO:0030496","cellular_component","midbody ","Q9UQB9; P06493; O14965; Q96GD4; O43663; Q16512; P20794; P07355; P53350; Q16513; Q96L34; P51955; P11166; Q02224; Q53EZ4; Q03188; P50995; P35580; O95785; Q14145; P20749; O75410; Q9NS56; P04899; Q15019; P50570; Q8WYL5; P14625; P35241; Q96Q89; Q9P2Y5; Q9NQW6; Q9UPY8; Q8WYJ6; O95425; O14578; P62826; Q9H0H5; O60716; O00562; Q8TAP9; Q15058; O15392; P42338; Q16181; Q9NQS7; O95235; Q8IWB6; Q9H8V3; Q8IYM1; P63244; P55040; Q53HL2; Q14194; Q6NXT1; Q9H2D6; Q9Y5B0; Q96R06; P46940; P31150; P11234; Q8NEM2; P36873; O95239; Q8NEB9; P61586; P60953; O75449; P40818; O75154; Q00839; Q13526; Q8IXJ6; Q96CF2; Q9Y371; Q02241; P11021"]
["GO:0005876","cellular_component","spindle microtubule ","Q9UQB9; P06493; Q96GD4; P48730; O43663; Q8IX90; P0DP23; Q9BXS6; P06746; Q96BD8; O15392; O15379; Q96R06; Q9BZK7; O95239; Q9NRH3; Q969S2; O75376; Q14980"]
["GO:0051233","cellular_component","spindle midzone ","Q9UQB9; O60566; O14965; Q96GD4; P53350; Q99741; Q96Q89; Q5UIP0; Q9H0H5; Q15058; P05067; P55040; Q53HL2; Q9Y5B0; Q49MG5; P60953"]
["GO:0031616","cellular_component","spindle pole centrosome ","Q9UQB9; P06748; O14965; Q96GD4; Q15398; Q9NXR1; Q14CS0; Q9UNZ2; Q14980"]
["GO:0032839","cellular_component","dendrite cytoplasm ","P45985; O76039; P28482; Q5S007; P78352; P11137; Q13002; Q92558; Q14254; Q6PJT7; Q9P2E2; P00441; P27824; P84074; P23246; Q8TAS1; Q00839; P35372"]
["GO:0071944","cellular_component","cell periphery ","P02686; Q02156; P35222; P15311; Q9P289; O14745; P26038; P35241; P14543; Q9BR76; P63267; Q04695; P22392; P08727; O14713; P61586; P05783; O15169; Q99623; Q99828"]
["GO:0043218","cellular_component","compact myelin ","P02686"]
["GO:0033269","cellular_component","internode region of axon ","P02686; Q8TEW0"]
["GO:0099061","cellular_component","integral component of postsynaptic density membrane ","Q12879; Q15303; Q05586; P42261; O43424; P41143; Q08828; P35462; Q9HCJ2; Q15768; P08588; Q9Y698; Q02297; Q16478; P20309; Q96PX8; P43146"]
["GO:0017146","cellular_component","NMDA selective glutamate receptor complex ","Q12879; Q05586; Q13224; Q14289; Q8N2Q7; Q9Y566; Q14957"]
["GO:0097060","cellular_component","synaptic membrane ","Q12879; P02511; Q05586; Q13224; P05129; P04083; O43426; Q9UQB8; O75096; Q13614"]
["GO:0009925","cellular_component","basal plasma membrane ","Q13873; Q96RT1; P08581; Q02763; P29972; Q13563; P42566; P28906; Q9UGH3; P13688; P55064; O14493; P30427; Q12955; Q9H244; P09758"]
["GO:0005901","cellular_component","caveola ","Q13873; P51636; P08631; P27361; O60674; P29475; Q6NZI2; P28482; Q03135; P35568; P29474; P06213; P12931; P35354; P11166; P28223; Q12791; Q14254; O00168; P48023; Q96QB1; Q14524; Q8WTV0; O95810; P10646; Q9UBN7; O75955; P37173; P35368; Q05469; P05023; P23634; P09601; Q9H244"]
["GO:0044214","cellular_component","spanning component of plasma membrane ","Q13873; Q8TD43"]
["GO:0033256","cellular_component","I-kappaB/NF-kappaB complex ","Q04206; P19838; P25963; Q01201; Q04864"]
["GO:0035525","cellular_component","NF-kappaB p/p6 complex ","Q04206"]
["GO:0005905","cellular_component","clathrin-coated pit ","Q2M2I8; Q07912; P49407; Q9P0V3; P01130; P14672; P53675; P02786; P42566; P10809; P50570; Q9Y6I3; P05067; Q96D71; P98082; O00429; Q99523; Q07954; Q14247; P32121; Q9UM54"]
["GO:0030136","cellular_component","clathrin-coated vesicle ","Q2M2I8; Q07912; Q9P0V3; P49757; P14672; O14640; P53675; Q15836; Q14677; O00443; Q8TEH3; P63027; P49795; P98082; Q99523; Q07954; Q00610"]
["GO:0019897","cellular_component","extrinsic component of plasma membrane ","Q2M2I8; P07355; Q8IYJ3; P49757; Q15075; Q06787; Q9UJZ1; P40818; Q14980"]
["GO:0009898","cellular_component","cytoplasmic side of plasma membrane ","P08575; P11413; P24666; P36507; P07101; Q9Y2R2; P10721; O14920; O15111; P60484; P35236; P41220; O43464; Q12933; P12830; Q15124; Q9NR28; P11171; P14923; Q9Y4K3; Q12959; Q13114; P26045; P55040"]
["GO:0009897","cellular_component","external side of plasma membrane ","P08575; P16284; P10721; Q99683; P06213; P40189; P02671; P16871; P01130; P14672; P16671; Q7Z2W7; P07766; P02786; P48544; Q03167; P43681; P51681; P05556; P28906; P42892; P15391; P32248; Q15762; P48023; P48549; P05107; Q01362; P40259; P41597; P17301; P20138; P11912; P51790; O14638; P30273; P17813; P37173; P01589; P13591; P14784; P21453; P10747; Q5ZPR3; P01375; Q02297; P18827; O95477; O00206; P31994; Q8NER1; P08758; P06127; Q14118; Q16206; Q9H244; P14778; P01730; Q4VCS5; P25942; P42262; P33151; P50895; P16410; P36894; P51170; P43121; Q8N2Q7; P12821; P51168; P55087"]
["GO:0098857","cellular_component","membrane microdomain ","P08575"]
["GO:0030667","cellular_component","secretory granule membrane ","P08575; P16284; Q7L591; P63000; P01889; P08473; Q13576; P16070; P61020; P21462; O43914; P63027; P11717; P51809; P17931; Q96D96; Q86WV6; P21730; O75022; P12318; P46940; O60610; Q86XR7; Q9Y6G9; P61586; Q96AX2; Q9NPY3; P19021"]
["GO:0002080","cellular_component","acrosomal membrane ","P51636; Q03135; Q14254; O94901"]
["GO:0031410","cellular_component","cytoplasmic vesicle ","P51636; O15530; P09619; P11362; P21802; Q06187; P07101; P49407; Q5S007; Q03135; P07332; Q9P0N9; Q13315; P28223; Q96BR1; Q96CV9; Q8WV24; Q16760; P47712; O00401; P23560; O14640; P19474; P02786; P41146; Q16625; P61073; Q08495; O15240; Q96P48; Q14254; Q9HBA0; Q92974; Q9UL54; Q9UIK4; P62195; Q9BTU6; Q15036; P30044; O15553; P63027; P54578; P51790; O43516; P49795; O14641; O75955; Q15569; P00441; O75581; P62491; P57737; Q07866; Q9UQD0; Q9UPT6; Q9HC62; Q9UMX0; Q9GZQ8; Q8TD08; P52566; Q9Y3E7; Q99523; Q09470; P09496; Q3V6T2; P35612; P32121; Q9BPZ7; O15169; Q9UM54; Q9BY84; Q9Y624; Q9Y371; P50281"]
["GO:0030133","cellular_component","transport vesicle ","P51636; P22455; P08631; P22607; Q15836; O15240; Q9BVK6; P11717; P24390; P62491; P20645; O60763; P30040; O75379"]
["GO:0036064","cellular_component","ciliary basal body ","P31749; O76039; Q9UPZ9; Q96L34; Q9P0N9; Q15131; P15311; Q96QF0; Q9HC77; Q13563; Q15154; Q9NS56; Q9NQC7; Q8TDM6; Q9P2E2; P41208; Q6IE81; Q8NHV4; P23258; Q5BJF6; Q8TD08; Q9NRY4; Q3V6T2; P48729; Q86YF9"]
["GO:0031982","cellular_component","vesicle ","P31749; Q05513; P14618; P60709; P07355; O43353; P23528; P04083; P15311; O14745; P15941; O15554; P62979; P26038; O00299; Q14254; Q92974; P42892; P0DP23; O00443; P0CG47; Q9Y6H6; P26678; P09211; Q9ULB1; P0DMV8; P58400; P21815; P63027; O43490; Q9BQE3; P62491; P20338; P04406; P22004; O60343; Q13409; P61586; P37802; P62987; P29401; P63104; P50395; Q8NFJ5; Q02539; Q09666; P33176; Q12929; Q99828"]
["GO:0098982","cellular_component","ABA-ergic synapse ","Q15303; Q9NZV8; P48167; Q01814; P21554; Q9NQ66; Q7L0J3; P35462; O43581; P56545; Q9ULB1; Q02108; Q9UBS5; P51790; O75955; P14416; P17677; O15083; Q14118; P21728; P47870; Q9UK17; Q96PX8; P14867; Q07021; Q13363; Q99623"]
["GO:0099056","cellular_component","integral component of presynaptic membrane ","Q15303; P29323; P54764; P28223; Q92542; P41143; P21554; P43681; Q16623; P28222; Q15768; P48549; O43581; Q01959; P08172; P58400; P22001; Q9Y5Y9; P14416; P49768; P16389; P41145; P49810; P48664; P21728; Q09470; P40145; Q16478; P20309; Q14832; P31645; P35372"]
["GO:0030669","cellular_component","clathrin-coated endocytic vesicle membrane ","Q01974; P01130; P02649; Q99962; Q96CW1; P63010; Q00610"]
["GO:0005795","cellular_component","olgi stack ","Q9H4B4; Q99996; Q7L5N7; P61106; Q99986; Q96JH7; O75674; Q9UNZ2; P46459; Q92538; O60763"]
["GO:0098554","cellular_component","cytoplasmic side of endoplasmic reticulum membrane ","P18031; P25686"]
["GO:0097443","cellular_component","sorting endosome ","P18031; P35968; P01130; P53675"]
["GO:0016235","cellular_component","aggresome ","P13639; Q9UHD2; P09769; Q04759; P42566; P0DMV8; Q9H0D6; Q13501; O14641; Q9UBN7; P49768; O95600; O95551; Q9UMX0; P46060; O60260; Q9NRD5"]
["GO:1904813","cellular_component","ficolin--rich granule lumen ","P13639; P14618; P09429; Q14004; P09917; P68104; P28482; Q16539; P08238; O75874; P07900; P53396; Q92882; P04075; P01009; P04040; P17980; P17858; P36871; O14727; O15511; P18206; P12956; P55072; P09211; P61160; P0DMV8; Q13200; P18669; P67870; P14923; O00571; P06396; P22392; P11142; P12268; P06737; Q9UNP9; Q7Z6Z7; P35998; Q9UJU6; P06744; O00231"]
["GO:0042788","cellular_component","polysomal ribosome ","P13639; P62917; P84098; P62913; Q8NE71; Q7Z417; Q07020; Q8TCS8"]
["GO:1990904","cellular_component","ribonucleoprotein complex ","P13639; P06748; P62753; P08670; P38398; Q13627; P60709; Q13469; Q5S007; Q00613; Q92630; Q9HC16; Q15717; P13010; Q9BRS8; P19474; Q14493; Q9NZI8; P05388; P17844; O43707; Q12906; Q96EP5; O60506; P23396; Q96PK6; P45973; Q6PJT7; Q06787; P19338; P0DMV8; Q12789; P09651; Q92879; P46782; P11308; Q02880; P40429; P11940; P14866; P11142; P22626; P04406; Q14103; P37198; Q9Y230; P67809; P52948; Q07352; P11388; P48729; O14980; P38159; Q00839; P05455; P26651; Q9UKV8; Q9Y265; P07814; Q09161; P55795"]
["GO:0034774","cellular_component","secretory granule lumen ","P13639; P14618; P09429; P09769; P09917; P19838; P68104; Q16539; P08238; O75874; Q13464; P07900; P13010; Q92882; P04075; P02765; P04040; P17980; P17858; O14727; O15511; P18206; P12956; P55072; P09211; Q13200; P18669; P67870; P07741; O00571; P06396; P22392; P11142; Q9UBU3; P31949; P12268; P06737; P06702; Q9ULZ3; Q9UNP9; Q7Z6Z7; P35998; P50395; Q9UJU6; P06744; O00231"]
["GO:0000785","cellular_component","chromatin ","P11802; P06400; P53350; P49407; Q8N3U4; P49736; O14757; P30279; Q9NTI5; Q29RF7; Q9Y4C1; O43464; P17535; Q14807; Q9NYY3; P05114; Q15651; Q6KC79; O15350; Q8IZD2; Q7Z5K2; P18754; P12004; Q13547; Q99497; P83916; Q9Y5V3; P82970; P04198; P15927; P42166; P67870; Q06609; Q16236; P50747; P63146; P56693; Q92900; P17275; Q9H1E3; O75179; O00255; Q9UQE7; Q9BXM7; P05204; P17655; Q8TEV9; P49459; P19784; Q7LBC6; P23246; P33993; O95243; Q15648; P46934; Q7Z2E3; Q13185; O75444; Q96QC0"]
["GO:0097129","cellular_component","cyclin D-CDK4 complex ","P11802; P30279; P55273"]
["GO:0000775","cellular_component","chromosome, centromeric region ","Q14683; Q9Y6K1; P62714; P67775; Q8N3U4; Q9NTI5; Q29RF7; Q02224; O95271; Q99661; Q8NCD3; P49450; Q7L2Z9; Q13362; Q7Z5K2; Q9P2Y5; Q06787; P83916; Q9UER7; O15392; Q9NQS7; Q562F6; Q53HL2; Q96FF9; Q9UQE7; P30153; P49711; Q13185; Q15172; Q5FBB7; O14777"]
["GO:0008278","cellular_component","cohesin complex ","Q14683; Q8N3U4; Q7Z5K2; Q96FF9; Q9UQE7"]
["GO:0000777","cellular_component","condensed chromosome kinetochore ","Q14683; O60566; Q12888; Q00613; P51955; Q71F23; Q02224; Q2NKX8; Q99661; Q8NCD3; Q6P1K2; Q9UEE9; O43683; Q15019; Q9GZM8; Q13257; Q9NXR1; Q96JM3; P50749; P57740; O15392; Q16181; Q9NQS7; Q8IWB6; Q8N2Z9; Q96BK5; Q562F6; O75122; Q8WUM0; Q96R06; Q9Y6D9; O43264; O43684; Q13352; Q8N4N8; Q9H410; P36873; Q9Y6G9; O75151; Q8NG31; P48729; Q9H211; P46060; Q00839; O00399; Q5FBB7; O14777"]
["GO:0000794","cellular_component","condensed nuclear chromosome ","Q14683; Q9UEY8; P16104; P51955; O14757; Q8WZ42; P18754; Q99626; Q06609; Q92878; P23258; Q9BYG3; Q9UH99; Q92547; O60885"]
["GO:0000776","cellular_component","kinetochore ","Q14683; P25054; O60566; Q96ST3; Q96GD4; P53350; O14974; Q00613; P51955; P33981; Q8IX90; Q02224; Q03188; Q99661; Q14807; O43683; Q9GZM8; Q13257; Q9NXR1; P45973; P50749; P12270; P30622; Q9NQS7; Q8IWB6; Q14203; P49768; Q96BK5; P49810; Q96R06; Q9Y6D9; Q9Y2Z0; O43264; O43684; P63167; Q9Y6G9; O75151; O14980; Q00839; Q5FBB7; O14777; P55854"]
["GO:0030893","cellular_component","meiotic cohesin complex ","Q14683; Q9UQE7"]
["GO:0097431","cellular_component","mitotic spindle pole ","Q14683; O14965; Q00613; Q8N3U4; O95271; P81274; Q96Q89; Q96SN8; Q9UQE7; Q96R06; O75449; Q14980"]
["GO:0019907","cellular_component","cyclin-dependent protein kinase activating kinase holoenzyme complex ","P50613; P51946"]
["GO:0005675","cellular_component","holo TFIIH complex ","P50613; P19447; P51946"]
["GO:0070985","cellular_component","TFIIK complex ","P50613; P51946"]
["GO:0031256","cellular_component","leading edge membrane ","Q15262; P29317; Q8NF50; P60953; P49418"]
["GO:0001750","cellular_component","photoreceptor outer segment ","Q15262; P20794; Q12866; P11488; P20941; Q9Y4I1; O43490; Q9UPX8; P46821; P08100"]
["GO:0042995","cellular_component","cell projection ","O15530; P78347; P08631; Q96RR4; P27708; P12814; P19174; P16591; P61978; P35222; P60484; Q05209; P15311; Q15642; P35462; P16070; Q5TCZ1; Q06787; Q9Y3M2; A1X283; Q8N264; O95684; Q96T49; O60500; O60711; Q7L0Q8; Q07157; Q96KG7; O94759; Q2M2Z5; Q9GZU1; Q14451; Q99961; Q66K74"]
["GO:0045179","cellular_component","apical cortex ","Q05513"]
["GO:0043203","cellular_component","axon hillock ","Q05513; O14965; Q9ULW0; P11137; Q9GZM8; P36955"]
["GO:0035748","cellular_component","myelin sheath abaxonal region ","Q05513; Q14160; P05556; Q12959"]
["GO:0098685","cellular_component","Schaffer collateral - CA1 synapse ","Q05513; P18433; P40763; Q9UQM7; P60709; P19174; P11274; P07737; Q00535; P06241; P54764; P41743; Q99767; O14640; Q08828; P05556; O14810; Q9HCJ2; P12036; P07196; Q9ULB1; P08588; Q9UBS5; Q08209; P41594; Q5T5C0; Q9Y698; Q92777; O60716; Q13255; Q9UQB8; P62491; Q99962; Q02410; Q9UBU3; P40145; P17600; P60953; P43146; Q99961; P63261; Q9Y566"]
["GO:0001725","cellular_component","stress fiber ","Q05513; Q05397; P12814; Q13418; Q04912; P49023; P35580; Q96AC1; Q9BX66; O43707; Q16658; P13498; Q15746; Q99439; Q15124; O75369; Q9ULK5; Q15942; O14492; Q16181; Q9BR76; Q9UHB6; P68133; Q8IYM1; Q9NPH5; Q4VCS5; Q9UHD8; P35579; P50479; O14950; P09493"]
["GO:0042383","cellular_component","sarcolemma ","Q13557; P24666; P29475; P07355; P04083; P11166; P29972; P05556; Q15149; O00168; P19022; P18206; P05787; O60706; Q14721; P32418; Q14524; Q15124; Q08209; Q12959; O75955; P30427; P46939; Q12955; P08727; Q14315; P05023; Q13424; Q14118; P17661; Q8IVF2; Q9UK17; Q6J4K2; Q02641; Q15842; Q09666; Q99828; P35372"]
["GO:0005929","cellular_component","cilium ","P14618; O14965; P25098; P20794; Q9UPZ9; Q03135; Q9UQ07; Q9NP97; Q08493; Q8NCW5; Q9NRJ4; Q13563; O60266; Q13371; Q9HBA0; Q86UC2; O75386; P10070; O43306; P67870; Q9P2E2; O43303; Q5BJF6; Q9BV73; P63167; Q4G0X9; Q9Y283; P98161; Q9Y496; P48729; P10071"]
["GO:0031012","cellular_component","extracellular matrix ","P14618; O15162; Q9UBB9; P02765; Q03167; P14625; P11047; P14543; P02649; P21815; P00441; P80108; P52272; P50281"]
["GO:1903561","cellular_component","extracellular vesicle ","P14618; P02671; P02786; O00560; P51674; P04899; P18206; P05107; P02649; P55011; Q13813; P05023; P48058; P16152; P12259; Q00610; Q8NCT1; Q7LC44"]
["GO:1902912","cellular_component","pyruvate kinase complex ","P14618"]
["GO:0099055","cellular_component","integral component of postsynaptic membrane ","Q16288; P29323; P54764; P28223; Q9Y4D2; Q01959; P32418; P08172; P22001; P14416; P41145; P27824; Q14416; P21728; Q09470; Q14832; Q8N2Q7; P31645; P35372"]
["GO:0005938","cellular_component","cell cortex ","P37840; Q9UEY8; P21802; Q05397; Q14289; P07355; Q14680; P16591; P31751; Q03135; P07737; Q14511; P54840; P35222; P49023; Q13459; P02671; Q9NZA1; P35580; Q96AC1; Q9UL63; P81274; Q86YS7; Q8TEW0; P53365; Q15642; P32298; Q12933; O14559; Q14155; Q12802; Q8IVT2; Q02952; P19338; O75369; Q9Y4K3; Q14203; P49768; P29966; Q14571; O75122; P49810; Q9UHY1; Q9P0K7; Q14831; Q99259; P61586; Q14247; Q92574; Q14980; P46934; Q9UM54; Q96J02; Q9UJU6; P21817; P52943; Q969H4; Q9NPB6; Q12929; Q7LC44"]
["GO:0016234","cellular_component","inclusion body ","P37840; Q5S007; P42858; P08238; P13807; P25686; P62195; P04156; P0DMV8; Q13501; Q9UBN7; P43686; Q16143"]
["GO:0005764","cellular_component","lysosome ","P37840; P08631; P00966; Q5S007; O14964; P17302; P42345; P12931; P01130; Q14134; P61106; Q15642; P13473; P61073; P04040; P14679; P28906; Q02962; Q9P2Y5; O43581; P25189; Q13107; O95999; P00441; O14773; P17181; P28799; O75674; Q12955; P49815; P51787; P17405; O60749; O75379; P17655; Q8N122; O94759; Q9GZU1; P07550; P15382; Q00610; Q9HB90; P12821; O43504; Q8ND25; Q99538"]
["GO:0005743","cellular_component","mitochondrial inner membrane ","P37840; P09769; P40763; Q5S007; P00403; P12931; Q16891; P30405; P47712; P55084; Q8NE86; P31323; P04818; Q13423; P10809; P23396; O43181; Q9H0U6; O14925; Q92665; O95202; Q9UJZ1; Q9NX63; P36542; P49768; P17931; P35232; Q16635; O95178; P49810; P12235; P51398; Q07817; Q12931; Q9BXM7; P99999; P19404; O95168; Q9P0J0; Q6J4K2; P18859; Q9BQ95; P31040; Q9NQ50; Q96KC9; P56134; O75616; Q9Y676; Q99623"]
["GO:0005640","cellular_component","nuclear outer membrane ","P37840; Q09013; Q8NF91; Q16873; Q02846; Q14573; P49768; P50402"]
["GO:0005791","cellular_component","rough endoplasmic reticulum ","P37840; P14598; P61106; P04844; Q5D1E8; P25189; Q9UQB8; P49768; P05067; P27824; Q07020; P63252; P04843; Q9H3D4"]
["GO:0099512","cellular_component","supramolecular fiber ","P37840"]
["GO:0030672","cellular_component","synaptic vesicle membrane ","P37840; Q5S007; O14994; P09497; Q7L0J3; Q5T7P8; P0DP23; Q9BTU6; P21579; O43581; P63027; Q92777; Q9Y2J0; P14416; Q99962; O95295; O00429; Q07817; Q8N9I0; Q8IV01; P09496; P23763; Q8ND25; P49418"]
["GO:0032587","cellular_component","ruffle membrane ","P51813; P35240; P25054; Q12792; Q9Y490; P09769; O76039; P29317; Q8IVT5; P68104; P05106; P31751; P63000; P12931; P23528; Q13153; P07900; P15311; Q9BY11; Q86YS7; O95786; P05556; P50570; Q9HBA0; Q92974; P23396; Q96QB1; O60331; Q12913; O75122; Q96SB3; Q7LDG7; Q13009; P15531; Q9UPN3; O60610; P13796; P61586; P58753; Q9NR80; Q9UM54; P08567; Q8IX03; O43597; P27815; P09493; Q12929; Q99828"]
["GO:0000502","cellular_component","proteasome complex ","P04792; O14818; P17980; P54727; P62195; P55072; P61289; Q99460; Q13200; P54578; P25788; Q05086; Q9UMX0; P43686; P60900; P35998; O00231"]
["GO:0030018","cellular_component","Z disc ","P04792; P02511; P12814; P29475; O60237; O14974; Q13153; P56524; O00757; P11166; P23327; O95817; O43707; Q8WZ42; P30626; Q9BR39; P05787; Q92736; P32418; Q14524; P52179; P54296; Q15124; Q08209; O75369; P50461; P14923; Q13936; P49768; Q01668; Q14192; P49810; P22460; Q9UQD0; Q12955; P21333; O15273; Q5JQC9; Q9UNE7; O14958; P08727; Q14315; Q07343; P23634; P02730; Q8WX93; Q86YM7; O94875; Q9Y281; P17661; Q8IVF2; O00151; Q9H2S1; P15382; Q14896; O14950; Q15172; Q00872"]
["GO:0005778","cellular_component","peroxisomal membrane ","P04035; P36507; P33121; Q7Z434; P04040; O43581; P50542; P40855; P12268; Q9NP80"]
["GO:0000786","cellular_component","nucleosome ","P33778; P16104; P84243; P16403; Q5QNW6; Q6DRA6; P58876; Q6DN03; P62807; P06899; P16401; P68431; P62805; P23527; Q16778; Q07889; P0C0S8; Q92794; Q99879; Q93079; Q99877; Q02539; O60814; Q71DI3"]
["GO:0005801","cellular_component","cis-olgi network ","Q96KG9; Q08379; P27986; Q99996; Q9HCX4; P53671; P24390; Q92538; P30533"]
["GO:0030126","cellular_component","CPI vesicle coat ","Q96KG9"]
["GO:0005793","cellular_component","endoplasmic reticulum-olgi intermediate compartment ","Q96KG9; P09429; P17706; P56962; Q9BVK6; O43490; P24390; Q92614; Q92538; P30533; Q96AX2; Q15084; O94768; P11021"]
["GO:0000922","cellular_component","spindle pole ","O95835; P62714; O43663; P53350; P14635; Q8TDX7; Q14511; Q16539; P67775; Q9Y6K9; Q08379; P51955; P35222; Q9HC98; Q9NRM7; Q9ULW0; O75351; O43566; Q99741; Q9NS56; P0DP23; Q12798; Q13257; Q9Y6A5; Q14203; P62491; Q96SN8; P30305; O43379; Q9Y5B0; Q8NHV4; O00139; Q5BJF6; Q9Y6D9; Q12834; O43264; Q9BQ89; Q3KR16; Q9H410; P37198; Q9NS23; Q9Y6G9; O75449; Q8WWK9; Q14980; P52732; Q00839; Q92547; Q5FBB7; Q96TC7"]
["GO:0005947","cellular_component","mitochondrial alpha-ketoglutarate dehydrogenase complex ","O14874; P12694; P21953"]
["GO:0001726","cellular_component","ruffle ","Q00534; Q13882; Q9Y490; P12814; P19174; P07355; Q13464; Q13153; P15311; P09327; O14745; Q9UL63; P53365; O43739; Q16658; P05556; P56945; P35241; O00592; Q96DR7; Q14155; O43312; O15553; Q9Y6W5; Q9Y4I1; O14492; P30622; O43516; Q9UQB8; P31950; Q8WWN8; P06396; P22392; P46940; Q8WX93; P20339; P31949; P13796; O14713; Q8TDY4; P20936; Q96QT4; Q14247; Q4VCS5; Q9UM54; P35579; Q9UJU6; Q9NPB6"]
["GO:0005669","cellular_component","transcription factor TFIID complex ","P35269; Q12962; P52655; P19447; Q15545; Q5VWG9; P29083; Q00403"]
["GO:0005674","cellular_component","transcription factor TFIIF complex ","P35269"]
["GO:0000123","cellular_component","histone acetyltransferase complex ","Q09472; P51610; O95251; Q9H9L4; Q92793; Q6IE81; Q9BVI0; Q96EZ8; O15294"]
["GO:0032993","cellular_component","protein-DNA complex ","Q09472; P06748; P15976; Q9UJU2; Q99459; P78527; P35222; P01100; Q99502; P13010; P17535; P15173; P43351; P12956; Q02962; Q15022; P11387; P52952; Q02447; P23511; P14923; Q16236; P08047; Q9NQB0; Q16621; P31270; Q9Y2W7; P61244; P35638; P29375; P52926; P09874; Q03014; Q15648; Q00403"]
["GO:0031143","cellular_component","pseudopodium ","P27361; P12814; P49407; P28482; P04049; P26038; O43707; P51809; P17655"]
["GO:0035579","cellular_component","specific granule membrane ","P23467; O94804; P16671; Q13393; Q5T4S7; P13498; O60784; P62834; P05107; Q12913; P20138; P13688; O00161; Q96D96; P00749; Q13303; P60880; O94759; P20333; Q96AX2; P23763; Q9NPY3; O00264; Q9H3Z4"]
["GO:0070821","cellular_component","tertiary granule membrane ","P23467; Q13393; Q5T4S7; P61106; P13498; P05107; P20138; P30273; P13688; O00161; P00749; Q13303; P63167; P60880; O94759; P23763; Q9NPY3; P01111; P78324"]
["GO:0035189","cellular_component","Rb-E2F complex ","P06400; Q01094"]
["GO:0016514","cellular_component","SWI/SNF complex ","P06400; O14497; Q12824; P51532; Q8TAQ2; Q969G3; Q6STE5; O94805; Q8NFD5"]
["GO:0017053","cellular_component","transcriptional repressor complex ","P15976; Q96ST3; P05412; P56524; Q9Y618; Q96T58; P56545; P45973; Q969G3; Q02447; Q99626; P08047; O15379; Q53H80; Q99708; Q9BZK7; P24385; Q5TB30; Q5TKA1; P29374; P51858; Q05516; O75376; P10071; P12755; Q13363; P31946; Q06330"]
["GO:0045177","cellular_component","apical part of cell ","P35240; Q04771; P15311; P29972; P01130; P49757; P26038; Q15154; P35462; Q13895; Q9NSB8; Q14573; O14641; P00918; P51809; P05067; Q8NHV4; P23258; O75553; P21730; Q07157; Q86YM7; P60953; Q9UM54; O14950; Q99538"]
["GO:0032154","cellular_component","cleavage furrow ","P35240; O00444; Q16512; Q16513; Q53EZ4; Q03188; P35580; Q15019; P05556; Q8WYL5; P35241; Q96GX5; Q15746; Q9NXR1; O95425; O14578; Q9H0H5; O00562; Q16181; O95235; Q9UHB6; Q9H8V3; Q8IYM1; P62491; O00255; P62745; Q3KR16; P36873; P61586; P11233; O75154; P35579"]
["GO:0030864","cellular_component","cortical actin cytoskeleton ","P35240; P68104; P54840; P23528; P11166; Q9ULJ8; Q9HBA0; P35241; P60981; Q96QB1; Q9BV36; Q01518; Q9H204; P06396; P46939; P17655; Q14847; Q15334"]
["GO:0031527","cellular_component","filopodium membrane ","P35240; P05106; P50552; P17677; P46939"]
["GO:0000791","cellular_component","euchromatin ","Q9Y6K1; Q00613; Q14684; Q9GZV1; Q96T88"]
["GO:0001741","cellular_component","XY body ","Q9Y6K1; O00444; P16104; P63146; P63165; P49459"]
["GO:0022627","cellular_component","cytosolic small ribosomal subunit ","P62753; P60866; P62280; P62979; P23396; P42677; P46782; P46783; P62841; Q9BY44; Q71UM5; P39019"]
["GO:0015935","cellular_component","small ribosomal subunit ","P62753; P62979; P63244"]
["GO:0070852","cellular_component","cell body fiber ","P00966; P28223; Q14654"]
["GO:0031235","cellular_component","intrinsic component of the cytoplasmic side of the plasma membrane ","P21359; Q5VWQ8; Q9UJF2; Q96PV0; P20936"]
["GO:0035866","cellular_component","alphav-beta integrin-PKCalpha complex ","P17252; P05106"]
["GO:0097542","cellular_component","ciliary tip ","Q6PHR2; O76039; P20794; Q9UPZ9; P08151; Q9NP97; Q9NQC7; P10070; P63167; Q9UMX1; Q9Y496; P10071"]
["GO:0000407","cellular_component","phagophore assembly site ","Q6PHR2; Q96BY7; Q13501; Q9Y4P8; Q9H6K1; Q8NEB9; O75143; Q7Z3C6; Q14457"]
["GO:0030870","cellular_component","Mre11 complex ","O60934; P49959; Q92878"]
["GO:0042405","cellular_component","nuclear inclusion body ","O60934; P49792; P12270; P54252; P49790; P54253; Q9UNE7; Q9NS91; P52948"]
["GO:0005657","cellular_component","replication fork ","O60934; P16104; Q12888; P04637; P54132; O43542; P26358; P12004; Q96T88; P63146; Q9NS91; Q14191"]
["GO:0035861","cellular_component","site of double-strand break ","O60934; P15336; P16104; Q12888; Q9H4L7; Q9Y3Z3; Q8IW19; P55072; Q9UMS4; P49959; Q5UIP0; Q53H47; Q06609; Q92878; Q9NS91; Q9BUR4; Q9NZC9; Q8WVD3"]
["GO:0005903","cellular_component","brush border ","Q9UEY8; P12814; P15311; Q13045; P29972; P09327; Q12967; O43707; P11168; O00299; P08473; Q15149; P18206; O75369; Q14573; P49795; P61158; O75553; P48764; P35579; O14950"]
["GO:0005882","cellular_component","intermediate filament ","P08670; P48681; P14136; P17302; P05787; P02545; Q9Y4I1; P30622; P14923; Q04695; P22392; P35900; P08727; Q86UE8; P17661; Q9NZQ3; P08729; P05783; P41219; P15924"]
["GO:0005777","cellular_component","peroxisome ","P08670; P35228; O75874; Q9GZY8; P04040; O43581; P47989; P30044; P50542; P00441; Q86WV6; O00429; Q92538; Q9UKA4; P40855; P22307; Q8NEB9; P29401; Q13907; Q9NP80; Q5T011"]
["GO:0045335","cellular_component","phagocytic vesicle ","P08670; P42768; Q9C0C7; P50995; P16671; P61106; Q9H3Q1; P62834; Q9P2Y5; P18084; O75369; Q15942; P51790; P51809; P61764; P62491; P06396; O95477; O00186; P60953; P30101; P63261; Q6ZWJ1; P33176; O14613; Q14457"]
["GO:0030863","cellular_component","cortical cytoskeleton ","P35228; P60709; P15311; P78352; O43707; Q08495; P11171; P21333; P02730; P28289; Q6X4W1; Q14247; Q16643"]
["GO:0005782","cellular_component","peroxisomal matrix ","P35228; O75874; P04040; P30044; P50542; P22307"]
["GO:0090575","cellular_component","RNA polymerase II transcription factor complex ","Q9H2X6; P49715; P37231; P19793; P40763; P17096; Q13263; P14859; P43694; P27540; O75461; P15923; Q14186; Q86X55; Q16665; P11473; O00716; P52952; O00482; P50553; P23511; Q13285; Q13133; O96004; P61244; P13349; Q16633; P23246; Q9NZC7; Q00403; P23409; Q13562"]
["GO:0032301","cellular_component","MutSalpha complex ","P52701; P43246"]
["GO:0016593","cellular_component","Cdc7/Paf complex ","Q6PD62; Q6P1J9; Q8WVC0"]
["GO:0035327","cellular_component","transcriptionally active chromatin ","Q6PD62; O75475; P03372; P16403; Q8IZD2; Q7KZ85; Q8IZL8; Q9NQT5; Q9NQT4; P55199"]
["GO:0016342","cellular_component","catenin complex ","P25054; P35221; P35222; P12830; P19022; P14923"]
["GO:0016328","cellular_component","lateral plasma membrane ","P25054; Q7KZI7; P21860; P17302; P35222; P04083; O14640; P81274; Q92913; Q16625; P12830; O95471; Q14721; O15551; Q14524; Q9ULK5; P14923; O14641; Q12959; P14416; P13688; Q9ULV4; O14493; Q12955; P46940; P30153; P08034; P98161; O15169; Q14980; Q03113; P09758"]
["GO:1990909","cellular_component","Wnt signalosome ","P25054; Q5S007; P49841; P35222; O14640; O75581"]
["GO:0031226","cellular_component","intrinsic component of plasma membrane ","P09619; P21980; P16234; Q9NZV8; P34998; P41143; Q9UBH6; Q99250; Q96A54; Q9Y3Q4; O43306; P21453; O00206; Q8NER1; Q9Y6Y9; P30203"]
["GO:0043202","cellular_component","lysosomal lumen ","P09619; P07900; P13473; P48023; Q6UVK1; O14773; P18827; P11142; P17405; P34741; P31431; O75056; Q99538"]
["GO:0032044","cellular_component","DSIF complex ","O00267"]
["GO:0032432","cellular_component","actin filament bundle ","P02511; P09327; P29966; P13796"]
["GO:0097512","cellular_component","cardiac myofibril ","P02511; P45379; P19429; P10916; P17661; Q14896"]
["GO:0031430","cellular_component","M band ","P02511; P06733; P04075; Q8WZ42; A8MU46; Q01082; P52179; P54296; Q14192; Q9UHP9; Q14896; Q15172; Q00872"]
["GO:0032444","cellular_component","activin responsive factor complex ","Q15796; Q13485"]
["GO:0071144","cellular_component","heteromeric SMAD protein complex ","Q15796; P84022"]
["GO:0071141","cellular_component","SMAD protein complex ","Q15796; Q15797; P84022; O15198; Q13485; P52926"]
["GO:0035869","cellular_component","ciliary transition zone ","Q00532; Q15154; Q9UPN4"]
["GO:0005680","cellular_component","anaphase-promoting complex ","O60566; Q13042; Q9UJX5; Q9H1A4; Q9UJX3; Q8NHZ8; Q16763; Q9UJX2; P30260"]
["GO:0000940","cellular_component","condensed chromosome outer kinetochore ","O60566; Q8IX90; Q96BD8"]
["GO:0000778","cellular_component","condensed nuclear chromosome kinetochore ","O60566; Q03188; P49450; Q6P0N0"]
["GO:0097125","cellular_component","cyclin B-CDK complex ","P06493; P14635"]
["GO:0072686","cellular_component","mitotic spindle ","P06493; O00311; P20794; P28482; Q9Y6K9; Q08379; Q9ULW0; Q13563; Q14807; Q14674; P23396; Q13257; Q9Y6A5; P12270; Q9H0H5; P27816; Q9H8V3; P55040; Q49MG5; Q96R06; Q9Y6D9; P63167; Q8N4N8; O60610; P37198; P60953; Q14980; P52732; P46060; Q00839; Q8IXJ6; Q00610; Q02241"]
["GO:0016580","cellular_component","Sin3 complex ","Q96ST3; P68400; Q9H7L9; Q92769; Q9UBU8; Q13547"]
["GO:0035868","cellular_component","alphav-beta integrin-HMB1 complex ","P09429; P05106"]
["GO:0097550","cellular_component","transcriptional preinitiation complex ","P03372; P29083; Q00403"]
["GO:0098797","cellular_component","plasma membrane protein complex ","P07949; Q07954"]
["GO:0062023","cellular_component","collagen-containing extracellular matrix ","P21980; P07355; P04083; P02671; P04004; P01009; P02765; P09382; P19022; P11047; P00747; P14543; Q6UVK1; P02649; Q14624; P08133; P32004; Q8IUX7; P13591; P17931; P08758; Q14118; P34741; P06702; P51858; P13726; O75056; P08253; P50895; P36955; Q01955"]
["GO:0097381","cellular_component","photoreceptor disc membrane ","Q15835; Q8WTQ7; P11488; P32298; O75916; Q02846; Q9UHM6; Q9UMX6; P18545; P08100"]
["GO:0030175","cellular_component","filopodium ","Q12792; O15357; Q00535; Q6IBS0; P54764; P15311; Q9ULJ8; P09327; Q70E73; O14745; Q9NZI8; P26038; Q92913; A0MZ66; Q9C0H9; P51674; Q16658; P05556; Q8N8S7; Q9HBA0; P35241; Q13576; O00592; Q8IVF5; Q9H4E7; P63267; Q9UQB8; P68133; Q8NEV4; Q96SB3; P46939; Q14204; Q14118; P13796; P60953; O95398"]
["GO:0030016","cellular_component","myofibril ","Q12792; P15172; Q05682; Q6IBS0; Q9UKX2; P10916; P28289; P60900; P63261; Q15842; Q9UKX3; Q00872"]
["GO:0031594","cellular_component","neuromuscular junction ","O15146; Q00535; Q96RT1; P46109; P54764; P56524; Q15650; Q9ULJ8; Q15078; Q07001; P05556; Q7L0J3; P07196; Q5T5C0; Q12959; Q71U36; P49768; Q8N9N2; P05067; P49810; Q02297; P46939; Q12955; P10644; Q13424; O75096; P17661; Q03721; P23763; P35579; P61266; O95886; Q9H3Z4"]
["GO:0031904","cellular_component","endosome lumen ","O60674; P01236; P05067; P30533; P16471"]
["GO:0000308","cellular_component","cytoplasmic cyclin-dependent protein kinase holoenzyme complex ","O94921; Q8ND76"]
["GO:0036398","cellular_component","TCR signalosome ","Q15831; Q13094"]
["GO:1990907","cellular_component","beta-catenin-TCF complex ","Q9UJU2; P35222; P15884; Q9BRQ0; Q04724"]
["GO:0002944","cellular_component","cyclin K-CDK1 complex ","Q9NYV4"]
["GO:0019908","cellular_component","nuclear cyclin-dependent protein kinase holoenzyme complex ","Q9NYV4; Q14004"]
["GO:0030176","cellular_component","integral component of endoplasmic reticulum membrane ","Q9NZJ5; Q9BSJ8; O75298; Q9UKV5; Q9NQC3; Q9NZS9; Q13586; O75460; P18850; Q14494; P17861; Q86XL3; Q9P2E9; P11021"]
["GO:0031092","cellular_component","platelet alpha granule membrane ","P16284; P05106; P16671; Q06481"]
["GO:0030485","cellular_component","smooth muscle contractile fiber ","P16284"]
["GO:0035061","cellular_component","interchromatin granule ","Q13148; Q01130"]
["GO:0005726","cellular_component","perichromatin fibrils ","Q13148; O15164"]
["GO:0016600","cellular_component","flotillin complex ","P22681; P35221; Q14254; P12830; Q01959; O75955; Q9ULV4; O75096"]
["GO:0005814","cellular_component","centriole ","O14965; O00444; P53350; P42858; Q13464; Q5SW79; Q53EZ4; Q9HC77; Q8TAP6; Q8TEP8; Q15154; Q9NYY3; Q9NS56; Q15468; Q5TZA2; Q12798; P0DMV8; P62826; Q96PF2; Q9Y3M2; O15392; O95684; O95613; Q9UJT2; Q14203; P41208; O43379; P41002; O43303; Q8NHV4; P23258; O00139; Q5BJF6; Q8N137; Q8TD08; Q9BV73; Q3V6T2; Q9Y496; Q8IXJ6; Q86YF9"]
["GO:0042585","cellular_component","germinal vesicle ","O14965; P29966"]
["GO:0072687","cellular_component","meiotic spindle ","O14965; Q9UKT4; Q8TD08; P54652; Q8IXJ6"]
["GO:0045120","cellular_component","pronucleus ","O14965; Q00613; Q15910; P07910"]
["GO:0060076","cellular_component","excitatory synapse ","Q05586; P21802; P78352; P21579; Q9UQB8; Q07343; Q8N0W4; P42262; Q8N2Q7; Q9Y566"]
["GO:0043083","cellular_component","synaptic cleft ","Q05586; P02649"]
["GO:0044232","cellular_component","organelle membrane contact site ","Q9BSJ8; Q14849"]
["GO:0005637","cellular_component","nuclear inner membrane ","Q15797; P84022; Q96EB6; P20700; P40305; Q5JTV8; Q03252; O75460; Q9Y2U8; P43243; Q14643; P49810; P50402; P42167; Q13185"]
["GO:0033565","cellular_component","ESCRT- complex ","O75886; O14964"]
["GO:0071565","cellular_component","nBAF complex ","O14497; Q12824; P51532; Q8TAQ2; Q969G3; Q92784; Q6STE5; O94805; Q8NFD5"]
["GO:0071564","cellular_component","npBAF complex ","O14497; Q12824; P51532; Q8TAQ2; Q969G3; Q6STE5"]
["GO:0044294","cellular_component","dendritic growth cone ","O76039; P08238; P07900; P11137; Q9UL54; Q9NQC3; Q9UQF2"]
["GO:0099092","cellular_component","postsynaptic density, intracellular component ","O76039; P11274; P06241; Q9UKE5; P50570; Q92974; O60716; Q9UQB8; Q99961"]
["GO:0010369","cellular_component","chromocenter ","Q96GD4; P45973; Q06787; P83916; Q9NQS7; Q53HL2"]
["GO:0000779","cellular_component","condensed chromosome, centromeric region ","Q96GD4; Q02224; P17676; Q13185; Q5FBB7; Q9BPX3"]
["GO:1990023","cellular_component","mitotic spindle midzone ","Q96GD4; Q02224; Q96Q89; Q49MG5; Q14247; Q14980; Q00839"]
["GO:0048179","cellular_component","activin receptor complex ","Q04771; P36896"]
["GO:0000159","cellular_component","protein phosphatase type 2A complex ","P62714; P67775; Q14738; Q13362; P99999; P30153; Q15172"]
["GO:0030659","cellular_component","cytoplasmic vesicle membrane ","Q8IYT8; Q07912; P49407; P42858; Q8NCB2; P04083; P14672; Q9BY11; P28472; P18507; Q86YS7; Q9UIQ6; Q13563; Q7L804; Q8NHG8; Q9UL54; P56817; P38484; Q9H310; Q15036; Q5T5C0; P30622; P62491; Q86WV6; Q9ULU8; P20338; P51787; Q96B97; Q99523; P47870; Q8IVF2; O94759; Q13261; Q5T5U3; P11233; P48050; Q5VZ89; P14867; Q8NFJ5; P51168"]
["GO:0034045","cellular_component","phagophore assembly site membrane ","Q8IYT8; O75385; Q5MNZ6; Q9H1Y0; Q96BY7; Q9Y4P8; Q676U5"]
["GO:0033391","cellular_component","chromatoid body ","P06730; O15516; O00327; Q9UHL0; P26196; Q08J23; Q9BXT4"]
["GO:0016281","cellular_component","eukaryotic translation initiation factor 4F complex ","P06730; P23588; Q04637; Q14240; Q15056; O43432"]
["GO:0005845","cellular_component","mRNA cap binding complex ","P06730; Q9BTL3; Q06787; O43148; P52298; Q9UKV8; Q09161"]
["GO:0000932","cellular_component","P-body ","P06730; Q9HC16; Q8NF91; O75175; P19474; Q9NRA8; Q86TB9; Q9UGP4; P17980; Q14671; Q5D1E8; Q93062; Q9BZB8; P11387; Q96F86; Q13501; Q92900; Q5TC82; Q9NPI6; Q9UPQ9; Q07352; Q9NZN8; Q9Y2V2; P60900; P35998; Q96IF1; P26651; P26196; Q9UKV8"]
["GO:0099524","cellular_component","postsynaptic cytosol ","P06730; P05129; P42345; P42858; P60484; Q01970; P38919; Q9UQB8; Q14118; Q13526; Q16643"]
["GO:0016442","cellular_component","RISC complex ","P06730; Q7KZF4; Q9UGP4; Q15633; P26196; Q9UKV8"]
["GO:0043020","cellular_component","NADPH oxidase complex ","Q15080; P14598; Q86UR1; P13498; Q8NFA2; Q9NPH5; P19878"]
["GO:0032010","cellular_component","phagolysosome ","Q15080; P14598; P19878"]
["GO:0005802","cellular_component","trans-olgi network ","Q15080; Q15139; Q5S007; P63000; P09958; Q96CV9; P53675; P09497; P61106; P13473; Q9NUY8; Q96P48; P12830; P50570; Q9Y6D6; P56817; Q9BTU6; Q92673; P63027; Q9Y3M2; P11717; P51809; P62491; Q92614; P57737; P20645; O75122; Q92538; Q13439; Q9H4A6; P60880; Q7Z3C6; P19021; P22059; Q04656; Q14457"]
["GO:0042406","cellular_component","extrinsic component of endoplasmic reticulum membrane ","P29590; P25686; Q5D1E8"]
["GO:0000792","cellular_component","heterochromatin ","P29590; Q00613; Q14684; Q9H4L7; Q9HC52; Q13547; Q96T88; Q13416; P63165; O95983; P51608; P26196"]
["GO:0070531","cellular_component","BRCA-A complex ","P38398; Q9NWV8; Q99728; Q96RL1; Q6UWZ7"]
["GO:0031436","cellular_component","BRCA-BARD complex ","P38398; Q99728"]
["GO:0008274","cellular_component","gamma-tubulin ring complex ","P38398"]
["GO:0000800","cellular_component","lateral element ","P38398; P54132; Q06609; Q9NQS7; Q9UQE7; P51587"]
["GO:0000151","cellular_component","ubiquitin ligase complex ","P38398; Q9Y6K9; Q92630; O75150; Q9UKT5; Q9UL63; Q12933; Q9NS56; P35226; P68036; Q9UNE7; Q13404; Q9Y2Z0; Q96S59; Q96Q27; Q9Y3C5; Q99728; P61088; Q96PM5; Q9H0M0; Q8WWI1; Q15648; P46934; Q9UBS8; O60260; Q5VTR2"]
["GO:0033116","cellular_component","endoplasmic reticulum-olgi intermediate compartment membrane ","P48730; Q08379; P42261; P01009; Q9BQQ3; P56962; Q9BVK6; P24390; P12259"]
["GO:0002945","cellular_component","cyclin K-CDK13 complex ","Q14004"]
["GO:0016592","cellular_component","mediator complex ","Q9Y2W1; P49336; Q15131; O60244; Q96PK6; Q9H204; Q15648"]
["GO:0070436","cellular_component","rb2-EFR complex ","Q07912; P62993"]
["GO:0031258","cellular_component","lamellipodium membrane ","P29317; P05106; P23528; P50552; Q96AC1; P16070; Q8NF50; Q6UVK1; P16389"]
["GO:0070938","cellular_component","contractile ring ","O43663; Q96Q89; Q14118"]
["GO:0098536","cellular_component","deuterosome ","O00444"]
["GO:0097441","cellular_component","basal dendrite ","P45983; P11137; Q99962; P46821"]
["GO:0005641","cellular_component","nuclear envelope lumen ","P09917; P07437; Q92673; P11717; P05067"]
["GO:0033162","cellular_component","melanosome membrane ","P07101; P14679"]
["GO:0005790","cellular_component","smooth endoplasmic reticulum ","P07101; P30626; Q92736; Q9Y4I1; P49768; P05067; P27824; P31415; P30040; P21817; P63252; P11021"]
["GO:0035580","cellular_component","specific granule lumen ","P19838; P42685; P18206; Q99439; Q13813; P14923; Q96NW7; P29350"]
["GO:0071013","cellular_component","catalytic step 2 spliceosome ","Q99459; Q13523; P61978; O43660; Q9NUU7; Q6NZY4; Q9UBB9; Q9Y5S9; P07910; P62316; P17844; Q8IYB3; P14678; P38919; O60506; Q01081; Q15459; Q9UMR2; Q13573; Q9UHL0; Q9UMS4; Q9UKM9; O75533; Q92620; P09651; Q07955; Q14562; O43379; Q9UQ35; P11940; P22626; Q13435; P52272; P31943; Q9UNP9; Q6P2Q9; Q15029; Q9UJV9; P38159; Q00839; P62304; Q9P013; Q86V81"]
["GO:0000974","cellular_component","Prp1 complex ","Q99459; O43660; Q9UMS4; P11142"]
["GO:0071007","cellular_component","U2-type catalytic step 2 spliceosome ","Q99459; O43660; P62316; P14678; Q13573; Q9UMS4; Q14562; Q9UQ35; Q9UNP9; Q6P2Q9; Q15029; P62304; Q9P013"]
["GO:0033257","cellular_component","Bcl/NF-kappaB complex ","Q00653; P20749"]
["GO:0001669","cellular_component","acrosomal vesicle ","P35221; P10721; P17612; P49761; Q16623; Q96LC9; Q9H0H5; Q96PF2; Q9NQ86; O60271; Q9UJT2; P37088; P14416; Q9UPN4; P46531; P19784; Q8NG31; P21731; Q13444; Q14654; P19878; Q9BXA7; Q7LC44"]
["GO:0014704","cellular_component","intercalated disc ","P35221; P17302; Q13153; P11166; Q04917; Q92913; P05556; Q9Y613; O00168; Q99250; P19022; P32418; Q14524; P19634; Q15124; P14923; Q12959; P22460; Q12955; P05023; P17661; P36383; P63252; Q14654; P15924"]
["GO:0005915","cellular_component","zonula adherens ","P35221; Q9BX66; Q92692; P18206; O60716; P14923"]
["GO:0005916","cellular_component","fascia adherens ","P12814; P17302; P19022; P18206; P14923; P17661; P15924"]
["GO:0031093","cellular_component","platelet alpha granule lumen ","P12814; P02671; P04075; P01009; P02765; O43707; P00747; P05067; P12259; Q9UNF1; Q9Y6I9"]
["GO:0099699","cellular_component","integral component of synaptic membrane ","P18433; P05556; Q5T7P8"]
["GO:0044305","cellular_component","calyx of Held ","P29475; P60709; P05129; Q9Y2X7; O95069; O14810; P28222; P22001; P16389; Q09470; P63261; Q6PUV4"]
["GO:0016529","cellular_component","sarcoplasmic reticulum ","P29475; O00631; O60936; P30626; Q92736; P47989; Q9Y272; Q9Y6F6; Q14643; Q12955; P31415; O14958; P21817; P16615"]
["GO:0030315","cellular_component","T-tubule ","P29475; P15311; P14672; O75298; P48544; P30626; O00168; P35241; Q99250; P48549; P32418; Q14524; P19634; Q12955; P31415; P05023; P23634; Q8IVF2; P21817; P63252; Q14654; Q09666; Q13698"]
["GO:0043034","cellular_component","costamere ","Q13418; P51114; Q15149; P18206; P05787; Q15124; O95425; P30427; Q12955; P08727; Q14315; Q14118; Q86YM7; P31431; Q8IVF2; Q9UHP9; Q09666"]
["GO:0043198","cellular_component","dendritic shaft ","Q13418; P54764; P11137; P28223; P31323; Q8TCU6; Q9H2X9; Q92974; Q96J84; P32418; P78559; Q96PV0; Q9UQB8; P49768; P05067; P49810; P46459; Q9ULU4; P21333; Q14831; Q8N2Q7"]
["GO:0030017","cellular_component","sarcomere ","Q13418; Q8NF91; P45379; P19429; P0DP23; Q9UKX2; O60706; Q13501; P68133; P10916; Q9H1R3; P47756; P28289; P60900; P08253; Q5JVS0; Q14896; P09493"]
["GO:0098574","cellular_component","cytoplasmic side of lysosomal membrane ","P68104; P14136; Q05639"]
["GO:0005853","cellular_component","eukaryotic translation elongation factor 1 complex ","P68104; P24534; P29692; Q05639"]
["GO:0000228","cellular_component","nuclear chromosome ","Q86U86; P05412; P84243; O96006; P54132; Q969G3; Q99592; O15392; Q06609; Q96BK5; Q9NYB0; P68431; Q06265; P62805; Q9BY41; P52926; Q00839"]
["GO:0016586","cellular_component","RSC-type complex ","Q86U86; Q15022"]
["GO:0005954","cellular_component","calcium- and calmodulin-dependent protein kinase complex ","Q9UQM7; Q96NX5"]
["GO:0005884","cellular_component","actin filament ","Q7KZI7; P42768; P06241; P07947; O43293; P12931; P15311; Q13459; Q96IZ0; Q14145; Q08495; Q12802; O14492; O43516; Q9BR76; Q9UBI6; P68133; P21333; P46940; Q5T1M5; Q8WX93; P13796; P47756; P28289; Q4VCS5; Q6JBY9; P17081; P63261; P09493"]
["GO:0097427","cellular_component","microtubule bundle ","Q7KZI7; Q14980"]
["GO:0005930","cellular_component","axoneme ","P20794; P08151; Q9C0C7; Q15019; Q9H1Y0; O75386; P10070; Q9P2E2; P27816; Q16181; Q9GZQ8; Q4G0X9; Q8NEB9; P10071; Q9UHD8; Q676U5"]
["GO:0031514","cellular_component","motile cilium ","P20794; P17612; P04083; P09622; Q13563; Q9Y365; Q16665; O75952; P10070; O15259; P37088; Q5JQC9; Q4G0X9; P98161; Q96KC9; Q13444; Q9BXA7"]
["GO:0032391","cellular_component","photoreceptor connecting cilium ","P20794; P11488; Q9NS56; Q15019; Q12798; O15259; Q9P2E2; P41208"]
["GO:0072562","cellular_component","blood microparticle ","P60709; P07737; P02671; P11166; P00736; P04004; P02786; P26038; P02765; O00560; Q4V328; O00299; P00747; P62195; P34931; P0DMV8; P02649; Q14624; P63267; P68133; P06396; P11142; P02730; P54652; Q9BY44; P63104; P00450; P63261"]
["GO:0097433","cellular_component","dense body ","P60709; Q7KZF4; P63261"]
["GO:0035267","cellular_component","NuA4 histone acetyltransferase complex ","P60709; Q9Y4A5; Q9UBU8; Q96L91; Q9H0E9; Q9Y230; Q92993; Q9Y265"]
["GO:0098871","cellular_component","postsynaptic actin cytoskeleton ","P60709; Q9ULJ8"]
["GO:0035985","cellular_component","senescence-associated heterochromatin focus ","P17096; P42771; P52926"]
["GO:0000421","cellular_component","autophagosome membrane ","Q15139; P04844; P56962; Q9GZQ8; Q9Y371; Q9H492; Q676U5"]
["GO:0008180","cellular_component","CP9 signalosome ","P19174; P62993; Q8N1K5; Q13098; Q7L5N1; Q9UNS2; O43561"]
["GO:0035578","cellular_component","azurophil granule lumen ","P07355; P28482; P42685; P53396; Q05655; O00560; P30041; P07437; P11216; P55072; P61160; Q99460; Q8N1F8; P28799; Q01518; P78371; Q14204; Q9H410; Q9ULZ3; Q9UQ80; P50395"]
["GO:0005765","cellular_component","lysosomal membrane ","P07355; P49407; P42345; P08238; P38606; Q92542; Q13393; Q9UP95; P61106; Q9UIQ6; P13473; Q8NHG8; O15455; P42892; Q14849; Q9BTU6; O43581; Q96JC1; Q8WTV0; P51148; P08133; Q01628; P11717; P51809; O75955; P49768; Q8N1F8; P80108; P20645; P49810; P98082; P46459; O95295; Q15382; P13569; P11142; Q8N122; Q99523; Q96CW1; O94759; Q9NRA0; Q07954; Q9GZU1; P62987; P00450; Q9UM54; Q09666; O43504; Q5T011; Q9H3Z4; P22413"]
["GO:0044354","cellular_component","macropinosome ","P07355; Q5VZK9; P50281"]
["GO:0042470","cellular_component","melanosome ","P07355; P49327; P05106; P63000; Q7KZF4; P08238; P07900; Q8IYJ3; P11166; P35749; Q14344; P50995; Q92542; P55209; P02786; O00560; P05556; P14679; P14625; P61020; P51148; Q9Y4I1; P08133; P62826; O75955; Q06830; P62258; O14773; P62820; P27824; P11142; Q14697; P30040; P05023; P20339; P30101; P63104; Q15084; P08195; Q9Y5S1; P36955; P31946; O43852; Q00610; P04843; P50281; P11021; Q9H3Z4"]
["GO:0035749","cellular_component","myelin sheath adaxonal region ","P07355; P60484"]
["GO:1990667","cellular_component","PCSK-AnxA2 complex ","P07355"]
["GO:0043220","cellular_component","Schmidt-Lanterman incisure ","P07355; P60484; P41743; Q8IXJ6"]
["GO:0097546","cellular_component","ciliary base ","Q9UPZ9; P13861; P17612; Q9UQ07; P22694; P08151; P31323; O75386; P10070; P10644; P22612; Q9UMX1; P10071"]
["GO:0000118","cellular_component","histone deacetylase complex ","Q9UQL6; P56524; Q9Y618; P49773; Q8WUI4; P48552; Q13547; P45973; Q9UBN7; O15379; Q9BY41; Q9H0D2; O94776; Q9UKV0"]
["GO:0042101","cellular_component","T cell receptor complex ","P43403; P43405; Q86WV1; P09693; P07766; P20963; Q6PIZ9; P01730"]
["GO:0005958","cellular_component","DNA-dependent protein kinase-DNA ligase 4 complex ","P78527; Q13426; P49917"]
["GO:0070419","cellular_component","nonhomologous end joining complex ","P78527; P13010; P12956; Q13426; Q9H9Q4; P49917; Q96SD1"]
["GO:0031264","cellular_component","death-inducing signaling complex ","Q13546; Q13158; P25445; Q14790; O15519; P42574"]
["GO:0097342","cellular_component","ripoptosome ","Q13546; Q13158; Q14790; O15519"]
["GO:0034451","cellular_component","centriolar satellite ","P53350; Q15154; Q02962; Q9UPT5; P05062; O95613; O75955; Q96R06; Q9UPN4; P05783; Q86YF9; Q9NPB6"]
["GO:0000942","cellular_component","condensed nuclear chromosome outer kinetochore ","P53350; P14635; O43683; O14777"]
["GO:0000795","cellular_component","synaptonemal complex ","P53350; Q7Z5K2; P40692; P63279; P17600; P54652"]
["GO:0031523","cellular_component","Myb complex ","P10244; P21333"]
["GO:0016459","cellular_component","myosin complex ","P19105; Q13459; P35580; Q96LC9; Q92614; Q8NEV4; P10916; Q01449; Q9P2M7"]
["GO:0001673","cellular_component","male germ cell nucleus ","P16104; P40692; P54652; Q05952; Q92547"]
["GO:0090734","cellular_component","site of DNA damage ","P16104; P13010; P27694; P45973; P83916; P09874; Q13185; Q6PCD5"]
["GO:0031307","cellular_component","integral component of mitochondrial outer membrane ","Q09013; Q8IWA4; P50416; Q8IXI2; P57105; Q9BXM7; Q16611"]
["GO:0031428","cellular_component","box C/D snoRNP complex ","Q14978; O43818; P22087"]
["GO:0031429","cellular_component","box H/ACA snoRNP complex ","Q14978; O60832"]
["GO:0035867","cellular_component","alphav-beta integrin-IF-1-IF1R complex ","P05106; P08069"]
["GO:0071062","cellular_component","alphav-beta3 integrin-vitronectin complex ","P05106; P04004"]
["GO:0034683","cellular_component","integrin alphav-beta complex ","P05106"]
["GO:0008305","cellular_component","integrin complex ","P05106; P05556; P26010; P05107; P17301; P16144"]
["GO:0031528","cellular_component","microvillus membrane ","P05106; P15311; Q8IYJ3; Q5T2W1; Q16790; O14745; P26038; O00592; Q8WTV0; O43490; P13688; Q6UY09"]
["GO:0044228","cellular_component","host cell surface ","P30530"]
["GO:1990391","cellular_component","DNA repair complex ","Q12888; Q13315; O60341"]
["GO:0005952","cellular_component","cAMP-dependent protein kinase complex ","P13861; P17612; P22694; P31323; Q15300; Q5JQC9; P10644"]
["GO:0044853","cellular_component","plasma membrane raft ","P13861; P17612; Q9NZV8; P15311; P36544; Q13094; Q86WV1; P19022; P05107; P10644; Q14118; P35612"]
["GO:1990589","cellular_component","ATF4-CREB transcription factor complex ","P16220; P18848"]
["GO:0005719","cellular_component","nuclear euchromatin ","P16220; P05412; Q13263; P35222; O15164; P16403; Q96EB6; Q9UBK2; Q96RI1; O43474; Q9Y230; Q6X4W1; P38159; Q13185; Q02539"]
["GO:0012506","cellular_component","vesicle membrane ","P42768; Q9Y2I7; P14672; Q9P289; Q9UKG1; P62993; Q12933; P16333; O43426; P51790; Q6ZS17; Q99259; P16615"]
["GO:0101003","cellular_component","ficolin--rich granule membrane ","Q7L591; P63000; Q5T4S7; P13473; P05107; P21462; P30273; P17931; P63167; O60610; Q9Y6G9; P61586; O94759; Q9NPY3; P78324; P15924"]
["GO:0000125","cellular_component","PCAF complex ","Q9Y4A5; Q12962"]
["GO:0030914","cellular_component","STAA complex ","Q9Y4A5; Q12962; O75529"]
["GO:0000812","cellular_component","Swr complex ","Q9Y4A5; Q96L91; O43257; Q9H0E9; Q9Y230; Q92993; Q9Y265"]
["GO:0033276","cellular_component","transcription factor TFTC complex ","Q9Y4A5; Q12962; O75529; Q15545"]
["GO:0043296","cellular_component","apical junction complex ","Q16513; P12830; Q07157; P61586"]
["GO:0045111","cellular_component","intermediate filament cytoskeleton ","Q16513; P48681; P49761; O75469; Q15149; P05787; Q86SQ0; P07197; Q14203; O43164; Q04695; Q9UNZ2; P48664; P17661; P50281"]
["GO:0031672","cellular_component","A band ","O60237; O14974; P56524; Q9UKX2; P10916; Q01449; Q14896"]
["GO:0035976","cellular_component","transcription factor AP-1 complex ","P05412; P01100; P17535; P17275; P35638"]
["GO:0032021","cellular_component","NELF complex ","P18615; Q8IXH7; Q9H3P2; Q8WX92"]
["GO:0000930","cellular_component","gamma-tubulin complex ","Q96L34; Q9NS56; P23258; Q07343; Q9NRH3"]
["GO:0032433","cellular_component","filopodium tip ","P54762; P09327; Q06787; Q9Y4I1; Q8NEV4; Q9NYB9; P61086; Q8IZP0; Q8N2Q7; Q99828"]
["GO:0035097","cellular_component","histone methyltransferase complex ","O14744; Q15291; Q9P0U4; Q9BTK6; P45973; Q9UPS6; Q14686; O00255; Q03164; O14686; Q9UKV0"]
["GO:0034709","cellular_component","methylosome ","O14744; P62316; P14678; Q9BQA1; P54105; P62304; Q99873"]
["GO:0022626","cellular_component","cytosolic ribosome ","Q9P2K8; Q9UBK2; P26373"]
["GO:0071339","cellular_component","MLL complex ","P51610; Q15291; O75461; Q15545; Q9Y4W2; Q9BVI0; Q8IZL8; P61244; Q9Y230; Q8IXM2; Q03164; Q96EZ8; Q9Y265"]
["GO:0048188","cellular_component","SetC/CMPASS complex ","P51610; Q15291; Q9P0U4; Q9UPS6"]
["GO:0044798","cellular_component","nuclear transcription factor complex ","Q13469; O43474; P48436"]
["GO:0044753","cellular_component","amphisome ","Q5S007; Q13501"]
["GO:0044754","cellular_component","autolysosome ","Q5S007; Q13772; P13473; Q13501; Q9GZQ8; Q8NEB9; Q9H492"]
["GO:0099400","cellular_component","caveola neck ","Q5S007"]
["GO:0032473","cellular_component","cytoplasmic side of mitochondrial outer membrane ","Q5S007"]
["GO:0005798","cellular_component","olgi-associated vesicle ","Q5S007; Q9P289; P14679; O75716"]
["GO:0005902","cellular_component","microvillus ","Q5S007; Q02763; P15311; P38606; Q9NQT8; P09327; O14745; P26038; Q16658; P35241; Q13576; P16150; P16070; Q9Y365; P55317; P00918; P55064; Q3KR16; Q9UM54; Q04656; O95398"]
["GO:0097487","cellular_component","multivesicular body, internal vesicle ","Q5S007"]
["GO:0000015","cellular_component","phosphopyruvate hydratase complex ","P09104; P06733"]
["GO:0098688","cellular_component","parallel fiber to Purkinje cell synapse ","P07737; O43424; P48549"]
["GO:0055038","cellular_component","recycling endosome membrane ","P63000; P42261; Q96CV9; P01889; Q9BXF6; Q15836; P61106; Q7L804; Q92597; Q15027; Q4V328; P62491; Q8N3F8; P20338; P13569; P30101; O75154; P50479; P01892"]
["GO:1990316","cellular_component","Atg/ULK kinase complex ","O75385; Q8TEV9; O75143"]
["GO:0005776","cellular_component","autophagosome ","O75385; P42858; Q9C0C7; Q96CV9; P19474; P48426; P56962; Q9H1Y0; O15553; Q13501; Q9UMX0; Q9GZQ8; Q8TD08; Q9H6K1; P78356; Q7Z3C6; Q9H492; Q676U5; Q14457"]
["GO:0097635","cellular_component","extrinsic component of autophagosome membrane ","O75385"]
["GO:0097629","cellular_component","extrinsic component of omegasome membrane ","O75385"]
["GO:0097632","cellular_component","extrinsic component of phagophore assembly site membrane ","O75385"]
["GO:0030478","cellular_component","actin cap ","Q05682; O00401; P61160; P06396"]
["GO:0097450","cellular_component","astrocyte end-foot ","P14136"]
["GO:0019815","cellular_component","B cell receptor complex ","P43405; P40259; P11912"]
["GO:0032009","cellular_component","early phagosome ","P43405; O43581"]
["GO:0000788","cellular_component","nuclear nucleosome ","P84243; P49450; P68431; P62805; Q15306; Q05952; P10412"]
["GO:0043292","cellular_component","contractile fiber ","O14974; P17302; Q15078; A8MU46; P35659"]
["GO:0016533","cellular_component","protein kinase  complex ","Q00535; Q15078; Q13319"]
["GO:0030670","cellular_component","phagocytic vesicle membrane ","Q13905; P01889; Q15836; P13473; P13498; P50570; Q9H1Y0; O43581; P51809; O00161; Q6WKZ4; P20339; Q9UGM3; Q8NEB9; Q9GZU1; Q04656; P01892"]
["GO:0032585","cellular_component","multivesicular body membrane ","O14964; Q9NV92"]
["GO:0097038","cellular_component","perinuclear endoplasmic reticulum ","P06241; P13498; Q5T7P8; Q9NPH5; P17655; P07108"]
["GO:0000243","cellular_component","commitment complex ","P08621; P26368; Q8TAS1"]
["GO:0071011","cellular_component","precatalytic spliceosome ","P08621; O43660; P62316; P55081; Q8NAV1; O43379; Q13435; P62304; Q9BWJ5"]
["GO:0005681","cellular_component","spliceosomal complex ","P08621; Q15427; Q9UBB9; P07910; P31942; P62316; O75940; P14678; Q01130; Q01081; Q15459; Q7L7V1; Q13573; P26368; Q96I25; O75533; O43395; P09651; Q9BTA9; Q14562; P17931; Q15382; P11142; P22626; Q15637; Q13435; Q12972; P52272; Q9UNY4; Q15029; O00148; P62304; Q9P013; Q8WXA9; Q92917"]
["GO:0005685","cellular_component","U1 snRNP ","P08621; P62316; O75400; P14678; Q93062; P62304; Q9Y383"]
["GO:0071004","cellular_component","U2-type prespliceosome ","P08621; O75400; P14678; Q15459; P26368; O75533; Q8TAS1; Q9Y383"]
["GO:0016028","cellular_component","rhabdomere ","Q12866"]
["GO:0005922","cellular_component","connexin complex ","P17302; P48165; Q9UKL4; P08034; P36383"]
["GO:0005921","cellular_component","gap junction ","P17302; Q96RD7; Q96RD6; P30301; Q07157; P36383; Q16643"]
["GO:0030660","cellular_component","olgi-associated vesicle membrane ","P17302; P13569; P98161; P17081; P08100"]
["GO:0005771","cellular_component","multivesicular body ","P17302; P14672; Q96PU5; P56817; P11912; Q9UBN7; P62491; P13693"]
["GO:0031931","cellular_component","TRC complex ","P42345; O43156; Q9Y4R8; Q8N122"]
["GO:0031932","cellular_component","TRC complex ","P42345; P85299; O43156; Q9Y4R8; Q6R327; Q9BPZ7"]
["GO:1990682","cellular_component","CSF-CSFR complex ","P07333"]
["GO:0002102","cellular_component","podosome ","P61978; P12931; Q05209; P14598; Q16658; Q92974; P18206; Q5TCZ1; O95425; Q9ULH1; A1X283; Q8TED9; P06396; O60711; Q7L0Q8; Q07157; Q8WX93; P13796; Q14247; Q99961; Q9UJU6"]
["GO:1990604","cellular_component","IRE-TRAF2-ASK complex ","Q99683; Q12933; O75460"]
["GO:1902911","cellular_component","protein kinase complex ","Q99683"]
["GO:0034704","cellular_component","calcium channel complex ","P17612; Q08499; Q8NE86; P0DP23; Q92736; O14958"]
["GO:0097225","cellular_component","sperm midpiece ","P17612; O14745; Q13501"]
["GO:0035631","cellular_component","CD4 receptor complex ","O14920; O15111; O43464; Q12933; Q9NR28; Q9Y4K3; Q13114; P25942"]
["GO:0008385","cellular_component","IkappaB kinase complex ","O14920; Q9Y6K9; O15111; Q9ULZ3"]
["GO:0032420","cellular_component","stereocilium ","Q6IBS0; P35241; Q12929"]
["GO:0005899","cellular_component","insulin receptor complex ","P35568; P06213"]
["GO:0097165","cellular_component","nuclear stress granule ","Q00613; Q92797; P63165; P31483"]
["GO:0043679","cellular_component","axon terminus ","P19419; P54764; P41180; O75150; Q9BY11; P41143; P30626; O43581; P17301; Q06787; Q9C0D5; P08172; P14416; P16389; P41145; Q9Y2W7; P20339; Q13303; Q09470; P20309; Q99259; Q03721; O43665"]
["GO:0005671","cellular_component","Ada2/cn/Ada3 transcription activator complex ","O43318"]
["GO:0099738","cellular_component","cell cortex region ","P06733; P81274; Q9NQW6; P11171; Q14203; Q14980; O14950"]
["GO:0043265","cellular_component","ectoplasm ","P54840"]
["GO:0030134","cellular_component","CPII-coated ER to olgi transport vesicle ","Q08379; P01009; P56962; Q9ULK5; P05067; P12259"]
["GO:0000137","cellular_component","olgi cis cisterna ","Q08379; Q15334"]
["GO:0032580","cellular_component","olgi cisterna membrane ","Q08379; Q96P48; Q8IYU2; O00562; Q8NBN3; Q9H4A6; Q08378; Q99523; O43150"]
["GO:0005751","cellular_component","mitochondrial respiratory chain complex IV ","P00403"]
["GO:0045277","cellular_component","respiratory chain complex IV ","P00403"]
["GO:0101031","cellular_component","chaperone complex ","P53041; Q16543; O95816; Q15185; P31948; Q9UNE7; P11142; Q92574"]
["GO:0005623","cellular_component","cell ","P29474; P18206; Q8IWB6; P36897; P35372"]
["GO:0005773","cellular_component","vacuole ","Q04912"]
["GO:0034751","cellular_component","aryl hydrocarbon receptor complex ","P08238; O00170"]
["GO:0044295","cellular_component","axonal growth cone ","P08238; P54764; P07900; Q8TEW0; A0MZ66; P51674; Q02790; Q9UL54; P32004; P58400; Q9UQF2; O75122; Q13009; Q9Y5S1; P33176; O60282"]
["GO:0031526","cellular_component","brush border membrane ","P08238; P29972; Q5T2W1; Q14344; P16671; O14745; Q03431; Q9BX84; Q9UHB6; Q9UPX8; P40855; P48764; Q03113; Q04656"]
["GO:1990917","cellular_component","ooplasm ","P08238"]
["GO:1990913","cellular_component","sperm head plasma membrane ","P08238"]
["GO:0032590","cellular_component","dendrite membrane ","P06213; P18507; P41143; P18848; P84074; P35372"]
["GO:0032809","cellular_component","neuronal cell body membrane ","P06213; Q9NZV8; Q5VWQ8; Q14721; Q9Y6H6; P16389; P84074"]
["GO:0030056","cellular_component","hemidesmosome ","Q96RT1; Q9UMD9; Q15149; P30427; P16144"]
["GO:0099572","cellular_component","postsynaptic specialization ","Q96RT1"]
["GO:0070369","cellular_component","beta-catenin-TCFL2 complex ","P35222; P15884; Q9NQB0"]
["GO:0016581","cellular_component","NuRD complex ","P68400; Q92769; Q14839; Q13330; Q13547; Q86YP4; O95983; O94776"]
["GO:0005956","cellular_component","protein kinase CK2 complex ","P68400; P67870"]
["GO:0032281","cellular_component","AMPA glutamate receptor complex ","P42261; P78352; Q9Y698; P48058; P42262"]
["GO:0044308","cellular_component","axonal spine ","P42261; Q15075"]
["GO:0032591","cellular_component","dendritic spine membrane ","P42261; Q8NER1"]
["GO:0012507","cellular_component","ER to olgi transport vesicle membrane ","P42261; P01889; P53992; P56962; P36956; Q15436; Q12772; O60763; P01892"]
["GO:0044309","cellular_component","neuron spine ","P42261; P78352; Q9BYB0; Q86YM7"]
["GO:1904724","cellular_component","tertiary granule lumen ","O75874; P04075; P36871; Q99439; Q13813; P29350; Q9UJU6"]
["GO:1990578","cellular_component","perinuclear endoplasmic reticulum membrane ","P27986"]
["GO:0032059","cellular_component","bleb ","Q13464; Q9Y613; Q96RD7; Q9NQW6; P09493"]
["GO:0098890","cellular_component","extrinsic component of postsynaptic membrane ","P46109"]
["GO:0001533","cellular_component","cornified envelope ","P04083; P14923; P15924"]
["GO:0031313","cellular_component","extrinsic component of endosome membrane ","P04083; P40818"]
["GO:0031232","cellular_component","extrinsic component of external side of plasma membrane ","P04083; P00747"]
["GO:0019898","cellular_component","extrinsic component of membrane ","P04083; P15311; O43521; O75150; P14598; Q9UEW8; Q5MNZ6; Q5T7P8; P04156; P12270; Q96BY7; Q15436; Q9Y2J0; Q9Y4P8; Q8N3F8; P84074; O60749; Q9Y5X2; Q9UGM3; P30419; Q14457"]
["GO:0001891","cellular_component","phagocytic cup ","P04083; Q15642; P50570; O60331; P63244; P01375; P13796; Q96KG7; Q9GZU1"]
["GO:0042555","cellular_component","MCM complex ","P49736; P25205; P33992; P33993; P33991"]
["GO:0005664","cellular_component","nuclear origin of replication recognition complex ","P49736; Q13416; Q13415; O43929; Q9Y5N6"]
["GO:0099060","cellular_component","integral component of postsynaptic specialization membrane ","Q9NZV8; Q07001; P47870; Q9UK17; P14867; Q8N2Q7"]
["GO:0008076","cellular_component","voltage-gated potassium channel complex ","Q9NZV8; O95069; Q99996; O43525; Q12791; Q6PIL6; O15554; P48544; Q9NS61; Q16623; P48048; P48549; Q14721; P22459; Q9Y6H6; O43526; P22001; Q92952; Q9NZI2; P16389; P22460; Q9Y2W7; P51787; Q12809; Q13303; Q09470; Q9UK17; Q03721; Q14247; P48050; P15382; Q15842; P63252; Q9UL51; Q9NPI9"]
["GO:0017109","cellular_component","glutamate-cysteine ligase complex ","P48506"]
["GO:0070557","cellular_component","PCNA-p21 complex ","P38936; P12004"]
["GO:0070110","cellular_component","ciliary neurotrophic factor receptor complex ","P40189"]
["GO:0005896","cellular_component","interleukin- receptor complex ","P40189"]
["GO:0005900","cellular_component","oncostatin-M receptor complex ","P40189; Q99650"]
["GO:0071437","cellular_component","invadopodium ","Q13153; P15311; P26038; Q16658; P61160; O95425; Q8TED9"]
["GO:0071682","cellular_component","endocytic vesicle lumen ","P07900; Q92598; P14625; P02649"]
["GO:0035098","cellular_component","ESC/E(Z) complex ","Q15910; Q92769; Q15022; Q9Y483"]
["GO:0009346","cellular_component","citrate lyase complex ","P53396"]
["GO:0031090","cellular_component","organelle membrane ","P35354; P08684; P10646; Q9GZQ8; P20813; P20815; P16662; Q9H492"]
["GO:0097449","cellular_component","astrocyte projection ","P15311; O95069; Q9H2B2; P05067; Q9BXM7"]
["GO:0051286","cellular_component","cell tip ","P15311; P35241"]
["GO:0098592","cellular_component","cytoplasmic side of apical plasma membrane ","P15311"]
["GO:0044393","cellular_component","microspike ","P15311; Q16658"]
["GO:0097454","cellular_component","Schwann cell microvillus ","P15311"]
["GO:0001931","cellular_component","uropod ","P15311; P26038; Q14254; P16150; O60331; O75955; O14986; P35579"]
["GO:0005524","molecular_function","ATP binding ","P24941; P15056; P35557; O14936; P49840; Q9BYP7; Q15118; P36888; O75116; O96013; Q8IWU2; Q13164; P00533; P08922; Q16875; Q13554; Q15349; Q8TDC3; P46734; Q9BRS2; Q13761; P42336; P50750; P04629; Q00537; P51617; Q16620; P51956; Q96PN8; Q96J92; Q6VAB6; O00141; Q5VT25; Q16659; P07948; P41279; P31152; P06239; Q13131; O00763; Q9UQB9; P42681; P45985; Q16566; Q9P1W9; Q9H4A3; O60825; Q13873; Q14164; Q2M2I8; Q8N5S9; P22455; Q16584; P31749; Q15303; O75676; Q01974; Q9H4B4; P11802; Q14683; P50613; Q9Y2K2; P24723; Q9NQU5; Q92918; Q15120; O15530; Q05513; Q13557; Q13163; P14618; Q16288; P54760; P54646; P17948; P53779; Q9H0K1; Q9Y3S1; P51813; Q13237; Q96KG9; O95835; P08631; O14874; Q00534; P49674; Q9UHD2; P27361; Q86Z02; P00966; P17252; Q6PHR2; Q99640; P55263; O15264; Q13882; Q9H2X6; P52701; Q96RR4; Q9H2K8; O00418; Q9Y243; Q00266; P00519; Q12851; Q01813; Q8IW41; O96017; P09619; Q12852; O60285; Q00532; P49137; O60566; P06493; P11362; O00311; P45984; P11309; P07949; Q15835; Q12792; O15146; O60674; O94921; Q15831; Q9NYV4; Q9NZJ5; Q8NFD2; Q13177; P36507; O14965; P30086; P09769; O76039; P21802; P78362; Q15119; P04626; Q96GD4; Q04771; Q8IYT8; P48730; O95382; P49759; Q16774; Q14004; Q04759; Q13627; Q06418; Q9Y2W1; P22607; Q05397; Q07912; P29317; O00444; P27708; Q06187; P45983; P35916; P80192; P42680; Q8IVT5; P25098; P29323; P29597; Q01196; Q13418; P21127; Q14289; P23443; Q9UM73; Q13523; Q16512; P34947; Q13085; Q9UQM7; P53778; Q7KZI7; P20794; P60709; Q15139; Q13233; Q9UPZ9; Q9NYL2; P43403; Q16654; P78527; Q13546; P14616; P53350; Q9BUB5; P11274; P35968; Q9BZL6; P30291; Q9HBH9; P53667; Q09013; Q9UBE8; Q14978; P49336; O75582; P30530; P27707; P51451; O95747; P05129; Q16513; Q00536; Q14680; Q08881; P21860; P16234; P16591; Q96L34; P10721; Q9BVS4; P51812; P41240; Q5TCX8; P31751; Q9UBS0; P54762; O95819; P28482; Q9P2K8; Q56UN5; Q86V86; Q5S007; Q8IVW4; Q9NWZ3; Q92772; Q9Y4K4; P04637; O75385; Q8IU85; P05771; P07332; P08069; P43405; O94804; Q9P286; Q96Q15; O75914; Q08345; Q9NR20; Q00535; Q6DT37; P06241; Q15759; Q8TDX7; Q16832; Q12866; Q9Y2U5; P42345; O14733; P07333; Q13043; Q02779; Q16539; Q13535; Q99683; P17612; P57059; O14920; Q6IBS0; O43353; P49841; P07947; P52564; Q9Y2I7; P42684; Q9P0L2; O43318; P54753; Q02750; Q16644; O94806; O43781; O43293; Q99558; Q8NCB2; P49761; P29320; O15111; Q7L7X3; P53041; P33121; Q04912; Q9Y6E0; P08238; P06213; Q13976; P12931; Q9UQ07; O00506; O43930; Q02156; P04049; O15075; P51955; Q9UKE5; P68400; P51817; P08581; Q15208; Q96Q40; Q9NRP7; Q13464; P57078; Q9UQ88; Q96KB5; Q96SB4; P54764; Q04637; Q9HC98; Q13315; Q9Y5S2; P10398; P49736; Q9H2G2; P33981; P23458; P41743; P52333; Q13555; P48506; Q15131; Q07002; Q92630; P00558; Q02763; Q8WTQ7; P29376; P42685; O14757; P22694; Q13153; P07900; Q14012; Q15418; P53396; Q05655; Q9BQI3; P21709; P00540; P19525; Q9NRM7; Q13470; P27448; P25205; Q13459; Q9HAN9; Q9ULW0; P46013; P38606; Q9NTI5; O14994; P35749; Q02224; Q9NUU7; Q96BR1; P08183; Q504Y2; Q2NKX8; P60891; Q99661; Q16760; P22314; Q00975; P13010; Q9NQT8; Q9BYN0; P35580; Q13705; Q8N4C8; Q9P289; P52789; Q01814; P35251; O75351; Q9Y259; P51003; P26640; P17844; P19447; Q5JTZ9; Q9UEW8; P54132; Q6P2M8; Q38SD2; P23677; O60266; P25092; P32298; Q92598; Q9H4L7; Q8WZ42; Q9Y2H1; Q13188; P38646; Q9UHI6; Q08828; P17980; Q14807; P51532; P17858; Q02790; O75962; Q8N3C0; Q8NG66; Q99741; Q15046; O43683; Q9NYY3; Q6UB35; O95786; Q8IWQ3; P33992; P10809; O15021; O43542; P48426; P11908; Q9Y6R4; O14727; Q9Y463; Q9HAZ1; Q9HBA0; Q14839; P38919; P29322; Q9UK32; Q15300; P16066; Q99986; P14625; Q13574; Q96GX5; Q9Y2R4; P12956; Q9UL54; Q6SA08; Q8NE63; O00443; Q9NPP4; Q99759; Q9UKX2; Q15746; Q52WX2; Q96T60; P49619; Q96P20; P48736; P48048; Q9UIK4; Q9UMR2; P62195; Q96L91; Q96Q89; O60331; Q9P2D1; O60706; Q14240; Q9BTU6; P56192; P55072; Q96PY6; P49915; Q7L7V1; P61160; Q9NRH2; O60229; Q9NQI0; Q9UH65; Q9UHL0; Q03468; P40692; Q9BX84; P34931; P35626; P0DMV8; Q8TF76; Q7RTN6; Q02846; Q9Y4I1; Q8IYB8; P11387; O14578; Q92620; O95363; Q9NYA1; P12277; Q9H6E5; P20648; P53671; P08237; Q9UNQ0; Q9NP81; P23743; Q6ZMQ8; O43306; Q9UIG0; Q9H422; O75460; Q92777; Q9HBY8; Q96PF2; Q14562; P51790; Q08462; Q9NTJ3; Q9P2E2; Q9UBL9; Q15058; P42338; P63279; Q06609; Q96S44; P33527; P68036; O95235; P53355; Q9GZR7; Q9UHH9; P49427; P78368; Q00526; Q15569; P37173; P63267; P50747; P63146; Q8IWB6; P68133; P18858; P00973; Q92900; P40937; Q8TD43; O00571; Q9BW19; Q02880; Q92614; Q9Y385; Q5MAI5; Q16763; P49916; P36897; Q8NEV4; Q92878; P46459; P06732; P33076; P17812; Q9Y285; P61158; P19367; O75943; Q9UHY1; Q9UQD0; Q6P5Z2; P13569; Q712K3; O00139; P22234; Q9UQE7; Q12931; Q8WVB6; P22392; Q9BYX4; O95477; Q6P0Q8; P11142; Q9BXM7; O75716; P78371; Q13569; Q13283; Q13415; Q8N884; P43246; P04183; P05023; P15531; P23634; Q8TD08; Q15772; Q8NE71; Q9NRF8; P49917; O15197; P35590; Q8NER1; Q14204; P35790; Q92841; Q9UJ70; P49459; P19784; P54619; P43686; P54819; Q8N4N8; Q9H1R3; P37023; P06737; P22612; Q9P0J0; P40145; Q86UE8; Q9NQX3; P17600; Q9Y230; Q96RG2; Q9UBF8; O95239; Q9Y572; Q8NEB9; P54652; Q9Y6G9; Q9UNY4; O14986; P00367; P49760; Q13950; Q9Y496; Q96NX5; P61086; O43929; Q14527; Q9NRA0; Q9UGI9; Q9Y2H9; O75449; Q96QT4; Q6ZN16; Q8IVH8; P11388; Q8TD19; P48729; P61088; P33993; Q16816; P78356; P43250; P30613; Q8TAS1; O00329; P52732; P33991; O00148; P36894; P35998; Q9UJV9; Q9UM54; O94768; Q00839; O94762; Q9H093; Q14191; Q9NR19; P35579; P16118; P26196; Q9NZC9; P36896; O60361; Q8NB16; P21817; P63261; Q15842; Q9UKX3; P78508; Q9H0S4; Q9Y265; Q8TCT0; Q9NP80; Q14654; P10412; Q9UKI8; Q04656; P07814; P33176; Q92698; O60282; O15523; P16615; Q9BXA7; Q02241; Q9C0C9; P11021; P22413"]
["GO:0030332","molecular_function","cyclin binding ","P24941; P50750; P11802; Q00534; P06493; O94921; Q9NYV4; Q14004; Q96Q40; P38936; P46527; P12956; Q9BWF3; Q5XUX0; Q00526; O15379; P63244; Q0VD86; Q969H0"]
["GO:0097472","molecular_function","cyclin-dependent protein kinase activity ","P24941; P06493"]
["GO:0004693","molecular_function","cyclin-dependent protein serine/threonine kinase activity ","P24941; P50750; P11802; P50613; Q00534; Q00532; P06493; O94921; Q9NYV4; P24864; Q14004; P21127; P14635; P49336; Q8IVW4; Q92772; Q00535; Q9UQ07; Q96Q40; Q9UQ88; Q15131; P38936; P46527; Q00526; Q5MAI5; P30281; P24385"]
["GO:0000287","molecular_function","magnesium ion binding ","P24941; Q15349; Q8TDC3; Q96PN8; Q5VT25; P41279; Q9H4A3; O75676; Q9Y2K2; P14618; Q9H0K1; P37840; O95835; P00519; Q15831; P78362; O95382; Q01167; P53778; Q7KZI7; Q9UPZ9; Q9NYL2; P53350; P30291; Q9UBE8; O75582; O95747; P51812; Q9NWZ3; P09104; Q6DT37; O14733; Q13043; Q99683; P57059; P42684; Q9P0L2; O43318; P06733; O43781; Q15208; O75874; P35813; Q96SB4; Q9HC98; Q9Y5S2; P48506; Q92630; P22694; Q15418; P41180; O00167; P60891; Q9P289; P51003; Q9Y2H1; Q13188; Q9H2U2; P36871; Q8IWQ3; O15021; P11908; P33316; Q9UK32; Q6SA08; Q9NPP4; Q9BTU6; O43236; Q9NRH2; P39748; Q15124; Q9NYA1; P62826; P20648; O75460; Q96PF2; Q08462; P78368; P55040; O95551; Q15382; O75688; Q6P0Q8; Q9BXM7; Q13569; P15531; Q9H773; O95989; Q9Y2H9; P11388; P30613; Q9H093; Q13907; Q14191; Q9HB90; Q8TCT0; Q9BXA7"]
["GO:0019904","molecular_function","protein domain specific binding ","P24941; Q06124; P41212; Q13422; P11474; Q05513; P37840; P35269; P08670; P10276; P21980; Q14653; Q00987; P07101; P78527; Q14978; P13861; O14964; P42345; P61978; Q99683; Q9Y6K9; P06213; P41743; O14757; P15311; Q13242; Q16254; Q155Q3; Q9ULJ8; Q04917; P35251; P19429; Q9HC77; P81274; P31323; P53365; Q02535; Q9Y261; Q16625; P13473; Q9UHI6; Q9C0H9; Q16623; P16333; Q9Y613; P07437; Q14186; P35241; P35462; P0DP23; P00747; Q9Y4H2; Q9NZ72; P55072; Q9H4P4; Q13829; P07196; Q16665; Q9NXR1; P54259; Q14524; P10827; Q15276; Q92665; Q9P1A6; O75925; P11387; P32004; Q9NSB8; P09651; Q14990; P27348; P67870; P31947; P55317; P23025; P53367; O14641; Q16236; P61764; Q14494; P61981; Q71U36; P62258; Q07869; P20248; Q99967; P62805; P15036; Q9HC62; O75525; Q13569; Q8N137; P46940; P10644; P05023; Q9BV73; P52272; P36873; Q15466; Q9UNN5; P61586; Q15596; Q13950; P98161; P51608; O14490; Q05516; P25942; P32121; P63104; Q14980; O14980; P12755; Q9H2S1; Q9NR80; P42575; P46934; Q9UDY2; P38159; Q13363; Q07666; P35579; P26196; P31946; P23497; Q9UJU6; Q13185; P22059; P61266; Q15672; O95886; O95398; Q9NRD5; P11021; P35372"]
["GO:0004674","molecular_function","protein serine/threonine kinase activity ","P24941; P15056; O14936; P49840; Q9BYP7; O75116; O96013; Q8IWU2; Q13164; Q13554; Q15349; Q8TDC3; P46734; Q9BRS2; P42336; P50750; Q00537; P51617; P51956; Q96PN8; Q96J92; Q6VAB6; O00141; Q5VT25; Q16659; P41279; P31152; P45985; Q9P1W9; Q9H4A3; Q2M2I8; Q16584; P31749; O75676; Q9H4B4; P50613; Q9Y2K2; Q9NQU5; Q92918; Q15120; O15530; Q05513; Q13557; Q13163; P54646; Q9H0K1; Q9Y3S1; O95835; O14874; P49674; Q9UHD2; P27361; Q86Z02; P17252; Q6PHR2; Q99640; O15264; Q9H2X6; Q9H2K8; Q9Y243; Q12851; Q8IW41; O96017; Q12852; O60285; P49137; O60566; P06493; O00311; P11309; Q15831; Q9NZJ5; Q8NFD2; Q13177; P36507; O14965; O76039; P78362; Q96GD4; Q04771; Q8IYT8; P48730; P49759; Q04759; Q13627; Q07912; O00444; P45983; P80192; Q13418; P21127; P23443; Q13523; Q16512; P34947; Q9UQM7; P53778; Q7KZI7; P20794; Q15139; Q13233; Q9UPZ9; Q9NYL2; P78527; Q13546; P53350; Q9BUB5; P11274; Q9BZL6; Q9HBH9; P53667; Q09013; Q9UBE8; P49336; O75582; O95747; Q16513; Q00536; Q14680; Q96L34; Q9BVS4; P51812; P31751; Q9UBS0; O95819; P28482; Q9P2K8; Q56UN5; Q86V86; Q5S007; Q9NWZ3; Q9Y4K4; P63000; O75385; P05771; P43405; O94804; Q9P286; Q96Q15; O75914; Q9NR20; Q00535; Q6DT37; Q15759; Q8TDX7; Q9Y2U5; P42345; O14733; Q13043; Q02779; Q16539; Q13535; Q99683; P17612; P57059; O14920; O43353; P49841; P52564; Q9P0L2; O43318; Q02750; Q16644; O94806; O43781; O43293; Q99558; P49761; Q7L7X3; Q9Y6E0; Q13976; Q9UQ07; O43930; Q02156; P04049; O15075; P51955; Q9UKE5; P68400; Q15208; Q96Q40; Q9NRP7; Q13464; P57078; Q9UQ88; Q96KB5; Q96SB4; Q9HC98; Q13315; Q9Y5S2; P10398; Q9H2G2; P33981; P41743; Q13555; Q15131; Q07002; Q92630; O14757; P22694; Q13153; Q15418; Q05655; P00540; P19525; Q9NRM7; P27448; Q96BR1; Q13705; Q8N4C8; Q9UEW8; Q38SD2; Q8WZ42; Q9Y2H1; Q13188; O75962; Q8NG66; O43683; Q9NYY3; Q8IWQ3; O15021; Q9Y463; Q9HAZ1; Q9UK32; Q99986; Q96GX5; Q9UL54; Q6SA08; Q8NE63; Q99759; Q52WX2; P48736; Q96FA3; Q9UIK4; O15297; Q96PY6; Q8N2H9; Q9NRH2; O60229; Q9BX84; P11387; O14578; P53671; Q9HAT8; Q6ZMQ8; P67870; Q9H422; O75460; Q9HBY8; Q96PF2; Q13501; Q96S44; P53355; P78368; Q15569; P36897; Q8NEV4; Q9UHY1; Q6P5Z2; P22392; Q6P0Q8; Q9BXM7; O75716; Q15772; P19784; P37023; P22612; Q86UE8; Q96RG2; Q9Y572; P60953; P49760; Q9Y2H9; Q96QT4; Q8IVH8; Q8TD19; P48729; O60563; Q8TAS1; P36894; O94768; Q9H093; P36896; Q9UKI8; Q9BXA7"]
["GO:0043022","molecular_function","ribosome binding ","P05198; P13639; P42345; Q9BRP8; P04844; Q5D1E8; Q9BZB8; Q6R327; P46379; Q06787; O95202; P62495; P56537; Q6N069; P63244; Q8NE71; Q9BY44; Q8NE35; P11021"]
["GO:0003723","molecular_function","RNA binding ","P05198; O75116; Q05193; P10636; P18031; P13639; Q14683; P14618; P04792; P49674; P35269; P06748; P62753; P00966; P55263; Q9NYF8; O75475; P19544; O00267; Q96ST3; P09429; Q13148; P17480; P30086; P78362; P06730; P38398; Q14004; Q9Y2W1; O43251; Q99459; P35221; P21127; Q13523; P68104; Q7KZI7; P07355; P21399; Q9NYL2; P23588; P78527; P49327; Q14978; Q6NZI2; Q16513; P05412; P18615; P17947; P07737; Q96Q15; P08621; P61978; Q6IBS0; Q7KZF4; Q08945; P06733; Q13263; P49761; P53041; P08238; P46109; Q96SB4; Q04637; P04150; P07900; P19525; P15311; Q15427; Q13242; Q7Z6E9; Q16891; Q92769; P46013; P62917; Q9HC16; Q9BTL3; P16403; Q9BRD0; P40926; Q99733; Q9NUU7; O14746; Q9H814; Q6NZY4; Q9NQZ2; Q99502; Q9Y5S9; Q6PKG0; Q86UE4; Q96CX2; Q96T58; P60866; Q15717; P50995; P62280; Q9BRP8; P22314; Q6UN15; Q8NF91; P07910; P13010; P31942; Q9UKV3; O95071; Q96PM9; Q15366; P62316; Q8N684; P55010; P51114; P55084; P04075; Q9NWH9; Q14684; P0C6L3; Q92904; P55209; Q8TBY0; P19474; P49411; Q9UBK2; P49792; Q9NR56; O60832; P51003; Q9NRA8; Q14493; Q9NZI8; P05388; P62979; P02786; P62993; P17844; O43865; Q13425; Q9Y3Y2; O60869; Q9Y5J1; Q8IYB3; Q9BY77; Q9Y4C8; O43707; Q86TB9; Q9Y3Z3; Q08170; P16989; Q14498; P38646; P09382; Q00059; O60936; Q2NL82; P51532; Q02790; P53999; Q8N3C0; Q16658; Q8IWZ3; Q96J01; Q5T8P6; Q12906; Q9H0Z9; Q99590; O75400; P10809; Q5BKY9; Q9Y4W2; Q12996; Q96EP5; P39687; Q9BQG0; O75940; O95218; P33316; P14678; Q14671; P35611; O43426; O60841; Q9Y2K5; P38919; Q15149; Q9H3Q1; Q01844; P14625; O60506; P26373; P35241; Q8NC51; Q99547; Q01082; Q9Y2R4; P23396; Q9Y580; P12956; Q13243; Q5D1E8; Q14151; Q01130; Q01081; P35659; Q15022; Q15459; Q8TBF4; Q9Y5B9; P42677; Q13428; Q9NQC3; Q93062; P62633; Q9NX07; P24928; Q96FV9; Q5TAX3; P56270; Q9UMR2; P26358; Q96D46; P42771; Q9BXS6; O43818; Q9Y237; Q8IX01; Q9BUJ2; Q14240; Q15424; Q96EV2; P55072; Q9Y3T9; P84098; Q9NZM5; Q7L7V1; Q13573; P26368; Q14157; Q96PK6; Q969S3; Q8IXH7; Q8N9T8; P98179; Q6PJT7; Q04837; Q9Y3F4; Q8NDD1; Q969G3; Q9UHL0; Q06787; Q9BTD8; Q13895; Q9UKM9; Q92665; P19338; P0DMV8; Q8WXF1; Q9UIF9; Q53EL6; O75369; Q15056; P82970; Q9H0L4; Q9Y4I1; Q8IYB8; P11387; Q96I25; Q05519; O75533; P12270; Q92620; P22087; Q9UL40; P62826; O43395; P62495; P17509; Q9H6E5; P62913; Q15942; P09651; Q9NP81; Q92879; Q9H0D6; Q07955; Q7Z2W4; Q9NTZ6; Q8WY41; Q14562; Q9P2K5; Q9UPS6; Q92888; P46782; Q53F19; P27816; P63279; Q9BWF3; Q9BVI4; Q9Y534; P43243; P61764; P68036; Q9GZR7; O60381; Q9ULM6; Q9H6F5; P36542; Q06830; P61981; Q7KZ85; Q15691; Q9UKD2; P62258; P18583; Q92900; P55081; P17931; Q8N9N2; P63165; Q96E39; P46778; P63244; P21291; P52292; O00571; Q9BXP5; Q9Y6M1; Q92614; P28799; Q8NAV1; Q8N163; P54105; P40429; Q8NEY8; Q9UPT8; Q86UR5; O43379; P46783; P31948; P16401; Q9H1E3; Q9P2N5; Q9UHX1; Q99543; Q14694; P51398; Q13247; Q9Y285; Q8WWM7; Q9UQ35; Q5JTH9; Q13049; P11940; Q15020; Q8IZL8; O95453; P27824; P21333; O75179; Q99598; Q00341; Q06265; Q12931; P62805; Q9NY61; P98175; P14866; Q5TC82; O75525; P11142; O60763; P48200; P62841; Q96AE4; Q9NQT5; P22626; Q96PU8; Q15024; Q9P2I0; Q8NI36; Q13283; Q9Y520; Q14697; Q15637; P15531; Q99714; P05204; Q9P2E9; P26599; Q14739; O75817; Q14103; P35637; Q9UKF6; Q8NE71; O15446; Q15287; O43432; Q14204; Q92841; Q8IY67; P49750; Q13435; P20042; O75152; P12268; Q9UPN3; O60610; O94875; P48634; Q12972; P52272; P36873; O00566; Q9UPQ9; P23246; P31943; P30050; O95707; Q7L2J0; P67809; Q99848; Q8IWR0; Q9UNP9; P46087; O43823; O43148; Q9Y6G9; Q8WX92; Q6P2Q9; Q15365; P30101; P51858; P13693; Q7Z6Z7; P52948; Q07352; Q9UQ80; P51608; Q14527; Q9BYG3; Q07954; Q96AH0; Q8NE35; P11388; Q6Y7W6; Q99728; P61088; O95319; Q99613; Q16666; P09874; P60900; Q9NQ50; Q7Z417; P05783; Q92945; Q9BUR4; Q15029; P63104; Q96NC0; Q5JVS0; Q9BVJ6; O14980; P27695; O00148; P08195; Q969Z0; Q9UJV9; Q8TAD8; Q9NRR4; P46060; Q9H4D5; P38159; Q00839; Q13151; Q07666; P05455; Q5JSZ5; Q14451; Q71UM5; P35579; P52298; Q14966; O75494; P26651; P26196; Q15654; P62304; Q9Y383; P50395; Q08J23; Q01860; Q07020; Q9NQT4; Q96QD9; Q9Y2T7; O75616; P25490; Q00610; Q96QC0; Q9UKV8; Q9H0S4; O15056; P04843; O76021; Q9NUK0; P33240; P10412; Q09666; Q9P013; Q9H5H4; Q9UMY1; Q09161; Q8WXA9; P01892; Q86V81; O15523; P55795; P31483; P10599; O75534; Q92667; P57721; Q9C0C9; Q8TCS8; P15924; Q9BWJ5; Q92917; P39019; Q99873"]
["GO:0003743","molecular_function","translation initiation factor activity ","P05198; P06730; P23588; Q04637; P55010; Q13144; O60841; Q14240; P41091; O00303; Q15056; P56537; O75822; O43432; P20042; Q14232; Q9BY44; Q99613; Q9ULC4; Q9UKV8"]
["GO:0016303","molecular_function","-phosphatidylinositol--kinase activity ","Q06124; P36888; P42336; Q13480; P22455; P11362; P21802; Q8WU20; P22607; P35568; O00459; P27986; Q13315; P62993; Q9GZV9; O00443; Q9Y4H2; P48736; P42338; P09038; Q92569; Q8NEB9; Q9UQC2; O00329"]
["GO:0050839","molecular_function","cell adhesion molecule binding ","Q06124; P13612; P10586; P05106; P15311; P26038; Q9P2S2; P05556; Q92692; P12830; O95471; P26010; Q9HCJ2; Q15762; P05107; Q9ULB1; P58400; P14923; P29350; Q8N0W4; Q8N2Q7; P15924"]
["GO:0031748","molecular_function","D dopamine receptor binding ","Q06124; P51636; P78352; P35462; Q9UD71; P32121"]
["GO:0005158","molecular_function","insulin receptor binding ","Q06124; P18031; O15530; P29353; P08069; P35568; P12931; P27986; Q9BX66; Q9Y4H2; O14654; P05067; Q13322; O60749; P22413"]
["GO:0043560","molecular_function","insulin receptor substrate binding ","Q06124; P42336; Q05513; O60674; P14616; P08069; P06213; P27986; Q05655; P62993; P42338"]
["GO:0004726","molecular_function","non-membrane spanning protein tyrosine phosphatase activity ","Q06124; P24666; P17706; Q05209; Q99952"]
["GO:0051428","molecular_function","peptide hormone receptor binding ","Q06124; O60674; P06241; P12272"]
["GO:0046934","molecular_function","phosphatidylinositol-,5-bisphosphate -kinase activity ","Q06124; P00533; P42336; Q13480; P06239; P22455; Q15303; P09619; P11362; P03372; P21802; Q8WU20; P04626; P22607; P21860; P16234; P10721; P06241; P35568; P12931; O00459; P08581; P27986; P15498; P62993; Q9GZV9; P15391; Q9Y4H2; P48736; P42338; P09038; Q6PIZ9; P10747; Q02297; Q6ZUJ8; O00329"]
["GO:0043274","molecular_function","phospholipase binding ","Q06124; O15530; Q05513; P37840; P42768; P20700; P07196; P61764; O60260"]
["GO:0004721","molecular_function","phosphoprotein phosphatase activity ","Q06124; P62136; P67775; P53041; P60484; Q05209; Q14738; Q15398; Q8WYL5; P30304; P30307; Q12959; P30305; Q9Y5B0; P36873; Q9BY84; Q15172"]
["GO:0001784","molecular_function","phosphotyrosine residue binding ","Q06124; P06239; P08631; P27361; P29353; P00519; P22681; P09769; P16885; P43403; P28482; P43405; P07947; P35568; P42684; O00459; P27986; P46109; P15498; P54829; P46108; Q15464; P62993; P52735; Q92529; Q13191; P78314; O14543; Q92569; P26045; P29350; P20936; Q9ULV8"]
["GO:0004725","molecular_function","protein tyrosine phosphatase activity ","Q06124; Q16825; P08575; P18031; Q15262; P18433; P10586; Q15678; Q9Y2R2; P17706; P60484; P35236; Q05209; P28827; P51452; P54829; O00167; Q99502; Q99504; Q8TE77; Q13202; O14522; Q8WYL5; Q12923; Q12913; Q15256; Q99952; P30304; P30307; P28562; O95278; P30305; P26045; Q16828; Q13614; P29350; Q9Y6W6; Q9BY84; Q16690"]
["GO:0030971","molecular_function","receptor tyrosine kinase binding ","Q06124; P18031; P22681; P19174; Q15678; P04637; P17706; O43318; O00459; P51452; P16333; Q92529; Q14449; P50616; P12004; Q9H4P4; Q13191; O00562; Q13501; P61981; P63244; Q02297; Q13009; Q96JJ3; O75096; Q9ULV8"]
["GO:0005070","molecular_function","SH3/SH2 adaptor activity ","Q06124; Q8WV28; Q13480; Q9NZM3; P12931; P46109; Q9NWQ8; P46108; Q86WV1; Q15464; P62993; Q9BX66; P16333; Q14449; P52757; P50616; P78314; O75563; Q9UKW4; O14654; O14492; P10747; Q13322; Q13625; Q9NP31; O43561; Q14847; Q07666; Q14451; Q12929"]
["GO:0005509","molecular_function","calcium ion binding ","P15056; Q9NZM3; P37840; Q96RR4; O00418; P07949; P22681; Q05586; Q01196; P12814; P19174; P07355; P19105; Q14680; P51178; P04083; Q01970; Q8IYJ3; P41180; P00736; O15162; Q9NYQ6; P50995; P01130; Q00975; P47712; P09327; Q15078; P23327; Q96PH1; Q01814; Q6PIL6; Q96C19; Q86YS7; Q7L5N7; Q13563; O43707; Q8WZ42; Q9NQ66; P42566; O60936; Q9NS61; P30626; P12830; Q8NF37; Q5T7P8; P14625; P19022; P0DP23; P49619; P14543; Q9Y4G8; Q12798; P21579; O43581; Q92736; Q13191; O75952; Q9ULB1; Q9UI40; P32418; Q9UH65; Q9NRY6; Q96D15; P14314; Q13586; Q08209; Q9Y4I1; O95202; P08133; Q8IXI2; Q13813; P23743; Q14573; Q9NZI2; O00562; Q9Y2J0; O14638; Q8NFH8; P31950; P41208; Q8TD43; Q14643; Q14571; Q8TER0; Q96D71; P06396; Q7LDG7; P27824; P84074; P31415; Q9Y2W7; P10916; Q8N9I0; Q8IV01; O14958; P46940; Q9NRD9; P17655; P46531; O75096; P31949; P08758; Q9UPN3; Q14118; Q9Y2I6; Q01449; P13796; P57796; Q14831; Q8IV61; P06702; Q9Y5H0; Q9Y680; P24844; P13693; O94759; O95302; Q16143; Q07954; O95267; Q9UMX6; P33151; O75154; Q9NPY3; P61601; Q15293; Q96KC9; P19021; O43852; O14950; P21817; P10412; Q9ULV8; P16615; Q9BRC7; P55327; P11021; Q99828; P22413"]
["GO:0042802","molecular_function","identical protein binding ","P15056; P00533; Q13554; P09467; Q05193; P10636; Q5VT25; P06239; O00763; Q04206; P14921; Q16584; P31749; Q13557; P14618; P37840; P04792; P11413; Q9UHD2; P27361; P06400; Q9Y6K1; P00966; P08670; Q13882; P25054; Q00266; Q01813; O96017; P02511; P11362; P03372; O60674; P42224; Q9NZJ5; Q13148; Q14653; Q13177; Q9BSJ8; Q15797; P21802; P04626; Q9H792; P37231; P38398; Q13627; P22607; Q07912; Q00987; O43663; O00444; P27708; Q06187; Q86YV5; Q14765; P29323; P19838; P42226; P35221; P23443; Q9UM73; P40763; Q13085; Q9UQM7; P25963; P60709; Q15139; P07355; Q01201; Q13546; P53350; P35968; P05106; P35520; Q6NZI2; P16220; P42768; O95747; P21860; P05412; P41240; P28482; O14744; P51610; Q5S007; P84022; Q03135; P04637; O75385; P14136; P08069; O94804; P06241; P52630; P42345; Q13043; P61978; Q99683; P42858; O14920; O43353; P52564; Q00613; Q9Y6K9; O43318; O43293; P49761; Q08379; P53041; P08238; P06213; Q13976; P04049; P68400; P08581; P60484; O75874; P46109; P54764; Q04637; Q9H2G2; Q13555; P28827; Q13153; P07900; P56524; P19525; P15311; O00757; Q9UBB4; O00501; Q9HAN9; Q96QF0; P06401; Q9HC16; P11166; Q9P0V3; O14818; O14746; Q13158; P04004; Q96CV9; Q96EB6; Q96CX2; P60891; P29972; Q9UJY1; Q9NP66; Q16760; O95816; Q13287; P01130; Q8NF91; Q8NCD3; P07910; O96006; Q9Y2G1; P28472; P09327; Q12791; P04075; Q9P289; Q9GZX7; Q04917; P01009; O14640; Q9Y295; Q92904; P19474; P10515; O75351; P61457; P55211; Q9UKG1; Q9HC77; Q14134; P81274; Q8NE86; P02786; P62993; O43865; Q9UFW8; P08476; O43464; Q8TEW0; Q38SD2; Q13563; P53365; Q15642; Q8WZ42; Q9Y3Z3; Q12933; Q13188; Q7L804; P04040; O00560; Q9UKV5; P42566; P17980; O60936; Q06481; Q9NS61; P00338; P01116; P30626; P17858; P53999; Q15154; Q15046; Q96D31; Q8WUF5; O95786; Q15019; Q16873; P11908; O43741; Q9NQ48; P19438; O14727; Q9Y613; Q92692; P12830; Q9HBA0; P32929; Q15468; O95471; Q9UH03; O15455; P43351; P78317; Q01844; Q14449; P49789; P25445; P19022; O15350; Q14151; Q9NPP4; Q13568; Q96P20; P48736; Q5VWQ8; O43918; Q9UIK4; Q07812; P20963; P12004; P55072; Q99697; P50416; Q9GZM8; P21579; P26678; Q13829; P07196; P40259; Q92736; Q9HBL8; Q9NZM5; P61289; Q99497; P04156; Q13257; Q13107; Q9NXR1; Q13485; O15551; P10415; Q9Y6H5; P45973; P46379; P02545; Q9UMS4; Q14790; Q06787; P49959; P52179; O43312; P19338; O15553; Q9UPY8; Q96A54; Q9Y5V3; P02649; Q13586; Q15555; Q8WYJ6; O75369; O95848; Q9H4B6; Q9Y4I1; P55212; Q96F86; P05062; P50461; O43395; Q96T88; P09651; P08237; Q92819; Q9UNQ0; Q9BUZ4; Q9Y3Q4; P27348; P54252; P21673; O43765; P67870; O43914; P31947; P15884; O75460; O14492; P30622; Q14562; O43541; Q9UBL9; P18850; Q13501; Q9Y3M2; O95999; P10912; O15392; P53805; Q16181; O14641; P11717; Q06609; Q13255; P62807; Q9BR76; P43243; P61764; Q9Y4K3; P48678; P53355; Q9NQG6; Q13426; P17813; O15217; Q15633; Q06830; P61981; P00441; Q15691; P56693; Q9UQB8; P14416; P62258; O75581; P13688; P13591; Q8IYM1; P07195; P05067; Q9Y2J4; P29966; P19235; Q99958; P49790; Q14192; Q96D96; P55064; Q86WV6; P43320; O14493; P54253; O96004; Q99962; Q9UHX1; P10747; P01375; P17812; P18827; P19367; Q8N3F8; Q13049; O00429; P23258; Q07817; P84074; P41182; P32322; Q13322; P31415; P22234; O43598; P18846; Q9Y6D9; Q5VSY0; Q9BYX4; Q99708; P98175; O00206; Q15631; O75525; Q13291; Q9NS91; Q13625; P22626; P98177; Q9Y6N7; P51587; Q9UMX0; P04183; Q8WXD9; Q15637; Q14315; P04406; P15531; Q12809; Q99750; P35637; Q9Y5X2; Q9Y3E7; Q13077; Q8NER1; Q9NPI6; Q9H773; Q16611; O75531; P34741; Q14232; P31431; P13796; P22415; P48357; P98170; Q9Y6R1; Q9Y230; P38432; P04179; P17661; Q14749; Q9ULZ3; Q9NS23; Q16478; Q14676; Q9Y572; P20265; P60953; P00367; P30101; P49760; O75056; P01730; Q05516; O76090; Q03393; Q92734; Q16666; P21796; P09874; P30048; Q13309; Q8WYQ5; P58753; P32121; O75762; Q9BUR4; O15169; Q03164; P63104; Q6ZUJ8; Q8N9N5; Q9Y4E8; P42575; O00148; Q9UM54; Q8IUQ4; P38159; Q9UH99; Q00839; O94762; Q13363; Q07666; Q5VWX1; Q14451; Q92547; Q9NQG5; Q9NR22; Q92731; P16118; P13224; P31946; P23497; Q99961; Q14896; Q04724; Q13185; Q8NB16; P63261; P63252; Q9Y371; P09493; Q96AV8; Q9Y566; Q969H0; Q9H3D4; Q676U5; Q13111; Q15109; P07814; P33176; O14777; O60260; Q9UL51; P30203; Q9NRD5; Q66K74; Q9BR01; Q16555; P55087; Q99873; Q9Y5I7"]
["GO:0004709","molecular_function","MAP kinase kinase kinase activity ","P15056; P00533; P41279; Q9H2K8; O95382; Q13233; Q9NYL2; Q9Y2U5; Q99683; O43318; Q99558; Q7L7X3; P04049; P10398; P00540; Q9Y6R4; Q9UL54; Q99759; P57077; Q6ZN16"]
["GO:0031434","molecular_function","mitogen-activated protein kinase kinase binding ","P15056; Q16584; Q8IVT5; P49407; P04049; P10398; Q9UL54; Q5VWQ8; Q12959; Q92519; Q9UQF2; Q13526; P12821"]
["GO:0004672","molecular_function","protein kinase activity ","P15056; Q9BYP7; Q15118; O96013; P50750; Q00537; P51617; Q6VAB6; Q13131; Q9UQB9; P45985; Q9H4A3; Q14164; Q16584; P31749; P50613; Q92918; Q15120; Q05513; Q13163; P54646; Q13237; P49674; Q9UHD2; P17252; Q99640; Q9H2X6; O00418; Q9Y243; P00519; Q12852; P49137; O60566; P06493; O00311; Q15835; O60674; Q9NYV4; Q9NZJ5; Q13177; O14965; O76039; Q15119; Q04771; P48730; Q14004; Q04759; Q13627; Q05397; P27708; Q86YV5; Q8IVT5; P25098; P21127; P23443; Q13523; Q16512; P20794; Q13233; Q9UPZ9; Q16654; P78527; Q13546; P53350; Q9BZL6; P53667; Q9UBE8; P49336; O75582; P05129; Q16513; P16234; P51812; Q9UBS0; Q5S007; Q8IVW4; Q9NWZ3; Q92772; Q9Y4K4; P43405; Q96Q15; Q00535; Q9Y2U5; P42345; Q13043; Q02779; Q13535; Q99683; P17612; O14920; P49841; P42684; O43318; Q02750; Q13263; O43781; Q99558; O15111; Q7L7X3; Q9Y6E0; Q13976; P12931; Q9UQ07; O00506; P04049; O15075; P51955; Q9UKE5; Q13464; Q9UQ88; Q96SB4; P54764; Q9Y5S2; P10398; P41743; Q02763; P29376; O14757; Q13153; Q05655; P21709; P19525; Q96BR1; Q504Y2; Q15078; Q8N4C8; Q9P289; P25092; Q13188; O43683; Q9Y463; Q9UK32; P16066; Q99986; Q99759; P48736; Q96PY6; P35626; Q8TF76; P50749; Q02846; Q9H422; P53355; Q8IWB6; P36897; Q8NEV4; Q6P5Z2; Q9Y478; Q9BXM7; Q8TD08; P54619; Q9Y572; Q8NEB9; Q8IVH8; P48729; Q969Z0; O94768; P48436"]
["GO:0033613","molecular_function","activating transcription factor binding ","P46937; Q06413; Q04206; Q09472; P06748; P01106; O75475; Q15796; P37231; P51610; Q02078; Q14814; Q9HC98; P43694; P56524; P06454; Q8WUI4; Q06546; Q13547; P61296; P33076; P29692"]
["GO:0003682","molecular_function","chromatin binding ","P46937; Q01826; P00533; P50750; Q06413; Q13131; Q04206; Q14683; P54646; Q09472; Q9Y6K1; P52701; O75475; O00267; Q15796; P06493; Q96ST3; P03372; Q9UJU2; P17480; P15336; P37231; O75030; P19838; Q00653; Q53ET0; Q16512; Q86U86; P15172; P17096; Q9UQL6; Q01201; P05412; P18615; P51610; Q13469; Q02078; P25440; P04637; P05771; P10275; Q08945; P19419; Q12778; Q13263; P35222; P23771; P01100; P43694; Q15910; Q92769; P08151; O15164; Q9BUL5; Q04864; P49450; Q9UPP1; Q8WUI4; P28324; Q00059; Q06546; Q9UBU8; P52945; Q7Z2Z1; Q9GZV1; Q99966; Q9Y294; Q13330; Q6KC79; Q92908; P17676; O15350; Q5D1E8; P35659; P17542; P37275; Q15003; P28069; O43918; Q96L91; P18754; P26367; Q9P2D1; P12004; Q8WYK2; Q15424; Q13112; Q9Y3T9; P36956; P56545; Q13485; O94763; P45973; Q04837; Q969G3; Q06787; Q03468; P40692; O00257; P83916; P82970; P11387; Q92886; Q92793; P12270; P62826; P52952; O00482; O60341; P67870; Q9BTA9; Q02447; Q9BTP7; P50553; O43541; O75496; Q13285; Q8N2Z9; Q92900; O15379; P11308; Q02880; Q9BRQ0; Q14686; Q9H1E3; Q99543; Q9ULU4; Q99967; O60479; O75943; Q8IZL8; Q6STE5; Q15047; P41182; O75179; Q96FF9; O00255; Q9UQE7; P40425; Q15788; Q8N6T7; Q13415; Q8N884; Q96LA8; Q9BY41; Q8TD08; Q14103; P55895; P37198; P23246; Q9H2P0; O96028; P67809; O00213; Q8N0Z6; O95983; Q15596; P51692; Q13950; P51608; P50221; P11388; Q99856; O60563; Q9H211; Q03164; Q03014; P10071; Q15648; Q96RK0; Q7Z2E3; P38159; P23769; Q00839; Q9H3R0; Q8IXJ6; Q96IF1; Q14191; O60885; P05549; Q06330; P15408; Q9H3D4; O94776; P05423; Q13111; P48436; Q13562; Q01851; Q01543; Q5VTR2"]
["GO:0070064","molecular_function","proline-rich region binding ","P46937; P00519; P41240; P07737; O75400; Q9NQC7; P10912; Q9UQB8; Q9NYB9; P24385; O00213; Q9UHR4; Q6Y7W6; P46934"]
["GO:0008022","molecular_function","protein C-terminus binding ","P46937; P54274; Q05193; P06239; Q13131; P50613; Q09472; P08670; P00519; O60674; P04626; P62714; P37231; P01112; Q8IVT5; Q14289; P41240; P67775; Q02750; O43293; P12931; P35222; P15311; P78352; P46013; O14746; Q96CV9; Q96EB6; Q00975; P13010; Q9ULJ8; Q14207; Q15554; Q01814; O75351; P81274; P41146; P19447; O00505; Q15599; Q99966; Q6KC79; Q13574; P55196; P12956; P24928; Q96FI4; P21579; P07196; Q15036; P49959; Q03468; P19338; Q9UPY8; O75925; P08237; P27348; P15884; P18848; Q9BYB0; P11171; P50542; O95999; Q06609; Q13426; Q12959; P08047; Q15569; Q12772; Q15691; Q9UQB8; P57105; P63165; P35232; Q02880; Q93009; P31948; P98082; P54253; Q99962; P33076; P18827; P11940; O00409; Q12800; Q9Y520; P51587; P43246; Q12834; Q13352; Q8N2W9; P49917; Q9BV73; O75531; P36873; P38432; Q14676; Q7Z7A4; Q05516; P11388; Q96H20; P30048; Q14980; P50895; Q8IUQ4; Q13363; Q92547; O14649; P41134; P31946; Q99961; Q9UJU6; Q9Y566; Q9UKV8; Q14654; Q99623; P19878; P16615; Q9NRD5; Q99828; P35372"]
["GO:0046982","molecular_function","protein heterodimerization activity ","P46937; P54274; P00533; P51617; Q16659; Q06413; P31152; Q04206; P51636; Q14683; P33778; P06748; O00267; Q15796; P10276; O14965; P04626; P15336; P37231; P29590; Q06418; Q9Y6Q9; P19793; Q01196; P19838; P35221; P15172; P53667; P16104; Q14978; P30530; P21860; P05412; O15525; O14744; Q02078; P84022; Q03135; P04637; P84243; O14920; P67775; Q00613; Q9Y6K9; Q14814; O15111; Q92934; O00459; P04049; P22736; P27986; P01100; P48506; Q9NP66; O43521; Q16760; P52655; P51114; P49450; Q04917; Q5QNW6; P09693; P07766; P08476; P30411; P27540; P15173; O00560; P30626; Q06546; Q15545; Q96N95; Q16623; P20823; Q5VWG9; Q92997; P05556; Q14254; Q9H2B2; P14679; P13498; P55347; P15923; P35611; P17676; O00327; Q9HAW7; P17542; Q13428; Q96RD7; Q07812; P05107; P18754; Q14721; Q8WYK2; P21579; P07196; Q16665; O75952; Q13485; Q6DRA6; P10415; P17301; Q06787; P08588; Q96A54; P58876; Q9Y5Q3; Q8NF99; Q08209; Q9UER7; P62826; P49116; P53671; Q9NSB8; P52952; Q9NUQ3; Q99814; Q92952; P15884; P18848; P51790; Q08462; Q9NTJ3; Q6DN03; P18850; O15392; Q07820; Q9P0W2; P62807; Q15853; Q14494; O75955; Q8N2Z9; P14416; P62258; P61296; P05067; P43354; P35368; Q02880; P06899; P54105; Q9UKY1; O75899; P68431; O96004; Q9UJY5; P17861; Q07817; Q9BXR0; Q9NP71; P18846; Q9UQE7; Q8NHW3; P62805; O00206; P23527; P61244; P24522; P13349; O60749; Q16778; P35638; P08913; P17655; Q9UH92; P46531; P22004; Q16611; Q07889; P22415; Q9H165; P0C0S8; Q86U44; Q99879; P28347; P30153; Q9NS23; Q99259; Q93079; P55957; O15519; O75449; Q99877; P11388; Q99728; P35869; P35612; P58753; P30556; Q5VWX1; Q9NR22; P09493; Q15672; Q9HB90; O60814; P48436; Q71DI3; P23409; P55327; Q13562"]
["GO:0000978","molecular_function","RNA polymerase II proximal promoter sequence-specific DNA binding ","P46937; P41212; P15407; O94916; P50750; P11474; Q06413; P42681; Q04206; P14921; Q09472; P15976; Q12968; P01106; Q15796; P03372; P42224; Q9UJU2; Q14653; Q15797; P49715; P10242; O75030; Q01167; Q01196; P42226; Q00653; P40763; P15172; Q9UQL6; Q14934; P10244; P41235; P16220; P05412; O15525; Q13469; Q02078; P84022; P17947; P04637; P35398; P11831; P61978; Q00613; P10275; P19419; Q14814; P14859; P23771; P01100; O43524; P04150; Q15910; P56524; P06401; Q13887; P08151; P78545; P22670; Q16254; Q9Y2X9; P07910; O96006; Q16649; Q8N680; Q9Y692; O15516; P09629; P15941; P49716; Q9C0K0; Q8TDD2; Q99801; P28324; Q9Y261; P17535; Q8IZQ8; P15173; Q32MZ4; O75626; P48552; Q06546; P52945; Q92858; P15923; Q13330; P58012; Q92908; P19532; P17676; P13056; O15350; Q15022; P28069; P56270; P26367; Q9P2D1; Q8WYK2; Q15424; Q99697; Q13547; Q13485; P55055; Q13118; P56178; P10070; Q9BZS1; Q9Y5Q3; P11387; P04198; P49116; P52952; O00482; Q02447; P15884; P18848; Q92985; P50553; O43541; P31314; P23511; P18850; Q9BU19; Q14494; P08047; Q9UBN7; Q12772; P28698; Q9NP62; P78337; Q9NQB0; P11308; P43354; Q07869; O95600; P17275; Q96BF6; Q9NZI5; Q6P1N0; O43474; O96004; Q6NUN9; P17861; P31269; P17544; Q8NHW3; P53539; Q9Y5B6; Q9Y2W7; P50549; P15036; P13349; Q9BWW4; P10914; O15119; P54845; P35638; P46531; P41970; O15534; Q99607; Q9H8N7; Q9H165; Q969T9; Q16633; Q9UBR4; Q15306; P67809; Q9BWG4; P20265; Q15583; Q15596; P51692; Q13950; Q14527; P52926; P50221; Q02556; Q16666; P43699; P51449; Q92785; Q03014; P10071; Q15648; P49711; P20393; P38159; P23769; Q00839; P10243; A0AVK6; P05549; Q92731; Q06330; P25490; Q96AV8; Q05195; Q9UQR1; P48436; Q9NRM2; P31260; P23409; Q9UMR3; Q01543"]
["GO:0003713","molecular_function","transcription coactivator activity ","P46937; P50613; P35269; Q09472; P06748; P06400; Q9H2X6; O75475; P10276; O14497; P49715; P15336; P24864; P29590; P38398; Q9Y2W1; Q9Y6Q9; P19793; Q00653; P20794; P15172; Q14934; P05412; P51610; Q02078; Q12824; Q13263; P35222; P23771; P43694; Q15650; O75469; O15164; P78545; Q96TA1; Q86UE4; Q14693; Q12962; P52655; Q14207; Q6P1K2; Q14684; Q9Y692; P61457; Q9UBK2; O15055; O75529; O60869; P27540; Q13772; P17535; Q8IZQ8; O60244; P48552; P51532; Q06546; Q15545; P53999; Q99966; Q9Y463; P15923; Q13330; Q14186; P78317; Q86X55; Q96RI1; Q8TAQ2; P37275; Q12948; Q93062; O60828; P28069; Q99697; P56545; Q99497; Q13573; Q969G3; Q9Y5T5; Q9Y5V3; O75925; Q9UER7; Q92793; Q15653; P62826; P49116; Q99592; Q969V6; P18850; P14923; O95999; P68036; Q13285; P56693; P61296; Q16621; Q9UK80; Q13133; P17275; O43294; Q6IE81; Q14192; Q14686; O75928; Q15327; O96004; P33076; Q99967; Q13049; Q6STE5; P61244; O94805; Q05086; Q86Y01; Q15788; Q13765; P54845; P35637; Q92841; Q969T9; Q16633; P29375; Q92794; Q9Y572; P20265; Q92993; Q15596; Q8NFD5; P52948; Q9GZV5; O00151; Q9NZC7; Q15648; P27695; O95905; Q8IX03; P05549; Q92731; P23497; Q14994; P25490; Q9Y2N7; Q9UBS8; Q9Y265; O00170; Q13562; Q9UMR3; Q01851; Q5VTR2"]
["GO:0003714","molecular_function","transcription corepressor activity ","P46937; Q9H2X6; P10276; Q96ST3; O43251; P50548; Q01201; O14744; Q02779; Q13263; P56524; Q9Y618; Q96IZ0; Q96EB6; Q9Y2X9; Q16649; Q14207; Q8WUI4; Q02535; P16989; P48552; O75461; Q99581; Q9UGP4; P51532; Q8WUF5; Q9BQG0; P25685; Q13330; O75081; Q01130; Q96RI1; P37275; P28069; Q14106; P50616; P10828; Q13547; Q9Y3T9; P56545; Q13573; O94763; P54259; Q06455; O00257; P0DMV8; Q9BZS1; O75925; Q9UER7; Q9H9S0; P54198; Q9UHJ3; O75496; Q9ULV5; Q99626; Q8IUX7; O15379; P17275; Q9UKY1; Q15327; O96004; P47928; O95551; Q9ULU4; Q99967; Q9NQR1; Q9Y2W7; Q99708; Q7RTU3; Q8N6T7; Q9BZK7; Q15637; P35638; Q9NRY4; Q8N2W9; P41970; P24385; Q15466; Q9Y230; Q9UMX1; Q15583; P51858; Q9GZV5; P51608; Q16385; Q99471; O75376; P12755; P49711; P27695; P20393; Q07021; Q00839; Q13363; Q96IF1; A0AVK6; P23497; Q04724; P25490; Q96AV8; Q9Y2N7; Q05195; O43255; Q9UKV0; Q01851"]
["GO:0001076","molecular_function","transcription factor activity, RNA polymerase II transcription factor binding ","P46937; P11831; Q8IZQ8; P18848; Q6P1J9"]
["GO:0044212","molecular_function","transcription regulatory region DNA binding ","P46937; P50750; Q13422; Q06413; Q04206; Q15303; P37840; P19544; Q9UJU2; Q9NYV4; P49715; P37231; P38398; Q14004; Q01196; P19838; Q99459; P40763; P41235; P49407; P05412; P84022; P04637; P10275; P23771; P01100; P43694; P08151; Q15291; Q9Y2X9; P13010; O95251; Q9C0K0; Q99801; Q9Y261; P17535; Q06546; Q15545; P20823; Q99966; Q92908; P19532; P19484; Q86X55; O15350; P12956; Q02962; P17542; Q12948; Q13568; O43918; Q13547; P15822; Q13485; P10827; O00257; P56178; Q9H9S0; P52952; P35548; O00482; O60341; Q13351; P18848; P55317; P41161; O43541; O15105; Q16236; P08047; P28698; Q9NQB0; P35232; Q96SN8; Q13133; Q99958; Q9NZI5; O43474; P33076; P01375; Q6NUN9; P17861; Q15561; O00255; P14866; Q9BZK7; Q9HCS4; P35638; P23246; P29374; P48431; P52926; Q9UL17; P35869; O60563; P43699; O75376; Q03164; Q03014; P49711; P20393; O14686; P05549; Q9H0D2; Q01860; P25490; Q9H3D4; O94776"]
["GO:0071532","molecular_function","ankyrin repeat binding ","P54274; Q04206; Q9C0C2; Q9Y566"]
["GO:0003677","molecular_function","DNA binding ","P54274; Q01538; P50750; Q13422; P42229; P10636; P11474; Q06413; Q04206; P14921; P78347; P33778; Q96KG9; P35269; Q09472; P06400; P15976; Q9Y6K1; P01106; P00519; Q9NYF8; O00267; Q9UJU2; Q14653; O14497; P49715; P37231; P29590; P38398; P19793; Q14765; Q01196; Q99459; P40763; Q86U86; P17096; P16104; Q14978; P41235; P05412; P28482; Q13469; Q12824; P04637; P52630; Q08050; P35398; Q13535; Q9UPN9; Q00613; P10275; Q08945; Q13263; P14859; P23771; P22736; Q13315; O43524; P49736; P43694; Q15910; P25205; P06401; P46013; Q9Y618; Q9NTI5; P08151; Q14469; Q9BX82; O15162; Q49AN0; O14746; Q2NKX8; P12524; P12980; Q03188; Q9NQV6; Q9NP66; Q12962; Q99996; Q96T58; Q16254; P49005; Q92610; Q9UQR0; Q8NCD3; P13010; P52655; Q9HC44; Q9Y2G1; Q96PM9; Q15366; Q16649; Q86UP8; Q6ZMG9; Q53HV7; Q9NVI1; Q16559; Q5QNW6; P35251; P19474; P20749; Q9UBK2; O15516; Q14202; Q96LX8; Q96KC8; P19447; Q8N9K5; Q9UBC0; P54132; Q8TDD2; Q8IYB3; Q6N043; P28324; Q9Y261; Q9H4L7; Q9Y5Q9; Q9UBW7; Q32MZ4; Q01105; O75461; Q9UHI6; Q06481; Q14807; O60673; P10588; Q06546; Q8NCP5; Q96N95; Q12906; P20823; P05114; Q9NS56; Q8TAQ5; P15923; Q14839; Q12899; Q6P4R8; P58012; Q14186; P43351; P17676; P78317; O00327; O15160; O15198; P51508; P13056; P82094; P23396; P12956; Q5D1E8; P55316; Q02962; P35659; Q8TAQ2; Q12948; P42677; P24928; O60828; Q96FV9; Q08999; Q96L91; P26358; Q9BXS6; Q9Y237; P26367; Q15906; P10828; Q01094; Q9NP87; P36956; P15822; Q8NCA9; P61218; O14771; Q6DRA6; Q9UH65; Q969G3; Q06455; P55055; P39748; Q03468; O94900; Q16526; Q13516; Q9BZS1; P58876; Q8NF99; P11473; Q9Y250; Q53H47; O75925; Q8IYB8; P11387; A8MT65; Q9H9S0; Q8N5B7; Q9BY66; Q9NYA1; P04198; P52952; Q03111; Q9BUZ4; O00482; Q9NZV7; Q9P2F9; Q99814; P42166; P15884; P18848; P55317; Q99592; Q92985; P41161; Q9BTP7; Q12946; Q6DN03; P23511; P53805; Q9P0W2; Q9HAW4; P62807; Q9Y534; Q16236; Q13285; O95625; O60381; P08047; Q7KZ85; Q9NP62; P56693; Q8N2Z9; P18858; P18583; Q16342; Q8NCK3; P40937; Q16621; P05067; P11308; P43354; Q07869; Q13133; O00571; Q9BXP5; Q8TBZ5; P17275; Q02880; Q92614; P06899; Q03112; P49790; Q9UKY1; P49916; Q7L2R6; O75928; Q92878; P54253; Q8TBC5; Q15327; Q9UHX1; Q99543; P17041; Q9BVI0; Q8TB69; Q9NYB9; P17861; Q9UK13; O14737; O60479; Q9UK11; Q7Z3K3; Q9BUG6; Q9NP71; Q15047; Q99598; P17544; Q8NHW3; P53539; P62805; Q8WVB6; Q9Y2W7; P22392; Q9BYX4; P0C1Z6; P15036; Q7RTU3; Q15631; Q86V15; P23527; Q12800; P62841; P61244; Q8WXB4; P29692; P98177; Q13569; Q15788; O95361; P10914; Q13765; Q16778; Q13283; Q9UGP5; Q13415; Q8N884; P43246; P54845; Q9HCS4; P35638; Q01954; Q6GQQ9; Q14739; Q9NRY4; P35637; Q8N2W9; Q9UH92; P49917; P55895; P12268; Q07889; O75531; Q9UGM3; Q12972; Q6P0N0; Q9H8N7; P0C0S8; Q68DY1; P29375; Q92794; P23246; Q15466; Q99879; Q8N9L1; P28347; Q9H2P0; Q16531; P67809; Q86WP2; O95239; E9PAV3; P29374; Q8N0Z6; O95983; Q93079; Q9UNY4; Q9UIS9; Q9Y3C5; P51858; Q8IXM2; Q9BVW5; Q8N720; Q8NFD5; Q7Z6Z7; Q07352; Q9UQ80; P51608; Q14527; Q05516; Q99877; P48431; P52926; Q9HD90; P11388; Q8NDW4; Q05952; P35869; O60563; Q9HCG1; P43699; P09874; Q9Y2V2; Q9H211; Q9BQW3; P14316; Q92945; Q8N726; Q96IT1; Q9HA82; P51449; Q96NC0; P42167; P13631; Q8N9N5; P27695; Q8TAW3; Q9UJV9; Q96RK0; P59923; Q00839; O94762; Q07666; Q96IQ9; Q14191; Q96E14; Q92547; O14686; P26651; Q03060; Q92731; Q06330; P23497; P18146; Q14994; Q01860; Q9BYE7; Q9Y2T7; P25490; Q9Y2N7; Q96QC0; Q9H3D4; Q14585; O60814; P05423; Q9H5H4; Q99676; Q92698; O15523; Q8ND82; Q15329; Q66K74; O95409; O75534; Q86VK4; Q9Y2K7; Q01543"]
["GO:0008301","molecular_function","DNA binding, bending ","P54274; P15976; P09429; Q9UJU2; Q00059; Q12948; P52926; P11388; Q03014"]
["GO:0003691","molecular_function","double-stranded telomeric DNA binding ","P54274; Q15554; Q92878; P27695"]
["GO:0098505","molecular_function","-rich strand telomeric DNA binding ","P54274; Q15554; P27694; Q9BQ15; P09651; P15927; Q9NYB0; P22626"]
["GO:0008017","molecular_function","microtubule binding ","P54274; Q9HC35; Q05193; P10636; P37840; P25054; P02511; O43663; P53350; Q96L34; O95819; Q5S007; P07332; Q08379; P53041; P15311; P11137; P08151; Q02224; Q32P44; O43521; Q9NQT8; Q92913; O43566; Q92597; Q14807; P50570; Q9HBA0; Q92974; P23396; P12036; Q96Q89; Q9BXS6; Q12798; Q9GZM8; P04156; Q9NXR1; Q06787; Q9UPY8; P06746; Q9Y250; Q15555; P78559; Q9H0H5; P30622; Q9P2E2; Q96BD8; P27816; Q15058; O15392; P07197; O95235; Q9UBN7; Q14203; P41208; P62491; Q96SN8; Q9P219; Q9BW19; O75122; O43602; Q49MG5; O00429; O00139; Q96R06; Q6P0Q8; Q13009; P46821; P04406; Q8N4N8; P06702; O95239; P13693; Q3V6T2; Q9Y496; O75449; Q969S2; Q14980; P52732; O94811; Q9UH99; P33176; O60282; Q15417; Q66K74; Q02241; Q16555"]
["GO:0042803","molecular_function","protein homodimerization activity ","P54274; P36888; P49585; Q13554; P04629; P51617; Q16620; P10636; P31152; Q04206; P51636; Q16584; P31749; Q15303; Q13557; P04792; P04035; Q13237; P11413; Q01581; P06748; P35228; O96017; P02511; Q15796; Q12852; P11362; P42224; Q9NZJ5; P16284; Q14653; P49715; P21802; Q15119; Q04771; P29590; P35916; P80192; Q01196; P19838; P12814; P40763; Q9UQM7; P49327; P41235; P27707; P35520; P21860; P16234; P05412; P10721; Q5TCX8; Q5S007; P84022; O94804; P11831; P07333; Q13043; Q02779; Q99683; O14920; O43353; Q9Y6K9; P06733; P54840; O43293; Q14814; O15111; P08238; O00506; O75874; P04083; Q9H2G2; P33981; Q13555; P40189; P07900; Q12882; Q9BQI3; P35354; Q9HC16; P36544; Q14469; P41180; Q9NSU2; O14746; P60891; O75150; Q16760; Q15717; Q13002; Q8NF91; Q9UKT5; Q8NCW5; Q12904; Q9ULJ8; P09327; Q15554; P51114; Q9P289; Q5VUA4; Q9GZY8; Q14145; Q9UL63; Q7Z2W7; O75351; P09693; P07766; O15245; Q03431; P02786; P47736; P54132; Q9Y210; Q13563; P27540; P04818; O43707; Q32MZ4; Q9NQ66; Q7L804; P04040; P30041; P09382; P51649; P17342; Q96N95; Q15046; P20823; Q6UB35; O14558; Q99966; Q9H2B2; P14679; P11908; Q9P1Z0; Q92692; P15923; P35611; Q5T7P8; P17676; P35241; Q14449; P42892; P13056; Q9UII2; Q86X55; Q15762; Q14849; Q9HAW7; Q9NPP4; Q93062; Q15075; Q5VWQ8; Q96Q89; Q07812; P20963; Q99697; P40259; P56545; P41597; O76061; Q99497; Q13257; Q13485; P10415; O43236; P45973; Q8WTV0; Q06787; P47989; P52179; Q15276; Q13516; P83916; Q9BZS1; Q9Y5Q3; Q8NF99; P02649; Q53H47; Q9UER7; Q8WUA7; Q8IYB8; Q8TCG1; Q92886; P12270; P08133; P31939; Q9NSB8; P52952; P08237; Q9UNQ0; P15884; O75460; P11912; P30622; P51790; P50553; P23025; Q13501; P14923; Q9Y3M2; P10912; O15392; Q07820; O95278; O95684; P30273; Q15853; P17813; O15217; Q15633; P08047; P00441; P28698; P50747; Q9H8V3; P14416; P31950; O75581; P13688; P61296; Q8IYM1; P05067; P43354; P63244; Q03112; Q96BF6; Q9NZI5; Q86WV6; P43320; O96004; Q99962; P17861; Q9UHY1; P09417; P28715; O00429; Q07817; Q9BXR0; P21333; P49815; Q9BUL8; O43598; Q8NHW3; Q9UNE7; P61244; P24522; O14958; O60749; Q13569; P43246; P30040; Q12809; P35638; Q9UPN4; Q8N335; P02730; P08913; P09601; Q9UH92; Q9Y3E7; Q9H816; P35790; O75096; P31949; Q16611; O75531; P22415; P06737; Q9H165; Q13614; P16471; P23246; Q15466; Q9Y230; Q9ULZ3; P08034; Q6J4K2; Q3V6T2; Q8N0W4; Q9GZV5; P01730; Q05516; Q03393; P11388; O95267; Q99728; P35869; Q7Z589; Q99856; P29401; Q96H20; P35612; Q96PM5; P07550; Q8WYQ5; P58753; O15169; P78356; Q03164; O75154; Q03014; P11926; Q9H2S1; P36894; Q9NRR4; P08567; Q13363; P24752; Q14191; A0AVK6; P35579; Q9NR22; P41134; P05549; P23497; P31645; Q96CF2; P50479; Q9Y371; P09493; Q15672; Q9H257; P07814; P55327; P22413; P39019; Q14457"]
["GO:0000981","molecular_function","RNA polymerase II transcription factor activity, sequence-specific DNA binding ","P54274; P41212; Q01538; Q01826; P15407; O94916; Q13761; Q13422; P42229; P11474; Q06413; Q04206; P14921; P78347; P15976; Q12968; Q9Y6K1; P01106; P19544; Q15796; P10276; P03372; P42224; Q9UJU2; Q14653; P17480; Q15797; O14497; P49715; P10242; P15336; P37231; O75030; Q9Y6Q9; Q01167; P19793; Q14765; P85037; Q01196; P19838; P42226; Q99459; Q00653; P40763; P15172; P17096; Q8WXI9; P50548; Q01201; Q14934; P10244; P41235; P16220; P05412; O15525; Q13469; Q02078; P84022; P17947; P04637; P52630; Q08050; P35398; P11831; Q00613; P10275; Q08945; P19419; Q12778; Q14814; P14859; P23771; P22736; P01100; O43524; P04150; P43694; Q15910; O75469; P06401; Q13887; Q9Y618; P08151; P78545; Q14469; Q9BX82; P12524; P12980; Q9NQV6; Q9NP66; P22670; Q16254; Q9Y2X9; Q92610; Q04864; Q14863; O96006; Q9Y2G1; Q96PM9; Q16649; Q86UP8; Q8N680; Q15554; Q6ZMG9; O95785; Q16559; P32314; Q9Y692; O43623; O15516; P09629; Q14202; P49716; O95251; P19622; Q96LX8; Q96KC8; Q8N9K5; P62508; Q9C0K0; Q9UBC0; Q8TDD2; Q02535; P27540; Q6N043; Q99801; P28324; Q9Y261; P17535; P16989; Q9UBW7; P15173; Q32MZ4; O75626; O60315; O75461; Q99581; P10588; Q06546; Q8NCP5; P52945; Q96N95; O95238; P20823; Q92858; Q8TAQ5; Q9P1Z0; P55347; P15923; Q13330; Q9P0U4; P58012; Q92908; P19532; Q14186; P17676; Q9H2A3; O00327; P19484; O15198; P51508; P23760; P13056; Q9HBU1; O15350; Q96RI1; P55316; Q02962; P17542; Q8TAQ2; P37275; Q12948; Q13568; P28069; O43918; P56270; Q99576; P26358; P26367; Q8WYK2; Q99697; P10828; Q01094; Q16665; P36956; P15822; Q8NCA9; Q13485; O14771; Q969S3; Q969G3; P55055; P10827; Q13118; O94900; P56178; Q13516; Q8WXF1; P10070; Q9BZS1; Q9Y5Q3; Q8NF99; P11473; Q96LI6; A8MT65; Q92886; Q9H9S0; P23759; Q9BY66; P17509; P04198; O00716; P49116; P52952; Q03111; Q9UIW0; P35548; O00482; Q9NZV7; Q9P2F9; Q99814; Q02447; Q13351; P15884; P18848; P55317; Q99592; Q92985; P41161; Q9P2K5; P50553; Q12946; O43541; P31314; P23511; P18850; O15105; Q9ULV5; P48443; Q99626; Q02363; Q9P0W2; Q9BVI4; P50219; Q16236; Q9BU19; Q15853; Q13285; O95625; Q14494; O60381; P08047; Q12772; P28698; Q9NP62; P56693; P78337; Q8NCK3; P61296; Q9NQB0; Q9BZI1; Q16621; P11308; P35232; P43354; Q07869; O95600; Q13133; Q99958; Q8TBZ5; P17275; Q6U7Q0; Q03112; P31270; Q96JP5; Q9UKY1; Q9UPT8; Q9NZI5; Q7L2R6; Q6P1N0; O43474; A8MYZ6; Q8TBC5; O96004; Q99543; P47928; P17041; Q9BVI0; Q8TB69; Q6NUN9; Q96HZ4; P08235; P17861; Q9UK13; Q15561; O60479; Q7Z3K3; Q9BUG6; P31269; Q9NP71; P41182; O00409; P17544; P18846; Q8NHW3; P53539; P40425; Q01892; P50549; P15036; Q7RTU3; Q86V15; Q12800; P61244; Q8WXB4; P13349; P98177; Q15788; P10914; P57682; O15119; P54845; Q9HCS4; P35638; Q01954; P41162; Q9Y3Q8; Q9UH92; Q9BYV9; O95863; P41970; Q86YP4; O75152; Q99607; P22415; Q6P0N0; Q9H8N7; Q9UBD0; Q9H165; Q68DY1; P29375; P23246; Q9UBR4; Q15466; Q8N9L1; P28347; Q9H2P0; Q15306; O96028; P67809; P29374; O15266; P20265; Q15583; O95644; Q9UIS9; Q15596; Q15365; P51692; Q8N720; Q13950; Q8NFD5; Q07352; Q05516; P48431; P52926; Q9HD90; Q9UL17; P50221; Q8NDW4; Q02556; P35869; Q99856; Q9HCG1; P43699; Q9Y2V2; Q9BQW3; P14316; O75376; Q96IT1; O14813; P51449; Q92785; Q03164; Q03014; P13631; P10071; P12755; Q15648; P49711; P20393; P36894; Q8TAW3; Q96RK0; P08567; P59923; Q9UPG8; P23769; Q96IQ9; P10243; A0AVK6; O14686; P41134; Q03060; P05549; Q92731; O95997; Q06330; P23497; P18146; Q9H0D2; Q14994; Q01860; P15408; Q9Y2T7; O75444; P25490; P49640; Q96AV8; Q9Y2N7; Q15672; Q9H3D4; Q14585; O94776; Q9NUK0; Q05195; Q9UQR1; Q9H5H4; Q99676; P48436; Q9NRM2; Q8ND82; P31260; P23409; Q15329; O95409; Q13562; Q9UMR3; Q01851; Q86VK4; Q9Y2K7; Q01543"]
["GO:0042162","molecular_function","telomeric DNA binding ","P54274; Q12888; Q96Q15; O14746; P13010; Q15554; P12956; P19338; O60341; Q92900; Q9NYB0; Q9BSI4; Q14103; Q96AP0"]
["GO:0004340","molecular_function","glucokinase activity ","P35557; P52789; P19367"]
["GO:0005536","molecular_function","glucose binding ","P35557; P11413; P13807; P52789; P19367; P06737"]
["GO:0005516","molecular_function","calmodulin binding ","O14936; P48454; P00533; P49585; Q13554; Q16566; P02686; Q8N5S9; Q13557; Q9UEY8; P35228; Q96RR4; O00418; Q8IW41; P49137; Q05586; P29475; Q9UQM7; Q9BUB5; Q9HBH9; Q8IU85; Q05682; Q16644; Q8NCB2; P29474; Q01970; Q13555; Q14012; Q13459; P11137; O15492; P35749; P08138; Q08AD1; P41220; P35580; O43525; P46020; Q01814; Q5T4S7; O15554; P17844; Q13425; Q6P2M8; P55042; O60869; P23677; O60266; O75628; Q8WZ42; A8MU46; Q9NQ66; Q08828; Q96D31; Q9NQA5; Q9HBA0; P32929; P35611; Q01844; Q13576; P25445; Q01082; Q9UII2; Q9UKX2; Q15746; Q15075; Q9UIK4; P21579; Q99439; O43581; Q92736; P32418; Q14524; P19634; Q08209; Q9Y4I1; Q9NYA1; O43526; Q13813; Q92952; P63027; P11171; Q13936; P49006; O95613; P53355; Q8IUX7; P17677; P13688; P29966; Q93100; Q96SN8; P54750; Q8TD43; P55040; P30301; Q8NEV4; P49798; Q8IW35; P51787; P46940; Q07157; P23634; Q92686; O43815; Q13424; Q8NER1; Q9H1R3; Q9Y283; Q9UBL0; P51911; Q96NX5; Q9H1D0; O14827; P35612; Q16816; Q9H2S1; Q9UM54; P35579; P21817; Q9UKX3; Q13698; Q15417"]
["GO:0004385","molecular_function","guanylate kinase activity ","O14936; Q16774; P78352; Q15700; Q14160; Q9BXL7; Q12959; Q9UDY2"]
["GO:0034236","molecular_function","protein kinase A catalytic subunit binding ","P49840; P13861; P41240; P49841; P15311; P61925; P31323; Q92736; O43164; P51787; P10644; P48436"]
["GO:0005102","molecular_function","signaling receptor binding ","P49840; P07948; P08631; P35228; Q13882; P00519; P09619; P10276; O60674; Q05586; Q05397; Q06187; P29323; Q14289; P43403; P41235; P51451; P41240; Q03135; P07737; P17302; O43353; P07947; P42684; P10275; P12931; P23528; Q96RT1; O75874; P04083; P23458; P52333; P42685; Q13470; P02671; P06401; O15164; Q99996; P01889; O43734; O14745; P26038; Q13563; P32942; P04040; P30626; Q08495; Q92997; Q15599; P16333; Q92692; P00747; P48023; Q96RD7; Q96F46; Q15036; Q99497; Q01959; Q9Y3F4; P46379; O43312; P30044; P0DMV8; P58400; Q9UJZ1; P67870; O43914; O60716; O75581; P05067; P56211; P63244; Q5ZPR3; Q02297; O43768; P22460; Q6STE5; O95477; O00206; P30533; O60610; P22307; P08833; P21854; Q14244; P20936; Q96PM5; P32121; P33151; P61266; P01892; Q9NRD5; O15117"]
["GO:0050321","molecular_function","tau-protein kinase activity ","P49840; Q8TDC3; Q13131; P48730; Q7KZI7; Q96L34; Q00535; P49841; Q9P0L2; P27448; Q8IWQ3; Q16816"]
["GO:0003700","molecular_function","DNA-binding transcription factor activity ","P41212; Q01538; P15407; O94916; Q13761; Q13422; P42229; P11474; Q06413; Q04206; P14921; P78347; P06400; P15976; P01106; P19544; Q15796; P10276; Q96ST3; P09429; P03372; P42224; Q9UJU2; Q13148; P22681; Q15797; P49715; P15336; P37231; Q01167; P19793; Q14765; Q01196; P19838; P42226; Q00653; P40763; P17096; Q01201; P10244; Q14978; P41235; P16220; P05412; O15525; P51610; Q13469; Q02078; P84022; P17947; P04637; Q08050; P35398; P11831; Q00613; P10275; P19419; Q13263; Q14814; P23771; P01100; O43524; P15498; P04150; P78545; Q14469; Q9BX82; Q9NP66; Q16254; Q9Y2X9; Q9UQR0; Q04864; Q9HC44; Q14863; O96006; Q9Y2G1; Q9Y4C1; Q16649; Q7Z5J4; P32314; P20749; O15516; P09629; Q14134; O75529; Q8N9K5; P27540; Q99801; P28324; Q9Y261; P16989; P15173; O75626; Q99581; Q00059; P10588; Q06546; P52945; P20823; Q99966; Q92858; Q8TAQ5; O95218; P55347; P15923; P58012; Q92908; P19532; Q14186; P17676; P78317; P19484; P51508; P23760; Q9HBU1; O15350; O75081; Q96RI1; P17542; P37275; Q12948; P62633; P28069; Q99576; P26367; Q99697; P10828; Q13547; Q01094; Q16665; P36956; Q06455; P10827; Q13118; P10070; Q9BZS1; Q9Y250; Q92886; Q9H9S0; P23759; Q92793; P04198; Q96T88; O00716; P49116; P54198; P52952; Q9UIW0; O00482; Q9NZV7; Q13351; P15884; P18848; P55317; Q99592; P41161; P50553; P23511; P18850; P53805; Q9ULV5; Q99626; P50219; Q16236; Q15853; Q14494; P08047; Q7KZ85; Q8IUX7; P28698; Q9NP62; P56693; P78337; Q9NQB0; Q16621; Q07869; Q99958; Q6U7Q0; Q03112; Q9UKY1; Q7L2R6; O43474; Q6NUN9; Q96HZ4; P08235; O60861; P17861; Q9UK13; Q15561; Q99967; O60479; Q9NP71; P41182; O00409; P17544; P18846; Q8NHW3; Q9Y5B6; Q9NY61; P22392; P50549; P15036; Q12800; Q96AE4; P61244; Q8WXB4; P98177; P57682; Q9HCS4; P35638; Q01954; Q9UH92; Q9BYV9; P46531; P41970; Q9H0E9; P29375; P28347; Q15306; P67809; Q86WP2; P29374; O15266; P20265; Q15583; O95644; P51692; Q8N720; Q13950; Q07352; Q9UQ80; P48431; Q9UL17; P50221; P35869; P43699; P14316; O14813; P51449; Q03164; P13631; P10071; Q8WWI1; P49711; Q9UPG8; P23769; Q13363; A0AVK6; Q92731; O95997; Q06330; P18146; Q9H0D2; Q14994; Q01860; P15408; Q9BYE7; P25490; P49640; Q96AV8; Q9H3D4; Q14585; Q05195; P48436; O60260; P23409; Q15329; O95409; Q13562; Q01543"]
["GO:0000977","molecular_function","RNA polymerase II regulatory region sequence-specific DNA binding ","P41212; Q01826; Q13761; P39880; Q06413; Q04206; P15976; Q9UJU2; P15336; P19793; P85037; Q01196; P19838; P42226; Q99459; P15172; Q01201; Q02078; Q08050; P35398; P06733; Q14814; P23771; P43694; O75469; P08151; P12980; O96006; Q16649; Q16559; Q9UFW8; P62508; O43707; P16989; P15173; P20823; Q9P1Z0; Q92908; P17676; Q9HBU1; Q96RI1; P17542; Q12948; P62633; O43918; P36956; Q9H9S0; P49116; P35548; Q02447; P41161; Q12946; P18850; P48443; Q13285; P08047; Q8IUX7; P61296; Q9Y483; P01375; Q9ULU4; Q96HZ4; P17861; P41182; P18846; P40425; P57682; P41162; Q9NRY4; Q9UH92; O95863; Q99856; P43699; P09874; P14316; O14813; P13631; P10071; P20393; P23769; Q03060; P18146; Q14994; P15408; Q9BYE7; Q9UMR3"]
["GO:0001077","molecular_function","transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding ","P41212; P15407; O94916; P11474; Q06413; P42681; Q04206; P14921; P15976; Q12968; P01106; P19544; Q15796; P03372; Q9UJU2; Q14653; Q15797; P49715; P10242; P15336; O75030; Q01167; Q00653; P40763; P10244; P41235; P16220; P05412; O15525; Q13469; Q02078; P17947; P11831; P61978; P10275; P19419; Q14814; P23771; P22736; P01100; P04150; P06401; Q13887; P78545; O15162; Q96EB6; Q16254; O96006; Q9Y692; P09629; P49716; Q9C0K0; Q9UBC0; Q8TDD2; P28324; P17535; Q8IZQ8; P15173; Q06546; P20823; Q92858; P58012; P19532; P17676; O15350; Q96RI1; P28069; P26367; Q99697; Q16665; P36956; Q13485; P55055; Q13118; P56178; P10070; Q9Y5Q3; P04198; P49116; P52952; O00482; Q99814; P15884; P18848; P55317; P31314; P18850; Q14494; P08047; P28698; Q9NP62; P78337; P61296; P11308; P43354; Q07869; Q99958; P17275; Q9NZI5; O43474; Q9H1E3; O60479; Q8NHW3; P53539; P50549; Q12800; O75716; Q9BWW4; P10914; P54845; P35638; P41970; Q99607; Q9UBR4; Q15306; P67809; Q9BWG4; P20265; P51692; Q13950; Q14527; P48431; P52926; P50221; P10071; Q9UPG8; P23769; P10243; P05549; Q06330; P18146; Q9H3D4; P48436; P31260; Q13562; Q9UMR3; Q01851; Q01543"]
["GO:0001227","molecular_function","transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding ","P41212; Q01826; Q12968; O75030; P19838; P50548; Q14934; Q08050; P06733; O43524; Q14863; Q9UFW8; P16989; O60315; O95238; Q9P1Z0; P37275; P62633; P26367; Q01094; Q9UIW0; P35548; Q9NX63; Q99626; Q8IUX7; Q9BZI1; Q96HZ4; P41182; P41162; Q9NRY4; Q9UH92; Q9UL17; Q03060; Q01860; Q9BYE7; Q96AV8; P57721"]
["GO:0008270","molecular_function","zinc ion binding ","Q01538; P11474; Q12879; P18031; P37840; Q09472; P15976; P17252; P19544; P10276; P03372; P37231; P29590; P38398; Q00987; Q13224; P19793; P27708; Q13233; Q8WXI9; P41235; P05129; P84022; P04637; P05771; P35398; Q9Y2I7; Q9UPN9; P10275; Q13263; P23771; P22736; P04150; P43694; P56524; O95376; Q7Z6E9; Q15650; P04731; O75469; P06401; O60941; Q9HC16; O15164; Q6NZY4; Q8TBK6; O75592; O95271; O95071; Q96PM9; Q16790; Q5VUA4; Q9GZX7; Q5T4S7; P19474; Q9Y6X9; Q14202; Q14134; Q9UPP1; O95251; P62508; Q5JTZ9; Q9H1K0; Q9UIQ6; P54132; Q9Y2K6; Q9Y3Z3; Q12933; Q9UBW7; Q9UGP4; P10588; O15304; O95786; P08473; P53992; Q14839; Q12899; Q13330; Q9P0U4; Q92974; Q92908; P78317; P42892; Q04760; P13056; Q9UBU7; Q96RI1; P37275; Q8TBF4; P42677; P62633; Q15075; O43918; Q5TAX3; P26358; Q96FI4; P53004; P10828; Q9H4P4; Q13191; Q9NQC7; Q969S3; Q9Y5T5; P55055; P10827; Q9NTG7; Q9UBF6; O15553; P10070; P11473; Q53H47; O75925; Q92793; P35226; Q9UL40; Q96T88; P49116; Q9BUZ4; O00482; Q9NZV7; Q9UIG0; Q86WB0; P30622; Q8WY41; Q9BYB0; Q15436; Q13501; O15392; Q9NQ86; P48443; Q9Y2J0; P00918; Q9BWF3; Q92784; O14638; P43243; Q9Y4K3; Q13285; Q9C0B9; Q9UBN7; Q8IUX7; P00441; Q9NP62; O15151; Q92900; Q13114; P43354; Q07869; P21291; Q13133; P49916; O75928; O43474; P08235; Q13049; P46939; Q15047; Q9BYX4; Q96KQ7; Q5TC82; P17405; Q86Y01; Q8N6T7; O95361; P04183; Q15637; Q6GQQ9; Q8N2W9; Q13077; Q86YP4; P55895; P29375; Q92794; P06702; Q9NS23; O43823; Q9UNY4; O75151; Q9UIS9; Q9Y3C5; P01730; Q14527; Q05952; O95267; Q969S2; Q9Y2Y1; P09874; Q96PM5; Q9Y2D0; P51449; P08253; Q03164; Q96NC0; P13631; P12755; P49711; P20393; Q8IUQ4; P23769; Q9H3R0; Q00403; Q8IXJ6; P19021; Q14966; Q92731; P18146; Q14142; Q14994; P25490; O94776; P12821; P50281; O43255; P07814; Q9ULV8; Q99676; P52943; O60260; Q9Y2K7; P22413"]
["GO:0005068","molecular_function","transmembrane receptor protein tyrosine kinase adaptor activity ","Q8WV28; P29353; Q8WU20; P35568; P27986; Q9NWQ8; O14492; Q6PIZ9; O60496; Q9UQC2"]
["GO:0019869","molecular_function","chloride channel inhibitor activity ","Q9BYP7; Q96J92; Q9H4A3; Q16623; P13569"]
["GO:0004740","molecular_function","pyruvate dehydrogenase (acetyl-transferring) kinase activity ","Q15118; Q15120; Q15119; Q16654"]
["GO:0004896","molecular_function","cytokine receptor activity ","P36888; P16871; Q99062; Q99650; P10912; P78552; P32927; P13726; Q13261"]
["GO:0035259","molecular_function","glucocorticoid receptor binding ","P36888; P40763; P84022; Q04917; P48552; Q02790; P17676; P63165; P43354; P15036; P51692"]
["GO:0044877","molecular_function","protein-containing complex binding ","P36888; Q05193; Q04206; P11802; P01106; Q01813; P02511; Q96ST3; Q12792; Q05586; P29323; P10586; Q14289; P25963; Q13546; Q9Y2X7; P54762; O75385; P06213; Q13315; Q9Y5S2; P38936; P78352; P28223; Q13158; Q5T2W1; O75150; P61224; P13010; Q86WV1; Q15554; O14745; P49792; Q92558; P14317; O95817; Q15750; P49918; Q12933; Q13371; P01116; Q9NYY3; P05556; Q9NQ48; Q9Y4R8; P50570; P07437; Q01082; P46527; P23396; P62834; P12956; Q5VWQ8; P05787; P05107; O75386; Q9GZM8; P36956; P56545; Q01959; P04156; P45973; P17301; P10827; Q14790; Q03468; P02649; Q9Y6W5; Q96PF2; Q9Y2J0; P49321; Q14494; O15143; Q96BK5; Q07869; Q96BF6; P46459; Q6NXT1; P33076; Q9NYB9; P10301; O00429; P18846; P98175; Q9NS91; P61244; Q5VZK9; P08727; P46940; P31994; Q9C0C2; Q9UPN4; O43815; Q9H816; P24385; Q8N122; P16473; P36873; O14713; Q15466; Q16531; O00213; Q9Y572; P09496; O15519; O14490; Q07954; Q7L5Y6; P21796; P63010; P07550; P32121; Q9BUR4; P42574; Q14980; P27695; P52732; Q96AP0; Q8IZP0; Q00839; Q07666; Q14191; P31946; P01111; Q8NB16; Q0VD86; Q9Y566; P42898; Q9BXA7; O15117"]
["GO:0043621","molecular_function","protein self-association ","P36888; P37231; Q13627; P04637; Q00613; P11166; P40926; P46108; O14745; P81274; Q03431; Q99801; Q8WZ42; Q08495; Q9Y613; Q92736; O43765; P63027; Q9BYB0; O95999; O14641; Q9P219; P54253; Q13049; Q13569; Q96IT1; P41134"]
["GO:0005088","molecular_function","Ras guanyl-nucleotide exchange factor activity ","P36888; P00533; Q13554; Q12879; P22455; Q15303; Q13557; P29353; P09619; P11362; P07949; O60674; Q05586; P21802; Q8WU20; P04626; P22607; Q05397; Q13224; P18433; Q9UQM7; P21860; P16234; P10721; P06241; P35568; P08581; P23458; P52333; Q13555; Q02763; P78352; Q99996; P62993; Q9GZV9; Q92529; Q01082; P0DP23; Q9Y4H2; Q9Y4G8; P07196; P08588; Q13813; P09038; P01589; P13591; P14784; Q02297; Q96S59; Q07889; O43561; P32927; Q13972; Q8IV61; O14827; O95267; Q14957"]
["GO:0004714","molecular_function","transmembrane receptor protein tyrosine kinase activity ","P36888; P00533; P08922; P04629; Q15303; Q01974; P54760; P17948; P07949; O15146; P04626; Q06418; P29317; P35916; Q9UM73; P14616; P35968; P30530; P16234; P10721; Q08345; Q16832; Q12866; Q02763; P29376; Q15300; P35590"]
["GO:0005021","molecular_function","vascular endothelial growth factor-activated receptor activity ","P36888; P17948; P35916; P35968; P16234"]
["GO:0033192","molecular_function","calmodulin-dependent protein phosphatase activity ","P48454; P35813; Q08209"]
["GO:0046872","molecular_function","metal ion binding ","P48454; O75116; P13612; P09467; Q9BRS2; P62140; P62136; Q13422; P51956; Q6VAB6; Q13131; O00763; Q13873; Q01974; P24723; Q05513; Q13163; P54646; P51813; Q9Y6K1; Q99640; P55263; P35228; Q00266; Q01813; O96017; P02511; Q15796; O60285; O00311; P21980; O15146; O60674; Q06203; P36507; Q9BSJ8; Q15797; Q9P212; P15336; Q96GD4; Q04771; P62714; Q04759; Q07912; Q06187; P42680; Q8IVT5; Q13085; Q9UQM7; P20794; Q15139; P21399; Q9UQL6; Q9BUB5; Q9BZL6; Q9HBH9; P53667; Q09013; P35520; Q08881; P10721; Q9BVS4; Q9Y2X7; P41240; P31751; Q96Q15; O75914; Q08345; Q9NR20; O14964; P06241; Q8TDX7; Q9Y2U5; P67775; Q9Y6K9; Q96HC4; O94806; P53041; Q9Y6E0; Q9UQ07; O00506; Q02156; P04049; P51955; Q96Q40; Q9NRP7; Q13464; P10398; P49736; P23458; P15498; P41743; Q9NZV8; P49023; P38936; P53396; Q12882; Q05655; P35354; Q9NRM7; O00757; Q13459; P02671; Q08499; Q13887; P08151; Q9BX82; Q9NSU2; P09958; O14746; Q13642; Q99502; Q96CV9; Q9BUL5; Q96EB6; Q08493; Q9NQV6; O75150; Q14344; Q9Y2X9; Q16760; Q92610; Q8NCW5; O96006; Q9UKT4; Q96T51; P12694; Q8N680; Q12791; Q13705; O95785; Q01814; Q7Z5J4; Q9Y692; P19429; O43623; P49792; Q9NR56; Q6ZVD8; P11488; P62979; Q96LX8; Q9NX46; O60346; Q8N9K5; Q8WUI4; Q9C0K0; Q38SD2; Q99504; Q8TDD2; O60266; Q6N043; Q9P2S2; O75626; O60315; P04040; Q9UKV5; Q08828; Q8NHG8; O60673; Q15027; P52735; P17858; Q8NCP5; Q8NG66; O15304; Q96N95; P53804; Q13370; Q5T8P6; Q96P48; Q5VWG9; Q01433; P19086; Q9NS56; P04899; Q9BYM8; Q99590; P29083; P05556; Q9H2B2; Q9Y6R4; Q8TAQ5; O95218; Q9NQA5; Q9P1Z0; P13498; Q9HBA0; Q12899; O60841; P43003; Q01844; P26010; Q13574; Q9NYJ8; O15198; P51508; Q8ND24; O15014; Q86VP1; O76074; O15350; Q8IZD2; O75081; Q8TDQ0; Q5D1E8; Q01081; Q8IW19; Q15022; Q99759; Q15746; Q7LG56; P52757; Q9Y4D2; P24928; Q9BZB8; P56270; Q9UBT6; P05107; O15297; O95861; Q96PY6; Q93052; Q9NP87; Q12802; Q9NZJ9; P15822; Q01959; Q8NCA9; P27694; Q13107; Q13485; O14771; Q96JM3; Q8WYH8; P17301; Q6PJT7; O60229; Q9UKW4; Q9NZS9; Q06455; Q13118; O94953; Q02153; Q9BX84; Q9BZS1; O15355; Q96A54; Q9UIF9; P06746; Q8NF99; P49643; Q9P0J1; O95848; A8MT65; O14578; Q9BY66; P50461; Q9H6E5; P78536; Q92994; P53671; Q9H0H5; Q15942; P58400; P08237; Q9Y253; Q9P2F9; O43306; P67870; Q02447; Q13351; Q9H0D6; Q9ULH1; Q7Z2W4; Q99592; P30622; P30679; P23025; O43541; P17936; Q96JY6; Q13936; O15105; Q96T23; O15392; Q8NHY2; Q9BU19; O95625; Q9ULM6; P08047; Q9UHB6; Q15569; P37173; P28698; Q9BV36; P18858; Q9HCR9; P00973; P43005; Q16342; O14773; Q8NEL9; Q8NCK3; O43164; O95600; P54750; Q9UK80; Q8TBZ5; Q02880; Q8N6H7; Q6U7Q0; O43257; Q03112; Q96JP5; Q9BRQ0; O43294; Q01668; P49790; Q9UKY1; Q14432; Q6IE81; Q9UPT8; Q8WWN8; Q14192; Q86UR5; P36897; Q7L2R6; Q14161; Q92878; Q8TBC5; P46459; Q9P2N5; P17041; Q9BVI0; Q7Z3T8; Q9Y483; Q8TB69; Q6NUN9; Q9ULU4; Q9UK13; Q9ULU8; Q8N3F8; O60711; Q9UK11; P28715; O95453; Q7Z3K3; Q9BUG6; Q9BXR0; Q7L0Q8; P41182; Q99598; P17544; P22392; P98175; Q86V15; Q9NS91; P48200; P99999; O43184; Q9NRG4; Q8WXB4; Q05086; P23975; Q8N5C8; Q9UGP5; O95180; P57682; Q8N884; Q9BY41; Q07343; Q9H8S9; P23634; Q01954; Q15057; P35637; Q9UKF6; P09601; P49917; Q7L9L4; O95863; Q8NER1; P19404; Q7LBC6; P20042; O75152; P12268; Q16611; Q9UK53; P36873; P48664; P37023; Q9H8N7; Q96EP1; O60678; Q9H165; P98170; Q8TDY4; P16471; Q68DY1; P40145; Q9UBR4; Q9NQX3; Q8N9L1; Q9ULX3; Q14847; O00625; Q4G163; O96028; Q8IWR0; P31350; Q9UK17; Q92993; Q8N720; Q9H0C8; Q99490; Q07352; Q9NRL2; Q05516; Q96QT4; Q6ZN16; Q9H1D0; Q03393; O00151; Q8NDW4; Q99728; Q8TD19; P29401; Q9HCG1; Q7Z6J0; Q9BQW3; Q8WYQ5; Q96IT1; O75689; Q92785; O94880; P10071; Q8WWI1; P27695; P36894; Q8TAW3; Q9UJV9; Q7Z2E3; O43150; Q9NRR4; P59923; Q9UPG8; Q9Y233; P24752; Q96IQ9; Q13907; Q71UM5; Q96IF1; O14686; Q03113; P26651; Q15654; Q14896; Q9H0D2; P36896; P31645; Q8WVD3; P27815; P50479; Q86YF9; Q9BYE7; O60361; Q6PCD5; Q9BXT4; Q96QC0; Q9UKV8; Q9UBS8; Q13444; Q8TCJ2; Q9H3D4; Q14585; Q9NUK0; Q5VWQ0; Q9UQR1; P08100; Q9UKV0; Q8ND25; Q9H5H4; Q9NRM2; Q8WU79; Q13698; Q8ND82; Q9NRD5; O95409; Q86VK4; Q5VTR2"]
["GO:0072518","molecular_function","Rho-dependent protein serine/threonine kinase activity ","O75116"]
["GO:0017048","molecular_function","Rho TPase binding ","O75116; Q5S007; P07737; O43293; Q9Y5S2; Q13459; P16989; Q92974; Q13576; Q12802; O14578; Q17R91; P21333; Q15669; O60610; Q27J81; Q9NSV4; Q96PY5; Q9BRV8; Q9NPB6"]
["GO:0005198","molecular_function","structural molecule activity ","O75116; P35221; P48681; Q03135; P04083; O00501; P02671; P11137; P53675; P09497; Q13425; Q9UH77; P20700; P35611; O95471; P07437; P18206; Q03252; P12036; P05787; Q5TZA2; P25189; O15551; O43236; P02545; Q15124; P02649; P78559; O15259; Q9BQE3; P14923; O95297; P27816; Q16181; P43243; P48678; Q96T17; Q71U36; P43320; O14493; Q5BJF6; P46821; Q13424; Q14244; Q99719; P09496; Q9NRH3; P08729; P35612; P68363; P05783; Q14980; P41219; Q00610; Q15334; Q3KQU3; Q01955; O00231; P15924; Q9Y5I7"]
["GO:0003690","molecular_function","double-stranded DNA binding ","Q01826; P00533; P10636; Q15796; P09429; P42224; Q13148; P37231; P19793; P78527; Q9NSU2; P13010; Q9NWH9; P35251; Q9UFW8; P16989; O95786; O43542; P12956; Q14151; Q96T60; O60828; Q9Y237; Q15424; P49959; P39748; Q16526; Q53H47; P11387; Q06609; P08047; Q9H1E3; P28715; O00255; Q13569; Q8N884; P22415; P67809; O43823; Q16666; Q7Z2E3; Q00839; Q14966; Q9H3D4; P10412; Q9NUW8; P57721"]
["GO:0098641","molecular_function","cadherin binding involved in cell-cell adhesion ","O96013; P62136; P07355; Q96HC4; P04083; Q9NYL9; Q14134; Q9UQB8; P31949; Q9UHR4; O00151; P05783; Q00587; Q15417"]
["GO:0048365","molecular_function","Rac TPase binding ","O96013; Q16584; Q9NQU5; Q13177; O76039; Q16512; P42768; Q03135; Q9P286; O75914; Q13153; O14640; Q86UR1; P23677; P53365; Q92997; Q92974; Q13576; Q15311; Q96N67; Q8IYU2; O43295; O14641; P00441; Q9ULV4; P21333; P46940; P52566; Q04656; P19878; Q12929"]
["GO:0070853","molecular_function","myosin VI binding ","Q8IWU2"]
["GO:0004864","molecular_function","protein phosphatase inhibitor activity ","Q8IWU2; Q01105; Q9Y570; Q96KR7; Q9UD71; O94763; P56211; Q96SB3; O43768; Q96C90; Q9NXH3; Q96A00; Q96QC0"]
["GO:0004707","molecular_function","MAP kinase activity ","Q13164; Q16659; P31152; P27361; O15264; P53778; Q9UBE8; P28482; Q15759; Q16539; Q8TD08"]
["GO:0051019","molecular_function","mitogen-activated protein kinase binding ","Q13164; P78347; P00519; Q8IW41; P49137; Q16644; Q96EB6; Q12913; O15297; P12270; P28562; P17544; P46940; P32121; P12821"]
["GO:0051015","molecular_function","actin filament binding ","P00533; P13639; P00519; Q9Y490; P35221; P12814; P42684; P23528; P15311; Q13045; P35749; Q8NF91; Q9ULJ8; P09327; Q15078; P35580; Q96AC1; P19429; O43707; Q8WZ42; A0MZ66; Q16658; Q9HBA0; P35611; Q13576; P55196; P60981; Q9UKX2; Q96RD7; P52179; P54296; O95425; Q9Y4I1; Q9BR76; Q9UHB6; Q9ULV4; P29966; Q92614; O75122; Q9H2D6; P06396; P46939; P21333; Q14315; Q9UPN3; P13796; Q9Y281; Q14847; P47756; P28289; Q01995; P35612; Q6JBY9; Q9UM54; Q96IF1; P35579; Q14896; P31645; Q9UJU6; P09493; Q9UKX3; Q00872; Q08289; Q9NRD5; Q66K74"]
["GO:0045296","molecular_function","cadherin binding ","P00533; P18031; P13639; Q9NQU5; P14618; Q96KG9; Q01813; Q12792; P42224; Q13177; P22681; Q9Y490; P48730; P29317; P35221; Q7KZI7; P49327; Q16513; P51610; P07737; Q05682; P61978; Q6IBS0; Q7KZF4; P06733; Q08379; Q9Y6E0; P08238; P12931; P35222; Q15208; O75874; P46109; Q9H2G2; Q01970; P50552; P28827; P15311; Q96TA1; Q6PKG0; P49757; Q6P996; Q15078; P55010; P04075; Q96C19; O95817; P53365; Q32MZ4; Q92597; P30041; A0MZ66; P42566; P00338; Q16658; O00299; Q8WUF5; Q14160; Q15019; P05556; Q15599; O14522; P16333; P12830; P25685; P35611; Q15149; P35241; P55196; Q53SF7; Q8NC51; Q01082; Q14677; Q9Y570; P18206; Q9NQC3; Q5VWQ8; Q99439; Q9NQW6; Q99497; Q9UH65; Q86SQ0; P49959; P41091; P26641; P0DMV8; Q9Y6W5; O75369; Q15056; Q8TCG1; P62826; P31939; Q13813; P42166; P31947; Q9ULH1; Q7Z2W4; O60716; O43490; P14923; Q16181; Q9BR76; Q12959; Q9UHB6; Q06830; Q15691; P49768; P62258; P63244; O00571; P62820; Q6P1N0; P68431; Q9UHX1; Q8WWM7; Q8N3F8; Q12955; P21333; Q00341; P22234; P15529; P11142; O60763; P29692; O60749; Q14C86; P46940; Q9C0C2; Q07157; Q9H0B6; Q08378; Q9UPN3; Q14847; P47756; P52907; Q15365; P50402; Q9P2M7; Q9NSV4; Q9BY44; Q6Y7W6; P37802; Q14247; P40818; P63104; Q96PY5; P08195; Q9UDY2; P46060; Q8IZP0; Q9UHD8; Q9Y266; P35579; P26196; Q9Y624; P31946; Q99961; Q9UJU6; Q9Y371; Q8NFJ5; O95433; O76021; Q9Y265; Q09666; P33176; Q16643; P11021; O95208"]
["GO:0019899","molecular_function","enzyme binding ","P00533; P10636; P07948; P31749; P18031; P24723; P17252; P09619; O00267; P10276; P03372; P42224; Q9NZJ5; P30086; Q9P212; P06730; P37231; P38398; Q00987; P19793; P27708; P45983; P07101; P25963; P17096; P78527; P16104; P05106; P35520; P16220; P05412; Q03135; P04637; P63000; P06241; O14733; Q16539; P07947; P10275; Q04912; P12931; Q02156; P04049; P35222; P60484; P49736; Q05655; P35354; Q9UBB4; Q9H7L9; P06401; Q92769; Q08499; Q96IZ0; O15162; Q96EB6; Q12962; Q8NF91; Q9UKV3; Q15366; Q15554; Q99638; Q04917; O14640; P17844; P26038; Q86UR1; P17535; Q8WZ42; Q12933; Q8TCU6; P13473; Q9NQ66; P04040; P10809; P50570; Q9UII2; P23396; Q8IZD2; P00747; Q9HAW7; P17542; P56817; O75386; Q9BUJ2; Q8NFA2; P12004; P10828; Q13547; Q92736; Q16665; O76061; Q99497; Q13573; O75952; P26368; Q14524; Q9NTG7; O00257; P0DMV8; P83916; P06746; O75925; Q08209; Q9UER7; P08684; Q9UL40; Q9H6E5; P15927; O60341; O75460; P50542; Q13501; O95999; O15392; P11717; P63279; P68036; Q13285; Q15633; Q9UBN7; P50747; P62258; O15151; Q16342; P40937; O15379; P63165; P05067; Q53H80; P35232; P63244; Q02880; Q8N163; Q14686; O96004; P13569; P31269; P17544; P22392; Q9UNE7; P11142; Q9H4A6; P98177; Q15788; P43246; Q9C0C2; Q96S59; Q12834; Q9Y2T1; P09601; P46531; P24385; O75531; P22415; Q99523; P0C0S8; Q9ULZ3; P54652; Q93079; Q9NT62; P01730; P11388; P18887; P25942; P43699; P09874; Q16816; P32121; Q9NZC7; P40337; O15169; P42575; P24752; Q9H3R0; O60885; P26651; Q92731; P31946; P62324; Q9Y383; Q13185; O60260; P16615; Q9NRD5; O96018; P55854; P11021; Q99873"]
["GO:0005006","molecular_function","epidermal growth factor-activated receptor activity ","P00533"]
["GO:0048408","molecular_function","epidermal growth factor binding ","P00533; P29353"]
["GO:0005178","molecular_function","integrin binding ","P00533; P07948; P17252; P09429; Q9Y490; P12814; Q13418; P35968; P05106; P17706; P14136; P43405; P12931; P49023; P41180; P04004; P32942; O43707; P05556; Q15762; P17301; P78536; P21815; P09038; P05067; Q02297; P46939; P13796; O14713; Q13444; Q01955; P50281"]
["GO:0019901","molecular_function","protein kinase binding ","P00533; Q05193; Q8TDC3; P46734; P62140; P50750; P10636; Q16659; P31152; P06239; Q9H4A3; O60825; Q04206; P08575; P51636; P18031; P13639; Q15262; O15530; Q05513; P04792; O95835; P06748; P62753; P25054; O96017; P09619; Q12852; P03372; O60674; Q9NYV4; Q13177; O14965; P30086; P09769; Q15797; P15336; P24864; Q14004; Q05397; O43663; Q99459; Q13418; P40763; P68104; P60709; P19174; Q13233; Q01201; P53350; P14635; P42768; O60237; Q02078; P84022; Q03135; P04637; P63000; P17706; P43405; O14974; Q00535; Q08050; Q9Y2U5; P42345; O14733; Q99683; P17612; P57059; O14920; P49841; P52564; Q00613; Q08379; P08238; Q92934; Q9HC98; P13807; O43524; P49023; P04150; P38936; P43694; Q13153; P56524; Q05655; P21709; P30279; Q7Z6E9; Q9ULW0; Q15650; Q16543; P51452; P41180; Q7Z434; O43521; Q15717; Q9NQT8; Q9ULJ8; Q15078; Q9UKT4; Q86WV1; Q8N6F7; Q99638; O14640; Q9UP95; P19429; P55211; Q9HC77; P07766; P11488; P14317; P62993; P26038; Q8WUI4; Q9UEW8; O43566; Q8WZ42; Q12933; Q7L804; Q9C0H9; Q18PE1; Q86T82; Q8IWQ3; Q7L0J3; O14559; Q9H2X9; P56962; Q9Y4R8; Q9P1Z0; P56945; P50570; Q9HBA0; Q92908; P16066; Q99986; Q8ND76; P46527; P19022; P23396; Q15762; O15350; Q9Y570; P0DP23; Q9Y4H2; Q5VWQ8; P12036; P05107; P42771; Q12913; P26367; P48551; Q14155; Q01094; Q15256; Q16665; Q9NQC7; P36956; P56545; Q6R327; Q14524; Q6UVK1; Q969U6; Q16526; Q9UPY8; Q96A54; Q9UER7; Q9BZR8; P30304; P18669; Q9H0H5; P55011; Q9BUZ4; O43306; Q6PGQ7; P31947; P18848; P30307; Q86WB0; O60716; Q13501; P14923; O95999; P10912; Q15058; O14641; O95684; P61764; Q9Y4K3; O95235; Q9UJT2; Q12959; Q15569; Q8IWB6; Q15691; Q14203; Q8N1F8; Q9NQB0; Q13114; Q96SN8; Q9BZL4; P30305; O75674; Q9Y666; Q86WV6; O43602; P20248; Q99962; P46459; Q05469; Q9H4X1; P10747; P17861; Q9ULU8; P46939; P22460; O95453; Q07817; Q15382; Q9BUL8; Q12931; Q9Y478; P30281; P46940; P43246; P05023; P23634; P08913; Q8TEV9; Q9BV73; P24385; Q8N122; P54619; O43561; P36873; P37023; P22415; O14713; Q9UNN5; P17600; Q9UMX1; Q05639; P29350; P60953; P98161; P01730; Q9UGI9; Q8TD19; Q2M2Z5; O60563; P35612; P21796; P09874; P30048; Q9BPZ7; O15169; P63104; O75143; P12755; P52732; Q13151; Q14451; Q9P2D0; P19021; P26651; O43597; Q8WVD3; Q8NB16; Q9UHW9; Q00610; Q15334; P61266; Q9BRV8; P55273; O60260; Q9UJM3; Q99828; P39019; Q14457"]
["GO:0019903","molecular_function","protein phosphatase binding ","P00533; P08922; P06239; P35269; Q9NZJ5; P04626; P37231; Q05397; P35916; P42226; P40763; P41240; P04637; O14733; P07333; Q16539; Q99683; O00459; P51955; P35222; P08581; P27986; P23458; P52333; P49023; P78352; Q9UQK1; Q86WV1; O15554; P62993; Q8TEW0; Q12933; P56962; P14625; P46527; P19022; Q9UJX5; Q9Y570; Q9Y4H2; P55072; Q9UJX3; P15927; P14923; Q9ULV5; P13688; Q13114; P63244; Q96P31; P46940; P30260; Q5H9R7; P33151; P50479"]
["GO:0004713","molecular_function","protein tyrosine kinase activity ","P00533; P08922; P46734; P39880; P04629; P42229; P07948; P06239; P45985; P22455; Q15303; Q13163; P54760; P51813; Q96KG9; P08631; Q13882; Q96RR4; P00519; P09619; P11362; P07949; O15146; O60674; P36507; P09769; P21802; P04626; Q13627; Q06418; P22607; Q05397; Q07912; Q06187; P29323; P29597; Q14289; Q9UM73; P43403; P11274; P35968; P30291; P30530; P51451; P21860; P16591; P10721; P41240; P54762; P07332; P08069; P43405; Q9NR20; P06241; O14733; P07947; P52564; P42684; P54753; Q02750; O43781; P49761; P06213; P52799; P12931; P08581; P33981; P23458; P52333; Q92630; Q02763; P29376; P42685; P07900; Q13470; O15164; Q16543; Q9GZV9; Q8WZ42; Q9UBW7; Q9Y463; Q9HAZ1; Q15768; P98172; Q96PY6; Q9UIG0; O95684; Q15569; P09038; Q02297; O15197; P32927; P51692; P49760"]
["GO:0004888","molecular_function","transmembrane signaling receptor activity ","P00533; P40238; P04626; P21860; P48167; Q9NYQ6; P08138; P09693; P07766; P31995; Q9P2S2; Q07001; Q9UBH6; O15455; P16150; P43220; P20963; P40259; O15551; O43157; Q92673; P58400; P11912; P17813; P20645; O14493; O00206; Q13291; O75022; O60602; P46531; Q8NER1; P06127; P48357; P21854; P14778; P01730; P50895; P43146; P13224; Q15109"]
["GO:0031625","molecular_function","ubiquitin protein ligase binding ","P00533; P07948; Q04206; Q14164; P06400; P25054; O96017; Q15796; O14965; P29590; P38398; Q07912; Q00987; Q14289; P15172; P25963; Q13546; Q9UBE8; P35520; P13861; Q9Y2R2; P49407; P21860; P05412; P84022; P04637; P17612; P49841; Q9Y6K9; Q12778; Q13263; P08238; P12931; Q9HC98; P23458; P49023; P38936; P22694; P07900; Q08499; Q9C0C7; P08138; O75150; O95816; Q13002; P13010; Q15366; Q9GZX7; Q9H3M7; Q15819; Q9UBK2; P25686; P31323; Q12933; P38646; P61073; P30041; P60174; O95786; P10809; P07437; P49789; O95140; P18206; Q9NQC3; P24928; P26367; P55072; Q16665; P10415; Q9Y6H5; Q14524; P46379; Q14790; P34931; P0DMV8; O75925; Q99460; Q9UER7; P32245; P12277; P62913; Q9BUZ4; P54252; P15927; O43541; P18850; Q13501; O95999; O15105; Q9Y4K3; P68036; P49427; Q9UBN7; P63146; P62258; Q92519; P63165; Q13114; Q9Y385; Q16763; Q93009; O75928; Q86WV6; P25788; Q9H2D6; Q9NYB9; Q6NUN9; P17861; O00429; Q712K3; Q9UNE7; Q9NS91; P11142; Q9BXM7; Q13404; Q86Y01; P78371; P10644; Q9UHP3; Q93034; Q12809; Q9Y2T1; Q9GZQ8; Q8N2W9; P43356; Q13077; P11234; P49459; Q96FW1; O15534; Q9UNN5; P55957; P61086; Q9UQ80; Q14527; P61088; P25942; P20333; P68363; Q7L5Y6; P11233; P32121; Q9BUR4; O15169; P63104; P12755; P46060; P36896; Q01860; P63261; P06744; Q9H492; Q969H0; Q04323; P56645; Q8IVM0; O60260; Q9C0C9; P11021; Q14457; Q5VTR2"]
["GO:0001618","molecular_function","virus receptor activity ","P00533; P06493; Q06418; P29317; P05106; P30530; P52799; P28223; P01130; P02786; P61073; O15304; P51681; P05556; Q92692; Q9UBH6; P26010; Q15768; P17301; Q8WTV0; P18084; P0DMV8; P13591; P15529; Q13291; Q14118; P49685; P01730; Q9Y624"]
["GO:0004105","molecular_function","choline-phosphate cytidylyltransferase activity ","P49585; Q9Y5K3"]
["GO:0031210","molecular_function","phosphatidylcholine binding ","P49585; P21359; P48739; O00562; Q00169; Q9Y3E7; O95267"]
["GO:0003873","molecular_function","6-phosphofructo-2-kinase activity ","Q16875; O60825; P16118"]
["GO:0004331","molecular_function","fructose-2,6-bisphosphate 2-phosphatase activity ","Q16875; O60825; P16118"]
["GO:0003779","molecular_function","actin binding ","Q13554; P10636; P37840; P35240; Q9UEY8; Q12792; Q13627; Q05397; O15357; P42768; Q5S007; P07737; Q05682; Q96HC4; P50552; P15311; Q13459; Q96IZ0; Q13045; Q9NYL9; Q8NF91; Q155Q3; P45379; O00401; P35580; Q12791; Q8N6F7; P04075; Q04917; P19429; Q92558; P14317; P60983; Q13425; P26038; Q9UH77; Q9Y210; Q9BX66; O43707; Q9Y2H1; P61073; Q08495; Q16658; Q8TE77; P51681; P05556; Q9Y613; Q8N8S7; Q9HBA0; Q8WYL5; P35611; Q15149; P35241; Q13576; O15511; Q01082; P18206; Q15746; Q96KR7; Q5TZA2; Q99439; Q9NQW6; Q8IVT2; P61160; O15553; Q9Y6W5; O75369; P78559; Q8IZ21; P50461; Q9NSB8; Q13813; Q9BYB0; P11171; O43516; Q969V6; Q17R91; P49006; O15143; Q9UBN7; Q9BV36; P13688; P57737; Q01518; Q8NEV4; Q8N556; Q9H204; Q96SB3; P30427; P06396; P61158; P46939; P84074; Q13319; P23975; Q5T1M5; Q8WX93; Q13424; Q9UPN3; Q14118; O60610; P13796; Q27J81; P17600; P47756; P52907; P28289; P51911; P50402; Q9UHR4; Q3V6T2; Q9P2M7; Q7Z7A4; Q9NSV4; Q96QT4; P35612; Q96PY5; P61601; Q9UM54; Q00839; P35579; Q9UJU6; P09493; P12821; P33241; O60260; Q15417; Q16643; Q12929"]
["GO:0004683","molecular_function","calmodulin-dependent protein kinase activity ","Q13554; Q16566; Q8N5S9; Q13557; Q96RR4; Q8IW41; P49137; Q14289; Q9UQM7; Q9BUB5; Q9HBH9; Q8IU85; Q16644; Q8NCB2; Q13555; Q14012; Q6P2M8; P23677; P53355; Q9H1R3; Q96NX5"]
["GO:0015026","molecular_function","coreceptor activity ","P13612; P05106; P08138; Q03167; P61073; P51681; P05556; Q96BF3; Q92692; P10747; P49685; P01730; Q9Y6Y9"]
["GO:0001968","molecular_function","fibronectin binding ","P13612; P05106; Q76M96; P05556; P17936; P31431"]
["GO:1990405","molecular_function","protein antigen binding ","P13612; P00747; Q96L91; P30153; P78324"]
["GO:0016208","molecular_function","AMP binding ","P09467; P07741; P54619; P06737; Q9NR19; P10412"]
["GO:0042132","molecular_function","fructose ,6-bisphosphate -phosphatase activity ","P09467; O00757"]
["GO:0048029","molecular_function","monosaccharide binding ","P09467"]
["GO:0001191","molecular_function","transcriptional repressor activity, RNA polymerase II transcription factor binding ","P09467; Q96T58; Q99697; Q92793"]
["GO:0016301","molecular_function","kinase activity ","Q15349; P42336; P50750; P51617; P07948; P06239; P31749; P50613; O15530; P14618; O14874; P27361; Q99640; P00519; O96017; O00311; O76039; P45983; P23443; Q9UQM7; Q15139; P53350; P11274; P30291; Q9Y4A5; Q16513; P51812; P41240; P28482; Q5S007; O75385; Q00535; P42345; P49841; O94806; Q99558; Q7L7X3; P12931; P04049; P68400; P54764; O14757; P22694; Q15418; P60891; Q15078; Q9UEW8; P11908; Q9UK32; Q13574; Q96GX5; P48736; P42771; Q96PY6; P23743; P51946; P42338; P33076; Q9BXM7; Q8TD08; Q8NEB9; P48729; P30613; O00329"]
["GO:0004712","molecular_function","protein serine/threonine/tyrosine kinase activity ","Q15349; O00141; Q9UQB9; P31749; P54646; P45984; P36507; O14965; Q96GD4; P49759; Q13627; Q07912; P23443; P05129; Q9NR20; P17612; Q02750; O43781; P49761; P33981; Q92630; Q15418; Q13705; Q9Y463; Q9HAZ1; Q15569; P49760"]
["GO:0031749","molecular_function","D2 dopamine receptor binding ","Q05193; P50570; Q9UD71"]
["GO:0003924","molecular_function","TPase activity ","Q05193; P13639; P01112; P68104; Q5S007; P63000; P62070; Q14344; P61224; P55010; P49411; P11488; P47736; P61106; P55042; O75628; P01116; Q2NL82; P19086; P04899; P50570; O60841; P07437; O95140; P62834; P61020; P0DPH7; Q8IWA4; O43236; P41091; P51148; Q9Y450; P62826; Q8IXI2; P30679; Q9Y272; Q9BQE3; Q9UBI6; Q71U36; P62491; O00571; P61587; P55040; P62820; P10301; O00429; P23258; Q15382; P20338; Q7L0Q8; Q15669; Q13509; P62745; P52566; Q9NRY4; P20339; P11234; Q13017; Q99719; Q05639; P61586; Q9NRH3; P60953; P20936; Q99490; P68363; P11233; Q96AX2; Q15029; Q9UHD8; Q03113; P01111; P17081; Q9HB90"]
["GO:0005525","molecular_function","TP binding ","Q05193; P13639; P21980; P01112; P68104; Q14978; Q5S007; P63000; P08238; P06213; Q9ULW0; P62070; Q14344; P61224; P55010; Q9Y295; P49411; P11488; P61106; Q38SD2; P55042; P25092; P53365; O75628; Q9Y3Z3; P01116; Q2NL82; Q02790; P19086; P04899; Q15019; P50570; O60841; Q9UH03; P07437; P16066; Q9BST9; O95140; P62834; P61020; P0DPH7; Q8IWA4; O43236; P41091; Q02153; Q02108; P51148; Q92599; Q8WYJ6; Q9Y450; Q02846; P08133; P62826; Q8IXI2; P05408; P30679; Q9Y272; Q9BQE3; Q16181; P53355; Q71U36; Q8IYM1; P62491; P61587; P55040; P62820; P33076; P51398; P10301; O00429; P23258; Q15382; P20338; Q7L0Q8; Q15669; Q13509; P62745; Q8N884; P15531; Q9NRY4; P20339; P11234; Q13017; Q99719; Q05639; P61586; Q9NRH3; P60953; P00367; Q99490; P55039; P68363; P11233; Q96AX2; Q15029; Q9UHD8; Q03113; P01111; P17081; O75616; Q9HB90; P10412"]
["GO:0050998","molecular_function","nitric-oxide synthase binding ","Q05193; P60709; Q03135; P50570; P0DP23; Q14524; P23634; Q13424; P31645"]
["GO:0046983","molecular_function","protein dimerization activity ","Q05193; P01106; P04626; Q15080; O75030; P40763; Q13043; P10275; P08238; P23771; Q13315; Q9NYQ6; P12524; P12980; Q16254; Q8TEM1; O96006; Q16559; O15516; Q02535; Q13188; O75461; P50502; P20823; Q92858; P19532; Q9H2A3; P19484; O15160; Q01094; P36956; Q9UI40; P30044; P02649; Q08209; P04198; O00716; Q02363; Q5XXA6; O95278; Q12772; P13688; P05067; P47928; Q96HZ4; Q7RTU3; Q15788; Q15596; P51692; Q9HD90; P07108; P35869; Q9BQW3; Q9NZC7; Q8N2Q7; P05549; Q9Y2N7; Q05195; Q15329"]
["GO:0017124","molecular_function","SH3 domain binding ","Q05193; P10636; P07948; P00519; P22681; Q13418; O15357; Q9Y2R2; P42768; Q92835; O75914; Q13905; P17302; P50552; Q05209; O14512; O15162; P46108; P14598; Q92882; Q96T51; Q86WV1; Q99638; P55211; P07766; P14317; P62993; Q86UR1; Q14195; P42566; P13498; Q8N8S7; P56945; P50570; Q2M1Z3; Q16204; Q5VWQ8; Q8TEH3; Q9P2Y5; Q13191; P78314; O75952; Q9NRY6; Q9Y6W5; O14578; Q96PV0; P78536; Q9NZH5; Q9ULH1; Q9BYB0; O43516; Q68EM7; O75674; Q96D71; Q9NYB9; Q9UPX8; Q8N4X5; Q92556; O75525; Q96JJ3; O43184; Q13625; Q96B97; Q86Y01; Q96PU8; P07203; Q8TD08; Q9NP31; Q07889; O60239; Q14185; Q16478; P29350; Q9NZQ3; P40818; Q8IZP0; Q07666; Q5VWX1; O95997; Q99961; Q9Y566; Q13444; P78324; Q9ULV8; O60260; Q9UJM3"]
["GO:0043015","molecular_function","gamma-tubulin binding ","Q8TDC3; P07948; Q96L34; Q155Q3; Q9BXF6; Q92597; Q9H0H5; Q96SN8; P51587; Q07343; Q99689"]
["GO:0004708","molecular_function","MAP kinase kinase activity ","P46734; P53779; P27361; Q8IW41; P36507; P80192; P28482; Q5S007; O75914; O14733; Q16539; P52564; Q02750; Q16644"]
["GO:0016787","molecular_function","hydrolase activity ","Q9BRS2; P49773; P49789; P18669; O75884; Q96S44; Q9NPI6; Q13907"]
["GO:0030674","molecular_function","protein binding, bridging ","P39880; P10636; P51636; P51610; Q03135; P04083; Q96CV9; P45379; P20749; Q9UKV5; Q9UHI6; P50502; Q02790; Q16658; Q16623; P16333; P12036; Q96D46; P07196; Q96PK6; P45973; Q9NZS9; P19634; O14641; Q9BV36; P63165; Q92878; Q12955; O15273; O00255; Q9UNE7; P11142; Q86YP4; Q8N122; Q16531; P58753; Q9UDY2; Q969H0; Q969H4; P15924"]
["GO:0043565","molecular_function","sequence-specific DNA binding ","P39880; P10636; P11474; P15976; P19544; Q9UJU2; Q14653; Q01167; P19793; Q99459; Q8WXI9; P50548; Q02078; P84022; P35398; Q00613; Q12778; Q13263; P14859; P22736; O43524; P43694; Q92769; P08151; Q14469; Q9Y2X9; Q9Y6H1; Q14863; O96006; Q9NWH9; P32314; P35251; Q9UBK2; O43623; O15516; P19622; Q9C0K0; O60869; Q99801; P15173; O60315; Q99581; Q00059; P10588; O95238; P29083; Q9P1Z0; P55347; O00327; P23760; Q14151; Q96RI1; P55316; Q12948; Q13568; Q96P20; Q15424; P10828; Q01094; P15822; P10415; Q9NTG7; P10070; Q9BZS1; P11473; Q96LI6; P23759; P17509; O00716; P49116; P52952; P35548; O00482; Q99814; P18848; P55317; Q99592; Q12946; P18850; Q9ULV5; P50219; Q15853; Q13285; P08047; Q9NQB0; Q9BZI1; Q16621; Q07869; Q99958; P31270; Q9NZI5; A8MYZ6; P08235; Q15561; O60479; P41182; O00409; Q99598; Q15631; Q12800; P98177; O15119; P54845; Q9HCS4; Q86YP4; P22415; Q9UBD0; Q9UBR4; P28347; Q15306; O96028; O15266; P48431; Q9UL17; P50221; P51449; Q03014; P49711; Q9UPG8; P05549; Q06330; P18146; Q01860; O75444; P49640; Q9H3D4; O94776; Q9UQR1; Q01851"]
["GO:0035005","molecular_function","1-phosphatidylinositol-4-phosphate -kinase activity ","P42336; O00443; P48736; P42338; O00329"]
["GO:0035004","molecular_function","phosphatidylinositol -kinase activity ","P42336; O00443; P48736; P42338; O00329"]
["GO:0030295","molecular_function","protein kinase activator activity ","P42336; Q9H4A3; Q15831; Q7KZI7; Q92913; Q99801; Q7RTN6; Q9UER7; O75674; Q9H4X1; Q8N122"]
["GO:0050115","molecular_function","myosin-light-chain-phosphatase activity ","P62140"]
["GO:0017018","molecular_function","myosin phosphatase activity ","P62140"]
["GO:0016791","molecular_function","phosphatase activity ","P62140; P62136; Q9Y2R2; P53041; P51452; Q13202; Q12913; O95278; P05023; P36873; Q9Y6W6; Q9BY84; Q16690"]
["GO:0097322","molecular_function","SK snRNA binding ","P50750; O94992; O60563"]
["GO:0008353","molecular_function","RNA polymerase II CTD heptapeptide repeat kinase activity ","P50750; P50613; P06493; Q9NYV4; Q14004; P49336; P28482; O60885"]
["GO:0001223","molecular_function","transcription coactivator binding ","P50750; P03372; P35398; Q12778; O14746; Q00059; Q12948; Q07869; P28347; P35869"]
["GO:0005004","molecular_function","PI-linked ephrin receptor activity ","P04629; Q16288; P29320; P54764; P29322"]
["GO:0019900","molecular_function","kinase binding ","P04629; P06400; P49715; Q96GD4; Q9Y2R2; P14136; P42858; P08238; P12931; P35222; Q05655; Q9Y3P8; P78352; Q16543; P11166; Q15700; P00338; P17858; Q99741; Q16623; P17676; P25445; Q86VP1; P23396; P00747; Q5VWQ8; Q99497; P52179; P54296; Q7RTN6; P04198; P08237; O95999; P13688; P07195; Q9NYB9; Q96P31; P84074; P21333; Q9UNE7; Q13009; P24522; Q9UMX0; Q7L9L4; O95863; O15534; Q8IV61; Q99728; P30048; Q8IX03; P16118; Q15654; P23497; P62324; Q15172; Q5FBB7; P56645; O60260"]
["GO:0048406","molecular_function","nerve growth factor binding ","P04629; P09958; P08138; Q99523"]
["GO:0010465","molecular_function","nerve growth factor receptor activity ","P04629; Q99523"]
["GO:0043121","molecular_function","neurotrophin binding ","P04629; Q16620; Q16288; P08138"]
["GO:0005166","molecular_function","neurotrophin p7 receptor binding ","P04629"]
["GO:0031072","molecular_function","heat shock protein binding ","P51617; P25963; P53667; Q09013; P42858; Q00613; P08238; Q92769; Q16543; O95816; Q00059; Q02790; O14727; P16150; P05107; P34931; P0DMV8; Q9UER7; P12270; Q9UNE7; P11142; P29692; Q16611; Q9UNN5; P26651; Q14654; O60260"]
["GO:0004704","molecular_function","NF-kappaB-inducing kinase activity ","P51617; Q14164; Q9UM73; Q99558; Q9Y572"]
["GO:0008157","molecular_function","protein phosphatase  binding ","P62136; O60927; Q99459; P16591; Q9ULJ8; Q96KR7; Q8IZ21; P48678; Q96SB3; P51787; Q9UKA4; P36873"]
["GO:0004722","molecular_function","protein serine/threonine phosphatase activity ","P62136; P06239; P62714; P67775; P53041; P60484; P35813; Q14738; Q9UQK1; Q6ZVD8; Q15750; O60346; Q9H2U2; O15297; O15355; Q9P0J1; Q08209; P28562; O95278; Q5JR12; O75688; P36873; P30153; Q9H0C8"]
["GO:0043021","molecular_function","ribonucleoprotein complex binding ","P62136; Q00987; O14744; Q15910; P17844; P38919; O60828; Q99697; P45973; P67870; Q9BYX4; Q8TAS1; Q00839; Q96J02"]
["GO:0060175","molecular_function","brain-derived neurotrophic factor-activated receptor activity ","Q16620"]
["GO:0048403","molecular_function","brain-derived neurotrophic factor binding ","Q16620"]
["GO:0038164","molecular_function","thrombopoietin receptor activity ","P40238"]
["GO:0034185","molecular_function","apolipoprotein binding ","P10636; P10809; P00747; Q8WTV0; O75581; P05067; P27824; O95477; O75096; Q07954"]
["GO:0003680","molecular_function","AT DNA binding ","P10636; Q06413; P17096; P61296; Q14103; P52926; Q03164"]
["GO:0051087","molecular_function","chaperone binding ","P10636; Q8IVT5; P04637; Q16543; Q14469; O14746; O95816; P25686; Q9UDY4; O95817; Q96KC8; Q9UKV5; O14558; P10809; P25685; P46527; P00747; Q07812; P04156; P30304; O15392; P00441; P05067; P31948; P13569; Q9UNE7; P11142; P30040; P05023; Q16611; Q15813; P54652; Q92574; Q9BUR4; P00450; O95433; Q04656; O60260; P11021"]
["GO:0034452","molecular_function","dynactin binding ","P10636; P42858; P49841"]
["GO:0099077","molecular_function","histone-dependent DNA binding ","P10636"]
["GO:0051879","molecular_function","Hsp protein binding ","P10636; Q9NZJ5; Q8IVT5; P35968; Q00535; Q00613; P53041; P68400; P04150; Q16543; Q9Y4R8; O00327; P23396; Q16665; Q15185; O75460; Q9UBN7; P31948; P49815; Q9UNE7; Q9BY41; P37198; P35869; Q92574; O95433"]
["GO:0071813","molecular_function","lipoprotein particle binding ","P10636; P16671; P02649"]
["GO:0099609","molecular_function","microtubule lateral binding ","P10636; P33176"]
["GO:0035091","molecular_function","phosphatidylinositol binding ","P10636; Q9Y490; P07332; Q96BR1; P14598; O14939; Q13393; Q9NRJ4; O14559; P48739; O00443; O75386; Q8NFA2; Q5TCZ1; Q15036; Q14573; O00562; Q9C0B9; Q8IYM1; Q14643; Q14571; O60749; Q00169; Q9Y5X2; Q8NER1; P55895; Q96RG2; Q3V6T2; Q7Z7A4; Q14980; Q14451"]
["GO:1902936","molecular_function","phosphatidylinositol bisphosphate binding ","P10636; O75689"]
["GO:0051721","molecular_function","protein phosphatase A binding ","P10636; P31749; P18031; P04035; P42224; P23443; P04637; Q12778; Q96GX5; Q9Y570; Q5VWQ8; Q01959; P10415; Q9NYA1; P56211; O43768; Q9P2B4; Q86XL3; O43815"]
["GO:0048018","molecular_function","receptor ligand activity ","P10636"]
["GO:0003697","molecular_function","single-stranded DNA binding ","P10636; P09429; P61978; P04083; Q9NSU2; Q49AN0; P54132; Q9Y3Z3; P16989; P53999; P10809; O43542; Q13156; P43351; P54727; P27694; Q04837; P49643; Q53H47; Q9BQ15; P11387; P09651; P15927; Q9P2K5; Q9NTJ3; Q06609; Q9H1E3; O95551; P28715; Q15631; Q96AE4; Q9BWW4; P51587; P67809; Q9BWG4; Q15365; Q96AH0; P33993; P33991; Q00839; Q8WVD3; Q8NFH5; Q9NUW8; Q01851"]
["GO:0005246","molecular_function","calcium channel regulator activity ","O00141; Q13976; Q96BR1; Q9P2S2; P30626; P26678; Q9ULB1; Q13586; Q9HBY8; P62258; Q14416; P57796; Q14831; Q14832"]
["GO:0017081","molecular_function","chloride channel regulator activity ","O00141; P36544; Q96BR1; O14745; Q9HBY8; P13569; Q8NER1"]
["GO:0015459","molecular_function","potassium channel regulator activity ","O00141; Q05513; Q96BR1; Q99996; Q96PU5; Q6PIL6; Q9NS61; O60706; Q9Y6H6; Q9HBY8; Q9NZI2; Q12959; P14416; P62258; P63165; P56211; P21333; Q9Y2W7; Q13303; P07550; P15382"]
["GO:0017080","molecular_function","sodium channel regulator activity ","O00141; P29475; Q96BR1; Q96PU5; Q04917; Q92913; O00168; Q9HBY8; P80108; P26045; Q8N335"]
["GO:0004879","molecular_function","nuclear receptor activity ","P11474; P37231; P19793; P40763; P41235; P35398; P10275; P22736; P04150; O75469; P06401; P10588; Q96RI1; P36956; P55055; O00482; Q13285; P43354; Q07869; Q13133; P35869; P51449; P20393; Q92731; Q14994"]
["GO:0005496","molecular_function","steroid binding ","P11474; P03372; P10275; P04150; P06401; P62508; P08684; P08235; Q92731; O00264"]
["GO:0003707","molecular_function","steroid hormone receptor activity ","P11474; P10276; P03372; P37231; P19793; P41235; P35398; P22736; O75469; P06401; P62508; P10588; P13056; Q96RI1; P10828; P55055; P10827; P11473; P49116; O00482; P48443; Q13285; P43354; Q07869; Q13133; P08235; Q15466; P51449; P13631; P20393; Q92731"]
["GO:0001078","molecular_function","transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding ","P11474; Q04206; P15976; Q14653; Q14934; Q13469; P17947; Q00613; Q12778; P06733; P23771; Q14469; Q9Y2X9; Q16649; Q8N680; O43623; Q32MZ4; O75626; P78543; P15923; P17676; P13056; Q8WYK2; Q99697; Q92793; Q02447; P50553; Q9BU19; Q14494; Q12772; P28698; Q07869; O95600; Q96BF6; Q6P1N0; O96004; Q6NUN9; Q9NP71; P17544; Q9Y2W7; P15036; P61244; O15119; O95863; Q9H165; Q15583; P51608; P52926; Q02556; Q16666; P51449; Q03014; P49711; P20393; A0AVK6; P05549; P25490; Q05195; Q9UQR1"]
["GO:0046875","molecular_function","ephrin receptor binding ","P07948; P18031; P29353; P00519; P22681; Q00535; P06241; P52799; P12931; P54764; P46108; Q15078; P62993; P16333; Q15768; P48736; P98172; P05067; Q92625; O43166"]
["GO:0043208","molecular_function","glycosphingolipid binding ","P07948"]
["GO:0044325","molecular_function","ion channel binding ","P07948; Q13557; P12814; P29475; P49407; Q5S007; Q03135; P06241; P42858; P07947; P08238; P12931; P35222; Q08499; P41180; Q13642; Q99996; O95816; Q96PU5; Q9ULJ8; Q86VP3; P23327; Q04917; Q92913; Q13563; O43707; Q9NS61; P30626; Q16623; O00168; P0DP23; Q96RD7; O60706; Q14721; Q9Y6H6; Q92736; P04156; P32418; Q14524; Q06787; P14314; Q6VY07; P27348; Q9Y5Y9; Q02363; Q12959; P62258; Q86UR5; Q14694; Q12955; P21333; O15273; Q9Y2W7; P51787; Q07343; Q8N335; Q13424; Q16611; Q86YM7; O60610; P57796; Q96CW1; Q9UK17; P98161; P21796; P33151; P63104; Q99961; Q14654; Q99828"]
["GO:0004715","molecular_function","non-membrane spanning protein tyrosine kinase activity ","P07948; P06239; P42681; P51813; P08631; Q13882; P00519; O60674; P09769; Q9H792; P49759; Q13627; Q05397; Q07912; Q06187; P42680; P29597; Q14289; P43403; P30291; P51451; Q14680; Q08881; P16591; P41240; P07332; P43405; P06241; O43353; P07947; P42684; P12931; P23458; P52333; P42685; Q05655; P19525; Q13470; Q504Y2; P62993; Q9UIG0; O75716"]
["GO:0051219","molecular_function","phosphoprotein binding ","P07948; P37840; Q9UHD2; P06400; Q9Y2W1; P42345; P12931; Q13563; Q02790; Q99697; O94763; O00257; P14314; P31947; P11171; P11717; P78368; P62258; Q8NER1; Q7Z2E3; Q13526; P31946"]
["GO:0140031","molecular_function","phosphorylation-dependent protein binding ","P07948; P29350"]
["GO:0005161","molecular_function","platelet-derived growth factor receptor binding ","P07948; P09619; P05106; P16234; P60484; Q12913; O75460; P14778"]
["GO:0042826","molecular_function","histone deacetylase binding ","Q06413; Q04206; P10276; Q9UJU2; P45983; Q16512; Q9UQL6; Q16513; Q02078; P04637; P63000; P11831; Q14814; P08238; P07900; P56524; Q9H7L9; Q92769; Q9Y618; Q14469; Q99638; Q99801; Q8IZQ8; O75626; P48552; Q9UHI6; Q14839; Q6KC79; P17676; P13056; P17542; Q13547; Q16665; P45973; Q16526; P0DMV8; Q9BZS1; O75496; Q9Y4K3; P08047; Q9UBN7; Q9NP62; P62258; O15379; P35232; P52292; Q02880; O43257; Q96BF6; O43474; P16401; Q15327; Q9NYF0; Q12834; Q14103; P43356; P24385; P22415; P23246; O43823; P11388; P09874; O75376; P10071; Q8IXJ6; P31946; P25490; O94776; Q9UKV0; O60260; P31260; Q9HCU9"]
["GO:0071837","molecular_function","HM box domain binding ","Q06413; P05412; P23771; P23760; P26367; P56178; Q13516; P08047; P50221; Q03014"]
["GO:0000980","molecular_function","RNA polymerase II distal enhancer sequence-specific DNA binding ","Q06413; Q04206; P15976; P15336; Q9Y2W1; P19838; Q01201; P16220; P05412; P17947; P04637; P84243; Q96EB6; Q9Y2X9; Q04864; P07910; O15516; Q13330; O00327; Q96RI1; P17542; P15822; O00482; P18848; Q99626; Q16236; Q13285; Q14494; Q01892; Q9BYV9; P23246; Q9Y230; O95644; Q05516; P43699; Q03164; P23769; Q01851; Q01543"]
["GO:0001205","molecular_function","transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific DNA binding ","Q06413; Q04206; Q13148; P19838; P17096; P51610; P17947; Q04864; O60315; P53999; Q16236; Q14494; Q01892; O95644; Q01851"]
["GO:0000983","molecular_function","transcription factor activity, RNA polymerase II core promoter sequence-specific DNA binding ","Q06413; Q04206; P42224; P84022; P14859; Q99801; P23759"]
["GO:0051117","molecular_function","ATPase binding ","P06239; P03372; Q03135; P63000; P10275; P15311; P06401; Q08499; O00631; P23327; Q9Y210; Q13563; Q8IWQ3; P25685; P35241; Q9UII2; Q5JTV8; P26678; P55055; P22087; P05062; P54252; P26045; Q9UNZ2; P20338; O95477; Q9UHP3; Q13424; P40855; P11234; Q9Y230; P11233; Q9Y265; Q04323"]
["GO:0042609","molecular_function","CD receptor binding ","P06239; P06241; O15162; Q14005"]
["GO:0042610","molecular_function","CD8 receptor binding ","P06239; P06241"]
["GO:0043548","molecular_function","phosphatidylinositol -kinase binding ","P06239; P09619; O60674; Q06418; P14616; P30530; P08069; P06241; P35568; P06213; P27986; P0DP23; Q9Y4H2; Q5VWQ8; O14654; O75553; P05023; Q14457"]
["GO:0042169","molecular_function","SH domain binding ","P06239; Q6PD62; P00519; O60674; Q05397; Q9UBE8; O15357; P43405; P35568; P12931; Q9Y3P8; Q9NWQ8; P46108; Q96T51; Q86WV1; Q96LC7; Q9HBA0; Q96QB1; Q13501; A1X283; P63244; Q9GZY6; Q8N4X5; Q8NEM2; Q14118; Q13017; P37198; P29350; Q5VWX1"]
["GO:0042608","molecular_function","T cell receptor binding ","P06239; P06241; P09693; P07766; P01892"]
["GO:0050405","molecular_function","[acetyl-CoA carboxylase] kinase activity ","Q13131; P54646"]
["GO:0047322","molecular_function","[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity ","Q13131; P54646"]
["GO:0004679","molecular_function","AMP-activated protein kinase activity ","Q13131; P54646; Q9Y478; Q9UGI9"]
["GO:0004691","molecular_function","cAMP-dependent protein kinase activity ","Q13131; P17612; P51817; P22694; Q15300; Q12802; P54619; P22612"]
["GO:0035174","molecular_function","histone serine kinase activity ","Q13131; Q9UQB9; P54646; O14965; Q96GD4"]
["GO:0003989","molecular_function","acetyl-CoA carboxylase activity ","O00763; Q13085"]
["GO:0009374","molecular_function","biotin binding ","O00763; P50747"]
["GO:0004075","molecular_function","biotin carboxylase activity ","O00763; Q13085"]
["GO:0001012","molecular_function","RNA polymerase II regulatory region DNA binding ","P42681; P43699"]
["GO:0008545","molecular_function","JUN kinase kinase activity ","P45985"]
["GO:0031435","molecular_function","mitogen-activated protein kinase kinase kinase binding ","P45985; Q16584; Q01974; Q12851; P28482; Q15208; Q12933; P15923; Q5VWQ8; Q9Y4K3; P37173; Q9UQF2; P60953"]
["GO:0009931","molecular_function","calcium-dependent protein serine/threonine kinase activity ","Q16566; Q8IW41; P49137; Q9UQM7; Q9BUB5; Q9HBH9; Q16644"]
["GO:0019902","molecular_function","phosphatase binding ","Q9H4A3; P27361; Q15796; P28482; Q13469; P84022; P43405; Q49AN0; O14745; Q8TEP8; Q96LC7; Q15599; Q16526; Q9NX63; Q12959; Q07869; Q9NYB0; Q96P31; P49815; Q6P0Q8; Q9H788; Q9Y2V2; Q86UL8; Q99961; P55199"]
["GO:0019870","molecular_function","potassium channel inhibitor activity ","Q9H4A3; O95069; Q96PU5; O43768; P22460; P20936"]
["GO:0030291","molecular_function","protein serine/threonine kinase inhibitor activity ","Q9H4A3; Q8N122; O43597; Q99828"]
["GO:0002020","molecular_function","protease binding ","P02686; P07355; P05106; P10721; P04637; P49841; Q15650; P09958; Q13158; P01130; Q15078; P01009; P30411; Q8WZ42; P30626; Q92997; P05556; Q14254; Q6P4R8; Q96RD7; Q5TCZ1; Q01959; P04156; P10415; Q13586; O95999; O75955; P10747; P01375; P17861; Q9BXM7; P51587; Q9ULZ3; P13726; P14778; O15519; Q07954; P42574; P21817"]
["GO:0019911","molecular_function","structural constituent of myelin sheath ","P02686"]
["GO:0022849","molecular_function","glutamate-gated calcium ion channel activity ","Q12879; Q05586; Q13224; Q14957"]
["GO:0004972","molecular_function","NMDA glutamate receptor activity ","Q12879; Q05586; Q13224; Q14289; Q14957"]
["GO:0016362","molecular_function","activin receptor activity, type II ","Q13873"]
["GO:0036122","molecular_function","BMP binding ","Q13873; O15273"]
["GO:0098821","molecular_function","BMP receptor activity ","Q13873; P37023; P36894"]
["GO:0019838","molecular_function","growth factor binding ","Q13873; P17948; P35916; P35968; P21860; Q02763; P40189; Q13705; Q99650; P42702; P28562; P10912"]
["GO:0042805","molecular_function","actinin binding ","Q04206; P19838; Q96HC4; Q9Y210; Q13563; Q8WZ42; P50461; O43490"]
["GO:0031490","molecular_function","chromatin DNA binding ","Q04206; Q09472; P15976; P10276; P19793; P40763; P15172; P84022; P11831; Q00613; O43524; Q15910; P16403; Q9Y4C1; Q9UBK2; O15516; O43707; P15173; Q92858; Q15022; Q99697; P10828; P10827; Q9UIW0; Q9Y2U8; Q99958; Q9NZI5; P16401; P17861; P41182; P46531; Q7LBC6; O15534; Q969T9; P29375; Q9Y230; Q15648; P27695; Q00839; Q02539; P10412; O95409"]
["GO:0051059","molecular_function","NF-kappaB binding ","Q04206; P06748; P25963; P49841; Q92769; Q86UE4; P42771; Q13547; Q9BZS1; O95999; O15379; Q13625; Q9UNN5; O43823; P60900; P27695; Q9HCU9"]
["GO:0042301","molecular_function","phosphate ion binding ","Q04206; Q9Y2J0; Q9UBI6"]
["GO:0047485","molecular_function","protein N-terminus binding ","Q04206; P37840; O60934; Q00987; Q9Y6Q9; P04637; Q96HC4; Q02750; P68400; Q13315; Q9Y618; O14746; Q14207; O14745; P19447; O43707; O00560; Q9NS61; P51532; Q9UBU8; Q16623; Q6KC79; Q13547; Q01959; Q969G3; Q03468; P0DMV8; Q9UER7; P27348; P15927; P11171; P50542; P61764; Q9Y4K3; Q15633; Q16621; P30427; Q9ULU4; Q9UQ35; P28715; Q9BUL8; O00255; P24522; Q15788; Q9BZK7; P40855; P19784; O75531; P36873; Q9NS23; Q99259; P51608; Q96H20; P09874; Q92574; Q7Z2E3; P41134; Q06330; Q99623; Q99689"]
["GO:0070491","molecular_function","repressing transcription factor binding ","Q04206; P01106; P09429; P42224; P06730; Q9UQL6; P56524; Q8WUI4; Q9UHI6; P30626; P15923; O00327; Q13547; Q9Y3T9; Q99497; P45973; O75496; P08047; Q9ULU4; P43356; Q92993; Q13950; Q03014; P12755; Q13363; Q06330; Q9UKV0"]
["GO:0003705","molecular_function","transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding ","Q04206; Q9UJU2; P49715; P15336; O75030; P15172; P41235; P16220; P05412; Q02078; P17947; P11831; P08151; P22670; P15173; P55347; Q92908; P17676; Q96RI1; Q12948; Q16665; Q13516; Q9BZS1; P52952; O00482; Q12946; Q15853; Q13285; Q99958; P18846; P13349; P22415; O95644; Q02556; P43699; P48436; P23409; Q01851"]
["GO:0008134","molecular_function","transcription factor binding ","Q04206; P14921; P35269; Q09472; P06748; P06400; O60934; P01106; Q15796; P10276; P09429; P03372; P45984; P11309; Q9NYV4; P49715; P37231; Q14004; O43251; Q01196; P19838; P40763; P25963; P17096; Q9UQL6; P78527; Q14934; Q9UBE8; Q14978; P49407; P05412; P28482; Q13469; P84022; P04637; P35398; P11831; Q13043; P42858; P10275; P35222; P23771; P27986; Q9NRP7; P01100; P43694; P56524; Q92769; Q13887; Q9Y618; Q14469; O00167; Q96EB6; Q16254; Q9Y6H1; P52655; Q14145; Q9Y295; P20749; Q9UBK2; P19447; Q02535; P27540; Q99801; Q9Y261; P17535; Q8IZQ8; P51532; Q15545; Q8WUF5; Q9BQG0; P28906; P15923; P35611; Q92974; Q92908; Q14186; O60504; P23396; O15350; Q02962; P37275; Q12948; Q96P20; P62195; P26367; Q99697; Q13547; Q01094; Q16665; Q99497; P10415; P10827; P10070; Q9Y5Q3; Q9UER7; Q92793; P28749; P52952; P35548; Q99814; O60341; P67870; P55317; P50052; O95999; P63279; Q9Y534; P08047; Q9NP62; P56693; Q92519; P61296; Q9NQB0; O15379; P63165; Q07869; O00571; P17275; Q93009; Q14192; O75928; Q86WV6; O96004; Q9H1E3; Q96HZ4; Q8IZL8; Q6STE5; P21333; Q9NP71; P17544; P53539; Q9Y5B6; P40425; Q12800; P98177; Q13569; Q9BY41; P35638; Q14103; Q99750; Q9UH92; P24385; O15534; Q92794; Q9UMX1; Q15306; O00213; P51608; P52926; P35869; Q16666; Q96H20; O60563; P09874; Q8N726; P40337; P63104; Q03014; Q15648; Q07021; P23769; Q13363; Q00403; Q8IXJ6; P41134; Q06330; P23497; Q9H0D2; Q01860; Q04724; Q15672; O00170; Q9UKV0; Q15329; Q9NPB6; Q13562"]
["GO:0035035","molecular_function","histone acetyltransferase binding ","P14921; P42224; P16220; Q02078; P04637; Q15650; Q8IZQ8; Q15545; P17676; P26367; P12004; Q16665; Q9BZS1; Q99814; P08047; Q99967; P10071; Q8IXJ6; O95905; P18146"]
["GO:0000982","molecular_function","transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding ","P14921; P42224; P05412; O15516; O00327; Q92985; P08047; P28347; P05549"]
["GO:0008384","molecular_function","IkappaB kinase activity ","Q14164; O14920; O15111"]
["GO:0036435","molecular_function","K8-linked polyubiquitin modification-dependent protein binding ","Q14164; P55072; Q04323"]
["GO:0035612","molecular_function","AP- adaptor complex binding ","Q2M2I8; P49407"]
["GO:0005112","molecular_function","Notch binding ","Q2M2I8; Q9Y618; Q13573; P78536; Q86Y01; P46531; Q96KG7"]
["GO:0043395","molecular_function","heparan sulfate proteoglycan binding ","P08575; P17301; P05067; Q07954"]
["GO:0008201","molecular_function","heparin binding ","P08575; P22455; P11362; P21802; P10586; P04004; Q03167; Q06481; Q76M96; P02649; Q14512; P09038; P05067; O14737; Q92915; P30533; P51858; Q02539; Q15109"]
["GO:0005001","molecular_function","transmembrane receptor protein tyrosine phosphatase activity ","P08575; Q15262; P23467; P18433; P10586; P28827; Q15256; P23469; P29350"]
["GO:0032947","molecular_function","protein-containing complex scaffold activity ","P51636; Q03135; Q04637; Q9H1K1; Q99996; O14745; Q15599; Q9Y4R8; Q12802; P19634; Q9H4B6; Q9NX63; O95613; Q12959; P63244; Q13155; P32121; O15169; Q8IX03"]
["GO:0097110","molecular_function","scaffold protein binding ","P51636; P27361; P08670; P17480; P36507; Q00987; P29475; P17302; O14920; O43318; Q02750; O15111; P29474; P12931; P07900; P78352; Q08499; Q16543; P46108; O43424; Q13428; Q96RD7; P05787; Q99497; Q14524; Q14790; O14578; Q9BYB0; Q9UQB8; P62258; Q14571; O43497; P22460; P51787; O95180; Q12809; P23634; O75096; Q8N0W4; P05783; Q8N2Q7; Q9Y566; P15924"]
["GO:0005007","molecular_function","fibroblast growth factor-activated receptor activity ","P22455; P11362; P21802; P22607"]
["GO:0017134","molecular_function","fibroblast growth factor binding ","P22455; P11362; P21802; P22607; Q03167; Q14524; Q14512; P39019"]
["GO:0004706","molecular_function","JUN kinase kinase kinase activity ","Q16584; Q12852; P80192; Q5TCX8; Q02779"]
["GO:0071889","molecular_function","4-3-3 protein binding ","P31749; Q05513; P78362; Q8IVT5; O14974; P57059; Q92934; Q02156; Q16613; Q9NQT8; Q8WUI4; Q9Y4H2; Q5VWQ8; Q96PY6; Q8WUA7; P27348; Q6ZS17; Q8N122; Q9UBF8; Q07352; P32121; P26651"]
["GO:0032794","molecular_function","TPase activating protein binding ","P31749; P51178; O43566; P12830; P07437; O43157; Q14C86; Q92574; Q13526"]
["GO:0030235","molecular_function","nitric-oxide synthase regulator activity ","P31749; P03372; P08238; P07900; P0DP23"]
["GO:0005547","molecular_function","phosphatidylinositol-3,,-trisphosphate binding ","P31749; Q06187; Q96AC1; Q8TEW0; O43739; Q96P48; Q9BR39; Q13576; Q9H0H5; Q9ULH1; Q9UN19; Q8WWN8; Q7Z3T8; Q92538; P46940; Q92686; P55895; O75689; Q9BPZ7; Q9UQC2; O15294"]
["GO:0043325","molecular_function","phosphatidylinositol-,-bisphosphate binding ","P31749; P14598; Q5TCZ1; Q9UN19; Q8WWN8; P55895; Q9BPZ7; Q9UQC2; P08567"]
["GO:0005080","molecular_function","protein kinase C binding ","P31749; P04792; P00519; Q16512; P34947; Q9UQL6; Q9BZL6; P05771; Q6IBS0; P35568; Q96HC4; P12931; P49773; Q8WUI4; Q9HBA0; Q01130; Q9HAW7; P14314; O43306; O95810; Q13501; P61981; P29966; P63244; Q02880; Q9NYF0; Q13569; P31431; P11388; P58753; Q07021; P08567; Q9UKV0; Q99689; Q9NRD5; P15924"]
["GO:0005154","molecular_function","epidermal growth factor receptor binding ","Q15303; P29353; P22681; Q07912; P16591; P07947; O15162; P62993; P52735; Q9UKW4; O60749; Q9ULV8"]
["GO:0004711","molecular_function","ribosomal protein S6 kinase activity ","O75676; P23443; Q9UBS0"]
["GO:1904929","molecular_function","coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway ","Q01974"]
["GO:0005109","molecular_function","frizzled binding ","Q01974; O14640; O00560; Q92997; O14641; O75581; P05067"]
["GO:0017147","molecular_function","Wnt-protein binding ","Q01974; O75581; O75096"]
["GO:0002039","molecular_function","p5 binding ","Q9H4B4; P13639; Q16288; Q09472; P15976; Q8IW41; O60285; Q15831; Q00987; Q12888; Q12824; P04637; Q00535; P42858; P49841; O15164; Q96EB6; Q96PM9; P15941; Q14134; P54132; P51532; Q5VWG9; P10809; O15350; Q13547; Q9NZM5; P61289; Q16665; Q9UER7; Q92793; Q9UL40; Q9HB09; O60341; Q96S44; P53801; Q93009; Q15327; Q14694; Q9NQR1; Q96KQ7; Q13625; Q9NRG4; Q96PM5; Q8N726; Q8N9N5; O60885; Q6PCD5; Q9H3D4; Q5VTR2"]
["GO:0005089","molecular_function","Rho guanyl-nucleotide exchange factor activity ","Q9NZM3; P11274; P15498; Q14344; Q8N5V2; Q8TCU6; P52735; O75962; Q92974; Q96DR7; Q14155; Q12802; Q8IVF5; O60229; Q9UKW4; Q96PE2; Q15052; Q9H7P9; Q92888; Q9H8V3; O94827; Q13009; Q3KR16; Q07889; Q13972; Q14185; O14827; Q9NR80; Q7Z628"]
["GO:0008097","molecular_function","5S rRNA binding ","P13639; Q00987; Q9H0U6; Q9NZM5; P62913"]
["GO:0003746","molecular_function","translation elongation factor activity ","P13639; P68104; P49411; P24534; P26641; Q9Y450; P29692; Q05639"]
["GO:0016538","molecular_function","cyclin-dependent protein serine/threonine kinase regulator activity ","P11802; P24864; Q8N1B3; Q8ND76; P51946; P24385; O60563; Q96S94"]
["GO:0004865","molecular_function","protein serine/threonine phosphatase inhibitor activity ","O60927; O96001; P41236; Q9UD71; Q8TAE6; Q96E09; Q12972; Q8WVI7; Q13522; Q9NXH3"]
["GO:0061630","molecular_function","ubiquitin protein ligase activity ","O60927; P22681; Q00987; O95376; Q7Z6E9; O15164; O15033; O75592; Q9UKT5; Q96PU5; O95071; Q15819; Q9UKV5; Q8NHG8; Q5T447; Q9NS56; Q14669; P78317; Q96FA3; Q9H4P4; Q13191; Q8N2H9; Q9NZS9; Q9UMS4; Q9UBF6; Q96T88; Q8IYU2; Q9HAT8; Q8NHY2; Q9Y4K3; P49427; P63146; O15151; O43164; Q9Y385; Q16763; Q13049; Q712K3; Q9UNE7; Q5TC82; Q9NS91; Q13404; Q05086; P49459; P55895; Q96EP1; P98170; Q96Q27; P60953; Q9Y3C5; Q7Z6Z7; Q14527; P61088; Q7Z6J0; Q13309; Q9H0M0; P40337; Q15648; P46934; Q8IUQ4; Q96J02; Q8WVD3; Q9UBS8; Q8ND25; Q9ULV8; O60260; Q9C0C9"]
["GO:0036033","molecular_function","mediator complex binding ","Q14683; Q6KC79; Q9UQE7; Q15648"]
["GO:0050681","molecular_function","androgen receptor binding ","P50613; Q09472; P06400; P24864; P38398; Q9Y6Q9; Q16512; P05771; P35222; Q9Y4C1; Q9UBK2; P17844; Q13772; P48552; P51532; P78317; Q99497; Q13573; O75925; Q9UER7; Q9BY66; P62826; O60341; O43294; Q14192; O75928; Q15788; Q92993; Q9H3R0; Q9UBS8"]
["GO:0008094","molecular_function","DNA-dependent ATPase activity ","P50613; P52701; P54132; P51532; O43542; Q03468; P43246; Q9UNY4; P11388; Q9NZC9"]
["GO:0008013","molecular_function","beta-catenin binding ","Q15262; Q09472; P25054; P03372; Q9UJU2; P35221; P84022; P35398; P49841; P10275; Q12778; O43524; P49023; P49757; O14745; O14640; Q92997; Q15599; O14522; P12830; Q86X55; P19022; P18206; Q12913; Q8TDM6; Q9UQB3; Q9Y3M2; O15105; Q9UBN7; P49768; Q9NQB0; P43354; O43474; Q9NYF0; P98177; Q9BZK7; Q9HCS4; Q9Y2T1; Q9Y230; Q9UMX1; O15169; P33151; P10071; Q13526; P48436; O60260"]
["GO:0045295","molecular_function","gamma-catenin binding ","Q15262; P25054; Q9UJU2; P35221; O14522; P12830; P19022; Q12913; Q9NQB0"]
["GO:0004699","molecular_function","calcium-independent protein kinase C activity ","P24723; Q02156; Q05655"]
["GO:0004697","molecular_function","protein kinase C activity ","P24723; Q05513; P17252; Q04759; Q16512; Q15139; Q9BZL6; P05129; Q16513; P05771; O94806; Q02156; P41743; Q05655; Q6P5Z2"]
["GO:0017160","molecular_function","Ral TPase binding ","P24723; Q15311; Q9H4P4; P21333; Q8IYI6"]
["GO:0008349","molecular_function","MAP kinase kinase kinase kinase activity ","Q92918; Q12851; O95819; Q9Y4K4; Q9Y6E0; O00506; Q9UKE5; Q8N4C8; Q9P289; Q8IVH8"]
["GO:0004676","molecular_function","3-phosphoinositide-dependent protein kinase activity ","O15530"]
["GO:0016004","molecular_function","phospholipase activator activity ","O15530"]
["GO:0019871","molecular_function","sodium channel inhibitor activity ","Q13557; Q96PU5; Q92681; P46934"]
["GO:0031432","molecular_function","titin binding ","Q13557; Q9GZV1; P0DP23; Q15327; O15273; Q14896; Q00872"]
["GO:0043531","molecular_function","ADP binding ","P14618; P53041; P48506; Q13459; P35580; O14727; P55072; O75460; Q9NQG6; P68133; Q92614; Q8NEV4; P05023; P54619; Q9Y230; P00367; Q9UM54; P35579; Q9Y265; P10412"]
["GO:0023026","molecular_function","MHC class II protein complex binding ","P14618; P08238; P07900; P50995; P62258; P11142"]
["GO:0030955","molecular_function","potassium ion binding ","P14618; P56524; P22459; Q9UI40; P05023; P30613; Q14654"]
["GO:0004743","molecular_function","pyruvate kinase activity ","P14618; P30613"]
["GO:0070324","molecular_function","thyroid hormone binding ","P14618; P10828; P10827"]
["GO:0005030","molecular_function","neurotrophin receptor activity ","Q16288"]
["GO:0005003","molecular_function","ephrin receptor activity ","P54760; P29317; P54753; O15197"]
["GO:0036332","molecular_function","placental growth factor-activated receptor activity ","P17948"]
["GO:0036326","molecular_function","VEF-A-activated receptor activity ","P17948"]
["GO:0036327","molecular_function","VEF-B-activated receptor activity ","P17948"]
["GO:0004705","molecular_function","JUN kinase activity ","P53779; P45984; P45983"]
["GO:0043014","molecular_function","alpha-tubulin binding ","P37840; P06241; Q7L7X3; Q15078; Q9UBK2; Q92598; Q9HBA0; Q9GZM8; Q9H0H5; Q9NQ86; Q9UBN7; P23975; P61601"]
["GO:0048487","molecular_function","beta-tubulin binding ","P37840; P17302; P42858; Q7L7X3; P41220; Q15078; Q92913; Q9HBA0; Q9GZM8; Q9H0H5; Q9UBN7; O14737; Q9UQE7; P23975; Q9H2P0; P50402; Q66K74"]
["GO:0005507","molecular_function","copper ion binding ","P37840; P04637; P00403; P14679; Q99497; P04156; Q9UBF6; P00441; Q9H2P0; P00450; P12259; P19021; Q04656"]
["GO:1903136","molecular_function","cuprous ion binding ","P37840; Q99497; P04156; Q16143; Q04656"]
["GO:0043027","molecular_function","cysteine-type endopeptidase inhibitor activity involved in apoptotic process ","P37840; Q9UJU2; P49407; P51812; Q15418; P09327; O60936; Q9NPP4; P30044; O15392; P98170; P30048"]
["GO:0070840","molecular_function","dynein complex binding ","P37840; P25054; O43521; P81274; P12036; Q06787; P12270; Q9UBN7; Q14203; Q9UQE7; Q14980"]
["GO:0008198","molecular_function","ferrous iron binding ","P37840; P07101; Q9H1K1; Q96KS0; Q16595"]
["GO:0042393","molecular_function","histone binding ","P37840; P06748; O60674; P42224; Q9UJU2; Q16512; P16104; P05771; P49736; Q96EB6; O95271; Q8NCD3; P06454; Q01105; P39687; Q9Y294; Q9NVP2; P35659; Q9Y5B9; O43918; P18754; Q15906; Q13112; Q9Y3T9; Q9Y5T5; Q9UIF9; Q9UER7; Q96T88; Q9UIG0; Q9UHJ3; Q96T23; P49321; Q7KZ85; Q9BRQ0; Q99543; Q15020; P62805; Q9BZK7; Q96LA8; P29375; O00213; Q92688; Q9BUR4; Q96RL1; Q5VTR2"]
["GO:0030544","molecular_function","Hsp7 protein binding ","P37840; P06493; P16220; P25686; P25685; P46527; P16150; P23396; Q07812; P46379; O75460; P31948; Q99543; Q9UNE7; Q9BY41; P37198; Q92574; O60260"]
["GO:0019894","molecular_function","kinesin binding ","P37840; O43663; P60709; Q9HC98; A0MZ66; P12036; Q5TZA2; O60271; Q9UQF2; P16389; Q9UPT6; Q9H0B6; Q9NPI6; P37198"]
["GO:0016491","molecular_function","oxidoreductase activity ","P37840; P08684; Q9BV57; O60341; Q96HE7; O00767; P20815; Q9NZC7; P27695"]
["GO:0005543","molecular_function","phospholipid binding ","P37840; P29353; P42680; P34947; Q92934; P04083; P41743; Q9BY11; Q8TCU6; Q01082; Q8NFA2; P02649; O00482; P23743; P63027; Q9UN19; O76054; O95810; Q13285; Q9UNA1; Q9UNZ2; O95477; Q9NRY4; P08758; P37198; Q86XR7; P13726; Q9H492; Q8NFH5; P49418"]
["GO:0048156","molecular_function","tau protein binding ","P37840; Q15796; Q13627; Q7KZI7; P06241; P08238; P07900; O95816; Q02790; P02649; Q9UBN7; Q9NY61; O00213; P54652"]
["GO:0044183","molecular_function","protein binding involved in protein folding ","P04792; P10809; P0DMV8; P78371"]
["GO:0008426","molecular_function","protein kinase C inhibitor activity ","P04792; P31947; P61981"]
["GO:0043130","molecular_function","ubiquitin binding ","P04792; Q00987; Q96L34; P84022; O95071; P25686; P61073; Q9BYM8; Q9Y5T5; Q13501; P15374; Q14CS0; Q9UBN7; O75674; Q9UNZ2; Q13049; Q9UHP3; O43684; P49459; Q96FW1; Q9H6K1; P37198; Q9UNN5; P11388; P61088; P46934; Q8IXJ6; Q04323; O60260"]
["GO:0050662","molecular_function","coenzyme binding ","P04035; P48506; Q9NZC7; P24752"]
["GO:0004420","molecular_function","hydroxymethylglutaryl-CoA reductase (NADPH) activity ","P04035"]
["GO:0042282","molecular_function","hydroxymethylglutaryl-CoA reductase activity ","P04035"]
["GO:0070402","molecular_function","NADPH binding ","P04035; P49327; P09417"]
["GO:0030553","molecular_function","cMP binding ","Q13237; Q13976; P29973; O76074; Q9HCR9; Q9Y233; P18545"]
["GO:0004692","molecular_function","cMP-dependent protein kinase activity ","Q13237; Q13976"]
["GO:0030331","molecular_function","estrogen receptor binding ","O95835; P03372; Q9UJU2; P37231; P49407; P12931; P35222; Q15650; Q12962; Q9UBK2; Q99801; P48552; P58012; Q9BTK6; P12004; Q14686; P17861; Q15788; P35637; O43815; Q969T9; P09874; Q15648; Q99623"]
["GO:0047323","molecular_function","[-methyl--oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity ","O14874"]
["GO:0098770","molecular_function","FBX family protein binding ","Q00534"]
["GO:0004345","molecular_function","glucose-6-phosphate dehydrogenase activity ","P11413"]
["GO:0050661","molecular_function","NADP binding ","P11413; P35228; P29475; P29474; O75874; Q12882; Q96PH1; P04040; Q13423; P31937; Q9NRD9; P04406; P35270; P42898"]
["GO:0008144","molecular_function","drug binding ","Q01581; P10276; P37231; P49327; P27707; O75469; Q08499; P41180; P28223; P21554; Q16658; P28222; P35462; Q9HAW7; P09211; Q08209; P08172; P14416; Q07869; P35790; P06737; P11388; P14867; P12821"]
["GO:0004421","molecular_function","hydroxymethylglutaryl-CoA synthase activity ","Q01581"]
["GO:0016853","molecular_function","isomerase activity ","Q01581"]
["GO:0043177","molecular_function","organic acid binding ","Q01581"]
["GO:0019211","molecular_function","phosphatase activator activity ","P35269; Q8WU20"]
["GO:1990841","molecular_function","promoter-specific chromatin binding ","P35269; P42224; P15172; P04637; Q00613; Q13263; Q15910; P56524; Q92769; Q16254; Q9UBK2; P17844; O75626; Q15022; Q12948; P24928; Q08999; P26358; Q9P2D1; Q13547; P10070; P35226; P28749; P56693; Q99958; O43474; Q15047; Q96KQ7; P98177; P54845; P52948; Q00839; Q00403; P18146"]
["GO:0016407","molecular_function","acetyltransferase activity ","Q09472; Q92793; Q92794; Q92993; Q00403"]
["GO:0003684","molecular_function","damaged DNA binding ","Q09472; O60934; P52701; P09429; P38398; P16104; Q12888; P04637; Q49AN0; P13010; P19447; O15287; P23396; O15350; P12956; Q96T60; P54727; Q9UBT6; Q96FI4; P12004; P27694; P39748; P06746; Q92793; Q9Y253; P15927; P23025; P13051; Q99708; Q9NS91; Q13569; P43246; Q9H816; Q16531; O60671; Q969S2; P27695; Q7Z2E3; Q96SD1; Q9H3D4"]
["GO:0004402","molecular_function","histone acetyltransferase activity ","Q09472; P15336; Q9Y6Q9; O15516; O95251; Q92793; Q15788; Q92794; Q92993; Q00403"]
["GO:0140069","molecular_function","histone butyryltransferase activity ","Q09472"]
["GO:0140068","molecular_function","histone crotonyltransferase activity ","Q09472"]
["GO:0004468","molecular_function","lysine N-acetyltransferase activity, acting on acetyl phosphate as donor ","Q09472"]
["GO:0035257","molecular_function","nuclear hormone receptor binding ","Q09472; P42224; Q9Y6Q9; P15172; P35222; Q96EB6; O43707; P48552; Q16665; Q13573; Q16526; Q9NQB0; Q6STE5; Q15788; Q15596; O75376; Q15648"]
["GO:0140065","molecular_function","peptide butyryltransferase activity ","Q09472"]
["GO:0061733","molecular_function","peptide-lysine-N-acetyltransferase activity ","Q09472"]
["GO:0034212","molecular_function","peptide N-acetyltransferase activity ","Q09472; Q92793"]
["GO:0097157","molecular_function","pre-mRNA intronic binding ","Q09472; Q9BWF3; P14866; P22626; Q6P2Q9; P48436"]
["GO:0061920","molecular_function","protein propionyltransferase activity ","Q09472"]
["GO:0001102","molecular_function","RNA polymerase II activating transcription factor binding ","Q09472; P06400; Q9H2X6; Q96ST3; P15336; P41235; Q12888; P16220; P05412; P84022; P35222; P01100; P40305; P28069; Q99697; Q92793; Q16236; Q06265; O15119; Q9HBH7; O75376; Q13562; Q9UMR3"]
["GO:0097677","molecular_function","STAT family protein binding ","Q09472; P17706; Q00613; Q93079"]
["GO:0001228","molecular_function","transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding ","Q09472; P15976; Q15796; Q9UJU2; Q14653; P49715; P15336; Q01196; P42226; Q99459; P40763; P15172; P16220; P84022; P04637; P35398; P11831; P23771; O43524; P43694; O75469; O96006; P62508; Q8IZQ8; P15173; Q06546; P55347; Q92908; Q9HBU1; Q12948; Q13568; O43918; Q16665; Q9H9S0; O00716; P49116; P52952; P41161; Q12946; P18850; Q9NZI5; P18846; P40425; P13349; P98177; Q9UBR4; O15266; Q99856; P09874; P14316; P23769; Q14994; P15408; O75444; P23409"]
["GO:0016746","molecular_function","transferase activity, transferring acyl groups ","Q09472; P33076; O60318"]
["GO:0003676","molecular_function","nucleic acid binding ","Q9UHD2; Q8TBK6; Q9UBB9; Q96T58; Q9UKV3; O95785; Q5VUA4; Q9H1K0; O75391; Q9H4L7; Q9Y3Z3; O00204; Q8N1G1; Q9H8M2; O15014; Q9UBU7; Q15075; Q96JM3; Q9NQI0; Q8N1G2; Q92784; O14638; Q9C0B9; Q96JP5; Q8N302; Q8IY67; O60678; O60318; Q16206; Q9UBL0; Q16385; Q9Y2Y1; Q86YF9; P22413"]
["GO:0001047","molecular_function","core promoter binding ","P06748; P04150; P28324; Q15648; Q00403; Q9UKV8"]
["GO:0004860","molecular_function","protein kinase inhibitor activity ","P06748; Q9H2K8; P38936; O14512; P60983; P49918; P16333; P46527; Q9HCJ2; Q9UD71; O14543; Q92519; Q9UQF2; Q8TEV9; O60239"]
["GO:0043023","molecular_function","ribosomal large subunit binding ","P06748; Q96D46; P56537"]
["GO:0043024","molecular_function","ribosomal small subunit binding ","P06748; P11309; P23588; Q15056; P13051; O00571; P15531; O75616"]
["GO:0030957","molecular_function","Tat protein binding ","P06748; P60709; Q12824; P51532; Q9Y5B0; Q13049"]
["GO:0051082","molecular_function","unfolded protein binding ","P06748; P02511; P08238; P07900; Q16543; Q99733; P25686; Q9UDY4; O43464; P38646; O14558; P10809; P25685; P14625; Q13112; Q15185; P34931; P0DMV8; P05408; P27824; Q12931; P11142; P78371; Q9Y230; P54652; Q99471; Q9Y266; O75494; O00170; Q13111; P11021"]
["GO:0097718","molecular_function","disordered domain specific binding ","P06400; Q15796; Q00987; Q9Y6Q9; P04637; P06241; P17302; P08238; P07900; P15311; Q14145; P0DP23; P0DMV8; Q9Y4I1; P04406; Q09470; P54652; Q8N726; Q14980; Q00610"]
["GO:0061676","molecular_function","importin-alpha family protein binding ","P06400; Q08379; Q9ULW0"]
["GO:0000987","molecular_function","proximal promoter sequence-specific DNA binding ","P06400; P84022; P23771; Q9P0U4; Q02962; Q01094; Q13485; Q92793; Q96T88; O00716; Q02447; Q13351; P08047; Q16621; O43474; Q12800; P28347; A0AVK6; P05549; P25490; Q96AV8"]
["GO:0070742","molecular_function","CH zinc finger domain binding ","P15976; P19544; Q9UJU2; P26368; Q9UQ35; Q96KQ7; P52926; P23769"]
["GO:0001085","molecular_function","RNA polymerase II transcription factor binding ","P15976; Q9UQL6; Q02078; P17947; P04637; P11831; P49841; P10275; P19419; P35222; P23771; P43694; P56524; Q86UE4; Q96T58; P14317; Q92908; P17542; P28069; Q99697; Q13547; Q13485; Q92793; P18848; P78337; O43474; Q15327; P47928; Q9NYF0; P17861; Q15561; O15119; Q9UBR4; P28347; O95644; P23769; O94776; Q9UMR3"]
["GO:0000976","molecular_function","transcription regulatory region sequence-specific DNA binding ","P15976; Q96ST3; P19838; P23771; Q49AN0; Q9Y4C1; O15055; Q99801; O00327; Q96RI1; Q99697; Q13547; P10827; Q8WXF1; O00482; P18850; Q16236; Q14494; Q16621; P35638; Q7LBC6; P23246; P48431; P05549; P18146; Q01860; O60260"]
["GO:0003886","molecular_function","DNA (cytosine-5-)-methyltransferase activity ","Q9Y6K1; P26358"]
["GO:0009008","molecular_function","DNA-methyltransferase activity ","Q9Y6K1; P26358"]
["GO:0003735","molecular_function","structural constituent of ribosome ","P62753; P62917; P60866; P62280; P05388; P62979; P26373; P05387; P23396; Q9H0U6; P42677; P84098; Q92665; P62913; P46782; P46778; P40429; P46783; P51398; P62841; P30050; P62987; Q71UM5; Q07020; Q9Y676; P39019"]
["GO:0016597","molecular_function","amino acid binding ","P00966; P07101; P41180; Q5JTZ9; Q15046"]
["GO:0004055","molecular_function","argininosuccinate synthase activity ","P00966"]
["GO:0015643","molecular_function","toxic substance binding ","P00966; P36544; Q9H814; P25092"]
["GO:0005096","molecular_function","TPase activator activity ","P21359; P11274; P49407; P05412; Q9Y2X7; Q5S007; O00459; Q9P0N9; Q13459; O15492; P41220; Q9NS28; P52565; Q13671; Q9P2F6; P47736; Q15642; O43566; Q8TCU6; Q9NQ66; Q15027; Q96P48; Q9NPQ8; O14559; O75916; Q7Z5H3; Q9H3Q1; Q2M1Z3; P52757; Q5VWQ8; Q15311; Q96QB1; Q9Y4G8; Q9UJF2; Q8IVF5; O60229; Q9UKW4; O43157; Q15276; P85298; Q8WUA7; Q5T5C0; O14921; Q9P227; Q96PV0; Q9H0H5; Q15052; Q9ULH1; P49795; Q92888; O43295; Q8N264; Q86TI0; Q9H8V3; Q9UNA1; Q8N6H7; Q68EM7; Q8WWN8; Q14161; P49798; O00429; P49815; Q14C86; P46940; P31150; Q9Y2T1; P52566; Q70Z35; Q9NRY4; Q15057; O15539; Q4KMP7; Q3KR16; Q07889; Q5TB30; Q13017; Q8TDY4; Q8IV61; P49802; O60343; Q14185; P20936; Q99490; O95267; Q5T5U3; O43665; O75689; Q00587; O15169; O43166; O43150; P46060; P50395; Q6P1M3; Q15334; Q684P5; Q8WU79; O14613; Q9UJM3"]
["GO:0008429","molecular_function","phosphatidylethanolamine binding ","P21359; P30086; P50995; Q9H492"]
["GO:0004698","molecular_function","calcium-dependent protein kinase C activity ","P17252; P05129; P05771"]
["GO:0035403","molecular_function","histone kinase activity (H-T6 specific) ","P17252; P05771"]
["GO:0005200","molecular_function","structural constituent of cytoskeleton ","Q9UEY8; P08670; Q9Y490; P60709; P14136; Q96RT1; P26038; P07437; O60504; O15511; Q01082; Q16204; P0DPH7; P12036; P07196; P61160; Q13813; P11171; Q9BQE3; P07197; O15143; Q71U36; P68133; Q04695; P30427; P61158; Q12955; P23258; P35900; Q13509; O94805; P08727; O94875; P17661; P68363; P63261; P09493; O14777; P15924"]
["GO:0003725","molecular_function","double-stranded RNA binding ","P08670; P12814; P08238; P19525; Q86UE4; Q15717; Q9NR56; P02786; P26038; Q32MZ4; Q12906; O95786; P10809; O15455; Q8IYB8; Q9UL40; Q15633; P00973; Q9BYX4; Q5TC82; P68363; Q8WYQ5; P08195; Q7Z2E3; Q9NRR4; Q00839; Q00610; Q9UKV8"]
["GO:1990254","molecular_function","keratin filament binding ","P08670; Q96EB6"]
["GO:0005212","molecular_function","structural constituent of eye lens ","P08670; P02511; O14558; P30301; P43320; P05813"]
["GO:0070888","molecular_function","E-box binding ","P01106; P37231; O75030; P15172; O14744; P23771; O15516; P15173; Q9BQG0; P15923; Q9H2A3; O00327; P17542; P37275; Q13547; Q16665; Q16526; Q8WXF1; Q92886; P15884; P50553; Q12772; P61296; P61244; O15534; P23246; P35869; P20393; Q15672; Q13562"]
["GO:0004001","molecular_function","adenosine kinase activity ","P55263"]
["GO:0034618","molecular_function","arginine binding ","P35228; P29475; P29474"]
["GO:0050660","molecular_function","flavin adenine dinucleotide binding ","P35228; P29475; P29474; Q12882; Q96PH1; P09622; P47989; O60341; Q9NPH5; P31040; P42898"]
["GO:0010181","molecular_function","FMN binding ","P35228; P29475; P29474"]
["GO:0020037","molecular_function","heme binding ","P35228; O60674; P29475; P35520; P29474; P12931; Q9BQI3; P35354; Q96PH1; P04040; P05093; P13498; O76061; P11511; Q02153; Q02108; P08684; P99999; Q9NPH5; Q9NRD9; P09601; P20813; P20815; Q8WYQ5; P20393; O00264"]
["GO:0003958","molecular_function","NADPH-hemoprotein reductase activity ","P35228; P29475; P29474"]
["GO:0004517","molecular_function","nitric-oxide synthase activity ","P35228; P29475; P29474"]
["GO:0034617","molecular_function","tetrahydrobiopterin binding ","P35228; P07101; P29475; P29474"]
["GO:0046332","molecular_function","SMAD binding ","Q9H2X6; Q15796; Q04771; P29590; Q02078; P35222; P17844; Q03167; P50616; Q13573; P37173; P36897; P98082; P21333; Q9UNE7; P37023; P52926; Q86UL8; O15169; Q9Y4E8; P12755; P36894; Q9NRR4; P36896; P25490"]
["GO:0046790","molecular_function","virion binding ","Q9H2X6"]
["GO:0032137","molecular_function","guanine/thymine mispair binding ","P52701; P40692; P43246"]
["GO:0035064","molecular_function","methylated histone binding ","P52701; Q12888; Q15291; Q9UPP1; Q8IZD2; Q15022; Q9HC52; P45973; Q8WYH8; Q06787; O00257; Q96T88; Q9Y483; Q9ULU4; P55895; Q9UK53; P29375; O75151"]
["GO:0030983","molecular_function","mismatched DNA binding ","P52701; Q13569"]
["GO:0016740","molecular_function","transferase activity ","Q9H2K8; Q7L7X3; Q12899; Q86Y01; Q8TAS1"]
["GO:0004686","molecular_function","elongation factor-2 kinase activity ","O00418"]
["GO:0008135","molecular_function","translation factor activity, RNA binding ","O00418; Q04637; P55010; Q9BZB8; P41091; Q15056; P29692; Q8NE71; O43432; P20042; Q05639; Q8NE35"]
["GO:0000993","molecular_function","RNA polymerase II complex binding ","Q6PD62; Q9Y6Q9; Q9BTA9; Q8N163; Q9NRG4; Q6P1J9; Q00839; O94762; Q00403; Q9NQG5; Q9UKV8"]
["GO:0005159","molecular_function","insulin-like growth factor receptor binding ","P29353; P49407; P35568; P06213; P27986; P46108; Q04917; P61981"]
["GO:0005168","molecular_function","neurotrophin TRKA receptor binding ","P29353; Q8WU20; P19174; P27986; P62993"]
["GO:0051010","molecular_function","microtubule plus-end binding ","P25054; Q99661; Q13586; P30622; Q15691; O75122; Q14980"]
["GO:0019887","molecular_function","protein kinase regulator activity ","P25054; P08238; Q16543; P67870; Q6NXT1; Q9UNN5; Q9ULH0"]
["GO:0004478","molecular_function","methionine adenosyltransferase activity ","Q00266"]
["GO:0098601","molecular_function","selenomethionine adenosyltransferase activity ","Q00266"]
["GO:0003785","molecular_function","actin monomer binding ","P00519; Q12792; P07737; Q6IBS0; P42684; P29474; Q02156; Q53SF7; O43312; Q969V6; Q9UHB6; P10916"]
["GO:0030145","molecular_function","manganese ion binding ","P00519; P11309; P42684; P35813; Q92630; P51003; P49959; Q08462; O95551; O75688; P04179; Q13907; Q14191"]
["GO:0038191","molecular_function","neuropilin binding ","P00519; P49023; Q9UL54"]
["GO:0004515","molecular_function","nicotinate-nucleotide adenylyltransferase activity ","P00519; Q9HAN9"]
["GO:0019905","molecular_function","syntaxin binding ","P00519; P17706; Q08379; Q8IYJ3; Q5T447; Q9H2B2; Q9BVK6; Q5T7P8; O43581; Q5T5C0; Q9NUQ3; P63027; Q9Y2J0; P51809; P61764; P62491; O00161; P20338; O95477; Q8N9I0; Q8IV01; O00186; P23763; Q6ZWJ1"]
["GO:0003872","molecular_function","6-phosphofructokinase activity ","Q01813; P17858; P08237"]
["GO:0097100","molecular_function","supercoiled DNA binding ","O75475; P09429; P23396; P11387"]
["GO:0010385","molecular_function","double-stranded methylated DNA binding ","P19544; Q9UIS9; P51608; P18146"]
["GO:0044729","molecular_function","hemi-methylated DNA-binding ","P19544; Q96T88; P18146"]
["GO:0004992","molecular_function","platelet activating factor receptor activity ","P09619"]
["GO:0005017","molecular_function","platelet-derived growth factor-activated receptor activity ","P09619"]
["GO:0005019","molecular_function","platelet-derived growth factor beta-receptor activity ","P09619"]
["GO:0048407","molecular_function","platelet-derived growth factor binding ","P09619; P16234"]
["GO:0038085","molecular_function","vascular endothelial growth factor binding ","P09619; P35968; P16234"]
["GO:0003729","molecular_function","mRNA binding ","O00267; O43251; P08621; Q04637; Q9Y5S9; Q15717; P51114; Q9NRA8; Q14493; Q9NZI8; Q9H0Z9; Q12996; P38919; P23396; Q5D1E8; Q99497; Q8NI27; Q06787; Q9BWU0; Q9H0L4; O75533; P12270; Q96F86; Q92879; Q07955; P46782; Q53F19; Q9BWF3; P40429; Q15631; Q96PU8; Q13283; Q9NPI6; Q12972; Q86U44; Q9UNP9; Q15365; P52948; Q07352; P51608; Q9BY44; Q13769; Q8TAD8; Q07021; Q9H4D5; P38159; P05455; P52298; P26651; Q9Y383; Q96QD9; P33240; Q09161; Q7LC44"]
["GO:0001540","molecular_function","amyloid-beta binding ","P02511; P29323; P06213; P42261; P36544; P01130; Q99767; P16671; P56817; P05107; P04156; P17301; Q8WTV0; Q92673; P02649; Q02410; P31994; P30533; O00213; P07550; P42262; Q8N2Q7; O95886; Q15109; O96018"]
["GO:0070410","molecular_function","co-SMAD binding ","Q15796; Q15797; P84022; Q9UPN9; P43694; Q99966; P26367; O43541; Q15583"]
["GO:0035326","molecular_function","enhancer binding ","Q15796; Q9UJU2; P84022; Q7Z5J4; P27540; P15923; Q9HB65; Q6U7Q0; P35869; P48436"]
["GO:0070411","molecular_function","I-SMAD binding ","Q15796; Q15797; P35222; Q13485; O43541; O15105; O43294; P36897; Q9Y2T1; O15169"]
["GO:0070878","molecular_function","primary miRNA binding ","Q15796; Q15797; P84022; P11831; Q15910; P17844; Q8WYQ5; Q9NRR4"]
["GO:0070412","molecular_function","R-SMAD binding ","Q15796; P05412; P84022; Q9UPN9; P01100; P35813; P17844; Q8IZQ8; O60315; P26367; Q13485; O43541; Q15327; Q9H4X1; Q9H6Z4; O00255; P09874; Q9NRR4"]
["GO:0030618","molecular_function","transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity ","Q15796; Q15797; P84022; O15198"]
["GO:0005160","molecular_function","transforming growth factor beta receptor binding ","Q15796; P84022; P08476; Q03167; P22004; Q9Y4E8; O95390"]
["GO:0034713","molecular_function","type I transforming growth factor beta receptor binding ","Q15796; O43541; O15105; P17813; P37173"]
["GO:0051393","molecular_function","alpha-actinin binding ","P10276; P37231; Q13936; Q01668; P22460; Q14118; Q9H2S1; P50479"]
["GO:0048027","molecular_function","mRNA 5'-UTR binding ","P10276; Q6PKG0; P35580; Q9BRS8; Q9NZI8; Q06787; P19338; O00571; Q9Y6M1; O76021"]
["GO:0051018","molecular_function","protein kinase A binding ","P10276; Q5S007; P15311; Q92558; O43572; P35241; P23396; Q12802; Q02952; Q9Y6W5; Q9NYF0; Q5JQC9; Q9UKA4"]
["GO:0043422","molecular_function","protein kinase B binding ","P10276; Q92934; Q9UKG1; Q13370; Q9GZV1; Q13243; Q07955; O95999; Q9Y4K3; Q9BXM7; Q3V6T2; P32121"]
["GO:0001972","molecular_function","retinoic acid binding ","P10276; P19793; Q9HAW7; P11717"]
["GO:0003708","molecular_function","retinoic acid receptor activity ","P10276; P19793; P62508; P13631"]
["GO:0044323","molecular_function","retinoic acid-responsive element binding ","P10276; P19793"]
["GO:0000900","molecular_function","translation repressor activity, mRNA regulatory element binding ","P10276; P04818; Q9BZB8; Q92879; Q8NE35"]
["GO:0035173","molecular_function","histone kinase activity ","P06493; P14635; Q9UIG0"]
["GO:0033558","molecular_function","protein deacetylase activity ","Q96ST3; Q9UQL6; P56524; Q92769; Q96EB6; Q13547; O15379; Q8IXJ6; Q9UKV0"]
["GO:0001103","molecular_function","RNA polymerase II repressing transcription factor binding ","Q96ST3; P40763; Q92769; P52655; Q14839; Q13330; Q92908; Q13547; P08047; Q9NQB0; Q07869; Q99708; Q06330; O94776"]
["GO:0090722","molecular_function","receptor-receptor interaction ","P11362; P09038"]
["GO:0000405","molecular_function","bubble DNA binding ","P09429; P54132; P28715; Q14191"]
["GO:0042056","molecular_function","chemoattractant activity ","P09429; P09038; P17931; P05067"]
["GO:0019958","molecular_function","C-X-C chemokine binding ","P09429"]
["GO:0005125","molecular_function","cytokine activity ","P09429; Q12904; Q14005; P08476; P48023; P09038; P28799; P01375; Q02297; P22004; P06744; O95390"]
["GO:0070182","molecular_function","DNA polymerase binding ","P09429; P08238; P07900; Q9NVI1; P51532; Q9BXW9; P12004; Q15185; Q9BQ15; Q06609; O14519; Q96AP0"]
["GO:0000400","molecular_function","four-way junction DNA binding ","P09429; P54132; Q06609; O00255; Q14191; P25490"]
["GO:0001530","molecular_function","lipopolysaccharide binding ","P09429; P10809; Q8WTV0; P06899; O00206; Q9UGM3; Q9Y6Y9; Q9NRR4; P30203"]
["GO:0016829","molecular_function","lyase activity ","P09429; P06746"]
["GO:0001786","molecular_function","phosphatidylserine binding ","P09429; Q9Y490; P30530; P51178; Q9P0L2; Q9BR39; Q9H2B2; Q5T7P8; P21579; O43581; Q8WTV0; Q9ULH1; O95810; Q8TDQ1; P17677; O95267"]
["GO:0050786","molecular_function","RAE receptor binding ","P09429; P21462; P06702"]
["GO:0003993","molecular_function","acid phosphatase activity ","P24666"]
["GO:0030284","molecular_function","estrogen receptor activity ","P03372; Q9UJU2; Q99801; Q92731"]
["GO:0034056","molecular_function","estrogen response element binding ","P03372; O15164; Q92731"]
["GO:0038052","molecular_function","RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding ","P03372; Q92731"]
["GO:0017025","molecular_function","TBP-class protein binding ","P03372; P52655; P17980; P62195; P10827; Q92994; P43686; Q9Y230; P35869; Q03014; P35998; Q00403; Q9Y265"]
["GO:0001093","molecular_function","TFIIB-class transcription factor binding ","P03372; P15884"]
["GO:0038023","molecular_function","signaling receptor activity ","P07949; Q9Y2W1; Q02763; P08138; Q99062; O60244; Q9UKV5; Q9UBH6; O15455; P26010; P25445; P13056; P04156; Q9ULB1; P20138; O43157; Q02153; P18084; Q02108; Q02846; P49116; P11717; P15529; O00206; O75022; Q93034; Q9P2E9; Q13651; O15197; P06127; P16473; P32927; P20309; P01730; Q07954; Q4VCS5; P25942; Q9NPY3; Q15648; Q8N2Q7; Q15109; P09758"]
["GO:0003810","molecular_function","protein-glutamine gamma-glutamyltransferase activity ","P21980"]
["GO:0004703","molecular_function","-protein coupled receptor kinase activity ","Q15835; P25098; P34947; Q8WTQ7; P32298; P35626; P43250"]
["GO:0050254","molecular_function","rhodopsin kinase activity ","Q15835; Q8WTQ7; P32298"]
["GO:0005546","molecular_function","phosphatidylinositol-,-bisphosphate binding ","Q12792; P07355; P51178; P07737; Q6IBS0; Q9P0L2; P09327; Q8TEW0; Q9NQ66; O00560; Q9BR39; P48048; O75386; Q5TCZ1; P21579; O43581; P19634; Q9ULH1; Q9Y2J0; P51787; P55895; P58753; Q9BPZ7; P63252"]
["GO:0033130","molecular_function","acetylcholine receptor binding ","O60674; P78352; Q9ULB1; P05067"]
["GO:0005131","molecular_function","growth hormone receptor binding ","O60674; P29597; P23458"]
["GO:0035401","molecular_function","histone kinase activity (H-Y specific) ","O60674"]
["GO:0005143","molecular_function","interleukin-2 receptor binding ","O60674"]
["GO:0031702","molecular_function","type  angiotensin receptor binding ","O60674; P29597; Q14344; P30411; Q96P48; P32121"]
["GO:0031730","molecular_function","CCR5 chemokine receptor binding ","P42224; P40763; P23458"]
["GO:0000979","molecular_function","RNA polymerase II core promoter sequence-specific DNA binding ","P42224; P84243; P14859; P01100; Q15910; Q9Y4C1; P17676; P26367; P24522; Q16633; Q9Y230; Q15648; Q00403; Q9NRM2"]
["GO:0005164","molecular_function","tumor necrosis factor receptor binding ","P42224; Q13158; Q12933; O15304; P48023; Q14790; Q9BUZ4; Q9Y4K3; Q13114; P01375; Q12931; Q13077"]
["GO:0044389","molecular_function","ubiquitin-like protein ligase binding ","P42224; P14635; O14964; P52630; Q15650; P17676; P55072; Q93079; Q96J02"]
["GO:0030275","molecular_function","LRR domain binding ","Q15831; P01116; Q9Y6N7"]
["GO:0070016","molecular_function","armadillo repeat domain binding ","Q9UJU2; Q9NQB0; O43815; O15169"]
["GO:0051539","molecular_function","4 iron, 4 sulfur cluster binding ","Q06203; P21399; Q12882; Q9H1K1; O60673; P49643; Q99798; P48200"]
["GO:0004044","molecular_function","amidophosphoribosyltransferase activity ","Q06203"]
["GO:0004694","molecular_function","eukaryotic translation initiation factor 2alpha kinase activity ","Q9NZJ5; Q9P2K8; Q9BQI3; P19525"]
["GO:0003730","molecular_function","mRNA '-UTR binding ","Q13148; P04637; Q6PKG0; O75150; Q15717; P07910; Q96PM9; P51114; Q92904; Q9NZI8; P17844; P16989; Q9H0Z9; Q14671; Q8NC51; Q5D1E8; Q9BZB8; Q06787; Q9H6E5; Q9BWF3; Q9Y534; Q9Y6M1; P11940; O95453; Q5TC82; P22626; Q15287; Q8NE35; Q9Y2V2; Q00839; O76021; Q5VTR2"]
["GO:0003712","molecular_function","transcription coregulator activity ","Q14653; Q9Y2W1; Q12888; Q15678; P16220; Q9Y4A5; P84022; Q7KZF4; Q13287; Q9UBK2; P15941; P28324; O60244; Q9GZV1; P82094; O43918; Q13485; Q96PK6; Q9UKM9; P52952; P35548; Q14494; Q9ULU4; Q96HZ4; Q02297; O60711; P61244; Q13569; Q16633; O00625; P52926; Q9NZN8; Q15648; P62324; O94776; Q05195"]
["GO:0001164","molecular_function","RNA polymerase I CRE element sequence-specific DNA binding ","P17480; Q12824; P51532; Q9UIF9; Q9NYV6"]
["GO:0001165","molecular_function","RNA polymerase I upstream control element sequence-specific DNA binding ","P17480"]
["GO:0030296","molecular_function","protein tyrosine kinase activator activity ","Q13177; P21860; Q03468; P41594; Q02297; Q8N4X5; Q9UBU3; Q8IZP0"]
["GO:0031267","molecular_function","small TPase binding ","Q13177; P42768; P50542; P21333; P49815; O95477; P50395; Q9UJM3"]
["GO:0036312","molecular_function","phosphatidylinositol -kinase regulatory subunit binding ","P22681; P27986; P50570; Q5VWQ8; Q12923; Q6ZUJ8"]
["GO:0004842","molecular_function","ubiquitin-protein transferase activity ","P22681; P38398; Q00987; Q9UPN9; Q13263; O95376; Q7Z6E9; O15164; O15033; O75150; Q9UKT5; Q96PU5; O95071; Q8N1E6; Q8N3Y1; Q5T4S7; P19474; Q12933; Q9UKV5; Q8NHG8; P53804; Q5T447; Q9NS56; Q9BYM8; Q14669; P78317; Q9UJX5; Q9NPP4; P26367; Q9H4P4; Q9UK99; Q969U6; Q96T88; Q8IYU2; O15392; Q8NHY2; Q9NQ86; Q9Y4K3; P68036; P49427; Q5XUX0; P63146; Q13114; O43164; Q96JP5; Q16763; P41002; Q13049; Q9UJX2; Q712K3; Q9UNE7; Q5TC82; Q05086; Q93034; P49459; Q96EP1; P98170; Q9Y3C5; Q7Z6Z7; P61086; Q99728; P61088; Q96PM5; Q13309; Q9H0M0; P40337; Q8WWI1; Q8IUQ4; Q96J02; Q6PCD5; Q969H0; O43255; Q8ND25; O60260; Q9C0C9; Q5VTR2"]
["GO:0030165","molecular_function","PDZ domain binding ","P36507; P23443; P17302; P42261; P60484; P78352; Q5T2W1; Q13002; O43424; Q01814; O14745; Q03167; Q9Y4G8; P08588; O14578; P78536; P51790; Q9UN19; Q15058; Q9UBI6; Q9UQB8; P49768; Q9P219; P46459; P13569; P23634; Q13424; P34741; P48764; Q14831; Q16478; P48050; P30874; Q8N2Q7; Q9Y624; Q6P1M3; O60260; Q9ULH0"]
["GO:0043539","molecular_function","protein serine/threonine kinase activator activity ","P36507; Q13043; Q02750; Q7L7X3; Q15078; Q13188; P0DP23; Q7RTN6; O00571; P46940; O43597"]
["GO:0016595","molecular_function","glutamate binding ","Q05586; Q13224; P48506; P43003; P43005; Q14831; Q99259"]
["GO:0016594","molecular_function","glycine binding ","Q05586; Q13224; P48167; Q14749"]
["GO:0042165","molecular_function","neurotransmitter binding ","Q05586"]
["GO:1904315","molecular_function","transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential ","Q05586; P42261; P14867"]
["GO:0008289","molecular_function","lipid binding ","Q9BSJ8; Q7KZI7; Q14680; P16591; P53041; Q92934; P60484; Q96T51; P16671; Q15642; Q18PE1; Q16873; Q9HBA0; Q14677; Q9Y365; Q96QB1; Q07812; Q9Y6I3; P55072; P02649; Q99418; P08133; Q14494; O60240; Q07869; Q99962; Q15438; Q9ULU8; Q7LDG7; O00429; Q13319; Q00341; Q641Q2; Q13009; Q96CW1; Q96SU4; Q9BXB4; O95267; P07108; Q9GZU1; Q99961; Q9Y371; O15117; O95208"]
["GO:0030274","molecular_function","LIM domain binding ","Q9Y490; O43353"]
["GO:0017166","molecular_function","vinculin binding ","Q9Y490; P35221; P12814; P49023; O60504; P46939; Q14118"]
["GO:0004867","molecular_function","serine-type endopeptidase inhibitor activity ","P30086; P09958; P01009; Q06481; Q14624; P10646; P05067; P36955"]
["GO:0034988","molecular_function","Fc-gamma receptor I complex binding ","P09769; P21333"]
["GO:0034987","molecular_function","immunoglobulin receptor binding ","P09769; P07332"]
["GO:0017151","molecular_function","DEAD/H-box RNA helicase binding ","Q15797; P84022; Q8TDD2; P41162; Q9NRR4"]
["GO:0016922","molecular_function","nuclear receptor binding ","O14497; Q9Y6Q9; P19793; Q15650; Q9Y618; O15164; Q9UBK2; P17535; Q96RI1; Q969G3; Q9UIF9; Q6STE5; Q15788; Q15596; O75376; Q15648"]
["GO:0031491","molecular_function","nucleosome binding ","O14497; Q99733; P78317; Q9Y5B9; P18754; Q9Y3T9; P54198; Q7KZ85; O43257"]
["GO:0001013","molecular_function","RNA polymerase I regulatory region DNA binding ","P49715"]
["GO:0001135","molecular_function","RNA polymerase II transcription factor recruiting activity ","P10242; Q99459; P10244; P10243"]
["GO:0005085","molecular_function","guanyl-nucleotide exchange factor activity ","Q9P212; Q13905; P15498; O75592; P43119; Q14344; Q12967; Q8N5V2; Q8TCU6; P52735; O75962; Q13144; Q9NPQ8; Q92974; Q9Y6D6; Q8NF50; Q96DR7; Q14155; Q12802; Q8IVF5; Q96N67; O60229; Q9UKW4; Q96PE2; Q15052; Q9H7P9; Q92888; Q9H8V3; Q7LDG7; Q92538; O94827; Q13009; Q14C86; Q8TEV9; Q96HP0; Q07889; Q13972; Q8IV61; Q9H244; O14827; O95267; P21731; Q9NR80; Q7Z628; O95398"]
["GO:0004435","molecular_function","phosphatidylinositol phospholipase C activity ","Q9P212; P19174; P16885; P51178; Q01970; P41180; P30411; Q9NQ66; P51681; Q15111; P20309; Q9BRC7"]
["GO:0004629","molecular_function","phospholipase C activity ","Q9P212; P19174; P16885; Q01970; Q9NQ66; Q15111; P30101"]
["GO:0017016","molecular_function","Ras TPase binding ","Q9P212; Q9P0V3; P47736; P55196; Q9NRA0; Q9BPZ7; Q99828"]
["GO:0005104","molecular_function","fibroblast growth factor receptor binding ","Q8WU20; P09038"]
["GO:0043125","molecular_function","ErbB- class receptor binding ","P04626; Q00535; P27986; Q02297"]
["GO:0001042","molecular_function","RNA polymerase I core binding ","P04626; Q14978; Q13428; Q9NYV6"]
["GO:0035497","molecular_function","cAMP response element binding ","P15336; P16220; P05412; P18850; P52926"]
["GO:0008140","molecular_function","cAMP response element binding protein binding ","P15336; Q53ET0; P57059; O43293; Q6UUV7; Q6UUV9; P35638; Q03060"]
["GO:0001158","molecular_function","enhancer sequence-specific DNA binding ","P15336; P17096; P23771; P43694; P17861; Q9H8N7; P23769; P25490; P48436"]
["GO:0048185","molecular_function","activin binding ","Q04771; Q13705; Q03167; O15105; P17813; P37023; P36896"]
["GO:0016361","molecular_function","activin receptor activity, type I ","Q04771; P37023; P36896"]
["GO:0017046","molecular_function","peptide hormone binding ","Q04771; Q03431; P08476; P17342; P32241; P16066; P42892; P32245; P50052; P10912; P16471; O43613"]
["GO:0050431","molecular_function","transforming growth factor beta binding ","Q04771; P16671; Q03167; P17813; P37173; P36897; P37023"]
["GO:0005025","molecular_function","transforming growth factor beta receptor activity, type I ","Q04771; P36897; P37023"]
["GO:0004675","molecular_function","transmembrane receptor protein serine/threonine kinase activity ","Q04771; Q13705; P37173; P37023; P36894; P36896"]
["GO:0031370","molecular_function","eukaryotic initiation factor 4 binding ","P06730"]
["GO:0000340","molecular_function","RNA 7-methylguanosine cap binding ","P06730; Q53F19; P52298; Q9UKV8; Q09161"]
["GO:0000339","molecular_function","RNA cap binding ","P06730; Q6PKG0; O95149; O43432; P52298; Q09161"]
["GO:0045182","molecular_function","translation regulator activity ","P06730; P42345; Q9NZI8; P38919; O43918; Q9Y6M1"]
["GO:0005086","molecular_function","ARF guanyl-nucleotide exchange factor activity ","Q15080; O43739; Q9Y6D6; Q99418; Q15438; Q92538"]
["GO:0032266","molecular_function","phosphatidylinositol--phosphate binding ","Q15080; Q8TEW0; Q5MNZ6; Q9BR39; Q5VWQ8; Q8TEH3; Q5TCZ1; Q9ULH1; A1X283; Q9Y4P8; Q9H4M7"]
["GO:0016176","molecular_function","superoxide-generating NADPH oxidase activator activity ","Q15080; P14598; Q86UR1; Q8NFA2; Q5TCZ1; A1X283; P19878"]
["GO:0050544","molecular_function","arachidonic acid binding ","P37231; P06702"]
["GO:0050692","molecular_function","DBD domain binding ","P37231; P19793"]
["GO:0050693","molecular_function","LBD domain binding ","P37231; P19793; Q99966; Q99967; Q15648"]
["GO:0030374","molecular_function","nuclear receptor transcription coactivator activity ","P37231; Q9Y2W1; Q9Y6Q9; P12814; Q16512; P17096; P05771; Q9UBK2; O43707; O60244; Q86X55; Q96PK6; Q9BQA1; O60341; P09038; Q14686; Q6STE5; Q15788; Q15596; Q15648"]
["GO:0042277","molecular_function","peptide binding ","P37231; P48730; P19793; P23443; Q9UBS0; P08238; P09958; P05388; P09497; Q9UIQ6; P17342; Q96P88; P08473; Q9ULH1; P78368; O14773; Q9H2P0; P09496; P30518; O43613"]
["GO:0004955","molecular_function","prostaglandin receptor activity ","P37231"]
["GO:0046965","molecular_function","retinoid X receptor binding ","P37231; P17096; P48552; Q96RI1; P55055; P11473; P43354; Q14686; P35637; Q15466; P13631"]
["GO:0050897","molecular_function","cobalt ion binding ","P29590; O15392"]
["GO:0032183","molecular_function","SUM binding ","P29590; P04150; O00257; Q9UER7; Q13569"]
["GO:0019789","molecular_function","SUM transferase activity ","P29590; Q00987; Q13263; P56524; O96006; P49792; Q8WUI4; Q9NS56; O00257; O75925; P63279; P63165; O75928; Q8N2W9; Q8N726"]
["GO:0070063","molecular_function","RNA polymerase binding ","P38398; Q16513; Q12962; Q03468; Q92688; O60563; P46934; P26651"]
["GO:0015631","molecular_function","tubulin binding ","P38398; Q13627; Q5S007; P04075; Q9HC77; P23396; Q9NZ72; P04156; P78559; P12270; P30622; Q15058; O15392; Q14203; Q96SN8; Q07866; Q14118; Q93045; Q14980; O94811; P61601; P16949; O60260; Q66K74"]
["GO:0008092","molecular_function","cytoskeletal protein binding ","Q13627; P07355; Q00535; P51452; P46108; P04075; Q13563; Q9BX66; Q5JTV8; P32418; Q8TDM6; P05062; Q12959; P26045; P30427; Q12955; Q14315; P17655; P63167; P17661; Q9NZQ3; Q8IZP0; P09493"]
["GO:0046966","molecular_function","thyroid hormone receptor binding ","Q9Y2W1; Q9Y6Q9; Q15545; Q15651; Q14669; Q14686; P35637; P37198; Q15466; O75376; Q15648; Q00403; Q15654"]
["GO:0042809","molecular_function","vitamin D receptor binding ","Q9Y2W1; P19793; O60244; Q15545; Q14106; Q13573; Q15648"]
["GO:0008432","molecular_function","JUN kinase binding ","Q05397; P09211; O60271; Q9UQF2; Q9UPT6; Q9Y6W6; P33176"]
["GO:0019003","molecular_function","DP binding ","P01112; P61224; P11488; P61106; P01116; P61020; P51148; P62826; Q9NQG6; Q8IYM1; P55040; P10301; Q15382; P20338; P62745; P20339; P11234; Q9Y6G9; P61586; P11233; Q9HB90"]
["GO:0005095","molecular_function","TPase inhibitor activity ","Q07912; Q13098; Q9BST9; Q13576; Q15669; P46940"]
["GO:0050699","molecular_function","WW domain binding ","Q07912; Q8N8S7; P50570; Q96Q89; Q9Y4G8; Q9BUZ4; P30307; P37088; Q16621; Q9NV92; Q6IPX3; P51170; Q9H3D4; P51168"]
["GO:0016874","molecular_function","ligase activity ","Q00987; P49917; Q96J02"]
["GO:0061663","molecular_function","NEDD8 ligase activity ","Q00987"]
["GO:0042975","molecular_function","peroxisome proliferator activated receptor binding ","Q00987; P17096; Q14934; Q9Y6K9; Q9UBK2; Q15466; Q15648"]
["GO:0033612","molecular_function","receptor serine/threonine kinase binding ","Q00987; Q13158; P41143; P41145"]
["GO:0004886","molecular_function","9-cis retinoic acid receptor activity ","P19793; P48443"]
["GO:0070335","molecular_function","aspartate binding ","P27708"]
["GO:0004070","molecular_function","aspartate carbamoyltransferase activity ","P27708"]
["GO:0004087","molecular_function","carbamoyl-phosphate synthase (ammonia) activity ","P27708"]
["GO:0004088","molecular_function","carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity ","P27708"]
["GO:0004151","molecular_function","dihydroorotase activity ","P27708"]
["GO:0035033","molecular_function","histone deacetylase regulator activity ","P45983"]
["GO:0036328","molecular_function","VEF-C-activated receptor activity ","P35916"]
["GO:0004051","molecular_function","arachidonate -lipoxygenase activity ","P09917"]
["GO:0005506","molecular_function","iron ion binding ","P09917; P00439; Q9H1K1; Q9Y4C1; Q9UPP1; P17752; P05093; P10109; P11511; P47989; P08684; Q9BV57; Q99798; O00767; P20813; Q8IWU9; P20815; O75151"]
["GO:0005078","molecular_function","MAP-kinase scaffold activity ","Q8IVT5; Q12802; O60271; Q9UQF2; Q9UPT6; Q7Z6J0"]
["GO:0031694","molecular_function","alpha-2A adrenergic receptor binding ","P25098; P08588"]
["GO:0047696","molecular_function","beta-adrenergic receptor kinase activity ","P25098; P34947; P35626; P43250"]
["GO:0031755","molecular_function","Edg-2 lysophosphatidic acid receptor binding ","P25098; P11233"]
["GO:0008046","molecular_function","axon guidance receptor activity ","P29323; P54762; P54753; Q9Y6N7"]
["GO:0005005","molecular_function","transmembrane-ephrin receptor activity ","P29323; P54762; P54764; P21709; Q15768"]
["GO:0035240","molecular_function","dopamine binding ","P07101; P35462; Q01959; P14416; P21728"]
["GO:0008199","molecular_function","ferric iron binding ","P07101; Q16595"]
["GO:0019825","molecular_function","oxygen binding ","P07101; P35520; P05093; P11511; P08684; P20815"]
["GO:0004511","molecular_function","tyrosine 3-monooxygenase activity ","P07101"]
["GO:0043522","molecular_function","leucine zipper domain binding ","Q99459; O43293; Q96IZ0; Q6P1K2; P18848; Q969V6; Q9NY61; P54845; P35638"]
["GO:0001222","molecular_function","transcription corepressor binding ","Q99459; P35398; Q9HC98; P63165; P51858; P20393"]
["GO:0071987","molecular_function","WD4-repeat domain binding ","Q99459; Q16531"]
["GO:0099186","molecular_function","structural constituent of postsynapse ","P12814"]
["GO:0046870","molecular_function","cadmium ion binding ","P29475; P29474"]
["GO:0035373","molecular_function","chondroitin sulfate proteoglycan binding ","P10586"]
["GO:0043423","molecular_function","-phosphoinositide-dependent protein kinase binding ","Q14289"]
["GO:0017049","molecular_function","TP-Rho binding ","Q16512; Q16513; Q13464; Q9H3Q1; Q9BST9; Q13829; Q9H2D6; Q6P5Z2; Q00587; Q7Z628; O14613"]
["GO:0035402","molecular_function","histone kinase activity (H-T11 specific) ","Q16512; O14757"]
["GO:0000049","molecular_function","tRNA binding ","P68104; Q9P2K8; O14746; Q12904; Q5JTZ9; Q15046; P56192; O95363; Q9Y285; Q99714; Q9UBP6; Q9BY44; P05455; Q08J23"]
["GO:0035254","molecular_function","glutamate receptor binding ","Q9UQM7; P19174; Q13972"]
["GO:0008139","molecular_function","nuclear localization sequence binding ","P25963; Q14978; P35658; O00505; P52294; A8CG34; P52292; P49790; P52948; Q96HA1"]
["GO:0098973","molecular_function","structural constituent of postsynaptic actin cytoskeleton ","P60709"]
["GO:0051575","molecular_function","'-deoxyribose--phosphate lyase activity ","P17096; P12956; Q9UGP5; P52926"]
["GO:0003906","molecular_function","DNA-(apurinic or apyrimidinic site) endonuclease activity ","P17096; P23396; Q8IW19; Q96FI4; P06746; P52926; P27695"]
["GO:0042974","molecular_function","retinoic acid receptor binding ","P17096; O43707; P56545; Q13573; Q15648"]
["GO:0044730","molecular_function","bone sialoprotein binding ","P07355"]
["GO:0005544","molecular_function","calcium-dependent phospholipid binding ","P07355; P04083; Q8IYJ3; P50995; P47712; Q86YS7; P21579; O43581; P08133; Q9Y2J0; Q8N9I0; Q8IV01; P08758"]
["GO:0048306","molecular_function","calcium-dependent protein binding ","P07355; P04083; P50995; P19429; P17844; Q16623; Q5T7P8; P0DP23; P21579; Q9NRY6; P19634; P08133; P58400; P63027; P31950; P45378; O14958; P31949; Q9UGM3; P17600; P60880; Q6X4W1; Q93045; Q6PUV4"]
["GO:0098772","molecular_function","molecular function regulator ","P07355"]
["GO:0019834","molecular_function","phospholipase A2 inhibitor activity ","P07355; P04083"]
["GO:0017137","molecular_function","Rab TPase binding ","P07355; P63000; O75385; Q9P0N9; Q8IYJ3; Q96CV9; P08138; Q9BXF6; Q9H1K0; Q7L804; Q92597; Q8WUA7; Q5T5C0; Q9Y4I1; Q8IYU2; Q9Y2J0; Q86TI0; Q9BV36; Q86UR5; P46459; Q8N3F8; O00429; Q5BJF6; P31150; Q6WKZ4; Q4KMP7; O60343; Q9Y496; O75154; Q6P1M3; P31645; Q15334"]
["GO:0044548","molecular_function","S1 protein binding ","P07355; P15311; P50995; P31950; P46940; P31949; O14649; Q09666; Q15109; P16615"]
["GO:0051538","molecular_function"," iron, 4 sulfur cluster binding ","P21399; Q99798"]
["GO:0003994","molecular_function","aconitate hydratase activity ","P21399; Q99798"]
["GO:0030350","molecular_function","iron-responsive element binding ","P21399; P48200"]
["GO:0004407","molecular_function","histone deacetylase activity ","Q9UQL6; P56524; Q9H7L9; Q92769; Q96EB6; Q14839; Q13330; Q13547; O60341; Q9P0W2; Q9UBN7; O15379; Q96BF6; Q9BY41; P29374; O95983; Q8IXJ6; O94776; Q9UKV0; Q9HCU9"]
["GO:0032041","molecular_function","NAD-dependent histone deacetylase activity (H-K specific) ","Q9UQL6; P56524; Q92769; Q8WUI4; Q13547; Q9UBN7; O15379; Q9BY41; Q9UKV0"]
["GO:0004386","molecular_function","helicase activity ","P23588; P49736; P25205; Q2NKX8; P19447; P54132; Q9H4L7; P51532; O95786; P33992; Q9UMR2; Q96L91; Q9P2D1; Q14240; Q03468; Q15056; Q8IYB8; Q92900; Q9BYX4; Q9UNY4; Q14527; Q14191; P26196; Q9NZC9; Q92698"]
["GO:0033592","molecular_function","RNA strand annealing activity ","P23588; P51114; Q06787; Q15056; O00571"]
["GO:0034057","molecular_function","RNA strand-exchange activity ","P23588; Q15056"]
["GO:0004677","molecular_function","DNA-dependent protein kinase activity ","P78527; Q13315; P52926"]
["GO:0070513","molecular_function","death domain binding ","Q13546; P51397"]
["GO:0005123","molecular_function","death receptor binding ","Q13546; Q13158; O60936; P48023; Q5VWQ8; Q14790; P55957; O15519; P42574"]
["GO:0010997","molecular_function","anaphase-promoting complex binding ","P53350; P60484; Q9HAW4; Q12834; Q9UM11"]
["GO:0004313","molecular_function","[acyl-carrier-protein] S-acetyltransferase activity ","P49327"]
["GO:0004314","molecular_function","[acyl-carrier-protein] S-malonyltransferase activity ","P49327"]
["GO:0047451","molecular_function","3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity ","P49327"]
["GO:0004316","molecular_function","-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity ","P49327"]
["GO:0004315","molecular_function","-oxoacyl-[acyl-carrier-protein] synthase activity ","P49327"]
["GO:0102131","molecular_function","-oxo-glutaryl-[acp] methyl ester reductase activity ","P49327"]
["GO:0102132","molecular_function","-oxo-pimeloyl-[acp] methyl ester reductase activity ","P49327"]
["GO:0047117","molecular_function","enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity ","P49327"]
["GO:0004312","molecular_function","fatty acid synthase activity ","P49327"]
["GO:0016295","molecular_function","myristoyl-[acyl-carrier-protein] hydrolase activity ","P49327"]
["GO:0004320","molecular_function","oleoyl-[acyl-carrier-protein] hydrolase activity ","P49327"]
["GO:0016296","molecular_function","palmitoyl-[acyl-carrier-protein] hydrolase activity ","P49327"]
["GO:0031177","molecular_function","phosphopantetheine binding ","P49327"]
["GO:0017020","molecular_function","myosin phosphatase regulator activity ","Q09013"]
["GO:0034512","molecular_function","box C/D snoRNA binding ","Q14978"]
["GO:0034513","molecular_function","box H/ACA snoRNA binding ","Q14978; O60832"]
["GO:0061575","molecular_function","cyclin-dependent protein serine/threonine kinase activator activity ","P14635"]
["GO:0005113","molecular_function","patched binding ","P14635; Q03135"]
["GO:0050840","molecular_function","extracellular matrix binding ","P05106; P04004"]
["GO:0003756","molecular_function","protein disulfide isomerase activity ","P05106; Q96HE7; P30101; Q9H3N1; Q15084"]
["GO:0043184","molecular_function","vascular endothelial growth factor receptor 2 binding ","P05106; Q5VWQ8"]
["GO:0005504","molecular_function","fatty acid binding ","P41235; P15090; P22392; Q5NUL3"]
["GO:0032036","molecular_function","myosin heavy chain binding ","P30530; P10916; Q14896; O14950"]
["GO:0061649","molecular_function","ubiquitin modification-dependent histone binding ","Q12888; Q99543; Q9Y4E8"]
["GO:0052659","molecular_function","inositol-1,3,4,-tetrakisphosphate -phosphatase activity ","O15357; Q92835; O43426"]
["GO:0034485","molecular_function","phosphatidylinositol-,,-trisphosphate -phosphatase activity ","O15357; Q92835"]
["GO:0004137","molecular_function","deoxycytidine kinase activity ","P27707"]
["GO:0019206","molecular_function","nucleoside kinase activity ","P27707; P04183"]
["GO:0070025","molecular_function","carbon monoxide binding ","P35520"]
["GO:0004122","molecular_function","cystathionine beta-synthase activity ","P35520"]
["GO:0072341","molecular_function","modified amino acid binding ","P35520; Q9NPH5; P42898"]
["GO:0070026","molecular_function","nitric oxide binding ","P35520; P09211"]
["GO:0050421","molecular_function","nitrite reductase (N-forming) activity ","P35520"]
["GO:0030170","molecular_function","pyridoxal phosphate binding ","P35520; Q6P996; Q8NHS2; P32929; P11216; O15269; P06737; Q99259; P11217"]
["GO:1904047","molecular_function","S-adenosyl-L-methionine binding ","P35520; Q86U44; Q9NR22; Q99873"]
["GO:0042134","molecular_function","rRNA primary transcript binding ","Q6NZI2"]
["GO:0030552","molecular_function","cAMP binding ","P13861; Q08499; P31323; Q9Y4G8; Q9Y3Q4; P10644; Q07343; Q9Y233; P27815; O95398; Q9UL51"]
["GO:0004862","molecular_function","cAMP-dependent protein kinase inhibitor activity ","P13861; P61925; P31323; Q9UD71; P10644"]
["GO:0008603","molecular_function","cAMP-dependent protein kinase regulator activity ","P13861; P31323; P10644; P54619"]
["GO:0031691","molecular_function","alpha-A adrenergic receptor binding ","P49407; P32121"]
["GO:0031692","molecular_function","alpha-B adrenergic receptor binding ","P49407; P08913; P32121"]
["GO:0031701","molecular_function","angiotensin receptor binding ","P49407; P32121"]
["GO:1990763","molecular_function","arrestin family protein binding ","P49407; P16220; P08172; P32121; Q96J02"]
["GO:0035615","molecular_function","clathrin adaptor activity ","P49407; P98082"]
["GO:0004857","molecular_function","enzyme inhibitor activity ","P49407; O14974; O00631; Q9H3M7; Q9UII2; Q9HAW7; P26678; P05408; Q8N163; P46531; P18545; O96018"]
["GO:0031762","molecular_function","follicle-stimulating hormone receptor binding ","P49407; P32121"]
["GO:0045309","molecular_function","protein phosphorylated amino acid binding ","P49407; P46108"]
["GO:0031896","molecular_function","V2 vasopressin receptor binding ","P49407"]
["GO:0001225","molecular_function","RNA polymerase II transcription coactivator binding ","P16220; O95644"]
["GO:0001190","molecular_function","transcriptional activator activity, RNA polymerase II transcription factor binding ","P16220; P05412; O15516; O00327; Q96RI1; P52952; Q14494; Q07869; O43474; P46531"]
["GO:0030695","molecular_function","TPase regulator activity ","P42768; O00401; Q12967; Q86UR5"]
["GO:0036459","molecular_function","thiol-dependent ubiquitinyl hydrolase activity ","Q9Y4A5; Q12962; Q9UPU5; Q96RU2; Q9Y2K6; Q86T82; Q70CQ2; Q9NQC7; Q13107; Q9Y5T5; P54252; P54578; O94782; P15374; Q9UK80; Q93009; Q14694; Q9UHP3; Q6GQQ9; Q9Y4E8"]
["GO:0008047","molecular_function","enzyme activator activity ","O60237; Q02156; Q05655; P13010; P35251; P55211; P60983; Q15750; Q16873; Q9UBU7; Q6R327; Q8IY92; Q9NPI6; O15519; Q9UJU6"]
["GO:0019208","molecular_function","phosphatase regulator activity ","O60237; O14974; O60315; Q9BZL4"]
["GO:0038132","molecular_function","neuregulin binding ","P21860"]
["GO:0005018","molecular_function","platelet-derived growth factor alpha-receptor activity ","P16234"]
["GO:0019215","molecular_function","intermediate filament binding ","P48681; P22392"]
["GO:0019955","molecular_function","cytokine binding ","P10721; P07333; Q99497; P15260"]
["GO:0005020","molecular_function","stem cell factor receptor activity ","P10721"]
["GO:0004111","molecular_function","creatine kinase activity ","O95819; P12277; P06732"]
["GO:0008469","molecular_function","histone-arginine N-methyltransferase activity ","O14744; Q86X55; Q96LA8; O60678; Q9NR22"]
["GO:0044020","molecular_function","histone methyltransferase activity (H-R3 specific) ","O14744; Q96LA8; Q99873"]
["GO:0008327","molecular_function","methyl-Cp binding ","O14744; Q9Y3Y2; Q9P1Z0; P26358; Q96T88; Q9BQA1; Q99626; O95983; Q9UIS9; P51608; Q99873"]
["GO:0008168","molecular_function","methyltransferase activity ","O14744; Q9NQV6; O75626; O60678; Q99873"]
["GO:0016274","molecular_function","protein-arginine N-methyltransferase activity ","O14744; Q86X55; Q9BQA1; Q96LA8; O60678; Q99873"]
["GO:0035243","molecular_function","protein-arginine omega-N symmetric methyltransferase activity ","O14744"]
["GO:1904713","molecular_function","beta-catenin destruction complex binding ","Q5S007"]
["GO:0030276","molecular_function","clathrin binding ","Q5S007; Q8IYJ3; Q9Y210; Q9H2B2; Q5T7P8; O60784; Q14677; P21579; O43581; Q9Y2J0; O75674; O00429; Q8N9I0; Q8IV01; P63010; P61601"]
["GO:0039706","molecular_function","co-receptor binding ","Q5S007"]
["GO:0034211","molecular_function","TP-dependent protein kinase activity ","Q5S007"]
["GO:0036479","molecular_function","peroxidase inhibitor activity ","Q5S007"]
["GO:0030159","molecular_function","receptor signaling complex scaffold activity ","Q5S007; P09693; P07766; O43566; P16333; Q8TDM6; O60271; Q9UPT6; P37198; Q86UL8; O15169"]
["GO:0000149","molecular_function","SNARE binding ","Q5S007; Q15836; Q16623; P53992; P56962; P21579; Q9P2Y5; P63027; P51809; P61764; P46459; O95295; Q96JG6; O75379; P61266"]
["GO:0017075","molecular_function","syntaxin- binding ","Q5S007; O75150; Q15836; Q9H2B2; O14810; P21579; Q5T5C0; P63027; P61764; P53355; P46459; O00186; P60880; P31645; Q6PUV4"]
["GO:0070300","molecular_function","phosphatidic acid binding ","P51178; Q9P0L2; Q9BR39; Q9Y4G8; O00562; Q8N3F8; Q92686; Q9BPZ7"]
["GO:0005149","molecular_function","interleukin- receptor binding ","Q9NWZ3; O60602; Q15654"]
["GO:0043425","molecular_function","bHLH transcription factor binding ","P84022; Q02779; Q96EB6; P15923; O00327; P15884; P50553; Q15853; P08047; O96004; P22415; Q13950; Q15672; P48436"]
["GO:0005518","molecular_function","collagen binding ","P84022; Q08345; Q16832; Q13153; P04004; Q8NC24; P16070; P14543; Q13485; P17301; O15105; Q8IUX7"]
["GO:0031962","molecular_function","mineralocorticoid receptor binding ","P84022"]
["GO:0015485","molecular_function","cholesterol binding ","Q03135; P49675; O00204; Q14849; P02649; P08133; Q14494; Q13133; O95477; P22307"]
["GO:0070320","molecular_function","inward rectifier potassium channel inhibitor activity ","Q03135"]
["GO:0016504","molecular_function","peptidase activator activity ","Q03135; P05067; Q9BXM7; O15519"]
["GO:0004445","molecular_function","inositol-polyphosphate -phosphatase activity ","Q92835"]
["GO:0016314","molecular_function","phosphatidylinositol-,,5-trisphosphate -phosphatase activity ","Q92835; P60484"]
["GO:0051425","molecular_function","PTB domain binding ","Q92835; P06213; P05067; P37198"]
["GO:0051525","molecular_function","NFAT protein binding ","P17947; Q16539; P43694; Q9BZS1; Q07869"]
["GO:0004634","molecular_function","phosphopyruvate hydratase activity ","P09104; P06733"]
["GO:0000774","molecular_function","adenyl-nucleotide exchange factor activity ","P07737; O95816; O95817; Q92598"]
["GO:0070577","molecular_function","lysine-acetylated histone binding ","P25440; O15164; P51532; Q9H8M2; Q86X55; Q9UIF9; Q9ULU4; Q03164; O60885"]
["GO:0001046","molecular_function","core promoter sequence-specific DNA binding ","P04637; Q13547; Q13118; P29375"]
["GO:0001094","molecular_function","TFIID-class transcription factor binding ","P04637; P22087; Q9Y230; P35869; Q9Y265"]
["GO:0001074","molecular_function","transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding involved in preinitiation complex assembly ","P04637"]
["GO:0051022","molecular_function","Rho DP-dissociation inhibitor binding ","P63000; P61586; P60953"]
["GO:0031996","molecular_function","thioesterase binding ","P63000; Q12933; Q9BUZ4; Q9Y4K3; Q13114; P08913; Q13077; P60953"]
["GO:0051020","molecular_function","TPase binding ","O75385; P06733; P07900; Q9C0C7; Q12904; Q9ULJ8; Q01082; Q9UJZ1; P21333; Q13439; P13796; P67809; P09496; P20936; Q99961; Q9HB90; Q676U5; P07814; Q01851; Q14457"]
["GO:0017022","molecular_function","myosin binding ","Q05682; Q9BRS8; Q16623; Q96J84; Q9Y6D6; Q9BV36; P68133; O60500; Q13049; P61586; Q96QT4; P11233; Q14896; P31645"]
["GO:0005523","molecular_function","tropomyosin binding ","Q05682; Q9NYL9; P45379; P45378; Q9ULZ3; P28289"]
["GO:0043559","molecular_function","insulin binding ","P08069; P06213; P27986"]
["GO:0005010","molecular_function","insulin-like growth factor-activated receptor activity ","P08069; P11717"]
["GO:0005520","molecular_function","insulin-like growth factor binding ","P08069; P17936; P08833"]
["GO:0031994","molecular_function","insulin-like growth factor I binding ","P08069; P06213; P17936; P08833"]
["GO:0035325","molecular_function","Toll-like receptor binding ","P43405; P16671"]
["GO:0031492","molecular_function","nucleosomal DNA binding ","P84243; P07910; P49450; P05114; Q15651; P18754; P82970; P68431; P05204; P52926; Q71DI3"]
["GO:0038062","molecular_function","protein tyrosine kinase collagen receptor activity ","Q08345; Q16832"]
["GO:0030549","molecular_function","acetylcholine receptor activator activity ","Q00535; P05067"]
["GO:0005176","molecular_function","ErbB-2 class receptor binding ","Q00535; Q96RT1; Q02297"]
["GO:0017034","molecular_function","Rap guanyl-nucleotide exchange factor activity ","Q13905; P62834; Q9Y4G8; O95398"]
["GO:0070851","molecular_function","growth factor receptor binding ","P06241; P12931; O14745; P05067"]
["GO:0031802","molecular_function","type 5 metabotropic glutamate receptor binding ","P06241; P04156"]
["GO:0030619","molecular_function","U snRNA binding ","P08621; Q93062; Q6P2Q9"]
["GO:1990446","molecular_function","U snRNP binding ","P08621; P62316"]
["GO:0008142","molecular_function","oxysterol binding ","P35398; P51449; P22059"]
["GO:0098531","molecular_function","transcription factor activity, direct ligand regulated sequence-specific DNA binding ","P35398; P51449"]
["GO:0071253","molecular_function","connexin binding ","P17302; P12931"]
["GO:0005243","molecular_function","gap junction channel activity ","P17302; P48165; Q9UKL4; P08034"]
["GO:0086075","molecular_function","gap junction channel activity involved in cardiac conduction electrical coupling ","P17302"]
["GO:1903763","molecular_function","gap junction channel activity involved in cell communication by electrical coupling ","P17302"]
["GO:0015075","molecular_function","ion transmembrane transporter activity ","P17302; Q14847; Q9Y5S1"]
["GO:1990782","molecular_function","protein tyrosine kinase binding ","P17302; Q14511; P60484; P54764; P07900; P51452; P46108; P20963; P41594; P13688; O75122; Q96P31; Q9NPH5; P01730"]
["GO:0010736","molecular_function","serum response element binding ","P11831; P52952"]
["GO:0001030","molecular_function","RNA polymerase III type  promoter DNA binding ","P42345; Q9H063; Q8N122"]
["GO:0001031","molecular_function","RNA polymerase III type 2 promoter DNA binding ","P42345; Q9H063; Q8N122"]
["GO:0001032","molecular_function","RNA polymerase III type  promoter DNA binding ","P42345; Q9H063; Q8N122"]
["GO:0001156","molecular_function","TFIIIC-class transcription factor binding ","P42345; Q8N122"]
["GO:0005011","molecular_function","macrophage colony-stimulating factor receptor activity ","P07333; Q04912"]
["GO:0048273","molecular_function","mitogen-activated protein kinase p binding ","Q16539; Q15750; O60271; O95644; Q9Y6W6; Q99873"]
["GO:0032405","molecular_function","MutLalpha complex binding ","Q13535; Q9NSU2; P12004"]
["GO:0032407","molecular_function","MutSalpha complex binding ","Q13535; Q9NSU2"]
["GO:0004505","molecular_function","phenylalanine -monooxygenase activity ","P00439; P61457"]
["GO:0045505","molecular_function","dynein intermediate chain binding ","P42858; Q9NP97; Q14204; P63167"]
["GO:0005522","molecular_function","profilin binding ","P42858; P50552; O43516; Q14247; P17081; P63261; Q16643"]
["GO:0034237","molecular_function","protein kinase A regulatory subunit binding ","P17612; P22694; P15311; Q99996; Q9BSF0; Q9Y6D6; Q92736; O43164; P51787; O43823; Q92667"]
["GO:0050811","molecular_function","ABA receptor binding ","P67775; Q15111; Q9H063; P18505"]
["GO:0050700","molecular_function","CARD domain binding ","O43353; Q7Z434; Q9BXL7; Q9H257"]
["GO:0089720","molecular_function","caspase binding ","O43353; Q13158; O60936; Q9NZS9"]
["GO:0008190","molecular_function","eukaryotic initiation factor 4E binding ","Q13541; Q04637; Q6PKG0; Q13542; O00571; Q03014"]
["GO:0030371","molecular_function","translation repressor activity ","Q13541; Q13542; Q06787; Q8WY41; P48200"]
["GO:0004519","molecular_function","endonuclease activity ","Q7KZF4; Q96T60; P39748; Q53H47; Q15631; Q13283; Q12972; P27695; Q96SD1"]
["GO:0004521","molecular_function","endoribonuclease activity ","Q7KZF4; Q5D1E8; O75460; Q9UKF6; Q9ULX3; Q9UKV8"]
["GO:0004518","molecular_function","nuclease activity ","Q7KZF4; P49959; Q9H0D6; O95551; O95453"]
["GO:1905172","molecular_function","RISC complex binding ","Q7KZF4"]
["GO:0000285","molecular_function","1-phosphatidylinositol-3-phosphate -kinase activity ","Q9Y2I7; O14986"]
["GO:0016308","molecular_function","-phosphatidylinositol-4-phosphate 5-kinase activity ","Q9Y2I7; P48426; O60331; O14986; P78356"]
["GO:0043813","molecular_function","phosphatidylinositol-,5-bisphosphate 5-phosphatase activity ","Q9Y2I7; O43426; O15056"]
["GO:0001162","molecular_function","RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding ","Q00613; Q9UIW0; Q15596"]
["GO:0098847","molecular_function","sequence-specific single stranded DNA binding ","Q00613; Q15365"]
["GO:0061770","molecular_function","translation elongation factor binding ","Q00613"]
["GO:0005497","molecular_function","androgen binding ","P10275"]
["GO:0004882","molecular_function","androgen receptor activity ","P10275; Q99801; Q14994"]
["GO:0070974","molecular_function","PU domain binding ","P10275"]
["GO:0070530","molecular_function","K6-linked polyubiquitin modification-dependent protein binding ","Q9Y6K9; Q96CV9; Q8WXE1; Q9NYJ8; Q13501; Q6GQQ9; Q6P2Q9; Q53GL7; Q96RL1"]
["GO:1990450","molecular_function","linear polyubiquitin binding ","Q9Y6K9"]
["GO:0004373","molecular_function","glycogen (starch) synthase activity ","P54840; P13807"]
["GO:0061547","molecular_function","glycogen synthase activity, transferring glucose--phosphate ","P54840; P13807"]
["GO:0070087","molecular_function","chromo shadow domain binding ","Q13263; Q6KC79; Q14739; P23497; Q13111"]
["GO:0035851","molecular_function","Krueppel-associated box domain binding ","Q13263; Q13547"]
["GO:0004129","molecular_function","cytochrome-c oxidase activity ","P00403"]
["GO:0001965","molecular_function","-protein alpha-subunit binding ","P53041; P28223; P41220; P81274; O43566; Q9NPQ8; P49795; P11717; P49798; O43665; P35372"]
["GO:0102391","molecular_function","decanoate-CoA ligase activity ","P33121"]
["GO:0004467","molecular_function","long-chain fatty acid-CoA ligase activity ","P33121"]
["GO:0042623","molecular_function","ATPase activity, coupled ","P08238; P07900; O75351; P0DMV8; P46459; P11142"]
["GO:0043008","molecular_function","ATP-dependent protein binding ","P08238; Q16623; Q9NYY3; P04156; Q9H3Z4"]
["GO:0002135","molecular_function","CTP binding ","P08238"]
["GO:0032564","molecular_function","dATP binding ","P08238; P10412"]
["GO:1990226","molecular_function","histone methyltransferase binding ","P08238; P83916; Q13185"]
["GO:0017098","molecular_function","sulfonylurea receptor binding ","P08238; Q15842"]
["GO:0030911","molecular_function","TPR domain binding ","P08238; P07900; Q9UNE7"]
["GO:0002134","molecular_function","UTP binding ","P08238"]
["GO:0005009","molecular_function","insulin-activated receptor activity ","P06213"]
["GO:0031995","molecular_function","insulin-like growth factor II binding ","P06213; P17936; P11717; P08833"]
["GO:0008656","molecular_function","cysteine-type endopeptidase activator activity involved in apoptotic process ","Q92934; O14727; P63244; Q9ULZ3; P42574; Q71UM5"]
["GO:0030346","molecular_function","protein phosphatase 2B binding ","Q92934; P19634; P00441; P23634"]
["GO:0051427","molecular_function","hormone receptor binding ","P12931; P15090"]
["GO:0046935","molecular_function","1-phosphatidylinositol--kinase regulator activity ","O00459; P27986; Q92569"]
["GO:0035276","molecular_function","ethanol binding ","Q02156"]
["GO:0030546","molecular_function","receptor activator activity ","Q02156; P05067"]
["GO:0010856","molecular_function","adenylate cyclase activator activity ","P04049; P0DP23"]
["GO:0008179","molecular_function","adenylate cyclase binding ","P04049; P0DP23; Q02952; Q08462; Q01518; P07550"]
["GO:0045294","molecular_function","alpha-catenin binding ","P35222; P49757; O14522; P19022; P18206; P14923; Q96IF1"]
["GO:0004971","molecular_function","AMPA glutamate receptor activity ","P42261; P48058; P42262"]
["GO:0005231","molecular_function","excitatory extracellular ligand-gated ion channel activity ","P42261; Q8NER1; P48058; P42262"]
["GO:0008066","molecular_function","glutamate receptor activity ","P42261; O43424; P41594; Q13255; Q14416; Q14831; Q14832"]
["GO:0099583","molecular_function","neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration ","P42261; P41594"]
["GO:0005134","molecular_function","interleukin-2 receptor binding ","P23771"]
["GO:0005008","molecular_function","hepatocyte growth factor-activated receptor activity ","P08581"]
["GO:0051717","molecular_function","inositol-,3,4,-tetrakisphosphate 3-phosphatase activity ","P60484"]
["GO:0035255","molecular_function","ionotropic glutamate receptor binding ","P60484; P78352; Q15078; Q15700; Q14160; Q14254; Q8NC67; Q9Y698; Q9BYB0; Q13501; Q12959; O75955; P14416; P46459; Q9UPX8; P27824; P20338; P35637; Q9Y566"]
["GO:0051800","molecular_function","phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity ","P60484"]
["GO:0004438","molecular_function","phosphatidylinositol--phosphatase activity ","P60484; O43426; Q13614; O15056"]
["GO:0008138","molecular_function","protein tyrosine/serine/threonine phosphatase activity ","P60484; P51452; Q8TE77; Q8WYL5; P28562; O95278; Q16828; Q13614; Q16690"]
["GO:1990381","molecular_function","ubiquitin-specific protease binding ","P60484; Q9UKV5; P55072; Q99497; P46379; Q15020; Q9Y3E7; Q00610; O60260"]
["GO:0051990","molecular_function","(R)-2-hydroxyglutarate dehydrogenase activity ","O75874"]
["GO:0004450","molecular_function","isocitrate dehydrogenase (NADP+) activity ","O75874"]
["GO:0051287","molecular_function","NAD binding ","O75874; P09622; P51649; P00338; Q13423; P40925; P56545; P07195; O60701; P31937; P04406; Q8N335; P05091; O43175; P09874; Q13363"]
["GO:0035014","molecular_function","phosphatidylinositol -kinase regulator activity ","P27986; O43474"]
["GO:0097161","molecular_function","DH domain binding ","P54764"]
["GO:0042731","molecular_function","PH domain binding ","P54764"]
["GO:0031369","molecular_function","translation initiation factor binding ","Q04637; Q6PKG0; Q13144; Q06787; O00303; O00571; Q13049; Q99613"]
["GO:1990814","molecular_function","DNA/DNA annealing activity ","P04083"]
["GO:0033676","molecular_function","double-stranded DNA-dependent ATPase activity ","P04083"]
["GO:0003727","molecular_function","single-stranded RNA binding ","P04083; O95786; Q9Y580; Q9HC52; O00257; P09651; Q9BYX4; P38159; Q00839; P26651; Q9UKV8"]
["GO:0034246","molecular_function","mitochondrial sequence-specific DNA-binding transcription factor activity ","O43524; Q00059"]
["GO:0001221","molecular_function","transcription cofactor binding ","O43524; Q16236; Q9UQB8; O43474"]
["GO:0003688","molecular_function","DNA replication origin binding ","P49736; O95251; P33992; P10809; Q13416; O43929; Q9Y5N6"]
["GO:0043515","molecular_function","kinetochore binding ","P33981; Q02224; Q9Y6D9"]
["GO:0030676","molecular_function","Rac guanyl-nucleotide exchange factor activity ","P15498; Q8TCU6; Q92974; O60229; Q9UKW4; Q13009; Q70Z35; Q9NR80"]
["GO:0005250","molecular_function","A-type (transient outward) potassium channel activity ","Q9NZV8; Q9NS61; Q9UK17"]
["GO:1905030","molecular_function","voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential ","Q9NZV8; Q09470"]
["GO:0005249","molecular_function","voltage-gated potassium channel activity ","Q9NZV8; O43525; Q12791; Q13563; P29973; P22459; Q9Y6H6; O43526; P22001; Q9Y3Q4; P16389; P51787; Q9NPC2; Q12809; Q13303; Q09470; P60880; Q03721; Q14654; Q9UL51"]
["GO:0004723","molecular_function","calcium-dependent protein serine/threonine phosphatase activity ","Q13555"]
["GO:0004357","molecular_function","glutamate-cysteine ligase activity ","P48506"]
["GO:0004883","molecular_function","glucocorticoid receptor activity ","P04150"]
["GO:0038050","molecular_function","RNA polymerase II transcription factor activity, glucocorticoid-activated sequence-specific DNA binding ","P04150"]
["GO:1990239","molecular_function","steroid hormone binding ","P04150; O00204; P05023"]
["GO:0004618","molecular_function","phosphoglycerate kinase activity ","P00558"]
["GO:0047134","molecular_function","protein-disulfide reductase activity ","P00558; P10599"]
["GO:0019912","molecular_function","cyclin-dependent protein kinase activating kinase activity ","P38936"]
["GO:0004861","molecular_function","cyclin-dependent protein serine/threonine kinase inhibitor activity ","P38936; P49918; P46527; O94992; P42771; P42574; Q0VD86; P55273"]
["GO:0004897","molecular_function","ciliary neurotrophic factor receptor activity ","P40189"]
["GO:0005127","molecular_function","ciliary neurotrophic factor receptor binding ","P40189; P42702"]
["GO:0019970","molecular_function","interleukin- binding ","P40189"]
["GO:0004921","molecular_function","interleukin- receptor activity ","P40189"]
["GO:0045509","molecular_function","interleukin-27 receptor activity ","P40189"]
["GO:0016887","molecular_function","ATPase activity ","P07900; Q13459; Q02224; Q99661; Q9NQT8; Q9UKV3; P35580; O75351; P19447; P54132; P17980; Q14807; P10809; P62195; Q96Q89; Q14240; P55072; Q9NQI0; P40692; P0DMV8; Q15058; P33527; O95235; O00571; Q9BW19; Q92878; P46459; P13569; O00139; O95477; P11142; Q8NE71; Q14204; P43686; Q9UPN3; Q8N4N8; Q14527; O00148; P35998; Q14191; P35579; Q9Y265; Q02241; P11021"]
["GO:0000166","molecular_function","nucleotide binding ","P07900; P49773; Q8NCW5; P81274; P04818; O60673; Q99741; O14727; P49789; Q8IW19; Q16526; Q9H9A7; Q9NPH5; P12268; Q96EP1; Q15722; P51858; P11217; O43929"]
["GO:0018024","molecular_function","histone-lysine N-methyltransferase activity ","Q15910; Q15291; Q8IZD2; Q9UPS6; Q03112; Q9NQR1; Q15047; Q96KQ7; Q9NRG4; O96028; Q03164; O14686"]
["GO:0042054","molecular_function","histone methyltransferase activity ","Q15910; Q86X55; Q15022; Q96LA8; Q99873"]
["GO:0046976","molecular_function","histone methyltransferase activity (H3-K2 specific) ","Q15910; Q96KQ7"]
["GO:0016279","molecular_function","protein-lysine N-methyltransferase activity ","Q15910; Q9NQR1; Q96KQ7; Q9NRG4; Q15306"]
["GO:0003878","molecular_function","ATP citrate synthase activity ","P53396"]
["GO:0048037","molecular_function","cofactor binding ","P53396; P04818; O15392; P29401; Q9NZC7"]
["GO:0017113","molecular_function","dihydropyrimidine dehydrogenase (NADP+) activity ","Q12882"]
["GO:0050473","molecular_function","arachidonate 1-lipoxygenase activity ","P35354"]
["GO:0016702","molecular_function","oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen ","P35354"]
["GO:0004601","molecular_function","peroxidase activity ","P35354; P30044; Q06830; Q9NRD9"]
["GO:0004666","molecular_function","prostaglandin-endoperoxide synthase activity ","P35354"]
["GO:0019888","molecular_function","protein phosphatase regulator activity ","P19525; Q14738; Q9UQK1; Q01105; Q13362; Q9Y570; Q9UD71; Q14CS0; Q96T49; P56211; Q9UNZ2; O43768; Q15435; Q86XL3; P30153; Q15172"]
["GO:0000375","biological_process","RNA splicing, via transesterification reactions ","Q15427; Q8IYB3; Q08170; Q99590; O75940; O75533; O43395; O00566; Q6P2Q9; Q92945; O75494"]
["GO:0031124","biological_process","mRNA '-end processing ","Q13242; Q9Y5S9; Q6UN15; Q8N684; P51003; Q9Y3Y2; Q8IYB3; Q9BY77; Q08170; Q96J01; Q12996; P38919; Q13243; Q01130; Q01081; Q96FV9; P26368; Q8NI27; Q9H0L4; Q05519; Q92620; Q92797; Q07955; Q13247; Q9P2I0; Q9UKF6; Q15287; O75152; Q13769; O00148; P52298; P33240; Q09161; Q86V81"]
["GO:0006376","biological_process","mRNA splice site selection ","Q13242; O60936; Q13243; Q92879; Q07955; Q13247; O95319; P38159; O75494; Q9Y383"]
["GO:0043279","biological_process","response to alkaloid ","Q13242"]
["GO:0097113","biological_process","AMPA glutamate receptor clustering ","P78352; P02649; Q9BYB0; Q8N2Q7"]
["GO:0002091","biological_process","negative regulation of receptor internalization ","P78352; O00560; P30533; Q13614"]
["GO:0099645","biological_process","neurotransmitter receptor localization to postsynaptic specialization membrane ","P78352; Q15700; Q9Y698; Q12959"]
["GO:0150012","biological_process","positive regulation of neuron projection arborization ","P78352; O14640; Q92997; O14641"]
["GO:0050806","biological_process","positive regulation of synaptic transmission ","P78352; Q13002; P43003; P21579"]
["GO:0097120","biological_process","receptor localization to synapse ","P78352; Q15700; Q14160; P58400; Q12959; Q8N2Q7"]
["GO:2000821","biological_process","regulation of grooming behavior ","P78352; Q9ULB1; P32245"]
["GO:0016188","biological_process","synaptic vesicle maturation ","P78352; P61764; O95295"]
["GO:0071625","biological_process","vocalization behavior ","P78352; Q9P2S2; Q9ULB1; P58400; Q9BYB0; Q9UPX8; Q8N0W4; Q9Y566"]
["GO:0035385","biological_process","Roundabout signaling pathway ","Q13459; Q96MS0; Q9Y6N7; P61586"]
["GO:0048588","biological_process","developmental cell growth ","O95376"]
["GO:0070936","biological_process","protein K48-linked ubiquitination ","O95376; Q96PU5; O95071; Q9UH77; Q9UKV5; P53804; Q9NS56; P78317; Q96FA3; Q9NZS9; Q8IYU2; P49427; P63146; Q712K3; Q05086; P49459; P61086; Q96J02; Q8ND25; O60260"]
["GO:0070534","biological_process","protein K6-linked ubiquitination ","O95376; Q15819; Q12933; P78317; Q96FA3; Q8N2H9; Q9NZS9; Q9UMS4; Q9Y4K3; P63146; Q96JP5; Q16763; Q9UNE7; Q13404; P61088; Q8N726; P46934; Q96J02; O60260; Q9C0C9"]
["GO:0016338","biological_process","calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules ","O00501; O95471; O15551; O14493; Q9Y5I7"]
["GO:1903142","biological_process","positive regulation of establishment of endothelial barrier ","O00501; P35611; P33151"]
["GO:0034628","biological_process","'de novo' NAD biosynthetic process from aspartate ","Q9HAN9"]
["GO:1990966","biological_process","ATP generation from poly-ADP-D-ribose ","Q9HAN9; P09874"]
["GO:0009435","biological_process","NAD biosynthetic process ","Q9HAN9"]
["GO:0019674","biological_process","NAD metabolic process ","Q9HAN9; P00338; P07195; Q8N335"]
["GO:0061053","biological_process","somite development ","Q7Z6E9; Q8WUM0; P50221"]
["GO:0042407","biological_process","cristae formation ","Q16891; O95202; Q9NX63; P36542; Q16635; P18859; P56134"]
["GO:0051560","biological_process","mitochondrial calcium ion homeostasis ","Q16891; O95202; P08133; Q6J4K2"]
["GO:0060236","biological_process","regulation of mitotic spindle organization ","Q9ULW0; P81274; Q9Y6A5; Q6PGQ7; Q14203; Q49MG5; Q14204; P37198; P98161; Q14980; Q00610"]
["GO:0006893","biological_process","olgi to plasma membrane transport ","Q96QF0; P50570; Q15334"]
["GO:0033365","biological_process","protein localization to organelle ","Q96QF0; P26367; Q5TZA2; P50461; Q9BV73"]
["GO:0045661","biological_process","regulation of myoblast differentiation ","Q15650; Q8IZQ8; Q14254; Q07352"]
["GO:0010038","biological_process","response to metal ion ","P04731; Q96PU5; Q92597; Q9NQX3; Q16143"]
["GO:0072377","biological_process","blood coagulation, common pathway ","P02671"]
["GO:0072378","biological_process","blood coagulation, fibrin clot formation ","P02671"]
["GO:0043152","biological_process","induction of bacterial agglutination ","P02671; Q9UGM3"]
["GO:2000261","biological_process","negative regulation of blood coagulation, common pathway ","P02671"]
["GO:0045921","biological_process","positive regulation of exocytosis ","P02671; Q5T5C0; O75122; P13569; P20339"]
["GO:0090277","biological_process","positive regulation of peptide hormone secretion ","P02671"]
["GO:0043687","biological_process","post-translational protein modification ","P02671; Q15291; O14818; Q9UKT5; Q8N1E6; P23327; Q8N3Y1; P01009; Q14145; Q9GZV9; Q9NRJ4; Q9UH77; P02765; P09382; P17980; Q06481; Q9BW61; O15240; Q9H0H3; Q9H1Y0; Q13098; P14625; P19022; P11047; P62195; Q7L5N1; P61289; Q16665; O76061; O14543; Q9UBF6; Q969U6; P14314; P02649; Q8TAA3; Q99460; Q13200; Q9NZJ0; Q99814; P17936; Q8NHY2; P15374; Q5XUX0; P05067; P62491; P62820; P41002; P25788; O00255; Q93034; P20339; P43686; Q9UNS2; P34741; P08833; Q96Q27; Q16531; Q05516; Q96AD5; Q13309; P60900; P40337; P00450; Q8WWI1; Q15084; P35998; P12259; Q15293; O43852; Q9Y2N7; Q8TCJ2; Q969H0; P05060; O00231"]
["GO:0051258","biological_process","protein polymerization ","P02671; P04004; P07196; P31415; O14958; Q9Y3E7"]
["GO:0046618","biological_process","drug export ","O75469"]
["GO:0008202","biological_process","steroid metabolic process ","O75469; O00204; P05093; Q14849; P08684; P20813; P20815; Q9NZC7; Q9BR01"]
["GO:0042908","biological_process","xenobiotic transport ","O75469; P33527"]
["GO:0070979","biological_process","protein K11-linked ubiquitination ","Q13042; P78317; Q9UJX5; Q9H1A4; Q9UJX3; Q8NHZ8; P68036; P63146; Q16763; Q9UJX2; P49459; P30260; Q9UM11; O60260"]
["GO:0038001","biological_process","paracrine signaling ","P06401; P28906; P09038; Q8N884"]
["GO:0048149","biological_process","behavioral response to ethanol ","Q92769; P14416; P35372"]
["GO:0003300","biological_process","cardiac muscle hypertrophy ","Q92769; Q8WZ42; Q92736; P50461; O15273; Q13009"]
["GO:0009913","biological_process","epidermal cell differentiation ","Q92769; P08151; Q13547; P10070; O43474"]
["GO:0061198","biological_process","fungiform papilla formation ","Q92769; Q13547"]
["GO:0060789","biological_process","hair follicle placode formation ","Q92769; Q13547"]
["GO:0061000","biological_process","negative regulation of dendritic spine development ","Q92769; Q9NYY3; P02649; Q9ULH1"]
["GO:2000757","biological_process","negative regulation of peptidyl-lysine acetylation ","Q92769; Q96EB6"]
["GO:0032732","biological_process","positive regulation of interleukin-1 production ","Q92769; Q8TDQ0; O00206"]
["GO:0010870","biological_process","positive regulation of receptor biosynthetic process ","Q92769; Q13547; Q16665; Q9UBN7; Q13133"]
["GO:0086024","biological_process","adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate ","Q08499"]
["GO:0071875","biological_process","adrenergic receptor signaling pathway ","Q08499; Q12802; P14416; P08913; P07550"]
["GO:0006198","biological_process","cAMP catabolic process ","Q08499; Q08493; Q07343; Q9Y233; P27815"]
["GO:0043951","biological_process","negative regulation of cAMP-mediated signaling ","Q08499; P41220; Q13370; Q6UUV7; P49427; P63146; Q14432; Q9Y233; P35372"]
["GO:1901898","biological_process","negative regulation of relaxation of cardiac muscle ","Q08499; Q07343"]
["GO:0099156","biological_process","cell-cell signaling via exosome ","Q13887"]
["GO:1901653","biological_process","cellular response to peptide ","Q13887; P41180; Q13118; Q13351; O43474; P57682; P41134"]
["GO:0060576","biological_process","intestinal epithelial cell development ","Q13887; O75626; O95238"]
["GO:0032534","biological_process","regulation of microvillus assembly ","Q13887; Q13393; Q16658; O00592"]
["GO:1902275","biological_process","regulation of chromatin organization ","P46013; Q00839"]
["GO:0072365","biological_process","regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter ","Q9Y618"]
["GO:0015991","biological_process","ATP hydrolysis coupled proton transport ","P38606; P20648"]
["GO:0036295","biological_process","cellular response to increased oxygen levels ","P38606"]
["GO:0002181","biological_process","cytoplasmic translation ","P62917; P60866; P05387; P23396; P84098; P62913; Q07020"]
["GO:0097402","biological_process","neuroblast migration ","Q9NTI5"]
["GO:0042094","biological_process","interleukin- biosynthetic process ","Q96IZ0"]
["GO:0042130","biological_process","negative regulation of T cell proliferation ","Q96IZ0; P17676; P16150; O76074; Q8TDQ0; Q96FA3; Q8TDM6; Q9BZS1; Q12959; P01589; Q9Y6D9; P31431; P29350; P16410"]
["GO:0042986","biological_process","positive regulation of amyloid precursor protein biosynthetic process ","Q96IZ0"]
["GO:0016553","biological_process","base conversion or substitution editing ","Q9HC16"]
["GO:0009972","biological_process","cytidine deamination ","Q9HC16"]
["GO:0070383","biological_process","DNA cytosine deamination ","Q9HC16"]
["GO:0010529","biological_process","negative regulation of transposition ","Q9HC16; Q9NQI0; P10243"]
["GO:0048525","biological_process","negative regulation of viral process ","Q9HC16"]
["GO:1904527","biological_process","negative regulation of microtubule binding ","P11137"]
["GO:2000575","biological_process","negative regulation of microtubule motor activity ","P11137"]
["GO:1901953","biological_process","positive regulation of anterograde dense core granule transport ","P11137"]
["GO:1903744","biological_process","positive regulation of anterograde synaptic vesicle transport ","P11137"]
["GO:1902513","biological_process","regulation of organelle transport along microtubule ","P11137; P12036; Q8IXI2"]
["GO:0021696","biological_process","cerebellar cortex morphogenesis ","P08151; P10070"]
["GO:0009953","biological_process","dorsal/ventral pattern formation ","P08151; P31270; Q16828; Q9UMR3"]
["GO:0060032","biological_process","notochord regression ","P08151; P10070"]
["GO:0009954","biological_process","proximal/distal pattern formation ","P08151; P10070; P31270; P31269; P40425; O75096; P10071; Q9H3D4; P31260"]
["GO:2000345","biological_process","regulation of hepatocyte proliferation ","P08151"]
["GO:0021938","biological_process","smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation ","P08151; P10070"]
["GO:0007418","biological_process","ventral midline development ","P08151; P10070"]
["GO:0070562","biological_process","regulation of vitamin D receptor signaling pathway ","O15164; Q13573; Q15648"]
["GO:0036031","biological_process","recruitment of mRNA capping enzyme to RNA polymerase II holoenzyme complex ","Q9BTL3"]
["GO:0106005","biological_process","RNA '-cap (guanine-N7)-methylation ","Q9BTL3"]
["GO:0048791","biological_process","calcium ion-regulated exocytosis of neurotransmitter ","Q8IYJ3; Q9H2B2; Q5T7P8; P21579; O43581; Q9Y2J0; Q86UR5; Q8N9I0; Q8IV01; P61266"]
["GO:0017158","biological_process","regulation of calcium ion-dependent exocytosis ","Q8IYJ3; Q5T7P8; P21579; O43581; Q9Y2J0; Q8N9I0; Q8IV01; Q9H1D0"]
["GO:0060088","biological_process","auditory receptor cell stereocilium organization ","Q9NZA1; O14745; Q14160; P00441; Q9H2D6"]
["GO:1902476","biological_process","chloride transmembrane transport ","Q9NZA1; P41180; P48167; P28472; P18507; P43003; P51790; P18505; Q5XXA6; P43005; P13569; P47870; P14867"]
["GO:0000045","biological_process","autophagosome assembly ","Q9C0C7; Q9Y4P1; Q86VP3; Q9H1Y0; Q96BY7; Q14CS0; P49768; Q9Y4P8; P62820; Q9UNZ2; Q9UMX0; Q9GZQ8; Q8NEB9; Q9NT62; O75143; Q7Z3C6; Q9H492; Q676U5; Q14457"]
["GO:0000423","biological_process","mitophagy ","Q9C0C7; Q13501; O75143; O60260; Q14457"]
["GO:0098780","biological_process","response to mitochondrial depolarisation ","Q9C0C7; Q13501; O75143; Q14457"]
["GO:0098779","biological_process","positive regulation of mitophagy in response to mitochondrial depolarization ","Q16543; Q9BXM7; O60260"]
["GO:0095500","biological_process","acetylcholine receptor signaling pathway ","P36544; P43681"]
["GO:0140059","biological_process","dendrite arborization ","P36544"]
["GO:0097061","biological_process","dendritic spine organization ","P36544; Q99538; Q9NRD5"]
["GO:0098815","biological_process","modulation of excitatory postsynaptic potential ","P36544; P05067; Q9ULU4; Q99961"]
["GO:1905920","biological_process","positive regulation of CoA-transferase activity ","P36544"]
["GO:1905906","biological_process","regulation of amyloid fibril formation ","P36544; P02649; P05067"]
["GO:1902991","biological_process","regulation of amyloid precursor protein catabolic process ","P36544"]
["GO:1905144","biological_process","response to acetylcholine ","P36544"]
["GO:0050893","biological_process","sensory processing ","P36544"]
["GO:0007614","biological_process","short-term memory ","P36544; Q9H2P0; P36955"]
["GO:0002377","biological_process","immunoglobulin production ","P16871; Q96BF3; Q9BXL7"]
["GO:0048535","biological_process","lymph node development ","P16871; Q13158; O94900; P06746; Q5TC82; Q9Y572; P51449"]
["GO:1904894","biological_process","positive regulation of STAT cascade ","P16871"]
["GO:0033089","biological_process","positive regulation of T cell differentiation in thymus ","P16871; P10070; O95267"]
["GO:0000018","biological_process","regulation of DNA recombination ","P16871; Q9H4L7; P52294; Q96FV9; P52292; Q86V81"]
["GO:0051014","biological_process","actin filament severing ","Q13045; P09327; P60981; P06396"]
["GO:0051568","biological_process","histone H3-K4 methylation ","Q15291; Q9P0U4; Q53H47; Q9UPS6; Q03164; O14686"]
["GO:0021984","biological_process","adenohypophysis development ","Q14469; Q01959; P14416; P48431"]
["GO:0035910","biological_process","ascending aorta morphogenesis ","Q14469"]
["GO:0042668","biological_process","auditory receptor cell fate determination ","Q14469; Q92858"]
["GO:0061309","biological_process","cardiac neural crest cell development involved in outflow tract morphogenesis ","Q14469; P61296"]
["GO:0072049","biological_process","comma-shaped body morphogenesis ","Q14469"]
["GO:0061009","biological_process","common bile duct development ","Q14469"]
["GO:0090162","biological_process","establishment of epithelial cell polarity ","Q14469; Q8TEW0; O43739; Q15438"]
["GO:0021575","biological_process","hindbrain morphogenesis ","Q14469; Q96QB1"]
["GO:0060122","biological_process","inner ear receptor cell stereocilium organization ","Q14469; Q9ULK5; P31431"]
["GO:0046331","biological_process","lateral inhibition ","Q14469"]
["GO:0072282","biological_process","metanephric nephron tubule morphogenesis ","Q14469"]
["GO:0021555","biological_process","midbrain-hindbrain boundary morphogenesis ","Q14469"]
["GO:2000978","biological_process","negative regulation of forebrain neuron differentiation ","Q14469"]
["GO:0060253","biological_process","negative regulation of glial cell proliferation ","Q14469; O14746; P46531"]
["GO:0045608","biological_process","negative regulation of inner ear auditory receptor cell differentiation ","Q14469; P46531"]
["GO:2000227","biological_process","negative regulation of pancreatic A cell differentiation ","Q14469"]
["GO:2000974","biological_process","negative regulation of pro-B cell differentiation ","Q14469; P46531"]
["GO:0061106","biological_process","negative regulation of stomach neuroendocrine cell differentiation ","Q14469"]
["GO:0021557","biological_process","oculomotor nerve development ","Q14469"]
["GO:0045977","biological_process","positive regulation of mitotic cell cycle, embryonic ","Q14469"]
["GO:0045598","biological_process","regulation of fat cell differentiation ","Q14469; Q9UBN7; P51449; P20393"]
["GO:0003266","biological_process","regulation of secondary heart field cardioblast proliferation ","Q14469; P61296"]
["GO:0060164","biological_process","regulation of timing of neuron differentiation ","Q14469"]
["GO:0072141","biological_process","renal interstitial fibroblast development ","Q14469"]
["GO:0072050","biological_process","S-shaped body morphogenesis ","Q14469"]
["GO:0021537","biological_process","telencephalon development ","Q14469; P32418; Q14524; Q92686"]
["GO:0021558","biological_process","trochlear nerve development ","Q14469"]
["GO:0060675","biological_process","ureteric bud morphogenesis ","Q14469; P09758"]
["GO:0097084","biological_process","vascular smooth muscle cell development ","Q14469; P17813"]
["GO:0006635","biological_process","fatty acid beta-oxidation ","Q16836; P55084; P50416; P24752"]
["GO:0120183","biological_process","positive regulation of focal adhesion disassembly ","P51452"]
["GO:0097091","biological_process","synaptic vesicle clustering ","O14994; P58400; Q92777; P17600; Q8N2Q7"]
["GO:0007193","biological_process","adenylate cyclase-inhibiting -protein coupled receptor signaling pathway ","P41180; P41143; P41146; O60266; Q08828; P17342; Q9NPQ8; P19086; P04899; P28222; Q02952; Q9UBS5; O43306; Q08462; P05067; P21453; P41145; P08913; Q14831; P40145; Q9H244; P30874"]
["GO:0032782","biological_process","bile acid secretion ","P41180; O14745; Q9Y365"]
["GO:0071305","biological_process","cellular response to vitamin D ","P41180; Q9GZV9"]
["GO:0005513","biological_process","detection of calcium ion ","P41180; Q9NS61; P0DP23; P21579; Q92736; Q13586; O14958"]
["GO:0060613","biological_process","fat pad development ","P41180; Q9BZK7"]
["GO:0007340","biological_process","acrosome reaction ","P48167; O60266; Q9NQ86; Q05952; Q9BRC7"]
["GO:0097112","biological_process","gamma-aminobutyric acid receptor clustering ","P48167; P58400; Q9NQX3"]
["GO:0060013","biological_process","righting reflex ","P48167; Q9Y566"]
["GO:0060012","biological_process","synaptic transmission, glycinergic ","P48167"]
["GO:0071474","biological_process","cellular hyperosmotic response ","P11166; P29972; P16989; Q92974; Q6JBY9; Q9UJM3"]
["GO:1904659","biological_process","glucose transmembrane transport ","P11166; P14672; P11168"]
["GO:0005989","biological_process","lactose biosynthetic process ","P11166"]
["GO:1904016","biological_process","response to Thyroglobulin triiodothyronine ","P11166"]
["GO:0006956","biological_process","complement activation ","P00736; Q9H4X1"]
["GO:0006958","biological_process","complement activation, classical pathway ","P00736; P15529; Q07021"]
["GO:0030449","biological_process","regulation of complement activation ","P00736; P04004; P15391; P15529; P21730; Q07021"]
["GO:0031638","biological_process","zymogen activation ","P00736; P09958; P50281"]
["GO:1902686","biological_process","mitochondrial outer membrane permeabilization involved in programmed cell death ","P30405"]
["GO:0032780","biological_process","negative regulation of ATPase activity ","P30405; P45379; P19429; Q9UII2; P26678; Q7Z7A4; Q92574; Q15417"]
["GO:0090324","biological_process","negative regulation of oxidative phosphorylation ","P30405; Q9NP71; P61586"]
["GO:2000276","biological_process","negative regulation of oxidative phosphorylation uncoupler activity ","P30405; Q15672"]
["GO:0000413","biological_process","protein peptidyl-prolyl isomerization ","P30405; P49792; Q9UNP9; Q13526"]
["GO:1902445","biological_process","regulation of mitochondrial membrane permeability involved in programmed necrotic cell death ","P30405; Q07812"]
["GO:0010939","biological_process","regulation of necrotic cell death ","P30405"]
["GO:0010849","biological_process","regulation of proton-transporting ATPase activity, rotational mechanism ","P30405"]
["GO:0030239","biological_process","myofibril assembly ","Q9NYL9; P28289"]
["GO:0051694","biological_process","pointed-end actin filament capping ","Q9NYL9; P28289"]
["GO:1901992","biological_process","positive regulation of mitotic cell cycle phase transition ","Q9NYL9"]
["GO:0048739","biological_process","cardiac muscle fiber development ","P35749; Q8WZ42; O15273"]
["GO:0048251","biological_process","elastic fiber assembly ","P35749; Q04656"]
["GO:0030241","biological_process","skeletal muscle myosin thick filament assembly ","P35749; Q8WZ42; O15273"]
["GO:0019886","biological_process","antigen processing and presentation of exogenous peptide antigen via MHC class II ","Q02224; Q99661; Q14807; P53992; P50570; Q9H0H5; Q15436; P30273; Q9Y4K3; Q14203; Q07866; Q99962; P27824; O00139; P31994; Q9H0B6; Q14204; P63167; Q8N4N8; P47756; O95239; Q96CW1; Q9Y6G9; Q13409; P52907; P09496; Q9Y496; P63010; P52732; O00399; Q00610; Q99538; Q02241"]
["GO:0051315","biological_process","attachment of mitotic spindle microtubules to kinetochore ","Q02224; Q03188; Q99661; Q96JM3; Q9Y6D9; Q9H211; O14777"]
["GO:0051382","biological_process","kinetochore assembly ","Q02224; Q03188; P49450; Q8N2Z9; Q7Z3K3"]
["GO:0099607","biological_process","lateral attachment of mitotic spindle microtubules to kinetochore ","Q02224"]
["GO:0051310","biological_process","metaphase plate congression ","Q02224; Q99661; Q7L2Z9; Q14807; P55040; Q8N4N8; O14777"]
["GO:0007018","biological_process","microtubule-based movement ","Q02224; Q9NP97; Q99661; Q9NQT8; Q14807; Q96Q89; Q9H0H5; Q9P2E2; Q15058; O95235; Q9BW19; Q07866; O00139; Q9H0B6; Q8N4N8; O95239; Q9Y6G9; Q13409; Q9Y496; P52732; P33176; O60282; Q02241"]
["GO:0099606","biological_process","microtubule plus-end directed mitotic chromosome migration ","Q02224"]
["GO:0007079","biological_process","mitotic chromosome movement towards spindle pole ","Q02224; Q15398"]
["GO:0006259","biological_process","DNA metabolic process ","Q9NSU2; P62826; P52292; Q92614; P04183; O94762; Q14191; Q92547; Q9NZC9; Q66K74"]
["GO:0071651","biological_process","positive regulation of chemokine (C-C motif) ligand  production ","Q7Z434; Q9HBA0; O00571; Q86XR7"]
["GO:0035549","biological_process","positive regulation of interferon-beta secretion ","Q7Z434; O95786; Q9BYX4"]
["GO:0071660","biological_process","positive regulation of IP- production ","Q7Z434"]
["GO:0060760","biological_process","positive regulation of response to cytokine stimulus ","Q7Z434; O95786; Q9BYX4"]
["GO:1900063","biological_process","regulation of peroxisome organization ","Q7Z434; Q9GZY8; O00429"]
["GO:0006659","biological_process","phosphatidylserine biosynthetic process ","O15162"]
["GO:0017121","biological_process","phospholipid scrambling ","O15162; Q9NRY6"]
["GO:2000373","biological_process","positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity ","O15162; Q53H47; Q96T88; Q00839"]
["GO:0045089","biological_process","positive regulation of innate immune response ","O15162; P08253; P05423"]
["GO:0030574","biological_process","collagen catabolic process ","P09958; P08253; Q13444; P50281"]
["GO:0070268","biological_process","cornification ","P09958; P05787; P14923; Q04695; P35900; P08727; P08729; P05783; P15924"]
["GO:0090472","biological_process","dibasic protein processing ","P09958"]
["GO:0022617","biological_process","extracellular matrix disassembly ","P09958; P16070; P11047; P00747; Q8NFA2; A1X283; P17813; O75955; P13796; P08253; Q13444; P50281; Q8IYI6"]
["GO:0032911","biological_process","negative regulation of transforming growth factor beta production ","P09958; Q92908"]
["GO:0032902","biological_process","nerve growth factor production ","P09958"]
["GO:0043043","biological_process","peptide biosynthetic process ","P09958"]
["GO:0016486","biological_process","peptide hormone processing ","P09958; P0DN86; P42892; P05408"]
["GO:0051044","biological_process","positive regulation of membrane protein ectodomain proteolysis ","P09958; P02649; P05067; P80108; P01375; P08913; P20333"]
["GO:0016485","biological_process","protein processing ","P09958; Q92542; P42892; Q8IUX7; P49768; P49810; Q8NEB9; P13726; P42574; P10071; P42575; P50281; O15294"]
["GO:0052548","biological_process","regulation of endopeptidase activity ","P09958; P25788"]
["GO:0051004","biological_process","regulation of lipoprotein lipase activity ","P09958"]
["GO:0045714","biological_process","regulation of low-density lipoprotein particle receptor biosynthetic process ","P09958"]
["GO:0006465","biological_process","signal peptide processing ","P09958"]
["GO:0019058","biological_process","viral life cycle ","P09958; Q96PU5; O75351; P62979; P0CG47; Q9Y3E7; Q8WUX9; P62987; Q96CF2"]
["GO:0019082","biological_process","viral protein processing ","P09958"]
["GO:0097341","biological_process","zymogen inhibition ","P09958"]
["GO:0045176","biological_process","apical protein localization ","Q9NYQ6; P35241; Q8TDM6; Q9ULK5"]
["GO:0048105","biological_process","establishment of body hair planar orientation ","Q9NYQ6; Q9ULK5"]
["GO:0001736","biological_process","establishment of planar polarity ","Q9NYQ6; Q9ULK5; Q9H3D4"]
["GO:0042249","biological_process","establishment of planar polarity of embryonic epithelium ","Q9NYQ6"]
["GO:0060490","biological_process","lateral sprouting involved in lung morphogenesis ","Q9NYQ6; Q9ULK5"]
["GO:0060488","biological_process","orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis ","Q9NYQ6; Q9ULK5"]
["GO:0090179","biological_process","planar cell polarity pathway involved in neural tube closure ","Q9NYQ6; O14640; Q92997; Q9ULK5; O14641"]
["GO:0060489","biological_process","planar dichotomous subdivision of terminal units involved in lung branching morphogenesis ","Q9NYQ6; Q9ULK5"]
["GO:0090251","biological_process","protein localization involved in establishment of planar polarity ","Q9NYQ6"]
["GO:0016584","biological_process","nucleosome positioning ","P16403; Q96T23; P49711; P10412"]
["GO:0009785","biological_process","blue light signaling pathway ","Q49AN0; Q16526"]
["GO:2000323","biological_process","negative regulation of glucocorticoid receptor signaling pathway ","Q49AN0; O15516; O00327; Q16526; P35232; O15534"]
["GO:0018298","biological_process","protein-chromophore linkage ","Q49AN0; Q16526; Q9UHM6; P08100"]
["GO:2000118","biological_process","regulation of sodium-dependent phosphate transport ","Q49AN0"]
["GO:0009060","biological_process","aerobic respiration ","P40926; P04040; Q9NTG7"]
["GO:0006108","biological_process","malate metabolic process ","P40926; P40925; P07954"]
["GO:0006734","biological_process","NADH metabolic process ","P40926; Q8NCW5; P55072; P40925; Q8N335"]
["GO:0061462","biological_process","protein localization to lysosome ","Q9P0V3; O43504; Q5T011"]
["GO:0007501","biological_process","mesodermal cell fate specification ","O00167; Q99502; Q02962; P31270"]
["GO:0097345","biological_process","mitochondrial outer membrane permeabilization ","O00167; Q8IXI2; P55957"]
["GO:0014706","biological_process","striated muscle tissue development ","O00167; Q99502"]
["GO:0010501","biological_process","RNA secondary structure unwinding ","Q9NUU7; P17844; Q9UHI6; P38919; Q9Y2R4; Q9UMR2; Q14240; Q9NQI0; Q9UHL0; Q9GZR7; O00571; Q92841; O00148; Q9UJV9; P26196; Q9UKV8; Q9H0S4; O15523"]
["GO:0071897","biological_process","DNA biosynthetic process ","O14746; P04818; P18858; P35232; P49916; Q9UGP5; P04183; P49917; Q5TKA1"]
["GO:0022616","biological_process","DNA strand elongation ","O14746"]
["GO:0070200","biological_process","establishment of protein localization to telomere ","O14746; Q9BQ15; P51587; Q96AP0"]
["GO:1903704","biological_process","negative regulation of production of siRNA involved in RNA interference ","O14746"]
["GO:0042635","biological_process","positive regulation of hair cycle ","O14746"]
["GO:1904751","biological_process","positive regulation of protein localization to nucleolus ","O14746; Q96D46; Q96BK5; Q96EZ8"]
["GO:1903620","biological_process","positive regulation of transdifferentiation ","O14746"]
["GO:0030422","biological_process","production of siRNA involved in RNA interference ","O14746; Q15633; Q9NRR4; Q9UKV8"]
["GO:0032774","biological_process","RNA biosynthetic process ","O14746"]
["GO:0006278","biological_process","RNA-dependent DNA biosynthetic process ","O14746; Q15554"]
["GO:0001172","biological_process","transcription, RNA-templated ","O14746"]
["GO:0032274","biological_process","gonadotropin secretion ","Q96TA1"]
["GO:0040019","biological_process","positive regulation of embryonic development ","Q96TA1; Q9Y261; Q9Y4C8; Q9NQ66; Q4VCS5"]
["GO:0051168","biological_process","nuclear export ","Q9H814; Q12802; P09651; P54253; P52298; Q09161"]
["GO:0006408","biological_process","snRNA export from nucleus ","Q9H814; P52298"]
["GO:0007292","biological_process","female gamete generation ","P0DN86; Q14106; Q17R91; P0DN87; O95453; P23945"]
["GO:0014824","biological_process","artery smooth muscle contraction ","P28223"]
["GO:0051967","biological_process","negative regulation of synaptic transmission, glutamatergic ","P28223; Q13002; P28222; P14416"]
["GO:0007208","biological_process","phospholipase C-activating serotonin receptor signaling pathway ","P28223"]
["GO:0010513","biological_process","positive regulation of phosphatidylinositol biosynthetic process ","P28223"]
["GO:0044380","biological_process","protein localization to cytoskeleton ","P28223"]
["GO:0007210","biological_process","serotonin receptor signaling pathway ","P28223"]
["GO:0014832","biological_process","urinary bladder smooth muscle contraction ","P28223; Q9UBL9"]
["GO:0097049","biological_process","motor neuron apoptotic process ","Q13158"]
["GO:0070236","biological_process","negative regulation of activation-induced cell death of T cells ","Q13158; Q99576; Q9Y3Q8"]
["GO:2000454","biological_process","positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation ","Q13158"]
["GO:0036462","biological_process","TRAIL-activated apoptotic signaling pathway ","Q13158; Q14790"]
["GO:0000462","biological_process","maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) ","Q9NQZ2; Q9Y5J1; Q2NL82; Q13895; Q9BVI4; P39019"]
["GO:0043268","biological_process","positive regulation of potassium ion transport ","Q13642; Q9UEW8; Q12959; P08913; P21728; P33176"]
["GO:1901016","biological_process","regulation of potassium ion transmembrane transporter activity ","Q13642; Q96PU5; P62258; Q01668; P46934"]
["GO:0030195","biological_process","negative regulation of blood coagulation ","P04004; P28906; P02649; P10646"]
["GO:0090103","biological_process","cochlea morphogenesis ","Q99502; O14640; Q02962; P37275; P10070; Q92886; Q9ULK5; O14641; Q8NEV4; P48436"]
["GO:0071600","biological_process","otic vesicle morphogenesis ","Q99502"]
["GO:0007389","biological_process","pattern specification process ","Q99502; P37275; P10070; Q96PV0"]
["GO:0072513","biological_process","positive regulation of secondary heart field cardioblast proliferation ","Q99502"]
["GO:0048752","biological_process","semicircular canal morphogenesis ","Q99502; P37275; Q9P2D1"]
["GO:0099040","biological_process","ceramide translocation ","P08183"]
["GO:0045332","biological_process","phospholipid translocation ","P08183; O15554; P33527; O95477"]
["GO:1901529","biological_process","positive regulation of anion channel activity ","P08183"]
["GO:2001225","biological_process","regulation of chloride transport ","P08183; P00918"]
["GO:0047484","biological_process","regulation of response to osmotic stress ","P08183; Q9HBA0"]
["GO:0048566","biological_process","embryonic digestive tract development ","Q504Y2; P10070; P01375; P10071"]
["GO:0035108","biological_process","limb morphogenesis ","Q504Y2; Q16611; P10071"]
["GO:1904876","biological_process","negative regulation of DNA ligase activity ","Q9UBB9"]
["GO:0031848","biological_process","protection from non-homologous end joining at telomere ","Q9UBB9; Q15554; Q9NYB0; Q9H816; Q96AP0; Q96SD1"]
["GO:0000390","biological_process","spliceosomal complex disassembly ","Q9UBB9; Q9H400"]
["GO:0050905","biological_process","neuromuscular process ","O75592; Q07001; Q14203; Q13303; Q09470"]
["GO:1902667","biological_process","regulation of axon guidance ","O75592"]
["GO:0043001","biological_process","olgi to plasma membrane protein transport ","Q96CV9; Q15836; Q01082; P63027; P51809; Q12955; Q13439; Q9H4A6; Q9UPN3"]
["GO:0001920","biological_process","negative regulation of receptor recycling ","Q96CV9; Q6PIZ9"]
["GO:0061734","biological_process","parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization ","Q96CV9; O95140; Q9UBN7; O60260"]
["GO:0045210","biological_process","FasL biosynthetic process ","Q8WV24"]
["GO:0072752","biological_process","cellular response to rapamycin ","Q6PKG0"]
["GO:1990928","biological_process","response to amino acid starvation ","Q6PKG0; Q9BY44"]
["GO:0016226","biological_process","iron-sulfur cluster assembly ","Q9H1K1; P38646; O76071; Q16595"]
["GO:0097428","biological_process","protein maturation by iron-sulfur cluster transfer ","Q9H1K1; O76071"]
["GO:0044281","biological_process","small molecule metabolic process ","Q9H1K1; P10109; Q16595"]
["GO:0007076","biological_process","mitotic chromosome condensation ","Q9BUL5; Q8WZ42; Q15003; Q9BXS6; Q9NTJ3; Q96FF9; O43823; Q9BPX3"]
["GO:1901097","biological_process","negative regulation of autophagosome maturation ","Q9BUL5"]
["GO:1903588","biological_process","negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis ","P08138; Q9BUL8"]
["GO:0043281","biological_process","regulation of cysteine-type endopeptidase activity involved in apoptotic process ","P08138; P48431; Q9H3D4"]
["GO:2001273","biological_process","regulation of glucose import in response to insulin stimulus ","P08138"]
["GO:0003231","biological_process","cardiac ventricle development ","O95069; Q8IZQ8; Q14524; Q13765"]
["GO:1900039","biological_process","positive regulation of cellular response to hypoxia ","O95069"]
["GO:0030322","biological_process","stabilization of membrane potential ","O95069; O15554; P57789; Q7Z418; Q9NPC2; O14649"]
["GO:0035735","biological_process","intraciliary transport involved in cilium assembly ","Q9NP97; Q15154; Q9P2E2; Q9UPN4; P63167; Q9Y496"]
["GO:0007632","biological_process","visual behavior ","Q9NP97; O15259"]
["GO:0000920","biological_process","cell separation after cytokinesis ","Q53EZ4; O75351; O95235; Q9Y3E7; Q8WUX9; Q96CF2"]
["GO:1904888","biological_process","cranial skeletal system development ","Q53EZ4; A1X283; Q9H3D4"]
["GO:0072001","biological_process","renal system development ","Q53EZ4; Q12946; P16144"]
["GO:0042595","biological_process","behavioral response to starvation ","Q96EB6"]
["GO:0035356","biological_process","cellular triglyceride homeostasis ","Q96EB6; Q96RI1; P17861"]
["GO:0000731","biological_process","DNA synthesis involved in DNA repair ","Q96EB6; Q15054; Q9Y253; Q9HCU8; Q14191; P55273"]
["GO:0006343","biological_process","establishment of chromatin silencing ","Q96EB6"]
["GO:0010934","biological_process","macrophage cytokine production ","Q96EB6"]
["GO:0060766","biological_process","negative regulation of androgen receptor signaling pathway ","Q96EB6; P51532; Q13547; P35232; O75928; P98082"]
["GO:2000655","biological_process","negative regulation of cellular response to testosterone stimulus ","Q96EB6"]
["GO:0071441","biological_process","negative regulation of histone H3-K acetylation ","Q96EB6"]
["GO:2000619","biological_process","negative regulation of histone H4-K acetylation ","Q96EB6; Q9H1Y0"]
["GO:1902166","biological_process","negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator ","Q96EB6; Q96PM9; P15941; P16070; P10415; Q9HB09; O60341; Q9HB65"]
["GO:0031393","biological_process","negative regulation of prostaglandin biosynthetic process ","Q96EB6"]
["GO:1904179","biological_process","positive regulation of adipose tissue development ","Q96EB6; Q96RI1; A1X283; Q8TD43; Q9UBU3"]
["GO:2000481","biological_process","positive regulation of cAMP-dependent protein kinase activity ","Q96EB6; Q9Y4G8; P23634; P07550"]
["GO:0045348","biological_process","positive regulation of MHC class II biosynthetic process ","Q96EB6; P33076; P17861"]
["GO:0051152","biological_process","positive regulation of smooth muscle cell differentiation ","Q96EB6; Q8IZQ8; O75925; Q6STE5"]
["GO:0000720","biological_process","pyrimidine dimer repair by nucleotide-excision repair ","Q96EB6; P05114"]
["GO:0010883","biological_process","regulation of lipid storage ","Q96EB6; Q969H0"]
["GO:0035358","biological_process","regulation of peroxisome proliferator activated receptor signaling pathway ","Q96EB6"]
["GO:0071900","biological_process","regulation of protein serine/threonine kinase activity ","Q96EB6; Q9P2Y5; P54619; Q9UGI9"]
["GO:0034391","biological_process","regulation of smooth muscle cell apoptotic process ","Q96EB6; P54750"]
["GO:0000012","biological_process","single strand break repair ","Q96EB6; Q8IW19; P49917; P18887; Q7Z2E3; Q9NUW8"]
["GO:0006642","biological_process","triglyceride mobilization ","Q96EB6; Q14693"]
["GO:0070914","biological_process","UV-damage excision repair ","Q96EB6; P23025; Q16531"]
["GO:1904908","biological_process","negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric ","O95271"]
["GO:1904743","biological_process","negative regulation of telomeric DNA binding ","O95271"]
["GO:0006471","biological_process","protein ADP-ribosylation ","O95271; Q93070; Q9NTG7; Q8N6T7; P09874; Q53GL7; Q8IXJ6"]
["GO:0070213","biological_process","protein auto-ADP-ribosylation ","O95271; Q53GL7"]
["GO:0070212","biological_process","protein poly-ADP-ribosylation ","O95271; P09874; Q53GL7"]
["GO:0045607","biological_process","regulation of inner ear auditory receptor cell differentiation ","P12524; P04198"]
["GO:0098810","biological_process","neurotransmitter reuptake ","Q99808; P23975"]
["GO:0006139","biological_process","nucleobase-containing compound metabolic process ","Q99808; P11908; P33316; Q9UGH3; O95861; P31939; Q14194; P17812; O43868; P04183; Q16555"]
["GO:0015858","biological_process","nucleoside transport ","Q99808"]
["GO:0015862","biological_process","uridine transport ","Q99808"]
["GO:0006015","biological_process","-phosphoribose -diphosphate biosynthetic process ","P60891; P11908; P06737"]
["GO:0046101","biological_process","hypoxanthine biosynthetic process ","P60891"]
["GO:0006144","biological_process","purine nucleobase metabolic process ","P60891"]
["GO:0006221","biological_process","pyrimidine nucleotide biosynthetic process ","P60891"]
["GO:0034418","biological_process","urate biosynthetic process ","P60891"]
["GO:0001955","biological_process","blood vessel maturation ","P12980; P21453; O75179; P35638; P37023; P08253; P33151"]
["GO:0051455","biological_process","attachment of spindle microtubules to kinetochore involved in homologous chromosome segregation ","Q03188"]
["GO:0015696","biological_process","ammonium transport ","P29972; Q9H310; P55011"]
["GO:0015701","biological_process","bicarbonate transport ","P29972; Q16790; P00918; P13569; P02730; Q9Y6R1; Q9Y2D0"]
["GO:0035378","biological_process","carbon dioxide transmembrane transport ","P29972"]
["GO:0015670","biological_process","carbon dioxide transport ","P29972; P00918; P55064"]
["GO:0019725","biological_process","cellular homeostasis ","P29972; Q9UKT5; Q9H1Y0; P41597; Q8IXI2; Q07820"]
["GO:0071241","biological_process","cellular response to inorganic substance ","P29972"]
["GO:0071288","biological_process","cellular response to mercury ion ","P29972; P41181"]
["GO:0071472","biological_process","cellular response to salt stress ","P29972; Q07352"]
["GO:0006884","biological_process","cell volume homeostasis ","P29972; Q16254; Q9UP95; O15554; Q9HBA0; P35611; P54105; Q9Y666"]
["GO:0033326","biological_process","cerebrospinal fluid secretion ","P29972"]
["GO:0030950","biological_process","establishment or maintenance of actin cytoskeleton polarity ","P29972; Q6R327; Q9NRY4; Q9BPZ7"]
["GO:0015793","biological_process","glycerol transport ","P29972; O43315; P41181"]
["GO:0085018","biological_process","maintenance of symbiont-containing vacuole by host ","P29972"]
["GO:0050891","biological_process","multicellular organismal water homeostasis ","P29972; Q9HBA0; P37088; P13569; P51170; P51168; P55087"]
["GO:0030185","biological_process","nitric oxide transport ","P29972"]
["GO:0030157","biological_process","pancreatic juice secretion ","P29972; P17342; P55064"]
["GO:0046878","biological_process","positive regulation of saliva secretion ","P29972"]
["GO:0003097","biological_process","renal water transport ","P29972; P41181"]
["GO:0035377","biological_process","transepithelial water transport ","P29972; P13569"]
["GO:0006833","biological_process","water transport ","P29972; O75631; O43315; P41181; P30301; P55064; P55087"]
["GO:0009062","biological_process","fatty acid catabolic process ","Q14693"]
["GO:0006646","biological_process","phosphatidylethanolamine biosynthetic process ","Q14693; Q9Y259; P35790"]
["GO:0030951","biological_process","establishment or maintenance of microtubule cytoskeleton polarity ","Q99661; P02545; P48678"]
["GO:0007019","biological_process","microtubule depolymerization ","Q99661; Q9HCH0; Q9NZ72; O00139; Q8N4N8; P16949"]
["GO:1901877","biological_process","negative regulation of calcium ion binding ","O00631; P26678"]
["GO:0090281","biological_process","negative regulation of calcium ion import ","O00631; P26678"]
["GO:1901020","biological_process","negative regulation of calcium ion transmembrane transporter activity ","O00631; P26678; P62258; P08913"]
["GO:0043242","biological_process","negative regulation of protein complex disassembly ","O00631; Q9UBN7; P01375"]
["GO:1901881","biological_process","positive regulation of protein depolymerization ","O00631"]
["GO:1901894","biological_process","regulation of calcium-transporting ATPase activity ","O00631; P26678"]
["GO:1901077","biological_process","regulation of relaxation of muscle ","O00631; P30626"]
["GO:0070296","biological_process","sarcoplasmic reticulum calcium ion transport ","O00631; Q92736; P16615"]
["GO:0032464","biological_process","positive regulation of protein homooligomerization ","Q9BXH1; O43521; Q13323; Q96LC9; P63244; P55957"]
["GO:0007189","biological_process","adenylate cyclase-activating -protein coupled receptor signaling pathway ","P43119; Q14344; P34998; Q03431; O60266; Q08828; P12272; P04899; P43220; P32245; O43306; Q08462; P05067; P22392; O95477; P08913; P16473; P21728; P40145; P23945"]
["GO:0051170","biological_process","import into nucleus ","O95149; P62316; Q9UHI6; P14678; P09651; Q9BYV9; P54619; Q9H840; P62304"]
["GO:0061015","biological_process","snRNA import into nucleus ","O95149; P62826"]
["GO:0006352","biological_process","DNA-templated transcription, initiation ","Q12962; Q15545; P15884; Q96T23; Q14686; P62805"]
["GO:0051101","biological_process","regulation of DNA binding ","Q12962; Q8NCD3; P20749; P67870; Q15109"]
["GO:0015879","biological_process","carnitine transport ","Q5T2W1"]
["GO:0015893","biological_process","drug transport ","Q5T2W1"]
["GO:1904064","biological_process","positive regulation of cation transmembrane transport ","Q5T2W1"]
["GO:0044070","biological_process","regulation of anion transport ","Q5T2W1; O43865; P00918"]
["GO:1902263","biological_process","apoptotic process involved in embryonic digit morphogenesis ","O43521; Q07812; P46531"]
["GO:0048066","biological_process","developmental pigmentation ","O43521; O60315"]
["GO:0002262","biological_process","myeloid cell homeostasis ","O43521; Q92542; Q07812; Q9BZS1; P00441; Q16611"]
["GO:2000271","biological_process","positive regulation of fibroblast apoptotic process ","O43521; P55957; O94768; P62324; Q9H3D4"]
["GO:0048563","biological_process","post-embryonic animal organ morphogenesis ","O43521"]
["GO:0070242","biological_process","thymocyte apoptotic process ","O43521; Q07812; Q16611; P10071"]
["GO:0035148","biological_process","tube formation ","O43521; Q5VWQ8; P46531; O14713"]
["GO:0051661","biological_process","maintenance of centrosome location ","Q99996; P81274"]
["GO:0007194","biological_process","negative regulation of adenylate cyclase activity ","Q99996; P17342; P04899; Q9NPC1; P41597; Q9UBS5; P14416; O75899; Q14416; Q14832; P35372"]
["GO:1901018","biological_process","positive regulation of potassium ion transmembrane transporter activity ","Q99996"]
["GO:1903358","biological_process","regulation of olgi organization ","Q99996; Q08AD1; Q9H1K0; P50570"]
["GO:0060306","biological_process","regulation of membrane repolarization ","Q99996; Q96PU5; P62258; P51787; O14958; Q12809; P63252"]
["GO:0050769","biological_process","positive regulation of neurogenesis ","Q96T58; P49757; P13010; P55209; O43566; P49675; Q13573; Q9BXP5; Q9HB65; Q13049; P49917; Q9Y6R0; P36955; P35372"]
["GO:1901800","biological_process","positive regulation of proteasomal protein catabolic process ","O75150; O95816; Q5VWQ8; Q06787; P17861; Q969H0; O60260"]
["GO:1902916","biological_process","positive regulation of protein polyubiquitination ","O75150; Q9UKT5; Q13309"]
["GO:0098534","biological_process","centriole assembly ","Q16254; Q96PK6; P37198"]
["GO:0044458","biological_process","motile cilium assembly ","Q16254; Q9HC77; Q5JQC9; Q4G0X9"]
["GO:1903251","biological_process","multi-ciliated epithelial cell differentiation ","Q16254; P22674"]
["GO:0010172","biological_process","embryonic body morphogenesis ","Q9Y2X9"]
["GO:0046339","biological_process","diacylglycerol metabolic process ","Q16760; Q13574; P23743"]
["GO:0046834","biological_process","lipid phosphorylation ","Q16760; Q13574; P49619; P23743"]
["GO:0042769","biological_process","DNA damage response, detection of DNA damage ","P49005; Q15054; P35251; P62979; P23396; P0CG47; Q96T60; P12004; Q96PY6; P27694; Q9NZJ0; P15927; O94782; P63146; P40937; Q9NS91; Q16531; Q9HCU8; P52926; P62987; P09874"]
["GO:0006271","biological_process","DNA strand elongation involved in DNA replication ","P49005; Q9Y248"]
["GO:0006297","biological_process","nucleotide-excision repair, DNA gap filling ","P49005; Q15054; P35251; P62979; P0CG47; Q9UBT6; P12004; P27694; P15927; P18858; P40937; P49916; P49917; Q9HCU8; P18887; P62987"]
["GO:0033683","biological_process","nucleotide-excision repair, DNA incision ","P49005; Q15054; P35251; P62979; P19447; P0CG47; Q9UBT6; P12004; P27694; P15927; P23025; P40937; P28715; Q16531; Q9HCU8; P62987; P09874"]
["GO:0006296","biological_process","nucleotide-excision repair, DNA incision, 5'-to lesion ","P49005; Q15054; P35251; P62979; P19447; P0CG47; Q9UBT6; P12004; P27694; P15927; P23025; P40937; P28715; Q16531; Q9HCU8; P62987; P09874"]
["GO:0032201","biological_process","telomere maintenance via semi-conservative replication ","P49005; Q15054; P35251; P12004; P27694; P39748; P49643; P15927; Q92900; P40937; Q9HCU8"]
["GO:0019985","biological_process","translesion synthesis ","P49005; Q15054; P35251; P62979; P0CG47; Q9UBT6; P12004; P55072; P27694; Q9NZJ0; Q9Y253; P15927; P40937; Q14694; Q9HCU8; P62987"]
["GO:1904667","biological_process","negative regulation of ubiquitin protein ligase activity ","O95816; Q9UKT4; Q13257; P62913; Q8N726"]
["GO:0046219","biological_process","indolalkylamine biosynthetic process ","Q16613"]
["GO:0030187","biological_process","melatonin biosynthetic process ","Q16613"]
["GO:0006474","biological_process","N-terminal protein amino acid acetylation ","Q16613; Q6N069"]
["GO:0009648","biological_process","photoperiodism ","Q16613; O15516"]
["GO:0034695","biological_process","response to prostaglandin E ","Q16613; Q03167; P32248"]
["GO:2000036","biological_process","regulation of stem cell population maintenance ","Q15717; Q9Y4C1; O75175; P17542; Q9H4B6; P52926; Q9NZN8; Q9H3R0"]
["GO:0045355","biological_process","negative regulation of interferon-alpha biosynthetic process ","Q13287"]
["GO:1902524","biological_process","positive regulation of protein K8-linked ubiquitination ","Q13287"]
["GO:0032506","biological_process","cytokinetic process ","P50995; P35579"]
["GO:0070508","biological_process","cholesterol import ","P01130; P16671; Q8WTV0"]
["GO:0034382","biological_process","chylomicron remnant clearance ","P01130; P02649"]
["GO:0030299","biological_process","intestinal cholesterol absorption ","P01130; P16671; Q9UHB6"]
["GO:0042159","biological_process","lipoprotein catabolic process ","P01130; P02649"]
["GO:0034383","biological_process","low-density lipoprotein particle clearance ","P01130; P16671; Q8WTV0; P09601; Q96CW1; P09496; P63010; Q6UWW8; Q00610"]
["GO:0061889","biological_process","negative regulation of astrocyte activation ","P01130"]
["GO:0015914","biological_process","phospholipid transport ","P01130; P48739; Q8WTV0; O00562; Q00169; P22307"]
["GO:0034381","biological_process","plasma lipoprotein particle clearance ","P01130; P16671"]
["GO:0010986","biological_process","positive regulation of lipoprotein particle clearance ","P01130"]
["GO:1905167","biological_process","positive regulation of lysosomal protein catabolic process ","P01130; Q07954"]
["GO:0010867","biological_process","positive regulation of triglyceride biosynthetic process ","P01130; P36956; P55055; Q8WTV0; P80108; Q13133"]
["GO:0090118","biological_process","receptor-mediated endocytosis involved in cholesterol transport ","P01130; O75581"]
["GO:0090181","biological_process","regulation of cholesterol metabolic process ","P01130; Q96RI1; P02649"]
["GO:0010899","biological_process","regulation of phosphatidylcholine catabolic process ","P01130; Q8WTV0"]
["GO:0061771","biological_process","response to caloric restriction ","P01130; P02649"]
["GO:1900037","biological_process","regulation of cellular response to hypoxia ","Q9Y6H1; Q96IF1"]
["GO:1903259","biological_process","exon-exon junction complex disassembly ","Q9BRP8"]
["GO:0033043","biological_process","regulation of organelle organization ","Q08AD1"]
["GO:0060080","biological_process","inhibitory postsynaptic potential ","Q13002; P28472; P43681"]
["GO:0048172","biological_process","regulation of short-term neuronal synaptic plasticity ","Q13002; Q03164"]
["GO:1903077","biological_process","negative regulation of protein localization to plasma membrane ","P49757; Q13136; P98082; Q07817; Q96CW1; P17081; Q00610; Q15172"]
["GO:0021849","biological_process","neuroblast division in subventricular zone ","P49757; Q9Y6R0"]
["GO:0086010","biological_process","membrane depolarization during action potential ","Q00975; Q04917; Q99250; Q14524; Q9Y5Y9; O43497; Q9UQD0; O95180; Q12809; Q13698"]
["GO:0006378","biological_process","mRNA polyadenylation ","Q6UN15; P51003; O43865; Q12996; Q9NP77; Q9H6E5; Q92797; P05067; P11940; Q9P2I0; Q9UKF6; Q6P1J9; Q8WVC0; P33240"]
["GO:0098789","biological_process","pre-mRNA cleavage required for polyadenylation ","Q6UN15; Q8N684; Q9H0L4; Q9H6E5; P52298; P33240; Q09161"]
["GO:0006369","biological_process","termination of RNA polymerase II transcription ","Q6UN15; Q8N684; P51003; Q14493; Q12996; P14678; P56270; Q9NP77; Q9H0L4; Q92797; Q9P2I0; Q9UKF6; Q9UNY4; P52298; P62304; P33240; Q09161"]
["GO:1990859","biological_process","cellular response to endothelin ","P46108"]
["GO:0045953","biological_process","negative regulation of natural killer cell mediated cytotoxicity ","P46108; P32121"]
["GO:0035020","biological_process","regulation of Rac protein signal transduction ","P46108; P50570; Q13972; O15294"]
["GO:0061847","biological_process","response to cholecystokinin ","P46108"]
["GO:0001878","biological_process","response to yeast ","P46108; P05067"]
["GO:0071538","biological_process","SH2 domain-mediated complex assembly ","P46108"]
["GO:0009154","biological_process","purine ribonucleotide catabolic process ","P49773"]
["GO:0090286","biological_process","cytoskeletal anchoring at nuclear membrane ","Q8NF91; O94901; Q9UH99"]
["GO:0090292","biological_process","nuclear matrix anchoring at nuclear membrane ","Q8NF91; O94901; Q9UH99"]
["GO:0006997","biological_process","nucleus organization ","Q8NF91; O75351; P48739; P48678; Q8WUX9; Q14980; Q96CF2"]
["GO:0019752","biological_process","carboxylic acid metabolic process ","Q6P996"]
["GO:2000001","biological_process","regulation of DNA damage checkpoint ","Q9UKT5; Q16526; P15927; Q6PCD5"]
["GO:0031146","biological_process","SCF-dependent proteasomal ubiquitin-dependent protein catabolic process ","Q9UKT5; Q9UBF6; Q969U6; Q15058; Q5XUX0; P41002; Q9GZV5; Q969H0"]
["GO:0035965","biological_process","cardiolipin acyl-chain remodeling ","P47712; Q16635"]
["GO:0071236","biological_process","cellular response to antibiotic ","P47712; P49675; P46527; P19634; Q04656; P11021"]
["GO:0046456","biological_process","icosanoid biosynthetic process ","P47712"]
["GO:0006690","biological_process","icosanoid metabolic process ","P47712"]
["GO:0006654","biological_process","phosphatidic acid biosynthetic process ","P47712; O14939; Q13393; Q8NF37; P23743; Q8N335"]
["GO:0036151","biological_process","phosphatidylcholine acyl-chain remodeling ","P47712; Q7L5N7; Q8NF37; P07108; Q9NP80"]
["GO:0036152","biological_process","phosphatidylethanolamine acyl-chain remodeling ","P47712; Q9NP80"]
["GO:0036148","biological_process","phosphatidylglycerol acyl-chain remodeling ","P47712; Q8NF37"]
["GO:0036149","biological_process","phosphatidylinositol acyl-chain remodeling ","P47712"]
["GO:0036150","biological_process","phosphatidylserine acyl-chain remodeling ","P47712"]
["GO:0006663","biological_process","platelet activating factor biosynthetic process ","P47712; Q7L5N7"]
["GO:0071800","biological_process","podosome assembly ","P14598; Q5TCZ1; A1X283; Q9UJU6"]
["GO:0045741","biological_process","positive regulation of epidermal growth factor-activated receptor activity ","P14598; P78536; P08913; Q969H0"]
["GO:0042554","biological_process","superoxide anion generation ","P14598; Q96PH1; P13498; P00441; Q9NPH5; Q9NRD9; P19878"]
["GO:0046496","biological_process","nicotinamide nucleotide metabolic process ","Q8NCW5"]
["GO:0071475","biological_process","cellular hyperosmotic salinity response ","P13010; P12956"]
["GO:1904430","biological_process","negative regulation of t-circle formation ","P13010; Q15554"]
["GO:0010021","biological_process","amylopectin biosynthetic process ","P14672"]
["GO:0046323","biological_process","glucose import ","P14672; P20823; Q99523; P21728; Q92574"]
["GO:0044381","biological_process","glucose import in response to insulin stimulus ","P14672"]
["GO:0098694","biological_process","regulation of synaptic vesicle budding from presynaptic endocytic zone membrane ","P14672"]
["GO:0030705","biological_process","cytoskeleton-dependent intracellular transport ","Q9NQT8; P07437; Q9BQE3; Q71U36; Q9P219; Q3V6T2; P68363; P33176; O60282"]
["GO:0021799","biological_process","cerebral cortex radially oriented cell migration ","Q155Q3; Q9GZM8; P20265"]
["GO:0021869","biological_process","forebrain ventricular zone progenitor cell division ","Q155Q3; P20265"]
["GO:0042987","biological_process","amyloid precursor protein catabolic process ","Q92542; P49768; P49810"]
["GO:0042982","biological_process","amyloid precursor protein metabolic process ","Q92542; P02649; Q12959; P49768"]
["GO:0007220","biological_process","Notch receptor processing ","Q92542; P78536; P49768; P49810"]
["GO:0035333","biological_process","Notch receptor processing, ligand-dependent ","Q92542; P49768; P49810"]
["GO:0006508","biological_process","proteolysis ","Q92542; Q9Y4P1; P09622; Q9UIQ6; O43464; P30626; P08473; P00747; P56817; Q13191; Q9UK99; Q14790; P55212; P78536; O14773; P55210; P00749; Q05086; Q9UHP3; P17655; P43686; Q9UMX1; P61088; P40337; P08253; P42574; P12821; P50281; Q99538"]
["GO:0002480","biological_process","antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent ","P01889; Q9UIQ6; P01892"]
["GO:0002474","biological_process","antigen processing and presentation of peptide antigen via MHC class I ","P01889; P53992; Q15436; P27824; P30101; P12821; P01892"]
["GO:0042270","biological_process","protection from natural killer cell mediated cytotoxicity ","P01889"]
["GO:2001198","biological_process","regulation of dendritic cell differentiation ","P01889"]
["GO:0032655","biological_process","regulation of interleukin-1 production ","P01889"]
["GO:0002667","biological_process","regulation of T cell anergy ","P01889; O60346; Q9BZS1"]
["GO:0006883","biological_process","cellular sodium ion homeostasis ","Q96PU5; P32418; P19634; P50052; P05023"]
["GO:2000009","biological_process","negative regulation of protein localization to cell surface ","Q96PU5"]
["GO:2001288","biological_process","positive regulation of caveolin-mediated endocytosis ","Q96PU5"]
["GO:0086005","biological_process","ventricular cardiac muscle cell action potential ","Q96PU5; Q92736; Q14524; P51787; Q12809; Q8N335; Q13424; P15382"]
["GO:0030104","biological_process","water homeostasis ","Q96PU5; O43315"]
["GO:0070094","biological_process","positive regulation of glucagon secretion ","Q12904"]
["GO:0006418","biological_process","tRNA aminoacylation for protein translation ","Q12904; P26640; Q9H2U2; Q15046; P56192; O95363; Q9NP81; Q13155; P07814"]
["GO:0097237","biological_process","cellular response to toxic substance ","Q9ULJ8; P41143; Q9BXM7; O60260"]
["GO:1904049","biological_process","negative regulation of spontaneous neurotransmitter secretion ","Q9ULJ8; O60260"]
["GO:1900454","biological_process","positive regulation of long term synaptic depression ","Q9ULJ8; O43424; Q14721"]
["GO:0051489","biological_process","regulation of filopodium assembly ","Q9ULJ8; Q08495; Q06787; Q96T49; P17677; P20339; P60953; O94759"]
["GO:0030263","biological_process","apoptotic chromosome condensation ","Q9UKV3; P11388"]
["GO:2000780","biological_process","negative regulation of double-strand break repair ","O95071; Q14669; Q96FW1; Q15672"]
["GO:1901315","biological_process","negative regulation of histone H2A K6-linked ubiquitination ","O95071; Q14669; Q96FW1"]
["GO:0022010","biological_process","central nervous system myelination ","Q9Y2G1; P56693; P47928; P78508"]
["GO:0031643","biological_process","positive regulation of myelination ","Q9Y2G1; Q8TEW0; P56693; Q02297; Q14118"]
["GO:0045576","biological_process","mast cell activation ","Q13094; Q92597; P30273; Q15669"]
["GO:0007599","biological_process","hemostasis ","Q96PM9; Q16621; Q9H244; P30518; P06744; Q01543"]
["GO:0010609","biological_process","mRNA localization resulting in posttranscriptional regulation of gene expression ","Q96PM9"]
["GO:0070889","biological_process","platelet alpha granule organization ","Q96PM9"]
["GO:1902164","biological_process","positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p class mediator ","Q96PM9"]
["GO:2000765","biological_process","regulation of cytoplasmic translation ","Q96PM9"]
["GO:0075522","biological_process","IRES-dependent viral translational initiation ","Q15366; O00303; P26599; Q9ULC4; P05455"]
["GO:0016071","biological_process","mRNA metabolic process ","Q15366; Q969Z0; P57721"]
["GO:0050687","biological_process","negative regulation of defense response to virus ","Q15366; P01589; O75688; Q07021; Q96J02"]
["GO:0046293","biological_process","formaldehyde biosynthetic process ","Q9Y4C1"]
["GO:0033169","biological_process","histone H-K demethylation ","Q9Y4C1; Q9UPP1; O94953; O60341; Q9ULV5; Q7LBC6; P29375; Q9H3R0"]
["GO:0036123","biological_process","histone H-K9 dimethylation ","Q9Y4C1"]
["GO:2000736","biological_process","regulation of stem cell differentiation ","Q9Y4C1; Q9H3R0"]
["GO:0007290","biological_process","spermatid nucleus elongation ","Q9Y4C1"]
["GO:0097320","biological_process","plasma membrane tubulation ","Q9BY11; O95810; Q8N3F8"]
["GO:0071420","biological_process","cellular response to histamine ","P28472; P18507; P18505; P35367; O60610; P47870; P14867"]
["GO:0007214","biological_process","gamma-aminobutyric acid signaling pathway ","P28472; P18507; Q15111; P04899; Q9UBS5; P55011; P18848; P18505; O75899; P47870; P14867"]
["GO:0060119","biological_process","inner ear receptor cell development ","P28472; P47870"]
["GO:0140194","biological_process","negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process ","P41220"]
["GO:0010614","biological_process","negative regulation of cardiac muscle hypertrophy ","P41220; P19438; Q13485; P46531; P20333"]
["GO:1900924","biological_process","negative regulation of glycine import across plasma membrane ","P41220; P49798"]
["GO:0045744","biological_process","negative regulation of -protein coupled receptor protein signaling pathway ","P41220; O43566; Q16526; O14921; P08567; P31946"]
["GO:0010519","biological_process","negative regulation of phospholipase activity ","P41220"]
["GO:0060452","biological_process","positive regulation of cardiac muscle contraction ","P41220; P51787"]
["GO:1990120","biological_process","messenger ribonucleoprotein complex assembly ","Q8N684"]
["GO:0110104","biological_process","mRNA alternative polyadenylation ","Q8N684"]
["GO:0048305","biological_process","immunoglobulin secretion ","O43734"]
["GO:0032972","biological_process","regulation of muscle filament sliding speed ","P45379"]
["GO:0051693","biological_process","actin filament capping ","P09327; Q08495; Q01082; Q13813; P06396"]
["GO:0045010","biological_process","actin nucleation ","P09327; P06396"]
["GO:0060327","biological_process","cytoplasmic actin-based contraction involved in cell motility ","P09327; A0MZ66"]
["GO:0051125","biological_process","regulation of actin nucleation ","P09327"]
["GO:2000392","biological_process","regulation of lamellipodium morphogenesis ","P09327; P16070"]
["GO:0061041","biological_process","regulation of wound healing ","P09327; Q13247; P00749"]
["GO:0009792","biological_process","embryo development ending in birth or egg hatching ","Q15078; Q6R327; O00482; Q92879; Q53H80; P49640"]
["GO:0098693","biological_process","regulation of synaptic vesicle cycle ","Q15078; Q13393; Q9ULB1; Q9H3Z4"]
["GO:0021722","biological_process","superior olivary nucleus maturation ","Q15078; Q13319"]
["GO:1903526","biological_process","negative regulation of membrane tubulation ","O00401; P50570"]
["GO:2000370","biological_process","positive regulation of clathrin-dependent endocytosis ","O00401; P50570; P98082"]
["GO:0051653","biological_process","spindle localization ","O00401; P61160; P61158"]
["GO:0030050","biological_process","vesicle transport along actin filament ","O00401; O43707; Q9Y4I1; Q9BV36"]
["GO:0045835","biological_process","negative regulation of meiotic nuclear division ","Q9UKT4; P10644; Q4G163"]
["GO:0045841","biological_process","negative regulation of mitotic metaphase/anaphase transition ","Q9UKT4"]
["GO:0070169","biological_process","positive regulation of biomineral tissue development ","Q9UKT4; P17676; P18848"]
["GO:1905322","biological_process","positive regulation of mesenchymal stem cell migration ","Q9UKT4"]
["GO:0021707","biological_process","cerebellar granule cell differentiation ","O43424; P58400"]
["GO:1904861","biological_process","excitatory synapse assembly ","O43424; Q8N2Q7"]
["GO:0007157","biological_process","heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules ","O43424; Q92692; P19022; Q15762; P58400; Q8N2Q7; P30203"]
["GO:0048017","biological_process","inositol lipid-mediated signaling ","O14939; Q13393"]
["GO:0036465","biological_process","synaptic vesicle recycling ","O14939; O43581; P20339"]
["GO:1902416","biological_process","positive regulation of mRNA binding ","Q9BRS8; Q06787; Q99613"]
["GO:0033634","biological_process","positive regulation of cell-cell adhesion mediated by integrin ","Q86WV1; P07766; O00592"]
["GO:0099087","biological_process","anterograde axonal transport of messenger ribonucleoprotein complex ","Q15554"]
["GO:1903770","biological_process","negative regulation of beta-galactosidase activity ","Q15554"]
["GO:0032205","biological_process","negative regulation of telomere maintenance ","Q15554; Q9NYB0"]
["GO:0032208","biological_process","negative regulation of telomere maintenance via recombination ","Q15554"]
["GO:1903824","biological_process","negative regulation of telomere single strand break repair ","Q15554"]
["GO:0044804","biological_process","autophagy of nucleus ","Q9Y4P1; Q5MNZ6; Q9H1Y0; Q96BY7; Q9Y4P8; Q9NT62; Q14457"]
["GO:0006501","biological_process","C-terminal protein lipidation ","Q9Y4P1; Q9H1Y0; P80108"]
["GO:0051697","biological_process","protein delipidation ","Q9Y4P1"]
["GO:0035725","biological_process","sodium ion transmembrane transport ","P55017; Q13563; Q99250; P32418; Q14524; Q9Y3Q4; Q9Y5Y9; P37088; P51170; P51168; P78348; Q9UL51"]
["GO:0034497","biological_process","protein localization to phagophore assembly site ","Q86VP3; Q5MNZ6; P56962; O95140; Q9Y4P8; Q8NEB9; Q7Z3C6; Q676U5"]
["GO:0046513","biological_process","ceramide biosynthetic process ","Q6ZMG9; Q8N5B7; O15269; P17405; Q9HA82"]
["GO:0010460","biological_process","positive regulation of heart rate ","P23327; Q92736; P43005; Q8TD43; P49798; P51787; P16615"]
["GO:1901899","biological_process","positive regulation of relaxation of cardiac muscle ","P23327"]
["GO:1903169","biological_process","regulation of calcium ion transmembrane transport ","P23327; P48736"]
["GO:0030007","biological_process","cellular potassium ion homeostasis ","Q12791; P05023; P63252"]
["GO:0060073","biological_process","micturition ","Q12791"]
["GO:0045794","biological_process","negative regulation of cell volume ","Q12791; Q9BYB0; P51790"]
["GO:0034465","biological_process","response to carbon monoxide ","Q12791; P00441"]
["GO:0060083","biological_process","smooth muscle contraction involved in micturition ","Q12791; Q8NER1"]
["GO:0061640","biological_process","cytoskeleton-dependent cytokinesis ","Q96PH1"]
["GO:0043012","biological_process","regulation of fusion of sperm to egg plasma membrane ","Q96PH1"]
["GO:0010155","biological_process","regulation of proton transport ","Q96PH1"]
["GO:0071726","biological_process","cellular response to diacyl bacterial lipopeptide ","P16671"]
["GO:0050702","biological_process","interleukin-1 beta secretion ","P16671; Q9NPP4; O95477; O00206"]
["GO:0055096","biological_process","low-density lipoprotein particle mediated signaling ","P16671"]
["GO:0044130","biological_process","negative regulation of growth of symbiont in host ","P16671; Q13501; P01375; Q02556; P58753"]
["GO:0150024","biological_process","oxidised low-density lipoprotein particle clearance ","P16671"]
["GO:0006910","biological_process","phagocytosis, recognition ","P16671"]
["GO:0030194","biological_process","positive regulation of blood coagulation ","P16671; Q08495; Q16236; P06702; P21731"]
["GO:2000334","biological_process","positive regulation of blood microparticle formation ","P16671; P01375"]
["GO:0010886","biological_process","positive regulation of cholesterol storage ","P16671; Q8WTV0; Q12772"]
["GO:0060907","biological_process","positive regulation of macrophage cytokine production ","P16671"]
["GO:1900227","biological_process","positive regulation of NLRP3 inflammasome complex assembly ","P16671; O00206"]
["GO:2000121","biological_process","regulation of removal of superoxide radicals ","P16671; Q16236"]
["GO:0070543","biological_process","response to linoleic acid ","P16671"]
["GO:0035634","biological_process","response to stilbenoid ","P16671"]
["GO:0038124","biological_process","toll-like receptor TLR6TLR signaling pathway ","P16671"]
["GO:0034197","biological_process","triglyceride transport ","P16671; P51809"]
["GO:0006532","biological_process","aspartate biosynthetic process ","Q8NHS2"]
["GO:0032927","biological_process","positive regulation of activin receptor signaling pathway ","Q13705; P67870; P36896"]
["GO:0045008","biological_process","depyrimidination ","Q53HV7; Q96FI4; P13051; Q13569; Q969S2; O95243"]
["GO:0000288","biological_process","nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay ","O75175; Q5TC82; Q07352; Q9NZN8; P26651"]
["GO:0000289","biological_process","nuclear-transcribed mRNA poly(A) tail shortening ","O75175; Q5TAX3; P40692; Q9ULM6; O95453; Q9C0C2; Q9NZN8; P26651"]
["GO:0006754","biological_process","ATP biosynthetic process ","P04075; P36542; P18859; P56134"]
["GO:0007339","biological_process","binding of sperm to zona pellucida ","P04075; Q14157; P34931; P78371; Q9UGM5"]
["GO:0070208","biological_process","protein heterotrimerization ","O95785; P37198"]
["GO:0043486","biological_process","histone exchange ","P06454; Q15906; P49321; O43257; Q92688"]
["GO:0031550","biological_process","positive regulation of brain-derived neurotrophic factor receptor signaling pathway ","P23560"]
["GO:0048672","biological_process","positive regulation of collateral sprouting ","P23560; Q9H165"]
["GO:1900122","biological_process","positive regulation of receptor binding ","P23560; Q15111; P05067"]
["GO:0060712","biological_process","spongiotrophoblast layer development ","Q8N3Y1; Q99966; Q9HC62; Q07352"]
["GO:1903205","biological_process","regulation of hydrogen peroxide-induced cell death ","Q9P289"]
["GO:0035795","biological_process","negative regulation of mitochondrial membrane permeability ","P52789"]
["GO:1904925","biological_process","positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization ","P52789; Q9UII2"]
["GO:0000076","biological_process","DNA replication checkpoint ","Q99638; Q99741; O75943; Q9BVW5; Q9H211"]
["GO:1902231","biological_process","positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage ","Q99638; P23396; Q96BF6; Q8N2W9"]
["GO:0080111","biological_process","DNA demethylation ","Q9GZX7; Q96QF7; Q13569; P27695"]
["GO:0090310","biological_process","negative regulation of methylation-dependent chromatin silencing ","Q9GZX7"]
["GO:0097752","biological_process","regulation of DNA stability ","Q9GZX7"]
["GO:0016445","biological_process","somatic diversification of immunoglobulins ","Q9GZX7"]
["GO:0006713","biological_process","glucocorticoid catabolic process ","Q04917"]
["GO:2000649","biological_process","regulation of sodium ion transmembrane transporter activity ","Q04917; O00168; P26045; P46939; Q8N335"]
["GO:0008053","biological_process","mitochondrial fusion ","Q9GZY8; O95140; Q07812; Q8IWA4; Q9NX63; Q16611"]
["GO:0070584","biological_process","mitochondrion morphogenesis ","Q9GZY8; Q07812; Q04837; Q8IYB8; O00429; Q07817; Q99689; Q8TCS8"]
["GO:0016559","biological_process","peroxisome fission ","Q9GZY8; O00429; P40855"]
["GO:0006626","biological_process","protein targeting to mitochondrion ","Q9GZY8; O95140; O14925; P55957; O00170"]
["GO:0010821","biological_process","regulation of mitochondrion organization ","Q9GZY8; Q13501; O00429; Q9BXM7; Q9H4A6; O60260"]
["GO:0050930","biological_process","induction of positive chemotaxis ","Q14005; Q15109"]
["GO:0030595","biological_process","leukocyte chemotaxis ","Q14005; P21453; P34972"]
["GO:0071228","biological_process","cellular response to tumor cell ","Q9H3M7"]
["GO:0021794","biological_process","thalamus development ","Q16559; Q13516; O75581"]
["GO:0010499","biological_process","proteasomal ubiquitin-independent protein catabolic process ","Q14145; Q16236"]
["GO:0040015","biological_process","negative regulation of multicellular organism growth ","Q7Z5J4; O76061; P08588; P07550; Q99538"]
["GO:0007191","biological_process","adenylate cyclase-activating dopamine receptor signaling pathway ","O14745; P35462; P21728; P35372"]
["GO:0030643","biological_process","cellular phosphate ion homeostasis ","O14745; Q9GZV9; Q9UBH6; P22413"]
["GO:0045198","biological_process","establishment of epithelial cell apical/basal polarity ","O14745; P26038; Q12946; P61586; P60953"]
["GO:0034635","biological_process","glutathione transport ","O14745"]
["GO:0032416","biological_process","negative regulation of sodiumproton antiporter activity ","O14745; P35462"]
["GO:0060158","biological_process","phospholipase C-activating dopamine receptor signaling pathway ","O14745; P30679; P14416; P21728"]
["GO:0034767","biological_process","positive regulation of ion transmembrane transport ","O14745"]
["GO:0044062","biological_process","regulation of excretion ","O14745; O60500"]
["GO:0032415","biological_process","regulation of sodiumproton antiporter activity ","O14745"]
["GO:0070293","biological_process","renal absorption ","O14745; O14493; P51787"]
["GO:0097291","biological_process","renal phosphate ion absorption ","O14745"]
["GO:0003096","biological_process","renal sodium ion transport ","O14745"]
["GO:0022007","biological_process","convergent extension involved in neural plate elongation ","O14640; Q9ULK5; O14641"]
["GO:0035567","biological_process","non-canonical Wnt signaling pathway ","O14640; Q92997; O14641"]
["GO:1905386","biological_process","positive regulation of protein localization to presynapse ","O14640"]
["GO:0099054","biological_process","presynapse assembly ","O14640; Q8N0W4; Q8N2Q7"]
["GO:0035372","biological_process","protein localization to microtubule ","O14640; Q96Q89; Q96JM3; Q15691; O60610"]
["GO:0001505","biological_process","regulation of neurotransmitter levels ","O14640"]
["GO:1901409","biological_process","positive regulation of phosphorylation of RNA polymerase II C-terminal domain ","Q8N1B3; P51946; O60563; Q96S94"]
["GO:0002090","biological_process","regulation of receptor internalization ","Q9UL63; O75955; Q99962"]
["GO:0075732","biological_process","viral penetration into host nucleus ","P0C6L3; O00505; P49790"]
["GO:0007147","biological_process","female meiosis II ","Q92904; Q96GX5"]
["GO:0045836","biological_process","positive regulation of meiotic nuclear division ","Q92904; Q8IXJ6"]
["GO:1901379","biological_process","regulation of potassium ion transmembrane transport ","Q6PIL6; Q9NS61; P04156; Q9NZI2; Q01668; Q9Y2W7; Q12809; Q13303; Q9H2S1; P15382"]
["GO:0090618","biological_process","DNA clamp unloading ","P35251"]
["GO:0006261","biological_process","DNA-dependent DNA replication ","P35251; O60673; Q96T60; P27694; P06746; O14519; Q9HCU8; Q9NRL2"]
["GO:0070987","biological_process","error-free translesion synthesis ","P35251; P62979; P0CG47; P12004; P55072; P27694; Q9Y253; P15927; P40937; P62987; Q96PM5"]
["GO:0042276","biological_process","error-prone translesion synthesis ","P35251; P62979; O60673; P0CG47; Q9UBT6; P12004; P27694; P15927; P40937; P62987"]
["GO:0042275","biological_process","error-free postreplication DNA repair ","Q15819"]
["GO:0090086","biological_process","negative regulation of protein deubiquitination ","P19474; P25686"]
["GO:0032897","biological_process","negative regulation of viral transcription ","P19474; Q01628; Q13049; P26651; P23497; Q14142"]
["GO:0046598","biological_process","positive regulation of viral entry into host cell ","P19474; P09382; P01730"]
["GO:0070206","biological_process","protein trimerization ","P19474; P05067"]
["GO:0070588","biological_process","calcium ion transmembrane transport ","Q7Z2W7; Q9Y210; Q13563; Q9NQA5; Q9HBA0; P32418; Q9BX84; Q9HCX4; Q9Y698; Q13507; Q13936; Q8TD43; Q01668; O43497; Q8NET8; P23634; Q8NER1; Q9H244; O94759; P98161; Q96QT4; Q9H1D0; Q9GZU1; O75762; Q9Y5S1; P78348; P16615"]
["GO:0016048","biological_process","detection of temperature stimulus ","Q7Z2W7"]
["GO:0050955","biological_process","thermoception ","Q7Z2W7; Q8NER1; O75762"]
["GO:0006086","biological_process","acetyl-CoA biosynthetic process from pyruvate ","P10515; P08559"]
["GO:0034109","biological_process","homotypic cell-cell adhesion ","Q8TCZ2; Q96KG7"]
["GO:2000391","biological_process","positive regulation of neutrophil extravasation ","Q8TCZ2; P14778"]
["GO:2000409","biological_process","positive regulation of T cell extravasation ","Q8TCZ2"]
["GO:0032510","biological_process","endosome to lysosome transport via multivesicular body sorting pathway ","O75351; P55072"]
["GO:1904903","biological_process","ESCRT III complex disassembly ","O75351; Q8WUX9"]
["GO:0061738","biological_process","late endosomal microautophagy ","O75351"]
["GO:1903542","biological_process","negative regulation of exosomal secretion ","O75351; O60260"]
["GO:1903724","biological_process","positive regulation of centriole elongation ","O75351; Q9HC77"]
["GO:1903902","biological_process","positive regulation of viral life cycle ","O75351"]
["GO:0048524","biological_process","positive regulation of viral process ","O75351"]
["GO:1902188","biological_process","positive regulation of viral release from host cell ","O75351; Q9Y3E7; Q16531; Q96CF2"]
["GO:0051261","biological_process","protein depolymerization ","O75351"]
["GO:0010824","biological_process","regulation of centrosome duplication ","O75351; O43542; Q969U6; Q9UPN4; Q9Y3E7; O14980; Q96CF2"]
["GO:0050792","biological_process","regulation of viral process ","O75351; Q9Y3E7; Q96CF2"]
["GO:0043162","biological_process","ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway ","O75351; Q9UBN7; O75674; P46934"]
["GO:0090611","biological_process","ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway ","O75351; Q96CF2"]
["GO:0039702","biological_process","viral budding via host ESCRT complex ","O75351; Q9Y3E7; Q8WUX9; Q96CF2"]
["GO:0019076","biological_process","viral release from host cell ","O75351"]
["GO:0060047","biological_process","heart contraction ","P19429; Q9H1Y0; P00441; P10916; P07203; P60953; P12821"]
["GO:0001980","biological_process","regulation of systemic arterial blood pressure by ischemic conditions ","P19429"]
["GO:0019730","biological_process","antimicrobial humoral response ","P20749; P06702"]
["GO:0002455","biological_process","humoral immune response mediated by circulating immunoglobulin ","P20749"]
["GO:0042536","biological_process","negative regulation of tumor necrosis factor biosynthetic process ","P20749; Q9UBU3; Q9UJM3"]
["GO:0045082","biological_process","positive regulation of interleukin-1 biosynthetic process ","P20749; Q15306"]
["GO:0010225","biological_process","response to UV-C ","P20749; P05114; Q9Y6R4; Q9Y253; P28715; P51587; Q16611; Q14191; P25490"]
["GO:0043496","biological_process","regulation of protein homodimerization activity ","P61457; Q07812; P10415; Q02297; Q16611"]
["GO:0006729","biological_process","tetrahydrobiopterin biosynthetic process ","P61457; P09417; P35270; Q03393"]
["GO:1990845","biological_process","adaptive thermogenesis ","Q9UBK2; Q00839"]
["GO:0071313","biological_process","cellular response to caffeine ","Q9UBK2; Q92736; P32418; O14958; P21817; Q13698"]
["GO:0071332","biological_process","cellular response to fructose stimulus ","Q9UBK2; P17861"]
["GO:0071250","biological_process","cellular response to nitrite ","Q9UBK2"]
["GO:1904639","biological_process","cellular response to resveratrol ","Q9UBK2"]
["GO:0007586","biological_process","digestion ","Q9UBK2; P25092; O00625"]
["GO:0051552","biological_process","flavone metabolic process ","Q9UBK2; Q9HAW7"]
["GO:0006012","biological_process","galactose metabolic process ","Q9UBK2"]
["GO:1901857","biological_process","positive regulation of cellular respiration ","Q9UBK2"]
["GO:1904635","biological_process","positive regulation of glomerular visceral epithelial cell apoptotic process ","Q9UBK2"]
["GO:1901860","biological_process","positive regulation of mitochondrial DNA metabolic process ","Q9UBK2"]
["GO:1901863","biological_process","positive regulation of muscle tissue development ","Q9UBK2"]
["GO:2000184","biological_process","positive regulation of progesterone biosynthetic process ","Q9UBK2"]
["GO:0022904","biological_process","respiratory electron transport chain ","Q9UBK2; P51649; Q9BQG0; Q9BXM7; P31040"]
["GO:0002021","biological_process","response to dietary excess ","Q9UBK2; O15240; P02649; Q9BZK7"]
["GO:0071871","biological_process","response to epinephrine ","Q9UBK2"]
["GO:1904640","biological_process","response to methionine ","Q9UBK2"]
["GO:0071873","biological_process","response to norepinephrine ","Q9UBK2"]
["GO:1903644","biological_process","regulation of chaperone-mediated protein folding ","P25686"]
["GO:0030433","biological_process","ubiquitin-dependent ERAD pathway ","P25686; Q9UKV5; P17980; P14625; P62195; P55072; P46379; O43765; Q9Y385; Q9UNE7; Q9UMX0; P43686; P35998; Q8TCJ2; P11021"]
["GO:0003273","biological_process","cell migration involved in endocardial cushion formation ","O43623; P17813; P46531"]
["GO:0035921","biological_process","desmosome disassembly ","O43623"]
["GO:0003198","biological_process","epithelial to mesenchymal transition involved in endocardial cushion formation ","O43623; Q13485; P35548; P17813; P46531; O95863; Q06330"]
["GO:0060429","biological_process","epithelium development ","O43623; Q9P2D1"]
["GO:1900387","biological_process","negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter ","O43623"]
["GO:0032331","biological_process","negative regulation of chondrocyte differentiation ","O43623; P12272; P10070; P36897; P13631; P48436"]
["GO:1902230","biological_process","negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage ","O43623; Q8N163; Q13049; Q07817; O95863; P55957; P13693; P55273"]
["GO:0070563","biological_process","negative regulation of vitamin D receptor signaling pathway ","O43623"]
["GO:0032642","biological_process","regulation of chemokine production ","O43623"]
["GO:0042634","biological_process","regulation of hair cycle ","O15516; Q6KC79; O00327; O15534"]
["GO:2000074","biological_process","regulation of type B pancreatic cell development ","O15516; O00327; Q15382"]
["GO:0051775","biological_process","response to redox state ","O15516; O00327; Q92736; Q9UBF6; Q8IXJ6"]
["GO:0006607","biological_process","NLS-bearing protein import into nucleus ","P49792; O00505; P52294; Q13191; P52292; Q9NZQ3; Q8NFH5; O15117"]
["GO:0046604","biological_process","positive regulation of mitotic centrosome separation ","P49792; Q14CS0; Q9UNZ2; Q9H6Z4; Q7Z3J3"]
["GO:0070536","biological_process","protein K-linked deubiquitination ","Q9NWV8; Q9Y2K6; Q9NQC7; P54252; Q9UHP3; Q6GQQ9; P40818"]
["GO:0070228","biological_process","regulation of lymphocyte apoptotic process ","P09693"]
["GO:0008635","biological_process","activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c ","P55211; O14727; Q07812; Q9NR28; P99999; Q16611"]
["GO:0032025","biological_process","response to cobalt ion ","P55211; Q14790; P18846; P42574"]
["GO:0000495","biological_process","box H/ACA snoRNA 3'-end processing ","O60832; O95453"]
["GO:0000455","biological_process","enzyme-directed rRNA pseudouridine synthesis ","O60832"]
["GO:1990481","biological_process","mRNA pseudouridine synthesis ","O60832"]
["GO:1904851","biological_process","positive regulation of establishment of protein localization to telomere ","O60832; P78371; Q9BUR4"]
["GO:1904871","biological_process","positive regulation of protein localization to Cajal body ","O60832; P78371"]
["GO:1904874","biological_process","positive regulation of telomerase RNA localization to Cajal body ","O60832; P78371; Q9Y230; Q9Y265"]
["GO:1904872","biological_process","regulation of telomerase RNA localization to Cajal body ","O60832; O95453"]
["GO:0031118","biological_process","rRNA pseudouridine synthesis ","O60832"]
["GO:0090666","biological_process","scaRNA localization to Cajal body ","O60832; P78371; Q9BUR4"]
["GO:0031120","biological_process","snRNA pseudouridine synthesis ","O60832"]
["GO:0090669","biological_process","telomerase RNA stabilization ","O60832; O95453"]
["GO:0090190","biological_process","positive regulation of branching involved in ureteric bud morphogenesis ","P09629; Q02962; Q9Y5V3; P50052; P48436"]
["GO:0016266","biological_process","-glycan processing ","P15941; Q7Z5P9"]
["GO:0043618","biological_process","regulation of transcription from RNA polymerase II promoter in response to stress ","P15941"]
["GO:0031440","biological_process","regulation of mRNA '-end processing ","P51003; O43865; Q07352"]
["GO:0043631","biological_process","RNA polyadenylation ","P51003; Q8TCS8"]
["GO:0008334","biological_process","histone mRNA metabolic process ","Q14493; P14678; P05455; P52298; P62304; Q09161"]
["GO:0006398","biological_process","mRNA '-end processing by stem-loop binding and cleavage ","Q14493; Q9P2I0; Q9UKF6"]
["GO:0033260","biological_process","nuclear DNA replication ","Q14493"]
["GO:0046541","biological_process","saliva secretion ","O15554; P55064; P20309"]
["GO:0061511","biological_process","centriole elongation ","Q9HC77"]
["GO:1904951","biological_process","positive regulation of establishment of protein localization ","Q9HC77"]
["GO:1902857","biological_process","positive regulation of non-motile cilium assembly ","Q9HC77; Q16181; Q9UHD8"]
["GO:0098939","biological_process","dendritic transport of mitochondrion ","Q92558"]
["GO:0072673","biological_process","lamellipodium morphogenesis ","Q92558; Q9Y6W5; O60749; Q8IZP0"]
["GO:0051388","biological_process","positive regulation of neurotrophin TRK receptor signaling pathway ","Q92558"]
["GO:0070934","biological_process","CRD-mediated mRNA stabilization ","Q9NZI8; O60506; P67809; Q00839"]
["GO:0022013","biological_process","pallium cell proliferation in forebrain ","Q9NZI8"]
["GO:0010610","biological_process","regulation of mRNA stability involved in response to stress ","Q9NZI8"]
["GO:1904778","biological_process","positive regulation of protein localization to cell cortex ","P81274; P11171; Q14980"]
["GO:1905832","biological_process","positive regulation of spindle assembly ","P81274; Q96R06; Q8TD08; Q14204; Q14980"]
["GO:0031291","biological_process","Ran protein signal transduction ","P81274"]
["GO:0002669","biological_process","positive regulation of T cell anergy ","P07766; Q9BZS1; Q96J02"]
["GO:0097167","biological_process","circadian regulation of translation ","O15055; Q9BWF3; Q14103; O15534"]
["GO:0019249","biological_process","lactate biosynthetic process ","O15055; Q99497"]
["GO:0070345","biological_process","negative regulation of fat cell proliferation ","O15055; Q14186; Q01094; O00716; P23769"]
["GO:0051946","biological_process","regulation of glutamate uptake involved in transmission of nerve impulse ","O15055"]
["GO:0019229","biological_process","regulation of vasoconstriction ","O15055; P30411; P42892; P22460; P35367; P08913; P30556; P12821"]
["GO:0048268","biological_process","clathrin coat assembly ","P53675; P42566; Q14677; O00443; P09496; P63010; Q00610"]
["GO:0001580","biological_process","detection of chemical stimulus involved in sensory perception of bitter taste ","P11488"]
["GO:0050908","biological_process","detection of light stimulus involved in visual perception ","P11488; O76090"]
["GO:0007603","biological_process","phototransduction, visible light ","P11488; P08100"]
["GO:0051343","biological_process","positive regulation of cyclic-nucleotide phosphodiesterase activity ","P11488; P0DP23; P63244"]
["GO:0009642","biological_process","response to light intensity ","P11488; P04040"]
["GO:0050917","biological_process","sensory perception of umami taste ","P11488; Q14573"]
["GO:1904401","biological_process","cellular response to Thyroid stimulating hormone ","P05388"]
["GO:0010269","biological_process","response to selenium ion ","P05388; P07203"]
["GO:0042254","biological_process","ribosome biogenesis ","P05388; Q9NY61; Q9NYV6; O14980; Q9NRR4"]
["GO:0036444","biological_process","calcium import into the mitochondrion ","Q8NE86"]
["GO:0006851","biological_process","mitochondrial calcium ion transmembrane transport ","Q8NE86; O95202; Q9UJZ1; P35232; Q6J4K2; P21796; Q99623"]
["GO:0071557","biological_process","histone H3-K2 demethylation ","Q9UPP1"]
["GO:0070544","biological_process","histone H3-K36 demethylation ","Q9UPP1; O94953; Q9H3R0; Q9Y2K7"]
["GO:0035574","biological_process","histone H-K2 demethylation ","Q9UPP1"]
["GO:0061188","biological_process","negative regulation of chromatin silencing at rDNA ","Q9UPP1; O75151"]
["GO:0015872","biological_process","dopamine transport ","O15245; Q01959; P21728; Q05940"]
["GO:0006855","biological_process","drug transmembrane transport ","O15245; Q15311; P33527"]
["GO:0048241","biological_process","epinephrine transport ","O15245"]
["GO:0010248","biological_process","establishment or maintenance of transmembrane electrochemical gradient ","O15245; Q07812; Q16611"]
["GO:0006836","biological_process","neurotransmitter transport ","O15245; O43426"]
["GO:0015874","biological_process","norepinephrine transport ","O15245; P23975"]
["GO:0015695","biological_process","organic cation transport ","O15245; Q9H310"]
["GO:0051458","biological_process","corticotropin secretion ","P34998"]
["GO:1901386","biological_process","negative regulation of voltage-gated calcium channel activity ","P34998; P41146; Q06787; P14416"]
["GO:0007567","biological_process","parturition ","P34998; P01236"]
["GO:0010578","biological_process","regulation of adenylate cyclase activity involved in -protein coupled receptor signaling pathway ","P34998"]
["GO:2000852","biological_process","regulation of corticosterone secretion ","P34998"]
["GO:0070911","biological_process","global genome nucleotide-excision repair ","P62979; P19447; P0CG47; P54727; P23025; P41208; Q16531; P62987; P09874"]
["GO:0075733","biological_process","intracellular transport of virus ","P62979; P52294; P0CG47; P62826; P62987; O14980"]
["GO:0000715","biological_process","nucleotide-excision repair, DNA damage recognition ","P62979; Q13098; P0CG47; P54727; Q7L5N1; P23025; P41208; Q9UNS2; Q16531; P62987; P09874"]
["GO:0019068","biological_process","virion assembly ","P62979; P0CG47; P02649; P62820; P62987"]
["GO:0034316","biological_process","negative regulation of Arp2/ complex-mediated actin nucleation ","P60983; Q9BR76; Q9NRD5"]
["GO:0071468","biological_process","cellular response to acidic pH ","Q9BXF6; P19634; Q8NER1"]
["GO:0070164","biological_process","negative regulation of adiponectin secretion ","Q9BXF6; Q6WKZ4; O75154"]
["GO:0045055","biological_process","regulated exocytosis ","Q9BXF6; Q7L804; Q86UR5; Q6WKZ4; Q9H3Z4"]
["GO:0043983","biological_process","histone H-K12 acetylation ","O95251; Q6IE81"]
["GO:0072716","biological_process","response to actinomycin D ","O95251"]
["GO:0072739","biological_process","response to anisomycin ","O95251"]
["GO:0072720","biological_process","response to dithiothreitol ","O95251"]
["GO:0072710","biological_process","response to hydroxyurea ","O95251"]
["GO:0072708","biological_process","response to sorbitol ","O95251; Q9H211"]
["GO:0097286","biological_process","iron ion import ","P02786"]
["GO:0017156","biological_process","calcium ion regulated exocytosis ","Q15836; P63027; P51809; Q86UR5"]
["GO:1903531","biological_process","negative regulation of secretion by cell ","Q15836"]
["GO:0035493","biological_process","SNARE complex assembly ","Q15836; Q16623; Q9P2Y5; P51809; O75379; P23763"]
["GO:0006904","biological_process","vesicle docking involved in exocytosis ","Q15836; Q14721; P61764; P13569; O00186; Q96AX2; P08567; P61266; Q6PUV4"]
["GO:0060837","biological_process","blood vessel endothelial cell differentiation ","Q9BSQ5"]
["GO:0001885","biological_process","endothelial cell development ","Q9BSQ5; P07203"]
["GO:0048845","biological_process","venous blood vessel morphogenesis ","Q9BSQ5; P17813"]
["GO:0006438","biological_process","valyl-tRNA aminoacylation ","P26640"]
["GO:0099642","biological_process","retrograde axonal protein transport ","Q15700; P78559"]
["GO:2001014","biological_process","regulation of skeletal muscle cell differentiation ","P17844; Q92841"]
["GO:0045069","biological_process","regulation of viral genome replication ","P17844; P10415"]
["GO:0042045","biological_process","epithelial fluid transport ","O43865; Q14643"]
["GO:0006611","biological_process","protein export from nucleus ","O43865; P38646; P35658; Q7RTN6; P62826; P98161; O14980"]
["GO:0032412","biological_process","regulation of ion transmembrane transporter activity ","O43865"]
["GO:0033353","biological_process","S-adenosylmethionine cycle ","O43865"]
["GO:0097201","biological_process","negative regulation of transcription from RNA polymerase II promoter in response to stress ","O95817; P25685; P0DMV8; Q14494"]
["GO:1990403","biological_process","embryonic brain development ","P19622; Q9NUY8"]
["GO:0030902","biological_process","hindbrain development ","P19622; O15198; P10070"]
["GO:0038003","biological_process","opioid receptor signaling pathway ","P41143; P41146; P41145; P35372"]
["GO:0051881","biological_process","regulation of mitochondrial membrane potential ","P41143; Q9H2U2; O00299; P0CG47; Q07812; Q99497; P10415; P00441; Q07817; P32322; Q9BXM7; Q16611; P30048; O60260"]
["GO:0055075","biological_process","potassium ion homeostasis ","O75631; P22460; Q12809; P78508"]
["GO:0055078","biological_process","sodium ion homeostasis ","O75631; P37088; P51170; P51168"]
["GO:0015840","biological_process","urea transport ","O75631"]
["GO:0060157","biological_process","urinary bladder development ","O75631; Q8IZQ8; Q9H3D4"]
["GO:0071451","biological_process","cellular response to superoxide ","Q9NX46"]
["GO:0098914","biological_process","membrane repolarization during atrial cardiac muscle cell action potential ","P48544; P48549; P22460; P51787; Q9H2S1"]
["GO:0010107","biological_process","potassium ion import ","P48544; P48048; P48549; O60706; Q14500; O60928; P05023; P48050; Q15842; P63252; Q9UHW9; P78508; Q14654; Q9NPI9"]
["GO:1990573","biological_process","potassium ion import across plasma membrane ","P48544; P48549; Q9Y3Q4; P05023; Q15842; Q9UL51"]
["GO:0099625","biological_process","ventricular cardiac muscle cell membrane repolarization ","P48544; P48549; Q9UK17"]
["GO:0035904","biological_process","aorta development ","Q15750; Q13563; O75626; P50570; Q15036; O43541; Q9Y6N7; Q9UMX1; P63010"]
["GO:0003279","biological_process","cardiac septum development ","Q15750; Q15036; Q9UMR3"]
["GO:0060976","biological_process","coronary vasculature development ","Q15750; O75626; P50570; Q15036; O43541; Q9UMX1; P63010"]
["GO:0050708","biological_process","regulation of protein secretion ","Q96KC8; Q5T5C0; P53367; P35900; Q8NEB9; P19021; Q6P1M3; Q15334"]
["GO:0046888","biological_process","negative regulation of hormone secretion ","Q9GZV9"]
["GO:0010980","biological_process","positive regulation of vitamin D 24-hydroxylase activity ","Q9GZV9; P11473"]
["GO:1904383","biological_process","response to sodium phosphate ","Q9GZV9; Q14103"]
["GO:0042369","biological_process","vitamin D catabolic process ","Q9GZV9"]
["GO:2001268","biological_process","negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway ","Q9H8G2; Q99497"]
["GO:0051068","biological_process","dihydrolipoamide metabolic process ","P09622"]
["GO:0106077","biological_process","histone succinylation ","P09622"]
["GO:0009106","biological_process","lipoate metabolic process ","P09622"]
["GO:0061732","biological_process","mitochondrial acetyl-CoA biosynthetic process from pyruvate ","P09622; P08559"]
["GO:0006120","biological_process","mitochondrial electron transport, NADH to ubiquinone ","P09622; O75489; O43181; O95178; P19404; O95168"]
["GO:1903697","biological_process","negative regulation of microvillus assembly ","P47736"]
["GO:0106072","biological_process","negative regulation of adenylate cyclase-activating -protein coupled receptor signaling pathway ","P41146; P35372"]
["GO:0060454","biological_process","positive regulation of gastric acid secretion ","P41146; Q8NER1"]
["GO:0035810","biological_process","positive regulation of urine volume ","P41146; P17342; P04899; P16066; Q92819; P14416"]
["GO:1904059","biological_process","regulation of locomotor rhythm ","P41146"]
["GO:0007600","biological_process","sensory perception ","P41146; Q9UHC3; Q9Y5Y9; P41145; Q9Y5S1; P35372"]
["GO:0000717","biological_process","nucleotide-excision repair, DNA duplex unwinding ","P19447"]
["GO:0006293","biological_process","nucleotide-excision repair, preincision complex stabilization ","P19447; P27694; P15927; P23025; P28715; Q16531; P09874"]
["GO:1901990","biological_process","regulation of mitotic cell cycle phase transition ","P19447; Q8NG66; Q16531"]
["GO:0009650","biological_process","UV protection ","P19447; P04040; P39748; P23025; P28715; P07203"]
["GO:1905342","biological_process","positive regulation of protein localization to kinetochore ","Q7L2Z9; Q9H211; O14777"]
["GO:0009649","biological_process","entrainment of circadian clock ","O60346; O15534"]
["GO:1900744","biological_process","regulation of p38MAPK cascade ","O60346; Q5VWQ8; O15534; Q15109"]
["GO:0090036","biological_process","regulation of protein kinase C signaling ","O60346; Q02952"]
["GO:0006895","biological_process","olgi to endosome transport ","P61106; Q9H1K0; P42566; P57737; Q92538; Q99523"]
["GO:0046907","biological_process","intracellular transport ","P61106; P02649; Q99666; O14715; P0DJD0; A6NKT7"]
["GO:0090382","biological_process","phagosome maturation ","P61106"]
["GO:0021902","biological_process","commitment of neuronal cell to specific neuron type in forebrain ","Q9C0K0; P26367; P50553; P23769"]
["GO:0003334","biological_process","keratinocyte development ","Q9C0K0; O75369; P31947; Q8WX93; P15408"]
["GO:0097535","biological_process","lymphoid lineage cell migration into thymus ","Q9C0K0"]
["GO:0071678","biological_process","olfactory bulb axon guidance ","Q9C0K0"]
["GO:0043368","biological_process","positive T cell selection ","Q9C0K0; Q8N1K5"]
["GO:0031077","biological_process","post-embryonic camera-type eye development ","Q9C0K0; O43474"]
["GO:0021773","biological_process","striatal medium spiny neuron differentiation ","Q9C0K0; P08476; Q9BYB0"]
["GO:0070143","biological_process","mitochondrial alanyl-tRNA aminoacylation ","Q5JTZ9"]
["GO:0033108","biological_process","mitochondrial respiratory chain complex assembly ","Q5JTZ9; Q00059"]
["GO:0006400","biological_process","tRNA modification ","Q5JTZ9; Q9BXR0; Q9UBP6; P05455; Q08J23"]
["GO:0090222","biological_process","centrosome-templated microtubule nucleation ","Q8TEP8"]
["GO:0048468","biological_process","cell development ","P08476; Q9ULV5; Q9Y4K3; P36383; O75444; O95390"]
["GO:0097154","biological_process","ABAergic neuron differentiation ","P08476; P23769"]
["GO:0042541","biological_process","hemoglobin biosynthetic process ","P08476; Q16665"]
["GO:0045578","biological_process","negative regulation of B cell differentiation ","P08476; Q02363"]
["GO:0046882","biological_process","negative regulation of follicle-stimulating hormone secretion ","P08476"]
["GO:0045077","biological_process","negative regulation of interferon-gamma biosynthetic process ","P08476; Q9BZS1"]
["GO:0046881","biological_process","positive regulation of follicle-stimulating hormone secretion ","P08476; P58012; Q13485"]
["GO:0060279","biological_process","positive regulation of ovulation ","P08476"]
["GO:0042701","biological_process","progesterone secretion ","P08476"]
["GO:0046880","biological_process","regulation of follicle-stimulating hormone secretion ","P08476"]
["GO:0036438","biological_process","maintenance of lens transparency ","Q9UEW8; Q12948"]
["GO:1905408","biological_process","negative regulation of creatine transmembrane transporter activity ","Q9UEW8"]
["GO:0034498","biological_process","early endosome to olgi transport ","Q9H1K0; O60749; Q9Y5X2"]
["GO:0034058","biological_process","endosomal vesicle fusion ","Q9H1K0; Q96JC1"]
["GO:0090160","biological_process","olgi to lysosome transport ","Q9H1K0"]
["GO:0000011","biological_process","vacuole inheritance ","Q9H1K0"]
["GO:0048731","biological_process","system development ","Q9UBC0"]
["GO:0043171","biological_process","peptide catabolic process ","Q9UIQ6; O14773; P12821"]
["GO:0072757","biological_process","cellular response to camptothecin ","P54132; Q06609; O94762"]
["GO:0072711","biological_process","cellular response to hydroxyurea ","P54132; Q06787"]
["GO:0044806","biological_process","-quadruplex DNA unwinding ","P54132; P22626; Q14191"]
["GO:0090329","biological_process","regulation of DNA-dependent DNA replication ","P54132"]
["GO:0048478","biological_process","replication fork protection ","P54132; P51587; Q9BVW5"]
["GO:1904924","biological_process","negative regulation of mitophagy in response to mitochondrial depolarization ","O43464"]
["GO:0019742","biological_process","pentacyclic triterpenoid metabolic process ","O43464"]
["GO:2001269","biological_process","positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway ","O43464; P25445; P06396"]
["GO:0016540","biological_process","protein autoprocessing ","O43464; P17655; P09874; Q16595"]
["GO:0006828","biological_process","manganese ion transport ","Q9Y210; Q9HCX4; Q13507"]
["GO:0031062","biological_process","positive regulation of histone methylation ","Q9Y3Y2; P23759; P17861; Q9Y5B6; Q5VTR2"]
["GO:0009311","biological_process","oligosaccharide metabolic process ","Q13724"]
["GO:0006487","biological_process","protein N-linked glycosylation ","Q13724; Q9BQQ3; P04844; O94808; Q06210; P15382"]
["GO:1902239","biological_process","negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p5 class mediator ","P30411"]
["GO:0006907","biological_process","pinocytosis ","P02765"]
["GO:1901842","biological_process","negative regulation of high voltage-gated calcium channel activity ","P55042; O75628; P55040"]
["GO:0045200","biological_process","establishment of neuroblast polarity ","Q92913; Q96N67"]
["GO:1990834","biological_process","response to odorant ","Q92913; P24394; P50281"]
["GO:0106015","biological_process","negative regulation of inflammatory response to wounding ","Q96LC7"]
["GO:0045446","biological_process","endothelial cell differentiation ","O60869; P21453"]
["GO:0071464","biological_process","cellular response to hydrostatic pressure ","Q13563"]
["GO:0050982","biological_process","detection of mechanical stimulus ","Q13563; P14923; O15273; P98161"]
["GO:0003127","biological_process","detection of nodal flow ","Q13563"]
["GO:0071910","biological_process","determination of liver left/right asymmetry ","Q13563; Q4G0X9"]
["GO:0072177","biological_process","mesonephric duct development ","Q13563; P98161"]
["GO:0072164","biological_process","mesonephric tubule development ","Q13563; P98161"]
["GO:0072218","biological_process","metanephric ascending thin limb development ","Q13563; P98161"]
["GO:0072214","biological_process","metanephric cortex development ","Q13563"]
["GO:0072219","biological_process","metanephric cortical collecting duct development ","Q13563"]
["GO:0072235","biological_process","metanephric distal tubule development ","Q13563"]
["GO:0035502","biological_process","metanephric part of ureteric bud development ","Q13563"]
["GO:0072208","biological_process","metanephric smooth muscle tissue development ","Q13563"]
["GO:0060315","biological_process","negative regulation of ryanodine-sensitive calcium-release channel activity ","Q13563; P30626; P0DP23; O14958"]
["GO:0061441","biological_process","renal artery morphogenesis ","Q13563"]
["GO:0006020","biological_process","inositol metabolic process ","P23677; P51608"]
["GO:0032958","biological_process","inositol phosphate biosynthetic process ","P23677; Q9UHH9; P09038"]
["GO:2000738","biological_process","positive regulation of stem cell differentiation ","Q8TDD2; P09758"]
["GO:0006171","biological_process","cAMP biosynthetic process ","O60266; Q08828; O43306; Q08462; P40145"]
["GO:1904322","biological_process","cellular response to forskolin ","O60266; Q08828; P10109; O43306; Q08462; P13569; Q9BY41; P35869"]
["GO:0006182","biological_process","cMP biosynthetic process ","O60266; P25092; Q08828; P16066; Q02153; Q02108; Q02846; O43306; Q08462; P40145"]
["GO:0030317","biological_process","flagellated sperm motility ","O60266; P82094; Q9NQI0; Q8IYM1; Q5JQC9; P23634; Q4G0X9"]
["GO:0007608","biological_process","sensory perception of smell ","O60266; Q01959; P14416; P27815"]
["GO:0007168","biological_process","receptor guanylyl cyclase signaling pathway ","P25092; P16066; Q02846; Q9UMX6"]
["GO:0034315","biological_process","regulation of Arp2/ complex-mediated actin nucleation ","P53365; P53367; Q9BR76; Q9NRD5"]
["GO:0072750","biological_process","cellular response to leptomycin B ","Q02535"]
["GO:0045662","biological_process","negative regulation of myoblast differentiation ","Q02535; Q9GZV1; P50461; P01375; O15119; P35638; P46531; Q9NUK0; P48436"]
["GO:0010921","biological_process","regulation of phosphatase activity ","O96001"]
["GO:0046886","biological_process","positive regulation of hormone biosynthetic process ","P27540; Q16665; P18146"]
["GO:0071108","biological_process","protein K4-linked deubiquitination ","Q9Y2K6; Q86T82; Q70CQ2; P54252; Q96JH7; Q9UHP3; Q6GQQ9; Q96FW1; P40818"]
["GO:0010070","biological_process","zygote asymmetric cell division ","O43566"]
["GO:0035907","biological_process","dorsal aorta development ","Q99801"]
["GO:0043569","biological_process","negative regulation of insulin-like growth factor receptor signaling pathway ","Q99801"]
["GO:2000836","biological_process","positive regulation of androgen secretion ","Q99801"]
["GO:0007431","biological_process","salivary gland development ","Q99801"]
["GO:0006231","biological_process","dTMP biosynthetic process ","P04818"]
["GO:0006235","biological_process","dTTP biosynthetic process ","P04818"]
["GO:0046078","biological_process","dUMP metabolic process ","P04818"]
["GO:0019088","biological_process","immortalization of host cell by virus ","P04818"]
["GO:0046683","biological_process","response to organophosphorus ","P04818; O95361"]
["GO:0035999","biological_process","tetrahydrofolate interconversion ","P04818; Q6UB35; P42898"]
["GO:0019860","biological_process","uracil metabolic process ","P04818"]
["GO:0097116","biological_process","gephyrin clustering involved in postsynaptic density assembly ","Q9P2S2; Q9ULB1; P58400"]
["GO:0097118","biological_process","neuroligin clustering involved in postsynaptic membrane assembly ","Q9P2S2; P19022; Q9ULB1; P58400; Q86UL8"]
["GO:0097119","biological_process","postsynaptic density protein 5 clustering ","Q9P2S2; Q9ULB1; P58400; Q8N2Q7"]
["GO:0001708","biological_process","cell fate specification ","Q9Y261; P05556; P28069; P49768; P46531; P48436"]
["GO:0071542","biological_process","dopaminergic neuron differentiation ","Q9Y261; Q16665; P55317; O75581; P43354; O14813"]
["GO:2000971","biological_process","negative regulation of detection of glucose ","Q9Y261"]
["GO:0033132","biological_process","negative regulation of glucokinase activity ","Q9Y261; O60260"]
["GO:0061987","biological_process","negative regulation of transcription from RNA polymerase II promoter by glucose ","Q9Y261"]
["GO:2000049","biological_process","positive regulation of cell-cell adhesion mediated by cadherin ","Q9Y261; P55196; P55317; O75955"]
["GO:2000543","biological_process","positive regulation of gastrulation ","Q9Y261; P63244"]
["GO:0000432","biological_process","positive regulation of transcription from RNA polymerase II promoter by glucose ","Q9Y261; Q15853; P22415"]
["GO:0070741","biological_process","response to interleukin-6 ","Q9Y261; Q99966"]
["GO:0038171","biological_process","cannabinoid signaling pathway ","P21554"]
["GO:0045759","biological_process","negative regulation of action potential ","P21554; P63165; P34972"]
["GO:0033602","biological_process","negative regulation of dopamine secretion ","P21554; P14416"]
["GO:0033004","biological_process","negative regulation of mast cell activation ","P21554; Q8TDQ1; P34972"]
["GO:0002866","biological_process","positive regulation of acute inflammatory response to antigenic stimulus ","P21554; Q99497"]
["GO:0045777","biological_process","positive regulation of blood pressure ","P21554; P43220; Q02363; P21731; Q9Y624"]
["GO:0060405","biological_process","regulation of penile erection ","P21554"]
["GO:0098921","biological_process","retrograde trans-synaptic signaling by endocannabinoid ","P21554; Q9Y4D2"]
["GO:0099553","biological_process","trans-synaptic signaling by endocannabinoid, modulating synaptic transmission ","P21554"]
["GO:0016973","biological_process","poly(A)+ mRNA export from nucleus ","Q9BY77; Q8NI27; O75152; Q03014; Q9H4D5"]
["GO:1900025","biological_process","negative regulation of substrate adhesion-dependent cell spreading ","O43707; Q08495; Q9ULV4; O14713; P09758"]
["GO:0032417","biological_process","positive regulation of sodiumproton antiporter activity ","O43707"]
["GO:1902396","biological_process","protein localization to bicellular tight junction ","O43707; P21333"]
["GO:1903506","biological_process","regulation of nucleic acid-templated transcription ","O43707; Q9UKM9"]
["GO:0051085","biological_process","chaperone cofactor-dependent protein refolding ","Q92598; P25685; Q15185; Q96HE7"]
["GO:1903751","biological_process","negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide ","Q92598; Q12931; Q9BXM7"]
["GO:0051135","biological_process","positive regulation of NK T cell activation ","Q92598"]
["GO:0009117","biological_process","nucleotide metabolic process ","Q9H4L7; P49789"]
["GO:0033962","biological_process","cytoplasmic mRNA processing body assembly ","Q86TB9; Q9UGP4; Q96F86; Q5TC82; Q14204; P26196"]
["GO:0000290","biological_process","deadenylation-dependent decapping of nuclear-transcribed mRNA ","Q86TB9; Q9NPI6"]
["GO:0043928","biological_process","exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay ","Q86TB9; Q9Y450; Q96F86; Q9ULM6; Q06265; Q9NQT5; Q15024; Q9NPI6; P26196; Q9NQT4"]
["GO:0055008","biological_process","cardiac muscle tissue morphogenesis ","Q8WZ42; P52952; Q15327; O15273; P46531; Q9H1R3; Q9UMR3"]
["GO:0035995","biological_process","detection of muscle stretch ","Q8WZ42; P50461; O15273"]
["GO:0048769","biological_process","sarcomerogenesis ","Q8WZ42; O15273"]
["GO:0030240","biological_process","skeletal muscle thin filament assembly ","Q8WZ42; P68133; O15273"]
["GO:0046061","biological_process","dATP catabolic process ","Q9Y3Z3"]
["GO:0009264","biological_process","deoxyribonucleotide catabolic process ","Q9Y3Z3"]
["GO:0006203","biological_process","dTP catabolic process ","Q9Y3Z3"]
["GO:0110025","biological_process","DNA strand resection involved in replication fork processing ","Q9Y3Z3; P49959"]
["GO:0009566","biological_process","fertilization ","P16989; Q92692; Q07812; Q07817"]
["GO:0048642","biological_process","negative regulation of skeletal muscle tissue development ","P16989; Q99576; Q15672"]
["GO:0051128","biological_process","regulation of cellular component organization ","Q9Y2H1"]
["GO:0035051","biological_process","cardiocyte differentiation ","Q8IZQ8"]
["GO:0043954","biological_process","cellular component maintenance ","Q8IZQ8"]
["GO:0097070","biological_process","ductus arteriosus closure ","Q8IZQ8; Q12946"]
["GO:2001015","biological_process","negative regulation of skeletal muscle cell differentiation ","Q8IZQ8"]
["GO:2000724","biological_process","positive regulation of cardiac vascular smooth muscle cell differentiation ","Q8IZQ8"]
["GO:2000721","biological_process","positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation ","Q8IZQ8"]
["GO:0001560","biological_process","regulation of cell growth by extracellular stimulus ","Q8IZQ8; Q96SB3"]
["GO:0035065","biological_process","regulation of histone acetylation ","Q8IZQ8; P23769"]
["GO:1900239","biological_process","regulation of phenotypic switching ","Q8IZQ8"]
["GO:0035886","biological_process","vascular smooth muscle cell differentiation ","Q8IZQ8; Q99697"]
["GO:0060317","biological_process","cardiac epithelial to mesenchymal transition ","Q03167; Q9NQC3; P36897; P46531; Q13444"]
["GO:0060318","biological_process","definitive erythrocyte differentiation ","Q03167"]
["GO:0060939","biological_process","epicardium-derived cardiac fibroblast cell development ","Q03167"]
["GO:0061384","biological_process","heart trabecula morphogenesis ","Q03167; P21453; Q13765; P46531; Q07889"]
["GO:0003150","biological_process","muscular septum morphogenesis ","Q03167; Q9ULK5"]
["GO:0032354","biological_process","response to follicle-stimulating hormone ","Q03167"]
["GO:0034699","biological_process","response to luteinizing hormone ","Q03167"]
["GO:0007181","biological_process","transforming growth factor beta receptor complex assembly ","Q03167"]
["GO:0060979","biological_process","vasculogenesis involved in coronary vascular morphogenesis ","Q03167; P46531"]
["GO:0003223","biological_process","ventricular compact myocardium morphogenesis ","Q03167; P36897; P36894; Q01851; P15924"]
["GO:1903265","biological_process","positive regulation of tumor necrosis factor-mediated signaling pathway ","Q12933; P0DMV8; P78536; Q13049; O60260"]
["GO:0051023","biological_process","regulation of immunoglobulin secretion ","Q12933; Q9Y4K3; P01375; P25942"]
["GO:0042791","biological_process","5S class rRNA transcription by RNA polymerase III ","Q9Y5Q9; Q12789"]
["GO:0006383","biological_process","transcription by RNA polymerase III ","Q9Y5Q9; O15160; P61218; Q12789; Q92994; Q9Y2Y1; Q14585; P05423"]
["GO:0042797","biological_process","tRNA transcription by RNA polymerase III ","Q9Y5Q9; Q12789"]
["GO:0071259","biological_process","cellular response to magnetism ","P15173; P50553"]
["GO:0014737","biological_process","positive regulation of muscle atrophy ","P15173"]
["GO:1903862","biological_process","positive regulation of oxidative phosphorylation ","P15173; P55072"]
["GO:1901739","biological_process","regulation of myoblast fusion ","P15173"]
["GO:0014842","biological_process","regulation of skeletal muscle satellite cell proliferation ","P15173; Q9Y5B6; O15519"]
["GO:0014873","biological_process","response to muscle activity involved in regulation of muscle adaptation ","P15173; Q9UGI9"]
["GO:0014891","biological_process","striated muscle atrophy ","P15173; P06396"]
["GO:0032981","biological_process","mitochondrial respiratory chain complex I assembly ","O75489; O43181; Q16635; O95178; P19404; O95168; Q9P0J0; Q9BQ95"]
["GO:0097352","biological_process","autophagosome maturation ","P13473; P56962; P55072; O95295; Q9UMX0; Q9GZQ8; Q9Y3E7; Q9GZU1; Q9H492"]
["GO:1905146","biological_process","lysosomal protein catabolic process ","P13473"]
["GO:0017038","biological_process","protein import ","P13473; P02649"]
["GO:0061740","biological_process","protein targeting to lysosome involved in chaperone-mediated autophagy ","P13473; P11142"]
["GO:0045647","biological_process","negative regulation of erythrocyte differentiation ","P38646; P17542; Q9Y5Q3; P51692; Q07352; P26651"]
["GO:1902037","biological_process","negative regulation of hematopoietic stem cell differentiation ","P38646; Q16236"]
["GO:0038203","biological_process","TRC signaling ","P85299; Q96A49; Q9BXM7; Q9BPZ7"]
["GO:0060466","biological_process","activation of meiosis involved in egg activation ","Q9NQ66"]
["GO:2000438","biological_process","negative regulation of monocyte extravasation ","Q9NQ66"]
["GO:2000344","biological_process","positive regulation of acrosome reaction ","Q9NQ66; O95180"]
["GO:2000560","biological_process","positive regulation of CD4 biosynthetic process ","Q9NQ66"]
["GO:0099170","biological_process","postsynaptic modulation of chemical synaptic transmission ","Q9NQ66; Q08209; P41594; P14416; Q92686; Q9UBU3; P43146"]
["GO:0080154","biological_process","regulation of fertilization ","Q9NQ66"]
["GO:0099178","biological_process","regulation of retrograde trans-synaptic signaling by endocanabinoid ","Q9NQ66"]
["GO:0003170","biological_process","heart valve development ","O75626; P48436"]
["GO:0001763","biological_process","morphogenesis of a branching structure ","O75626; Q12946"]
["GO:0031665","biological_process","negative regulation of lipopolysaccharide-mediated signaling pathway ","O75626"]
["GO:0033082","biological_process","regulation of extrathymic T cell differentiation ","O75626"]
["GO:0032823","biological_process","regulation of natural killer cell differentiation ","O75626"]
["GO:0051136","biological_process","regulation of NK T cell differentiation ","O75626"]
["GO:1990654","biological_process","sebum secreting cell proliferation ","O75626"]
["GO:0008333","biological_process","endosome to lysosome transport ","A2RUS2; Q96JC1; Q99626; P51809; P20645; O95295; P62745; Q99523; Q9Y5H0; P07550"]
["GO:0032012","biological_process","regulation of ARF protein signal transduction ","O43739; Q9Y6D6; Q99418; Q15438; Q92538"]
["GO:0038160","biological_process","CXCL2-activated CXCR4 signaling pathway ","P61073"]
["GO:0030260","biological_process","entry into host cell ","P61073; P51681; P01730"]
["GO:0019064","biological_process","fusion of virus membrane with host plasma membrane ","P61073; P51681; Q92692; P01730"]
["GO:0043217","biological_process","myelin maintenance ","P61073"]
["GO:0021846","biological_process","cell proliferation in forebrain ","O60315; Q15058"]
["GO:0021540","biological_process","corpus callosum morphogenesis ","O60315; Q5T011"]
["GO:0061373","biological_process","mammillary axonal complex development ","O60315"]
["GO:1902748","biological_process","positive regulation of lens fiber cell differentiation ","O60315"]
["GO:0048023","biological_process","positive regulation of melanin biosynthetic process ","O60315"]
["GO:0045636","biological_process","positive regulation of melanocyte differentiation ","O60315; P10415"]
["GO:1903056","biological_process","regulation of melanosome organization ","O60315"]
["GO:0020027","biological_process","hemoglobin metabolic process ","P04040; P35611"]
["GO:0042744","biological_process","hydrogen peroxide catabolic process ","P04040; P30041; P30044; Q06830; P07203; Q9NRD9; P30048; P32119"]
["GO:0014854","biological_process","response to inactivity ","P04040; P14416"]
["GO:0033591","biological_process","response to L-ascorbic acid ","P04040; P09211; P17301"]
["GO:0010193","biological_process","response to ozone ","P04040"]
["GO:0080184","biological_process","response to phenylpropanoid ","P04040"]
["GO:1903553","biological_process","positive regulation of extracellular exosome assembly ","O00560; P18827; P31431"]
["GO:0006930","biological_process","substrate-dependent cell migration, cell extension ","O00560; A0MZ66; P16333; Q9H244; Q14247"]
["GO:0099173","biological_process","postsynapse organization ","Q92597"]
["GO:0098869","biological_process","cellular oxidant detoxification ","P30041; Q13423"]
["GO:0046475","biological_process","glycerophospholipid catabolic process ","P30041"]
["GO:0035095","biological_process","behavioral response to nicotine ","P43681; Q07869"]
["GO:0050877","biological_process","nervous system process ","P43681; Q14654"]
["GO:0007274","biological_process","neuromuscular synaptic transmission ","P43681; Q07001; P41161; Q9UBL9; P61764; Q9H1R3; P07510"]
["GO:0007271","biological_process","synaptic transmission, cholinergic ","P43681; Q07001; P02649; P08172; P08173; P07510; P20309"]
["GO:1904380","biological_process","endoplasmic reticulum mannose trimming ","Q9UKV5"]
["GO:0001543","biological_process","ovarian follicle rupture ","P48552"]
["GO:0061573","biological_process","actin filament bundle retrograde transport ","A0MZ66"]
["GO:0061163","biological_process","endoplasmic reticulum polarization ","A0MZ66"]
["GO:2001224","biological_process","positive regulation of neuron migration ","A0MZ66; Q6KC79; Q92974; O15014; Q5VWQ8; Q96Q89; Q9Y4G8; Q5XUX0; P21333; Q6X4W1"]
["GO:0098884","biological_process","postsynaptic neurotransmitter receptor internalization ","P42566; P63010"]
["GO:0010812","biological_process","negative regulation of cell-substrate adhesion ","P09382; Q08495; P00747; O00255; P46531; P61586"]
["GO:0002317","biological_process","plasma cell differentiation ","P09382"]
["GO:0034120","biological_process","positive regulation of erythrocyte aggregation ","P09382"]
["GO:0050810","biological_process","regulation of steroid biosynthetic process ","Q9UHI6; Q13285; Q15637"]
["GO:0000244","biological_process","spliceosomal tri-snRNP complex assembly ","Q9UHI6; Q13107; Q9UMS4; O43395; Q15020; Q6P2Q9; O75494"]
["GO:0018279","biological_process","protein N-linked glycosylation via asparagine ","P04844; P55072; O95848; Q9Y385; Q8TCJ2; P04843"]
["GO:0043383","biological_process","negative T cell selection ","Q8N1K5"]
["GO:0060213","biological_process","positive regulation of nuclear-transcribed mRNA poly(A) tail shortening ","P78543; P50616; P11940; Q9UPQ9; Q8NE35; P26651; Q9UKV8"]
["GO:0006479","biological_process","protein methylation ","P78543; P14678; P62495; O60678; Q9NR22; Q99873"]
["GO:0006699","biological_process","bile acid biosynthetic process ","P49675; P22307; Q96SU4; P22059"]
["GO:0018879","biological_process","biphenyl metabolic process ","P49675"]
["GO:0006700","biological_process","C21-steroid hormone biosynthetic process ","P49675; Q14849; P10109"]
["GO:0071378","biological_process","cellular response to growth hormone stimulus ","P49675"]
["GO:0071373","biological_process","cellular response to luteinizing hormone stimulus ","P49675; P20248"]
["GO:0042747","biological_process","circadian sleep/wake cycle, REM sleep ","P49675"]
["GO:0018894","biological_process","dibenzo-p-dioxin metabolic process ","P49675"]
["GO:0006703","biological_process","estrogen biosynthetic process ","P49675; P11511"]
["GO:0008211","biological_process","glucocorticoid metabolic process ","P49675; P51608"]
["GO:0017143","biological_process","insecticide metabolic process ","P49675"]
["GO:0032367","biological_process","intracellular cholesterol transport ","P49675; O95477; P22059"]
["GO:0018958","biological_process","phenol-containing compound metabolic process ","P49675"]
["GO:0070859","biological_process","positive regulation of bile acid biosynthetic process ","P49675; P20393"]
["GO:0060992","biological_process","response to fungicide ","P49675; O60341"]
["GO:0006694","biological_process","steroid biosynthetic process ","P49675; P05093; P11511; P22307; P16471"]
["GO:0061370","biological_process","testosterone biosynthetic process ","P49675; P11511"]
["GO:0035195","biological_process","gene silencing by miRNA ","Q9UGP4; P56537; Q9ULM6; Q96IF1"]
["GO:0006391","biological_process","transcription initiation from mitochondrial promoter ","Q00059"]
["GO:0043921","biological_process","modulation by host of viral transcription ","P17980"]
["GO:0010659","biological_process","cardiac muscle cell apoptotic process ","O60936; O14727"]
["GO:1990001","biological_process","inhibition of cysteine-type endopeptidase activity involved in apoptotic process ","O60936; Q9NPP4; Q9HB09; O15392; P98170"]
["GO:1902109","biological_process","negative regulation of mitochondrial membrane permeability involved in apoptotic process ","O60936"]
["GO:0060547","biological_process","negative regulation of necrotic cell death ","O60936"]
["GO:0014808","biological_process","release of sequestered calcium ion into cytosol by sarcoplasmic reticulum ","O60936; P51681; Q92736; P21817"]
["GO:0014876","biological_process","response to injury involved in regulation of muscle adaptation ","O60936"]
["GO:0006083","biological_process","acetate metabolic process ","P51649"]
["GO:0006681","biological_process","galactosylceramide metabolic process ","P51649"]
["GO:0009450","biological_process","gamma-aminobutyric acid catabolic process ","P51649"]
["GO:0006678","biological_process","glucosylceramide metabolic process ","P51649"]
["GO:0006540","biological_process","glutamate decarboxylation to succinate ","P51649; Q99259"]
["GO:0006650","biological_process","glycerophospholipid metabolic process ","P51649"]
["GO:0042135","biological_process","neurotransmitter catabolic process ","P51649; P21397"]
["GO:0046459","biological_process","short-chain fatty acid metabolic process ","P51649"]
["GO:0045163","biological_process","clustering of voltage-gated potassium channels ","Q9NS61"]
["GO:0086009","biological_process","membrane repolarization ","Q9NS61; P05023; Q12809; Q9UK17; P15382"]
["GO:0086013","biological_process","membrane repolarization during cardiac muscle cell action potential ","Q9NS61; P62258; P51787; P05023; Q12809; Q9UK17; P15382; P63252"]
["GO:0071435","biological_process","potassium ion export ","Q9NS61; P22460; P51787; Q7Z418; Q12809; Q9UK17; P15382"]
["GO:0097623","biological_process","potassium ion export across plasma membrane ","Q9NS61; P51787; Q12809; Q9UK17"]
["GO:2001257","biological_process","regulation of cation channel activity ","Q9NS61; Q86YM7"]
["GO:1902605","biological_process","heterotrimeric -protein complex assembly ","Q13371"]
["GO:0008616","biological_process","queuosine biosynthetic process ","Q13371; P20941"]
["GO:0048569","biological_process","post-embryonic animal organ development ","P00338"]
["GO:0006090","biological_process","pyruvate metabolic process ","P00338; Q04760; P07195; P29803; P21796"]
["GO:0038002","biological_process","endocrine signaling ","P01116"]
["GO:0060441","biological_process","epithelial tube branching involved in lung morphogenesis ","P01116; Q8TDM6; P55317; Q12946; Q14118; P43699; P48436"]
["GO:0035022","biological_process","positive regulation of Rac protein signal transduction ","P01116"]
["GO:0071344","biological_process","diphosphate metabolic process ","Q9H2U2"]
["GO:0006880","biological_process","intracellular sequestering of iron ion ","P30626"]
["GO:0055118","biological_process","negative regulation of cardiac muscle contraction ","P30626; O76074; Q5D1E8; P48736"]
["GO:0010459","biological_process","negative regulation of heart rate ","P30626; P26678; P50052"]
["GO:1901841","biological_process","regulation of high voltage-gated calcium channel activity ","P30626; P0DP23; Q07343"]
["GO:0006942","biological_process","regulation of striated muscle contraction ","P30626; P45378; P10916; Q14896"]
["GO:0098655","biological_process","cation transmembrane transport ","Q07001; P07510"]
["GO:0050881","biological_process","musculoskeletal movement ","Q07001; Q6Y7W6"]
["GO:0048630","biological_process","skeletal muscle tissue growth ","Q07001"]
["GO:0002084","biological_process","protein depalmitoylation ","Q5VWZ2"]
["GO:0000479","biological_process","endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) ","Q2NL82"]
["GO:0003407","biological_process","neural retina development ","P51532; P51674; P49768; Q6STE5; P23634; P42575"]
["GO:0050709","biological_process","negative regulation of protein secretion ","Q9C0H9; Q9H2B2; P35462; P14416; P30040"]
["GO:0050807","biological_process","regulation of synapse organization ","P51674; P07437; P55072; P41161; Q71U36; Q13651; Q14118"]
["GO:0045653","biological_process","negative regulation of megakaryocyte differentiation ","Q06546; P62805; Q99828; Q99873"]
["GO:0098887","biological_process","neurotransmitter receptor transport, endosome to postsynaptic membrane ","Q4V328; Q14160; P62491"]
["GO:0099152","biological_process","regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane ","Q4V328"]
["GO:0099158","biological_process","regulation of recycling endosome localization within postsynapse ","Q4V328"]
["GO:0008645","biological_process","hexose transmembrane transport ","P11168"]
["GO:0106001","biological_process","intestinal hexose absorption ","P11168"]
["GO:0060260","biological_process","regulation of transcription initiation from RNA polymerase II promoter ","Q15545"]
["GO:0051123","biological_process","RNA polymerase II transcriptional preinitiation complex assembly ","Q15545; Q00403"]
["GO:0000296","biological_process","spermine transport ","Q15545"]
["GO:0006825","biological_process","copper ion transport ","Q02790; P00450; Q04656"]
["GO:0046661","biological_process","male sex differentiation ","Q02790"]
["GO:0031111","biological_process","negative regulation of microtubule polymerization or depolymerization ","Q02790"]
["GO:0031503","biological_process","protein-containing complex localization ","Q02790; O15392"]
["GO:0006463","biological_process","steroid hormone receptor complex assembly ","Q02790"]
["GO:0022027","biological_process","interkinetic nuclear migration ","Q15154; Q96N67; Q03014"]
["GO:0034453","biological_process","microtubule anchoring ","Q15154; O95684; O75122; Q14118"]
["GO:0034454","biological_process","microtubule anchoring at centrosome ","Q15154; Q14203; Q9Y496"]
["GO:0050768","biological_process","negative regulation of neurogenesis ","Q15154; Q92974; P26367; Q92673; P01375; P46531; P36894"]
["GO:0006307","biological_process","DNA dealkylation involved in DNA repair ","Q8N3C0; Q8N9N2"]
["GO:0044772","biological_process","mitotic cell cycle phase transition ","Q8NG66; Q9Y250"]
["GO:2000675","biological_process","negative regulation of type B pancreatic cell apoptotic process ","P52945; Q9NQB0; Q13247; Q13562"]
["GO:0003309","biological_process","type B pancreatic cell differentiation ","P52945; Q92908; P26367; O00255"]
["GO:0090527","biological_process","actin filament reorganization ","Q08495; P06396"]
["GO:0035585","biological_process","calcium-mediated signaling using extracellular calcium source ","Q08495; Q13936; Q9H244"]
["GO:0090315","biological_process","negative regulation of protein targeting to membrane ","Q08495; P31150; O14713; P15382"]
["GO:2001046","biological_process","positive regulation of integrin-mediated signaling pathway ","Q08495; P21333"]
["GO:1901731","biological_process","positive regulation of platelet aggregation ","Q08495"]
["GO:0070560","biological_process","protein secretion by platelet ","Q08495; P08567"]
["GO:1904117","biological_process","cellular response to vasopressin ","Q99741; O43306; P46060"]
["GO:0051984","biological_process","positive regulation of chromosome segregation ","Q99741; Q9NS91; Q14980"]
["GO:0002158","biological_process","osteoclast proliferation ","P17342"]
["GO:0019054","biological_process","modulation by virus of host process ","O00505; P52294; P52292"]
["GO:0050968","biological_process","detection of chemical stimulus involved in sensory perception of pain ","Q9UHC3; Q8NER1; O75762"]
["GO:0050915","biological_process","sensory perception of sour taste ","Q9UHC3; P78348"]
["GO:0032364","biological_process","oxygen homeostasis ","Q13423; Q16665; P04179"]
["GO:1902600","biological_process","proton transmembrane transport ","Q13423; P19634; Q96D96; P56134"]
["GO:0033273","biological_process","response to vitamin ","Q13423; Q15047"]
["GO:0006865","biological_process","amino acid transport ","P48065; Q99624; P31641; P08195"]
["GO:0002276","biological_process","basophil activation involved in immune response ","Q15046; O14638"]
["GO:0006430","biological_process","lysyl-tRNA aminoacylation ","Q15046"]
["GO:1900017","biological_process","positive regulation of cytokine production involved in inflammatory response ","Q15046; Q96F46; O00206; P30203"]
["GO:0008033","biological_process","tRNA processing ","Q15046; O95363; Q96S44; O75817; O95707; P05455"]
["GO:0002115","biological_process","store-operated calcium entry ","Q96D31; Q13586"]
["GO:2000348","biological_process","regulation of CD signaling pathway ","O15360; Q9BXW9"]
["GO:0033500","biological_process","carbohydrate homeostasis ","O15240"]
["GO:2000110","biological_process","negative regulation of macrophage apoptotic process ","P51681; Q92985"]
["GO:0023052","biological_process","signaling ","P51681; Q14106; O95886"]
["GO:0010701","biological_process","positive regulation of norepinephrine secretion ","Q16623; Q14721"]
["GO:0010807","biological_process","regulation of synaptic vesicle priming ","Q16623; P61764; P61266"]
["GO:0016081","biological_process","synaptic vesicle docking ","Q16623; P60880; P61266"]
["GO:0031629","biological_process","synaptic vesicle fusion to presynaptic active zone membrane ","Q16623; O00161; O95295; P60880; P61266"]
["GO:0046784","biological_process","viral mRNA export from host cell nucleus ","Q96J01; Q96FV9; Q8NI27; Q13769; Q86V81"]
["GO:0060480","biological_process","lung goblet cell differentiation ","O95238"]
["GO:0010454","biological_process","negative regulation of cell fate commitment ","O95238"]
["GO:0010455","biological_process","positive regulation of cell fate commitment ","O95238"]
["GO:0046166","biological_process","glyceraldehyde-3-phosphate biosynthetic process ","P60174; P29401"]
["GO:0019563","biological_process","glycerol catabolic process ","P60174"]
["GO:0035623","biological_process","renal glucose absorption ","P20823"]
["GO:0050427","biological_process","3'-phosphoadenosine '-phosphosulfate metabolic process ","O00204; O95861; Q9BR01; P22413"]
["GO:0045606","biological_process","positive regulation of epidermal cell differentiation ","O00204; P31947"]
["GO:0000103","biological_process","sulfate assimilation ","O00204"]
["GO:0007063","biological_process","regulation of sister chromatid cohesion ","O43683"]
["GO:0030037","biological_process","actin filament reorganization involved in cell cycle ","Q96P48"]
["GO:0051270","biological_process","regulation of cellular component movement ","Q96P48"]
["GO:0009257","biological_process","1-formyltetrahydrofolate biosynthetic process ","Q6UB35"]
["GO:0048702","biological_process","embryonic neurocranium morphogenesis ","Q6UB35; O75386"]
["GO:0006760","biological_process","folic acid-containing compound metabolic process ","Q6UB35"]
["GO:0046655","biological_process","folic acid metabolic process ","Q6UB35; P42898"]
["GO:0015942","biological_process","formate metabolic process ","Q6UB35"]
["GO:0071711","biological_process","basement membrane organization ","Q9NPQ8; P05556; P14543; Q14118"]
["GO:0070586","biological_process","cell-cell adhesion involved in gastrulation ","Q9NPQ8"]
["GO:0042074","biological_process","cell migration involved in gastrulation ","Q9NPQ8; Q4VCS5"]
["GO:0061182","biological_process","negative regulation of chondrocyte development ","P12272"]
["GO:0033314","biological_process","mitotic DNA replication checkpoint ","Q7Z2Z1; Q9HAW4; O75943; Q92547"]
["GO:0052652","biological_process","cyclic purine nucleotide metabolic process ","Q01433"]
["GO:0006188","biological_process","IMP biosynthetic process ","Q01433"]
["GO:0032264","biological_process","IMP salvage ","Q01433"]
["GO:0019388","biological_process","galactose catabolic process ","P36871"]
["GO:0005980","biological_process","glycogen catabolic process ","P36871; P11216; P08237; P06737; P11217"]
["GO:1901666","biological_process","positive regulation of NAD+ ADP-ribosyltransferase activity ","P05114"]
["GO:0048597","biological_process","post-embryonic camera-type eye morphogenesis ","P05114; Q07812; Q16611"]
["GO:0040034","biological_process","regulation of development, heterochronic ","P05114"]
["GO:0048871","biological_process","multicellular organismal homeostasis ","Q8WUF5"]
["GO:0003229","biological_process","ventricular cardiac muscle tissue development ","Q8WUF5"]
["GO:0035871","biological_process","protein K-linked deubiquitination ","Q86T82; Q96JH7; Q6GQQ9"]
["GO:0038031","biological_process","non-canonical Wnt signaling pathway via JNK cascade ","Q92997"]
["GO:0035845","biological_process","photoreceptor cell outer segment organization ","Q9NS56"]
["GO:0046549","biological_process","retinal cone cell development ","Q9NS56; P10828; P57796"]
["GO:0043615","biological_process","astrocyte cell migration ","Q14160; P50281"]
["GO:0021747","biological_process","cochlear nucleus development ","Q14160; P10415"]
["GO:0098968","biological_process","neurotransmitter receptor transport postsynaptic membrane to endosome ","Q14160"]
["GO:0071896","biological_process","protein localization to adherens junction ","Q14160; Q8TDM6; P15924"]
["GO:0039563","biological_process","suppression by virus of host STAT1 activity ","Q14160"]
["GO:0039564","biological_process","suppression by virus of host STAT2 activity ","Q14160"]
["GO:0039502","biological_process","suppression by virus of host type I interferon-mediated signaling pathway ","Q14160"]
["GO:0016080","biological_process","synaptic vesicle targeting ","Q14160; P49768; Q99719; Q8N2Q7"]
["GO:0039528","biological_process","cytoplasmic pattern recognition receptor signaling pathway in response to virus ","O95786; Q9BYX4"]
["GO:0009597","biological_process","detection of virus ","O95786; O15455; Q9BYX4"]
["GO:0032725","biological_process","positive regulation of granulocyte macrophage colony-stimulating factor production ","O95786; O95267"]
["GO:0034344","biological_process","regulation of type III interferon production ","O95786; Q9BYX4"]
["GO:0039529","biological_process","RI-I signaling pathway ","O95786"]
["GO:0001973","biological_process","adenosine receptor signaling pathway ","P04899"]
["GO:0140199","biological_process","negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process ","P04899; P23634"]
["GO:0045955","biological_process","negative regulation of calcium ion-dependent exocytosis ","P04899; Q9H2B2; P08913; P46531; O00186"]
["GO:1903614","biological_process","negative regulation of protein tyrosine phosphatase activity ","P04899"]
["GO:0050805","biological_process","negative regulation of synaptic transmission ","P04899; Q9H2P0"]
["GO:0033864","biological_process","positive regulation of NAD(P)H oxidase activity ","P04899; P13498; Q99497; P30556"]
["GO:0035815","biological_process","positive regulation of renal sodium excretion ","P04899; P16066; P35462; P50052; P14416"]
["GO:0036503","biological_process","ERAD pathway ","Q8IWQ3; P55072; O60260"]
["GO:1904152","biological_process","regulation of retrograde protein transport, ER to cytosol ","Q8IWQ3"]
["GO:0097039","biological_process","protein linear polyubiquitination ","Q9BYM8"]
["GO:0097211","biological_process","cellular response to gonadotropin-releasing hormone ","Q96P88"]
["GO:0050435","biological_process","amyloid-beta metabolic process ","P08473; P56817; P49810; P12821; Q14457"]
["GO:0002003","biological_process","angiotensin maturation ","P08473; P12821"]
["GO:0071492","biological_process","cellular response to UV-A ","P08473"]
["GO:0006518","biological_process","peptide metabolic process ","P08473; Q9NYG2; Q8IUX7"]
["GO:0006458","biological_process","'de novo' protein folding ","P10809"]
["GO:0002368","biological_process","B cell cytokine production ","P10809"]
["GO:0051702","biological_process","interaction with symbiont ","P10809; P00747; Q9UQE7; P07203; Q16531"]
["GO:0048291","biological_process","isotype switching to Ig isotypes ","P10809"]
["GO:0002842","biological_process","positive regulation of T cell mediated immune response to tumor cell ","P10809"]
["GO:0045041","biological_process","protein import into mitochondrial intermembrane space ","P10809"]
["GO:0051604","biological_process","protein maturation ","P10809; Q92673; O95295; Q9UNE7"]
["GO:0007161","biological_process","calcium-independent cell-matrix adhesion ","P05556; P98161"]
["GO:0033631","biological_process","cell-cell adhesion mediated by integrin ","P05556"]
["GO:2000273","biological_process","positive regulation of signaling receptor activity ","P05556; P17542; Q15648"]
["GO:0010710","biological_process","regulation of collagen catabolic process ","P05556"]
["GO:0006497","biological_process","protein lipidation ","Q5MNZ6; Q9Y4P8; O95477; Q8NEB9"]
["GO:0090110","biological_process","cargo loading into CPII-coated vesicle ","P53992; Q15436; P62820"]
["GO:0016480","biological_process","negative regulation of transcription by RNA polymerase III ","Q9H063; P30044"]
["GO:0000707","biological_process","meiotic DNA recombinase assembly ","O43542"]
["GO:0090267","biological_process","positive regulation of mitotic cell cycle spindle assembly checkpoint ","O43542; Q13257; P12270; Q9Y6G9; O14777"]
["GO:0071140","biological_process","resolution of mitotic recombination intermediates ","O43542"]
["GO:0042148","biological_process","strand invasion ","O43542; Q06609"]
["GO:0000722","biological_process","telomere maintenance via recombination ","O43542; Q06609; Q92878; P51587"]
["GO:0090657","biological_process","telomeric loop disassembly ","O43542"]
["GO:0000478","biological_process","endonucleolytic cleavage involved in rRNA processing ","Q9Y4W2"]
["GO:0000460","biological_process","maturation of 5.8S rRNA ","Q9Y4W2; Q99547; P56537"]
["GO:0000470","biological_process","maturation of LSU-rRNA ","Q9Y4W2; P56537; P46087; O76021"]
["GO:0060402","biological_process","calcium ion transport into cytosol ","Q9BR39; Q92736; P32418; Q14573; Q13936"]
["GO:0060316","biological_process","positive regulation of ryanodine-sensitive calcium-release channel activity ","Q9BR39; P0DP23"]
["GO:0055024","biological_process","regulation of cardiac muscle tissue development ","Q9BR39"]
["GO:0014052","biological_process","regulation of gamma-aminobutyric acid secretion ","Q7L0J3"]
["GO:0016082","biological_process","synaptic vesicle priming ","Q7L0J3; O43426; P61764; O15083; O00161; Q9ULU8; P60880; P23763"]
["GO:1902253","biological_process","regulation of intrinsic apoptotic signaling pathway by p class mediator ","Q9GZV1"]
["GO:2000291","biological_process","regulation of myoblast proliferation ","Q9GZV1; O15014"]
["GO:0000578","biological_process","embryonic axis specification ","Q99966; Q15468"]
["GO:0042438","biological_process","melanin biosynthetic process ","Q99966; P14679; Q9Y4I1"]
["GO:0071105","biological_process","response to interleukin- ","Q99966"]
["GO:0071107","biological_process","response to parathyroid hormone ","Q99966; P17301"]
["GO:0040001","biological_process","establishment of mitotic spindle localization ","Q14674; Q9BXS6"]
["GO:0051307","biological_process","meiotic chromosome separation ","Q14674"]
["GO:0045875","biological_process","negative regulation of sister chromatid cohesion ","Q14674; Q7Z5K2"]
["GO:0098937","biological_process","anterograde dendritic transport ","Q14254"]
["GO:1903905","biological_process","positive regulation of establishment of T cell polarity ","Q14254; Q8NF50"]
["GO:0033604","biological_process","negative regulation of catecholamine secretion ","Q9H2B2"]
["GO:1905433","biological_process","negative regulation of retrograde trans-synaptic signaling by neuropeptide ","Q9H2B2"]
["GO:0048174","biological_process","negative regulation of short-term neuronal synaptic plasticity ","Q9H2B2"]
["GO:0031339","biological_process","negative regulation of vesicle fusion ","Q9H2B2; O60343"]
["GO:0014049","biological_process","positive regulation of glutamate secretion ","Q9H2B2"]
["GO:0061792","biological_process","secretory granule maturation ","Q9H2B2"]
["GO:0061782","biological_process","vesicle fusion with vesicle ","Q9H2B2"]
["GO:0006726","biological_process","eye pigment biosynthetic process ","P14679"]
["GO:0006583","biological_process","melanin biosynthetic process from tyrosine ","P14679"]
["GO:0030644","biological_process","cellular chloride ion homeostasis ","Q9H2X9; P48023; P12277"]
["GO:0006873","biological_process","cellular ion homeostasis ","Q9H2X9; P02730"]
["GO:0006971","biological_process","hypotonic response ","Q9H2X9; P17301"]
["GO:0040040","biological_process","thermosensory behavior ","Q9H2X9"]
["GO:0009165","biological_process","nucleotide biosynthetic process ","P11908"]
["GO:0006379","biological_process","mRNA cleavage ","Q12996; O75460; Q9P2I0; Q9UKF6"]
["GO:0016240","biological_process","autophagosome membrane docking ","P56962"]
["GO:0097111","biological_process","endoplasmic reticulum-olgi intermediate compartment organization ","P56962; Q92538"]
["GO:0042667","biological_process","auditory receptor cell fate specification ","Q92858"]
["GO:0045609","biological_process","positive regulation of inner ear auditory receptor cell differentiation ","Q92858"]
["GO:0060718","biological_process","chorionic trophoblast cell differentiation ","Q9Y6R4; A0AVK6; Q96AV8"]
["GO:0019100","biological_process","male germ-line sex determination ","Q9Y6R4; P48436"]
["GO:0009072","biological_process","aromatic amino acid family metabolic process ","P17752; Q8IWU9"]
["GO:0042427","biological_process","serotonin biosynthetic process ","P17752; Q8IWU9"]
["GO:1903912","biological_process","negative regulation of endoplasmic reticulum stress-induced eIF alpha phosphorylation ","P16333"]
["GO:1903676","biological_process","positive regulation of cap-dependent translational initiation ","P16333"]
["GO:1903679","biological_process","positive regulation of cap-independent translational initiation ","P16333; Q86U44"]
["GO:0036493","biological_process","positive regulation of translation in response to endoplasmic reticulum stress ","P16333"]
["GO:0051707","biological_process","response to other organism ","P16333; P05787; O43516"]
["GO:0098967","biological_process","exocytic insertion of neurotransmitter receptor to postsynaptic membrane ","O14810; P60880; P61266"]
["GO:0017157","biological_process","regulation of exocytosis ","O14810; P21579; Q5T5C0; P63027; P46459; Q99719; P11233; Q96AX2; Q6P1M3; Q15334; Q6PUV4"]
["GO:0031630","biological_process","regulation of synaptic vesicle fusion to presynaptic active zone membrane ","O14810; P61764; Q16478; P23763; Q6PUV4"]
["GO:0048205","biological_process","CPI coating of olgi vesicle ","Q9BVK6; Q92538"]
["GO:0010638","biological_process","positive regulation of organelle organization ","Q9BVK6"]
["GO:0006702","biological_process","androgen biosynthetic process ","P05093; Q8WTV0; Q15648"]
["GO:0006704","biological_process","glucocorticoid biosynthetic process ","P05093"]
["GO:0042446","biological_process","hormone biosynthetic process ","P05093; P10109; Q9NRD9"]
["GO:0042448","biological_process","progesterone metabolic process ","P05093; P51692"]
["GO:0016125","biological_process","sterol metabolic process ","P05093; P10109; P11511"]
["GO:1903568","biological_process","negative regulation of protein localization to ciliary membrane ","Q9NQ48"]
["GO:1903565","biological_process","negative regulation of protein localization to cilium ","Q9NQ48"]
["GO:0003176","biological_process","aortic valve development ","P19438; P20333; Q06330"]
["GO:0003332","biological_process","negative regulation of extracellular matrix constituent secretion ","P19438; P46531; P20333"]
["GO:1902339","biological_process","positive regulation of apoptotic process involved in morphogenesis ","P19438; P46531; P20333"]
["GO:0006693","biological_process","prostaglandin metabolic process ","P19438"]
["GO:0003177","biological_process","pulmonary valve development ","P19438; P20333; Q06330"]
["GO:0098703","biological_process","calcium ion import across plasma membrane ","Q9NQA5; P23634; Q8NER1; O94759; Q9H1D0"]
["GO:0035809","biological_process","regulation of urine volume ","Q9NQA5"]
["GO:1902510","biological_process","regulation of apoptotic DNA fragmentation ","O14727; Q8N726"]
["GO:0072432","biological_process","response to 1 DNA damage checkpoint signaling ","O14727"]
["GO:0031581","biological_process","hemidesmosome assembly ","Q9UMD9; Q15149; P11047; P30427; P16144"]
["GO:0006226","biological_process","dUMP biosynthetic process ","P33316"]
["GO:0046081","biological_process","dUTP catabolic process ","P33316"]
["GO:1904263","biological_process","positive regulation of TRC signaling ","Q9Y4R8"]
["GO:1904515","biological_process","positive regulation of TRC2 signaling ","Q9Y4R8"]
["GO:1905912","biological_process","regulation of calcium ion export across plasma membrane ","O75916"]
["GO:0006335","biological_process","DNA replication-dependent nucleosome assembly ","Q9Y294; Q9NVP2; Q13112; P49321; P68431; P62805; Q13111"]
["GO:0061157","biological_process","mRNA destabilization ","Q14671; Q86U44; Q6Y7W6"]
["GO:1900246","biological_process","positive regulation of RI-I signaling pathway ","Q14671; Q7Z2W4; O75179"]
["GO:0016441","biological_process","posttranscriptional gene silencing ","Q14671; Q6Y7W6"]
["GO:0035196","biological_process","production of miRNAs involved in gene silencing by miRNA ","Q14671; Q15633; Q8IWR0; Q8TAD8; Q9UKV8"]
["GO:0001675","biological_process","acrosome assembly ","Q92692; P82094; Q8NG31"]
["GO:0044406","biological_process","adhesion of symbiont to host ","Q92692; Q8WTV0"]
["GO:0032990","biological_process","cell part morphogenesis ","Q92692"]
["GO:0046814","biological_process","coreceptor-mediated virion attachment to host cell ","Q92692"]
["GO:0002891","biological_process","positive regulation of immunoglobulin mediated immune response ","Q92692; Q15762"]
["GO:0033005","biological_process","positive regulation of mast cell activation ","Q92692; Q15762"]
["GO:0002860","biological_process","positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target ","Q92692; Q15762"]
["GO:0046596","biological_process","regulation of viral entry into host cell ","Q92692"]
["GO:0007289","biological_process","spermatid nucleus differentiation ","Q92692; P82094; Q9BRQ0"]
["GO:0030382","biological_process","sperm mitochondrion organization ","Q92692; O43236"]
["GO:0042271","biological_process","susceptibility to natural killer cell mediated cytotoxicity ","Q92692"]
["GO:0060370","biological_process","susceptibility to T cell mediated cytotoxicity ","Q92692"]
["GO:0017004","biological_process","cytochrome complex assembly ","P13498"]
["GO:0050665","biological_process","hydrogen peroxide biosynthetic process ","P13498; P00441; Q9NRD9"]
["GO:0003106","biological_process","negative regulation of glomerular filtration by angiotensin ","P13498"]
["GO:1900426","biological_process","positive regulation of defense response to bacterium ","P13498; Q8TDQ0"]
["GO:0034137","biological_process","positive regulation of toll-like receptor 2 signaling pathway ","P13498; O43164; P58753"]
["GO:1904044","biological_process","response to aldosterone ","P13498; P09874"]
["GO:0014895","biological_process","smooth muscle hypertrophy ","P13498"]
["GO:0071971","biological_process","extracellular exosome assembly ","P28906"]
["GO:0003094","biological_process","glomerular filtration ","P28906; P43121"]
["GO:0035759","biological_process","mesangial cell-matrix adhesion ","P28906"]
["GO:0072254","biological_process","metanephric glomerular mesangial cell differentiation ","P28906"]
["GO:1900035","biological_process","negative regulation of cellular response to heat ","P28906"]
["GO:1900038","biological_process","negative regulation of cellular response to hypoxia ","P28906"]
["GO:1900168","biological_process","positive regulation of glial cell-derived neurotrophic factor secretion ","P28906; P14416"]
["GO:0071657","biological_process","positive regulation of granulocyte colony-stimulating factor production ","P28906"]
["GO:0042482","biological_process","positive regulation of odontogenesis ","P28906"]
["GO:0061042","biological_process","vascular wound healing ","P28906; P43121"]
["GO:0050851","biological_process","antigen receptor-mediated signaling pathway ","P56945; O14492"]
["GO:0099576","biological_process","regulation of protein catabolic process at postsynapse, modulating synaptic transmission ","P12830; P40818"]
["GO:2001246","biological_process","negative regulation of phosphatidylcholine biosynthetic process ","Q8NF37"]
["GO:0008654","biological_process","phospholipid biosynthetic process ","Q8NF37"]
["GO:0043129","biological_process","surfactant homeostasis ","Q8NF37; Q99814"]
["GO:0071245","biological_process","cellular response to carbon monoxide ","P50570"]
["GO:1903408","biological_process","positive regulation of sodiumpotassium-exchanging ATPase activity ","P50570"]
["GO:0097497","biological_process","blood vessel endothelial cell delamination ","Q9HBA0"]
["GO:0060351","biological_process","cartilage development involved in endochondral bone morphogenesis ","Q9HBA0; P31270"]
["GO:0071477","biological_process","cellular hypotonic salinity response ","Q9HBA0; Q9UHW9"]
["GO:0002024","biological_process","diet induced thermogenesis ","Q9HBA0; P08588; P32245; Q8NER1; P07550"]
["GO:0042538","biological_process","hyperosmotic salinity response ","Q9HBA0"]
["GO:1903444","biological_process","negative regulation of brown fat cell differentiation ","Q9HBA0"]
["GO:0007231","biological_process","osmosensory signaling pathway ","Q9HBA0"]
["GO:2000340","biological_process","positive regulation of chemokine (C-X-C motif) ligand 1 production ","Q9HBA0; P58753"]
["GO:0071642","biological_process","positive regulation of macrophage inflammatory protein  alpha production ","Q9HBA0"]
["GO:0031117","biological_process","positive regulation of microtubule depolymerization ","Q9HBA0; Q93045"]
["GO:0071639","biological_process","positive regulation of monocyte chemotactic protein- production ","Q9HBA0; Q15672; Q15109"]
["GO:0043117","biological_process","positive regulation of vascular permeability ","Q9HBA0; Q14432"]
["GO:1903759","biological_process","signal transduction involved in regulation of aerobic respiration ","Q9HBA0"]
["GO:0030103","biological_process","vasopressin secretion ","Q9HBA0"]
["GO:2000045","biological_process","regulation of 1/S transition of mitotic cell cycle ","P15923; Q01094; P61289; Q15058; Q02363; Q9HC62; P55957; P29350; O95905"]
["GO:0071266","biological_process","'de novo' L-methionine biosynthetic process ","P32929"]
["GO:1904831","biological_process","positive regulation of aortic smooth muscle cell differentiation ","P32929"]
["GO:0018272","biological_process","protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine ","P32929"]
["GO:0044524","biological_process","protein sulfhydration ","P32929"]
["GO:0000098","biological_process","sulfur amino acid catabolic process ","P32929"]
["GO:0033504","biological_process","floor plate development ","Q15468"]
["GO:1904719","biological_process","positive regulation of AMPA glutamate receptor clustering ","Q8WYL5"]
["GO:0032268","biological_process","regulation of cellular protein metabolic process ","Q8WYL5"]
["GO:0007198","biological_process","adenylate cyclase-inhibiting serotonin receptor signaling pathway ","P28222"]
["GO:0071502","biological_process","cellular response to temperature stimulus ","P28222; Q8NER1; O94759"]
["GO:0042756","biological_process","drinking behavior ","P28222; P14416"]
["GO:0014063","biological_process","negative regulation of serotonin secretion ","P28222"]
["GO:0032229","biological_process","negative regulation of synaptic transmission, ABAergic ","P28222; P61764; P34972"]
["GO:0050795","biological_process","regulation of behavior ","P28222"]
["GO:0046597","biological_process","negative regulation of viral entry into host cell ","Q12899; Q01628; P06396"]
["GO:1904980","biological_process","positive regulation of endosome organization ","O43426"]
["GO:0016191","biological_process","synaptic vesicle uncoating ","O43426; Q99962; Q99961"]
["GO:0072715","biological_process","cellular response to selenite ion ","P38919"]
["GO:1904570","biological_process","negative regulation of selenocysteine incorporation ","P38919"]
["GO:1904574","biological_process","negative regulation of selenocysteine insertion sequence binding ","P38919"]
["GO:0071921","biological_process","cohesin loading ","Q6KC79"]
["GO:0042471","biological_process","ear morphogenesis ","Q6KC79"]
["GO:0035115","biological_process","embryonic forelimb morphogenesis ","Q6KC79; P35548; Q13936; P31270; P31269; O15119; Q13950; P05549; Q15672; Q9H3D4"]
["GO:0035261","biological_process","external genitalia morphogenesis ","Q6KC79; O75581"]
["GO:0048592","biological_process","eye morphogenesis ","Q6KC79"]
["GO:0035136","biological_process","forelimb morphogenesis ","Q6KC79; O15119; Q05516"]
["GO:0061010","biological_process","gall bladder development ","Q6KC79; Q03014"]
["GO:0061038","biological_process","uterus morphogenesis ","Q6KC79"]
["GO:0016322","biological_process","neuron remodeling ","P29322; P05067; Q92625"]
["GO:0006929","biological_process","substrate-dependent cell migration ","P29322; P17301; Q92625"]
["GO:0060478","biological_process","acrosomal vesicle exocytosis ","Q5T7P8"]
["GO:0099525","biological_process","presynaptic dense core vesicle exocytosis ","Q5T7P8; P61764; Q9ULU8"]
["GO:0048048","biological_process","embryonic eye morphogenesis ","P58012; Q9UIW0; O15169; P13631"]
["GO:0002074","biological_process","extraocular skeletal muscle development ","P58012; Q99697; P52179; P54296"]
["GO:0019101","biological_process","female somatic sex determination ","P58012"]
["GO:0060014","biological_process","granulosa cell differentiation ","P58012"]
["GO:0001555","biological_process","oocyte growth ","P58012; O14686"]
["GO:0033686","biological_process","positive regulation of luteinizing hormone secretion ","P58012; Q13485"]
["GO:0009987","biological_process","cellular process ","P07437; P05067; P46821"]
["GO:0042267","biological_process","natural killer cell mediated cytotoxicity ","P07437; Q06830; P29350; P43629"]
["GO:0045992","biological_process","negative regulation of embryonic development ","Q9UK32"]
["GO:2000381","biological_process","negative regulation of mesoderm development ","Q9UK32; Q9H3D4"]
["GO:0031223","biological_process","auditory behavior ","P43003; Q92886; P14416"]
["GO:0070779","biological_process","D-aspartate import across plasma membrane ","P43003; P43005"]
["GO:0009449","biological_process","gamma-aminobutyric acid biosynthetic process ","P43003; Q99259"]
["GO:0006537","biological_process","glutamate biosynthetic process ","P43003; P00367"]
["GO:0140009","biological_process","L-aspartate import across plasma membrane ","P43003; P43005"]
["GO:0051938","biological_process","L-glutamate import ","P43003; P43005"]
["GO:0098712","biological_process","L-glutamate import across plasma membrane ","P43003; P43005; P48664"]
["GO:0015813","biological_process","L-glutamate transmembrane transport ","P43003; P43005; P48664"]
["GO:0001504","biological_process","neurotransmitter uptake ","P43003; P48664; P60880"]
["GO:0035435","biological_process","phosphate ion transmembrane transport ","Q9UBH6"]
["GO:0055059","biological_process","asymmetric neuroblast division ","Q92974"]
["GO:0071802","biological_process","negative regulation of podosome assembly ","Q92974"]
["GO:0060486","biological_process","Clara cell differentiation ","Q92908; P43699; Q06330"]
["GO:0007493","biological_process","endodermal cell fate determination ","Q92908"]
["GO:0032912","biological_process","negative regulation of transforming growth factor beta production ","Q92908"]
["GO:0003310","biological_process","pancreatic A cell differentiation ","Q92908"]
["GO:0035239","biological_process","tube morphogenesis ","Q92908"]
["GO:0060510","biological_process","type II pneumocyte differentiation ","Q92908; Q13155; P43699"]
["GO:0035973","biological_process","aggrephagy ","Q9H1Y0; Q13501; Q9UMX0"]
["GO:0019883","biological_process","antigen processing and presentation of endogenous antigen ","Q9H1Y0"]
["GO:0006995","biological_process","cellular response to nitrogen starvation ","Q9H1Y0; Q9GZQ8; Q9H492; Q14457"]
["GO:0039689","biological_process","negative stranded viral RNA replication ","Q9H1Y0; Q676U5"]
["GO:0048840","biological_process","otolith development ","Q9H1Y0"]
["GO:0061739","biological_process","protein lipidation involved in autophagosome assembly ","Q9H1Y0; Q9Y4P8; Q676U5"]
["GO:0002739","biological_process","regulation of cytokine secretion involved in immune response ","Q9H1Y0"]
["GO:0009620","biological_process","response to fungus ","Q9H1Y0; O95999; Q16611; Q9H257"]
["GO:0000338","biological_process","protein deneddylation ","Q13098; Q7L5N1; Q9UNS2"]
["GO:1903278","biological_process","positive regulation of sodium ion export across plasma membrane ","O00168"]
["GO:0086036","biological_process","regulation of cardiac muscle cell membrane potential ","O00168; P26678; P19634; Q6J4K2; P16615"]
["GO:0034128","biological_process","negative regulation of MyD-independent toll-like receptor signaling pathway ","O15455; O00206; Q86XR7; Q9Y6Y9"]
["GO:0045080","biological_process","positive regulation of chemokine biosynthetic process ","O15455; P01375; P09601; P18146"]
["GO:0045356","biological_process","positive regulation of interferon-alpha biosynthetic process ","O15455"]
["GO:0045078","biological_process","positive regulation of interferon-gamma biosynthetic process ","O15455; Q5ZPR3"]
["GO:0034123","biological_process","positive regulation of toll-like receptor signaling pathway ","O15455; O60602"]
["GO:0034346","biological_process","positive regulation of type III interferon production ","O15455"]
["GO:0002730","biological_process","regulation of dendritic cell cytokine production ","O15455"]
["GO:0010792","biological_process","DNA double-strand break processing involved in repair via single-strand annealing ","P43351; Q8IY92; Q99708; Q8WVD3"]
["GO:0000730","biological_process","DNA recombinase assembly ","P43351; Q06609"]
["GO:2000819","biological_process","regulation of nucleotide-excision repair ","P43351"]
["GO:0002432","biological_process","granuloma formation ","P17676"]
["GO:2000120","biological_process","positive regulation of sodium-dependent phosphate transport ","P17676; P18848"]
["GO:0045408","biological_process","regulation of interleukin-6 biosynthetic process ","P17676; Q9H257"]
["GO:1901329","biological_process","regulation of odontoblast differentiation ","P17676; Q14494"]
["GO:0006867","biological_process","asparagine transport ","Q99624"]
["GO:0006868","biological_process","glutamine transport ","Q99624"]
["GO:0015817","biological_process","histidine transport ","Q99624"]
["GO:0015808","biological_process","L-alanine transport ","Q99624"]
["GO:2000487","biological_process","positive regulation of glutamine transport ","Q99624"]
["GO:0061402","biological_process","positive regulation of transcription from RNA polymerase II promoter in response to acidic pH ","Q99624"]
["GO:0090234","biological_process","regulation of kinetochore assembly ","P78317"]
["GO:0090169","biological_process","regulation of spindle assembly ","P78317"]
["GO:0010753","biological_process","positive regulation of cMP-mediated signaling ","P16066; Q8N884"]
["GO:0097746","biological_process","regulation of blood vessel diameter ","P16066; O43306; P30556; P12821"]
["GO:0032185","biological_process","septin cytoskeleton organization ","Q9BST9"]
["GO:0072355","biological_process","histone H-T phosphorylation ","Q99986"]
["GO:0007084","biological_process","mitotic nuclear envelope reassembly ","Q99986; P02545; Q86XL3; O75531; P50402"]
["GO:0031247","biological_process","actin rod assembly ","P14625"]
["GO:0036500","biological_process","ATF-mediated unfolded protein response ","P14625; P18850; P17861; P35638; P11021"]
["GO:0034975","biological_process","protein folding in endoplasmic reticulum ","P14625; P27824; Q96HE7; P30101; P11021"]
["GO:0030970","biological_process","retrograde protein transport, ER to cytosol ","P14625; P55072"]
["GO:0051208","biological_process","sequestering of calcium ion ","P14625; O14958"]
["GO:1903392","biological_process","negative regulation of adherens junction organization ","P35241"]
["GO:0034111","biological_process","negative regulation of homotypic cell-cell adhesion ","P35241"]
["GO:0032231","biological_process","regulation of actin filament bundle assembly ","P35241"]
["GO:0032487","biological_process","regulation of Rap protein signal transduction ","P35241; Q15058"]
["GO:0060137","biological_process","maternal process involved in parturition ","O00327; O60229; O95751"]
["GO:0034314","biological_process","Arp2/ complex-mediated actin nucleation ","Q13576; O15511; P61160; O15143; P61158"]
["GO:0070493","biological_process","thrombin-activated receptor signaling pathway ","Q13576; P08567"]
["GO:0006525","biological_process","arginine metabolic process ","Q93070"]
["GO:0051495","biological_process","positive regulation of cytoskeleton organization ","O60504"]
["GO:0046486","biological_process","glycerolipid metabolic process ","Q13574; P49619; P23743"]
["GO:0010815","biological_process","bradykinin catabolic process ","P42892"]
["GO:0010816","biological_process","calcitonin catabolic process ","P42892"]
["GO:0034959","biological_process","endothelin maturation ","P42892"]
["GO:0042447","biological_process","hormone catabolic process ","P42892; P12821"]
["GO:0010814","biological_process","substance P catabolic process ","P42892"]
["GO:0097581","biological_process","lamellipodium organization ","O15511; Q14247"]
["GO:0061842","biological_process","microtubule organizing center localization ","O15511"]
["GO:0009438","biological_process","methylglyoxal metabolic process ","Q04760; Q99497"]
["GO:0036337","biological_process","Fas signaling pathway ","P25445"]
["GO:0001768","biological_process","establishment of T cell polarity ","P32248; P35579"]
["GO:0072610","biological_process","interleukin- secretion ","P32248"]
["GO:0097029","biological_process","mature conventional dendritic cell differentiation ","P32248"]
["GO:0002408","biological_process","myeloid dendritic cell chemotaxis ","P32248"]
["GO:0002606","biological_process","positive regulation of dendritic cell antigen processing and presentation ","P32248"]
["GO:2000510","biological_process","positive regulation of dendritic cell chemotaxis ","P32248; Q07021"]
["GO:2000526","biological_process","positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation ","P32248"]
["GO:0002922","biological_process","positive regulation of humoral immune response ","P32248; P31994"]
["GO:0002885","biological_process","positive regulation of hypersensitivity ","P32248"]
["GO:2000522","biological_process","positive regulation of immunological synapse formation ","P32248"]
["GO:2000525","biological_process","positive regulation of T cell costimulation ","P32248"]
["GO:2000547","biological_process","regulation of dendritic cell dendrite assembly ","P32248"]
["GO:0032649","biological_process","regulation of interferon-gamma production ","P32248; Q9Y572"]
["GO:0050706","biological_process","regulation of interleukin-1 beta secretion ","P32248"]
["GO:0071731","biological_process","response to nitric oxide ","P32248"]
["GO:0051546","biological_process","keratinocyte migration ","Q9NPC1"]
["GO:0061951","biological_process","establishment of protein localization to plasma membrane ","P55196"]
["GO:0046717","biological_process","acid secretion ","P35462"]
["GO:0007195","biological_process","adenylate cyclase-inhibiting dopamine receptor signaling pathway ","P35462; P14416; P21333"]
["GO:0035483","biological_process","gastric emptying ","P35462; Q9UBU3"]
["GO:0050883","biological_process","musculoskeletal movement, spinal reflex action ","P35462; P50553"]
["GO:0060160","biological_process","negative regulation of dopamine receptor signaling pathway ","P35462; P14416; P49798"]
["GO:0002016","biological_process","regulation of blood volume by renin-angiotensin ","P35462"]
["GO:0045187","biological_process","regulation of circadian sleep/wake cycle, sleep ","P35462; O43613; P56645"]
["GO:0051584","biological_process","regulation of dopamine uptake involved in synaptic transmission ","P35462; P14416; P21728"]
["GO:0090325","biological_process","regulation of locomotion involved in locomotory behavior ","P35462; P14416"]
["GO:0034776","biological_process","response to histamine ","P35462; P14416"]
["GO:0003333","biological_process","amino acid transmembrane transport ","P31641"]
["GO:0006520","biological_process","cellular amino acid metabolic process ","P31641; P18848; P09417; Q03393; P42898"]
["GO:0015734","biological_process","taurine transport ","P31641"]
["GO:0048386","biological_process","positive regulation of retinoic acid receptor signaling pathway ","P13056; P56545; O95361"]
["GO:0071709","biological_process","membrane assembly ","Q01082; Q12955"]
["GO:0007009","biological_process","plasma membrane organization ","Q01082; O43312; Q9UQB8; Q12955; Q9UHR4"]
["GO:0060390","biological_process","regulation of SMAD protein signal transduction ","Q01082; P50616; Q9GZV5"]
["GO:0015882","biological_process","L-ascorbic acid transmembrane transport ","Q9UGH3"]
["GO:0015851","biological_process","nucleobase transport ","Q9UGH3"]
["GO:0070904","biological_process","transepithelial L-ascorbic acid transport ","Q9UGH3"]
["GO:0006783","biological_process","heme biosynthetic process ","Q9UII2; Q14494; Q16595"]
["GO:1903052","biological_process","positive regulation of proteolysis involved in cellular protein catabolic process ","Q9UII2"]
["GO:1903578","biological_process","regulation of ATP metabolic process ","Q9UII2"]
["GO:1903214","biological_process","regulation of protein targeting to mitochondrion ","Q9UII2; P36956; Q9BXM7; Q8N726; O60260"]
["GO:0048102","biological_process","autophagic cell death ","P46527; Q9Y371; P55273"]
["GO:0007096","biological_process","regulation of exit from mitosis ","P46527; Q9NQW6; Q96SB3; Q9UJX2; O43264; Q8IXJ6"]
["GO:1902746","biological_process","regulation of lens fiber cell differentiation ","P46527"]
["GO:2000404","biological_process","regulation of T cell migration ","P16150"]
["GO:0055123","biological_process","digestive system development ","Q9HBU1"]
["GO:0034971","biological_process","histone H-R methylation ","Q86X55; Q96RI1"]
["GO:0034970","biological_process","histone H-R2 methylation ","Q86X55; Q96LA8"]
["GO:2000171","biological_process","negative regulation of dendrite development ","Q86X55; Q9H165; P43146"]
["GO:0003420","biological_process","regulation of growth plate cartilage chondrocyte proliferation ","Q86X55"]
["GO:1902415","biological_process","regulation of mRNA binding ","Q86X55"]
["GO:0001825","biological_process","blastocyst formation ","O95140; Q9H3R0"]
["GO:0032275","biological_process","luteinizing hormone secretion ","P82094; O15119"]
["GO:0008627","biological_process","intrinsic apoptotic signaling pathway in response to osmotic stress ","Q99250; P42574"]
["GO:0016339","biological_process","calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules ","P19022; P58400; Q8N2Q7; Q96IF1"]
["GO:0010001","biological_process","glial cell differentiation ","P19022; Q02962; P17677; Q86Y01; Q9HD90"]
["GO:2000809","biological_process","positive regulation of synaptic vesicle clustering ","P19022; Q86UL8; Q8N2Q7"]
["GO:0070445","biological_process","regulation of oligodendrocyte progenitor proliferation ","P19022"]
["GO:1902897","biological_process","regulation of postsynaptic density protein 5 clustering ","P19022; Q9ULU4"]
["GO:0046069","biological_process","cMP catabolic process ","O76074; P54750; Q9Y233"]
["GO:0060282","biological_process","positive regulation of oocyte development ","O76074; Q14432"]
["GO:0010749","biological_process","regulation of nitric oxide mediated signal transduction ","O76074"]
["GO:0045738","biological_process","negative regulation of DNA repair ","P23396"]
["GO:1905053","biological_process","positive regulation of base-excision repair ","P23396"]
["GO:2001272","biological_process","positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis ","P23396"]
["GO:1902546","biological_process","positive regulation of DNA N-glycosylase activity ","P23396"]
["GO:0061481","biological_process","response to TNF agonist ","P23396"]
["GO:0002729","biological_process","positive regulation of natural killer cell cytokine production ","Q15762"]
["GO:0071763","biological_process","nuclear membrane organization ","Q5JTV8"]
["GO:0030214","biological_process","hyaluronan catabolic process ","P16070; P19634; P09038"]
["GO:0070487","biological_process","monocyte aggregation ","P16070"]
["GO:1900625","biological_process","positive regulation of monocyte aggregation ","P16070; Q92819"]
["GO:0006482","biological_process","protein demethylation ","Q9Y570; O60341; O75151"]
["GO:0007276","biological_process","gamete generation ","Q9BXW9; Q9UQR1"]
["GO:2000301","biological_process","negative regulation of synaptic vesicle exocytosis ","P62834; Q06787"]
["GO:0097327","biological_process","response to antineoplastic agent ","P62834"]
["GO:0006266","biological_process","DNA ligation ","P12956; P18858; P49916; P49917; P11388; Q7Z2E3"]
["GO:0097680","biological_process","double-strand break repair via classical nonhomologous end joining ","P12956; Q9P2Y5; P49917"]
["GO:0006701","biological_process","progesterone biosynthetic process ","Q14849; P22307"]
["GO:0099044","biological_process","vesicle tethering to endoplasmic reticulum ","Q14849"]
["GO:1905437","biological_process","positive regulation of histone H-K trimethylation ","Q8IZD2"]
["GO:0150020","biological_process","basal dendrite arborization ","Q9UL54"]
["GO:0150019","biological_process","basal dendrite morphogenesis ","Q9UL54"]
["GO:1903715","biological_process","regulation of aerobic respiration ","O75081; P55072; Q9NZM5; Q16665"]
["GO:2000312","biological_process","regulation of kainate selective glutamate receptor activity ","Q8NC67"]
["GO:0090151","biological_process","establishment of protein localization to mitochondrial membrane ","P0DP23"]
["GO:0075206","biological_process","positive regulation by host of symbiont cAMP-mediated signal transduction ","P0DP23"]
["GO:0002519","biological_process","natural killer cell tolerance induction ","Q8TDQ0"]
["GO:1900425","biological_process","negative regulation of defense response to bacterium ","Q8TDQ0; Q8IXJ6"]
["GO:0071656","biological_process","negative regulation of granulocyte colony-stimulating factor production ","Q8TDQ0"]
["GO:2000521","biological_process","negative regulation of immunological synapse formation ","Q8TDQ0; P17931"]
["GO:0032687","biological_process","negative regulation of interferon-alpha production ","Q8TDQ0"]
["GO:0032712","biological_process","negative regulation of interleukin- production ","Q8TDQ0"]
["GO:0030886","biological_process","negative regulation of myeloid dendritic cell activation ","Q8TDQ0"]
["GO:0032815","biological_process","negative regulation of natural killer cell activation ","Q8TDQ0"]
["GO:0002859","biological_process","negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target ","Q8TDQ0; P13688"]
["GO:2001189","biological_process","negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell ","Q8TDQ0; P17931"]
["GO:0002826","biological_process","negative regulation of T-helper 1 type immune response ","Q8TDQ0"]
["GO:0002652","biological_process","regulation of tolerance induction dependent upon immune response ","Q8TDQ0"]
["GO:0034154","biological_process","toll-like receptor 7 signaling pathway ","Q8TDQ0; Q6ZUJ8"]
["GO:0016198","biological_process","axon choice point recognition ","Q15768; P17677"]
["GO:0061158","biological_process","3'-UTR-mediated mRNA destabilization ","Q5D1E8; Q92900; Q5TC82; Q96PU8; Q14103; Q07352; Q8NE35; Q92945; P26651"]
["GO:0002757","biological_process","immune response-activating signal transduction ","Q5D1E8; O75563"]
["GO:1900016","biological_process","negative regulation of cytokine production involved in inflammatory response ","Q5D1E8; O15553; Q53EL6; Q9H467"]
["GO:1902714","biological_process","negative regulation of interferon-gamma secretion ","Q5D1E8; Q96RI1"]
["GO:0043031","biological_process","negative regulation of macrophage activation ","Q5D1E8; Q13133; P31994"]
["GO:2000320","biological_process","negative regulation of T-helper 17 cell differentiation ","Q5D1E8; Q9BZS1; O15105; Q5TC82; Q9UL17"]
["GO:1904468","biological_process","negative regulation of tumor necrosis factor secretion ","Q5D1E8; Q96RI1; Q9UBU3"]
["GO:0000294","biological_process","nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay ","Q5D1E8; Q92900"]
["GO:2000627","biological_process","positive regulation of miRNA catabolic process ","Q5D1E8; Q8TCS8"]
["GO:0061014","biological_process","positive regulation of mRNA catabolic process ","Q5D1E8; Q7Z2W4; Q92900; Q5TC82; Q92945; Q8TCS8"]
["GO:1903003","biological_process","positive regulation of protein deubiquitination ","Q5D1E8"]
["GO:0090501","biological_process","RNA phosphodiester bond hydrolysis ","Q5D1E8"]
["GO:0090502","biological_process","RNA phosphodiester bond hydrolysis, endonucleolytic ","Q5D1E8; O75817; Q8WYQ5"]
["GO:0052213","biological_process","interaction with symbiont via secreted substance involved in symbiotic interaction ","P00747"]
["GO:0052182","biological_process","modification by host of symbiont morphology or physiology via secreted substance ","P00747"]
["GO:2000048","biological_process","negative regulation of cell-cell adhesion mediated by cadherin ","P00747; Q9H4X1"]
["GO:0051918","biological_process","negative regulation of fibrinolysis ","P00747; P22415"]
["GO:0051919","biological_process","positive regulation of fibrinolysis ","P00747"]
["GO:0048771","biological_process","tissue remodeling ","P00747; Q6UVK1; P50281"]
["GO:0060008","biological_process","Sertoli cell differentiation ","Q14151; P48436"]
["GO:0014829","biological_process","vascular smooth muscle contraction ","O00443; P32418"]
["GO:0052695","biological_process","cellular glucuronidation ","Q9HAW7; P16662"]
["GO:0009804","biological_process","coumarin metabolic process ","Q9HAW7"]
["GO:0052696","biological_process","flavonoid glucuronidation ","Q9HAW7"]
["GO:2001030","biological_process","negative regulation of cellular glucuronidation ","Q9HAW7"]
["GO:0045922","biological_process","negative regulation of fatty acid metabolic process ","Q9HAW7"]
["GO:1904224","biological_process","negative regulation of glucuronosyltransferase activity ","Q9HAW7"]
["GO:0042573","biological_process","retinoic acid metabolic process ","Q9HAW7"]
["GO:0052697","biological_process","xenobiotic glucuronidation ","Q9HAW7"]
["GO:1901798","biological_process","positive regulation of signal transduction by p53 class mediator ","O94992; Q8N726"]
["GO:0045191","biological_process","regulation of isotype switching ","Q8IW19; Q7KZ85"]
["GO:0008206","biological_process","bile acid metabolic process ","Q96RI1; O00482"]
["GO:0038183","biological_process","bile acid signaling pathway ","Q96RI1; P11473"]
["GO:0072615","biological_process","interleukin- secretion ","Q96RI1"]
["GO:0038185","biological_process","intracellular bile acid receptor signaling pathway ","Q96RI1"]
["GO:0070858","biological_process","negative regulation of bile acid biosynthetic process ","Q96RI1"]
["GO:0032692","biological_process","negative regulation of interleukin-1 production ","Q96RI1; P13688"]
["GO:0001080","biological_process","nitrogen catabolite activation of transcription from RNA polymerase II promoter ","Q96RI1"]
["GO:2001250","biological_process","positive regulation of ammonia assimilation cycle ","Q96RI1"]
["GO:2000213","biological_process","positive regulation of glutamate metabolic process ","Q96RI1"]
["GO:1905695","biological_process","positive regulation of phosphatidic acid biosynthetic process ","Q96RI1"]
["GO:0034255","biological_process","regulation of urea metabolic process ","Q96RI1"]
["GO:0070125","biological_process","mitochondrial translational elongation ","Q9H0U6; Q92665; Q8TAE8; P51398; Q9NQ50; O75616; Q9Y676"]
["GO:0070126","biological_process","mitochondrial translational termination ","Q9H0U6; Q92665; Q8TAE8; P51398; Q9NQ50; O75616; Q9Y676"]
["GO:0035928","biological_process","rRNA import into mitochondrion ","Q9H0U6; Q8TCS8"]
["GO:0010256","biological_process","endomembrane system organization ","Q9Y6D6"]
["GO:0090284","biological_process","positive regulation of protein glycosylation in olgi ","Q9Y6D6"]
["GO:0003337","biological_process","mesenchymal to epithelial transition involved in metanephros morphogenesis ","Q02962"]
["GO:0072205","biological_process","metanephric collecting duct development ","Q02962; Q8TDM6; P41181; P98161"]
["GO:0072221","biological_process","metanephric distal convoluted tubule development ","Q02962"]
["GO:0072289","biological_process","metanephric nephron tubule formation ","Q02962; P48436"]
["GO:1900215","biological_process","negative regulation of apoptotic process involved in metanephric collecting duct development ","Q02962"]
["GO:1900218","biological_process","negative regulation of apoptotic process involved in metanephric nephron tubule development ","Q02962"]
["GO:0045918","biological_process","negative regulation of cytolysis ","Q02962"]
["GO:0072305","biological_process","negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis ","Q02962"]
["GO:1900212","biological_process","negative regulation of mesenchymal cell apoptotic process involved in metanephros development ","Q02962"]
["GO:0061360","biological_process","optic chiasma development ","Q02962"]
["GO:0002072","biological_process","optic cup morphogenesis involved in camera-type eye development ","Q02962"]
["GO:0021554","biological_process","optic nerve development ","Q02962"]
["GO:0021633","biological_process","optic nerve structural organization ","Q02962; P16389"]
["GO:0072108","biological_process","positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis ","Q02962"]
["GO:2000594","biological_process","positive regulation of metanephric DCT cell differentiation ","Q02962"]
["GO:2000597","biological_process","positive regulation of optic nerve formation ","Q02962"]
["GO:0039003","biological_process","pronephric field specification ","Q02962"]
["GO:0048793","biological_process","pronephros development ","Q02962"]
["GO:0035566","biological_process","regulation of metanephros size ","Q02962; P50052"]
["GO:0003406","biological_process","retinal pigment epithelium development ","Q02962; P13631; Q15648"]
["GO:0072189","biological_process","ureter development ","Q02962; Q12946"]
["GO:0021650","biological_process","vestibulocochlear nerve formation ","Q02962; Q92886"]
["GO:0048227","biological_process","plasma membrane to endosome transport ","P61020; P51148; P62491; Q99523"]
["GO:2001032","biological_process","regulation of double-strand break repair via nonhomologous end joining ","P35659; O96028"]
["GO:0016574","biological_process","histone ubiquitination ","Q15022; Q9HC52; Q96T88; Q7Z6Z7; P61088"]
["GO:0016045","biological_process","detection of bacterium ","Q9NPP4"]
["GO:0070269","biological_process","pyroptosis ","Q9NPP4"]
["GO:0060018","biological_process","astrocyte fate commitment ","P17542; Q9NP62; P48436"]
["GO:0060217","biological_process","hemangioblast cell differentiation ","P17542"]
["GO:0045799","biological_process","positive regulation of chromatin assembly or disassembly ","P17542"]
["GO:0060375","biological_process","regulation of mast cell differentiation ","P17542"]
["GO:0021527","biological_process","spinal cord association neuron differentiation ","P17542; P23759; P50553; Q9UBR4"]
["GO:0000389","biological_process","mRNA '-splice site recognition ","Q15459; Q15637"]
["GO:0007506","biological_process","gonadal mesoderm development ","Q01534"]
["GO:0045602","biological_process","negative regulation of endothelial cell differentiation ","P37275; P47989; P37023; P41134"]
["GO:0010464","biological_process","regulation of mesenchymal cell proliferation ","P37275"]
["GO:0047497","biological_process","mitochondrion transport along microtubule ","P0CG47; Q8IXI2; P46821; Q66K74"]
["GO:1902255","biological_process","positive regulation of intrinsic apoptotic signaling pathway by p3 class mediator ","P0CG47"]
["GO:1902527","biological_process","positive regulation of protein monoubiquitination ","P0CG47"]
["GO:0035050","biological_process","embryonic heart tube development ","Q12948; P52952; Q99958; O96004; Q03014; Q15648"]
["GO:0072010","biological_process","glomerular epithelium development ","Q12948"]
["GO:0030203","biological_process","glycosaminoglycan metabolic process ","Q12948"]
["GO:0014031","biological_process","mesenchymal cell development ","Q12948; P10415; P46531"]
["GO:1902257","biological_process","negative regulation of apoptotic process involved in outflow tract morphogenesis ","Q12948; Q99958"]
["GO:1901534","biological_process","positive regulation of hematopoietic progenitor cell differentiation ","Q12948"]
["GO:1902038","biological_process","positive regulation of hematopoietic stem cell differentiation ","Q12948"]
["GO:0051309","biological_process","female meiosis chromosome separation ","Q15003; Q6IBW4"]
["GO:0010032","biological_process","meiotic chromosome condensation ","Q15003; Q9NTJ3; Q6IBW4"]
["GO:0034724","biological_process","DNA replication-independent nucleosome organization ","Q9Y5B9"]
["GO:0000028","biological_process","ribosomal small subunit assembly ","P42677; P46782; P46783; P62841; Q71UM5; O75616; P39019"]
["GO:0021801","biological_process","cerebral cortex radial glia guided migration ","Q9NQC3"]
["GO:0071787","biological_process","endoplasmic reticulum tubular network formation ","Q9NQC3"]
["GO:1990809","biological_process","endoplasmic reticulum tubular network membrane organization ","Q9NQC3"]
["GO:0071786","biological_process","endoplasmic reticulum tubular network organization ","Q9NQC3"]
["GO:1903860","biological_process","negative regulation of dendrite extension ","Q9NQC3"]
["GO:1905943","biological_process","negative regulation of formation of growth cone in injured axon ","Q9NQC3"]
["GO:0051292","biological_process","nuclear pore complex assembly ","Q9NQC3; Q9BTX1; P57740; P49790; P52948"]
["GO:0048694","biological_process","positive regulation of collateral sprouting of injured axon ","Q9NQC3"]
["GO:1905580","biological_process","positive regulation of ERBB3 signaling pathway ","Q9NQC3"]
["GO:0033601","biological_process","positive regulation of mammary gland epithelial cell proliferation ","Q9NQC3; P24385; Q15648"]
["GO:1905552","biological_process","positive regulation of protein localization to endoplasmic reticulum ","Q9NQC3"]
["GO:0001778","biological_process","plasma membrane repair ","Q9UKX2; O43581"]
["GO:0048388","biological_process","endosomal lumen acidification ","P48023; P51790"]
["GO:0006925","biological_process","inflammatory cell apoptotic process ","P48023"]
["GO:1903514","biological_process","release of sequestered calcium ion into cytosol by endoplasmic reticulum ","P48023"]
["GO:0046666","biological_process","retinal cell programmed cell death ","P48023; Q07812"]
["GO:0060414","biological_process","aorta smooth muscle tissue morphogenesis ","Q15746"]
["GO:0014820","biological_process","tonic smooth muscle contraction ","Q15746"]
["GO:0009200","biological_process","deoxyribonucleoside triphosphate metabolic process ","Q7LG56"]
["GO:0009263","biological_process","deoxyribonucleotide biosynthetic process ","Q7LG56; P31350"]
["GO:0006264","biological_process","mitochondrial DNA replication ","Q7LG56"]
["GO:0060391","biological_process","positive regulation of SMAD protein signal transduction ","Q93062; Q13485; P36897; P98082; P22004; P09874; P36894; Q01860"]
["GO:0098504","biological_process","DNA 3' dephosphorylation involved in DNA repair ","Q96T60"]
["GO:0010836","biological_process","negative regulation of protein ADP-ribosylation ","Q96T60; Q9BSI4; P18887"]
["GO:0000718","biological_process","nucleotide-excision repair, DNA damage removal ","Q96T60"]
["GO:0032494","biological_process","response to peptidoglycan ","Q13568; P21730; Q9H257"]
["GO:0046340","biological_process","diacylglycerol catabolic process ","Q9Y4D2; Q05469"]
["GO:0071926","biological_process","endocannabinoid signaling pathway ","Q9Y4D2"]
["GO:0007216","biological_process","-protein coupled glutamate receptor signaling pathway ","Q9Y4D2; P41594; Q9NSB8; Q13255; Q14416; Q14832"]
["GO:0016189","biological_process","synaptic vesicle to endosome fusion ","Q15075; O75379"]
["GO:0001514","biological_process","selenocysteine incorporation ","Q9NX07"]
["GO:0002374","biological_process","cytokine secretion involved in immune response ","Q96P20"]
["GO:0009595","biological_process","detection of biotic stimulus ","Q96P20"]
["GO:0032621","biological_process","interleukin-8 production ","Q96P20"]
["GO:0032611","biological_process","interleukin- beta production ","Q96P20"]
["GO:0050701","biological_process","interleukin- secretion ","Q96P20"]
["GO:0044546","biological_process","NLRP3 inflammasome complex assembly ","Q96P20"]
["GO:2000321","biological_process","positive regulation of T-helper 7 cell differentiation ","Q96P20"]
["GO:0002830","biological_process","positive regulation of type  immune response ","Q96P20"]
["GO:0035747","biological_process","natural killer cell chemotaxis ","P48736; O00329"]
["GO:0010897","biological_process","negative regulation of triglyceride catabolic process ","P48736; P80108"]
["GO:0002679","biological_process","respiratory burst involved in defense response ","P48736; O00329"]
["GO:0032252","biological_process","secretory granule localization ","P48736; Q9Y4I1; O95267"]
["GO:0010818","biological_process","T cell chemotaxis ","P48736; P55011; O00329"]
["GO:0050717","biological_process","positive regulation of interleukin- alpha secretion ","Q96RD7"]
["GO:0034214","biological_process","protein hexamerization ","Q96RD7; P55072; O95202; Q96RD6"]
["GO:0021814","biological_process","cell motility involved in cerebral cortex radial glia guided migration ","Q5VWQ8"]
["GO:1903363","biological_process","negative regulation of cellular protein catabolic process ","Q5VWQ8"]
["GO:0010633","biological_process","negative regulation of epithelial cell migration ","Q5VWQ8; Q15256; Q9Y3F4; Q96A54; Q9ULV4; Q9Y6W6; P09758"]
["GO:0043553","biological_process","negative regulation of phosphatidylinositol -kinase activity ","Q5VWQ8"]
["GO:1900747","biological_process","negative regulation of vascular endothelial growth factor signaling pathway ","Q5VWQ8; P47989; O43597"]
["GO:0038026","biological_process","reelin-mediated signaling pathway ","Q5VWQ8"]
["GO:0036324","biological_process","vascular endothelial growth factor receptor- signaling pathway ","Q5VWQ8"]
["GO:0030031","biological_process","cell projection assembly ","P12036"]
["GO:0033693","biological_process","neurofilament bundle assembly ","P12036; P07196; P07197"]
["GO:0060052","biological_process","neurofilament cytoskeleton organization ","P12036; Q9GZM8; P07196; P00441"]
["GO:0048936","biological_process","peripheral nervous system neuron axonogenesis ","P12036"]
["GO:0031424","biological_process","keratinization ","P05787; P31947; P14923; Q04695; Q8NEY8; P35900; P08727; P08729; P05783; P15924"]
["GO:0036336","biological_process","dendritic cell migration ","Q8NF50; P60953; Q12929"]
["GO:0061485","biological_process","memory T cell proliferation ","Q8NF50"]
["GO:1900753","biological_process","doxorubicin transport ","Q15311"]
["GO:0048297","biological_process","negative regulation of isotype switching to IgA isotypes ","Q96FV9"]
["GO:0043331","biological_process","response to dsRNA ","Q96FA3; Q13794"]
["GO:0008063","biological_process","Toll signaling pathway ","Q96FA3; Q8N2H9; Q9HAT8; Q13114"]
["GO:0035360","biological_process","positive regulation of peroxisome proliferator activated receptor signaling pathway ","Q9Y365; Q99967"]
["GO:0032962","biological_process","positive regulation of inositol trisphosphate biosynthetic process ","P28069; P35367"]
["GO:0043567","biological_process","regulation of insulin-like growth factor receptor signaling pathway ","P28069; P17936; P08833"]
["GO:0060133","biological_process","somatotropin secreting cell development ","P28069"]
["GO:0002509","biological_process","central tolerance induction to self antigen ","O43918"]
["GO:0032602","biological_process","chemokine production ","O43918; P06702"]
["GO:0002458","biological_process","peripheral T cell tolerance induction ","O43918"]
["GO:2000410","biological_process","regulation of thymocyte migration ","O43918"]
["GO:0097536","biological_process","thymus epithelium morphogenesis ","O43918"]
["GO:0010586","biological_process","miRNA metabolic process ","Q5TAX3; P62826; Q15633; Q92841; Q92945; Q9NRR4; Q9UKV8"]
["GO:1990074","biological_process","polyuridylation-dependent mRNA catabolic process ","Q5TAX3"]
["GO:0031054","biological_process","pre-miRNA processing ","Q5TAX3; Q15633; Q9NRR4; Q9UKV8"]
["GO:0031123","biological_process","RNA '-end processing ","Q5TAX3"]
["GO:0071076","biological_process","RNA 3' uridylation ","Q5TAX3"]
["GO:0072175","biological_process","epithelial tube formation ","O00592"]
["GO:0072015","biological_process","glomerular visceral epithelial cell development ","O00592; O60500; P46940; Q86UL8"]
["GO:2000766","biological_process","negative regulation of cytoplasmic translation ","Q9BZB8; Q06787; Q8NE35"]
["GO:2000424","biological_process","positive regulation of eosinophil chemotaxis ","Q9UIK4"]
["GO:2001242","biological_process","regulation of intrinsic apoptotic signaling pathway ","Q9UIK4; Q9NQC7; Q9ULZ3"]
["GO:1903438","biological_process","positive regulation of mitotic cytokinetic process ","Q96Q89; P37198"]
["GO:0016458","biological_process","gene silencing ","P26358; P51787; Q8IXJ6"]
["GO:0010216","biological_process","maintenance of DNA methylation ","P26358; Q96T88; Q93009"]
["GO:1905460","biological_process","negative regulation of vascular associated smooth muscle cell apoptotic process ","P26358"]
["GO:1905931","biological_process","negative regulation of vascular smooth muscle cell differentiation involved in phenotypic switching ","P26358"]
["GO:0032074","biological_process","negative regulation of nuclease activity ","Q96FI4"]
["GO:1902680","biological_process","positive regulation of RNA biosynthetic process ","Q96D46"]
["GO:0000055","biological_process","ribosomal large subunit export from nucleus ","Q96D46; Q9NZM5; P62826; O14980"]
["GO:0002358","biological_process","B cell homeostatic proliferation ","Q07812; P55895"]
["GO:0002352","biological_process","B cell negative selection ","Q07812; Q16611"]
["GO:1990117","biological_process","B cell receptor apoptotic signaling pathway ","Q07812"]
["GO:0045136","biological_process","development of secondary sexual characteristics ","Q07812"]
["GO:0002904","biological_process","positive regulation of B cell apoptotic process ","Q07812"]
["GO:0048087","biological_process","positive regulation of developmental pigmentation ","Q07812"]
["GO:0033599","biological_process","regulation of mammary gland epithelial cell proliferation ","Q07812; Q9BRQ0; P07203"]
["GO:0006808","biological_process","regulation of nitrogen utilization ","Q07812; P10415"]
["GO:0032976","biological_process","release of matrix enzymes from mitochondria ","Q07812"]
["GO:0060011","biological_process","Sertoli cell proliferation ","Q07812"]
["GO:0048515","biological_process","spermatid differentiation ","Q07812; O15259; Q6P0Q8; P26196"]
["GO:0001777","biological_process","T cell homeostatic proliferation ","Q07812"]
["GO:0045123","biological_process","cellular extravasation ","P05107"]
["GO:0002523","biological_process","leukocyte migration involved in inflammatory response ","P05107; P06702"]
["GO:0030101","biological_process","natural killer cell activation ","P05107; P46379; Q14790; Q06830; O00329"]
["GO:0006911","biological_process","phagocytosis, engulfment ","P05107; P51809; P30273; P06396; Q92556; O95477; P31994; Q14185; P60953; P35579"]
["GO:0043315","biological_process","positive regulation of neutrophil degranulation ","P05107"]
["GO:2000363","biological_process","positive regulation of prostaglandin-E synthase activity ","P05107"]
["GO:0032623","biological_process","interleukin- production ","P20963; Q9UJZ1; P30273"]
["GO:0060434","biological_process","bronchus morphogenesis ","O75386; P37173"]
["GO:0021953","biological_process","central nervous system neuron differentiation ","O75386; Q01851"]
["GO:0061548","biological_process","ganglion development ","O75386"]
["GO:0021914","biological_process","negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning ","O75386"]
["GO:1903546","biological_process","protein localization to photoreceptor outer segment ","O75386; Q9NYG2"]
["GO:0097500","biological_process","receptor localization to non-motile cilium ","O75386"]
["GO:0060831","biological_process","smoothened signaling pathway involved in dorsal/ventral neural tube patterning ","O75386; P10070; P10071"]
["GO:0032483","biological_process","regulation of Rab protein signal transduction ","Q8TEH3"]
["GO:1903671","biological_process","negative regulation of sprouting angiogenesis ","Q9Y6I3; P57105; O95208"]
["GO:0045132","biological_process","meiotic chromosome segregation ","Q7Z5K2; Q9NTJ3; Q5FBB7"]
["GO:0006613","biological_process","cotranslational protein targeting to membrane ","P43307"]
["GO:0043116","biological_process","negative regulation of vascular permeability ","Q12913; P13688; Q14432; Q9NRY4; Q4VCS5"]
["GO:0042167","biological_process","heme catabolic process ","P53004; P09601"]
["GO:0050832","biological_process","defense response to fungus ","Q96F46; P04406; P06702"]
["GO:0072537","biological_process","fibroblast activation ","Q96F46; Q9H4X1"]
["GO:0097400","biological_process","interleukin-1-mediated signaling pathway ","Q96F46"]
["GO:0032747","biological_process","positive regulation of interleukin- production ","Q96F46"]
["GO:2001236","biological_process","regulation of extrinsic apoptotic signaling pathway ","Q8TB45; Q13077"]
["GO:0021796","biological_process","cerebral cortex regionalization ","P26367"]
["GO:0061303","biological_process","cornea development in camera-type eye ","P26367; P53671"]
["GO:0009950","biological_process","dorsal/ventral axis specification ","P26367; Q9UIW0; Q9HC62; Q99750; P36894"]
["GO:0021798","biological_process","forebrain dorsal/ventral pattern formation ","P26367; P43699; P10071"]
["GO:0021905","biological_process","forebrain-midbrain boundary formation ","P26367"]
["GO:0021986","biological_process","habenula development ","P26367; P43354; Q01851"]
["GO:0048663","biological_process","neuron fate commitment ","P26367; Q13485; Q13516; P23759; P50553; Q02363; P36897; Q02297; P20265"]
["GO:0021778","biological_process","oligodendrocyte cell fate specification ","P26367"]
["GO:0003322","biological_process","pancreatic A cell development ","P26367"]
["GO:0030858","biological_process","positive regulation of epithelial cell differentiation ","P26367; P48436"]
["GO:0009786","biological_process","regulation of asymmetric cell division ","P26367; Q01860"]
["GO:0048505","biological_process","regulation of timing of cell differentiation ","P26367; Q06330"]
["GO:0021918","biological_process","regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment ","P26367"]
["GO:0021912","biological_process","regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification ","P26367"]
["GO:0021913","biological_process","regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification ","P26367; P49640"]
["GO:0035116","biological_process","embryonic hindlimb morphogenesis ","Q9P2D1; Q99697; P35548; P78337; O15119; P46531; Q05516; P13631; Q15648; Q15672; Q9H3D4"]
["GO:0030540","biological_process","female genitalia development ","Q9P2D1; P11511; O15119"]
["GO:0043584","biological_process","nose development ","Q9P2D1"]
["GO:0042048","biological_process","olfactory behavior ","Q9P2D1; Q9Y566"]
["GO:0060123","biological_process","regulation of growth hormone secretion ","Q9P2D1"]
["GO:0003226","biological_process","right ventricular compact myocardium morphogenesis ","Q9P2D1"]
["GO:0003222","biological_process","ventricular trabecula myocardium morphogenesis ","Q9P2D1; P52952; P17813; P36897; Q02297; P46531; Q15648; P36894; Q06330"]
["GO:0071880","biological_process","adenylate cyclase-activating adrenergic receptor signaling pathway ","Q9Y4G8; P08588; P35368; P08913; P07550"]
["GO:0071321","biological_process","cellular response to cMP ","Q9Y4G8; Q9Y3Q4; Q14432; P31645; Q9UL51"]
["GO:0021884","biological_process","forebrain neuron development ","Q9Y4G8"]
["GO:0048022","biological_process","negative regulation of melanin biosynthetic process ","Q9Y4G8"]
["GO:0043950","biological_process","positive regulation of cAMP-mediated signaling ","Q9Y4G8; P08588; Q8N884; P35372"]
["GO:0021591","biological_process","ventricular system development ","Q9Y4G8; P51608; Q92688"]
["GO:0060212","biological_process","negative regulation of nuclear-transcribed mRNA poly(A) tail shortening ","P50616"]
["GO:1900153","biological_process","positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay ","P50616; Q8WY41; P11940; Q9UPQ9; Q07352; Q8NE35; P26651; Q9UKV8"]
["GO:0098900","biological_process","regulation of action potential ","Q14721"]
["GO:2000671","biological_process","regulation of motor neuron apoptotic process ","Q14721"]
["GO:1990613","biological_process","mitochondrial membrane fusion ","Q8IWA4"]
["GO:0006272","biological_process","leading strand elongation ","P12004"]
["GO:1902990","biological_process","mitotic telomere maintenance via semi-conservative replication ","P12004"]
["GO:0032077","biological_process","positive regulation of deoxyribonuclease activity ","P12004"]
["GO:0072675","biological_process","osteoclast fusion ","Q5TCZ1"]
["GO:0010457","biological_process","centriole-centriole cohesion ","Q5TZA2; Q14203; Q5BJF6; Q9BV73; Q9Y496; Q5FBB7"]
["GO:0032053","biological_process","ciliary basal body organization ","Q5TZA2; O43303"]
["GO:0051656","biological_process","establishment of organelle localization ","Q5TZA2"]
["GO:1903566","biological_process","positive regulation of protein localization to cilium ","Q5TZA2; Q3V6T2"]
["GO:1900260","biological_process","negative regulation of RNA-directed 5'-3' RNA polymerase activity ","Q14240"]
["GO:0007621","biological_process","negative regulation of female receptivity ","Q9UD71; P10828"]
["GO:0002561","biological_process","basophil degranulation ","Q9BTU6"]
["GO:0006431","biological_process","methionyl-tRNA aminoacylation ","P56192"]
["GO:1902260","biological_process","negative regulation of delayed rectifier potassium channel activity ","Q9Y6H6; P63165; Q12955; P51787; P15382"]
["GO:1905025","biological_process","negative regulation of membrane repolarization during ventricular cardiac muscle cell action potential ","Q9Y6H6"]
["GO:1903765","biological_process","negative regulation of potassium ion export across plasma membrane ","Q9Y6H6"]
["GO:1903817","biological_process","negative regulation of voltage-gated potassium channel activity ","Q9Y6H6; P51787"]
["GO:1901387","biological_process","positive regulation of voltage-gated calcium channel activity ","Q9Y6H6"]
["GO:0070842","biological_process","aggresome assembly ","P55072; Q9UBN7; O60260"]
["GO:1903843","biological_process","cellular response to arsenite ion ","P55072"]
["GO:0061857","biological_process","endoplasmic reticulum stress-induced pre-emptive quality control ","P55072; P46379"]
["GO:0071712","biological_process","ER-associated misfolded protein catabolic process ","P55072; P46379"]
["GO:0072389","biological_process","flavin adenine dinucleotide catabolic process ","P55072"]
["GO:1903007","biological_process","positive regulation of Lys6-specific deubiquitinase activity ","P55072"]
["GO:1903006","biological_process","positive regulation of protein K-linked deubiquitination ","P55072; Q9NZM5"]
["GO:0010498","biological_process","proteasomal protein catabolic process ","P55072; Q9H4P4; P46379; Q9UMS4; Q16531; P20393; Q13794; O60260"]
["GO:0060124","biological_process","positive regulation of growth hormone secretion ","Q14155; P14416; Q9UBU3"]
["GO:1904424","biological_process","regulation of TP binding ","Q14155; P48729"]
["GO:0006177","biological_process","MP biosynthetic process ","P49915; P12268"]
["GO:0055009","biological_process","atrial cardiac muscle tissue morphogenesis ","Q99697; P17813"]
["GO:0003171","biological_process","atrioventricular valve development ","Q99697"]
["GO:0003253","biological_process","cardiac neural crest cell migration involved in outflow tract morphogenesis ","Q99697; P61296; Q15672"]
["GO:0061325","biological_process","cell proliferation involved in outflow tract morphogenesis ","Q99697; P61296"]
["GO:0035993","biological_process","deltoid tuberosity development ","Q99697"]
["GO:0061031","biological_process","endodermal digestive tract morphogenesis ","Q99697; Q02363"]
["GO:0021855","biological_process","hypothalamus cell migration ","Q99697"]
["GO:0070986","biological_process","left/right axis specification ","Q99697; Q99967; P46531"]
["GO:0060460","biological_process","left lung morphogenesis ","Q99697"]
["GO:2000288","biological_process","positive regulation of myoblast proliferation ","Q99697; P23759; P22460; Q9Y5B6"]
["GO:0060127","biological_process","prolactin secreting cell differentiation ","Q99697"]
["GO:0003350","biological_process","pulmonary myocardium development ","Q99697; P52952"]
["GO:0060577","biological_process","pulmonary vein morphogenesis ","Q99697; Q9UMR3"]
["GO:0060126","biological_process","somatotropin secreting cell differentiation ","Q99697"]
["GO:0021763","biological_process","subthalamic nucleus development ","Q99697"]
["GO:0060578","biological_process","superior vena cava morphogenesis ","Q99697"]
["GO:0008050","biological_process","female courtship behavior ","P10828; P10827"]
["GO:0042480","biological_process","negative regulation of eye photoreceptor cell development ","P10828"]
["GO:0097474","biological_process","retinal cone cell apoptotic process ","P10828"]
["GO:1901525","biological_process","negative regulation of mitophagy ","Q9H4P4; P49815"]
["GO:0045619","biological_process","regulation of lymphocyte differentiation ","Q9H4P4"]
["GO:0009437","biological_process","carnitine metabolic process ","P50416"]
["GO:0051303","biological_process","establishment of chromosome localization ","Q9GZM8; Q9NXR1; O15392"]
["GO:0001833","biological_process","inner cell mass cell proliferation ","Q9GZM8; Q9UMS4; P51587"]
["GO:0032418","biological_process","lysosome localization ","Q9GZM8; Q9UBN7; O95295"]
["GO:0048680","biological_process","positive regulation of axon regeneration ","Q9GZM8"]
["GO:2000574","biological_process","regulation of microtubule motor activity ","Q9GZM8; Q9NXR1"]
["GO:0008090","biological_process","retrograde axonal transport ","Q9GZM8; P07196; P00441; O95295"]
["GO:0099502","biological_process","calcium-dependent activation of synaptic vesicle fusion ","P21579; O43581"]
["GO:0098746","biological_process","fast, calcium ion-dependent exocytosis of neurotransmitter ","P21579"]
["GO:1903305","biological_process","regulation of regulated secretory pathway ","P21579"]
["GO:0086023","biological_process","adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process ","P26678; Q12802"]
["GO:1902081","biological_process","negative regulation of calcium ion import into sarcoplasmic reticulum ","P26678"]
["GO:1901895","biological_process","negative regulation of calcium-transporting ATPase activity ","P26678"]
["GO:0086092","biological_process","regulation of the force of heart contraction by cardiac conduction ","P26678; P19634"]
["GO:1990086","biological_process","lens fiber cell apoptotic process ","Q01094; P37173"]
["GO:0032970","biological_process","regulation of actin filament-based process ","Q99439"]
["GO:0008089","biological_process","anterograde axonal transport ","P07196; P00441; O95295; O95239"]
["GO:0045105","biological_process","intermediate filament polymerization or depolymerization ","P07196"]
["GO:0040011","biological_process","locomotion ","P07196"]
["GO:0014012","biological_process","peripheral nervous system axon regeneration ","P07196"]
["GO:0031133","biological_process","regulation of axon diameter ","P07196"]
["GO:1903937","biological_process","response to acrylamide ","P07196; P41145"]
["GO:1903935","biological_process","response to sodium arsenite ","P07196"]
["GO:0070634","biological_process","transepithelial ammonium transport ","Q9H310; P55011"]
["GO:0051684","biological_process","maintenance of olgi location ","Q9P2Y5; Q5T5U3"]
["GO:0071985","biological_process","multivesicular body sorting pathway ","Q9P2Y5; Q9Y3E7; Q96H20"]
["GO:1901098","biological_process","positive regulation of autophagosome maturation ","Q9P2Y5; Q8TEV9; P07550"]
["GO:1990927","biological_process","calcium ion regulated lysosome exocytosis ","O43581"]
["GO:0090385","biological_process","phagosome-lysosome fusion ","O43581"]
["GO:0070092","biological_process","regulation of glucagon secretion ","O43581; Q96RG2"]
["GO:1990926","biological_process","short-term synaptic potentiation ","O43581; P60880"]
["GO:0090119","biological_process","vesicle-mediated cholesterol transport ","O43581"]
["GO:0072599","biological_process","establishment of protein localization to endoplasmic reticulum ","Q92736"]
["GO:0003220","biological_process","left ventricular cardiac muscle tissue morphogenesis ","Q92736; Q13485"]
["GO:1901896","biological_process","positive regulation of calcium-transporting ATPase activity ","Q92736; P63165; P54652"]
["GO:0051284","biological_process","positive regulation of sequestering of calcium ion ","Q92736"]
["GO:0086029","biological_process","Purkinje myocyte to ventricular cardiac muscle cell signaling ","Q92736; O14958"]
["GO:0098910","biological_process","regulation of atrial cardiac muscle cell action potential ","Q92736"]
["GO:0098904","biological_process","regulation of AV node cell action potential ","Q92736"]
["GO:0098907","biological_process","regulation of SA node cell action potential ","Q92736"]
["GO:0097050","biological_process","type B pancreatic cell apoptotic process ","Q92736"]
["GO:0042273","biological_process","ribosomal large subunit biogenesis ","Q9Y3T9; Q969S3; P62913; Q99848"]
["GO:0098743","biological_process","cell aggregation ","P25189"]
["GO:1901837","biological_process","negative regulation of transcription of nucleolar large rRNA by RNA polymerase I ","Q9NZM5"]
["GO:1902570","biological_process","protein localization to nucleolus ","Q9NZM5; P62826; Q96BK5; Q14191"]
["GO:1990173","biological_process","protein localization to nucleoplasm ","Q9NZM5"]
["GO:0039535","biological_process","regulation of RI-I signaling pathway ","Q9NZM5"]
["GO:0000027","biological_process","ribosomal large subunit assembly ","Q9NZM5; P62913; Q9UKD2; P30050; P46087"]
["GO:0090521","biological_process","glomerular visceral epithelial cell migration ","Q9NQW6"]
["GO:1904172","biological_process","positive regulation of bleb assembly ","Q9NQW6"]
["GO:0000921","biological_process","septin ring assembly ","Q9NQW6"]
["GO:0032963","biological_process","collagen metabolic process ","Q16665; P41134"]
["GO:0002248","biological_process","connective tissue replacement involved in inflammatory response wound healing ","Q16665"]
["GO:0051541","biological_process","elastin metabolic process ","Q16665"]
["GO:0061030","biological_process","epithelial cell differentiation involved in mammary gland alveolus development ","Q16665; Q12946; Q02363"]
["GO:2001054","biological_process","negative regulation of mesenchymal cell apoptotic process ","Q16665; P48436"]
["GO:1903377","biological_process","negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway ","Q16665; Q99497; O60260"]
["GO:0021502","biological_process","neural fold elevation formation ","Q16665"]
["GO:0070101","biological_process","positive regulation of chemokine-mediated signaling pathway ","Q16665"]
["GO:0061419","biological_process","positive regulation of transcription from RNA polymerase II promoter in response to hypoxia ","Q16665; Q16236; P46531; Q06330"]
["GO:0010573","biological_process","vascular endothelial growth factor production ","Q16665"]
["GO:0043369","biological_process","CD-positive or CD8-positive, alpha-beta T cell lineage commitment ","Q9NQC7"]
["GO:0045581","biological_process","negative regulation of T cell differentiation ","Q9NQC7; Q86Y01"]
["GO:1990108","biological_process","protein linear deubiquitination ","Q9NQC7"]
["GO:0003062","biological_process","regulation of heart rate by chemical signal ","P36956"]
["GO:0010611","biological_process","regulation of cardiac muscle hypertrophy ","Q12802"]
["GO:1900169","biological_process","regulation of glucocorticoid mediated signaling pathway ","Q12802"]
["GO:1901911","biological_process","adenosine 5'-(hexahydrogen pentaphosphate) catabolic process ","Q9NZJ9; O95989"]
["GO:0019935","biological_process","cyclic-nucleotide-mediated signaling ","Q9NZJ9"]
["GO:1901909","biological_process","diadenosine hexaphosphate catabolic process ","Q9NZJ9; O95989"]
["GO:1901907","biological_process","diadenosine pentaphosphate catabolic process ","Q9NZJ9; O95989"]
["GO:0071543","biological_process","diphosphoinositol polyphosphate metabolic process ","Q9NZJ9"]
["GO:0071460","biological_process","cellular response to cell-matrix adhesion ","P09211; Q13309"]
["GO:1901687","biological_process","glutathione derivative biosynthetic process ","P09211; O15217"]
["GO:0009890","biological_process","negative regulation of biosynthetic process ","P09211"]
["GO:0032691","biological_process","negative regulation of interleukin- beta production ","P09211; O15553; Q9UBU3; P32121; Q9UJM3"]
["GO:0070664","biological_process","negative regulation of leukocyte proliferation ","P09211"]
["GO:0051771","biological_process","negative regulation of nitric-oxide synthase biosynthetic process ","P09211"]
["GO:0071672","biological_process","negative regulation of smooth muscle cell chemotaxis ","P09211; Q9BR76"]
["GO:0035732","biological_process","nitric oxide storage ","P09211"]
["GO:0006707","biological_process","cholesterol catabolic process ","Q15036; Q8WTV0; P02649"]
["GO:1990126","biological_process","retrograde transport, endosome to plasma membrane ","Q15036; Q96JC1; Q8N3F8"]
["GO:0035563","biological_process","positive regulation of chromatin binding ","P56545; O60341; O75496; Q9BRQ0; Q9H211"]
["GO:0061756","biological_process","leukocyte adhesion to vascular endothelial cell ","P41597"]
["GO:0043310","biological_process","negative regulation of eosinophil degranulation ","P41597"]
["GO:2000464","biological_process","positive regulation of astrocyte chemotaxis ","P41597"]
["GO:2000451","biological_process","positive regulation of CD8-positive, alpha-beta T cell extravasation ","P41597"]
["GO:0090265","biological_process","positive regulation of immune complex clearance by monocytes and macrophages ","P41597"]
["GO:2000439","biological_process","positive regulation of monocyte extravasation ","P41597"]
["GO:0002827","biological_process","positive regulation of T-helper 1 type immune response ","P41597"]
["GO:0010574","biological_process","regulation of vascular endothelial growth factor production ","P41597; Q9UN36"]
["GO:0035705","biological_process","T-helper 1 cell chemotaxis ","P41597"]
["GO:0046885","biological_process","regulation of hormone biosynthetic process ","O76061"]
["GO:2001256","biological_process","regulation of store-operated calcium entry ","O76061; Q13586; P31415; Q86YM7; Q6J4K2"]
["GO:0006710","biological_process","androgen catabolic process ","P11511"]
["GO:0002677","biological_process","negative regulation of chronic inflammatory response ","P11511; Q9BZS1"]
["GO:0010760","biological_process","negative regulation of macrophage chemotaxis ","P11511"]
["GO:2000866","biological_process","positive regulation of estradiol secretion ","P11511"]
["GO:0036471","biological_process","cellular response to glyoxal ","Q99497"]
["GO:0010273","biological_process","detoxification of copper ion ","Q99497; Q04656"]
["GO:0050787","biological_process","detoxification of mercury ion ","Q99497"]
["GO:0018323","biological_process","enzyme active site formation via L-cysteine sulfinic acid ","Q99497"]
["GO:0036531","biological_process","glutathione deglycation ","Q99497"]
["GO:0046295","biological_process","glycolate biosynthetic process ","Q99497"]
["GO:1903189","biological_process","glyoxal metabolic process ","Q99497"]
["GO:0106044","biological_process","guanine deglycation ","Q99497"]
["GO:0106046","biological_process","guanine deglycation, glyoxal removal ","Q99497"]
["GO:0106045","biological_process","guanine deglycation, methylglyoxal removal ","Q99497"]
["GO:1903073","biological_process","negative regulation of death-inducing signaling complex assembly ","Q99497"]
["GO:1903208","biological_process","negative regulation of hydrogen peroxide-induced neuron death ","Q99497; P63244"]
["GO:1903384","biological_process","negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway ","Q99497; Q9BXM7"]
["GO:1905259","biological_process","negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway ","Q99497"]
["GO:1903094","biological_process","negative regulation of protein K8-linked deubiquitination ","Q99497; Q04323"]
["GO:1903427","biological_process","negative regulation of reactive oxygen species biosynthetic process ","Q99497; Q12931; Q05940; P61586; O15519"]
["GO:1903122","biological_process","negative regulation of TRAIL-activated apoptotic signaling pathway ","Q99497"]
["GO:2000157","biological_process","negative regulation of ubiquitin-specific protease activity ","Q99497; Q04323"]
["GO:0036527","biological_process","peptidyl-arginine deglycation ","Q99497"]
["GO:0036526","biological_process","peptidyl-cysteine deglycation ","Q99497"]
["GO:0036528","biological_process","peptidyl-lysine deglycation ","Q99497"]
["GO:2000825","biological_process","positive regulation of androgen receptor activity ","Q99497"]
["GO:1903181","biological_process","positive regulation of dopamine biosynthetic process ","Q99497"]
["GO:1903197","biological_process","positive regulation of L-dopa biosynthetic process ","Q99497"]
["GO:1903200","biological_process","positive regulation of L-dopa decarboxylase activity ","Q99497"]
["GO:1902958","biological_process","positive regulation of mitochondrial electron transport, NADH to ubiquinone ","Q99497; Q9BXM7"]
["GO:2000277","biological_process","positive regulation of oxidative phosphorylation uncoupler activity ","Q99497"]
["GO:1902177","biological_process","positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway ","Q99497; P00441; P23246"]
["GO:1903168","biological_process","positive regulation of pyrroline-5-carboxylate reductase activity ","Q99497"]
["GO:1901671","biological_process","positive regulation of superoxide dismutase activity ","Q99497; P01375"]
["GO:1903178","biological_process","positive regulation of tyrosine -monooxygenase activity ","Q99497"]
["GO:0036529","biological_process","protein deglycation, glyoxal removal ","Q99497"]
["GO:0036530","biological_process","protein deglycation, methylglyoxal removal ","Q99497"]
["GO:0006517","biological_process","protein deglycosylation ","Q99497; O60502"]
["GO:1902903","biological_process","regulation of supramolecular fiber organization ","Q99497"]
["GO:0000350","biological_process","generation of catalytic spliceosome for second transesterification step ","Q13573"]
["GO:0070564","biological_process","positive regulation of vitamin D receptor signaling pathway ","Q13573"]
["GO:0048385","biological_process","regulation of retinoic acid receptor signaling pathway ","Q13573"]
["GO:0042420","biological_process","dopamine catabolic process ","Q01959; P21397"]
["GO:0090494","biological_process","dopamine uptake ","Q01959; P23975; Q8TD08"]
["GO:0015844","biological_process","monoamine transport ","Q01959; P23975; Q05940; P31645; Q9NRD5"]
["GO:0042053","biological_process","regulation of dopamine metabolic process ","Q01959; P43354; P21728; O60260"]
["GO:0070940","biological_process","dephosphorylation of RNA polymerase II C-terminal domain ","Q9NP77; Q9Y5B0; Q9NQG5"]
["GO:0006878","biological_process","cellular copper ion homeostasis ","P04156; P05067; Q04656"]
["GO:0090647","biological_process","modulation of age-related behavioral decline ","P04156; P41594; P49768; P05067; Q15109"]
["GO:0046007","biological_process","negative regulation of activated T cell proliferation ","P04156; Q9BZS1; Q5TC82; P10644; P42574"]
["GO:0032700","biological_process","negative regulation of interleukin-1 production ","P04156; Q9BZS1; O00206"]
["GO:1902938","biological_process","regulation of intracellular calcium activated chloride channel activity ","P04156; P41594"]
["GO:0018345","biological_process","protein palmitoylation ","Q9NYG2"]
["GO:0034502","biological_process","protein localization to chromosome ","P27694; P15927"]
["GO:0003190","biological_process","atrioventricular valve formation ","Q13485"]
["GO:0003360","biological_process","brainstem development ","Q13485; Q14524; P31939; Q8N0W4"]
["GO:0060956","biological_process","endocardial cell differentiation ","Q13485; Q02297; P46531"]
["GO:0061040","biological_process","female gonad morphogenesis ","Q13485"]
["GO:0048859","biological_process","formation of anatomical boundary ","Q13485"]
["GO:0072133","biological_process","metanephric mesenchyme morphogenesis ","Q13485"]
["GO:1905305","biological_process","negative regulation of cardiac myofibril assembly ","Q13485"]
["GO:0072134","biological_process","nephrogenic mesenchyme morphogenesis ","Q13485"]
["GO:0003251","biological_process","positive regulation of cell proliferation involved in heart valve morphogenesis ","Q13485"]
["GO:0051797","biological_process","regulation of hair follicle development ","Q13485"]
["GO:0048733","biological_process","sebaceous gland development ","Q13485; Q06330"]
["GO:0032525","biological_process","somite rostral/caudal axis specification ","Q13485"]
["GO:0061484","biological_process","hematopoietic stem cell homeostasis ","Q14157"]
["GO:1902774","biological_process","late endosome to lysosome transport ","Q96JC1; O95295"]
["GO:0043375","biological_process","CD8-positive, alpha-beta T cell lineage commitment ","P10415"]
["GO:0006582","biological_process","melanin metabolic process ","P10415"]
["GO:0032848","biological_process","negative regulation of cellular pH reduction ","P10415"]
["GO:0033033","biological_process","negative regulation of myeloid cell apoptotic process ","P10415"]
["GO:0046671","biological_process","negative regulation of retinal cell programmed cell death ","P10415"]
["GO:0048753","biological_process","pigment granule organization ","P10415"]
["GO:0099150","biological_process","regulation of postsynaptic specialization assembly ","Q9ULB1; P17677"]
["GO:0050896","biological_process","response to stimulus ","Q9UI40; P37088; P30301; Q86UR5; Q8NEV4; P43320; Q8NI36; P54845; Q6J4K2; P51170; P18545; P51168"]
["GO:0090083","biological_process","regulation of inclusion body assembly ","Q9Y6H5"]
["GO:0000447","biological_process","endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) ","Q8N9T8"]
["GO:1901660","biological_process","calcium ion export ","P32418; P23634"]
["GO:0060401","biological_process","cytosolic calcium ion transport ","P32418"]
["GO:0086012","biological_process","membrane depolarization during cardiac muscle cell action potential ","P32418; Q14524; Q9Y3Q4; Q13936; Q01668; P63252; Q9UL51"]
["GO:0044557","biological_process","relaxation of smooth muscle ","P32418"]
["GO:0036376","biological_process","sodium ion export across plasma membrane ","P32418; P19634; P05023"]
["GO:0098719","biological_process","sodium ion import across plasma membrane ","P32418; P19634; Q9Y3Q4; Q8TD43; P48764; Q14940; Q9UL51"]
["GO:0016482","biological_process","cytosolic transport ","P61160; O75494"]
["GO:0016344","biological_process","meiotic chromosome movement towards spindle pole ","P61160; P61158"]
["GO:0033206","biological_process","meiotic cytokinesis ","P61160; P61158"]
["GO:0038065","biological_process","collagen-activated signaling pathway ","P17301"]
["GO:0031346","biological_process","positive regulation of cell projection organization ","P17301"]
["GO:0033343","biological_process","positive regulation of collagen binding ","P17301"]
["GO:0002687","biological_process","positive regulation of leukocyte migration ","P17301"]
["GO:0051971","biological_process","positive regulation of transmission of nerve impulse ","P17301"]
["GO:0086016","biological_process","AV node cell action potential ","Q14524; Q9Y5Y9; O43497"]
["GO:0086067","biological_process","AV node cell to bundle of His cell communication ","Q14524"]
["GO:0086043","biological_process","bundle of His cell action potential ","Q14524; Q9Y5Y9"]
["GO:0086002","biological_process","cardiac muscle cell action potential involved in contraction ","Q14524; Q13936; Q01668; O43497; P05023; P15382; P63252"]
["GO:0098912","biological_process","membrane depolarization during atrial cardiac muscle cell action potential ","Q14524; Q13936; Q08289"]
["GO:0086045","biological_process","membrane depolarization during AV node cell action potential ","Q14524; Q13936; Q8TD43; O43497; Q08289"]
["GO:0086048","biological_process","membrane depolarization during bundle of His cell action potential ","Q14524; Q8TD43"]
["GO:0086047","biological_process","membrane depolarization during Purkinje myocyte cell action potential ","Q14524; Q8TD43"]
["GO:0086046","biological_process","membrane depolarization during SA node cell action potential ","Q14524; Q9Y3Q4; Q01668; O43497"]
["GO:0045760","biological_process","positive regulation of action potential ","Q14524; P19634"]
["GO:0060372","biological_process","regulation of atrial cardiac muscle cell membrane repolarization ","Q14524; Q01668; P22460; P51787"]
["GO:1902305","biological_process","regulation of sodium ion transmembrane transport ","Q14524; Q12959; P23634; Q13424"]
["GO:0086015","biological_process","SA node cell action potential ","Q14524; Q9Y3Q4; O43497"]
["GO:0060708","biological_process","spongiotrophoblast differentiation ","O14543"]
["GO:0010739","biological_process","positive regulation of protein kinase A signaling ","Q02952; P58400; P05067; P07550"]
["GO:0046959","biological_process","habituation ","O60229; O95278; P21728; Q9Y566"]
["GO:0048659","biological_process","smooth muscle cell proliferation ","O60229"]
["GO:0030277","biological_process","maintenance of gastrointestinal epithelium ","Q9Y3F4"]
["GO:0060394","biological_process","negative regulation of pathway-restricted SMAD protein phosphorylation ","Q9Y3F4; O43541; O15105; P17813; P17861"]
["GO:0002429","biological_process","immune response-activating cell surface receptor signaling pathway ","P46379"]
["GO:1904378","biological_process","maintenance of unfolded protein involved in ERAD pathway ","P46379"]
["GO:1904294","biological_process","positive regulation of ERAD pathway ","P46379; P54252"]
["GO:1904379","biological_process","protein localization to cytosolic proteasome complex involved in ERAD pathway ","P46379; P54252"]
["GO:0007130","biological_process","synaptonemal complex assembly ","P46379"]
["GO:0071816","biological_process","tail-anchored membrane protein insertion into ER membrane ","P46379; O43765"]
["GO:0007141","biological_process","male meiosis I ","Q9NQI0; P51587; P54652; P10243"]
["GO:1990511","biological_process","piRNA biosynthetic process ","Q9NQI0; P10243"]
["GO:0034587","biological_process","piRNA metabolic process ","Q9NQI0; Q9BXT4"]
["GO:0030835","biological_process","negative regulation of actin filament depolymerization ","Q9UH65; Q9UHB6"]
["GO:1902309","biological_process","negative regulation of peptidyl-serine dephosphorylation ","Q9UH65; Q96T49; P62258"]
["GO:0060754","biological_process","positive regulation of mast cell chemotaxis ","Q9UH65"]
["GO:0070537","biological_process","histone H2A K6-linked deubiquitination ","Q9Y5T5; Q96RL1"]
["GO:0140014","biological_process","mitotic nuclear division ","Q9Y5T5"]
["GO:0035522","biological_process","monoubiquitinated histone HA deubiquitination ","Q9Y5T5"]
["GO:0045901","biological_process","positive regulation of translational elongation ","Q9Y5T5"]
["GO:1903895","biological_process","negative regulation of IRE-mediated unfolded protein response ","Q9NZS9; P11021"]
["GO:0015837","biological_process","amine transport ","O43315"]
["GO:0015722","biological_process","canalicular bile acid transport ","O43315"]
["GO:0046942","biological_process","carboxylic acid transport ","O43315"]
["GO:0015791","biological_process","polyol transport ","O43315"]
["GO:0006863","biological_process","purine nucleobase transport ","O43315"]
["GO:0015855","biological_process","pyrimidine nucleobase transport ","O43315"]
["GO:0046689","biological_process","response to mercury ion ","O43315"]
["GO:1904261","biological_process","positive regulation of basement membrane assembly involved in embryonic body morphogenesis ","Q86SQ0; O75122; Q14118; Q86UU1"]
["GO:0044255","biological_process","cellular lipid metabolic process ","P55055"]
["GO:0032376","biological_process","positive regulation of cholesterol transport ","P55055; Q13133"]
["GO:0045723","biological_process","positive regulation of fatty acid biosynthetic process ","P55055; Q13133; Q9NP71"]
["GO:0090108","biological_process","positive regulation of high-density lipoprotein particle assembly ","P55055"]
["GO:0051006","biological_process","positive regulation of lipoprotein lipase activity ","P55055; Q13133"]
["GO:0090187","biological_process","positive regulation of pancreatic juice secretion ","P55055"]
["GO:0090340","biological_process","positive regulation of secretion of lysosomal enzymes ","P55055"]
["GO:0072201","biological_process","negative regulation of mesenchymal cell proliferation ","P02545; P48678"]
["GO:0090343","biological_process","positive regulation of cell aging ","P02545; P48678"]
["GO:2000143","biological_process","negative regulation of DNA-templated transcription, initiation ","P10827"]
["GO:0045925","biological_process","positive regulation of female receptivity ","P10827"]
["GO:0002155","biological_process","regulation of thyroid hormone mediated signaling pathway ","P10827; Q15788"]
["GO:0000349","biological_process","generation of catalytic spliceosome for first transesterification step ","Q9UMS4"]
["GO:0033344","biological_process","cholesterol efflux ","Q8WTV0; P02649; Q9UNQ0; O95477"]
["GO:0032497","biological_process","detection of lipopolysaccharide ","Q8WTV0; O00206; Q9Y6Y9"]
["GO:0034384","biological_process","high-density lipoprotein particle clearance ","Q8WTV0; P02649; Q00341"]
["GO:0034375","biological_process","high-density lipoprotein particle remodeling ","Q8WTV0; P02649"]
["GO:0015920","biological_process","lipopolysaccharide transport ","Q8WTV0"]
["GO:0043654","biological_process","recognition of apoptotic cell ","Q8WTV0; Q96KG7"]
["GO:0043691","biological_process","reverse cholesterol transport ","Q8WTV0; P02649; O95477"]
["GO:0035461","biological_process","vitamin transmembrane transport ","Q8WTV0"]
["GO:0060544","biological_process","regulation of necroptotic process ","Q14790; O15519"]
["GO:0039650","biological_process","suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process ","Q14790"]
["GO:0060715","biological_process","syncytiotrophoblast cell differentiation involved in labyrinthine layer development ","Q14790"]
["GO:0044830","biological_process","modulation by host of viral RNA genome replication ","Q06787"]
["GO:1900453","biological_process","negative regulation of long term synaptic depression ","Q06787; Q15109"]
["GO:1902373","biological_process","negative regulation of mRNA catabolic process ","Q06787"]
["GO:1901254","biological_process","positive regulation of intracellular transport of viral material ","Q06787"]
["GO:0098908","biological_process","regulation of neuronal action potential ","Q06787"]
["GO:2001213","biological_process","negative regulation of vasculogenesis ","P47989"]
["GO:0006195","biological_process","purine nucleotide catabolic process ","P47989; O43598; P07203"]
["GO:0009115","biological_process","xanthine catabolic process ","P47989"]
["GO:0000019","biological_process","regulation of mitotic recombination ","P49959; Q92878"]
["GO:0045116","biological_process","protein neddylation ","Q9UBF6"]
["GO:1903281","biological_process","positive regulation of calciumsodium antiporter activity ","P19634"]
["GO:0035794","biological_process","positive regulation of mitochondrial membrane permeability ","P19634"]
["GO:0051453","biological_process","regulation of intracellular pH ","P19634; P00918; P02730; P48764; Q9Y6R1; Q14940"]
["GO:0043137","biological_process","DNA replication, removal of RNA primer ","P39748"]
["GO:0090305","biological_process","nucleic acid phosphodiester bond hydrolysis ","P39748; Q53H47; Q92878; P22413"]
["GO:0045876","biological_process","positive regulation of sister chromatid cohesion ","P39748; P23246"]
["GO:0030150","biological_process","protein import into mitochondrial matrix ","O14925"]
["GO:0030206","biological_process","chondroitin sulfate biosynthetic process ","Q6UVK1"]
["GO:0030207","biological_process","chondroitin sulfate catabolic process ","Q6UVK1"]
["GO:0030208","biological_process","dermatan sulfate biosynthetic process ","Q6UVK1"]
["GO:0043931","biological_process","ossification involved in bone maturation ","O43157; P61586; P21817"]
["GO:1900220","biological_process","semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis ","O43157"]
["GO:0030859","biological_process","polarized epithelial cell differentiation ","Q8TDM6; Q9H3D4"]
["GO:0035332","biological_process","positive regulation of hippo signaling ","Q8TDM6"]
["GO:0045186","biological_process","zonula adherens assembly ","Q8TDM6"]
["GO:0001732","biological_process","formation of cytoplasmic translation initiation complex ","O00303; O75822; Q99613"]
["GO:0006290","biological_process","pyrimidine dimer repair ","Q03468; P06746; Q9Y253"]
["GO:0000303","biological_process","response to superoxide ","Q03468; P00441; P04179"]
["GO:0006362","biological_process","transcription elongation from RNA polymerase I promoter ","Q03468"]
["GO:0048541","biological_process","Peyer's patch development ","O94900; Q02363; P51692; P51449"]
["GO:0007060","biological_process","male meiosis chromosome segregation ","P40692"]
["GO:0043060","biological_process","meiotic metaphase I plate congression ","P40692"]
["GO:0051257","biological_process","meiotic spindle midzone assembly ","P40692"]
["GO:0045950","biological_process","negative regulation of mitotic recombination ","P40692"]
["GO:0048298","biological_process","positive regulation of isotype switching to IgA isotypes ","P40692; P43246; O96028"]
["GO:0000712","biological_process","resolution of meiotic recombination intermediates ","P40692; Q8IY92; Q8N2Z9; Q02880; P11388"]
["GO:0038060","biological_process","nitric oxide-cMP-mediated signaling pathway ","Q02153"]
["GO:0071688","biological_process","striated muscle myosin thick filament assembly ","P52179; P54296; Q14896; Q00872"]
["GO:0042596","biological_process","fear response ","P08588"]
["GO:0031649","biological_process","heat generation ","P08588; P07550"]
["GO:0002025","biological_process","norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure ","P08588; P07550"]
["GO:0001996","biological_process","positive regulation of heart rate by epinephrine-norepinephrine ","P08588"]
["GO:0001997","biological_process","positive regulation of the force of heart contraction by epinephrine-norepinephrine ","P08588"]
["GO:2000850","biological_process","negative regulation of glucocorticoid secretion ","Q16526"]
["GO:0097376","biological_process","interneuron axon guidance ","P56178"]
["GO:0060166","biological_process","olfactory pit development ","P56178; P50553"]
["GO:1902960","biological_process","negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process ","Q92673"]
["GO:1902963","biological_process","negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process ","Q92673"]
["GO:1902997","biological_process","negative regulation of neurofibrillary tangle assembly ","Q92673"]
["GO:1902948","biological_process","negative regulation of tau-protein kinase activity ","Q92673"]
["GO:1902771","biological_process","positive regulation of choline -acetyltransferase activity ","Q92673"]
["GO:1902955","biological_process","positive regulation of early endosome to recycling endosome transport ","Q92673"]
["GO:2001137","biological_process","positive regulation of endocytic recycling ","Q92673"]
["GO:1902953","biological_process","positive regulation of ER to olgi vesicle-mediated transport ","Q92673"]
["GO:0070863","biological_process","positive regulation of protein exit from endoplasmic reticulum ","Q92673"]
["GO:0006892","biological_process","post-olgi vesicle-mediated transport ","Q92673; Q9Y4I1; O00161; Q92538"]
["GO:0045053","biological_process","protein retention in olgi apparatus ","Q92673; Q9H4A6"]
["GO:0014910","biological_process","regulation of smooth muscle cell migration ","Q92673; P00749; P12821"]
["GO:0021522","biological_process","spinal cord motor neuron differentiation ","Q13516; Q6Y7W6"]
["GO:0021530","biological_process","spinal cord oligodendrocyte cell fate specification ","Q13516; P50553"]
["GO:0000706","biological_process","meiotic DNA double-strand break processing ","Q8IY92"]
["GO:1904431","biological_process","positive regulation of t-circle formation ","Q8IY92"]
["GO:0072429","biological_process","response to intra-S DNA damage checkpoint signaling ","Q8IY92"]
["GO:0070995","biological_process","NADPH oxidation ","P30044; Q13303"]
["GO:0051354","biological_process","negative regulation of oxidoreductase activity ","P30044; Q9UBN7"]
["GO:2001057","biological_process","reactive nitrogen species metabolic process ","P30044"]
["GO:0060785","biological_process","regulation of apoptosis involved in tissue homeostasis ","P30044"]
["GO:0070370","biological_process","cellular heat acclimation ","P0DMV8"]
["GO:0006402","biological_process","mRNA catabolic process ","P0DMV8; O75460; Q86U44; P13489; Q92945; P26651; Q8TCS8"]
["GO:1901029","biological_process","negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway ","P0DMV8"]
["GO:1902380","biological_process","positive regulation of endoribonuclease activity ","P0DMV8"]
["GO:0090063","biological_process","positive regulation of microtubule nucleation ","P0DMV8; Q14203; P51608"]
["GO:0070434","biological_process","positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway ","P0DMV8"]
["GO:0071641","biological_process","negative regulation of macrophage inflammatory protein  alpha production ","O15553"]
["GO:1900226","biological_process","negative regulation of NLRP3 inflammasome complex assembly ","O15553; Q8IXJ6"]
["GO:0021508","biological_process","floor plate formation ","P10070"]
["GO:0007442","biological_process","hindgut morphogenesis ","P10070; P10071"]
["GO:0060513","biological_process","prostatic bud formation ","P10070; Q9H3D4"]
["GO:0021776","biological_process","smoothened signaling pathway involved in spinal cord motor neuron cell fate specification ","P10070; Q9UMX1; P10071"]
["GO:0021775","biological_process","smoothened signaling pathway involved in ventral spinal cord interneuron specification ","P10070; Q9UMX1; P10071"]
["GO:0021513","biological_process","spinal cord dorsal/ventral patterning ","P10070"]
["GO:0021965","biological_process","spinal cord ventral commissure morphogenesis ","P10070; P43146"]
["GO:0021517","biological_process","ventral spinal cord development ","P10070; Q14203; O75553"]
["GO:1902850","biological_process","microtubule cytoskeleton organization involved in mitosis ","Q9Y6A5"]
["GO:0052565","biological_process","response to defense-related host nitric oxide production ","Q02108"]
["GO:0098925","biological_process","retrograde trans-synaptic signaling by nitric oxide, modulating synaptic transmission ","Q02108"]
["GO:1903033","biological_process","positive regulation of microtubule plus-end binding ","Q9UPY8; Q15691"]
["GO:2000751","biological_process","histone H3-T3 phosphorylation involved in chromosome passenger complex localization to kinetochore ","Q8TF76"]
["GO:0002362","biological_process","CD4-positive, CD5-positive, alpha-beta regulatory T cell lineage commitment ","Q9BZS1"]
["GO:0042036","biological_process","negative regulation of cytokine biosynthetic process ","Q9BZS1; P31483"]
["GO:0031064","biological_process","negative regulation of histone deacetylation ","Q9BZS1"]
["GO:0048294","biological_process","negative regulation of isotype switching to IgE isotypes ","Q9BZS1; P41182"]
["GO:0002725","biological_process","negative regulation of T cell cytokine production ","Q9BZS1; O15105"]
["GO:0032831","biological_process","positive regulation of CD4-positive, CD5-positive, alpha-beta regulatory T cell differentiation ","Q9BZS1"]
["GO:0033092","biological_process","positive regulation of immature T cell proliferation in thymus ","Q9BZS1"]
["GO:0002851","biological_process","positive regulation of peripheral T cell tolerance induction ","Q9BZS1"]
["GO:0032914","biological_process","positive regulation of transforming growth factor beta production ","Q9BZS1"]
["GO:0048302","biological_process","regulation of isotype switching to Ig isotypes ","Q9BZS1"]
["GO:0002456","biological_process","T cell mediated immunity ","Q9BZS1; P15529"]
["GO:0006348","biological_process","chromatin silencing at telomere ","Q5UIP0; Q8IXJ6"]
["GO:2001034","biological_process","positive regulation of double-strand break repair via nonhomologous end joining ","Q5UIP0; Q53H47; Q9BUR4"]
["GO:0043247","biological_process","telomere maintenance in response to DNA damage ","Q5UIP0"]
["GO:0038168","biological_process","epidermal growth factor receptor signaling pathway via I-kappaB kinase/NF-kappaB cascade ","P50749"]
["GO:0021599","biological_process","abducens nerve formation ","Q9Y5Q3"]
["GO:0035284","biological_process","brain segmentation ","Q9Y5Q3"]
["GO:0021571","biological_process","rhombomere  development ","Q9Y5Q3"]
["GO:0021572","biological_process","rhombomere 6 development ","Q9Y5Q3"]
["GO:0007379","biological_process","segment specification ","Q9Y5Q3; P35226; O14641; Q9Y483"]
["GO:0007423","biological_process","sensory organ development ","Q9Y5Q3"]
["GO:0060940","biological_process","epithelial to mesenchymal transition involved in cardiac fibroblast development ","Q53EL6"]
["GO:0006286","biological_process","base-excision repair, base-free sugar-phosphate removal ","P06746; P27695"]
["GO:0006288","biological_process","base-excision repair, DNA ligation ","P06746; P49916; P18887"]
["GO:0006287","biological_process","base-excision repair, gap-filling ","P06746; Q9UGP5"]
["GO:0071707","biological_process","immunoglobulin heavy chain V-D-J recombination ","P06746"]
["GO:0006491","biological_process","N-glycan processing ","P14314; Q14697"]
["GO:0060558","biological_process","regulation of calcidiol 1-monooxygenase activity ","P11473"]
["GO:0042359","biological_process","vitamin D metabolic process ","P11473; P08684; Q8N2W9; Q99538"]
["GO:0034378","biological_process","chylomicron assembly ","P02649; Q9UPG8"]
["GO:0034371","biological_process","chylomicron remodeling ","P02649"]
["GO:0010877","biological_process","lipid transport involved in lipid storage ","P02649"]
["GO:0042158","biological_process","lipoprotein biosynthetic process ","P02649"]
["GO:0034374","biological_process","low-density lipoprotein particle remodeling ","P02649; P30556"]
["GO:0051651","biological_process","maintenance of location in cell ","P02649"]
["GO:0045541","biological_process","negative regulation of cholesterol biosynthetic process ","P02649; P00441"]
["GO:0090370","biological_process","negative regulation of cholesterol efflux ","P02649; Q12772"]
["GO:1903001","biological_process","negative regulation of lipid transport across blood brain barrier ","P02649"]
["GO:1902999","biological_process","negative regulation of phospholipid efflux ","P02649"]
["GO:1901627","biological_process","negative regulation of postsynaptic membrane organization ","P02649"]
["GO:1901630","biological_process","negative regulation of presynaptic membrane organization ","P02649"]
["GO:0090209","biological_process","negative regulation of triglyceride metabolic process ","P02649"]
["GO:0097114","biological_process","NMDA glutamate receptor clustering ","P02649; P58400; Q9BYB0; Q8N2Q7"]
["GO:0033700","biological_process","phospholipid efflux ","P02649; O95477"]
["GO:1905908","biological_process","positive regulation of amyloid fibril formation ","P02649; P49768; P05067"]
["GO:0010873","biological_process","positive regulation of cholesterol esterification ","P02649; P30556"]
["GO:1902952","biological_process","positive regulation of dendritic spine maintenance ","P02649; Q9ULU4"]
["GO:1905855","biological_process","positive regulation of heparan sulfate binding ","P02649"]
["GO:1905860","biological_process","positive regulation of heparan sulfate proteoglycan binding ","P02649"]
["GO:1903002","biological_process","positive regulation of lipid transport across blood brain barrier ","P02649"]
["GO:0032805","biological_process","positive regulation of low-density lipoprotein particle receptor catabolic process ","P02649"]
["GO:1902998","biological_process","positive regulation of neurofibrillary tangle assembly ","P02649"]
["GO:1902995","biological_process","positive regulation of phospholipid efflux ","P02649"]
["GO:1901628","biological_process","positive regulation of postsynaptic membrane organization ","P02649"]
["GO:1901631","biological_process","positive regulation of presynaptic membrane organization ","P02649; O75096"]
["GO:1900221","biological_process","regulation of amyloid-beta clearance ","P02649"]
["GO:2000822","biological_process","regulation of behavioral fear response ","P02649"]
["GO:1905890","biological_process","regulation of cellular response to very-low-density lipoprotein particle stimulus ","P02649"]
["GO:0032462","biological_process","regulation of protein homooligomerization ","P02649"]
["GO:1902947","biological_process","regulation of tau-protein kinase activity ","P02649"]
["GO:0001523","biological_process","retinoid metabolic process ","P02649; P18827; P34741; P31431; O75056; Q07954; P08100"]
["GO:0019433","biological_process","triglyceride catabolic process ","P02649; P15090; Q05469; Q96AD5"]
["GO:0034447","biological_process","very-low-density lipoprotein particle clearance ","P02649"]
["GO:0034372","biological_process","very-low-density lipoprotein particle remodeling ","P02649"]
["GO:0006269","biological_process","DNA replication, synthesis of RNA primer ","P49643"]
["GO:0000737","biological_process","DNA catabolic process, endonucleolytic ","Q53H47"]
["GO:0097676","biological_process","histone H3-K3 dimethylation ","Q53H47"]
["GO:0010452","biological_process","histone H3-K36 methylation ","Q53H47; O96028"]
["GO:0044774","biological_process","mitotic DNA integrity checkpoint ","Q53H47; Q02880; P11388"]
["GO:2001251","biological_process","negative regulation of chromosome organization ","Q53H47"]
["GO:0001667","biological_process","ameboidal-type cell migration ","Q9Y6W5; Q01518"]
["GO:0065004","biological_process","protein-DNA complex assembly ","O75925; P15884"]
["GO:1903244","biological_process","positive regulation of cardiac muscle hypertrophy in response to stress ","Q08209; Q13507"]
["GO:0014883","biological_process","transition between fast and slow fiber ","Q08209; P16615"]
["GO:0002023","biological_process","reduction of food intake in response to dietary excess ","Q9H9A7"]
["GO:0006384","biological_process","transcription initiation from RNA polymerase III promoter ","Q12789; Q92994"]
["GO:0009304","biological_process","tRNA transcription ","Q12789; Q92994"]
["GO:0031338","biological_process","regulation of vesicle fusion ","Q8WUA7; Q86TI0; Q4KMP7; O60343"]
["GO:0042116","biological_process","macrophage activation ","Q6UUV7; O00206; Q9NPY3"]
["GO:2000252","biological_process","negative regulation of feeding behavior ","P32245"]
["GO:0019222","biological_process","regulation of metabolic process ","P32245; O14492"]
["GO:0031081","biological_process","nuclear pore distribution ","Q9BTX1; Q8WUM0"]
["GO:1902817","biological_process","negative regulation of protein localization to microtubule ","P78559"]
["GO:0009822","biological_process","alkaloid catabolic process ","P08684; P20815"]
["GO:0042737","biological_process","drug catabolic process ","P08684; P20815"]
["GO:0046483","biological_process","heterocycle metabolic process ","P08684"]
["GO:0002933","biological_process","lipid hydroxylation ","P08684; P20815"]
["GO:0016098","biological_process","monoterpenoid metabolic process ","P08684"]
["GO:0070989","biological_process","oxidative demethylation ","P08684; P20815"]
["GO:0006706","biological_process","steroid catabolic process ","P08684"]
["GO:0007196","biological_process","adenylate cyclase-inhibiting -protein coupled glutamate receptor signaling pathway ","P41594; Q13255; Q14831"]
["GO:0007206","biological_process","phospholipase C-activating -protein coupled glutamate receptor signaling pathway ","P41594; Q86YM7"]
["GO:0006448","biological_process","regulation of translational elongation ","P41594"]
["GO:1902268","biological_process","negative regulation of polyamine transmembrane transport ","O95190"]
["GO:0006596","biological_process","polyamine biosynthetic process ","O95190; P21673"]
["GO:0006595","biological_process","polyamine metabolic process ","O95190; P11926"]
["GO:0006521","biological_process","regulation of cellular amino acid metabolic process ","O95190; P11926"]
["GO:0007197","biological_process","adenylate cyclase-inhibiting -protein coupled acetylcholine receptor signaling pathway ","P08172; P08173; P20309"]
["GO:0007207","biological_process","phospholipase C-activating -protein coupled acetylcholine receptor signaling pathway ","P08172; P08173; P30679; P20309"]
["GO:0099089","biological_process","establishment of endoplasmic reticulum localization to postsynapse ","Q9Y4I1"]
["GO:0031987","biological_process","locomotion involved in locomotory behavior ","Q9Y4I1"]
["GO:0032402","biological_process","melanosome transport ","Q9Y4I1; Q14203; Q9BV36; P62491; P62820"]
["GO:0031585","biological_process","regulation of inositol ,4,-trisphosphate-sensitive calcium-release channel activity ","Q9Y4I1"]
["GO:0099566","biological_process","regulation of postsynaptic cytosolic calcium ion concentration ","Q9Y4I1"]
["GO:0070827","biological_process","chromatin maintenance ","Q8IYB8; Q7KZ85"]
["GO:0000958","biological_process","mitochondrial mRNA catabolic process ","Q8IYB8; Q8TCS8"]
["GO:0035946","biological_process","mitochondrial mRNA surveillance ","Q8IYB8"]
["GO:0035945","biological_process","mitochondrial ncRNA surveillance ","Q8IYB8"]
["GO:0000965","biological_process","mitochondrial RNA 3'-end processing ","Q8IYB8; Q8TCS8"]
["GO:2000827","biological_process","mitochondrial RNA surveillance ","Q8IYB8"]
["GO:0000962","biological_process","positive regulation of mitochondrial RNA catabolic process ","Q8IYB8; Q8TCS8"]
["GO:0040016","biological_process","embryonic cleavage ","P11387; P42338; Q9NY61; P11388"]
["GO:0019509","biological_process","L-methionine salvage from methylthioadenosine ","Q9BV57"]
["GO:0099093","biological_process","calcium export from the mitochondrion ","O95202; Q6J4K2"]
["GO:0006875","biological_process","cellular metal ion homeostasis ","O95202; Q9Y5I7"]
["GO:0097094","biological_process","craniofacial suture morphogenesis ","Q92886; O00409; P50281"]
["GO:0035112","biological_process","genitalia morphogenesis ","Q92886"]
["GO:1905748","biological_process","hard palate morphogenesis ","Q92886"]
["GO:0098583","biological_process","learned vocalization behavior ","Q92886"]
["GO:0071626","biological_process","mastication ","Q92886"]
["GO:1901078","biological_process","negative regulation of relaxation of muscle ","Q92886"]
["GO:1905747","biological_process","negative regulation of saliva secretion ","Q92886"]
["GO:0030432","biological_process","peristalsis ","Q92886; Q9UBL9; Q12959; P14416; P21728; P30874"]
["GO:0031536","biological_process","positive regulation of exit from mitosis ","Q92886; O15392; Q96FF9; Q99623"]
["GO:0048634","biological_process","regulation of muscle organ development ","Q92886"]
["GO:0021559","biological_process","trigeminal nerve development ","Q92886; P05549; Q01851"]
["GO:0001714","biological_process","endodermal cell fate specification ","Q9H9S0; P48431; Q01860"]
["GO:0021904","biological_process","dorsal/ventral neural tube patterning ","P23759; P55317; P49768"]
["GO:0048706","biological_process","embryonic skeletal system development ","P23759; Q02447; P31269"]
["GO:0060415","biological_process","muscle tissue morphogenesis ","P23759; P13349; P23409"]
["GO:0014813","biological_process","skeletal muscle satellite cell commitment ","P23759"]
["GO:0072734","biological_process","cellular response to staurosporine ","P55212; P55210; P42574"]
["GO:0042592","biological_process","homeostatic process ","Q92793; O00482; Q96PX8"]
["GO:0031990","biological_process","mRNA export from nucleus in response to heat stress ","P12270"]
["GO:0046832","biological_process","negative regulation of RNA export from nucleus ","P12270; P49790"]
["GO:0006999","biological_process","nuclear pore organization ","P12270; Q8WUM0; P52948; Q8NFH5"]
["GO:0031453","biological_process","positive regulation of heterochromatin assembly ","P12270"]
["GO:0010965","biological_process","regulation of mitotic sister chromatid separation ","P12270"]
["GO:0006404","biological_process","RNA import into nucleus ","P12270"]
["GO:0061386","biological_process","closure of optic fissure ","Q8IZ21"]
["GO:0035787","biological_process","cell migration involved in kidney development ","Q9ULK5"]
["GO:0036514","biological_process","dopaminergic neuron axon guidance ","Q9ULK5"]
["GO:0090177","biological_process","establishment of planar polarity involved in neural tube closure ","Q9ULK5"]
["GO:0015012","biological_process","heparan sulfate proteoglycan biosynthetic process ","Q9ULK5"]
["GO:0003402","biological_process","planar cell polarity pathway involved in axis elongation ","Q9ULK5; Q86UL8"]
["GO:1904938","biological_process","planar cell polarity pathway involved in axon guidance ","Q9ULK5"]
["GO:0061346","biological_process","planar cell polarity pathway involved in heart morphogenesis ","Q9ULK5"]
["GO:0036515","biological_process","serotonergic neuron axon guidance ","Q9ULK5"]
["GO:0036353","biological_process","histone H2A-K119 monoubiquitination ","P35226; Q9BYE7"]
["GO:0006432","biological_process","phenylalanyl-tRNA aminoacylation ","O95363; Q9Y285"]
["GO:0031087","biological_process","deadenylation-independent decapping of nuclear-transcribed mRNA ","Q96F86; Q9NPI6"]
["GO:0000494","biological_process","box C/D snoRNA 3'-end processing ","P22087"]
["GO:1990258","biological_process","histone glutamine methylation ","P22087"]
["GO:0031167","biological_process","rRNA methylation ","P22087"]
["GO:0048254","biological_process","snoRNA localization ","P22087"]
["GO:0034720","biological_process","histone H-K demethylation ","Q9BY66; O60341; P29375"]
["GO:0002457","biological_process","T cell antigen processing and presentation ","Q9BY66"]
["GO:0061624","biological_process","fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate ","P05062"]
["GO:0006116","biological_process","NADH oxidation ","P05062"]
["GO:0070072","biological_process","vacuolar proton-transporting V-type ATPase complex assembly ","P05062"]
["GO:0032651","biological_process","regulation of interleukin- beta production ","Q9NYA1"]
["GO:0046521","biological_process","sphingoid catabolic process ","Q9NYA1"]
["GO:0046512","biological_process","sphingosine biosynthetic process ","Q9NYA1; O15269; Q9NRA0"]
["GO:0006670","biological_process","sphingosine metabolic process ","Q9NYA1"]
["GO:1903919","biological_process","negative regulation of actin filament severing ","P50461; P35579"]
["GO:1903920","biological_process","positive regulation of actin filament severing ","P50461"]
["GO:0035281","biological_process","pre-miRNA export from nucleus ","P62826"]
["GO:0000056","biological_process","ribosomal small subunit export from nucleus ","P62826; P62841; O14980"]
["GO:0006409","biological_process","tRNA export from nucleus ","P62826; P05455"]
["GO:0034640","biological_process","establishment of mitochondrion localization by microtubule attachment ","Q8IXI2"]
["GO:0006449","biological_process","regulation of translational termination ","P62495; Q92900"]
["GO:0090308","biological_process","regulation of methylation-dependent chromatin silencing ","Q96T88; Q01860"]
["GO:0050803","biological_process","regulation of synapse structure or activity ","Q96PV0; P05067"]
["GO:0046452","biological_process","dihydrofolate metabolic process ","P31939"]
["GO:0010035","biological_process","response to inorganic substance ","P31939; Q9H2P0; Q05639"]
["GO:0046654","biological_process","tetrahydrofolate biosynthetic process ","P31939"]
["GO:0016180","biological_process","snRNA processing ","Q9H6E5"]
["GO:0031935","biological_process","regulation of chromatin silencing ","P54198"]
["GO:0071403","biological_process","cellular response to high density lipoprotein particle stimulus ","P78536"]
["GO:0051088","biological_process","PMA-inducible membrane protein ectodomain proteolysis ","P78536"]
["GO:0002690","biological_process","positive regulation of leukocyte chemotaxis ","P78536"]
["GO:0033025","biological_process","regulation of mast cell apoptotic process ","P78536"]
["GO:0035313","biological_process","wound healing, spreading of epidermal cells ","P78536; P35548; P37023; Q96IF1"]
["GO:0070897","biological_process","DNA-templated transcriptional preinitiation complex assembly ","Q92994"]
["GO:1903348","biological_process","positive regulation of bicellular tight junction assembly ","O15259"]
["GO:0043456","biological_process","regulation of pentose-phosphate shunt ","P18669"]
["GO:2000435","biological_process","negative regulation of protein neddylation ","P62913; Q8N726"]
["GO:0060322","biological_process","head development ","P53671; Q9BWW4; P50281"]
["GO:0060082","biological_process","eye blink reflex ","Q9Y698"]
["GO:0099590","biological_process","neurotransmitter receptor internalization ","Q9Y698; P60880"]
["GO:0098943","biological_process","neurotransmitter receptor transport, postsynaptic endosome to lysosome ","Q9Y698"]
["GO:2000969","biological_process","positive regulation of AMPA receptor activity ","Q9Y698; Q9BYB0; P07550; Q7LC44"]
["GO:1904510","biological_process","positive regulation of protein localization to basolateral plasma membrane ","Q9Y698"]
["GO:0098970","biological_process","postsynaptic neurotransmitter receptor diffusion trapping ","Q9Y698"]
["GO:0019226","biological_process","transmission of nerve impulse ","Q9Y698; P00441; P21453; P21728"]
["GO:0046032","biological_process","ADP catabolic process ","Q9BW91"]
["GO:0046709","biological_process","IDP catabolic process ","Q9BW91"]
["GO:0034656","biological_process","nucleobase-containing small molecule catabolic process ","Q9BW91"]
["GO:2000816","biological_process","negative regulation of mitotic sister chromatid separation ","Q9NZH5; O95997"]
["GO:0048875","biological_process","chemical homeostasis within a tissue ","Q9NSB8; Q86YM7"]
["GO:0003278","biological_process","apoptotic process involved in heart morphogenesis ","P52952; P61296"]
["GO:0055014","biological_process","atrial cardiac muscle cell development ","P52952; Q14192"]
["GO:0060928","biological_process","atrioventricular node cell development ","P52952"]
["GO:0060929","biological_process","atrioventricular node cell fate commitment ","P52952"]
["GO:0003166","biological_process","bundle of His development ","P52952; Q02363"]
["GO:0003161","biological_process","cardiac conduction system development ","P52952; Q02297; P60953; P36894"]
["GO:0060971","biological_process","embryonic heart tube left/right pattern formation ","P52952; Q99967"]
["GO:0003342","biological_process","proepicardium development ","P52952; Q07352"]
["GO:0003168","biological_process","Purkinje myocyte differentiation ","P52952"]
["GO:0060043","biological_process","regulation of cardiac muscle cell proliferation ","P52952; P36897; P36894"]
["GO:0003221","biological_process","right ventricular cardiac muscle tissue morphogenesis ","P52952"]
["GO:0003285","biological_process","septum secundum development ","P52952"]
["GO:0000915","biological_process","actomyosin contractile ring assembly ","Q9H0H5; Q02241"]
["GO:0008272","biological_process","sulfate transport ","Q9H0H5"]
["GO:0045795","biological_process","positive regulation of cell volume ","P55011"]
["GO:0030321","biological_process","transepithelial chloride transport ","P55011; O76090"]
["GO:0097117","biological_process","guanylate kinase-associated protein clustering ","P58400; Q9BYB0"]
["GO:0023041","biological_process","neuronal signal transduction ","P58400; Q09470; Q8N2Q7"]
["GO:1905520","biological_process","positive regulation of presynaptic active zone assembly ","P58400; Q8N2Q7"]
["GO:0090126","biological_process","protein-containing complex assembly involved in synapse maturation ","P58400"]
["GO:0093001","biological_process","glycolysis from storage polysaccharide through glucose--phosphate ","P08237"]
["GO:0061615","biological_process","glycolytic process through fructose--phosphate ","P08237"]
["GO:0090500","biological_process","endocardial cushion to mesenchymal transition ","Q92819"]
["GO:0085029","biological_process","extracellular matrix assembly ","Q92819"]
["GO:0045226","biological_process","extracellular polysaccharide biosynthetic process ","Q92819"]
["GO:0030213","biological_process","hyaluronan biosynthetic process ","Q92819"]
["GO:0010838","biological_process","positive regulation of keratinocyte proliferation ","Q92819; Q9H3D4; Q6ZWJ1"]
["GO:1901201","biological_process","regulation of extracellular matrix assembly ","Q92819; P46531"]
["GO:0070295","biological_process","renal water absorption ","Q92819"]
["GO:0046415","biological_process","urate metabolic process ","Q9UNQ0; Q5VZK9"]
["GO:0097056","biological_process","selenocysteinyl-tRNA(Sec) biosynthetic process ","Q9NP81"]
["GO:0006434","biological_process","seryl-tRNA aminoacylation ","Q9NP81"]
["GO:0030323","biological_process","respiratory tube development ","Q9BUZ4; Q12946"]
["GO:0090427","biological_process","activation of meiosis ","P35548"]
["GO:0060346","biological_process","bone trabecula formation ","P35548; P08253"]
["GO:0060363","biological_process","cranial suture morphogenesis ","P35548; Q15672"]
["GO:0035880","biological_process","embryonic nail plate morphogenesis ","P35548"]
["GO:0060364","biological_process","frontal suture morphogenesis ","P35548; P10071"]
["GO:0045617","biological_process","negative regulation of keratinocyte differentiation ","P35548; Q13247; Q9H3D4"]
["GO:2001055","biological_process","positive regulation of mesenchymal cell apoptotic process ","P35548"]
["GO:0051795","biological_process","positive regulation of timing of catagen ","P35548"]
["GO:0097720","biological_process","calcineurin-mediated signaling ","O00482; Q13285"]
["GO:0061113","biological_process","pancreas morphogenesis ","O00482"]
["GO:0016246","biological_process","RNA interference ","Q92879"]
["GO:0034766","biological_process","negative regulation of ion transmembrane transport ","P27348"]
["GO:0071870","biological_process","cellular response to catecholamine stimulus ","O43306; P21728"]
["GO:0035811","biological_process","negative regulation of urine volume ","O43306"]
["GO:0006333","biological_process","chromatin assembly or disassembly ","Q9UIG0; Q9BY41; O94776; Q9BW71"]
["GO:0071218","biological_process","cellular response to misfolded protein ","P54252; Q9UBN7; Q9UNE7"]
["GO:0035520","biological_process","monoubiquitinated protein deubiquitination ","P54252; O94782; Q93009; Q9Y4E8"]
["GO:0006515","biological_process","protein quality control for misfolded or incompletely synthesized proteins ","P54252; Q9UBN7; Q9UNE7"]
["GO:0010810","biological_process","regulation of cell-substrate adhesion ","P54252"]
["GO:0009447","biological_process","putrescine catabolic process ","P21673"]
["GO:0032918","biological_process","spermidine acetylation ","P21673"]
["GO:0046208","biological_process","spermine catabolic process ","P21673"]
["GO:1903070","biological_process","negative regulation of ER-associated ubiquitin-dependent protein catabolic process ","O43765; P54578"]
["GO:0006048","biological_process","UDP-N-acetylglucosamine biosynthetic process ","O94808; Q9UJ70; Q06210"]
["GO:0006047","biological_process","UDP-N-acetylglucosamine metabolic process ","O94808; Q06210"]
["GO:0048625","biological_process","myoblast fate commitment ","Q99814; P78337; Q9NQB0"]
["GO:0042415","biological_process","norepinephrine metabolic process ","Q99814; Q04656; O60260"]
["GO:0002430","biological_process","complement receptor mediated signaling pathway ","P21462; P80108"]
["GO:0046098","biological_process","guanine metabolic process ","O60341"]
["GO:0033184","biological_process","positive regulation of histone ubiquitination ","O60341"]
["GO:0035710","biological_process","CD4-positive, alpha-beta T cell activation ","Q9UJZ1"]
["GO:0010876","biological_process","lipid localization ","Q9UJZ1"]
["GO:0042776","biological_process","mitochondrial ATP synthesis coupled proton transport ","Q9UJZ1; P36542; P18859; P56134"]
["GO:0034982","biological_process","mitochondrial protein processing ","Q9UJZ1"]
["GO:1900210","biological_process","positive regulation of cardiolipin metabolic process ","Q9UJZ1; Q16635"]
["GO:0090297","biological_process","positive regulation of mitochondrial DNA replication ","Q9UJZ1"]
["GO:1990046","biological_process","stress-induced mitochondrial fusion ","Q9UJZ1"]
["GO:2001204","biological_process","regulation of osteoclast development ","O43914"]
["GO:0044783","biological_process","1 DNA damage checkpoint ","Q9BTA9"]
["GO:0071894","biological_process","histone H2B conserved C-terminal lysine ubiquitination ","Q9BTA9"]
["GO:0016320","biological_process","endoplasmic reticulum membrane fusion ","Q96JH7"]
["GO:0050913","biological_process","sensory perception of bitter taste ","Q14573"]
["GO:0050916","biological_process","sensory perception of sweet taste ","Q14573"]
["GO:0010482","biological_process","regulation of epidermal cell division ","P31947; Q9H3D4"]
["GO:0000738","biological_process","DNA catabolic process, exonucleolytic ","Q9H0D6"]
["GO:1901142","biological_process","insulin metabolic process ","O75460"]
["GO:0098787","biological_process","mRNA cleavage involved in mRNA processing ","O75460"]
["GO:0070054","biological_process","mRNA splicing, via endonucleolytic cleavage and ligation ","O75460"]
["GO:1990579","biological_process","peptidyl-serine trans-autophosphorylation ","O75460"]
["GO:1902626","biological_process","assembly of large subunit precursor of preribosome ","P56537"]
["GO:0042256","biological_process","mature ribosome assembly ","P56537; O00571; Q07021"]
["GO:0000054","biological_process","ribosomal subunit export from nucleus ","P56537; O14980"]
["GO:0043308","biological_process","eosinophil degranulation ","P63027; P51809"]
["GO:1902259","biological_process","regulation of delayed rectifier potassium channel activity ","P63027; P15382"]
["GO:1903204","biological_process","negative regulation of oxidative stress-induced neuron death ","P18848; Q9BXM7; Q92574"]
["GO:0061395","biological_process","positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance ","P18848"]
["GO:0036091","biological_process","positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress ","P18848; Q16236"]
["GO:0061144","biological_process","alveolar secondary septum development ","P55317"]
["GO:0060743","biological_process","epithelial cell maturation involved in prostate gland development ","P55317"]
["GO:0060738","biological_process","epithelial-mesenchymal signaling involved in prostate gland development ","P55317"]
["GO:0060741","biological_process","prostate gland stromal morphogenesis ","P55317; P47928"]
["GO:1902691","biological_process","respiratory basal cell differentiation ","P55317"]
["GO:1903527","biological_process","positive regulation of membrane tubulation ","Q9ULH1; Q99962; Q9Y371"]
["GO:0000973","biological_process","posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery ","P57740; P52948"]
["GO:0070197","biological_process","meiotic attachment of telomere to nuclear envelope ","Q9Y2U8; O94901"]
["GO:1902531","biological_process","regulation of intracellular signal transduction ","Q9Y2U8; Q6NXT1"]
["GO:0017196","biological_process","N-terminal peptidyl-methionine acetylation ","Q6N069"]
["GO:0044861","biological_process","protein transport into plasma membrane raft ","P30622"]
["GO:0097309","biological_process","cap1 mRNA methylation ","Q8N1G2"]
["GO:0080009","biological_process","mRNA methylation ","Q8N1G2; Q86U44"]
["GO:0048635","biological_process","negative regulation of muscle organ development ","Q9UHJ3"]
["GO:0035932","biological_process","aldosterone secretion ","P50052"]
["GO:0002033","biological_process","angiotensin-mediated vasodilation involved in regulation of systemic arterial blood pressure ","P50052"]
["GO:0002035","biological_process","brain renin-angiotensin system ","P50052"]
["GO:0007199","biological_process","-protein coupled receptor signaling pathway coupled to cMP nucleotide second messenger ","P50052"]
["GO:0032304","biological_process","negative regulation of icosanoid secretion ","P50052"]
["GO:0051387","biological_process","negative regulation of neurotrophin TRK receptor signaling pathway ","P50052; O43597"]
["GO:0010700","biological_process","negative regulation of norepinephrine secretion ","P50052; P08913; Q9H244"]
["GO:0001991","biological_process","regulation of systemic arterial blood pressure by circulatory renin-angiotensin ","P50052"]
["GO:0002018","biological_process","renin-angiotensin regulation of aldosterone production ","P50052; P30556"]
["GO:0019043","biological_process","establishment of viral latency ","Q92985"]
["GO:0032607","biological_process","interferon-alpha production ","Q92985"]
["GO:0032608","biological_process","interferon-beta production ","Q92985; Q86WV6"]
["GO:0002819","biological_process","regulation of adaptive immune response ","Q92985; P10914; P31994; Q9Y572; Q9Y6W6"]
["GO:0045655","biological_process","regulation of monocyte differentiation ","Q92985"]
["GO:0034124","biological_process","regulation of MyD88-dependent toll-like receptor signaling pathway ","Q92985; P10914"]
["GO:0034127","biological_process","regulation of MyD88-independent toll-like receptor signaling pathway ","Q92985"]
["GO:0048133","biological_process","male germ-line stem cell asymmetric division ","P41161; Q05516"]
["GO:0060762","biological_process","regulation of branching involved in mammary gland duct morphogenesis ","P41161; Q99623"]
["GO:0098749","biological_process","cerebellar neuron development ","Q8WY41"]
["GO:1900451","biological_process","positive regulation of glutamate receptor signaling pathway ","Q9BYB0"]
["GO:0070970","biological_process","interleukin-2 secretion ","Q9BXL7"]
["GO:0051383","biological_process","kinetochore organization ","Q9NTJ3; Q9H211; O14777"]
["GO:0061104","biological_process","adrenal chromaffin cell differentiation ","P50553"]
["GO:0061103","biological_process","carotid body glomus cell differentiation ","P50553"]
["GO:0021892","biological_process","cerebral cortex ABAergic interneuron differentiation ","P50553; P43699"]
["GO:0061100","biological_process","lung neuroendocrine cell differentiation ","P50553"]
["GO:0007400","biological_process","neuroblast fate determination ","P50553"]
["GO:0003358","biological_process","noradrenergic neuron development ","P50553"]
["GO:0003359","biological_process","noradrenergic neuron fate commitment ","P50553"]
["GO:0030856","biological_process","regulation of epithelial cell differentiation ","P50553; P51692"]
["GO:0060165","biological_process","regulation of timing of subpallium neuron differentiation ","P50553"]
["GO:0061102","biological_process","stomach neuroendocrine cell differentiation ","P50553"]
["GO:0060163","biological_process","subpallium neuron fate commitment ","P50553"]
["GO:0060579","biological_process","ventral spinal cord interneuron fate commitment ","P50553"]
["GO:0021750","biological_process","vestibular nucleus development ","P50553"]
["GO:0014822","biological_process","detection of wounding ","Q12946"]
["GO:0048613","biological_process","embryonic ectodermal digestive tract morphogenesis ","Q12946"]
["GO:0048371","biological_process","lateral mesodermal cell differentiation ","Q12946"]
["GO:0060426","biological_process","lung vasculature development ","Q12946; P41134; Q9UJM3"]
["GO:0090131","biological_process","mesenchyme migration ","Q12946; P63267; P68133"]
["GO:0043305","biological_process","negative regulation of mast cell degranulation ","Q12946; P09601"]
["GO:0060461","biological_process","right lung morphogenesis ","Q12946"]
["GO:0060438","biological_process","trachea development ","Q12946"]
["GO:1901255","biological_process","nucleotide-excision repair involved in interstrand cross-link repair ","P23025"]
["GO:0010996","biological_process","response to auditory stimulus ","P23025"]
["GO:2001107","biological_process","negative regulation of Rho guanyl-nucleotide exchange factor activity ","Q6ZS17"]
["GO:1903589","biological_process","positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis ","Q14512; Q96T49; P09601; P30556; P23769"]
["GO:0098971","biological_process","anterograde dendritic transport of neurotransmitter receptor complex ","Q9P2E2"]
["GO:1901094","biological_process","negative regulation of protein homotetramerization ","P50542"]
["GO:0016558","biological_process","protein import into peroxisome matrix ","P50542"]
["GO:0016560","biological_process","protein import into peroxisome matrix, docking ","P50542"]
["GO:0016561","biological_process","protein import into peroxisome matrix, translocation ","P50542"]
["GO:0045046","biological_process","protein import into peroxisome membrane ","P50542; P40855"]
["GO:0048266","biological_process","behavioral response to pain ","Q9UBL9; Q8NER1"]
["GO:0003029","biological_process","detection of hypoxic conditions in blood by carotid body chemoreceptor signaling ","Q9UBL9"]
["GO:0006450","biological_process","regulation of translational fidelity ","P46782"]
["GO:0060219","biological_process","camera-type eye photoreceptor cell differentiation ","O43490"]
["GO:0072139","biological_process","glomerular parietal epithelial cell differentiation ","O43490"]
["GO:2000768","biological_process","positive regulation of nephron tubule epithelial cell differentiation ","O43490"]
["GO:0060042","biological_process","retina morphogenesis in camera-type eye ","O43490"]
["GO:1903893","biological_process","positive regulation of ATF6-mediated unfolded protein response ","P18850"]
["GO:1905719","biological_process","protein localization to perinuclear region of cytoplasm ","Q13501"]
["GO:0061635","biological_process","regulation of protein complex stability ","Q13501; P11142; Q96H20"]
["GO:0061912","biological_process","selective autophagy ","Q13501"]
["GO:0086073","biological_process","bundle of His cell-Purkinje myocyte adhesion involved in cell communication ","P14923; P15924"]
["GO:0071603","biological_process","endothelial cell-cell adhesion ","P14923"]
["GO:0042226","biological_process","interleukin- biosynthetic process ","O95999"]
["GO:0042109","biological_process","lymphotoxin A biosynthetic process ","O95999"]
["GO:0002906","biological_process","negative regulation of mature B cell apoptotic process ","O95999"]
["GO:0045416","biological_process","positive regulation of interleukin-8 biosynthetic process ","O95999; P01375; O00206"]
["GO:0032765","biological_process","positive regulation of mast cell cytokine production ","O95999; P30273"]
["GO:0050856","biological_process","regulation of T cell receptor signaling pathway ","O95999; Q5TC82"]
["GO:0002237","biological_process","response to molecule of bacterial origin ","O95999"]
["GO:0042631","biological_process","cellular response to water deprivation ","P41181"]
["GO:0061577","biological_process","calcium ion transmembrane transport via high voltage-gated calcium channel ","Q13936"]
["GO:0046898","biological_process","response to cycloheximide ","P10912; Q07817"]
["GO:0071163","biological_process","DNA replication preinitiation complex assembly ","O75496; Q9H211"]
["GO:2000104","biological_process","negative regulation of DNA-dependent DNA replication ","O75496"]
["GO:2000317","biological_process","negative regulation of T-helper  type immune response ","O15105"]
["GO:0032925","biological_process","regulation of activin receptor signaling pathway ","O15105; O00255"]
["GO:0002051","biological_process","osteoblast fate commitment ","A1X283; Q13950"]
["GO:0060378","biological_process","regulation of brood size ","A1X283"]
["GO:0007007","biological_process","inner mitochondrial membrane organization ","Q9NX63"]
["GO:0051294","biological_process","establishment of spindle orientation ","P27816; Q96R06"]
["GO:0051012","biological_process","microtubule sliding ","P27816"]
["GO:0021685","biological_process","cerebellar granular layer structural organization ","Q15058"]
["GO:0021693","biological_process","cerebellar Purkinje cell layer structural organization ","Q15058"]
["GO:0033624","biological_process","negative regulation of integrin activation ","Q15058"]
["GO:1903429","biological_process","regulation of cell maturation ","Q15058"]
["GO:0007598","biological_process","blood coagulation, extrinsic pathway ","P10646; P13726"]
["GO:0016476","biological_process","regulation of embryonic cell shape ","Q16181; Q14118"]
["GO:0014807","biological_process","regulation of somitogenesis ","Q99626; P46531"]
["GO:0071931","biological_process","positive regulation of transcription involved in /S transition of mitotic cell cycle ","Q02363"]
["GO:0001966","biological_process","thigmotaxis ","Q02363"]
["GO:0015705","biological_process","iodide transport ","Q5XXA6"]
["GO:0044340","biological_process","canonical Wnt signaling pathway involved in regulation of cell proliferation ","O14641; O75581"]
["GO:0007041","biological_process","lysosomal transport ","P11717; P46934"]
["GO:1903755","biological_process","positive regulation of SUM transferase activity ","P63279"]
["GO:0032849","biological_process","positive regulation of cellular pH reduction ","P00918"]
["GO:2001150","biological_process","positive regulation of dipeptide transmembrane transport ","P00918"]
["GO:0009268","biological_process","response to pH ","P00918; Q96D96; P19021; P78348"]
["GO:1903378","biological_process","positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway ","Q07820; Q969H0"]
["GO:0006621","biological_process","protein retention in ER lumen ","P24390; Q16478"]
["GO:0002369","biological_process","T cell cytokine production ","P24390; Q12959"]
["GO:0070192","biological_process","chromosome organization involved in meiotic cell cycle ","Q06609; Q92878"]
["GO:0006312","biological_process","mitotic recombination ","Q06609; Q8N2Z9"]
["GO:1990426","biological_process","mitotic recombination-dependent replication fork processing ","Q06609; P51587"]
["GO:0010833","biological_process","telomere maintenance via telomere lengthening ","Q06609; Q9NYB0; Q9H816"]
["GO:0035305","biological_process","negative regulation of dephosphorylation ","O95278; P46940"]
["GO:0046838","biological_process","phosphorylated carbohydrate dephosphorylation ","O95278"]
["GO:1904780","biological_process","negative regulation of protein localization to centrosome ","Q14CS0; Q9UNZ2"]
["GO:0031468","biological_process","nuclear envelope reassembly ","Q14CS0; Q9UNZ2; Q8WUX9"]
["GO:0002190","biological_process","cap-independent translational initiation ","Q9BWF3"]
["GO:0032055","biological_process","negative regulation of translation in response to stress ","Q9BWF3"]
["GO:0070525","biological_process","tRNA threonylcarbamoyladenosine metabolic process ","Q96S44"]
["GO:0043320","biological_process","natural killer cell degranulation ","P51809"]
["GO:1903595","biological_process","positive regulation of histamine secretion by mast cell ","P51809"]
["GO:1900483","biological_process","regulation of protein targeting to vacuolar membrane ","P51809"]
["GO:0048280","biological_process","vesicle fusion with olgi apparatus ","P51809; O60763"]
["GO:0009235","biological_process","cobalamin metabolic process ","P33527"]
["GO:0034775","biological_process","glutathione transmembrane transport ","P33527"]
["GO:0099039","biological_process","sphingolipid translocation ","P33527"]
["GO:0019731","biological_process","antibacterial humoral response ","P62807; P05067; P06899; Q16778; O60814; P01892"]
["GO:0061844","biological_process","antimicrobial humoral immune response mediated by antimicrobial peptide ","P62807; P17931; P05067; P06899; Q16778; P04406; P05204; Q9UGM3; P06702; O60814; P39019"]
["GO:0009143","biological_process","nucleoside triphosphate catabolic process ","O14638; Q9H773; P22413"]
["GO:0021520","biological_process","spinal cord motor neuron cell fate specification ","P50219; Q7RTU3; Q9UBR4"]
["GO:0042590","biological_process","antigen processing and presentation of exogenous peptide antigen via MHC class I ","P30273"]
["GO:0038094","biological_process","Fc-gamma receptor signaling pathway ","P30273"]
["GO:0033026","biological_process","negative regulation of mast cell apoptotic process ","P30273"]
["GO:0001798","biological_process","positive regulation of type IIa hypersensitivity ","P30273"]
["GO:0002292","biological_process","T cell differentiation involved in immune response ","P30273"]
["GO:1902463","biological_process","protein localization to cell leading edge ","Q9BR76"]
["GO:0046223","biological_process","aflatoxin catabolic process ","Q16236"]
["GO:1903788","biological_process","positive regulation of glutathione biosynthetic process ","Q16236"]
["GO:0007412","biological_process","axon target recognition ","P61764"]
["GO:0003006","biological_process","developmental process involved in reproduction ","P61764"]
["GO:1903296","biological_process","positive regulation of glutamate secretion, neurotransmission ","P61764"]
["GO:0106022","biological_process","positive regulation of vesicle docking ","P61764"]
["GO:0035542","biological_process","regulation of SNARE complex assembly ","P61764"]
["GO:0045410","biological_process","positive regulation of interleukin-6 biosynthetic process ","Q9Y4K3; P58753"]
["GO:0035308","biological_process","negative regulation of protein dephosphorylation ","Q96T49; P56211; O43768; Q12972; P31946"]
["GO:0035304","biological_process","regulation of protein dephosphorylation ","Q96T49; Q9NXH3"]
["GO:1904178","biological_process","negative regulation of adipose tissue development ","P48678"]
["GO:0006168","biological_process","adenine salvage ","P07741"]
["GO:0007625","biological_process","grooming behavior ","P07741; P14416; P21728"]
["GO:0006166","biological_process","purine ribonucleoside salvage ","P07741"]
["GO:1902412","biological_process","regulation of mitotic cytokinesis ","Q9NQS7; Q49MG5"]
["GO:0016199","biological_process","axon midline choice point recognition ","Q96MS0; P05067; Q9Y6N7"]
["GO:0019086","biological_process","late viral transcription ","Q15853; P22415"]
["GO:0000430","biological_process","regulation of transcription from RNA polymerase II promoter by glucose ","Q15853; P22415"]
["GO:0007538","biological_process","primary sex determination ","Q13285"]
["GO:0097210","biological_process","response to gonadotropin-releasing hormone ","Q13285"]
["GO:0006817","biological_process","phosphate ion transport ","Q9UHH9"]
["GO:0021817","biological_process","nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration ","O94901; Q9UH99"]
["GO:0051351","biological_process","positive regulation of ligase activity ","Q13426; Q9H9Q4; Q9Y572"]
["GO:1905222","biological_process","atrioventricular canal morphogenesis ","P17813"]
["GO:0003209","biological_process","cardiac atrium morphogenesis ","P17813; P46531; Q07889"]
["GO:0022009","biological_process","central nervous system vasculogenesis ","P17813"]
["GO:0001300","biological_process","chronological cell aging ","P17813"]
["GO:0070483","biological_process","detection of hypoxia ","P17813"]
["GO:0070278","biological_process","extracellular matrix constituent secretion ","P17813"]
["GO:0031960","biological_process","response to corticosteroid ","P17813; P46531"]
["GO:0097510","biological_process","base-excision repair, AP site formation via deaminated base removal ","P13051"]
["GO:0060856","biological_process","establishment of blood-brain barrier ","Q86X29"]
["GO:1904274","biological_process","tricellular tight junction assembly ","Q86X29"]
["GO:0035280","biological_process","miRNA loading onto RISC involved in gene silencing by miRNA ","Q15633; Q9UKV8"]
["GO:1903798","biological_process","regulation of production of miRNAs involved in gene silencing by miRNA ","Q15633"]
["GO:0090065","biological_process","regulation of production of siRNA involved in RNA interference ","Q15633"]
["GO:0046782","biological_process","regulation of viral transcription ","Q15633"]
["GO:0035087","biological_process","siRNA loading onto RISC involved in RNA interference ","Q15633; Q9UKV8"]
["GO:0030423","biological_process","targeting of mRNA for destruction involved in RNA interference ","Q15633"]
["GO:0070966","biological_process","nuclear-transcribed mRNA catabolic process, no-go decay ","Q9ULM6; O75534"]
["GO:0010606","biological_process","positive regulation of cytoplasmic mRNA processing body assembly ","Q9ULM6; Q9NZN8"]
["GO:2000327","biological_process","positive regulation of nuclear receptor transcription coactivator activity ","Q9ULM6"]
["GO:0035772","biological_process","interleukin-1-mediated signaling pathway ","Q8TDQ1"]
["GO:0034125","biological_process","negative regulation of MyD88-dependent toll-like receptor signaling pathway ","Q8TDQ1"]
["GO:2000427","biological_process","positive regulation of apoptotic cell clearance ","Q8TDQ1"]
["GO:1902216","biological_process","positive regulation of interleukin-4-mediated signaling pathway ","Q8TDQ1"]
["GO:0060022","biological_process","hard palate development ","Q12959"]
["GO:0031579","biological_process","membrane raft organization ","Q12959"]
["GO:1903764","biological_process","regulation of potassium ion export across plasma membrane ","Q12959"]
["GO:1903286","biological_process","regulation of potassium ion import ","Q12959"]
["GO:1903760","biological_process","regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization ","Q12959"]
["GO:0018401","biological_process","peptidyl-proline hydroxylation to -hydroxy-L-proline ","Q96KS0"]
["GO:1904828","biological_process","positive regulation of hydrogen sulfide biosynthetic process ","P08047"]
["GO:0100057","biological_process","regulation of phenotypic switching by transcription from RNA polymerase II promoter ","P08047"]
["GO:0035967","biological_process","cellular response to topologically incorrect protein ","Q9UBN7"]
["GO:0070846","biological_process","Hsp9 deacetylation ","Q9UBN7"]
["GO:0010727","biological_process","negative regulation of hydrogen peroxide metabolic process ","Q9UBN7"]
["GO:0070845","biological_process","polyubiquitinated misfolded protein transport ","Q9UBN7"]
["GO:0090035","biological_process","positive regulation of chaperone-mediated protein complex assembly ","Q9UBN7; Q9UNE7"]
["GO:0032984","biological_process","protein-containing complex disassembly ","Q9UBN7"]
["GO:0070201","biological_process","regulation of establishment of protein localization ","Q9UBN7; O96028"]
["GO:0060632","biological_process","regulation of microtubule-based movement ","Q9UBN7"]
["GO:0051788","biological_process","response to misfolded protein ","Q9UBN7"]
["GO:0090042","biological_process","tubulin deacetylation ","Q9UBN7; Q8IXJ6"]
["GO:0045023","biological_process"," to 1 transition ","Q00526; O15151"]
["GO:0033227","biological_process","dsRNA transport ","O75955"]
["GO:0044854","biological_process","plasma membrane raft assembly ","O75955"]
["GO:1901890","biological_process","positive regulation of cell junction assembly ","O75955"]
["GO:0032226","biological_process","positive regulation of synaptic transmission, dopaminergic ","O75955; Q9BXM7; P32121"]
["GO:1903044","biological_process","protein localization to membrane raft ","O75955"]
["GO:0006119","biological_process","oxidative phosphorylation ","P36542; P43246"]
["GO:0003430","biological_process","growth plate cartilage chondrocyte growth ","P37173; P13631"]
["GO:1905317","biological_process","inferior endocardial cushion morphogenesis ","P37173"]
["GO:1990428","biological_process","miRNA transport ","P37173; P22626"]
["GO:0002663","biological_process","positive regulation of B cell tolerance induction ","P37173"]
["GO:2000563","biological_process","positive regulation of CD4-positive, alpha-beta T cell proliferation ","P37173"]
["GO:0051138","biological_process","positive regulation of NK T cell differentiation ","P37173; Q05516"]
["GO:0002666","biological_process","positive regulation of T cell tolerance induction ","P37173"]
["GO:0002651","biological_process","positive regulation of tolerance induction to self antigen ","P37173"]
["GO:0061086","biological_process","negative regulation of histone H3-K27 methylation ","Q7KZ85; Q9Y483"]
["GO:0034728","biological_process","nucleosome organization ","Q7KZ85"]
["GO:1904026","biological_process","regulation of collagen fibril organization ","Q8IUX7"]
["GO:0097332","biological_process","response to antipsychotic drug ","P00441"]
["GO:0072368","biological_process","regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter ","Q12772; O75376"]
["GO:0006768","biological_process","biotin metabolic process ","P50747"]
["GO:0071110","biological_process","histone biotinylation ","P50747"]
["GO:0009305","biological_process","protein biotinylation ","P50747"]
["GO:0070781","biological_process","response to biotin ","P50747"]
["GO:1903547","biological_process","regulation of growth hormone activity ","O95751; Q53GA4"]
["GO:0051026","biological_process","chiasma assembly ","P63146"]
["GO:0033522","biological_process","histone HA ubiquitination ","P63146; P49459"]
["GO:0070076","biological_process","histone lysine demethylation ","P63146"]
["GO:0033128","biological_process","negative regulation of histone phosphorylation ","P63146; Q15672"]
["GO:0010845","biological_process","positive regulation of reciprocal meiotic recombination ","P63146"]
["GO:0007288","biological_process","sperm axoneme assembly ","P63146"]
["GO:0070193","biological_process","synaptonemal complex organization ","P63146"]
["GO:0043063","biological_process","intercellular bridge organization ","Q8IWB6"]
["GO:0051306","biological_process","mitotic sister chromatid separation ","Q8IWB6; P30153; Q6IBW4"]
["GO:0010626","biological_process","negative regulation of Schwann cell proliferation ","P56693; P12755"]
["GO:0099558","biological_process","maintenance of synapse structure ","Q14203"]
["GO:1904398","biological_process","positive regulation of neuromuscular junction development ","Q14203"]
["GO:0010970","biological_process","transport along microtubule ","Q14203; P63167; Q13409"]
["GO:0099564","biological_process","modification of synaptic structure, modulating synaptic transmission ","Q9UQB8"]
["GO:1905274","biological_process","regulation of modification of postsynaptic actin cytoskeleton ","Q9UQB8; Q13009; P61586"]
["GO:0009991","biological_process","response to extracellular stimulus ","P68133; P39019"]
["GO:0014843","biological_process","growth factor dependent regulation of skeletal muscle satellite cell proliferation ","P09038"]
["GO:0010764","biological_process","negative regulation of fibroblast migration ","P09038; O14713"]
["GO:0042660","biological_process","positive regulation of cell fate specification ","P09038"]
["GO:2000544","biological_process","regulation of endothelial cell chemotaxis to fibroblast growth factor ","P09038"]
["GO:1903461","biological_process","kazaki fragment processing involved in mitotic DNA replication ","P18858"]
["GO:0021853","biological_process","cerebral cortex ABAergic interneuron migration ","P14416; P21728"]
["GO:0042321","biological_process","negative regulation of circadian sleep/wake cycle, sleep ","P14416"]
["GO:0001976","biological_process","neurological system process involved in regulation of systemic arterial blood pressure ","P14416; P51608"]
["GO:0051586","biological_process","positive regulation of dopamine uptake involved in synaptic transmission ","P14416"]
["GO:0045745","biological_process","positive regulation of -protein coupled receptor protein signaling pathway ","P14416; P05067; P35232; P18545"]
["GO:0002265","biological_process","astrocyte activation involved in immune response ","P49768; P05067; Q07954"]
["GO:0021870","biological_process","Cajal-Retzius cell differentiation ","P49768"]
["GO:0015871","biological_process","choline transport ","P49768"]
["GO:1904797","biological_process","negative regulation of core promoter binding ","P49768"]
["GO:0050820","biological_process","positive regulation of coagulation ","P49768"]
["GO:0002038","biological_process","positive regulation of L-glutamate import across plasma membrane ","P49768"]
["GO:0060075","biological_process","regulation of resting membrane potential ","P49768; P63252; P78508"]
["GO:0051563","biological_process","smooth endoplasmic reticulum calcium ion homeostasis ","P49768; P05067"]
["GO:1905913","biological_process","negative regulation of calcium ion export across plasma membrane ","P62258"]
["GO:0003064","biological_process","regulation of heart rate by hormone ","P62258; Q12809"]
["GO:0008152","biological_process","metabolic process ","Q9HCR9; P48200"]
["GO:0090245","biological_process","axis elongation involved in somitogenesis ","O75581"]
["GO:0044335","biological_process","canonical Wnt signaling pathway involved in neural crest cell differentiation ","O75581"]
["GO:0060026","biological_process","convergent extension ","O75581"]
["GO:0030917","biological_process","midbrain-hindbrain boundary development ","O75581"]
["GO:0034392","biological_process","negative regulation of smooth muscle cell apoptotic process ","O75581; P32121"]
["GO:0003344","biological_process","pericardium morphogenesis ","O75581; P46531; Q07889; Q9UMR3"]
["GO:0060535","biological_process","trachea cartilage morphogenesis ","O75581"]
["GO:1904953","biological_process","Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation ","O75581"]
["GO:0090244","biological_process","Wnt signaling pathway involved in somitogenesis ","O75581"]
["GO:0060700","biological_process","regulation of ribonuclease activity ","P00973"]
["GO:0042883","biological_process","cysteine transport ","P43005"]
["GO:0046013","biological_process","regulation of T cell homeostatic proliferation ","P01589"]
["GO:0002664","biological_process","regulation of T cell tolerance induction ","P01589"]
["GO:1902035","biological_process","positive regulation of hematopoietic stem cell proliferation ","Q16342"]
["GO:0045081","biological_process","negative regulation of interleukin- biosynthetic process ","Q92519"]
["GO:0038158","biological_process","granulocyte colony-stimulating factor signaling pathway ","P13688"]
["GO:1901143","biological_process","insulin catabolic process ","P13688"]
["GO:0038016","biological_process","insulin receptor internalization ","P13688"]
["GO:0043318","biological_process","negative regulation of cytotoxic T cell degranulation ","P13688; P31994"]
["GO:2000346","biological_process","negative regulation of hepatocyte proliferation ","P13688; Q969H0"]
["GO:0045601","biological_process","regulation of endothelial cell differentiation ","P13688"]
["GO:1903385","biological_process","regulation of homophilic cell adhesion ","P13688"]
["GO:1903670","biological_process","regulation of sprouting angiogenesis ","P13688"]
["GO:0014707","biological_process","branchiomeric skeletal muscle development ","P78337"]
["GO:1904744","biological_process","positive regulation of telomeric DNA binding ","Q96BK5"]
["GO:0051972","biological_process","regulation of telomerase activity ","Q96BK5"]
["GO:2001260","biological_process","regulation of semaphorin-plexin signaling pathway ","P13591"]
["GO:0048245","biological_process","eosinophil chemotaxis ","P17931; P35367"]
["GO:0031640","biological_process","killing of cells of other organism ","P17931; P06899; P04406; P05204; O60814; P39019"]
["GO:0048246","biological_process","macrophage chemotaxis ","P17931"]
["GO:0071674","biological_process","mononuclear cell migration ","P17931"]
["GO:0071677","biological_process","positive regulation of mononuclear cell migration ","P17931; P01375"]
["GO:0042129","biological_process","regulation of T cell proliferation ","P17931; Q07889"]
["GO:0051051","biological_process","negative regulation of transport ","Q6PIZ9; Q92681"]
["GO:0003219","biological_process","cardiac right ventricle formation ","P61296; O96004; Q6STE5; P46531"]
["GO:0060982","biological_process","coronary artery morphogenesis ","P61296; P36897; P46531"]
["GO:0010463","biological_process","mesenchymal cell proliferation ","P61296"]
["GO:0003357","biological_process","noradrenergic neuron differentiation ","P61296; O14813"]
["GO:2000764","biological_process","positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis ","P61296"]
["GO:2000763","biological_process","positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process ","P61296"]
["GO:1903929","biological_process","primary palate development ","P61296"]
["GO:0034103","biological_process","regulation of tissue remodeling ","P61296"]
["GO:1900264","biological_process","positive regulation of DNA-directed DNA polymerase activity ","P40937; Q8WVB6"]
["GO:0043570","biological_process","maintenance of DNA repeat elements ","Q9NQB0; P43246; Q9Y2T1"]
["GO:0032350","biological_process","regulation of hormone metabolic process ","Q9NQB0"]
["GO:0072272","biological_process","proximal/distal pattern formation involved in metanephric nephron development ","Q9BZI1"]
["GO:0072086","biological_process","specification of loop of Henle identity ","Q9BZI1"]
["GO:0090204","biological_process","protein localization to nuclear pore ","P63165"]
["GO:0019732","biological_process","antifungal humoral response ","P05067"]
["GO:0008088","biological_process","axo-dendritic transport ","P05067; Q02410"]
["GO:0071874","biological_process","cellular response to norepinephrine stimulus ","P05067"]
["GO:0048669","biological_process","collateral sprouting in absence of injury ","P05067"]
["GO:0042157","biological_process","lipoprotein metabolic process ","P05067; Q07869; Q07954"]
["GO:0014005","biological_process","microglia development ","P05067"]
["GO:0010823","biological_process","negative regulation of mitochondrion organization ","P05067"]
["GO:0061903","biological_process","positive regulation of -phosphatidylinositol--kinase activity ","P05067; Q99490"]
["GO:0061890","biological_process","positive regulation of astrocyte activation ","P05067; Q15109"]
["GO:1905893","biological_process","positive regulation of cellular response to thapsigargin ","P05067"]
["GO:1905896","biological_process","positive regulation of cellular response to tunicamycin ","P05067"]
["GO:1904022","biological_process","positive regulation of -protein coupled receptor internalization ","P05067"]
["GO:1903223","biological_process","positive regulation of oxidative stress-induced neuron death ","P05067; O00206"]
["GO:1904591","biological_process","positive regulation of protein import ","P05067"]
["GO:1905898","biological_process","positive regulation of response to endoplasmic reticulum stress ","P05067; P31994"]
["GO:1903048","biological_process","regulation of acetylcholine-gated cation channel activity ","P05067"]
["GO:1902950","biological_process","regulation of dendritic spine maintenance ","P05067; P31994; Q86YM7"]
["GO:1905945","biological_process","regulation of response to calcium ion ","P05067"]
["GO:0150003","biological_process","regulation of spontaneous synaptic transmission ","P05067; Q15109"]
["GO:0051124","biological_process","synaptic growth at neuromuscular junction ","P05067; O75096"]
["GO:0032640","biological_process","tumor necrosis factor production ","P05067"]
["GO:2000564","biological_process","regulation of CD8-positive, alpha-beta T cell proliferation ","Q9UQF2; P10914; Q7Z6J0"]
["GO:0045188","biological_process","regulation of circadian sleep/wake cycle, non-REM sleep ","P16389"]
["GO:0010950","biological_process","positive regulation of endopeptidase activity ","Q53H80"]
["GO:0003199","biological_process","endocardial cushion to mesenchymal transition involved in heart valve formation ","P11308"]
["GO:2000504","biological_process","positive regulation of blood vessel remodeling ","P11308"]
["GO:0045917","biological_process","positive regulation of complement activation ","P35232"]
["GO:0071401","biological_process","cellular response to triglyceride ","P80108"]
["GO:0006507","biological_process","PI anchor release ","P80108"]
["GO:0097241","biological_process","hematopoietic stem cell migration to bone marrow ","P80108"]
["GO:0046470","biological_process","phosphatidylcholine metabolic process ","P80108; P51608"]
["GO:0045919","biological_process","positive regulation of cytolysis ","P80108"]
["GO:0010983","biological_process","positive regulation of high-density lipoprotein particle clearance ","P80108"]
["GO:0051047","biological_process","positive regulation of secretion ","P80108"]
["GO:1900076","biological_process","regulation of cellular response to insulin stimulus ","P80108"]
["GO:0070633","biological_process","transepithelial transport ","P80108"]
["GO:0050688","biological_process","regulation of defense response to virus ","Q13114"]
["GO:0032648","biological_process","regulation of interferon-beta production ","Q13114; P58753"]
["GO:0030162","biological_process","regulation of proteolysis ","Q13114"]
["GO:0051866","biological_process","general adaptation syndrome ","P43354"]
["GO:0072594","biological_process","establishment of protein localization to organelle ","P62491"]
["GO:1990182","biological_process","exosomal secretion ","P62491"]
["GO:0010796","biological_process","regulation of multivesicular body size ","P62491"]
["GO:0051223","biological_process","regulation of protein transport ","P62491; Q14C86"]
["GO:0099003","biological_process","vesicle-mediated transport in synapse ","P62491"]
["GO:0031023","biological_process","microtubule organizing center organization ","Q96SN8; O75122"]
["GO:0015908","biological_process","fatty acid transport ","Q07869"]
["GO:0032099","biological_process","negative regulation of appetite ","Q07869"]
["GO:0072366","biological_process","regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter ","Q07869"]
["GO:0072363","biological_process","regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter ","Q07869"]
["GO:1900102","biological_process","negative regulation of endoplasmic reticulum unfolded protein response ","P63244; P17861"]
["GO:0042998","biological_process","positive regulation of olgi to plasma membrane protein transport ","P63244"]
["GO:0072344","biological_process","rescue of stalled ribosome ","P63244"]
["GO:0001994","biological_process","norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure ","P35368"]
["GO:0090341","biological_process","negative regulation of secretion of lysosomal enzymes ","Q13133"]
["GO:2000325","biological_process","regulation of nuclear receptor transcription coactivator activity ","Q13133"]
["GO:0055092","biological_process","sterol homeostasis ","Q13133; P17861"]
["GO:0045938","biological_process","positive regulation of circadian sleep/wake cycle, sleep ","Q9UHM6"]
["GO:0098662","biological_process","inorganic cation transmembrane transport ","Q8TD43; O95180"]
["GO:1903949","biological_process","positive regulation of atrial cardiac muscle cell action potential ","Q8TD43"]
["GO:1904199","biological_process","positive regulation of regulation of vascular smooth muscle cell membrane depolarization ","Q8TD43"]
["GO:0002724","biological_process","regulation of T cell cytokine production ","Q8TD43"]
["GO:0072144","biological_process","glomerular mesangial cell development ","Q99958; P46531"]
["GO:0048343","biological_process","paraxial mesodermal cell fate commitment ","Q99958"]
["GO:0035470","biological_process","positive regulation of vascular wound healing ","Q99958; P17861"]
["GO:1903608","biological_process","protein localization to cytoplasmic stress granule ","O00571; Q9NPI6; P67809; P05455; P31483"]
["GO:0032049","biological_process","cardiolipin biosynthetic process ","Q16635"]
["GO:0006354","biological_process","DNA-templated transcription, elongation ","Q9HB65"]
["GO:0098792","biological_process","xenophagy ","Q9Y4P8; Q676U5"]
["GO:0033687","biological_process","osteoblast proliferation ","P17275"]
["GO:0003245","biological_process","cardiac muscle tissue growth involved in heart morphogenesis ","P21453"]
["GO:0090164","biological_process","asymmetric olgi ribbon formation ","Q92614; Q9H4A6"]
["GO:1903028","biological_process","positive regulation of opsonization ","Q92614"]
["GO:0031063","biological_process","regulation of histone deacetylation ","O43257"]
["GO:0050849","biological_process","negative regulation of calcium-mediated signaling ","Q14643; P08567"]
["GO:0007144","biological_process","female meiosis I ","P30305"]
["GO:0060272","biological_process","embryonic skeletal joint morphogenesis ","P31270; O15169"]
["GO:0010720","biological_process","positive regulation of cell development ","P31270"]
["GO:1904153","biological_process","negative regulation of retrograde protein transport, ER to cytosol ","Q9Y385"]
["GO:0042534","biological_process","regulation of tumor necrosis factor biosynthetic process ","Q9Y385; Q9H257"]
["GO:0098902","biological_process","regulation of membrane depolarization during action potential ","P26045"]
["GO:0010458","biological_process","exit from mitosis ","Q16763; O75122; Q9Y5B0; Q8WUX9; Q12929"]
["GO:0010994","biological_process","free ubiquitin chain polymerization ","Q16763; P61086; O60260"]
["GO:0044314","biological_process","protein K27-linked ubiquitination ","Q16763; O60260"]
["GO:0035519","biological_process","protein K2-linked ubiquitination ","Q16763; Q96J02; O60260"]
["GO:0030579","biological_process","ubiquitin-dependent SMAD protein catabolic process ","O43294; Q9UNE7"]
["GO:0035616","biological_process","histone H2B conserved C-terminal lysine deubiquitination ","Q93009; Q9Y4E8"]
["GO:1901537","biological_process","positive regulation of DNA demethylation ","Q93009"]
["GO:1904353","biological_process","regulation of telomere capping ","Q93009"]
["GO:2000003","biological_process","positive regulation of DNA damage checkpoint ","Q8N163"]
["GO:0090311","biological_process","regulation of protein deacetylation ","Q8N163"]
["GO:0031635","biological_process","adenylate cyclase-inhibiting opioid receptor signaling pathway ","P41145; P35372"]
["GO:1990708","biological_process","conditioned place preference ","P41145"]
["GO:0033685","biological_process","negative regulation of luteinizing hormone secretion ","P41145"]
["GO:0033603","biological_process","positive regulation of dopamine secretion ","P41145; Q9BXM7"]
["GO:0040017","biological_process","positive regulation of locomotion ","P41145"]
["GO:1901381","biological_process","positive regulation of potassium ion transmembrane transport ","P41145; P21333; P51787; Q12809; P15382; P63252"]
["GO:0046877","biological_process","regulation of saliva secretion ","P41145"]
["GO:0050951","biological_process","sensory perception of temperature stimulus ","P41145"]
["GO:0051798","biological_process","positive regulation of hair follicle development ","Q04695; P01375; Q14980"]
["GO:1900477","biological_process","negative regulation of /S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter ","Q96BF6"]
["GO:0033299","biological_process","secretion of lysosomal enzymes ","P20645"]
["GO:1903020","biological_process","positive regulation of glycoprotein metabolic process ","P62820"]
["GO:0021503","biological_process","neural fold bending ","Q86V48"]
["GO:1901194","biological_process","negative regulation of formation of translation preinitiation complex ","P40429"]
["GO:0000972","biological_process","transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery ","Q8WUM0"]
["GO:0040020","biological_process","regulation of meiotic nuclear division ","Q14432; Q12834; Q9UM11"]
["GO:0048239","biological_process","negative regulation of DNA recombination at telomere ","Q9NYB0"]
["GO:0035036","biological_process","sperm-egg recognition ","Q96D96"]
["GO:1990349","biological_process","gap junction-mediated intercellular transport ","P30301"]
["GO:0002934","biological_process","desmosome organization ","Q9NZI5; P15924"]
["GO:0097151","biological_process","positive regulation of inhibitory postsynaptic potential ","Q86UR5"]
["GO:0043504","biological_process","mitochondrial DNA repair ","P49916; P09874"]
["GO:0090298","biological_process","negative regulation of mitochondrial DNA replication ","P49916"]
["GO:0060978","biological_process","angiogenesis involved in coronary vascular morphogenesis ","P36897"]
["GO:1905223","biological_process","epicardium morphogenesis ","P36897"]
["GO:0043062","biological_process","extracellular structure organization ","P36897"]
["GO:1905075","biological_process","positive regulation of occluding junction disassembly ","P36897"]
["GO:0071409","biological_process","cellular response to cycloheximide ","O43474"]
["GO:0007500","biological_process","mesodermal cell fate determination ","O43474"]
["GO:1904998","biological_process","negative regulation of leukocyte adhesion to arterial endothelial cell ","O43474"]
["GO:0046985","biological_process","positive regulation of hemoglobin biosynthetic process ","O43474; Q99873"]
["GO:0035166","biological_process","post-embryonic hemopoiesis ","O43474"]
["GO:0071169","biological_process","establishment of protein localization to chromatin ","P16401; Q9Y230"]
["GO:1904530","biological_process","negative regulation of actin filament binding ","Q14194"]
["GO:0044843","biological_process","cell cycle 1/S phase transition ","P20248"]
["GO:0071314","biological_process","cellular response to cocaine ","P20248"]
["GO:0051151","biological_process","negative regulation of smooth muscle cell differentiation ","Q9H204; O75179; P98177; P51608"]
["GO:0003218","biological_process","cardiac left ventricle formation ","O96004"]
["GO:0003144","biological_process","embryonic heart tube formation ","O96004"]
["GO:0060485","biological_process","mesenchyme development ","O96004"]
["GO:1903026","biological_process","negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding ","O96004; P35638; P41134"]
["GO:0086027","biological_process","AV node cell to bundle of His cell signaling ","O43497"]
["GO:0010045","biological_process","response to nickel cation ","O43497"]
["GO:0086018","biological_process","SA node cell to atrial cardiac muscle cell signaling ","O43497"]
["GO:0060988","biological_process","lipid tube assembly ","Q99962"]
["GO:0097753","biological_process","membrane bending ","Q99962"]
["GO:0097749","biological_process","membrane tubulation ","Q99962"]
["GO:0099050","biological_process","vesicle scission ","Q99962"]
["GO:1990791","biological_process","dorsal root ganglion development ","P49798"]
["GO:0110053","biological_process","regulation of actin filament organization ","P49798"]
["GO:0045026","biological_process","plasma membrane fusion ","P46459; P35590"]
["GO:0035494","biological_process","SNARE complex disassembly ","P46459"]
["GO:0035822","biological_process","gene conversion ","Q9H1E3"]
["GO:1990968","biological_process","modulation by host of RNA binding by virus ","Q9H1E3"]
["GO:1990969","biological_process","modulation by host of viral RNA-binding transcription factor activity ","Q9H1E3"]
["GO:0044829","biological_process","positive regulation by host of viral genome replication ","Q9H1E3"]
["GO:0060382","biological_process","regulation of DNA strand elongation ","Q9H1E3"]
["GO:0071315","biological_process","cellular response to morphine ","Q96SB3; P35372"]
["GO:2000474","biological_process","regulation of opioid receptor signaling pathway ","Q96SB3"]
["GO:0046314","biological_process","phosphocreatine biosynthetic process ","P06732"]
["GO:0000320","biological_process","re-entry into mitotic cell cycle ","P41002; P24385"]
["GO:0042663","biological_process","regulation of endodermal cell fate specification ","Q16828"]
["GO:0060420","biological_process","regulation of heart growth ","Q16828"]
["GO:0051083","biological_process","'de novo' cotranslational protein folding ","Q99543"]
["GO:0042758","biological_process","long-chain fatty acid catabolic process ","Q05469"]
["GO:0021895","biological_process","cerebral cortex neuron differentiation ","P47928"]
["GO:0061682","biological_process","seminal vesicle morphogenesis ","P47928"]
["GO:0015866","biological_process","ADP transport ","P12235"]
["GO:0001100","biological_process","negative regulation of exit from mitosis ","Q9H4X1"]
["GO:1901991","biological_process","negative regulation of mitotic cell cycle phase transition ","Q9H4X1; Q07352"]
["GO:0003331","biological_process","positive regulation of extracellular matrix constituent secretion ","Q9H4X1"]
["GO:0030047","biological_process","actin modification ","Q9H2D6"]
["GO:0048619","biological_process","embryonic hindgut morphogenesis ","Q9NYF0"]
["GO:1904864","biological_process","negative regulation of beta-catenin-TCF complex assembly ","Q9NYF0"]
["GO:2000095","biological_process","regulation of Wnt signaling pathway, planar cell polarity pathway ","Q9NYF0"]
["GO:0061087","biological_process","positive regulation of histone H3-K2 methylation ","Q9Y483; O15294"]
["GO:1904356","biological_process","regulation of telomere maintenance via telomere lengthening ","Q9BSI4"]
["GO:0032202","biological_process","telomere assembly ","Q9BSI4; Q96AP0"]
["GO:0042089","biological_process","cytokine biosynthetic process ","P10747"]
["GO:0002863","biological_process","positive regulation of inflammatory response to antigenic stimulus ","P10747"]
["GO:0045066","biological_process","regulatory T cell differentiation ","P10747"]
["GO:0002439","biological_process","chronic inflammatory response to antigenic stimulus ","P01375"]
["GO:0010693","biological_process","negative regulation of alkaline phosphatase activity ","P01375"]
["GO:0061048","biological_process","negative regulation of branching involved in lung morphogenesis ","P01375"]
["GO:0002740","biological_process","negative regulation of cytokine secretion involved in immune response ","P01375"]
["GO:0060559","biological_process","positive regulation of calcidiol 1-monooxygenase activity ","P01375"]
["GO:2000343","biological_process","positive regulation of chemokine (C-X-C motif) ligand  production ","P01375; P58753"]
["GO:0002876","biological_process","positive regulation of chronic inflammatory response to antigenic stimulus ","P01375"]
["GO:0050754","biological_process","positive regulation of fractalkine biosynthetic process ","P01375"]
["GO:1904999","biological_process","positive regulation of leukocyte adhesion to arterial endothelial cell ","P01375"]
["GO:0051222","biological_process","positive regulation of protein transport ","P01375; Q07954"]
["GO:0060557","biological_process","positive regulation of vitamin D biosynthetic process ","P01375"]
["GO:0032800","biological_process","receptor biosynthetic process ","P01375"]
["GO:0060693","biological_process","regulation of branching involved in salivary gland morphogenesis ","P01375"]
["GO:0030730","biological_process","sequestering of triglyceride ","P01375; P22413"]
["GO:0051127","biological_process","positive regulation of actin nucleation ","P06396"]
["GO:1902174","biological_process","positive regulation of keratinocyte apoptotic process ","P06396; Q8N2W9"]
["GO:1903923","biological_process","positive regulation of protein processing in phagocytic vesicle ","P06396; P35579"]
["GO:1903903","biological_process","regulation of establishment of T cell polarity ","P06396"]
["GO:1903906","biological_process","regulation of plasma membrane raft polarization ","P06396"]
["GO:1903909","biological_process","regulation of receptor clustering ","P06396"]
["GO:0097017","biological_process","renal protein absorption ","P06396"]
["GO:0006516","biological_process","glycoprotein catabolic process ","O60502; Q8TCJ2"]
["GO:0006044","biological_process","N-acetylglucosamine metabolic process ","O60502; Q9UJ70"]
["GO:0006493","biological_process","protein -linked glycosylation ","O60502; P15382; O15294"]
["GO:0050859","biological_process","negative regulation of B cell receptor signaling pathway ","Q96P31; O60711; P29350"]
["GO:1905184","biological_process","positive regulation of protein serine/threonine phosphatase activity ","Q96P31; Q9NXH3"]
["GO:0050864","biological_process","regulation of B cell activation ","Q96P31"]
["GO:0034163","biological_process","regulation of toll-like receptor 9 signaling pathway ","Q96P31"]
["GO:1903758","biological_process","negative regulation of transcription from RNA polymerase II promoter by histone modification ","Q9ULU4; Q13363"]
["GO:0044210","biological_process","'de novo' CTP biosynthetic process ","P17812; Q9NRF8"]
["GO:0006241","biological_process","CTP biosynthetic process ","P17812; P22392; P15531; O60361"]
["GO:0060691","biological_process","epithelial cell maturation involved in salivary gland development ","P17861"]
["GO:0006996","biological_process","organelle organization ","P17861; Q9H8Y8; O95239; Q9Y496; O60282; P16615"]
["GO:2000347","biological_process","positive regulation of hepatocyte proliferation ","P17861; O15519; Q15648"]
["GO:0002639","biological_process","positive regulation of immunoglobulin production ","P17861; P24394; O75995"]
["GO:0051024","biological_process","positive regulation of immunoglobulin secretion ","P17861; P06744"]
["GO:1903489","biological_process","positive regulation of lactation ","P17861"]
["GO:1900413","biological_process","positive regulation of phospholipid biosynthetic process by positive regulation of transcription from RNA polymerase II promoter ","P17861"]
["GO:1900100","biological_process","positive regulation of plasma cell differentiation ","P17861"]
["GO:0048490","biological_process","anterograde synaptic vesicle transport ","O95295"]
["GO:0007042","biological_process","lysosomal lumen acidification ","O95295"]
["GO:0032438","biological_process","melanosome organization ","O95295"]
["GO:1902824","biological_process","positive regulation of late endosome to lysosome transport ","O95295"]
["GO:0072553","biological_process","terminal button organization ","O95295; Q8N2Q7"]
["GO:0070358","biological_process","actin polymerization-dependent cell motility ","P61158; Q12929"]
["GO:0010603","biological_process","regulation of cytoplasmic mRNA processing body assembly ","Q8WWM7"]
["GO:0050432","biological_process","catecholamine secretion ","Q9ULU8; P51608"]
["GO:0060972","biological_process","left/right pattern formation ","Q99967; O95863"]
["GO:0061428","biological_process","negative regulation of transcription from RNA polymerase II promoter in response to hypoxia ","Q99967; P40337; Q8IXJ6"]
["GO:1900164","biological_process","nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry ","Q99967"]
["GO:1903645","biological_process","negative regulation of chaperone-mediated protein folding ","O14737"]
["GO:1903638","biological_process","positive regulation of protein import into mitochondrial outer membrane ","O14737"]
["GO:0007171","biological_process","activation of transmembrane receptor protein tyrosine kinase activity ","Q02297; P16471; P07550"]
["GO:0060379","biological_process","cardiac muscle cell myoblast differentiation ","Q02297"]
["GO:0043624","biological_process","cellular protein complex disassembly ","Q02297"]
["GO:0021842","biological_process","chemorepulsion involved in interneuron migration from the subpallium to the cortex ","Q02297"]
["GO:0009790","biological_process","embryo development ","Q02297"]
["GO:0038129","biological_process","ERBB signaling pathway ","Q02297"]
["GO:0038130","biological_process","ERBB4 signaling pathway ","Q02297"]
["GO:0021781","biological_process","glial cell fate commitment ","Q02297; P48431"]
["GO:0045213","biological_process","neurotransmitter receptor metabolic process ","Q02297"]
["GO:0051155","biological_process","positive regulation of striated muscle cell differentiation ","Q02297; Q13049"]
["GO:0006027","biological_process","glycosaminoglycan catabolic process ","P18827; P34741; P31431; O75056"]
["GO:0048627","biological_process","myoblast development ","P18827"]
["GO:0055002","biological_process","striated muscle cell development ","P18827"]
["GO:0036010","biological_process","protein localization to endosome ","Q8N3F8; Q15057"]
["GO:0032458","biological_process","slow endocytic recycling ","Q8N3F8"]
["GO:0007014","biological_process","actin ubiquitination ","Q13049"]
["GO:1903886","biological_process","positive regulation of chemokine (C-C motif) ligand 2 production ","Q13049"]
["GO:1903883","biological_process","positive regulation of interleukin-7-mediated signaling pathway ","Q13049"]
["GO:1902631","biological_process","negative regulation of membrane hyperpolarization ","Q6UUV9"]
["GO:2000623","biological_process","negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay ","P11940"]
["GO:1903586","biological_process","positive regulation of histone deubiquitination ","Q15020"]
["GO:0051066","biological_process","dihydrobiopterin metabolic process ","P09417"]
["GO:0010044","biological_process","response to aluminum ion ","P09417"]
["GO:0006295","biological_process","nucleotide-excision repair, DNA incision, 3'-to lesion ","P28715"]
["GO:0002521","biological_process","leukocyte differentiation ","P10301"]
["GO:1904579","biological_process","cellular response to thapsigargin ","O00429"]
["GO:0090149","biological_process","mitochondrial membrane fission ","O00429"]
["GO:0010637","biological_process","negative regulation of mitochondrial fusion ","O00429; O60260"]
["GO:2000302","biological_process","positive regulation of synaptic vesicle exocytosis ","O00429; Q8N2Q7"]
["GO:0032459","biological_process","regulation of protein oligomerization ","O00429"]
["GO:1905395","biological_process","response to flavonoid ","O00429"]
["GO:0036466","biological_process","synaptic vesicle recycling via endosome ","O00429"]
["GO:0018026","biological_process","peptidyl-lysine monomethylation ","Q9NQR1; Q9NRG4; Q03164"]
["GO:0043516","biological_process","regulation of DNA damage response, signal transduction by p class mediator ","Q9NQR1; Q9NRG4"]
["GO:0086050","biological_process","membrane repolarization during bundle of His cell action potential ","P22460"]
["GO:0086052","biological_process","membrane repolarization during SA node cell action potential ","P22460"]
["GO:0110008","biological_process","ncRNA deadenylation ","O95453"]
["GO:0071051","biological_process","polyadenylation-dependent snoRNA 3'-end processing ","O95453; Q9NQT5; Q9NQT4"]
["GO:0009451","biological_process","RNA modification ","O95453"]
["GO:0090503","biological_process","RNA phosphodiester bond hydrolysis, exonucleolytic ","O95453; Q9NZN8"]
["GO:0046511","biological_process","sphinganine biosynthetic process ","O15269"]
["GO:0006686","biological_process","sphingomyelin biosynthetic process ","O15269"]
["GO:0009306","biological_process","protein secretion ","P27824; Q9H4A6; P30040; Q96AX2"]
["GO:0072660","biological_process","maintenance of protein location in plasma membrane ","Q12955"]
["GO:2001259","biological_process","positive regulation of cation channel activity ","Q12955; Q14654"]
["GO:0010650","biological_process","positive regulation of cell communication by electrical coupling ","Q12955"]
["GO:0034112","biological_process","positive regulation of homotypic cell-cell adhesion ","Q12955"]
["GO:1900827","biological_process","positive regulation of membrane depolarization during cardiac muscle cell action potential ","Q12955"]
["GO:0045838","biological_process","positive regulation of membrane potential ","Q12955"]
["GO:0071839","biological_process","apoptotic process in bone marrow ","Q07817"]
["GO:1900118","biological_process","negative regulation of execution phase of apoptosis ","Q07817"]
["GO:0019471","biological_process","-hydroxyproline metabolic process ","Q96HE7"]
["GO:0010260","biological_process","animal organ senescence ","Q96HE7"]
["GO:0022417","biological_process","protein maturation by protein folding ","Q96HE7; O00170"]
["GO:0009266","biological_process","response to temperature stimulus ","Q96HE7; Q9Y5S1"]
["GO:0032482","biological_process","Rab protein signal transduction ","P20338; P31150"]
["GO:2000097","biological_process","regulation of smooth muscle cell-matrix adhesion ","P00749"]
["GO:1904009","biological_process","cellular response to monosodium glutamate ","P84074"]
["GO:0031283","biological_process","negative regulation of guanylate cyclase activity ","P84074"]
["GO:1901385","biological_process","regulation of voltage-gated calcium channel activity ","P84074; Q02641; Q09666; Q08289"]
["GO:1904010","biological_process","response to Aroclor 25 ","P84074"]
["GO:1901986","biological_process","response to ketamine ","P84074"]
["GO:0101030","biological_process","tRNA-guanine transglycosylation ","Q9BXR0"]
["GO:0097368","biological_process","establishment of Sertoli cell barrier ","P21333; P29374"]
["GO:0016479","biological_process","negative regulation of transcription by RNA polymerase I ","P21333"]
["GO:1905000","biological_process","regulation of membrane repolarization during atrial cardiac muscle cell action potential ","P21333"]
["GO:1905031","biological_process","regulation of membrane repolarization during cardiac muscle cell action potential ","P21333"]
["GO:0051454","biological_process","intracellular pH elevation ","P13569"]
["GO:1902161","biological_process","positive regulation of cyclic nucleotide-gated ion channel activity ","P13569"]
["GO:1902943","biological_process","positive regulation of voltage-gated chloride channel activity ","P13569"]
["GO:0071322","biological_process","cellular response to carbohydrate stimulus ","Q9NP71"]
["GO:0010255","biological_process","glucose mediated signaling pathway ","Q9NP71; Q15109"]
["GO:0032764","biological_process","negative regulation of mast cell cytokine production ","P41182; P09601"]
["GO:1903464","biological_process","negative regulation of mitotic cell cycle DNA replication ","P41182"]
["GO:0045591","biological_process","positive regulation of regulatory T cell differentiation ","P41182; P15529; Q9Y6W6"]
["GO:0043380","biological_process","regulation of memory T cell differentiation ","P41182"]
["GO:0042092","biological_process","type  immune response ","P41182"]
["GO:0033564","biological_process","anterior/posterior axon guidance ","O95185; P43146"]
["GO:0015860","biological_process","purine nucleoside transmembrane transport ","O43868"]
["GO:0055129","biological_process","L-proline biosynthetic process ","P32322; Q96C36"]
["GO:0006561","biological_process","proline biosynthetic process ","P32322; Q96C36"]
["GO:0002263","biological_process","cell activation involved in immune response ","Q92538"]
["GO:0061162","biological_process","establishment of monopolar cell polarity ","Q92538; P46821"]
["GO:0070973","biological_process","protein localization to endoplasmic reticulum exit site ","Q92538"]
["GO:1903420","biological_process","protein localization to endoplasmic reticulum tubular network ","Q92538"]
["GO:1903409","biological_process","reactive oxygen species biosynthetic process ","Q92538; Q9NPH5"]
["GO:1900245","biological_process","positive regulation of MDA- signaling pathway ","O75179"]
["GO:1901341","biological_process","positive regulation of store-operated calcium channel activity ","P31415"]
["GO:0014809","biological_process","regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion ","P31415"]
["GO:0000467","biological_process","exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) ","Q06265; Q9NQT5; Q15024"]
["GO:0071028","biological_process","nuclear mRNA surveillance ","Q06265; Q15024; Q9NQT4"]
["GO:0071042","biological_process","nuclear polyadenylation-dependent mRNA catabolic process ","Q06265; Q15024; Q8TCS8"]
["GO:0071035","biological_process","nuclear polyadenylation-dependent rRNA catabolic process ","Q06265; Q9NQT5; Q15024"]
["GO:0071038","biological_process","nuclear polyadenylation-dependent tRNA catabolic process ","Q06265; Q9NQT5; Q15024"]
["GO:0034427","biological_process","nuclear-transcribed mRNA catabolic process, exonucleolytic, '-5' ","Q06265; Q9NQT5; Q15024; Q9NQT4"]
["GO:0034473","biological_process","U1 snRNA '-end processing ","Q06265; Q15024"]
["GO:0034475","biological_process","U snRNA '-end processing ","Q06265; Q9NQT5; Q15024; Q9NQT4"]
["GO:0034476","biological_process","U5 snRNA '-end processing ","Q06265; Q15024"]
["GO:0009159","biological_process","deoxyribonucleoside monophosphate catabolic process ","O43598"]
["GO:0006011","biological_process","UDP-glucose metabolic process ","O60701"]
["GO:0006065","biological_process","UDP-glucuronate biosynthetic process ","O60701"]
["GO:0034968","biological_process","histone lysine methylation ","O00255; Q96KQ7"]
["GO:1902807","biological_process","negative regulation of cell cycle /S phase transition ","O00255; P55273"]
["GO:0032388","biological_process","positive regulation of intracellular transport ","Q96R06; Q14204; Q14980"]
["GO:0090235","biological_process","regulation of metaphase plate congression ","Q96R06; Q9Y6D9; Q14204; Q14980"]
["GO:1901856","biological_process","negative regulation of cellular respiration ","Q12931"]
["GO:0006950","biological_process","response to stress ","Q12931; O95433"]
["GO:0009386","biological_process","translational attenuation ","Q12931; Q9Y2T7"]
["GO:0035878","biological_process","nail development ","Q9Y478; P16144"]
["GO:0042985","biological_process","negative regulation of amyloid precursor protein biosynthetic process ","Q9NY61"]
["GO:0032929","biological_process","negative regulation of superoxide anion generation ","Q9NY61"]
["GO:0099575","biological_process","regulation of protein catabolic process at presynapse, modulating synaptic transmission ","O94827"]
["GO:0021813","biological_process","cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration ","O75553"]
["GO:0021589","biological_process","cerebellum structural organization ","O75553; P11021"]
["GO:0097477","biological_process","lateral motor column neuron migration ","O75553"]
["GO:0042636","biological_process","negative regulation of hair cycle ","Q8NET8"]
["GO:1901187","biological_process","regulation of ephrin receptor signaling pathway ","Q92625"]
["GO:0006183","biological_process","TP biosynthetic process ","P22392; P15531; P12268; O60361"]
["GO:0009142","biological_process","nucleoside triphosphate biosynthetic process ","P22392"]
["GO:0045682","biological_process","regulation of epidermis development ","P22392"]
["GO:0001835","biological_process","blastocyst hatching ","Q99708"]
["GO:0042694","biological_process","muscle cell fate specification ","P10916"]
["GO:0007638","biological_process","mechanosensory behavior ","P50549"]
["GO:0001712","biological_process","ectodermal cell fate commitment ","P15036"]
["GO:0018027","biological_process","peptidyl-lysine dimethylation ","Q96KQ7; Q9NRG4"]
["GO:0016926","biological_process","protein desumoylation ","Q9HC62"]
["GO:0032875","biological_process","regulation of DNA endoreduplication ","Q9HC62"]
["GO:0060155","biological_process","platelet dense granule organization ","O95477"]
["GO:0090107","biological_process","regulation of high-density lipoprotein particle assembly ","O95477"]
["GO:0043382","biological_process","positive regulation of memory T cell differentiation ","P15529"]
["GO:0035581","biological_process","sequestering of extracellular ligand from receptor ","P15529"]
["GO:0097476","biological_process","spinal cord motor neuron migration ","Q7RTU3"]
["GO:0016046","biological_process","detection of fungus ","O00206"]
["GO:0060729","biological_process","intestinal epithelial structure maintenance ","O00206; P48436"]
["GO:1903974","biological_process","positive regulation of cellular response to macrophage colony-stimulating factor stimulus ","O00206"]
["GO:0010572","biological_process","positive regulation of platelet activation ","O00206; P08567"]
["GO:0045075","biological_process","regulation of interleukin-12 biosynthetic process ","Q6P0Q8"]
["GO:0086011","biological_process","membrane repolarization during action potential ","P51787; Q12809; P15382; P63252"]
["GO:0098915","biological_process","membrane repolarization during ventricular cardiac muscle cell action potential ","P51787; Q12809; Q9UK17; P15382; Q15842"]
["GO:0031943","biological_process","regulation of glucocorticoid metabolic process ","Q9UNE7"]
["GO:0006576","biological_process","cellular biogenic amine metabolic process ","P21397; P51608"]
["GO:0042133","biological_process","neurotransmitter metabolic process ","P21397"]
["GO:0098989","biological_process","NMDA selective glutamate receptor signaling pathway ","Q13009"]
["GO:1904268","biological_process","positive regulation of Schwann cell chemotaxis ","Q13009"]
["GO:1904338","biological_process","regulation of dopaminergic neuron differentiation ","Q13009"]
["GO:2000050","biological_process","regulation of non-canonical Wnt signaling pathway ","Q13009"]
["GO:0002635","biological_process","negative regulation of germinal center formation ","Q5TC82"]
["GO:0045623","biological_process","negative regulation of T-helper cell differentiation ","Q5TC82"]
["GO:2000628","biological_process","regulation of miRNA metabolic process ","Q5TC82; Q92945; Q9NRR4"]
["GO:0061470","biological_process","T follicular helper cell differentiation ","Q5TC82"]
["GO:0046649","biological_process","lymphocyte activation ","Q13291"]
["GO:0002277","biological_process","myeloid dendritic cell activation involved in immune response ","Q13291; Q9ULZ3"]
["GO:2000349","biological_process","negative regulation of CD signaling pathway ","Q13291"]
["GO:0006106","biological_process","fumarate metabolic process ","P07954"]
["GO:0021534","biological_process","cell proliferation in hindbrain ","P21730"]
["GO:0038178","biological_process","complement component C5a signaling pathway ","P21730"]
["GO:0007606","biological_process","sensory perception of chemical stimulus ","P21730"]
["GO:1904764","biological_process","chaperone-mediated autophagy translocation complex disassembly ","P11142"]
["GO:0061741","biological_process","chaperone-mediated protein transport involved in chaperone-mediated autophagy ","P11142"]
["GO:1902904","biological_process","negative regulation of supramolecular fiber organization ","P11142"]
["GO:1904589","biological_process","regulation of protein import ","P11142"]
["GO:0048211","biological_process","olgi vesicle docking ","O60763"]
["GO:0099074","biological_process","mitochondrion to lysosome transport ","Q9BXM7; O60260"]
["GO:1903147","biological_process","negative regulation of autophagy of mitochondrion ","Q9BXM7"]
["GO:1903852","biological_process","positive regulation of cristae formation ","Q9BXM7"]
["GO:1904544","biological_process","positive regulation of free ubiquitin chain polymerization ","Q9BXM7"]
["GO:1900407","biological_process","regulation of cellular response to oxidative stress ","Q9BXM7; O60260"]
["GO:0002082","biological_process","regulation of oxidative phosphorylation ","Q9BXM7; Q04656"]
["GO:0006826","biological_process","iron ion transport ","P48200"]
["GO:0006782","biological_process","protoporphyrinogen IX biosynthetic process ","P48200"]
["GO:0006122","biological_process","mitochondrial electron transport, ubiquinol to cytochrome c ","P99999; P51608"]
["GO:0006685","biological_process","sphingomyelin catabolic process ","P17405"]
["GO:0006684","biological_process","sphingomyelin metabolic process ","P17405"]
["GO:0060352","biological_process","cell adhesion molecule production ","Q9H4A6"]
["GO:0010467","biological_process","gene expression ","Q9H4A6; Q9NPH5; O43561"]
["GO:0009101","biological_process","glycoprotein biosynthetic process ","Q9H4A6"]
["GO:1901843","biological_process","positive regulation of high voltage-gated calcium channel activity ","Q92915; Q08289"]
["GO:0060078","biological_process","regulation of postsynaptic membrane potential ","Q92915"]
["GO:0043588","biological_process","skin development ","P16144; Q9UMX1; P98161; P21817; Q04656"]
["GO:0048792","biological_process","spontaneous exocytosis of neurotransmitter ","Q8IV01"]
["GO:0035037","biological_process","sperm entry ","Q05086"]
["GO:0051638","biological_process","barbed-end actin filament uncapping ","Q5VZK9"]
["GO:2000813","biological_process","negative regulation of barbed-end actin filament capping ","Q5VZK9"]
["GO:1902745","biological_process","positive regulation of lamellipodium organization ","Q5VZK9"]
["GO:0071034","biological_process","CUT catabolic process ","Q9NQT5"]
["GO:0045006","biological_process","DNA deamination ","Q9NQT5; Q9NQT4"]
["GO:0071049","biological_process","nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription ","Q9NQT5"]
["GO:1905663","biological_process","positive regulation of telomerase RNA reverse transcriptase activity ","P22626; Q14103"]
["GO:0050658","biological_process","RNA transport ","P22626"]
["GO:0051086","biological_process","chaperone mediated protein folding independent of cofactor ","P78371"]
["GO:0006285","biological_process","base-excision repair, AP site formation ","Q13569"]
["GO:0035511","biological_process","oxidative DNA demethylation ","Q13569"]
["GO:1902544","biological_process","regulation of DNA N-glycosylase activity ","Q13569"]
["GO:1904017","biological_process","cellular response to Thyroglobulin triiodothyronine ","Q15788; Q15596"]
["GO:0060713","biological_process","labyrinthine layer morphogenesis ","Q15788"]
["GO:0000435","biological_process","positive regulation of transcription from RNA polymerase II promoter by galactose ","Q15788"]
["GO:2001038","biological_process","regulation of cellular response to drug ","Q15788; P52926"]
["GO:0060323","biological_process","head morphogenesis ","Q9BWW4"]
["GO:0021547","biological_process","midbrain-hindbrain boundary initiation ","Q9BWW4"]
["GO:2000744","biological_process","positive regulation of anterior head development ","Q9BWW4"]
["GO:0021501","biological_process","prechordal plate formation ","Q9BWW4"]
["GO:0034763","biological_process","negative regulation of transmembrane transport ","Q9P2B4"]
["GO:0014051","biological_process","gamma-aminobutyric acid secretion ","Q02410"]
["GO:1902732","biological_process","positive regulation of chondrocyte proliferation ","Q8N6T7"]
["GO:0031940","biological_process","positive regulation of chromatin silencing at telomere ","Q8N6T7"]
["GO:1905549","biological_process","positive regulation of telomeric heterochromatin assembly ","Q8N6T7"]
["GO:0003247","biological_process","post-embryonic cardiac muscle cell growth involved in heart morphogenesis ","Q8N6T7"]
["GO:1902410","biological_process","mitotic cytokinetic process ","Q8N137"]
["GO:0045590","biological_process","negative regulation of regulatory T cell differentiation ","P10914; P16410"]
["GO:0051450","biological_process","myoblast proliferation ","P07203"]
["GO:0002862","biological_process","negative regulation of inflammatory response to antigenic stimulus ","P07203"]
["GO:1902905","biological_process","positive regulation of supramolecular fiber organization ","P07203"]
["GO:0018158","biological_process","protein oxidation ","P07203"]
["GO:0009609","biological_process","response to symbiotic bacterium ","P07203"]
["GO:1901227","biological_process","negative regulation of transcription from RNA polymerase II promoter involved in heart development ","Q13765"]
["GO:2000138","biological_process","positive regulation of cell proliferation involved in heart morphogenesis ","Q13765; Q06330; P48436"]
["GO:1901228","biological_process","positive regulation of transcription from RNA polymerase II promoter involved in heart development ","Q13765"]
["GO:0043947","biological_process","positive regulation by host of symbiont catalytic activity ","Q9Y2Z0"]
["GO:0021836","biological_process","chemorepulsion involved in postnatal olfactory bulb interneuron migration ","Q9Y6N7"]
["GO:0003272","biological_process","endocardial cushion formation ","Q9Y6N7; P36894; Q9UMR3"]
["GO:0070100","biological_process","negative regulation of chemokine-mediated signaling pathway ","Q9Y6N7"]
["GO:0050925","biological_process","negative regulation of negative chemotaxis ","Q9Y6N7"]
["GO:0035481","biological_process","positive regulation of Notch signaling pathway involved in heart induction ","Q9Y6N7"]
["GO:1900748","biological_process","positive regulation of vascular endothelial growth factor signaling pathway ","Q9Y6N7"]
["GO:0032342","biological_process","aldosterone biosynthetic process ","O95180"]
["GO:0034651","biological_process","cortisol biosynthetic process ","O95180"]
["GO:0003167","biological_process","atrioventricular bundle cell differentiation ","O15119"]
["GO:0046884","biological_process","follicle-stimulating hormone secretion ","O15119"]
["GO:0021761","biological_process","limbic system development ","O15119"]
["GO:0060596","biological_process","mammary placode formation ","O15119"]
["GO:0048332","biological_process","mesoderm morphogenesis ","O15119"]
["GO:0060931","biological_process","sinoatrial node cell development ","O15119"]
["GO:0010159","biological_process","specification of animal organ position ","O15119"]
["GO:0090207","biological_process","regulation of triglyceride metabolic process ","Q9BZK7"]
["GO:0006574","biological_process","valine catabolic process ","P31937"]
["GO:0071219","biological_process","cellular response to molecule of bacterial origin ","P31994; Q8IXJ6"]
["GO:0002266","biological_process","follicular dendritic cell activation ","P31994"]
["GO:0002436","biological_process","immune complex clearance by monocytes and macrophages ","P31994"]
["GO:0002313","biological_process","mature B cell differentiation involved in immune response ","P31994"]
["GO:0002865","biological_process","negative regulation of acute inflammatory response to antigenic stimulus ","P31994"]
["GO:0001814","biological_process","negative regulation of antibody-dependent cellular cytotoxicity ","P31994"]
["GO:0050869","biological_process","negative regulation of B cell activation ","P31994"]
["GO:0002605","biological_process","negative regulation of dendritic cell antigen processing and presentation ","P31994"]
["GO:2001199","biological_process","negative regulation of dendritic cell differentiation ","P31994"]
["GO:0002924","biological_process","negative regulation of humoral immune response mediated by circulating immunoglobulin ","P31994; P29350"]
["GO:1902564","biological_process","negative regulation of neutrophil activation ","P31994"]
["GO:0001811","biological_process","negative regulation of type I hypersensitivity ","P31994"]
["GO:0002622","biological_process","regulation of B cell antigen processing and presentation ","P31994"]
["GO:0090264","biological_process","regulation of immune complex clearance by monocytes and macrophages ","P31994"]
["GO:0019919","biological_process","peptidyl-arginine methylation, to asymmetrical-dimethyl arginine ","Q96LA8; Q9NR22"]
["GO:0019724","biological_process","B cell mediated immunity ","P43246"]
["GO:0006311","biological_process","meiotic gene conversion ","P43246"]
["GO:0045128","biological_process","negative regulation of reciprocal meiotic recombination ","P43246"]
["GO:1901340","biological_process","negative regulation of store-operated calcium channel activity ","Q9UMX0"]
["GO:0034140","biological_process","negative regulation of toll-like receptor  signaling pathway ","Q9UMX0"]
["GO:1902175","biological_process","regulation of oxidative stress-induced intrinsic apoptotic signaling pathway ","Q9UMX0"]
["GO:0045872","biological_process","positive regulation of rhodopsin gene expression ","P54845"]
["GO:0007468","biological_process","regulation of rhodopsin gene expression ","P54845"]
["GO:2000616","biological_process","negative regulation of histone H3-K9 acetylation ","Q9BY41"]
["GO:0042335","biological_process","cuticle development ","Q9NRD9"]
["GO:0006590","biological_process","thyroid hormone generation ","Q9NRD9; Q15648"]
["GO:0046104","biological_process","thymidine metabolic process ","P04183"]
["GO:1903966","biological_process","monounsaturated fatty acid biosynthetic process ","O00767"]
["GO:0006636","biological_process","unsaturated fatty acid biosynthetic process ","O00767"]
["GO:0030575","biological_process","nuclear body organization ","Q15637"]
["GO:1904293","biological_process","negative regulation of ERAD pathway ","Q9UHP3; Q04323"]
["GO:0051873","biological_process","killing by host of symbiont cells ","P04406"]
["GO:0035606","biological_process","peptidyl-cysteine S-trans-nitrosylation ","P04406; P06702"]
["GO:0052501","biological_process","positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction ","P04406"]
["GO:1901350","biological_process","cell-cell signaling involved in cell-cell junction organization ","Q07157"]
["GO:0031947","biological_process","negative regulation of glucocorticoid biosynthetic process ","P05023"]
["GO:0045989","biological_process","positive regulation of striated muscle contraction ","P05023"]
["GO:1902303","biological_process","negative regulation of potassium ion export ","Q12809"]
["GO:1900082","biological_process","negative regulation of arginine catabolic process ","P23634"]
["GO:1903249","biological_process","negative regulation of citrulline biosynthetic process ","P23634"]
["GO:0010751","biological_process","negative regulation of nitric oxide mediated signal transduction ","P23634"]
["GO:1902083","biological_process","negative regulation of peptidyl-cysteine S-nitrosylation ","P23634; Q13424"]
["GO:0098736","biological_process","negative regulation of the force of heart contraction ","P23634"]
["GO:1902806","biological_process","regulation of cell cycle /S phase transition ","P23634; Q969H0"]
["GO:1990442","biological_process","intrinsic apoptotic signaling pathway in response to nitrosative stress ","P35638"]
["GO:2000016","biological_process","negative regulation of determination of dorsal identity ","P35638"]
["GO:0044324","biological_process","regulation of transcription involved in anterior/posterior axis specification ","P35638"]
["GO:1990180","biological_process","mitochondrial tRNA 3'-end processing ","Q99714"]
["GO:0097745","biological_process","mitochondrial tRNA '-end processing ","Q99714"]
["GO:0070901","biological_process","mitochondrial tRNA methylation ","Q99714"]
["GO:0090646","biological_process","mitochondrial tRNA processing ","Q99714"]
["GO:0003413","biological_process","chondrocyte differentiation involved in endochondral bone morphogenesis ","Q9Y2T1; P48436"]
["GO:0001957","biological_process","intramembranous ossification ","Q9Y2T1; P08253"]
["GO:0061181","biological_process","regulation of chondrocyte development ","Q9Y2T1"]
["GO:0032423","biological_process","regulation of mismatch repair ","Q9Y2T1"]
["GO:0046168","biological_process","glycerol-3-phosphate catabolic process ","Q8N335"]
["GO:0090038","biological_process","negative regulation of protein kinase C signaling ","Q8N335"]
["GO:1905188","biological_process","positive regulation of metaphase/anaphase transition of meiosis I ","Q8TD08"]
["GO:1904491","biological_process","protein localization to ciliary transition zone ","Q8TD08"]
["GO:0003400","biological_process","regulation of CPII vesicle coating ","Q8TD08"]
["GO:0051148","biological_process","negative regulation of muscle cell differentiation ","P26599"]
["GO:0033119","biological_process","negative regulation of RNA splicing ","P26599"]
["GO:0006820","biological_process","anion transport ","P02730; P21796"]
["GO:0071461","biological_process","cellular response to redox state ","P52566"]
["GO:1901164","biological_process","negative regulation of trophoblast cell migration ","P52566"]
["GO:1900116","biological_process","extracellular negative regulation of signal transduction ","P30533"]
["GO:0010916","biological_process","negative regulation of very-low-density lipoprotein particle clearance ","P30533"]
["GO:0048259","biological_process","regulation of receptor-mediated endocytosis ","P30533"]
["GO:0002385","biological_process","mucosal immune response ","Q6GQQ9"]
["GO:0071947","biological_process","protein deubiquitination involved in ubiquitin-dependent protein catabolic process ","Q6GQQ9"]
["GO:0016126","biological_process","sterol biosynthetic process ","Q14739"]
["GO:0001682","biological_process","tRNA 5'-leader removal ","O75817; O95707; P05455"]
["GO:0071881","biological_process","adenylate cyclase-inhibiting adrenergic receptor signaling pathway ","P08913"]
["GO:0032811","biological_process","negative regulation of epinephrine secretion ","P08913"]
["GO:0071882","biological_process","phospholipase C-activating adrenergic receptor signaling pathway ","P08913"]
["GO:1904586","biological_process","cellular response to putrescine ","Q14103"]
["GO:1990828","biological_process","hepatocyte dedifferentiation ","Q14103"]
["GO:1901355","biological_process","response to rapamycin ","Q14103"]
["GO:0051036","biological_process","regulation of endosome size ","P20339"]
["GO:0008343","biological_process","adult feeding behavior ","Q9UBU3"]
["GO:0043400","biological_process","cortisol secretion ","Q9UBU3"]
["GO:0001696","biological_process","gastric acid secretion ","Q9UBU3"]
["GO:0042322","biological_process","negative regulation of circadian sleep/wake cycle, REM sleep ","Q9UBU3"]
["GO:0040013","biological_process","negative regulation of locomotion ","Q9UBU3"]
["GO:0032100","biological_process","positive regulation of appetite ","Q9UBU3; P35372"]
["GO:1903012","biological_process","positive regulation of bone development ","Q9UBU3"]
["GO:0046010","biological_process","positive regulation of circadian sleep/wake cycle, non-REM sleep ","Q9UBU3"]
["GO:0051461","biological_process","positive regulation of corticotropin secretion ","Q9UBU3"]
["GO:0051464","biological_process","positive regulation of cortisol secretion ","Q9UBU3"]
["GO:1904346","biological_process","positive regulation of gastric mucosal blood circulation ","Q9UBU3"]
["GO:0040010","biological_process","positive regulation of growth rate ","Q9UBU3"]
["GO:0120058","biological_process","positive regulation of small intestinal transit ","Q9UBU3"]
["GO:1905333","biological_process","regulation of gastric motility ","Q9UBU3"]
["GO:0051969","biological_process","regulation of transmission of nerve impulse ","Q9UBU3"]
["GO:0072719","biological_process","cellular response to cisplatin ","P09601"]
["GO:0006788","biological_process","heme oxidation ","P09601"]
["GO:1904036","biological_process","negative regulation of epithelial cell apoptotic process ","P09601"]
["GO:0002686","biological_process","negative regulation of leukocyte migration ","P09601"]
["GO:0034395","biological_process","regulation of transcription from RNA polymerase II promoter in response to iron ","P09601"]
["GO:0002246","biological_process","wound healing involved in inflammatory response ","P09601"]
["GO:0034146","biological_process","toll-like receptor 5 signaling pathway ","O60602"]
["GO:0061763","biological_process","multivesicular body-lysosome fusion ","Q9Y3E7"]
["GO:0051102","biological_process","DNA ligation involved in DNA recombination ","P49917"]
["GO:2001252","biological_process","positive regulation of chromosome organization ","P49917"]
["GO:0060842","biological_process","arterial endothelial cell differentiation ","P46531"]
["GO:0003162","biological_process","atrioventricular node development ","P46531"]
["GO:0009912","biological_process","auditory receptor cell fate commitment ","P46531; Q06330"]
["GO:0003207","biological_process","cardiac chamber formation ","P46531; Q9UMR3"]
["GO:0003213","biological_process","cardiac right atrium morphogenesis ","P46531"]
["GO:0060948","biological_process","cardiac vascular smooth muscle cell development ","P46531"]
["GO:0021515","biological_process","cell differentiation in spinal cord ","P46531"]
["GO:0072044","biological_process","collecting duct development ","P46531"]
["GO:0007386","biological_process","compartment pattern specification ","P46531"]
["GO:0003182","biological_process","coronary sinus valve morphogenesis ","P46531"]
["GO:0003169","biological_process","coronary vein morphogenesis ","P46531"]
["GO:0072017","biological_process","distal tubule development ","P46531"]
["GO:0003160","biological_process","endocardium morphogenesis ","P46531; Q06330"]
["GO:0007440","biological_process","foregut morphogenesis ","P46531"]
["GO:0003241","biological_process","growth involved in heart morphogenesis ","P46531"]
["GO:0003192","biological_process","mitral valve formation ","P46531"]
["GO:2001027","biological_process","negative regulation of endothelial cell chemotaxis ","P46531"]
["GO:0045967","biological_process","negative regulation of growth rate ","P46531"]
["GO:0046533","biological_process","negative regulation of photoreceptor cell differentiation ","P46531; P48436"]
["GO:0061314","biological_process","Notch signaling involved in heart development ","P46531; O95863; Q06330"]
["GO:0003270","biological_process","Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation ","P46531"]
["GO:1903849","biological_process","positive regulation of aorta morphogenesis ","P46531"]
["GO:0062043","biological_process","positive regulation of cardiac epithelial to mesenchymal transition ","P46531"]
["GO:0045603","biological_process","positive regulation of endothelial cell differentiation ","P46531; P22004; P37023; P62324"]
["GO:0060768","biological_process","regulation of epithelial cell proliferation involved in prostate gland development ","P46531"]
["GO:0003256","biological_process","regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation ","P46531; Q06330"]
["GO:0060843","biological_process","venous endothelial cell differentiation ","P46531"]
["GO:0070925","biological_process","organelle assembly ","Q9H8Y8"]
["GO:0070828","biological_process","heterochromatin organization ","O95863"]
["GO:0060806","biological_process","negative regulation of cell differentiation involved in embryonic placenta development ","O95863"]
["GO:0072321","biological_process","chaperone-mediated protein transport ","P40855"]
["GO:0072663","biological_process","establishment of protein localization to peroxisome ","P40855"]
["GO:1900131","biological_process","negative regulation of lipid binding ","P40855"]
["GO:0016557","biological_process","peroxisome membrane biogenesis ","P40855"]
["GO:0007031","biological_process","peroxisome organization ","P40855"]
["GO:0050960","biological_process","detection of temperature stimulus involved in thermoception ","Q8NER1"]
["GO:0001660","biological_process","fever generation ","Q8NER1"]
["GO:0090212","biological_process","negative regulation of establishment of blood-brain barrier ","Q8NER1"]
["GO:0002790","biological_process","peptide secretion ","Q8NER1"]
["GO:1901594","biological_process","response to capsazepine ","Q8NER1"]
["GO:0050954","biological_process","sensory perception of mechanical stimulus ","Q8NER1"]
["GO:0051293","biological_process","establishment of spindle localization ","Q14204"]
["GO:0072382","biological_process","minus-end-directed vesicle transport along microtubule ","Q14204"]
["GO:0019695","biological_process","choline metabolic process ","P35790"]
["GO:0006580","biological_process","ethanolamine metabolic process ","P35790"]
["GO:1904681","biological_process","response to 3-methylcholanthrene ","P35790"]
["GO:0001928","biological_process","regulation of exocyst assembly ","P11234"]
["GO:0060178","biological_process","regulation of exocyst localization ","P11234"]
["GO:0006051","biological_process","N-acetylmannosamine metabolic process ","Q9UJ70"]
["GO:0019262","biological_process","N-acetylneuraminate catabolic process ","Q9UJ70"]
["GO:1904395","biological_process","positive regulation of skeletal muscle acetylcholine-gated channel clustering ","O75096"]
["GO:0044332","biological_process","Wnt signaling pathway involved in dorsal/ventral axis specification ","O75096"]
["GO:0071281","biological_process","cellular response to iron ion ","P22004; P05549; Q04656"]
["GO:0060586","biological_process","multicellular organismal iron ion homeostasis ","P22004"]
["GO:0032349","biological_process","positive regulation of aldosterone biosynthetic process ","P22004"]
["GO:2000860","biological_process","positive regulation of aldosterone secretion ","P22004"]
["GO:0006253","biological_process","dCTP catabolic process ","Q9H773"]
["GO:0072718","biological_process","response to cisplatin ","Q7LBC6"]
["GO:0006066","biological_process","alcohol metabolic process ","P05091"]
["GO:0006068","biological_process","ethanol catabolic process ","P05091"]
["GO:0006069","biological_process","ethanol oxidation ","P05091; Q9NR19"]
["GO:0002176","biological_process","male germ cell proliferation ","P20042"]
["GO:0050819","biological_process","negative regulation of coagulation ","P08758"]
["GO:0006891","biological_process","intra-olgi vesicle-mediated transport ","Q08378"]
["GO:1904693","biological_process","midbrain morphogenesis ","Q07889"]
["GO:2000973","biological_process","regulation of pro-B cell differentiation ","Q07889"]
["GO:0006172","biological_process","ADP biosynthetic process ","P54819"]
["GO:0046033","biological_process","AMP metabolic process ","P54819"]
["GO:0002260","biological_process","lymphocyte homeostasis ","O43561"]
["GO:0016340","biological_process","calcium-dependent cell-matrix adhesion ","Q14118; Q96QT4"]
["GO:0021682","biological_process","nerve maturation ","Q14118"]
["GO:0098942","biological_process","retrograde trans-synaptic signaling by trans-synaptic protein complex ","Q14118; Q8N2Q7"]
["GO:0022615","biological_process","protein to membrane docking ","O00186"]
["GO:2000582","biological_process","positive regulation of ATP-dependent microtubule motor activity, plus-end-directed ","P63167; Q13409"]
["GO:1904588","biological_process","cellular response to glycoprotein ","P16473"]
["GO:1905229","biological_process","cellular response to thyrotropin-releasing hormone ","P16473"]
["GO:0038194","biological_process","thyroid-stimulating hormone signaling pathway ","P16473"]
["GO:0038043","biological_process","interleukin-5-mediated signaling pathway ","P32927"]
["GO:0033540","biological_process","fatty acid beta-oxidation using acyl-CoA oxidase ","P22307"]
["GO:1901373","biological_process","lipid hydroperoxide transport ","P22307"]
["GO:0032385","biological_process","positive regulation of intracellular cholesterol transport ","P22307"]
["GO:0045940","biological_process","positive regulation of steroid metabolic process ","P22307"]
["GO:0034402","biological_process","recruitment of '-end processing factors to RNA polymerase II holoenzyme complex ","Q6P1J9"]
["GO:0051456","biological_process","attachment of spindle microtubules to kinetochore involved in meiotic sister chromatid segregation ","Q9H410"]
["GO:0001787","biological_process","natural killer cell proliferation ","Q99607"]
["GO:0001866","biological_process","NK T cell proliferation ","Q99607"]
["GO:0015810","biological_process","aspartate transmembrane transport ","P48664"]
["GO:0032971","biological_process","regulation of muscle filament sliding ","Q9H1R3; Q14896"]
["GO:0014816","biological_process","skeletal muscle satellite cell differentiation ","Q9H1R3; Q96KG7"]
["GO:0015961","biological_process","diadenosine polyphosphate catabolic process ","O95989"]
["GO:0071544","biological_process","diphosphoinositol polyphosphate catabolic process ","O95989"]
["GO:0001936","biological_process","regulation of endothelial cell proliferation ","P37023"]
["GO:0045990","biological_process","carbon catabolite regulation of transcription ","P22415"]
["GO:0008594","biological_process","photoreceptor cell morphogenesis ","P57796"]
["GO:0060040","biological_process","retinal bipolar neuron differentiation ","P57796"]
["GO:0098868","biological_process","bone growth ","P48357"]
["GO:0035194","biological_process","posttranscriptional gene silencing by RNA ","Q9UPQ9; Q9UKV8"]
["GO:0019941","biological_process","modification-dependent protein catabolic process ","Q96EP1"]
["GO:0009448","biological_process","gamma-aminobutyric acid metabolic process ","O43175"]
["GO:0021782","biological_process","glial cell development ","O43175; Q9NRD5"]
["GO:0006544","biological_process","glycine metabolic process ","O43175"]
["GO:0006564","biological_process","L-serine biosynthetic process ","O43175"]
["GO:0006566","biological_process","threonine metabolic process ","O43175"]
["GO:2000645","biological_process","negative regulation of receptor catabolic process ","Q13614"]
["GO:0060304","biological_process","regulation of phosphatidylinositol dephosphorylation ","Q13614"]
["GO:0032509","biological_process","endosome transport via multivesicular body sorting pathway ","Q99523"]
["GO:0051005","biological_process","negative regulation of lipoprotein lipase activity ","Q99523"]
["GO:0055070","biological_process","copper ion homeostasis ","P98170"]
["GO:1902530","biological_process","positive regulation of protein linear polyubiquitination ","P98170; O60260"]
["GO:0030510","biological_process","regulation of BMP signaling pathway ","P98170"]
["GO:0070424","biological_process","regulation of nucleotide-binding oligomerization domain containing signaling pathway ","P98170"]
["GO:0014050","biological_process","negative regulation of glutamate secretion ","Q14831"]
["GO:0006382","biological_process","adenosine to inosine editing ","Q86U44"]
["GO:0098508","biological_process","endothelial to hematopoietic transition ","Q86U44"]
["GO:1990744","biological_process","primary miRNA methylation ","Q86U44"]
["GO:0001510","biological_process","RNA methylation ","Q86U44; Q7L2J0"]
["GO:0071426","biological_process","ribonucleoprotein complex export from nucleus ","P37198"]
["GO:0042180","biological_process","cellular ketone metabolic process ","P20813; P30419"]
["GO:0019373","biological_process","epoxygenase P45 pathway ","P20813"]
["GO:1901726","biological_process","negative regulation of histone deacetylase activity ","P29375"]
["GO:0035106","biological_process","operant conditioning ","P21728"]
["GO:0046960","biological_process","sensitization ","P21728"]
["GO:0006323","biological_process","DNA packaging ","Q92794"]
["GO:0070286","biological_process","axonemal dynein complex assembly ","Q4G0X9"]
["GO:0003341","biological_process","cilium movement ","Q4G0X9"]
["GO:0071907","biological_process","determination of digestive tract left/right asymmetry ","Q4G0X9"]
["GO:0035469","biological_process","determination of pancreatic left/right asymmetry ","Q4G0X9"]
["GO:0060287","biological_process","epithelial cilium movement involved in determination of left/right asymmetry ","Q4G0X9"]
["GO:0036159","biological_process","inner dynein arm assembly ","Q4G0X9"]
["GO:0003356","biological_process","regulation of cilium beat frequency ","Q4G0X9"]
["GO:0050976","biological_process","detection of mechanical stimulus involved in sensory perception of touch ","Q09470"]
["GO:1903818","biological_process","positive regulation of voltage-gated potassium channel activity ","Q09470"]
["GO:0042843","biological_process","D-xylose catabolic process ","Q9UQ10"]
["GO:0045039","biological_process","protein import into mitochondrial inner membrane ","Q9P0J0"]
["GO:1902742","biological_process","apoptotic process involved in development ","Q96KG7"]
["GO:0043652","biological_process","engulfment of apoptotic cell ","Q96KG7; Q14457"]
["GO:0033002","biological_process","muscle cell proliferation ","Q96KG7"]
["GO:0048641","biological_process","regulation of skeletal muscle tissue development ","Q96KG7"]
["GO:0014841","biological_process","skeletal muscle satellite cell proliferation ","Q96KG7"]
["GO:0098963","biological_process","dendritic transport of messenger ribonucleoprotein complex ","P23246; Q00839"]
["GO:0021526","biological_process","medial motor column neuron differentiation ","Q9UBR4"]
["GO:0021521","biological_process","ventral spinal cord interneuron specification ","Q9UBR4"]
["GO:0001672","biological_process","regulation of chromatin assembly or disassembly ","Q86UE8; Q9UKI8"]
["GO:0035821","biological_process","modification of morphology or physiology of other organism ","P06702"]
["GO:0070488","biological_process","neutrophil aggregation ","P06702"]
["GO:0002793","biological_process","positive regulation of peptide secretion ","P06702"]
["GO:0045113","biological_process","regulation of integrin biosynthetic process ","P06702"]
["GO:0032119","biological_process","sequestering of zinc ion ","P06702"]
["GO:0072579","biological_process","glycine receptor clustering ","Q9NQX3"]
["GO:0018315","biological_process","molybdenum incorporation into molybdenum-molybdopterin complex ","Q9NQX3"]
["GO:0032324","biological_process","molybdopterin cofactor biosynthetic process ","Q9NQX3"]
["GO:0006777","biological_process","Mo-molybdopterin cofactor biosynthetic process ","Q9NQX3"]
["GO:0060989","biological_process","lipid tube assembly involved in organelle fusion ","Q9Y5H0"]
["GO:0000469","biological_process","cleavage involved in rRNA processing ","Q9ULX3"]
["GO:0000492","biological_process","box C/D snoRNP assembly ","Q9Y230; Q9Y265"]
["GO:1990592","biological_process","protein K6-linked ufmylation ","O94874"]
["GO:0071569","biological_process","protein ufmylation ","O94874"]
["GO:0051232","biological_process","meiotic spindle elongation ","P30153"]
["GO:1903538","biological_process","regulation of meiotic cell cycle process involved in oocyte maturation ","P30153"]
["GO:0010835","biological_process","regulation of protein ADP-ribosylation ","Q9H2P0"]
["GO:0035518","biological_process","histone H2A monoubiquitination ","Q16531"]
["GO:0046726","biological_process","positive regulation by virus of viral protein levels in host cell ","Q16531"]
["GO:0003069","biological_process","acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure ","P04179"]
["GO:0001315","biological_process","age-dependent response to reactive oxygen species ","P04179"]
["GO:1905932","biological_process","positive regulation of vascular smooth muscle cell differentiation involved in phenotypic switching ","P04179"]
["GO:0098700","biological_process","neurotransmitter loading into synaptic vesicle ","Q05940"]
["GO:0042137","biological_process","sequestering of neurotransmitter ","Q05940"]
["GO:0016073","biological_process","snRNA metabolic process ","Q7L2J0"]
["GO:0040031","biological_process","snRNA modification ","Q7L2J0"]
["GO:0071650","biological_process","negative regulation of chemokine (C-C motif) ligand  production ","Q86XR7"]
["GO:2000494","biological_process","positive regulation of interleukin-18-mediated signaling pathway ","Q86XR7"]
["GO:0045368","biological_process","positive regulation of interleukin-1 biosynthetic process ","Q15306"]
["GO:0045404","biological_process","positive regulation of interleukin- biosynthetic process ","Q15306"]
["GO:0045622","biological_process","regulation of T-helper cell differentiation ","Q15306"]
["GO:0007624","biological_process","ultradian rhythm ","Q16206"]
["GO:0034641","biological_process","cellular nitrogen compound metabolic process ","Q14749"]
["GO:0006555","biological_process","methionine metabolic process ","Q14749; P42898"]
["GO:0046500","biological_process","S-adenosylmethionine metabolic process ","Q14749; P42898"]
["GO:0002588","biological_process","positive regulation of antigen processing and presentation of peptide antigen via MHC class II ","Q9ULZ3"]
["GO:2000484","biological_process","positive regulation of interleukin- secretion ","Q9ULZ3"]
["GO:0007028","biological_process","cytoplasm organization ","Q9NYV6; P33176"]
["GO:2000142","biological_process","regulation of DNA-templated transcription, initiation ","Q9NYV6"]
["GO:0030001","biological_process","metal ion transport ","Q9NV92"]
["GO:0051224","biological_process","negative regulation of protein transport ","Q9NV92"]
["GO:0007034","biological_process","vacuolar transport ","Q9NV92; Q96CF2"]
["GO:0051598","biological_process","meiotic recombination checkpoint ","O60671"]
["GO:0051649","biological_process","establishment of localization in cell ","Q16478"]
["GO:0007023","biological_process","post-chaperonin tubulin folding pathway ","Q15813"]
["GO:0036124","biological_process","histone H-K9 trimethylation ","P29374"]
["GO:0034773","biological_process","histone H-K2 trimethylation ","P29374"]
["GO:0070475","biological_process","rRNA base methylation ","P46087"]
["GO:0050760","biological_process","negative regulation of thymidylate synthase biosynthetic process ","O00213"]
["GO:0044839","biological_process","cell cycle 2/M phase transition ","O43823"]
["GO:0033127","biological_process","regulation of histone phosphorylation ","O43823"]
["GO:1905183","biological_process","negative regulation of protein serine/threonine phosphatase activity ","Q9NXH3"]
["GO:0090218","biological_process","positive regulation of lipid kinase activity ","Q05639"]
["GO:0032802","biological_process","low-density lipoprotein particle receptor catabolic process ","Q96CW1; P09496; P63010; Q00610"]
["GO:0097494","biological_process","regulation of vesicle size ","Q96CW1"]
["GO:0010922","biological_process","positive regulation of phosphatase activity ","Q9Y572"]
["GO:0046006","biological_process","regulation of activated T cell proliferation ","Q9Y572"]
["GO:0070235","biological_process","regulation of activation-induced cell death of T cells ","Q9Y572"]
["GO:2000452","biological_process","regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation ","Q9Y572"]
["GO:0001914","biological_process","regulation of T cell mediated cytotoxicity ","Q9Y572; Q15109"]
["GO:0030242","biological_process","autophagy of peroxisome ","Q8NEB9"]
["GO:0021979","biological_process","hypothalamus cell differentiation ","P20265"]
["GO:0021985","biological_process","neurohypophysis development ","P20265"]
["GO:0003056","biological_process","regulation of vascular smooth muscle contraction ","P20309"]
["GO:0006538","biological_process","glutamate catabolic process ","Q99259; P00367"]
["GO:0018352","biological_process","protein-pyridoxal--phosphate linkage ","Q99259"]
["GO:0021808","biological_process","cytosolic calcium signaling involved in initiation of cell movement in glial-mediated radial cell migration ","Q9H244"]
["GO:0033626","biological_process","positive regulation of integrin activation by cell surface receptor linked signal transduction ","Q9H244"]
["GO:0043270","biological_process","positive regulation of ion transport ","Q9H244"]
["GO:1904141","biological_process","positive regulation of microglial cell migration ","Q9H244"]
["GO:1904139","biological_process","regulation of microglial cell migration ","Q9H244"]
["GO:0002363","biological_process","alpha-beta T cell lineage commitment ","P61586"]
["GO:0001998","biological_process","angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure ","P61586"]
["GO:0097498","biological_process","endothelial tube lumen extension ","P61586"]
["GO:1903673","biological_process","mitotic cleavage furrow formation ","P61586"]
["GO:0033144","biological_process","negative regulation of intracellular steroid hormone receptor signaling pathway ","P61586"]
["GO:0060193","biological_process","positive regulation of lipase activity ","P61586"]
["GO:1904695","biological_process","positive regulation of vascular smooth muscle contraction ","P61586"]
["GO:1902766","biological_process","skeletal muscle satellite cell migration ","P61586"]
["GO:0061383","biological_process","trabecula morphogenesis ","P61586"]
["GO:0099563","biological_process","modification of synaptic structure ","P60953; O95886"]
["GO:0048664","biological_process","neuron fate determination ","P60953"]
["GO:0072384","biological_process","organelle transport along microtubule ","P60953; Q5T5U3"]
["GO:0060661","biological_process","submandibular salivary gland formation ","P60953"]
["GO:0072350","biological_process","tricarboxylic acid metabolic process ","P00367"]
["GO:0015868","biological_process","purine ribonucleotide transport ","P08034"]
["GO:0046543","biological_process","development of secondary female sexual characteristics ","P51692"]
["GO:0046544","biological_process","development of secondary male sexual characteristics ","P51692"]
["GO:0097531","biological_process","mast cell migration ","P51692"]
["GO:0032819","biological_process","positive regulation of natural killer cell proliferation ","P51692"]
["GO:1903632","biological_process","positive regulation of aminoacyl-tRNA ligase activity ","Q13155"]
["GO:0033262","biological_process","regulation of nuclear cell cycle DNA replication ","Q9BVW5; Q9H211"]
["GO:0043111","biological_process","replication fork arrest ","Q9BVW5"]
["GO:0002543","biological_process","activation of blood coagulation via clotting cascade ","P13726"]
["GO:0002541","biological_process","activation of plasma proteins involved in acute inflammatory response ","P13726"]
["GO:0071415","biological_process","cellular response to purine-containing compound ","O94759"]
["GO:0071577","biological_process","zinc ion transmembrane transport ","O94759"]
["GO:1901623","biological_process","regulation of lymphocyte chemotaxis ","Q6J4K2"]
["GO:0042487","biological_process","regulation of odontogenesis of dentin-containing tooth ","Q13950"]
["GO:0097026","biological_process","dendritic cell dendrite assembly ","Q8NFD5"]
["GO:0051252","biological_process","regulation of RNA metabolic process ","P20936"]
["GO:0060428","biological_process","lung epithelium development ","P98161; Q9UJM3"]
["GO:0036303","biological_process","lymph vessel morphogenesis ","P98161"]
["GO:0072287","biological_process","metanephric distal tubule morphogenesis ","P98161"]
["GO:0072237","biological_process","metanephric proximal tubule development ","P98161"]
["GO:0072383","biological_process","plus-end-directed vesicle transport along microtubule ","Q9Y496; P33176; Q02241"]
["GO:0034398","biological_process","telomere tethering at nuclear periphery ","P52948"]
["GO:0017145","biological_process","stem cell division ","Q9GZV5"]
["GO:2000661","biological_process","positive regulation of interleukin--mediated signaling pathway ","P14778"]
["GO:2000556","biological_process","positive regulation of T-helper 1 cell cytokine production ","P14778"]
["GO:1903845","biological_process","negative regulation of cellular response to transforming growth factor beta stimulus ","O15519"]
["GO:1903944","biological_process","negative regulation of hepatocyte apoptotic process ","O15519"]
["GO:1901740","biological_process","negative regulation of myoblast fusion ","O15519"]
["GO:0072126","biological_process","positive regulation of glomerular mesangial cell proliferation ","O15519"]
["GO:0014866","biological_process","skeletal myofibril assembly ","O15519"]
["GO:0043271","biological_process","negative regulation of ion transport ","Q7Z7A4"]
["GO:0035397","biological_process","helper T cell enhancement of adaptive immune response ","P01730"]
["GO:0006948","biological_process","induction by virus of host cell-cell fusion ","P01730"]
["GO:0045058","biological_process","T cell selection ","P01730"]
["GO:0097403","biological_process","cellular response to raffinose ","Q07352"]
["GO:0048382","biological_process","mesendoderm development ","Q07352; P36894"]
["GO:0031086","biological_process","nuclear-transcribed mRNA catabolic process, deadenylation-independent decay ","Q07352; P26651"]
["GO:1904582","biological_process","positive regulation of intracellular mRNA localization ","Q07352; P26651"]
["GO:1902172","biological_process","regulation of keratinocyte apoptotic process ","Q07352; P26651"]
["GO:0032048","biological_process","cardiolipin metabolic process ","P51608"]
["GO:0031061","biological_process","negative regulation of histone methylation ","P51608"]
["GO:2000820","biological_process","negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation ","P51608"]
["GO:0009405","biological_process","pathogenesis ","P51608"]
["GO:1905643","biological_process","positive regulation of DNA methylation ","P51608"]
["GO:1900114","biological_process","positive regulation of histone H3-K trimethylation ","P51608"]
["GO:0019230","biological_process","proprioception ","P51608"]
["GO:0002087","biological_process","regulation of respiratory gaseous exchange by neurological system process ","P51608; Q8N2Q7"]
["GO:0006669","biological_process","sphinganine-1-phosphate biosynthetic process ","Q9NRA0"]
["GO:0002532","biological_process","production of molecular mediator involved in inflammatory response ","P24394"]
["GO:0051341","biological_process","regulation of oxidoreductase activity ","Q9BQ95"]
["GO:0032933","biological_process","SREBP signaling pathway ","Q9BY44"]
["GO:0010890","biological_process","positive regulation of sequestering of triglyceride ","Q9BXB4"]
["GO:0031052","biological_process","chromosome breakage ","P52926"]
["GO:0031507","biological_process","heterochromatin assembly ","P52926"]
["GO:0035978","biological_process","histone H2A-S1 phosphorylation ","P52926"]
["GO:0003131","biological_process","mesodermal-endodermal cell signaling ","P52926"]
["GO:2000685","biological_process","positive regulation of cellular response to X-ray ","P52926"]
["GO:0032370","biological_process","positive regulation of lipid transport ","Q07954"]
["GO:0032374","biological_process","regulation of cholesterol transport ","Q07954"]
["GO:0032429","biological_process","regulation of phospholipase A activity ","Q07954"]
["GO:1903507","biological_process","negative regulation of nucleic acid-templated transcription ","Q16385"]
["GO:0010961","biological_process","cellular magnesium ion homeostasis ","Q96QT4"]
["GO:0045324","biological_process","late endosome to vacuole transport ","Q8WUX9; Q14457"]
["GO:0035881","biological_process","amacrine cell differentiation ","Q9HD90; Q13562"]
["GO:2000329","biological_process","negative regulation of T-helper 17 cell lineage commitment ","Q9UL17"]
["GO:2000552","biological_process","negative regulation of T-helper  cell cytokine production ","Q9UL17"]
["GO:0061056","biological_process","sclerotome development ","P50221"]
["GO:0001757","biological_process","somite specification ","P50221"]
["GO:1900248","biological_process","negative regulation of cytoplasmic translational elongation ","Q8NE35"]
["GO:0009061","biological_process","anaerobic respiration ","P31040"]
["GO:0006121","biological_process","mitochondrial electron transport, succinate to ubiquinone ","P31040"]
["GO:1905463","biological_process","negative regulation of DNA duplex unwinding ","P11388"]
["GO:0045870","biological_process","positive regulation of single stranded viral RNA replication via double stranded DNA intermediate ","P11388"]
["GO:1905765","biological_process","negative regulation of protection from non-homologous end joining at telomere ","P18887"]
["GO:1904877","biological_process","positive regulation of DNA ligase activity ","P18887"]
["GO:1903518","biological_process","positive regulation of single strand break repair ","P18887; P09874"]
["GO:1990414","biological_process","replication-born double-strand break repair via sister chromatid exchange ","P18887; O94762"]
["GO:0061819","biological_process","telomeric DNA-containing double minutes formation ","P18887"]
["GO:0010936","biological_process","negative regulation of macrophage cytokine production ","Q9H467"]
["GO:0007341","biological_process","penetration of zona pellucida ","Q05952"]
["GO:0035093","biological_process","spermatogenesis, exchange of chromosomal proteins ","Q05952"]
["GO:0031441","biological_process","negative regulation of mRNA '-end processing ","Q99728"]
["GO:0006637","biological_process","acyl-CoA metabolic process ","P07108"]
["GO:1904613","biological_process","cellular response to 2,,7,8-tetrachlorodibenzodioxine ","P35869"]
["GO:0030888","biological_process","regulation of B cell proliferation ","P35869"]
["GO:0031058","biological_process","positive regulation of histone modification ","P61088"]
["GO:0033182","biological_process","regulation of histone ubiquitination ","P61088"]
["GO:0036155","biological_process","acylglycerol acyl-chain remodeling ","Q96AD5"]
["GO:0034389","biological_process","lipid droplet organization ","Q96AD5"]
["GO:0010898","biological_process","positive regulation of triglyceride catabolic process ","Q96AD5"]
["GO:0003365","biological_process","establishment of cell polarity involved in ameboidal cell migration ","Q4VCS5"]
["GO:0036261","biological_process","7-methylguanosine cap hypermethylation ","Q96RS0"]
["GO:0009452","biological_process","7-methylguanosine RNA capping ","Q96RS0"]
["GO:0022613","biological_process","ribonucleoprotein complex biogenesis ","Q96RS0"]
["GO:0036018","biological_process","cellular response to erythropoietin ","P25942"]
["GO:1901652","biological_process","response to peptide ","P25942; P30518; O43613"]
["GO:0009052","biological_process","pentose-phosphate shunt, non-oxidative branch ","P29401"]
["GO:0005999","biological_process","xylulose biosynthetic process ","P29401"]
["GO:2000117","biological_process","negative regulation of cysteine-type endopeptidase activity ","Q16666"]
["GO:0043328","biological_process","protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway ","Q96H20"]
["GO:0010797","biological_process","regulation of multivesicular body size involved in endosome transport ","Q96H20"]
["GO:1903772","biological_process","regulation of viral budding via host ESCRT complex ","Q96H20"]
["GO:0050779","biological_process","RNA destabilization ","P20333"]
["GO:0031128","biological_process","developmental induction ","P43699"]
["GO:0021877","biological_process","forebrain neuron fate commitment ","P43699"]
["GO:0021759","biological_process","globus pallidus development ","P43699"]
["GO:0006386","biological_process","termination of RNA polymerase III transcription ","Q9Y2Y1"]
["GO:0042779","biological_process","tRNA 3'-trailer cleavage ","Q9Y2Y1"]
["GO:0032790","biological_process","ribosome disassembly ","Q9ULC4"]
["GO:0002188","biological_process","translation reinitiation ","Q9ULC4"]
["GO:0006273","biological_process","lagging strand elongation ","P09874"]
["GO:0032042","biological_process","mitochondrial DNA metabolic process ","P09874"]
["GO:2001170","biological_process","negative regulation of ATP biosynthetic process ","P09874"]
["GO:0018312","biological_process","peptidyl-serine ADP-ribosylation ","P09874"]
["GO:1904762","biological_process","positive regulation of myofibroblast differentiation ","P09874"]
["GO:0036211","biological_process","protein modification process ","P09874"]
["GO:1903376","biological_process","regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway ","P09874"]
["GO:0010990","biological_process","regulation of SMAD protein complex assembly ","P09874"]
["GO:0018171","biological_process","peptidyl-cysteine oxidation ","P30048"]
["GO:0051665","biological_process","membrane raft localization ","P11233"]
["GO:0018283","biological_process","iron incorporation into metallo-sulfur cluster ","Q16595"]
["GO:1904234","biological_process","positive regulation of aconitate hydratase activity ","Q16595"]
["GO:0051349","biological_process","positive regulation of lyase activity ","Q16595"]
["GO:1904231","biological_process","positive regulation of succinate dehydrogenase activity ","Q16595"]
["GO:0010722","biological_process","regulation of ferrochelatase activity ","Q16595"]
["GO:1902426","biological_process","deactivation of mitotic spindle assembly checkpoint ","Q9H211"]
["GO:1905341","biological_process","negative regulation of protein localization to kinetochore ","Q9H211"]
["GO:2000105","biological_process","positive regulation of DNA-dependent DNA replication ","Q9H211"]
["GO:2001178","biological_process","positive regulation of mediator complex assembly ","Q9H211"]
["GO:0002032","biological_process","desensitization of -protein coupled receptor protein signaling pathway by arrestin ","P07550; P32121"]
["GO:0061885","biological_process","positive regulation of mini excitatory postsynaptic potential ","P07550"]
["GO:0043379","biological_process","memory T cell differentiation ","Q92574"]
["GO:0006407","biological_process","rRNA export from nucleus ","Q92574"]
["GO:0043000","biological_process","olgi to plasma membrane CFTR protein transport ","P05783"]
["GO:2000191","biological_process","regulation of fatty acid transport ","O75376"]
["GO:0072362","biological_process","regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter ","O75376"]
["GO:0071221","biological_process","cellular response to bacterial lipopeptide ","P58753"]
["GO:0032738","biological_process","positive regulation of interleukin-15 production ","P58753"]
["GO:0035665","biological_process","TIRAP-dependent toll-like receptor 4 signaling pathway ","P58753"]
["GO:0021703","biological_process","locus ceruleus development ","O14813"]
["GO:0021623","biological_process","oculomotor nerve formation ","O14813; P05549"]
["GO:0021523","biological_process","somatic motor neuron differentiation ","O14813"]
["GO:0021642","biological_process","trochlear nerve formation ","O14813"]
["GO:0042093","biological_process","T-helper cell differentiation ","P51449; Q04656"]
["GO:0030576","biological_process","Cajal body organization ","Q9BUR4"]
["GO:1905168","biological_process","positive regulation of double-strand break repair via homologous recombination ","Q9BUR4"]
["GO:1904867","biological_process","protein localization to Cajal body ","Q9BUR4"]
["GO:0034337","biological_process","RNA folding ","Q9BUR4"]
["GO:0090671","biological_process","telomerase RNA localization to Cajal body ","Q9BUR4"]
["GO:0032203","biological_process","telomere formation via telomerase ","Q9BUR4"]
["GO:0060823","biological_process","canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation ","O15169"]
["GO:0021797","biological_process","forebrain anterior/posterior pattern specification ","O15169"]
["GO:0030910","biological_process","olfactory placode formation ","O15169"]
["GO:0001743","biological_process","optic placode formation ","O15169"]
["GO:0021881","biological_process","Wnt-activated signaling pathway involved in forebrain neuron fate commitment ","O15169"]
["GO:1902975","biological_process","mitotic DNA replication initiation ","Q9Y248"]
["GO:0044648","biological_process","histone H3-K dimethylation ","Q03164"]
["GO:1905642","biological_process","negative regulation of DNA methylation ","Q03164"]
["GO:2001040","biological_process","positive regulation of cellular response to drug ","Q03164"]
["GO:0071440","biological_process","regulation of histone H3-K acetylation ","Q03164"]
["GO:1901674","biological_process","regulation of histone H3-K2 acetylation ","Q03164"]
["GO:0035864","biological_process","response to potassium ion ","Q03164"]
["GO:0090128","biological_process","regulation of synapse maturation ","P63104"]
["GO:0008039","biological_process","synaptic target recognition ","P63104"]
["GO:0071103","biological_process","DNA conformation change ","Q03014"]
["GO:0061011","biological_process","hepatic duct development ","Q03014"]
["GO:0061017","biological_process","hepatoblast differentiation ","Q03014"]
["GO:0002573","biological_process","myeloid leukocyte differentiation ","Q03014"]
["GO:0010621","biological_process","negative regulation of transcription by transcription factor localization ","Q03014; P41134"]
["GO:0060431","biological_process","primary lung bud formation ","Q03014"]
["GO:0033387","biological_process","putrescine biosynthetic process from ornithine ","P11926"]
["GO:1905042","biological_process","negative regulation of epithelium regeneration ","Q9Y6W6"]
["GO:0060266","biological_process","negative regulation of respiratory burst involved in inflammatory response ","Q9Y6W6; P39019"]
["GO:0070384","biological_process","Harderian gland development ","P13631; P48436"]
["GO:1900045","biological_process","negative regulation of protein K63-linked ubiquitination ","Q53GL7"]
["GO:0010847","biological_process","regulation of chromatin assembly ","Q53GL7"]
["GO:0055048","biological_process","anastral spindle assembly ","Q14980"]
["GO:1905820","biological_process","positive regulation of chromosome separation ","Q14980"]
["GO:1902846","biological_process","positive regulation of mitotic spindle elongation ","Q14980"]
["GO:1902365","biological_process","positive regulation of protein localization to spindle pole body ","Q14980"]
["GO:2000791","biological_process","negative regulation of mesenchymal cell proliferation involved in lung development ","O94880"]
["GO:2000584","biological_process","negative regulation of platelet-derived growth factor receptor-alpha signaling pathway ","O94880"]
["GO:0001992","biological_process","regulation of systemic arterial blood pressure by vasopressin ","P30518"]
["GO:0060873","biological_process","anterior semicircular canal development ","P10071"]
["GO:0061005","biological_process","cell differentiation involved in kidney development ","P10071"]
["GO:0060366","biological_process","lambdoid suture morphogenesis ","P10071"]
["GO:0022018","biological_process","lateral ganglionic eminence cell proliferation ","P10071"]
["GO:0060875","biological_process","lateral semicircular canal development ","P10071"]
["GO:0060594","biological_process","mammary gland specification ","P10071"]
["GO:0046639","biological_process","negative regulation of alpha-beta T cell differentiation ","P10071"]
["GO:0043585","biological_process","nose morphogenesis ","P10071; P12755"]
["GO:1903010","biological_process","regulation of bone development ","P10071"]
["GO:0060367","biological_process","sagittal suture morphogenesis ","P10071"]
["GO:0002089","biological_process","lens morphogenesis in camera-type eye ","P12755"]
["GO:1901657","biological_process","glycosyl compound metabolic process ","P09848"]
["GO:0044245","biological_process","polysaccharide digestion ","P09848"]
["GO:0023051","biological_process","regulation of signaling ","Q8WWI1"]
["GO:0042373","biological_process","vitamin K metabolic process ","P16152"]
["GO:0035754","biological_process","B cell chemotaxis ","O00329"]
["GO:0048822","biological_process","enucleate erythrocyte development ","Q15648"]
["GO:0060744","biological_process","mammary gland branching involved in thelarche ","Q15648; Q99623"]
["GO:0070318","biological_process","positive regulation of  to  transition ","Q15648"]
["GO:0002154","biological_process","thyroid hormone mediated signaling pathway ","Q15648"]
["GO:0040030","biological_process","regulation of molecular function, epigenetic ","P49711"]
["GO:0097698","biological_process","telomere maintenance via base-excision repair ","P27695"]
["GO:0001554","biological_process","luteolysis ","P42575"]
["GO:0060086","biological_process","circadian temperature homeostasis ","P20393"]
["GO:0035621","biological_process","ER to olgi ceramide transport ","Q9Y5P4"]
["GO:0120012","biological_process","intermembrane sphingolipid transfer ","Q9Y5P4"]
["GO:1905285","biological_process","fibrous ring of heart morphogenesis ","P36894"]
["GO:0060914","biological_process","heart formation ","P36894"]
["GO:0035137","biological_process","hindlimb morphogenesis ","P36894"]
["GO:0001880","biological_process","Mullerian duct regression ","P36894"]
["GO:0021998","biological_process","neural plate mediolateral regionalization ","P36894"]
["GO:0048352","biological_process","paraxial mesoderm structural organization ","P36894"]
["GO:1904414","biological_process","positive regulation of cardiac ventricle development ","P36894"]
["GO:1903801","biological_process","L-leucine import across plasma membrane ","P08195"]
["GO:0015827","biological_process","tryptophan transport ","P08195"]
["GO:0086097","biological_process","phospholipase C-activating angiotensin-activated signaling pathway ","P30556"]
["GO:0032430","biological_process","positive regulation of phospholipase A activity ","P30556"]
["GO:0002034","biological_process","regulation of blood vessel diameter by renin-angiotensin ","P30556"]
["GO:0035813","biological_process","regulation of renal sodium excretion ","P30556"]
["GO:0003081","biological_process","regulation of systemic arterial blood pressure by renin-angiotensin ","P30556; P12821"]
["GO:0090615","biological_process","mitochondrial mRNA processing ","Q969Z0"]
["GO:0044528","biological_process","regulation of mitochondrial mRNA stability ","Q969Z0"]
["GO:0044111","biological_process","development involved in symbiotic interaction ","P46934"]
["GO:0010768","biological_process","negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage ","P46934"]
["GO:0046824","biological_process","positive regulation of nucleocytoplasmic transport ","P46934"]
["GO:0019089","biological_process","transmission of virus ","P46934"]
["GO:0033563","biological_process","dorsal/ventral axon guidance ","P43146"]
["GO:1902842","biological_process","negative regulation of netrin-activated signaling pathway ","P43146; Q8IUQ4; O43255"]
["GO:0007597","biological_process","blood coagulation, intrinsic pathway ","Q07021; P13224"]
["GO:0039534","biological_process","negative regulation of MDA- signaling pathway ","Q07021"]
["GO:0039536","biological_process","negative regulation of RI-I signaling pathway ","Q07021"]
["GO:0070131","biological_process","positive regulation of mitochondrial translation ","Q07021"]
["GO:1901165","biological_process","positive regulation of trophoblast cell migration ","Q07021; P36896; Q9UKV8"]
["GO:0051046","biological_process","regulation of secretion ","Q9UM54"]
["GO:0060381","biological_process","positive regulation of single-stranded telomeric DNA binding ","Q96AP0"]
["GO:0071279","biological_process","cellular response to cobalt ion ","P36955; Q04656"]
["GO:0016075","biological_process","rRNA catabolic process ","Q9NRR4; Q9NQT4"]
["GO:0010920","biological_process","negative regulation of inositol phosphate biosynthetic process ","P08567"]
["GO:0030845","biological_process","phospholipase C-inhibiting -protein coupled receptor signaling pathway ","P08567"]
["GO:0010925","biological_process","positive regulation of inositol-polyphosphate -phosphatase activity ","P08567"]
["GO:0060305","biological_process","regulation of cell diameter ","P08567"]
["GO:0031022","biological_process","nuclear migration along microfilament ","Q9UH99"]
["GO:0021533","biological_process","cell differentiation in hindbrain ","P23769"]
["GO:0045654","biological_process","positive regulation of megakaryocyte differentiation ","P23769"]
["GO:2000977","biological_process","regulation of forebrain neuron differentiation ","P23769"]
["GO:0060872","biological_process","semicircular canal development ","P23769"]
["GO:0021514","biological_process","ventral spinal cord interneuron differentiation ","P23769"]
["GO:1902425","biological_process","positive regulation of attachment of mitotic spindle microtubules to kinetochore ","Q00839; Q14457"]
["GO:1902889","biological_process","protein localization to spindle microtubule ","Q00839"]
["GO:1990280","biological_process","RNA localization to chromatin ","Q00839"]
["GO:0010754","biological_process","negative regulation of cMP-mediated signaling ","Q9Y233"]
["GO:0060393","biological_process","regulation of pathway-restricted SMAD protein phosphorylation ","Q13526"]
["GO:0046833","biological_process","positive regulation of RNA export from nucleus ","Q07666; P52298"]
["GO:0046831","biological_process","regulation of RNA export from nucleus ","Q07666"]
["GO:0046356","biological_process","acetyl-CoA catabolic process ","P24752"]
["GO:0015937","biological_process","coenzyme A biosynthetic process ","P24752"]
["GO:0006550","biological_process","isoleucine catabolic process ","P24752"]
["GO:0046951","biological_process","ketone body biosynthetic process ","P24752"]
["GO:0046952","biological_process","ketone body catabolic process ","P24752"]
["GO:1902224","biological_process","ketone body metabolic process ","P24752"]
["GO:0072229","biological_process","metanephric proximal convoluted tubule development ","P24752"]
["GO:1902860","biological_process","propionyl-CoA biosynthetic process ","P24752"]
["GO:0048789","biological_process","cytoskeletal matrix organization at active zone ","Q8N2Q7"]
["GO:0097115","biological_process","neurexin clustering involved in presynaptic membrane assembly ","Q8N2Q7"]
["GO:0010841","biological_process","positive regulation of circadian sleep/wake cycle, wakefulness ","Q8N2Q7"]
["GO:0098698","biological_process","postsynaptic specialization assembly ","Q8N2Q7"]
["GO:0071045","biological_process","nuclear histone mRNA catabolic process ","P05455"]
["GO:0042780","biological_process","tRNA 3'-end processing ","P05455"]
["GO:0050992","biological_process","dimethylallyl diphosphate biosynthetic process ","Q13907"]
["GO:0009240","biological_process","isopentenyl diphosphate biosynthetic process ","Q13907"]
["GO:0086053","biological_process","AV node cell to bundle of His cell communication by electrical coupling ","P36383"]
["GO:0086021","biological_process","SA node cell to atrial cardiac muscle cell communication by electrical coupling ","P36383"]
["GO:1990114","biological_process","RNA polymerase II core complex assembly ","Q00403"]
["GO:0001174","biological_process","transcriptional start site selection at RNA polymerase II promoter ","Q00403"]
["GO:0044242","biological_process","cellular lipid catabolic process ","Q8IXJ6"]
["GO:0061433","biological_process","cellular response to caloric restriction ","Q8IXJ6"]
["GO:0070446","biological_process","negative regulation of oligodendrocyte progenitor proliferation ","Q8IXJ6"]
["GO:0046474","biological_process","glycerophospholipid biosynthetic process ","Q96IF1"]
["GO:0031328","biological_process","positive regulation of cellular biosynthetic process ","Q96IF1"]
["GO:0051345","biological_process","positive regulation of hydrolase activity ","Q14191"]
["GO:0098530","biological_process","positive regulation of strand invasion ","Q14191"]
["GO:0040009","biological_process","regulation of growth rate ","Q14191"]
["GO:0033045","biological_process","regulation of sister chromatid segregation ","Q96E14"]
["GO:0033301","biological_process","cell cycle comprising mitosis without cytokinesis ","A0AVK6"]
["GO:0032877","biological_process","positive regulation of DNA endoreduplication ","A0AVK6; Q96AV8"]
["GO:0019413","biological_process","acetate biosynthetic process ","Q9NR19"]
["GO:0019427","biological_process","acetyl-CoA biosynthetic process from acetate ","Q9NR19"]
["GO:0019542","biological_process","propionate biosynthetic process ","Q9NR19"]
["GO:0051295","biological_process","establishment of meiotic spindle localization ","P35579"]
["GO:0032796","biological_process","uropod organization ","P35579"]
["GO:0044805","biological_process","late nucleophagy ","Q7Z3C6"]
["GO:0032386","biological_process","regulation of intracellular transport ","Q8IX03"]
["GO:2001255","biological_process","positive regulation of histone H3-K36 trimethylation ","O60885"]
["GO:1901407","biological_process","regulation of phosphorylation of RNA polymerase II C-terminal domain ","O60885"]
["GO:0045292","biological_process","mRNA cis splicing, via spliceosome ","P52298; Q09161"]
["GO:0001519","biological_process","peptide amidation ","P19021"]
["GO:0018032","biological_process","protein amidation ","P19021"]
["GO:0009404","biological_process","toxin metabolic process ","P19021"]
["GO:0045204","biological_process","MAPK export from nucleus ","Q9BY84"]
["GO:0045209","biological_process","MAPK phosphatase export from nucleus, leptomycin B sensitive ","Q9BY84"]
["GO:1904246","biological_process","negative regulation of polynucleotide adenylyltransferase activity ","P26651"]
["GO:1901835","biological_process","positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA ","P26651"]
["GO:0036164","biological_process","cell-abiotic substrate adhesion ","P41134"]
["GO:0046642","biological_process","negative regulation of alpha-beta T cell proliferation ","Q96J02"]
["GO:0090085","biological_process","regulation of protein deubiquitination ","Q96J02"]
["GO:0003409","biological_process","optic cup structural organization ","P05549"]
["GO:0003404","biological_process","optic vesicle morphogenesis ","P05549"]
["GO:0070172","biological_process","positive regulation of tooth mineralization ","P05549"]
["GO:0019074","biological_process","viral RNA genome packaging ","P26196"]
["GO:0060844","biological_process","arterial endothelial cell fate commitment ","Q06330"]
["GO:0097101","biological_process","blood vessel endothelial cell fate specification ","Q06330"]
["GO:0072554","biological_process","blood vessel lumenization ","Q06330"]
["GO:0009957","biological_process","epidermal cell fate specification ","Q06330"]
["GO:1901297","biological_process","positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment ","Q06330"]
["GO:1901189","biological_process","positive regulation of ephrin receptor signaling pathway ","Q06330"]
["GO:1901186","biological_process","positive regulation of ERBB signaling pathway ","Q06330"]
["GO:0031345","biological_process","negative regulation of cell projection organization ","O43597"]
["GO:0040037","biological_process","negative regulation of fibroblast growth factor receptor signaling pathway ","O43597"]
["GO:0045185","biological_process","maintenance of protein location ","P23497"]
["GO:1902044","biological_process","regulation of Fas signaling pathway ","P23497"]
["GO:0071504","biological_process","cellular response to heparin ","P18146; P48436"]
["GO:0098759","biological_process","cellular response to interleukin- ","P18146"]
["GO:0071506","biological_process","cellular response to mycophenolic acid ","P18146"]
["GO:0072110","biological_process","glomerular mesangial cell proliferation ","P18146"]
["GO:0072303","biological_process","positive regulation of glomerular metanephric mesangial cell proliferation ","P18146"]
["GO:0050725","biological_process","positive regulation of interleukin-1 beta biosynthetic process ","P18146"]
["GO:2000182","biological_process","regulation of progesterone biosynthetic process ","P18146"]
["GO:0033233","biological_process","regulation of protein sumoylation ","P18146"]
["GO:0046545","biological_process","development of primary female sexual characteristics ","P36896"]
["GO:0021941","biological_process","negative regulation of cerebellar granule cell precursor proliferation ","P31645"]
["GO:0014064","biological_process","positive regulation of serotonin secretion ","P31645"]
["GO:0090067","biological_process","regulation of thalamus size ","P31645"]
["GO:0006837","biological_process","serotonin transport ","P31645"]
["GO:0051610","biological_process","serotonin uptake ","P31645"]
["GO:0042713","biological_process","sperm ejaculation ","P31645"]
["GO:0033313","biological_process","meiotic cell cycle checkpoint ","Q08J23"]
["GO:0030488","biological_process","tRNA methylation ","Q08J23"]
["GO:0003130","biological_process","BMP signaling pathway involved in heart induction ","Q01860"]
["GO:0060913","biological_process","cardiac cell fate determination ","Q01860"]
["GO:0060795","biological_process","cell fate commitment involved in formation of primary germ layer ","Q01860"]
["GO:0090081","biological_process","regulation of heart induction by regulation of canonical Wnt signaling pathway ","Q01860"]
["GO:0043949","biological_process","regulation of cAMP-mediated signaling ","P27815"]
["GO:0031125","biological_process","rRNA '-end processing ","Q9NQT4"]
["GO:0015693","biological_process","magnesium ion transport ","P63252"]
["GO:0014861","biological_process","regulation of skeletal muscle contraction via regulation of action potential ","P63252"]
["GO:0090076","biological_process","relaxation of skeletal muscle ","P63252"]
["GO:0090361","biological_process","regulation of platelet-derived growth factor production ","Q9UN36"]
["GO:0032330","biological_process","regulation of chondrocyte differentiation ","O75444"]
["GO:0090148","biological_process","membrane fission ","Q9Y371"]
["GO:1903778","biological_process","protein localization to vacuolar membrane ","Q9Y371"]
["GO:0034696","biological_process","response to prostaglandin F ","P25490"]
["GO:0006403","biological_process","RNA localization ","P25490"]
["GO:0044128","biological_process","positive regulation of growth of symbiont in host ","P22059"]
["GO:0015918","biological_process","sterol transport ","P22059"]
["GO:0003065","biological_process","positive regulation of heart rate by epinephrine ","P09493"]
["GO:1900126","biological_process","negative regulation of hyaluronan biosynthetic process ","Q00610"]
["GO:0043372","biological_process","positive regulation of CD-positive, alpha-beta T cell differentiation ","O75995"]
["GO:0032543","biological_process","mitochondrial translation ","Q9Y676"]
["GO:0050894","biological_process","determination of affect ","Q9Y566"]
["GO:1905302","biological_process","negative regulation of macropinocytosis ","P61266"]
["GO:1903422","biological_process","negative regulation of synaptic vesicle recycling ","P61266"]
["GO:1904050","biological_process","positive regulation of spontaneous neurotransmitter secretion ","P61266"]
["GO:0061669","biological_process","spontaneous neurotransmitter secretion ","P61266"]
["GO:1904290","biological_process","negative regulation of mitotic DNA damage checkpoint ","Q96QC0"]
["GO:0035279","biological_process","mRNA cleavage involved in gene silencing by miRNA ","Q9UKV8"]
["GO:0090625","biological_process","mRNA cleavage involved in gene silencing by siRNA ","Q9UKV8"]
["GO:0042796","biological_process","snRNA transcription by RNA polymerase III ","P55199"]
["GO:2000793","biological_process","cell proliferation involved in heart valve development ","Q15672"]
["GO:0060900","biological_process","embryonic camera-type eye formation ","Q15672"]
["GO:0035359","biological_process","negative regulation of peroxisome proliferator activated receptor signaling pathway ","Q15672"]
["GO:2000802","biological_process","positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation ","Q15672"]
["GO:0051935","biological_process","glutamate reuptake ","P78508"]
["GO:0070829","biological_process","heterochromatin maintenance ","P42898"]
["GO:0031060","biological_process","regulation of histone methylation ","P42898"]
["GO:0033274","biological_process","response to vitamin B ","P42898"]
["GO:0045076","biological_process","regulation of interleukin-2 biosynthetic process ","Q9H257"]
["GO:0002418","biological_process","immune response to tumor cell ","Q13444"]
["GO:0043686","biological_process","co-translational protein modification ","Q8TCJ2"]
["GO:2001205","biological_process","negative regulation of osteoclast development ","Q969H0"]
["GO:2000639","biological_process","negative regulation of SREBP signaling pathway ","Q969H0"]
["GO:0060197","biological_process","cloacal septation ","Q9H3D4"]
["GO:0007499","biological_process","ectoderm and mesoderm interaction ","Q9H3D4"]
["GO:0010481","biological_process","epidermal cell division ","Q9H3D4"]
["GO:0048807","biological_process","female genitalia morphogenesis ","Q9H3D4"]
["GO:0043616","biological_process","keratinocyte proliferation ","Q9H3D4"]
["GO:1904674","biological_process","positive regulation of somatic stem cell population maintenance ","Q9H3D4"]
["GO:0071838","biological_process","cell proliferation in bone marrow ","P12821"]
["GO:0032943","biological_process","mononuclear cell proliferation ","P12821"]
["GO:1903597","biological_process","negative regulation of gap junction assembly ","P12821"]
["GO:2000170","biological_process","positive regulation of peptidyl-cysteine S-nitrosylation ","P12821"]
["GO:0060177","biological_process","regulation of angiotensin metabolic process ","P12821"]
["GO:0002019","biological_process","regulation of renal output by angiotensin ","P12821"]
["GO:0034638","biological_process","phosphatidylcholine catabolic process ","Q9NP80"]
["GO:0046338","biological_process","phosphatidylethanolamine catabolic process ","Q9NP80"]
["GO:0046879","biological_process","hormone secretion ","Q5NUL3"]
["GO:0016038","biological_process","absorption of visible light ","P08100"]
["GO:1905523","biological_process","positive regulation of macrophage migration ","P50281"]
["GO:0090219","biological_process","negative regulation of lipid kinase activity ","Q15172"]
["GO:0006584","biological_process","catecholamine metabolic process ","Q04656"]
["GO:0060003","biological_process","copper ion export ","Q04656"]
["GO:0015677","biological_process","copper ion import ","Q04656"]
["GO:0051542","biological_process","elastin biosynthetic process ","Q04656"]
["GO:0042414","biological_process","epinephrine metabolic process ","Q04656"]
["GO:0034760","biological_process","negative regulation of iron ion transmembrane transport ","Q04656"]
["GO:0015679","biological_process","plasma membrane copper ion transport ","Q04656"]
["GO:1903036","biological_process","positive regulation of response to wounding ","Q04656"]
["GO:1904959","biological_process","regulation of cytochrome-c oxidase activity ","Q04656"]
["GO:0006568","biological_process","tryptophan metabolic process ","Q04656"]
["GO:0051153","biological_process","regulation of striated muscle cell differentiation ","Q9UKV0"]
["GO:0001927","biological_process","exocyst assembly ","Q8IYI6"]
["GO:0051601","biological_process","exocyst localization ","Q8IYI6"]
["GO:0071962","biological_process","mitotic sister chromatid cohesion, centromeric ","Q5FBB7"]
["GO:1904604","biological_process","negative regulation of advanced glycation end-product receptor activity ","Q15109"]
["GO:1904597","biological_process","negative regulation of connective tissue replacement involved in inflammatory response wound healing ","Q15109"]
["GO:2000514","biological_process","regulation of CD-positive, alpha-beta T cell activation ","Q15109"]
["GO:0006424","biological_process","glutamyl-tRNA aminoacylation ","P07814"]
["GO:0006433","biological_process","prolyl-tRNA aminoacylation ","P07814"]
["GO:1990048","biological_process","anterograde neuronal dense core vesicle transport ","P33176"]
["GO:1905152","biological_process","positive regulation of voltage-gated sodium channel activity ","P33176"]
["GO:1990049","biological_process","retrograde neuronal dense core vesicle transport ","P33176"]
["GO:0097264","biological_process","self proteolysis ","Q99538"]
["GO:0006624","biological_process","vacuolar protein processing ","Q99538"]
["GO:1905216","biological_process","positive regulation of RNA binding ","Q09161"]
["GO:0034242","biological_process","negative regulation of syncytium formation by plasma membrane fusion ","O95398"]
["GO:0097065","biological_process","anterior head development ","P48436"]
["GO:0003415","biological_process","chondrocyte hypertrophy ","P48436"]
["GO:0060517","biological_process","epithelial cell proliferation involved in prostatic bud elongation ","P48436"]
["GO:0003188","biological_process","heart valve formation ","P48436"]
["GO:0035622","biological_process","intrahepatic bile duct development ","P48436"]
["GO:0061138","biological_process","morphogenesis of a branching epithelium ","P48436"]
["GO:0002683","biological_process","negative regulation of immune system process ","P48436"]
["GO:0014036","biological_process","neural crest cell fate specification ","P48436"]
["GO:0090184","biological_process","positive regulation of kidney development ","P48436"]
["GO:2000741","biological_process","positive regulation of mesenchymal stem cell differentiation ","P48436"]
["GO:0061046","biological_process","regulation of branching involved in lung morphogenesis ","P48436"]
["GO:0060784","biological_process","regulation of cell proliferation involved in tissue homeostasis ","P48436"]
["GO:2000794","biological_process","regulation of epithelial cell proliferation involved in lung morphogenesis ","P48436"]
["GO:0072034","biological_process","renal vesicle induction ","P48436"]
["GO:0060221","biological_process","retinal rod cell differentiation ","P48436"]
["GO:0072197","biological_process","ureter morphogenesis ","P48436"]
["GO:0072193","biological_process","ureter smooth muscle cell differentiation ","P48436"]
["GO:0072190","biological_process","ureter urothelium development ","P48436"]
["GO:0061881","biological_process","positive regulation of anterograde axonal transport of mitochondrion ","Q99689"]
["GO:0018008","biological_process","N-terminal peptidyl-glycine N-myristoylation ","P30419"]
["GO:0019885","biological_process","antigen processing and presentation of endogenous peptide antigen via MHC class I ","P01892"]
["GO:0002486","biological_process","antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent ","P01892"]
["GO:2001187","biological_process","positive regulation of CD-positive, alpha-beta T cell activation ","P01892"]
["GO:2000566","biological_process","positive regulation of CD8-positive, alpha-beta T cell proliferation ","P01892"]
["GO:2000568","biological_process","positive regulation of memory T cell activation ","P01892"]
["GO:0140112","biological_process","extracellular vesicle biogenesis ","Q8NCT1"]
["GO:1903382","biological_process","negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway ","O60260"]
["GO:1905366","biological_process","negative regulation of intralumenal vesicle formation ","O60260"]
["GO:1902283","biological_process","negative regulation of primary amine oxidase activity ","O60260"]
["GO:0010636","biological_process","positive regulation of mitochondrial fusion ","O60260"]
["GO:0051582","biological_process","positive regulation of neurotransmitter uptake ","O60260"]
["GO:1905281","biological_process","positive regulation of retrograde transport, endosome to olgi ","O60260"]
["GO:0032368","biological_process","regulation of lipid transport ","O60260"]
["GO:0055069","biological_process","zinc ion homeostasis ","O60260"]
["GO:1990036","biological_process","calcium ion import into sarcoplasmic reticulum ","P16615"]
["GO:1903515","biological_process","calcium ion transport from cytosol to endoplasmic reticulum ","P16615"]
["GO:0006984","biological_process","ER-nucleus signaling pathway ","P16615"]
["GO:0032470","biological_process","positive regulation of endoplasmic reticulum calcium ion concentration ","P16615"]
["GO:1903233","biological_process","regulation of calcium ion-dependent exocytosis of neurotransmitter ","P16615"]
["GO:0033292","biological_process","T-tubule organization ","P16615"]
["GO:0002438","biological_process","acute inflammatory response to antigenic stimulus ","P30203; P35372"]
["GO:0036294","biological_process","cellular response to decreased oxygen levels ","Q9NRD5"]
["GO:0045161","biological_process","neuronal ion channel clustering ","Q9NRD5"]
["GO:0090191","biological_process","negative regulation of branching involved in ureteric bud morphogenesis ","P09758"]
["GO:1900028","biological_process","negative regulation of ruffle assembly ","P09758"]
["GO:0010848","biological_process","regulation of chromatin disassembly ","Q66K74"]
["GO:0006662","biological_process","glycerol ether metabolic process ","P10599"]
["GO:0035883","biological_process","enteroendocrine cell differentiation ","Q13562"]
["GO:0003326","biological_process","pancreatic A cell fate commitment ","Q13562"]
["GO:0003329","biological_process","pancreatic PP cell fate commitment ","Q13562"]
["GO:0060730","biological_process","regulation of intestinal epithelial structure maintenance ","Q13562"]
["GO:0036306","biological_process","embryonic heart tube elongation ","Q9UMR3"]
["GO:0035922","biological_process","foramen ovale closure ","Q9UMR3"]
["GO:0048370","biological_process","lateral mesoderm formation ","Q9UMR3"]
["GO:0003193","biological_process","pulmonary valve formation ","Q9UMR3"]
["GO:0003175","biological_process","tricuspid valve development ","Q9UMR3"]
["GO:0021524","biological_process","visceral motor neuron differentiation ","Q9UMR3"]
["GO:0043248","biological_process","proteasome assembly ","O00231"]
["GO:0030832","biological_process","regulation of actin filament length ","Q12929"]
["GO:0021535","biological_process","cell migration in hindbrain ","Q01851"]
["GO:2001208","biological_process","negative regulation of transcription elongation by RNA polymerase I ","Q01851"]
["GO:0051355","biological_process","proprioception involved in equilibrioception ","Q01851"]
["GO:0048880","biological_process","sensory system development ","Q01851"]
["GO:0021680","biological_process","cerebellar Purkinje cell layer development ","P11021"]
["GO:0035437","biological_process","maintenance of protein localization in endoplasmic reticulum ","P11021"]
["GO:1903891","biological_process","regulation of ATF6-mediated unfolded protein response ","P11021"]
["GO:1903894","biological_process","regulation of IRE-mediated unfolded protein response ","P11021"]
["GO:1903897","biological_process","regulation of PERK-mediated unfolded protein response ","P11021"]
["GO:0060904","biological_process","regulation of protein folding in endoplasmic reticulum ","P11021"]
["GO:1904313","biological_process","response to methamphetamine hydrochloride ","P11021"]
["GO:0097501","biological_process","stress response to metal ion ","P11021"]
["GO:0097222","biological_process","mitochondrial mRNA polyadenylation ","Q8TCS8"]
["GO:0000964","biological_process","mitochondrial RNA 5'-end processing ","Q8TCS8"]
["GO:0000957","biological_process","mitochondrial RNA catabolic process ","Q8TCS8"]
["GO:0035927","biological_process","RNA import into mitochondrion ","Q8TCS8"]
["GO:1901668","biological_process","regulation of superoxide dismutase activity ","Q5T011"]
["GO:2000256","biological_process","positive regulation of male germ cell proliferation ","Q99828"]
["GO:0038163","biological_process","thrombopoietin-mediated signaling pathway ","Q99828"]
["GO:0030505","biological_process","inorganic diphosphate transport ","P22413"]
["GO:0006771","biological_process","riboflavin metabolic process ","P22413"]
["GO:0060265","biological_process","positive regulation of respiratory burst involved in inflammatory response ","P39019"]
["GO:0110077","biological_process","vesicle-mediated intercellular transport ","Q7LC44"]
["GO:0071275","biological_process","cellular response to aluminum ion ","Q14457"]
["GO:1905672","biological_process","negative regulation of lysosome organization ","Q14457"]
["GO:0070873","biological_process","regulation of glycogen metabolic process ","Q53GA4"]
["GO:0060721","biological_process","regulation of spongiotrophoblast cell proliferation ","Q53GA4"]
["GO:0061358","biological_process","negative regulation of Wnt protein secretion ","P35372"]
["GO:0021512","biological_process","spinal cord anterior/posterior patterning ","O95390"]
["GO:0080008","cellular_component","Cul4-RIN E3 ubiquitin ligase complex ","O43660; Q9BW61; Q9UBF6; Q969U6; Q9NZJ0; Q93034; Q16531; Q7L5Y6"]
["GO:0005689","cellular_component","U12-type spliceosomal complex ","Q15427; P62316; P14678; Q8TBF4; O75533; Q13435; P67809; P62304; Q9BWJ5"]
["GO:0044300","cellular_component","cerebellar mossy fiber ","P78352; Q5VWQ8; Q9Y698"]
["GO:0044224","cellular_component","juxtaparanode region of axon ","P78352; Q15700; P16389; Q13303; Q09470; Q8IXJ6"]
["GO:0044306","cellular_component","neuron projection terminus ","P78352; P08473; Q9H2B2; P21579; P63027; Q9UQB8"]
["GO:0098839","cellular_component","postsynaptic density membrane ","P78352; Q7LC44"]
["GO:0005658","cellular_component","alpha DNA polymeraseprimase complex ","P25205; P49643"]
["GO:0016327","cellular_component","apicolateral plasma membrane ","O00501; Q16625; O95471; P05787; O15551; P14923; O14493; P08727; P46934"]
["GO:0061617","cellular_component","MICS complex ","Q16891; Q9NX63"]
["GO:0070822","cellular_component","Sin3-type complex ","Q9H7L9; Q9HCU9"]
["GO:0099053","cellular_component","activating signal cointegrator 1 complex ","Q15650; Q8N3C0"]
["GO:0005577","cellular_component","fibrinogen complex ","P02671"]
["GO:0031091","cellular_component","platelet alpha granule ","P02671; P51809; P61764; O00186"]
["GO:0005891","cellular_component","voltage-gated calcium channel complex ","Q08499; Q00975; Q9Y698; Q13936; Q01668; O43497; O95180; Q07343; Q02641; Q08289; Q13698"]
["GO:0016469","cellular_component","proton-transporting two-sector ATPase complex ","P38606"]
["GO:0033180","cellular_component","proton-transporting V-type ATPase, V domain ","P38606"]
["GO:0022625","cellular_component","cytosolic large ribosomal subunit ","P62917; P05388; P26373; P05387; P84098; Q969S3; P62913; P46778; P40429; P30050; P62987; Q07020"]
["GO:0030895","cellular_component","apolipoprotein B mRNA editing enzyme complex ","Q9HC16"]
["GO:0150014","cellular_component","apical distal dendrite ","P11137"]
["GO:0043194","cellular_component","axon initial segment ","P11137; O43525; P78559; O43526; Q9UQD0; Q12955"]
["GO:0097442","cellular_component","CA3 pyramidal cell dendrite ","P11137"]
["GO:0044307","cellular_component","dendritic branch ","P11137; Q99996; P78559"]
["GO:1902737","cellular_component","dendritic filopodium ","P11137; Q06787"]
["GO:0150002","cellular_component","distal dendrite ","P11137"]
["GO:0150001","cellular_component","primary dendrite ","P11137; P78559"]
["GO:1990769","cellular_component","proximal neuron projection ","P11137"]
["GO:0031533","cellular_component","mRNA cap methyltransferase complex ","Q9BTL3; O43148"]
["GO:0070382","cellular_component","exocytic vesicle ","Q8IYJ3; Q14195"]
["GO:0034707","cellular_component","chloride channel complex ","Q9NZA1; P28472; P18507; O00299; P18505; Q5XXA6; O14493; P13569; P47870; O76090; Q96S66; P14867"]
["GO:1990565","cellular_component","HSP-CDC37 chaperone complex ","Q16543"]
["GO:0031224","cellular_component","intrinsic component of membrane ","O15492; Q9BTU6; Q14500; Q16635; Q9H244; P63252"]
["GO:0005892","cellular_component","acetylcholine-gated channel complex ","P36544; P43681; Q07001; Q5T5C0; P07510"]
["GO:0044666","cellular_component","MLL3/ complex ","Q15291; Q9BTK6; O14686"]
["GO:0016935","cellular_component","glycine-gated chloride channel complex ","P48167"]
["GO:0098690","cellular_component","glycinergic synapse ","P48167"]
["GO:0001939","cellular_component","female pronucleus ","P11166; P83916; Q5UIP0; P20248; O43823"]
["GO:0005757","cellular_component","mitochondrial permeability transition pore complex ","P30405; Q07812; P21796"]
["GO:0005865","cellular_component","striated muscle thin filament ","Q9NYL9; P45379; Q8WZ42; P68133; P28289"]
["GO:0005859","cellular_component","muscle myosin complex ","P35749; Q8WZ42; Q9UKX2; P54296; P24844; Q9UKX3; Q00872"]
["GO:0032982","cellular_component","myosin filament ","P35749; Q9UKX2; P54296; P63267; Q9UKX3; Q00872"]
["GO:0005871","cellular_component","kinesin complex ","Q02224; Q99661; Q9NQT8; Q14807; Q96Q89; Q9GZM8; Q9NXR1; Q9P2E2; Q15058; O95235; P62258; Q9BW19; Q07866; O00139; Q9H0B6; Q8N4N8; O95239; P52732; P33176; O60282; Q02241"]
["GO:0005828","cellular_component","kinetochore microtubule ","Q02224; O75122; O43264"]
["GO:0005796","cellular_component","olgi lumen ","P09958; P04004; P15941; Q9GZV9; Q6UVK1; P05067; Q7Z5P9; P18827; P30533; Q14118; P34741; P31431; O75056; P50281"]
["GO:0030140","cellular_component","trans-olgi network transport vesicle ","P09958; P14672; P61106; Q9BVK6; P11717; Q99523; Q04656"]
["GO:0070274","cellular_component","RES complex ","Q9BRD0"]
["GO:0005643","cellular_component","nuclear pore ","Q9NUU7; O95271; O95149; Q8TEM1; P49792; O00505; P52294; A8CG34; Q9UMR2; Q9BTX1; P12270; P62826; P57740; P63165; P52292; P49790; Q8WUM0; Q9HC62; P37198; O60318; O14715; P52948; Q96HA1; P46060; Q9UKX7"]
["GO:0005839","cellular_component","proteasome core complex ","O14818; P25788; P60900"]
["GO:0019773","cellular_component","proteasome core complex, alpha-subunit complex ","O14818; Q8TAA3; P25788; P60900"]
["GO:0042645","cellular_component","mitochondrial nucleoid ","O14746; P55084; P49411; P38646; Q00059; Q04837; Q8IYB8; P21796"]
["GO:0031379","cellular_component","RNA-directed RNA polymerase complex ","O14746"]
["GO:0000333","cellular_component","telomerase catalytic core complex ","O14746"]
["GO:0005697","cellular_component","telomerase holoenzyme complex ","O14746; P07910; O60832; P14678; Q15185; Q9BUR4; Q00839; P62304"]
["GO:1990572","cellular_component","TERT-RMRP complex ","O14746"]
["GO:0120103","cellular_component","centriolar subdistal appendage ","Q5SW79; Q14203; O00139; Q5BJF6"]
["GO:0031499","cellular_component","TRAMP complex ","Q6NZY4"]
["GO:0031265","cellular_component","CD9 death-inducing signaling complex ","Q13158; P25445; Q14790; Q9UNN5; O15519"]
["GO:0032040","cellular_component","small-subunit processome ","Q9NQZ2; Q9Y5J1; O43818; P22087; Q9BVI4; Q8NI36; O00566; Q9BVJ6"]
["GO:0048237","cellular_component","rough endoplasmic reticulum lumen ","P04004; P30533"]
["GO:0071008","cellular_component","U2-type post-mRNA release spliceosomal complex ","Q9UBB9; Q9H400"]
["GO:0035145","cellular_component","exon-exon junction complex ","Q9Y5S9; Q9BRP8; P38919; Q92900"]
["GO:0046581","cellular_component","intercellular canaliculus ","Q86UE4; Q9Y365"]
["GO:0005868","cellular_component","cytoplasmic dynein complex ","Q9NP97; P12270; Q14204; P63167; Q9Y6G9; Q13409"]
["GO:0036157","cellular_component","outer dynein arm ","Q9NP97"]
["GO:0090543","cellular_component","Flemming body ","Q53EZ4; Q03188; O75351; Q9UPT5; Q96JM3; Q9H0H5; Q15058; P37198; P11233; Q96CF2; Q02241"]
["GO:0005677","cellular_component","chromatin silencing complex ","Q96EB6; Q9UIF9; Q8IXJ6"]
["GO:0033553","cellular_component","rDNA heterochromatin ","Q96EB6; Q9UIF9"]
["GO:0005721","cellular_component","pericentric heterochromatin ","Q03188; P26358; P45973; P83916; Q9UIG0; Q9NQS7; O95863; Q9H3R0"]
["GO:0020003","cellular_component","symbiont-containing vacuole ","P29972"]
["GO:0035371","cellular_component","microtubule plus-end ","Q99661; Q9HCH0; Q9UPY8; Q15555; Q9Y4I1; P30622; Q15691; Q14203; Q96SN8; Q96R06; Q14980"]
["GO:0097136","cellular_component","Bcl-2 family protein complex ","O43521; Q07812; Q07820; Q07817"]
["GO:0097141","cellular_component","BIM-BCL-2 complex ","O43521"]
["GO:0097140","cellular_component","BIM-BCL-xl complex ","O43521"]
["GO:0099147","cellular_component","extrinsic component of postsynaptic density membrane ","Q99996; Q14160; Q13009"]
["GO:0033503","cellular_component","HULC complex ","O75150; P63146; P49459; Q5VTR2"]
["GO:0005834","cellular_component","heterotrimeric -protein complex ","Q14344; P11488; P19086; P04899; P30679; Q9UBI6; Q03113"]
["GO:0043625","cellular_component","delta DNA polymerase complex ","P49005; Q15054; Q9HCU8"]
["GO:1901588","cellular_component","dendritic microtubule ","O95816; P78559"]
["GO:0072669","cellular_component","tRNA-splicing ligase complex ","Q9BVC5"]
["GO:0042582","cellular_component","azurophil granule ","P50995; O00161"]
["GO:0042581","cellular_component","specific granule ","P50995; P51790; O00161; O00186"]
["GO:0036020","cellular_component","endolysosome membrane ","P01130; O15455; Q96CW1; P09496; P63010; Q00610"]
["GO:0034362","cellular_component","low-density lipoprotein particle ","P01130; Q92673; P02649; Q86X29"]
["GO:1990666","cellular_component","PCSK-LDLR complex ","P01130"]
["GO:1990752","cellular_component","microtubule end ","Q08AD1"]
["GO:0032983","cellular_component","kainate selective glutamate receptor complex ","Q13002; Q16478"]
["GO:0031519","cellular_component","Pc protein complex ","Q9UQR0; Q9HC52; Q14157; O00257; P35226; O95931; Q9BYE7; P25490"]
["GO:0005847","cellular_component","mRNA cleavage and polyadenylation specificity factor complex ","Q6UN15; Q8N684; Q9NP77; Q9H0L4; Q9P2I0; Q9UKF6; P33240"]
["GO:0034993","cellular_component","meiotic nuclear membrane microtubule tethering complex ","Q8NF91; O94901; Q9UH99"]
["GO:0019005","cellular_component","SCF ubiquitin ligase complex ","Q9UKT5; Q8N3Y1; Q969U6; Q5XUX0; P41002; Q13309; Q969H0"]
["GO:0035577","cellular_component","azurophil granule membrane ","P61224; Q92542; P13473; Q8NF37; O60784; P51148; P21462; P51809; P49768; Q96AX2; Q9H3Z4"]
["GO:0043564","cellular_component","Ku7Ku8 complex ","P13010; P12956"]
["GO:0032593","cellular_component","insulin-responsive compartment ","P14672; Q9Y4I1; P20338; Q5VZ89"]
["GO:0033270","cellular_component","paranode region of axon ","Q9NQT8; Q99250; Q09470; Q8IXJ6"]
["GO:0005672","cellular_component","transcription factor TFIIA complex ","P52655"]
["GO:0070765","cellular_component","gamma-secretase complex ","Q92542; P49768"]
["GO:0071556","cellular_component","integral component of lumenal side of endoplasmic reticulum membrane ","P01889; Q13563; P27824; P01892"]
["GO:0042612","cellular_component","MHC class I protein complex ","P01889; P01892"]
["GO:0017101","cellular_component","aminoacyl-tRNA synthetase multienzyme complex ","Q12904; Q15046; P56192; Q13155; P07814"]
["GO:0017102","cellular_component","methionyl glutamyl tRNA synthetase complex ","Q12904"]
["GO:0044326","cellular_component","dendritic spine neck ","Q9ULJ8; P30626; Q9UD71"]
["GO:1990761","cellular_component","growth cone lamellipodium ","Q9ULJ8; P05067; O00213"]
["GO:0061574","cellular_component","ASAP complex ","Q9UKV3; Q15287"]
["GO:0034715","cellular_component","pICln-Sm protein complex ","P62316; P54105; P62304"]
["GO:0030532","cellular_component","small nuclear ribonucleoprotein complex ","P62316; P14678; Q9Y6D6; Q96RS0; P62304"]
["GO:0034719","cellular_component","SMN-Sm protein complex ","P62316; Q9UHI6; P14678; Q9Y3F4; Q9H840; P62304"]
["GO:0005686","cellular_component","U2 snRNP ","P62316; P14678; Q15459; O75533; Q13435; Q96F63; P62304; Q9BWJ5"]
["GO:0046540","cellular_component","U/U x U tri-snRNP complex ","P62316; P14678; O43395; Q6P2Q9; Q15029; Q96NC0; P62304"]
["GO:0005687","cellular_component","U4 snRNP ","P62316; P14678; P62304"]
["GO:0005682","cellular_component","U snRNP ","P62316; P14678; O43379; Q6P2Q9; P62304"]
["GO:1902711","cellular_component","ABA-A receptor complex ","P28472; P18507; P18505; P47870; P14867"]
["GO:0005849","cellular_component","mRNA cleavage factor complex ","Q8N684"]
["GO:1990584","cellular_component","cardiac Troponin complex ","P45379; P19429"]
["GO:0005861","cellular_component","troponin complex ","P45379; P19429; P45378"]
["GO:0008328","cellular_component","ionotropic glutamate receptor complex ","O43424"]
["GO:0016460","cellular_component","myosin II complex ","P35580; P35579; O14950"]
["GO:0097513","cellular_component","myosin II filament ","P35580; P35579"]
["GO:0097504","cellular_component","emini of coiled bodies ","Q14207; Q9UHI6; Q9H840; Q5JVS0"]
["GO:0031674","cellular_component","I band ","Q96AC1; P04075; Q8WZ42; A8MU46; Q9GZV1; Q15327; O15273; P31415; Q9Y281; P21817; Q13698"]
["GO:0033268","cellular_component","node of Ranvier ","O43525; Q99250; O43526; Q12959; Q9UQD0; Q12955; Q14118"]
["GO:0033018","cellular_component","sarcoplasmic reticulum lumen ","P23327; P31415; O14958; O43852"]
["GO:0005964","cellular_component","phosphorylase kinase complex ","P46020; Q93100; Q16816"]
["GO:0035770","cellular_component","ribonucleoprotein granule ","P51114; P14866; Q8TAS1"]
["GO:0005740","cellular_component","mitochondrial envelope ","P55084"]
["GO:0030014","cellular_component","CCR-NT complex ","O75175; P50616; Q9ULM6; Q9C0C2; Q8NE35; Q9NZN8"]
["GO:0030015","cellular_component","CCR4-NT core complex ","O75175; Q9NZN8"]
["GO:0061827","cellular_component","sperm head ","P04075; P25685"]
["GO:0000939","cellular_component","condensed chromosome inner kinetochore ","P49450; Q13416"]
["GO:0000444","cellular_component","MIS12/MIND type complex ","Q6P1K2; Q9H410"]
["GO:0000818","cellular_component","nuclear MIS2/MIND complex ","Q6P1K2; Q9H410"]
["GO:0031467","cellular_component","Cul-RIN ubiquitin ligase complex ","Q8N3Y1; Q9UBF6"]
["GO:0030896","cellular_component","checkpoint clamp complex ","Q99638; O60671"]
["GO:0032592","cellular_component","integral component of mitochondrial membrane ","Q9GZY8; P21554; P12235; P55957; Q6J4K2"]
["GO:0001652","cellular_component","granular component ","Q14684; P22087"]
["GO:0030687","cellular_component","preribosome, large subunit precursor ","Q14684; Q9Y4W2; Q969S3; P56537; Q99848"]
["GO:0031463","cellular_component","Cul-RIN ubiquitin ligase complex ","Q14145; Q9UH77; Q9H0H3; Q13829; Q9UBF6; Q9BYV9"]
["GO:0032426","cellular_component","stereocilium tip ","O14745; Q9NSB8; Q8NEV4"]
["GO:0042025","cellular_component","host cell nucleus ","P0C6L3"]
["GO:0019012","cellular_component","virion ","P0C6L3"]
["GO:0098981","cellular_component","cholinergic synapse ","Q13393; P07196; P08172; O95886"]
["GO:0005663","cellular_component","DNA replication factor C complex ","P35251; P12004; P40937"]
["GO:0031391","cellular_component","Elg RFC-like complex ","P35251"]
["GO:0031372","cellular_component","UBC-MMS complex ","Q15819; P61088"]
["GO:0045254","cellular_component","pyruvate dehydrogenase complex ","P10515; P09622; P08559; P29803"]
["GO:0032996","cellular_component","Bcl-Bcl1 complex ","P20749"]
["GO:1990844","cellular_component","interfibrillar mitochondrion ","Q9UBK2"]
["GO:0005665","cellular_component","RNA polymerase II, core complex ","Q9UBK2; P24928; P61218; O94763; Q9H5H4"]
["GO:1990843","cellular_component","subsarcolemmal mitochondrion ","Q9UBK2"]
["GO:0031227","cellular_component","intrinsic component of endoplasmic reticulum membrane ","P25686"]
["GO:0005642","cellular_component","annulate lamellae ","P49792; P37198; O14980"]
["GO:1990723","cellular_component","cytoplasmic periphery of the nuclear pore complex ","P49792; P46060"]
["GO:0044614","cellular_component","nuclear pore cytoplasmic filaments ","P49792; P52948; P46060"]
["GO:0044615","cellular_component","nuclear pore nuclear basket ","P49792; P35658; P12270; P49790; P52948; Q8NFH5"]
["GO:0014802","cellular_component","terminal cisterna ","O75298; P21817"]
["GO:0070552","cellular_component","BRISC complex ","Q9NWV8"]
["GO:0042105","cellular_component","alpha-beta T cell receptor complex ","P09693; P07766; P20963; P29350"]
["GO:0043293","cellular_component","apoptosome ","P55211; O14727"]
["GO:0072589","cellular_component","box H/ACA scaRNP complex ","O60832"]
["GO:0090661","cellular_component","box H/ACA telomerase RNP complex ","O60832"]
["GO:0042622","cellular_component","photoreceptor outer segment membrane ","Q6ZVD8; P11488; P29973; O43490; P08100"]
["GO:0071204","cellular_component","histone pre-mRNA 3'end processing complex ","Q14493; P14678; O60506; P67809"]
["GO:0008275","cellular_component","gamma-tubulin small complex ","Q9HC77"]
["GO:0031209","cellular_component","SCAR complex ","Q92558; Q9Y6W5; Q9NYB9; Q8IZP0"]
["GO:0070937","cellular_component","CRD-mediated mRNA stability complex ","Q9NZI8; O60506; P67809; Q00839; O75534"]
["GO:0097575","cellular_component","lateral cell cortex ","P81274; Q14980"]
["GO:0045334","cellular_component","clathrin-coated endocytic vesicle ","P53675; P09497; P50570; O14641; Q96CW1; P09496; P63010; P16410; Q00610"]
["GO:0030130","cellular_component","clathrin coat of trans-olgi network vesicle ","P53675; P09497; P09496; P61601; Q00610"]
["GO:0071439","cellular_component","clathrin complex ","P53675; Q9Y5Y9; P09496; Q00610"]
["GO:0030135","cellular_component","coated vesicle ","P53675; P10809"]
["GO:0031305","cellular_component","integral component of mitochondrial inner membrane ","Q8NE86; O14925"]
["GO:1990246","cellular_component","uniplex complex ","Q8NE86"]
["GO:0043657","cellular_component","host cell ","P62979; O00505; P52294; P0CG47; P62826; P49790; P62987; O14980"]
["GO:0030141","cellular_component","secretory granule ","Q9BXF6; Q15836; P10809; P01236; P13498; P05408; P63027; P51790; Q9Y2J0; P51809; Q9UQB8; O95295; P51587; P60953; Q04656; P05060"]
["GO:0030658","cellular_component","transport vesicle membrane ","Q9BXF6; Q13425; P51790; P41181; P13688; Q14643; P62820"]
["GO:1990712","cellular_component","HFE-transferrin receptor complex ","P02786; P36894"]
["GO:0030285","cellular_component","integral component of synaptic vesicle membrane ","Q15836; P41143; Q16623; Q7L0J3; Q9H2B2; P21579; P51790; P51809; P41145; O75379; P23763"]
["GO:0031201","cellular_component","SNARE complex ","Q15836; Q16623; P56962; P21579; P63027; Q92777; P51809; O00161; O75379; P60880; P23763; P61266"]
["GO:0032588","cellular_component","trans-olgi network membrane ","Q15836; P53365; P53367; P11717; P05067; P20645; O75379; P09496; Q00610; Q15334"]
["GO:0030118","cellular_component","clathrin coat ","P09497; P11717; P09496; Q00610"]
["GO:0030132","cellular_component","clathrin coat of coated pit ","P09497; O43426; P09496; Q00610"]
["GO:0030125","cellular_component","clathrin vesicle coat ","P09497; P09496"]
["GO:0098992","cellular_component","neuronal dense core vesicle ","P41143"]
["GO:0097444","cellular_component","spine apparatus ","P41143; P35372"]
["GO:0120001","cellular_component","apical plasma membrane urothelial plaque ","O75631"]
["GO:0043159","cellular_component","acrosomal matrix ","P09622"]
["GO:0045252","cellular_component","oxoglutarate dehydrogenase complex ","P09622"]
["GO:0000439","cellular_component","core TFIIH complex ","P19447"]
["GO:0016010","cellular_component","dystrophin-associated glycoprotein complex ","Q13425; P05787; Q15124; P46939; P08727; Q14118"]
["GO:0042175","cellular_component","nuclear outer membrane-endoplasmic reticulum membrane network ","P61106"]
["GO:0043509","cellular_component","activin A complex ","P08476"]
["GO:0043512","cellular_component","inhibin A complex ","P08476"]
["GO:0010009","cellular_component","cytoplasmic side of endosome membrane ","Q9H1K0"]
["GO:0031905","cellular_component","early endosome lumen ","Q9UIQ6; P50479"]
["GO:1905370","cellular_component","serine-type endopeptidase complex ","O43464"]
["GO:0036057","cellular_component","slit diaphragm ","Q9Y210; O00592; Q08209; O60500; P46940; Q86UL8; Q9Y624"]
["GO:0000346","cellular_component","transcription export complex ","Q9Y3Y2; Q96J01; Q96FV9; Q8NI27; Q13769; Q86V81"]
["GO:0031941","cellular_component","filamentous actin ","Q14195; Q16658; Q8NEV4; Q5VZK9; Q9UM54; P50479; P63261"]
["GO:0045180","cellular_component","basal cortex ","Q13563; Q86SQ0; O75122; Q86UU1"]
["GO:0071458","cellular_component","integral component of cytoplasmic side of endoplasmic reticulum membrane ","Q13563"]
["GO:0097730","cellular_component","non-motile cilium ","Q13563; Q15019; Q16181; P14416; P23258; P21728; Q9UHD8"]
["GO:0002133","cellular_component","polycystin complex ","Q13563; P98161"]
["GO:0034388","cellular_component","Pwp2p-containing subcomplex of 9S preribosome ","Q9Y5J1; Q8NI36"]
["GO:0008074","cellular_component","guanylate cyclase complex, soluble ","O60266; P25092; Q08828; P16066; Q02153; Q02108; Q02846; O43306; Q08462; P40145"]
["GO:0005924","cellular_component","cell-substrate adherens junction ","Q9BX66"]
["GO:0031011","cellular_component","Ino8 complex ","Q8NBZ0; Q6P4R8; P0C1Z6; Q9Y230; Q96EZ8; P25490; Q9Y265"]
["GO:0043596","cellular_component","nuclear replication fork ","Q9H4L7; P12004"]
["GO:0034673","cellular_component","inhibin-betaglycan-ActRII complex ","Q03167"]
["GO:1990597","cellular_component","AIP-IRE complex ","Q12933; Q5VWQ8; O75460"]
["GO:0097057","cellular_component","TRAF2-STP1 complex ","Q12933; P09211"]
["GO:0000127","cellular_component","transcription factor TFIIIC complex ","Q9Y5Q9; Q12789"]
["GO:0005747","cellular_component","mitochondrial respiratory chain complex I ","O75489; O43181; O95178; P19404; O95168; Q9P0J0"]
["GO:0061742","cellular_component","chaperone-mediated autophagy translocation complex ","P13473"]
["GO:0097637","cellular_component","integral component of autophagosome membrane ","P13473"]
["GO:1990836","cellular_component","lysosomal matrix ","P13473"]
["GO:0031088","cellular_component","platelet dense granule membrane ","P13473; Q14643"]
["GO:0070847","cellular_component","core mediator complex ","O60244"]
["GO:0005895","cellular_component","interleukin- receptor complex ","O00560"]
["GO:1990876","cellular_component","cytoplasmic side of nuclear pore ","P35658"]
["GO:0044613","cellular_component","nuclear pore central transport channel ","P35658; P37198; Q8NFH5"]
["GO:0098691","cellular_component","dopaminergic synapse ","P43681; P35462; Q01959; O75955; P14416; Q05940"]
["GO:0036513","cellular_component","Derlin- retrotranslocation complex ","Q9UKV5; P55072"]
["GO:0044322","cellular_component","endoplasmic reticulum quality control compartment ","Q9UKV5; P27824"]
["GO:0030122","cellular_component","AP- adaptor complex ","P42566; Q96CW1; P63010; Q16572"]
["GO:0090571","cellular_component","RNA polymerase II transcription repressor complex ","Q9UHI6; P41162"]
["GO:0032797","cellular_component","SMN complex ","Q9UHI6; Q9Y3F4; Q9H840"]
["GO:0008250","cellular_component","oligosaccharyltransferase complex ","P04844; Q8TCJ2; P04843"]
["GO:0071203","cellular_component","WASH complex ","Q9NUY8; Q641Q2; Q5SRD0; P47756; P52907"]
["GO:0098686","cellular_component","hippocampal mossy fiber to CA3 synapse ","Q08828; Q15768; P56817; P21579; O43581; Q9Y698; O60716; P51809; Q99962; P40145; Q16478; P63104; Q99961"]
["GO:0031597","cellular_component","cytosolic proteasome complex ","P17980; P62195; P43686; P35998"]
["GO:0031595","cellular_component","nuclear proteasome complex ","P17980; P62195; P43686; P35998"]
["GO:0022624","cellular_component","proteasome accessory complex ","P17980; P62195; Q99460; Q13200; P43686; P35998; O00231"]
["GO:0008540","cellular_component","proteasome regulatory particle, base subcomplex ","P17980; P62195; Q99460; Q13200; P43686; P35998"]
["GO:0034705","cellular_component","potassium channel complex ","Q9NS61; P22460"]
["GO:0016035","cellular_component","zeta DNA polymerase complex ","O60673"]
["GO:0005614","cellular_component","interstitial matrix ","Q76M96"]
["GO:0099059","cellular_component","integral component of presynaptic active zone membrane ","P51674; Q9ULB1; Q01668; Q02297; P27824; P23634"]
["GO:0005945","cellular_component","6-phosphofructokinase complex ","P17858; P08237"]
["GO:0098998","cellular_component","extrinsic component of postsynaptic early endosome membrane ","Q4V328"]
["GO:0098837","cellular_component","postsynaptic recycling endosome ","Q4V328; P62491; P20338"]
["GO:0031253","cellular_component","cell projection membrane ","Q08495; Q16658; Q96J84; Q9ULH1; Q12959; Q15691"]
["GO:0031095","cellular_component","platelet dense tubular network membrane ","Q08495; Q14573; Q9Y6F6; Q14643; Q14571; P16615"]
["GO:0014731","cellular_component","spectrin-associated cytoskeleton ","Q08495; Q01082; Q9H310; P11171; Q12955"]
["GO:0005746","cellular_component","mitochondrial respiratory chain ","Q13423; Q9P0J0"]
["GO:0043240","cellular_component","Fanconi anaemia nuclear complex ","O15360; O15287; Q9BTP7; Q8N2Z9; Q9HB96"]
["GO:0032045","cellular_component","guanyl-nucleotide exchange factor complex ","Q13370; P62834; Q92556; Q8TEV9; Q8IV61; Q14185"]
["GO:0005851","cellular_component","eukaryotic translation initiation factor 2B complex ","Q13144; Q14232"]
["GO:0048787","cellular_component","presynaptic active zone membrane ","Q16623; P61764; Q02410; P61266"]
["GO:0070044","cellular_component","synaptobrevin 2-SNAP-25-syntaxin-1a complex ","Q16623; P63027"]
["GO:0070032","cellular_component","synaptobrevin -SNAP-5-syntaxin-1a-complexin I complex ","Q16623; O14810; P63027; P60880"]
["GO:0070033","cellular_component","synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex ","Q16623; P63027; Q6PUV4"]
["GO:0000445","cellular_component","TH complex part of transcription export complex ","Q96J01; Q96FV9; Q8NI27; Q13769"]
["GO:0044291","cellular_component","cell-cell contact zone ","Q14160; Q14254; Q92692; P55196; O75955; Q13009; Q09666"]
["GO:0034750","cellular_component","Scrib-APC-beta-catenin complex ","Q14160"]
["GO:0005638","cellular_component","lamin filament ","P20700; Q03252; P02545; P56537; P48678"]
["GO:0071797","cellular_component","LUBAC complex ","Q9BYM8"]
["GO:0000145","cellular_component","exocyst ","Q15019; Q9UPT5; Q8IYI6"]
["GO:0031105","cellular_component","septin complex ","Q15019; O43236; Q16181; Q8IYM1; Q9UHD8"]
["GO:0097227","cellular_component","sperm annulus ","Q15019; O43236; Q16181; Q8IYM1; P26196"]
["GO:0046696","cellular_component","lipopolysaccharide receptor complex ","P10809; O00206; Q9Y6Y9"]
["GO:0034680","cellular_component","integrin alpha1-beta1 complex ","P05556"]
["GO:0034681","cellular_component","integrin alpha-beta complex ","P05556"]
["GO:0034665","cellular_component","integrin alpha1-beta1 complex ","P05556"]
["GO:0034667","cellular_component","integrin alpha-beta1 complex ","P05556"]
["GO:0034677","cellular_component","integrin alpha-beta1 complex ","P05556"]
["GO:0034678","cellular_component","integrin alpha-beta1 complex ","P05556"]
["GO:0071438","cellular_component","invadopodium membrane ","P05556"]
["GO:0030127","cellular_component","CPII vesicle coat ","P53992; Q15436"]
["GO:0060077","cellular_component","inhibitory synapse ","Q9H063; Q99259"]
["GO:0033063","cellular_component","Rad51B-Rad51C-Rad51D-XRCC2 complex ","O43542"]
["GO:0033065","cellular_component","Rad1C-XRCC complex ","O43542"]
["GO:0030314","cellular_component","junctional membrane complex ","Q9BR39; O14958; P21817"]
["GO:0014701","cellular_component","junctional sarcoplasmic reticulum membrane ","Q9BR39; Q92736; O14958; P21817"]
["GO:0099029","cellular_component","anchored component of presynaptic active zone membrane ","Q14254"]
["GO:0032127","cellular_component","dense core granule membrane ","Q9H2B2"]
["GO:0030173","cellular_component","integral component of olgi membrane ","Q9H2B2"]
["GO:0099066","cellular_component","integral component of neuronal dense core vesicle membrane ","Q9H2B2"]
["GO:1990742","cellular_component","microvesicle ","Q9H2B2"]
["GO:0005662","cellular_component","DNA replication factor A complex ","Q13156; P27694; P15927"]
["GO:0044233","cellular_component","ER-mitochondrion membrane contact site ","P56962; Q9H1Y0; P27824"]
["GO:0030868","cellular_component","smooth endoplasmic reticulum membrane ","P56962; O00264"]
["GO:0070554","cellular_component","synaptobrevin 2-SNAP-2-syntaxin-3-complexin complex ","O14810; Q6PUV4"]
["GO:0042564","cellular_component","NLS-dependent protein nuclear import complex ","Q9BQG0"]
["GO:0016591","cellular_component","RNA polymerase II, holoenzyme ","Q5VT52; Q9Y5B0; Q9UM54; O94762; Q9NQG5"]
["GO:0005581","cellular_component","collagen trimer ","Q9UMD9"]
["GO:0071005","cellular_component","U2-type precatalytic spliceosome ","P14678; O75533; O43395; Q6P2Q9; Q96NC0; Q9BWJ5"]
["GO:0005683","cellular_component","U7 snRNP ","P14678; P62304"]
["GO:0036053","cellular_component","glomerular endothelium fenestra ","P28906"]
["GO:0005881","cellular_component","cytoplasmic microtubule ","Q9HBA0; Q9NYZ3; P30622; O95999; O15392; Q9UBN7; Q71U36; Q15691; O75122; P23258; Q9NRH3; P68363; Q8WWK9"]
["GO:0099154","cellular_component","serotonergic synapse ","P28222; P31645"]
["GO:0008290","cellular_component","F-actin capping protein complex ","P35611; P47756; P52907; P35612"]
["GO:0032039","cellular_component","integrator complex ","Q6KC79; O15014"]
["GO:0090694","cellular_component","Scc2-Scc cohesin loading complex ","Q6KC79"]
["GO:0032116","cellular_component","SMC loading complex ","Q6KC79"]
["GO:0034274","cellular_component","Atg1-Atg5-Atg16 complex ","Q9H1Y0"]
["GO:0005890","cellular_component","sodiumpotassium-exchanging ATPase complex ","O00168; P05023"]
["GO:0036488","cellular_component","CHP-C/EBP complex ","P17676; P35638"]
["GO:0034663","cellular_component","endoplasmic reticulum chaperone complex ","P14625; Q15084; P11021"]
["GO:0097452","cellular_component","AIT complex ","O60506; P40429; P04406; P07814"]
["GO:0031225","cellular_component","anchored component of membrane ","Q93070; P10646; P13591"]
["GO:0005736","cellular_component","RNA polymerase I complex ","O15160; P61218"]
["GO:0005666","cellular_component","RNA polymerase III complex ","O15160; P61218; Q9Y2Y1; P05423"]
["GO:0031302","cellular_component","intrinsic component of endosome membrane ","P42892"]
["GO:0033093","cellular_component","Weibel-Palade body ","P42892"]
["GO:0005885","cellular_component","Arp2/3 protein complex ","O15511; P61160; O15143; P61158"]
["GO:0000178","cellular_component","exosome (RNase complex) ","Q99547; Q06265; Q9NQT5; Q15024; Q9NQT4"]
["GO:0032437","cellular_component","cuticular plate ","Q01082; Q9H2D6"]
["GO:0008091","cellular_component","spectrin ","Q01082; Q13813"]
["GO:0031464","cellular_component","CulA-RIN E ubiquitin ligase complex ","P46527; Q9NZJ0; Q8NHY2; Q16531; Q7L5Y6"]
["GO:0031306","cellular_component","intrinsic component of mitochondrial outer membrane ","O95140"]
["GO:0034706","cellular_component","sodium channel complex ","Q99250; P37088; Q8TD43; P51170; P51168"]
["GO:0001518","cellular_component","voltage-gated sodium channel complex ","Q99250; Q14524; Q9Y5Y9; Q9UQD0"]
["GO:0071159","cellular_component","NF-kappaB complex ","P23396"]
["GO:0035692","cellular_component","macrophage migration inhibitory factor receptor complex ","P16070"]
["GO:0030055","cellular_component","cell-substrate junction ","P18206"]
["GO:0090637","cellular_component","inner dense plaque of desmosome ","P18206"]
["GO:0090636","cellular_component","outer dense plaque of desmosome ","P18206"]
["GO:1990357","cellular_component","terminal web ","P18206; P08727"]
["GO:1902494","cellular_component","catalytic complex ","P0DP23"]
["GO:0043259","cellular_component","laminin-1 complex ","P11047"]
["GO:0043260","cellular_component","laminin-11 complex ","P11047"]
["GO:0005606","cellular_component","laminin-1 complex ","P11047"]
["GO:0030867","cellular_component","rough endoplasmic reticulum membrane ","Q5D1E8; Q9UBF8"]
["GO:0044218","cellular_component","other organism cell membrane ","P00747"]
["GO:0089701","cellular_component","U2AF ","Q01081; P26368; Q8TAS1"]
["GO:0005762","cellular_component","mitochondrial large ribosomal subunit ","Q9H0U6; Q9NQ50"]
["GO:0005761","cellular_component","mitochondrial ribosome ","Q9H0U6; Q9NQ50"]
["GO:0098993","cellular_component","anchored component of synaptic vesicle membrane ","P61020; P51148; P20338; P17600; Q9H3Z4"]
["GO:0001739","cellular_component","sex chromatin ","Q15022"]
["GO:0072557","cellular_component","IPAF inflammasome complex ","Q9NPP4"]
["GO:0005684","cellular_component","U2-type spliceosomal complex ","Q15459; Q13435"]
["GO:0000796","cellular_component","condensin complex ","Q15003; Q9NTJ3; Q6IBW4; Q9BPX3"]
["GO:0000799","cellular_component","nuclear condensin complex ","Q15003"]
["GO:0035101","cellular_component","FACT complex ","Q9Y5B9"]
["GO:0071782","cellular_component","endoplasmic reticulum tubular network ","Q9NQC3; Q9H4P4"]
["GO:0098826","cellular_component","endoplasmic reticulum tubular network membrane ","Q9NQC3"]
["GO:0005826","cellular_component","actomyosin contractile ring ","Q9UKX2; Q9NQW6; P35579"]
["GO:0060205","cellular_component","cytoplasmic vesicle lumen ","P48023"]
["GO:0005971","cellular_component","ribonucleoside-diphosphate reductase complex ","Q7LG56; P31350"]
["GO:0005969","cellular_component","serine-pyruvate aminotransferase complex ","Q15075"]
["GO:0035102","cellular_component","PRC complex ","Q9HC52; O00257; P35226; O95931; Q9BYE7"]
["GO:0072559","cellular_component","NLRP3 inflammasome complex ","Q96P20; Q9ULZ3"]
["GO:0005944","cellular_component","phosphatidylinositol 3-kinase complex, class IB ","P48736"]
["GO:0044301","cellular_component","climbing fiber ","Q5VWQ8"]
["GO:1990032","cellular_component","parallel fiber ","Q5VWQ8"]
["GO:0071598","cellular_component","neuronal ribonucleoprotein granule ","O60828; Q06787; Q8TAS1"]
["GO:0005883","cellular_component","neurofilament ","P12036; P07196; Q9P1A6; P07197"]
["GO:0099160","cellular_component","postsynaptic intermediate filament cytoskeleton ","P12036; P07196"]
["GO:0045095","cellular_component","keratin filament ","P05787; P08729; P05783"]
["GO:0000347","cellular_component","TH complex ","Q96FV9; Q8NI27; Q13769"]
["GO:0070931","cellular_component","olgi-associated vesicle lumen ","P56817"]
["GO:0071942","cellular_component","XPC complex ","P54727; P41208"]
["GO:1990124","cellular_component","messenger ribonucleoprotein complex ","Q9BZB8; Q06787; Q8NE35"]
["GO:0034423","cellular_component","autophagosome lumen ","Q9UIK4"]
["GO:0097144","cellular_component","BAX complex ","Q07812"]
["GO:0046930","cellular_component","pore complex ","Q07812; P10415; Q16611; P21796"]
["GO:0034687","cellular_component","integrin alphaL-beta2 complex ","P05107"]
["GO:0034688","cellular_component","integrin alphaM-beta2 complex ","P05107"]
["GO:0032998","cellular_component","Fc-epsilon receptor I complex ","Q01362; P30273"]
["GO:0097731","cellular_component","+ non-motile cilium ","O75386"]
["GO:0030684","cellular_component","preribosome ","Q9Y237"]
["GO:0008282","cellular_component","inward rectifying potassium channel ","O60706; Q15842; Q14654"]
["GO:0098799","cellular_component","outer mitochondrial membrane protein complex ","Q8IWA4"]
["GO:0043626","cellular_component","PCNA complex ","P12004"]
["GO:0030894","cellular_component","replisome ","P12004"]
["GO:0035253","cellular_component","ciliary rootlet ","Q5TZA2; P49768; P05067; P49810; P33176; O60282"]
["GO:0044327","cellular_component","dendritic spine head ","Q9UD71; P84074; P35637; Q92686"]
["GO:0035838","cellular_component","growing cell tip ","Q9BTU6"]
["GO:0044231","cellular_component","host cell presynaptic membrane ","Q9BTU6"]
["GO:1904949","cellular_component","ATPase complex ","P55072"]
["GO:0034098","cellular_component","VCP-NPL-UFD1 AAA ATPase complex ","P55072; Q9UNN5; Q04323"]
["GO:1990730","cellular_component","VCP-NSFLC complex ","P55072; Q9UNZ2"]
["GO:0033186","cellular_component","CAF- complex ","Q13112; Q13111"]
["GO:0000322","cellular_component","storage vacuole ","Q14155; P60953"]
["GO:0090724","cellular_component","central region of growth cone ","Q9GZM8; P62258"]
["GO:0060053","cellular_component","neurofilament cytoskeleton ","Q9GZM8"]
["GO:0042584","cellular_component","chromaffin granule membrane ","P21579; Q8N9I0"]
["GO:0060201","cellular_component","clathrin-sculpted acetylcholine transport vesicle membrane ","P21579; Q16572"]
["GO:0061202","cellular_component","clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane ","P21579; P63027; P11142; Q99259; Q9H3Z4"]
["GO:0060203","cellular_component","clathrin-sculpted glutamate transport vesicle membrane ","P21579; P63027"]
["GO:0070083","cellular_component","clathrin-sculpted monoamine transport vesicle membrane ","P21579; P63027; Q05940"]
["GO:0031045","cellular_component","dense core granule ","P21579; O43581; P00441"]
["GO:0090534","cellular_component","calcium ion-transporting ATPase complex ","P26678; P16615"]
["GO:0099182","cellular_component","presynaptic intermediate filament cytoskeleton ","P07196"]
["GO:0046658","cellular_component","anchored component of plasma membrane ","Q9H310"]
["GO:0030690","cellular_component","Noc1p-Noc2p complex ","Q9Y3T9"]
["GO:0030691","cellular_component","Noc2p-Nocp complex ","Q9Y3T9"]
["GO:0008537","cellular_component","proteasome activator complex ","P61289"]
["GO:0032584","cellular_component","growth cone membrane ","Q9UPT5; P17677; Q9Y5S1"]
["GO:0098831","cellular_component","presynaptic active zone cytoplasmic component ","P56545; O60716; O15083; Q13363"]
["GO:0097470","cellular_component","ribbon synapse ","P56545; P16615"]
["GO:0071014","cellular_component","post-mRNA release spliceosomal complex ","Q13573"]
["GO:0097229","cellular_component","sperm end piece ","O75952"]
["GO:0035686","cellular_component","sperm fibrous sheath ","O75952; Q5JQC9"]
["GO:0097228","cellular_component","sperm principal piece ","O75952; P08237; P37088; O00139; Q5JQC9; P23634"]
["GO:0031362","cellular_component","anchored component of external side of plasma membrane ","P04156"]
["GO:0030123","cellular_component","AP- adaptor complex ","Q96JC1"]
["GO:0030897","cellular_component","HPS complex ","Q96JC1"]
["GO:0030686","cellular_component","9S preribosome ","Q8N9T8; O76021"]
["GO:0070776","cellular_component","MZ/MRF histone acetyltransferase complex ","Q8WYH8; Q92794"]
["GO:0061825","cellular_component","podosome core ","P61160"]
["GO:0045178","cellular_component","basal part of cell ","P17301; Q96N67"]
["GO:0071818","cellular_component","BAT3 complex ","P46379"]
["GO:0043186","cellular_component","P granule ","Q9NQI0; Q9Y2V2; Q9BXT4"]
["GO:0071546","cellular_component","pi-body ","Q9NQI0; Q9BXT4"]
["GO:0071547","cellular_component","piP-body ","Q9NQI0"]
["GO:0071006","cellular_component","U2-type catalytic step  spliceosome ","Q9UMS4"]
["GO:1990812","cellular_component","growth cone filopodium ","Q06787; P05067; O00213"]
["GO:0019034","cellular_component","viral replication complex ","Q06787"]
["GO:0031462","cellular_component","Cul-RIN ubiquitin ligase complex ","Q9UBF6"]
["GO:0031466","cellular_component","Cul5-RIN ubiquitin ligase complex ","Q9UBF6; Q93034; Q96Q27"]
["GO:0043224","cellular_component","nuclear SCF ubiquitin ligase complex ","Q9UBF6"]
["GO:0090533","cellular_component","cation-transporting ATPase complex ","P19634"]
["GO:0005744","cellular_component","mitochondrial inner membrane presequence translocase complex ","O14925"]
["GO:0002116","cellular_component","semaphorin receptor complex ","O43157"]
["GO:0016282","cellular_component","eukaryotic 43S preinitiation complex ","O00303; O75822; Q99613"]
["GO:0005852","cellular_component","eukaryotic translation initiation factor 3 complex ","O00303; O75822; Q99613"]
["GO:0071541","cellular_component","eukaryotic translation initiation factor 3 complex, eIF3m ","O00303"]
["GO:0005712","cellular_component","chiasma ","P40692"]
["GO:0005715","cellular_component","late recombination nodule ","P40692"]
["GO:0032389","cellular_component","MutLalpha complex ","P40692"]
["GO:0005863","cellular_component","striated muscle myosin thick filament ","P52179; Q13049; Q14896"]
["GO:0002199","cellular_component","zona pellucida receptor complex ","P34931; P78371"]
["GO:0034684","cellular_component","integrin alphav-beta5 complex ","P18084"]
["GO:0031985","cellular_component","olgi cisterna ","Q92673; O14578; Q9H4A6"]
["GO:0033557","cellular_component","Slx1-Slx4 complex ","Q8IY92"]
["GO:0005763","cellular_component","mitochondrial small ribosomal subunit ","Q92665; P51398; Q9Y676"]
["GO:0042382","cellular_component","paraspeckles ","Q8WXF1; P52272; P23246"]
["GO:0001940","cellular_component","male pronucleus ","P83916; Q5UIP0; P20248"]
["GO:0038039","cellular_component","-protein coupled receptor heterodimeric complex ","Q9UBS5; O75899"]
["GO:0017177","cellular_component","glucosidase II complex ","P14314; Q14697"]
["GO:0005914","cellular_component","spot adherens junction ","Q15124"]
["GO:0042627","cellular_component","chylomicron ","P02649; Q86X29"]
["GO:0034365","cellular_component","discoidal high-density lipoprotein particle ","P02649"]
["GO:0034364","cellular_component","high-density lipoprotein particle ","P02649; P05067; Q00341"]
["GO:0034363","cellular_component","intermediate-density lipoprotein particle ","P02649; P05067"]
["GO:1990777","cellular_component","lipoprotein particle ","P02649; P05067"]
["GO:0034361","cellular_component","very-low-density lipoprotein particle ","P02649; Q86X29"]
["GO:1990111","cellular_component","spermatoproteasome complex ","Q8TAA3"]
["GO:0032541","cellular_component","cortical endoplasmic reticulum ","Q13586"]
["GO:0005838","cellular_component","proteasome regulatory particle ","Q99460; Q13200"]
["GO:0034515","cellular_component","proteasome storage granule ","Q99460; Q13200"]
["GO:0005955","cellular_component","calcineurin complex ","Q08209; Q14643"]
["GO:0031422","cellular_component","RecQ helicase-Topo III complex ","Q9H9A7"]
["GO:0036449","cellular_component","microtubule minus-end ","O95425; Q14980"]
["GO:0070762","cellular_component","nuclear pore transmembrane ring ","Q9BTX1"]
["GO:0070176","cellular_component","DRM complex ","Q52LA3"]
["GO:0032279","cellular_component","asymmetric synapse ","P08172; Q14831"]
["GO:0032280","cellular_component","symmetric synapse ","P08172"]
["GO:0070876","cellular_component","SSS complex ","Q9BQ15; Q96AH0"]
["GO:0098888","cellular_component","extrinsic component of presynaptic membrane ","Q5T5C0"]
["GO:0016461","cellular_component","unconventional myosin complex ","Q9Y4I1; Q9UM54"]
["GO:0045025","cellular_component","mitochondrial degradosome ","Q8IYB8; Q8TCS8"]
["GO:0009330","cellular_component","DNA topoisomerase complex (ATP-hydrolyzing) ","P11387; P11388"]
["GO:0031298","cellular_component","replication fork protection complex ","P11387; Q9BVW5; Q9Y248"]
["GO:0043229","cellular_component","intracellular organelle ","Q9BZR8"]
["GO:0031089","cellular_component","platelet dense granule lumen ","Q14624"]
["GO:0031465","cellular_component","CulB-RIN E ubiquitin ligase complex ","Q9NZJ0; Q16531"]
["GO:0034693","cellular_component","U11/U12 snRNP ","O75533"]
["GO:0060187","cellular_component","cell pole ","Q9ULK5"]
["GO:0001651","cellular_component","dense fibrillar component ","P22087"]
["GO:0030137","cellular_component","CPI-coated vesicle ","Q6VY07"]
["GO:0042565","cellular_component","RNA nuclear export complex ","P62826"]
["GO:0000126","cellular_component","transcription factor TFIIIB complex ","Q92994"]
["GO:0097149","cellular_component","centralspindlin complex ","Q9H0H5; Q9H8V3; Q02241"]
["GO:0001520","cellular_component","outer dense fiber ","Q14990; Q5BJF6; P26196"]
["GO:0098855","cellular_component","HCN channel complex ","Q9Y3Q4; Q9UL51"]
["GO:0098850","cellular_component","extrinsic component of synaptic vesicle membrane ","O43765; P17600"]
["GO:1990332","cellular_component","Ire complex ","O75460"]
["GO:1990630","cellular_component","IRE-RACK-PP2A complex ","O75460; P63244"]
["GO:0042589","cellular_component","zymogen granule membrane ","P63027; Q9UGM3"]
["GO:1990590","cellular_component","ATF-ATF4 transcription factor complex ","P18848; P18846"]
["GO:1990617","cellular_component","CHP-ATF4 complex ","P18848; P35638"]
["GO:1990037","cellular_component","Lewy body core ","P18848"]
["GO:0031080","cellular_component","nuclear pore outer ring ","P57740; Q8WUM0; P52948"]
["GO:0005639","cellular_component","integral component of nuclear inner membrane ","Q9Y2U8; Q9UBL9; O94901; Q14739; Q9UH99"]
["GO:0031415","cellular_component","NatA complex ","Q6N069"]
["GO:0032449","cellular_component","CBM complex ","Q9BXL7; O95999"]
["GO:0000110","cellular_component","nucleotide-excision repair factor  complex ","P23025"]
["GO:0030992","cellular_component","intraciliary transport particle B ","Q9P2E2"]
["GO:1990075","cellular_component","periciliary membrane compartment ","Q9P2E2"]
["GO:0016942","cellular_component","insulin-like growth factor binding protein complex ","P17936"]
["GO:0042567","cellular_component","insulin-like growth factor ternary complex ","P17936"]
["GO:0070971","cellular_component","endoplasmic reticulum exit site ","Q15436; Q92734; P01892"]
["GO:0016602","cellular_component","CCAAT-binding factor complex ","P23511"]
["GO:0097413","cellular_component","Lewy body ","Q13501; Q9BXM7; O60260"]
["GO:0034518","cellular_component","RNA cap binding complex ","Q53F19; P52298; Q09161"]
["GO:0030057","cellular_component","desmosome ","P14923; P15924"]
["GO:0071665","cellular_component","gamma-catenin-TCFL2 complex ","P14923"]
["GO:1990454","cellular_component","L-type voltage-gated calcium channel complex ","Q13936; Q01668; Q08289; Q13698"]
["GO:0070195","cellular_component","growth hormone receptor complex ","P10912"]
["GO:0031213","cellular_component","RSF complex ","Q96T23"]
["GO:0031021","cellular_component","interphase microtubule organizing center ","O15392"]
["GO:1990356","cellular_component","sumoylated E2 ligase complex ","P63279"]
["GO:1990234","cellular_component","transferase complex ","P63279; Q8N2W9"]
["GO:0030663","cellular_component","CPI-coated vesicle membrane ","P24390"]
["GO:0038037","cellular_component","-protein coupled receptor dimeric complex ","Q13255"]
["GO:0038038","cellular_component","-protein coupled receptor homodimeric complex ","Q13255"]
["GO:0098556","cellular_component","cytoplasmic side of rough endoplasmic reticulum membrane ","O95278"]
["GO:0000408","cellular_component","EKC/KEPS complex ","Q96S44; Q9BXV9"]
["GO:0030692","cellular_component","Noc4p-Nop14p complex ","Q9BVI4"]
["GO:0000808","cellular_component","origin recognition complex ","Q13416; Q13415; O43929; Q9Y5N6"]
["GO:0000801","cellular_component","central element ","Q9NQS7"]
["GO:0036284","cellular_component","tubulobulbar complex ","O15143"]
["GO:0032807","cellular_component","DNA ligase IV complex ","Q13426; Q9H9Q4; P49917"]
["GO:0072563","cellular_component","endothelial microparticle ","P17813; P08758"]
["GO:0070022","cellular_component","transforming growth factor beta receptor complex ","P17813; P37173; P36897"]
["GO:0061689","cellular_component","tricellular tight junction ","Q86X29"]
["GO:0035068","cellular_component","micro-ribonucleoprotein complex ","Q15633; Q9UKV8"]
["GO:0070578","cellular_component","RISC-loading complex ","Q15633; Q9UKV8"]
["GO:0043219","cellular_component","lateral loop ","Q12959; Q8IXJ6"]
["GO:0097025","cellular_component","MPP-DL1-LIN complex ","Q12959"]
["GO:0005753","cellular_component","mitochondrial proton-transporting ATP synthase complex ","P36542; P18859; P56134"]
["GO:0000275","cellular_component","mitochondrial proton-transporting ATP synthase complex, catalytic core F(1) ","P36542"]
["GO:0032937","cellular_component","SREBP-SCAP-Insig complex ","Q12772"]
["GO:0030981","cellular_component","cortical microtubule cytoskeleton ","Q15691"]
["GO:0005869","cellular_component","dynactin complex ","Q14203; O00399"]
["GO:0030286","cellular_component","dynein complex ","Q14203"]
["GO:0071821","cellular_component","FANCM-MHF complex ","Q8N2Z9"]
["GO:0061846","cellular_component","dendritic spine cytoplasm ","Q9UQB8"]
["GO:0061845","cellular_component","neuron projection branch point ","Q9UQB8"]
["GO:0036126","cellular_component","sperm flagellum ","P14416; P23634"]
["GO:1990851","cellular_component","Wnt-Frizzled-LRP/6 complex ","O75581"]
["GO:0044530","cellular_component","supraspliceosomal complex ","Q92900; P38159"]
["GO:0001527","cellular_component","microfibril ","P55081"]
["GO:0044216","cellular_component","other organism cell ","P17931"]
["GO:0031390","cellular_component","Ctf8 RFC-like complex ","P40937; Q8WVB6"]
["GO:0031510","cellular_component","SUM activating enzyme complex ","P63165"]
["GO:0030892","cellular_component","mitotic cohesin complex ","Q562F6"]
["GO:0106003","cellular_component","amyloid-beta complex ","P05067"]
["GO:0070381","cellular_component","endosome to plasma membrane transport vesicle ","P05067"]
["GO:0044302","cellular_component","dentate gyrus mossy fiber ","Q9UQF2"]
["GO:0033010","cellular_component","paranodal junction ","P16389; Q8IXJ6"]
["GO:0089717","cellular_component","spanning component of membrane ","Q8TD43; Q8N0W4; Q8N2Q7"]
["GO:0098892","cellular_component","extrinsic component of postsynaptic specialization membrane ","P52292"]
["GO:0031094","cellular_component","platelet dense tubular network ","Q14643"]
["GO:0098683","cellular_component","cochlear hair cell ribbon synapse ","Q01668"]
["GO:0044609","cellular_component","DBIRD complex ","Q8N163"]
["GO:1903754","cellular_component","cortical microtubule plus-end ","O75122"]
["GO:0015934","cellular_component","large ribosomal subunit ","P40429"]
["GO:1902710","cellular_component","ABA receptor complex ","O75899; P14867"]
["GO:0070421","cellular_component","DNA ligase III-XRCC complex ","P49916"]
["GO:0120044","cellular_component","stereocilium base ","Q9H2D6"]
["GO:0120043","cellular_component","stereocilium shaft ","Q9H2D6"]
["GO:0010370","cellular_component","perinucleolar chromocenter ","Q9BSI4"]
["GO:0000235","cellular_component","astral microtubule ","Q49MG5"]
["GO:0098636","cellular_component","protein complex involved in cell adhesion ","P10747; P16410"]
["GO:0030131","cellular_component","clathrin adaptor complex ","Q9UJY5"]
["GO:0009328","cellular_component","phenylalanine-tRNA ligase complex ","Q9Y285"]
["GO:0005898","cellular_component","interleukin-13 receptor complex ","P78552"]
["GO:0031083","cellular_component","BLC- complex ","O95295"]
["GO:0099078","cellular_component","BRC complex ","O95295"]
["GO:0031389","cellular_component","Rad7 RFC-like complex ","O75943"]
["GO:0046691","cellular_component","intracellular canaliculus ","P22460"]
["GO:0017059","cellular_component","serine C-palmitoyltransferase complex ","O15269"]
["GO:0035339","cellular_component","SPTS complex ","O15269"]
["GO:0005827","cellular_component","polar microtubule ","P23258"]
["GO:0033596","cellular_component","TSC1-TSC2 complex ","P49815; Q92574"]
["GO:0014804","cellular_component","terminal cisterna lumen ","P31415"]
["GO:0000177","cellular_component","cytoplasmic exosome (RNase complex) ","Q06265; Q9NQT5; Q15024; Q9Y2V2; Q9NQT4"]
["GO:0000176","cellular_component","nuclear exosome (RNase complex) ","Q06265; Q9NQT5; Q15024; Q9NQT4"]
["GO:0097539","cellular_component","ciliary transition fiber ","Q5BJF6; Q86YF9"]
["GO:0034991","cellular_component","nuclear meiotic cohesin complex ","Q9UQE7"]
["GO:0002079","cellular_component","inner acrosomal membrane ","P15529"]
["GO:0034702","cellular_component","ion channel complex ","P51787"]
["GO:0031371","cellular_component","ubiquitin conjugating enzyme complex ","Q9UNE7; Q13404"]
["GO:0045239","cellular_component","tricarboxylic acid cycle enzyme complex ","P07954"]
["GO:0097505","cellular_component","Rad6-Rad18 complex ","Q9NS91"]
["GO:0098575","cellular_component","lumenal side of lysosomal membrane ","P11142"]
["GO:0070469","cellular_component","respiratory chain ","P99999"]
["GO:0042599","cellular_component","lamellar body ","P17405"]
["GO:0035370","cellular_component","UBC1-UEV1A complex ","Q13404; P61088"]
["GO:0030905","cellular_component","retromer, tubulation complex ","O60749"]
["GO:0030904","cellular_component","retromer complex ","O60749; Q5VZ89"]
["GO:0005832","cellular_component","chaperonin-containing T-complex ","P78371"]
["GO:0005724","cellular_component","nuclear telomeric heterochromatin ","Q8N6T7"]
["GO:0005854","cellular_component","nascent polypeptide-associated complex ","Q13765; E9PAV3"]
["GO:0097457","cellular_component","hippocampal mossy fiber ","P46821"]
["GO:0033593","cellular_component","BRCA2-MAE-D1 complex ","P51587"]
["GO:0032302","cellular_component","MutSbeta complex ","P43246"]
["GO:1990745","cellular_component","EARP complex ","Q96JG6"]
["GO:1902937","cellular_component","inward rectifier potassium channel complex ","Q12809"]
["GO:1990622","cellular_component","CHP-ATF3 complex ","P35638"]
["GO:0097361","cellular_component","CIA complex ","O76071"]
["GO:0071817","cellular_component","MMXD complex ","O76071"]
["GO:0030678","cellular_component","mitochondrial ribonuclease P complex ","Q99714"]
["GO:0009331","cellular_component","glycerol--phosphate dehydrogenase complex ","Q8N335"]
["GO:0070939","cellular_component","Dsl1/NZR complex ","O43264"]
["GO:1990423","cellular_component","RZZ complex ","O43264"]
["GO:0030681","cellular_component","multimeric ribonuclease P complex ","O75817; O95707"]
["GO:0005655","cellular_component","nucleolar ribonuclease P complex ","O75817"]
["GO:0000172","cellular_component","ribonuclease MRP complex ","O75817; O95707"]
["GO:0016938","cellular_component","kinesin I complex ","Q9H0B6"]
["GO:1990298","cellular_component","bub-bub3 complex ","O43684"]
["GO:0033597","cellular_component","mitotic checkpoint complex ","O43684"]
["GO:0012510","cellular_component","trans-olgi network transport vesicle membrane ","Q92686"]
["GO:0098559","cellular_component","cytoplasmic side of early endosome membrane ","P20339"]
["GO:0000815","cellular_component","ESCRT III complex ","Q9Y3E7; Q8WUX9; Q96CF2"]
["GO:0000120","cellular_component","RNA polymerase I transcription factor complex ","O15446"]
["GO:0002193","cellular_component","MAML-RBP-Jkappa- ICN complex ","P46531; Q06330"]
["GO:0016013","cellular_component","syntrophin complex ","Q13424"]
["GO:0090498","cellular_component","extrinsic component of olgi membrane ","Q08378"]
["GO:0017119","cellular_component","olgi transport complex ","Q08378; P60953"]
["GO:0097145","cellular_component","BAK complex ","Q16611"]
["GO:0043527","cellular_component","tRNA methyltransferase complex ","Q9UBP6"]
["GO:1990031","cellular_component","pinceau fiber ","Q13303"]
["GO:0097226","cellular_component","sperm mitochondrial sheath ","P54819"]
["GO:0016011","cellular_component","dystroglycan complex ","Q14118"]
["GO:0070820","cellular_component","tertiary granule ","O00186"]
["GO:0030526","cellular_component","granulocyte macrophage colony-stimulating factor receptor complex ","P32927"]
["GO:0000941","cellular_component","condensed nuclear chromosome inner kinetochore ","Q9H410"]
["GO:0034457","cellular_component","Mpp1 complex ","O00566"]
["GO:0005732","cellular_component","small nucleolar ribonucleoprotein complex ","O00566"]
["GO:0005774","cellular_component","vacuolar membrane ","Q13614"]
["GO:0036396","cellular_component","RNA N-methyladenosine methyltransferase complex ","Q86U44"]
["GO:0097255","cellular_component","RTP complex ","Q9Y230; Q9Y265"]
["GO:0030677","cellular_component","ribonuclease P complex ","O95707"]
["GO:0097169","cellular_component","AIM2 inflammasome complex ","Q9ULZ3"]
["GO:0072558","cellular_component","NLRP1 inflammasome complex ","Q9ULZ3"]
["GO:0035032","cellular_component","phosphatidylinositol -kinase complex, class III ","Q8NEB9; Q14457"]
["GO:0034271","cellular_component","phosphatidylinositol -kinase complex, class III, type I ","Q8NEB9; Q14457"]
["GO:0034272","cellular_component","phosphatidylinositol -kinase complex, class III, type II ","Q8NEB9; Q14457"]
["GO:0036128","cellular_component","CatSper complex ","P54652"]
["GO:0070652","cellular_component","HAUS complex ","Q7Z4H7"]
["GO:0032777","cellular_component","Piccolo NuA4 histone acetyltransferase complex ","Q92993"]
["GO:0016589","cellular_component","NURF complex ","Q8IXM2"]
["GO:0031233","cellular_component","intrinsic component of external side of plasma membrane ","P13726"]
["GO:1905286","cellular_component","serine-type peptidase complex ","P13726"]
["GO:0000153","cellular_component","cytoplasmic ubiquitin ligase complex ","Q9NT62"]
["GO:0098985","cellular_component","asymmetric, glutamatergic, excitatory synapse ","Q8N0W4; Q8N2Q7"]
["GO:0098983","cellular_component","symmetric, ABA-ergic, inhibitory synapse ","Q8N0W4"]
["GO:0032299","cellular_component","ribonuclease H complex ","Q8TDP1"]
["GO:0016939","cellular_component","kinesin II complex ","Q9Y496"]
["GO:0032311","cellular_component","angiogenin-PRI complex ","P13489"]
["GO:0000276","cellular_component","mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) ","P18859; P56134"]
["GO:0016590","cellular_component","ACF complex ","Q9NRL2"]
["GO:0008623","cellular_component","CHRAC ","Q9NRL2"]
["GO:0005749","cellular_component","mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) ","P31040"]
["GO:0016272","cellular_component","prefoldin complex ","Q99471"]
["GO:0070522","cellular_component","ERCC4-ERCC1 complex ","P18887"]
["GO:0034752","cellular_component","cytosolic aryl hydrocarbon receptor complex ","P35869"]
["GO:0034753","cellular_component","nuclear aryl hydrocarbon receptor complex ","P35869"]
["GO:0000814","cellular_component","ESCRT II complex ","Q96H20"]
["GO:1990221","cellular_component","L-cysteine desulfurase complex ","Q16595"]
["GO:0098843","cellular_component","postsynaptic endocytic zone ","P42262"]
["GO:0070877","cellular_component","microprocessor complex ","Q8WYQ5; Q9NRR4"]
["GO:0030891","cellular_component","VCB complex ","P40337"]
["GO:0032421","cellular_component","stereocilium bundle ","O75762"]
["GO:0000811","cellular_component","INS complex ","Q9Y248"]
["GO:0055028","cellular_component","cortical microtubule ","Q14980"]
["GO:1905720","cellular_component","cytoplasmic microtubule bundle ","Q14980"]
["GO:0061673","cellular_component","mitotic spindle astral microtubule ","Q14980"]
["GO:0005927","cellular_component","muscle tendon junction ","Q9UHP9"]
["GO:0045098","cellular_component","type III intermediate filament ","P41219"]
["GO:0042272","cellular_component","nuclear RNA export factor complex ","Q9H4D5"]
["GO:0098577","cellular_component","inactive sex chromosome ","Q00839"]
["GO:1990498","cellular_component","mitotic spindle microtubule ","Q00839; Q00610"]
["GO:0070618","cellular_component","rb2-Sos complex ","Q07666"]
["GO:0005846","cellular_component","nuclear cap binding complex ","P52298; Q09161"]
["GO:0098753","cellular_component","anchored component of the cytoplasmic side of the plasma membrane ","Q9NR22"]
["GO:0043540","cellular_component","6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex ","P16118"]
["GO:0061830","cellular_component","concave side of sperm head ","P26196"]
["GO:0014705","cellular_component","C zone ","Q14896"]
["GO:0034777","cellular_component","recycling endosome lumen ","P50479"]
["GO:0031301","cellular_component","integral component of organelle membrane ","P21817"]
["GO:1990425","cellular_component","ryanodine receptor complex ","P21817"]
["GO:0005862","cellular_component","muscle thin filament tropomyosin ","P09493"]
["GO:0035363","cellular_component","histone locus body ","P55199"]
["GO:1990452","cellular_component","Parkin-FBXW7-Cul ubiquitin ligase complex ","Q969H0; O60260"]
["GO:0034448","cellular_component","E complex ","Q9HB90"]
["GO:1990131","cellular_component","tr-tr2 TPase complex ","Q9HB90"]
["GO:0071920","cellular_component","cleavage body ","P33240"]
["GO:0005587","cellular_component","collagen type IV trimer ","Q01955"]
["GO:0060342","cellular_component","photoreceptor inner segment membrane ","P08100"]
["GO:0071986","cellular_component","Ragulator complex ","O43504"]
["GO:0036021","cellular_component","endolysosome lumen ","Q99538"]
["GO:0031262","cellular_component","Ndc8 complex ","O14777"]
["GO:0009507","cellular_component","chloroplast ","P31954"]
["GO:0005797","cellular_component","olgi medial cisterna ","P01892"]
["GO:0030121","cellular_component","AP- adaptor complex ","Q16572"]
["GO:0014801","cellular_component","longitudinal sarcoplasmic reticulum ","P16615"]
["GO:0008541","cellular_component","proteasome regulatory particle, lid subcomplex ","O00231"]
["GO:0140007","cellular_component","KICSTR complex ","Q5T011"]
["GO:0030128","cellular_component","clathrin coat of endocytic vesicle ","O95208"]
["GO:0098845","cellular_component","postsynaptic endosome ","Q7LC44"]
["GO:0031697","molecular_function","beta- adrenergic receptor binding ","P78352; Q9Y4G8; Q86UL8; Q99961"]
["GO:0015276","molecular_function","ligand-gated ion channel activity ","P78352; P36544; Q13002; P43681; Q07001; P0DP23; P39086; P08133; Q9UBL9; P18505; Q12959; P07510; Q16478; P61601"]
["GO:0097109","molecular_function","neuroligin family protein binding ","P78352; Q9P2S2; Q9ULB1; P58400"]
["GO:0031812","molecular_function","PY nucleotide receptor binding ","P78352"]
["GO:0000146","molecular_function","microfilament motor activity ","Q13459; P35580; Q9UKX2; Q9Y4I1; Q8NEV4; P35579; Q9UKX3"]
["GO:0048495","molecular_function","Roundabout binding ","Q13459; O43294"]
["GO:0031624","molecular_function","ubiquitin conjugating enzyme binding ","O95376; O75150; Q13002; Q9UBW7; P58012; Q9Y4K3; Q07869; Q8WVD3; Q9UBS8; O43255; O60260"]
["GO:0000309","molecular_function","nicotinamide-nucleotide adenylyltransferase activity ","Q9HAN9"]
["GO:0017112","molecular_function","Rab guanyl-nucleotide exchange factor activity ","Q96QF0; Q13671; P78524; A2RUS2; Q8TEH3; Q8TBN0; P62258; Q14C86; Q5VZ89"]
["GO:0005201","molecular_function","extracellular matrix structural constituent ","P02671; P04004; P11047; P14543; Q8IUX7; P01730"]
["GO:0019213","molecular_function","deacetylase activity ","Q92769; Q96EB6; Q13547"]
["GO:0004115","molecular_function","3','-cyclic-AMP phosphodiesterase activity ","Q08499; Q08493; Q13370; Q9HCR9; P54750; Q14432; Q07343; Q9Y233; P27815"]
["GO:0004114","molecular_function","3',5'-cyclic-nucleotide phosphodiesterase activity ","Q08499; Q13370; O76074; Q9HCR9; Q9Y233"]
["GO:0031698","molecular_function","beta-2 adrenergic receptor binding ","Q08499; O14745; P46934"]
["GO:0046961","molecular_function","proton-transporting ATPase activity, rotational mechanism ","P38606"]
["GO:0019843","molecular_function","rRNA binding ","P62917; P62280; P46782; P30050; O75616"]
["GO:0004126","molecular_function","cytidine deaminase activity ","Q9HC16; Q9GZX7"]
["GO:0008829","molecular_function","dCTP deaminase activity ","Q9HC16"]
["GO:0047844","molecular_function","deoxycytidine deaminase activity ","Q9HC16"]
["GO:0002162","molecular_function","dystroglycan binding ","P11137; P18206; O75122; Q14118"]
["GO:0042043","molecular_function","neurexin family protein binding ","Q8IYJ3; Q8N0W4; Q8N2Q7"]
["GO:0005254","molecular_function","chloride channel activity ","Q9NZA1; P18507; O00299; O00168; P51790; Q5XXA6; O14493; P13569; P47870; O76090; Q96S66"]
["GO:0005244","molecular_function","voltage-gated ion channel activity ","Q9NZA1; Q6PIL6; Q13563; O00299; Q99250; Q14524; P57789; P22001; Q9NZI2; Q9Y5Y9; Q9UQD0; Q9Y2W7; O95180"]
["GO:0042166","molecular_function","acetylcholine binding ","P36544; P43681; Q07001; P20309; Q16572"]
["GO:0022848","molecular_function","acetylcholine-gated cation-selective channel activity ","P36544; P43681; Q07001; P07510"]
["GO:0015464","molecular_function","acetylcholine receptor activity ","P36544; P43681; P07510"]
["GO:0005262","molecular_function","calcium channel activity ","P36544; Q00975; Q7Z2W7; Q8NE86; Q9Y210; P51674; Q9NQA5; Q9HBA0; Q96RD7; Q92736; Q9UI40; Q9BX84; Q9HCX4; Q9Y698; Q13507; P49768; Q8TD43; Q01668; Q8NET8; Q93034; Q8NER1; O94759; P98161; Q96QT4; Q9H1D0; Q9GZU1; O75762; Q9Y5S1; P21817; Q08289"]
["GO:0005216","molecular_function","ion channel activity ","P36544; Q9Y5S1; P51170; P36383; O14649"]
["GO:0003823","molecular_function","antigen binding ","P16871; Q9NS56; Q13291; P25942"]
["GO:0004917","molecular_function","interleukin- receptor activity ","P16871"]
["GO:0071820","molecular_function","N-box binding ","Q14469"]
["GO:0003857","molecular_function","-hydroxyacyl-CoA dehydrogenase activity ","Q16836; P55084; Q99714"]
["GO:0070403","molecular_function","NAD+ binding ","Q16836; Q96EB6; Q9NTG7; Q8N6T7; P00367; Q8IXJ6"]
["GO:0033549","molecular_function","MAP kinase phosphatase activity ","P51452; Q9Y6W6"]
["GO:0004930","molecular_function","-protein coupled receptor activity ","P41180; Q9NYQ6; P41146; P61073; Q9UBH6; P32248; P41594; Q13255; P21453; P35367; P21730; Q14416; P49685; Q14832; O43613; Q8NFJ5; Q5NUL3; P08100; P35372"]
["GO:0019808","molecular_function","polyamine binding ","P41180"]
["GO:0016934","molecular_function","extracellularly glycine-gated chloride channel activity ","P48167"]
["GO:0016933","molecular_function","extracellularly glycine-gated ion channel activity ","P48167"]
["GO:0033300","molecular_function","dehydroascorbic acid transmembrane transporter activity ","P11166; P11168"]
["GO:0055056","molecular_function","D-glucose transmembrane transporter activity ","P11166; P14672; P11168"]
["GO:0005355","molecular_function","glucose transmembrane transporter activity ","P11166; P14672; P11168"]
["GO:0042910","molecular_function","xenobiotic transmembrane transporter activity ","P11166"]
["GO:0004252","molecular_function","serine-type endopeptidase activity ","P00736; P09958; O43464; P00747; O14773; P00749; P08253; P50281"]
["GO:0008236","molecular_function","serine-type peptidase activity ","P00736; O43464; P00747; O14773; P52948"]
["GO:0016018","molecular_function","cyclosporin A binding ","P30405; Q08209; Q9UNP9"]
["GO:0003755","molecular_function","peptidyl-prolyl cis-trans isomerase activity ","P30405; Q02790; Q9Y237; Q9Y680; Q9UNP9; O95302; Q13526"]
["GO:0003774","molecular_function","motor activity ","P35749; Q14203; Q07866; O00139; P63167; Q9P2M7; Q9UM54; Q13526; P35579"]
["GO:0008307","molecular_function","structural constituent of muscle ","P35749; Q8WZ42; Q9GZV1; Q15149; P52179; P54296; P50461; O15273; P10916; P08727; Q14118; O94875; P24844; Q14896; P09493; Q00872"]
["GO:0003777","molecular_function","microtubule motor activity ","Q02224; Q9NP97; Q99661; Q9NQT8; Q14807; Q15058; O95235; Q9BW19; Q07866; O00139; Q9UQE7; Q9H0B6; Q14204; Q8N4N8; O95239; Q9Y6G9; Q13409; P52732; P33176; O60282; Q02241"]
["GO:0008296","molecular_function","3'-5'-exodeoxyribonuclease activity ","Q9NSU2"]
["GO:0008408","molecular_function","3'-5' exonuclease activity ","Q9NSU2; Q99638; Q8IW19; P49959; O60671; P27695; Q14191"]
["GO:0032558","molecular_function","adenyl deoxyribonucleotide binding ","Q9NSU2"]
["GO:0008853","molecular_function","exodeoxyribonuclease III activity ","Q9NSU2; Q99638; O60671"]
["GO:0035591","molecular_function","signaling adaptor activity ","Q7Z434; Q5VWQ8; Q9NRF2; Q9UGK3; P63244; Q8N4X5; Q86YM7; O15169; Q9UQQ2"]
["GO:0017128","molecular_function","phospholipid scramblase activity ","O15162; Q9NRY6"]
["GO:0004175","molecular_function","endopeptidase activity ","P09958; Q92542; Q9Y4P1; P08473; P42892; P00747; P49768; O14773; P49810; Q9HC62; P60900; P12821; P50281"]
["GO:0008233","molecular_function","peptidase activity ","P09958; Q9Y2G1; P55211; O43464; P56817; Q99497; Q14790; O94782; P15374; O14773; P55210; Q9UHP3; P42574; Q99538"]
["GO:0009882","molecular_function","blue light photoreceptor activity ","Q49AN0; Q16526"]
["GO:0071949","molecular_function","FAD binding ","Q49AN0; P47989"]
["GO:0030060","molecular_function","L-malate dehydrogenase activity ","P40926; P40925; O43175"]
["GO:0046554","molecular_function","malate dehydrogenase (NADP+) activity ","P40926"]
["GO:0005092","molecular_function","DP-dissociation inhibitor activity ","Q9P0V3; P81274; O43566; P31150; O14713"]
["GO:0004004","molecular_function","ATP-dependent RNA helicase activity ","Q9NUU7; P17844; Q9UHI6; P38919; Q9Y2R4; Q9UMR2; Q14240; Q7L7V1; Q9NQI0; Q9UHL0; Q8IYB8; Q92620; Q14562; Q9GZR7; Q92900; O00571; Q13283; Q92841; O00148; Q9UJV9; P26196; Q9H0S4; O15523"]
["GO:0004298","molecular_function","threonine-type endopeptidase activity ","O14818; Q8TAA3; P25788; P60900"]
["GO:0016779","molecular_function","nucleotidyltransferase activity ","O14746"]
["GO:0003968","molecular_function","RNA-directed 5'-' RNA polymerase activity ","O14746; P24928"]
["GO:0003964","molecular_function","RNA-directed DNA polymerase activity ","O14746"]
["GO:0003720","molecular_function","telomerase activity ","O14746; O60832; Q15185"]
["GO:0070034","molecular_function","telomerase RNA binding ","O14746; P07910; O60832; P14678; Q96BK5; O95453; Q9BUR4; Q00839"]
["GO:0003721","molecular_function","telomerase RNA reverse transcriptase activity ","O14746"]
["GO:0098680","molecular_function","template-free RNA nucleotidyltransferase ","O14746"]
["GO:0005179","molecular_function","hormone activity ","P0DN86; P08476; O15240; P12272; P01236; O76061; P0DN87; P05060"]
["GO:0071886","molecular_function","-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding ","P28223"]
["GO:0004993","molecular_function","-protein coupled serotonin receptor activity ","P28223; P28222"]
["GO:0030594","molecular_function","neurotransmitter receptor activity ","P28223; P28222"]
["GO:0051378","molecular_function","serotonin binding ","P28223; P28222"]
["GO:0035877","molecular_function","death effector domain binding ","Q13158; O60936; Q14790"]
["GO:0032813","molecular_function","tumor necrosis factor receptor superfamily binding ","Q13158"]
["GO:0030247","molecular_function","polysaccharide binding ","P04004; O14638; P22413"]
["GO:0005044","molecular_function","scavenger receptor activity ","P04004; P16671; Q8WTV0; O14638; P06127; Q9UGM3; Q96KG7; Q07954; Q15109; P30203; P22413"]
["GO:0042626","molecular_function","ATPase activity, coupled to transmembrane movement of substances ","P08183; Q15311; O60706; Q9UNQ0; P33527; P13569; O95477"]
["GO:0099038","molecular_function","ceramide-translocating ATPase activity ","P08183"]
["GO:0090554","molecular_function","phosphatidylcholine-translocating ATPase activity ","P08183; O95477"]
["GO:0090555","molecular_function","phosphatidylethanolamine-translocating ATPase activity ","P08183"]
["GO:0005215","molecular_function","transporter activity ","P08183; Q5T2W1; P55017; P48065; Q13428; O60706; Q8WTV0; Q9UNQ0; P33527; O95235; Q08378; P17600; Q96CW1; P52948; P18859; O14980"]
["GO:0008559","molecular_function","xenobiotic transmembrane transporting ATPase activity ","P08183; Q9UNQ0; P33527"]
["GO:0008536","molecular_function","Ran TPase binding ","O75592; P49792; P18754; O15392; Q9H6Z4; Q96S59; Q7Z3J3; O14715; O14980; P46060; Q9UKX7"]
["GO:0031593","molecular_function","polyubiquitin modification-dependent protein binding ","Q96CV9; P25686; P42566; P54727; P55072; P46379; Q9UBN7; Q9NS91; Q9UMX0; Q04323; Q6UWZ7"]
["GO:0015616","molecular_function","DNA translocase activity ","Q2NKX8"]
["GO:0008494","molecular_function","translation activator activity ","Q6PKG0; Q92904; P11940; Q8NE71; Q71UM5"]
["GO:0051537","molecular_function","2 iron, 2 sulfur cluster binding ","Q9H1K1; P10109; P47989; P19404; Q16595"]
["GO:0036455","molecular_function","iron-sulfur transferase activity ","Q9H1K1"]
["GO:0005035","molecular_function","death receptor activity ","P08138"]
["GO:0005031","molecular_function","tumor necrosis factor-activated receptor activity ","P08138; P19438; P25445; P25942; P20333"]
["GO:0015271","molecular_function","outward rectifier potassium channel activity ","O95069; Q13563; P22001; P16389; P22460; P51787; Q7Z418"]
["GO:0022841","molecular_function","potassium ion leak channel activity ","O95069; P57789; Q7Z418; Q9NPC2; O14649"]
["GO:0043398","molecular_function","HLH domain binding ","Q96EB6; Q13563; P63279"]
["GO:0017136","molecular_function","NAD-dependent histone deacetylase activity ","Q96EB6; Q9NTG7; Q8N6T7; Q8IXJ6"]
["GO:0046969","molecular_function","NAD-dependent histone deacetylase activity (H3-K specific) ","Q96EB6; Q8N6T7"]
["GO:0034979","molecular_function","NAD-dependent protein deacetylase activity ","Q96EB6; Q9NTG7; Q8N6T7; Q8IXJ6"]
["GO:0003950","molecular_function","NAD+ ADP-ribosyltransferase activity ","O95271; Q9NTG7; Q8N6T7; P09874; Q53GL7"]
["GO:0005337","molecular_function","nucleoside transmembrane transporter activity ","Q99808"]
["GO:0004749","molecular_function","ribose phosphate diphosphokinase activity ","P60891; P11908"]
["GO:0019237","molecular_function","centromeric DNA binding ","Q03188; Q99661; P43246; O43264"]
["GO:0008519","molecular_function","ammonium transmembrane transporter activity ","P29972; Q9H310; P55011"]
["GO:0035379","molecular_function","carbon dioxide transmembrane transporter activity ","P29972"]
["GO:0015168","molecular_function","glycerol transmembrane transporter activity ","P29972; P41181"]
["GO:0005223","molecular_function","intracellular cMP-activated cation channel activity ","P29972"]
["GO:0030184","molecular_function","nitric oxide transmembrane transporter activity ","P29972"]
["GO:0005267","molecular_function","potassium channel activity ","P29972; Q6PIL6; O15554; Q13563; O60706; P57789; Q9NZI2; P16389; Q9Y2W7; Q7Z418; Q9NPC2; Q09470; Q03721; O14649"]
["GO:0015079","molecular_function","potassium ion transmembrane transporter activity ","P29972; Q09470; Q9UHW9"]
["GO:0022857","molecular_function","transmembrane transporter activity ","P29972; Q7L0J3; Q15311; P36542; P18859; P56134"]
["GO:0015250","molecular_function","water channel activity ","P29972; O43315; P41181; P30301; P55064; P55087"]
["GO:0005372","molecular_function","water transmembrane transporter activity ","P29972; O43315; P41181; P55087"]
["GO:0008195","molecular_function","phosphatidate phosphatase activity ","Q14693"]
["GO:0016501","molecular_function","prostacyclin receptor activity ","P43119"]
["GO:0061608","molecular_function","nuclear import signal receptor activity ","O95149; O00505; P52294; P52292"]
["GO:0005124","molecular_function","scavenger receptor binding ","Q5T2W1; P21462"]
["GO:0031752","molecular_function","D dopamine receptor binding ","Q14344; Q9UD71; Q03113"]
["GO:0031683","molecular_function","-protein beta/gamma-subunit complex binding ","Q14344; P11488; P19086; P04899; Q12798; P30679; P41208; Q03113"]
["GO:0019992","molecular_function","diacylglycerol binding ","Q16760; Q9Y4G8; Q7LDG7; Q8IV61; O95267"]
["GO:0004143","molecular_function","diacylglycerol kinase activity ","Q16760; Q13574; P49619; P23743"]
["GO:0003951","molecular_function","NAD+ kinase activity ","Q16760; Q13574; P49619; Q9NYA1; P23743; Q9NRA0; Q8TCT0"]
["GO:0003887","molecular_function","DNA-directed DNA polymerase activity ","P49005; Q15054; O60673; Q9UBT6; Q9NP87; P06746; P49643; Q9Y253; Q9UGP5; Q9HCU8"]
["GO:0004059","molecular_function","aralkylamine N-acetyltransferase activity ","Q16613"]
["GO:0004060","molecular_function","arylamine N-acetyltransferase activity ","Q16613"]
["GO:0017091","molecular_function","AU-rich element binding ","Q15717; Q12906; Q06265; Q15024; Q13151; P26651; P31483"]
["GO:0035198","molecular_function","miRNA binding ","Q15717; Q14671; Q5D1E8; Q5TAX3; Q06787; Q9UL40; P09651; Q9BWF3; P43243; Q15633; P98175; Q5TC82; P22626; Q8IWR0; P48431; Q01860; Q9UKV8; Q8TCS8"]
["GO:0035925","molecular_function","mRNA '-UTR AU-rich region binding ","Q15717; Q5D1E8; Q9BZB8; Q14103; Q07352; Q8NE35; Q92945; P26651"]
["GO:0032050","molecular_function","clathrin heavy chain binding ","P01130; P09497; P09496; Q07954"]
["GO:0030169","molecular_function","low-density lipoprotein particle binding ","P01130; P16671; Q8WTV0; Q92673"]
["GO:0005041","molecular_function","low-density lipoprotein particle receptor activity ","P01130; P16671; Q92673; O75581; Q07954"]
["GO:0030229","molecular_function","very-low-density lipoprotein particle receptor activity ","P01130"]
["GO:0051011","molecular_function","microtubule minus-end binding ","Q08AD1; Q9UPN3; Q14980"]
["GO:0030507","molecular_function","spectrin binding ","Q08AD1; Q08495; P35611; P11171; Q12955; Q9Y496; P35612; P18545"]
["GO:0005234","molecular_function","extracellularly glutamate-gated ion channel activity ","Q13002"]
["GO:0015277","molecular_function","kainate selective glutamate receptor activity ","Q13002; P39086; Q16478"]
["GO:0004839","molecular_function","ubiquitin activating enzyme activity ","P22314"]
["GO:0008331","molecular_function","high voltage-gated calcium channel activity ","Q00975; Q13936; Q01668; Q02641; Q13698"]
["GO:0005245","molecular_function","voltage-gated calcium channel activity ","Q00975; Q13563; Q9Y698; Q13936; Q01668; Q02641; P21817; Q08289; Q13698; P35372"]
["GO:0005521","molecular_function","lamin binding ","Q8NF91; Q9NQ66; P40305; Q5JTV8; P04156; P42166; O94901; Q14739; P36873; P42167; Q9UH99"]
["GO:0016831","molecular_function","carboxy-lyase activity ","Q6P996; P12694"]
["GO:0047498","molecular_function","calcium-dependent phospholipase A2 activity ","P47712"]
["GO:0004622","molecular_function","lysophospholipase activity ","P47712; Q5VWZ2; Q9NP80"]
["GO:0008970","molecular_function","phosphatidylcholine 1-acylhydrolase activity ","P47712"]
["GO:0004623","molecular_function","phospholipase A activity ","P47712; Q9NP80"]
["GO:0102567","molecular_function","phospholipase A activity (consuming ,-dipalmitoylphosphatidylcholine) ","P47712; P30041"]
["GO:0102568","molecular_function","phospholipase A activity consuming ,-dioleoylphosphatidylethanolamine) ","P47712; P30041"]
["GO:0009055","molecular_function","electron transfer activity ","P14598; P09622; O75489; P13498; P10109; P11511; P47989; P09417; O60701; Q9NPH5; P19404; P05091; O43175; Q9UQ10; P31040; P19878"]
["GO:0016175","molecular_function","superoxide-generating NADPH oxidase activity ","P14598; Q96PH1; P13498; Q02962; Q9NPH5; P19878"]
["GO:0052856","molecular_function","NADHX epimerase activity ","Q8NCW5"]
["GO:0052857","molecular_function","NADPHX epimerase activity ","Q8NCW5"]
["GO:1990247","molecular_function","N6-methyladenosine-containing RNA binding ","P07910; P22626"]
["GO:0008266","molecular_function","poly(U) RNA binding ","P07910; Q86TB9; Q96EP5; Q06787; P54253; P11940; P31943; Q96EZ8; Q07666; P05455; Q5VWX1; Q8TCS8"]
["GO:0004003","molecular_function","ATP-dependent DNA helicase activity ","P13010; P19447; P54132; Q14839; P12956; O00571; Q13283; Q9Y230; Q14191; Q9Y265"]
["GO:0016667","molecular_function","oxidoreductase activity, acting on a sulfur group of donors ","Q9BYN0"]
["GO:0032542","molecular_function","sulfiredoxin activity ","Q9BYN0"]
["GO:0042605","molecular_function","peptide antigen binding ","P01889; P01892"]
["GO:0004803","molecular_function","transposase activity ","O96006"]
["GO:0034450","molecular_function","ubiquitin-ubiquitin ligase activity ","O95071; Q9UKV5; Q96FA3; Q9UMS4; Q9HAT8; Q9UNE7; P61086"]
["GO:0004089","molecular_function","carbonate dehydratase activity ","Q16790; P00918; Q9Y2D0"]
["GO:0051213","molecular_function","dioxygenase activity ","Q9Y4C1; Q9BY66; Q7LBC6; P29375; O75151; Q5VWQ0"]
["GO:0032452","molecular_function","histone demethylase activity ","Q9Y4C1; Q9UPP1; O94953; Q9BY66; O60341; Q7LBC6; P29375; O75151; Q9H3R0; Q9Y2K7"]
["GO:0032454","molecular_function","histone demethylase activity (H-K9 specific) ","Q9Y4C1; Q9UPP1; O94953; O60341; Q7LBC6; O75151; Q9H3R0"]
["GO:0004890","molecular_function","ABA-A receptor activity ","P28472; P18507; P18505; P47870; P14867"]
["GO:0022851","molecular_function","ABA-gated chloride ion channel activity ","P28472; P18505; P14867"]
["GO:0030172","molecular_function","troponin C binding ","P45379; P19429; P45378"]
["GO:0031013","molecular_function","troponin I binding ","P45379; P45378"]
["GO:0035727","molecular_function","lysophosphatidic acid binding ","P09327; P17677"]
["GO:0016534","molecular_function","cyclin-dependent protein kinase  activator activity ","Q15078; Q13319"]
["GO:1990948","molecular_function","ubiquitin ligase inhibitor activity ","Q9UKT4; P62913; Q8N726"]
["GO:0008565","molecular_function","protein transporter activity ","Q96T51; Q9NRA8; O00505; P52294; P62834; P52292; Q7Z3T8; P20338; Q99598; O60763; O14713; Q8WUX9; O14980"]
["GO:0004970","molecular_function","ionotropic glutamate receptor activity ","O43424; P48058; P42262"]
["GO:0030898","molecular_function","actin-dependent ATPase activity ","P35580; Q8NEV4; P35579"]
["GO:0035613","molecular_function","RNA stem-loop binding ","P35580; Q9BRS8; Q96EP5; P38919; Q5D1E8; Q06787; O00571; Q5TC82; Q8NE35; P07814"]
["GO:0003863","molecular_function","-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity ","P12694; P21953"]
["GO:0003826","molecular_function","alpha-ketoacid dehydrogenase activity ","P12694; P21953"]
["GO:0070290","molecular_function","N-acylphosphatidylethanolamine-specific phospholipase D activity ","O14939; Q13393"]
["GO:0004630","molecular_function","phospholipase D activity ","O14939; Q13393; P80108; P09601"]
["GO:1990825","molecular_function","sequence-specific mRNA binding ","Q9BRS8; P04818; Q08170; Q06787; P62495; P05455"]
["GO:0004197","molecular_function","cysteine-type endopeptidase activity ","Q9Y4P1; P55211; Q9Y2K6; Q86T82; Q14674; Q70CQ2; Q9Y5T5; Q14790; P55212; P54578; O94782; Q93009; P55210; Q14694; P30101; P40818; P42574; Q9Y4E8; P42575; Q99538"]
["GO:0008234","molecular_function","cysteine-type peptidase activity ","Q9Y4P1; Q14674; Q14790; P55212; Q9UK80; P55210; Q6GQQ9; P17655"]
["GO:0015378","molecular_function","sodiumchloride symporter activity ","P55017"]
["GO:0050291","molecular_function","sphingosine N-acyltransferase activity ","Q6ZMG9; Q8N5B7; Q9HA82"]
["GO:0071074","molecular_function","eukaryotic initiation factor eIF2 binding ","P55010; P16333"]
["GO:0015269","molecular_function","calcium-activated potassium channel activity ","Q12791; O15554; Q92952; Q7Z418; Q9H2S1"]
["GO:0060072","molecular_function","large conductance calcium-activated potassium channel activity ","Q12791"]
["GO:0004689","molecular_function","phosphorylase kinase activity ","P46020; Q93100; Q16816"]
["GO:0015252","molecular_function","proton channel activity ","Q96PH1"]
["GO:0002151","molecular_function","-quadruplex RNA binding ","P51114; Q06787; Q96EZ8"]
["GO:0003988","molecular_function","acetyl-CoA C-acyltransferase activity ","P55084"]
["GO:0004300","molecular_function","enoyl-CoA hydratase activity ","P55084"]
["GO:0016509","molecular_function","long-chain-3-hydroxyacyl-CoA dehydrogenase activity ","P55084"]
["GO:0008035","molecular_function","high-density lipoprotein particle binding ","P16671; P10809; Q8WTV0; O95477"]
["GO:0070892","molecular_function","lipoteichoic acid receptor activity ","P16671"]
["GO:0150025","molecular_function","oxidised low-density lipoprotein particle receptor activity ","P16671"]
["GO:0070053","molecular_function","thrombospondin receptor activity ","P16671; P31431"]
["GO:0008503","molecular_function","benzodiazepine receptor activity ","P18507"]
["GO:0005230","molecular_function","extracellular ligand-gated ion channel activity ","P18507; Q8NER1"]
["GO:0045159","molecular_function","myosin II binding ","Q8N6F7; O14745; Q9H2D6; P06396"]
["GO:0004069","molecular_function","L-aspartate2-oxoglutarate aminotransferase activity ","Q8NHS2"]
["GO:0019104","molecular_function","DNA N-glycosylase activity ","Q53HV7; Q96FI4; Q13569; Q969S2; O95243"]
["GO:0000703","molecular_function","oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity ","Q53HV7"]
["GO:0017065","molecular_function","single-strand selective uracil DNA N-glycosylase activity ","Q53HV7"]
["GO:0004844","molecular_function","uracil DNA N-glycosylase activity ","Q53HV7; P13051; Q13569; P27695"]
["GO:0070061","molecular_function","fructose binding ","P04075; P17858; P05062; P08237"]
["GO:0004332","molecular_function","fructose-bisphosphate aldolase activity ","P04075; P05062"]
["GO:0070984","molecular_function","SET domain binding ","O95785"]
["GO:0008083","molecular_function","growth factor activity ","P23560; P60983; Q9GZV9; P08476; Q92913; O15240; Q15276; P09038; P28799; Q02297; Q92915; P22004; P51858; O14649; P06744; O95390"]
["GO:0005169","molecular_function","neurotrophin TRKB receptor binding ","P23560"]
["GO:0008865","molecular_function","fructokinase activity ","P52789; P19367"]
["GO:0004396","molecular_function","hexokinase activity ","P52789; P19367"]
["GO:0019158","molecular_function","mannokinase activity ","P52789; P19367"]
["GO:0005388","molecular_function","calcium-transporting ATPase activity ","Q01814; P23634; P16615"]
["GO:1905059","molecular_function","calcium-transporting ATPase activity involved in regulation of postsynaptic cytosolic calcium ion concentration ","Q01814"]
["GO:1905056","molecular_function","calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration ","Q01814"]
["GO:0050780","molecular_function","dopamine receptor binding ","O14745"]
["GO:0015379","molecular_function","potassiumchloride symporter activity ","Q9UP95; Q9H2X9; Q9Y666; Q9UHW9"]
["GO:0005094","molecular_function","Rho DP-dissociation inhibitor activity ","P52565; P52566"]
["GO:0003689","molecular_function","DNA clamp loader activity ","P35251; O75943"]
["GO:0061860","molecular_function","DNA clamp unloader activity ","P35251"]
["GO:0061631","molecular_function","ubiquitin conjugating enzyme activity ","Q15819; P68036; P49427; P63146; Q9Y385; Q16763; Q712K3; P49459; P61088; Q9C0C9"]
["GO:0004742","molecular_function","dihydrolipoyllysine-residue acetyltransferase activity ","P10515"]
["GO:0019855","molecular_function","calcium channel inhibitor activity ","P19429; Q16623; P0DP23; Q14643"]
["GO:0031014","molecular_function","troponin T binding ","P19429"]
["GO:0008124","molecular_function","-alpha-hydroxytetrahydrobiopterin dehydratase activity ","P61457"]
["GO:0001671","molecular_function","ATPase activator activity ","P25686; Q9UDY4; Q96KC8; P25685; Q5JTV8; Q99543; P20338; Q14896; O95433"]
["GO:0070628","molecular_function","proteasome binding ","P25686; P46379; P54578; P41134"]
["GO:0140036","molecular_function","ubiquitin-dependent protein binding ","P25686"]
["GO:0097199","molecular_function","cysteine-type endopeptidase activity involved in apoptotic signaling pathway ","P55211; Q14790; P42574"]
["GO:0097200","molecular_function","cysteine-type endopeptidase activity involved in execution phase of apoptosis ","P55211; Q14790; P55212; P55210; O15519; P42574; P42575"]
["GO:0001069","molecular_function","regulatory region RNA binding ","Q9NR56"]
["GO:0009982","molecular_function","pseudouridine synthase activity ","O60832"]
["GO:0004103","molecular_function","choline kinase activity ","Q9Y259; P35790"]
["GO:0004305","molecular_function","ethanolamine kinase activity ","Q9Y259; P35790"]
["GO:0004652","molecular_function","polynucleotide adenylyltransferase activity ","P51003; Q9H6E5"]
["GO:0071208","molecular_function","histone pre-mRNA DCP binding ","Q14493; P14678"]
["GO:0071207","molecular_function","histone pre-mRNA stem-loop binding ","Q14493"]
["GO:0016286","molecular_function","small conductance calcium-activated potassium channel activity ","O15554; Q92952; Q9H2S1"]
["GO:0032051","molecular_function","clathrin light chain binding ","P53675; Q00610"]
["GO:0000035","molecular_function","acyl binding ","P11488"]
["GO:0001664","molecular_function","-protein coupled receptor binding ","P11488; Q9Y2K6; P19086; P04899; P0DMV8; P30679; Q92888; P21453; P21333; Q9UNE7; P11142; P16144; Q9UBU3; P32121; O60260; Q9NRD5"]
["GO:0015292","molecular_function","uniporter activity ","Q8NE86"]
["GO:0071558","molecular_function","histone demethylase activity (H3-K2 specific) ","Q9UPP1"]
["GO:0051864","molecular_function","histone demethylase activity (H3-K3 specific) ","Q9UPP1; O94953; Q9H3R0; Q9Y2K7"]
["GO:0035575","molecular_function","histone demethylase activity (H4-K2 specific) ","Q9UPP1"]
["GO:0016706","molecular_function","oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors ","Q9UPP1; Q96KS0"]
["GO:0005277","molecular_function","acetylcholine transmembrane transporter activity ","O15245; Q16572"]
["GO:0008504","molecular_function","monoamine transmembrane transporter activity ","O15245; Q01959; P23975; Q05940; P31645"]
["GO:0008514","molecular_function","organic anion transmembrane transporter activity ","O15245"]
["GO:0015101","molecular_function","organic cation transmembrane transporter activity ","O15245"]
["GO:0015651","molecular_function","quaternary ammonium group transmembrane transporter activity ","O15245"]
["GO:0008513","molecular_function","secondary active organic cation transmembrane transporter activity ","O15245"]
["GO:0015056","molecular_function","corticotrophin-releasing factor receptor activity ","P34998"]
["GO:0071933","molecular_function","Arp2/ complex binding ","P60983; Q13576; Q9BR76; Q9NRD5"]
["GO:0004991","molecular_function","parathyroid hormone receptor activity ","Q03431"]
["GO:0004998","molecular_function","transferrin receptor activity ","P02786"]
["GO:0033570","molecular_function","transferrin transmembrane transporter activity ","P02786"]
["GO:0005484","molecular_function","SNAP receptor activity ","Q15836; Q16623; P56962; P63027; P51809; O00161; O75379; P60880; P23763; P61266"]
["GO:0002161","molecular_function","aminoacyl-tRNA editing activity ","P26640"]
["GO:0004832","molecular_function","valine-tRNA ligase activity ","P26640"]
["GO:0098919","molecular_function","structural constituent of postsynaptic density ","Q15700; Q12959"]
["GO:0035500","molecular_function","MH2 domain binding ","P17844; P52926"]
["GO:0036002","molecular_function","pre-mRNA binding ","P17844; Q01130; P09651; Q92879; Q15633; Q13247; P26599; O95319; Q00839"]
["GO:0003724","molecular_function","RNA helicase activity ","P17844; Q9GZR7; Q92841; P26196"]
["GO:0051916","molecular_function","granulocyte colony-stimulating factor binding ","Q99062"]
["GO:0038046","molecular_function","enkephalin receptor activity ","P41143"]
["GO:0042923","molecular_function","neuropeptide binding ","P41143; P41146; P32245; P41145; P30874; P35372"]
["GO:0004985","molecular_function","opioid receptor activity ","P41143; P41145; Q9NZT2"]
["GO:0004649","molecular_function","poly(ADP-ribose) glycohydrolase activity ","Q9NX46"]
["GO:0015467","molecular_function","-protein activated inward rectifier potassium channel activity ","P48544; P48549; Q14500; P48050; P63252; P78508; Q9NPI9"]
["GO:0086089","molecular_function","voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization ","P48544; P48549; P22460; P51787"]
["GO:1902282","molecular_function","voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization ","P48544; P48549; P51787; Q12809; Q15842"]
["GO:0019209","molecular_function","kinase activator activity ","Q15750; Q7L9L4"]
["GO:0005105","molecular_function","type  fibroblast growth factor receptor binding ","Q9GZV9; P58400"]
["GO:0004148","molecular_function","dihydrolipoyl dehydrogenase activity ","P09622"]
["GO:0043544","molecular_function","lipoamide binding ","P09622"]
["GO:0001626","molecular_function","nociceptin receptor activity ","P41146"]
["GO:0003841","molecular_function","-acylglycerol--phosphate -acyltransferase activity ","Q7L5N7; Q8NF37; Q16635"]
["GO:0047184","molecular_function","-acylglycerophosphocholine -acyltransferase activity ","Q7L5N7; Q8NF37; Q16635"]
["GO:0047192","molecular_function","-alkylglycerophosphocholine -acetyltransferase activity ","Q7L5N7; Q8NF37"]
["GO:0047144","molecular_function","2-acylglycerol-3-phosphate -acyltransferase activity ","Q7L5N7; Q8NF37"]
["GO:0043138","molecular_function","'-5' DNA helicase activity ","P19447; Q14191"]
["GO:0019864","molecular_function","Ig binding ","P31995; P30273; P12318; P31994"]
["GO:0050682","molecular_function","AF- domain binding ","P62508"]
["GO:0031489","molecular_function","myosin V binding ","P61106; P62491; P35637"]
["GO:0004813","molecular_function","alanine-tRNA ligase activity ","Q5JTZ9"]
["GO:0004843","molecular_function","thiol-dependent ubiquitin-specific protease activity ","Q96RU2; Q9Y2K6; Q86T82; Q70CQ2; Q9NQC7; Q13107; Q9Y5T5; O00303; P54252; Q96JH7; P54578; O94782; P15374; Q9UK80; Q93009; Q14694; Q9UHP3; Q6GQQ9; Q96FW1; P40818; Q9Y4E8"]
["GO:0034711","molecular_function","inhibin binding ","P08476; P36896"]
["GO:0070699","molecular_function","type II activin receptor binding ","P08476; Q86UL8"]
["GO:0004177","molecular_function","aminopeptidase activity ","Q9UIQ6"]
["GO:0070006","molecular_function","metalloaminopeptidase activity ","Q9UIQ6; P50281"]
["GO:0008237","molecular_function","metallopeptidase activity ","Q9UIQ6; P08473; P78536; O43184; P08253; Q13444; P12821"]
["GO:1905773","molecular_function","8-hydroxy-2'-deoxyguanosine DNA binding ","P54132; Q14191"]
["GO:0036310","molecular_function","annealing helicase activity ","P54132; Q9NZC9; Q92698"]
["GO:0043140","molecular_function","ATP-dependent '-5' DNA helicase activity ","P54132; Q8N3C0; O94762; Q14191"]
["GO:0008026","molecular_function","ATP-dependent helicase activity ","P54132"]
["GO:0003678","molecular_function","DNA helicase activity ","P54132; Q8IYB8; Q9Y230; P33993; P33991; O94762; Q14191; Q9Y265"]
["GO:0061749","molecular_function","forked DNA-dependent helicase activity ","P54132; Q14191"]
["GO:0009378","molecular_function","four-way junction helicase activity ","P54132; O94762; Q14191"]
["GO:0051880","molecular_function","-quadruplex DNA binding ","P54132; Q92878; Q14191"]
["GO:0061821","molecular_function","telomeric D-loop binding ","P54132; Q14191"]
["GO:0061849","molecular_function","telomeric -quadruplex DNA binding ","P54132; Q14191"]
["GO:0000403","molecular_function","Y-form DNA binding ","P54132; O00255; Q9NS91; P43246; Q14191"]
["GO:0005261","molecular_function","cation channel activity ","Q9Y210; Q9UHC3; Q9HBA0; O94759; Q9GZU1; Q9Y5S1"]
["GO:0070679","molecular_function","inositol 1,4,5 trisphosphate binding ","Q9Y210; Q15111; Q99418; Q13507; Q14573; Q9Y2J0; Q14643; Q14571"]
["GO:0015279","molecular_function","store-operated calcium channel activity ","Q9Y210; Q96D31; Q9HCX4; Q13507"]
["GO:0015926","molecular_function","glucosidase activity ","Q13724"]
["GO:0004573","molecular_function","mannosyl-oligosaccharide glucosidase activity ","Q13724"]
["GO:0004947","molecular_function","bradykinin receptor activity ","P30411"]
["GO:0004869","molecular_function","cysteine-type endopeptidase inhibitor activity ","P02765; O15392; Q9UGM5; O95997"]
["GO:0004866","molecular_function","endopeptidase inhibitor activity ","P02765; Q14624; P54578; P10646"]
["GO:0019210","molecular_function","kinase inhibitor activity ","P02765; O75581; Q15669"]
["GO:0030246","molecular_function","carbohydrate binding ","Q96LC7; P28906; P20138; O95278; P17931; P27824; Q14697; P21854; Q9Y4K1; A4D1S0; P98161; Q9NPY3"]
["GO:0035374","molecular_function","chondroitin sulfate binding ","Q14195"]
["GO:0031005","molecular_function","filamin binding ","Q14195; P13688; Q14194; P35372"]
["GO:0016810","molecular_function","hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds ","Q14195; Q14194"]
["GO:0048763","molecular_function","calcium-induced calcium release activity ","Q13563; Q92736; P21817"]
["GO:0051371","molecular_function","muscle alpha-actinin binding ","Q13563; Q8WZ42; P52179; P54296; Q8WX93; Q14896; Q00872"]
["GO:0022843","molecular_function","voltage-gated cation channel activity ","Q13563; Q96D96"]
["GO:0005248","molecular_function","voltage-gated sodium channel activity ","Q13563; Q99250; Q14524; Q9Y3Q4; Q9Y5Y9; O43497; Q9UQD0; O95180; Q9UL51"]
["GO:0008440","molecular_function","inositol-1,,5-trisphosphate 3-kinase activity ","P23677; P0DP23"]
["GO:0004016","molecular_function","adenylate cyclase activity ","O60266; Q08828; O43306; Q08462; P40145"]
["GO:0004383","molecular_function","guanylate cyclase activity ","O60266; P25092; Q08828; P16066; Q02153; Q02108; Q02846; O43306; Q08462; P40145"]
["GO:0030742","molecular_function","TP-dependent protein binding ","P53365; P61020; Q15075; O00429; P60953; Q9NPB6"]
["GO:0070273","molecular_function","phosphatidylinositol-4-phosphate binding ","P53365; Q9BR39; Q5VWQ8; Q5TCZ1; P53367; A1X283; Q9H4A6; Q9Y5P4; P22059"]
["GO:1901707","molecular_function","leptomycin B binding ","Q02535"]
["GO:0004874","molecular_function","aryl hydrocarbon receptor activity ","P27540; P35869"]
["GO:0017162","molecular_function","aryl hydrocarbon receptor binding ","P27540; O00327; Q15788; Q15596; O00170"]
["GO:1990837","molecular_function","sequence-specific double-stranded DNA binding ","P27540; Q92886; P35869; Q00839"]
["GO:0097162","molecular_function","MADS box domain binding ","Q99801"]
["GO:0005542","molecular_function","folic acid binding ","P04818; Q14749"]
["GO:0004799","molecular_function","thymidylate synthase activity ","P04818"]
["GO:0004949","molecular_function","cannabinoid receptor activity ","P21554; P34972"]
["GO:0001882","molecular_function","nucleoside binding ","O43707"]
["GO:0034046","molecular_function","poly() binding ","Q86TB9; Q96EP5; Q06787; P54253; Q96EZ8; Q00839; Q8TCS8"]
["GO:0097493","molecular_function","structural molecule activity conferring elasticity ","Q8WZ42; P52179; P54296; Q14896; Q09666; Q00872"]
["GO:0031433","molecular_function","telethonin binding ","Q8WZ42; P50461; P15382"]
["GO:0008832","molecular_function","dTPase activity ","Q9Y3Z3"]
["GO:0032567","molecular_function","dTP binding ","Q9Y3Z3"]
["GO:0004540","molecular_function","ribonuclease activity ","Q9Y3Z3; Q5D1E8"]
["GO:0016793","molecular_function","triphosphoric monoester hydrolase activity ","Q9Y3Z3"]
["GO:1905538","molecular_function","polysome binding ","P16989"]
["GO:0061629","molecular_function","RNA polymerase II sequence-specific DNA-binding transcription factor binding ","Q8IZQ8; Q9GZV1; Q15327"]
["GO:0005539","molecular_function","glycosaminoglycan binding ","Q03167; P04156; P17813; P37173"]
["GO:0005024","molecular_function","transforming growth factor beta-activated receptor activity ","Q03167; P17813; P37173; P36897; P37023"]
["GO:0070123","molecular_function","transforming growth factor beta receptor activity, type III ","Q03167"]
["GO:0005114","molecular_function","type II transforming growth factor beta receptor binding ","Q03167; P17813; P36897"]
["GO:0005174","molecular_function","CD receptor binding ","Q12933"]
["GO:0046625","molecular_function","sphingolipid binding ","Q12933; P21453"]
["GO:0001004","molecular_function","RNA polymerase III transcription factor recruiting activity ","Q9Y5Q9"]
["GO:0008137","molecular_function","NADH dehydrogenase (ubiquinone) activity ","O75489; O43181; O95178; P19404; O95168; Q9P0J0"]
["GO:0003954","molecular_function","NADH dehydrogenase activity ","O75489; Q9P0J0"]
["GO:0019957","molecular_function","C-C chemokine binding ","P61073; P51681; P26651"]
["GO:0016494","molecular_function","C-X-C chemokine receptor activity ","P61073"]
["GO:0038147","molecular_function","C-X-C motif chemokine 2 receptor activity ","P61073"]
["GO:0032027","molecular_function","myosin light chain binding ","P61073"]
["GO:0004046","molecular_function","aminoacylase activity ","P04040"]
["GO:0016209","molecular_function","antioxidant activity ","P04040; P30044; P02649; Q7LBC6; P06702; P32119"]
["GO:0004096","molecular_function","catalase activity ","P04040"]
["GO:0016684","molecular_function","oxidoreductase activity, acting on peroxide as acceptor ","P04040; Q99497"]
["GO:0008093","molecular_function","cytoskeletal adaptor activity ","O00560; P16333; P78559; Q9UQB8; Q9NYB9; O94875"]
["GO:0005137","molecular_function","interleukin- receptor binding ","O00560"]
["GO:0045545","molecular_function","syndecan binding ","O00560"]
["GO:0047499","molecular_function","calcium-independent phospholipase A2 activity ","P30041; Q9NP80"]
["GO:0004602","molecular_function","glutathione peroxidase activity ","P30041; Q16873; P09211; P07203"]
["GO:0051920","molecular_function","peroxiredoxin activity ","P30041; Q99497; P30044"]
["GO:0005049","molecular_function","nuclear export signal receptor activity ","P35658; O14980"]
["GO:0017056","molecular_function","structural constituent of nuclear pore ","P35658; A8CG34; Q9BTX1; P12270; P57740; P49790; Q8WUM0; P37198; P52948; Q96HA1"]
["GO:1904288","molecular_function","BAT3 complex binding ","Q9UKV5; P55072; O43765"]
["GO:0038024","molecular_function","cargo receptor activity ","P42566; P98082; P63010"]
["GO:0030395","molecular_function","lactose binding ","P09382"]
["GO:0043236","molecular_function","laminin binding ","P09382; P05556; P14543; P17301; P17931; P50895"]
["GO:0017127","molecular_function","cholesterol transporter activity ","P49675; Q14849; P02649; O95477"]
["GO:0008294","molecular_function","calcium- and calmodulin-responsive adenylate cyclase activity ","Q08828; P40145"]
["GO:0001018","molecular_function","mitochondrial promoter sequence-specific DNA binding ","Q00059"]
["GO:0036402","molecular_function","proteasome-activating ATPase activity ","P17980; P62195; P43686; P35998"]
["GO:0004777","molecular_function","succinate-semialdehyde dehydrogenase (NAD+) activity ","P51649"]
["GO:0009013","molecular_function","succinate-semialdehyde dehydrogenase [NAD(P)+] activity ","P51649"]
["GO:0046914","molecular_function","transition metal ion binding ","Q06481; P05067; Q16143"]
["GO:0046923","molecular_function","ER retention sequence binding ","Q9NS61"]
["GO:0004459","molecular_function","L-lactate dehydrogenase activity ","P00338; P07195"]
["GO:0019002","molecular_function","MP binding ","P01116"]
["GO:0004427","molecular_function","inorganic diphosphatase activity ","Q9H2U2"]
["GO:0004859","molecular_function","phospholipase inhibitor activity ","P20941; P08758; Q16143"]
["GO:0004198","molecular_function","calcium-dependent cysteine-type endopeptidase activity ","P30626; P17655"]
["GO:0052689","molecular_function","carboxylic ester hydrolase activity ","Q5VWZ2; Q8N0W4; Q6UWW8; Q8N2Q7"]
["GO:0008474","molecular_function","palmitoyl-(protein) hydrolase activity ","Q5VWZ2"]
["GO:0034511","molecular_function","U snoRNA binding ","Q2NL82; O43818"]
["GO:0015267","molecular_function","channel activity ","P48165; Q07812; P10415; P07510; O75762"]
["GO:0004887","molecular_function","thyroid hormone receptor activity ","P10588; Q96RI1; P10828; P10827; Q9H0E9; Q14994"]
["GO:0070095","molecular_function","fructose-6-phosphate binding ","P17858; P16118"]
["GO:0015149","molecular_function","hexose transmembrane transporter activity ","P11168"]
["GO:0032767","molecular_function","copper-dependent protein binding ","Q02790; Q04656"]
["GO:0005528","molecular_function","FK6 binding ","Q02790; Q9Y680; O95644; O95302"]
["GO:0005175","molecular_function","CD2 receptor binding ","O15304"]
["GO:0005221","molecular_function","intracellular cyclic nucleotide activated cation channel activity ","P29973"]
["GO:0031404","molecular_function","chloride ion binding ","P17342; Q13569; Q8N0W4; P12821"]
["GO:0008528","molecular_function","-protein coupled peptide receptor activity ","P17342; P16066; Q9NPC1; P16473; Q15722; P23945"]
["GO:0042562","molecular_function","hormone binding ","P17342; P16066"]
["GO:0016941","molecular_function","natriuretic peptide receptor activity ","P17342; P16066"]
["GO:0044736","molecular_function","acid-sensing ion channel activity ","Q9UHC3; P78348"]
["GO:0042931","molecular_function","enterobactin transmembrane transporter activity ","Q9UHC3"]
["GO:0005272","molecular_function","sodium channel activity ","Q9UHC3; Q8TD43; O94759; P51170"]
["GO:0008750","molecular_function","NAD(P)+ transhydrogenase (AB-specific) activity ","Q13423"]
["GO:0003957","molecular_function","NAD(P)+ transhydrogenase (B-specific) activity ","Q13423"]
["GO:0008746","molecular_function","NAD(P)+ transhydrogenase activity ","Q13423; Q9UQ10"]
["GO:0015171","molecular_function","amino acid transmembrane transporter activity ","P48065; P43003; Q99624; P31641; P43005; P48664"]
["GO:0005332","molecular_function","gamma-aminobutyric acidsodium symporter activity ","P48065"]
["GO:0003877","molecular_function","ATP adenylyltransferase activity ","Q15046"]
["GO:0004824","molecular_function","lysine-tRNA ligase activity ","Q15046"]
["GO:0047555","molecular_function","3','-cyclic-MP phosphodiesterase activity ","Q13370; O76074; Q9HCR9; P54750; Q14432; Q9Y233; P18545"]
["GO:0004119","molecular_function","cMP-inhibited cyclic-nucleotide phosphodiesterase activity ","Q13370; Q14432"]
["GO:0005184","molecular_function","neuropeptide hormone activity ","O15240"]
["GO:0016493","molecular_function","C-C chemokine receptor activity ","P51681; P32248; P41597"]
["GO:0071791","molecular_function","chemokine (C-C motif) ligand 5 binding ","P51681"]
["GO:0004950","molecular_function","chemokine receptor activity ","P51681; P41597"]
["GO:0032028","molecular_function","myosin head/neck binding ","Q16623"]
["GO:0004807","molecular_function","triose-phosphate isomerase activity ","P60174"]
["GO:0004027","molecular_function","alcohol sulfotransferase activity ","O00204"]
["GO:0050294","molecular_function","steroid sulfotransferase activity ","O00204"]
["GO:0004329","molecular_function","formate-tetrahydrofolate ligase activity ","Q6UB35"]
["GO:0004477","molecular_function","methenyltetrahydrofolate cyclohydrolase activity ","Q6UB35"]
["GO:0004488","molecular_function","methylenetetrahydrofolate dehydrogenase (NADP+) activity ","Q6UB35"]
["GO:0017017","molecular_function","MAP kinase tyrosine/serine/threonine phosphatase activity ","Q13202; P28562; Q16828; Q9Y6W6; Q9BY84; Q16690"]
["GO:0003876","molecular_function","AMP deaminase activity ","Q01433"]
["GO:0004614","molecular_function","phosphoglucomutase activity ","P36871"]
["GO:0031821","molecular_function","-protein coupled serotonin receptor binding ","P19086"]
["GO:0004527","molecular_function","exonuclease activity ","Q8N1G1; P39748; Q14191; Q9NUW8; P22413"]
["GO:0044547","molecular_function","DNA topoisomerase binding ","Q9NS56; Q15003; P19338; Q53H47; Q07955"]
["GO:0060590","molecular_function","ATPase regulator activity ","Q8IWQ3"]
["GO:0004968","molecular_function","gonadotropin-releasing hormone receptor activity ","Q96P88"]
["GO:0008238","molecular_function","exopeptidase activity ","P08473; P12821"]
["GO:0004222","molecular_function","metalloendopeptidase activity ","P08473; P42892; P78536; O43184; P08253; Q13444; P50281"]
["GO:0004364","molecular_function","glutathione transferase activity ","Q16873; P09211; P26641; O15217"]
["GO:0004464","molecular_function","leukotriene-C synthase activity ","Q16873"]
["GO:0034186","molecular_function","apolipoprotein A-I binding ","P10809; Q8WTV0; O95477"]
["GO:0098639","molecular_function","collagen binding involved in cell-matrix adhesion ","P05556; P17301"]
["GO:0080025","molecular_function","phosphatidylinositol-3,-bisphosphate binding ","Q5MNZ6; Q9BR39; A1X283; Q9Y4P8; Q92538; P55895; Q9BPZ7"]
["GO:0000994","molecular_function","RNA polymerase III core binding ","Q9H063"]
["GO:0000150","molecular_function","recombinase activity ","O43542; Q06609; Q06330"]
["GO:0004999","molecular_function","vasoactive intestinal polypeptide receptor activity ","P32241"]
["GO:0015278","molecular_function","calcium-release channel activity ","Q9BR39; Q92736; Q14573; Q14643; Q8NER1; O94759; O75762; P21817"]
["GO:0010314","molecular_function","phosphatidylinositol-5-phosphate binding ","Q9BR39; Q5TCZ1; A1X283; Q9Y4P8"]
["GO:0052811","molecular_function","-phosphatidylinositol-3-phosphate 4-kinase activity ","P48426; O60331; O14986; P78356"]
["GO:0016309","molecular_function","-phosphatidylinositol-5-phosphate 4-kinase activity ","P48426; P78356"]
["GO:0003824","molecular_function","catalytic activity ","Q14674; P49789; P08195"]
["GO:0030348","molecular_function","syntaxin- binding ","Q9H2B2; P21579"]
["GO:0004497","molecular_function","monooxygenase activity ","P14679; P08684; P20813; P20815"]
["GO:0004503","molecular_function","monophenol monooxygenase activity ","P14679"]
["GO:0005148","molecular_function","prolactin receptor binding ","P01236"]
["GO:0015108","molecular_function","chloride transmembrane transporter activity ","Q9H2X9; P43005; P13569; P02730"]
["GO:0070097","molecular_function","delta-catenin binding ","O14522; Q12913; Q9NYF0"]
["GO:0004510","molecular_function","tryptophan -monooxygenase activity ","P17752; Q8IWU9"]
["GO:0060090","molecular_function","molecular adaptor activity ","P16333"]
["GO:0005326","molecular_function","neurotransmitter transporter activity ","O14810"]
["GO:0047442","molecular_function","1-alpha-hydroxyprogesterone aldolase activity ","P05093"]
["GO:0004508","molecular_function","steroid 17-alpha-monooxygenase activity ","P05093"]
["GO:0004144","molecular_function","diacylglycerol -acyltransferase activity ","P31951"]
["GO:0050348","molecular_function","trehalose -mycolyltransferase activity ","P31951"]
["GO:0043120","molecular_function","tumor necrosis factor binding ","P19438; P25445"]
["GO:0004170","molecular_function","dUTP diphosphatase activity ","P33316"]
["GO:0030620","molecular_function","U snRNA binding ","P14678; Q6P2Q9"]
["GO:0004919","molecular_function","interleukin- receptor activity ","Q01113"]
["GO:0010428","molecular_function","methyl-CpNp binding ","Q9P1Z0"]
["GO:0043199","molecular_function","sulfate binding ","P28906; P18754; Q13485"]
["GO:0030506","molecular_function","ankyrin binding ","P12830; Q15149; Q01082; Q9H310; P32418; Q14524; O43526; Q01668; P30427; Q14315; P05023; P02730; Q14654"]
["GO:0047159","molecular_function","-alkenylglycerophosphocholine -acyltransferase activity ","Q8NF37"]
["GO:0047191","molecular_function","-alkylglycerophosphocholine -acyltransferase activity ","Q8NF37"]
["GO:0005034","molecular_function","osmosensor activity ","Q9HBA0"]
["GO:0015275","molecular_function","stretch-activated, cation-selective, calcium channel activity ","Q9HBA0"]
["GO:0070644","molecular_function","vitamin D response element binding ","P15923"]
["GO:0016846","molecular_function","carbon-sulfur lyase activity ","P32929"]
["GO:0004123","molecular_function","cystathionine gamma-lyase activity ","P32929"]
["GO:0003962","molecular_function","cystathionine gamma-synthase activity ","P32929"]
["GO:0047982","molecular_function","homocysteine desulfhydrase activity ","P32929"]
["GO:0080146","molecular_function","L-cysteine desulfhydrase activity ","P32929"]
["GO:0044540","molecular_function","L-cystine L-cysteine-lyase (deaminating) ","P32929"]
["GO:0052658","molecular_function","inositol-1,4,-trisphosphate -phosphatase activity ","O43426"]
["GO:0052629","molecular_function","phosphatidylinositol-3,-bisphosphate 3-phosphatase activity ","O43426; Q13614; O15056"]
["GO:0004439","molecular_function","phosphatidylinositol-,5-bisphosphate 5-phosphatase activity ","O43426; O15056"]
["GO:0043812","molecular_function","phosphatidylinositol--phosphate phosphatase activity ","O43426"]
["GO:0034596","molecular_function","phosphatidylinositol phosphate -phosphatase activity ","O43426; O15056"]
["GO:0034595","molecular_function","phosphatidylinositol phosphate -phosphatase activity ","O43426"]
["GO:0008143","molecular_function","poly(A) binding ","P38919; O60506; Q93062; Q6PJT7; O00571; P11940; Q9UNP9; Q00839; Q07666; Q5VWX1; P31483"]
["GO:0035368","molecular_function","selenocysteine insertion sequence binding ","P38919"]
["GO:0045322","molecular_function","unmethylated Cp binding ","Q9P0U4; Q03164"]
["GO:0043028","molecular_function","cysteine-type endopeptidase regulator activity involved in apoptotic process ","P58012"]
["GO:0042288","molecular_function","MHC class I protein binding ","P07437; P55072"]
["GO:0015501","molecular_function","glutamatesodium symporter activity ","P43003; P43005"]
["GO:0005314","molecular_function","high-affinity glutamate transmembrane transporter activity ","P43003; P43005; P48664"]
["GO:0005313","molecular_function","L-glutamate transmembrane transporter activity ","P43003; P43005"]
["GO:0015562","molecular_function","efflux transmembrane transporter activity ","Q9UBH6"]
["GO:0000822","molecular_function","inositol hexakisphosphate binding ","Q9UBH6; Q14573"]
["GO:0015114","molecular_function","phosphate ion transmembrane transporter activity ","Q9UBH6"]
["GO:0015297","molecular_function","antiporter activity ","Q99624; P51790"]
["GO:0015180","molecular_function","L-alanine transmembrane transporter activity ","Q99624"]
["GO:0015182","molecular_function","L-asparagine transmembrane transporter activity ","Q99624"]
["GO:0015186","molecular_function","L-glutamine transmembrane transporter activity ","Q99624"]
["GO:0005290","molecular_function","L-histidine transmembrane transporter activity ","Q99624"]
["GO:0015293","molecular_function","symporter activity ","Q99624; Q9UI40"]
["GO:0032184","molecular_function","SUM polymer binding ","P78317"]
["GO:0035175","molecular_function","histone kinase activity (H-S specific) ","Q99986"]
["GO:0072354","molecular_function","histone kinase activity (H-T specific) ","Q99986; Q8TF76"]
["GO:0031493","molecular_function","nucleosomal histone binding ","Q99986; Q96T88"]
["GO:0050750","molecular_function","low-density lipoprotein particle receptor binding ","P14625; P21579; Q15036; P02649; P05067; P30533; Q96CW1; Q00610"]
["GO:0003956","molecular_function","NAD(P)+-protein-arginine ADP-ribosyltransferase activity ","Q93070; Q8N6T7"]
["GO:0003899","molecular_function","DNA-directed 5'-' RNA polymerase activity ","O15160; P24928; P61218; O15446; Q9Y2Y1; P05423"]
["GO:0001727","molecular_function","lipid kinase activity ","Q13574"]
["GO:0004462","molecular_function","lactoylglutathione lyase activity ","Q04760"]
["GO:0047710","molecular_function","bis(5'-adenosyl)-triphosphatase activity ","P49789"]
["GO:0038117","molecular_function","C-C motif chemokine 9 receptor activity ","P32248"]
["GO:0038121","molecular_function","C-C motif chemokine  receptor activity ","P32248"]
["GO:0035757","molecular_function","chemokine (C-C motif) ligand 19 binding ","P32248"]
["GO:0035758","molecular_function","chemokine (C-C motif) ligand 21 binding ","P32248"]
["GO:0001632","molecular_function","leukotriene B4 receptor activity ","Q9NPC1; Q15722"]
["GO:0004974","molecular_function","leukotriene receptor activity ","Q9NPC1; Q15722"]
["GO:0001591","molecular_function","dopamine neurotransmitter receptor activity, coupled via i/o ","P35462; P14416"]
["GO:0008511","molecular_function","sodiumpotassiumchloride symporter activity ","Q13621; P55011"]
["GO:0005328","molecular_function","neurotransmittersodium symporter activity ","P31641; Q01959; P23975"]
["GO:0005369","molecular_function","taurinesodium symporter activity ","P31641"]
["GO:0015229","molecular_function","L-ascorbic acid transmembrane transporter activity ","Q9UGH3"]
["GO:0015205","molecular_function","nucleobase transmembrane transporter activity ","Q9UGH3"]
["GO:0070890","molecular_function","sodium-dependent L-ascorbate transmembrane transporter activity ","Q9UGH3"]
["GO:0043532","molecular_function","angiostatin binding ","Q9UII2; Q4VCS5"]
["GO:0042030","molecular_function","ATPase inhibitor activity ","Q9UII2; P26678; Q92574"]
["GO:0005072","molecular_function","transforming growth factor beta receptor, cytoplasmic mediator activity ","P46527; P17813"]
["GO:0035642","molecular_function","histone methyltransferase activity (H-R17 specific) ","Q86X55"]
["GO:0035242","molecular_function","protein-arginine omega-N asymmetric methyltransferase activity ","Q86X55; Q96LA8; O60678; Q9NR22; Q99873"]
["GO:0008276","molecular_function","protein methyltransferase activity ","Q86X55; Q99873"]
["GO:0098632","molecular_function","cell-cell adhesion mediator activity ","Q9HCJ2"]
["GO:0140078","molecular_function","class I DNA-(apurinic or apyrimidinic site) endonuclease activity ","P23396; Q8IW19; Q96FI4; Q969S2; P27695"]
["GO:0004520","molecular_function","endodeoxyribonuclease activity ","P23396; Q8IW19; P49959; Q8IY92; P28715; O95243; P27695"]
["GO:0051536","molecular_function","iron-sulfur cluster binding ","P23396"]
["GO:0032357","molecular_function","oxidized purine DNA binding ","P23396"]
["GO:0032358","molecular_function","oxidized pyrimidine DNA binding ","P23396"]
["GO:0070181","molecular_function","small ribosomal subunit rRNA binding ","P23396"]
["GO:0044390","molecular_function","ubiquitin-like protein conjugating enzyme binding ","P23396; Q99497"]
["GO:0005540","molecular_function","hyaluronic acid binding ","P16070; Q07021"]
["GO:0097371","molecular_function","MDM2/MDM4 family protein binding ","O15350; P61289; Q07869; Q8N726; Q6PCD5; Q9H3D4"]
["GO:0051722","molecular_function","protein C-terminal methylesterase activity ","Q9Y570"]
["GO:0031997","molecular_function","N-terminal myristoylation domain binding ","P0DP23"]
["GO:0072542","molecular_function","protein phosphatase activator activity ","P0DP23; Q8IZ21"]
["GO:0031800","molecular_function","type  metabotropic glutamate receptor binding ","P0DP23"]
["GO:0004532","molecular_function","exoribonuclease activity ","Q5D1E8; Q9ULM6"]
["GO:1904854","molecular_function","proteasome core complex binding ","P00747"]
["GO:0008525","molecular_function","phosphatidylcholine transporter activity ","P48739; Q00169"]
["GO:0008526","molecular_function","phosphatidylinositol transporter activity ","P48739; O00562; Q00169; P22307"]
["GO:0030628","molecular_function","pre-mRNA '-splice site binding ","Q01081; P26368; Q8TAS1"]
["GO:0015020","molecular_function","glucuronosyltransferase activity ","Q9HAW7; P16662"]
["GO:0017069","molecular_function","snRNA binding ","O94992; Q00839; P52298"]
["GO:0032052","molecular_function","bile acid binding ","Q96RI1; P06737"]
["GO:0038181","molecular_function","bile acid receptor activity ","Q96RI1"]
["GO:1902122","molecular_function","chenodeoxycholic acid binding ","Q96RI1"]
["GO:0004923","molecular_function","leukemia inhibitory factor receptor activity ","P42702"]
["GO:0072587","molecular_function","DNA topoisomerase (ATP-hydrolyzing) activator activity ","Q15003"]
["GO:0004687","molecular_function","myosin light chain kinase activity ","Q15746; Q9H1R3"]
["GO:0004748","molecular_function","ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor ","Q7LG56; P31350"]
["GO:0035614","molecular_function","snRNA stem-loop binding ","Q93062"]
["GO:0046404","molecular_function","ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity ","Q96T60"]
["GO:0050145","molecular_function","nucleoside monophosphate kinase activity ","Q96T60"]
["GO:0046403","molecular_function","polynucleotide '-phosphatase activity ","Q96T60; Q7Z2E3"]
["GO:0017076","molecular_function","purine nucleotide binding ","Q96T60"]
["GO:0047372","molecular_function","acylglycerol lipase activity ","Q9Y4D2"]
["GO:0005545","molecular_function","1-phosphatidylinositol binding ","Q15075; P21579; Q8WTV0; P11171; Q7Z3T8"]
["GO:0097027","molecular_function","ubiquitin-protein transferase activator activity ","Q9HC52; P68036; Q12834; Q969H0; Q9UM11"]
["GO:0042834","molecular_function","peptidoglycan binding ","Q96P20; P19367"]
["GO:0055077","molecular_function","gap junction hemi-channel activity ","Q96RD7; Q96RD6"]
["GO:0022840","molecular_function","leak channel activity ","Q96RD7"]
["GO:0015272","molecular_function","ATP-activated inward rectifier potassium channel activity ","P48048; Q15842; P78508; Q14654"]
["GO:0005242","molecular_function","inward rectifier potassium channel activity ","P48048; Q14500; O60928; Q12809; P48050; Q15842; P63252; P78508; Q9NPI9"]
["GO:0044508","molecular_function","glucagon-like peptide 1 receptor activity ","P43220"]
["GO:0004967","molecular_function","glucagon receptor activity ","P43220"]
["GO:0099184","molecular_function","structural constituent of postsynaptic intermediate filament cytoskeleton ","P12036; P07196"]
["GO:0015238","molecular_function","drug transmembrane transporter activity ","Q15311"]
["GO:0050265","molecular_function","RNA uridylyltransferase activity ","Q5TAX3; Q9H6E5"]
["GO:0004190","molecular_function","aspartic-type endopeptidase activity ","P56817; P49768; P49810; Q9BQI9; P42574"]
["GO:0008798","molecular_function","beta-aspartyl-peptidase activity ","P56817"]
["GO:0043237","molecular_function","laminin-1 binding ","P14543; Q14118"]
["GO:0043394","molecular_function","proteoglycan binding ","P14543"]
["GO:0031531","molecular_function","thyrotropin-releasing hormone receptor binding ","P62195"]
["GO:0008184","molecular_function","glycogen phosphorylase activity ","P11216; P06737; P11217"]
["GO:0102250","molecular_function","linear malto-oligosaccharide phosphorylase activity ","P11216; P06737; P11217"]
["GO:0102499","molecular_function","SH alpha-glucan phosphorylase activity ","P11216; P06737; P11217"]
["GO:0043426","molecular_function","MRF binding ","Q99576; Q92793; O60341"]
["GO:0008574","molecular_function","ATP-dependent microtubule motor activity, plus-end-directed ","Q96Q89; Q9P2E2; Q15058; O95239; Q9Y496; P52732; P33176; O60282"]
["GO:0016798","molecular_function","hydrolase activity, acting on glycosyl bonds ","Q96FI4; P17405"]
["GO:0052812","molecular_function","phosphatidylinositol-3,4-bisphosphate -kinase activity ","O60331; O14986"]
["GO:0051434","molecular_function","BH domain binding ","Q07812; P10415; Q07820; Q07817"]
["GO:0001851","molecular_function","complement component C3b binding ","P05107; P35232"]
["GO:0030369","molecular_function","ICAM- receptor activity ","P05107"]
["GO:0004906","molecular_function","interferon-gamma receptor activity ","P38484; P15260"]
["GO:0004920","molecular_function","interleukin-1 receptor activity ","P38484; P17181; Q13651"]
["GO:0019863","molecular_function","IgE binding ","Q01362; P30273; P17931"]
["GO:0120160","molecular_function","intraciliary transport particle A binding ","O75386"]
["GO:1901981","molecular_function","phosphatidylinositol phosphate binding ","Q8TEH3; Q9Y2J0; P17677"]
["GO:0003681","molecular_function","bent DNA binding ","Q9Y237"]
["GO:0004074","molecular_function","biliverdin reductase activity ","P53004"]
["GO:0030368","molecular_function","interleukin-17 receptor activity ","Q96F46"]
["GO:0005087","molecular_function","Ran guanyl-nucleotide exchange factor activity ","P18754"]
["GO:0043225","molecular_function","ATPase-coupled anion transmembrane transporter activity ","O60706; P33527; P13569"]
["GO:0008281","molecular_function","sulfonylurea receptor activity ","O60706"]
["GO:0005251","molecular_function","delayed rectifier potassium channel activity ","Q14721; P22001; P16389; P22460; P51787; Q12809; Q09470; P15382"]
["GO:0032139","molecular_function","dinucleotide insertion or deletion binding ","P12004"]
["GO:0030337","molecular_function","DNA polymerase processivity factor activity ","P12004"]
["GO:0000701","molecular_function","purine-specific mismatch base pair DNA N-glycosylase activity ","P12004"]
["GO:0031750","molecular_function","D dopamine receptor binding ","Q9UD71"]
["GO:0031751","molecular_function","D4 dopamine receptor binding ","Q9UD71"]
["GO:0004430","molecular_function","1-phosphatidylinositol -kinase activity ","Q9BTU6; Q9UBF8"]
["GO:0035651","molecular_function","AP- adaptor complex binding ","Q9BTU6"]
["GO:0004825","molecular_function","methionine-tRNA ligase activity ","P56192"]
["GO:0008441","molecular_function","3'(2'),5'-bisphosphate nucleotidase activity ","O95861"]
["GO:0032795","molecular_function","heterotrimeric -protein binding ","Q12798; P41208; P08913"]
["GO:0035800","molecular_function","deubiquitinase activator activity ","P55072"]
["GO:0019962","molecular_function","type I interferon binding ","P48551; P17181"]
["GO:0004905","molecular_function","type I interferon receptor activity ","P48551; P17181"]
["GO:0003922","molecular_function","MP synthase (glutamine-hydrolyzing) activity ","P49915"]
["GO:0003921","molecular_function","MP synthase activity ","P49915"]
["GO:0016462","molecular_function","pyrophosphatase activity ","P49915"]
["GO:0005128","molecular_function","erythropoietin receptor binding ","Q9H4P4"]
["GO:0005135","molecular_function","interleukin- receptor binding ","Q9H4P4"]
["GO:0004095","molecular_function","carnitine -palmitoyltransferase activity ","P50416"]
["GO:1990698","molecular_function","palmitoleoyltransferase activity ","P50416"]
["GO:0070012","molecular_function","oligopeptidase activity ","Q9GZM8"]
["GO:0047860","molecular_function","diiodophenylpyruvate reductase activity ","P40925"]
["GO:0004470","molecular_function","malic enzyme activity ","P40925"]
["GO:0005219","molecular_function","ryanodine-sensitive calcium-release channel activity ","Q92736; P21817"]
["GO:0043924","molecular_function","suramin binding ","Q92736"]
["GO:1990932","molecular_function","5.8S rRNA binding ","P84098"]
["GO:0070180","molecular_function","large ribosomal subunit rRNA binding ","P84098"]
["GO:0061133","molecular_function","endopeptidase activator activity ","P61289"]
["GO:1990380","molecular_function","Lys4-specific deubiquitinase activity ","Q9NQC7; P54252; Q93009; Q6GQQ9"]
["GO:0061578","molecular_function","Lys3-specific deubiquitinase activity ","Q9NQC7; P54252"]
["GO:0032810","molecular_function","sterol response element binding ","P36956; Q13133"]
["GO:0034431","molecular_function","bis(5'-adenosyl)-hexaphosphatase activity ","Q9NZJ9; O95989"]
["GO:0034432","molecular_function","bis(5'-adenosyl)-pentaphosphatase activity ","Q9NZJ9; O95989"]
["GO:0008486","molecular_function","diphosphoinositol-polyphosphate diphosphatase activity ","Q9NZJ9; O95989"]
["GO:0000298","molecular_function","endopolyphosphatase activity ","Q9NZJ9; O95989"]
["GO:0052846","molecular_function","inositol-1,-bisdiphosphate-,3,,-tetrakisphosphate 1-diphosphatase activity ","Q9NZJ9; O95989"]
["GO:0052847","molecular_function","inositol-1,-bisdiphosphate-,3,,6-tetrakisphosphate -diphosphatase activity ","Q9NZJ9; O95989"]
["GO:0052843","molecular_function","inositol-1-diphosphate-,,,,6-pentakisphosphate diphosphatase activity ","Q9NZJ9; O95989"]
["GO:0052848","molecular_function","inositol-3,-bisdiphosphate-,3,,6-tetrakisphosphate -diphosphatase activity ","Q9NZJ9; O95989"]
["GO:0052844","molecular_function","inositol-3-diphosphate-1,,,,6-pentakisphosphate diphosphatase activity ","Q9NZJ9; O95989"]
["GO:0052845","molecular_function","inositol--diphosphate-1,,3,,6-pentakisphosphate diphosphatase activity ","Q9NZJ9; O95989"]
["GO:0052841","molecular_function","inositol bisdiphosphate tetrakisphosphate diphosphatase activity ","Q9NZJ9; O95989"]
["GO:0052842","molecular_function","inositol diphosphate pentakisphosphate diphosphatase activity ","Q9NZJ9; O95989"]
["GO:0052840","molecular_function","inositol diphosphate tetrakisphosphate diphosphatase activity ","Q9NZJ9; O95989"]
["GO:0050072","molecular_function","m(')pppN diphosphatase activity ","Q9NZJ9; O95989"]
["GO:0030515","molecular_function","snoRNA binding ","Q9NZJ9"]
["GO:0035731","molecular_function","dinitrosyl-iron complex binding ","P09211"]
["GO:0043295","molecular_function","glutathione binding ","P09211"]
["GO:0019207","molecular_function","kinase regulator activity ","P09211"]
["GO:0035730","molecular_function","S-nitrosoglutathione binding ","P09211"]
["GO:0030267","molecular_function","glyoxylate reductase (NADP) activity ","P56545; Q13363"]
["GO:0016618","molecular_function","hydroxypyruvate reductase activity ","P56545; Q13363"]
["GO:0031727","molecular_function","CCR chemokine receptor binding ","P41597"]
["GO:0035716","molecular_function","chemokine (C-C motif) ligand 2 binding ","P41597"]
["GO:0035715","molecular_function","chemokine (C-C motif) ligand 2 binding ","P41597"]
["GO:0035717","molecular_function","chemokine (C-C motif) ligand  binding ","P41597"]
["GO:0001206","molecular_function","transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding ","P15822; Q9BYV9; Q05516"]
["GO:0070330","molecular_function","aromatase activity ","P11511; P20815"]
["GO:0016712","molecular_function","oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen ","P11511; P08684; P20813"]
["GO:0008395","molecular_function","steroid hydroxylase activity ","P11511; P08684; P20813"]
["GO:1903135","molecular_function","cupric ion binding ","Q99497; P04156"]
["GO:0036478","molecular_function","L-dopa decarboxylase activator activity ","Q99497"]
["GO:0045340","molecular_function","mercury ion binding ","Q99497"]
["GO:0036524","molecular_function","protein deglycase activity ","Q99497"]
["GO:0044388","molecular_function","small protein activating enzyme binding ","Q99497; P63279; P63165"]
["GO:0016532","molecular_function","superoxide dismutase copper chaperone activity ","Q99497; Q04656"]
["GO:0036470","molecular_function","tyrosine -monooxygenase activator activity ","Q99497"]
["GO:0005330","molecular_function","dopaminesodium symporter activity ","Q01959; P31645"]
["GO:0008420","molecular_function","RNA polymerase II CTD heptapeptide repeat phosphatase activity ","Q9NP77; Q9Y5B0"]
["GO:0008187","molecular_function","poly-pyrimidine tract binding ","P26368; P26599; Q8TAS1"]
["GO:0016409","molecular_function","palmitoyltransferase activity ","Q9NYG2"]
["GO:0019706","molecular_function","protein-cysteine S-palmitoyltransferase activity ","Q9NYG2; Q9H8X9"]
["GO:0031685","molecular_function","adenosine receptor binding ","Q13107"]
["GO:0030616","molecular_function","transforming growth factor beta receptor, common-partner cytoplasmic mediator activity ","Q13485"]
["GO:0019212","molecular_function","phosphatase inhibitor activity ","O94763; P56211; O43768"]
["GO:0016248","molecular_function","channel inhibitor activity ","P10415"]
["GO:0050220","molecular_function","prostaglandin-E synthase activity ","Q15185"]
["GO:0008273","molecular_function","calcium, potassiumsodium antiporter activity ","Q9UI40"]
["GO:0031402","molecular_function","sodium ion binding ","Q9UI40; Q13569; P05023"]
["GO:0005432","molecular_function","calciumsodium antiporter activity ","P32418; Q6J4K2; P08195"]
["GO:0099580","molecular_function","ion antiporter activity involved in regulation of postsynaptic membrane potential ","P32418"]
["GO:0038064","molecular_function","collagen receptor activity ","P17301"]
["GO:0086060","molecular_function","voltage-gated sodium channel activity involved in AV node cell action potential ","Q14524"]
["GO:0086061","molecular_function","voltage-gated sodium channel activity involved in bundle of His cell action potential ","Q14524"]
["GO:0086006","molecular_function","voltage-gated sodium channel activity involved in cardiac muscle cell action potential ","Q14524"]
["GO:0086062","molecular_function","voltage-gated sodium channel activity involved in Purkinje myocyte action potential ","Q14524"]
["GO:0086063","molecular_function","voltage-gated sodium channel activity involved in SA node cell action potential ","Q14524"]
["GO:0051787","molecular_function","misfolded protein binding ","P46379; Q9UBN7; Q9UNE7; P11021"]
["GO:0008080","molecular_function","N-acetyltransferase activity ","Q969G3"]
["GO:0005275","molecular_function","amine transmembrane transporter activity ","O43315"]
["GO:0046943","molecular_function","carboxylic acid transmembrane transporter activity ","O43315"]
["GO:0015254","molecular_function","glycerol channel activity ","O43315"]
["GO:0015166","molecular_function","polyol transmembrane transporter activity ","O43315"]
["GO:0015288","molecular_function","porin activity ","O43315; P21796"]
["GO:0005345","molecular_function","purine nucleobase transmembrane transporter activity ","O43315"]
["GO:0005350","molecular_function","pyrimidine nucleobase transmembrane transporter activity ","O43315"]
["GO:0015265","molecular_function","urea channel activity ","O43315"]
["GO:0034191","molecular_function","apolipoprotein A-I receptor binding ","P55055; P60953"]
["GO:0002153","molecular_function","steroid receptor RNA activator RNA binding ","P10827"]
["GO:0070506","molecular_function","high-density lipoprotein particle receptor activity ","Q8WTV0"]
["GO:0001875","molecular_function","lipopolysaccharide receptor activity ","Q8WTV0; O00206; Q9Y6Y9"]
["GO:0097153","molecular_function","cysteine-type endopeptidase activity involved in apoptotic process ","Q14790; Q9ULZ3; P42574"]
["GO:0035197","molecular_function","siRNA binding ","Q06787; Q15633; P51608; Q9UKV8"]
["GO:0043546","molecular_function","molybdopterin cofactor binding ","P47989; Q9NQX3"]
["GO:0016903","molecular_function","oxidoreductase activity, acting on the aldehyde or oxo group of donors ","P47989"]
["GO:0004854","molecular_function","xanthine dehydrogenase activity ","P47989"]
["GO:0004855","molecular_function","xanthine oxidase activity ","P47989"]
["GO:0008409","molecular_function","5'-3' exonuclease activity ","P49959; P39748; Q9H0D6; Q9UKF6; Q9H816; Q96SD1"]
["GO:0000014","molecular_function","single-stranded DNA endodeoxyribonuclease activity ","P49959; Q53H47; Q99708; Q96SD1"]
["GO:0097602","molecular_function","cullin family protein binding ","Q9UBF6; Q16531; O60260"]
["GO:0019788","molecular_function","NEDD transferase activity ","Q9UBF6"]
["GO:0015386","molecular_function","potassiumproton antiporter activity ","P19634; P48764; Q14940"]
["GO:0015385","molecular_function","sodiumproton antiporter activity ","P19634; P48764; Q14940"]
["GO:0086040","molecular_function","sodiumproton antiporter activity involved in regulation of cardiac muscle cell membrane potential ","P19634"]
["GO:0015299","molecular_function","soluteproton antiporter activity ","P19634"]
["GO:0017108","molecular_function","5'-flap endonuclease activity ","P39748; Q8IY92"]
["GO:0008309","molecular_function","double-stranded DNA exodeoxyribonuclease activity ","P39748; P27695"]
["GO:0048256","molecular_function","flap endonuclease activity ","P39748"]
["GO:0004523","molecular_function","RNA-DNA hybrid ribonuclease activity ","P39748; P27695"]
["GO:0015450","molecular_function","P-P-bond-hydrolysis-driven protein transmembrane transporter activity ","O14925"]
["GO:0017154","molecular_function","semaphorin receptor activity ","O43157"]
["GO:0030215","molecular_function","semaphorin receptor binding ","O43157"]
["GO:0004940","molecular_function","beta1-adrenergic receptor activity ","P08588"]
["GO:0004939","molecular_function","beta-adrenergic receptor activity ","P08588"]
["GO:0051379","molecular_function","epinephrine binding ","P08588; P08913; P07550"]
["GO:0099579","molecular_function","-protein coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential ","P08588; Q9UBS5"]
["GO:0051380","molecular_function","norepinephrine binding ","P08588; P08913; P07550"]
["GO:0030306","molecular_function","ADP-ribosylation factor binding ","Q92673; Q9UJY5; O75154"]
["GO:0072541","molecular_function","peroxynitrite reductase activity ","P30044"]
["GO:0001016","molecular_function","RNA polymerase III regulatory region DNA binding ","P30044"]
["GO:0008379","molecular_function","thioredoxin peroxidase activity ","P30044; Q06830; P30048; P32119"]
["GO:0055131","molecular_function","CHC4-type RIN finger domain binding ","P0DMV8; P11142; Q9BXM7; Q12809"]
["GO:0031249","molecular_function","denatured protein binding ","P0DMV8"]
["GO:0097003","molecular_function","adipokinetic hormone receptor activity ","Q96A54"]
["GO:0055100","molecular_function","adiponectin binding ","Q96A54"]
["GO:0004965","molecular_function","-protein coupled ABA receptor activity ","Q9UBS5; O75899"]
["GO:1902098","molecular_function","calcitriol binding ","P11473"]
["GO:0008434","molecular_function","calcitriol receptor activity ","P11473"]
["GO:1902121","molecular_function","lithocholic acid binding ","P11473"]
["GO:0038186","molecular_function","lithocholic acid receptor activity ","P11473"]
["GO:0016868","molecular_function","intramolecular transferase activity, phosphotransferases ","Q15124"]
["GO:0005319","molecular_function","lipid transporter activity ","P02649"]
["GO:0046911","molecular_function","metal chelating activity ","P02649"]
["GO:0060228","molecular_function","phosphatidylcholine-sterol -acyltransferase activator activity ","P02649"]
["GO:0070326","molecular_function","very-low-density lipoprotein particle receptor binding ","P02649; P30533"]
["GO:0003896","molecular_function","DNA primase activity ","P49643"]
["GO:0046975","molecular_function","histone methyltransferase activity (H3-K3 specific) ","Q53H47; Q9NRG4"]
["GO:0042800","molecular_function","histone methyltransferase activity (H3-K specific) ","Q53H47; Q03164; O14686"]
["GO:0061665","molecular_function","SUM ligase activity ","O75925; O75928; Q8N2W9"]
["GO:0030234","molecular_function","enzyme regulator activity ","Q99460; Q13200; Q15435; Q9NPI6"]
["GO:0004741","molecular_function","[pyruvate dehydrogenase (lipoamide)] phosphatase activity ","Q9P0J1"]
["GO:0001002","molecular_function","RNA polymerase III type  promoter sequence-specific DNA binding ","Q12789"]
["GO:0001003","molecular_function","RNA polymerase III type 2 promoter sequence-specific DNA binding ","Q12789"]
["GO:0047631","molecular_function","ADP-ribose diphosphatase activity ","O95848; Q9BW91"]
["GO:0008768","molecular_function","UDP-sugar diphosphatase activity ","O95848"]
["GO:0004977","molecular_function","melanocortin receptor activity ","P32245"]
["GO:0004980","molecular_function","melanocyte-stimulating hormone receptor activity ","P32245"]
["GO:0034875","molecular_function","caffeine oxidase activity ","P08684"]
["GO:0101020","molecular_function","estrogen 6-alpha-hydroxylase activity ","P08684; P20815"]
["GO:0050649","molecular_function","testosterone -beta-hydroxylase activity ","P08684"]
["GO:0070576","molecular_function","vitamin D 24-hydroxylase activity ","P08684"]
["GO:0030343","molecular_function","vitamin D 25-hydroxylase activity ","P08684"]
["GO:0099530","molecular_function","-protein coupled receptor activity involved in regulation of postsynaptic membrane potential ","P41594"]
["GO:0008073","molecular_function","ornithine decarboxylase inhibitor activity ","O95190"]
["GO:0016907","molecular_function","-protein coupled acetylcholine receptor activity ","P08172; P08173; P20309"]
["GO:0034458","molecular_function","'-' RNA helicase activity ","Q8IYB8"]
["GO:0003917","molecular_function","DNA topoisomerase type I activity ","P11387"]
["GO:0010309","molecular_function","acireductone dioxygenase [iron(II)-requiring] activity ","Q9BV57"]
["GO:0015369","molecular_function","calciumproton antiporter activity ","O95202"]
["GO:0071535","molecular_function","RIN-like zinc finger domain binding ","P35226; P63279"]
["GO:0004826","molecular_function","phenylalanine-tRNA ligase activity ","O95363; Q9Y285"]
["GO:1990174","molecular_function","phosphodiesterase decapping endonuclease activity ","Q96F86"]
["GO:1990259","molecular_function","histone-glutamine methyltransferase activity ","P22087"]
["GO:0008649","molecular_function","rRNA methyltransferase activity ","P22087"]
["GO:0032453","molecular_function","histone demethylase activity (H-K specific) ","Q9BY66; O60341"]
["GO:0061609","molecular_function","fructose--phosphate aldolase activity ","P05062"]
["GO:0017050","molecular_function","D-erythro-sphingosine kinase activity ","Q9NYA1; Q9NRA0"]
["GO:0008481","molecular_function","sphinganine kinase activity ","Q9NYA1; Q9NRA0"]
["GO:0038036","molecular_function","sphingosine-1-phosphate receptor activity ","Q9NYA1; P21453; Q9NRA0"]
["GO:0003747","molecular_function","translation release factor activity ","P62495"]
["GO:0008079","molecular_function","translation termination factor activity ","P62495"]
["GO:0003937","molecular_function","IMP cyclohydrolase activity ","P31939"]
["GO:0004643","molecular_function","phosphoribosylaminoimidazolecarboxamide formyltransferase activity ","P31939"]
["GO:0036041","molecular_function","long-chain fatty acid binding ","P15090"]
["GO:0005324","molecular_function","long-chain fatty acid transporter activity ","P15090"]
["GO:0008900","molecular_function","potassiumproton exchanging ATPase activity ","P20648"]
["GO:0005391","molecular_function","sodiumpotassium-exchanging ATPase activity ","P20648; P05023"]
["GO:0005138","molecular_function","interleukin-6 receptor binding ","P78536; Q9ULZ3"]
["GO:0000995","molecular_function","RNA polymerase III general transcription initiation factor activity ","Q92994"]
["GO:0046538","molecular_function","2,-bisphosphoglycerate-dependent phosphoglycerate mutase activity ","P18669"]
["GO:0004082","molecular_function","bisphosphoglycerate mutase activity ","P18669"]
["GO:0004619","molecular_function","phosphoglycerate mutase activity ","P18669"]
["GO:0016247","molecular_function","channel regulator activity ","Q9Y698; Q96H20"]
["GO:0043262","molecular_function","adenosine-diphosphatase activity ","Q9BW91"]
["GO:0019144","molecular_function","ADP-sugar diphosphatase activity ","Q9BW91"]
["GO:0030414","molecular_function","peptidase inhibitor activity ","Q9NZH5; O95997"]
["GO:0030160","molecular_function","KAP/Homer scaffold activity ","Q9NSB8; Q9BYB0; Q9UPX8; Q9Y566"]
["GO:0035256","molecular_function","-protein coupled glutamate receptor binding ","Q9NSB8; Q86YM7"]
["GO:0004045","molecular_function","aminoacyl-tRNA hydrolase activity ","Q9Y3E5"]
["GO:0061752","molecular_function","telomeric repeat-containing RNA binding ","P09651; O60341"]
["GO:0050501","molecular_function","hyaluronan synthase activity ","Q92819"]
["GO:0015232","molecular_function","heme transporter activity ","Q9UNQ0"]
["GO:0004828","molecular_function","serine-tRNA ligase activity ","Q9NP81"]
["GO:0000989","molecular_function","transcription factor activity, transcription factor binding ","P35548"]
["GO:0042835","molecular_function","BRE binding ","Q92879"]
["GO:0005222","molecular_function","intracellular cAMP-activated cation channel activity ","Q9Y3Q4; Q9UL51"]
["GO:0086041","molecular_function","voltage-gated potassium channel activity involved in SA node cell action potential depolarization ","Q9Y3Q4"]
["GO:0004145","molecular_function","diamine N-acetyltransferase activity ","P21673"]
["GO:0019809","molecular_function","spermidine binding ","P21673"]
["GO:0097367","molecular_function","carbohydrate derivative binding ","O94808; Q06210"]
["GO:0004360","molecular_function","glutamine-fructose--phosphate transaminase (isomerizing) activity ","O94808; Q06210"]
["GO:0004875","molecular_function","complement receptor activity ","P21462"]
["GO:0004982","molecular_function","N-formyl peptide receptor activity ","P21462"]
["GO:0032451","molecular_function","demethylase activity ","O60341"]
["GO:0034648","molecular_function","histone demethylase activity (H-dimethyl-K specific) ","O60341; P29375"]
["GO:1901612","molecular_function","cardiolipin binding ","Q9UJZ1"]
["GO:0043533","molecular_function","inositol 1,,, tetrakisphosphate binding ","Q14573; Q8N9I0; O75689"]
["GO:0005220","molecular_function","inositol 1,4,-trisphosphate-sensitive calcium-release channel activity ","Q14573; Q14643; Q14571"]
["GO:0000175","molecular_function","3'-'-exoribonuclease activity ","Q9H0D6; Q06265; Q9NQT5; Q15024; Q9NQT4; Q8TCS8"]
["GO:0004534","molecular_function","'-' exoribonuclease activity ","Q9H0D6"]
["GO:0001147","molecular_function","transcription termination site sequence-specific DNA binding ","Q9H0D6"]
["GO:0001011","molecular_function","transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting ","P15884"]
["GO:0050733","molecular_function","RS domain binding ","Q07955; P18583; O75494"]
["GO:0008269","molecular_function","JAK pathway signal transduction adaptor activity ","O14492"]
["GO:0008193","molecular_function","tRNA guanylyltransferase activity ","P54578"]
["GO:0022829","molecular_function","wide pore channel activity ","Q96RD6"]
["GO:0004483","molecular_function","mRNA (nucleoside-2'--)-methyltransferase activity ","Q8N1G2"]
["GO:0004945","molecular_function","angiotensin type II receptor activity ","P50052; P30556"]
["GO:0048019","molecular_function","receptor antagonist activity ","P50052; P30533; Q92731"]
["GO:0005247","molecular_function","voltage-gated chloride channel activity ","P51790; Q5XXA6"]
["GO:0072320","molecular_function","volume-sensitive chloride channel activity ","P51790"]
["GO:0008431","molecular_function","vitamin E binding ","O76054"]
["GO:0030617","molecular_function","transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity ","O43541; O15105"]
["GO:0070698","molecular_function","type I activin receptor binding ","O43541"]
["GO:0008160","molecular_function","protein tyrosine phosphatase activator activity ","P17936"]
["GO:0005052","molecular_function","peroxisome matrix targeting signal-1 binding ","P50542"]
["GO:0000268","molecular_function","peroxisome targeting sequence binding ","P50542"]
["GO:0004931","molecular_function","extracellularly ATP-gated cation channel activity ","Q9UBL9"]
["GO:0001614","molecular_function","purinergic nucleotide receptor activity ","Q9UBL9"]
["GO:0086083","molecular_function","cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication ","P14923; P15924"]
["GO:0005199","molecular_function","structural constituent of cell wall ","P14923"]
["GO:0086056","molecular_function","voltage-gated calcium channel activity involved in AV node cell action potential ","Q13936; O43497"]
["GO:0086007","molecular_function","voltage-gated calcium channel activity involved in cardiac muscle cell action potential ","Q13936; Q01668"]
["GO:0008330","molecular_function","protein tyrosine/threonine phosphatase activity ","P28562; Q9Y6W6"]
["GO:0004102","molecular_function","choline -acetyltransferase activity ","P28329"]
["GO:0008597","molecular_function","calcium-dependent protein serine/threonine phosphatase regulator activity ","P53805"]
["GO:0005227","molecular_function","calcium activated cation channel activity ","Q5XXA6; Q8TD43"]
["GO:0005229","molecular_function","intracellular calcium activated chloride channel activity ","Q5XXA6; O76090"]
["GO:0015111","molecular_function","iodide transmembrane transporter activity ","Q5XXA6"]
["GO:0005537","molecular_function","mannose binding ","P11717; P20645"]
["GO:0008430","molecular_function","selenium binding ","Q9Y2J0"]
["GO:0061656","molecular_function","SUM conjugating enzyme activity ","P63279"]
["GO:0004064","molecular_function","arylesterase activity ","P00918"]
["GO:0008320","molecular_function","protein transmembrane transporter activity ","Q07820"]
["GO:0005046","molecular_function","KDEL sequence binding ","P24390"]
["GO:0043142","molecular_function","single-stranded DNA-dependent ATPase activity ","Q06609; Q9NS91"]
["GO:0098872","molecular_function","-protein coupled neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration ","Q13255"]
["GO:0019203","molecular_function","carbohydrate phosphatase activity ","O95278"]
["GO:2001069","molecular_function","glycogen binding ","O95278"]
["GO:2001070","molecular_function","starch binding ","O95278"]
["GO:0019784","molecular_function","NEDD-specific protease activity ","P15374; Q9UK80; Q96FW1"]
["GO:0097158","molecular_function","pre-mRNA intronic pyrimidine-rich binding ","Q9BWF3"]
["GO:0015420","molecular_function","cobalamin-transporting ATPase activity ","P33527"]
["GO:0015431","molecular_function","glutathione S-conjugate-exporting ATPase activity ","P33527"]
["GO:0034634","molecular_function","glutathione transmembrane transporter activity ","P33527"]
["GO:0004012","molecular_function","phospholipid-translocating ATPase activity ","P33527"]
["GO:0046623","molecular_function","sphingolipid-translocating ATPase activity ","P33527"]
["GO:0030292","molecular_function","protein tyrosine kinase inhibitor activity ","O95684; P63244; Q9P2D0"]
["GO:0035529","molecular_function","NADH pyrophosphatase activity ","O14638; P22413"]
["GO:0047429","molecular_function","nucleoside-triphosphate diphosphatase activity ","O14638; Q9H773; P22413"]
["GO:0004528","molecular_function","phosphodiesterase I activity ","O14638; P27695; P22413"]
["GO:0019767","molecular_function","IgE receptor activity ","P30273"]
["GO:0002055","molecular_function","adenine binding ","P07741"]
["GO:0003999","molecular_function","adenine phosphoribosyltransferase activity ","P07741"]
["GO:0000827","molecular_function","inositol-1,3,4,5,6-pentakisphosphate kinase activity ","Q9UHH9"]
["GO:0052836","molecular_function","inositol -diphosphate pentakisphosphate -kinase activity ","Q9UHH9"]
["GO:0052839","molecular_function","inositol diphosphate tetrakisphosphate kinase activity ","Q9UHH9"]
["GO:0000829","molecular_function","inositol heptakisphosphate kinase activity ","Q9UHH9"]
["GO:0052723","molecular_function","inositol hexakisphosphate 1-kinase activity ","Q9UHH9"]
["GO:0052724","molecular_function","inositol hexakisphosphate 3-kinase activity ","Q9UHH9"]
["GO:0000832","molecular_function","inositol hexakisphosphate 5-kinase activity ","Q9UHH9"]
["GO:0000828","molecular_function","inositol hexakisphosphate kinase activity ","Q9UHH9"]
["GO:0043495","molecular_function","protein membrane anchor ","O94901; P49790; P02730; Q9UH99; P35579; Q99828"]
["GO:0005534","molecular_function","galactose binding ","P17813"]
["GO:0070883","molecular_function","pre-miRNA binding ","Q15633"]
["GO:0004535","molecular_function","poly(A)-specific ribonuclease activity ","Q9ULM6; O95453"]
["GO:0097001","molecular_function","ceramide binding ","Q8TDQ1; Q9Y5P4"]
["GO:0005136","molecular_function","interleukin-4 receptor binding ","Q8TDQ1"]
["GO:0097016","molecular_function","L2 domain binding ","Q12959"]
["GO:0031418","molecular_function","L-ascorbic acid binding ","Q96KS0; P19021"]
["GO:0019826","molecular_function","oxygen sensor activity ","Q96KS0; Q9NPH5"]
["GO:0031545","molecular_function","peptidyl-proline -dioxygenase activity ","Q96KS0"]
["GO:0042903","molecular_function","tubulin deacetylase activity ","Q9UBN7; Q8IXJ6"]
["GO:0015280","molecular_function","ligand-gated sodium channel activity ","P37088; P51170; P51168; P78348"]
["GO:0046933","molecular_function","proton-transporting ATP synthase activity, rotational mechanism ","P36542"]
["GO:0005026","molecular_function","transforming growth factor beta receptor activity, type II ","P37173"]
["GO:0034714","molecular_function","type III transforming growth factor beta receptor binding ","P37173"]
["GO:0000991","molecular_function","transcription factor activity, core RNA polymerase II binding ","Q7KZ85"]
["GO:0004180","molecular_function","carboxypeptidase activity ","Q8IUX7; P12821"]
["GO:0004181","molecular_function","metallocarboxypeptidase activity ","Q8IUX7"]
["GO:0004185","molecular_function","serine-type carboxypeptidase activity ","Q8IUX7"]
["GO:0004784","molecular_function","superoxide dismutase activity ","P00441; P04179"]
["GO:0004077","molecular_function","biotin-[acetyl-CoA-carboxylase] ligase activity ","P50747"]
["GO:0004078","molecular_function","biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity ","P50747"]
["GO:0004079","molecular_function","biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity ","P50747"]
["GO:0004080","molecular_function","biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity ","P50747"]
["GO:0018271","molecular_function","biotin-protein ligase activity ","P50747"]
["GO:0003910","molecular_function","DNA ligase (ATP) activity ","P18858; P49916; P49917; P09874"]
["GO:0003909","molecular_function","DNA ligase activity ","P18858; P49916; P49917; P18887"]
["GO:0042500","molecular_function","aspartic endopeptidase activity, intramembrane cleaving ","P49768; P49810"]
["GO:0050815","molecular_function","phosphoserine residue binding ","P62258; P46934; Q13526; P31946"]
["GO:0004118","molecular_function","cMP-stimulated cyclic-nucleotide phosphodiesterase activity ","Q9HCR9; Q9Y233"]
["GO:0004112","molecular_function","cyclic-nucleotide phosphodiesterase activity ","Q9HCR9"]
["GO:1904928","molecular_function","coreceptor activity involved in canonical Wnt signaling pathway ","O75581"]
["GO:0071936","molecular_function","coreceptor activity involved in Wnt signaling pathway ","O75581"]
["GO:0019534","molecular_function","toxin transmembrane transporter activity ","O75581"]
["GO:0042813","molecular_function","Wnt-activated receptor activity ","O75581; O75096"]
["GO:0001730","molecular_function","2'-5'-oligoadenylate synthetase activity ","P00973"]
["GO:0033229","molecular_function","cysteine transmembrane transporter activity ","P43005"]
["GO:0045027","molecular_function","DNA end binding ","Q9H9Q4"]
["GO:0019976","molecular_function","interleukin-2 binding ","P01589; P14784"]
["GO:0004911","molecular_function","interleukin-2 receptor activity ","P01589; P14784"]
["GO:0055106","molecular_function","ubiquitin-protein transferase regulator activity ","Q92519"]
["GO:0015125","molecular_function","bile acid transmembrane transporter activity ","P13688"]
["GO:0008240","molecular_function","tripeptidyl-peptidase activity ","O14773; P12821"]
["GO:0004620","molecular_function","phospholipase activity ","Q8NEL9"]
["GO:0010521","molecular_function","telomerase inhibitor activity ","Q96BK5; Q96EZ8"]
["GO:0070492","molecular_function","oligosaccharide binding ","P17931"]
["GO:0031386","molecular_function","protein tag ","P63165; Q6EEV6; P55854"]
["GO:0097645","molecular_function","amylin binding ","P05067"]
["GO:1904399","molecular_function","heparan sulfate binding ","P05067; Q9UGM3"]
["GO:0001850","molecular_function","complement component C3a binding ","P35232"]
["GO:0031871","molecular_function","proteinase activated receptor binding ","P35232"]
["GO:0098882","molecular_function","structural constituent of presynaptic active zone ","O15083"]
["GO:0004621","molecular_function","glycosylphosphatidylinositol phospholipase D activity ","P80108"]
["GO:0008200","molecular_function","ion channel inhibitor activity ","P63244; O43768"]
["GO:0051959","molecular_function","dynein light intermediate chain binding ","Q9P219; Q14204; P63167; Q3V6T2; O75154"]
["GO:0048101","molecular_function","calcium- and calmodulin-regulated 3',5'-cyclic-MP phosphodiesterase activity ","P54750"]
["GO:0004117","molecular_function","calmodulin-dependent cyclic-nucleotide phosphodiesterase activity ","P54750"]
["GO:0004937","molecular_function","alpha1-adrenergic receptor activity ","P35368"]
["GO:0004900","molecular_function","erythropoietin receptor activity ","P19235"]
["GO:0005502","molecular_function","11-cis retinal binding ","Q9UHM6; P08100"]
["GO:0008020","molecular_function","-protein coupled photoreceptor activity ","Q9UHM6; P08100"]
["GO:0043273","molecular_function","CTPase activity ","O00571"]
["GO:0017111","molecular_function","nucleoside-triphosphatase activity ","O00571"]
["GO:0008374","molecular_function","-acyltransferase activity ","Q16635"]
["GO:0003918","molecular_function","DNA topoisomerase type II (ATP-hydrolyzing) activity ","Q02880; P11388"]
["GO:0015085","molecular_function","calcium ion transmembrane transporter activity ","Q14643; Q14571"]
["GO:0035034","molecular_function","histone acetyltransferase regulator activity ","Q9BRQ0"]
["GO:0086059","molecular_function","voltage-gated calcium channel activity involved SA node cell action potential ","Q01668; O43497"]
["GO:0101005","molecular_function","ubiquitinyl hydrolase activity ","Q93009"]
["GO:0038048","molecular_function","dynorphin receptor activity ","P41145"]
["GO:0042289","molecular_function","MHC class II protein binding ","Q04695; P01730"]
["GO:0032395","molecular_function","MHC class II receptor activity ","Q04695"]
["GO:0015578","molecular_function","mannose transmembrane transporter activity ","P20645"]
["GO:1905394","molecular_function","retromer complex binding ","P20645"]
["GO:0030171","molecular_function","voltage-gated proton channel activity ","Q96D96"]
["GO:0001010","molecular_function","RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity ","O43474"]
["GO:0060002","molecular_function","plus-end directed microfilament motor activity ","Q8NEV4"]
["GO:0035438","molecular_function","cyclic-di-MP binding ","Q86WV6"]
["GO:0061507","molecular_function","cyclic-MP-AMP binding ","Q86WV6"]
["GO:0004017","molecular_function","adenylate kinase activity ","Q92878; P54819"]
["GO:0043047","molecular_function","single-stranded telomeric DNA binding ","Q92878; P22626"]
["GO:0008332","molecular_function","low voltage-gated calcium channel activity ","O43497; O95180"]
["GO:0033878","molecular_function","hormone-sensitive lipase activity ","Q05469"]
["GO:0017171","molecular_function","serine hydrolase activity ","Q05469"]
["GO:0004806","molecular_function","triglyceride lipase activity ","Q05469; Q96AD5"]
["GO:0070260","molecular_function","5'-tyrosyl-DNA phosphodiesterase activity ","O95551"]
["GO:0036317","molecular_function","tyrosyl-RNA phosphodiesterase activity ","O95551"]
["GO:0015207","molecular_function","adenine transmembrane transporter activity ","P12235"]
["GO:0005471","molecular_function","ATPADP antiporter activity ","P12235"]
["GO:0001096","molecular_function","TFIIF-class transcription factor binding ","Q9Y5B0"]
["GO:0102571","molecular_function","[protein]-3--(N-acetyl-D-glucosaminyl)-L-serine/L-threonine -N-acetyl-alpha-D-glucosaminase activity ","O60502"]
["GO:0102167","molecular_function","[protein]-3--(N-acetyl-D-glucosaminyl)-L-serine -N-acetyl-alpha-D-glucosaminase activity ","O60502"]
["GO:0102166","molecular_function","[protein]-3--(N-acetyl-D-glucosaminyl)-L-threonine -N-acetyl-alpha-D-glucosaminase activity ","O60502"]
["GO:0016231","molecular_function","beta-N-acetylglucosaminidase activity ","O60502"]
["GO:0004415","molecular_function","hyalurononglucosaminidase activity ","O60502"]
["GO:0003883","molecular_function","CTP synthase activity ","P17812; Q9NRF8"]
["GO:0010698","molecular_function","acetyltransferase activator activity ","O14737"]
["GO:0045499","molecular_function","chemorepellent activity ","Q02297"]
["GO:0030297","molecular_function","transmembrane receptor protein tyrosine kinase activator activity ","Q02297"]
["GO:0030621","molecular_function","U4 snRNA binding ","Q15020"]
["GO:0030624","molecular_function","Uatac snRNA binding ","Q15020"]
["GO:0017070","molecular_function","U6 snRNA binding ","Q15020; Q6P2Q9"]
["GO:0004155","molecular_function","6,7-dihydropteridine reductase activity ","P09417"]
["GO:0070404","molecular_function","NADH binding ","P09417"]
["GO:0051433","molecular_function","BH2 domain binding ","O00429"]
["GO:0042799","molecular_function","histone methyltransferase activity (H-K specific) ","Q9NQR1; O96028"]
["GO:0016278","molecular_function","lysine N-methyltransferase activity ","Q9NQR1; Q9NRG4"]
["GO:0086087","molecular_function","voltage-gated potassium channel activity involved in bundle of His cell action potential repolarization ","P22460"]
["GO:0086090","molecular_function","voltage-gated potassium channel activity involved in SA node cell action potential repolarization ","P22460"]
["GO:0043169","molecular_function","cation binding ","O95453"]
["GO:0004758","molecular_function","serine C-palmitoyltransferase activity ","O15269"]
["GO:0015036","molecular_function","disulfide oxidoreductase activity ","Q96HE7; P30101; Q9H3N1"]
["GO:0016671","molecular_function","oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor ","Q96HE7; P10599"]
["GO:0015035","molecular_function","protein disulfide oxidoreductase activity ","Q96HE7; Q16206; P10599"]
["GO:0008479","molecular_function","queuine tRNA-ribosyltransferase activity ","Q9BXR0"]
["GO:0031852","molecular_function","mu-type opioid receptor binding ","P21333"]
["GO:0015106","molecular_function","bicarbonate transmembrane transporter activity ","P13569; P02730; O76090"]
["GO:0005260","molecular_function","intracellularly ATP-gated chloride channel activity ","P13569"]
["GO:0035538","molecular_function","carbohydrate response element binding ","Q9NP71"]
["GO:0051373","molecular_function","FATZ binding ","O15273"]
["GO:0070080","molecular_function","titin Z domain binding ","O15273"]
["GO:0001161","molecular_function","intronic transcription regulatory region sequence-specific DNA binding ","P41182; P43699"]
["GO:0005042","molecular_function","netrin receptor activity ","O95185; P43146"]
["GO:0005415","molecular_function","nucleosidesodium symporter activity ","O43868"]
["GO:0015211","molecular_function","purine nucleoside transmembrane transporter activity ","O43868"]
["GO:0004735","molecular_function","pyrroline--carboxylate reductase activity ","P32322; Q96C36"]
["GO:0000182","molecular_function","rDNA binding ","Q9H2G4"]
["GO:0043727","molecular_function","5-amino--imidazole carboxylate lyase activity ","P22234"]
["GO:0004638","molecular_function","phosphoribosylaminoimidazole carboxylase activity ","P22234"]
["GO:0004639","molecular_function","phosphoribosylaminoimidazolesuccinocarboxamide synthase activity ","P22234"]
["GO:0070694","molecular_function","deoxyribonucleoside 5'-monophosphate N-glycosidase activity ","O43598"]
["GO:0003979","molecular_function","UDP-glucose 6-dehydrogenase activity ","O60701"]
["GO:0004969","molecular_function","histamine receptor activity ","P35367"]
["GO:0004550","molecular_function","nucleoside diphosphate kinase activity ","P22392; P15531; O60361"]
["GO:0004673","molecular_function","protein histidine kinase activity ","P22392"]
["GO:0046974","molecular_function","histone methyltransferase activity (H3-K specific) ","Q96KQ7"]
["GO:0070139","molecular_function","SUM-specific endopeptidase activity ","Q9HC62"]
["GO:0070140","molecular_function","SUM-specific isopeptidase activity ","Q9HC62"]
["GO:0008509","molecular_function","anion transmembrane transporter activity ","O95477; P02730"]
["GO:0034188","molecular_function","apolipoprotein A-I receptor activity ","O95477"]
["GO:0090556","molecular_function","phosphatidylserine-translocating ATPase activity ","O95477"]
["GO:0005548","molecular_function","phospholipid transporter activity ","O95477"]
["GO:0004997","molecular_function","thyrotropin-releasing hormone receptor activity ","P34981"]
["GO:0086008","molecular_function","voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization ","P51787; Q12809; P63252"]
["GO:0008131","molecular_function","primary amine oxidase activity ","P21397"]
["GO:0004333","molecular_function","fumarate hydratase activity ","P07954"]
["GO:0001856","molecular_function","complement component Ca binding ","P21730"]
["GO:0004878","molecular_function","complement component C5a receptor activity ","P21730"]
["GO:0010857","molecular_function","calcium-dependent protein kinase activity ","Q9BXM7"]
["GO:0045155","molecular_function","electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity ","P99999"]
["GO:0061750","molecular_function","acid sphingomyelin phosphodiesterase activity ","P17405"]
["GO:0004767","molecular_function","sphingomyelin phosphodiesterase activity ","P17405"]
["GO:0005334","molecular_function","norepinephrinesodium symporter activity ","P23975"]
["GO:1990460","molecular_function","leptin receptor binding ","O60749"]
["GO:1990459","molecular_function","transferrin receptor binding ","O60749"]
["GO:0043739","molecular_function","/U mismatch-specific uracil-DNA glycosylase activity ","Q13569"]
["GO:0008263","molecular_function","pyrimidine-specific mismatch base pair DNA N-glycosylase activity ","Q13569; O95243"]
["GO:0019966","molecular_function","interleukin- binding ","O95361; P14778"]
["GO:0032089","molecular_function","NACHT domain binding ","O95361"]
["GO:0016174","molecular_function","NAD(P)H oxidase activity ","Q9NPH5; Q9NRD9"]
["GO:0008442","molecular_function","3-hydroxyisobutyrate dehydrogenase activity ","P31937"]
["GO:0019772","molecular_function","low-affinity Ig receptor activity ","P31994"]
["GO:0061501","molecular_function","cyclic-MP-AMP synthase activity ","Q8N884"]
["GO:0070612","molecular_function","histone methyltransferase activity (HA-R3 specific) ","Q96LA8"]
["GO:0070611","molecular_function","histone methyltransferase activity (H3-R2 specific) ","Q96LA8"]
["GO:0035241","molecular_function","protein-arginine omega-N monomethyltransferase activity ","Q96LA8; Q9NR22; Q99873"]
["GO:0005093","molecular_function","Rab DP-dissociation inhibitor activity ","P31150; P50395"]
["GO:0010484","molecular_function","H3 histone acetyltransferase activity ","P51587"]
["GO:0010485","molecular_function","H histone acetyltransferase activity ","P51587"]
["GO:0033919","molecular_function","glucan ,-alpha-glucosidase activity ","Q14697"]
["GO:0000406","molecular_function","double-strand/single-strand DNA junction binding ","P43246"]
["GO:0000404","molecular_function","heteroduplex DNA loop binding ","P43246"]
["GO:0004797","molecular_function","thymidine kinase activity ","P04183"]
["GO:0001641","molecular_function","group II metabotropic glutamate receptor activity ","Q14416; Q14832"]
["GO:0004768","molecular_function","stearoyl-CoA 9-desaturase activity ","O00767"]
["GO:0045131","molecular_function","pre-mRNA branch point binding ","Q15637"]
["GO:1904455","molecular_function","ubiquitin-specific protease activity involved in negative regulation of ERAD pathway ","Q9UHP3"]
["GO:0019828","molecular_function","aspartic-type endopeptidase inhibitor activity ","P04406"]
["GO:0004365","molecular_function","glyceraldehyde--phosphate dehydrogenase (NAD+) (phosphorylating) activity ","P04406"]
["GO:0035605","molecular_function","peptidyl-cysteine S-nitrosylase activity ","P04406"]
["GO:0004536","molecular_function","deoxyribonuclease activity ","P15531"]
["GO:0000155","molecular_function","phosphorelay sensor kinase activity ","Q12809"]
["GO:0036487","molecular_function","nitric-oxide synthase inhibitor activity ","P23634"]
["GO:0047015","molecular_function","3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity ","Q99714"]
["GO:0008709","molecular_function","cholate -alpha-dehydrogenase activity ","Q99714"]
["GO:0030283","molecular_function","testosterone dehydrogenase [NAD(P)] activity ","Q99714"]
["GO:0004367","molecular_function","glycerol--phosphate dehydrogenase [NAD+] activity ","Q8N335"]
["GO:1901611","molecular_function","phosphatidylglycerol binding ","Q00169"]
["GO:0015301","molecular_function","anionanion antiporter activity ","P02730"]
["GO:0005452","molecular_function","inorganic anion exchanger activity ","P02730; Q9Y6R1"]
["GO:0008510","molecular_function","sodiumbicarbonate symporter activity ","P02730; Q9Y6R1"]
["GO:0035473","molecular_function","lipase binding ","P30533"]
["GO:0050613","molecular_function","delta4-sterol reductase activity ","Q14739"]
["GO:0016627","molecular_function","oxidoreductase activity, acting on the CH-CH group of donors ","Q14739"]
["GO:0004526","molecular_function","ribonuclease P activity ","O75817; O95707"]
["GO:0004938","molecular_function","alpha2-adrenergic receptor activity ","P08913"]
["GO:0031696","molecular_function","alpha-2C adrenergic receptor binding ","P08913"]
["GO:0031768","molecular_function","ghrelin receptor binding ","Q9UBU3"]
["GO:0016608","molecular_function","growth hormone-releasing hormone activity ","Q9UBU3"]
["GO:0004392","molecular_function","heme oxygenase (decyclizing) activity ","P09601"]
["GO:0019969","molecular_function","interleukin- binding ","Q13651"]
["GO:0035312","molecular_function","'-' exodeoxyribonuclease activity ","Q9H816; Q96SD1"]
["GO:0032422","molecular_function","purine-rich negative regulatory element binding ","P41970"]
["GO:0036105","molecular_function","peroxisome membrane class- targeting sequence binding ","P40855"]
["GO:0004739","molecular_function","pyruvate dehydrogenase (acetyl-transferring) activity ","P08559; P29803"]
["GO:0034604","molecular_function","pyruvate dehydrogenase (NAD+) activity ","P08559; P29803"]
["GO:0004738","molecular_function","pyruvate dehydrogenase activity ","P08559"]
["GO:0097603","molecular_function","temperature-gated ion channel activity ","Q8NER1"]
["GO:0045503","molecular_function","dynein light chain binding ","Q14204; Q13409"]
["GO:0033265","molecular_function","choline binding ","P35790"]
["GO:0004104","molecular_function","cholinesterase activity ","P35790"]
["GO:0008186","molecular_function","RNA-dependent ATPase activity ","Q92841"]
["GO:0045127","molecular_function","N-acetylglucosamine kinase activity ","Q9UJ70"]
["GO:0070700","molecular_function","BMP receptor binding ","P22004; Q9ULZ3"]
["GO:0047840","molecular_function","dCTP diphosphatase activity ","Q9H773"]
["GO:0032556","molecular_function","pyrimidine deoxyribonucleotide binding ","Q9H773"]
["GO:0004029","molecular_function","aldehyde dehydrogenase (NAD) activity ","P05091"]
["GO:0004030","molecular_function","aldehyde dehydrogenase [NAD(P)+] activity ","P05091"]
["GO:0043878","molecular_function","glyceraldehyde--phosphate dehydrogenase (NAD+) (non-phosphorylating) activity ","P05091"]
["GO:0003938","molecular_function","IMP dehydrogenase activity ","P12268"]
["GO:0051400","molecular_function","BH domain binding ","Q16611"]
["GO:0008176","molecular_function","tRNA (guanine-N-)-methyltransferase activity ","Q9UBP6"]
["GO:0097726","molecular_function","LEM domain binding ","O75531"]
["GO:0004033","molecular_function","aldo-keto reductase (NADP) activity ","Q13303; P35270"]
["GO:0070891","molecular_function","lipoteichoic acid binding ","Q9UGM3; P30203"]
["GO:0038187","molecular_function","pattern recognition receptor activity ","Q9UGM3"]
["GO:0008329","molecular_function","signaling pattern recognition receptor activity ","Q9UGM3"]
["GO:0035375","molecular_function","zymogen binding ","Q9UGM3"]
["GO:0004996","molecular_function","thyroid-stimulating hormone receptor activity ","P16473"]
["GO:0000062","molecular_function","fatty-acyl-CoA binding ","P22307"]
["GO:0036042","molecular_function","long-chain fatty acyl-CoA binding ","P22307; P07108"]
["GO:0070538","molecular_function","oleic acid binding ","P22307"]
["GO:0033814","molecular_function","propanoyl-CoA C-acyltransferase activity ","P22307"]
["GO:0050632","molecular_function","propionyl-CoA C-trimethyltridecanoyltransferase activity ","P22307"]
["GO:0015248","molecular_function","sterol transporter activity ","P22307; Q96SU4; P22059"]
["GO:0008995","molecular_function","ribonuclease E activity ","Q12972"]
["GO:0015183","molecular_function","L-aspartate transmembrane transporter activity ","P48664"]
["GO:0038021","molecular_function","leptin receptor activity ","P48357"]
["GO:0002060","molecular_function","purine nucleobase binding ","P06737"]
["GO:0019842","molecular_function","vitamin binding ","P06737"]
["GO:0004617","molecular_function","phosphoglycerate dehydrogenase activity ","O43175"]
["GO:0030379","molecular_function","neurotensin receptor activity, non--protein coupled ","Q99523"]
["GO:0010855","molecular_function","adenylate cyclase inhibitor activity ","Q14831"]
["GO:0001642","molecular_function","group III metabotropic glutamate receptor activity ","Q14831"]
["GO:0070905","molecular_function","serine binding ","Q14831"]
["GO:0016422","molecular_function","mRNA ('--methyladenosine-N-)-methyltransferase activity ","Q86U44"]
["GO:0008173","molecular_function","RNA methyltransferase activity ","Q86U44; Q7L2J0; Q96RS0"]
["GO:0008392","molecular_function","arachidonic acid epoxygenase activity ","P20813"]
["GO:0042978","molecular_function","ornithine decarboxylase activator activity ","P16471"]
["GO:0004925","molecular_function","prolactin receptor activity ","P16471"]
["GO:0034647","molecular_function","histone demethylase activity (H-trimethyl-K specific) ","P29375"]
["GO:0004952","molecular_function","dopamine neurotransmitter receptor activity ","P21728"]
["GO:0001588","molecular_function","dopamine neurotransmitter receptor activity, coupled via s ","P21728"]
["GO:0099508","molecular_function","voltage-gated ion channel activity involved in regulation of presynaptic membrane potential ","Q09470"]
["GO:0047837","molecular_function","D-xylose 1-dehydrogenase (NADP+) activity ","Q9UQ10"]
["GO:0047115","molecular_function","trans-,2-dihydrobenzene-,2-diol dehydrogenase activity ","Q9UQ10"]
["GO:0001849","molecular_function","complement component Cq binding ","Q96KG7; Q9NPY3; Q07021"]
["GO:0005237","molecular_function","inhibitory extracellular ligand-gated ion channel activity ","P47870"]
["GO:0035662","molecular_function","Toll-like receptor 4 binding ","P06702; Q9Y6Y9; P58753"]
["GO:0061598","molecular_function","molybdopterin adenylyltransferase activity ","Q9NQX3"]
["GO:0061599","molecular_function","molybdopterin molybdotransferase activity ","Q9NQX3"]
["GO:0008940","molecular_function","nitrate reductase activity ","Q9NQX3"]
["GO:0043141","molecular_function","ATP-dependent 5'-' DNA helicase activity ","Q9Y230; Q9Y265"]
["GO:0031681","molecular_function","-protein beta-subunit binding ","P49802; P35372"]
["GO:0071568","molecular_function","UFM transferase activity ","O94874"]
["GO:0001134","molecular_function","transcription factor recruiting activity ","P28347"]
["GO:0008127","molecular_function","quercetin ,3-dioxygenase activity ","O00625"]
["GO:0033204","molecular_function","ribonuclease P RNA binding ","O95707"]
["GO:0008757","molecular_function","S-adenosylmethionine-dependent methyltransferase activity ","Q7L2J0; Q9NR22"]
["GO:0017174","molecular_function","glycine N-methyltransferase activity ","Q14749"]
["GO:0017024","molecular_function","myosin I binding ","Q9ULZ3"]
["GO:0032090","molecular_function","Pyrin domain binding ","Q9ULZ3"]
["GO:0001181","molecular_function","RNA polymerase I general transcription initiation factor activity ","Q9NYV6"]
["GO:0009383","molecular_function","rRNA (cytosine-C5-)-methyltransferase activity ","P46087"]
["GO:0070975","molecular_function","FHA domain binding ","Q14676"]
["GO:0005048","molecular_function","signal sequence binding ","Q96CW1; P63010"]
["GO:0051861","molecular_function","glycolipid binding ","P54652"]
["GO:0004482","molecular_function","mRNA (guanine-N7-)-methyltransferase activity ","O43148"]
["GO:0004351","molecular_function","glutamate decarboxylase activity ","Q99259"]
["GO:0045504","molecular_function","dynein heavy chain binding ","Q9Y6G9; Q13409"]
["GO:0001621","molecular_function","ADP receptor activity ","Q9H244"]
["GO:0001609","molecular_function","-protein coupled adenosine receptor activity ","Q9H244"]
["GO:0000386","molecular_function","second spliceosomal transesterification activity ","Q6P2Q9"]
["GO:0030623","molecular_function","U5 snRNA binding ","Q6P2Q9"]
["GO:0052810","molecular_function","-phosphatidylinositol--kinase activity ","O14986"]
["GO:0030375","molecular_function","thyroid hormone receptor coactivator activity ","Q15596; Q15648"]
["GO:0032427","molecular_function","BD domain binding ","P60953; P17081"]
["GO:0004352","molecular_function","glutamate dehydrogenase (NAD+) activity ","P00367"]
["GO:0004353","molecular_function","glutamate dehydrogenase [NAD(P)+] activity ","P00367"]
["GO:0070728","molecular_function","leucine binding ","P00367"]
["GO:0015037","molecular_function","peptide disulfide oxidoreductase activity ","P30101; Q15084; P10599"]
["GO:0004757","molecular_function","sepiapterin reductase activity ","P35270"]
["GO:0019777","molecular_function","Atg2 transferase activity ","Q9NT62"]
["GO:0019776","molecular_function","Atg8 ligase activity ","Q9NT62"]
["GO:0019787","molecular_function","ubiquitin-like protein transferase activity ","Q9NT62; Q96J02; Q9UBS8; Q676U5"]
["GO:0099604","molecular_function","ligand-gated calcium channel activity ","O94759; Q9GZU1"]
["GO:0015368","molecular_function","calciumcation antiporter activity ","Q6J4K2"]
["GO:0086038","molecular_function","calciumsodium antiporter activity involved in regulation of cardiac muscle cell membrane potential ","Q6J4K2"]
["GO:0008428","molecular_function","ribonuclease inhibitor activity ","P13489"]
["GO:0004909","molecular_function","interleukin-1, type I, activating receptor activity ","P14778"]
["GO:0004908","molecular_function","interleukin-1 receptor activity ","P14778"]
["GO:0015078","molecular_function","proton transmembrane transporter activity ","P18859"]
["GO:0019865","molecular_function","immunoglobulin binding ","P01730"]
["GO:0042011","molecular_function","interleukin-6 binding ","P01730"]
["GO:0042012","molecular_function","interleukin-6 receptor activity ","P01730"]
["GO:0004913","molecular_function","interleukin- receptor activity ","P24394"]
["GO:0016651","molecular_function","oxidoreductase activity, acting on NAD(P)H ","Q9BQ95"]
["GO:0008568","molecular_function","microtubule-severing ATPase activity ","O75449"]
["GO:0035501","molecular_function","MH domain binding ","P52926"]
["GO:0016964","molecular_function","alpha-2 macroglobulin receptor activity ","Q07954"]
["GO:0030226","molecular_function","apolipoprotein receptor activity ","Q07954"]
["GO:0070325","molecular_function","lipoprotein particle receptor binding ","Q07954"]
["GO:0042954","molecular_function","lipoprotein transporter activity ","Q07954"]
["GO:0008177","molecular_function","succinate dehydrogenase (ubiquinone) activity ","P31040"]
["GO:0003874","molecular_function","6-pyruvoyltetrahydropterin synthase activity ","Q03393"]
["GO:1990599","molecular_function","3' overhang single-stranded DNA endodeoxyribonuclease activity ","P18887"]
["GO:0032356","molecular_function","oxidized DNA binding ","P18887"]
["GO:0030156","molecular_function","benzodiazepine receptor binding ","P07108"]
["GO:1990269","molecular_function","RNA polymerase II C-terminal domain phosphoserine binding ","Q8WVC0"]
["GO:0004961","molecular_function","thromboxane A2 receptor activity ","P21731"]
["GO:0001226","molecular_function","RNA polymerase II transcription corepressor binding ","Q9NZN8"]
["GO:0097682","molecular_function","intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity ","Q9GZU1"]
["GO:0005381","molecular_function","iron ion transmembrane transporter activity ","Q9GZU1"]
["GO:0072345","molecular_function","NAADP-sensitive calcium-release channel activity ","Q9GZU1"]
["GO:0016411","molecular_function","acylglycerol -acyltransferase activity ","Q96AD5"]
["GO:0004465","molecular_function","lipoprotein lipase activity ","Q96AD5"]
["GO:0071164","molecular_function","RNA trimethylguanosine synthase activity ","Q96RS0"]
["GO:0004802","molecular_function","transketolase activity ","P29401"]
["GO:0044213","molecular_function","intronic transcription regulatory region DNA binding ","P43699"]
["GO:1990756","molecular_function","protein binding, bridging involved in substrate recognition for ubiquitination ","Q7L5Y6; Q8NCT1"]
["GO:0008308","molecular_function","voltage-gated anion channel activity ","P21796"]
["GO:1990404","molecular_function","protein ADP-ribosylase activity ","P09874"]
["GO:0008785","molecular_function","alkyl hydroperoxide reductase activity ","P30048"]
["GO:0004322","molecular_function","ferroxidase activity ","Q16595; P00450"]
["GO:0034986","molecular_function","iron chaperone activity ","Q16595"]
["GO:0008048","molecular_function","calcium sensitive guanylate cyclase activator activity ","Q9UMX6"]
["GO:0004941","molecular_function","beta2-adrenergic receptor activity ","P07550"]
["GO:0035639","molecular_function","purine ribonucleoside triphosphate binding ","P60900"]
["GO:0008191","molecular_function","metalloendopeptidase inhibitor activity ","Q9UGM5; Q01955"]
["GO:0035663","molecular_function","Toll-like receptor 2 binding ","P58753"]
["GO:0031859","molecular_function","platelet activating factor receptor binding ","P32121"]
["GO:0031826","molecular_function","type A serotonin receptor binding ","P32121"]
["GO:0055105","molecular_function","ubiquitin-protein transferase inhibitor activity ","Q8N726"]
["GO:0003696","molecular_function","satellite DNA binding ","O95243"]
["GO:0097604","molecular_function","temperature-gated cation channel activity ","O75762"]
["GO:0004586","molecular_function","ornithine decarboxylase activity ","P11926"]
["GO:0016005","molecular_function","phospholipase A2 activator activity ","P42574"]
["GO:0005055","molecular_function","laminin receptor activity ","P50895"]
["GO:0005000","molecular_function","vasopressin receptor activity ","P30518"]
["GO:0046811","molecular_function","histone deacetylase inhibitor activity ","P12755"]
["GO:0008422","molecular_function","beta-glucosidase activity ","P09848"]
["GO:0017042","molecular_function","glycosylceramidase activity ","P09848"]
["GO:0000016","molecular_function","lactase activity ","P09848"]
["GO:0047021","molecular_function","5-hydroxyprostaglandin dehydrogenase (NADP+) activity ","P16152"]
["GO:0004090","molecular_function","carbonyl reductase (NADPH) activity ","P16152"]
["GO:0016655","molecular_function","oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor ","P16152"]
["GO:0050221","molecular_function","prostaglandin-E 9-reductase activity ","P16152"]
["GO:0043035","molecular_function","chromatin insulator sequence binding ","P49711"]
["GO:0008311","molecular_function","double-stranded DNA '-5' exodeoxyribonuclease activity ","P27695"]
["GO:0008081","molecular_function","phosphoric diester hydrolase activity ","P27695"]
["GO:0016890","molecular_function","site-specific endodeoxyribonuclease activity, specific for altered base ","P27695"]
["GO:0120017","molecular_function","intermembrane ceramide transfer activity ","Q9Y5P4"]
["GO:0015175","molecular_function","neutral amino acid transmembrane transporter activity ","P08195"]
["GO:0001596","molecular_function","angiotensin type I receptor activity ","P30556"]
["GO:0031711","molecular_function","bradykinin receptor binding ","P30556; P12821"]
["GO:0050816","molecular_function","phosphothreonine residue binding ","P46934; Q13526; Q969H0"]
["GO:0120108","molecular_function","DNA-3'-diphospho-5'-guanosine diphosphatase ","Q7Z2E3"]
["GO:0033699","molecular_function","DNA 5'-adenosine monophosphate hydrolase activity ","Q7Z2E3"]
["GO:0008967","molecular_function","phosphoglycolate phosphatase activity ","Q7Z2E3"]
["GO:0031690","molecular_function","adrenergic receptor binding ","Q07021"]
["GO:0030984","molecular_function","kininogen binding ","Q07021"]
["GO:0097177","molecular_function","mitochondrial ribosome binding ","Q07021"]
["GO:0060001","molecular_function","minus-end directed microfilament motor activity ","Q9UM54"]
["GO:0004525","molecular_function","ribonuclease III activity ","Q9NRR4"]
["GO:0017130","molecular_function","poly(C) RNA binding ","Q00839"]
["GO:0099122","molecular_function","RNA polymerase II C-terminal domain binding ","Q00839; O60885"]
["GO:0001097","molecular_function","TFIIH-class transcription factor binding ","Q00839"]
["GO:0003985","molecular_function","acetyl-CoA C-acetyltransferase activity ","P24752"]
["GO:0016830","molecular_function","carbon-carbon lyase activity ","P24752"]
["GO:0016885","molecular_function","ligase activity, forming carbon-carbon bonds ","P24752"]
["GO:0004994","molecular_function","somatostatin receptor activity ","P30874"]
["GO:0004452","molecular_function","isopentenyl-diphosphate delta-isomerase activity ","Q13907"]
["GO:0086077","molecular_function","gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling ","P36383"]
["GO:0086020","molecular_function","gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling ","P36383"]
["GO:0046970","molecular_function","NAD-dependent histone deacetylase activity (H-K1 specific) ","Q8IXJ6"]
["GO:0070337","molecular_function","'-flap-structured DNA binding ","Q14191"]
["GO:0003987","molecular_function","acetate-CoA ligase activity ","Q9NR19"]
["GO:0004598","molecular_function","peptidylamidoglycolate lyase activity ","P19021"]
["GO:0004504","molecular_function","peptidylglycine monooxygenase activity ","P19021"]
["GO:0005252","molecular_function","open rectifier potassium channel activity ","O14649"]
["GO:0045236","molecular_function","CXCR chemokine receptor binding ","Q96J02"]
["GO:0019811","molecular_function","cocaine binding ","P31645"]
["GO:0005335","molecular_function","serotoninsodium symporter activity ","P31645"]
["GO:0016428","molecular_function","tRNA (cytosine-5-)-methyltransferase activity ","Q08J23"]
["GO:0016499","molecular_function","orexin receptor activity ","O43613"]
["GO:0004347","molecular_function","glucose-6-phosphate isomerase activity ","P06744"]
["GO:0031877","molecular_function","somatostatin receptor binding ","Q9Y566"]
["GO:0004963","molecular_function","follicle-stimulating hormone receptor activity ","P23945"]
["GO:0090624","molecular_function","endoribonuclease activity, cleaving miRNA-paired mRNA ","Q9UKV8"]
["GO:0070551","molecular_function","endoribonuclease activity, cleaving siRNA-paired mRNA ","Q9UKV8"]
["GO:0098808","molecular_function","mRNA cap binding ","Q9UKV8"]
["GO:0004489","molecular_function","methylenetetrahydrofolate reductase (NAD(P)H) activity ","P42898"]
["GO:0004579","molecular_function","dolichyl-diphosphooligosaccharide-protein glycotransferase activity ","Q8TCJ2; P04843"]
["GO:0070573","molecular_function","metallodipeptidase activity ","P12821"]
["GO:0008241","molecular_function","peptidyl-dipeptidase activity ","P12821"]
["GO:0001729","molecular_function","ceramide kinase activity ","Q8TCT0"]
["GO:0102773","molecular_function","dihydroceramide kinase activity ","Q8TCT0"]
["GO:0036004","molecular_function","AF domain binding ","O00170"]
["GO:0030020","molecular_function","extracellular matrix structural constituent conferring tensile strength ","Q01955"]
["GO:0008527","molecular_function","taste receptor activity ","Q5NUL3"]
["GO:0071796","molecular_function","K-linked polyubiquitin modification-dependent protein binding ","Q04323"]
["GO:0004008","molecular_function","copper-exporting ATPase activity ","Q04656"]
["GO:0005375","molecular_function","copper ion transmembrane transporter activity ","Q04656"]
["GO:0033218","molecular_function","amide binding ","Q99623"]
["GO:1904599","molecular_function","advanced glycation end-product binding ","Q15109"]
["GO:0050785","molecular_function","advanced glycation end-product receptor activity ","Q15109"]
["GO:0004818","molecular_function","glutamate-tRNA ligase activity ","P07814"]
["GO:0004827","molecular_function","proline-tRNA ligase activity ","P07814"]
["GO:0004379","molecular_function","glycylpeptide N-tetradecanoyltransferase activity ","P30419"]
["GO:0019107","molecular_function","myristoyltransferase activity ","P30419"]
["GO:0030881","molecular_function","beta-2-microglobulin binding ","P01892"]
["GO:0046977","molecular_function","TAP binding ","P01892"]
["GO:0008375","molecular_function","acetylglucosaminyltransferase activity ","O15294"]
["GO:0016262","molecular_function","protein N-acetylglucosaminyltransferase activity ","O15294"]
["GO:0097363","molecular_function","protein -lcNAc transferase activity ","O15294"]
["GO:1990444","molecular_function","F-box domain binding ","O60260"]
["GO:0086039","molecular_function","calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential ","P16615"]
["GO:0031775","molecular_function","lutropin-choriogonadotropic hormone receptor binding ","P16615"]
["GO:0004791","molecular_function","thioredoxin-disulfide reductase activity ","P10599"]
["GO:0004062","molecular_function","aryl sulfotransferase activity ","Q9BR01"]
["GO:0008146","molecular_function","sulfotransferase activity ","Q9BR01"]
["GO:0017005","molecular_function","3'-tyrosyl-DNA phosphodiesterase activity ","Q9NUW8"]
["GO:1990829","molecular_function","C-rich single-stranded DNA binding ","P57721"]
["GO:0001515","molecular_function","opioid peptide activity ","O14613"]
["GO:0004654","molecular_function","polyribonucleotide nucleotidyltransferase activity ","Q8TCS8"]
["GO:0008427","molecular_function","calcium-dependent protein kinase inhibitor activity ","Q99828"]
["GO:0004157","molecular_function","dihydropyrimidinase activity ","Q16555"]
["GO:0050656","molecular_function","3'-phosphoadenosine '-phosphosulfate binding ","P22413"]
["GO:0004551","molecular_function","nucleotide diphosphatase activity ","P22413"]
["GO:0008170","molecular_function","N-methyltransferase activity ","Q99873"]
["GO:0015095","molecular_function","magnesium ion transmembrane transporter activity ","Q9Y5I7"]
["GO:0004979","molecular_function","beta-endorphin receptor activity ","P35372"]
["GO:0038047","molecular_function","morphine receptor activity ","P35372"]
["GO:0030109","molecular_function","HLA-B specific inhibitory MHC class I receptor activity ","P43629"]

{"sheet":"Kinexus Ab Testing Links","index":5,"n_rows":877,"n_cols":9,"rows_kept":877}
["URL Links For Kinexus Antibody Testing    (Copy and paste the shown url in your web browser to view each figure)"]
["Antibody Code","Ab Name","Figure1","Figure2","Figure3","Figure4","Figure5","Figure6","Figure7"]
["PN550","4E-BP1-pT37+pT46","http://www.kinexusproducts.ca/Images/images/PN550_4E-BP1-pT37-pT46_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN550_4E-BP1-pT37-pT46_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PN550_4E-BP1-pT37-pT46_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN550_4E-BP1-pT37-pT46_P-SiteMatch.jpg"]
["PK500","A-Raf-pY302","http://www.kinexusproducts.ca/Images/images/PK500_A-Raf-pY302_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK500_A-Raf-pY302_SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK500_A-Raf-pY302_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK500_A-Raf-pY302_P-SiteMatch.jpg"]
["PK501","A6-pY309","http://www.kinexusproducts.ca/Images/images/PK501_A6-pY309_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK501_A6-pY309_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK501_A6-pY309_P-SiteMatch.jpg"]
["PK502","A6r-pY309","http://www.kinexusproducts.ca/Images/images/PK502_A6r-pY309_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK502_A6r-pY309_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK502_A6r-pY309_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK502_A6r-pY309_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK502_A6r-pY309_P-SiteMatch.jpg"]
["PK503","AAK1-pS637","http://www.kinexusproducts.ca/Images/images/PK503_AAK1-pS637_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK503_AAK1-pS637_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK503_AAK1-pS637_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK503_AAK1-pS637_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK503_AAK1-pS637_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK503_AAK1-pS637_P-SiteMatch.jpg"]
["PK873","Abl-pY393+pT394","http://www.kinexusproducts.ca/Images/images/PK873_Abl-pY393-pT394_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK873_Abl1-pY393-pT394_HumanCells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK873_Abl-pY393-pT394_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK873_Abl-pY393-pT394_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK873_Abl-pY393-pT394_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK873_Abl-pY393-pT394_P-SiteMatch.jpg"]
["NK001-2","Abl1","http://www.kinexusproducts.ca/Images/images/NK001-2_Abl1_HumanCell_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK001-2_Abl1-2_KinaseDotBlot.jpg"]
["PK506","Abl1- pY257","http://www.kinexusproducts.ca/Images/images/PK506_Abl1-pY257_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK506_Abl1-pY257_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK506_Abl1-pY257_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK506_Abl1-pY257_P-SiteMatch.jpg"]
["PK507","Abl1- pY264","http://www.kinexusproducts.ca/Images/images/PK507_Abl1-pY264_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK507_Abl1-pY264_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK507_Abl1-pY264_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK507_Abl1-pY264_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK507_Abl1-pY264_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK507_Abl1-pY264_P-SiteMatch.jpg"]
["PK508","Abl1- pY469","http://www.kinexusproducts.ca/Images/images/PK508_Abl1-pY469_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK508_Abl1-pY469_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK508_Abl1-pY469_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK508_Abl1-pY469_P-SiteMatch.jpg"]
["PK504","Abl1-pY139","http://www.kinexusproducts.ca/Images/images/PK504_Abl1-pY139_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK504_Abl1-pY139_SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK504_Abl1-pY139_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK504_Abl1-pY139_P-SiteMatch.jpg"]
["PK505","Abl1-pY226","http://www.kinexusproducts.ca/Images/images/PK505_Abl1-pY226_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK505_Abl1-pY226_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK505_Abl1-pY226_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK505_Abl1-pY226_P-SiteMatch.jpg"]
["NK238-1","Abl2-1","http://www.kinexusproducts.ca/Images/images/NK238-1_Abl2-1_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK238-1_Abl2-1_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK238-1_Abl2-1_KinaseDotBlot.jpg"]
["PK509","Abl2-pY439","http://www.kinexusproducts.ca/Images/images/PK509_Abl2-pY439_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK509_Abl2-pY439_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK509_Abl2-pY439_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK509_Abl2-pY439_P-SiteMatch.jpg"]
["PK510","Abl2-pY439+pT440","http://www.kinexusproducts.ca/Images/images/PK510_Abl2-pY439-pT440_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK510_Abl2-pY439-pT440_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK510_Abl2-pY439-pT440_P-SiteMatch.jpg"]
["PN733","ACC1-pS29","http://www.kinexusproducts.ca/Images/images/PN733_ACC1-pS29_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN733_ACC1-pS29_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN733_ACC1-pS29_P-SiteMatch.jpg"]
["PN734","ACC2-pT1342","http://www.kinexusproducts.ca/Images/images/PN734_ACC2-pT1342_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN734_ACC2-pT1342_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN734_ACC2-pT1342_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN734_ACC2-pT1342_P-SiteMatch.jpg"]
["PK511","ACK1-pY284","http://www.kinexusproducts.ca/Images/images/PK511_ACK1-pY284_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK511_ACK1-pY284_Cells-EGF_WesternBlots.jpg","http://www.kinexusproducts.ca/Images/images/PK511_ACK1-pY284_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK511_ACK1-pY284_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK511_ACK1-pY284_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK511_ACK1-pY284_P-SiteMatch.jpg"]
["PK512","ACK1-pY518","http://www.kinexusproducts.ca/Images/images/PK512_ACK1-pY518_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK512_ACK1-pY518_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK512_ACK1-pY518_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK512_ACK1-pY518_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK512_ACK1-pY518_P-SiteMatch.jpg"]
["PK513","ACK1-pY859+pY860","http://www.kinexusproducts.ca/Images/images/PK513_ACK1-pY859-pY860_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK513_ACK1-pY859-pY860_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK513_ACK1-pY859-pY860_Tissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK513_ACK1-pY859-pY860_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK513_ACK1-pY859-pY860_P-SiteMatch.jpg"]
["PN735","ACLY-pS455","http://www.kinexusproducts.ca/Images/images/PN735_ACLY-pS455_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN735_ACLY-pS455_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN735_ACLY-pS455_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN735_ACLY-pS455_P-SiteMatch.jpg"]
["PN686","ACLY-pY682","http://www.kinexusproducts.ca/Images/images/PN686_ACLY-pY682_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN686_ACLY-pY682_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN686_ACLY-pY682_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN686_ACLY-pY682_P-SiteMatch.jpg"]
["PN736","ACO1-pS711","http://www.kinexusproducts.ca/Images/images/PN736_ACO1-pS711_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN736_ACO1-pS711_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN736_ACO1-pS711_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN736_ACO1-pS711_P-SiteMatch.jpg"]
["PN737","ACO1-pS806","http://www.kinexusproducts.ca/Images/images/PN737_ACO1-pS806_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN737_ACO1-pS806_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN737_ACO1-pS806_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN737_ACO1-pS806_P-SiteMatch.jpg"]
["PN687","ACP1-pY132+pY133","http://www.kinexusproducts.ca/Images/images/PN687_ACP1-pY132-pY133_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN687_ACP1-pY132-pY133_Tissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN687_ACP1-pY132-pY133_P-SiteMatch.jpg"]
["PN688","ACS1-pY567","http://www.kinexusproducts.ca/Images/images/PN688_ACS1-pY567_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN688_ACS1-pY567_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN688_ACS1-pY567_P-SiteMatch.jpg"]
["PN500","ACTB-pY294","http://www.kinexusproducts.ca/Images/images/PN500_ACTB-pY294_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PN500_ACTB-pY294_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN500_ACTB-pY294_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN500_ACTB-pY294_P-SiteMatch.jpg"]
["PN501","ACTB-pY53","http://www.kinexusproducts.ca/Images/images/PN501_ACTB-pY53_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PN501_ACTB-pY53_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN501_ACTB-pY53_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN501_ACTB-pY53_12DotBlot-2.jpg","http://www.kinexusproducts.ca/Images/images/PN501_ACTB-pY53_P-SiteMatch.jpg"]
["PN502","ACTN1-pY246","http://www.kinexusproducts.ca/Images/images/PN502_ACTN1-pY246_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PN502_ACTN1-pY246_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN502_ACTN1-pY246_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN502_ACTN1-pY246_P-SiteMatch.jpg"]
["PN689","ADK-pS86","http://www.kinexusproducts.ca/Images/images/PN689_ADK-pS86_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN689_ADK-pS86_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN689_ADK-pS86_P-SiteMatch.jpg"]
["NK129-3","Akt1-1","http://www.kinexusproducts.ca/Images/images/NK129-3_Akt1-1_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK129-3_Akt1-1_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK129-3_Akt1-1_KinaseDotBlot.jpg"]
["NK129-5","Akt1-3","http://www.kinexusproducts.ca/Images/images/NK129-5_Akt1-3_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK129-5_Akt1-3_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK129-5_Akt1-3_MouseTissues-HumanCells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/NK129-5_Akt1-3_KinaseDotBlot.jpg"]
["PK869","Akt1-pS473","http://www.kinexusproducts.ca/Images/images/PK869_Akt1-pS473_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK869_Akt1-pS473_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK869_Akt1-pS473_P-SiteMatch.jpg"]
["PK515","Akt1-pT308","http://www.kinexusproducts.ca/Images/images/PK515_Akt1-pT308_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK515_Akt1-pT308_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK515_Akt1-pT308_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK515_Akt1-pT308_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK515_Akt1-pT308_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK515_Akt1-pT308_P-SiteMatch.jpg"]
["PK516","Akt1-pY315","http://www.kinexusproducts.ca/Images/images/PK516_Akt1-pY315_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK516_Akt1-pY315_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK516_Akt1-pY315_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK516_Akt1-pY315_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK516_Akt1-pY315_P-SiteMatch.jpg"]
["PK517","Akt1-pY326","http://www.kinexusproducts.ca/Images/images/PK626_ERK5-pY221_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK517_Akt1-pY326_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK517_Akt1-pY326_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK517_Akt1-pY326_SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK517_Akt1-pY326_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK517_Akt1-pY326_P-SiteMatch.jpg"]
["NK130-8","Akt2-2","http://www.kinexusproducts.ca/Images/images/NK130-8_Akt2-2_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK130-8_Akt2-2_HumanCells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/NK130-8_Akt2-2_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK130-8_Akt2-2_MouseTissues-HumanCells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/NK130-8_Akt2-2_KinaseDotBlot.jpg"]
["NK130-9","Akt2-3","http://www.kinexusproducts.ca/Images/images/NK130-9_Akt2-3_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK130-9_Akt2-3_MouseTissues-HumanCells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/NK130-9_Akt2-3_KinaseDotBlot.jpg"]
["NK131-3","Akt3-2","http://www.kinexusproducts.ca/Images/images/NK131-3_Akt3-2_HumanCells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/NK131-3_Akt3-2_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK131-3_Akt3-2_MouseTissues-HumanCells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/NK131-3_Akt3-2_KinaseDotBlot.jpg"]
["NK003-2","ALK-AKCD","http://www.kinexusproducts.ca/Images/images/NK003-2_ALK-AKCD_Tissues-Cells_Western.jpg"]
["NK003-3","ALK-BKCD","http://www.kinexusproducts.ca/Images/images/NK003-3_ALK-BKCD_Tissues-Cells_Western.jpg"]
["PK518","ALK-pY1092","http://www.kinexusproducts.ca/Images/images/PK518_ALK-pY1092_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK518_ALK-pY1092_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK518_ALK-pY1092_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK518_ALK-pY1092_P-SiteMatch.jpg"]
["PK519","ALK-pY1096","http://www.kinexusproducts.ca/Images/images/PK519_ALK-pY1096_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK519_ALK-pY1096_SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK519_ALK-pY1096_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK519_ALK-pY1096_P-SiteMatch.jpg"]
["PK520","ALK-pY1507","http://www.kinexusproducts.ca/Images/images/PK520_ALK-pY1507_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK520_ALK-pY1507_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK520_ALK-pY1507_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK520_ALK-pY1507_P-SiteMatch.jpg"]
["PN738","ALOX5-pS272","http://www.kinexusproducts.ca/Images/images/PN738_ALOX5-pS272_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN738_ALOX5-pS272_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN738_ALOX5-pS272_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN738_ALOX5-pS272_P-SiteMatch.jpg"]
["PN568","AML1-pT273","http://www.kinexusproducts.ca/Images/images/PN568_AML1-pT273_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN568_AML1-pT273_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN568_AML1-pT273_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN568_AML1-pT273_P-SiteMatch.jpg"]
["PN569","AML2-pT231","http://www.kinexusproducts.ca/Images/images/PN569_AML2-pT231_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN569_AML2-pT231_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN569_AML2-pT231_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN569_AML2-pT231_P-SiteMatch.jpg"]
["NK259-1","AMPKa1-AKCD","http://www.kinexusproducts.ca/Images/images/NK259-1_AMPKa1-AKCD_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK259-1_AMPKa1-AKCD_KinaseDotBlot.jpg"]
["NK259-2","AMPKa1-NT","http://www.kinexusproducts.ca/Images/images/NK259-2_AMPKa1-NT_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK259-2_AMPKa1-NT_KinaseDotBlot.jpg"]
["PK521","AMPKa1-pT183+pS184","http://www.kinexusproducts.ca/Images/images/PK521_AMPKa1-pT183-pS184_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK521_AMPKa1-pT183-pS184_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK521_AMPKa1-pT183-pS184_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK521_AMPKa1-pT183-pS184_P-SiteMatch.jpg"]
["NK260-2","AMPKa2-AKCD1","http://www.kinexusproducts.ca/Images/images/NK260-2_AMPKa2-AKCD1_Tissues-Cells_Western.jpg"]
["NK260-1","AMPKa2-AKCD2","http://www.kinexusproducts.ca/Images/images/NK260-1_AMPKa2-AKCD2_Tissues-Cells_Western.jpg"]
["PK522","AMPKa2-pS377","http://www.kinexusproducts.ca/Images/images/PK522_AMPKa2-pS377_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK522_AMPKa2-pS377_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK522_AMPKa2-pS377_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK522_AMPKa2-pS377_P-SiteMatch.jpg"]
["PK523","ANKRD3-pS438","http://www.kinexusproducts.ca/Images/images/PK523_ANKRD3-pS438_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK523_ANKRD3-pS438_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK523_ANKRD3-pS438_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK523_ANKRD3-pS438_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK523_ANKRD3-pS438_P-SiteMatch.jpg"]
["PN503; PN551","ANXA1-pY207","http://www.kinexusproducts.ca/Images/images/PN503_ANXA1-pY207_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PN503_ANXA1-pY207_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN503_ANXA1-pY207_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN503_ANXA1-pY207_P-SiteMatch.jpg"]
["PN504","ANXA2-pY238","http://www.kinexusproducts.ca/Images/images/PN504_ANXA2-pY238_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN504_ANXA2-pY238_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN504_ANXA2-pY238_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PN504_ANXA2-pY238_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN504_ANXA2-pY238_P-SiteMatch.jpg"]
["PN739","APC-pS2129","http://www.kinexusproducts.ca/Images/images/PN739_APC-pS2129_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN739_APC-pS2129_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN739_APC-pS2129_P-SiteMatch.jpg"]
["PN571","AR-pS308","http://www.kinexusproducts.ca/Images/images/PN571_AR-pS310_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN571_AR-pS308_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN571_AR-pS308_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN571_AR-pS308_P-SiteMatch.jpg"]
["PN570","AR-pS94","http://www.kinexusproducts.ca/Images/images/PN570_AR-pS96_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN570_AR-pS94_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN570_AR-pS94_P-SiteMatch.jpg"]
["NK205-3","ARaf-2","http://www.kinexusproducts.ca/Images/images/NK205-3_A-Raf_HumanCells_Western-1.jpg","http://www.kinexusproducts.ca/Images/images/NK205-3_A-Raf-2_HumanCells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/NK205-3_A-Raf-2_KinaseDotBlot.jpg"]
["NK205-4","ARaf-3","http://www.kinexusproducts.ca/Images/images/NK205-4_A-Raf_HumanCell_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK205-4_A-Raf-3_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK205-4_A-Raf-3_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK205-4_A-Raf-3_KinaseDotBlot.jpg"]
["PN740","ARID1A-pS363","http://www.kinexusproducts.ca/Images/images/PN740_ARID1A-pS363_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN740_ARID1A-pS363_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN740_ARID1A-pS363_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN740_ARID1A-pS363_P-SiteMatch.jpg"]
["PK524","ASK1-pS1033","http://www.kinexusproducts.ca/Images/images/PK524_ASK1-pS1033_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK524_ASK1-pS1033_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK524_ASK1-pS1033_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK524_ASK1-pS1033_12DotBlot-2.jpg","http://www.kinexusproducts.ca/Images/images/PK524_ASK1-pS1033_P-SiteMatch.jpg"]
["PK525","ASK1-pT838","http://www.kinexusproducts.ca/Images/images/PK525_ASK1-pT838_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK525_ASK1-pT838_SeastarOocyte_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK525_ASK1-pT838_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK525_ASK1-pT838_P-SiteMatch.jpg"]
["PN741","ASS1-pT174+pS180","http://www.kinexusproducts.ca/Images/images/PN741_ASS1-pT174-pS180_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN741_ASS1-pT174-pS180_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN741_ASS1-pT174-pS180_P-SiteMatch.jpg"]
["PN742","ATASE-pT356","http://www.kinexusproducts.ca/Images/images/PN742_ATASE-pT356_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN742_ATASE-pT356_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN742_ATASE-pT356_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN742_ATASE-pT356_P-SiteMatch.jpg"]
["PN572","ATF2-pT69+pT71","http://www.kinexusproducts.ca/Images/images/PN572_ATF2-pT69-pT71_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN572_ATF2-pT69-pT71_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN572_ATF2-pT69-pT71_P-SiteMatch.jpg"]
["NK230-2","ATM-1","http://www.kinexusproducts.ca/Images/images/NK230-2_ATM-1_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK230-2_ATM-1_MouseTissues_Western.jpg"]
["NK230-1","ATM-2","http://www.kinexusproducts.ca/Images/images/NK230-1_ATM-2_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK230-1_ATM-2_MouseTissues-HumanCells_Western-2.jpg"]
["PK526","ATM-pS1981","http://www.kinexusproducts.ca/Images/images/PK526_ATM-pS1981_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK526_ATM-pS1981_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK526_ATM-pS1981_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK526_ATM-pS1981_P-SiteMatch.jpg"]
["PK527","ATM-pY2969","http://www.kinexusproducts.ca/Images/images/PK527_ATM-pY2969_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK527_ATM-pY2969_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK527_ATM-pY2969_P-SiteMatch.jpg"]
["NK237-1","ATR-2","http://www.kinexusproducts.ca/Images/images/NK237-1_ATR-2_Tissues-Cells_Western.jpg"]
["NK237-3","ATR-4","http://www.kinexusproducts.ca/Images/images/NK237-3_ATR-4_HumanCells_Western.jpg"]
["PK528","ATR-pS435+pS436","http://www.kinexusproducts.ca/Images/images/PK528_ATR-pS435-pS436_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK528_ATR-pS435-pS436_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK528_ATR-pS435-pS436_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK528_ATR-pS435-pS436_P-SiteMatch.jpg"]
["NK008-3","AurKA-1","http://www.kinexusproducts.ca/Images/images/NK008-3_AurKA_HumanCell_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK008-3_AurKA-1_KinaseDotBlot.jpg"]
["NK008-4","AurKA-2","http://www.kinexusproducts.ca/Images/images/NK008-4_AurKA-2_HumanCells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/NK008-4_AurKA-2_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK008-4_AurKA-2_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK008-4_AurKA-2_KinaseDotBlot.jpg"]
["PK529","AurKA-pT287+pT288","http://www.kinexusproducts.ca/Images/images/PK529-AurKA-pT287-pT288_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK529-AurKA-pT287-pT288_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK529_AurKA-pT287-pT288_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK529_AurKA-pT287-pT288_P-SiteMatch.jpg"]
["NK193-2","AurKB-1","http://www.kinexusproducts.ca/Images/images/NK193-2_AurKB-1_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK193-2_AurKB-1_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK193-2_AurKB-1_KinaseDotBlot.jpg"]
["NK193-3","AurKB-2","http://www.kinexusproducts.ca/Images/images/NK193-3_AurKB-2_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK193-3_AurKB-2_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK193-3_AurKB-2_KinaseDotBlot.jpg"]
["PK530","AurKB-pS227","http://www.kinexusproducts.ca/Images/images/PK530_AurkB-pS227_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK530_AurkB-pS227_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK530_AurKB-pS227_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK530_AurKB-pS227_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK530_AurKB-pS227_P-SiteMatch.jpg"]
["PK531","AurKB-pT232","http://www.kinexusproducts.ca/Images/images/PK531_AurKB-pT232_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK531_AurKB-pT232_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK531_AurKB-pT232_SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK531_AurKB-pT232_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK531_AurKB-pT232_P-SiteMatch.jpg"]
["NK009-2","AurKC-1","http://www.kinexusproducts.ca/Images/images/NK009-2_AurKC-1_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK009-2_AurKC-1_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK009-2_AurKC-1_KinaseDotBlot.jpg"]
["NK009-3","AurKC-2","http://www.kinexusproducts.ca/Images/images/NK009-3_AurKC-2_Tissues-Cells_Western.jpg"]
["PK532","AurKC-pS193","http://www.kinexusproducts.ca/Images/images/PK532_AurKC-pS193_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK532_AurKC-pS193_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK532_AurKC-pS193_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK532_AurKC-pS193_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK532_AurKC-pS193_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK532_AurKC-pS193_P-SiteMatch.jpg"]
["NK010-2","Axl-AKCD","http://www.kinexusproducts.ca/Images/images/NK010-2_Axl-AKCD_Tissues-Cells_Western.jpg"]
["NK010-3","Axl-BKCD","http://www.kinexusproducts.ca/Images/images/NK010-3_Axl-BKCD_Tissues-Cells_Western.jpg"]
["PK533","Axl-pY702+pY703","http://www.kinexusproducts.ca/Images/images/PK533_Axl-pY702-pY703_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK533_Axl-pY702-pY703_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK533_Axl-pY702-pY703_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK533_Axl-pY702-pY703_P-SiteMatch.jpg"]
["PN573","B-Myb -pT487","http://www.kinexusproducts.ca/Images/images/PN573_B-Myb-pT487_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN573_B-Myb -pT487_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN573_B-Myb-pT487_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN573_B-Myb-pT487_P-SiteMatch.jpg"]
["PK534","B-Raf-pS446+pS447","http://www.kinexusproducts.ca/Images/images/PK534_B-Raf-pS446-pS447_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK534_B-Raf-pS446-pS447_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK534_B-Raf-pS446-pS447_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK534_B-Raf-pS446-pS447_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK534_B-Raf-pS446-pS447_P-SiteMatch.jpg"]
["PK535","B-Raf-pS729","http://www.kinexusproducts.ca/Images/images/PK535_B-Raf-pS729_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK535_B-Raf-pS729_P-SIteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK535_B-Raf-pS729_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK535_B-Raf-pS729_P-SiteMatch.jpg"]
["PK536","BARK1-pS670","http://www.kinexusproducts.ca/Images/images/PK536_BARK1-pS670_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK536_BARK1-pS670_SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK536_BARK1-pS670_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK536_BARK1-pS670_P-SiteMatch.jpg"]
["PK537","BARK1-Y356","http://www.kinexusproducts.ca/Images/images/PK537_BARK1-pY356_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK537_BARK1-Y356_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK537_BARK1-Y356_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK537_BARK1-Y356_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK537_BARK1-Y356_P-SiteMatch.jpg"]
["NK257-1","BCKD-1","http://www.kinexusproducts.ca/Images/images/NK257-1_BCKD-1_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK257-1_BCKD-1_MouseTissues-HumanCells_Western-2.jpg"]
["NK257-2","BCKD-2","http://www.kinexusproducts.ca/Images/images/NK257-2_BCKD-2_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK257-2_BCKD-2_MouseTissues-HumanCells_Western-2.jpg"]
["PN574","BCLAF1-pS512","http://www.kinexusproducts.ca/Images/images/PN574_BCLAF1-pS512_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN574_BCLAF1-pS512_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN574_BCLAF1-pS512_P-SiteMatch.jpg"]
["PK538","Bcr-pY177","http://www.kinexusproducts.ca/Images/images/PK538_Bcr-pY177_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK538_Bcr-pY177_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK538_Bcr-pY177_P-SiteMatch.jpg"]
["PK539","Bcr-pY591","http://www.kinexusproducts.ca/Images/images/PK539_Bcr-pY591_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK539_Bcr-pY591_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK539_Bcr-pY591_P-SiteMatch.jpg"]
["PK540","Bcr-pY644","http://www.kinexusproducts.ca/Images/images/PK540_Bcr-pY644_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK540_Bcr-pY644_SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK540_Bcr-pY644_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK540_Bcr-pY644_P-SiteMatch.jpg"]
["PK541","BLK-pY187","http://www.kinexusproducts.ca/Images/images/PK541_BLK-pY187_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK541_BLK-pY187_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK541_BLK-pY187_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK541_BLK-pY187_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK541_BLK-pY187_P-SiteMatch.jpg"]
["PK542","BLK-pY188","http://www.kinexusproducts.ca/Images/images/PK542_BLK-pY188_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK542_BLK-pY188_HumanCells-EGF_WesternBlots.jpg","http://www.kinexusproducts.ca/Images/images/PK542_BLK-pY188_SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK542_BLK-pY188_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK542_BLK-pY188_P-SiteMatch.jpg"]
["PK543","BLK-pY389","http://www.kinexusproducts.ca/Images/images/PK543_BLK-pY389_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK543_BLK-pY389_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK543_BLK-pY389_SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK543_BLK-pY389_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK543_BLK-pY389_P-SiteMatch.jpg"]
["PK544","BMPR2-pS375","http://www.kinexusproducts.ca/Images/images/PK544_BMPR2-pS375_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK544_BMPR2-pS375_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK544_BMPR2-pS375_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK544_BMPR2-pS375_P-SiteMatch.jpg"]
["PK545","Bmx-Y40","http://www.kinexusproducts.ca/Images/images/PK545_Bmx-pY40_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK545_Bmx-pY40_SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK545_Bmx-pY40_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK545_Bmx-pY40_P-SiteMatch.jpg"]
["NK156-6","BRaf-2","http://www.kinexusproducts.ca/Images/images/NK156-6_B-Raf-2_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK156-6_B-Raf-2_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK156-6_BRaf-2_KinaseDotBlot.jpg"]
["NK156-4","BRaf-3","http://www.kinexusproducts.ca/Images/images/NK156-4_B-Raf_HumanCell_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK156-4_B-Raf-3_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK156-4_B-Raf-3_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK156-4_BRaf-3_KinaseDotBlot.jpg"]
["PN690","BRCA1-pT509","http://www.kinexusproducts.ca/Images/images/PN690_BRCA1-pT509_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN690_BRCA1-pT509_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN690_BRCA1-pT509_P-SiteSpecificitySPOTBlot.jpg"]
["PK546","BRD2-pS37","http://www.kinexusproducts.ca/Images/images/PK546_BRD2-pS37_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK546_BRD2-pS37_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK546_BRD2-pS37_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK546_BRD2-pS37_P-SiteMatch.jpg"]
["PK547","BRK-pS446+pY447","http://www.kinexusproducts.ca/Images/images/PK547_Brk-pS446-pY447_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK547_Brk-pS446-pY447_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK547_Brk-pS446-pY447_Tissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK547_Brk-pS446-pY447_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK547_Brk-pS446-pY447_P-SiteMatch.jpg"]
["PK548","BRK-pY342","http://www.kinexusproducts.ca/Images/images/PK548_Brk-pY342_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK548_Brk-pY342_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK548_Brk-pY342_P-SiteMatch.jpg"]
["PK549","BRSK1-pT189","http://www.kinexusproducts.ca/Images/images/PK549_BRSK1-pT189_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK549_BRSK1-pT189_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK549_BRSK1-pT189_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK549_BRSK1-pT189_P-SiteMatch.jpg"]
["PK550","Btk-pY223+pY225","http://www.kinexusproducts.ca/Images/images/PK550_Btk-pY223-pY225_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK550_Btk-pY223-pY225_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK550_Btk-pY223-pY225_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK550_Btk-pY223-pY225_P-SiteMatch.jpg"]
["PK551","Btk-pY551","http://www.kinexusproducts.ca/Images/images/PK551_Btk-pY551_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK551_Btk-pY551_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK551_Btk-pY551_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK551_Btk-pY551_SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK551_Btk-pY551_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK551_Btk-pY551_P-SiteMatch.jpg"]
["PK552","BUB1B-pS670","http://www.kinexusproducts.ca/Images/images/PK552_BUB1B-pS670_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK552_BUB1B-pS670_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK552_BUB1B-pS670_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK552_BUB1B-pS670_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK552_BUB1B-pS670_P-SiteMatch.jpg"]
["PN575","C-EBPa-pT226+pT230","http://www.kinexusproducts.ca/Images/images/PN575_cEBPa-pT226-pT230_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN575_cEBPa-pT226-pT230_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN575_cEBPa-pT226-pT230_P-SiteMatch.jpg"]
["PN691","CAD-pS1859","http://www.kinexusproducts.ca/Images/images/PN691_CAD-pS1859_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN691_CAD-pS1859_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN691_CAD-pS1859_P-SiteMatch.jpg"]
["PK553","CaMK1a-pT177","http://www.kinexusproducts.ca/Images/images/PK553_CaMK1a-pT177_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK553_CaMK1a-pT177_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK553_CaMK1a-pT177_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK553_CaMK1a-pT177_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK553_CaMK1a-pT177_P-SiteMatch.jpg"]
["PK874","CAMK1a-pY235","http://www.kinexusproducts.ca/Images/images/PK874_CAMK1a-pY235_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK874_CAMK1a-pY235_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK874_CAMK1a-pY235_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK874_CAMK1a-pY235_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK874_CAMK1a-pY235_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK874_CAMK1a-pY235_P-SiteMatch.jpg"]
["PK554","CaMK1d-pT180","http://www.kinexusproducts.ca/Images/images/PK554_CaMK1d-pT180_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK554_CaMK1d-pT180_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK554_CaMK1d-pT180_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK554_CaMK1d-pT180_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK554_CaMK1d-pT180_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK554_CaMK1d-pT180_P-SiteMatch.jpg"]
["PK555","CaMK2a-pT286","http://www.kinexusproducts.ca/Images/images/PK555_CaMK2a-pT286_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK555_CaMK2a-pT286_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK555_CaMK2a-pT286_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK555_CaMK2a-pT286_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK555_CaMK2a-pT286_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK555_CaMK2a-pT286_P-SiteMatch.jpg"]
["PK875","CaMK2A-pY230","http://www.kinexusproducts.ca/Images/images/PK875_CAMK2A-pY230_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK875_CAMK2A-pY230_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK875_CaMK2A-pY230_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK875_CaMK2A-pY230_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK875_CaMK2A-pY230_P-SiteMatch.jpg"]
["NK018-3","CaMK2b-PAD","http://www.kinexusproducts.ca/Images/images/NK018-3_CaMK2b-PAD_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK018-3_CaMK2b-PAD_KinaseDotBlot.jpg"]
["NK019-3","CaMK2d-NT","http://www.kinexusproducts.ca/Images/images/NK019-3_CaMK2d-NT_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK019-3_CaMK2d-NT_KinaseDotBlot.jpg"]
["NK020-1","CaMK2g-PAD","http://www.kinexusproducts.ca/Images/images/NK020-1_CaMK2g-PAD_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK020-1_CaMK2g-PAD_KinaseDotBlot.jpg"]
["NK021-2","CaMK4-CT (CaMK4-1)","http://www.kinexusproducts.ca/Images/images/NK021-2_CaMK4-1_KinaseDotBlot.jpg"]
["PK556","CaMK4-pT200","http://www.kinexusproducts.ca/Images/images/PK556_CaMK4-pT200_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK556_CaMK4-pT200_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK556_CaMK4-pT200_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK556_CaMK4-pT200_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK556_CaMK4-pT200_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK556_CaMK4-pT200_P-SiteMatch.jpg"]
["NK022","CaMKK1 (CaMKK1-1)","http://www.kinexusproducts.ca/Images/images/NK022_CaMKK1-1_KinaseDotBlot.jpg"]
["PK557","CaMKK1-pS74","http://www.kinexusproducts.ca/Images/images/PK557_CaMKK1-pS74_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK557_CaMKK1-pS74_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK557_CaMKK1-pS74_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK557_CaMKK1-pS74_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK557_CaMKK1-pS74_12DotBlot-2.jpg","http://www.kinexusproducts.ca/Images/images/PK557_CaMKK1-pS74_P-SiteMatch.jpg"]
["PN505","Cas-L-pY166","http://www.kinexusproducts.ca/Images/images/PN505_CasL-pY166_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PN505_Cas-L-pY166_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN505_Cas-L-pY166_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN505_Cas-L-pY166_P-SiteMatch.jpg"]
["PN743","CBL-pY674","http://www.kinexusproducts.ca/Images/images/PN743_CBL-pY674_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN743_CBL-pY674_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN743_CBL-pY674_P-SiteMatch.jpg"]
["PN744","CBS-pS227","http://www.kinexusproducts.ca/Images/images/PN744_CBS-pS227_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN744_CBS-pS227_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN744_CBS-pS227_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN744_CBS-pS227_P-SiteMatch.jpg"]
["PP527","CD45-pY1216","http://www.kinexusproducts.ca/Images/images/PP527_CD45-pY1216_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP527_CD45-pY1216_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP527_CD45-pY1216_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PP527_CD45-pY1216_P-SiteMatch.jpg"]
["PN576","CDC5L-pT385","http://www.kinexusproducts.ca/Images/images/PN576_CDC5L-pT385_HumanCells-EGF_WesternBlots.jpg","http://www.kinexusproducts.ca/Images/images/PN576_CDC5L-pT385_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN576_CDC5L-pT385_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN576_CDC5L-pT385_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN576_CDC5L-pT385_P-SiteMatch.jpg"]
["PK558","CDC7-pT376","http://www.kinexusproducts.ca/Images/images/PK558_CDC7-pT376_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK558_CDC7-pT376_SeastarOocyte_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK558_CDC7-pT376_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK558_CDC7-pT376_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK558_CDC7-pT376_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK558_CDC7-pT376_12DotBlot-2.jpg","http://www.kinexusproducts.ca/Images/images/PK558_CDC7-pT376_P-SiteMatch.jpg"]
["PK559","CDK1-pT14","http://www.kinexusproducts.ca/Images/images/PK559_CDK1-pT14_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK559_CDK1-pT14_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK559_CDK1-pT14_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK559_CDK1-pT14_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK559_CDK1-pT14_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK559_CDK1-pT14_P-SiteMatch.jpg"]
["PK560","CDK1-pT14+pY15","http://www.kinexusproducts.ca/Images/images/PK560_CDK1-pT14-pY15_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK560_CDK1-pT14-pY15_Cells-EGF_WesternBlots.jpg","http://www.kinexusproducts.ca/Images/images/PK560_CDK1-pT14-pY15_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK560_CDK1-pT14-pY15_Tissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK560_CDK1-pT14-pY15_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK560_CDK1-pT14-pY15_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK560_CDK1-pT14-pY15_P-SiteMatch.jpg"]
["PK561","CDK1-pT161","http://www.kinexusproducts.ca/Images/images/PK561_CDK1-pT161_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK561_CDK1-pT161_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK561_CDK1-pT161_SeastarOocyte_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK561_CDK1-pT161_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK561_CDK1-pT161_P-SIteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK561_CDK1-pT161_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK561_CDK1-pT161_P-SiteMatch.jpg"]
["NK033-2","CDK10-ANT","http://www.kinexusproducts.ca/Images/images/NK033-2_CDK10-ANT_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK033-2_CDK10-ANT_MouseTissues_Western.jpg"]
["NK033-3","CDK10-CT","http://www.kinexusproducts.ca/Images/images/NK033-3_CDK10-CT_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK033-3_CDK10-CT_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK033-3_CDK10-CT_Tissues-Cells_Western.jpg"]
["PK564","CDK10-pT196","http://www.kinexusproducts.ca/Images/images/PK564_CDK10-pT196_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK564_CDK10-pT196_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK564_CDK10-pT196_P-SiteMatch.jpg"]
["PK565","CDK11A-pT583","http://www.kinexusproducts.ca/Images/images/PK565_CDK11A-pT583_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK565_CDK11A-pT583_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK565_CDK11A-pT583_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK565_CDK11A-pT583_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK565_CDK11A-pT583_P-SiteMatch.jpg"]
["PK566","CDK12-pS383+pS385","http://www.kinexusproducts.ca/Images/images/PK566_CDK12-pS383-pS385_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK566_CDK12-pS383-pS385_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK566_CDK12-pS383-pS385_P-SiteMatch.jpg"]
["PK567","CDK12-pT893","http://www.kinexusproducts.ca/Images/images/PK567_CDK12-pT893_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK567_CDK12-pT893_P-SiteMatch.jpg"]
["NK199","CDK1L-1 (KKIALRE-CT)","http://www.kinexusproducts.ca/Images/images/NK199_CDKL1-1_MouseTissues_Western.jpg"]
["PK568","CDK2-pT160","http://www.kinexusproducts.ca/Images/images/PK568_CDK2-pT160_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK568_CDK2-pT160_Cells-2_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK568_CDK2-pT160_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK568_CDK2-pT160_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK568_CDK2-pT160_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK568_CDK2-pT160_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK568_CDK2-pT160_P-SiteMatch.jpg"]
["PK569","CDK4-pT172","http://www.kinexusproducts.ca/Images/images/PK569_CDK4-pT172_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK569_CDK4-pT172_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK569_CDK4-pT172_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK569_CDK4-pT172_P-SiteMatch.jpg"]
["PK570","CDK5-pY15","http://www.kinexusproducts.ca/Images/images/PK570_CDK5-pY15_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK570_CDK5-pY15_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK570_CDK5-pY15_SIiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK570_CDK5-pY15_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK570_CDK5-pY15_P-SiteMatch.jpg"]
["PK571","CDK6-pY13","http://www.kinexusproducts.ca/Images/images/PK571_CDK6-pY13_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK571_CDK6-pY13_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK571_CDK6-pY13_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK571_CDK6-pY13_P-SiteMatch.jpg"]
["PK572","CDK6-pY24","http://www.kinexusproducts.ca/Images/images/PK572_CDK6-pY24_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK572_CDK6-pY24_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK572_CDK6-pY24_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK572_CDK6-pY24_P-SiteMatch.jpg"]
["NK030-1","CDK7 (CDK7-1)","http://www.kinexusproducts.ca/Images/images/NK030-1_CDK7-1_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK030-1_CDK7-1_KinaseDotBlot.jpg"]
["PK573","CDK7-pY170","http://www.kinexusproducts.ca/Images/images/PK573_CDK7-pY170_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK573_CDK7-pY170_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK573_CDK7-pY170_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK573_CDK7-pY170_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK573_CDK7-pY170_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK573_CDK7-pY170_P-SiteMatch.jpg"]
["NK031-4","CDK8-NT (CDK8-1)","http://www.kinexusproducts.ca/Images/images/NK031-4_CDK8-1_MouseTissues_Western.jpg"]
["PK574","CDK9-pS347","http://www.kinexusproducts.ca/Images/images/PK574_CDK9-pS347_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK574_CDK9-pS347_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK574_CDK9-pS347_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK574_CDK9-pS347_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK574_CDK9-pS347_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK574_CDK9-pS347_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK574_CDK9-pS347_P-SiteMatch.jpg"]
["PK575","CDK9-pT186","http://www.kinexusproducts.ca/Images/images/PK575_CDK9-pT186_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK575_CDK9-pT186_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK575_CDK9-pT186_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK575_CDK9-pT186_P-SiteMatch.jpg"]
["NK261-1","CDKL2-CT","http://www.kinexusproducts.ca/Images/images/NK261-1_CDKL2-CT_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK261-1_CDKL2-CT_Tissues-Cells_Western.jpg"]
["NK262-1","CDKL3-BCT","http://www.kinexusproducts.ca/Images/images/NK262-1_CDKL3-BCT_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK262-1_CDKL3-BCT_Tissues-Cells_Western.jpg"]
["PK576","CDKL5-pY171","http://www.kinexusproducts.ca/Images/images/PK576_CDKL5-pY171_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK576_CDKL5-pY171_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK576_CDKL5-pY171_P-SiteMatch.jpg"]
["NK024-2","CHED-BKCD (CDC2L5-BKCD)","http://www.kinexusproducts.ca/Images/images/NK024-2_CHED-BKCD_Tissues-Cells_Western.jpg"]
["PK577","Chk1-pS280","http://www.kinexusproducts.ca/Images/images/PK577_Chk1-pS280_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK577_Chk1-pS280_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK577_Chk1-pS280_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK577_Chk1-pS280_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK577_Chk1-pS280_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK577_Chk1-pS280_P-SiteMatch.jpg"]
["PK578","Chk1-pS317","http://www.kinexusproducts.ca/Images/images/PK578_Chk1-pS317_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK578_Chk1-pS317_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK578_Chk1-pS317_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK578_Chk1-pS317_P-SIteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK578_Chk1-pS317_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK578_Chk1-pS317_P-SiteMatch.jpg"]
["PK579","Chk1-pS345","http://www.kinexusproducts.ca/Images/images/PK579_Chk1-pS345_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK579_Chk1-pS345_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK579_Chk1-pS345_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK579_Chk1-pS345_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK579_Chk1-pS345_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK579_Chk1-pS345_P-SiteMatch.jpg"]
["PK580","Chk2-pT383","http://www.kinexusproducts.ca/Images/images/PK580_Chk2-pT383_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK580_Chk2-pT383_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK580_Chk2-pT383_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK580_Chk2-pT383_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK580_Chk2-pT383_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK580_Chk2-pT383_P-SiteMatch.jpg"]
["PK581","Chk2-pT68","http://www.kinexusproducts.ca/Images/images/PK581_Chk2-pT68_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK581_Chk2-pT68_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK581_Chk2-pT68_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK581_Chk2-pT68_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK581_Chk2-pT68_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK581_Chk2-pT68_P-SiteMatch.jpg"]
["PK582","CK2a-pY255","http://www.kinexusproducts.ca/Images/images/PK582_CK2a-pY255_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK582_CK2a-pY255_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK582_CK2a-pY255_SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK582_CK2a-pY255_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK582_CK2a-pY255_P-SiteMatch.jpg"]
["NK041-2","CK2a1-ANT","http://www.kinexusproducts.ca/Images/images/NK041-2_CK2a1-ANT_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK041-2_CK2a1-ANT_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK041-2_CK2a1-ANT_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK041-2_CK2a1-ANT_KinaseDotBlot.jpg"]
["PK583","CLK1-pS337","http://www.kinexusproducts.ca/Images/images/PK583_CLK1-pS337_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK583_CLK1-pS337_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK583_CLK1-pS337_P-SiteMatch.jpg"]
["PK584","CLK1-pS337+pT338","http://www.kinexusproducts.ca/Images/images/PK584_CLK1-pS337-pT338_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK584_CLK1-pS337-pT338_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK584_CLK1-pS337-pT338_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK584_CLK1-pS337-pT338_P-SiteMatch.jpg"]
["NK042-1","COT (COT-1)","http://www.kinexusproducts.ca/Images/images/NK042-1_COT-1_KinaseDotBlot.jpg"]
["NK042-2","COT-CT (COT-2)","http://www.kinexusproducts.ca/Images/images/NK042-2_COT-2_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK042-2_COT-CT_KinaseDotBlot.jpg"]
["PK585","COT-pS334","http://www.kinexusproducts.ca/Images/images/PK585_COT-pS334_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK585_COT-pS334_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK585_COT-pS334_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK585_COT-pS334_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK585_COT-pS334_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK585_COT-pS334_P-SiteMatch.jpg"]
["PN695","COX2-pY446","http://www.kinexusproducts.ca/Images/images/PN695_COX2-pY446_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN695_COX2-pY446_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN695_COX2-pY446_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN695_COX2-pY446_P-SiteMatch.jpg"]
["PN553","CREB-pS133","http://www.kinexusproducts.ca/Images/images/PN553_CREB1-pS133_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN553_CREB-pS133_Cells-EGF_WesternBlots.jpg","http://www.kinexusproducts.ca/Images/images/PN553_CREB-pS133_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN553_CREB-pS133_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN553_CREB-pS133_P-SiteMatch.jpg"]
["PN577","CREB1-pS129+pS133","http://www.kinexusproducts.ca/Images/images/PN577_CREB1-pS129-pS133_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN577_CREB1-pS129-pS133_Cells-EGF_WesternBlots.jpg","http://www.kinexusproducts.ca/Images/images/PN577_CREB1-pS129-pS133_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN577_CREB1-pS129-pS133_P-SiteMatch.jpg"]
["PN507","CrkL-pY251","http://www.kinexusproducts.ca/Images/images/PN507_CrkL-pY251_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN507_CrkL-pY251_P-SiteMatch.jpg"]
["NK234-3","CSF1R -1","http://www.kinexusproducts.ca/Images/images/NK234-3_CSF1R-1_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK234-3_CSF1R-1_HumanCells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/NK234-3_CSF1R-1_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK234-3_CSF1R-1_KinaseDotBlot.jpg"]
["NK234-4","CSF1R -3","http://www.kinexusproducts.ca/Images/images/NK234-4_CSF1R-3_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK234-4_CSF1R-3_HumanCells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/NK234-4_CSF1R-3_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK234-4_CSF1R-3_KinaseDotBlot.jpg"]
["PK586","CSF1R-pS807+pY809","http://www.kinexusproducts.ca/Images/images/PK586_CSF1R-pS807-pY809_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK586_CSF1R-pS807-pY809_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK586_CSF1R-pS807-pY809_P-SiteMatch.jpg"]
["PK587","CSF1R-pY699","http://www.kinexusproducts.ca/Images/images/PK587_CSF1R-pY699_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK587_CSF1R-pY699_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK587_CSF1R-pY699_P-SiteMatch.jpg"]
["PK588","CSF1R-pY809","http://www.kinexusproducts.ca/Images/images/PK588_CSF1R-pY809_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK588_CSF1R-pY809_P-SiteMatch.jpg"]
["PK589","Csk-pY184","http://www.kinexusproducts.ca/Images/images/PK589_Csk-pY184_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK589_Csk-pY184_SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK589_Csk-pY184_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK589_Csk-pY184_12DotBlot-2.jpg","http://www.kinexusproducts.ca/Images/images/PK589_Csk-pY184_P-SiteMatch.jpg"]
["PN578","CTNNB1-pS33+pS37+pT41+pS45","http://www.kinexusproducts.ca/Images/images/PN578_CTNNB1-pS33+pS37+pT41+pS45_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN578_CTNNB1-pS33-pS37-pT41-pS45_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN578_CTNNB1-pS33-pS37-pT41-pS45_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN578_CTNNB1-pS33-pS37-pT41-pS45_P-SiteMatch.jpg"]
["PN745","CTNNB1-pY489","http://www.kinexusproducts.ca/Images/images/PN745_CTNNB1-pY489_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN745_CTNNB1-pY489_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN745_CTNNB1-pY489_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN745_CTNNB1-pY489_P-SiteMatch.jpg"]
["PN579","CTNNB1-pY654","http://www.kinexusproducts.ca/Images/images/PN579_CTNNB1-pY654_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN579_CTNNB1-pY654_P-SiteMatch.jpg"]
["PN580","CUX1-pS1270","http://www.kinexusproducts.ca/Images/images/PN580_CUX1-pS1270_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN580_CUX1-pS1270_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN580_CUX1-pS1270_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN580_CUX1-pS1270_P-SiteMatch.jpg"]
["PK590","DAPK-pS269","http://www.kinexusproducts.ca/Images/images/PK590_DAPK-pS269_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK590_DAPK-pS269_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK590_DAPK-pS269_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK590_DAPK-pS269_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK590_DAPK-pS269_P-SiteMatch.jpg"]
["PN696","DCK-pS74","http://www.kinexusproducts.ca/Images/images/PN696_DCK-pS74_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN696_DCK-pS74_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN696_DCK-pS74_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN696_DCK-pS74_P-SiteMatch.jpg"]
["NK263-1","DDR1-BCT","http://www.kinexusproducts.ca/Images/images/NK263-1_DDR1-BCT_Tissues-Cells_Western.jpg"]
["PK591","DDR1-pY796+pY797","http://www.kinexusproducts.ca/Images/images/PK591_DDR1-pY796-pY797_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK591_DDR1-pY796-pY797_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK591_DDR1-pY796-pY797_P-SiteMatch.jpg"]
["PK592","DDR1-pY797","http://www.kinexusproducts.ca/Images/images/PK592_DDR1-pY797_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK592_DDR1-pY797_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK592_DDR1-pY797_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK592_DDR1-pY797_P-SiteMatch.jpg"]
["PK594","DDR2-pY740","http://www.kinexusproducts.ca/Images/images/PK594_DDR-pY740_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK594_DDR-pY740_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK594_DDR2-pY740_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK594_DDR2-pY740_P-SiteMatch.jpg"]
["NK264-1","DMPK1-AKCD","http://www.kinexusproducts.ca/Images/images/NK264-1_DMPK1-AKCD_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK265-1_DMPK2-NT_HumanCells_Western.jpg"]
["NK265-1","DMPK2-NT","http://www.kinexusproducts.ca/Images/images/NK265-1_DMPK2-NT_Tissues-Cells_Western.jpg",null,"http://www.kinexusproducts.ca/Images/images/NK265-1_DMPK2-NT_MouseTissues_Western.jpg"]
["PK595","DNAPK-pT2609","http://www.kinexusproducts.ca/Images/images/PK595_DNAPK-pT2609_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK595_DNAPK-pT2609_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK595_DNAPK-pT2609_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK595_DNAPK-pT2609_P-SiteMatch.jpg"]
["PK596","DNAPK-pY883","http://www.kinexusproducts.ca/Images/images/PK596_DNAPK-pY883_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK596_DNAPK-pY883_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK596_DNAPK-pY883_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK596_DNAPK-pY883_P-SiteMatch.jpg"]
["PN746","DNMT3A-pS105","http://www.kinexusproducts.ca/Images/images/PN746_DNMT3A-pS105_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN746_DNMT3A-pS105_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN746_DNMT3A-pS105_P-SiteMatch.jpg"]
["PN508","Dok3-pY398","http://www.kinexusproducts.ca/Images/images/PN508_Dok3-pY398_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN508_Dok3-pY398_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN508_Dok3-pY398_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN508_Dok3-pY398_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN508_Dok3-pY398_P-SiteMatch.jpg"]
["PN747","DPYD-pS766+pT768","http://www.kinexusproducts.ca/Images/images/PN747_DPYD-pS766-pT768_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN747_DPYD-pS766-pT768_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN747_DPYD-pS766-pT768_P-SiteMatch.jpg"]
["PK597","DYRK1A-pY321","http://www.kinexusproducts.ca/Images/images/PK597_DYRK1A-pY321_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK597_DYRK1A-pY321_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK597_DYRK1A-pY321_P-SIteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK597_DYRK1A-pY321_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK597_DYRK1A-pY321_P-SiteMatch.jpg"]
["NK266-1","DYRK2-ANT","http://www.kinexusproducts.ca/Images/images/NK266-1_DYRK2-ANT_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK266-1_DYRK2-ANT_KinaseDotBlot.jpg"]
["PK598","DYRK2-pY382","http://www.kinexusproducts.ca/Images/images/PK598_DYRK2-pY382_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK598_DYRK2-pY382_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK598_DYRK2-pY382_P-SIteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK598_DYRK2-pY382_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK598_DYRK2-pY382_P-SiteMatch.jpg"]
["PN509","EEF1A1-pY141","http://www.kinexusproducts.ca/Images/images/PN509_eEF1A1-pY141_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PN509_EEF1A1-pY141_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN509_EEF1A1-pY141_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN509_EEF1A1-pY141_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN509_EEF1A1-pY141_P-SiteMatch.jpg"]
["PN555","EEF2-pT57","http://www.kinexusproducts.ca/Images/images/PN555_EEF2-pT57_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN555_EEF2-pT57_HumanCells-EGF_WesternBlots.jpg","http://www.kinexusproducts.ca/Images/images/PN555_EEF2-pT57_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PN555_EEF2-pT57_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN555_EEF2-pT57_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN555_EEF2-pT57_P-SiteMatch.jpg"]
["NK052-5","EGFR-1","http://www.kinexusproducts.ca/Images/images/NK052-5_EGFR-1_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK052-5_EGFR-1_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK052-5_EGFR-1_KinaseDotBlot.jpg"]
["NK052-6","EGFR-2","http://www.kinexusproducts.ca/Images/images/NK052-6_EGFR-2_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK052-6_EGFR-2_KinaseDotBlot.jpg"]
["NK052-4","EGFR-3","http://www.kinexusproducts.ca/Images/images/NK052-4_EGFR-3_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK052-4_EGFR-3_Cells-EGF_WesternBlots.jpg","http://www.kinexusproducts.ca/Images/images/NK052-4_EGFR-3_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/NK052-4_EGFR-3_MouseTissues_Western.jpg"]
["PK599","EGFR-pY1069","http://www.kinexusproducts.ca/Images/images/PK599_EGFR-pY1069_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK599_EGFR-pY1069_Cells-EGF_WesternBlots.jpg","http://www.kinexusproducts.ca/Images/images/PK599_EGFR-pY1069_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK599_EGFR-pY1069_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK599_EGFR-pY1069_P-SiteMatch.jpg"]
["PK600","EGFR-pY1110","http://www.kinexusproducts.ca/Images/images/PK600_EGFR-pY1110_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK600_EGFR-pY1110_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK600_EGFR-pY1110_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK600_EGFR-pY1110_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK600_EGFR-pY1110_P-SiteMatch.jpg"]
["PK601","EGFR-pY1172","http://www.kinexusproducts.ca/Images/images/PK601_EGFR-pY1172_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK601_EGFR-pY1172_HumanCells-EGF_WesternBlots.jpg","http://www.kinexusproducts.ca/Images/images/PK601_EGFR-pY1172_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK601_EGFR-pY1172_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK601_EGFR-pY1172_P-SiteMatch.jpg"]
["PK602","EGFR-pY869","http://www.kinexusproducts.ca/Images/images/PK602_EGFR-pY869_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK602_EGFR-pY869_Cells-EGF_WesternBlots.jpg","http://www.kinexusproducts.ca/Images/images/PK602_EGFR-pY869_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK602_EGFR-pY869_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK602_EGFR-pY869_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK602_EGFR-pY869_P-SiteMatch.jpg"]
["PK603","EGFR-pY998","http://www.kinexusproducts.ca/Images/images/PK603_EGFR-pY998_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK603_EGFR-pY998_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK603_EGFR-pY998_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK603_EGFR-pY998_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK603_EGFR-pY998_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK603_EGFR-pY998_P-SiteMatch.jpg"]
["PK876","EIF2AK1-pS258","http://www.kinexusproducts.ca/Images/images/PK876_EIF2AK1-pS258_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK876_EIF2AK1-pS258_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK876_EIF2AK1-pS258_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK876_EIF2AK1-pS258_P-SiteMatch.jpg"]
["PK604","EIF2AK3-pT982","http://www.kinexusproducts.ca/Images/images/PK604_EIF2AK3-pT982_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK604_EIF2AK3-pT982_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK604_EIF2AK3-pT982_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK604_EIF2AK3-pT982_12DotBlot.jpg"]
["PK877","EIF2AK4-pT667","http://www.kinexusproducts.ca/Images/images/PK877_EIF2AK4-pT667_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK877_EIF2AK4-pT667_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK877_EIF2AK4-pT667_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK877_EIF2AK4-pT667_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK877_EIF2AK4-pT667_P-SiteMatch.jpg"]
["PN581","Elk1-pS324","http://www.kinexusproducts.ca/Images/images/PN581_Elk1-pS324_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN581_Elk1-pS324_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN581_Elk1-pS324_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN581_Elk1-pS324_P-SiteMatch.jpg"]
["PN510","EML4-pY226","http://www.kinexusproducts.ca/Images/images/PN510_EML4-pY226_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN510_EML4-pY226_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN510_EML4-pY226_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN510_EML4-pY226_P-SiteMatch.jpg"]
["PN511","ENO1-pY44","http://www.kinexusproducts.ca/Images/images/PN511_ENO1-pY44_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN511_ENO1-pY44_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN511_ENO1-pY44_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN511_ENO1-pY44_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN511_ENO1-pY44_P-SiteMatch.jpg"]
["PN512","ENO2-pY25","http://www.kinexusproducts.ca/Images/images/PN512_ENO2-pY25_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN512_ENO2-pY25_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN512_ENO2-pY25_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN512_ENO2-pY25_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN512_ENO2-pY25_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN512_ENO2-pY25_12DotBlot-2.jpg","http://www.kinexusproducts.ca/Images/images/PN512_ENO2-pY25_P-SiteMatch.jpg"]
["PN748","EP300-pS2279","http://www.kinexusproducts.ca/Images/images/PN748_EP300-pS2279_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN748_EP300-pS2279_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN748_EP300-pS2279_P-SiteMatch.jpg"]
["PK605","EphA1-pY781","http://www.kinexusproducts.ca/Images/images/PK605_EphA1-pY781_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK605_EphA1-pY781_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK605_EphA1-pY781_P-SiteMatch.jpg"]
["PK606","EphA2-pY588","http://www.kinexusproducts.ca/Images/images/PK606_EphA2-pY588_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK606_EphA2-pY588_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK606_EphA2-pY588_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK606_EphA2-pY588_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK606_EphA2-pY588_P-SiteMatch.jpg"]
["PK607","EphA2-pY772","http://www.kinexusproducts.ca/Images/images/PK607_EphA2-pY772_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK607_EphA2-pY772_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK607_EphA2-pY772_P-SiteMatch.jpg"]
["PK608","EphA3-pY779","http://www.kinexusproducts.ca/Images/images/PK608_EphA3-pY779_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK608_EphA3-pY779_SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK608_EphA3-pY779_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK608_EphA3-pY779_P-SiteMatch.jpg"]
["PK609","EphB1-pY594","http://www.kinexusproducts.ca/Images/images/PK609_EphB1-pY594_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK609_EphB1-pY594_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK609_EphB1-pY594_P-SiteMatch.jpg"]
["NK267-1","EphB2-BKCD","http://www.kinexusproducts.ca/Images/images/NK267-1_EphB2-BKCD_Tissues-Cells_Western.jpg"]
["NK267-2","EphB2-PCT","http://www.kinexusproducts.ca/Images/images/NK267-2_EphB2-PCT_Tissues-Cells_Western.jpg"]
["PK610","EphB2-pY780","http://www.kinexusproducts.ca/Images/images/PK610_EphB2-pY780_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK610_EphB2-pY780_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK610_EphB2-pY780_P-SiteMatch.jpg"]
["PK611","EphB3-pY600","http://www.kinexusproducts.ca/Images/images/PK611_EphB3-pY600_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK611_EphB3-pY600_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK611_EphB3-pY600_P-SiteMatch.jpg"]
["PK612","EphB4-pY596","http://www.kinexusproducts.ca/Images/images/PK612_EphB4-pY596_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK612_EphB4-pY596_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK612_EphB4-pY596_P-SiteMatch.jpg"]
["PN583","ERa-pS167","http://www.kinexusproducts.ca/Images/images/PN583_ERa-pS167_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN583_ERa-pS167_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN583_ERa-pS167_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN583_ERa-pS167_P-SiteMatch.jpg"]
["NK054-4","ErbB2-1","http://www.kinexusproducts.ca/Images/images/NK054-4_ErbB2_HumanCell_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK054-4_ErbB2-1_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK054-4_ErbB2-1_KinaseDotBlot.jpg"]
["NK054-6","ErbB2-3","http://www.kinexusproducts.ca/Images/images/NK054-6_ErbB2-3_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK054-6_ErbB2-3_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK054-6_ErbB2-3_KinaseDotBlot.jpg"]
["PK613","ErbB2-pY1248","http://www.kinexusproducts.ca/Images/images/PK613_ErbB2-pY1248_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK613_ErbB2-pY1248_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK613_ErbB2-pY1248_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK613_ErbB2-pY1248_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK613_ErbB2-pY1248_12DotBlot-2.jpg","http://www.kinexusproducts.ca/Images/images/PK613_ErbB2-pY1248_P-SiteMatch.jpg"]
["PK614","ErbB2-pY735","http://www.kinexusproducts.ca/Images/images/PK614_ErbB2-pY735_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK614_ErbB2-pY735_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK614_ErbB2-pY735_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK614_ErbB2-pY735_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK614_ErbB2-pY735_P-SiteMatch.jpg"]
["PK615","ErbB2-pY877","http://www.kinexusproducts.ca/Images/images/PK615_ErbB2-pY877_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK615_ErbB2-pY877_P-SIteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK615_ErbB2-pY877_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK615_ErbB2-pY877_P-SiteMatch.jpg"]
["PN513","ERBB2IP-pY1104","http://www.kinexusproducts.ca/Images/images/PN513_ERBB2IP-pY1104_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN513_ERBB2IP-pY1104_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN513_ERBB2IP-pY1104_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PN513_ERBB2IP-pY1104_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN513_ERBB2IP-pY1104_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN513_ERBB2IP-pY1104_P-SiteMatch.jpg"]
["NK231-2","ErbB3-1","http://www.kinexusproducts.ca/Images/images/NK231-2_ErbB3-1_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK231-2_ErbB3-1_HumanCells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/NK231-2_ErbB3-1_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK231-2_ErbB3-1_KinaseDotBlot.jpg"]
["NK231-3","ErbB3-2","http://www.kinexusproducts.ca/Images/images/NK231-3_ErbB3-2_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK231-3_ErbB3-2_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK231-3_ErbB3-2_KinaseDotBlot.jpg"]
["PK616","ErbB3-pY1289","http://www.kinexusproducts.ca/Images/images/PK616_ErbB3-pY1289_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK616_ErbB3-pY1289_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK616_ErbB3-pY1289_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK616_ErbB3-pY1289_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK616_ErbB3-pY1289_12DotBlot-2.jpg","http://www.kinexusproducts.ca/Images/images/PK616_ErbB3-pY1289_P-SiteMatch.jpg"]
["PK617","ErbB3-pY1307","http://www.kinexusproducts.ca/Images/images/PK617_ErbB3-pY1307_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK617_ErbB3-pY1307_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK617_ErbB3-pY1307_P-SiteMatch.jpg"]
["PK618","ErbB3-pY1328","http://www.kinexusproducts.ca/Images/images/PK618_ErbB3-pY1328_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK618_ErbB3-pY1328_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK618_ErbB3-pY1328_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK618_ErbB3-pY1328_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK618_ErbB3-pY1328_12DotBlot-2.jpg","http://www.kinexusproducts.ca/Images/images/PK618_ErbB3-pY1328_P-SiteMatch.jpg"]
["NK235-1","ErbB4-1","http://www.kinexusproducts.ca/Images/images/NK235-1_ErbB4-1_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK235-1_ErbB4-1_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK235-1_ErbB4-1_KinaseDotBlot.jpg"]
["NK235-3","ErbB4-3","http://www.kinexusproducts.ca/Images/images/NK235-3_ErbB4-3_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK235-3_ErbB4-3_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK235-3_ErbB4-3_KinaseDotBlot.jpg"]
["PK619","ErbB4-pY733","http://www.kinexusproducts.ca/Images/images/PK619_ErbB4-pY733_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK619_ErbB4-pY733_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK619_ErbB4-pY733_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK619_ErbB4-pY733_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK619_ErbB4-pY733_P-SiteMatch.jpg"]
["PK620","ErbB4-pY875","http://www.kinexusproducts.ca/Images/images/PK620_ErbB4-pY875_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK620_ErbB4-pY875_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK620_ErbB4-pY875_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK620_ErbB4-pY875_P-SiteMatch.jpg"]
["PN584","ERF-pT526","http://www.kinexusproducts.ca/Images/images/PN584_ERF-pT526_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN584_ERF-pT526_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN584_ERF-pT526_P-SiteMatch.jpg"]
["NK055-1","ERK1-1","http://www.kinexusproducts.ca/Images/images/NK055-1_ERK1-1_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK055-ERK1__HumanCell_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/NK055-1_ERK1-1_KinaseDotBlot.jpg"]
["NK055-3","ERK1-3","http://www.kinexusproducts.ca/Images/images/NK055-3_ERK1-3_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK055-3_ERK1-3_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK055-3_ERK1-3_KinaseDotBlot.jpg"]
["NK055-4","ERK1-NT (ERK1-4)","http://www.kinexusproducts.ca/Images/images/NK055-4_ERK1-4_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK055-4_ERK1-4_KinaseDotBlot.jpg"]
["PK878","ERK1-pS265","http://www.kinexusproducts.ca/Images/images/PK878_ERK1-pS265_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK878_ERK1-pS265_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK878_ERK1-pS265_P-SIteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK878_ERK1-pS265_12DotBlot.jpg"]
["PK879","ERK1-pS283","http://www.kinexusproducts.ca/Images/images/PK879_ERK1-pS283_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK879_ERK1-pS283_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK879_ERK1-pS283_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK879_ERK1-pS283_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK879_ERK1-pS283_P-SiteMatch.jpg"]
["PK621","ERK1-pT202+pY204","http://www.kinexusproducts.ca/Images/images/PK621_ERK1-pT202-pY204_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK621_ERK1-pT202-pY204_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK621_ERK1-pT202-pY204_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK621_ERK1-pT202-pY204_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK621_ERK1-pT202-pY204_P-SiteMatch.jpg"]
["PK865","ERK1-pT207","http://www.kinexusproducts.ca/Images/images/PK865_ERK1-pT207_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK865_ERK1-pT207_MEK1phosphorylationERK1_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK865_ERK1-pT207_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK865_ERK1-pT207_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK865_ERK1-pT207_AbEpitopeMap.jpg","http://www.kinexusproducts.ca/Images/images/PK865_ERK1-pT207_P-SiteMatch.jpg"]
["PK864","ERK1-pY204","http://www.kinexusproducts.ca/Images/images/PK864_ERK1-pY204_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK864_ERK1-pY204_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK864_ERK1-pY204_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK864_ERK1-pY204_P-SiteMatch.jpg"]
["PK866","ERK1-pY204+pY207","http://www.kinexusproducts.ca/Images/images/PK866_ERK1-pY204-pT207_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK866_ERK1-pY204-pY207_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK866_ERK1-pY204-pT207_AbEpitopeMap.jpg","http://www.kinexusproducts.ca/Images/images/PK866_ERK1-pY204-pT207_P-SiteMatch.jpg"]
["NK056-3","ERK2-2","http://www.kinexusproducts.ca/Images/images/NK056-3_ERK2-2_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK056-3_ERK2-2_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK056-3_ERK2-2_KinaseDotBlot.jpg"]
["NK056-4","ERK2-3","http://www.kinexusproducts.ca/Images/images/NK056-4_ERK2-3_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK056-4_ERK2-3_HumanCells-2_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK056-4_ERK2-3_HumanCells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/NK056-4_ERK2-3_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK056-4_ERK2-3_KinaseDotBlot.jpg"]
["PK880","ERK2-pY263+S266","http://www.kinexusproducts.ca/Images/images/PK880_ERK2-pY263-pS266_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK880_ERK2-pY263-pS266_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK880_ERK2-pY263-S266_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK880_ERK2-pY263-S266_P-SiteMatch.jpg"]
["PK623","ERK3-pS189","http://www.kinexusproducts.ca/Images/images/PK623_ERK3-pS189_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK623_ERK3-pS189_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK623_ERK3-pS189_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK623_ERK3-pS189_P-SIteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK623_ERK3-pS189_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK623_ERK3-pS189_P-SiteMatch.jpg"]
["PK624","ERK4-pS186","http://www.kinexusproducts.ca/Images/images/PK624_ERK4-pS186_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK624_ERK4-pS186_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK624_ERK4-pS186_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK624_ERK4-pS186_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK624_ERK4-pS186_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK624_ERK4-pS186_P-SiteMatch.jpg"]
["NK206-5","ERK5-3","http://www.kinexusproducts.ca/Images/images/NK206-5_ERK5-3_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK206-5_ERK5-3_KinaseDotBlot.jpg"]
["PK626","ERK5-pY221","http://www.kinexusproducts.ca/Images/images/PK626_ERK5-pY221_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK626_ERK5-pY221_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK626_ERK5-pY221_Cells-EGF_WesternBlots.ai","http://www.kinexusproducts.ca/Images/images/PK626_ERK5-pY221_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK626_ERK5-pY221_P-SIteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK626_ERK5-pY221_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK626_ERK5-pY221_P-SiteMatch.jpg"]
["PN585","ESRRA-pS19+pS22","http://www.kinexusproducts.ca/Images/images/PN585_ESRRA-pS19-pS22_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN585_ESRRA-pS19-pS22_P-SiteMatch.jpg"]
["PN514","ESYT1-pY822","http://www.kinexusproducts.ca/Images/images/PN514_ESYT1-pY822_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN514_ESYT1-pY822_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PN514_ESYT1-pY822_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN514_ESYT1-pY822_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN514_ESYT1-pY822_P-SiteMatch.jpg"]
["PN586","Ets-1-pS282","http://www.kinexusproducts.ca/Images/images/PN586_Ets1-pS282_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN586_Ets-1-pS282-pS285_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN586_Ets-1-pS282-pS285_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN586_Ets-1-pS282-pS285_P-SiteMatch.jpg"]
["PN587","ETV6-pS22","http://www.kinexusproducts.ca/Images/images/PN587_ETV6-pS22_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN587_ETV6-pS22_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN587_ETV6-pS22_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN587_ETV6-pS22_P-SiteMatch.jpg"]
["PN697","EZH2-pT487","http://www.kinexusproducts.ca/Images/images/PN697_EZH2-pT487_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN697_EZH2-pT487_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN697_EZH2-pT487_P-SiteMatch.jpg"]
["PK627","FAK-pY397","http://www.kinexusproducts.ca/Images/images/PK627_FAK-pY397_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK627_FAK-pY397_SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK627_FAK-pY397_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK627_FAK-pY397_P-SiteMatch.jpg"]
["PK628","FAK-pY576+pY577","http://www.kinexusproducts.ca/Images/images/PK628_FAK-pY576-pY577_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK628_FAK-pY576-pY577_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK628_FAK-pY576-pY577_12DotBlot-2.jpg","http://www.kinexusproducts.ca/Images/images/PK628_FAK-pY576-pY577_P-SiteMatch.jpg"]
["PK629","FAK-pY577","http://www.kinexusproducts.ca/Images/images/PK629_FAK-pY577_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK629_FAK-pY577_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK629_FAK-pY577_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK629_FAK-pY577_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK629_FAK-pY577_P-SiteMatch.jpg"]
["PN698","FASN-pS207","http://www.kinexusproducts.ca/Images/images/PN698_FASN-pS207_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN698_FASN-pS207_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN698_FASN-pS207_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN698_FASN-pS207_P-SiteMatch.jpg"]
["PN749","FASN-pY45","http://www.kinexusproducts.ca/Images/images/PN749_FASN-pY45_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN749_FASN-pY45_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN749_FASN-pY45_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN749_FASN-pY45_P-SiteMatch.jpg"]
["PN750","FBPase-pS88","http://www.kinexusproducts.ca/Images/images/PN750_FBPase-pS88_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN750_FBPase-pS88_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN750_FBPase-pS88_P-SiteSpecificitySPOTBlot.jpg"]
["PN699","FBPase-pY265","http://www.kinexusproducts.ca/Images/images/PN699_FBPase-pY265_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN699_FBPase-pY265_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN699_FBPase-pY265_HumanCells_Western.jpg"]
["PN700","FBPase2-pY216","http://www.kinexusproducts.ca/Images/images/PN700_FBPase2-pY216_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN700_FBPase2-pY216_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN700_FBPase2-pY216_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN700_FBPase2-pY216_P-SiteMatch.jpg"]
["PN751","FBPase2-pY259","http://www.kinexusproducts.ca/Images/images/PN751_FBPase2-pY259_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN751_FBPase2-pY259_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN751_FBPase2-pY259_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN751_FBPase2-pY259_P-SiteMatch.jpg"]
["PK630","FER-pY402","http://www.kinexusproducts.ca/Images/images/PK630_Fer-pY402_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK630_Fer-pY402_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK630_Fer-pY402_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK630_Fer-pY402_P-SiteMatch.jpg"]
["PK632","FES-pY713","http://www.kinexusproducts.ca/Images/images/PK632_Fes-pY713_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK632_Fes-pY713_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK632_Fes-pY713_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK632_Fes-pY713_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK632_Fes-pY713_P-SiteMatch.jpg"]
["PK633","FES-pY713+pS716","http://www.kinexusproducts.ca/Images/images/PK633_Fes-pY713-pS716_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK633_Fes-pY713-pS716_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK633_Fes-pY713-pS716_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK633_Fes-pY713-pS716_P-SiteMatch.jpg"]
["NK062-3","FGFR1-3","http://www.kinexusproducts.ca/Images/images/NK062-3_FGFR1-3_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK062-3_FGFR1-3_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK062-3_FGFR1-3_KinaseDotBlot.jpg"]
["PK634","FGFR1-pY653+pY654","http://www.kinexusproducts.ca/Images/images/PK634_FGFR1-pY653-pY654_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK634_FGFR1-pY653-pY654_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK634_FGFR1-pY653-pY654_P-SiteMatch.jpg"]
["NK063-4","FGFR2-2","http://www.kinexusproducts.ca/Images/images/NK063-4_FGFR2-2_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK063-4_FGFR2-2_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK063-4_FGFR2-2_KinaseDotBlot.jpg"]
["NK063-2","FGFR2-3","http://www.kinexusproducts.ca/Images/images/NK063-2_FGFR2-3_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK063-2_FGFR2-3_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK063-2_FGFR2-3_KinaseDotBlot.jpg"]
["PK635","FGFR2-pY656+pY657","http://www.kinexusproducts.ca/Images/images/PK635_FGFR2-pY656-pY657_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK635_FGFR2-pY656-pY657_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK635_FGFR2-pY656-pY657_12DotBlot-2.jpg","http://www.kinexusproducts.ca/Images/images/PK635_FGFR2-pY656-pY657_P-SiteMatch.jpg"]
["NK236-2","FGFR3-2","http://www.kinexusproducts.ca/Images/images/NK236-2_FGFR3-2_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK236-2_FGFR3-2_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK236-2_FGFR3-2_KinaseDotBlot.jpg"]
["NK236-3","FGFR3-3","http://www.kinexusproducts.ca/Images/images/NK236-3_FGFR3-3_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK236-3_FGFR3-3_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK236-3_FGFR3-3_KinaseDotBlot.jpg"]
["PK636","FGFR3-pY647+pY648","http://www.kinexusproducts.ca/Images/images/PK636_FGFR3-pY647-pY648_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK636_FGFR3-pY647-pY648_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK636_FGFR3-pY647-pY648_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK636_FGFR3-pY647-pY648_12DotBlot-2.jpg","http://www.kinexusproducts.ca/Images/images/PK636_FGFR3-pY647-pY648_P-SiteMatch.jpg"]
["PK637","FGFR3-pY647+pY648","http://www.kinexusproducts.ca/Images/images/PK637_FGFR3-pY647-pY648_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK637_FGFR3-pY647-pY648_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK637_FGFR3-pY647-pY648_P-SiteMatch.jpg"]
["NK239-3","FGFR4-4","http://www.kinexusproducts.ca/Images/images/NK239-3_FGFR4-4_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK239-3_FGFR4-4_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK239-3_FGFR4-4_KinaseDotBlot.jpg"]
["NK268-1","Fgr-ANT","http://www.kinexusproducts.ca/Images/images/NK268-1_Fgr-ANT_Tissues-Cells_Western.jpg"]
["PK638","FGR-pY208+pY209","http://www.kinexusproducts.ca/Images/images/PK638_FGR-pY208-pY209_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK638_FGR-pY208-pY209_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK638_FGR-pY208-pY209_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK638_FGR-pY208-pY209_P-SiteMatch.jpg"]
["PK639","FGR-pY412","http://www.kinexusproducts.ca/Images/images/PK639_FGR-pY412_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK639_FGR-pY412_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK639_FGR-pY412_P-SiteMatch.jpg"]
["NK240-1","Flt3-1","http://www.kinexusproducts.ca/Images/images/NK240-1_Flt3-1_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK240-1_Flt3-1_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK240-1_Flt3-1_KinaseDotBlot.jpg"]
["NK240-2","Flt3-2","http://www.kinexusproducts.ca/Images/images/NK240-2_Flt3-2_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK240-2_Flt3-2_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK240-2_Flt3-2_KinaseDotBlot.jpg"]
["PK640","Flt3-pY842","http://www.kinexusproducts.ca/Images/images/PK640_Flt3-pY842_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK640_Flt3-pY842_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK640_Flt3-pY842_P-SiteMatch.jpg"]
["PN589","Fos-pS362+pS363","http://www.kinexusproducts.ca/Images/images/PN589_Fos-pS362-pS363_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN589_Fos-pS362-pS363_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN589_Fos-pS362-pS363_P-SiteMatch.jpg"]
["PN588","Fos-pT232","http://www.kinexusproducts.ca/Images/images/PN588_Fos-pT232_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN588_Fos-pT232_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN588_Fos-pT232_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN588_Fos-pT232_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN588_Fos-pT232_P-SiteMatch.jpg"]
["PN590","FOXK1-pS441+pS445","http://www.kinexusproducts.ca/Images/images/PN590_FOXK1-pS441-pS445_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN590_FOXK1-pS441-pS445_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN590_FOXK1-pS441-pS445_P-SiteMatch.jpg"]
["PN591","FOXK2-pS424+pS428","http://www.kinexusproducts.ca/Images/images/PN591_FOXK2-pS424-pS428_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN591_FOXK2-pS424-pS428_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN591_FOXK2-pS424-pS428_P-SiteMatch.jpg"]
["PN592","FOXM1-pT611","http://www.kinexusproducts.ca/Images/images/PN592_FOXM1-pT611_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN592_FOXM1-pT611_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN592_FOXM1-pT611_P-SiteMatch.jpg"]
["PN593","FOXO1-pS256","http://www.kinexusproducts.ca/Images/images/PN593_FOXO1-pS256_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN593_FOXO1-pS256_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN593_FOXO1-pS256_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN593_FOXO1-pS256_P-SiteMatch.jpg"]
["PN594","FOXO1-pS319","http://www.kinexusproducts.ca/Images/images/PN594_FOXO1-pS319_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN594_FOXO1-pS319_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN594_FOXO1-pS319_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN594_FOXO1-pS319_P-SiteMatch.jpg"]
["PN595","FOXO1-pS329","http://www.kinexusproducts.ca/Images/images/PN595_FOXO1-pS329_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN595_FOXO1-pS329_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN595_FOXO1-pS329_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN595_FOXO1-pS329_P-SiteMatch.jpg"]
["PN597","FOXO3-pS294","http://www.kinexusproducts.ca/Images/images/PN597_FOXO3-pS294_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN597_FOXO3-pS294_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN597_FOXO3-pS294_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN597_FOXO3-pS294_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN597_FOXO3-pS294_P-SiteMatch.jpg"]
["PN596","FOXO3-pT32","http://www.kinexusproducts.ca/Images/images/PN596_FOXO3-pT32_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN596_FOXO3-pT32_MouseTissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN596_FOXO3-pT32_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN596_FOXO3-pT32_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN596_FOXO3-pT32_P-SiteMatch.jpg"]
["PN599","FRA1-pS265","http://www.kinexusproducts.ca/Images/images/PN599_FRA1-pS265_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN599_FRA1-pS265_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN599_FRA1-pS265_P-SiteMatch.jpg"]
["NK269-1","Frk-ANT","http://www.kinexusproducts.ca/Images/images/NK269-1_Frk-ANT_Tissues-Cells_Western.jpg"]
["NK269-2","Frk-NT","http://www.kinexusproducts.ca/Images/images/NK269-2_Frk-NT_Tissues-Cells_Western.jpg"]
["PK641","Frk-pY387","http://www.kinexusproducts.ca/Images/images/PK641_Frk-pY387_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK641_Frk-pY387_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK641_Frk-pY387_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK641_FRK-pY387_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK641_Frk-pY387_P-SiteMatch.jpg"]
["PK642","Frk-pY497","http://www.kinexusproducts.ca/Images/images/PK642_Frk-pY497_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK642_Frk-pY497_P-SiteMatch.jpg"]
["PK643","Fused-pS159","http://www.kinexusproducts.ca/Images/images/PK643_Fused-pS159_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK643_Fused-pS159_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK643_Fused-pS159_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK643_Fused-pS159_12DotBlot.jpg"]
["NK065-2","Fyn-ANT","http://www.kinexusproducts.ca/Images/images/NK065-2_Fyn-ANT_Tissues-Cells_Western.jpg"]
["PK644","Fyn-pY213+pY214","http://www.kinexusproducts.ca/Images/images/PK644_Fyn-pY213-pY214_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK644_Fyn-pY213-pY214_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK644_Fyn-pY213-pY214_P-SiteMatch.jpg"]
["PK881","Fyn-pY420","http://www.kinexusproducts.ca/Images/images/PK881_Fyn-pY420_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK881_Fyn-pY420_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK881_Fyn-pY420_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK881_Fyn-pY420_P-SiteMatch.jpg"]
["PK645","Fyn-pY531","http://www.kinexusproducts.ca/Images/images/PK645_Fyn-pY531_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK645_Fyn-pY531_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK645_Fyn-pY531_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK645_Fyn-pY531_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK645_Fyn-pY531_12DotBlot-2.jpg","http://www.kinexusproducts.ca/Images/images/PK645_Fyn-pY531_P-SiteMatch.jpg"]
["PN515","G6PD-pY401","http://www.kinexusproducts.ca/Images/images/PN515_G6PD-pY401_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN515_G6PD-pY401_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PN515_G6PD-pY401_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN515_G6PD-pY401_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN515_G6PD-pY401_P-SiteMatch.jpg"]
["PN701","G6PD-pY503+pY507","http://www.kinexusproducts.ca/Images/images/PN701_G6PD-pY503-pY507_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN701_G6PD-pY503-pY507_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN701_G6PD-pY503-pY507_P-SiteMatch.jpg"]
["PN516","Gab1-pY406","http://www.kinexusproducts.ca/Images/images/PN516_Gab1-pY406_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN516_Gab1-pY406_P-SiteMatch.jpg"]
["PN702","GATA3-pS369","http://www.kinexusproducts.ca/Images/images/PN702_GATA3-pS369_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN702_GATA3-pS369_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN702_GATA3-pS369_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN702_GATA3-pS369_P-SiteMatch.jpg"]
["PN600","GATAD2B-pT120+pS122","http://www.kinexusproducts.ca/Images/images/PN600_GATAD2B-pT120-pS122_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN600_GATAD2B-pT120-pS122_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN600_GATAD2B-pT120-pS122_P-SiteMatch.jpg"]
["PK646","GCK-pS170","http://www.kinexusproducts.ca/Images/images/PK646_GCK-pS170_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK646_GCK-pS170_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK646_GCK-pS170_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK646_GCK-pS170_12DotBlot-2.jpg","http://www.kinexusproducts.ca/Images/images/PK646_GCK-pS170_P-SiteMatch.jpg"]
["PK893","GCK-pS411","http://www.kinexusproducts.ca/Images/images/PK893_GCK-pS411_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK893_GCK-pS411_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK893_GCK-pS411_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK893_GCK-pS411_P-SiteMatch.jpg"]
["PN752","GCLC-pS5+pS8","http://www.kinexusproducts.ca/Images/images/PN752_GCLC-pS5-pS8_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN752_GCLC-pS5-pS8_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN752_GCLC-pS5-pS8_P-SiteMatch.jpg"]
["PN517","GIT1-pY545","http://www.kinexusproducts.ca/Images/images/PN517_GIT1-pY545_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN517_GIT1-pY545_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PN517_GIT1-pY545_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN517_GIT1-pY545_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN517_GIT1-pY545_P-SiteMatch.jpg"]
["PN601","GR-pS226","http://www.kinexusproducts.ca/Images/images/PN601_GR-pS226_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN601_GR-pS226_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN601_GR-pS226_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN601_GR-pS226_P-SiteMatch.jpg"]
["NK069-3","GSK3a-BKCD","http://www.kinexusproducts.ca/Images/images/NK069-3_GSK3a-BKCD_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK069-3_GSK3a-BKCD_KinaseDotBlot.jpg"]
["PK647","GSK3a-pS278+pY279","http://www.kinexusproducts.ca/Images/images/PK647_GSK3a-pS278-pY279_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK647_GSK3a-pS278-pY279_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK647_GSK3a-pS278-pY279_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK647_GSK3a-pS278-pY279_P-SiteMatch.jpg"]
["PK648","GSK3a-pT19+pS21","http://www.kinexusproducts.ca/Images/images/PK648_GSK3a-pT19-pS21_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK648_GSK3a-pT19-pS21_HumanCells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK648_GSK3a-pT19-pS21_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK648_GSK3a-pT19-pS21_P-SiteMatch.jpg"]
["PK649","GSK3a-pY279","http://www.kinexusproducts.ca/Images/images/PK649_GSK3a-pY279_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK649_GSK3a-pY279_P-SiteMatch.jpg"]
["PK650","GSK3a-pY284+pY285","http://www.kinexusproducts.ca/Images/images/PK650_GSK3a-pY284-pY285_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK650_GSK3a-pY284-pY285_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK650_GSK3a-pY284-pY285_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK650_GSK3a-pY284-pY285_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK650_GSK3a-pY284-pY285_P-SiteMatch.jpg"]
["NK270-3","GSK3b-ANT","http://www.kinexusproducts.ca/Images/images/NK270-3_GSK3b-ANT_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK270-3_GSK3b-ANT_KinaseDotBlot.jpg"]
["PK883","GSK3b-pT275+pT277","http://www.kinexusproducts.ca/Images/images/PK883_GSK3b-pT275-pT277_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK883_GSK3b-pT275-pT277_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK883_GSK3b-pT275-pT277_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK883_GSK3b-pT275-pT277_P-SiteMatch.jpg"]
["NK070","GSK3b-XI (GSK3b-1)","http://www.kinexusproducts.ca/Images/images/NK070_GSK3b-1_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK070_GSK3b-1_KinaseDotBlot.jpg"]
["PK651","GTF2F1-pS385+pT389","http://www.kinexusproducts.ca/Images/images/PK651_GTF2F1-pS385-pT389_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK651_GTF2F1-pS385-pT389_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK651_GTF2F1-pS385-pT389_P-SiteMatch.jpg"]
["PN602","GTF2I-pS412","http://www.kinexusproducts.ca/Images/images/PN602_GTF2I-pS412_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN602_GTF2I-pS412_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN602_GTF2I-pS412_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN602_GTF2I-pS412_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN602_GTF2I-pS412_P-SiteMatch.jpg"]
["PK652","GUK1-pY53","http://www.kinexusproducts.ca/Images/images/PK652_GUK1-pY53_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK652_GUK1-pY53_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK652_GUK1-pY53_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK652_GUK1-pY53_P-SiteMatch.jpg"]
["PN703","GYS1-pS641+pS645","http://www.kinexusproducts.ca/Images/images/PN703_GYS1-pS641-pS645_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN703_GYS1-pS641-pS645_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN703_GYS1-pS641-pS645_P-SiteMatch.jpg"]
["PN704","GYS2-pY45","http://www.kinexusproducts.ca/Images/images/PN704_GYS2-pY45_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN704_GYS2-pY45_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN704_GYS2-pY45_P-SiteMatchTable.jpg"]
["PN518","HCA59-pY147","http://www.kinexusproducts.ca/Images/images/PN518_HCA59-pY147_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN518_HCA59-pY147_Tissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN518_HCA59-pY147_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN518_HCA59-pY147_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN518_HCA59-pY147_P-SiteMatch.jpg"]
["PN604","HCFC1-pS1507","http://www.kinexusproducts.ca/Images/images/PN604_HCFC1-pS1507_HumanCells-EGF_WesternBlots.jpg","http://www.kinexusproducts.ca/Images/images/PN604_HCFC1-pS1507_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN604_HCFC1-pS1507_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN604_HCFC1-pS1507_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN604_HCFC1-pS1507_P-SiteMatch.jpg"]
["NK271-1","Hck-ANT","http://www.kinexusproducts.ca/Images/images/NK271-1_HCK-ANT_Tissues-Cells_Western.jpg"]
["PP528","HePTP-pS143","http://www.kinexusproducts.ca/Images/images/PP528_HePTP-pS143_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP528_HePTP-pS143_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP528_HePTP-pS143_P-SiteSpecificitySPOTBlot.jpg"]
["PP500","HePTP-pS44","http://www.kinexusproducts.ca/Images/images/PP500_HePTP-pS44_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP500_HePTP-pS44_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP500_HePTP-pS44_P-SiteMatch.jpg"]
["PP501","HePTP-pT66","http://www.kinexusproducts.ca/Images/images/PP501_HePTP-pT66_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP501_HePTP-pT66_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP501_HePTP-pT66_P-SiteMatch.jpg"]
["NK300-1","HGK-NT","http://www.kinexusproducts.ca/Images/images/NK300-1_HGK-NT_Tissues-Cells_Western.jpg"]
["PK653","HGK-pT187","http://www.kinexusproducts.ca/Images/images/PK653_HGK-pT187_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK653_HGK-pT187_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK653_HGK-pT187_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK653_HGK-pT187_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK653_HGK-pT187_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK653_HGK-pT187_P-SiteMatch.jpg"]
["PN519","HGS-pY216","http://www.kinexusproducts.ca/Images/images/PN519_HGS-pY216_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN519_HGS-pY216_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN519_HGS-pY216_P-SiteMatch.jpg"]
["PK654","HIPK1-pY352","http://www.kinexusproducts.ca/Images/images/PK654_HIPK1-pY352_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK654_HIPK1-pY352_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK654_HIPK1-pY352_P-SiteMatch.jpg"]
["NK272-1","HIPK2-BCT","http://www.kinexusproducts.ca/Images/images/NK272-1_HIPK2-BCT_Tissues-Cells_Western.jpg"]
["PN605","HMGA1-pS36+pT39","http://www.kinexusproducts.ca/Images/images/PN605_HMGA1-pS36-pT39_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN605_HMGA1-pS36-pT39_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN605_HMGA1-pS36-pT39_P-SiteMatch.jpg"]
["PN606","HMGA1-pT53","http://www.kinexusproducts.ca/Images/images/PN606_HMGA1-pT53_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN606_HMGA1-pT53_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN606_HMGA1-pT53_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN606_HMGA1-pT53_P-SiteMatch.jpg"]
["PN607","HMGB1-pS35+pS39","http://www.kinexusproducts.ca/Images/images/PN607_HMGB1-pS35-pS39_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN607_HMGB1-pS35-pS39_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN607_HMGB1-pS35-pS39_P-SiteMatch.jpg"]
["PN705","HMGCR-pS872","http://www.kinexusproducts.ca/Images/images/PN705_HMGCR-pS872_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN705_HMGCR-pS872_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN705_HMGCR-pS872_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN705_HMGCR-pS872_P-SiteMatch.jpg"]
["PN754","HMGCS1-pS495","http://www.kinexusproducts.ca/Images/images/PN754_HMGCS1-pS495_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN754_HMGCS1-pS495_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN754_HMGCS1-pS495_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN754_HMGCS1-pS495_P-SiteMatch.jpg"]
["PN608","HNF4A-pS167","http://www.kinexusproducts.ca/Images/images/PN608_HNF4A-pS167_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN608_HNF4A-pS167_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN608_HNF4A-pS167_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN608_HNF4A-pS167_P-SiteMatch.jpg"]
["NN281-3","HRAS-Pan","http://www.kinexusproducts.ca/Images/images/NN281-3_HRAS-Pan_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NN281-3_HRAS-Pan_MouseTissues_Western.jpg"]
["PN755","HRAS-pY157","http://www.kinexusproducts.ca/Images/images/PN755_HRAS-pY157_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN755_HRAS-pY157_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN755_HRAS-pY157_P-SiteMatch.jpg"]
["PN609","HSF1-pS303+pS307","http://www.kinexusproducts.ca/Images/images/PN609_HSF1-pS303-pS307_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN609_HSF1-pS303-pS307_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN609_HSF1-pS303-pS307_P-SiteMatch.jpg"]
["PN520","HSP90AB1-pY484","http://www.kinexusproducts.ca/Images/images/PN520_HSP90AB1-pY484_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN520_HSP90AB1-pY484_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PN520_HSP90AB1-pY484_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN520_HSP90AB1-pY484_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN520_HSP90AB1-pY484_12DotBlot-2.jpg","http://www.kinexusproducts.ca/Images/images/PN520_HSP90AB1-pY484_P-SiteMatch.jpg"]
["PK655","ICK-pY156+pT157","http://www.kinexusproducts.ca/Images/images/PK655_ICK-pY156-pT157_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK655_ICK-pY156-pT157_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK655_ICK-pY156-pT157_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK655_ICK-pY156-pT157_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK655_ICK-pY156-pT157_P-SiteMatch.jpg"]
["PK656","ICK-pY159","http://www.kinexusproducts.ca/Images/images/PK656_ICK-pY159_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK656_ICK-pY159_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK656_ICK-pY159_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK656_ICK-pY159_SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK656_ICK-pY159_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK656_ICK-pY159_P-SiteMatch.jpg"]
["PN706","IDH1-pT75+pT77","http://www.kinexusproducts.ca/Images/images/PN706_IDH1-pT75-pT77_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN706_IDH1-pT75-pT77_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN706_IDH1-pT75-pT77_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN706_IDH1-pT75-pT77_P-SiteMatch.jpg"]
["PN757","IDH1-pY391","http://www.kinexusproducts.ca/Images/images/PN757_IDH1-pY391_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN757_IDH1-pY391_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN757_IDH1-pY391_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN757_IDH1-pY391_P-SiteMatch.jpg"]
["NK074-2","IGF1R-BKCD","http://www.kinexusproducts.ca/Images/images/NK074-2_IGF1R-BKCD_Tissues-Cells_Western.jpg"]
["PK657","IGF1R-pY1161+pT1163","http://www.kinexusproducts.ca/Images/images/PK657_IGF1R-pY1161-pT1163_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK657_IGF1R-pY1161-pT1163_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK657_IGF1R-pY1161-pT1163_P-SiteMatch.jpg"]
["PK658","IGF1R-pY1346","http://www.kinexusproducts.ca/Images/images/PK658_IGF1R-pY1346_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK658_IGF1R-pY1346_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK658_IGF1R-pY1346_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK658_IGF1R-pY1346_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK658_IGF1R-pY1346_P-SiteMatch.jpg"]
["PK659","IKKa-pT179+pS180","http://www.kinexusproducts.ca/Images/images/PK659_IKKa-pT179-pS180_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK659_IKKa-pT179-pS180_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK659_IKKa-pT179-pS180_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK659_IKKa-pT179-pS180_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK659_IKKa-pT179-pS180_P-SiteMatch.jpg"]
["NK076-5","IKKb-BCT","http://www.kinexusproducts.ca/Images/images/NK076-5_IKKb-BCT_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK076-5_IKKb-BCT_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK076-5_IKKb-BCT_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK076-5_IKKb-BCT_KinaseDotBlot.jpg"]
["PK660","IKKe-pS172","http://www.kinexusproducts.ca/Images/images/PK660_IKKe-pS172_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK660_IKKe-pS172_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK660_IKKe-pS172_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK660_IKKe-pS172_P-SiteMatch.jpg"]
["PN758","IKKg-pS377","http://www.kinexusproducts.ca/Images/images/PN758_IKKg-pS377_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN758_IKKg-pS377_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN758_IKKg-pS377_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN758_IKKg-pS377_P-SiteMatch.jpg"]
["PN707","IKZF1-pY413","http://www.kinexusproducts.ca/Images/images/PN707_IKZF1-pY413_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN707_IKZF1-pY413_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN707_IKZF1-pY413_P-SiteMatch.jpg"]
["PK661","ILK1-pS343","http://www.kinexusproducts.ca/Images/images/PK661_ILK1-pS343_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK661_ILK1-pS343_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK661_ILK1-pS343_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK661_ILK1-pS343_P-SiteMatch.jpg"]
["PK662","ILK1-pY351","http://www.kinexusproducts.ca/Images/images/PK662_ILK1-pY351_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK662_ILK1-pY351_P-SIteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK662_ILK1-pY351_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK662_ILK1-pY351_P-SiteMatch.jpg"]
["NK079-2","InsR-BCT","http://www.kinexusproducts.ca/Images/images/NK079-2_INSR-BCT_Tissues-Cells_Western.jpg"]
["PK663","InsR-pY1189","http://www.kinexusproducts.ca/Images/images/PK663_InsR-pY1189_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK663_InsR-pY1189_P-SIteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK663_InsR-pY1189_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK663_InsR-pY1189_P-SiteMatch.jpg"]
["PK664","IRAK1-pT387","http://www.kinexusproducts.ca/Images/images/PK664_IRAK1-pT387_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK664_IRAK1-pT387_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK664_IRAK1-pT387_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK664_IRAK1-pT387_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK664_IRAK1-pT387_P-SiteMatch.jpg"]
["PK665","IRAK4-pT345+pS346","http://www.kinexusproducts.ca/Images/images/PK665_IRAK4-pT345-pS346_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK665_IRAK4-pT345-pS346_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK665_IRAK4-pT345-pS346_P-SiteMatch.jpg"]
["PN610","IRF3-pT135","http://www.kinexusproducts.ca/Images/images/PN610_IRF3-pT135_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN610_IRF3-pT135_HumanCells-EGF_WesternBlots.jpg","http://www.kinexusproducts.ca/Images/images/PN610_IRF3-pT135_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN610_IRF3-pT135_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN610_IRF3-pT135_P-SiteMatch.jpg"]
["NK273-1","IRR-BCT","http://www.kinexusproducts.ca/Images/images/NK273-1_IRR-BCT_Tissues-Cells_Western.jpg"]
["NK274-1","ITK-BCT","http://www.kinexusproducts.ca/Images/images/NK274-1_ITK-BCT_Tissues-Cells_Western.jpg"]
["PK666","ITK-pY512","http://www.kinexusproducts.ca/Images/images/PK666_ITK-pY512_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK666_ITK-pY512_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK666_ITK-pY512_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK666_ITK-pY512_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK666_ITK-pY512_P-SiteMatch.jpg"]
["PN521","ITSN2-pY968","http://www.kinexusproducts.ca/Images/images/PN521_ITSN2-pY968_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN521_ITSN2-pY968_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PN521_ITSN2-pY968_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN521_ITSN2-pY968_12DotBlot.jpg"]
["PN611","IWS1-S720+T721+T725","http://www.kinexusproducts.ca/Images/images/PN611_IWS1-pS720-pT721-pT725_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN611_IWS1-pS720-pT721-pT725_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN611_IWS1-pS720-pT721-pT725_P-SiteMatch.jpg"]
["NK084-5","JAK1-3","http://www.kinexusproducts.ca/Images/images/NK084-5_JAK1-3_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK084-5_JAK1-3_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK084-5_JAK1-3_KinaseDotBlot.jpg"]
["PK895","JAK1-pT1107","http://www.kinexusproducts.ca/Images/images/PK895_JAK1-pT1107_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK895_JAK1-pT1107_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK895_JAK1-pT1107_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK895_JAK1-pT1107_P-SiteMatch.jpg"]
["PK884","JAK1-pY1034+pY1035","http://www.kinexusproducts.ca/Images/images/PK884_JAK1-pY1034-pY1035_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK884_JAK1-pY1034-pY1035_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK884_JAK1-pY1034-pY1035_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK884_JAK1-pY1034-pY1035_P-SiteMatch.jpg"]
["NK085-3","JAK2-3","http://www.kinexusproducts.ca/Images/images/NK085-3_JAK2-3_HumanCells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/NK085-3_JAK2-3_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK085-3_JAK2-3_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK085-3_JAK2-3_KinaseDotBlot.jpg"]
["NK085-4","JAK2-4","http://www.kinexusproducts.ca/Images/images/NK085-4_JAK2-4_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK085-4_JAK2-4_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK085-4_JAK2-4_KinaseDotBlot.jpg"]
["PK667","JAK2-pY1007+pY1008","http://www.kinexusproducts.ca/Images/images/PK667_JAK2-pY1007-pY1008_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK667_JAK2-pY1007-pY1008_P-SIteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK667_JAK2-pY1007-pY1008_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK667_JAK2-pY1007-pY1008_P-SiteMatch.jpg"]
["PK668","JAK2-pY570","http://www.kinexusproducts.ca/Images/images/PK668_JAK2-pY570_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK668_JAK2-pY570_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK668_JAK2-pY570_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK668_JAK2-pY570_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK668_JAK2-pY570_P-SiteMatch.jpg"]
["NK086-4","JAK3-3","http://www.kinexusproducts.ca/Images/images/NK086-4_JAK3-3_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK086-4_JAK3-3_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK086-4_JAK3-3_KinaseDotBlot.jpg"]
["PK669","JAK3-pY980+pY981","http://www.kinexusproducts.ca/Images/images/PK669_JAK3-pY980-pY981_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK669_JAK3-pY980-pY981_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK669_JAK3-pY980-pY981_P-SiteMatch.jpg"]
["NK217-2","JNK1-1","http://www.kinexusproducts.ca/Images/images/NK217-2_JNK1-1_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK217-2_JNK1-1_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK217-2_JNK1-1_KinaseDotBlot.jpg"]
["PK670","JNK1-pY185","http://www.kinexusproducts.ca/Images/images/PK670_JNK1-pY185_HumanCells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK670_JNK1-pY185_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK670_JNK1-pY185_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK670_JNK1-pY185_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK670_JNK1-pY185_P-SiteMatch.jpg"]
["NK189-2","JNK2-1","http://www.kinexusproducts.ca/Images/images/NK189-2_JNK2-1_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK189-2_JNK2-1_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK189-2_JNK2-1_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK189-2_JNK2-1_KinaseDotBlot.jpg"]
["NK189-3","JNK2-2","http://www.kinexusproducts.ca/Images/images/NK189-3_JNK2-2_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK189-3_JNK2-2_KinaseDotBlot.jpg"]
["NK197-2","JNK3-1","http://www.kinexusproducts.ca/Images/images/NK197-2_JNK3-1_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK197-2_JNK3-1_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK197-2_JNK3-1_KinaseDotBlot.jpg"]
["PN614","Jun-pS243","http://www.kinexusproducts.ca/Images/images/PN614_Jun-pS243_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN614_Jun-pS243_HumanCells-EGF_WesternBlots.jpg","http://www.kinexusproducts.ca/Images/images/PN614_Jun-pS243_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN614_Jun-pS243_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN614_Jun-pS243_P-SiteMatch.jpg"]
["PN557","Jun-pS63","http://www.kinexusproducts.ca/Images/images/PN557_Jun-pS63_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN557_Jun-pS63_P-SiteMatch.jpg"]
["PN612","Jun-pS73","http://www.kinexusproducts.ca/Images/images/PN612_Jun-pS73_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN612_Jun-pS73_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN612_Jun-pS73_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN612_Jun-pS73_P-SiteMatch.jpg"]
["PN613","Jun-pT239","http://www.kinexusproducts.ca/Images/images/PN613_Jun-pT239_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN613_Jun-pT239_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN613_Jun-pT239_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN613_Jun-pT239_P-SiteMatch.jpg"]
["PK671","KHS1-pS174","http://www.kinexusproducts.ca/Images/images/PK671_KHS1-pS174_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK671_KHS1-pS174_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK671_KHS1-pS174_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK671_KHS1-pS174_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK671_KHS1-pS174_P-SiteMatch.jpg"]
["PK672","KHS1-pY31","http://www.kinexusproducts.ca/Images/images/PK672_KHS1-pY31_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK672_KHS1-pY31_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK672_KHS1-pY31_P-SiteMatch.jpg"]
["NK241-2","KIT-2","http://www.kinexusproducts.ca/Images/images/NK241-2_Kit-2_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK241-2_Kit-2_HumanCells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/NK241-2_Kit-2_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK241-2_KIT-2_KinaseDotBlot.jpg"]
["PK674","Kit-pS821+pY823","http://www.kinexusproducts.ca/Images/images/PK674_Kit-pS821-pY823_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK674_Kit-pS821-pY823_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK674_Kit-pS821-pY823_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK674_Kit-pS821-pY823_P-SiteMatch.jpg"]
["PK885","Kit-pY721","http://www.kinexusproducts.ca/Images/images/PK885_Kit-pY721_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK885_Kit-pY721_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK885_Kit-pY721_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK885_Kit-pY721_P-SiteMatch.jpg"]
["PK673","Kit-pY936","http://www.kinexusproducts.ca/Images/images/PK673_Kit-pY936_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK673_Kit-pY936_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK673_Kit-pY936_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK673_Kit-pY936_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK673_Kit-pY936_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK673_Kit-pY936_12DotBlot-2.jpg","http://www.kinexusproducts.ca/Images/images/PK673_Kit-pY936_P-SiteMatch.jpg"]
["NK090-1","Ksr1 (KSR1-1)","http://www.kinexusproducts.ca/Images/images/NK090-1_KSR1-1_MouseTissues_Western.jpg"]
["PK675","Ksr1-pS406","http://www.kinexusproducts.ca/Images/images/PK675_Ksr1-pS406_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK675_Ksr1-pS406_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK675_Ksr1-pS406_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK675_Ksr1-pS406_P-SiteMatch.jpg"]
["PK676","Ksr2-pS490","http://www.kinexusproducts.ca/Images/images/PK676_Ksr2-pS490_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK676_Ksr2-pS490_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK676_Ksr2-pS490_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK676_Ksr2-pS490_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK676_Ksr2-pS490_P-SiteMatch.jpg"]
["NK091-2","LATS1-CT","http://www.kinexusproducts.ca/Images/images/NK091-2_LATS1-CT_Tissues-Cells_Western.jpg"]
["PK677","LATS1-pS464","http://www.kinexusproducts.ca/Images/images/PK677_LATS1-pS464_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK677_LATS1-pS464_MouseTissues_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK677_LATS1-pS464_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK677_LATS1-pS464_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK677_LATS1-pS464_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK677_LATS1-pS464_12DotBlot-2.jpg","http://www.kinexusproducts.ca/Images/images/PK677_LATS1-pS464_P-SiteMatch.jpg"]
["PK678","LATS1-pS909","http://www.kinexusproducts.ca/Images/images/PK678_LATS1-pS909_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK678_LATS1-pS909_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK678_LATS1-pS909_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK678_LATS1-pS909_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK678_LATS1-pS909_12DotBlot-2.jpg","http://www.kinexusproducts.ca/Images/images/PK678_LATS1-pS909_P-SiteMatch.jpg"]
["NK092-1","LATS2-ANT","http://www.kinexusproducts.ca/Images/images/NK092-1_LATS2-ANT_Tissues-Cells_Western.jpg"]
["NK092-2","LATS2-CT","http://www.kinexusproducts.ca/Images/images/NK092-2_LATS2-CT_Tissues-Cells_Western.jpg"]
["PK679","Lck-pY192","http://www.kinexusproducts.ca/Images/images/PK679_Lck-pY192_P-SIteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK679_Lck-pY192_P-SiteMatch.jpg"]
["PK680","Lck-pY263+pY264","http://www.kinexusproducts.ca/Images/images/PK680_Lck-pY263-pY264_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK680_Lck-pY263-pY264_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK680_Lck-pY263-pY264_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK680_Lck-pY263-pY264_12DotBlot-2.jpg","http://www.kinexusproducts.ca/Images/images/PK680_Lck-pY263-pY264_P-SiteMatch.jpg"]
["PN615","LEDGF-pS273+pS275 ","http://www.kinexusproducts.ca/Images/images/PN615_LEDGF-pS273-pS275_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN615_LEDGF-pS273-pS275_P-SiteMatch.jpg"]
["PN616","LEF1-pT155","http://www.kinexusproducts.ca/Images/images/PN616_LEF1-pT155_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN616_LEF1-pT155_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN616_LEF1-pT155_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN616_LEF1-pT155_P-SiteMatch.jpg"]
["PK681","LIMK1-pT508","http://www.kinexusproducts.ca/Images/images/PK681_LIMK1-pT508_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK681_LIMK1-pT508_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK681_LIMK1-pT508_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK681_LIMK1-pT508_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK681_LIMK1-pT508_P-SiteMatch.jpg"]
["PK682","LKB1 (STK11)-pS31","http://www.kinexusproducts.ca/Images/images/PK682_LKB1-pS31_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK682_LKB1-pS31_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK682_LKB1-pS31_P-SIteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK682_LKB1-pS31_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK682_LKB1-pS31_P-SiteMatch.jpg"]
["PK683","LKB1 (STK11)-pS428","http://www.kinexusproducts.ca/Images/images/PK683_LKB1-pS248_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK683_LKB1-pS248_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK683_LKB1-pS428_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK683_LKB1-pS428_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK683_LKB1-pS428_P-SiteMatch.jpg"]
["NK227-3","LKB1-2","http://www.kinexusproducts.ca/Images/images/NK227-3_LKB1_HumanCell_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK227-3_LKB1-2_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK227-3_LKB1-2_HumanCells_Western-2.jpg",null,"http://www.kinexusproducts.ca/Images/images/NK227-3_LKB1-2_MouseTissues_Western-2.jpg"]
["NK227-4","LKB1-3","http://www.kinexusproducts.ca/Images/images/NK227-4_LKB1-3_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK227-4_LKB1-3_HumanCells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/NK227-4_LKB1-3_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK227-4_LKB1-3_MouseTissues_Western-2.jpg"]
["PK684","LMR2-pS1450","http://www.kinexusproducts.ca/Images/images/PK684_LMR2-pS1450_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK684_LMR2-pS1450_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK684_LMR2-pS1450_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK684_LMR2-pS1450_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK684_LMR2-pS1450_P-SiteMatch.jpg"]
["PK685","LOK-pS191","http://www.kinexusproducts.ca/Images/images/PK685_LOK-pS191_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK685_LOK-pS191_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK685_LOK-pS191_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK685_LOK-pS191_P-SiteMatch.jpg"]
["PK686","LOK-pT952","http://www.kinexusproducts.ca/Images/images/PK686_LOK-pT952_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK686_LOK-pT952_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK686_LOK-pT952_P-SiteSpecificitySPOTDotBlotai.jpg","http://www.kinexusproducts.ca/Images/images/PK686_LOK-pT952_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK686_LOK-pT952_P-SiteMatch.jpg"]
["PK687","LTK-pY672","http://www.kinexusproducts.ca/Images/images/PK687_LTK-pY672_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK687_LTK-pY672_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK687_LTK-pY672_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK687_LTK-pY672_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK687_LTK-pY672_P-SiteMatch.jpg"]
["NK095-2","Lyn-ANT","http://www.kinexusproducts.ca/Images/images/NK095-2_Lyn-ANT_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK095-2_Lyn-ANT_MouseTissues_Western.jpg"]
["PK688","Lyn-pY508","http://www.kinexusproducts.ca/Images/images/PK688_Lyn-pY508_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK688_Lyn-pY508_P-SIteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK688_Lyn-pY508_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK688_Lyn-pY508_P-SiteMatch.jpg"]
["PN617","MAFG-pS124","http://www.kinexusproducts.ca/Images/images/PN617_MAFG-pS124_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN617_MAFG-pS124_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN617_MAFG-pS124_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN617_MAFG-pS124_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN617_MAFG-pS124_P-SiteMatch.jpg"]
["PK689","MAK-pT157","http://www.kinexusproducts.ca/Images/images/PK689_MAK-pT157_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK689_MAK-pT157_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK689_MAK-pT157_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK689_MAK-pT157_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK689_MAK-pT157_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK689_MAK-pT157_P-SiteMatch.jpg"]
["NK097-2","MAPKAPK2-2","http://www.kinexusproducts.ca/Images/images/NK097-2_MAPKAPK2-2_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK097-2_MAPKAPK2-2_MouseTissues_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK097-2_MAPKAPK2-2_Tissues-Cells_Western.jpg"]
["PK690","MAPKAPK2-pT222","http://www.kinexusproducts.ca/Images/images/PK690_MAPKAPK2-pT222_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK690_MAPKAPK2-pT222_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK690_MAPKAPK2-pT222_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK690_MAPKAPK2-pT222_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK690_MAPKAPK2-pT222_P-SiteMatch.jpg"]
["PK691","MAPKAPK2-pY225+pT226","http://www.kinexusproducts.ca/Images/images/PK691_MAPKAPK2-pY225-pT226_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK691_MAPKAPK2-pY225-pT226_Tissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK691_MAPKAPK2-pY225-pT226_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK691_MAPKAPK2-pY225-pT226_P-SiteMatch.jpg"]
["PK692","MAPKAPK3-pY76","http://www.kinexusproducts.ca/Images/images/PK692_MAPKAPK3-pY76_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK692_MAPKAPK3-pY76_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK692_MAPKAPK3-pY76_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK692_MAPKAPK3-pY76_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK692_MAPKAPK3-pY76_P-SiteMatch.jpg"]
["PK693","MAPKAPK5-pT186","http://www.kinexusproducts.ca/Images/images/PK693_MAPKAPK5-pT186_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK693_MAPKAPK5-pT186_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK693_MAPKAPK5-pT186_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK693_MAPKAPK5-pT186_P-SiteMatch.jpg"]
["NK098-2","MARK1-ANT","http://www.kinexusproducts.ca/Images/images/NK098-2_MARK1-ANT_Tissues-Cells_Western.jpg"]
["PK695","MARK1-pT215","http://www.kinexusproducts.ca/Images/images/PK695_MARK1-pT215_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK695_MARK1-pT215_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK695_MARK1-pT215_P-SiteMatch.jpg"]
["NK275-1","MARK2-ANT","http://www.kinexusproducts.ca/Images/images/NK275-1_MARK2-ANT_Tissues-Cells_Western.jpg"]
["NK275-2","MARK2-BCT","http://www.kinexusproducts.ca/Images/images/NK275-2_MARK2-BCT_Tissues-Cells_Western.jpg"]
["NK276-1","MARK3-ANT","http://www.kinexusproducts.ca/Images/images/NK276-1_MARK3-ANT_Tissues-Cells_Western.jpg"]
["NK276-2","MARK3-BCT","http://www.kinexusproducts.ca/Images/images/NK276-2_MARK3-BCT_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK276-2_MARK3-BCT_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK276-2_MARK3-BCT_MouseTissues_Western.jpg"]
["PK697","MARK3-pT507","http://www.kinexusproducts.ca/Images/images/PK697_MARK3-pT507_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK697_MARK3-pT507_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK697_MARK3-pT507_12DotBlot.jpg"]
["NK277-1","MARK4-ANT","http://www.kinexusproducts.ca/Images/images/NK277-1_MARK4-ANT_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK277-1_MARK4-ANT_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK277-1_MARK4-ANT_MouseTissues_Western.jpg"]
["NK277-2","MARK4-NT","http://www.kinexusproducts.ca/Images/images/NK277-2_MARK4-NT_Tissues-Cells_Western.jpg"]
["PN759","MAT1A-pT341","http://www.kinexusproducts.ca/Images/images/PN759_MAT1A-pT341_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN759_MAT1A-pT341_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN759_MAT1A-pT341_P-SiteMatch.jpg"]
["PN558","MBP-pT232","http://www.kinexusproducts.ca/Images/images/PN558_MBP-pT232_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PN558_MBP-pT232_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN558_MBP-pT232_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN558_MBP-pT232_P-SiteMatch.jpg"]
["PN618","MCM2-pS40+pS41","http://www.kinexusproducts.ca/Images/images/PN618_MCM2-pS40-pS41_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN618_MCM2-pS40-pS41_P-SiteMatch.jpg"]
["PN620","MCM2-pY137+pS139","http://www.kinexusproducts.ca/Images/images/PN620_MCM2-pY137-pS139_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN620_MCM2-pY137-pS139_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN620_MCM2-pY137-pS139_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN620_MCM2-pY137-pS139_P-SiteMatch.jpg"]
["PN622","MEF2A-pT108","http://www.kinexusproducts.ca/Images/images/PN622_MEF2A-pT108_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN622_MEF2A-pT108_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN622_MEF2A-pT108_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN622_MEF2A-pT108_P-SiteMatch.jpg"]
["PN623","MEF2C-pS396","http://www.kinexusproducts.ca/Images/images/PN623_MEF2C-pS396_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN623_MEF2C-pS396_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN623_MEF2C-pS396_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN623_MEF2C-pS396_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN623_MEF2C-pS396_P-SiteMatch.jpg"]
["PN624","MEF2D-pS121","http://www.kinexusproducts.ca/Images/images/PN624_MEF2D-pS121_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN624_MEF2D-pS121_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN624_MEF2D-pS121_P-SiteMatch.jpg"]
["PN625","MEF2D-pS180","http://www.kinexusproducts.ca/Images/images/PN625_MEF2D-pS180_HumanCells-EGF_WesternBlots.jpg","http://www.kinexusproducts.ca/Images/images/PN625_MEF2D-pS180_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN625_MEF2D-pS180_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN625_MEF2D-pS180_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN625_MEF2D-pS180_P-SiteMatch.jpg"]
["NK099-7","MEK1-3 (MEK1-7)","http://www.kinexusproducts.ca/Images/images/NK099-7_MEK1-3_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK099-7_MEK1-3_HumanCells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/NK099-7_MEK1-3_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK099-7_MEK1-3_KinaseDotBlot.jpg"]
["NK099-3","MEK1-5 (MEK1-XI)","http://www.kinexusproducts.ca/Images/images/NK099-3_MEK1-5_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK099-3_MEK1-5_KinaseDotBlot.jpg"]
["PK698","MEK1-pS222","http://www.kinexusproducts.ca/Images/images/PK698_MEK1-pS222_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK698_MEK1-pS222_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK698_MEK1-pS222_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK698_MEK1-pS222_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK698_MEK1-pS222_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK698_MEK1-pS222_P-SiteMatch.jpg"]
["PK886","MEK1-pT286","http://www.kinexusproducts.ca/Images/images/PK886_MEK1-pT286_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK886_MEK1-pT286_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK886_MEK1-pT286_P-SiteMatch.jpg"]
["NK100-5","MEK2-1","http://www.kinexusproducts.ca/Images/images/NK100-5_MEK2-1_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK100-5_MEK2-1_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK100-5_MEK2-1_KinaseDotBlot.jpg"]
["NK100-4","MEK2-2","http://www.kinexusproducts.ca/Images/images/NK100-4_MEK2-2_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK100-4_MEK2-2_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK100-4_MEK2-2_KinaseDotBlot.jpg"]
["NK104-2","MEK5-PNT (MEK5-4)","http://www.kinexusproducts.ca/Images/images/NK104-2_MEK5-4_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK104-2_MEK5-4_KinaseDotBlot.jpg"]
["PK699","MEK5-pS311","http://www.kinexusproducts.ca/Images/images/PK699_MEK5-pS311_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK699_MEK5-pS311_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK699_MEK5-pS311_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK699_MEK5-pS311_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK699_MEK5-pS311_P-SiteMatch.jpg"]
["NK107-3","MEKK-NT (MEKK1-1)","http://www.kinexusproducts.ca/Images/images/NK107-3_MEKK1-1_MouseTissues_Western.jpg"]
["NK108-3","MEKK2-1","http://www.kinexusproducts.ca/Images/images/NK108-3_MEKK2-1_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK108-3_MEKK2-1_HumanCells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/NK108-3_MEKK2-1_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK108-3_MEKK2-1_KinaseDotBlot.jpg"]
["NK108-4","MEKK2-2","http://www.kinexusproducts.ca/Images/images/NK108-4_MEKK2-2_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK108-4_MEKK2-2_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK108-4_MEKK2-2_KinaseDotBlot.jpg"]
["PK700","MEKK2-pS239","http://www.kinexusproducts.ca/Images/images/PK700_MEKK2-pS239_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK700_MEKK2-pS239_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK700_MEKK2-pS239_P-SiteMatch.jpg"]
["NK225-2","MEKK6-2","http://www.kinexusproducts.ca/Images/images/NK225-2_MEKK6_HumanCell_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK225-2_MEKK6-2_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK225-2_MEKK6-2_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK225-2_MEKK6-2_KinaseDotBlot.jpg"]
["NK229-2","MELK-1","http://www.kinexusproducts.ca/Images/images/NK229-2_MELK_HumanCell_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK229-2_MELK-1_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK229-2_MELK-1_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK229-2_MELK-1_KinaseDotBlot.jpg"]
["NK229-3","MELK-2","http://www.kinexusproducts.ca/Images/images/NK229-3_MELK-2_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK229-3_MELK-2_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK229-3_MELK-2_KinaseDotBlot.jpg"]
["PK701","MELK-pY438","http://www.kinexusproducts.ca/Images/images/PK701_MELK-pY438_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK701_MELK-pY438_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK701_MELK-pY438_P-SiteMatch.jpg"]
["PK702","MERTK-pY749","http://www.kinexusproducts.ca/Images/images/PK702_MERTK-pY749_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK702_MERTK-pY749_P-SiteMatch.jpg"]
["PK703","MERTK-pY749+pY753","http://www.kinexusproducts.ca/Images/images/PK703_MERTK-pY749-pY753_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK703_MERTK-pY749-pY753_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK703_MERTK-pY749-pY753_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK703_MERTK-pY749-pY753_12DotBlot-2.jpg","http://www.kinexusproducts.ca/Images/images/PK703_MERTK-pY749-pY753_P-SiteMatch.jpg"]
["PK704","MERTK-pY753","http://www.kinexusproducts.ca/Images/images/PK704_MERTK-pY753_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK704_MERTK-pY753_12DotBlot-2.jpg","http://www.kinexusproducts.ca/Images/images/PK704_MERTK-pY753_P-SiteMatch.jpg"]
["NK110-2","Met-1","http://www.kinexusproducts.ca/Images/images/NK110-2_Met-1_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK110-2_Met-1_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK110-2_Met-1_KinaseDotBlot.jpg"]
["NK110-3","Met-2","http://www.kinexusproducts.ca/Images/images/NK110-3_Met-2_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK110-3_Met-2_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK110-3_Met-2_KinaseDotBlot.jpg"]
["PK705","Met-pS1236","http://www.kinexusproducts.ca/Images/images/PK705_Met-pS1236_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK705_Met-pS1236_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK705_Met-pS1236_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK705_Met-pS1236_P-SiteMatch.jpg"]
["PK706","Met-pT1241","http://www.kinexusproducts.ca/Images/images/PK706_Met-pT1241_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK706_Met-pT1241_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK706_Met-pT1241_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK706_Met-pT1241_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK706_Met-pT1241_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK706_Met-pT1241_P-SiteMatch.jpg"]
["PK707","Met-pT1355+pY1356","http://www.kinexusproducts.ca/Images/images/PK707_Met-pT1355-pY1356_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK707_Met-pT1355-pY1356_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK707_Met-pT1355-pY1356_P-SiteMatch.jpg"]
["PK708","Met-pY1003","http://www.kinexusproducts.ca/Images/images/PK708_Met-pY1003_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK708_Met-pY1003_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK708_Met-pY1003_P-SiteMatch.jpg"]
["PK709","Met-pY1230","http://www.kinexusproducts.ca/Images/images/PK709_Met-pY1230_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK709_Met-pY1230_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK709_Met-pY1230_P-SiteMatch.jpg"]
["PK710","Met-pY1234","http://www.kinexusproducts.ca/Images/images/PK710_Met-pY1234_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK710_Met-pY1234_P-SIteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK710_Met-pY1234_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK710_Met-pY1234_P-SiteMatch.jpg"]
["PK711","Met-pY1234+pY1235","http://www.kinexusproducts.ca/Images/images/PK711_Met-pY1234-pY1235_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK711_Met-pY1234-pY1235_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK711_Met-pY1234-pY1235_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK711_Met-pY1234-pY1235_12DotBlot-2.jpg","http://www.kinexusproducts.ca/Images/images/PK711_Met-pY1234-pY1235_P-SiteMatch.jpg"]
["PN626","MITF-pS414","http://www.kinexusproducts.ca/Images/images/PN626_MITF-pS414_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN626_MITF-pS414_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN626_MITF-pS414_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN626_MITF-pS414_P-SiteMatch.jpg"]
["NK101-4","MKK3-1","http://www.kinexusproducts.ca/Images/images/NK101-4_MKK3-1_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK101-4_MKK3-1_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK101-4_MKK3-1_KinaseDotBlot.jpg"]
["NK101-5","MKK3-2","http://www.kinexusproducts.ca/Images/images/NK101-5_MKK3-2_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK101-5_MKK3-2_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK101-5_MKK3-2_KinaseDotBlot.jpg"]
["PK713","MKK3-pS218","http://www.kinexusproducts.ca/Images/images/PK713_MKK3-pS218_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK713_MKK3-pS218_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK713_MKK3-pS218_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK713_MKK3-pS218_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK713_MKK3-pS218_P-SiteMatch.jpg"]
["PK714","MKK3-pY230","http://www.kinexusproducts.ca/Images/images/PK714_MKK3-pY230_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK714_MKK3-pY230_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK714_MKK3-pY230_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK714_MKK3-pY230_P-SiteMatch.jpg"]
["NK103-5","MKK4-2","http://www.kinexusproducts.ca/Images/images/NK103-5_MKK4-2_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK103-5_MKK4-2_KinaseDotBlot.jpg"]
["NK103-6","MKK4-3","http://www.kinexusproducts.ca/Images/images/NK103-6_MKK4-3_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK103-6_MKK4-3_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK103-6_MKK4-3_KinaseDotBlot.jpg"]
["PK715","MKK4-pS257","http://www.kinexusproducts.ca/Images/images/PK715_MKK4-pS257_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK715_MKK4-pS257_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK715_MKK4-pS257_P-SiteMatch.jpg"]
["PK716","MKK4-pS80","http://www.kinexusproducts.ca/Images/images/PK716_MKK4-pS80_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK716_MKK4-pS80_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK716_MKK4-pS80_P-SiteMatch.jpg"]
["NK105-4","MKK6-2","http://www.kinexusproducts.ca/Images/images/NK105-4_MKK6-2_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK105-4_MKK6-2_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK105-4_MKK6-2_KinaseDotBlot.jpg"]
["NK105-5","MKK6-4","http://www.kinexusproducts.ca/Images/images/NK105-5_MKK6-4_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK105-5_MKK6-4_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK105-5_MKK6-4_KinaseDotBlot.jpg"]
["NK106-4","MKK7-2","http://www.kinexusproducts.ca/Images/images/NK106-4_MKK7-2_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK106-4_MKK7-2_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK106-4_MKK7-2_KinaseDotBlot.jpg"]
["NK106-5","MKK7-3","http://www.kinexusproducts.ca/Images/images/NK106-5_MKK7-3_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK106-5_MKK7-3_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK106-5_MKK7-3_KinaseDotBlot.jpg"]
["PK717","MKK7-pT275","http://www.kinexusproducts.ca/Images/images/PK717_MKK7-pT275_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK717_MKK7-pT275_P-SIteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK717_MKK7-pT275_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK717_MKK7-pT275_P-SiteMatch.jpg"]
["NK278-1","MLK1-CT","http://www.kinexusproducts.ca/Images/images/NK278-1_MLK1-CT_Tissues-Cells_Western.jpg"]
["NK279-1","MLK2-BCT","http://www.kinexusproducts.ca/Images/images/NK279-1_MLK2-BCT_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK279-1_MLK2-BCT_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK279-1_MLK2-BCT_MouseTissues_Western.jpg"]
["PK718","MLK3-pS281","http://www.kinexusproducts.ca/Images/images/PK718_MLK3-pS281_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK718_MLK3-pS281_P-SiteMatch.jpg"]
["PK870","MLK3-pT277+pS281","http://www.kinexusproducts.ca/Images/images/PK870_MLK3-pT277-pS281_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK870_MLK3-pT277-pS281_P-SiteMatch.jpg"]
["NK280-1","MLK4-CT","http://www.kinexusproducts.ca/Images/images/NK280-1_MLK4-CT_Tissues-Cells_Western.jpg"]
["PK719","MLTK-pT161+pT162","http://www.kinexusproducts.ca/Images/images/PK719_MLTK-pT161-pT162_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK719_MLTK-pT161-pT162_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK719_MLTK-pT161-pT162_P-SiteMatch.jpg"]
["NK281-1","MOK-AKCD","http://www.kinexusproducts.ca/Images/images/NK281-1_MOK-AKCD_Tissues-Cells_Western.jpg"]
["NK281-2","MOK-CT","http://www.kinexusproducts.ca/Images/images/NK281-2_MOK-CT_Tissues-Cells_Western.jpg"]
["PK720","MOK-pT159+pY161","http://www.kinexusproducts.ca/Images/images/PK720_MOK-pT159-pY161_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK720_MOK-pT159-pY161_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK720_MOK-pT159-pY161_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK720_MOK-pT159-pY161_P-SiteMatch.jpg"]
["PK721","MOK-pY167","http://www.kinexusproducts.ca/Images/images/PK721_MOK-pY167_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK721_MOK-pY167_P-SIteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK721_MOK-pY167_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK721_MOK-pY167_P-SiteMatch.jpg"]
["NK112","Mos (Mos-1)","http://www.kinexusproducts.ca/Images/images/NK112_Mos-1_MouseTissues_Western.jpg"]
["PK722","Mos-pY263","http://www.kinexusproducts.ca/Images/images/PK722_Mos-pY263_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK722_Mos-pY263_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK722_Mos-pY263_P-SiteMatch.jpg"]
["PN760","MPL-pY591","http://www.kinexusproducts.ca/Images/images/PN760_MPL-pY591_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN760_MPL-pY591_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN760_MPL-pY591_P-SiteMatch.jpg"]
["NK282-1","MRCKa-AKCD","http://www.kinexusproducts.ca/Images/images/NK282-1_MRCKa-AKCD_Tissues-Cells_Western.jpg"]
["NK283-1","MRCKb-AKCD","http://www.kinexusproducts.ca/Images/images/NK283-1_MRCKb-AKCD_Tissues-Cells_Western.jpg"]
["PN708","MSH6-pS14","http://www.kinexusproducts.ca/Images/images/PN708_MSH6-pS14_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN708_MSH6-pS14_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN708_MSH6-pS14_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN708_MSH6-pS14_P-SiteMatch.jpg"]
["PK723","MSK1-pS212","http://www.kinexusproducts.ca/Images/images/PK723_MSK1-pS212_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK723_MSK1-pS212_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK723_MSK1-pS212_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK723_MSK1-pS212_P-SiteMatch.jpg"]
["PK868","MSK2-pT194+pS196","http://www.kinexusproducts.ca/Images/images/PK868_MSK2-pT194-pS196_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK868_MSK2-pT194-pS196_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK868_MSK2-pT194-pS196_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK868_MSK2-pT194-pS196_P-SiteMatch.jpg"]
["PK725","MSK2-pT687","http://www.kinexusproducts.ca/Images/images/PK725_MSK2-pT687_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK725_MSK2-pT687_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK725_MSK2-pT687_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK725_MSK2-pT687_P-SiteMatch.jpg"]
["PK871","MST1-pT183","http://www.kinexusproducts.ca/Images/images/PK871_MST1-pT183_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK871_MST1-pT183_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK871_MST1-pT183_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK871_MST1-pT183_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK871_MST1-pT183_P-SiteMatch.jpg"]
["PK726","MST1-pT187","http://www.kinexusproducts.ca/Images/images/PK726_MST1-pT187_P-SiteMatch.jpg"]
["PK727","MST3-pT184","http://www.kinexusproducts.ca/Images/images/PK727_MST3-pT184_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK727_MST3-pT184_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK727_MST3-pT184_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK727_MST3-pT184_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK727_MST3-pT184_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK727_MST3-pT184_12DotBlot-2.jpg","http://www.kinexusproducts.ca/Images/images/PK727_MST3-pT184_P-SiteMatch.jpg"]
["PK728","MST3-pT190","http://www.kinexusproducts.ca/Images/images/PK728_MST3-pT190_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK728_MST3-pT190_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK728_MST3-pT190_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK728_MST3-pT190_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK728_MST3-pT190_P-SiteMatch.jpg"]
["NK116-5","mTOR-1","http://www.kinexusproducts.ca/Images/images/NK116-5_mTOR-1_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK116-5_mTOR-1_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK116-5_mTOR-1_KinaseDotBlot.jpg"]
["NK116-4","mTOR-2","http://www.kinexusproducts.ca/Images/images/NK116-4_mTOR-2_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK116-4_mTOR-2_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK116-4_mTOR-2_KinaseDotBlot.jpg"]
["NK116-3","mTOR-3","http://www.kinexusproducts.ca/Images/images/NK116-3_mTOR-3_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK116-3_mTOR-3_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK116-3_mTOR-3_KinaseDotBlot.jpg"]
["PK729","mTOR-pS2448","http://www.kinexusproducts.ca/Images/images/PK729_mTOR-pS2448_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK729_mTOR-pS2448_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK729_mTOR-pS2448_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK729_mTOR-pS2448_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK729_mTOR-pS2448_P-SiteMatch.jpg"]
["PK730","mTOR-pS2478+pS2481","http://www.kinexusproducts.ca/Images/images/PK730_mTOR-pS2478-pS2481_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK730_mTOR-pS2478-pS2481_P-SiteMatch.jpg"]
["PK872","MUSK-pY756","http://www.kinexusproducts.ca/Images/images/PK872_MUSK-pY756_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK872_MUSK-pY756_P-SiteMatch.jpg"]
["PN627","Myb-pS532","http://www.kinexusproducts.ca/Images/images/PN627_Myb-pS532_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN627_Myb-pS532_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN627_Myb-pS532_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN627_Myb-pS532_P-SiteMatch.jpg"]
["PN628","Myc-pT58+pS62","http://www.kinexusproducts.ca/Images/images/PN628_Myc-pT58-pS62_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN628_Myc-pT58-pS62_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN628_Myc-pT58-pS62_P-SiteMatch.jpg"]
["PK887","MYT1-pS143","http://www.kinexusproducts.ca/Images/images/PK887_MYT1-pS143_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK887_MYT1-pS143_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK887_MYT1-pS143_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK887_MYT1-pS143_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK887_MYT1-pS143_P-SiteMatch.jpg"]
["PN629","NCoA3-pS867","http://www.kinexusproducts.ca/Images/images/PN629_NCoA3-pS867_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN629_NCoA3-pS867_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN629_NCoA3-pS867_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN629_NCoA3-pS867_P-SiteMatch.jpg"]
["PK731","NDR1-pS281+pT282","http://www.kinexusproducts.ca/Images/images/PK731_NDR1-pS281-pT282_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK731_NDR1-pS281-pT282_P-SiteMatch.jpg"]
["PK732","Nek2-pS171","http://www.kinexusproducts.ca/Images/images/PK732_Nek2-pS171_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK732_Nek2-pS171_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK732_Nek2-pS171_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK732_Nek2-pS171_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK732_Nek2-pS171_P-SiteMatch.jpg"]
["PK733","Nek2-pT170+pS171","http://www.kinexusproducts.ca/Images/images/PK733_Nek2-pT170-pS171_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK733_Nek2-pT170-pS171_P-SiteMatch.jpg"]
["PK734","Nek6-pS206","http://www.kinexusproducts.ca/Images/images/PK734_Nek6-pS206_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK734_Nek6-pS206_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK734_Nek6-pS206_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK734_Nek6-pS206_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK734_Nek6-pS206_12DotBlot-2.jpg","http://www.kinexusproducts.ca/Images/images/PK734_Nek6-pS206_P-SiteMatch.jpg"]
["PK735","Nek7-pT191+S195","http://www.kinexusproducts.ca/Images/images/PK735_Nek7-pT191-S195_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK735_Nek7-pT191-S195_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK735_Nek7-pT191-S195_P-SiteMatch.jpg"]
["PN761","NF1-pY2577","http://www.kinexusproducts.ca/Images/images/PN761_NF1-pY2577_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN761_NF1-pY2577_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN761_NF1-pY2577_P-SiteMatch.jpg"]
["PN709","NF2-pS518","http://www.kinexusproducts.ca/Images/images/PN709_NF2-pS518_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN709_NF2-pS518_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN709_NF2-pS518_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN709_NF2-pS518_P-SiteMatch.jpg"]
["PN630","NFAT1-pS217+pS221","http://www.kinexusproducts.ca/Images/images/PN630_NFAT1-pS217-pS221_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN630_NFAT1-pS225-pS229_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN630_NFAT1-pS217-pS221_P-SiteMatch.jpg"]
["PN631","NFAT3-pS213+pS217","http://www.kinexusproducts.ca/Images/images/PN631_NFAT3-pS213-pS217_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN631_NFAT3-pS213-pS217_P-SiteMatch.jpg"]
["PN632","NFAT5-pT135","http://www.kinexusproducts.ca/Images/images/PN632_NFAT5-pT135_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN632_NFAT5-pT135_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN632_NFAT5-pT135_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN632_NFAT5-pT135_P-SiteMatch.jpg"]
["PN633","NFKB1-pS866","http://www.kinexusproducts.ca/Images/images/PN633_NFKB1-pS866-pS870_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN633_NFKB1-pS866_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN633_NFKB1-pS866_P-SiteMatch.jpg"]
["PN634","NFKB1-pS903+pS907","http://www.kinexusproducts.ca/Images/images/PN634_NFKB1-pS903-pS907_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN634_NFKB1-pS903-pS907_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN634_NFKB1-pS903_P-SiteMatch.jpg","http://www.kinexusproducts.ca/Images/images/PN634_NFKB1-pS903-pS907_P-SiteMatch.jpg"]
["PK736","NLK-pT298","http://www.kinexusproducts.ca/Images/images/PK736_NLK-pT298_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK736_NLK-pT298_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK736_NLK-pT298_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK736_NLK-pT298_12DotBlot.jpg"]
["PN710","NMDAR2A-pY943","http://www.kinexusproducts.ca/Images/images/PN710_NMDAR2A-pY943_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN710_NMDAR2A-pY943_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN710_NMDAR2A-pY943_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN710_NMDAR2A-pY943_P-SiteMatch.jpg"]
["PN635","NOLC1-pT607+pT610","http://www.kinexusproducts.ca/Images/images/PN635_NOLC1-pT607-pT610_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN635_NOLC1-pT607-pT610_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN635_NOLC1-pT607-pT610_P-SiteMatch.jpg"]
["PN762","NOS1-pS746","http://www.kinexusproducts.ca/Images/images/PN762_NOS1-pS746_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN762_NOS1-pS746_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN762_NOS1-pS746_P-SiteMatch.jpg"]
["PN711","NOS2-pS745","http://www.kinexusproducts.ca/Images/images/PN711_NOS2-pS745_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN711_NOS2-pS745_Tissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN711_NOS2-pS745_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN711_NOS2-pS745_P-SiteMatch.jpg"]
["PN712","NOS3-pT1175+pS1177","http://www.kinexusproducts.ca/Images/images/PN712_NOS3-pT1175-pS1177_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN712_NOS3-pT1175-pS1177_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN712_NOS3-pT1175-pS1177_P-SiteMatch.jpg"]
["PK737","NuaK1-pT211","http://www.kinexusproducts.ca/Images/images/PK737_NuaK1-pT211_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK737_Nuak1-pT211_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK737_NuaK1-pT211_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK737_NuaK1-pT211_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK737_NuaK1-pT211_P-SiteMatch.jpg"]
["PN636","Nur77-pS351","http://www.kinexusproducts.ca/Images/images/PN636_Nur77-pS351_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN636_Nur77-pS351_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN636_Nur77-pS351_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN636_Nur77-pS351_P-SiteMatch.jpg"]
["PK738","OSR1-pT185","http://www.kinexusproducts.ca/Images/images/PK738_OSR1-pT185_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK738_OSR1-pT185_P-SIteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK738_OSR1-pT185_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK738_OSR1-pT185_P-SiteMatch.jpg"]
["PK739","p38a-pT180+pY182","http://www.kinexusproducts.ca/Images/images/PK739_p38a-pT180-pY182_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK739_p38a-pT180-pY182_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK739_p38a-pT180-pY182_12DotBlot-2.jpg","http://www.kinexusproducts.ca/Images/images/PK739_p38a-pT180-pY182_P-SiteMatch.jpg"]
["NK248-1","p38b-1","http://www.kinexusproducts.ca/Images/images/NK248-1_p38b-1_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK248-1_p38b-1_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK248-1_p38b-1_KinaseDotBlot.jpg"]
["NK248-2","p38b-2","http://www.kinexusproducts.ca/Images/images/NK248-2_p38b-2_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK248-2_p38b-2_HumanCells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/NK248-2_p38b-2_HumanCells_Western-3.jpg","http://www.kinexusproducts.ca/Images/images/NK248-2_p38b-2_MouseTissues_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/NK248-2_p38b-2_KinaseDotBlot.jpg"]
["PK741","p38b-pT180+pY182","http://www.kinexusproducts.ca/Images/images/PK741_p38b-pT180-pY182_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK741_p38b-pT180-pY182_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK741_p38b-pT180-pY182_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK741_p38b-pT180-pY182_P-SiteMatch.jpg"]
["NK121-2","p38d-1","http://www.kinexusproducts.ca/Images/images/NK121-2_p38d-1_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK121-2_p38d-1_HumanCells-EGF_WesternBlots.jpg","http://www.kinexusproducts.ca/Images/images/NK121-2_p38d-1_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK121-2_p38d-1_KinaseDotBlot.jpg"]
["NK121-3","p38d-2","http://www.kinexusproducts.ca/Images/images/NK121-3_p38d-2_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK121-3_p38d-2_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK121-3_p38d-2_KinaseDotBlot.jpg"]
["PK888","p38d-pS261+pT265","http://www.kinexusproducts.ca/Images/images/PK888_p38d-pS261-pT265_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK888_p38d-pS261-pT265_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK888_p38d-pS261-pT265_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK888_p38d-pS261-pT265_P-SiteMatch.jpg"]
["PK742","p38d-pT180+pY182","http://www.kinexusproducts.ca/Images/images/PK742_p38d-pT180-pY182_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK742_p38d-pT180-pY182_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK742_p38d-pT180-pY182_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK742_p38d-pT180-pY182_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK742_p38d-pT180-pY182_P-SiteMatch.jpg"]
["PK743","p38d-pY182","http://www.kinexusproducts.ca/Images/images/PK743_p38d-pY182_HumanCells-EGF_WesternBlots.jpg","http://www.kinexusproducts.ca/Images/images/PK743_p38d-pY182_Cells-EGF_WesternBlots.jpg","http://www.kinexusproducts.ca/Images/images/PK743_p38d-pY182_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK743_p38d-pY182_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK743_p38d-pY182_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK743_p38d-pY182_P-SiteMatch.jpg"]
["NK059-3","p38g-1","http://www.kinexusproducts.ca/Images/images/NK059-3_p38g-1_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK059-3_p38g-1_Cells-EGF_WesternBlots.jpg","http://www.kinexusproducts.ca/Images/images/NK059-3_p38g-1_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK059-3_p38g-1_KinaseDotBlot.jpg"]
["NK059-4","p38g-2","http://www.kinexusproducts.ca/Images/images/NK059-4_p38g-2_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK059-4_p38g-2_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK059-4_p38g-2_KinaseDotBlot.jpg"]
["NK120-10","p38HOG-NT (p38a-5)","http://www.kinexusproducts.ca/Images/images/NK120-10_p38a-5_MouseTissues_Western.jpg"]
["PN640","p53-pS392","http://www.kinexusproducts.ca/Images/images/PN640_p53-pS392_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN640_p53-pS392_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN640_p53-pS392_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN640_p53-pS392_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN640_p53-pS392_P-SiteMatch.jpg"]
["PN637","p53-pS6+pS9","http://www.kinexusproducts.ca/Images/images/PN637_p53-pS6-pS9_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN637_p53-pS6-pS9_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN637_p53-pS6-pS9_P-SiteMatch.jpg"]
["PN638","p53-pT18+pS20","http://www.kinexusproducts.ca/Images/images/PN638_p53-pT18-pS20_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN638_p53-pT18-pS20_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN638_p53-pT18-pS20_P-SiteMatch.jpg"]
["NK223-2","p70S6K-1 (S6K-PNT)","http://www.kinexusproducts.ca/Images/images/NK223-2_p70S6K-1_MouseTissues_Western.jpg"]
["PK744","p70S6K-pT252","http://www.kinexusproducts.ca/Images/images/PK744_p70S6K-pT252_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK744_p70S6K-pT252_HumanCells-EGF_WesternBlots.jpg","http://www.kinexusproducts.ca/Images/images/PK744_p70S6K-pT252_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK744_p70S6K-pT252_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK744_p70S6K-pT252_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK744_p70S6K-pT252_P-SiteMatch.jpg"]
["PK745","p70S6K-pT412","http://www.kinexusproducts.ca/Images/images/PK745_p70S6K-pT412_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK745_p70S6K-pT412_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK745_p70S6K-pT412_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK745_p70S6K-pT412_P-SiteMatch.jpg"]
["PK746","p70S6K-pT444+pS447","http://www.kinexusproducts.ca/Images/images/PK746_p70S6KB-pT444-pS447_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK746_p70S6K-pT444-pS447_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK746_p70S6KB-pT444-pS447_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK746_p70S6K-pT444-pS447_12DotBlot-2.jpg","http://www.kinexusproducts.ca/Images/images/PK746_p70S6K-pT444-pS447_P-SiteMatch.jpg"]
["PK747","p70S6KB-pS423","http://www.kinexusproducts.ca/Images/images/PK747_p70S6KB-pS423_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK747_p70S6KB-pS423_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK747_p70S6KB-pS423_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK747_p70S6KB-pS423_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK747_p70S6KB-pS423_P-SiteMatch.jpg"]
["PN713","PAH-pS16","http://www.kinexusproducts.ca/Images/images/PN713_PAH-pS16_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN713_PAH-pS16_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN713_PAH-pS16_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN713_PAH-pS16_P-SiteMatch.jpg"]
["NK122-2","PAK1-NT (PAK1-1)","http://www.kinexusproducts.ca/Images/images/NK122-2_PAK1-1_MouseTissues_Western.jpg"]
["PK748","PAK1-pS144","http://www.kinexusproducts.ca/Images/images/PK748_PAK1-pS144_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK748_PAK1-pS144_HumanCells-EGF_WesternBlots.jpg","http://www.kinexusproducts.ca/Images/images/PK748_PAK1-pS144_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK748_PAK1-pS144_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK748_PAK1-pS144_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK748_PAK1-pS144_P-SiteMatch.jpg"]
["PK749","PAK1-pT423","http://www.kinexusproducts.ca/Images/images/PK749_PAK1-pT423_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK749_PAK1-pT423_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK749_PAK1-pT423_P-SiteMatch.jpg"]
["PK750","PAK2-pS141","http://www.kinexusproducts.ca/Images/images/PK750_PAK2-pS141_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK750_PAK2-pS141_P-SIteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK750_PAK2-pS141_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK750_PAK2-pS141_P-SiteMatch.jpg"]
["PK751","PAK2-pY130","http://www.kinexusproducts.ca/Images/images/PK751_PAK2-pY130_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK751_PAK2-pY130_12DotBlot-2.jpg","http://www.kinexusproducts.ca/Images/images/PK751_PAK2-pY130_P-SiteMatch.jpg"]
["PK752","PAK4-pS474","http://www.kinexusproducts.ca/Images/images/PK752_PAK4-pS474_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK752_PAK4-pS474_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK752_PAK4-pS474_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK752_PAK4-pS474_P-SiteMatch.jpg"]
["NK190-2","PAK5-ANT","http://www.kinexusproducts.ca/Images/images/NK190-2_PAK5-ANT_Tissues-Cells_Western.jpg"]
["NK190-3","PAK5-APBD","http://www.kinexusproducts.ca/Images/images/NK190-3_PAK5-APBD_Tissues-Cells_Western.jpg"]
["PK753","PAK5-pS602","http://www.kinexusproducts.ca/Images/images/PK753_PAK5-pS602_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK753_PAK5-pS602_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK753_PAK5-pS602_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK753_PAK5-pS602_P-SiteMatch.jpg"]
["NK124-2","PAK6-APBD","http://www.kinexusproducts.ca/Images/images/NK124-2_PAK6-APBD_Tissues-Cells_Western.jpg"]
["NK284-1","PBK-NT","http://www.kinexusproducts.ca/Images/images/NK284-1_PBK-NT_Tissues-Cells_Western.jpg"]
["PK889","PBK-pY272","http://www.kinexusproducts.ca/Images/images/PK889_PBK-pY272_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK889_PBK-pY272_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK889_PBK-pY272_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK889_PBK-pY272_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK889_PBK-pY272_P-SiteMatch.jpg"]
["PK754","PBK-pY74","http://www.kinexusproducts.ca/Images/images/PK754_PBK-pY74_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK754_PBK-pY74_P-SiteMatch.jpg"]
["PN714","PBRM1-pS948","http://www.kinexusproducts.ca/Images/images/PN714_PBRM1-pS948_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN714_PBRM1-pS948_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN714_PBRM1-pS948_P-SiteMatch.jpg"]
["PK755","PCTK1-pY176","http://www.kinexusproducts.ca/Images/images/PK755_PCTK1-pY176_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK755_PCTK1-pY176_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK755_PCTK1-pY176_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK755_PCTK1-pY176_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK755_PCTK1-pY176_P-SiteMatch.jpg"]
["NK285-1","PCTK2-ANT","http://www.kinexusproducts.ca/Images/images/NK285-1_PCTK2-ANT_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK285-1_PCTK2-ANT_KinaseDotBlot.jpg"]
["PK756","PCTK2-pS180","http://www.kinexusproducts.ca/Images/images/PK756_PCTK2-pS180_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK756_PCTK2-pS180_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK756_PCTK2-pS180_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK756_PCTK2-pS180_P-SiteMatch.jpg"]
["NK286-1","PCTK3-ANT","http://www.kinexusproducts.ca/Images/images/NK286-1_PCTK3-ANT_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK286-1_PCTK3-ANT_KinaseDotBlot.jpg"]
["PN561","PCYT1A-pS329+pS331","http://www.kinexusproducts.ca/Images/images/PN561_PCYT1A-pS329-pS331_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN561_PCYT1A-pS329-pS331_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN561_PCYT1A-pS329-pS331_P-SiteMatch.jpg","http://www.kinexusproducts.ca/Images/images/PN561_PCYT1A-pS329-pS331_HeLa_Oleate-PMA_Western.jpg"]
["PN547","PCYT1A-pT342+pS343","http://www.kinexusproducts.ca/Images/images/PN547_PCYT1A-pT342-pS343_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN547_PCYT1A-pT342-pS343_HeLa_Oleate-PMA_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN547_PCYT1A-pT342-pS343_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN547_PCYT1A-pT342-pS343_P-SiteMatch.jpg"]
["PN548","PCYT1A-pY359+pS362","http://www.kinexusproducts.ca/Images/images/PN548_PCYT1A-pY359-pS362_HeLa_Oleate-PMA_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN548_PCYT1A-pY359-pS362_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN548_PCYT1A-pY359-pS362_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN548_PCYT1A-pY359-pS362_P-SiteMatch.jpg"]
["PN546","PCYT1B-pS315+pS319","http://www.kinexusproducts.ca/Images/images/PN546_PCYT1B-pS315-pS319_HeLa_Oleate-PMA_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN546_PCYT1B-pS315-pS319_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN546_PCYT1B-pS315-pS319_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN546_PCYT1B-pS315-pS319_P-SiteMatch.jpg"]
["NK242-1","PDGFRA-1","http://www.kinexusproducts.ca/Images/images/NK242-1_PDGFRA-1_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK242-1_PDGFRA-1_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK242-1_PDGFRA-1_KinaseDotBlot.jpg"]
["NK242-2","PDGFRA-2","http://www.kinexusproducts.ca/Images/images/NK242-2_PDGFRA-2_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK242-2_PDGFRA-2_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK242-2_PDGFRA-2_KinaseDotBlot.jpg"]
["PK757","PDGFRa-pS847+pY849","http://www.kinexusproducts.ca/Images/images/PK757_PDGFRa-pS847-pY849_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK757_PDGFRa-pS847-pY849_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK757_PDGFRa-pS847-pY849_P-SiteMatch.jpg"]
["PK758","PDGFRa-pY762","http://www.kinexusproducts.ca/Images/images/PK758_PDGFRa-pY762_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK758_PDGFRa-pY762_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK758_PDGFRa-pY762_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK758_PDGFRa-pY762_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK758_PDGFRa-pY762_P-SiteMatch.jpg"]
["PK759","PDGFRa-pY768","http://www.kinexusproducts.ca/Images/images/PK759_PDGFRa-pY768_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK759_PDGFRa-pY768_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK759_PDGFRa-pY768_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK759_PDGFRa-pY768_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK759_PDGFRa-pY768_P-SiteMatch.jpg"]
["NK243-1","PDGFRB-2","http://www.kinexusproducts.ca/Images/images/NK243-1_PDGFRB-2_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK243-1_PDGFRB-2_MouseTissues-HumanCells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/NK243-1_PDGFRB-2_KinaseDotBlot.jpg"]
["NK243-3","PDGFRB-4","http://www.kinexusproducts.ca/Images/images/NK243-3_PDGFRB-4_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK243-3_PDGFRB-4_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK243-3_PDGFRB-4_KinaseDotBlot.jpg"]
["NN179-1","PDK1-2","http://www.kinexusproducts.ca/Images/images/NN179-1_PDK1-2_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NN179-1_PDK1-2_HumanCells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/NN179-1_PDK1-2_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NN179-1_PDK1-2_KinaseDotBlot.jpg"]
["NK126-4","PDK1-NT","http://www.kinexusproducts.ca/Images/images/NK126-4_PDK1-NT_Tissues-Cells_Western.jpg"]
["PK760","PDK1-pS241","http://www.kinexusproducts.ca/Images/images/PK760_PDK1-pS241_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK760_PDK1-pS241_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK760_PDK1-pS241_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK760_PDK1-pS241_P-SiteMatch.jpg"]
["NN180-2","PDK2-3","http://www.kinexusproducts.ca/Images/images/NN180-2_PDK2-3_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NN180-2_PDK2-3_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NN180-2_PDK2-3_KinaseDotBlot.jpg"]
["NN181-2","PDK3-3","http://www.kinexusproducts.ca/Images/images/NN181-2_PDK3-3_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NN181-2_PDK3-3_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NN181-2_PDK3-3_KinaseDotBlot.jpg"]
["NN178-2","PDK4-1","http://www.kinexusproducts.ca/Images/images/NN178-2_PDK4-2_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NN178-2_PDK4-1_HumanCells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/NN178-2_PDK4-1_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NN178-2_PDK4-1_KinaseDotBlot.jpg"]
["PN522","PDLIM5-pY251","http://www.kinexusproducts.ca/Images/images/PN522_PDLIM5-pY251_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN522_PDLIM5-pY251_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PN522_PDLIM5-pY251_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN522_PDLIM5-pY251_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN522_PDLIM5-pY251_P-SiteMatch.jpg"]
["PN523","PECAM-1-pY713","http://www.kinexusproducts.ca/Images/images/PN523_PECAM1-pY713_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PN523_PECAM1-pY713_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN523_PECAM1-pY713_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN523_PECAM1-pY713_P-SiteMatch.jpg"]
["PN715","PFKFB3-pS461","http://www.kinexusproducts.ca/Images/images/PN715_PFKFB3-pS461_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN715_PFKFB3-pS461_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN715_PFKFB3-pS461_P-SiteMatch.jpg"]
["PN716","PFKP-pS386","http://www.kinexusproducts.ca/Images/images/PN716_PFKP-pS386_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN716_PFKP-pS386_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN716_PFKP-pS386_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN716_PFKP-pS386_P-SiteMatch.jpg"]
["PN524","PFN1-pY129","http://www.kinexusproducts.ca/Images/images/PN524_PFN1-pY129_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN524_PFN1-pY129_P-SiteMatch.jpg"]
["NK287-1","PFTAIRE1-ANT","http://www.kinexusproducts.ca/Images/images/NK287-1_PFTAIRE1-ANT_Tissues-Cells_Western.jpg"]
["NK004-2","PFTAIRE2-ANT","http://www.kinexusproducts.ca/Images/images/NK004-2_PFTAIRE2-ANT_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK004-2_PFTAIRE2-ANT_KinaseDotBlot.jpg"]
["NK004-3","PFTAIRE2-CT","http://www.kinexusproducts.ca/Images/images/NK004-3_PFTAIRE2-CT_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK004-3_PFTAIRE2-CT_KinaseDotBlot.jpg"]
["PN525","PGK1-pY196","http://www.kinexusproducts.ca/Images/images/PN525_PGK1-pY196_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PN525_PGK1-pY196_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN525_PGK1-pY196_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN525_PGK1-pY196_P-SiteMatch.jpg"]
["PK894","PIK3CA-pY317","http://www.kinexusproducts.ca/Images/images/PK894_PIK3CA-pY317_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK894_PIK3CA-pY317_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK894_PIK3CA-pY317_Tissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK894_PIK3CA-pY317__P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK894_PIK3CA-pY317_P-SiteMatch.jpg"]
["PN526","PIK3R1-pY467","http://www.kinexusproducts.ca/Images/images/PN526_PIK3R1-pY467_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN526_PIK3R1-pY467_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PN526_PIK3R1-pY467_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN526_PIK3R1-pY467_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN526_PIK3R1-pY467_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN526_PIK3R1-pY467_P-SiteMatch.jpg"]
["PN527","PIK3R1-pY580","http://www.kinexusproducts.ca/Images/images/PN527_PIK3R1-pY580_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN527_PIK3R1-pY580_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN527_PIK3R1-pY580_P-SiteMatch.jpg"]
["PN528","PIK3R2-pY464","http://www.kinexusproducts.ca/Images/images/PN528_PIK3R2-pY464_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN528_PIK3R2-pY464_P-SiteMatch.jpg"]
["NK288-1","Pim2-BKCD","http://www.kinexusproducts.ca/Images/images/NK288-1_Pim2-BKCD_Tissues-Cells_Western.jpg"]
["NK288-2","Pim2-CT","http://www.kinexusproducts.ca/Images/images/NK288-2_Pim2-CT_Tissues-Cells_Western.jpg"]
["PK761","Pim2-pT195","http://www.kinexusproducts.ca/Images/images/PK761_Pim2-pT195_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK761_Pim2-pT195_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK761_Pim2-pT195_P-SiteMatch.jpg"]
["NK289-1","Pim3-ANT","http://www.kinexusproducts.ca/Images/images/NK289-1_Pim3-ANT_Tissues-Cells_Western.jpg"]
["PK762","PIP5K-pS307","http://www.kinexusproducts.ca/Images/images/PK762_PIP5K-pS307_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK762_PIP5K-pS307_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK762_PIP5K-pS307_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK762_PIP5K-pS307_P-SiteMatch.jpg"]
["NK201","PKCa-1 (PKC-III)","http://www.kinexusproducts.ca/Images/images/NK201_PKCa-1_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK201_PKC-III_KinaseDotBlot.jpg"]
["PK763","PKCa-pT497","http://www.kinexusproducts.ca/Images/images/PK763_PKCa-pT497_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK763_PKCa-pT497_HeLa_Oleate-PMA_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK763_PKCa-pT497_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK763_PKCa-pT497_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK763_PKCa-pT497_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK763_PKCa-pT497_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK763_PKCa-pT497_P-SiteMatch.jpg"]
["PK764","PKCa-pY195","http://www.kinexusproducts.ca/Images/images/PK764_PKCa-pY195_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK764_PKCa-pY195_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK764_PKCa-pY195_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK764_PKCa-pY195_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK764_PKCa-pY195_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK764_PKCa-pY195_P-SiteMatch.jpg"]
["PK765","PKCb-pS661","http://www.kinexusproducts.ca/Images/images/PK765_PKCb-pS661_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK765_PKCb-pS661_HeLa_Oleate-PMA_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK765_PKCb-pS661_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK765_PKCb-pS661_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK765_PKCb-pS661_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK765_PKCb-pS661_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK765_PKCb-pS661_P-SiteMatch.jpg"]
["PK766","PKCb-pT500","http://www.kinexusproducts.ca/Images/images/PK766_PKCb-pT500_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK766_PKCb-pT500_HeLa_Oleate-PMA_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK766_PKCb-pT500_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK766_PKCb-pT500_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK766_PKCb-pT500_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK766_PKCb-pT500_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK766_PKCb-pT500_P-SiteMatch.jpg"]
["PK767","PKCd-pT507","http://www.kinexusproducts.ca/Images/images/PK767_PKCd-pT507_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK767_PKCd-pT507_HeLa_Oleate-PMA_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK767_PKCd-pT507_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK767_PKCd-pT507_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK767_PKCd-pT507_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK767_PKCd-pT507_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK767_PKCd-pT507_P-SiteMatch.jpg"]
["PK768","PKCd-pY313","http://www.kinexusproducts.ca/Images/images/PK768_PKCd-pY313_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK768_PKCd-pY313_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK768_PKCd-pY313_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK768_PKCd-pY313_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK768_PKCd-pY313_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK768_PKCd-pY313_P-SiteMatch.jpg"]
["PK769","PKCd-pY334","http://www.kinexusproducts.ca/Images/images/PK769_PKCd-pY334_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK769_PKCd-pY334_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK769_PKCd-pY334_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK769_PKCd-pY334_P-SIteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK769_PKCd-pY334_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK769_PKCd-pY334_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK769_PKCd-pY334_P-SiteMatch.jpg"]
["PK770","PKCm-pS205","http://www.kinexusproducts.ca/Images/images/PK770_PKCm-pS205_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK770_PKCm-pS205_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK770_PKCm-pS205_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK770_PKCm-pS205_P-SIteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK770_PKCm-pS205_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK770_PKCm-pS205_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK770_PKCm-pS205_P-SiteMatch.jpg"]
["PK771","PKCm-pS738+pS742","http://www.kinexusproducts.ca/Images/images/PK771_PKCm-pS738-pS742_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK771_PKCm-pS738-pS742_HeLa_Oleate-PMA_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK771_PKCm-pS738-pS742_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK771_PKCm-pS738-pS742_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK771_PKCm-pS738-pS742_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK771_PKCm-pS738-pS742_P-SiteMatch.jpg"]
["PK772","PKCq-pS695","http://www.kinexusproducts.ca/Images/images/PK772_PKCq-pS695_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK772_PKCq-pS695_HumanCells-EGF_WesternBlots.jpg","http://www.kinexusproducts.ca/Images/images/PK772_PKCq-pS695_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK772_PKCq-pS695_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK772_PKCq-pS695_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK772_PKCq-pS695_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK772_PKCq-pS695_P-SiteMatch.jpg"]
["PK773","PKCq-pY545","http://www.kinexusproducts.ca/Images/images/PK773_PKCq-pY545_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK773_PKCq-pY545_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK773_PKCq-pY545_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK773_PKCq-pY545_P-SIteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK773_PKCq-pY545_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK773_PKCq-pY545_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK773_PKCq-pY545_P-SiteMatch.jpg"]
["PK774","PKCz-pS262+pY263","http://www.kinexusproducts.ca/Images/images/PK774_PKCz-pS262-pY263_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK774_PKCz-pS262_pY263_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK774_PKCz-pS262-pY263_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK774_PKCz-pS262-pY263_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK774_PKCz-pS262-pY263_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK774_PKCz-pS262-pY263_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK774_PKCz-pS262-pY263_P-SiteMatch.jpg"]
["PK775","PKCz-pT410","http://www.kinexusproducts.ca/Images/images/PK775_PKCz-pT410_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK775_PKCz-pT410_HeLa_Oleate-PMA_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK775_PKCz-pT410_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK775_PKCz-pT410_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK775_PKCz-pT410_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK775_PKCz-pT410_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK775_PKCz-pT410_P-SiteMatch.jpg"]
["NK139-2","PKD3-BKCD","http://www.kinexusproducts.ca/Images/images/NK139-2_PKD3-BKCD_Tissues-Cells_Western.jpg"]
["PK776","PKG1-pT515+pT517","http://www.kinexusproducts.ca/Images/images/PK776_PKG1-pT515-pT517_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK776_PKCb-pT500_HeLa_Oleate-PMA_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK776_PKG1-pT515-pT517_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK776_PKG1-pT515-pT517_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK776_PKG1-pT515-pT517_P-SiteMatch.jpg"]
["NK202","PKG1a-1 (PKG1a-NT)","http://www.kinexusproducts.ca/Images/images/NK202_PKG1a-1_MouseTissues_Western.jpg"]
["NK290-1","PKG2-AcNMP2","http://www.kinexusproducts.ca/Images/images/NK290-1_PKG2-ACNMP2_Tissues-Cells_Western.jpg"]
["NK290-2","PKG2-BKCD","http://www.kinexusproducts.ca/Images/images/NK290-2_PKG2-BKCD_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK290-2_PKG2-BKCD_MouseTissues_Western.jpg"]
["PN718","PKM2-pS37","http://www.kinexusproducts.ca/Images/images/PN718_PKM2-pS37_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN718_PKM2-pS37_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN718_PKM2-pS37_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN718_PKM2-pS37_Tissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN718_PKM2-pS37_P-SiteMatch.jpg"]
["PN717","PKM2-pY148","http://www.kinexusproducts.ca/Images/images/PN717_PKM2-pY148_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN717_PKM2-pY148_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN717_PKM2-pY148_P-SiteMatch.jpg"]
["PN529","PKM2-pY390","http://www.kinexusproducts.ca/Images/images/PN529_PKM2-pY390_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN529_PKM2-pY390_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PN529_PKM2-pY390_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN529_PKM2-pY390_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN529_PKM2-pY390_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN529_PKM2-pY390_P-SiteMatch.jpg"]
["NK149-3","PKN2-BKCD","http://www.kinexusproducts.ca/Images/images/NK149-3_PKN2-BKCD_Tissues-Cells_Western.jpg"]
["PK777","PKR1-pT446","http://www.kinexusproducts.ca/Images/images/PK777_PKR1-pT446_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK777_PKR1-pT446_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK777_PKR1-pT446_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK777_PKR1-pT446_P-SiteMatch.jpg"]
["PN719","PLCB3-pS1105","http://www.kinexusproducts.ca/Images/images/PN719_PLCB3-pS1105_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN719_PLCB3-pS1105_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN719_PLCB3-pS1105_P-SiteMatch.jpg"]
["PN720","PLCD1-pS460","http://www.kinexusproducts.ca/Images/images/PN720_PLCD1-pS460_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN720_PLCD1-pS460_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN720_PLCD1-pS460_P-SiteMatch.jpg"]
["PN721","PLCE1-pS1096+pT1100","http://www.kinexusproducts.ca/Images/images/PN721_PLCE1-pS1096-pT1100_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN721_PLCE1-pS1096-pT1100_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN721_PLCE1-pS1096-pT1100_P-SiteMatch.jpg"]
["PN530","PLCG1-pY783","http://www.kinexusproducts.ca/Images/images/PN530_PLCG1-pY783_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN530_PLCG1-pY783_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN530_PLCG1-pY783_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN530_PLCG1-pY783_P-SiteMatch.jpg"]
["PN722","PLCG1-pY977","http://www.kinexusproducts.ca/Images/images/PN722_PLCG1-pY977_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN722_PLCG1-pY977_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN722_PLCG1-pY977_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN722_PLCG1-pY977_P-SiteMatch.jpg"]
["PN723","PLCG2-pY753","http://www.kinexusproducts.ca/Images/images/PN723_PLCG2-pY753_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN723_PLCG2-pY753_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN723_PLCG2-pY753_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN723_PLCG2-pY753_P-SiteMatch.jpg"]
["PN531","PLCG2-pY759","http://www.kinexusproducts.ca/Images/images/PN531_PLCG2-pY759_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN531_PLCG2-pY759_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN531_PLCG2-pY759_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN531_PLCG2-pY759_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN531_PLCG2-pY759_P-SiteMatch.jpg"]
["NK145-2","Plk1-BKCD","http://www.kinexusproducts.ca/Images/images/NK145-2_PLK1-BKCD_Tissues-Cells_Western.jpg"]
["PK778","Plk1-pT210","http://www.kinexusproducts.ca/Images/images/PK778_Plk1-pT210_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK778_Plk1-pT210_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK778_Plk1-pT210_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK778_Plk1-pT210_P-SiteMatch.jpg"]
["PK779","Plk1-pY217","http://www.kinexusproducts.ca/Images/images/PK779_Plk1-pY217_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK779_Plk1-pY217_P-SIteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK779_Plk1-pY217_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK779_Plk1-pY217_P-SiteMatch.jpg"]
["NK147-2","Plk3-AKCD","http://www.kinexusproducts.ca/Images/images/NK147-2_Plk3-AKCD_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK147-2_Plk3-AKCD_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK147-2_Plk3-AKCD_Tissues-Cells_Western.jpg"]
["NK291-1","Plk4-MID","http://www.kinexusproducts.ca/Images/images/NK291-1_Plk4-MID_Tissues-Cells_Western.jpg"]
["PK780","Plk4-pT170","http://www.kinexusproducts.ca/Images/images/PK780_Plk4-pT170_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK780_Plk4-pT170_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK780_Plk4-pT170_P-SiteMatch.jpg"]
["PN641","PML-pS518","http://www.kinexusproducts.ca/Images/images/PN641_PML-pS518_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN641_PML-pS518_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN641_PML-pS518_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN641_PML-pS518_P-SiteMatch.jpg"]
["PN643","POU2F1-pS385","http://www.kinexusproducts.ca/Images/images/PN643_POU2F1-pS385_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN643_POU2F1-pS385_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN643_POU2F1-pS385_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN643_POU2F1-pS385_P-SiteMatch.jpg"]
["PN644","PPARg-1-pS112","http://www.kinexusproducts.ca/Images/images/PN644_PPARg-1-pS112_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN644_PPARg-1-pS112_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN644_PPARg-1-pS112_P-SiteMatch.jpg"]
["PP502","PPP1CB-pT316","http://www.kinexusproducts.ca/Images/images/PP502_PPP1CB-pT316_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP502_PPP1CB-pT316_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP502_PPP1CB-pT316_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PP502_PPP1CB-pT316_P-SiteMatch.jpg"]
["PN532","PPP1R11-pY64","http://www.kinexusproducts.ca/Images/images/PN532_PPP1R11-pY64_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN532_PPP1R11-pY64_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN532_PPP1R11-pY64_P-SiteMatch.jpg"]
["PP503","PPP1R12B-pT646","http://www.kinexusproducts.ca/Images/images/PP503_PPP1R12B-pT646_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP503_PPP1R12B-pT646_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP503_PPP1R12B-pT646_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PP503_PPP1R12B-pT646_P-SiteMatch.jpg"]
["PP504","PPP2CA-pY307","http://www.kinexusproducts.ca/Images/images/PP504_PPP2CA-pY307_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP504_PPP2CA-pY307_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP504_PPP2CA-pY307_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PP504_PPP2CA-pY307_P-SiteMatch.jpg"]
["PP505","PPP2CB-pT304","http://www.kinexusproducts.ca/Images/images/PP505_PPP2CB-pT304_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP505_PPP2CB-pT304_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP505_PPP2CB-pT304_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PP505_PPP2CB-pT304_P-SiteMatch.jpg"]
["PP506","PPP3CC-pS463","http://www.kinexusproducts.ca/Images/images/PP506_PPP3CC-pS463_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP506_PPP3CC-pS463_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP506_PPP3CC-pS463_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PP506_PPP3CC-pS463_P-SiteMatch.jpg"]
["PP507","PPP5C-pY119","http://www.kinexusproducts.ca/Images/images/PP507_PPP5C-pY119_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP507_PPP5C-pY119_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP507_PPP5C-pY119_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PP507_PPP5C-pY119_P-SiteMatch.jpg"]
["PP508","PPPM1A-pY362","http://www.kinexusproducts.ca/Images/images/PP508_PPPM1A-pY362_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP508_PPPM1A-pY362_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP508_PPPM1A-pY362_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PP508_PPPM1A-pY362_P-SiteMatch.jpg"]
["PK781","PRK1-pT774","http://www.kinexusproducts.ca/Images/images/PK781_PRK1-pT774_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK781_PRK1-pT774_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK781_PRK1-pT774_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK781_PRK1-pT774_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK781_PRK1-pT774_P-SiteMatch.jpg"]
["PK782","PRKACA-pT196+pT198","http://www.kinexusproducts.ca/Images/images/PK782_PRKACA-pT196-pT198_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK782_PRKACA-pT196-pT198_Cells-EGF_WesternBlots.jpg","http://www.kinexusproducts.ca/Images/images/PK782_PRKACA-pT196-pT198_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK782_PRKACA-pT196-pT198_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK782_PRKACA-pT196-pT198_P-SiteMatch.jpg"]
["PK783","PRKACB-pY69","http://www.kinexusproducts.ca/Images/images/PK783_PRKACB-pY69_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK783_PRKACB-pY69_P-SiteMatch.jpg"]
["PK784","PRKD2-pS197+pS198","http://www.kinexusproducts.ca/Images/images/PK784_PRKD2-pS197-pS198_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK784_PRKD2-pS197-pS198_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK784_PRKD2-pS197-pS198_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK784_PRKD2-pS197-pS198_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK784_PRKD2-pS197-pS198_P-SiteMatch.jpg"]
["NK048-4","PRKDC-1 (DNAPK)","http://www.kinexusproducts.ca/Images/images/NK048-4_PRKDC_HumanCell_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK048-4_PRKDC-1_HumanCells_Western.jpg"]
["NK048-7","PRKDC-4 (DNAPK)","http://www.kinexusproducts.ca/Images/images/NK048-7_PRKDC-4_HumanCells_Western.jpg"]
["NK292-1","PRKX-CT","http://www.kinexusproducts.ca/Images/images/NK292-1_PRKX-CT_Tissues-Cells_Western.jpg"]
["PK785","PRKX-p T201+pT203","http://www.kinexusproducts.ca/Images/images/PK785_PRKX-pT201-pT203_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK785_PRKX-pT201-pT203_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK785_PRKX-pT201-pT203_P-SiteMatch.jpg"]
["NK293-1","PRKY-ANT","http://www.kinexusproducts.ca/Images/images/NK293-1_PRKY-ANT_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK293-1_PRKY-ANT_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK293-1_PRKY-ANT_MouseTissues_Western.jpg"]
["PN549","PRMT5-pT634","http://www.kinexusproducts.ca/Images/images/PN549_PRMT5-pT634_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN549_PRMT5-pT634_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN549_PRMT5-pT634_P-SiteSpecificitySPOTDotBlot.jpg"]
["PK786","PRP4K-pY849","http://www.kinexusproducts.ca/Images/images/PK786_PRP4K-pY849_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK786_PRP4K-pY849_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK786_PRP4K-pY849_P-SiteMatch.jpg"]
["NK204","PSTAIRE (CDK1-2)","http://www.kinexusproducts.ca/Images/images/NK204_CDK1-2_MouseTissues_Western.jpg"]
["NP023-5","PTEN-3","http://www.kinexusproducts.ca/Images/images/NP023-5_PTEN-3_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NP023-5_PTEN-3_HumanCells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/NP023-5_PTEN-3_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NP023-5_PTEN-3_PhosphataseDotBlot.jpg"]
["PP509","PTP1B-pS50","http://www.kinexusproducts.ca/Images/images/PP509_PTP1B-pS50_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP509_PTP1B-pS50_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP509_PTP1B-pS50_P-SiteMatch.jpg"]
["PP510","PTP1B-pY66","http://www.kinexusproducts.ca/Images/images/PP510_PTP1B-pY66_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP510_PTP1B-pY66_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP510_PTP1B-pY66_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PP510_PTP1B-pY66_P-SiteMatch.jpg"]
["PP512","PTPN11-pY62","http://www.kinexusproducts.ca/Images/images/PP512_PTPN11-pY62_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP512_PTPN11-pY62_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP512_PTPN11-pY62_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PP512_PTPN11-pY62_P-SiteMatch.jpg"]
["PP513","PTPN12-pS39","http://www.kinexusproducts.ca/Images/images/PP513_PTPN12-pS39_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP513_PTPN12-pS39_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP513_PTPN12-pS39_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PP513_PTPN12-pS39_P-SiteMatch.jpg"]
["PP514","PTPN14-pS486","http://www.kinexusproducts.ca/Images/images/PP514_PTPN14-pS486_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP514_PTPN14-pS486_MouseTissues_Western.jpgg","http://www.kinexusproducts.ca/Images/images/PP514_PTPN14-pS486_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PP514_PTPN14-pS486_P-SiteMatch.jpg"]
["PP515","PTPN2-pS304","http://www.kinexusproducts.ca/Images/images/PP515_PTPN2-pS304_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP515_PTPN2-pS304_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP515_PTPN2-pS304_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PP515_PTPN2-pS304_P-SiteMatch.jpg"]
["PP516","PTPN21-pS637","http://www.kinexusproducts.ca/Images/images/PP516_PTPN21-pS637_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP516_PTPN21-pS637_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP516_PTPN21-pS637_P-SiteMatch.jpg"]
["PP517","PTPN22-pY499","http://www.kinexusproducts.ca/Images/images/PP517_PTPN22-pY499_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP517_PTPN22-pY499_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP517_PTPN22-pY499_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PP517_PTPN22-pY499_P-SiteMatch.jpg"]
["PP521","PTPRA-pY798","http://www.kinexusproducts.ca/Images/images/PP521_PTPRA-pY798_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP521_PTPRA-pY798_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP521_PTPRA-pY798_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PP521_PTPRA-pY798_P-SiteMatch.jpg"]
["PP522","PTPRB-pY1981","http://www.kinexusproducts.ca/Images/images/PP522_PTPRB-pY1981_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP522_PTPRB-pY1981_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP522_PTPRB-pY1981_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PP522_PTPRB-pY1981_P-SiteMatch.jpg"]
["PP523","PTPRF-pY1621","http://www.kinexusproducts.ca/Images/images/PP523_PTPRF-pY1621_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP523_PTPRF-pY1621_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP523_PTPRF-pY1621_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PP523_PTPRF-pY1621_P-SiteMatch.jpg"]
["PP524","PTPRK-pY916","http://www.kinexusproducts.ca/Images/images/PP524_PTPRK-pY916_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP524_PTPRK-pY916_MouseTissues_Western.jpg"]
["PP526","PTPRM-pY929","http://www.kinexusproducts.ca/Images/images/PP526_PTPRM-pY929_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP526_PTPRM-pY929_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PP526_PTPRM-pY929_P-SiteSpecificitySPOTDotBlot.jpg"]
["PN646","PTRF-pY308","http://www.kinexusproducts.ca/Images/images/PN646_PTRF-pY308_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN646_PTRF-pY308_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN646_PTRF-pY308_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN646_PTRF-pY308_P-SiteMatch.jpg"]
["PN647","PU.1-pS146","http://www.kinexusproducts.ca/Images/images/PN647_PU.1-pS146_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN647_PU.1-pS146_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN647_PU.1-pS146_P-SiteMatch.jpg"]
["PK787","PYK2-pY402","http://www.kinexusproducts.ca/Images/images/PK787_Pyk2-pY402_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK787_Pyk2-pY402_P-SIteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK787_Pyk2-pY402_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK787_Pyk2-pY402_P-SiteMatch.jpg"]
["PK788","PYK2-pY402","http://www.kinexusproducts.ca/Images/images/PK788_PYK2-pY402_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK788_Pyk2-pY402_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK788_Pyk2-pY402_P-SiteMatch.jpg"]
["PK789","PYK2-pY579+pY580","http://www.kinexusproducts.ca/Images/images/PK789_Pyk2-pY579-pY580_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK789_Pyk2-pY579-pY580_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK789_Pyk2-pY579-pY580_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK789_Pyk2-pY579-pY580_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK789_Pyk2-pY579-pY580_P-SiteMatch.jpg"]
["NK155-7","Raf1-3","http://www.kinexusproducts.ca/Images/images/NK155-7_Raf1-3_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK155-7_Raf1-3_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK155-7_Raf1-3_KinaseDotBlot.jpg"]
["NK155-8","Raf1-6","http://www.kinexusproducts.ca/Images/images/NK155-8_Raf1-6_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK155-8_Raf1-6_HumanCells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/NK155-8_Raf1-6_Cells-EGF_WesternBlots.jpg","http://www.kinexusproducts.ca/Images/images/NK155-8_Raf1-6_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK155-8_Raf1-6_MouseTissues_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/NK155-8_Raf1-6_KinaseDotBlot.jpg"]
["PK790","Raf1-pS259","http://www.kinexusproducts.ca/Images/images/PK790_Raf1-pS259_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK790_Raf1-pS259_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK790_Raf1-pS259_P-SIteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK790_Raf1-pS259_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK790_Raf1-pS259_P-SiteMatch.jpg"]
["PK791","Raf1-pS296","http://www.kinexusproducts.ca/Images/images/PK791_Raf1-pS296_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK791_Raf1-pS296_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK791_Raf1-pS296_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK791_Raf1-pS296_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK791_Raf1-pS296_P-SiteMatch.jpg"]
["PK792","Raf1-pS301+pT303","http://www.kinexusproducts.ca/Images/images/PK792_Raf1-pS301-pT303_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK792_Raf1-pS301-pT303_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK792_Raf1-pS301-pT303_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK792_Raf1-pS301-pT303_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK792_Raf1-pS301-pT303_P-SiteMatch.jpg"]
["PN648","RARA-pS77","http://www.kinexusproducts.ca/Images/images/PN648_RARA-pS77_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN648_RARA-pS77_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN648_RARA-pS77_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN648_RARA-pS77_P-SiteMatch.jpg"]
["PN649","RBM9-pT7","http://www.kinexusproducts.ca/Images/images/PN649_RBM9-pT7_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN649_RBM9-pT7_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN649_RBM9-pT7_P-SiteMatch.jpg"]
["PN650","RDBP-pS89+pT91","http://www.kinexusproducts.ca/Images/images/PN650_RDBP-pS89-pT91_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN650_RDBP-pS89-pT91_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN650_RDBP-pS89-pT91_P-SiteMatch.jpg"]
["NK244-2","Ret-2","http://www.kinexusproducts.ca/Images/images/NK244-2_Ret-2_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK244-2_Ret-2_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK244-2_Ret-2_KinaseDotBlot.jpg"]
["PK793","Ret-pY905","http://www.kinexusproducts.ca/Images/images/PK793_Ret-pY905_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK793_Ret-pY905_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK793_Ret-pY905_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK793_Ret-pY905_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK793_Ret-pY905_P-SiteMatch.jpg"]
["PK794","RIOK1-pY466","http://www.kinexusproducts.ca/Images/images/PK794_RIOK1-pY466_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK794_RIOK1-pY466_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK794_RIOK1-pY466_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK794_RIOK1-pY466_P-SiteMatch.jpg"]
["PK890","RIOK2-pS332+pS335+pS337","http://www.kinexusproducts.ca/Images/images/PK890_RIOK2-pS332-pS335-pS337_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK890_RIOK2-pS332-pS335-pS337_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK890_RIOK2-pS332-pS335-pS337_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK890_RIOK2-pS332-pS335-pS337_P-SiteMatch.jpg"]
["PK795","RIPK1-pY384","http://www.kinexusproducts.ca/Images/images/PK795_RIPK1-pY384_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK795_RIPK1-pY384_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK795_RIPK1-pY384_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK795_RIPK1-pY384_P-SiteMatch.jpg"]
["PK796","RIPK2-pS176","http://www.kinexusproducts.ca/Images/images/PK796_RIPK2-pS176_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK796_RIPK2-pS176_P-SIteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK796_RIPK2-pS176_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK796_RIPK2-pS176_P-SiteMatch.jpg"]
["PK797","RIPK2-pY381","http://www.kinexusproducts.ca/Images/images/PK797_RIPK2-pY381_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK797_RIPK2-pY381_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK797_RIPK2-pY381_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK797_RIPK2-pY381_P-SiteMatch.jpg"]
["PK798","ROCK1-pY913","http://www.kinexusproducts.ca/Images/images/PK798_ROCK1-pY913_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK798_ROCK1-pY913_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK798_ROCK1-pY913_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK798_ROCK1-pY913_P-SiteMatch.jpg"]
["PK799","ROCK2-pY722","http://www.kinexusproducts.ca/Images/images/PK799_ROCK2-pY722_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK799_ROCK2-pY722_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK799_ROCK2-pY722_P-SiteMatch.jpg"]
["NK161-2","Ron-1","http://www.kinexusproducts.ca/Images/images/NK161-2_Ron-1_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK161-2_Ron-1_KinaseDotBlot.jpg"]
["PK800","Ron-pY1238","http://www.kinexusproducts.ca/Images/images/PK800_Ron-pY1238_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK800_Ron-pY1238_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK800_Ron-pY1238_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK800_Ron-pY1238_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK800_Ron-pY1238_12DotBlot-2.jpg","http://www.kinexusproducts.ca/Images/images/PK800_Ron-pY1238_P-SiteMatch.jpg"]
["PK801","Ron-pY1238 +pY1239","http://www.kinexusproducts.ca/Images/images/PK801_Ron-pY1238-pY1239_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK801_Ron-pY1238-pY1239_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK801_Ron-pY1238-pY1239_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK801_Ron-pY1238-pY1239_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK801_Ron-pY1238-pY1239_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK801_Ron-pY1238-pY1239_P-SiteMatch.jpg"]
["PK802","ROR2-pY645+pY646","http://www.kinexusproducts.ca/Images/images/PK802_ROR2-pY645-pY646_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK802_ROR2-pY645-pY646_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK802_ROR2-pY645-pY646_P-SiteMatch.jpg"]
["PN651","RORA-pS35","http://www.kinexusproducts.ca/Images/images/PN651_RORA-pS35_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN651_RORA-pS35_Tissues-Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PN651_RORA-pS35_P-SiteSpecificitySPOTDotBlot.jpg"]
["NK163-3","Ros-2","http://www.kinexusproducts.ca/Images/images/NK163-3_Ros-2_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK163-3_Ros-2_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK163-3_Ros-2_KinaseDotBlot.jpg"]
["NK163-4","Ros-3","http://www.kinexusproducts.ca/Images/images/NK163-4_Ros-3_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK163-4_Ros-3_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK163-4_Ros-3_KinaseDotBlot.jpg"]
["PK803","Ros-pY2114+pY2115","http://www.kinexusproducts.ca/Images/images/PK803_Ros-pY2114-pY2115_HumanCells-EGF_WesternBlots.jpg","http://www.kinexusproducts.ca/Images/images/PK803_Ros-pY2114-pY2115_Cells-EGF_WesternBlots.jpg","http://www.kinexusproducts.ca/Images/images/PK803_Ros-pY2114-pY2115_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK803_Ros-pY2114-pY2115_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK803_Ros-pY2114-pY2115_P-SiteMatch.jpg"]
["PN685","RPS6-pS235+pS236","http://www.kinexusproducts.ca/Images/images/PN685_RPS6-pS235-pS236_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN685_RPS6-pS235-pS236_Tissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN685_RPS6-pS235-pS236_Insulin_HeLaCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN685_RPS6-pS235-pS236_pS235P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN685_RPS6-pS235-pS236_pS236P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN685_RPS6-pS235-pS236_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN685_RPS6-pS235-pS236_P-SiteMatch.jpg"]
["PN559","RPS6-pS235+pS236+pS240","http://www.kinexusproducts.ca/Images/images/PN559_RPS6-pS235-pS236-pS240_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN559_RPS6-pS235-pS236-pS240_Insulin_HeLaCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN559_RPS6-pS235-pS236-pS240_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN559_RPS6-pS235-pS236-pS240_pS235P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN559_RPS6-pS235-pS236-pS240_pS236P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN559_RPS6-pS235-pS236-pS240_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN559_RPS6-pS235-pS236-pS240_P-SiteMatch.jpg"]
["NK164-3","RSK1-CT","http://www.kinexusproducts.ca/Images/images/NK164-3_RSK1-CT_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK164-3_RSK1-CT_KinaseDotBlot.jpg"]
["PK804","RSK1-pS221","http://www.kinexusproducts.ca/Images/images/PK804_RSK1-pS221_HumanCells-EGF_WesternBlots.jpg","http://www.kinexusproducts.ca/Images/images/PK804_RSK1-pS221_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK804_RSK1-pS221_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK804_RSK1-pS221_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK804_RSK1-pS221_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK804_RSK1-pS221_P-SiteMatch.jpg"]
["PK805","RSK1-pS380","http://www.kinexusproducts.ca/Images/images/PK805_RSK1-pS380_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK805_RSK1-pS380_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK805_RSK1-pS380_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK805_RSK1-pS380_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK805_RSK1-pS380_P-SiteMatch.jpg"]
["PK806","RSK1-pT573","http://www.kinexusproducts.ca/Images/images/PK806_RSK1-pT573_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK806_RSK1-pT573_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK806_RSK1-pT573_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK806_RSK1-pT573_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK806_RSK1-pT573_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK806_RSK1-pT573_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK806_RSK1-pT573_P-SiteMatch.jpg"]
["PK807","RSK1-pY220+pS221","http://www.kinexusproducts.ca/Images/images/PK807_RSK1-pY220-pS221_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK807_RSK1-pY220-pS221_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK807_RSK1-pY220-pS221_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK807_RSK1-pY220-pS221_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK807_RSK1-pY220-pS221_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK807_RSK1-pY220-pS221_12DotBlot-2.jpg","http://www.kinexusproducts.ca/Images/images/PK807_RSK1-pY220-pS221_P-SiteMatch.jpg"]
["NK165-2","RSK2-BKCD","http://www.kinexusproducts.ca/Images/images/NK165-2_RSK2-BKCD_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK165-2_RSK2-BKCD_KinaseDotBlot.jpg"]
["NK165-3","RSK2-PCT","http://www.kinexusproducts.ca/Images/images/NK165-3_RSK2-PCT_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK165-3_RSK2-PCT_KinaseDotBlot.jpg"]
["PK808","RSK3-pY217+pS218","http://www.kinexusproducts.ca/Images/images/PK808_RSK3-pY217-pS218_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK808_RSK3-pY217-pS218_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK808_RSK3-pY217-pS218_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK808_RSK3-pY217-pS218_P-SiteMatch.jpg"]
["PN652","RXRa-pS260","http://www.kinexusproducts.ca/Images/images/PN652_RXRa-pS260_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN652_RXRa-pS260_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN652_RXRa-pS260_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN652_RXRa-pS260_P-SiteMatch.jpg"]
["NK223-4","S6K-III","http://www.kinexusproducts.ca/Images/images/NK223-4_S6K-III_Tissues-Cells_Western.jpg"]
["PN653","SATB1-pS38","http://www.kinexusproducts.ca/Images/images/PN653_SATB1-pS38_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN653_SATB1-pS38_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN653_SATB1-pS38_P-SiteMatch.jpg"]
["PK809","SCYL1-pS754","http://www.kinexusproducts.ca/Images/images/PK809_SCYL1-pS754_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK809_SCYL1-pS754_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK809_SCYL1-pS754_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK809_SCYL1-pS754_P-SiteMatch.jpg"]
["NK294-1","SGK1-NT","http://www.kinexusproducts.ca/Images/images/NK294-1_SGK1-NT_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK294-1_SGK1-NT_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK294-1_SGK1-NT_Tissues-Cells_Western.jpg"]
["PK810","Sgk223-pY413","http://www.kinexusproducts.ca/Images/images/PK810_Sgk223-pY413_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK810_Sgk223-pY413_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK810_Sgk223-pY413_12DotBlot-2.jpg","http://www.kinexusproducts.ca/Images/images/PK810_Sgk223-pY413_P-SiteMatch.jpg"]
["PK811","SgK269-pY635","http://www.kinexusproducts.ca/Images/images/PK811_SgK269-pY635_P-SIteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK811_SgK269-pY635_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK811_SgK269-pY635_P-SiteMatch.jpg"]
["NK295-1","SgK288-ANT","http://www.kinexusproducts.ca/Images/images/NK295-1_SgK288_Tissues-Cells_Western.jpg"]
["PN654","SH2BP1-pT925","http://www.kinexusproducts.ca/Images/images/PN654_SH2BP1-pT925_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN654_SH2BP1-pT925_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN654_SH2BP1-pT925_P-SiteMatch.jpg"]
["NP044-3","SHIP1-3","http://www.kinexusproducts.ca/Images/images/NP044-3_SHIP1-3_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NP044-3_SHIP1-3_MouseTissues_Western.jpg"]
["PN560","SHIP1-pY187","http://www.kinexusproducts.ca/Images/images/PN560_SHIP1-pT187_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN560_SHIP1-pT187_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN560_SHIP1-pY187_P-SiteMatch.jpg"]
["NP045-2","SHIP2-2","http://www.kinexusproducts.ca/Images/images/NP045-2_SHIP2-2_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NP045-2_SHIP2-2_MouseTissues_Western.jpg"]
["PN534","SHIP2-pY886","http://www.kinexusproducts.ca/Images/images/PN534_SHIP2-pY886_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN534_SHIP2-pY882_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PN534_SHIP2-pY886_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN534_SHIP2-pY886_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN534_SHIP2-pY886_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN534_SHIP2-pY886_P-SiteMatch.jpg"]
["PK812","SIK-pT182","http://www.kinexusproducts.ca/Images/images/PK812_SIK-pT182_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK812_SIK-pT182_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK812_SIK-pT182_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK812_SIK-pT182_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK812_SIK-pT182_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK812_SIK-pT182_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK812_SIK-pT182_P-SiteMatch.jpg"]
["NK249-2","SIK2-2","http://www.kinexusproducts.ca/Images/images/NK249-2_SIK2-2_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK249-2_SIK2-2_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK249-2_SIK2-2_KinaseDotBlot.jpg"]
["NK249-3","SIK2-3","http://www.kinexusproducts.ca/Images/images/NK249-3_SIK2-3_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK249-3_SIK2-3_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK249-3_SIK2-3_KinaseDotBlot.jpg"]
["PK813","SIK2-pS358","http://www.kinexusproducts.ca/Images/images/PK813_SIK2-pS358_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK813_SIK2-pS358_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK813_SIK2-pS358_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK813_SIK2-pS358_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK813_SIK2-pS358_P-SiteMatch.jpg"]
["NK250-2","SIK3-2","http://www.kinexusproducts.ca/Images/images/NK250-2_SIK3-2_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK250-2_SIK3-2_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK250-2_SIK3-2_KinaseDotBlot.jpg"]
["NK250-3","SIK3-3","http://www.kinexusproducts.ca/Images/images/NK250-3_SIK3-3_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK250-3_SIK3-3_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK250-3_SIK3-3_KinaseDotBlot.jpg"]
["PK814","SIK3-pT163","http://www.kinexusproducts.ca/Images/images/PK814_SIK3-pT163_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK814_SIK3-pT163_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK814_SIK3-pT163_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK814_SIK3-pT163_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK814_SIK3-pT163_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK814_SIK3-pT163_P-SiteMatch.jpg"]
["PK815","SIK3-pT411","http://www.kinexusproducts.ca/Images/images/PK815_SIK3-pT411_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK815_SIK3-pT411_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK815_SIK3-pT411_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK815_SIK3-pT411_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK815_SIK3-pT411_P-SiteMatch.jpg"]
["PN655","SIN3A-pS832","http://www.kinexusproducts.ca/Images/images/PN655_SIN3A-pS832_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN655_SIN3A-pS832_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN655_SIN3A-pS832_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN655_SIN3A-pS832_P-SiteMatch.jpg"]
["PN535","SIT-pY90","http://www.kinexusproducts.ca/Images/images/PN535_SIT-pY90_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN535_SIT-pY90_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PN535_SIT-pY90_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN535_SIT-pY90_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN535_SIT-pY90_P-SiteMatch.jpg"]
["PN536","SIT-pY95","http://www.kinexusproducts.ca/Images/images/PN536_SIT-pY95_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN536_SIT-pY95_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN536_SIT-pY95_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN536_SIT-pY95_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN536_SIT-pY95_P-SiteMatch.jpg"]
["PK816","SLK-pS189","http://www.kinexusproducts.ca/Images/images/PK816_SLK-pS189_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK816_SLK-pS189_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK816_SLK-pS189_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK816_SLK-pS189_P-SiteMatch.jpg"]
["PN658","Smad3-pT8","http://www.kinexusproducts.ca/Images/images/PN658_Smad3-pT8_Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN658_Smad3-pT8_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN658_Smad3-pT8_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN658_Smad3-pT8_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN658_Smad3-pT8_P-SiteMatch.jpg"]
["PN727","SMARCB1-pT134","http://www.kinexusproducts.ca/Images/images/PN727_SMARCB1-pT134_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN727_SMARCB1-pT134_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN727_SMARCB1-pT134_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN727_SMARCB1-pT134_P-SiteMatch.jpg"]
["NK233-2","SMG1-1","http://www.kinexusproducts.ca/Images/images/NK233-2_SMG1-1_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK233-2_S6K-PNT(p70S6K-1)_Cells-EGF_WesternBlots.jpg","http://www.kinexusproducts.ca/Images/images/NK233-2_SMG1-1_MouseTissues_Western.jpg"]
["NK233-1","SMG1-2","http://www.kinexusproducts.ca/Images/images/NK233-1_SMG1-2_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK233-1_SMG1-2_MouseTissues_Western.jpg"]
["PK817","SMG1-pT3550","http://www.kinexusproducts.ca/Images/images/PK817_SMG1-pT3550_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK817_SMG1-pT3550_P-SiteMatch.jpg"]
["PN661","SND1-pY908","http://www.kinexusproducts.ca/Images/images/PN661_SND1-pY908_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN661_SND1-pY908_P-SiteMatch.jpg"]
["NK251-2","SNF1LK-2 (SIK-1)","http://www.kinexusproducts.ca/Images/images/NK251-2_SNF1LK-2_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK251-2_SNF1LK-2_MouseTissues_Western.jpg"]
["NK251-3","SNF1LK-3 (SIK-1)","http://www.kinexusproducts.ca/Images/images/NK251-3_SNF1IK-3_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK251-3_SNF1LK-3_MouseTissues_Western.jpg"]
["PN537","snRNP70-pY126","http://www.kinexusproducts.ca/Images/images/PN537_snRNP70-pY126_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN537_snRNP70-pY126_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PN537_snRNP70-pY126_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN537_snRNP70-pY126_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN537_snRNP70-pY126_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN537_snRNP70-pY126_P-SiteMatch.jpg"]
["PN728","SOCS7-pY561","http://www.kinexusproducts.ca/Images/images/PN728_SOCS7-pY561_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN728_SOCS7-pY561_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN728_SOCS7-pY561_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN728_SOCS7-pY561_P-SiteMatch.jpg"]
["PN663","SPT5-pT791","http://www.kinexusproducts.ca/Images/images/PN663_SPT5-pT791_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN663_SPT5-pT791_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN663_SPT5-pT791_P-SiteMatch.jpg"]
["PK818","Src-pY419","http://www.kinexusproducts.ca/Images/images/PK818_Src-pY419_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK818_Src-pY419_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK818_Src-pY419_P-SiteMatch.jpg"]
["PN664","SRF-pS224","http://www.kinexusproducts.ca/Images/images/PN664_SRF-pS224_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN664_SRF-pS224_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN664_SRF-pS224_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN664_SRF-pS224_P-SiteMatch.jpg"]
["PK819","SRPK1-pS222","http://www.kinexusproducts.ca/Images/images/PK819_SRPK1-pS222_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK819_SRPK1-pS222_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK819_SRPK1-pS222_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK819_SRPK1-pS222_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK819_SRPK1-pS222_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK819_SRPK1-pS222_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK819_SRPK1-pS222_P-SiteMatch.jpg"]
["PK891","SRPK1-pS587","http://www.kinexusproducts.ca/Images/images/PK891_SRPK1-pS587_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK891_SRPK1-pS587_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK891_SRPK1-pS587_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK891_SRPK1-pS587_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK891_SRPK1-pS587_P-SiteMatch.jpg"]
["NK296-1","SRPK2-IKCD","http://www.kinexusproducts.ca/Images/images/NK296-1_SRPK2-IKCD_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK296-1_SRPK2-IKCD_KinaseDotBlot.jpg"]
["PK820","SRPK2-pY319","http://www.kinexusproducts.ca/Images/images/PK820_SRPK2-pY319_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK820_SRPK2-pY319_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK820_SRPK2-pY319_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK820_SRPK2-pY319_P-SiteMatch.jpg"]
["PN665","SSRP1-pY441+pS444","http://www.kinexusproducts.ca/Images/images/PN665_SSRP1-pY441-pS444_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN665_SSRP1-pY441-pS444_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN665_SSRP1-pY441-pS444_P-SiteMatch.jpg"]
["PN729","STAG2-pY433","http://www.kinexusproducts.ca/Images/images/PN729_STAG2-pY433_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN729_STAG2-pY433_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN729_STAG2-pY433_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN729_STAG2-pY433_P-SiteMatch.jpg"]
["PN538","STAM2-pY374","http://www.kinexusproducts.ca/Images/images/PN538_STAM2-pY374_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN538_STAM2-pY374_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN538_STAM2-pY374_P-SiteMatch.jpg"]
["PN667","STAT1-pS727","http://www.kinexusproducts.ca/Images/images/PN667_STAT1-pS727_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN667_STAT1-pS727_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN667_STAT1-pS727_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN667_STAT1-pS727_P-SiteMatch.jpg"]
["PN666","STAT1-pY701","http://www.kinexusproducts.ca/Images/images/PN666_STAT1-pY701_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN666_STAT1-pY701_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN666_STAT1-pY701_P-SiteMatch.jpg"]
["PN668","STAT2-pY690","http://www.kinexusproducts.ca/Images/images/PN668_STAT2-pY690_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN668_STAT2-pY690_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN668_STAT2-pY690_P-SiteMatch.jpg"]
["PN669","STAT3-pS727","http://www.kinexusproducts.ca/Images/images/PN669_STAT3-pS727_HumanCells-EGF_WesternBlots.jpg","http://www.kinexusproducts.ca/Images/images/PN669_STAT3-pS727_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN669_STAT3-pS727_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN669_STAT3-pS727_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN669_STAT3-pS727_P-SiteMatch.jpg"]
["PN539","STAT3-pY705+pT708","http://www.kinexusproducts.ca/Images/images/PN539_STAT3-pY705-pT708_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN539_STAT3-pY705-pT708_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN539_STAT3-pY705-pT708_P-SiteMatch.jpg"]
["PN670","STAT4-pY693","http://www.kinexusproducts.ca/Images/images/PN670_STAT4-pY693_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN670_STAT4-pY693_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN670_STAT4-pY693_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN670_STAT4-pY693_P-SiteMatch.jpg"]
["PN672","STAT5A-pS780","http://www.kinexusproducts.ca/Images/images/PN672_STAT5A-pS780_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN672_STAT5A-pS780_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN672_STAT5A-pS780_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN672_STAT5A-pS780_P-SiteMatch.jpg"]
["PN671","STAT5A-pY694","http://www.kinexusproducts.ca/Images/images/PN671_STAT5A-pY694_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN671_STAT5A-pY694_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN671_STAT5A-pY694_P-SiteMatch.jpg"]
["PN673","STAT6-pY641","http://www.kinexusproducts.ca/Images/images/PN673_STAT6-pY641_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN673_STAT6-pY641_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN673_STAT6-pY641_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN673_STAT6-pY641_P-SiteMatch.jpg","http://www.kinexusproducts.ca/Images/images/PN673_STAT6-pY641_P-SiteMatchTable.jpg"]
["PK821","Syk-pY323","http://www.kinexusproducts.ca/Images/images/PK821_Syk-pY323_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK821_Syk-pY323_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK821_Syk-pY323_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK821_Syk-pY323_P-SiteMatch.jpg"]
["PK822","Syk-pY352","http://www.kinexusproducts.ca/Images/images/PK822_Syk-pY352_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK822_Syk-pY352_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK822_Syk-pY352_P-SiteMatch.jpg"]
["PK823","Syk-pY525+pY526","http://www.kinexusproducts.ca/Images/images/PK823_Syk-pY525-pY526_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK823_Syk-pY525-pY526_P-SiteMatch.jpg"]
["NK175-3","TAK1-CT (TAK1-4)","http://www.kinexusproducts.ca/Images/images/NK175-3_TAK1-4_MouseTissues_Western.jpg"]
["PK824","TAK1-pS439","http://www.kinexusproducts.ca/Images/images/PK824_TAK1-pS439_HumanCells-EGF_WesternBlots.jpg","http://www.kinexusproducts.ca/Images/images/PK824_TAK1-pS439_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK824_TAK1-pS439_P-SIteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK824_TAK1-pS439_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK824_TAK1-pS439_P-SiteMatch.jpg"]
["PK825","TAK1-pT184+pT187","http://www.kinexusproducts.ca/Images/images/PK825_TAK1-pT184-pT187_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK825_TAK1-pT184-pT187_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK825_TAK1-pT184-pT187_P-SiteMatch.jpg"]
["PK826","TAO1-pS181","http://www.kinexusproducts.ca/Images/images/PK826_TAO1-pS181_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK826_TAO1-pS181_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK826_TAO1-pS181_P-SiteMatch.jpg"]
["PK827","TAO1-pY309","http://www.kinexusproducts.ca/Images/images/PK827_TAO1-pY309_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK827_TAO1-pY309_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK827_TAO1-pY309_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK827_TAO1-pY309_P-SiteMatch.jpg"]
["NK087-2","TAOK3-AKCD","http://www.kinexusproducts.ca/Images/images/NK087-2_TAOK3-AKCD_Tissues-Cells_Western.jpg"]
["PN674","TARDBP-pS409+pS410","http://www.kinexusproducts.ca/Images/images/PN674_TARDBP-pS409-pS410_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN674_TARDBP-pS409-pS410_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN674_TARDBP-pS409-pS410_P-SiteMatch.jpg"]
["PN540","TBC1D7-pY14","http://www.kinexusproducts.ca/Images/images/PN540_TBC1D7-pY14_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN540_TBC1D7-pY14_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN540_TBC1D7-pY14_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN540_TBC1D7-pY14_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN540_TBC1D7-pY14_P-SiteMatch.jpg"]
["PK828","TBK1-pS172","http://www.kinexusproducts.ca/Images/images/PK828_TBK1-pS172_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK828_TBK1-pS172_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK828_TBK1-pS172_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK828_TBK1-pS172_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK828_TBK1-pS172_P-SiteMatch.jpg"]
["PK829","TEC-pY519","http://www.kinexusproducts.ca/Images/images/PK829_TEC-pY519_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK829_TEC-pY519_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK829_TEC-pY519_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK829_TEC-pY519_P-SiteMatch.jpg"]
["PN675","TERF1-pT371","http://www.kinexusproducts.ca/Images/images/PN675_TERF1-pT371_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN675_TERF1-pT371_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN675_TERF1-pT371_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN675_TERF1-pT371_P-SiteMatch.jpg"]
["PN541","TGM2-pY369","http://www.kinexusproducts.ca/Images/images/PN541_TGM2-pY369_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN541_TGM2-pY369_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN541_TGM2-pY369_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN541_TGM2-pY369_P-SiteMatch.jpg"]
["PN731","TH-pS19","http://www.kinexusproducts.ca/Images/images/PN731_TH-pS19_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN731_TH-pS19_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN731_TH-pS19_P-SiteMatch.jpg"]
["PN730","TH-pS71","http://www.kinexusproducts.ca/Images/images/PN730_TH-pS71_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN730_TH-pS71_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN730_TH-pS71_P-SiteMatch.jpg"]
["PN676","THRAP3-pS253","http://www.kinexusproducts.ca/Images/images/PN676_THRAP3-pS253_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN676_THRAP3-pS253_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN676_THRAP3-pS253_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN676_THRAP3-pS253_P-SiteMatch.jpg"]
["PK830","TIE2-pY897","http://www.kinexusproducts.ca/Images/images/PK830_TIE2-pY897_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK830_TIE2-pY897_P-SiteMatch.jpg"]
["PK831","TIE2-pY992","http://www.kinexusproducts.ca/Images/images/PK831_TIE2-pY992_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK831_TIE2-pY992_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK831_TIE2-pY992_P-SiteMatch.jpg"]
["PN542","TLN1-pY70","http://www.kinexusproducts.ca/Images/images/PN542_TLN1-pY70_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN542_TLN1-pY70_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN542_TLN1-pY70_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN542_TLN1-pY70_P-SiteMatch.jpg"]
["PK832","TNK1-pY277","http://www.kinexusproducts.ca/Images/images/PK832_TNK1-pY277_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK832_TNK1-pY277_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK832_TNK1-pY277_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK832_TNK1-pY277_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK832_TNK1-pY277_P-SiteMatch.jpg"]
["PN677","TORC2-pS433","http://www.kinexusproducts.ca/Images/images/PN677_TORC2-pS433_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN677_TORC2-pS433_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN677_TORC2-pS433_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN677_TORC2-pS433_P-SiteMatch.jpg"]
["PN678","TP53BP1-pT1056","http://www.kinexusproducts.ca/Images/images/PN678_TP53BP1-pT1056_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN678_TP53BP1-pT1056_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN678_TP53BP1-pT1056_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN678_TP53BP1-pT1056_P-SiteMatch.jpg"]
["PK833","TRIM28-pS473","http://www.kinexusproducts.ca/Images/images/PK833_TRIM28-pS473_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK833_TRIM28-pS473_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK833_TRIM28-pS473_P-SiteMatch.jpg"]
["PK834","TRIM28-pY458","http://www.kinexusproducts.ca/Images/images/PK834_TRIM28-pY458_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK834_TRIM28-pY458_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK834_TRIM28-pY458_P-SiteMatch.jpg"]
["PK835","TRIM28-pY517","http://www.kinexusproducts.ca/Images/images/PK835_TRIM28-pY517_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK835_TRIM28-pY517_P-SiteMatch.jpg"]
["PK836","TRIM33-pS1119","http://www.kinexusproducts.ca/Images/images/PK836_TRIM33-pS1119_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK836_TRIM33-pS1119_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK836_TRIM33-pS1119_P-SiteMatch.jpg"]
["PK837","TrkA-pY680+pY681","http://www.kinexusproducts.ca/Images/images/PK837_TrkA-pY680-pY681_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK837_TrkA-pY680-pY681_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK837_TrkA-pY680-pY681_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK837_TrkA-pY680-pY681_P-SiteMatch.jpg"]
["PK838","TrkB-pY516","http://www.kinexusproducts.ca/Images/images/PK838_TrkB-pY516_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK838_TrkB-pY516_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK838_TrkB-pY516_P-SIteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK838_TrkB-pY516_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK838_TrkB-pY516_P-SiteMatch.jpg"]
["PK839","TrkB-pY702","http://www.kinexusproducts.ca/Images/images/PK839_TrkB-pY702_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK839_TrkB-pY702_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK839_TrkB-pY702_P-SiteMatch.jpg"]
["PK840","TrkC-pY709+pY710","http://www.kinexusproducts.ca/Images/images/PK840_TrkC-pY709-pY710_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK840_TrkC-pY709-pY710_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK840_TrkC-pY709-pY710_P-SiteMatch.jpg"]
["NK232-3","TRRAP-2","http://www.kinexusproducts.ca/Images/images/NK232-3_TRRAP-2_HumanCells_Western.jpg"]
["NK232-1","TRRAP-3","http://www.kinexusproducts.ca/Images/images/NK232-1_TRRAP-3_HumanCells_Western.jpg"]
["PK841","TSSK3-pT168","http://www.kinexusproducts.ca/Images/images/PK841_TSSK3-pT168_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK841_TSSK3-pT168_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK841_TSSK3-pT168_P-SiteMatch.jpg"]
["PK842","TTK-pS677","http://www.kinexusproducts.ca/Images/images/PK842_TTK-pS677_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK842_TTK-pS677_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK842_TTK-pS677_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK842_TTK-pS677_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK842_TTK-pS677_P-SiteMatch.jpg"]
["PK843","TTK-pY833+pY836","http://www.kinexusproducts.ca/Images/images/PK843_TTK-pY833-pY836_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK843_TTK-pY833-pY836_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK843_TTK-pY833-pY836_P-SiteMatch.jpg"]
["PK844","TXK-pY420","http://www.kinexusproducts.ca/Images/images/PK844_TXK-pY420_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK844_TXK-pY420_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK844_TXK-pY420_P-SiteMatch.jpg"]
["NK181-3","TYK2-1","http://www.kinexusproducts.ca/Images/images/NK181-3_TYK2-1_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK181-3_TYK2-1_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK181-3_TYK2-1_KinaseDotBlot.jpg"]
["NK181-5","TYK2-3","http://www.kinexusproducts.ca/Images/images/NK181-5_TYK2-3_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK181-5_TYK2-3_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK181-5_TYK2-3_KinaseDotBlot.jpg"]
["PK845","TYK2-pY1054+pY1055","http://www.kinexusproducts.ca/Images/images/PK845_TYK2-pY1054-pY1055_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK845_TYK2-pY1054-pY1055_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK845_TYK2-pY1054-pY1055_P-SiteMatch.jpg"]
["PK846","TYK2-pY292","http://www.kinexusproducts.ca/Images/images/PK846_TYK2-pY292_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK846_TYK2-pY292_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK846_TYK2-pY292_P-SiteMatch.jpg"]
["PK847","Tyro3-pY681","http://www.kinexusproducts.ca/Images/images/PK847_Tyro3-pY681_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK847_Tyro3-pY681_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK847_Tyro3-pY681_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK847_Tyro3-pY681_P-SiteMatch.jpg"]
["PK848","Tyro3-pY685+pY686","http://www.kinexusproducts.ca/Images/images/PK848_Tyro3-pY685-pY686_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK848_Tyro3-pY685-pY686_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK848_Tyro3-pY685-pY686_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK848_Tyro3-pY685-pY686_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK848_Tyro3-pY685-pY686_P-SiteMatch.jpg"]
["PN679","UBF-pS484","http://www.kinexusproducts.ca/Images/images/PN679_UBF-pS484_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN679_UBF-pS484_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN679_UBF-pS484_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN679_UBF-pS484_P-SiteMatch.jpg"]
["PN680","UBF-pT201","http://www.kinexusproducts.ca/Images/images/PN680_UBF-pT201_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN680_UBF-pT201_P-SiteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN680_UBF-pT201_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN680_UBF-pT201_P-SiteMatch.jpg"]
["NK298-1","ULK1-NT","http://www.kinexusproducts.ca/Images/images/NK298-1_ULK1-NT_Tissues-Cells_Western.jpg"]
["PK892","VACAMKL-pY245","http://www.kinexusproducts.ca/Images/images/PK892_VACAMKL-pY245_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK892_VACAMKL-pY245_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK892_VACAMKL-pY245_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK892_VACAMKL-pY245_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK892_VACAMKL-pY245_P-SiteMatch.jpg"]
["PN543","VAV1-pY826","http://www.kinexusproducts.ca/Images/images/PN543_VAV1-pY826_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN543_VAV1-pY826_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PN543_VAV1-pY826_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN543_VAV1-pY826_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN543_VAV1-pY826_P-SiteMatch.jpg"]
["NK226-2","VEGFR1-1","http://www.kinexusproducts.ca/Images/images/NK226-2_VEGFR1_HumanCell_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK226-2_VEGFR1-1_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK226-2_VEGFR1-1_KinaseDotBlot.jpg"]
["PK850","VEGFR1-pY1048","http://www.kinexusproducts.ca/Images/images/PK850_VEGFR1-pY1048_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK850_VEGFR1-pY1048_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK850_VEGFR1-pY1048_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK850_VEGFR1-pY1048_P-SiteMatch.jpg"]
["PK851","VEGFR1-pY1053","http://www.kinexusproducts.ca/Images/images/PK851_VEGFR1-pY1053_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK851_VEGFR1-pY1053_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK851_VEGFR1-pY1053_P-SIteSpecificitySPOTBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK851_VEGFR1-pY1053_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK851_VEGFR1-pY1053_P-SiteMatch.jpg"]
["NK245-2","VEGFR2-2","http://www.kinexusproducts.ca/Images/images/NK245-2_VEGFR2-2_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK245-2_VGFR2-2_KinaseDotBlot.jpg"]
["NK245-3","VEGFR2-3","http://www.kinexusproducts.ca/Images/images/NK245-3_VEGFR2-3_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK245-3_VEGFR2-3_HumanCells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/NK245-3_VEGFR2-3_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK245-3_VGFR2-3_KinaseDotBlot.jpg"]
["PK852","VEGFR2-pY1054","http://www.kinexusproducts.ca/Images/images/PK852_VEGFR2-pY1054_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK852_VEGFR2-pY1054_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK852_VEGFR2-pY1054_P-SiteMatch.jpg"]
["PK853","VEGFR3-pY1068","http://www.kinexusproducts.ca/Images/images/PK853_VEGFR3-pY1068_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK853_VEGFR3-pY1068_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK853_VEGFR3-pY1068_KinaseDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK853_VEGFR3-pY1068_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK853_VEGFR3-pY1068_P-SiteMatch.jpg"]
["NK064-2","VGFR3-1","http://www.kinexusproducts.ca/Images/images/NK064-2_VGFR3-1_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK064-2_VGFR3-1_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK064-2_VGFR3-1_KinaseDotBlot.jpg"]
["NK064-3","VGFR3-2","http://www.kinexusproducts.ca/Images/images/NK064-3_VGFR3-2_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK064-3_VGFR3-2_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK064-3_VGFR3-2_KinaseDotBlot.jpg"]
["PN544","VIM-pY117","http://www.kinexusproducts.ca/Images/images/PN544_VIM-pY117_MouseTissues-HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN544_VIM-pY117_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PN544_VIM-pY117_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN544_VIM-pY117_P-SiteMatch.jpg"]
["PN545","WASP-pY291","http://www.kinexusproducts.ca/Images/images/PN545_WASP-pY291_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN545_WASP-pY291_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN545_WASP-pY291_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN545_WASP-pY291_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN545_WASP-pY291_P-SiteMatch.jpg"]
["PK854","Wee1-pS642","http://www.kinexusproducts.ca/Images/images/PK854_Wee1-pS642_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK854_Wee1-pS642_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK854_Wee1-pS642_P-SiteMatch.jpg"]
["NK252-1","WNK1-1","http://www.kinexusproducts.ca/Images/images/NK252-1_WNK1-1_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK252-1_WNK1-1_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK252-1_WNK1-1_KinaseDotBlot.jpg"]
["NK252-3","WNK1-3","http://www.kinexusproducts.ca/Images/images/NK252-3_WNK1-3_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK252-3_WNK1-3_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/NK252-3_WNK1-3_KinaseDotBlot.jpg"]
["PK855","WNK1-pS382","http://www.kinexusproducts.ca/Images/images/PK855_WNK1-pS382_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK855_WNK1-pS382_MouseTissues_Western.jpg","http://www.kinexusproducts.ca/Images/images/PK855_WNK1-pS382_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK855_WNK1-pS382_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK855_WNK1-pS382_P-SiteMatch.jpg"]
["PK857","WNK1-pT2245","http://www.kinexusproducts.ca/Images/images/PK857_WNK1-pT2245_Cells_Western-2.jpg","http://www.kinexusproducts.ca/Images/images/PK857_WNK1-pT2245_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PK857_WNK1-pT2245_P-SiteMatch.jpg"]
["PK856","WNK1-pT60","PK856_WNK1-pT60_MouseTissues-HumanCells_Western.jpg","PK856_WNK1-pT60_Cells_Western-2.jpg","PK856_WNK1-pT60_P-SiteSpecificitySPOTDotBlot.jpg","PK856_WNK1-pT60_12DotBlot.jpg","PK856_WNK1-pT60_P-SiteMatch.jpg","",""]
["NK253-1","WNK2-1","NK253-1_WNK2-1_HumanCells_Western.jpg","NK253-1_WNK2-1_MouseTissues_Western.jpg","NK253-1_WNK2-1_KinaseDotBlot.jpg","","","",""]
["NK253-2","WNK2-2","NK253-2_WNK2-2_HumanCells_Western.jpg","NK253-2_WNK2-2_MouseTissues_Western.jpg","NK253-2_WNK2-2_KinaseDotBlot.jpg","","","",""]
["NK254-1","WNK3-1","NK254-1_WNK3-1_HumanCells_Western.jpg","NK254-1_WNK3-1_MouseTissues_Western.jpg","NK254-1_WNK3-1_KinaseDotBlot.jpg","","","",""]
["NK254-3","WNK3-3","NK254-3_WNK3-3_HumanCells_Western.jpg","NK254-3_WNK3-3_MouseTissues_Western.jpg","NK254-3_WNK3-3_KinaseDotBlot.jpg","","","",""]
["NK255-1","WNK4-1","NK255-1_WNK4-1_HumanCells_Western.jpg","NK255-1_WNK4-1_MouseTissues_Western.jpg","NK255-1_WNK4-1_KinaseDotBlot.jpg","","","",""]
["NK255-3","WNK4-3","NK255-3_WNK4-3_HumanCells_Western.jpg","NK255-3_WNK4-3_MouseTissues_Western.jpg","NK255-3_WNK4-3_KinaseDotBlot.jpg","","","",""]
["PN732","WT1-pS365","PN732_WT1-pS365_HumanCells_Western.jpg","PN732_WT1-pS365_MouseTissues_Western.jpg","PN732_WT1-pS365_P-SiteSpecificitySPOTDotBlot.jpg","PN732_WT1-pS365_P-SiteMatch.jpg","","",""]
["PN681","YAP1-pS109","http://www.kinexusproducts.ca/Images/images/PN681_YAP1-pS109_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN681_YAP1-pS109_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN681_YAP1-pS109_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN681_YAP1-pS109_P-SiteMatch.jpg","","",""]
["PN683","YAP1-pS127","http://www.kinexusproducts.ca/Images/images/PN683_YAP1-pS127_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN683_YAP1-pS127_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN683_YAP1-pS127_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN683_YAP1-pS127_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN683_YAP1-pS127_P-SiteMatch.jpg","",""]
["PN682","YAP1-pT119","http://www.kinexusproducts.ca/Images/images/PN682_YAP1-pT119_HumanCells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN682_YAP1-pT119_Tissues-Cells_Western.jpg","http://www.kinexusproducts.ca/Images/images/PN682_YAP1-pT119_P-SiteSpecificitySPOTDotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN682_YAP1-pT119_12DotBlot.jpg","http://www.kinexusproducts.ca/Images/images/PN682_YAP1-pT119_P-SiteMatch.jpg","",""]
["PK858","Yes-pY222+pY223","PK858_Yes-pY222-pY223_MouseTissues-HumanCells_Western.jpg","PK858_Yes-pY222-pY223_12DotBlot.jpg","PK858_Yes-pY222-pY223_P-SiteMatch.jpg","","","",""]
["PK859","YSK1-pT174","PK859_YSK1-pT174_MouseTissues-HumanCells_Western.jpg","PK859_YSK1-pT174_Cells_Western-2.jpg","PK859_YSK1-pT174_P-SiteSpecificitySPOTDotBlot.jpg","PK859_YSK1-pT174_12DotBlot.jpg","PK859_YSK1-pT174_P-SiteMatch.jpg","",""]
["NK256-2","YSK4-2","NK256-2_YSK4-2_HumanCells_Western.jpg","NK256-2_YSK4-2_MouseTissues_Western.jpg","NK256-2_YSK4-2_KinaseDotBlot.jpg","","","",""]
["NK256-3","YSK4-3","NK256-3_YSK4-3_HumanCells_Western.jpg","NK256-3_YSK4-3_MouseTissues_Western.jpg","NK256-3_YSK4-3_KinaseDotBlot.jpg","","","",""]
["PK860","ZAP70-pY248","PK860_ZAP70-pY248_MouseTissues-HumanCells_Western.jpg","PK860_ZAP70-pY248_P-SiteSpecificitySPOTDotBlot.jpg","PK860_ZAP70-pY248_12DotBlot.jpg","PK860_ZAP70-pY248_P-SiteMatch.jpg","","",""]
["PK861","ZAP70-pY292","PK861_ZAP70-pY292_HumanCells_Western.jpg","PK861_ZAP70-pY292_MouseTissues_Western.jpg","PK861_ZAP70-pY292_P-SIteSpecificitySPOTBlot.jpg","PK861_ZAP70-pY292_12DotBlot.jpg","PK861_ZAP70-pY292_P-SiteMatch.jpg","",""]
["PK862","ZAP70-pY319","PK862_ZAP70-pY319_HumanCells_Western.jpgpg","PK862_ZAP70-pY319_MouseTissues_Western.jpg","PK862_ZAP70-pY319_P-SiteSpecificitySPOTDotBlot.jpg","PK862_ZAP70-pY319_12DotBlot.jpg","PK862_ZAP70-pY319_P-SiteMatch.jpg","",""]
["PK863","ZAP70-pY492+pY493","PK863_ZAP70-pY492-pY493_HumanCells_Western.jpg","PK863_ZAP70-pY492-pY493_12DotBlot.jpg","PK863_ZAP70-pY492-pY493_P-SiteMatch.jpg","","","",""]
["NK301-1","ZC2-CT","NK301-1_ZC2-CT_Tissues-Cells_Western.jpg","","","","","",""]